CDISC SDTM Controlled Terminology CDISC SDTM Controlled Terminology, 2026-03-27 CDISC SDTM Controlled Terminology 10-Meter Walk/Run test code. TENMW1-Was Walk/Run Performed 10-Meter Walk/Run - Was the 10-meter walk/run performed? 10-Meter Walk/Run - Was Walk/Run Performed TENMW1-Time to Walk/Run 10 Meters 10-Meter Walk/Run - If yes, time to walk or run 10 meters. 10-Meter Walk/Run - Time to Walk/Run 10 Meters TENMW1-Wear Orthoses 10-Meter Walk/Run - If yes, did subject wear orthoses? 10-Meter Walk/Run - Wear Orthoses TENMW1-Test Grade 10-Meter Walk/Run - Test grade. 10-Meter Walk/Run - Test Grade TENMW1TC 10-Meter Walk/Run Functional Test Test Code CDISC Functional Test 10-Meter Walk/Run Test Code Terminology 10-Meter Walk/Run test name. TENMW1-Test Grade 10-Meter Walk/Run - Test grade. 10-Meter Walk/Run - Test Grade TENMW1-Time to Walk/Run 10 Meters 10-Meter Walk/Run - If yes, time to walk or run 10 meters. 10-Meter Walk/Run - Time to Walk/Run 10 Meters TENMW1-Was Walk/Run Performed 10-Meter Walk/Run - Was the 10-meter walk/run performed? 10-Meter Walk/Run - Was Walk/Run Performed TENMW1-Wear Orthoses 10-Meter Walk/Run - If yes, did subject wear orthoses? 10-Meter Walk/Run - Wear Orthoses TENMW1TN 10-Meter Walk/Run Functional Test Test Name CDISC Functional Test 10-Meter Walk/Run Test Name Terminology 4-Stair Ascend test code. A4STR1-Was 4-Stair Ascend Performed 4-Stair Ascend - Was the 4-stair ascend performed? 4-Stair Ascend - Was 4-Stair Ascend Performed A4STR1-Time to Do 4-Stair Ascend 4-Stair Ascend - If yes, time taken to do 4-stair ascend. 4-Stair Ascend - Time to Do 4-Stair Ascend A4STR1-Wear Orthoses 4-Stair Ascend - If yes, did subject wear orthoses? 4-Stair Ascend - Wear Orthoses A4STR1-Test Grade 4-Stair Ascend - Test grade. 4-Stair Ascend - Test Grade A4STR1TC 4-Stair Ascend Functional Test Test Code CDISC Functional Test 4-Stair Ascend Test Code Terminology 4-Stair Ascend test name. A4STR1-Test Grade 4-Stair Ascend - Test grade. 4-Stair Ascend - Test Grade A4STR1-Time to Do 4-Stair Ascend 4-Stair Ascend - If yes, time taken to do 4-stair ascend. 4-Stair Ascend - Time to Do 4-Stair Ascend A4STR1-Was 4-Stair Ascend Performed 4-Stair Ascend - Was the 4-stair ascend performed? 4-Stair Ascend - Was 4-Stair Ascend Performed A4STR1-Wear Orthoses 4-Stair Ascend - If yes, did subject wear orthoses? 4-Stair Ascend - Wear Orthoses A4STR1TN 4-Stair Ascend Functional Test Test Name CDISC Functional Test 4-Stair Ascend Test Name Terminology 4-Stair Descend test code. D4STR1-Was 4-Stair Descend Performed 4-Stair Descend - Was the 4-stair descend performed? 4-Stair Descend - Was 4-Stair Descend Performed D4STR1-Time to Do 4-Stair Descend 4-Stair Descend - If yes, time taken to do 4-stair descend. 4-Stair Descend - Time to Do 4-Stair Descend D4STR1-Wear Orthoses 4-Stair Descend - If yes, did subject wear orthoses? 4-Stair Descend - Wear Orthoses D4STR1-Test Grade 4-Stair Descend - Test grade. 4-Stair Descend - Test Grade D4STR1TC 4-Stair Descend Functional Test Test Code CDISC Functional Test 4-Stair Descend Test Code Terminology 4-Stair Descend test name. D4STR1-Test Grade 4-Stair Descend - Test grade. 4-Stair Descend - Test Grade D4STR1-Time to Do 4-Stair Descend 4-Stair Descend - If yes, time taken to do 4-stair descend. 4-Stair Descend - Time to Do 4-Stair Descend D4STR1-Was 4-Stair Descend Performed 4-Stair Descend - Was the 4-stair descend performed? 4-Stair Descend - Was 4-Stair Descend Performed D4STR1-Wear Orthoses 4-Stair Descend - If yes, did subject wear orthoses? 4-Stair Descend - Wear Orthoses D4STR1TN 4-Stair Descend Functional Test Test Name CDISC Functional Test 4-Stair Descend Test Name Terminology 6 Minute Walk Test test code. SIXMW1-Distance at 1 Minute 6 Minute Walk Test - Distance at 1 minute. 6MWT - Distance at 1 Minute SIXMW1-Distance at 2 Minutes 6 Minute Walk Test - Distance at 2 minutes. 6MWT - Distance at 2 Minutes SIXMW1-Distance at 3 Minutes 6 Minute Walk Test - Distance at 3 minutes. 6MWT - Distance at 3 Minutes SIXMW1-Distance at 4 Minutes 6 Minute Walk Test - Distance at 4 minutes. 6MWT - Distance at 4 Minutes SIXMW1-Distance at 5 Minutes 6 Minute Walk Test - Distance at 5 minutes. 6MWT - Distance at 5 Minutes SIXMW1-Distance at 6 Minutes 6 Minute Walk Test - Distance at 6 minutes. 6MWT - Distance at 6 Minutes SIXMW1TC 6 Minute Walk Functional Test Test Code CDISC Functional Test 6MWT Test Code Terminology 6 Minute Walk Test test name. SIXMW1-Distance at 1 Minute 6 Minute Walk Test - Distance at 1 minute. 6MWT - Distance at 1 Minute SIXMW1-Distance at 2 Minutes 6 Minute Walk Test - Distance at 2 minutes. 6MWT - Distance at 2 Minutes SIXMW1-Distance at 3 Minutes 6 Minute Walk Test - Distance at 3 minutes. 6MWT - Distance at 3 Minutes SIXMW1-Distance at 4 Minutes 6 Minute Walk Test - Distance at 4 minutes. 6MWT - Distance at 4 Minutes SIXMW1-Distance at 5 Minutes 6 Minute Walk Test - Distance at 5 minutes. 6MWT - Distance at 5 Minutes SIXMW1-Distance at 6 Minutes 6 Minute Walk Test - Distance at 6 minutes. 6MWT - Distance at 6 Minutes SIXMW1TN 6 Minute Walk Functional Test Test Name CDISC Functional Test 6MWT Test Name Terminology Abnormal Involuntary Movement Scale original result for AIMS0101 through AIMS0107 test and test code. AIMS0101 through AIMS0107-Mild Abnormal Involuntary Movement Scale original result for AIMS0101 through AIMS0107-Mild. Abnormal Involuntary Movement Scale AIMS0101 Through AIMS0107 Original Result - Mild AIMS0101 through AIMS0107-Minimal, may be extreme normal Abnormal Involuntary Movement Scale original result for AIMS0101 through AIMS0107-Minimal, may be extreme normal. Abnormal Involuntary Movement Scale AIMS0101 Through AIMS0107 Original Result - Minimal, may be extreme normal AIMS0101 through AIMS0107-Moderate Abnormal Involuntary Movement Scale original result for AIMS0101 through AIMS0107-Moderate. Abnormal Involuntary Movement Scale AIMS0101 Through AIMS0107 Original Result - Moderate AIMS0101 through AIMS0107-None Abnormal Involuntary Movement Scale original result for AIMS0101 through AIMS0107-None. Abnormal Involuntary Movement Scale AIMS0101 Through AIMS0107 Original Result - None AIMS0101 through AIMS0107-Severe Abnormal Involuntary Movement Scale original result for AIMS0101 through AIMS0107-Severe. Abnormal Involuntary Movement Scale AIMS0101 Through AIMS0107 Original Result - Severe AIMS0101T07OR Abnormal Involuntary Movement Scale Clinical Classification ORRES for AIMS0101 Through AIMS0107 TN/TC CDISC Clinical Classification Abnormal Involuntary Movement Scale AIMS0101 Through AIMS0107 Original Response Terminology Abnormal Involuntary Movement Scale original result for AIMS0108 through AIMS0109 test and test code. AIMS0108 through AIMS0109-Mild Abnormal Involuntary Movement Scale original result for AIMS0108 through AIMS0109-Mild. Abnormal Involuntary Movement Scale AIMS0108 Through AIMS0109 Original Result - Mild AIMS0108 through AIMS0109-Minimal Abnormal Involuntary Movement Scale original result for AIMS0108 through AIMS0109-Minimal. Abnormal Involuntary Movement Scale AIMS0108 Through AIMS0109 Original Result - Minimal AIMS0108 through AIMS0109-Moderate Abnormal Involuntary Movement Scale original result for AIMS0108 through AIMS0109-Moderate. Abnormal Involuntary Movement Scale AIMS0108 Through AIMS0109 Original Result - Moderate AIMS0108 through AIMS0109-None, normal Abnormal Involuntary Movement Scale original result for AIMS0108 through AIMS0109-None, normal. Abnormal Involuntary Movement Scale AIMS0108 Through AIMS0109 Original Result - None, normal AIMS0108 through AIMS0109-Severe Abnormal Involuntary Movement Scale original result for AIMS0108 through AIMS0109-Severe. Abnormal Involuntary Movement Scale AIMS0108 Through AIMS0109 Original Result - Severe AIMS0108T09OR Abnormal Involuntary Movement Scale Clinical Classification ORRES for AIMS0108 Through AIMS0109 TN/TC CDISC Clinical Classification Abnormal Involuntary Movement Scale AIMS0108 Through AIMS0109 Original Response Terminology Abnormal Involuntary Movement Scale original result for AIMS0110 test and test code. AIMS0110-Aware, mild distress Abnormal Involuntary Movement Scale original result for AIMS0110-Aware, mild distress. Abnormal Involuntary Movement Scale AIMS0110 Original Result - Aware, mild distress AIMS0110-Aware, moderate distress Abnormal Involuntary Movement Scale original result for AIMS0110-Aware, moderate distress. Abnormal Involuntary Movement Scale AIMS0110 Original Result - Aware, moderate distress AIMS0110-Aware, no distress Abnormal Involuntary Movement Scale original result for AIMS0110-Aware, no distress. Abnormal Involuntary Movement Scale AIMS0110 Original Result - Aware, no distress AIMS0110-Aware, severe distress Abnormal Involuntary Movement Scale original result for AIMS0110-Aware, severe distress. Abnormal Involuntary Movement Scale AIMS0110 Original Result - Aware, severe distress AIMS0110-No awareness Abnormal Involuntary Movement Scale original result for AIMS0110-No awareness. Abnormal Involuntary Movement Scale AIMS0110 Original Result - No awareness AIMS0110OR Abnormal Involuntary Movement Scale Clinical Classification ORRES for AIMS0110 TN/TC CDISC Clinical Classification Abnormal Involuntary Movement Scale AIMS0110 Original Response Terminology Abnormal Involuntary Movement Scale original result for AIMS0111 through AIMS0112 test and test code. AIMS0111 through AIMS0112-No Abnormal Involuntary Movement Scale original result for AIMS0111 through AIMS0112-No. Abnormal Involuntary Movement Scale AIMS0111 Through AIMS0112 Original Result - No AIMS0111 through AIMS0112-Yes Abnormal Involuntary Movement Scale original result for AIMS0111 through AIMS0112-Yes. Abnormal Involuntary Movement Scale AIMS0111 Through AIMS0112 Original Result - Yes AIMS0111T12OR Abnormal Involuntary Movement Scale Clinical Classification ORRES for AIMS0111 Through AIMS0112 TN/TC CDISC Clinical Classification Abnormal Involuntary Movement Scale AIMS0111 Through AIMS0112 Original Response Terminology Abnormal Involuntary Movement Scale standardized character result for AIMS0101 through AIMS0107 test and test code. AIMS0101 through AIMS0107-0 Abnormal Involuntary Movement Scale standardized character result for AIMS0101 through AIMS0107-None. Abnormal Involuntary Movement Scale AIMS0101 Through AIMS0107 Standardized Character Result 0 AIMS0101 through AIMS0107-1 Abnormal Involuntary Movement Scale standardized character result for AIMS0101 through AIMS0107-Minimal, may be extreme normal . Abnormal Involuntary Movement Scale AIMS0101 Through AIMS0107 Standardized Character Result 1 AIMS0101 through AIMS0107-2 Abnormal Involuntary Movement Scale standardized character result for AIMS0101 through AIMS0107-Mild. Abnormal Involuntary Movement Scale AIMS0101 Through AIMS0107 Standardized Character Result 2 AIMS0101 through AIMS0107-3 Abnormal Involuntary Movement Scale standardized character result for AIMS0101 through AIMS0107-Moderate. Abnormal Involuntary Movement Scale AIMS0101 Through AIMS0107 Standardized Character Result 3 AIMS0101 through AIMS0107-4 Abnormal Involuntary Movement Scale standardized character result for AIMS0101 through AIMS0107-Severe. Abnormal Involuntary Movement Scale AIMS0101 Through AIMS0107 Standardized Character Result 4 AIMS0101T07STR Abnormal Involuntary Movement Scale Clinical Classification STRESC for AIMS0101 Through AIMS0107 TN/TC CDISC Clinical Classification Abnormal Involuntary Movement Scale AIMS0101 Through AIMS0107 Standardized Character Response Terminology Abnormal Involuntary Movement Scale standardized character result for AIMS0108 through AIMS0109 test and test code. AIMS0108 through AIMS0109-0 Abnormal Involuntary Movement Scale standardized character result for AIMS0108 through AIMS0109-None, normal. Abnormal Involuntary Movement Scale AIMS0108 Through AIMS0109 Standardized Character Result 0 AIMS0108 through AIMS0109-1 Abnormal Involuntary Movement Scale standardized character result for AIMS0108 through AIMS0109-Minimal. Abnormal Involuntary Movement Scale AIMS0108 Through AIMS0109 Standardized Character Result 1 AIMS0108 through AIMS0109-2 Abnormal Involuntary Movement Scale standardized character result for AIMS0108 through AIMS0109-Mild. Abnormal Involuntary Movement Scale AIMS0108 Through AIMS0109 Standardized Character Result 2 AIMS0108 through AIMS0109-3 Abnormal Involuntary Movement Scale standardized character result for AIMS0108 through AIMS0109-Moderate. Abnormal Involuntary Movement Scale AIMS0108 Through AIMS0109 Standardized Character Result 3 AIMS0108 through AIMS0109-4 Abnormal Involuntary Movement Scale standardized character result for AIMS0108 through AIMS0109-Severe. Abnormal Involuntary Movement Scale AIMS0108 Through AIMS0109 Standardized Character Result 4 AIMS0108T09STR Abnormal Involuntary Movement Scale Clinical Classification STRESC for AIMS0108 Through AIMS0109 TN/TC CDISC Clinical Classification Abnormal Involuntary Movement Scale AIMS0108 Through AIMS0109 Standardized Character Response Terminology Abnormal Involuntary Movement Scale standardized character result for AIMS0110 test and test code. AIMS0110-0 Abnormal Involuntary Movement Scale standardized character result for AIMS0110-No awareness. Abnormal Involuntary Movement Scale AIMS0110 Standardized Character Result 0 AIMS0110-1 Abnormal Involuntary Movement Scale standardized character result for AIMS0110-Aware, no distress. Abnormal Involuntary Movement Scale AIMS0110 Standardized Character Result 1 AIMS0110-2 Abnormal Involuntary Movement Scale standardized character result for AIMS0110-Aware, mild distress. Abnormal Involuntary Movement Scale AIMS0110 Standardized Character Result 2 AIMS0110-3 Abnormal Involuntary Movement Scale standardized character result for AIMS0110-Aware, moderate distress. Abnormal Involuntary Movement Scale AIMS0110 Standardized Character Result 3 AIMS0110-4 Abnormal Involuntary Movement Scale standardized character result for AIMS0110-Aware, severe distress. Abnormal Involuntary Movement Scale AIMS0110 Standardized Character Result 4 AIMS0110STR Abnormal Involuntary Movement Scale Clinical Classification STRESC for AIMS0110 TN/TC CDISC Clinical Classification Abnormal Involuntary Movement Scale AIMS0110 Standardized Character Response Terminology Abnormal Involuntary Movement Scale standardized character result for AIMS0111 through AIMS0112 test and test code. AIMS0111 through AIMS0112-0 Abnormal Involuntary Movement Scale standardized character result for AIMS0111 through AIMS0112-No. Abnormal Involuntary Movement Scale AIMS0111 through AIMS0112 Standardized Character Result 0 AIMS0111 through AIMS0112-1 Abnormal Involuntary Movement Scale standardized character result for AIMS0111 through AIMS0112-Yes. Abnormal Involuntary Movement Scale AIMS0111 through AIMS0112 Standardized Character Result 1 AIMS0111T12STR Abnormal Involuntary Movement Scale Clinical Classification STRESC for AIMS0111 Through AIMS0112 TN/TC CDISC Clinical Classification Abnormal Involuntary Movement Scale AIMS0111 Through AIMS0112 Standardized Character Response Terminology Abnormal Involuntary Movement Scale test code. AIMS01-Muscles of Facial Expression Abnormal Involuntary Movement Scale - Facial and Oral Movements, Muscles of facial expression, e.g., movements of forehead, eyebrows, periorbital area, cheeks. Include frowning, blinking, grimacing of upper face. AIMS - Muscles of Facial Expression AIMS01-Lips and Perioral Area Abnormal Involuntary Movement Scale - Facial and Oral Movements, Lips and perioral area, e.g., puckering, pouting, smacking. AIMS - Lips and Perioral Area AIMS01-Jaw Abnormal Involuntary Movement Scale - Facial and Oral Movements, Jaw, e.g., biting, clenching, chewing, mouth opening, lateral movement. AIMS - Jaw AIMS01-Tongue Abnormal Involuntary Movement Scale - Facial and Oral Movements, Tongue. Rate only increase in movement both in and out of mouth, not inability to sustain movement. AIMS - Tongue AIMS01-Upper Extremities Abnormal Involuntary Movement Scale - Extremity Movements, Upper (arms, wrists, hands, fingers). Include movements that are choreic (rapid, objectively purposeless, irregular, spontaneous) or athetoid (slow, irregular, complex, serpentine). Do not include tremor (repetitive, regular, rhythmic movements). AIMS - Upper Extremities AIMS01-Lower Extremities Abnormal Involuntary Movement Scale - Extremity Movements, Lower (legs, knees, ankles, toes), e.g., lateral knee movement, foot tapping, heel dropping, foot squirming, inversion and eversion of foot. AIMS - Lower Extremities AIMS01-Neck, Shoulders, Hips Abnormal Involuntary Movement Scale - Trunk Movements, Neck, shoulders, hips, e.g., rocking, twisting, squirming, pelvic gyrations. Include diaphragmatic movements. AIMS - Neck, Shoulders, Hips AIMS01-Severity of Abnormal Movements Abnormal Involuntary Movement Scale - Global Judgments, Severity of abnormal movements, based on the highest single score on the above items. AIMS - Severity of Abnormal Movements AIMS01-Incapacitation due Abn Movements Abnormal Involuntary Movement Scale - Global Judgments, Incapacitation due to abnormal movements. AIMS - Incapacitation Due to Abnormal Movements AIMS01-Patient Awareness Abn Movements Abnormal Involuntary Movement Scale - Global Judgments, Patient's awareness of abnormal movements. AIMS - Patient's Awareness of Abnormal Movements AIMS01-Current Problems Teeth/Dentures Abnormal Involuntary Movement Scale - Dental Status, Current problems with teeth and/or dentures. AIMS - Current Teeth/Dentures Problems AIMS01-Patient Usually Wear Dentures Abnormal Involuntary Movement Scale - Dental Status, Does patient usually wear dentures? AIMS - Patient Usually Wears Dentures AIMS01TC Abnormal Involuntary Movement Scale Clinical Classification Test Code CDISC Clinical Classification AIMS Test Code Terminology Abnormal Involuntary Movement Scale test name. AIMS01-Current Problems Teeth/Dentures Abnormal Involuntary Movement Scale - Dental Status, Current problems with teeth and/or dentures. AIMS - Current Teeth/Dentures Problems AIMS01-Incapacitation due Abn Movements Abnormal Involuntary Movement Scale - Global Judgments, Incapacitation due to abnormal movements. AIMS - Incapacitation Due to Abnormal Movements AIMS01-Jaw Abnormal Involuntary Movement Scale - Facial and Oral Movements, Jaw, e.g., biting, clenching, chewing, mouth opening, lateral movement. AIMS - Jaw AIMS01-Lips and Perioral Area Abnormal Involuntary Movement Scale - Facial and Oral Movements, Lips and perioral area, e.g., puckering, pouting, smacking. AIMS - Lips and Perioral Area AIMS01-Lower Extremities Abnormal Involuntary Movement Scale - Extremity Movements, Lower (legs, knees, ankles, toes), e.g., lateral knee movement, foot tapping, heel dropping, foot squirming, inversion and eversion of foot. AIMS - Lower Extremities AIMS01-Muscles of Facial Expression Abnormal Involuntary Movement Scale - Facial and Oral Movements, Muscles of facial expression, e.g., movements of forehead, eyebrows, periorbital area, cheeks. Include frowning, blinking, grimacing of upper face. AIMS - Muscles of Facial Expression AIMS01-Neck, Shoulders, Hips Abnormal Involuntary Movement Scale - Trunk Movements, Neck, shoulders, hips, e.g., rocking, twisting, squirming, pelvic gyrations. Include diaphragmatic movements. AIMS - Neck, Shoulders, Hips AIMS01-Patient Awareness Abn Movements Abnormal Involuntary Movement Scale - Global Judgments, Patient's awareness of abnormal movements. AIMS - Patient's Awareness of Abnormal Movements AIMS01-Patient Usually Wear Dentures Abnormal Involuntary Movement Scale - Dental Status, Does patient usually wear dentures? AIMS - Patient Usually Wears Dentures AIMS01-Severity of Abnormal Movements Abnormal Involuntary Movement Scale - Global Judgments, Severity of abnormal movements, based on the highest single score on the above items. AIMS - Severity of Abnormal Movements AIMS01-Tongue Abnormal Involuntary Movement Scale - Facial and Oral Movements, Tongue. Rate only increase in movement both in and out of mouth, not inability to sustain movement. AIMS - Tongue AIMS01-Upper Extremities Abnormal Involuntary Movement Scale - Extremity Movements, Upper (arms, wrists, hands, fingers). Include movements that are choreic (rapid, objectively purposeless, irregular, spontaneous) or athetoid (slow, irregular, complex, serpentine). Do not include tremor (repetitive, regular, rhythmic movements). AIMS - Upper Extremities AIMS01TN Abnormal Involuntary Movement Scale Clinical Classification Test Name CDISC Clinical Classification AIMS Test Name Terminology Terminology relevant to the role of the individual or entity responsible for the receipt of the transferred object (e.g., device, specimen). Site Any healthcare organization, institution, facility or provider directly involved in conducting or facilitating a particular clinical study. Clinical Study Site A person or group that facilitates the exchange of items or information. Courier The location at which a study investigator conducts study activities. Study Site An organization with the capability and competency to perform scientific research, experiments, and measurements. (BRIDG) Laboratory Manufacturer The organization defined as being responsible for creating the product as stated on the package in which the product is supplied. (BRIDG) Manufacturer Clinical Study Sponsor Sponsor Study Sponsor An individual, company, institution, or organization that takes responsibility for the initiation, management, and/or financing of a clinical study. [After ICH E6, WHO, 21 CFR 50.3 (e), and after IDMP] Clinical Study Sponsor The organization that manages the storage of items. Storage Facility An individual who is observed, analyzed, examined, investigated, experimented upon, or/and treated in the course of a particular study. Study Subject ACCPARTY Accountable Party CDISC SDTM Accountable Party Terminology Terminology specifying changes to the study treatment as a result of an adverse event. An indication that a medication schedule was modified by addition; either by changing the frequency, strength or amount. (NCI) Dose Increased An indication that a medication schedule was maintained. (NCI) Dose Not Changed An indication that the administration of a medication was modified by reducing the rate at which the dose was given, without reducing the total dose administered. Dose Rate Reduced An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount. (NCI) Dose Reduced An indication that a medication schedule was modified by temporarily terminating a prescribed regimen of medication. (NCI) Drug Interrupted An indication that a medication schedule was modified through termination of a prescribed regimen of medication. (NCI) Drug Withdrawn NA Not Applicable Determination of a value is not relevant in the current context. (NCI) Not Applicable U UNK Unknown Not known, not observed, not recorded, or refused. (NCI) Unknown ACN Action Taken with Study Treatment CDISC SDTM Action Taken with Study Treatment Terminology Terminology specifying changes to product usage as a result of an adverse experience. NA Not Applicable Determination of a value is not relevant in the current context. (NCI) Not Applicable An indication that product usage was increased, either by changing the frequency, strength or amount. Product Increased An indication that product usage was temporarily halted. Product Interrupted An indication that product usage was maintained. Product Not Changed Product Decreased An indication that product usage was decreased, either by changing the frequency, strength or amount. Product Reduced An indication that product usage was permanently halted. Product Stopped U UNK Unknown Not known, not observed, not recorded, or refused. (NCI) Unknown TPACN Action Taken with Tobacco Product CDISC SDTM Action Taken with Tobacco Product Terminology A classification of the presentation of acute coronary syndrome. NON-STEMI NSTEMI A myocardial infarction that does not produce elevation in the ST segments of the ECG. Non-ST Elevation Myocardial Infarction by ECG Finding STEMI A myocardial infarction that produces elevation in the ST segments of the ECG. ST Elevation Myocardial Infarction by ECG Finding Angina pectoris which has not recently changed in frequency, duration or intensity. Stable angina pectoris is relieved by rest or administration of oral, sublingual or transdermal antianginal medications. Stable Angina Angina pectoris (or equivalent type of ischemic discomfort) which has recently changed in frequency, duration, intensity, or occurs at rest. Unstable Angina ACSPCAT Acute Coronary Syndrome Presentation Category CDISC SDTM Acute Coronary Syndrome Presentation Category Terminology Acute Physiology and Chronic Health Evaluation II original result for APCH101 test and test code. APCH101-30-31.9 Acute Physiology and Chronic Health Evaluation II original result for APCH101-30-31.9. Acute Physiology and Chronic Health Evaluation II APCH101 Original Result - 30-31.9 APCH101-32-33.9 Acute Physiology and Chronic Health Evaluation II original result for APCH101-32-33.9. Acute Physiology and Chronic Health Evaluation II APCH101 Original Result - 32-33.9 APCH101-34-35.9 Acute Physiology and Chronic Health Evaluation II original result for APCH101-34-35.9. Acute Physiology and Chronic Health Evaluation II APCH101 Original Result - 34-35.9 APCH101-36-38.4 Acute Physiology and Chronic Health Evaluation II original result for APCH101-36-38.4. Acute Physiology and Chronic Health Evaluation II APCH101 Original Result - 36-38.4 APCH101-38.5-38.9 Acute Physiology and Chronic Health Evaluation II original result for APCH101-38.5-38.9. Acute Physiology and Chronic Health Evaluation II APCH101 Original Result - 38.5-38.9 APCH101-39-40.9 Acute Physiology and Chronic Health Evaluation II original result for APCH101-39-40.9. Acute Physiology and Chronic Health Evaluation II APCH101 Original Result - 39-40.9 APCH101-<=29.9 Acute Physiology and Chronic Health Evaluation II original result for APCH101-Less than or equal to 29.9. Acute Physiology and Chronic Health Evaluation II APCH101 Original Result - <=29.9 APCH101->=41 Acute Physiology and Chronic Health Evaluation II original result for APCH101-Greater than or equal to 41. Acute Physiology and Chronic Health Evaluation II APCH101 Original Result - >=41 APCH101OR Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH101 TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH101 Original Response Terminology Acute Physiology and Chronic Health Evaluation II original result for APCH102 test and test code. APCH102-110-129 Acute Physiology and Chronic Health Evaluation II original result for APCH102-110-129. Acute Physiology and Chronic Health Evaluation II APCH102 Original Result - 110-129 APCH102-130-159 Acute Physiology and Chronic Health Evaluation II original result for APCH102-130-159. Acute Physiology and Chronic Health Evaluation II APCH102 Original Result - 130-159 APCH102-50-69 Acute Physiology and Chronic Health Evaluation II original result for APCH102-50-69. Acute Physiology and Chronic Health Evaluation II APCH102 Original Result - 50-69 APCH102-70-109 Acute Physiology and Chronic Health Evaluation II original result for APCH102-70-109. Acute Physiology and Chronic Health Evaluation II APCH102 Original Result - 70-109 APCH102-<=49 Acute Physiology and Chronic Health Evaluation II original result for APCH102-Less than or equal to 49. Acute Physiology and Chronic Health Evaluation II APCH102 Original Result - <=49 APCH102->=160 Acute Physiology and Chronic Health Evaluation II original result for APCH102-Greater than or equal to 160. Acute Physiology and Chronic Health Evaluation II APCH102 Original Result - >=160 APCH102OR Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH102 TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH102 Original Response Terminology Acute Physiology and Chronic Health Evaluation II original result for APCH103 test and test code. APCH103-110-139 Acute Physiology and Chronic Health Evaluation II original result for APCH103-110-139. Acute Physiology and Chronic Health Evaluation II APCH103 Original Result - 110-139 APCH103-140-179 Acute Physiology and Chronic Health Evaluation II original result for APCH103-140-179. Acute Physiology and Chronic Health Evaluation II APCH103 Original Result - 140-179 APCH103-40-54 Acute Physiology and Chronic Health Evaluation II original result for APCH103-40-54. Acute Physiology and Chronic Health Evaluation II APCH103 Original Result - 40-54 APCH103-55-69 Acute Physiology and Chronic Health Evaluation II original result for APCH103-55-69. Acute Physiology and Chronic Health Evaluation II APCH103 Original Result - 55-69 APCH103-70-109 Acute Physiology and Chronic Health Evaluation II original result for APCH103-70-109. Acute Physiology and Chronic Health Evaluation II APCH103 Original Result - 70-109 APCH103-<=39 Acute Physiology and Chronic Health Evaluation II original result for APCH103-Less than or equal to 39. Acute Physiology and Chronic Health Evaluation II APCH103 Original Result - <=39 APCH103->=180 Acute Physiology and Chronic Health Evaluation II original result for APCH103-Greater than or equal to 180. Acute Physiology and Chronic Health Evaluation II APCH103 Original Result - >=180 APCH103OR Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH103 TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH103 Original Response Terminology Acute Physiology and Chronic Health Evaluation II original result for APCH104 test and test code. APCH104-10-11 Acute Physiology and Chronic Health Evaluation II original result for APCH104-10-11. Acute Physiology and Chronic Health Evaluation II APCH104 Original Result - 10-11 APCH104-12-24 Acute Physiology and Chronic Health Evaluation II original result for APCH104-12-24. Acute Physiology and Chronic Health Evaluation II APCH104 Original Result - 12-24 APCH104-25-34 Acute Physiology and Chronic Health Evaluation II original result for APCH104-25-34. Acute Physiology and Chronic Health Evaluation II APCH104 Original Result - 25-34 APCH104-35-49 Acute Physiology and Chronic Health Evaluation II original result for APCH104-35-49. Acute Physiology and Chronic Health Evaluation II APCH104 Original Result - 35-49 APCH104-6-9 Acute Physiology and Chronic Health Evaluation II original result for APCH104-6-9. Acute Physiology and Chronic Health Evaluation II APCH104 Original Result - 6-9 APCH104-<=5 Acute Physiology and Chronic Health Evaluation II original result for APCH104-Less than or equal to 5. Acute Physiology and Chronic Health Evaluation II APCH104 Original Result - <=5 APCH104->=50 Acute Physiology and Chronic Health Evaluation II original result for APCH104-Greater than or equal to 50. Acute Physiology and Chronic Health Evaluation II APCH104 Original Result - >=50 APCH104OR Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH104 TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH104 Original Response Terminology Acute Physiology and Chronic Health Evaluation II original result for APCH105A test and test code. APCH105A-200-349 Acute Physiology and Chronic Health Evaluation II original result for APCH105A-200-349. Acute Physiology and Chronic Health Evaluation II APCH105A Original Result - 200-349 APCH105A-350-499 Acute Physiology and Chronic Health Evaluation II original result for APCH105A-350-499. Acute Physiology and Chronic Health Evaluation II APCH105A Original Result - 350-499 APCH105A-<200 Acute Physiology and Chronic Health Evaluation II original result for APCH105A-Less than 200. Acute Physiology and Chronic Health Evaluation II APCH105A Original Result - <200 APCH105A->=500 Acute Physiology and Chronic Health Evaluation II original result for APCH105A-Greater than or equal to 500. Acute Physiology and Chronic Health Evaluation II APCH105A Original Result - >=500 APCH105AOR Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH105A TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH105A Original Response Terminology Acute Physiology and Chronic Health Evaluation II original result for APCH105B test and test code. APCH105B-55-60 Acute Physiology and Chronic Health Evaluation II original result for APCH105B-55-60. Acute Physiology and Chronic Health Evaluation II APCH105B Original Result - 55-60 APCH105B-61-70 Acute Physiology and Chronic Health Evaluation II original result for APCH105B-61-70. Acute Physiology and Chronic Health Evaluation II APCH105B Original Result - 61-70 APCH105B-<55 Acute Physiology and Chronic Health Evaluation II original result for APCH105B-Less than 55. Acute Physiology and Chronic Health Evaluation II APCH105B Original Result - <55 APCH105B->70 Acute Physiology and Chronic Health Evaluation II original result for APCH105B-Greater than 70. Acute Physiology and Chronic Health Evaluation II APCH105B Original Result - >70 APCH105BOR Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH105B TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH105B Original Response Terminology Acute Physiology and Chronic Health Evaluation II original result for APCH106A test and test code. APCH106A-7.15-7.24 Acute Physiology and Chronic Health Evaluation II original result for APCH106A-7.15-7.24. Acute Physiology and Chronic Health Evaluation II APCH106A Original Result - 7.15-7.24 APCH106A-7.25-7.32 Acute Physiology and Chronic Health Evaluation II original result for APCH106A-7.25-7.32. Acute Physiology and Chronic Health Evaluation II APCH106A Original Result - 7.25-7.32 APCH106A-7.33-7.49 Acute Physiology and Chronic Health Evaluation II original result for APCH106A-7.33-7.49. Acute Physiology and Chronic Health Evaluation II APCH106A Original Result - 7.33-7.49 APCH106A-7.5-7.59 Acute Physiology and Chronic Health Evaluation II original result for APCH106A-7.5-7.59. Acute Physiology and Chronic Health Evaluation II APCH106A Original Result - 7.5-7.59 APCH106A-7.6-7.69 Acute Physiology and Chronic Health Evaluation II original result for APCH106A-7.6-7.69. Acute Physiology and Chronic Health Evaluation II APCH106A Original Result - 7.6-7.69 APCH106A-<7.15 Acute Physiology and Chronic Health Evaluation II original result for APCH106A-Less than 7.15. Acute Physiology and Chronic Health Evaluation II APCH106A Original Result - <7.15 APCH106A->=7.7 Acute Physiology and Chronic Health Evaluation II original result for APCH106A-Greater than or equal to 7.7. Acute Physiology and Chronic Health Evaluation II APCH106A Original Result - >=7.7 APCH106AOR Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH106A TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH106A Original Response Terminology Acute Physiology and Chronic Health Evaluation II original result for APCH106B test and test code. APCH106B-15-17.9 Acute Physiology and Chronic Health Evaluation II original result for APCH106B-15-17.9. Acute Physiology and Chronic Health Evaluation II APCH106B Original Result - 15-17.9 APCH106B-18-21.9 Acute Physiology and Chronic Health Evaluation II original result for APCH106B-18-21.9. Acute Physiology and Chronic Health Evaluation II APCH106B Original Result - 18-21.9 APCH106B-22-31.9 Acute Physiology and Chronic Health Evaluation II original result for APCH106B-22-31.9. Acute Physiology and Chronic Health Evaluation II APCH106B Original Result - 22-31.9 APCH106B-32-40.9 Acute Physiology and Chronic Health Evaluation II original result for APCH106B-32-40.9. Acute Physiology and Chronic Health Evaluation II APCH106B Original Result - 32-40.9 APCH106B-41-51.9 Acute Physiology and Chronic Health Evaluation II original result for APCH106B-41-51.9. Acute Physiology and Chronic Health Evaluation II APCH106B Original Result - 41-51.9 APCH106B-<15 Acute Physiology and Chronic Health Evaluation II original result for APCH106B-Less than 15. Acute Physiology and Chronic Health Evaluation II APCH106B Original Result - <15 APCH106B->=52 Acute Physiology and Chronic Health Evaluation II original result for APCH106B-Greater than or equal to 52. Acute Physiology and Chronic Health Evaluation II APCH106B Original Result - >=52 APCH106BOR Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH106B TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH106B Original Response Terminology Acute Physiology and Chronic Health Evaluation II original result for APCH107 test and test code. APCH107-111-119 Acute Physiology and Chronic Health Evaluation II original result for APCH107-111-119. Acute Physiology and Chronic Health Evaluation II APCH107 Original Result - 111-119 APCH107-120-129 Acute Physiology and Chronic Health Evaluation II original result for APCH107-120-129. Acute Physiology and Chronic Health Evaluation II APCH107 Original Result - 120-129 APCH107-130-149 Acute Physiology and Chronic Health Evaluation II original result for APCH107-130-149. Acute Physiology and Chronic Health Evaluation II APCH107 Original Result - 130-149 APCH107-150-154 Acute Physiology and Chronic Health Evaluation II original result for APCH107-150-154. Acute Physiology and Chronic Health Evaluation II APCH107 Original Result - 150-154 APCH107-155-159 Acute Physiology and Chronic Health Evaluation II original result for APCH107-155-159. Acute Physiology and Chronic Health Evaluation II APCH107 Original Result - 155-159 APCH107-160-179 Acute Physiology and Chronic Health Evaluation II original result for APCH107-160-179. Acute Physiology and Chronic Health Evaluation II APCH107 Original Result - 160-179 APCH107-<=110 Acute Physiology and Chronic Health Evaluation II original result for APCH107-Less than or equal to 110. Acute Physiology and Chronic Health Evaluation II APCH107 Original Result - <=110 APCH107->=180 Acute Physiology and Chronic Health Evaluation II original result for APCH107-Greater than or equal to 180. Acute Physiology and Chronic Health Evaluation II APCH107 Original Result - >=180 APCH107OR Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH107 TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH107 Original Response Terminology Acute Physiology and Chronic Health Evaluation II original result for APCH108 test and test code. APCH108-2.5-2.9 Acute Physiology and Chronic Health Evaluation II original result for APCH108-2.5-2.9. Acute Physiology and Chronic Health Evaluation II APCH108 Original Result - 2.5-2.9 APCH108-3-3.4 Acute Physiology and Chronic Health Evaluation II original result for APCH108-3-3.4. Acute Physiology and Chronic Health Evaluation II APCH108 Original Result - 3-3.4 APCH108-3.5-5.4 Acute Physiology and Chronic Health Evaluation II original result for APCH108-3.5-5.4. Acute Physiology and Chronic Health Evaluation II APCH108 Original Result - 3.5-5.4 APCH108-5.5-5.9 Acute Physiology and Chronic Health Evaluation II original result for APCH108-5.5-5.9. Acute Physiology and Chronic Health Evaluation II APCH108 Original Result - 5.5-5.9 APCH108-6-6.9 Acute Physiology and Chronic Health Evaluation II original result for APCH108-6-6.9. Acute Physiology and Chronic Health Evaluation II APCH108 Original Result - 6-6.9 APCH108-<2.5 Acute Physiology and Chronic Health Evaluation II original result for APCH108-Less than 2.5. Acute Physiology and Chronic Health Evaluation II APCH108 Original Result - <2.5 APCH108->=7 Acute Physiology and Chronic Health Evaluation II original result for APCH108-Greater than or equal to 7. Acute Physiology and Chronic Health Evaluation II APCH108 Original Result - >=7 APCH108OR Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH108 TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH108 Original Response Terminology Acute Physiology and Chronic Health Evaluation II original result for APCH109 test and test code. APCH109-0.6-1.4 Acute Physiology and Chronic Health Evaluation II original result for APCH109-0.6-1.4. Acute Physiology and Chronic Health Evaluation II APCH109 Original Result - 0.6-1.4 APCH109-1.5-1.9 and acute renal failure Acute Physiology and Chronic Health Evaluation II original result for APCH109-1.5-1.9 and acute renal failure. Acute Physiology and Chronic Health Evaluation II APCH109 Original Result - 1.5-1.9 and acute renal failure APCH109-1.5-1.9 Acute Physiology and Chronic Health Evaluation II original result for APCH109-1.5-1.9. Acute Physiology and Chronic Health Evaluation II APCH109 Original Result - 1.5-1.9 APCH109-2-3.4 and acute renal failure Acute Physiology and Chronic Health Evaluation II original result for APCH109-2-3.4 and acute renal failure. Acute Physiology and Chronic Health Evaluation II APCH109 Original Result - 2-3.4 and acute renal failure APCH109-2-3.4 Acute Physiology and Chronic Health Evaluation II original result for APCH109-2-3.4. Acute Physiology and Chronic Health Evaluation II APCH109 Original Result - 2-3.4 APCH109-<0.6 Acute Physiology and Chronic Health Evaluation II original result for APCH109-Less than 0.6. Acute Physiology and Chronic Health Evaluation II APCH109 Original Result - <0.6 APCH109->=3.5 and acute renal failure Acute Physiology and Chronic Health Evaluation II original result for APCH109-Greater than or equal to 3.5 and acute renal failure. Acute Physiology and Chronic Health Evaluation II APCH109 Original Result - >=3.5 and acute renal failure APCH109->=3.5 Acute Physiology and Chronic Health Evaluation II original result for APCH109-Greater than or equal to 3.5. Acute Physiology and Chronic Health Evaluation II APCH109 Original Result - >=3.5 APCH109OR Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH109 TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH109 Original Response Terminology Acute Physiology and Chronic Health Evaluation II original result for APCH110 test and test code. APCH110-20-29.9 Acute Physiology and Chronic Health Evaluation II original result for APCH110-20-29.9. Acute Physiology and Chronic Health Evaluation II APCH110 Original Result - 20-29.9 APCH110-30-45.9 Acute Physiology and Chronic Health Evaluation II original result for APCH110-30-45.9. Acute Physiology and Chronic Health Evaluation II APCH110 Original Result - 30-45.9 APCH110-46-49.9 Acute Physiology and Chronic Health Evaluation II original result for APCH110-46-49.9. Acute Physiology and Chronic Health Evaluation II APCH110 Original Result - 46-49.9 APCH110-50-59.9 Acute Physiology and Chronic Health Evaluation II original result for APCH110-50-59.9. Acute Physiology and Chronic Health Evaluation II APCH110 Original Result - 50-59.9 APCH110-<20 Acute Physiology and Chronic Health Evaluation II original result for APCH110-Less than 20. Acute Physiology and Chronic Health Evaluation II APCH110 Original Result - <20 APCH110->=60 Acute Physiology and Chronic Health Evaluation II original result for APCH110-Greater than or equal to 60. Acute Physiology and Chronic Health Evaluation II APCH110 Original Result - >=60 APCH110OR Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH110 TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH110 Original Response Terminology Acute Physiology and Chronic Health Evaluation II original result for APCH111 test and test code. APCH111-1-2.9 Acute Physiology and Chronic Health Evaluation II original result for APCH111-1-2.9. Acute Physiology and Chronic Health Evaluation II APCH111 Original Result - 1-2.9 APCH111-15-19.9 Acute Physiology and Chronic Health Evaluation II original result for APCH111-15-19.9. Acute Physiology and Chronic Health Evaluation II APCH111 Original Result - 15-19.9 APCH111-20-39.9 Acute Physiology and Chronic Health Evaluation II original result for APCH111-20-39.9. Acute Physiology and Chronic Health Evaluation II APCH111 Original Result - 20-39.9 APCH111-3-14.9 Acute Physiology and Chronic Health Evaluation II original result for APCH111-3-14.9. Acute Physiology and Chronic Health Evaluation II APCH111 Original Result - 3-14.9 APCH111-<1 Acute Physiology and Chronic Health Evaluation II original result for APCH111-Less than 1. Acute Physiology and Chronic Health Evaluation II APCH111 Original Result - <1 APCH111->=40 Acute Physiology and Chronic Health Evaluation II original result for APCH111-Greater than or equal to 40. Acute Physiology and Chronic Health Evaluation II APCH111 Original Result - >=40 APCH111OR Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH111 TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH111 Original Response Terminology Acute Physiology and Chronic Health Evaluation II original result for APCH114 test and test code. APCH114-45-54 Acute Physiology and Chronic Health Evaluation II original result for APCH114-45-54. Acute Physiology and Chronic Health Evaluation II APCH114 Original Result - 45-54 APCH114-55-64 Acute Physiology and Chronic Health Evaluation II original result for APCH114-55-64. Acute Physiology and Chronic Health Evaluation II APCH114 Original Result - 55-64 APCH114-65-74 Acute Physiology and Chronic Health Evaluation II original result for APCH114-65-74. Acute Physiology and Chronic Health Evaluation II APCH114 Original Result - 65-74 APCH114-<=44 Acute Physiology and Chronic Health Evaluation II original result for APCH114-Less than or equal to 44. Acute Physiology and Chronic Health Evaluation II APCH114 Original Result - <=44 APCH114->=75 Acute Physiology and Chronic Health Evaluation II original result for APCH114-Greater than or equal to 75. Acute Physiology and Chronic Health Evaluation II APCH114 Original Result - >=75 APCH114OR Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH114 TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH114 Original Response Terminology Acute Physiology and Chronic Health Evaluation II original result for APCH115 test and test code. APCH115-for elective postoperative patients Acute Physiology and Chronic Health Evaluation II original result for APCH115-for elective postoperative patients. Acute Physiology and Chronic Health Evaluation II APCH115 Original Result - for elective postoperative patients APCH115-for nonoperative or emergency postoperative patients Acute Physiology and Chronic Health Evaluation II original result for APCH115-for nonoperative or emergency postoperative patients. Acute Physiology and Chronic Health Evaluation II APCH115 Original Result - for nonoperative or emergency postoperative patients APCH115OR Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH115 TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH115 Original Response Terminology Acute Physiology and Chronic Health Evaluation II standardized character result for APCH101 test and test code. APCH101-0 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH101-36-38.4. Acute Physiology and Chronic Health Evaluation II APCH101 Standardized Character Result 0 APCH101-1 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH101-38.5-38.9; 34-35.9. Acute Physiology and Chronic Health Evaluation II APCH101 Standardized Character Result 1 APCH101-2 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH101-32-33.9. Acute Physiology and Chronic Health Evaluation II APCH101 Standardized Character Result 2 APCH101-3 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH101-39-40.9; 30-31.9. Acute Physiology and Chronic Health Evaluation II APCH101 Standardized Character Result 3 APCH101-4 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH101-Greater than or equal to 41; Less than or equal to 29.9. Acute Physiology and Chronic Health Evaluation II APCH101 Standardized Character Result 4 APCH101STR Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH101 TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH101 Standardized Character Response Terminology Acute Physiology and Chronic Health Evaluation II standardized character result for APCH102 test and test code. APCH102-0 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH102-70-109. Acute Physiology and Chronic Health Evaluation II APCH102 Standardized Character Result 0 APCH102-2 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH102-110-129; 50-69. Acute Physiology and Chronic Health Evaluation II APCH102 Standardized Character Result 2 APCH102-3 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH102-130-159. Acute Physiology and Chronic Health Evaluation II APCH102 Standardized Character Result 3 APCH102-4 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH102-Greater than or equal to 160; less than or equal to 49. Acute Physiology and Chronic Health Evaluation II APCH102 Standardized Character Result 4 APCH102STR Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH102 TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH102 Standardized Character Response Terminology Acute Physiology and Chronic Health Evaluation II standardized character result for APCH103 test and test code. APCH103-0 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH103-70-109. Acute Physiology and Chronic Health Evaluation II APCH103 Standardized Character Result 0 APCH103-2 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH103-110-139; 55-69. Acute Physiology and Chronic Health Evaluation II APCH103 Standardized Character Result 2 APCH103-3 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH103-140-179; 40-54. Acute Physiology and Chronic Health Evaluation II APCH103 Standardized Character Result 3 APCH103-4 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH103-Greater than or equal to 180; Less than or equal 39. Acute Physiology and Chronic Health Evaluation II APCH103 Standardized Character Result 4 APCH103STR Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH103 TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH103 Standardized Character Response Terminology Acute Physiology and Chronic Health Evaluation II standardized character result for APCH104 test and test code. APCH104-0 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH104-12-24. Acute Physiology and Chronic Health Evaluation II APCH104 Standardized Character Result 0 APCH104-1 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH104-25-34; 10-11. Acute Physiology and Chronic Health Evaluation II APCH104 Standardized Character Result 1 APCH104-2 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH104-6-9. Acute Physiology and Chronic Health Evaluation II APCH104 Standardized Character Result 2 APCH104-3 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH104-35-49. Acute Physiology and Chronic Health Evaluation II APCH104 Standardized Character Result 3 APCH104-4 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH104-Greater than or equal to 50; Less than or equal to 5. Acute Physiology and Chronic Health Evaluation II APCH104 Standardized Character Result 4 APCH104STR Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH104 TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH104 Standardized Character Response Terminology Acute Physiology and Chronic Health Evaluation II standardized character result for APCH105A test and test code. APCH105A-0 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH105A-Less than 200. Acute Physiology and Chronic Health Evaluation II APCH105A Standardized Character Result 0 APCH105A-2 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH105A-200-349. Acute Physiology and Chronic Health Evaluation II APCH105A Standardized Character Result 2 APCH105A-3 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH105A-350-499. Acute Physiology and Chronic Health Evaluation II APCH105A Standardized Character Result 3 APCH105A-4 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH105A-Greater than or equal to 500. Acute Physiology and Chronic Health Evaluation II APCH105A Standardized Character Result 4 APCH105ASTR Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH105A TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH105A Standardized Character Response Terminology Acute Physiology and Chronic Health Evaluation II standardized character result for APCH105B test and test code. APCH105B-0 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH105B-Greater than 70. Acute Physiology and Chronic Health Evaluation II APCH105B Standardized Character Result 0 APCH105B-1 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH105B-61-70. Acute Physiology and Chronic Health Evaluation II APCH105B Standardized Character Result 1 APCH105B-3 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH105B-55-60. Acute Physiology and Chronic Health Evaluation II APCH105B Standardized Character Result 3 APCH105B-4 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH105B-Less than 55. Acute Physiology and Chronic Health Evaluation II APCH105B Standardized Character Result 4 APCH105BSTR Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH105B TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH105B Standardized Character Response Terminology Acute Physiology and Chronic Health Evaluation II standardized character result for APCH106A test and test code. APCH106A-0 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH106A-7.33-7.49. Acute Physiology and Chronic Health Evaluation II APCH106A Standardized Character Result 0 APCH106A-1 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH106A-7.5-7.59. Acute Physiology and Chronic Health Evaluation II APCH106A Standardized Character Result 1 APCH106A2 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH106A-7.25-7.32. Acute Physiology and Chronic Health Evaluation II APCH106A Standardized Character Result 2 APCH106A-3 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH106A-7.6-7.69; 7.15-7.24. Acute Physiology and Chronic Health Evaluation II APCH106A Standardized Character Result 3 APCH106A-4 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH106A-Greater than or equal to 7.7; Less than 7.15. Acute Physiology and Chronic Health Evaluation II APCH106A Standardized Character Result 4 APCH106ASTR Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH106A TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH106A Standardized Character Response Terminology Acute Physiology and Chronic Health Evaluation II standardized character result for APCH106B test and test code. APCH106B-0 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH106B-22-31.9. Acute Physiology and Chronic Health Evaluation II APCH106B Standardized Character Result 0 APCH106B-1 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH106B-32-40.9. Acute Physiology and Chronic Health Evaluation II APCH106B Standardized Character Result 1 APCH106B-2 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH106B-18-21.9. Acute Physiology and Chronic Health Evaluation II APCH106B Standardized Character Result 2 APCH106B-3 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH106B-41-51.9; 15-17.9. Acute Physiology and Chronic Health Evaluation II APCH106B Standardized Character Result 3 APCH106B-4 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH106B-Greater than or equal to 52; Less than 15. Acute Physiology and Chronic Health Evaluation II APCH106B Standardized Character Result 4 APCH106BSTR Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH106B TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH106B Standardized Character Response Terminology Acute Physiology and Chronic Health Evaluation II standardized character result for APCH107 test and test code. APCH107-0 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH107-130-149. Acute Physiology and Chronic Health Evaluation II APCH107 Standardized Character Result 0 APCH107-1 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH107-150-154. Acute Physiology and Chronic Health Evaluation II APCH107 Standardized Character Result 1 APCH107-2 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH107-155-159; 120-129. Acute Physiology and Chronic Health Evaluation II APCH107 Standardized Character Result 2 APCH107-3 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH107-160-179; 111-119. Acute Physiology and Chronic Health Evaluation II APCH107 Standardized Character Result 3 APCH107-4 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH107-Greater than or equal to 180; Less than or equal to 110. Acute Physiology and Chronic Health Evaluation II APCH107 Standardized Character Result 4 APCH107STR Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH107 TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH107 Standardized Character Response Terminology Acute Physiology and Chronic Health Evaluation II standardized character result for APCH108 test and test code. APCH108-0 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH108-3.5-5.4. Acute Physiology and Chronic Health Evaluation II APCH108 Standardized Character Result 0 APCH108-1 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH108-5.5-5.9; 3-3.4. Acute Physiology and Chronic Health Evaluation II APCH108 Standardized Character Result 1 APCH108-2 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH108-2.5-2.9. Acute Physiology and Chronic Health Evaluation II APCH108 Standardized Character Result 2 APCH108-3 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH108-6-6.9. Acute Physiology and Chronic Health Evaluation II APCH108 Standardized Character Result 3 APCH108-4 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH108-Greater than or equal to 7; Less than 2.5. Acute Physiology and Chronic Health Evaluation II APCH108 Standardized Character Result 4 APCH108STR Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH108 TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH108 Standardized Character Response Terminology Acute Physiology and Chronic Health Evaluation II standardized character result for APCH109 test and test code. APCH109-0 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH109-0.6-1.4. Acute Physiology and Chronic Health Evaluation II APCH109 Standardized Character Result 0 APCH109-2 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH109-1.5-1.9; Less than 0.6. Acute Physiology and Chronic Health Evaluation II APCH109 Standardized Character Result 2 APCH109-3 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH109-2-3.4. Acute Physiology and Chronic Health Evaluation II APCH109 Standardized Character Result 3 APCH109-4 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH109-1.5-1.9 and acute renal failure; Greater than or equal to 3.5. Acute Physiology and Chronic Health Evaluation II APCH109 Standardized Character Result 4 APCH109-6 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH109-2-3.4 and acute renal failure. Acute Physiology and Chronic Health Evaluation II APCH109 Standardized Character Result 6 APCH109-8 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH109-Greater than or equal to 3.5 and acute renal failure. Acute Physiology and Chronic Health Evaluation II APCH109 Standardized Character Result 8 APCH109STR Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH109 TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH109 Standardized Character Response Terminology Acute Physiology and Chronic Health Evaluation II standardized character result for APCH110 test and test code. APCH110-0 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH110-30-45.9. Acute Physiology and Chronic Health Evaluation II APCH110 Standardized Character Result 0 APCH110-1 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH110-46-49.9. Acute Physiology and Chronic Health Evaluation II APCH110 Standardized Character Result 1 APCH110-2 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH110-50-59.9; 20-29.9. Acute Physiology and Chronic Health Evaluation II APCH110 Standardized Character Result 2 APCH110-4 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH110-Greater than or equal to 60; Less than 20. Acute Physiology and Chronic Health Evaluation II APCH110 Standardized Character Result 4 APCH110STR Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH110 TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH110 Standardized Character Response Terminology Acute Physiology and Chronic Health Evaluation II standardized character result for APCH111 test and test code. APCH111-0 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH111-3-14.9. Acute Physiology and Chronic Health Evaluation II APCH111 Standardized Character Result 0 APCH111-1 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH111-15-19.9. Acute Physiology and Chronic Health Evaluation II APCH111 Standardized Character Result 1 APCH111-2 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH111-20-39.9; 1-2.9. Acute Physiology and Chronic Health Evaluation II APCH111 Standardized Character Result 2 APCH111-4 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH111-Greater than or equal to 40; Less than 1. Acute Physiology and Chronic Health Evaluation II APCH111 Standardized Character Result 4 APCH111STR Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH111 TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH111 Standardized Character Response Terminology Acute Physiology and Chronic Health Evaluation II standardized character result for APCH114 test and test code. APCH114-0 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH114-Less than or equal to 44. Acute Physiology and Chronic Health Evaluation II APCH114 Standardized Character Result 0 APCH114-2 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH114-45-54. Acute Physiology and Chronic Health Evaluation II APCH114 Standardized Character Result 2 APCH114-3 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH114-55-64. Acute Physiology and Chronic Health Evaluation II APCH114 Standardized Character Result 3 APCH114-5 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH114-65-74. Acute Physiology and Chronic Health Evaluation II APCH114 Standardized Character Result 5 APCH114-6 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH114-Greater than or equal to 75. Acute Physiology and Chronic Health Evaluation II APCH114 Standardized Character Result 6 APCH114STR Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH114 TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH114 Standardized Character Response Terminology Acute Physiology and Chronic Health Evaluation II standardized character result for APCH115 test and test code. APCH115-2 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH115-for elective postoperative patients. Acute Physiology and Chronic Health Evaluation II APCH115 Standardized Character Result 2 APCH115-5 Acute Physiology and Chronic Health Evaluation II standardized character result for APCH115-for nonoperative or emergency postoperative patients. Acute Physiology and Chronic Health Evaluation II APCH115 Standardized Character Result 5 APCH115STR Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH115 TN/TC CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH115 Standardized Character Response Terminology Acute Physiology and Chronic Health Evaluation II test code. APCH1-Temperature - Rectal Acute Physiology and Chronic Health Evaluation II - Temperature - rectal (degree C). APACHE II - Temperature, Rectal APCH1-Mean Arterial Pressure Acute Physiology and Chronic Health Evaluation II - Mean arterial pressure - mmHg. APACHE II - Mean Arterial Pressure APCH1-Heart Rate Acute Physiology and Chronic Health Evaluation II - Heart rate (ventricular response). APACHE II - Heart Rate APCH1-Respiratory Rate Acute Physiology and Chronic Health Evaluation II - Respiratory rate (non-ventilated or ventilated). APACHE II - Respiratory Rate APCH1-Oxygenation: A-aDO2 Acute Physiology and Chronic Health Evaluation II - Oxygenation (mmHg): FIO2 greater than or equal to 0.5 record A-aDO2. APACHE II - Oxygenation, A-aDO2 APCH1-Oxygenation: PaO2 Acute Physiology and Chronic Health Evaluation II - Oxygenation (mmHg): FIO2 less than 0.5 record only PaO2. APACHE II - Oxygenation, PaO2 APCH1-Arterial pH Acute Physiology and Chronic Health Evaluation II - Arterial pH (preferred). APACHE II - Arterial pH APCH1-Serum HCO3 Acute Physiology and Chronic Health Evaluation II - Serum HCO3 (venous mMol/L) (Not preferred, use if no ABGs). APACHE II - Serum HCO3 APCH1-Serum Sodium Acute Physiology and Chronic Health Evaluation II - Serum sodium (mMol/L). APACHE II - Serum Sodium APCH1-Serum Potassium Acute Physiology and Chronic Health Evaluation II - Serum potassium (mMol/L). APACHE II - Serum Potassium APCH1-Serum Creatinine Acute Physiology and Chronic Health Evaluation II - Serum creatinine (mg/100 mL) (double point score for acute renal failure). APACHE II - Serum Creatinine APCH1-Hematocrit Acute Physiology and Chronic Health Evaluation II - Hematocrit (%). APACHE II - Hematocrit APCH1-White Blood Count Acute Physiology and Chronic Health Evaluation II - White blood count (total/mm3) (in 1,000s). APACHE II - White Blood Count APCH1-15 Minus Glasgow Coma Score Acute Physiology and Chronic Health Evaluation II - Glasgow coma score: Score equals 15 minus actual GCS. APACHE II - 15 Minus Glasgow Coma Score APCH1-A: Total Acute Physiology Score Acute Physiology and Chronic Health Evaluation II - A: Total acute physiology score. APACHE II - A, Total Acute Physiology Score APCH1-B: Age Points Acute Physiology and Chronic Health Evaluation II - B: Age points (years). APACHE II - B, Age Points APCH1-C: Chronic Health Points Acute Physiology and Chronic Health Evaluation II - C: Chronic health points. APACHE II - C, Chronic Health Points APCH1-Total APACHE II Score Acute Physiology and Chronic Health Evaluation II - Total APACHE II score. APACHE II - Total APACHE II Score APCH1TC Acute Physiology and Chronic Health Evaluation II Clinical Classification Test Code CDISC Clinical Classification APACHE II Test Code Terminology Acute Physiology and Chronic Health Evaluation II test name. APCH1-15 Minus Glasgow Coma Score Acute Physiology and Chronic Health Evaluation II - Glasgow coma score: Score equals 15 minus actual GCS. APACHE II - 15 Minus Glasgow Coma Score APCH1-A: Total Acute Physiology Score Acute Physiology and Chronic Health Evaluation II - A: Total acute physiology score. APACHE II - A, Total Acute Physiology Score APCH1-Arterial pH Acute Physiology and Chronic Health Evaluation II - Arterial pH (preferred). APACHE II - Arterial pH APCH1-B: Age Points Acute Physiology and Chronic Health Evaluation II - B: Age points (years). APACHE II - B, Age Points APCH1-C: Chronic Health Points Acute Physiology and Chronic Health Evaluation II - C: Chronic health points. APACHE II - C, Chronic Health Points APCH1-Heart Rate Acute Physiology and Chronic Health Evaluation II - Heart rate (ventricular response). APACHE II - Heart Rate APCH1-Hematocrit Acute Physiology and Chronic Health Evaluation II - Hematocrit (%). APACHE II - Hematocrit APCH1-Mean Arterial Pressure Acute Physiology and Chronic Health Evaluation II - Mean arterial pressure - mmHg. APACHE II - Mean Arterial Pressure APCH1-Oxygenation: A-aDO2 Acute Physiology and Chronic Health Evaluation II - Oxygenation (mmHg): FIO2 greater than or equal to 0.5 record A-aDO2. APACHE II - Oxygenation, A-aDO2 APCH1-Oxygenation: PaO2 Acute Physiology and Chronic Health Evaluation II - Oxygenation (mmHg): FIO2 less than 0.5 record only PaO2. APACHE II - Oxygenation, PaO2 APCH1-Respiratory Rate Acute Physiology and Chronic Health Evaluation II - Respiratory rate (non-ventilated or ventilated). APACHE II - Respiratory Rate APCH1-Serum Creatinine Acute Physiology and Chronic Health Evaluation II - Serum creatinine (mg/100 mL) (double point score for acute renal failure). APACHE II - Serum Creatinine APCH1-Serum HCO3 Acute Physiology and Chronic Health Evaluation II - Serum HCO3 (venous mMol/L) (Not preferred, use if no ABGs). APACHE II - Serum HCO3 APCH1-Serum Potassium Acute Physiology and Chronic Health Evaluation II - Serum potassium (mMol/L). APACHE II - Serum Potassium APCH1-Serum Sodium Acute Physiology and Chronic Health Evaluation II - Serum sodium (mMol/L). APACHE II - Serum Sodium APCH1-Temperature - Rectal Acute Physiology and Chronic Health Evaluation II - Temperature - rectal (degree C). APACHE II - Temperature, Rectal APCH1-Total APACHE II Score Acute Physiology and Chronic Health Evaluation II - Total APACHE II score. APACHE II - Total APACHE II Score APCH1-White Blood Count Acute Physiology and Chronic Health Evaluation II - White blood count (total/mm3) (in 1,000s). APACHE II - White Blood Count APCH1TN Acute Physiology and Chronic Health Evaluation II Clinical Classification Test Name CDISC Clinical Classification APACHE II Test Name Terminology Addiction Research Center Inventory 49 Check-list original result for ARCI01 test and test code. ARCI0101 through ARCI0149-FALSE Addiction Research Center Inventory 1971 original result for ARCI0101 through ARCI0149-False. Addiction Research Center Inventory 49 Check-list ARCI01 Original Result - False ARCI0101 through ARCI0149-TRUE Addiction Research Center Inventory 1971 original result for ARCI0101 through ARCI0149-True. Addiction Research Center Inventory 49 Check-list ARCI01 Original Result - True ARCI01OR Addiction Research Center Inventory 49 Check-list ORRES for ARCI01 TN/TC CDISC Questionnaire Addiction Research Center Inventory 49 Check-list ARCI01 Original Response Terminology Addiction Research Center Inventory 49 Check-list standardized character result for ARCI01 test and test code. ARCI0101 through ARCI0149-0 Addiction Research Center Inventory 1971 standardized character result for ARCI0101 through ARCI0149-False. Addiction Research Center Inventory 49 Check-list ARCI01 Standardized Character Result 0 ARCI0101 through ARCI0149-1 Addiction Research Center Inventory 1971 standardized character result for ARCI0101 through ARCI0149-True. Addiction Research Center Inventory 49 Check-list ARCI01 Standardized Character Result 1 ARCI01STR Addiction Research Center Inventory 49 Check-list STRESC for ARCI01 TN/TC CDISC Questionnaire Addiction Research Center Inventory 49 Check-list ARCI01 Standardized Character Response Terminology Addiction Research Center Inventory 49 Check-list test code. ARCI01-Speech Is Slurred Addiction Research Center Inventory 1971 - My speech is slurred. ARCI-49 - Speech Is Slurred ARCI01-Not as Active as Usual Addiction Research Center Inventory 1971 - I am not as active as usual. ARCI-49 - Not as Active as Usual ARCI01-Feeling of Just Dragging Along Addiction Research Center Inventory 1971 - I have a feeling of just dragging along rather than coasting. ARCI-49 - Feeling of Just Dragging Along ARCI01-Feel Sluggish Addiction Research Center Inventory 1971 - I feel sluggish. ARCI-49 - Feel Sluggish ARCI01-Head Feels Heavy Addiction Research Center Inventory 1971 - My head feels heavy. ARCI-49 - Head Feels Heavy ARCI01-Feel Like Avoiding People Addiction Research Center Inventory 1971 - I feel like avoiding people although I usually do not feel this way. ARCI-49 - Feel Like Avoiding People ARCI01-Feel Dizzy Addiction Research Center Inventory 1971 - I feel dizzy. ARCI-49 - Feel Dizzy ARCI01-Harder Than Usual to Move Around Addiction Research Center Inventory 1971 - It seems harder than usual to move around. ARCI-49 - Harder Than Usual to Move Around ARCI01-Moody Addiction Research Center Inventory 1971 - I am moody. ARCI-49 - Moody ARCI01-People Say I Am Dull Today Addiction Research Center Inventory 1971 - People might say that I am a little dull today. ARCI-49 - People Say I Am Dull Today ARCI01-Feel Drowsy Addiction Research Center Inventory 1971 - I feel drowsy. ARCI-49 - Feel Drowsy ARCI01-Full of Energy Addiction Research Center Inventory 1971 - I am full of energy. ARCI-49 - Full of Energy ARCI01-Today I Say Things in Easiest Way Addiction Research Center Inventory 1971 - Today I say things in the easiest possible way. ARCI-49 - Today I Say Things in Easiest Way ARCI01-Things Around Seem More Pleasing Addiction Research Center Inventory 1971 - Things around me seem more pleasing than usual. ARCI-49 - Things Around Seem More Pleasing ARCI01-Pleasant Feeling in My Stomach Addiction Research Center Inventory 1971 - I have a pleasant feeling in my stomach. ARCI-49 - Pleasant Feeling in My Stomach ARCI01-Feel I Will Lose the Contentment Addiction Research Center Inventory 1971 - I feel I will lose the contentment that I have now. ARCI-49 - Feel I Will Lose the Contentment ARCI01-Feel in Complete Harmony w/World Addiction Research Center Inventory 1971 - I feel in complete harmony with the world and those about me. ARCI-49 - Feel in Complete Harmony With World ARCI01-Appreciate What Others Are Saying Addiction Research Center Inventory 1971 - I can completely appreciate what others are saying when I am in this mood. ARCI-49 - Appreciate What Others Are Saying ARCI01-Happy if I Felt as I Feel Now Addiction Research Center Inventory 1971 - I would be happy all the time if I felt as I feel now. ARCI-49 - Happy if I Felt as I Feel Now ARCI01-Feel Good Other People Can Tell Addiction Research Center Inventory 1971 - I feel so good that I know other people can tell it. ARCI-49 - Feel Good Other People Can Tell ARCI01-Feel Something Pleasant Happened Addiction Research Center Inventory 1971 - I feel as if something pleasant had just happened to me. ARCI-49 - Feel Something Pleasant Happened ARCI01-Happy if I Felt as I Do Now Addiction Research Center Inventory 1971 - I would be happy all the time if I felt as I do now. ARCI-49 - Happy if I Felt as I Do Now ARCI01-More Clear Headed Than Dreamy Addiction Research Center Inventory 1971 - I feel more clear headed than dreamy. ARCI-49 - More Clear Headed Than Dreamy ARCI01-Would Be More Popular w/People Addiction Research Center Inventory 1971 - I feel as if I would be more popular with people today. ARCI-49 - Would Be More Popular With People ARCI01-Feel a Very Pleasant Emptiness Addiction Research Center Inventory 1971 - I feel a very pleasant emptiness. ARCI-49 - Feel a Very Pleasant Emptiness ARCI01-Thoughts Come More Easily Usual Addiction Research Center Inventory 1971 - My thoughts come more easily than usual. ARCI-49 - Thoughts Come More Easily Usual ARCI01-Feel Less Discouraged Than Usual Addiction Research Center Inventory 1971 - I feel less discouraged than usual. ARCI-49 - Feel Less Discouraged Than Usual ARCI01-Mood to Talk About Feelings Addiction Research Center Inventory 1971 - I am in the mood to talk about the feelings I have. ARCI-49 - Mood to Talk About Feelings ARCI01-More Excited Than Dreamy Addiction Research Center Inventory 1971 - I feel more excited than dreamy. ARCI-49 - More Excited Than Dreamy ARCI01-Answering Questions Was Very Easy Addiction Research Center Inventory 1971 - Answering these questions was very easy today. ARCI-49 - Answering Questions Was Very Easy ARCI01-Memory Seems Sharper Than Usual Addiction Research Center Inventory 1971 - My memory seems sharper to me than usual. ARCI-49 - Memory Seems Sharper Than Usual ARCI01-Could Write for Hours Addiction Research Center Inventory 1971 - I feel as if I could write for hours. ARCI-49 - Could Write for Hours ARCI01-Feel Very Patient Addiction Research Center Inventory 1971 - I feel very patient. ARCI-49 - Feel Very Patient ARCI01-Parts of My Body Are Tingling Addiction Research Center Inventory 1971 - Some parts of my body are tingling. ARCI-49 - Parts of My Body Are Tingling ARCI01-Have a Weird Feeling Addiction Research Center Inventory 1971 - I have a weird feeling. ARCI-49 - Have a Weird Feeling ARCI01-Movements Seem Faster Than Usual Addiction Research Center Inventory 1971 - My movements seem faster than usual. ARCI-49 - Movements Seem Faster Than Usual ARCI01-Have Better Control Than Usual Addiction Research Center Inventory 1971 - I have better control over myself than usual. ARCI-49 - Have Better Control Than Usual ARCI01-Movements Seem Slower Than Usual Addiction Research Center Inventory 1971 - My movements seem slower than usual. ARCI-49 - Movements Seem Slower Than Usual ARCI01-Hard to Keep Mind on Task/Job Addiction Research Center Inventory 1971 - I find it hard to keep my mind on a task or job. ARCI-49 - Hard to Keep Mind on Task or Job ARCI01-Don't Feel Like Reading Right Now Addiction Research Center Inventory 1971 - I don't feel like reading anything right now. ARCI-49 - Don't Feel Like Reading Right Now ARCI01-Spending Longer on Each Question Addiction Research Center Inventory 1971 - It seems I am spending longer than I should on each of these questions. ARCI-49 - Spending Longer on Each Question ARCI01-Hand Feels Clumsy Addiction Research Center Inventory 1971 - My hand feels clumsy. ARCI-49 - Hand Feels Clumsy ARCI01-Hand Shakes When I Write Addiction Research Center Inventory 1971 - I notice my hand shakes when I write. ARCI-49 - Hand Shakes When I Write ARCI01-Have Disturbance in My Stomach Addiction Research Center Inventory 1971 - I have a disturbance in my stomach. ARCI-49 - Have Disturbance in My Stomach ARCI01-Awareness of Bodily Sensations Addiction Research Center Inventory 1971 - I have an increasing awareness of bodily sensations. ARCI-49 - Awareness of Bodily Sensations ARCI01-Feel Anxious & Upset Addiction Research Center Inventory 1971 - I feel anxious and upset. ARCI-49 - Feel Anxious and Upset ARCI01-Unusual Weakness of My Muscles Addiction Research Center Inventory 1971 - I have unusual weakness of my muscles. ARCI-49 - Unusual Weakness of My Muscles ARCI01-Thrill Gone Through Me Addiction Research Center Inventory 1971 - A thrill has gone through me one or more times since I started this test. ARCI-49 - Thrill Gone Through Me ARCI01-Movement Free Relaxed&Pleasurable Addiction Research Center Inventory 1971 - My movements are free, relaxed, and pleasurable. ARCI-49 - Movement Free Relaxed and Pleasurable ARCI01-PCAG Scale Addiction Research Center Inventory 1971 - Pentobarbital, chlorpromazine, alcohol group scale. ARCI-49 - PCAG Scale ARCI01-MBG Scale Addiction Research Center Inventory 1971 - Morphine-benzedrine group scale. ARCI-49 - MBG Scale ARCI01-LSD Scale Addiction Research Center Inventory 1971 - Lysergic acid diethylamide group scale. ARCI-49 - LSD Scale ARCI01-BG Scale Addiction Research Center Inventory 1971 - Benzedrine group scale. ARCI-49 - BG Scale ARCI01-A Scale Addiction Research Center Inventory 1971 - Amphetamine scale. ARCI-49 - A Scale ARCI01TC Addiction Research Center Inventory 49 Check-list Test Code CDISC Questionnaire ARCI-49 Test Code Terminology Addiction Research Center Inventory 49 Check-list test name. ARCI01-A Scale Addiction Research Center Inventory 1971 - Amphetamine scale. ARCI-49 - A Scale ARCI01-Answering Questions Was Very Easy Addiction Research Center Inventory 1971 - Answering these questions was very easy today. ARCI-49 - Answering Questions Was Very Easy ARCI01-Appreciate What Others Are Saying Addiction Research Center Inventory 1971 - I can completely appreciate what others are saying when I am in this mood. ARCI-49 - Appreciate What Others Are Saying ARCI01-Awareness of Bodily Sensations Addiction Research Center Inventory 1971 - I have an increasing awareness of bodily sensations. ARCI-49 - Awareness of Bodily Sensations ARCI01-BG Scale Addiction Research Center Inventory 1971 - Benzedrine group scale. ARCI-49 - BG Scale ARCI01-Could Write for Hours Addiction Research Center Inventory 1971 - I feel as if I could write for hours. ARCI-49 - Could Write for Hours ARCI01-Don't Feel Like Reading Right Now Addiction Research Center Inventory 1971 - I don't feel like reading anything right now. ARCI-49 - Don't Feel Like Reading Right Now ARCI01-Feel a Very Pleasant Emptiness Addiction Research Center Inventory 1971 - I feel a very pleasant emptiness. ARCI-49 - Feel a Very Pleasant Emptiness ARCI01-Feel Anxious & Upset Addiction Research Center Inventory 1971 - I feel anxious and upset. ARCI-49 - Feel Anxious and Upset ARCI01-Feel Dizzy Addiction Research Center Inventory 1971 - I feel dizzy. ARCI-49 - Feel Dizzy ARCI01-Feel Drowsy Addiction Research Center Inventory 1971 - I feel drowsy. ARCI-49 - Feel Drowsy ARCI01-Feel Good Other People Can Tell Addiction Research Center Inventory 1971 - I feel so good that I know other people can tell it. ARCI-49 - Feel Good Other People Can Tell ARCI01-Feel I Will Lose the Contentment Addiction Research Center Inventory 1971 - I feel I will lose the contentment that I have now. ARCI-49 - Feel I Will Lose the Contentment ARCI01-Feel in Complete Harmony w/World Addiction Research Center Inventory 1971 - I feel in complete harmony with the world and those about me. ARCI-49 - Feel in Complete Harmony With World ARCI01-Feel Less Discouraged Than Usual Addiction Research Center Inventory 1971 - I feel less discouraged than usual. ARCI-49 - Feel Less Discouraged Than Usual ARCI01-Feel Like Avoiding People Addiction Research Center Inventory 1971 - I feel like avoiding people although I usually do not feel this way. ARCI-49 - Feel Like Avoiding People ARCI01-Feel Sluggish Addiction Research Center Inventory 1971 - I feel sluggish. ARCI-49 - Feel Sluggish ARCI01-Feel Something Pleasant Happened Addiction Research Center Inventory 1971 - I feel as if something pleasant had just happened to me. ARCI-49 - Feel Something Pleasant Happened ARCI01-Feel Very Patient Addiction Research Center Inventory 1971 - I feel very patient. ARCI-49 - Feel Very Patient ARCI01-Feeling of Just Dragging Along Addiction Research Center Inventory 1971 - I have a feeling of just dragging along rather than coasting. ARCI-49 - Feeling of Just Dragging Along ARCI01-Full of Energy Addiction Research Center Inventory 1971 - I am full of energy. ARCI-49 - Full of Energy ARCI01-Hand Feels Clumsy Addiction Research Center Inventory 1971 - My hand feels clumsy. ARCI-49 - Hand Feels Clumsy ARCI01-Hand Shakes When I Write Addiction Research Center Inventory 1971 - I notice my hand shakes when I write. ARCI-49 - Hand Shakes When I Write ARCI01-Happy if I Felt as I Do Now Addiction Research Center Inventory 1971 - I would be happy all the time if I felt as I do now. ARCI-49 - Happy if I Felt as I Do Now ARCI01-Happy if I Felt as I Feel Now Addiction Research Center Inventory 1971 - I would be happy all the time if I felt as I feel now. ARCI-49 - Happy if I Felt as I Feel Now ARCI01-Hard to Keep Mind on Task/Job Addiction Research Center Inventory 1971 - I find it hard to keep my mind on a task or job. ARCI-49 - Hard to Keep Mind on Task or Job ARCI01-Harder Than Usual to Move Around Addiction Research Center Inventory 1971 - It seems harder than usual to move around. ARCI-49 - Harder Than Usual to Move Around ARCI01-Have a Weird Feeling Addiction Research Center Inventory 1971 - I have a weird feeling. ARCI-49 - Have a Weird Feeling ARCI01-Have Better Control Than Usual Addiction Research Center Inventory 1971 - I have better control over myself than usual. ARCI-49 - Have Better Control Than Usual ARCI01-Have Disturbance in My Stomach Addiction Research Center Inventory 1971 - I have a disturbance in my stomach. ARCI-49 - Have Disturbance in My Stomach ARCI01-Head Feels Heavy Addiction Research Center Inventory 1971 - My head feels heavy. ARCI-49 - Head Feels Heavy ARCI01-LSD Scale Addiction Research Center Inventory 1971 - Lysergic acid diethylamide group scale. ARCI-49 - LSD Scale ARCI01-MBG Scale Addiction Research Center Inventory 1971 - Morphine-benzedrine group scale. ARCI-49 - MBG Scale ARCI01-Memory Seems Sharper Than Usual Addiction Research Center Inventory 1971 - My memory seems sharper to me than usual. ARCI-49 - Memory Seems Sharper Than Usual ARCI01-Mood to Talk About Feelings Addiction Research Center Inventory 1971 - I am in the mood to talk about the feelings I have. ARCI-49 - Mood to Talk About Feelings ARCI01-Moody Addiction Research Center Inventory 1971 - I am moody. ARCI-49 - Moody ARCI01-More Clear Headed Than Dreamy Addiction Research Center Inventory 1971 - I feel more clear headed than dreamy. ARCI-49 - More Clear Headed Than Dreamy ARCI01-More Excited Than Dreamy Addiction Research Center Inventory 1971 - I feel more excited than dreamy. ARCI-49 - More Excited Than Dreamy ARCI01-Movement Free Relaxed&Pleasurable Addiction Research Center Inventory 1971 - My movements are free, relaxed, and pleasurable. ARCI-49 - Movement Free Relaxed and Pleasurable ARCI01-Movements Seem Faster Than Usual Addiction Research Center Inventory 1971 - My movements seem faster than usual. ARCI-49 - Movements Seem Faster Than Usual ARCI01-Movements Seem Slower Than Usual Addiction Research Center Inventory 1971 - My movements seem slower than usual. ARCI-49 - Movements Seem Slower Than Usual ARCI01-Not as Active as Usual Addiction Research Center Inventory 1971 - I am not as active as usual. ARCI-49 - Not as Active as Usual ARCI01-Parts of My Body Are Tingling Addiction Research Center Inventory 1971 - Some parts of my body are tingling. ARCI-49 - Parts of My Body Are Tingling ARCI01-PCAG Scale Addiction Research Center Inventory 1971 - Pentobarbital, chlorpromazine, alcohol group scale. ARCI-49 - PCAG Scale ARCI01-People Say I Am Dull Today Addiction Research Center Inventory 1971 - People might say that I am a little dull today. ARCI-49 - People Say I Am Dull Today ARCI01-Pleasant Feeling in My Stomach Addiction Research Center Inventory 1971 - I have a pleasant feeling in my stomach. ARCI-49 - Pleasant Feeling in My Stomach ARCI01-Speech Is Slurred Addiction Research Center Inventory 1971 - My speech is slurred. ARCI-49 - Speech Is Slurred ARCI01-Spending Longer on Each Question Addiction Research Center Inventory 1971 - It seems I am spending longer than I should on each of these questions. ARCI-49 - Spending Longer on Each Question ARCI01-Things Around Seem More Pleasing Addiction Research Center Inventory 1971 - Things around me seem more pleasing than usual. ARCI-49 - Things Around Seem More Pleasing ARCI01-Thoughts Come More Easily Usual Addiction Research Center Inventory 1971 - My thoughts come more easily than usual. ARCI-49 - Thoughts Come More Easily Usual ARCI01-Thrill Gone Through Me Addiction Research Center Inventory 1971 - A thrill has gone through me one or more times since I started this test. ARCI-49 - Thrill Gone Through Me ARCI01-Today I Say Things in Easiest Way Addiction Research Center Inventory 1971 - Today I say things in the easiest possible way. ARCI-49 - Today I Say Things in Easiest Way ARCI01-Unusual Weakness of My Muscles Addiction Research Center Inventory 1971 - I have unusual weakness of my muscles. ARCI-49 - Unusual Weakness of My Muscles ARCI01-Would Be More Popular w/People Addiction Research Center Inventory 1971 - I feel as if I would be more popular with people today. ARCI-49 - Would Be More Popular With People ARCI01TN Addiction Research Center Inventory 49 Check-list Test Name CDISC Questionnaire ARCI-49 Test Name Terminology Terminology relevant to the product administration technique used. A multiple puncture tuberculin skin test in which a Heaf gun (device containing 6 needles arranged in a circular pattern) is dipped into tuberculin purified protein derivative and pushed into the skin of the flexor surface of the left forearm. (NCI) Heaf Tuberculin Skin Test A single puncture tuberculin skin test in which a standard dose of 5 Tuberculin units of purified protein derivative is injected under the skin of the inner surface of the forearm. Mantoux Tuberculin Skin Test A multiple puncture tuberculin skin test in which tuberculin antigen (either purified protein derivative or old) is pushed into the skin via a device containing 4-6 needles that are coated in tuberculin antigen. (NCI) Tine Tuberculin Skin Test ADTNQRS Administration Technique Response CDISC SDTM Administration Technique Response Terminology ADNI AVLT test code. AVL01-List A Recall 1 Word 1 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 1. ADNI AVLT - List A Recall 1 Word 1 AVL01-List A Recall 1 Word 2 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 2. ADNI AVLT - List A Recall 1 Word 2 AVL01-List A Recall 1 Word 3 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 3. ADNI AVLT - List A Recall 1 Word 3 AVL01-List A Recall 1 Word 4 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 4. ADNI AVLT - List A Recall 1 Word 4 AVL01-List A Recall 1 Word 5 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 5. ADNI AVLT - List A Recall 1 Word 5 AVL01-List A Recall 1 Word 6 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 6. ADNI AVLT - List A Recall 1 Word 6 AVL01-List A Recall 1 Word 7 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 7. ADNI AVLT - List A Recall 1 Word 7 AVL01-List A Recall 1 Word 8 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 8. ADNI AVLT - List A Recall 1 Word 8 AVL01-List A Recall 1 Word 9 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 9. ADNI AVLT - List A Recall 1 Word 9 AVL01-List A Recall 1 Word 10 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 10. ADNI AVLT - List A Recall 1 Word 10 AVL01-List A Recall 1 Word 11 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 11. ADNI AVLT - List A Recall 1 Word 11 AVL01-List A Recall 1 Word 12 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 12. ADNI AVLT - List A Recall 1 Word 12 AVL01-List A Recall 1 Word 13 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 13. ADNI AVLT - List A Recall 1 Word 13 AVL01-List A Recall 1 Word 14 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 14. ADNI AVLT - List A Recall 1 Word 14 AVL01-List A Recall 1 Word 15 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 15. ADNI AVLT - List A Recall 1 Word 15 AVL01-List A Recall 1 Total Auditory Verbal Learning Test Version A - The number of words recalled from List A, first attempt. ADNI AVLT - List A Recall 1 Total AVL01-List A Intrusions 1 Auditory Verbal Learning Test Version A - The number of intrusions while recalling List A, first attempt. ADNI AVLT - List A Intrusions 1 AVL01-List A Recall 2 Word 1 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 1. ADNI AVLT - List A Recall 2 Word 1 AVL01-List A Recall 2 Word 2 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 2. ADNI AVLT - List A Recall 2 Word 2 AVL01-List A Recall 2 Word 3 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 3. ADNI AVLT - List A Recall 2 Word 3 AVL01-List A Recall 2 Word 4 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 4. ADNI AVLT - List A Recall 2 Word 4 AVL01-List A Recall 2 Word 5 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 5. ADNI AVLT - List A Recall 2 Word 5 AVL01-List A Recall 2 Word 6 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 6. ADNI AVLT - List A Recall 2 Word 6 AVL01-List A Recall 2 Word 7 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 7. ADNI AVLT - List A Recall 2 Word 7 AVL01-List A Recall 2 Word 8 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 8. ADNI AVLT - List A Recall 2 Word 8 AVL01-List A Recall 2 Word 9 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 9. ADNI AVLT - List A Recall 2 Word 9 AVL01-List A Recall 2 Word 10 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 10. ADNI AVLT - List A Recall 2 Word 10 AVL01-List A Recall 2 Word 11 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 11. ADNI AVLT - List A Recall 2 Word 11 AVL01-List A Recall 2 Word 12 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 12. ADNI AVLT - List A Recall 2 Word 12 AVL01-List A Recall 2 Word 13 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 13. ADNI AVLT - List A Recall 2 Word 13 AVL01-List A Recall 2 Word 14 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 14. ADNI AVLT - List A Recall 2 Word 14 AVL01-List A Recall 2 Word 15 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 15. ADNI AVLT - List A Recall 2 Word 15 AVL01-List A Recall 2 Total Auditory Verbal Learning Test Version A - The number of words recalled from List A, second attempt. ADNI AVLT - List A Recall 2 Total AVL01-List A Intrusions 2 Auditory Verbal Learning Test Version A - The number of intrusions while recalling List A, second attempt. ADNI AVLT - List A Intrusions 2 AVL01-List A Recall 3 Word 1 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 1. ADNI AVLT - List A Recall 3 Word 1 AVL01-List A Recall 3 Word 2 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 2. ADNI AVLT - List A Recall 3 Word 2 AVL01-List A Recall 3 Word 3 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 3. ADNI AVLT - List A Recall 3 Word 3 AVL01-List A Recall 3 Word 4 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 4. ADNI AVLT - List A Recall 3 Word 4 AVL01-List A Recall 3 Word 5 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 5. ADNI AVLT - List A Recall 3 Word 5 AVL01-List A Recall 3 Word 6 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 6. ADNI AVLT - List A Recall 3 Word 6 AVL01-List A Recall 3 Word 7 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 7. ADNI AVLT - List A Recall 3 Word 7 AVL01-List A Recall 3 Word 8 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 8. ADNI AVLT - List A Recall 3 Word 8 AVL01-List A Recall 3 Word 9 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 9. ADNI AVLT - List A Recall 3 Word 9 AVL01-List A Recall 3 Word 10 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 10. ADNI AVLT - List A Recall 3 Word 10 AVL01-List A Recall 3 Word 11 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 11. ADNI AVLT - List A Recall 3 Word 11 AVL01-List A Recall 3 Word 12 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 12. ADNI AVLT - List A Recall 3 Word 12 AVL01-List A Recall 3 Word 13 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 13. ADNI AVLT - List A Recall 3 Word 13 AVL01-List A Recall 3 Word 14 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 14. ADNI AVLT - List A Recall 3 Word 14 AVL01-List A Recall 3 Word 15 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 15. ADNI AVLT - List A Recall 3 Word 15 AVL01-List A Recall 3 Total Auditory Verbal Learning Test Version A - The number of words recalled from List A, third attempt. ADNI AVLT - List A Recall 3 Total AVL01-List A Intrusions 3 Auditory Verbal Learning Test Version A - The number of intrusions while recalling List A, third attempt. ADNI AVLT - List A Intrusions 3 AVL01-List A Recall 4 Word 1 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 1. ADNI AVLT - List A Recall 4 Word 1 AVL01-List A Recall 4 Word 2 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 2. ADNI AVLT - List A Recall 4 Word 2 AVL01-List A Recall 4 Word 3 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 3. ADNI AVLT - List A Recall 4 Word 3 AVL01-List A Recall 4 Word 4 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 4. ADNI AVLT - List A Recall 4 Word 4 AVL01-List A Recall 4 Word 5 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 5. ADNI AVLT - List A Recall 4 Word 5 AVL01-List A Recall 4 Word 6 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 6. ADNI AVLT - List A Recall 4 Word 6 AVL01-List A Recall 4 Word 7 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 7. ADNI AVLT - List A Recall 4 Word 7 AVL01-List A Recall 4 Word 8 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 8. ADNI AVLT - List A Recall 4 Word 8 AVL01-List A Recall 4 Word 9 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 9. ADNI AVLT - List A Recall 4 Word 9 AVL01-List A Recall 4 Word 10 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 10. ADNI AVLT - List A Recall 4 Word 10 AVL01-List A Recall 4 Word 11 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 11. ADNI AVLT - List A Recall 4 Word 11 AVL01-List A Recall 4 Word 12 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 12. ADNI AVLT - List A Recall 4 Word 12 AVL01-List A Recall 4 Word 13 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 13. ADNI AVLT - List A Recall 4 Word 13 AVL01-List A Recall 4 Word 14 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 14. ADNI AVLT - List A Recall 4 Word 14 AVL01-List A Recall 4 Word 15 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 15. ADNI AVLT - List A Recall 4 Word 15 AVL01-List A Recall 4 Total Auditory Verbal Learning Test Version A - The number of words recalled from List A, fourth attempt. ADNI AVLT - List A Recall 4 Total AVL01-List A Intrusions 4 Auditory Verbal Learning Test Version A - The number of intrusions while recalling List A, fourth attempt. ADNI AVLT - List A Intrusions 4 AVL01-List A Recall 5 Word 1 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 1. ADNI AVLT - List A Recall 5 Word 1 AVL01-List A Recall 5 Word 2 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 2. ADNI AVLT - List A Recall 5 Word 2 AVL01-List A Recall 5 Word 3 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 3. ADNI AVLT - List A Recall 5 Word 3 AVL01-List A Recall 5 Word 4 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 4. ADNI AVLT - List A Recall 5 Word 4 AVL01-List A Recall 5 Word 5 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 5. ADNI AVLT - List A Recall 5 Word 5 AVL01-List A Recall 5 Word 6 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 6. ADNI AVLT - List A Recall 5 Word 6 AVL01-List A Recall 5 Word 7 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 7. ADNI AVLT - List A Recall 5 Word 7 AVL01-List A Recall 5 Word 8 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 8. ADNI AVLT - List A Recall 5 Word 8 AVL01-List A Recall 5 Word 9 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 9. ADNI AVLT - List A Recall 5 Word 9 AVL01-List A Recall 5 Word 10 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 10. ADNI AVLT - List A Recall 5 Word 10 AVL01-List A Recall 5 Word 11 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 11. ADNI AVLT - List A Recall 5 Word 11 AVL01-List A Recall 5 Word 12 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 12. ADNI AVLT - List A Recall 5 Word 12 AVL01-List A Recall 5 Word 13 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 13. ADNI AVLT - List A Recall 5 Word 13 AVL01-List A Recall 5 Word 14 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 14. ADNI AVLT - List A Recall 5 Word 14 AVL01-List A Recall 5 Word 15 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 15. ADNI AVLT - List A Recall 5 Word 15 AVL01-List A Recall 5 Total Auditory Verbal Learning Test Version A - The number of words recalled from List A, fifth attempt. ADNI AVLT - List A Recall 5 Total AVL01-List A Intrusions 5 Auditory Verbal Learning Test Version A - The number of intrusions while recalling List A, fifth attempt. ADNI AVLT - List A Intrusions 5 AVL01-List A Recall 6 (After B) Word 1 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 1. ADNI AVLT - List A Recall 6 (After B) Word 1 AVL01-List A Recall 6 (After B) Word 2 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 2. ADNI AVLT - List A Recall 6 (After B) Word 2 AVL01-List A Recall 6 (After B) Word 3 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 3. ADNI AVLT - List A Recall 6 (After B) Word 3 AVL01-List A Recall 6 (After B) Word 4 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 4. ADNI AVLT - List A Recall 6 (After B) Word 4 AVL01-List A Recall 6 (After B) Word 5 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 5. ADNI AVLT - List A Recall 6 (After B) Word 5 AVL01-List A Recall 6 (After B) Word 6 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 6. ADNI AVLT - List A Recall 6 (After B) Word 6 AVL01-List A Recall 6 (After B) Word 7 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 7. ADNI AVLT - List A Recall 6 (After B) Word 7 AVL01-List A Recall 6 (After B) Word 8 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 8. ADNI AVLT - List A Recall 6 (After B) Word 8 AVL01-List A Recall 6 (After B) Word 9 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 9. ADNI AVLT - List A Recall 6 (After B) Word 9 AVL01-List A Recall 6 (After B) Word 10 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 10. ADNI AVLT - List A Recall 6 (After B) Word 10 AVL01-List A Recall 6 (After B) Word 11 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 11. ADNI AVLT - List A Recall 6 (After B) Word 11 AVL01-List A Recall 6 (After B) Word 12 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 12. ADNI AVLT - List A Recall 6 (After B) Word 12 AVL01-List A Recall 6 (After B) Word 13 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 13. ADNI AVLT - List A Recall 6 (After B) Word 13 AVL01-List A Recall 6 (After B) Word 14 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 14. ADNI AVLT - List A Recall 6 (After B) Word 14 AVL01-List A Recall 6 (After B) Word 15 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 15. ADNI AVLT - List A Recall 6 (After B) Word 15 AVL01-List A Recall 6 (After B) Total Auditory Verbal Learning Test Version A - The number of words recalled from List A, sixth attempt (after List B recall). ADNI AVLT - List A Recall 6 (After B) Total AVL01-List A Intrusions 6 Auditory Verbal Learning Test Version A - The number of intrusions while recalling List A, sixth attempt (after List B recall). ADNI AVLT - List A Intrusions 6 AVL01-List B Recall Word 1 Auditory Verbal Learning Test Version A - List B, Word 1. ADNI AVLT - List B Recall Word 1 AVL01-List B Recall Word 2 Auditory Verbal Learning Test Version A - List B, Word 2. ADNI AVLT - List B Recall Word 2 AVL01-List B Recall Word 3 Auditory Verbal Learning Test Version A - List B, Word 3. ADNI AVLT - List B Recall Word 3 AVL01-List B Recall Word 4 Auditory Verbal Learning Test Version A - List B, Word 4. ADNI AVLT - List B Recall Word 4 AVL01-List B Recall Word 5 Auditory Verbal Learning Test Version A - List B, Word 5. ADNI AVLT - List B Recall Word 5 AVL01-List B Recall Word 6 Auditory Verbal Learning Test Version A - List B, Word 6. ADNI AVLT - List B Recall Word 6 AVL01-List B Recall Word 7 Auditory Verbal Learning Test Version A - List B, Word 7. ADNI AVLT - List B Recall Word 7 AVL01-List B Recall Word 8 Auditory Verbal Learning Test Version A - List B, Word 8. ADNI AVLT - List B Recall Word 8 AVL01-List B Recall Word 9 Auditory Verbal Learning Test Version A - List B, Word 9. ADNI AVLT - List B Recall Word 9 AVL01-List B Recall Word 10 Auditory Verbal Learning Test Version A - List B, Word 10. ADNI AVLT - List B Recall Word 10 AVL01-List B Recall Word 11 Auditory Verbal Learning Test Version A - List B, Word 11. ADNI AVLT - List B Recall Word 11 AVL01-List B Recall Word 12 Auditory Verbal Learning Test Version A - List B, Word 12. ADNI AVLT - List B Recall Word 12 AVL01-List B Recall Word 13 Auditory Verbal Learning Test Version A - List B, Word 13. ADNI AVLT - List B Recall Word 13 AVL01-List B Recall Word 14 Auditory Verbal Learning Test Version A - List B, Word 14. ADNI AVLT - List B Recall Word 14 AVL01-List B Recall Word 15 Auditory Verbal Learning Test Version A - List B, Word 15. ADNI AVLT - List B Recall Word 15 AVL01-List B Recall Total Auditory Verbal Learning Test Version A - The number of words recalled from List B. ADNI AVLT - List B Recall Total AVL01-List B Intrusions Auditory Verbal Learning Test Version A - The number of intrusions while recalling List B. ADNI AVLT - List B Intrusions AVL01-List A 30 Min Delay Recall Word 1 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 1. ADNI AVLT - List A 30 Min Delay Recall Word 1 AVL01-List A 30 Min Delay Recall Word 2 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 2. ADNI AVLT - List A 30 Min Delay Recall Word 2 AVL01-List A 30 Min Delay Recall Word 3 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 3. ADNI AVLT - List A 30 Min Delay Recall Word 3 AVL01-List A 30 Min Delay Recall Word 4 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 4. ADNI AVLT - List A 30 Min Delay Recall Word 4 AVL01-List A 30 Min Delay Recall Word 5 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 5. ADNI AVLT - List A 30 Min Delay Recall Word 5 AVL01-List A 30 Min Delay Recall Word 6 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 6. ADNI AVLT - List A 30 Min Delay Recall Word 6 AVL01-List A 30 Min Delay Recall Word 7 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 7. ADNI AVLT - List A 30 Min Delay Recall Word 7 AVL01-List A 30 Min Delay Recall Word 8 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 8. ADNI AVLT - List A 30 Min Delay Recall Word 8 AVL01-List A 30 Min Delay Recall Word 9 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 9. ADNI AVLT - List A 30 Min Delay Recall Word 9 AVL01-List A 30 Min Delay Recall Word 10 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 10. ADNI AVLT - List A 30 Min Delay Recall Word 10 AVL01-List A 30 Min Delay Recall Word 11 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 11. ADNI AVLT - List A 30 Min Delay Recall Word 11 AVL01-List A 30 Min Delay Recall Word 12 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 12. ADNI AVLT - List A 30 Min Delay Recall Word 12 AVL01-List A 30 Min Delay Recall Word 13 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 13. ADNI AVLT - List A 30 Min Delay Recall Word 13 AVL01-List A 30 Min Delay Recall Word 14 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 14. ADNI AVLT - List A 30 Min Delay Recall Word 14 AVL01-List A 30 Min Delay Recall Word 15 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 15. ADNI AVLT - List A 30 Min Delay Recall Word 15 AVL01-List A 30 Min Delay Recall Total Auditory Verbal Learning Test Version A - The number of words recalled from List A, 30 Minute Delay recall. ADNI AVLT - List A 30 Min Delay Recall Total AVL01-List A 30 Min Delay Intrusions Auditory Verbal Learning Test Version A - The number of intrusions while recalling List A, 30 Minute Delay. ADNI AVLT - List A 30 Min Delay Intrusions AVL01-List A Recognition Total Auditory Verbal Learning Test Version A - The number of words correct on recognition test. ADNI AVLT - List A Recognition Total AVL01-List A Recognition Intrusions Auditory Verbal Learning Test Version A - The number of intrusions on recognition test. ADNI AVLT - List A Recognition Intrusions AVL01TC ADNI Auditory Verbal Learning Functional Test Test Code CDISC Functional Test ADNI AVLT Test Code Terminology ADNI AVLT test name. AVL01-List A 30 Min Delay Intrusions Auditory Verbal Learning Test Version A - The number of intrusions while recalling List A, 30 Minute Delay. ADNI AVLT - List A 30 Min Delay Intrusions AVL01-List A 30 Min Delay Recall Total Auditory Verbal Learning Test Version A - The number of words recalled from List A, 30 Minute Delay recall. ADNI AVLT - List A 30 Min Delay Recall Total AVL01-List A 30 Min Delay Recall Word 1 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 1. ADNI AVLT - List A 30 Min Delay Recall Word 1 AVL01-List A 30 Min Delay Recall Word 10 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 10. ADNI AVLT - List A 30 Min Delay Recall Word 10 AVL01-List A 30 Min Delay Recall Word 11 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 11. ADNI AVLT - List A 30 Min Delay Recall Word 11 AVL01-List A 30 Min Delay Recall Word 12 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 12. ADNI AVLT - List A 30 Min Delay Recall Word 12 AVL01-List A 30 Min Delay Recall Word 13 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 13. ADNI AVLT - List A 30 Min Delay Recall Word 13 AVL01-List A 30 Min Delay Recall Word 14 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 14. ADNI AVLT - List A 30 Min Delay Recall Word 14 AVL01-List A 30 Min Delay Recall Word 15 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 15. ADNI AVLT - List A 30 Min Delay Recall Word 15 AVL01-List A 30 Min Delay Recall Word 2 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 2. ADNI AVLT - List A 30 Min Delay Recall Word 2 AVL01-List A 30 Min Delay Recall Word 3 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 3. ADNI AVLT - List A 30 Min Delay Recall Word 3 AVL01-List A 30 Min Delay Recall Word 4 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 4. ADNI AVLT - List A 30 Min Delay Recall Word 4 AVL01-List A 30 Min Delay Recall Word 5 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 5. ADNI AVLT - List A 30 Min Delay Recall Word 5 AVL01-List A 30 Min Delay Recall Word 6 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 6. ADNI AVLT - List A 30 Min Delay Recall Word 6 AVL01-List A 30 Min Delay Recall Word 7 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 7. ADNI AVLT - List A 30 Min Delay Recall Word 7 AVL01-List A 30 Min Delay Recall Word 8 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 8. ADNI AVLT - List A 30 Min Delay Recall Word 8 AVL01-List A 30 Min Delay Recall Word 9 Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 9. ADNI AVLT - List A 30 Min Delay Recall Word 9 AVL01-List A Intrusions 1 Auditory Verbal Learning Test Version A - The number of intrusions while recalling List A, first attempt. ADNI AVLT - List A Intrusions 1 AVL01-List A Intrusions 2 Auditory Verbal Learning Test Version A - The number of intrusions while recalling List A, second attempt. ADNI AVLT - List A Intrusions 2 AVL01-List A Intrusions 3 Auditory Verbal Learning Test Version A - The number of intrusions while recalling List A, third attempt. ADNI AVLT - List A Intrusions 3 AVL01-List A Intrusions 4 Auditory Verbal Learning Test Version A - The number of intrusions while recalling List A, fourth attempt. ADNI AVLT - List A Intrusions 4 AVL01-List A Intrusions 5 Auditory Verbal Learning Test Version A - The number of intrusions while recalling List A, fifth attempt. ADNI AVLT - List A Intrusions 5 AVL01-List A Intrusions 6 Auditory Verbal Learning Test Version A - The number of intrusions while recalling List A, sixth attempt (after List B recall). ADNI AVLT - List A Intrusions 6 AVL01-List A Recall 1 Total Auditory Verbal Learning Test Version A - The number of words recalled from List A, first attempt. ADNI AVLT - List A Recall 1 Total AVL01-List A Recall 1 Word 1 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 1. ADNI AVLT - List A Recall 1 Word 1 AVL01-List A Recall 1 Word 10 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 10. ADNI AVLT - List A Recall 1 Word 10 AVL01-List A Recall 1 Word 11 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 11. ADNI AVLT - List A Recall 1 Word 11 AVL01-List A Recall 1 Word 12 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 12. ADNI AVLT - List A Recall 1 Word 12 AVL01-List A Recall 1 Word 13 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 13. ADNI AVLT - List A Recall 1 Word 13 AVL01-List A Recall 1 Word 14 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 14. ADNI AVLT - List A Recall 1 Word 14 AVL01-List A Recall 1 Word 15 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 15. ADNI AVLT - List A Recall 1 Word 15 AVL01-List A Recall 1 Word 2 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 2. ADNI AVLT - List A Recall 1 Word 2 AVL01-List A Recall 1 Word 3 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 3. ADNI AVLT - List A Recall 1 Word 3 AVL01-List A Recall 1 Word 4 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 4. ADNI AVLT - List A Recall 1 Word 4 AVL01-List A Recall 1 Word 5 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 5. ADNI AVLT - List A Recall 1 Word 5 AVL01-List A Recall 1 Word 6 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 6. ADNI AVLT - List A Recall 1 Word 6 AVL01-List A Recall 1 Word 7 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 7. ADNI AVLT - List A Recall 1 Word 7 AVL01-List A Recall 1 Word 8 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 8. ADNI AVLT - List A Recall 1 Word 8 AVL01-List A Recall 1 Word 9 Auditory Verbal Learning Test Version A - List A, Recall 1, Word 9. ADNI AVLT - List A Recall 1 Word 9 AVL01-List A Recall 2 Total Auditory Verbal Learning Test Version A - The number of words recalled from List A, second attempt. ADNI AVLT - List A Recall 2 Total AVL01-List A Recall 2 Word 1 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 1. ADNI AVLT - List A Recall 2 Word 1 AVL01-List A Recall 2 Word 10 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 10. ADNI AVLT - List A Recall 2 Word 10 AVL01-List A Recall 2 Word 11 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 11. ADNI AVLT - List A Recall 2 Word 11 AVL01-List A Recall 2 Word 12 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 12. ADNI AVLT - List A Recall 2 Word 12 AVL01-List A Recall 2 Word 13 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 13. ADNI AVLT - List A Recall 2 Word 13 AVL01-List A Recall 2 Word 14 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 14. ADNI AVLT - List A Recall 2 Word 14 AVL01-List A Recall 2 Word 15 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 15. ADNI AVLT - List A Recall 2 Word 15 AVL01-List A Recall 2 Word 2 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 2. ADNI AVLT - List A Recall 2 Word 2 AVL01-List A Recall 2 Word 3 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 3. ADNI AVLT - List A Recall 2 Word 3 AVL01-List A Recall 2 Word 4 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 4. ADNI AVLT - List A Recall 2 Word 4 AVL01-List A Recall 2 Word 5 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 5. ADNI AVLT - List A Recall 2 Word 5 AVL01-List A Recall 2 Word 6 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 6. ADNI AVLT - List A Recall 2 Word 6 AVL01-List A Recall 2 Word 7 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 7. ADNI AVLT - List A Recall 2 Word 7 AVL01-List A Recall 2 Word 8 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 8. ADNI AVLT - List A Recall 2 Word 8 AVL01-List A Recall 2 Word 9 Auditory Verbal Learning Test Version A - List A, Recall 2, Word 9. ADNI AVLT - List A Recall 2 Word 9 AVL01-List A Recall 3 Total Auditory Verbal Learning Test Version A - The number of words recalled from List A, third attempt. ADNI AVLT - List A Recall 3 Total AVL01-List A Recall 3 Word 1 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 1. ADNI AVLT - List A Recall 3 Word 1 AVL01-List A Recall 3 Word 10 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 10. ADNI AVLT - List A Recall 3 Word 10 AVL01-List A Recall 3 Word 11 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 11. ADNI AVLT - List A Recall 3 Word 11 AVL01-List A Recall 3 Word 12 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 12. ADNI AVLT - List A Recall 3 Word 12 AVL01-List A Recall 3 Word 13 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 13. ADNI AVLT - List A Recall 3 Word 13 AVL01-List A Recall 3 Word 14 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 14. ADNI AVLT - List A Recall 3 Word 14 AVL01-List A Recall 3 Word 15 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 15. ADNI AVLT - List A Recall 3 Word 15 AVL01-List A Recall 3 Word 2 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 2. ADNI AVLT - List A Recall 3 Word 2 AVL01-List A Recall 3 Word 3 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 3. ADNI AVLT - List A Recall 3 Word 3 AVL01-List A Recall 3 Word 4 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 4. ADNI AVLT - List A Recall 3 Word 4 AVL01-List A Recall 3 Word 5 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 5. ADNI AVLT - List A Recall 3 Word 5 AVL01-List A Recall 3 Word 6 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 6. ADNI AVLT - List A Recall 3 Word 6 AVL01-List A Recall 3 Word 7 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 7. ADNI AVLT - List A Recall 3 Word 7 AVL01-List A Recall 3 Word 8 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 8. ADNI AVLT - List A Recall 3 Word 8 AVL01-List A Recall 3 Word 9 Auditory Verbal Learning Test Version A - List A, Recall 3, Word 9. ADNI AVLT - List A Recall 3 Word 9 AVL01-List A Recall 4 Total Auditory Verbal Learning Test Version A - The number of words recalled from List A, fourth attempt. ADNI AVLT - List A Recall 4 Total AVL01-List A Recall 4 Word 1 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 1. ADNI AVLT - List A Recall 4 Word 1 AVL01-List A Recall 4 Word 10 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 10. ADNI AVLT - List A Recall 4 Word 10 AVL01-List A Recall 4 Word 11 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 11. ADNI AVLT - List A Recall 4 Word 11 AVL01-List A Recall 4 Word 12 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 12. ADNI AVLT - List A Recall 4 Word 12 AVL01-List A Recall 4 Word 13 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 13. ADNI AVLT - List A Recall 4 Word 13 AVL01-List A Recall 4 Word 14 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 14. ADNI AVLT - List A Recall 4 Word 14 AVL01-List A Recall 4 Word 15 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 15. ADNI AVLT - List A Recall 4 Word 15 AVL01-List A Recall 4 Word 2 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 2. ADNI AVLT - List A Recall 4 Word 2 AVL01-List A Recall 4 Word 3 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 3. ADNI AVLT - List A Recall 4 Word 3 AVL01-List A Recall 4 Word 4 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 4. ADNI AVLT - List A Recall 4 Word 4 AVL01-List A Recall 4 Word 5 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 5. ADNI AVLT - List A Recall 4 Word 5 AVL01-List A Recall 4 Word 6 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 6. ADNI AVLT - List A Recall 4 Word 6 AVL01-List A Recall 4 Word 7 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 7. ADNI AVLT - List A Recall 4 Word 7 AVL01-List A Recall 4 Word 8 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 8. ADNI AVLT - List A Recall 4 Word 8 AVL01-List A Recall 4 Word 9 Auditory Verbal Learning Test Version A - List A, Recall 4, Word 9. ADNI AVLT - List A Recall 4 Word 9 AVL01-List A Recall 5 Total Auditory Verbal Learning Test Version A - The number of words recalled from List A, fifth attempt. ADNI AVLT - List A Recall 5 Total AVL01-List A Recall 5 Word 1 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 1. ADNI AVLT - List A Recall 5 Word 1 AVL01-List A Recall 5 Word 10 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 10. ADNI AVLT - List A Recall 5 Word 10 AVL01-List A Recall 5 Word 11 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 11. ADNI AVLT - List A Recall 5 Word 11 AVL01-List A Recall 5 Word 12 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 12. ADNI AVLT - List A Recall 5 Word 12 AVL01-List A Recall 5 Word 13 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 13. ADNI AVLT - List A Recall 5 Word 13 AVL01-List A Recall 5 Word 14 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 14. ADNI AVLT - List A Recall 5 Word 14 AVL01-List A Recall 5 Word 15 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 15. ADNI AVLT - List A Recall 5 Word 15 AVL01-List A Recall 5 Word 2 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 2. ADNI AVLT - List A Recall 5 Word 2 AVL01-List A Recall 5 Word 3 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 3. ADNI AVLT - List A Recall 5 Word 3 AVL01-List A Recall 5 Word 4 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 4. ADNI AVLT - List A Recall 5 Word 4 AVL01-List A Recall 5 Word 5 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 5. ADNI AVLT - List A Recall 5 Word 5 AVL01-List A Recall 5 Word 6 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 6. ADNI AVLT - List A Recall 5 Word 6 AVL01-List A Recall 5 Word 7 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 7. ADNI AVLT - List A Recall 5 Word 7 AVL01-List A Recall 5 Word 8 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 8. ADNI AVLT - List A Recall 5 Word 8 AVL01-List A Recall 5 Word 9 Auditory Verbal Learning Test Version A - List A, Recall 5, Word 9. ADNI AVLT - List A Recall 5 Word 9 AVL01-List A Recall 6 (After B) Total Auditory Verbal Learning Test Version A - The number of words recalled from List A, sixth attempt (after List B recall). ADNI AVLT - List A Recall 6 (After B) Total AVL01-List A Recall 6 (After B) Word 1 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 1. ADNI AVLT - List A Recall 6 (After B) Word 1 AVL01-List A Recall 6 (After B) Word 10 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 10. ADNI AVLT - List A Recall 6 (After B) Word 10 AVL01-List A Recall 6 (After B) Word 11 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 11. ADNI AVLT - List A Recall 6 (After B) Word 11 AVL01-List A Recall 6 (After B) Word 12 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 12. ADNI AVLT - List A Recall 6 (After B) Word 12 AVL01-List A Recall 6 (After B) Word 13 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 13. ADNI AVLT - List A Recall 6 (After B) Word 13 AVL01-List A Recall 6 (After B) Word 14 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 14. ADNI AVLT - List A Recall 6 (After B) Word 14 AVL01-List A Recall 6 (After B) Word 15 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 15. ADNI AVLT - List A Recall 6 (After B) Word 15 AVL01-List A Recall 6 (After B) Word 2 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 2. ADNI AVLT - List A Recall 6 (After B) Word 2 AVL01-List A Recall 6 (After B) Word 3 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 3. ADNI AVLT - List A Recall 6 (After B) Word 3 AVL01-List A Recall 6 (After B) Word 4 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 4. ADNI AVLT - List A Recall 6 (After B) Word 4 AVL01-List A Recall 6 (After B) Word 5 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 5. ADNI AVLT - List A Recall 6 (After B) Word 5 AVL01-List A Recall 6 (After B) Word 6 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 6. ADNI AVLT - List A Recall 6 (After B) Word 6 AVL01-List A Recall 6 (After B) Word 7 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 7. ADNI AVLT - List A Recall 6 (After B) Word 7 AVL01-List A Recall 6 (After B) Word 8 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 8. ADNI AVLT - List A Recall 6 (After B) Word 8 AVL01-List A Recall 6 (After B) Word 9 Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 9. ADNI AVLT - List A Recall 6 (After B) Word 9 AVL01-List A Recognition Intrusions Auditory Verbal Learning Test Version A - The number of intrusions on recognition test. ADNI AVLT - List A Recognition Intrusions AVL01-List A Recognition Total Auditory Verbal Learning Test Version A - The number of words correct on recognition test. ADNI AVLT - List A Recognition Total AVL01-List B Intrusions Auditory Verbal Learning Test Version A - The number of intrusions while recalling List B. ADNI AVLT - List B Intrusions AVL01-List B Recall Total Auditory Verbal Learning Test Version A - The number of words recalled from List B. ADNI AVLT - List B Recall Total AVL01-List B Recall Word 1 Auditory Verbal Learning Test Version A - List B, Word 1. ADNI AVLT - List B Recall Word 1 AVL01-List B Recall Word 10 Auditory Verbal Learning Test Version A - List B, Word 10. ADNI AVLT - List B Recall Word 10 AVL01-List B Recall Word 11 Auditory Verbal Learning Test Version A - List B, Word 11. ADNI AVLT - List B Recall Word 11 AVL01-List B Recall Word 12 Auditory Verbal Learning Test Version A - List B, Word 12. ADNI AVLT - List B Recall Word 12 AVL01-List B Recall Word 13 Auditory Verbal Learning Test Version A - List B, Word 13. ADNI AVLT - List B Recall Word 13 AVL01-List B Recall Word 14 Auditory Verbal Learning Test Version A - List B, Word 14. ADNI AVLT - List B Recall Word 14 AVL01-List B Recall Word 15 Auditory Verbal Learning Test Version A - List B, Word 15. ADNI AVLT - List B Recall Word 15 AVL01-List B Recall Word 2 Auditory Verbal Learning Test Version A - List B, Word 2. ADNI AVLT - List B Recall Word 2 AVL01-List B Recall Word 3 Auditory Verbal Learning Test Version A - List B, Word 3. ADNI AVLT - List B Recall Word 3 AVL01-List B Recall Word 4 Auditory Verbal Learning Test Version A - List B, Word 4. ADNI AVLT - List B Recall Word 4 AVL01-List B Recall Word 5 Auditory Verbal Learning Test Version A - List B, Word 5. ADNI AVLT - List B Recall Word 5 AVL01-List B Recall Word 6 Auditory Verbal Learning Test Version A - List B, Word 6. ADNI AVLT - List B Recall Word 6 AVL01-List B Recall Word 7 Auditory Verbal Learning Test Version A - List B, Word 7. ADNI AVLT - List B Recall Word 7 AVL01-List B Recall Word 8 Auditory Verbal Learning Test Version A - List B, Word 8. ADNI AVLT - List B Recall Word 8 AVL01-List B Recall Word 9 Auditory Verbal Learning Test Version A - List B, Word 9. ADNI AVLT - List B Recall Word 9 AVL01TN ADNI Auditory Verbal Learning Functional Test Test Name CDISC Functional Test ADNI AVLT Test Name Terminology Those units of time that are routinely used to express the age of a subject. A unit of measurement of time equal to 24 hours. Day h Hours hr A unit of measurement of time equal to 60 minutes. Hour Month One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks. (NCI) Month Week Any period of seven consecutive days. (NCI) Week Year The period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period. (NCI) Year AGEU Age Unit CDISC SDTM Age Unit Terminology Airway Questionnaire 20 test code. AQ01-Cough Often During Day Airway Questionnaire 20 - Do you cough often during the day? AQ20 - Cough Often During the Day AQ01-Feel Restless Due to Chest Trouble Airway Questionnaire 20 - Does your chest trouble often make you feel restless? AQ20 - Chest Trouble Make You Feel Restless AQ01-Gardening Make You Breathless Airway Questionnaire 20 - Does gardening make you breathless? AQ20 - Gardening Make You Breathless AQ01-Chest Upset at Friend House Airway Questionnaire 20 - Do you worry when going to a friend's house that there might be something there that will upset your chest? AQ20 - Worry When Going to Friend House Something Will Upset Your Chest AQ01-Chest Prob Smell/Fume/Smoke/Perfume Airway Questionnaire 20 - Do you get chest problems when you come into contact with strong smells, exhaust fumes, cigarette smoke, perfume etc? AQ20 - Get Chest Problems When Contact With Strong Smells AQ01-Partner Upset by Your Chest Trouble Airway Questionnaire 20 - Does your partner find your chest trouble upsetting? AQ20 - Partner Find Your Chest Trouble Upsetting AQ01-Breathless When Trying to Sleep Airway Questionnaire 20 - Do you feel breathless when trying to sleep? AQ20 - Feel Breathless When Trying to Sleep AQ01-Long Term Effects of Drugs Airway Questionnaire 20 - Do you worry about the long term effects of the drugs you take for your chest trouble? AQ20 - Worry About Long Term Effects of Drugs for Chest Trouble AQ01-Emotional Upset Worse Chest Trouble Airway Questionnaire 20 - Does getting emotionally upset make your chest trouble worse? AQ20 - Getting Emotionally Upset Make Chest Trouble Worse AQ01-Difficulty Getting Around the House Airway Questionnaire 20 - Are there times when you have difficulty getting around the house because of your chest trouble? AQ20 - Difficulty Getting Around the House Because of Chest Trouble AQ01-Breathless Carry out Work Activity Airway Questionnaire 20 - Does your chest problem make you breathless when you do things at work? (paid employment). AQ20 - Chest Problem Make You Breathless at Work AQ01-Breathless Walking Upstairs Airway Questionnaire 20 - Does walking upstairs make you breathless? AQ20 - Walking Upstairs Make You Breathless AQ01-Get Breathless Doing Housework Airway Questionnaire 20 - Do you get breathless doing housework? AQ20 - Get Breathless Doing Housework AQ01-Go Home Sooner Than Others Airway Questionnaire 20 - Does your chest trouble make you go home sooner than others after a night out? AQ20 - Chest Trouble Make You Go Home Sooner Than Others AQ01-Breathlessness When Laugh Airway Questionnaire 20 - Do you suffer from breathlessness when you laugh? AQ20 - Suffer From Breathlessness When Laugh AQ01-Impatient Due to Chest Trouble Airway Questionnaire 20 - Does your chest trouble often make you feel impatient? AQ20 - Chest Trouble Make You Feel Impatient AQ01-Full Life Limited by Chest Trouble Airway Questionnaire 20 - Do you think the fullness of your life is limited by your chest trouble? AQ20 - Fullness of Life is Limited by Chest Trouble AQ01-Drained After a Cold Airway Questionnaire 20 - Do you feel drained after a cold because of your chest trouble? AQ20 - Feel Drained After a Cold Because of Chest Trouble AQ01-Feeling of Chest Heaviness Airway Questionnaire 20 - Do you have a feeling of chest heaviness? AQ20 - Feeling of Chest Heaviness AQ01-Worry About Chest Trouble Airway Questionnaire 20 - Do you worry a lot about your chest trouble? AQ20 - Worry a Lot About Chest Trouble AQ01TC Airway Questionnaire 20 Questionnaire Test Code CDISC Questionnaire AQ20 Test Code Terminology Airway Questionnaire 20 test name. AQ01-Breathless Carry out Work Activity Airway Questionnaire 20 - Does your chest problem make you breathless when you do things at work? (paid employment). AQ20 - Chest Problem Make You Breathless at Work AQ01-Breathless Walking Upstairs Airway Questionnaire 20 - Does walking upstairs make you breathless? AQ20 - Walking Upstairs Make You Breathless AQ01-Breathless When Trying to Sleep Airway Questionnaire 20 - Do you feel breathless when trying to sleep? AQ20 - Feel Breathless When Trying to Sleep AQ01-Breathlessness When Laugh Airway Questionnaire 20 - Do you suffer from breathlessness when you laugh? AQ20 - Suffer From Breathlessness When Laugh AQ01-Chest Prob Smell/Fume/Smoke/Perfume Airway Questionnaire 20 - Do you get chest problems when you come into contact with strong smells, exhaust fumes, cigarette smoke, perfume etc? AQ20 - Get Chest Problems When Contact With Strong Smells AQ01-Chest Upset at Friend House Airway Questionnaire 20 - Do you worry when going to a friend's house that there might be something there that will upset your chest? AQ20 - Worry When Going to Friend House Something Will Upset Your Chest AQ01-Cough Often During Day Airway Questionnaire 20 - Do you cough often during the day? AQ20 - Cough Often During the Day AQ01-Difficulty Getting Around the House Airway Questionnaire 20 - Are there times when you have difficulty getting around the house because of your chest trouble? AQ20 - Difficulty Getting Around the House Because of Chest Trouble AQ01-Drained After a Cold Airway Questionnaire 20 - Do you feel drained after a cold because of your chest trouble? AQ20 - Feel Drained After a Cold Because of Chest Trouble AQ01-Emotional Upset Worse Chest Trouble Airway Questionnaire 20 - Does getting emotionally upset make your chest trouble worse? AQ20 - Getting Emotionally Upset Make Chest Trouble Worse AQ01-Feel Restless Due to Chest Trouble Airway Questionnaire 20 - Does your chest trouble often make you feel restless? AQ20 - Chest Trouble Make You Feel Restless AQ01-Feeling of Chest Heaviness Airway Questionnaire 20 - Do you have a feeling of chest heaviness? AQ20 - Feeling of Chest Heaviness AQ01-Full Life Limited by Chest Trouble Airway Questionnaire 20 - Do you think the fullness of your life is limited by your chest trouble? AQ20 - Fullness of Life is Limited by Chest Trouble AQ01-Gardening Make You Breathless Airway Questionnaire 20 - Does gardening make you breathless? AQ20 - Gardening Make You Breathless AQ01-Get Breathless Doing Housework Airway Questionnaire 20 - Do you get breathless doing housework? AQ20 - Get Breathless Doing Housework AQ01-Go Home Sooner Than Others Airway Questionnaire 20 - Does your chest trouble make you go home sooner than others after a night out? AQ20 - Chest Trouble Make You Go Home Sooner Than Others AQ01-Impatient Due to Chest Trouble Airway Questionnaire 20 - Does your chest trouble often make you feel impatient? AQ20 - Chest Trouble Make You Feel Impatient AQ01-Long Term Effects of Drugs Airway Questionnaire 20 - Do you worry about the long term effects of the drugs you take for your chest trouble? AQ20 - Worry About Long Term Effects of Drugs for Chest Trouble AQ01-Partner Upset by Your Chest Trouble Airway Questionnaire 20 - Does your partner find your chest trouble upsetting? AQ20 - Partner Find Your Chest Trouble Upsetting AQ01-Worry About Chest Trouble Airway Questionnaire 20 - Do you worry a lot about your chest trouble? AQ20 - Worry a Lot About Chest Trouble AQ01TN Airway Questionnaire 20 Questionnaire Test Name CDISC Questionnaire AQ20 Test Name Terminology AJCC TNM Staging System 7th Edition test code. AJCC1-Primary Tumor (T) AJCC TNM Staging System 7th Edition - Primary tumor (T). AJCC v7 - Primary Tumor (T) AJCC1-Regional Lymph Nodes (N) AJCC TNM Staging System 7th Edition - Regional lymph nodes (N). AJCC v7 - Regional Lymph Nodes (N) AJCC1-Distant Metastasis (M) AJCC TNM Staging System 7th Edition - Distant metastasis (M). AJCC v7 - Distant Metastasis (M) AJCC1-Anatomic Stage AJCC TNM Staging System 7th Edition - Anatomic stage. AJCC v7 - Anatomic Stage AJCC1-Residual Tumor (R) AJCC TNM Staging System 7th Edition - Residual tumor (R). AJCC v7 - Residual Tumor (R) AJCC1TC AJCC TNM Staging System 7th Edition Clinical Classification Test Code CDISC Clinical Classification AJCC v7 Test Code Terminology AJCC TNM Staging System 7th Edition test name. AJCC1-Anatomic Stage AJCC TNM Staging System 7th Edition - Anatomic stage. AJCC v7 - Anatomic Stage AJCC1-Distant Metastasis (M) AJCC TNM Staging System 7th Edition - Distant metastasis (M). AJCC v7 - Distant Metastasis (M) AJCC1-Primary Tumor (T) AJCC TNM Staging System 7th Edition - Primary tumor (T). AJCC v7 - Primary Tumor (T) AJCC1-Regional Lymph Nodes (N) AJCC TNM Staging System 7th Edition - Regional lymph nodes (N). AJCC v7 - Regional Lymph Nodes (N) AJCC1-Residual Tumor (R) AJCC TNM Staging System 7th Edition - Residual tumor (R). AJCC v7 - Residual Tumor (R) AJCC1TN AJCC TNM Staging System 7th Edition Clinical Classification Test Name CDISC Clinical Classification AJCC v7 Test Name Terminology Terminology relevant to the American Joint Committee on Cancer (AJCC) tumor grading system responses. AJCC Grade 1 A morphologic qualifier by the American Joint Cancer Committee (AJCC) indicating that a cancerous lesion is well differentiated. AJCC Grade 1 AJCC Grade 2 A morphologic qualifier by the American Joint Cancer Committee (AJCC) indicating that a cancerous lesion is moderately differentiated. AJCC Grade 2 AJCC Grade 3 A morphologic qualifier by the American Joint Cancer Committee (AJCC) indicating that a cancerous lesion is poorly differentiated. AJCC Grade 3 AJCC Grade 4 A morphologic qualifier by the American Joint Cancer Committee (AJCC) indicating that a cancerous lesion is undifferentiated. AJCC Grade 4 AJCC Grade X A morphologic qualifier by the American Joint Cancer Committee (AJCC) indicating that the grade of a cancerous lesion cannot be assessed. AJCC Grade X AJCCGRD AJCC Tumor Grade Response CDISC SDTM AJCC Tumor Grade Response Terminology Alcohol Use Disorder Identification Test-Consumption Questions test code. ADTC01-How Often Drink Alcohol Alcohol Use Disorder Identification Test-Consumption questions - How often do you have a drink containing alcohol? AUDIT-C - How Often Have Alcohol Drink ADTC01-Alcohol Drinks on a Typical Day Alcohol Use Disorder Identification Test-Consumption questions - How many standard drinks containing alcohol do you have on a typical day? AUDIT-C - How Many Alcohol Drinks on a Typical Day ADTC01-Six or More Drinks One Occasion Alcohol Use Disorder Identification Test-Consumption questions - How often do you have six or more drinks on one occasion? AUDIT-C - How Often Have Six or More Drinks ADTC01TC Alcohol Use Disorder Identification Test-Consumption Questions Questionnaire Test Code CDISC Questionnaire AUDIT-C Test Code Terminology Alcohol Use Disorder Identification Test-Consumption Questions test name. ADTC01-Alcohol Drinks on a Typical Day Alcohol Use Disorder Identification Test-Consumption questions - How many standard drinks containing alcohol do you have on a typical day? AUDIT-C - How Many Alcohol Drinks on a Typical Day ADTC01-How Often Drink Alcohol Alcohol Use Disorder Identification Test-Consumption questions - How often do you have a drink containing alcohol? AUDIT-C - How Often Have Alcohol Drink ADTC01-Six or More Drinks One Occasion Alcohol Use Disorder Identification Test-Consumption questions - How often do you have six or more drinks on one occasion? AUDIT-C - How Often Have Six or More Drinks ADTC01TN Alcohol Use Disorder Identification Test-Consumption Questions Questionnaire Test Name CDISC Questionnaire AUDIT-C Test Name Terminology Alcohol Use Disorder Identification Test: Self-Report Version test code. ADT01-How Often Drink Alcohol Alcohol Use Disorder Identification Test: Self-Report Version - How often do you have a drink containing alcohol? AUDIT - How Often Have Alcohol Drink ADT01-Alcohol Drinks on a Typical Day Alcohol Use Disorder Identification Test: Self-Report Version - How many drinks containing alcohol do you have on a typical day when you are drinking? AUDIT - How Many Alcohol Drinks on a Typical Day ADT01-Six or More Drinks One Occasion Alcohol Use Disorder Identification Test: Self-Report Version - How often do you have six or more drinks on one occasion? AUDIT - How Often Have Six or More Drinks ADT01-Not Able Stop Drinking Once Start Alcohol Use Disorder Identification Test: Self-Report Version - How often during the last year have you found that you were not able to stop drinking once you had started? AUDIT - How Often Last Year You Found Not Able to Stop Drinking ADT01-Failed to Do as Expected Alcohol Use Disorder Identification Test: Self-Report Version - How often during the last year have you failed to do what was normally expected of you because of drinking? AUDIT - How Often Last Year You Failed to Do Normally Expected of You ADT01-Need Drink Morning After Drinking Alcohol Use Disorder Identification Test: Self-Report Version - How often during the last year have you needed a first drink in the morning to get yourself going after a heavy drinking session? AUDIT - How Often Last Year Need a Drink in the Morning to Get Going ADT01-Feeling of Guilt or Remorse Alcohol Use Disorder Identification Test: Self-Report Version - How often during the last year have you had a feeling of guilt or remorse after drinking? AUDIT - How Often Last Year You Feel Guilt or Remorse After Drinking ADT01-Unable to Remember What Happened Alcohol Use Disorder Identification Test: Self-Report Version - How often during the last year have you been unable to remember what happened the night before because of your drinking? AUDIT - How Often Last Year You Unable to Remember What Happened the Night Before ADT01-Injured Because of Your Drinking Alcohol Use Disorder Identification Test: Self-Report Version - Have you or someone else been injured because of your drinking? AUDIT - Injured Because of Drinking ADT01-Suggested to Cut Down Alcohol Use Disorder Identification Test: Self-Report Version - Has a relative, friend, doctor, or other health care worker been concerned about your drinking or suggested you cut down? AUDIT - Concerned About Your Drinking ADT01-Total Alcohol Use Disorder Identification Test: Self-Report Version - Total. AUDIT - Total ADT01TC Alcohol Use Disorder Identification Test: Self-Report Version Questionnaire Test Code CDISC Questionnaire AUDIT-SR Test Code Terminology Alcohol Use Disorder Identification Test: Self-Report Version test name. ADT01-Alcohol Drinks on a Typical Day Alcohol Use Disorder Identification Test: Self-Report Version - How many drinks containing alcohol do you have on a typical day when you are drinking? AUDIT - How Many Alcohol Drinks on a Typical Day ADT01-Failed to Do as Expected Alcohol Use Disorder Identification Test: Self-Report Version - How often during the last year have you failed to do what was normally expected of you because of drinking? AUDIT - How Often Last Year You Failed to Do Normally Expected of You ADT01-Feeling of Guilt or Remorse Alcohol Use Disorder Identification Test: Self-Report Version - How often during the last year have you had a feeling of guilt or remorse after drinking? AUDIT - How Often Last Year You Feel Guilt or Remorse After Drinking ADT01-How Often Drink Alcohol Alcohol Use Disorder Identification Test: Self-Report Version - How often do you have a drink containing alcohol? AUDIT - How Often Have Alcohol Drink ADT01-Injured Because of Your Drinking Alcohol Use Disorder Identification Test: Self-Report Version - Have you or someone else been injured because of your drinking? AUDIT - Injured Because of Drinking ADT01-Need Drink Morning After Drinking Alcohol Use Disorder Identification Test: Self-Report Version - How often during the last year have you needed a first drink in the morning to get yourself going after a heavy drinking session? AUDIT - How Often Last Year Need a Drink in the Morning to Get Going ADT01-Not Able Stop Drinking Once Start Alcohol Use Disorder Identification Test: Self-Report Version - How often during the last year have you found that you were not able to stop drinking once you had started? AUDIT - How Often Last Year You Found Not Able to Stop Drinking ADT01-Six or More Drinks One Occasion Alcohol Use Disorder Identification Test: Self-Report Version - How often do you have six or more drinks on one occasion? AUDIT - How Often Have Six or More Drinks ADT01-Suggested to Cut Down Alcohol Use Disorder Identification Test: Self-Report Version - Has a relative, friend, doctor, or other health care worker been concerned about your drinking or suggested you cut down? AUDIT - Concerned About Your Drinking ADT01-Total Alcohol Use Disorder Identification Test: Self-Report Version - Total. AUDIT - Total ADT01-Unable to Remember What Happened Alcohol Use Disorder Identification Test: Self-Report Version - How often during the last year have you been unable to remember what happened the night before because of your drinking? AUDIT - How Often Last Year You Unable to Remember What Happened the Night Before ADT01TN Alcohol Use Disorder Identification Test: Self-Report Version Questionnaire Test Name CDISC Questionnaire AUDIT-SR Test Name Terminology Alcohol Use Disorders Identification Test-Concise Interview Version original result for ADTC0301 test and test code. ADTC0301-2-3 times a week Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 original result for ADTC0301-2-3 times a week. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0301 Original Result - 2-3 times a week ADTC0301-2-4 times a month Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 original result for ADTC0301-2-4 times a month. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0301 Original Result - 2-4 times a month ADTC0301-4 or more times a week Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 original result for ADTC0301-4 or more times a week. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0301 Original Result - 4 or more times a week ADTC0301-Monthly or less Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 original result for ADTC0301-Monthly or less. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0301 Original Result - Monthly or less ADTC0301-Never Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 original result for ADTC0301-Never. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0301 Original Result - Never ADTC0301OR Alcohol Use Disorders Identification Test-Concise Interview Version ORRES for ADTC0301 TN/TC CDISC Questionnaire Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0301 Original Response Terminology Alcohol Use Disorders Identification Test-Concise Interview Version ORRES forADTC0302 test and test code. ADTC0302-1 or 2 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 original result for ADTC0302-1 or 2 drinks. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0302 Original Result - 1 to 2 ADTC0302-10 or more Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 original result for ADTC0302-10 or more drinks. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0302 Original Result - 10 or More ADTC0302-3 or 4 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 original result for ADTC0302-3 or 4 drinks. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0302 Original Result - 3 or 4 ADTC0302-5 or 6 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 original result for ADTC0302-5 or 6 drinks. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0302 Original Result - 5 or 6 ADTC0302-7 to 9 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 original result for ADTC0302-7 to 9 drinks. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0302 Original Result - 7 to 9 ADTC0302OR Alcohol Use Disorders Identification Test-Concise Interview Version ORRES for ADTC0302 TN/TC CDISC Questionnaire Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0302 Original Response Terminology Alcohol Use Disorders Identification Test-Concise Interview Version ORRES forADTC0303 test and test code. ADTC0303-Daily or almost daily Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 original result for ADTC0303-Daily or almost daily. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0303 Original Result - Daily or almost daily ADTC0303-Less than monthly Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 original result for ADTC0303-Less than monthly. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0303 Original Result - Less than monthly ADTC0303-Monthly Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 original result for ADTC0303-Monthly. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0303 Original Result - Monthly ADTC0303-Never Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 original result for ADTC0303-Never. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0303 Original Result - Never ADTC0303-Weekly Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 original result for ADTC0303-Weekly. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0303 Original Result - Weekly ADTC0303OR Alcohol Use Disorders Identification Test-Concise Interview Version ORRES for ADTC0303 TN/TC CDISC Questionnaire Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0303 Original Response Terminology Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire test code. ADTC03-How Often Drink Alcohol Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 - How often do you have a drink containing alcohol? AUDIT-C Interview Version - How Often Drink Alcohol ADTC03-Alcohol Drinks on a Typical Day Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 - How many drinks containing alcohol do you have on a typical day? AUDIT-C Interview Version - Alcohol Drinks on a Typical Day ADTC03-Six or More Drinks One Occasion Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 - How often do you have six or more drinks on one occasion? AUDIT-C Interview Version - Six or More Drinks One Occasion ADTC03-Total Score Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 - Total score. AUDIT-C Interview Version - Total Score ADTC03TC Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire Test Code CDISC Questionnaire AUDIT-C Interview Version Test Code Terminology Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire test name. ADTC03-Alcohol Drinks on a Typical Day Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 - How many drinks containing alcohol do you have on a typical day? AUDIT-C Interview Version - Alcohol Drinks on a Typical Day ADTC03-How Often Drink Alcohol Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 - How often do you have a drink containing alcohol? AUDIT-C Interview Version - How Often Drink Alcohol ADTC03-Six or More Drinks One Occasion Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 - How often do you have six or more drinks on one occasion? AUDIT-C Interview Version - Six or More Drinks One Occasion ADTC03-Total Score Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 - Total score. AUDIT-C Interview Version - Total Score ADTC03TN Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire Test Name CDISC Questionnaire AUDIT-C Interview Version Test Name Terminology Alcohol Use Disorders Identification Test-Concise Interview Version standardized character result for ADTC0301 test and test code. ADTC0301-0 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 standardized character result for ADTC0301-Never. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0301 Standardized Character Result 0 ADTC0301-1 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 standardized character result for ADTC0301-Monthly or less. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0301 Standardized Character Result 1 ADTC0301-2 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 standardized character result for ADTC0301-2-4 times a month. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0301 Standardized Character Result 2 ADTC0301-3 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 standardized character result for ADTC0301-2-3 times a week. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0301 Standardized Character Result 3 ADTC0301-4 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 standardized character result for ADTC0301-4 or more times a week. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0301 Standardized Character Result 4 ADTC0301STR Alcohol Use Disorders Identification Test-Concise Interview Version STRESC for ADTC0301 TN/TC CDISC Questionnaire Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0301 Standardized Character Response Terminology Alcohol Use Disorders Identification Test-Concise Interview Version STRESC forADTC0302 test and test code. ADTC0302-0 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 standardized character result for ADTC0302-1 or 2 drinks. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0302 Standardized Character Result 0 ADTC0302-1 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 standardized character result for ADTC0302-3 or 4 drinks. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0302 Standardized Character Result 1 ADTC0302-2 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 standardized character result for ADTC0302-5 or 6 drinks. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0302 Standardized Character Result 2 ADTC0302-3 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 standardized character result for ADTC0302-7 to 9 drinks. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0302 Standardized Character Result 3 ADTC0302-4 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 standardized character result for ADTC0302-10 or more drinks. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0302 Standardized Character Result 4 ADTC0302STR Alcohol Use Disorders Identification Test-Concise Interview Version STRESC for ADTC0302 TN/TC CDISC Questionnaire Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0302 Standardized Character Response Terminology Alcohol Use Disorders Identification Test-Concise Interview Version STRESC forADTC0303 test and test code. ADTC0303-0 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 standardized character result for ADTC0303-Never. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0303 Standardized Character Result 0 ADTC0303-1 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 standardized character result for ADTC0303-Less than monthly. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0303 Standardized Character Result 1 ADTC0303-2 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 standardized character result for ADTC0303-Monthly. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0303 Standardized Character Result 2 ADTC0303-3 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 standardized character result for ADTC0303-Weekly. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0303 Standardized Character Result 3 ADTC0303-4 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 standardized character result for ADTC0303-Daily or almost daily. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0303 Standardized Character Result 4 ADTC0303STR Alcohol Use Disorders Identification Test-Concise Interview Version STRESC for ADTC0303 TN/TC CDISC Questionnaire Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC0303 Standardized Character Response Terminology Alcohol Use Disorders Identification Test-Concise Self-Report Version ORRES forADTC0201 test and test code. ADTC0201-2-3 times a week Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 original result for ADTC0201-2-3 times a week. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0201 Original Result - 2-3 times a week ADTC0201-2-4 times a month Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 original result for ADTC0201-2-4 times a month. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0201 Original Result - 2-4 times a month ADTC0201-4 or more times a week Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 original result for ADTC0201-4 or more times a week. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0201 Original Result - 4 or more times a week ADTC0201-Monthly or less Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 original result for ADTC0201-Monthly or less. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0201 Original Result - Monthly or less ADTC0201-Never Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 original result for ADTC0201-Never. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0201 Original Result - Never ADTC0201OR Alcohol Use Disorders Identification Test-Concise Self-Report Version ORRES for ADTC0201 TN/TC CDISC Questionnaire Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0201 Original Response Terminology Alcohol Use Disorders Identification Test-Concise Self-Report Version ORRES forADTC0202 test and test code. ADTC0202-0 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 original result for ADTC0202-0 drinks. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0202 Original Result - 0 ADTC0202-1 or 2 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 original result for ADTC0202-1 or 2 drinks. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0202 Original Result - 1 to 2 ADTC0202-10 or more Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 original result for ADTC0202-10 or more drinks. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0202 Original Result - 10 or more ADTC0202-3 or 4 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 original result for ADTC0202-3 or 4 drinks. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0202 Original Result - 3 or 4 ADTC0202-5 or 6 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 original result for ADTC0202-5 or 6 drinks. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0202 Original Result - 5 or 6 ADTC0202-7 to 9 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 original result for ADTC0202-7 to 9 drinks. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0202 Original Result - 7 to 9 ADTC0202OR Alcohol Use Disorders Identification Test-Concise Self-Report Version ORRES for ADTC0202 TN/TC CDISC Questionnaire Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0202 Original Response Terminology Alcohol Use Disorders Identification Test-Concise Self-Report Version ORRES forADTC0203 test and test code. ADTC0203-Daily or almost daily Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 original result for ADTC0203-Daily or almost daily. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0203 Original Result - Daily or almost daily ADTC0203-Less than monthly Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 original result for ADTC0203-Less than monthly. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0203 Original Result - Less than monthly ADTC0203-Monthly Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 original result for ADTC0203-Monthly. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0203 Original Result - Monthly ADTC0203-Never Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 original result for ADTC0203-Never. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0203 Original Result - Never ADTC0203-Weekly Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 original result for ADTC0203-Weekly. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0203 Original Result - Weekly ADTC0203OR Alcohol Use Disorders Identification Test-Concise Self-Report Version ORRES for ADTC0203 TN/TC CDISC Questionnaire Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0203 Original Response Terminology Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire test code. ADTC02-How Often Drink Alcohol Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 - How often do you have a drink containing alcohol? AUDIT-C Self-Report Version - How Often Drink Alcohol ADTC02-Alcohol Drinks on a Typical Day Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 - How many drinks containing alcohol do you have on a typical day when you are drinking? AUDIT-C Self-Report Version - Alcohol Drinks on a Typical Day ADTC02-Six or More Drinks One Occasion Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 - How often do you have six or more drinks on one occasion? AUDIT-C Self-Report Version - Six or More Drinks One Occasion ADTC02-Total Score Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 - Total score. AUDIT-C Self-Report Version - Total Score ADTC02TC Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire Test Code CDISC Questionnaire AUDIT-C Self-Report Version Test Code Terminology Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire test name. ADTC02-Alcohol Drinks on a Typical Day Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 - How many drinks containing alcohol do you have on a typical day when you are drinking? AUDIT-C Self-Report Version - Alcohol Drinks on a Typical Day ADTC02-How Often Drink Alcohol Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 - How often do you have a drink containing alcohol? AUDIT-C Self-Report Version - How Often Drink Alcohol ADTC02-Six or More Drinks One Occasion Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 - How often do you have six or more drinks on one occasion? AUDIT-C Self-Report Version - Six or More Drinks One Occasion ADTC02-Total Score Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 - Total score. AUDIT-C Self-Report Version - Total Score ADTC02TN Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire Test Name CDISC Questionnaire AUDIT-C Self-Report Version Test Name Terminology Alcohol Use Disorders Identification Test-Concise Self-Report Version STRESC forADTC0201 test and test code. ADTC0201-0 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 standardized character result for ADTC0201-Never. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0201 Standardized Character Result 0 ADTC0201-1 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 standardized character result for ADTC0201-Monthly or less. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0201 Standardized Character Result 1 ADTC0201-2 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 standardized character result for ADTC0201-2-4 times a month. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0201 Standardized Character Result 2 ADTC0201-3 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 standardized character result for ADTC0201-2-3 times a week. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0201 Standardized Character Result 3 ADTC0201-4 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 standardized character result for ADTC0201-4 or more times a week. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0201 Standardized Character Result 4 ADTC0201STR Alcohol Use Disorders Identification Test-Concise Self-Report Version STRESC for ADTC0201 TN/TC CDISC Questionnaire Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0201 Standardized Character Response Terminology Alcohol Use Disorders Identification Test-Concise Self-Report Version STRESC forADTC0202 test and test code. ADTC0202-0 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 standardized character result for ADTC0202-0 drinks; 1 or 2 drinks. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0202 Standardized Character Result 0 ADTC0202-1 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 standardized character result for ADTC0202-3 or 4 drinks. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0202 Standardized Character Result 1 ADTC0202-2 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 standardized character result for ADTC0202-5 or 6 drinks. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0202 Standardized Character Result 2 ADTC0202-3 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 standardized character result for ADTC0202-7 to 9 drinks. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0202 Standardized Character Result 3 ADTC0202-4 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 standardized character result for ADTC0202-10 or more drinks. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0202 Standardized Character Result 4 ADTC0202STR Alcohol Use Disorders Identification Test-Concise Self-Report Version STRESC for ADTC0202 TN/TC CDISC Questionnaire Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0202 Standardized Character Response Terminology Alcohol Use Disorders Identification Test-Concise Self-Report Version STRESC forADTC0203 test and test code. ADTC0203-0 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 standardized character result for ADTC0203-Never. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0203 Standardized Character Result 0 ADTC0203-1 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 standardized character result for ADTC0203-Less than monthly. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0203 Standardized Character Result 1 ADTC0203-2 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 standardized character result for ADTC0203-Monthly. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0203 Standardized Character Result 2 ADTC0203-3 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 standardized character result for ADTC0203-Weekly. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0203 Standardized Character Result 3 ADTC0203-4 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 standardized character result for ADTC0203-Daily or almost daily. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0203 Standardized Character Result 4 ADTC0203STR Alcohol Use Disorders Identification Test-Concise Self-Report Version STRESC for ADTC0203 TN/TC CDISC Questionnaire Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire ADTC0203 Standardized Character Response Terminology Alert Verbal Painful Unresponsive Scale test code. AVPU01-Responsiveness Alert Verbal Painful Unresponsive Scale - Responsivenesss. AVPU - Responsiveness AVPU01TC Alert Verbal Painful Unresponsive Scale Clinical Classification Test Code CDISC Clinical Classification AVPU Test Code Terminology Alert Verbal Painful Unresponsive Scale test name. AVPU01-Responsiveness Alert Verbal Painful Unresponsive Scale - Responsivenesss. AVPU - Responsiveness AVPU01TN Alert Verbal Painful Unresponsive Scale Clinical Classification Test Name CDISC Clinical Classification AVPU Test Name Terminology ADAS-Cog CDISC Version test code. Commands Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for commands. CDISC ADAS-Cog - Commands Summary Score Commands: Fist Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Commands task for making a fist. CDISC ADAS-Cog - Commands: Fist Commands: Ceiling Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Commands task for pointing to the ceiling then to the floor. CDISC ADAS-Cog - Commands: Ceiling Commands: Pencil Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Commands task for put the pencil on top of the card and then put it back. CDISC ADAS-Cog - Commands: Pencil Commands: Watch Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Commands task for put the watch on the other side of the pencil and then turn over the card. CDISC ADAS-Cog - Commands: Watch Commands: Shoulder Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Commands task for tap each shoulder twice with two fingers keeping your eyes shut. CDISC ADAS-Cog - Commands: Shoulder Comprehension Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Ability to comprehend speech. CDISC ADAS-Cog - Comprehension Concentration/Distractibility Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Ability to concentrate or easily be distracted. CDISC ADAS-Cog - Concentration/Distractibility Constructional Praxis Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for constructional praxis. CDISC ADAS-Cog - Constructional Praxis Summary Score Constructional Praxis: Circle Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Constructional praxis task for copying a circle. CDISC ADAS-Cog - Constructional Praxis: Circle Constructional Praxis: 2 Rectangles Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Constructional praxis task for copying two overlapping rectangles. CDISC ADAS-Cog - Constructional Praxis: 2 Rectangles Constructional Praxis: Diamond Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Constructional praxis task for copying a diamond. CDISC ADAS-Cog - Constructional Praxis: Diamond Constructional Praxis: Cube Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Constructional praxis task for copying a cube. CDISC ADAS-Cog - Constructional Praxis: Cube Attempt to Draw Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Constructional praxis attempted to draw, but drew no forms correctly. CDISC ADAS-Cog - Attempt to Draw Word Finding Difficulty in Spont Speech Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Difficulty finding the desired word in spontaneous speech. CDISC ADAS-Cog - Word Difficulty in Spontaneous Speech Delayed Word Recall Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for delayed word recall. CDISC ADAS-Cog - Delayed Word Recall Summary Score Delayed Word Recall: Word [1] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 1. CDISC ADAS-Cog - Delayed Word Recall: Word 1 Delayed Word Recall: Word [2] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 2. CDISC ADAS-Cog - Delayed Word Recall: Word 2 Delayed Word Recall: Word [3] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 3. CDISC ADAS-Cog - Delayed Word Recall: Word 3 Delayed Word Recall: Word [4] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 4. CDISC ADAS-Cog - Delayed Word Recall: Word 4 Delayed Word Recall: Word [5] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 5. CDISC ADAS-Cog - Delayed Word Recall: Word 5 Delayed Word Recall: Word [6] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 6. CDISC ADAS-Cog - Delayed Word Recall: Word 6 Delayed Word Recall: Word [7] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 7. CDISC ADAS-Cog - Delayed Word Recall: Word 7 Delayed Word Recall: Word [8] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 8. CDISC ADAS-Cog - Delayed Word Recall: Word 8 Delayed Word Recall: Word [9] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 9. CDISC ADAS-Cog - Delayed Word Recall: Word 9 Delayed Word Recall: Word [10] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 10. CDISC ADAS-Cog - Delayed Word Recall: Word 10 Ideational Praxis Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for ideational praxis. CDISC ADAS-Cog - Ideational Praxis Summary Score Ideational Praxis: Fold Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Ideational praxis task for folding the paper. CDISC ADAS-Cog - Ideational Praxis: Fold Ideational Praxis: Insert Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Ideational praxis task for put the paper in the envelop. CDISC ADAS-Cog - Ideational Praxis: Insert Ideational Praxis: Seal Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Ideational praxis task for seal the envelop. CDISC ADAS-Cog - Ideational Praxis: Seal Ideational Praxis: Address Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Ideational praxis task for address the envelop to yourself. CDISC ADAS-Cog - Ideational Praxis: Address Ideational Praxis: Stamp Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Ideational praxis task for showing where the stamp goes. CDISC ADAS-Cog - Ideational Praxis: Stamp Executive Function Maze Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for the executive function maze tasks. CDISC ADAS-Cog - Executive Function Maze Summary Score Executive Function Maze: Errors Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Number of errors during the executive function maze task. CDISC ADAS-Cog - Executive Function Maze: Errors Executive Function Maze: Time Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - The time in seconds stored in ISO 8601 time for the executive function maze task. CDISC ADAS-Cog - Executive Function Maze: Time Number Cancellation Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for the number cancellation tasks. CDISC ADAS-Cog - Number Cancellation Summary Score Number Cancellation: Correct Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Number of targets hit during the number cancellation task. CDISC ADAS-Cog - Number Cancellation: Correct Number Cancellation: Errors Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Number of errors during the number cancellation task. CDISC ADAS-Cog - Number Cancellation: Errors Number Cancellation: Remind Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Number of times reminded for the number cancellation task. CDISC ADAS-Cog - Number Cancellation: Remind Naming Objects and Fingers Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task summary score for object and fingers. CDISC ADAS-Cog - Naming Objects and Fingers Summary Score Naming Objects and Fingers: Thumb Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for fingers of the dominant hand, thumb. CDISC ADAS-Cog - Naming Objects and Fingers: Thumb Naming Objects and Fingers: Pointer Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for fingers of the dominant hand, index, or pointer finger. CDISC ADAS-Cog - Naming Objects and Fingers: Pointer Naming Objects and Fingers: Middle Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for fingers of the dominant hand, middle finger. CDISC ADAS-Cog - Naming Objects and Fingers: Middle Naming Objects and Fingers: Ring Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for fingers of the dominant hand, ring finger. CDISC ADAS-Cog - Naming Objects and Fingers: Ring Naming Objects and Fingers: Pinky Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for fingers of the dominant hand, little finger or pinky. CDISC ADAS-Cog - Naming Objects and Fingers: Pinky Naming Objects and Fingers: 1 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 1. CDISC ADAS-Cog - Naming Objects and Fingers: 1 Naming Objects and Fingers: 2 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 2. CDISC ADAS-Cog - Naming Objects and Fingers: 2 Naming Objects and Fingers: 3 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 3. CDISC ADAS-Cog - Naming Objects and Fingers: 3 Naming Objects and Fingers: 4 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 4. CDISC ADAS-Cog - Naming Objects and Fingers: 4 Naming Objects and Fingers: 5 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 5. CDISC ADAS-Cog - Naming Objects and Fingers: 5 Naming Objects and Fingers: 6 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 6. CDISC ADAS-Cog - Naming Objects and Fingers: 6 Naming Objects and Fingers: 7 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 7. CDISC ADAS-Cog - Naming Objects and Fingers: 7 Naming Objects and Fingers: 8 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 8. CDISC ADAS-Cog - Naming Objects and Fingers: 8 Naming Objects and Fingers: 9 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 9. CDISC ADAS-Cog - Naming Objects and Fingers: 9 Naming Objects and Fingers: 10 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 10. CDISC ADAS-Cog - Naming Objects and Fingers: 10 Naming Objects and Fingers: 11 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 11. CDISC ADAS-Cog - Naming Objects and Fingers: 11 Naming Objects and Fingers: 12 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 12. CDISC ADAS-Cog - Naming Objects and Fingers: 12 Orientation Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for orientation. CDISC ADAS-Cog - Orientation Summary Score Orientation: Full Name Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing one's own full name. CDISC ADAS-Cog - Orientation: Full Name Orientation: Month Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing the current month. CDISC ADAS-Cog - Orientation: Month Orientation: Date Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing the current day. CDISC ADAS-Cog - Orientation: Date Orientation: Year Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing the current year. CDISC ADAS-Cog - Orientation: Year Orientation: Day of Week Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing the current day of the week. CDISC ADAS-Cog - Orientation: Day of Week Orientation: Season Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing the current season. CDISC ADAS-Cog - Orientation: Season Orientation: Place Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing the current place. CDISC ADAS-Cog - Orientation: Place Orientation: Time Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing the approximate current clock time. CDISC ADAS-Cog - Orientation: Time Word Recognition Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for word recognition across trials 1-3. CDISC ADAS-Cog - Word Recognition Summary Score Word Recognition Trial 1 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Sub-score for word recognition trial 1. CDISC ADAS-Cog - Word Recognition Trial 1 Summary Score Word Recognition Trial 2 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Sub-score for word recognition trial 2. CDISC ADAS-Cog - Word Recognition Trial 2 Summary Score Word Recognition Trial 3 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Sub-score for word recognition trial 3. CDISC ADAS-Cog - Word Recognition Trial 3 Summary Score Word Recognition: Word [1] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 1 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 1 Word Recognition: Word [2] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 2 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 2 Word Recognition: Word [3] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 3 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 3 Word Recognition: Word [4] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 4 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 4 Word Recognition: Word [5] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 5 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 5 Word Recognition: Word [6] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 6 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 6 Word Recognition: Word [7] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 7 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 7 Word Recognition: Word [8] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 8 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 8 Word Recognition: Word [9] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 9 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 9 Word Recognition: Word [10] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 10 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 10 Word Recognition: Word [11] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 11 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 11 Word Recognition: Word [12] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 12 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 12 Word Recognition: Word [13] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 13 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 13 Word Recognition: Word [14] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 14 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 14 Word Recognition: Word [15] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 15 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 15 Word Recognition: Word [16] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 16 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 16 Word Recognition: Word [17] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 17 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 17 Word Recognition: Word [18] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 18 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 18 Word Recognition: Word [19] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 19 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 19 Word Recognition: Word [20] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 20 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 20 Word Recognition: Word [21] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 21 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 21 Word Recognition: Word [22] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 22 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 22 Word Recognition: Word [23] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 23 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 23 Word Recognition: Word [24] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 24 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 24 Remembering Test Instructions Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Remembering test instructions. CDISC ADAS-Cog - Remembering Test Instructions Word Recall Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word average score of trials 1, 2, 3. CDISC ADAS-Cog - Word Recall Average Score Word Recall Trial 1 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Sub-score for word recall task trial 1. CDISC ADAS-Cog - Word Recall Trial 1 Subscore Word Recall Trial 2 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Sub-score for word recall task trial 2. CDISC ADAS-Cog - Word Recall Trial 2 Subscore Word Recall Trial 3 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Sub-score for word recall task trial 3. CDISC ADAS-Cog - Word Recall Trial 3 Subscore Word Recall: Word [1] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 1 for trial 1, 2, 3. CDISC ADAS-Cog - Word Recall: Word 1 Word Recall: Word [2] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 2 for trial 1, 2, 3. CDISC ADAS-Cog - Word Recall: Word 2 Word Recall: Word [3] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 3 for trial 1, 2, 3. CDISC ADAS-Cog - Word Recall: Word 3 Word Recall: Word [4] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 4 for trial 1, 2, 3. CDISC ADAS-Cog - Word Recall: Word 4 Word Recall: Word [5] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 5 for trial 1, 2, 3. CDISC ADAS-Cog - Word Recall: Word 5 Word Recall: Word [6] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 6 for trial 1, 2, 3. CDISC ADAS-Cog - Word Recall: Word 6 Word Recall: Word [7] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 7 for trial 1, 2, 3. CDISC ADAS-Cog - Word Recall: Word 7 Word Recall: Word [8] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 8 for trial 1, 2, 3. CDISC ADAS-Cog - Word Recall: Word 8 Word Recall: Word [9] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 9 for trial 1, 2, 3. CDISC ADAS-Cog - Word Recall: Word 9 Word Recall: Word [10] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 10 for trial 1, 2, 3. CDISC ADAS-Cog - Word Recall: Word 10 Spoken Language Ability Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Global rating of the quality of speech, or difficulty in making oneself understood. CDISC ADAS-Cog - Spoken Language Ability Total Score Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Total score. CDISC ADAS-Cog - Total Score ADCTC Alzheimer's Disease Assessment Scale - Cognitive CDISC Version Functional Test Test Code CDISC Functional Test ADAS-Cog CDISC Version Test Code Terminology ADAS-Cog CDISC Version test name. Attempt to Draw Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Constructional praxis attempted to draw, but drew no forms correctly. CDISC ADAS-Cog - Attempt to Draw Commands Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for commands. CDISC ADAS-Cog - Commands Summary Score Commands: Ceiling Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Commands task for pointing to the ceiling then to the floor. CDISC ADAS-Cog - Commands: Ceiling Commands: Fist Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Commands task for making a fist. CDISC ADAS-Cog - Commands: Fist Commands: Pencil Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Commands task for put the pencil on top of the card and then put it back. CDISC ADAS-Cog - Commands: Pencil Commands: Shoulder Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Commands task for tap each shoulder twice with two fingers keeping your eyes shut. CDISC ADAS-Cog - Commands: Shoulder Commands: Watch Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Commands task for put the watch on the other side of the pencil and then turn over the card. CDISC ADAS-Cog - Commands: Watch Comprehension Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Ability to comprehend speech. CDISC ADAS-Cog - Comprehension Concentration/Distractibility Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Ability to concentrate or easily be distracted. CDISC ADAS-Cog - Concentration/Distractibility Constructional Praxis Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for constructional praxis. CDISC ADAS-Cog - Constructional Praxis Summary Score Constructional Praxis: 2 Rectangles Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Constructional praxis task for copying two overlapping rectangles. CDISC ADAS-Cog - Constructional Praxis: 2 Rectangles Constructional Praxis: Circle Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Constructional praxis task for copying a circle. CDISC ADAS-Cog - Constructional Praxis: Circle Constructional Praxis: Cube Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Constructional praxis task for copying a cube. CDISC ADAS-Cog - Constructional Praxis: Cube Constructional Praxis: Diamond Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Constructional praxis task for copying a diamond. CDISC ADAS-Cog - Constructional Praxis: Diamond Delayed Word Recall Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for delayed word recall. CDISC ADAS-Cog - Delayed Word Recall Summary Score Delayed Word Recall: Word [10] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 10. CDISC ADAS-Cog - Delayed Word Recall: Word 10 Delayed Word Recall: Word [1] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 1. CDISC ADAS-Cog - Delayed Word Recall: Word 1 Delayed Word Recall: Word [2] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 2. CDISC ADAS-Cog - Delayed Word Recall: Word 2 Delayed Word Recall: Word [3] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 3. CDISC ADAS-Cog - Delayed Word Recall: Word 3 Delayed Word Recall: Word [4] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 4. CDISC ADAS-Cog - Delayed Word Recall: Word 4 Delayed Word Recall: Word [5] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 5. CDISC ADAS-Cog - Delayed Word Recall: Word 5 Delayed Word Recall: Word [6] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 6. CDISC ADAS-Cog - Delayed Word Recall: Word 6 Delayed Word Recall: Word [7] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 7. CDISC ADAS-Cog - Delayed Word Recall: Word 7 Delayed Word Recall: Word [8] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 8. CDISC ADAS-Cog - Delayed Word Recall: Word 8 Delayed Word Recall: Word [9] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 9. CDISC ADAS-Cog - Delayed Word Recall: Word 9 Executive Function Maze Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for the executive function maze tasks. CDISC ADAS-Cog - Executive Function Maze Summary Score Executive Function Maze: Errors Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Number of errors during the executive function maze task. CDISC ADAS-Cog - Executive Function Maze: Errors Executive Function Maze: Time Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - The time in seconds stored in ISO 8601 time for the executive function maze task. CDISC ADAS-Cog - Executive Function Maze: Time Ideational Praxis Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for ideational praxis. CDISC ADAS-Cog - Ideational Praxis Summary Score Ideational Praxis: Address Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Ideational praxis task for address the envelop to yourself. CDISC ADAS-Cog - Ideational Praxis: Address Ideational Praxis: Fold Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Ideational praxis task for folding the paper. CDISC ADAS-Cog - Ideational Praxis: Fold Ideational Praxis: Insert Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Ideational praxis task for put the paper in the envelop. CDISC ADAS-Cog - Ideational Praxis: Insert Ideational Praxis: Seal Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Ideational praxis task for seal the envelop. CDISC ADAS-Cog - Ideational Praxis: Seal Ideational Praxis: Stamp Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Ideational praxis task for showing where the stamp goes. CDISC ADAS-Cog - Ideational Praxis: Stamp Naming Objects and Fingers Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task summary score for object and fingers. CDISC ADAS-Cog - Naming Objects and Fingers Summary Score Naming Objects and Fingers: 1 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 1. CDISC ADAS-Cog - Naming Objects and Fingers: 1 Naming Objects and Fingers: 10 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 10. CDISC ADAS-Cog - Naming Objects and Fingers: 10 Naming Objects and Fingers: 11 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 11. CDISC ADAS-Cog - Naming Objects and Fingers: 11 Naming Objects and Fingers: 12 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 12. CDISC ADAS-Cog - Naming Objects and Fingers: 12 Naming Objects and Fingers: 2 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 2. CDISC ADAS-Cog - Naming Objects and Fingers: 2 Naming Objects and Fingers: 3 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 3. CDISC ADAS-Cog - Naming Objects and Fingers: 3 Naming Objects and Fingers: 4 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 4. CDISC ADAS-Cog - Naming Objects and Fingers: 4 Naming Objects and Fingers: 5 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 5. CDISC ADAS-Cog - Naming Objects and Fingers: 5 Naming Objects and Fingers: 6 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 6. CDISC ADAS-Cog - Naming Objects and Fingers: 6 Naming Objects and Fingers: 7 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 7. CDISC ADAS-Cog - Naming Objects and Fingers: 7 Naming Objects and Fingers: 8 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 8. CDISC ADAS-Cog - Naming Objects and Fingers: 8 Naming Objects and Fingers: 9 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 9. CDISC ADAS-Cog - Naming Objects and Fingers: 9 Naming Objects and Fingers: Middle Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for fingers of the dominant hand, middle finger. CDISC ADAS-Cog - Naming Objects and Fingers: Middle Naming Objects and Fingers: Pinky Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for fingers of the dominant hand, little finger or pinky. CDISC ADAS-Cog - Naming Objects and Fingers: Pinky Naming Objects and Fingers: Pointer Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for fingers of the dominant hand, index, or pointer finger. CDISC ADAS-Cog - Naming Objects and Fingers: Pointer Naming Objects and Fingers: Ring Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for fingers of the dominant hand, ring finger. CDISC ADAS-Cog - Naming Objects and Fingers: Ring Naming Objects and Fingers: Thumb Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for fingers of the dominant hand, thumb. CDISC ADAS-Cog - Naming Objects and Fingers: Thumb Number Cancellation Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for the number cancellation tasks. CDISC ADAS-Cog - Number Cancellation Summary Score Number Cancellation: Correct Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Number of targets hit during the number cancellation task. CDISC ADAS-Cog - Number Cancellation: Correct Number Cancellation: Errors Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Number of errors during the number cancellation task. CDISC ADAS-Cog - Number Cancellation: Errors Number Cancellation: Remind Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Number of times reminded for the number cancellation task. CDISC ADAS-Cog - Number Cancellation: Remind Orientation Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for orientation. CDISC ADAS-Cog - Orientation Summary Score Orientation: Date Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing the current day. CDISC ADAS-Cog - Orientation: Date Orientation: Day of Week Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing the current day of the week. CDISC ADAS-Cog - Orientation: Day of Week Orientation: Full Name Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing one's own full name. CDISC ADAS-Cog - Orientation: Full Name Orientation: Month Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing the current month. CDISC ADAS-Cog - Orientation: Month Orientation: Place Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing the current place. CDISC ADAS-Cog - Orientation: Place Orientation: Season Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing the current season. CDISC ADAS-Cog - Orientation: Season Orientation: Time Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing the approximate current clock time. CDISC ADAS-Cog - Orientation: Time Orientation: Year Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing the current year. CDISC ADAS-Cog - Orientation: Year Remembering Test Instructions Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Remembering test instructions. CDISC ADAS-Cog - Remembering Test Instructions Spoken Language Ability Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Global rating of the quality of speech, or difficulty in making oneself understood. CDISC ADAS-Cog - Spoken Language Ability Total Score Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Total score. CDISC ADAS-Cog - Total Score Word Finding Difficulty in Spont Speech Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Difficulty finding the desired word in spontaneous speech. CDISC ADAS-Cog - Word Difficulty in Spontaneous Speech Word Recall Trial 1 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Sub-score for word recall task trial 1. CDISC ADAS-Cog - Word Recall Trial 1 Subscore Word Recall Trial 2 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Sub-score for word recall task trial 2. CDISC ADAS-Cog - Word Recall Trial 2 Subscore Word Recall Trial 3 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Sub-score for word recall task trial 3. CDISC ADAS-Cog - Word Recall Trial 3 Subscore Word Recall Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word average score of trials 1, 2, 3. CDISC ADAS-Cog - Word Recall Average Score Word Recall: Word [10] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 10 for trial 1, 2, 3. CDISC ADAS-Cog - Word Recall: Word 10 Word Recall: Word [1] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 1 for trial 1, 2, 3. CDISC ADAS-Cog - Word Recall: Word 1 Word Recall: Word [2] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 2 for trial 1, 2, 3. CDISC ADAS-Cog - Word Recall: Word 2 Word Recall: Word [3] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 3 for trial 1, 2, 3. CDISC ADAS-Cog - Word Recall: Word 3 Word Recall: Word [4] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 4 for trial 1, 2, 3. CDISC ADAS-Cog - Word Recall: Word 4 Word Recall: Word [5] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 5 for trial 1, 2, 3. CDISC ADAS-Cog - Word Recall: Word 5 Word Recall: Word [6] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 6 for trial 1, 2, 3. CDISC ADAS-Cog - Word Recall: Word 6 Word Recall: Word [7] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 7 for trial 1, 2, 3. CDISC ADAS-Cog - Word Recall: Word 7 Word Recall: Word [8] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 8 for trial 1, 2, 3. CDISC ADAS-Cog - Word Recall: Word 8 Word Recall: Word [9] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 9 for trial 1, 2, 3. CDISC ADAS-Cog - Word Recall: Word 9 Word Recognition Trial 1 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Sub-score for word recognition trial 1. CDISC ADAS-Cog - Word Recognition Trial 1 Summary Score Word Recognition Trial 2 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Sub-score for word recognition trial 2. CDISC ADAS-Cog - Word Recognition Trial 2 Summary Score Word Recognition Trial 3 Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Sub-score for word recognition trial 3. CDISC ADAS-Cog - Word Recognition Trial 3 Summary Score Word Recognition Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for word recognition across trials 1-3. CDISC ADAS-Cog - Word Recognition Summary Score Word Recognition: Word [10] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 10 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 10 Word Recognition: Word [11] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 11 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 11 Word Recognition: Word [12] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 12 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 12 Word Recognition: Word [13] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 13 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 13 Word Recognition: Word [14] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 14 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 14 Word Recognition: Word [15] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 15 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 15 Word Recognition: Word [16] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 16 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 16 Word Recognition: Word [17] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 17 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 17 Word Recognition: Word [18] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 18 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 18 Word Recognition: Word [19] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 19 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 19 Word Recognition: Word [1] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 1 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 1 Word Recognition: Word [20] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 20 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 20 Word Recognition: Word [21] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 21 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 21 Word Recognition: Word [22] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 22 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 22 Word Recognition: Word [23] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 23 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 23 Word Recognition: Word [24] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 24 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 24 Word Recognition: Word [2] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 2 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 2 Word Recognition: Word [3] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 3 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 3 Word Recognition: Word [4] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 4 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 4 Word Recognition: Word [5] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 5 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 5 Word Recognition: Word [6] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 6 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 6 Word Recognition: Word [7] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 7 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 7 Word Recognition: Word [8] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 8 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 8 Word Recognition: Word [9] Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 9 Trials 1, 2, 3. CDISC ADAS-Cog - Word Recognition: Word 9 ADCTN Alzheimer's Disease Assessment Scale - Cognitive CDISC Version Functional Test Test Name CDISC Functional Test ADAS-Cog CDISC Version Test Name Terminology Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 test code. ADC1-Word Recall: Score Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recall: Summary score. ADAS-COG Date 30th June 2015 Version - Word Recall: Score ADC1-Word Recall: Word [1] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recall: Word 1. ADAS-COG Date 30th June 2015 Version - Word Recall: Word [1] ADC1-Word Recall: Word [2] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recall: Word 2. ADAS-COG Date 30th June 2015 Version - Word Recall: Word [2] ADC1-Word Recall: Word [3] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recall: Word 3. ADAS-COG Date 30th June 2015 Version - Word Recall: Word [3] ADC1-Word Recall: Word [4] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recall: Word 4. ADAS-COG Date 30th June 2015 Version - Word Recall: Word [4] ADC1-Word Recall: Word [5] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recall: Word 5. ADAS-COG Date 30th June 2015 Version - Word Recall: Word [5] ADC1-Word Recall: Word [6] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recall: Word 6. ADAS-COG Date 30th June 2015 Version - Word Recall: Word [6] ADC1-Word Recall: Word [7] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recall: Word 7. ADAS-COG Date 30th June 2015 Version - Word Recall: Word [7] ADC1-Word Recall: Word [8] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recall: Word 8. ADAS-COG Date 30th June 2015 Version - Word Recall: Word [8] ADC1-Word Recall: Word [9] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recall: Word 9. ADAS-COG Date 30th June 2015 Version - Word Recall: Word [9] ADC1-Word Recall: Word [10] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recall: Word 10. ADAS-COG Date 30th June 2015 Version - Word Recall: Word [10] ADC1-Word Recall: Trial Score Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recall: Trial score. ADAS-COG Date 30th June 2015 Version - Word Recall: Trial Score ADC1-Commands: Score Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Commands: Summary score. ADAS-COG Date 30th June 2015 Version - Commands: Score ADC1-Commands: None Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Commands: None - no command was performed correctly. ADAS-COG Date 30th June 2015 Version - Commands: None ADC1-Commands: Fist Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Commands: Make a fist. ADAS-COG Date 30th June 2015 Version - Commands: Fist ADC1-Commands: Ceiling Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Commands: Point to the ceiling, then to the floor. ADAS-COG Date 30th June 2015 Version - Commands: Ceiling ADC1-Commands: Pencil Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Commands: Put the pencil on top of the card, then put it back. ADAS-COG Date 30th June 2015 Version - Commands: Pencil ADC1-Commands: Watch Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Commands: Put the watch on the other side of the pencil and turn over the card. ADAS-COG Date 30th June 2015 Version - Commands: Watch ADC1-Commands: Shoulder Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Commands: Tap each shoulder twice with two fingers keeping your eyes shut. ADAS-COG Date 30th June 2015 Version - Commands: Shoulder ADC1-Constructional Praxis: Score Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Constructional praxis: Summary score. ADAS-COG Date 30th June 2015 Version - Constructional Praxis: Score ADC1-Constructional Praxis: None Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Constructional praxis: None - attempted but drew no forms correctly. ADAS-COG Date 30th June 2015 Version - Constructional Praxis: None ADC1-Constructional Praxis: Drew No Form Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Constructional praxis: Patient drew no forms; scribbled; wrote words. ADAS-COG Date 30th June 2015 Version - Constructional Praxis: Drew No Form ADC1-Constructional Praxis: Circle Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Constructional praxis: Circle. ADAS-COG Date 30th June 2015 Version - Constructional Praxis: Circle ADC1-Constructional Praxis: 2 Rectangles Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Constructional praxis: Two overlapping rectangles. ADAS-COG Date 30th June 2015 Version - Constructional Praxis: 2 Rectangles ADC1-Constructional Praxis: Rhombus Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Constructional praxis: Rhombus. ADAS-COG Date 30th June 2015 Version - Constructional Praxis: Rhombus ADC1-Constructional Praxis: Cube Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Constructional praxis: Cube. ADAS-COG Date 30th June 2015 Version - Constructional Praxis: Cube ADC1-Delayed Word Recall: Score Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Delayed word recall: Summary score. ADAS-COG Date 30th June 2015 Version - Delayed Word Recall: Score ADC1-Delayed Word Recall: Word [1] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Delayed word recall: Word 1. ADAS-COG Date 30th June 2015 Version - Delayed Word Recall: Word [1] ADC1-Delayed Word Recall: Word [2] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Delayed word recall: Word 2. ADAS-COG Date 30th June 2015 Version - Delayed Word Recall: Word [2] ADC1-Delayed Word Recall: Word [3] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Delayed word recall: Word 3. ADAS-COG Date 30th June 2015 Version - Delayed Word Recall: Word [3] ADC1-Delayed Word Recall: Word [4] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Delayed word recall: Word 4. ADAS-COG Date 30th June 2015 Version - Delayed Word Recall: Word [4] ADC1-Delayed Word Recall: Word [5] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Delayed word recall: Word 5. ADAS-COG Date 30th June 2015 Version - Delayed Word Recall: Word [5] ADC1-Delayed Word Recall: Word [6] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Delayed word recall: Word 6. ADAS-COG Date 30th June 2015 Version - Delayed Word Recall: Word [6] ADC1-Delayed Word Recall: Word [7] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Delayed word recall: Word 7. ADAS-COG Date 30th June 2015 Version - Delayed Word Recall: Word [7] ADC1-Delayed Word Recall: Word [8] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Delayed word recall: Word 8. ADAS-COG Date 30th June 2015 Version - Delayed Word Recall: Word [8] ADC1-Delayed Word Recall: Word [9] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Delayed word recall: Word 9. ADAS-COG Date 30th June 2015 Version - Delayed Word Recall: Word [9] ADC1-Delayed Word Recall: Word [10] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Delayed word recall: Word 10. ADAS-COG Date 30th June 2015 Version - Delayed Word Recall: Word [10] ADC1-Naming: Score Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Summary score. ADAS-COG Date 30th June 2015 Version - Naming: Score ADC1-Naming: None Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: None - no object or finger was named correctly. ADAS-COG Date 30th June 2015 Version - Naming: None ADC1-Naming: Flower Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Flower. ADAS-COG Date 30th June 2015 Version - Naming: Flower ADC1-Naming: Bed Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Bed. ADAS-COG Date 30th June 2015 Version - Naming: Bed ADC1-Naming: Whistle Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Whistle. ADAS-COG Date 30th June 2015 Version - Naming: Whistle ADC1-Naming: Pencil Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Pencil. ADAS-COG Date 30th June 2015 Version - Naming: Pencil ADC1-Naming: Rattle Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Rattle. ADAS-COG Date 30th June 2015 Version - Naming: Rattle ADC1-Naming: Mask Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Mask. ADAS-COG Date 30th June 2015 Version - Naming: Mask ADC1-Naming: Scissors Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Scissors. ADAS-COG Date 30th June 2015 Version - Naming: Scissors ADC1-Naming: Comb Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Comb. ADAS-COG Date 30th June 2015 Version - Naming: Comb ADC1-Naming: Wallet Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Wallet. ADAS-COG Date 30th June 2015 Version - Naming: Wallet ADC1-Naming: Harmonica Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Harmonica. ADAS-COG Date 30th June 2015 Version - Naming: Harmonica ADC1-Naming: Stethoscope Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Stethoscope. ADAS-COG Date 30th June 2015 Version - Naming: Stethoscope ADC1-Naming: Tongs Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Tongs. ADAS-COG Date 30th June 2015 Version - Naming: Tongs ADC1-Naming: Thumb Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Thumb. ADAS-COG Date 30th June 2015 Version - Naming: Thumb ADC1-Naming: Index/Forefinger/Pointer Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Index/forefinger/pointer. ADAS-COG Date 30th June 2015 Version - Naming: Index/Forefinger/Pointer ADC1-Naming: Middle Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Middle. ADAS-COG Date 30th June 2015 Version - Naming: Middle ADC1-Naming: Ring Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Ring. ADAS-COG Date 30th June 2015 Version - Naming: Ring ADC1-Naming: Pinky/Little Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Pinky/little. ADAS-COG Date 30th June 2015 Version - Naming: Pinky/Little ADC1-Ideational Praxis: Score Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Ideational praxis: Summary score. ADAS-COG Date 30th June 2015 Version - Ideational Praxis: Score ADC1-Ideational Praxis: None Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Ideational praxis: None - no ideational step was completed correctly. ADAS-COG Date 30th June 2015 Version - Ideational Praxis: None ADC1-Ideational Praxis: Fold a Letter Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Ideational praxis: Fold a letter. ADAS-COG Date 30th June 2015 Version - Ideational Praxis: Fold a Letter ADC1-Ideational Praxis: Put in Envelope Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Ideational praxis: Put letter in envelope. ADAS-COG Date 30th June 2015 Version - Ideational Praxis: Put in Envelope ADC1-Ideational Praxis: Seal Envelope Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Ideational praxis: Seal envelope. ADAS-COG Date 30th June 2015 Version - Ideational Praxis: Seal Envelope ADC1-Ideational Praxis: Address Envelope Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Ideational praxis: Address envelope. ADAS-COG Date 30th June 2015 Version - Ideational Praxis: Address Envelope ADC1-Ideational Praxis: Where Stamp Goes Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Ideational praxis: Indicate where stamp goes. ADAS-COG Date 30th June 2015 Version - Ideational Praxis: Where Stamp Goes ADC1-Orientation: Score Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Orientation: Summary score. ADAS-COG Date 30th June 2015 Version - Orientation: Score ADC1-Orientation: None Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Orientation: None - no orientation item was answered correctly. ADAS-COG Date 30th June 2015 Version - Orientation: None ADC1-Orientation: Full Name Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Orientation: Full name. ADAS-COG Date 30th June 2015 Version - Orientation: Full Name ADC1-Orientation: Month Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Orientation: Month. ADAS-COG Date 30th June 2015 Version - Orientation: Month ADC1-Orientation: Date Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Orientation: Date. ADAS-COG Date 30th June 2015 Version - Orientation: Date ADC1-Orientation: Year Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Orientation: Year. ADAS-COG Date 30th June 2015 Version - Orientation: Year ADC1-Orientation: Day Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Orientation: Day. ADAS-COG Date 30th June 2015 Version - Orientation: Day ADC1-Orientation: Season Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Orientation: Season. ADAS-COG Date 30th June 2015 Version - Orientation: Season ADC1-Orientation: Place Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Orientation: Place. ADAS-COG Date 30th June 2015 Version - Orientation: Place ADC1-Orientation: Time of Day Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Orientation: Time of day. ADAS-COG Date 30th June 2015 Version - Orientation: Time of Day ADC1-Word Recognition: Score Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Summary score. ADAS-COG Date 30th June 2015 Version - Word Recognition: Score ADC1-Word Recognition: Word [1] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 1. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [1] ADC1-Word Recognition: Word [2] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 2. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [2] ADC1-Word Recognition: Word [3] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 3. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [3] ADC1-Word Recognition: Word [4] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 4. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [4] ADC1-Word Recognition: Word [5] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 5. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [5] ADC1-Word Recognition: Word [6] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 6. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [6] ADC1-Word Recognition: Word [7] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 7. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [7] ADC1-Word Recognition: Word [8] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 8. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [8] ADC1-Word Recognition: Word [9] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 9. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [9] ADC1-Word Recognition: Word [10] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 10. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [10] ADC1-Word Recognition: Word [11] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 11. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [11] ADC1-Word Recognition: Word [12] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 12. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [12] ADC1-Word Recognition: Word [13] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 13. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [13] ADC1-Word Recognition: Word [14] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 14. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [14] ADC1-Word Recognition: Word [15] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 15. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [15] ADC1-Word Recognition: Word [16] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 16. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [16] ADC1-Word Recognition: Word [17] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 17. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [17] ADC1-Word Recognition: Word [18] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 18. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [18] ADC1-Word Recognition: Word [19] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 19. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [19] ADC1-Word Recognition: Word [20] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 20. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [20] ADC1-Word Recognition: Word [21] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 21. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [21] ADC1-Word Recognition: Word [22] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 22. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [22] ADC1-Word Recognition: Word [23] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 23. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [23] ADC1-Word Recognition: Word [24] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 24. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [24] ADC1-Word Recognition: Trial Score Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Trial score. ADAS-COG Date 30th June 2015 Version - Word Recognition: Trial Score ADC1-Remember Word Recog Test Instruct Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Remembering word recognition test instructions. ADAS-COG Date 30th June 2015 Version - Remember Word Recognition Test Instruct ADC1-Comprehension of Spoken Language Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Comprehension of spoken language. ADAS-COG Date 30th June 2015 Version - Comprehension of Spoken Language ADC1-Word Finding Difficulty Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word finding difficulty. ADAS-COG Date 30th June 2015 Version - Word Finding Difficulty ADC1-Spoken Language Ability Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Spoken language ability. ADAS-COG Date 30th June 2015 Version - Spoken Language Ability ADC1-Maze Task/Executive Function: Score Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Maze task/executive function: Summary score. ADAS-COG Date 30th June 2015 Version - Maze Task/Executive Function: Score ADC1-Maze Task/Executive Function: Error Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Maze task/executive function: Number of errors. ADAS-COG Date 30th June 2015 Version - Maze Task/Executive Function: Error ADC1-Maze Task/Executive Function: Time Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Maze task/executive function: Time at completion or second error. ADAS-COG Date 30th June 2015 Version - Maze Task/Executive Function: Time ADC1-Number Cancellation Task: Score Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Number cancellation task: Summary score. ADAS-COG Date 30th June 2015 Version - Number Cancellation Task: Score ADC1-Number Cancellation Task:Target Hit Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Number cancellation task: Number of targets hit. ADAS-COG Date 30th June 2015 Version - Number Cancellation Task: Target Hit ADC1-Number Cancellation Task: Errors Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Number cancellation task: Number of errors. ADAS-COG Date 30th June 2015 Version - Number Cancellation Task: Errors ADC1-Number Cancellation Task: Remind Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Number cancellation task: Number of times to remind of task. ADAS-COG Date 30th June 2015 Version - Number Cancellation Task: Remind ADC1-Concentration/Distractibility Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Concentration/distractibility. ADAS-COG Date 30th June 2015 Version - Concentration/Distractibility ADC1-Total Score Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Total score. ADAS-COG Date 30th June 2015 Version - Total Score ADC1TC Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 Functional Test Test Code CDISC Functional Test Alzheimer's Disease Assessment Scale-Cognitive Date 30th June 2015 Version Test Code Terminology Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 test name. ADC1-Commands: Ceiling Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Commands: Point to the ceiling, then to the floor. ADAS-COG Date 30th June 2015 Version - Commands: Ceiling ADC1-Commands: Fist Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Commands: Make a fist. ADAS-COG Date 30th June 2015 Version - Commands: Fist ADC1-Commands: None Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Commands: None - no command was performed correctly. ADAS-COG Date 30th June 2015 Version - Commands: None ADC1-Commands: Pencil Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Commands: Put the pencil on top of the card, then put it back. ADAS-COG Date 30th June 2015 Version - Commands: Pencil ADC1-Commands: Score Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Commands: Summary score. ADAS-COG Date 30th June 2015 Version - Commands: Score ADC1-Commands: Shoulder Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Commands: Tap each shoulder twice with two fingers keeping your eyes shut. ADAS-COG Date 30th June 2015 Version - Commands: Shoulder ADC1-Commands: Watch Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Commands: Put the watch on the other side of the pencil and turn over the card. ADAS-COG Date 30th June 2015 Version - Commands: Watch ADC1-Comprehension of Spoken Language Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Comprehension of spoken language. ADAS-COG Date 30th June 2015 Version - Comprehension of Spoken Language ADC1-Concentration/Distractibility Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Concentration/distractibility. ADAS-COG Date 30th June 2015 Version - Concentration/Distractibility ADC1-Constructional Praxis: 2 Rectangles Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Constructional praxis: Two overlapping rectangles. ADAS-COG Date 30th June 2015 Version - Constructional Praxis: 2 Rectangles ADC1-Constructional Praxis: Circle Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Constructional praxis: Circle. ADAS-COG Date 30th June 2015 Version - Constructional Praxis: Circle ADC1-Constructional Praxis: Cube Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Constructional praxis: Cube. ADAS-COG Date 30th June 2015 Version - Constructional Praxis: Cube ADC1-Constructional Praxis: Drew No Form Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Constructional praxis: Patient drew no forms; scribbled; wrote words. ADAS-COG Date 30th June 2015 Version - Constructional Praxis: Drew No Form ADC1-Constructional Praxis: None Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Constructional praxis: None - attempted but drew no forms correctly. ADAS-COG Date 30th June 2015 Version - Constructional Praxis: None ADC1-Constructional Praxis: Rhombus Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Constructional praxis: Rhombus. ADAS-COG Date 30th June 2015 Version - Constructional Praxis: Rhombus ADC1-Constructional Praxis: Score Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Constructional praxis: Summary score. ADAS-COG Date 30th June 2015 Version - Constructional Praxis: Score ADC1-Delayed Word Recall: Score Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Delayed word recall: Summary score. ADAS-COG Date 30th June 2015 Version - Delayed Word Recall: Score ADC1-Delayed Word Recall: Word [10] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Delayed word recall: Word 10. ADAS-COG Date 30th June 2015 Version - Delayed Word Recall: Word [10] ADC1-Delayed Word Recall: Word [1] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Delayed word recall: Word 1. ADAS-COG Date 30th June 2015 Version - Delayed Word Recall: Word [1] ADC1-Delayed Word Recall: Word [2] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Delayed word recall: Word 2. ADAS-COG Date 30th June 2015 Version - Delayed Word Recall: Word [2] ADC1-Delayed Word Recall: Word [3] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Delayed word recall: Word 3. ADAS-COG Date 30th June 2015 Version - Delayed Word Recall: Word [3] ADC1-Delayed Word Recall: Word [4] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Delayed word recall: Word 4. ADAS-COG Date 30th June 2015 Version - Delayed Word Recall: Word [4] ADC1-Delayed Word Recall: Word [5] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Delayed word recall: Word 5. ADAS-COG Date 30th June 2015 Version - Delayed Word Recall: Word [5] ADC1-Delayed Word Recall: Word [6] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Delayed word recall: Word 6. ADAS-COG Date 30th June 2015 Version - Delayed Word Recall: Word [6] ADC1-Delayed Word Recall: Word [7] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Delayed word recall: Word 7. ADAS-COG Date 30th June 2015 Version - Delayed Word Recall: Word [7] ADC1-Delayed Word Recall: Word [8] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Delayed word recall: Word 8. ADAS-COG Date 30th June 2015 Version - Delayed Word Recall: Word [8] ADC1-Delayed Word Recall: Word [9] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Delayed word recall: Word 9. ADAS-COG Date 30th June 2015 Version - Delayed Word Recall: Word [9] ADC1-Ideational Praxis: Address Envelope Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Ideational praxis: Address envelope. ADAS-COG Date 30th June 2015 Version - Ideational Praxis: Address Envelope ADC1-Ideational Praxis: Fold a Letter Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Ideational praxis: Fold a letter. ADAS-COG Date 30th June 2015 Version - Ideational Praxis: Fold a Letter ADC1-Ideational Praxis: None Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Ideational praxis: None - no ideational step was completed correctly. ADAS-COG Date 30th June 2015 Version - Ideational Praxis: None ADC1-Ideational Praxis: Put in Envelope Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Ideational praxis: Put letter in envelope. ADAS-COG Date 30th June 2015 Version - Ideational Praxis: Put in Envelope ADC1-Ideational Praxis: Score Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Ideational praxis: Summary score. ADAS-COG Date 30th June 2015 Version - Ideational Praxis: Score ADC1-Ideational Praxis: Seal Envelope Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Ideational praxis: Seal envelope. ADAS-COG Date 30th June 2015 Version - Ideational Praxis: Seal Envelope ADC1-Ideational Praxis: Where Stamp Goes Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Ideational praxis: Indicate where stamp goes. ADAS-COG Date 30th June 2015 Version - Ideational Praxis: Where Stamp Goes ADC1-Maze Task/Executive Function: Error Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Maze task/executive function: Number of errors. ADAS-COG Date 30th June 2015 Version - Maze Task/Executive Function: Error ADC1-Maze Task/Executive Function: Score Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Maze task/executive function: Summary score. ADAS-COG Date 30th June 2015 Version - Maze Task/Executive Function: Score ADC1-Maze Task/Executive Function: Time Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Maze task/executive function: Time at completion or second error. ADAS-COG Date 30th June 2015 Version - Maze Task/Executive Function: Time ADC1-Naming: Bed Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Bed. ADAS-COG Date 30th June 2015 Version - Naming: Bed ADC1-Naming: Comb Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Comb. ADAS-COG Date 30th June 2015 Version - Naming: Comb ADC1-Naming: Flower Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Flower. ADAS-COG Date 30th June 2015 Version - Naming: Flower ADC1-Naming: Harmonica Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Harmonica. ADAS-COG Date 30th June 2015 Version - Naming: Harmonica ADC1-Naming: Index/Forefinger/Pointer Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Index/forefinger/pointer. ADAS-COG Date 30th June 2015 Version - Naming: Index/Forefinger/Pointer ADC1-Naming: Mask Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Mask. ADAS-COG Date 30th June 2015 Version - Naming: Mask ADC1-Naming: Middle Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Middle. ADAS-COG Date 30th June 2015 Version - Naming: Middle ADC1-Naming: None Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: None - no object or finger was named correctly. ADAS-COG Date 30th June 2015 Version - Naming: None ADC1-Naming: Pencil Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Pencil. ADAS-COG Date 30th June 2015 Version - Naming: Pencil ADC1-Naming: Pinky/Little Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Pinky/little. ADAS-COG Date 30th June 2015 Version - Naming: Pinky/Little ADC1-Naming: Rattle Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Rattle. ADAS-COG Date 30th June 2015 Version - Naming: Rattle ADC1-Naming: Ring Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Ring. ADAS-COG Date 30th June 2015 Version - Naming: Ring ADC1-Naming: Scissors Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Scissors. ADAS-COG Date 30th June 2015 Version - Naming: Scissors ADC1-Naming: Score Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Summary score. ADAS-COG Date 30th June 2015 Version - Naming: Score ADC1-Naming: Stethoscope Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Stethoscope. ADAS-COG Date 30th June 2015 Version - Naming: Stethoscope ADC1-Naming: Thumb Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Thumb. ADAS-COG Date 30th June 2015 Version - Naming: Thumb ADC1-Naming: Tongs Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Tongs. ADAS-COG Date 30th June 2015 Version - Naming: Tongs ADC1-Naming: Wallet Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Wallet. ADAS-COG Date 30th June 2015 Version - Naming: Wallet ADC1-Naming: Whistle Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Naming: Whistle. ADAS-COG Date 30th June 2015 Version - Naming: Whistle ADC1-Number Cancellation Task: Errors Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Number cancellation task: Number of errors. ADAS-COG Date 30th June 2015 Version - Number Cancellation Task: Errors ADC1-Number Cancellation Task: Remind Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Number cancellation task: Number of times to remind of task. ADAS-COG Date 30th June 2015 Version - Number Cancellation Task: Remind ADC1-Number Cancellation Task: Score Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Number cancellation task: Summary score. ADAS-COG Date 30th June 2015 Version - Number Cancellation Task: Score ADC1-Number Cancellation Task:Target Hit Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Number cancellation task: Number of targets hit. ADAS-COG Date 30th June 2015 Version - Number Cancellation Task: Target Hit ADC1-Orientation: Date Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Orientation: Date. ADAS-COG Date 30th June 2015 Version - Orientation: Date ADC1-Orientation: Day Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Orientation: Day. ADAS-COG Date 30th June 2015 Version - Orientation: Day ADC1-Orientation: Full Name Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Orientation: Full name. ADAS-COG Date 30th June 2015 Version - Orientation: Full Name ADC1-Orientation: Month Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Orientation: Month. ADAS-COG Date 30th June 2015 Version - Orientation: Month ADC1-Orientation: None Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Orientation: None - no orientation item was answered correctly. ADAS-COG Date 30th June 2015 Version - Orientation: None ADC1-Orientation: Place Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Orientation: Place. ADAS-COG Date 30th June 2015 Version - Orientation: Place ADC1-Orientation: Score Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Orientation: Summary score. ADAS-COG Date 30th June 2015 Version - Orientation: Score ADC1-Orientation: Season Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Orientation: Season. ADAS-COG Date 30th June 2015 Version - Orientation: Season ADC1-Orientation: Time of Day Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Orientation: Time of day. ADAS-COG Date 30th June 2015 Version - Orientation: Time of Day ADC1-Orientation: Year Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Orientation: Year. ADAS-COG Date 30th June 2015 Version - Orientation: Year ADC1-Remember Word Recog Test Instruct Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Remembering word recognition test instructions. ADAS-COG Date 30th June 2015 Version - Remember Word Recognition Test Instruct ADC1-Spoken Language Ability Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Spoken language ability. ADAS-COG Date 30th June 2015 Version - Spoken Language Ability ADC1-Total Score Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Total score. ADAS-COG Date 30th June 2015 Version - Total Score ADC1-Word Finding Difficulty Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word finding difficulty. ADAS-COG Date 30th June 2015 Version - Word Finding Difficulty ADC1-Word Recall: Score Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recall: Summary score. ADAS-COG Date 30th June 2015 Version - Word Recall: Score ADC1-Word Recall: Trial Score Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recall: Trial score. ADAS-COG Date 30th June 2015 Version - Word Recall: Trial Score ADC1-Word Recall: Word [10] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recall: Word 10. ADAS-COG Date 30th June 2015 Version - Word Recall: Word [10] ADC1-Word Recall: Word [1] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recall: Word 1. ADAS-COG Date 30th June 2015 Version - Word Recall: Word [1] ADC1-Word Recall: Word [2] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recall: Word 2. ADAS-COG Date 30th June 2015 Version - Word Recall: Word [2] ADC1-Word Recall: Word [3] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recall: Word 3. ADAS-COG Date 30th June 2015 Version - Word Recall: Word [3] ADC1-Word Recall: Word [4] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recall: Word 4. ADAS-COG Date 30th June 2015 Version - Word Recall: Word [4] ADC1-Word Recall: Word [5] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recall: Word 5. ADAS-COG Date 30th June 2015 Version - Word Recall: Word [5] ADC1-Word Recall: Word [6] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recall: Word 6. ADAS-COG Date 30th June 2015 Version - Word Recall: Word [6] ADC1-Word Recall: Word [7] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recall: Word 7. ADAS-COG Date 30th June 2015 Version - Word Recall: Word [7] ADC1-Word Recall: Word [8] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recall: Word 8. ADAS-COG Date 30th June 2015 Version - Word Recall: Word [8] ADC1-Word Recall: Word [9] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recall: Word 9. ADAS-COG Date 30th June 2015 Version - Word Recall: Word [9] ADC1-Word Recognition: Score Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Summary score. ADAS-COG Date 30th June 2015 Version - Word Recognition: Score ADC1-Word Recognition: Trial Score Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Trial score. ADAS-COG Date 30th June 2015 Version - Word Recognition: Trial Score ADC1-Word Recognition: Word [10] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 10. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [10] ADC1-Word Recognition: Word [11] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 11. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [11] ADC1-Word Recognition: Word [12] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 12. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [12] ADC1-Word Recognition: Word [13] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 13. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [13] ADC1-Word Recognition: Word [14] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 14. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [14] ADC1-Word Recognition: Word [15] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 15. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [15] ADC1-Word Recognition: Word [16] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 16. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [16] ADC1-Word Recognition: Word [17] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 17. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [17] ADC1-Word Recognition: Word [18] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 18. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [18] ADC1-Word Recognition: Word [19] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 19. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [19] ADC1-Word Recognition: Word [1] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 1. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [1] ADC1-Word Recognition: Word [20] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 20. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [20] ADC1-Word Recognition: Word [21] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 21. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [21] ADC1-Word Recognition: Word [22] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 22. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [22] ADC1-Word Recognition: Word [23] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 23. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [23] ADC1-Word Recognition: Word [24] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 24. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [24] ADC1-Word Recognition: Word [2] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 2. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [2] ADC1-Word Recognition: Word [3] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 3. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [3] ADC1-Word Recognition: Word [4] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 4. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [4] ADC1-Word Recognition: Word [5] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 5. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [5] ADC1-Word Recognition: Word [6] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 6. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [6] ADC1-Word Recognition: Word [7] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 7. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [7] ADC1-Word Recognition: Word [8] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 8. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [8] ADC1-Word Recognition: Word [9] Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 - Word recognition: Word 9. ADAS-COG Date 30th June 2015 Version - Word Recognition: Word [9] ADC1TN Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 Functional Test Test Name CDISC Functional Test Alzheimer's Disease Assessment Scale-Cognitive Date 30th June 2015 Version Test Name Terminology Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory MCI Version test code. ADL03-Find Personal Belongings Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} usually manage to find his/her personal belongings at home? ADCS-ADL MCI - Find Personal Belongings ADL03-Find Belongings Usual Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes how he /she usually performed. ADCS-ADL MCI - Description of Usual Performance of Finding Belongings ADL03-Select First Clothes for the Day Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} select his/her first set of clothes for the day? ADCS-ADL MCI - Select First Clothes for the Day ADL03-Usual Dressing Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes his/her usual performance. ADCS-ADL MCI - Description of Usual Performance of Selecting First Clothes for the Day ADL03-Usual Physically Dressing Perform Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Regarding physically getting dressed, which best describes his/her usual performance in the past 4 weeks. ADCS-ADL MCI - Description of Usual Performance of Physically Getting Dressed ADL03-Clean Room Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} clean a living-, sitting-, or family room? ADCS-ADL MCI - Clean Room ADL03-Clean Room Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes how he/she usually performed. ADCS-ADL MCI - Description of Usual Performance of Cleaning Room ADL03-Balance Checkbook Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} balance his/her checkbook or credit card statement? ADCS-ADL MCI - Balance Checkbook ADL03-Balance Checkbook Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes how he/she usually performed. ADCS-ADL MCI - Description of Usual Performance of Balancing Checkbook ADL03-Write Things Down Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} ever write things down? ADCS-ADL MCI - Write Things Down ADL03-Most Complicated Writings Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes the most complicated things that he/she wrote. ADCS-ADL MCI - Description of Usual Performance of Most Complicated Things Written ADL03-Clean Laundry Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} clean a load of laundry? ADCS-ADL MCI - Clean Laundry ADL03-Laundry Cleaning Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes how he/she usually performed. ADCS-ADL MCI - Description of Usual Performance of Clean Laundry ADL03-Keep Appointments Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} keep appointments or meetings with other people, such as relatives, a doctor, the hairdresser, etc.? ADCS-ADL MCI - Keep Appointments ADL03-Aware of Appointment Ahead of Time Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes his/her awareness of the meeting ahead of time. ADCS-ADL MCI - Description of Awareness of the Meeting Ahead of Time ADL03-Use a Telephone Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} use a telephone? ADCS-ADL MCI - Use a Telephone ADL03-Highest Telephone Use Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes his/her highest level of performance. ADCS-ADL MCI - Description of Highest Level of Performance of Telephone Use ADL03-Make a Meal Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} make him/herself a meal or snack at home? ADCS-ADL MCI - Make a Meal or Snack ADL03-Highest Level of Food Preparation Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes his/her highest level of food preparation. ADCS-ADL MCI - Description of Highest Level of Food Preparation ADL03-Get Around Outside Home Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} get around (or travel) outside of his/her home? ADCS-ADL MCI - Travel Outside Home ADL03-Get Around Optimal Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes his/her optimal performance. ADCS-ADL MCI - Description of Optimal Performance of Travelling Outside Home ADL03-Talk About Current Events Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} talk about current events? ADCS-ADL MCI - Talk About Current Events ADL03-Regional, National, International Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, did {S} talk about regional, national or international events? ADCS-ADL MCI - Talk About Regional, National or International Events ADL03-Talk About Outside Events Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} talk about events outside home involving family, friends, or neighbors? ADCS-ADL MCI - Talk About Outside Home Events ADL03-Talk About at Home Events Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} talk about events that occurred at home that he/she took part in or watched? ADCS-ADL MCI - Talk About at Home Events ADL03-Talk Without Repeating Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} converse without repeating him/herself, or asking the same questions repeatedly? ADCS-ADL MCI - Converse Without Repeating ADL03-Read More Than 5 Minutes Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} read a magazine, newspaper or book for more than 5 minutes at a time? ADCS-ADL MCI - Read More Than 5 Minutes ADL03-Select/Ask for Something to Read Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} usually select or ask for something to read? ADCS-ADL MCI - Select or Ask for Something to Read ADL03-Talk Within 1 Hour After Reading Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} usually talk about what he/she read while or shortly after reading (less than 1 hour)? ADCS-ADL MCI - Talk Within 1 Hour After Reading ADL03-Talk Within 1 Day After Reading Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} usually talk about what he/she read 1-24 hours after reading? ADCS-ADL MCI - Talk Within 24 Hours After Reading ADL03-Watch Television Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} watch television? ADCS-ADL MCI - Watch Television ADL03-Select Television Program Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} usually select or ask for different programs or his/her favorite show? ADCS-ADL MCI - Select or Ask for Programs or Show ADL03-Talk About TV Content While Watch Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} usually talk about the content of a program while watching it? ADCS-ADL MCI - Talk About Content of Program While Watching ADL03-Talk About TV Content Within a Day Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} talk about the content of a program within a day (24 hours) after watching it? ADCS-ADL MCI - Talk About Content of Program After Watching Within a Day ADL03-Go Shopping Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} ever go shopping at a store? ADCS-ADL MCI - Go Shopping At a Store ADL03-Select Items Without Help Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} usually select correct items without supervision or help? ADCS-ADL MCI - Select Correct Items Without Help ADL03-Pay Items On His/Her Own Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} usually pay for items on his/her own? ADCS-ADL MCI - Pay for Items on His or Her Own ADL03-Left On His/Her Own Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, was {S} ever left on his/her own? ADCS-ADL MCI - Left on His or Her Own ADL03-Left Away From Home Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Was {S} left away from home, for 15 minutes or longer, during the day? ADCS-ADL MCI - Left Away From Home Longer Than 15 Minutes ADL03-Left at Home for 1 Hour or Longer Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Was {S} left at home, for an hour or longer, during the day? ADCS-ADL MCI - Left at Home Longer Than an Hour ADL03-Left at Home for Less Than 1 Hour Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Was {S} left at home, for less than 1 hour, during the day? ADCS-ADL MCI - Left at Home Less Than an Hour ADL03-Use Household Appliance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} use a household appliance to do chores? ADCS-ADL MCI - Use Household Appliance ADL03-Appliance: Washer Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: washer. ADCS-ADL MCI - Use Household Appliance: Washer ADL03-Appliance: Dryer Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: dryer. ADCS-ADL MCI - Use Household Appliance: Dryer ADL03-Appliance: Vacuum Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: vacuum. ADCS-ADL MCI - Use Household Appliance: Vacuum ADL03-Appliance: Dishwasher Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: dishwasher. ADCS-ADL MCI - Use Household Appliance: Dishwasher ADL03-Appliance: Power Tools Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: power tool (s). ADCS-ADL MCI - Use Household Appliance: Power Tools ADL03-Appliance: Toaster Oven Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: toaster oven. ADCS-ADL MCI - Use Household Appliance: Toaster Oven ADL03-Appliance: Range Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: range. ADCS-ADL MCI - Use Household Appliance: Range ADL03-Appliance: Microwave Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: microwave. ADCS-ADL MCI - Use Household Appliance: Microwave ADL03-Appliance: Food Processor Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: food processor. ADCS-ADL MCI - Use Household Appliance: Food Processor ADL03-Appliance: Other Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: other. ADCS-ADL MCI - Use Household Appliance: Other ADL03-Appliance: Other Specify Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: other specify. ADCS-ADL MCI - Use Household Appliance: Other Specify ADL03-Use Common Used Appliances (q17a) Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - For the 1 or 2 most commonly used appliances, which best describes how {S} usually used them. ADCS-ADL MCI - Description of Usual Use of Commonly Used Appliances ADL03-Perform Pastime Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} perform a pastime, hobby or game? ADCS-ADL MCI - Perform Pastime, Hobby or Game ADL03-Pastime: Card or Board Games Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: card or board games. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Card or Board Games ADL03-Pastime: Bingo Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: bingo. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Bingo ADL03-Pastime: Crosswords Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: crosswords. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Crosswords ADL03-Pastime: Art Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: art. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Art ADL03-Pastime: Musical Instrument Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: musical instrument. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Musical Instrument ADL03-Pastime: Knitting Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: knitting. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Knitting ADL03-Pastime: Sewing Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: sewing. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Sewing ADL03-Pastime: Reading Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: reading. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Reading ADL03-Pastime: Gardening Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: gardening. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Gardening ADL03-Pastime: Golf Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: golf. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Golf ADL03-Pastime: Tennis Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: tennis. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Tennis ADL03-Pastime: Workshop Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: workshop. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Workshop ADL03-Pastime: Fishing Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: fishing. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Fishing ADL03-Pastime: Other Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: other. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Other ADL03-Pastime: Other Specify Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: other specify. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Other Specify ADL03-Hobbies Needed Help (Q18a) Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} require supervision, or help, to perform any of these hobbies? ADCS-ADL MCI - Require Help to Perform Hobbies ADL03-Hobbies Unable to Perform (Q18b) Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - List any hobby (ies) that the subject has lost the ability to perform. ADCS-ADL MCI - List Hobbies Lost Ability to Perform ADL03-Drive Car Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} drive a car? ADCS-ADL MCI - Drive a Car ADL03-Drive Car Optimal Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes his/her optimal performance. ADCS-ADL MCI - Description of Optimal Performance of Driving Car ADL03-Take Medications Regularly Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - During the past 4 weeks, did {S} take his/her medications regularly? ADCS-ADL MCI - Take Medications Regularly ADL03-Take Medications Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, was this. ADCS-ADL MCI - Description of Taking Medications Regularly ADL03-Complete Complex Activities Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - During the past 4 weeks, did {S} usually carry through complex or time-consuming activities to completion? ADCS-ADL MCI - Carry Through Complex Activities to Completion ADL03-Extent Needed Reminders Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes extent to which he/she needed reminders. ADCS-ADL MCI - Description of Extent Needing Reminder ADL03-Initiate Complex Activities Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - During the past 4 weeks, to what extent did {S} initiate complex daily activities or projects (e.g., hobbies, travel)? ADCS-ADL MCI - Initiate Complex Daily Activities ADL03-Time to Complete Complex Tasks Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - During the past 4 weeks, how long did it usually take {S} to complete complex or time-consuming tasks or activities? ADCS-ADL MCI - Time Taken to Complete Complex Activities ADL03-Extenuating Circumstances Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Has an extenuating circumstance (such as a physical health problem, change in residence, change in support network, death of a family member, etc.) contributed to a recent alteration in the subject's activities of daily living? ADCS-ADL MCI - Extenuating Circumstance ADL03-Explain Circumstance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, explain. ADCS-ADL MCI - Explain Extenuating Circumstance ADL03-Total Points for 'Don't Know' Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Were any questions (1-18) answered 'Don't Know'? If yes, calculate total points for 'Don't Know'. ADCS-ADL MCI - Points for Questions (1-18) Answered 'Don't Know' ADL03-Subscore for Items 1 to 3 Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 1. ADCS-ADL MCI - Subscore for Items 1 to 3 ADL03-Subscore for Items 4 to 7 Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 2. ADCS-ADL MCI - Subscore for Items 4 to 7 ADL03-Subscore for Items 8 to 10 Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 3. ADCS-ADL MCI - Subscore for Items 8 to 10 ADL03-Subscore for Items 11 to 12d Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 4. ADCS-ADL MCI - Subscore for Items 11 to 12 ADL03-Subscore for Items 13 to 14c Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 5. ADCS-ADL MCI - Subscore for Items 13 to 14 ADL03-Subscore for Items 15 to 16c Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 6. ADCS-ADL MCI - Subscore for Items 15 to 16 ADL03-Subscore for Item 17 Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 7. ADCS-ADL MCI - Subscore for Item 17 ADL03-Subscore for Item 18 Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 8. ADCS-ADL MCI - Subscore for Item 18 ADL03-Total ADCS-ADL Score Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Total Score. ADCS-ADL MCI - ADL Total Score ADL03TC Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory MCI Version Questionnaire Test Code CDISC Questionnaire ADCS-ADL MCI Test Code Terminology Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory MCI Version test name. ADL03-Appliance: Dishwasher Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: dishwasher. ADCS-ADL MCI - Use Household Appliance: Dishwasher ADL03-Appliance: Dryer Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: dryer. ADCS-ADL MCI - Use Household Appliance: Dryer ADL03-Appliance: Food Processor Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: food processor. ADCS-ADL MCI - Use Household Appliance: Food Processor ADL03-Appliance: Microwave Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: microwave. ADCS-ADL MCI - Use Household Appliance: Microwave ADL03-Appliance: Other Specify Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: other specify. ADCS-ADL MCI - Use Household Appliance: Other Specify ADL03-Appliance: Other Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: other. ADCS-ADL MCI - Use Household Appliance: Other ADL03-Appliance: Power Tools Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: power tool (s). ADCS-ADL MCI - Use Household Appliance: Power Tools ADL03-Appliance: Range Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: range. ADCS-ADL MCI - Use Household Appliance: Range ADL03-Appliance: Toaster Oven Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: toaster oven. ADCS-ADL MCI - Use Household Appliance: Toaster Oven ADL03-Appliance: Vacuum Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: vacuum. ADCS-ADL MCI - Use Household Appliance: Vacuum ADL03-Appliance: Washer Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: washer. ADCS-ADL MCI - Use Household Appliance: Washer ADL03-Aware of Appointment Ahead of Time Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes his/her awareness of the meeting ahead of time. ADCS-ADL MCI - Description of Awareness of the Meeting Ahead of Time ADL03-Balance Checkbook Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes how he/she usually performed. ADCS-ADL MCI - Description of Usual Performance of Balancing Checkbook ADL03-Balance Checkbook Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} balance his/her checkbook or credit card statement? ADCS-ADL MCI - Balance Checkbook ADL03-Clean Laundry Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} clean a load of laundry? ADCS-ADL MCI - Clean Laundry ADL03-Clean Room Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes how he/she usually performed. ADCS-ADL MCI - Description of Usual Performance of Cleaning Room ADL03-Clean Room Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} clean a living-, sitting-, or family room? ADCS-ADL MCI - Clean Room ADL03-Complete Complex Activities Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - During the past 4 weeks, did {S} usually carry through complex or time-consuming activities to completion? ADCS-ADL MCI - Carry Through Complex Activities to Completion ADL03-Drive Car Optimal Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes his/her optimal performance. ADCS-ADL MCI - Description of Optimal Performance of Driving Car ADL03-Drive Car Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} drive a car? ADCS-ADL MCI - Drive a Car ADL03-Explain Circumstance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, explain. ADCS-ADL MCI - Explain Extenuating Circumstance ADL03-Extent Needed Reminders Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes extent to which he/she needed reminders. ADCS-ADL MCI - Description of Extent Needing Reminder ADL03-Extenuating Circumstances Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Has an extenuating circumstance (such as a physical health problem, change in residence, change in support network, death of a family member, etc.) contributed to a recent alteration in the subject's activities of daily living? ADCS-ADL MCI - Extenuating Circumstance ADL03-Find Belongings Usual Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes how he /she usually performed. ADCS-ADL MCI - Description of Usual Performance of Finding Belongings ADL03-Find Personal Belongings Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} usually manage to find his/her personal belongings at home? ADCS-ADL MCI - Find Personal Belongings ADL03-Get Around Optimal Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes his/her optimal performance. ADCS-ADL MCI - Description of Optimal Performance of Travelling Outside Home ADL03-Get Around Outside Home Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} get around (or travel) outside of his/her home? ADCS-ADL MCI - Travel Outside Home ADL03-Go Shopping Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} ever go shopping at a store? ADCS-ADL MCI - Go Shopping At a Store ADL03-Highest Level of Food Preparation Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes his/her highest level of food preparation. ADCS-ADL MCI - Description of Highest Level of Food Preparation ADL03-Highest Telephone Use Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes his/her highest level of performance. ADCS-ADL MCI - Description of Highest Level of Performance of Telephone Use ADL03-Hobbies Needed Help (Q18a) Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} require supervision, or help, to perform any of these hobbies? ADCS-ADL MCI - Require Help to Perform Hobbies ADL03-Hobbies Unable to Perform (Q18b) Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - List any hobby (ies) that the subject has lost the ability to perform. ADCS-ADL MCI - List Hobbies Lost Ability to Perform ADL03-Initiate Complex Activities Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - During the past 4 weeks, to what extent did {S} initiate complex daily activities or projects (e.g., hobbies, travel)? ADCS-ADL MCI - Initiate Complex Daily Activities ADL03-Keep Appointments Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} keep appointments or meetings with other people, such as relatives, a doctor, the hairdresser, etc.? ADCS-ADL MCI - Keep Appointments ADL03-Laundry Cleaning Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes how he/she usually performed. ADCS-ADL MCI - Description of Usual Performance of Clean Laundry ADL03-Left at Home for 1 Hour or Longer Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Was {S} left at home, for an hour or longer, during the day? ADCS-ADL MCI - Left at Home Longer Than an Hour ADL03-Left at Home for Less Than 1 Hour Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Was {S} left at home, for less than 1 hour, during the day? ADCS-ADL MCI - Left at Home Less Than an Hour ADL03-Left Away From Home Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Was {S} left away from home, for 15 minutes or longer, during the day? ADCS-ADL MCI - Left Away From Home Longer Than 15 Minutes ADL03-Left On His/Her Own Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, was {S} ever left on his/her own? ADCS-ADL MCI - Left on His or Her Own ADL03-Make a Meal Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} make him/herself a meal or snack at home? ADCS-ADL MCI - Make a Meal or Snack ADL03-Most Complicated Writings Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes the most complicated things that he/she wrote. ADCS-ADL MCI - Description of Usual Performance of Most Complicated Things Written ADL03-Pastime: Art Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: art. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Art ADL03-Pastime: Bingo Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: bingo. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Bingo ADL03-Pastime: Card or Board Games Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: card or board games. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Card or Board Games ADL03-Pastime: Crosswords Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: crosswords. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Crosswords ADL03-Pastime: Fishing Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: fishing. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Fishing ADL03-Pastime: Gardening Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: gardening. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Gardening ADL03-Pastime: Golf Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: golf. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Golf ADL03-Pastime: Knitting Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: knitting. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Knitting ADL03-Pastime: Musical Instrument Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: musical instrument. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Musical Instrument ADL03-Pastime: Other Specify Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: other specify. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Other Specify ADL03-Pastime: Other Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: other. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Other ADL03-Pastime: Reading Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: reading. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Reading ADL03-Pastime: Sewing Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: sewing. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Sewing ADL03-Pastime: Tennis Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: tennis. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Tennis ADL03-Pastime: Workshop Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: workshop. ADCS-ADL MCI - Perform Pastime, Hobby or Game: Workshop ADL03-Pay Items On His/Her Own Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} usually pay for items on his/her own? ADCS-ADL MCI - Pay for Items on His or Her Own ADL03-Perform Pastime Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} perform a pastime, hobby or game? ADCS-ADL MCI - Perform Pastime, Hobby or Game ADL03-Read More Than 5 Minutes Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} read a magazine, newspaper or book for more than 5 minutes at a time? ADCS-ADL MCI - Read More Than 5 Minutes ADL03-Regional, National, International Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, did {S} talk about regional, national or international events? ADCS-ADL MCI - Talk About Regional, National or International Events ADL03-Select First Clothes for the Day Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} select his/her first set of clothes for the day? ADCS-ADL MCI - Select First Clothes for the Day ADL03-Select Items Without Help Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} usually select correct items without supervision or help? ADCS-ADL MCI - Select Correct Items Without Help ADL03-Select Television Program Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} usually select or ask for different programs or his/her favorite show? ADCS-ADL MCI - Select or Ask for Programs or Show ADL03-Select/Ask for Something to Read Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} usually select or ask for something to read? ADCS-ADL MCI - Select or Ask for Something to Read ADL03-Subscore for Item 17 Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 7. ADCS-ADL MCI - Subscore for Item 17 ADL03-Subscore for Item 18 Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 8. ADCS-ADL MCI - Subscore for Item 18 ADL03-Subscore for Items 1 to 3 Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 1. ADCS-ADL MCI - Subscore for Items 1 to 3 ADL03-Subscore for Items 11 to 12d Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 4. ADCS-ADL MCI - Subscore for Items 11 to 12 ADL03-Subscore for Items 13 to 14c Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 5. ADCS-ADL MCI - Subscore for Items 13 to 14 ADL03-Subscore for Items 15 to 16c Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 6. ADCS-ADL MCI - Subscore for Items 15 to 16 ADL03-Subscore for Items 4 to 7 Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 2. ADCS-ADL MCI - Subscore for Items 4 to 7 ADL03-Subscore for Items 8 to 10 Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 3. ADCS-ADL MCI - Subscore for Items 8 to 10 ADL03-Take Medications Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, was this. ADCS-ADL MCI - Description of Taking Medications Regularly ADL03-Take Medications Regularly Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - During the past 4 weeks, did {S} take his/her medications regularly? ADCS-ADL MCI - Take Medications Regularly ADL03-Talk About at Home Events Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} talk about events that occurred at home that he/she took part in or watched? ADCS-ADL MCI - Talk About at Home Events ADL03-Talk About Current Events Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} talk about current events? ADCS-ADL MCI - Talk About Current Events ADL03-Talk About Outside Events Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} talk about events outside home involving family, friends, or neighbors? ADCS-ADL MCI - Talk About Outside Home Events ADL03-Talk About TV Content While Watch Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} usually talk about the content of a program while watching it? ADCS-ADL MCI - Talk About Content of Program While Watching ADL03-Talk About TV Content Within a Day Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} talk about the content of a program within a day (24 hours) after watching it? ADCS-ADL MCI - Talk About Content of Program After Watching Within a Day ADL03-Talk Within 1 Day After Reading Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} usually talk about what he/she read 1-24 hours after reading? ADCS-ADL MCI - Talk Within 24 Hours After Reading ADL03-Talk Within 1 Hour After Reading Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} usually talk about what he/she read while or shortly after reading (less than 1 hour)? ADCS-ADL MCI - Talk Within 1 Hour After Reading ADL03-Talk Without Repeating Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} converse without repeating him/herself, or asking the same questions repeatedly? ADCS-ADL MCI - Converse Without Repeating ADL03-Time to Complete Complex Tasks Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - During the past 4 weeks, how long did it usually take {S} to complete complex or time-consuming tasks or activities? ADCS-ADL MCI - Time Taken to Complete Complex Activities ADL03-Total ADCS-ADL Score Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Total Score. ADCS-ADL MCI - ADL Total Score ADL03-Total Points for 'Don't Know' Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Were any questions (1-18) answered 'Don't Know'? If yes, calculate total points for 'Don't Know'. ADCS-ADL MCI - Points for Questions (1-18) Answered 'Don't Know' ADL03-Use a Telephone Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} use a telephone? ADCS-ADL MCI - Use a Telephone ADL03-Use Common Used Appliances (q17a) Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - For the 1 or 2 most commonly used appliances, which best describes how {S} usually used them. ADCS-ADL MCI - Description of Usual Use of Commonly Used Appliances ADL03-Use Household Appliance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} use a household appliance to do chores? ADCS-ADL MCI - Use Household Appliance ADL03-Usual Dressing Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes his/her usual performance. ADCS-ADL MCI - Description of Usual Performance of Selecting First Clothes for the Day ADL03-Usual Physically Dressing Perform Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Regarding physically getting dressed, which best describes his/her usual performance in the past 4 weeks. ADCS-ADL MCI - Description of Usual Performance of Physically Getting Dressed ADL03-Watch Television Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} watch television? ADCS-ADL MCI - Watch Television ADL03-Write Things Down Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} ever write things down? ADCS-ADL MCI - Write Things Down ADL03TN Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory MCI Version Questionnaire Test Name CDISC Questionnaire ADCS-ADL MCI Test Name Terminology Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory test code. ADL01-Usual Eating Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Regarding eating: which best describes {S} usual performance during the past 4 weeks? ADCS-ADL - Description of Usual Performance of Eating ADL01-Optimal Walking Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Regarding walking (or getting around in a wheelchair), in the past 4 weeks, which best describes his/her optimal performance. ADCS-ADL - Description of Optimal Performance of Walking ADL01-Usual Bowel/Bladder Function Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Regarding bowel and bladder function at the toilet, which best describes his/her usual performance in the past 4 weeks. ADCS-ADL - Usual Bowel and Bladder Function at Toilet ADL01-Usual Bathing Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Regarding bathing, in the past 4 weeks, which best describes his/her usual performance. ADCS-ADL - Description of Usual Performance of Bathing ADL01-Optimal Grooming Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Regarding grooming, in the past 4 weeks, which best describes his/her optimal performance. ADCS-ADL - Description of Optimal Performance of Grooming ADL01-Select First Clothes for the Day Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Regarding dressing in the past 4 weeks: Did {S} select his/her first set of clothes for the day? ADCS-ADL - Select First Clothes for the Day ADL01-Usual Dressing Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes usual performance. ADCS-ADL - Description of Usual Performance of Dressing ADL01-Usual Physically Dressing Perform Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Regarding physically getting dressed, which best describes his/her usual performance in the past 4 weeks. ADCS-ADL - Description of Usual Performance of Physically Getting Dressed ADL01-Use a Telephone Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} use a telephone? ADCS-ADL - Use a Telephone ADL01-Highest Telephone Use Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes his/her highest level of performance. ADCS-ADL - Description of Highest Performance of Telephone Use ADL01-Watch Television Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} watch television? ADCS-ADL - Watch Television ADL01-Select Television Program Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} usually select or ask for different programs or his/her favorite show? ADCS-ADL - Select or Ask for Television Program ADL01-Talk About TV Content While Watch Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} usually talk about the content of a program while watching it? ADCS-ADL - Talk About TV Content While Watching ADL01-Talk About TV Content Within a Day Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} talk about the content of a program within a day (24 hours) after watching it? ADCS-ADL - Talk About TV Content Within a Day After Watching ADL01-Pay Attention to Conversation Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} ever appear to pay attention to conversation or small talk for at least 5 minutes? ADCS-ADL - Pay Attention to Conversation ADL01-Usual Conversation Participation Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes his/her usual degree of participation. ADCS-ADL - Usual Conversation Participation ADL01-Clear Dishes Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} clear the dishes from the table after a meal or snack? ADCS-ADL - Clear Dishes After Meal or Snack ADL01-Clear Dishes Usual Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes how he/she usually performed. ADCS-ADL - Description of Usual Performance of Clearing Dishes ADL01-Find Belongings Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} usually manage to find his/her personal belongings at home? ADCS-ADL - Find Personal Belongings at Home ADL01-Find Belongings Usual Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes how he/she usually performed. ADCS-ADL - Description of Usual Performance of Finding Personal Belonging at Home ADL01-Obtain Beverage Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} obtain a hot or cold beverage for him/herself? ADCS-ADL - Obtain Beverage for Self ADL01-Obtain Beverage Highest Perform Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes his/her highest level of performance. ADCS-ADL - Description of Highest Performance of Obtaining Beverage ADL01-Make a Meal Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} make him/herself a meal or snack at home? ADCS-ADL - Make a Meal or Snack at Home ADL01-Highest Level of Food Preparation Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes his/her highest level of food preparation. ADCS-ADL - Highest Level of Food Preparation ADL01-Dispose of Garbage Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} dispose of garbage or litter in an appropriate place or container at home? ADCS-ADL - Dispose of Garbage in Appropriate Place at Home ADL01-Dispose Garbage Usual Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes how he/she usually performed. ADCS-ADL - Description of Usual Performance of Garbage Disposal ADL01-Get Around Outside Home Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} get around (or travel) outside of his/her home? ADCS-ADL - Get Around Outside Home ADL01-Get Around Optimal Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes his/her optimal performance. ADCS-ADL - Description of Optimal Performance of Getting Around Outside of Home ADL01-Go Shopping Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} ever go shopping? ADCS-ADL - Go Shopping ADL01-How Usually Selects Items Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which one best describes how {S} usually selects items. ADCS-ADL - How Subject Usually Selects Items ADL01-Pay Without Supervision Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} usually pay for items without supervision or physical help? ADCS-ADL - Pay for Items Without Supervision or Physical Help ADL01-Keep Appointments Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} keep appointments or meetings with other people, such as relatives, a doctor, the hairdresser, etc.? ADCS-ADL - Keep Appointments or Meetings with Others ADL01-Aware of Appointment Ahead of Time Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes his/her awareness of the meeting ahead of time. ADCS-ADL - Description of Awareness of Appointment Ahead of Time ADL01-Left On His/Her Own Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, was {S} ever left on his/her own? ADCS-ADL - Subject Left on Their Own ADL01-Left Away From Home Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Was {S} left away from home, for 15 minutes or longer, during the day? ADCS-ADL - Left Away From Home for Fifteen Minutes or Longer ADL01-Left at Home for 1 Hour or Longer Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Was {S} left: at home, for an hour or longer, during the day? ADCS-ADL - Left at Home for One Hour or Longer ADL01-Left at Home for Less Than 1 Hour Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Was {S} left at home, for less than 1 hour, during the day? ADCS-ADL - Left at Home for Less Than One Hour ADL01-Talk About Current Events Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} talk about current events? ADCS-ADL - Talk About Current Events ADL01-Talk About Events Heard/Read About Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} talk about events that he/she heard or read about or saw on TV but did not take part in? ADCS-ADL - Talk About Events on TV that Subject Did not Take Part In ADL01-Talk About Outside Events Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} talk about events that he/she took part in outside home involving family, friends, or neighbors? ADCS-ADL - Talk About Events Outside of Home that Subject Took Part In ADL01-Talk About at Home Events Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} talk about events that occurred at home that he/she took part in or watched? ADCS-ADL - Talk About Events at Home that Subject Took Part in or Watched ADL01-Read More Than 5 Minutes Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} read a magazine, newspaper or book for more than 5 minutes at a time? ADCS-ADL - Read for More Than Five Minutes ADL01-Talk Within 1 Hour After Reading Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} usually talk about details of what he/she read while or shortly (less than 1 hour) after reading? ADCS-ADL - Talk About What Subject Read Less Than One Hour After Reading ADL01-Talk 1 Hour or More After Reading Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} usually talk about what he/she read 1 hour or longer after reading? ADCS-ADL - Talk About What Subject Read More Than One Hour After Reading ADL01-Write Things Down Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} ever write things down? ADCS-ADL - Write Things Down ADL01-Most Complicated Writings Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes the most complicated things that he/she wrote. ADCS-ADL - Description of Most Complicated Writings ADL01-Perform Pastime Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} perform a pastime, hobby or game? ADCS-ADL - Perform Pastime, Hobby or Game ADL01-Pastime: Card or Board Games Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: Card or board games. ADCS-ADL - Pastime: Card or Board Games ADL01-Pastime: Bingo Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: bingo. ADCS-ADL - Pastime: Bingo ADL01-Pastime: Crosswords Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: crosswords. ADCS-ADL - Pastime: Crosswords ADL01-Pastime: Art Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: art. ADCS-ADL - Pastime: Art ADL01-Pastime: Musical Instrument Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: musical instrument. ADCS-ADL - Pastime: Musical Instrument ADL01-Pastime: Knitting Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: knitting. ADCS-ADL - Pastime: Knitting ADL01-Pastime: Sewing Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: sewing. ADCS-ADL - Pastime: Sewing ADL01-Pastime: Reading Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: reading. ADCS-ADL - Pastime: Reading ADL01-Pastime: Gardening Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: gardening. ADCS-ADL - Pastime: Gardening ADL01-Pastime: Golf Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: golf. ADCS-ADL - Pastime: Golf ADL01-Pastime: Tennis Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: tennis. ADCS-ADL - Pastime: Tennis ADL01-Pastime: Workshop Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: workshop. ADCS-ADL - Pastime: Workshop ADL01-Pastime: Fishing Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: fishing. ADCS-ADL - Pastime: Fishing ADL01-Pastime: Other Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: other. ADCS-ADL - Pastime: Other ADL01-Pastime: Other Specify Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: other specify. ADCS-ADL - Pastime: Other Specify ADL01-Hobbies Only at Day Care Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If {S} performs hobbies/pastimes only at day care, check here. ADCS-ADL - Performed Hobbies Only at Day Care ADL01-Usual Common Pastimes Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, how did {S} usually perform his/her most common pastimes. ADCS-ADL - Description of Usual Performance of Common Pastimes ADL01-Use Household Appliance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} use a household appliance to do chores? ADCS-ADL - Use Household Appliance to do Chores ADL01-Appliance: Washer Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: washer. ADCS-ADL - Appliance: Washer ADL01-Appliance: Dryer Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: dryer. ADCS-ADL - Appliance: Dryer ADL01-Appliance: Vacuum Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: vacuum. ADCS-ADL - Appliance: Vacuum ADL01-Appliance: Dishwasher Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: dishwasher. ADCS-ADL - Appliance: Dishwasher ADL01-Appliance: Toaster Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: toaster. ADCS-ADL - Appliance: Toaster ADL01-Appliance: Toaster Oven Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: toaster oven. ADCS-ADL - Appliance: Toaster Oven ADL01-Appliance: Range Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: range. ADCS-ADL - Appliance: Range ADL01-Appliance: Microwave Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: microwave. ADCS-ADL - Appliance: Microwave ADL01-Appliance: Food Processor Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: food processor. ADCS-ADL - Appliance: Food Processor ADL01-Appliance: Other Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: other. ADCS-ADL - Appliance: Other ADL01-Appliance: Other Specify Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: other specify. ADCS-ADL - Appliance: Other Specify ADL01-Use Common Used Appliances Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, for the most commonly used appliances, which best describes how {S} usually used them. ADCS-ADL - Description of Usual Use of Commonly Used Appliances ADL01-Total ADCS-ADL Score Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Total Score. ADCS-ADL - Total Score ADL01-Number Don't Know Responses Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Number of 'Don't Know' Responses. ADCS-ADL - Number of 'Don't Know' Responses ADL01TC Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory Questionnaire Test Code CDISC Questionnaire ADCS-ADL Test Code Terminology Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory test name. ADL01-Appliance: Dishwasher Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: dishwasher. ADCS-ADL - Appliance: Dishwasher ADL01-Appliance: Dryer Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: dryer. ADCS-ADL - Appliance: Dryer ADL01-Appliance: Food Processor Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: food processor. ADCS-ADL - Appliance: Food Processor ADL01-Appliance: Microwave Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: microwave. ADCS-ADL - Appliance: Microwave ADL01-Appliance: Other Specify Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: other specify. ADCS-ADL - Appliance: Other Specify ADL01-Appliance: Other Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: other. ADCS-ADL - Appliance: Other ADL01-Appliance: Range Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: range. ADCS-ADL - Appliance: Range ADL01-Appliance: Toaster Oven Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: toaster oven. ADCS-ADL - Appliance: Toaster Oven ADL01-Appliance: Toaster Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: toaster. ADCS-ADL - Appliance: Toaster ADL01-Appliance: Vacuum Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: vacuum. ADCS-ADL - Appliance: Vacuum ADL01-Appliance: Washer Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: washer. ADCS-ADL - Appliance: Washer ADL01-Aware of Appointment Ahead of Time Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes his/her awareness of the meeting ahead of time. ADCS-ADL - Description of Awareness of Appointment Ahead of Time ADL01-Clear Dishes Usual Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes how he/she usually performed. ADCS-ADL - Description of Usual Performance of Clearing Dishes ADL01-Clear Dishes Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} clear the dishes from the table after a meal or snack? ADCS-ADL - Clear Dishes After Meal or Snack ADL01-Dispose Garbage Usual Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes how he/she usually performed. ADCS-ADL - Description of Usual Performance of Garbage Disposal ADL01-Dispose of Garbage Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} dispose of garbage or litter in an appropriate place or container at home? ADCS-ADL - Dispose of Garbage in Appropriate Place at Home ADL01-Find Belongings Usual Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes how he/she usually performed. ADCS-ADL - Description of Usual Performance of Finding Personal Belonging at Home ADL01-Find Belongings Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} usually manage to find his/her personal belongings at home? ADCS-ADL - Find Personal Belongings at Home ADL01-Get Around Optimal Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes his/her optimal performance. ADCS-ADL - Description of Optimal Performance of Getting Around Outside of Home ADL01-Get Around Outside Home Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} get around (or travel) outside of his/her home? ADCS-ADL - Get Around Outside Home ADL01-Go Shopping Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} ever go shopping? ADCS-ADL - Go Shopping ADL01-Highest Level of Food Preparation Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes his/her highest level of food preparation. ADCS-ADL - Highest Level of Food Preparation ADL01-Highest Telephone Use Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes his/her highest level of performance. ADCS-ADL - Description of Highest Performance of Telephone Use ADL01-Hobbies Only at Day Care Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If {S} performs hobbies/pastimes only at day care, check here. ADCS-ADL - Performed Hobbies Only at Day Care ADL01-How Usually Selects Items Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which one best describes how {S} usually selects items. ADCS-ADL - How Subject Usually Selects Items ADL01-Keep Appointments Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} keep appointments or meetings with other people, such as relatives, a doctor, the hairdresser, etc.? ADCS-ADL - Keep Appointments or Meetings with Others ADL01-Left at Home for 1 Hour or Longer Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Was {S} left: at home, for an hour or longer, during the day? ADCS-ADL - Left at Home for One Hour or Longer ADL01-Left at Home for Less Than 1 Hour Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Was {S} left at home, for less than 1 hour, during the day? ADCS-ADL - Left at Home for Less Than One Hour ADL01-Left Away From Home Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Was {S} left away from home, for 15 minutes or longer, during the day? ADCS-ADL - Left Away From Home for Fifteen Minutes or Longer ADL01-Left On His/Her Own Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, was {S} ever left on his/her own? ADCS-ADL - Subject Left on Their Own ADL01-Make a Meal Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} make him/herself a meal or snack at home? ADCS-ADL - Make a Meal or Snack at Home ADL01-Most Complicated Writings Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes the most complicated things that he/she wrote. ADCS-ADL - Description of Most Complicated Writings ADL01-Number Don't Know Responses Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Number of 'Don't Know' Responses. ADCS-ADL - Number of 'Don't Know' Responses ADL01-Obtain Beverage Highest Perform Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes his/her highest level of performance. ADCS-ADL - Description of Highest Performance of Obtaining Beverage ADL01-Obtain Beverage Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} obtain a hot or cold beverage for him/herself? ADCS-ADL - Obtain Beverage for Self ADL01-Optimal Grooming Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Regarding grooming, in the past 4 weeks, which best describes his/her optimal performance. ADCS-ADL - Description of Optimal Performance of Grooming ADL01-Optimal Walking Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Regarding walking (or getting around in a wheelchair), in the past 4 weeks, which best describes his/her optimal performance. ADCS-ADL - Description of Optimal Performance of Walking ADL01-Pastime: Art Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: art. ADCS-ADL - Pastime: Art ADL01-Pastime: Bingo Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: bingo. ADCS-ADL - Pastime: Bingo ADL01-Pastime: Card or Board Games Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: Card or board games. ADCS-ADL - Pastime: Card or Board Games ADL01-Pastime: Crosswords Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: crosswords. ADCS-ADL - Pastime: Crosswords ADL01-Pastime: Fishing Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: fishing. ADCS-ADL - Pastime: Fishing ADL01-Pastime: Gardening Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: gardening. ADCS-ADL - Pastime: Gardening ADL01-Pastime: Golf Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: golf. ADCS-ADL - Pastime: Golf ADL01-Pastime: Knitting Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: knitting. ADCS-ADL - Pastime: Knitting ADL01-Pastime: Musical Instrument Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: musical instrument. ADCS-ADL - Pastime: Musical Instrument ADL01-Pastime: Other Specify Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: other specify. ADCS-ADL - Pastime: Other Specify ADL01-Pastime: Other Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: other. ADCS-ADL - Pastime: Other ADL01-Pastime: Reading Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: reading. ADCS-ADL - Pastime: Reading ADL01-Pastime: Sewing Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: sewing. ADCS-ADL - Pastime: Sewing ADL01-Pastime: Tennis Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: tennis. ADCS-ADL - Pastime: Tennis ADL01-Pastime: Workshop Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: workshop. ADCS-ADL - Pastime: Workshop ADL01-Pay Attention to Conversation Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} ever appear to pay attention to conversation or small talk for at least 5 minutes? ADCS-ADL - Pay Attention to Conversation ADL01-Pay Without Supervision Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} usually pay for items without supervision or physical help? ADCS-ADL - Pay for Items Without Supervision or Physical Help ADL01-Perform Pastime Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} perform a pastime, hobby or game? ADCS-ADL - Perform Pastime, Hobby or Game ADL01-Read More Than 5 Minutes Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} read a magazine, newspaper or book for more than 5 minutes at a time? ADCS-ADL - Read for More Than Five Minutes ADL01-Select First Clothes for the Day Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Regarding dressing in the past 4 weeks: Did {S} select his/her first set of clothes for the day? ADCS-ADL - Select First Clothes for the Day ADL01-Select Television Program Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} usually select or ask for different programs or his/her favorite show? ADCS-ADL - Select or Ask for Television Program ADL01-Talk 1 Hour or More After Reading Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} usually talk about what he/she read 1 hour or longer after reading? ADCS-ADL - Talk About What Subject Read More Than One Hour After Reading ADL01-Talk About at Home Events Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} talk about events that occurred at home that he/she took part in or watched? ADCS-ADL - Talk About Events at Home that Subject Took Part in or Watched ADL01-Talk About Current Events Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} talk about current events? ADCS-ADL - Talk About Current Events ADL01-Talk About Events Heard/Read About Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} talk about events that he/she heard or read about or saw on TV but did not take part in? ADCS-ADL - Talk About Events on TV that Subject Did not Take Part In ADL01-Talk About Outside Events Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} talk about events that he/she took part in outside home involving family, friends, or neighbors? ADCS-ADL - Talk About Events Outside of Home that Subject Took Part In ADL01-Talk About TV Content While Watch Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} usually talk about the content of a program while watching it? ADCS-ADL - Talk About TV Content While Watching ADL01-Talk About TV Content Within a Day Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} talk about the content of a program within a day (24 hours) after watching it? ADCS-ADL - Talk About TV Content Within a Day After Watching ADL01-Talk Within 1 Hour After Reading Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} usually talk about details of what he/she read while or shortly (less than 1 hour) after reading? ADCS-ADL - Talk About What Subject Read Less Than One Hour After Reading ADL01-Total ADCS-ADL Score Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Total Score. ADCS-ADL - Total Score ADL01-Use a Telephone Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} use a telephone? ADCS-ADL - Use a Telephone ADL01-Use Common Used Appliances Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, for the most commonly used appliances, which best describes how {S} usually used them. ADCS-ADL - Description of Usual Use of Commonly Used Appliances ADL01-Use Household Appliance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} use a household appliance to do chores? ADCS-ADL - Use Household Appliance to do Chores ADL01-Usual Bathing Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Regarding bathing, in the past 4 weeks, which best describes his/her usual performance. ADCS-ADL - Description of Usual Performance of Bathing ADL01-Usual Bowel/Bladder Function Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Regarding bowel and bladder function at the toilet, which best describes his/her usual performance in the past 4 weeks. ADCS-ADL - Usual Bowel and Bladder Function at Toilet ADL01-Usual Common Pastimes Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, how did {S} usually perform his/her most common pastimes. ADCS-ADL - Description of Usual Performance of Common Pastimes ADL01-Usual Conversation Participation Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes his/her usual degree of participation. ADCS-ADL - Usual Conversation Participation ADL01-Usual Dressing Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes usual performance. ADCS-ADL - Description of Usual Performance of Dressing ADL01-Usual Eating Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Regarding eating: which best describes {S} usual performance during the past 4 weeks? ADCS-ADL - Description of Usual Performance of Eating ADL01-Usual Physically Dressing Perform Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Regarding physically getting dressed, which best describes his/her usual performance in the past 4 weeks. ADCS-ADL - Description of Usual Performance of Physically Getting Dressed ADL01-Watch Television Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} watch television? ADCS-ADL - Watch Television ADL01-Write Things Down Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} ever write things down? ADCS-ADL - Write Things Down ADL01TN Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory Questionnaire Test Name CDISC Questionnaire ADCS-ADL Test Name Terminology Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory Severe Dementia Version test code. ADL02-Usual Eating Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Regarding eating, which best describes {S} usual performance during the last 4 weeks? ADCS-ADL Severe Dementia - Description of Usual Performance of Eating ADL02-Optimal Walking Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Regarding walking (or getting around in a wheelchair) in the past 4 weeks, which best describes {S} optimal performance? ADCS-ADL Severe Dementia - Description of Optimal Performance of Walking ADL02-Usual Bowel/Bladder Function Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Regarding bowel and bladder function at the toilet, which best describes {S} usual performance during the past 4 weeks? ADCS-ADL Severe Dementia - Usual Bowel and Bladder Function at Toilet ADL02-Usual Bathing Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Regarding bathing, in the past 4 weeks, which best describes {S} usual performance? ADCS-ADL Severe Dementia - Description of Usual Performance of Bathing ADL02-Optimal Grooming Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Regarding grooming, in the past 4 weeks, which best describes {S} optimal performance? ADCS-ADL Severe Dementia - Description of Optimal Performance of Grooming ADL02-Usual Physically Dressing Perform Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Regarding physically getting dressed, which best describes {S} usual performance in the past 4 weeks? ADCS-ADL Severe Dementia - Description of Usual Performance of Physically Getting Dressed ADL02-Use a Telephone Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} use a telephone? ADCS-ADL Severe Dementia - Use a Telephone ADL02-Highest Telephone Use Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - If yes, which best describes {S} highest level of performance. ADCS-ADL Severe Dementia - Description of Highest Performance of Telephone Use ADL02-Watch Television Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} watch television? ADCS-ADL Severe Dementia - Watch Television ADL02-Select Television Program Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Did {S} usually select or ask for different programs or {S} favorite show? ADCS-ADL Severe Dementia - Select or Ask for Television Program ADL02-Talk About TV Content While Watch Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Did {S} usually talk about the content of a program while watching it? ADCS-ADL Severe Dementia - Talk About TV Content While Watching ADL02-Talk About TV Content Within a Day Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Did {S} talk about the content of a program within a day (24 hours) after watching it? ADCS-ADL Severe Dementia - Talk About TV Content Within a Day After Watching ADL02-Pay Attention to Conversation Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} ever appear to pay attention to conversation or small talk for at least 5 minutes? ADCS-ADL Severe Dementia - Pay Attention to Conversation ADL02-Usual Conversation Participation Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - If yes, which best describes {S} usual degree of participation. ADCS-ADL Severe Dementia - Usual Conversation Participation ADL02-Clear Dishes Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Did {S} clear the dishes from the table after a meal or snack? ADCS-ADL Severe Dementia - Clear Dishes After Meal or Snack ADL02-Clear Dishes Usual Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - If yes, which best describes how {S} usually performed. ADCS-ADL Severe Dementia - Description of Usual Performance of Clearing Dishes ADL02-Find Belongings Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} usually manage to find his/her personal belongings at home? ADCS-ADL Severe Dementia - Find Personal Belongings at Home ADL02-Find Belongings Usual Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - If yes, which best describes how {S} usually performed. ADCS-ADL Severe Dementia - Description of Usual Performance of Finding Personal Belonging at Home ADL02-Obtain Beverage Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} obtain a hot or cold beverage for him/herself? ADCS-ADL Severe Dementia - Obtain Beverage for Self ADL02-Obtain Beverage Highest Perform Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - If yes, which best describes {S} highest level of performance. ADCS-ADL Severe Dementia - Description of Highest Performance of Obtaining Beverage ADL02-Dispose of Garbage Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} dispose of garbage or litter in an appropriate place or container at home? ADCS-ADL Severe Dementia - Dispose of Garbage in Appropriate Place at Home ADL02-Dispose Garbage Usual Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - If yes, which best describes how {S} usually performed. ADCS-ADL Severe Dementia - Description of Usual Performance of Garbage Disposal ADL02-Get Around Outside Home Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} get around (or travel) outside of his/her home? ADCS-ADL Severe Dementia - Get Around Outside Home ADL02-Get Around Optimal Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - If yes, which best describes {S} optimal performance. ADCS-ADL Severe Dementia - Description of Optimal Performance of Getting Around Outside of Home ADL02-Left On His/Her Own Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, was {S} ever left on his/her own? ADCS-ADL Severe Dementia - Subject Left on Their Own ADL02-Left Away From Home Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Was {S} left: away from home for 15 minutes or longer, during the day? ADCS-ADL Severe Dementia - Alone Away From Home for Fifteen Minutes or Longer ADL02-Left at Home for 1 Hour or Longer Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Was {S} left: at home for an hour or longer during the day? ADCS-ADL Severe Dementia - Alone at Home for One Hour or Longer ADL02-Left at Home for Less Than 1 Hour Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Was {S} left: at home for less than 1 hour during the day? ADCS-ADL Severe Dementia - Alone at Home for Less Than One Hour ADL02-Run Water Faucet to Wash Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} usually run water from a faucet to wash {S} hands or face without help? ADCS-ADL Severe Dementia - Turn On Faucet to Wash Without Help ADL02-Turn Off Faucet Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} usually turn off the faucet after finishing running water without help? ADCS-ADL Severe Dementia - Turn Off Faucet After Wash Without Help ADL02-Turn On Light Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} usually turn on a light without help when entering a dark room or area? ADCS-ADL Severe Dementia - Turn On Light Without Help Entering Room ADL02-Turn Off Light Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} usually turn off lights without help when leaving a room or going to sleep? ADCS-ADL Severe Dementia - Turn Off Light Without Help Leaving Room ADL02-Sum 1 to 5 Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Sum of Items 1-5. ADCS-ADL Severe Dementia - Sum of Items 1-5 ADL02-Sum 6 to 8 Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Sum of Items 6-8. ADCS-ADL Severe Dementia - Sum of Items 6-8 ADL02-Sum 9 to 12 Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Sum of Items 9-12. ADCS-ADL Severe Dementia - Sum of Items 9-12 ADL02-Sum 13 to 15 Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Sum of Items 13-15. ADCS-ADL Severe Dementia - Sum of Items 13-15 ADL02-Sum 16 to 19 Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Sum of Items 16-19. ADCS-ADL Severe Dementia - Sum of Items 16-19 ADL02-Total ADCS-ADL Score Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Total Score. ADCS-ADL Severe Dementia - Total Score ADL02TC Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory Severe Dementia Version Questionnaire Test Code CDISC Questionnaire ADCS-ADL Severe Dementia Test Code Terminology Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory Severe Dementia Version test name. ADL02-Clear Dishes Usual Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - If yes, which best describes how {S} usually performed. ADCS-ADL Severe Dementia - Description of Usual Performance of Clearing Dishes ADL02-Clear Dishes Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Did {S} clear the dishes from the table after a meal or snack? ADCS-ADL Severe Dementia - Clear Dishes After Meal or Snack ADL02-Dispose Garbage Usual Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - If yes, which best describes how {S} usually performed. ADCS-ADL Severe Dementia - Description of Usual Performance of Garbage Disposal ADL02-Dispose of Garbage Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} dispose of garbage or litter in an appropriate place or container at home? ADCS-ADL Severe Dementia - Dispose of Garbage in Appropriate Place at Home ADL02-Find Belongings Usual Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - If yes, which best describes how {S} usually performed. ADCS-ADL Severe Dementia - Description of Usual Performance of Finding Personal Belonging at Home ADL02-Find Belongings Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} usually manage to find his/her personal belongings at home? ADCS-ADL Severe Dementia - Find Personal Belongings at Home ADL02-Get Around Optimal Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - If yes, which best describes {S} optimal performance. ADCS-ADL Severe Dementia - Description of Optimal Performance of Getting Around Outside of Home ADL02-Get Around Outside Home Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} get around (or travel) outside of his/her home? ADCS-ADL Severe Dementia - Get Around Outside Home ADL02-Highest Telephone Use Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - If yes, which best describes {S} highest level of performance. ADCS-ADL Severe Dementia - Description of Highest Performance of Telephone Use ADL02-Left at Home for 1 Hour or Longer Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Was {S} left: at home for an hour or longer during the day? ADCS-ADL Severe Dementia - Alone at Home for One Hour or Longer ADL02-Left at Home for Less Than 1 Hour Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Was {S} left: at home for less than 1 hour during the day? ADCS-ADL Severe Dementia - Alone at Home for Less Than One Hour ADL02-Left Away From Home Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Was {S} left: away from home for 15 minutes or longer, during the day? ADCS-ADL Severe Dementia - Alone Away From Home for Fifteen Minutes or Longer ADL02-Left On His/Her Own Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, was {S} ever left on his/her own? ADCS-ADL Severe Dementia - Subject Left on Their Own ADL02-Obtain Beverage Highest Perform Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - If yes, which best describes {S} highest level of performance. ADCS-ADL Severe Dementia - Description of Highest Performance of Obtaining Beverage ADL02-Obtain Beverage Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} obtain a hot or cold beverage for him/herself? ADCS-ADL Severe Dementia - Obtain Beverage for Self ADL02-Optimal Grooming Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Regarding grooming, in the past 4 weeks, which best describes {S} optimal performance? ADCS-ADL Severe Dementia - Description of Optimal Performance of Grooming ADL02-Optimal Walking Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Regarding walking (or getting around in a wheelchair) in the past 4 weeks, which best describes {S} optimal performance? ADCS-ADL Severe Dementia - Description of Optimal Performance of Walking ADL02-Pay Attention to Conversation Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} ever appear to pay attention to conversation or small talk for at least 5 minutes? ADCS-ADL Severe Dementia - Pay Attention to Conversation ADL02-Run Water Faucet to Wash Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} usually run water from a faucet to wash {S} hands or face without help? ADCS-ADL Severe Dementia - Turn On Faucet to Wash Without Help ADL02-Select Television Program Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Did {S} usually select or ask for different programs or {S} favorite show? ADCS-ADL Severe Dementia - Select or Ask for Television Program ADL02-Sum 1 to 5 Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Sum of Items 1-5. ADCS-ADL Severe Dementia - Sum of Items 1-5 ADL02-Sum 13 to 15 Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Sum of Items 13-15. ADCS-ADL Severe Dementia - Sum of Items 13-15 ADL02-Sum 16 to 19 Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Sum of Items 16-19. ADCS-ADL Severe Dementia - Sum of Items 16-19 ADL02-Sum 6 to 8 Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Sum of Items 6-8. ADCS-ADL Severe Dementia - Sum of Items 6-8 ADL02-Sum 9 to 12 Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Sum of Items 9-12. ADCS-ADL Severe Dementia - Sum of Items 9-12 ADL02-Talk About TV Content While Watch Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Did {S} usually talk about the content of a program while watching it? ADCS-ADL Severe Dementia - Talk About TV Content While Watching ADL02-Talk About TV Content Within a Day Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Did {S} talk about the content of a program within a day (24 hours) after watching it? ADCS-ADL Severe Dementia - Talk About TV Content Within a Day After Watching ADL02-Total ADCS-ADL Score Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Total Score. ADCS-ADL Severe Dementia - Total Score ADL02-Turn Off Faucet Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} usually turn off the faucet after finishing running water without help? ADCS-ADL Severe Dementia - Turn Off Faucet After Wash Without Help ADL02-Turn Off Light Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} usually turn off lights without help when leaving a room or going to sleep? ADCS-ADL Severe Dementia - Turn Off Light Without Help Leaving Room ADL02-Turn On Light Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} usually turn on a light without help when entering a dark room or area? ADCS-ADL Severe Dementia - Turn On Light Without Help Entering Room ADL02-Use a Telephone Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} use a telephone? ADCS-ADL Severe Dementia - Use a Telephone ADL02-Usual Bathing Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Regarding bathing, in the past 4 weeks, which best describes {S} usual performance? ADCS-ADL Severe Dementia - Description of Usual Performance of Bathing ADL02-Usual Bowel/Bladder Function Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Regarding bowel and bladder function at the toilet, which best describes {S} usual performance during the past 4 weeks? ADCS-ADL Severe Dementia - Usual Bowel and Bladder Function at Toilet ADL02-Usual Conversation Participation Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - If yes, which best describes {S} usual degree of participation. ADCS-ADL Severe Dementia - Usual Conversation Participation ADL02-Usual Eating Performance Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Regarding eating, which best describes {S} usual performance during the last 4 weeks? ADCS-ADL Severe Dementia - Description of Usual Performance of Eating ADL02-Usual Physically Dressing Perform Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Regarding physically getting dressed, which best describes {S} usual performance in the past 4 weeks? ADCS-ADL Severe Dementia - Description of Usual Performance of Physically Getting Dressed ADL02-Watch Television Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} watch television? ADCS-ADL Severe Dementia - Watch Television ADL02TN Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory Severe Dementia Version Questionnaire Test Name CDISC Questionnaire ADCS-ADL Severe Dementia Test Name Terminology Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change test code. ACGC01-Clinical Impression of Change Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change - Clinical impression of change from baseline. ADCS-CGIC - Clinical Impression of Change from Baseline ACGC01TC Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change Questionnaire Test Code CDISC Questionnaire ADCS-CGIC Test Code Terminology Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change test name. ACGC01-Clinical Impression of Change Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change - Clinical impression of change from baseline. ADCS-CGIC - Clinical Impression of Change from Baseline ACGC01TN Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change Questionnaire Test Name CDISC Questionnaire ADCS-CGIC Test Name Terminology Terminology codelist used for anatomical location within CDISC. The spinous process of the 5th lumbar vertebra. Fifth Lumbar Spinous Process The portion of the descending aorta that lies within the abdomen, beginning below the diaphragm and ending at its division into the right and left common iliac arteries. (NCI) Abdominal Aorta Abdomen The body cavity between the thoracic and pelvic cavities in mammals. Abdomen Any lymph node within the abdomen. Abdominal Lymph Node The left lower quadrant of the abdomen. Left Lower Quadrant of Abdomen The left upper quadrant of the abdomen. Left Upper Quadrant of Abdomen The right lower quadrant of the abdomen. Right Lower Quadrant of Abdomen The right upper quadrant of the abdomen. Right Upper Quadrant of Abdomen Any portion of the body that lies within the boundary, either internally or externally, of the abdomen: superior margin, the thorax; inferior margin, the pelvis; lateral margins, the ribs. Abdominal Region Abdominal Skin The integument that covers the abdomen. Abdominal Skin The soft tissue of the abdominal wall. Abdominal Wall Soft Tissue The tissue that surrounds the organs present in the abdominal cavity. Abdominal Wall The sixth cranial nerve. Abducens Nerve A muscle of the hand, in general extending from the pisiform bone, the pisohamate ligament, and the flexor retinaculum to the ulnopalmar margin of the proximal phalanx. Primary function is abduction of the little finger and flexion of the phalanx nearest the hand. Abductor Digiti Minimi Muscle of the Hand Abductor Digiti Minimi Abductor Minimi Digiti A muscle in the foot, in general extending from the medial and lateral processes of the posterior calcaneal tuberosity to the lateral side of the base of the proximal phalanx of the fifth toe and the fifth metatarsal; primary function is to abduct the fifth toe at the metatarsophalangeal joint and support the lateral arch. Abductor Digiti Minimi Muscle A muscle in the foot, in general extending from the medial process of the posterior calcaneal tuberosity to the medial side of the base of the proximal phalanx of the big toe; primary function is to abduct and flex the big toe at the metatarsophalangeal joint. Abductor Hallucis Muscle A muscle of the hand, in general extending from the flexor retinaculum and the tubercles of the scaphoid and trapezium bones to the outer side of the base of the proximal phalanx of the thumb. Primary function is abduction of the thumb away from the palm. Abductor Pollicis Brevis Muscle A skeletal muscle of the forearm originating from the posterior surfaces of the ulna and radius and the interosseous membrane. (NCI) Abductor Pollicis Longus An additional renal vessel originating from the aorta and entering the kidney at the proximal or distal end of the organ. Accessory renal arteries are found in 26-30% of humans. Accessory Renal Artery Acetabulum Two cup shaped areas, one each on the lateral side of the lower pelvis that house the head of the femur to form the ball and socket joint of the hip. (NCI) Acetabulum The tendon that, in general, attaches the gastrocnemius muscle to the calcaneous bone in the tarsus. Achilles Tendon Acromioclavicular Joint The junction of the upper distal end of the scapula to the distal edge of the collarbone, also known as the acromion and the clavicle. (NCI) Acromioclavicular Joint Acromion The upper distal process of the scapula. (NCI) Acromion ACUTE MARGINAL ARTERY SEGMENT(S) AMARG The arteries that arise at the junction of the proximal and mid-right coronary artery conduit segments. Acute Marginal Artery A muscle in the leg, in general extending from the external surface of the body of pubis and the anterior surface of the inferior pubic ramus to the pectineal line and the medial lip of the linea aspera; primary function is to adduct, flex, and rotate the thigh. Adductor Brevis Muscle The larger of two heads of the adductor hallucis muscle, in general originating from the sheath of the peroneus longus tendon and the plantar surface of the bases of the second to fourth metatarsal bones in the foot. Oblique Head of Adductor Hallucis Muscle The smaller of two heads of the adductor hallucis muscle, in general originating from the deep transverse metatarsal ligament and the plantar surface of the metatarsophalangeal joints of the lateral three toes. Transverse Head of Adductor Hallucis Muscle A muscle in the thigh, in general extending from the external surface of the body of pubis to the middle third of the linea aspera; primary function is to adduct and medially rotate the thigh. Adductor Longus Muscle A muscle in the thigh, in general extending from the ischiopubic ramus and ischial tuberosity to the gluteal tuberosity of the femur, medial lip of the linea aspera, medial supracondylar ridge, and adductor tubercle; primary function is to adduct, flex, extend, and medially rotate the thigh at the hip joint. Adductor Magnus Muscle A muscle of the hand that extends from the capitate and bases of the second and third metacarpals for the oblique head, and the anterior surface of body of the third metacarpal for the transverse head, to the base of proximal phalanx and extensor hood of the thumb; primary function is to draw the first metacarpal laterally to oppose the thumb toward the center of palm and rotate it medially. Adductor Pollicis Muscle The endocrine glands adjacent to the kidneys that consist of the outer adrenal cortex and the inner adrenal medulla in mammals. Adrenal Gland Greater Wing of the Sphenoid Bone The bony process of the sphenoid bone, extending from the side of the body of the sphenoid and curving upward, laterally, and backward. Sphenoid Wing Alveolar Margin Alveolar Ridge The thickened bony structures in the mandible and maxilla that contain the sockets of the teeth. Alveolar Ridge Alveoli Any of the terminal sacs in the lungs through which gas exchange takes place with the pulmonary capillary blood. Alveolus Aqua Amnii The fluid within the amniotic cavity which surrounds and protects the developing embryo. (NCI) Amniotic Fluid The junction of the common bile and main pancreatic ducts, which protrudes into the medial aspect of the descending duodenum at the major duodenal papilla. Ampulla of Vater Amygdala Amygdaloid Body Amygdaloid Nucleus A group of nuclei adjacent to the lateral ventricle of the brain within the temporal lobe, and is part of the limbic system. Amygdala The terminal section of the alimentary canal, which extends from the anorectal junction and ends at the anal opening. (NCI) Anal Canal The area that includes the anus and the perianal skin. Anal Region The internal and external muscles surrounding the anus that maintain continence. Anal Sphincter The transitional zone between the moist, hairless, modified skin of the anal canal and the perianal skin. Anal Margin Anastomosis A natural or surgically-induced connection between tubular structures in the body. (NCI) Anastomosis A muscle of the elbow, in general extending from the lateral epicondyle of the humerus to the lateral surface of the ulnar olecranon; primary function is to extend the forearm and stabilize the elbow joint. Anconeus Muscle A ridge on the posterior part of the inferior parietal lobule. Angular Gyrus A group of muscles in the ankle, the tibialis anterior and extensor hallucis longus muscles; primary function is to dorsiflex the ankle. Ankle Dorsiflexor Muscles The tendons in the anterior compartment of the leg that cross the tibiotalar joint anteriorly and connect muscles that originate on the surfaces of the tibia and fibula to bones in the toes, enabling dorsiflexion of the foot at the ankle and extension of the toes. (NCI) Ankle Joint Anterior Extensor Tendons The tendons in the anterior compartment of the leg that connect muscles that originate on the surfaces of the femur, tibia, and fibula to bones in the toes, enabling plantar flexion of the foot at the ankle. (NCI) Ankle Joint Anterior Flexor Tendons Ankle Ankle Joint A gliding joint between the distal ends of the tibia and fibula and the proximal end of the talus. (NCI) Ankle Joint Talar Mortise A rectangular socket or bony arch that connects the ends of the tibia and fibula to the talus. Ankle Mortise The distal portion of the gastrointestinal tract that includes the anal canal and rectum. Anorectal Area Antecubital Region A triangular space on the anterior side of the elbow joint. Three main veins of the arm, the brachial artery, the medial nerve and the tendon of the biceps muscle pass through this space. Antecubital Fossa ACA The smaller paired arteries (left and right) that arise from the internal carotid artery and form a portion of the Circle of Willis. Anterior Cerebral Artery The part of the cingulate cortex that lies most frontal, with the most anterior portion of the cortex bending in a horseshoe shape around the genu of the corpus callosum. Anterior Cingulate Cortex The part of the cingulate gyrus that lies inferior to the superior frontal gyrus, and is separated from it by the cingulate sulcus; it ends inferior to the rostrum of the corpus callosum. Anterior Cingulate Gyrus Frontal Horn of the Lateral Ventricle The part of the lateral ventricle located in the frontal lobe, anterior to the interventricular foramen of Monroe, and bounded by the septum pellucidum, fornix, and genu of the corpus callosum. Frontal Horn of the Lateral Ventricle AICA A basilar artery branch that supplies the anterior portion of the inferior surface of the cerebellum. Anterior Inferior Cerebellar Artery Prevascular Lymph Node A lymph node located in the anterior part of the mediastinum. Anterior Mediastinal Lymph Node A bony projection from the anterior region of the iliac crest, and is the site of attachment for the sartorius and tensor fascia latae muscles and the inguinal ligament. Anterior Superior Iliac Spine An artery of the lower extremity that supplies blood to the anterior part of the leg and the foot. Anterior Tibial Artery The vein that runs parallel to the anterior tibial artery and empties into the popliteal vein. Anterior Tibial Vein Antrum Pylori The initial part of the pyloric canal of the stomach. This site contains endocrine cells that produce gastrin and somatostatin. (NCI) Antrum Pylori The distal orifice of the digestive tract located between the rectum and the external surface of the body, comprising glandular, transitional, and squamous epithelium. Anus The major artery of the body; it arises from the left ventricle of the heart and terminally bifurcates into the common iliac arteries. Aorta Aortic Arch The curved segment of the aorta between the ascending and the descending segments. Aortic Arch A small mass that is located on the inferior surface of the aortic arch. It functions as a peripheral chemoreceptor and is composed of glomus cells. Aortic Body A fibrous membrane that attaches to, and provides support for, the aortic valve leaflets. Aortic Valve Annulus A cardiac valve located between the left ventricle and the aorta. Aortic Valve Aortic Valve, Left Semilunar Cusp The cusp of the aortic valve that overlies the left coronary ostium. Left Coronary Cusp of the Aortic Valve Aortic Valve, Posterior Semilunar Cusp The cusp of the aortic valve that is positioned posteriorly relative to the left and right aortic cusps. Non-Coronary Cusp of the Aortic Valve Aortic Valve, Right Semilunar Cusp The cusp of the aortic valve that overlies the right coronary ostium. Right Coronary Cusp of the Aortic Valve The wall that separates the aorta and pulmonary arteries during embryonic development. Aorticopulmonary Septum The segment of the blood vessels that includes the iliac artery and its origin from the aorta. Aortoiliac Artery Segment A lymph node located in the area between the abdominal aorta and inferior vena cava. (NCI) Aortocaval Lymph Node A lymph node located in the aortopulmonary window. Aortopulmonary Window Lymph Node The distal end of the appendix. (NCI) Appendiceal Tip The part of the skeleton that includes the bones of the upper and lower limbs, including the shoulder and pelvic girdles Appendicular Skeleton A pouch-like tissue attached to the cecum, which may exist as a diverticulum. Appendix Aqueous Humour The watery fluid which is present in the anterior and posterior chambers of the eye. (NCI) Aqueous Humor Arm Skin The integument that covers the arm. Arm Skin Arm Brachium Upper Arm The portion of the upper extremity between the shoulder and the elbow. Arm Artery A blood vessel that carries blood away from the heart. (NCI) Artery The portion of the aorta that emerges from the left ventricle and precedes the aortic arch. Ascending Aorta The portion of the ascending aorta between the aortic annulus and the sinotubular junction. Aortic Root The terminus of the aortic root; the point at which the aorta attains a tubular configuration. Sinotubular Junction Any one of the naturally occurring sinuses of the aortic root distal to the semilunar valve. Sinus of Valsalva The confluence of the atrial septum and the ventricular septum. Atrioventricular Septum Either of the two valves in the heart situated between the atria and ventricles, i.e., the mitral valve or the tricuspid valve. Atrioventricular Valve Ossicles of the Ear Any of the small bones in the middle ear that transmit acoustic vibrations from the eardrum to the inner ear. Auditory Ossicle The part of the skeleton that includes the skull and spinal column and sternum and ribs. (NCI) Axial Skeleton Armpit Axilla The underside concavity where the arm and the shoulder are joined. (NCI) Axilla An artery that originates from the subclavian artery at the lateral margin of the first rib. It supplies the brachial artery. Axillary Artery Axillary lymph nodes located inferolateral to pectoralis minor. Axillary Lymph Node Level I Axillary lymph nodes located posterior to pectoralis minor. Axillary Lymph Node Level II Axillary lymph nodes located superomedial to pectoralis minor. Axillary Lymph Node Level III Lymph node(s) in the axillary region. Axillary Lymph Node A large blood vessel which returns blood to the heart from the lateral thorax, axilla and upper limb. Each side of the body contains one axillary vein. Axillary Vein A blood vessel which returns blood to the heart from the posterior walls of the thorax and abdomen. Azygos Vein Back The dorsal area between the base of the neck and the sacrum. (NCI) Back Clusters of neurons comprising the globus pallidus, putamen, caudate, nucleus accumbens, substantia nigra and subthalamic nucleus. Basal Ganglia The posterior one third of the tongue behind the terminal sulcus that forms the anterior aspect of the oro-pharynx. Base of Tongue An artery of the brain; in general it arises from the union of the two vertebral arteries at the posterior border of the pons and branches at the anterior border to form the two superior and two posterior cerebral arteries. Basilar Artery Basilic Vein One of the moderately large superficial veins of the forearm that transports blood from the hand and the medial aspect of the forearm to the axillary vein. (NCI) Basilic Vein The basilar portion of the occipital bone; it is present during fetal development and later fuses with the occipital bone. Basioccipital Bone One of the bones of the orbit, situated rostrally to the basilar part of the occipital bone; it is present during fetal development and later fuses to form the posterior portion of the sphenoid bone. Basisphenoid Bone A muscle of the proximal arm/forelimb, in general extending from the scapula to the radius and adjacent fascia; primary function is flexion of the elbow joint and, in some species, also functions in supination of the antebrachium. Biceps Brachii The tendons that attach the biceps brachii muscle superiorly to the caricoid process and glenoid fossa of the scapula, and inferiorly to the radius bones. Biceps Brachii Tendon A muscle in the thigh, in general extending from the ischial tuberosity and posterior femur to the fibula; primary function is to extend the femorotibial joint. Biceps Femoris The long head of the biceps femoris muscle that is located medially and crosses both the hip and knee joints. Long Head of Biceps Femoris Muscle The short head of the biceps femoris muscle that is located laterally and crosses only the knee joint. Short Head of Biceps Femoris Muscle Any of the ducts conveying bile between the liver and the intestine, including hepatic, cystic, and common bile duct. Bile Duct Biliary Tract The duct system that transports bile from its origination by hepatocytes in the liver to the small intestine. It is comprised of the common bile duct that connects the liver and gall bladder to the small intestine and the cystic duct that connects the gall bladder to the common bile duct. (NCI) Biliary Tract The tissue layers that form the urinary bladder. They include the mucosa, submucosa, smooth muscle, and serosa. Bladder Wall Urinary Bladder The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra. (NCI) Bladder The anterosuperior part of the bladder that points towards the abdominal wall. Bladder Apex The large area of the bladder situated between the apex and the fundus. Bladder Body Dome of the Bladder The upper, convex surface of the bladder. (NCI) Dome of the Bladder Fundus of the Bladder The portion of the bladder that is formed by the posterior wall and is located opposite to the bladder opening. (NCI) Bladder Fundus Neck of the Bladder The inferior portion of the urinary bladder which is formed as the walls of the bladder converge and become contiguous with the proximal urethra. (NCI) Bladder Neck Trigone of the Bladder The triangular area in the bladder mucosa that is formed by the two ureteral orifices and the urethral orifice. (NCI) Bladder Trigone A tubular structure through which the blood circulates in the body. Blood vessels constitute a network composed of arteries, arterioles, capillaries, venules, and veins. (NCI) Blood Vessel Peripheral Blood Whole Blood A liquid tissue with the primary function of transporting oxygen and carbon dioxide. It supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Blood Body of Stomach The main section of the digestive tube that connects the esophagus to the small intestine. The body proper excludes the upper and lower sections of the fundus and pyloric portion respectively. (NCI) Body of Stomach Whole Body The entire physical structure of an organism. It is composed of anatomic systems, regions, cavities, and spaces. (NCI) Body The tissue occupying the spaces of some bones. It consists of blood vessel sinuses and a network of hematopoietic cells. Bone Marrow Calcified connective tissue that forms the skeletal components of the body. (NCI) Bone An artery of the forelimb; in general it arises from the axillary artery and branches to form the radial and ulnar arteries. Brachial Artery Lymph node(s) adjacent to the brachial vein. Brachial Lymph Node Brachial Plexus A nerve network originating from spinal nerves in the cervical and thoracic vertebrae and giving rise to multiple nerves that innervate the arm/forelimb. Brachial Plexus A vein of the arm/forelimb; in general it arises from the union of the radial and ulnar veins and drains into the axillary vein. Brachial Vein A muscle that originates from the lower two-thirds of the anterior surface of the humerus that flexes the elbow. (NCI) Brachialis Innominate Artery An artery of the mediastinum; in general it arises from the aortic arch and branches to form the right subclavian artery and one or both common carotid arteries. Innominate Artery A muscle in the forearm, in general extending from the proximal two-thirds of the lateral supracondylar ridge of the humerus and inserting into the styloid process of the radius; primary function is flexion of the elbow and pronation and supination of the forearm. Brachioradialis Muscle Brain Stem The part of the brain that connects the cerebral hemispheres with the spinal cord. It consists of the mesencephalon, pons, and medulla oblongata. (NCI) Brain Stem Brain Ventricle The four connected cavities (hollow spaces) centrally located within the brain that connect posteriorly with the central canal of the spinal cord. (NCI) Brain Ventricle The rostral extensions of the ventricular system of the brain consisting of two cavities, one on each side of the brain within the central regions of each cerebral hemisphere. Cerebrospinal fluid flows from the lateral ventricles into the centrally third ventricle via the foramen of Monroe. (NCI) Lateral Ventricle Nervous System, Brain An organ composed of gray and white matter that is the center for intelligence and reasoning. It is protected by the bony cranium. Brain A thin lamina of white matter comprising long association fibers located between the claustrum and putamen in the brain, and which connects the midportion of the superotemporal region with the midportion of the ventral and lateral aspects of the prefrontal cortex. External Capsule A diamond-shaped cavity filled with cerebrospinal fluid within the pons, extending between the obex in the caudal medulla and the aqueduct of Sylvius in the cerebellum. Fourth Ventricle A white matter structure in the subcortical region of the brain that contains a high concentration of motor and sensory projection nerve fibers. It consists of the anterior limb, genu, posterior limb, and the retrolentiform and sublentiform parts. Internal Capsule The area of the body surrounding the ventricles of the brain. Periventricular Region A centrally placed component of the ventricular system of the brain that is located in the diencephalon; the thalamus and the hypothalamus border the third ventricle. Third Ventricle Breast One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest. (NCI) Breast A wide fold of peritoneum that connects the uterus to the lateral walls and floor of the pelvis, and also attaches to the ovaries, fallopian tubes, ovarian ligaments, round ligament of the uterus, and ovarian and uterine arteries. Broad Ligament BA 10 One of 52 cytoarchitecturally or histologically defined portions of the brain that includes the area anterior-most portion of the prefrontal cortex and is involved in a variety of functions including but not limited to memory recall and executive functions. Brodmann Area 10 BA 8 One of 52 cytoarchitecturally or histologically defined portions of the brain that includes the area anterior to the premotor cortex and is involved in planning of complex movements and frontal eye fields. Brodmann Area 8 The part of a bronchus that remains after resection. Bronchial Stump The smallest subdivisions of the bronchial tree, which are both acartilagenous and aglandular. Bronchiole Bronchi Tubular structure in continuation with the trachea, serving as an air passage. Bronchus Buccinator Lymph Node Lymph node(s) that are located superficial to the buccinator muscle. Buccal Lymph Node The mucosal membranes located on the inside of the cheek, in the buccal cavity. (NCI) Buccal Mucosa The part of the conjunctiva that covers the eyeball. Bulbar Conjunctiva Buttock Either of the fleshy mounds in the rear pelvic area of the human body formed by the gluteal muscles. Buttock C1 Vertebra The first of the seven cervical vertebrae. (NCI) C1 Vertebra C2 Nerve Root Dermatome The area of the skin innervated by the second cervical spinal nerve, covering the upper neck and posterior scalp behind and above the ears. C2 Dermatome C2 Vertebra The second of the seven cervical vertebrae. (NCI) C2 Vertebra C3 Nerve Root Dermatome The area of the skin innervated by the third cervical spinal nerve, encompassing the lower part of the neck and extending to the upper shoulders and the area behind the ears. C3 Dermatome C3 Vertebra The third of the seven cervical vertebrae. (NCI) C3 Vertebra C4 Nerve Root Dermatome The area of the skin innervated by the fourth cervical spinal nerve, covering the lower neck, upper shoulders, and the clavicular region. C4 Dermatome C4 Vertebra The fourth of the seven cervical vertebrae. (NCI) C4 Vertebra C5 Nerve Root Dermatome The area of the skin innervated by the fifth cervical spinal nerve, including the lateral aspect of the upper arm down to the elbow. C5 Dermatome C5 Vertebra The fifth of the seven cervical vertebrae. (NCI) C5 Vertebra C6 Nerve Root Dermatome The area of the skin innervated by the sixth cervical spinal nerve, covering the lateral aspect of the forearm and including the thumb. C6 Dermatome C6 Vertebra The sixth of the seven cervical vertebrae. (NCI) C6 Vertebra C7 Nerve Root Dermatome The area of the skin innervated by the seventh cervical spinal nerve, including the central part of the posterior forearm and extending to the middle finger. C7 Dermatome C7 Vertebra The seventh of the seven cervical vertebrae. (NCI) C7 Vertebra C8 Nerve Root Dermatome The area of the skin innervated by the eighth cervical spinal nerve, covering the medial aspect of the forearm and including the ring and little fingers. C8 Dermatome A roughened surface on the superior portion of the posterior half of the calcaneus, where the calcaneal (Achilles) tendon inserts. Calcaneal Tuberosity Calcaneum Calcaneus Bone The irregular and largest tarsal bone that forms the heel. (NCI) Calcaneum A cerebral fissure that originates near the occipital lobe and terminates below the corpus callosum. (NCI) Calcarine Sulcus Any of the veins located within the muscles of the posterior lower leg, such as the gastrocnemial, soleal, and gemellar veins. Calf Muscular Vein The posterior aspect of the lower extremity that extends from the knee to the foot. (NCI) Calf Canine Tooth A single-cusped (pointed) and usually single-rooted tooth located between the incisors and premolars. (NCI) Canine Tooth Capitate Bone The largest of eight carpal bones, located in the center of the hand. (NCI) Capitate Bone A condyloid synovial joint within the wrist connecting the capitate bone to the hamate bone. Capitate-Hamate Joint A condyloid synovial joint within the wrist connecting the capitate bone to the lunate bone. Capitate-Lunate Joint A valve located in the heart. Cardiac Valve All of the tissue that comprises the solid, outer structure of the heart, including the epicardium, the myocardium, and the endocardium. Cardiac Wall Cardiophrenic Angle Lymph Node A lymph node located in the angle between the heart and diaphragm. Cardiophrenic Lymph Node Circulatory System A collection of organs including the heart and the blood vessels. Cardiovascular System Carina, Tracheal A ridge at the bifurcation of the trachea where the primary bronchi meet. Carina Common Carotid Artery An artery of the mediastinum and neck; in general it arises as a primary or secondary branch of the aortic arch and branches into the internal and external carotid arteries. Common Carotid Artery A cluster of cells that function as chemo-receptors, located near the bifurcation of the carotid artery. Carotid Body Any of the bones of the joint located between the radius and ulna and metacarpus. Carpal Bone CMC1 A saddle-shaped synovial joint between the metacarpal of the thumb and the trapezium. (NCI) Carpometacarpal Joint 1 CMC2 A plane joint primarily between the second metacarpal and the trapezoid, which also connects with the trapezium and capitate. (NCI) Carpometacarpal Joint 2 CMC3 A plane joint between the third metacarpal and the capitate. (NCI) Carpometacarpal Joint 3 CMC4 A plane joint between the fourth metacarpal and the hamate. (NCI) Carpometacarpal Joint 4 CMC5 A plane joint between the fifth metacarpal and the pisiform. (NCI) Carpometacarpal Joint 5 The articulation of the proximal bases of the metacarpal bones and the distal carpal bones in the fingers, and the first metacarpal bone and the trapezium bone of the wrist in the thumb. Carpometacarpal Joint A type of connective tissue composed of chondrocytes and an extracellular matrix composed of collagen, elastin, and ground substance. There are three types of cartilage; namely elastic, hyaline, and fibrocartilage. Cartilage Any of the vertebrae below or posterior to the sacral vertebrae and that form the tail. Caudal Vertebra The gray matter adjacent to each lateral ventricle of the brain that comprises the medial dorsal striatum of the basal ganglia. Caudate Nucleus The pouch-like portion of the proximal large intestine opening into the colon. Cecum Celiac Trunk An artery of the abdomen; in general it arises from the abdominal aorta below the diaphragm and branches to form the left gastric artery, common hepatic artery, and splenic artery. Celiac Artery Celiac Axis Lymph Node Celiac Lymph Node A lymph node at the base of the celiac artery. (NCI) Celiac Lymph Node The part of the nervous system that consists of the brain, spinal cord, and meninges. (NCI) Central Nervous System Vena Cephalica A vein of the arm/forelimb; in general it arises from the dorsal venous network of the hand/forefoot and drains into the axillary vein. Cephalic Vein Any one of the individual lobes that make up the cerebellum of the brain. Cerebellar Lobe Any one of three pairs of nerve fiber bundles that originate from the cerebellum and link it to the brainstem. Cerebellar Peduncle A medial, narrow structure connecting the two hemispheres of the cerebellum. Vermis The portion of the brain that extends from the brainstem through the cerebellar folia. Cerebellum Any artery supplying the cerebral cortex. Cerebral Artery Cerebral Cortex The outer layer of the cerebrum composed of neurons and unmyelinated nerve fibers. It is responsible for memory, attention, consciousness and other higher levels of mental function. Cerebral Cortex The left half of the cerebrum. Left Cerebral Hemisphere The right half of the cerebrum. Right Cerebral Hemisphere The paired anterior portions of the midbrain consisting of the crus cerebri, the tegmentum, and the substantia nigra. Cerebral Peduncle Cerebral Subcortex The layer located below the cerebral cortex that includes the forebrain, midbrain and hindbrain. (NCI) Cerebral Subcortex Any of the external or internal veins that drain the cerebral hemispheres. Cerebral Vein The portion of the brain comprising the frontal, parietal, temporal, and occipital lobes and extending through the thalamus. Cerebral Hemisphere Cervical lymph nodes located in the upper jugular group above the level of the hyoid bone. Neck Lymph Node Boundary Level II Cervical lymph nodes located in the middle jugular group located between the hyoid bone and the cricoid cartilage. Neck Lymph Node Boundary Level III Cervical lymph nodes located in the lower jugular group located around the lower third of the internal jugular vein extending from the inferior border of the cricoid cartilage (above) to the clavicle (below). Neck Lymph Node Boundary Level IV Cervical lymph nodes located in the posterior triangle group located posteriorly to the sternocleidomastoid muscle around the lower part of the spinal accessory nerve and the transverse cervical vessels. Neck Lymph Node Boundary Level V Central Compartment Lymph Nodes Cervical lymph nodes located in the anterior compartment of the neck, between the hyoid bone and the suprasternal notch. Anterior Compartment Lymph Node Group (Level VI) Lymph node(s) in the cervical region, or neck. Cervical Lymph Node The set of vertebrae immediately caudal to the skull. Cervical Spine Any one of the seven vertebrae that are caudal to the skull, denoted as C1, C2, C3, C4, C5, C6 or C7. Cervical Vertebra The region of the body that comprises the uterine cervix and vagina. (NCI) Cervicovaginal Region Cervix Uteri Uterine Cervix The portion of the uterus (or uterine horns) that empties into the vagina. Cervix Uteri The soft tissue on the lateral aspects of the face, generally bounded by the eyes, nose, ear, and jaw line. Cheek Chest Wall The total system of structures outside the lungs that move as a part of breathing; it includes all structures from the skin to the parietal pleura. (NCI) Chest Wall Chest The anterior side of the thorax from the neck to the abdomen. The shape of the chest is often regarded as potential insight into a disease process, as in the case of barrel chest and respiratory dysfunction. (NCI) Chest The part of the face below the lower lip and including the protruding part of the lower jaw. Mentum Chorda Tendinea Any of the tendons that connect the papillary muscles to the tricuspid and mitral valves. Chordae Tendineae Blood vessels and ependyma forming villous structures in the ventricles of the brain. Choroid Plexus A blood vessel-containing membrane of the eye that lies between the retina and the sclera. (NCI) Choroid Circumferential tissue located behind the iris and composed of muscle and epithelium. Ciliary Body Part of the medial aspect of the cerebral cortex. (NCI) Cingulate Cortex CIRC AV CIRCUMFLEX ARTERY AV GROOVE CONTINUATION ARTERY SEGMENT The segment of the left circumflex artery that is distal to the third marginal branch, located in the atrioventricular groove. Circumflex Artery AV Groove Continuation Artery The left circumflex coronary artery and all of its branches. Circumflex Artery and its Branches The paired bone that is situated between the sternum and the shoulder. Clavicle The curved, pointed appendage on the distal end of a digit, composed of keratin. Claw The erectile tissue in the vulva. It is composed of the corpora cavernosa and the glans clitoris. Clitoris A sloped depression between the dorsum sellae and foramen magnum at the base of the skull. Clivus Coccygeal Vertebra Four vertebral segments positioned at the base of the spine that are fused. (NCI) Coccygeal Vertebra Coccyx A small bone located at the bottom of the spine. The coccyx is a result of 3-5 fused rudimentary vertebrae. (NCI) Coccyx A lymph node located in the colon. Colon Lymph Node The portion of the gastrointestinal tract wall that surrounds the cavity of the colon and contains teniae coli, haustra, and epiploic appendages. Colon Wall The portion of the large intestine which extends from the cecum (or small intestine in animals that don't have a cecum) to the rectum. Colon Ascending Colon The first part of the colon (large intestine) that starts in the right lower quadrant of the abdomen and ends at the transverse colon in the right upper quadrant of the abdomen. (NCI) Ascending Colon Descending Colon The fourth portion of the large intestine (colon) that communicates with the transverse colon in the left-upper quadrant of the abdomen and the rectum below. (NCI) Descending Colon Hepatic Flexure Right Colic Flexure The bend at the junction of the ascending and transverse colon. Hepatic Flexure Left Colon The portion of the large intestine that includes the descending and sigmoid colon. (NCI) Left Colon A portion of the large intestine that includes the sigmoid colon and rectum. Rectosigmoid Colon Right Colon The proximal segment of the large intestine that is located in the right side of the abdominal cavity. It includes the cecum (with the attached appendix) and the ascending colon. (NCI) Right Colon Sigmoid Colon The portion of the colon that connects to the descending colon above and the rectum below. (NCI) Sigmoid Colon Left Colic Flexure Splenic Flexure The bend at the junction of the transverse and descending colon. Splenic Flexure Transverse Colon The third division of the colon (large intestine). It communicates with the ascending colon in the upper right-hand quadrant of the abdomen and the descending colon in the upper left-hand quadrant. (NCI) Transverse Colon The mucosal membranes that line the inner surface of the colon. Colonic Mucosa Common Duct A duct that conveys bile from the convergence of the cystic and hepatic duct to the duodenum. Common Bile Duct An artery arising from the external iliac artery at the inguinal ligament which bifurcates forming the deep and superficial femoral arteries. Common Femoral Artery A vein that accompanies the common femoral artery and originates at the confluence of the femoral vein and the deep femoral vein. Common Femoral Vein An artery arising from the bifurcation of the abdominal aorta which then bifurcates forming the internal and external iliac arteries. Common Iliac Artery A lymph node located adjacent to the common iliac artery. (NCI) Common Iliac Lymph Node Any of the arteries arising from the superficial palmar arch which run distally on the second, third and fourth lumbricals muscles to the interdigital clefts where each artery then separates into two proper palmar digital arteries. Common Palmar Digital Artery A thin tissue divided into the palpebral conjunctiva (covering the inner side of the eye lid) and the bulbar conjunctiva (covering the eyeball). (NCI) Conjunctiva The transparent, avascular tissue covering the front of the eye and is continuous with the sclera. Cornea The endothelial layer of the cornea. Corneal Endothelium The epithelial layer of the cornea. Corneal Epithelium The stromal layer of the cornea. Corneal Stroma One of the arteries of the heart; in general it arises from the aortic root and supplies the myocardium. Coronary Artery Anterior Descending Coronary Artery Left Anterior Descending Coronary Artery A left coronary artery branch that descends on the anterior portion of the heart through the anterior interventricular groove. (NCI) Anterior Descending Coronary Artery Left Coronary Artery Left Main Coronary Artery Left Main Coronary Artery Segment LM A coronary artery that arises from the aorta and bifurcates into the left anterior descending artery and the left circumflex artery. (NCI) Left Coronary Artery Right Coronary Artery A coronary artery that originates above the right coronary cusp and supplies blood predominantly to the right side of the heart. (NCI) Right Coronary Artery The coronary vein that terminates in the right atrium and transports deoxygenated blood from the coronary circulation. Coronary Sinus A blood vessel in the heart which returns coronary blood to the right atrium. Coronary Vein A white matter structure within the brain that connects the left and right cerebral hemispheres. Corpus Callosum An area within the corpus callosum between the genu (anterior region) and the splenium (posterior region). Body of the Corpus Callosum The anterior portion of the corpus callosum that bends down and back. Genu of the Corpus Callosum The thick, convex posterior region of the corpus callosum. Splenium of the Corpus Callosum Corpus Luteum A group of cells that remain of the Graafian follicle following ovulation. This structure is composed of endocrine tissue and produces progesterone. This is needed to prepare the uterine lining for implantation by the fertilized egg. (NCI) Corpus Luteum The portion of the brain consisting of the neostriatum and globus pallidus. Corpus Striatum Uterine Body Uterus, Corpus The body of the uterus. Corpus Uteri A muscle of the face, in general extending from the medial superciliary arch to the skin above the middle of the supraorbital margins; primary function is to move the eyebrows. Corrugator Supercilii Muscle Costal Cartilage The cartilage positioned between the anterior end of the rib and the sternum. Its elasticity allows the ribcage to expand while breathing. (NCI) Costal Cartilage The first hyaline cartilaginous joint between the ribs and costal cartilage. Costochondral Joint 1 The seventh hyaline cartilaginous joint between the ribs and costal cartilage. Costochondral Joint 7 Intracranial Cavity The space that is formed by the bones of the skull, and contains the brain. Cranial Cavity Any of the 12 paired nerves that originate in the brain stem. (NCI) Cranial Nerve Cuboid Bone A bone on the lateral side of the tarsus between the calcaneus and the fourth and fifth metatarsal bones. (NCI) Cuboid Bone The muscle that creates the rounded contour of the shoulder which originates from the lateral third of the clavicle, the superior surface of the acromion process, and the posterior border of the spine of the scapula and inserts on the lateral side of the shaft of the humerus. (NCI) Deltoid The curved or bowlike structure formed by the arrangement of teeth within the jaw. Dental Arch Dermal projection on the face, generally associated with whiskers. (Makris S, Solomon HM, Clark R, Shiota K, Barbellion S, Buschmann J, Ema M, Fujiwara M, Grote K, Hazelden KP, Hew KW, Horimoto M, Ooshima Y, Parkinson M, Wise LD. Terminology of developmental abnormalities in common laboratory mammals (Version 2). Part B. Birth Defects Res B Dev Reprod Toxicol. 2009 Aug;86(4):227-327.) Dermal Papillae of the Face The portion of the aorta distal to the aortic arch which passes into the chest and abdomen to create the thoracic and abdominal segments. Descending Aorta A musculotendinous sheet separating the thoracic cavity from the abdominal cavity. Diaphragm Lymph node located adjacent to the diaphragm. Diaphragmatic Lymph Node The most distal structure of the limb, usually containing claws or nails and pads. Digit A type of artery that supplies blood to the fingers and toes. In the hand, the digital arteries include the common palmar digital arteries that arise from the superficial palmar arch, the proper palmar digital arteries that are branches of the common palmar digital arteries and occasionally have dorsal branches distal to the proximal interphalangeal joints, and the dorsal digital arteries that are branches of the dorsal metacarpal arteries. In the foot, the digital arteries include the plantar digital arteries that arise from the plantar arch and the dorsal digital arteries that are branches of the dorsal metatarsal arteries. (NCI) Digital Artery DCIRC DISTAL CIRCUMFLEX ARTERY SEGMENT The segment of the left circumflex artery that is between the second and third obtuse marginal branches. Distal Circumflex Artery The portion of the common bile duct that is closest to the intestine and furthest from the hepatic and cystic ducts. Distal Common Bile Duct The area of the body that extends from where the cystic duct meets the common bile duct to the common bile duct's insertion into the small intestine. Distal Extrahepatic Bile Duct Region The portion of the distal femur, identified during a dual x-ray absorptiometry (DXA) scan, that contains primarily metaphyseal or trabecular bone. Distal Femur R1 DIP2 of the Foot A ginglymoid (hinge) synovial joint within the second digit of the foot articulating the middle and distal phalanges. (NCI) Distal Interphalangeal Joint 2 of the Foot DIP2 of the Hand A ginglymoid (hinge) synovial joint within the second digit of the hand articulating the middle and distal phalanges. (NCI) Distal Interphalangeal Joint 2 of the Hand DIP2 A condyloid synovial joint within the second digit of the hand or foot articulating the middle and distal phalanges. (NCI) Distal Interphalangeal Joint 2 DIP3 of the Foot A ginglymoid (hinge) synovial joint within the third digit of the foot articulating the middle and distal phalanges. (NCI) Distal Interphalangeal Joint 3 of the Foot DIP3 of the Hand A ginglymoid (hinge) synovial joint within the third digit of the hand articulating the middle and distal phalanges. (NCI) Distal Interphalangeal Joint 3 of the Hand DIP3 A condyloid synovial joint within the third digit of the hand or foot articulating the middle and distal phalanges. (NCI) Distal Interphalangeal Joint 3 DIP4 of the Foot A ginglymoid (hinge) synovial joint within the fourth digit of the foot articulating the middle and distal phalanges. (NCI) Distal Interphalangeal Joint 4 of the Foot DIP4 of the Hand A ginglymoid (hinge) synovial joint within the fourth digit of the hand articulating the middle and distal phalanges. (NCI) Distal Interphalangeal Joint 4 of the Hand DIP4 A condyloid synovial joint within the fourth digit of the hand or foot articulating the middle and distal phalanges. (NCI) Distal Interphalangeal Joint 4 DIP5 of the Foot A ginglymoid (hinge) synovial joint within the fifth digit of the foot articulating the middle and distal phalanges. (NCI) Distal Interphalangeal Joint 5 of the Foot DIP5 of the Hand A ginglymoid (hinge) synovial joint within the fifth digit of the hand articulating the middle and distal phalanges. (NCI) Distal Interphalangeal Joint 5 of the Hand DIP5 A condyloid synovial joint within the fifth digit of the hand or foot articulating the middle and distal phalanges. (NCI) Distal Interphalangeal Joint 5 DISTAL LAD ARTERY SEGMENT DLAD The segment of the left anterior descending (LAD) artery that is distal to the third diagonal branch. Distal Left Anterior Descending Artery The bone that forms the tip of the second finger, as counted from the thenar side of the hand. Hand Digit 2 Distal Phalanx The bone that forms the tip of the third finger, as counted from the thenar side of the hand. Hand Digit 3 Distal Phalanx The bone that forms the tip of the fourth finger, as counted from the thenar side of the hand. Hand Digit 4 Distal Phalanx The bone that forms the tip of the fifth finger, as counted from the thenar side of the hand. Hand Digit 5 Distal Phalanx The articulation of the distal head of the ulna bone and the ulnar notch of the radius. Distal Radioulnar Joint DISTAL RIGHT CORONARY ARTERY CONDUIT SEGMENT DRCA The section of the right coronary artery distal to the origin of the acute marginal artery. Distal Right Coronary Artery Conduit Lymph node(s) that is distant to the anatomic region of interest. Distant Lymph Node A brain nucleus located in the medulla oblongata. (NCI) Dorsal Motor Nucleus Dorsal Pedal Artery Dorsalis Pedis Artery An artery of the dorsal surface of the foot, originating from the anterior tibial artery of the lower leg. The following arterial branches originate from the dorsalis pedis artery: the arcuate artery of the foot and deep plantar artery. (NCI) Dorsalis Pedis Artery An embryonic blood vessel that allows blood to bypass the lungs by connecting the pulmonary artery and the proximal descending aorta. Ductus Arteriosus The portion of the small intestine between the stomach and jejunum. Duodenum The outermost, toughest, and most fibrous of the three membranes (meninges) that surround and protect the brain and spinal cord. (NCI) Dura Mater Venous channels within the dura mater of the brain which receives both blood from blood vessels within the brain as well as cerebrospinal fluid then drains into the internal jugular vein. Unlike other blood vessels, dural venous sinuses lack valves and other vessel associated layers. Dural Venous Sinus A sensory organ that contains auditory and vestibular apparatuses. Ear Internal Ear Labyrinth The innermost portion of the ear that contains the vestibule, cochlea and semicircular canals. Inner Ear Auricle External Ear Pinna The external part of the ear. (NCI) External Ear The soft fleshy portion of the lower external ear composed of areolar and adipose connective tissues. (NCI) Lobule of the Auricle A group of two muscles in the upper extremity, the triceps brachii and anconeus; primary function is to straighten the arm at the elbow joint. Elbow Extensors A group of three muscles in the upper extremity, the brachialis, biceps brachii, and the brachioradialis; primary function is to bend the arm at the elbow joint. Elbow Flexors The tendons that connect the muscles of the forearm and upper arm to the bones of the elbow joint. Elbow Joint Tendon Elbow Elbow Joint A joint involving the humerus, radius and ulna bones. Elbow Joint The layer of endothelial cells and connective tissue lining the chambers of the heart. (NCI) Endocardium The portion of the cervix which is lined by single columnar epithelium (mucosa). (NCI) Endocervix Endometrial Cavity A space inside the uterus lined by a layer of mucous membranes called the endometrium. Endometrial Cavity The mucous membrane comprising the inner layer of the uterine wall. Endometrium A brain region in the medial temporal lobe near the hippocampus. (NCI) Entorhinal Cortex The outer membranous connective tissue layer of the heart tissue. (NCI) Epicardium Epicondyle A bone prominence to which ligaments and tendons of the joints are attached. (NCI) Epicondyle A crescent-like structure located adjacent to the testis. It consists of a single highly coiled duct and is divided into 3 regions: caput (head), corpus (body) and cauda (tail). Epididymis The body space between the dura mater and the walls of the vertebral canal. Epidural Spinal Space A parietal lymph node located along the inferior epigastric vessels. Epigastric Lymph Node The most superior, central area of the abdomen, lying immediately superior to the umbilicus and bounded laterally by the costal margins. Epigastric Region Epiglottis A small cartilagenous flap-like valve that closes over the larynx during swallowing to prevent food entering the lungs. (NCI) Epiglottis A lymph node located above and adjacent to the elbow. (NCI) Epitrochlear Lymph Node Any lymph node located near the esophagus, including cervical, and upper, middle, and lower thoracic lymph nodes. Esophageal Lymph Node The mucosal membranes that line the inner surface of the esophagus. Esophageal Mucosa The portion of the digestive tract between the pharynx and stomach. Esophagus Abdominal Esophagus Clinical esophageal segment composed of smooth muscle. It corresponds to the inferior part of the lower third topographic segment of the esophagus. (NCI) Abdominal Esophagus Cervical Esophagus Clinical esophageal segment composed of skeletal muscle. It corresponds to the superior part of the upper third topographic segment of the esophagus. (NCI) Cervical Esophagus Lower Third of the Esophagus The lower one third of the esophagus in which the muscle layer is composed of muscle cells predominantly of the smooth type. (NCI) Lower Third of the Esophagus Middle Third of the Esophagus The middle one third of the esophagus in which the muscle layer is composed of muscle cells of the striated and smooth types. Middle Third of the Esophagus The portion of the thoracic esophagus from midway between the tracheal bifurcation and gastroesophageal junction to gastroesophageal junction, including abdominal esophagus. (SEER) Lower Thoracic Esophagus Middle Thoracic Esophagus The portion of the thoracic esophagus from the tracheal bifurcation midway to the gastroesophageal junction. (SEER) Middle Thoracic Esophagus The portion of the thoracic esophagus from the thoracic inlet to the level of the tracheal bifurcation. (SEER) Upper Thoracic Esophagus Thoracic Esophagus Clinical esophageal segment composed of smooth muscle. It includes the middle third topographic segment, as well as parts of the upper and lower thirds. (NCI) Thoracic Esophagus Upper Third of the Esophagus The upper one third of esophagus in which the muscle layer is composed of muscle cells of the striated type. (NCI) Upper Third of the Esophagus Ethmoid Bone A light and spongy bone that is cubical in shape. This bone is positioned at the anterior part of the cranium, sitting between the two orbits, at the roof of the nose. It consists of four parts: a horizontal or cribriform plate; a perpendicular plate; and two lateral masses or labyrinths. (NCI) Ethmoid Bone Ethmoid Sinus A sinus of the meatuses of the nasal cavity. (NCI) Ethmoid Sinus The lateral portions of the occipital bone lying on either side of the foramen magnum; it is present during fetal development and later fuses with the occipital bone. Exoccipital Bone A group of two muscles of the hand, the extensor carpi radialis brevis and extensor carpi radialis longus. Primary function is radial extension and abduction or deviation of the wrist. Extensor Carpi Radialis Muscles A muscle of the wrist, in general extending from the humeral and ulnar heads to the base of the fifth metacarpal bone; primary function is to extend and abduct the wrist toward the ulna. Extensor Carpi Ulnaris A muscle of the forearm, in general extending from the lateral epicondyle of the humerus to the extensor expansion of the fifth digit; primary function is to extend the fifth digit at the metacarpophalangeal joint. Extensor Digiti Minimi Muscle A muscle in the foot, in general extending from the superolateral surface of the anterior calcaneus to the lateral sides of the tendons of extensor digitorum longus on the second, third and fourth toes; primary function is to extend the second, third and fourth toes. Extensor Digitorum Brevis Muscle Long Digital Extensor Muscle A muscle extending from the lateral surface of the tibia to the digits; primary function is the extension of the digits and flexion of the tarsal joint. Extensor Digitorum Longus A muscle of the hand, in general extending from the lateral epicondyle of the humerus to the base of the proximal, middle, and distal phalanges; primary function is to extend the fingers. Extensor Digitorum Communis A muscle in the foot, in general extending from the superior surface of the anterior calcaneus to the dorsal surface of the base of the proximal phalanx of the big toe; primary function is to extend the big toe. Extensor Hallucis Brevis Muscle A muscle of the lower leg, in general extending from the middle third of the medial surface of the fibula and the adjacent interosseous membrane to the base and dorsal center of the distal phalanx of the great toe; primary function is to extend the big toe and dorsiflex the ankle. Extensor Hallucis Longus Muscle A muscle of the forearm, in general extending from the posterior surface of the ulna to the base of the second proximal phalanx and the tendon of the extensor digitorum muscle; primary function is to extend the second digit at metacarpophalangeal and interphalangeal joints. Extensor Indicis Proprius Muscle A muscle of the forearm, in general extending from the posterior surface of the distal third of the radius and the adjacent interosseous membrane to the posterior surface of the base of the proximal phalanx of the thumb; primary function is to extend the thumb at the carpometacarpal and metacarpophalangeal joints. Extensor Pollicis Brevis Muscle A muscle of the forearm, in general extending from the posterior surface of the middle third of the ulna and the adjacent interosseous membrane to the posterior surface of the base of the distal phalanx of the thumb; primary function is to extend the thumb at the metacarpophalangeal and interphalangeal joints and extend and abduct the wrist joint. Extensor Pollicis Longus Muscle Auditory Canal Ear Canal External Acoustic Meatus External Auditory Canal External Auditory Meatus A tubular structure that runs from the outer ear to the tympanic membrane. External Acoustic Meatus An artery arising from the bifurcation of the common iliac artery in the lower torso. The external iliac artery becomes the femoral artery and is the main blood supply for the leg. External Iliac Artery A lymph node located along the external iliac artery. (NCI) External Iliac Lymph Node A lymph node that is located outside of the abdominal wall. Extra-Abdominal Lymph Node The portion of the biliary tract outside the liver; the common hepatic duct joins the cystic duct to form the common bile duct. (NCI) Extrahepatic Bile Duct The area of the body where the right and left hepatic ducts exit the liver and join to form the common hepatic duct that is proximal to the origin of the cystic duct. (PDQ) Extrahepatic Perihilar Bile Duct Region Any portion of the body that lies outside of a lymph node. Extranodal Region Oculomotor Muscle A group of muscles in the orbit extending from the posterior orbit to the eye and upper eyelid; primary function is the movement of the eye and retraction of the upper eyelid. Extraocular Muscle The external protuberance of the eyeball beneath the eyelid. (Makris S, Solomon HM, Clark R, Shiota K, Barbellion S, Buschmann J, Ema M, Fujiwara M, Grote K, Hazelden KP, Hew KW, Horimoto M, Ooshima Y, Parkinson M, Wise LD. Terminology of developmental abnormalities in common laboratory mammals (Version 2). Part B. Birth Defects Res B Dev Reprod Toxicol. 2009 Aug;86(4):227-327.) Eye Bulge Eyeball The sensory organ of vision. Eye The space in the eye filled with aqueous humor and bounded by the cornea, a small portion of the sclera, a small portion of the ciliary body, the iris and lens. (Cline et al., Dictionary of Visual Science, 4th ed, p109) Anterior Chamber of the Eye The front part of the eye, which is posteriorly bordered by posterior surfaces of the posterior lens capsule, lens zonules, and ciliary body; it includes the cornea, conjunctiva, lacrimal gland, tear film, iris, lens, ciliary body, anterior portion of the sclera, and anterior chamber. Anterior Eye Segment Postremal Chamber The largest space within the eye which is bounded by the lens and the retina and filled with the gelatinous vitreous humor. (NCI) Vitreous Chamber The arched strip of hairs (supercilia) on the brow ridge (supercilium) above each eye socket. Eyebrow Anyone of the short hairs that grow on the edge of the eyelid. (NCI) Eyelash Palpebra The section of skin, containing muscle and conjunctiva, that covers and protects the eye. Eyelid The portion of the head that contains the structures such as the eyes, nose, mouth, and jaws. Face Facet Joint A synovial joint between two adjacent vertebrae. The facet joint links the articular process of one vertebra and the inferior articular process of the adjacent vertebra. (NCI) Facet Joint Facial Bone Any bone that contributes to the facial structures, except those bones that are part of the braincase. (NCI) Facial Bone Mimetic Muscles Any of the muscles of the face that are supplied by the facial nerve and control facial expressions. Facial Muscle Seventh Cranial Nerve A cranial nerve extending from the brain stem between the pons and medulla, which innervates the facial muscles, glands and the tongue. Facial Nerve A fold of tissue consisting of two layers of peritoneum extending from the notch of the anterior margin of the liver to the anterior abdominal wall and diaphragm. Falciform Ligament Fallopian Tube The tube through which eggs pass from an ovary. Fallopian Tube A sheet or band of fibrous connective tissue enveloping, separating, or binding together muscles, organs and other soft structures of the body. Fascia Encapsulated adipose tissue within the body. Fat Pad Isthmus of Fauces Oropharyngeal Isthmus The anatomical opening formed by the arch of the hard palate at the back of the mouth, where the oral cavity and pharynx meet. Oropharyngeal Isthmus Female Genitalia Female internal and external organs of reproduction. Female Genitalia The sex organs of the female. Female Reproductive System An artery of the thigh; in general it arises from the external iliac artery distal to the inguinal ligment and continues as the popliteal artery. Femoral Artery The rounded bony projection at the distal end of the femur. Femoral Condyle Femur Head The highest portion of the femoral bone that articulates with the acetabulum. (NCI) Head of the Femur A lymph node located in the upper inner portion of the thigh. (NCI) Femoral Lymph Node Femoral Neck The short, constricted portion of the thigh bone between the femur head and the trochanter. (NCI) Femoral Neck A vein of the thigh; in general it arises from the popliteal vein and drains into the external iliac vein. Femoral Vein The segment of the blood vessels that includes the popliteal artery and its origin from the femoral artery. Femoropopliteal Artery Segment The cylindrical body of the femur. (NCI) Femoral Shaft Bone, Femoral The bone positioned between the pelvis and the femorotibial joint. Femur The elongated bony body of the fibula. Fibular Shaft The long bone that is lateral to the tibia. Fibula A vein that arises from the plantar veins of the foot, accompanies the peroneal artery, and travels up the back of the leg to join the anterior and posterior tibial veins in forming the popliteal vein on the posterior surface of the knee. Fibular Vein A group of six muscles in the upper extremity, the abductor pollicis longus, extensor pollicis brevis, extensor pollicis longus, extensor indicis, extensor digitorum, and extensor digiti minimi muscles; primary function is to straighten the fingers to open the hand. Finger Extensors The tendons located on the dorsal side of the fingers that connect muscles of the forearm and hand to bones in the fingers, enabling extension of the fingers. (NCI) Finger Extensor Tendons A group of three muscles in the upper extremity, the flexor digitorum superficialis, flexor digitorum profundus, and flexor pollicis longus muscles; primary function is to bend the fingers. Finger Flexors The tendons located on the palm side of the fingers that connect the flexor muscles of the forearm and hand to bones in the fingers, enabling flexion towards the palm. (NCI) Finger Flexor Tendons Finger Any of the digits of the hand. (NCI) Finger Fingernail The nail at the end of a finger. (NCI) Fingernail The most distal end of the finger, beyond the nail bed. Fingertip 1ST DIAG FIRST DIAGONAL BRANCH ARTERY SEGMENT The first artery arising from the left anterior descending (LAD) artery that supplies the anterolateral wall, when counted from proximal to distal. First Diagonal Branch Artery A dorsal interosseous muscle of the foot that originates on the lateral side of the first metatarsal and the medial side of the second metatarsal, and inserts into the medial side of the base of the proximal phalanx of the second toe. First Dorsal Interosseous Muscle of the Foot A dorsal interosseous muscle of the hand that originates on the proximal half of the lateral border of the index metacarpal and the full length of the medial border of the thumb metacarpal, and inserts into the lateral side of the index finger. First Dorsal Interosseous Muscle of the Hand 1ST LPL FIRST LEFT POSTEROLATERAL BRANCH ARTERY SEGMENT In an individual with a left-dominant heart, this is the first branch that arises from the circumflex artery atrioventricular groove continuation when counted from proximal to distal. It supplies the posterolateral wall. First Left Posterolateral Branch Artery 1ST OM FIRST OBTUSE MARGINAL BRANCH ARTERY SEGMENT The first artery arising from the left circumflex artery that supplies the lateral wall, when counted from proximal to distal. First Obtuse Marginal Branch Artery 1ST RPL FIRST RIGHT POSTEROLATERAL ARTERY SEGMENT In an individual with a right-dominant heart, this is the first branch that arises from the right coronary artery distal to the right posterior descending artery, when counted from proximal to distal. First Right Posterolateral Artery The region on either side of the body that extends from the last rib to the hip. Flank A muscle in the forearm running from the head of the humerus to the radial side of the wrist that flexes and radially abducts the hand. (NCI) Flexor Carpi Radialis A muscle in the forearm running from the humeral and ulnar heads to the ulnar side of the wrist that flexes and abducts the hand toward the ulna. (NCI) Flexor Carpi Ulnaris A muscle in the foot, in general extending from the medial process of the posterior calcaneal tuberosity to the borders of the middle phalanx of the four lateral toes; primary function is flexion of the four lateral toes and support of the medial and lateral longitudinal arches. Flexor Digitorum Brevis Muscle A muscle in the leg/hindlimb and foot/hindpaw, in general extending from the tibia to the phalanges; primary function is to flex the digits. Flexor Digitorum Longus A muscle in the forearm beginning at the head of the ulna and ending with four tendons projecting to the second, third, fourth, and fifth fingers which flexes the midcarpal, metacarpophalangeal and interphalangeal joints. (NCI) Flexor Digitorum Profundus A muscle in the forearm, in general extending from the humeroulnar and radial heads of the forearm to the middle phalanges of the second through fifth digits of the hand; primary function is flexion of the fingers at the proximal interphalangeal joints. Flexor Digitorum Superficialis Muscle A muscle in the foot, in general extending from the plantar surface of the cuboid bone to the medial and lateral sesamoid bones at the base of the proximal phalanx of the big toe; primary function is flexion of the big toe and the support of the medial longitudinal arch. Flexor Hallucis Brevis Muscle A muscle in the leg and foot, in general extending from the fibula to the distal surface of the big toe phalanx; primary function is to flex the big toe. Flexor Hallucis Longus A muscle of the hand, whose superficial head extends from the flexor retinaculum and tubercle of the trapezium bone and deep head that extends from the trapezoid and capitate bones, extending to the lateral side of the base of the proximal phalanx of the thumb; primary function is to flex the thumb at the metacarpophalangeal joint. Flexor Pollicis Brevis Muscle A muscle in the forearm, in general extending from the anterior surface of the radius and interosseous membrane to the palmar aspect of the base of the distal phalanx of the thumb; primary function is flexion of the thumb. Flexor Pollicis Longus Muscle The area of the mouth under the ventral surface of the tongue. Floor of Mouth Fontanel Soft Spot The membrane-covered space between the skull bones of a neonate or fetus where ossification is not complete and sutures are not fully formed. Fontanelle Big Toe The largest and most medial toe of the foot. (NCI) Foot Digit 1 Index Toe The second toe from the medial side of the foot. (NCI) Foot Digit 2 Middle Toe The middle or third toe from the medial side of the foot. (NCI) Foot Digit 3 Fourth Toe The fourth toe from the medial side of the foot. (NCI) Foot Digit 4 Little Toe The smallest and most lateral toe of the foot. (NCI) Foot Digit 5 Foot Phalanx A bone of the foot. (NCI) Foot Phalanx The entire structure distal to the ankle joint/tarsus, which includes the metatarsus and digit(s). Foot A group of muscles in the ankle, the brachioradialis, pronator teres, pronator quadratus, and flexor carpi radialis muscles; primary function is to rotate the forearm so that the palm faces downward when the arm is extended at a right angle to the body. Forearm Pronator Muscles Forearm The structure on the upper limb, between the elbow and the wrist. (NCI) Forearm The largest part of the brain composed of the cerebral hemispheres, thalamus, hypothalamus, and the limbic system. (NCI) Forebrain Forehead The part of the face between the eyebrows and the normal hairline. Forehead The anterior, front or upper limb of an animal. Fore Limb Forepaw Phalange Any of the bones that make up the digits of the forepaw. Forepaw Phalanx Male Prepuce A fold of skin covering the tip of the penis. Male Prepuce Fovea Centralis Area consisting of a small depression in the retina containing only cones and where vision is most acute. Fovea Centralis A bone of the skull forming the front part of the skull, root of the nose, and the roof of both orbits. Frontal Bone The outermost layer of the frontal lobe of the brain, made up of gray matter. Frontal Lobe Cortex Frontal Lobe The part of the brain located anterior to the parietal lobes at the front of each cerebral hemisphere. (NCI) Frontal Lobe Frontal Sinus The paired, mucosal lined air spaces located above the orbit and communicating with the nasal passages. (NCI) Frontal Sinus A muscle of the forehead, in general extending from the galea aponeurotica at the top of the skull to the skin around the eyebrows and the top of the nose; primary function is to raise the eyebrows. Frontalis Muscle The area of the brain where the frontal and parietal lobes meet. Fronto-Parietal Region The area of the brain where the frontal and temporal lobes meet. Fronto-Temporal Region The portion of the interior of the eye that includes the sensory retina, the optic disc, and the macula. Eye Fundus The blind sac region of the glandular stomach. Fundus of the Stomach The upper, rounded portion of the uterus that is opposite from the cervix. Fundus Uteri A sac-like organ located adjacent to the liver that stores and concentrates bile produced by the liver. Gallbladder Ganglia Ganglion Neural Ganglion A cluster of nervous tissue principally composed of neuronal cell bodies external to the central nervous system (CNS). (NCI) Ganglion The region of the stomach adjacent to the esophogastric junction. Gastric Cardia Lymph node(s) located between the two layers of the greater omentum, either superiorly along the cardiac half of the lesser curvature of the stomach or inferiorly along the pyloric half of the greater curvature of the stomach. Gastric Curvature Lymph Node Stomach Mucosa The mucosal membranes that line the inner surface of the stomach. Gastric Mucosa A bipennate muscle extending from the femoral condyles to the calcaneus; primary function is the extension of the tarsal joint and flexion of the femorotibial joint. Gastrocnemius Muscle One of two heads of the gastrocnemius muscle, in general originating from the lateral femoral condyle. Lateral Head of Gastrocnemius Muscle One of two heads of the gastrocnemius muscle, in general originating from the medial femoral condyle. Medial Head of Gastrocnemius Muscle Gastroesophageal Junction The anatomical location where the esophagus joins to the stomach. (NCI) Gastroesophageal Junction Gastrointestinal System The system that includes the esophagus, stomach, small and large intestine, anus, liver, biliary tract, and pancreas. (NCI) Digestive System Gastrointestinal Tract The upper gastrointestinal (GI) tract is comprised of mouth, pharynx, esophagus and stomach while the lower GI tract consists of intestines and anus. The primary function of the GI tract is to ingest, digest, absorb and ultimately excrete food stuff. (NCI) Gastrointestinal Tract Lower Gastrointestinal Tract The lower part of the gastrointestinal tract that includes the jejunum and ileum of the small intestine and the large intestine. (NCI) Lower Gastrointestinal Tract The portion of the gastrointestinal tract wall that surrounds the cavities of the duodenum, jejunum, ileum, colon, rectum, and anus. Lower Gastrointestinal Tract Wall Upper Gastrointestinal Tract The upper part of the gastrointestinal tract that includes the esophagus, stomach, and duodenum. (NCI) Upper Gastrointestinal Tract The portion of the gastrointestinal tract wall that surrounds the cavities of the esophagus and stomach. The proximal duodenum is also sometimes considered part of the upper gastrointestinal tract. Upper Gastrointestinal Tract Wall The multiple layers of specialized tissue that surround the cavity of the gastrointestinal tract, including the mucosa, submucosa, muscular layers, and serosa. Gastrointestinal Tract Wall A muscle of the tongue, in general extending from the mental spine of the mandible to the hyoid bone at the bottom of the tongue; primary function is to depress and protrude the tongue. Genioglossus A protruding body of tissue that forms in the ventral caudal region during embryonic development. Genital Tubercle The external sex organs. (NCI) Genitalia The body system that includes all organs involved in reproduction and in the formation and voidance of urine. Genitourinary System Gum The soft tissue surrounding the neck of individual teeth as well as covering the alveolar bone. The tissue is fibrous and continuous with the periodontal ligament and mucosal covering. (NCI) Gingiva The portion of the oral mucosa that surrounds the cervical aspect of teeth and the alveolar process of the jaw. Gingival Mucosa Glenoid Fossa The trough in the head of the scapula that receives the head of the humerus to form the shoulder joint. (NCI) Glenoid Fossa Paired nuclei at the base of the forebrain that, along with the putamen, form the lentiform nucleus of the basal ganglia. Globus Pallidus A cluster of convoluted capillaries beginning at each nephric tubule in the kidney and held together by connective tissue. Glomerulus The ninth cranial nerve. Glossopharyngeal Nerve Glottis The space in which the vocal cords are located. (NCI) Glottis Laryngeal Anterior Commissure The anterior surface of the glottic opening, located within the larynx, that constitutes the junction of the conus elasticus and the thyroepiglottic, vestibular, and vocal ligaments. Laryngeal Anterior Commissure Laryngeal Posterior Commissure The posterior surface of the glottic opening at the level of the vocal cords. Laryngeal Posterior Commissure A group of three muscles (gluteus maximus, gluteus medius, gluteus minimus) extending from the ilium and sacrum to the femur; primary function is extension and abduction of the hip joint. Gluteal Muscle The outermost and largest muscle of the buttocks. (NCI) Gluteus Maximus A muscle of the hip and buttock, in general extending from the gluteal surface of the ilium to the lateral aspect of the greater trochanter of the femur; primary function is to abduct and rotate the thigh. Gluteus Medius A reproductive organ that produces gametes. Gonad A muscle in the thigh, in general extending from the lower half of the symphysis pubis and the upper half of the pubic arch to the upper part of the medial surface of the tibia; primary function is to adduct the thigh, rotate the leg/hindlimb medially and flex the knee. Gracilis Long Saphenous Vein A long superficial vein originating from the dorsal vein at the big toe and the dorsal venous arch of the foot and extending up the inner leg to empty into the femoral artery in the groin area. Long Saphenous Vein Great Trochanter A large, irregular, quadrilateral area of bone found at the neck of the femur. (NCI) Great Trochanter Any of the major arteries or veins attached to the cardiac atria or ventricles. Great Blood Vessel Greater Curvature of the Stomach The lateral and inferior border of the stomach. Attached to it is the greater omentum. (NCI) Greater Curvature of the Stomach GALT Lymphoid tissue located in the mucosa of the digestive tract. Gut-Associated Lymphoid Tissue The lower segment of the hair that circles the dermal papilla and the hair matrix. (NCI) Hair Bulb A tube-like invagination of the epidermis from which the hair shaft develops and into which the sebaceous glands open; the follicle is lined by a cellular inner and outer root sheath of epidermal origin and is invested with a fibrous sheath derived from the dermis. (NCI) Hair Follicle The portion of the hair that is enclosed within the hair follicle. (NCI) Hair Root Shaft of the Hair The segment of the hair that projects above the skin surface. (NCI) Shaft of the Hair Hair The filamentous outgrowth of the epidermis. (NCI) Hair Hamate Bone The medial bone in the distal row of carpal bones. (NCI) Hamate Bone A group of three muscles in the lower extremity, the biceps femoris, semimembranosus muscle and semitendinosus muscle; primary function is to extend the hip when the trunk is fixed and flex the knee, and medially rotate the lower leg when the knee is bent. Hamstring Thumb Artery Any of the arteries that supply blood to the thumb; either the ulnopalmar, radiopalmar, ulnodorsal, or radiodorsal digital artery to the thumb, or the princeps pollicis artery. Hand Digit 1 Artery Thumb The thick and short hand digit which is next to the index finger in humans. (NCI) Hand Digit 1 Index Finger Artery Any of the arteries that supply blood to the index finger, either the radial artery of the index finger or the ulnar proper digital artery. Hand Digit 2 Artery Index Finger The second finger from the radial side of the hand, next to the thumb. (NCI) Hand Digit 2 Middle Finger Artery Any of the arteries that supply blood to the middle finger, either the ulnar or radial proper digital artery. Hand Digit 3 Artery Middle Finger The middle or third finger from the radial side of the hand. (NCI) Hand Digit 3 Ring Finger Artery Any of the arteries that supply blood to the ring finger, either the ulnar or radial proper digital artery. Hand Digit 4 Artery Ring Finger The fourth finger from the radial side of the hand. (NCI) Hand Digit 4 Little Finger Artery Any of the arteries that supply blood to the little finger, either the ulnar or radial proper digital artery. Hand Digit 5 Artery Little Finger The fifth and smallest finger from the radial side of the hand. (NCI) Hand Digit 5 Hand Phalanx A bone of the hand. (NCI) Hand Phalanx Hand The distal portion of the upper extremity. It consists of the carpus, metacarpus, and digits. (NCI) Hand The part of the roof of the mouth supported by bone. Hard Palate The area of the body comprising the skull, facial bones and the cervical vertebrae, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature, soft tissue and lymph nodes draining these areas. Head and Neck Fibular Head The upper rounded part of the fibula that articulates with the tibia. Head of the Fibula Head of the Humerus The upper rounded part of the humerus that fits into the glenoid cavity of the scapula. (NCI) Head of the Humerus The soft tissue of the head. Head Soft Tissue The portion of the body containing the mouth, the brain and multiple sensory organs. Head A hollow muscular organ which receives the blood from the veins and pumps it into the arteries. Heart Apex of the Heart The most outer superficial part of the heart which is situated on the left 5th intercostal space. (NCI) Apex of the Heart Cardiac Atrium The smaller chamber(s) of the heart that receives blood from the peripheral circulation and/or the lungs. Cardiac Atrium Base of the Heart The superior portion of the heart located opposite to the apical portion. It is formed mainly by the left atrium. (NCI) Base of the Heart An opening between the right and left atria in the fetal heart that allows blood to bypass the lungs and flow directly into the systemic circulation. Foramen Ovale of the Fetal Heart A small muscular pouch located in the wall of the left atrium. Left Atrial Appendage The smaller chamber on the left side of the heart, which receives oxygenated blood from the pulmonary veins and pumps it through the left atrioventricular valve into the left ventricle. Left Atrium Left Ventricle The larger chamber on the left side of the heart, which receives oxygenated blood from the left atrium and pumps it through the aortic valve into the aorta. Left Ventricle The apical short axis slice of the left ventricular myocardium. (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.) Left Ventricle Apex Short Axis The basal short axis slice of the left ventricular myocardium. (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.) Left Ventricle Base Short Axis The mid-cavity short axis slice of the left ventricular myocardium. (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.) Left Ventricle Mid-level Short Axis The structure through which blood flows from the left ventricle into the aortic root. Left Ventricular Outflow Tract The wall of the left ventricle, comprising anterior, inferior, lateral, apical, basal wall; and excluding the interventricular septum. Left Ventricular Wall A small muscular pouch located in the wall of the right atrium. Right Atrial Appendage The smaller chamber on the right side of the heart, which receives deoxygenated blood from the body and pumps it through the right atrioventricular valve into the right ventricle. Right Atrium Right Ventricle The larger chamber on the right side of the heart, which receives deoxygenated blood from the right atrium and pumps it through the pulmonic valve into the pulmonary arteries. Right Ventricle The inferior portion of the right ventricle of the heart. Base of the Right Ventricle The central portion of the right ventricle of the heart. Mid Level Right Ventricle The lateral segment of the right ventricular wall, excluding the anterior and inferior right ventricular wall. Right Ventricular Free Wall The structure through which blood flows from the right ventricle into the pulmonary trunk. Right Ventricular Outflow Tract The wall of the right ventricle, comprising anterior, inferior, and lateral walls; and excluding the interventricular septum. Right Ventricular Wall Cardiac Septum The tissue in the heart that separates the two atria (atrial septum) and the two ventricles (ventricular septum). (NCI) Heart Septum Cardiac Ventricle The larger chamber(s) of the heart that receives blood from an atrium and pushes it out of the heart into the peripheral circulation and/or the lungs. Cardiac Ventricle The anatomical space of a cardiac ventricle. Heart, Ventricular Chamber The tissue layers that form the cardiac ventricle. They include myocardium, endocardium, and pericardium. (NCI) Ventricular Wall of the Heart The rounded back part of the foot below the ankle and behind the arch. (NCI) Heel of the Foot Heel of the Palm The raised part of the palm of the hand that is adjacent to the wrist. (NCI) Heel of the Hand An artery arising from the celiac trunk that supplies the liver and branches to form the cystic, gastro-duodenalis and pyloric arteries. Common Hepatic Artery Lymph node(s) adjacent to the liver. Hepatic Lymph Node The blood vessels that drain blood from the central veins of the liver into the inferior vena cava. Hepatic Vein The body system that includes the liver, gallbladder, and associated ducts. Hepatobiliary System A lymph node located in the hilum of the lung within the mediastinum. Pulmonary Hilar Lymph Node Hilar Refers to the area associated with the hilum. (NCI) Hilar The posterior, rear or lower limb of an animal. Hind Limb Hindpaw Phalange Any of the bones that make up the digits of the hindpaw. Hindpaw Phalanx A group of muscles in the hip, the gluteus medius, gluteus minimus, tensor fasciae latae, piriformis, sartorius, and gluteus maximus muscles; primary function is to abduct the hip. Hip Abductor Muscles A group of muscles in the hip, the gracilis, obturator externus, adductor brevis, adductor longus and adductor magnus muscles; primary function is to adduct the hip. Hip Adductor Muscles A group of muscles generally extending from the pubis to the femur; primary function is adduction of the thigh. Adductor Group of the Leg A group of muscles in the hip, the gluteus maximus, adductor magnus, semitendinosus, semimembranosus, and the biceps femoris muscles; primary function is to extend the hip. Hip Extensor Muscles A group of muscles in the hip, the psoas major, iliacus, rectus femoris, pectineus, and sartorius; primary function is to move the leg or knee towards the torso and bend at the waist. Hip Flexor Muscles Coxofemoral Joint Hip Joint A ball-and-socket joint between the head of the femur and the acetabulum. (NCI) Hip Joint Hip The lateral prominence of the pelvis from the waist to the thigh. (NCI) Hip A curved gray matter structure of the cerebrum that is part of the limbic system. Hippocampus The bone prominence at the distal end of the humerus to which ligaments and tendons of the joints are attached. Humeral Epicondyle The cylindrical, elongated bony body of the humerus. Humeral Shaft Bone, Humeral The bone between the scapulohumeral and humeroulnar joints. Humerus The outer edge of the hymen or hymenal remnants. Hymenal Ring Hyoid Bone A U-shaped bone supporting the tongue. This bone is located at the base of the tongue and is suspended from the tips of the styloid processes of the temporal bones by the stylohyoid ligaments. (NCI) Hyoid Bone The twelfth cranial nerve. Hypoglossal Nerve Hypopharynx The lower part of the pharynx that connects to the esophagus. (NCI) Hypopharynx A small region of the brain composed of multiple nuclei and located underneath the thalamus. Hypothalamus Ileocecal Region The segment of the gastrointestinal tract where the terminal ileum transitions to the cecum, and where the ileocecal sphincter regulates the movement of chyme from the small intestine into the large intestine. (NCI) Ileocecal Junction A superior mesenteric lymph node located near the ileocolic artery. Ileocolic Lymph Node A lymph node located in the ileum. Ileum Lymph Node The portion of the gastrointestinal tract wall that surrounds the cavity of the ileum and contains collections of lymphatic tissue called Peyer patches, as well as receptors for bile salts and vitamin B12. Ileum Wall The portion of the small intestine between the jejunum and large intestine. Ileum Terminal Ileum The most distal section of the ileum that is continuous with the cecum. (NCI) Terminal Ileum A predominate bone structure which borders the ilium wing stretching from the anterior superior iliac spine to the posterior superior iliac spine. Iliac Crest The large smooth and concave surface of the ilium. (NCI) Iliac Fossa Lymph node(s) adjacent to the iliac vessels in the iliosacral region and cranial to the iliofemoral lymph node. Iliac Lymph Node Veins in the pelvis, which include the common, external and internal iliac veins. Iliac Vein A combination of two muscles found in the thigh, the iliacus and the psoas major, which have different sites of origin but a common insertion on the lesser trochanter of the femur; primary function is flexion of the hip. Iliopsoas Muscle A dense band of avascular, regular connective tissue. It is formed as the union of the superficial and deep layers of the tensor fascia latae, creating a thick band that extends inferiorly, taking its origins from the iliac crest, the tensor fascia latae, and the gluteus maximus, travelling inferiolaterally along the thigh, and inserting on Gerdy's tubercle on the lateral aspect of the tibia. Functionally, the iliotibial band helps to flex, abduct, and medially rotate the femur at the hip joint, and it also helps to stabilize the knee laterally. Iliotibial Band Ilium The broad, dorsal, upper, and widest of the three principal bones composing either half of the pelvis. (NCI) Ilium A tooth between the canines in either jaw. Incisor Incus One of the three bones comprising the middle ear. This anvil-shaped bone is positioned between the malleus and the stapes. (NCI) Incus A group of lymph nodes located in the inferior part of the mediastinum. (NCI) Inferior Mediastinal Lymph Node The portion of the pubic ramus that lies between the superior pubic ramus and the inferior ramus of the ischium. Inferior Pubic Ramus A ridge on the outer surface of the temporal lobe below the middle sulcus. (NCI) Inferior Temporal Gyrus Caudal Vena Cava Posterior Vena Cava A large vein that returns blood from the lower half of the body to the heart. Inferior Vena Cava Infraclavicular Lymph Node Subclavicular Lymph Node A lymph node located in the area below the clavicle. (NCI) Infraclavicular Lymph Node The portion of the abdominal aorta distal to the renal arteries. Infrarenal Aortic Segment A muscle of the rotator cuff, in general extending from the infraspinatus fossa of the scapula to the greater tubercle of the humerus; primary function is to extend and rotate the arm laterally. Infraspinatus One of the four rotator cuff muscle tendons in the shoulder; it is located below the supraspinatus tendon, anterior to the posterior labrum, and inserts into the greater tuberosity of the humerus. Infraspinatus Tendon The part of the brain below the tentorium cerebellum. (NCI) Infratentorial Brain Lymph node(s) in the inguinal region. Inguinal Lymph Node Groin The lower region of the anterior abdominal wall located laterally to the pubic region. (NCI) Inguinal Region Central Lobe A distinct cerebral lobe positioned in the depth of the Sylvian fissures and overlaid entirely by adjacent regions of the cerebral hemispheres. Central Lobe Atrial Septum Heart, Atrial Septum The wall of tissue that separates the right atrium from the left atrium in the heart. Interatrial Septum A short thick blood vessel arising from the bifurcation of the common iliac artery with numerous branches that supply the organs, walls and viscera of the pelvis as well as the inner thigh. Internal Iliac Artery A lymph node located along the internal iliac artery. (NCI) Internal Iliac Lymph Node An artery of the thoracic wall; in general it arises from the subclavian artery and branches into the musculophrenic and superior epigastric arteries. Internal Mammary Artery Lymph node(s) in or adjacent to the mammary gland. Internal Mammary Lymph Node A bone of the skull situated between the parietal and supraoccipital bones. Interparietal Bone IP1 of the Foot A ginglymoid (hinge) synovial joint within the first digit of the foot articulating the proximal and distal phalanges. (NCI) Interphalangeal Joint 1 of the Foot IP1 A ginglymoid (hinge) synovial joint within the first digit of the hand or foot articulating the proximal and distal phalanges. (NCI) Interphalangeal Joint 1 IP2 of the Foot A ginglymoid (hinge) synovial joint between the phalanges of the second digit of the foot. (NCI) Interphalangeal Joint 2 of the Foot IP2 of the Hand A ginglymoid (hinge) synovial joint between the phalanges of the second digit of the hand. (NCI) Interphalangeal Joint 2 of the Hand IP2 A ginglymoid (hinge) synovial joint between the phalanges of the second digit of the hand or foot. (NCI) Interphalangeal Joint 2 IP3 of the Foot A ginglymoid (hinge) synovial joint between the phalanges of the third digit of the foot. (NCI) Interphalangeal Joint 3 of the Foot IP3 of the Hand A ginglymoid (hinge) synovial joint between the phalanges of the third digit of the hand. (NCI) Interphalangeal Joint 3 of the Hand IP3 A ginglymoid (hinge) synovial joint between the phalanges of the third digit of the hand or foot. (NCI) Interphalangeal Joint 3 IP4 of the Foot A ginglymoid (hinge) synovial joint between the phalanges of the fourth digit of the foot. (NCI) Interphalangeal Joint 4 of the Foot IP4 of the Hand A ginglymoid (hinge) synovial joint between the phalanges of the fourth digit of the hand. (NCI) Interphalangeal Joint 4 of the Hand IP4 A ginglymoid (hinge) synovial joint between the phalanges of the fourth digit of the hand or foot. (NCI) Interphalangeal Joint 4 IP5 of the Foot A ginglymoid (hinge) synovial joint between the phalanges of the fifth digit of the foot. (NCI) Interphalangeal Joint 5 of the Foot IP5 of the Hand A ginglymoid (hinge) synovial joint between the phalanges of the fifth digit of the hand. (NCI) Interphalangeal Joint 5 of the Hand IP5 A ginglymoid (hinge) synovial joint between the phalanges of the fifth digit of the hand or foot. (NCI) Interphalangeal Joint 5 Interphalangeal Joint of the Hand The hinge synovial joints between the phalanges of the fingers. (NCI) Interphalangeal Joint of the Hand IP of the Foot The hinge synovial joints between the bones of the toes. (NCI) Interphalangeal Joint of the Foot Interphalangeal Joint 1 of the Hand IP THUMB IP1 of the Hand A condyloid synovial joint within the thumb articulating the proximal and distal phalanges. Interphalangeal Thumb Joint The bony region in the proximal portion of the femur between the greater, lesser and sub- (also called the third) trochanters. Intertrochanteric Region Heart, Ventricular Septum Interventricular Septal Wall Ventricular Septum The wall that separates the left and right ventricles of the heart. (NCI) Interventricular Septum The tissue that forms the wall of the small and large intestine. Intestinal Wall Tissue The portion of the gastrointestinal tract that includes the small and large intestines. Intestine Any of the arteries that originate within the intracranial cavity. Intracranial Artery The bile ducts that pass through and drain bile from the liver. (NCI) Intrahepatic Bile Duct Perihilar Bile Duct The larger bile ducts which are located within the liver and drain bile from the smaller peripheral intrahepatic bile ducts into the right and left hepatic ducts. Intrahepatic Large Bile Duct The potential space within the retinal layers. Intraretinal Space Any lymph node within the thoracic cavity. Intrathoracic Lymph Node The tissue in the eye that separates the anterior chamber from the posterior chamber. Iris The bony prominence of the lower part of the ischium. (NCI) Ischial Tuberosity A tetrahedral region of adipose tissue located in the ischiorectal region with its base between the tuberosity of the ischium and the lower end of the rectum and its apex at the point where the obturator fascia and the Levator ani membrane divide. Ischiorectal Fossa Ischium The most posterior and ventral bone making up the pelvis. (NCI) Ischium The structures of the skull that frame the mouth. Jaw Bone The portion of the small intestine between the duodenum and ileum. Jejunum Articulation Joint The connection point between two bones or skeletal elements. The joint may be fixed or movable. (NCI) Joint Vena Jugularis One of the veins of the neck; in general it arises from the junction of the maxillary and linguofacial veins and drains into the brachiocephalic or the cranial caval vein. Jugular Vein The portion of the kidney that is located between the upper and lower poles and contains the renal hilum. Kidney Interpolar Region The organs of the urinary tract located in the retroperitoneal cavity adjacent to the spine and composed of the renal cortex and the renal medulla. Kidney Renal Cortex The division of the renal parenchyma located between the renal capsule and the renal medulla, which contains glomeruli and tubules for filtering blood. Renal Cortex Hilar Area of the Kidney The concave area of the kidney through which the renal artery enters and the renal vein and ureter exit the organ. (NCI) Hilar Area of the Kidney Lower Pole of the Kidney The lowermost portion of the kidney. Lower Pole of Kidney Renal Medulla The deepest division of the renal parenchyma, comprising the renal pyramids, which contain a dense network of nephrons, all of which are part of the blood filtration process. Renal Medulla Upper Pole of the Kidney The uppermost portion of the kidney. Upper Pole of Kidney A group of muscles in the knee, the rectus femoris, vastus lateralis, vastus medius, and vastus intermedius muscles; primary function is to extend the knee. Knee Extensor Muscles A group of muscles in the knee, the sartorius, popliteus, gastrocnemius, gracilis, semi-tendinosis, semi-membranosis, and bicep femoris muscles; primary function is to flex the knee. Knee Flexor Muscles The tendons that connect the quadriceps muscles to the kneecap, the hamstring muscles to the shin bone and fibula, and the patella to the top part of the fibula, enabling flexion, extension, and slight rotation of the knee. (NCI) Knee Joint Tendons Femorotibial Joint Joint, Stifle Knee Tibiofemoral Joint The joint connecting the lower part of the femur with the upper part of the tibia. Knee Joint L1 Nerve Root Dermatome The area of the skin innervated by the first lumbar spinal nerve, covering the groin and the uppermost part of the inner thigh. L1 Dermatome L1 Vertebra The first lumbar vertebra counting from the top down. (NCI) L1 Vertebra L2 Nerve Root Dermatome The area of the skin innervated by the second lumbar spinal nerve, extending from the upper part of the anterior thigh down to just above the middle thigh. L2 Dermatome L2 Vertebra The second lumbar vertebra counting from the top down. (NCI) L2 Vertebra The space between the L2 and L3 vertebrae. L2-L3 Intervertebral Space L3 Nerve Root Dermatome The area of the skin innervated by the third lumbar spinal nerve, covering the middle to lower anterior thigh and extending over the medial knee area. L3 Dermatome L3 Vertebra The third lumbar vertebra counting from the top down. (NCI) L3 Vertebra The space between the L3 and L4 vertebrae. L3-L4 Intervertebral Space L4 Nerve Root Dermatome The area of the skin innervated by the fourth lumbar spinal nerve, encompassing the front of the knee, the medial side of the lower leg, and ending at the medial malleolus (inside part of the ankle). L4 Dermatome L4 Vertebra The fourth lumbar vertebra counting from the top down. (NCI) L4 Vertebra The space between the L4 and L5 vertebrae. L4-L5 Intervertebral Space L5 Nerve Root Dermatome The area of the skin innervated by the fifth lumbar spinal nerve, covering the lateral part of the lower leg and extending down to the dorsum of the foot, including the great toe. L5 Dermatome L5 Vertebra The fifth lumbar vertebra counting from the top down. (NCI) L5 Vertebra The space between the L5 and S1 vertebrae. L5-S1 Intervertebral Space A congenital anomaly of the spine, where an extra or supernumerary lumbar vertebra arises from below the 5th lumbar vertebra. Extra Lumbar Vertebra Lacrimal Bone A small rectangular thin plate forming part of the medial orbit wall. It is located posterior to the frontal process of the maxilla and articulates with the inferior nasal concha, ethmoid, frontal, and maxillary bones. (NCI) Lacrimal Bone Canaliculus of the Eye Either of two ducts (superior and inferior) that originate at the puncta lacrimalia of the eye and terminate at the lacrimal sac. Lacrimal Canaliculus The exocrine glands that produce the watery serous component of tears. Lacrimal Gland LAD SEPTAL PERFORATOR ARTERY SEGMENTS LAD SP The arteries that arise from the left anterior descending (LAD) artery that supply the interventricular septum. Left Anterior Descending Septal Perforator Artery Large Bowel The avillous section of the intestine composed of crypts and extending from the terminal small intestine to the external orifice. Large Intestine The cartilaginous structure of the respiratory tract between the pharynx and the trachea. Larynx LAT 1ST DIAG LATERAL FIRST DIAGONAL BRANCH ARTERY SEGMENT The lateral branch distal to a bifurcation of the first diagonal artery. Lateral First Diagonal Branch Artery First Obtuse Marginal Lateral Branch LAT 1ST OM LATERAL FIRST OBTUSE MARGINAL BRANCH ARTERY SEGMENT The lateral branch distal to a bifurcation of the first obtuse marginal artery. Lateral First Obtuse Marginal Branch Artery A bone prominence at the distal end of the humerus to which the radial collateral ligament of the elbow joint, the anconeus and supinator muscles, and the common extensor tendon are attached. Lateral Humeral Epicondyle LAT RAMUS LATERAL RAMUS INTERMEDIUS ARTERY SEGMENT The lateral branch distal to a bifurcation of the ramus intermedius artery. Lateral Ramus Intermedius Artery LAT 2ND DIAG LATERAL SECOND DIAGONAL BRANCH ARTERY SEGMENT The lateral branch distal to a bifurcation of the second diagonal artery. Lateral Second Diagonal Branch Artery LAT 2ND OM LATERAL SECOND OBTUSE MARGINAL BRANCH ARTERY SEGMENT Second Obtuse Marginal Lateral Branch The lateral branch distal to a bifurcation of the second obtuse marginal artery. Lateral Second Obtuse Marginal Branch Artery LAT 3RD DIAG LATERAL THIRD DIAGONAL BRANCH ARTERY SEGMENT The lateral branch distal to a bifurcation of the third diagonal artery. Lateral Third Diagonal Branch Artery LAT 3RD OM LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY SEGMENT Third Obtuse Marginal Lateral Branch The lateral branch distal to a bifurcation of the third obtuse marginal artery. Lateral Third Obtuse Marginal Branch Artery Musculus Latissimus Dorsi A muscle of the back, in general extending from the thoracolumbar vertebrae and scapula to the proximal humerus; primary function is adduction, extension, and medial rotation of the shoulder joint. Musculus Latissimus Dorsi The opening of the left anterior descending coronary artery at its origin. Left Anterior Descending Artery Ostium The innermost layer of endothelial cells and connective tissue that lines the left atrium. Left Atrial Endocardium The first posterolateral branch originating from the posterior atrioventricular left circumflex artery in left dominant and mixed circulations. Left Atrioventricular Artery The opening of the left circumflex artery at its origin. Left Circumflex Artery Ostium An artery arising from the bifurcation of the left coronary artery that runs along the coronary groove. Circumflex Branch of the Left Coronary Artery The portion of the distal end of the left main coronary artery that branches into the left anterior descending artery and the left circumflex artery. Left Main Coronary Artery Bifurcation The segment of the left main coronary artery that is bounded by its ostium and bifurcation. Left Main Coronary Artery Body The opening of the left coronary artery at its origin. Left Main Coronary Artery Ostium The second posterolateral branch originating from the posterior atrioventricular left circumflex artery in left dominant and mixed circulations. Left Posterior Descending Artery LEFT POSTEROLATERAL DESCENDING ARTERY SEGMENT LPDA In an individual with a left-dominant heart, this branch arises from the circumflex artery atrioventricular groove continuation and supplies the inferior apex of the heart. Left Posterolateral Descending Artery The apical cap division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). Left Ventricular Apex Segment The anterior portion of the apical division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). Left Ventricular Apical Anterior Segment The inferior portion of the apical division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). Left Ventricular Apical Inferior Segment The lateral portion of the apical division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). Left Ventricular Apical Lateral Segment The septal portion of the apical division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). Left Ventricular Apical Septal Segment The anterior portion of the basal division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). Left Ventricular Basal Anterior Segment The anterolateral portion of the basal division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). Left Ventricular Basal Anterolateral Segment The anteroseptal portion of the basal division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). Left Ventricular Basal Anteroseptal Segment The inferior portion of the basal division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). Left Ventricular Basal Inferior Segment The inferolateral portion of the basal division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). Left Ventricular Basal Inferolateral Segment The inferoseptal portion of the basal division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). Left Ventricular Basal Inferoseptal Segment The innermost layer of endothelial cells and connective tissue that lines the left ventricle. Left Ventricular Endocardium The outermost layer of cardiac tissue lining of the left ventricle. Left Ventricular Epicardium The anterior portion of the mid-cavity division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). Left Ventricular Mid Anterior Segment The anterolateral portion of the mid-cavity division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). Left Ventricular Mid Anterolateral Segment The anteroseptal portion of the mid-cavity division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). Left Ventricular Mid Anteroseptal Segment The inferior portion of the mid-cavity division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). Left Ventricular Mid Inferior Segment The inferolateral portion of the mid-cavity division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). Left Ventricular Mid Inferolateral Segment The inferoseptal portion of the mid-cavity division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). Left Ventricular Mid Inferoseptal Segment Leg Skin The integument that covers the leg. Leg Skin Leg The portion of the lower extremity between the knee and the ankle. Leg Crystalline Lens Ocular Lens The structure of the eye through which light is focused onto the retina. Lens The two innermost layers of tissue that cover the brain and spinal cord, the arachnoid mater and the pia mater. (NCI) Leptomeninges The medial border of the stomach. It is concave in shape and extends from the cardiac orifice to the pyloric orifice. Lesser Curvature of the Stomach A cone-shaped projection in the shaft of the femur in which the iliopsoas muscle is attached. (NCI) Lesser Trochanter Ligament Band of fibrous tissue connecting bone to bone or cartilage to bone thereby supporting or strengthening a joint. (NCI) Ligament Extremity A jointed extremity of the upper/thoracic or lower/pelvic regions. Limb Lower Extremity The limb that is composed of the hip, thigh, leg and foot. (NCI) Lower Extremity Upper Extremity The region of the body that extends distal to the scapulohumeral joint. Upper Extremity A small tongue-like projection from the lower portion of the upper lobe of the left lung. Lingula of the Lung Lip Vermillion of the Lip Fleshy fold which surrounds the opening of the mouth. (NCI) Lip External Lower Lip The external surface of the lower lip. (NCI) External Lower Lip External Upper Lip The external surface of the upper lip. (NCI) External Upper Lip Liver Fissure A groove on the surface of the liver. Liver Fissure Any of the large divisions of the liver. Liver Lobe An abdominal organ that has variable lobation which are composed mainly of hepatic lobules. Liver Couinaud Segment I The lobe of the liver situated posteriorly located between the left lobe and the inferior vena cava. Caudate Lobe Couinaud Segment III The lateral segment of the left lobe of the liver, located to the left of the inferior portion of the falciform ligament, anteriorly overlapping the stomach. (NCI) Left Anterolateral Segment Couinaud Segment IVb The medial segment of the left lobe of the liver, located inferiorly. (NCI) Left Inferomedial Segment Couinaud Segment IV The medial segment of the left lobe of the liver. Left Medial Segment of Liver Couinaud Segment II The lateral segment of the left lobe of the liver, located to the left of the superior portion of the falciform ligament and the fissure for the ligamentum venosum. (NCI) Left Posterolateral Segment Couinaud segment IVa The medial segment of the left lobe of the liver, located superiorly. (NCI) Left Superomedial Segment The smaller lobe of the liver extending into the left side of the body. Left Lobe of the Liver An oblong shaped area of the liver that is situated inferior to the right lobe, bounded by the anterior margin of the liver and the porta hepatis. Quadrate Lobe of Liver Couinaud Segment V The anterior segment of the right lobe of the liver, located inferiorly. (NCI) Right Anteroinferior Segment Couinaud Segment VIII The anterior segment of the right lobe of the liver, located superiorly. (NCI) Right Anterosuperior Segment Couinaud Segment VI The posterior segment of the right lobe of the liver, located inferiorly. (NCI) Right Posteroinferior Segment Couinaud Segment VII The posterior segment of the right lobe of the liver, located superiorly. (NCI) Right Posterosuperior Segment The larger lobe of the liver extending into the right side of the body. Right Lobe of the Liver A brainstem nucleus. It is the major brain site for the synthesis and secretion of norepinephrine. (NCI) Locus Coeruleus A lymph node located in the lower gastrointestinal tract. Lower Gastrointestinal Tract Lymph Node Any lymph nodes located within close proximity to the lower third of the internal jugular vein, extending from the inferior border of the cricoid cartilage (superiorly) to the clavicle (inferiorly). The anterior (medial) boundary is the lateral border of the sternohyoid muscle and the posterior (lateral) boundary is the posterior border of the sternocleidomastoid muscle. (AJCC 8th ed.) Lower Jugular Lymph Node Group (Level IV) The soft tissue of the lower limb(s). Lower Limb Soft Tissue The part of the respiratory system below the bifurcation of the trachea. It includes the lungs and the parts of the lungs such as the bronchi, bronchioles and alveoli. Lower Respiratory System The area of the body below the ribs and above the hipbones. (NCI) Lumbar Region The vertebrae located below the thoracic and above the sacral vertebrae. Lumbar Spine Lumbar Vertebra Any of the vertebrae situated between the thoracic vertebrae and the sacrum in the lower part of the spine. Lumbar Vertebra Lumbosacral Region The part of the spine in the lower back that consists of the lumbar region and the sacrum. Lumbosacral Region A group of muscles in the sole of the foot that extend from the tendons of the flexor digitorum longus muscle to the medial bases of the proximal phalanges and the extensor expansion of the second through fifth digits; primary function is to flex and adduct the lateral four toes at the metatarsophalangeal joints and extend them at the interphalangeal joints. Lumbrical Muscles of the Foot One of a group of four short muscles in the hand that extend from the radial and ulnar sides of the tendons of the flexor digitorum profundus to the radial lateral band of the extensor expansion tendon; primary function is extension of the proximal and distal interphalangeal joints. Lumbrical Muscle Lunate Bone The bone in the proximal row of carpal bones that lies between the scaphoid and triquetral bones. (NCI) Lunate Bone Any of the large divisions of the lung. Lung Lobe A thoracic organ that has variable lobation and is the primary respiratory organ of mammals. Lung Hilar Area of the Lung The wedge-shaped area at the central portion of the lung through which the bronchi, vessels and nerves enter or exit the organ. (NCI) Hilar Area of the Lung Lower Lobe of the Left Lung The larger lobe of the left lung, situated below and behind the oblique fissure. (NCI) Lower Lobe of the Left Lung Upper Lobe of the Left Lung The smaller lobe of the left lung, situated above and in front the oblique fissure, which includes the apex. (NCI) Upper Lobe of the Left Lung Left Lung The 2-lobed lung located on the left side of the body. (NCI) Left Lung The anterior basal segment of the inferior lobe of the left lung. Left Lung, Inferior Lobe, Anterior Basal Segment The lateral basal segment of the inferior lobe of the left lung. Left Lung, Inferior Lobe, Lateral Basal Segment The medial basal segment of the inferior lobe of the left lung. Left Lung, Inferior Lobe, Medial Basal Segment The posterior basal segment of the inferior lobe of the left lung. Left Lung, Inferior Lobe, Posterior Basal Segment The superior segment of the inferior lobe of the left lung. Left Lung, Inferior Lobe, Superior Segment The anterior segment of the superior lobe of the left lung. Left Lung, Superior Lobe, Anterior Segment The apicoposterior segment of the superior lobe of the left lung. Left Lung, Superior Lobe, Apicoposterior Segment The inferior lingular segment of the superior lobe of the left lung. Left Lung, Superior Lobe, Inferior Lingular Segment The superior lingular segment of the superior lobe of the left lung. Left Lung, Superior Lobe, Superior Lingular Segment Lower Lobe of the Right Lung The lobe of the right lung situated below the oblique fissure. (NCI) Lower Lobe of the Right Lung Middle Lobe of the Right Lung The smallest lobe of the right lung, situated above the oblique fissure and below the horizontal fissure. (NCI) Middle Lobe of the Right Lung Upper Lobe of the Right Lung The lobe of the right lung, situated above the horizontal fissure, which includes the apex. (NCI) Upper Lobe of the Right Lung Right Lung The 3-lobed lung located on the right side of the body. (NCI) Right Lung The anterior basal segment of the inferior lobe of the right lung. Right Lung, Inferior Lobe, Anterior Basal Segment The lateral basal segment of the inferior lobe of the right lung. Right Lung, Inferior Lobe, Lateral Basal Segment The medial basal segment of the inferior lobe of the right lung. Right Lung, Inferior Lobe, Medial Basal Segment The posterior basal segment of the inferior lobe of the right lung. Right Lung, Inferior Lobe, Posterior Basal Segment The superior segment of the inferior lobe of the right lung. Right Lung, Inferior Lobe, Superior Segment The lateral segment of the middle lobe of the right lung. Right Lung, Middle Lobe, Lateral Segment The medial segment of the middle lobe of the right lung. Right Lung, Middle Lobe, Medial Segment The anterior segment of the superior lobe of the right lung. Right Lung, Superior Lobe, Anterior Segment The apical segment of the superior lobe of the right lung. Right Lung, Superior Lobe, Apical Segment The posterior segment of the superior lobe of the right lung. Right Lung, Superior Lobe, Posterior Segment Lymph Node Hilum The concave side of the lymph node. (NCI) Lymph Node Hilum Lymphatic Gland Secondary lymphoid organ associated with lymphatic vessels and consisting of an outer cortex, inner medulla and sinuses. Lymph Node An oval-shaped, yellow pigmented area located on the center of the retina, which contains a high density of cones for high-acuity vision. Macula Left Main Bronchus One of the two main bronchi. It is narrower but longer than the right main bronchus and connects to the left lung. (NCI) Left Main Bronchus Right Main Bronchus One of the two main bronchi. It is wider but shorter than the left main bronchus and connects to the right lung. (NCI) Right Main Bronchus Male Genitalia Male internal and external organs of reproduction. Male Genitalia The sex organs of the male. Male Reproductive System Malleus A hammer-shaped bone, part of three interconnected small bones located in the middle ear. It is attached to the inner surface of the tympanic membrane and its function is to transmit sound vibrations. (NCI) Malleus The exocrine glands of the mammae that produce milk in females, and are composed of lobules, alveolar ducts and alveoli. Mammary Gland Bone, Mandibular Inferior Maxillary Bone Lower Jaw Mandible The lower jaw bone holding the lower teeth. (NCI) Mandible A muscle extending from the zygomatic arch to the lateral surface of mandibular ramus; primary function is elevation of the mandible (closing of the mouth). Masseter Muscle Mastoid Process A honeycombed section of bone located near the base of the skull, protruding behind the outer ear. It is connected to the middle ear. (NCI) Mastoid Process The upper jaw bone holding the upper teeth. Maxilla Maxillary Sinus A pyramidal-shaped, thin-walled, air-filled cavity located in the maxilla. It is lined by mucus membrane and periosteum (mucoperiosteum) which contains cilia. It is adjacent to the nasal cavity and communicates with the middle meatus of the nose. It is the largest paranasal sinus and is composed of three recesses: alveolar, zygomatic, and infraorbital. (NCI) Maxillary Sinus An opening in the medial portion of the middle cranial fossa through which the trigeminal nerve passes. Trigeminal Cave A rounded, bony projection on the inner side of the distal end of the femur to which the medial collateral and the posterior cruciate ligaments are attached. Medial Femoral Condyle Media Nasal Concha Nasal Middle Turbinate The largest of the ethmoidal nasal turbinates in some species, extending from the ethmoidal crest into the middle of the nasal cavity. Medial Nasal Turbinate Median Cubital Vein A vein between the biceps and pronator radii teres muscles that unites with the common ulnar vein to form the basilic vein within the forearm. Median Basilic Vein A nerve extending from the brachial plexus traveling the length of the arm/thoracic limb, which innervates some flexor muscles of the arm/forelimb and the skin on the palmar aspect of the carpus, metacarpus and digits. Median Nerve A lymph node located in the median or lower region of the neck. (NCI) Median Or Lower Cervical Lymph Node Lymph node(s) in the mediastinal region. Mediastinal Lymph Node The soft tissue of the mediastinum. Mediastinal Soft Tissue The central region of the thoracic cavity of mammals containing a group of organs surrounded by loose connective tissue, which separates the two pleural sacs. Mediastinum Anterior Mediastinum The area between the lungs; it contains the thymus, some lymph nodes, and vessels and branches of the internal thoracic artery. (NCI) Anterior Mediastinum Middle Mediastinum The broadest part of the lower portion of the mediastinum. It contains the heart and the great vessels. (NCI) Middle Mediastinum Posterior Mediastinum The part of the lower portion of the mediastinum that is located behind the pericardium. (NCI) Posterior Mediastinum Superior Mediastinum The part of the mediastinum that is located between the upper part of the sternum in the front and the upper thoracic vertebrae in the back. (NCI) Superior Mediastinum The portion of the brainstem between the pons and cervical spinal cord. Medulla Oblongata Any one of three membranes that surround the brain and spinal cord. (NCI) Meninges A muscle of the jaw, in general extending from the incisive fossa of the mandible to the skin of the lower lip; primary function is to elevate and protrude the lower lip and elevate the skin of the chin. Mentalis Muscle One of the arteries of the abdomen; in general it arises from the abdominal aorta and supplies blood mainly to the intestines. Mesenteric Artery Lymph node(s) in or adjacent to the mesentery. Mesenteric Lymph Node A vein of the abdomen; in general it arises from the intestines and pancreas, combines with the splenic vein, and drains into the portal vein. Mesenteric Vein A double layer of peritoneum that attaches to the wall of the abdominal cavity and supports the small intestines. Mesentery A simple layer of cells, derived from the mesoderm, that covers the serous membranes including the peritoneum, pericardium, and pleura. Mesothelium The proximal end of the first metacarpal bone. Metacarpal 1 Base The first of the five long bones located in the palm of the hand, as counted from the thenar side of the hand; it articulates proximally with the trapezium and distally with the thenar phalanx (thumb). Metacarpal Bone Digit 1 The second of the five long bones located in the palm of the hand, as counted from the thenar side of the hand; it articulates proximally with the trapezoid and distally with the second phalanx (index finger). Metacarpal Bone Digit 2 The third of the five long bones located in the palm of the hand, as counted from the thenar side of the hand; it articulates proximally with the capitate and the second and fourth metacarpals, and distally with the third phalanx (middle finger). Metacarpal Bone Digit 3 The fourth of the five long bones located in the palm of the hand, as counted from the thenar side of the hand; it articulates proximally with the capitate, hamate, and third and fifth metacarpal bones, and distally with the fourth phalanx (ring finger). Metacarpal Bone Digit 4 The fifth of the five long bones located in the palm of the hand, as counted from the thenar side of the hand; it articulates proximally with the hamate and fourth metacarpal, and distally with the fifth phalanx (small finger). Metacarpal Bone Digit 5 Any of the bones between the carpus and the phalanges. Metacarpal Bone MCP1 A condyloid synovial joint within the first digit of the hand articulating the metacarpal to the proximal phalanx. Metacarpophalangeal Joint 1 MCP2 A condyloid synovial joint within the second digit of the hand articulating the metacarpal to the proximal phalanx. Metacarpophalangeal Joint 2 MCP3 A condyloid synovial joint within the third digit of the hand articulating the metacarpal to the proximal phalanx. Metacarpophalangeal Joint 3 MCP4 A condyloid synovial joint within the fourth digit of the hand articulating the metacarpal to the proximal phalanx. Metacarpophalangeal Joint 4 MCP5 A condyloid synovial joint within the fifth digit of the hand articulating the metacarpal to the proximal phalanx. Metacarpophalangeal Joint 5 Metatarsal Bone Any of the bones between the tarsus and the phalanges. Metatarsal Bone MTP1 A condyloid synovial joint within the first digit of the foot articulating metatarsal with the proximal phalanx. Metatarsophalangeal Joint 1 MTP2 A condyloid synovial joint within the second digit of the foot articulating metatarsal with the proximal phalanx. Metatarsophalangeal Joint 2 MTP3 A condyloid synovial joint within the third digit of the foot articulating metatarsal with the proximal phalanx. Metatarsophalangeal Joint 3 MTP4 A condyloid synovial joint within the fourth digit of the foot articulating metatarsal with the proximal phalanx. Metatarsophalangeal Joint 4 MTP5 A condyloid synovial joint within the fifth digit of the foot articulating metatarsal with the proximal phalanx. Metatarsophalangeal Joint 5 Metatarsophalangeal Joint A spheroid joint located between the heads of the metatarsal bone and the base of the proximal phalanx of the toe. (NCI) Metatarsophalangeal Joint MCIRC MID-CIRCUMFLEX ARTERY SEGMENT The segment of the left circumflex artery between the first and second marginal branches. Mid-Circumflex Artery Any lymph nodes located within close proximity to the middle third of the internal jugular vein, extending from the inferior border of the hyoid bone (superiorly) to the inferior border of the cricoid cartilage (inferiorly). The anterior (medial) boundary is the lateral border of the sternohyoid muscle, and the posterior (lateral) boundary is the posterior border of the sternocleidomastoid muscle. (AJCC 8th ed.) Middle Jugular Lymph Node Group (Level III) MID-LAD ARTERY SEGMENT MLAD The segment of the left anterior descending (LAD) artery between the first and third diagonal branches. Mid-Left Anterior Descending Artery Mid-right Coronary Artery MID-RIGHT CORONARY ARTERY CONDUIT SEGMENT MRCA The section of the right coronary artery between the right ventricular artery and the acute marginal artery. Mid-Right Coronary Artery Conduit All of the arterial branches distal to the proximal left anterior descending coronary artery. Mid-Distal Left Anterior Descending Coronary Artery and All Diagonal Coronary Branches Mesencephalon The portion of the brainstem between the pons and diencephalon. Mesencephalon MCA The larger paired arteries (left and right) that arise from the internal carotid artery and that run along the fissure of Sylvius. Middle Cerebral Artery The part of the ear including the eardrum and ossicles. Middle Ear A ridge on the lateral surface of the frontal lobe, which lies between the superior and inferior frontal sulci, and rostral to the precentral gyrus. Middle Frontal Gyrus The long bone in the second finger, as counted from the thenar side of the hand; it is located between, and articulates with, the proximal and distal phalanges. Hand Digit 2 Middle Phalanx The long bone in the third finger, as counted from the thenar side of the hand; it is located between, and articulates with, the proximal and distal phalanges. Hand Digit 3 Middle Phalanx The long bone in the fourth finger, as counted from the thenar side of the hand; it is located between, and articulates with, the proximal and distal phalanges. Hand Digit 4 Middle Phalanx The long bone in the fifth finger, as counted from the thenar side of the hand; it is located between, and articulates with, the proximal and distal phalanges. Hand Digit 5 Middle Phalanx A ridge on the outer surface of the temporal lobe between the superior and middle temporal sulci. (NCI) Middle Temporal Gyrus A fibrous membrane that attaches to, and provides support for, the mitral valve leaflets. Mitral Valve Annulus Left Atrioventricular Valve Mitral Valve A cardiac valve located between the left atrium and ventricle. Mitral Valve Mitral Valve, Anteroseptal Annulus The portion of the mitral valve annulus that attaches to the anterior mitral valve leaflet. Anterior Annulus of the Mitral Valve The cusp of the mitral valve that is anchored to the aortic-mitral curtain. Anterior Cusp of the Mitral Valve Mitral Valve, Posterolateral Annulus The portion of the mitral valve annulus that attaches to the posterior mitral valve leaflet. Posterior Annulus of the Mitral Valve The cusp of the mitral valve that is located posterior to the two commissures, and which has no attachment to the aortic root. Posterior Cusp of the Mitral Valve A brain region that is located in the dorsal part of the precentral gyrus. (NCI) Primary Motor Cortex The lining of the fleshy folds surrounding the mouth. It is comprised of the epithelium, basement membrane, lamina propria mucosae, and lamina muscularis mucosae. (NCI) Mucosa of the Lip Mucosa Mucous Membrane The moist, inner lining of some organs and body cavities (such as the nose, mouth, lungs, and stomach). Glands in the mucosa make mucus (a thick, slippery fluid). Mucosa A fibrous soft tissue with the ability to contract to produce force and motion. Muscle The system of muscles, tendons, ligaments, bones, joints and associated tissues. Musculoskeletal System Myocardium The striated muscle tissue of the heart enveloped by the epicardium and the endocardium. (NCI) Myocardium Myometrium The smooth muscle lining the uterus. (NCI) Myometrium The integument under the nail plate. Nail Bed Nail The cutaneous plate on the dorsal surface of the distal end of a finger or toe. (NCI) Nail Nasal Bone A bone of the skull forming the middle and upper part of the face. Nasal Bone The upper respiratory tract extending from the nares to the pharynx. Nasal Cavity Nasal Septum The thin wall between the two nasal cavities. (NCI) Nasal Septum The soft tissue of the nose. Nasal Soft Tissue The part of the pharynx above the soft palate, which is continuous with the nasal cavity and extends to the oropharynx. Nasopharynx Navicular Bone An oval-shaped bone of the tarsus found on the medial side of the foot. (NCI) Navicular Bone A group of muscles in the neck, the trapezius, splenius capitis, splenius cervicis, semispinalis capitis, and semispinalis cervicis muscles; primary function is to extend the neck. Neck Extensor Muscles The soft tissue of the neck. Neck Soft Tissue Neck The region that connects the head to the rest of the body. (NCI) Neck A bundle of neuronal fibers that transmits electrochemical impulses encoding sensory and motor information from one body part to another. Nerve The protuberance in the skin where the ducts of the mammary gland open. Nipple Nose A structure of special sense serving as an organ of the sense of smell and as an entrance to the respiratory tract. (NCI) Nose Naris Nostril One of the two channels of the nose, from the point where they divide to the external opening. (NCI) Nostril Any lymph node located in the posterior of the neck, including the postauricular, superficial occipital, middle posterior cervical chain, and lower posterior cervical chain. Nuchal Lymph Node A nucleus comprising neurons in the forebrain, ventral to the dorsal caudate and putamen. Accumbens Nucleus BASAL NUCLEUS/DIAGONAL BAND A brain structure that is part of the septal nuclear complex. It is connected with the hippocampus, hypothalamus and amygdala. Nucleus of Diagonal Band A muscle of the pelvis that originates on the obturator foramen and obturatory membrane and inserts on the trochanteric fossa of the femur. Obturator Externus Muscle A muscle of the pelvis that originates on the ischiopubic ramus and obturator membrane and inserts on the greater trochanter. Obturator Internus Muscle A pelvic lymph node located along the obturator artery. Obturator Lymph Node One of two muscles located in the pelvis: the obturator externus muscle or the obturator internus muscle. (NCI) Obturator Muscle The trapezoidal-shaped bone on the posterior portion of the skull that forms part of the base of the skull. Occipital Bone The outermost layer of the occipital lobe of the brain, made up of gray matter. Occipital Lobe Cortex One of the four regions of cortex in each cerebral hemisphere, located posterior to the temporal lobe and inferior to the parietal lobe. Occipital Lobe A lymph node located in the back of the head adjacent to the trapezius muscle. Occipital Lymph Node The occipital region of the skin that covers the top of the head. (NCI) Occipital Scalp The area of the brain where the occipital and temporal lobes meet. Occipito-Temporal Region Third Cranial Nerve A cranial nerve extending from the oculomotor nucleus and accessory parasympathetic nucleus, which innervates the pupil, lens, upper eyelid, and eye muscles. Oculomotor Nerve A synovial bursa in the elbow that is located between the olecranon and the skin. Olecranon Bursa Olecranon A prominence at the proximal end of the ulna. It forms the tip of the elbow. (NCI) Olecranon The portion of the vertebrate forebrain that lies behind the ethmoid bones; it begins the rhinencephalon. Olfactory Bulb The part of the nasal mucosa composed of neuroepithelial tissue and mucus-producing Bowman's glands. Olfactory Mucosa The first cranial nerve. Olfactory Nerve A double layer of peritoneum covering abdominal organs. Omentum An artery arising from the internal carotid artery that branches into two groups of vessels; the orbital group that supplies the orbit and surrounding parts and the ocular group that supplies the globe and muscles of the eye. Ophthalmic Artery A muscle of the arm, in general extending from the distal border of the flexor retinaculum and the tubercles of the scaphoid and trapezium, to the lateral aspect of the first metacarpal; primary function is rotation and flexion of the thumb. Opponens Pollicis Muscle An anatomic structure formed by the crossing of the two optic nerves under the hypothalamus. (NCI) Optic Chiasm Optic Nerve Head The portion of the retina at which the axons of the ganglion cells exit the eyeball to form the optic nerve. Optic Disc Second Cranial Nerve A cranial nerve extending between the retina and optic chiasma, which innervates the eye. Optic Nerve Buccal cavity Mouth The cavity of the mouth. Oral Cavity The mucosal membranes that line the oral cavity. Oral Mucosa A ring-like band of skeletal muscle on the palpebrae, temple, cheeks, and surrounding the orbit, which originates on the frontal bone, medial palpebral ligament, and lacrimal bone, and which inserts into the lateral palpebral raphe. Orbicularis Oculi Muscle Eye Socket Ocular Orbit Orbit The bony cavity that contains the eye and its associated structures. Orbit The soft tissue of the oropharyngeal region. Oropharyngeal Soft Tissue The part of the pharynx between the soft palate and the upper portion of the epiglottis. (NCI) Oropharynx Osteomeatal Complex A narrow channel that connects the frontal sinus, anterior ethmoid air cells, and maxillary sinus to the middle meatus, allowing drainage and ventilation. It includes the maxillary ostium, infundibulum, ethmoid bulla, uncinate process, and hiatus semilunaris. Ostiomeatal Complex A spherical aggregation of cells found in the ovaries that contains a single oocyte. (NCI) Ovarian Follicle The female gonad. Ovary Palatine Rugae The creases or folds in the oral mucosa covering the anterior portion of the hard palate. Palatal Rugae The roof of the oral cavity. It separates the oral cavity from the nasal cavity. Palate Palatine Bone An irregularly shaped bone positioned at the back part of the nasal cavity between the maxilla and the pterygoid process of the sphenoid. It forms the posterior part of the hard palate and the lateral wall of the nasal fossa and helps to form the floor of the orbit as well as several adjoining parts. (NCI) Palatine Bone The fleshy lobe that is suspended from the back of the soft palate in the oral cavity. Uvula The undersurface of the hand. (NCI) Palmar Region A type of artery that supplies blood to the fingers and includes the common palmar digital arteries, the dorsal digital arteries of the hand, and the proper palmar digital arteries. (NCI) Palmar Digital Artery The part of the conjunctiva that covers the inner surface of the eyelid. Palpebral Conjunctiva The elliptical shaped curve of the bottom border of the upper eyelid, extending from the medial canthus to the lateral canthus. Palpebral Fissure A digestive organ in the abdomen that has both endocrine and exocrine functions. Pancreas Body of the Pancreas The part of the pancreas from the point where it crosses the portal vein to the point where it enters the lienorenal ligament. (NCI) Body of the Pancreas Endocrine Pancreas The pancreatic tissue that contains the islets of Langerhans. It is responsible for the production and secretions of the pancreatic hormones. (NCI) Islet of Langerhans Exocrine Pancreas An enzyme producing region of the pancreatic tissue containing the pancreatic acini and exocrine intralobular ducts which collectively secrete the digestive enzymes into the main pancreatic duct to drain into the duodenal part of the small intestine. (NCI) Exocrine Pancreas Head of the Pancreas That portion of the pancreas lying in the concavity of the duodenum. (NCI) Head of the Pancreas The portion of the pancreas that is the junction of the head and body of the pancreas, and lies anterior to the aorta. Neck of the Pancreas Tail of the Pancreas The left extremity of the pancreas within the lienorenal ligament. (NCI) Tail of the Pancreas A duct that conveys pancreatic secretions from the pancreas to the duodenum. Pancreatic Duct Papillary Muscle Any one of the group of small muscles in the heart ventricles, in general extending from the ventricular wall to the free edge of the atrioventricular valves; primary function is to keep the valves closed during ventricular systole. Papillary Muscle Lymph Node, Para-Aortic Lymph node(s) adjacent to the lumbar vertebral column. Paraaortic Lymph Node A lymph node located adjacent to the lumbar region of the spine, along the right lateral aspect of the inferior vena cava. (NCI) Paracaval Lymph Node Naturally occurring spaces between the colon and the abdominal wall, lateral to the ascending and descending colons. Paracolic Gutter A superior mediastinal lymph node located near the esophagus. Paraesophageal Lymph Node A lymph node located adjacent to the larynx, in the parapharyngeal space. Paralaryngeal Lymph Node Parametrium The subserous connective tissue of the pelvic floor of the supracervical portion of the uterus. The parametrium extends laterally between the layers of the broad ligament. (NCI) Parametrium The air-filled cavities adjacent to the nasal cavity lined by a mucous membrane and located in the bones of the skull. Paranasal Sinus Any lymph node located in the potential space of the neck, which is bounded superiorly by the base of the skull, inferiorly by the greater cornu of the hyoid bone, anteriorly by the investing fascia of the deep cervical fascia covering the medial pterygoid muscle, posteriorly by the prevertebral layer of the deep cervical fascia, medially by the middle (pretracheal) layer of the deep cervical fascia, and laterally by the investing fascia of the deep cervical fascia covering the deep lobe of the parotid. Parapharyngeal Lymph Node Erector Spinae Extensor Spinae Sacrospinalis Muscle A group of three paired epaxial muscle bundles (iliocostalis, longissimus, and spinalis) and transversospinales muscles (semispinalis, multifidus, and rotatores) extending along and lateral to the spinous processes of the cervical, thoracic, and lumbar vertebrae; primary function is extension and rotation of the spine. Erector Spinae The area of the body surrounding the spinal column. Paraspinal Region The soft tissue of the paraspinal region. Paraspinal Soft Tissue A usually small autonomic ganglion of the parasympathetic nervous system. The majority are located near or in the organs that they innervate. (NCI) Parasympathetic Ganglion Endocrine gland, usually in close proximity to the thyroid gland, that produces parathyroid hormone. Parathyroid Gland A lymph node located adjacent to the trachea within the mediastinum. (NCI) Paratracheal Lymph Node A lymph node located adjacent to the trachea within the mediastinum, above the inferior margin of the left brachiocephalic vein crossing the trachea on the left and the superior border of the aortic arch on the right. Upper Paratracheal Lymph Node Paraspinal Ganglion Spinal Ganglion A cluster of neuronal cell bodies and their dendrites located just ventral and lateral to the spinal cord that give rise to the sympathetic nervous system. Para-Spinal Ganglion A bone of the skull that forms the sides and roof of the skull. Parietal Bone The outermost layer of the parietal lobe of the brain, made up primarily of gray matter. Parietal Lobe Cortex Parietal Lobe One of the lobes of the cerebral hemisphere located superiorly to the occipital lobe and posteriorly to the frontal lobe. Cognition and visuospatial processing are its main function. (NCI) Parietal Lobe The outermost of the two pleural membranes. Parietal Pleura The area of the brain where the parietal and occipital lobes meet. Parieto-Occipital Region The area of the brain where the parietal and temporal lobes meet. Parieto-Temporal Region Parotid Gland Lymph Node Lymph node(s) in or adjacent to the parotid gland. Parotid Gland Lymph Node The salivary gland located adjacent to the ear. Parotid Gland A part of the substantia nigra. The pars compacta nerve cells contain melanin and are involved in motor control. (NCI) Pars Compacta A small bone in front of the femorotibial joint that articulates with the femur. Patella A fibrous band extending from the distal end of the quadriceps femoris to the top of the patella. Patellar Tendon The entire structure distal to the ankle joint/tarsus or wrist joint/carpus in quadruped animals. Paw An axillary lymph node located along the lower edge of the pectoralis minor. (NCI) Pectoral Lymph Node Either of two large muscles of the anterior chest wall, which has two heads: the clavicular head, which originates on the medial half of the clavicle, and the sternal head, which originates on the sternum and the first six costal cartilages; the muscles insert onto the lateral lip of the intertubercular groove of the humerus and the crest of the greater tubercle of the humerus respectively; primary function is flexion, adduction, and medial rotation of the shoulder joint. Pectoralis Major A muscle in the chest, in general extending from the third to fifth ribs near their costal cartilages to the medial border and superior surface of the coracoid process of the scapula; primary function is to stabilize the scapula against the thoracic wall. Pectoralis Minor Pelvic Bone The bony structure composed of the ilium, ishium, pubis and sacrum, which are typically fused during maturation. Pelvic Bone Pelvic Lymph Node Any lymph node within the pelvic region. (NCI) Pelvic Lymph Node Any of the muscles of the pelvis. Pelvic Muscle The part of the pelvic wall that is formed by the piriformis and obturator internus muscles and contains the iliac vessels, pelvic ureters, and lateral pelvic lymph nodes. Pelvic Sidewall The soft tissue of the pelvis. Pelvic Soft Tissue Pelvic Region Pelvis The bony, basin-shaped structure formed by the bones of the pelvis. Pelvis Any of the arteries that supply blood to the penis, including the common penile artery, which is the termination of the internal pudendal artery, and the bulbourethral, dorsal, and cavernosal branches of the common penile artery. (NCI) Penile Artery The male organ of urination and copulation. (NCI) Penis The portion of the penis between the glans penis and the radix penis. Body of the Penis The most distal portion of the penis covered by the foreskin. Glans Penis The portion of the penis between the descending portion of the pubic bone and the body of the penis. Radix Penis The soft tissue of the peri-orbital region. Periorbital Soft Tissue The skin area around the anus. (NCI) Perianal Region The body space between the epicardium and the pericardium. Pericardial Cavity A lymph node located anterior to the pericardium, posterior to the xiphoid process, and in the right and left cardiophrenic fat. (NCI) Pericardial Lymph Node The tissue layers that form the pericardium of the heart, including the fibrous pericardium, and the parietal and visceral layers of the serous pericardium. Pericardial Wall The membrane surrounding the heart and roots of the vessels at the base of the heart. Pericardium A lymph node located above the mandibular margin of the submandibular triangle and is associated with the anterior facial vein and facial artery. Perifacial Lymph Node A lymph node located in the area around the hilum. Perihilar Lymph Node The space surrounding the meninges. Perimeningeal Space Perineum The area located between the anus and vulva in females, and anus and scrotum in males. (NCI) Perineum Lymph node(s) in or adjacent to the pancreas. Pancreatic Lymph Node Any nerve outside the brain or spinal cord that connects with peripheral receptors or effectors. (NCI) Peripheral Nerve Lymph node(s) located in the connective tissue adjacent to the rectum. Perirectal Lymph Node A part of the abdominal cavity that lies between the visceral and parietal peritoneum. Peritoneal Cavity The fluid within the peritoneal cavity. Peritoneal Fluid A lymph node located in the peritoneum. Peritoneal Lymph Node The membrane that lines the abdominal and pelvic cavities. Peritoneum The region of the body that immediately surrounds the umbilicus. Periumbilical Region The tissue surrounding the ureter. Periureteral Region The tissue surrounding the urethra. Periurethral Region The region of the body surrounding the urinary bladder. (NCI) Perivesical Region An artery arising from the posterior tibial artery that supplies the muscles on the lateral side of the lower leg. Peroneal Artery Nerve, Fibular A branch of the sciatic nerve that includes the common, deep, and/or superficial peroneal nerves, which innervates multiple muscles in the distal region of the leg/hindlimb. Peroneal Nerve A muscle of the lower leg, in general extending from the distal two-thirds of the lateral surface of the fibula and the anterior intermuscular septum to the tuberosity of the fifth metatarsal bone; primary function is to plantar flex and evert the foot. Peroneus Brevis Muscle A muscle of the lower leg, in general extending from the superior lateral shaft of the fibula to the first metatarsal and the medial cuneiform; primary function is to plantar flex and evert the foot and support the lateral, longitudinal, and transverse arches. Peroneus Longus A synovial bursa in the knee that is located between the hamstring tendons and the tibia. Pes Anserine Bursa Adenoid A tonsil in the mucosa of the nasopharynx. Pharyngeal Tonsil A passageway in the head and neck that includes the nasopharynx, oropharynx and laryngopharynx. Pharynx Either of a pair of nerves that arise in the cervical plexus and provide innervation of the diaphragm. (NCI) Phrenic Nerve Pineal Body A small endocrine gland that arises from the central posterior aspect of the diencephalon. Pineal Gland Pisiform Bone The medial bone of the proximal row of carpal bones. (NCI) Pisiform Bone Hypophysis Hypophysis Cerebri A small endocrine gland extending from the hypothalamus at the base of the brain. Pituitary Gland An organ present in true mammals during embryonic developmen that provides the fetus with nutrients and oxygen, facilitates gas and waste exchange between the fetus and mother. Placenta A group of muscles in the ankle, the gastrocnemius, soleus, plantaris, tibialis posterior, flexor hallucis longus, and flexor digitorum longus muscles; primary function is to extend the ankle, flexing the foot downward toward the sole. Plantar Flexor Muscles The serous membrane that lines the wall of the thoracic cavity and the surface of the lungs. Pleura A part of the thoracic cavity that lies between the visceral and parietal pleura. Pleural Cavity The fluid within the pleural cavity. Pleural Fluid Pons Pons Varolii The portion of the brainstem between the midbrain and medulla oblongata. Pons Varolii The segment of the popliteal artery that is located above the knee. Popliteal Artery Above the Knee The segment of the popliteal artery that is located below the knee. Popliteal Artery Below the Knee One of the arteries of the leg; in general it arises from the femoral artery and descends behind the knee joint before branching into the anterior and posterior tibial arteries. Popliteal Artery A diamond-shaped depression located in the back of the knee joint bounded by the medial and lateral heads of the gastrocnemius muscle, the semimembranosus muscle, and the biceps femoris. Popliteal Fossa Lymph node(s) adjacent to the femorotibial joint. Popliteal Lymph Node A vein originating from the anterior and posterior tibial veins that ascends the popliteal space to drain blood from the calf, knee joint, and thigh. The popliteal vein ultimately becomes the femoral vein. Popliteal Vein A lymph node located in the transverse fissure of the liver. (NCI) Porta Hepatis Lymph Node Portocaval Lymph Node A lymph node located in the space between the portal vein and inferior vena cava, along the hepatoduodenal ligament. (NCI) Portacaval Lymph Node Periportal Lymph Node Lymph node(s) adjacent to the portal vein. Portal Lymph Node The portion of the distal end of the main portal vein that branches into the left and right portal veins. Portal Vein Bifurcation Hepatic Portal Vein A vein lying in the lower part of the abdomen; in general it arises from the junction of the mesenteric and splenic veins and draining into the liver. Portal Vein The left branch of the main portal vein within the liver. Left Portal Vein The right branch of the main portal vein in the liver. Right Portal Vein A ridge on the parietal lobe of the brain, located between the central and postcentral sulci, that corresponds to the primary somatic sensory cortex area. Postcentral Gyrus PCA The paired arteries (left and right) that arise from the bifurcation of the basilar artery and form a portion of the Circle of Willis. Posterior Cerebral Artery A lymph node located in the posterior region of the neck. (NCI) Posterior Cervical Lymph Node The caudal region of the cingulate cortex, located within the medial part of the inferior parietal lobule, that is thought to function as an interface between emotion and cognition. Posterior Cingulate Cortex PDSP POSTERIOR DESCENDING SEPTAL PERFORATORS ARTERY SEGMENT The arteries arising from the right posterior descending artery that supply the interventricular septum. Septal Perforator Artery PICA An artery arising from the vertebral artery that supplies the cerebellum, choroid plexus and the lateral medulla. Posterior Inferior Cerebellar Artery Occipital Part of Internal Capsule Posterior Limb of Internal Capsule The portion of the internal capsule of the brain that is located posterior to the genu. Posterior Limb of Internal Capsule The scleral curvature of the eye comprising the retina, inclusive of the macula and optic disc. Posterior Pole of the Eye A bony projection from the posterior region of the iliac crest that lies over the sacroiliac joint and is the site of attachment for the thoracolumbar fascia and the posterior sacroiliac and sacrotuberous ligaments. Posterior Superior Iliac Spine A terminal branch of the popliteal artery that runs along the tibia from the lower portion of the popliteus muscle to the lower ankle with numerous branches supplying the lower leg and foot. Posterior Tibial Artery A vein in the foot that originates at the union of the external and internal plantar veins and which becomes the popliteal vein. Posterior Tibial Vein In an individual with a right-dominant heart, the arterial branch that arises from the distal right coronary artery in the posterior atrioventricular groove after the origin of the right posterior descending artery. Posterolateral Coronary Artery A lymph node located anterior to the auricle of the ear. (NCI) Preauricular Lymph Node A ridge on the convex side of both cerebral hemispheres, anterior to the postcentral gyrus and parallel to the central sulcus, which separates the pre- and postcentral gyri. Precentral Gyrus The posteromedial region of the parietal lobe bounded by the marginal branch of the cingulate sulcus anteriorly, by the medial portion of the parieto-occipital fissure posteriorly and by the subparietal sulcus inferiorly. Precuneus The gray matter on the medial, lateral, and orbital surfaces of the anterior part of the frontal cortex, which play a role in complex cognitive control, emotion, and social behavior. Prefrontal Cortex A lymph node located anterior to the larynx. Prelaryngeal Lymph Node Paired bones at the anterior tip of the upper jaw that are generally tooth bearing; they are present during fetal development and later fuse with the maxilla. Premaxilla Bone A synovial bursa in the knee that is located between the patella and the skin. Prepatellar Bursa Exocrine glands of the male reproductive system located adjacent to the prepuce. Preputial Gland Lymph node(s) located in the mesorectum, between the rectum and the sacrum. Presacral Lymph Node The potential body space formed between the rectum and the sacrum. Presacral Space One of the bones of the orbit, situated dorsally to the basisphenoid bone; it is present during fetal development and later fuses to form the anterior portion of the sphenoid bone. Presphenoid Bone A lymph node located anterior to the trachea, between the isthmus of the thyroid gland and the innominate vein. Pretracheal Lymph Node A pelvic lymph node located within the retropubic space, between the pubic symphysis and the anterior wall of the urinary bladder. Prevesical Lymph Node A brain region in the occipital cortex that receives visual stimuli from the retina. (NCI) Primary Visual Cortex A muscle in the face, in general extending from the lower part of the nasal bone to the frontalis muscle in the forehead; primary function is to move the skin between the eyebrows. Procerus Muscle An artery arising from the common femoral artery just below the inguinal ligament running close to the femur and ending in the lower third of the thigh with branches supplying the thigh muscles. Deep Femoral Artery Deep Femoral Vein A vein located in the upper thigh that connects, through tributaries, to the popliteal and inferior gluteal veins, and joins the superficial femoral vein at the groin to form the common femoral vein. Deep Femoral Vein A muscle of the forearm, in general extending from the distal anteromedial surface of the ulna to the distal anterolateral surface of the radius; primary function is pronation of the forearm. Pronator Quadratus Muscle A muscle of the superficial flexor compartment of the forearm, in general extending from the humeral and ulnar heads to the body of the radius; primary function is pronation of the arm and flexion of the elbow. Pronator Teres Muscle The anatomical space just below the bladder within which the prostate is situated. Prostate Bed The male reproductive accessory gland that produces prostatic fluid and is located adjacent to or around the urethra distal to the urinary bladder in mammals. Prostate Gland Lateral Lobe of the Prostate The prostate gland lobe that is located on the lateral side of the organ. (NCI) Lateral Lobe of the Prostate Middle Lobe of the Prostate The upper, smaller part of the prostate between the ejaculatory ducts and the urethra. (NCI) Middle Lobe of the Prostate Posterior Lobe of the Prostate The prostate gland lobe that is located on the posterior side of the organ. (NCI) Posterior Lobe of the Prostate PCIRC PROXIMAL CIRCUMFLEX ARTERY SEGMENT The section of the left circumflex coronary artery that arises from the left main coronary artery and extends to the first marginal branch. Proximal Circumflex Artery PIP2 of the Foot A ginglymoid (hinge) synovial joint within the second digit of the foot articulating the proximal and middle phalanges. (NCI) Proximal Interphalangeal Joint 2 of the Foot PIP2 of the Hand A ginglymoid (hinge) synovial joint within the second digit of the hand articulating the proximal and middle phalanges. (NCI) Proximal Interphalangeal Joint 2 of the Hand PIP2 A condyloid synovial joint within the second digit of the hand or foot articulating the proximal and middle phalanges. (NCI) Proximal Interphalangeal Joint 2 PIP3 of the Foot A ginglymoid (hinge) synovial joint within the third digit of the foot articulating the proximal and middle phalanges. (NCI) Proximal Interphalangeal Joint 3 of the Foot PIP3 of the Hand A ginglymoid (hinge) synovial joint within the third digit of the hand articulating the proximal and middle phalanges. (NCI) Proximal Interphalangeal Joint 3 of the Hand PIP3 A condyloid synovial joint within the third digit of the hand or foot articulating the proximal and middle phalanges. (NCI) Proximal Interphalangeal Joint 3 PIP4 of the Foot A condyloid synovial joint within the fourth digit of the hand or foot articulating the proximal and middle phalanges. (NCI) Proximal Interphalangeal Joint 4 of the Foot PIP4 of the Hand A ginglymoid (hinge) synovial joint within the fourth digit of the hand articulating the proximal and middle phalanges. (NCI) Proximal Interphalangeal Joint 4 of the Hand PIP4 A condyloid synovial joint within the fourth digit of the hand or foot articulating the proximal and middle phalanges. (NCI) Proximal Interphalangeal Joint 4 PIP5 of the Foot A ginglymoid (hinge) synovial joint within the fifth digit of the foot articulating the proximal and middle phalanges. (NCI) Proximal Interphalangeal Joint 5 of the Foot PIP5 of the Hand A ginglymoid (hinge) synovial joint within the fifth digit of the hand articulating the proximal and middle phalanges. (NCI) Proximal Interphalangeal Joint 5 of the Hand PIP5 A condyloid synovial joint within the fifth digit of the hand or foot articulating the proximal and middle phalanges. (NCI) Proximal Interphalangeal Joint 5 PLAD PROXIMAL LAD ARTERY SEGMENT The section of the left anterior descending coronary artery that arises from the left main coronary artery and extends to the first diagonal branch. Proximal Left Anterior Descending Artery The long bone in the first finger, as counted from the thenar side of the hand; it is located between, and articulates with, the first metacarpal and the distal phalanx. Hand Digit 1 Proximal Phalanx The long bone in the second finger, as counted from the thenar side of the hand; it is located between, and articulates with, the second metacarpal and the middle phalanx. Hand Digit 2 Proximal Phalanx The long bone in the third finger, as counted from the thenar side of the hand; it is located between, and articulates with, the third metacarpal and the middle phalanx. Hand Digit 3 Proximal Phalanx The long bone in the fourth finger, as counted from the thenar side of the hand; it is located between, and articulates with, the fourth metacarpal and the middle phalanx. Hand Digit 4 Proximal Phalanx The long bone in the fifth finger, as counted from the thenar side of the hand; it is located between, and articulates with, the fifth metacarpal and the middle phalanx. Hand Digit 5 Proximal Phalanx PRCA PROXIMAL RIGHT CORONARY ARTERY CONDUIT SEGMENT The section of the right coronary artery proximal to the origin of the right ventricular artery. Proximal Right Coronary Artery Conduit The part of the urethra that is close to the bladder. Proximal Urethra Pubis Either of the two bones (left and right) that form the front of the pelvis. (NCI) Pubic Bone Symphysis Pubis The joint between the left and right pubic bones at the front of the pelvis. (NCI) Pubic Symphysis One of the arteries of the thorax; in general it arises from the pulmonary trunk and branches into the lungs. Pulmonary Artery A pulmonary lymph node located between the origin of the lobar bronchi. Pulmonary Interlobar Lymph Node An inferior mediastinal lymph node located within the pulmonary ligament. Pulmonary Ligament Lymph Node A pulmonary lymph node located within the lobes of the lung. Pulmonary Lobar Lymph Node A lymph node that is found within the parenchyma of the lung. (NCI) Pulmonary Lymph Node A pulmonary lymph node located within the segmental bronchi. Pulmonary Segmental Lymph Node A pulmonary lymph node located within the subsegmental bronchi. Pulmonary Subsegmental Lymph Node Main Pulmonary Artery The artery arising from the right ventricle of the heart that bifurcates into the left and right pulmonary arteries. Pulmonary Trunk A cardiac valve located between the right ventricle and the pulmonary artery. Pulmonary Valve Pulmonary Valve, Anterior Semilunar Cusp The cusp of the pulmonic valve that has no attachment to the cardiac septum. Anterior Cusp of the Pulmonary Valve Pulmonary Valve, Left Semilunar Cusp The cusp of the pulmonic valve attached to the left side of the cardiac septum. Left Cusp of the Pulmonary Valve Pulmonary Valve, Right Semilunar Cusp The cusp of the pulmonic valve attached to the right side of the cardiac septum. Right Cusp of the Pulmonary Valve Any of the veins that carry oxygenated blood from the lungs to the heart. Pulmonary Vein The round opening in the center of the iris in the eye. Pupil Putamen The gray matter, located between the globus pallidus and the external capsule of the brain, that comprises the lateral dorsal striatum of the basal ganglia. Putamen Pyloric Sphincter The muscular structure at the distal portion of the stomach, opening into the duodenum. (NCI) Pyloric Sphincter The region of the stomach that connects to the duodenum. Pylorus The segments of the corticospinal and corticobulbar tracts that either traverse or terminate in the brainstem. (NCI) Brainstem Portion of the Pyramidal Tracts The segments of the corticospinal and corticobulbar tracts that traverse the internal capsule. Internal Capsule of the Pyramidal Tracts A group of muscles in the thigh, in general extending from the pelvis to the patella and tibia; primary function is extension of the femorotibial joint. Quadriceps Muscle of the Thigh Radial Artery The branch of the brachial artery that passes down the forearm. (NCI) Radial Artery A nerve extending from the brachial plexus traveling the length of the arm/forelimb, which innervates the extensor muscles of the elbow, carpus and phalanges, as well as the skin on the dorsal aspect of the carpus, metacarpus and digits. Radial Nerve Musculospiral Groove Radial Groove Spiral Groove A shallow groove in the shaft of the humerus through which the radial nerve and deep brachial artery course. Radial Sulcus The slightly curved, prismoid, elongated bony body of the radius. Radius Shaft The long bone that lies between the radiohumeral joint and the carpus and is adjacent to the ulna. Radius Bone A condyloid synovial joint within the wrist articulating the radius bone to the lunate bone. Radius-Lunate Joint RAMUS RAMUS ARTERY RAMUS INTERMEDIUS ARTERY SEGMENT An artery that arises from the left main coronary artery and is positioned between the left anterior descending coronary artery and the circumflex artery. Ramus Intermedius Artery A group of nuclei that are located in the midline of the brainstem and release serotonin. (NCI) Raphe Nuclei An extension of the peritoneum between the uterus and the rectum in females, which is formally bounded thusly: anteriorly by the uterus and posterior fornix of the vagina; posteriorly by the rectum; inferiorly by the peritoneal rectovaginal fold. Recto-Vaginal Pouch The area where the sigmoid colon joins the rectum. Rectosigmoid Region The anatomical space located between the vagina and rectum, extending from the superior border of the perineal body to the underside of the rectouterine Douglas pouch, which has its formal borders noted thusly: anteriorly by the rectovaginal septum; posteriorly by the anterior rectal wall; and laterally by the descending rectal septa that separate the rectovaginal space from the pararectal space on each side. Rectovaginal Space The terminal portion of the large intestine extending from the terminus of the colon to the anus or anal canal. Rectum The distal one-third of the rectum, which is supplied by the middle and inferior rectal arteries. Lower Third of Rectum The central one-third of the rectum, which is supplied by the middle and superior rectal arteries. Middle Third of Rectum The proximal one-third of the rectum, which is supplied by the superior rectal artery. Upper Third of Rectum A muscle in the quadriceps femoris muscle group between the vastus lateralis and vastus medialis and lying on the vastus intermedius; primary function is extension of the femorotibilal joint. Rectus Femoris Lymph node(s) that drains the lymph from a region of interest. Regional Lymph Node One of the arteries of the abdomen; in general it arises from the abdominal aorta and supplies blood to the kidney. Renal Artery Kidney Bed The anatomical space within which the kidney is situated. Renal Bed The usual retroperitoneal location of the kidney in the dorsolumbar region of the body. Renal Fossa The tip of a renal pyramid. Renal Papilla The funnel-shaped proximal portion of the ureter located within the kidney into which urine is secreted, from the collecting duct system of the kidney. (NCI) Renal Pelvis A vein arising from the kidney; in general it drains into the caudal vena cava vein. Renal Vein The organs and anatomic structures involved in inspiration and expiration of air and the exchange of carbon dioxide and oxygen. Respiratory System Retina A light-sensitive membrane that lines the back wall of the eyeball. The retina is continuous with the optic nerve and this way transmits optical images to the brain. (NCI) Retina An artery arising from the ophthalmic artery that supplies the retina. Retinal Artery A retina layer that contains the axons of ganglion cells. It collects the visual impulses. (NCI) Layer of the Ophthalmic Nerve Fibers A continuous, insulating monolayer of cuboidal/columnar epithelium which extends from the margins of the optic nerve head to the ora serrata where it is continuous with the pigment epithelium of the pars plana. (NCI) Retinal Pigment Epithelium Any of the veins that drain the retina of the eye. Retinal Vein Retro-Orbital Area The area behind the orbit of the eye. Retro-Orbital Region Mastoid Lymph Node Posterior Auricular Lymph Node The lymph nodes located immediately posterior to the ear. Retroauricular Lymph Node A lymph node located within the most inferior portion of the posterior mediastinum. (NCI) Retrocrural Lymph Node A lymph node located in the retroperitoneal space. (NCI) Retroperitoneal Lymph Node The region of the abdomen outside the peritoneum, where the kidneys lie and the great blood vessels run. Retroperitoneum Suprapharyngeal Lymph Node Lymph node(s) in the retropharyngeal space. Retropharyngeal Lymph Node A lymph node located posterior to the sternum. Retrosternal Lymph Node A superior mediastinal lymph node located posterior to the trachea. Retrotracheal Lymph Node A muscle of the back, in general extending from the spinous processes of the second to fifth thoracic vertebrae to the medial border of the scapula; primary function is to stabilize and retract the scapula. Rhomboid Major Muscle A muscle of the back, in general extending from the nuchal ligament and spinal processes of the seventh cervical and first thoracic vertebrae to the medial border of the scapula; primary function is to stabilize and retract the scapula. Rhomboid Minor Muscle Rib 1 The first rib counting from the top of the rib cage down. (NCI) Rib 1 Rib 10 The tenth rib counting from the top of the rib cage down. (NCI) Rib 10 Rib 11 The eleventh rib counting from the top of the rib cage down. (NCI) Rib 11 Rib 12 The twelfth rib counting from the top of the rib cage down. (NCI) Rib 12 Rib 2 The second rib counting from the top of the rib cage down. (NCI) Rib 2 Rib 3 The third rib counting from the top of the rib cage down. (NCI) Rib 3 Rib 4 The fourth rib counting from the top of the rib cage down. (NCI) Rib 4 Rib 5 The fifth rib counting from the top of the rib cage down. (NCI) Rib 5 Rib 6 The sixth rib counting from the top of the rib cage down. (NCI) Rib 6 Rib 7 The seventh rib counting from the top of the rib cage down. (NCI) Rib 7 Rib 8 The eighth rib counting from the top of the rib cage down. (NCI) Rib 8 Rib 9 The ninth rib counting from the top of the rib cage down. (NCI) Rib 9 Any one of the paired bones, extending from the thoracic vertebrae toward the median line on the ventral aspect of the trunk. Rib The innermost layer of endothelial cells and connective tissue that lines the right atrium. Right Atrial Endocardium The opening of the right coronary artery at its origin. Right Coronary Artery Ostium The right coronary artery and all of its branches. Right Coronary Artery and its Branches RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY SEGMENT RPAV The arterial branch between the right posterior descending artery segment and the first right posterolateral segment. Right Posterior Atrioventricular Artery RIGHT POSTERIOR DESCENDING ARTERY SEGMENT RPDA In an individual with a right-dominant heart, the arterial branch that arises from the distal right coronary artery between the acute marginal artery and the first right posterolateral segment. It supplies the inferior apex of the heart. Right Posterior Descending Artery The branch of the right coronary artery that supplies blood to the right ventricular wall. Right Ventricular Branch of Right Coronary Artery The innermost layer of endothelial cells and connective tissue that lines the right ventricle. Right Ventricular Endocardium Band of fibrous tissue that anchors various organs in place. Round Ligament S1 Nerve Root Dermatome The area of the skin innervated by the first sacral spinal nerve, covering the lateral and plantar aspects of the foot, including the heel, and extends up the posterior aspect of the lower leg and calf. S1 Dermatome S2 Nerve Root Dermatome The area of the skin innervated by the second sacral spinal nerve, covering the posterior aspect of the thigh and the upper portion of the calf. This dermatome extends vertically along the back of the leg, providing sensory innervation to the skin in these regions. S2 Dermatome S3 Nerve Root Dermatome The area of the skin innervated by the third sacral spinal nerve, covering the region around the buttocks and extending around the inner thigh. S3 Dermatome S4 Nerve Root Dermatome The area of the skin innervated by the fourth sacral spinal nerve, covering a portion of the perineal region, including parts of the genital area. S4 Dermatome S5 Nerve Root Dermatome An innervation area by the fifth sacral spinal nerve, primarily covering the skin around the coccyx and anus. S5 Dermatome The prominence on the lateral surface of the sacrum, posterior to the auricular surface of the sacrum. (NCI) Sacral Tuberosity Any one of the vertebrae situated between the lumbar vertebrae and the caudal vertebrae or coccyx. Sacral Vertebra Sacroiliac Joint The joint located between the sacrum and the ilium. (NCI) Sacroiliac Joint Sacrum The triangular bone, made up of 5 fused bones of the spine, located in the lower area of the spine between the fifth lumbar vertebra and the coccyx. (NCI) Sacrum Any number of exocrine glands that secrete saliva into the oral cavity. Salivary Gland The salivary gland located under the tongue in the floor of the oral cavity or adjacent to the submandibular salivary gland. Sublingual Salivary Gland Saphenous Vein A vein of the leg/hindlimb; in general it arises from the venous network of the leg/hindfoot and drains into the femoral vein. Saphenous Vein A muscle in the thigh, in general extending from the anterior superior iliac spine of the pelvic bone to the anteromedial surface of the upper tibia in the pes anserinus; primary function is to flex, abduct, and laterally rotate the thigh at the hip joint, and to flex the leg at the knee joint. Sartorius Muscle Inferior Deep Cervical Lymph Node A lymph node located in proximity to any of the scalene muscles. Scalene Lymph Node The skin which covers the top of the head and which is usually covered by hair. (NCI) Scalp Scaphoid Bone A nut-shaped bone of the wrist located in the radial site of the hand. It is one of the eight carpal bones. (NCI) Scaphoid Bone A condyloid synovial joint within the wrist articulating the scaphoid bone to the capitate bone. Scaphoid-Capitate Joint A condyloid synovial joint within the wrist articulating the scaphoid bone to the lunate bone. Scaphoid-Lunate Joint A condyloid synovial joint within the wrist articulating the scaphoid, lunate, and capitate bones. Scaphoid-Lunate-Capitate Joint A condyloid synovial joint within the wrist articulating the scaphoid bone to the radius bone. Scaphoid-Radius Joint A condyloid synovial joint within the wrist articulating the scaphoid bone to the trapezium bone. Scaphoid-Trapezium Joint A condyloid synovial joint within the wrist articulating the scaphoid bone to the trapezoid bone. Scaphoid-Trapezoid Joint Shoulder Blade A bone that articulates with the humerus and is part of the scapulohumeral joint. Scapula A nerve arising from the merge of the lumbar and sacral rami in the pelvis and dividing into the common peroneal and tibial nerves, and which innervates the muscles of the thigh. Sciatic Nerve The fibrous, outer tunic of the eyeball that is continuous with the cornea. Sclera The pouch that encloses the testicles. Scrotum Small glands located within the skin that are usually associated with the hair follicle. Sebaceous Gland 2ND DIAG SECOND DIAGONAL BRANCH ARTERY SEGMENT The second artery arising from the left anterior descending (LAD) artery that supplies the anterolateral wall, when counted from proximal to distal. Second Diagonal Branch Artery 2ND LPL SECOND LEFT POSTEROLATERAL BRANCH ARTERY SEGMENT In an individual with a left-dominant heart, this is the second branch that arises from the circumflex artery atrioventricular groove continuation when counted from proximal to distal. It supplies the posterolateral wall. Second Left Posterolateral Branch Artery 2ND OM SECOND OBTUSE MARGINAL BRANCH ARTERY SEGMENT The second artery arising from the left circumflex artery that supplies the lateral wall, when counted from proximal to distal. Second Obtuse Marginal Branch Artery 2ND RPL SECOND RIGHT POSTEROLATERAL ARTERY SEGMENT In an individual with a right-dominant heart, this is the second branch that arises from the right coronary artery distal to the right posterior descending artery, when counted from proximal to distal. Second Right Posterolateral Artery A muscle located in the posterior compartment of the thigh, in general extending from the ischial tuberosity to the medial tibial condyle; primary function is to extend the leg/hindlimb at the hip and to flex the leg/hindlimb at the knee. Semimembranosus Muscle Seminal Sacs A mammalian male reproductive accessory gland located adjacent to the urinary bladder and proximal to the prostate. Seminal Vesicle A muscle of the thigh, in general extends from the ishium to the medial tibia; primary function is the extension of the hip. Semitendinosus The region of the brain that consists of the precentral and postcentral gyri and is involved in somatosensory and motor functions. Sensorimotor Cortex A muscle of the thorax, in general extending from the first through the eighth or ninth rib to the scapula; primary function is anteversion of the arm, protraction of the scapula, and stabilization of the scapula against the thoracic wall. Serratus Anterior Muscle The front part of the leg from below the knee to the ankle. Shin A group of muscles in the shoulder, the supraspinatus, deltoid, trapezius, and serratus anterior muscles; primary function is to abduct the shoulder. Shoulder Abductor Muscles A group of muscles in the shoulder, the infraspinatus, supraspinatus, subscapularis, and teres minor muscles; primary function is to externally rotate the shoulder. Shoulder External Rotator Muscles The tendons that connect the muscles and bones that comprise the glenohumeral and acromioclavicular joints and enable abduction of the arm and stabilization of the shoulder. (NCI) Shoulder Joint Tendons Shoulder Joint A ball-and-socket joint at the upper end of the humerus, located at the junction of humerus and scapula. (NCI) Shoulder Joint Any of the muscles of the shoulder. Shoulder Muscle The soft tissue of the shoulder. Shoulder Soft Tissue Shoulder The region of the body between the neck and the upper arm. (NCI) Shoulder Pars Sigmoid Either of the two dural venous sinuses that receive blood from the transverse sinus and empty into the internal jugular vein. Sinus Sigmoideus Sinus A recess, cavity, or channel. (NCI) Sinus The integument that covers the area above the eyebrow. Skin Above the Eyebrow The skin surrounding the eye, including the skin of the eyelid. Skin Around the Eye The skin surrounding the mouth, including the skin of the lip. Skin Around the Mouth The integument that covers the area located medial to the orbital ridges and superior to the nose. Skin Between the Eyebrows An area of the integument that folds upon itself. Skinfold The integument that covers the underarm. Skin of the Axilla The integument that covers the back. Skin Of The Back The integument that covers the bending joint. Skin of the Bending Joint The integument that covers the buttock. Skin of the Buttock The integument that covers the chest. Skin of the Chest The integument that covers the chin. Skin Of The Chin The integument that covers the ear. Ear Skin The integument that covers the elbow joint. Elbow Skin The skin or integument that covers the face. Skin of the Face The integument that covers the finger. Hand Digit Skin The integument that covers the foot. Foot Skin The integument that covers the forearm. Skin of the Forearm The integument that covers the hand. Hand Skin The integument that covers the head, including the face and scalp. Head Skin The integument that covers the region of the back, lateral to the vertebral region and below the scapula. (NCI) Skin of the Infrascapular Region The integument that covers the inguinal region. Skin of the Inguinal Region The integument that covers the knee joint. Knee Skin The skin portion of the lip that contains hair. Skin of the Lip The integument that covers the lower limb. Skin of the Lower Extremity The integument that covers the neck. Neck Skin The integument that covers the outer corner of the eye were the upper and lower eyelids meet. Skin of the Outer Canthus of the Eye The integument that covers the palm. Skin of the Palm The integument that covers the sole. Skin of the Sole The integument that covers the thigh. Skin of the Thigh Skin of the Trunk The integument that covers the trunk of the body. Skin of the Trunk The integument that covers the upper limb. Skin of the Upper Extremity Skin of the Tear Trough The integument that covers the area directly below the eye. Skin Under the Eye Integument Skin An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages. (NCI) Skin Bone, Skull Cranium Skull Bone The bones that form the head, made up of the bones of the braincase and face. (NCI) Skull Base of the Skull The portion of the skull that forms the floor on which the brain lies; the internal surface of the cranial base has three large depressions that lie on different levels known as the anterior, middle, and posterior cranial fossae. Base of the Skull Small Bowel Mucosa The mucosal membranes that line the inner surface of the small intestine. Small Intestinal Mucosa The villous section of the intestine extending from the pylorus to the proximal large intestine. Small Intestine A superficial vein originating from the dorsal vein at the fifth toe and the dorsal venous arch of the foot; it extends up the back of the leg to empty into the popliteal vein at the knee joint. Short Saphenous Vein Muzzle The projection on the anterior portion of the face that includes the nares, mouth, and jaw. Snout The part of the roof of the mouth not supported by bone. Soft Palate Soft Tissue Refers to muscle, fat, fibrous tissue, blood vessels, organ parenchyma, or other supporting tissue of the body. Soft Tissue The undersurface of the foot. (NCI) Plantar Region A muscle in the crus, in general extending from the tibia and fibula to the calcaneous; primary function is plantarflexion of the foot. Soleus The butterfly-shaped bone located at the base of the skull that forms the orbit of the eye. Sphenoid Bone Either of the paired paranasal sinuses located in the anterior part of the body of the sphenoid bone, and communicating with the superior meatus of the nasal cavity on the same side. Sphenoid Sinus ACCESSORY NERVE CRANIAL ACCESSORY NERVE The eleventh cranial nerve. Accessory Nerve Vertebral Canal The space formed by the series of interconnected canals that run through the vertebral bodies of the spinal column, and which houses the spinal cord and meninges. Vertebral Canal The parenchyma of the spinal cord, which consists of a canal surrounded by a neuron containing gray matter centrally and white matter containing myelinated nerve tracts peripherally. Spinal Cord Parenchyma Medulla Spinalis The portion of the central nervous system that lies within the vertebral canal and from which the spinal nerves emerge. Spinal Cord The segment of the spinal cord between the end of the brain stem and the thoracic spinal cord. Cervical Spinal Cord A bony projection arising from the posterior vertebral arch that serves for the attachment of muscles and ligaments. Spinous Process An abdominal organ that is part of the hematopoietic and immune systems. It is composed of the white pulp and the red pulp and is surrounded by a capsule. Spleen Splenic Hilum The area of the spleen through which the vessels and nerves enter or exit the organ. (NCI) Splenic Hilum An artery arising from the celiac trunk with four main branches that supply the spleen, stomach and pancreas. Splenic Artery A lymph node located in the hilar region of the spleen. (NCI) Splenic Hilar Lymph Node Any lymph node located along the splenic artery that receives afferent drainage from the pancreas, spleen, and stomach, and which generally has their efferents join the celiac group of preaortic lymph nodes. Splenic Lymph Node A vein arising from the splenic trabecular vein in the hilum of the spleen that drains into the portal vein. Splenic Vein Sternal Manubrium The upper segment of the sternum, quadrangular in shape, as well as wider superiorly and narrower inferiorly. The sternal manubrium articulates with the clavicle and first two ribs. (NCI) Sternal Manubrium Any of the segments of the body of the sternum. Sternebra Sternoclavicular Joint The synovial juncture between the medial end of the clavicle and the anterior segment of the sternum. (NCI) Sternoclavicular Joint SCM Sternomastoid Muscle A muscle of the neck; in general extending from the manubrium and the clavicle to the mastoid process and the superior nuchal line. Primary function is to flex the neck, move the chin cranially, and assist in elevating the rib cage during inspiration. Sternocleidomastoid Muscle Sterna The long, flat bone or sternebrae connecting with the cartilage of some ribs. Sternum Gastric Wall The tissue that forms the wall of the stomach. Stomach Wall The portion of the gastrointestinal tract located between the esophagus and the proximal duodenum. Stomach A group of subcortical nuclei of the basal ganglia comprising the caudate and putamen dorsally, and the nucleus accumbens as well as the olfactory tubercle ventrally. Striatum Nuclei A synovial bursa in the shoulder that is located between the rotator cuff tendons and the acromion. Subacromial Bursa A mediastinal lymph node located between the aortic arch and the left pulmonary artery, in the aortopulmonary window lateral to the ligamentum arteriosum. Subaortic Lymph Node Subarachnoid Subarachnoid Area The space between the arachnoid membrane and the pia mater. Subarachnoid Space A lymph node located in the thoracic cavity between the lungs. It is bordered by the carina of the trachea, lower lobe bronchus on the left and the bronchus intermedius on the right. (NCI) Subcarinal Lymph Node One of the arteries of the thorax; in general it arises from the brachiocephalic artery or the aortic arch and branches into several arteries to supply blood to the head, neck, and arm/forelimb. Subclavian Artery The vein that drains the axillary vein and joins the internal jugular vein to form the brachiocephalic vein. It runs parallel to the subclavian artery. Subclavian Vein Subcutaneous Tissue Adipose and connective tissue located deep to the dermis. Subcutis The potential body space between the arachnoid membrane and the dura mater. Subdural Space Subglottis The area of the larynx below the vocal cords down to the trachea. (NCI) Subglottis A body region relating to the area under or adjacent to the tongue. Sublingual Region Gland, Salivary, Mandibular Submaxillary Gland The salivary gland located adjacent to the mandible. Submandibular Salivary Gland Lymph Node, Submandibular Lymph node(s) adjacent to the mandible. Submandibular Lymph Node The area of the body that is located between the body of the mandible and the hyoid bone; it is formed by the submental and submandibular triangles. Submandibular Region Suprahyoid Lymph Nodes The lymph nodes located between the anterior bellies of the digastric muscles. (NCI) Submental Lymph Node The area of the body that is located under the chin; it is bordered superiorly by the mylohyoid muscle, inferiorly by the platysma muscle, laterally by the anterior bellies of the digastric muscles, anteriorly by the mandible, and posteriorly by the hyoid bone. Submental Region The space between the neurosensory retina and retinal pigmented epithelial layer. Subretinal Space A muscle in the shoulder, in general extending from the subscapular fossa to the lesser tubercle of the humerus; primary function is to medially rotate the humerus. Subscapularis Muscle One of the four rotator cuff muscle tendons in the shoulder; it is located on the anterior surface of the lesser tuberosity of the humerus and inserts into the lesser tuberosity of the humerus. Subscapularis Tendon The portion of the midbrain composed of two parts, the pars compacta and pars reticulata. Substantia Nigra Talocalcaneal Joint The plane synovial joint between the talus and calcaneus bones of the foot. Subtalar Joint Sweat Gland The small coiled tubular glands in the skin that produce and secrete sweat. Sweat Gland The portion of the femoral artery distal to the branching of the deep femoral artery that runs close to the skin. Superficial Femoral Artery A lymph node located in a superficial part of the body. Superficial Lymph Node Any of the veins that drain the subcutaneous tissue layers. Superficial Vein A ridge on the frontal lobe of the brain located above the superior frontal sulcus. Superior Frontal Gyrus Lymph nodes in this group include pretracheal, paratracheal, and esophageal groove lymph nodes, extending from the level of the suprasternal notch cephalad and up to the innominate artery caudad. These nodes are at greatest risk of involvement by thyroid cancer and cancer of the esophagus. (AJCC 8th ed.) Superior Mediastinal Lymph Node Group (Level VII) The portion of the pubic ramus that lies between the body of the ilium and the inferior pubic ramus. Superior Pubic Ramus An intracranial venous sinus that lies in a superior and midline location above the interhemispheric fissure along the superior border of the falx cerebri of the brain. The sinus receives blood from the cerebral veins and drains posteriorly into the lateral sinuses of the brain, which in turn drain into the internal jugular veins. Superior Sagittal Sinus A ridge on the outer surface of the temporal lobe between the horizontal portion of the fissure of Sylvius and the superior temporal sulcus. (NCI) Superior Temporal Gyrus Anterior Vena Cava Cranial Vena Cava The large vein that terminates in the right atrium and transports deoxygenated blood from the head, neck, arms, and chest to the heart. Superior Vena Cava A muscle of the forearm, in general extending from the posterior proximal shaft of the ulna and the lateral epicondyle of the humerus to the proximal third of the radius on the anterolateral and posterior surface; primary function is to supinate the forearm. Supinator Muscle A depression found at the base of the neck that is bounded thusly: superiorly by the posterior belly of the omohyoid muscle; inferiorly by the clavicle; and medially by the sternocleidomastoid muscle. Supraclavicular Fossa Supraclavicular Lymph Node A lymph node which is located above the clavicle. (NCI) Supraclavicular Lymph Node The upper part of the larynx, including the epiglottis; the area above the vocal cords. Supraglottis A ridge on the anterior part of the inferior parietal lobe of the brain. Supramarginal Gyrus The superior portion of the occipital bone on the dorsal side of the foramen magnum; it is present during fetal development and later fuses with the occipital bone. Supraoccipital Bone The lowest central region of the abdomen, below the umbilical region and between the two iliac regions. (NCI) Hypogastric Region The portion of the abdominal aorta cranial to the renal arteries. Suprarenal Aorta One of four muscles surrounding the glenohumeral joint, in general extending from the supraspinous fossa of the scapula to the greater tubercle of the humerus; primary function is to abduct the arm and provide muscular support to the shoulder. Supraspinatus Muscle One of the four rotator cuff muscle tendons in the shoulder; it lies in the subacromial space and inserts into the greater tuberosity of the humerus. Supraspinatus Tendon The part of the brain above the tentorium cerebellum. (NCI) Supratentorial Brain A minor branch of the sciatic nerve that includes the lateral and caudal sural nerves, which innervates the skin of the crus, tarsus and metatarsus. Sural Nerve Rigid, fibrous joints between the ossified bones of the skull. Cranial Suture A mass containing the cell bodies of sympathetic nerves. Sympathetic ganglia exist as paravertebral ganglia (located bilaterally adjacent to the spinal cord) or prevertebral ganglia (located close to the target organ). Sympathetic Ganglion Synovia The fluid within a joint capsule. Synovial Fluid Synovial Membrane Synovial Stratum The connective tissue and synoviocytes that line the inner surface of the joint capsule. Synovial Membrane T1 Nerve Root Dermatome The area of the skin innervated by the first thoracic spinal nerve, covering the medial aspect of the upper arm near the axilla (armpit). T1 Dermatome T1 Vertebra The first thoracic vertebra counting from the top down. (NCI) T1 Vertebra T10 Nerve Root Dermatome The area of the skin innervated by the tenth thoracic spinal nerve, corresponding approximately to the level of the umbilicus (navel). T10 Dermatome T10 Vertebra The tenth thoracic vertebra counting from the top down. (NCI) T10 Vertebra T11 Nerve Root Dermatome The area of the skin innervated by the eleventh thoracic spinal nerve, covering a horizontal segment of the lower abdomen, situated just below the T10 dermatome (which is at the level of the umbilicus), and extends around the body towards the back. T11 Dermatome T11 Vertebra The eleventh thoracic vertebra counting from the top down. (NCI) T11 Vertebra T12 Nerve Root Dermatome The area of the skin innervated by the twelfth thoracic spinal nerve, covering the lower abdomen and upper aspect of the groin area. T12 Dermatome T12 Vertebra The twelfth thoracic vertebra counting from the top down. (NCI) T12 Vertebra T2 Nerve Root Dermatome The area of the skin innervated by the second thoracic spinal nerve, covering the upper chest and extending to the upper medial aspect of the arm. T2 Dermatome T2 Vertebra The second thoracic vertebra counting from the top down. (NCI) T2 Vertebra T3 Nerve Root Dermatome The area of the skin innervated by the third thoracic spinal nerve, covering the upper part of the chest, just below the clavicle, and extending around the upper portion of the back. T3 Dermatome T3 Vertebra The third thoracic vertebra counting from the top down. (NCI) T3 Vertebra T4 Nerve Root Dermatome The area of the skin innervated by the fourth thoracic spinal nerve, located at the level of the nipples, extending around the chest and upper back. T4 Dermatome T4 Vertebra The fourth thoracic vertebra counting from the top down. (NCI) T4 Vertebra T5 Nerve Root Dermatome The area of the skin innervated by the fifth thoracic spinal nerve, located just below the T4 dermatome, and covers a horizontal band between the nipple line and the lower sternum. T5 Dermatome T5 Vertebra The fifth thoracic vertebra counting from the top down. (NCI) T5 Vertebra T6 Nerve Root Dermatome The area of the skin innervated by the sixth thoracic spinal nerve, located at the level of the xiphoid process of the sternum, wrapping around the mid-to-lower chest and back. T6 Dermatome T6 Vertebra The sixth thoracic vertebra counting from the top down. (NCI) T6 Vertebra T7 Nerve Root Dermatome The area of the skin innervated by the seventh thoracic spinal nerve and covers a horizontal band just below the T6 dermatome, extending around the lower part of the chest and the upper abdomen. T7 Dermatome T7 Vertebra The seventh thoracic vertebra counting from the top down. (NCI) T7 Vertebra T8 Nerve Root Dermatome The area of the skin innervated by the eighth thoracic spinal nerve, located below the T7 dermatome, wrapping around midway between the xiphoid process and the umbilicus, covering part of the upper abdomen. T8 Dermatome T8 Vertebra The eighth thoracic vertebra counting from the top down. (NCI) T8 Vertebra T9 Nerve Root Dermatome The area of the skin innervated by the ninth thoracic spinal nerve, covering a horizontal segment just above the umbilicus, extending around the middle section of the abdomen and back. T9 Dermatome T9 Vertebra The ninth thoracic vertebra counting from the top down. (NCI) T9 Vertebra A flexible appendage caudal to the sacrum. Tail Talus The bone of the foot that connects with the tibia and fibula to form the ankle joint. (NCI) Talus A joint formed by the union of tarsal bones. Tarsal Joint Bone, Tarsal Any of the short bones between the tibiotarsal joint and the tarsometatarsal joint. Tarsal Bone The dorsal part or roof plate of the midbrain, which consists of the pretectal area and the paired superior and inferior colliculi. Tectum Mesencephali The flat area on either side of the head that is located posterior to the eye and forehead, anterior to the ear, and superior to the cheekbone. Temple A terminal branch of the external carotid artery that branches into the anterior and posterior temporal arteries. (NCI) Temporal Artery Temporal Bone A large irregular bone situated at the base and side of the skull, connected with the mandible via the temporomandibular joint. The temporal bone consists of the squamous, tympanic and petrous parts. The petrous portion of the temporal bone contains the vestibulocochlear organ of the inner ear. (NCI) Temporal Bone The outermost layer of the temporal lobe of the brain, made up of gray matter. Temporal Lobe Cortex The second largest of the four cerebral lobes, the temporal lobe is approximately twenty two percent of the total neocortical volume. The temporal lobe can be divided into two main sections: first, the neocortex, comprising its lateral and inferolateral surfaces, and its standard cerebral cortex; and, second, the mesial temporal lobe, which is sometimes referred to as the limbic lobe, and includes the hippocampus, the amygdala, and the parahippocampal gyrus. Grossly, the lobe extends superiorly to the Sylvian fissure, and posteriorly to an imaginary line, the lateral parietotemporal line, which separates the temporal lobe from the inferior parietal lobule superiorly and the occipital lobe inferiorly. The middle cranial fossa forms its anterior and inferior boundaries. Temporal Lobe Jaw Joint TMJ The joint between the head of the lower mandible and the temporal bone. (NCI) Jaw Joint A band of fibrous connective tissue that joins bone to muscle. (NCI) Tendon Tensor Fasciae Latae Muscle TFL Muscle A muscle of the gluteal region, in general extending from the iliac crest to the iliotibial tract of the fascia lata; primary function is to stabilize the knee in extension and in hip flexion. Tensor Fasciae Lata A laminar extension of the dura mater that lies between, and separates, the cerebrum and the cerebellum. (NCI) Tentorium Cerebelli One of the four rotator cuff muscle tendons in the shoulder; it is located inferior to the infraspinatus tendon, deep to the deltoid muscle, and inserts into the greater tuberosity of the humerus. Teres Minor Tendon Testicle The male gonad. Testis The portion of the diencephalon forming most of each lateral wall of the third ventricle. Thalamus Thigh A part of the lower limb, located between hip and knee. (NCI) Thigh 3RD DIAG THIRD DIAGONAL BRANCH ARTERY SEGMENT The third artery arising from the left anterior descending (LAD) artery that supplies the anterolateral wall, when counted from proximal to distal. Third Diagonal Branch Artery 3RD OM THIRD OBTUSE MARGINAL BRANCH ARTERY SEGMENT The third artery arising from the left circumflex artery that supplies the lateral wall, when counted from proximal to distal. Third Obtuse Marginal Branch Artery 3RD LPL THIRD POSTEROLATERAL DESCENDING ARTERY SEGMENT In an individual with a left-dominant heart, this is the third branch that arises from the circumflex artery atrioventricular groove continuation when counted from proximal to distal. It supplies the posterolateral wall. Third Posterolateral Descending Artery 3RD RPL THIRD RIGHT POSTEROLATERAL ARTERY SEGMENT In an individual with a right-dominant heart, this is the third branch that arises from the right coronary artery distal to the right posterior descending artery, when counted from proximal to distal. Third Right Posterolateral Artery The section of the aorta between the lower border of the fourth dorsal vertebrae and the aortic opening in the diaphragm. (NCI) Thoracic Aorta An artery that branches from the axillary artery or one of its branches, and that supplies the muscles and organs of the thorax. Thoracic Artery The cavity enclosed by the ribs between the diaphragm and the neck. Thoracic Cavity Lymph node located in the thoracic cavity. (NCI) Thoracic Lymph Node The soft tissue of the thorax. Thoracic Soft Tissue The vertebrae of the thoracic spine, numbered one through twelve in humans. Thoracic Spine Thoracic Vertebra Any of the vertebrae situated between the cervical and lumbar vertebrae. Thoracic Vertebra Thorax The division of the body lying between the neck and the abdomen. (NCI) Thorax Throat The narrow passage from the mouth to the cavity at the back of the mouth. (NCI) Throat Thymus Gland A primary lymphoid organ generally located in the mediastinum near the thoracic inlet and/or along lateral aspects of the neck. Thymus Gland The narrow, central portion of the thyroid gland that crosses the trachea anteriorly and connects the two lobes of the gland. (NCI) Thyroid Gland Isthmus Endocrine gland(s) adjacent to the trachea in mammals that produce thyroxine and other hormones. Thyroid Gland Left Thyroid Gland Lobe The cone-like lobe of the thyroid gland that is located in the left side of the trachea. (NCI) Left Thyroid Gland Lobe Right Thyroid Gland Lobe The cone-like lobe of the thyroid gland that is located in the right side of the trachea. (NCI) Right Thyroid Gland Lobe The triangular prismoid, elongated bony body of the tibia. Tibial Shaft The long bone that is medial to the fibula. Tibia Tibial Epiphyseal Plate Tibial Physis Tibial Plateau Growth Plate A layer of cartilaginous tissue located in the tibia of children and adolescents that separates the epiphysis from the metaphysis and is the site of longitudinal bone growth until skeletal maturity. Tibial Growth Plate A branch of the sciatic nerve that divides into the medial and lateral plantar nerves, and which innervates the muscles of the crus and the skin of the tarsus. Tibial Nerve The blood vessels segment that includes the crural artery and the tibial artery. Tibialcrural Artery A muscle that originates from the lateral condyle of tibia, spans the upper two-thirds of the lateral surface of the tibia, and is attached to the first cuneiform and metatarsal bones of the foot. It is a dorsiflexor of the ankle and invertor of the foot. Tibialis Anterior Muscle A muscle in the lower leg, in general extending from the inner posterior borders of the tibia and fibula to the posterior tibial tendon at the posterior aspect of the medial malleolus; primary function is to stabilize the ankle, as well as invert and plantar flex the foot at the ankle. Posterior Tibialis Muscle An arterial trunk that contains parts of the posterior tibial artery and fibular artery. Tibioperoneal Arterial Trunk The joint connecting the lower part of the tibia with the upper part of the tarsus bones, specifically articulating with the talus bone. Tibiotarsal Joint Toe One of the terminal digits of the foot. (NCI) Toe Toenail A thin, horny translucent plate covering the end of each toe. (NCI) Toenail The muscular organ in the mouth used in taste perception and food ingestion. Tongue A secondary lymphoid tissue in the mucosa of the pharynx. Tonsil Tooth Canal The anatomic space in the root of a tooth that contains nerves, blood vessels, and connective tissue. (NCI) Tooth Canal A hard calcified structure in the jaw; primarily used for eating. Tooth Windpipe The fibrocartilaginous tube extending from the larynx to the bronchi. Trachea An anatomical structure comprised of trachea, bronchi, and bronchioles that terminate with the alveolar ducts, sacs, and alveoli. (NCI) Tracheobronchial Tree Mid-Tarsal Joint A combination of syndesmosis and synovial joints formed by the articulation of the talus with the navicular and the calcaneus with the cuboid. Transverse Tarsal Joint Trapezium A carpal bone on the thumb side of the hand that articulates with the 1st and 2nd metacarpals. (NCI) Trapezial Bone A condyloid synovial joint within the wrist articulating the trapezium bone to the trapezoid bone. Trapezium-Trapezoid Joint Trapezius Muscle One of a pair of flat, large, triangular muscles that extend from the external occipital protuberance and the medial third of the superior nuchal line of the occipital bone to the middle of the back. The trapezius muscle is involved in moving the shoulder and arm. (NCI) Trapezius Muscle Trapezoid Bone A carpal bone located between the trapezium and capitate bones. (NCI) Trapezoid Bone A condyloid synovial joint within the wrist articulating the trapezoid bone to the capitate bone. Trapezoid-Capitate Joint Triquetral Bone A carpal bone located between the lunate and pisiform bones. (NCI) Triangular Bone Triquetral-Hamate Joint Triquetrum-Hamate Joint The point of articulation in the wrist between the hamate and the triquetral bones. Triangular-Hamate Joint Triquetral-Lunate Joint Triquetrum-Lunate Joint The point of articulation in the wrist between the lunate and the triquetral bones. Lunotriquetral Joint A muscle of the proximal arm/forelimb, in general extending from the scapula and humerus to the olecranon of the ulna; primary function is extension of humeroulnar joint. Triceps Brachii A fibrous membrane that attaches to, and provides support for, the tricuspid valve leaflets. Tricuspid Valve Annulus Right Atrioventricular Valve Tricuspid Valve A cardiac valve located between the right atrium and ventricle. Tricuspid Valve The cusp of the tricuspid valve that is located between the atrioventricular orifice and the conus arteriosus. Anterior Cusp of the Tricuspid Valve The portion of the tricuspid valve annulus that attaches to both the posterior and lateral tricuspid valve leaflets. Posterior Annulus of the Tricuspid Valve The cusp of the tricuspid valve that is located posterior and on the margin of the right ventricle. Posterior Cusp of the Tricuspid Valve The cusp of the tricuspid valve that is attached to the right and left fibrous trigones and the atrial and ventricular septa. Septal Cusp of the Tricuspid Valve Fifth Cranial Nerve A cranial nerve extending from the pons, which innervates the skin, mucous membranes, and masticatory muscles of the head. Trigeminal Nerve Trochanter A bony protrusion on the femoral bone to which muscles are attached. (NCI) Trochanter A synovial bursa on the outer side of the hip that is located between the greater trochanter bone, the tendon of the gluteus medius, and the iliotibial tract. Trochanteric Bursa Trochlear Nerve The cranial nerve that controls the superior oblique muscle of the eye. (NCI) Trochlear Nerve Torso The body excluding the head, neck and appendages. Trunk Tunica Intima The inner most layer of the blood vessel wall. The consistency of the intima will vary depending on the type of blood vessel, but will always have an endothelial layer with a basal lamina. It may contain collagen and elastic fibers. (NCI) Tunica Intima Tympanic Membrane A thin membrane that separates the external auditory canal from the middle ear. Tympanic Membrane The prismatic, elongated bony body of the ulna. Ulnar Shaft The bone that contains the olecranon process, lies between the radiohumeral joint and the carpus, and is adjacent to the radius. Ulna An artery of the forearm; in general it arises from the brachial artery just below the elbow and forms numerous branches supplying the forearm, wrist and hand. Ulnar Artery A nerve arising from spinal nerves C8, T1 and T2, which innervates the flexor muscles of the arm/forelimb and skin of the arm/forelimb and lateral manus. Ulnar Nerve Either of two arteries located in the umbilical cord. Umbilical Artery Extraembryonic structure that connects the fetus to the placenta. Umbilical Cord The vein located in the umbilical cord. Umbilical Vein Navel The depression or scar on the abdomen that marks the former site of attachment of the umbilical cord. (NCI) Umbilicus Uncinate Process of Pancreas A portion of the pancreas that extends behind the superior mesenteric artery and superior mesenteric vein. (NCI) Uncinate Process of Pancreas A lymph node located in the upper region of the neck. (NCI) Upper Cervical Lymph Node The soft tissue of the upper limb(s). Upper Limb Soft Tissue The sinuses and those parts of the respiratory system above the trachea. It includes the nares, nasopharynx, oropharynx, larynx, vocal cords, glottis and upper trachea. Upper Respiratory System Upper Urinary Tract The division of the urinary tract comprising the kidney and the ureters. Upper Urinary System A cord of fibrous tissue that extends from the urinary bladder to the umbilicus; the urachus is a remnant of the fetal urinary canal. Urachus The tube that extends from each kidney to the urinary bladder. Ureter The opening of the ureter in the bladder that is situated at the lateral angle of the trigone. Ureteric Orifice The tube that extends from the urinary bladder to the urethral opening. Urethra Anterior Portion of the Urethra The portion of the urethra that extends from the meatus to the membranous urethra. (NCI) Anterior Portion of the Urethra Penile Portion of the Urethra The portion of the urethra that spans the corpus spongiosum. (NCI) Penile Portion of the Urethra Posterior Portion of the Urethra The portion of the urethra that is located on the posterior aspect of the urogenital diaphragm. (NCI) Posterior Portion of the Urethra Prostatic Urethra That part of the male urethra that passes through the prostate gland. (NCI) Prostatic Urethra One or both of the muscles that surround the urethra and contract to control the flow of urine, either involuntarily (the internal sphincter) or voluntarily (the external sphincter). Urethral Sphincter Urinary System The organs involved in the creation and excretion of urine. (NCI) Urinary System An artery that arises most often as a branch of the anterior division of the internal iliac artery; it continues medially in the pelvis within the base of the broad ligament, to the exterior surface of the uterus where it branches into the descending, transverse, and ascending divisions, which further branch into the following: the helicine branches that supply the uterus; the vaginal branch, which anastomoses with the vaginal artery to supply the vagina; the ovarian branch, which anastomoses with ovarian artery to supply the ovaries; and the tubal branch that supplies the fallopian tubes. Uterine Artery The portion of the uterus that connects the oviduct to the corpus uteri. Uterine Horn Any of the ligaments attached to the uterus, which may include the anterior, posterior, lateral, sacro-uterine, and round ligaments. Uterine Ligament Uterus Wall The tissue that forms the wall of the uterus. Wall of Body of Uterus Womb A hollow muscular organ within which the fertilized egg implants and the embryo/fetus develops during pregnancy. Uterus Uvea The pigmented layer of the eyeball between the tough, white outer coat of the eye and the retina. (NCI) Uvea Vagina The female genital canal, extending from the uterus to the vulva. (NCI) Vagina The tissue layers that enclose the vaginal canal. (NCI) Vaginal Wall Tenth Cranial Nerve A cranial nerve arising from the medulla oblongata, which provides efferent parasympathetic innervation to tissues and viscera in the neck, thorax and abdomen; it also includes somatic and visceral afferent nerve fibers. Vagus Nerve Ductus Deferens A duct carrying spermatozoa from the epididymides to the urethra. Vas Deferens A muscle in the quadriceps femoris muscle group between the vastus lateralis and vastus medialis deep to the rectus femoris; primary function is the extension of the femorotibial joint. Vastus Intermedius Muscle A muscle in the quadriceps femoris muscle group lateral to the vastus intermedius; primary function is the extension of the femorotibial joint. Vastus Lateralis A muscle in the quadriceps femoris muscle group medial to the vastus intermedius; primary function is the extension of the femorotibial joint. Vastus Medialis Muscle Vein A blood vessel that carries blood towards the heart. Vein The two major veins (caudal or cranial) that carry deoxygenated blood from the body and drain into the right atrium of the heart. Vena Cava An endothelium-lined passageway or channel that drains venous blood. Venous Sinus Vertebra Vertebral Bone Any of the small bones that comprise the vertebral column. Vertebral Bone The first branch of the subclavian artery that ascends both sides of the neck and merges at the middle line to form the basilar artery at the level of the pons. Vertebral Artery Vertebral Column The series of vertebrae and other tissues extending from the skull to the last tailbone. Vertebral Column Ureterovesical Junction UVJ VUJ The area where the ureter joins to the urinary bladder. Ureterovesical Junction Eighth Cranial Nerve A cranial nerve extending from the inner ear and entering the cranial cavity through the internal auditory foramen where it joins the brainstem. Vestibulocochlear Nerve Vocal Cord A pair of small bands of muscle that stretch from the thyroid cartilage in front to the arytenoid cartilage in back of the larynx. The vocal cords help prevent food entering the lungs and produce sound through vibration. (NCI) Vocal Cord Vomer A thin, paired or unpaired, trapezoidal bone of the skull located in the floor of the nasal cavity. The vomer forms the posterior and inferior parts of the nasal septum. (NCI) Vomer The external, visible part of the female genitalia surrounding the urethral and vaginal opening(s). Vulva The body region comprising the vulva and vagina. Vulvovaginal Region Waist The abdominal circumference at the navel. (NCI) Waist The ring of lymphoid tissue located in the pharynx, consisting of the pharyngeal, tubal, palatine, and lingual tonsils. (NCI) Waldeyer Ring An area of low density in the femoral neck, as seen by radiography, which is bounded by the principle compressive, secondary compressive and primary tensile trabeculae. Ward's Triangle Vibrissa Vibrissae Whisker Stiff sensory hairs that project outward from the snout. Whiskers A group of muscles in the upper extremity, the extensor carpi radialis longus, extensor carpi radialis brevis, extensor digitorum, extensor digiti minimi, extensor carpi ulnaris, extensor indicis, extensor pollicis longus, extensor pollicis brevis, and abductor pollicis longus muscles; primary function is extension and abduction of the wrist and extension of the fingers. Wrist Joint Extensor Muscles The tendons located along the back part of the forearm that cross to the thumb side of the wrist and connect muscles of the forearm to the base of hand bones, enabling extension of the wrist. (NCI) Wrist Joint Extensor Tendons A group of muscles in the upper extremity, the flexor carpi radialis, palmaris longus, flexor carpi ulnaris, flexor digitorum superficialis, flexor digitorum profundus, and flexor pollicis longus muscles; primary function is flexion, adduction, and abduction of the wrist, and flexion and adduction of the fingers. Wrist Joint Flexor Muscles The tendons located along the inside of the forearm that cross at the wrist and connect muscles of the forearm to wrist and hand bones, enabling flexion of the wrist. (NCI) Wrist Joint Flexor Tendons Radiocarpal Joint Wrist A joint between the distal end of the radius and the proximal row of carpal bones. (NCI) Wrist Joint Xiphoid Process The cartilage just below the sternal body. (NCI) Xiphoid Process Cheekbone Malar Bone Zygomatic Buttress A bone of the eye socket that articulates with the maxilla, the temporal bone, the sphenoid bone and the frontal bone, to form the prominence of the cheek. Zygomatic Bone LOC Anatomical Location CDISC SDTM Anatomical Location Terminology A terminology codelist to describe the anti-viral outcome of treatment. RVR A finding of aviremia at a specified timepoint, early during the treatment period. Rapid Virologic Response SVR A finding of aviremia at a predetermined time point after the end of planned or actual treatment. Sustained Virologic Response VBT The subject becomes viremic during the treatment period after a period of treatment-induced aviremia or has an increase in viral load from nadir above a predetermined threshold during the treatment period. Viral Breakthrough A recurrence of the same virus after a finding of aviremia at the end of planned or actual treatment. Viral Relapse A finding of aviremia at the end of the planned or actual end of treatment period. Virologic End Of Treatment Response A finding of viremia at or after end of planned or actual treatment, excluding treatment discontinuations for non-virologic reasons. Virologic Failure The subject remains viremic during the treatment period. Virologic Non-Response The subject remains viremic during the treatment period and the decrease in viral load from baseline at a specified timepoint is below or equal to a predetermined threshold. Virologic Null-Response The subject remains viremic during the treatment period and the decrease in viral load from baseline at a specified timepoint is above a predetermined threshold. Virologic Partial Response AVOUTTRT Anti-Viral Outcome of Treatment CDISC SDTM Anti-Viral Outcome of Treatment Terminology Apgar Score V1 test code. APGR01-Appearance/Color Apgar Score V1 - Appearance, skin color, or color score. Apgar Score Version 1 - Appearance or Color APGR01-Pulse/Heart Rate Apgar Score V1 - Pulse or heart rate score. Apgar Score Version 1 - Pulse or Heart Rate APGR01-Grimace/Reflex Irritability Apgar Score V1 - Grimace or reflex irritability score. Apgar Score Version 1 - Grimace or Reflex Irritability APGR01-Activity/Muscle Tone Apgar Score V1 - Activity or muscle tone score. Apgar Score Version 1 - Activity or Muscle Tone APGR01-Respiration/Respiratory Effort Apgar Score V1 - Respiration or respiratory effort score. Apgar Score Version 1 - Respiration or Respiratory Effort APGR01-Total Apgar Score Apgar Score V1 - Total Apgar score. Apgar Score Version 1 - Total Apgar Score APGR01TC Apgar Score V1 Clinical Classification Test Code CDISC Clinical Classification APGAR Score Version 1 Test Code Terminology Apgar Score V1 test name. APGR01-Activity/Muscle Tone Apgar Score V1 - Activity or muscle tone score. Apgar Score Version 1 - Activity or Muscle Tone APGR01-Appearance/Color Apgar Score V1 - Appearance, skin color, or color score. Apgar Score Version 1 - Appearance or Color APGR01-Grimace/Reflex Irritability Apgar Score V1 - Grimace or reflex irritability score. Apgar Score Version 1 - Grimace or Reflex Irritability APGR01-Pulse/Heart Rate Apgar Score V1 - Pulse or heart rate score. Apgar Score Version 1 - Pulse or Heart Rate APGR01-Respiration/Respiratory Effort Apgar Score V1 - Respiration or respiratory effort score. Apgar Score Version 1 - Respiration or Respiratory Effort APGR01-Total Apgar Score Apgar Score V1 - Total Apgar score. Apgar Score Version 1 - Total Apgar Score APGR01TN Apgar Score V1 Clinical Classification Test Name CDISC Clinical Classification APGAR Score Version 1 Test Name Terminology Arizona Sexual Experiences Scale - Female test code. ASEX01-Sex Drive Arizona Sexual Experiences Scale Female - How strong is your sex drive? ASEX-Female Version - Sex Drive ASEX01-Sexually Aroused Arizona Sexual Experiences Scale Female - How easily are you sexually aroused (turned on)? ASEX-Female Version - Sexually Aroused ASEX01-Vagina Become Moist Arizona Sexual Experiences Scale Female - How easily does your vagina become moist or wet during sex? ASEX-Female Version - Vagina Become Moist ASEX01-Reach Orgasm Arizona Sexual Experiences Scale Female - How easily can you reach an orgasm? ASEX-Female Version - Reach Orgasm ASEX01-Orgasms Satisfying Arizona Sexual Experiences Scale Female - Are your orgasms satisfying? ASEX-Female Version - Orgasms Satisfying ASEX01-Comments Arizona Sexual Experiences Scale Female - Comments. ASEX-Female Version - Comments ASEX01TC Arizona Sexual Experiences Scale - Female Questionnaire Test Code CDISC Questionnaire ASEX-Female Version Test Code Terminology Arizona Sexual Experiences Scale - Female test name. ASEX01-Comments Arizona Sexual Experiences Scale Female - Comments. ASEX-Female Version - Comments ASEX01-Orgasms Satisfying Arizona Sexual Experiences Scale Female - Are your orgasms satisfying? ASEX-Female Version - Orgasms Satisfying ASEX01-Reach Orgasm Arizona Sexual Experiences Scale Female - How easily can you reach an orgasm? ASEX-Female Version - Reach Orgasm ASEX01-Sex Drive Arizona Sexual Experiences Scale Female - How strong is your sex drive? ASEX-Female Version - Sex Drive ASEX01-Sexually Aroused Arizona Sexual Experiences Scale Female - How easily are you sexually aroused (turned on)? ASEX-Female Version - Sexually Aroused ASEX01-Vagina Become Moist Arizona Sexual Experiences Scale Female - How easily does your vagina become moist or wet during sex? ASEX-Female Version - Vagina Become Moist ASEX01TN Arizona Sexual Experiences Scale - Female Questionnaire Test Name CDISC Questionnaire ASEX-Female Version Test Name Terminology Arizona Sexual Experiences Scale - Male test code. ASEX02-Sex Drive Arizona Sexual Experiences Scale Male - How strong is your sex drive? ASEX-Male Version - Sex Drive ASEX02-Sexually Aroused Arizona Sexual Experiences Scale Male - How easily are you sexually aroused (turned on)? ASEX-Male Version - Sexually Aroused ASEX02-Keep Erection Arizona Sexual Experiences Scale Male - Can you easily get and keep an erection? ASEX-Male Version - Keep Erection ASEX02-Reach Orgasm Arizona Sexual Experiences Scale Male - How easily can you reach an orgasm? ASEX-Male Version - Reach Orgasm ASEX02-Orgasms Satisfying Arizona Sexual Experiences Scale Male - Are your orgasms satisfying? ASEX-Male Version - Orgasms Satisfying ASEX02-Comments Arizona Sexual Experiences Scale Male - Comments. ASEX-Male Version - Comments ASEX02TC Arizona Sexual Experiences Scale - Male Questionnaire Test Code CDISC Questionnaire ASEX-Male Version Test Code Terminology Arizona Sexual Experiences Scale - Male test name. ASEX02-Comments Arizona Sexual Experiences Scale Male - Comments. ASEX-Male Version - Comments ASEX02-Keep Erection Arizona Sexual Experiences Scale Male - Can you easily get and keep an erection? ASEX-Male Version - Keep Erection ASEX02-Orgasms Satisfying Arizona Sexual Experiences Scale Male - Are your orgasms satisfying? ASEX-Male Version - Orgasms Satisfying ASEX02-Reach Orgasm Arizona Sexual Experiences Scale Male - How easily can you reach an orgasm? ASEX-Male Version - Reach Orgasm ASEX02-Sex Drive Arizona Sexual Experiences Scale Male - How strong is your sex drive? ASEX-Male Version - Sex Drive ASEX02-Sexually Aroused Arizona Sexual Experiences Scale Male - How easily are you sexually aroused (turned on)? ASEX-Male Version - Sexually Aroused ASEX02TN Arizona Sexual Experiences Scale - Male Questionnaire Test Name CDISC Questionnaire ASEX-Male Version Test Name Terminology Terminology relevant to the reason for why an arm and/or an actual arm is null. The subject, who met eligibility criteria, was assigned to an arm but was not treated. (NCI) Subject Assigned to Arm But Not Treated The subject, who met eligibility criteria, was not assigned to an arm and was not treated. (NCI) Subject Not Assigned to Arm Failure to Meet Inclusion/Exclusion Criteria The potential subject who does not meet eligibility (inclusion/exclusion) criteria during the screening period. Trial Screen Failure An indication that the subject did not complete the screening process. Screening Not Completed The subject, who met eligibility criteria, was assigned to an arm but received treatment not associated with any of the planned arms. Subject Received Unplanned Treatment ARMNULRS Arm Null Reason CDISC SDTM Arm Null Reason Response Terminology ASSIGN Cardiovascular Disease 10-Year Risk Score test code. ASSG01-ASSIGN Score ASSIGN Cardiovascular Disease 10-Year Risk Score - ASSIGN score. ASSIGN Score - Risk Score ASSG01TC ASSIGN Cardiovascular Disease 10-Year Risk Score Clinical Classification Test Code CDISC Clinical Classification ASSIGN Score Test Code Terminology ASSIGN Cardiovascular Disease 10-Year Risk Score test name. ASSG01-ASSIGN Score ASSIGN Cardiovascular Disease 10-Year Risk Score - ASSIGN score. ASSIGN Score - Risk Score ASSG01TN ASSIGN Cardiovascular Disease 10-Year Risk Score Clinical Classification Test Name CDISC Clinical Classification ASSIGN Score Test Name Terminology Asthma Daytime Symptom Diary v1.0 test code. ADSD01-Rate Breathing at Its Worst Asthma Daytime Symptom Diary v1.0 - Please rate your difficulty breathing at its worst since you got up this morning. ADSD Version 1.0 - Rate Breathing at Its Worst ADSD01-Rate Wheezing at Its Worst Asthma Daytime Symptom Diary v1.0 - Please rate your wheezing at its worst since you got up this morning. ADSD Version 1.0 - Rate Wheezing at Its Worst ADSD01-Rate Shortness of Breath at Worst Asthma Daytime Symptom Diary v1.0 - Please rate your shortness of breath at its worst since you got up this morning. ADSD Version 1.0 - Rate Shortness of Breath at Worst ADSD01-Rate Chest Tightness at Its Worst Asthma Daytime Symptom Diary v1.0 - Please rate your chest tightness at its worst since you got up this morning. ADSD Version 1.0 - Rate Chest Tightness at Its Worst ADSD01-Rate Chest Pain at Its Worst Asthma Daytime Symptom Diary v1.0 - Please rate your chest pain at its worst since you got up this morning. ADSD Version 1.0 - Rate Chest Pain at Its Worst ADSD01-Rate Cough at Its Worst Asthma Daytime Symptom Diary v1.0 - Please rate your cough at its worst since you got up this morning. ADSD Version 1.0 - Rate Cough at Its Worst ADSD01-Total Score Asthma Daytime Symptom Diary v1.0 - Total score. ADSD Version 1.0 - Total Score ADSD01TC Asthma Daytime Symptom Diary v1.0 Questionnaire Test Code CDISC Questionnaire ADSD Version 1.0 Test Code Terminology Asthma Daytime Symptom Diary v1.0 test name. ADSD01-Rate Breathing at Its Worst Asthma Daytime Symptom Diary v1.0 - Please rate your difficulty breathing at its worst since you got up this morning. ADSD Version 1.0 - Rate Breathing at Its Worst ADSD01-Rate Chest Pain at Its Worst Asthma Daytime Symptom Diary v1.0 - Please rate your chest pain at its worst since you got up this morning. ADSD Version 1.0 - Rate Chest Pain at Its Worst ADSD01-Rate Chest Tightness at Its Worst Asthma Daytime Symptom Diary v1.0 - Please rate your chest tightness at its worst since you got up this morning. ADSD Version 1.0 - Rate Chest Tightness at Its Worst ADSD01-Rate Cough at Its Worst Asthma Daytime Symptom Diary v1.0 - Please rate your cough at its worst since you got up this morning. ADSD Version 1.0 - Rate Cough at Its Worst ADSD01-Rate Shortness of Breath at Worst Asthma Daytime Symptom Diary v1.0 - Please rate your shortness of breath at its worst since you got up this morning. ADSD Version 1.0 - Rate Shortness of Breath at Worst ADSD01-Rate Wheezing at Its Worst Asthma Daytime Symptom Diary v1.0 - Please rate your wheezing at its worst since you got up this morning. ADSD Version 1.0 - Rate Wheezing at Its Worst ADSD01-Total Score Asthma Daytime Symptom Diary v1.0 - Total score. ADSD Version 1.0 - Total Score ADSD01TN Asthma Daytime Symptom Diary v1.0 Questionnaire Test Name CDISC Questionnaire ADSD Version 1.0 Test Name Terminology Terminology relevant to the test codes that describe findings about an asthma event or intervention. Occurrence Indicator An indication as to whether something has happened, such as an event or incident. Occurrence Indicator ASFATSCD Asthma Findings About Test Code CDISC SDTM Asthma Findings About Test Code Terminology Terminology relevant to the test names that describe findings about an asthma event or intervention. Occurrence Indicator An indication as to whether something has happened, such as an event or incident. Occurrence Indicator ASFATS Asthma Findings About Test Name CDISC SDTM Asthma Findings About Test Name Terminology Asthma Nighttime Symptom Diary v1.0 test code. ANSD01-Rate Breathing at Its Worst Asthma Nighttime Symptom Diary v1.0 - Please rate your difficulty breathing at its worst since you went to bed last night. ANSD Version 1.0 - Rate Breathing at Its Worst ANSD01-Rate Wheezing at Its Worst Asthma Nighttime Symptom Diary v1.0 - Please rate your wheezing at its worst since you went to bed last night. ANSD Version 1.0 - Rate Wheezing at Its Worst ANSD01-Rate Shortness of Breath at Worst Asthma Nighttime Symptom Diary v1.0 - Please rate your shortness of breath at its worst since you went to bed last night. ANSD Version 1.0 - Rate Shortness of Breath at Worst ANSD01-Rate Chest Tightness at Its Worst Asthma Nighttime Symptom Diary v1.0 - Please rate your chest tightness at its worst since you went to bed last night. ANSD Version 1.0 - Rate Chest Tightness at Its Worst ANSD01-Rate Chest Pain at Its Worst Asthma Nighttime Symptom Diary v1.0 - Please rate your chest pain at its worst since you went to bed last night. ANSD Version 1.0 - Rate Chest Pain at Its Worst ANSD01-Rate Cough at Its Worst Asthma Nighttime Symptom Diary v1.0 - Please rate your cough at its worst since you went to bed last night. ANSD Version 1.0 - Rate Cough at Its Worst ANSD01-Total Score Asthma Nighttime Symptom Diary v1.0 - Total score. ANSD Version 1.0 - Total Score ANSD01TC Asthma Nighttime Symptom Diary v1.0 Questionnaire Test Code CDISC Questionnaire ANSD Version 1.0 Test Code Terminology Asthma Nighttime Symptom Diary v1.0 test name. ANSD01-Rate Breathing at Its Worst Asthma Nighttime Symptom Diary v1.0 - Please rate your difficulty breathing at its worst since you went to bed last night. ANSD Version 1.0 - Rate Breathing at Its Worst ANSD01-Rate Chest Pain at Its Worst Asthma Nighttime Symptom Diary v1.0 - Please rate your chest pain at its worst since you went to bed last night. ANSD Version 1.0 - Rate Chest Pain at Its Worst ANSD01-Rate Chest Tightness at Its Worst Asthma Nighttime Symptom Diary v1.0 - Please rate your chest tightness at its worst since you went to bed last night. ANSD Version 1.0 - Rate Chest Tightness at Its Worst ANSD01-Rate Cough at Its Worst Asthma Nighttime Symptom Diary v1.0 - Please rate your cough at its worst since you went to bed last night. ANSD Version 1.0 - Rate Cough at Its Worst ANSD01-Rate Shortness of Breath at Worst Asthma Nighttime Symptom Diary v1.0 - Please rate your shortness of breath at its worst since you went to bed last night. ANSD Version 1.0 - Rate Shortness of Breath at Worst ANSD01-Rate Wheezing at Its Worst Asthma Nighttime Symptom Diary v1.0 - Please rate your wheezing at its worst since you went to bed last night. ANSD Version 1.0 - Rate Wheezing at Its Worst ANSD01-Total Score Asthma Nighttime Symptom Diary v1.0 - Total score. ANSD Version 1.0 - Total Score ANSD01TN Asthma Nighttime Symptom Diary v1.0 Questionnaire Test Name CDISC Questionnaire ANSD Version 1.0 Test Name Terminology Atherosclerotic Cardiovascular Disease 10-Year Risk Estimator test code. ASCVD1-ASCVD 10-Year Risk Score Atherosclerotic Cardiovascular Disease 10-Year Risk Estimator - Risk score. ASCVD 10-Year Risk Estimator - Risk Score ASCVD1TC Atherosclerotic Cardiovascular Disease 10-Year Risk Estimator Clinical Classification Test Code CDISC Clinical Classification Atherosclerotic Cardiovascular Disease 10-Year Risk Estimator Test Code Terminology Atherosclerotic Cardiovascular Disease 10-Year Risk Estimator test name. ASCVD1-ASCVD 10-Year Risk Score Atherosclerotic Cardiovascular Disease 10-Year Risk Estimator - Risk score. ASCVD 10-Year Risk Estimator - Risk Score ASCVD1TN Atherosclerotic Cardiovascular Disease 10-Year Risk Estimator Clinical Classification Test Name CDISC Clinical Classification Atherosclerotic Cardiovascular Disease 10-Year Risk Estimator Test Name Terminology ATLAS original result for ATLAS101 test and test code. ATLAS101-60-79 ATLAS original result for ATLAS101-60-79. ATLAS Score ATLAS101 Original Result - 60-79 ATLAS101-<60 ATLAS original result for ATLAS101-Less than 60. ATLAS Score ATLAS101 Original Result - <60 ATLAS101->=80 ATLAS original result for ATLAS101-Greater than or equal to 80. ATLAS Score ATLAS101 Original Result - >=80 ATLAS101OR ATLAS Clinical Classification ORRES for ATLAS101 TN/TC CDISC Clinical Classification ATLAS Score ATLAS101 Original Response Terminology ATLAS original result for ATLAS102 test and test code. ATLAS102-No ATLAS original result for ATLAS102-No. ATLAS Score ATLAS102 Original Result - No ATLAS102-Yes ATLAS original result for ATLAS102-Yes. ATLAS Score ATLAS102 Original Result - Yes ATLAS102OR ATLAS Clinical Classification ORRES for ATLAS102 TN/TC CDISC Clinical Classification ATLAS Score ATLAS102 Original Response Terminology ATLAS original result for ATLAS103 test and test code. ATLAS103-16,000-25,000 ATLAS original result for ATLAS103-16,000-25,000. ATLAS Score ATLAS103 Original Result - 16,000-25,000 ATLAS103-<16,000 ATLAS original result for ATLAS103-Less than16,000. ATLAS Score ATLAS103 Original Result - <16,000 ATLAS103->25,000 ATLAS original result for ATLAS103-Greater than 25,000. ATLAS Score ATLAS103 Original Result - >25,000 ATLAS103OR ATLAS Clinical Classification ORRES for ATLAS103 TN/TC CDISC Clinical Classification ATLAS Score ATLAS103 Original Response Terminology ATLAS original result for ATLAS104 test and test code. ATLAS104-26-35 ATLAS original result for ATLAS104-26-35. ATLAS Score ATLAS104 Original Result - 26-35 ATLAS104-<=25 ATLAS original result for ATLAS104-Less than or equal to 25. ATLAS Score ATLAS104 Original Result - <=25 ATLAS104->35 ATLAS original result for ATLAS104-Greater than 35. ATLAS Score ATLAS104 Original Result - >35 ATLAS104OR ATLAS Clinical Classification ORRES for ATLAS104 TN/TC CDISC Clinical Classification ATLAS Score ATLAS104 Original Response Terminology ATLAS original result for ATLAS105 test and test code. ATLAS105-121-179 ATLAS original result for ATLAS105-121-179. ATLAS Score ATLAS105 Original Result - 121-179 ATLAS105-<=120 ATLAS original result for ATLAS105-Less than or equal to 120. ATLAS Score ATLAS105 Original Result - <=120 ATLAS105->=180 ATLAS original result for ATLAS105-Greater than or equal to 180. ATLAS Score ATLAS105 Original Result - >=180 ATLAS105OR ATLAS Clinical Classification ORRES for ATLAS105 TN/TC CDISC Clinical Classification ATLAS Score ATLAS105 Original Response Terminology ATLAS standardized character result for ATLAS101 test and test code. ATLAS101-0 ATLAS standardized character result for ATLAS101-Less than 60. ATLAS Score ATLAS101 Standardized Character Result 0 ATLAS101-1 ATLAS standardized character result for ATLAS101-60-79. ATLAS Score ATLAS101 Standardized Character Result 1 ATLAS101-2 ATLAS standardized character result for ATLAS101-Greater than or equal to 80. ATLAS Score ATLAS101 Standardized Character Result 2 ATLAS101STR ATLAS Clinical Classification STRESC for ATLAS101 TN/TC CDISC Clinical Classification ATLAS Score ATLAS101 Standardized Character Response Terminology ATLAS standardized character result for ATLAS102 test and test code. ATLAS102-0 ATLAS standardized character result for ATLAS102-No. ATLAS Score ATLAS102 Standardized Character Result 0 ATLAS102-2 ATLAS standardized character result for ATLAS102-Yes. ATLAS Score ATLAS102 Standardized Character Result 2 ATLAS102STR ATLAS Clinical Classification STRESC for ATLAS102 TN/TC CDISC Clinical Classification ATLAS Score ATLAS102 Standardized Character Response Terminology ATLAS standardized character result for ATLAS103 test and test code. ATLAS103-0 ATLAS standardized character result for ATLAS103-Less than 16,000. ATLAS Score ATLAS103 Standardized Character Result 0 ATLAS103-1 ATLAS standardized character result for ATLAS103-16,000-25,000. ATLAS Score ATLAS103 Standardized Character Result 1 ATLAS103-2 ATLAS standardized character result for ATLAS103-Greater than 25,000. ATLAS Score ATLAS103 Standardized Character Result 2 ATLAS103STR ATLAS Clinical Classification STRESC for ATLAS103 TN/TC CDISC Clinical Classification ATLAS Score ATLAS103 Standardized Character Response Terminology ATLAS standardized character result for ATLAS104 test and test code. ATLAS104-0 ATLAS standardized character result for ATLAS104-Greater than 35. ATLAS Score ATLAS104 Standardized Character Result 0 ATLAS104-1 ATLAS standardized character result for ATLAS104-26-35. ATLAS Score ATLAS104 Standardized Character Result 1 ATLAS104-2 ATLAS standardized character result for ATLAS104-Less than or equal to 25. ATLAS Score ATLAS104 Standardized Character Result 2 ATLAS104STR ATLAS Clinical Classification STRESC for ATLAS104 TN/TC CDISC Clinical Classification ATLAS Score ATLAS104 Standardized Character Response Terminology ATLAS standardized character result for ATLAS105 test and test code. ATLAS105-0 ATLAS standardized character result for ATLAS105-Less than or equal to 120. ATLAS Score ATLAS105 Standardized Character Result 0 ATLAS105-1 ATLAS standardized character result for ATLAS105-121-179. ATLAS Score ATLAS105 Standardized Character Result 1 ATLAS105-2 ATLAS standardized character result for ATLAS105-Greater than or equal to 180. ATLAS Score ATLAS105 Standardized Character Result 2 ATLAS105STR ATLAS Clinical Classification STRESC for ATLAS105 TN/TC CDISC Clinical Classification ATLAS Score ATLAS105 Standardized Character Response Terminology ATLAS test code. ATLAS1-Age Age, treatment with systemic antibiotics, leukocyte count, serum albumin, and serum creatinine as a measure of renal function - Age. ATLAS - Age ATLAS1-Treatment With Antibiotics Age, treatment with systemic antibiotics, leukocyte count, serum albumin, and serum creatinine as a measure of renal function - Treatment with systemic antibiotics during CDI therapy (>= 1 day). ATLAS - Treatment With Antibiotics ATLAS1-Leukocyte Count Age, treatment with systemic antibiotics, leukocyte count, serum albumin, and serum creatinine as a measure of renal function - Leukocyte count (total). ATLAS - Leukocyte Count ATLAS1-Albumin Age, treatment with systemic antibiotics, leukocyte count, serum albumin, and serum creatinine as a measure of renal function - Albumin (serum). ATLAS - Albumin ATLAS1-Serum Creatinine Age, treatment with systemic antibiotics, leukocyte count, serum albumin, and serum creatinine as a measure of renal function - Serum creatinine (as a measure of renal function). ATLAS - Serum Creatinine ATLAS1-Score Age, treatment with systemic antibiotics, leukocyte count, serum albumin, and serum creatinine as a measure of renal function - Score. ATLAS - Score ATLAS1TC ATLAS Clinical Classification Test Code CDISC Clinical Classification ATLAS Test Code Terminology ATLAS test name. ATLAS1-Age Age, treatment with systemic antibiotics, leukocyte count, serum albumin, and serum creatinine as a measure of renal function - Age. ATLAS - Age ATLAS1-Albumin Age, treatment with systemic antibiotics, leukocyte count, serum albumin, and serum creatinine as a measure of renal function - Albumin (serum). ATLAS - Albumin ATLAS1-Leukocyte Count Age, treatment with systemic antibiotics, leukocyte count, serum albumin, and serum creatinine as a measure of renal function - Leukocyte count (total). ATLAS - Leukocyte Count ATLAS1-Score Age, treatment with systemic antibiotics, leukocyte count, serum albumin, and serum creatinine as a measure of renal function - Score. ATLAS - Score ATLAS1-Serum Creatinine Age, treatment with systemic antibiotics, leukocyte count, serum albumin, and serum creatinine as a measure of renal function - Serum creatinine (as a measure of renal function). ATLAS - Serum Creatinine ATLAS1-Treatment With Antibiotics Age, treatment with systemic antibiotics, leukocyte count, serum albumin, and serum creatinine as a measure of renal function - Treatment with systemic antibiotics during CDI therapy (>= 1 day). ATLAS - Treatment With Antibiotics ATLAS1TN ATLAS Clinical Classification Test Name CDISC Clinical Classification ATLAS Test Name Terminology A terminology codelist to describe the test code for a physiological examination of the auditory system. Auditory Brainstem Response An assessment of auditory brainstem function in response to auditory stimuli. Auditory Brainstem Response Air to Bone Sound Conduction Comparison A relative assessment of sound transmission through air conduction versus bone conduction. Air to Bone Sound Conduction Comparison Air Pressure The force exerted by air upon a surface. Air Pressure Auditory Lateralization Hearing Lateralization An auditory assessment that determines the perceived relative volume of sound in the left and right cochlea. Hearing Lateralization Hearing Loss Type Type of Hearing Loss A classification or categorization of hearing loss experienced by an individual. Hearing Loss Type Otoacoustic Emission An assessment of the otoacoustic sound emissions from the cochlea when stimulated by soft clicking sounds introduced into the ear canal. Otoacoustic Emission Overall Hearing Assessment An assessment to evaluate the overall hearing of an individual. Overall Hearing Assessment Physiological Compliance An index reflecting distensibility of elastic organ(s) defined as the change in volume per unit change in pressure (dV/dP). Index of Expandability Tympanogram Tracing Type Tympanogram Type An interpretive summary of the tympanogram tracing result. Tympanogram Tracing Type Volume A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. Volume Measurement AUTESTCD Auricular Findings Test Code CDISC SDTM Auricular Findings Test Code Terminology A terminology codelist to describe the test name for a physiological examination of the auditory system. Air Pressure The force exerted by air upon a surface. Air Pressure Air to Bone Sound Conduction Comparison A relative assessment of sound transmission through air conduction versus bone conduction. Air to Bone Sound Conduction Comparison Auditory Brainstem Response An assessment of auditory brainstem function in response to auditory stimuli. Auditory Brainstem Response Auditory Lateralization Hearing Lateralization An auditory assessment that determines the perceived relative volume of sound in the left and right cochlea. Hearing Lateralization Hearing Loss Type Type of Hearing Loss A classification or categorization of hearing loss experienced by an individual. Hearing Loss Type Otoacoustic Emission An assessment of the otoacoustic sound emissions from the cochlea when stimulated by soft clicking sounds introduced into the ear canal. Otoacoustic Emission Overall Hearing Assessment An assessment to evaluate the overall hearing of an individual. Overall Hearing Assessment Physiological Compliance An index reflecting distensibility of elastic organ(s) defined as the change in volume per unit change in pressure (dV/dP). Index of Expandability Tympanogram Tracing Type Tympanogram Type An interpretive summary of the tympanogram tracing result. Tympanogram Tracing Type Volume A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. Volume Measurement AUTEST Auricular Findings Test Name CDISC SDTM Auricular Findings Test Name Terminology Baby Eating Behaviour Questionnaire Concurrent Version test code. BEBQ01-Baby Seems Contented Feeding Baby Eating Behaviour Questionnaire - Concurrent - My baby seems contented while feeding. BEBQ Concurrent Version - Baby Seems Contented Feeding BEBQ01-Baby Frequently Wants More Milk Baby Eating Behaviour Questionnaire - Concurrent - My baby frequently wants more milk than I provide. BEBQ Concurrent Version - Baby Frequently Wants More Milk BEBQ01-Baby Loves Milk Baby Eating Behaviour Questionnaire - Concurrent - My baby loves milk. BEBQ Concurrent Version - Baby Loves Milk BEBQ01-Baby Has a Big Appetite Baby Eating Behaviour Questionnaire - Concurrent - My baby has a big appetite. BEBQ Concurrent Version - Baby Has a Big Appetite BEBQ01-Baby Finishes Feeding Quickly Baby Eating Behaviour Questionnaire - Concurrent - My baby finishes feeding quickly. BEBQ Concurrent Version - Baby Finishes Feeding Quickly BEBQ01-Baby Becomes Distressed Feeding Baby Eating Behaviour Questionnaire - Concurrent - My baby becomes distressed while feeding. BEBQ Concurrent Version - Baby Becomes Distressed Feeding BEBQ01-Baby Gets Full Up Easily Baby Eating Behaviour Questionnaire - Concurrent - My baby gets full up easily. BEBQ Concurrent Version - Baby Gets Full Up Easily BEBQ01-Baby Would Take Too Much Milk Baby Eating Behaviour Questionnaire - Concurrent - If allowed to, my baby would take too much milk. BEBQ Concurrent Version - Baby Would Take Too Much Milk BEBQ01-Baby Takes More Than 30 Minutes Baby Eating Behaviour Questionnaire - Concurrent - My baby takes more than 30 minutes to finish feeding. BEBQ Concurrent Version - Baby Takes More Than 30 Minutes BEBQ01-Gets Full Before Taking All Milk Baby Eating Behaviour Questionnaire - Concurrent - My baby gets full before taking all the milk I think he/she should have. BEBQ Concurrent Version - Gets Full Before Taking All Milk BEBQ01-Baby Feeds Slowly Baby Eating Behaviour Questionnaire - Concurrent - My baby feeds slowly. BEBQ Concurrent Version - Baby Feeds Slowly BEBQ01-Just Eaten Is Happy to Feed Again Baby Eating Behaviour Questionnaire - Concurrent - Even when my baby has just eaten well he/she is happy to feed again if offered. BEBQ Concurrent Version - Just Eaten Is Happy to Feed Again BEBQ01-Difficult Manage Complete Feed Baby Eating Behaviour Questionnaire - Concurrent - My baby finds it difficult to manage a complete feed. BEBQ Concurrent Version - Difficult Manage Complete Feed BEBQ01-Baby Is Always Demanding a Feed Baby Eating Behaviour Questionnaire - Concurrent - My baby is always demanding a feed. BEBQ Concurrent Version - Baby Is Always Demanding a Feed BEBQ01-Baby Sucks More and More Slowly Baby Eating Behaviour Questionnaire - Concurrent - My baby sucks more and more slowly during the course of a feed. BEBQ Concurrent Version - Baby Sucks More and More Slowly BEBQ01-Baby Would Always Be Feeding Baby Eating Behaviour Questionnaire - Concurrent - If given the chance, my baby would always be feeding. BEBQ Concurrent Version - Baby Would Always Be Feeding BEBQ01-Baby Enjoys Feeding Time Baby Eating Behaviour Questionnaire - Concurrent - My baby enjoys feeding time. BEBQ Concurrent Version - Baby Enjoys Feeding Time BEBQ01-Take a Feed Within 30 Minutes Baby Eating Behaviour Questionnaire - Concurrent - My baby can easily take a feed within 30 minutes of the last one. BEBQ Concurrent Version - Take a Feed Within 30 Minutes BEBQ01TC Baby Eating Behaviour Questionnaire Concurrent Version Questionnaire Test Code CDISC Questionnaire BEBQ Concurrent Version Test Code Terminology Baby Eating Behaviour Questionnaire Concurrent Version test name. BEBQ01-Baby Becomes Distressed Feeding Baby Eating Behaviour Questionnaire - Concurrent - My baby becomes distressed while feeding. BEBQ Concurrent Version - Baby Becomes Distressed Feeding BEBQ01-Baby Enjoys Feeding Time Baby Eating Behaviour Questionnaire - Concurrent - My baby enjoys feeding time. BEBQ Concurrent Version - Baby Enjoys Feeding Time BEBQ01-Baby Feeds Slowly Baby Eating Behaviour Questionnaire - Concurrent - My baby feeds slowly. BEBQ Concurrent Version - Baby Feeds Slowly BEBQ01-Baby Finishes Feeding Quickly Baby Eating Behaviour Questionnaire - Concurrent - My baby finishes feeding quickly. BEBQ Concurrent Version - Baby Finishes Feeding Quickly BEBQ01-Baby Frequently Wants More Milk Baby Eating Behaviour Questionnaire - Concurrent - My baby frequently wants more milk than I provide. BEBQ Concurrent Version - Baby Frequently Wants More Milk BEBQ01-Baby Gets Full Up Easily Baby Eating Behaviour Questionnaire - Concurrent - My baby gets full up easily. BEBQ Concurrent Version - Baby Gets Full Up Easily BEBQ01-Baby Has a Big Appetite Baby Eating Behaviour Questionnaire - Concurrent - My baby has a big appetite. BEBQ Concurrent Version - Baby Has a Big Appetite BEBQ01-Baby Is Always Demanding a Feed Baby Eating Behaviour Questionnaire - Concurrent - My baby is always demanding a feed. BEBQ Concurrent Version - Baby Is Always Demanding a Feed BEBQ01-Baby Loves Milk Baby Eating Behaviour Questionnaire - Concurrent - My baby loves milk. BEBQ Concurrent Version - Baby Loves Milk BEBQ01-Baby Seems Contented Feeding Baby Eating Behaviour Questionnaire - Concurrent - My baby seems contented while feeding. BEBQ Concurrent Version - Baby Seems Contented Feeding BEBQ01-Baby Sucks More and More Slowly Baby Eating Behaviour Questionnaire - Concurrent - My baby sucks more and more slowly during the course of a feed. BEBQ Concurrent Version - Baby Sucks More and More Slowly BEBQ01-Baby Takes More Than 30 Minutes Baby Eating Behaviour Questionnaire - Concurrent - My baby takes more than 30 minutes to finish feeding. BEBQ Concurrent Version - Baby Takes More Than 30 Minutes BEBQ01-Baby Would Always Be Feeding Baby Eating Behaviour Questionnaire - Concurrent - If given the chance, my baby would always be feeding. BEBQ Concurrent Version - Baby Would Always Be Feeding BEBQ01-Baby Would Take Too Much Milk Baby Eating Behaviour Questionnaire - Concurrent - If allowed to, my baby would take too much milk. BEBQ Concurrent Version - Baby Would Take Too Much Milk BEBQ01-Difficult Manage Complete Feed Baby Eating Behaviour Questionnaire - Concurrent - My baby finds it difficult to manage a complete feed. BEBQ Concurrent Version - Difficult Manage Complete Feed BEBQ01-Gets Full Before Taking All Milk Baby Eating Behaviour Questionnaire - Concurrent - My baby gets full before taking all the milk I think he/she should have. BEBQ Concurrent Version - Gets Full Before Taking All Milk BEBQ01-Just Eaten Is Happy to Feed Again Baby Eating Behaviour Questionnaire - Concurrent - Even when my baby has just eaten well he/she is happy to feed again if offered. BEBQ Concurrent Version - Just Eaten Is Happy to Feed Again BEBQ01-Take a Feed Within 30 Minutes Baby Eating Behaviour Questionnaire - Concurrent - My baby can easily take a feed within 30 minutes of the last one. BEBQ Concurrent Version - Take a Feed Within 30 Minutes BEBQ01TN Baby Eating Behaviour Questionnaire Concurrent Version Questionnaire Test Name CDISC Questionnaire BEBQ Concurrent Version Test Name Terminology Baby Eating Behaviour Questionnaire Retrospective Version test code. BEBQ02-Baby Seemed Contented Feeding Baby Eating Behaviour Questionnaire - Retrospective - My baby seemed contented while feeding. BEBQ Retrospective Version - Baby Seemed Contented Feeding BEBQ02-Baby Frequently Wanted More Milk Baby Eating Behaviour Questionnaire - Retrospective - My baby frequently wanted more milk than I provided. BEBQ Retrospective Version - Baby Frequently Wanted More Milk BEBQ02-Baby Loved Milk Baby Eating Behaviour Questionnaire - Retrospective - My baby loved milk. BEBQ Retrospective Version - Baby Loved Milk BEBQ02-Baby Had a Big Appetite Baby Eating Behaviour Questionnaire - Retrospective - My baby had a big appetite. BEBQ Retrospective Version - Baby Had a Big Appetite BEBQ02-Baby Finished Feeding Quickly Baby Eating Behaviour Questionnaire - Retrospective - My baby finished feeding quickly. BEBQ Retrospective Version - Baby Finished Feeding Quickly BEBQ02-Baby Became Distressed Feeding Baby Eating Behaviour Questionnaire - Retrospective - My baby became distressed while feeding. BEBQ Retrospective Version - Baby Became Distressed Feeding BEBQ02-Baby Got Full Up Easily Baby Eating Behaviour Questionnaire - Retrospective - My baby got full up easily. BEBQ Retrospective Version - Baby Got Full Up Easily BEBQ02-Baby Would Take Too Much Milk Baby Eating Behaviour Questionnaire - Retrospective - If allowed to, my baby would take too much milk. BEBQ Retrospective Version - Baby Would Take Too Much Milk BEBQ02-Baby Took More Than 30 Minutes Baby Eating Behaviour Questionnaire - Retrospective - My baby took more than 30 minutes to finish feeding. BEBQ Retrospective Version - Baby Took More Than 30 Minutes BEBQ02-Got Full Before Taking All Milk Baby Eating Behaviour Questionnaire - Retrospective - My baby got full before taking all the milk I think he/she should have. BEBQ Retrospective Version - Got Full Before Taking All Milk BEBQ02-Baby Fed Slowly Baby Eating Behaviour Questionnaire - Retrospective - My baby fed slowly. BEBQ Retrospective Version - Baby Fed Slowly BEBQ02-Just Eaten Happy to Feed Again Baby Eating Behaviour Questionnaire - Retrospective - Even when my baby had just eaten well he/she was happy to feed again if offered. BEBQ Retrospective Version - Just Eaten Happy to Feed Again BEBQ02-Difficult Manage Complete Feed Baby Eating Behaviour Questionnaire - Retrospective - My baby found it difficult to manage a complete feed. BEBQ Retrospective Version - Difficult Manage Complete Feed BEBQ02-Baby Was Always Demanding a Feed Baby Eating Behaviour Questionnaire - Retrospective - My baby was always demanding a feed. BEBQ Retrospective Version - Baby Was Always Demanding a Feed BEBQ02-Baby Sucked More and More Slowly Baby Eating Behaviour Questionnaire - Retrospective - My baby sucked more and more slowly during the course of a feed. BEBQ Retrospective Version - Baby Sucked More and More Slowly BEBQ02-Baby Would Always Be Feeding Baby Eating Behaviour Questionnaire - Retrospective - If given the chance, my baby would always be feeding. BEBQ Retrospective Version - Baby Would Always Be Feeding BEBQ02-Baby Enjoyed Feeding Time Baby Eating Behaviour Questionnaire - Retrospective - My baby enjoyed feeding time. BEBQ Retrospective Version - Baby Enjoyed Feeding Time BEBQ02-Take a Feed Within 30 Minutes Baby Eating Behaviour Questionnaire - Retrospective - My baby could easily take a feed within 30 minutes of the last one. BEBQ Retrospective Version - Take a Feed Within 30 Minutes BEBQ02TC Baby Eating Behaviour Questionnaire Retrospective Version Questionnaire Test Code CDISC Questionnaire BEBQ Retrospective Version Test Code Terminology Baby Eating Behaviour Questionnaire Retrospective Version test name. BEBQ02-Baby Became Distressed Feeding Baby Eating Behaviour Questionnaire - Retrospective - My baby became distressed while feeding. BEBQ Retrospective Version - Baby Became Distressed Feeding BEBQ02-Baby Enjoyed Feeding Time Baby Eating Behaviour Questionnaire - Retrospective - My baby enjoyed feeding time. BEBQ Retrospective Version - Baby Enjoyed Feeding Time BEBQ02-Baby Fed Slowly Baby Eating Behaviour Questionnaire - Retrospective - My baby fed slowly. BEBQ Retrospective Version - Baby Fed Slowly BEBQ02-Baby Finished Feeding Quickly Baby Eating Behaviour Questionnaire - Retrospective - My baby finished feeding quickly. BEBQ Retrospective Version - Baby Finished Feeding Quickly BEBQ02-Baby Frequently Wanted More Milk Baby Eating Behaviour Questionnaire - Retrospective - My baby frequently wanted more milk than I provided. BEBQ Retrospective Version - Baby Frequently Wanted More Milk BEBQ02-Baby Got Full Up Easily Baby Eating Behaviour Questionnaire - Retrospective - My baby got full up easily. BEBQ Retrospective Version - Baby Got Full Up Easily BEBQ02-Baby Had a Big Appetite Baby Eating Behaviour Questionnaire - Retrospective - My baby had a big appetite. BEBQ Retrospective Version - Baby Had a Big Appetite BEBQ02-Baby Loved Milk Baby Eating Behaviour Questionnaire - Retrospective - My baby loved milk. BEBQ Retrospective Version - Baby Loved Milk BEBQ02-Baby Seemed Contented Feeding Baby Eating Behaviour Questionnaire - Retrospective - My baby seemed contented while feeding. BEBQ Retrospective Version - Baby Seemed Contented Feeding BEBQ02-Baby Sucked More and More Slowly Baby Eating Behaviour Questionnaire - Retrospective - My baby sucked more and more slowly during the course of a feed. BEBQ Retrospective Version - Baby Sucked More and More Slowly BEBQ02-Baby Took More Than 30 Minutes Baby Eating Behaviour Questionnaire - Retrospective - My baby took more than 30 minutes to finish feeding. BEBQ Retrospective Version - Baby Took More Than 30 Minutes BEBQ02-Baby Was Always Demanding a Feed Baby Eating Behaviour Questionnaire - Retrospective - My baby was always demanding a feed. BEBQ Retrospective Version - Baby Was Always Demanding a Feed BEBQ02-Baby Would Always Be Feeding Baby Eating Behaviour Questionnaire - Retrospective - If given the chance, my baby would always be feeding. BEBQ Retrospective Version - Baby Would Always Be Feeding BEBQ02-Baby Would Take Too Much Milk Baby Eating Behaviour Questionnaire - Retrospective - If allowed to, my baby would take too much milk. BEBQ Retrospective Version - Baby Would Take Too Much Milk BEBQ02-Difficult Manage Complete Feed Baby Eating Behaviour Questionnaire - Retrospective - My baby found it difficult to manage a complete feed. BEBQ Retrospective Version - Difficult Manage Complete Feed BEBQ02-Got Full Before Taking All Milk Baby Eating Behaviour Questionnaire - Retrospective - My baby got full before taking all the milk I think he/she should have. BEBQ Retrospective Version - Got Full Before Taking All Milk BEBQ02-Just Eaten Happy to Feed Again Baby Eating Behaviour Questionnaire - Retrospective - Even when my baby had just eaten well he/she was happy to feed again if offered. BEBQ Retrospective Version - Just Eaten Happy to Feed Again BEBQ02-Take a Feed Within 30 Minutes Baby Eating Behaviour Questionnaire - Retrospective - My baby could easily take a feed within 30 minutes of the last one. BEBQ Retrospective Version - Take a Feed Within 30 Minutes BEBQ02TN Baby Eating Behaviour Questionnaire Retrospective Version Questionnaire Test Name CDISC Questionnaire BEBQ Retrospective Version Test Name Terminology Barnes Akathisia Rating Scale test code. BARS01-Objective Barnes Akathisia Rating Scale - Objective. BARS - Objective BARS01-Subjective, Awareness Barnes Akathisia Rating Scale - Subjective, awareness of restlessness. BARS - Subjective, Awareness BARS01-Subjective, Distress Barnes Akathisia Rating Scale - Subjective, distress related to restlessness. BARS - Subjective, Distress BARS01-Global Clinical Assessment Barnes Akathisia Rating Scale - Global clinical assessment of akathisia. BARS - Global Clinical Assessment BARS01TC Barnes Akathisia Rating Scale Clinical Classification Test Code CDISC Clinical Classification BARS Test Code Terminology Barnes Akathisia Rating Scale test name. BARS01-Global Clinical Assessment Barnes Akathisia Rating Scale - Global clinical assessment of akathisia. BARS - Global Clinical Assessment BARS01-Objective Barnes Akathisia Rating Scale - Objective. BARS - Objective BARS01-Subjective, Awareness Barnes Akathisia Rating Scale - Subjective, awareness of restlessness. BARS - Subjective, Awareness BARS01-Subjective, Distress Barnes Akathisia Rating Scale - Subjective, distress related to restlessness. BARS - Subjective, Distress BARS01TN Barnes Akathisia Rating Scale Clinical Classification Test Name CDISC Clinical Classification BARS Test Name Terminology Baseline Dyspnea Index test code. BDI01-Functional Impairment Baseline Dyspnea Index - Functional impairment. BDI - Functional Impairment BDI01-Magnitude of Task Baseline Dyspnea Index - Magnitude of task. BDI - Magnitude of Task BDI01-Magnitude of Effort Baseline Dyspnea Index - Magnitude of effort. BDI - Magnitude of Effort BDI01-Baseline Focal Score Baseline Dyspnea Index - Baseline focal score. BDI - Baseline Focal Score BDI01TC Baseline Dyspnea Index Clinical Classification Test Code CDISC Clinical Classification BDI Test Code Terminology Baseline Dyspnea Index test name. BDI01-Baseline Focal Score Baseline Dyspnea Index - Baseline focal score. BDI - Baseline Focal Score BDI01-Functional Impairment Baseline Dyspnea Index - Functional impairment. BDI - Functional Impairment BDI01-Magnitude of Effort Baseline Dyspnea Index - Magnitude of effort. BDI - Magnitude of Effort BDI01-Magnitude of Task Baseline Dyspnea Index - Magnitude of task. BDI - Magnitude of Task BDI01TN Baseline Dyspnea Index Clinical Classification Test Name CDISC Clinical Classification BDI Test Name Terminology A terminology codelist relevant to the description of the agent that is binding to the entity in the ISTEST variable. AcChR Membrane proteins in the acetylcholine receptor family that bind to and mediate the neurotransmission of acetylcholine. They can be considered as autoantigens and are commonly associated with the autoimmune disease myasthenia gravis. Acetylcholine Receptor A Disintegrin and Metalloproteinase with Thrombospondin Type 1 Motif 13 ADAM Metallopeptidase With Thrombospondin Type 1 Motif 13 Von Willebrand Coagulation Factor Cleaving Protease An antigen encoded by the ADAMTS13 gene and cleaves von Willebrand Factor (vWF). It can be considered as an autoantigen and is commonly associated with the autoimmune disease immune-mediated thrombotic thrombocytopenic purpura (iTTP). A Disintegrin and Metalloproteinase with Thrombospondin Motifs 13 Adenylate Kinase 6 AK5 AK6 ATP-AMP Transphosphorylase 5 An antigen encoded by the AK5 gene and is involved in regulating the adenine nucleotide composition. It can be considered as an autoantigen and is commonly associated with autoimmune limbic encephalitis. Adenylate Kinase Isoenzyme 5 A group of autoimmune substances found in the adrenal gland that may be comprised of (but not limited to) 21-hydroxylase, 17-hydroxylase and P450scc (cholesterol side-chain cleavage enzyme). They are commonly associated with autoimmune adrenal diseases, such as adrenocortical insufficiency and Addison's disease. Adrenal Autoantigens Almond Allergen Prunus amygdalus Antigen Prunus dulcis Antigen Antigen(s) from the seed of the species Prunus dulcis (almond) that are considered as food allergen(s). Almond Antigen ALA alpha-LA The approximately 14 kDa milk whey protein and a component of lactose synthase that is considered as a food allergen. Alpha-Lactalbumin American Cockroach Allergen Periplaneta americana Antigen Antigen(s) from the species Periplaneta americana (American cockroach) that are considered as insect allergen(s). Periplaneta americana Antigen American House Dust Mite Allergen Dermatophagoides farinae Antigen Antigen(s) from the species Dermatophagoides farinae (American house dust mite) that are considered as insect allergen(s). Dermatophagoides farinae Antigen ARS tRNA-Ligase One or more of the antigen(s) from the aminoacyl-tRNA synthetase family and are enzymes that attach the appropriate amino acids onto their corresponding tRNAs. This family of proteins may be comprised of (but not limited to) histidyl- (Jo-1), threonyl- (PL-7), alanyl- (PL-12), glycyl- (EJ), isoleucyl- (OJ), asparaginyl- (KS), phenylalanyl- (Zo), and tyrosyl- (YRS) tRNA synthetases. They can be considered as autoantigens and are commonly associated with the autoimmune diseases polymyositis and dermatomyositis. Aminoacyl-tRNA Ligase Family Alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate Receptor 1 AMPA-Selective Glutamate Receptor 1 GluA1 GluR1 Glutamate Ionotropic Receptor AMPA Type Subunit 1 Glutamate Receptor 1 An antigen encoded by the GRIA1 gene that binds to and mediates the neurotransmission of glutamate. It can be considered as an autoantigen and is commonly associated with autoimmune encephalopathies. Glutamate Receptor 1 Alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate Receptor 2 AMPA-Selective Glutamate Receptor 2 GluA2 Glutamate Ionotropic Receptor AMPA Type Subunit 2 Glutamate receptor 2, GluR2 An antigen encoded by the GRIA2 gene that binds to and mediates the neurotransmission of glutamate. It can be considered as an autoantigen and is commonly associated with autoimmune encephalopathies. Glutamate Receptor 2 GLuR1-4 GLuRs The ligand-gated, transmembrane proteins in the glutamate receptor family that bind to and mediate the neurotransmission of glutamate. They can be considered as autoantigens and are commonly associated with autoimmune encephalopathies. AMPA Receptor Complex AMPH An antigen encoded by the AMPH gene that is involved in both exocytosis and cytoskeletal arrangement. It can be considered as a neuronal autoantigen and is commonly associated with autoimmune neurodegenerative disorders related to cancer, such as paraneoplastic neurologic syndrome. Amphiphysin Animal Mix Allergens Antigen(s) from a mix of animals that are considered as animal allergen(s). Animal Mix Antigens AQP-4 Aquaporin 4 Receptor Aquaporin 4 Water Channel Mercurial-Insensitive Water Channel An antigen encoded by the AQP4 gene that forms water-selective channels in the plasma membranes of cells, and thereby regulates brain water homeostasis. It can be considered as an autoantigen and is commonly associated with the autoimmune disease neuromyelitis optica. Aquaporin-4 Anthrax Toxin Protective Antigen Bacillus anthracis PA The 83 kDa cell-binding protein from Bacillus anthracis that forms membrane spanning pores which mediate and allow the translocation of the anthrax toxin proteins into the cytoplasm of the host cells. Bacillus anthracis Protective Antigen Bactericidal/Permeability-Increasing Protein BPI RBPI An antigen encoded by the BPI gene and an endogenous antibiotic, cytotoxic protein in the innate immune system. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases inflammatory bowel disease, systemic lupus erythematosus and rheumatoid arthritis. Bactericidal Permeability-Increasing Protein Musa Species Antigen Musa spp Antigen Antigen(s) from the fruit of the various species under the genus Musa that are considered as food allergen(s). This includes both edible (dessert) banana and cooking banana (plantains). Banana Antigen Basement Membrane Autoantigens A group of autoimmune substances found in the extracellular matrix basement membrane that may be comprised of (but not limited to) collagens and basement membrane proteins. They are commonly associated with the autoimmune diseases bullous pemphigoid, glomerulonephritis, Goodpasture's disease, and rheumatoid arthritis. Basement Membrane Antigens BMZ BP180 BP180 BPAG2 Bullous Pemphigoid Antigen 2 Collagen Type XVII Alpha 1 Chain An antigen encoded by the COL17A1 gene and is involved in the attachment of keratinocytes to the basement membrane. It can be considered as an autoantigen and is commonly associated with the autoimmune disease bullous pemphigoid. Collagen Alpha-1(XVII) Chain BMZ BP230 BP230 BPAG1 Bullous Pemphigoid Antigen 1 Dystonin An antigen encoded by the DST gene and promotes cytoskeleton networking. It can be considered as an autoantigen and is commonly associated with the autoimmune disease bullous pemphigoid. Dystonin Bee Mix Venom Allergens Antigen(s) in the Hymenoptera venom from a mix of bees that are considered as insect allergen(s). Multiple Bee Mix Hymenoptera venom Antigens Beef Allergen Bos taurus Meat Antigen Cow Meat Antigen Antigen(s) in the meat of the species Bos taurus (cow) that are considered as food allergen(s). Beef Antigen Bermuda Grass Pollen Allergen Cynodon dactylon Pollen Antigen Antigen(s) in the pollen of the species Cynodon dactylon (Bermuda grass) that are considered as plant allergen(s). Cynodon dactylon Pollen Antigen beta-LG BLG The approximately 18.4 kDa lipocalin, a major milk whey protein that is considered as a food allergen. Beta Lactoglobulin Apo-H Apolipoprotein H B2GPI Beta-2-Glycoprotein I An antigen of the cardiolipin-binding protein encoded by the APOH gene. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases antiphospholipid syndrome and systemic rheumatic diseases like systemic lupus erythematosus. Beta-2-Glycoprotein 1 Boiled Cow Milk Allergen Antigen(s) from cow milk that has been boiled, that are considered as food allergen(s). Boiled Cow Milk Antigen Bordetella pertussis FHA The approximately 220-250 kDa cell surface, adhesin protein and the virulence factor for Bordetella pertussis. Bordetella pertussis Filamentous Hemagglutinin A mixture of fimbriae antigens from Bordetella pertussis. Bordetella pertussis Fimbriae Antigens PRN The approximately 69 kDa cell surface, autotransporter protein and the virulence factor for Bordetella pertussis. Bordetella pertussis Pertactin Antigen PT The approximately 105 kDa secreted exotoxin and the virulence factor for Bordetella pertussis. Bordetella pertussis Toxin Borrelia burgdorferi Protein p18 The approximately 18 kDa protein encoded by the bacteria Borrelia burgdorferi which is a Lyme disease antigen. Borrelia Burgdorferi 18 kDa Antigen Borrelia burgdorferi OspC Borrelia burgdorferi Outer surface protein C Borrelia burgdorferi Protein p23 The approximately 23 kDa protein encoded by the bacteria Borrelia burgdorferi which is a Lyme disease antigen. Borrelia Burgdorferi 23 kDa Antigen Borrelia burgdorferi Protein p28 The approximately 28 kDa protein encoded by the bacteria Borrelia burgdorferi which is a Lyme disease antigen. Borrelia Burgdorferi 28 kDa Antigen Borrelia burgdorferi Protein p30 The approximately 30 kDa protein encoded by the bacteria Borrelia burgdorferi which is a Lyme disease antigen. Borrelia Burgdorferi 30 kDa Antigen Borrelia burgdorferi Protein p39 The approximately 39 kDa protein encoded by the bacteria Borrelia burgdorferi which is a Lyme disease antigen. Borrelia Burgdorferi 39 kDa Antigen Borrelia burgdorferi Protein p41 The approximately 41 kDa protein encoded by the bacteria Borrelia burgdorferi which is a Lyme disease antigen. Borrelia Burgdorferi 41 kDa Antigen Borrelia burgdorferi Protein p45 The approximately 45 kDa protein encoded by the bacteria Borrelia burgdorferi which is a Lyme disease antigen. Borrelia Burgdorferi 45 kDa Antigen Borrelia burgdorferi Protein p58 The approximately 58 kDa protein encoded by the bacteria Borrelia burgdorferi which is a Lyme disease antigen. Borrelia Burgdorferi 58 kDa Antigen Borrelia burgdorferi Protein p66 The approximately 66 kDa protein encoded by the bacteria Borrelia burgdorferi which is a Lyme disease antigen. Borrelia Burgdorferi 66 kDa Antigen Borrelia burgdorferi Protein p93 The approximately 93 kDa protein encoded by the bacteria Borrelia burgdorferi which is a Lyme disease antigen. Borrelia Burgdorferi 93 kDa Antigen Acer negundo Pollen Antigen Box Elder Pollen Allergen Boxelder Pollen Antigen Antigen(s) in the pollen of the species Acer negundo (box elder tree) that are considered as plant allergen(s). Acer negundo Pollen Antigen Budgerigar Dropping Allergen Melopsittacus undulatus Dropping Antigen Antigen(s) in the feces of the species Melopsittacus undulatus (budgerigar) that are considered as animal allergen(s). Budgerigar Dropping Antigen Budgerigar Feather Allergen Melopsittacus undulatus Feather Antigen Antigen(s) in the feather of the species Melopsittacus undulatus (budgerigar) that are considered as animal allergen(s). Budgerigar Feather Antigen Budgerigar Serum Antigens Budgerigar Serum Protein Allergen Melopsittacus undulatus Serum Proteins Protein(s) in the serum of the species Melopsittacus undulatus (budgerigar) that are considered as animal allergen(s). Budgerigar Serum Proteins Brown Crab Antigen Cancer pagurus Allergen Rock Crab Antigen Antigen(s) from the species Cancer pagurus (brown crab) that are considered as food allergen(s). Cancer pagurus Antigen CA8 Carbonic anhydrase VIII Carbonic anhydrase-related protein CARP An antigen encoded by the CA8 gene and regulates calcium release and neuron mobility. It can be considered as an autoantigen and is commonly associated with autoimmune paraneoplastic cerebellar degeneration and autoimmune dementia. Carbonic Anhydrase-Related Protein An antigen of the diphosphatidylglycerol lipid found uniquely in the inner membrane of mitochondria. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases antiphospholipid syndrome and systemic rheumatic diseases. Cardiolipin The approximately 20-25 kDa milk protein that is the dominant constituent of total milk protein and is considered as a food allergen. Casein Anacardium occidentale Nut Antigen Cashew Nut Allergen Antigen(s) from the seed of the species Anacardium occidentale (cashew nut) that are considered as food allergen(s). Anacardium occidentale Nut Antigen Cat Dander Allergen Domestic Cat Dander Antigen Felis catus Dander Antigen Antigen(s) in the dander (skin flakes) of the species Felis catus (domestic cat) that are considered as animal allergen(s). Cat Dander Antigen Antigen(s) of the lysosomal proteinase or endopeptidase family and are encoded by the CTS gene. They can be considered as autoantigens and are commonly associated with systemic vasculitis, inflammatory rheumatic diseases, autoimmune hepatitis, and chronic inflammatory bowel diseases. Cathepsin CENP-A Centromere Autoantigen A Centromere Protein A An antigen of the centromere protein encoded by the CENPA gene, with a designation of A. It can be considered as an autoantigen and is commonly associated with the autoimmune disease CREST syndrome. Histone H3-Like Centromeric Protein A CENP-B Centromere Protein B Major Centromere Autoantigen B An antigen of the centromere protein encoded by the CENPB gene, with a designation of B. It can be considered as an autoantigen and is commonly associated with the autoimmune disease CREST syndrome. Major Centromere Autoantigen B Centromere Protein Antigen(s) of the centromere protein family and are encoded by the CENP gene. They can be considered as autoantigens and are commonly associated with the autoimmune diseases Sjogren's syndrome, systemic sclerosis, and CREST syndrome. Centromere Protein Chemical Mix Allergens Antigen(s) from a mix of workplace or household chemicals that are considered as allergen(s). Multiple Chemical Mix Antigens Chicken Meat Allergen Gallus domesticus Meat Antigen Gallus gallus Meat Antigen Antigen(s) in the meat of the species Gallus domesticus (chicken) that are considered as food allergen(s). Chicken Meat Antigen The mixture of DNA and proteins that form the chromosomes. It can be considered as an autoantigen and is commonly associated with the autoimmune disease systemic lupus erythematosus. Chromatin TeNT Tetanospasmin Tetanus Toxin The approximately 150 kDa secreted protein toxin and the virulence factor for Clostridium tetani. Clostridium tetani Toxin The purified and detoxified form of the Clostridium tetani toxin. Toxicity of this toxin is suppressed or inactivated either by heat or with formaldehyde. Clostridium tetani Toxoid Christmas Factor Factor IX FIX An antigen encoded by the F9 gene and plays a role in the intrinsic pathway of blood coagulation through the mediation of proteolysis that converts factor X into an active protease. Coagulation Factor IX Antihemophilic Factor Factor VIII FVIII An antigen encoded by the F8 gene and plays a role in the modulation of coagulation factor VIII activity and blood coagulation. Coagulation Factor VIII Collagen 7 COLVII A member of the collagen superfamily with a Roman numeral designation of VII. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases bullous pemphigoid and epidermolysis bullosa acquisita. Type VII Collagen Common Buckwheat Allergen Fagopyrum esculentum Antigen Antigen(s) from the seed of the species Fagopyrum esculentum (common buckwheat) that are considered as food allergen(s). Common Buckwheat Antigen Ambrosia artemisiifolia Pollen Antigen Ambrosia elatior Pollen Antigen Common Ragweed Pollen Allergen Short Ragweed Pollen Antigen Antigen(s) in the pollen of the species Ambrosia artemisiifolia (common ragweed) that are considered as plant allergen(s). Ambrosia elatior Pollen Antigen An antigen of the "q" subcomponent of the C1 complement protein complex. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases systemic lupus erythematosus and severe rheumatoid arthritis. Complement Component C1q An antigen of the cleaved "d" fragment of the C3 complement protein. It can be considered as an autoantigen and is commonly associated with the autoimmune disease systemic lupus erythematosus. Complement C3d MAC Membrane Attack Complex TCC Terminal Complement Complex A protein complex composed of five activated complement proteins (C5b, C6, C7, C8 and C9) and a cytolytic effector of innate and adaptive immunity, which may be the target of autoantibodies. MAC forms pores in the plasma membrane of pathogens or targeted cells, leading to osmolysis and cell death. Membrane Attack Complex Glycoprotein GP135 Neural Cell Surface Protein F3 An antigen encoded by the CNTN1 gene that functions as a cell adhesion molecule, and plays a role in the formation of axon connections in the developing nervous system. It can be considered as an autoantigen and is commonly associated with autoimmune neuropathies. Contactin-1 Caspr1 CNTNAP1 Neurexin 4 NRXN4 An antigen encoded by the CNTNAP1 gene and is involved in the organization of myelinated axons and neuronal signaling. It can be considered as an autoantigen and is commonly associated with autoimmune neuropathies. Contactin-Associated Protein 1 CASPR2 An antigen encoded by the CNTNAP2 gene and is involved in the structural organization of axons. It can be considered as an autoantigen and is commonly associated with autoimmune encephalitis and Morvan syndrome. Contactin-Associated Protein-Like 2 Corn Allergen Maize Antigen Zea mays Antigen Antigen(s) from the fruit (i.e. kernel/maize) of the species Zea mays (corn) that are considered as food allergen(s). Zea mays Antigen Common Hazel Nut Antigen Common Hazelnut Antigen Corylus avellana Nut Allergen European Hazel Nut Antigen Antigen(s) from the fruit of the species Corylus avellana (common hazel) that are considered as food allergen(s). Corylus Avellana Nut Antigen The purified and detoxified form of the Corynebacterium diphtheriae toxin. Toxicity of this toxin is suppressed or inactivated either by heat or with formaldehyde. Corynebacterium diphtheriae Toxoid Bos taurus Dander Antigen Cattle Dander Antigen Cow Dander Allergen Antigen(s) in the dander (skin flakes) of the species Bos taurus (cow) that are considered as animal allergen(s). Cow Dander Antigen Cow Milk Allergen Antigen(s) from the milk produced by a cow that are considered as food allergen(s). Cow Milk Antigen Cow Whey Allergen Antigen(s) from cow milk that has been curdled and strained, that are considered as food allergen(s). Cow Whey Antigen Avena sativa Cultivated Pollen Antigen Avena sativa Pollen Antigen Cultivated Oat Pollen Allergen Antigen(s) in the pollen of the species Avena sativa (cultivated oat) that are considered as plant allergen(s). Cultivated Oat Pollen Antigen Collapsin Response Mediator Protein 5 CRMP5 CV2 An antigen encoded by the DPYSL5 gene that regulates neurite outgrowth and neurogenesis. It can be considered as a neuronal autoantigen and is commonly associated with autoimmune neurodegenerative disorders related to cancer, such as paraneoplastic neurologic syndrome. Dihydropyrimidinase-Related Protein 5 CCP An antigen of the citrulline-containing peptide with a cyclic structure. It can be considered as an autoantigen and is commonly associated with the autoimmune disease rheumatoid arthritis. Cyclic Citrullinated Peptide cN-1A Mup44 An antigen encoded by the NT5C1A gene and is involved in the dephosphorylation of nucleotides to nucleosides. It can be considered as an autoantigen and is commonly associated with autoimmune disease sporadic inclusion body myositis. Cytosolic 5'-Nucleotidase 1A PGDH An antigen encoded by the PHGDH gene and is involved in the serine biosynthesis pathway. It can be considered as an autoantigen and is commonly associated with autoimmune liver diseases. D-3-Phosphoglycerate Dehydrogenase Dairy Mix Allergens Antigen(s) in the mix of foods made from mammalian milk that are considered as food allergen(s). Multiple Dairy Mix Antigens DNase B Group A Streptococcus Deoxyribonuclease-B The B subtype of nuclease produced by group A beta-hemolytic streptococci. Group A Streptococcus Deoxyribonuclease-B An antigen of the cell-cell adhesion protein encoded by the DSG1 gene. It can be considered as an autoantigen and is commonly associated with autoimmune diseases pemphigus foliaceus and pemphigus vulgaris. Desmoglein-1 An antigen of the cell-cell adhesion protein encoded by the DSG3 gene. It can be considered as an autoantigen and is commonly associated with autoimmune disease pemphigus vulgaris. Desmoglein-3 Dipeptidyl peptidase 6 DPPX An antigen encoded by the DPP6 gene that binds to and regulates the biophysical characteristics of voltage-gated potassium channels. It can be considered as an autoantigen and is commonly associated with autoimmune encephalitis. A-Type Potassium Channel Modulatory Protein DPP6 Canis familiaris Dander Antigen Canis lupus familiaris Dander Antigen Dog Dander Allergen Antigen(s) in the dander (skin flakes) of the species Canis lupus familiaris (dog) that are considered as animal allergen(s). Dog Dander Antigen DRD2 An antigen encoded by the DRD2 gene and is involved in dopamine binding, angiogenesis inhibition, and receptor signaling. It can be considered as an autoantigen and is commonly associated with autoimmune encephalitic syndromes and neuropsychiatric abnormalities. D(2) Dopamine Receptor Deoxyribonucleic Acid Double-stranded DNA ds-DNA dsDNA A long linear double-stranded polymer formed from nucleotides attached to a deoxyribose backbone; associated with the transmission of genetic information. DNA Egg White Allergen Antigen(s) from the clear and liquid substance around the yolk of an egg that are considered as food allergen(s). Egg White Antigen Glycyl-tRNA Synthetase GlyRS An antigen encoded by the GARS1 gene that regulates glycyl-transfer RNA synthesis (attaches glycine to tRNA). It can be considered as an autoantigen and is commonly associated with the autoimmune diseases anti-synthetase syndrome, polymyositis and dermatomyositis. Glycine-tRNA Ligase A group of autoimmune substances found in the endometrium. They are commonly associated with autoimmune endometriosis. Endometrial Autoantigen Antigen(s) in the endomysium that can be considered as autoantigens and are commonly associated with the autoimmune diseases dermatitis herpetiformis and celiac disease. Endomysial Autoantigens English Plantain Pollen Allergen Plantago lanceolata Pollen Antigen Antigen(s) in the pollen of the species Plantago lanceolata (English plantain) that are considered as plant allergen(s). Plantago lanceolata Pollen Antigen English Walnut Allergen Juglans regia Antigen Antigen(s) from the fruit(s) of the species Juglans regia (English walnut) that are considered as food allergen(s). English Walnut Antigen EBV-VCA The approximately 110 kDa structural protein that forms the nucleocapsid of the Epstein-Barr virus. Epstein-Barr Virus Capsid Antigen EBV EA A complex of viral antigens from the Epstein-Barr virus expressed during the lytic cycle. It is comprised of restricted (EA-R) components, found only in the cytoplasm, and diffuse (EA-D) components, located in the nucleus and the cytoplasm. Epstein-Barr Virus Early Antigen EBV EA-D Epstein-Barr Virus Early Antigen Diffuse Component Epstein-Barr Virus Early Antigen-Diffuse The approximately 46-55 kDa lytic protein from the Epstein-Barr virus and is the diffuse component of the Epstein-Barr virus-induced early antigen (EA) complex. Epstein-Barr Virus Early Antigen Diffuse Component EBNA1 EBV Nuclear Antigen 1 The approximately 66 kDa DNA-binding protein with a designation nuclear antigen 1, from the 6 nuclear antigens produced by the Epstein-Barr virus. Epstein-Barr Nuclear Antigen 1 EBNA One or more proteins from the 6 nuclear antigens (EBNA 1, 2, 3, 4, 5 and/or 6) produced by the Epstein-Barr virus. Epstein-Barr Nuclear Antigen Dermatophagoides pteronyssinus Antigen European House Dust Mite Allergen Antigen(s) from the species Dermatophagoides pteronyssinus (European house dust mite) that are considered as insect allergen(s). Dermatophagoides pteronyssinus Antigen ENAs Extractable Nuclear Antigens Saline-extracted Nuclear Antigens A group of autoimmune substances found in the nucleus of a cell which can be extracted from the saline soluble fraction of cells, and may be comprised of (but not limited to) ribonucleoproteins, Smith antigens, Sjogren's antigens, Scl-70 and/or Jo-1 antigens. Extractable Nuclear Autoantigen F-actin A fibrillar actin polymer. It can be considered as an autoantigen and is commonly associated with autoimmune hepatitis and primary biliary cirrhosis. F-actin Atlantic Cod Antigen Cod Antigen Gadus morhua Allergen Antigen(s) from the species Gadus morhua (Atlantic cod) that are considered as food allergen(s). Gadus Morhua Antigen GABABR Gamma-aminobutyric Acid B Receptor The type B receptor in the GABA receptor family that binds to and mediates the neurotransmission of gamma-aminobutyric acid. It can be considered as an autoantigen and is commonly associated with the autoimmune disease limbic encephalitis. Gamma Aminobutyrate B Receptor A sialic acid-containing glycosphingolipid antigen and a component of the cell plasma membrane that modulates cell signal transduction, with a designation of GD1a. It can be considered as an autoantigen and is commonly associated with autoimmune neuropathies such as Guillain-Barre syndrome and multiple sclerosis. Ganglioside GD1A A sialic acid-containing glycosphingolipid antigen and a component of the cell plasma membrane that modulates cell signal transduction, with a designation of GD1b. It can be considered as an autoantigen and is commonly associated with autoimmune neuropathies such as Guillain-Barre syndrome and multiple sclerosis. Ganglioside GD1B A sialic acid-containing glycosphingolipid antigen and a component of the cell plasma membrane that modulates cell signal transduction, with a designation of GD2. It can be considered as an autoantigen and is commonly associated with autoimmune neuropathies such as Guillain-Barre syndrome and multiple sclerosis. Ganglioside GD2 A sialic acid-containing glycosphingolipid antigen and a component of the cell plasma membrane that modulates cell signal transduction, with a designation of GD3. It can be considered as an autoantigen and is commonly associated with autoimmune neuropathies such as Guillain-Barre syndrome and multiple sclerosis. Ganglioside GD3 A sialic acid-containing glycosphingolipid antigen and a component of the cell plasma membrane that modulates cell signal transduction, with a designation of GM1. It can be considered as an autoantigen and is commonly associated with autoimmune neuropathies such as Guillain-Barre syndrome and multiple sclerosis. Monosialotetrahexosylganglioside A sialic acid-containing glycosphingolipid antigen and a component of the cell plasma membrane that modulates cell signal transduction, with a designation of GM2. It can be considered as an autoantigen and is commonly associated with autoimmune neuropathies such as Guillain-Barre syndrome and multiple sclerosis. Ganglioside GM2 A sialic acid-containing glycosphingolipid antigen and a component of the cell plasma membrane that modulates cell signal transduction, with a designation of GM3. It can be considered as an autoantigen and is commonly associated with autoimmune neuropathies such as Guillain-Barre syndrome and multiple sclerosis. Ganglioside GM3 A sialic acid-containing glycosphingolipid antigen and a component of the cell plasma membrane that modulates cell signal transduction, with a designation of GM4. It can be considered as an autoantigen and is commonly associated with autoimmune neuropathies such as Guillain-Barre syndrome and multiple sclerosis. Ganglioside GM4 A sialic acid-containing glycosphingolipid antigen and a component of the cell plasma membrane that modulates cell signal transduction, with a designation of GQ1b. It can be considered as an autoantigen and is commonly associated with autoimmune neuropathies such as Guillain-Barre syndrome and multiple sclerosis. Ganglioside GQ1B A sialic acid-containing glycosphingolipid antigen and a component of the cell plasma membrane that modulates cell signal transduction, with a designation of GT1a. It can be considered as an autoantigen and is commonly associated with autoimmune neuropathies such as Guillain-Barre syndrome and multiple sclerosis. Ganglioside GT1A A sialic acid-containing glycosphingolipid antigen and a component of the cell plasma membrane that modulates cell signal transduction, with a designation of GT1b. It can be considered as an autoantigen and is commonly associated with autoimmune neuropathies such as Guillain-Barre syndrome and multiple sclerosis. Ganglioside GT1B Blattella germanica Antigen German Cockroach Allergen Antigen(s) from the species Blattella germanica (German cockroach) that are considered as insect allergen(s). Blattella germanica Antigen An antigen and alcohol-soluble fraction of gluten from wheat and other grains that is considered as a food allergen. Gliadin Antigen One or more of the gliadin peptides that have been deamidated (where glutamine residues are turned into glutamic acid). Gliadin is a component of gluten which is considered as a food allergen. Deamidated Gliadin Peptide GFAP GFAP-alpha GFAP-alpha Isoform GFAPa The alpha isoform (i.e. the canonical form) of the glial fibrillary acidic protein which is involved in both neuronal maintenance and astrocyte morphology and motility. It can be considered as an autoantigen and is commonly associated with autoimmune astrocytopathy. Glial Fibrillary Acidic Protein Glial Nuclear Type 1 Autoantigen Sox1 Sox1 Nuclear Antigen Transcription Factor SOX-1 An antigen encoded by the Sox1 gene. This protein is a transcription activator and may be involved in neuronal development. It can be considered as an autoantigen and is commonly associated with autoimmune neuropathies. Transcription Factor SOX-1 GBM Antigens GBM Autoantigens A group of autoimmune substances found in the glomerular basement membrane that may be comprised of (but not limited to) the alpha 3 chain of type IV collagen. They are commonly associated with autoimmune disease Goodpasture syndrome. Glomerular Basement Membrane Autoantigens GAD67 Glutamate decarboxylase 67 Glutamic Acid Decarboxylase 67 An antigen of the 67 kDa isoform of GAD which is encoded by the GAD1 gene. It can be considered as an autoantigen and is commonly associated with the autoimmune disease type 1 diabetes. Glutamate Decarboxylase 1 GAD65 Glutamate decarboxylase 65 Glutamic Acid Decarboxylase 65 An antigen of the 65 kDa isoform of GAD which is encoded by the GAD2 gene. It can be considered as an autoantigen and is commonly associated with the autoimmune disease type 1 diabetes. Glutamate Decarboxylase 2 GAD Any antigen(s) encoded by the GAD gene that catalyze the decarboxylation of glutamate to GABA. They can be considered as autoantigens and are commonly associated with the autoimmune diseases type 1 diabetes, autoimmune polyendocrine syndrome types 1 and 2, and stiff man syndrome. Glutamate Decarboxylase GLRA1 Glycine Glycine Receptor 48 kDa Subunit GlyRa1 An antigen encoded by the GLRA1 gene and the alpha helical transmembrane subunit of the glycine receptor. It can be considered as an autoantigen and is commonly associated with the autoimmune neurological disorder stiff-person syndrome. Glycine Receptor Subunit Alpha-1 GlyR The ligand-gated chloride ion channel that binds to and mediates the neurotransmission of glycine. Glycine receptors are composed of two main subunits, alpha and beta. It can be considered as an autoantigen and is commonly associated with the autoimmune neurological disorder stiff-person syndrome. Glycine Receptor Complex Chenopodium album Pollen Antigen Goosefoot Pollen Allergen Lamb's Quarters Pollen Antigen White Goosefoot Pollen Antigen Antigen(s) in the pollen of the species Chenopodium album (goosefoot) that are considered as plant allergen(s). Goosefoot Pollen Grass Mix Pollens Allergens Antigen(s) in the pollens of a mix of grasses that are considered as plant allergen(s). Multiple Grass Mix Pollen Antigens Actinidia deliciosa Antigen Chinese Gooseberry Antigen Green Kiwifruit Allergen Antigen(s) from the fruit of the species Actinidia deliciosa (green/fuzzy kiwi) that are considered as food allergen(s). Green Kiwifruit Antigen Alnus incana Pollen Antigen Grey Alder Pollen Allergen Antigen(s) in the pollen of the species Alnus incana (grey alder tree) that are considered as plant allergen(s). Grey Alder Pollen Antigen HBcAg Hepatitis B Virus Capsid Antigen The approximately 21.5 kDa structural protein that forms the nucleocapsid of the Hepatitis B virus. Hepatitis B Virus Capsid Antigen HBeAg Hepatitis B Virus Early Antigen The approximately 16-18 kDa nonstructural tolerogen that forms in-between the nucleocapsid and the lipid envelope of, and is secreted by the Hepatitis B virus. Hepatitis B Virus Early Antigen HBsAg One or more of the three structural surface proteins, small, HBsAg S (26 kDa); middle, HBsAg M (33 kDa); and large, HBsAg L (41 kDa), that form the hepatitis B viral lipid envelope. Hepatitis B Virus HBsAg Surface Protein Antigen HCV 5-1-1 The 42 amino acid synthetic peptide encoded by the putative NS4 region of the Hepatitis C virus genome. Hepatitis C Virus 5-1-1 Peptide HCV C100-3 The 16 amino acid synthetic peptide encoded by the putative NS4 region of the Hepatitis C virus genome. Hepatitis C Virus C100-3 Peptide HCV C22-3 The 44 amino acid synthetic peptide encoded by the putative nucleocapsid core region of the Hepatitis C virus genome. Hepatitis C Virus C22-3 Peptide HCV C33c The 266 amino acid recombinant protein encoded by the putative NS3 region of the Hepatitis C virus genome. Hepatitis C Virus C33C Antigen HCV Nonstructural Protein 5 The nonstructural protein encoded by the putative NS5 region of the Hepatitis C virus genome. Hepatitis C Virus Ns5 Antigen HSV Types Mix Human Herpes Simplex Virus Types Mix A mixture of multiple, different human herpes simplex virus types. Mixed Herpes Simplex Virus Types An antigen in the core histone family and a subunit of the nucleosome complex, with a designation of H1. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases systemic lupus erythematosus and rheumatoid arthritis. Histone H1 An antigen in the core histone family and a subunit of the nucleosome complex, with a designation of H2A. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases systemic lupus erythematosus and rheumatoid arthritis. Histone H2A An antigen in the core histone family and a subunit of the nucleosome complex, with a designation of H2B. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases systemic lupus erythematosus and rheumatoid arthritis. Histone H2B An antigen in the core histone family and a subunit of the nucleosome complex, with a designation of H3. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases systemic lupus erythematosus and rheumatoid arthritis. Histone H3 An antigen in the core histone family and a subunit of the nucleosome complex, with a designation of H4. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases systemic lupus erythematosus and rheumatoid arthritis. Histone H4 Any antigen(s) of the histone nuclear protein family. They can be considered as autoantigens and are commonly associated with the autoimmune diseases systemic lupus erythematosus and rheumatoid arthritis. Histone Histoplasma capsulatum Glycoprotein H The approximately 115 kDa secreted, immunogenic glycoprotein, with potential beta-glucosidase activity, encoded by the H antigen gene (HAG1) from the fungus Histoplasma capsulatum. Histoplasma capsulatum H Antigen Histoplasma capsulatum Glycoprotein M The approximately 70-94 kDa secreted, immunogenic glycoprotein, with potential catalase activity, encoded by the M antigen gene, from the fungus Histoplasma capsulatum. Histoplasma capsulatum M Antigen A mixture of multiple, different species (or below the species level classifications) of the human immunodeficiency viruses. Mixed Human Immunodeficiency Viruses HIV-1 Glycoprotein 120 The approximately 120 kDa envelope glycoprotein encoded by the human immunodeficiency virus 1. Hiv-1 Gp120 HIV-1 Glycoprotein 160 The approximately 160 kDa envelope glycoprotein from the human immunodeficiency virus 1. This precursor protein is further cleaved into the gp120 and gp41 proteins. HIV-1 gp160 HIV-1 Glycoprotein 40 The approximately 40 kDa envelope glycoprotein encoded from the human immunodeficiency virus 1. Hiv-1 Gp40 HIV-1 Glycoprotein 41 The approximately 41 kDa transmembrane, envelope glycoprotein from the human immunodeficiency virus 1. This transmembrane protein is cleaved from the precursor GP160 protein. HIV-1 gp41 HIV-1 Gag p18 Protein The approximately 18 kDa product from the GAG polyprotein encoded by the human immunodeficiency virus 1. Hiv-1 P18 HIV-1 Gag p24 Protein HIV-1 P24 Capsid Protein The approximately 24 kDa structural protein that forms the nucleocapsid of the human immunodeficiency virus 1. HIV-1 p24 HIV-1 IN The approximately 31 kDa integrase from the human immunodeficiency virus 1. HIV-1 p31 HIV-1 Reverse Transcriptase p51 Subunit HIV-1 RT p51 Protein The approximately 51 kDa protein subunit of the reverse transcriptase encoded by the human immunodeficiency virus 1. Hiv-1 P51 HIV-1 Gag p55 Protein HIV-1 Gag Precursor Protein 55 HIV-1 Pr55 Gag The approximately 55 kDa Gag polyprotein product encoded by the human immunodeficiency virus 1. It is a precursor protein for several proteins that form the core structure of the HIV-1 virus. Hiv-1 P55 HIV-1 RT p65 Protein The approximately 65 kDa protein subunit of the reverse transcriptase encoded by the human immunodeficiency virus 1. Hiv-1 P65 HIV-2 Glycoprotein 140 The approximately 140 kDa envelope glycoprotein from the human immunodeficiency virus 2. HIV-2 gp140 HIV-2 Glycoprotein 36 The approximately 36 kDa transmembrane, envelope glycoprotein from the human immunodeficiency virus 2. HIV-2 gp36 A group of human leukocyte antigens that are typically expressed as transmembrane glycoproteins on the surface of all nucleated cells, and consist mainly of (but are not limited to) HLA-A, HLA-B and HLA-C. MHC Class I Protein A group of human leukocyte antigens that are typically expressed on professional antigen-presenting cells, and consist mainly of (but are not limited to) HLA-DR, HLA-DP and HLA-DQ. MHC Class II Protein HLA-A11 The human leukocyte antigen serotype A11 from the HLA-A serotype group encoded by the HLA-A gene. HLA Class I Histocompatibility Antigen, A-11 Alpha Chain HLA-A2 The human leukocyte antigen serotype A2 from the HLA-A serotype group encoded by the HLA-A gene. HLA Class I Histocompatibility Antigen, A-2 Alpha Chain HLA-A23 The human leukocyte antigen serotype A23 from the HLA-A serotype group encoded by the HLA-A gene. HLA Class I Histocompatibility Antigen, A-23 Alpha Chain HLA-A32 The human leukocyte antigen serotype A32 from the HLA-A serotype group encoded by the HLA-A gene. HLA Class I Histocompatibility Antigen, A-32 Alpha Chain HLA-B27 The human leukocyte antigen serotype B27 from the HLA-B serotype group encoded by the HLA-B gene. HLA Class I Histocompatibility Antigen, B-27 Alpha Chain HLA-B35 The human leukocyte antigen serotype B35 from the HLA-B serotype group encoded by the HLA-B gene. HLA Class I Histocompatibility Antigen, B-35 Alpha Chain HLA-C15 The human leukocyte antigen serotype C15 from the HLA-C serotype group encoded by the HLA-C gene. HLA Class I Histocompatibility Antigen, C-15 Alpha Chain HLA-C4 The human leukocyte antigen serotype C4 from the HLA-C serotype group encoded by the HLA-C gene. HLA Class I Histocompatibility Antigen, C-4 Alpha Chain HLA-DR11 The human leukocyte antigen serotype DR11 from the HLA-DR serotype group encoded by the HLA-DRB1 gene. HLA Class II Histocompatibility Antigen, DRB1-11 Beta Chain HLA-DR14 The human leukocyte antigen serotype DR14 from the HLA-DR serotype group encoded by the HLA-DRB1 gene. HLA Class II Histocompatibility Antigen, DRB1-14 Beta Chain HLA-DR51 The human leukocyte antigen serotype DR51 from the HLA-DR serotype group encoded by the HLA-DRB5 gene. HLA-DR51 Antigen HLA-DR52 The human leukocyte antigen serotype DR52 from the HLA-DR serotype group encoded by the HLA-DRB3 gene. HLA-DR52 Antigen HLA-DR53 The human leukocyte antigen serotype DR53 from the HLA-DR serotype group encoded by the HLA-DRB4 gene. HLA-DR53 Antigen Domestic Horse Dander Antigen Equus caballus Dander Antigen Horse Dander Allergen Antigen(s) in the dander (skin flakes) of the species Equus caballus (domestic horse) that are considered as animal allergen(s). Horse Dander Antigen Antigen(s) from house dust that are considered as allergen(s). House Dust Antigen A mixture of multiple, different species (or below the species level classifications) of the human T-cell lymphotropic viruses. Mixed Human T-cell Lymphotropic Viruses HAS Human Serum Albumin An antigen of plasma protein and encoded by the ALB gene. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases systemic lupus erythematosus and type 1 diabetes. Albumin (Human) The fragment crystallizable region (Fc) of the immunoglobulin G. Immunoglobulin Fc Calocedrus decurrens Pollen Antigen Incense Cedar Pollen Allergen Libocedrus decurrens Pollen Antigen Antigen(s) in the pollen of the species Calocedrus decurrens (incense cedar tree) that are considered as plant allergen(s). Incense Cedar Pollen Multiple Inhalant Allergens Antigen(s) from a mix of common airborne and inhaled substance(s) that are considered as aeroallergen(s) which cause inhalant allergy. Inhalant Mix Antigens An antigen encoded by the INS gene and regulates glucose metabolism. It can be considered as an autoantigen and is commonly associated with autoimmune diabetes mellitus. Insulin IA-2 INSM2 Zinc Finger Protein IA-6 An antigen encoded by the INSM2 gene and regulates insulin secretion. It can be considered as an autoantigen and is commonly associated with the autoimmune disease type 1 diabetes. Insulinoma-Associated Protein 2 Cobalamin Binding Intrinsic Factor Gastric Intrinsic Factor GIF TCN3 Transcobalamin 3 A glycoprotein encoded by the CBLIF gene, produced by the parietal cells in the stomach, and is necessary for the absorption of vitamin B12 (cobalamin) in the distal ileum of the small intestine. It can be considered as an autoantigen and is commonly associated with the autoimmune disease pernicious anemia. Cobalamin Binding Intrinsic Factor IA-2 ICA512 Islet Antigen 2 Islet Cell Autoantigen 3 PTP-IA2 Receptor-type Tyrosine-protein Phosphatase-like N An antigen encoded by the PTPRN gene and regulates insulin secretion. It can be considered as an autoantigen and is commonly associated with the autoimmune disease type 1 diabetes. Receptor-Type Tyrosine-Protein Phosphatase-Like N Islet Autoantigens A group of autoimmune substances found in the pancreatic islet beta cells. They are commonly associated with the autoimmune disease type 1 diabetes. Islet Cell Autoantigen A group of autoimmune substances found in the cytoplasm of pancreatic islet cells that are the target of autoantibodies. They are commonly associated with the autoimmune disease type 1 diabetes. Islet Cell Cytoplasmic Autoantigen INGAP An antigen encoded by the INGAP gene and can stimulate the creation of new islet mass from adult pancreatic progenitor cells. It can be considered as an autoantigen and is commonly associated with autoimmune diabetes. Regenerating Islet-Derived Protein 3-Alpha Cupressus sempervirens Pollen Antigen Funeral Cypress Pollen Antigen Italian Cypress Pollen Allergen Mediterranean Cypress Pollen Antigen Antigen(s) in the pollen of the species Cupressus sempervirens (Italian cypress) that are considered as plant allergen(s). Italian Cypress Pollen Antigen Alnus japonica Pollen Antigen Japanese Alder Pollen Allergen Antigen(s) in the pollen of the species Alnus japonica (Japanese alder tree) that are considered as plant allergen(s). Japanese Alder Pollen Cryptomeria japonica Pollen Antigen Japanese Cedar Pollen Allergen Antigen(s) in the pollen of the species Cryptomeria japonica (Japanese cedar tree) that are considered as plant allergen(s). Japanese Cedar Pollen Antigen Chamaecyparis obtusa Pollen Antigen Hinoki Cypress Pollen Antigen Japanese Cypress Pollen Allergen Antigen(s) in the pollen of the species Chamaecyparis obtusa (Japanese cypress tree) that are considered as plant allergen(s). Japanese Cypress Pollen HisRS Histidine tRNA Ligase 1, Cytoplasmic Histidyl-tRNA Synthetase 1 An antigen encoded by the HARS1 gene that regulates histidyl-transfer RNA synthesis (attaches histidine to tRNA). It can be considered as an autoantigen and is commonly associated with the autoimmune diseases anti-synthetase syndrome, polymyositis and dermatomyositis. Histidine-tRNA Ligase, Cytoplasmic Johnson Grass Pollen Allergen Sorghum halepense Pollen Sorghum halepense Pollen Antigen Antigen(s) in the pollen of the species Sorghum halepense (Johnson grass) that are considered as plant allergen(s). Sorghum halepense Pollen Antigen June Grass Pollen Antigen Kentucky Bluegrass Pollen Allergen Poa pratensis Pollen Antigen Antigen(s) in the pollen of the species Poa pratensis (Kentucky bluegrass) that are considered as plant allergen(s). Kentucky Bluegrass Pollen Antigen KLH Megathura crenulata Hemocyanin An antigen found in the hemolymph of the species Megathura crenulata (giant keyhole limpet) that is also considered as a food allergen. Megathura crenulata Hemocyanin Antigen Ku Autoantigen A heterodimer (Ku70/Ku80) DNA-binding nuclear protein that is involved in nonhomologous end-joining DNA repair, and the recognition and repair of double-stranded DNA breaks. It can be considered as an autoantigen and is commonly associated with autoimmune connective tissue diseases and systemic sclerosis. Ku Protein Lactotransferrin An antigen encoded by the LTF gene that binds to iron and has antimicrobial function. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases rheumatoid vasculitis and arthritis, systemic lupus erythematosus, ulcerative colitis, and Crohn's disease. Lactotransferrin LGI1 An antigen encoded by the LGI1 gene and is involved in the regulation of voltage-gated potassium channel assembly and activity. It can be considered as an autoantigen and is commonly associated with autoimmune encephalitis. Leucine-Rich Glioma-Inactivated Protein 1 Formiminotransferase-Cyclodeaminase LC-1 Liver Cytosol Type 1 An antigen of the human liver 58 kDa cytosolic polypeptide encoded by the FTCD gene. It can be considered as an autoantigen and is commonly associated with type 2 autoimmune hepatitis. Formimidoyltransferase-Cyclodeaminase LKM Antigens A group of autoimmune substances in the P450 mixed-function oxidase system that may be comprised of (but not limited to) cytochrome P450 2D6 (LKM type 1), P450 2C9 (LKM type 2) and P450 1A2 (LKM type 3). They are commonly associated with autoimmune hepatitis. Liver Kidney Microsomal Antigens CYP2D6 Cytochrome P450 2D6 Liver Kidney Microsomal 1 Antigen An antigen in the cytochrome P450 mixed-function oxidase system and is encoded by the CYP2D6 gene, it is a major drug metabolizing enzyme. It can be considered as an autoantigen and is commonly associated with the autoimmune hepatitis. Cytochrome P450 2D6 LDL Receptor Related Protein 4 LRP4 MEGF7 Multiple Epidermal Growth Factor-like Domains 7 Sclerosteosis 2 SOST2 An antigen encoded by the LRP4 gene and a regulator of the Wnt signaling that is involved in neuromuscular junction formation. It can be considered as an autoantigen and is commonly associated with the autoimmune disease myasthenia gravis. Low-Density Lipoprotein Receptor-Related Protein 4 Paraneoplastic Antigen Ma1 PNMA1 An antigen encoded by the PNMA1 gene that may promote apoptosis. It can be considered as a neuronal autoantigen and is commonly associated with autoimmune neurodegenerative disorders related to cancer, such as paraneoplastic neurologic syndrome. Paraneoplastic Antigen Ma1 Paraneoplastic Antigen Ma2 PNMA2 Ta Antigen An antigen encoded by the PNMA2 gene and regulates apoptosis. It can be considered as a neuronal autoantigen and is commonly associated with autoimmune neurodegenerative disorders related to cancer, such as paraneoplastic neurologic syndrome. Paraneoplastic Antigen Ma2 CADM-140 Autoantigen Interferon Induced With Helicase C Domain 1 Melanoma Differentiation-Associated Protein 5 An antigen encoded by the IFIH1 gene and is involved in the induction of antiviral responses. It can be considered as an autoantigen and is commonly associated with autoimmune dermatomyositis and interstitial lung disease. IFIH1 wt Allele Festuca elatior Pollen Antigen Lolium arundinaceum Pollen Antigen Meadow Fescue Pollen Allergen Tall Fescue Pollen Antigen Antigen(s) in the pollen of the species Festuca elatior (meadow fescue) that are considered as plant allergen(s). Meadow Fescue Pollen Antigen mGluR5 An antigen encoded by the GRM5 gene and is involved in both glutamate binding and downstream signal transduction. It can be considered as an autoantigen and is commonly associated with autoimmune encephalitis. Metabotropic Glutamate Receptor 5 Dermatomyositis Autoantigen Mi-2 Alpha MI-2 Alpha MI-2a The 220 kDa alpha isoform of the MI-2 antigen encoded by CHD3 gene, which is a helicase in the nucleosome remodeling-deacetylase complex involved in transcription regulation. It can be considered as an autoantigen and is commonly associated with the systemic autoimmune myopathy dermatomyositis. Chromodomain-Helicase-DNA-Binding Protein 3 Dermatomyositis Autoantigen Mi-2 Major Dermatomyositis-specific Mi-2 Autoantigen Antigens derived from certain helicases in the nucleosome remodeling-deacetylase complex (NuRD) involved in transcription regulation that may be comprised of (but not limited to) two isoforms Mi-2 alpha and Mi-2 beta. They can be considered as autoantigens and are commonly associated with systemic autoimmune myopathy dermatomyositis. MI-2 Antigens Chromodomain-Helicase-DNA-Binding Protein 4 Dermatomyositis Autoantigen Mi-2 Beta MI-2 Beta MI-2b The 218 kDa beta isoform of the MI-2 antigen encoded by CHD4 gene, which is a helicase in the nucleosome remodeling-deacetylase complex involved in transcription regulation. It can be considered as an autoantigen and is commonly associated with the systemic autoimmune myopathy dermatomyositis. Chromodomain-Helicase-DNA-Binding Protein 4 Antigen(s) from any dietary milk that are considered as food allergen(s). Dairy Milk Antigen M2-3E (BPO) A recombinant fusion protein that is made of the E2-subunits from three main M2-antigens branched-chain 2-oxoacid dehydrogenase, pyruvate dehydrogenase complex (PDC) and 2-oxoglutarate dehydrogenase. It can be considered as an autoantigen and is commonly associated with primary biliary liver cirrhosis and other autoimmune liver diseases. Mitochondria M2-3E Antigen A group of autoimmune, multienzyme complexes found within the inner and outer lining of the mitochondria that may be comprised of (but not limited to) M1 through M9 antigens. They are commonly associated with autoimmune hepatitis and primary biliary cholangitis/cirrhosis. Mitochondrial Autoantigen Mitochondrial Antigen M2 Mitochondrial Autoantigen M2 Antigen(s) of the inner mitochondrial membrane proteins, with a designation of M2, and may be comprised of (but not limited to) protein X, the E2 component, E1a and E1b subunits of the pyruvate dehydrogenase complex (PDC). They can be considered as autoantigens and are commonly associated with autoimmune hepatitis and primary biliary cholangitis/cirrhosis. Mitochondrial M2 Antigen Mixed Allergens Antigen(s) from a mix of types of sources that are considered as allergen(s). Multiple Mixed Antigens MORC3 Nuclear Matrix Protein 2 NXP2 An antigen encoded by the MORC3 gene that is involved in both RNA binding and nuclear matrix protein binding. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases polymyositis and dermatomyositis. MORC Family CW-Type Zinc Finger Protein 3 Mold Mix Allergens Antigen(s) from a mix of molds that are considered as allergen(s). Multiple Mold Mix Antigens Artemisia vulgaris Pollen Antigen Chrysanthemum Weed Pollen Antigen Common Wormwood Pollen Antigen Mugwort Pollen Allergens Antigen(s) in the pollen of the species Artemisia vulgaris (mugwort) that are considered as plant allergen(s). Mugwort Pollen Antigen Muscle Specific Receptor Tyrosine Kinase MuSK An antigen encoded by the MUSK gene and is involved in receptor signaling, tyrosine phosphorylation and both the development and maintenance of the postsynaptic side of the neuromuscular junction. It can be considered as an autoantigen and is commonly associated with autoimmune disease myasthenia gravis. Muscle, Skeletal Receptor Tyrosine-Protein Kinase A group of autoimmune substances found in the myelin sheath, which is a layer of phospholipids and protein found on neuronal axons. They are commonly associated with the autoimmune diseases multiple sclerosis and Guillain-Barre syndrome. Myelin Autoantigens MOG An antigen encoded by the MOG gene and is involved in the myelination of nerves in the central nervous system. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases multiple sclerosis and other demyelinating diseases. Myelin-Oligodendrocyte Glycoprotein MPO An antigen encoded by the MPO gene that regulates innate immunity through hypohalous acids production. It can be considered as an autoantigen and is commonly associated with autoimmune systemic vasculitis diseases, cystic fibrosis, COPD and other inflammatory conditions. Myeloperoxidase Natural Rubber Latex Allergen NRL Antigen Antigen(s) in the extract (natural latex sap) from the species Hevea brasiliensis (rubber tree) that are considered as occupational allergen(s). Natural Rubber Latex Antigen A group of autoimmune substances found in the neurons that may be comprised of (but not limited to) Hu, Tr, Yo and Ri proteins. They can be considered as neuronal autoantigens and are commonly associated with autoimmune neurodegenerative disorders related to cancer, such as paraneoplastic neurologic syndrome. Neuronal Nuclear Autoantigens ANNA-1 Antigens Hu Antigens A group of autoimmune substances found in the neurons that may be comprised of (but not limited to) the Hu proteins HuD, HuC, HuR (HuA), and HuB (Hel-N1) and Hel-N2. They can be considered as neuronal autoantigens and are commonly associated with autoimmune neurodegenerative disorders related to cancer, such as paraneoplastic neurologic syndrome. Neuronal Nuclear Type 1 Autoantigens ANNA-2 Antigens Ri Antigens A group of autoimmune substances found in the neurons that may be comprised of (but not limited to) the Ri proteins Nova-1 and Nova-2. They can be considered as neuronal autoantigens and are commonly associated with autoimmune neurodegenerative disorders related to cancer, such as paraneoplastic neurologic syndrome. Neuronal Nuclear Type 2 Autoantigens ANNA-3 Antigen DACH1 Dachshund Family Transcription Factor 1 Dachshund-Homolog 1 An antigen encoded by the DACH1 gene and regulates gene expression and cell fate determination during development. It can be considered as a neuronal autoantigen and is commonly associated with autoimmune neurodegenerative and paraneoplastic disorders related to cancer. Dachshund Homolog 1 N-Methyl-D-Aspartate Receptor An antigen of the NMDA receptor that binds to and mediates the neurotransmission of N-methyl-D-aspartic acid and iron. It can be considered as an autoantigen and is commonly associated with autoimmune encephalitis. N-Methyl-D-Aspartate Receptor SP100 Sp100 Nuclear Antigen An antigen encoded by the SP100 gene and is involved in promyelocytic leukemia nuclear (PML) body function, transcriptional regulation and DNA binding. It can be considered as an autoantigen and is commonly associated with the autoimmune disease primary biliary cholangitis. Nuclear Autoantigen Sp-100 A group of autoimmune substances found in the nucleus of a cell that are the target of autoantibodies. Nuclear Autoantigen GP120 Nuclear Pore Membrane Glycoprotein 210 Nucleoporin 210kDa An antigen encoded by the NUP210 gene and is essential for assembly and fusion, spacing and structural integrity of the nuclear pore. It can be considered as an autoantigen and is commonly associated with the autoimmune disease primary biliary cirrhosis. Nuclear Pore Membrane Glycoprotein 210 Antigen(s) of DNA packaging complexes comprising of a strand of DNA winding around a protein core and an octamer of histones. They can be considered as autoantigens and are commonly and mainly associated with the autoimmune disease systemic lupus erythematosus. Nucleosome Nut Mix Allergens Antigen(s) from a mix of edible nuts that are considered as food allergen(s). Multiple Nut Mix Antigens IleRS Isoleucyl-tRNA Synthetase An antigen encoded by the IARS1 gene that regulates isoleucyl-transfer RNA synthesis (attaches isoleucine to tRNA). It can be considered as an autoantigen and is commonly associated with the autoimmune diseases anti-synthetase syndrome, polymyositis and dermatomyositis. Isoleucine-tRNA Ligase, Cytoplasmic Common Olive Pollen Antigen Olea europaea Pollen Antigen Olive Tree Pollen Allergen Antigen(s) in the pollen of the species Olea europaea (olive tree) that are considered as plant allergen(s). Olea europaea Pollen Antigen Cocksfoot Grass Pollen Antigen Dactylis glomerata Pollen Antigen Orchard Grass Pollen Allergen Antigen(s) in the pollen of the species Dactylis glomerata (orchard grass) that are considered as plant allergen(s). Dactylis glomerata Pollen Antigen Blatta orientalis Antigen Oriental Cockroach Allergen Antigen(s) from the species Blatta orientalis (Oriental Cockroach) that are considered as insect allergen(s). Oriental Cockroach Antigen Gal d 2 The 44 kDa egg white, heat-labile protein that is considered as a food allergen. Ovalbumin Ovary Autoantigens A group of autoimmune substances found in the ovaries that may be mainly comprised of (but not limited to) 17-alpha-hydroxylase and members of the aldehyde dehydrogenase family. They can be considered as autoantigens and are commonly associated with the autoimmune diseases premature ovarian failure with Addison's disease and polyendocrinopathy syndromes. Ovarian Autoantigens Gal d 1 The 28 kDa egg white glycoprotein with trypsin inhibitor activity that is considered as a food allergen. Ovomucoid Ox-LDL Oxidized LDL Cholesterol An antigen of low density lipoprotein cholesterol that is also oxidized. It can be considered as an autoantigen and is commonly associated inflammatory and autoimmune conditions. Oxidized Low Density Lipoprotein Cholesterol EXOSC10 Exosome Component 10 PM/Scl 2 PM/Scl-100 Polymyositis/Scleroderma Autoantigen 2 An antigen encoded by the EXOSC10 gene and is involved in the maturation and degradation of RNA. It can be considered as an autoantigen and is commonly associated with the autoimmune disease polymyositis-scleroderma overlap syndrome. Exosome Component 10 EXOSC9 Exosome Component 9 PM/Scl 2 PM/Scl-75 Polymyositis/Scleroderma autoantigen 1 An antigen encoded by the EXOSC9 gene and is involved in the maturation and degradation of RNA. It can be considered as an autoantigen and is commonly associated with the autoimmune disease polymyositis-scleroderma overlap syndrome. Exosome Complex Component RRP45 Northern Red Shrimp Antigen Northern Shrimp Antigen Pandalus borealis Allergen Antigen(s) from the species Pandalus borealis (Northern shrimp) that are considered as food allergen(s). Pandalus Borealis Antigen Gastric Parietal Cell Autoantigens A group of autoimmune substances found in the parietal cells, which are epithelial cells located in the mucous membrane of the stomach. They are commonly associated with autoimmune gastritis and pernicious anemia. Gastric Parietal Cell Autoantigens Parietaria judaica Pollen Allergen Parietaria judaica Pollen Antigen Wall Pellitory (judaica) Pollen Antigen Antigen(s) in the pollen of the species Parietaria judaica (wall pellitory) that are considered as plant allergen(s). Parietaria judaica Pollen Antigen Parietaria officinalis Pollen Allergen Parietaria officinalis Pollen Antigen Wall Pellitory (officinalis) Pollen Antigen Antigen(s) in the pollen of the species Parietaria officinalis (wall pellitory) that are considered as plant allergen(s). Parietaria officinalis Pollen Antigen Peach Allergen Prunus persica Antigen Antigen(s) from the fruit(s) of the species Prunus persica (peach) that are considered as food allergen(s). Peach Antigen Arachis hypogaea Antigen Peanut Allergen Antigen(s) from the seed of the species Arachis hypogaea (peanut) that are considered as food allergen(s). Arachis hypogaea Antigen Carya illinoinensis Nut Antigen Hickory Nut Antigen Pecan Nut Allergen Antigen(s) from the seed of the species Carya illinoinensis (pecan) that are considered as food allergen(s). Pecan Nut Antigen A group of autoimmune substances related to the Pemphigoid diseases that may be mainly comprised of (but not limited to) the basement membrane zone antigens and proteins from the collagen superfamily. Pemphigoid Autoantigens Lolium perenne Pollen Antigen Perennial Ryegrass Pollen Allergen Rye grass Pollen Antigen Antigen(s) in the pollen of the species Lolium perenne (perennial ryegrass) that are considered as plant allergen(s). Perennial Ryegrass Pollen Antigen An antigen of the phospholipid containing serine in the inner cell membrane. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases of antiphospholipid syndrome and systemic sclerosis. Phosphatidylserine M-Type Phospholipase A2 Receptor PLA2R An antigen encoded by the PLA2R1 gene and is involved in the modulation of phospholipase activity. It can be considered as an autoantigen and is commonly associated with autoimmune disease membranous nephropathy. Secretory Phospholipase A2 Receptor Antigen(s) of the phosphate-containing lipids. They can be considered as autoantigens and are commonly and mainly associated with the autoimmune diseases antiphospholipid syndrome and systemic rheumatic diseases such as systemic lupus erythematosus. Phospholipid Columba livia Serum Proteins Domestic Pigeon Serum Antigens Protein(s) in the serum of the species Columba livia (pigeon) that are considered as animal allergen(s). Pigeon Serum Protein Pistachio Allergen Pistacia vera Antigen Antigen(s) from the seed of the species Pistacia vera (pistachio) that are considered as food allergen(s). Pistachio Antigen AARS Alanyl-tRNA Synthetase AlaRS An antigen encoded by the AARS1 gene that regulates alanyl-transfer RNA synthesis (attaches alanine to tRNA). It can be considered as an autoantigen and is commonly associated with the autoimmune diseases anti-synthetase syndrome, polymyositis and dermatomyositis. Alanine-tRNA Ligase, Cytoplasmic Threonyl-tRNA Synthetase ThrRS TRS An antigen encoded by the TARS1 gene that regulates threonyl-transfer RNA synthesis (attaches threonine to tRNA). It can be considered as an autoantigen and is commonly associated with the autoimmune diseases anti-synthetase syndrome, polymyositis and dermatomyositis. Threonine-tRNA Ligase 1, Cytoplasmic PF4-Heparin An antigen of the protein complex comprising of platelet factor 4 and heparin. It can be considered as an autoantigen and is commonly associated with the autoimmune disease heparin-induced thrombocytopenia. Platelet Factor 4-Heparin Complex Platelet GPIb/Ix A glycoprotein complex and platelet surface receptor composed of the transmembrane GPIb and GPIX subunits. It mediates platelet adhesion, activation, clearance, and thrombopoiesis. This complex can be considered as an autoantigen and is commonly associated with autoimmune thrombocytopenic purpura. Glycoprotein Ib/IX Complex CD41/61 Integrin Alpha IIb/Beta 3 Platelet GPIIb/IIIa A glycoprotein complex and platelet surface receptor composed of the transmembrane GPIIb and GPIIIa subunits. It mediates platelet adhesion, activation, clearance, and thrombopoiesis. This complex can be considered as an autoantigen and is commonly associated with autoimmune thrombocytopenic purpura. Integrin Alpha-IIb/Beta-3 Pig Meat Antigen Pork Allergen Sus domesticus Meat Antigen Antigen(s) in the meat of the species Sus domesticus (domestic pig) that are considered as food allergen(s). Pork Antigen PML PML Protein A nucleoprotein that functions as a transformation and cell growth suppressor, and is aberrantly expressed in promyelocytic leukemia cells. It can be considered as an autoantigen and is commonly associated with primary biliary liver cirrhosis and other autoimmune liver diseases. Protein PML Myeloblastin PR3 Wegener Granulomatosis Autoantigen An antigen encoded by the PRTN3 gene that regulates extracellular matrix protein proteolysis. It can be considered as an autoantigen and is commonly associated with the autoimmune systemic vasculitis disease, Wegener's granulomatosis. Myeloblastin A mixture of multiple, different species (or below the species level classifications) of parasitic protozoans. Mixed Protozoans PCA Purkinje Cell Antigens A group of autoimmune substances found in the Purkinje neurons in the cerebellum that may be comprised of (but not limited to) Yo and Tr proteins. They can be considered as neuronal autoantigens and are commonly associated with autoimmune neurodegenerative disorders related to cancer, such as paraneoplastic cerebellar degeneration. Purkinje Cell Autoantigens PCA-1 Antigens PCA-Yo Antigens Yo Antigens Antigens that may be comprised of (but not limited to) CDR1 and CDR2 proteins, and are involved in cell cycle regulation, mitosis, and transcriptional regulation. They can be considered as neuronal autoantigens and are commonly associated with autoimmune neurodegenerative disorders related to cancer, such as paraneoplastic cerebellar degeneration. Purkinje Cell Cytoplasmic Type 1 Antigens MAP1B MAP5 Microtubule Associated Protein 1B PCA-2 Antigen An antigen encoded by the MAP1B gene and is involved in microtubule assembly and neurogenesis. It can be considered as a neuronal autoantigen and is commonly associated with autoimmune neurodegenerative and paraneoplastic disorders related to cancer. Microtubule-Associated Protein 1B Delta and Notch-like Epidermal Growth Factor-related Receptor DENR PCA-Tr Antigen Purkinje Cell Cytoplasmic-Tr Tr Antigen An antigen encoded by the DENR gene and regulates Notch-mediated signaling and central nervous system development. It can be considered as a neuronal autoantigen and is commonly associated with autoimmune neurodegenerative disorders related to cancer, such as paraneoplastic cerebellar degeneration. Delta and Notch-Like Epidermal Growth Factor-Related Receptor RNP Antigen(s) of the ribonucleic acid and RNA-binding protein multienzyme complexes. They can be considered as autoantigens and are commonly associated with the autoimmune diseases mixed connective tissue disease, systemic rheumatic diseases, and progressive systemic sclerosis. Ribonucleoprotein Ribosomal-P Antigen(s) of the three phosphoproteins, P0, P1 and P2 which are components of ribosomes. They can be considered as autoantigens and are commonly associated with the autoimmune disease systemic lupus erythematosus. Ribosomal P Protein Asian Cultivated Rice Antigen Asian Rice Antigen Oryza sativa Antigen Rice Allergen Antigen(s) in the seed of the species Oryza sativa (Asian rice) that are considered as food allergen(s). Rice Antigen Rickettsia (Proteus vulgaris OX19) Antigen The shared lipopolysaccharide (LPS) O-antigen from a certain species within the Rickettsia genus and the Proteus vulgaris OX19 strain. Rickettsia proteus OXS19 Antigen Rickettsia (Proteus vulgaris OX2) Antigen The shared lipopolysaccharide (LPS) O-antigen from a certain species within the Rickettsia genus and the Proteus vulgaris OX2 strain. Rickettsia proteus OX2 Antigen Rickettsia (Proteus mirabilis OXK) Antigen The shared lipopolysaccharide (LPS) O-antigen from a certain species within the Rickettsia genus and the Proteus mirabilis OXK strain. Rickettsia proteus OXK Antigen Pol III RNAP III An antigen of the polymerase protein complex with a designation of III, that transcribes DNA into tRNA, rRNA and small RNAs. It can be considered as an autoantigen and is commonly associated with the autoimmune disease systemic sclerosis. RNA Polymerase III Common Saltwort Pollen Antigen Kali turgidum Pollen Antigen Russian Thistle Pollen Allergen Salsola kali Pollen Antigen Antigen(s) in the pollen of the species Kali turgidum (Russian thistle) that are considered as plant allergen(s). Kali turgidum Pollen Antigen Atlantic Salmon Antigen Salmo salar Allergen Antigen(s) from the species Salmo salar (Atlantic Salmon) that are considered as food allergen(s). Salmo Salar Antigen Salmonella enterica subsp. enterica serotype typhi O Antigen Salmonella typhi TO Salmonella typhi Type O Antigen The polymer with highly antigenically variable oligosaccharide repeating subunits in the surface lipopolysaccharide (LPS) from the bacteria Salmonella enterica subsp. enterica serotype typhi. Salmonella Typhi O Antigen SARS-CoV-2 Nucleocapsid N Protein The approximately 45.6 kDa structural protein that forms the nucleocapsid of the Severe Acute Respiratory Syndrome Coronavirus 2 virus (SARS-CoV-2). SARS-CoV-2 Nucleoprotein SARS-CoV-2 S Protein RBD SARS-CoV-2 Spike Protein Receptor-Binding Domain The region within the spike protein of the Severe Acute Respiratory Syndrome Coronavirus 2 virus (SARS-CoV-2) that enables viral binding to angiotensin-converting enzyme 2 (ACE2) receptor and fusion into the membrane of host epithelial cells. SARS-CoV-2 Spike Receptor Binding Domain SARS-CoV-2 S Protein The approximately 180-200 kDa transmembrane, receptor binding protein from the Severe Acute Respiratory Syndrome Coronavirus 2 virus (SARS-CoV-2). SARS-CoV-2 Spike Glycoprotein DNA Topoisomerase I Scl-70 Antigen Scleroderma-70 An antigen of the nuclear enzyme topoisomerase 1 encoded by the TOP1 gene that relaxes coiled DNA. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases systemic sclerosis and systemic lupus erythematosus. DNA Topoisomerase 1 Beniseed Antigen Benne Seed Antigen Sesame Seed Allergen Sesamum indicum Seed Antigen Antigen(s) from the seed of the species Sesamum indicum (sesame) that are considered as food allergen(s). Sesame Seed Antigen Shellfish Mix Allergens Antigen(s) from any member(s) of the aquatic invertebrate animal having a shell and belonging to the phylum Mollusca, the class Crustacea (phylum Arthropoda), or the phylum Echinodermata that are considered as food allergen(s). Multiple Shellfish Mix Antigens SRP An antigen derived from the ribonucleoprotein complex that targets signal peptide-bearing proteins to the prokaryotic plasma membrane or the eukaryotic endoplasmic reticulum membrane for secretion or membrane insertion. It can be considered as an autoantigen and is commonly associated with the autoimmune disease polymyositis. Signal Recognition Particle Ribonucleoprotein Complex Betula pendula Pollen Antigen Betula verrucosa Pollen Antigen European White Birch Pollen Antigen Silver Birch Pollen Allergen Antigen(s) in the pollen of the species Betula pendula (silver birch tree) that are considered as plant allergen(s). Betula pendula Pollen Antigen Single-stranded DNA A long linear single-stranded polymer formed from nucleotides attached to a deoxyribose backbone. (NCI) Single-stranded DNA Sjogren's Ro Antigen SSA Antigen(s) encoded by the Ro gene and are the Sjogren's type A antigens, SSA-52 and SSA-60. They can be considered as autoantigens and are commonly associated with the autoimmune disease Sjogren's Syndrome. Sjogrens SS-A Antigen Ro52 Sjogren's Ro 52kDa Antigen SSA-52 An autoantigen encoded by the Ro52 gene (also called the TRIM21 gene) and has a molecular weight of 52 kDa. It is associated with the autoimmune disease Sjogren's Syndrome. Sjogren's SS-A52 Antigen Ro60 Sjogren's Ro 60kDa Antigen SSA-60 An autoantigen encoded by the Ro60 gene and has a molecular weight of 60 kDa. It is associated with the autoimmune disease Sjogren's Syndrome. Sjogren's SS-A60 Antigen Sjogren's La Antigen SSB An autoantigen encoded by the SSB gene. It is associated with the autoimmune disease Sjogren's Syndrome. Sjogren's SS-B Antigen Ribonucleoprotein Smith Complex Sm/RNP Complex Antigen(s) of small nuclear ribonucleoprotein (snRNP) complexes family of U1, U2, U4, U5, and U6, which contains a single nuclear RNA (snRNA) molecule, the associated proteins, and the seven core Smith (Sm) proteins. They can be considered as autoantigens and are commonly associated with the autoimmune disease systemic lupus erythematosus. Smith/Ribonuclear Protein Complex Antigen Smith Autoantigens Antigen(s) of the extractable nuclear RNA-binding proteins that may be comprised of (but not limited to) Smith B, B', N, D1, D2, D3, E, F and G. They are commonly associated with the autoimmune disease systemic lupus erythematosus. Smith Antigen A group of autoimmune substances found in the smooth muscles that may be comprised of (but not limited to) actin and non-actin cytoskeleton components such as vimentin, tubulin, and desmin. They are commonly associated with autoimmune hepatitis. Smooth Muscle Autoantigen SLA Soluble Liver Autoantigen A soluble cytosolic liver antigen which is most frequently the 50 kDa UGA serine tRNA-associated protein complex (tRNP(Ser)Sec). It can be considered as an autoantigen and is commonly associated with type 1 and 2 autoimmune hepatitis. Soluble Liver Antigen Glycine max Antigen Soybean Allergen Antigen(s) from the seed of the species Glycine max (soybean) that are considered as food allergen(s). Glycine max Antigen SEA The biotoxin Staphylococcal enterotoxin A. Staphylococcal Enterotoxin A SEB The biotoxin Staphylococcal enterotoxin B. Staphylococcal Enterotoxin B Stinging Nettle Pollen Allergen Urtica dioica Pollen Antigen Antigen(s) in the pollen of the species Urtica dioica (stinging nettle) that are considered as plant allergen(s). Stinging Nettle Pollen Antigen SLO Streptococcal Toxin Streptolysin O The approximately 60 kDa protein that is an oxygen-labile exotoxin produced by beta-hemolytic streptococci. Streptococcal Toxin Streptolysin O A group of autoimmune substances found in the striated muscles that may be comprised of (but not limited to) the muscle proteins titin, myosin, actin, ryanodine receptor and potassium voltage-gated channel subunit Kv1.4. They are commonly associated with the autoimmune diseases rheumatic fever and myasthenia gravis. Striated Muscle Autoantigens SM4 Sulphatide A class of sulfated galactosylceramides and a major lipid component in myelin. It can be considered as an autoantigen and is commonly associated with autoimmune disease-related peripheral neuropathies. Sulfatide Compound SAE1 SUA1 Ubiquitin-like 1-activating enzyme E1A An antigen encoded by the SAE1 gene that regulates post-translational protein modification and sumoylation. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases rheumatoid arthritis, primary biliary cirrhosis and dermatomyositis. SUMO-Activating Enzyme Subunit 1 SAE2 UBA2 Ubiquitin-like 1-activating enzyme E1B An antigen encoded by the UBA2 gene that regulates post-translational protein modification and sumoylation. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases rheumatoid arthritis, primary biliary cirrhosis and dermatomyositis. SUMO-Activating Enzyme Subunit 2 Anthoxanthum odoratum Pollen Antigen Sweet Vernal Grass Pollen Allergen Antigen(s) in the pollen of the species Anthoxanthum odoratum (sweet vernal grass) that are considered as plant allergen(s). Sweet Vernal Grass Pollen Antigen Thunnus albacares Allergen Yellow Fin Tuna Antigen Antigen(s) from the species Thunnus albacares (yellow fin tuna) that are considered as food allergen(s). Thunnus albacares Antigen Tg Thyroid Thyroglobulin An antigen encoded by the TG gene that regulates thyroid hormone synthesis. It can be considered as an autoantigen and is commonly associated with autoimmune thyroid diseases. Thyroglobulin A group of autoimmune substances found in thyroid cells that may be comprised of (but not limited to) thyroglobulin, thyroid peroxidase, thyrotropin and/or thyrotropin receptor. They are commonly associated with autoimmune thyroid diseases. Thyroid Autoantigens Thyroperoxidase TPO An antigen encoded by the TPO gene that regulates thyroid hormones synthesis. It can be considered as an autoantigen and is commonly associated with autoimmune thyroid disease. Thyroid Peroxidase Thyroid-Stimulating Hormone Receptor TSH Receptor TSHR An antigen encoded by the TSHR gene that responds to thyroid-stimulating hormone and is involved in the regulation of thyroid function. It can be considered as an autoantigen and is commonly associated with autoimmune thyroid diseases. Thyrotropin Receptor E3 Ubiquitin-Protein Ligase TRIM33 TIF1G Transcriptional Intermediary Factor 1-Gamma Tripartite Motif Containing 33 An antigen encoded by the TRIM33 gene and is involved in transcriptional repression and chromatin remodeling. It can be considered as an autoantigen and is commonly associated with autoimmune dermatomyositis. E3 Ubiquitin-Protein Ligase TRIM33 Phleum pratense Pollen Antigen Timothy Grass Pollen Allergen Antigen(s) in the pollen of the species Phleum pratense (Timothy grass) that are considered as plant allergen(s). Phleum pratense Pollen Antigen TG2 tTG An antigen of the transglutaminase enzyme family and catalyzes the crosslinking of proteins with a molecular weight of approximate 78 kDa. It can be considered as an autoantigen and is commonly associated with the autoimmune disease celiac disease. Protein-Glutamine Gamma-Glutamyltransferase 2 An antigen encoded by the TTN gene and is involved in muscle filament structure and contraction. It can be considered as an autoantigen and is commonly associated with the autoimmune disease myasthenia gravis. Titin Lycopersicon lycopersicum Antigen Tomato Allergen Antigen(s) from the fruit(s) of the species Lycopersicon lycopersicum (Tomato) that are considered as food allergen(s). Tomato Antigen Tree Mix Pollens Allergens Antigen(s) in the pollens of a mix of trees that are considered as plant allergen(s). Multiple Tree Mix Pollen Antigens Bread Wheat Antigen Common Wheat Antigen Triticum aestivum Allergen Antigen(s) from the species Triticum aestivum (common wheat) that are considered as food allergen(s). Triticum Aestivum Antigen Triticum Species Allergen Antigen(s) from the wheat species within the genus Triticum that are considered as food allergen(s). Triticum Species Antigen Ribonucleoprotein-70 snRNP70 U1 snRNP 70 kDa An antigen of the U1 small nuclear ribonucleoprotein (snRNP) complex, which contains the U1-snRNA, the U1-associated proteins 70kDa-U1, U1A, U1C, and the seven core Smith (Sm) proteins. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases systemic lupus erythematosus and mixed connective tissue disease. U1 Small Nuclear Ribonucleoprotein Vesicular Stomatitis Indiana Virus G Protein VSIV G protein VSV Indiana Glycoprotein The approximately 67 kDa membrane fusion glycoprotein encoded by the vesicular stomatitis Indiana virus VSIVgp4 (G) gene that enables viral-host receptor recognition and binding. Vesicular Stomatitis Indiana Virus Glycoprotein CTB The approximately 55 kDa, receptor binding B subunit of the Cholera toxin and the virulence factor for Vibrio cholerae. Cholera Toxin B Subunit Walnut Allergen Antigen(s) from the fruit(s) of the Juglans species (walnut) that are considered as food allergen(s). Walnut Antigen Weed Mix Pollens Allergens Antigen(s) in the pollens of a mix of weeds that are considered as plant allergen(s). Multiple Weed Mix Pollen Antigens Ambrosia psilostachya Pollen Antigen Western Ragweed Pollen Allergen Antigen(s) in the pollen of the species Ambrosia psilostachya (Western ragweed) that are considered as plant allergen(s). Ambrosia psilostachya Pollen Antigen Betula populifolia Pollen Antigen Gray Birch Pollen Antigen White Birch Pollen Allergen Antigen(s) in the pollen of the species Betula populifolia (white birch tree) that are considered as plant allergen(s). White Birch Pollen Antigen American elm Pollen Antigen Ulmus americana Pollen Antigen White Elm Pollen Allergen Antigen(s) in the pollen of the species Ulmus americana (white elm tree) that are considered as plant allergen(s). Ulmus americana Pollen Antigen Quercus alba Pollen Antigen White Oak Pollen Allergen Antigen(s) in the pollen of the species Quercus alba (white oak tree) that are considered as plant allergen(s). Quercus alba Pollen Antigen Gallus gallus Egg Antigen Whole Egg Allergen Antigen(s) from a chicken egg (including egg white and the yolk) that are considered as food allergen(s). Whole Egg Antigen Elymus triticoides Pollen Antigen Leymus triticoides Pollen Antigen Wild Rye Grass Pollen Allergen Antigen(s) in the pollen of the species Leymus triticoides (wild rye grass) that are considered as plant allergen(s). Leymus triticoides Pollen Antigen ZnT8 An islet beta-cell secretory membrane protein encoded by the SLC30A8 gene and regulates biosynthesis and secretion of insulin. It can be considered as an autoantigen and is commonly associated with the autoimmune disease type 1 diabetes mellitus. Zinc Transporter 8 ISBDAGT Binding Agent for Immunogenicity Tests CDISC SDTM Binding Agent for Immunogenicity Tests Terminology Terminology relevant to the test codes that describe the characteristics of biospecimens and extracted samples. A260/A230 Ratio An assessment of nucleic acid purity that is measured by determining the ratio of light absorbance of the nucleic acid sample at 260nm and 230nm respectively. A260 to A230 Ratio A260/A280 Ratio An assessment of nucleic acid purity that is measured by determining the ratio of light absorbance of the nucleic acid sample at 260nm and 280nm respectively. A260 to A280 Ratio Area The extent of a 2-dimensional surface enclosed within a boundary. (NCI) Area Adequate Surgical Margins Indicator An indication as to whether there is adequate distance of apparently non-tumorous tissue from the resected tumor. Adequate Surgical Margin Indicator Concentration The quantity of a specified substance in a unit volume or weight of another substance. Concentration Derived Specimen Count The number of derived specimens that are produced from a parent specimen. Number of Derived Specimens Fixative Name The name of the substance or material that preserves tissues and cells for study. Name of Fixative Fluorescent Label The type of fluorescent label or dye that is used in a fluorescence-based assay. Fluorescent Tag Type 28S/18S An assessment of ribonucleic acid integrity that is measured by determining the ratio of the nucleotide length of 28S rRNA and 18S rRNA, respectively, in a biological specimen. 28S Ribosomal RNA to 18S Ribosomal RNA Ratio Length The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI) Length Mass The amount of matter in an object. Mass Mononuclear Cells Mononucleated Cells A measurement of the mononuclear cells in a biological specimen. Mononuclear Cell Count Nucleic Acid Concentration A measurement of the nucleic acids in a unit volume or weight of another substance. Nucleic Acid Concentration Measurement Nucleic Acid Purity A measurement of the homogeneity or uniformity of a mixture of nucleic acids. Nucleic Acid Purity Measurement Quality An assessment of excellence, worth, or fitness for use. Quality Ribonucleic Acid Integrity RNA Integrity Number A numerical assessment of the integrity of RNA based on the entire electrophoretic trace of the RNA sample, including the presence or absence of degradation products. (NCI) RNA Integrity Number Size The physical magnitude of something. (NCI) Size Dimension Spatial Dimension The three dimensional magnitude of an entity expressed as the three axes of length, width, and height (or thickness). Dimension Specimen Weight A measurement of the weight of a biological specimen. Specimen Weight Measurement Tumor Bed Margin Orientation A description as to whether the tumor bed margin is or is not oriented to the true margin surface. Tumor Bed Margin Orientation Assessment Temperature The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI) Temperature Thickness The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. Thickness Number of Tissue Samples in Specimen The total number of tissue samples within the specimen. Number of Tissue Samples in Specimen Cancer Cellularity Neoplastic Cells/Total Cells Tumor Cells/Total Cells A relative measurement (ratio or percentage) of the neoplastic cells to total cells in a biological specimen. Cancer Cellularity Measurement Tumor Tissue Origin A characterization of the tumor tissue sample based upon whether it was taken from a tumor that originated after the disease spread. Tumor Tissue Origin Sample Viability Indicator An indication as to whether the sample contains viable (capable of life or normal growth and development) cells or tissues. Sample Viability Indicator Sample Viability Percent A measurement of the percent of a sample that is viable (capable of life or normal growth and development) for further processing or testing. Sample Viability Percent Measurement Volume A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. Volume Measurement Leukocytes White Blood Cells A measurement of the leukocytes in a biological specimen. Leukocyte Count Width The extent or measurement of something from side to side. (NCI) Width BSTESTCD Biospecimen Characteristics Test Code CDISC SDTM Biospecimen Characteristics Test Code Terminology Terminology relevant to the test names that describe the characteristics of biospecimens and extracted samples. 28S/18S An assessment of ribonucleic acid integrity that is measured by determining the ratio of the nucleotide length of 28S rRNA and 18S rRNA, respectively, in a biological specimen. 28S Ribosomal RNA to 18S Ribosomal RNA Ratio A260/A230 Ratio An assessment of nucleic acid purity that is measured by determining the ratio of light absorbance of the nucleic acid sample at 260nm and 230nm respectively. A260 to A230 Ratio A260/A280 Ratio An assessment of nucleic acid purity that is measured by determining the ratio of light absorbance of the nucleic acid sample at 260nm and 280nm respectively. A260 to A280 Ratio Adequate Surgical Margins Indicator An indication as to whether there is adequate distance of apparently non-tumorous tissue from the resected tumor. Adequate Surgical Margin Indicator Area The extent of a 2-dimensional surface enclosed within a boundary. (NCI) Area Concentration The quantity of a specified substance in a unit volume or weight of another substance. Concentration Derived Specimen Count The number of derived specimens that are produced from a parent specimen. Number of Derived Specimens Fixative Name The name of the substance or material that preserves tissues and cells for study. Name of Fixative Fluorescent Label The type of fluorescent label or dye that is used in a fluorescence-based assay. Fluorescent Tag Type Length The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI) Length Leukocytes White Blood Cells A measurement of the leukocytes in a biological specimen. Leukocyte Count Mass The amount of matter in an object. Mass Mononuclear Cells Mononucleated Cells A measurement of the mononuclear cells in a biological specimen. Mononuclear Cell Count Nucleic Acid Concentration A measurement of the nucleic acids in a unit volume or weight of another substance. Nucleic Acid Concentration Measurement Nucleic Acid Purity A measurement of the homogeneity or uniformity of a mixture of nucleic acids. Nucleic Acid Purity Measurement Number of Tissue Samples in Specimen The total number of tissue samples within the specimen. Number of Tissue Samples in Specimen Quality An assessment of excellence, worth, or fitness for use. Quality Ribonucleic Acid Integrity RNA Integrity Number A numerical assessment of the integrity of RNA based on the entire electrophoretic trace of the RNA sample, including the presence or absence of degradation products. (NCI) RNA Integrity Number Sample Viability Indicator An indication as to whether the sample contains viable (capable of life or normal growth and development) cells or tissues. Sample Viability Indicator Sample Viability Percent A measurement of the percent of a sample that is viable (capable of life or normal growth and development) for further processing or testing. Sample Viability Percent Measurement Size The physical magnitude of something. (NCI) Size Dimension Spatial Dimension The three dimensional magnitude of an entity expressed as the three axes of length, width, and height (or thickness). Dimension Specimen Weight A measurement of the weight of a biological specimen. Specimen Weight Measurement Temperature The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI) Temperature Thickness The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. Thickness Tumor Bed Margin Orientation A description as to whether the tumor bed margin is or is not oriented to the true margin surface. Tumor Bed Margin Orientation Assessment Cancer Cellularity Neoplastic Cells/Total Cells Tumor Cells/Total Cells A relative measurement (ratio or percentage) of the neoplastic cells to total cells in a biological specimen. Cancer Cellularity Measurement Tumor Tissue Origin A characterization of the tumor tissue sample based upon whether it was taken from a tumor that originated after the disease spread. Tumor Tissue Origin Volume A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. Volume Measurement Width The extent or measurement of something from side to side. (NCI) Width BSTEST Biospecimen Characteristics Test Name CDISC SDTM Biospecimen Characteristics Test Name Terminology A terminology codelist based on the standardized or preprinted name of the biospecimen event that occurs. The act of dividing a liquid item into multiple items of smaller volume. Aliquotting The act of removing a biological specimen from a biobank or other biorepository for further use. Archive Sample Retrieval Separating and isolating components of different density and size in a specimen using centrifugal force. Centrifugation The act of gathering an item. Collection The act of increasing the density of a substance and decreasing its volume. Concentrate The act of using something up to the point of depletion. Consumption The act of maintaining and/or attempting to grow explanted cells in an in vitro environment. Tissue Culture The act of ridding of contamination. Decontamination The act of demolishing an item to make it unusable or unanalyzable. Destruction To reduce in strength or concentration by the addition of diluent. Dilute To surround an object with a firm chemical substance such as wax or resin. Embedding The act of taking out, extracting, or withdrawing an entity from a location. Extraction To chemically preserve so as to maintain structural and/or molecular features. Fixation To freeze rapidly so as to preserve structure and prevent ice crystal formation. Quick Freeze The process whereby cold changes the water component from a liquid to a solid. Freezing The act of keeping an entity in a controlled environment to promote favorable growth, development, or reaction. Incubated The act of separating out a target entity from a larger set of such entities. Specimen Isolation To affix a prepared biospecimen to a microscope slide or other mounting device. Mount The act of using something up without full depletion. Partial Consumption The act of combining together into a single unit, group, sample, or biospecimen. Pool A status indicating that the entity comes into one's possession after conveyance from a sender. Receive To cool an item to a temperature above the freezing point but below ambient temperature. Refrigerate The act of accessing information or removing an item from storage. Retrieval To cut a very thin slice of tissue or other substance. Sectioning Being transported or conveyed by an intermediary to a destination, from the sender to the intended receiver. Shipping To dye or tint tissues or other biological samples for the purpose of imaging structures. Staining Method The act of safekeeping items in a depository. Storage The process whereby heat changes the water component from a solid to a liquid. Thaw BEDECOD Biospecimen Events Dictionary Derived Term CDISC SDTM Biospecimen Events Dictionary Derived Term Terminology Bladder Control Scale test code. BLCS01-Lost Control of Bladder Bladder Control Scale - During the past 4 weeks, how often have you lost control of your bladder or had an accident? BLCS - Lost Control of Your Bladder BLCS01-Almost Lost Control of Bladder Bladder Control Scale - During the past 4 weeks, how often have you almost lost control of your bladder or had an accident? BLCS - Almost Lost Control of Your Bladder BLCS01-Altered Activity Because Bladder Bladder Control Scale - During the past 4 weeks, how often have you altered your activities because of bladder problems? BLCS - Altered Activities Because Bladder Problems BLCS01-Bladder Restricted Lifestyle Bladder Control Scale - During the past 4 weeks, how much have bladder problems restricted your overall lifestyle? BLCS - Bladder Problems Restrict Overall Lifestyle BLCS01TC Bladder Control Scale Questionnaire Test Code CDISC Questionnaire Bladder Control Scale Test Code Terminology Bladder Control Scale test name. BLCS01-Almost Lost Control of Bladder Bladder Control Scale - During the past 4 weeks, how often have you almost lost control of your bladder or had an accident? BLCS - Almost Lost Control of Your Bladder BLCS01-Altered Activity Because Bladder Bladder Control Scale - During the past 4 weeks, how often have you altered your activities because of bladder problems? BLCS - Altered Activities Because Bladder Problems BLCS01-Bladder Restricted Lifestyle Bladder Control Scale - During the past 4 weeks, how much have bladder problems restricted your overall lifestyle? BLCS - Bladder Problems Restrict Overall Lifestyle BLCS01-Lost Control of Bladder Bladder Control Scale - During the past 4 weeks, how often have you lost control of your bladder or had an accident? BLCS - Lost Control of Your Bladder BLCS01TN Bladder Control Scale Questionnaire Test Name CDISC Questionnaire Bladder Control Scale Test Name Terminology Borg CR10 scale test code. BCR101-Rating Borg CR10 Scale - Rating. Borg CR10 - Rating BCR101TC Borg CR10 Scale Questionnaire Test Code CDISC Questionnaire Borg CR10 Test Code Terminology Borg CR10 scale test name. BCR101-Rating Borg CR10 Scale - Rating. Borg CR10 - Rating BCR101TN Borg CR10 Scale Questionnaire Test Name CDISC Questionnaire Borg CR10 Test Name Terminology Bowel Control Scale test code. BWCS01-Been Constipated Bowel Control Scale - During the past 4 weeks, how often have you been constipated? BWCS - Been Constipated BWCS01-Lost Control of Bowels Bowel Control Scale - During the past 4 weeks, how often have you lost control of your bowels or had an accident? BWCS - Lost Control of Your Bowels BWCS01-Almost Lost Control of Bowels Bowel Control Scale - During the past 4 weeks, how often have you almost lost control of your bowels or almost had an accident? BWCS - Almost Lost Control of Your Bowels BWCS01-Altered Activity Because Bowels Bowel Control Scale - During the past 4 weeks, how often have you altered your activities because of bowel control problems? BWCS - Altered Activities Because Bowel Control Problems BWCS01-Bowels Restricted Lifestyle Bowel Control Scale - During the past 4 weeks, how much have bowel problems restricted your overall lifestyle? BWCS - Bowel Problems Restrict Overall Lifestyle BWCS01TC Bowel Control Scale Questionnaire Test Code CDISC Questionnaire Bowel Control Scale Test Code Terminology Bowel Control Scale test name. BWCS01-Almost Lost Control of Bowels Bowel Control Scale - During the past 4 weeks, how often have you almost lost control of your bowels or almost had an accident? BWCS - Almost Lost Control of Your Bowels BWCS01-Altered Activity Because Bowels Bowel Control Scale - During the past 4 weeks, how often have you altered your activities because of bowel control problems? BWCS - Altered Activities Because Bowel Control Problems BWCS01-Been Constipated Bowel Control Scale - During the past 4 weeks, how often have you been constipated? BWCS - Been Constipated BWCS01-Bowels Restricted Lifestyle Bowel Control Scale - During the past 4 weeks, how much have bowel problems restricted your overall lifestyle? BWCS - Bowel Problems Restrict Overall Lifestyle BWCS01-Lost Control of Bowels Bowel Control Scale - During the past 4 weeks, how often have you lost control of your bowels or had an accident? BWCS - Lost Control of Your Bowels BWCS01TN Bowel Control Scale Questionnaire Test Name CDISC Questionnaire Bowel Control Scale Test Name Terminology The modes that may be applied to an entity as it passes through various phases of a life cycle or business process. To execute and carry through to completion. Performed To order a planned list of activities or events. Scheduled BRDGMOOD BRIDG Activity Mood CDISC SDTM BRIDG Activity Mood Terminology Brief Assessment of Cognition in Schizophrenia test code. BACS1-Number of Items Recalled Brief Assessment of Cognition in Schizophrenia - Verbal Memory-Number of items recalled on each trial. BACS - Number of Items Recalled BACS1-Number of Items Recalled Total Brief Assessment of Cognition in Schizophrenia - Verbal Memory-Total number of items recalled. BACS - Number of Items Recalled Total BACS1-Number of Correct Sequences Brief Assessment of Cognition in Schizophrenia - Digit Sequencing-Number of correct sequences. BACS - Number of Correct Sequences BACS1-Number of Tokens Left on the Table Brief Assessment of Cognition in Schizophrenia - Token Motor Task-Total number of tokens left on the table. BACS - Number of Tokens Left on the Table BACS1-Total Number Tokens in Container Brief Assessment of Cognition in Schizophrenia - Token Motor Task-Total number of tokens placed in the container. BACS - Total Number Tokens in Container BACS1-Number Tokens Incorrectly Placed Brief Assessment of Cognition in Schizophrenia Questionnaire - Token Motor Task-Total number of tokens incorrectly placed in container. BACS - Number Tokens Incorrectly Placed BACS1-Number of Tokens Correctly Placed Brief Assessment of Cognition in Schizophrenia Questionnaire - Token Motor Task-Number of tokens correctly placed. BACS - Number of Tokens Correctly Placed BACS1-Category Instances Brief Assessment of Cognition in Schizophrenia Questionnaire - Verbal Fluency-Category instances. BACS - Category Instances BACS1-Letter Fluency 1 Brief Assessment of Cognition in Schizophrenia Questionnaire - Verbal Fluency-Letter fluency 1. BACS - Letter Fluency 1 BACS1-Letter Fluency 2 Brief Assessment of Cognition in Schizophrenia Questionnaire - Verbal Fluency-Letter fluency 2. BACS - Letter Fluency 2 BACS1-Verbal Fluency Total Brief Assessment of Cognition in Schizophrenia Questionnaire - Verbal Fluency-Total number of Verbal Fluency items. BACS - Verbal Fluency Total BACS1-Symbol Coding Raw Score Brief Assessment of Cognition in Schizophrenia Questionnaire - Symbol Coding-Raw score. BACS - Symbol Coding Raw Score BACS1-Tower of London Correct Responses Brief Assessment of Cognition in Schizophrenia Questionnaire - Tower of London-Number of correct responses. BACS - Tower of London Correct Responses BACS1TC Brief Assessment of Cognition in Schizophrenia Functional Test Test Code CDISC Functional Test BACS Test Code Terminology Brief Assessment of Cognition in Schizophrenia test name. BACS1-Category Instances Brief Assessment of Cognition in Schizophrenia Questionnaire - Verbal Fluency-Category instances. BACS - Category Instances BACS1-Letter Fluency 1 Brief Assessment of Cognition in Schizophrenia Questionnaire - Verbal Fluency-Letter fluency 1. BACS - Letter Fluency 1 BACS1-Letter Fluency 2 Brief Assessment of Cognition in Schizophrenia Questionnaire - Verbal Fluency-Letter fluency 2. BACS - Letter Fluency 2 BACS1-Number of Correct Sequences Brief Assessment of Cognition in Schizophrenia - Digit Sequencing-Number of correct sequences. BACS - Number of Correct Sequences BACS1-Number of Items Recalled Total Brief Assessment of Cognition in Schizophrenia - Verbal Memory-Total number of items recalled. BACS - Number of Items Recalled Total BACS1-Number of Items Recalled Brief Assessment of Cognition in Schizophrenia - Verbal Memory-Number of items recalled on each trial. BACS - Number of Items Recalled BACS1-Number of Tokens Correctly Placed Brief Assessment of Cognition in Schizophrenia Questionnaire - Token Motor Task-Number of tokens correctly placed. BACS - Number of Tokens Correctly Placed BACS1-Number of Tokens Left on the Table Brief Assessment of Cognition in Schizophrenia - Token Motor Task-Total number of tokens left on the table. BACS - Number of Tokens Left on the Table BACS1-Number Tokens Incorrectly Placed Brief Assessment of Cognition in Schizophrenia Questionnaire - Token Motor Task-Total number of tokens incorrectly placed in container. BACS - Number Tokens Incorrectly Placed BACS1-Symbol Coding Raw Score Brief Assessment of Cognition in Schizophrenia Questionnaire - Symbol Coding-Raw score. BACS - Symbol Coding Raw Score BACS1-Total Number Tokens in Container Brief Assessment of Cognition in Schizophrenia - Token Motor Task-Total number of tokens placed in the container. BACS - Total Number Tokens in Container BACS1-Tower of London Correct Responses Brief Assessment of Cognition in Schizophrenia Questionnaire - Tower of London-Number of correct responses. BACS - Tower of London Correct Responses BACS1-Verbal Fluency Total Brief Assessment of Cognition in Schizophrenia Questionnaire - Verbal Fluency-Total number of Verbal Fluency items. BACS - Verbal Fluency Total BACS1TN Brief Assessment of Cognition in Schizophrenia Functional Test Test Name CDISC Functional Test BACS Test Name Terminology Brief Pain Inventory test code. BPI1-Marital Status Brief Pain Inventory - Marital status. BPI - Marital Status BPI1-Education Brief Pain Inventory - Education. BPI - Education BPI1-Professional Degree Brief Pain Inventory - Education. Professional degree. BPI - Professional Degree BPI1-Current Occupation Brief Pain Inventory - Current occupation. BPI - Current Occupation BPI1-Spouse's Occupation Brief Pain Inventory - Spouse's occupation. BPI - Spouse's Occupation BPI1-Current Job Status Brief Pain Inventory - Which of the following best describes your current job status? BPI - Current Job Status BPI1-How Long Since Diagnosis Brief Pain Inventory - How long has it been since you first learned your diagnosis? BPI - How Long Since Diagnosis BPI1-Pain Due to Present Disease Brief Pain Inventory - Have you ever had pain due to your present disease? BPI - Pain Due to Present Disease BPI1-Pain One of Your Symptoms Brief Pain Inventory - When you first received your diagnosis, was pain one of your symptoms? BPI - Pain as a Symptom BPI1-Surgery in Past Month Brief Pain Inventory - Have you had surgery in the past month? BPI - Surgery in Past Month BPI1-Kind of Surgery in Past Month Brief Pain Inventory - What kind of surgery have you had in the past month? BPI - Kind of Surgery in Past Month BPI1-Pain Other than Everyday Kinds Brief Pain Inventory - Have you had pain other than these everyday kinds of pain during the last week? BPI - Pain Other than Everyday Kinds BPI1-Pain Medications in the Last 7 Days Brief Pain Inventory - Did you take pain medications in the last 7 days? BPI - Pain Medications in the Last 7 Days BPI1-Pain Requires Medication Daily Brief Pain Inventory - I feel I have some form of pain that requires medication each and every day. BPI - Pain Requires Medication Daily BPI1-Areas of Pain Brief Pain Inventory - On the diagram, shade in the areas where you feel pain. BPI - Areas of Pain BPI1-Area Hurts Most Brief Pain Inventory - On the diagram, put an X on the area that hurts the most. BPI - Area Hurts Most BPI1-Pain at its Worst in Last Week Brief Pain Inventory - Please rate your pain by circling the one number that best describes your pain at its worst in the last week. BPI - Pain at its Worst in Last Week BPI1-Pain at its Least in Last Week Brief Pain Inventory - Please rate your pain by circling the one number that best describes your pain at its least in the last week. BPI - Pain at its Least in Last Week BPI1-Pain on the Average Brief Pain Inventory - Please rate your pain by circling the one number that best describes your pain on the average. BPI - Pain on the Average BPI1-Pain Right Now Brief Pain Inventory - Please rate your pain by circling the one number that tells how much pain you have right now. BPI - Pain Right Now BPI1-Things that Make Pain Feel Better Brief Pain Inventory - What kinds of things make your pain feel better? BPI - Things that Make Pain Feel Better BPI1-Things that Make your Pain Worse Brief Pain Inventory - What kinds of things make your pain feel worse? BPI - Things that Make your Pain Worse BPI1-Treatments Receiving for Pain Brief Pain Inventory - What treatments or medications are you receiving for your pain? BPI - Treatments Receiving for Pain BPI1-Relief Pain Treatments Provided Brief Pain Inventory - In the last week, how much relief have pain treatments or medications provided? Please circle the one percentage that most shows how much relief you have received. BPI - Relief Pain Treatments Provided BPI1-Hours before Pain Returns Brief Pain Inventory - If you take pain medication, how many hours does it take before the pain returns? BPI - Hours before Pain Returns BPI1-Pain Due to Effects of Treatment Brief Pain Inventory - I believe my pain is due to the effects of treatment. BPI - Pain Due to Effects of Treatment BPI1-Pain Due to Primary Disease Brief Pain Inventory - I believe my pain is due to my primary disease. BPI - Pain Due to Primary Disease BPI1-Pain Due to Unrelated Med Condition Brief Pain Inventory - I believe my pain is due to a medical condition unrelated to my primary disease. BPI - Pain Due to Unrelated Medical Condition BPI1-Describe Unrelated Med Condition Brief Pain Inventory - I believe my pain is due to a medical condition unrelated to my primary disease. Please describe condition. BPI - Describe Unrelated Medical Condition BPI1-Aching Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: aching. BPI - Aching BPI1-Throbbing Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: throbbing. BPI - Throbbing BPI1-Shooting Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: shooting. BPI - Shooting BPI1-Stabbing Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: stabbing. BPI - Stabbing BPI1-Gnawing Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: gnawing. BPI - Gnawing BPI1-Sharp Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: sharp. BPI - Sharp BPI1-Tender Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: tender. BPI - Tender BPI1-Burning Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: burning. BPI - Burning BPI1-Exhausting Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: exhausting. BPI - Exhausting BPI1-Tiring Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: tiring. BPI - Tiring BPI1-Penetrating Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: penetrating. BPI - Penetrating BPI1-Nagging Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: nagging. BPI - Nagging BPI1-Numb Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: numb. BPI - Numb BPI1-Miserable Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: miserable. BPI - Miserable BPI1-Unbearable Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: unbearable. BPI - Unbearable BPI1-Pain Interfered General Activity Brief Pain Inventory - Circle the one number that describes how, during the past week, pain has interfered with your general activity. BPI - Pain Interfered with General Activity BPI1-Pain Interfered with Mood Brief Pain Inventory - Circle the one number that describes how, during the past week, pain has interfered with your mood. BPI - Pain Interfered with Mood BPI1-Pain Interfered Walking Ability Brief Pain Inventory - Circle the one number that describes how, during the past week, pain has interfered with your walking ability. BPI - Pain Interfered with Walking Ability BPI1-Pain Interfered with Normal Work Brief Pain Inventory - Circle the one number that describes how, during the past week, pain has interfered with your normal work. BPI - Pain Interfered with Normal Work BPI1-Pain Interfered with Relations Brief Pain Inventory - Circle the one number that describes how, during the past week, pain has interfered with your relations with other people. BPI - Pain Interfered with Relations BPI1-Pain Interfered with Sleep Brief Pain Inventory - Circle the one number that describes how, during the past week, pain has interfered with your sleep. BPI - Pain Interfered with Sleep BPI1-Pain Interfered Enjoyment of Life Brief Pain Inventory - Circle the one number that describes how, during the past week, pain has interfered with your enjoyment of life. BPI - Pain Interfered with Enjoyment of Life BPI1-Prefer to Take Pain Medicine Brief Pain Inventory - I prefer to take my pain medicine. BPI - Prefer to Take Pain Medicine BPI1-Take my Pain Medicine Brief Pain Inventory - I take my pain medicine (in a 24 hour period). BPI - Take my Pain Medicine BPI1-Need Stronger Type of Pain Med Brief Pain Inventory - Do you feel you need a stronger type of pain medication? BPI - Need Stronger Type of Pain Medication BPI1-Need more Pain Med than Prescribed Brief Pain Inventory - Do you feel you need to take more of the pain medication than your doctor has prescribed? BPI - Need more Pain Medication than Prescribed BPI1-Concerned Use Too Much Pain Med Brief Pain Inventory - Are you concerned that you use too much pain medication? BPI - Concerned with Too Much Pain Medication Use BPI1-Why Concerned Use Too Much Pain Med Brief Pain Inventory - Are you concerned that you use too much pain medication? If Yes, why? BPI - Why Concerned with Too Much Pain Medication Use BPI1-Problems with Side Effects Pain Med Brief Pain Inventory - Are you having problems with side effects from your pain medication? BPI - Problems with Side Effects Pain Medication BPI1-Which Side Effects from Pain Med Brief Pain Inventory - Are you having problems with side effects from your pain medication? Which side effects? BPI - What Side Effects from Pain Medication BPI1-Need Further Info about Pain Med Brief Pain Inventory - Do you feel you need to receive further information about your pain medication? BPI - Need Further Information about Pain Medication BPI1-Warm Compresses to Relieve Pain Brief Pain Inventory - Other methods I use to relieve pain include: warm compresses. BPI - Warm Compresses to Relieve Pain BPI1-Cold Compresses to Relieve Pain Brief Pain Inventory - Other methods I use to relieve pain include: cold compresses. BPI - Cold Compresses to Relieve Pain BPI1-Relaxation Techniques Relieve Pain Brief Pain Inventory - Other methods I use to relieve pain include: relaxation techniques. BPI - Relaxation Techniques Relieve Pain BPI1-Distraction to Relieve Pain Brief Pain Inventory - Other methods I use to relieve pain include: distraction. BPI - Distraction to Relieve Pain BPI1-Biofeedback to Relieve Pain Brief Pain Inventory - Other methods I use to relieve pain include: biofeedback. BPI - Biofeedback to Relieve Pain BPI1-Hypnosis to Relieve Pain Brief Pain Inventory - Other methods I use to relieve pain include: hypnosis. BPI - Hypnosis to Relieve Pain BPI1-Other to Relieve Pain Brief Pain Inventory - Other methods I use to relieve pain include: other. BPI - Other Methods to Relieve Pain BPI1-Other specify to Relieve Pain Brief Pain Inventory - Other methods I use to relieve pain include: other. Please specify. BPI - Specified Other Method to Relieve Pain BPI1-Meds not Prescribed Taken for Pain Brief Pain Inventory - Medications not prescribed by my doctor that I take for pain are. BPI - Medications not Prescribed Taken for Pain BPI1TC Brief Pain Inventory Questionnaire Test Code CDISC Questionnaire BPI Test Code Terminology Brief Pain Inventory test name. BPI1-Aching Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: aching. BPI - Aching BPI1-Area Hurts Most Brief Pain Inventory - On the diagram, put an X on the area that hurts the most. BPI - Area Hurts Most BPI1-Areas of Pain Brief Pain Inventory - On the diagram, shade in the areas where you feel pain. BPI - Areas of Pain BPI1-Biofeedback to Relieve Pain Brief Pain Inventory - Other methods I use to relieve pain include: biofeedback. BPI - Biofeedback to Relieve Pain BPI1-Burning Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: burning. BPI - Burning BPI1-Cold Compresses to Relieve Pain Brief Pain Inventory - Other methods I use to relieve pain include: cold compresses. BPI - Cold Compresses to Relieve Pain BPI1-Concerned Use Too Much Pain Med Brief Pain Inventory - Are you concerned that you use too much pain medication? BPI - Concerned with Too Much Pain Medication Use BPI1-Current Job Status Brief Pain Inventory - Which of the following best describes your current job status? BPI - Current Job Status BPI1-Current Occupation Brief Pain Inventory - Current occupation. BPI - Current Occupation BPI1-Describe Unrelated Med Condition Brief Pain Inventory - I believe my pain is due to a medical condition unrelated to my primary disease. Please describe condition. BPI - Describe Unrelated Medical Condition BPI1-Distraction to Relieve Pain Brief Pain Inventory - Other methods I use to relieve pain include: distraction. BPI - Distraction to Relieve Pain BPI1-Education Brief Pain Inventory - Education. BPI - Education BPI1-Exhausting Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: exhausting. BPI - Exhausting BPI1-Gnawing Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: gnawing. BPI - Gnawing BPI1-Hours before Pain Returns Brief Pain Inventory - If you take pain medication, how many hours does it take before the pain returns? BPI - Hours before Pain Returns BPI1-How Long Since Diagnosis Brief Pain Inventory - How long has it been since you first learned your diagnosis? BPI - How Long Since Diagnosis BPI1-Hypnosis to Relieve Pain Brief Pain Inventory - Other methods I use to relieve pain include: hypnosis. BPI - Hypnosis to Relieve Pain BPI1-Kind of Surgery in Past Month Brief Pain Inventory - What kind of surgery have you had in the past month? BPI - Kind of Surgery in Past Month BPI1-Marital Status Brief Pain Inventory - Marital status. BPI - Marital Status BPI1-Meds not Prescribed Taken for Pain Brief Pain Inventory - Medications not prescribed by my doctor that I take for pain are. BPI - Medications not Prescribed Taken for Pain BPI1-Miserable Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: miserable. BPI - Miserable BPI1-Nagging Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: nagging. BPI - Nagging BPI1-Need Further Info about Pain Med Brief Pain Inventory - Do you feel you need to receive further information about your pain medication? BPI - Need Further Information about Pain Medication BPI1-Need more Pain Med than Prescribed Brief Pain Inventory - Do you feel you need to take more of the pain medication than your doctor has prescribed? BPI - Need more Pain Medication than Prescribed BPI1-Need Stronger Type of Pain Med Brief Pain Inventory - Do you feel you need a stronger type of pain medication? BPI - Need Stronger Type of Pain Medication BPI1-Numb Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: numb. BPI - Numb BPI1-Other specify to Relieve Pain Brief Pain Inventory - Other methods I use to relieve pain include: other. Please specify. BPI - Specified Other Method to Relieve Pain BPI1-Other to Relieve Pain Brief Pain Inventory - Other methods I use to relieve pain include: other. BPI - Other Methods to Relieve Pain BPI1-Pain at its Least in Last Week Brief Pain Inventory - Please rate your pain by circling the one number that best describes your pain at its least in the last week. BPI - Pain at its Least in Last Week BPI1-Pain at its Worst in Last Week Brief Pain Inventory - Please rate your pain by circling the one number that best describes your pain at its worst in the last week. BPI - Pain at its Worst in Last Week BPI1-Pain Due to Effects of Treatment Brief Pain Inventory - I believe my pain is due to the effects of treatment. BPI - Pain Due to Effects of Treatment BPI1-Pain Due to Present Disease Brief Pain Inventory - Have you ever had pain due to your present disease? BPI - Pain Due to Present Disease BPI1-Pain Due to Primary Disease Brief Pain Inventory - I believe my pain is due to my primary disease. BPI - Pain Due to Primary Disease BPI1-Pain Due to Unrelated Med Condition Brief Pain Inventory - I believe my pain is due to a medical condition unrelated to my primary disease. BPI - Pain Due to Unrelated Medical Condition BPI1-Pain Interfered Enjoyment of Life Brief Pain Inventory - Circle the one number that describes how, during the past week, pain has interfered with your enjoyment of life. BPI - Pain Interfered with Enjoyment of Life BPI1-Pain Interfered General Activity Brief Pain Inventory - Circle the one number that describes how, during the past week, pain has interfered with your general activity. BPI - Pain Interfered with General Activity BPI1-Pain Interfered Walking Ability Brief Pain Inventory - Circle the one number that describes how, during the past week, pain has interfered with your walking ability. BPI - Pain Interfered with Walking Ability BPI1-Pain Interfered with Mood Brief Pain Inventory - Circle the one number that describes how, during the past week, pain has interfered with your mood. BPI - Pain Interfered with Mood BPI1-Pain Interfered with Normal Work Brief Pain Inventory - Circle the one number that describes how, during the past week, pain has interfered with your normal work. BPI - Pain Interfered with Normal Work BPI1-Pain Interfered with Relations Brief Pain Inventory - Circle the one number that describes how, during the past week, pain has interfered with your relations with other people. BPI - Pain Interfered with Relations BPI1-Pain Interfered with Sleep Brief Pain Inventory - Circle the one number that describes how, during the past week, pain has interfered with your sleep. BPI - Pain Interfered with Sleep BPI1-Pain Medications in the Last 7 Days Brief Pain Inventory - Did you take pain medications in the last 7 days? BPI - Pain Medications in the Last 7 Days BPI1-Pain on the Average Brief Pain Inventory - Please rate your pain by circling the one number that best describes your pain on the average. BPI - Pain on the Average BPI1-Pain One of Your Symptoms Brief Pain Inventory - When you first received your diagnosis, was pain one of your symptoms? BPI - Pain as a Symptom BPI1-Pain Other than Everyday Kinds Brief Pain Inventory - Have you had pain other than these everyday kinds of pain during the last week? BPI - Pain Other than Everyday Kinds BPI1-Pain Requires Medication Daily Brief Pain Inventory - I feel I have some form of pain that requires medication each and every day. BPI - Pain Requires Medication Daily BPI1-Pain Right Now Brief Pain Inventory - Please rate your pain by circling the one number that tells how much pain you have right now. BPI - Pain Right Now BPI1-Penetrating Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: penetrating. BPI - Penetrating BPI1-Prefer to Take Pain Medicine Brief Pain Inventory - I prefer to take my pain medicine. BPI - Prefer to Take Pain Medicine BPI1-Problems with Side Effects Pain Med Brief Pain Inventory - Are you having problems with side effects from your pain medication? BPI - Problems with Side Effects Pain Medication BPI1-Professional Degree Brief Pain Inventory - Education. Professional degree. BPI - Professional Degree BPI1-Relaxation Techniques Relieve Pain Brief Pain Inventory - Other methods I use to relieve pain include: relaxation techniques. BPI - Relaxation Techniques Relieve Pain BPI1-Relief Pain Treatments Provided Brief Pain Inventory - In the last week, how much relief have pain treatments or medications provided? Please circle the one percentage that most shows how much relief you have received. BPI - Relief Pain Treatments Provided BPI1-Sharp Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: sharp. BPI - Sharp BPI1-Shooting Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: shooting. BPI - Shooting BPI1-Spouse's Occupation Brief Pain Inventory - Spouse's occupation. BPI - Spouse's Occupation BPI1-Stabbing Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: stabbing. BPI - Stabbing BPI1-Surgery in Past Month Brief Pain Inventory - Have you had surgery in the past month? BPI - Surgery in Past Month BPI1-Take my Pain Medicine Brief Pain Inventory - I take my pain medicine (in a 24 hour period). BPI - Take my Pain Medicine BPI1-Tender Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: tender. BPI - Tender BPI1-Things that Make Pain Feel Better Brief Pain Inventory - What kinds of things make your pain feel better? BPI - Things that Make Pain Feel Better BPI1-Things that Make your Pain Worse Brief Pain Inventory - What kinds of things make your pain feel worse? BPI - Things that Make your Pain Worse BPI1-Throbbing Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: throbbing. BPI - Throbbing BPI1-Tiring Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: tiring. BPI - Tiring BPI1-Treatments Receiving for Pain Brief Pain Inventory - What treatments or medications are you receiving for your pain? BPI - Treatments Receiving for Pain BPI1-Unbearable Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: unbearable. BPI - Unbearable BPI1-Warm Compresses to Relieve Pain Brief Pain Inventory - Other methods I use to relieve pain include: warm compresses. BPI - Warm Compresses to Relieve Pain BPI1-Which Side Effects from Pain Med Brief Pain Inventory - Are you having problems with side effects from your pain medication? Which side effects? BPI - What Side Effects from Pain Medication BPI1-Why Concerned Use Too Much Pain Med Brief Pain Inventory - Are you concerned that you use too much pain medication? If Yes, why? BPI - Why Concerned with Too Much Pain Medication Use BPI1TN Brief Pain Inventory Questionnaire Test Name CDISC Questionnaire BPI Test Name Terminology Brief Pain Inventory Short Form test code. BPI2-Pain Other Than Everyday Kinds Brief Pain Inventory Short Form - Have you had pain other than these everyday kinds of pain today? BPI Short Form - Pain Other Than Everyday Kinds BPI2-Areas of Pain Brief Pain Inventory Short Form - On the diagram, shade in the areas where you feel pain. BPI Short Form - Areas of Pain BPI2-Area Hurts Most Brief Pain Inventory Short Form - On the diagram, put an X on the area that hurts the most. BPI Short Form - Area that Hurts Most BPI2-Pain at its Worst in Last 24 Hours Brief Pain Inventory Short Form - Please rate your pain by circling the one number that best describes your pain at its worst in the last 24 hours. BPI Short Form - Pain at its Worst in Last 24 Hours BPI2-Pain at its Least in Last 24 Hours Brief Pain Inventory Short Form - Please rate your pain by circling the one number that best describes your pain at its least in the last 24 hours. BPI Short Form - Pain at its Least in Last 24 Hours BPI2-Pain on the Average Brief Pain Inventory Short Form - Please rate your pain by circling the one number that best describes your pain on the average. BPI Short Form - Pain on the Average BPI2-Pain Right Now Brief Pain Inventory Short Form - Please rate your pain by circling the one number that tells how much pain you have right now. BPI Short Form - Pain Right Now BPI2-Treatments Receiving for Pain Brief Pain Inventory Short Form - What treatments or medications are you receiving for your pain? BPI Short Form - Treatments or Medications Receiving for Pain BPI2-Relief Pain Treatments Provided Brief Pain Inventory Short Form - In the last 24 hours, how much relief have pain treatments or medications provided? Please circle the one percentage that most shows how much relief you have received. BPI Short Form - Relief from Pain Treatments Provided BPI2-Pain Interfered General Activity Brief Pain Inventory Short Form - Circle the one number that describes how, during the past 24 hours, pain has interfered with your general activity. BPI Short Form - Pain Interfered with General Activity BPI2-Pain Interfered with Mood Brief Pain Inventory Short Form - Circle the one number that describes how, during the past 24 hours, pain has interfered with your mood. BPI Short Form - Pain Interfered with Mood BPI2-Pain Interfered Walking Ability Brief Pain Inventory Short Form - Circle the one number that describes how, during the past 24 hours, pain has interfered with your walking ability. BPI Short Form - Pain Interfered with Walking Ability BPI2-Pain Interfered with Normal Work Brief Pain Inventory Short Form - Circle the one number that describes how, during the past 24 hours, pain has interfered with your normal work. BPI Short Form - Pain Interfered with Normal Work BPI2-Pain Interfered with Relations Brief Pain Inventory Short Form - Circle the one number that describes how, during the past 24 hours, pain has interfered with your relations with other people. BPI Short Form - Pain Interfered with Relations BPI2-Pain Interfered with Sleep Brief Pain Inventory Short Form - Circle the one number that describes how, during the past 24 hours, pain has interfered with your sleep. BPI Short Form - Pain Interfered with Sleep BPI2-Pain Interfered Enjoyment of Life Brief Pain Inventory Short Form - Circle the one number that describes how, during the past 24 hours, pain has interfered with your enjoyment of life. BPI Short Form - Pain Interfered with Enjoyment of Life BPI2TC Brief Pain Inventory Short Form Questionnaire Test Code CDISC Questionnaire BPI Short Form Test Code Terminology Brief Pain Inventory Short Form test name. BPI2-Area Hurts Most Brief Pain Inventory Short Form - On the diagram, put an X on the area that hurts the most. BPI Short Form - Area that Hurts Most BPI2-Areas of Pain Brief Pain Inventory Short Form - On the diagram, shade in the areas where you feel pain. BPI Short Form - Areas of Pain BPI2-Pain at its Least in Last 24 Hours Brief Pain Inventory Short Form - Please rate your pain by circling the one number that best describes your pain at its least in the last 24 hours. BPI Short Form - Pain at its Least in Last 24 Hours BPI2-Pain at its Worst in Last 24 Hours Brief Pain Inventory Short Form - Please rate your pain by circling the one number that best describes your pain at its worst in the last 24 hours. BPI Short Form - Pain at its Worst in Last 24 Hours BPI2-Pain Interfered Enjoyment of Life Brief Pain Inventory Short Form - Circle the one number that describes how, during the past 24 hours, pain has interfered with your enjoyment of life. BPI Short Form - Pain Interfered with Enjoyment of Life BPI2-Pain Interfered General Activity Brief Pain Inventory Short Form - Circle the one number that describes how, during the past 24 hours, pain has interfered with your general activity. BPI Short Form - Pain Interfered with General Activity BPI2-Pain Interfered Walking Ability Brief Pain Inventory Short Form - Circle the one number that describes how, during the past 24 hours, pain has interfered with your walking ability. BPI Short Form - Pain Interfered with Walking Ability BPI2-Pain Interfered with Mood Brief Pain Inventory Short Form - Circle the one number that describes how, during the past 24 hours, pain has interfered with your mood. BPI Short Form - Pain Interfered with Mood BPI2-Pain Interfered with Normal Work Brief Pain Inventory Short Form - Circle the one number that describes how, during the past 24 hours, pain has interfered with your normal work. BPI Short Form - Pain Interfered with Normal Work BPI2-Pain Interfered with Relations Brief Pain Inventory Short Form - Circle the one number that describes how, during the past 24 hours, pain has interfered with your relations with other people. BPI Short Form - Pain Interfered with Relations BPI2-Pain Interfered with Sleep Brief Pain Inventory Short Form - Circle the one number that describes how, during the past 24 hours, pain has interfered with your sleep. BPI Short Form - Pain Interfered with Sleep BPI2-Pain on the Average Brief Pain Inventory Short Form - Please rate your pain by circling the one number that best describes your pain on the average. BPI Short Form - Pain on the Average BPI2-Pain Other Than Everyday Kinds Brief Pain Inventory Short Form - Have you had pain other than these everyday kinds of pain today? BPI Short Form - Pain Other Than Everyday Kinds BPI2-Pain Right Now Brief Pain Inventory Short Form - Please rate your pain by circling the one number that tells how much pain you have right now. BPI Short Form - Pain Right Now BPI2-Relief Pain Treatments Provided Brief Pain Inventory Short Form - In the last 24 hours, how much relief have pain treatments or medications provided? Please circle the one percentage that most shows how much relief you have received. BPI Short Form - Relief from Pain Treatments Provided BPI2-Treatments Receiving for Pain Brief Pain Inventory Short Form - What treatments or medications are you receiving for your pain? BPI Short Form - Treatments or Medications Receiving for Pain BPI2TN Brief Pain Inventory Short Form Questionnaire Test Name CDISC Questionnaire BPI Short Form Test Name Terminology Brief Psychiatric Rating Scale 1988 Version test code. BPRS01-Somatic Concern Brief Psychiatric Rating Scale 1988 Version - Somatic concern. BPRS 1988 Version - Somatic Concern BPRS01-Anxiety Brief Psychiatric Rating Scale 1988 Version - Anxiety. BPRS 1988 Version - Anxiety BPRS01-Emotional Withdrawal Brief Psychiatric Rating Scale 1988 Version - Emotional withdrawal. BPRS 1988 Version - Emotional Withdrawal BPRS01-Conceptual Disorganization Brief Psychiatric Rating Scale 1988 Version - Conceptual disorganization. BPRS 1988 Version - Conceptual Disorganization BPRS01-Guilt Feelings Brief Psychiatric Rating Scale 1988 Version - Guilt feelings. BPRS 1988 Version - Guilt Feelings BPRS01-Tension Brief Psychiatric Rating Scale 1988 Version - Tension. BPRS 1988 Version - Tension BPRS01-Mannerisms and Posturing Brief Psychiatric Rating Scale 1988 Version - Mannerisms and posturing. BPRS 1988 Version - Mannerisms and Posturing BPRS01-Grandiosity Brief Psychiatric Rating Scale 1988 Version - Grandiosity. BPRS 1988 Version - Grandiosity BPRS01-Depressive Mood Brief Psychiatric Rating Scale 1988 Version - Depressive mood. BPRS 1988 Version - Depressive Mood BPRS01-Hostility Brief Psychiatric Rating Scale 1988 Version - Hostility. BPRS 1988 Version - Hostility BPRS01-Suspiciousness Brief Psychiatric Rating Scale 1988 Version - Suspiciousness. BPRS 1988 Version - Suspiciousness BPRS01-Hallucinatory Behavior Brief Psychiatric Rating Scale 1988 Version - Hallucinatory behavior. BPRS 1988 Version - Hallucinatory Behavior BPRS01-Motor Retardation Brief Psychiatric Rating Scale 1988 Version - Motor retardation. BPRS 1988 Version - Motor Retardation BPRS01-Uncooperativeness Brief Psychiatric Rating Scale 1988 Version - Uncooperativeness. BPRS 1988 Version - Uncooperativeness BPRS01-Unusual Thought Content Brief Psychiatric Rating Scale 1988 Version - Unusual thought content. BPRS 1988 Version - Unusual Thought Content BPRS01-Blunted Affect Brief Psychiatric Rating Scale 1988 Version - Blunted affect. BPRS 1988 Version - Blunted Affect BPRS01-Excitement Brief Psychiatric Rating Scale 1988 Version - Excitement. BPRS 1988 Version - Excitement BPRS01-Disorientation Brief Psychiatric Rating Scale 1988 Version - Disorientation. BPRS 1988 Version - Disorientation BPRS01-Total Score Brief Psychiatric Rating Scale 1988 Version - Total score. BPRS 1988 Version - Total Score BPRS01TC Brief Psychiatric Rating Scale 1988 Version Clinical Classification Test Code CDISC Clinical Classification BPRS 1988 Version Test Code Terminology Brief Psychiatric Rating Scale 1988 Version test name. BPRS01-Anxiety Brief Psychiatric Rating Scale 1988 Version - Anxiety. BPRS 1988 Version - Anxiety BPRS01-Blunted Affect Brief Psychiatric Rating Scale 1988 Version - Blunted affect. BPRS 1988 Version - Blunted Affect BPRS01-Conceptual Disorganization Brief Psychiatric Rating Scale 1988 Version - Conceptual disorganization. BPRS 1988 Version - Conceptual Disorganization BPRS01-Depressive Mood Brief Psychiatric Rating Scale 1988 Version - Depressive mood. BPRS 1988 Version - Depressive Mood BPRS01-Disorientation Brief Psychiatric Rating Scale 1988 Version - Disorientation. BPRS 1988 Version - Disorientation BPRS01-Emotional Withdrawal Brief Psychiatric Rating Scale 1988 Version - Emotional withdrawal. BPRS 1988 Version - Emotional Withdrawal BPRS01-Excitement Brief Psychiatric Rating Scale 1988 Version - Excitement. BPRS 1988 Version - Excitement BPRS01-Grandiosity Brief Psychiatric Rating Scale 1988 Version - Grandiosity. BPRS 1988 Version - Grandiosity BPRS01-Guilt Feelings Brief Psychiatric Rating Scale 1988 Version - Guilt feelings. BPRS 1988 Version - Guilt Feelings BPRS01-Hallucinatory Behavior Brief Psychiatric Rating Scale 1988 Version - Hallucinatory behavior. BPRS 1988 Version - Hallucinatory Behavior BPRS01-Hostility Brief Psychiatric Rating Scale 1988 Version - Hostility. BPRS 1988 Version - Hostility BPRS01-Mannerisms and Posturing Brief Psychiatric Rating Scale 1988 Version - Mannerisms and posturing. BPRS 1988 Version - Mannerisms and Posturing BPRS01-Motor Retardation Brief Psychiatric Rating Scale 1988 Version - Motor retardation. BPRS 1988 Version - Motor Retardation BPRS01-Somatic Concern Brief Psychiatric Rating Scale 1988 Version - Somatic concern. BPRS 1988 Version - Somatic Concern BPRS01-Suspiciousness Brief Psychiatric Rating Scale 1988 Version - Suspiciousness. BPRS 1988 Version - Suspiciousness BPRS01-Tension Brief Psychiatric Rating Scale 1988 Version - Tension. BPRS 1988 Version - Tension BPRS01-Total Score Brief Psychiatric Rating Scale 1988 Version - Total score. BPRS 1988 Version - Total Score BPRS01-Uncooperativeness Brief Psychiatric Rating Scale 1988 Version - Uncooperativeness. BPRS 1988 Version - Uncooperativeness BPRS01-Unusual Thought Content Brief Psychiatric Rating Scale 1988 Version - Unusual thought content. BPRS 1988 Version - Unusual Thought Content BPRS01TN Brief Psychiatric Rating Scale 1988 Version Clinical Classification Test Name CDISC Clinical Classification BPRS 1988 Version Test Name Terminology Brief Psychiatric Rating Scale-Anchored original result for BPRSA118 test and test code. BPRSA118-Cannot be assessed adequately because of severe formal thought disorder, uncooperativeness, or marked evasiveness/guardedness or Not assessed Brief Psychiatric Rating Scale-Anchored original result for BPRSA118 with response-Cannot be assessed adequately because of severe formal thought disorder, uncooperativeness, or marked evasiveness/guardedness; or not assessed. Brief Psychiatric Rating Scale-Anchored BPRSA118 Original Result - Cannot be Assessed Adequately Because of Severe Formal Thought Disorder, Uncooperativeness, or Marked Evasiveness/Guardedness; or Not Assessed BPRSA118-Mild Brief Psychiatric Rating Scale-Anchored original result for BPRSA118 with response-Mild. Brief Psychiatric Rating Scale-Anchored BPRSA118 Original Result - Mild BPRSA118-Moderate Brief Psychiatric Rating Scale-Anchored original result for BPRSA118 with response-Moderate. Brief Psychiatric Rating Scale-Anchored BPRSA118 Original Result - Moderate BPRSA118-Moderately Severe Brief Psychiatric Rating Scale-Anchored original result for BPRSA118 with response-Moderately severe. Brief Psychiatric Rating Scale-Anchored BPRSA118 Original Result - Moderately Severe BPRSA118-Not observed Brief Psychiatric Rating Scale-Anchored original result for BPRSA118 with response-Not observed. Brief Psychiatric Rating Scale-Anchored BPRSA118 Original Result - Not Observed BPRSA118-Severe Brief Psychiatric Rating Scale-Anchored original result for BPRSA118 with response-Severe. Brief Psychiatric Rating Scale-Anchored BPRSA118 Original Result - Severe BPRSA118-Very Mild Brief Psychiatric Rating Scale-Anchored original result for BPRSA118 with response-Very mild. Brief Psychiatric Rating Scale-Anchored BPRSA118 Original Result - Very Mild BPRSA118-Very Severe Brief Psychiatric Rating Scale-Anchored original result for BPRSA118 with response-Very severe. Brief Psychiatric Rating Scale-Anchored BPRSA118 Original Result - Very Severe BPRSA118OR Brief Psychiatric Rating Scale-Anchored Clinical Classification ORRES for BPRSA118 TN/TC CDISC Clinical Classification Brief Psychiatric Rating Scale-Anchored BPRSA118 Original Response Terminology Brief Psychiatric Rating Scale-Anchored original result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115 test and test code. BPRSA1SET1-Cannot be assessed adequately because of severe formal thought disorder, uncooperativeness, or marked evasiveness/guardedness or Not assessed Brief Psychiatric Rating Scale-Anchored original result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Cannot be assessed adequately because of severe formal thought disorder, uncooperativeness, or marked evasiveness/guardedness; or not assessed. Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Original Result - Cannot be Assessed Adequately Because of Severe Formal Thought Disorder, Uncooperativeness, or Marked Evasiveness/Guardedness; or Not Assessed BPRSA1SET1-Mild Brief Psychiatric Rating Scale-Anchored original result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Mild. Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Original Result - Mild BPRSA1SET1-Moderate Brief Psychiatric Rating Scale-Anchored original result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Moderate. Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Original Result - Moderate BPRSA1SET1-Moderately Severe Brief Psychiatric Rating Scale-Anchored original result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Moderately severe. Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Original Result - Moderately Severe BPRSA1SET1-Not reported Brief Psychiatric Rating Scale-Anchored original result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Not reported. Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Original Result - Not Reported BPRSA1SET1-Severe Brief Psychiatric Rating Scale-Anchored original result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Severe. Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Original Result - Severe BPRSA1SET1-Very Mild Brief Psychiatric Rating Scale-Anchored original result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Very mild. Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Original Result - Very Mild BPRSA1SET1-Very Severe Brief Psychiatric Rating Scale-Anchored original result for BPRSA101 and items with equivalent response set-Very severe. Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Original Result - Very Severe BPRSA1SET1OR Brief Psychiatric Rating Scale-Anchored Clinical Classification ORRES the Same as BPRSA101 TN/TC CDISC Clinical Classification Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Original Response Terminology Brief Psychiatric Rating Scale-Anchored original result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117 test and test code. BPRSA1SET2-Mild Brief Psychiatric Rating Scale-Anchored original result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117-Mild. Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Original Result - Mild BPRSA1SET2-Moderate Brief Psychiatric Rating Scale-Anchored original result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117-Moderate. Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Original Result - Moderate BPRSA1SET2-Moderately Severe Brief Psychiatric Rating Scale-Anchored original result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117-Moderately severe. Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Original Result - Moderately Severe BPRSA1SET2-Not observed Brief Psychiatric Rating Scale-Anchored original result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117-Not observed. Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Original Result - Not observed BPRSA1SET2-Severe Brief Psychiatric Rating Scale-Anchored original result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117-Severe. Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Original Result - Severe BPRSA1SET2-Very Mild Brief Psychiatric Rating Scale-Anchored original result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117-Very mild. Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Original Result - Very Mild BPRSA1SET2-Very Severe Brief Psychiatric Rating Scale-Anchored original result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117-Very severe. Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Original Result - Very Severe BPRSA1SET2OR Brief Psychiatric Rating Scale-Anchored Clinical Classification ORRES the Same as BPRSA103 TN/TC CDISC Clinical Classification Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Original Response Terminology Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA118 test and test code. BPRSA118-1 Brief Psychiatric Rating Scale-Anchored standardized character result BPRSA118-Not observed. Brief Psychiatric Rating Scale-Anchored BPRSA118 Standardized Character Result 1 BPRSA118-2 Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA118-Very mild. Brief Psychiatric Rating Scale-Anchored BPRSA118 Standardized Character Result 2 BPRSA118-3 Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA118-Mild. Brief Psychiatric Rating Scale-Anchored BPRSA118 Standardized Character Result 3 BPRSA118-4 Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA118-Moderate. Brief Psychiatric Rating Scale-Anchored BPRSA118 Standardized Character Result 4 BPRSA118-5 Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA118-Moderately severe. Brief Psychiatric Rating Scale-Anchored BPRSA118 Standardized Character Result 5 BPRSA118-6 Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA118-Severe. Brief Psychiatric Rating Scale-Anchored BPRSA118 Standardized Character Result 6 BPRSA118-7 Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA118-Very severe. Brief Psychiatric Rating Scale-Anchored BPRSA118 Standardized Character Result 7 BPRSA118-9 Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA118-Cannot be assessed adequately because of severe formal thought disorder, uncooperativeness, or marked evasiveness/guardedness; or not assessed. Brief Psychiatric Rating Scale-Anchored BPRSA118 Standardized Character Result 9 BPRSA118STR Brief Psychiatric Rating Scale-Anchored Clinical Classification STRESC for BPRSA118 TN/TC CDISC Clinical Classification Brief Psychiatric Rating Scale-Anchored BPRSA118 Standardized Character Response Terminology Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115 test and test code. BPRSA1SET1-1 Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Not reported. Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Standardized Character Result 1 BPRSA1SET1-2 Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Very mild. Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Standardized Character Result 2 BPRSA1SET1-3 Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Mild. Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Standardized Character Result 3 BPRSA1SET1-4 Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Moderate. Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Standardized Character Result 4 BPRSA1SET1-5 Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Moderately severe. Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Standardized Character Result 5 BPRSA1SET1-6 Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Severe. Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Standardized Character Result 6 BPRSA1SET1-7 Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Very severe. Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Standardized Character Result 7 BPRSA1SET1-9 Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Cannot be assessed adequately because of severe formal thought disorder, uncooperativeness, or marked evasiveness/guardedness; or not assessed. Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Standardized Character Result 9 BPRSA1SET1STR Brief Psychiatric Rating Scale-Anchored Clinical Classification STRESC the Same as BPRSA101 TN/TC CDISC Clinical Classification Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Standardized Character Response Terminology Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117 test and test code. BPRSA1SET2-1 Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117-Not observed. Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Standardized Character Result 1 BPRSA1SET2-2 Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117-Very mild. Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Standardized Character Result 2 BPRSA1SET2-3 Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117-Mild. Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Standardized Character Result 3 BPRSA1SET2-4 Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117-Moderate. Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Standardized Character Result 4 BPRSA1SET2-5 Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117-Moderately severe. Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Standardized Character Result 5 BPRSA1SET2-6 Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117-Severe. Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Standardized Character Result 6 BPRSA1SET2-7 Brief Psychiatric Rating Scale-Anchored Standardized character result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117-Very severe. Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Standardized Character Result 7 BPRSA1SET2STR Brief Psychiatric Rating Scale-Anchored Clinical Classification STRESC the Same as BPRSA103 TN/TC CDISC Clinical Classification Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Standardized Character Response Terminology The Brief Psychiatric Rating Scale-Anchored test code. BPRSA1-Somatic Concern Brief Psychiatric Rating Scale-Anchored - Somatic Concern. BPRS-Anchored - Somatic Concern BPRSA1-Anxiety Brief Psychiatric Rating Scale-Anchored - Anxiety. BPRS-Anchored - Anxiety BPRSA1-Emotional Withdrawal Brief Psychiatric Rating Scale-Anchored - Emotional Withdrawal. BPRS-Anchored - Emotional Withdrawal BPRSA1-Conceptual Disorganization Brief Psychiatric Rating Scale-Anchored - Conceptual Disorganization. BPRS-Anchored - Conceptual Disorganization BPRSA1-Guilt Feelings Brief Psychiatric Rating Scale-Anchored - Guilt Feelings. BPRS-Anchored - Guilt Feelings BPRSA1-Tension Brief Psychiatric Rating Scale-Anchored - Tension. BPRS-Anchored - Tension BPRSA1-Mannerisms and Posturing Brief Psychiatric Rating Scale-Anchored - Mannerisms and Posturing. BPRS-Anchored - Mannerisms and Posturing BPRSA1-Grandiosity Brief Psychiatric Rating Scale-Anchored - Grandiosity. BPRS-Anchored - Grandiosity BPRSA1-Depressive Mood Brief Psychiatric Rating Scale-Anchored - Depressive Mood. BPRS-Anchored - Depressive Mood BPRSA1-Hostility Brief Psychiatric Rating Scale-Anchored - Hostility. BPRS-Anchored - Hostility BPRSA1-Suspiciousness Brief Psychiatric Rating Scale-Anchored - Suspiciousness. BPRS-Anchored - Suspiciousness BPRSA1-Hallucinatory Behavior Brief Psychiatric Rating Scale-Anchored - Hallucinatory Behavior. BPRS-Anchored - Hallucinatory Behavior BPRSA1-Motor Retardation Brief Psychiatric Rating Scale-Anchored - Motor Retardation. BPRS-Anchored - Motor Retardation BPRSA1-Uncooperativeness Brief Psychiatric Rating Scale-Anchored - Uncooperativeness. BPRS-Anchored - Uncooperativeness BPRSA1-Unusual Thought Content Brief Psychiatric Rating Scale-Anchored - Unusual Thought Content. BPRS-Anchored - Unusual Thought Content BPRSA1-Blunted Affect Brief Psychiatric Rating Scale-Anchored - Blunted Affect. BPRS-Anchored - Blunted Affect BPRSA1-Excitement Brief Psychiatric Rating Scale-Anchored - Excitement. BPRS-Anchored - Excitement BPRSA1-Disorientation Brief Psychiatric Rating Scale-Anchored - Disorientation. BPRS-Anchored - Disorientation BPRSA1TC Brief Psychiatric Rating Scale-Anchored Clinical Classification Test Code CDISC Clinical Classification BPRS-Anchored Test Code Terminology The Brief Psychiatric Rating Scale-Anchored test name. BPRSA1-Anxiety Brief Psychiatric Rating Scale-Anchored - Anxiety. BPRS-Anchored - Anxiety BPRSA1-Blunted Affect Brief Psychiatric Rating Scale-Anchored - Blunted Affect. BPRS-Anchored - Blunted Affect BPRSA1-Conceptual Disorganization Brief Psychiatric Rating Scale-Anchored - Conceptual Disorganization. BPRS-Anchored - Conceptual Disorganization BPRSA1-Depressive Mood Brief Psychiatric Rating Scale-Anchored - Depressive Mood. BPRS-Anchored - Depressive Mood BPRSA1-Disorientation Brief Psychiatric Rating Scale-Anchored - Disorientation. BPRS-Anchored - Disorientation BPRSA1-Emotional Withdrawal Brief Psychiatric Rating Scale-Anchored - Emotional Withdrawal. BPRS-Anchored - Emotional Withdrawal BPRSA1-Excitement Brief Psychiatric Rating Scale-Anchored - Excitement. BPRS-Anchored - Excitement BPRSA1-Grandiosity Brief Psychiatric Rating Scale-Anchored - Grandiosity. BPRS-Anchored - Grandiosity BPRSA1-Guilt Feelings Brief Psychiatric Rating Scale-Anchored - Guilt Feelings. BPRS-Anchored - Guilt Feelings BPRSA1-Hallucinatory Behavior Brief Psychiatric Rating Scale-Anchored - Hallucinatory Behavior. BPRS-Anchored - Hallucinatory Behavior BPRSA1-Hostility Brief Psychiatric Rating Scale-Anchored - Hostility. BPRS-Anchored - Hostility BPRSA1-Mannerisms and Posturing Brief Psychiatric Rating Scale-Anchored - Mannerisms and Posturing. BPRS-Anchored - Mannerisms and Posturing BPRSA1-Motor Retardation Brief Psychiatric Rating Scale-Anchored - Motor Retardation. BPRS-Anchored - Motor Retardation BPRSA1-Somatic Concern Brief Psychiatric Rating Scale-Anchored - Somatic Concern. BPRS-Anchored - Somatic Concern BPRSA1-Suspiciousness Brief Psychiatric Rating Scale-Anchored - Suspiciousness. BPRS-Anchored - Suspiciousness BPRSA1-Tension Brief Psychiatric Rating Scale-Anchored - Tension. BPRS-Anchored - Tension BPRSA1-Uncooperativeness Brief Psychiatric Rating Scale-Anchored - Uncooperativeness. BPRS-Anchored - Uncooperativeness BPRSA1-Unusual Thought Content Brief Psychiatric Rating Scale-Anchored - Unusual Thought Content. BPRS-Anchored - Unusual Thought Content BPRSA1TN Brief Psychiatric Rating Scale-Anchored Clinical Classification Test Name CDISC Clinical Classification BPRS-Anchored Test Name Terminology Brooke Upper Extremity Rating Scale test code. BUERS1-Brooke Upper Extremity Rating Brooke Upper Extremity Rating Scale - Brooke upper extremity rating scale. BUERS - Brooke Upper Extremity Rating Scale BUERS1TC Brooke Upper Extremity Rating Scale Clinical Classification Test Code CDISC Clinical Classification BUERS Test Code Terminology Brooke Upper Extremity Rating Scale test name. BUERS1-Brooke Upper Extremity Rating Brooke Upper Extremity Rating Scale - Brooke upper extremity rating scale. BUERS - Brooke Upper Extremity Rating Scale BUERS1TN Brooke Upper Extremity Rating Scale Clinical Classification Test Name CDISC Clinical Classification BUERS Test Name Terminology Canadian Cardiovascular Society Grading of Angina Pectoris test code. CCSGA1-Canadian CV Society Grade Canadian Cardiovascular Society Grading Scale of Angina Pectoris - Grade. CCS Grading of Angina Pectoris - Grade CCSGA1TC Canadian Cardiovascular Society Grading of Angina Pectoris Clinical Classification Test Code CDISC Clinical Classification Canadian Cardiovascular Society Grading of Angina Pectoris Test Code Terminology Canadian Cardiovascular Society Grading of Angina Pectoris test name. CCSGA1-Canadian CV Society Grade Canadian Cardiovascular Society Grading Scale of Angina Pectoris - Grade. CCS Grading of Angina Pectoris - Grade CCSGA1TN Canadian Cardiovascular Society Grading of Angina Pectoris Clinical Classification Test Name CDISC Clinical Classification Canadian Cardiovascular Society Grading of Angina Pectoris Test Name Terminology Canadian Cardiovascular Society Grading Scale of Angina Pectoris original result for CCSGA101 test and test code. CCSGA101-Grade I Canadian Cardiovascular Society Grading Scale of Angina Pectoris original result for CCSGA101-Grade I: Ordinary physical activity does not cause angina, such as walking and climbing stairs. Angina with strenuous or rapid or prolonged exertion at work or recreation. Canadian Cardiovascular Society Grading of Angina Pectoris CCSGA101 Original Result - Grade I CCSGA101-Grade II Canadian Cardiovascular Society Grading Scale of Angina Pectoris original result for CCSGA101-Grade II: Slight limitation of ordinary activity. Walking or climbing stairs rapidly, walking uphill, walking or stair climbing after meals, or in cold, or in wind, or under emotional stress, or only during the few hours after awakening. Walking more than two blocks on the level and climbing more than one flight of ordinary stairs at a normal pace and in normal conditions. Canadian Cardiovascular Society Grading of Angina Pectoris CCSGA101 Original Result - Grade II CCSGA101-Grade III Canadian Cardiovascular Society Grading Scale of Angina Pectoris original result for CCSGA101-Grade III: Marked limitation of ordinary physical activity. Walking one or two blocks on the level and climbing one flight of stairs in normal conditions and at normal pace. Canadian Cardiovascular Society Grading of Angina Pectoris CCSGA101 Original Result - Grade III CCSGA101-Grade IV Canadian Cardiovascular Society Grading Scale of Angina Pectoris original result for CCSGA101-Grade IV: Inability to carry on any physical activity without discomfort, anginal syndrome may be present at rest. Canadian Cardiovascular Society Grading of Angina Pectoris CCSGA101 Original Result - Grade IV CCSGA101OR Canadian Cardiovascular Society Grading Scale of Angina Pectoris Clinical Classification ORRES for CCSGA101 TN/TC CDISC Clinical Classification Canadian Cardiovascular Society Grading of Angina Pectoris CCSGA101 Original Response Terminology Canadian Cardiovascular Society Grading Scale of Angina Pectoris standardized character result for CCSGA101 test and test code. CCSGA101-Grade I Canadian Cardiovascular Society Grading Scale of Angina Pectoris standardized character result for CCSGA101-Grade I: Ordinary physical activity does not cause angina, such as walking and climbing stairs. Angina with strenuous or rapid or prolonged exertion at work or recreation. Canadian Cardiovascular Society Grading of Angina Pectoris CCSGA101 Standardized Character Result Grade I CCSGA101-Grade II Canadian Cardiovascular Society Grading Scale of Angina Pectoris standardized character result for CCSGA101-Grade II: Slight limitation of ordinary activity. Walking or climbing stairs rapidly, walking uphill, walking or stair climbing after meals, or in cold, or in wind, or under emotional stress, or only during the few hours after awakening. Walking more than two blocks on the level and climbing more than one flight of ordinary stairs at a normal pace and in normal conditions. Canadian Cardiovascular Society Grading of Angina Pectoris CCSGA101 Standardized Character Result Grade II CCSGA101-Grade III Canadian Cardiovascular Society Grading Scale of Angina Pectoris standardized character result for CCSGA101-Grade III: Marked limitation of ordinary physical activity. Walking one or two blocks on the level and climbing one flight of stairs in normal conditions and at normal pace. Canadian Cardiovascular Society Grading of Angina Pectoris CCSGA101 Standardized Character Result Grade III CCSGA101-Grade IV Canadian Cardiovascular Society Grading Scale of Angina Pectoris standardized character result for CCSGA101-Grade IV: Inability to carry on any physical activity without discomfort, anginal syndrome may be present at rest. Canadian Cardiovascular Society Grading of Angina Pectoris CCSGA101 Standardized Character Result Grade IV CCSGA101STR Canadian Cardiovascular Society Grading Scale of Angina Pectoris Clinical Classification STRESC for CCSGA101 TN/TC CDISC Clinical Classification Canadian Cardiovascular Society Grading of Angina Pectoris CCSGA101 Standardized Character Response Terminology The reason that a subject had a cardiac procedure. The intended recipient of a heart transplant. Candidate to Receive Cardiac Transplant An episode of cardiac arrest or arrhythmia where the etiology was unknown. Cardiac Arrest/Arrhythmia Etiology Unknown A disease of the heart muscle or myocardium proper. Cardiomyopathies may be classified as either primary or secondary, on the basis of etiology, or on the pathophysiology of the lesion: hypertrophic, dilated, or restrictive. Cardiomyopathy A longstanding, complete blockage of a vessel. Chronic Total Occlusion Vessel The subject contributing a heart for a cardiac transplant. Donor for Cardiac Transplant The battery that supplies the device has reached the end of its life. End of Expected Battery Life There is a faulty connector/header in the device. Faulty Device Connector/Header A cardiac lead requires revision, at which time the generator to the device will be replaced. Cardiac Device Generator is Being Replaced at Time of Lead Revision The device has a generator malfunction. Device Generator Malfunction An immediate percutaneous coronary intervention is necessary for a myocardial infarction that presents with ST segment elevation. Immediate Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact. (NCI) Infectious Disorder A cardiac lead has damaged local tissue enough to require treatment. Cardiac Lead Erosion The degree of impairment of the left cardiac ventricle to contract efficiently. Left Ventricular Systolic Dysfunction An imperative issued by the manufacturer of a device that the device needs to be returned to a designated source for repair or replacement. Manufacturer Recall The device manufacturer had recognized a recurrent performance failure in the device. Manufacturer Recognized a Recurring Performance Failure The medical condition or the procedure affects the device implantation site. Medical Condition or Procedure Affects Implantation Site An intended medical or surgical procedure necessitates the relocation of a cardiac lead. Medical or Surgical Procedure Requiring Relocation of Lead Includes patients with unstable angina or Non-STEMI who have high risk features for short-term risk of death or nonfatal MI. High risk features includes at least one of the following: history of accelerating tempo of ischemic symptoms in preceding 48 hours; character of pain - prolonged ongoing (greater than 20 minutes) rest pain; clinical findings - pulmonary edema, most likely due to ischemia or new or worsening mitral regurgitation murmur; or S3 or new worsening rales or Hypotension, bradycardia, tachycardia or age greater than 75 years; ECG - angina at rest with transient ST-segment changes greater than 0.5 mm or bundle-branch block, new or presumed new or sustained ventricular tachycardia; cardiac markers - NSTEMI patients with elevated cardiac TnT, Tnl, or CK-MB. Percutaneous Coronary Intervention for High Risk Non-ST Elevation Myocardial Infarction or Unstable Angina A percutaneous coronary intervention is necessary for a myocardial infarction that presents with ST segment elevation and the subject does not have recurrent or persistent symptoms, symptoms of heart failure or ventricular arrhythmia after a successful dose of thrombolytic therapy. Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction-Stable After Successful Full-Dose Thrombolytic Therapy A percutaneous coronary intervention is necessary for a myocardial infarction that presents with ST segment elevation and the subject does not have recurrent or persistent symptoms, symptoms of heart failure or ventricular arrhythmia. The presentation is past twelve hours since onset of symptoms. Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction-Stable-Over 12 Hours From Symptom Onset A percutaneous coronary intervention is necessary for a myocardial infarction that presents with ST segment elevation and the subject has recurrent or persistent symptoms, symptoms of heart failure or ventricular arrhythmia. The presentation is past twelve hours since onset of symptoms. Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction-Unstable-Over 12 Hours From Symptom Onset A procedure to evaluate the health of an individual after receiving a heart transplant. Post-Cardiac Transplant Evaluation A procedure to evaluate the health of the cardiac system to determine feasibility of a non-cardiac related surgical procedure. Pre-Operative Evaluation for Non-Cardiovascular Surgery A procedure performed to avoid the first occurrence of a disease condition. Primary Prevention A percutaneous coronary intervention is imperative for a myocardial infarction that presents with ST segment elevation after an unsatisfactory response to a full dose of thrombolytic therapy. Rescue Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction After Failed Full-Dose Thrombolytic Therapy A procedure performed to avoid a subsequent occurrence of a disease condition. Secondary Prevention Ventricular tachycardia that occurs without provocation and does not resolve spontaneously. Spontaneous Sustained Ventricular Tachycardia by ECG Finding A subsequent Percutaneous Coronary Intervention in a planned series of procedures, where the first PCI could have been during a prior admission, or during this admission. Staged Percutaneous Coronary Intervention A sudden loss of consciousness with loss of postural tone not related to anesthesia with high risk characteristics. High risk characteristics include non-ischemic dilated cardiomyopathy, or ischemic heart disease with significant ventricular dysfunction, hypertrophic cardiomyopathy, Brugada Syndrome, or Long QT Syndrome. Syncope with High Risk Cardiac Characteristics Sudden loss of consciousness with loss of postural tone not related to anesthesia with ventricular tachycardia (VT) that can be induced during an electrophysiological study. Syncope with Inducible Ventricular Tachycardia by ECG Finding U UNK Unknown Not known, not observed, not recorded, or refused. (NCI) Unknown A device with additional pacing capabilities is replacing the current device. Upgrade to Cardiac Device with Additional Pacing Capabilities Ventricular Fibrillation is characterized by rapid, usually more than 300 bpm (cycle length: 180 ms or less), grossly irregular ventricular rhythm with marked variability in QRS cycle length, morphology, and amplitude. Ventricular Fibrillation CVPRCIND Cardiac Procedure Indication CDISC SDTM Cardiac Procedure Indication Terminology The effect that a cardiac rhythm device malfunction had on the ability to stimulate the heart. The cardiac rhythm device malfunction affected atrial pacing. Cardiac Atrial Pacing Malfunction The cardiac rhythm device malfunction affected the defibrillator. Cardiac Defibrillator Malfunction The cardiac rhythm device malfunction affected the left ventricular (LV) pacing. Left Cardiac Ventricular Pacing Malfunction The cardiac rhythm device malfunction affected the right ventricular (RV) pacing. Right Cardiac Ventricle Pacing Malfunction CRYDFMAN Cardiac Rhythm Device Failure Manifestation CDISC SDTM Cardiac Rhythm Device Failure Manifestation Terminology Terminology responses used for the cardiovascular findings about test codes and names codelist within CDISC. The X-ray examination of blood vessels or chambers of the heart after introduction of a radiopaque substance. X-ray Angiography Initiation or intensification of orally administered medication(s) that promote diuresis to treat heart failure. Oral Diuretic Therapy Augmentation for Heart Failure A postmortem examination of the body. Autopsy Weight gain thought to be related to fluid retention. Weight Gain Due to Fluid Retention Angiographic evidence of new or worse greater than or equal to 70 percent lesion and/or thrombus in an epicardial coronary artery believed to be responsible for the myocardial ischemic symptoms/signs. (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press) Coronary Lesion by Angiographic Finding Need for coronary revascularization procedure (PCI or CABG) for the presumed culprit lesion(s). This criterion would be fulfilled if revascularization was undertaken during the unscheduled hospitalization, or subsequent to transfer to another institution without interceding home discharge. (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press) Coronary Revascularization Procedure Reduced ability to withstand or participate in activities that induce physical or mental exertion. Decreased Exercise Tolerance Includes dyspnea on exertion, dyspnea at rest, orthopnea, and paroxysmal nocturnal dyspnea. Dyspnea Unusual tiredness and inability to perform usual activities. Fatigue An event where the patient is admitted to the hospital with a primary diagnosis of heart failure (HF), where the length of stay is at least 24 hours (or extends over a calendar date), where the patient exhibits new or worsening symptoms of HF on presentation, has objective evidence of new or worsening HF, and receives initiation or intensification of treatment specifically for HF. (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press) Hospitalization Due to Heart Failure An acute episode of focal or global cerebral or spinal dysfunction caused by intraparenchymal, intraventricular, or subarachnoid hemorrhage. Hemorrhagic Stroke Biomarker increase (B-type natriuretic peptide (BNP)/ N-terminal pro-BNP (NT-proBNP)) consistent with decompensation of heart failure (such as BNP greater than 500 pg/mL or NT-proBNP greater than 2,000 pg/mL). In patients with chronically elevated natriuretic peptides, a significant increase above baseline is required. (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press) Increase in B-type Natriuretic Peptide or N-terminal pro-B-type Natriuretic Peptide Increase in the estimated height of the mean jugular venous waveform above the right atrium in cm. Increase in Jugular Venous Pressure Ascites Abnormal collection of fluid in the peritoneal cavity. Peritoneal Effusion Definite evidence of inducible myocardial ischemia believed to be responsible for the myocardial ischemic symptoms/signs, demonstrated by any of the following: a) an early positive exercise stress test, defined as ST elevation of greater than or equal to 2 mm ST depression prior to 5 mets, b) stress echocardiography (reversible wall motion abnormality), c) myocardial scintigraphy (reversible perfusion defect), d) MRI (myocardial perfusion deficit under pharmacologic stress). (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press) Inducible Myocardial Ischemia Initiation or intensification of medication(s) administered by vein to treat heart failure, to increase the production of urine, increase cardiac performance, and/or reduce cardiac preload or afterload. Intravenous Diuretic, Inotropic or Vasodilator Augmentation for Heart Failure Invasive diagnostic evidence with right heart catheterization showing a pulmonary capillary wedge pressure (pulmonary artery occlusion pressure) greater than or equal to 18 mmHg, central venous pressure greater than or equal to 12 mmHg, or a cardiac index less than 2.2 L/min/m2. (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press) Heart Failure by Invasive Diagnostic Technique Ischemic stroke is defined as an acute episode of focal cerebral, spinal, or retinal dysfunction caused by infarction of central nervous system tissue. Ischemic Stroke Angiographic loss of patency of a side branch. Loss of Patency of Side Branch Angiographic loss of patency of a major epicardial vessel. Loss of Patency of Major Vessel Mechanical circulatory support (e.g., intra-aortic balloon pump, ventricular assist device, extracorporeal membrane oxygenation, total artificial heart) or mechanical fluid removal (e.g., ultrafiltration, hemofiltration, dialysis). (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press) Vasculature Mechanical or Surgical Intervention Non-invasive imaging evidence of a loss of viable myocardium when compared with the most recent previous non-invasive imaging study. New Loss of Viable Myocardium by Non-invasive Imaging Technique Non-invasive imaging evidence of a decrease in regional wall motion contractility compared with the most recent previous non-invasive imaging study. New Regional Wall Motion Abnormality by Non-invasive Imaging Technique Non-invasive diagnostic evidence of clinically significant elevated left- or right-sided ventricular filling pressure or low cardiac output. For example, echocardiographic criteria could include: E/e' greater than 15 or D-dominant pulmonary venous inflow pattern, plethoric inferior vena cava with minimal collapse on inspiration, or decreased left ventricular outflow tract (LVOT) minute stroke distance (time velocity integral (TVI)). (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press) Heart Failure by Non-invasive Diagnostic Technique Increased tissue fluid indicated by perceptible pitting indentation on lower leg, foot or sacrum after palpation. Edema Limbs Abnormal breath sounds caused by the accumulation of fluid in the lungs. Rales Imaging findings consistent with increased intravascular blood volume in the lungs. Pulmonary Congestion by Radiological Technique New or worsening ST or T wave changes on resting ECG (in the absence of confounders, such as LBBB or LVH), defined as either: a) Transient ST elevation (duration less than 20 minutes): new ST elevation at the J point in any two contiguous leads (other than leads V2-V3) of greater than or equal to 0.1 mV. In leads V2-V3, the following cut-points apply: greater than or equal to 0.2 mV in men greater than or equal to 40 years, greater than or equal to 0.25 mV in men less than 40 years, and greater than or equal to 0.15 mV in women, or b) ST depression and T-wave changes: new horizontal or down-sloping ST depression greater than or equal to 0.05 mV in two contiguous leads and/or new T inversion greater than or equal to 0.3 mV in two contiguous leads with prominent R wave or R/S ratio greater than 1. Resting ECG Changes Presence of mid-diastolic heart sound. S3 Gallop Angiographic reduction of flow into the coronary microcirculation. Flow Reduced in Coronary Microcirculation 0 to 24 hours after stent implantation. (Cutlip DE, Windecker S, Mehran R, et al. Clinical End Points in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351) Academic Research Council Acute Stent Thrombosis Greater than 30 days to 1 year after stent implantation. (Cutlip DE, Windecker S, Mehran R, et al. Clinical End Points in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351) Academic Research Council Late Stent Thrombosis Greater than 24 hours to 30 days after stent implantation. (Cutlip DE, Windecker S, Mehran R, et al. Clinical End Points in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351) Academic Research Council Subacute Stent Thrombosis Greater than 1 year after stent implantation. (Cutlip DE, Windecker S, Mehran R, et al. Clinical End Points in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351) Academic Research Council Very Late Stent Thrombosis Spontaneous clinical syndrome related to atherosclerotic plaque rupture, ulceration, fissuring, erosion, or dissection, with resulting intraluminal thrombus, and leading to decreased myocardial blood flow or distal platelet emboli with ensuing myocyte necrosis. This classification requires a) detection of a rise and/or fall of cardiac biomarker values [preferably cardiac troponin (cTn)] with at least one value greater than 99th percentile of the upper reference limit (URL) and b) at least one of the following: symptoms of myocardial ischemia; new or presumed new significant ST-segment-T wave (ST-T) changes or new left bundle branch block (LBBB) on the ECG; development of pathological Q waves on the ECG; imaging evidence of new loss of viable myocardium or new regional wall motion abnormality; identification of an intracoronary thrombus by angiography or autopsy. (Universal definition of myocardial infarction, Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Eur Heart J (2007) 28 (20): 2525-2538.) Joint Task Force Type 1 Myocardial Infarction Ischemic imbalance: Spontaneous clinical syndrome where a condition other than coronary artery disease contributes to an imbalance between myocardial oxygen supply and/or demand, e.g. coronary endothelial dysfunction, coronary artery spasm, coronary embolism, tachy-/brady-arrhythmias, anemia, respiratory failure, hypotension, and hypertension with or without left ventricular hypertrophy. This classification requires detection of a rise and/or fall of cardiac biomarker values [preferably cardiac troponin (cTn)] with at least one value greater than 99th percentile of the upper reference limit (URL) and b) at least one of the following: symptoms of myocardial ischemia; new or presumed new significant ST-segment-T wave (ST-T) changes or new left bundle branch block (LBBB) on the ECG; development of pathological Q waves on the ECG; imaging evidence of new loss of viable myocardium or new regional wall motion abnormality. (Universal definition of myocardial infarction, Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Eur Heart J (2007) 28 (20): 2525-2538.) Joint Task Force Type 2 Myocardial Infarction Death, No Biomarkers: Death where symptoms suggestive of myocardial ischemia are present, and with (presumed) new ischemic changes or new LBBB on ECG, but where death occurs before cardiac biomarkers can be obtained, or before cardiac biomarker values could rise. (Universal definition of myocardial infarction, Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Eur Heart J (2007) 28 (20): 2525-2538.) Joint Task Force Type 3 Myocardial Infarction PCI Related: PCI Related Myocardial infarction associated with and occurring within 48h of percutaneous coronary intervention, with elevation of cardiac biomarker values to greater than 5x 99th percentile of the upper reference limit (URL) in patients with normal baseline values (less than or equal to 99th percentile URL), or a rise of cardiac biomarker values greater than or equal to 20% if the baseline values are elevated and are stable or falling. This classification also requires at least one of the following: symptoms of myocardial ischemia; new ischemic ECG changes or new LBBB; angiographic loss of patency of a major coronary artery or a side branch or persistent slow- or no-flow or embolization; imaging evidence of new loss of viable myocardium or new regional wall motion abnormality. (Universal definition of myocardial infarction, Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Eur Heart J (2007) 28 (20): 2525-2538.) Joint Task Force Type 4A Myocardial Infarction Stent Thrombosis: Myocardial infarction associated with stent thrombosis as detected by coronary angiography or at autopsy, where symptoms suggestive of myocardial ischemia are present, and with a rise and/or fall of cardiac biomarkers values, with at least one value greater than 99th percentile of the upper reference limit. (Universal definition of myocardial infarction, Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Eur Heart J (2007) 28 (20): 2525-2538.) Joint Task Force Type 4B Myocardial Infarction Stent Restenosis: Myocardial infarction associated with stent restenosis as detected by coronary angiography or at autopsy, occurring more than 48h after percutaneous coronary intervention, without evidence of stent thrombosis but with symptoms suggestive of myocardial ischemia, and with elevation of cardiac biomarker values to greater than 99th percentile of the upper reference limit (URL). This classification also requires the following: does not meet criteria for any other classification of myocardial infarction; presence of a greater than or equal to 50 percent stenosis at the site of previous successful stent PCI. (Universal definition of myocardial infarction, Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Eur Heart J (2007) 28 (20): 2525-2538.) Joint Task Force Type 4C Myocardial Infarction CABG Related: Myocardial infarction associated with and occurring within 48h of coronary artery bypass graft surgery, with elevation of cardiac biomarker values to greater than 10x 99th percentile of the upper reference limit (URL) in patients with normal baseline cardiac biomarker values (less than or equal to 99th percentile URL). This classification also requires at least one of the following: new pathologic Q waves or new LBBB on ECG; angiographic new graft or new native coronary artery occlusion; imaging evidence of new loss of viable myocardium or new regional wall motion abnormality. (Universal definition of myocardial infarction, Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Eur Heart J (2007) 28 (20): 2525-2538.) Joint Task Force Type 5 Myocardial Infarction An acute episode of focal or global neurological dysfunction caused by presumed brain, spinal cord, or retinal vascular injury as a result of hemorrhage or infarction but with insufficient information to allow categorization as ischemic or hemorrhagic. Stroke An event where the patient has an urgent, unscheduled office/practice or emergency department visit for a primary diagnosis of heart failure (HF) but is not admitted to the hospital, where the patient exhibits new or worsening symptoms of HF on presentation, has objective evidence of new or worsening HF, and receives initiation or intensification of treatment specifically for HF, with the exception that changes to oral diuretic therapy do no qualify as initiation or intensification of treatment. (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press) ER or Office Visit Due to Heart Failure Excessive accumulation of intravascular fluid resulting from compromised regulatory mechanisms. Hypervolemia Decreased blood supply to the vital organs (kidney, liver, lungs, heart, brain). Worsened End-Organ Perfusion CVFARS Cardiovascular Findings About Results CDISC SDTM Cardiovascular Findings About Results Terminology Terminology relevant to the test codes that describe findings about a cardiovascular event or intervention. Acute Myocardial Infarction Type Categorization of the type of acute myocardial infarction. Acute Myocardial Infarction Type Coronary Artery Thrombosis Method Ident The method by which the coronary artery thrombosis event is determined or diagnosed. Coronary Artery Thrombosis Method of Identification Endpoint Event Indicator An indication as to whether the event meets the criteria for being a clinical endpoint. Endpoint Event Indicator Healthcare Encounter Type Categorization of the type of healthcare encounter. Healthcare Encounter Type Heart Failure New/Worsening Lab Findings Categorization of the type(s) of new and/or worsening laboratory findings of heart failure present at the time of patient presentation. Lab Findings of New or Worsening Heart Failure Heart Failure New/Worsening PE Findings Categorization of the type(s) of new and/or worsening physical exam findings of heart failure present at the time of patient presentation. Physical Examination Findings of New or Worsening Heart Failure Heart Failure Therapy, Intensification Categorization of the type(s) of new and/or intensified treatment administered for heart failure management. Heart Failure Therapy Intensification Type Ischemic Discomfort Indicator An indicator as to whether the subject has symptoms of ischemic discomfort. Ischemic Discomfort Indicator Ischemic Evidence Type Categorization of the type of objective evidence of new or worsening ischemia. Ischemic Evidence Type Exclusion of Type 1 and Type 2 MI An indication of whether a Type 1 and Type 2 myocardial infarction is excluded as a diagnosis. Exclusion of Type 1 and Type 2 Myocardial Infarction Diagnosis Indicator Non-Invasive Imaging Change A description of the clinical change to the subject after a non-invasive imaging procedure. Clinical Change by Non-Invasive Imaging Procedure New or Worsening Symptoms A description of the new or worsening symptoms related to a clinical event. New or Worsening Symptom PCI Acute Angiographic Complication Categorization of the type of acute PCI angiographic complication resulting in acute myocardial ischemia. Acute Myocardial Infarction From PCI Complication Type Procedure Success Indicator An indication as to whether the procedure is considered successful. Procedure Success Indicator Procedure Urgency Status Type The degree of urgency in which a medical procedure must be performed. Triage Status Stent Thrombosis, Coronary, ARC Timing Categorization of the timing of coronary stent thrombosis occurrence per the classification schema described by the Academic Research Consortium (ARC). Academic Research Council Coronary Stent Thrombosis Timing Stroke Type Categorization of the type of stroke. Stroke Type Symptom Indicator An indication as to whether the subject had symptoms related to the clinical event. Symptom Indicator Symptom Onset Date The date time of the onset of symptoms of the clinical event. Symptom Onset Date Vessel Occlusion After CABG 48 Ind An indication as to whether vessel occlusion, in the native or bypass graft, occurred within 48 hours after the coronary artery bypass graft procedure. Vessel Occlusion 48 Hours after CABG Indicator CVFATSCD Cardiovascular Findings About Test Code CDISC SDTM Cardiovascular Findings About Test Code Terminology Terminology relevant to the test names that describe findings about a cardiovascular event or intervention. Acute Myocardial Infarction Type Categorization of the type of acute myocardial infarction. Acute Myocardial Infarction Type Coronary Artery Thrombosis Method Ident The method by which the coronary artery thrombosis event is determined or diagnosed. Coronary Artery Thrombosis Method of Identification Endpoint Event Indicator An indication as to whether the event meets the criteria for being a clinical endpoint. Endpoint Event Indicator Exclusion of Type 1 and Type 2 MI An indication of whether a Type 1 and Type 2 myocardial infarction is excluded as a diagnosis. Exclusion of Type 1 and Type 2 Myocardial Infarction Diagnosis Indicator Healthcare Encounter Type Categorization of the type of healthcare encounter. Healthcare Encounter Type Heart Failure New/Worsening Lab Findings Categorization of the type(s) of new and/or worsening laboratory findings of heart failure present at the time of patient presentation. Lab Findings of New or Worsening Heart Failure Heart Failure New/Worsening PE Findings Categorization of the type(s) of new and/or worsening physical exam findings of heart failure present at the time of patient presentation. Physical Examination Findings of New or Worsening Heart Failure Heart Failure Therapy, Intensification Categorization of the type(s) of new and/or intensified treatment administered for heart failure management. Heart Failure Therapy Intensification Type Ischemic Discomfort Indicator An indicator as to whether the subject has symptoms of ischemic discomfort. Ischemic Discomfort Indicator Ischemic Evidence Type Categorization of the type of objective evidence of new or worsening ischemia. Ischemic Evidence Type New or Worsening Symptoms A description of the new or worsening symptoms related to a clinical event. New or Worsening Symptom Non-Invasive Imaging Change A description of the clinical change to the subject after a non-invasive imaging procedure. Clinical Change by Non-Invasive Imaging Procedure PCI Acute Angiographic Complication Categorization of the type of acute PCI angiographic complication resulting in acute myocardial ischemia. Acute Myocardial Infarction From PCI Complication Type Procedure Success Indicator An indication as to whether the procedure is considered successful. Procedure Success Indicator Procedure Urgency Status Type The degree of urgency in which a medical procedure must be performed. Triage Status Stent Thrombosis, Coronary, ARC Timing Categorization of the timing of coronary stent thrombosis occurrence per the classification schema described by the Academic Research Consortium (ARC). Academic Research Council Coronary Stent Thrombosis Timing Stroke Type Categorization of the type of stroke. Stroke Type Symptom Indicator An indication as to whether the subject had symptoms related to the clinical event. Symptom Indicator Symptom Onset Date The date time of the onset of symptoms of the clinical event. Symptom Onset Date Vessel Occlusion After CABG 48 Ind An indication as to whether vessel occlusion, in the native or bypass graft, occurred within 48 hours after the coronary artery bypass graft procedure. Vessel Occlusion 48 Hours after CABG Indicator CVFATS Cardiovascular Findings About Test Name CDISC SDTM Cardiovascular Findings About Test Name Terminology A terminology codelist to describe the test code for a physiological examination of the cardiovascular system. Aortic Augmentation Index The augmentation pressure divided by the aortic pulse pressure (aortic systolic minus aortic diastolic pressure) multiplied by 100, expressed as a percentage. Aortic Augmentation Index Measurement Aortic Augmentation Index at 75bpm The aortic augmentation index normalized to a heart rate of 75 beats per minute. Aortic Augmentation Index at 75bpm Aortic Augmentation Pressure The difference between the second pressure peak in the aortic wave, secondary to the pressure wave reflection from the sites of peripheral arterial impedance mismatch (P2) and the first pressure peak in the aortic wave form, secondary to ventricular ejection (P1). Aortic Augmentation Pressure Aortic Augmentation Pressure Peak P1 The first pressure peak in the aortic wave form secondary to ventricular ejection. Augmentation Pressure Point P1 Aortic Augmentation Pressure Peak P2 The second pressure peak in the aortic waveform secondary to pressure wave reflection from the periphery. Augmentation Pressure Point P2 Aortic Coarctation Indicator An indication as to whether there is coarctation of the aorta. Aortic Coarctation Indicator Aortic Coarctation Severity The assessment of the severity of aortic coarctation. Aortic Coarctation Severity Acute Coronary Syndrome Presentation Cat Acute Coronary Syndrome Presentation Category A classification of the compilation of symptoms and/or clinical manifestation of acute coronary syndrome. Acute Coronary Syndrome Presentation Category Aortic Ductal Coarctation Severity Aortic Juxta-ductal Coarctation Severity The assessment of the severity of ductal aortic coarctation. Aortic Juxta-ductal Coarctation Severity Aneurysm Indicator An indication as to whether there is the presence of one or more aneurysms. Aneurysm Indicator Annular a' Velocity The peak velocity of the annular motion during late ventricular diastole (the active filling of the ventricle). Annular a' Velocity Annular e' Velocity The peak velocity of the annular motion during early ventricular diastole (the passive filling of the ventricle). Annular e' Velocity Annular S' Velocity The peak velocity of the annular motion during ventricular systole. Annular S' Velocity Aortic Postductal Coarctation Severity The assessment of the severity of postductal aortic coarctation. Aortic Postductal Coarctation Severity Aortic Preductal Coarctation Severity The assessment of the severity of preductal aortic coarctation. Aortic Preductal Coarctation Severity Annular Plane Systolic Excursion The longitudinal displacement of a cardiac valve annulus toward the apex of the heart. Annular Plane Systolic Excursion Area, End Ventricular Diastole The 2-dimensional surface enclosed within a boundary of a cardiovascular structure and measured at end ventricular diastole. Area at End Ventricular Diastole Area, End Ventricular Systole The 2-dimensional surface enclosed within a boundary of a cardiovascular structure and measured at end ventricular systole. Area at End Ventricular Systole Aortic Regur Jet Width LVOT Diam Rt Aortic Regurgitant Jet Width to Left Ventricular Outflow Tract Diameter Ratio A relative measurement (ratio) of the aortic regurgitant jet width to left ventricular outflow tract (LVOT) diameter. Aortic Regurgitant Jet Width to Left Ventricular Outflow Tract Diameter Ratio Aortic Valve Regurgitant Fraction A measurement of the volume of retrograde blood flow across the orifice of the aortic valve expressed as a percentage of the anterograde flow volume. Aortic Valve Regurgitant Fraction Aortic Valve Regurgitant Jet Width The measured width of the regurgitant jet of blood into the left ventricular outflow tract. Aortic Valve Regurgitant Jet Width Aortic Valve Regurgitant Volume A measurement of the volume of retrograde blood flow across the orifice of the aortic valve. Aortic Valve Regurgitant Volume Aortic Valve Vena Contracta Area The area of the vena contracta of the aortic valve. Aortic Valve Vena Contracta Area Aortic Valve Vena Contracta Width The width of the vena contracta of the aortic valve. Aortic Valve Vena Contracta Width Blood Flow Rate The volume of blood per unit time passing through a specified location, such as a point in a blood vessel or an entire organ. Blood Flow Rate Coronary Artery Disease Presentation The compilation of symptoms and/or clinical manifestation of coronary artery disease. Coronary Artery Disease Presentation Coronary Artery Disease Risk Category The classification of the likelihood that an individual will develop coronary artery disease. Coronary Artery Disease Risk Category Coronary Artery Disease Symptoms Subjective evidence of coronary artery disease perceived by the patient. Coronary Artery Disease Symptoms Coronary Artery No Reflow Indicator An indication as to whether there is a new acute reduction in coronary flow (TIMI grade 0-1) in the absence of dissection, thrombus, spasm, or high-grade residual stenosis at the original PCI lesion site. Coronary No Reflow at PCI Site Indicator Cardiac Index The measure of an individual's cardiac output divided by the individual's body surface area (CI= CO/BSA). Cardiac Index Cardiac Output The total volume of blood pumped by the heart over a set period of time, conventionally one minute; it is calculated as heart rate times stroke volume (CO= HR x SV). Cardiac Output Circumferential Strain A measurement of the change in length of the myocardium along the circumferential axis of the ventricle or atrium as viewed in the short axis. Circumferential Strain Measurement Cardiac Muscle Hypertrophy Indicator An indication as to whether there is a hypertrophied cardiac muscle. Heart Chamber Hypertrophy Indicator Coronary Artery Dominance The pattern of the epicardial vessels supplying the posterolateral and posterior descending coronary arteries. Coronary Artery Dominance Indication for Cardiac Procedure The condition, disease or disorder that the cardiac procedure is intended to investigate or address. Indication for Cardiac Procedure Cardiac Rhythm Device Fail Manifestation Cardiac Rhythm Device Failure Manifestation The outcome of the cardiac rhythm device failure. Cardiac Rhythm Device Fail Manifestation Cross-sectional Diameter A measurement of a structure taken along the plane that is perpendicular to the long axis. Cross-sectional Diameter Cross-sec Diameter, EVD Cross-sectional Diameter, End Ventricular Diastole The cross sectional diameter of a cardiovascular structure measured at end ventricular diastole. Cross-sectional Diameter at End Ventricular Diastole Cross-sec Diameter, EVS Cross-sectional Diameter, End Ventricular Systole The cross sectional diameter of a cardiovascular structure measured at end ventricular systole. Cross-sectional Diameter at End Ventricular Systole Cross-sec Diameter, MVS Cross-sectional Diameter, Mid Ventricular Systole The cross sectional diameter of a cardiovascular structure measured at mid ventricular systole. Cross-sectional Diameter at Mid Ventricular Systole Cusp Doming Indicator An indication as to whether there is doming of a cardiac valve cusp. Cusp Doming Indicator Cusp Doming Severity The assessment of the severity of doming of a cardiac valve cusp. Cusp Doming Severity Cusp Flail Indicator An indication as to whether there is a flailing cardiac valve cusp. Cusp Flail Indicator Cusp Flail Severity The assessment of the severity of a flailing cardiac valve cusp. Cusp Flail Severity Cusp Flail Timing The time point during the cardiac cycle when the flail of one or more cardiac valve cusps occurs. Cusp Flail Timing Cusp Prolapse Indicator An indication as to whether there is a prolapsing cardiac valve cusp. Cusp Prolapse Indicator Cusp Prolapse Severity The assessment of the severity of a prolapsing cardiac valve cusp. Cusp Prolapse Severity Cusp Prolapse Timing The time point during the cardiac cycle when the prolapse of one or more cardiac valve cusps occurs. Cusp Prolapse Timing Cusp Restricted Motion Indicator An indication as to whether there is restricted motion of a cardiac valve cusp. Cusp Restricted Motion Indicator Cusp Restricted Motion Severity The assessment of the severity of restricted motion of a cardiac valve cusp. Cusp Restricted Motion Severity Cusp Tethering Indicator An indication as to whether there is tethering of a cardiac valve cusp. Cusp Tethering Indicator Cusp Tethering Severity The assessment of the severity of tethering of a cardiac valve cusp. Cusp Tethering Severity Cusp Thickening Indicator An indication as to whether there is a thickened cardiac valve cusp. Cusp Thickening Indicator Cusp Thickening Severity The assessment of the severity of a thickening cardiac cusp. Cusp Thickening Severity Chordae Tendineae Prolapse Indicator An indication as to whether there is prolapsing of a cardiac valve chordae tendinae. Chordae Tendineae Prolapse Indicator Coronary Vessel Disease Extent The range, magnitude, or distance over which disease is present in the coronary vessels. Coronary Vessel Disease Extent Cardiac Valvular Regurgitation Severity The qualitative measurement of the severity of cardiac valvular regurgitation. Cardiac Valvular Regurgitation Severity Cardiac Valvular Stenosis Severity The qualitative measurement of the severity of cardiac valvular stenosis. Cardiac Valvular Stenosis Severity Cardiac Valvular Regurgitation Indicator An indication as to whether a specific cardiac valve is regurgitant. Cardiac Valvular Regurgitation Indicator Cardiac Valve Regur Jet Direction Cardiac Valve Regurgitation Jet Direction The trajectory of the retrograde blood flow from a cardiac valve. Cardiac Valve Regurgitant Jet Direction Cardiac Valvular Regur Likely Etiology Cardiac Valvular Regurgitation Likely Etiology An estimation as to the cause of the pathology responsible for the cardiac valve regurgitation. Cardiac Valvular Regurgitation Likely Etiology Cardiac Wall Motion Type The assessment of the movement of the cardiac muscle, either as a whole or at one or more specific anatomical locations. Cardiac Wall Motion Type DeBakey AoD Classification DeBakey Aortic Dissection Classification The type of aortic dissection present as defined by the DeBakey Classification System (DeBakey ME, Henly WS, Cooley DA, Morris GC Jr, Crawford ES, Beall AC Jr. Surgical management of dissecting aneurysms of the aorta. J Thorac Cardiovasc Surg. 1965 Jan;49:130-49). DeBakey Aortic Dissection Classification Depth The extent downward or inward; the perpendicular measurement from the surface downward to determine deepness. (NCI) Depth Dimensionless Index Dimensionless Velocity Index The ratio of the blood velocity in the left ventricular outflow tract (LVOT) to the maximum blood velocity across the aortic valve. Dimensionless Index Dissection Indicator An indication as to whether there is the presence of blood vessel dissection. Dissection Indicator End Diastolic Blood Volume End Diastolic Volume The volume of blood remaining in the ventricle or atrium at end diastole. End Diastolic Volume Effective Regurgitant Orifice Area A measurement of the effective regurgitant orifice area of the valve. Effective Regurgitant Orifice Area Ejection Wave Amplitude The magnitude of the ejection wave that occurs when blood is ejected into the aorta by the left ventricle. Ejection Wave Amplitude Effective Orifice Area The calculated estimate of the area of a cardiac valve at the point of maximum opening. Effective Orifice Area Effective Orifice Area Index The ratio of the effective orifice area (EOA) to the body surface area (BSA). Effective Orifice Area Index Eccentric Regurgitant Jet Indicator An indication as to whether an eccentric regurgitant jet direction is present. Eccentric Regurgitant Jet Indicator End Systolic Blood Volume End Systolic Volume The volume of blood remaining in the ventricle or atrium at end systole. End Systolic Volume Fractional Area Change The percent reduction in the area of a given structure with the following formula: (EDA-ESA)/EDA times 100, where EDA is end diastolic area and ESA is end systolic area. Fractional Area Change Observed Foreign Body Indicator An indication as to whether a medical or non-medical foreign body is present in a subject. Observed Foreign Body Indicator Global Circumferential Strain A measurement of the global myocardial circumferential strain of the ventricle or atrium, via an automated algorithm. Global Circumferential Strain Measurement Global Circumferential Strain, Cal Global Circumferential Strain, Calculated A calculation of the global myocardial circumferential strain of the ventricle or atrium, by averaging the collected segmental circumferential strains. Calculated Global Circumferential Strain Measurement Global Longitudinal Strain A measurement of the global myocardial longitudinal strain of the ventricle or atrium, via an automated algorithm. Global Longitudinal Strain Measurement Global Longitudinal Strain, Cal Global Longitudinal Strain, Calculated A calculation of the global myocardial longitudinal strain of the ventricle or atrium, by averaging the collected longitudinal strains from all or any of the three imaging views (i.e., 4-, 3-, 2-chamber views). Calculated Global Longitudinal Strain Measurement Heart Chamber Enlargement Indicator An indication as to whether there is an enlarged heart chamber. Heart Chamber Enlargement Indicator In-Stent Restenosis Indicator An indication as to whether there is re-narrowing of a stent implanted at a lesion site to treat a prior stenosis, to a diameter stenosis of greater than 50% within the stent. In-Stent Restenosis Indicator Interpretation An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. Interpretation Ischemic Myocardium Percentage The percentage of myocardial tissue which exhibits characteristics of inadequate blood flow (ischemia). Ischemic Myocardium Percentage Inferior Vena Cava Collapse Indicator Inferior Vena Cava Collapse Sniff Ind An indication as to whether inferior vena cava collapse occurred with sniff. Inferior Vena Cava Collapse Due to Sniff Test Indicator Largest Cross-sec Diameter, EVD Largest Cross-sectional Diameter, End Ventricular Diastole The largest cross sectional diameter of a vascular structure measured at end ventricular diastole. Largest Cross-sectional Diameter at End Ventricular Diastole Loc of Most Sev Stenosis Within a Graft Location of Most Severe Stenosis Within a Graft The portion of the graft that is most severely stenotic. Location of Most Severe Stenosis Within a Graft Length The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI) Length Late Gadolinium Enhancement The phenomenon of a delay in the accumulation and relative excess concentration of gadolinium-based contrast materials in tissues with increased extracellular space, which may be caused by conditions that expand the extracellular matrix, or less frequently slow gadolinium exit. Late Gadolinium Enhancement Late Gadolinium Enhancement Percentage The percentage of a region which exabits characteristics of late gadolinium enhancement. Late Gadolinium Enhancement Percentage Late Gadolinium Enhancement Segment Count Late Gadolinium Enhancement Segment CT The number of segments which exabit characteristics of late gadolinium enhancement. Late Gadolinium Enhancement Segment Count Largest Cross-sec Thickness Largest Cross-sectional Thickness The assessment of the largest cross-sectional thickness of a tissue. Largest Cross-sectional Thickness Late Lumen Loss The difference between the mean minimum lumen diameter (MLD) assessed immediately after an index procedure and the MLD assessed at follow-up angiography. Late Lumen Loss Measurement Longitudinal Deformation Longitudinal Shortening Longitudinal Strain A measurement of the change in length of the myocardium along the long axis (from base to apex) of the ventricle or atrium. Longitudinal Strain Measurement Lesion Restenosis Indicator An indication as to whether there is re-narrowing of a lesion site following treatment of a prior stenosis, to a diameter stenosis of greater than 50% at the previously treated lesion site. Lesion Restenosis Indicator Left Ventricular Ejection Fraction The percent or fraction of the left ventricular end diastolic volume ejected during systole that can be measured by visual estimation or calculation. Left Ventricular Ejection Fraction Left Ventricular Ejection Fraction, Cal Left Ventricular Ejection Fraction, Calculated A calculated percent or fraction of the volume of blood ejected from the left ventricle during left ventricular systole, calculated as the left ventricular stroke volume divided by the left ventricular end diastolic volume. Calculated Left Ventricular Ejection Fraction Left Ventricular Ejection Fraction, Est Left Ventricular Ejection Fraction, Estimated A visual estimation of the percent or fraction of the volume of blood ejected from the left ventricle during left ventricular systole. Estimated Left Ventricular Ejection Fraction Left Ventricular Ejection Fraction Interpretation Left Ventricular Ejection Fraction Intp The explication or explanation of the meaning of the left ventricular ejection fraction measurement. Left Ventricular Ejection Fraction Interpretation Left Ventricular Fractional Shortening The reduction in the length of the end-diastolic diameter dimension that occurs between end-systole and end-diastole, expressed as a fraction of the end-diastolic dimension. Calculation of the left ventricular fractional shortening is per the following formula: [(end-diastolic dimension minus end-systolic dimension) divided by end-diastolic dimension] multiplied by 100. Left Ventricular Fractional Shortening Determination Left Ventricular Mass, Estimated The weight of the left ventricle in grams as estimated by a formula that uses estimated measurements from echocardiographic exams, as well as constants like the specific gravity of the myocardium. Left ventricular mass is estimated using the following equation, LV Mass (g) = 0.8 {1.04[([LVEDD + IVSd + PWd]^3 - LVEDD^3)]} + 0.6, where LVEDD is LV end-diastolic dimension, IVSd is interventricular septal thickness at end-diastole, and PWd is posterior wall thickness at end-diastole. Estimated Mass of Left Ventricle Left Ventricular Mass Index The left ventricular mass divided by the subject's body surface area. Left Ventricular Mass Index Left Ventricular Outflow Tract Peak Velocity LVOT Peak Velocity A measurement of the maximum velocity of blood flow measured in the left ventricular outflow tract during left ventricular systole. Left Ventricular Outflow Tract Peak Velocity Left Ventricular Outflow Tract Velocity Time Integral LVOT Velocity Time Integral The integral of all of the instantaneous flow velocities within the left ventricular outflow tract during left ventricular systole. Left Ventricular Outflow Tract Velocity Time Integral Mass The amount of matter in an object. Mass Maximal Pericardial Effusion Width The quantitative measurement of the maximum separation between the parietal and visceral pericardia during diastole. Maximal Pericardial Effusion Width Mean Blood Flow Velocity A measurement of the mean velocity of blood across an area or tissue. Mean Blood Flow Velocity Mean Blood Pressure, Estimated The estimated average blood pressure. (NCI) Estimated Mean Blood Pressure Mean Vessel Diameter The mean of the inside diameters of the normal blood vessel segments. Mean Vessel Diameter Mech Circ Support Placement Timing Mechanical Circulatory Support Placement Timing A description of the timepoint at which the mechanical circulatory support device was implanted. Mechanical Circulatory Support Placement Timing Mean Pressure Gradient A value that represents the mean pressure gradient that exists between two points across a structure. Mean Pressure Gradient Minimum Vessel Lumen Diameter The minimum diameter of the inside of a blood vessel (lumen) derived quantitatively in a single view. Minimum Vessel Lumen Diameter Mitral E/A Ratio The ratio of the peak early ventricular diastolic (E) transmitral velocity to the peak late ventricular diastolic (A) transmitral velocity. Mitral E/A Ratio Mitral E/e' Ratio The ratio of the peak early ventricular diastolic (E) transmitral velocity to the peak early mitral annular motion velocity (e'). Mitral E/e' Ratio Major Axis Cross-sec. Diameter Major Axis Cross-sectional Diameter The cross sectional diameter of a tissue, organ, or structure measured along its major axis. (NCI) Major Axis Cross-sectional Diameter Major Axis Cross-sec Diameter, EVD Major Axis Cross-sectional Diameter, End Ventricular Diastole The cross sectional diameter of a cardiovascular structure measured along its major axis at end ventricular diastole. Major Axis Cross-sectional Diameter at End Ventricular Diastole Major Axis Cross-sec Diameter, EVS Major Axis Cross-sectional Diameter, End Ventricular Systole The cross sectional diameter of a cardiovascular structure measured along its major axis at end ventricular systole. Major Axis Cross-sectional Diameter at End Ventricular Systole Major Axis Cross-sec. Diameter, MVS Major Axis Cross-sectional Diameter, Mid Ventricular Systole The cross-sectional diameter of a cardiovascular structure measured along its major axis at mid ventricular systole. Major Axis Cross-sectional Diameter at Mid Ventricular Systole Major Axis Internal Diameter, End Ventricular Diastole Major Axis Internal Diameter, EVD The internal diameter of a cardiovascular structure measured along its major axis at end ventricular diastole. Major Axis Internal Diameter at End Ventricular Diastole Major Axis Internal Diameter, End Ventricular Systole Major Axis Internal Diameter, EVS The internal diameter of a cardiovascular structure measured along its major axis at end ventricular systole. Major Axis Internal Diameter at End Ventricular Systole Minor Axis Cross-sec. Diameter Minor Axis Cross-sectional Diameter The cross sectional diameter of a tissue, organ, or structure measured along its minor axis. (NCI) Minor Axis Cross-sectional Diameter Minor Axis Cross-sec Diameter, EVD Minor Axis Cross-sectional Diameter, End Ventricular Diastole The cross sectional diameter of a cardiovascular structure measured along its minor axis at end ventricular diastole. Minor Axis Cross-sectional Diameter at End Ventricular Diastole Minor Axis Cross-sec Diameter, EVS Minor Axis Cross-sectional Diameter, End Ventricular Systole The cross sectional diameter of a cardiovascular structure measured along its minor axis at end ventricular systole. Minor Axis Cross-sectional Diameter at End Ventricular Systole Minor Axis Cross-sec. Diameter, MVS Minor Axis Cross-sectional Diameter, Mid Ventricular Systole The cross-sectional diameter of a cardiovascular structure measured along its minor axis at mid ventricular systole. Minor Axis Cross-sectional Diameter at Mid Ventricular Systole Minor Axis Internal Diameter, End Ventricular Diastole Minor Axis Internal Diameter, EVD The internal diameter of a cardiovascular structure measured along its minor axis at end ventricular diastole. Minor Axis Internal Diameter at End Ventricular Diastole Minor Axis Internal Diameter, End Ventricular Systole Minor Axis Internal Diameter, EVS The internal diameter of a cardiovascular structure measured along its minor axis at end ventricular systole. Minor Axis Internal Diameter at End Ventricular Systole Myocardial Performance Index A calculated result that uses the following base formula to quantify both systolic and diastolic ventricular function: MPI = (IVCT + IVRT)/VET, where IVCT is isovolumetric contraction time, IVRT is isovolumetric relaxation time, and VET is ventricular ejection time. Myocardial Performance Index Mitral Regur Jet Area L Atrial Area Rt Mitral Regurgitant Jet Area to Left Atrial Area Ratio A relative measurement (ratio) of the mitral regurgitant jet area to left atrial area. Mitral Regurgitant Jet Area to Left Atrial Area Ratio Mitral Valve Regurgitant Fraction A measurement of the volume of retrograde blood flow across the orifice of the mitral valve expressed as a percentage of the anterograde flow volume. Mitral Valve Regurgitant Fraction Mitral Valve Regurgitant Jet Area The measured area of the regurgitant jet of blood into the left atrium. Mitral Valve Regurgitant Jet Area Mitral Valve Regurgitant Volume A measurement of the volume of retrograde blood flow across the orifice of the mitral valve. Mitral Valve Regurgitant Volume Mitral Valve Vena Contracta Area The area of the vena contracta of the mitral valve. Mitral Valve Vena Contracta Area Mitral Valve Vena Contracta Width The width of the vena contracta of the mitral valve. Mitral Valve Vena Contracta Width MECV Myocardial Extracellular Volume The percent of myocardial tissue comprised of extracellular space calculated from native and post-contrast T1 maps and a contemporaneous hematocrit level. Myocardial Extracellular Volume Native Cardiac Valve Intervention Type A description of what kind of intervention has been performed on a native cardiac valve. Native Cardiac Valve Intervention Type Non-System Reason for PCI Delay An explanation as to why the percutaneous coronary intervention procedure was delayed, not including those related to medical procedures or other systemic factors. Non-System Reason for PCI Delay Number of Cusps A quantitative determination of the number of cusps composing a given cardiac valve. Number of Cardiac Valve Cusps Number of Diseased Coronary Vessels Number of major epicardial vessels with greater than or equal to 70% reduction in diameter or greater than or equal to 50% reduction in cross-sectional area. Number of Diseased Coronary Artery Vessels Obs Med Device Type In Intended Loc Observed Medical Device In The Intended Location A description of the type of medical device that is found in a subject and is in its intended location. Observed Medical Device Type In Intended Location Obs Med Device Type Not In Intended Loc A description of the type of medical device that is found in a subject but is not in its intended location. Observed Medical Device Type Not Present In Intended Location Type Observed Non-Medical Foreign Body Type A description of the type of non-medical foreign body that is found in a subject. Observed Non-Medical Foreign Body Type Pulmonary Arterial Hypertension Ind Pulmonary Arterial Hypertension Indicator An indication as to whether pulmonary arterial hypertension is present. Pulmonary Arterial Hypertension Indicator Peak Blood Flow Velocity A measurement of the maximum velocity of blood across an area or tissue. Peak Blood Flow Velocity Percent Diameter Stenosis The value calculated as 100 x (1 - MLD/RVD), using the mean quantitative values for minimum lumen diameter (MLD) and reference vessel diameter (RVD). Percent Diameter Stenosis Prosthetic Cardiac Valve Type A description of the type of artificial cardiac valve in use. Prosthetic Cardiac Valve Type Pericardial Effusion Indicator An indication as to whether there is effusion between the parietal and visceral pericardia. Pericardial Effusion Indicator Pericardial Effusion Size The qualitative description of the overall size of a pericardial effusion as assessed at the point of greatest separation between the parietal and visceral pericardia during diastole. Pericardial Effusion Size Peak Pressure Gradient A value that represents the maximum pressure gradient that exists between two points across a structure. Peak Pressure Gradient Peak A Velocity The peak velocity of blood flow across a cardiac valve during late ventricular diastole (the active filling of the ventricle). Peak A Velocity Peak E Velocity The peak velocity of blood flow across a cardiac valve during early ventricular diastole (the passive filling of the ventricle). Peak E Velocity Peak Pressure Rise Rate The greatest rate of increase in peak pressure. Peak Pressure Rise Rate Pressure Half Time The amount of time required for the peak transvalvular pressure gradient to decrease to one half of the value. Pressure Half Time Pulmonic Regur Jet Width RVOT Diam Rt Pulmonic Regurgitant Jet Width to Right Ventricular Outflow Tract Diameter Ratio A relative measurement (ratio) of the pulmonic regurgitant jet width to right ventricular outflow tract (RVOT) diameter. Pulmonic Regurgitant Jet Width to Right Ventricular Outflow Tract Diameter Ratio Pulmonary Vein Dominance The determination of whether blood flow in the pulmonary veins is greater during ventricular systole or diastole. Pulmonary Vein Dominance Pulmonary Vascular Resistance The resistance to blood flow through the pulmonary vasculature. Pulmonary Vascular Resistance Pulmonary Valve Regurgitant Fraction A measurement of the volume of retrograde blood flow across the orifice of the pulmonic valve expressed as a percentage of the anterograde flow volume. Pulmonary Valve Regurgitant Fraction Pulmonic Valve Regurgitant Jet Width The measured width of the regurgitant jet of blood into the right ventricular outflow tract. Pulmonic Valve Regurgitant Jet Width Pulmonary Valve Regurgitant Volume A measurement of the volume of retrograde blood flow across the orifice of the pulmonic valve. Pulmonary Valve Regurgitant Volume Pulmonary Valve Vena Contracta Area The area of the vena contracta of the pulmonic valve. Pulmonary Valve Vena Contracta Area Pulmonary Valve Vena Contracta Width The width of the vena contracta of the pulmonic valve. Pulmonary Valve Vena Contracta Width Pulse Wave Velocity The distance traveled by the peak of the ventricular ejection pressure wave per unit of time. Pulse Wave Velocity Reflection Magnitude The reflected-to-forward pressure wave amplitude ratio. (Hashimoto J et al, J Hypertens. 2008 May;26(5):1017-24) Reflection Magnitude Reflection Wave Amplitude The summation of the numerous waves being reflected by sites of impedance mismatch where central elastic arteries join more muscular arteries. Reflection Wave Amplitude Reason CS/LV Lead Not Implanted An explanation as to why the CS/LV lead was not implanted into the subject. Reason CS/LV Lead Not Implanted Right Ventricular Ejection Fraction The percent or fraction of the right ventricular end diastolic volume ejected during systole that can be measured by visual estimation or calculation. Right Ventricular Ejection Fraction Right Ventricular Ejection Fraction, Cal Right Ventricular Ejection Fraction, Calculated A calculated percent or fraction of the volume of blood ejected from the right ventricle during right ventricular systole, calculated as the right ventricular stroke volume divided by the right ventricular end diastolic volume. Calculated Right Ventricular Ejection Fraction Right Ventricular Ejection Fraction, Est Right Ventricular Ejection Fraction, Estimated A visual estimation of the percent or fraction of the volume of blood ejected from the right ventricle during right ventricular systole. Estimated Right Ventricular Ejection Fraction SAM Indicator Systolic Anterior Motion Indicator An indication as to whether there is systolic anterior motion of a cardiac valve and its associated structures. Systolic Anterior Motion Indicator SAM Severity Systolic Anterior Motion Severity The assessment of the severity of the systolic anterior motion of a cardiac valve and its associated structures. Systolic Anterior Motion Severity Sudden Death Syndrome Risk Type A characterization or classification of the syndromes or conditions that put a subject at risk for sudden death. Sudden Death Syndrome Risk Type Segmental Late Gadolinium Enhancement The identification of the segment which exabits characteristics of late gadolinium enhancement. Segmental Late Gadolinium Enhancement Stanford AoD Classification Stanford Aortic Dissection Classification The type of aortic dissection present as defined by the Stanford Classification System (Daily PO, Trueblood HW, Stinson EB, Wuerflein RD, Shumway NE. Management of acute aortic dissections. Ann Thorac Surg. 1970 Sep;10(3):237-47). Stanford Aortic Dissection Classification Stroke Volume The difference in the volumes of blood between the points of maximum dilation and maximum contraction. This is the end diastolic volume minus the end systolic volume. Stroke Volume Systemic Vascular Resistance Total Peripheral Resistance The resistance to blood flow through the systemic vasculature. Systemic Vascular Resistance Systolic Pressure, Estimated A quantitative estimate of the pressure in a given cardiovascular structure during ventricular systole. Estimated Systolic Blood Pressure Longitudinal Relaxation Time Spin-Lattice Relaxation Time T1 Relaxation Time T1 Time The time constant representing the decay of longitudinal magnetization. Longitudinal Relaxation Time Spin-Spin Relaxation T2 Relaxation Time T2 Time Transverse Relaxation Time The time constant representing the decay of transverse magnetization. Transverse Spin Relaxation Time Cross-sec Thickness, EVD Cross-sectional Thickness, End Ventricular Diastole The cross-sectional thickness of a cardiovascular structure measured at end ventricular diastole. Cross-sectional Thickness at End Ventricular Diastole Cross-sec Thickness, EVS Cross-sectional Thickness, End Ventricular Systole The cross-sectional thickness of a cardiovascular structure measured at end ventricular systole. Cross-sectional Thickness at End Ventricular Systole Tricus Regur Jet Area R Atrial Area Rt Tricuspid Regurgitant Jet Area to Right Atrial Area Ratio A relative measurement (ratio) of the tricuspid regurgitant jet area to the right atrial area. Tricuspid Regurgitant Jet Area to Right Atrial Area Ratio Tricuspid Valve Regurgitant Fraction A measurement of the volume of retrograde blood flow across the orifice of the tricuspid valve expressed as a percentage of the anterograde flow volume. Tricuspid Valve Regurgitant Fraction Tricuspid Valve Regurgitant Jet Area The measured area of the regurgitant jet of blood into the right atrium. Tricuspid Valve Regurgitant Jet Area Tricuspid Valve Regurgitant Volume A measurement of the volume of retrograde blood flow across the orifice of the tricuspid valve. Tricuspid Valve Regurgitant Volume Tricuspid Valve Vena Contracta Area The area of the vena contracta of the tricuspid valve. Tricuspid Valve Vena Contracta Area Tricuspid Valve Vena Contracta Width The width of the vena contracta of the tricuspid valve. Tricuspid Valve Vena Contracta Width Valve Area Index The ratio of the valve area to the body surface area. Valve Area Index Velocity Time Integral, Blood Flow The integral of all of the forward flow velocities during the time of blood flow across or within a specified area. Blood Flow Velocity Time Integral Cardiac Valvular Stenosis Indicator An indication as to whether the cardiac valve in question has stenosis. Cardiac Valvular Stenosis Indicator Cardiac Valve Stenosis Likely Etiology A description of the likely cause of the pathology responsible for the cardiac valve stenosis. Cardiac Valve Stenosis Likely Etiology Valve Area The quantitative measurement estimating the surface area of a valve. Valve Area Weight The vertical force exerted by a mass as a result of gravity. (NCI) Weight Width The extent or measurement of something from side to side. (NCI) Width CVTESTCD Cardiovascular Test Code CDISC SDTM Cardiovascular Test Code Terminology A terminology codelist to describe the test name for a physiological examination of the cardiovascular system. Acute Coronary Syndrome Presentation Cat Acute Coronary Syndrome Presentation Category A classification of the compilation of symptoms and/or clinical manifestation of acute coronary syndrome. Acute Coronary Syndrome Presentation Category Aneurysm Indicator An indication as to whether there is the presence of one or more aneurysms. Aneurysm Indicator Annular a' Velocity The peak velocity of the annular motion during late ventricular diastole (the active filling of the ventricle). Annular a' Velocity Annular e' Velocity The peak velocity of the annular motion during early ventricular diastole (the passive filling of the ventricle). Annular e' Velocity Annular Plane Systolic Excursion The longitudinal displacement of a cardiac valve annulus toward the apex of the heart. Annular Plane Systolic Excursion Annular S' Velocity The peak velocity of the annular motion during ventricular systole. Annular S' Velocity Aortic Augmentation Index at 75bpm The aortic augmentation index normalized to a heart rate of 75 beats per minute. Aortic Augmentation Index at 75bpm Aortic Augmentation Index The augmentation pressure divided by the aortic pulse pressure (aortic systolic minus aortic diastolic pressure) multiplied by 100, expressed as a percentage. Aortic Augmentation Index Measurement Aortic Augmentation Pressure Peak P1 The first pressure peak in the aortic wave form secondary to ventricular ejection. Augmentation Pressure Point P1 Aortic Augmentation Pressure Peak P2 The second pressure peak in the aortic waveform secondary to pressure wave reflection from the periphery. Augmentation Pressure Point P2 Aortic Augmentation Pressure The difference between the second pressure peak in the aortic wave, secondary to the pressure wave reflection from the sites of peripheral arterial impedance mismatch (P2) and the first pressure peak in the aortic wave form, secondary to ventricular ejection (P1). Aortic Augmentation Pressure Aortic Coarctation Indicator An indication as to whether there is coarctation of the aorta. Aortic Coarctation Indicator Aortic Coarctation Severity The assessment of the severity of aortic coarctation. Aortic Coarctation Severity Aortic Ductal Coarctation Severity Aortic Juxta-ductal Coarctation Severity The assessment of the severity of ductal aortic coarctation. Aortic Juxta-ductal Coarctation Severity Aortic Postductal Coarctation Severity The assessment of the severity of postductal aortic coarctation. Aortic Postductal Coarctation Severity Aortic Preductal Coarctation Severity The assessment of the severity of preductal aortic coarctation. Aortic Preductal Coarctation Severity Aortic Regur Jet Width LVOT Diam Rt Aortic Regurgitant Jet Width to Left Ventricular Outflow Tract Diameter Ratio A relative measurement (ratio) of the aortic regurgitant jet width to left ventricular outflow tract (LVOT) diameter. Aortic Regurgitant Jet Width to Left Ventricular Outflow Tract Diameter Ratio Aortic Valve Regurgitant Fraction A measurement of the volume of retrograde blood flow across the orifice of the aortic valve expressed as a percentage of the anterograde flow volume. Aortic Valve Regurgitant Fraction Aortic Valve Regurgitant Jet Width The measured width of the regurgitant jet of blood into the left ventricular outflow tract. Aortic Valve Regurgitant Jet Width Aortic Valve Regurgitant Volume A measurement of the volume of retrograde blood flow across the orifice of the aortic valve. Aortic Valve Regurgitant Volume Aortic Valve Vena Contracta Area The area of the vena contracta of the aortic valve. Aortic Valve Vena Contracta Area Aortic Valve Vena Contracta Width The width of the vena contracta of the aortic valve. Aortic Valve Vena Contracta Width Area, End Ventricular Diastole The 2-dimensional surface enclosed within a boundary of a cardiovascular structure and measured at end ventricular diastole. Area at End Ventricular Diastole Area, End Ventricular Systole The 2-dimensional surface enclosed within a boundary of a cardiovascular structure and measured at end ventricular systole. Area at End Ventricular Systole Blood Flow Rate The volume of blood per unit time passing through a specified location, such as a point in a blood vessel or an entire organ. Blood Flow Rate Cardiac Index The measure of an individual's cardiac output divided by the individual's body surface area (CI= CO/BSA). Cardiac Index Cardiac Muscle Hypertrophy Indicator An indication as to whether there is a hypertrophied cardiac muscle. Heart Chamber Hypertrophy Indicator Cardiac Output The total volume of blood pumped by the heart over a set period of time, conventionally one minute; it is calculated as heart rate times stroke volume (CO= HR x SV). Cardiac Output Cardiac Rhythm Device Fail Manifestation Cardiac Rhythm Device Failure Manifestation The outcome of the cardiac rhythm device failure. Cardiac Rhythm Device Fail Manifestation Cardiac Valve Regur Jet Direction Cardiac Valve Regurgitation Jet Direction The trajectory of the retrograde blood flow from a cardiac valve. Cardiac Valve Regurgitant Jet Direction Cardiac Valve Stenosis Likely Etiology A description of the likely cause of the pathology responsible for the cardiac valve stenosis. Cardiac Valve Stenosis Likely Etiology Cardiac Valvular Regur Likely Etiology Cardiac Valvular Regurgitation Likely Etiology An estimation as to the cause of the pathology responsible for the cardiac valve regurgitation. Cardiac Valvular Regurgitation Likely Etiology Cardiac Valvular Regurgitation Indicator An indication as to whether a specific cardiac valve is regurgitant. Cardiac Valvular Regurgitation Indicator Cardiac Valvular Regurgitation Severity The qualitative measurement of the severity of cardiac valvular regurgitation. Cardiac Valvular Regurgitation Severity Cardiac Valvular Stenosis Indicator An indication as to whether the cardiac valve in question has stenosis. Cardiac Valvular Stenosis Indicator Cardiac Valvular Stenosis Severity The qualitative measurement of the severity of cardiac valvular stenosis. Cardiac Valvular Stenosis Severity Cardiac Wall Motion Type The assessment of the movement of the cardiac muscle, either as a whole or at one or more specific anatomical locations. Cardiac Wall Motion Type Chordae Tendineae Prolapse Indicator An indication as to whether there is prolapsing of a cardiac valve chordae tendinae. Chordae Tendineae Prolapse Indicator Circumferential Strain A measurement of the change in length of the myocardium along the circumferential axis of the ventricle or atrium as viewed in the short axis. Circumferential Strain Measurement Coronary Artery Disease Presentation The compilation of symptoms and/or clinical manifestation of coronary artery disease. Coronary Artery Disease Presentation Coronary Artery Disease Risk Category The classification of the likelihood that an individual will develop coronary artery disease. Coronary Artery Disease Risk Category Coronary Artery Disease Symptoms Subjective evidence of coronary artery disease perceived by the patient. Coronary Artery Disease Symptoms Coronary Artery Dominance The pattern of the epicardial vessels supplying the posterolateral and posterior descending coronary arteries. Coronary Artery Dominance Coronary Artery No Reflow Indicator An indication as to whether there is a new acute reduction in coronary flow (TIMI grade 0-1) in the absence of dissection, thrombus, spasm, or high-grade residual stenosis at the original PCI lesion site. Coronary No Reflow at PCI Site Indicator Coronary Vessel Disease Extent The range, magnitude, or distance over which disease is present in the coronary vessels. Coronary Vessel Disease Extent Cross-sec Diameter, EVD Cross-sectional Diameter, End Ventricular Diastole The cross sectional diameter of a cardiovascular structure measured at end ventricular diastole. Cross-sectional Diameter at End Ventricular Diastole Cross-sec Diameter, EVS Cross-sectional Diameter, End Ventricular Systole The cross sectional diameter of a cardiovascular structure measured at end ventricular systole. Cross-sectional Diameter at End Ventricular Systole Cross-sec Diameter, MVS Cross-sectional Diameter, Mid Ventricular Systole The cross sectional diameter of a cardiovascular structure measured at mid ventricular systole. Cross-sectional Diameter at Mid Ventricular Systole Cross-sec Thickness, EVD Cross-sectional Thickness, End Ventricular Diastole The cross-sectional thickness of a cardiovascular structure measured at end ventricular diastole. Cross-sectional Thickness at End Ventricular Diastole Cross-sec Thickness, EVS Cross-sectional Thickness, End Ventricular Systole The cross-sectional thickness of a cardiovascular structure measured at end ventricular systole. Cross-sectional Thickness at End Ventricular Systole Cross-sectional Diameter A measurement of a structure taken along the plane that is perpendicular to the long axis. Cross-sectional Diameter Cusp Doming Indicator An indication as to whether there is doming of a cardiac valve cusp. Cusp Doming Indicator Cusp Doming Severity The assessment of the severity of doming of a cardiac valve cusp. Cusp Doming Severity Cusp Flail Indicator An indication as to whether there is a flailing cardiac valve cusp. Cusp Flail Indicator Cusp Flail Severity The assessment of the severity of a flailing cardiac valve cusp. Cusp Flail Severity Cusp Flail Timing The time point during the cardiac cycle when the flail of one or more cardiac valve cusps occurs. Cusp Flail Timing Cusp Prolapse Indicator An indication as to whether there is a prolapsing cardiac valve cusp. Cusp Prolapse Indicator Cusp Prolapse Severity The assessment of the severity of a prolapsing cardiac valve cusp. Cusp Prolapse Severity Cusp Prolapse Timing The time point during the cardiac cycle when the prolapse of one or more cardiac valve cusps occurs. Cusp Prolapse Timing Cusp Restricted Motion Indicator An indication as to whether there is restricted motion of a cardiac valve cusp. Cusp Restricted Motion Indicator Cusp Restricted Motion Severity The assessment of the severity of restricted motion of a cardiac valve cusp. Cusp Restricted Motion Severity Cusp Tethering Indicator An indication as to whether there is tethering of a cardiac valve cusp. Cusp Tethering Indicator Cusp Tethering Severity The assessment of the severity of tethering of a cardiac valve cusp. Cusp Tethering Severity Cusp Thickening Indicator An indication as to whether there is a thickened cardiac valve cusp. Cusp Thickening Indicator Cusp Thickening Severity The assessment of the severity of a thickening cardiac cusp. Cusp Thickening Severity DeBakey AoD Classification DeBakey Aortic Dissection Classification The type of aortic dissection present as defined by the DeBakey Classification System (DeBakey ME, Henly WS, Cooley DA, Morris GC Jr, Crawford ES, Beall AC Jr. Surgical management of dissecting aneurysms of the aorta. J Thorac Cardiovasc Surg. 1965 Jan;49:130-49). DeBakey Aortic Dissection Classification Depth The extent downward or inward; the perpendicular measurement from the surface downward to determine deepness. (NCI) Depth Dimensionless Index Dimensionless Velocity Index The ratio of the blood velocity in the left ventricular outflow tract (LVOT) to the maximum blood velocity across the aortic valve. Dimensionless Index Dissection Indicator An indication as to whether there is the presence of blood vessel dissection. Dissection Indicator Eccentric Regurgitant Jet Indicator An indication as to whether an eccentric regurgitant jet direction is present. Eccentric Regurgitant Jet Indicator Effective Orifice Area Index The ratio of the effective orifice area (EOA) to the body surface area (BSA). Effective Orifice Area Index Effective Orifice Area The calculated estimate of the area of a cardiac valve at the point of maximum opening. Effective Orifice Area Effective Regurgitant Orifice Area A measurement of the effective regurgitant orifice area of the valve. Effective Regurgitant Orifice Area Ejection Wave Amplitude The magnitude of the ejection wave that occurs when blood is ejected into the aorta by the left ventricle. Ejection Wave Amplitude End Diastolic Blood Volume End Diastolic Volume The volume of blood remaining in the ventricle or atrium at end diastole. End Diastolic Volume End Systolic Blood Volume End Systolic Volume The volume of blood remaining in the ventricle or atrium at end systole. End Systolic Volume Fractional Area Change The percent reduction in the area of a given structure with the following formula: (EDA-ESA)/EDA times 100, where EDA is end diastolic area and ESA is end systolic area. Fractional Area Change Global Circumferential Strain A measurement of the global myocardial circumferential strain of the ventricle or atrium, via an automated algorithm. Global Circumferential Strain Measurement Global Circumferential Strain, Cal Global Circumferential Strain, Calculated A calculation of the global myocardial circumferential strain of the ventricle or atrium, by averaging the collected segmental circumferential strains. Calculated Global Circumferential Strain Measurement Global Longitudinal Strain A measurement of the global myocardial longitudinal strain of the ventricle or atrium, via an automated algorithm. Global Longitudinal Strain Measurement Global Longitudinal Strain, Cal Global Longitudinal Strain, Calculated A calculation of the global myocardial longitudinal strain of the ventricle or atrium, by averaging the collected longitudinal strains from all or any of the three imaging views (i.e., 4-, 3-, 2-chamber views). Calculated Global Longitudinal Strain Measurement Heart Chamber Enlargement Indicator An indication as to whether there is an enlarged heart chamber. Heart Chamber Enlargement Indicator In-Stent Restenosis Indicator An indication as to whether there is re-narrowing of a stent implanted at a lesion site to treat a prior stenosis, to a diameter stenosis of greater than 50% within the stent. In-Stent Restenosis Indicator Indication for Cardiac Procedure The condition, disease or disorder that the cardiac procedure is intended to investigate or address. Indication for Cardiac Procedure Inferior Vena Cava Collapse Indicator Inferior Vena Cava Collapse Sniff Ind An indication as to whether inferior vena cava collapse occurred with sniff. Inferior Vena Cava Collapse Due to Sniff Test Indicator Interpretation An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. Interpretation Ischemic Myocardium Percentage The percentage of myocardial tissue which exhibits characteristics of inadequate blood flow (ischemia). Ischemic Myocardium Percentage Largest Cross-sec Diameter, EVD Largest Cross-sectional Diameter, End Ventricular Diastole The largest cross sectional diameter of a vascular structure measured at end ventricular diastole. Largest Cross-sectional Diameter at End Ventricular Diastole Largest Cross-sec Thickness Largest Cross-sectional Thickness The assessment of the largest cross-sectional thickness of a tissue. Largest Cross-sectional Thickness Late Gadolinium Enhancement Percentage The percentage of a region which exabits characteristics of late gadolinium enhancement. Late Gadolinium Enhancement Percentage Late Gadolinium Enhancement Segment Count Late Gadolinium Enhancement Segment CT The number of segments which exabit characteristics of late gadolinium enhancement. Late Gadolinium Enhancement Segment Count Late Gadolinium Enhancement The phenomenon of a delay in the accumulation and relative excess concentration of gadolinium-based contrast materials in tissues with increased extracellular space, which may be caused by conditions that expand the extracellular matrix, or less frequently slow gadolinium exit. Late Gadolinium Enhancement Late Lumen Loss The difference between the mean minimum lumen diameter (MLD) assessed immediately after an index procedure and the MLD assessed at follow-up angiography. Late Lumen Loss Measurement Left Ventricular Ejection Fraction Interpretation Left Ventricular Ejection Fraction Intp The explication or explanation of the meaning of the left ventricular ejection fraction measurement. Left Ventricular Ejection Fraction Interpretation Left Ventricular Ejection Fraction The percent or fraction of the left ventricular end diastolic volume ejected during systole that can be measured by visual estimation or calculation. Left Ventricular Ejection Fraction Left Ventricular Ejection Fraction, Cal Left Ventricular Ejection Fraction, Calculated A calculated percent or fraction of the volume of blood ejected from the left ventricle during left ventricular systole, calculated as the left ventricular stroke volume divided by the left ventricular end diastolic volume. Calculated Left Ventricular Ejection Fraction Left Ventricular Ejection Fraction, Est Left Ventricular Ejection Fraction, Estimated A visual estimation of the percent or fraction of the volume of blood ejected from the left ventricle during left ventricular systole. Estimated Left Ventricular Ejection Fraction Left Ventricular Fractional Shortening The reduction in the length of the end-diastolic diameter dimension that occurs between end-systole and end-diastole, expressed as a fraction of the end-diastolic dimension. Calculation of the left ventricular fractional shortening is per the following formula: [(end-diastolic dimension minus end-systolic dimension) divided by end-diastolic dimension] multiplied by 100. Left Ventricular Fractional Shortening Determination Left Ventricular Mass Index The left ventricular mass divided by the subject's body surface area. Left Ventricular Mass Index Left Ventricular Mass, Estimated The weight of the left ventricle in grams as estimated by a formula that uses estimated measurements from echocardiographic exams, as well as constants like the specific gravity of the myocardium. Left ventricular mass is estimated using the following equation, LV Mass (g) = 0.8 {1.04[([LVEDD + IVSd + PWd]^3 - LVEDD^3)]} + 0.6, where LVEDD is LV end-diastolic dimension, IVSd is interventricular septal thickness at end-diastole, and PWd is posterior wall thickness at end-diastole. Estimated Mass of Left Ventricle Length The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI) Length Lesion Restenosis Indicator An indication as to whether there is re-narrowing of a lesion site following treatment of a prior stenosis, to a diameter stenosis of greater than 50% at the previously treated lesion site. Lesion Restenosis Indicator Loc of Most Sev Stenosis Within a Graft Location of Most Severe Stenosis Within a Graft The portion of the graft that is most severely stenotic. Location of Most Severe Stenosis Within a Graft Longitudinal Relaxation Time Spin-Lattice Relaxation Time T1 Relaxation Time T1 Time The time constant representing the decay of longitudinal magnetization. Longitudinal Relaxation Time Longitudinal Deformation Longitudinal Shortening Longitudinal Strain A measurement of the change in length of the myocardium along the long axis (from base to apex) of the ventricle or atrium. Longitudinal Strain Measurement Left Ventricular Outflow Tract Peak Velocity LVOT Peak Velocity A measurement of the maximum velocity of blood flow measured in the left ventricular outflow tract during left ventricular systole. Left Ventricular Outflow Tract Peak Velocity Left Ventricular Outflow Tract Velocity Time Integral LVOT Velocity Time Integral The integral of all of the instantaneous flow velocities within the left ventricular outflow tract during left ventricular systole. Left Ventricular Outflow Tract Velocity Time Integral Major Axis Cross-sec Diameter, EVD Major Axis Cross-sectional Diameter, End Ventricular Diastole The cross sectional diameter of a cardiovascular structure measured along its major axis at end ventricular diastole. Major Axis Cross-sectional Diameter at End Ventricular Diastole Major Axis Cross-sec Diameter, EVS Major Axis Cross-sectional Diameter, End Ventricular Systole The cross sectional diameter of a cardiovascular structure measured along its major axis at end ventricular systole. Major Axis Cross-sectional Diameter at End Ventricular Systole Major Axis Cross-sec. Diameter Major Axis Cross-sectional Diameter The cross sectional diameter of a tissue, organ, or structure measured along its major axis. (NCI) Major Axis Cross-sectional Diameter Major Axis Cross-sec. Diameter, MVS Major Axis Cross-sectional Diameter, Mid Ventricular Systole The cross-sectional diameter of a cardiovascular structure measured along its major axis at mid ventricular systole. Major Axis Cross-sectional Diameter at Mid Ventricular Systole Major Axis Internal Diameter, End Ventricular Diastole Major Axis Internal Diameter, EVD The internal diameter of a cardiovascular structure measured along its major axis at end ventricular diastole. Major Axis Internal Diameter at End Ventricular Diastole Major Axis Internal Diameter, End Ventricular Systole Major Axis Internal Diameter, EVS The internal diameter of a cardiovascular structure measured along its major axis at end ventricular systole. Major Axis Internal Diameter at End Ventricular Systole Mass The amount of matter in an object. Mass Maximal Pericardial Effusion Width The quantitative measurement of the maximum separation between the parietal and visceral pericardia during diastole. Maximal Pericardial Effusion Width Mean Blood Flow Velocity A measurement of the mean velocity of blood across an area or tissue. Mean Blood Flow Velocity Mean Blood Pressure, Estimated The estimated average blood pressure. (NCI) Estimated Mean Blood Pressure Mean Pressure Gradient A value that represents the mean pressure gradient that exists between two points across a structure. Mean Pressure Gradient Mean Vessel Diameter The mean of the inside diameters of the normal blood vessel segments. Mean Vessel Diameter Mech Circ Support Placement Timing Mechanical Circulatory Support Placement Timing A description of the timepoint at which the mechanical circulatory support device was implanted. Mechanical Circulatory Support Placement Timing Minimum Vessel Lumen Diameter The minimum diameter of the inside of a blood vessel (lumen) derived quantitatively in a single view. Minimum Vessel Lumen Diameter Minor Axis Cross-sec Diameter, EVD Minor Axis Cross-sectional Diameter, End Ventricular Diastole The cross sectional diameter of a cardiovascular structure measured along its minor axis at end ventricular diastole. Minor Axis Cross-sectional Diameter at End Ventricular Diastole Minor Axis Cross-sec Diameter, EVS Minor Axis Cross-sectional Diameter, End Ventricular Systole The cross sectional diameter of a cardiovascular structure measured along its minor axis at end ventricular systole. Minor Axis Cross-sectional Diameter at End Ventricular Systole Minor Axis Cross-sec. Diameter Minor Axis Cross-sectional Diameter The cross sectional diameter of a tissue, organ, or structure measured along its minor axis. (NCI) Minor Axis Cross-sectional Diameter Minor Axis Cross-sec. Diameter, MVS Minor Axis Cross-sectional Diameter, Mid Ventricular Systole The cross-sectional diameter of a cardiovascular structure measured along its minor axis at mid ventricular systole. Minor Axis Cross-sectional Diameter at Mid Ventricular Systole Minor Axis Internal Diameter, End Ventricular Diastole Minor Axis Internal Diameter, EVD The internal diameter of a cardiovascular structure measured along its minor axis at end ventricular diastole. Minor Axis Internal Diameter at End Ventricular Diastole Minor Axis Internal Diameter, End Ventricular Systole Minor Axis Internal Diameter, EVS The internal diameter of a cardiovascular structure measured along its minor axis at end ventricular systole. Minor Axis Internal Diameter at End Ventricular Systole Mitral E/A Ratio The ratio of the peak early ventricular diastolic (E) transmitral velocity to the peak late ventricular diastolic (A) transmitral velocity. Mitral E/A Ratio Mitral E/e' Ratio The ratio of the peak early ventricular diastolic (E) transmitral velocity to the peak early mitral annular motion velocity (e'). Mitral E/e' Ratio Mitral Regur Jet Area L Atrial Area Rt Mitral Regurgitant Jet Area to Left Atrial Area Ratio A relative measurement (ratio) of the mitral regurgitant jet area to left atrial area. Mitral Regurgitant Jet Area to Left Atrial Area Ratio Mitral Valve Regurgitant Fraction A measurement of the volume of retrograde blood flow across the orifice of the mitral valve expressed as a percentage of the anterograde flow volume. Mitral Valve Regurgitant Fraction Mitral Valve Regurgitant Jet Area The measured area of the regurgitant jet of blood into the left atrium. Mitral Valve Regurgitant Jet Area Mitral Valve Regurgitant Volume A measurement of the volume of retrograde blood flow across the orifice of the mitral valve. Mitral Valve Regurgitant Volume Mitral Valve Vena Contracta Area The area of the vena contracta of the mitral valve. Mitral Valve Vena Contracta Area Mitral Valve Vena Contracta Width The width of the vena contracta of the mitral valve. Mitral Valve Vena Contracta Width MECV Myocardial Extracellular Volume The percent of myocardial tissue comprised of extracellular space calculated from native and post-contrast T1 maps and a contemporaneous hematocrit level. Myocardial Extracellular Volume Myocardial Performance Index A calculated result that uses the following base formula to quantify both systolic and diastolic ventricular function: MPI = (IVCT + IVRT)/VET, where IVCT is isovolumetric contraction time, IVRT is isovolumetric relaxation time, and VET is ventricular ejection time. Myocardial Performance Index Native Cardiac Valve Intervention Type A description of what kind of intervention has been performed on a native cardiac valve. Native Cardiac Valve Intervention Type Non-System Reason for PCI Delay An explanation as to why the percutaneous coronary intervention procedure was delayed, not including those related to medical procedures or other systemic factors. Non-System Reason for PCI Delay Number of Cusps A quantitative determination of the number of cusps composing a given cardiac valve. Number of Cardiac Valve Cusps Number of Diseased Coronary Vessels Number of major epicardial vessels with greater than or equal to 70% reduction in diameter or greater than or equal to 50% reduction in cross-sectional area. Number of Diseased Coronary Artery Vessels Obs Med Device Type In Intended Loc Observed Medical Device In The Intended Location A description of the type of medical device that is found in a subject and is in its intended location. Observed Medical Device Type In Intended Location Obs Med Device Type Not In Intended Loc A description of the type of medical device that is found in a subject but is not in its intended location. Observed Medical Device Type Not Present In Intended Location Type Observed Foreign Body Indicator An indication as to whether a medical or non-medical foreign body is present in a subject. Observed Foreign Body Indicator Observed Non-Medical Foreign Body Type A description of the type of non-medical foreign body that is found in a subject. Observed Non-Medical Foreign Body Type Peak A Velocity The peak velocity of blood flow across a cardiac valve during late ventricular diastole (the active filling of the ventricle). Peak A Velocity Peak Blood Flow Velocity A measurement of the maximum velocity of blood across an area or tissue. Peak Blood Flow Velocity Peak E Velocity The peak velocity of blood flow across a cardiac valve during early ventricular diastole (the passive filling of the ventricle). Peak E Velocity Peak Pressure Gradient A value that represents the maximum pressure gradient that exists between two points across a structure. Peak Pressure Gradient Peak Pressure Rise Rate The greatest rate of increase in peak pressure. Peak Pressure Rise Rate Percent Diameter Stenosis The value calculated as 100 x (1 - MLD/RVD), using the mean quantitative values for minimum lumen diameter (MLD) and reference vessel diameter (RVD). Percent Diameter Stenosis Pericardial Effusion Indicator An indication as to whether there is effusion between the parietal and visceral pericardia. Pericardial Effusion Indicator Pericardial Effusion Size The qualitative description of the overall size of a pericardial effusion as assessed at the point of greatest separation between the parietal and visceral pericardia during diastole. Pericardial Effusion Size Pressure Half Time The amount of time required for the peak transvalvular pressure gradient to decrease to one half of the value. Pressure Half Time Prosthetic Cardiac Valve Type A description of the type of artificial cardiac valve in use. Prosthetic Cardiac Valve Type Pulmonary Arterial Hypertension Ind Pulmonary Arterial Hypertension Indicator An indication as to whether pulmonary arterial hypertension is present. Pulmonary Arterial Hypertension Indicator Pulmonary Valve Regurgitant Fraction A measurement of the volume of retrograde blood flow across the orifice of the pulmonic valve expressed as a percentage of the anterograde flow volume. Pulmonary Valve Regurgitant Fraction Pulmonary Valve Regurgitant Volume A measurement of the volume of retrograde blood flow across the orifice of the pulmonic valve. Pulmonary Valve Regurgitant Volume Pulmonary Valve Vena Contracta Area The area of the vena contracta of the pulmonic valve. Pulmonary Valve Vena Contracta Area Pulmonary Valve Vena Contracta Width The width of the vena contracta of the pulmonic valve. Pulmonary Valve Vena Contracta Width Pulmonary Vascular Resistance The resistance to blood flow through the pulmonary vasculature. Pulmonary Vascular Resistance Pulmonary Vein Dominance The determination of whether blood flow in the pulmonary veins is greater during ventricular systole or diastole. Pulmonary Vein Dominance Pulmonic Regur Jet Width RVOT Diam Rt Pulmonic Regurgitant Jet Width to Right Ventricular Outflow Tract Diameter Ratio A relative measurement (ratio) of the pulmonic regurgitant jet width to right ventricular outflow tract (RVOT) diameter. Pulmonic Regurgitant Jet Width to Right Ventricular Outflow Tract Diameter Ratio Pulmonic Valve Regurgitant Jet Width The measured width of the regurgitant jet of blood into the right ventricular outflow tract. Pulmonic Valve Regurgitant Jet Width Pulse Wave Velocity The distance traveled by the peak of the ventricular ejection pressure wave per unit of time. Pulse Wave Velocity Reason CS/LV Lead Not Implanted An explanation as to why the CS/LV lead was not implanted into the subject. Reason CS/LV Lead Not Implanted Reflection Magnitude The reflected-to-forward pressure wave amplitude ratio. (Hashimoto J et al, J Hypertens. 2008 May;26(5):1017-24) Reflection Magnitude Reflection Wave Amplitude The summation of the numerous waves being reflected by sites of impedance mismatch where central elastic arteries join more muscular arteries. Reflection Wave Amplitude Right Ventricular Ejection Fraction The percent or fraction of the right ventricular end diastolic volume ejected during systole that can be measured by visual estimation or calculation. Right Ventricular Ejection Fraction Right Ventricular Ejection Fraction, Cal Right Ventricular Ejection Fraction, Calculated A calculated percent or fraction of the volume of blood ejected from the right ventricle during right ventricular systole, calculated as the right ventricular stroke volume divided by the right ventricular end diastolic volume. Calculated Right Ventricular Ejection Fraction Right Ventricular Ejection Fraction, Est Right Ventricular Ejection Fraction, Estimated A visual estimation of the percent or fraction of the volume of blood ejected from the right ventricle during right ventricular systole. Estimated Right Ventricular Ejection Fraction Segmental Late Gadolinium Enhancement The identification of the segment which exabits characteristics of late gadolinium enhancement. Segmental Late Gadolinium Enhancement Stanford AoD Classification Stanford Aortic Dissection Classification The type of aortic dissection present as defined by the Stanford Classification System (Daily PO, Trueblood HW, Stinson EB, Wuerflein RD, Shumway NE. Management of acute aortic dissections. Ann Thorac Surg. 1970 Sep;10(3):237-47). Stanford Aortic Dissection Classification Stroke Volume The difference in the volumes of blood between the points of maximum dilation and maximum contraction. This is the end diastolic volume minus the end systolic volume. Stroke Volume Sudden Death Syndrome Risk Type A characterization or classification of the syndromes or conditions that put a subject at risk for sudden death. Sudden Death Syndrome Risk Type Systemic Vascular Resistance Total Peripheral Resistance The resistance to blood flow through the systemic vasculature. Systemic Vascular Resistance SAM Indicator Systolic Anterior Motion Indicator An indication as to whether there is systolic anterior motion of a cardiac valve and its associated structures. Systolic Anterior Motion Indicator SAM Severity Systolic Anterior Motion Severity The assessment of the severity of the systolic anterior motion of a cardiac valve and its associated structures. Systolic Anterior Motion Severity Systolic Pressure, Estimated A quantitative estimate of the pressure in a given cardiovascular structure during ventricular systole. Estimated Systolic Blood Pressure Spin-Spin Relaxation T2 Relaxation Time T2 Time Transverse Relaxation Time The time constant representing the decay of transverse magnetization. Transverse Spin Relaxation Time Tricus Regur Jet Area R Atrial Area Rt Tricuspid Regurgitant Jet Area to Right Atrial Area Ratio A relative measurement (ratio) of the tricuspid regurgitant jet area to the right atrial area. Tricuspid Regurgitant Jet Area to Right Atrial Area Ratio Tricuspid Valve Regurgitant Fraction A measurement of the volume of retrograde blood flow across the orifice of the tricuspid valve expressed as a percentage of the anterograde flow volume. Tricuspid Valve Regurgitant Fraction Tricuspid Valve Regurgitant Jet Area The measured area of the regurgitant jet of blood into the right atrium. Tricuspid Valve Regurgitant Jet Area Tricuspid Valve Regurgitant Volume A measurement of the volume of retrograde blood flow across the orifice of the tricuspid valve. Tricuspid Valve Regurgitant Volume Tricuspid Valve Vena Contracta Area The area of the vena contracta of the tricuspid valve. Tricuspid Valve Vena Contracta Area Tricuspid Valve Vena Contracta Width The width of the vena contracta of the tricuspid valve. Tricuspid Valve Vena Contracta Width Valve Area Index The ratio of the valve area to the body surface area. Valve Area Index Valve Area The quantitative measurement estimating the surface area of a valve. Valve Area Velocity Time Integral, Blood Flow The integral of all of the forward flow velocities during the time of blood flow across or within a specified area. Blood Flow Velocity Time Integral Weight The vertical force exerted by a mass as a result of gravity. (NCI) Weight Width The extent or measurement of something from side to side. (NCI) Width CVTEST Cardiovascular Test Name CDISC SDTM Cardiovascular Test Name Terminology Terminology relevant to how actively a search was performed for identifying individuals with a particular disease. Purposefully looking for subjects with a particular characteristic or disease. Active Case Search Finding subjects with a particular characteristic or disease without actively searching. Passive Case Search CASEFIND Case Finding CDISC SDTM Case Finding Terminology Terminology relevant to the category of cell phenotyping tests. An assay type that examines a cellular pathway or biological process. Cell Function Assay An assay type that examines the types of markers or antigens associated with the cell surface, nucleus, or cytoplasm. Immunophenotyping Assay An assay type that examines the interaction of ligands with their target biomolecules. Target Engagement Assay CPCAT Category for Cell Phenotyping CDISC SDTM Category for Cell Phenotyping Terminology A grouping of observations within the Disease Response and Clin Classification domain. AIMS01 Abnormal Involuntary Movement Scale (AIMS) (Guy W. Ed. ECDEU Assessment Manual for Psychopharmacology. Rockville MD: US Dept of Health, Education and Welfare. 1976, Publication No. (ADM) 76-338). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Abnormal Involuntary Movement Scale Clinical Classification AJCC3 AJCC Manual for Staging of Cancer 4th Edition (AJCC V4) (Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, editors. AJCC manual for staging of cancer (4th ed). Philadelphia, PA: J.B. Lippincott; 1992). No part of the AJCC V4 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Springer and payment of any applicable fees. Copyright J.B. Lippincott Company 1992. All rights reserved. AJCC Cancer Staging Manual 4th Edition AJCC4 AJCC Cancer Staging Manual 5th Edition (AJCC V5) (Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, O'Sullivan B, Sobin LH, Yarbo JW, editors. AJCC cancer staging manual (5th ed). Philadelphia, PA: Lippincott-Raven; 1997). No part of the AJCC V5 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Springer and payment of any applicable fees. Copyright Lippincott-Raven 1997. All rights reserved. AJCC Cancer Staging Manual 5th Edition AJCC5 AJCC Cancer Staging Manual 6th Edition (AJCC V6) (Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M, editors. AJCC cancer staging manual (6th ed). New York, NY: Springer; 2002). No part of the AJCC V6 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Springer and payment of any applicable fees. Copyright Springer 2002. All rights reserved. AJCC Cancer Staging Manual 6th Edition AJCC1 AJCC TNM Staging System 7th Edition (AJCC V7) (Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual (7th ed). New York, NY: Springer; 2010). No part of the AJCC V7 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Springer and payment of any applicable fees. Copyright Springer 2010. All rights reserved. AJCC Cancer Staging Manual 7th Edition AJCC2 AJCC TNM Staging System 8th Edition (AJCC V8) (Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017. AJCC Cancer Staging Manual, Eighth Edition. Copyright 2017 American College of Surgeons. All rights reserved). No part of the AJCC V8 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Springer and payment of any applicable fees. Copyright American College of Surgeons 2017. All rights reserved. AJCC Cancer Staging Manual 8th Edition APCH1 Acute Physiology and Chronic Health Evaluation II (APACHE II) (Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Critical Care Medicine 1985; 13(10):818-29). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Acute Physiology and Chronic Health Evaluation II Clinical Classification APGR01 Apgar Score V1 (APGAR SCORE V1) (Apgar, Virginia 1953. A Proposal for a New Method of Evaluation of the Newborn Infant. Cur Res in Anesth Analg. 1953 Jul-Aug;32(4):260-7. Butterfield J, Covey MJ. Practical Epigram of the Apgar Score. JAMA. 1962; 181(4):353). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Apgar Score Version 1 Clinical Classification STCG01 Stent Thrombosis Coronary ARC Grade (Cutlip DE, Windecker S, Mehran R, et al. Clinical End Points in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Stent Thrombosis Coronary ARC Grade Clinical Classification ASCVD1 Atherosclerotic Cardiovascular Disease 10-Year Risk Estimator (Goff Jr DC et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129: S49-S73). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Atherosclerotic Cardiovascular Disease 10-Year Risk Estimator Clinical Classification ASSG01 ASSIGN Cardiovascular Disease 10-Year Risk Score (Woodward M, Brindle P, Tunstall-Pedoe H, for the SIGN group on risk estimation. Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart 2007; 93: 172-176). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. ASSIGN Cardiovascular Disease 10-Year Risk Score Clinical Classification ATLAS1 Age, treatment with systemic antibiotics, leukocyte count, serum albumin, and serum creatinine as a measure of renal function (ATLAS) (Miller, M.A., Louie,T., Mullane, K., Weiss, K., Lentnek, A., Golan, Y., et al. (2013). Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy. BMC Infectious Diseases, 13: 148). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. ATLAS Score Clinical Classification AVPU01 Alert Verbal Painful Unresponsive (AVPU) Scale (American College of Surgeons Committee on Trauma. Advanced trauma life support course for physicians. Chicago, IL: American College of Surgeons; 1989. Kelly CA, Upex A, Bateman DN. Comparison of consciousness level assessment in the poisoned patient using the alert/verbal/painful/unresponsive scale and the Glasgow Coma Scale. Annals of Emergency Medicine 2004 Aug;44(2):108-13). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Alert Verbal Painful Unresponsive Scale Clinical Classification BARS01 Barnes Akathisia Rating Scale (BARS) (Barnes TR: A Rating Scale for Drug-Induced Akathisia. British Journal of Psychiatry 154:672-676, 1989). Barnes Akathisia Rating Scale Clinical Classification BDI01 Baseline Dyspnea Index (BDI) (Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984, 85: 751-758). No part of the BDI may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Donald A. Mahler, MD and payment of any applicable fees. Copyright Donald A. Mahler. All rights reserved. Baseline Dyspnea Index Clinical Classification BODE01 The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index (BODE Index) (Bartolome R. Celli, M.D., Claudia G. Cote, M.D., Jose M. Marin, M.D., Ciro Casanova, M.D., Maria Montes de Oca, M.D., Reina A. Mendez, M.D., Victor Pinto Plata, M.D., and Howard J. Cabral, Ph.D.; N Engl J Med 2004;350:1005-12). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index Clinical Classification BPRS01 Brief Psychiatric Rating Scale 1988 Version (BPRS 1988 VERSION) (Overall, JE, Gorham DR: The Brief Psychiatric Rating Scale (BPRS): recent developments in ascertainment and scaling. Psychopharmacology Bulletin 24:97-99, 1988). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Brief Psychiatric Rating Scale 1988 Version Clinical Classification BPRSA1 Brief Psychiatric Rating Scale - Anchored (BPRS-A) (Woerner MB, Mannuzza S, and Kane JM. Anchoring the BPRS: An Aid to Improved Reliability. Psychopharmacology Bulletin 1988; 24(1):112-117). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Brief Psychiatric Rating Scale A Clinical Classification BUERS1 Brooke Upper Extremity Rating Scale (BUERS) (Brooke MG, Griggs RC, Mendell JR, Fenichel, GM, Shumate JB and Peggegrino RJ (1981). Clinical trial in duchenne dystrophy. I The Design of the Protocol. Muscle and Nerve: 4:186-197). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Brooke Upper Extremity Rating Scale Clinical Classification CCSGA1 Canadian Cardiovascular Society Grading of Angina Pectoris (CANADIAN CV SOCIETY GRADING ANGINA) (Campeau Lucien. Grading of angina pectoris. Circulation 1976;54:522-3. Available on the Canadian Cardiovascular Society Website at www.ccs.ca). CDISC believes this instrument to be in the public domain, by you should perform your own assessment. Canadian Cardiovascular Society Grading of Angina Pectoris Clinical Classification CAP01 Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version (CAPS DSM-5 WITH DSM IV SCORING 2016 VERSION) (2016 Version Copyrighted. Sara Freedman, Michal Achituv, Arieh Y Shalev. Center for Traumatic Stress Studies. Shaare Zedek Medical Center, Jerusalem). No part of the CAPS DSM-5 WITH DSM IV SCORING 2016 VERSION may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the copyright holders and payment of any applicable fees. Copyright Sara Freedman, Michal Achituv, Arieh Y Shalev. All rights reserved. Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version Clinical Classification CHIVC1 CDC Classification System for HIV-Infected Adults and Adolescents (Centers for Disease Control and Prevention. 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. MMWR Recomm Rep. 1992 Dec 18;41(RR-17):1-19). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Center for Disease Control and Prevention Classification System for HIV-Infected Adults and Adolescents Clinical Classification CDR01 Clinical Dementia Rating (CDR) (Morris JC. The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 43(11):2412-4, 1993. Copyright Lippincott, Williams & Wilkins. All rights reserved. Copyright 2001 by Washington University in St. Louis, Missouri). No part of the CDR may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Washington University and Lippincott, Williams & Wilkins and payment of any applicable fees. Copyright Washington University 2001. All rights reserved. Clinical Dementia Rating Clinical Classification CDRS1 Children's Depression Rating Scale, Revised (CDRS-R) (Copyright 1995 by WESTERN PSYCHOLOGICAL SERVICES. Not to be reproduced in whole or in part without written permission. All rights reserved). No part of the CDRS-R may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of WESTERN PSYCHOLOGICAL SERVICES and payment of any applicable fees. Copyright WESTERN PSYCHOLOGICAL SERVICES. All rights reserved. Children's Depression Rating Scale, Revised Clinical Classification CPS01 Child-Pugh Classification (Guidance for Industry Pharmacokinetics in Patients with Impaired Hepatic Function: Study Design, Data Analysis, and Impact on Dosing and Labeling. U.S. Department of Health and Human Services; Food and Drug Administration; Center for Drug Evaluation and Research (CDER); Center for Biologics Evaluation and Research (CBER). May 2003, Clinical Pharmacology. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM072123.pdf; http://www.halaven.com/sites/default/files/ChildPugh_FlashCard.pdf). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Child-Pugh Clinical Classification CIRSG1 Cumulative Illness Rating Scale for Geriatrics (CIRS-G) (A Manual of Guidelines for Scoring the Cumulative Illness Rating Scale for Geriatrics (CIRS-G), May 1991, written by Mark D. Miller, M.D. with Adele Towers, M.D., University of Pittsburgh School of Medicine, Department of Geriatric Psychiatry, Western Psychiatric Institute and Clinic, 3811 O'Hara Street Pittsburgh, Pennsylvania 15213). No part of the CIRS-G may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Mark D. Miller and Adele Towers and payment of any applicable fees. Copyright Mark D. Miller and Adele Towers 1991. All rights reserved. Cumulative Illness Rating Scale for Geriatrics Clinical Classification CBS01 Comfort Behavior Scale (COMFORT-B SCALE) (Boerlage AA, Ista E, Duivenvoorden HJ, de Wildt SN, Tibboel D, van Dijk M. The COMFORT behaviour scale detects clinically meaningful effects of analgesic and sedative treatment. Eur J Pain. 2015 Apr;19(4):473-9. Van Dijk M, Peters JW, van Deventer P, Tibboel D. The COMFORT Behavior Scale: a tool for assessing pain and sedation in infants. Am J Nurs 2005; 105 (1): 33-6. Copyright English Version: Monique van Dijk en Erwin Ista). No part of the Comfort-B Scale may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Monique van Dijk en Erwin Ista and payment of any applicable fees. Copyright Monique van Dijk en Erwin Ista. All rights reserved. Comfort Behavior Scale Clinical Classification COVI01 Covi Anxiety Scale (COVI) (Lipman RS. Differentiating anxiety and depression in anxiety disorders: use of rating scales. Psychopharmacol Bull 1982; 18(4):69-77). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Covi Anxiety Scale Clinical Classification CRSR01 JFK Coma Recovery Scale-Revised (CRS-R) (Joseph T. Giacino, Kathleen Kalmar, John Whyte. The JFK Coma Recovery Scale-Revised: Measurement Characteristics and Diagnostic Utility. Arch Phys Med Rehabil Vol 85, December 2004). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. JFK Coma Recovery Scale-Revised Clinical Classification DS01 Disease Steps (DS) (Hohol MJ, Orav EJ, Weiner HL. Disease steps in multiple sclerosis: a simple approach to evaluate disease progression. Neurology. 1995 Feb;45(2):251-5). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Disease Steps Clinical Classification DRS01 Disability Rating Scale (DRS) (Rappaport et al. (1982) Disability Rating Scale for Severe Head Trauma Patients: Coma to Community. Archives of Physical Medicine and Rehabilitation, 63:118-123). Disability Rating Scale Clinical Classification ETRP01 Emory Treatment Resistance Interview for PTSD (E-TRIP) (Dunlop BW, Kaye JL, Youngner C, Rothbaum B. Assessing Treatment-Resistant Posttraumatic Stress Disorder: The Emory Treatment Resistance Interview for PTSD (E-TRIP). Behav Sci (Basel) 2014; Dec 8; 4(4):511-527). No part of the E-TRIP may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Boadie W. Dunlop, MD and payment of any applicable fees. Copyright Boadie W. Dunlop, MD, 2018. All rights reserved. Emory Treatment Resistance Interview for PTSD Clinical Classification ECOG1 Eastern Cooperative Oncology Group (ECOG) Performance Status (Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982 Dec;5(6):649-55). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Eastern Cooperative Oncology Group Performance Status Clinical Classification EDSS01 Kurtzke Expanded Disability Status Scale (EDSS) (Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983 Nov;33(11):1444-52). Kurtzke Expanded Disability Status Scale Clinical Classification ESRSA1 Extrapyramidal Symptom Rating Scale-Abbreviated (ESRS-A) (Copyright 2006 Larry Alphs, MD, PhD, Guy Chouinard, MD, All Rights Reserved). Extrapyramidal Symptom Rating Scale-Abbreviated Clinical Classification FAQ01 Functional Activities Questionnaire (FAQ) (Pfeiffer, RI.; Kurosaki, TT.; Harrah, CH. Jr.; Chance, JM.; and Filos, S. (1982). Measurement of functional activities in older adults in the community. Journal of Gerontology, 37(3), 323-329.). No part of the FAQ may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Robert I Pfeffer and payment of any applicable fees. Copyright Robert I Pfeffer 1987. All rights reserved. Functional Activities Questionnaire Clinical Classification FAQNA1 Functional Assessment Questionnaire-NACC UDS V2.0 (FAQ-NACC UDS V2.0) (Pfeffer, RI.; Kurosaki, TT.; Harrah, CH. Jr.; Chance, JM.; and Filos, S. (1982). Measurement of functional activities in older adults in the community. Journal of Gerontology, 37(3), 323-329.). (Reproduced with permission. Copyright 2011 University of Washington. Created and published by the ADC Clinical Task Force. John C. Morris, MD, Chair, and the National Alzheimer's Coordinating Center. U01 AG016976 - Walter A. Kukull, PhD, Director). No part of the FAQ-NACC UDS V2.0 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the University of Washington and payment of any applicable fees. Copyright University of Washington 2011. All rights reserved. Functional Assessment Questionnaire-NACC UDS Version 2.0 Clinical Classification FASNA1 Functional Assessment Scale-NACC UDS v3.0 (FAS-NACC UDS V3.0) (These materials discuss and/or include NACC Functional Assessment Scale (FAS) v3.0 which is owned exclusively by the University of Washington. Copyright Reproduced with permission. Copyright 2006, 2008, 2015, 2017 University of Washington. Created and published by the ADC Clinical Task Force (John C. Morris, MD, Chair) and the National Alzheimer's Coordinating Center (U01 AG016976 - Walter A. Kukull, PhD, Director). All rights reserved). No part of the FAS-NACC UDS V3.0 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without prior written permission of the University of Washington and payment of any applicable fees. Copyright 2006, 2008, 2015, 2017 University of Washington. All rights reserved. Functional Assessment Scale-NACC UDS Version 3.0 Clinical Classification FCVD1 Framingham Heart Study Cardiovascular Disease 10-Year Risk Score (D'Agostino Sr RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, and Kannel WB. General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study. Circulation 2008; 117: 743-753). Framingham Heart Study Cardiovascular Disease 10-Year Risk Score Clinical Classification GCS01 Glasgow Coma Scale (GCS) The National Institute of Neurological Disorders and Stroke (NINDS) Version 1.0 (GCS NINDS V1.0) (Graham Teasdale and Bryan Jennett. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974 Jul 13; 2(7872):81-4. The NINDS Common Data Elements Traumatic Brain Injury website is at: https://wiki.cdisc.org/pages/viewpage.action?pageId=129043959.). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Glasgow Coma Scale-NINDS Version 1.0 Clinical Classification GDRS1 Global Dystonia Severity Rating Scale (GDRS) (Comella CL, Leurgans S, Wuu J, Stebbins GT, Chmura T; Dystonia Study Group. Rating scales for dystonia: a multicenter assessment. Mov Disord. 2003 Mar;18(3):303-12. Copyright 2018 International Parkinson and Movement Disorder Society. All rights reserved.). No part of the Global Dystonia Severity Rating Scale may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the International Parkinson and Movement Disorder Society and payment of any applicable fees. Copyright International Parkinson and Movement Disorder Society 2018. All rights reserved. Global Dystonia Severity Rating Scale Clinical Classification HAMA1 The Hamilton Anxiety Rating Scale (HAM-A) (Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32:50-55). Hamilton Anxiety Rating Scale Clinical Classification HAMD1 The Hamilton Depression Rating Scale 17-Item (HAMD 17) (Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6(4):278-96. Assessment Scales in Depression, Mania and Anxiety, Raymond W Lam, Erin E. Michalak, Richard P Swinson, Copyright 2005 Taylor & Francis, an imprint of the Taylor & Francis Group. Guy W, ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: US Department of Health, Education, and Welfare, 1976. The Hamilton Rating Scale for Depression: The making of a ''gold standard'' and the unmaking of a chronic illness, 1960-1980). Hamilton Depression Rating Scale 17 Item Clinical Classification HAMD2 The Hamilton Depression Rating Scale 21-Item (HAMD 21) (Hedlund and Vieweg, The Hamilton rating scale for depression. Journal of Operational Psychiatry, 1979;10(2):149-165). Hamilton Depression Rating Scale 21-Item Clinical Classification HAMD3 The Hamilton Depression Rating Scale 24-Item (HAM-D24) (Clinical Psychometrics: Per Bech, MD; John Wiley & Sons, Ltd. 2012). Hamilton Depression Rating Scale-24 Item Clinical Classification HAMD4 The Hamilton Depression Rating Scale 6 - Clinician Version (HAM-D6 - Clinician Version) (Clinical Research: Rating scales in depression: limitations and pitfalls; Per Bech, MD; Copyright 2006 LLS SAS. All rights reserved). Hamilton Depression Rating Scale 6 Clinician Version Clinical Classification HSB01 HAS-BLED Bleeding Risk Score (HAS-BLED) (This image was published in Chest, 138 (5), Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY, A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation: The Euro Heart Survey, Copyright Elsevier (2010). http://www.sciencedirect.com/science/journal/00123692). HAS-BLED Bleeding Risk Score Clinical Classification HBI01 Harvey-Bradshaw Index (HBI) (Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet. 1980 Mar 8;1(8167):514). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Harvey-Bradshaw Index Clinical Classification IDSC1 Inventory of Depressive Symptomatology - Clinician-Rated (IDS-C) (Copyright UT Southwestern Medical Center at Dallas. Rush, A.J., Giles, D.E., Schlesser, M.A., Fulton, C.L.,Weissenburger, J.E. and Burns, C.T. The Inventory of Depressive Symptomatology (IDS): Preliminary findings. Psychiatry Research, 18:65-87, 1986). Inventory of Depressive Symptomatology Clinician-Rated Version Clinical Classification KDIGO1 Kidney Disease: Improving Global Outcomes Staging For Acute Kidney Injury (KDIGO AKI) (Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney inter., Suppl. 2012; 2:1-138). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Kidney Disease Improving Global Outcomes Staging For Acute Kidney Injury Clinical Classification KDPI01 Kidney Donor Profile Index (KDPI) (OPTN/UNOS. A guide to calculating and interpreting the Kidney Donor Profile Index (KDPI). [Accessed April 18, 2016]. Available at: https://optn.transplant.hrsa.gov/media/1512/guide_to_calculating_interpreting_kdpi.pdf. Rao PS, Schaubel DE, Guidinger MK, et al. A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index. Transplantation 2009 Jul 27;88(2):231-6). Kidney Donor Profile Index Clinical Classification KFSS1 Kurtzke Functional Systems Scores (FSS) (Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983 Nov;33(11):1444-52). Kurtzke Functional Systems Scores Clinical Classification KPSS01 The Karnofsky Performance Status Scale (KPSS) (Karnofsky DA, Burchenal JH. (1949). "The Clinical Evaluation of Chemotherapeutic Agents in Cancer." In: MacLeod CM (Ed), Evaluation of Chemotherapeutic Agents. Columbia Univ Press. Page 196). Karnofsky Performance Status Scale Clinical Classification LPPSS1 The Lansky Play-Performance Status Scale (LPSS) (Lansky SB, List MA, Lansky LL, Ritter-Sterr C, Miller DR. The measurement of performance in childhood cancer patients. Cancer. 1987 Oct 1;60(7):1651-6). The Lansky Play-Performance Status Scale Clinical Classification MADRS1 Montgomery-Asberg Depression Rating Scale (MADRS) (Copyright Stuart Montgomery 1978, Measures of Depression, Fulcrum Press, London. Stuart A. Montgomery and Marie Asberg. A new depression scale designed to be sensitive to change. Br. J. Psychiat. (1979), 134:382-389). Montgomery-Asberg Depression Rating Scale Clinical Classification MELD01 Model for End Stage Liver Disease (MELD) (Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC (April 2000). A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31 (4): 864-71). Model for End Stage Liver Disease Clinical Classification MELD02 Model for End Stage Liver Disease - Serum Na 2008 (MELDNA 2008) (Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, Edwards E, Therneau TM. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008 Sep 4;359(10):1018-26). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Model for End Stage Liver Disease - Serum Na 2008 Clinical Classification MCHR01 Montreal Classification for Crohn's Disease (MONTREAL CROHN'S) (Silverberg MS, Satsangi J, Ahmad T, Silverberg MS, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005;19(Suppl A):5A-36A). These materials discuss and/or include the Montreal Classification for Crohn's Disease (MONTREAL CLASSIFICATION CROHN'S), is owned by the consortium of the 2005 Montreal World Congress of Gastroenterology. Use of the Montreal Classification for Crohn's Disease is subject to the consortium's terms of use. Montreal Classification for Crohn's Disease Clinical Classification MRS01 Modified Rankin Scale (MRS) (Van Swieten J., Koudstaal P., Visser M., Schouten H., and Van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients, 1988. Stroke 19: 604-607). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Modified Rankin Scale Clinical Classification MVAI1 Modified Van Assche Index (MVAI) (van Rijn KL, Lansdorp CA, Tielbeek JAW, Nio CY, Buskens CJ, D'Haens GRAM, Lowenberg M, Stoker J. Evaluation of the modified Van Assche index for assessing response to anti-TNF therapy with MRI in perianal fistulizing Crohn's disease. Clin Imaging. 2020 Feb;59(2):179-187). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Modified Van Assche Index Clinical Classification NEWS1 National Early Warning Score 2 (NEWS2) (Royal College of Physicians. National Early Warning Score (NEWS) 2: Standardising the assessment of acute-illness severity in the NHS. Updated report of a working party. London: RCP, 2017). National Early Warning Score 2 Clinical Classification CADG01 Coronary Artery Dissection NHLBI Grade (Coronary Artery angiographic changes after PTCA: Manual of Operations NHBLI PTCA Registry 1985-6:9). Coronary Artery Dissection NHLBI Grade Clinical Classification NSA01 Negative Symptom Assessment-16 (NSA-16) (Version 2.0, Copyright 2006, Larry Alphs, MD, PhD, All Right Reserved). Negative Symptom Assessment-16 Clinical Classification NSAA2 North Star Ambulatory Assessment 2017 (NSAA 2017) (North Star Ambulatory Assessment (NSAA) Copyright 2017 Great Ormond Street Hospital NHS Foundation Trust & The Newcastle upon Tyne Hospitals NHS Foundation Trust on behalf of the UK North Star Clinical Network and Muscular Dystrophy UK). These materials discuss the North Star Ambulatory Assessment 2017, which is owned exclusively by Great Ormond Street Hospital NHS Foundation Trust & The Newcastle upon Tyne Hospitals NHS Foundation Trust. No part of the North Star Ambulatory Assessment 2017 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Great Ormond Street Hospital NHS Foundation Trust & The Newcastle upon Tyne Hospitals NHS Foundation Trust and payment of any applicable fees. All rights reserved. North Star Ambulatory Assessment 2017 Clinical Classification NSAA1 North Star Ambulatory Assessment (NSAA) (Copyright the North Star Clinical Network UK. Scott E, Eagle M, Mayhew A, Freeman J, Main M, Sheehan J, Manzur A, Muntoni F; North Star Clinical Network for Paediatric Neuromuscular Disease. Development of a functional assessment scale for ambulatory boys with Duchenne muscular dystrophy. Physiother Res Int. 2012 Jun;17(2):101-9. The support of Muscular Dystrophy United Kingdom in developing the North Star Ambulatory Assessment is gratefully acknowledged). North Star Ambulatory Assessment Clinical Classification PANSS1 Positive and Negative Syndrome Scale (PANSS) (Copyright 1992 Multi-Health Systems Inc. All rights reserved). Positive and Negative Syndrome Scale Clinical Classification PASI05 Psoriasis Area and Severity Index Version Bozek (PASI BOZEK) (Bozek A, Reich A. The reliability of three psoriasis assessment tools: Psoriasis area and severity index, body surface area and physician global assessment. Adv Clin Exp Med. 2017;26(5):851- 856). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Psoriasis Area and Severity Index Bozek Version Clinical Classification PASI04 Psoriasis Area and Severity Index Version EMA (PASI EMA) (European Medical Agency Committee for Medicinal Products for Human Use (CHMP). Guideline on Clinical Investigation of Medicinal Products Indicated for the Treatment of Psoriasis. Published November 18, 2004. [Accessed June 15, 2022]. Available at: https://www.ema.europa.eu/en/clinical-investigation-medicinal-products-indicated-treatment-psoriasis). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Psoriasis Area and Severity Index European Medical Agency Version Clinical Classification PASI02 Psoriasis Area and Severity Index Version Feldman (PASI FELDMAN) (Feldman SR, Krueger GG. Psoriasis assessment tools in clinical trials. Ann Rheum Dis. 2005;64(Suppl 2):ii65-ii73). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Psoriasis Area and Severity Index Feldman Version Clinical Classification PASI03 Psoriasis Area and Severity Index Version Fredriksson (PASI FREDRIKSSON) (Fredriksson T, Pettersson U. Severe Psoriasis - Oral Therapy with a New Retinoid. Dermatologica. 1978; 157(4):238-244). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Psoriasis Area and Severity Index Fredriksson Version Clinical Classification QIDSC1 Quick Inventory of Depressive Symptomatology - Clinician-Rated (QIDS-C) (Copyright UT Southwestern Medical Center at Dallas. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB. The 16-item Quick Inventory of Depressive Symptomatology (QIDS) Clinician Rating (QIDS-C) and Self-Report (QIDS-SR): A psychometric evaluation in patients with chronic major depression. Biological Psychiatry, 54:573-583, 2003). Quick Inventory of Depressive Symptomatology Clinician-Rated Version Clinical Classification RASS01 Richmond Agitation-Sedation Scale (RASS) (Sessler CN, Gosnell M, Grap MJ, Brophy GT, O'Neal PV, Keane KA et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care patients. Am J Respir Crit Care Med. 2002 Nov 15;166:1338-1344. Copyright Virginia Commonwealth University 2000. All Rights Reserved). Richmond Agitation-Sedation Scale Clinical Classification RCVD01 Reynolds Cardiovascular Disease 10-Year Risk Score (Ridker PM, Buring JE, Rifai N, Cook NR. Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women: The Reynolds Risk Score. Jama 2007; 297: 611-619), (Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR. C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men. Circulation2008; 118(22): 2243-2251). Reynolds Cardiovascular Disease 10-Year Risk Score Clinical Classification RETT1 Rett Syndrome Severity Scale (RSSS) (Kalkwarf HJ, Zemel BS, Gilsanz V, Lappe JM, Horlick M, Oberfield S, Mahboubi S, Fan B, Frederick MM, Winer K, Shepherd JA. The bone mineral density in childhood study: bone mineral content and density according to age, sex, and race. J Clin Endocrinol Metab. 2007 Jun;92(6):2087-99). Rett Syndrome Severity Scale Clinical Classification RUTG01 Rutgeerts Score (RUTGEERTS SCORE) (Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990; 99 (4): 956-963). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Rutgeerts Score Clinical Classification SAS01 Riker Sedation-Agitation Scale (SAS) (Riker, Richard R. MD, FCCP; Picard, Jean T. BSN, CCRN; Fraser, Gilles L. PharmD. Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients. Critical Care Medicine. July 1999; 27:7:1325-1329. Copyright Lippincott Williams & Wilkins, Inc. 1999. All Rights Reserved). Riker Sedation-Agitation Scale Clinical Classification SES01 Simple Endoscopic Score for Crohn's Disease Version 1 (SES-CD V1) (Daperno M, D'Haens G, Van Assche G, Baert F, Bulois P, Maunoury V, Sostegni R, Rocca R, Pera A, Gevers A, Mary JY, Colombel JF, Rutgeerts P. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest Endosc 2004; 60 (4): 505-512). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Simple Endoscopic Score for Crohn's Disease Version 1 Clinical Classification Sequential Organ Failure Assessment 27MAR2024 SOFA01 Sepsis-related Organ Failure Assessment 27MAR2024 (SOFA 27MAR2024) (Vincent, J-L., et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Medicine, 22:707 - 710. 1996). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Sepsis-related Organ Failure Assessment 27th March 2024 Version Clinical Classification TANN02 Tanner Scale Boy (Marshall WA, Tanner JM. Variations in pattern of pubertal changes in boys. Arch Dis Child 1970 Feb;45(239):13-23). Tanner Scale Boy Version TANN01 Tanner Scale Girl (Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969 Jun; 44(235): 291-303). Tanner Scale Girl Version TDI01 Transition Dyspnea Index (TDI) (Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984, 85: 751-758). Transition Dyspnea Index Clinical Classification TIMG01 Coronary Thrombus TIMI Grade (TIMI Definitions for Commonly Used Terms in Clinical Trials. Available at http://www.timi.org/wp-content/uploads/2010/10/TIMI-Definitions.pdf. Accessed November 30, 2013). Coronary Thrombus TIMI Grade Clinical Classification UHDR1 Unified Huntington's Disease Rating Scale '99 (UHDRS 1999) (Huntington Study Group. (1996). Unified Huntington's Disease Rating Scale: Reliability and Consistency. Movement Disorders, 11(2), 136-142). Unified Huntington's Disease Rating Scale 1999 Version Clinical Classification UPD1 Unified Parkinson's Disease Rating Scale (UPDRS) (Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent Developments in Parkinson's Disease, Vol 2. Florham Park, NJ. Macmillan Health Care Information 1987, pp 153-163, 293-304). Unified Parkinson's Disease Rating Scale Clinical Classification VALG01 Veterans Administration Lung Study Group (VALG) (Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer--what limits limited disease? Micke P, Faldum A, Metz T, Beeh K.-M, Bittinger F, Hengstler J.-G, Buhl R, Lung Cancer 2002;37:271-276). Veterans Administration Lung Study Group Clinical Classification IGAAD1 Validated Investigator Global Assessment scale for Atopic Dermatitis 2017 (VIGA-AD 2017) (Simpson E, Bissonnette R, Eichenfield LF. The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis. J Am Acad Dermatol. 2020 Sep;83(3):839-846. Copyright 2017 Eli Lilly and Company - Used with the permission of Eli Lilly and Company under a Creative Commons Attribution-NoDerivatives 4.0 International Licence - https://creativecommons.org/licenses/by-nd/4.0/). No part of the VIGA-AD 2017 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Eli Lilly and Company and payment of any applicable fees. Copyright 2017 Eli Lilly and Company. All rights reserved. Validated Investigator Global Assessment scale for Atopic Dermatitis 2017 VLERS1 Vignos Lower Extremity Rating Scale (VLERS) (Vignos PJ, Spencer CE, Archibald KC. (1963) Management of progressive muscular dystrophy in childhood.JAMA 184:389-96. Brooke MG, Griggs RC, Mendell JR, Fenichel, GM, Shumate JB and Peggegrino RJ (1981). Clinical trial in duchenne dystrophy. I The Design of the Protocol. Muscle and Nerve: 4:186-197). Vignos Lower Extremity Rating Scale Clinical Classification WHEG01 West Haven Hepatic Encephalopathy Grade (Blei AT, Cordoba J. Hepatic Encephalopathy. Am J Gastroenterol. 2001 Jul. 96(7):1968-76). West Haven Hepatic Encephalopathy Grade Clinical Classification WHIVS1 WHO Clinical Staging of HIV/AIDS for Adults and Adolescents (Copyright World Health Organization 2007, World Health Organization. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children; 2007. Retrieved from http://www.who.int/hiv/pub/vct/hivstaging/en/). World Health Organization Clinical Staging of HIV/AIDS for Adults and Adolescents Clinical Classification WHIVS2 WHO Clinical Staging of HIV/AIDS for Children (Copyright World Health Organization 2007, World Health Organization. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children; 2007. Retrieved from http://www.who.int/hiv/pub/vct/hivstaging/en/). World Health Organization Clinical Staging of HIV/AIDS for Children Clinical Classification YMRS02 Young Mania Rating Scale Structured Interview Version (YMRS STRUCTURED INTERVIEW) (Young RC, Biggs JT, Ziegler VE et al: A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133: 429-435, 1978. Sachs GS, Gaughan S. STEP-BD Clinician's Handbook. Massachusetts general Hospital, 2001). These materials discuss the Young Mania Rating Scale Structured Interview (YMRS STRUCTURED INTERVIEW), which is owned exclusively by Gary Sachs. No part of the YMRS STRUCTURED INTERVIEW may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Gary Sachs and payment of any applicable fees. Copyright Gary Sachs, 2001-2023. All rights reserved. Young Mania Rating Scale Structured Interview Version Clinical Classification YMRS01 Young Mania Rating Scale (YMRS) (Young RC, Biggs JT, Ziegler VE et al: A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133: 429-435, 1978. Copyright 1978 The Royal College of Psychiatrists). No part of the YMRS may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the Royal College of Psychiatrists and payment of any applicable fees. Copyright the Royal College of Psychiatrists, 1978. All rights reserved. Young Mania Rating Scale Clinical Classification CCCAT Category of Clinical Classification CDISC Clinical Classification Category Terminology A terminology codelist based on the category of related records for the device event. Calibrate, Failure To Failure to Calibrate Issue associated with the failure of the device to perform a self-calibration procedure or process designed to assure the accuracy and proper performance of the device. (FDA) Failure to Calibrate Problem Software Malfunction Issue associated with written programs, codes, and/or software system that affects device performance or communication with another device. (NCI) Computer Software Problem Issue associated with the failure of the software to store collected data. Data Storage Failure Device Operational Malfunction Issue associated with any deviations from specifications relating to device operations (e.g. deployment, connection, electrical, computer software, infusion/flow, output, protective-measure, and incompatibility issues). Medical Device Operational Issue Non-Study Equipment Malfunction Issue associated with any deviations from specifications relating to non-study device or equipment operations. Non-Study Device Issue An inspection and/or surveillance activity that has been anticipated to occur and was assigned a time or date when that activity is to be performed. (NCI) Scheduled Maintenance All program coding after initial deployment to correct coding errors, enhance the functionality of the software, and perfect the functioning of the software. (NCI) Software Maintenance DECAT Category of Device Events CDISC SDTM Device Events Category Terminology Classifications that describe and group pertinent events that occur throughout the conduct of a clinical trial. Disposition Event The group of incidents that occur during a clinical trial and describe whether a subject completed the study epoch or the reason this event did not occur. The subject's disposition is often described for each phase of the study. Protocol Disposition Event Other Event Other important events that occur during a trial but are not driven by protocol requirements. Non-Protocol Disposition Event Protocol Milestone Occurrences within some epochs that are initiated by a protocol-specified event. The most common protocol milestone is "Informed Consent Obtained" which usually documents the start of the study. Protocol Milestone DSCAT Category of Disposition Event CDISC SDTM Category For Disposition Event Terminology A grouping of observations within the Functional Tests domain. Ten Meter Walk/Run TENMW1 10-Meter Walk/Run (McDonald CM, Henricson EK, Abresch RT, et al. The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study. Muscle Nerve. 2013;48(3):357-68.). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. 10-Meter Walk/Run Test Functional Test A4STR1 4 Stair Ascend (McDonald CM, Henricson EK, Abresch RT, et al. The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study. Muscle Nerve. 2013;48(3):357-68.). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Four Stair Ascend Test Functional Test D4STR1 4-Stair Descend (McDonald CM, Henricson EK, Abresch RT, et al. The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study. Muscle Nerve. 2013;48(3):357-68.). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Four Stair Descend Test Functional Test ADC1 Alzheimer's Disease Assessment Scale-Cognitive 30JUN2015 (ADAS-COG 30JUN2015) (This version is based on the Administration and Scoring Manual for the Alzheimer's Disease Assessment Scale 1994 Revised Edition, Richard C. Mohs, Ph.D. 10/10/13 (Updated 6/30/15). Copyright 1994 by Mount Sinai School of Medicine. Mohs RC, Knopman D, Petersen RC et al. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord 1997;11 Suppl 2:S13-S21). No part of the ADAS-COG Version 6/30/15 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. Richard C. Mohs and payment of any applicable fees. Copyright Dr. Richard C. Mohs, 1994. All rights reserved. Alzheimer's Disease Assessment Scale-Cognitive Date 30th June 2015 Version Functional Test ADC The CDISC version of the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog CDISC Version) containing 15 summary-level tests. This version is based on combining the total pool of ADAS-Cog tests that were observed during a review of multiple case report forms administered in clinical trials of Alzheimer's disease, as well as the CRF administered in the Alzheimer's Disease Neuroimaging Initiative (ADNI) observational study. (Modified from Mohs RC, Rosen WG, Davis KL. The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy. Psychopharmacol Bull 1983;19(3):448-450. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984;141(11):1356-1364. Mohs RC, Knopman D, Petersen RC et al. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord 1997;11 Suppl 2:S13-S21. Wouters H, van Gool WA, Schmand B, Lindeboom R. Revising the ADAS-cog for a more accurate assessment of cognitive impairment. Alzheimer Dis Assoc Disord 2008;22(3):236-244.). Alzheimer's Disease Assessment Scale-Cognitive CDISC Version Functional Test AVL01 The Alzheimer's Disease Neuroimaging Initiative's (ADNI) version of the Auditory Verbal Learning Test (AVLT Version A) modified from Rey A. L'examen clinique en psychologie [Clinical tests in psychology]. Paris: Presses Universitaires de France; 1964. Alzheimer's Disease Neuroimaging Initiative Auditory Verbal Learning Test Functional Test AVL02 Auditory Verbal Learning Test (AVLT-Rey) (Modified from Rey A. L'examen clinique en psychologie [Clinical tests in psychology]. Paris: Presses Universitaires de France; 1964. Test-Retest Reliability of a New Form of Auditory Verbal Learning Test (AVLT); Archives of Clinical Neuropsycology, Vol. 9, No. 4, pp. 303-316, 1994. Performance of Healthy Subjects and Patients with Resection from the Anterior Temporal Lobe on Matched Tests of Verbal and Visuoperceptual Learning; Journal of Clinical and Experimental Neuropsychology 1996, Vol. 18, No. 3, pp. 416-430). Rey Auditory Verbal Learning Functional Test BACS1 Brief Assessment of Cognition in Schizophrenia (BACS) (Richard Keefe, PhD, Copyright 1999 Duke University Medical Center, Licenses available through Neurocog Trials, Inc.). Brief Assessment of Cognition in Schizophrenia Functional Test COWAT1 Controlled Oral Word Association Test (COWAT) (Benton, A.L., Hamsher, K., & Sivan, A.B. (1994). Multilingual Aphasia Examination (3rd ed.). Iowa City, IA: AJA Associates). Controlled Oral Word Association Test EMO1 Emotion Recognition (Ekman P, Friesen WV. Measuring facial movement. Environmental Psychology and Nonverbal Behavior. 1976;1(1):56-75). Emotion Recognition Test Functional Test HAI01 Hauser Ambulation Index (AI) (Hauser SL, Dawson DM, Lehrich JR, Beal MF, Kevy SV, Propper RD, Mills JA, Weiner HL. Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. N Engl J Med. 1983 Jan 27;308(4):173-80). Hauser Ambulation Index Functional Test HDCAB1 Huntington's Disease Cognitive Assessment Battery (HD-CAB) (Copyright 2014 Monash University. All Rights Reserved. Stout, J.C. et al. HD-CAB: A cognitive assessment battery for clinical trials in Huntington's disease. Movement Disorders. 2014;29(10):1281-1288). Huntington's Disease Cognitive Assessment Battery Functional Test MMS1 Mini-Mental State Examination (MMSE) (MMSE Copyright 1975, 1998, 2001 by MiniMental, LLC All rights reserved. Published 2001 by Psychological Assessment Resources, Inc. May not be reproduced in whole or in part in any form or by any means without written permission of Psychological Assessment Resources, Inc.). Mini-Mental Status Exam MMS2 Mini-Mental State Examination 2 Standard Version (MMSE-2 STANDARD VERSION) (MMSE-2 Copyright 2010 by Mini Mental, LLC. All rights reserved. Published 2010 by Psychological Assessment Resources, Inc (PAR). May not be reproduced in whole or in part in any form or by any means without written permission of Psychological Assessment Resources, Inc.). Mini-Mental State Examination 2 Standard Version Functional Test MOCA01 Montreal Cognitive Assessment (MoCA) (Copyright Z. Nasreddine MD. Ziad S. Nasreddine, Natalie A. Phillips, Valerie Bedirian, Simon Charbonneau, Victor Whitehead, Isabelle Collin, Jeffrey L. Cummings and Howard Chertkow. The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment. J Am Geriatr Soc. 2005 Apr;53(4):695-9). Montreal Cognitive Assessment Functional Test NHPT01 Nine-Hole Peg Test (NHPT) (Copyright 2001, National Multiple Sclerosis Society). Nine-Hole Peg Functional Test PTAP1 Paced Tapping (Rowe KC, Paulsen JS, Langbehn DR, et al. Self-paced timing detects and tracks change in prodromal Huntington disease. Neuropsychology. 2010;24(4):435-442). Paced Tapping Test Functional Test PASAT1 Paced Auditory Serial Addition Test (PASAT) (Copyright 2001, National Multiple Sclerosis Society). Paced Auditory Serial Addition Functional Test PUL01 Performance of the Upper Limb Module for DMD Version 1.2 (PUL V1.2) (Mayhew A, Mazzone ES, Eagle M, et al. (2013). Development of the Performance of the Upper Limb module for Duchenne muscular dystrophy. Dev Med Child Neurol; 55:1038-45). Performance of the Upper Limb Module for DMD 1.2 Functional Test PUL02 Performance of the Upper Limb Module for DMD Version 2.0 (PUL V2.0) (Mayhew A, Mazzone ES, Eagle M, et al. (2013). Development of the Performance of the Upper Limb module for Duchenne muscular dystrophy. Dev Med Child Neurol; 55:1038-45). Performance of the Upper Limb Module for DMD 2.0 Functional Test RISEF1 Stand From Supine Rising From Floor (McDonald CM, Henricson EK, Abresch RT, et al. The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study. Muscle Nerve. 2013;48(3):357-68.). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Rising From Floor Test Functional Test ROCK01 Rockport One Mile Walk Test Version 1.0 (ROCKPORT ONE MILE WALK TEST V1.0) (Kline GM, Porcari JP, Hintermeister R, et. al. 1987. Estimation of VO2 Max from a one mile track walk, gender, age, and body weight. Medicine and Science in sports and Exercise. 19:253-59). [The NCI Thesaurus contains biomedical terminologies that NCI does not own or control. This concept contains gender-related content that does not comply with Executive Order 14168.] Rockport One Mile Walk Test Version 1.0 Functional Test SDMT01 Symbol Digit Modalities Test (SDMT) (Copyright 1973 by Western Psychological Services). Symbol Digit Modalities Functional Test SIXMW2 6 Minute Walk Test 2002 (SIX MINUTE WALK 2002) (ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002). ATS statement: guidelines for the six-minute walk test. American journal of respiratory and critical care medicine, 166(1), 111-117). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. 6 Minute Walk Functional Test 2002 Version Six Minute Walk 2008 SIXMW1 6 Minute Walk Test 2008 (SIX MINUTE WALK 2008) (Goldman MD, Marrie RA, Cohen JA. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls. Multiple Sclerosis 2008; 14: 383-390). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. 6 Minute Walk Functional Test 2008 Version SPPB1 Short Physical Performance Battery V1.2 (SPPB V1.2) (Guralnik JM, Ferrucci L, Pieper CF, Leveille SG, Markides KS, Ostir GV, Studenski S, Berkman LF, Wallace RB. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci 2000 April;55(4):M221-M231). Short Physical Performance Battery Version 1.2 Functional Test T25FW1 Timed 25-Foot Walk (T25FW) (Copyright 2001, National Multiple Sclerosis Society). Timed 25-Foot Walk Functional Test TMT01 Trail Making Test (TMT) [(Copyright Owner: Dr. Jim Hom, The Neuropsychology Center, 500 N. Central Expressway, Suite 272, Plano TX 75074-6877. Ph: 469-429-8890, www.neuropsych.com.)(Manual: Army Individual Test. War Department, The Adjutant General's Office, 1944.)(Reitan RM. The Relation of the Trail Making Test to Organic Brain Damage; Journal of Consulting Psychology 1955 Oct 19(5):393-4.)(Reitan R.M. (1958). The validity of the Trail Making Test as an indicator of organic brain damage; Perceptual and Motor Skills, 8, 271-276.)]. Trail Making Test TUG01 Timed Up and Go (TUG) (Podsiadlo D, Richardson S. The Timed 'Up & Go': a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991; 39:142-148). Timed Up and Go Functional Test FTCAT Category of Functional Test CDISC Functional Test Category Terminology A collection of criteria on which subjects are evaluated and that must be met by all study subjects. (NCI) List of characteristics in a protocol, any one of which makes a potential subject ineligible to participate in a study. Exclusion Criteria The criteria in a protocol that prospective subjects must meet to be eligible to participate in a study. Inclusion Criteria IECAT Category of Inclusion/Exclusion CDISC SDTM Category for Inclusion And Or Exclusion Terminology Terminology relevant to the categories for ingredient quantities by component. Substances, compounds, or additives contained within or added to the tobacco, paper, filter, or any other component or part of a tobacco product, including substances and compounds reasonably expected to be formed through a chemical reaction during tobacco product manufacturing (except that such term does not include tobacco). (FDA CTP) Non-Tobacco Ingredient A tobacco product substance that consists of a part of the tobacco plant, such as leaves or stems, or is derived from a part of the tobacco plant, or is a by-product of processing a part of the tobacco plant, such as tobacco scrap dust. (FDA CTP) Tobacco Ingredient IQCAT Category of Ingredient Quantities by Component CDISC SDTM Category of Ingredient Quantities by Component Terminology The named criteria used for the grouping of assessments of response to treatment or therapy observations for oncology studies within the Disease Response and Clinical Classification domain. A new 123I-MIBG whole body scan scoring method--application to the prediction of the response of metastases to induction chemotherapy in stage IV neuroblastoma. (N Ady, J M Zucker, B Asselain, V Edeline, F Bonnin, J Michon, R Gongora, L Manil. A new 123I-MIBG whole body scan scoring method--application to the prediction of the response of metastases to induction chemotherapy in stage IV neuroblastoma. Eur J Cancer. 1995;31A(2):256-61.) Ady Neuroblastoma 1995 Oncology Response Criteria AJCC3 AJCC Manual for Staging of Cancer 4th Edition (AJCC V4) (Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, editors. AJCC manual for staging of cancer (4th ed). Philadelphia, PA: J.B. Lippincott; 1992). No part of the AJCC V4 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Springer and payment of any applicable fees. Copyright J.B. Lippincott Company 1992. All rights reserved. AJCC Cancer Staging Manual 4th Edition AJCC4 AJCC Cancer Staging Manual 5th Edition (AJCC V5) (Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, O'Sullivan B, Sobin LH, Yarbo JW, editors. AJCC cancer staging manual (5th ed). Philadelphia, PA: Lippincott-Raven; 1997). No part of the AJCC V5 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Springer and payment of any applicable fees. Copyright Lippincott-Raven 1997. All rights reserved. AJCC Cancer Staging Manual 5th Edition AJCC5 AJCC Cancer Staging Manual 6th Edition (AJCC V6) (Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M, editors. AJCC cancer staging manual (6th ed). New York, NY: Springer; 2002). No part of the AJCC V6 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Springer and payment of any applicable fees. Copyright Springer 2002. All rights reserved. AJCC Cancer Staging Manual 6th Edition AJCC1 AJCC TNM Staging System 7th Edition (AJCC V7) (Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual (7th ed). New York, NY: Springer; 2010). No part of the AJCC V7 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Springer and payment of any applicable fees. Copyright Springer 2010. All rights reserved. AJCC Cancer Staging Manual 7th Edition AJCC2 AJCC TNM Staging System 8th Edition (AJCC V8) (Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017. AJCC Cancer Staging Manual, Eighth Edition. Copyright 2017 American College of Surgeons. All rights reserved). No part of the AJCC V8 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Springer and payment of any applicable fees. Copyright American College of Surgeons 2017. All rights reserved. AJCC Cancer Staging Manual 8th Edition Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases. (Blazer DG 3rd, Kishi Y, Maru DM, Kopetz S, Chun YS, Overman MJ, Fogelman D, Eng C, Chang DZ, Wang H, Zorzi D, Ribero D, Ellis LM, Glover KY, Wolff RA, Curley SA, Abdalla EK, Vauthey JN. Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases. J Clin Oncol. 2008 Nov 20;26(33):5344-51.) Blazer Colorectal Cancer 2008 Oncology Response Criteria CT findings of response and recurrence, independent of change in tumor size, in colorectal liver metastasis treated with bevacizumab. (Boonsirikamchai P, Asran MA, Maru DM, Vauthey JN, Kaur H, Kopetz S, Loyer EM. CT findings of response and recurrence, independent of change in tumor size, in colorectal liver metastasis treated with bevacizumab. AJR Am J Roentgenol. 2011 Dec;197(6):W1060-6.) Boonsirikamchai Colorectal Cancer 2011 Oncology Response Criteria Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. (Bruggemann M, Schrauder A, Raff T, Pfeifer H, Dworzak M, Ottmann OG, Asnafi V, Baruchel A, Bassan R, Benoit Y, Biondi A, Cave H, Dombret H, Fielding AK, Foa R, Gokbuget N, Goldstone AH, Goulden N, Henze G, Hoelzer D, Janka-Schaub GE, Macintyre EA, Pieters R, Rambaldi A, Ribera JM, Schmiegelow K, Spinelli O, Stary J, von Stackelberg A, Kneba M, Schrappe M, van Dongen JJ; European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL); International Berlin-Frankfurt-Munster Study Group (I-BFM-SG). Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. Leukemia. 2010 Mar;24(3):521-35.) Bruggemann MRD 2010 Oncology Response Criteria Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer. (Burcombe RJ, Makris A, Richman PI, Daley FM, Noble S, Pittam M, Wright D, Allen SA, Dove J, Wilson GD. Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer. Br J Cancer. 2005 Jan 17;92(1):147-55.) Burcombe Breast Cancer 2005 Oncology Response Criteria CLL response criteria. (Cheson BD. CLL response criteria.Clin Adv Hematol Oncol. 2006 May;4(5):4-5; discussion 10; suppl 12.) Cheson CLL 2006 Oncology Response Criteria Novel targeted agents and the need to refine clinical end points in chronic lymphocytic leukemia. (Cheson BD, Byrd JC, Rai KR, Kay NE, O'Brien SM, Flinn IW, Wiestner A, Kipps TJ. Novel targeted agents and the need to refine clinical end points in chronic lymphocytic leukemia. J Clin Oncol. 2012 Aug 10;30(23):2820-2.) Cheson CLL 2012 Oncology Response Criteria New staging and response criteria for non-Hodgkin lymphoma and Hodgkin lymphoma. (Cheson BD. New staging and response criteria for non-Hodgkin lymphoma and Hodgkin lymphoma. Radiol Clin North Am. 2008 Mar;46(2):213-23, vii.) Cheson Hodgkins Non-Hodgkins Lymphoma 2008 Oncology Response Criteria New response criteria for lymphomas in clinical trials. (Cheson BD. New response criteria for lymphomas in clinical trials. Ann Oncol. 2008 Jun;19 Suppl 4:iv35-8.) Cheson Lymphoma 2008 Oncology Response Criteria Revised response criteria for malignant lymphoma. (Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V; International Harmonization Project on Lymphoma. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007 Feb 10;25(5):579-86. Epub 2007 Jan 22.) Cheson Malignant Lymphoma 2007 Oncology Response Criteria Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate. (Chevallier B, Roche H, Olivier JP, Chollet P, Hurteloup P. Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate. Am J Clin Oncol. 1993 Jun;16(3):223-8.) Cheson Non-Hodgkins Hodgkins Lymphoma 1993 Oncology Response Criteria Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas. (Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-Lopez A, Hagenbeek A, Cabanillas F, Klippensten D, Hiddemann W, Castellino R, Harris NL, Armitage JO, Carter W, Hoppe R, Canellos GP. Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas. J Clin Oncol. 1999 Apr;17(4):1244.) Cheson Non-Hodgkins Lymphoma 1999 Oncology Response Criteria Response Evaluation of Gastrointestinal Stromal Tumors. (Choi H, Charnsangavej C, Faria SC, Macapinlac HA, Burgess MA, Patel SR, Chen LL, Podoloff DA, Benjamin RS. Response Evaluation of Gastrointestinal Stromal Tumors. Oncologist. 2008;13 Suppl 2:4-7.) Choi Response Criteria in the Evaluation of Gastrointestinal Stromal Tumors Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer. (Chollet P, Amat S, Cure H, de Latour M, Le Bouedec G, Mouret-Reynier MA, Ferriere JP, Achard JL, Dauplat J, Penault-Llorca F. Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer. Br J Cancer. 2002 Apr 8;86(7):1041-6.) Chollet Breast Cancer 2002 Oncology Response Criteria Treatment recommendations for patients with Waldenstrom macroglobulinemia (WM) and related disorders: IWWM-7 consensus. (Meletios A Dimopoulos, Efstathios Kastritis, Roger G. Owen, Robert A Kyle, Ola Landgren, Enrica Morra, Xavier Leleu, Ramon Garcia-Sanz, Nikhil Munshi, Kenneth C Anderson, Evangelos Terpos, Irene M Ghobrial, Pierre Morel, David Maloney, Mathias Rummel, Veronique Leblond, Ranjana H Advani, Morie A Gertz, Charalampia Kyriakou, Sheeba K Thomas, Bart Barlogie, Stephanie A Gregory, Eva Kimby, Giampaolo Merlini, Steven P Treon. Treatment recommendations for patients with Waldenstrom macroglobulinemia (WM) and related disorders: IWWM-7 consensus. Blood. 2014 Aug 28;124(9):1404-11). Dimopoulos IWWM-7 Consensus 2014 Oncology Response Criteria Phase 3 Trial of Ibrutinib plus Rituximab in Waldenstrom's Macroglobulinemia. (Dimopoulos MA, Tedeschi A, Trotman J, Garcia Sanz R, Macdonald D, Leblond V, Mahe B, Herbaux C, Tam C, Orsucci L, Palomba ML, Matous JV, Shustik C, Kastritis E, Treon SP, Li J, Salman Z, Graef T, Buske C. Phase 3 Trial of Ibrutinib plus Rituximab in Waldenstrom's Macroglobulinemia for the iNNOVATE Study Group and the European Consortium for Waldenstrom's Macroglobulinemia. N Engl J Med 2018;378:2399-410.) Dimopoulos Waldenstroms Macroglobulinemia 2018 Oncology Response Criteria Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. (Dohner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK, Dombret H, Fenaux P, Grimwade D, Larson RA, Lo-Coco F, Naoe T, Niederwieser D, Ossenkoppele GJ, Sanz MA, Sierra J, Tallman MS, Lowenberg B, Bloomfield CD; European LeukemiaNet Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010 Jan 21;115(3):453-74.) Dohner AML 2010 Oncology Response Criteria International uniform response criteria for multiple myeloma. (Durie BG, Harousseau JL, Miguel JS, Blade J, Barlogie B, Anderson K, Gertz M, Dimopoulos M, Westin J, Sonneveld P, Ludwig H, Gahrton G, Beksac M, Crowley J, Belch A, Boccadaro M, Cavo M, Turesson I, Joshua D, Vesole D, Kyle R, Alexanian R, Tricot G, Attal M, Merlini G, Powles R, Richardson P, Shimizu K, Tosi P, Morgan G, Rajkumar SV; International Myeloma Working Group. International uniform response criteria for multiple myeloma. Leukemia. 2006 Sep;20(9):1467-73. Epub 2006 Jul 20.) Durie Multiple Myeloma 2006 Oncology Response Criteria Clinical management, of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL conference-European Association for the Study of the Liver. (Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J; EASL Panel of Experts on HCC. Clinical management, of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL conference-European Association for the Study of the Liver. J Hepatol. 2001 Sep;35(3):421-30.) EASL Bruix Liver Cancer 2001 Oncology Response Criteria Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant. (Blade J, Samson D, Reece D, Apperley J, Bjorkstrand B, Gahrton G, Gertz M, Giralt S, Jagannath S, Vesole D. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant. Br J Haematol. 1998 Sep;102(5):1115-23.) EBMT Blade Myeloma 1998 Oncology Response Criteria Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. (Hartmut Dohner, Elihu Estey, David Grimwade, Sergio Amadori, Frederick R. Appelbaum, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood (2017) 129 (4): 424-447.) ELN Dohner AML 2017 Oncology Response Criteria Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. (Dohner H, Wei AH, Appelbaum FR, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022 Sep 22;140(12):1345-1377.) ELN Dohner AML 2022 Oncology Response Criteria Clinical End Points and Response Criteria in Mycosis Fungoides and Sezary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. (Olsen EA, Whittaker S, Kim YH, Duvic M, Prince HM, Lessin SR, Wood GS, Willemze R, Demierre MF, Pimpinelli N, Bernengo MG, Ortiz-Romero PL, Bagot M, Estrach T, Guitart J, Knobler R, Sanches JA, Iwatsuki K, Sugaya M, Dummer R, Pittelkow M, Hoppe R, Parker S, Geskin L, Pinter-Brown L, Girardi M, Burg G, Ranki A, Vermeer M, Horwitz S, Heald P, Rosen S, Cerroni L, Dreno B, Vonderheid EC; International Society for Cutaneous Lymphomas; United States Cutaneous Lymphoma Consortium; Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. Clinical End Points and Response Criteria in Mycosis Fungoides and Sezary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol. 2011 Jun 20;29(18):2598-607.) EORTC Olsen Mycosis Fungoides And Sezary Syndrome 2011 Oncology Response Criteria Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. (Baccarani M, Saglio G, Goldman J, Hochhaus A, Simonsson B, Appelbaum F, Apperley J, Cervantes F, Cortes J, Deininger M, Gratwohl A, Guilhot F, Horowitz M, Hughes T, Kantarjian H, Larson R, Niederwieser D, Silver R, Hehlmann R; European LeukemiaNet. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood. 2006 Sep 15;108(6):1809-20. Epub 2006 May 18.) European Leukemianet Baccarani CML 2006 Oncology Response Criteria Supplement to: Farooqui MZH, Valdez J, Martyr S, et al. Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial. Lancet Oncol 2014; published online Dec 31. http://dx.doi.org/10.1016/S1470-2045(14)71182-9. (Available at http://www.thelancet.com/cms/attachment/2026086364/2045255220/mmc1.pdf. Accessed April 27, 2016) Supplement to Farooqui CLL 2014 Oncology Response Criteria Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG). (Rustin GJ, Vergote I, Eisenhauer E, Pujade-Lauraine E, Quinn M, Thigpen T, du Bois A, Kristensen G, Jakobsen A, Sagae S, Greven K, Parmar M, Friedlander M, Cervantes A, Vermorken J; Gynecological Cancer Intergroup. Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG). Int J Gynecol Cancer. 2011 Feb;21(2):419-23.) GCIG Rustin Ovarian Cancer 2011 Oncology Response Criteria Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase. (Guilhot F, Apperley J, Kim DW, Bullorsky EO, Baccarani M, Roboz GJ, Amadori S, de Souza CA, Lipton JH, Hochhaus A, Heim D, Larson RA, Branford S, Muller MC, Agarwal P, Gollerkeri A, Talpaz M. Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase. Blood. 2007 May 15;109(10):4143-50. Epub 2007 Jan 30.) Guilhot CML 2007 Oncology Response Criteria CA125 Response: Can it Replace the Traditional Response Criteria in Ovarian Cancer? (Guppy AE, Rustin GJS. CA125 Response: Can it Replace the Traditional Response Criteria in Ovarian Cancer? Oncologist. 2002;7(5):437-43.) Guppy Ovarian Cancer 2002 Oncology Response Criteria Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer. (Hamaoka T, Costelloe CM, Madewell JE, Liu P, Berry DA, Islam R, Theriault RL, Hortobagyi GN, Ueno NT. Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer. Br J Cancer. 2010 Feb 16;102(4):651-7.) Hamaoka Breast Cancer 2010 Oncology Response Criteria Assessing treatment effect in pancreatic cancer. (Hartman DJ, Krasinskas AM. Assessing treatment effect in pancreatic cancer. Arch Pathol Lab Med. 2012 Jan;136(1):100-9.) Hartman Pancreatic Cancer 2012 Oncology Response Criteria Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors. (Hartmann JT, Nichols CR, Droz JP, Horwich A, Gerl A, Fossa SD, Beyer J, Pont J, Kanz L, Einhorn L, Bokemeyer C. Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors. Ann Oncol. 2002 Jul;13(7):1017-28.) Hartmann Germ Cell Cancer 2002 Oncology Response Criteria International Neuroblastoma Response Criteria 1993 Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. (Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol. 1993 Aug;11(8):1466-77.) International Neuroblastoma Response Criteria, Brodeur 1993 International Neuroblastoma Response Criteria 2017 Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting. (Park JR, Bagatell R, Cohn SL, Pearson AD, Villablanca JG, Berthold F, Burchill S, et al. Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting. J Clin Oncol. 2017 Aug 1;35(22):2580-2587.) International Neuroblastoma Response Criteria, Park 2017 International Neuroblastoma Response Criteria 2019 The new international neuroblastoma response criteria. (Orr KE, McHugh K. The new international neuroblastoma response criteria. Pediatr Radiol. 2019 Oct;49(11):1433-1440.) International Neuroblastoma Response Criteria 2019 Immunotherapy response assessment in neuro-oncology: a report of the RANO working group. (Okada H, Weller M, Huang R, Finocchiaro G, Gilbert MR, Wick W, Ellingson BM, Hashimoto N, Pollack IF, Brandes AA, Franceschi E, Herold-Mende C, Nayak L, Panigrahy A, Pope WB, Prins R, Sampson JH, Wen PY, Reardon DA. Immunotherapy response assessment in neuro-oncology: a report of the RANO working group. Lancet Oncol. 2015 Nov;16(15):e534-e542.) IRANO Okada 2015 Oncology Response Criteria iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. (Seymour L, Bogaerts J, Perrone A, Ford R, Schwartz LH, Mandrekar S, Lin NU, Litiere S, Dancey J, Chen A, Hodi FS, Therasse P, Hoekstra OS, Shankar LK, Wolchok JD, Ballinger M, Caramella C, de Vries EG; RECIST working group. iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. Lancet Oncol. 2017 Mar;18(3):e143-e152.) Immune-Modified Response Evaluation Criteria in Solid Tumors A practical guide from the International Thymic Malignancy Interest Group (ITMIG) regarding radiographic assessment of treatment response of thymic epithelial tumors using modified RECIST criteria. (Marcelo F Benveniste, Robert J Korst, Arun Rajan, Frank C Detterbeck, Edith M Marom, International Thymic Malignancy Interest Group. A practical guide from the International Thymic Malignancy Interest Group (ITMIG) regarding the radiographic assessment of treatment response of thymic epithelial tumors using modified RECIST criteria. J Thorac Oncol. 2014 Sep;9(9 Suppl 2):S119-24.) ITMIG MRECIST Benveniste Thymic Epithelial Tumors 2014 Oncology Response Criteria Intratumoral RECIST Response criteria for intratumoral immunotherapy in solid tumors: itRECIST (Goldmacher GV, Khilnani AD, MD1, Andtbacka RHI, Luke JJ, Hodi FS, Marabelle A, Harrington K, Perrone A, Tse A, Madoff DC, Schwartz LH. Response criteria for intratumoral immunotherapy in solid tumors: itRECIST. J Clin Oncol. 2020 Aug 10;38(23):2667-2676.) itRECIST Goldmacher 2020 Oncology Response Criteria Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. (Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H, Hillmen P, Keating MJ, Montserrat E, Rai KR, Kipps TJ. International Workshop on Chronic Lymphocytic Leukemia.Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008 Jun 15;111(12):5446-56.) IWC Hallek CLL 2008 Oncology Response Criteria Guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the 2008 International Workshop on Chronic Lymphocytic Leukemia (iwCLL) published consensus guidelines for the design and conduct of clinical trials for patients with CLL. (Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H, Hillmen P, Keating MJ, Montserrat E, Chiorazzi N, Stilgenbauer S, Rai KR, Byrd JC, Eichhorst B, O'Brien S, Robak T, Seymour JF, Kipps TJ. Blood. 2018 Jun 21;131(25):2745-60.) IWC Hallek CLL 2018 Oncology Response Criteria Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. (Cheson BD, Bennett JM, Kopecky KJ, Buchner T, Willman CL, Estey EH, Schiffer CA, Doehner H, Tallman MS, Lister TA, Lo-Coco F, Willemze R, Biondi A, Hiddemann W, Larson RA, Lowenberg B, Sanz MA, Head DR, Ohno R, Bloomfield CD; International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol. 2003 Dec 15;21(24):4642-9.) IWG Cheson AML 2003 Oncology Response Criteria Report of an international working group to standardize response criteria for myelodysplastic syndromes. (Cheson BD, Bennett JM, Kantarjian H, Pinto A, Schiffer CA, Nimer SD, Lowenberg B, Beran M, de Witte TM, Stone RM, Mittelman M, Sanz GF, Wijermans PW, Gore S, Greenberg PL; World Health Organization(WHO) international working group. Report of an international working group to standardize response criteria for myelodysplastic syndromes. Blood. 2000 Dec 1;96(12):3671-4.) IWG Cheson MDS 2000 Oncology Response Criteria Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. (Cheson BD, Greenberg PL, Bennett JM, Lowenberg B, Wijermans PW, Nimer SD, Pinto A, Beran M, de Witte TM, Stone RM, Mittelman M, Sanz GF, Gore SD, Schiffer CA, Kantarjian H. Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. Blood. 2006 Jul 15;108(2):419-25. Epub 2006 Apr 11.) IWG Cheson MDS 2006 Oncology Response Criteria Preoperative external beam radiotherapy and reduced dose brachytherapy for carcinoma of the cervix: survival and pathological response. (Jacinto AA, Castilho MS, Novaes PE, Novick PR, Viani GA, Salvajoli JV, Ferrigno R, Pellizzon AC, Lima SS, Maia MA, Fogaroli RC. Preoperative external beam radiotherapy and reduced dose brachytherapy for carcinoma of the cervix: survival and pathological response. Radiat Oncol. 2007 Feb 22;2:9.) Jacinto Cervical Cancer 2007 Oncology Response Criteria Japanese classification of gastric carcinoma: 3rd English edition. ([No authors listed]. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011 Jun;14(2):101-12.) Japanese Classification Gastric Cancer 2011 Oncology Response Criteria Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography. (Juweid ME, Wiseman GA, Vose JM, Ritchie JM, Menda Y, Wooldridge JE, Mottaghy FM, Rohren EM, Blumstein NM, Stolpen A, Link BK, Reske SN, Graham MM, Cheson BD. Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography.J Clin Oncol. 2005 Jul 20;23(21):4652-61.) Juweid Non-Hodgkins Lymphoma 2005 Oncology Response Criteria Clinical usefulness of AJCC response criteria for neoadjuvant chemotherapy in breast cancer. (Keam B, Im SA, Lim Y, Han SW, Moon HG, Oh DY, Cho N, Lee SH, Han W, Moon WK, Kim DW, Kim TY, Park IA, Noh DY. Clinical usefulness of AJCC response criteria for neoadjuvant chemotherapy in breast cancer. Ann Surg Oncol. 2013 Jul;20(7):2242-9.) Keam Breast Cancer 2013 Oncology Response Criteria Update on Recommendations for Assessing Response from the Third International Workshop on Waldenstrom's Macroglobulinemia. (Kimby E, Treon SP, Anagnostopoulos A, Dimopoulos M, Garcia-Sanz R, Gertz MA, Johnson S, LeBlond V, Fermand JP, Maloney DG, Merlini G, Morel P, Morra E, Nichols G, Ocio EM, Owen R, Stone M, Blade J. Update on Recommendations for Assessing Response from the Third International Workshop on Waldenstrom's Macroglobulinemia. Clin Lymphoma Myeloma. 2006 Mar;6(5):380-3.) Kimby Waldenstroms Macroglobulinemia 2006 Oncology Response Criteria Primary central nervous system lymphomas (PCNSL): MRI response criteria revised. (Kuker W, Nagele T, Thiel E, Weller M, Herrlinger U. Primary central nervous system lymphomas (PCNSL): MRI response criteria revised. Neurology. 2005 Oct 11;65(7):1129-31.) Kuker Lymphoma 2005 Oncology Response Criteria International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. (Kumar S, Paiva B, Anderson KC, Durie B, et al. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol. 2016 Aug;17(8):e328-46.) Kumar IMWG 2016 Oncology Response Criteria New CT response criteria in non-small cell lung cancer: proposal and application in EGFR tyrosine kinase inhibitor therapy. (Lee HY, Lee KS, Ahn MJ, Hwang HS, Lee JW, Park K, Ahn JS, Kim TS, Yi CA, Chung MJ. New CT response criteria in non-small cell lung cancer: proposal and application in EGFR tyrosine kinase inhibitor therapy. Lung Cancer. 2011 Jul;73(1):63-9.) Lee Lung Cancer 2011 Oncology Response Criteria Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification. (Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA; Alliance, Australasian Leukaemia and Lymphoma Group; Eastern Cooperative Oncology Group; European Mantle Cell Lymphoma Consortium; Italian Lymphoma Foundation; European Organisation for Research; Treatment of Cancer/Dutch Hemato-Oncology Group; Grupo Espanol de Medula Osea; German High-Grade Lymphoma Study Group; German Hodgkin's Study Group; Japanese Lymphorra Study Group; Lymphoma Study Association; NCIC Clinical Trials Group; Nordic Lymphoma Study Group; Southwest Oncology Group; United Kingdom National Cancer Research Institute. Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification. J Clin Oncol. 2014 Sep 20;32(27):3059-68.) Lugano Classification Oncology Response Criteria Response criteria for phase II studies of supratentorial malignant glioma. (Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol. 1990 Jul;8(7):1277-80.) Macdonald Glioma 1990 Oncology Response Criteria Morphology, Attenuation, Size, and Structure (MASS) criteria: assessing response and predicting clinical outcome in metastatic renal cell carcinoma on antiangiogenic targeted therapy. (Smith AD, Shah SN, Rini BI, Lieber ML, Remer EM. Morphology, Attenuation, Size, and Structure (MASS) criteria: assessing response and predicting clinical outcome in metastatic renal cell carcinoma on antiangiogenic targeted therapy. AJR Am J Roentgenol. 2010 Jun;194(6):1470-8.) Morphology, Attenuation, Size, and Structure Criteria An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults. (Savona MR, Malcovati L, Komrokji R, et al. An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults. Blood. 2015;125(12):1857-1865.) MDS/MPN IWC Savona 2015 Oncology Response Criteria Langerhans Cell Histiocytosis: Histiocyte Society Evaluation and Treatment Guidelines April 2009. (Minkov, M., Grois, N., McClain, K., Nanduri, V., Rodriguez-Galindo, C., Simonitsch-Klupp, I., Visser, J., Weitzman, S., Whitlock, J., Windebank, K. (April 2009). Langerhans Cell Histiocytosis: Histiocyte Society Evaluation and Treatment Guidelines April 2009 [pdf]. Retrieved from https://www.histiocytesociety.org/document.doc?id=290) Minkov Langerhans Cell Histiocytosis 2009 Oncology Response Criteria Chronic lymphocytic leukemia: recommendations for diagnosis, staging, and response criteria. International Workshop on Chronic Lymphocytic Leukemia. ([No authors listed]. Chronic lymphocytic leukemia: recommendations for diagnosis, staging, and response criteria. International Workshop on Chronic Lymphocytic Leukemia. Ann Intern Med. 1989 Feb 1;110(3):236-8.) Montserrat CLL 1989 Oncology Response Criteria Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. (van den Bent MJ, Wefel JS, Schiff D, Taphoorn MJ, Jaeckle K, Junck L, Armstrong T, Choucair A, Waldman AD, Gorlia T, Chamberlain M, Baumert BG, Vogelbaum MA, Macdonald DR, Reardon DA, Wen PY, Chang SM, Jacobs AH. Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol. 2011 Jun;12(6):583-93.) Modified RANO Van Den Bent Glioma 2011 Oncology Response Criteria Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. (Armato SG 3rd, Nowak AK. Revised modified response evaluation criteria in solid tumors for assessment of response in malignant pleural mesothelioma (Version 1.1). J. Thorac. Oncol. 2018 Apr;13(7):1012-21.) MRECIST Armato Mesothelioma 2018 Oncology Response Criteria Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. (Byrne MJ, Nowak AK. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol. 2004 Feb;15(2):257-60.) Modified RECIST Byrne Mesothelioma 2004 Oncology Response Criteria Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma. (Lencioni R, Llovet JM. Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma. Semin Liver Dis. 2010 Feb;30(1):52-60.) Modified RECIST Lencioni Liver Cancer 2010 Oncology Response Criteria Response criteria for the prostate of the USA National Prostatic Cancer Project. (Murphy GP, Slack NH. Response criteria for the prostate of the USA National Prostatic Cancer Project. Prostate. 1980;1(3):375-82.) Murphy Prostate Cancer 1980 Oncology Response Criteria NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Acute Lymphoblastic Leukemia Version 1.2014 06/06/14 (NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Acute Lymphoblastic Leukemia Version 1.2014 06/06/14) NCCN ALL MRD 2014 Oncology Response Criteria National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. (Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S, Rai KR. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood. 1996 Jun 15;87(12):4990-7.) NCIWG Cheson CLL 1996 Oncology Response Criteria Response assessment in Waldenstrom macroglobulinaemia: update from the VIth International Workshop. (Roger G. Owen, Robert A. Kyle, Marvin J. Stone, Andy C. Rawstron, Veronique Leblond, et al. Response assessment in Waldenstrom macroglobulinaemia: update from the VIth International Workshop. Br J Haematol. 2013 Jan;160(2):171-6.) Owen Waldenstroms Macroglobulinemia 2013 Oncology Response Criteria Palumbo IMWG 2009 International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation. (Palumbo A, Sezer O, Kyle R, Miguel JS, Orlowski RZ, Moreau P, Niesvizky R, Morgan G, Comenzo R, Sonneveld P, Kumar S, Hajek R, Giralt S, Bringhen S, Anderson KC, Richardson PG, Cavo M, Davies F, Blade J, Einsele H, Dimopoulos MA, Spencer A, Dispenzieri A, Reiman T, Shimizu K, Lee JH, Attal M, Boccadoro M, Mateos M, Chen W, Ludwig H, Joshua D, Chim J, Hungria V, Turesson I, Durie BG, Lonial S; IMWG. International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation. Leukemia. 2009 Oct;23(10):1716-30.) Palumbo Multiple Myeloma 2009 Oncology Response Criteria PCWG1 Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. (Bubley GJ, Carducci M, Dahut W, Dawson N, Daliani D, Eisenberger M, Figg WD, Freidlin B, Halabi S, Hudes G, Hussain M, Kaplan R, Myers C, Oh W, Petrylak DP, Reed E, Roth B, Sartor O, Scher H, Simons J, Sinibaldi V, Small EJ, Smith MR, Trump DL, Wilding G, et al. Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol. 1999 Nov;17(11):3461-7.) PCWG Bubley Prostate Cancer 1999 Oncology Response Criteria PCWG2 Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group. (Scher HI, Halabi S, Tannock I, Morris M, Sternberg CN, Carducci MA, Eisenberger MA, Higano C, Bubley GJ, Dreicer R, Petrylak D, Kantoff P, Basch E, Kelly WK, Figg WD, Small EJ, Beer TM, Wilding G, Martin A, Hussain M; Prostate Cancer Clinical Trials Working Group. Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group. J Clin Oncol. 2008 Mar 1;26(7):1148-59.) PCWG Scher Prostate Cancer 2008 Oncology Response Criteria PCWG3 Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3. (Scher HI, Morris MJ, Stadler WM, Higano C, Basch E, Fizazi K, Antonarakis ES, Beer TM, Carducci MA, Chi KN, Corn PG, de Bono JS, Dreicer R, George DJ, Heath EI, Hussain M, Kelly WK, Liu G, Logothetis C, Nanus D, Stein MN, Rathkopf DE, Slovin SF, Ryan CJ, Sartor O, Small EJ, Smith MR, Sternberg CN, Taplin ME, Wilding G, Nelson PS, Schwartz LH, Halabi S, Kantoff PW, Armstrong AJ. Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3. J Clin Oncol. 2016 Apr 20;34(12):1402-18.) PCWG Scher Prostate Cancer 2016 Oncology Response Criteria From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors. (Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009 May;50 Suppl 1:122S-50S.) PET Response Criteria in Solid Tumors Chemotherapy Response of Breast Cancer Depends on HER-2 Status and Anthracycline Dose Intensity in the Neoadjuvant Setting. (Petit T, Borel C, Ghnassia JP, Rodier JF, Escande A, Mors R, Haegele P. Chemotherapy Response of Breast Cancer Depends on HER-2 Status and Anthracycline Dose Intensity in the Neoadjuvant Setting. Clin Cancer Res. 2001 Jun;7(6):1577-81.) Petit Breast Cancer 2001 Oncology Response Criteria Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno Consortium. (Buchmann S, Schrappe M, Baruchel A, Biondi A, Borowitz M, Campbell M, Cario G, Cazzaniga G, Escherich G, Harrison CJ, Heyman M, Hunger SP, Kiss C, Liu HC, Locatelli F, Loh ML, Manabe A, Mann G, Pieters R, Pui CH, Rives S, Schmiegelow K, Silverman LB, Stary J, Vora A, Brown P. Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno Consortium. Blood. 2022 Mar 24;139(12):1785-1793.) Ponte-di-Legno Consortium 2022 Phase III Placebo-Controlled Trial of Denileukin Diftitox for Patients with Cutaneous T-cell Lymphoma. (Prince HM, Duvic M, Martin A, Sterry W, Assaf C, Sun Y, Straus D, Acosta M, Negro-Vilar A. Phase III Placebo-Controlled Trial of Denileukin Diftitox for Patients with Cutaneous T-cell Lymphoma. J Clin Oncol. 2010 Apr 10;28(11):1870-7.) Prince T Cell Lymphoma 2010 Oncology Response Criteria A description of the disease response to treatment as characterized by the clinical trial protocol. Protocol Defined Response Criteria Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1. (Rajkumar SV, Harousseau JL, Durie B, Anderson KC, Dimopoulos M, Kyle R, Blade J, Richardson P, Orlowski R, Siegel D, Jagannath S, Facon T, Avet-Loiseau H, Lonial S, Palumbo A, Zonder J, Ludwig H, Vesole D, Sezer O, Munshi NC, San Miguel J; International Myeloma Workshop Consensus Panel 1. Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1. Blood. 2011 May 5;117(18):4691-5.) Rajkumar Myeloma 2011 Oncology Response Criteria Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials (Benjamin M. Ellingson, Patrick Y. Wen, Timothy F. Cloughesy. Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials. Neurotherapeutics (2017) 14:307-320). RANO Ellingson 2017 Oncology Response Criteria Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group. (Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, Degroot J, Wick W, Gilbert MR, Lassman AB, Tsien C, Mikkelsen T, Wong ET, Chamberlain MC, Stupp R, Lamborn KR, Vogelbaum MA, van den Bent MJ, Chang SM. Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group. J Clin Oncol. 2010 Apr 10;28(11):1963-72.) Response Assessment in Neuro-Oncology Criteria RANO-BM Lin Brain Metastases 2015 Response assessment criteria for brain metastases: proposal from the RANO group. (Lin NU, Lee EQ, Aoyama H, et al. Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol. 2015;16(6):e270-e278.) RANO-BM Lin Brain Metastases 2015 Response Evaluation Criteria in Cancer of the Liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 revised version). (Kudo M, Kubo S, Takayasu K, Sakamoto M, Tanaka M, Ikai I, Furuse J, Nakamura K, Makuuchi M; Liver Cancer Study Group of Japan (Committee for Response Evaluation Criteria in Cancer of the Liver, Liver Cancer Study Group of Japan). Response Evaluation Criteria in Cancer of the Liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 revised version). Hepatol Res. 2010 Jul;40(7):686-92.) Response Evaluation Criteria in Cancer of the Liver Response Evaluation Criteria in Solid Tumors (RECIST) version 1.0 (Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubenstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG. New Guidelines to Evaluate the Response to Treatment in Solid Tumors. Journal of the National Cancer Institute 2000; 92(3):205-216). Response Evaluation Criteria in Solid Tumors Version 1.0 Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1 (E.A. Eisenhauer, P. Therasse, J. Bogaerts, L.H. Schwartz, D. Sargent, R. Ford, J. Dancey, S. Arbuck, S. Gwyther, M. Mooney, L. Rubinstein, L. Shankar, L. Dodd, R. Kaplan, D. Lacombe, J. Verweij. New response evaluation criteria in solid tumours; Revised RECIST guideline (version 1.1). European Journal of Cancer 2009; 45:228-247). Response Evaluation Criteria in Solid Tumors Version 1.1 Assessing tumor response and detecting recurrence in metastatic renal cell carcinoma on targeted therapy: importance of size and attenuation on contrast-enhanced CT. (Smith AD, Lieber ML, Shah SN. Assessing tumor response and detecting recurrence in metastatic renal cell carcinoma on targeted therapy: importance of size and attenuation on contrast-enhanced CT. AJR Am J Roentgenol. 2010 Jan;194(1):157-65.) Size and Attenuation CT Criteria International Pediatric Non-Hodgkin Lymphoma Response Criteria. (Sandlund JT, Guillerman RP, Perkins SL, Pinkerton CR, Rosolen A, Patte C, Reiter A, Cairo MS. International Pediatric Non-Hodgkin Lymphoma Response Criteria. J Clin Oncol. 2015 Jun 20;33(18):2106-11.) International Pediatric Non-Hodgkin Lymphoma Response Criteria End Points and Outcomes in Castration-Resistant Prostate Cancer: From Clinical Trials to Clinical Practice. (Scher HI, Morris MJ, Basch E, Heller G. End Points and Outcomes in Castration-Resistant Prostate Cancer: From Clinical Trials to Clinical Practice. J Clin Oncol. 2011 Sep 20;29(27):3695-704.) Scher Prostate Cancer 2011 Oncology Response Criteria The Role of 18F-FDG PET in Assessing Therapy Response in Cancer of the Cervix and Ovaries. (Schwarz JK, Grigsby PW, Dehdashti F, Delbeke D. The Role of 18F-FDG PET in Assessing Therapy Response in Cancer of the Cervix and Ovaries. J Nucl Med. 2009 May;50 Suppl 1:64S-73S.) Schwarz Cervical Cancer 2009 Oncology Response Criteria Non-Size-Based Response Criteria to Preoperative Chemotherapy in Patients With Colorectal Liver Metastases: The Morphologic Response Criteria. (Shindoh J, Chun YS, Loyer EM, Vauthey JN. Non-Size-Based Response Criteria to Preoperative Chemotherapy in Patients With Colorectal Liver Metastases: The Morphologic Response Criteria. Curr Colorectal Cancer Rep. 2013 Jun 1;9(2):198-202.) Shindoh Colorectal Cancer 2013 Oncology Response Criteria 123I-MIBG scintigraphy in neuroblastoma: development of a SIOPEN semi-quantitative reporting, method by an international panel. (Lewington V., Lambert B., Poetschger U., Bar Sever Z., Giammarile F., McEwan A.J.B., Rita Castellani R., Lynch T., Shulkin B., Drobics M., Staudenherz A., Landenstein R. 123I-MIBG scintigraphy in neuroblastoma: development of a SIOPEN semi-quantitative reporting, method by an international panel. J Nucl Med Mol Imaging. 2017 Feb;44(2):234-241.) SIOPEN Lewington Neuroblastoma 2017 Oncology Response Criteria Definition, Prognostic Factors, Treatment, and Response Criteria of Adult T-Cell Leukemia-Lymphoma: A Proposal From an International Consensus Meeting. (Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington W Jr, O'Mahony D, Janik JE, Bittencourt AL, Taylor GP, Yamaguchi K, Utsunomiya A, Tobinai K, Watanabe T. Definition, Prognostic Factors, Treatment, and Response Criteria of Adult T-Cell Leukemia-Lymphoma: A Proposal From an International Consensus Meeting. J Clin Oncol. 2009 Jan 20;27(3):453-9.) Tsukasaki Leukemia Lymphoma 2009 Oncology Response Criteria Not stated explicitly or in detail. Unspecified Guidelines for Management of Breast Cancer. (WHO (2006). Guidelines for Management of Breast Cancer. Retrieved from http://applications.emro.who.int/dsaf/dsa697.pdf) Guidelines for Management of Breast Cancer WHO 2006 irRC irRECIST Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria. (Wolchok JD, Hoos A, O'Day S, Weber JS, Hamid O, Lebbe C, Maio M, Binder M, Bohnsack O, Nichol G, Humphrey R, Hodi FS. Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria. Clin Cancer Res. 2009 Dec 1;15(23):7412-20.) Wolchok Solid Tumors 2009 Oncology Response Criteria ONCRSCAT Category of Oncology Response Assessment CDISC SDTM Category of Oncology Response Assessment Terminology Terminology relevant to the category of protocol deviations. A grouping of protocol deviations where the subject/participant or treatment was either discontinued in error or continued in error Discontinuation Protocol Deviation Category A grouping of protocol deviations related to study inclusion and exclusion criteria. Inclusion/Exclusion Protocol Deviation Category A grouping of protocol deviations related to the informed consent/assent process. Informed Consent/Assent Protocol Deviation Category A grouping of protocol deviations related to a prohibited concomitant intervention. Prohibited Concomitant Intervention Protocol Deviation Category A grouping of protocol deviations related to safety reporting. Safety Reporting Protocol Deviation Category A grouping of protocol deviations related to the study intervention. Study Intervention Protocol Deviation Category A grouping of protocol deviations related to trial procedures. Trial Procedures Protocol Deviation Category DVCAT Category of Protocol Deviation CDISC SDTM Category of Protocol Deviation Terminology A grouping of observations within the Questionnaires domain. ABC01 Activities-Specific Balance Confidence Scale (ABC) (Powell LE, Myers AM. The Activities-specific Balance Confidence (ABC) Scale. J Gerontol A Biol Sci Med Sci. 1995 Jan;50A(1):M28-34. ABC scale Anita M. Myers, 1995. All rights reserved.). No part of the Activities-Specific Balance Confidence Scale may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Anita M. Myers and payment of any applicable fees. Copyright Anita M. Myers, 1995. All rights reserved. Activities-Specific Balance Confidence Scale Questionnaire ACQ01 Asthma Control Questionnaire (ACQ) (The Asthma Control Questionnaire is copyrighted. It may not be changed, translated or sold [paper or software] without the permission of Elizabeth Juniper. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999;14:902-907). Asthma Control Questionnaire ACT01 Asthma Control Test (ACT) (Asthma Control Test copyright, QualityMetric Incorporated 2002, 2004. All Rights Reserved. Asthma Control Test is a trademark of QualityMetric Incorporated. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004 Jan;113(1):59-65). Asthma Control Test Questionnaire ADL03 Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory (ADCS-ADL), MCI Version (Galasko, D., Bennett, D., Sano, M., Ernesto, C., Thomas, R., Grundman, M., Ferris, S., and the ADCS. An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimer's Disease. Alzheimer's Disease and Associated Disorders, 1997. Volume 11(2): S33-S39). Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory Mild Cognitive Impairment Questionnaire ADL02 Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory (ADCS-ADL), Severe Dementia Version (Galasko, D., Bennett, D., Sano, M., Ernesto, C., Thomas, R., Grundman, M., Ferris, S., and the ADCS. An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimer's Disease. Alzheimer's Disease and Associated Disorders, 1997. Volume 11(2): S33-S39). Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory Severe Dementia Questionnaire ADL01 Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory (ADCS-ADL) (Galasko, D., Bennett, D., Sano, M., Ernesto, C., Thomas, R., Grundman, M., Ferris, S., and the ADCS. "An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimer's Disease." Alzheimer's Disease and Associated Disorders, 1997. Volume 11(2): S33-S39). Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory Questionnaire ACGC01 Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change (ADCS-CGIC) (Schneider LS, Olin JT, Doody RS, Clark CM, Morris JC, Reisberg B, Schmitt FA, Grundman M, Thomas RG, Ferris SH, and the Alzheimer's Disease Cooperative Study. Validity and Reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. Alzheimer Disease and Associated Disorders. 1997; 11(2):S22-S32). Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change Questionnaire ADHD01 ADHD Rating Scale-IV (ADHD-RS-IV) Home Version (Copyright 1998. DuPaul GJ, Power TJ, Anastopoulos AD, Reid R. ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation. New York: The Guilford Press; 1998). ADHD Rating Scale-IV Home Version Questionnaire ADSD01 Asthma Daytime Symptom Diary v1.0 (ADSD V1.0) (Version 1.0 Copyright 2018 Critical Path Institute. All Rights Reserved. Gater A, Nelsen L, Fleming S, Lundy J.J, Bonner N, Hall R, Marshall C, Staunton H, Krishnan JA, Stoloff S, Schatz M, Haughney J on behalf of the Patient-Reported Outcome Consortium's Asthma Working Group. Assessing asthma symptoms in adolescents and adults: qualitative research supporting development of the Asthma Daily Symptom Diary. Value in Health 2016; 19:440-450. Patient-Reported Outcome (PRO) Consortium - Asthma Daytime Symptom Diary (ADSD) and Asthma Nighttime Symptom Diary (ANSD) User Manual, Version 1: March 30, 2019). No part of the ADSD V1.0 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the Critical Path Institute and payment of any applicable fees. Copyright Critical Path Institute, 2018. All rights reserved. Asthma Daytime Symptom Diary V1.0 Questionnaire ANSD01 Asthma Nighttime Symptom Diary v1.0 (ANSD V1.0) (Version 1.0 Copyright 2018 Critical Path Institute. All Rights Reserved. Gater A, Nelsen L, Fleming S, Lundy J.J, Bonner N, Hall R, Marshall C, Staunton H, Krishnan JA, Stoloff S, Schatz M, Haughney J on behalf of the Patient-Reported Outcome Consortium's Asthma Working Group. Assessing asthma symptoms in adolescents and adults: qualitative research supporting development of the Asthma Daily Symptom Diary. Value in Health 2016; 19:440-450. Patient-Reported Outcome (PRO) Consortium - Asthma Daytime Symptom Diary (ADSD) and Asthma Nighttime Symptom Diary (ANSD) User Manual, Version 1: March 30, 2019). No part of the ANSD V1.0 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the Critical Path Institute and payment of any applicable fees. Copyright Critical Path Institute, 2018. All rights reserved. Asthma Nighttime Symptom Diary V1.0 Questionnaire AQ01 Airway Questionnaire 20 (AQ20) (Barley EA, Quirk FH, Jones PW. Asthma health status in clinical practice: validity of a new short and simple instrument. Respir Med 1998; 92:1207-14. Copyright Reserved P.W. Jones, PhD FRCP). Airway Questionnaire 20 AQLQ01 Asthma Quality of Life Questionnaire (AQLQ) (The AQLQ is copyrighted. It may not be altered, sold [paper or electronic], translated or adapted for another medium without the permission of Elizabeth Juniper. Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health-related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992; 47:76-83). Asthma Quality of Life Questionnaire ARCI01 Addiction Research Center Inventory 1971 (ARCI-49 1971) (Martin WR, Sloan JW, Sapira JD, Jasinski DR. Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther. 1971; 12(2):245-258). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Addiction Research Center Inventory 49 Check-list ASEX01 Arizona Sexual Experiences Scale (ASEX)-Female (Copyright 1997 by Arizona Board of Regents, University of Arizona. All rights reserved). Arizona Sexual Experiences Scale-Female Version Questionnaire ASEX02 Arizona Sexual Experiences Scale (ASEX)-Male (Copyright 1997 by Arizona Board of Regents, University of Arizona. All rights reserved). Arizona Sexual Experiences Scale-Male Version Questionnaire ADTC01 Alcohol Use Disorder Identification Test-Consumption Questions (AUDIT-C) (Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA; for the Ambulatory Care Quality Improvement Project (ACQUIP). The AUDIT Alcohol Consumption Questions (AUDIT-C) An Effective Brief Screening Test for Problem Drinking. Arch Intern Med. Sep 14 1998;158:1789-1795). Alcohol Use Disorder Identification Test Alcohol Consumption Questions Questionnaire ADT01 Alcohol Use Disorder Identification Test: Self-Report Version (AUDIT) (Saunders JB, Aasland, OG, Babor, TF, De La Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with harmful Alcohol Consumption-II. Addiction (1993) 88:791-804). Alcohol Use Disorder Identification Test Self-Report Version Questionnaire BEBQ01 Baby Eating Behaviour Questionnaire - Concurrent (BEBQ CONCURRENT) (Llewellyn, C. H., van Jaarsveld, C. H., Johnson, L., Carnell, S., & Wardle, J. Development and factor structure of the Baby Eating Behaviour Questionnaire in the Gemini birth cohort. Appetite 57.2, 2011, 388-396). Baby Eating Behaviour Questionnaire Concurrent Version BEBQ02 Baby Eating Behaviour Questionnaire - Retrospective (BEBQ RETROSPECTIVE) (Llewellyn, C. H., van Jaarsveld, C. H., Johnson, L., Carnell, S., & Wardle, J. Development and factor structure of the Baby Eating Behaviour Questionnaire in the Gemini birth cohort. Appetite 57.2, 2011, 388-396). Baby Eating Behaviour Questionnaire Retrospective Version BD01 BDI-II Beck Depression Inventory-Second Edition (BECK DEPRESSION INVENTORY-II) (The Psychological Corporation Harcourt Brace & Company Copyright 1996, by Aaron T. Beck. All rights reserved. Beck AT, Steer RA, Brown GK. BDI-II Manual. The Psychological Corporation, San Antonio, TX, USA. 1996; 38p. Copyright 1996, 1987 Aaron T Beck). No part of the Beck Depression Inventory-Second Edition may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the Psychological Corporation Harcourt Brace & Company and payment of any applicable fees. Copyright Psychological Corporation Harcourt Brace & Company 1996 and Aaron T. Beck. All rights reserved. Beck Depression Inventory-Second Edition Questionnaire BFI01 Brief Fatigue Inventory (BFI) (Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, Huber SL. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer. 1999 Mar 1;85(5):1186-96. Copyright 1999. The University of Texas M. D. Anderson Cancer Center. All rights reserved). No part of the Brief Fatigue Inventory may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the University of Texas M. D. Anderson Cancer Center and payment of any applicable fees. Copyright the University of Texas M. D. Anderson Cancer Center 1999. All rights reserved. Brief Fatigue Inventory BIS01 Barratt Impulsiveness Scale 1995 Version (BIS-11) (Patton JH, Stanford MS, and Barratt ES (1995). Factor structure of the Barratt impulsiveness scale. Journal of Clinical Psychology, 51, 768-774. Copyright International Society for Research on Impulsivity and it's licensor's. All Rights Reserved). Barratt Impulsiveness Scale 1995 Version Questionnaire BLCS01 Bladder Control Scale (BLCS) (1997 by the National Multiple Sclerosis Society. All rights reserved). Bladder Control Scale Questionnaire BCR101 Borg CR10 Scale (BORG CR10) (Borg CR10 Scale. Copyright Gunnar Borg, 1982, 1998, 2004). Borg Category-Ratio 10 Scale Questionnaire BRPE01 Borg Ratings of Perceived Exertion (BORG RPE) (Borg RPE Scale. Ratings (R) of Perceived (P) Exertion (E). Copyright Gunnar Borg, 1970, 1998, 2017). Borg Scale Rating of Perceived Exertion Questionnaire BPI2 Brief Pain Inventory Short Form (BPI2) (copyright 1991 Charles S. Cleeland, PhD, Pain Research Group, All Right Reserved). Brief Pain Inventory Short Form Questionnaire BPI1 Brief Pain Inventory (BPI) (copyright 1991 Charles S. Cleeland, PhD, Pain Research Group, All Right Reserved). Brief Pain Inventory Questionnaire BSFS01 Bristol Stool Form Scale (BSFS) (Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997 Sep;32(9):920-4. Copyright by ROME Foundation. All rights reserved). Bristol Stool Scale BSI181 Brief Symptom Inventory-18 (BSI-18) (Leonard R. Derogatis. Brief Symptom Inventory (BSI)-18: Administration, scoring and procedures manual. Minneapolis 2001: NCS Pearson, Inc). Brief Symptom Inventory 18 BWCS01 Bowel Control Scale (BWCS) (1997 by the National Multiple Sclerosis Society. All rights reserved). Bowel Control Scale Questionnaire CSS05 Columbia-Suicide Severity Rating Scale (C-SSRS) Already Enrolled Subjects Version 1/14/2009 (Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.; Burke, A.; Oquendo, M.; Mann, J.; copyright 2008 The Research Foundation for Mental Hygiene, Inc.). Columbia-Suicide Severity Rating Scale Already Enrolled Subjects Questionnaire CSS01 Columbia-Suicide Severity Rating Scale (C-SSRS) Baseline Version 2009-01-14 (Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.; Burke, A.; Oquendo, M.; Mann, J.; copyright 2008 The Research Foundation for Mental Hygiene, Inc.). Columbia-Suicide Severity Rating Scale Baseline Questionnaire CSS03 Columbia-Suicide Severity Rating Scale (C-SSRS) Baseline/Screening Version Phase 1 Study Version 1/14/2009 (Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.; Burke, A.; Oquendo, M.; Mann, J.; copyright 2008 The Research Foundation for Mental Hygiene, Inc.). Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study 1/14/09 Questionnaire CSS04 Columbia-Suicide Severity Rating Scale (C-SSRS) Baseline/Screening Version 1/14/2009 (Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.; Burke, A.; Oquendo, M.; Mann, J.; copyright 2008 The Research Foundation for Mental Hygiene, Inc.). Columbia-Suicide Severity Rating Scale Baseline/Screening Version Questionnaire CSS06 Columbia-Suicide Severity Rating Scale (C-SSRS) Children's Baseline Version 6/23/2010 (Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.; Burke, A.; Oquendo, M.; Mann, J.; copyright 2008 The Research Foundation for Mental Hygiene, Inc.). Columbia-Suicide Severity Rating Scale Children's Baseline Questionnaire CSS07 Columbia-Suicide Severity Rating Scale (C-SSRS) Children's Baseline/Screening Version 6/23/2010 (Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.; Burke, A.; Oquendo, M.; Mann, J.; copyright 2008 The Research Foundation for Mental Hygiene, Inc.). Columbia-Suicide Severity Rating Scale Children's Baseline/Screening Questionnaire CSS08 Columbia-Suicide Severity Rating Scale (C-SSRS) Children's Since Last Visit Version 6/23/2010 (Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.; Burke, A.; Oquendo, M.; Mann, J.; copyright 2008 The Research Foundation for Mental Hygiene, Inc.). Columbia-Suicide Severity Rating Scale Children's Since Last Visit Questionnaire CSS11 Columbia-Suicide Severity Rating Scale (C-SSRS) Lifetime/Recent Version 1/14/2009 (Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.; Burke, A.; Oquendo, M.; Mann, J.; copyright 2008 The Research Foundation for Mental Hygiene, Inc.). Columbia-Suicide Severity Rating Scale Lifetime/Recent Version Questionnaire CSS10 Columbia-Suicide Severity Rating Scale (C-SSRS) Pediatric/Cognitively Impaired Lifetime/Recent Version 6/23/2010 (Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.; Burke, A.; Oquendo, M.; Mann, J.; copyright 2008 The Research Foundation for Mental Hygiene, Inc.). Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent Questionnaire CSS12 Columbia-Suicide Severity Rating Scale (C-SSRS) Pediatric/Cognitively Impaired - Lifetime Recent - Clinical Version 6/23/2010 (Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.; Burke, A.; Oquendo, M.; Mann, J.; copyright 2008 The Research Foundation for Mental Hygiene, Inc). Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired - Lifetime Recent - Clinical Questionnaire CSS13 Columbia-Suicide Severity Rating Scale (C-SSRS) Pediatric/Cognitively Impaired - Since Last Visit - Clinical Version 6/23/2010 (Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.; Burke, A.; Oquendo, M.; Mann, J.; copyright 2008 The Research Foundation for Mental Hygiene, Inc). Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired - Since Last Visit - Clinical Questionnaire CSS09 Columbia-Suicide Severity Rating Scale (C-SSRS) Screening Version 1/14/2009 (Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.; Burke, A.; Oquendo, M.; Mann, J.; copyright 2008 The Research Foundation for Mental Hygiene, Inc.). Columbia-Suicide Severity Rating Scale Screening Questionnaire CSS02 Columbia-Suicide Severity Rating Scale (C-SSRS) Since Last Visit Version 1/14/2009 (Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.; Burke, A.; Oquendo, M.; Mann, J.; copyright 2008 The Research Foundation for Mental Hygiene, Inc.). Columbia-Suicide Severity Rating Scale Since Last Visit Questionnaire CCQ02 Clinical COPD Questionnaire (CCQ) 1 Week Version (The CCQ is copyrighted 1999. It may not be altered, sold (paper or electronic), translated or adapted for another medium without the permission of T. van der Molen, Dept. of General Practice, University Medical Center Groningen, Postbus 196, 9700 AD Groningen, The Netherlands.). Clinical COPD Questionnaire 1 Week Version CCQ01 Clinical COPD Questionnaire (CCQ) 24 Hour Version (The CCQ is copyrighted 1999. It may not be altered, sold (paper or electronic), translated or adapted for another medium without the permission of T. van der Molen, Dept. of General Practice, University Medical Center Groningen, Postbus 196, 9700 AD Groningen, The Netherlands.). Clinical COPD Questionnaire 24 Hour Version CDAI01 Crohn's Disease Activity Index Version 1 (CDAI V1) (Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976 Mar;70(3):439-44). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Crohn's Disease Activity Index Version 1 Questionnaire CDLQ1 Children's Dermatology Life Quality Index (CDLQI) (Copyright of M.S. Lewis-Jones, A.Y. Finlay, May 1993, this must not be copied without the permission of the authors). Children's Dermatology Life Quality Index Questionnaire CES01 Combat Exposure Scale (CES) (Keane, T.M., Fairbank, J.A., Caddell, J.M., Zimering, R.T., Taylor, K.L., & Mora, C. (1989). Clinical evaluation of a measure to assess combat exposure (PDF). Psychological Assessment, 1, 53-55). Combat Exposure Scale Questionnaire CGI02 Clinical Global Impression (CGI) generic modification for any disease/condition concept use case (Modified from Guy W: ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: U.S. Department of Health, Education, and Welfare; 1976). Clinical Global Impression Generic Modification Version Questionnaire CHSF1 Craig Handicap Assessment and Reporting Technique - Short Form Interview Version (CHART-SF INTERVIEW VERSION) (Whiteneck GG, Charlifue SW, Gerhart KA, Overholser JD, Richardson GN. Quantifying handicap: a new measure of long-term rehabilitation outcomes. Arch Phys Med Rehabil. 1992;73:519-526). Craig Handicap Assessment and Reporting Technique-Short Form Interview Version Questionnaire CHSF2 Craig Handicap Assessment and Reporting Technique - Short Form Paper Version (CHART-SF PAPER VERSION) (Whiteneck GG, Charlifue SW, Gerhart KA, Overholser JD, Richardson GN. Quantifying handicap: a new measure of long-term rehabilitation outcomes. Arch Phys Med Rehabil. 1992;73:519-526). Craig Handicap Assessment and Reporting Technique - Short Form Paper Version Questionnaire COMM1 Current Opioid Misuse Measure (COMM) (copyright 2010 Inflexxion, Inc., All rights reserved). Current Opioid Misuse Measure Questionnaire CAT01 COPD Assessment Test (CAT) (COPD Assessment Test and the CAT logo is a trade mark of the GlaxoSmithKline group of companie. Copyright 2009 GlaxoSmithKline group of companies. All rights reserved). COPD Assessment Test Questionnaire COWS1 The Clinical Opiate Withdrawal Scale (COWS) (Wesson DR and Ling W. The Clinical Opiate Withdrawal Scale (COWS). J Psychoactive Drugs 2003;35(2):253-259). Clinical Opiate Withdrawal Scale Questionnaire CRQ01 Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version (Copyright 2001 McMaster University, Hamilton, Ontario, Canada. The Chronic Respiratory Questionnaire Self-Administered including the standardized Dyspnea Domain (CRQSAS), Principal authors G.H. Guyatt and Dr. H.J. Schunemann, is the copyright of McMaster University (Copyright 2001, McMaster University). Chronic Respiratory Questionnaire Self-Administered Standardized Format First Administration Version Questionnaire CRQ02 Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version (Copyright 2001 McMaster University, Hamilton, Ontario, Canada. The Chronic Respiratory Questionnaire Self-Administered including the standardized Dyspnea Domain (CRQSAS), Principal authors G.H. Guyatt and Dr. H.J. Schunemann, is the copyright of McMaster University (Copyright 2001, McMaster University). Chronic Respiratory Questionnaire Self-Administered Standardized Format Follow-Up Administration Version Questionnaire DAD01 Disability Assessment for Dementia (DAD) (copyright 1994 by L. Gauthier I. Gelinas. All rights reserved.). Disability Assessment for Dementia Questionnaire DIBC01 Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 (DIBSS-C V1.0) (Copyright 2018 by the Critical Path Institute. All rights reserved. Fehnel S, Ervin C, McLeod L, Carson RT, Reasner DS, Hanlon J, Eremenco S, Coons SJ. Psychometric Evaluation of the Diary for Irritable Bowel Syndrome Symptoms-Constipation (DIBSS-C). Poster presented at ISPOR Europe 2018; November 10-14, 2018. Barcelona, Spain. Fehnel SE, Ervin CM, Carson RT, Rigoni G, Lackner JM, Coons SJ. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research. Value in Health 2017;20(4):618-626. Patient-Reported Outcome (PRO) Consortium Diary for Irritable Bowel Syndrome Symptoms-Constipation (DIBSS-C) v1.0 User Manual). No part of the DIBSS-C V1.0 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the Critical Path Institute and payment of any applicable fees. Copyright Critical Path Institute, 2018. All rights reserved. Diary for Irritable Bowel Syndrome Symptoms-Constipation Version 1.0 Questionnaire DLQI1 Dermatology Life Quality Index (DLQI) (Copyright Dermatology Life Quality Index. A Y Finlay, G K Khan, April 1992 and Cardiff University. www.dermatology.org.uk. Finlay A. Y. and Khan, G. K. 1994. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clinical and Experimental Dermatology 19 (3), pp.210-216.). No part of the DLQI may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Cardiff University and payment of any applicable fees. Copyright AY Finlay, GK Khan and Cardiff University. All rights reserved. Dermatology Life Quality Index Questionnaire DRRI1 Deployment Risk and Resilience Inventory-2 (DRRI-2) (Vogt, D., Smith, B. N., King, D. W., & King, L. A. (2012). The Deployment Risk and Resilience Inventory-2 (DRRI-2) [Measurement instrument]. Available from http.ptsd.va.gov). Deployment Risk and Resilience Inventory-2 Questionnaire DSQ1 DePaul Post Exertional Malaise Questionnaire 2018 (DSQ-PEM 2018) (Cotler J, Holtzman C, Dudun C, Jason LA. A Brief Questionnaire to Assess Post-Exertional Malaise. Diagnostics (Basel). 2018 Sep 11;8(3):66). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. DePaul Symptom Questionnaire - Post Exertional Malaise 2018 Version - 10 Item EOR30 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items (EORTC QLQ-ANL27) (QLQ-ANL27 Copyright 2016 EORTC Quality of Life Group. All rights reserved). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items EOR24 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items (EORTC QLQ-BIL21) (QLQ-BIL21 Copyright 2011 EORTC Quality of Life Group. All rights reserved. (Validated module)). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items EOR03 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items (EORTC QLQ-BM22) (QLQ-BM22 Copyright 2008 EORTC Quality of Life Group. All rights reserved. (Validated module)). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items EOR04 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Brain Cancer 20 Items (EORTC QLQ-BN20) (QLQ-BN20 Copyright 1994 EORTC Quality of Life Group. All rights reserved. (Validated module)). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. Quality of Life Questionnaire-Brain Neoplasm 20 Items EOR05 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer Version 1.0 23 Items (EORTC QLQ-BR23 V1.0) (QLQ-BR23 Copyright 1994 EORTC Quality of Life Group. All rights reserved. (Validated module). Version 1.0). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer Version 1.0 23 Items EOR35 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items (EORTC QLQ-BR42) (QLQ-BR42 Copyright 2024 EORTC Quality of life Group. All rights reserved. (Validated module)). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items EOR31 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer Phase IV Module 45 Items (EORTC QLQ-BR45 PHASE IV MODULE) (QLQ-BR45 Copyright 2018 EORTC Quality of Life Group. All rights reserved. (Phase IV module)). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer Phase IV Module Version 45 Items EOR32 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Reconstruction 23 Items (EORTC QLQ-BRECON23) (QLQ-BRECON23 Copyright 2017 EORTC Quality of Life Group. All rights reserved. (Validated module)). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Reconstruction 23 Items EOR02 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Paliative Care Version 1.0 (EORTC QLQ-C15-PAL V1.0) (Copyright 1995 and 2005 EORTC Quality of Life Group. All rights reserved. Version 1.0. (Validated module)). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 EOR01 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 (EORTC QLQ-C30 V3.0) (Copyright 1995 EORTC Quality of Life Group. All rights reserved. Version 3.0. (Validated module)). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 EOR25 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chemotherapy-Induced Peripheral Neuropathy 20 Items (EORTC QLQ-CIPN20) (QLQ-CIPN20 Copyright 2003 EORTC Quality of Life Group. All rights reserved). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. Quality of Life Questionnaire - Chemotherapy-Induced Peripheral Neuropathy 20 Items EOR29 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items (EORTC QLQ-CLL17) (QLQ-CLL17 Copyright 2015 EORTC Quality of Life Group. All rights reserved). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukemia 17 Items EOR06 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items (EORTC QLQ-CR29 V2.1) (QLQ-CR29 Copyright 2006 EORTC Quality of Life Group. All rights reserved. Version 2.1. (Validated module)). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items EOR07 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cervical Cancer 24 Items (EORTC QLQ-CX24) (QLQ-CX24 Copyright 2003 EORTC Quality of Life Group. All rights reserved. (Validated module)). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Cervical Cancer 24 Items EOR08 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Elderly Cancer Patients 14 Items (EORTC QLQ-ELD14) (QLQ-ELD14 Copyright 2001 EORTC Quality of Life Group. All rights reserved. (Validated module)). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Elderly Cancer Patients 14 Items EOR09 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Endometrial Cancer 24 Items (EORTC QLQ-EN24) (QLQ-EN24 Copyright 2010 EORTC Quality of Life Group. All rights reserved. (Validated module)). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Endometrial Cancer 24 Items EOR10 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cancer Related Fatigue 12 Items (EORTC QLQ-FA12) (QLQ-FA12 Copyright 2016 EORTC Quality of Life Group. All rights reserved. (Validated module)). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Cancer Related Fatigue 12 Items EOR15 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Neuroendocrine Carcinoid 21 Items, Date 20th February 2006 Version (EORTC QLQ-GINET21 DATE 20TH FEBRUARY 2006) (QLQ-G.I.NET21 Copyright 2004 EORTC Quality of Life Group. All rights reserved. Date: 20th February 2006. (Validated module)). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Neuroendocrine Carcinoid 21 Items, Date 20th February 2006 Version EOR11 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head & Neck Cancer Version 1 35 Items (EORTC QLQ-H&N35 V1) (Copyright QLQ-H&N35 1994 EORTC Quality of Life Group, version 1. All rights reserved. (Validated module)). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Head & Neck Cancer Version 1 35 Items EOR36 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items (EORTC QLQ-H&N43 PHASE IV MODULE) (Copyright 2014 EORTC Quality of Life Group. All rights reserved. Phase IV module). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module Version 43 Items EOR16 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Hepatocellular Carcinoma 18 Items (EORTC QLQ-HCC18) (QLQ-HCC18 Copyright 2002 EORTC Quality of Life Group. All rights reserved. (Validated module)). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Hepatocellular Carcinoma 18 Items EOR17 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items (EORTC QLQ-INFO25) (QLQ-C30-INFO25 Copyright 2004 EORTC Quality of Life Group. All rights reserved. (Validated module)). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items EOR18 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items (EORTC QLQ-LC13) (QLQ-C30-LC13 Copyright 1994 EORTC Quality of life Group. All rights reserved. (Validated module)). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items EOR33 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 24 Items (EORTC QLQ-LC24) (QLQ-LC24 Copyright 2016 EORTC Quality of life Group. All rights reserved. (Validated module)). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 24 Items EOR34 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 29 Items (EORTC QLQ-LC29) (QLQ-LC29 Copyright 2017 EORTC Quality of life Group. All rights reserved. (Validated module)). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 29 Items EOR12 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items (EORTC QLQ-LMC21) (QLQ-LMC21 Copyright 2002 EORTC Quality of Life Group. All rights reserved. (Validated module)). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items EOR19 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items (EORTC QLQ-MY20) (QLQ-MY20 Copyright 1999 EORTC Quality of Life Group. All rights reserved. (Validated module)). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. Quality of Life Questionnaire-Multiple Myeloma 20 EOR28 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items (EORTC QLQ-NMIBC24) (QLQ-NMIBC24 Copyright 1994 EORTC Quality of Life Group. All rights reserved). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items EOR20 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items (EORTC QLQ-OES18) (QLQ-OES18 Copyright 1999 EORTC Quality of Life Group. All rights reserved. (Validated module)). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Esophageal Cancer 18 Items EOR21 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items (EORTC QLQ-OG25 PHASE IV MODULE) (QLQ-OG25 Copyright 2007 EORTC Quality of Life Group. All rights reserved. (Phase IV module)). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Esophago-Gastric Cancer Phase IV Module Version 25 Items EOR13 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oral Health 15 Items (EORTC QLQ-OH15) (QLQ-OH15 Copyright 2016 EORTC Quality of Life Group. All rights reserved. (Validated module)). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Oral Health 15 Items EOR22 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Ovarian Cancer 28 Items (EORTC QLQ-OV28) (QLQ-OV28 Copyright 1997 EORTC Quality of Life Group. All rights reserved. (Validated module)). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Ovarian Cancer 28 Items EOR26 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Pancreatic Cancer Phase III Module 26 Items (EORTC QLQ-PAN26 PHASE III MODULE) (QLQ-C30-PAN26 Copyright 1999 EORTC Quality of Life Group. All rights reserved. (Phase III module)). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Pancreatic Cancer Phase III Module Version 26 Items EOR23 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Prostate Cancer 25 Items (EORTC QLQ-PR25) (QLQ-PR25 Copyright 1999 EORTC Quality of Life Group. All rights reserved. (Validated module)). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Prostate Cancer 25 Items EOR14 European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Gastric Cancer 22 Items (EORTC QLQ-STO22) (QLQ-STO22 Copyright 1999 EORTC Quality of Life Group. All rights reserved. (Validated module)). These materials discuss and/or include the EORTC system of measures which is owned exclusively by the European Organisation for the Research and Treatment of Cancer (EORTC). No part of the EORTC system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the European Organisation for the Research and Treatment of Cancer (EORTC). All rights reserved. European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Gastric Cancer 22 Items EPDS01 Edinburgh Postnatal Depression Scale (EPDS) (Copyright by Cox, J.L., Holden, J.M., and Sagovsky, R. 1987. Detection of postnatal depression: Development of the 10-item Edinburgh Postnatal Depression Scale. British Journal of Psychiatry 150:782-786). Edinburgh Postnatal Depression Scale Questionnaire EPIC1 The Expanded Prostate Cancer Index Composite Short Form (EPIC-26) (Copyright 2002. The University of Michigan. All rights reserved). The Expanded Prostate Cancer Index Composite Short Form Questionnaire EPIC2 Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP) (Copyright 2016 Beth Israel Deaconess Medical Center 330 Brookline Avenue, Boston, MA 02215). Expanded Prostate Cancer Index Composite for Clinical Practice Questionnaire EQ5D01 European Quality of Life Five Dimension Three Level Scale (EQ-5D-3L) (Copyright EuroQol Research Foundation. EQ-5D is a trade mark of the EuroQol Research Foundation.). No part of the European Quality of Life Five Dimension scales may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of EuroQol Research Foundation and payment of any applicable fees. Copyright EuroQol Research Foundation. All rights reserved. European Quality of Life Five Dimension Three Level Questionnaire EQ5D03 European Quality of Life Five Dimension Five Level Scale Version for Interviewer Administration USA English V1.2 (EQ-5D-5L INTERVIEWER VERSION V1.2) (Copyright EuroQol Research Foundation. EQ-5D is a trade mark of the EuroQol Research Foundation. USA English v1.2.). No part of the European Quality of Life Five Dimension scales may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of EuroQol Research Foundation and payment of any applicable fees. Copyright EuroQol Research Foundation. All rights reserved. European Quality of Life Five Dimension Five Level Scale Interviewer Administered Questionnaire Version 1.2 EQ5D04 European Quality of Life Five Dimension Five Level Scale Version for Proxy1 USA English V2.0 (EQ-5D-5L PROXY1 VERSION V2.0) (Copyright EuroQol Research Foundation. EQ-5D is a trade mark of the EuroQol Research Foundation. USA English v2.0.). No part of the European Quality of Life Five Dimension scales may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of EuroQol Research Foundation and payment of any applicable fees. Copyright EuroQol Research Foundation. All rights reserved. European Quality of Life Five Dimension Five Level Scale Proxy 1 Questionnaire Version 2.0 EQ5D02 European Quality of Life Five Dimension Five Level Scale (EQ-5D-5L) (Copyright EuroQol Research Foundation. EQ-5D is a trade mark of the EuroQol Research Foundation.). No part of the European Quality of Life Five Dimension scales may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of EuroQol Research Foundation and payment of any applicable fees. Copyright EuroQol Research Foundation. All rights reserved. European Quality of Life Five Dimension Five Level Scale Questionnaire ESS01 Epworth Sleepiness Scale (ESS) (copyright Murray W. Johns, 1990-1997. All rights reserved.). Epworth Sleepiness Scale Questionnaire EXACT1 Exacerbations of Chronic Pulmonary Disease Tool (EXACT) Patient-Reported Outcome (PRO) (Nancy K. Leidy, EXACT-PRO Initiative, Evidera, 7101 Wisconsin Avenue, Suite 1400, Bethesda, MD; EXACT copyright 2013, Evidera, Inc. All rights reserved). This also includes the subset EXACT-Respiratory Symptoms (E-RS) questions. http://www.exactproinitiative.com Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome Questionnaire ED1 Expanded Disability Rating Scale - Postacute Interview Caregiver Version (EXPANDED DRS-PI CAREGIVER VERSION) (Malec JF, Hammond FM, Giacino JT, Whyte J, Wright J. Structured Interview to Improve the Reliability and Psychometric Integrity of the Disability Rating Scale. Arch Phys Med Rehabil Sept 2012;93:1603-1608). Expanded Disability Rating Scale - Postacute Interview Caregiver Version Questionnaire ED2 Expanded Disability Rating Scale - Postacute Interview Survivor Version (EXPANDED DRS-PI SURVIVOR VERSION) (Malec JF, Hammond FM, Giacino JT, Whyte J, Wright J. Structured Interview to Improve the Reliability and Psychometric Integrity of the Disability Rating Scale. Arch Phys Med Rehabil Sept 2012;93:1603-1608). Expanded Disability Rating Scale - Postacute Interview Survivor Version Questionnaire FAC065 Functional Assessment of Anorexia/Cachexia Treatment Version 4 (FAACT V4) (Copyright 1987, 1997 David Cella, Ph.D. All Rights Reserved; Questionnaires and all related subscales, translations, and adaptations ('FACIT System') are owned and copyrighted by David Cella, Ph.D. The ownership and copyright of the FACIT System resides strictly with Dr. Cella. Dr. Cella has granted FACIT.org the right to license usage of the FACIT System to other parties). Functional Assessment of Anorexia/Cachexia Treatment Version 4 Questionnaire FAC100 Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank (FACIT-DYSPNEA 33 ITEM BANK) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank Questionnaire FAC084 Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form (FACIT-DYSPNEA SF) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) FACIT-Dyspnea 10 Item Short Form FAC071 Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 (FACIT-F V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 Questionnaire FAC070 Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 (FACIT-FATIGUE 13-Item V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 Questionnaire FAC101 Functional Assessment of Chronic Illness Therapy-Item GP5 Version 4 (FACIT-ITEM GP5 V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved). Functional Assessment of Chronic Illness Therapy-Item GP5 Version 4 Questionnaire FSIL Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult (FACIT-SEARCHABLE ITEM LIBRARY ADULT) (These materials discuss and/or include the FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved). Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult Version Questionnaire FSLP Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric (FACIT-SEARCHABLE ITEM LIBRARY PEDIATRIC) (These materials discuss and/or include the FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved). Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric Version Questionnaire FAC005 Functional Assessment of Cancer Therapy-Breast Version 4 (FACT-B V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) Functional Assessment of Cancer Therapy-Breast Version 4 Questionnaire FAC006 Functional Assessment of Cancer Therapy-Bladder Version 4 (FACT-BL V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) Functional Assessment of Cancer Therapy-Bladder Version 4 Questionnaire FAC061 Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 (FACT-BMT V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 Questionnaire FAC074 Functional Assessment of Cancer Therapy-Bone Pain Version 4 (FACT-BP V4) (Copyright 1987, 1997 David Cella, Ph.D. All Rights Reserved; Questionnaires and all related subscales, translations, and adaptations ('FACIT System') are owned and copyrighted by David Cella, Ph.D. The ownership and copyright of the FACIT System resides strictly with Dr. Cella. Dr. Cella has granted FACIT.org the right to license usage of the FACIT System to other parties). These materials discuss and/or include the Functional Assessment of Cancer Therapy-Bone Pain Version 4 (FACT-BP V4), which is owned exclusively by David Cella, Ph.D. No part of the FACT-BP V4 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying recording, or other electronic or mechanical methods, without the prior written permission of David Cella, Ph.D. and payment of any applicable fees. Copyright David Cella 1987, 1997. All rights reserved. Functional Assessment of Cancer Therapy-Bone Pain Version 4 Questionnaire FAC062 Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 (FACT-BRM V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 Questionnaire FAC008 Functional Assessment of Cancer Therapy-Colorectal Version 4 (FACT-C V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) Functional Assessment of Cancer Therapy-Colorectal Version 4 Questionnaire FAC075 Functional Assessment of Cancer Therapy-Cognitive Function Version 3 (FACT-COG V3) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) FACT-Cognitive Function FAC001 Functional Assessment of Cancer Therapy-General Version 4 (FACT-G V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) Functional Assessment of Cancer Therapy-General Version 4 Questionnaire FAC015 Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 (FACT-HEP V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 Questionnaire FAC104 Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4 (FACT-ICM V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved). Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4 Questionnaire - 52 Item FAC016 Functional Assessment of Cancer Therapy-Lung Version 4 (FACT-L V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) Functional Assessment of Cancer Therapy-Lung Version 4 Questionnaire FAC017 Functional Assessment of Cancer Therapy-Leukemia Version 4 (FACT-LEU V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) Functional Assessment of Cancer Therapy-Leukemia Version 4 Questionnaire FAC018 Functional Assessment of Cancer Therapy-Lymphoma Version 4 (FACT-LYM V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) Functional Assessment of Cancer Therapy-Lymphoma Version 4 Questionnaire FAC103 Functional Assessment of Cancer Therapy-Melanoma Non-Surgery Version 4 (FACT-M NON-SURGERY V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) Functional Assessment of Cancer Therapy-Melanoma Non-Surgery Version 4 Questionnaire FAC019 Functional Assessment of Cancer Therapy-Melanoma Version 4 (FACT-M V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) Functional Assessment of Cancer Therapy-Melanoma Version 4 Questionnaire FAC023 Functional Assessment of Cancer Therapy-Prostate Version 4 (FACT-P V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) Functional Assessment of Cancer Therapy-Prostate Version 4 Questionnaire FAC063 Functional Assessment of Cancer Therapy-Taxane Version 4 (FACT-Taxane V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) Functional Assessment of Cancer Therapy-Taxane Version 4 Questionnaire FAC102 Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 (FACT/GOG-NTX SUBSCALE V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved). Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 Questionnaire FAC057 Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 (FACT/GOG-NTX V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 Questionnaire FAMS01 Functional Assessment of Multiple Sclerosis Version 4 (FAMS) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) Functional Assessment of Multiple Sclerosis Questionnaire FAC029 Functional Assessment of Cancer Therapy-Brain Symptom Index (FBRSI) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) Functional Assessment of Cancer Therapy-Brain Symptom Index Questionnaire FES01 Falls Efficacy Scale (FES) (Reprinted with permission, Mary E. Tinetti, M.D. Copyright; 2006. Tinetti ME, Richman D, Powell L. Falls efficacy as a measure of fear of falling. J Gerontol 1990;45:239-243). These materials discuss and/or include the Falls Efficacy Scale, which are owned exclusively by Mary E. Tinetti, M.D. No part of the Falls Efficacy Scale may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Mary E. Tinetti, M.D. and payment of any applicable fees. Reprinted with permission, Mary E. Tinetti, M.D. Copyright; 2006 All rights reserved. Falls Efficacy Scale Questionnaire FIQR01 Revised Fibromyalgia Impact Questionnaire (FIQR) (copyright 2009 Bennett RM and Friend. All Rights Reserved.). No part of the FIQR may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Bennett RM and Friend and payment of any applicable fees. Copyright Bennett RM and Friend, 2009. All rights reserved. Revised Fibromyalgia Impact Questionnaire FAC039 Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 (FKSI-15) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) FKSI-15 Questionnaire FAC041 Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 (FKSI-DRS V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 Questionnaire FAC043 Functional Assessment of Cancer Therapy-Lung Symptom Index (FLSI) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) Functional Assessment of Cancer Therapy-Lung Symptom Index Questionnaire FLUIQ1 Influenza Intensity and Impact Questionnaire (Flu-iiQ) Once Daily (FLU-IIQ ONCE DAILY) (Copyright RH Osborne 2006. No part of the FLU-IIQ ONCE DAILY may be copied or reproduced in any form without written permission from the author: measuredsolutions (at) bigpond (dot) com). No part of the Flu-iiQ may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of RH Osborne and payment of any applicable fees. Copyright RH Osborne, 2006. All rights reserved. Influenza Intensity and Impact Questionnaire Once Daily Version FLUIQ2 Influenza Intensity and Impact Questionnaire (Flu-iiQ) Twice Daily (FLU-IIQ TWICE DAILY) (Copyright RH Osborne 2006. No part of the Flu-iiQ may be copied or reproduced in any form without written permission from the author: measuredsolutions (at) bigpond (dot) com). No part of the FLU-IIQ TWICE DAILY may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of RH Osborne and payment of any applicable fees. Copyright RH Osborne, 2006. All rights reserved. Influenza Intensity and Impact Questionnaire Twice Daily Version FAC049 Functional Assessment of Cancer Therapy-Ovarian Symptom Index (FOSI) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) Functional Assessment of Cancer Therapy-Ovarian Symptom Index Questionnaire FPSR1 Faces Pain Scale - Revised (FPS-R) (Hicks CL, von Baeyer CL, van Korlaar I, Goodenough B. Faces Pain Scale-Revised: Toward a Common Metric in Pediatric Pain Measurement. Pain 2001; 93:173-183). Faces Pain Scale Revised Questionnaire FSS01 Fatigue Severity Scale (FSS) (Copyright Lauren B. Krupp). Fatigue Severity Scale FTCD01 Fagerstrom Test for Cigarette Dependence (FTCD) (Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerstrom, K. O. (1991). The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. British journal of addiction, 86(9), 1119-1127. These materials discuss and/or include Fagerstrom Test for Cigarette Dependence, which are owned exclusively by Karl Fagerstrom. No part of the Fagerstrom Test for Cigarette Dependence may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Karl Fagerstrom and payment of any applicable fees. Copyright Karl Fagerstrom. All rights reserved). Fagerstrom Test for Cigarette Dependence Questionnaire GAD02 Generalized Anxiety Disorder - 7 Version 2 (GAD-7 V2) (Spitzer RL, Kroenke K, Williams JBW, Lowe B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med 2006; 166:1092-1097). Generalized Anxiety Disorder - 7 Version 2 Questionnaire GAD01 Generalized Anxiety Disorder - 7 (GAD-7) (Spitzer RL, Kroenke K, Williams JBW, Lowe B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med 2006; 166:1092-1097). Generalized Anxiety Disorder - 7 Questionnaire GCGI01 The General Clinical Global Impressions (GCGI v1) questions were created by STANDARDS (Standardized Analgesic Database for Research, Discovery, and Submissions) and sponsored by ACTTION (Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks) www.acttion.org; 2012-08-07 v1. STANDARDS General Clinical Global Impressions Questionnaire GDS02 Geriatric Depression Scale Short Form (GDS Short Form) (Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Gerontol. 1986 June;5(1/2):165-173). Geriatric Depression Scale Short Form Questionnaire GDS01 Geriatric Depression Scale (GDS) (Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatry Res. 1983;17(1):37-49). Geriatric Depression Scale Questionnaire GMSS01 The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes (GMSS VERSION TYPE 1 DIABETES) (Polonsky WH, Fisher L, Hessler D, Edelman SV. Development of a New Measure for Assessing Glucose Monitoring Device-Related Treatment Satisfaction and Quality of Life. Diabetes Technol Ther 2015; 17(9): 657-663). The Glucose Monitoring Satisfaction Survey Version: Type 1 Diabetes Questionnaire GOSE1 Extended Glasgow Outcome Scale (GOSE) (Wilson JT, Pettigrew LE, Teasdale GM. Structured interviews for the Glasgow Outcome Scale and the Extended Glasgow Outcome Scale: Guidelines for their use. Journal of Neurotrauma 1998;15:573-585). Extended Glasgow Outcome Scale Questionnaire HADS01 Hospital Anxiety and Depression Scale (HADS) (copyright 1983, 1992, 1994 by R.P. Snaith and A.S. Zigmond. All rights reserved.). Hospital Anxiety and Depression Scale Questionnaire HM09 Hemophilia Quality of Life Questionnaire Adult Version (Haem-A-QoL) (The Haemo-QoL questionnaire-set is a joint property of the Haemo-QoL Study Centre at the University of Hamburg, Germany and Bayer Biological Products, Research Triangle Park, North Carolina, USA. Development of new translations, modified versions or any other derivatives - such as electronic versions - are not permitted without special permission and involvement of the Haemo-QoL Study Group; Von Mackensen S, Scalone L, Ravera S, Mantovani L, Gringeri A, The COCHE Study Group. Assessment of health-related quality of life in patients with Hemophilia with the newly developed Hemophilia-specific instrument (Haem-A-QoL). Value Health 2005; 8:A127). Hemophilia Quality of Life Questionnaire Adult Version HM01 Hemophilia Quality of Life (HAEMO-QOL) Questionnaire Children's Long Version Age Group I (The Haemo-QoL questionnaire-set is a joint property of the Haemo-QoL Study Centre at the University of Hamburg, Germany and Bayer Biological Products, Research Triangle Park, North Carolina, USA. Development of new translations, modified versions or any other derivatives - such as electronic versions - are not permitted without special permission and involvement of the Haemo-QoL Study Group). Hemophilia Quality of Life Questionnaire Children's Long Version Age Group I HM02 Hemophilia Quality of Life (HAEMO-QOL) Questionnaire Children's Long Version Age Group II (The Haemo-QoL questionnaire-set is a joint property of the Haemo-QoL Study Centre at the University of Hamburg, Germany and Bayer Biological Products, Research Triangle Park, North Carolina, USA. Development of new translations, modified versions or any other derivatives - such as electronic versions - are not permitted without special permission and involvement of the Haemo-QoL Study Group). Hemophilia Quality of Life Questionnaire Children's Long Version Age Group II HM03 Hemophilia Quality of Life (HAEMO-QOL) Questionnaire Children's Long Version Age Group III (The Haemo-QoL questionnaire-set is a joint property of the Haemo-QoL Study Centre at the University of Hamburg, Germany and Bayer Biological Products, Research Triangle Park, North Carolina, USA. Development of new translations, modified versions or any other derivatives - such as electronic versions - are not permitted without special permission and involvement of the Haemo-QoL Study Group). Hemophilia Quality of Life Questionnaire Children's Long Version Age Group III HM04 Hemophilia Quality of Life (HAEMO-QOL) Questionnaire Children's Short Version Age Group I (The Haemo-QoL questionnaire-set is a joint property of the Haemo-QoL Study Centre at the University of Hamburg, Germany and Bayer Biological Products, Research Triangle Park, North Carolina, USA. Development of new translations, modified versions or any other derivatives - such as electronic versions - are not permitted without special permission and involvement of the Haemo-QoL Study Group). Hemophilia Quality of Life Questionnaire Children's Short Version Age Group I HM05 Hemophilia Quality of Life (HAEMO-QOL) Questionnaire Children's Short Version Age Group II/III (The Haemo-QoL questionnaire-set is a joint property of the Haemo-QoL Study Centre at the University of Hamburg, Germany and Bayer Biological Products, Research Triangle Park, North Carolina, USA. Development of new translations, modified versions or any other derivatives - such as electronic versions - are not permitted without special permission and involvement of the Haemo-QoL Study Group). Hemophilia Quality of Life Questionnaire Children's Short Version Age Group II/III HM06 Hemophilia Quality of Life (HAEMO-QOL) Questionnaire Parent's Long Version Age Group I (The Haemo-QoL questionnaire-set is a joint property of the Haemo-QoL Study Centre at the University of Hamburg, Germany and Bayer Biological Products, Research Triangle Park, North Carolina, USA. Development of new translations, modified versions or any other derivatives - such as electronic versions - are not permitted without special permission and involvement of the Haemo-QoL Study Group). Hemophilia Quality of Life Questionnaire Parent's Long Version Age Group I HM07 Hemophilia Quality of Life (HAEMO-QOL) Questionnaire Parent's Long Version Age Group II (The Haemo-QoL questionnaire-set is a joint property of the Haemo-QoL Study Centre at the University of Hamburg, Germany and Bayer Biological Products, Research Triangle Park, North Carolina, USA. Development of new translations, modified versions or any other derivatives - such as electronic versions - are not permitted without special permission and involvement of the Haemo-QoL Study Group). Hemophilia Quality of Life Questionnaire Parent's Long Version Age Group II HM08 Hemophilia Quality of Life (HAEMO-QOL) Questionnaire Parent's Long Version Age Group III (The Haemo-QoL questionnaire-set is a joint property of the Haemo-QoL Study Centre at the University of Hamburg, Germany and Bayer Biological Products, Research Triangle Park, North Carolina, USA. Development of new translations, modified versions or any other derivatives - such as electronic versions - are not permitted without special permission and involvement of the Haemo-QoL Study Group). Hemophilia Quality of Life Questionnaire Parent's Long Version Age Group III HAMDS1 The Hamilton Depression Rating Scale 6 Self-Report Version (HAM-D6 - Self-Report Version) (Clinical Research: Rating scales in depression: limitations and pitfalls; Per Bech, MD; Copyright 2006 LLS SAS. All rights reserved). Hamilton Depression Rating Scale 6 Self-Report Version Questionnaire HAQ01 Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale (HAQ-DI WITH VAS) (Fries JF. The assessment of disability: from first to future principles. Br J Rheumatol. 1983 Aug; 22(3 Suppl):48-58). Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale Questionnaire HAQ02 Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale (HAQ-DI WITHOUT VAS) (Copyright 2003 Fries JF. Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: Dimensions and Practical Applications. Health and Quality of Life Outcomes 2003. 9 June 2003; 1:20 1-6). Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale HCS01 Hypoglycemic Confidence Scale (HCS) (Polonsky WH, Fisher L, Hessler D, Edelman SV. Investigating Hypoglycemic Confidence in Type 1 and Type 2 Diabetes. Diabetes Technol Ther 2017; 19(2): 131-6). Hypoglycemic Confidence Scale Questionnaire IBDQ01 Quality of Life in Inflammatory Bowel Disease Questionnaire (IBDQ) (Copyright 1989, McMaster University, Hamilton, Ontario, Canada. The Inflammatory Bowel Disease Questionnaire, authored by Dr. Jan Irvine et. al., was made under license from McMaster University, Hamilton, Canada (Copyright 1989, McMaster University). The IBDQ is provided under license from McMaster University and may not be copied, distributed or used in any way without the prior written consent of McMaster University. Contact the McMaster Industry Liaison Office at: milo at mcmaster.ca for licensing details). Quality of Life in Inflammatory Bowel Disease Questionnaire IDSR1 Inventory of Depressive Symptomatology - Self-Report (IDS-SR) (Copyright UT Southwestern Medical Center at Dallas. Rush, A.J., Carmody, T. and Reimitz, P.E. The Inventory of Depressive Symptomatology (IDS): Clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms. International Journal of Methods in Psychiatric Research, 9:45-59, 2000). Inventory of Depressive Symptomatology Self-Report Version Questionnaire IIEF01 International Index of Erectile Function (IIEF) (Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, and Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997 49(6): 822-830). International Index of Erectile Function Questionnaire IPAQ02 International Physical Activity Questionnaire (November 2002) Long Last 7 Days Telephone Format (IPAQ-LF PHONE VERSION)(Booth, M.L. (2000). Assessment of Physical Activity: An International Perspective. Research Quarterly for Exercise and Sport, 71 (2): s114-20. Retrieved from the International Physical Activity Questionnaire website: http://www.ipaq.ki.se). International Physical Activity Questionnaire (November 2002) Long Last 7 Days Telephone Format IPAQ03 International Physical Activity Questionnaire (October 2002) Long Last 7 Days Self-Administered Format (IPAQ-LF SELF-ADMINISTERED VERSION) (Booth, M.L. (2000). Assessment of Physical Activity: An International Perspective. Research Quarterly for Exercise and Sport, 71 (2): s114-20. Retrieved from the International Physical Activity Questionnaire website: http://www.ipaq.ki.se). International Physical Activity Questionnaire (August 2002) Long Last 7 Days Self-Administered Format IPAQ01 International Physical Activity Questionnaire (August 2002) Short Last 7 Days Telephone Format (IPAQ-SF PHONE VERSION)(Booth, M.L. (2000). Assessment of Physical Activity: An International Perspective. Research Quarterly for Exercise and Sport, 71 (2): s114-20. Retrieved from the International Physical Activity Questionnaire website: http://www.ipaq.ki.se). International Physical Activity Questionnaire (August 2002) Short Last 7 Days Telephone Format IPAQ04 International Physical Activity Questionnaire (August 2002) Short Last 7 Days Self-Administered Format (IPAQ-SF SELF-ADMINISTERED VERSION)(Booth, M.L. (2000). Assessment of Physical Activity: An International Perspective. Research Quarterly for Exercise and Sport, 71 (2): s114-20. Retrieved from the International Physical Activity Questionnaire website: http://www.ipaq.ki.se). International Physical Activity Questionnaire (August 2002) Short Last 7 Days Self-Administered Format I-PSS IPS01 International Prostate Symptom Score (IPSS) (Barry MJ, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992; 148: 1549-1557). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. International Prostate Symptom Score IVIS01 Impact of Visual Impairment Scale (IVIS) (1997 by the National Multiple Sclerosis Society. All rights reserved). Impact of Visual Impairment Scale Questionnaire KDQ1 Kidney Disease and Quality of Life-36 Version 1 (KDQOL-36 V1) (Copyright 2000 by RAND and the University of Arizona). No part of the KDQOL-36 V1 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of RAND and the University of Arizona and payment of any applicable fees. Copyright RAND and the University of Arizona 2000. All rights reserved. Kidney Disease and Quality of Life-36 Version 1 Questionnaire LCSS1 Lung Cancer Symptom Scale (LCSS) (Hollen PJ, Gralla RJ, Kris MG, Potanovich LM. Quality of life assessment in individuals with lung cancer: testing the Lung Cancer Symptom Scale (LCSS). Eur J Cancer. 1993;29A Suppl 1:S51-8. U.S. Copyright 1995, Reproduced by permission of Quality of Life Research Associates, LLC). No part of the Lung Cancer Symptom Scale may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the Quality of Life Research Associates, LLC and payment of any applicable fees. Copyright Quality of Life Research Associates, LLC 1995. All rights reserved. Lung Cancer Symptom Scale Questionnaire LEC01 Life Events Checklist for DSM-5, Standard Version (LEC-5 STANDARD VERSION) (Weathers, F.W., Blake, D.D., Schnurr, P.P., Kaloupek, D.G., Marx, B.P., & Keane, T.M. (2013). The Life Events Checklist for DSM-5 (LEC-5). Retrieved from the National Center for PTSD website: http://www.ptsd.va.gov). Life Events Checklist for DSM-5 Standard Version Questionnaire MCEQ01 Modified Cigarette Evaluation Questionnaire (MCEQ) (Cappelleri JC, Bushmakin AG, Baker CL, Merikle E, Olufade AO, Gilbert DG. Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire. Addict Behav. 2007 May;32(5):912-23). These materials discuss the Modified Cigarette Evaluation Questionnaire, which is owned exclusively by Jed E. Rose and David Gilbert. No part of the Modified Cigarette Evaluation Questionnaire may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Jed E. Rose and David Gilbert and payment of any applicable fees. All rights reserved. Modified Cigarette Evaluation Questionnaire MDDI01 The MD Anderson Dysphagia Inventory (MDADI) (Chen AY, Frankowski R, Bishop-Leone J, et al. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg. 2001;127(7):870-876). No part of the MD Anderson Dysphagia Inventory may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the JAMA Network and payment of any applicable fees. Copyright JAMA Network 2001. All rights reserved. MD Anderson Dysphagia Inventory MDQ01 Menstrual Distress Questionnaire Form-T (Today) (MDQ-T) (Copyright 1968, 1989, 1991, 2000, 2010 by Rudolf H. Moos. All Rights Reserved. Published by Mind Garden, Inc. Moos RH. The development of a menstrual distress questionnaire. Psychosom Med. 1968 Nov-Dec;30(6):853-67). Menstrual Distress Questionnaire Form-T (Today) UPD2 The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) (copyright 2008 Movement Disorder Society. All Rights Reserved). Movement Disorder Society Unified Parkinson's Disease Rating Scale Questionnaire MFIS01 Modified Fatigue Impact Scale (MFIS) (1997 by the National Multiple Sclerosis Society. All rights reserved). Modified Fatigue Impact Scale Questionnaire MHIS01 Modified Hachinski Ischemic Scale-NACC Version (MHIS-NACC) Reproduced with permission. Copyright 2011 University of Washington. Created and published by the ADC Clinical Task Force (John C. Morris, MD, Chair) and the National Alzheimer's Coordinating Center (Walter A. Kukull, PhD, Director). This publication was funded by the National Institutes of Health through the National Institute on Aging (Cooperative Agreement U01 AG016976). Modified Hachinski Ischemic Scale-NACC Version Questionnaire MMRC01 Modified Medical Research Council dyspnea scale (MMRC) (Mahler DA, Wells CK. Evaluation of Clinical Methods for Rating Dyspnea. Chest 1988; 93:580-586). Modified Medical Research Council Dyspnea Scale Questionnaire MNSI1 Michigan Neuropathy Screening Instrument (MNSI) (copyright University of Michigan, 2000, All rights reserved). Michigan Neuropathy Screening Instrument Questionnaire ADTC03 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Interview Version 2001 (MODIFIED AUDIT-C FROM WHO AUDIT: INTERVIEW VERSION 2001) (Modified from: World Health Organization, Babor, Thomas F., Higgins-Biddle, John C., Saunders, John B. & Monteiro, Maristela G. (‎2001)‎. AUDIT: the alcohol use Disorders identification test: guidelines for use in primary health care, 2nd ed. World Health Organization). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Alcohol Use Disorders Identification Test-Concise Interview Version Questionnaire ADTC02 Modified Alcohol Use Disorders Identification Test-Consumption Questions From World Health Organization AUDIT: Self-Report Version 2001 (MODIFIED AUDIT-C FROM WHO AUDIT: SELF-REPORT VERSION 2001) (Modified from: World Health Organization, Babor, Thomas F., Higgins-Biddle, John C., Saunders, John B. & Monteiro, Maristela G. (‎2001)‎. AUDIT: the alcohol use Disorders identification test: guidelines for use in primary health care, 2nd ed. World Health Organization). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Alcohol Use Disorders Identification Test-Concise Self-Report Version Questionnaire MPAI1 The Mayo-Portland Adaptability Inventory-4 (MPAI-4) (Malec, J. (2005). The Mayo-Portland Adaptability Inventory-4. The Center for Outcome Measurement in Brain Injury. http://www.tbims.org/combi/mpai). Mayo-Portland Adaptability Inventory-4 Questionnaire MSIS01 Multiple Sclerosis Impact Scale version 1 (MSIS-29v1) (Copyright 2000 Neurological Outcome Measures Unit, Institute of Neurology, University College London, UK). Multiple Sclerosis Impact Scale Version 1 Questionnaire MSIS02 Multiple Sclerosis Impact Scale version 2 (MSIS-29v2) (Copyright 2005 Neurological Outcome Measures Unit, Peninsula Medical School, Plymouth, UK). Multiple Sclerosis Impact Scale Version 2 Questionnaire MSQL1 Multiple Sclerosis Quality of Life-54 Instrument (MSQOL-54) (Copyright 1995, University of California, Los Angeles). Multiple Sclerosis Quality of Life-54 Instrument Questionnaire MSWS01 12-Item Multiple Sclerosis Walking Scale (MSWS-12) (Copyright 2000 Neurological Outcome Measures Unit). 12-Item Multiple Sclerosis Walking Scale Questionnaire MTWSR1 Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) (Hughes JR. Measurement of the effects of abstinence from tobacco. A qualitative review. Psychol Addict Behav 2007;21:127-137). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Minnesota Tobacco Withdrawal Scale-Revised Questionnaire FAC028 National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 (NCCN-FACT FBlSI-18 V2) (Copyright 2001 David Cella, Ph.D. All Rights Reserved;Questionnaires and all related subscales, translations, and adaptations ('FACIT System') are owned and copyrighted by David Cella, Ph.D. The ownership and copyright of the FACIT System resides strictly with Dr. Cella. Dr. Cella has granted FACIT.org the right to license usage of the FACIT System to other parties). National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 Questionnaire FAC030 National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 (NCCN-FACT FBRSI-24 V2) (Copyright 1987, 1997 David Cella, Ph.D. All Rights Reserved; Questionnaires and all related subscales, translations, and adaptations ('FACIT System') are owned and copyrighted by David Cella, Ph.D. The ownership and copyright of the FACIT System resides strictly with Dr. Cella. Dr. Cella has granted FACIT.org the right to license usage of the FACIT System to other parties). National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 Questionnaire FAC036 National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 (NCCN-FACT FHNSI-22 V2) (Copyright 1987, 1997 David Cella, Ph.D. All Rights Reserved; Questionnaires and all related subscales, translations, and adaptations ('FACIT System') are owned and copyrighted by David Cella, Ph.D. The ownership and copyright of the FACIT System resides strictly with Dr. Cella. Dr. Cella has granted FACIT.org the right to license usage of the FACIT System to other parties). National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 Questionnaire FAC042 National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 (NCCN-FACT FKSI-19 V2) (Copyright 2001 David Cella, Ph.D. All Rights Reserved;Questionnaires and all related subscales, translations, and adaptations ('FACIT System') are owned and copyrighted by David Cella, Ph.D. The ownership and copyright of the FACIT System resides strictly with Dr. Cella. Dr. Cella has granted FACIT.org the right to license usage of the FACIT System to other parties). National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 Questionnaire FAC050 National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 (NCCN-FACT FOSI-18 V2) (Copyright 1987, 1997 David Cella, Ph.D. All Rights Reserved; Questionnaires and all related subscales, translations, and adaptations ('FACIT System') are owned and copyrighted by David Cella, Ph.D. The ownership and copyright of the FACIT System resides strictly with Dr. Cella. Dr. Cella has granted FACIT.org the right to license usage of the FACIT System to other parties). National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 Questionnaire FAC052 National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 (NCCN-FACT-FPSI 17 V2) (Copyright 2001 David Cella, Ph.D. All Rights Reserved; Questionnaires and all related subscales, translations, and adaptations ('FACIT System') are owned and copyrighted by David Cella, Ph.D. The ownership and copyright of the FACIT System resides strictly with Dr. Cella. Dr. Cella has granted FACIT.org the right to license usage of the FACIT System to other parties). National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 Questionnaire FAC032 National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index-16 Item Version 2 (NFBSI-16 V2) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved). National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index-16 Version 2 Questionnaire NPI-12 NPI1 Neuropsychiatric Inventory (NPI) (copyright JL Cummings, 1994, all rights reserved; permission for commercial use required; npiTEST.net). No part of the NPI may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the JL Cummings and payment of any applicable fees. Copyright JL Cummings, 1994, all rights reserved. Neuropsychiatric Inventory - 12 Item Version Questionnaire NPS01 Neuropathic Pain Scale (NPS) (copyright Brad Galer and Mark Jensen. All rights reserved.). Neuropathic Pain Scale Questionnaire NSCLC1 Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 (NSCLC-SAQ V1.0) (Version 1.0 Copyright 2015 Critical Path Institute. All Rights Reserved. McCarrier KP, Atkinson TM, DeBusk KP, Liepa AM, Scanlon M, Coons SJ and on behalf of the Patient-Reported Outcome Consortium. Qualitative Development and Content Validity of the Non-small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-reported Outcome Instrument. Clinical Therapeutics 2016; 38(4):794-810. Patient-Reported Outcome (PRO) Consortium - Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ) Provisional User Manual, Version 6: March 24, 2017). No part of the NSCLC-SAQ V1.0 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the Critical Path Institute and payment of any applicable fees. Copyright Critical Path Institute, 2018. All rights reserved). Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 NY1 National Youth Tobacco Survey (NYTS) 2022 Questionnaire (NYTS 2022) (Cooper M, Park-Lee E, Ren C, Cornelius M, Jamal A, Cullen KA. Notes from the Field: E-cigarette Use Among Middle and High School Students - United States, 2022. MMWR Morb Mortal Wkly Rep 2022;71:1283-1285. Park-Lee E, Ren C, Cooper M, Cornelius M, Jamal A, Cullen KA. Tobacco Product Use Among Middle and High School Students - United States, 2022. MMWR Morb Mortal Wkly Rep 2022;71:1429-1435. Office on Smoking and Health. 2020 National Youth Tobacco Survey: Methodology Report. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2020). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. National Youth Tobacco Survey 2022 Version Questionnaire OABQ02 The Overactive Bladder Questionnaire Short Form (OAB-q Short Form) (Karin S. Coyne, Christine L. Thompson, Jin-Shei Lai, and Chris C. Sexton. An Overactive Bladder Symptom and Health-Related Quality of Life Short-Form: Validation of the OAB-q SF. Neurourology and Urodynamics 34:255-263, 2015). The Overactive Bladder Questionnaire Short Form OABQ01 The Overactive Bladder Questionnaire (OAB-q) (Coyne K, Revicki D, Hunt T, et al. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res. Sep 2002; 11(6):563-574). The Overactive Bladder Questionnaire OCI01 Ocular Comfort Index (OCI) (The copyright owner of the Ocular Comfort Index is Dr. Michael Edward Johnson. Michael E. Johnson and Paul J. Murphy. Measurement of Ocular Surface Irritation on a Linear Interval Scale with the Ocular Comfort Index. Investigative Ophthalmology and Visual Science, October 2007, Vol. 48, No.10). Ocular Comfort Index Questionnaire ODI01 The Oswestry Disability Index Version 2.1a (ODI v2.1A) (copyright 1980 Jeremy Fairbank. All Rights Reserved.). The Oswestry Disability Index Version 2.1a Questionnaire OGI01 Observer Global Impression (OGI) generic modification for any disease/condition concept use case (Modified from Guy W: ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: U.S. Department of Health, Education, and Welfare; 1976). Observer Global Impression Generic Modification Version Questionnaire DDS02 Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes (PARENT-DDS) (Hessler D, Fisher L, Polonsky W, Johnson N. Understanding the Areas and Correlates of Diabetes-Related Distress in Parent of Teens With Type 1 Diabetes. Journal of Pediatric Psychology 2016; 41(7): 750-758). Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes Questionnaire DDS03 Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes (PARTNER-DDS) (Polonsky WH, Fisher L, Hessler D, Johnson N. Emotional Distress in the Partners of Type 1 Diabetes Adults: Worries About Hypoglycemia and Other Key Concerns. Diabetes Technology & Therapeutics May 2016; 18(5): 292-297). Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes Questionnaire PCL01 The PTSD Checklist for DSM-5 (PCL-5) (Weathers, F.W., Litz, B. T., Keane, T. M., Palmieri, P. A., Marx, B. P., & Schnurr, P. P. (2013). The PTSD Checklist for DSM-5 (PCL-5). Retrieved from the National Center for PTSD website: http://www.ptsd.va.gov). The PTSD Checklist for DSM-5 Questionnaire PDAI01 Perianal Crohn's Disease Activity Index (PDAI) (Irvine EJ. Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group. J Clin Gastroenterol. 1995;20(1):27-32. Perianal Disease Activity Index, authored by Dr. Jan Irvine, was made under license from McMaster University, Hamilton, Canada (Copyright 1995, McMaster University). The PDAI is provided under license from McMaster University and may not be copied, distributed or used in any way without the prior written consent of McMaster University. Contact the McMaster Industry Liaison Office at: milo at mcmaster.ca for licensing details). Perianal Crohn's Disease Activity Index Questionnaire PDDS01 Patient Determined Disease Steps (PDDS) (Hohol MJ, Orav EJ, Weiner HL. Disease Steps in multiple sclerosis: A simple approach to evaluate disease progression. Neurology 1995; 45: 251-55). (Hohol MJ, Orav EJ, Weiner HL. Disease Steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression. Multiple Sclerosis 1999; 5: 349-54). (Marrie RA and Goldman M. Validity of performance scales for disability assessment in multiple sclerosis. Multiple Sclerosis 2007; 13: 1176-1182). (The PDDS and/or PS are provided for use by the NARCOMS Registry: www.narcoms.org/pdds. NARCOMS is supported in part by the Consortium of Multiple Sclerosis Centers (CMSC) and the CMSC Foundation). Patient Determined Disease Steps Questionnaire PD01 Parkinson's Disease Questionnaire-39 (PDQ-39) (Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res. 1995 Jun;4(3):241-8. PDQ-39 copyright Oxford University Innovation Limited 1993. All Rights Reserved. The authors, being Professor Crispin Jenkinson, Professor Ray Fitzpatrick and Ms. Viv Peto, have asserted their moral rights). No part of the Parkinson's Disease Questionnaire-39 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the Oxford University Innovation Limited and payment of any applicable fees. Copyright Oxford University Innovation Limited 1993. All Rights Reserved. Parkinson's Disease Questionnaire-39 PDQ01 Parkinson's Disease Quality of Life Scale (PDQUALIF) (Welsh M, McDermott MP, Holloway RG, Plumb S, Pfeiffer R, Hubble J, and The Parkinson Study Group. Development and Testing of the Parkinson's Disease Quality of Life Scale. Movement Disorders, 2003, Vol. 18; 637-645). Parkinson's Disease Quality of Life Scale Questionnaire FAC099 Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue (PEDS-FACIT-F) (Copyright 1987, 1997 David Cella, Ph.D. All Rights Reserved; Questionnaires and all related subscales, translations, and adaptations ('FACIT System') are owned and copyrighted by David Cella, Ph.D. The ownership and copyright of the FACIT System resides strictly with Dr. Cella. Dr. Cella has granted FACIT.org the right to license usage of the FACIT System to other parties). Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue Questionnaire PQL15 Pediatric Quality of Life (PedsQL) Neuromuscular Module Acute Version 3 Child Parent Report (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Parent Report for Child Questionnaire PQL14 Pediatric Quality of Life (PedsQL) Neuromuscular Module Acute Version 3 Child (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Child Report Questionnaire PQL13 Pediatric Quality of Life (PedsQL) Neuromuscular Module Acute Version 3 Teen Parent Report (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Parent Report for Teen Questionnaire PQL12 Pediatric Quality of Life (PedsQL) Neuromuscular Module Acute Version 3 Teen (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Teen Report Questionnaire PQL18 Pediatric Quality of Life (PedsQL) Neuromuscular Module Acute Version 3 Toddler Parent Report (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Parent of Toddler Questionnaire PQL11 Pediatric Quality of Life (PedsQL) Neuromuscular Module Acute Version 3 Young Adult Parent Report (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults Questionnaire PQL10 Pediatric Quality of Life (PedsQL) Neuromuscular Module Acute Version 3 Young Adult (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Young Adult Report Questionnaire PQL17 Pediatric Quality of Life (PedsQL) Neuromuscular Module Acute Version 3 Young Child Parent Report (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Parent Report for Young Child Questionnaire PQL16 Pediatric Quality of Life (PedsQL) Neuromuscular Module Acute Version 3 Young Child (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Young Child Report Questionnaire PQL06 Pediatric Quality of Life (PedsQL) Neuromuscular Module Version 3 Child Parent Report (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). Pediatric Quality of Life Neuromuscular Module Version 3.0 Parent Report for Child Questionnaire PQL05 Pediatric Quality of Life (PedsQL) Neuromuscular Module Version 3 Child (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). Pediatric Quality of Life Neuromuscular Module Version 3.0 Child Report Questionnaire PQL04 Pediatric Quality of Life (PedsQL) Neuromuscular Module Version 3 Teen Parent Report (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). Pediatric Quality of Life Neuromuscular Module Version 3.0 Parent Report for Teen Questionnaire PQL03 Pediatric Quality of Life (PedsQL) Neuromuscular Module Version 3 Teen (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). Pediatric Quality of Life Neuromuscular Module Version 3.0 Teen Report Questionnaire PQL09 Pediatric Quality of Life (PedsQL) Neuromuscular Module Version 3 Toddler Parent Report (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). Pediatric Quality of Life Neuromuscular Module Version 3.0 Parent of Toddler Questionnaire PQL02 Pediatric Quality of Life (PedsQL) Neuromuscular Module Version 3 Young Adult Parent Report (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). Pediatric Quality of Life Neuromuscular Module Version 3.0 Parent Report for Young Adults Report Questionnaire PQL01 Pediatric Quality of Life (PedsQL) Neuromuscular Module Version 3 Young Adult (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). Pediatric Quality of Life Neuromuscular Module Version 3.0 Young Adult Report Questionnaire PQL08 Pediatric Quality of Life (PedsQL) Neuromuscular Module Version 3 Young Child Parent Report (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). Pediatric Quality of Life Neuromuscular Module Version 3.0 Parent Report for Young Child Questionnaire PQL07 Pediatric Quality of Life (PedsQL) Neuromuscular Module Version 3 Young Child (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). Pediatric Quality of Life Neuromuscular Module Version 3.0 Young Child Report Questionnaire PGI01 Patient Global Impression (PGI) generic modification for any disease/condition concept use case (Modified from Guy W: ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: U.S. Department of Health, Education, and Welfare; 1976). Patient Global Impression Generic Modification Version Questionnaire PHQ03 Patient Health Questionnaire Screener Version (PHQ Screener) (Spitzer RL, Kroenke K, Williams JBW, for the Patient Health Questionnaire Primary Care Study Group. Validation and utility of a self-report version of PRIME-MD: the PHQ Primary Care Study. JAMA 1999;282:1737-1744. http://www.phqscreeners.com/instructions/instructions.pdf). Patient Health Questionnaire Screener Version PHQ02 Patient Health Questionnaire - 15 (PHQ-15) (Kroenke K, Spitzer RL, Williams JBW. The PHQ-15: Validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002; 64:258-266). Patient Health Questionnaire - 15 Item PHQ04 Patient Health Questionnaire-2 (PHQ-2) (Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: Validity of a Two-Item Depression Screener. Medical Care. 2003;41:1284-92). Patient Health Questionnaire-2 PHQ05 The Patient Health Questionnaire - 8 (PHQ-8) (Kroenke, K, Strine, TW, Spitzer, RL, Williams, JBW, Berry, JT, Mokdad, AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord. 2009 Apr;114(1-3):163-73). These materials discuss and/or include the Patient Health Questionnaire - 8 (PHQ-8) which is owned exclusively by the Pfizer. Inc. Use of the PHQ-8 is subject to Pfizer. Inc. terms of use. See (https://www.phqscreeners.com/select-screener PHQ-8 copyright 2009, Pfizer. Inc. The Patient Health Questionnaire - 8 Item PHQ01 Patient Health Questionnaire - 9 (PHQ-9) (Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med 2001; 16:606-613). Patient Health Questionnaire - 9 Item PI01 Pain Intensity (PI) (STANDARDS, Standardized Analgesic Database for Research, Discovery, and Submissions, and sponsored by ACTTION, Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks. www.acttion.org; 2012-08-07 v1. Handbook of Pain Assessment, Third Edition [Hardcover] Chapter 2 - Self-Report Scales and Procedures for Assessing Pain in Adults: Dennis C. Turk PhD (Editor), Ronald Melzack PhD (Editor)). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. STANDARDS Pain Intensity Questionnaire PODCI2 Pediatric Outcomes Data Collection Instrument (PODCI), Adolescent Parent-Reported (Daltroy LH, Liang MH, Fossel AH, Goldberg MJ, and The Outcomes Instrument Development Work Group. The POSNA Pediatric Musculoskeletal Functional Health Questionnaire:report on reliability, validity, and sensitivity to change. J Pediatr Orthop 1998; 18: 561-71). Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported Version Questionnaire PODCI3 Pediatric Outcomes Data Collection Instrument (PODCI), Adolescent Self-Reported (Daltroy LH, Liang MH, Fossel AH, Goldberg MJ, and The Outcomes Instrument Development Work Group. The POSNA Pediatric Musculoskeletal Functional Health Questionnaire:report on reliability, validity, and sensitivity to change. J Pediatr Orthop 1998; 18: 561-71). Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported Version Questionnaire PODCI1 Pediatric Outcomes Data Collection Instrument (PODCI), Pediatric Parent-Reported (Daltroy LH, Liang MH, Fossel AH, Goldberg MJ, and The Outcomes Instrument Development Work Group. The POSNA Pediatric Musculoskeletal Functional Health Questionnaire: report on reliability, validity, and sensitivity to change. J Pediatr Orthop 1998; 18: 561-71). Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported Version Questionnaire PR01 Pain Relief (PR) (STANDARDS, Standardized Analgesic Database for Research, Discovery, and Submissions, and sponsored by ACTTION, Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks. www.acttion.org; 2012-08-07 v1. Handbook of Pain Assessment, Third Edition [Hardcover] Chapter 2 - Self-Report Scales and Procedures for Assessing Pain in Adults: Dennis C. Turk PhD (Editor), Ronald Melzack PhD (Editor)). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. STANDARDS Pain Relief Questionnaire PT01 Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Library Version 1.0 (PRO-CTCAE V1.0) (The PRO-CTCAE trademark items and information herein were developed by the Division of Cancer Control and Population Sciences in the National Cancer Institute at the National Institutes of Health, in Bethesda, Maryland, U.S.A. Use of the PRO-CTCAE is subject to NCI's "Terms of Use". PRO-CTCAE Measurement System content should be downloaded using the "Instrument & Form Builder". https://healthcaredelivery.cancer.gov/pro-ctcae/. Basch E, Reeve BB, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, Mendoza TR, Hay J, Atkinson TM, Abernethy AP, Bruner DW, Cleeland CS, Sloan JA, Chilukuri R, Baumgartner P, Denicoff A, St Germain D, O'Mara AM, Chen A, Kelaghan J, Bennett AV, Sit L, Rogak L, Barz A, Paul DB, Schrag D. Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).J Natl Cancer Inst 2014 Sep 29;106(9). National Institutes of Health - National Cancer Institute, Division of Cancer Control & Population Sciences. (2017, July 2) https://healthcaredelivery.cancer.gov/pro-ctcae/overview.html). These materials discuss and/or include the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Library Version 1.0 (PRO-CTCAE V1.0) which is owned exclusively by the Division of Cancer Control and Population Sciences in the National Cancer Institute (NCI) at the National Institutes of Health (NIH). No part of the PRO-CTCAE V1.0 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying recording, or other electronic or mechanical methods, without the prior written permission of NCI and payment of any applicable fees. PRO-CTCAE V1.0 copyright, National Cancer Institute at the National Institutes of Health. All rights reserved. Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 Questionnaire PA136 PROMIS Item Bank v1.0 - Fatigue - Short Form 7a (PROMIS IB V1.0 FATIGUE SF 7A) (These materials discuss and/or include the PROMIS system of measures which is owned by the PROMIS Health Organization (PHO)). No part of the PHO system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the PHO. All rights reserved. PROMIS Item Bank Version 1.0 Fatigue Short Form 7a Questionnaire PA215 PROMIS Item Bank v1.0 - Sleep Disturbance - Short Form 4a (PROMIS IB V1.0 SLEEP DISTURANCE SF 4A) (These materials discuss and/or include the PROMIS system of measures which is owned by the PROMIS Health Organization (PHO)). No part of the PHO system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the PHO. All rights reserved. PROMIS Item Bank v1.0 - Sleep Disturbance - Short Form 4a Questionnaire PA020 PROMIS Item Bank v2.0 - Cognitive Function - Abilities Subset - Short Form 6a (PROMIS IB V2.0 COGNITIVE FUNCTION ABILITIES SF 6A) (These materials discuss and/or include the PROMIS system of measures which is owned by the PROMIS Health Organization (PHO). No part of the PHO system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the PHO. All rights reserved.) PROMIS Item Bank v2.0 - Cognitive Function - Abilities Subset - Short Form 6a Questionnaire PA016 PROMIS Item Bank v2.0 - Cognitive Function - Short Form 6a (PROMIS IB V2.0 COGNITIVE FUNCTION SF 6A) (These materials discuss and/or include the PROMIS system of measures which is owned by the PROMIS Health Organization (PHO)). No part of the PHO system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the PHO. All rights reserved. PROMIS Item Bank Version 2.0 Cognitive Function Short Form 6a Questionnaire PA261 PROMIS-29 Profile v2.1 (PROMIS-29 PROFILE V2.1) (These materials discuss and/or include the PROMIS system of measures which is owned by the PROMIS Health Organization (PHO). No part of the PHO system of measures may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the PHO. All rights reserved.) PROMIS-29 Profile Version 2.1 Questionnaire PROS01 Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) (Stockler MR, Osoba D, Corey P, Goodwin PJ, Tannock IF. Convergent discriminitive, and predictive validity of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) assessment and comparison with analogous scales from the EORTC QLQ-C30 and a trial-specific module. European Organisation for Research and Treatment of Cancer. Core Quality of Life Questionnaire. JClinEpidemiol 1999;52:653-66) Prostate Cancer Specific Quality of Life Instrument Questionnaire Penn State Nicotine Dependence Index PSECD1 Penn State Electronic Cigarette Dependence Index (PSECDI) (Jonathan Foulds, Susan Veldheer, Jessica Yingst, Shari Hrabovsky, Stephen J. Wilson, Travis T. Nichols, Thomas Eissenberg, Development of a Questionnaire for Assessing Dependence on Electronic Cigarettes Among a Large Sample of Ex-Smoking E-cigarette Users, Nicotine & Tobacco Research, Volume 17, Issue 2, February 2015, Pages 186-192, https://doi.org/10.1093/ntr/ntu204). No part of the PSECDI may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. Jonathan Foulds and payment of any applicable fees. Copyright Dr. Jonathan Foulds 2011. All rights reserved. Penn State Electronic Cigarette Dependence Index Questionnaire PSQI1 Pittsburgh Sleep Quality Index (PSQI) (Copyright 1989, University of Pittsburgh. Buysse,D.J., Reynolds,C.F., Monk,T.H., Berman,S.R., & Kupfer, D.J. The Pittsburgh Sleep Quality Index (PSQI): A new instrument for psychiatric practice and research. Psychiatry Research, 1989, 28(2):193-213). Pittsburgh Sleep Quality Index QLES1 Quality Of Life Enjoyment And Satisfaction Questionnaire (Q-LES-Q) (Copyright Jean Endicott, PhD; Unit 123, 1051 Riverside Drive, New York, NY 10032. 212-543-5536; Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull. 1993;29(2):321-6). Quality Of Life Enjoyment And Satisfaction Questionnaire QLES2 Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form (Q-LES-Q-SF) (Copyright Jean Endicott, PhD; Unit 123, 1051 Riverside Drive, New York, NY 10032. 212-543-5536; Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull. 1993;29(2):321-6). Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form QIDSR1 Quick Inventory of Depressive Symptomatology - Self-Report (QIDS-SR) (Copyright UT Southwestern Medical Center at Dallas. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB. The 16-item Quick Inventory of Depressive Symptomatology (QIDS) Clinician Rating (QIDS-C) and Self-Report (QIDS-SR): A psychometric evaluation in patients with chronic major depression. Biological Psychiatry, 54:573-583, 2003). Quick Inventory of Depressive Symptomatology Self-Report Version Questionnaire QSUB01 Questionnaire on Smoking Urges-Brief (QSU-BRIEF) (Cox, L. S., Tiffany, S. T., & Christen, A. G. (2001). Evaluation of the brief questionnaire of smoking urges (QSU-Brief) in laboratory and clinical settings. Nicotine and Tobacco Research, 3, 7-16). These materials discuss and/or include the Questionnaire on Smoking Urges-Brief (QSU-Brief), which are owned exclusively by Stephen T Tiffany. No part of the Questionnaire on Smoking Urges-Brief (QSU-Brief) may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Stephen T Tiffany and payment of any applicable fees. Copyright Stephen T Tiffany. All rights reserved. Brief Questionnaire of Smoking Urges RSSS01 RAND Social Support Survey Instrument (Copyright the RAND Corporation. Developed at RAND as part of the Medical Outcomes Study). RAND Social Support Survey Instrument Questionnaire R3601 RAND 36-Item Health Survey 1.0 (RAND-36) (Copyright the RAND Corporation. Developed at RAND as part of the Medical Outcomes Study). RAND 36-Item Health Survey 1.0 Questionnaire RBD1 REM Sleep Behavior Disorder Screening Questionnaire (RBDSQ) (Stiasny-Kolster K, Mayer G, Schafer S, Moller JC, Heinzel-Gutenbrunner M, Oertel WH. The REM sleep behavior disorder screening questionnaire--a new diagnostic instrument. Mov Disord. 2007 Dec;22(16):2386-93. RBDSQ 2007 International Parkinson and Movement Disorder Society (MDS). All Rights Reserved). No part of the REM Sleep Behavior Disorder Screening Questionnaire may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of International Parkinson and Movement Disorder Society and payment of any applicable fees. Copyright International Parkinson and Movement Disorder Society 2007. All Rights Reserved. REM Sleep Behavior Disorder Screening Questionnaire RDQ01 Roland Morris Disability Questionnaire (RDQ) (Roland MO, Morris RW. A study of the natural history of back pain. Part 1: Development of a reliable and sensitive measure of disability in low back pain. Spine 1983;8:141-144). Roland Morris Disability Questionnaire RPQ01 Rivermead Post Concussion Symptoms Questionnaire (RPQ) (King NS, Crawford S, Wenden FJ, Moss NEG, Wade DT. The Rivermead Post Concussion Symptoms Questionnaire: a measure of symptoms commonly experienced after head injury and its reliability. J Neurol. 1995;242:587-592). Rivermead Post-Concussion Symptoms Questionnaire SP1 Scales for Outcomes in Parkinson's Disease - Autonomic Dysfunction (SCOPA-AUT) (Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ. Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT. Mov Disord 2004;19:1306-12. Copyright 2019 International Parkinson and Movement Disorder Society. All rights reserved.). No part of the Scales for Outcomes in Parkinson's Disease - Autonomic Dysfunction may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the International Parkinson and Movement Disorder Society and payment of any applicable fees. Copyright International Parkinson and Movement Disorder Society 2019. All rights reserved. Scales for Outcomes in Parkinson's Disease - Autonomic Dysfunction Questionnaire SDS01 Sheehan Disability Scale (Copyright 1983, 2010, 2011 David V. Sheehan. All rights reserved.). Sheehan Disability Scale Questionnaire SF102 The Short Form 10 Health Survey for Children, Acute, US Version 1.0 (SF10 v1.0 CHILDREN ACUTE) (copyright 2001, 2005, 2011 QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric Incorporated and payment of any applicable fees. Copyright QualityMetric Incorporated. All rights reserved. Short Form 10 Health Survey for Children Acute, US Version 1.0 Questionnaire SF101 The Short Form 10 Health Survey for Children, Standard, US Version 1.0 (SF10 v1.0 CHILDREN STANDARD) (copyright 2001, 2005 QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric Incorporated and payment of any applicable fees. Copyright QualityMetric Incorporated. All rights reserved. Short Form 10 Health Survey for Children Standard, US Version 1.0 Questionnaire SF122 The Short Form 12 Health Survey, Acute, US Version 1.0 (SF12 v1.0 ACUTE) (copyright 1994, 2002 by Medical Outcomes Trust and QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric Incorporated and payment of any applicable fees. Copyright QualityMetric Incorporated. All rights reserved. Short Form 12 Health Survey Acute, US Version 1.0 Questionnaire SF121 The Short Form 12 Health Survey, Standard, US Version 1.0 (SF12 v1.0 STANDARD) (copyright 1994, 2002 by Medical Outcomes Trust and QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric Incorporated and payment of any applicable fees. Copyright QualityMetric Incorporated. All rights reserved. Short Form 12 Health Survey Standard, US Version 1.0 Questionnaire SF124 The Short Form 12 Health Survey, Acute, US Version 2.0 (SF12 v2.0 ACUTE) (copyright 1994, 2002 Medical Outcomes Trust and QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric Incorporated and payment of any applicable fees. Copyright QualityMetric Incorporated. All rights reserved. Short Form 12 Health Survey Acute, US Version 2.0 Questionnaire SF123 The Short Form 12 Health Survey, Standard, US Version 2.0 (SF12 v2.0 STANDARD) (copyright 1994, 2002 Medical Outcomes Trust and QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric Incorporated and payment of any applicable fees. Copyright QualityMetric Incorporated. All rights reserved. Short Form 12 Health Survey Standard, US Version 2.0 Questionnaire SF362 The Short Form 36 Health Survey Acute, US Version 1.0 (SF36 V1.0 ACUTE) (copyright 1988, 2002 by Medical Outcomes Trust and QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric Incorporated and payment of any applicable fees. Copyright QualityMetric Incorporated. All rights reserved. Short Form 36 Health Survey Acute, US Version 1.0 Questionnaire SF361 The Short Form 36 Health Survey Standard, US Version 1.0 (SF36 V1.0 STANDARD) (copyright 1988, 2002 by Medical Outcomes Trust and QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric Incorporated and payment of any applicable fees. Copyright QualityMetric Incorporated. All rights reserved. Short Form 36 Health Survey Standard, US Version 1.0 Questionnaire SF364 The Short Form 36 Health Survey Acute, US Version 2.0 (SF36 V2.0 ACUTE) (copyright 1992, 1996, 2000 Medical Outcomes Trust and QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric Incorporated and payment of any applicable fees. Copyright QualityMetric Incorporated. All rights reserved. Short Form 36 Health Survey Acute, US Version 2.0 Questionnaire SF363 The Short Form 36 Health Survey Standard, US Version 2.0 (SF36 V2.0 STANDARD) (copyright 1992, 1996, 2000 Medical Outcomes Trust and QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric Incorporated and payment of any applicable fees. Copyright QualityMetric Incorporated. All rights reserved. Short Form 36 Health Survey Standard, US Version 2.0 Questionnaire SF6D2 SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) (copyright 2021 QualityMetric Incorporated, LLC. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated, LLC. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric and payment of any applicable fees. Copyright QualityMetric Incorporated, LLC. All rights reserved. SF-6Dv2 Health Utility Survey Acute, English Version 2.0 Questionnaire SF6D1 SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) (copyright 2021 QualityMetric Incorporated, LLC. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated, LLC. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric and payment of any applicable fees. Copyright QualityMetric Incorporated, LLC. All rights reserved. SF-6Dv2 Health Utility Survey Standard, English Version 2.0 Questionnaire SF82 The Short Form 8 Health Survey, Acute, US Version 1.0 (SF8 v1.0 ACUTE) (copyright 1999, 2001 QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric Incorporated and payment of any applicable fees. Copyright QualityMetric Incorporated. All rights reserved. Short Form 8 Health Survey Acute, US Version 1.0 Questionnaire SF81 The Short Form 8 Health Survey, Standard, US Version 1.0 (SF8 v1.0 STANDARD) (copyright 1998, 1999 QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric Incorporated and payment of any applicable fees. Copyright QualityMetric Incorporated. All rights reserved. Short Form 8 Health Survey Standard, US Version 1.0 Questionnaire SGRQ01 St. George's Respiratory Questionnaire (SGRQ) Past 3 Months Version (copyright P.W. Jones, St. George's University of London). St. George's Respiratory Questionnaire Past 3 Months Version SGRQ02 St. George's Respiratory Questionnaire (SGRQ) Past 4 Weeks Version (copyright P.W. Jones, St. George's University of London). St. George's Respiratory Questionnaire Past 4 Weeks Version SGRQC1 St. George's Respiratory Questionnaire for COPD Patients (SGRQ-C) (Jones PW, Quirk FH, Baveystock CM, and Littlejohns PA. Self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis. 1992 Jun; 145(6):1321-7). St. George's Respiratory Questionnaire for Chronic Obstructive Pulmonary Disease Patients SFMP2 Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2) (Copyright R. Melzack and the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT), 2009, All Rights Reserved). Short-Form McGill Pain Questionnaire-2 SIQ01 Suicidal Ideation Questionnaire (SIQ) (Copyright 1987 Psychological Assessment Resources, Inc. (PAR). All rights reserved. May not be reproduced in whole or in part in any form or by any means without written permission of Psychological Assessment Resources, Inc.). Suicidal Ideation Questionnaire SIQ02 Suicidal Ideation Questionnaire-JR (SIQ-JR) (Copyright 1987 Psychological Assessment Resources, Inc. (PAR). All rights reserved. May not be reproduced in whole or in part in any form or by any means without written permission of Psychological Assessment Resources, Inc.). Suicidal Ideation Questionnaire-Junior SIQR01 Symptom Impact Questionnaire (SIQR) (copyright 2009 Bennett RM and Friend. All Rights Reserved.). Symptom Impact Questionnaire SMDDS1 Symptoms of Major Depressive Disorder Scale v1.0 (SMDDS V1.0) (Version 1.0 Copyright 2015 Critical Path Institute. All Rights Reserved. McCarrier KP, Deal LS, Abraham L, Blum SI, Bush EN, Martin M, Thase ME, Coons SJ on behalf of the Patient-Reported Outcome Consortium's Depression Working Group. Patient-centered research to support the development of the Symptoms of Major Depressive Disorder Scale (SMDDS): initial qualitative research. The Patient-Patient-Centered Outcomes Research 2016;9:117-134. Patient-Reported Outcome (PRO) Consortium - Symptoms of Major Depressive Disorder Scale (SMDDS) User Manual, Version 1: October 31, 2017). No part of the SMDDS V1.0 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the Critical Path Institute and payment of any applicable fees. Copyright Critical Path Institute, 2018. All rights reserved). Symptoms of Major Depressive Disorder Scale v1.0 Questionnaire SOAPR1 Screener and Opioid Assessment for Patients with Pain Revised (SOAPP-R) (copyright 2007 Inflexxion, Inc., All rights reserved). Screener and Opioid Assessment for Patients with Pain Revised Questionnaire SOBDA1 Shortness of Breath with Daily Activities Questionnaire (SOBDA) (Wilcox TK, Chen WH, Howard KA, Wiklund I, Brooks J, Watkins ML, Cates CE, Tabberer MM, Crim C. Item selection, reliability and validity of the Shortness of Breath with Daily Activities (SOBDA) questionnaire: a new outcome measure for evaluating dyspnea in chronic obstructive pulmonary disease. Health and Quality of Life Outcomes 2013 11:196). Shortness of Breath with Daily Activities Questionnaire SOWSB1 Short Opiate Withdrawal Scale (SOWS SHORT) (Gossop, M. The development of a short opiate withdrawal scale. Addictive Behaviors 1990; 15:487-490). Short Opiate Withdrawal Scale Questionnaire SOWSA1 The Subjective Opiate Withdrawal Scale (SOWS) (Handelsman, L., Cochrane, K. J., Aronson, M. J. Ness, R., Rubinstein K.J., Kanof, P.D. (1987) Two New Rating Scales for Opiate Withdrawal. American Journal of Alcohol Abuse, 13, 293-308). Subjective Opiate Withdrawal Scale Questionnaire SSS01 Stanford Sleepiness Scale (SSS) (Hoddes E, Dement W, Zarcone V. The development and use of the Stanford Sleepiness Scale (SSS). Psychophysiology 1971;9:150. Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC. Quantification of sleepiness: a new approach. Psychophysiology. 1973 Jul;10(4):431-6). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. Stanford Sleepiness Scale Questionnaire SWLS01 The Satisfaction With Life Scale (SWLS) (Diener, E., Emmons, R., Larsen, J., and Griffin, S. (1985). The Satisfaction With Life Scale. J Personality Assessment, 49(1): 71-75). Satisfaction With Life Scale Questionnaire DDS01 Diabetes Distress Scale for Adults with Type 1 Diabetes (T1-DDS) (Fisher L, Polonsky WH, Hessler DM, Masharani U, Blumer I, Peters AL, Strycker LA, Bowyer V. Understanding the sources of diabetes distress in adults with type 1 diabetes. J Diabetes Complications 2015; 29(4): 572-7). Diabetes Distress Scale for Adults with Type 1 Diabetes Questionnaire TSCC01 Trauma Symptom Checklist for Children (TSCC) (Copyright 1989, 1996 by PAR. All rights reserved. May not be reproduced in whole or in part in any form or by any means without written permission of PAR). Trauma Symptom Checklist for Children Questionnaire TSCYC1 Trauma Symptom Checklist for Young Children (TSCYC) (Copyright 1999, 2005 by Psychological Assessment Resources, Inc. (PAR). All rights reserved. May not be reproduced in whole or in part in any form or by any means without written permission of Psychological Assessment Resources, Inc). Trauma Symptom Checklist for Young Children Questionnaire TSQM01 Treatment Satisfaction Questionnaire for Medication - Version 1.4 (TSQM V1.4) (Copyright 2004, Quintiles. All Rights Reserved). Treatment Satisfaction Questionnaire for Medication Version 1.4 UPS01 Urgency Perception Scale (UPS) (copyright Pfizer. All rights reserved.). Urgency Perception Scale Questionnaire VFQ1 National Eye Institute Visual Functioning Questionnaire - 25 (VFQ-25) Version 2000 Interviewer-Administered Format (Mangione, C. M., Lee, P. P., Gutierrez, P. R., Spritzer, K., Berry, S., & Hays, R. D. Development of the 25-item National Eye Institute Visual Function Questionnaire (VFQ-25). Archives of Ophthalmology. 2001; 119:1050-1058). (This instrument was developed at RAND under the sponsorship of the National Eye Institute). Visual Functioning Questionnaire 25-Interviewer Administered Format Version 2000 VFQ2 National Eye Institute Visual Functioning Questionnaire - 25 (VFQ-25) Version 2000 Self-Administered Format (Mangione, C. M., Lee, P. P., Gutierrez, P. R., Spritzer, K., Berry, S., & Hays, R. D. Development of the 25-item National Eye Institute Visual Function Questionnaire (VFQ-25). Archives of Ophthalmology. 2001; 119:1050-1058). (This instrument was developed at RAND under the sponsorship of the National Eye Institute). Visual Functioning Questionnaire 25-Self Administered Format Version 2000 VHI01 Voice Handicap Index (VHI) (Development and Validation. Barbara H. Jacobson, Alex Johnson, Cynthia Grywalski, Alice Silbergleit, Gary Jaconsen, Michael S. Benninger. American Journal of Speech-Language Pathology, Vol 6(3), 66-70, 1997. The Voice Handicap Index is reprinted with permission from all authors and ASHA. Copyright 1997-2001 American Speech-Language-Hearing Association). No part of the VHI may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the authors and American Speech-Language-Hearing Association and payment of any applicable fees. Copyright American Speech-Language-Hearing Association 1997-2001. All rights reserved. Voice Handicap Index WD4 World Health Organization Disability Assessment Schedule 2.0 - 12+24-item Version, Interviewer-administered (WHODAS 2.0 - 12+24-item Version Interviewer-administered) (Reproduced, with permission of WHO, from Measuring Health and Disability: Manual for WHO Disability Assessment Schedule (WHODAS 2.0). Geneva,World Health Organization, 2010 (WHODAS 2.0 12+24-Item Version, Interviewer-Administered www.who.int/classifications/icf/whodasii/en)). World Health Organization Disability Assessment Schedule 2.0 12+24-item Version Interviewer-administered Questionnaire WD1 World Health Organization Disability Assessment Schedule 2.0 - 12-item Version, Interviewer-administered (WHODAS 2.0 - 12-item Version Interviewer-administered) (Reproduced, with permission of WHO, from Measuring Health and Disability: Manual for WHO Disability Assessment Schedule (WHODAS 2.0). Geneva,World Health Organization, 2010 (WHODAS 2.0 12-Item Version, Interviewer-Administered www.who.int/classifications/icf/whodasii/en)). World Health Organization Disability Assessment Schedule 2.0 12-item Version Interviewer-administered Questionnaire WD2 World Health Organization Disability Assessment Schedule 2.0 - 12-item Version, Proxy-administered (WHODAS 2.0 - 12-item Version Proxy-administered) (Reproduced, with permission of WHO, from Measuring Health and Disability: Manual for WHO Disability Assessment Schedule (WHODAS 2.0). Geneva,World Health Organization, 2010 (WHODAS 2.0 12-Item Version, Proxy-Administered www.who.int/classifications/icf/whodasii/en)). World Health Organization Disability Assessment Schedule 2.0 12-item Version Proxy-administered Questionnaire WD3 World Health Organization Disability Assessment Schedule 2.0 - 12-item Version, Self-administered (WHODAS 2.0 - 12-item Version Self-administered) (Reproduced, with permission of WHO, from Measuring Health and Disability: Manual for WHO Disability Assessment Schedule (WHODAS 2.0). Geneva,World Health Organization, 2010 (WHODAS 2.0 12-Item Version, Self-Administered www.who.int/classifications/icf/whodasii/en)). World Health Organization Disability Assessment Schedule 2.0 12-item Version Self-administered Questionnaire WD5 World Health Organization Disability Assessment Schedule 2.0 - 36-item Version, Interviewer-administered (WHODAS 2.0 - 36-item Version Interviewer-administered) (Reproduced, with permission of WHO, from Measuring Health and Disability: Manual for WHO Disability Assessment Schedule (WHODAS 2.0). Geneva,World Health Organization, 2010 (WHODAS 2.0 36-Item Version, Interviewer-Administered www.who.int/classifications/icf/whodasii/en)). World Health Organization Disability Assessment Schedule 2.0 36-item Version Interviewer-administered Questionnaire WD6 World Health Organization Disability Assessment Schedule 2.0 - 36-item Version, Proxy-administered (WHODAS 2.0 - 36-item Version Proxy-administered) (Reproduced, with permission of WHO, from Measuring Health and Disability: Manual for WHO Disability Assessment Schedule (WHODAS 2.0). Geneva,World Health Organization, 2010 (WHODAS 2.0 36-Item Version, Proxy-Administered www.who.int/classifications/icf/whodasii/en)). World Health Organization Disability Assessment Schedule 2.0 36-item Version Proxy-administered Questionnaire WD7 World Health Organization Disability Assessment Schedule 2.0 - 36-item Version, Self-administered (WHODAS 2.0 - 36-item Version Self-administered) (Reproduced, with permission of WHO, from Measuring Health and Disability: Manual for WHO Disability Assessment Schedule (WHODAS 2.0). Geneva,World Health Organization, 2010 (WHODAS 2.0 36-Item Version, Self-Administered www.who.int/classifications/icf/whodasii/en)). World Health Organization Disability Assessment Schedule 2.0 36-item Version Self-administered Questionnaire WLQ01 Work Limitations Questionnaire (WLQ) (copyright 1998. The Health Institute, Tufts Medical Center f/k/a New England Medical Center Hospitals, Inc.; Debra Lerner, Ph.D.; Benjamin Amick III, Ph.D.; and GlaxoWellcome, Inc. All Rights Reserved). Work Limitations Questionnaire WOMAC1 Western Ontario and McMaster Universities Osteoarthritis Index Version 3.1 Likert Scale Format (WOMAC LK 3.1) (Bellamy N. WOMAC Osteoarthritis Index User Guide. Version V. Brisbane, Australia 2002; WOMAC 3.1 User Guide XI; WOMAC is a registered trade-mark. Copyright 2008. Prof Nicholas Bellamy. All Rights Reserved). Western Ontario and McMaster Universities Osteoarthritis Index Version 3.1 Likert Scale Format Questionnaire WOMAC2 Western Ontario and McMaster Universities Osteoarthritis Index Version 3.1 Numerical Rating Scale Format (WOMAC NRS 3.1) (Bellamy N. WOMAC Osteoarthritis Index User Guide. Version V. Brisbane, Australia 2002; WOMAC 3.1 User Guide XI; WOMAC is a registered trade-mark. Copyright 2008. Prof Nicholas Bellamy. All Rights Reserved). Western Ontario and McMaster Universities Osteoarthritis Index Version 3.1 Numerical Rating Scale Format Questionnaire WOMAC3 Western Ontario and McMaster Universities Osteoarthritis Index Version 3.1 Visual Analog Scale Format (WOMAC VA 3.1) (Bellamy N. WOMAC Osteoarthritis Index User Guide. Version V. Brisbane, Australia 2002; WOMAC 3.1 User Guide XI; WOMAC is a registered trade-mark. Copyright 2008. Prof Nicholas Bellamy. All Rights Reserved). Western Ontario and McMaster Universities Osteoarthritis Index Version 3.1 Visual Analog Scale Format Questionnaire WPAI02 The Work Productivity and Activity Impairment - General Health Version 2.0 (WPAI-GH V2.0) (Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics 1993; 4(5):353-65. http://www.reillyassociates.net/WPAI_GH.html. http://www.reillyassociates.net/WPAI_General.html). Work Productivity and Activity Impairment General Health V2.0 Questionnaire WPAI01 The Work Productivity and Activity Impairment - Specific Health Problems Questionnaire Version 2.0 (WPAI-SHP V2.0) (Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics 1993; 4(5):353-65. These materials discuss and/or include the Work Productivity and Activity Impairment Specific Health Problems Questionnaire Version 2.0 (WPAI-SHP V2.0), which is owned exclusively by Reilly Associates. Use of the WPAI-SHP is subject to Reilly Associates terms of use (See http://www.reillyassociates.net/WPAI_General.html). Work Productivity and Activity Impairment Specific Health Problems Version 2.0 Questionnaire QSCAT Category of Questionnaire CDISC Questionnaire Category Terminology Terminology relevant to the categories for tobacco product testing. A study or examination of a product's conformance to design parameters and features. Product Design Parameter Testing A study or examination of the presence and/or amount of harmful and potentially harmful constituents in tobacco products and smoke or aerosol. Harmful and Potentially Harmful Constituents Testing A study or examination of the parameters of a material or a product over storage time to determine product shelf life. Product Stability Testing PTCAT Category of Tobacco Product Testing CDISC SDTM Category of Product Testing Terminology A terminology codelist relevant to the categories for tobacco products. Any product that is considered as a comparator to the product under review. A comparison product is not a new, predicate, or original product and is used by the applicant to provide information or data as part of an application. Comparison Tobacco Product Any tobacco product (including those products in test markets) that was not commercially marketed in the United States as of February 15, 2007; or (B) any modification (including a change in design, any component, any part, or any constituent, including a smoke constituent, or in the content, delivery or form of nicotine, or any other additive or ingredient) of a tobacco product where the modified product was commercially marketed in the United States after February 15, 2007. (FDA CTP) New Tobacco Product A product that can be legally marketed and that the manufacturer will compare a new product in an EX Report to (either a pre-existing product or a product that has previously received an SE, PMTA, or EX Order). (FDA CTP) Original Tobacco Product Grandfathered Tobacco Product Pre-Existing Tobacco Product A tobacco product that the manufacturer will compare a new product in an SE Report to (either a pre-existing product or a product that has previously received an SE Order). (FDA CTP) Predicate Tobacco Product TOCAT Category of Tobacco Products CDISC SDTM Category of Tobacco Products Terminology Terminology relevant to the test codes that describe findings about Clostridium difficile-associated diarrhea event or intervention. Number of Episodes The total number of episodes that have occurred for the condition. Number of Episodes Severity/Intensity The degree of something undesirable. Severity Volume A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. Volume Measurement CDFATSCD CDAD Findings About Test Code CDISC SDTM CDAD Findings About Test Code Terminology Terminology relevant to the test names that describe findings about Clostridium difficile-associated diarrhea event or intervention. Number of Episodes The total number of episodes that have occurred for the condition. Number of Episodes Severity/Intensity The degree of something undesirable. Severity Volume A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. Volume Measurement CDFATS CDAD Findings About Test Name CDISC SDTM CDAD Findings About Test Name Terminology CDC Classification System for HIV-Infected Adults and Adolescents test code. CHIVC1-CDC HIV Infection Category CDC Classification System for HIV-Infected Adults and Adolescents - CDC HIV infection category. CDC Classification System for HIV-Infected Adults and Adolescents - CDC HIV Infection Category CHIVC1TC CDC Classification System for HIV-Infected Adults and Adolescents Clinical Classification Test Code CDISC Clinical Classification CDC Classification System for HIV-Infected Adults and Adolescents Test Code Terminology CDC Classification System for HIV-Infected Adults and Adolescents test name. CHIVC1-CDC HIV Infection Category CDC Classification System for HIV-Infected Adults and Adolescents - CDC HIV infection category. CDC Classification System for HIV-Infected Adults and Adolescents - CDC HIV Infection Category CHIVC1TN CDC Classification System for HIV-Infected Adults and Adolescents Clinical Classification Test Name CDISC Clinical Classification CDC Classification System for HIV-Infected Adults and Adolescents Test Name Terminology A terminology codelist relevant to the name and version of the CDISC therapeutic area user guide that is being used in the study submission. Version 1.0 of the CDISC Acute Kidney Injury therapeutic area user guide. CDISC Acute Kidney Injury Therapeutic Area User Guide v1.0 Version 1.0 of the CDISC Alzheimer's therapeutic area user guide. CDISC Alzheimer's Therapeutic Area User Guide Version 1.0 Version 2.0 of the CDISC Alzheimer's therapeutic area user guide. CDISC Alzheimer's Therapeutic Area User Guide Version 2.0 Version 1.0 of the CDISC Asthma therapeutic area user guide. CDISC Asthma Therapeutic Area User Guide Version 1.0 Version 1.0 of the CDISC Breast Cancer therapeutic area user guide. CDISC Breast Cancer Therapeutic Area User Guide Version 1.0 Version 1.0 of the CDISC Cardiovascular Studies therapeutic area user guide. CDISC Cardiovascular Studies Therapeutic Area User Guide Version 1.0 Clostridium difficile-associated Diarrhea Therapeutic Area User Guide v1.0 Version 1.0 of the CDISC CDAD therapeutic area user guide. CDISC CDAD Therapeutic Area User Guide v1.0 Version 1.0 of the CDISC Chronic Hepatitis C therapeutic area user guide. CDISC Chronic Hepatitis C Therapeutic Area User Guide Version 1.0 Version 1.0 of the CDISC Colorectal Cancer therapeutic area user guide. CDISC Colorectal Cancer Therapeutic Area User Guide Version 1.0 Version 1.0 of the CDISC COPD therapeutic area user guide. CDISC COPD Therapeutic Area User Guide Version 1.0 Version 1.0 of the CDISC Crohn's Disease therapeutic area user guide. CDISC Crohn's Disease Therapeutic Area User Guide v1.0 Version 1.0 of the CDISC Diabetes - Type 1 therapeutic area user guide - Pediatrics and Devices Modules. CDISC Type 1 Diabetes Therapeutic Area User Guide v1.0 - Pediatrics and Devices Modules Version 1.0 of the CDISC Diabetes therapeutic area user guide ADaM supplement. CDISC Diabetes Therapeutic Area User Guide Version 1.0 - Supplement for ADaM Version 1.0 of the CDISC Diabetic Kidney Disease therapeutic area user guide. CDISC Diabetic Kidney Disease Therapeutic Area User Guide Version 1.0 Version 1.0 of the CDISC Duchenne Muscular Dystrophy therapeutic area user guide. CDISC Duchenne Muscular Dystrophy Therapeutic Area User Guide Version 1.0 Version 1.0 of the CDISC Dyslipidemia therapeutic area user guide. CDISC Dyslipidemia Therapeutic Area User Guide Version 1.0 Version 1.0 of the CDISC Ebola therapeutic area user guide. CDISC Ebola Therapeutic Area User Guide Version 1.0 Version 1.0 of the CDISC Heart Failure therapeutic area user guide. CDISC Heart Failure Therapeutic Area User Guide v1.0 Version 1.0 of the CDISC HIV therapeutic area user guide. CDISC HIV Therapeutic Area User Guide Version 1.0 Version 1.0 of the CDISC Huntington's Disease therapeutic area user guide. CDISC Huntington's Disease Therapeutic Area User Guide Version 1.0 Version 1.0 of the CDISC Influenza therapeutic area user guide. CDISC Influenza Therapeutic Area User Guide Version 1.0 Version 1.1 of the CDISC Influenza therapeutic area user guide. CDISC Influenza Therapeutic Area User Guide Version 1.1 Version 1.0 of the CDISC interim user guide for COVID-19. CDISC Interim User Guide for COVID-19 v1.0 Version 1.0 of the CDISC Kidney Transplant therapeutic area user guide. CDISC Kidney Transplant Therapeutic Area User Guide Version 1.0 Version 1.0 of the CDISC Lung Cancer therapeutic area user guide. CDISC Lung Cancer Therapeutic Area User Guide v1.0 Version 1.0 of the CDISC Major Depressive Disorder therapeutic area user guide. CDISC Major Depressive Disorder Therapeutic Area User Guide Version 1.0 Version 1.0 of the CDISC Malaria therapeutic area user guide. CDISC Malaria Therapeutic Area User Guide Version 1.0 Version 1.0 of the CDISC Multiple Sclerosis therapeutic area user guide. CDISC Multiple Sclerosis Therapeutic Area User Guide Version 1.0 Version 1.0 of the CDISC Nutrition therapeutic area user guide. CDISC Nutrition Therapeutic Area User Guide v1.0 Version 1.0 of the CDISC Pain therapeutic area user guide. CDISC Pain Therapeutic Area User Guide Version 1.0 Version 1.1 of the CDISC Pain therapeutic area user guide. CDISC Pain Therapeutic Area User Guide Version 1.1 Version 1.0 of the Parkinson's Disease CDISC therapeutic area user guide. CDISC Parkinson's Disease Therapeutic Area User Guide Version 1.0 Version 1.0 of the Polycystic Kidney Disease CDISC therapeutic area user guide. CDISC Polycystic Kidney Disease (PKD) Therapeutic Area User Guide Version 1.0 Version 1.0 of the Post Traumatic Stress Disorder CDISC therapeutic area user guide. CDISC Post Traumatic Stress Disorder Therapeutic Area User Guide Version 1.0 Version 1.0 of the CDISC Prostate Cancer therapeutic area user guide. CDISC Prostate Cancer Therapeutic Area User Guide Version 1.0 Version 1.0 of the CDISC Psoriasis therapeutic area user guide. CDISC Psoriasis Therapeutic Area User Guide v1.0 Version 1.0 of the CDISC QT Studies therapeutic area user guide. CDISC QT Studies Therapeutic Area User Guide Version 1.0 Version 1.0 of the CDISC Rheumatoid Arthritis therapeutic area user guide. CDISC Rheumatoid Arthritis Therapeutic Area User Guide Version 1.0 Version 1.0 of the CDISC Schizophrenia therapeutic area user guide. CDISC Schizophrenia Therapeutic Area User Guide Version 1.0 Version 1.1 of the CDISC Schizophrenia therapeutic area user guide. CDISC Schizophrenia Therapeutic Area User Guide Version 1.1 Version 1.0 of the CDISC Traditional Chinese Medicine - Coronary Artery Disease-Angina therapeutic area user guide. CDISC Traditional Chinese Medicine - Coronary Artery Disease-Angina Therapeutic Area User Guide v1.0 Version 1.0 of the CDISC Traumatic Brain Injury therapeutic area user guide. CDISC Traumatic Brain Injury Therapeutic Area User Guide Version 1.0 Version2.0 of the CDISC Tuberculosis therapeutic area user guide. CDISC Tuberculosis Therapeutic Area User Guide Version 2.0 Version 1.1 of the CDISC Vaccines therapeutic area user guide. CDISC Vaccines Therapeutic Area User Guide Version 1.1 Version 2.0 of the CDISC Virology therapeutic area user guide. CDISC Virology Therapeutic Area User Guide Version 2.0 Version 2.1 of the CDISC Virology therapeutic area user guide. CDISC Virology Therapeutic Area User Guide Version 2.1 CTAUGRS CDISC Therapeutic Area User Guide Response CDISC Therapeutic Area User Guide Response Terminology Terminology relevant to the test codes that describe cell phenotype findings. Abn Blast Cells Abnormal Blast Cells A measurement of the abnormal blast cells in a biological specimen. Abnormal Blast Count Abn Blast Cells/Total Cells Abnormal Blast Cells/Total Cells A relative measurement (ratio or percentage) of the abnormal blast cells to total cells in a biological specimen. Abnormal Blast to Total Cell Ratio Measurement Abn Kappa+ PC Abn Kappa+ Plasma Cells Abnormal Kappa+ Plasma Cells A measurement of the abnormal kappa+ plasma cells in a biological specimen. Abnormal Kappa Positive Plasma Cell Count Abn Kappa+ PC/Abn Lambda+ PC Abnormal Kappa+ Plasma Cells/Abnormal Lambda+ Plasma Cells A relative measurement (ratio) of the abnormal kappa+ plasma cells to abnormal lambda+ plasma cells in a biological specimen. Abnormal Kappa Positive Plasma Cell to Abnormal Lambda Positive Plasma Cell Ratio Measurement Abn Lambda+ PC Abn Lambda+ Plasma Cells Abnormal Lambda+ Plasma Cells A measurement of the abnormal lambda+ plasma cells in a biological specimen. Abnormal Lambda Positive Plasma Cell Count B-Lymphocytes Antibody-Secreting BLym Ab-Secreting BLym AbSc A measurement of the antibody-secreting B-lymphocytes in a biological specimen. Antibody-secreting B-Lymphocytes Count B-Lymphocytes Antibody-Secreting/B-Lymphocytes BLym Ab-Secreting/Blym BLym AbSc/BLym A relative measurement (ratio or percentage) of the antibody-secreting B-lymphocytes to total B-lymphocytes in a biological specimen. Antibody-secreting B-Lymphocyte to B-Lymphocyte Ratio Measurement B-Lymphocytes Antibody-Secreting/B-Lymphocytes Memory Class-Switched BLym Ab-Secreting/BLym Mem Sw BLym Ab-Secreting/BLymMSw BLym AbSc/BLymMSw A relative measurement (ratio or percentage) of antibody-secreting B-lymphocytes to total class-switched memory B-lymphocyte in a biological specimen. Antibody-Secreting B-Lymphocyte to Class-Switched Memory B-Lymphocyte Ratio Measurement B-Lymphocytes Antibody-Secreting/Leukocytes BLym Ab-Secreting/Leuk BLym AbSc/Leuk A relative measurement (ratio or percentage) of the antibody-secreting B-lymphocytes to leukocytes in a biological specimen. Antibody-secreting B-Lymphocyte to Leukocyte Ratio Measurement B-Lymphocytes Antibody-Secreting Sub-Population/B-Lymphocytes Antibody-Secreting BLym Ab-Secreting Sub/BLym AbSc BLym AbSc Sub/BLym AbSc A relative measurement (ratio or percentage) of a sub-population of antibody-secreting B-lymphocytes to antibody-secreting B-lymphocytes in a biological specimen. Antibody-secreting B-Lymphocyte Subpopulation to Antibody-secreting B-Lymphocyte Ratio Measurement Basophils A measurement of the basophils in a biological specimen. Absolute Basophil Count Basophils/Leukocytes A relative measurement (ratio or percentage) of the basophils to leukocytes in a biological specimen. Basophil to Leukocyte Ratio Basophils Sub Basophils Sub-Population A measurement of a sub-population of basophils in a biological specimen. Basophil Subpopulation Count Basophils Sub-Population/Basophils Basophils Sub/Basophils A relative measurement (ratio or percentage) of a sub-population of basophils to total basophils in a biological specimen. Basophil Subpopulation to Basophil Ratio Measurement ATBLym Sub/ATBLym Sub Atypical B-Lymphocytes Sub-Population/Atypical B-Lymphocytes Sub-Population BLym Aty Sub/BLym Aty Sub A relative measurement (ratio or percentage) of a sub-population of atypical B-lymphocytes to a sub-population of atypical B-lymphocytes in a biological specimen. Atypical B-Lymphocyte Subpopulation to Atypical B-Lymphocyte Subpopulation Ratio Measurement B-Lymphocytes Classical Memory Sub-Population/B-Lymphocytes Classical Memory Sub-Population BLym Class Mem Sub/BLym Class Mem Sub BLym Classic MemSub/BLym Classic MemSub BLym Classical Mem Sub/BLym Classical Mem Sub A relative measurement (ratio or percentage) of a sub-population of classical memory B-lymphocytes to a sub population of classical memory B-lymphocytes in a biological specimen. Classical Memory B-Lymphocyte Subpopulation to Classical Memory B-Lymphocyte Subpopulation Ratio Measurement B-Lymphocytes Double Negative BLym Dbl Neg BLym DN BLym Double Neg A measurement of the double-negative B-lymphocytes (B-lymphocyte that are both CD27-IgD-) in a biological specimen. Double-Negative B-Lymphocyte Count B-Lymphocytes Double Negative/B-Lymphocytes BLym Dbl Neg/BLym BLym DN/BLym A relative measurement (ratio or percentage) of double negative B-lymphocytes to B-lymphocytes in a biological specimen. Double-Negative B-Lymphocyte to B-Lymphocyte Ratio Measurement B-Lymphocytes Double Negative Sub-Population BLym Dbl Neg Sub BLym DN Sub BLym Double Neg Sub A measurement of a sub-population of double-negative B-lymphocytes (B-lymphocytes that are both CD27-IgD-) in a biological specimen. Double-Negative B-Lymphocyte Subpopulation Count B-Lymphocytes Double Negative Sub-Population/B-Lymphocytes BLym Dbl Neg Sub/BLym BLym DN Sub/BLym A relative measurement (ratio or percentage) of a sub-population of double negative B-lymphocytes to B-lymphocytes in a biological specimen. Double-Negative B-Lymphocyte Subpopulation to B-Lymphocyte Ratio Measurement B-Lymphocytes Double Negative Sub-Population/B-Lymphocytes Double Negative BLym Dbl Neg Sub/BLym Dbl Neg BLym DN Sub/BLym DN A relative measurement (ratio or percentage) of a sub-population of double negative B-lymphocytes to double negative B-lymphocytes in a biological specimen. Double-Negative B-Lymphocyte Subpopulation to Double-Negative B-Lymphocyte Ratio Measurement B-Lymphocytes IgG+ BLym IgG+ A measurement of the IgG+ B-lymphocytes in a biological specimen. IgG-positive B-Lymphocyte Count B-Lymphocytes IgG+/B-Lymphocytes BLym IgG+/BLym A relative measurement (ratio or percentage) of the IgG+ B-lymphocytes to total B-lymphocytes in a biological specimen. IgG-positive B-Lymphocyte to B-Lymphocyte Ratio Measurement B-Lymphocytes IgM+ BLym IgM+ A measurement of the IgM+ B-lymphocytes in a biological specimen. IgM-positive B-Lymphocyte Count B-Lymphocytes IgM+/B-Lymphocytes BLym IgM+/BLym A relative measurement (ratio or percentage) of the IgM+ B-lymphocytes to total B-lymphocytes in a biological specimen. IgM-positive B-Lymphocyte to B-Lymphocyte Ratio Measurement B-Lymphocytes Classical Memory/B-Lymphocytes BLym Classic Mem/BLym A relative measurement (ratio or percentage) of classical memory B-lymphocytes to total B-lymphocytes in a biological specimen. Classical Memory B-Lymphocyte to B-Lymphocyte Ratio Measurement B-Lymphocytes Classical Memory Sub-Population/B-Lymphocytes Classical Memory BLym Classic Mem Sub/BLym Classic Mem BLym Classical Mem Sub/BLym Classical Mem A relative measurement (ratio or percentage) of a sub-population of classical memory B-lymphocytes to all classical memory B-lymphocytes in a biological specimen. Classical Memory B-Lymphocyte Subpopulation to Classical Memory B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Sub-Population/B-Lymphocytes Memory Sub-Population BLym Mem Sub/BLym Mem Sub A relative measurement (ratio or percentage) of a sub-population of memory B-lymphocyte cells to a sub-population of memory B-lymphocyte cells in a biological specimen. Memory B-Lymphocyte Subpopulation to Memory B-Lymphocyte Subpopulation Ratio Measurement B-Lymphocytes Naive Mature/B-Lymphocytes BLym Naive Mat/BLym A relative measurement (ratio or percentage) of naive mature B-lymphocytes to B-lymphocytes in a biological specimen. Naive Mature B-Lymphocytes to Total B-Lymphocytes Ratio Measurement B-Lymphocytes Naive Mature Sub-Population/B-Lymphocytes Naive Mature BLym Naive Mat Sub/BLym Naive Mat BLym Naive Mat Sub/BLymNM A relative measurement (ratio or percentage) a sub-population of naive mature B-lymphocytes to total naive mature B-lymphocytes in a biological specimen. Naive Mature B-Lymphocyte Subpopulation to Total Naive Mature B-Lymphocyte Ratio Measurement B-Lymphocytes Regulatory Memory BLym Reg Mem A measurement of the regulatory memory B-lymphocytes in a biological specimen. Regulatory Memory B-Lymphocyte Count B-Lymphocytes Regulatory Memory/B-Lymphocytes BLym Reg Mem/BLym A relative measurement (ratio or percentage) of regulatory memory B-lymphocytes to total B-lymphocytes in a biological specimen. Regulatory Memory B-Lymphocyte to B-Lymphocyte Ratio Measurement B-Lymphocytes Regulatory Memory/B-Lymphocytes Regulatory BLym Reg Mem/BLym Reg A relative measurement (ratio or percentage) of regulatory memory B-lymphocytes to regulatory B-lymphocytes in a biological specimen. Regulatory Memory B-Lymphocyte to Regulatory B-Lymphocyte Ratio Measurement B-Lymphocytes Regulatory Memory Sub-Population BLym Mem Reg Sub BLym Reg Mem Sub A measurement of a sub-population of regulatory memory B-lymphocytes in a biological specimen. Regulatory Memory B-Lymphocyte Subpopulation Count B-Lymphocytes Regulatory Memory Sub-Population/B-Lymphocytes BLym Reg Mem Sub/BLym A relative measurement (ratio or percentage) of a sub-population of regulatory memory B-lymphocytes to total B-lymphocytes in a biological specimen. Regulatory Memory B-Lymphocyte Subpopulation to B-Lymphocyte Ratio Measurement B-Lymphocytes Regulatory Memory Sub-Population/B-Lymphocytes Regulatory BLym Reg Mem Sub/BLym Reg A relative measurement (ratio or percentage) of a sub-population of regulatory memory B-lymphocytes to regulatory B-lymphocytes in a biological specimen. Regulatory Memory B-Lymphocyte Subpopulation to Regulatory B-Lymphocyte Ratio Measurement B-Lymphocytes Regulatory Memory Sub-Population/B-Lymphocytes Regulatory Memory BLym Reg Mem Sub/BLym Reg Mem A relative measurement (ratio or percentage) of a sub-population of regulatory memory B-lymphocytes to total regulatory memory B-lymphocytes in a biological specimen. Regulatory Memory B-Lymphocyte Subpopulation to Regulatory Memory B-Lymphocyte Ratio Measurement B-Lymphocytes Sub-Population/Lymphocytes BLym Sub/Lym A relative measurement (ratio or percentage) of a sub-population of B-lymphocytes to lymphocytes in a biological specimen. B-Lymphocyte Subpopulation to Lymphocyte Ratio Measurement ATBLym/BLym Atypical B-Lymphocytes/B-Lymphocytes BLym Aty/BLym A relative measurement (ratio or percentage) of atypical B-lymphocytes to total B-lymphocytes in a biological specimen. Atypical B-Lymphocyte to B-Lymphocyte Ratio Measurement ATBLym Sub/ATBLym Atypical B-Lymphocytes Sub-Population/Atypical B-Lymphocytes BLym Aty Sub/BLym Aty A relative measurement (ratio or percentage) of a sub-population of atypical B-lymphocytes to total atypical B-lymphocytes in a biological specimen. Atypical B-Lymphocyte Subpopulation to Atypical B-Lymphocyte Ratio Measurement B-Lymphocytes B1 BLym B1 A measurement of B-lymphocytes B1 in a biological specimen. B-Lymphocytes B1 Count B-Lymphocytes B1a BLym B1a A measurement of the B1a B-lymphocytes in a biological specimen. B-Lymphocyte B1a Count B-Lymphocytes B1b BLym B1b A measurement of the B1b B-lymphocytes in a biological specimen. B-Lymphocyte B1b Count B-Lymphocytes B1 Sub-Population BLym B1 Sub A measurement of a sub-population of B-lymphocytes B1 in a biological specimen. B-Lymphocytes B1 Subpopulation Count B-Lymphocytes B1 Transitional BLym B1 Trans A measurement of the transitional B1 B-lymphocytes in a biological specimen. Transitional B-Lymphocyte B1 Count B-Lymphocytes B2 Immature BLym B2 Immat A measurement of the immature B2 B-lymphocytes in a biological specimen. Immature B-Lymphocyte B2 Count B-Lymphocytes B2 Mature BLym B2 Mat A measurement of the mature B2 B-lymphocytes in a biological specimen. Mature B-Lymphocyte B2 Count B-Lymphocytes B2 Transitional BLym B2 Trans A measurement of the transitional B2 B-lymphocytes in a biological specimen. Transitional B-Lymphocyte B2 Count B Cells B-Cell Lymphocytes B-Cells B-Lymphocytes A measurement of the B-lymphocytes in a biological specimen. B-Lymphocyte Count B-Lymphocytes/Total Cells A relative measurement (ratio or percentage) of the B-lymphocytes to total cells in a biological specimen. B-Lymphocyte to Total Cells Ratio Measurement B Cells/Leukocytes B-Lymphocytes/Leukocytes BLym/Leuk A relative measurement (ratio or percentage) of B-lymphocytes to leukocytes in a biological specimen. B-Lymphocyte to Leukocyte Ratio Measurement B-Lymphocytes/Lymphocytes A relative measurement (ratio or percentage) of the B-lymphocytes to total lymphocytes in a biological specimen. B-Lymphocyte to Lymphocyte Ratio Measurement B-Lymphocytes Effector BLym Eff A measurement of the effector B-lymphocytes in a biological specimen. Effector B-Lymphocyte Count B-Lymphocytes Effector 1 BLym Eff 1 A measurement of the effector 1 B-lymphocytes in a biological specimen. Effector 1 B-Lymphocyte Count B-Lymphocytes Effector 1 Sub-Population BLym Eff 1 Sub A measurement of a sub-population of effector 1 B-lymphocytes in a biological specimen. Effector 1 B-Lymphocyte Subpopulation Count B-Lymphocytes Effector 2 BLym Eff 2 A measurement of the effector 2 B-lymphocytes in a biological specimen. Effector 2 B-Lymphocyte Count B-Lymphocytes Effector 2 Sub-Population BLym Eff 2 Sub A measurement of a sub-population of effector 2 B-lymphocytes in a biological specimen. Effector 2 B-Lymphocyte Subpopulation Count B-Lymphocytes Effector Sub-Population BLym Eff Sub A measurement of a sub-population of effector B-lymphocytes in a biological specimen. Effector B-Lymphocyte Subpopulation Count B-Lymphocytes Follicular BLym Foll A measurement of the follicular B-lymphocytes in a biological specimen. Follicular B-Lymphocyte Count B-Lymphocytes Follicular Sub-Population BLym Foll Sub A measurement of a sub-population of follicular B-lymphocytes in a biological specimen. Follicular B-Lymphocyte Subpopulation Count B-Lymphocytes Germinal Center BLym Germ Ctr A measurement of the germinal center B-lymphocytes in a biological specimen. Germinal Center B-Lymphocyte Count B-Lymphocytes Germinal Center Sub-Population BLym Germ Ctr Sub A measurement of a sub-population of germinal center B-lymphocytes in a biological specimen. Germinal Center B-Lymphocyte Subpopulation Count B-Lymphocytes Immature BLym Immat A measurement of the immature B-lymphocytes in a biological specimen. Immature B-Lymphocyte Count B-Lymphocytes/Lymphocyte and Monocytes BLym/Lym+Mono A relative measurement (ratio or percentage) of B-lymphocytes to lymphocytes and monocytes in a biological specimen. B-Lymphocyte to Lymphocyte and Monocyte Ratio Measurement B-Lymphocytes Memory BLym Mem A measurement of the memory B-lymphocytes in a biological specimen. Memory B-Lymphocyte Count B-Lymphocytes Mature BLym Mat A measurement of the mature B-lymphocytes in a biological specimen. Mature B-Lymphocyte Count B-Lymphocytes Memory/B-Lymphocytes BLym Mem/BLym A relative measurement (ratio or percentage) of memory B-lymphocytes to total B-lymphocytes in a biological specimen. Memory B-Lymphocytes to Total B-Lymphocytes Ratio Measurement B-Lymphocytes Memory cB1 BLym Mem cB1 A measurement of the cB1 memory B-lymphocytes in a biological specimen. Memory B-Lymphocyte cB1 Count B-Lymphocytes Memory cB2 BLym Mem cB2 A measurement of the cB2 memory B-lymphocytes in a biological specimen. Memory B-Lymphocyte cB2 Count B-Lymphocytes Memory cB3 BLym Mem cB3 A measurement of the cB3 memory B-lymphocytes in a biological specimen. Memory B-Lymphocyte cB3 Count B-Lymphocytes Memory Immature BLym Mem Immat A measurement of the memory immature B-lymphocytes in a biological specimen. Immature Memory B-Lymphocyte Count B-Lymphocytes Memory Mature BLym Mem Mat A measurement of the memory mature B-lymphocytes in a biological specimen. Mature Memory B-Lymphocyte Count B-Lymphocytes Memory Non-Class-Switched B-Lymphocytes Memory Unswitched BLym Mem NSw A measurement of the non-class-switched memory B-lymphocytes in a biological specimen. Nonclass-switched Memory B-Lymphocyte Count B-Lymphocytes Memory Non-Class-Switched IgG+ B-Lymphocytes Memory Unswitched IgG+ BLym Mem NSw IgG+ A measurement of the IgG+ non-class-switched memory B-lymphocytes in a biological specimen. Non-class-switched IgG-positive Memory B-Lymphocyte Count B-Lymphocytes Memory Non-Class-Switched IgM+ B-Lymphocytes Memory Unswitched IgM+ BLym Mem NSw IgM+ A measurement of the IgM+ non-class-switched memory B-lymphocytes in a biological specimen. Non-class-switched IgM-positive Memory B-Lymphocyte Count B-Lymphocytes Memory Non-Class-Switched Sub-Population B-Lymphocytes Memory Unswitched Sub-Population BLym Mem NSw Sub A measurement of a sub-population of non-class-switched memory B-lymphocytes in a biological specimen. Nonclass-switched Memory B-Lymphocyte Subpopulation Count B-Lymphocytes Memory Sub-Population BLym Mem Sub A measurement of a sub-population of memory B-lymphocytes in a biological specimen. Memory B-Lymphocyte Subpopulation Count B-Lymphocytes Memory Sub-Population/B-Lymphocytes BLym Mem Sub/BLym A relative measurement (ratio or percentage) of a sub-population of memory B-lymphocytes to total B-lymphocytes in a biological specimen. Memory B-Lymphocyte Subpopulation to B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Sub-Population/B-Lymphocytes Memory BLym Mem Sub/BLym Mem A relative measurement (ratio or percentage) of a sub-population of memory B-lymphocytes to total memory B-lymphocytes in a biological specimen. Memory B-Lymphocyte Subpopulation to Memory B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Class-Switched B-Lymphocytes Memory Switched BLym Mem Sw A measurement of the class-switched memory B-lymphocytes in a biological specimen. Class-switched Memory B-Lymphocyte Count B-Lymphocytes Memory Class-Switched Sub-Population BLym Mem Sw Sub A measurement of a sub-population of class-switched memory B-lymphocytes in a biological specimen. Class-switched Memory B-Lymphocyte Subpopulation Count B-Lymphocytes Marginal Zone BLym Marg Zn A measurement of the marginal zone B-lymphocytes in a biological specimen. Marginal Zone B-Lymphocyte Count B-Lymphocytes, Naive BLym Naive Naive B Cells Naive B-Lymphocytes A measurement of the naive B-lymphocytes in a biological specimen. Naive B-Lymphocyte Measurement B Cell, Naive/B Cell B-Lymphocyte, Naive/B-Lymphocyte BLym Naive/BLym Naive B-Lymphocytes/B-Lymphocytes A relative measurement (ratio or percentage) of naive B-lymphocytes to B-lymphocytes in a biological specimen. Naive B-Lymphocytes to Total B-Lymphocytes Ratio Measurement B-Lymphocytes Naive IgG+ BLym Naive IgG+ A measurement of the IgG+ naive B-lymphocytes in a biological specimen. IgG-positive Naive B-Lymphocyte Count B-Lymphocytes Naive IgG+/B-Lymphocytes Naive BLym Naive IgG+/BLym Naive BLym Naive IgG+/BLymN A relative measurement (ratio or percentage) of the IgG+ naive B-lymphocytes to total naive B-lymphocytes in a biological specimen. IgG-positive Naive B-Lymphocyte to Naive B-Lymphocyte Ratio Measurement B-Lymphocytes Naive/Leukocytes BLym Naive/Leuk A relative measurement (ratio or percentage) of naive B-lymphocytes to total leukocytes in a biological specimen. Naive B-Lymphocyte to Leukocyte Ratio Measurement B-Lymphocytes Naive IgM+ BLym Naive IgM+ A measurement of the IgM+ naive B-lymphocytes in a biological specimen. IgM-positive Naive B-Lymphocyte Count B-Lymphocytes Naive Mature BLym Naive Mat A measurement of the naive mature B-lymphocytes in a biological specimen. Naive Mature B-Lymphocyte Count B-Lymphocytes Naive Mature Sub-Population BLym Naive Mat Sub A measurement of a sub-population of naive mature B-lymphocytes in a biological specimen. Naive Mature B-Lymphocyte Subpopulation Count B-Lymphocytes Naive IgM+/B-Lymphocytes Naive BLym Naive IgM+/BLym Naive BLym Naive IgM+/BLymN A relative measurement (ratio or percentage) of the IgM+ naive B-lymphocytes to total naive B-lymphocytes in a biological specimen. IgM-positive Naive B-Lymphocyte to Naive B-Lymphocyte Ratio Measurement B-Lymphocytes Naive Sub-Population BLym Naive Sub A measurement of a sub-population of naive B-lymphocytes in a biological specimen. Naive B-Lymphocyte Subpopulation Count B-Lymphocyte Precursor Cells Pre-B Cells Pre-BLym Precursor B-Lymphocytes A measurement of the precursor B-lymphocytes in a biological specimen. Precursor B-Lymphocyte Count B-Lymphocyte Progenitor Cells Pro-B Cells Pro-BLym Progenitor B-Lymphocytes A measurement of the progenitor B-lymphocytes in a biological specimen. Progenitor B-Lymphocyte Count B-Lymphocyte Progenitor Cells/Total Cells Pro-B Cells/Total Cells Pro-BLym/Total Cells A relative measurement (ratio or percentage) of the progenitor B-lymphocytes to total cells in a biological specimen. Progenitor B-Lymphocyte to Total Cells Ratio Measurement B-Lymphocytes Regulatory BLym Reg A measurement of the regulatory B-lymphocytes in a biological specimen. Regulatory B-Lymphocyte Count B-Lymphocytes Regulatory Sub-Population BLym Reg Sub A measurement of the sub-population of regulatory B-lymphocytes in a biological specimen. Regulatory B-Lymphocyte Subpopulation Count B-Lymphocytes Sub-Population BLym Sub A measurement of a sub-population of B-lymphocytes in a biological specimen. B-Lymphocytes Subpopulation Count B-Lymphocyte Sub-Population/B-Lymphocyte BLym Sub/BLym A relative measurement (ratio or percentage) of a sub-population of B-lymphocytes to B-lymphocytes in a biological specimen. B-Lymphocytes Subpopulation to Total B-Lymphocytes Ratio Measurement B-Lymphocytes Sub-Population/B-Lymphocytes Sub-Population BLym Sub/BLym Sub A relative measurement (ratio or percentage) of a sub-population of B-lymphocytes to a sub-population of B-lymphocytes in a biological specimen. B-Lymphocyte Subpopulation to B-Lymphocyte Subpopulation Ratio Measurement B-Lymphocytes Sub-Population/Leukocytes BLym Sub/Leuk BLym Sub/Leukocytes A relative measurement (ratio or percentage) of a sub-population of B-lymphocytes to leukocytes in a biological specimen. B-Lymphocyte Subpopulation to Leukocyte Ratio Measurement B-Lymphocytes Transitional BLym Trans A measurement of the transitional B-lymphocytes in a biological specimen. Transitional B-Lymphocyte Count B-Lymphocytes Transitional 1 BLym Trans 1 A measurement of the transitional 1 B-lymphocytes in a biological specimen. Transitional 1 B-Lymphocyte Count B-Lymphocytes Transitional 2 BLym Trans 2 A measurement of the transitional 2 B-lymphocytes in a biological specimen. Transitional 2 B-Lymphocyte Count B-Lymphocytes Transitional 2/B-Lymphocytes BLym Trans 2/BLym Transitional T2 B-Lymphocytes/B-Lymphocytes A relative measurement (ratio or percentage) of the transitional 2 B-lymphocytes to total B-lymphocytes in a biological specimen. Transitional 2 B-Lymphocyte to B-Lymphocyte Ratio Measurement B-Lymphocytes Transitional 2 Sub-Population/B-Lymphocytes BLym Trans 2 Sub/BLym Transitional T2 B-Lymphocytes Subpopulation/B-Lymphocytes A relative measurement (ratio or percentage) of a sub-population of transitional 2 B-lymphocytes to total B-lymphocytes in a biological specimen. Transitional 2 B-Lymphocyte Subpopulation to B-Lymphocyte Ratio Measurement B-Lymphocytes Transitional 2 Sub-Population/B-Lymphocytes Transitional 2 BLym Trans 2 Sub/BLym Trans 2 Transitional T2 B-Lymphocytes Subpopulation/Transitional T2 B-Lymphocytes A relative measurement (ratio or percentage) of a sub-population of transitional 2 B-lymphocytes to total transitional 2 B-lymphocytes in a biological specimen. Transitional 2 B-Lymphocyte Subpopulation to Transitional 2 B-Lymphocyte Ratio Measurement B-Lymphocytes Transitional 3 BLym Trans 3 A measurement of the transitional 3 B-lymphocytes in a biological specimen. Transitional 3 B-Lymphocyte Count B-Lymphocytes Transitional/B-Lymphocytes BLym Trans/BLym A relative measurement (ratio or percentage) of transitional B-lymphocytes to B-lymphocytes in a biological specimen. Transitional B-Lymphocytes to B-Lymphocytes Ratio Measurement B-Lymphocytes Transitional/B-Lymphocytes Naive BLym Trans/BLym Naive BLym Trans/BLymN A relative measurement (ratio or percentage) of the transitional B-lymphocytes to the naive B-lymphocytes in a biological specimen. Transitional B-Lymphocyte to Naive B-Lymphocyte Ratio Measurement B-Lymphocytes Transitional Sub-Population BLym Trans Sub A measurement of a sub-population of transitional B-lymphocytes in a biological specimen. Transitional B-Lymphocyte Subpopulation Count B-Lymphocytes Transitional Sub-Population/B-Lymphocytes BLym Trans Sub/BLym A relative measurement (ratio or percentage) of a sub-population of transitional B-lymphocytes to B-lymphocytes in a biological specimen. Transitional B-Lymphocyte Subpopulation to B-Lymphocyte Ratio Measurement B-Lymphocytes Transitional Sub-Population/B-Lymphocytes Transitional BLym Trans Sub/BLym Trans A relative measurement (ratio or percentage) of a sub-population of transitional B-lymphocytes to total transitional B-lymphocytes in a biological specimen. Transitional B-Lymphocyte Subpopulation to Total Transitional B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Non-Class-Switched/B-Lymphocytes B-Lymphocytes Memory Unswitched/B-Lymphocytes BLym Mem NSw/BLym A relative measurement (ratio or percentage) of the non-class-switched memory B-lymphocytes to total B-lymphocytes in a biological specimen. Non-class-switched Memory B-Lymphocyte to Total B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Non-Class-Switched/Leukocytes B-Lymphocytes Memory Unswitched/Leukocytes BLym Mem NSw/Leuk A relative measurement (ratio or percentage) of the non-class-switched memory B-lymphocytes to total leukocytes in a biological specimen. Non-class-switched Memory B-Lymphocyte to Leukocyte Ratio Measurement B-Lymphocytes Memory Non-Class-Switched Sub-Population/B-Lymphocytes B-Lymphocytes Memory Unswitched Sub-Population/B-Lymphocytes BLym Mem NSw Sub/BLym A relative measurement (ratio or percentage) of a sub-population of non-class-switched memory B-lymphocytes to total B-lymphocytes in a biological specimen. Non-class-switched Memory B-Lymphocyte Subpopulation to B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Non-Class-Switched Sub-Population/B-Lymphocytes Memory Non-Class-Switched B-Lymphocytes Memory Unswitched Sub-Population/B-Lymphocytes Memory Unswitched BLym Mem NSw Sub/BLymMNSw A relative measurement (ratio or percentage) of a sub-population of non-class-switched memory B-lymphocytes to total non-class-switched memory B-lymphocytes in a biological specimen. Non-class-switched Memory B-Lymphocyte Subpopulation to Total Non-class-switched Memory B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Class-Switched/B-Lymphocytes B-Lymphocytes Memory Switched/B-Lymphocytes BLym Mem Sw/Blym A relative measurement (ratio or percentage) of the class-switched memory B-lymphocytes to total B-lymphocytes in a biological specimen. Class-switched Memory B-Lymphocyte to B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Switched IgG+ BLym Mem Sw IgG+ A measurement of the IgG+ class-switched memory B-lymphocytes in a biological specimen. Immunoglobulin G Positive Class-switched Memory B-Lymphocyte Count B-Lymphocytes Memory Switched IgG+/B-Lymphocytes Memory Switched BLym Mem Sw IgG+/BLym Mem Sw A relative measurement (ratio or percentage) of IgG+ memory switched B-Lymphocytes to class-switched memory B-lymphocytes in a biological specimen. Immunoglobulin G Positive Memory Switched B-Lymphocyte to Memory Switched B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Switched IgM+ BLym Mem Sw IgM+ A measurement of the IgM+ class-switched memory B-lymphocytes in a biological specimen. Immunoglobulin M Positive Class-switched Memory B-Lymphocyte Count B-Lymphocytes Memory Switched IgM+/B-Lymphocytes Memory Switched BLym Mem Sw IgM+/BLym Mem Sw A relative measurement (ratio or percentage) of IgM+ class-switched memory B-Lymphocytes to class-switched memory B-lymphocytes in a biological specimen. Immunoglobulin M Positive Memory Switched B-Lymphocyte to Memory Switched B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Class-Switched Unconventional B-Lymphocytes Memory Switched Unconventional BLym Mem Sw Uncv A measurement of the unconventional class-switched memory B-lymphocytes in a biological specimen. Unconventional Class-switched Memory B-Lymphocyte Count B-Lymphocytes Memory Class-Switched Unconventional/B-Lymphocytes B-Lymphocytes Memory Switched Unconventional/B-Lymphocytes BLym Mem Sw Uncv/BLym A relative measurement (ratio or percentage) the unconventional class-switched memory B-lymphocytes to B-lymphocytes in a biological specimen. Unconventional Class-switched Memory B-Lymphocyte to B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Switched Unconventional IgG+ BLym Mem Sw Uncv IgG+ A measurement of the unconventional class-switched IgG-positive memory B-lymphocytes in a biological specimen. Unconventional Class-switched IgG-positive Memory B-Lymphocyte Count B-Lymphocytes Memory Class-Switched Unconventional/Leukocytes B-Lymphocytes Memory Switched Unconventional/Leukcoytes BLym Mem Sw Uncv/Leuk A relative measurement (ratio or percentage) of the unconventional class-switched memory B-lymphocytes to leukocytes in a biological specimen. Unconventional Class-switched Memory B-Lymphocyte to Leukocyte Ratio Measurement B-Lymphocytes Memory Class-Switched Unconventional Sub-Population B-Lymphocytes Memory Switched Unconventional Sub-Population BLym Mem Sw Uncv Sub A measurement of a sub-population of unconventional class-switched memory B-lymphocytes in a biological specimen. Unconventional Class-switched Memory B-Lymphocyte Subpopulation Count B-Lymphocytes Memory Class-Switched Unconventional Sub-Population/B-Lymphocytes Memory Class-Switched Unconventional B-Lymphocytes Memory Switched Unconventional Sub-Population/B-Lymphocytes Memory Switched Unconventional BLym Mem Sw Uncv Sub/BLym Mem Sw Uncv A relative measurement (ratio or percentage) of a sub-population of unconventional class-switched memory B-lymphocytes to unconventional class-switched memory B-lymphocytes in a biological specimen. Unconventional Class-switched Memory B-Lymphocyte Subpopulation to Unconventional Class-switched Memory B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Class-Switched Sub-Population/B-Lymphocytes B-Lymphocytes Memory Switched Sub-Population/B-Lymphocytes BLym Mem Sw Sub/BLym A relative measurement (ratio or percentage) of a sub-population of class-switched memory B-lymphocytes to total B-lymphocytes in a biological specimen. Class-switched Memory B-Lymphocyte Subpopulation to Total B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Class-Switched Sub-Population/B-Lymphocytes Memory Class-Switched B-Lymphocytes Memory Switched Sub-Population/B-Lymphocytes Memory Switched BLym Mem Sw Sub/BLym Mem Sw BLym Mem Sw Sub/BLymMSw A relative measurement (ratio or percentage) of a sub-population of class-switched memory B-lymphocytes to total class-switched memory B-lymphocytes in a biological specimen. Class-switched Memory B-Lymphocytes Subpopulation to Total Class-switched Memory B-Lymphocytes Ratio Measurement B-Lymphocytes Naive Sub-Population/B-Lymphocytes BLym Naive Sub/BLym A relative measurement (ratio or percentage) of a sub-population of naive B-lymphocytes to total B-lymphocytes in a biological specimen. Naive B-Lymphocyte Subpopulation to B-Lymphocyte Ratio Measurement B-Lymphocytes Naive Sub-Population/B-Lymphocytes, Naive BLym Naive Sub/BLym Naive A relative measurement (ratio or percentage) of a sub-population of naive B-lymphocytes to naive B-lymphocytes in a biological specimen. Naive B-Lymphocytes Subpopulation to Total B-Lymphocytes Naive Ratio Measurement Mono/Non-TBNK Leuk A relative measurement (ratio or percentage) of the monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells in a biological specimen. Monocyte to Non-TBNK Leukocyte Ratio Measurement Mono Classic Sub-population/Non-TBNK Leukocytes Mono Classic Sub/Non-TBNK Leuk A relative measurement (ratio or percentage) of a sub-population of classical monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. Classical Monocyte Subpopulation to Non-TBNK Leukocyte Ratio Measurement Mono Intermed Sub/Non-TBNK Mono Intermed Sub/Non-TBNK Leuk Monocytes Intermediate Sub-Population/Non-TBNK Leukocytes A relative measurement (ratio or percentage) of a sub-population of intermediate monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. Intermediate Monocyte Subpopulation to Non-TBNK Leukocyte Ratio Measurement Mono NonClassic Sub/Non-TBNK Leuk Monocytes Non-Classical Sub-Population/Non-TBNK Leukocytes A relative measurement (ratio or percentage) of a sub-population of non-classical monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. Non-Classical Monocyte Subpopulation to Non-TBNK Leukocyte Ratio Measurement MDSC/Non-TBNK Leuk MDSC/Non-TBNK Leukocytes Myeloid-Derived Suppressor Cells/Non-TBNK Leukocytes A relative measurement (ratio or percentage) of the myeloid-derived suppressor cells to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. Myeloid-Derived Suppressor Cell to Non-TBNK Leukocyte Ratio Measurement Mono Classic/Non-TBNK Leuk Monocytes Classical/Non-TBNK Leukocytes A relative measurement (ratio or percentage) of the classical monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. Classical Monocyte to Non-TBNK Leukocyte Ratio Measurement Mono Intermed/Non-TBNK Leuk Monocytes Intermediate/Non-TBNK Leukocytes A relative measurement (ratio or percentage) of the intermediate monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. Intermediate Monocyte to Non-TBNK Leukocyte Ratio Measurement Mono NonClassic/Non-TBNK Leuk Monocytes Non-Classical/Non-TBNK Leukocytes A relative measurement (ratio or percentage) of the non-classical monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. Non-Classical Monocyte to Non-TBNK Leukocyte Ratio Measurement T-Lymphocytes Cytotoxic Stem Cell Memory Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx SC Mem Sub/TLym Cytx A relative measurement (ratio or percentage) of a sub-population of cytotoxic stem cell memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Stem Cell Memory Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Stem Cell Memory/T-Lymphocytes Cytotoxic TLym Cytx SC Mem/TLym Cytx A relative measurement (ratio or percentage) of the cytotoxic stem cell memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Stem Cell Memory Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Stem Cell Memory/T-Lymphocytes Cytotoxic Naive TLym Cytx SC Mem/TLymCN A relative measurement (ratio or percentage) of the cytotoxic stem cell memory T-lymphocytes to cytotoxic naive T-lymphocytes in a biological specimen. Stem Cell Memory Cytotoxic T-Lymphocyte to Naive Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx Term Mem Sub/TLym Cytx A relative measurement (ratio or percentage) of a sub-population of cytotoxic terminal memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Terminal Memory Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic Memory TLym Cytx Mem GH Sub/TLym Cytx Mem TLym Cytx Mem GH Sub/TLymCM A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic memory T-lymphocytes to total cytotoxic memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Memory T-Lymphocyte Subpopulation to Cytotoxic Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic Memory TLym Cytx Mem SH Sub/TLym Cytx Mem TLym Cytx Mem SH Sub/TLymCM A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic memory T-lymphocytes to total cytotoxic memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Memory T-Lymphocyte Subpopulation to Cytotoxic Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Central Memory Gut-Homing/T-Lymphocytes Cytotoxic Central Memory TLym Cytx Cen Mem GH/TLym Cytx Cen Mem TLym Cytx Cen Mem GH/TLymCCM A relative measurement (ratio or percentage) of the gut-homing cytotoxic central memory T-lymphocytes to total cytotoxic central memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Central Memory T-Lymphocyte to Cytotoxic Central Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Central Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx Cen Mem GH Sub/TLym Cytx TLym Cytx Cen Mem GH Sub/TLymC A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic central memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Central Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic Central Memory TLym Cytx Cen Mem GH Sub/TLym Cytx Cen Mem TLym Cytx Cen Mem GH Sub/TLymCCM TLym Cytx Cen Mem Gut-Homing Sub/TLymCCM A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic central memory T-lymphocytes to total gut-homing cytotoxic T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation to Gut-Homing Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Central Memory Skin-Homing/T-Lymphocytes Cytotoxic Central Memory TLym Cytx Cen Mem SH/TLym Cytx Cen Mem TLym Cytx Cen Mem SH/TLymCCM A relative measurement (ratio or percentage) of the skin-homing cytotoxic central memory T-lymphocytes to total cytotoxic central memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Central Memory T-Lymphocyte to Cytotoxic Central Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Central Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx Cen Mem SH Sub/TLym Cytx TLym Cytx Cen Mem SH Sub/TLymC A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic central memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Central Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic Central Memory TLym Cytx Cen Mem SH Sub/TLym Cytx Cen Mem TLym Cytx Cen Mem SH Sub/TLymCCM TLym Cytx Cen Mem Skin-Homing Sub/TLymCCM A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic central memory T-lymphocytes to total cytotoxic central memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation to Cytotoxic Central Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory Gut-Homing/T-Lymphocytes Cytotoxic Effector Memory TLym Cytx Eff Mem GH/TLym Cytx Eff Mem TLym Cytx Eff Mem GH/TLymCEM A relative measurement (ratio or percentage) of the gut-homing cytotoxic effector memory T-lymphocytes to total cytotoxic effector memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Effector Memory T-Lymphocyte to Cytotoxic T-Lymphocyte to Cytotoxic Effector Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx Eff Mem GH Sub/TLym Cytx TLym Cytx Eff Mem GH Sub/TLymC A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic effector memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic Effector Memory TLym Cytx Eff Mem GH Sub/TLym Cytx Eff Mem TLym Cytx Eff Mem GH Sub/TLymCEM TLym Cytx Eff Mem Gut-Homing Sub/TLymCEM A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic effector memory T-lymphocytes to total cytotoxic effector T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation to Cytotoxic Effector T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory Skin-Homing/T-Lymphocytes Cytotoxic Effector Memory TLym Cytx Eff Mem SH/TLym Cytx Eff Mem TLym Cytx Eff Mem SH/TLymCEM A relative measurement (ratio or percentage) of the skin-homing cytotoxic effector memory T-lymphocytes to total cytotoxic effector memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Effector Memory T-Lymphocyte to Cytotoxic Effector Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx Eff Mem SH Sub/TLym Cytx TLym Cytx Eff Mem SH Sub/TLymC A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic effector memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic Effector Memory TLym Cytx Eff Mem SH Sub/TLym Cytx Eff Mem TLym Cytx Eff Mem SH Sub/TLymCEM TLym Cytx Eff Mem Skin-Homing Sub/TLymCEM A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic effector memory T-lymphocytes to total cytotoxic effector memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation to Cytotoxic Effector Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory Gut-Homing/T-Lymphocytes Cytotoxic Terminal Memory TLym Cytx Term Mem GH/TLym Cytx Term Mem TLym Cytx Term Mem GH/TLymCTM A relative measurement (ratio or percentage) of the gut-homing cytotoxic terminal memory T-lymphocytes to total cytotoxic terminal memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Terminal Memory T-Lymphocyte to Cytotoxic Terminal Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx Term Mem GH Sub/TLym Cytx TLym Cytx Term Mem GH Sub/TLymC A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic terminal memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic Terminal Memory TLym Cytx Term Mem GH Sub/TLym Cytx Term Mem TLym Cytx Term Mem GH Sub/TLymCTM TLym Cytx Term Mem Gut-Homing Sub/TLymCTM A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic terminal memory T-lymphocytes to total cytotoxic terminal memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation to Cytotoxic Terminal Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory Skin-Homing/T-Lymphocytes Cytotoxic Terminal Memory TLym Cytx Term Mem SH/TLym Cytx Term Mem TLym Cytx Term Mem SH/TLymCTM A relative measurement (ratio or percentage) of the skin-homing cytotoxic terminal memory T-lymphocytes to total cytotoxic terminal memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Terminal Memory T-Lymphocyte to Cytotoxic Terminal Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx Term Mem SH Sub/TLym Cytx TLym Cytx Term Mem SH Sub/TLymC A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic terminal memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic Terminal Memory TLym Cytx Term Mem SH Sub/TLym Cytx Term Mem TLym Cytx Term Mem SH Sub/TLymCTM TLym Cytx Term Mem Skin-Homing Sub/TLymCTM A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic terminal memory T-lymphocytes to total cytotoxic terminal memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation to Cytotoxic Terminal Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Memory Gut-Homing Sub-Population/T-Lymphocytes Helper Memory TLym Help Mem GH Sub/TLym Help Mem TLym Help Mem GH Sub/TLymHM A relative measurement (ratio or percentage) of a sub-population of gut-homing helper memory T-lymphocytes to total helper memory T-lymphocytes in a biological specimen. Gut-Homing Helper Memory T-Lymphocyte Subpopulation to Helper Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Memory Skin-Homing Sub-Population/T-Lymphocytes Helper Memory TLym Help Mem SH Sub/TLym Help Mem TLym Help Mem SH Sub/TLymHM A relative measurement (ratio or percentage) of a sub-population of skin-homing helper memory T-lymphocytes to total helper memory T-lymphocytes in a biological specimen. Skin-Homing Helper Memory T-Lymphocyte Subpopulation to Helper Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Central Memory Gut-Homing/T-Lymphocytes Helper Central Memory TLym Help Cen Mem GH/TLym Help Cen Mem TLym Help Cen Mem GH/TLymHCM A relative measurement (ratio or percentage) of the gut-homing helper central memory T-lymphocytes to total helper central memory T-lymphocytes in a biological specimen. Gut-Homing Helper Central Memory T-Lymphocyte to Helper Central Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Central Memory Gut-Homing Sub-Population/T-Lymphocytes Helper TLym Help Cen Mem GH Sub/TLym Help TLym Help Cen Mem GH Sub/TLymH A relative measurement (ratio or percentage) of a sub-population of gut-homing helper central memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Gut-Homing Helper Central Memory T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Central Memory Gut-Homing Sub-Population/T-Lymphocytes Helper Central Memory TLym Help Cen Mem GH Sub/TLym Help Cen Mem TLym Help Cen Mem GH Sub/TLymHCM TLym Help Cen Mem Gut-Homing Sub/TLymHCM A relative measurement (ratio or percentage) of a sub-population of gut-homing helper central memory T-lymphocytes to total helper central memory T-lymphocytes in a biological specimen. Gut-Homing Helper Central Memory T-Lymphocyte Subpopulation to Helper Central Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Central Memory Skin-Homing/T-Lymphocytes Helper Central Memory TLym Help Cen Mem SH/TLym Help Cen Mem TLym Help Cen Mem SH/TLymHCM A relative measurement (ratio or percentage) of the skin-homing helper central memory T-lymphocytes to total helper central memory T-lymphocytes in a biological specimen. Skin-Homing Helper Central Memory T-Lymphocyte to Helper Central Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Central Memory Skin-Homing Sub-Population/T-Lymphocytes Helper TLym Help Cen Mem SH Sub/TLym Help TLym Help Cen Mem SH Sub/TLymH A relative measurement (ratio or percentage) of a sub-population of skin-homing helper central memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Skin-Homing Helper Central Memory T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Central Memory Skin-Homing Sub-Population/T-Lymphocytes Helper Central Memory TLym Help Cen Mem SH Sub/TLym Help Cen Mem TLym Help Cen Mem SH Sub/TLymHCM TLym Help Cen Mem Skin-Homing Sub/TLymHCM A relative measurement (ratio or percentage) of a sub-population of skin-homing helper central memory T-lymphocytes to total helper central memory T-lymphocytes in a biological specimen. Skin-Homing Helper Central Memory T-Lymphocyte Subpopulation to Helper Central Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Effector Memory Gut-Homing/T-Lymphocytes Helper Effector Memory TLym Help Eff Mem GH/TLym Help Eff Mem TLym Help Eff Mem GH/TLymHEM A relative measurement (ratio or percentage) of the gut-homing helper effector memory T-lymphocytes to total helper effector memory T-lymphocytes in a biological specimen. Gut-Homing Helper Effector Memory T-Lymphocyte to Helper Effector Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Effector Memory Gut-Homing Sub-Population/T-Lymphocytes Helper TLym Help Eff Mem GH Sub/TLym Help TLym Help Eff Mem GH Sub/TLymH A relative measurement (ratio or percentage) of a sub-population of gut-homing helper effector memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Gut-Homing Helper Effector Memory T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Effector Memory Gut-Homing Sub-Population/T-Lymphocytes Helper Effector Memory TLym Help Eff Mem GH Sub/TLym Help Eff Mem TLym Help Eff Mem GH Sub/TLymHEM TLym Help Eff Mem Gut-Homing Sub/TLymHEM A relative measurement (ratio or percentage) of a sub-population of gut-homing helper effector memory T-lymphocytes to total helper effector memory T-lymphocytes in a biological specimen. Gut-Homing Helper Effector Memory T-Lymphocyte Subpopulation to Helper Effector Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Effector Memory Skin-Homing/T-Lymphocytes Helper Effector Memory TLym Help Eff Mem SH/TLym Help Eff Mem TLym Help Eff Mem SH/TLymHEM A relative measurement (ratio or percentage) of the skin-homing helper effector memory T-lymphocytes to total helper effector memory T-lymphocytes in a biological specimen. Skin-Homing Helper Effector Memory T-Lymphocyte to Helper Effector Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Effector Memory Skin-Homing Sub-Population/T-Lymphocytes Helper TLym Help Eff Mem SH Sub/TLym Help TLym Help Eff Mem SH Sub/TLymH A relative measurement (ratio or percentage) of a sub-population of skin-homing helper effector memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Skin-Homing Helper Effector Memory T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Effector Memory Skin-Homing Sub-Population/T-Lymphocytes Helper Effector Memory TLym Help Eff Mem SH Sub/TLym Help Eff Mem TLym Help Eff Mem SH Sub/TLymHEM TLym Help Eff Mem Skin-Homing Sub/TLymHEM A relative measurement (ratio or percentage) of a sub-population of skin-homing helper effector memory T-lymphocytes to total helper effector memory T-lymphocytes in a biological specimen. Skin-Homing Helper Effector Memory T-Lymphocyte Subpopulation to Helper Effector Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Terminal Memory Gut-Homing/T-Lymphocytes Helper Terminal Memory TLym Help Term Mem GH/TLym Help Term Mem TLym Help Term Mem GH/TLymHTM A relative measurement (ratio or percentage) of the gut-homing helper terminal memory T-lymphocytes to total helper terminal memory T-lymphocytes in a biological specimen. Gut-Homing Helper Terminal Memory T-Lymphocyte to Helper Terminal Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Terminal Memory Gut-Homing Sub-Population/T-Lymphocytes Helper TLym Help Term Mem GH Sub/TLym Help TLym Help Term Mem GH Sub/TLymH A relative measurement (ratio or percentage) of a sub-population of gut-homing helper terminal memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Gut-Homing Helper Terminal Memory T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Terminal Memory Gut-Homing Sub-Population/T-Lymphocytes Helper Terminal Memory TLym Help Term Mem GH Sub/TLym Help Term Mem TLym Help Term Mem GH Sub/TLymHTM A relative measurement (ratio or percentage) of a sub-population of gut-homing helper terminal memory T-lymphocytes to total helper terminal memory T-lymphocytes in a biological specimen. Gut-Homing Helper Terminal Memory T-Lymphocyte Subpopulation to Helper Terminal Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Terminal Memory Skin-Homing/T-Lymphocytes Helper Terminal Memory TLym Help Term Mem SH/TLym Help Term Mem TLym Help Term Mem SH/TLymHTM A relative measurement (ratio or percentage) of the skin-homing helper terminal memory T-lymphocytes to total helper terminal memory T-lymphocytes in a biological specimen. Skin-Homing Helper Terminal Memory T-Lymphocyte to Helper Terminal Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Terminal Memory Skin-Homing Sub-Population/T-Lymphocytes Helper TLym Help Term Mem SH Sub/TLym Help TLym Help Term Mem SH Sub/TLymH A relative measurement (ratio or percentage) of a sub-population of skin-homing helper terminal memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Skin-Homing Helper Terminal Memory T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Terminal Memory Skin-Homing Sub-Population/T-Lymphocytes Helper Terminal Memory TLym Help Term Mem SH Sub/TLym Help Term Mem TLym Help Term Mem SH Sub/TLymHTM A relative measurement (ratio or percentage) of a sub-population of skin-homing helper terminal memory T-lymphocytes to total helper terminal memory T-lymphocytes in a biological specimen. Skin-Homing Helper Terminal Memory T-Lymphocyte Subpopulation to Helper Terminal Memory T-Lymphocyte Ratio Measurement Granulocytes//Non-TBNK Leukocytes Granulocytes/Non-TBNK Leuk A relative measurement (ratio or percentage) of granulocytes to the non-classical monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. Granulocyte to Non-TBNK Leukocyte Ratio Measurement B-Lymphocytes/Non-TNK Leukocytes BLym/Non-TNK Leuk A relative measurement (ratio or percentage) of B-lymphocytes to leukocytes that are not T cells or natural killer cells in a biological specimen. B-Lymphocyte to Non-TNK Leukocyte Ratio Measurement Non-TBNK Leuk Sub/Non-TBNK Leuk Non-TBNK Leukocytes Sub-Population/Non-TBNK Leukocytes A relative measurement (ratio or percentage) of a sub-population of leukocytes that are not T cells, B cells or natural killer cells to leukocytes that are not T cells, B cells or natural killer cells in a biological specimen. Non-TBNK Leukocyte Subpopulation to Non-TBNK Leukocyte Ratio Measurement MDSC Sub/Non-TBNK Leuk Myeloid Derived Suppressor Cell Sub-Population/Non-TBNK Leukocytes A relative measurement (ratio or percentage) of a sub-population of myeloid derived suppressor cells to leukocytes that are not T cells, B cells or natural killer cells in a biological specimen. Myeloid Derived Suppressor Cell Subpopulation to Non-TBNK Leukocyte Ratio Measurement Natural Killer Cells/Non-TB Leukocytes NK Cells/Non-TB Leuk A relative measurement (ratio or percentage) of natural killer cells to leukocytes that are not T cells or B cells in a biological specimen. Natural Killer Cell to Non-TB Leukocyte Ratio Measurement DC/Non-TBNK Leuk Dendritic Cells/Non-TBNK Leukocytes A relative measurement (ratio or percentage) of dendritic cells to leukocytes that are not T cells, B cells or natural killer cells in a biological specimen. Dendritic Cell to Non-TBNK Leukocyte Ratio Measurement B-Lymphocytes Memory Class-Switched/Leukocytes B-Lymphocytes Memory Switched/Leukocytes BLym Mem Sw/Leuk A relative measurement (ratio or percentage) of class-switched memory B-lymphocytes to leukocytes in a biological specimen. Class-switched Memory B-Lymphocyte to Leukocyte Ratio Measurement B-Lymphocytes Memory Class-Switched Sub-Population/B-Lymphocytes Memory Class-Switched Sub-Population B-Lymphocytes Memory Switched Sub-Population/B-Lymphocytes Memory Switched Sub-Population BLym Mem Sw Sub/BLymMSwS A relative measurement (ratio or percentage) of a sub-population of class-switched memory B-lymphocytes to a sub-population of class-switched memory B-lymphocytes. Class-switched Memory B-Lymphocyte Subpopulation to Class-switched Memory B-Lymphocyte Sub-population Ratio Measurement B-Lymphocytes Memory Class-Switched Sub-Population/Leukocytes B-Lymphocytes Memory Switched Sub-Population/Leukcoytes BLym Mem Sw Sub/Leuk A relative measurement (ratio or percentage) of a sub-population of class-switched memory B-lymphocytes to leukocytes in a biological specimen. Class-switched Memory B-Lymphocyte Subpopulation to Leukocyte Ratio Measurement B-Lymphocytes Memory Switched Unconventional IgG+/B-Lymphocytes Memory Switched Unconventional BLym Mem Sw Uncv IgG+/BLym Mem Sw Uncv A relative measurement (ratio or percentage) of the unconventional class-switched IgG-positive memory B-lymphocytes to total unconventional class-switched memory B-lymphocytes in a biological specimen. Unconventional Class-switched IgG-positive Memory B-Lymphocyte to Unconventional Class-switched Memory B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Switched Unconventional IgM+ BLym Mem Sw Uncv IgM+ A measurement of the IgM+ class-switched unconventional memory B-lymphocytes in a biological specimen. Unconventional Class-switched IgM-positive Memory B-Lymphocyte Count B-Lymphocytes Memory Switched Unconventional IgM+/B-Lymphocytes Memory Switched Unconventional BLym Mem Sw Uncv IgM+/BLym Mem Sw Uncv BLym Mem Sw Uncv IgM+/BLymMSwU A relative measurement (ratio or percentage) of the IgM+ class-switched unconventional memory B-lymphocytes to total class-switched unconventional memory B-lymphocytes in a biological specimen. Unconventional Class-switched IgM-positive Memory B-Lymphocyte to Unconventional Class-switched Memory B-Lymphocyte Ratio Measurement Granulocytes Sub-Population/Granulocytes Sub-Population Granulocytes Sub/Granulocytes Sub A relative measurement (ratio or percentage) of a sub-population of granulocytes to a sub-population of granulocytes in a biological specimen. Granulocyte Subpopulation to Granulocyte Subpopulation Ratio Measurement ILC1 Sub-Population/ILC Sub-Population Innate LC1 Sub/ILC Sub Innate Lymphoid Cells Type 1 Sub-Population/Innate Lymphoid Cells Sub-Population A relative measurement (ratio or percentage) of a sub-population of type 1 innate lymphoid cells to a sub-population of innate lymphoid cells in a biological specimen. Type 1 Innate Lymphoid Cell Subpopulation to Innate Lymphoid Cell Subpopulation Ratio Measurement ILC1 Sub/ILC1 Sub Innate LC1 Sub/ILC1 Sub Innate Lymphoid Cells Type 1 Sub-Population/Innate Lymphoid Cells Type 1 Sub-Population A relative measurement (ratio or percentage) of a sub-population of type 1 innate lymphoid cells to a sub-population of type 1 innate lymphoid cells in a biological specimen. Type 1 Innate Lymphoid Cell Subpopulation to Type 1 Innate Lymphoid Cell Subpopulation Ratio Measurement ILC2 Sub-Population/ILC Sub-Population Innate LC2 Sub/ILC Sub Innate Lymphoid Cells Type 2 Sub-Population/Innate Lymphoid Cells Sub-Population A relative measurement (ratio or percentage) of a sub-population of type 2 innate lymphoid cells to a sub-population of innate lymphoid cells in a biological specimen. Type 2 Innate Lymphoid Cell Subpopulation to Innate Lymphoid Cell Subpopulation Ratio Measurement ILC2 Sub-Population/ILC2 Sub-Population Innate LC2 Sub/ILC2 Sub Innate Lymphoid Cells Type 2 Sub-Population/Innate Lymphoid Cells Type 2 Sub-Population A relative measurement (ratio or percentage) of a sub-population of type 2 innate lymphoid cells to a sub-population of type 2 innate lymphoid cells in a biological specimen. Type 2 Innate Lymphoid Cell Subpopulation to Type 2 Innate Lymphoid Cell Subpopulation Ratio Measurement ILC3 Sub-Population/ILC Sub-Population Innate LC3 Sub/ILC Sub Innate Lymphoid Cells Type 3 Sub-Population/Innate Lymphoid Cells Sub-Population A relative measurement (ratio or percentage) of a sub-population of type 3 innate lymphoid cells to a sub-population of innate lymphoid cells in a biological specimen. Type 3 Innate Lymphoid Cell Subpopulation to Innate Lymphoid Cell Subpopulation Ratio Measurement ILC3 Sub-Population/ILC3 Sub-Population Innate LC3 Sub/ILC3 Sub Innate Lymphoid Cells Type 3 Sub-Population/Innate Lymphoid Cells Type 3 Sub-Population A relative measurement (ratio or percentage) of a sub-population of type 3 innate lymphoid cells to a sub-population of type 3 innate lymphoid cells in a biological specimen. Type 3 Innate Lymphoid Cell Subpopulation to Type 3 Innate Lymphoid Cell Subpopulation Ratio Measurement iNKT Sub-Population/iNKT Sub-Population Natural Killer T-Lymphocytes Invariant Sub-Population/Natural Killer T-Lymphocytes Invariant Sub-Population NK TLym Invar Sub/NKT Invar Sub A relative measurement (ratio or percentage) of a sub-population of invariant natural killer T-lymphocytes to a sub-population of invariant natural killer T-lymphocytes in a biological specimen. Invariant Natural Killer T-Lymphocyte Subpopulation to Invariant Natural Killer T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Peripheral Sub-Population/T-Lymphocytes Helper Peripheral Sub-Population TLym Help Peripheral Sub/TLym Help Sub TLym Help Peripheral Sub/TLymHPS Tph Sub/Tph Sub A relative measurement (ratio or percentage) of a sub-population of peripheral helper T-lymphocytes to a sub-population of peripheral helper T-lymphocytes in a biological specimen. Peripheral Helper T-Lymphocyte Subpopulation to Peripheral Helper T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Peripheral Sub-Population/T-Lymphocytes Helper Memory Sub-Population TLym Help Peripheral Sub/TLym Help Mem Sub TLym Help Peripheral Sub/TLymHMS Tph Sub/TLym Help Mem Sub A relative measurement (ratio or percentage) of a sub-population of peripheral helper T-lymphocytes to a sub-population of memory helper T-lymphocytes in a biological specimen. Peripheral Helper T-Lymphocyte Subpopulation to Helper Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Cytotoxic Central Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic Central Memory Gut-Homing Sub-Population TLym Cytx Cen Mem GH Sub/TLym Cytx Cen Mem GH Sub TLym Cytx Cen Mem GH Sub/TLymCCMGHS A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic central memory T-lymphocytes to a sub-population of gut-homing cytotoxic central memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation to Gut-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Cytotoxic Central Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic Central Memory Skin-Homing Sub-Population TLym Cytx Cen Mem SH Sub/TLym Cytx Cen Mem SH Sub TLym Cytx Cen Mem SH Sub/TLymCCMSHS A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic central memory T-lymphocytes to a sub-population of skin-homing cytotoxic central memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation to Skin-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Cytotoxic Central Memory Sub-Population/T-Lymphocytes Central Memory Sub-Population TLym Cytx Cen Mem Sub/TLym Cytx Cen Mem Sub TLym Cytx Cen Mem Sub/TLymCCMS A relative measurement (ratio or percentage) of a sub-population of cytotoxic central memory T-lymphocytes to a sub-population of cytotoxic central memory T-lymphocytes in a biological specimen. Central Memory Cytotoxic T-Lymphocyte Subpopulation to Central Memory Cytotoxic T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic Effector Memory Gut-Homing Sub-Population TLym Cytx Eff Mem GH Sub/TLym Cytx Eff Mem GH Sub TLym Cytx Eff Mem GH Sub/TLymCEMGHS A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic effector memory T-lymphocytes to a sub-population of gut-homing cytotoxic effector memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation to Gut-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic Effector Memory Skin-Homing Sub-Population TLym Cytx Eff Mem SH Sub/TLym Cytx Eff Mem SH Sub TLym Cytx Eff Mem SH Sub/TLymCEMSHS A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic effector memory T-lymphocytes to a sub-population of skin-homing cytotoxic effector memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation to Skin-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Cytotoxic Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic Memory Gut-Homing Sub-Population TLym Cytx Mem GH Sub/TLym Cytx Mem GH Sub TLym Cytx Mem GH Sub/TLymCMGHS A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic memory T-lymphocytes to a sub-population of gut-homing cytotoxic memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Memory T-Lymphocyte Subpopulation to Gut-Homing Cytotoxic Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Cytotoxic Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic Memory Skin-Homing Sub-Population TLym Cytx Mem SH Sub/TLym Cytx Mem SH Sub TLym Cytx Mem SH Sub/TLymCMSHS A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic memory T-lymphocytes to a sub-population of skin-homing cytotoxic memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Memory T-Lymphocyte Subpopulation to Skin-Homing Cytotoxic Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Cytotoxic Naive Sub-Population/T-Lymphocytes Cytotoxic Naive Sub-Population TLym Cytx Naive Sub/TLym Cytx Naive Sub TLym Cytx Naive Sub/TLymCNS A relative measurement (ratio or percentage) of a sub-population of cytotoxic naive T-lymphocytes to a sub-population of cytotoxic naive T-lymphocytes in a biological specimen. Naive Cytotoxic T-Lymphocyte Subpopulation to Naive Cytotoxic T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Cytotoxic Stem Cell Memory Sub-Population/T-Lymphocytes Cytotoxic Stem Cell Memory Sub-Population TLym Cytx SC Mem Sub/TLym Cytx SC Mem Sub TLym Cytx SC Mem Sub/TLymCSCMS A relative measurement (ratio or percentage) of a sub-population of cytotoxic stem cell memory T-lymphocytes to a sub-population of cytotoxic stem cell memory T-lymphocytes in a biological specimen. Stem Cell Memory Cytotoxic T-Lymphocyte Subpopulation to Stem Cell Memory Cytotoxic T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic Terminal Memory Gut-Homing Sub-Population TLym Cytx Term Mem GH Sub/TLym Cytx Term Mem GH Sub TLym Cytx Term Mem GH Sub/TLymCTMGHS A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic terminal memory T-lymphocytes to a sub-population of gut-homing cytotoxic terminal memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation to Gut-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic Terminal Memory Skin-Homing Sub-Population TLym Cytx Term Mem SH Sub/TLym Cytx Term Mem SH Sub TLym Cytx Term Mem SH Sub/TLymCTMSHS A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic terminal memory T-lymphocytes to a sub-population of skin-homing cytotoxic terminal memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation to Skin-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory Sub-Population/T-Lymphocytes Cytotoxic Terminal Memory Sub-Population TLym Cytx Term Mem Sub/TLym Cytx Term Mem Sub TLym Cytx Term Mem Sub/TLymCTMS A relative measurement (ratio or percentage) of a sub-population of cytotoxic terminal memory T-lymphocytes to a sub-population of cytotoxic terminal memory T-lymphocytes in a biological specimen. Terminal Memory Cytotoxic T-Lymphocyte Subpopulation to Terminal Memory Cytotoxic T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Central Memory Gut-Homing Sub-Population/T-Lymphocytes Helper Central Memory Gut-Homing Sub-Population TLym Help Cen Mem GH Sub/TLym Help Cen Mem GH Sub TLym Help Cen Mem GH Sub/TLymHCMGHS A relative measurement (ratio or percentage) of a sub-population of gut-homing helper central memory T-lymphocytes to a sub-population of gut-homing helper central memory T-lymphocytes in a biological specimen. Gut-Homing Helper Central Memory T-Lymphocyte Subpopulation to Gut-Homing Helper Central Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Central Memory Skin-Homing Sub-Population/T-Lymphocytes Helper Central Memory Skin-Homing Sub-Population TLym Help Cen Mem SH Sub/TLym Help Cen Mem SH Sub TLym Help Cen Mem SH Sub/TLymHCMSHS A relative measurement (ratio or percentage) of a sub-population of skin-homing helper central memory T-lymphocytes to a sub-population of skin-homing helper central memory T-lymphocytes in a biological specimen. Skin-Homing Helper Central Memory T-Lymphocyte Subpopulation to Skin-Homing Helper Central Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Central Memory Sub-Population/T-Lymphocytes Helper Central Memory Sub-Population TLym Help Cen Mem Sub/TLym Help Cen Mem Sub TLym Help Cen Mem Sub/TLymHCMS A relative measurement (ratio or percentage) of a sub-population of helper central memory T-lymphocytes to a sub-population of helper central memory T-lymphocytes in a biological specimen. Central Memory Helper T-Lymphocyte Subpopulation to Central Memory Helper T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Effector Memory Gut-Homing Sub-Population/T-Lymphocytes Helper Effector Memory Gut-Homing Sub-Population TLym Help Eff Mem GH Sub/TLym Help Eff Mem GH Sub TLym Help Eff Mem GH Sub/TLymHEMGHS A relative measurement (ratio or percentage) of a sub-population of gut-homing helper effector memory T-lymphocytes to a sub-population of gut-homing helper effector memory T-lymphocytes in a biological specimen. Gut-Homing Helper Effector Memory T-Lymphocyte Subpopulation to Gut-Homing Helper Effector Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Effector Memory Skin-Homing Sub-Population/T-Lymphocytes Helper Effector Memory Skin-Homing Sub-Population TLym Help Eff Mem SH Sub/TLym Help Eff Mem SH Sub TLym Help Eff Mem SH Sub/TLymHEMSHS A relative measurement (ratio or percentage) of a sub-population of skin-homing helper effector memory T-lymphocytes to a sub-population of skin-homing helper effector memory T-lymphocytes in a biological specimen. Skin-Homing Helper Effector Memory T-Lymphocyte Subpopulation to Skin-Homing Helper Effector Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Effector Memory Sub-Population/T-Lymphocytes Helper Effector Memory Sub-Population TLym Help Eff Mem Sub/TLym Help Eff Mem Sub TLym Help Eff Mem Sub/TLymHEMS A relative measurement (ratio or percentage) of a sub-population of helper effector memory T-lymphocytes to a sub-population of helper effector memory T-lymphocytes in a biological specimen. Effector Memory Helper T-Lymphocyte Subpopulation to Effector Memory Helper T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Follicular Sub-Population/T-Lymphocytes Helper Follicular Sub-Population TLym Help Foll Sub/TLym Help Foll Sub TLym Help Foll Sub/TLymHFS A relative measurement (ratio or percentage) of a sub-population of helper follicular T-lymphocytes to a sub-population of helper follicular T-lymphocytes in a biological specimen. Follicular Helper T-Lymphocyte Subpopulation to Follicular Helper T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Memory Gut-Homing Sub-Population/T-Lymphocytes Helper Memory Gut-Homing Sub-Population TLym Help Mem GH Sub/TLym Help Mem GH Sub TLym Help Mem GH Sub/TLymHMGHS A relative measurement (ratio or percentage) of a sub-population of gut-homing helper memory T-lymphocytes to a sub-population of gut-homing helper memory T-lymphocytes in a biological specimen. Gut-Homing Helper Memory T-Lymphocyte Subpopulation to Gut-Homing Helper Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Memory Skin-Homing Sub-Population/T-Lymphocytes Helper Memory Skin-Homing Sub-Population TLym Help Mem SH Sub/TLym Help Mem SH Sub TLym Help Mem SH Sub/TLymHMSHS A relative measurement (ratio or percentage) of a sub-population of skin-homing helper memory T-lymphocytes to a sub-population of skin-homing helper memory T-lymphocytes in a biological specimen. Skin-Homing Helper Memory T-Lymphocyte Subpopulation to Skin-Homing Helper Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Naive Sub-Population/T-Lymphocytes Helper Naive Sub-Population TLym Help Naive Sub/TLym Help Naive Sub TLym Help Naive Sub/TLymHNS A relative measurement (ratio or percentage) of a sub-population of helper naive T-lymphocytes to a sub-population of helper naive T-lymphocytes in a biological specimen. Naive Helper T-Lymphocyte Subpopulation to Naive Helper T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Regulatory Effector Sub-Population/T-Lymphocytes Helper Regulatory Effector Sub-Population TLym Help Reg Eff Sub/TLym Help Reg Eff Sub TLym Help Reg Eff Sub/TLymHRES A relative measurement (ratio or percentage) of a sub-population of helper regulatory effector T-lymphocytes to a sub-population of helper regulatory effector T-lymphocytes in a biological specimen. Regulatory Effector Helper T-Lymphocyte Subpopulation to Regulatory Effector Helper T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Regulatory Memory Sub-Population/T-Lymphocytes Helper Regulatory Memory Sub-Population TLym Help Reg Mem Sub/TLym Help Reg Mem Sub TLym Help Reg Mem Sub/TLymHRMS A relative measurement (ratio or percentage) of a sub-population of helper regulatory memory T-lymphocytes to a sub-population of helper regulatory memory T-lymphocytes in a biological specimen. Regulatory Memory Helper T-Lymphocyte Subpopulation to Regulatory Memory Helper T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Regulatory Naive Sub-Population/T-Lymphocytes Helper Regulatory Naive Sub-Population TLym Help Reg Naive Sub/TLym Help Reg Naive Sub TLym Help Reg Naive Sub/TLymHRNS A relative measurement (ratio or percentage) of a sub-population of helper regulatory naive T-lymphocytes to a sub-population of helper regulatory naive T-lymphocytes in a biological specimen. Naive Regulatory Helper T-Lymphocyte Subpopulation to Naive Regulatory Helper T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Regulatory Sub-Population/T-Lymphocytes Helper Regulatory Sub-Population TLym Help Reg Sub/TLym Help Reg Sub TLym Help Reg Sub/TLymHRS A relative measurement (ratio or percentage) of a sub-population of helper regulatory T-lymphocytes to a sub-population of helper regulatory T-lymphocytes in a biological specimen. Regulatory Helper T-Lymphocyte Subpopulation to Regulatory Helper T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Terminal Memory Gut-Homing Sub-Population/T-Lymphocytes Helper Terminal Memory Gut-Homing Sub-Population TLym Help Term Mem GH Sub/TLym Help Term Mem GH Sub TLym Help Term Mem GH Sub/TLymHTMGHS A relative measurement (ratio or percentage) of a sub-population of gut-homing helper terminal memory T-lymphocytes to a sub-population of gut-homing helper terminal memory T-lymphocytes in a biological specimen. Gut-Homing Helper Terminal Memory T-Lymphocyte Subpopulation to Gut-Homing Helper Terminal Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Terminal Memory Skin-Homing Sub-Population/T-Lymphocytes Helper Terminal Memory Skin-Homing Sub-Population TLym Help Term Mem SH Sub/TLym Help Term Mem SH Sub TLym Help Term Mem SH Sub/TLymHTMSHS A relative measurement (ratio or percentage) of a sub-population of skin-homing helper terminal memory T-lymphocytes to a sub-population of skin-homing helper terminal memory T-lymphocytes in a biological specimen. Skin-Homing Helper Terminal Memory T-Lymphocyte Subpopulation to Skin-Homing Helper Terminal Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Terminal Memory Sub-Population/T-Lymphocytes Helper Terminal Memory Sub-Population TLym Help Term Mem Sub/TLym Help Term Mem Sub TLym Help Term Mem Sub/TLymHTMS A relative measurement (ratio or percentage) of a sub-population of helper terminal memory T-Lymphocytes to a sub-population of helper terminal memory T-Lymphocytes in a biological specimen. Terminal Memory Helper T-Lymphocyte Subpopulation to Terminal Memory Helper T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory Sub-Population/T-Lymphocytes Cytotoxic Effector Memory Sub-Population TLym Cytx Eff Mem Sub/TLym Cytx Eff Mem Sub TLym Cytx Eff Mem Sub/TLymCEMS A relative measurement (ratio or percentage) of a sub-population of cytotoxic effector memory T-lymphocytes to a sub-population of cytotoxic effector memory T-lymphocytes in a biological specimen. Effector Memory Cytotoxic T-Lymphocyte Subpopulation to Effector Memory Cytotoxic T-Lymphocyte Subpopulation Ratio Measurement B-Lymphocytes Memory Non-Class-Switched IgG+/B-Lymphocytes Memory Non-Class-Switched B-Lymphocytes Memory Unswitched IgG+/B-Lymphocytes Memory Unswitched BLym Mem NSw IgG+/BLym Mem NSw BLym Mem NSw IgG+/BLymMNSw A relative measurement (ratio or percentage) of the IgG+ non-class-switched memory B-lymphocytes to total non-class-switched memory B-lymphocytes in a biological specimen. Non-class-switched IgG-positive Memory B-Lymphocyte to Non-class-switched Memory B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Non-Class-Switched IgM+/B-Lymphocytes Memory Non-Class-Switched B-Lymphocytes Memory Unswitched IgM+/B-Lymphocytes Memory Unswitched BLym Mem NSw IgM+/BLym Mem NSw BLym Mem NSw IgM+/BLymMNSw A relative measurement (ratio or percentage) of the IgM+ non-class-switched memory B-lymphocytes to total non-class-switched memory B-lymphocytes in a biological specimen. Non-class-switched IgM-positive Memory B-Lymphocyte to Non-class-switched Memory B-Lymphocyte Ratio Measurement Mono NonClassic Sub/Mono Intermed Monocytes Non-Classic Sub-Population/Monocytes Intermediate Monocytes Non-Classical Sub-Population/Monocytes Intermediate A relative measurement (ratio or percentage) of a sub-population of non-classical monocytes to intermediate monocytes in a biological specimen. Non-Classical Monocyte Subpopulation to Intermediate Monocyte Ratio Measurement Plasma Cells/B-Lymphocytes Memory Switched Plasma Cells/BLym Mem Sw Plasma Cells/BLymMSw A relative measurement (ratio or percentage) of the plasma cells to the class-switched memory B-lymphocytes in a biological specimen. Plasma Cell to Class-switched Memory B-Lymphocyte Ratio Measurement T-Lymphocytes Conventional Stem Cell Memory/T-Lymphocytes Conventional TLym Conv SC Mem/TLymCv A relative measurement (ratio or percentage) of conventional stem cell memory T-lymphocytes to the conventional T-lymphocytes in a biological specimen. Conventional Stem Cell Memory T-Lymphocyte to Conventional T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Effector Th17-like/T-Lymphocytes Helper Regulatory TLym Help Reg Eff Th17/TLym Help Reg A relative measurement (ratio or percentage) of a population of Th17-like helper regulatory effector T-lymphocytes to total helper regulatory T-lymphocytes in a biological specimen. Th17-like Regulatory Effector Helper T-Lymphocyte to Helper Regulatory T-Lymphocyte Ratio Measurement Lym+Mono Sub, Lin neg Lym+Mono Sub, Lin- Lymphocytes + Monocytes Subpopulation, Lineage Negative A measurement of a sub-population of cells containing both lymphocytes and monocytes, which do not express any of the lineage-defining markers assessed, in a biological specimen. Lineage Negative Lymphocyte and Monocyte Subpopulation Count cCD223 Expression Cytoplasmic CD223 Expression A measurement of cellular cytoplasmic CD223 expression in a biological specimen. Cytoplasmic CD223 Expression Measurement CD107a Expression LAMP-1 Expression Lysosomal-associated Membrane Protein 1 Expression A measurement of cellular CD107a expression in a biological specimen. CD107a Expression Measurement CD117 Expression A measurement of cellular CD117 expression in a biological specimen. CD117 Expression Measurement CD123 Expression CDC123 Expression Cell Division Cycle 123 Protein Expression A measurement of cellular CD123 expression in a biological specimen. CD123 Expression Measurement CD134 Expression OX40 Expression A measurement of cellular CD134 expression in a biological specimen. CD134 Expression Measurement CD137 Expression A measurement of cellular CD137 expression in a biological specimen. CD137 Expression Measurement CD152 Expression CTLA-4 Expression A measurement of cellular CD152 expression in a biological specimen. CD152 Expression Measurement CD154 Expression A measurement of cellular CD154 expression in a biological specimen. CD154 Expression Measurement CD156c Expression A measurement of cellular CD156c expression in a biological specimen. CD156c Expression Measurement CD159a Expression A measurement of cellular CD159a expression in a biological specimen. CD159a Expression Measurement CD159c Expression KLRC2 Expression NKG2C Expression A measurement of cellular CD159c expression in a biological specimen. CD159c Expression Measurement CD163 Expression M130 Expression A measurement of cellular CD163 expression in a biological specimen. CD163 Expression Measurement CD169 Expression A measurement of cellular CD169 expression in a biological specimen. CD169 Expression Measurement CD16 Expression A measurement of cellular CD16 expression in a biological specimen. CD16 Expression Measurement CD192 Expression A measurement of cellular CD192 expression in a biological specimen. CD192 Expression Measurement CD198 Expression A measurement of cellular CD198 expression in a biological specimen. CD198 Expression Measurement CD21 Expression A measurement of cellular CD21 expression in a biological specimen. CD21 Expression Measurement CD223 Expression LAG3 Expression A measurement of cellular CD223 expression in a biological specimen. CD223 Expression Measurement CD226 Expression A measurement of cellular CD226 expression in a biological specimen. CD226 Expression Measurement CD25 Expression A measurement of cellular CD25 expression in a biological specimen. CD25 Expression Measurement B-Cell Maturation Antigen Expression BCMA Expression CD269 Expression A measurement of cellular CD269 expression in a biological specimen. CD269 Expression Measurement CD274 Expression PD-L1 Expression A measurement of cellular CD274 expression in a biological specimen. CD274 Expression Measurement CD278 Expression ICOS Expression A measurement of cellular CD278 expression in a biological specimen. CD278 Expression Measurement CD279 Expression PD1 Expression A measurement of cellular CD279 expression in a biological specimen. CD279 Expression Measurement CD288 Expression TLR8 Expression A measurement of cellular CD288 expression in a biological specimen. CD288 Expression Measurement CD28 Expression A measurement of cellular CD28 expression in a biological specimen. CD28 Expression Measurement CD294 Expression CRTH2 Expression A measurement of cellular CD294 expression in a biological specimen. CD294 Expression Measurement CD314 Expression KLR Expression KLRK1 Expression NKG2D Expression A measurement of cellular CD314 expression in a biological specimen. CD314 Expression Measurement CD31 Expression PECAM1 Expression A measurement of cellular CD31 expression in a biological specimen. CD31 Expression Measurement CD32b Expression A measurement of cellular CD32b expression in a biological specimen. CD32b Expression Measurement CD32 Expression A measurement of cellular CD32 expression in a biological specimen. CD32 Expression Measurement CD337 Expression A measurement of cellular CD337 expression in a biological specimen. CD337 Expression Measurement CD366 Expression TIM3 Expression A measurement of cellular CD366 expression in a biological specimen. CD366 Expression Measurement CD38 Expression A measurement of cellular CD38 expression in a biological specimen. CD38 Expression Measurement CD40 Expression A measurement of cellular CD40 expression in a biological specimen. CD40 Expression Measurement CD57 Expression A measurement of cellular CD57 expression in a biological specimen. CD57 Expression Measurement CD5 Expression A measurement of cellular CD5 expression in a biological specimen. CD5 Expression Measurement CD64 Expression A measurement of cellular CD64 expression in a biological specimen. CD64 Expression Measurement CD69 Expression A measurement of cellular CD69 expression in a biological specimen. CD69 Expression Measurement CD71 Expression A measurement of cellular CD71 expression in a biological specimen. CD71 Expression Measurement CD73 Expression A measurement of cellular CD73 expression in a biological specimen. CD73 Expression Measurement CD79b Expression A measurement of cellular CD79b expression in a biological specimen. CD79b Expression Measurement CD80 Expression A measurement of cellular CD80 expression in a biological specimen. CD80 Expression Measurement CD83 Expression A measurement of cellular CD83 expression in a biological specimen. CD83 Expression Measurement CD86 Expression A measurement of cellular CD86 expression in a biological specimen. CD86 Expression Measurement CD95 Expression A measurement of cellular CD95 expression in a biological specimen. CD95 Cell Surface Expression Measurement CD96 Expression A measurement of cellular CD96 expression in a biological specimen. CD96 Expression Measurement Cells Total Cells A measurement of the total nucleated cells in a biological specimen. Cell Count Clonal Plasma Cells A measurement of the clonal plasma cells in a biological specimen. Clonal Plasma Cell Count Clonal Plasma Cells/Total Cells A relative measurement (ratio or percentage) of the clonal plasma cells to total cells in a biological specimen. Clonal Plasma Cell to Total Cell Ratio Measurement DC Dendritic Cells A measurement of the dendritic cells in a biological specimen. Dendritic Cells Count Dendritic Cells/Total Cells A relative measurement (ratio or percentage) of the dendritic cells to total cells in a biological specimen. Dendritic Cells to Total Cells Ratio Measurement DC/Leuk Dendritic Cells/Leukocytes A relative measurement (ratio or percentage) of dendritic cells to leukocytes in a biological specimen. Dendritic Cell to Leukocyte Ratio Measurement Dendritic Cells/Lym+Mono Dendritic Cells/Lymphocytes and Monocytes A relative measurement (ratio or percentage) of the dendritic cells to lymphocytes and monocytes in a biological specimen. Dendritic Cells to Lymphocytes and Monocytes Ratio Measurement cDC Conventional DC DC Myeloid Dendritic Cells Myeloid mDC A measurement of the myeloid dendritic cells in a biological specimen. Myeloid Dendritic Cell Count cDC1 Classical DC Type 1 Conventional DC Type 1 DC Myeloid 1 DC Myeloid Type 1 Dendritic Cells Myeloid 1 mDC1 A measurement of the type 1 myeloid dendritic cells in a biological specimen. Type 1 Myeloid Dendritic Cell Count cDC1/DC Classical DC Type 1/DC Conventional DC Type 1/DC DC Myeloid 1/DCM Dendritic Cells Myeloid 1/Dendritic Cells mDC1/DC A relative measurement (ratio or percentage) of the type 1 myeloid dendritic cells to total dendritic cells in a biological specimen. Type 1 Myeloid Dendritic Cell to Dendritic Cell Ratio Measurement cDC1/cDC Classical DC Type 1/Classical DC Conventional DC Type 1/Conventional DC DC Myeloid 1/DC Myeloid DC Myeloid 1/DCM mDC1/mDC A relative measurement (ratio or percentage) of the type 1 myeloid dendritic cells to total myeloid dendritic cells in a biological specimen. Type 1 Myeloid Dendritic Cell to Total Myeloid Dendritic Cell Ratio Measurement cDC1/Leukocytes Classical DC Type 1/Leukocytes Conventional DC Type 1/Leukocytes DC Myeloid 1/Leuk DC Myeloid 1/Leukocytes mDC1/Leukocytes A relative measurement (ratio or percentage) of the type 1 myeloid dendritic cells to leukocytes in a biological specimen. Type 1 Myeloid Dendritic Cell to Leukocyte Ratio Measurement cDC1 Sub-Population Classical DC Type 1 Sub-Population Conventional DC Type 1 Sub-Population DC Myeloid 1 Sub Dendritic Cells Myeloid 1 Sub-Population mDC1 Sub-Population A measurement of a sub-population of type 1 myeloid dendritic cells in a biological specimen. Type 1 Myeloid Dendritic Cell Subpopulation Count cDC1 Sub-Population/DC Classical DC Type 1 Sub-Population/DC Conventional DC Type 1 Sub-Population/DC DC Myeloid 1 Sub/DCM Dendritic Cells Myeloid 1 Sub-Population/Dendritic Cells mDC1 Sub-Population/DC A relative measurement (ratio or percentage) of a sub-population of the type 1 myeloid dendritic cells to total dendritic cells in a biological specimen. Type 1 Myeloid Dendritic Cell Subpopulation to Dendritic Cell Ratio Measurement cDC1 Sub-Population/cDC Classical DC Type 1 Sub-Population/Classical DC Conventional DC Type 1 Sub-Population/Conventional DC DC Myeloid 1 Sub/DCM Dendritic Cells Myeloid 1 Sub-Population/Dendritic Cells Myeloid mDC1 Sub-Population/mDC A relative measurement (ratio or percentage) of a sub-population of type 1 myeloid dendritic cells to total myeloid dendritic cells in a biological specimen. Type 1 Myeloid Dendritic Cell Subpopulation to Total Myeloid Dendritic Cell Ratio Measurement Classical DC Type 1 Sub-Population/Classical DC Type 1 Conventional DC Type 1 Sub-Population/Conventional DC Type 1 DC Myeloid 1 Sub-Population/DC Myeloid 1 DC Myeloid 1 Sub/DC Myeloid 1 DC Myeloid 1 Sub/DCM1 mDC1 Sub/mDC1 A relative measurement (ratio or percentage) of a sub-population of the type 1 myeloid dendritic cells to total type 1 myeloid dendritic cells in a biological specimen. Type 1 Myeloid Dendritic Cell Subpopulation to Type 1 Myeloid Dendritic Cell Ratio Measurement cDC2 Classical DC Type 2 Conventional DC Type 2 DC Myeloid 2 DC Myeloid Type 2 Dendritic Cells Myeloid 2 mDC2 A measurement of the type 2 myeloid dendritic cells in a biological specimen. Type 2 Myeloid Dendritic Cell Count cDC2/DC Classical DC Type 2/DC Conventional DC Type 2/DC DC Myeloid 2/DCM Dendritic Cells Myeloid 2/Dendritic Cells mDC2/DC A relative measurement (ratio or percentage) of the type 2 myeloid dendritic cells to total dendritic cells in a biological specimen. Type 2 Myeloid Dendritic Cell to Dendritic Cell Ratio Measurement cDC2/cDC Classical DC Type 2/Classical DC Conventional DC Type 2/Conventional DC DC Myeloid 2/DC Myeloid DC Myeloid 2/DCM mDC2/mDC A relative measurement (ratio or percentage) of the type 2 myeloid dendritic cells to total myeloid dendritic cells in a biological specimen. Type 2 Myeloid Dendritic Cell to Total Myeloid Dendritic Cell Ratio Measurement cDC2/Leukocytes Classical DC Type 2/Leukocytes Conventional DC Type 2/Leukocytes DC Myeloid 2/Leuk DC Myeloid 2/Leukocytes mDC2/Leukocytes A relative measurement (ratio or percentage) of the type 2 myeloid dendritic cells to leukocytes in a biological specimen. Type 2 Myeloid Dendritic Cell to Leukocyte Ratio Measurement cDC2 Sub-Population Classical DC Type 2 Sub-Population Conventional DC Type 2 Sub-Population DC Myeloid 2 Sub Dendritic Cells Myeloid 2 Sub-Population mDC2 Sub-Population A measurement of a sub-population of type 2 myeloid dendritic cells in a biological specimen. Type 2 Myeloid Dendritic Cell Subpopulation Count cDC2 Sub-Population/DC Classical DC Type 2 Sub-Population/DC Conventional DC Type 2 Sub-Population/DC DC Myeloid 2 Sub/DCM Dendritic Cells Myeloid 2 Sub-Population/Dendritic Cells mDC2 Sub-Population/DC A relative measurement (ratio or percentage) of a sub-population of the type 2 myeloid dendritic cells to total dendritic cells in a biological specimen. Type 2 Myeloid Dendritic Cell Subpopulation to Dendritic Cell Ratio Measurement cDC2 Sub-Population/cDC Classical DC Type 2 Sub-Population/Classical DC Conventional DC Type 2 Sub-Population/Conventional DC DC Myeloid 2 Sub/DCM Dendritic Cells Myeloid 2 Sub-Population/Dendritic Cells Myeloid mDC2 Sub-Population/mDC A relative measurement (ratio or percentage) of a sub-population of type 2 myeloid dendritic cells to total myeloid dendritic cells in a biological specimen. Type 2 Myeloid Dendritic Cell Subpopulation to Total Myeloid Dendritic Cell Ratio Measurement Classical DC Type 2 Sub-Population/Classical DC Type 2 Conventional DC Type 2 Sub-Population/Conventional DC Type 2 DC Myeloid 2 Sub-Population/DC Myeloid 2 DC Myeloid 2 Sub/DC Myeloid 2 DC Myeloid 2 Sub/DCM2 mDC2 Sub/mDC2 A relative measurement (ratio or percentage) of a sub-population of the type 2 myeloid dendritic cells to total type 2 myeloid dendritic cells in a biological specimen. Type 2 Myeloid Dendritic Cell Subpopulation to Type 2 Myeloid Dendritic Cell Ratio Measurement cDC3 Classical DC Type 3 Conventional DC Type 3 DC Myeloid 3 DC Myeloid Type 3 Dendritic Cells Myeloid 3 mDC3 A measurement of the type 3 myeloid dendritic cells in a biological specimen. Type 3 Myeloid Dendritic Cell Count cDC3/Leukocytes Classical DC Type 3/Leukocytes Conventional DC Type 3/Leukocytes DC Myeloid 3/Leuk DC Myeloid 3/Leukocytes mDC3/Leukocytes A relative measurement (ratio or percentage) of the type 3 myeloid dendritic cells to total leukocytes in a biological specimen. Type 3 Myeloid Dendritic Cell to Leukocyte Ratio Measurement Classical DC Type 3 Sub-Population/Classical DC Type 3 Conventional DC Type 3 Sub-Population/Conventional DC Type 3 DC Myeloid 3 Sub-Population/DC Myeloid 3 DC Myeloid 3 Sub/DC Myeloid 3 mDC3 Sub/mDC3 A relative measurement (ratio or percentage) of a sub-population of type 3 myeloid dendritic cells to type 3 myeloid dendritic cells in a biological specimen. Type 3 Myeloid Dendritic Cell Subpopulation to Type 3 Myeloid Dendritic Cell Ratio Measurement cDC4 Classical DC Type 4 Conventional DC Type 4 DC Myeloid 4 DC Myeloid Type 4 endritic Cells Myeloid 4 mDC4 A measurement of the type 4 myeloid dendritic cells in a biological specimen. Type 4 Myeloid Dendritic Cell Count cDC4/Leukocytes Classical DC Type 4/Leukocytes Conventional DC Type 4/Leukocytes DC Myeloid 4/Leuk DC Myeloid 4/Leukocytes mDC4/Leukocytes A relative measurement (ratio or percentage) of the type 4 myeloid dendritic cells to total leukocytes in a biological specimen. Type 4 Myeloid Dendritic Cell to Leukocyte Ratio Measurement Classical DC Type 4 Sub-Population/Classical DC Type 4 Conventional DC Type 4 Sub-Population/Conventional DC Type 4 DC Myeloid 4 Sub-Population/DC Myeloid 4 DC Myeloid 4 Sub/DC Myeloid 4 mDC4 Sub/mDC4 A relative measurement (ratio or percentage) of a sub-population of type 4 myeloid dendritic cells to type 4 myeloid dendritic cells in a biological specimen. Type 4 Myeloid Dendritic Cell Subpopulation to Type 4 Myeloid Dendritic Cell Ratio Measurement DC Myeloid Dbl Neg DC Myeloid Double Negative Dendritic Cells Myeloid Double Negative mDC DN A measurement of the double-negative myeloid dendritic cells (any myeloid dendritic cell that is both CD1c-CD141-) in a biological specimen. Double-Negative Myeloid Dendritic Cell Count DC Myeloid Dbl Neg/DC Myeloid Dendritic Cells Myeloid Double Negative/ Dendritic Cells Myeloid mDC DN/mDC A relative measurement (ratio or percentage) of the double negative myeloid dendritic cells to total myeloid dendritic cells in a biological specimen. Double-Negative Myeloid Dendritic Cell to Myeloid Dendritic Cell Ratio Measurement cDC/Leukocytes Classical DC/Leukocytes Conventional DC/Leukocytes DC Myeloid/Leuk DC Myeloid/Leukocytes mDC/Leukocytes A relative measurement (ratio or percentage) of the myeloid dendritic cells to leukocytes in a biological specimen. Myeloid Dendritic Cell to Leukocyte Ratio Measurement cDC/Myeloid Cells Classical DC/Myeloid Cells Conventional DC/Myeloid Cells DC Myeloid/Myeloid Cells Dendritic Cells Myeloid/Myeloid Cells mDC/Myeloid Cells A relative measurement (ratio or percentage) of the myeloid dendritic cells to total myeloid cells in a biological specimen. Myeloid Dendritic Cell to Myeloid Cell Ratio Measurement DC/Mono NonClassic Dendritic Cells/Monocytes Non-Classical A relative measurement (ratio or percentage) of dendritic cells to non-classical monocytes in a biological specimen. Dendritic Cell to Non-Classical Monocyte Ratio Measurement cDC/DC Classical DC/DC Conventional DC/DC DC Myeloid/DC Dendritic Cells Myeloid/Dendritic Cells mDC/DC A relative measurement (ratio or percentage) of the myeloid dendritic cells to total dendritic cells in a biological specimen. Myeloid Dendritic Cell to Total Dendritic Cell Ratio Measurement DC Myeloid Sub Dendritic Cells Myeloid Sub-Population A measurement of a sub-population of myeloid dendritic cells in a biological specimen. Myeloid Dendritic Cell Subpopulation Count cDC Sub-Population/DC Classical DC Sub-Population/DC Conventional DC Sub-Population/DC DC Myeloid Sub/DC Dendritic Cells Myeloid Sub-Population/Dendritic Cells mDC Sub-Population/DC A relative measurement (ratio or percentage) of a sub-population of myeloid dendritic cells to total dendritic cells in a biological specimen. Myeloid Dendritic Cell Subpopulation to Total Dendritic Cell Ratio Measurement DC Myeloid Sub/DC Myeloid Sub DC Myeloid Sub/DCMS Dendritic Cells Myeloid Sub-Population/Dendritic Cells Myeloid Sub-Population A relative measurement (ratio or percentage) of a sub-population of myeloid dendritic cells to a sub-population of myeloid dendritic cells in a biological specimen. Myeloid Dendritic Cell Sub-population to Myeloid Dendritic Cell Subpopulation Ratio Measurement cDC Sub-Population/cDC Classical DC Sub-Population/Classical DC Conventional DC Sub-Population/Conventional DC DC Myeloid Sub/DCM Dendritic Cells Myeloid Sub-Population/Dendritic Cells Myeloid mDC Sub-Population/mDC A relative measurement (ratio or percentage) of a sub-population of myeloid dendritic cells to total myeloid dendritic cells in a biological specimen. Myeloid Dendritic Cell Subpopulation to Total Myeloid Dendritic Cell Ratio Measurement DC/Myeloid Cells Dendritic Cells/Myeloid Cells A relative measurement (ratio or percentage) of the dendritic cells to total myeloid cells in a biological specimen. Dendritic Cell to Myeloid Cell Ratio Measurement DC Plasmacytoid Plasmacytoid Dendritic Cells A measurement of the plasmacytoid dendritic cells in a biological specimen. Plasmacytoid Dendritic Cell Count DC Plasmacytoid/DC DC Plasmacytoid/Dendritic Cells Plasmacytoid Dendritic Cells/Dendritic Cells A relative measurement (ratio or percentage) of the plasmacytoid dendritic cells to dendritic cells in a biological specimen. Plasmacytoid Dendritic Cells to Dendritic Cells Ratio Measurement DC Plasmacytoid/Leuk DC Plasmacytoid/Leukocytes Dendritic Cells Plasmacytoid/Leukocytes A relative measurement (ratio or percentage) of the plasmacytoid dendritic cells to total leukocytes in a biological specimen. Plasmacytoid Dendritic Cell to Leukocyte Ratio Measurement DC Plasmacytoid/Myeloid Cells pDC/Myeloid Cells A relative measurement (ratio or percentage) of the plasmacytoid dendritic cells to total myeloid cells in a biological specimen. Plasmacytoid Dendritic Cell to Myeloid Cell Ratio Measurement Dendritic Cell Precursor Cells Pre-DC Pre-Dendritic Cells Precursor Dendritic Cells PreDC A measurement of the precursor dendritic cells in a biological specimen. Pre-Dendritic Cell Count Pre-DC/DC Pre-Dendritic Cells/DC Pre-Dendritic Cells/Dendritic Cells Precursor Dendritic Cells/Dendritic Cells PreDC/DC A relative measurement (ratio or percentage) of the precursor dendritic cells to total dendritic cells in a biological specimen. Pre-Dendritic Cell to Dendritic Cell Ratio Measurement Dendritic Cell Precursor Cells Sub-Population Pre-DC Sub Pre-Dendritic Cells Sub Precursor Dendritic Cells Sub-Population PreDC Sub A measurement of a sub-population of precursor dendritic cells in a biological specimen. Pre-Dendritic Cell Subpopulation Count DC Plasmacytoid Sub Plasmacytoid Dendritic Cells Sub-Population A measurement of a sub-population of plasmacytoid dendritic cells in a biological specimen. Plasmacytoid Dendritic Cell Subpopulation Count DC Plasmacytoid Sub/DC Plasmacytoid Plasmacytoid Dendritic Cells Sub-Population/Plasmacytoid Dendritic Cells A relative measurement (ratio or percentage) of a sub-population of plasmacytoid dendritic cells to total plasmacytoid dendritic cells in a biological specimen. Plasmacytoid Dendritic Cells Subpopulation to Dendritic Cells Plasmacytoid Ratio Measurement DC Plasmacytoid Sub/DC Plasmacytoid Sub DC Plasmacytoid Sub/DCPS Dendritic Cells Plasmacytoid Sub-Population/Dendritic Cells Plasmacytoid Sub-Population A relative measurement (ratio or percentage) of a sub-population of plasmacytoid dendritic cells to a second sub-population of plasmacytoid dendritic cells (e.g., a child/parent based on two or more sub-population-defining markers) in a biological specimen. Plasmacytoid Dendritic Cell Subpopulation to Plasmacytoid Dendritic Cell Subpopulation Ratio Measurement DC Sub Dendritic Cells Sub-Population A measurement of a sub-population of dendritic cells in a biological specimen. Dendritic Cell Subpopulation Count DC Sub-Population/DC DC Sub/DC Dendritic Cell Sub-Population/Dendritic Cells A relative measurement (ratio or percentage) of a sub-population of dendritic cells to total dendritic cells in a biological specimen. Dendritic Cell Subpopulation to Dendritic Cell Ratio Measurement Endothelial Cells A measurement of the endothelial cells in a biological specimen. Endothelial Cell Count Eosinophils A measurement of the eosinophils in a biological specimen. Eosinophil Count Eosinophils/Total Cells A relative measurement (ratio or percentage) of the eosinophils to total cells in a biological specimen (for example a bone marrow specimen). Eosinophils to Total Cell Ratio Measurement Eosinophils/Leukocytes A relative measurement (ratio or percentage) of the eosinophils to leukocytes in a biological specimen. Eosinophil to Leukocyte Ratio Eosinophils/Nucleated Cells A relative measurement (ratio or percentage) of eosinophils to nucleated cells in a biological specimen. Eosinophils to Nucleated Cells Ratio Measurement Epithelial Cells A measurement of the epithelial cells in a biological specimen. Epithelial Cell Count Epithelial Cells/Total Cells A relative measurement (ratio or percentage) of the epithelial cells to total cells in a biological specimen. Epithelial Cells to Total Cells Ratio Measurement Fibroblasts A measurement of the fibroblasts in a biological specimen. Fibroblast Count FoxP3 Expression FP3 Expression A measurement of cellular FoxP3 expression in a biological specimen. FoxP3 Expression Measurement Granulocytes Polymorphonuclear Leukocytes A measurement of the granulocytes in a biological specimen. Granulocyte Count Gran/Leuk Granulocytes/Leukocytes Polymorphonuclear Leukocytes/Leukocytes A relative measurement (ratio or percentage) of the granulocytes to total leukocytes in a biological specimen. Granulocytes to Leukocytes Ratio Measurement Granulocytes Sub Granulocytes Sub-Population A measurement of a sub-population of granulocytes in a biological specimen. Granulocyte Subpopulation Count Granulocytes Sub-Population/Granulocytes Granulocytes Sub/Granulocytes A relative measurement (ratio or percentage) of a sub-population of granulocytes to total granulocytes in a biological specimen. Granulocytes Subpopulation to Granulocytes Ratio Measurement Granzyme B Expression GZB Expression GzmB Expression A measurement of cellular granzyme b expression in a biological specimen. GZB Expression Measurement HLADR Expression A measurement of cellular HLA-DR expression in a biological specimen. HLA-DR Cell Surface Expression Measurement IE Lym Intraepithelial Lymphocytes A measurement of the intraepithelial lymphocytes in a biological specimen. Intraepithelial Lymphocyte Count IgD Expression Immunoglobulin D Expression A measurement of cellular IgD expression in a biological specimen. IgD Expression Measurement IgG Expression Immunoglobulin G Expression A measurement of cellular IgG expression in a biological specimen. IgG Expression Measurement IgM Expression Immunoglobulin M Expression A measurement of cellular IgM expression in a biological specimen. IgM Expression Measurement ILC Innate LC Innate Lymphoid Cells A measurement of the innate lymphoid cells in a biological specimen. Innate Lymphoid Cell Count ILC1 Innate LC1 Innate Lymphoid Cells Type 1 A measurement of type 1 innate lymphoid cells in a biological specimen. Type 1 Innate Lymphoid Cell Count ILC1/ILC Innate LC1/ILC Innate Lymphoid Cells Type 1/Innate Lymphoid Cells A relative measurement (ratio or percentage) of type 1 innate lymphoid cells to total innate lymphoid cells in a biological specimen. Type 1 Innate Lymphoid Cell to Innate Lymphoid Cell Ratio Measurement ILC1/Leukocytes Innate LC1/Leuk Innate Lymphoid Cells Type 1/Leukocytes A relative measurement (ratio or percentage) of type 1 innate lymphoid cells to total leukocytes in a biological specimen. Type 1 Innate Lymphoid Cell to Leukocyte Ratio Measurement ILC1 Sub-Population Innate LC1 Sub Innate Lymphoid Cells Type 1 Sub-Population A measurement of a sub-population of type 1 innate lymphoid cells in a biological specimen. Type 1 Innate Lymphoid Cell Subpopulation Count ILC1 Sub-Population/ILC Innate LC1 Sub/ILC Innate Lymphoid Cells Type 1 Sub-Population/Innate Lymphoid Cells A relative measurement (ratio or percentage) of a sub-population of type 1 innate lymphoid cells to total innate lymphoid cells in a biological specimen. Type 1 Innate Lymphoid Cell Subpopulation to Innate Lymphoid Cell Ratio Measurement ILC1 Sub-Population/Leukocytes Innate LC1 Sub/Leuk Innate Lymphoid Cells Type 1 Sub-Population/Leukocytes A relative measurement (ratio or percentage) of a sub-population of type 1 innate lymphoid cells to total leukocytes in a biological specimen. Type 1 Innate Lymphoid Cell Subpopulation to Leukocyte Ratio Measurement ILC1 Sub-Population/ILC1 Innate LC1 Sub/ILC1 Innate Lymphoid Cells Type 1 Sub-Population/Innate Lymphoid Cells Type 1 A relative measurement (ratio or percentage) of a sub-population of type 1 innate lymphoid cells to total type 1 innate lymphoid cells in a biological specimen. Type 1 Innate Lymphoid Cell Subpopulation to Type 1 Innate Lymphoid Cell Ratio Measurement ILC2 Innate LC2 Innate Lymphoid Cells Type 2 A measurement of the type 2 innate lymphoid cells in a biological specimen. Type 2 Innate Lymphoid Cell Count ILC2/ILC Innate LC2/ILC Innate Lymphoid Cells Type 2/Innate Lymphoid Cells A relative measurement (ratio or percentage) of type 2 innate lymphoid cells to total innate lymphoid cells in a biological specimen. Type 2 Innate Lymphoid Cell to Innate Lymphoid Cell Ratio Measurement ILC2/Leukocytes Innate LC2/Leuk Innate Lymphoid Cells Type 2/Leukocytes A relative measurement (ratio or percentage) of type 2 innate lymphoid cells to total leukocytes in a biological specimen. Type 2 Innate Lymphoid Cell to Leukocyte Ratio Measurement ILC2 Sub Innate LC2 Sub Innate Lymphoid Cells Type 2 Sub-Population A measurement of a sub-population of type 2 innate lymphoid cells in a biological specimen. Type 2 Innate Lymphoid Cell Subpopulation Count ILC2 Sub-Population/ILC Innate LC2 Sub/ILC Innate Lymphoid Cells Type 2 Sub-Population/Innate Lymphoid Cells A relative measurement (ratio or percentage) of a sub-population of type 2 innate lymphoid cells to total innate lymphoid cells in a biological specimen. Type 2 Innate Lymphoid Cell Subpopulation to Innate Lymphoid Cell Ratio Measurement ILC2 Sub-Population/Leukocytes Innate LC2 Sub/Leuk Innate Lymphoid Cells Type 2 Sub-Population/Leukocytes A relative measurement (ratio or percentage) of a sub-population of type 2 innate lymphoid cells to total leukocytes in a biological specimen. Type 2 Innate Lymphoid Cell Subpopulation to Leukocyte Ratio Measurement ILC2 Sub-Population/ILC2 Innate LC2 Sub/ILC2 Innate Lymphoid Cells Type 2 Sub-Population/Innate Lymphoid Cells Type 2 A relative measurement (ratio or percentage) of a sub-population of type 2 innate lymphoid cells to total type 2 innate lymphoid cells in a biological specimen. Type 2 Innate Lymphoid Cell Subpopulation to Type 2 Innate Lymphoid Cell Ratio Measurement ILC3 Innate LC3 Innate Lymphoid Cells Type 3 A measurement of the type 3 innate lymphoid cells in a biological specimen. Type 3 Innate Lymphoid Cell Count ILC3/ILC Innate LC3/ILC Innate Lymphoid Cells Type 3/Innate Lymphoid Cells A relative measurement (ratio or percentage) of type 3 innate lymphoid cells to total innate lymphoid cells in a biological specimen. Type 3 Innate Lymphoid Cell to Innate Lymphoid Cell Ratio Measurement ILC3/Leukocytes Innate LC3/Leuk Innate Lymphoid Cells Type 3/Leukocytes A relative measurement (ratio or percentage) of type 3 innate lymphoid cells to total leukocytes in a biological specimen. Type 3 Innate Lymphoid Cell to Leukocyte Ratio Measurement ILC3 Sub Innate LC3 Sub Innate Lymphoid Cells Type 3 Sub-Population A measurement of a sub-population of type 3 innate lymphoid cells in a biological specimen. Type 3 Innate Lymphoid Cell Subpopulation Count ILC3 Sub-Population/ILC Innate LC3 Sub/ILC Innate Lymphoid Cells Type 3 Sub-Population/Innate Lymphoid Cells A relative measurement (ratio or percentage) of a sub-population of type 3 innate lymphoid cells to total innate lymphoid cells in a biological specimen. Type 3 Innate Lymphoid Cell Subpopulation to Innate Lymphoid Cell Ratio Measurement ILC3 Sub-Population/Leukocytes Innate LC3 Sub/Leuk Innate Lymphoid Cells Type 3 Sub-Population/Leukocytes A relative measurement (ratio or percentage) of a sub-population of type 3 innate lymphoid cells to total leukocytes in a biological specimen. Type 3 Innate Lymphoid Cell Subpopulation to Leukocyte Ratio Measurement ILC3 Sub-Population/ILC3 Innate LC3 Sub/ILC3 Innate Lymphoid Cells Type 3 Sub-Population/Innate Lymphoid Cells Type 3 A relative measurement (ratio or percentage) of a sub-population of type 3 innate lymphoid cells to total type 3 innate lymphoid cells in a biological specimen. Type 3 Innate Lymphoid Cell Subpopulation to Type 3 Innate Lymphoid Cell Ratio Measurement ILC Sub-Population Innate LC Sub Innate Lymphoid Cells Sub Innate Lymphoid Cells Sub-Population A measurement of a sub-population of innate lymphoid cells in a biological specimen. Innate Lymphoid Cell Subpopulation Count ILC Sub-Population/ILC Sub-Population Innate LC Sub/ILC Sub Innate Lymphoid Cells Sub-Population/Innate Lymphoid Cells Sub-Population A relative measurement (ratio or percentage) of a sub-population of innate lymphoid cells to a sub-population of innate lymphoid cells in a biological specimen. Innate Lymphoid Cell Subpopulation to Innate Lymphoid Cell Subpopulation Ratio Measurement ILC Sub/Leukocytes Innate LC Sub/Leuk Innate Lymphoid Cells Sub-Population/Leukocytes A relative measurement (ratio or percentage) of a sub-population of innate lymphoid cells to leukocytes in a biological specimen. Innate Lymphoid Cell Subpopulation to Leukocyte Ratio Measurement ILC Sub-Population/ILC Innate LC Sub/ILC Innate LC Sub/Innate LC Innate Lymphoid Cells Sub-Population/Innate Lymphoid Cells A relative measurement (ratio or percentage) of a sub-population of innate lymphoid cells to total innate lymphoid cells in a biological specimen. Innate Lymphoid Cell Subpopulation to Innate Lymphoid Cell Ratio Measurement Interpretation An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. Interpretation Ki67 Expression A measurement of cellular Ki67 expression in a biological specimen. Ki67 Cell Surface Expression Measurement KLRG1 Expression A measurement of cellular KLRG1 expression in a biological specimen. KLRG1 Expression Measurement Kappa+ PC Kappa+ Plasma Cells A measurement of the kappa+ plasma cells in a biological specimen. Kappa Positive Plasma Cell Count Kappa+ PC/Lambda+ PC Kappa+ Plasma Cells/Lambda+ Plasma Cells A relative measurement (ratio) of the kappa+ plasma cells to lambda+ plasma cells in a biological specimen. Kappa Positive Plasma Cell to Lambda Positive Plasma Cell Ratio Measurement Megakaryocytes/Total Cells A relative measurement (ratio or percentage) of the megakaryocytes to total cells in a biological specimen (for example a bone marrow specimen). Megakaryocyte to Total Cell Ratio Measurement Megakaryocytes/Leukocytes A relative measurement (ratio or percentage) of the megakaryocytes to leukocytes in a biological specimen. Megakaryocytes to Leukocytes Ratio Measurement Leuk NonViable/Leuk Leukocytes NonViable/Leukocytes A relative measurement (ratio) of nonviable leukocytes to total leukocytes in a biological specimen. Nonviable Leukocyte to Leukocyte Ratio Measurement Leuk Sub Leukocytes Sub-Population WBC Sub-Population White Blood Cell Sub-Population A measurement of a sub-population of leukocytes in a biological specimen. Leukocyte Subpopulation Count Leuk Sub/Leuk Sub Leukocytes Sub-Population/Leukocytes Sub-Population WBC Sub-Population/WBC Sub-Population White Blood Cell Sub-Population/White Blood Cell Sub-Population A relative measurement (ratio or percentage) of a sub-population of leukocytes to a sub-population of leukocytes in a biological specimen. Leukocyte Subpopulation to Leukocyte Subpopulation Ratio Measurement Leuk Sub/Leuk Leuk Sub/Leukocytes Leukocytes Sub-Population/Leukocytes WBC Sub-Population/WBC White Blood Cell Sub-Population/White Blood Cell A relative measurement (ratio or percentage) of a sub-population of leukocytes to total leukocytes in a biological specimen. Leukocyte Subpopulation to Leukocyte Ratio Measurement Leukocytes/Live Cells Leukocytes/Viable Cells Live Leukocytes/Live Cells Viable Leukocytes/Viable Cells A relative measurement (ratio) of leukocytes to total viable cells in a biological specimen. Leukocyte to Viable Cell Ratio Measurement Leuk Viable/Leuk Leukocytes Viable/Leukocytes A relative measurement (ratio) of viable leukocytes to total leukocytes in a biological specimen. Viable Leukocyte to Leukocyte Ratio Measurement Leuk Viable/Leuk NonViable Leukocytes Viable/Leukocytes NonViable A relative measurement (ratio) of viable leukocytes to non-viable leukocytes in a biological specimen. Viable Leukocyte to Nonviable Leukocyte Ratio Measurement Lambda+ PC Lambda+ Plasma Cells A measurement of the lambda+ plasma cells in a biological specimen. Lambda Positive Plasma Cell Count Lymphocytes A measurement of the lymphocytes in a biological specimen. Lymphocyte Count Lymphocytes/Total Cells A relative measurement (ratio or percentage) of the lymphocytes to total cells in a biological specimen (for example a bone marrow specimen). Lymphocyte to Total Cell Ratio Measurement Lymphocytes/Leukocytes A relative measurement (ratio or percentage) of the lymphocytes to leukocytes in a biological specimen. Lymphocyte to Leukocyte Ratio Lym+Mono Lymphocytes and Monocytes A measurement of a cell population containing both lymphocytes and monocytes in a biological specimen. Lymphocytes and Monocytes Count Lymphocytes and Monocytes/Leukocytes A relative measurement (ratio or percentage) of the lymphocytes and monocytes to total leukocytes in a biological specimen. Lymphocytes and Monocytes to Leukocytes Ratio Measurement Lym+Mono, Lin neg Lym+Mono, Lin- Lymphocytes + Monocytes, Lineage Negative A measurement of a cell population containing both lymphocytes and monocytes, which do not express any of the lineage-defining markers assessed, in a biological specimen. Lineage Negative Lymphocyte and Monocyte Count Lym+Mono Sub Lymphocytes + Monocytes Subpopulation A measurement of a cell sub-population containing both lymphocytes and monocytes in a biological specimen. Lymphocyte and Monocyte Subpopulation Count Lym Sub Lymphocytes Sub Lymphocytes Sub-Population A measurement of a sub-population of lymphocytes in a biological specimen. Lymphocytes Subpopulation Count Lym Sub-Population/WBC Lym Sub/Leuk Lymphocytes Sub-Population/Leukocytes Lymphocytes Sub-Population/White Blood Cells A relative measurement (ratio or percentage) of a sub-population of lymphocytes to total leukocytes in a biological specimen. Lymphocyte Subpopulation to Leukocyte Ratio Measurement Lym Sub/Lym Lymphocytes Sub-Population/Lymphocytes Lymphocytes Sub/Lymphocytes A relative measurement (ratio or percentage) of a sub-population of lymphocytes to lymphocytes in a biological specimen. Lymphocyte Subpopulation to Total Lymphocytes Ratio Measurement Lym Sub/Lym Sub Lymphocytes Sub-Population/Lymphocytes Sub-Population A relative measurement (ratio or percentage) of a sub-population of lymphocytes to a sub-population of lymphocytes in a biological specimen. Lymphocyte Subpopulation to Lymphocyte Subpopulation Ratio Measurement MAIT MAIT cells Mucosal-Associated Invariant T Cells Mucosal-Associated Invariant T-Lym Mucosal-Associated Invariant T-Lymphocytes A measurement of mucosal-associated invariant T-lymphocytes in a biological specimen. Mucosal-Associated Invariant T-Lymphocyte Count MAIT Cells/Leukocytes MAIT/Leuk Mucosal-Associated Invariant T-Lymphocytes/Leukocytes A relative measurement (ratio or percentage) of mucosal-associated invariant T-lymphocytes to leukocytes in a biological specimen. Mucosal-Associated Invariant T-Lymphocyte to Leukocyte Ratio Measurement MAIT cells Sub/MAIT cells MAIT Sub/MAIT Mucosal-Associated Invariant T Cells Sub-Population/Mucosal-Associated Invariant T Cells Mucosal-Associated Invariant T-Lymphocytes Sub-Population/Mucosal-Associated Invariant T-Lymphocytes A relative measurement of a sub-population of mucosal-associated invariant T-lymphocytes to all mucosal associated T-lymphocytes in a biological specimen. Mucosal-Associated Invariant T-Lymphocyte Subpopulation to Mucosal-Associated T-Lymphocyte Ratio Measurement MAIT Cells/T Cells MAIT/TLym Mucosal-Associated Invariant T Cells/T-Lymphocytes Mucosal-Associated Invariant T-Lymphocytes/T-Lymphocytes A relative measurement (ratio or percentage) of mucosal-associated invariant T-lymphocytes to T-lymphocytes in a biological specimen. Mucosal-Associated Invariant T-Lymphocyte to T-Lymphocyte Ratio Measurement Mast Cells Mastocytes A measurement of the mast cells in a biological specimen. Mast Cell Count Mast Cells/Total Cells A relative measurement (ratio or percentage) of the mast cells to total cells in a biological specimen. Mast Cell to Total Cell Ratio Measurement Macrophages A measurement of the macrophages in a biological specimen. Macrophage Count Macrophages/Total Cells A relative measurement (ratio or percentage) of the macrophages to total cells in a biological specimen. Macrophage to Total Cell Ratio Measurement Macrophages/Leukocytes A relative measurement (ratio or percentage) of the macrophages to leukocytes in a biological specimen. Macrophage to Leukocyte Ratio Macrophages M1 A measurement of the M1 macrophages in a biological specimen. M1 Macrophage Count Macrophages M2 A measurement of the M2 macrophages in a biological specimen. M2 Macrophage Count Macrophages/Monocytes A relative measurement (ratio or percentage) of the macrophages to monocytes in a biological specimen. Macrophage to Monocyte Ratio Measurement Macrophages/Myeloid Cells A relative measurement (ratio or percentage) of the macrophages to myeloid cells in a biological specimen. Macrophage to Myeloid Cell Ratio Measurement Macrophages Sub-Population/Macrophages Macrophages Sub/Macrophages A relative measurement (ratio or percentage) of a sub-population of macrophages to total macrophages in a biological specimen. Macrophage Subpopulation to Macrophage Ratio Measurement Macrophages Sub Macrophages Sub-Population A measurement of a sub-population of macrophages in a biological specimen. Macrophage Subpopulation Count Macrophages Sub-Population/Macrophages Sub-Population Macrophages Sub/Macrophages Sub A relative measurement (ratio or percentage) of a sub-population of macrophages to sub-population of macrophages in a biological specimen. Macrophage Subpopulation to Macrophage Subpopulation Ratio Measurement Myeloid Cells/Leuk Myeloid Cells/Leukocytes A relative measurement (ratio or percentage) of the myeloid cells to leukocytes in a biological specimen. Myeloid Cell to Leukocyte Ratio Measurement MDSC Myeloid-Derived Suppressor Cells A measurement of the myeloid-derived suppressor cells in a biological specimen. Myeloid-Derived Suppressor Cell Count G-MDSC gMDSC MDSC Gran Myeloid-Derived Suppressor Cells Granulocytic PMN-MDSC A measurement of the granulocytic myeloid-derived suppressor cells in a biological specimen. Granulocytic Myeloid-Derived Suppressor Cell Count MDSC Gran Sub Myeloid-Derived Suppressor Cells Granulocytic Sub-Population A measurement of a sub-population of granulocytic myeloid-derived suppressor cells in a biological specimen. Granulocytic Myeloid-Derived Suppressor Cell Subpopulation Count MDSC/Leuk Sub Myeloid-Derived Suppressor Cells/Leukocytes Sub-Population A relative measurement (ratio or percentage) of the myeloid-derived suppressor cells to a sub-population of leukocytes in a biological specimen. Myeloid Derived Suppressor Cell to Leukocyte Subpopulation Ratio Measurement MDSC/Lym+Mono MDSC/Lymphocytes and Monocytes Myeloid-Derived Suppressor Cells/Lymphocytes and Monocytes A relative measurement (ratio or percentage) of myeloid-derived suppressor cells to lymphocytes and monocytes in a biological specimen. Myeloid-Derived Suppressor Cell to Lymphocyte and Monocyte Ratio Measurement M-MDSC MDSC Mono mMDSC Myeloid-Derived Suppressor Cells Monocytic A measurement of the monocytic myeloid-derived suppressor cells in a biological specimen. Monocytic Myeloid-Derived Suppressor Cell Count MDSC Mono Sub Myeloid-Derived Suppressor Cells Monocytic Sub-Population A measurement of a sub-population of monocytic myeloid-derived suppressor cells in a biological specimen. Monocytic Myeloid-Derived Suppressor Cell Subpopulation Count MDSC Sub MDSC Sub-Population Myeloid-Derived Suppressor Cells Sub-Population A measurement of a sub-population of myeloid-derived suppressor cells in a biological specimen. Myeloid-Derived Suppressor Cell Subpopulation Count MDSC Dbl Neg Myeloid-Derived Suppressor Cells Double Negative A measurement of the double-negative myeloid-derived suppressor cells (any MDSC that is both CD14-CD15-) in a biological specimen. Double-Negative Myeloid-Derived Suppressor Cell Count MDSC Dbl Neg/MDSC Myeloid-Derived Suppressor Cells Double Negative/Myeloid-Derived Suppressor Cells A relative measurement (ratio or percentage) of the double negative myeloid-derived suppressor cells to all myeloid-derived suppressor cells in a biological specimen. Double-Negative Myeloid-Derived Suppressor Cell to Myeloid-Derived Suppressor Cell Ratio Measurement Double-Negative Myeloid-Derived Suppressor Cells Sub-Population MDSC Dbl Neg Sub MDSC Double-Negative Sub-Population A measurement of a sub-population of double-negative myeloid-derived suppressor cells in a biological specimen. Double-Negative Myeloid-Derived Suppressor Subpopulation Count MDSC Dbl Neg Sub/MDSC Myeloid-Derived Suppressor Cell Double Negative Sub-Population/Myeloid-Derived Suppressor Cells A relative measurement (ratio or percentage) of a sub-population of double-negative myeloid-derived suppressor cells to all myeloid-derived suppressor cells in a biological specimen. Double-Negative Myeloid-Derived Suppressor Cell Subpopulation to Myeloid-Derived Suppressor Cell Ratio Measurement MDSC Dbl Neg Sub/MDSC Dbl Neg Myeloid-Derived Suppressor Cell Double Negative Sub-Population/Myeloid-Derived Suppressor Cells Double Negative A relative measurement (ratio or percentage) of a sub-population of double-negative myeloid-derived suppressor cells to all double-negative myeloid-derived suppressor cells in a biological specimen. Double-Negative Myeloid-Derived Suppressor Cell Subpopulation to Double-Negative Myeloid-Derived Suppressor Cell Ratio Measurement MDSC Gran/Gran Myeloid-Derived Suppressor Cells Granulocytic/Granulocytes PMN-MDSC/Gran A relative measurement (ratio or percentage) of the granulocytic myeloid-derived suppressor cells to total granulocytes in a biological specimen. Granulocytic Myeloid-Derived Suppressor Cell to Granulocyte Ratio Measurement MDSC Gran/Leuk Myeloid-Derived Suppressor Cells Granulocytic/Leukocytes PMN-MDSC/Leuk A relative measurement (ratio or percentage) of the granulocytic myeloid-derived suppressor cells to total leukocytes in a biological specimen. Granulocytic Myeloid-Derived Suppressor Cell to Leukocyte Ratio Measurement MDSC Gran/Lym Sub Myeloid-Derived Suppressor Cells Granulocytic/Lymphocyte Sub-Population PMN-MDSC/Lym Sub A relative measurement (ratio or percentage) of the granulocytic myeloid-derived suppressor cells to a sub-population of lymphocytes in a biological specimen. Granulocytic Myeloid-Derived Suppressor Cell to Lymphocyte Subpopulation Ratio Measurement MDSC Gran/MDSC Myeloid-Derived Suppressor Cells Granulocytic/Myeloid-Derived Suppressor Cells PMN-MDSC/MDSC A relative measurement (ratio or percentage) of the granulocytic myeloid-derived suppressor cells to all myeloid-derived suppressor cells in a biological specimen. Granulocytic Myeloid-Derived Suppressor Cell to Myeloid-Derived Suppressor Cell Ratio Measurement MDSC Gran Sub/MDSC Myeloid-Derived Suppressor Cell Granulocytic Sub-Population/Myeloid-Derived Suppressor Cells PMN-MDSC Sub/MDSC A relative measurement (ratio or percentage) of a sub-population of granulocytic myeloid-derived suppressor cells to all myeloid-derived suppressor cells in a biological specimen. Granulocytic Myeloid-Derived Suppressor Cell Subpopulation to Myeloid-Derived Suppressor Cell Ratio Measurement MDSC Gran Sub/MDSC Gran Myeloid-Derived Suppressor Cells Granulocytic Sub-Population/Myeloid-Derived Suppressor Cells Granulocytic PMN-MDSC Sub/MDSC Gran A relative measurement (ratio or percentage) of a sub-population of granulocytic myeloid-derived suppressor cells to all granulocytic myeloid-derived suppressor cells in a biological specimen. Granulocytic Myeloid-Derived Suppressor Cell Subpopulation to Granulocytic Myeloid-Derived Suppressor Cell Ratio Measurement MDSC/Leuk Myeloid-Derived Suppressor Cells/Leukocytes A relative measurement (ratio or percentage) of the myeloid-derived suppressor cells to total leukocytes in a biological specimen. Myeloid-Derived Suppressor Cell to Leukocyte Ratio Measurement M-MDSC/Leuk MDSC Mono/Leuk Myeloid-Derived Suppressor Cells Monocytic/Leukocytes A relative measurement (ratio or percentage) of the monocytic myeloid-derived suppressor cells to total leukocytes in a biological specimen. Monocytic Myeloid-Derived Suppressor Cell to Leukocyte Ratio Measurement M-MDSC/Mono MDSC Mono/Mono Myeloid-Derived Suppressor Cells Monocytic/Monocytes A relative measurement (ratio) of the monocytic myeloid-derived suppressor cells to total monocytes in a biological specimen. Monocytic Myeloid-Derived Suppressor Cell to Monocyte Ratio Measurement M-MDSC/MDSC MDSC Mono/MDSC Myeloid-Derived Suppressor Cells Monocytic/Myeloid-Derived Suppressor Cells A relative measurement (ratio or percentage) of the monocytic myeloid-derived suppressor cells to total myeloid-derived suppressor cells in a biological specimen. Monocytic Myeloid-Derived Suppressor Cell to Myeloid-Derived Suppressor Cell Ratio Measurement M-MDSC Sub/MDSC MDSC Mono Sub/MDSC Myeloid-Derived Suppressor Cell Monocytic Sub-Population/Myeloid-Derived Suppressor Cells A relative measurement (ratio or percentage) of a sub-population of monocytic myeloid-derived suppressor cells to all myeloid-derived suppressor cells in a biological specimen. Monocytic Myeloid-Derived Suppressor Cell Subpopulation to Myeloid-Derived Suppressor Cell Ratio Measurement M-MDSC Sub/MDSC Mono MDSC Mono Sub/MDSC Mono Myeloid-Derived Suppressor Cell Monocytic Sub-Population/Myeloid-Derived Suppressor Cells Monocytic A relative measurement (ratio or percentage) of a sub-population of monocytic myeloid-derived suppressor cells to all monocytic myeloid-derived suppressor cells in a biological specimen. Monocytic Myeloid-Derived Suppressor Cell Subpopulation to Monocytic Myeloid-Derived Suppressor Cell Ratio Measurement MDSC/Leuk Non-Gran MDSC/Non-Gran Leuk Myeloid-Derived Suppressor Cells/Leukocytes Non-Granulocytic A relative measurement (ratio or percentage) of the myeloid-derived suppressor cells to total non-granulocytic leukocytes in a biological specimen. Myeloid-Derived Suppressor Cell to Non-Granulocytic Leukocyte Ratio Measurement MDSC Sub/Leuk Myeloid Derived Suppressor Cell Sub-Population/Leukocytes A relative measurement (ratio or percentage) of a sub-population of myeloid derived suppressor cells to leukocytes in a biological specimen. Myeloid Derived Suppressor Cell Subpopulation to Leukocyte Ratio Measurement MDSC Sub/MDSC Sub Myeloid-Derived Suppressor Cells Sub-Population/Myeloid-Derived Suppressor Cells Sub-Population A relative measurement (ratio or percentage) of a sub-population of myeloid-derived suppressor cells to a sub-population of myeloid-derived suppressor cells in a biological specimen. Myeloid-Derived Suppressor Cell Subpopulation to Myeloid-Derived Suppressor Cell Subpopulation Ratio Measurement MDSC Sub/MDSC Myeloid-Derived Suppressor Cell Sub-Population/Myeloid-Derived Suppressor Cells A relative measurement (ratio or percentage) of a sub-population of myeloid-derived suppressor cells to all myeloid-derived suppressor cells in a biological specimen. Myeloid-Derived Suppressor Cell Subpopulation to Myeloid-Derived Suppressor Cell Ratio Measurement Mono Classic Monocytes Classical A measurement of the classical monocytes in a biological specimen. Classic Monocytes Count Mono Classic/Leuk Monocytes Classic/Leukocytes A relative measurement (ratio or percentage) of the classical monocytes to total leukocytes in a biological specimen. Classical Monocyte to Leukocyte Ratio Measurement Mono Classic/Leuk Sub Monocytes Classic/Leukocytes Sub-Population Monocytes Classical/Leukocytes Sub-Population A relative measurement (ratio or percentage) of the classical monocytes to a sub-population of leukocytes in a biological specimen. Classical Monocyte to Leukocyte Subpopulation Ratio Measurement Mono Classic/Lym+Mono Monocytes Classic/Lymphocytes and Monocytes Monocytes Classical/Lymphocytes and Monocytes A relative measurement (ratio or percentage) of the classical monocytes to lymphocytes and monocytes in a biological specimen. Classical Monocyte to Lymphocyte and Monocyte Ratio Measurement Mono Classic/Lym Sub Monocytes Classic/Lymphocytes Sub-Population Monocytes Classical/Lymphocytes Sub-Population A relative measurement (ratio or percentage) of the classical monocytes to a sub-population of lymphocytes in a biological specimen. Classical Monocyte to Lymphocyte Subpopulation Ratio Measurement Mono Classic/Mono Monocytes Classic/Monocytes Monocytes Classical/Monocytes A relative measurement (ratio or percentage) of classical monocytes to monocytes in a biological specimen. Classical Monocyte to Monocyte Ratio Measurement Mono Classic/Myeloid Cells Monocytes Classic/Myeloid Cells A relative measurement (ratio or percentage) of the classical monocytes to total myeloid cells in a biological specimen. Classical Monocyte to Myeloid Cell Ratio Measurement Mono Classic Sub Monocytes Classical Sub-Population A measurement of a sub-population of classical monocytes in a biological specimen. Classical Monocyte Subpopulation Count Mono Classic Sub/Mono Classic Monocytes Classical Sub-Population/Monocytes Classical A relative measurement (ratio or percentage) of a sub-population of classical monocytes to total classical monocytes in a biological specimen. Classical Monocyte Subpopulation to Classical Monocyte Ratio Measurement Mono Inflamm Monocytes Inflammatory A measurement of the inflammatory monocytes in a biological specimen. Inflammatory Monocytes Count Mono Intermed Monocytes Intermediate A measurement of the intermediate monocytes in a biological specimen. Intermediate Monocytes Count Mono Intermed/Leuk Monocytes Intermediate/Leukocytes A relative measurement (ratio or percentage) of the intermediate monocytes to total leukocytes in a biological specimen. Intermediate Monocyte to Leukocyte Ratio Measurement Mono Intermed/Leuk Sub Monocytes Intermediate/Leukocytes Sub-Population A relative measurement (ratio or percentage) of the intermediate monocytes to a sub-population of leukocytes in a biological specimen. Intermediate Monocyte to Leukocyte Subpopulation Ratio Measurement Mono Intermed/Lym+Mono Monocytes Intermediate/Lymphocytes and Monocytes A relative measurement (ratio or percentage) of the intermediate monocytes to lymphocytes and monocytes in a biological specimen. Intermediate Monocyte to Lymphocyte and Monocyte Ratio Measurement Mono Intermed/Lym Sub Monocytes Intermediate/Lymphocytes Sub-Population A relative measurement (ratio or percentage) of the intermediate monocytes to a sub-population of lymphocytes in a biological specimen. Intermediate Monocytes to Lymphocyte Subpopulation Ratio Measurement Mono Intermed/Mono Monocytes Intermediate/Monocytes A relative measurement (ratio or percentage) of intermediate monocytes to monocytes in a biological specimen. Intermediate Monocyte to Monocyte Ratio Measurement Mono Intermed/Myeloid Cells Monocytes Intermediate/Myeloid Cells A relative measurement (ratio or percentage) of the intermediate monocytes to myeloid cells in a biological specimen. Intermediate Monocyte to Myeloid Cell Ratio Measurement Mono Intermed Sub Monocytes Intermediate Sub-Population A measurement of a sub-population of intermediate monocytes in a biological specimen. Intermediate Monocyte Subpopulation Count Mono Intermed Sub/Mono Int Mono Intermed Sub/Mono Intermed Monocytes Intermediate Sub-Population/Monocytes Intermediate A relative measurement (ratio or percentage) of a sub-population of intermediate monocytes to total intermediate monocytes in a biological specimen. Intermediate Monocyte Subpopulation to Intermediate Monocyte Ratio Measurement Mono Mat Monocytes Mature A measurement of the mature monocytes in a biological specimen. Mature Monocytes Count Mono NonClassic Monocytes Non-Classical A measurement of the non-classical monocytes in a biological specimen. Non-Classical Monocytes Count Mono NonClassic/Leuk Monocytes Non-Classic/Leukocytes Monocytes Non-Classical/Leukocytes A relative measurement (ratio or percentage) of the non-classical monocytes to total leukocytes in a biological specimen. Non-Classical Monocyte to Leukocyte Ratio Measurement Mono NonClassic/Leuk Sub Monocytes Non-Classic/Leukocytes Sub-Population Monocytes Non-Classical/Leukocytes Sub-Population A relative measurement (ratio or percentage) of the non-classical monocytes to a sub-population of leukocytes in a biological specimen. Non-Classical Monocyte to Leukocyte Subpopulation Ratio Measurement Mono NonClassic/Lym Sub Monocytes Non-Classic/Lymphocytes Sub-Population Monocytes Non-Classical/Lymphocytes Sub-Population A relative measurement (ratio or percentage) of the non-classical monocytes to a sub-population of lymphocytes in a biological specimen. Non-Classical Monocyte to Lymphocyte Subpopulation Ratio Measurement Mono NonClassic/Mono A relative measurement (ratio or percentage) of non-classical monocytes to monocytes in a biological specimen. Non-Classical Monocyte to Monocyte Ratio Measurement Mono NonClassic/Myeloid Cells Monocytes Non-Classic/Myeloid Cells Monocytes Non-Classical/Myeloid Cells A relative measurement (ratio or percentage) of the non-classical monocytes to myeloid cells in a biological specimen. Non-Classical Monocyte to Myeloid Cell Ratio Measurement Mono NonClassic Sub Monocytes Non-Classical Sub-Population A measurement of a sub-population of non-classical monocytes in a biological specimen. Non-Classical Monocyte Subpopulation Count Mono NonClassic Sub/Mono NonClassic Monocytes Non-Classical Sub-Population/Monocytes Non-Classical A relative measurement (ratio or percentage) of a sub-population of non-classical monocytes to total non-classical monocytes in a biological specimen. Non-Classical Monocyte Subpopulation to Non-Classical Monocyte Ratio Measurement Mono NonClassic/Lym+Mono Monocytes Non-Classic/Lymphocytes and Monocytes Monocytes Non-Classical/Lymphocytes and Monocytes A relative measurement (ratio or percentage) of the non-classical monocytes to lymphocytes and monocytes in a biological specimen. Non-Classical Monocyte to Lymphocyte and Monocyte Ratio Measurement Mono Proinflam Monocytes Proinflammatory A measurement of the pro-inflammatory monocytes in a biological specimen. Proinflammatory Monocytes Count Mono Proinflam/Mono Monocytes Proinflammatory/Monocytes A relative measurement (ratio or percentage) of the proinflammatory monocytes to total monocytes in a biological specimen. Proinflammatory Monocyte to Monocyte Ratio Measurement Mono Proinflam Sub Monocytes Proinflammatory Sub-Population Proinflammatory Monocytes Sub-Population A measurement of a sub-population of proinflammatory monocytes in a biological specimen. Proinflammatory Monocyte Subpopulation Count Mono Proinflam Sub/Mono Proinflam Mono Proinflam Sub/MonoPI Monocytes Proinflammatory Sub-Population/Monocytes Proinflammatory A relative measurement (ratio or percentage) of a sub-population of proinflammatory monocytes to total proinflammatory monocytes in a biological specimen. Proinflammatory Monocyte Subpopulation to Proinflammatory Monocyte Ratio Measurement Mono Resident Monocytes Resident A measurement of the resident monocytes in a biological specimen. Resident Monocytes Count Mono Sub Monocytes Sub Monocytes Sub-Population A measurement of a sub-population of monocytes in a biological specimen. Monocytes Subpopulation Count Mono Sub/Mono Monocytes Sub-Population/Monocytes Monocytes Sub/Monocytes A relative measurement (ratio or percentage) of a sub-population of monocytes to monocytes in a biological specimen. Monocyte Subpopulation to Total Monocytes Ratio Measurement Mono Sub/Mono Sub Monocytes Sub-Population/Monocytes Sub-Population A relative measurement (ratio or percentage) of a sub-population of monocytes to a sub-population of monocytes in a biological specimen. Monocyte Subpopulation to Monocyte Subpopulation Ratio Measurement Monocytes and Macrophages/Leukocytes A relative measurement (ratio or percentage) of the monocytes and macrophages to total leukocytes in a biological specimen. Monocytes and Macrophages to Leukocytes Ratio Measurement Monocytes A measurement of the monocytes in a biological specimen. Monocyte Count Monocytes/Total Cells A relative measurement (ratio or percentage) of the monocytes to total cells in a biological specimen (for example a bone marrow specimen). Monocytes to Total Cell Ratio Measurement Immature Monocytes A measurement of the immature monocytes in a biological specimen. Immature Monocyte Count Monocytes/Leukocytes A relative measurement (ratio or percentage) of the monocytes to leukocytes in a biological specimen. Monocyte to Leukocyte Ratio Mono/Leuk Sub Monocytes/Leukocytes Sub-Population A relative measurement (ratio or percentage) of the monocytes to a sub-population of leukocytes in a biological specimen. Monocyte to Leukocyte Subpopulation Ratio Measurement Mono/Lym Sub Monocytes/Lymphocytes Sub-Population A relative measurement (ratio or percentage) of the monocytes to a sub-population of lymphocytes in a biological specimen. Monocyte to Lymphocyte Subpopulation Ratio Measurement Mono/Myeloid Cells Monocytes/Myeloid Cells A relative measurement (ratio or percentage) of the monocytes to myeloid cells in a biological specimen. Monocyte to Myeloid Cell Ratio Measurement Mono Sub/Leuk Monocytes Sub-Population/Leukocytes A relative measurement (ratio or percentage) of a sub-population of monocytes to total leukocytes in a biological specimen. Monocyte Subpopulation to Leukocyte Ratio Measurement Interferon-induced GTP-binding Protein Mx1 Expression MX1 Expression MxA Expression Myxovirus Resistance Protein 1 Expression A measurement of cellular MX1 expression in a biological specimen. MX1 Expression Measurement Myeloid Cells A measurement of the myeloid cells in a biological specimen. Myeloid Cell Count Neutrophils A measurement of the neutrophils in a biological specimen. Absolute Neutrophil Count Leukocytes, Non-Granulocytic Non-Gran Leuk Non-Granulocytic Leukocytes A measurement of the non-granulocytic leukocytes in a biological specimen. Non-Granulocytic Leukocyte Count Natural Killer Cells A measurement of the total natural killer cells in a biological specimen. Natural Killer Cell Count Natural Killer Cells/Total Cells A relative measurement (ratio or percentage) of the natural killer cells to total cells in a biological specimen. Natural Killer Cells to Total Cells Ratio Measurement Natural Killer Cells Immature NK Cells Immat A measurement of the immature natural killer cells in a biological specimen. Immature Natural Killer Cell Count Natural Killer Cells Immature Intermediate NK Cells Immat Int A measurement of the immature intermediate natural killer cells in a biological specimen. Immature Intermediate Natural Killer Cell Count Natural Killer Cells Immature Intermediate/Leukocytes NK Cells Immat Int/Leuk A relative measurement (ratio or percentage) of the immature intermediate natural killer cells to leukocytes in a biological specimen. Immature Intermediate Natural Killer Cell to Leukocyte Ratio Measurement Natural Killer Cells Immature Intermediate/Natural Killer Cells NK Cells Immat Int/NK Cells A relative measurement (ratio or percentage) of the immature intermediate natural killer cells to total natural killer cells in a biological specimen. Immature Intermediate Natural Killer Cell to Natural Killer Cell Ratio Measurement Natural Killer Cells Immature Intermediate Sub-Population/Natural Killer Cells Immature Intermediate NK Cells Immat Int Sub/NK Immat Int A relative measurement (ratio or percentage) of a sub-population of immature intermediate natural killer cells to total immature intermediate natural killer cells in a biological specimen. Immature Intermediate Natural Killer Cell Subpopulation to Immature Intermediate Natural Killer Cell Ratio Measurement Natural Killer Cells Immature/Leukocytes NK Cells Immat/Leuk A relative measurement (ratio or percentage) of the immature natural killer cells to total leukocytes in a biological specimen. Immature Natural Killer Cell to Leukocyte Ratio Measurement Natural Killer Cells Immature/Lymphocytes NK Cells Immat/Lym A relative measurement (ratio or percentage) of the immature natural killer cells to total lymphocytes in a biological specimen. Immature Natural Killer Cell to Lymphocyte Ratio Measurement Natural Killer Cells Immature/Lymphocytes Sub-Population NK Cells Immat/Lym Sub A relative measurement (ratio or percentage) of the immature natural killer cells to a sub-population of lymphocytes in a biological specimen. Immature Natural Killer Cell to Lymphocyte Subpopulation Ratio Measurement Natural Killer Cells Immature/Natural Killer Cells NK Cells Immat/NK A relative measurement (ratio or percentage) of the immature natural killer cells to total natural killer cells in a biological specimen. Immature Natural Killer Cell to Natural Killer Cell Ratio Measurement Immature Natural Killer Cells Sub-Population Immature NK Sub-Population Immature NKC Sub-Population Natural Killer Cells Immature Sub-Population NK Cells Immat Sub A measurement of a sub-population of immature natural killer cells in a biological specimen. Immature Natural Killer Cell Subpopulation Count Natural Killer Cells Immature Sub-Population/Natural Killer Cells Immature NK Cells Immat Sub/NK Immat A relative measurement (ratio or percentage) of a sub-population of immature natural killer cells to total immature natural killer cells in a biological specimen. Immature Natural Killer Cell Subpopulation to Immature Natural Killer Cell Ratio Measurement Natural Killer Cells Intermediate NK Cells Intermed A measurement of the intermediate natural killer cells in a biological specimen. Intermediate Natural Killer Cell Count Natural Killer Cells Intermediate/Leukocytes NK Cells Intermed/Leuk A relative measurement (ratio or percentage) of the intermediate natural killer cells to total leukocytes in a biological specimen. Intermediate Natural Killer Cell to Leukocyte Ratio Measurement Natural Killer Cells Intermediate/Lymphocytes NK Cells Intermed/Lym A relative measurement (ratio or percentage) of the intermediate natural killer cells to total lymphocytes in a biological specimen. Intermediate Natural Killer Cell to Lymphocyte Ratio Measurement Natural Killer Cells Intermediate/Lymphocytes Sub-Population NK Cells Intermed/Lym Sub A relative measurement (ratio or percentage) of the intermediate natural killer cells to a sub-population of lymphocytes in a biological specimen. Intermediate Natural Killer Cell to Lymphocyte Subpopulation Ratio Measurement Natural Killer Cells Intermediate/Natural Killer Cells NK Cells Intermed/NK A relative measurement (ratio or percentage) of the intermediate natural killer cells to total natural killer cells in a biological specimen. Intermediate Natural Killer Cell to Natural Killer Cell Ratio Measurement Intermediate Natural Killer Cells Sub-Population Intermediate NK Sub-Population Intermediate NKC Sub-Population Natural Killer Cells Intermediate Sub-Population NK Cells Intermed Sub A measurement of a sub-population of intermediate natural killer cells in a biological specimen. Intermediate Natural Killer Cell Subpopulation Count Natural Killer Cells Intermediate Sub-Population/Leukocytes NK Cells Intermed Sub/Leuk A relative measurement (ratio or percentage) of a sub-population of intermediate natural killer cells to total leukocytes in a biological specimen. Intermediate Natural Killer Cell Subpopulation to Leukocyte Ratio Measurement Natural Killer Cells Intermediate Sub-Population/Lymphocytes NK Cells Intermed Sub/Lym A relative measurement (ratio or percentage) of a sub-population of intermediate natural killer cells to total lymphocytes in a biological specimen. Intermediate Natural Killer Cell Subpopulation to Lymphocyte Ratio Measurement Natural Killer Cells Intermediate Sub-Population/Natural Killer Cells Intermediate NK Cells Intermed Sub/NK Intermed A relative measurement (ratio or percentage) of a sub-population of intermediate natural killer cells to total intermediate natural killer cells in a biological specimen. Intermediate Natural Killer Cell Subpopulation to Intermediate Natural Killer Cell Ratio Measurement Natural Killer Cells/Leukocytes NK Cells/Leuk A relative measurement (ratio or percentage) of the natural killer cells to leukocytes in a biological specimen. Natural Killer Cells to Leukocytes Ratio Measurement Natural Killer Cells/Lymphocytes NK Cells/Lym A relative measurement (ratio or percentage) of the natural killer cells to lymphocytes in a biological specimen. Natural Killer Cells to Lymphocytes Ratio Measurement Natural Killer Cells/Lymphocytes Sub-Population NK Cells/Lym Sub A relative measurement (ratio or percentage) of natural killer cells to a sub-population of lymphocytes in a biological specimen. Natural Killer Cell to Lymphocyte Subpopulation Ratio Measurement Natural Killer Cells Mature NK Cells Mat A measurement of the mature natural killer cells in a biological specimen. Mature Natural Killer Cell Count Natural Killer Cells Mature/Leukocytes NK Cells Mat/Leuk A relative measurement (ratio or percentage) of the mature natural killer cells to total leukocytes in a biological specimen. Mature Natural Killer Cell to Leukocyte Ratio Measurement Natural Killer Cells Mature/Lymphocytes NK Cells Mat/Lym A relative measurement (ratio or percentage) of the mature natural killer cells to total lymphocytes in a biological specimen. Mature Natural Killer Cell to Lymphocyte Ratio Measurement Natural Killer Cells Mature/Lymphocytes Sub-Population NK Cells Mat/Lym Sub A relative measurement (ratio or percentage) of the mature natural killer cells to a sub-population of lymphocytes in a biological specimen. Mature Natural Killer Cell to Lymphocyte Subpopulation Ratio Measurement Natural Killer Cells Mature/Natural Killer Cells NK Cells Mat/NK A relative measurement (ratio or percentage) of the mature natural killer cells to total natural killer cells in a biological specimen. Mature Natural Killer Cell to Natural Killer Cell Ratio Measurement Mature Natural Killer Cells Sub-Population Mature NK Sub-Population Mature NKC Sub-Population Natural Killer Cells Mature Sub-Population NK Cells Mat Sub A measurement of a sub-population of mature natural killer cells in a biological specimen. Mature Natural Killer Cell Subpopulation Count Natural Killer Cells Mature Sub-Population/Leukocytes NK Cells Mat Sub/Leuk A relative measurement (ratio or percentage) of a sub-population of mature natural killer cells to total leukocytes in a biological specimen. Mature Natural Killer Cell Subpopulation to Leukocyte Ratio Measurement Natural Killer Cells Mature Sub-Population/Lymphocytes NK Cells Mat Sub/Lym A relative measurement (ratio or percentage) of a sub-population of mature natural killer cells to total lymphocytes in a biological specimen. Mature Natural Killer Cell Subpopulation to Lymphocyte Ratio Measurement Natural Killer Cells Mature Sub-Population/Natural Killer Cells NK Cells Mat Sub/NK A relative measurement (ratio or percentage) of a sub-population of mature natural killer cells to total natural killer cells in a biological specimen. Mature Natural Killer Cell Subpopulation to Natural Killer Cell Ratio Measurement Natural Killer Cells Mature Sub-Population/Natural Killer Cells Mature NK Cells Mat Sub/NK Mat A relative measurement (ratio or percentage) of a sub-population of mature natural killer cells to total mature natural killer cells in a biological specimen. Mature Natural Killer Cell Subpopulation to Mature Natural Killer Cell Ratio Measurement Natural Killer Cells Sub-Population NK Cells Sub NK Cells Sub-Population A measurement of a sub-population of natural killer cells in a biological specimen. Natural Killer Cells Subpopulation Count Natural Killer Cells Sub-Population/Leukocytes NK Cells Sub/Leuk A relative measurement (ratio or percentage) of a sub-population of natural killer cells to total leukocytes in a biological specimen. Natural Killer Cell Subpopulation to Leukocyte Ratio Measurement Natural Killer Cells Sub-Population/Lymphocytes Sub-Population NK Cells Sub/Lym Sub A relative measurement (ratio or percentage) of a sub-population of natural killer cells to a sub-population of lymphocytes in a biological specimen. Natural Killer Cell Subpopulation to Lymphocyte Subpopulation Ratio Measurement Natural Killer Cells Sub-Population/Natural Killer Cells NK Cells Sub/NK Cells A relative measurement (ratio or percentage) of a sub population of natural killer cells to total natural killer cells in a biological specimen. Natural Killer Cells Subpopulation to Total Natural Killer Cells Ratio Measurement Natural Killer Cells Sub-Population/Natural Killer Cells Sub-Population NK Cells Sub/NK Cells Sub A relative measurement (ratio or percentage) of a sub-population of natural killer cells to a sub-population of natural killer cells in a biological specimen. Natural Killer Cell Subpopulation to Natural Killer Cell Subpopulation Ratio Measurement Natural Killer T-Cells Natural Killer T-Lymphocytes NK TLym NKT A measurement of the natural killer T-lymphocytes in a biological specimen. Natural Killer T-Lymphocyte Count iNKT Natural Killer T-Lymphocytes Invariant NK TLym Invar A measurement of the invariant natural killer T-lymphocytes in a biological specimen. Invariant Natural Killer T-Lymphocyte Count Natural Killer T-Lymphocytes Invariant/Natural Killer T-Lymphocytes NK TLym Invar/NKT A relative measurement (ratio or percentage) of the invariant natural killer T-lymphocytes to total natural killer T-lymphocytes in a biological specimen. Invariant Natural Killer T-Lymphocyte to Natural Killer T-Lymphocyte Ratio Measurement iNKT Sub-population Natural Killer T-Lymphocytes Invariant Sub-Population NK TLym Invar Sub A measurement of a sub-population of invariant natural killer T-lymphocytes in a biological specimen. Invariant Natural Killer T-Lymphocyte Subpopulation Count iNKT Sub-Population/iNKT Natural Killer T-Lymphocytes Invariant Sub-Population/Natural Killer T-Lymphocytes Invariant NK TLym Invar Sub/NK TLym Invar NK TLym Invar Sub/NKT Invar A relative measurement (ratio or percentage) of a sub-population of invariant natural killer T-lymphocytes to total invariant natural killer T-lymphocytes in a biological specimen. Invariant Natural Killer T-Lymphocyte Subpopulation to Invariant Natural Killer T-Lymphocyte Ratio Measurement Natural Killer T-Lymphocytes/Leukocytes NK TLym/Leuk NK TLym/Leukocytes NKT/Leuk A relative measurement (ratio or percentage) of natural killer T-lymphocytes to leukocytes in a biological specimen. Natural Killer T-Lymphocyte to Leukocyte Ratio Measurement Natural Killer T-Lymphocytes/Lymphocytes NK TLym/Lym NKT/Lym A relative measurement (ratio or percentage) of the natural killer T-lymphocytes to total lymphocytes in a biological specimen. Natural Killer T-Lymphocytes to Lymphocytes Ratio Measurement Natural Killer T-Cells Sub-Population Natural Killer T-Lymphocytes Sub-Population NK TLym Sub NKT Sub A measurement of a sub-population of natural killer T-lymphocytes in a biological specimen. Natural Killer T-Lymphocyte Subpopulation Count Natural Killer T-Lymphocytes Sub-Population/Natural Killer T-Lymphocytes Sub-Population NK TLym Sub/NK TLym Sub NKT Sub/NKT Sub A relative measurement (ratio or percentage) of a sub-population of natural killer T-lymphocytes to a sub-population of natural killer T-lymphocytes in a biological specimen. Natural Killer T-Lymphocyte Subpopulation to Natural Killer T-Lymphocyte Subpopulation Ratio Measurement Natural Killer T-Lymphocytes Sub-Population/Natural Killer T-Lymphocytes NK TLym Sub/NKT NKT Sub/NKT A relative measurement (ratio or percentage) of a sub-population of natural killer T-lymphocytes to total natural killer T-lymphocytes in a biological specimen. Natural Killer T-Lymphocyte Subpopulation to Natural Killer T-Lymphocyte Ratio Measurement Natural Killer T-Lymphocytes Sub-Population/T-Lymphocytes NK TLym Sub/TLym NKT Sub/TLym A relative measurement (ratio or percentage) of a sub-population of natural killer T-lymphocytes to total T-lymphocytes in a biological specimen. Natural Killer T-Lymphocyte Subpopulation to T-Lymphocyte Ratio Measurement Natural Killer T-Lymphocytes/T-Lymphocytes NK TLym/TLym NKT/TLym A relative measurement (ratio or percentage) of the natural killer T-lymphocytes to total T-lymphocytes in a biological specimen. Natural Killer T-Lymphocyte to T-Lymphocyte Ratio Measurement Non-TBNK Leuk Non-TBNK Leukocytes A measurement of the leukocytes that are not T-cells, B-cells, or natural killer cells in a biological specimen. Non-TBNK Leukocyte Count Non-TBNK Leuk/Leuk Non-TBNK Leukocytes/Leukocytes A relative measurement (ratio or percentage) of the leukocytes that are not T-cells, B-cells, or natural killer cells to total leukocytes in a biological specimen. Non-TBNK Leukocyte to Leukocyte Ratio Measurement Nucleated Cells A measurement of the nucleated cells in a biological specimen. Nucleated Cell Count Plasmablast Precursor Plasma Cells A measurement of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) in a biological specimen. Precursor Plasma Cell Count Plasmablasts/B-Lymphocytes Plasmablasts/BLym Precursor Plasma Cells/B-Lymphocytes A relative measurement (ratio or percentage) of plasmablasts to B-lymphocytes in a biological specimen. Plasmablasts to Total B-Lymphocytes Ratio Measurement Plasmablasts IgG+ A measurement of the IgG+ plasmablasts in a biological specimen. Immunoglobulin G Positive Plasmablast Count Plasmablasts IgG+/PB Plasmablasts IgG+/Plasmablasts A relative measurement (ratio or percentage) of the IgG+ plasmablasts to total plasmablasts in a biological specimen. Immunoglobulin G Positive Plasmablast to Plasmablast Ratio Measurement Plasmablasts IgG+ Sub Plasmablasts IgG+ Sub-Population A measurement of a sub-population of IgG+ plasmablasts in a biological specimen. Immunoglobulin G Positive Plasmablast Subpopulation Count Plasmablasts IgG+ Sub-Population/Plasmablasts IgG+ Plasmablasts IgG+ Sub/PB IgG+ A relative measurement (ratio or percentage) of a sub-population of IgG+ plasmablasts to total IgG+ plasmablasts in a biological specimen. Immunoglobulin G Positive Plasmablast Subpopulation to Total Immunoglobulin G Positive Plasmablast Ratio Measurement Plasmablasts IgM+ A measurement of the IgM+ plasmablasts in a biological specimen. Immunoglobulin M Positive Plasmablast Count Plasmablasts IgM+/PB Plasmablasts IgM+/Plasmablasts A relative measurement (ratio or percentage) of the IgM+ plasmablasts to total plasmablasts in a biological specimen. Immunoglobulin M Positive Plasmablast to Plasmablast Ratio Measurement Plasmablasts IgM+ Sub Plasmablasts IgM+ Sub-Population A measurement of a sub-population of IgM+ plasmablasts in a biological specimen. Immunoglobulin M Positive Plasmablast Subpopulation Count Plasmablasts IgM+ Sub-Population/Plasmablasts IgM+ Plasmablasts IgM+ Sub/PB IgM+ A relative measurement (ratio or percentage) of a sub-population of IgM+ plasmablasts to total IgM+ plasmablasts in a biological specimen. Immunoglobulin M Positive Plasmablast Subpopulation to Total Immunoglobulin M Positive Plasmablast Ratio Measurement Plasmablasts Sub Plasmablasts Sub-Population Precursor Plasma Cells Sub-Population A measurement of a sub-population of plasmablasts in a biological specimen. Plasmablast Subpopulation Count Plasmablasts Sub-Population/B-Lymphocytes Plasmablasts Sub/BLym A relative measurement (ratio or percentage) of a sub-population of plasmablasts to B-lymphocytes in a biological specimen. Plasmablast Subpopulation to B-Lymphocyte Ratio Measurement Plasmablasts Sub-Population/Leukocytes Plasmablasts Sub/Leuk A relative measurement (ratio or percentage) of a sub-population of plasmablasts to leukocytes in a biological specimen. Plasmablast Subpopulation to Leukocyte Ratio Measurement Plasmablasts Sub-Population/Plasmablasts Plasmablasts Sub/PB A relative measurement (ratio or percentage) of a sub-population of plasmablasts to total plasmablasts in a biological specimen. Plasmablast Subpopulation to Total Plasmablast Ratio Measurement Total Plasma Cells A measurement of the total plasma cells in a biological specimen. Plasma Cell Count PC/BLym AbSc Plasma Cells/B-Lymphocytes Antibody-Secreting Plasma Cells/BLym Ab-Secreting A relative measurement (ratio or percentage) of plasma cells to antibody-secreting B-lymphocytes in a biological specimen. Plasma Cell to Antibody-secreting B-Lymphocyte Ratio Measurement PC/BLym Plasma Cells/B-Lymphocytes Plasma Cells/BLym A relative measurement (ratio or percentage) of plasma cells to B-lymphocytes in a biological specimen. Plasma Cell to B-Lymphocyte Ratio Measurement Plasma Cells/Leuk Total Plasma Cells/Leukocytes A relative measurement (ratio or percentage) of the total plasma cells to leukocytes in a biological specimen. Plasma Cells to Leukocytes Ratio Measurement Plasma Cells Sub Plasma Cells Sub-Population Total Plasma Cells Sub A measurement of a sub-population of plasma cells in a biological specimen. Plasma Cell Subpopulation Count PC Sub/BLym Plasma Cells Sub-Population/B-Lymphocytes Plasma Cells Sub/B-Lymphocytes Plasma Cells Sub/BLym A relative measurement (ratio or percentage) of a sub-population of plasma cells to total B-lymphocytes in a biological specimen. Plasma Cell Subpopulation to B-Lymphocyte Ratio Measurement PC Sub/Leuk Plasma Cells Sub-Population/Leukocytes Plasma Cells Sub/Leuk Plasma Cells Sub/Leukocytes A relative measurement (ratio or percentage) of a sub-population of plasma cells to total leukocytes in a biological specimen. Plasma Cell Subpopulation to Leukocyte Ratio Measurement PC Sub/PC Plasma Cells Sub-Population/Plasma Cells Plasma Cells Sub/Plasma Cells A relative measurement (ratio or percentage) of a sub-population of plasma cells to total plasma cells in a biological specimen. Plasma Cell Subpopulation to Plasma Cell Ratio Measurement PC Sub/PC Sub Plasma Cells Sub-Population/Plasma Cells Sub-Population Plasma Cells Sub/Plasma Cells Sub A relative measurement (ratio or percentage) of a sub-population of plasma cells to a sub-population of plasma cells in a biological specimen. Plasma Cell Subpopulation to Plasma Cell Subpopulation Ratio Measurement pERK Expression Phospho-ERK Expression A measurement of cellular phosphorylated ERK expression in a biological specimen. pERK Expression Measurement Platelets A measurement of the platelets (non-nucleated thrombocytes) in a biological specimen. Platelet Count Platelets Sub-Population A measurement of a sub-population of platelets in a biological specimen. Platelet Subpopulation Count Monoclonal Plasma Cells Monotypic Plasma Cells Neoplastic Plasma Cells A measurement of the neoplastic plasma cells in a biological specimen. Neoplastic Plasma Cell Count Neoplastic Plasma Cells/Total Cells A relative measurement (ratio or percentage) of the neoplastic plasma cells to total cells in a biological specimen. Neoplastic Plasma Cell to Total Cell Ratio Measurement Plasma Cells/Total Cells Total Plasma Cells/Total Cells A relative measurement (ratio or percentage) of the total plasma cells to total cells in a biological specimen. Plasma Cell to Total Cell Ratio Measurement Prostate Circulating Tumor Cells A measurement of the prostate circulating tumor cells in a biological specimen. Circulating Prostate Tumor Cell Count Erythrocytes Red Blood Cells A measurement of the total erythrocytes in a biological specimen. Erythrocyte Count Cell Surface CD223 Expression Membrane CD223 Expression Plasma Membrane CD223 Expression sCD223 Expression A measurement of cellular plasma membrane (surface) CD223 expression in a biological specimen. Plasma Membrane CD223 Expression Measurement Stimulation Index A relative measurement (ratio or percentage) of a cell characteristic or response in the presence of a stimulating agent relative to a non-stimulated control. Stimulation Index Count T-Lymphocytes Cytotoxic Central Memory Gut-Homing TLym Cytx Cen Mem GH A measurement of the gut-homing cytotoxic central memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Central Memory T-Lymphocyte Count T-Lymphocytes Cytotoxic Central Memory Gut-Homing Sub-Population TLym Cytx Cen Mem GH Sub A measurement of a sub-population of gut-homing cytotoxic central memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Central Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic Central Memory Gut-Homing TLym Cytx Cen Mem GH Sub/TLym Cytx Cen Mem GH TLym Cytx Cen Mem GH Sub/TLymCCMGH A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic central memory T-lymphocytes to total gut-homing cytotoxic central memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation to Gut-Homing Cytotoxic Central Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Central Memory Gut-Homing/T-Lymphocytes Cytotoxic TLym Cytx Cen Mem GH/TLym Cytx TLym Cytx Cen Mem GH/TLymC A relative measurement (ratio or percentage) of the gut-homing cytotoxic central memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Central Memory T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Central Memory Skin-Homing TLym Cytx Cen Mem SH A measurement of the skin-homing cytotoxic central memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Central Memory T-Lymphocyte Count T-Lymphocytes Cytotoxic Central Memory Skin-Homing Sub-Population TLym Cytx Cen Mem SH Sub A measurement of a sub-population of skin-homing cytotoxic central memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Central Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic Central Memory Skin-Homing TLym Cytx Cen Mem SH Sub/TLym Cytx Cen Mem SH TLym Cytx Cen Mem SH Sub/TLymCCMSH A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic central memory T-lymphocytes to total skin-homing cytotoxic central memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation to Skin-Homing Cytotoxic Central Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Central Memory Skin-Homing/T-Lymphocytes Cytotoxic TLym Cytx Cen Mem SH/TLym Cytx TLym Cytx Cen Mem SH/TLymC A relative measurement (ratio or percentage) of the skin-homing cytotoxic central memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Central Memory T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory Gut-Homing TLym Cytx Eff Mem GH A measurement of the gut-homing cytotoxic effector memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Effector Memory T-Lymphocyte Count T-Lymphocytes Cytotoxic Effector Memory Gut-Homing Sub-Population TLym Cytx Eff Mem GH Sub A measurement of a sub-population of gut-homing cytotoxic effector memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Effector Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic Effector Memory Gut-Homing TLym Cytx Eff Mem GH Sub/TLym Cytx Eff Mem GH TLym Cytx Eff Mem GH Sub/TLymCEMGH A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic effector memory T-lymphocytes to total gut-homing cytotoxic effector memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation to Gut-Homing Cytotoxic Effector Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory Gut-Homing/T-Lymphocytes Cytotoxic TLym Cytx Eff Mem GH/TLym Cytx TLym Cytx Eff Mem GH/TLymC A relative measurement (ratio or percentage) of the gut-homing cytotoxic effector memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Effector Memory T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory Skin-Homing TLym Cytx Eff Mem SH A measurement of the skin-homing cytotoxic effector memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Effector Memory T-Lymphocyte Count T-Lymphocytes Cytotoxic Effector Memory Skin-Homing Sub-Population TLym Cytx Eff Mem SH Sub A measurement of a sub-population of skin-homing cytotoxic effector memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Effector Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic Effector Memory Skin-Homing TLym Cytx Eff Mem SH Sub/TLymCEMSH TLym Cytx Eff Mem Sub/TLym Cytx Eff Mem SH A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic effector memory T-lymphocytes to total skin-homing cytotoxic effector memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation to Skin-Homing Cytotoxic Effector Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory Skin-Homing/T-Lymphocytes Cytotoxic TLym Cytx Eff Mem SH/TLym Cytx TLym Cytx Eff Mem SH/TLymC A relative measurement (ratio or percentage) of the skin-homing cytotoxic effector memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Effector Memory T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement CD8 TPEX T-Lymphocytes Cytotoxic Exhausted Precursor TLym Cytx Exh Pre A measurement of the cytotoxic exhausted precursor T-lymphocytes in a biological specimen. Cytotoxic Exhausted Precursor T-Lymphocyte Count CD8 TPEX Sub-Population T-Lymphocytes Cytotoxic Exhausted Precursor Sub-Population TLym Cytx Exh Pre Sub A measurement of a sub-population of cytotoxic exhausted precursor T-lymphocytes in a biological specimen. Cytotoxic Exhausted Precursor T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Exhausted Precursor Sub-Population/T-Lymphocytes Cytotoxic Exhausted Precursor TLym Cytx Exh Pre Sub/TLymCExhPre A relative measurement (ratio or percentage) of a sub-population of cytotoxic exhausted precursor T-lymphocytes to the total cytotoxic exhausted precursor T-lymphocytes in a biological specimen. Cytotoxic Exhausted Precursor T-Lymphocyte Subpopulation to Cytotoxic Exhausted Precursor T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Exhausted Precursor/T-Lymphocytes Cytotoxic TLym Cytx Exh Pre/TLym Cytx A relative measurement (ratio or percentage) of cytotoxic exhausted precursor T-lymphocytes to cytotoxic T-lymphocytes in a biological specimen. Cytotoxic Exhausted Precursor T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T Cell Factor 1 Expression T Cell Factor 7 Expression TCF-1 Expression TCF-7 Expression TCF1 Expression TCF7 Expression A measurement of cellular TCF7 expression in a biological specimen. Transcription Factor 7 Expression Measurement T-Lymphocytes Cytotoxic Memory Gut-Homing TLym Cytx Mem GH A measurement of the gut-homing cytotoxic memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Memory T-Lymphocyte Count T-Lymphocytes Cytotoxic Memory Gut-Homing Sub-Population TLym Cytx Mem GH Sub A measurement of a sub-population of gut-homing cytotoxic memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic Memory Gut-Homing TLym Cytx Mem GH Sub/TLym Cytx Mem GH TLym Cytx Mem GH Sub/TLymCMGH A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic memory T-lymphocytes to total gut-homing cytotoxic memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Memory T-Lymphocyte Subpopulation to Gut-Homing Cytotoxic Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx Mem GH Sub/TLym Cytx TLym Cytx Mem GH Sub/TLymC A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Memory T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Memory Gut-Homing/T-Lymphocytes Cytotoxic TLym Cytx Mem GH/TLym Cytx TLym Cytx Mem GH/TLymC A relative measurement (ratio or percentage) of the gut-homing cytotoxic memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Memory T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Memory Gut-Homing/T-Lymphocytes Cytotoxic Memory TLym Cytx Mem GH/TLym Cytx Mem TLym Cytx Mem GH/TLymCM A relative measurement (ratio or percentage) of the gut-homing cytotoxic memory T-lymphocytes to total cytotoxic memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Memory T-Lymphocyte to Cytotoxic Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Memory Skin-Homing TLym Cytx Mem SH A measurement of the skin-homing cytotoxic memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Memory T-Lymphocyte Count T-Lymphocytes Cytotoxic Memory Skin-Homing Sub-Population TLym Cytx Mem SH Sub A measurement of a sub-population of skin-homing cytotoxic memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic Memory Skin-Homing TLym Cytx Mem SH Sub/TLym Cytx Mem SH TLym Cytx Mem SH Sub/TLymCMSH A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic memory T-lymphocytes to total skin-homing cytotoxic memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Memory T-Lymphocyte Subpopulation to Skin-Homing Cytotoxic Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx Mem SH Sub/TLym Cytx TLym Cytx Mem SH Sub/TLymC A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Memory T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Memory Skin-Homing/T-Lymphocytes Cytotoxic TLym Cytx Mem SH/TLym Cytx TLym Cytx Mem SH/TLymC A relative measurement (ratio or percentage) of the skin-homing cytotoxic memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Memory T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Membrane Skin-Homing/T-Lymphocytes Cytotoxic Memory TLym Cytx Mem SH/TLym Cytx Mem TLym Cytx Mem SH/TLymCM A relative measurement (ratio or percentage) of the skin-homing cytotoxic memory T-lymphocytes to total cytotoxic memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Memory T-Lymphocyte to Cytotoxic Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Sub-Population/T-Lymphocytes Cytotoxic Sub-Population TLym Cytx Sub/TLym Cytx Sub A relative measurement (ratio or percentage) of a sub-population of cytotoxic T-lymphocytes to a sub-population of cytotoxic T-lymphocytes in a biological specimen. Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Cytotoxic Sub-Population/T-Lymphocytes Sub-Population TLym Cytx Sub/TLym Sub A relative measurement (ratio or percentage) of a sub-population of cytotoxic T-lymphocytes to a sub-population of T-lymphocytes in a biological specimen. Cytotoxic T-Lymphocyte Subpopulation to T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Cytotoxic Terminally Differentiated Exhausted TLym Cytx Term Diff Exh A measurement of the cytotoxic terminally differentiated exhausted T-lymphocytes in a biological specimen. Cytotoxic Terminally Differentiated Exhausted T-Lymphocyte Count T-Lymphocytes Cytotoxic Terminally Differentiated Exhausted Sub-Population TLym Cytx Term Diff Exh Sub A measurement of a sub-population of cytotoxic terminally differentiated exhausted T-lymphocytes in a biological specimen. Cytotoxic Terminally Differentiated Exhausted T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Terminally Differentiated Exhausted Sub-Population/T-Lymphocytes Cytotoxic Terminally Differentiated Exhausted TLym Cytx Term Diff Exh Sub/TLymCTDExh A relative measurement (ratio or percentage) of a sub-population of cytotoxic terminally differentiated exhausted T-lymphocytes to the total cytotoxic terminally differentiated exhausted T-lymphocytes in a biological specimen. Cytotoxic Terminally Differentiated Exhausted T-Lymphocyte Subpopulation to Cytotoxic Terminally Differentiated Exhausted T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Terminally Differentiated Exhausted/T-Lymphocytes Cytotoxic TLym Cytx Term Diff Exh/TLym Cytx A relative measurement (ratio or percentage) of cytotoxic terminally differentiated exhausted T-lymphocytes to the total cytotoxic T-lymphocytes in a biological specimen. Cytotoxic Terminally Differentiated Exhausted T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory Gut-Homing TLym Cytx Term Mem GH A measurement of the gut-homing cytotoxic terminal memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Terminal Memory T-Lymphocyte Count T-Lymphocytes Cytotoxic Terminal Memory Gut-Homing Sub-Population TLym Cytx Term Mem GH Sub A measurement of a sub-population of gut-homing cytotoxic terminal memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Terminal Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic Terminal Memory Gut-Homing TLym Cytx Term Mem GH Sub/TLym Cytx Term Mem GH TLym Cytx Term Mem GH Sub/TLymCTMGH A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic terminal memory T-lymphocytes to total gut-homing cytotoxic terminal memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation to Gut-Homing Cytotoxic Terminal Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory Gut-Homing/T-Lymphocytes Cytotoxic TLym Cytx Term Mem GH/TLym Cytx TLym Cytx Term Mem GH/TLymC A relative measurement (ratio or percentage) of the gut-homing cytotoxic terminal memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Terminal Memory T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory Skin-Homing TLym Cytx Term Mem SH A measurement of the skin-homing cytotoxic terminal memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Terminal Memory T-Lymphocyte Count T-Lymphocytes Cytotoxic Terminal Memory Skin-Homing Sub-Population TLym Cytx Term Mem SH Sub A measurement of the gut-homing helper memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Terminal Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic Terminal Memory Skin-Homing TLym Cytx Term Mem SH Sub/TLym Cytx Term Mem SH TLym Cytx Term Mem SH Sub/TLymCTMSH A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic terminal memory T-lymphocytes to total skin-homing cytotoxic terminal memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation to Skin-Homing Cytotoxic Terminal Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory Skin-Homing/T-Lymphocytes Cytotoxic TLym Cytx Term Mem SH/TLym Cytx TLym Cytx Term Mem SH/TLymC A relative measurement (ratio or percentage) of the skin-homing cytotoxic terminal memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Terminal Memory T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement TLym Conv TLym Conventional A measurement of the conventional T-lymphocytes in a biological specimen. Conventional T-Lymphocyte Count TLym Conv Cen Mem TLym Conv Central Memory A measurement of the conventional central memory T-lymphocytes in a biological specimen. Conventional Central Memory T-Lymphocyte Count TLym Conv Cen Mem Sub TLym Conv Central Memory Sub-Population A measurement of a sub-population of conventional central memory T-lymphocytes in a biological specimen. Conventional Central Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Conventional Central Memory Sub-Population/T-Lymphocytes Conventional Central Memory TLym Conv Cen Mem Sub/TLymCvCM A relative measurement (ratio or percentage) of a sub-population of conventional central memory T-lymphocytes to total conventional central memory T-lymphocytes in a biological specimen. Conventional Central Memory T-Lymphocyte Subpopulation to Conventional Central Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional Central Memory/T-Lymphocytes TLym Conv Cen Mem/Tlym A relative measurement (ratio or percentage) of the conventional central memory T-lymphocytes to T-lymphocytes in a biological specimen. Conventional Central Memory T-Lymphocyte to T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional Central Memory/T-Lymphocytes Conventional TLym Conv Cen Mem/TLymCv A relative measurement (ratio or percentage) of the conventional central memory T-lymphocytes to conventional T-lymphocytes in a biological specimen. Conventional Central Memory T-Lymphocyte to Conventional T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional Central Memory/T-Lymphocytes Helper TLym Conv Cen Mem/TLymH A relative measurement (ratio or percentage) of the conventional central memory T-lymphocytes to helper T-lymphocytes in a biological specimen. Conventional Central Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement TLym Conv Eff Mem TLym Conventional Effector Memory A measurement of the conventional effector memory T-lymphocytes in a biological specimen. Conventional Effector Memory T-Lymphocyte Count TLym Conv Eff Mem Sub TLym Conventional Effector Memory Sub-Population A measurement of a sub-population of conventional effector memory T-lymphocytes in a biological specimen. Conventional Effector Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Conventional Effector Memory Sub-Population/T-Lymphocytes Conventional Effector Memory TLym Conv Eff Mem Sub/TLymCvEM A relative measurement (ratio or percentage) of a sub-population of conventional effector memory T-lymphocytes to total conventional effector memory T-lymphocytes in a biological specimen. Conventional Effector Memory T-Lymphocyte Subpopulation to Conventional Effector Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional Effector Memory/T-Lymphocytes TLym Conv Eff Mem/Tlym A relative measurement (ratio or percentage) of the conventional effector memory T-lymphocytes to T-lymphocytes in a biological specimen. Conventional Effector Memory T-Lymphocyte to T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional Effector Memory/T-Lymphocytes Conventional TLym Conv Eff Mem/TLymCv A relative measurement (ratio or percentage) of the conventional effector memory T-lymphocytes to conventional T-lymphocytes in a biological specimen. Conventional Effector Memory T-Lymphocyte to Conventional T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional Effector Memory/T-Lymphocytes Helper TLym Conv Eff Mem/TLymH A relative measurement (ratio or percentage) of the conventional effector memory T-lymphocytes to helper T-lymphocytes in a biological specimen. Conventional Effector Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional/Leukocytes TLym Conv/Leuk A relative measurement (ratio or percentage of the conventional T-lymphocytes to leukocytes in a biological specimen. Conventional T-Lymphocyte to Leukocyte Ratio Measurement TLym Conv Naive TLym Conventional Naive A measurement of the conventional naive T-lymphocytes in a biological specimen. Conventional Naive T-Lymphocyte Count TLym Conv Naive Sub TLym Conventional Naive Sub-Population A measurement of a sub-population of conventional naive T-lymphocytes in a biological specimen. Conventional Naive T-Lymphocyte Subpopulation Count T-Lymphocytes Conventional Naive Sub-Population/T-Lymphocytes Conventional Naive TLym Conv Naive Sub/TLymCvN A relative measurement (ratio or percentage) of a sub-population of conventional naive T-lymphocytes to the conventional naive T-lymphocytes in a biological specimen. Conventional Naive T-Lymphocyte Subpopulation to Conventional Naive T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional Naive/T-Lymphocytes TLym Conv Naive/Tlym A relative measurement (ratio or percentage) of conventional naive T-lymphocytes to the T-lymphocytes in a biological specimen. Conventional Naive T-Lymphocyte to T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional Naive/T-Lymphocytes Conventional TLym Conv Naive/TLymCv A relative measurement (ratio or percentage) of conventional naive T-lymphocytes to the conventional T-lymphocytes in a biological specimen. Conventional Naive T-Lymphocyte to Conventional T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional Naive/T-Lymphocytes Helper TLym Conv Naive/TLymH A relative measurement (ratio or percentage) of the conventional naive T-lymphocytes to the helper T-lymphocytes in a biological specimen. Conventional Naive T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement TLym Conv Sub TLym Conventional Sub-Population A measurement of a sub-population of conventional T-lymphocytes in a biological specimen. Conventional T-Lymphocyte Subpopulation Count T-Lymphocytes Conventional Stem Cell Memory TLym Conv SC Mem A measurement of the conventional stem cell memory T-lymphocytes in a biological specimen. Conventional Stem Cell Memory T-Lymphocyte Count T-Lymphocytes Conventional Stem Cell Memory Sub-Population TLym Conv SC Mem Sub A measurement of a sub-population of conventional stem cell memory T-lymphocytes in a biological specimen. Conventional Stem Cell Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Conventional Stem Cell Memory Sub-Population/T-Lymphocytes Conventional Stem Cell Memory TLym Conv SC Mem Sub/TLymCvSCM A relative measurement (ratio or percentage) of a sub-population of conventional stem cell memory T-lymphocytes to the conventional stem cell memory T-lymphocytes in a biological specimen. Conventional Stem Cell Memory T-Lymphocyte Subpopulation to Conventional Stem Cell Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional Stem Cell Memory/T-Lymphocytes TLym Conv SC Mem/TLym A relative measurement (ratio or percentage) of conventional stem cell memory T-lymphocytes to the T-lymphocytes in a biological specimen. Conventional Stem Cell Memory T-Lymphocyte to T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional Stem Cell Memory/T-Lymphocytes Helper TLym Conv SC Mem/TLymH A relative measurement (ratio or percentage) of conventional stem cell memory T-lymphocytes to the helper T-lymphocytes in a biological specimen. Conventional Stem Cell Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional Sub-Population/T-Lymphocytes Conventional TLym Conv Sub/TLymCv A relative measurement (ratio or percentage) of a sub-population of conventional T-lymphocytes to the conventional T-lymphocytes in a biological specimen. Conventional T-Lymphocyte Subpopulation to Conventional T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional/T-Lymphocytes TLym Conv/TLym A relative measurement (ratio or percentage) of conventional T-lymphocytes to the T-lymphocytes in a biological specimen. Conventional T-Lymphocyte Subpopulation to T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional/T-Lymphocytes Helper TLym Conv/TLymH A relative measurement (ratio or percentage) conventional T-lymphocytes to the helper T-lymphocytes in a biological specimen. Conventional T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement TLym Conv Term Mem TLym Conventional Terminal Memory A measurement of the conventional terminal memory T-lymphocytes in a biological specimen. Conventional Terminal Memory T-Lymphocyte Count TLym Conv Term Mem Sub TLym Conventional Terminal Memory Sub-Population A measurement of a sub-population of conventional terminal memory T-lymphocytes in a biological specimen. Conventional Terminal Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Conventional Terminal Memory Sub-Population/T-Lymphocytes Conventional Terminal Memory TLym Conv Term Mem Sub/TLymCvTM A relative measurement (ratio or percentage) of a sub-population of conventional terminal memory T-lymphocytes to total conventional terminal memory T-lymphocytes in a biological specimen. Conventional Terminal Memory T-Lymphocyte Subpopulation to Conventional Terminal Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional Terminal Memory/T-Lymphocytes TLym Conv Term Mem/TLym A relative measurement (ratio or percentage) of the conventional terminal memory T-lymphocytes to T-lymphocytes in a biological specimen. Conventional Terminal Memory T-Lymphocyte to T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional Terminal Memory/T-Lymphocytes Conventional TLym Conv Term Mem/TLymCv A relative measurement (ratio or percentage) of the conventional terminal memory T-lymphocytes to conventional T-lymphocytes in a biological specimen. Conventional Terminal Memory T-Lymphocyte to Conventional T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional Terminal Memory/T-Lymphocytes Helper TLym Conv Term Mem/TLymH A relative measurement (ratio or percentage) of the conventional terminal memory T-lymphocytes to helper T-lymphocytes in a biological specimen. Conventional Terminal Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Double Negative TLym Dbl Neg TLym DN A measurement of the double-negative T-lymphocytes (T-lymphocyte that are both CD4-CD8-) in a biological specimen. Double-Negative T-Lymphocyte Count T-Lymphocytes Double Negative/Lymphocytes TLym Dbl Neg/Lym TLym DN/Lym A relative measurement (ratio or percentage) of double-negative T-lymphocytes to lymphocytes in a biological specimen. Double-Negative T-Lymphocyte to Lymphocyte Ratio Measurement T-Lymphocytes Double Negative Sub-Population TLym Dbl Neg Sub TLym DN Sub A measurement of a sub-population of double-negative T-lymphocytes (T-lymphocyte that are both CD4-CD8-) in a biological specimen. Double-Negative T-Lymphocyte Subpopulation Count T-Lymphocytes Double Negative Sub-Population/T-Lymphocytes Double Negative TLym Dbl Neg Sub/TLym Dbl Neg TLym DN Sub/TLym DN A relative measurement (ratio or percentage) of a sub-population of double-negative T-lymphocytes to total double-negative T-lymphocytes in a biological specimen. Double-Negative T-Lymphocyte Subpopulation to Double-Negative T-Lymphocyte Ratio Measurement T-Lymphocytes Double Negative/T-Lymphocytes TLym Dbl Neg/TLym TLym DN/TLym A relative measurement (ratio or percentage) of double-negative T-lymphocytes to T-lymphocytes in a biological specimen. Double-Negative T-Lymphocyte to T-Lymphocyte Ratio Measurement T-Lymphocytes Double Positive TLym Dbl Pos TLym DP A measurement of the double-positive T-lymphocytes (T-lymphocyte that are both CD4+CD8+) in a biological specimen. Double-Positive T-Lymphocyte Count T-Lymphocytes Double Positive/Lymphocytes TLym Dbl Pos/Lym TLym DP/Lym A relative measurement (ratio or percentage) of double-positive T-lymphocytes to lymphocytes in a biological specimen. Double-Positive T-Lymphocyte to Lymphocyte Ratio Measurement T-Lymphocytes Double Positive Sub-Population TLym Dbl Pos Sub TLym DP Sub A measurement of a sub-population of double-positive T-lymphocytes (T-lymphocyte that are both CD4+CD8+) in a biological specimen. Double-Positive T-Lymphocyte Subpopulation Count T-Lymphocytes Double Positive Sub-Population/T-Lymphocytes Double Positive TLym Dbl Pos Sub/TLym Dbl Pos TLym DP Sub/TLym DP A relative measurement (ratio or percentage) of a sub-population of double-positive T-lymphocytes to total double-positive T-lymphocytes in a biological specimen. Double-Positive T-Lymphocyte Subpopulation to Double-Positive T-Lymphocyte Ratio Measurement T-Lymphocytes Double Positive/T-Lymphocytes TLym Dbl Pos/TLym TLym DP/TLym A relative measurement (ratio or percentage) of double-positive T-lymphocytes to T-lymphocytes in a biological specimen. Double-Positive T-Lymphocyte to T-Lymphocyte Ratio Measurement Target Bound A measurement of the bound target in a biological specimen, prior to background subtraction. Target Bound Measurement Target Bound, Background A measurement of the background associated with the bound target measurement in a biological specimen. Target Bound, Background Measurement Target Bound, Delta Bound Background A measurement of the difference between bound target and background target in a biological specimen. Target, Bound Delta Bound Background Measurement Target Free A measurement of the free target in a biological specimen, prior to background subtraction. Target Free Measurement Target Free, Background A measurement of the background associated with the free target measurement in a biological specimen. Target Free, Background Measurement Target Free, Delta Free Background A measurement of the difference between free target and free background target in a biological specimen. Target, Free Delta Free Background Measurement Percent Occupancy Percent Saturation Target Occupancy A relative measurement (ratio or percentage) of the specifically bound target to total target in a biological specimen. Target Occupancy Ratio Measurement Target Total A measurement of the total target in a biological specimen, prior to background subtraction. Target Total Measurement Target Total, Background A measurement of the background associated with the total target measurement in a biological specimen. Target Total, Background Measurement Target Total, Delta Total Background A measurement of the difference between total target and target total background in a biological specimen. Target, Total Delta Total Background Measurement T-Lymphocytes Helper 17.1 Sub-Population/T-Lymphocytes Helper 17.1 TLym Help 17.1 Sub/TLymH17.1 A relative measurement (ratio or percentage) of a sub-population of helper 17.1 T-lymphocytes to total helper 17.1 T-lymphocytes in a biological specimen. Helper 17.1 T-Lymphocyte Subpopulation to Helper 17.1 T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 17.1 Sub-Population/T-Lymphocytes Helper TLym Help 17.1 Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of helper 17.1 T-lymphocytes to total helper T-lymphocytes in a biological specimen. Helper 17.1 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 17.1/T-Lymphocytes Helper TLym Help 17.1/TLym Help A relative measurement (ratio or percentage) of the helper 17.1 T-lymphocytes to total helper T-lymphocytes in a biological specimen. Helper 17.1 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Effector Th17-Like Sub/TLym Help Reg Eff Th17-like TLym Help Reg Eff Th17 Sub/TLym Help Reg Eff Th17 TLym Help Reg Eff Th17 Sub/TLymHRE Th17 A relative measurement (ratio or percentage) of a sub-population of Th17-like helper regulatory effector T-lymphocytes to total Th17-like helper regulatory effector T-lymphocytes in a biological specimen. Th17-like Helper Regulatory Effector T-Lymphocyte Subpopulation to Th17-like Helper Regulatory Effector T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 17 Sub-Population/T-Lymphocytes Helper 17 TLym Help 17 Sub/TLymH17 A relative measurement (ratio or percentage) of a sub-population of helper 17 T-lymphocytes to total helper 17 T-lymphocytes in a biological specimen. Helper 17 T-Lymphocyte Subpopulation to Helper 17 T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 17 Sub-Population/T-Lymphocytes Helper TLym Help 17 Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of helper 17 T-lymphocytes to total helper T-lymphocytes in a biological specimen. Helper 17 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 17/T-Lymphocytes Helper TLym Help 17/TLym Help A relative measurement (ratio or percentage) of the helper 17 T-lymphocytes to total helper T-lymphocytes in a biological specimen. Helper 17 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Effector Th1-Like Sub/TLym Help Reg Eff Th1-Like TLym Help Reg Eff Th1 Sub/TLym Help Reg Eff Th1 TLym Help Reg Eff Th1 Sub/TLymHRE Th1 A relative measurement (ratio or percentage) of a sub-population of Th1-like helper regulatory effector T-lymphocytes to total Th1-like helper regulatory effector T-lymphocytes in a biological specimen. Th1-like Helper Regulatory Effector T-Lymphocyte Subpopulation to Th1-like Helper Regulatory Effector T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Effector Th1-Like/T-Lymphocytes Helper Regulatory TLym Help Reg Eff Th1/TLym Help Reg A relative measurement (ratio or percentage) of a population of Th1-like helper regulatory effector T-lymphocytes to total helper regulatory T-lymphocytes in a biological specimen. Th1-like Helper Regulatory Effector T-Lymphocyte Subpopulation to Helper Regulatory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 1 Sub-Population/T-Lymphocytes Helper 1 TLym Help 1 Sub/TLymH1 A relative measurement (ratio or percentage) of a sub-population of helper 1 T-lymphocytes to total helper 1 T-lymphocytes in a biological specimen. Helper 1 T-Lymphocyte Subpopulation to Helper 1 T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 1 Sub-Population/T-Lymphocytes Helper TLym Help 1 Sub/TLym Helper A relative measurement (ratio or percentage) of a sub-population of helper 1 T-lymphocytes to total helper T-lymphocytes in a biological specimen. Helper 1 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 1/T-Lymphocytes Helper TLym Help 1/TLym Help A relative measurement (ratio or percentage) of the helper 1 T-lymphocytes to total helper T-lymphocytes in a biological specimen. Helper 1 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 22 Sub-Population/T-Lymphocytes Helper 22 TLym Help 22 Sub/TLymH22 A relative measurement (ratio or percentage) of a sub-population of helper 22 T-lymphocytes to total helper 22 T-lymphocytes in a biological specimen. Helper 22 T-Lymphocyte Subpopulation to Helper 22 T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 22 Sub-Population/T-Lymphocytes Helper TLym Help 22 Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of helper 22 T-lymphocytes to total helper T-lymphocytes in a biological specimen. Helper 22 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 22/T-Lymphocytes Helper TLym Help 22/TLym Help A relative measurement (ratio or percentage) of the helper 22 T-lymphocytes to total helper T-lymphocytes in a biological specimen. Helper 22 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Effector Th2-Like Sub/TLym Help Reg Eff Th2-Like TLym Help Reg Eff Th2 Sub/TLym Help Reg Eff Th2 TLym Help Reg Eff Th2 Sub/TLymHRE Th2 A relative measurement (ratio or percentage) of a sub-population of Th2-like helper regulatory effector T-lymphocytes to total Th2-like helper regulatory effector T-lymphocytes in a biological specimen. Th2-like Helper Regulatory Effector T-Lymphocyte Subpopulation to Th2-like Helper Regulatory Effector T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Effector Th17-Like/T-Lymphocytes Helper Regulatory TLym Help Reg Eff Th2/TLym Help Reg A relative measurement (ratio or percentage) of a population of Th2-like helper regulatory effector T-lymphocytes to total helper regulatory T-lymphocytes in a biological specimen. Th2-like Helper Regulatory Effector T-Lymphocyte Subpopulation to Helper Regulatory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 2 Sub-Population/T-Lymphocytes Helper 2 TLym Help 2 Sub/TLymH2 A relative measurement (ratio or percentage) of a sub-population of helper 2 T-lymphocytes to total helper 2 T-lymphocytes in a biological specimen. Helper 2 T-Lymphocyte Subpopulation to Helper 2 T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 2 Sub-Population/T-Lymphocytes Helper TLym Help 2 Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of helper 2 T-lymphocytes to total helper T-lymphocytes in a biological specimen. Helper 2 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 2/T-Lymphocytes Helper TLym Help 2/TLym Help A relative measurement (ratio or percentage) of the helper 2 T-lymphocytes to total helper T-lymphocytes in a biological specimen. Helper 2 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 9 Sub-Population/T-Lymphocytes Helper 9 TLym Help 9 Sub/TLymH9 A relative measurement (ratio or percentage) of a sub-population of helper 9 T-lymphocytes to total helper 9 T-lymphocytes in a biological specimen. Helper 9 T-Lymphocyte Subpopulation to Helper 9 T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 9 Sub-Population/T-Lymphocytes Helper TLym Help 9 Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of helper 9 T-lymphocytes to total helper T-lymphocytes in a biological specimen. Helper 9 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 9/T-Lymphocytes Helper TLym Help 9/TLym Help A relative measurement (ratio or percentage) of the helper 9 T-lymphocytes to total helper T-lymphocytes in a biological specimen. Helper 9 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Central Memory Gut-Homing TLym Help Cen Mem GH A measurement of the gut-homing helper central memory T-lymphocytes in a biological specimen. Gut-Homing Helper Central Memory T-Lymphocyte Count T-Lymphocytes Helper Central Memory Gut-Homing Sub-Population/T-Lymphocytes Helper Central Memory Gut-Homing TLym Help Cen Mem GH Sub/TLym Help Cen Mem GH TLym Help Cen Mem GH Sub/TLymHCMGH A relative measurement (ratio or percentage) of a sub-population of gut-homing helper central memory T-lymphocytes to total gut-homing helper central memory T-lymphocytes in a biological specimen. Gut-Homing Helper Central Memory T-Lymphocyte Subpopulation to Gut-Homing Helper Central Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Help Central Memory Gut-Homing Sub-Population TLym Help Cen Mem GH Sub A measurement of a sub-population of gut-homing helper central memory T-lymphocytes in a biological specimen. Gut-Homing Helper Central Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Central Memory Gut-Homing/T-Lymphocytes Helper TLym Help Cen Mem GH/TLym Help TLym Help Cen Mem GH/TLymH A relative measurement (ratio or percentage) of the gut-homing helper central memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Gut-Homing Helper Central Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Central Memory Skin-Homing TLym Help Cen Mem SH A measurement of the skin-homing helper central memory T-lymphocytes in a biological specimen. Skin-Homing Helper Central Memory T-Lymphocyte Count T-Lymphocytes Helper Central Memory Skin-Homing Sub-Population TLym Help Cen Mem SH Sub A measurement of a sub-population of skin-homing helper central memory T-lymphocytes in a biological specimen. Skin-Homing Helper Central Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Central Memory Skin-Homing Sub-Population/T-Lymphocytes Helper Central Memory Skin-Homing TLym Help Cen Mem SH Sub/TLym Help Cen Mem SH TLym Help Cen Mem SH Sub/TLymHCMSH A relative measurement (ratio or percentage) of a sub-population of skin-homing helper central memory T-lymphocytes to total skin-homing helper central memory T-lymphocytes in a biological specimen. Skin-Homing Helper Central Memory T-Lymphocyte Subpopulation to Skin-Homing Helper Central Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Central Memory Skin-Homing/T-Lymphocytes Helper TLym Help Cen Mem SH/TLym Help TLym Help Cen Mem SH/TLymH A relative measurement (ratio or percentage) of the skin-homing helper central memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Skin-Homing Helper Central Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Effector Memory Gut-Homing TLym Help Eff Mem GH A measurement of the gut-homing helper effector memory T-lymphocytes in a biological specimen. Gut-Homing Helper Effector Memory T-Lymphocyte Count T-Lymphocytes Helper Effector Memory Gut-Homing Sub-Population TLym Help Eff Mem GH Sub A measurement of a sub-population of gut-homing helper effector memory T-lymphocytes in a biological specimen. Gut-Homing Helper Effector Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Effector Memory Gut-Homing Sub-Population/T-Lymphocytes Helper Effector Memory Gut-Homing TLym Help Eff Mem GH Sub/TLym Help Eff Mem GH TLym Help Eff Mem GH Sub/TLymHEMGH A relative measurement (ratio or percentage) of a sub-population of gut-homing helper effector memory T-lymphocytes to total gut-homing helper effector memory T-lymphocytes in a biological specimen. Gut-Homing Helper Effector Memory T-Lymphocyte Subpopulation to Gut-Homing Helper Effector Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Effector Memory Gut-Homing/T-Lymphocytes Helper TLym Help Eff Mem GH/TLym Help TLym Help Eff Mem GH/TLymH A relative measurement (ratio or percentage) of the gut-homing helper effector memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Gut-Homing Helper Effector Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Effector Memory Skin-Homing TLym Help Eff Mem SH A measurement of the skin-homing helper effector memory T-lymphocytes in a biological specimen. Skin-Homing Helper Effector Memory T-Lymphocyte Count T-Lymphocytes Helper Effector Memory Skin-Homing Sub-Population TLym Help Eff Mem SH Sub A measurement of a sub-population of skin-homing helper effector memory T-lymphocytes in a biological specimen. Skin-Homing Helper Effector Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Effector Memory Skin-Homing Sub-Population/T-Lymphocytes Helper Effector Memory Skin-Homing TLym Help Eff Mem SH Sub/TLym Help Eff Mem SH TLym Help Eff Mem SH Sub/TLymHEMSH A relative measurement (ratio or percentage) of a sub-population of skin-homing helper effector memory T-lymphocytes to total skin-homing helper effector memory T-lymphocytes in a biological specimen. Skin-Homing Helper Effector Memory T-Lymphocyte Subpopulation to Skin-Homing Helper Effector Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Effector Memory Skin-Homing/T-Lymphocytes Helper TLym Help Eff Mem SH/TLym Help TLym Help Eff Mem SH/TLymH A relative measurement (ratio or percentage) of the skin-homing helper effector memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Skin-Homing Helper Effector Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Follicular Sub-Population/T-Lymphocytes Helper Sub-Population TLym Help Foll Sub/TLym Help Sub A relative measurement (ratio or percentage) of a sub-population of helper follicular T-lymphocytes to a sub-population of helper T-lymphocytes in a biological specimen. Follicular Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Follicular Sub-Population/T-Lymphocytes Memory Sub-Population TLym Help Foll Sub/TLym Mem Sub A relative measurement (ratio or percentage) of a sub-population of helper follicular T-lymphocytes to a sub-population of memory T-lymphocytes in a biological specimen. Follicular Helper T-Lymphocyte Subpopulation to Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Memory Gut-Homing TLym Help Mem GH A measurement of the gut-homing helper memory T-lymphocytes in a biological specimen. Gut-Homing Helper Memory T-Lymphocyte Count T-Lymphocytes Helper Memory Gut-Homing Sub-Population TLym Help Mem GH Sub A measurement of a sub-population of gut-homing helper memory T-lymphocytes in a biological specimen. Gut-Homing Helper Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Memory Gut-Homing Sub-Population/T-Lymphocytes Helper Memory Gut-Homing TLym Help Mem GH Sub/TLym Help Mem GH TLym Help Mem GH Sub/TLymHMGH A relative measurement (ratio or percentage) of a sub-population of gut-homing helper memory T-lymphocytes to total gut-homing helper memory T-lymphocytes in a biological specimen. Gut-Homing Helper Memory T-Lymphocyte Subpopulation to Gut-Homing Helper Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Memory Gut-Homing Sub-Population/T-Lymphocytes Helper TLym Help Mem GH Sub/TLym Help TLym Help Mem GH Sub/TLymH A relative measurement (ratio or percentage) of a sub-population of gut-homing helper memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Gut-Homing Helper Memory T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Memory Gut-Homing/T-Lymphocytes Helper TLym Help Mem GH/TLym Help TLym Help Mem GH/TLymH A relative measurement (ratio or percentage) of the gut-homing helper memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Gut-Homing Helper Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Memory Gut-Homing/T-Lymphocytes Helper Memory Gut-Homing/T-Lymphocytes Helper Memory TLym Help Mem GH/TLym Help Mem TLym Help Mem GH/TLymHM A relative measurement (ratio or percentage) of the gut-homing helper memory T-lymphocytes to total helper memory T-lymphocytes in a biological specimen. Gut-Homing Helper Memory T-Lymphocyte to Helper Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Memory Skin-Homing TLym Help Mem SH A measurement of the skin-homing helper memory T-lymphocytes in a biological specimen. Skin-Homing Helper Memory T-Lymphocyte Count T-Lymphocytes Helper Memory Skin-Homing Sub-Population TLym Help Mem SH Sub A measurement of a sub-population of skin-homing helper memory T-lymphocytes in a biological specimen. Skin-Homing Helper Memory T-Lymphocyte Subpopulation T-Lymphocytes Helper Memory Skin-Homing Sub-Population/T-Lymphocytes Helper Memory Skin-Homing TLym Help Mem SH Sub/TLym Help Mem SH TLym Help Mem SH Sub/TLymHMSH A relative measurement (ratio or percentage) of a sub-population of skin-homing helper memory T-lymphocytes to total skin-homing helper memory T-lymphocytes in a biological specimen. Skin-Homing Helper Memory T-Lymphocyte Subpopulation to Skin-Homing Helper Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Memory Skin-Homing Sub-Population/T-Lymphocytes Helper TLym Help Mem SH Sub/TLym Help TLym Help Mem SH Sub/TLymH A relative measurement (ratio or percentage) of a sub-population of skin-homing helper memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Skin-Homing Helper Memory T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Memory Skin-Homing/T-Lymphocytes Helper TLym Help Mem SH/TLym Help TLym Help Mem SH/TLymH A relative measurement (ratio or percentage) of the skin-homing helper memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Skin-Homing Helper Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Memory Skin-Homing/T-Lymphocytes Helper Memory TLym Help Mem SH/TLym Help Mem TLym Help Mem SH/TLymHM A relative measurement (ratio or percentage) of the skin-homing helper memory T-lymphocytes to total helper memory T-lymphocytes in a biological specimen. Skin-Homing Helper Memory T-Lymphocyte to Helper Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Effector Sub-Population/T-Lymphocytes Helper Regulatory Effector TLym Help Reg Eff Sub/TLym Help Reg Eff TLym Help Reg Eff Sub/TLymHRE A relative measurement (ratio or percentage) of a sub-population of helper regulatory effector T-lymphocytes to total helper regulatory effector T-lymphocytes in a biological specimen. Regulatory Effector Helper T-Lymphocyte Subpopulation to Regulatory Effector Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory/Leukocytes TLym Help Reg/Leuk A relative measurement (ratio or percentage) of the helper regulatory T-lymphocytes to leukocytes in a biological specimen. Regulatory Helper T-Lymphocyte to Leukocyte Ratio Measurement T-Lymphocytes Helper Regulatory Naive Sub-Population/T-Lymphocytes Helper Regulatory TLym Help Reg Naive Sub/TLymHR A relative measurement (ratio or percentage) of a sub-population of helper regulatory naive T-lymphocytes to total helper regulatory T-lymphocytes in a biological specimen. Naive Helper Regulatory T-Lymphocyte Subpopulation to Helper Regulatory T-Lymphocyte Ratio Measurement T Lymphocytes Helper Stem Cell Memory Sub-Population/T-Lymphocytes Helper TLym Help SC Mem Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of helper stem cell memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Stem Cell Memory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Stem Cell Memory/T-Lymphocytes Helper Naive TLym Help SC Mem/TLymHN A relative measurement (ratio or percentage) of the helper stem cell memory T-lymphocytes to total helper naive T-lymphocytes in a biological specimen. Stem Cell Memory Helper T-Lymphocyte Subpopulation to Naive Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Sub-Population/T-Lymphocytes Helper Sub-Population TLym Help Sub/TLym Help Sub A relative measurement (ratio or percentage) of a sub-population of helper T-Lymphocytes to a sub-population of helper T-lymphocytes in a biological specimen. Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Sub-Population/T-Lymphocytes Sub-Population TLym Help Sub/TLym Sub A relative measurement (ratio or percentage) of a sub-population of helper T-Lymphocytes to a sub-population of T-lymphocytes in a biological specimen. Helper T-Lymphocyte Subpopulation to T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Terminal Memory Gut-Homing TLym Help Term Mem GH A measurement of the gut-homing helper terminal memory T-lymphocytes in a biological specimen. Gut-Homing Helper Terminal Memory T-Lymphocyte Count T-Lymphocytes Helper Terminal Memory Gut-Homing Sub-Population TLym Help Term Mem GH Sub A measurement of a sub-population of gut-homing helper terminal memory T-lymphocytes in a biological specimen. Gut-Homing Helper Terminal Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Terminal Memory Gut-Homing Sub-Population/T-Lymphocytes Helper Terminal Memory Gut-Homing TLym Help Term Mem GH Sub/TLym Help Term Mem GH TLym Help Term Mem GH Sub/TLymHTMGH A relative measurement (ratio or percentage) of a sub-population of gut-homing helper terminal memory T-lymphocytes to total gut-homing helper terminal memory T-lymphocytes in a biological specimen. Gut-Homing Helper Terminal Memory T-Lymphocyte Subpopulation to Gut-Homing Helper Terminal Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Terminal Memory Gut-Homing/T-Lymphocytes Helper TLym Help Term Mem GH/TLym Help TLym Help Term Mem GH/TLymH A relative measurement (ratio or percentage) of the gut-homing helper terminal memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Gut-Homing Helper Terminal Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Terminal Memory Skin-Homing TLym Help Term Mem SH A measurement of the skin-homing helper terminal memory T-lymphocytes in a biological specimen. Skin-Homing Helper Terminal Memory T-Lymphocyte Count T-Lymphocytes Helper Terminal Memory Skin-Homing Sub-Population TLym Help Term Mem SH Sub A measurement of a sub-population of skin-homing helper terminal memory T-lymphocytes in a biological specimen. Skin-Homing Helper Terminal Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Terminal Memory Skin-Homing Sub-Population/T-Lymphocytes Helper Terminal Memory Skin-Homing TLym Help Term Mem SH Sub/TLym Help Term Mem SH TLym Help Term Mem SH Sub/TLymHTMSH A relative measurement (ratio or percentage) of a sub-population of skin-homing helper terminal memory T-lymphocytes to total skin-homing helper terminal memory T-lymphocytes in a biological specimen. Skin-Homing Helper Terminal Memory T-Lymphocyte Subpopulation to Skin-Homing Helper Terminal Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Terminal Memory Skin-Homing/T-Lymphocytes Helper TLym Help Term Mem SH/TLym Help TLym Help Term Mem SH/TLymH A relative measurement (ratio or percentage) of the skin-homing helper terminal memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Skin-Homing Helper Terminal Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Cell Immunoreceptor with Ig and ITIM Domains Expression TIGIT Expression A measurement of cellular TIGIT expression in a biological specimen. TIGIT Expression Measurement T-Lymphocytes Alpha-Beta T-Lymphocytes TCR Alpha-Beta TCR Alpha-Beta T-Cells TLym AB A measurement of the alpha-beta T-lymphocytes in a biological specimen. Alpha-Beta T-Lymphocyte Count T-Lymphocytes Alpha-Beta Sub T-Lymphocytes TCR Alpha-Beta Sub TLym AB Sub A measurement of a sub-population of alpha-beta T-lymphocytes in a biological specimen. Alpha-Beta T-Lymphocyte Subpopulation Count T-Lymphocytes Alpha-Beta Sub-Population/T-Lymphocytes Alpha-Beta T-Lymphocytes TCR Alpha-Beta Sub-Population/T-Lymphocytes TCR Alpha-Beta TCR Alpha-Beta T-Cells Sub/TCR Alpha-Beta T-Cells TLym AB Sub/TLym AB A relative measurement (ratio or percentage) of a sub-population of alpha-beta T-lymphocytes to total alpha-beta T-lymphocytes in a biological specimen. Alpha-Beta T-Lymphocyte Subpopulation to Alpha-Beta T-Lymphocyte Ratio Measurement T-Lymphocytes Alpha-Beta/T-Lymphocytes T-Lymphocytes TCR Alpha-Beta/T-Lymphocytes TCR Alpha-Beta T-Cells/T-Lymphocytes TLym AB/TLym A relative measurement (ratio or percentage) of the alpha-beta T-lymphocytes to total T-lymphocytes in a biological specimen. Alpha-Beta T-Lymphocyte to T-Lymphocyte Ratio Measurement Cytotoxic T Cells Cytotoxic T-Lymphocytes TLym Cytx A measurement of the cytotoxic T-lymphocytes in a biological specimen. Cytotoxic T-Lymphocyte Count T-Lymphocytes Cytotoxic Alpha-Beta T-Lymphocytes Cytotoxic TCR Alpha-Beta TLym Cytx AB A measurement of the cytotoxic alpha-beta T-lymphocytes in a biological specimen. Cytotoxic Alpha-Beta T-Lymphocyte Count T-Lymphocytes Cytotoxic Alpha-Beta Sub-Population T-Lymphocytes Cytotoxic TCR Alpha-Beta Sub-Population TLym Cytx AB Sub A measurement of a sub-population of cytotoxic alpha-beta T-lymphocytes in a biological specimen. Alpha-Beta Cytotoxic T-Lymphocyte Subpopulation Count T Cells, Cytotoxic/Total Cells T-Lym, CTX/Total Cells T-Lymphocytes, Cytotoxic/Total Cells TLym Cytx/Total Cells A relative measurement (ratio or percentage) of the cytotoxic T-lymphocytes to total cells in a biological specimen. Cytotoxic T-Lymphocytes to Total Cells Ratio Measurement T-Lymphocytes Cytotoxic Central Memory TLym Cytx Cen Mem A measurement of the cytotoxic central memory T-lymphocytes in a biological specimen. Central Memory Cytotoxic T-Lymphocyte Count T-Lymphocytes Cytotoxic Central Memory Sub-Population TLym Cytx Cen Mem Sub A measurement of a sub-population of cytotoxic central memory T-lymphocytes in a biological specimen. Central Memory Cytotoxic T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Central Memory Sub-Population/T-Lymphocytes Cytotoxic Central Memory TLym Cytx Cen Mem Sub/TLymCCM A relative measurement (ratio or percentage) of a sub-population of central memory cytotoxic T-lymphocytes to total central memory cytotoxic T-lymphocytes in a biological specimen. Central Memory Cytotoxic T-Lymphocyte Subpopulation to Central Memory Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Central Memory Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx Cen Mem Sub/TLymC A relative measurement (ratio or percentage) of a sub-population of central memory cytotoxic T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Central Memory Cytotoxic T-Lymphocyte Sub-Population to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Central Memory/T-Lymphocytes Cytotoxic TLym Cytx Cen Mem/TLym Cytx A relative measurement (ratio or percentage) of the cytotoxic central memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Central Memory Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Effector TLym Cytx Eff A measurement of the cytotoxic effector T-lymphocytes in a biological specimen. Effector Cytotoxic T-Lymphocyte Count T-Lymphocytes Cytotoxic Effector Memory TLym Cytx Eff Mem A measurement of the cytotoxic effector memory T-lymphocytes in a biological specimen. Effector Memory Cytotoxic T-Lymphocyte Count T-Lymphocytes Cytotoxic Effector Memory Sub-Population TLym Cytx Eff Mem Sub A measurement of a sub-population of cytotoxic effector memory T-lymphocytes in a biological specimen. Effector Memory Cytotoxic T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Effector Memory Sub-Population/T-Lymphocytes Cytotoxic Effector Memory TLym Cytx Eff Mem Sub/TLymCEM A relative measurement (ratio or percentage) of a sub-population of effector memory cytotoxic T-lymphocytes to total effector memory cytotoxic T-lymphocytes in a biological specimen. Effector Memory Cytotoxic T-Lymphocyte Subpopulation to Effector Memory Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx Eff Mem Sub/TLymC A relative measurement (ratio or percentage) of a sub-population of effector memory cytotoxic T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Effector Memory Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory/T-Lymphocytes Cytotoxic TLym Cytx Eff Mem/TLym Cytx A relative measurement (ratio or percentage) of the cytotoxic effector memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Effector Memory Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Effector Sub-Population TLym Cytx Eff Sub A measurement of a sub-population of cytotoxic effector T-lymphocytes in a biological specimen. Effector Cytotoxic T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Gamma-Delta T-Lymphocytes Cytotoxic TCR Gamma-Delta TLym Cytx GD A measurement of the cytotoxic gamma-delta T-lymphocytes in a biological specimen. Cytotoxic Gamma-Delta T-Lymphocyte Count T-Lymphocytes Cytotoxic Gamma-Delta Sub-Population T-Lymphocytes Cytotoxic TCR Gamma-Delta Sub-Population TLym Cytx GD Sub A measurement of a sub-population of cytotoxic gamma-delta T-lymphocytes in a biological specimen. Cytotoxic Gamma-Delta T-Lymphocyte Subpopulation Count T Cells, Cytotoxic/Leukocytes T-Lymphocytes, Cytotoxic/Leukocytes TLym Cytx/Leuk A relative measurement (ratio or percentage) of the cytotoxic T-lymphocytes to leukocytes in a biological specimen. Cytotoxic T-Lymphocytes to Leukocytes Ratio Measurement T-Lymphocytes Cytotoxic/Lymphocytes TLym Cytx/Lym A relative measurement (ratio or percentage) of the cytotoxic T-lymphocytes to total lymphocytes in a biological specimen. Cytotoxic T-Lymphocytes to Lymphocytes Ratio Measurement T-Lymphocytes Cytotoxic Memory TLym Cytx Mem A measurement of memory cytotoxic T-lymphocytes in a biological specimen. Memory Cytotoxic T-Lymphocyte Count T-Lymphocytes Cytotoxic Memory Sub-Population TLym Cytx Mem Sub A measurement of a sub-population of memory cytotoxic T-lymphocytes in a biological specimen. Memory Cytotoxic T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Memory Sub-Population/T-Lymphocytes Cytotoxic Memory TLym Cytx Mem Sub/TLymCM A relative measurement (ratio or percentage) of a sub-population of memory cytotoxic T-lymphocytes to total memory cytotoxic T-lymphocytes in a biological specimen. Memory Cytotoxic T-Lymphocyte Subpopulation to Memory Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Memory Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx Mem Sub/TLymC A relative measurement (ratio or percentage) of a sub-population of memory cytotoxic T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Memory Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Memory/T-Lymphocytes Cytotoxic TLym Cytx Mem/TLym Cytx A relative measurement (ratio or percentage) of memory cytotoxic T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Memory Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Naive TLym Cytx Naive A measurement of the cytotoxic naive T-lymphocytes in a biological specimen. Naive Cytotoxic T-Lymphocyte Count T-Lymphocytes Central Memory TLym Cen Mem A measurement of the central memory T-lymphocytes in a biological specimen. Central Memory T-Lymphocyte Count T-Lymphocytes Cytotoxic Naive Sub-Population TLym Cytx Naive Sub A measurement of a sub-population of cytotoxic naive T-lymphocytes in a biological specimen. Naive Cytotoxic T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Naive Sub-Population/T-Lymphocytes Cytotoxic Naive TLym Cytx Naive Sub/TLymCN A relative measurement (ratio or percentage) of a sub-population of naive cytotoxic T-lymphocytes to total naive cytotoxic T-lymphocytes in a biological specimen. Naive Cytotoxic T-Lymphocyte Subpopulation to Naive Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Naive Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx Naive Sub/TLymC A relative measurement (ratio or percentage) of a sub-population of naive cytotoxic T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Naive Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Naive/T-Lymphocytes Cytotoxic TLym Cytx Naive/TLym Cytx A relative measurement (ratio or percentage) of the cytotoxic naive T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Naive Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Regulatory TLym Cytx Reg A measurement of the cytotoxic regulatory T-lymphocytes in a biological specimen. Regulatory Cytotoxic T-Lymphocyte Count T-Lymphocytes Cytotoxic Regulatory Sub-Population TLym Cytx Reg Sub A measurement of a sub-population of cytotoxic regulatory T-lymphocytes in a biological specimen. Regulatory Cytotoxic T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Regulatory Sub-Population/T-Lymphocytes Cytotoxic Regulatory TLym Cytx Reg Sub/TLymCR A relative measurement (ratio or percentage) of a sub-population of cytotoxic regulatory T-lymphocytes to total cytotoxic regulatory T-lymphocytes in a biological specimen. Regulatory Cytotoxic T-Lymphocyte Subpopulation to Regulatory Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Regulatory Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx Reg Sub/TLym Cytx A relative measurement (ratio or percentage) of a sub-population of cytotoxic regulatory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Regulatory Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Regulatory/T-Lymphocytes Cytotoxic TLym Cytx Reg/TLym Cytx A relative measurement (ratio or percentage) of the cytotoxic regulatory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Regulatory Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement Cytotoxic T-Lymphocytes Sub-Population TLym Cytx Sub A measurement of the sub-population of cytotoxic T-lymphocytes in a biological specimen. Cytotoxic T-Lymphocyte Subpopulation Count Cytotoxic Stem Cell Memory T-Lymphocytes T-Lymphocytes Cytotoxic Stem Cell Memory TLym Cytx SC Mem TLymCSCM A measurement of the cytotoxic stem cell memory T-lymphocytes in a biological specimen. Stem Cell Memory Cytotoxic T-Lymphocyte Count T-Lymphocytes Cytotoxic SC Memory Sub-Population TLym Cytx SC Mem Sub A measurement of a sub-population of cytotoxic stem cell memory T-lymphocytes in a biological specimen. Stem Cell Memory Cytotoxic T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Stem Cell Memory Sub-Population/T-Lymphocytes Cytotoxic Stem Cell Memory TLym Cytx SC Mem Sub/TLymCSCM A relative measurement (ratio or percentage) of a sub-population of cytotoxic stem cell memory T-lymphocytes to total cytotoxic stem cell memory T-lymphocytes in a biological specimen. Stem Cell Memory Cytotoxic T-Lymphocyte Subpopulation to Stem Cell Memory Cytotoxic T-Lymphocyte Ratio Measurement Cytotoxic T-Lymphocytes Sub-Population/Cytotoxic T-Lymphocytes TLym Cytx Sub/TLym Cytx A relative measurement (ratio or percentage) of a sub-population of cytotoxic T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Cytotoxic T-Lymphocyte Subpopulation to Total Cytotoxic T-Lymphocytes Ratio Measurement T-Lymphocytes Cytotoxic Sub-Population/T-Lymphocytes TLym Cytx Sub/TLym A relative measurement (ratio or percentage) of a sub-population of cytotoxic T-lymphocytes to total T-lymphocytes in a biological specimen. Cytotoxic T-Lymphocyte Subpopulation to T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory TLym Cytx Term Mem A measurement of the cytotoxic terminal memory T-lymphocytes in a biological specimen. Terminal Memory Cytotoxic T-Lymphocyte Count T-Lymphocytes Cytotoxic Terminal Memory Sub-Population TLym Cytx Term Mem Sub A measurement of a sub-population of cytotoxic terminal memory T-lymphocytes in a biological specimen. Terminal Memory Cytotoxic T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Terminal Memory Sub-Population/T-Lymphocytes Cytotoxic Terminal Memory TLym Cytx Term Mem Sub/TLymCTM A relative measurement (ratio or percentage) of a sub-population of terminal memory cytotoxic T-lymphocytes to the total terminal memory cytotoxic T-lymphocytes in a biological specimen. Terminal Memory Cytotoxic T-Lymphocyte Subpopulation to Terminal Memory Cytotoxic T-Lymphocyte Ratio Measurement T-lymphocytes Cytotoxic Terminal Memory/T-lymphocytes Cytotoxic TLym Cytx Term Mem/TLymC A relative measurement (ratio or percentage) of the terminal memory cytotoxic T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Terminal Memory Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Effector Memory TLym Eff Mem A measurement of the effector memory T-lymphocytes in a biological specimen. Effector Memory T-Lymphocyte Count T-Lymphocytes Effector Memory Sub-Population TLym Eff Mem Sub A measurement of a sub-population of effector memory T-lymphocytes in a biological specimen. Effector Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Gamma-Delta T-Lymphocytes TCR Gamma-Delta TCR Gamma-Delta T-Cells TLym GD A measurement of the gamma-delta T-lymphocytes in a biological specimen. Gamma-Delta T-Lymphocyte Count T-Lymphocytes Gamma-Delta/Leukocytes TCR Gamma-Delta T-Cells/Leukocytes TLym GD/Leuk A relative measurement (ratio or percentage) of the gamma-delta T-lymphocytes to leukocytes in a biological specimen. Gamma-Delta T-Lymphocyte to Leukocyte Ratio Measurement T-Lymphocytes Gamma-Delta/Lymphocytes TCR Gamma-Delta T-Cells/Lymphocyte TLym GD/Lym A relative measurement (ratio or percentage) of the gamma-delta T-lymphocytes to total lymphocytes in a biological specimen. Gamma-Delta T-Lymphocyte to Lymphocyte Ratio Measurement T-Lymphocytes Gamma-Delta Sub-Population T-Lymphocytes TCR Gamma-Delta Sub-Population TLym GD Sub A measurement of a sub-population of gamma-delta T-lymphocytes in a biological specimen. Gamma-Delta T-Lymphocyte Subpopulation Count T-Lymphocytes Gamma-Delta Sub-Population/T-Lymphocytes Gamma-Delta TCR Gamma-Delta T-Cells Sub/TCR Gamma-Delta T-Cells TLym GD Sub/TLym GD A relative measurement (ratio or percentage) of a sub-population of gamma-delta T-lymphocytes to total gamma-delta T-lymphocytes in a biological specimen. Gamma-Delta T-Lymphocyte Subpopulation to Gamma-Delta T-Lymphocyte Ratio Measurement T-Lymphocytes Gamma-Delta/T-Lymphocytes TCR Gamma-Delta T-Cells/T-Lymphocytes TLym GD/TLym A relative measurement (ratio or percentage) of the gamma-delta T-lymphocytes to total T-lymphocytes in a biological specimen. Gamma-Delta T-Lymphocyte to T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 1 Th1 TLym Help 1 A measurement of the helper 1 T-lymphocytes in a biological specimen. Helper 1 T-Lymphocyte Count T-Lymphocytes Helper 17 Th17 TLym Help 17 A measurement of the helper 17 T-lymphocytes in a biological specimen. Helper 17 T-Lymphocyte Count T-Lymphocytes Helper 17.1 Th17.1 TLym Help 17.1 A measurement of the helper 17.1 T-lymphocytes in a biological specimen. Helper 17.1 T-Lymphocyte Count T-Lymphocytes Helper 17.1 Sub-Population Th17.1 Sub TLym Help 17.1 Sub A measurement of a sub-population of helper 17.1 T-lymphocytes in a biological specimen. Helper 17.1 T-Lymphocyte Subpopulation Count T-Lymphocytes Helper 17 Sub-Population Th17 Sub TLym Help 17 Sub A measurement of a sub-population of helper 17 T-lymphocytes in a biological specimen. Helper 17 T-Lymphocyte Subpopulation Count T-Lymphocytes Helper 1 Sub-Population Th1 Sub TLym Help 1 Sub A measurement of a sub-population of helper 1 T-lymphocytes in a biological specimen. Helper 1 T-Lymphocyte Subpopulation Count T-Lymphocytes Helper 2 Th2 TLym Help 2 A measurement of the helper 2 T-lymphocytes in a biological specimen. Helper 2 T-Lymphocyte Count T-Lymphocytes Helper 22 Th22 TLym Help 22 A measurement of the helper 22 T-lymphocytes in a biological specimen. Helper 22 T-Lymphocyte Count T-Lymphocytes Helper 22 Sub-Population Th22 Sub TLym Help 22 Sub A measurement of a sub-population of helper 22 T-lymphocytes in a biological specimen. Helper 22 T-Lymphocyte Subpopulation Count T-Lymphocytes Helper 2 Sub-Population Th2 Sub TLym Help 2 Sub A measurement of a sub-population of helper 2 T-lymphocytes in a biological specimen. Helper 2 T-Lymphocyte Subpopulation Count T-Lymphocytes Helper 9 Th9 TLym Help 9 A measurement of the helper 9 T-lymphocytes in a biological specimen. Helper 9 T-Lymphocyte Count T-Lymphocytes Helper 9 Sub-Population Th9 Sub TLym Help 9 Sub A measurement of a sub-population of helper 22 T-lymphocytes in a biological specimen. Helper 9 T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Alpha-Beta T-Lymphocytes Helper TCR Alpha-Beta TLym Help AB A measurement of the helper alpha-beta T-lymphocytes in a biological specimen. Alpha-Beta Helper T-Lymphocyte Count T-Lymphocytes Helper Alpha-Beta Sub-Population T-Lymphocytes Helper TCR Alpha-Beta Sub-Population TLym Help AB Sub A measurement of a sub-population of helper alpha-beta T-lymphocytes in a biological specimen. Alpha-Beta Helper T-Lymphocyte Subpopulation Count T Cells, Helper/Total Cells T-Lym, Helper/Total Cells T-Lymphocytes, Helper/Total Cells TLym Help/Total Cells A relative measurement (ratio or percentage) of the helper T-lymphocytes to total cells in a biological specimen. Helper T-Lymphocytes to Total Cells Ratio Measurement T-Lymphocytes Helper Central Memory TLym Help Cen Mem A measurement of the helper central memory T-lymphocytes in a biological specimen. Central Memory Helper T-Lymphocyte Count T-Lymphocytes Helper Central Memory Sub-Population TLym Help Cen Mem Sub A measurement of a sub-population of helper central memory T-lymphocytes in a biological specimen. Central Memory Helper T-Lymphocyte Sub-Population Count T-Lymphocytes Helper Central Memory Sub-Population/T-Lymphocytes Helper Central Memory TLym Help Cen Mem Sub/TLymHCM A relative measurement (ratio or percentage) of a sub-population of helper central memory T-lymphocytes to total helper central memory T-lymphocytes in a biological specimen. Central Memory Helper T-Lymphocyte Subpopulation to Central Memory Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Central Memory Sub-Population/T-Lymphocytes Helper TLym Help Cen Mem Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of helper central memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Central Memory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Central Memory/T-Lymphocytes Helper TLym Help Cen Mem/TLym Help A relative measurement (ratio or percentage) of the helper central memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Central Memory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Effector TLym Help Eff A measurement of the helper effector T-lymphocytes in a biological specimen. Effector Helper T-Lymphocyte Count T-Lymphocytes Helper Effector Memory TLym Help Eff Mem A measurement of the helper effector memory T-lymphocytes in a biological specimen. Effector Memory Helper T-Lymphocyte Count T-Lymphocytes Helper Effector Memory Sub-Population TLym Help Eff Mem Sub A measurement of a sub-population of helper effector memory T-lymphocytes in a biological specimen. Effector Memory Helper T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Effector Memory Sub-Population/T-Lymphocytes Helper Effector Memory TLym Help Eff Mem Sub/TLymHEM A relative measurement (ratio or percentage) of a sub-population of helper effector memory T-lymphocytes to total helper effector memory T-lymphocytes in a biological specimen. Effector Memory Helper T-Lymphocyte Subpopulation to Effector Memory Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Effector Memory Sub-Population/T-Lymphocytes Helper TLym Help Eff Mem Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of helper effector memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Effector Memory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Effector Memory/T-Lymphocytes Helper TLym Help Eff Mem/TLym Help A relative measurement (ratio or percentage) of the helper effector memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Effector Memory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Effector Sub-Population TLym Help Eff Sub A measurement of a sub-population of helper effector T-lymphocytes in a biological specimen. Effector Helper T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Follicular TLym Help Foll A measurement of the helper follicular T-lymphocytes in a biological specimen. Follicular Helper T-Lymphocyte Count Follicular Helper T-Lymphocytes Sub-Population T-Lymphocytes Helper Follicular Sub-Population TLym Help Foll Sub A measurement of a sub-population of follicular helper T-lymphocytes in a biological specimen. Follicular Helper T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Foll Sub-Population/T-Lymphocytes Helper Follicular TLym Help Foll Sub/TLymHF A relative measurement (ratio or percentage) of a sub-population of helper follicular T-lymphocytes to total helper follicular T-lymphocytes in a biological specimen. Follicular Helper T-Lymphocyte Subpopulation to Follicular Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Foll Sub-Population/T-Lymphocytes Helper TLym Help Foll Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of helper follicular T-lymphocytes to total helper T-lymphocytes in a biological specimen. Follicular Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Foll/T-Lymphocytes Helper TLym Help Foll/TLym Help A relative measurement (ratio or percentage) of the helper follicular T-lymphocytes to total helper T-lymphocytes in a biological specimen. Follicular Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Gamma-Delta T-Lymphocytes Helper TCR Gamma-Delta TLym Help GD A measurement of the helper gamma-delta T-lymphocytes in a biological specimen. Gamma-Delta Helper T-Lymphocyte Count T-Lymphocytes Helper Gamma-Delta Sub-Population T-Lymphocytes Helper TCR Gamma-Delta Sub-Population TLym Help GD Sub A measurement of a sub-population of helper gamma-delta T-lymphocytes in a biological specimen. Helper Gamma-Delta T-Lymphocyte Subpopulation Count T Cells, Helper/Leukocytes T-Lymphocytes, Helper/Leukocytes TLym Help/Leuk A relative measurement (ratio or percentage) of the helper T-lymphocytes to leukocytes in a biological specimen. Helper T-Lymphocytes to Leukocytes Ratio Measurement T-Lymphocytes Helper/Lymphocytes TLym Help/Lym A relative measurement (ratio or percentage) of the helper T-lymphocytes to total lymphocytes in a biological specimen. Helper T-Lymphocyte to Lymphocyte Ratio Measurement T-Lymphocytes Helper Memory TLym Help Mem A measurement of the helper memory T-lymphocytes in a biological specimen. Memory Helper T-Lymphocyte Count T-Lymphocytes Helper Memory Sub-Population TLym Help Mem Sub A measurement of a sub-population of helper memory T-lymphocytes in a biological specimen. Memory Helper T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Memory Sub-Population/T-Lymphocytes Helper Memory TLym Help Mem Sub/TLymHM A relative measurement (ratio or percentage) of a sub-population of helper memory T-lymphocytes to total helper memory T-lymphocytes. Memory Helper T-Lymphocyte Subpopulation to Memory Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Memory Sub-Population/T-Lymphocytes Helper TLym Help Mem Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of helper memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Memory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Memory/T-Lymphocytes Helper TLym Help Mem/TLym Help A relative measurement (ratio or percentage) of the helper memory T-lymphocytes to total helper T-Lymphocytes in a biological specimen. Memory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Naive TLym Help Naive A measurement of the helper naive T-lymphocytes in a biological specimen. Naive Helper T-Lymphocyte Count T-Lymphocytes Helper Naive Sub-Population TLym Help Naive Sub A measurement of a sub-population of helper naive T-lymphocytes in a biological specimen. Naive Helper T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Naive Sub-Population/T-Lymphocytes Helper Naive TLym Help Naive Sub/TLymHN A relative measurement (ratio or percentage) of a sub-population of helper naive T-lymphocytes to total helper naive T-lymphocytes in a biological specimen. Naive Helper T-Lymphocyte Subpopulation to Naive Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Naive Sub-Population/T-Lymphocytes Helper TLym Help Naive Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of helper naive T-lymphocytes to total helper T-lymphocytes in a biological specimen. Naive Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Naive/T-Lymphocytes Helper TLym Help Naive/TLym Help A relative measurement (ratio or percentage) of the helper naive T-lymphocytes to total helper T-lymphocytes in a biological specimen. Naive Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Peripheral TLym Help Peripheral Tph A measurement of the peripheral helper T-lymphocytes in a biological specimen. Peripheral Helper T-Lymphocyte Count T-Lymphocytes Helper Peripheral Sub-Population TLym Help Peripheral Sub Tph Sub A measurement of a sub-population of peripheral helper T-lymphocytes in a biological specimen. Peripheral Helper T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Peripheral Sub-Population/T-Lymphocytes Helper Peripheral TLym Help Peripheral Sub/TLym Help Peripheral TLym Help Peripheral Sub/TLymHP Tph Sub/Tph A relative measurement (ratio or percentage) of a sub-population of peripheral helper T-lymphocytes to total peripheral helper T-lymphocytes in a biological specimen. Peripheral Helper T-Lymphocyte Subpopulation to Peripheral Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Peripheral Sub-Population/T-Lymphocytes Helper TLym Help Peripheral Sub/TLym Help TLym Help Peripheral Sub/TLymH Tph Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of peripheral helper T-lymphocytes to total helper T-lymphocytes in a biological specimen. Peripheral Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Peripheral/T-Lymphocytes Helper TLym Help Peripheral/TLym Help TLym Help Peripheral/TLymH Tph/TLymH A relative measurement (ratio or percentage) of the peripheral helper T-lymphocytes to total helper T-lymphocytes in a biological specimen. Peripheral Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Peripheral/T-Lymphocytes Helper Sub-Population TLym Help Peripheral/TLym Help Sub TLym Help Peripheral/TLymHS Tph/TLym Help Sub A relative measurement (ratio) of helper peripheral T-lymphocytes to a sub-population of helper T-lymphocytes in a biological specimen. Helper Peripheral T-Lymphocyte to Helper T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Regulatory Effector TLym Help Reg Eff A measurement of the helper regulatory effector T-lymphocytes in a biological specimen. Regulatory Effector Helper T-Lymphocyte Count T-Lymphocytes Helper Regulatory Effector/Leukocytes TLym Help Reg Eff/Leuk TLym Help Reg Eff/Leukocytes A relative measurement (ratio or percentage) of the helper regulatory effector T-lymphocytes to total leukocytes in a biological specimen. Effector Helper Regulatory T-Lymphocyte to Leukocyte Ratio Measurement T-Lymphocytes Helper Regulatory Effector/Lymphocytes TLym Help Reg Eff/Lym TLym Help Reg Eff/Lymphocytes A relative measurement (ratio or percentage) of the helper regulatory effector T-lymphocytes to total lymphocytes in a biological specimen. Effector Helper Regulatory T-Lymphocyte to Lymphocyte Ratio Measurement T-Lymphocytes, Helper Regulatory Effector Sub-Population TLym Help Reg Eff Sub A measurement of a sub-population of helper regulatory effector T-lymphocytes in a biological specimen. Regulatory Effector Helper T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Regulatory Effector/T-Lymphocytes Helper Regulatory TLym Help Reg Eff/TLymHR A relative measurement (ratio or percentage) of the helper regulatory effector T-lymphocytes to total helper regulatory T-lymphocytes in a biological specimen. Effector Helper Regulatory T-Lymphocyte to Regulatory Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Effector/T-Lymphocytes Helper TLym Help Reg Eff/TLym Help A relative measurement (ratio or percentage) of the helper regulatory effector T-lymphocytes to total helper T-lymphocytes in a biological specimen. Effector Helper Regulatory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Effector/T-Lymphocytes TLym Help Reg Eff/T-Lymphocytes TLym Help Reg Eff/TLym A relative measurement (ratio or percentage) of the helper regulatory effector T-lymphocytes to total T-lymphocytes in a biological specimen. Effector Helper Regulatory T-Lymphocyte to T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Memory TLym Help Reg Mem A measurement of the helper regulatory memory T-lymphocytes in a biological specimen. Regulatory Memory Helper T-Lymphocyte Count T-Lymphocytes Helper Regulatory Memory Sub-Population TLym Help Reg Mem Sub A measurement of a sub-population of helper regulatory memory T-lymphocytes in a biological specimen. Regulatory Memory Helper T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Regulatory Memory Sub-Population/T-Lymphocytes Helper Regulatory Memory TLym Help Reg Mem Sub/TLymHRM A relative measurement (ratio or percentage) of a sub-population of helper regulatory memory T-lymphocytes to total helper regulatory memory T-lymphocytes in a biological specimen. Regulatory Memory Helper T-Lymphocyte Subpopulation to Regulatory Memory Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Memory/T-Lymphocytes Helper Regulatory TLym Help Reg Mem/TLymHR A relative measurement (ratio or percentage) of the helper regulatory memory T-lymphocytes to total helper regulatory T-lymphocytes in a biological specimen. Regulatory Memory Helper T-Lymphocyte to Regulatory Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Naive TLym Help Reg Naive A measurement of the helper regulatory naive T-lymphocytes in a biological specimen. Naive Regulatory Helper T-Lymphocyte Count T-Lymphocytes Helper Regulatory Naive/Leukocytes TLym Help Reg Naive/Leuk A relative measurement (ratio or percentage) of the helper regulatory naive T-lymphocytes to leukocytes in a biological specimen. Naive Regulatory Helper T-Lymphocyte to Leukocyte Ratio Measurement T-Lymphocytes Helper Regulatory Naive Sub-Population TLym Help Reg Naive Sub A measurement of a sub-population of helper regulatory naive T-lymphocytes in a biological specimen. Naive Regulatory Helper T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Regulatory Naive Sub-Population/T-Lymphocytes Helper Regulatory Naive TLym Help Reg Naive Sub/TLymHRN A relative measurement (ratio or percentage) of a sub-population of helper regulatory naive T-lymphocytes to total helper regulatory naive T-lymphocytes in a biological specimen. Naive Regulatory Helper T-Lymphocyte Subpopulation to Naive Regulatory Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Naive/T-Lymphocytes Helper Regulatory TLym Help Reg Naive/TLymHR A relative measurement (ratio or percentage) of the helper regulatory naive T-lymphocytes to total helper regulatory T-lymphocytes in a biological specimen. Naive Regulatory Helper T-Lymphocyte to Regulatory Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Naive/T-Lymphocytes Helper TLym Help Reg Naive/TLym Help A relative measurement (ratio or percentage) of the helper regulatory naive T-lymphocytes to total helper T-lymphocytes in a biological specimen. Naive Regulatory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Naive/T-Lymphocytes TLym Help Reg Naive/T-Lymphocytes TLym Help Reg Naive/TLym A relative measurement (ratio or percentage) of the helper regulatory naive T-lymphocytes to total T-lymphocytes in a biological specimen. Naive Regulatory Helper T-Lymphocyte to T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Sub-Population TLym Help Reg Sub A measurement of a sub-population of helper regulatory T-lymphocytes in a biological specimen. Helper Regulatory T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Regulatory Sub-Population/T-Lymphocytes Helper Regulatory TLym Help Reg Sub/TLymHR A relative measurement (ratio or percentage) of a sub-population of helper regulatory T-lymphocytes to total helper regulatory T-lymphocytes in a biological specimen. Regulatory Helper T-Lymphocyte Subpopulation to Regulatory Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Sub-Population/T-Lymphocytes Helper TLym Help Reg Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of helper regulatory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Regulatory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory/T-Lymphocytes Helper TLym Help Reg/TLym Help A relative measurement (ratio or percentage) of the helper regulatory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Regulatory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory/T-Lymphocytes TLym Help Reg/TLym A relative measurement (ratio or percentage) of the helper regulatory T-lymphocytes to total T-lymphocytes in a biological specimen. Regulatory Helper T-Lymphocyte to T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Stem Cell Memory TLym Help SC Mem A measurement of the helper stem cell memory T-lymphocytes in a biological specimen. Stem Cell Memory Helper T-Lymphocyte Count T-Lymphocytes Helper Stem Cell Memory Sub-Population TLym Help SC Mem Sub A measurement of a sub-population of helper stem cell memory T-lymphocytes in a biological specimen. Stem Cell Memory Helper T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Stem Cell Memory Sub-Population/T-Lymphocytes Helper Stem Cell Memory TLym Help SC Mem Sub/TLymHSCM A relative measurement (ratio or percentage) of a sub-population of helper stem cell memory T-lymphocytes to total helper stem cell memory T-lymphocytes in a biological specimen. Stem Cell Memory Helper T-Lymphocyte Subpopulation to Stem Cell Memory Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Stem Cell Memory/T-Lymphocytes Helper TLym Help SC Mem/TLym Help A relative measurement (ratio or percentage) of the helper stem cell memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Stem Cell Memory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Sub-Population/Helper T-Lymphocytes TLym Help Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of helper T-lymphocytes to total helper T-lymphocytes in a biological specimen. Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Terminal Memory TLym Help Term Mem A measurement of the helper terminal memory T-lymphocytes in a biological specimen. Terminal Memory Helper T-Lymphocyte Count T-Lymphocytes Helper Terminal Memory Sub-Population TLym Help Term Mem Sub A measurement of a sub-population of helper terminal memory T-lymphocytes in a biological specimen. Terminal Memory Helper T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Terminal Memory Sub-Population/T-Lymphocytes Helper Terminal Memory TLym Help Term Mem Sub/TLymHTM A relative measurement (ratio or percentage) of a sub-population of helper terminal memory T-lymphocytes to total helper terminal memory T-lymphocytes in a biological specimen. Terminal Memory Helper T-Lymphocyte Subpopulation to Terminal Memory Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Terminal Memory Sub-Population/T-Lymphocytes Helper TLym Help Term Mem Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of helper terminal memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Terminal Memory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Terminal Memory/T-Lymphocytes Helper TLym Help Term Mem/TLym Help A relative measurement (ratio or percentage) of the helper terminal memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Terminal Memory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T Cells/Leukocytes T-Lymphocytes/Leukocytes TLym/Leuk A relative measurement (ratio or percentage) of the T-lymphocytes to leukocytes in a biological specimen. T-Lymphocytes to Leukocytes Ratio Measurement T-Lymphocytes Naive TLym Naive A measurement of the naive T-lymphocytes in a biological specimen. Naive T-Lymphocyte Count T-Lymphocytes Regulatory TLym Reg A measurement of the regulatory T-lymphocytes in a biological specimen. Regulatory T-Lymphocyte Count T-Lymphocytes Regulatory/Lymphocytes TLym Reg/Lym A relative measurement (ratio or percentage) of the regulatory T-lymphocytes to total lymphocytes in a biological specimen. Regulatory T-Lymphocyte to Total Lymphocyte Ratio Measurement T-Lymphocytes Sub-Population TLym Sub A measurement of a sub-population of T-lymphocytes in a biological specimen. T-Lymphocyte Subpopulation Count T-Lymphocytes Sub-Population/Leukocytes TLym Sub/Leuk A relative measurement (ratio or percentage) of a sub-population of T-lymphocytes to total leukocytes in a biological specimen. T-Lymphocyte Subpopulation to Leukocyte Ratio Measurement T-Lymphocytes Sub-Population/T-Lymphocytes Sub-Population TLym Sub/TLym Sub A relative measurement (ratio or percentage) of a sub-population of T-lymphocytes to a sub-population of T-lymphocytes in a biological specimen. T-Lymphocyte Subpopulation to T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Sub-Population/T-Lymphocytes TLym Sub/TLym A relative measurement (ratio or percentage) of the T-lymphocyte sub-population to total T-lymphocytes in a biological specimen. T-Lymphocytes Subpopulation to Total T-Lymphocytes Ratio Measurement T-Lymphocytes Terminal Memory TEMRA TLym Term Mem A measurement of the terminal memory T-lymphocytes in a biological specimen. Terminal Memory T-Lymphocyte Count T Cells T-Cell Lymphocytes T-Cells T-Lymphocytes A measurement of the total thymocyte-derived lymphocytes in a biological specimen. T-Lymphocyte Count Cytotoxic T Cells/T Cells Cytotoxic T-Lymphocytes/T-Lymphocytes TLym Cytx/TLym A relative measurement (ratio or percentage) of the cytotoxic T-lymphocytes to total T-lymphocytes in a biological specimen. Cytotoxic T-Lymphocytes to Total T-Lymphocytes Ratio Measurement Helper T Cells Helper T-Lymphocytes TLym Help A measurement of the helper T-lymphocytes in a biological specimen. Helper T-Lymphocytes Count T-Lymphocytes Helper Regulatory TLym Help Reg A measurement of helper regulatory T-lymphocytes in a biological specimen. Helper Regulatory T-Lymphocyte Count T-Lymphocytes Helper Regulatory/Lymphocytes TLym Help Reg/Lym A relative measurement (ratio or percentage) of helper regulatory T-lymphocytes to total lymphocytes in a biological specimen. Helper Regulatory T-Lymphocyte to Lymphocyte Ratio Measurement T-Lymphocytes Helper Sub-Population TLym Help Sub A measurement of a sub-population of helper T-lymphocytes in a biological specimen. Helper T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Subpopulation/Lymphocytes TLym Help Sub/Lym A relative measurement (ratio or percentage) of the sub-population of helper T-lymphocytes to total lymphocytes in a biological specimen. Helper T-Lymphocyte Subpopulation to Total Lymphocyte Ratio Measurement Helper T Cells/T Cells Helper T-Lymphocytes/T-Lymphocytes TLym Help/TLym A relative measurement (ratio or percentage) of the helper T-lymphocytes to total T-lymphocytes in a biological specimen. Helper T-Lymphocytes to Total T-Lymphocytes Ratio Measurement Helper T Cells/Cytotoxic T Cells Helper T-Lymphocytes/Cytotoxic T-Lymphocytes TLym Help/TLym Cytx A relative measurement (ratio) of the helper T-lymphocytes to cytotoxic T-lymphocytes in a biological specimen. Helper T-Lymphocytes to Cytotoxic T-Lymphocytes Ratio Measurement T Cells/Lymphocytes T-Lymphocytes/Lymphocytes TLym/Lym A relative measurement (ratio or percentage) of the T-lymphocytes to total lymphocytes in a biological specimen. T-Lymphocytes to Lymphocytes Ratio Measurement T-Lymphocytes Sub-Population/Lymphocytes TLym Sub/Lym A relative measurement (ratio or percentage) of the sub-population of T-lymphocytes to total lymphocytes in a biological specimen. T-Lymphocyte Subpopulation to Total Lymphocyte Ratio Measurement TOX1+TOX2 Expression TOX1/2 Expression A measurement of cellular TOX1 and cellular TOX2 expression in a biological specimen. TOX1 and TOX2 Expression Measurement Live Cells Viable Cells A measurement of the viable cells in a biological specimen. Viable Cell Count Cell Viability % Live Cells/Total Cells Viable Cells/Total Cells A relative measurement (ratio or percentage) of viable cells to total cells in a biological specimen. Viable Cell to Total Cell Ratio Measurement Leukocyte Viability % Live Leukocytes/Total Cells Viable Leukocytes/Total Cells A relative measurement (ratio or percentage) of viable leukocytes to total cells in a biological specimen. Viable Leukocyte to Total Cell Ratio Measurement Leukocytes White Blood Cells A measurement of the leukocytes in a biological specimen. Leukocyte Count Leukocytes/Total Cells WBC/Total Cells A relative measurement (ratio or percentage) of the leukocytes to total cells in a biological specimen. Leukocytes to Total Cells Ratio Measurement CPTESTCD Cell Phenotyping Test Code CDISC SDTM Cell Phenotyping Test Code Terminology Terminology relevant to the test names that describe cell phenotype findings. Abn Blast Cells Abnormal Blast Cells A measurement of the abnormal blast cells in a biological specimen. Abnormal Blast Count Abn Blast Cells/Total Cells Abnormal Blast Cells/Total Cells A relative measurement (ratio or percentage) of the abnormal blast cells to total cells in a biological specimen. Abnormal Blast to Total Cell Ratio Measurement Abn Kappa+ PC/Abn Lambda+ PC Abnormal Kappa+ Plasma Cells/Abnormal Lambda+ Plasma Cells A relative measurement (ratio) of the abnormal kappa+ plasma cells to abnormal lambda+ plasma cells in a biological specimen. Abnormal Kappa Positive Plasma Cell to Abnormal Lambda Positive Plasma Cell Ratio Measurement Abn Kappa+ PC Abn Kappa+ Plasma Cells Abnormal Kappa+ Plasma Cells A measurement of the abnormal kappa+ plasma cells in a biological specimen. Abnormal Kappa Positive Plasma Cell Count Abn Lambda+ PC Abn Lambda+ Plasma Cells Abnormal Lambda+ Plasma Cells A measurement of the abnormal lambda+ plasma cells in a biological specimen. Abnormal Lambda Positive Plasma Cell Count B Cells B-Cell Lymphocytes B-Cells B-Lymphocytes A measurement of the B-lymphocytes in a biological specimen. B-Lymphocyte Count B-Lymphocytes/Lymphocytes A relative measurement (ratio or percentage) of the B-lymphocytes to total lymphocytes in a biological specimen. B-Lymphocyte to Lymphocyte Ratio Measurement B-Lymphocytes/Total Cells A relative measurement (ratio or percentage) of the B-lymphocytes to total cells in a biological specimen. B-Lymphocyte to Total Cells Ratio Measurement Basophils Sub Basophils Sub-Population A measurement of a sub-population of basophils in a biological specimen. Basophil Subpopulation Count Basophils Sub-Population/Basophils Basophils Sub/Basophils A relative measurement (ratio or percentage) of a sub-population of basophils to total basophils in a biological specimen. Basophil Subpopulation to Basophil Ratio Measurement Basophils A measurement of the basophils in a biological specimen. Absolute Basophil Count Basophils/Leukocytes A relative measurement (ratio or percentage) of the basophils to leukocytes in a biological specimen. Basophil to Leukocyte Ratio B-Lymphocytes Antibody-Secreting Sub-Population/B-Lymphocytes Antibody-Secreting BLym Ab-Secreting Sub/BLym AbSc BLym AbSc Sub/BLym AbSc A relative measurement (ratio or percentage) of a sub-population of antibody-secreting B-lymphocytes to antibody-secreting B-lymphocytes in a biological specimen. Antibody-secreting B-Lymphocyte Subpopulation to Antibody-secreting B-Lymphocyte Ratio Measurement B-Lymphocytes Antibody-Secreting BLym Ab-Secreting BLym AbSc A measurement of the antibody-secreting B-lymphocytes in a biological specimen. Antibody-secreting B-Lymphocytes Count B-Lymphocytes Antibody-Secreting/B-Lymphocytes BLym Ab-Secreting/Blym BLym AbSc/BLym A relative measurement (ratio or percentage) of the antibody-secreting B-lymphocytes to total B-lymphocytes in a biological specimen. Antibody-secreting B-Lymphocyte to B-Lymphocyte Ratio Measurement B-Lymphocytes Antibody-Secreting/B-Lymphocytes Memory Class-Switched BLym Ab-Secreting/BLym Mem Sw BLym Ab-Secreting/BLymMSw BLym AbSc/BLymMSw A relative measurement (ratio or percentage) of antibody-secreting B-lymphocytes to total class-switched memory B-lymphocyte in a biological specimen. Antibody-Secreting B-Lymphocyte to Class-Switched Memory B-Lymphocyte Ratio Measurement B-Lymphocytes Antibody-Secreting/Leukocytes BLym Ab-Secreting/Leuk BLym AbSc/Leuk A relative measurement (ratio or percentage) of the antibody-secreting B-lymphocytes to leukocytes in a biological specimen. Antibody-secreting B-Lymphocyte to Leukocyte Ratio Measurement ATBLym Sub/ATBLym Sub Atypical B-Lymphocytes Sub-Population/Atypical B-Lymphocytes Sub-Population BLym Aty Sub/BLym Aty Sub A relative measurement (ratio or percentage) of a sub-population of atypical B-lymphocytes to a sub-population of atypical B-lymphocytes in a biological specimen. Atypical B-Lymphocyte Subpopulation to Atypical B-Lymphocyte Subpopulation Ratio Measurement ATBLym Sub/ATBLym Atypical B-Lymphocytes Sub-Population/Atypical B-Lymphocytes BLym Aty Sub/BLym Aty A relative measurement (ratio or percentage) of a sub-population of atypical B-lymphocytes to total atypical B-lymphocytes in a biological specimen. Atypical B-Lymphocyte Subpopulation to Atypical B-Lymphocyte Ratio Measurement ATBLym/BLym Atypical B-Lymphocytes/B-Lymphocytes BLym Aty/BLym A relative measurement (ratio or percentage) of atypical B-lymphocytes to total B-lymphocytes in a biological specimen. Atypical B-Lymphocyte to B-Lymphocyte Ratio Measurement B-Lymphocytes B1 Sub-Population BLym B1 Sub A measurement of a sub-population of B-lymphocytes B1 in a biological specimen. B-Lymphocytes B1 Subpopulation Count B-Lymphocytes B1 Transitional BLym B1 Trans A measurement of the transitional B1 B-lymphocytes in a biological specimen. Transitional B-Lymphocyte B1 Count B-Lymphocytes B1 BLym B1 A measurement of B-lymphocytes B1 in a biological specimen. B-Lymphocytes B1 Count B-Lymphocytes B1a BLym B1a A measurement of the B1a B-lymphocytes in a biological specimen. B-Lymphocyte B1a Count B-Lymphocytes B1b BLym B1b A measurement of the B1b B-lymphocytes in a biological specimen. B-Lymphocyte B1b Count B-Lymphocytes B2 Immature BLym B2 Immat A measurement of the immature B2 B-lymphocytes in a biological specimen. Immature B-Lymphocyte B2 Count B-Lymphocytes B2 Mature BLym B2 Mat A measurement of the mature B2 B-lymphocytes in a biological specimen. Mature B-Lymphocyte B2 Count B-Lymphocytes B2 Transitional BLym B2 Trans A measurement of the transitional B2 B-lymphocytes in a biological specimen. Transitional B-Lymphocyte B2 Count B-Lymphocytes Classical Memory Sub-Population/B-Lymphocytes Classical Memory BLym Classic Mem Sub/BLym Classic Mem BLym Classical Mem Sub/BLym Classical Mem A relative measurement (ratio or percentage) of a sub-population of classical memory B-lymphocytes to all classical memory B-lymphocytes in a biological specimen. Classical Memory B-Lymphocyte Subpopulation to Classical Memory B-Lymphocyte Ratio Measurement B-Lymphocytes Classical Memory/B-Lymphocytes BLym Classic Mem/BLym A relative measurement (ratio or percentage) of classical memory B-lymphocytes to total B-lymphocytes in a biological specimen. Classical Memory B-Lymphocyte to B-Lymphocyte Ratio Measurement B-Lymphocytes Classical Memory Sub-Population/B-Lymphocytes Classical Memory Sub-Population BLym Class Mem Sub/BLym Class Mem Sub BLym Classic MemSub/BLym Classic MemSub BLym Classical Mem Sub/BLym Classical Mem Sub A relative measurement (ratio or percentage) of a sub-population of classical memory B-lymphocytes to a sub population of classical memory B-lymphocytes in a biological specimen. Classical Memory B-Lymphocyte Subpopulation to Classical Memory B-Lymphocyte Subpopulation Ratio Measurement B-Lymphocytes Double Negative Sub-Population BLym Dbl Neg Sub BLym DN Sub BLym Double Neg Sub A measurement of a sub-population of double-negative B-lymphocytes (B-lymphocytes that are both CD27-IgD-) in a biological specimen. Double-Negative B-Lymphocyte Subpopulation Count B-Lymphocytes Double Negative Sub-Population/B-Lymphocytes Double Negative BLym Dbl Neg Sub/BLym Dbl Neg BLym DN Sub/BLym DN A relative measurement (ratio or percentage) of a sub-population of double negative B-lymphocytes to double negative B-lymphocytes in a biological specimen. Double-Negative B-Lymphocyte Subpopulation to Double-Negative B-Lymphocyte Ratio Measurement B-Lymphocytes Double Negative Sub-Population/B-Lymphocytes BLym Dbl Neg Sub/BLym BLym DN Sub/BLym A relative measurement (ratio or percentage) of a sub-population of double negative B-lymphocytes to B-lymphocytes in a biological specimen. Double-Negative B-Lymphocyte Subpopulation to B-Lymphocyte Ratio Measurement B-Lymphocytes Double Negative BLym Dbl Neg BLym DN BLym Double Neg A measurement of the double-negative B-lymphocytes (B-lymphocyte that are both CD27-IgD-) in a biological specimen. Double-Negative B-Lymphocyte Count B-Lymphocytes Double Negative/B-Lymphocytes BLym Dbl Neg/BLym BLym DN/BLym A relative measurement (ratio or percentage) of double negative B-lymphocytes to B-lymphocytes in a biological specimen. Double-Negative B-Lymphocyte to B-Lymphocyte Ratio Measurement B-Lymphocytes Effector 1 Sub-Population BLym Eff 1 Sub A measurement of a sub-population of effector 1 B-lymphocytes in a biological specimen. Effector 1 B-Lymphocyte Subpopulation Count B-Lymphocytes Effector 1 BLym Eff 1 A measurement of the effector 1 B-lymphocytes in a biological specimen. Effector 1 B-Lymphocyte Count B-Lymphocytes Effector 2 Sub-Population BLym Eff 2 Sub A measurement of a sub-population of effector 2 B-lymphocytes in a biological specimen. Effector 2 B-Lymphocyte Subpopulation Count B-Lymphocytes Effector 2 BLym Eff 2 A measurement of the effector 2 B-lymphocytes in a biological specimen. Effector 2 B-Lymphocyte Count B-Lymphocytes Effector Sub-Population BLym Eff Sub A measurement of a sub-population of effector B-lymphocytes in a biological specimen. Effector B-Lymphocyte Subpopulation Count B-Lymphocytes Effector BLym Eff A measurement of the effector B-lymphocytes in a biological specimen. Effector B-Lymphocyte Count B-Lymphocytes Follicular Sub-Population BLym Foll Sub A measurement of a sub-population of follicular B-lymphocytes in a biological specimen. Follicular B-Lymphocyte Subpopulation Count B-Lymphocytes Follicular BLym Foll A measurement of the follicular B-lymphocytes in a biological specimen. Follicular B-Lymphocyte Count B-Lymphocytes Germinal Center Sub-Population BLym Germ Ctr Sub A measurement of a sub-population of germinal center B-lymphocytes in a biological specimen. Germinal Center B-Lymphocyte Subpopulation Count B-Lymphocytes Germinal Center BLym Germ Ctr A measurement of the germinal center B-lymphocytes in a biological specimen. Germinal Center B-Lymphocyte Count B-Lymphocytes IgG+ BLym IgG+ A measurement of the IgG+ B-lymphocytes in a biological specimen. IgG-positive B-Lymphocyte Count B-Lymphocytes IgG+/B-Lymphocytes BLym IgG+/BLym A relative measurement (ratio or percentage) of the IgG+ B-lymphocytes to total B-lymphocytes in a biological specimen. IgG-positive B-Lymphocyte to B-Lymphocyte Ratio Measurement B-Lymphocytes IgM+ BLym IgM+ A measurement of the IgM+ B-lymphocytes in a biological specimen. IgM-positive B-Lymphocyte Count B-Lymphocytes IgM+/B-Lymphocytes BLym IgM+/BLym A relative measurement (ratio or percentage) of the IgM+ B-lymphocytes to total B-lymphocytes in a biological specimen. IgM-positive B-Lymphocyte to B-Lymphocyte Ratio Measurement B-Lymphocytes Immature BLym Immat A measurement of the immature B-lymphocytes in a biological specimen. Immature B-Lymphocyte Count B-Lymphocytes Marginal Zone BLym Marg Zn A measurement of the marginal zone B-lymphocytes in a biological specimen. Marginal Zone B-Lymphocyte Count B-Lymphocytes Mature BLym Mat A measurement of the mature B-lymphocytes in a biological specimen. Mature B-Lymphocyte Count B-Lymphocytes Memory cB1 BLym Mem cB1 A measurement of the cB1 memory B-lymphocytes in a biological specimen. Memory B-Lymphocyte cB1 Count B-Lymphocytes Memory cB2 BLym Mem cB2 A measurement of the cB2 memory B-lymphocytes in a biological specimen. Memory B-Lymphocyte cB2 Count B-Lymphocytes Memory cB3 BLym Mem cB3 A measurement of the cB3 memory B-lymphocytes in a biological specimen. Memory B-Lymphocyte cB3 Count B-Lymphocytes Memory Immature BLym Mem Immat A measurement of the memory immature B-lymphocytes in a biological specimen. Immature Memory B-Lymphocyte Count B-Lymphocytes Memory Mature BLym Mem Mat A measurement of the memory mature B-lymphocytes in a biological specimen. Mature Memory B-Lymphocyte Count B-Lymphocytes Memory Non-Class-Switched IgG+ B-Lymphocytes Memory Unswitched IgG+ BLym Mem NSw IgG+ A measurement of the IgG+ non-class-switched memory B-lymphocytes in a biological specimen. Non-class-switched IgG-positive Memory B-Lymphocyte Count B-Lymphocytes Memory Non-Class-Switched IgG+/B-Lymphocytes Memory Non-Class-Switched B-Lymphocytes Memory Unswitched IgG+/B-Lymphocytes Memory Unswitched BLym Mem NSw IgG+/BLym Mem NSw BLym Mem NSw IgG+/BLymMNSw A relative measurement (ratio or percentage) of the IgG+ non-class-switched memory B-lymphocytes to total non-class-switched memory B-lymphocytes in a biological specimen. Non-class-switched IgG-positive Memory B-Lymphocyte to Non-class-switched Memory B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Non-Class-Switched IgM+ B-Lymphocytes Memory Unswitched IgM+ BLym Mem NSw IgM+ A measurement of the IgM+ non-class-switched memory B-lymphocytes in a biological specimen. Non-class-switched IgM-positive Memory B-Lymphocyte Count B-Lymphocytes Memory Non-Class-Switched IgM+/B-Lymphocytes Memory Non-Class-Switched B-Lymphocytes Memory Unswitched IgM+/B-Lymphocytes Memory Unswitched BLym Mem NSw IgM+/BLym Mem NSw BLym Mem NSw IgM+/BLymMNSw A relative measurement (ratio or percentage) of the IgM+ non-class-switched memory B-lymphocytes to total non-class-switched memory B-lymphocytes in a biological specimen. Non-class-switched IgM-positive Memory B-Lymphocyte to Non-class-switched Memory B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Non-Class-Switched Sub-Population B-Lymphocytes Memory Unswitched Sub-Population BLym Mem NSw Sub A measurement of a sub-population of non-class-switched memory B-lymphocytes in a biological specimen. Nonclass-switched Memory B-Lymphocyte Subpopulation Count B-Lymphocytes Memory Non-Class-Switched Sub-Population/B-Lymphocytes B-Lymphocytes Memory Unswitched Sub-Population/B-Lymphocytes BLym Mem NSw Sub/BLym A relative measurement (ratio or percentage) of a sub-population of non-class-switched memory B-lymphocytes to total B-lymphocytes in a biological specimen. Non-class-switched Memory B-Lymphocyte Subpopulation to B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Non-Class-Switched Sub-Population/B-Lymphocytes Memory Non-Class-Switched B-Lymphocytes Memory Unswitched Sub-Population/B-Lymphocytes Memory Unswitched BLym Mem NSw Sub/BLymMNSw A relative measurement (ratio or percentage) of a sub-population of non-class-switched memory B-lymphocytes to total non-class-switched memory B-lymphocytes in a biological specimen. Non-class-switched Memory B-Lymphocyte Subpopulation to Total Non-class-switched Memory B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Non-Class-Switched B-Lymphocytes Memory Unswitched BLym Mem NSw A measurement of the non-class-switched memory B-lymphocytes in a biological specimen. Nonclass-switched Memory B-Lymphocyte Count B-Lymphocytes Memory Non-Class-Switched/B-Lymphocytes B-Lymphocytes Memory Unswitched/B-Lymphocytes BLym Mem NSw/BLym A relative measurement (ratio or percentage) of the non-class-switched memory B-lymphocytes to total B-lymphocytes in a biological specimen. Non-class-switched Memory B-Lymphocyte to Total B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Non-Class-Switched/Leukocytes B-Lymphocytes Memory Unswitched/Leukocytes BLym Mem NSw/Leuk A relative measurement (ratio or percentage) of the non-class-switched memory B-lymphocytes to total leukocytes in a biological specimen. Non-class-switched Memory B-Lymphocyte to Leukocyte Ratio Measurement B-Lymphocytes Memory Sub-Population BLym Mem Sub A measurement of a sub-population of memory B-lymphocytes in a biological specimen. Memory B-Lymphocyte Subpopulation Count B-Lymphocytes Memory Sub-Population/B-Lymphocytes Memory Sub-Population BLym Mem Sub/BLym Mem Sub A relative measurement (ratio or percentage) of a sub-population of memory B-lymphocyte cells to a sub-population of memory B-lymphocyte cells in a biological specimen. Memory B-Lymphocyte Subpopulation to Memory B-Lymphocyte Subpopulation Ratio Measurement B-Lymphocytes Memory Sub-Population/B-Lymphocytes Memory BLym Mem Sub/BLym Mem A relative measurement (ratio or percentage) of a sub-population of memory B-lymphocytes to total memory B-lymphocytes in a biological specimen. Memory B-Lymphocyte Subpopulation to Memory B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Sub-Population/B-Lymphocytes BLym Mem Sub/BLym A relative measurement (ratio or percentage) of a sub-population of memory B-lymphocytes to total B-lymphocytes in a biological specimen. Memory B-Lymphocyte Subpopulation to B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Switched IgG+ BLym Mem Sw IgG+ A measurement of the IgG+ class-switched memory B-lymphocytes in a biological specimen. Immunoglobulin G Positive Class-switched Memory B-Lymphocyte Count B-Lymphocytes Memory Switched IgG+/B-Lymphocytes Memory Switched BLym Mem Sw IgG+/BLym Mem Sw A relative measurement (ratio or percentage) of IgG+ memory switched B-Lymphocytes to class-switched memory B-lymphocytes in a biological specimen. Immunoglobulin G Positive Memory Switched B-Lymphocyte to Memory Switched B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Switched IgM+ BLym Mem Sw IgM+ A measurement of the IgM+ class-switched memory B-lymphocytes in a biological specimen. Immunoglobulin M Positive Class-switched Memory B-Lymphocyte Count B-Lymphocytes Memory Switched IgM+/B-Lymphocytes Memory Switched BLym Mem Sw IgM+/BLym Mem Sw A relative measurement (ratio or percentage) of IgM+ class-switched memory B-Lymphocytes to class-switched memory B-lymphocytes in a biological specimen. Immunoglobulin M Positive Memory Switched B-Lymphocyte to Memory Switched B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Class-Switched Sub-Population BLym Mem Sw Sub A measurement of a sub-population of class-switched memory B-lymphocytes in a biological specimen. Class-switched Memory B-Lymphocyte Subpopulation Count B-Lymphocytes Memory Class-Switched Sub-Population/B-Lymphocytes B-Lymphocytes Memory Switched Sub-Population/B-Lymphocytes BLym Mem Sw Sub/BLym A relative measurement (ratio or percentage) of a sub-population of class-switched memory B-lymphocytes to total B-lymphocytes in a biological specimen. Class-switched Memory B-Lymphocyte Subpopulation to Total B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Class-Switched Sub-Population/B-Lymphocytes Memory Class-Switched B-Lymphocytes Memory Switched Sub-Population/B-Lymphocytes Memory Switched BLym Mem Sw Sub/BLym Mem Sw BLym Mem Sw Sub/BLymMSw A relative measurement (ratio or percentage) of a sub-population of class-switched memory B-lymphocytes to total class-switched memory B-lymphocytes in a biological specimen. Class-switched Memory B-Lymphocytes Subpopulation to Total Class-switched Memory B-Lymphocytes Ratio Measurement B-Lymphocytes Memory Class-Switched Sub-Population/B-Lymphocytes Memory Class-Switched Sub-Population B-Lymphocytes Memory Switched Sub-Population/B-Lymphocytes Memory Switched Sub-Population BLym Mem Sw Sub/BLymMSwS A relative measurement (ratio or percentage) of a sub-population of class-switched memory B-lymphocytes to a sub-population of class-switched memory B-lymphocytes. Class-switched Memory B-Lymphocyte Subpopulation to Class-switched Memory B-Lymphocyte Sub-population Ratio Measurement B-Lymphocytes Memory Class-Switched Sub-Population/Leukocytes B-Lymphocytes Memory Switched Sub-Population/Leukcoytes BLym Mem Sw Sub/Leuk A relative measurement (ratio or percentage) of a sub-population of class-switched memory B-lymphocytes to leukocytes in a biological specimen. Class-switched Memory B-Lymphocyte Subpopulation to Leukocyte Ratio Measurement B-Lymphocytes Memory Switched Unconventional IgG+ BLym Mem Sw Uncv IgG+ A measurement of the unconventional class-switched IgG-positive memory B-lymphocytes in a biological specimen. Unconventional Class-switched IgG-positive Memory B-Lymphocyte Count B-Lymphocytes Memory Switched Unconventional IgG+/B-Lymphocytes Memory Switched Unconventional BLym Mem Sw Uncv IgG+/BLym Mem Sw Uncv A relative measurement (ratio or percentage) of the unconventional class-switched IgG-positive memory B-lymphocytes to total unconventional class-switched memory B-lymphocytes in a biological specimen. Unconventional Class-switched IgG-positive Memory B-Lymphocyte to Unconventional Class-switched Memory B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Switched Unconventional IgM+ BLym Mem Sw Uncv IgM+ A measurement of the IgM+ class-switched unconventional memory B-lymphocytes in a biological specimen. Unconventional Class-switched IgM-positive Memory B-Lymphocyte Count B-Lymphocytes Memory Switched Unconventional IgM+/B-Lymphocytes Memory Switched Unconventional BLym Mem Sw Uncv IgM+/BLym Mem Sw Uncv BLym Mem Sw Uncv IgM+/BLymMSwU A relative measurement (ratio or percentage) of the IgM+ class-switched unconventional memory B-lymphocytes to total class-switched unconventional memory B-lymphocytes in a biological specimen. Unconventional Class-switched IgM-positive Memory B-Lymphocyte to Unconventional Class-switched Memory B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Class-Switched Unconventional Sub-Population B-Lymphocytes Memory Switched Unconventional Sub-Population BLym Mem Sw Uncv Sub A measurement of a sub-population of unconventional class-switched memory B-lymphocytes in a biological specimen. Unconventional Class-switched Memory B-Lymphocyte Subpopulation Count B-Lymphocytes Memory Class-Switched Unconventional Sub-Population/B-Lymphocytes Memory Class-Switched Unconventional B-Lymphocytes Memory Switched Unconventional Sub-Population/B-Lymphocytes Memory Switched Unconventional BLym Mem Sw Uncv Sub/BLym Mem Sw Uncv A relative measurement (ratio or percentage) of a sub-population of unconventional class-switched memory B-lymphocytes to unconventional class-switched memory B-lymphocytes in a biological specimen. Unconventional Class-switched Memory B-Lymphocyte Subpopulation to Unconventional Class-switched Memory B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Class-Switched Unconventional B-Lymphocytes Memory Switched Unconventional BLym Mem Sw Uncv A measurement of the unconventional class-switched memory B-lymphocytes in a biological specimen. Unconventional Class-switched Memory B-Lymphocyte Count B-Lymphocytes Memory Class-Switched Unconventional/B-Lymphocytes B-Lymphocytes Memory Switched Unconventional/B-Lymphocytes BLym Mem Sw Uncv/BLym A relative measurement (ratio or percentage) the unconventional class-switched memory B-lymphocytes to B-lymphocytes in a biological specimen. Unconventional Class-switched Memory B-Lymphocyte to B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Class-Switched Unconventional/Leukocytes B-Lymphocytes Memory Switched Unconventional/Leukcoytes BLym Mem Sw Uncv/Leuk A relative measurement (ratio or percentage) of the unconventional class-switched memory B-lymphocytes to leukocytes in a biological specimen. Unconventional Class-switched Memory B-Lymphocyte to Leukocyte Ratio Measurement B-Lymphocytes Memory Class-Switched B-Lymphocytes Memory Switched BLym Mem Sw A measurement of the class-switched memory B-lymphocytes in a biological specimen. Class-switched Memory B-Lymphocyte Count B-Lymphocytes Memory Class-Switched/B-Lymphocytes B-Lymphocytes Memory Switched/B-Lymphocytes BLym Mem Sw/Blym A relative measurement (ratio or percentage) of the class-switched memory B-lymphocytes to total B-lymphocytes in a biological specimen. Class-switched Memory B-Lymphocyte to B-Lymphocyte Ratio Measurement B-Lymphocytes Memory Class-Switched/Leukocytes B-Lymphocytes Memory Switched/Leukocytes BLym Mem Sw/Leuk A relative measurement (ratio or percentage) of class-switched memory B-lymphocytes to leukocytes in a biological specimen. Class-switched Memory B-Lymphocyte to Leukocyte Ratio Measurement B-Lymphocytes Memory BLym Mem A measurement of the memory B-lymphocytes in a biological specimen. Memory B-Lymphocyte Count B-Lymphocytes Memory/B-Lymphocytes BLym Mem/BLym A relative measurement (ratio or percentage) of memory B-lymphocytes to total B-lymphocytes in a biological specimen. Memory B-Lymphocytes to Total B-Lymphocytes Ratio Measurement B-Lymphocytes Naive IgG+ BLym Naive IgG+ A measurement of the IgG+ naive B-lymphocytes in a biological specimen. IgG-positive Naive B-Lymphocyte Count B-Lymphocytes Naive IgG+/B-Lymphocytes Naive BLym Naive IgG+/BLym Naive BLym Naive IgG+/BLymN A relative measurement (ratio or percentage) of the IgG+ naive B-lymphocytes to total naive B-lymphocytes in a biological specimen. IgG-positive Naive B-Lymphocyte to Naive B-Lymphocyte Ratio Measurement B-Lymphocytes Naive IgM+ BLym Naive IgM+ A measurement of the IgM+ naive B-lymphocytes in a biological specimen. IgM-positive Naive B-Lymphocyte Count B-Lymphocytes Naive IgM+/B-Lymphocytes Naive BLym Naive IgM+/BLym Naive BLym Naive IgM+/BLymN A relative measurement (ratio or percentage) of the IgM+ naive B-lymphocytes to total naive B-lymphocytes in a biological specimen. IgM-positive Naive B-Lymphocyte to Naive B-Lymphocyte Ratio Measurement B-Lymphocytes Naive Mature Sub-Population BLym Naive Mat Sub A measurement of a sub-population of naive mature B-lymphocytes in a biological specimen. Naive Mature B-Lymphocyte Subpopulation Count B-Lymphocytes Naive Mature Sub-Population/B-Lymphocytes Naive Mature BLym Naive Mat Sub/BLym Naive Mat BLym Naive Mat Sub/BLymNM A relative measurement (ratio or percentage) a sub-population of naive mature B-lymphocytes to total naive mature B-lymphocytes in a biological specimen. Naive Mature B-Lymphocyte Subpopulation to Total Naive Mature B-Lymphocyte Ratio Measurement B-Lymphocytes Naive Mature BLym Naive Mat A measurement of the naive mature B-lymphocytes in a biological specimen. Naive Mature B-Lymphocyte Count B-Lymphocytes Naive Mature/B-Lymphocytes BLym Naive Mat/BLym A relative measurement (ratio or percentage) of naive mature B-lymphocytes to B-lymphocytes in a biological specimen. Naive Mature B-Lymphocytes to Total B-Lymphocytes Ratio Measurement B-Lymphocytes Naive Sub-Population BLym Naive Sub A measurement of a sub-population of naive B-lymphocytes in a biological specimen. Naive B-Lymphocyte Subpopulation Count B-Lymphocytes Naive Sub-Population/B-Lymphocytes, Naive BLym Naive Sub/BLym Naive A relative measurement (ratio or percentage) of a sub-population of naive B-lymphocytes to naive B-lymphocytes in a biological specimen. Naive B-Lymphocytes Subpopulation to Total B-Lymphocytes Naive Ratio Measurement B-Lymphocytes Naive Sub-Population/B-Lymphocytes BLym Naive Sub/BLym A relative measurement (ratio or percentage) of a sub-population of naive B-lymphocytes to total B-lymphocytes in a biological specimen. Naive B-Lymphocyte Subpopulation to B-Lymphocyte Ratio Measurement B-Lymphocytes, Naive BLym Naive Naive B Cells Naive B-Lymphocytes A measurement of the naive B-lymphocytes in a biological specimen. Naive B-Lymphocyte Measurement B Cell, Naive/B Cell B-Lymphocyte, Naive/B-Lymphocyte BLym Naive/BLym Naive B-Lymphocytes/B-Lymphocytes A relative measurement (ratio or percentage) of naive B-lymphocytes to B-lymphocytes in a biological specimen. Naive B-Lymphocytes to Total B-Lymphocytes Ratio Measurement B-Lymphocytes Naive/Leukocytes BLym Naive/Leuk A relative measurement (ratio or percentage) of naive B-lymphocytes to total leukocytes in a biological specimen. Naive B-Lymphocyte to Leukocyte Ratio Measurement B-Lymphocytes Regulatory Memory Sub-Population BLym Mem Reg Sub BLym Reg Mem Sub A measurement of a sub-population of regulatory memory B-lymphocytes in a biological specimen. Regulatory Memory B-Lymphocyte Subpopulation Count B-Lymphocytes Regulatory Memory Sub-Population/B-Lymphocytes Regulatory Memory BLym Reg Mem Sub/BLym Reg Mem A relative measurement (ratio or percentage) of a sub-population of regulatory memory B-lymphocytes to total regulatory memory B-lymphocytes in a biological specimen. Regulatory Memory B-Lymphocyte Subpopulation to Regulatory Memory B-Lymphocyte Ratio Measurement B-Lymphocytes Regulatory Memory Sub-Population/B-Lymphocytes Regulatory BLym Reg Mem Sub/BLym Reg A relative measurement (ratio or percentage) of a sub-population of regulatory memory B-lymphocytes to regulatory B-lymphocytes in a biological specimen. Regulatory Memory B-Lymphocyte Subpopulation to Regulatory B-Lymphocyte Ratio Measurement B-Lymphocytes Regulatory Memory Sub-Population/B-Lymphocytes BLym Reg Mem Sub/BLym A relative measurement (ratio or percentage) of a sub-population of regulatory memory B-lymphocytes to total B-lymphocytes in a biological specimen. Regulatory Memory B-Lymphocyte Subpopulation to B-Lymphocyte Ratio Measurement B-Lymphocytes Regulatory Memory BLym Reg Mem A measurement of the regulatory memory B-lymphocytes in a biological specimen. Regulatory Memory B-Lymphocyte Count B-Lymphocytes Regulatory Memory/B-Lymphocytes Regulatory BLym Reg Mem/BLym Reg A relative measurement (ratio or percentage) of regulatory memory B-lymphocytes to regulatory B-lymphocytes in a biological specimen. Regulatory Memory B-Lymphocyte to Regulatory B-Lymphocyte Ratio Measurement B-Lymphocytes Regulatory Memory/B-Lymphocytes BLym Reg Mem/BLym A relative measurement (ratio or percentage) of regulatory memory B-lymphocytes to total B-lymphocytes in a biological specimen. Regulatory Memory B-Lymphocyte to B-Lymphocyte Ratio Measurement B-Lymphocytes Regulatory Sub-Population BLym Reg Sub A measurement of the sub-population of regulatory B-lymphocytes in a biological specimen. Regulatory B-Lymphocyte Subpopulation Count B-Lymphocytes Regulatory BLym Reg A measurement of the regulatory B-lymphocytes in a biological specimen. Regulatory B-Lymphocyte Count B-Lymphocytes Sub-Population BLym Sub A measurement of a sub-population of B-lymphocytes in a biological specimen. B-Lymphocytes Subpopulation Count B-Lymphocytes Sub-Population/B-Lymphocytes Sub-Population BLym Sub/BLym Sub A relative measurement (ratio or percentage) of a sub-population of B-lymphocytes to a sub-population of B-lymphocytes in a biological specimen. B-Lymphocyte Subpopulation to B-Lymphocyte Subpopulation Ratio Measurement B-Lymphocyte Sub-Population/B-Lymphocyte BLym Sub/BLym A relative measurement (ratio or percentage) of a sub-population of B-lymphocytes to B-lymphocytes in a biological specimen. B-Lymphocytes Subpopulation to Total B-Lymphocytes Ratio Measurement B-Lymphocytes Sub-Population/Leukocytes BLym Sub/Leuk BLym Sub/Leukocytes A relative measurement (ratio or percentage) of a sub-population of B-lymphocytes to leukocytes in a biological specimen. B-Lymphocyte Subpopulation to Leukocyte Ratio Measurement B-Lymphocytes Sub-Population/Lymphocytes BLym Sub/Lym A relative measurement (ratio or percentage) of a sub-population of B-lymphocytes to lymphocytes in a biological specimen. B-Lymphocyte Subpopulation to Lymphocyte Ratio Measurement B-Lymphocytes Transitional 1 BLym Trans 1 A measurement of the transitional 1 B-lymphocytes in a biological specimen. Transitional 1 B-Lymphocyte Count B-Lymphocytes Transitional 2 Sub-Population/B-Lymphocytes Transitional 2 BLym Trans 2 Sub/BLym Trans 2 Transitional T2 B-Lymphocytes Subpopulation/Transitional T2 B-Lymphocytes A relative measurement (ratio or percentage) of a sub-population of transitional 2 B-lymphocytes to total transitional 2 B-lymphocytes in a biological specimen. Transitional 2 B-Lymphocyte Subpopulation to Transitional 2 B-Lymphocyte Ratio Measurement B-Lymphocytes Transitional 2 Sub-Population/B-Lymphocytes BLym Trans 2 Sub/BLym Transitional T2 B-Lymphocytes Subpopulation/B-Lymphocytes A relative measurement (ratio or percentage) of a sub-population of transitional 2 B-lymphocytes to total B-lymphocytes in a biological specimen. Transitional 2 B-Lymphocyte Subpopulation to B-Lymphocyte Ratio Measurement B-Lymphocytes Transitional 2 BLym Trans 2 A measurement of the transitional 2 B-lymphocytes in a biological specimen. Transitional 2 B-Lymphocyte Count B-Lymphocytes Transitional 2/B-Lymphocytes BLym Trans 2/BLym Transitional T2 B-Lymphocytes/B-Lymphocytes A relative measurement (ratio or percentage) of the transitional 2 B-lymphocytes to total B-lymphocytes in a biological specimen. Transitional 2 B-Lymphocyte to B-Lymphocyte Ratio Measurement B-Lymphocytes Transitional 3 BLym Trans 3 A measurement of the transitional 3 B-lymphocytes in a biological specimen. Transitional 3 B-Lymphocyte Count B-Lymphocytes Transitional Sub-Population BLym Trans Sub A measurement of a sub-population of transitional B-lymphocytes in a biological specimen. Transitional B-Lymphocyte Subpopulation Count B-Lymphocytes Transitional Sub-Population/B-Lymphocytes Transitional BLym Trans Sub/BLym Trans A relative measurement (ratio or percentage) of a sub-population of transitional B-lymphocytes to total transitional B-lymphocytes in a biological specimen. Transitional B-Lymphocyte Subpopulation to Total Transitional B-Lymphocyte Ratio Measurement B-Lymphocytes Transitional Sub-Population/B-Lymphocytes BLym Trans Sub/BLym A relative measurement (ratio or percentage) of a sub-population of transitional B-lymphocytes to B-lymphocytes in a biological specimen. Transitional B-Lymphocyte Subpopulation to B-Lymphocyte Ratio Measurement B-Lymphocytes Transitional BLym Trans A measurement of the transitional B-lymphocytes in a biological specimen. Transitional B-Lymphocyte Count B-Lymphocytes Transitional/B-Lymphocytes BLym Trans/BLym A relative measurement (ratio or percentage) of transitional B-lymphocytes to B-lymphocytes in a biological specimen. Transitional B-Lymphocytes to B-Lymphocytes Ratio Measurement B-Lymphocytes Transitional/B-Lymphocytes Naive BLym Trans/BLym Naive BLym Trans/BLymN A relative measurement (ratio or percentage) of the transitional B-lymphocytes to the naive B-lymphocytes in a biological specimen. Transitional B-Lymphocyte to Naive B-Lymphocyte Ratio Measurement B Cells/Leukocytes B-Lymphocytes/Leukocytes BLym/Leuk A relative measurement (ratio or percentage) of B-lymphocytes to leukocytes in a biological specimen. B-Lymphocyte to Leukocyte Ratio Measurement B-Lymphocytes/Lymphocyte and Monocytes BLym/Lym+Mono A relative measurement (ratio or percentage) of B-lymphocytes to lymphocytes and monocytes in a biological specimen. B-Lymphocyte to Lymphocyte and Monocyte Ratio Measurement B-Lymphocytes/Non-TNK Leukocytes BLym/Non-TNK Leuk A relative measurement (ratio or percentage) of B-lymphocytes to leukocytes that are not T cells or natural killer cells in a biological specimen. B-Lymphocyte to Non-TNK Leukocyte Ratio Measurement cCD223 Expression Cytoplasmic CD223 Expression A measurement of cellular cytoplasmic CD223 expression in a biological specimen. Cytoplasmic CD223 Expression Measurement CD107a Expression LAMP-1 Expression Lysosomal-associated Membrane Protein 1 Expression A measurement of cellular CD107a expression in a biological specimen. CD107a Expression Measurement CD117 Expression A measurement of cellular CD117 expression in a biological specimen. CD117 Expression Measurement CD123 Expression CDC123 Expression Cell Division Cycle 123 Protein Expression A measurement of cellular CD123 expression in a biological specimen. CD123 Expression Measurement CD134 Expression OX40 Expression A measurement of cellular CD134 expression in a biological specimen. CD134 Expression Measurement CD137 Expression A measurement of cellular CD137 expression in a biological specimen. CD137 Expression Measurement CD152 Expression CTLA-4 Expression A measurement of cellular CD152 expression in a biological specimen. CD152 Expression Measurement CD154 Expression A measurement of cellular CD154 expression in a biological specimen. CD154 Expression Measurement CD156c Expression A measurement of cellular CD156c expression in a biological specimen. CD156c Expression Measurement CD159a Expression A measurement of cellular CD159a expression in a biological specimen. CD159a Expression Measurement CD159c Expression KLRC2 Expression NKG2C Expression A measurement of cellular CD159c expression in a biological specimen. CD159c Expression Measurement CD16 Expression A measurement of cellular CD16 expression in a biological specimen. CD16 Expression Measurement CD163 Expression M130 Expression A measurement of cellular CD163 expression in a biological specimen. CD163 Expression Measurement CD169 Expression A measurement of cellular CD169 expression in a biological specimen. CD169 Expression Measurement CD192 Expression A measurement of cellular CD192 expression in a biological specimen. CD192 Expression Measurement CD198 Expression A measurement of cellular CD198 expression in a biological specimen. CD198 Expression Measurement CD21 Expression A measurement of cellular CD21 expression in a biological specimen. CD21 Expression Measurement CD223 Expression LAG3 Expression A measurement of cellular CD223 expression in a biological specimen. CD223 Expression Measurement CD226 Expression A measurement of cellular CD226 expression in a biological specimen. CD226 Expression Measurement CD25 Expression A measurement of cellular CD25 expression in a biological specimen. CD25 Expression Measurement B-Cell Maturation Antigen Expression BCMA Expression CD269 Expression A measurement of cellular CD269 expression in a biological specimen. CD269 Expression Measurement CD274 Expression PD-L1 Expression A measurement of cellular CD274 expression in a biological specimen. CD274 Expression Measurement CD278 Expression ICOS Expression A measurement of cellular CD278 expression in a biological specimen. CD278 Expression Measurement CD279 Expression PD1 Expression A measurement of cellular CD279 expression in a biological specimen. CD279 Expression Measurement CD28 Expression A measurement of cellular CD28 expression in a biological specimen. CD28 Expression Measurement CD288 Expression TLR8 Expression A measurement of cellular CD288 expression in a biological specimen. CD288 Expression Measurement CD294 Expression CRTH2 Expression A measurement of cellular CD294 expression in a biological specimen. CD294 Expression Measurement CD31 Expression PECAM1 Expression A measurement of cellular CD31 expression in a biological specimen. CD31 Expression Measurement CD314 Expression KLR Expression KLRK1 Expression NKG2D Expression A measurement of cellular CD314 expression in a biological specimen. CD314 Expression Measurement CD32 Expression A measurement of cellular CD32 expression in a biological specimen. CD32 Expression Measurement CD32b Expression A measurement of cellular CD32b expression in a biological specimen. CD32b Expression Measurement CD337 Expression A measurement of cellular CD337 expression in a biological specimen. CD337 Expression Measurement CD366 Expression TIM3 Expression A measurement of cellular CD366 expression in a biological specimen. CD366 Expression Measurement CD38 Expression A measurement of cellular CD38 expression in a biological specimen. CD38 Expression Measurement CD40 Expression A measurement of cellular CD40 expression in a biological specimen. CD40 Expression Measurement CD5 Expression A measurement of cellular CD5 expression in a biological specimen. CD5 Expression Measurement CD57 Expression A measurement of cellular CD57 expression in a biological specimen. CD57 Expression Measurement CD64 Expression A measurement of cellular CD64 expression in a biological specimen. CD64 Expression Measurement CD69 Expression A measurement of cellular CD69 expression in a biological specimen. CD69 Expression Measurement CD71 Expression A measurement of cellular CD71 expression in a biological specimen. CD71 Expression Measurement CD73 Expression A measurement of cellular CD73 expression in a biological specimen. CD73 Expression Measurement CD79b Expression A measurement of cellular CD79b expression in a biological specimen. CD79b Expression Measurement CD80 Expression A measurement of cellular CD80 expression in a biological specimen. CD80 Expression Measurement CD83 Expression A measurement of cellular CD83 expression in a biological specimen. CD83 Expression Measurement CD86 Expression A measurement of cellular CD86 expression in a biological specimen. CD86 Expression Measurement CD95 Expression A measurement of cellular CD95 expression in a biological specimen. CD95 Cell Surface Expression Measurement CD96 Expression A measurement of cellular CD96 expression in a biological specimen. CD96 Expression Measurement Clonal Plasma Cells A measurement of the clonal plasma cells in a biological specimen. Clonal Plasma Cell Count Clonal Plasma Cells/Total Cells A relative measurement (ratio or percentage) of the clonal plasma cells to total cells in a biological specimen. Clonal Plasma Cell to Total Cell Ratio Measurement cDC1 Sub-Population Classical DC Type 1 Sub-Population Conventional DC Type 1 Sub-Population DC Myeloid 1 Sub Dendritic Cells Myeloid 1 Sub-Population mDC1 Sub-Population A measurement of a sub-population of type 1 myeloid dendritic cells in a biological specimen. Type 1 Myeloid Dendritic Cell Subpopulation Count Classical DC Type 1 Sub-Population/Classical DC Type 1 Conventional DC Type 1 Sub-Population/Conventional DC Type 1 DC Myeloid 1 Sub-Population/DC Myeloid 1 DC Myeloid 1 Sub/DC Myeloid 1 DC Myeloid 1 Sub/DCM1 mDC1 Sub/mDC1 A relative measurement (ratio or percentage) of a sub-population of the type 1 myeloid dendritic cells to total type 1 myeloid dendritic cells in a biological specimen. Type 1 Myeloid Dendritic Cell Subpopulation to Type 1 Myeloid Dendritic Cell Ratio Measurement cDC1 Sub-Population/DC Classical DC Type 1 Sub-Population/DC Conventional DC Type 1 Sub-Population/DC DC Myeloid 1 Sub/DCM Dendritic Cells Myeloid 1 Sub-Population/Dendritic Cells mDC1 Sub-Population/DC A relative measurement (ratio or percentage) of a sub-population of the type 1 myeloid dendritic cells to total dendritic cells in a biological specimen. Type 1 Myeloid Dendritic Cell Subpopulation to Dendritic Cell Ratio Measurement cDC1 Sub-Population/cDC Classical DC Type 1 Sub-Population/Classical DC Conventional DC Type 1 Sub-Population/Conventional DC DC Myeloid 1 Sub/DCM Dendritic Cells Myeloid 1 Sub-Population/Dendritic Cells Myeloid mDC1 Sub-Population/mDC A relative measurement (ratio or percentage) of a sub-population of type 1 myeloid dendritic cells to total myeloid dendritic cells in a biological specimen. Type 1 Myeloid Dendritic Cell Subpopulation to Total Myeloid Dendritic Cell Ratio Measurement cDC1 Classical DC Type 1 Conventional DC Type 1 DC Myeloid 1 DC Myeloid Type 1 Dendritic Cells Myeloid 1 mDC1 A measurement of the type 1 myeloid dendritic cells in a biological specimen. Type 1 Myeloid Dendritic Cell Count cDC1/DC Classical DC Type 1/DC Conventional DC Type 1/DC DC Myeloid 1/DCM Dendritic Cells Myeloid 1/Dendritic Cells mDC1/DC A relative measurement (ratio or percentage) of the type 1 myeloid dendritic cells to total dendritic cells in a biological specimen. Type 1 Myeloid Dendritic Cell to Dendritic Cell Ratio Measurement cDC1/cDC Classical DC Type 1/Classical DC Conventional DC Type 1/Conventional DC DC Myeloid 1/DC Myeloid DC Myeloid 1/DCM mDC1/mDC A relative measurement (ratio or percentage) of the type 1 myeloid dendritic cells to total myeloid dendritic cells in a biological specimen. Type 1 Myeloid Dendritic Cell to Total Myeloid Dendritic Cell Ratio Measurement cDC1/Leukocytes Classical DC Type 1/Leukocytes Conventional DC Type 1/Leukocytes DC Myeloid 1/Leuk DC Myeloid 1/Leukocytes mDC1/Leukocytes A relative measurement (ratio or percentage) of the type 1 myeloid dendritic cells to leukocytes in a biological specimen. Type 1 Myeloid Dendritic Cell to Leukocyte Ratio Measurement cDC2 Sub-Population Classical DC Type 2 Sub-Population Conventional DC Type 2 Sub-Population DC Myeloid 2 Sub Dendritic Cells Myeloid 2 Sub-Population mDC2 Sub-Population A measurement of a sub-population of type 2 myeloid dendritic cells in a biological specimen. Type 2 Myeloid Dendritic Cell Subpopulation Count Classical DC Type 2 Sub-Population/Classical DC Type 2 Conventional DC Type 2 Sub-Population/Conventional DC Type 2 DC Myeloid 2 Sub-Population/DC Myeloid 2 DC Myeloid 2 Sub/DC Myeloid 2 DC Myeloid 2 Sub/DCM2 mDC2 Sub/mDC2 A relative measurement (ratio or percentage) of a sub-population of the type 2 myeloid dendritic cells to total type 2 myeloid dendritic cells in a biological specimen. Type 2 Myeloid Dendritic Cell Subpopulation to Type 2 Myeloid Dendritic Cell Ratio Measurement cDC2 Sub-Population/DC Classical DC Type 2 Sub-Population/DC Conventional DC Type 2 Sub-Population/DC DC Myeloid 2 Sub/DCM Dendritic Cells Myeloid 2 Sub-Population/Dendritic Cells mDC2 Sub-Population/DC A relative measurement (ratio or percentage) of a sub-population of the type 2 myeloid dendritic cells to total dendritic cells in a biological specimen. Type 2 Myeloid Dendritic Cell Subpopulation to Dendritic Cell Ratio Measurement cDC2 Sub-Population/cDC Classical DC Type 2 Sub-Population/Classical DC Conventional DC Type 2 Sub-Population/Conventional DC DC Myeloid 2 Sub/DCM Dendritic Cells Myeloid 2 Sub-Population/Dendritic Cells Myeloid mDC2 Sub-Population/mDC A relative measurement (ratio or percentage) of a sub-population of type 2 myeloid dendritic cells to total myeloid dendritic cells in a biological specimen. Type 2 Myeloid Dendritic Cell Subpopulation to Total Myeloid Dendritic Cell Ratio Measurement cDC2 Classical DC Type 2 Conventional DC Type 2 DC Myeloid 2 DC Myeloid Type 2 Dendritic Cells Myeloid 2 mDC2 A measurement of the type 2 myeloid dendritic cells in a biological specimen. Type 2 Myeloid Dendritic Cell Count cDC2/DC Classical DC Type 2/DC Conventional DC Type 2/DC DC Myeloid 2/DCM Dendritic Cells Myeloid 2/Dendritic Cells mDC2/DC A relative measurement (ratio or percentage) of the type 2 myeloid dendritic cells to total dendritic cells in a biological specimen. Type 2 Myeloid Dendritic Cell to Dendritic Cell Ratio Measurement cDC2/cDC Classical DC Type 2/Classical DC Conventional DC Type 2/Conventional DC DC Myeloid 2/DC Myeloid DC Myeloid 2/DCM mDC2/mDC A relative measurement (ratio or percentage) of the type 2 myeloid dendritic cells to total myeloid dendritic cells in a biological specimen. Type 2 Myeloid Dendritic Cell to Total Myeloid Dendritic Cell Ratio Measurement cDC2/Leukocytes Classical DC Type 2/Leukocytes Conventional DC Type 2/Leukocytes DC Myeloid 2/Leuk DC Myeloid 2/Leukocytes mDC2/Leukocytes A relative measurement (ratio or percentage) of the type 2 myeloid dendritic cells to leukocytes in a biological specimen. Type 2 Myeloid Dendritic Cell to Leukocyte Ratio Measurement Classical DC Type 3 Sub-Population/Classical DC Type 3 Conventional DC Type 3 Sub-Population/Conventional DC Type 3 DC Myeloid 3 Sub-Population/DC Myeloid 3 DC Myeloid 3 Sub/DC Myeloid 3 mDC3 Sub/mDC3 A relative measurement (ratio or percentage) of a sub-population of type 3 myeloid dendritic cells to type 3 myeloid dendritic cells in a biological specimen. Type 3 Myeloid Dendritic Cell Subpopulation to Type 3 Myeloid Dendritic Cell Ratio Measurement cDC3 Classical DC Type 3 Conventional DC Type 3 DC Myeloid 3 DC Myeloid Type 3 Dendritic Cells Myeloid 3 mDC3 A measurement of the type 3 myeloid dendritic cells in a biological specimen. Type 3 Myeloid Dendritic Cell Count cDC3/Leukocytes Classical DC Type 3/Leukocytes Conventional DC Type 3/Leukocytes DC Myeloid 3/Leuk DC Myeloid 3/Leukocytes mDC3/Leukocytes A relative measurement (ratio or percentage) of the type 3 myeloid dendritic cells to total leukocytes in a biological specimen. Type 3 Myeloid Dendritic Cell to Leukocyte Ratio Measurement Classical DC Type 4 Sub-Population/Classical DC Type 4 Conventional DC Type 4 Sub-Population/Conventional DC Type 4 DC Myeloid 4 Sub-Population/DC Myeloid 4 DC Myeloid 4 Sub/DC Myeloid 4 mDC4 Sub/mDC4 A relative measurement (ratio or percentage) of a sub-population of type 4 myeloid dendritic cells to type 4 myeloid dendritic cells in a biological specimen. Type 4 Myeloid Dendritic Cell Subpopulation to Type 4 Myeloid Dendritic Cell Ratio Measurement cDC4 Classical DC Type 4 Conventional DC Type 4 DC Myeloid 4 DC Myeloid Type 4 endritic Cells Myeloid 4 mDC4 A measurement of the type 4 myeloid dendritic cells in a biological specimen. Type 4 Myeloid Dendritic Cell Count cDC4/Leukocytes Classical DC Type 4/Leukocytes Conventional DC Type 4/Leukocytes DC Myeloid 4/Leuk DC Myeloid 4/Leukocytes mDC4/Leukocytes A relative measurement (ratio or percentage) of the type 4 myeloid dendritic cells to total leukocytes in a biological specimen. Type 4 Myeloid Dendritic Cell to Leukocyte Ratio Measurement DC Myeloid Dbl Neg DC Myeloid Double Negative Dendritic Cells Myeloid Double Negative mDC DN A measurement of the double-negative myeloid dendritic cells (any myeloid dendritic cell that is both CD1c-CD141-) in a biological specimen. Double-Negative Myeloid Dendritic Cell Count DC Myeloid Dbl Neg/DC Myeloid Dendritic Cells Myeloid Double Negative/ Dendritic Cells Myeloid mDC DN/mDC A relative measurement (ratio or percentage) of the double negative myeloid dendritic cells to total myeloid dendritic cells in a biological specimen. Double-Negative Myeloid Dendritic Cell to Myeloid Dendritic Cell Ratio Measurement DC Myeloid Sub Dendritic Cells Myeloid Sub-Population A measurement of a sub-population of myeloid dendritic cells in a biological specimen. Myeloid Dendritic Cell Subpopulation Count cDC Sub-Population/DC Classical DC Sub-Population/DC Conventional DC Sub-Population/DC DC Myeloid Sub/DC Dendritic Cells Myeloid Sub-Population/Dendritic Cells mDC Sub-Population/DC A relative measurement (ratio or percentage) of a sub-population of myeloid dendritic cells to total dendritic cells in a biological specimen. Myeloid Dendritic Cell Subpopulation to Total Dendritic Cell Ratio Measurement cDC Sub-Population/cDC Classical DC Sub-Population/Classical DC Conventional DC Sub-Population/Conventional DC DC Myeloid Sub/DCM Dendritic Cells Myeloid Sub-Population/Dendritic Cells Myeloid mDC Sub-Population/mDC A relative measurement (ratio or percentage) of a sub-population of myeloid dendritic cells to total myeloid dendritic cells in a biological specimen. Myeloid Dendritic Cell Subpopulation to Total Myeloid Dendritic Cell Ratio Measurement DC Myeloid Sub/DC Myeloid Sub DC Myeloid Sub/DCMS Dendritic Cells Myeloid Sub-Population/Dendritic Cells Myeloid Sub-Population A relative measurement (ratio or percentage) of a sub-population of myeloid dendritic cells to a sub-population of myeloid dendritic cells in a biological specimen. Myeloid Dendritic Cell Sub-population to Myeloid Dendritic Cell Subpopulation Ratio Measurement cDC Conventional DC DC Myeloid Dendritic Cells Myeloid mDC A measurement of the myeloid dendritic cells in a biological specimen. Myeloid Dendritic Cell Count cDC/DC Classical DC/DC Conventional DC/DC DC Myeloid/DC Dendritic Cells Myeloid/Dendritic Cells mDC/DC A relative measurement (ratio or percentage) of the myeloid dendritic cells to total dendritic cells in a biological specimen. Myeloid Dendritic Cell to Total Dendritic Cell Ratio Measurement cDC/Leukocytes Classical DC/Leukocytes Conventional DC/Leukocytes DC Myeloid/Leuk DC Myeloid/Leukocytes mDC/Leukocytes A relative measurement (ratio or percentage) of the myeloid dendritic cells to leukocytes in a biological specimen. Myeloid Dendritic Cell to Leukocyte Ratio Measurement cDC/Myeloid Cells Classical DC/Myeloid Cells Conventional DC/Myeloid Cells DC Myeloid/Myeloid Cells Dendritic Cells Myeloid/Myeloid Cells mDC/Myeloid Cells A relative measurement (ratio or percentage) of the myeloid dendritic cells to total myeloid cells in a biological specimen. Myeloid Dendritic Cell to Myeloid Cell Ratio Measurement DC Plasmacytoid Sub Plasmacytoid Dendritic Cells Sub-Population A measurement of a sub-population of plasmacytoid dendritic cells in a biological specimen. Plasmacytoid Dendritic Cell Subpopulation Count DC Plasmacytoid Sub/DC Plasmacytoid Plasmacytoid Dendritic Cells Sub-Population/Plasmacytoid Dendritic Cells A relative measurement (ratio or percentage) of a sub-population of plasmacytoid dendritic cells to total plasmacytoid dendritic cells in a biological specimen. Plasmacytoid Dendritic Cells Subpopulation to Dendritic Cells Plasmacytoid Ratio Measurement DC Plasmacytoid Sub/DC Plasmacytoid Sub DC Plasmacytoid Sub/DCPS Dendritic Cells Plasmacytoid Sub-Population/Dendritic Cells Plasmacytoid Sub-Population A relative measurement (ratio or percentage) of a sub-population of plasmacytoid dendritic cells to a second sub-population of plasmacytoid dendritic cells (e.g., a child/parent based on two or more sub-population-defining markers) in a biological specimen. Plasmacytoid Dendritic Cell Subpopulation to Plasmacytoid Dendritic Cell Subpopulation Ratio Measurement DC Plasmacytoid Plasmacytoid Dendritic Cells A measurement of the plasmacytoid dendritic cells in a biological specimen. Plasmacytoid Dendritic Cell Count DC Plasmacytoid/DC DC Plasmacytoid/Dendritic Cells Plasmacytoid Dendritic Cells/Dendritic Cells A relative measurement (ratio or percentage) of the plasmacytoid dendritic cells to dendritic cells in a biological specimen. Plasmacytoid Dendritic Cells to Dendritic Cells Ratio Measurement DC Plasmacytoid/Leuk DC Plasmacytoid/Leukocytes Dendritic Cells Plasmacytoid/Leukocytes A relative measurement (ratio or percentage) of the plasmacytoid dendritic cells to total leukocytes in a biological specimen. Plasmacytoid Dendritic Cell to Leukocyte Ratio Measurement DC Plasmacytoid/Myeloid Cells pDC/Myeloid Cells A relative measurement (ratio or percentage) of the plasmacytoid dendritic cells to total myeloid cells in a biological specimen. Plasmacytoid Dendritic Cell to Myeloid Cell Ratio Measurement DC Sub Dendritic Cells Sub-Population A measurement of a sub-population of dendritic cells in a biological specimen. Dendritic Cell Subpopulation Count DC Sub-Population/DC DC Sub/DC Dendritic Cell Sub-Population/Dendritic Cells A relative measurement (ratio or percentage) of a sub-population of dendritic cells to total dendritic cells in a biological specimen. Dendritic Cell Subpopulation to Dendritic Cell Ratio Measurement DC/Leuk Dendritic Cells/Leukocytes A relative measurement (ratio or percentage) of dendritic cells to leukocytes in a biological specimen. Dendritic Cell to Leukocyte Ratio Measurement DC/Mono NonClassic Dendritic Cells/Monocytes Non-Classical A relative measurement (ratio or percentage) of dendritic cells to non-classical monocytes in a biological specimen. Dendritic Cell to Non-Classical Monocyte Ratio Measurement DC/Non-TBNK Leuk Dendritic Cells/Non-TBNK Leukocytes A relative measurement (ratio or percentage) of dendritic cells to leukocytes that are not T cells, B cells or natural killer cells in a biological specimen. Dendritic Cell to Non-TBNK Leukocyte Ratio Measurement DC Dendritic Cells A measurement of the dendritic cells in a biological specimen. Dendritic Cells Count Dendritic Cells/Lym+Mono Dendritic Cells/Lymphocytes and Monocytes A relative measurement (ratio or percentage) of the dendritic cells to lymphocytes and monocytes in a biological specimen. Dendritic Cells to Lymphocytes and Monocytes Ratio Measurement DC/Myeloid Cells Dendritic Cells/Myeloid Cells A relative measurement (ratio or percentage) of the dendritic cells to total myeloid cells in a biological specimen. Dendritic Cell to Myeloid Cell Ratio Measurement Dendritic Cells/Total Cells A relative measurement (ratio or percentage) of the dendritic cells to total cells in a biological specimen. Dendritic Cells to Total Cells Ratio Measurement Endothelial Cells A measurement of the endothelial cells in a biological specimen. Endothelial Cell Count Eosinophils A measurement of the eosinophils in a biological specimen. Eosinophil Count Eosinophils/Leukocytes A relative measurement (ratio or percentage) of the eosinophils to leukocytes in a biological specimen. Eosinophil to Leukocyte Ratio Eosinophils/Nucleated Cells A relative measurement (ratio or percentage) of eosinophils to nucleated cells in a biological specimen. Eosinophils to Nucleated Cells Ratio Measurement Eosinophils/Total Cells A relative measurement (ratio or percentage) of the eosinophils to total cells in a biological specimen (for example a bone marrow specimen). Eosinophils to Total Cell Ratio Measurement Epithelial Cells A measurement of the epithelial cells in a biological specimen. Epithelial Cell Count Epithelial Cells/Total Cells A relative measurement (ratio or percentage) of the epithelial cells to total cells in a biological specimen. Epithelial Cells to Total Cells Ratio Measurement Erythrocytes Red Blood Cells A measurement of the total erythrocytes in a biological specimen. Erythrocyte Count Fibroblasts A measurement of the fibroblasts in a biological specimen. Fibroblast Count FoxP3 Expression FP3 Expression A measurement of cellular FoxP3 expression in a biological specimen. FoxP3 Expression Measurement Gran/Leuk Granulocytes/Leukocytes Polymorphonuclear Leukocytes/Leukocytes A relative measurement (ratio or percentage) of the granulocytes to total leukocytes in a biological specimen. Granulocytes to Leukocytes Ratio Measurement Granulocytes Sub Granulocytes Sub-Population A measurement of a sub-population of granulocytes in a biological specimen. Granulocyte Subpopulation Count Granulocytes Sub-Population/Granulocytes Sub-Population Granulocytes Sub/Granulocytes Sub A relative measurement (ratio or percentage) of a sub-population of granulocytes to a sub-population of granulocytes in a biological specimen. Granulocyte Subpopulation to Granulocyte Subpopulation Ratio Measurement Granulocytes Sub-Population/Granulocytes Granulocytes Sub/Granulocytes A relative measurement (ratio or percentage) of a sub-population of granulocytes to total granulocytes in a biological specimen. Granulocytes Subpopulation to Granulocytes Ratio Measurement Granulocytes Polymorphonuclear Leukocytes A measurement of the granulocytes in a biological specimen. Granulocyte Count Granulocytes//Non-TBNK Leukocytes Granulocytes/Non-TBNK Leuk A relative measurement (ratio or percentage) of granulocytes to the non-classical monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. Granulocyte to Non-TBNK Leukocyte Ratio Measurement Granzyme B Expression GZB Expression GzmB Expression A measurement of cellular granzyme b expression in a biological specimen. GZB Expression Measurement HLADR Expression A measurement of cellular HLA-DR expression in a biological specimen. HLA-DR Cell Surface Expression Measurement IE Lym Intraepithelial Lymphocytes A measurement of the intraepithelial lymphocytes in a biological specimen. Intraepithelial Lymphocyte Count IgD Expression Immunoglobulin D Expression A measurement of cellular IgD expression in a biological specimen. IgD Expression Measurement IgG Expression Immunoglobulin G Expression A measurement of cellular IgG expression in a biological specimen. IgG Expression Measurement IgM Expression Immunoglobulin M Expression A measurement of cellular IgM expression in a biological specimen. IgM Expression Measurement Immature Monocytes A measurement of the immature monocytes in a biological specimen. Immature Monocyte Count ILC Sub-Population/ILC Sub-Population Innate LC Sub/ILC Sub Innate Lymphoid Cells Sub-Population/Innate Lymphoid Cells Sub-Population A relative measurement (ratio or percentage) of a sub-population of innate lymphoid cells to a sub-population of innate lymphoid cells in a biological specimen. Innate Lymphoid Cell Subpopulation to Innate Lymphoid Cell Subpopulation Ratio Measurement ILC Sub-Population/ILC Innate LC Sub/ILC Innate LC Sub/Innate LC Innate Lymphoid Cells Sub-Population/Innate Lymphoid Cells A relative measurement (ratio or percentage) of a sub-population of innate lymphoid cells to total innate lymphoid cells in a biological specimen. Innate Lymphoid Cell Subpopulation to Innate Lymphoid Cell Ratio Measurement ILC Sub/Leukocytes Innate LC Sub/Leuk Innate Lymphoid Cells Sub-Population/Leukocytes A relative measurement (ratio or percentage) of a sub-population of innate lymphoid cells to leukocytes in a biological specimen. Innate Lymphoid Cell Subpopulation to Leukocyte Ratio Measurement ILC1 Sub-Population Innate LC1 Sub Innate Lymphoid Cells Type 1 Sub-Population A measurement of a sub-population of type 1 innate lymphoid cells in a biological specimen. Type 1 Innate Lymphoid Cell Subpopulation Count ILC1 Sub-Population/ILC Sub-Population Innate LC1 Sub/ILC Sub Innate Lymphoid Cells Type 1 Sub-Population/Innate Lymphoid Cells Sub-Population A relative measurement (ratio or percentage) of a sub-population of type 1 innate lymphoid cells to a sub-population of innate lymphoid cells in a biological specimen. Type 1 Innate Lymphoid Cell Subpopulation to Innate Lymphoid Cell Subpopulation Ratio Measurement ILC1 Sub-Population/ILC Innate LC1 Sub/ILC Innate Lymphoid Cells Type 1 Sub-Population/Innate Lymphoid Cells A relative measurement (ratio or percentage) of a sub-population of type 1 innate lymphoid cells to total innate lymphoid cells in a biological specimen. Type 1 Innate Lymphoid Cell Subpopulation to Innate Lymphoid Cell Ratio Measurement ILC1 Sub/ILC1 Sub Innate LC1 Sub/ILC1 Sub Innate Lymphoid Cells Type 1 Sub-Population/Innate Lymphoid Cells Type 1 Sub-Population A relative measurement (ratio or percentage) of a sub-population of type 1 innate lymphoid cells to a sub-population of type 1 innate lymphoid cells in a biological specimen. Type 1 Innate Lymphoid Cell Subpopulation to Type 1 Innate Lymphoid Cell Subpopulation Ratio Measurement ILC1 Sub-Population/ILC1 Innate LC1 Sub/ILC1 Innate Lymphoid Cells Type 1 Sub-Population/Innate Lymphoid Cells Type 1 A relative measurement (ratio or percentage) of a sub-population of type 1 innate lymphoid cells to total type 1 innate lymphoid cells in a biological specimen. Type 1 Innate Lymphoid Cell Subpopulation to Type 1 Innate Lymphoid Cell Ratio Measurement ILC1 Sub-Population/Leukocytes Innate LC1 Sub/Leuk Innate Lymphoid Cells Type 1 Sub-Population/Leukocytes A relative measurement (ratio or percentage) of a sub-population of type 1 innate lymphoid cells to total leukocytes in a biological specimen. Type 1 Innate Lymphoid Cell Subpopulation to Leukocyte Ratio Measurement ILC1 Innate LC1 Innate Lymphoid Cells Type 1 A measurement of type 1 innate lymphoid cells in a biological specimen. Type 1 Innate Lymphoid Cell Count ILC1/ILC Innate LC1/ILC Innate Lymphoid Cells Type 1/Innate Lymphoid Cells A relative measurement (ratio or percentage) of type 1 innate lymphoid cells to total innate lymphoid cells in a biological specimen. Type 1 Innate Lymphoid Cell to Innate Lymphoid Cell Ratio Measurement ILC1/Leukocytes Innate LC1/Leuk Innate Lymphoid Cells Type 1/Leukocytes A relative measurement (ratio or percentage) of type 1 innate lymphoid cells to total leukocytes in a biological specimen. Type 1 Innate Lymphoid Cell to Leukocyte Ratio Measurement ILC2 Sub Innate LC2 Sub Innate Lymphoid Cells Type 2 Sub-Population A measurement of a sub-population of type 2 innate lymphoid cells in a biological specimen. Type 2 Innate Lymphoid Cell Subpopulation Count ILC2 Sub-Population/ILC Sub-Population Innate LC2 Sub/ILC Sub Innate Lymphoid Cells Type 2 Sub-Population/Innate Lymphoid Cells Sub-Population A relative measurement (ratio or percentage) of a sub-population of type 2 innate lymphoid cells to a sub-population of innate lymphoid cells in a biological specimen. Type 2 Innate Lymphoid Cell Subpopulation to Innate Lymphoid Cell Subpopulation Ratio Measurement ILC2 Sub-Population/ILC Innate LC2 Sub/ILC Innate Lymphoid Cells Type 2 Sub-Population/Innate Lymphoid Cells A relative measurement (ratio or percentage) of a sub-population of type 2 innate lymphoid cells to total innate lymphoid cells in a biological specimen. Type 2 Innate Lymphoid Cell Subpopulation to Innate Lymphoid Cell Ratio Measurement ILC2 Sub-Population/ILC2 Sub-Population Innate LC2 Sub/ILC2 Sub Innate Lymphoid Cells Type 2 Sub-Population/Innate Lymphoid Cells Type 2 Sub-Population A relative measurement (ratio or percentage) of a sub-population of type 2 innate lymphoid cells to a sub-population of type 2 innate lymphoid cells in a biological specimen. Type 2 Innate Lymphoid Cell Subpopulation to Type 2 Innate Lymphoid Cell Subpopulation Ratio Measurement ILC2 Sub-Population/ILC2 Innate LC2 Sub/ILC2 Innate Lymphoid Cells Type 2 Sub-Population/Innate Lymphoid Cells Type 2 A relative measurement (ratio or percentage) of a sub-population of type 2 innate lymphoid cells to total type 2 innate lymphoid cells in a biological specimen. Type 2 Innate Lymphoid Cell Subpopulation to Type 2 Innate Lymphoid Cell Ratio Measurement ILC2 Sub-Population/Leukocytes Innate LC2 Sub/Leuk Innate Lymphoid Cells Type 2 Sub-Population/Leukocytes A relative measurement (ratio or percentage) of a sub-population of type 2 innate lymphoid cells to total leukocytes in a biological specimen. Type 2 Innate Lymphoid Cell Subpopulation to Leukocyte Ratio Measurement ILC2 Innate LC2 Innate Lymphoid Cells Type 2 A measurement of the type 2 innate lymphoid cells in a biological specimen. Type 2 Innate Lymphoid Cell Count ILC2/ILC Innate LC2/ILC Innate Lymphoid Cells Type 2/Innate Lymphoid Cells A relative measurement (ratio or percentage) of type 2 innate lymphoid cells to total innate lymphoid cells in a biological specimen. Type 2 Innate Lymphoid Cell to Innate Lymphoid Cell Ratio Measurement ILC2/Leukocytes Innate LC2/Leuk Innate Lymphoid Cells Type 2/Leukocytes A relative measurement (ratio or percentage) of type 2 innate lymphoid cells to total leukocytes in a biological specimen. Type 2 Innate Lymphoid Cell to Leukocyte Ratio Measurement ILC3 Sub Innate LC3 Sub Innate Lymphoid Cells Type 3 Sub-Population A measurement of a sub-population of type 3 innate lymphoid cells in a biological specimen. Type 3 Innate Lymphoid Cell Subpopulation Count ILC3 Sub-Population/ILC Sub-Population Innate LC3 Sub/ILC Sub Innate Lymphoid Cells Type 3 Sub-Population/Innate Lymphoid Cells Sub-Population A relative measurement (ratio or percentage) of a sub-population of type 3 innate lymphoid cells to a sub-population of innate lymphoid cells in a biological specimen. Type 3 Innate Lymphoid Cell Subpopulation to Innate Lymphoid Cell Subpopulation Ratio Measurement ILC3 Sub-Population/ILC Innate LC3 Sub/ILC Innate Lymphoid Cells Type 3 Sub-Population/Innate Lymphoid Cells A relative measurement (ratio or percentage) of a sub-population of type 3 innate lymphoid cells to total innate lymphoid cells in a biological specimen. Type 3 Innate Lymphoid Cell Subpopulation to Innate Lymphoid Cell Ratio Measurement ILC3 Sub-Population/ILC3 Sub-Population Innate LC3 Sub/ILC3 Sub Innate Lymphoid Cells Type 3 Sub-Population/Innate Lymphoid Cells Type 3 Sub-Population A relative measurement (ratio or percentage) of a sub-population of type 3 innate lymphoid cells to a sub-population of type 3 innate lymphoid cells in a biological specimen. Type 3 Innate Lymphoid Cell Subpopulation to Type 3 Innate Lymphoid Cell Subpopulation Ratio Measurement ILC3 Sub-Population/ILC3 Innate LC3 Sub/ILC3 Innate Lymphoid Cells Type 3 Sub-Population/Innate Lymphoid Cells Type 3 A relative measurement (ratio or percentage) of a sub-population of type 3 innate lymphoid cells to total type 3 innate lymphoid cells in a biological specimen. Type 3 Innate Lymphoid Cell Subpopulation to Type 3 Innate Lymphoid Cell Ratio Measurement ILC3 Sub-Population/Leukocytes Innate LC3 Sub/Leuk Innate Lymphoid Cells Type 3 Sub-Population/Leukocytes A relative measurement (ratio or percentage) of a sub-population of type 3 innate lymphoid cells to total leukocytes in a biological specimen. Type 3 Innate Lymphoid Cell Subpopulation to Leukocyte Ratio Measurement ILC3 Innate LC3 Innate Lymphoid Cells Type 3 A measurement of the type 3 innate lymphoid cells in a biological specimen. Type 3 Innate Lymphoid Cell Count ILC3/ILC Innate LC3/ILC Innate Lymphoid Cells Type 3/Innate Lymphoid Cells A relative measurement (ratio or percentage) of type 3 innate lymphoid cells to total innate lymphoid cells in a biological specimen. Type 3 Innate Lymphoid Cell to Innate Lymphoid Cell Ratio Measurement ILC3/Leukocytes Innate LC3/Leuk Innate Lymphoid Cells Type 3/Leukocytes A relative measurement (ratio or percentage) of type 3 innate lymphoid cells to total leukocytes in a biological specimen. Type 3 Innate Lymphoid Cell to Leukocyte Ratio Measurement ILC Sub-Population Innate LC Sub Innate Lymphoid Cells Sub Innate Lymphoid Cells Sub-Population A measurement of a sub-population of innate lymphoid cells in a biological specimen. Innate Lymphoid Cell Subpopulation Count ILC Innate LC Innate Lymphoid Cells A measurement of the innate lymphoid cells in a biological specimen. Innate Lymphoid Cell Count Interpretation An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. Interpretation Kappa+ PC/Lambda+ PC Kappa+ Plasma Cells/Lambda+ Plasma Cells A relative measurement (ratio) of the kappa+ plasma cells to lambda+ plasma cells in a biological specimen. Kappa Positive Plasma Cell to Lambda Positive Plasma Cell Ratio Measurement Kappa+ PC Kappa+ Plasma Cells A measurement of the kappa+ plasma cells in a biological specimen. Kappa Positive Plasma Cell Count Ki67 Expression A measurement of cellular Ki67 expression in a biological specimen. Ki67 Cell Surface Expression Measurement KLRG1 Expression A measurement of cellular KLRG1 expression in a biological specimen. KLRG1 Expression Measurement Lambda+ PC Lambda+ Plasma Cells A measurement of the lambda+ plasma cells in a biological specimen. Lambda Positive Plasma Cell Count Leuk NonViable/Leuk Leukocytes NonViable/Leukocytes A relative measurement (ratio) of nonviable leukocytes to total leukocytes in a biological specimen. Nonviable Leukocyte to Leukocyte Ratio Measurement Leuk Sub Leukocytes Sub-Population WBC Sub-Population White Blood Cell Sub-Population A measurement of a sub-population of leukocytes in a biological specimen. Leukocyte Subpopulation Count Leuk Sub/Leuk Sub Leukocytes Sub-Population/Leukocytes Sub-Population WBC Sub-Population/WBC Sub-Population White Blood Cell Sub-Population/White Blood Cell Sub-Population A relative measurement (ratio or percentage) of a sub-population of leukocytes to a sub-population of leukocytes in a biological specimen. Leukocyte Subpopulation to Leukocyte Subpopulation Ratio Measurement Leuk Sub/Leuk Leuk Sub/Leukocytes Leukocytes Sub-Population/Leukocytes WBC Sub-Population/WBC White Blood Cell Sub-Population/White Blood Cell A relative measurement (ratio or percentage) of a sub-population of leukocytes to total leukocytes in a biological specimen. Leukocyte Subpopulation to Leukocyte Ratio Measurement Leuk Viable/Leuk NonViable Leukocytes Viable/Leukocytes NonViable A relative measurement (ratio) of viable leukocytes to non-viable leukocytes in a biological specimen. Viable Leukocyte to Nonviable Leukocyte Ratio Measurement Leuk Viable/Leuk Leukocytes Viable/Leukocytes A relative measurement (ratio) of viable leukocytes to total leukocytes in a biological specimen. Viable Leukocyte to Leukocyte Ratio Measurement Leukocytes White Blood Cells A measurement of the leukocytes in a biological specimen. Leukocyte Count Leukocytes/Total Cells WBC/Total Cells A relative measurement (ratio or percentage) of the leukocytes to total cells in a biological specimen. Leukocytes to Total Cells Ratio Measurement Leukocytes/Live Cells Leukocytes/Viable Cells Live Leukocytes/Live Cells Viable Leukocytes/Viable Cells A relative measurement (ratio) of leukocytes to total viable cells in a biological specimen. Leukocyte to Viable Cell Ratio Measurement Lym Sub Lymphocytes Sub Lymphocytes Sub-Population A measurement of a sub-population of lymphocytes in a biological specimen. Lymphocytes Subpopulation Count Lym Sub-Population/WBC Lym Sub/Leuk Lymphocytes Sub-Population/Leukocytes Lymphocytes Sub-Population/White Blood Cells A relative measurement (ratio or percentage) of a sub-population of lymphocytes to total leukocytes in a biological specimen. Lymphocyte Subpopulation to Leukocyte Ratio Measurement Lym Sub/Lym Sub Lymphocytes Sub-Population/Lymphocytes Sub-Population A relative measurement (ratio or percentage) of a sub-population of lymphocytes to a sub-population of lymphocytes in a biological specimen. Lymphocyte Subpopulation to Lymphocyte Subpopulation Ratio Measurement Lym Sub/Lym Lymphocytes Sub-Population/Lymphocytes Lymphocytes Sub/Lymphocytes A relative measurement (ratio or percentage) of a sub-population of lymphocytes to lymphocytes in a biological specimen. Lymphocyte Subpopulation to Total Lymphocytes Ratio Measurement Lym+Mono Sub Lymphocytes + Monocytes Subpopulation A measurement of a cell sub-population containing both lymphocytes and monocytes in a biological specimen. Lymphocyte and Monocyte Subpopulation Count Lym+Mono Sub, Lin neg Lym+Mono Sub, Lin- Lymphocytes + Monocytes Subpopulation, Lineage Negative A measurement of a sub-population of cells containing both lymphocytes and monocytes, which do not express any of the lineage-defining markers assessed, in a biological specimen. Lineage Negative Lymphocyte and Monocyte Subpopulation Count Lym+Mono Lymphocytes and Monocytes A measurement of a cell population containing both lymphocytes and monocytes in a biological specimen. Lymphocytes and Monocytes Count Lym+Mono, Lin neg Lym+Mono, Lin- Lymphocytes + Monocytes, Lineage Negative A measurement of a cell population containing both lymphocytes and monocytes, which do not express any of the lineage-defining markers assessed, in a biological specimen. Lineage Negative Lymphocyte and Monocyte Count Lymphocytes and Monocytes/Leukocytes A relative measurement (ratio or percentage) of the lymphocytes and monocytes to total leukocytes in a biological specimen. Lymphocytes and Monocytes to Leukocytes Ratio Measurement Lymphocytes A measurement of the lymphocytes in a biological specimen. Lymphocyte Count Lymphocytes/Leukocytes A relative measurement (ratio or percentage) of the lymphocytes to leukocytes in a biological specimen. Lymphocyte to Leukocyte Ratio Lymphocytes/Total Cells A relative measurement (ratio or percentage) of the lymphocytes to total cells in a biological specimen (for example a bone marrow specimen). Lymphocyte to Total Cell Ratio Measurement Macrophages M1 A measurement of the M1 macrophages in a biological specimen. M1 Macrophage Count Macrophages M2 A measurement of the M2 macrophages in a biological specimen. M2 Macrophage Count Macrophages Sub Macrophages Sub-Population A measurement of a sub-population of macrophages in a biological specimen. Macrophage Subpopulation Count Macrophages Sub-Population/Macrophages Sub-Population Macrophages Sub/Macrophages Sub A relative measurement (ratio or percentage) of a sub-population of macrophages to sub-population of macrophages in a biological specimen. Macrophage Subpopulation to Macrophage Subpopulation Ratio Measurement Macrophages Sub-Population/Macrophages Macrophages Sub/Macrophages A relative measurement (ratio or percentage) of a sub-population of macrophages to total macrophages in a biological specimen. Macrophage Subpopulation to Macrophage Ratio Measurement Macrophages A measurement of the macrophages in a biological specimen. Macrophage Count Macrophages/Leukocytes A relative measurement (ratio or percentage) of the macrophages to leukocytes in a biological specimen. Macrophage to Leukocyte Ratio Macrophages/Monocytes A relative measurement (ratio or percentage) of the macrophages to monocytes in a biological specimen. Macrophage to Monocyte Ratio Measurement Macrophages/Myeloid Cells A relative measurement (ratio or percentage) of the macrophages to myeloid cells in a biological specimen. Macrophage to Myeloid Cell Ratio Measurement Macrophages/Total Cells A relative measurement (ratio or percentage) of the macrophages to total cells in a biological specimen. Macrophage to Total Cell Ratio Measurement MAIT cells Sub/MAIT cells MAIT Sub/MAIT Mucosal-Associated Invariant T Cells Sub-Population/Mucosal-Associated Invariant T Cells Mucosal-Associated Invariant T-Lymphocytes Sub-Population/Mucosal-Associated Invariant T-Lymphocytes A relative measurement of a sub-population of mucosal-associated invariant T-lymphocytes to all mucosal associated T-lymphocytes in a biological specimen. Mucosal-Associated Invariant T-Lymphocyte Subpopulation to Mucosal-Associated T-Lymphocyte Ratio Measurement MAIT Cells/Leukocytes MAIT/Leuk Mucosal-Associated Invariant T-Lymphocytes/Leukocytes A relative measurement (ratio or percentage) of mucosal-associated invariant T-lymphocytes to leukocytes in a biological specimen. Mucosal-Associated Invariant T-Lymphocyte to Leukocyte Ratio Measurement MAIT Cells/T Cells MAIT/TLym Mucosal-Associated Invariant T Cells/T-Lymphocytes Mucosal-Associated Invariant T-Lymphocytes/T-Lymphocytes A relative measurement (ratio or percentage) of mucosal-associated invariant T-lymphocytes to T-lymphocytes in a biological specimen. Mucosal-Associated Invariant T-Lymphocyte to T-Lymphocyte Ratio Measurement Mast Cells Mastocytes A measurement of the mast cells in a biological specimen. Mast Cell Count Mast Cells/Total Cells A relative measurement (ratio or percentage) of the mast cells to total cells in a biological specimen. Mast Cell to Total Cell Ratio Measurement Double-Negative Myeloid-Derived Suppressor Cells Sub-Population MDSC Dbl Neg Sub MDSC Double-Negative Sub-Population A measurement of a sub-population of double-negative myeloid-derived suppressor cells in a biological specimen. Double-Negative Myeloid-Derived Suppressor Subpopulation Count MDSC Dbl Neg Sub/MDSC Dbl Neg Myeloid-Derived Suppressor Cell Double Negative Sub-Population/Myeloid-Derived Suppressor Cells Double Negative A relative measurement (ratio or percentage) of a sub-population of double-negative myeloid-derived suppressor cells to all double-negative myeloid-derived suppressor cells in a biological specimen. Double-Negative Myeloid-Derived Suppressor Cell Subpopulation to Double-Negative Myeloid-Derived Suppressor Cell Ratio Measurement MDSC Dbl Neg Sub/MDSC Myeloid-Derived Suppressor Cell Double Negative Sub-Population/Myeloid-Derived Suppressor Cells A relative measurement (ratio or percentage) of a sub-population of double-negative myeloid-derived suppressor cells to all myeloid-derived suppressor cells in a biological specimen. Double-Negative Myeloid-Derived Suppressor Cell Subpopulation to Myeloid-Derived Suppressor Cell Ratio Measurement MDSC Dbl Neg Myeloid-Derived Suppressor Cells Double Negative A measurement of the double-negative myeloid-derived suppressor cells (any MDSC that is both CD14-CD15-) in a biological specimen. Double-Negative Myeloid-Derived Suppressor Cell Count MDSC Dbl Neg/MDSC Myeloid-Derived Suppressor Cells Double Negative/Myeloid-Derived Suppressor Cells A relative measurement (ratio or percentage) of the double negative myeloid-derived suppressor cells to all myeloid-derived suppressor cells in a biological specimen. Double-Negative Myeloid-Derived Suppressor Cell to Myeloid-Derived Suppressor Cell Ratio Measurement MDSC Gran Sub Myeloid-Derived Suppressor Cells Granulocytic Sub-Population A measurement of a sub-population of granulocytic myeloid-derived suppressor cells in a biological specimen. Granulocytic Myeloid-Derived Suppressor Cell Subpopulation Count MDSC Gran Sub/MDSC Gran Myeloid-Derived Suppressor Cells Granulocytic Sub-Population/Myeloid-Derived Suppressor Cells Granulocytic PMN-MDSC Sub/MDSC Gran A relative measurement (ratio or percentage) of a sub-population of granulocytic myeloid-derived suppressor cells to all granulocytic myeloid-derived suppressor cells in a biological specimen. Granulocytic Myeloid-Derived Suppressor Cell Subpopulation to Granulocytic Myeloid-Derived Suppressor Cell Ratio Measurement MDSC Gran Sub/MDSC Myeloid-Derived Suppressor Cell Granulocytic Sub-Population/Myeloid-Derived Suppressor Cells PMN-MDSC Sub/MDSC A relative measurement (ratio or percentage) of a sub-population of granulocytic myeloid-derived suppressor cells to all myeloid-derived suppressor cells in a biological specimen. Granulocytic Myeloid-Derived Suppressor Cell Subpopulation to Myeloid-Derived Suppressor Cell Ratio Measurement G-MDSC gMDSC MDSC Gran Myeloid-Derived Suppressor Cells Granulocytic PMN-MDSC A measurement of the granulocytic myeloid-derived suppressor cells in a biological specimen. Granulocytic Myeloid-Derived Suppressor Cell Count MDSC Gran/Gran Myeloid-Derived Suppressor Cells Granulocytic/Granulocytes PMN-MDSC/Gran A relative measurement (ratio or percentage) of the granulocytic myeloid-derived suppressor cells to total granulocytes in a biological specimen. Granulocytic Myeloid-Derived Suppressor Cell to Granulocyte Ratio Measurement MDSC Gran/Leuk Myeloid-Derived Suppressor Cells Granulocytic/Leukocytes PMN-MDSC/Leuk A relative measurement (ratio or percentage) of the granulocytic myeloid-derived suppressor cells to total leukocytes in a biological specimen. Granulocytic Myeloid-Derived Suppressor Cell to Leukocyte Ratio Measurement MDSC Gran/Lym Sub Myeloid-Derived Suppressor Cells Granulocytic/Lymphocyte Sub-Population PMN-MDSC/Lym Sub A relative measurement (ratio or percentage) of the granulocytic myeloid-derived suppressor cells to a sub-population of lymphocytes in a biological specimen. Granulocytic Myeloid-Derived Suppressor Cell to Lymphocyte Subpopulation Ratio Measurement MDSC Gran/MDSC Myeloid-Derived Suppressor Cells Granulocytic/Myeloid-Derived Suppressor Cells PMN-MDSC/MDSC A relative measurement (ratio or percentage) of the granulocytic myeloid-derived suppressor cells to all myeloid-derived suppressor cells in a biological specimen. Granulocytic Myeloid-Derived Suppressor Cell to Myeloid-Derived Suppressor Cell Ratio Measurement MDSC Mono Sub Myeloid-Derived Suppressor Cells Monocytic Sub-Population A measurement of a sub-population of monocytic myeloid-derived suppressor cells in a biological specimen. Monocytic Myeloid-Derived Suppressor Cell Subpopulation Count M-MDSC Sub/MDSC Mono MDSC Mono Sub/MDSC Mono Myeloid-Derived Suppressor Cell Monocytic Sub-Population/Myeloid-Derived Suppressor Cells Monocytic A relative measurement (ratio or percentage) of a sub-population of monocytic myeloid-derived suppressor cells to all monocytic myeloid-derived suppressor cells in a biological specimen. Monocytic Myeloid-Derived Suppressor Cell Subpopulation to Monocytic Myeloid-Derived Suppressor Cell Ratio Measurement M-MDSC Sub/MDSC MDSC Mono Sub/MDSC Myeloid-Derived Suppressor Cell Monocytic Sub-Population/Myeloid-Derived Suppressor Cells A relative measurement (ratio or percentage) of a sub-population of monocytic myeloid-derived suppressor cells to all myeloid-derived suppressor cells in a biological specimen. Monocytic Myeloid-Derived Suppressor Cell Subpopulation to Myeloid-Derived Suppressor Cell Ratio Measurement M-MDSC MDSC Mono mMDSC Myeloid-Derived Suppressor Cells Monocytic A measurement of the monocytic myeloid-derived suppressor cells in a biological specimen. Monocytic Myeloid-Derived Suppressor Cell Count M-MDSC/Leuk MDSC Mono/Leuk Myeloid-Derived Suppressor Cells Monocytic/Leukocytes A relative measurement (ratio or percentage) of the monocytic myeloid-derived suppressor cells to total leukocytes in a biological specimen. Monocytic Myeloid-Derived Suppressor Cell to Leukocyte Ratio Measurement M-MDSC/MDSC MDSC Mono/MDSC Myeloid-Derived Suppressor Cells Monocytic/Myeloid-Derived Suppressor Cells A relative measurement (ratio or percentage) of the monocytic myeloid-derived suppressor cells to total myeloid-derived suppressor cells in a biological specimen. Monocytic Myeloid-Derived Suppressor Cell to Myeloid-Derived Suppressor Cell Ratio Measurement M-MDSC/Mono MDSC Mono/Mono Myeloid-Derived Suppressor Cells Monocytic/Monocytes A relative measurement (ratio) of the monocytic myeloid-derived suppressor cells to total monocytes in a biological specimen. Monocytic Myeloid-Derived Suppressor Cell to Monocyte Ratio Measurement MDSC Sub MDSC Sub-Population Myeloid-Derived Suppressor Cells Sub-Population A measurement of a sub-population of myeloid-derived suppressor cells in a biological specimen. Myeloid-Derived Suppressor Cell Subpopulation Count MDSC Sub/Leuk Myeloid Derived Suppressor Cell Sub-Population/Leukocytes A relative measurement (ratio or percentage) of a sub-population of myeloid derived suppressor cells to leukocytes in a biological specimen. Myeloid Derived Suppressor Cell Subpopulation to Leukocyte Ratio Measurement MDSC Sub/MDSC Sub Myeloid-Derived Suppressor Cells Sub-Population/Myeloid-Derived Suppressor Cells Sub-Population A relative measurement (ratio or percentage) of a sub-population of myeloid-derived suppressor cells to a sub-population of myeloid-derived suppressor cells in a biological specimen. Myeloid-Derived Suppressor Cell Subpopulation to Myeloid-Derived Suppressor Cell Subpopulation Ratio Measurement MDSC Sub/MDSC Myeloid-Derived Suppressor Cell Sub-Population/Myeloid-Derived Suppressor Cells A relative measurement (ratio or percentage) of a sub-population of myeloid-derived suppressor cells to all myeloid-derived suppressor cells in a biological specimen. Myeloid-Derived Suppressor Cell Subpopulation to Myeloid-Derived Suppressor Cell Ratio Measurement MDSC Sub/Non-TBNK Leuk Myeloid Derived Suppressor Cell Sub-Population/Non-TBNK Leukocytes A relative measurement (ratio or percentage) of a sub-population of myeloid derived suppressor cells to leukocytes that are not T cells, B cells or natural killer cells in a biological specimen. Myeloid Derived Suppressor Cell Subpopulation to Non-TBNK Leukocyte Ratio Measurement MDSC Myeloid-Derived Suppressor Cells A measurement of the myeloid-derived suppressor cells in a biological specimen. Myeloid-Derived Suppressor Cell Count MDSC/Leuk Sub Myeloid-Derived Suppressor Cells/Leukocytes Sub-Population A relative measurement (ratio or percentage) of the myeloid-derived suppressor cells to a sub-population of leukocytes in a biological specimen. Myeloid Derived Suppressor Cell to Leukocyte Subpopulation Ratio Measurement MDSC/Leuk Myeloid-Derived Suppressor Cells/Leukocytes A relative measurement (ratio or percentage) of the myeloid-derived suppressor cells to total leukocytes in a biological specimen. Myeloid-Derived Suppressor Cell to Leukocyte Ratio Measurement MDSC/Lym+Mono MDSC/Lymphocytes and Monocytes Myeloid-Derived Suppressor Cells/Lymphocytes and Monocytes A relative measurement (ratio or percentage) of myeloid-derived suppressor cells to lymphocytes and monocytes in a biological specimen. Myeloid-Derived Suppressor Cell to Lymphocyte and Monocyte Ratio Measurement MDSC/Leuk Non-Gran MDSC/Non-Gran Leuk Myeloid-Derived Suppressor Cells/Leukocytes Non-Granulocytic A relative measurement (ratio or percentage) of the myeloid-derived suppressor cells to total non-granulocytic leukocytes in a biological specimen. Myeloid-Derived Suppressor Cell to Non-Granulocytic Leukocyte Ratio Measurement MDSC/Non-TBNK Leuk MDSC/Non-TBNK Leukocytes Myeloid-Derived Suppressor Cells/Non-TBNK Leukocytes A relative measurement (ratio or percentage) of the myeloid-derived suppressor cells to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. Myeloid-Derived Suppressor Cell to Non-TBNK Leukocyte Ratio Measurement Megakaryocytes/Leukocytes A relative measurement (ratio or percentage) of the megakaryocytes to leukocytes in a biological specimen. Megakaryocytes to Leukocytes Ratio Measurement Megakaryocytes/Total Cells A relative measurement (ratio or percentage) of the megakaryocytes to total cells in a biological specimen (for example a bone marrow specimen). Megakaryocyte to Total Cell Ratio Measurement Mono Classic Sub Monocytes Classical Sub-Population A measurement of a sub-population of classical monocytes in a biological specimen. Classical Monocyte Subpopulation Count Mono Classic Sub/Mono Classic Monocytes Classical Sub-Population/Monocytes Classical A relative measurement (ratio or percentage) of a sub-population of classical monocytes to total classical monocytes in a biological specimen. Classical Monocyte Subpopulation to Classical Monocyte Ratio Measurement Mono Classic Sub-population/Non-TBNK Leukocytes Mono Classic Sub/Non-TBNK Leuk A relative measurement (ratio or percentage) of a sub-population of classical monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. Classical Monocyte Subpopulation to Non-TBNK Leukocyte Ratio Measurement Mono Classic Monocytes Classical A measurement of the classical monocytes in a biological specimen. Classic Monocytes Count Mono Classic/Leuk Sub Monocytes Classic/Leukocytes Sub-Population Monocytes Classical/Leukocytes Sub-Population A relative measurement (ratio or percentage) of the classical monocytes to a sub-population of leukocytes in a biological specimen. Classical Monocyte to Leukocyte Subpopulation Ratio Measurement Mono Classic/Leuk Monocytes Classic/Leukocytes A relative measurement (ratio or percentage) of the classical monocytes to total leukocytes in a biological specimen. Classical Monocyte to Leukocyte Ratio Measurement Mono Classic/Lym Sub Monocytes Classic/Lymphocytes Sub-Population Monocytes Classical/Lymphocytes Sub-Population A relative measurement (ratio or percentage) of the classical monocytes to a sub-population of lymphocytes in a biological specimen. Classical Monocyte to Lymphocyte Subpopulation Ratio Measurement Mono Classic/Lym+Mono Monocytes Classic/Lymphocytes and Monocytes Monocytes Classical/Lymphocytes and Monocytes A relative measurement (ratio or percentage) of the classical monocytes to lymphocytes and monocytes in a biological specimen. Classical Monocyte to Lymphocyte and Monocyte Ratio Measurement Mono Classic/Mono Monocytes Classic/Monocytes Monocytes Classical/Monocytes A relative measurement (ratio or percentage) of classical monocytes to monocytes in a biological specimen. Classical Monocyte to Monocyte Ratio Measurement Mono Classic/Myeloid Cells Monocytes Classic/Myeloid Cells A relative measurement (ratio or percentage) of the classical monocytes to total myeloid cells in a biological specimen. Classical Monocyte to Myeloid Cell Ratio Measurement Mono Classic/Non-TBNK Leuk Monocytes Classical/Non-TBNK Leukocytes A relative measurement (ratio or percentage) of the classical monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. Classical Monocyte to Non-TBNK Leukocyte Ratio Measurement Mono Inflamm Monocytes Inflammatory A measurement of the inflammatory monocytes in a biological specimen. Inflammatory Monocytes Count Mono Intermed Sub Monocytes Intermediate Sub-Population A measurement of a sub-population of intermediate monocytes in a biological specimen. Intermediate Monocyte Subpopulation Count Mono Intermed Sub/Mono Int Mono Intermed Sub/Mono Intermed Monocytes Intermediate Sub-Population/Monocytes Intermediate A relative measurement (ratio or percentage) of a sub-population of intermediate monocytes to total intermediate monocytes in a biological specimen. Intermediate Monocyte Subpopulation to Intermediate Monocyte Ratio Measurement Mono Intermed Sub/Non-TBNK Mono Intermed Sub/Non-TBNK Leuk Monocytes Intermediate Sub-Population/Non-TBNK Leukocytes A relative measurement (ratio or percentage) of a sub-population of intermediate monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. Intermediate Monocyte Subpopulation to Non-TBNK Leukocyte Ratio Measurement Mono Intermed Monocytes Intermediate A measurement of the intermediate monocytes in a biological specimen. Intermediate Monocytes Count Mono Intermed/Leuk Sub Monocytes Intermediate/Leukocytes Sub-Population A relative measurement (ratio or percentage) of the intermediate monocytes to a sub-population of leukocytes in a biological specimen. Intermediate Monocyte to Leukocyte Subpopulation Ratio Measurement Mono Intermed/Leuk Monocytes Intermediate/Leukocytes A relative measurement (ratio or percentage) of the intermediate monocytes to total leukocytes in a biological specimen. Intermediate Monocyte to Leukocyte Ratio Measurement Mono Intermed/Lym Sub Monocytes Intermediate/Lymphocytes Sub-Population A relative measurement (ratio or percentage) of the intermediate monocytes to a sub-population of lymphocytes in a biological specimen. Intermediate Monocytes to Lymphocyte Subpopulation Ratio Measurement Mono Intermed/Lym+Mono Monocytes Intermediate/Lymphocytes and Monocytes A relative measurement (ratio or percentage) of the intermediate monocytes to lymphocytes and monocytes in a biological specimen. Intermediate Monocyte to Lymphocyte and Monocyte Ratio Measurement Mono Intermed/Mono Monocytes Intermediate/Monocytes A relative measurement (ratio or percentage) of intermediate monocytes to monocytes in a biological specimen. Intermediate Monocyte to Monocyte Ratio Measurement Mono Intermed/Myeloid Cells Monocytes Intermediate/Myeloid Cells A relative measurement (ratio or percentage) of the intermediate monocytes to myeloid cells in a biological specimen. Intermediate Monocyte to Myeloid Cell Ratio Measurement Mono Intermed/Non-TBNK Leuk Monocytes Intermediate/Non-TBNK Leukocytes A relative measurement (ratio or percentage) of the intermediate monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. Intermediate Monocyte to Non-TBNK Leukocyte Ratio Measurement Mono Mat Monocytes Mature A measurement of the mature monocytes in a biological specimen. Mature Monocytes Count Mono NonClassic Sub Monocytes Non-Classical Sub-Population A measurement of a sub-population of non-classical monocytes in a biological specimen. Non-Classical Monocyte Subpopulation Count Mono NonClassic Sub/Mono Intermed Monocytes Non-Classic Sub-Population/Monocytes Intermediate Monocytes Non-Classical Sub-Population/Monocytes Intermediate A relative measurement (ratio or percentage) of a sub-population of non-classical monocytes to intermediate monocytes in a biological specimen. Non-Classical Monocyte Subpopulation to Intermediate Monocyte Ratio Measurement Mono NonClassic Sub/Mono NonClassic Monocytes Non-Classical Sub-Population/Monocytes Non-Classical A relative measurement (ratio or percentage) of a sub-population of non-classical monocytes to total non-classical monocytes in a biological specimen. Non-Classical Monocyte Subpopulation to Non-Classical Monocyte Ratio Measurement Mono NonClassic Sub/Non-TBNK Leuk Monocytes Non-Classical Sub-Population/Non-TBNK Leukocytes A relative measurement (ratio or percentage) of a sub-population of non-classical monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. Non-Classical Monocyte Subpopulation to Non-TBNK Leukocyte Ratio Measurement Mono NonClassic Monocytes Non-Classical A measurement of the non-classical monocytes in a biological specimen. Non-Classical Monocytes Count Mono NonClassic/Leuk Sub Monocytes Non-Classic/Leukocytes Sub-Population Monocytes Non-Classical/Leukocytes Sub-Population A relative measurement (ratio or percentage) of the non-classical monocytes to a sub-population of leukocytes in a biological specimen. Non-Classical Monocyte to Leukocyte Subpopulation Ratio Measurement Mono NonClassic/Leuk Monocytes Non-Classic/Leukocytes Monocytes Non-Classical/Leukocytes A relative measurement (ratio or percentage) of the non-classical monocytes to total leukocytes in a biological specimen. Non-Classical Monocyte to Leukocyte Ratio Measurement Mono NonClassic/Lym Sub Monocytes Non-Classic/Lymphocytes Sub-Population Monocytes Non-Classical/Lymphocytes Sub-Population A relative measurement (ratio or percentage) of the non-classical monocytes to a sub-population of lymphocytes in a biological specimen. Non-Classical Monocyte to Lymphocyte Subpopulation Ratio Measurement Mono NonClassic/Lym+Mono Monocytes Non-Classic/Lymphocytes and Monocytes Monocytes Non-Classical/Lymphocytes and Monocytes A relative measurement (ratio or percentage) of the non-classical monocytes to lymphocytes and monocytes in a biological specimen. Non-Classical Monocyte to Lymphocyte and Monocyte Ratio Measurement Mono NonClassic/Mono A relative measurement (ratio or percentage) of non-classical monocytes to monocytes in a biological specimen. Non-Classical Monocyte to Monocyte Ratio Measurement Mono NonClassic/Myeloid Cells Monocytes Non-Classic/Myeloid Cells Monocytes Non-Classical/Myeloid Cells A relative measurement (ratio or percentage) of the non-classical monocytes to myeloid cells in a biological specimen. Non-Classical Monocyte to Myeloid Cell Ratio Measurement Mono NonClassic/Non-TBNK Leuk Monocytes Non-Classical/Non-TBNK Leukocytes A relative measurement (ratio or percentage) of the non-classical monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. Non-Classical Monocyte to Non-TBNK Leukocyte Ratio Measurement Mono Proinflam Sub Monocytes Proinflammatory Sub-Population Proinflammatory Monocytes Sub-Population A measurement of a sub-population of proinflammatory monocytes in a biological specimen. Proinflammatory Monocyte Subpopulation Count Mono Proinflam Sub/Mono Proinflam Mono Proinflam Sub/MonoPI Monocytes Proinflammatory Sub-Population/Monocytes Proinflammatory A relative measurement (ratio or percentage) of a sub-population of proinflammatory monocytes to total proinflammatory monocytes in a biological specimen. Proinflammatory Monocyte Subpopulation to Proinflammatory Monocyte Ratio Measurement Mono Proinflam Monocytes Proinflammatory A measurement of the pro-inflammatory monocytes in a biological specimen. Proinflammatory Monocytes Count Mono Proinflam/Mono Monocytes Proinflammatory/Monocytes A relative measurement (ratio or percentage) of the proinflammatory monocytes to total monocytes in a biological specimen. Proinflammatory Monocyte to Monocyte Ratio Measurement Mono Resident Monocytes Resident A measurement of the resident monocytes in a biological specimen. Resident Monocytes Count Mono Sub Monocytes Sub Monocytes Sub-Population A measurement of a sub-population of monocytes in a biological specimen. Monocytes Subpopulation Count Mono Sub/Leuk Monocytes Sub-Population/Leukocytes A relative measurement (ratio or percentage) of a sub-population of monocytes to total leukocytes in a biological specimen. Monocyte Subpopulation to Leukocyte Ratio Measurement Mono Sub/Mono Sub Monocytes Sub-Population/Monocytes Sub-Population A relative measurement (ratio or percentage) of a sub-population of monocytes to a sub-population of monocytes in a biological specimen. Monocyte Subpopulation to Monocyte Subpopulation Ratio Measurement Mono Sub/Mono Monocytes Sub-Population/Monocytes Monocytes Sub/Monocytes A relative measurement (ratio or percentage) of a sub-population of monocytes to monocytes in a biological specimen. Monocyte Subpopulation to Total Monocytes Ratio Measurement Mono/Leuk Sub Monocytes/Leukocytes Sub-Population A relative measurement (ratio or percentage) of the monocytes to a sub-population of leukocytes in a biological specimen. Monocyte to Leukocyte Subpopulation Ratio Measurement Mono/Lym Sub Monocytes/Lymphocytes Sub-Population A relative measurement (ratio or percentage) of the monocytes to a sub-population of lymphocytes in a biological specimen. Monocyte to Lymphocyte Subpopulation Ratio Measurement Mono/Myeloid Cells Monocytes/Myeloid Cells A relative measurement (ratio or percentage) of the monocytes to myeloid cells in a biological specimen. Monocyte to Myeloid Cell Ratio Measurement Mono/Non-TBNK Leuk A relative measurement (ratio or percentage) of the monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells in a biological specimen. Monocyte to Non-TBNK Leukocyte Ratio Measurement Monocytes and Macrophages/Leukocytes A relative measurement (ratio or percentage) of the monocytes and macrophages to total leukocytes in a biological specimen. Monocytes and Macrophages to Leukocytes Ratio Measurement Monocytes A measurement of the monocytes in a biological specimen. Monocyte Count Monocytes/Leukocytes A relative measurement (ratio or percentage) of the monocytes to leukocytes in a biological specimen. Monocyte to Leukocyte Ratio Monocytes/Total Cells A relative measurement (ratio or percentage) of the monocytes to total cells in a biological specimen (for example a bone marrow specimen). Monocytes to Total Cell Ratio Measurement MAIT MAIT cells Mucosal-Associated Invariant T Cells Mucosal-Associated Invariant T-Lym Mucosal-Associated Invariant T-Lymphocytes A measurement of mucosal-associated invariant T-lymphocytes in a biological specimen. Mucosal-Associated Invariant T-Lymphocyte Count Interferon-induced GTP-binding Protein Mx1 Expression MX1 Expression MxA Expression Myxovirus Resistance Protein 1 Expression A measurement of cellular MX1 expression in a biological specimen. MX1 Expression Measurement Myeloid Cells A measurement of the myeloid cells in a biological specimen. Myeloid Cell Count Myeloid Cells/Leuk Myeloid Cells/Leukocytes A relative measurement (ratio or percentage) of the myeloid cells to leukocytes in a biological specimen. Myeloid Cell to Leukocyte Ratio Measurement Natural Killer Cells A measurement of the total natural killer cells in a biological specimen. Natural Killer Cell Count Natural Killer Cells/Total Cells A relative measurement (ratio or percentage) of the natural killer cells to total cells in a biological specimen. Natural Killer Cells to Total Cells Ratio Measurement Monoclonal Plasma Cells Monotypic Plasma Cells Neoplastic Plasma Cells A measurement of the neoplastic plasma cells in a biological specimen. Neoplastic Plasma Cell Count Neoplastic Plasma Cells/Total Cells A relative measurement (ratio or percentage) of the neoplastic plasma cells to total cells in a biological specimen. Neoplastic Plasma Cell to Total Cell Ratio Measurement Neutrophils A measurement of the neutrophils in a biological specimen. Absolute Neutrophil Count Natural Killer Cells Immature Intermediate Sub-Population/Natural Killer Cells Immature Intermediate NK Cells Immat Int Sub/NK Immat Int A relative measurement (ratio or percentage) of a sub-population of immature intermediate natural killer cells to total immature intermediate natural killer cells in a biological specimen. Immature Intermediate Natural Killer Cell Subpopulation to Immature Intermediate Natural Killer Cell Ratio Measurement Natural Killer Cells Immature Intermediate NK Cells Immat Int A measurement of the immature intermediate natural killer cells in a biological specimen. Immature Intermediate Natural Killer Cell Count Natural Killer Cells Immature Intermediate/Leukocytes NK Cells Immat Int/Leuk A relative measurement (ratio or percentage) of the immature intermediate natural killer cells to leukocytes in a biological specimen. Immature Intermediate Natural Killer Cell to Leukocyte Ratio Measurement Natural Killer Cells Immature Intermediate/Natural Killer Cells NK Cells Immat Int/NK Cells A relative measurement (ratio or percentage) of the immature intermediate natural killer cells to total natural killer cells in a biological specimen. Immature Intermediate Natural Killer Cell to Natural Killer Cell Ratio Measurement Immature Natural Killer Cells Sub-Population Immature NK Sub-Population Immature NKC Sub-Population Natural Killer Cells Immature Sub-Population NK Cells Immat Sub A measurement of a sub-population of immature natural killer cells in a biological specimen. Immature Natural Killer Cell Subpopulation Count Natural Killer Cells Immature Sub-Population/Natural Killer Cells Immature NK Cells Immat Sub/NK Immat A relative measurement (ratio or percentage) of a sub-population of immature natural killer cells to total immature natural killer cells in a biological specimen. Immature Natural Killer Cell Subpopulation to Immature Natural Killer Cell Ratio Measurement Natural Killer Cells Immature NK Cells Immat A measurement of the immature natural killer cells in a biological specimen. Immature Natural Killer Cell Count Natural Killer Cells Immature/Leukocytes NK Cells Immat/Leuk A relative measurement (ratio or percentage) of the immature natural killer cells to total leukocytes in a biological specimen. Immature Natural Killer Cell to Leukocyte Ratio Measurement Natural Killer Cells Immature/Lymphocytes Sub-Population NK Cells Immat/Lym Sub A relative measurement (ratio or percentage) of the immature natural killer cells to a sub-population of lymphocytes in a biological specimen. Immature Natural Killer Cell to Lymphocyte Subpopulation Ratio Measurement Natural Killer Cells Immature/Lymphocytes NK Cells Immat/Lym A relative measurement (ratio or percentage) of the immature natural killer cells to total lymphocytes in a biological specimen. Immature Natural Killer Cell to Lymphocyte Ratio Measurement Natural Killer Cells Immature/Natural Killer Cells NK Cells Immat/NK A relative measurement (ratio or percentage) of the immature natural killer cells to total natural killer cells in a biological specimen. Immature Natural Killer Cell to Natural Killer Cell Ratio Measurement Intermediate Natural Killer Cells Sub-Population Intermediate NK Sub-Population Intermediate NKC Sub-Population Natural Killer Cells Intermediate Sub-Population NK Cells Intermed Sub A measurement of a sub-population of intermediate natural killer cells in a biological specimen. Intermediate Natural Killer Cell Subpopulation Count Natural Killer Cells Intermediate Sub-Population/Leukocytes NK Cells Intermed Sub/Leuk A relative measurement (ratio or percentage) of a sub-population of intermediate natural killer cells to total leukocytes in a biological specimen. Intermediate Natural Killer Cell Subpopulation to Leukocyte Ratio Measurement Natural Killer Cells Intermediate Sub-Population/Lymphocytes NK Cells Intermed Sub/Lym A relative measurement (ratio or percentage) of a sub-population of intermediate natural killer cells to total lymphocytes in a biological specimen. Intermediate Natural Killer Cell Subpopulation to Lymphocyte Ratio Measurement Natural Killer Cells Intermediate Sub-Population/Natural Killer Cells Intermediate NK Cells Intermed Sub/NK Intermed A relative measurement (ratio or percentage) of a sub-population of intermediate natural killer cells to total intermediate natural killer cells in a biological specimen. Intermediate Natural Killer Cell Subpopulation to Intermediate Natural Killer Cell Ratio Measurement Natural Killer Cells Intermediate NK Cells Intermed A measurement of the intermediate natural killer cells in a biological specimen. Intermediate Natural Killer Cell Count Natural Killer Cells Intermediate/Leukocytes NK Cells Intermed/Leuk A relative measurement (ratio or percentage) of the intermediate natural killer cells to total leukocytes in a biological specimen. Intermediate Natural Killer Cell to Leukocyte Ratio Measurement Natural Killer Cells Intermediate/Lymphocytes Sub-Population NK Cells Intermed/Lym Sub A relative measurement (ratio or percentage) of the intermediate natural killer cells to a sub-population of lymphocytes in a biological specimen. Intermediate Natural Killer Cell to Lymphocyte Subpopulation Ratio Measurement Natural Killer Cells Intermediate/Lymphocytes NK Cells Intermed/Lym A relative measurement (ratio or percentage) of the intermediate natural killer cells to total lymphocytes in a biological specimen. Intermediate Natural Killer Cell to Lymphocyte Ratio Measurement Natural Killer Cells Intermediate/Natural Killer Cells NK Cells Intermed/NK A relative measurement (ratio or percentage) of the intermediate natural killer cells to total natural killer cells in a biological specimen. Intermediate Natural Killer Cell to Natural Killer Cell Ratio Measurement Mature Natural Killer Cells Sub-Population Mature NK Sub-Population Mature NKC Sub-Population Natural Killer Cells Mature Sub-Population NK Cells Mat Sub A measurement of a sub-population of mature natural killer cells in a biological specimen. Mature Natural Killer Cell Subpopulation Count Natural Killer Cells Mature Sub-Population/Leukocytes NK Cells Mat Sub/Leuk A relative measurement (ratio or percentage) of a sub-population of mature natural killer cells to total leukocytes in a biological specimen. Mature Natural Killer Cell Subpopulation to Leukocyte Ratio Measurement Natural Killer Cells Mature Sub-Population/Lymphocytes NK Cells Mat Sub/Lym A relative measurement (ratio or percentage) of a sub-population of mature natural killer cells to total lymphocytes in a biological specimen. Mature Natural Killer Cell Subpopulation to Lymphocyte Ratio Measurement Natural Killer Cells Mature Sub-Population/Natural Killer Cells Mature NK Cells Mat Sub/NK Mat A relative measurement (ratio or percentage) of a sub-population of mature natural killer cells to total mature natural killer cells in a biological specimen. Mature Natural Killer Cell Subpopulation to Mature Natural Killer Cell Ratio Measurement Natural Killer Cells Mature Sub-Population/Natural Killer Cells NK Cells Mat Sub/NK A relative measurement (ratio or percentage) of a sub-population of mature natural killer cells to total natural killer cells in a biological specimen. Mature Natural Killer Cell Subpopulation to Natural Killer Cell Ratio Measurement Natural Killer Cells Mature NK Cells Mat A measurement of the mature natural killer cells in a biological specimen. Mature Natural Killer Cell Count Natural Killer Cells Mature/Leukocytes NK Cells Mat/Leuk A relative measurement (ratio or percentage) of the mature natural killer cells to total leukocytes in a biological specimen. Mature Natural Killer Cell to Leukocyte Ratio Measurement Natural Killer Cells Mature/Lymphocytes Sub-Population NK Cells Mat/Lym Sub A relative measurement (ratio or percentage) of the mature natural killer cells to a sub-population of lymphocytes in a biological specimen. Mature Natural Killer Cell to Lymphocyte Subpopulation Ratio Measurement Natural Killer Cells Mature/Lymphocytes NK Cells Mat/Lym A relative measurement (ratio or percentage) of the mature natural killer cells to total lymphocytes in a biological specimen. Mature Natural Killer Cell to Lymphocyte Ratio Measurement Natural Killer Cells Mature/Natural Killer Cells NK Cells Mat/NK A relative measurement (ratio or percentage) of the mature natural killer cells to total natural killer cells in a biological specimen. Mature Natural Killer Cell to Natural Killer Cell Ratio Measurement Natural Killer Cells Sub-Population NK Cells Sub NK Cells Sub-Population A measurement of a sub-population of natural killer cells in a biological specimen. Natural Killer Cells Subpopulation Count Natural Killer Cells Sub-Population/Leukocytes NK Cells Sub/Leuk A relative measurement (ratio or percentage) of a sub-population of natural killer cells to total leukocytes in a biological specimen. Natural Killer Cell Subpopulation to Leukocyte Ratio Measurement Natural Killer Cells Sub-Population/Lymphocytes Sub-Population NK Cells Sub/Lym Sub A relative measurement (ratio or percentage) of a sub-population of natural killer cells to a sub-population of lymphocytes in a biological specimen. Natural Killer Cell Subpopulation to Lymphocyte Subpopulation Ratio Measurement Natural Killer Cells Sub-Population/Natural Killer Cells Sub-Population NK Cells Sub/NK Cells Sub A relative measurement (ratio or percentage) of a sub-population of natural killer cells to a sub-population of natural killer cells in a biological specimen. Natural Killer Cell Subpopulation to Natural Killer Cell Subpopulation Ratio Measurement Natural Killer Cells Sub-Population/Natural Killer Cells NK Cells Sub/NK Cells A relative measurement (ratio or percentage) of a sub population of natural killer cells to total natural killer cells in a biological specimen. Natural Killer Cells Subpopulation to Total Natural Killer Cells Ratio Measurement Natural Killer Cells/Leukocytes NK Cells/Leuk A relative measurement (ratio or percentage) of the natural killer cells to leukocytes in a biological specimen. Natural Killer Cells to Leukocytes Ratio Measurement Natural Killer Cells/Lymphocytes Sub-Population NK Cells/Lym Sub A relative measurement (ratio or percentage) of natural killer cells to a sub-population of lymphocytes in a biological specimen. Natural Killer Cell to Lymphocyte Subpopulation Ratio Measurement Natural Killer Cells/Lymphocytes NK Cells/Lym A relative measurement (ratio or percentage) of the natural killer cells to lymphocytes in a biological specimen. Natural Killer Cells to Lymphocytes Ratio Measurement Natural Killer Cells/Non-TB Leukocytes NK Cells/Non-TB Leuk A relative measurement (ratio or percentage) of natural killer cells to leukocytes that are not T cells or B cells in a biological specimen. Natural Killer Cell to Non-TB Leukocyte Ratio Measurement iNKT Sub-population Natural Killer T-Lymphocytes Invariant Sub-Population NK TLym Invar Sub A measurement of a sub-population of invariant natural killer T-lymphocytes in a biological specimen. Invariant Natural Killer T-Lymphocyte Subpopulation Count iNKT Sub-Population/iNKT Sub-Population Natural Killer T-Lymphocytes Invariant Sub-Population/Natural Killer T-Lymphocytes Invariant Sub-Population NK TLym Invar Sub/NKT Invar Sub A relative measurement (ratio or percentage) of a sub-population of invariant natural killer T-lymphocytes to a sub-population of invariant natural killer T-lymphocytes in a biological specimen. Invariant Natural Killer T-Lymphocyte Subpopulation to Invariant Natural Killer T-Lymphocyte Subpopulation Ratio Measurement iNKT Sub-Population/iNKT Natural Killer T-Lymphocytes Invariant Sub-Population/Natural Killer T-Lymphocytes Invariant NK TLym Invar Sub/NK TLym Invar NK TLym Invar Sub/NKT Invar A relative measurement (ratio or percentage) of a sub-population of invariant natural killer T-lymphocytes to total invariant natural killer T-lymphocytes in a biological specimen. Invariant Natural Killer T-Lymphocyte Subpopulation to Invariant Natural Killer T-Lymphocyte Ratio Measurement iNKT Natural Killer T-Lymphocytes Invariant NK TLym Invar A measurement of the invariant natural killer T-lymphocytes in a biological specimen. Invariant Natural Killer T-Lymphocyte Count Natural Killer T-Lymphocytes Invariant/Natural Killer T-Lymphocytes NK TLym Invar/NKT A relative measurement (ratio or percentage) of the invariant natural killer T-lymphocytes to total natural killer T-lymphocytes in a biological specimen. Invariant Natural Killer T-Lymphocyte to Natural Killer T-Lymphocyte Ratio Measurement Natural Killer T-Cells Sub-Population Natural Killer T-Lymphocytes Sub-Population NK TLym Sub NKT Sub A measurement of a sub-population of natural killer T-lymphocytes in a biological specimen. Natural Killer T-Lymphocyte Subpopulation Count Natural Killer T-Lymphocytes Sub-Population/Natural Killer T-Lymphocytes Sub-Population NK TLym Sub/NK TLym Sub NKT Sub/NKT Sub A relative measurement (ratio or percentage) of a sub-population of natural killer T-lymphocytes to a sub-population of natural killer T-lymphocytes in a biological specimen. Natural Killer T-Lymphocyte Subpopulation to Natural Killer T-Lymphocyte Subpopulation Ratio Measurement Natural Killer T-Lymphocytes Sub-Population/Natural Killer T-Lymphocytes NK TLym Sub/NKT NKT Sub/NKT A relative measurement (ratio or percentage) of a sub-population of natural killer T-lymphocytes to total natural killer T-lymphocytes in a biological specimen. Natural Killer T-Lymphocyte Subpopulation to Natural Killer T-Lymphocyte Ratio Measurement Natural Killer T-Lymphocytes Sub-Population/T-Lymphocytes NK TLym Sub/TLym NKT Sub/TLym A relative measurement (ratio or percentage) of a sub-population of natural killer T-lymphocytes to total T-lymphocytes in a biological specimen. Natural Killer T-Lymphocyte Subpopulation to T-Lymphocyte Ratio Measurement Natural Killer T-Cells Natural Killer T-Lymphocytes NK TLym NKT A measurement of the natural killer T-lymphocytes in a biological specimen. Natural Killer T-Lymphocyte Count Natural Killer T-Lymphocytes/Leukocytes NK TLym/Leuk NK TLym/Leukocytes NKT/Leuk A relative measurement (ratio or percentage) of natural killer T-lymphocytes to leukocytes in a biological specimen. Natural Killer T-Lymphocyte to Leukocyte Ratio Measurement Natural Killer T-Lymphocytes/Lymphocytes NK TLym/Lym NKT/Lym A relative measurement (ratio or percentage) of the natural killer T-lymphocytes to total lymphocytes in a biological specimen. Natural Killer T-Lymphocytes to Lymphocytes Ratio Measurement Natural Killer T-Lymphocytes/T-Lymphocytes NK TLym/TLym NKT/TLym A relative measurement (ratio or percentage) of the natural killer T-lymphocytes to total T-lymphocytes in a biological specimen. Natural Killer T-Lymphocyte to T-Lymphocyte Ratio Measurement Leukocytes, Non-Granulocytic Non-Gran Leuk Non-Granulocytic Leukocytes A measurement of the non-granulocytic leukocytes in a biological specimen. Non-Granulocytic Leukocyte Count Non-TBNK Leuk Sub/Non-TBNK Leuk Non-TBNK Leukocytes Sub-Population/Non-TBNK Leukocytes A relative measurement (ratio or percentage) of a sub-population of leukocytes that are not T cells, B cells or natural killer cells to leukocytes that are not T cells, B cells or natural killer cells in a biological specimen. Non-TBNK Leukocyte Subpopulation to Non-TBNK Leukocyte Ratio Measurement Non-TBNK Leuk Non-TBNK Leukocytes A measurement of the leukocytes that are not T-cells, B-cells, or natural killer cells in a biological specimen. Non-TBNK Leukocyte Count Non-TBNK Leuk/Leuk Non-TBNK Leukocytes/Leukocytes A relative measurement (ratio or percentage) of the leukocytes that are not T-cells, B-cells, or natural killer cells to total leukocytes in a biological specimen. Non-TBNK Leukocyte to Leukocyte Ratio Measurement pERK Expression Phospho-ERK Expression A measurement of cellular phosphorylated ERK expression in a biological specimen. pERK Expression Measurement Plasma Cells Sub Plasma Cells Sub-Population Total Plasma Cells Sub A measurement of a sub-population of plasma cells in a biological specimen. Plasma Cell Subpopulation Count PC Sub/BLym Plasma Cells Sub-Population/B-Lymphocytes Plasma Cells Sub/B-Lymphocytes Plasma Cells Sub/BLym A relative measurement (ratio or percentage) of a sub-population of plasma cells to total B-lymphocytes in a biological specimen. Plasma Cell Subpopulation to B-Lymphocyte Ratio Measurement PC Sub/Leuk Plasma Cells Sub-Population/Leukocytes Plasma Cells Sub/Leuk Plasma Cells Sub/Leukocytes A relative measurement (ratio or percentage) of a sub-population of plasma cells to total leukocytes in a biological specimen. Plasma Cell Subpopulation to Leukocyte Ratio Measurement PC Sub/PC Sub Plasma Cells Sub-Population/Plasma Cells Sub-Population Plasma Cells Sub/Plasma Cells Sub A relative measurement (ratio or percentage) of a sub-population of plasma cells to a sub-population of plasma cells in a biological specimen. Plasma Cell Subpopulation to Plasma Cell Subpopulation Ratio Measurement PC Sub/PC Plasma Cells Sub-Population/Plasma Cells Plasma Cells Sub/Plasma Cells A relative measurement (ratio or percentage) of a sub-population of plasma cells to total plasma cells in a biological specimen. Plasma Cell Subpopulation to Plasma Cell Ratio Measurement Total Plasma Cells A measurement of the total plasma cells in a biological specimen. Plasma Cell Count PC/BLym AbSc Plasma Cells/B-Lymphocytes Antibody-Secreting Plasma Cells/BLym Ab-Secreting A relative measurement (ratio or percentage) of plasma cells to antibody-secreting B-lymphocytes in a biological specimen. Plasma Cell to Antibody-secreting B-Lymphocyte Ratio Measurement PC/BLym Plasma Cells/B-Lymphocytes Plasma Cells/BLym A relative measurement (ratio or percentage) of plasma cells to B-lymphocytes in a biological specimen. Plasma Cell to B-Lymphocyte Ratio Measurement Plasma Cells/B-Lymphocytes Memory Switched Plasma Cells/BLym Mem Sw Plasma Cells/BLymMSw A relative measurement (ratio or percentage) of the plasma cells to the class-switched memory B-lymphocytes in a biological specimen. Plasma Cell to Class-switched Memory B-Lymphocyte Ratio Measurement Plasma Cells/Leuk Total Plasma Cells/Leukocytes A relative measurement (ratio or percentage) of the total plasma cells to leukocytes in a biological specimen. Plasma Cells to Leukocytes Ratio Measurement Plasmablasts IgG+ Sub Plasmablasts IgG+ Sub-Population A measurement of a sub-population of IgG+ plasmablasts in a biological specimen. Immunoglobulin G Positive Plasmablast Subpopulation Count Plasmablasts IgG+ Sub-Population/Plasmablasts IgG+ Plasmablasts IgG+ Sub/PB IgG+ A relative measurement (ratio or percentage) of a sub-population of IgG+ plasmablasts to total IgG+ plasmablasts in a biological specimen. Immunoglobulin G Positive Plasmablast Subpopulation to Total Immunoglobulin G Positive Plasmablast Ratio Measurement Plasmablasts IgG+ A measurement of the IgG+ plasmablasts in a biological specimen. Immunoglobulin G Positive Plasmablast Count Plasmablasts IgG+/PB Plasmablasts IgG+/Plasmablasts A relative measurement (ratio or percentage) of the IgG+ plasmablasts to total plasmablasts in a biological specimen. Immunoglobulin G Positive Plasmablast to Plasmablast Ratio Measurement Plasmablasts IgM+ Sub Plasmablasts IgM+ Sub-Population A measurement of a sub-population of IgM+ plasmablasts in a biological specimen. Immunoglobulin M Positive Plasmablast Subpopulation Count Plasmablasts IgM+ Sub-Population/Plasmablasts IgM+ Plasmablasts IgM+ Sub/PB IgM+ A relative measurement (ratio or percentage) of a sub-population of IgM+ plasmablasts to total IgM+ plasmablasts in a biological specimen. Immunoglobulin M Positive Plasmablast Subpopulation to Total Immunoglobulin M Positive Plasmablast Ratio Measurement Plasmablasts IgM+ A measurement of the IgM+ plasmablasts in a biological specimen. Immunoglobulin M Positive Plasmablast Count Plasmablasts IgM+/PB Plasmablasts IgM+/Plasmablasts A relative measurement (ratio or percentage) of the IgM+ plasmablasts to total plasmablasts in a biological specimen. Immunoglobulin M Positive Plasmablast to Plasmablast Ratio Measurement Plasmablasts Sub Plasmablasts Sub-Population Precursor Plasma Cells Sub-Population A measurement of a sub-population of plasmablasts in a biological specimen. Plasmablast Subpopulation Count Plasmablasts Sub-Population/B-Lymphocytes Plasmablasts Sub/BLym A relative measurement (ratio or percentage) of a sub-population of plasmablasts to B-lymphocytes in a biological specimen. Plasmablast Subpopulation to B-Lymphocyte Ratio Measurement Plasmablasts Sub-Population/Leukocytes Plasmablasts Sub/Leuk A relative measurement (ratio or percentage) of a sub-population of plasmablasts to leukocytes in a biological specimen. Plasmablast Subpopulation to Leukocyte Ratio Measurement Plasmablasts Sub-Population/Plasmablasts Plasmablasts Sub/PB A relative measurement (ratio or percentage) of a sub-population of plasmablasts to total plasmablasts in a biological specimen. Plasmablast Subpopulation to Total Plasmablast Ratio Measurement Plasmablast Precursor Plasma Cells A measurement of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) in a biological specimen. Precursor Plasma Cell Count Plasmablasts/B-Lymphocytes Plasmablasts/BLym Precursor Plasma Cells/B-Lymphocytes A relative measurement (ratio or percentage) of plasmablasts to B-lymphocytes in a biological specimen. Plasmablasts to Total B-Lymphocytes Ratio Measurement Platelets Sub-Population A measurement of a sub-population of platelets in a biological specimen. Platelet Subpopulation Count Platelets A measurement of the platelets (non-nucleated thrombocytes) in a biological specimen. Platelet Count B-Lymphocyte Precursor Cells Pre-B Cells Pre-BLym Precursor B-Lymphocytes A measurement of the precursor B-lymphocytes in a biological specimen. Precursor B-Lymphocyte Count Dendritic Cell Precursor Cells Sub-Population Pre-DC Sub Pre-Dendritic Cells Sub Precursor Dendritic Cells Sub-Population PreDC Sub A measurement of a sub-population of precursor dendritic cells in a biological specimen. Pre-Dendritic Cell Subpopulation Count Dendritic Cell Precursor Cells Pre-DC Pre-Dendritic Cells Precursor Dendritic Cells PreDC A measurement of the precursor dendritic cells in a biological specimen. Pre-Dendritic Cell Count Pre-DC/DC Pre-Dendritic Cells/DC Pre-Dendritic Cells/Dendritic Cells Precursor Dendritic Cells/Dendritic Cells PreDC/DC A relative measurement (ratio or percentage) of the precursor dendritic cells to total dendritic cells in a biological specimen. Pre-Dendritic Cell to Dendritic Cell Ratio Measurement B-Lymphocyte Progenitor Cells Pro-B Cells Pro-BLym Progenitor B-Lymphocytes A measurement of the progenitor B-lymphocytes in a biological specimen. Progenitor B-Lymphocyte Count B-Lymphocyte Progenitor Cells/Total Cells Pro-B Cells/Total Cells Pro-BLym/Total Cells A relative measurement (ratio or percentage) of the progenitor B-lymphocytes to total cells in a biological specimen. Progenitor B-Lymphocyte to Total Cells Ratio Measurement Prostate Circulating Tumor Cells A measurement of the prostate circulating tumor cells in a biological specimen. Circulating Prostate Tumor Cell Count Cell Surface CD223 Expression Membrane CD223 Expression Plasma Membrane CD223 Expression sCD223 Expression A measurement of cellular plasma membrane (surface) CD223 expression in a biological specimen. Plasma Membrane CD223 Expression Measurement Stimulation Index A relative measurement (ratio or percentage) of a cell characteristic or response in the presence of a stimulating agent relative to a non-stimulated control. Stimulation Index Count T Cells T-Cell Lymphocytes T-Cells T-Lymphocytes A measurement of the total thymocyte-derived lymphocytes in a biological specimen. T-Lymphocyte Count Target Bound A measurement of the bound target in a biological specimen, prior to background subtraction. Target Bound Measurement Target Bound, Background A measurement of the background associated with the bound target measurement in a biological specimen. Target Bound, Background Measurement Target Bound, Delta Bound Background A measurement of the difference between bound target and background target in a biological specimen. Target, Bound Delta Bound Background Measurement Target Free A measurement of the free target in a biological specimen, prior to background subtraction. Target Free Measurement Target Free, Background A measurement of the background associated with the free target measurement in a biological specimen. Target Free, Background Measurement Target Free, Delta Free Background A measurement of the difference between free target and free background target in a biological specimen. Target, Free Delta Free Background Measurement Percent Occupancy Percent Saturation Target Occupancy A relative measurement (ratio or percentage) of the specifically bound target to total target in a biological specimen. Target Occupancy Ratio Measurement Target Total A measurement of the total target in a biological specimen, prior to background subtraction. Target Total Measurement Target Total, Background A measurement of the background associated with the total target measurement in a biological specimen. Target Total, Background Measurement Target Total, Delta Total Background A measurement of the difference between total target and target total background in a biological specimen. Target, Total Delta Total Background Measurement T Cell Factor 1 Expression T Cell Factor 7 Expression TCF-1 Expression TCF-7 Expression TCF1 Expression TCF7 Expression A measurement of cellular TCF7 expression in a biological specimen. Transcription Factor 7 Expression Measurement T-Cell Immunoreceptor with Ig and ITIM Domains Expression TIGIT Expression A measurement of cellular TIGIT expression in a biological specimen. TIGIT Expression Measurement T-Lymphocytes Alpha-Beta Sub T-Lymphocytes TCR Alpha-Beta Sub TLym AB Sub A measurement of a sub-population of alpha-beta T-lymphocytes in a biological specimen. Alpha-Beta T-Lymphocyte Subpopulation Count T-Lymphocytes Alpha-Beta Sub-Population/T-Lymphocytes Alpha-Beta T-Lymphocytes TCR Alpha-Beta Sub-Population/T-Lymphocytes TCR Alpha-Beta TCR Alpha-Beta T-Cells Sub/TCR Alpha-Beta T-Cells TLym AB Sub/TLym AB A relative measurement (ratio or percentage) of a sub-population of alpha-beta T-lymphocytes to total alpha-beta T-lymphocytes in a biological specimen. Alpha-Beta T-Lymphocyte Subpopulation to Alpha-Beta T-Lymphocyte Ratio Measurement T-Lymphocytes Alpha-Beta T-Lymphocytes TCR Alpha-Beta TCR Alpha-Beta T-Cells TLym AB A measurement of the alpha-beta T-lymphocytes in a biological specimen. Alpha-Beta T-Lymphocyte Count T-Lymphocytes Alpha-Beta/T-Lymphocytes T-Lymphocytes TCR Alpha-Beta/T-Lymphocytes TCR Alpha-Beta T-Cells/T-Lymphocytes TLym AB/TLym A relative measurement (ratio or percentage) of the alpha-beta T-lymphocytes to total T-lymphocytes in a biological specimen. Alpha-Beta T-Lymphocyte to T-Lymphocyte Ratio Measurement T-Lymphocytes Central Memory TLym Cen Mem A measurement of the central memory T-lymphocytes in a biological specimen. Central Memory T-Lymphocyte Count TLym Conv Cen Mem Sub TLym Conv Central Memory Sub-Population A measurement of a sub-population of conventional central memory T-lymphocytes in a biological specimen. Conventional Central Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Conventional Central Memory Sub-Population/T-Lymphocytes Conventional Central Memory TLym Conv Cen Mem Sub/TLymCvCM A relative measurement (ratio or percentage) of a sub-population of conventional central memory T-lymphocytes to total conventional central memory T-lymphocytes in a biological specimen. Conventional Central Memory T-Lymphocyte Subpopulation to Conventional Central Memory T-Lymphocyte Ratio Measurement TLym Conv Cen Mem TLym Conv Central Memory A measurement of the conventional central memory T-lymphocytes in a biological specimen. Conventional Central Memory T-Lymphocyte Count T-Lymphocytes Conventional Central Memory/T-Lymphocytes TLym Conv Cen Mem/Tlym A relative measurement (ratio or percentage) of the conventional central memory T-lymphocytes to T-lymphocytes in a biological specimen. Conventional Central Memory T-Lymphocyte to T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional Central Memory/T-Lymphocytes Conventional TLym Conv Cen Mem/TLymCv A relative measurement (ratio or percentage) of the conventional central memory T-lymphocytes to conventional T-lymphocytes in a biological specimen. Conventional Central Memory T-Lymphocyte to Conventional T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional Central Memory/T-Lymphocytes Helper TLym Conv Cen Mem/TLymH A relative measurement (ratio or percentage) of the conventional central memory T-lymphocytes to helper T-lymphocytes in a biological specimen. Conventional Central Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement TLym Conv Eff Mem Sub TLym Conventional Effector Memory Sub-Population A measurement of a sub-population of conventional effector memory T-lymphocytes in a biological specimen. Conventional Effector Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Conventional Effector Memory Sub-Population/T-Lymphocytes Conventional Effector Memory TLym Conv Eff Mem Sub/TLymCvEM A relative measurement (ratio or percentage) of a sub-population of conventional effector memory T-lymphocytes to total conventional effector memory T-lymphocytes in a biological specimen. Conventional Effector Memory T-Lymphocyte Subpopulation to Conventional Effector Memory T-Lymphocyte Ratio Measurement TLym Conv Eff Mem TLym Conventional Effector Memory A measurement of the conventional effector memory T-lymphocytes in a biological specimen. Conventional Effector Memory T-Lymphocyte Count T-Lymphocytes Conventional Effector Memory/T-Lymphocytes TLym Conv Eff Mem/Tlym A relative measurement (ratio or percentage) of the conventional effector memory T-lymphocytes to T-lymphocytes in a biological specimen. Conventional Effector Memory T-Lymphocyte to T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional Effector Memory/T-Lymphocytes Conventional TLym Conv Eff Mem/TLymCv A relative measurement (ratio or percentage) of the conventional effector memory T-lymphocytes to conventional T-lymphocytes in a biological specimen. Conventional Effector Memory T-Lymphocyte to Conventional T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional Effector Memory/T-Lymphocytes Helper TLym Conv Eff Mem/TLymH A relative measurement (ratio or percentage) of the conventional effector memory T-lymphocytes to helper T-lymphocytes in a biological specimen. Conventional Effector Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement TLym Conv Naive Sub TLym Conventional Naive Sub-Population A measurement of a sub-population of conventional naive T-lymphocytes in a biological specimen. Conventional Naive T-Lymphocyte Subpopulation Count T-Lymphocytes Conventional Naive Sub-Population/T-Lymphocytes Conventional Naive TLym Conv Naive Sub/TLymCvN A relative measurement (ratio or percentage) of a sub-population of conventional naive T-lymphocytes to the conventional naive T-lymphocytes in a biological specimen. Conventional Naive T-Lymphocyte Subpopulation to Conventional Naive T-Lymphocyte Ratio Measurement TLym Conv Naive TLym Conventional Naive A measurement of the conventional naive T-lymphocytes in a biological specimen. Conventional Naive T-Lymphocyte Count T-Lymphocytes Conventional Naive/T-Lymphocytes TLym Conv Naive/Tlym A relative measurement (ratio or percentage) of conventional naive T-lymphocytes to the T-lymphocytes in a biological specimen. Conventional Naive T-Lymphocyte to T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional Naive/T-Lymphocytes Conventional TLym Conv Naive/TLymCv A relative measurement (ratio or percentage) of conventional naive T-lymphocytes to the conventional T-lymphocytes in a biological specimen. Conventional Naive T-Lymphocyte to Conventional T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional Naive/T-Lymphocytes Helper TLym Conv Naive/TLymH A relative measurement (ratio or percentage) of the conventional naive T-lymphocytes to the helper T-lymphocytes in a biological specimen. Conventional Naive T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional Stem Cell Memory Sub-Population TLym Conv SC Mem Sub A measurement of a sub-population of conventional stem cell memory T-lymphocytes in a biological specimen. Conventional Stem Cell Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Conventional Stem Cell Memory Sub-Population/T-Lymphocytes Conventional Stem Cell Memory TLym Conv SC Mem Sub/TLymCvSCM A relative measurement (ratio or percentage) of a sub-population of conventional stem cell memory T-lymphocytes to the conventional stem cell memory T-lymphocytes in a biological specimen. Conventional Stem Cell Memory T-Lymphocyte Subpopulation to Conventional Stem Cell Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional Stem Cell Memory TLym Conv SC Mem A measurement of the conventional stem cell memory T-lymphocytes in a biological specimen. Conventional Stem Cell Memory T-Lymphocyte Count T-Lymphocytes Conventional Stem Cell Memory/T-Lymphocytes TLym Conv SC Mem/TLym A relative measurement (ratio or percentage) of conventional stem cell memory T-lymphocytes to the T-lymphocytes in a biological specimen. Conventional Stem Cell Memory T-Lymphocyte to T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional Stem Cell Memory/T-Lymphocytes Conventional TLym Conv SC Mem/TLymCv A relative measurement (ratio or percentage) of conventional stem cell memory T-lymphocytes to the conventional T-lymphocytes in a biological specimen. Conventional Stem Cell Memory T-Lymphocyte to Conventional T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional Stem Cell Memory/T-Lymphocytes Helper TLym Conv SC Mem/TLymH A relative measurement (ratio or percentage) of conventional stem cell memory T-lymphocytes to the helper T-lymphocytes in a biological specimen. Conventional Stem Cell Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement TLym Conv Sub TLym Conventional Sub-Population A measurement of a sub-population of conventional T-lymphocytes in a biological specimen. Conventional T-Lymphocyte Subpopulation Count T-Lymphocytes Conventional Sub-Population/T-Lymphocytes Conventional TLym Conv Sub/TLymCv A relative measurement (ratio or percentage) of a sub-population of conventional T-lymphocytes to the conventional T-lymphocytes in a biological specimen. Conventional T-Lymphocyte Subpopulation to Conventional T-Lymphocyte Ratio Measurement TLym Conv Term Mem Sub TLym Conventional Terminal Memory Sub-Population A measurement of a sub-population of conventional terminal memory T-lymphocytes in a biological specimen. Conventional Terminal Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Conventional Terminal Memory Sub-Population/T-Lymphocytes Conventional Terminal Memory TLym Conv Term Mem Sub/TLymCvTM A relative measurement (ratio or percentage) of a sub-population of conventional terminal memory T-lymphocytes to total conventional terminal memory T-lymphocytes in a biological specimen. Conventional Terminal Memory T-Lymphocyte Subpopulation to Conventional Terminal Memory T-Lymphocyte Ratio Measurement TLym Conv Term Mem TLym Conventional Terminal Memory A measurement of the conventional terminal memory T-lymphocytes in a biological specimen. Conventional Terminal Memory T-Lymphocyte Count T-Lymphocytes Conventional Terminal Memory/T-Lymphocytes TLym Conv Term Mem/TLym A relative measurement (ratio or percentage) of the conventional terminal memory T-lymphocytes to T-lymphocytes in a biological specimen. Conventional Terminal Memory T-Lymphocyte to T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional Terminal Memory/T-Lymphocytes Conventional TLym Conv Term Mem/TLymCv A relative measurement (ratio or percentage) of the conventional terminal memory T-lymphocytes to conventional T-lymphocytes in a biological specimen. Conventional Terminal Memory T-Lymphocyte to Conventional T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional Terminal Memory/T-Lymphocytes Helper TLym Conv Term Mem/TLymH A relative measurement (ratio or percentage) of the conventional terminal memory T-lymphocytes to helper T-lymphocytes in a biological specimen. Conventional Terminal Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement TLym Conv TLym Conventional A measurement of the conventional T-lymphocytes in a biological specimen. Conventional T-Lymphocyte Count T-Lymphocytes Conventional/Leukocytes TLym Conv/Leuk A relative measurement (ratio or percentage of the conventional T-lymphocytes to leukocytes in a biological specimen. Conventional T-Lymphocyte to Leukocyte Ratio Measurement T-Lymphocytes Conventional/T-Lymphocytes TLym Conv/TLym A relative measurement (ratio or percentage) of conventional T-lymphocytes to the T-lymphocytes in a biological specimen. Conventional T-Lymphocyte Subpopulation to T-Lymphocyte Ratio Measurement T-Lymphocytes Conventional/T-Lymphocytes Helper TLym Conv/TLymH A relative measurement (ratio or percentage) conventional T-lymphocytes to the helper T-lymphocytes in a biological specimen. Conventional T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Alpha-Beta Sub-Population T-Lymphocytes Cytotoxic TCR Alpha-Beta Sub-Population TLym Cytx AB Sub A measurement of a sub-population of cytotoxic alpha-beta T-lymphocytes in a biological specimen. Alpha-Beta Cytotoxic T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Alpha-Beta T-Lymphocytes Cytotoxic TCR Alpha-Beta TLym Cytx AB A measurement of the cytotoxic alpha-beta T-lymphocytes in a biological specimen. Cytotoxic Alpha-Beta T-Lymphocyte Count T-Lymphocytes Cytotoxic Central Memory Gut-Homing Sub-Population TLym Cytx Cen Mem GH Sub A measurement of a sub-population of gut-homing cytotoxic central memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Central Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx Cen Mem GH Sub/TLym Cytx TLym Cytx Cen Mem GH Sub/TLymC A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic central memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Central Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic Central Memory TLym Cytx Cen Mem GH Sub/TLym Cytx Cen Mem TLym Cytx Cen Mem GH Sub/TLymCCM TLym Cytx Cen Mem Gut-Homing Sub/TLymCCM A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic central memory T-lymphocytes to total gut-homing cytotoxic T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation to Gut-Homing Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Central Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic Central Memory Gut-Homing TLym Cytx Cen Mem GH Sub/TLym Cytx Cen Mem GH TLym Cytx Cen Mem GH Sub/TLymCCMGH A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic central memory T-lymphocytes to total gut-homing cytotoxic central memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation to Gut-Homing Cytotoxic Central Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Central Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic Central Memory Gut-Homing Sub-Population TLym Cytx Cen Mem GH Sub/TLym Cytx Cen Mem GH Sub TLym Cytx Cen Mem GH Sub/TLymCCMGHS A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic central memory T-lymphocytes to a sub-population of gut-homing cytotoxic central memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation to Gut-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Cytotoxic Central Memory Gut-Homing TLym Cytx Cen Mem GH A measurement of the gut-homing cytotoxic central memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Central Memory T-Lymphocyte Count T-Lymphocytes Cytotoxic Central Memory Gut-Homing/T-Lymphocytes Cytotoxic TLym Cytx Cen Mem GH/TLym Cytx TLym Cytx Cen Mem GH/TLymC A relative measurement (ratio or percentage) of the gut-homing cytotoxic central memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Central Memory T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Central Memory Gut-Homing/T-Lymphocytes Cytotoxic Central Memory TLym Cytx Cen Mem GH/TLym Cytx Cen Mem TLym Cytx Cen Mem GH/TLymCCM A relative measurement (ratio or percentage) of the gut-homing cytotoxic central memory T-lymphocytes to total cytotoxic central memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Central Memory T-Lymphocyte to Cytotoxic Central Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Central Memory Skin-Homing Sub-Population TLym Cytx Cen Mem SH Sub A measurement of a sub-population of skin-homing cytotoxic central memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Central Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx Cen Mem SH Sub/TLym Cytx TLym Cytx Cen Mem SH Sub/TLymC A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic central memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Central Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic Central Memory TLym Cytx Cen Mem SH Sub/TLym Cytx Cen Mem TLym Cytx Cen Mem SH Sub/TLymCCM TLym Cytx Cen Mem Skin-Homing Sub/TLymCCM A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic central memory T-lymphocytes to total cytotoxic central memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation to Cytotoxic Central Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Central Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic Central Memory Skin-Homing TLym Cytx Cen Mem SH Sub/TLym Cytx Cen Mem SH TLym Cytx Cen Mem SH Sub/TLymCCMSH A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic central memory T-lymphocytes to total skin-homing cytotoxic central memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation to Skin-Homing Cytotoxic Central Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Central Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic Central Memory Skin-Homing Sub-Population TLym Cytx Cen Mem SH Sub/TLym Cytx Cen Mem SH Sub TLym Cytx Cen Mem SH Sub/TLymCCMSHS A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic central memory T-lymphocytes to a sub-population of skin-homing cytotoxic central memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation to Skin-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Cytotoxic Central Memory Skin-Homing TLym Cytx Cen Mem SH A measurement of the skin-homing cytotoxic central memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Central Memory T-Lymphocyte Count T-Lymphocytes Cytotoxic Central Memory Skin-Homing/T-Lymphocytes Cytotoxic TLym Cytx Cen Mem SH/TLym Cytx TLym Cytx Cen Mem SH/TLymC A relative measurement (ratio or percentage) of the skin-homing cytotoxic central memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Central Memory T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Central Memory Skin-Homing/T-Lymphocytes Cytotoxic Central Memory TLym Cytx Cen Mem SH/TLym Cytx Cen Mem TLym Cytx Cen Mem SH/TLymCCM A relative measurement (ratio or percentage) of the skin-homing cytotoxic central memory T-lymphocytes to total cytotoxic central memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Central Memory T-Lymphocyte to Cytotoxic Central Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Central Memory Sub-Population TLym Cytx Cen Mem Sub A measurement of a sub-population of cytotoxic central memory T-lymphocytes in a biological specimen. Central Memory Cytotoxic T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Central Memory Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx Cen Mem Sub/TLymC A relative measurement (ratio or percentage) of a sub-population of central memory cytotoxic T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Central Memory Cytotoxic T-Lymphocyte Sub-Population to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Central Memory Sub-Population/T-Lymphocytes Cytotoxic Central Memory TLym Cytx Cen Mem Sub/TLymCCM A relative measurement (ratio or percentage) of a sub-population of central memory cytotoxic T-lymphocytes to total central memory cytotoxic T-lymphocytes in a biological specimen. Central Memory Cytotoxic T-Lymphocyte Subpopulation to Central Memory Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Central Memory Sub-Population/T-Lymphocytes Central Memory Sub-Population TLym Cytx Cen Mem Sub/TLym Cytx Cen Mem Sub TLym Cytx Cen Mem Sub/TLymCCMS A relative measurement (ratio or percentage) of a sub-population of cytotoxic central memory T-lymphocytes to a sub-population of cytotoxic central memory T-lymphocytes in a biological specimen. Central Memory Cytotoxic T-Lymphocyte Subpopulation to Central Memory Cytotoxic T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Cytotoxic Central Memory TLym Cytx Cen Mem A measurement of the cytotoxic central memory T-lymphocytes in a biological specimen. Central Memory Cytotoxic T-Lymphocyte Count T-Lymphocytes Cytotoxic Central Memory/T-Lymphocytes Cytotoxic TLym Cytx Cen Mem/TLym Cytx A relative measurement (ratio or percentage) of the cytotoxic central memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Central Memory Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory Gut-Homing Sub-Population TLym Cytx Eff Mem GH Sub A measurement of a sub-population of gut-homing cytotoxic effector memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Effector Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx Eff Mem GH Sub/TLym Cytx TLym Cytx Eff Mem GH Sub/TLymC A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic effector memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic Effector Memory TLym Cytx Eff Mem GH Sub/TLym Cytx Eff Mem TLym Cytx Eff Mem GH Sub/TLymCEM TLym Cytx Eff Mem Gut-Homing Sub/TLymCEM A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic effector memory T-lymphocytes to total cytotoxic effector T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation to Cytotoxic Effector T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic Effector Memory Gut-Homing TLym Cytx Eff Mem GH Sub/TLym Cytx Eff Mem GH TLym Cytx Eff Mem GH Sub/TLymCEMGH A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic effector memory T-lymphocytes to total gut-homing cytotoxic effector memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation to Gut-Homing Cytotoxic Effector Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic Effector Memory Gut-Homing Sub-Population TLym Cytx Eff Mem GH Sub/TLym Cytx Eff Mem GH Sub TLym Cytx Eff Mem GH Sub/TLymCEMGHS A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic effector memory T-lymphocytes to a sub-population of gut-homing cytotoxic effector memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation to Gut-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory Gut-Homing TLym Cytx Eff Mem GH A measurement of the gut-homing cytotoxic effector memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Effector Memory T-Lymphocyte Count T-Lymphocytes Cytotoxic Effector Memory Gut-Homing/T-Lymphocytes Cytotoxic TLym Cytx Eff Mem GH/TLym Cytx TLym Cytx Eff Mem GH/TLymC A relative measurement (ratio or percentage) of the gut-homing cytotoxic effector memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Effector Memory T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory Gut-Homing/T-Lymphocytes Cytotoxic Effector Memory TLym Cytx Eff Mem GH/TLym Cytx Eff Mem TLym Cytx Eff Mem GH/TLymCEM A relative measurement (ratio or percentage) of the gut-homing cytotoxic effector memory T-lymphocytes to total cytotoxic effector memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Effector Memory T-Lymphocyte to Cytotoxic T-Lymphocyte to Cytotoxic Effector Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory Skin-Homing Sub-Population TLym Cytx Eff Mem SH Sub A measurement of a sub-population of skin-homing cytotoxic effector memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Effector Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx Eff Mem SH Sub/TLym Cytx TLym Cytx Eff Mem SH Sub/TLymC A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic effector memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic Effector Memory TLym Cytx Eff Mem SH Sub/TLym Cytx Eff Mem TLym Cytx Eff Mem SH Sub/TLymCEM TLym Cytx Eff Mem Skin-Homing Sub/TLymCEM A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic effector memory T-lymphocytes to total cytotoxic effector memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation to Cytotoxic Effector Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic Effector Memory Skin-Homing TLym Cytx Eff Mem SH Sub/TLymCEMSH TLym Cytx Eff Mem Sub/TLym Cytx Eff Mem SH A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic effector memory T-lymphocytes to total skin-homing cytotoxic effector memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation to Skin-Homing Cytotoxic Effector Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic Effector Memory Skin-Homing Sub-Population TLym Cytx Eff Mem SH Sub/TLym Cytx Eff Mem SH Sub TLym Cytx Eff Mem SH Sub/TLymCEMSHS A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic effector memory T-lymphocytes to a sub-population of skin-homing cytotoxic effector memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation to Skin-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory Skin-Homing TLym Cytx Eff Mem SH A measurement of the skin-homing cytotoxic effector memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Effector Memory T-Lymphocyte Count T-Lymphocytes Cytotoxic Effector Memory Skin-Homing/T-Lymphocytes Cytotoxic TLym Cytx Eff Mem SH/TLym Cytx TLym Cytx Eff Mem SH/TLymC A relative measurement (ratio or percentage) of the skin-homing cytotoxic effector memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Effector Memory T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory Skin-Homing/T-Lymphocytes Cytotoxic Effector Memory TLym Cytx Eff Mem SH/TLym Cytx Eff Mem TLym Cytx Eff Mem SH/TLymCEM A relative measurement (ratio or percentage) of the skin-homing cytotoxic effector memory T-lymphocytes to total cytotoxic effector memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Effector Memory T-Lymphocyte to Cytotoxic Effector Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory Sub-Population TLym Cytx Eff Mem Sub A measurement of a sub-population of cytotoxic effector memory T-lymphocytes in a biological specimen. Effector Memory Cytotoxic T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Effector Memory Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx Eff Mem Sub/TLymC A relative measurement (ratio or percentage) of a sub-population of effector memory cytotoxic T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Effector Memory Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory Sub-Population/T-Lymphocytes Cytotoxic Effector Memory TLym Cytx Eff Mem Sub/TLymCEM A relative measurement (ratio or percentage) of a sub-population of effector memory cytotoxic T-lymphocytes to total effector memory cytotoxic T-lymphocytes in a biological specimen. Effector Memory Cytotoxic T-Lymphocyte Subpopulation to Effector Memory Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory Sub-Population/T-Lymphocytes Cytotoxic Effector Memory Sub-Population TLym Cytx Eff Mem Sub/TLym Cytx Eff Mem Sub TLym Cytx Eff Mem Sub/TLymCEMS A relative measurement (ratio or percentage) of a sub-population of cytotoxic effector memory T-lymphocytes to a sub-population of cytotoxic effector memory T-lymphocytes in a biological specimen. Effector Memory Cytotoxic T-Lymphocyte Subpopulation to Effector Memory Cytotoxic T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Cytotoxic Effector Memory TLym Cytx Eff Mem A measurement of the cytotoxic effector memory T-lymphocytes in a biological specimen. Effector Memory Cytotoxic T-Lymphocyte Count T-Lymphocytes Cytotoxic Effector Memory/T-Lymphocytes Cytotoxic TLym Cytx Eff Mem/TLym Cytx A relative measurement (ratio or percentage) of the cytotoxic effector memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Effector Memory Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Effector Sub-Population TLym Cytx Eff Sub A measurement of a sub-population of cytotoxic effector T-lymphocytes in a biological specimen. Effector Cytotoxic T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Effector TLym Cytx Eff A measurement of the cytotoxic effector T-lymphocytes in a biological specimen. Effector Cytotoxic T-Lymphocyte Count CD8 TPEX Sub-Population T-Lymphocytes Cytotoxic Exhausted Precursor Sub-Population TLym Cytx Exh Pre Sub A measurement of a sub-population of cytotoxic exhausted precursor T-lymphocytes in a biological specimen. Cytotoxic Exhausted Precursor T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Exhausted Precursor Sub-Population/T-Lymphocytes Cytotoxic Exhausted Precursor TLym Cytx Exh Pre Sub/TLymCExhPre A relative measurement (ratio or percentage) of a sub-population of cytotoxic exhausted precursor T-lymphocytes to the total cytotoxic exhausted precursor T-lymphocytes in a biological specimen. Cytotoxic Exhausted Precursor T-Lymphocyte Subpopulation to Cytotoxic Exhausted Precursor T-Lymphocyte Ratio Measurement CD8 TPEX T-Lymphocytes Cytotoxic Exhausted Precursor TLym Cytx Exh Pre A measurement of the cytotoxic exhausted precursor T-lymphocytes in a biological specimen. Cytotoxic Exhausted Precursor T-Lymphocyte Count T-Lymphocytes Cytotoxic Exhausted Precursor/T-Lymphocytes Cytotoxic TLym Cytx Exh Pre/TLym Cytx A relative measurement (ratio or percentage) of cytotoxic exhausted precursor T-lymphocytes to cytotoxic T-lymphocytes in a biological specimen. Cytotoxic Exhausted Precursor T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Gamma-Delta Sub-Population T-Lymphocytes Cytotoxic TCR Gamma-Delta Sub-Population TLym Cytx GD Sub A measurement of a sub-population of cytotoxic gamma-delta T-lymphocytes in a biological specimen. Cytotoxic Gamma-Delta T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Gamma-Delta T-Lymphocytes Cytotoxic TCR Gamma-Delta TLym Cytx GD A measurement of the cytotoxic gamma-delta T-lymphocytes in a biological specimen. Cytotoxic Gamma-Delta T-Lymphocyte Count T-Lymphocytes Cytotoxic Memory Gut-Homing Sub-Population TLym Cytx Mem GH Sub A measurement of a sub-population of gut-homing cytotoxic memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx Mem GH Sub/TLym Cytx TLym Cytx Mem GH Sub/TLymC A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Memory T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic Memory TLym Cytx Mem GH Sub/TLym Cytx Mem TLym Cytx Mem GH Sub/TLymCM A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic memory T-lymphocytes to total cytotoxic memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Memory T-Lymphocyte Subpopulation to Cytotoxic Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic Memory Gut-Homing TLym Cytx Mem GH Sub/TLym Cytx Mem GH TLym Cytx Mem GH Sub/TLymCMGH A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic memory T-lymphocytes to total gut-homing cytotoxic memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Memory T-Lymphocyte Subpopulation to Gut-Homing Cytotoxic Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic Memory Gut-Homing Sub-Population TLym Cytx Mem GH Sub/TLym Cytx Mem GH Sub TLym Cytx Mem GH Sub/TLymCMGHS A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic memory T-lymphocytes to a sub-population of gut-homing cytotoxic memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Memory T-Lymphocyte Subpopulation to Gut-Homing Cytotoxic Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Cytotoxic Memory Gut-Homing TLym Cytx Mem GH A measurement of the gut-homing cytotoxic memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Memory T-Lymphocyte Count T-Lymphocytes Cytotoxic Memory Gut-Homing/T-Lymphocytes Cytotoxic TLym Cytx Mem GH/TLym Cytx TLym Cytx Mem GH/TLymC A relative measurement (ratio or percentage) of the gut-homing cytotoxic memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Memory T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Memory Gut-Homing/T-Lymphocytes Cytotoxic Memory TLym Cytx Mem GH/TLym Cytx Mem TLym Cytx Mem GH/TLymCM A relative measurement (ratio or percentage) of the gut-homing cytotoxic memory T-lymphocytes to total cytotoxic memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Memory T-Lymphocyte to Cytotoxic Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Memory Skin-Homing Sub-Population TLym Cytx Mem SH Sub A measurement of a sub-population of skin-homing cytotoxic memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx Mem SH Sub/TLym Cytx TLym Cytx Mem SH Sub/TLymC A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Memory T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic Memory TLym Cytx Mem SH Sub/TLym Cytx Mem TLym Cytx Mem SH Sub/TLymCM A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic memory T-lymphocytes to total cytotoxic memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Memory T-Lymphocyte Subpopulation to Cytotoxic Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic Memory Skin-Homing TLym Cytx Mem SH Sub/TLym Cytx Mem SH TLym Cytx Mem SH Sub/TLymCMSH A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic memory T-lymphocytes to total skin-homing cytotoxic memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Memory T-Lymphocyte Subpopulation to Skin-Homing Cytotoxic Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic Memory Skin-Homing Sub-Population TLym Cytx Mem SH Sub/TLym Cytx Mem SH Sub TLym Cytx Mem SH Sub/TLymCMSHS A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic memory T-lymphocytes to a sub-population of skin-homing cytotoxic memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Memory T-Lymphocyte Subpopulation to Skin-Homing Cytotoxic Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Cytotoxic Memory Skin-Homing TLym Cytx Mem SH A measurement of the skin-homing cytotoxic memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Memory T-Lymphocyte Count T-Lymphocytes Cytotoxic Memory Skin-Homing/T-Lymphocytes Cytotoxic TLym Cytx Mem SH/TLym Cytx TLym Cytx Mem SH/TLymC A relative measurement (ratio or percentage) of the skin-homing cytotoxic memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Memory T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Membrane Skin-Homing/T-Lymphocytes Cytotoxic Memory TLym Cytx Mem SH/TLym Cytx Mem TLym Cytx Mem SH/TLymCM A relative measurement (ratio or percentage) of the skin-homing cytotoxic memory T-lymphocytes to total cytotoxic memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Memory T-Lymphocyte to Cytotoxic Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Memory Sub-Population TLym Cytx Mem Sub A measurement of a sub-population of memory cytotoxic T-lymphocytes in a biological specimen. Memory Cytotoxic T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Memory Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx Mem Sub/TLymC A relative measurement (ratio or percentage) of a sub-population of memory cytotoxic T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Memory Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Memory Sub-Population/T-Lymphocytes Cytotoxic Memory TLym Cytx Mem Sub/TLymCM A relative measurement (ratio or percentage) of a sub-population of memory cytotoxic T-lymphocytes to total memory cytotoxic T-lymphocytes in a biological specimen. Memory Cytotoxic T-Lymphocyte Subpopulation to Memory Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Memory TLym Cytx Mem A measurement of memory cytotoxic T-lymphocytes in a biological specimen. Memory Cytotoxic T-Lymphocyte Count T-Lymphocytes Cytotoxic Memory/T-Lymphocytes Cytotoxic TLym Cytx Mem/TLym Cytx A relative measurement (ratio or percentage) of memory cytotoxic T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Memory Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Naive Sub-Population TLym Cytx Naive Sub A measurement of a sub-population of cytotoxic naive T-lymphocytes in a biological specimen. Naive Cytotoxic T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Naive Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx Naive Sub/TLymC A relative measurement (ratio or percentage) of a sub-population of naive cytotoxic T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Naive Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Naive Sub-Population/T-Lymphocytes Cytotoxic Naive TLym Cytx Naive Sub/TLymCN A relative measurement (ratio or percentage) of a sub-population of naive cytotoxic T-lymphocytes to total naive cytotoxic T-lymphocytes in a biological specimen. Naive Cytotoxic T-Lymphocyte Subpopulation to Naive Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Naive Sub-Population/T-Lymphocytes Cytotoxic Naive Sub-Population TLym Cytx Naive Sub/TLym Cytx Naive Sub TLym Cytx Naive Sub/TLymCNS A relative measurement (ratio or percentage) of a sub-population of cytotoxic naive T-lymphocytes to a sub-population of cytotoxic naive T-lymphocytes in a biological specimen. Naive Cytotoxic T-Lymphocyte Subpopulation to Naive Cytotoxic T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Cytotoxic Naive TLym Cytx Naive A measurement of the cytotoxic naive T-lymphocytes in a biological specimen. Naive Cytotoxic T-Lymphocyte Count T-Lymphocytes Cytotoxic Naive/T-Lymphocytes Cytotoxic TLym Cytx Naive/TLym Cytx A relative measurement (ratio or percentage) of the cytotoxic naive T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Naive Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Regulatory Sub-Population TLym Cytx Reg Sub A measurement of a sub-population of cytotoxic regulatory T-lymphocytes in a biological specimen. Regulatory Cytotoxic T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Regulatory Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx Reg Sub/TLym Cytx A relative measurement (ratio or percentage) of a sub-population of cytotoxic regulatory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Regulatory Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Regulatory Sub-Population/T-Lymphocytes Cytotoxic Regulatory TLym Cytx Reg Sub/TLymCR A relative measurement (ratio or percentage) of a sub-population of cytotoxic regulatory T-lymphocytes to total cytotoxic regulatory T-lymphocytes in a biological specimen. Regulatory Cytotoxic T-Lymphocyte Subpopulation to Regulatory Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Regulatory TLym Cytx Reg A measurement of the cytotoxic regulatory T-lymphocytes in a biological specimen. Regulatory Cytotoxic T-Lymphocyte Count T-Lymphocytes Cytotoxic Regulatory/T-Lymphocytes Cytotoxic TLym Cytx Reg/TLym Cytx A relative measurement (ratio or percentage) of the cytotoxic regulatory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Regulatory Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic SC Memory Sub-Population TLym Cytx SC Mem Sub A measurement of a sub-population of cytotoxic stem cell memory T-lymphocytes in a biological specimen. Stem Cell Memory Cytotoxic T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Stem Cell Memory Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx SC Mem Sub/TLym Cytx A relative measurement (ratio or percentage) of a sub-population of cytotoxic stem cell memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Stem Cell Memory Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Stem Cell Memory Sub-Population/T-Lymphocytes Cytotoxic Stem Cell Memory TLym Cytx SC Mem Sub/TLymCSCM A relative measurement (ratio or percentage) of a sub-population of cytotoxic stem cell memory T-lymphocytes to total cytotoxic stem cell memory T-lymphocytes in a biological specimen. Stem Cell Memory Cytotoxic T-Lymphocyte Subpopulation to Stem Cell Memory Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Stem Cell Memory Sub-Population/T-Lymphocytes Cytotoxic Stem Cell Memory Sub-Population TLym Cytx SC Mem Sub/TLym Cytx SC Mem Sub TLym Cytx SC Mem Sub/TLymCSCMS A relative measurement (ratio or percentage) of a sub-population of cytotoxic stem cell memory T-lymphocytes to a sub-population of cytotoxic stem cell memory T-lymphocytes in a biological specimen. Stem Cell Memory Cytotoxic T-Lymphocyte Subpopulation to Stem Cell Memory Cytotoxic T-Lymphocyte Subpopulation Ratio Measurement Cytotoxic Stem Cell Memory T-Lymphocytes T-Lymphocytes Cytotoxic Stem Cell Memory TLym Cytx SC Mem TLymCSCM A measurement of the cytotoxic stem cell memory T-lymphocytes in a biological specimen. Stem Cell Memory Cytotoxic T-Lymphocyte Count T-Lymphocytes Cytotoxic Stem Cell Memory/T-Lymphocytes Cytotoxic TLym Cytx SC Mem/TLym Cytx A relative measurement (ratio or percentage) of the cytotoxic stem cell memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Stem Cell Memory Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Stem Cell Memory/T-Lymphocytes Cytotoxic Naive TLym Cytx SC Mem/TLymCN A relative measurement (ratio or percentage) of the cytotoxic stem cell memory T-lymphocytes to cytotoxic naive T-lymphocytes in a biological specimen. Stem Cell Memory Cytotoxic T-Lymphocyte to Naive Cytotoxic T-Lymphocyte Ratio Measurement Cytotoxic T-Lymphocytes Sub-Population TLym Cytx Sub A measurement of the sub-population of cytotoxic T-lymphocytes in a biological specimen. Cytotoxic T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Sub-Population/T-Lymphocytes Cytotoxic Sub-Population TLym Cytx Sub/TLym Cytx Sub A relative measurement (ratio or percentage) of a sub-population of cytotoxic T-lymphocytes to a sub-population of cytotoxic T-lymphocytes in a biological specimen. Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Subpopulation Ratio Measurement Cytotoxic T-Lymphocytes Sub-Population/Cytotoxic T-Lymphocytes TLym Cytx Sub/TLym Cytx A relative measurement (ratio or percentage) of a sub-population of cytotoxic T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Cytotoxic T-Lymphocyte Subpopulation to Total Cytotoxic T-Lymphocytes Ratio Measurement T-Lymphocytes Cytotoxic Sub-Population/T-Lymphocytes Sub-Population TLym Cytx Sub/TLym Sub A relative measurement (ratio or percentage) of a sub-population of cytotoxic T-lymphocytes to a sub-population of T-lymphocytes in a biological specimen. Cytotoxic T-Lymphocyte Subpopulation to T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Cytotoxic Sub-Population/T-Lymphocytes TLym Cytx Sub/TLym A relative measurement (ratio or percentage) of a sub-population of cytotoxic T-lymphocytes to total T-lymphocytes in a biological specimen. Cytotoxic T-Lymphocyte Subpopulation to T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Terminally Differentiated Exhausted Sub-Population TLym Cytx Term Diff Exh Sub A measurement of a sub-population of cytotoxic terminally differentiated exhausted T-lymphocytes in a biological specimen. Cytotoxic Terminally Differentiated Exhausted T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Terminally Differentiated Exhausted Sub-Population/T-Lymphocytes Cytotoxic Terminally Differentiated Exhausted TLym Cytx Term Diff Exh Sub/TLymCTDExh A relative measurement (ratio or percentage) of a sub-population of cytotoxic terminally differentiated exhausted T-lymphocytes to the total cytotoxic terminally differentiated exhausted T-lymphocytes in a biological specimen. Cytotoxic Terminally Differentiated Exhausted T-Lymphocyte Subpopulation to Cytotoxic Terminally Differentiated Exhausted T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Terminally Differentiated Exhausted TLym Cytx Term Diff Exh A measurement of the cytotoxic terminally differentiated exhausted T-lymphocytes in a biological specimen. Cytotoxic Terminally Differentiated Exhausted T-Lymphocyte Count T-Lymphocytes Cytotoxic Terminally Differentiated Exhausted/T-Lymphocytes Cytotoxic TLym Cytx Term Diff Exh/TLym Cytx A relative measurement (ratio or percentage) of cytotoxic terminally differentiated exhausted T-lymphocytes to the total cytotoxic T-lymphocytes in a biological specimen. Cytotoxic Terminally Differentiated Exhausted T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory Gut-Homing Sub-Population TLym Cytx Term Mem GH Sub A measurement of a sub-population of gut-homing cytotoxic terminal memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Terminal Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx Term Mem GH Sub/TLym Cytx TLym Cytx Term Mem GH Sub/TLymC A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic terminal memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic Terminal Memory TLym Cytx Term Mem GH Sub/TLym Cytx Term Mem TLym Cytx Term Mem GH Sub/TLymCTM TLym Cytx Term Mem Gut-Homing Sub/TLymCTM A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic terminal memory T-lymphocytes to total cytotoxic terminal memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation to Cytotoxic Terminal Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic Terminal Memory Gut-Homing TLym Cytx Term Mem GH Sub/TLym Cytx Term Mem GH TLym Cytx Term Mem GH Sub/TLymCTMGH A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic terminal memory T-lymphocytes to total gut-homing cytotoxic terminal memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation to Gut-Homing Cytotoxic Terminal Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory Gut-Homing Sub-Population/T-Lymphocytes Cytotoxic Terminal Memory Gut-Homing Sub-Population TLym Cytx Term Mem GH Sub/TLym Cytx Term Mem GH Sub TLym Cytx Term Mem GH Sub/TLymCTMGHS A relative measurement (ratio or percentage) of a sub-population of gut-homing cytotoxic terminal memory T-lymphocytes to a sub-population of gut-homing cytotoxic terminal memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation to Gut-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory Gut-Homing TLym Cytx Term Mem GH A measurement of the gut-homing cytotoxic terminal memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Terminal Memory T-Lymphocyte Count T-Lymphocytes Cytotoxic Terminal Memory Gut-Homing/T-Lymphocytes Cytotoxic TLym Cytx Term Mem GH/TLym Cytx TLym Cytx Term Mem GH/TLymC A relative measurement (ratio or percentage) of the gut-homing cytotoxic terminal memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Terminal Memory T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory Gut-Homing/T-Lymphocytes Cytotoxic Terminal Memory TLym Cytx Term Mem GH/TLym Cytx Term Mem TLym Cytx Term Mem GH/TLymCTM A relative measurement (ratio or percentage) of the gut-homing cytotoxic terminal memory T-lymphocytes to total cytotoxic terminal memory T-lymphocytes in a biological specimen. Gut-Homing Cytotoxic Terminal Memory T-Lymphocyte to Cytotoxic Terminal Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory Skin-Homing Sub-Population TLym Cytx Term Mem SH Sub A measurement of the gut-homing helper memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Terminal Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx Term Mem SH Sub/TLym Cytx TLym Cytx Term Mem SH Sub/TLymC A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic terminal memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic Terminal Memory TLym Cytx Term Mem SH Sub/TLym Cytx Term Mem TLym Cytx Term Mem SH Sub/TLymCTM TLym Cytx Term Mem Skin-Homing Sub/TLymCTM A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic terminal memory T-lymphocytes to total cytotoxic terminal memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation to Cytotoxic Terminal Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic Terminal Memory Skin-Homing TLym Cytx Term Mem SH Sub/TLym Cytx Term Mem SH TLym Cytx Term Mem SH Sub/TLymCTMSH A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic terminal memory T-lymphocytes to total skin-homing cytotoxic terminal memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation to Skin-Homing Cytotoxic Terminal Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory Skin-Homing Sub-Population/T-Lymphocytes Cytotoxic Terminal Memory Skin-Homing Sub-Population TLym Cytx Term Mem SH Sub/TLym Cytx Term Mem SH Sub TLym Cytx Term Mem SH Sub/TLymCTMSHS A relative measurement (ratio or percentage) of a sub-population of skin-homing cytotoxic terminal memory T-lymphocytes to a sub-population of skin-homing cytotoxic terminal memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation to Skin-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory Skin-Homing TLym Cytx Term Mem SH A measurement of the skin-homing cytotoxic terminal memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Terminal Memory T-Lymphocyte Count T-Lymphocytes Cytotoxic Terminal Memory Skin-Homing/T-Lymphocytes Cytotoxic TLym Cytx Term Mem SH/TLym Cytx TLym Cytx Term Mem SH/TLymC A relative measurement (ratio or percentage) of the skin-homing cytotoxic terminal memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Terminal Memory T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory Skin-Homing/T-Lymphocytes Cytotoxic Terminal Memory TLym Cytx Term Mem SH/TLym Cytx Term Mem TLym Cytx Term Mem SH/TLymCTM A relative measurement (ratio or percentage) of the skin-homing cytotoxic terminal memory T-lymphocytes to total cytotoxic terminal memory T-lymphocytes in a biological specimen. Skin-Homing Cytotoxic Terminal Memory T-Lymphocyte to Cytotoxic Terminal Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory Sub-Population TLym Cytx Term Mem Sub A measurement of a sub-population of cytotoxic terminal memory T-lymphocytes in a biological specimen. Terminal Memory Cytotoxic T-Lymphocyte Subpopulation Count T-Lymphocytes Cytotoxic Terminal Memory Sub-Population/T-Lymphocytes Cytotoxic TLym Cytx Term Mem Sub/TLym Cytx A relative measurement (ratio or percentage) of a sub-population of cytotoxic terminal memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Terminal Memory Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory Sub-Population/T-Lymphocytes Cytotoxic Terminal Memory TLym Cytx Term Mem Sub/TLymCTM A relative measurement (ratio or percentage) of a sub-population of terminal memory cytotoxic T-lymphocytes to the total terminal memory cytotoxic T-lymphocytes in a biological specimen. Terminal Memory Cytotoxic T-Lymphocyte Subpopulation to Terminal Memory Cytotoxic T-Lymphocyte Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory Sub-Population/T-Lymphocytes Cytotoxic Terminal Memory Sub-Population TLym Cytx Term Mem Sub/TLym Cytx Term Mem Sub TLym Cytx Term Mem Sub/TLymCTMS A relative measurement (ratio or percentage) of a sub-population of cytotoxic terminal memory T-lymphocytes to a sub-population of cytotoxic terminal memory T-lymphocytes in a biological specimen. Terminal Memory Cytotoxic T-Lymphocyte Subpopulation to Terminal Memory Cytotoxic T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Cytotoxic Terminal Memory TLym Cytx Term Mem A measurement of the cytotoxic terminal memory T-lymphocytes in a biological specimen. Terminal Memory Cytotoxic T-Lymphocyte Count T-lymphocytes Cytotoxic Terminal Memory/T-lymphocytes Cytotoxic TLym Cytx Term Mem/TLymC A relative measurement (ratio or percentage) of the terminal memory cytotoxic T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. Terminal Memory Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement Cytotoxic T Cells Cytotoxic T-Lymphocytes TLym Cytx A measurement of the cytotoxic T-lymphocytes in a biological specimen. Cytotoxic T-Lymphocyte Count T Cells, Cytotoxic/Leukocytes T-Lymphocytes, Cytotoxic/Leukocytes TLym Cytx/Leuk A relative measurement (ratio or percentage) of the cytotoxic T-lymphocytes to leukocytes in a biological specimen. Cytotoxic T-Lymphocytes to Leukocytes Ratio Measurement T-Lymphocytes Cytotoxic/Lymphocytes TLym Cytx/Lym A relative measurement (ratio or percentage) of the cytotoxic T-lymphocytes to total lymphocytes in a biological specimen. Cytotoxic T-Lymphocytes to Lymphocytes Ratio Measurement Cytotoxic T Cells/T Cells Cytotoxic T-Lymphocytes/T-Lymphocytes TLym Cytx/TLym A relative measurement (ratio or percentage) of the cytotoxic T-lymphocytes to total T-lymphocytes in a biological specimen. Cytotoxic T-Lymphocytes to Total T-Lymphocytes Ratio Measurement T Cells, Cytotoxic/Total Cells T-Lym, CTX/Total Cells T-Lymphocytes, Cytotoxic/Total Cells TLym Cytx/Total Cells A relative measurement (ratio or percentage) of the cytotoxic T-lymphocytes to total cells in a biological specimen. Cytotoxic T-Lymphocytes to Total Cells Ratio Measurement T-Lymphocytes Double Negative Sub-Population TLym Dbl Neg Sub TLym DN Sub A measurement of a sub-population of double-negative T-lymphocytes (T-lymphocyte that are both CD4-CD8-) in a biological specimen. Double-Negative T-Lymphocyte Subpopulation Count T-Lymphocytes Double Negative Sub-Population/T-Lymphocytes Double Negative TLym Dbl Neg Sub/TLym Dbl Neg TLym DN Sub/TLym DN A relative measurement (ratio or percentage) of a sub-population of double-negative T-lymphocytes to total double-negative T-lymphocytes in a biological specimen. Double-Negative T-Lymphocyte Subpopulation to Double-Negative T-Lymphocyte Ratio Measurement T-Lymphocytes Double Negative TLym Dbl Neg TLym DN A measurement of the double-negative T-lymphocytes (T-lymphocyte that are both CD4-CD8-) in a biological specimen. Double-Negative T-Lymphocyte Count T-Lymphocytes Double Negative/Lymphocytes TLym Dbl Neg/Lym TLym DN/Lym A relative measurement (ratio or percentage) of double-negative T-lymphocytes to lymphocytes in a biological specimen. Double-Negative T-Lymphocyte to Lymphocyte Ratio Measurement T-Lymphocytes Double Negative/T-Lymphocytes TLym Dbl Neg/TLym TLym DN/TLym A relative measurement (ratio or percentage) of double-negative T-lymphocytes to T-lymphocytes in a biological specimen. Double-Negative T-Lymphocyte to T-Lymphocyte Ratio Measurement T-Lymphocytes Double Positive Sub-Population TLym Dbl Pos Sub TLym DP Sub A measurement of a sub-population of double-positive T-lymphocytes (T-lymphocyte that are both CD4+CD8+) in a biological specimen. Double-Positive T-Lymphocyte Subpopulation Count T-Lymphocytes Double Positive Sub-Population/T-Lymphocytes Double Positive TLym Dbl Pos Sub/TLym Dbl Pos TLym DP Sub/TLym DP A relative measurement (ratio or percentage) of a sub-population of double-positive T-lymphocytes to total double-positive T-lymphocytes in a biological specimen. Double-Positive T-Lymphocyte Subpopulation to Double-Positive T-Lymphocyte Ratio Measurement T-Lymphocytes Double Positive TLym Dbl Pos TLym DP A measurement of the double-positive T-lymphocytes (T-lymphocyte that are both CD4+CD8+) in a biological specimen. Double-Positive T-Lymphocyte Count T-Lymphocytes Double Positive/Lymphocytes TLym Dbl Pos/Lym TLym DP/Lym A relative measurement (ratio or percentage) of double-positive T-lymphocytes to lymphocytes in a biological specimen. Double-Positive T-Lymphocyte to Lymphocyte Ratio Measurement T-Lymphocytes Double Positive/T-Lymphocytes TLym Dbl Pos/TLym TLym DP/TLym A relative measurement (ratio or percentage) of double-positive T-lymphocytes to T-lymphocytes in a biological specimen. Double-Positive T-Lymphocyte to T-Lymphocyte Ratio Measurement T-Lymphocytes Effector Memory Sub-Population TLym Eff Mem Sub A measurement of a sub-population of effector memory T-lymphocytes in a biological specimen. Effector Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Effector Memory TLym Eff Mem A measurement of the effector memory T-lymphocytes in a biological specimen. Effector Memory T-Lymphocyte Count T-Lymphocytes Gamma-Delta Sub-Population T-Lymphocytes TCR Gamma-Delta Sub-Population TLym GD Sub A measurement of a sub-population of gamma-delta T-lymphocytes in a biological specimen. Gamma-Delta T-Lymphocyte Subpopulation Count T-Lymphocytes Gamma-Delta Sub-Population/T-Lymphocytes Gamma-Delta TCR Gamma-Delta T-Cells Sub/TCR Gamma-Delta T-Cells TLym GD Sub/TLym GD A relative measurement (ratio or percentage) of a sub-population of gamma-delta T-lymphocytes to total gamma-delta T-lymphocytes in a biological specimen. Gamma-Delta T-Lymphocyte Subpopulation to Gamma-Delta T-Lymphocyte Ratio Measurement T-Lymphocytes Gamma-Delta T-Lymphocytes TCR Gamma-Delta TCR Gamma-Delta T-Cells TLym GD A measurement of the gamma-delta T-lymphocytes in a biological specimen. Gamma-Delta T-Lymphocyte Count T-Lymphocytes Gamma-Delta/Leukocytes TCR Gamma-Delta T-Cells/Leukocytes TLym GD/Leuk A relative measurement (ratio or percentage) of the gamma-delta T-lymphocytes to leukocytes in a biological specimen. Gamma-Delta T-Lymphocyte to Leukocyte Ratio Measurement T-Lymphocytes Gamma-Delta/Lymphocytes TCR Gamma-Delta T-Cells/Lymphocyte TLym GD/Lym A relative measurement (ratio or percentage) of the gamma-delta T-lymphocytes to total lymphocytes in a biological specimen. Gamma-Delta T-Lymphocyte to Lymphocyte Ratio Measurement T-Lymphocytes Gamma-Delta/T-Lymphocytes TCR Gamma-Delta T-Cells/T-Lymphocytes TLym GD/TLym A relative measurement (ratio or percentage) of the gamma-delta T-lymphocytes to total T-lymphocytes in a biological specimen. Gamma-Delta T-Lymphocyte to T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 1 Sub-Population Th1 Sub TLym Help 1 Sub A measurement of a sub-population of helper 1 T-lymphocytes in a biological specimen. Helper 1 T-Lymphocyte Subpopulation Count T-Lymphocytes Helper 1 Sub-Population/T-Lymphocytes Helper TLym Help 1 Sub/TLym Helper A relative measurement (ratio or percentage) of a sub-population of helper 1 T-lymphocytes to total helper T-lymphocytes in a biological specimen. Helper 1 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 1 Sub-Population/T-Lymphocytes Helper 1 TLym Help 1 Sub/TLymH1 A relative measurement (ratio or percentage) of a sub-population of helper 1 T-lymphocytes to total helper 1 T-lymphocytes in a biological specimen. Helper 1 T-Lymphocyte Subpopulation to Helper 1 T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 1 Th1 TLym Help 1 A measurement of the helper 1 T-lymphocytes in a biological specimen. Helper 1 T-Lymphocyte Count T-Lymphocytes Helper 1/T-Lymphocytes Helper TLym Help 1/TLym Help A relative measurement (ratio or percentage) of the helper 1 T-lymphocytes to total helper T-lymphocytes in a biological specimen. Helper 1 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 17 Sub-Population Th17 Sub TLym Help 17 Sub A measurement of a sub-population of helper 17 T-lymphocytes in a biological specimen. Helper 17 T-Lymphocyte Subpopulation Count T-Lymphocytes Helper 17 Sub-Population/T-Lymphocytes Helper TLym Help 17 Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of helper 17 T-lymphocytes to total helper T-lymphocytes in a biological specimen. Helper 17 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 17 Sub-Population/T-Lymphocytes Helper 17 TLym Help 17 Sub/TLymH17 A relative measurement (ratio or percentage) of a sub-population of helper 17 T-lymphocytes to total helper 17 T-lymphocytes in a biological specimen. Helper 17 T-Lymphocyte Subpopulation to Helper 17 T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 17 Th17 TLym Help 17 A measurement of the helper 17 T-lymphocytes in a biological specimen. Helper 17 T-Lymphocyte Count T-Lymphocytes Helper 17.1 Sub-Population Th17.1 Sub TLym Help 17.1 Sub A measurement of a sub-population of helper 17.1 T-lymphocytes in a biological specimen. Helper 17.1 T-Lymphocyte Subpopulation Count T-Lymphocytes Helper 17.1 Sub-Population/T-Lymphocytes Helper TLym Help 17.1 Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of helper 17.1 T-lymphocytes to total helper T-lymphocytes in a biological specimen. Helper 17.1 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 17.1 Sub-Population/T-Lymphocytes Helper 17.1 TLym Help 17.1 Sub/TLymH17.1 A relative measurement (ratio or percentage) of a sub-population of helper 17.1 T-lymphocytes to total helper 17.1 T-lymphocytes in a biological specimen. Helper 17.1 T-Lymphocyte Subpopulation to Helper 17.1 T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 17.1 Th17.1 TLym Help 17.1 A measurement of the helper 17.1 T-lymphocytes in a biological specimen. Helper 17.1 T-Lymphocyte Count T-Lymphocytes Helper 17.1/T-Lymphocytes Helper TLym Help 17.1/TLym Help A relative measurement (ratio or percentage) of the helper 17.1 T-lymphocytes to total helper T-lymphocytes in a biological specimen. Helper 17.1 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 17/T-Lymphocytes Helper TLym Help 17/TLym Help A relative measurement (ratio or percentage) of the helper 17 T-lymphocytes to total helper T-lymphocytes in a biological specimen. Helper 17 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 2 Sub-Population Th2 Sub TLym Help 2 Sub A measurement of a sub-population of helper 2 T-lymphocytes in a biological specimen. Helper 2 T-Lymphocyte Subpopulation Count T-Lymphocytes Helper 2 Sub-Population/T-Lymphocytes Helper TLym Help 2 Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of helper 2 T-lymphocytes to total helper T-lymphocytes in a biological specimen. Helper 2 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 2 Sub-Population/T-Lymphocytes Helper 2 TLym Help 2 Sub/TLymH2 A relative measurement (ratio or percentage) of a sub-population of helper 2 T-lymphocytes to total helper 2 T-lymphocytes in a biological specimen. Helper 2 T-Lymphocyte Subpopulation to Helper 2 T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 2 Th2 TLym Help 2 A measurement of the helper 2 T-lymphocytes in a biological specimen. Helper 2 T-Lymphocyte Count T-Lymphocytes Helper 2/T-Lymphocytes Helper TLym Help 2/TLym Help A relative measurement (ratio or percentage) of the helper 2 T-lymphocytes to total helper T-lymphocytes in a biological specimen. Helper 2 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 22 Sub-Population Th22 Sub TLym Help 22 Sub A measurement of a sub-population of helper 22 T-lymphocytes in a biological specimen. Helper 22 T-Lymphocyte Subpopulation Count T-Lymphocytes Helper 22 Sub-Population/T-Lymphocytes Helper TLym Help 22 Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of helper 22 T-lymphocytes to total helper T-lymphocytes in a biological specimen. Helper 22 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 22 Sub-Population/T-Lymphocytes Helper 22 TLym Help 22 Sub/TLymH22 A relative measurement (ratio or percentage) of a sub-population of helper 22 T-lymphocytes to total helper 22 T-lymphocytes in a biological specimen. Helper 22 T-Lymphocyte Subpopulation to Helper 22 T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 22 Th22 TLym Help 22 A measurement of the helper 22 T-lymphocytes in a biological specimen. Helper 22 T-Lymphocyte Count T-Lymphocytes Helper 22/T-Lymphocytes Helper TLym Help 22/TLym Help A relative measurement (ratio or percentage) of the helper 22 T-lymphocytes to total helper T-lymphocytes in a biological specimen. Helper 22 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 9 Sub-Population Th9 Sub TLym Help 9 Sub A measurement of a sub-population of helper 22 T-lymphocytes in a biological specimen. Helper 9 T-Lymphocyte Subpopulation Count T-Lymphocytes Helper 9 Sub-Population/T-Lymphocytes Helper TLym Help 9 Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of helper 9 T-lymphocytes to total helper T-lymphocytes in a biological specimen. Helper 9 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 9 Sub-Population/T-Lymphocytes Helper 9 TLym Help 9 Sub/TLymH9 A relative measurement (ratio or percentage) of a sub-population of helper 9 T-lymphocytes to total helper 9 T-lymphocytes in a biological specimen. Helper 9 T-Lymphocyte Subpopulation to Helper 9 T-Lymphocyte Ratio Measurement T-Lymphocytes Helper 9 Th9 TLym Help 9 A measurement of the helper 9 T-lymphocytes in a biological specimen. Helper 9 T-Lymphocyte Count T-Lymphocytes Helper 9/T-Lymphocytes Helper TLym Help 9/TLym Help A relative measurement (ratio or percentage) of the helper 9 T-lymphocytes to total helper T-lymphocytes in a biological specimen. Helper 9 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Alpha-Beta Sub-Population T-Lymphocytes Helper TCR Alpha-Beta Sub-Population TLym Help AB Sub A measurement of a sub-population of helper alpha-beta T-lymphocytes in a biological specimen. Alpha-Beta Helper T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Alpha-Beta T-Lymphocytes Helper TCR Alpha-Beta TLym Help AB A measurement of the helper alpha-beta T-lymphocytes in a biological specimen. Alpha-Beta Helper T-Lymphocyte Count T-Lymphocytes Help Central Memory Gut-Homing Sub-Population TLym Help Cen Mem GH Sub A measurement of a sub-population of gut-homing helper central memory T-lymphocytes in a biological specimen. Gut-Homing Helper Central Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Central Memory Gut-Homing Sub-Population/T-Lymphocytes Helper TLym Help Cen Mem GH Sub/TLym Help TLym Help Cen Mem GH Sub/TLymH A relative measurement (ratio or percentage) of a sub-population of gut-homing helper central memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Gut-Homing Helper Central Memory T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Central Memory Gut-Homing Sub-Population/T-Lymphocytes Helper Central Memory TLym Help Cen Mem GH Sub/TLym Help Cen Mem TLym Help Cen Mem GH Sub/TLymHCM TLym Help Cen Mem Gut-Homing Sub/TLymHCM A relative measurement (ratio or percentage) of a sub-population of gut-homing helper central memory T-lymphocytes to total helper central memory T-lymphocytes in a biological specimen. Gut-Homing Helper Central Memory T-Lymphocyte Subpopulation to Helper Central Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Central Memory Gut-Homing Sub-Population/T-Lymphocytes Helper Central Memory Gut-Homing TLym Help Cen Mem GH Sub/TLym Help Cen Mem GH TLym Help Cen Mem GH Sub/TLymHCMGH A relative measurement (ratio or percentage) of a sub-population of gut-homing helper central memory T-lymphocytes to total gut-homing helper central memory T-lymphocytes in a biological specimen. Gut-Homing Helper Central Memory T-Lymphocyte Subpopulation to Gut-Homing Helper Central Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Central Memory Gut-Homing Sub-Population/T-Lymphocytes Helper Central Memory Gut-Homing Sub-Population TLym Help Cen Mem GH Sub/TLym Help Cen Mem GH Sub TLym Help Cen Mem GH Sub/TLymHCMGHS A relative measurement (ratio or percentage) of a sub-population of gut-homing helper central memory T-lymphocytes to a sub-population of gut-homing helper central memory T-lymphocytes in a biological specimen. Gut-Homing Helper Central Memory T-Lymphocyte Subpopulation to Gut-Homing Helper Central Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Central Memory Gut-Homing TLym Help Cen Mem GH A measurement of the gut-homing helper central memory T-lymphocytes in a biological specimen. Gut-Homing Helper Central Memory T-Lymphocyte Count T-Lymphocytes Helper Central Memory Gut-Homing/T-Lymphocytes Helper TLym Help Cen Mem GH/TLym Help TLym Help Cen Mem GH/TLymH A relative measurement (ratio or percentage) of the gut-homing helper central memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Gut-Homing Helper Central Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Central Memory Gut-Homing/T-Lymphocytes Helper Central Memory TLym Help Cen Mem GH/TLym Help Cen Mem TLym Help Cen Mem GH/TLymHCM A relative measurement (ratio or percentage) of the gut-homing helper central memory T-lymphocytes to total helper central memory T-lymphocytes in a biological specimen. Gut-Homing Helper Central Memory T-Lymphocyte to Helper Central Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Central Memory Skin-Homing Sub-Population TLym Help Cen Mem SH Sub A measurement of a sub-population of skin-homing helper central memory T-lymphocytes in a biological specimen. Skin-Homing Helper Central Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Central Memory Skin-Homing Sub-Population/T-Lymphocytes Helper TLym Help Cen Mem SH Sub/TLym Help TLym Help Cen Mem SH Sub/TLymH A relative measurement (ratio or percentage) of a sub-population of skin-homing helper central memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Skin-Homing Helper Central Memory T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Central Memory Skin-Homing Sub-Population/T-Lymphocytes Helper Central Memory TLym Help Cen Mem SH Sub/TLym Help Cen Mem TLym Help Cen Mem SH Sub/TLymHCM TLym Help Cen Mem Skin-Homing Sub/TLymHCM A relative measurement (ratio or percentage) of a sub-population of skin-homing helper central memory T-lymphocytes to total helper central memory T-lymphocytes in a biological specimen. Skin-Homing Helper Central Memory T-Lymphocyte Subpopulation to Helper Central Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Central Memory Skin-Homing Sub-Population/T-Lymphocytes Helper Central Memory Skin-Homing TLym Help Cen Mem SH Sub/TLym Help Cen Mem SH TLym Help Cen Mem SH Sub/TLymHCMSH A relative measurement (ratio or percentage) of a sub-population of skin-homing helper central memory T-lymphocytes to total skin-homing helper central memory T-lymphocytes in a biological specimen. Skin-Homing Helper Central Memory T-Lymphocyte Subpopulation to Skin-Homing Helper Central Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Central Memory Skin-Homing Sub-Population/T-Lymphocytes Helper Central Memory Skin-Homing Sub-Population TLym Help Cen Mem SH Sub/TLym Help Cen Mem SH Sub TLym Help Cen Mem SH Sub/TLymHCMSHS A relative measurement (ratio or percentage) of a sub-population of skin-homing helper central memory T-lymphocytes to a sub-population of skin-homing helper central memory T-lymphocytes in a biological specimen. Skin-Homing Helper Central Memory T-Lymphocyte Subpopulation to Skin-Homing Helper Central Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Central Memory Skin-Homing TLym Help Cen Mem SH A measurement of the skin-homing helper central memory T-lymphocytes in a biological specimen. Skin-Homing Helper Central Memory T-Lymphocyte Count T-Lymphocytes Helper Central Memory Skin-Homing/T-Lymphocytes Helper TLym Help Cen Mem SH/TLym Help TLym Help Cen Mem SH/TLymH A relative measurement (ratio or percentage) of the skin-homing helper central memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Skin-Homing Helper Central Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Central Memory Skin-Homing/T-Lymphocytes Helper Central Memory TLym Help Cen Mem SH/TLym Help Cen Mem TLym Help Cen Mem SH/TLymHCM A relative measurement (ratio or percentage) of the skin-homing helper central memory T-lymphocytes to total helper central memory T-lymphocytes in a biological specimen. Skin-Homing Helper Central Memory T-Lymphocyte to Helper Central Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Central Memory Sub-Population TLym Help Cen Mem Sub A measurement of a sub-population of helper central memory T-lymphocytes in a biological specimen. Central Memory Helper T-Lymphocyte Sub-Population Count T-Lymphocytes Helper Central Memory Sub-Population/T-Lymphocytes Helper TLym Help Cen Mem Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of helper central memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Central Memory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Central Memory Sub-Population/T-Lymphocytes Helper Central Memory TLym Help Cen Mem Sub/TLymHCM A relative measurement (ratio or percentage) of a sub-population of helper central memory T-lymphocytes to total helper central memory T-lymphocytes in a biological specimen. Central Memory Helper T-Lymphocyte Subpopulation to Central Memory Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Central Memory Sub-Population/T-Lymphocytes Helper Central Memory Sub-Population TLym Help Cen Mem Sub/TLym Help Cen Mem Sub TLym Help Cen Mem Sub/TLymHCMS A relative measurement (ratio or percentage) of a sub-population of helper central memory T-lymphocytes to a sub-population of helper central memory T-lymphocytes in a biological specimen. Central Memory Helper T-Lymphocyte Subpopulation to Central Memory Helper T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Central Memory TLym Help Cen Mem A measurement of the helper central memory T-lymphocytes in a biological specimen. Central Memory Helper T-Lymphocyte Count T-Lymphocytes Helper Central Memory/T-Lymphocytes Helper TLym Help Cen Mem/TLym Help A relative measurement (ratio or percentage) of the helper central memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Central Memory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Effector Memory Gut-Homing Sub-Population TLym Help Eff Mem GH Sub A measurement of a sub-population of gut-homing helper effector memory T-lymphocytes in a biological specimen. Gut-Homing Helper Effector Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Effector Memory Gut-Homing Sub-Population/T-Lymphocytes Helper TLym Help Eff Mem GH Sub/TLym Help TLym Help Eff Mem GH Sub/TLymH A relative measurement (ratio or percentage) of a sub-population of gut-homing helper effector memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Gut-Homing Helper Effector Memory T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Effector Memory Gut-Homing Sub-Population/T-Lymphocytes Helper Effector Memory TLym Help Eff Mem GH Sub/TLym Help Eff Mem TLym Help Eff Mem GH Sub/TLymHEM TLym Help Eff Mem Gut-Homing Sub/TLymHEM A relative measurement (ratio or percentage) of a sub-population of gut-homing helper effector memory T-lymphocytes to total helper effector memory T-lymphocytes in a biological specimen. Gut-Homing Helper Effector Memory T-Lymphocyte Subpopulation to Helper Effector Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Effector Memory Gut-Homing Sub-Population/T-Lymphocytes Helper Effector Memory Gut-Homing TLym Help Eff Mem GH Sub/TLym Help Eff Mem GH TLym Help Eff Mem GH Sub/TLymHEMGH A relative measurement (ratio or percentage) of a sub-population of gut-homing helper effector memory T-lymphocytes to total gut-homing helper effector memory T-lymphocytes in a biological specimen. Gut-Homing Helper Effector Memory T-Lymphocyte Subpopulation to Gut-Homing Helper Effector Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Effector Memory Gut-Homing Sub-Population/T-Lymphocytes Helper Effector Memory Gut-Homing Sub-Population TLym Help Eff Mem GH Sub/TLym Help Eff Mem GH Sub TLym Help Eff Mem GH Sub/TLymHEMGHS A relative measurement (ratio or percentage) of a sub-population of gut-homing helper effector memory T-lymphocytes to a sub-population of gut-homing helper effector memory T-lymphocytes in a biological specimen. Gut-Homing Helper Effector Memory T-Lymphocyte Subpopulation to Gut-Homing Helper Effector Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Effector Memory Gut-Homing TLym Help Eff Mem GH A measurement of the gut-homing helper effector memory T-lymphocytes in a biological specimen. Gut-Homing Helper Effector Memory T-Lymphocyte Count T-Lymphocytes Helper Effector Memory Gut-Homing/T-Lymphocytes Helper TLym Help Eff Mem GH/TLym Help TLym Help Eff Mem GH/TLymH A relative measurement (ratio or percentage) of the gut-homing helper effector memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Gut-Homing Helper Effector Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Effector Memory Gut-Homing/T-Lymphocytes Helper Effector Memory TLym Help Eff Mem GH/TLym Help Eff Mem TLym Help Eff Mem GH/TLymHEM A relative measurement (ratio or percentage) of the gut-homing helper effector memory T-lymphocytes to total helper effector memory T-lymphocytes in a biological specimen. Gut-Homing Helper Effector Memory T-Lymphocyte to Helper Effector Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Effector Memory Skin-Homing Sub-Population TLym Help Eff Mem SH Sub A measurement of a sub-population of skin-homing helper effector memory T-lymphocytes in a biological specimen. Skin-Homing Helper Effector Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Effector Memory Skin-Homing Sub-Population/T-Lymphocytes Helper TLym Help Eff Mem SH Sub/TLym Help TLym Help Eff Mem SH Sub/TLymH A relative measurement (ratio or percentage) of a sub-population of skin-homing helper effector memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Skin-Homing Helper Effector Memory T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Effector Memory Skin-Homing Sub-Population/T-Lymphocytes Helper Effector Memory TLym Help Eff Mem SH Sub/TLym Help Eff Mem TLym Help Eff Mem SH Sub/TLymHEM TLym Help Eff Mem Skin-Homing Sub/TLymHEM A relative measurement (ratio or percentage) of a sub-population of skin-homing helper effector memory T-lymphocytes to total helper effector memory T-lymphocytes in a biological specimen. Skin-Homing Helper Effector Memory T-Lymphocyte Subpopulation to Helper Effector Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Effector Memory Skin-Homing Sub-Population/T-Lymphocytes Helper Effector Memory Skin-Homing TLym Help Eff Mem SH Sub/TLym Help Eff Mem SH TLym Help Eff Mem SH Sub/TLymHEMSH A relative measurement (ratio or percentage) of a sub-population of skin-homing helper effector memory T-lymphocytes to total skin-homing helper effector memory T-lymphocytes in a biological specimen. Skin-Homing Helper Effector Memory T-Lymphocyte Subpopulation to Skin-Homing Helper Effector Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Effector Memory Skin-Homing Sub-Population/T-Lymphocytes Helper Effector Memory Skin-Homing Sub-Population TLym Help Eff Mem SH Sub/TLym Help Eff Mem SH Sub TLym Help Eff Mem SH Sub/TLymHEMSHS A relative measurement (ratio or percentage) of a sub-population of skin-homing helper effector memory T-lymphocytes to a sub-population of skin-homing helper effector memory T-lymphocytes in a biological specimen. Skin-Homing Helper Effector Memory T-Lymphocyte Subpopulation to Skin-Homing Helper Effector Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Effector Memory Skin-Homing TLym Help Eff Mem SH A measurement of the skin-homing helper effector memory T-lymphocytes in a biological specimen. Skin-Homing Helper Effector Memory T-Lymphocyte Count T-Lymphocytes Helper Effector Memory Skin-Homing/T-Lymphocytes Helper TLym Help Eff Mem SH/TLym Help TLym Help Eff Mem SH/TLymH A relative measurement (ratio or percentage) of the skin-homing helper effector memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Skin-Homing Helper Effector Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Effector Memory Skin-Homing/T-Lymphocytes Helper Effector Memory TLym Help Eff Mem SH/TLym Help Eff Mem TLym Help Eff Mem SH/TLymHEM A relative measurement (ratio or percentage) of the skin-homing helper effector memory T-lymphocytes to total helper effector memory T-lymphocytes in a biological specimen. Skin-Homing Helper Effector Memory T-Lymphocyte to Helper Effector Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Effector Memory Sub-Population TLym Help Eff Mem Sub A measurement of a sub-population of helper effector memory T-lymphocytes in a biological specimen. Effector Memory Helper T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Effector Memory Sub-Population/T-Lymphocytes Helper TLym Help Eff Mem Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of helper effector memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Effector Memory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Effector Memory Sub-Population/T-Lymphocytes Helper Effector Memory TLym Help Eff Mem Sub/TLymHEM A relative measurement (ratio or percentage) of a sub-population of helper effector memory T-lymphocytes to total helper effector memory T-lymphocytes in a biological specimen. Effector Memory Helper T-Lymphocyte Subpopulation to Effector Memory Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Effector Memory Sub-Population/T-Lymphocytes Helper Effector Memory Sub-Population TLym Help Eff Mem Sub/TLym Help Eff Mem Sub TLym Help Eff Mem Sub/TLymHEMS A relative measurement (ratio or percentage) of a sub-population of helper effector memory T-lymphocytes to a sub-population of helper effector memory T-lymphocytes in a biological specimen. Effector Memory Helper T-Lymphocyte Subpopulation to Effector Memory Helper T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Effector Memory TLym Help Eff Mem A measurement of the helper effector memory T-lymphocytes in a biological specimen. Effector Memory Helper T-Lymphocyte Count T-Lymphocytes Helper Effector Memory/T-Lymphocytes Helper TLym Help Eff Mem/TLym Help A relative measurement (ratio or percentage) of the helper effector memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Effector Memory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Effector Sub-Population TLym Help Eff Sub A measurement of a sub-population of helper effector T-lymphocytes in a biological specimen. Effector Helper T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Effector TLym Help Eff A measurement of the helper effector T-lymphocytes in a biological specimen. Effector Helper T-Lymphocyte Count Follicular Helper T-Lymphocytes Sub-Population T-Lymphocytes Helper Follicular Sub-Population TLym Help Foll Sub A measurement of a sub-population of follicular helper T-lymphocytes in a biological specimen. Follicular Helper T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Follicular Sub-Population/T-Lymphocytes Helper Sub-Population TLym Help Foll Sub/TLym Help Sub A relative measurement (ratio or percentage) of a sub-population of helper follicular T-lymphocytes to a sub-population of helper T-lymphocytes in a biological specimen. Follicular Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Foll Sub-Population/T-Lymphocytes Helper TLym Help Foll Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of helper follicular T-lymphocytes to total helper T-lymphocytes in a biological specimen. Follicular Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Follicular Sub-Population/T-Lymphocytes Memory Sub-Population TLym Help Foll Sub/TLym Mem Sub A relative measurement (ratio or percentage) of a sub-population of helper follicular T-lymphocytes to a sub-population of memory T-lymphocytes in a biological specimen. Follicular Helper T-Lymphocyte Subpopulation to Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Foll Sub-Population/T-Lymphocytes Helper Follicular TLym Help Foll Sub/TLymHF A relative measurement (ratio or percentage) of a sub-population of helper follicular T-lymphocytes to total helper follicular T-lymphocytes in a biological specimen. Follicular Helper T-Lymphocyte Subpopulation to Follicular Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Follicular Sub-Population/T-Lymphocytes Helper Follicular Sub-Population TLym Help Foll Sub/TLym Help Foll Sub TLym Help Foll Sub/TLymHFS A relative measurement (ratio or percentage) of a sub-population of helper follicular T-lymphocytes to a sub-population of helper follicular T-lymphocytes in a biological specimen. Follicular Helper T-Lymphocyte Subpopulation to Follicular Helper T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Follicular TLym Help Foll A measurement of the helper follicular T-lymphocytes in a biological specimen. Follicular Helper T-Lymphocyte Count T-Lymphocytes Helper Foll/T-Lymphocytes Helper TLym Help Foll/TLym Help A relative measurement (ratio or percentage) of the helper follicular T-lymphocytes to total helper T-lymphocytes in a biological specimen. Follicular Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Gamma-Delta Sub-Population T-Lymphocytes Helper TCR Gamma-Delta Sub-Population TLym Help GD Sub A measurement of a sub-population of helper gamma-delta T-lymphocytes in a biological specimen. Helper Gamma-Delta T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Gamma-Delta T-Lymphocytes Helper TCR Gamma-Delta TLym Help GD A measurement of the helper gamma-delta T-lymphocytes in a biological specimen. Gamma-Delta Helper T-Lymphocyte Count T-Lymphocytes Helper Memory Gut-Homing Sub-Population TLym Help Mem GH Sub A measurement of a sub-population of gut-homing helper memory T-lymphocytes in a biological specimen. Gut-Homing Helper Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Memory Gut-Homing Sub-Population/T-Lymphocytes Helper TLym Help Mem GH Sub/TLym Help TLym Help Mem GH Sub/TLymH A relative measurement (ratio or percentage) of a sub-population of gut-homing helper memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Gut-Homing Helper Memory T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Memory Gut-Homing Sub-Population/T-Lymphocytes Helper Memory TLym Help Mem GH Sub/TLym Help Mem TLym Help Mem GH Sub/TLymHM A relative measurement (ratio or percentage) of a sub-population of gut-homing helper memory T-lymphocytes to total helper memory T-lymphocytes in a biological specimen. Gut-Homing Helper Memory T-Lymphocyte Subpopulation to Helper Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Memory Gut-Homing Sub-Population/T-Lymphocytes Helper Memory Gut-Homing TLym Help Mem GH Sub/TLym Help Mem GH TLym Help Mem GH Sub/TLymHMGH A relative measurement (ratio or percentage) of a sub-population of gut-homing helper memory T-lymphocytes to total gut-homing helper memory T-lymphocytes in a biological specimen. Gut-Homing Helper Memory T-Lymphocyte Subpopulation to Gut-Homing Helper Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Memory Gut-Homing Sub-Population/T-Lymphocytes Helper Memory Gut-Homing Sub-Population TLym Help Mem GH Sub/TLym Help Mem GH Sub TLym Help Mem GH Sub/TLymHMGHS A relative measurement (ratio or percentage) of a sub-population of gut-homing helper memory T-lymphocytes to a sub-population of gut-homing helper memory T-lymphocytes in a biological specimen. Gut-Homing Helper Memory T-Lymphocyte Subpopulation to Gut-Homing Helper Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Memory Gut-Homing TLym Help Mem GH A measurement of the gut-homing helper memory T-lymphocytes in a biological specimen. Gut-Homing Helper Memory T-Lymphocyte Count T-Lymphocytes Helper Memory Gut-Homing/T-Lymphocytes Helper TLym Help Mem GH/TLym Help TLym Help Mem GH/TLymH A relative measurement (ratio or percentage) of the gut-homing helper memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Gut-Homing Helper Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Memory Gut-Homing/T-Lymphocytes Helper Memory Gut-Homing/T-Lymphocytes Helper Memory TLym Help Mem GH/TLym Help Mem TLym Help Mem GH/TLymHM A relative measurement (ratio or percentage) of the gut-homing helper memory T-lymphocytes to total helper memory T-lymphocytes in a biological specimen. Gut-Homing Helper Memory T-Lymphocyte to Helper Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Memory Skin-Homing Sub-Population TLym Help Mem SH Sub A measurement of a sub-population of skin-homing helper memory T-lymphocytes in a biological specimen. Skin-Homing Helper Memory T-Lymphocyte Subpopulation T-Lymphocytes Helper Memory Skin-Homing Sub-Population/T-Lymphocytes Helper TLym Help Mem SH Sub/TLym Help TLym Help Mem SH Sub/TLymH A relative measurement (ratio or percentage) of a sub-population of skin-homing helper memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Skin-Homing Helper Memory T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Memory Skin-Homing Sub-Population/T-Lymphocytes Helper Memory TLym Help Mem SH Sub/TLym Help Mem TLym Help Mem SH Sub/TLymHM A relative measurement (ratio or percentage) of a sub-population of skin-homing helper memory T-lymphocytes to total helper memory T-lymphocytes in a biological specimen. Skin-Homing Helper Memory T-Lymphocyte Subpopulation to Helper Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Memory Skin-Homing Sub-Population/T-Lymphocytes Helper Memory Skin-Homing TLym Help Mem SH Sub/TLym Help Mem SH TLym Help Mem SH Sub/TLymHMSH A relative measurement (ratio or percentage) of a sub-population of skin-homing helper memory T-lymphocytes to total skin-homing helper memory T-lymphocytes in a biological specimen. Skin-Homing Helper Memory T-Lymphocyte Subpopulation to Skin-Homing Helper Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Memory Skin-Homing Sub-Population/T-Lymphocytes Helper Memory Skin-Homing Sub-Population TLym Help Mem SH Sub/TLym Help Mem SH Sub TLym Help Mem SH Sub/TLymHMSHS A relative measurement (ratio or percentage) of a sub-population of skin-homing helper memory T-lymphocytes to a sub-population of skin-homing helper memory T-lymphocytes in a biological specimen. Skin-Homing Helper Memory T-Lymphocyte Subpopulation to Skin-Homing Helper Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Memory Skin-Homing TLym Help Mem SH A measurement of the skin-homing helper memory T-lymphocytes in a biological specimen. Skin-Homing Helper Memory T-Lymphocyte Count T-Lymphocytes Helper Memory Skin-Homing/T-Lymphocytes Helper TLym Help Mem SH/TLym Help TLym Help Mem SH/TLymH A relative measurement (ratio or percentage) of the skin-homing helper memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Skin-Homing Helper Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Memory Skin-Homing/T-Lymphocytes Helper Memory TLym Help Mem SH/TLym Help Mem TLym Help Mem SH/TLymHM A relative measurement (ratio or percentage) of the skin-homing helper memory T-lymphocytes to total helper memory T-lymphocytes in a biological specimen. Skin-Homing Helper Memory T-Lymphocyte to Helper Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Memory Sub-Population TLym Help Mem Sub A measurement of a sub-population of helper memory T-lymphocytes in a biological specimen. Memory Helper T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Memory Sub-Population/T-Lymphocytes Helper TLym Help Mem Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of helper memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Memory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Memory Sub-Population/T-Lymphocytes Helper Memory TLym Help Mem Sub/TLymHM A relative measurement (ratio or percentage) of a sub-population of helper memory T-lymphocytes to total helper memory T-lymphocytes. Memory Helper T-Lymphocyte Subpopulation to Memory Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Memory TLym Help Mem A measurement of the helper memory T-lymphocytes in a biological specimen. Memory Helper T-Lymphocyte Count T-Lymphocytes Helper Memory/T-Lymphocytes Helper TLym Help Mem/TLym Help A relative measurement (ratio or percentage) of the helper memory T-lymphocytes to total helper T-Lymphocytes in a biological specimen. Memory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Naive Sub-Population TLym Help Naive Sub A measurement of a sub-population of helper naive T-lymphocytes in a biological specimen. Naive Helper T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Naive Sub-Population/T-Lymphocytes Helper TLym Help Naive Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of helper naive T-lymphocytes to total helper T-lymphocytes in a biological specimen. Naive Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Naive Sub-Population/T-Lymphocytes Helper Naive TLym Help Naive Sub/TLymHN A relative measurement (ratio or percentage) of a sub-population of helper naive T-lymphocytes to total helper naive T-lymphocytes in a biological specimen. Naive Helper T-Lymphocyte Subpopulation to Naive Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Naive Sub-Population/T-Lymphocytes Helper Naive Sub-Population TLym Help Naive Sub/TLym Help Naive Sub TLym Help Naive Sub/TLymHNS A relative measurement (ratio or percentage) of a sub-population of helper naive T-lymphocytes to a sub-population of helper naive T-lymphocytes in a biological specimen. Naive Helper T-Lymphocyte Subpopulation to Naive Helper T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Naive TLym Help Naive A measurement of the helper naive T-lymphocytes in a biological specimen. Naive Helper T-Lymphocyte Count T-Lymphocytes Helper Naive/T-Lymphocytes Helper TLym Help Naive/TLym Help A relative measurement (ratio or percentage) of the helper naive T-lymphocytes to total helper T-lymphocytes in a biological specimen. Naive Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Peripheral Sub-Population TLym Help Peripheral Sub Tph Sub A measurement of a sub-population of peripheral helper T-lymphocytes in a biological specimen. Peripheral Helper T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Peripheral Sub-Population/T-Lymphocytes Helper TLym Help Peripheral Sub/TLym Help TLym Help Peripheral Sub/TLymH Tph Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of peripheral helper T-lymphocytes to total helper T-lymphocytes in a biological specimen. Peripheral Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Peripheral Sub-Population/T-Lymphocytes Helper Memory Sub-Population TLym Help Peripheral Sub/TLym Help Mem Sub TLym Help Peripheral Sub/TLymHMS Tph Sub/TLym Help Mem Sub A relative measurement (ratio or percentage) of a sub-population of peripheral helper T-lymphocytes to a sub-population of memory helper T-lymphocytes in a biological specimen. Peripheral Helper T-Lymphocyte Subpopulation to Helper Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Peripheral Sub-Population/T-Lymphocytes Helper Peripheral TLym Help Peripheral Sub/TLym Help Peripheral TLym Help Peripheral Sub/TLymHP Tph Sub/Tph A relative measurement (ratio or percentage) of a sub-population of peripheral helper T-lymphocytes to total peripheral helper T-lymphocytes in a biological specimen. Peripheral Helper T-Lymphocyte Subpopulation to Peripheral Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Peripheral Sub-Population/T-Lymphocytes Helper Peripheral Sub-Population TLym Help Peripheral Sub/TLym Help Sub TLym Help Peripheral Sub/TLymHPS Tph Sub/Tph Sub A relative measurement (ratio or percentage) of a sub-population of peripheral helper T-lymphocytes to a sub-population of peripheral helper T-lymphocytes in a biological specimen. Peripheral Helper T-Lymphocyte Subpopulation to Peripheral Helper T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Peripheral TLym Help Peripheral Tph A measurement of the peripheral helper T-lymphocytes in a biological specimen. Peripheral Helper T-Lymphocyte Count T-Lymphocytes Helper Peripheral/T-Lymphocytes Helper TLym Help Peripheral/TLym Help TLym Help Peripheral/TLymH Tph/TLymH A relative measurement (ratio or percentage) of the peripheral helper T-lymphocytes to total helper T-lymphocytes in a biological specimen. Peripheral Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Peripheral/T-Lymphocytes Helper Sub-Population TLym Help Peripheral/TLym Help Sub TLym Help Peripheral/TLymHS Tph/TLym Help Sub A relative measurement (ratio) of helper peripheral T-lymphocytes to a sub-population of helper T-lymphocytes in a biological specimen. Helper Peripheral T-Lymphocyte to Helper T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes, Helper Regulatory Effector Sub-Population TLym Help Reg Eff Sub A measurement of a sub-population of helper regulatory effector T-lymphocytes in a biological specimen. Regulatory Effector Helper T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Regulatory Effector Sub-Population/T-Lymphocytes Helper Regulatory Effector TLym Help Reg Eff Sub/TLym Help Reg Eff TLym Help Reg Eff Sub/TLymHRE A relative measurement (ratio or percentage) of a sub-population of helper regulatory effector T-lymphocytes to total helper regulatory effector T-lymphocytes in a biological specimen. Regulatory Effector Helper T-Lymphocyte Subpopulation to Regulatory Effector Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Effector Sub-Population/T-Lymphocytes Helper Regulatory Effector Sub-Population TLym Help Reg Eff Sub/TLym Help Reg Eff Sub TLym Help Reg Eff Sub/TLymHRES A relative measurement (ratio or percentage) of a sub-population of helper regulatory effector T-lymphocytes to a sub-population of helper regulatory effector T-lymphocytes in a biological specimen. Regulatory Effector Helper T-Lymphocyte Subpopulation to Regulatory Effector Helper T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Regulatory Effector Th1-Like Sub/TLym Help Reg Eff Th1-Like TLym Help Reg Eff Th1 Sub/TLym Help Reg Eff Th1 TLym Help Reg Eff Th1 Sub/TLymHRE Th1 A relative measurement (ratio or percentage) of a sub-population of Th1-like helper regulatory effector T-lymphocytes to total Th1-like helper regulatory effector T-lymphocytes in a biological specimen. Th1-like Helper Regulatory Effector T-Lymphocyte Subpopulation to Th1-like Helper Regulatory Effector T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Effector Th1-Like/T-Lymphocytes Helper Regulatory TLym Help Reg Eff Th1/TLym Help Reg A relative measurement (ratio or percentage) of a population of Th1-like helper regulatory effector T-lymphocytes to total helper regulatory T-lymphocytes in a biological specimen. Th1-like Helper Regulatory Effector T-Lymphocyte Subpopulation to Helper Regulatory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Effector Th17-Like Sub/TLym Help Reg Eff Th17-like TLym Help Reg Eff Th17 Sub/TLym Help Reg Eff Th17 TLym Help Reg Eff Th17 Sub/TLymHRE Th17 A relative measurement (ratio or percentage) of a sub-population of Th17-like helper regulatory effector T-lymphocytes to total Th17-like helper regulatory effector T-lymphocytes in a biological specimen. Th17-like Helper Regulatory Effector T-Lymphocyte Subpopulation to Th17-like Helper Regulatory Effector T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Effector Th17-like/T-Lymphocytes Helper Regulatory TLym Help Reg Eff Th17/TLym Help Reg A relative measurement (ratio or percentage) of a population of Th17-like helper regulatory effector T-lymphocytes to total helper regulatory T-lymphocytes in a biological specimen. Th17-like Regulatory Effector Helper T-Lymphocyte to Helper Regulatory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Effector Th2-Like Sub/TLym Help Reg Eff Th2-Like TLym Help Reg Eff Th2 Sub/TLym Help Reg Eff Th2 TLym Help Reg Eff Th2 Sub/TLymHRE Th2 A relative measurement (ratio or percentage) of a sub-population of Th2-like helper regulatory effector T-lymphocytes to total Th2-like helper regulatory effector T-lymphocytes in a biological specimen. Th2-like Helper Regulatory Effector T-Lymphocyte Subpopulation to Th2-like Helper Regulatory Effector T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Effector Th17-Like/T-Lymphocytes Helper Regulatory TLym Help Reg Eff Th2/TLym Help Reg A relative measurement (ratio or percentage) of a population of Th2-like helper regulatory effector T-lymphocytes to total helper regulatory T-lymphocytes in a biological specimen. Th2-like Helper Regulatory Effector T-Lymphocyte Subpopulation to Helper Regulatory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Effector TLym Help Reg Eff A measurement of the helper regulatory effector T-lymphocytes in a biological specimen. Regulatory Effector Helper T-Lymphocyte Count T-Lymphocytes Helper Regulatory Effector/Leukocytes TLym Help Reg Eff/Leuk TLym Help Reg Eff/Leukocytes A relative measurement (ratio or percentage) of the helper regulatory effector T-lymphocytes to total leukocytes in a biological specimen. Effector Helper Regulatory T-Lymphocyte to Leukocyte Ratio Measurement T-Lymphocytes Helper Regulatory Effector/Lymphocytes TLym Help Reg Eff/Lym TLym Help Reg Eff/Lymphocytes A relative measurement (ratio or percentage) of the helper regulatory effector T-lymphocytes to total lymphocytes in a biological specimen. Effector Helper Regulatory T-Lymphocyte to Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Effector/T-Lymphocytes Helper TLym Help Reg Eff/TLym Help A relative measurement (ratio or percentage) of the helper regulatory effector T-lymphocytes to total helper T-lymphocytes in a biological specimen. Effector Helper Regulatory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Effector/T-Lymphocytes TLym Help Reg Eff/T-Lymphocytes TLym Help Reg Eff/TLym A relative measurement (ratio or percentage) of the helper regulatory effector T-lymphocytes to total T-lymphocytes in a biological specimen. Effector Helper Regulatory T-Lymphocyte to T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Effector/T-Lymphocytes Helper Regulatory TLym Help Reg Eff/TLymHR A relative measurement (ratio or percentage) of the helper regulatory effector T-lymphocytes to total helper regulatory T-lymphocytes in a biological specimen. Effector Helper Regulatory T-Lymphocyte to Regulatory Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Memory Sub-Population TLym Help Reg Mem Sub A measurement of a sub-population of helper regulatory memory T-lymphocytes in a biological specimen. Regulatory Memory Helper T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Regulatory Memory Sub-Population/T-Lymphocytes Helper Regulatory Memory TLym Help Reg Mem Sub/TLymHRM A relative measurement (ratio or percentage) of a sub-population of helper regulatory memory T-lymphocytes to total helper regulatory memory T-lymphocytes in a biological specimen. Regulatory Memory Helper T-Lymphocyte Subpopulation to Regulatory Memory Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Memory Sub-Population/T-Lymphocytes Helper Regulatory Memory Sub-Population TLym Help Reg Mem Sub/TLym Help Reg Mem Sub TLym Help Reg Mem Sub/TLymHRMS A relative measurement (ratio or percentage) of a sub-population of helper regulatory memory T-lymphocytes to a sub-population of helper regulatory memory T-lymphocytes in a biological specimen. Regulatory Memory Helper T-Lymphocyte Subpopulation to Regulatory Memory Helper T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Regulatory Memory TLym Help Reg Mem A measurement of the helper regulatory memory T-lymphocytes in a biological specimen. Regulatory Memory Helper T-Lymphocyte Count T-Lymphocytes Helper Regulatory Memory/T-Lymphocytes Helper Regulatory TLym Help Reg Mem/TLymHR A relative measurement (ratio or percentage) of the helper regulatory memory T-lymphocytes to total helper regulatory T-lymphocytes in a biological specimen. Regulatory Memory Helper T-Lymphocyte to Regulatory Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Naive Sub-Population TLym Help Reg Naive Sub A measurement of a sub-population of helper regulatory naive T-lymphocytes in a biological specimen. Naive Regulatory Helper T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Regulatory Naive Sub-Population/T-Lymphocytes Helper Regulatory TLym Help Reg Naive Sub/TLymHR A relative measurement (ratio or percentage) of a sub-population of helper regulatory naive T-lymphocytes to total helper regulatory T-lymphocytes in a biological specimen. Naive Helper Regulatory T-Lymphocyte Subpopulation to Helper Regulatory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Naive Sub-Population/T-Lymphocytes Helper Regulatory Naive TLym Help Reg Naive Sub/TLymHRN A relative measurement (ratio or percentage) of a sub-population of helper regulatory naive T-lymphocytes to total helper regulatory naive T-lymphocytes in a biological specimen. Naive Regulatory Helper T-Lymphocyte Subpopulation to Naive Regulatory Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Naive Sub-Population/T-Lymphocytes Helper Regulatory Naive Sub-Population TLym Help Reg Naive Sub/TLym Help Reg Naive Sub TLym Help Reg Naive Sub/TLymHRNS A relative measurement (ratio or percentage) of a sub-population of helper regulatory naive T-lymphocytes to a sub-population of helper regulatory naive T-lymphocytes in a biological specimen. Naive Regulatory Helper T-Lymphocyte Subpopulation to Naive Regulatory Helper T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Regulatory Naive TLym Help Reg Naive A measurement of the helper regulatory naive T-lymphocytes in a biological specimen. Naive Regulatory Helper T-Lymphocyte Count T-Lymphocytes Helper Regulatory Naive/Leukocytes TLym Help Reg Naive/Leuk A relative measurement (ratio or percentage) of the helper regulatory naive T-lymphocytes to leukocytes in a biological specimen. Naive Regulatory Helper T-Lymphocyte to Leukocyte Ratio Measurement T-Lymphocytes Helper Regulatory Naive/T-Lymphocytes Helper TLym Help Reg Naive/TLym Help A relative measurement (ratio or percentage) of the helper regulatory naive T-lymphocytes to total helper T-lymphocytes in a biological specimen. Naive Regulatory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Naive/T-Lymphocytes TLym Help Reg Naive/T-Lymphocytes TLym Help Reg Naive/TLym A relative measurement (ratio or percentage) of the helper regulatory naive T-lymphocytes to total T-lymphocytes in a biological specimen. Naive Regulatory Helper T-Lymphocyte to T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Naive/T-Lymphocytes Helper Regulatory TLym Help Reg Naive/TLymHR A relative measurement (ratio or percentage) of the helper regulatory naive T-lymphocytes to total helper regulatory T-lymphocytes in a biological specimen. Naive Regulatory Helper T-Lymphocyte to Regulatory Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Sub-Population TLym Help Reg Sub A measurement of a sub-population of helper regulatory T-lymphocytes in a biological specimen. Helper Regulatory T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Regulatory Sub-Population/T-Lymphocytes Helper TLym Help Reg Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of helper regulatory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Regulatory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Sub-Population/T-Lymphocytes Helper Regulatory TLym Help Reg Sub/TLymHR A relative measurement (ratio or percentage) of a sub-population of helper regulatory T-lymphocytes to total helper regulatory T-lymphocytes in a biological specimen. Regulatory Helper T-Lymphocyte Subpopulation to Regulatory Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory Sub-Population/T-Lymphocytes Helper Regulatory Sub-Population TLym Help Reg Sub/TLym Help Reg Sub TLym Help Reg Sub/TLymHRS A relative measurement (ratio or percentage) of a sub-population of helper regulatory T-lymphocytes to a sub-population of helper regulatory T-lymphocytes in a biological specimen. Regulatory Helper T-Lymphocyte Subpopulation to Regulatory Helper T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Regulatory TLym Help Reg A measurement of helper regulatory T-lymphocytes in a biological specimen. Helper Regulatory T-Lymphocyte Count T-Lymphocytes Helper Regulatory/Leukocytes TLym Help Reg/Leuk A relative measurement (ratio or percentage) of the helper regulatory T-lymphocytes to leukocytes in a biological specimen. Regulatory Helper T-Lymphocyte to Leukocyte Ratio Measurement T-Lymphocytes Helper Regulatory/Lymphocytes TLym Help Reg/Lym A relative measurement (ratio or percentage) of helper regulatory T-lymphocytes to total lymphocytes in a biological specimen. Helper Regulatory T-Lymphocyte to Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory/T-Lymphocytes Helper TLym Help Reg/TLym Help A relative measurement (ratio or percentage) of the helper regulatory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Regulatory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Regulatory/T-Lymphocytes TLym Help Reg/TLym A relative measurement (ratio or percentage) of the helper regulatory T-lymphocytes to total T-lymphocytes in a biological specimen. Regulatory Helper T-Lymphocyte to T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Stem Cell Memory Sub-Population TLym Help SC Mem Sub A measurement of a sub-population of helper stem cell memory T-lymphocytes in a biological specimen. Stem Cell Memory Helper T-Lymphocyte Subpopulation Count T Lymphocytes Helper Stem Cell Memory Sub-Population/T-Lymphocytes Helper TLym Help SC Mem Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of helper stem cell memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Stem Cell Memory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Stem Cell Memory Sub-Population/T-Lymphocytes Helper Stem Cell Memory TLym Help SC Mem Sub/TLymHSCM A relative measurement (ratio or percentage) of a sub-population of helper stem cell memory T-lymphocytes to total helper stem cell memory T-lymphocytes in a biological specimen. Stem Cell Memory Helper T-Lymphocyte Subpopulation to Stem Cell Memory Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Stem Cell Memory TLym Help SC Mem A measurement of the helper stem cell memory T-lymphocytes in a biological specimen. Stem Cell Memory Helper T-Lymphocyte Count T-Lymphocytes Helper Stem Cell Memory/T-Lymphocytes Helper TLym Help SC Mem/TLym Help A relative measurement (ratio or percentage) of the helper stem cell memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Stem Cell Memory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Stem Cell Memory/T-Lymphocytes Helper Naive TLym Help SC Mem/TLymHN A relative measurement (ratio or percentage) of the helper stem cell memory T-lymphocytes to total helper naive T-lymphocytes in a biological specimen. Stem Cell Memory Helper T-Lymphocyte Subpopulation to Naive Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Sub-Population TLym Help Sub A measurement of a sub-population of helper T-lymphocytes in a biological specimen. Helper T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Subpopulation/Lymphocytes TLym Help Sub/Lym A relative measurement (ratio or percentage) of the sub-population of helper T-lymphocytes to total lymphocytes in a biological specimen. Helper T-Lymphocyte Subpopulation to Total Lymphocyte Ratio Measurement T-Lymphocytes Helper Sub-Population/T-Lymphocytes Helper Sub-Population TLym Help Sub/TLym Help Sub A relative measurement (ratio or percentage) of a sub-population of helper T-Lymphocytes to a sub-population of helper T-lymphocytes in a biological specimen. Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Sub-Population/Helper T-Lymphocytes TLym Help Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of helper T-lymphocytes to total helper T-lymphocytes in a biological specimen. Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Sub-Population/T-Lymphocytes Sub-Population TLym Help Sub/TLym Sub A relative measurement (ratio or percentage) of a sub-population of helper T-Lymphocytes to a sub-population of T-lymphocytes in a biological specimen. Helper T-Lymphocyte Subpopulation to T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Terminal Memory Gut-Homing Sub-Population TLym Help Term Mem GH Sub A measurement of a sub-population of gut-homing helper terminal memory T-lymphocytes in a biological specimen. Gut-Homing Helper Terminal Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Terminal Memory Gut-Homing Sub-Population/T-Lymphocytes Helper TLym Help Term Mem GH Sub/TLym Help TLym Help Term Mem GH Sub/TLymH A relative measurement (ratio or percentage) of a sub-population of gut-homing helper terminal memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Gut-Homing Helper Terminal Memory T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Terminal Memory Gut-Homing Sub-Population/T-Lymphocytes Helper Terminal Memory TLym Help Term Mem GH Sub/TLym Help Term Mem TLym Help Term Mem GH Sub/TLymHTM A relative measurement (ratio or percentage) of a sub-population of gut-homing helper terminal memory T-lymphocytes to total helper terminal memory T-lymphocytes in a biological specimen. Gut-Homing Helper Terminal Memory T-Lymphocyte Subpopulation to Helper Terminal Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Terminal Memory Gut-Homing Sub-Population/T-Lymphocytes Helper Terminal Memory Gut-Homing TLym Help Term Mem GH Sub/TLym Help Term Mem GH TLym Help Term Mem GH Sub/TLymHTMGH A relative measurement (ratio or percentage) of a sub-population of gut-homing helper terminal memory T-lymphocytes to total gut-homing helper terminal memory T-lymphocytes in a biological specimen. Gut-Homing Helper Terminal Memory T-Lymphocyte Subpopulation to Gut-Homing Helper Terminal Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Terminal Memory Gut-Homing Sub-Population/T-Lymphocytes Helper Terminal Memory Gut-Homing Sub-Population TLym Help Term Mem GH Sub/TLym Help Term Mem GH Sub TLym Help Term Mem GH Sub/TLymHTMGHS A relative measurement (ratio or percentage) of a sub-population of gut-homing helper terminal memory T-lymphocytes to a sub-population of gut-homing helper terminal memory T-lymphocytes in a biological specimen. Gut-Homing Helper Terminal Memory T-Lymphocyte Subpopulation to Gut-Homing Helper Terminal Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Terminal Memory Gut-Homing TLym Help Term Mem GH A measurement of the gut-homing helper terminal memory T-lymphocytes in a biological specimen. Gut-Homing Helper Terminal Memory T-Lymphocyte Count T-Lymphocytes Helper Terminal Memory Gut-Homing/T-Lymphocytes Helper TLym Help Term Mem GH/TLym Help TLym Help Term Mem GH/TLymH A relative measurement (ratio or percentage) of the gut-homing helper terminal memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Gut-Homing Helper Terminal Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Terminal Memory Gut-Homing/T-Lymphocytes Helper Terminal Memory TLym Help Term Mem GH/TLym Help Term Mem TLym Help Term Mem GH/TLymHTM A relative measurement (ratio or percentage) of the gut-homing helper terminal memory T-lymphocytes to total helper terminal memory T-lymphocytes in a biological specimen. Gut-Homing Helper Terminal Memory T-Lymphocyte to Helper Terminal Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Terminal Memory Skin-Homing Sub-Population TLym Help Term Mem SH Sub A measurement of a sub-population of skin-homing helper terminal memory T-lymphocytes in a biological specimen. Skin-Homing Helper Terminal Memory T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Terminal Memory Skin-Homing Sub-Population/T-Lymphocytes Helper TLym Help Term Mem SH Sub/TLym Help TLym Help Term Mem SH Sub/TLymH A relative measurement (ratio or percentage) of a sub-population of skin-homing helper terminal memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Skin-Homing Helper Terminal Memory T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Terminal Memory Skin-Homing Sub-Population/T-Lymphocytes Helper Terminal Memory TLym Help Term Mem SH Sub/TLym Help Term Mem TLym Help Term Mem SH Sub/TLymHTM A relative measurement (ratio or percentage) of a sub-population of skin-homing helper terminal memory T-lymphocytes to total helper terminal memory T-lymphocytes in a biological specimen. Skin-Homing Helper Terminal Memory T-Lymphocyte Subpopulation to Helper Terminal Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Terminal Memory Skin-Homing Sub-Population/T-Lymphocytes Helper Terminal Memory Skin-Homing TLym Help Term Mem SH Sub/TLym Help Term Mem SH TLym Help Term Mem SH Sub/TLymHTMSH A relative measurement (ratio or percentage) of a sub-population of skin-homing helper terminal memory T-lymphocytes to total skin-homing helper terminal memory T-lymphocytes in a biological specimen. Skin-Homing Helper Terminal Memory T-Lymphocyte Subpopulation to Skin-Homing Helper Terminal Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Terminal Memory Skin-Homing Sub-Population/T-Lymphocytes Helper Terminal Memory Skin-Homing Sub-Population TLym Help Term Mem SH Sub/TLym Help Term Mem SH Sub TLym Help Term Mem SH Sub/TLymHTMSHS A relative measurement (ratio or percentage) of a sub-population of skin-homing helper terminal memory T-lymphocytes to a sub-population of skin-homing helper terminal memory T-lymphocytes in a biological specimen. Skin-Homing Helper Terminal Memory T-Lymphocyte Subpopulation to Skin-Homing Helper Terminal Memory T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Terminal Memory Skin-Homing TLym Help Term Mem SH A measurement of the skin-homing helper terminal memory T-lymphocytes in a biological specimen. Skin-Homing Helper Terminal Memory T-Lymphocyte Count T-Lymphocytes Helper Terminal Memory Skin-Homing/T-Lymphocytes Helper TLym Help Term Mem SH/TLym Help TLym Help Term Mem SH/TLymH A relative measurement (ratio or percentage) of the skin-homing helper terminal memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Skin-Homing Helper Terminal Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Terminal Memory Skin-Homing/T-Lymphocytes Helper Terminal Memory TLym Help Term Mem SH/TLym Help Term Mem TLym Help Term Mem SH/TLymHTM A relative measurement (ratio or percentage) of the skin-homing helper terminal memory T-lymphocytes to total helper terminal memory T-lymphocytes in a biological specimen. Skin-Homing Helper Terminal Memory T-Lymphocyte to Helper Terminal Memory T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Terminal Memory Sub-Population TLym Help Term Mem Sub A measurement of a sub-population of helper terminal memory T-lymphocytes in a biological specimen. Terminal Memory Helper T-Lymphocyte Subpopulation Count T-Lymphocytes Helper Terminal Memory Sub-Population/T-Lymphocytes Helper TLym Help Term Mem Sub/TLym Help A relative measurement (ratio or percentage) of a sub-population of helper terminal memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Terminal Memory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Terminal Memory Sub-Population/T-Lymphocytes Helper Terminal Memory TLym Help Term Mem Sub/TLymHTM A relative measurement (ratio or percentage) of a sub-population of helper terminal memory T-lymphocytes to total helper terminal memory T-lymphocytes in a biological specimen. Terminal Memory Helper T-Lymphocyte Subpopulation to Terminal Memory Helper T-Lymphocyte Ratio Measurement T-Lymphocytes Helper Terminal Memory Sub-Population/T-Lymphocytes Helper Terminal Memory Sub-Population TLym Help Term Mem Sub/TLym Help Term Mem Sub TLym Help Term Mem Sub/TLymHTMS A relative measurement (ratio or percentage) of a sub-population of helper terminal memory T-Lymphocytes to a sub-population of helper terminal memory T-Lymphocytes in a biological specimen. Terminal Memory Helper T-Lymphocyte Subpopulation to Terminal Memory Helper T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Helper Terminal Memory TLym Help Term Mem A measurement of the helper terminal memory T-lymphocytes in a biological specimen. Terminal Memory Helper T-Lymphocyte Count T-Lymphocytes Helper Terminal Memory/T-Lymphocytes Helper TLym Help Term Mem/TLym Help A relative measurement (ratio or percentage) of the helper terminal memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. Terminal Memory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement Helper T Cells Helper T-Lymphocytes TLym Help A measurement of the helper T-lymphocytes in a biological specimen. Helper T-Lymphocytes Count T Cells, Helper/Leukocytes T-Lymphocytes, Helper/Leukocytes TLym Help/Leuk A relative measurement (ratio or percentage) of the helper T-lymphocytes to leukocytes in a biological specimen. Helper T-Lymphocytes to Leukocytes Ratio Measurement T-Lymphocytes Helper/Lymphocytes TLym Help/Lym A relative measurement (ratio or percentage) of the helper T-lymphocytes to total lymphocytes in a biological specimen. Helper T-Lymphocyte to Lymphocyte Ratio Measurement Helper T Cells/Cytotoxic T Cells Helper T-Lymphocytes/Cytotoxic T-Lymphocytes TLym Help/TLym Cytx A relative measurement (ratio) of the helper T-lymphocytes to cytotoxic T-lymphocytes in a biological specimen. Helper T-Lymphocytes to Cytotoxic T-Lymphocytes Ratio Measurement Helper T Cells/T Cells Helper T-Lymphocytes/T-Lymphocytes TLym Help/TLym A relative measurement (ratio or percentage) of the helper T-lymphocytes to total T-lymphocytes in a biological specimen. Helper T-Lymphocytes to Total T-Lymphocytes Ratio Measurement T Cells, Helper/Total Cells T-Lym, Helper/Total Cells T-Lymphocytes, Helper/Total Cells TLym Help/Total Cells A relative measurement (ratio or percentage) of the helper T-lymphocytes to total cells in a biological specimen. Helper T-Lymphocytes to Total Cells Ratio Measurement T-Lymphocytes Naive TLym Naive A measurement of the naive T-lymphocytes in a biological specimen. Naive T-Lymphocyte Count T-Lymphocytes Regulatory TLym Reg A measurement of the regulatory T-lymphocytes in a biological specimen. Regulatory T-Lymphocyte Count T-Lymphocytes Regulatory/Lymphocytes TLym Reg/Lym A relative measurement (ratio or percentage) of the regulatory T-lymphocytes to total lymphocytes in a biological specimen. Regulatory T-Lymphocyte to Total Lymphocyte Ratio Measurement T-Lymphocytes Sub-Population TLym Sub A measurement of a sub-population of T-lymphocytes in a biological specimen. T-Lymphocyte Subpopulation Count T-Lymphocytes Sub-Population/Leukocytes TLym Sub/Leuk A relative measurement (ratio or percentage) of a sub-population of T-lymphocytes to total leukocytes in a biological specimen. T-Lymphocyte Subpopulation to Leukocyte Ratio Measurement T-Lymphocytes Sub-Population/Lymphocytes TLym Sub/Lym A relative measurement (ratio or percentage) of the sub-population of T-lymphocytes to total lymphocytes in a biological specimen. T-Lymphocyte Subpopulation to Total Lymphocyte Ratio Measurement T-Lymphocytes Sub-Population/T-Lymphocytes Sub-Population TLym Sub/TLym Sub A relative measurement (ratio or percentage) of a sub-population of T-lymphocytes to a sub-population of T-lymphocytes in a biological specimen. T-Lymphocyte Subpopulation to T-Lymphocyte Subpopulation Ratio Measurement T-Lymphocytes Sub-Population/T-Lymphocytes TLym Sub/TLym A relative measurement (ratio or percentage) of the T-lymphocyte sub-population to total T-lymphocytes in a biological specimen. T-Lymphocytes Subpopulation to Total T-Lymphocytes Ratio Measurement T-Lymphocytes Terminal Memory TEMRA TLym Term Mem A measurement of the terminal memory T-lymphocytes in a biological specimen. Terminal Memory T-Lymphocyte Count T Cells/Leukocytes T-Lymphocytes/Leukocytes TLym/Leuk A relative measurement (ratio or percentage) of the T-lymphocytes to leukocytes in a biological specimen. T-Lymphocytes to Leukocytes Ratio Measurement T Cells/Lymphocytes T-Lymphocytes/Lymphocytes TLym/Lym A relative measurement (ratio or percentage) of the T-lymphocytes to total lymphocytes in a biological specimen. T-Lymphocytes to Lymphocytes Ratio Measurement Cells Total Cells A measurement of the total nucleated cells in a biological specimen. Cell Count Nucleated Cells A measurement of the nucleated cells in a biological specimen. Nucleated Cell Count Plasma Cells/Total Cells Total Plasma Cells/Total Cells A relative measurement (ratio or percentage) of the total plasma cells to total cells in a biological specimen. Plasma Cell to Total Cell Ratio Measurement TOX1+TOX2 Expression TOX1/2 Expression A measurement of cellular TOX1 and cellular TOX2 expression in a biological specimen. TOX1 and TOX2 Expression Measurement Live Cells Viable Cells A measurement of the viable cells in a biological specimen. Viable Cell Count Cell Viability % Live Cells/Total Cells Viable Cells/Total Cells A relative measurement (ratio or percentage) of viable cells to total cells in a biological specimen. Viable Cell to Total Cell Ratio Measurement Leukocyte Viability % Live Leukocytes/Total Cells Viable Leukocytes/Total Cells A relative measurement (ratio or percentage) of viable leukocytes to total cells in a biological specimen. Viable Leukocyte to Total Cell Ratio Measurement CPTEST Cell Phenotyping Test Name CDISC SDTM Cell Phenotyping Test Name Terminology Terminology relevant to the values that describe the subset of the cell population based on a particular functional and/or biological state. Pertaining to the state of being activated, in which a characteristic function or property has been induced to occur. Activation Pertaining to the state of being apoptotic, in which programmed cell death is occurring. Apoptotic Pertaining to the state of being exhausted, in which the entity is functionally inept and incapable of exhibiting the usual array of activities. Exhaustion Pertaining to the state of non-proliferation, in which the entity is not actively multiplying or increasing in number. Non-Proliferating Pertaining to the state of being non-viable, in which the entity is not capable of life or normal growth and development. Non-Viable Pertaining to the state of proliferation, in which the entity is actively multiplying or increasing in number. Proliferation Pertaining to the state of being senescent, in which there is irreversible cell-cycle and/or functional arrest related to cell aging or disease. Senescence Pertaining to the state of being viable, in which the entity is capable of life or normal growth and development. Viable CELSTATE Cell State Response CDISC SDTM Cell State Response Terminology Child-Pugh Classification original result for CPS0101 test and test code. CPS0101-1 or 2 Child-Pugh Classification original result for CPS0101 - 1 or 2. Child-Pugh Classification CPS0101 Original Result - 1 or 2 CPS0101-3 or 4 Child-Pugh Classification original result for CPS0101 - 3 or 4. Child-Pugh Classification CPS0101 Original Result - 3 or 4 CPS0101-none Child-Pugh Classification original result for CPS0101 - None. Child-Pugh Classification CPS0101 Original Result - None CPS0101OR Child-Pugh Classification Clinical Classification ORRES for CPS0101 TN/TC CDISC Clinical Classification Child-Pugh Classification CPS0101 Original Response Terminology Child-Pugh Classification original result for CPS0102 test and test code. CPS0102-absent Child-Pugh Classification original result for CPS0102 - Absent. Child-Pugh Classification CPS0102 Original Result - Absent CPS0102-moderate Child-Pugh Classification original result for CPS0102 - Moderate. Child-Pugh Classification CPS0102 Original Result - Moderate CPS0102-slight Child-Pugh Classification original result for CPS0102 - Slight. Child-Pugh Classification CPS0102 Original Result - Slight CPS0102OR Child-Pugh Classification Clinical Classification ORRES for CPS0102 TN/TC CDISC Clinical Classification Child-Pugh Classification CPS0102 Original Response Terminology Child-Pugh Classification original result for CPS0103 test and test code. CPS0103-2 to 3 Child-Pugh Classification original result for CPS0103 - 2 to 3. Child-Pugh Classification CPS0103 Original Result - 2 to 3 CPS0103-<2 Child-Pugh Classification original result for CPS0103 - Less than 2. Child-Pugh Classification CPS0103 Original Result - <2 CPS0103->3 Child-Pugh Classification original result for CPS0103 - Greater than 3. Child-Pugh Classification CPS0103 Original Result - >3 CPS0103OR Child-Pugh Classification Clinical Classification ORRES for CPS0103 TN/TC CDISC Clinical Classification Child-Pugh Classification CPS0103 Original Response Terminology Child-Pugh Classification original result for CPS0104 test and test code. CPS0104-2.8 to 3.5 Child-Pugh Classification original result for CPS0104 - 2.8 to 3.5. Child-Pugh Classification CPS0104 Original Result - 2.8 to 3.5 CPS0104-<2.8 Child-Pugh Classification original result for CPS0104 - Less than 2.8. Child-Pugh Classification CPS0104 Original Result - <2.8 CPS0104->3.5 Child-Pugh Classification original result for CPS0104 - Greater than 3.5. Child-Pugh Classification CPS0104 Original Result - >3.5 CPS0104OR Child-Pugh Classification Clinical Classification ORRES for CPS0104 TN/TC CDISC Clinical Classification Child-Pugh Classification CPS0104 Original Response Terminology Child-Pugh Classification original result for CPS0105A test and test code. CPS0105A-4 to 6 Child-Pugh Classification original result for CPS0105A - 4 to 6. Child-Pugh Classification CPS0105A Original Result - 4 to 6 CPS0105A-<4 Child-Pugh Classification original result for CPS0105A - Less than 4. Child-Pugh Classification CPS0105A Original Result - <4 CPS0105A->6 Child-Pugh Classification original result for CPS0105A - Greater than 6. Child-Pugh Classification CPS0105A Original Result - >6 CPS0105AOR Child-Pugh Classification Clinical Classification ORRES for CPS0105A TN/TC CDISC Clinical Classification Child-Pugh Classification CPS0105A Original Response Terminology Child-Pugh Classification original result for CPS0105B test and test code. CPS0105B-1.7-2.3 Child-Pugh Classification original result for CPS0105B - 1.7-2.3. Child-Pugh Classification CPS0105B Original Result - 1.7-2.3 CPS0105B-<1.7 Child-Pugh Classification original result for CPS0105B - Less than 1.7. Child-Pugh Classification CPS0105B Original Result - <1.7 CPS0105B->2.3 Child-Pugh Classification original result for CPS0105B - Greater than 2.3. Child-Pugh Classification CPS0105B Original Result - >2.3 CPS0105BOR Child-Pugh Classification Clinical Classification ORRES for CPS0105B TN/TC CDISC Clinical Classification Child-Pugh Classification CPS0105B Original Response Terminology Child-Pugh Classification original result for CPS0107 test and test code. CPS0107-A Child-Pugh Classification original result for CPS0107 - A or mild. Child-Pugh Classification CPS0107 Original Result - A CPS0107-B Child-Pugh Classification original result for CPS0107 - B or moderate. Child-Pugh Classification CPS0107 Original Result - B CPS0107-C Child-Pugh Classification original result for CPS0107 - C or severe. Child-Pugh Classification CPS0107 Original Result - C CPS0107OR Child-Pugh Classification Clinical Classification ORRES for CPS0107 TN/TC CDISC Clinical Classification Child-Pugh Classification CPS0107 Original Response Terminology Child-Pugh Classification standardized character result for CPS0101 test and test code. CPS0101-1 Child-Pugh Classification standardized character result for CPS0101 - None. Child-Pugh Classification CPS0101 Standardized Character Result 1 CPS0101-2 Child-Pugh Classification standardized character result for CPS0101 - 1 or 2. Child-Pugh Classification CPS0101 Standardized Character Result 2 CPS0101-3 Child-Pugh Classification standardized character result for CPS0101 - 3 or 4. Child-Pugh Classification CPS0101 Standardized Character Result 3 CPS0101STR Child-Pugh Classification Clinical Classification STRESC for CPS0101 TN/TC CDISC Clinical Classification Child-Pugh Classification CPS0101 Standardized Character Response Terminology Child-Pugh Classification standardized character result for CPS0102 test and test code. CPS0102-1 Child-Pugh Classification standardized character result for CPS0102 - Absent. Child-Pugh Classification CPS0102 Standardized Character Result 1 CPS0102-2 Child-Pugh Classification standardized character result for CPS0102 - Slight. Child-Pugh Classification CPS0102 Standardized Character Result 2 CPS0102-3 Child-Pugh Classification standardized character result for CPS0102 - Moderate. Child-Pugh Classification CPS0102 Standardized Character Result 3 CPS0102STR Child-Pugh Classification Clinical Classification STRESC for CPS0102 TN/TC CDISC Clinical Classification Child-Pugh Classification CPS0102 Standardized Character Response Terminology Child-Pugh Classification standardized character result for CPS0103 test and test code. CPS0103-1 Child-Pugh Classification standardized character result for CPS0103 - Less than 2. Child-Pugh Classification CPS0103 Standardized Character Result 1 CPS0103-2 Child-Pugh Classification standardized character result for CPS0103 - 2 to 3. Child-Pugh Classification CPS0103 Standardized Character Result 2 CPS0103-3 Child-Pugh Classification standardized character result for CPS0103 - Greater than 3. Child-Pugh Classification CPS0103 Standardized Character Result 3 CPS0103STR Child-Pugh Classification Clinical Classification STRESC for CPS0103 TN/TC CDISC Clinical Classification Child-Pugh Classification CPS0103 Standardized Character Response Terminology Child-Pugh Classification standardized character result for CPS0104 test and test code. CPS0104-1 Child-Pugh Classification standardized character result for CPS0104 - Greater than 3.5. Child-Pugh Classification CPS0104 Standardized Character Result 1 CPS0104-2 Child-Pugh Classification standardized character result for CPS0104 - 2.8 to 3.5. Child-Pugh Classification CPS0104 Standardized Character Result 2 CPS0104-3 Child-Pugh Classification standardized character result for CPS0104 - Less than 2.8. Child-Pugh Classification CPS0104 Standardized Character Result 3 CPS0104STR Child-Pugh Classification Clinical Classification STRESC for CPS0104 TN/TC CDISC Clinical Classification Child-Pugh Classification CPS0104 Standardized Character Response Terminology Child-Pugh Classification standardized character result for CPS0105A test and test code. CPS0105A-1 Child-Pugh Classification standardized character result for CPS0105A - Less than 4. Child-Pugh Classification CPS0105A Standardized Character Result 1 CPS0105A-2 Child-Pugh Classification standardized character result for CPS0105A - 4 to 6. Child-Pugh Classification CPS0105A Standardized Character Result 2 CPS0105A-3 Child-Pugh Classification standardized character result for CPS0105A - Greater than 6. Child-Pugh Classification CPS0105A Standardized Character Result 3 CPS0105ASTR Child-Pugh Classification Clinical Classification STRESC for CPS0105A TN/TC CDISC Clinical Classification Child-Pugh Classification CPS0105A Standardized Character Response Terminology Child-Pugh Classification standardized character result for CPS0105B test and test code. CPS0105B-1 Child-Pugh Classification standardized character result for CPS0105B - Less than 1.7. Child-Pugh Classification CPS0105B Standardized Character Result 1 CPS0105B-2 Child-Pugh Classification standardized character result for CPS0105B - 1.7-2.3. Child-Pugh Classification CPS0105B Standardized Character Result 2 CPS0105B-3 Child-Pugh Classification standardized character result for CPS0105B - Greater than 2.3. Child-Pugh Classification CPS0105B Standardized Character Result 3 CPS0105BSTR Child-Pugh Classification Clinical Classification STRESC for CPS0105B TN/TC CDISC Clinical Classification Child-Pugh Classification CPS0105B Standardized Character Response Terminology Child-Pugh Classification standardized character result for CPS0107 test and test code. CPS0107-A Child-Pugh Classification standardized character result for CPS0107 - A or mild. Child-Pugh Classification CPS0107 Standardized Character Result 1 CPS0107-B Child-Pugh Classification standardized character result for CPS0107 - B or moderate. Child-Pugh Classification CPS0107 Standardized Character Result 2 CPS0107-C Child-Pugh Classification standardized character result for CPS0107 - C or severe. Child-Pugh Classification CPS0107 Standardized Character Result 3 CPS0107STR Child-Pugh Classification Clinical Classification STRESC for CPS0107 TN/TC CDISC Clinical Classification Child-Pugh Classification CPS0107 Standardized Character Response Terminology Child-Pugh Classification test code. CPS01-Encephalopathy Grade Child-Pugh Classification - Encephalopathy grade. Child-Pugh - Encephalopathy Grade CPS01-Ascites Child-Pugh Classification - Ascites. Child-Pugh - Ascites CPS01-Serum Bilirubin Child-Pugh Classification - Serum bilirubin, mg/dL. Child-Pugh - Serum Bilirubin CPS01-Serum Albumin Child-Pugh Classification - Serum albumin, g/dL. Child-Pugh - Serum Albumin CPS01-PT, Sec Prolonged Child-Pugh Classification - Prothrombin time, sec prolonged. Child-Pugh - PT, Sec Prolonged CPS01-PT, INR Child-Pugh Classification - Prothrombin time, international normalized ratio (INR). Child-Pugh - PT, INR CPS01-Total Score Child-Pugh Classification - Child-Pugh total score. Child-Pugh - Total Score CPS01-Grade Child-Pugh Classification - Child-Pugh grade. Child-Pugh - Grade CPS01TC Child-Pugh Classification Clinical Classification Test Code CDISC Clinical Classification Child-Pugh Test Code Terminology Child-Pugh Classification test name. CPS01-Ascites Child-Pugh Classification - Ascites. Child-Pugh - Ascites CPS01-Encephalopathy Grade Child-Pugh Classification - Encephalopathy grade. Child-Pugh - Encephalopathy Grade CPS01-Grade Child-Pugh Classification - Child-Pugh grade. Child-Pugh - Grade CPS01-PT, INR Child-Pugh Classification - Prothrombin time, international normalized ratio (INR). Child-Pugh - PT, INR CPS01-PT, Sec Prolonged Child-Pugh Classification - Prothrombin time, sec prolonged. Child-Pugh - PT, Sec Prolonged CPS01-Serum Albumin Child-Pugh Classification - Serum albumin, g/dL. Child-Pugh - Serum Albumin CPS01-Serum Bilirubin Child-Pugh Classification - Serum bilirubin, mg/dL. Child-Pugh - Serum Bilirubin CPS01-Total Score Child-Pugh Classification - Child-Pugh total score. Child-Pugh - Total Score CPS01TN Child-Pugh Classification Clinical Classification Test Name CDISC Clinical Classification Child-Pugh Test Name Terminology Children's Depression Rating Scale, Revised test code. CDRS1-Impaired Schoolwork Children's Depression Rating Scale, Revised - Impaired schoolwork. CDRS-R - Impaired Schoolwork CDRS1-Impaired Schoolwork Comment Children's Depression Rating Scale, Revised - Impaired schoolwork comment. CDRS-R - Impaired Schoolwork Comment CDRS1-Difficulty Having Fun Children's Depression Rating Scale, Revised - Difficulty having fun. CDRS-R - Difficulty Having Fun CDRS1-Difficulty Having Fun Comment Children's Depression Rating Scale, Revised - Difficulty having fun comment. CDRS-R - Difficulty Having Fun Comment CDRS1-Social Withdrawal Children's Depression Rating Scale, Revised - Social withdrawal. CDRS-R - Social Withdrawal CDRS1-Social Withdrawal Comment Children's Depression Rating Scale, Revised - Social withdrawal comment. CDRS-R - Social Withdrawal Comment CDRS1-Sleep Disturbance Children's Depression Rating Scale, Revised - Sleep disturbance. CDRS-R - Sleep Disturbance CDRS1-Sleep Disturbance Comment Children's Depression Rating Scale, Revised - Sleep disturbance comment. CDRS-R - Sleep Disturbance Comment CDRS1-Appetite Disturbance Children's Depression Rating Scale, Revised - Appetite disturbance. CDRS-R - Appetite Disturbance CDRS1-Appetite Disturbance Comment Children's Depression Rating Scale, Revised - Appetite disturbance comment. CDRS-R - Appetite Disturbance Comment CDRS1-Excessive Fatigue Children's Depression Rating Scale, Revised - Excessive fatigue. CDRS-R - Excessive Fatigue CDRS1-Excessive Fatigue Comment Children's Depression Rating Scale, Revised - Excessive fatigue comment. CDRS-R - Excessive Fatigue Comment CDRS1-Physical Complaints Children's Depression Rating Scale, Revised - Physical complaints. CDRS-R - Physical Complaints CDRS1-Physical Complaints Comment Children's Depression Rating Scale, Revised - Physical complaints comment. CDRS-R - Physical Complaints Comment CDRS1-Irritability Children's Depression Rating Scale, Revised - Irritability. CDRS-R - Irritability CDRS1-Irritability Comment Children's Depression Rating Scale, Revised - Irritability comment. CDRS-R - Irritability Comment CDRS1-Excessive Guilt Children's Depression Rating Scale, Revised - Excessive guilt. CDRS-R - Excessive Guilt CDRS1-Excessive Guilt Comment Children's Depression Rating Scale, Revised - Excessive guilt comment. CDRS-R - Excessive Guilt Comment CDRS1-Low Self-esteem Children's Depression Rating Scale, Revised - Low self-esteem. CDRS-R - Low Self-esteem CDRS1-Low Self-esteem Comment Children's Depression Rating Scale, Revised - Low self-esteem comment. CDRS-R - Low Self-esteem Comment CDRS1-Depressed Feelings Children's Depression Rating Scale, Revised - Depressed feelings. CDRS-R - Depressed Feelings CDRS1-Depressed Feelings Comment Children's Depression Rating Scale, Revised - Depressed feelings comment. CDRS-R - Depressed Feelings Comment CDRS1-Morbid Ideation Children's Depression Rating Scale, Revised - Morbid ideation. CDRS-R - Morbid Ideation CDRS1-Morbid Ideation Comment Children's Depression Rating Scale, Revised - Morbid ideation comment. CDRS-R - Morbid Ideation Comment CDRS1-Suicidal Ideation Children's Depression Rating Scale, Revised - Suicidal ideation. CDRS-R - Suicidal Ideation CDRS1-Suicidal Ideation Comment Children's Depression Rating Scale, Revised - Suicidal ideation comment. CDRS-R - Suicidal Ideation Comment CDRS1-Excessive Weeping Children's Depression Rating Scale, Revised - Excessive weeping. CDRS-R - Excessive Weeping CDRS1-Excessive Weeping Comment Children's Depression Rating Scale, Revised - Excessive weeping comment. CDRS-R - Excessive Weeping Comment CDRS1-Depressed Facial Affect Children's Depression Rating Scale, Revised - Depressed facial affect. CDRS-R - Depressed Facial Affect CDRS1-Depressed Facial Affect Comment Children's Depression Rating Scale, Revised - Depressed facial affect comment. CDRS-R - Depressed Facial Affect Comment CDRS1-Listless Speech Children's Depression Rating Scale, Revised - Listless speech. CDRS-R - Listless Speech CDRS1-Listless Speech Comment Children's Depression Rating Scale, Revised - Listless speech comment. CDRS-R - Listless Speech Comment CDRS1-Hypoactivity Children's Depression Rating Scale, Revised - Hypoactivity. CDRS-R - Hypoactivity CDRS1-Hypoactivity Comment Children's Depression Rating Scale, Revised - Hypoactivity comment. CDRS-R - Hypoactivity Comment CDRS1-Subtotal 1 Children's Depression Rating Scale, Revised - Subtotal 1 - sum of questions 1 to 6. CDRS-R - Subtotal 1 CDRS1-Subtotal 2 Children's Depression Rating Scale, Revised - Subtotal 2 - sum of questions 7 to 14. CDRS-R - Subtotal 2 CDRS1-Subtotal 3 Children's Depression Rating Scale, Revised - Subtotal 3 - sum of questions 15 to 17. CDRS-R - Subtotal 3 CDRS1-CDRS-R Raw Summary Score Children's Depression Rating Scale, Revised - CDRS-R raw summary score. CDRS-R - CDRS-R Raw Summary Score CDRS1-CDRS-R T-Score Children's Depression Rating Scale, Revised - CDRS-R T-score. CDRS-R - CDRS-R T-Score CDRS1-CDRS-R Percentile Children's Depression Rating Scale, Revised - CDRS-R Percentile. CDRS-R - CDRS-R Percentile CDRS1-CDRS-R T-Score Range Children's Depression Rating Scale, Revised - CDRS-R T-score range. CDRS-R - CDRS-R T-Score Range CDRS1TC Children's Depression Rating Scale, Revised Clinical Classification Test Code CDISC Clinical Classification CDRS-R Test Code Terminology Children's Depression Rating Scale, Revised test name. CDRS1-Appetite Disturbance Comment Children's Depression Rating Scale, Revised - Appetite disturbance comment. CDRS-R - Appetite Disturbance Comment CDRS1-Appetite Disturbance Children's Depression Rating Scale, Revised - Appetite disturbance. CDRS-R - Appetite Disturbance CDRS1-CDRS-R Percentile Children's Depression Rating Scale, Revised - CDRS-R Percentile. CDRS-R - CDRS-R Percentile CDRS1-CDRS-R Raw Summary Score Children's Depression Rating Scale, Revised - CDRS-R raw summary score. CDRS-R - CDRS-R Raw Summary Score CDRS1-CDRS-R T-Score Range Children's Depression Rating Scale, Revised - CDRS-R T-score range. CDRS-R - CDRS-R T-Score Range CDRS1-CDRS-R T-Score Children's Depression Rating Scale, Revised - CDRS-R T-score. CDRS-R - CDRS-R T-Score CDRS1-Depressed Facial Affect Comment Children's Depression Rating Scale, Revised - Depressed facial affect comment. CDRS-R - Depressed Facial Affect Comment CDRS1-Depressed Facial Affect Children's Depression Rating Scale, Revised - Depressed facial affect. CDRS-R - Depressed Facial Affect CDRS1-Depressed Feelings Comment Children's Depression Rating Scale, Revised - Depressed feelings comment. CDRS-R - Depressed Feelings Comment CDRS1-Depressed Feelings Children's Depression Rating Scale, Revised - Depressed feelings. CDRS-R - Depressed Feelings CDRS1-Difficulty Having Fun Comment Children's Depression Rating Scale, Revised - Difficulty having fun comment. CDRS-R - Difficulty Having Fun Comment CDRS1-Difficulty Having Fun Children's Depression Rating Scale, Revised - Difficulty having fun. CDRS-R - Difficulty Having Fun CDRS1-Excessive Fatigue Comment Children's Depression Rating Scale, Revised - Excessive fatigue comment. CDRS-R - Excessive Fatigue Comment CDRS1-Excessive Fatigue Children's Depression Rating Scale, Revised - Excessive fatigue. CDRS-R - Excessive Fatigue CDRS1-Excessive Guilt Comment Children's Depression Rating Scale, Revised - Excessive guilt comment. CDRS-R - Excessive Guilt Comment CDRS1-Excessive Guilt Children's Depression Rating Scale, Revised - Excessive guilt. CDRS-R - Excessive Guilt CDRS1-Excessive Weeping Comment Children's Depression Rating Scale, Revised - Excessive weeping comment. CDRS-R - Excessive Weeping Comment CDRS1-Excessive Weeping Children's Depression Rating Scale, Revised - Excessive weeping. CDRS-R - Excessive Weeping CDRS1-Hypoactivity Comment Children's Depression Rating Scale, Revised - Hypoactivity comment. CDRS-R - Hypoactivity Comment CDRS1-Hypoactivity Children's Depression Rating Scale, Revised - Hypoactivity. CDRS-R - Hypoactivity CDRS1-Impaired Schoolwork Comment Children's Depression Rating Scale, Revised - Impaired schoolwork comment. CDRS-R - Impaired Schoolwork Comment CDRS1-Impaired Schoolwork Children's Depression Rating Scale, Revised - Impaired schoolwork. CDRS-R - Impaired Schoolwork CDRS1-Irritability Comment Children's Depression Rating Scale, Revised - Irritability comment. CDRS-R - Irritability Comment CDRS1-Irritability Children's Depression Rating Scale, Revised - Irritability. CDRS-R - Irritability CDRS1-Listless Speech Comment Children's Depression Rating Scale, Revised - Listless speech comment. CDRS-R - Listless Speech Comment CDRS1-Listless Speech Children's Depression Rating Scale, Revised - Listless speech. CDRS-R - Listless Speech CDRS1-Low Self-esteem Comment Children's Depression Rating Scale, Revised - Low self-esteem comment. CDRS-R - Low Self-esteem Comment CDRS1-Low Self-esteem Children's Depression Rating Scale, Revised - Low self-esteem. CDRS-R - Low Self-esteem CDRS1-Morbid Ideation Comment Children's Depression Rating Scale, Revised - Morbid ideation comment. CDRS-R - Morbid Ideation Comment CDRS1-Morbid Ideation Children's Depression Rating Scale, Revised - Morbid ideation. CDRS-R - Morbid Ideation CDRS1-Physical Complaints Comment Children's Depression Rating Scale, Revised - Physical complaints comment. CDRS-R - Physical Complaints Comment CDRS1-Physical Complaints Children's Depression Rating Scale, Revised - Physical complaints. CDRS-R - Physical Complaints CDRS1-Sleep Disturbance Comment Children's Depression Rating Scale, Revised - Sleep disturbance comment. CDRS-R - Sleep Disturbance Comment CDRS1-Sleep Disturbance Children's Depression Rating Scale, Revised - Sleep disturbance. CDRS-R - Sleep Disturbance CDRS1-Social Withdrawal Comment Children's Depression Rating Scale, Revised - Social withdrawal comment. CDRS-R - Social Withdrawal Comment CDRS1-Social Withdrawal Children's Depression Rating Scale, Revised - Social withdrawal. CDRS-R - Social Withdrawal CDRS1-Subtotal 1 Children's Depression Rating Scale, Revised - Subtotal 1 - sum of questions 1 to 6. CDRS-R - Subtotal 1 CDRS1-Subtotal 2 Children's Depression Rating Scale, Revised - Subtotal 2 - sum of questions 7 to 14. CDRS-R - Subtotal 2 CDRS1-Subtotal 3 Children's Depression Rating Scale, Revised - Subtotal 3 - sum of questions 15 to 17. CDRS-R - Subtotal 3 CDRS1-Suicidal Ideation Comment Children's Depression Rating Scale, Revised - Suicidal ideation comment. CDRS-R - Suicidal Ideation Comment CDRS1-Suicidal Ideation Children's Depression Rating Scale, Revised - Suicidal ideation. CDRS-R - Suicidal Ideation CDRS1TN Children's Depression Rating Scale, Revised Clinical Classification Test Name CDISC Clinical Classification CDRS-R Test Name Terminology Chronic Respiratory Questionnaire Self-Administered Standardized Format First Administration Version test code. CRQ01-Feeling Emotional Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - Feeling emotional such as angry or upset. CRQ-SAS First Administration Version - Feeling Emotional CRQ01-Take Care of Basic Needs Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - Taking care of your basic needs. CRQ-SAS First Administration Version - Take Care of Basic Needs CRQ01-Walking Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - Walking. CRQ-SAS First Administration Version - Walking CRQ01-Performing Chores Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - Performing chores. CRQ-SAS First Administration Version - Performing Chores CRQ01-Participate in Social Activities Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - Participating in social activities. CRQ-SAS First Administration Version - Participate in Social Activities CRQ01-Felt Frustrated or Impatient Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - In general, how much of the time during the last 2 weeks have you felt frustrated or impatient? CRQ-SAS First Administration Version - Felt Frustrated or Impatient CRQ01-Feeling of Fear or Panic Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How often during the last 2 weeks did you have a feeling of fear or panic when you had difficulty getting your breath? CRQ-SAS First Administration Version - Feeling of Fear or Panic CRQ01-Fatigue Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How about fatigue? How tired have you felt over the last 2 weeks? CRQ-SAS First Administration Version - Fatigue CRQ01-Embarrassed by Coughing Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How often during the last 2 weeks have you felt embarrassed by your coughing or heavy breathing? CRQ-SAS First Administration Version - Embarrassed by Coughing CRQ01-Confident to Deal With Illness Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - In the last 2 weeks, how much of the time did you feel very confident and sure that you could deal with your illness? CRQ-SAS First Administration Version - Feel Confident to Deal With Illness CRQ01-Energy Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How much energy have you had in the last 2 weeks? CRQ-SAS First Administration Version - Energy CRQ01-Feel Upset, Worried or Depressed Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - In general, how much of the time did you feel upset, worried, or depressed during the last 2 weeks? CRQ-SAS First Administration Version - Feel Upset, Worried or Depressed CRQ01-Control of Breathing Problems Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How often during the last 2 weeks did you feel you had complete control of your breathing problems? CRQ-SAS First Administration Version - Had Control of Breathing Problems CRQ01-Feel Relaxed and Free of Tension Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How much of the time during the last 2 weeks did you feel relaxed and free of tension? CRQ-SAS First Administration Version - Feel Relaxed and Free of Tension CRQ01-Felt Low in Energy Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How often during the last 2 weeks have you felt low in energy? CRQ-SAS First Administration Version - Felt Low in Energy CRQ01-Felt Discouraged or Down Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - In general, how often during the last 2 weeks have you felt discouraged or down in the dumps? CRQ-SAS First Administration Version - Felt Discouraged or Down CRQ01-Felt Worn Out or Sluggish Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How often during the last 2 weeks have you felt worn out or sluggish? CRQ-SAS First Administration Version - Felt Worn Out or Sluggish CRQ01-Happy, Satisfied or Pleased Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How happy, satisfied, or pleased have you been with your personal life during the last 2 weeks? CRQ-SAS First Administration Version - Happy, Satisfied or Pleased With Life CRQ01-Feel Upset Diff Getting Breath Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How often during the last 2 weeks did you feel upset or scared when you had difficulty getting your breath? CRQ-SAS First Administration Version - Feel Upset When Had Difficulty Getting Breath CRQ01-Felt Restless, Tense or Uptight Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - In general, how often during the last 2 weeks have you felt restless, tense, or uptight? CRQ-SAS First Administration Version - Felt Restless, Tense or Uptight CRQ01TC Chronic Respiratory Questionnaire Self-Administered Standardized Format First Administration Version Questionnaire Test Code CDISC Questionnaire CRQ-SAS First Administration Version Test Code Terminology Chronic Respiratory Questionnaire Self-Administered Standardized Format First Administration Version test name. CRQ01-Confident to Deal With Illness Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - In the last 2 weeks, how much of the time did you feel very confident and sure that you could deal with your illness? CRQ-SAS First Administration Version - Feel Confident to Deal With Illness CRQ01-Control of Breathing Problems Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How often during the last 2 weeks did you feel you had complete control of your breathing problems? CRQ-SAS First Administration Version - Had Control of Breathing Problems CRQ01-Embarrassed by Coughing Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How often during the last 2 weeks have you felt embarrassed by your coughing or heavy breathing? CRQ-SAS First Administration Version - Embarrassed by Coughing CRQ01-Energy Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How much energy have you had in the last 2 weeks? CRQ-SAS First Administration Version - Energy CRQ01-Fatigue Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How about fatigue? How tired have you felt over the last 2 weeks? CRQ-SAS First Administration Version - Fatigue CRQ01-Feel Relaxed and Free of Tension Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How much of the time during the last 2 weeks did you feel relaxed and free of tension? CRQ-SAS First Administration Version - Feel Relaxed and Free of Tension CRQ01-Feel Upset Diff Getting Breath Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How often during the last 2 weeks did you feel upset or scared when you had difficulty getting your breath? CRQ-SAS First Administration Version - Feel Upset When Had Difficulty Getting Breath CRQ01-Feel Upset, Worried or Depressed Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - In general, how much of the time did you feel upset, worried, or depressed during the last 2 weeks? CRQ-SAS First Administration Version - Feel Upset, Worried or Depressed CRQ01-Feeling Emotional Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - Feeling emotional such as angry or upset. CRQ-SAS First Administration Version - Feeling Emotional CRQ01-Feeling of Fear or Panic Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How often during the last 2 weeks did you have a feeling of fear or panic when you had difficulty getting your breath? CRQ-SAS First Administration Version - Feeling of Fear or Panic CRQ01-Felt Discouraged or Down Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - In general, how often during the last 2 weeks have you felt discouraged or down in the dumps? CRQ-SAS First Administration Version - Felt Discouraged or Down CRQ01-Felt Frustrated or Impatient Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - In general, how much of the time during the last 2 weeks have you felt frustrated or impatient? CRQ-SAS First Administration Version - Felt Frustrated or Impatient CRQ01-Felt Low in Energy Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How often during the last 2 weeks have you felt low in energy? CRQ-SAS First Administration Version - Felt Low in Energy CRQ01-Felt Restless, Tense or Uptight Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - In general, how often during the last 2 weeks have you felt restless, tense, or uptight? CRQ-SAS First Administration Version - Felt Restless, Tense or Uptight CRQ01-Felt Worn Out or Sluggish Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How often during the last 2 weeks have you felt worn out or sluggish? CRQ-SAS First Administration Version - Felt Worn Out or Sluggish CRQ01-Happy, Satisfied or Pleased Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How happy, satisfied, or pleased have you been with your personal life during the last 2 weeks? CRQ-SAS First Administration Version - Happy, Satisfied or Pleased With Life CRQ01-Participate in Social Activities Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - Participating in social activities. CRQ-SAS First Administration Version - Participate in Social Activities CRQ01-Performing Chores Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - Performing chores. CRQ-SAS First Administration Version - Performing Chores CRQ01-Take Care of Basic Needs Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - Taking care of your basic needs. CRQ-SAS First Administration Version - Take Care of Basic Needs CRQ01-Walking Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - Walking. CRQ-SAS First Administration Version - Walking CRQ01TN Chronic Respiratory Questionnaire Self-Administered Standardized Format First Administration Version Questionnaire Test Name CDISC Questionnaire CRQ-SAS First Administration Version Test Name Terminology Chronic Respiratory Questionnaire Self-Administered Standardized Format Follow-Up Administration Version test code. CRQ02-Feeling Emotional Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - Feeling emotional such as angry or upset. CRQ-SAS Follow-Up Administration Version - Feeling Emotional CRQ02-Take Care of Basic Needs Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - Taking care of your basic needs. CRQ-SAS Follow-Up Administration Version - Take Care of Basic Needs CRQ02-Walking Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - Walking. CRQ-SAS Follow-Up Administration Version - Walking CRQ02-Performing Chores Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - Performing chores. CRQ-SAS Follow-Up Administration Version - Performing Chores CRQ02-Participate in Social Activities Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - Participating in social activities. CRQ-SAS Follow-Up Administration Version - Participate in Social Activities CRQ02-Felt Frustrated or Impatient Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - In general, how much of the time during the last 2 weeks have you felt frustrated or impatient? CRQ-SAS Follow-Up Administration Version - Felt Frustrated or Impatient CRQ02-Feeling of Fear or Panic Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How often during the last 2 weeks did you have a feeling of fear or panic when you had difficulty getting your breath? CRQ-SAS Follow-Up Administration Version - Feeling of Fear or Panic CRQ02-Fatigue Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How about fatigue? How tired have you felt over the last 2 weeks? CRQ-SAS Follow-Up Administration Version - Fatigue CRQ02-Embarrassed by Coughing Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How often during the last 2 weeks have you felt embarrassed by your coughing or heavy breathing? CRQ-SAS Follow-Up Administration Version - Embarrassed by Coughing CRQ02-Confident to Deal With Illness Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - In the last 2 weeks, how much of the time did you feel very confident and sure that you could deal with your illness? CRQ-SAS Follow-Up Administration Version - Feel Confident to Deal With Illness CRQ02-Energy Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How much energy have you had in the last 2 weeks? CRQ-SAS Follow-Up Administration Version - Energy CRQ02-Feel Upset, Worried or Depressed Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - In general, how much of the time did you feel upset, worried, or depressed during the last 2 weeks? CRQ-SAS Follow-Up Administration Version - Feel Upset, Worried or Depressed CRQ02-Control of Breathing Problems Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How often during the last 2 weeks did you feel you had complete control of your breathing problems? CRQ-SAS Follow-Up Administration Version - Had Control of Breathing Problems CRQ02-Feel Relaxed and Free of Tension Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How much of the time during the last 2 weeks did you feel relaxed and free of tension? CRQ-SAS Follow-Up Administration Version - Feel Relaxed and Free of Tension CRQ02-Felt Low in Energy Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How often during the last 2 weeks have you felt low in energy? CRQ-SAS Follow-Up Administration Version - Felt Low in Energy CRQ02-Felt Discouraged or Down Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - In general, how often during the last 2 weeks have you felt discouraged or down in the dumps? CRQ-SAS Follow-Up Administration Version - Felt Discouraged or Down CRQ02-Felt Worn Out or Sluggish Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How often during the last 2 weeks have you felt worn out or sluggish? CRQ-SAS Follow-Up Administration Version - Felt Worn Out or Sluggish CRQ02-Happy, Satisfied or Pleased Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How happy, satisfied, or pleased have you been with your personal life during the last 2 weeks? CRQ-SAS Follow-Up Administration Version - Happy, Satisfied or Pleased With Life CRQ02-Feel Upset Diff Getting Breath Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How often during the last 2 weeks did you feel upset or scared when you had difficulty getting your breath? CRQ-SAS Follow-Up Administration Version - Feel Upset When Had Difficulty Getting Breath CRQ02-Felt Restless, Tense or Uptight Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - In general, how often during the last 2 weeks have you felt restless, tense, or uptight? CRQ-SAS Follow-Up Administration Version - Felt Restless, Tense or Uptight CRQ02TC Chronic Respiratory Questionnaire Self-Administered Standardized Format Follow-Up Administration Version Questionnaire Test Code CDISC Questionnaire CRQ-SAS Follow-Up Administration Version Test Code Terminology Chronic Respiratory Questionnaire Self-Administered Standardized Format Follow-Up Administration Version test name. CRQ02-Confident to Deal With Illness Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - In the last 2 weeks, how much of the time did you feel very confident and sure that you could deal with your illness? CRQ-SAS Follow-Up Administration Version - Feel Confident to Deal With Illness CRQ02-Control of Breathing Problems Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How often during the last 2 weeks did you feel you had complete control of your breathing problems? CRQ-SAS Follow-Up Administration Version - Had Control of Breathing Problems CRQ02-Embarrassed by Coughing Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How often during the last 2 weeks have you felt embarrassed by your coughing or heavy breathing? CRQ-SAS Follow-Up Administration Version - Embarrassed by Coughing CRQ02-Energy Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How much energy have you had in the last 2 weeks? CRQ-SAS Follow-Up Administration Version - Energy CRQ02-Fatigue Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How about fatigue? How tired have you felt over the last 2 weeks? CRQ-SAS Follow-Up Administration Version - Fatigue CRQ02-Feel Relaxed and Free of Tension Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How much of the time during the last 2 weeks did you feel relaxed and free of tension? CRQ-SAS Follow-Up Administration Version - Feel Relaxed and Free of Tension CRQ02-Feel Upset Diff Getting Breath Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How often during the last 2 weeks did you feel upset or scared when you had difficulty getting your breath? CRQ-SAS Follow-Up Administration Version - Feel Upset When Had Difficulty Getting Breath CRQ02-Feel Upset, Worried or Depressed Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - In general, how much of the time did you feel upset, worried, or depressed during the last 2 weeks? CRQ-SAS Follow-Up Administration Version - Feel Upset, Worried or Depressed CRQ02-Feeling Emotional Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - Feeling emotional such as angry or upset. CRQ-SAS Follow-Up Administration Version - Feeling Emotional CRQ02-Feeling of Fear or Panic Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How often during the last 2 weeks did you have a feeling of fear or panic when you had difficulty getting your breath? CRQ-SAS Follow-Up Administration Version - Feeling of Fear or Panic CRQ02-Felt Discouraged or Down Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - In general, how often during the last 2 weeks have you felt discouraged or down in the dumps? CRQ-SAS Follow-Up Administration Version - Felt Discouraged or Down CRQ02-Felt Frustrated or Impatient Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - In general, how much of the time during the last 2 weeks have you felt frustrated or impatient? CRQ-SAS Follow-Up Administration Version - Felt Frustrated or Impatient CRQ02-Felt Low in Energy Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How often during the last 2 weeks have you felt low in energy? CRQ-SAS Follow-Up Administration Version - Felt Low in Energy CRQ02-Felt Restless, Tense or Uptight Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - In general, how often during the last 2 weeks have you felt restless, tense, or uptight? CRQ-SAS Follow-Up Administration Version - Felt Restless, Tense or Uptight CRQ02-Felt Worn Out or Sluggish Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How often during the last 2 weeks have you felt worn out or sluggish? CRQ-SAS Follow-Up Administration Version - Felt Worn Out or Sluggish CRQ02-Happy, Satisfied or Pleased Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How happy, satisfied, or pleased have you been with your personal life during the last 2 weeks? CRQ-SAS Follow-Up Administration Version - Happy, Satisfied or Pleased With Life CRQ02-Participate in Social Activities Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - Participating in social activities. CRQ-SAS Follow-Up Administration Version - Participate in Social Activities CRQ02-Performing Chores Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - Performing chores. CRQ-SAS Follow-Up Administration Version - Performing Chores CRQ02-Take Care of Basic Needs Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - Taking care of your basic needs. CRQ-SAS Follow-Up Administration Version - Take Care of Basic Needs CRQ02-Walking Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - Walking. CRQ-SAS Follow-Up Administration Version - Walking CRQ02TN Chronic Respiratory Questionnaire Self-Administered Standardized Format Follow-Up Administration Version Questionnaire Test Name CDISC Questionnaire CRQ-SAS Follow-Up Administration Version Test Name Terminology Clinical COPD Questionnaire 1 Week Version test code. CCQ02-Short of Breath at Rest Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how often did you feel: Short of breath while at rest? CCQ 1 Week Version - Short of Breath at Rest CCQ02-Short of Breath Physical Activity Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how often did you feel: Short of breath while doing physical activities? CCQ 1 Week Version - Short of Breath Doing Physical Activity CCQ02-Concern About Breathing Get Worse Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how often did you feel: Concerned about getting a cold or your breathing getting worse? CCQ 1 Week Version - Concern About Breathing Get Worse CCQ02-Depressed for Breathing Problem Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how often did you feel: Depressed because of your breathing problems? CCQ 1 Week Version - Depressed Because of Breathing Problem CCQ02-Cough Clinical COPD Questionnaire 1 Week Version - In general, during the past 7 days, how much of the time: Did you cough? CCQ 1 Week Version - Did You Cough CCQ02-Produce Sputum or Phlegm Clinical COPD Questionnaire 1 Week Version - In general, during the past 7 days, how much of the time: Did you produce sputum or phlegm? CCQ 1 Week Version - Produce Sputum or Phlegm CCQ02-Breathing Limit Strenuous Activity Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how limited were you in these activities because of your breathing problems: Strenuous physical activities? CCQ 1 Week Version - Breathing Problems Limit Strenuous Activity CCQ02-Breathing Limit Moderate Activity Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how limited were you in these activities because of your breathing problems: Moderate physical activities? CCQ 1 Week Version - Breathing Problems Limit Moderate Activity CCQ02-Breathing Limit Daily Activity Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how limited were you in these activities because of your breathing problems: Daily activities at home? CCQ 1 Week Version - Breathing Problems Limit Daily Activity CCQ02-Breathing Limit Social Activity Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how limited were you in these activities because of your breathing problems: Social activities? CCQ 1 Week Version - Breathing Problems Limit Social Activity CCQ02TC Clinical COPD Questionnaire 1 Week Version Questionnaire Test Code CDISC Questionnaire CCQ 1 Week Version Test Code Terminology Clinical COPD Questionnaire 1 Week Version test name. CCQ02-Breathing Limit Daily Activity Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how limited were you in these activities because of your breathing problems: Daily activities at home? CCQ 1 Week Version - Breathing Problems Limit Daily Activity CCQ02-Breathing Limit Moderate Activity Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how limited were you in these activities because of your breathing problems: Moderate physical activities? CCQ 1 Week Version - Breathing Problems Limit Moderate Activity CCQ02-Breathing Limit Social Activity Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how limited were you in these activities because of your breathing problems: Social activities? CCQ 1 Week Version - Breathing Problems Limit Social Activity CCQ02-Breathing Limit Strenuous Activity Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how limited were you in these activities because of your breathing problems: Strenuous physical activities? CCQ 1 Week Version - Breathing Problems Limit Strenuous Activity CCQ02-Concern About Breathing Get Worse Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how often did you feel: Concerned about getting a cold or your breathing getting worse? CCQ 1 Week Version - Concern About Breathing Get Worse CCQ02-Cough Clinical COPD Questionnaire 1 Week Version - In general, during the past 7 days, how much of the time: Did you cough? CCQ 1 Week Version - Did You Cough CCQ02-Depressed for Breathing Problem Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how often did you feel: Depressed because of your breathing problems? CCQ 1 Week Version - Depressed Because of Breathing Problem CCQ02-Produce Sputum or Phlegm Clinical COPD Questionnaire 1 Week Version - In general, during the past 7 days, how much of the time: Did you produce sputum or phlegm? CCQ 1 Week Version - Produce Sputum or Phlegm CCQ02-Short of Breath at Rest Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how often did you feel: Short of breath while at rest? CCQ 1 Week Version - Short of Breath at Rest CCQ02-Short of Breath Physical Activity Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how often did you feel: Short of breath while doing physical activities? CCQ 1 Week Version - Short of Breath Doing Physical Activity CCQ02TN Clinical COPD Questionnaire 1 Week Version Questionnaire Test Name CDISC Questionnaire CCQ 1 Week Version Test Name Terminology Clinical COPD Questionnaire 24 Hour Version test code. CCQ01-Short of Breath at Rest Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how often did you feel: Short of breath while at rest? CCQ 24 Hour Version - Short of Breath at Rest CCQ01-Short of Breath Physical Activity Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how often did you feel: Short of breath while doing physical activities? CCQ 24 Hour Version - Short of Breath Doing Physical Activity CCQ01-Concern About Breathing Get Worse Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how often did you feel: Concerned about getting a cold or your breathing getting worse? CCQ 24 Hour Version - Concern About Breathing Get Worse CCQ01-Depressed for Breathing Problem Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how often did you feel: Depressed because of your breathing problems? CCQ 24 Hour Version - Depressed Because of Breathing Problem CCQ01-Cough Clinical COPD Questionnaire 24 Hour Version - In general, during the past 24 hours, how much of the time: Did you cough? CCQ 24 Hour Version - Did You Cough CCQ01-Produce Sputum or Phlegm Clinical COPD Questionnaire 24 Hour Version - In general, during the past 24 hours, how much of the time: Did you produce sputum or phlegm? CCQ 24 Hour Version - Produce Sputum or Phlegm CCQ01-Breathing Limit Strenuous Activity Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how limited were you in these activities because of your breathing problems: Strenuous physical activities? CCQ 24 Hour Version - Breathing Problems Limit Strenuous Activity CCQ01-Breathing Limit Moderate Activity Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how limited were you in these activities because of your breathing problems: Moderate physical activities? CCQ 24 Hour Version - Breathing Problems Limit Moderate Activity CCQ01-Breathing Limit Daily Activity Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how limited were you in these activities because of your breathing problems: Daily activities at home? CCQ 24 Hour Version - Breathing Problems Limit Daily Activity CCQ01-Breathing Limit Social Activity Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how limited were you in these activities because of your breathing problems: Social activities? CCQ 24 Hour Version - Breathing Problems Limit Social Activity CCQ01TC Clinical COPD Questionnaire 24 Hour Version Questionnaire Test Code CDISC Questionnaire CCQ 24 Hour Version Test Code Terminology Clinical COPD Questionnaire 24 Hour Version test name. CCQ01-Breathing Limit Daily Activity Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how limited were you in these activities because of your breathing problems: Daily activities at home? CCQ 24 Hour Version - Breathing Problems Limit Daily Activity CCQ01-Breathing Limit Moderate Activity Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how limited were you in these activities because of your breathing problems: Moderate physical activities? CCQ 24 Hour Version - Breathing Problems Limit Moderate Activity CCQ01-Breathing Limit Social Activity Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how limited were you in these activities because of your breathing problems: Social activities? CCQ 24 Hour Version - Breathing Problems Limit Social Activity CCQ01-Breathing Limit Strenuous Activity Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how limited were you in these activities because of your breathing problems: Strenuous physical activities? CCQ 24 Hour Version - Breathing Problems Limit Strenuous Activity CCQ01-Concern About Breathing Get Worse Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how often did you feel: Concerned about getting a cold or your breathing getting worse? CCQ 24 Hour Version - Concern About Breathing Get Worse CCQ01-Cough Clinical COPD Questionnaire 24 Hour Version - In general, during the past 24 hours, how much of the time: Did you cough? CCQ 24 Hour Version - Did You Cough CCQ01-Depressed for Breathing Problem Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how often did you feel: Depressed because of your breathing problems? CCQ 24 Hour Version - Depressed Because of Breathing Problem CCQ01-Produce Sputum or Phlegm Clinical COPD Questionnaire 24 Hour Version - In general, during the past 24 hours, how much of the time: Did you produce sputum or phlegm? CCQ 24 Hour Version - Produce Sputum or Phlegm CCQ01-Short of Breath at Rest Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how often did you feel: Short of breath while at rest? CCQ 24 Hour Version - Short of Breath at Rest CCQ01-Short of Breath Physical Activity Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how often did you feel: Short of breath while doing physical activities? CCQ 24 Hour Version - Short of Breath Doing Physical Activity CCQ01TN Clinical COPD Questionnaire 24 Hour Version Questionnaire Test Name CDISC Questionnaire CCQ 24 Hour Version Test Name Terminology Clinical Dementia Rating test code. CDR01-Memory Clinical Dementia Rating - Memory. CDR - Memory CDR01-Orientation Clinical Dementia Rating - Orientation. CDR - Orientation CDR01-Judgment and Problem Solving Clinical Dementia Rating - Judgment and problem solving. CDR - Judgment and Problem Solving CDR01-Community Affairs Clinical Dementia Rating - Community affairs. CDR - Community Affairs CDR01-Home and Hobbies Clinical Dementia Rating - Home and hobbies. CDR - Home and Hobbies CDR01-Personal Care Clinical Dementia Rating - Personal care. CDR - Personal Care CDR01-Sum of Boxes Clinical Dementia Rating - Sum of Boxes. CDR - Sum of Boxes CDR01-Global CDR Clinical Dementia Rating - Global CDR. CDR - Global CDR CDR01TC Clinical Dementia Rating Clinical Classification Test Code CDISC Clinical Classification CDR Test Code Terminology Clinical Dementia Rating test name. CDR01-Community Affairs Clinical Dementia Rating - Community affairs. CDR - Community Affairs CDR01-Global CDR Clinical Dementia Rating - Global CDR. CDR - Global CDR CDR01-Home and Hobbies Clinical Dementia Rating - Home and hobbies. CDR - Home and Hobbies CDR01-Judgment and Problem Solving Clinical Dementia Rating - Judgment and problem solving. CDR - Judgment and Problem Solving CDR01-Memory Clinical Dementia Rating - Memory. CDR - Memory CDR01-Orientation Clinical Dementia Rating - Orientation. CDR - Orientation CDR01-Personal Care Clinical Dementia Rating - Personal care. CDR - Personal Care CDR01-Sum of Boxes Clinical Dementia Rating - Sum of Boxes. CDR - Sum of Boxes CDR01TN Clinical Dementia Rating Clinical Classification Test Name CDISC Clinical Classification CDR Test Name Terminology Clinical Global Impression Generic Modification Version test code. CGI02-Severity Clinical Global Impression - Considering your total clinical experience with this particular population, how severe is the subject's condition at this time? CGI Generic Modification Version - Severity CGI02-Change Clinical Global Impression - Rate total change whether or not, in your judgement, it is due entirely to drug treatment. Compared to the subject's condition <at previously assessed protocol specified time point>, how much has the subject changed? CGI Generic Modification Version - Change CGI02-Improvement Clinical Global Impression - Rate total improvement whether or not, in your judgement, it is due entirely to drug treatment. Compared to the subject's condition <at previously assessed protocol specified time point>, how much has the subject improved? CGI Generic Modification Version - Improvement CGI02TC Clinical Global Impression Generic Modification Version Questionnaire Test Code CDISC Questionnaire CGI Generic Modification Version Test Code Terminology Clinical Global Impression Generic Modification Version test name. CGI02-Change Clinical Global Impression - Rate total change whether or not, in your judgement, it is due entirely to drug treatment. Compared to the subject's condition <at previously assessed protocol specified time point>, how much has the subject changed? CGI Generic Modification Version - Change CGI02-Improvement Clinical Global Impression - Rate total improvement whether or not, in your judgement, it is due entirely to drug treatment. Compared to the subject's condition <at previously assessed protocol specified time point>, how much has the subject improved? CGI Generic Modification Version - Improvement CGI02-Severity Clinical Global Impression - Considering your total clinical experience with this particular population, how severe is the subject's condition at this time? CGI Generic Modification Version - Severity CGI02TN Clinical Global Impression Generic Modification Version Questionnaire Test Name CDISC Questionnaire CGI Generic Modification Version Test Name Terminology Clinical Opiate Withdrawal Scale test code. COWS1-Resting Pulse Rate Clinical Opiate Withdrawal Scale - Resting pulse rate. COWS - Resting Pulse Rate COWS1-Resting Pulse Rate Beats/Minute Clinical Opiate Withdrawal Scale - Resting pulse rate: beats/minute. COWS - Resting Pulse Rate: Beats/Minute COWS1-Sweating Clinical Opiate Withdrawal Scale - Sweating. COWS - Sweating COWS1-Restlessness Clinical Opiate Withdrawal Scale - Restlessness. COWS - Restlessness COWS1-Pupil Size Clinical Opiate Withdrawal Scale - Pupil size. COWS - Pupil Size COWS1-Bone or Joint Aches Clinical Opiate Withdrawal Scale - Bone or joint aches. COWS - Bone or Joint Aches COWS1-Runny Nose or Tearing Clinical Opiate Withdrawal Scale - Runny nose or tearing. COWS - Runny Nose or Tearing COWS1-GI Upset Clinical Opiate Withdrawal Scale - GI upset. COWS - GI Upset COWS1-Tremor Clinical Opiate Withdrawal Scale - Tremor. COWS - Tremor COWS1-Yawning Clinical Opiate Withdrawal Scale - Yawning. COWS - Yawning COWS1-Anxiety or Irritability Clinical Opiate Withdrawal Scale - Anxiety or irritability. COWS - Anxiety or Irritability COWS1-Gooseflesh Skin Clinical Opiate Withdrawal Scale - Gooseflesh skin. COWS - Gooseflesh Skin COWS1-Total Score Clinical Opiate Withdrawal Scale - Total score. COWS - Total Score COWS1TC Clinical Opiate Withdrawal Scale Questionnaire Test Code CDISC Questionnaire COWS Test Code Terminology Clinical Opiate Withdrawal Scale test name. COWS1-Anxiety or Irritability Clinical Opiate Withdrawal Scale - Anxiety or irritability. COWS - Anxiety or Irritability COWS1-Bone or Joint Aches Clinical Opiate Withdrawal Scale - Bone or joint aches. COWS - Bone or Joint Aches COWS1-GI Upset Clinical Opiate Withdrawal Scale - GI upset. COWS - GI Upset COWS1-Gooseflesh Skin Clinical Opiate Withdrawal Scale - Gooseflesh skin. COWS - Gooseflesh Skin COWS1-Pupil Size Clinical Opiate Withdrawal Scale - Pupil size. COWS - Pupil Size COWS1-Resting Pulse Rate Beats/Minute Clinical Opiate Withdrawal Scale - Resting pulse rate: beats/minute. COWS - Resting Pulse Rate: Beats/Minute COWS1-Resting Pulse Rate Clinical Opiate Withdrawal Scale - Resting pulse rate. COWS - Resting Pulse Rate COWS1-Restlessness Clinical Opiate Withdrawal Scale - Restlessness. COWS - Restlessness COWS1-Runny Nose or Tearing Clinical Opiate Withdrawal Scale - Runny nose or tearing. COWS - Runny Nose or Tearing COWS1-Sweating Clinical Opiate Withdrawal Scale - Sweating. COWS - Sweating COWS1-Total Score Clinical Opiate Withdrawal Scale - Total score. COWS - Total Score COWS1-Tremor Clinical Opiate Withdrawal Scale - Tremor. COWS - Tremor COWS1-Yawning Clinical Opiate Withdrawal Scale - Yawning. COWS - Yawning COWS1TN Clinical Opiate Withdrawal Scale Questionnaire Test Name CDISC Questionnaire COWS Test Name Terminology Terminology codelist relevant to the responses for clinical status of disease. The disease or condition is apparent. Active Condition The disease or condition is not apparent; no symptomatology. Inactive Condition Recurrent Relapse The disease or condition has returned after a period of inactivity, improvement, or remission. Recurrent Condition The disease or condition is not apparent, but there is a risk of the disease or condition returning. Condition in Remission The disease or condition is not apparent, and there is negligible risk of the disease or condition returning. Resolved Condition U UNK Unknown Not known, not observed, not recorded, or refused. (NCI) Unknown CLINSTRS Clinical Status of Disease Response CDISC SDTM Clinical Status of Disease Response Terminology Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version test code. CAP01-Recurrent Distressing Memories Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Recurrent, involuntary, and intrusive distressing memories of the traumatic event(s). CAPS DSM-5 With DSM IV Scoring 2016 Version - Recurrent Distressing Memories CAP01-Recurrent Distressing Recol Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Recurrent and intrusive distressing recollections of the event, including images, thoughts, or perceptions: Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Recurrent Distressing Recollections Frequency CAP01-Recurrent Distressing Recol Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Recurrent and intrusive distressing recollections of the event, including images, thoughts, or perceptions: Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Recurrent Distressing Recollections Intensity CAP01-Recurrent Distressing Dream Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Recurrent distressing dreams in which the content and/or affect of the dream is related to the event(s). CAPS DSM-5 With DSM IV Scoring 2016 Version - Recurrent Distressing Dream CAP01-Recurrent Distressing Dream Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Recurrent distressing dreams of the event: Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Recurrent Distressing Dream Frequency CAP01-Recurrent Distressing Dream Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Recurrent distressing dreams of the event: Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Recurrent Distressing Dream Intensity CAP01-Feel as if Event Recurring Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Dissociative reactions (e.g., flashbacks) in which the individual feels or acts as if the traumatic event(s) were recurring. (Such reactions may occur on a continuum, with the most extreme expression being a complete loss of awareness of present surroundings.) CAPS DSM-5 With DSM IV Scoring 2016 Version - Feel as if Event Recurring CAP01-Feel as if Event Recurring Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Acting or feeling as if the traumatic event were recurring (includes a sense of reliving the experience, illusions, hallucinations, and dissociative flashback episodes, including those that occur on awakening or when intoxicated.): Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Feel as if Event Recurring Frequency CAP01-Feel as if Event Recurring Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Acting or feeling as if the traumatic event were recurring (includes a sense of reliving the experience, illusions, hallucinations, and dissociative flashback episodes, including those that occur on awakening or when intoxicated.): Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Feel as if Event Recurring Intensity CAP01-Psych Distress at Exposure Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Intense or prolonged psychological distress at exposure to internal or external cues that symbolize or resemble an aspect of the traumatic event(s). CAPS DSM-5 With DSM IV Scoring 2016 Version - Psychological Distress at Exposure CAP01-Psych Distress at Exposure Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Intense psychological distress at exposure to internal or external cues that symbolize or resemble an aspect of the traumatic event: Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Psychological Distress at Exposure Frequency CAP01-Psych Distress at Exposure Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Intense psychological distress at exposure to internal or external cues that symbolize or resemble an aspect of the traumatic event: Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Psychological Distress at Exposure Intensity CAP01-Physiological React to Cues Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Marked physiological reactions to internal or external cues that symbolize or resemble an aspect of the traumatic event(s). CAPS DSM-5 With DSM IV Scoring 2016 Version - Physiological Reactions to Cues CAP01-Physiological React to Cues Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Physiological reactivity on exposure to internal or external cues that symbolize or resemble an aspect of the traumatic event: Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Physiological Reactions to Cues Frequency CAP01-Physiological React to Cues Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Physiological reactivity on exposure to internal or external cues that symbolize or resemble an aspect of the traumatic event: Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Physiological Reactions to Cues Intensity CAP01-Avoid Thoughts Associated Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Avoidance or efforts to avoid distressing memories, thoughts, or feelings about or closely associated with the traumatic event(s). CAPS DSM-5 With DSM IV Scoring 2016 Version - Avoid Thoughts Associated CAP01-Avoid Thoughts Associated Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Efforts to avoid thoughts, feelings, or conversations associated with the trauma: Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Avoid Thoughts Associated Frequency CAP01-Avoid Thoughts Associated Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Efforts to avoid thoughts, feelings, or conversations associated with the trauma: Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Avoid Thoughts Associated Intensity CAP01-Efforts to Avoid External Reminder Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Avoidance or efforts to avoid external reminders (people, places, conversations, activities, objects, situations) that arouse distressing memories, thoughts, or feelings about or closely associated with the traumatic event(s). CAPS DSM-5 With DSM IV Scoring 2016 Version - Efforts to Avoid External Reminder CAP01-Efforts to Avoid Activities Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Efforts to avoid activities, places, or people that arouse recollections of the trauma: Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Efforts to Avoid Activities Frequency CAP01-Efforts to Avoid Activities Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Efforts to avoid activities, places, or people that arouse recollections of the trauma: Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Efforts to Avoid Activities Intensity CAP01-Inability to Remember Aspect Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Inability to remember an important aspect of the traumatic event(s) (typically dissociative amnesia that is not due to head injury, alcohol, or drugs). CAPS DSM-5 With DSM IV Scoring 2016 Version - Inability to Remember Aspect CAP01-Inability to Recall Aspect Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Inability to recall an important aspect of the trauma: Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Inability to Recall Aspect Frequency CAP01-Inability to Recall Aspect Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Inability to recall an important aspect of the trauma: Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Inability to Recall Aspect Intensity CAP01-Persistent Exaggerated Neg Beliefs Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Persistent and exaggerated negative beliefs or expectations about oneself, others, or the world (e.g., "I am bad," "No one can be trusted," "The world is completely dangerous"). (Alternatively, this might be expressed as, e.g., "I've lost my soul forever," "My whole nervous system is permanently ruined."). CAPS DSM-5 With DSM IV Scoring 2016 Version - Persistent Exaggerated Negative Beliefs CAP01-Persistent Blame of Self/Others Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Persistent, distorted blame of self or others about the cause or consequences of the traumatic event(s). CAPS DSM-5 With DSM IV Scoring 2016 Version - Persistent Blame of Self or Others CAP01-Persistent Neg Emotional State Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Persistent negative emotional state (e.g., fear, horror, anger, guilt, or shame). CAPS DSM-5 With DSM IV Scoring 2016 Version - Persistent Negative Emotional State CAP01-Diminished Interest Activ Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Markedly diminished interest or participation in significant activities. CAPS DSM-5 With DSM IV Scoring 2016 Version - Diminished Interest Activities CAP01-Diminished Interest Activ Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Markedly diminished interest or participation in significant activities: Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Diminished Interest Activities Frequency CAP01-Diminished Interest Activ Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Markedly diminished interest or participation in significant activities: Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Diminished Interest Activities Intensity CAP01-Feeling of Detachment Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Feelings of detachment or estrangement from others. CAPS DSM-5 With DSM IV Scoring 2016 Version - Feeling of Detachment CAP01-Feeling of Detachment Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Feeling of detachment or estrangement from others: Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Feeling of Detachment Frequency CAP01-Feeling of Detachment Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Feeling of detachment or estrangement from others: Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Feeling of Detachment Intensity CAP01-Inability Positive Emotions Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Persistent inability to experience positive emotions (e.g., inability to experience happiness, satisfaction, or loving feelings). CAPS DSM-5 With DSM IV Scoring 2016 Version - Inability Positive Emotions CAP01-Restricted Range of Affect Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Restricted range of affect (e.g., unable to have loving feelings): Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Restricted Range of Affect Frequency CAP01-Restricted Range of Affect Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Restricted range of affect (e.g., unable to have loving feelings): Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Restricted Range of Affect Intensity CAP01-Sense Foreshortened Future Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Sense of a foreshortened future (e.g., does not expect to have a career, marriage, children, or a normal life span): Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Sense Foreshortened Future Frequency CAP01-Sense Foreshortened Future Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Sense of a foreshortened future (e.g., does not expect to have a career, marriage, children, or a normal life span): Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Sense Foreshortened Future Intensity CAP01-Irritable Behavior Angry Outbursts Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Irritable behavior and angry outbursts (with little or no provocation) typically expressed as verbal or physical aggression toward people or objects. CAPS DSM-5 With DSM IV Scoring 2016 Version - Irritable Behavior Angry Outbursts CAP01-Irritability/Outbursts Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Irritability or outbursts of anger: Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Irritability or Outbursts Frequency CAP01-Irritability/Outbursts Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Irritability or outbursts of anger: Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Irritability or Outbursts Intensity CAP01-Reckless or Self-destructive Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Reckless or self-destructive behavior. CAPS DSM-5 With DSM IV Scoring 2016 Version - Reckless or Self-destructive CAP01-Hypervigilance Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Hypervigilance. CAPS DSM-5 With DSM IV Scoring 2016 Version - Hypervigilance CAP01-Hypervigilance Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Hypervigilance: Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Hypervigilance Frequency CAP01-Hypervigilance Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Hypervigilance: Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Hypervigilance Intensity CAP01-Exaggerated Response Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Exaggerated startle response. CAPS DSM-5 With DSM IV Scoring 2016 Version - Exaggerated Response CAP01-Exaggerated Response Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Exaggerated startle response: Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Exaggerated Response Frequency CAP01-Exaggerated Response Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Exaggerated startle response: Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Exaggerated Response Intensity CAP01-Problems With Concentration Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Problems with concentration. CAPS DSM-5 With DSM IV Scoring 2016 Version - Problems With Concentration CAP01-Difficulty Concentrating Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Difficulty concentrating: Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Difficulty Concentrating Frequency CAP01-Difficulty Concentrating Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Difficulty concentrating: Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Difficulty Concentrating Intensity CAP01-Sleep Disturbance Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Sleep disturbance (e.g., difficulty falling or staying asleep or restless sleep). CAPS DSM-5 With DSM IV Scoring 2016 Version - Sleep Disturbance CAP01-Difficulty Falling Asleep Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Difficulty falling or staying asleep: Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Difficulty Falling Asleep Frequency CAP01-Difficulty Falling Asleep Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Difficulty falling or staying asleep: Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Difficulty Falling Asleep Intensity CAP01-Symptoms Total Months Delay Onset Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Onset of symptoms: Total # months delay in onset. CAPS DSM-5 With DSM IV Scoring 2016 Version - Symptoms Total Months Delay Onset CAP01-Symptoms With Delayed Onset Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Onset of symptoms: With delayed onset (>= 6 months)? CAPS DSM-5 With DSM IV Scoring 2016 Version - Symptoms With Delayed Onset CAP01-Symptoms Current Months Duration Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Duration of symptoms: [CURRENT] Total # months duration. CAPS DSM-5 With DSM IV Scoring 2016 Version - Symptoms Current Months Duration CAP01-Symptoms Current More Than Month Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Duration of symptoms: [CURRENT] Duration more than 1 month? CAPS DSM-5 With DSM IV Scoring 2016 Version - Symptoms Current More Than Month CAP01-Symptoms Lifetime Months Duration Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Duration of symptoms: [LIFETIME] Total # months duration. CAPS DSM-5 With DSM IV Scoring 2016 Version - Symptoms Lifetime Months Duration CAP01-Symptoms Lifetime More Than Month Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Duration of symptoms: [LIFETIME] Duration more than 1 month? CAPS DSM-5 With DSM IV Scoring 2016 Version - Symptoms Lifetime More Than Month CAP01-Subjective Distress Past Month Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Subjective distress: In the past month. CAPS DSM-5 With DSM IV Scoring 2016 Version - Subjective Distress Past Month CAP01-Subjective Distress Lifetime Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Subjective distress: Lifetime. CAPS DSM-5 With DSM IV Scoring 2016 Version - Subjective Distress Lifetime CAP01-Social Functioning Past Month Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Impairment in social functioning: In the past month. CAPS DSM-5 With DSM IV Scoring 2016 Version - Social Functioning Past Month CAP01-Social Functioning Lifetime Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Impairment in social functioning: Lifetime. CAPS DSM-5 With DSM IV Scoring 2016 Version - Social Functioning Lifetime CAP01-Occupation Functioning Past Month Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Impairment in occupational or other important area of functioning: In the past month. CAPS DSM-5 With DSM IV Scoring 2016 Version - Occupation Functioning Past Month CAP01-Occupation Functioning Lifetime Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Impairment in occupational or other important area of functioning: Lifetime. CAPS DSM-5 With DSM IV Scoring 2016 Version - Occupation Functioning Lifetime CAP01-Global Validity Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Global validity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Global Validity CAP01-Global Severity Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Global severity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Global Severity CAP01-Global Improvement Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Global improvement. CAPS DSM-5 With DSM IV Scoring 2016 Version - Global Improvement CAP01-Depersonalization Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Depersonalization: Persistent or recurrent experiences of feeling detached from, and as if one were an outside observer of, one's mental processes or body (e.g., feeling as though one were in a dream; feeling a sense of unreality of self or body or of time moving slowly). CAPS DSM-5 With DSM IV Scoring 2016 Version - Depersonalization CAP01-Derealization Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Derealization: Persistent or recurrent experiences of unreality of surroundings (e.g., the world around the individual is experienced as unreal, dreamlike, distant, or distorted). CAPS DSM-5 With DSM IV Scoring 2016 Version - Derealization CAP01-DSM IV Total Score Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV total score. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Total Score CAP01-DSM IV Criterion B Score Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV criterion B score. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Criterion B Score CAP01-DSM IV Criterion C Score Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV criterion C score. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Criterion C Score CAP01-DSM IV Criterion D Score Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV criterion D score. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Criterion D Score CAP01-DSM IV Criterion E Score Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV criterion E score. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Criterion E Score CAP01-DSM IV Criterion G Score Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV criterion G score. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Criterion G Score CAP01-DSM IV Dissociation Score Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV dissociation score. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Dissociation Score CAP01-DSM IV PTSD Diagnosis Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV PTSD diagnosis. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV PTSD Diagnosis CAP01-DSM IV Other Diagnosis 1 Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV other diagnosis 1. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Other Diagnosis 1 CAP01-DSM IV Other Diagnosis 2 Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV other diagnosis 2. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Other Diagnosis 2 CAP01-DSM-5 Total Score Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 total score. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Total Score CAP01-DSM-5 Criterion B Score Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 criterion B score. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Criterion B Score CAP01-DSM-5 Criterion C Score Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 criterion C score. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Criterion C Score CAP01-DSM-5 Criterion D Score Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 criterion D score. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Criterion D Score CAP01-DSM-5 Criterion E Score Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 criterion E score. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Criterion E Score CAP01-DSM-5 Criterion G Score Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 criterion G score. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Criterion G Score CAP01-DSM-5 Dissociation Score Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 dissociation score. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Dissociation Score CAP01-DSM-5 PTSD Diagnosis Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 PTSD diagnosis. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 PTSD Diagnosis CAP01-DSM-5 Other Diagnosis 1 Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 other diagnosis 1. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Other Diagnosis 1 CAP01-DSM-5 Other Diagnosis 2 Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 other diagnosis 2. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Other Diagnosis 2 CAP01-The Event You Recently Endured Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - The event you have recently endured was: Index event (specify). CAPS DSM-5 With DSM IV Scoring 2016 Version - The Event You Recently Endured CAP01-Exposure Type Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Exposure type. CAPS DSM-5 With DSM IV Scoring 2016 Version - Exposure Type CAP01-Life Threat Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Life threat? CAPS DSM-5 With DSM IV Scoring 2016 Version - Life Threat CAP01-Life Threat Self Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Life threat: Self. CAPS DSM-5 With DSM IV Scoring 2016 Version - Life Threat Self CAP01-Life Threat Other Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Life threat: Other. CAPS DSM-5 With DSM IV Scoring 2016 Version - Life Threat Other CAP01-Serious Injury Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Serious injury? CAPS DSM-5 With DSM IV Scoring 2016 Version - Serious Injury CAP01-Serious Injury Self Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Serious injury: Self. CAPS DSM-5 With DSM IV Scoring 2016 Version - Serious Injury Self CAP01-Serious Injury Other Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Serious injury: Other. CAPS DSM-5 With DSM IV Scoring 2016 Version - Serious Injury Other CAP01-Sexual Violation Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Sexual violation? CAPS DSM-5 With DSM IV Scoring 2016 Version - Sexual Violation CAP01-Sexual Violation Self Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Sexual violation: Self. CAPS DSM-5 With DSM IV Scoring 2016 Version - Sexual Violation Self CAP01-Sexual Violation Other Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Sexual violation: Other. CAPS DSM-5 With DSM IV Scoring 2016 Version - Sexual Violation Other CAP01-Criterion A Met Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Criterion A met? CAPS DSM-5 With DSM IV Scoring 2016 Version - Criterion A Met CAP01TC Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version Clinical Classification Test Code CDISC Clinical Classification Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version Test Code Terminology Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version test name. CAP01-Avoid Thoughts Associated Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Efforts to avoid thoughts, feelings, or conversations associated with the trauma: Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Avoid Thoughts Associated Frequency CAP01-Avoid Thoughts Associated Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Efforts to avoid thoughts, feelings, or conversations associated with the trauma: Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Avoid Thoughts Associated Intensity CAP01-Avoid Thoughts Associated Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Avoidance or efforts to avoid distressing memories, thoughts, or feelings about or closely associated with the traumatic event(s). CAPS DSM-5 With DSM IV Scoring 2016 Version - Avoid Thoughts Associated CAP01-Criterion A Met Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Criterion A met? CAPS DSM-5 With DSM IV Scoring 2016 Version - Criterion A Met CAP01-Depersonalization Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Depersonalization: Persistent or recurrent experiences of feeling detached from, and as if one were an outside observer of, one's mental processes or body (e.g., feeling as though one were in a dream; feeling a sense of unreality of self or body or of time moving slowly). CAPS DSM-5 With DSM IV Scoring 2016 Version - Depersonalization CAP01-Derealization Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Derealization: Persistent or recurrent experiences of unreality of surroundings (e.g., the world around the individual is experienced as unreal, dreamlike, distant, or distorted). CAPS DSM-5 With DSM IV Scoring 2016 Version - Derealization CAP01-Difficulty Concentrating Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Difficulty concentrating: Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Difficulty Concentrating Frequency CAP01-Difficulty Concentrating Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Difficulty concentrating: Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Difficulty Concentrating Intensity CAP01-Difficulty Falling Asleep Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Difficulty falling or staying asleep: Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Difficulty Falling Asleep Frequency CAP01-Difficulty Falling Asleep Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Difficulty falling or staying asleep: Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Difficulty Falling Asleep Intensity CAP01-Diminished Interest Activ Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Markedly diminished interest or participation in significant activities: Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Diminished Interest Activities Frequency CAP01-Diminished Interest Activ Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Markedly diminished interest or participation in significant activities: Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Diminished Interest Activities Intensity CAP01-Diminished Interest Activ Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Markedly diminished interest or participation in significant activities. CAPS DSM-5 With DSM IV Scoring 2016 Version - Diminished Interest Activities CAP01-DSM IV Criterion B Score Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV criterion B score. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Criterion B Score CAP01-DSM IV Criterion C Score Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV criterion C score. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Criterion C Score CAP01-DSM IV Criterion D Score Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV criterion D score. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Criterion D Score CAP01-DSM IV Criterion E Score Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV criterion E score. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Criterion E Score CAP01-DSM IV Criterion G Score Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV criterion G score. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Criterion G Score CAP01-DSM IV Dissociation Score Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV dissociation score. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Dissociation Score CAP01-DSM IV Other Diagnosis 1 Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV other diagnosis 1. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Other Diagnosis 1 CAP01-DSM IV Other Diagnosis 2 Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV other diagnosis 2. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Other Diagnosis 2 CAP01-DSM IV PTSD Diagnosis Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV PTSD diagnosis. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV PTSD Diagnosis CAP01-DSM IV Total Score Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV total score. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Total Score CAP01-DSM-5 Criterion B Score Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 criterion B score. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Criterion B Score CAP01-DSM-5 Criterion C Score Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 criterion C score. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Criterion C Score CAP01-DSM-5 Criterion D Score Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 criterion D score. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Criterion D Score CAP01-DSM-5 Criterion E Score Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 criterion E score. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Criterion E Score CAP01-DSM-5 Criterion G Score Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 criterion G score. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Criterion G Score CAP01-DSM-5 Dissociation Score Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 dissociation score. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Dissociation Score CAP01-DSM-5 Other Diagnosis 1 Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 other diagnosis 1. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Other Diagnosis 1 CAP01-DSM-5 Other Diagnosis 2 Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 other diagnosis 2. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Other Diagnosis 2 CAP01-DSM-5 PTSD Diagnosis Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 PTSD diagnosis. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 PTSD Diagnosis CAP01-DSM-5 Total Score Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 total score. CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Total Score CAP01-Efforts to Avoid Activities Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Efforts to avoid activities, places, or people that arouse recollections of the trauma: Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Efforts to Avoid Activities Frequency CAP01-Efforts to Avoid Activities Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Efforts to avoid activities, places, or people that arouse recollections of the trauma: Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Efforts to Avoid Activities Intensity CAP01-Efforts to Avoid External Reminder Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Avoidance or efforts to avoid external reminders (people, places, conversations, activities, objects, situations) that arouse distressing memories, thoughts, or feelings about or closely associated with the traumatic event(s). CAPS DSM-5 With DSM IV Scoring 2016 Version - Efforts to Avoid External Reminder CAP01-Exaggerated Response Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Exaggerated startle response: Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Exaggerated Response Frequency CAP01-Exaggerated Response Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Exaggerated startle response: Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Exaggerated Response Intensity CAP01-Exaggerated Response Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Exaggerated startle response. CAPS DSM-5 With DSM IV Scoring 2016 Version - Exaggerated Response CAP01-Exposure Type Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Exposure type. CAPS DSM-5 With DSM IV Scoring 2016 Version - Exposure Type CAP01-Feel as if Event Recurring Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Acting or feeling as if the traumatic event were recurring (includes a sense of reliving the experience, illusions, hallucinations, and dissociative flashback episodes, including those that occur on awakening or when intoxicated.): Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Feel as if Event Recurring Frequency CAP01-Feel as if Event Recurring Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Acting or feeling as if the traumatic event were recurring (includes a sense of reliving the experience, illusions, hallucinations, and dissociative flashback episodes, including those that occur on awakening or when intoxicated.): Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Feel as if Event Recurring Intensity CAP01-Feel as if Event Recurring Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Dissociative reactions (e.g., flashbacks) in which the individual feels or acts as if the traumatic event(s) were recurring. (Such reactions may occur on a continuum, with the most extreme expression being a complete loss of awareness of present surroundings.) CAPS DSM-5 With DSM IV Scoring 2016 Version - Feel as if Event Recurring CAP01-Feeling of Detachment Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Feeling of detachment or estrangement from others: Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Feeling of Detachment Frequency CAP01-Feeling of Detachment Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Feeling of detachment or estrangement from others: Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Feeling of Detachment Intensity CAP01-Feeling of Detachment Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Feelings of detachment or estrangement from others. CAPS DSM-5 With DSM IV Scoring 2016 Version - Feeling of Detachment CAP01-Global Improvement Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Global improvement. CAPS DSM-5 With DSM IV Scoring 2016 Version - Global Improvement CAP01-Global Severity Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Global severity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Global Severity CAP01-Global Validity Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Global validity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Global Validity CAP01-Hypervigilance Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Hypervigilance: Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Hypervigilance Frequency CAP01-Hypervigilance Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Hypervigilance: Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Hypervigilance Intensity CAP01-Hypervigilance Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Hypervigilance. CAPS DSM-5 With DSM IV Scoring 2016 Version - Hypervigilance CAP01-Inability Positive Emotions Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Persistent inability to experience positive emotions (e.g., inability to experience happiness, satisfaction, or loving feelings). CAPS DSM-5 With DSM IV Scoring 2016 Version - Inability Positive Emotions CAP01-Inability to Recall Aspect Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Inability to recall an important aspect of the trauma: Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Inability to Recall Aspect Frequency CAP01-Inability to Recall Aspect Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Inability to recall an important aspect of the trauma: Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Inability to Recall Aspect Intensity CAP01-Inability to Remember Aspect Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Inability to remember an important aspect of the traumatic event(s) (typically dissociative amnesia that is not due to head injury, alcohol, or drugs). CAPS DSM-5 With DSM IV Scoring 2016 Version - Inability to Remember Aspect CAP01-Irritability/Outbursts Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Irritability or outbursts of anger: Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Irritability or Outbursts Frequency CAP01-Irritability/Outbursts Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Irritability or outbursts of anger: Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Irritability or Outbursts Intensity CAP01-Irritable Behavior Angry Outbursts Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Irritable behavior and angry outbursts (with little or no provocation) typically expressed as verbal or physical aggression toward people or objects. CAPS DSM-5 With DSM IV Scoring 2016 Version - Irritable Behavior Angry Outbursts CAP01-Life Threat Other Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Life threat: Other. CAPS DSM-5 With DSM IV Scoring 2016 Version - Life Threat Other CAP01-Life Threat Self Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Life threat: Self. CAPS DSM-5 With DSM IV Scoring 2016 Version - Life Threat Self CAP01-Life Threat Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Life threat? CAPS DSM-5 With DSM IV Scoring 2016 Version - Life Threat CAP01-Occupation Functioning Lifetime Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Impairment in occupational or other important area of functioning: Lifetime. CAPS DSM-5 With DSM IV Scoring 2016 Version - Occupation Functioning Lifetime CAP01-Occupation Functioning Past Month Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Impairment in occupational or other important area of functioning: In the past month. CAPS DSM-5 With DSM IV Scoring 2016 Version - Occupation Functioning Past Month CAP01-Persistent Blame of Self/Others Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Persistent, distorted blame of self or others about the cause or consequences of the traumatic event(s). CAPS DSM-5 With DSM IV Scoring 2016 Version - Persistent Blame of Self or Others CAP01-Persistent Exaggerated Neg Beliefs Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Persistent and exaggerated negative beliefs or expectations about oneself, others, or the world (e.g., "I am bad," "No one can be trusted," "The world is completely dangerous"). (Alternatively, this might be expressed as, e.g., "I've lost my soul forever," "My whole nervous system is permanently ruined."). CAPS DSM-5 With DSM IV Scoring 2016 Version - Persistent Exaggerated Negative Beliefs CAP01-Persistent Neg Emotional State Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Persistent negative emotional state (e.g., fear, horror, anger, guilt, or shame). CAPS DSM-5 With DSM IV Scoring 2016 Version - Persistent Negative Emotional State CAP01-Physiological React to Cues Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Physiological reactivity on exposure to internal or external cues that symbolize or resemble an aspect of the traumatic event: Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Physiological Reactions to Cues Frequency CAP01-Physiological React to Cues Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Physiological reactivity on exposure to internal or external cues that symbolize or resemble an aspect of the traumatic event: Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Physiological Reactions to Cues Intensity CAP01-Physiological React to Cues Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Marked physiological reactions to internal or external cues that symbolize or resemble an aspect of the traumatic event(s). CAPS DSM-5 With DSM IV Scoring 2016 Version - Physiological Reactions to Cues CAP01-Problems With Concentration Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Problems with concentration. CAPS DSM-5 With DSM IV Scoring 2016 Version - Problems With Concentration CAP01-Psych Distress at Exposure Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Intense psychological distress at exposure to internal or external cues that symbolize or resemble an aspect of the traumatic event: Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Psychological Distress at Exposure Frequency CAP01-Psych Distress at Exposure Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Intense psychological distress at exposure to internal or external cues that symbolize or resemble an aspect of the traumatic event: Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Psychological Distress at Exposure Intensity CAP01-Psych Distress at Exposure Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Intense or prolonged psychological distress at exposure to internal or external cues that symbolize or resemble an aspect of the traumatic event(s). CAPS DSM-5 With DSM IV Scoring 2016 Version - Psychological Distress at Exposure CAP01-Reckless or Self-destructive Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Reckless or self-destructive behavior. CAPS DSM-5 With DSM IV Scoring 2016 Version - Reckless or Self-destructive CAP01-Recurrent Distressing Dream Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Recurrent distressing dreams of the event: Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Recurrent Distressing Dream Frequency CAP01-Recurrent Distressing Dream Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Recurrent distressing dreams of the event: Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Recurrent Distressing Dream Intensity CAP01-Recurrent Distressing Dream Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Recurrent distressing dreams in which the content and/or affect of the dream is related to the event(s). CAPS DSM-5 With DSM IV Scoring 2016 Version - Recurrent Distressing Dream CAP01-Recurrent Distressing Memories Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Recurrent, involuntary, and intrusive distressing memories of the traumatic event(s). CAPS DSM-5 With DSM IV Scoring 2016 Version - Recurrent Distressing Memories CAP01-Recurrent Distressing Recol Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Recurrent and intrusive distressing recollections of the event, including images, thoughts, or perceptions: Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Recurrent Distressing Recollections Frequency CAP01-Recurrent Distressing Recol Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Recurrent and intrusive distressing recollections of the event, including images, thoughts, or perceptions: Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Recurrent Distressing Recollections Intensity CAP01-Restricted Range of Affect Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Restricted range of affect (e.g., unable to have loving feelings): Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Restricted Range of Affect Frequency CAP01-Restricted Range of Affect Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Restricted range of affect (e.g., unable to have loving feelings): Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Restricted Range of Affect Intensity CAP01-Sense Foreshortened Future Freq Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Sense of a foreshortened future (e.g., does not expect to have a career, marriage, children, or a normal life span): Frequency. CAPS DSM-5 With DSM IV Scoring 2016 Version - Sense Foreshortened Future Frequency CAP01-Sense Foreshortened Future Intens Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Sense of a foreshortened future (e.g., does not expect to have a career, marriage, children, or a normal life span): Intensity. CAPS DSM-5 With DSM IV Scoring 2016 Version - Sense Foreshortened Future Intensity CAP01-Serious Injury Other Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Serious injury: Other. CAPS DSM-5 With DSM IV Scoring 2016 Version - Serious Injury Other CAP01-Serious Injury Self Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Serious injury: Self. CAPS DSM-5 With DSM IV Scoring 2016 Version - Serious Injury Self CAP01-Serious Injury Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Serious injury? CAPS DSM-5 With DSM IV Scoring 2016 Version - Serious Injury CAP01-Sexual Violation Other Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Sexual violation: Other. CAPS DSM-5 With DSM IV Scoring 2016 Version - Sexual Violation Other CAP01-Sexual Violation Self Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Sexual violation: Self. CAPS DSM-5 With DSM IV Scoring 2016 Version - Sexual Violation Self CAP01-Sexual Violation Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Sexual violation? CAPS DSM-5 With DSM IV Scoring 2016 Version - Sexual Violation CAP01-Sleep Disturbance Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Sleep disturbance (e.g., difficulty falling or staying asleep or restless sleep). CAPS DSM-5 With DSM IV Scoring 2016 Version - Sleep Disturbance CAP01-Social Functioning Lifetime Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Impairment in social functioning: Lifetime. CAPS DSM-5 With DSM IV Scoring 2016 Version - Social Functioning Lifetime CAP01-Social Functioning Past Month Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Impairment in social functioning: In the past month. CAPS DSM-5 With DSM IV Scoring 2016 Version - Social Functioning Past Month CAP01-Subjective Distress Lifetime Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Subjective distress: Lifetime. CAPS DSM-5 With DSM IV Scoring 2016 Version - Subjective Distress Lifetime CAP01-Subjective Distress Past Month Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Subjective distress: In the past month. CAPS DSM-5 With DSM IV Scoring 2016 Version - Subjective Distress Past Month CAP01-Symptoms Current Months Duration Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Duration of symptoms: [CURRENT] Total # months duration. CAPS DSM-5 With DSM IV Scoring 2016 Version - Symptoms Current Months Duration CAP01-Symptoms Current More Than Month Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Duration of symptoms: [CURRENT] Duration more than 1 month? CAPS DSM-5 With DSM IV Scoring 2016 Version - Symptoms Current More Than Month CAP01-Symptoms Lifetime Months Duration Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Duration of symptoms: [LIFETIME] Total # months duration. CAPS DSM-5 With DSM IV Scoring 2016 Version - Symptoms Lifetime Months Duration CAP01-Symptoms Lifetime More Than Month Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Duration of symptoms: [LIFETIME] Duration more than 1 month? CAPS DSM-5 With DSM IV Scoring 2016 Version - Symptoms Lifetime More Than Month CAP01-Symptoms Total Months Delay Onset Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Onset of symptoms: Total # months delay in onset. CAPS DSM-5 With DSM IV Scoring 2016 Version - Symptoms Total Months Delay Onset CAP01-Symptoms With Delayed Onset Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Onset of symptoms: With delayed onset (>= 6 months)? CAPS DSM-5 With DSM IV Scoring 2016 Version - Symptoms With Delayed Onset CAP01-The Event You Recently Endured Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - The event you have recently endured was: Index event (specify). CAPS DSM-5 With DSM IV Scoring 2016 Version - The Event You Recently Endured CAP01TN Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version Clinical Classification Test Name CDISC Clinical Classification Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version Test Name Terminology A terminology codelist relevant to the summary type for the source collected result or dose value. %CV Coefficient of Variance CV The ratio of the standard deviation to the mean, expressed as a percentage or fraction. Coefficient of Variance The largest value in quantity or degree in a set of values. Maximum A mean of a set of observations where the mathematic calculation is unspecified or unknown. Mean Based on Unspecified Calculation Arithmetic Mean The sum of the values of all observations or data points divided by the number of observations; an arithmetic average. (CDISC Glossary) Arithmetic Mean Geometric Mean The n-th root of the multiple products of n values; a geometric average. Geometric Mean The middle value in an ordered set of values. In the case of an even number of values, it is the average of the two middle values. Median The smallest value in quantity or degree in a set of values. Minimum Lowest The lowest value in terms of position, place, magnitude, level, or rank. Lowest RMSD Root Mean Square Deviation SD Std Dev A measure of the relative variability of a variable around its mean; the square root of the variance. Standard Deviation A measure of the variability in a sample or population. It is calculated as the mean squared deviation (MSD) of the individual values from their common mean. In calculating the MSD, the divisor n is commonly used for a population variance and the divisor n-1 for a sample variance. (CDISC Glossary) Variance COLSTYP Collected Summarized Value Type Response CDISC SDTM Collected Summarized Value Type Response Terminology Columbia-Suicide Severity Rating Scale Already Enrolled Subject test code. CSS05-Wish to be Dead-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you wished you were dead or wished you could go to sleep and not wake up? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Wish to Be Dead (Prior to Study Entry) CSS05-Wish to be Dead-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you wished you were dead or wished you could go to sleep and not wake up? (Since Study Start). C-SSRS Already Enrolled Subjects - Wish to Be Dead (Since Study Start) CSS05-Wish to be Dead, Describe Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of wishing to be dead. C-SSRS Already Enrolled Subjects - Description of Wish to Be Dead CSS05-Non-Spec Suicid Thought-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you actually had any thoughts of killing yourself? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Non-Specific Active Suicidal Thoughts (Prior to Study Entry) CSS05-Non-Spec Suicid Thought-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you actually had any thoughts of killing yourself? (Since Study Start). C-SSRS Already Enrolled Subjects - Non-Specific Active Suicidal Thoughts (Since Study Start) CSS05-Non-Spec Suicid Thought, Describe Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of non-specific active suicidal thoughts. C-SSRS Already Enrolled Subjects - Description of Non-Specific Active Suicidal Thoughts CSS05-Idea, No Intent, No Plan-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you been thinking about how you might do this? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Active Suicidal Ideation With Any Methods (Not Plan) Without Intent to Act (Prior to Study Entry) CSS05-Idea, No Intent, No Plan-Since Columbia-Suicide Suicide Rating Scale Already Enrolled Subjects - Have you been thinking about how you might do this? (Since Study Start). C-SSRS Already Enrolled Subjects - Active Suicidal Ideation With Any Methods (Not Plan) Without Intent to Act (Since Study Start) CSS05-Idea, No Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of active suicidal ideation with any methods (not plan) without intent to act. C-SSRS Already Enrolled Subjects - Description of Active Suicidal Ideation With Any Methods (Not Plan) Without Intent to Act CSS05-Idea, Intent, No Plan-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you had these thoughts and had some intention of acting on them? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Active Suicidal Ideation With Some Intent to Act, Without Specific Plan (Prior to Study Entry) CSS05-Idea, Intent, No Plan-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you had these thoughts and had some intention of acting on them? (Since Study Start). C-SSRS Already Enrolled Subjects - Active Suicidal Ideation With Some Intent to Act, Without Specific Plan (Since Study Start) CSS05-Idea, Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of active suicidal ideation with some intent to act, without specific plan. C-SSRS Already Enrolled Subjects - Description of Active Suicidal Ideation With Some Intent to Act, Without Specific Plan CSS05-Idea, Plan, Intent-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Active Suicidal Ideation With Specific Plan and Intent (Prior to Study Entry) CSS05-Idea, Plan, Intent-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Since Study Start). C-SSRS Already Enrolled Subjects - Active Suicidal Ideation With Specific Plan and Intent (Since Study Start) CSS05-Idea, Plan, Intent, Describe Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of active suicidal ideation with specific plan and intent. C-SSRS Already Enrolled Subjects - Description of Active Suicidal Ideation With Specific Plan and Intent CSS05-Most Severe Idea-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most severe ideation. (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Most Severe Ideation (Prior to Study Entry) CSS05-Most Severe Idea, Desc-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of most severe ideation. (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Describe Most Severe Ideation (Prior to Study Entry) CSS05-Most Severe Idea-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most severe ideation. (Since Study Start). C-SSRS Already Enrolled Subjects - Most Severe Ideation (Since Study Start) CSS05-Most Severe Idea, Desc-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of most severe ideation. (Since Study Start). C-SSRS Already Enrolled Subjects - Describe Most Severe Ideation (Since Study Start) CSS05-Most Severe Idea, Frequency-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - How many times have you had these thoughts? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Frequency of Most Severe Ideation (Prior to Study Entry) CSS05-Most Severe Idea, Frequency-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - How many times have you had these thoughts? (Since Study Start). C-SSRS Already Enrolled Subjects - Frequency of Most Severe Ideation (Since Study Start) CSS05-Most Severe Idea, Duration-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - When you have the thoughts how long do they last? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Duration of Most Severe Ideation (Prior to Study Entry) CSS05-Most Severe Idea, Duration-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - When you have the thoughts how long do they last? (Since Study Start). C-SSRS Already Enrolled Subjects - Duration of Most Severe Ideation (Since Study Start) CSS05-Most Severe Idea, Control-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Controllability of Most Severe Ideation (Prior to Study Entry) CSS05-Most Severe Idea, Control-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Since Study Start). C-SSRS Already Enrolled Subjects - Controllability of Most Severe Ideation (Since Study Start) CSS05-Most Severe Idea, Deterrents-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Are there things-anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Deterrents to Most Severe Ideation (Prior to Study Entry) CSS05-Most Severe Idea, Deterrents-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Are there things-anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Since Study Start). C-SSRS Already Enrolled Subjects - Deterrents to Most Severe Ideation (Since Study Start) CSS05-Most Severe Idea, Reasons-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Reasons For Most Severe Ideation (Prior to Study Entry) CSS05-Most Severe Idea, Reasons-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Since Study Start). C-SSRS Already Enrolled Subjects - Reasons For Most Severe Ideation (Since Study Start) CSS05-Actual Attempt-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Actual Suicide Attempt (Prior to Study Entry) CSS05-Actual Attempt-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? (Since Study Start). C-SSRS Already Enrolled Subjects - Actual Suicide Attempt (Since Study Start) CSS05-Number of Actual Attempts-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Total number of actual attempts. (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Number of Actual Suicide Attempts (Prior to Study Entry) CSS05-Number of Actual Attempts-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Total number of actual attempts. (Since Study Start). C-SSRS Already Enrolled Subjects - Number of Actual Suicide Attempts (Since Study Start) CSS05-Actual Attempt, Describe Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of actual attempt. C-SSRS Already Enrolled Subjects - Description of Actual Suicide Attempt CSS05-Non-suicid Self-injur Behav-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Has the subject engaged in non-suicidal self-injurious behavior? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Non-suicidal Self-injurious Behavior (Prior to Study Entry) CSS05-Non-suicid Self-injur Behav-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Has the subject engaged in non-suicidal self-injurious behavior? (Since Study Start). C-SSRS Already Enrolled Subjects - Non-suicidal Self-injurious Behavior (Since Study Start) CSS05-Interrupted Attempt-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Has there been a time when you started to do something to end your life but someone or something stopped you before you actually did anything? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Interrupted Suicide Attempt (Prior to Study Entry) CSS05-Interrupted Attempt-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Has there been a time when you started to do something to end your life but someone or something stopped you before you actually did anything? (Since Study Start). C-SSRS Already Enrolled Subjects - Interrupted Suicide Attempt (Since Study Start) CSS05-Num of Interrupted Attempts-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Total number of interrupted attempts. (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Number of Interrupted Suicide Attempts (Prior to Study Entry) CSS05-Num of Interrupted Attempts-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Total number of interrupted attempts. (Since Study Start). C-SSRS Already Enrolled Subjects - Number of Interrupted Suicide Attempts (Since Study Start) CSS05-Interrupted Attempt, Describe Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of interrupted attempt. C-SSRS Already Enrolled Subjects - Description of Interrupted Suicide Attempt CSS05-Aborted Attempt-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Aborted Suicide Attempt (Prior to Study Entry) CSS05-Aborted Attempt-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? (Since Study Start). C-SSRS Already Enrolled Subjects - Aborted Suicide Attempt (Since Study Start) CSS05-Number of Aborted Attempts-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Total number of aborted attempts. (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Number of Aborted Suicide Attempts (Prior to Study Entry) CSS05-Number of Aborted Attempts-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Total number of aborted attempts. (Since Study Start). C-SSRS Already Enrolled Subjects - Number of Aborted Suicide Attempts (Since Study Start) CSS05-Aborted Attempt, Describe Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of aborted attempt. C-SSRS Already Enrolled Subjects - Description of Aborted Suicide Attempt CSS05-Preparatory Acts/Behavior-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Preparatory Acts or Behaviors Toward Suicide Attempt (Prior to Study Entry) CSS05-Preparatory Acts/Behavior-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? (Since Study Start). C-SSRS Already Enrolled Subjects - Preparatory Acts or Behaviors Toward Suicide Attempt (Since Study Start) CSS05-Preparatory Acts/Behavior, Descr Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of preparatory acts or behavior. C-SSRS Already Enrolled Subjects - Description of Preparatory Acts or Behaviors Toward Suicide Attempt CSS05-Suicidal Behavior-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Suicidal behavior was present during the assessment period? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Suicidal Behavior (Prior to Study Entry) CSS05-Suicidal Behavior-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Suicidal behavior was present during the assessment period? (Since Study Start). C-SSRS Already Enrolled Subjects - Suicidal Behavior (Since Study Start) CSS05-Completed Suicide-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Completed suicide? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Completed Suicide (Prior to Study Entry) CSS05-Completed Suicide-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Completed suicide? (Since Study Start). C-SSRS Already Enrolled Subjects - Completed Suicide (Since Study Start) CSS05-Most Recent Attempt Date Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most recent attempt date. C-SSRS Already Enrolled Subjects - Most Recent Suicide Attempt Date CSS05-Most Recent Attempt Damage Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most recent attempt actual lethality/medical damage. C-SSRS Already Enrolled Subjects - Most Recent Suicide Attempt Actual Lethality/Medical Damage CSS05-Most Recent Attempt Potential Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most recent attempt potential lethality. C-SSRS Already Enrolled Subjects - Most Recent Suicide Attempt Potential Lethality CSS05-Most Lethal Attempt Date Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most lethal attempt date. C-SSRS Already Enrolled Subjects - Most Lethal Suicide Attempt Date CSS05-Most Lethal Attempt Damage Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most lethal attempt actual lethality/medical damage. C-SSRS Already Enrolled Subjects - Most Lethal Suicide Attempt Actual Lethality/Medical Damage CSS05-Most Lethal Attempt Potential Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most lethal attempt potential lethality. C-SSRS Already Enrolled Subjects - Most Lethal Suicide Attempt Potential Lethality CSS05-First Attempt Date Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Initial/first attempt date. C-SSRS Already Enrolled Subjects - First Suicide Attempt Date CSS05-First Attempt Damage Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Initial/first attempt actual lethality/medical damage. C-SSRS Already Enrolled Subjects - First Suicide Attempt Actual Lethality/Medical Damage CSS05-First Attempt Potential Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Initial/first attempt potential lethality. C-SSRS Already Enrolled Subjects - First Suicide Attempt Potential Lethality CSS05TC Columbia-Suicide Severity Rating Scale Already Enrolled Subjects Questionnaire Test Code CDISC Questionnaire C-SSRS Already Enrolled Subjects Test Code Terminology Columbia-Suicide Severity Rating Scale Already Enrolled Subject test name. CSS05-Aborted Attempt, Describe Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of aborted attempt. C-SSRS Already Enrolled Subjects - Description of Aborted Suicide Attempt CSS05-Aborted Attempt-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Aborted Suicide Attempt (Prior to Study Entry) CSS05-Aborted Attempt-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? (Since Study Start). C-SSRS Already Enrolled Subjects - Aborted Suicide Attempt (Since Study Start) CSS05-Actual Attempt, Describe Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of actual attempt. C-SSRS Already Enrolled Subjects - Description of Actual Suicide Attempt CSS05-Actual Attempt-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Actual Suicide Attempt (Prior to Study Entry) CSS05-Actual Attempt-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? (Since Study Start). C-SSRS Already Enrolled Subjects - Actual Suicide Attempt (Since Study Start) CSS05-Completed Suicide-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Completed suicide? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Completed Suicide (Prior to Study Entry) CSS05-Completed Suicide-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Completed suicide? (Since Study Start). C-SSRS Already Enrolled Subjects - Completed Suicide (Since Study Start) CSS05-First Attempt Damage Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Initial/first attempt actual lethality/medical damage. C-SSRS Already Enrolled Subjects - First Suicide Attempt Actual Lethality/Medical Damage CSS05-First Attempt Date Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Initial/first attempt date. C-SSRS Already Enrolled Subjects - First Suicide Attempt Date CSS05-First Attempt Potential Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Initial/first attempt potential lethality. C-SSRS Already Enrolled Subjects - First Suicide Attempt Potential Lethality CSS05-Idea, Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of active suicidal ideation with some intent to act, without specific plan. C-SSRS Already Enrolled Subjects - Description of Active Suicidal Ideation With Some Intent to Act, Without Specific Plan CSS05-Idea, Intent, No Plan-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you had these thoughts and had some intention of acting on them? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Active Suicidal Ideation With Some Intent to Act, Without Specific Plan (Prior to Study Entry) CSS05-Idea, Intent, No Plan-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you had these thoughts and had some intention of acting on them? (Since Study Start). C-SSRS Already Enrolled Subjects - Active Suicidal Ideation With Some Intent to Act, Without Specific Plan (Since Study Start) CSS05-Idea, No Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of active suicidal ideation with any methods (not plan) without intent to act. C-SSRS Already Enrolled Subjects - Description of Active Suicidal Ideation With Any Methods (Not Plan) Without Intent to Act CSS05-Idea, No Intent, No Plan-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you been thinking about how you might do this? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Active Suicidal Ideation With Any Methods (Not Plan) Without Intent to Act (Prior to Study Entry) CSS05-Idea, No Intent, No Plan-Since Columbia-Suicide Suicide Rating Scale Already Enrolled Subjects - Have you been thinking about how you might do this? (Since Study Start). C-SSRS Already Enrolled Subjects - Active Suicidal Ideation With Any Methods (Not Plan) Without Intent to Act (Since Study Start) CSS05-Idea, Plan, Intent, Describe Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of active suicidal ideation with specific plan and intent. C-SSRS Already Enrolled Subjects - Description of Active Suicidal Ideation With Specific Plan and Intent CSS05-Idea, Plan, Intent-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Active Suicidal Ideation With Specific Plan and Intent (Prior to Study Entry) CSS05-Idea, Plan, Intent-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Since Study Start). C-SSRS Already Enrolled Subjects - Active Suicidal Ideation With Specific Plan and Intent (Since Study Start) CSS05-Interrupted Attempt, Describe Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of interrupted attempt. C-SSRS Already Enrolled Subjects - Description of Interrupted Suicide Attempt CSS05-Interrupted Attempt-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Has there been a time when you started to do something to end your life but someone or something stopped you before you actually did anything? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Interrupted Suicide Attempt (Prior to Study Entry) CSS05-Interrupted Attempt-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Has there been a time when you started to do something to end your life but someone or something stopped you before you actually did anything? (Since Study Start). C-SSRS Already Enrolled Subjects - Interrupted Suicide Attempt (Since Study Start) CSS05-Most Lethal Attempt Damage Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most lethal attempt actual lethality/medical damage. C-SSRS Already Enrolled Subjects - Most Lethal Suicide Attempt Actual Lethality/Medical Damage CSS05-Most Lethal Attempt Date Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most lethal attempt date. C-SSRS Already Enrolled Subjects - Most Lethal Suicide Attempt Date CSS05-Most Lethal Attempt Potential Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most lethal attempt potential lethality. C-SSRS Already Enrolled Subjects - Most Lethal Suicide Attempt Potential Lethality CSS05-Most Recent Attempt Damage Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most recent attempt actual lethality/medical damage. C-SSRS Already Enrolled Subjects - Most Recent Suicide Attempt Actual Lethality/Medical Damage CSS05-Most Recent Attempt Date Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most recent attempt date. C-SSRS Already Enrolled Subjects - Most Recent Suicide Attempt Date CSS05-Most Recent Attempt Potential Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most recent attempt potential lethality. C-SSRS Already Enrolled Subjects - Most Recent Suicide Attempt Potential Lethality CSS05-Most Severe Idea, Control-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Controllability of Most Severe Ideation (Prior to Study Entry) CSS05-Most Severe Idea, Control-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Since Study Start). C-SSRS Already Enrolled Subjects - Controllability of Most Severe Ideation (Since Study Start) CSS05-Most Severe Idea, Desc-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of most severe ideation. (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Describe Most Severe Ideation (Prior to Study Entry) CSS05-Most Severe Idea, Desc-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of most severe ideation. (Since Study Start). C-SSRS Already Enrolled Subjects - Describe Most Severe Ideation (Since Study Start) CSS05-Most Severe Idea, Deterrents-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Are there things-anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Deterrents to Most Severe Ideation (Prior to Study Entry) CSS05-Most Severe Idea, Deterrents-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Are there things-anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Since Study Start). C-SSRS Already Enrolled Subjects - Deterrents to Most Severe Ideation (Since Study Start) CSS05-Most Severe Idea, Duration-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - When you have the thoughts how long do they last? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Duration of Most Severe Ideation (Prior to Study Entry) CSS05-Most Severe Idea, Duration-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - When you have the thoughts how long do they last? (Since Study Start). C-SSRS Already Enrolled Subjects - Duration of Most Severe Ideation (Since Study Start) CSS05-Most Severe Idea, Frequency-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - How many times have you had these thoughts? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Frequency of Most Severe Ideation (Prior to Study Entry) CSS05-Most Severe Idea, Frequency-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - How many times have you had these thoughts? (Since Study Start). C-SSRS Already Enrolled Subjects - Frequency of Most Severe Ideation (Since Study Start) CSS05-Most Severe Idea, Reasons-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Reasons For Most Severe Ideation (Prior to Study Entry) CSS05-Most Severe Idea, Reasons-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Since Study Start). C-SSRS Already Enrolled Subjects - Reasons For Most Severe Ideation (Since Study Start) CSS05-Most Severe Idea-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most severe ideation. (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Most Severe Ideation (Prior to Study Entry) CSS05-Most Severe Idea-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most severe ideation. (Since Study Start). C-SSRS Already Enrolled Subjects - Most Severe Ideation (Since Study Start) CSS05-Non-Spec Suicid Thought, Describe Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of non-specific active suicidal thoughts. C-SSRS Already Enrolled Subjects - Description of Non-Specific Active Suicidal Thoughts CSS05-Non-Spec Suicid Thought-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you actually had any thoughts of killing yourself? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Non-Specific Active Suicidal Thoughts (Prior to Study Entry) CSS05-Non-Spec Suicid Thought-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you actually had any thoughts of killing yourself? (Since Study Start). C-SSRS Already Enrolled Subjects - Non-Specific Active Suicidal Thoughts (Since Study Start) CSS05-Non-suicid Self-injur Behav-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Has the subject engaged in non-suicidal self-injurious behavior? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Non-suicidal Self-injurious Behavior (Prior to Study Entry) CSS05-Non-suicid Self-injur Behav-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Has the subject engaged in non-suicidal self-injurious behavior? (Since Study Start). C-SSRS Already Enrolled Subjects - Non-suicidal Self-injurious Behavior (Since Study Start) CSS05-Num of Interrupted Attempts-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Total number of interrupted attempts. (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Number of Interrupted Suicide Attempts (Prior to Study Entry) CSS05-Num of Interrupted Attempts-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Total number of interrupted attempts. (Since Study Start). C-SSRS Already Enrolled Subjects - Number of Interrupted Suicide Attempts (Since Study Start) CSS05-Number of Aborted Attempts-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Total number of aborted attempts. (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Number of Aborted Suicide Attempts (Prior to Study Entry) CSS05-Number of Aborted Attempts-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Total number of aborted attempts. (Since Study Start). C-SSRS Already Enrolled Subjects - Number of Aborted Suicide Attempts (Since Study Start) CSS05-Number of Actual Attempts-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Total number of actual attempts. (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Number of Actual Suicide Attempts (Prior to Study Entry) CSS05-Number of Actual Attempts-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Total number of actual attempts. (Since Study Start). C-SSRS Already Enrolled Subjects - Number of Actual Suicide Attempts (Since Study Start) CSS05-Preparatory Acts/Behavior, Descr Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of preparatory acts or behavior. C-SSRS Already Enrolled Subjects - Description of Preparatory Acts or Behaviors Toward Suicide Attempt CSS05-Preparatory Acts/Behavior-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Preparatory Acts or Behaviors Toward Suicide Attempt (Prior to Study Entry) CSS05-Preparatory Acts/Behavior-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? (Since Study Start). C-SSRS Already Enrolled Subjects - Preparatory Acts or Behaviors Toward Suicide Attempt (Since Study Start) CSS05-Suicidal Behavior-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Suicidal behavior was present during the assessment period? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Suicidal Behavior (Prior to Study Entry) CSS05-Suicidal Behavior-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Suicidal behavior was present during the assessment period? (Since Study Start). C-SSRS Already Enrolled Subjects - Suicidal Behavior (Since Study Start) CSS05-Wish to be Dead, Describe Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of wishing to be dead. C-SSRS Already Enrolled Subjects - Description of Wish to Be Dead CSS05-Wish to be Dead-Prior Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you wished you were dead or wished you could go to sleep and not wake up? (Prior to Study Entry). C-SSRS Already Enrolled Subjects - Wish to Be Dead (Prior to Study Entry) CSS05-Wish to be Dead-Since Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you wished you were dead or wished you could go to sleep and not wake up? (Since Study Start). C-SSRS Already Enrolled Subjects - Wish to Be Dead (Since Study Start) CSS05TN Columbia-Suicide Severity Rating Scale Already Enrolled Subjects Questionnaire Test Name CDISC Questionnaire C-SSRS Already Enrolled Subjects Test Name Terminology Columbia-Suicide Severity Rating Scale Baseline test code. CSS01-Wish to be Dead Columbia-Suicide Severity Rating Scale Baseline - Have you wished you were dead or wished you could go to sleep and not wake up? C-SSRS Baseline - Wish to be Dead or go to Sleep and not Wake Up CSS01-Wish to be Dead, Describe Columbia-Suicide Severity Rating Scale Baseline - Description of wishing to be dead. C-SSRS Baseline - Description of Wish to be Dead CSS01-Non-Specific Suicidal Thought Columbia-Suicide Severity Rating Scale Baseline - Have you actually had any thoughts of killing yourself? C-SSRS Baseline - Non-Specific Suicidal Thought CSS01-Non-Specific Suicid Thought, Descr Columbia-Suicide Severity Rating Scale Baseline - Description of non-specific active suicidal thoughts. C-SSRS Baseline - Description of Non-Specific Suicide Thought CSS01-Suicidal Ideation-No Intent Columbia-Suicide Severity Rating Scale Baseline - Have you been thinking about how you might do this? C-SSRS Baseline - Suicidal Ideation-No Intent CSS01-Suicidal Ideation-No Intent, Descr Columbia-Suicide Severity Rating Scale Baseline - Description of active suicidal ideation with any methods (not plan) without intent to act. C-SSRS Baseline - Description of Suicidal Ideation-No Intent CSS01-Ideation With Intent, No Plan Columbia-Suicide Severity Rating Scale Baseline - Have you have these thoughts and had some intention of acting on them? C-SSRS Baseline - Ideation With Intent, No Plan CSS01-Ideation With Intent No Plan Descr Columbia-Suicide Severity Rating Scale Baseline - Description of active suicidal ideation with some intent to act, without specific plan. C-SSRS Baseline - Description of Ideation With Intent, No Plan CSS01-Ideation With Plan/Intent Columbia-Suicide Severity Rating Scale Baseline - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? C-SSRS Baseline - Ideation With Plan/Intent CSS01-Ideation With Plan/Intent, Descr Columbia-Suicide Severity Rating Scale Baseline - Description of active suicidal ideation with specific plan and intent. C-SSRS Baseline - Description of Ideation With Plan and Intent CSS01-Most Severe Ideation Columbia-Suicide Severity Rating Scale Baseline - Most severe ideation. C-SSRS Baseline - Most Severe Ideation CSS01-Most Severe Ideation, Description Columbia-Suicide Severity Rating Scale Baseline - Description of most severe ideation. C-SSRS Baseline - Describe Most Severe Ideation CSS01-Most Severe Ideation, Frequency Columbia-Suicide Severity Rating Scale Baseline - How many times have you had these thoughts? C-SSRS Baseline - Frequency of Most Severe Ideation CSS01-Most Severe Ideation, Duration Columbia-Suicide Severity Rating Scale Baseline - When you have the thoughts, how long do they last? C-SSRS Baseline - Duration of Most Severe Ideation CSS01-Most Severe Ideation, Control Columbia-Suicide Severity Rating Scale Baseline - Could/can you stop thinking about killing yourself or wanting to die if you want to? C-SSRS Baseline - Control over Most Severe Ideation CSS01-Most Severe Ideation, Deterrents Columbia-Suicide Severity Rating Scale Baseline - Are there things - anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? C-SSRS Baseline - Deterrents to Most Severe Ideation CSS01-Most Severe Ideation, Reasons Columbia-Suicide Severity Rating Scale Baseline - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? C-SSRS Baseline - Reasons for Most Severe Ideation CSS01-Actual Attempt Columbia-Suicide Severity Rating Scale Baseline - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? C-SSRS Baseline - Actual Suicide Attempt CSS01-Number of Actual Attempts Columbia-Suicide Severity Rating Scale Baseline - Total number of actual attempts. C-SSRS Baseline - Number of Actual Suicide Attempts CSS01-Actual Attempt, Describe Columbia-Suicide Severity Rating Scale Baseline - Description of actual attempt. C-SSRS Baseline - Description of Actual Suicide Attempts CSS01-Non-suicidal Self-injurious Behav Columbia-Suicide Severity Rating Scale Baseline - Has the subject engaged in non-suicidal self-injurious behavior. C-SSRS Baseline - Non-suicidal Self-injurious Behavior CSS01-Interrupted Attempt Columbia-Suicide Severity Rating Scale Baseline - Has there been a time when you started to do something to end your life but someone or something stopped you before you actually did anything? C-SSRS Baseline - Interrupted Suicide Attempt CSS01-Number of Interrupted Attempts Columbia-Suicide Severity Rating Scale Baseline - Total number of interrupted attempts. C-SSRS Baseline - Number of Interrupted Suicide Attempts CSS01-Interrupted Attempt, Describe Columbia-Suicide Severity Rating Scale Baseline - Description of interrupted attempt. C-SSRS Baseline - Description of Interrupted Suicide Attempt CSS01-Aborted Attempt Columbia-Suicide Severity Rating Scale Baseline - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? C-SSRS Baseline - Aborted Suicide Attempt CSS01-Number of Aborted Attempts Columbia-Suicide Severity Rating Scale Baseline - Total number of aborted attempts. C-SSRS Baseline - Number of Aborted Suicide Attempts CSS01-Aborted Attempt, Describe Columbia-Suicide Severity Rating Scale Baseline - Description of aborted attempt. C-SSRS Baseline - Description of Aborted Suicide Attempt CSS01-Preparatory Acts/Behavior Columbia-Suicide Severity Rating Scale Baseline - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? C-SSRS Baseline - Preparatory Acts or Behaviors Toward Suicide Attempt CSS01-Preparatory Acts/Behavior, Descr Columbia-Suicide Severity Rating Scale Baseline - Description of preparatory acts or behavior. C-SSRS Baseline - Description of Preparatory Acts or Behaviors Toward Suicide Attempt CSS01-Suicidal Behavior Columbia-Suicide Severity Rating Scale Baseline - Suicidal behavior was present during the assessment period? C-SSRS Baseline - Suicidal Behavior CSS01-Most Recent Attempt Date Columbia-Suicide Severity Rating Scale Baseline - Most recent attempt date. C-SSRS Baseline - Most Recent Suicide Attempt Date CSS01-Most Recent Attempt Damage Columbia-Suicide Severity Rating Scale Baseline - Most recent attempt actual lethality/medical damage. C-SSRS Baseline - Most Recent Suicide Attempt Damage CSS01-Most Recent Attempt Potential Columbia-Suicide Severity Rating Scale Baseline - Most recent attempt potential lethality. C-SSRS Baseline - Most Recent Suicide Attempt Potential CSS01-Most Lethal Attempt Date Columbia-Suicide Severity Rating Scale Baseline - Most lethal attempt date. C-SSRS Baseline - Most Lethal Suicide Attempt Date CSS01-Most Lethal Attempt Damage Columbia-Suicide Severity Rating Scale Baseline - Most lethal attempt actual lethality/medical damage. C-SSRS Baseline - Most Lethal Suicide Attempt Damage CSS01-Most Lethal Attempt Potential Columbia-Suicide Severity Rating Scale Baseline - Most lethal attempt potential lethality. C-SSRS Baseline - Most Lethal Suicide Attempt Potential CSS01-First Attempt Date Columbia-Suicide Severity Rating Scale Baseline - Initial/first attempt date. C-SSRS Baseline - First Suicide Attempt Date CSS01-First Attempt Damage Columbia-Suicide Severity Rating Scale Baseline - Initial/first attempt actual lethality/medical damage. C-SSRS Baseline - First Suicide Attempt Damage CSS01-First Attempt Potential Columbia-Suicide Severity Rating Scale Baseline - Initial/first attempt potential lethality. C-SSRS Baseline - First Suicide Attempt Potential CSS01TC Columbia-Suicide Severity Rating Scale Baseline Questionnaire Test Code CDISC Questionnaire C-SSRS Baseline Test Code Terminology Columbia-Suicide Severity Rating Scale Baseline test name. CSS01-Aborted Attempt Columbia-Suicide Severity Rating Scale Baseline - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? C-SSRS Baseline - Aborted Suicide Attempt CSS01-Aborted Attempt, Describe Columbia-Suicide Severity Rating Scale Baseline - Description of aborted attempt. C-SSRS Baseline - Description of Aborted Suicide Attempt CSS01-Actual Attempt Columbia-Suicide Severity Rating Scale Baseline - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? C-SSRS Baseline - Actual Suicide Attempt CSS01-Actual Attempt, Describe Columbia-Suicide Severity Rating Scale Baseline - Description of actual attempt. C-SSRS Baseline - Description of Actual Suicide Attempts CSS01-First Attempt Damage Columbia-Suicide Severity Rating Scale Baseline - Initial/first attempt actual lethality/medical damage. C-SSRS Baseline - First Suicide Attempt Damage CSS01-First Attempt Date Columbia-Suicide Severity Rating Scale Baseline - Initial/first attempt date. C-SSRS Baseline - First Suicide Attempt Date CSS01-First Attempt Potential Columbia-Suicide Severity Rating Scale Baseline - Initial/first attempt potential lethality. C-SSRS Baseline - First Suicide Attempt Potential CSS01-Ideation With Intent No Plan Descr Columbia-Suicide Severity Rating Scale Baseline - Description of active suicidal ideation with some intent to act, without specific plan. C-SSRS Baseline - Description of Ideation With Intent, No Plan CSS01-Ideation With Intent, No Plan Columbia-Suicide Severity Rating Scale Baseline - Have you have these thoughts and had some intention of acting on them? C-SSRS Baseline - Ideation With Intent, No Plan CSS01-Ideation With Plan/Intent Columbia-Suicide Severity Rating Scale Baseline - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? C-SSRS Baseline - Ideation With Plan/Intent CSS01-Ideation With Plan/Intent, Descr Columbia-Suicide Severity Rating Scale Baseline - Description of active suicidal ideation with specific plan and intent. C-SSRS Baseline - Description of Ideation With Plan and Intent CSS01-Interrupted Attempt Columbia-Suicide Severity Rating Scale Baseline - Has there been a time when you started to do something to end your life but someone or something stopped you before you actually did anything? C-SSRS Baseline - Interrupted Suicide Attempt CSS01-Interrupted Attempt, Describe Columbia-Suicide Severity Rating Scale Baseline - Description of interrupted attempt. C-SSRS Baseline - Description of Interrupted Suicide Attempt CSS01-Most Lethal Attempt Damage Columbia-Suicide Severity Rating Scale Baseline - Most lethal attempt actual lethality/medical damage. C-SSRS Baseline - Most Lethal Suicide Attempt Damage CSS01-Most Lethal Attempt Date Columbia-Suicide Severity Rating Scale Baseline - Most lethal attempt date. C-SSRS Baseline - Most Lethal Suicide Attempt Date CSS01-Most Lethal Attempt Potential Columbia-Suicide Severity Rating Scale Baseline - Most lethal attempt potential lethality. C-SSRS Baseline - Most Lethal Suicide Attempt Potential CSS01-Most Recent Attempt Damage Columbia-Suicide Severity Rating Scale Baseline - Most recent attempt actual lethality/medical damage. C-SSRS Baseline - Most Recent Suicide Attempt Damage CSS01-Most Recent Attempt Date Columbia-Suicide Severity Rating Scale Baseline - Most recent attempt date. C-SSRS Baseline - Most Recent Suicide Attempt Date CSS01-Most Recent Attempt Potential Columbia-Suicide Severity Rating Scale Baseline - Most recent attempt potential lethality. C-SSRS Baseline - Most Recent Suicide Attempt Potential CSS01-Most Severe Ideation Columbia-Suicide Severity Rating Scale Baseline - Most severe ideation. C-SSRS Baseline - Most Severe Ideation CSS01-Most Severe Ideation, Control Columbia-Suicide Severity Rating Scale Baseline - Could/can you stop thinking about killing yourself or wanting to die if you want to? C-SSRS Baseline - Control over Most Severe Ideation CSS01-Most Severe Ideation, Description Columbia-Suicide Severity Rating Scale Baseline - Description of most severe ideation. C-SSRS Baseline - Describe Most Severe Ideation CSS01-Most Severe Ideation, Deterrents Columbia-Suicide Severity Rating Scale Baseline - Are there things - anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? C-SSRS Baseline - Deterrents to Most Severe Ideation CSS01-Most Severe Ideation, Duration Columbia-Suicide Severity Rating Scale Baseline - When you have the thoughts, how long do they last? C-SSRS Baseline - Duration of Most Severe Ideation CSS01-Most Severe Ideation, Frequency Columbia-Suicide Severity Rating Scale Baseline - How many times have you had these thoughts? C-SSRS Baseline - Frequency of Most Severe Ideation CSS01-Most Severe Ideation, Reasons Columbia-Suicide Severity Rating Scale Baseline - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? C-SSRS Baseline - Reasons for Most Severe Ideation CSS01-Non-Specific Suicid Thought, Descr Columbia-Suicide Severity Rating Scale Baseline - Description of non-specific active suicidal thoughts. C-SSRS Baseline - Description of Non-Specific Suicide Thought CSS01-Non-Specific Suicidal Thought Columbia-Suicide Severity Rating Scale Baseline - Have you actually had any thoughts of killing yourself? C-SSRS Baseline - Non-Specific Suicidal Thought CSS01-Non-suicidal Self-injurious Behav Columbia-Suicide Severity Rating Scale Baseline - Has the subject engaged in non-suicidal self-injurious behavior. C-SSRS Baseline - Non-suicidal Self-injurious Behavior CSS01-Number of Aborted Attempts Columbia-Suicide Severity Rating Scale Baseline - Total number of aborted attempts. C-SSRS Baseline - Number of Aborted Suicide Attempts CSS01-Number of Actual Attempts Columbia-Suicide Severity Rating Scale Baseline - Total number of actual attempts. C-SSRS Baseline - Number of Actual Suicide Attempts CSS01-Number of Interrupted Attempts Columbia-Suicide Severity Rating Scale Baseline - Total number of interrupted attempts. C-SSRS Baseline - Number of Interrupted Suicide Attempts CSS01-Preparatory Acts/Behavior Columbia-Suicide Severity Rating Scale Baseline - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? C-SSRS Baseline - Preparatory Acts or Behaviors Toward Suicide Attempt CSS01-Preparatory Acts/Behavior, Descr Columbia-Suicide Severity Rating Scale Baseline - Description of preparatory acts or behavior. C-SSRS Baseline - Description of Preparatory Acts or Behaviors Toward Suicide Attempt CSS01-Suicidal Behavior Columbia-Suicide Severity Rating Scale Baseline - Suicidal behavior was present during the assessment period? C-SSRS Baseline - Suicidal Behavior CSS01-Suicidal Ideation-No Intent Columbia-Suicide Severity Rating Scale Baseline - Have you been thinking about how you might do this? C-SSRS Baseline - Suicidal Ideation-No Intent CSS01-Suicidal Ideation-No Intent, Descr Columbia-Suicide Severity Rating Scale Baseline - Description of active suicidal ideation with any methods (not plan) without intent to act. C-SSRS Baseline - Description of Suicidal Ideation-No Intent CSS01-Wish to be Dead Columbia-Suicide Severity Rating Scale Baseline - Have you wished you were dead or wished you could go to sleep and not wake up? C-SSRS Baseline - Wish to be Dead or go to Sleep and not Wake Up CSS01-Wish to be Dead, Describe Columbia-Suicide Severity Rating Scale Baseline - Description of wishing to be dead. C-SSRS Baseline - Description of Wish to be Dead CSS01TN Columbia-Suicide Severity Rating Scale Baseline Questionnaire Test Name CDISC Questionnaire C-SSRS Baseline Test Name Terminology Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study Version 1/14/2009 Questionnaire test code. CSS03-Wish to be Dead-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you wished you were dead or wished you could go to sleep and not wake up? (Lifetime). C-SSRS Baseline/Screening Version Phase 1 Study - Wish to be Dead (Lifetime) CSS03-Wish to be Dead-P6M Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you wished you were dead or wished you could go to sleep and not wake up? (Past 6 Months). C-SSRS Baseline/Screening Version Phase 1 Study - Wish to be Dead (Past 6 Months) CSS03-Wish to be Dead, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of wishing to be dead. C-SSRS Baseline/Screening Version Phase 1 Study - Description of Wish to be Dead (Lifetime) CSS03-Non-Spec Suicid Thought-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you actually had any thoughts of killing yourself? (Lifetime). C-SSRS Baseline/Screening Version Phase 1 Study - Non-Specific Active Suicidal Thoughts (Lifetime) CSS03-Non-Spec Suicid Thought-P6M Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you actually had any thoughts of killing yourself? (Past 6 Months). C-SSRS Baseline/Screening Version Phase 1 Study - Non-Specific Active Suicidal Thoughts (Past 6 Months) CSS03-Non-Spec Suicid Thought, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of non-specific active suicidal thoughts. C-SSRS Baseline/Screening Version Phase 1 Study - Description of Non-Specific Active Suicidal Thoughts (Lifetime) CSS03-Idea, No Intent, No Plan-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you been thinking about how you might do this? (Lifetime). C-SSRS Baseline/Screening Version Phase 1 Study - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Lifetime) CSS03-Idea, No Intent, No Plan-P6M Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you been thinking about how you might do this? (Past 6 Months). C-SSRS Baseline/Screening Version Phase 1 Study - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Past 6 Months) CSS03-Idea, No Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of active suicidal ideation with any methods (not plan) without intent to act. C-SSRS Baseline/Screening Version Phase 1 Study - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Lifetime) CSS03-Idea, Intent, No Plan-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you had these thoughts and had some intention of acting on them? (Lifetime). C-SSRS Baseline/Screening Version Phase 1 Study - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Lifetime) CSS03-Idea, Intent, No Plan-P6M Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you had these thoughts and had some intention of acting on them? (Past 6 Months). C-SSRS Baseline/Screening Version Phase 1 Study - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Past 6 Months) CSS03-Idea, Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of active suicidal ideation with some intent to act, without specific plan. C-SSRS Baseline/Screening Version Phase 1 Study - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Lifetime) CSS03-Idea, Plan, Intent-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Lifetime). C-SSRS Baseline/Screening Version Phase 1 Study - Active Suicidal Ideation with Specific Plan and Intent (Lifetime) CSS03-Idea, Plan, Intent-P6M Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Past 6 Months). C-SSRS Baseline/Screening Version Phase 1 Study - Active Suicidal Ideation with Specific Plan and Intent (Past 6 Months) CSS03-Idea, Plan, Intent, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of active suicidal ideation with specific plan and intent. C-SSRS Baseline/Screening Version Phase 1 Study - Description of Active Suicidal Ideation with Specific Plan and Intent (Lifetime) CSS03-Most Severe Idea-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most severe ideation. (Lifetime). C-SSRS Baseline/Screening Version Phase 1 Study - Most Severe Ideation (Lifetime) CSS03-Most Severe Idea, Desc-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of most severe ideation. (Lifetime). C-SSRS Baseline/Screening Version Phase 1 Study - Describe Most Severe Ideation (Lifetime) CSS03-Most Severe Idea-P6M Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most severe ideation. (Past 6 Months). C-SSRS Baseline/Screening Version Phase 1 Study - Most Severe Ideation (Past 6 Months) CSS03-Most Severe Idea, Desc-P6M Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of most severe ideation. (Past 6 Months). C-SSRS Baseline/Screening Version Phase 1 Study - Describe Most Severe Ideation (Past 6 Months) CSS03-Most Severe Idea, Frequency-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - How many times have you had these thoughts? (Lifetime). C-SSRS Baseline/Screening Version Phase 1 Study - Frequency of Most Severe Ideation (Lifetime) CSS03-Most Severe Idea, Frequency-P6M Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - How many times have you had these thoughts? (Past 6 Months). C-SSRS Baseline/Screening Version Phase 1 Study - Frequency of Most Severe Ideation (Past 6 Months) CSS03-Most Severe Idea, Duration-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - When you have the thoughts how long do they last? (Lifetime). C-SSRS Baseline/Screening Version Phase 1 Study - Duration of Most Severe Ideation (Lifetime) CSS03-Most Severe Idea, Duration-P6M Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - When you have the thoughts how long do they last? (Past 6 Months). C-SSRS Baseline/Screening Version Phase 1 Study - Duration of Most Severe Ideation (Past 6 Months) CSS03-Most Severe Idea, Control-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Lifetime). C-SSRS Baseline/Screening Version Phase 1 Study - Controllability of Most Severe Ideation (Lifetime) CSS03-Most Severe Idea, Control-P6M Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Past 6 Months). C-SSRS Baseline/Screening Version Phase 1 Study - Controllability of Most Severe Ideation (Past 6 Months) CSS03-Most Severe Idea, Deterrents-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Are there things-anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Lifetime). C-SSRS Baseline/Screening Version Phase 1 Study - Deterrents to Most Severe Ideation (Lifetime) CSS03-Most Severe Idea, Deterrents-P6M Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Are there things-anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Past 6 Months). C-SSRS Baseline/Screening Version Phase 1 Study - Deterrents to Most Severe Ideation (Past 6 Months) CSS03-Most Severe Idea, Reasons-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Lifetime). C-SSRS Baseline/Screening Version Phase 1 Study - Reasons for Most Severe Ideation (Lifetime) CSS03-Most Severe Idea, Reasons-P6M Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Past 6 Months). C-SSRS Baseline/Screening Version Phase 1 Study - Reasons for Most Severe Ideation (Past 6 Months) CSS03-Actual Attempt Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? C-SSRS Baseline/Screening Version Phase 1 Study - Actual Suicide Attempt CSS03-Number of Actual Attempts Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Total number of actual attempts. C-SSRS Baseline/Screening Version Phase 1 Study - Number of Actual Suicide Attempts CSS03-Actual Attempt, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of actual attempt. C-SSRS Baseline/Screening Version Phase 1 Study - Description of Actual Suicide Attempt CSS03-Non-suicidal Self-injurious Behav Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Has the subject engaged in non-suicidal self-injurious behavior. C-SSRS Baseline/Screening Version Phase 1 Study - Non-suicidal Self-injurious Behavior CSS03-Interrupted Attempt Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Has there been a time when you started to do something to end your life but someone or something stopped you before you actually did anything? C-SSRS Baseline/Screening Version Phase 1 Study - Interrupted Suicide Attempt CSS03-Number of Interrupted Attempts Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Total number of interrupted attempts. C-SSRS Baseline/Screening Version Phase 1 Study - Number of Interrupted Suicide Attempts CSS03-Interrupted Attempt, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of interrupted attempt. C-SSRS Baseline/Screening Version Phase 1 Study - Description of Interrupted Suicide Attempt CSS03-Aborted Attempt Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? C-SSRS Baseline/Screening Version Phase 1 Study - Aborted Suicide Attempt CSS03-Number of Aborted Attempts Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Total number of aborted attempts. C-SSRS Baseline/Screening Version Phase 1 Study - Number of Aborted Suicide Attempts CSS03-Aborted Attempt, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of aborted attempt. C-SSRS Baseline/Screening Version Phase 1 Study - Description of Aborted Suicide Attempt CSS03-Preparatory Acts/Behavior Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? C-SSRS Baseline/Screening Version Phase 1 Study - Preparatory Acts or Behaviors Toward Suicide Attempt CSS03-Preparatory Acts/Behavior, Descr Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of preparatory acts or behavior. C-SSRS Baseline/Screening Version Phase 1 Study - Description of Preparatory Acts or Behaviors Toward Suicide Attempt CSS03-Suicidal Behavior Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Suicidal behavior was present during the assessment period? C-SSRS Baseline/Screening Version Phase 1 Study - Suicidal Behavior CSS03-Most Recent Attempt Date Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most recent attempt date. C-SSRS Baseline/Screening Version Phase 1 Study - Most Recent Suicide Attempt Date CSS03-Most Recent Attempt Damage Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most recent attempt actual lethality/medical damage. C-SSRS Baseline/Screening Version Phase 1 Study - Most Recent Suicide Attempt Actual Lethality/Medical Damage CSS03-Most Recent Attempt Potential Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most recent attempt potential lethality. C-SSRS Baseline/Screening Version Phase 1 Study - Most Recent Suicide Attempt Potential Lethality CSS03-Most Lethal Attempt Date Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most lethal attempt date. C-SSRS Baseline/Screening Version Phase 1 Study - Most Lethal Suicide Attempt Date CSS03-Most Lethal Attempt Damage Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most lethal attempt actual lethality/medical damage. C-SSRS Baseline/Screening Version Phase 1 Study - Most Lethal Suicide Attempt Actual Lethality/Medical Damage CSS03-Most Lethal Attempt Potential Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most lethal attempt potential lethality. C-SSRS Baseline/Screening Version Phase 1 Study - Most Lethal Suicide Attempt Potential Lethality CSS03-First Attempt Date Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Initial/first attempt date. C-SSRS Baseline/Screening Version Phase 1 Study - First Suicide Attempt Date CSS03-First Attempt Damage Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Initial/first attempt actual lethality/medical damage. C-SSRS Baseline/Screening Version Phase 1 Study - First Suicide Attempt Actual Lethality/Medical Damage CSS03-First Attempt Potential Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Initial/first attempt potential lethality. C-SSRS Baseline/Screening Version Phase 1 Study - First Suicide Attempt Potential Lethality CSS03TC Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study Questionnaire Test Code CDISC Questionnaire C-SSRS Baseline/Screening Version Phase 1 Study Version 1/14/09 Test Code Terminology Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study Version 1/14/2009 test name. CSS03-Aborted Attempt Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? C-SSRS Baseline/Screening Version Phase 1 Study - Aborted Suicide Attempt CSS03-Aborted Attempt, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of aborted attempt. C-SSRS Baseline/Screening Version Phase 1 Study - Description of Aborted Suicide Attempt CSS03-Actual Attempt Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? C-SSRS Baseline/Screening Version Phase 1 Study - Actual Suicide Attempt CSS03-Actual Attempt, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of actual attempt. C-SSRS Baseline/Screening Version Phase 1 Study - Description of Actual Suicide Attempt CSS03-First Attempt Damage Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Initial/first attempt actual lethality/medical damage. C-SSRS Baseline/Screening Version Phase 1 Study - First Suicide Attempt Actual Lethality/Medical Damage CSS03-First Attempt Date Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Initial/first attempt date. C-SSRS Baseline/Screening Version Phase 1 Study - First Suicide Attempt Date CSS03-First Attempt Potential Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Initial/first attempt potential lethality. C-SSRS Baseline/Screening Version Phase 1 Study - First Suicide Attempt Potential Lethality CSS03-Idea, Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of active suicidal ideation with some intent to act, without specific plan. C-SSRS Baseline/Screening Version Phase 1 Study - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Lifetime) CSS03-Idea, Intent, No Plan-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you had these thoughts and had some intention of acting on them? (Lifetime). C-SSRS Baseline/Screening Version Phase 1 Study - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Lifetime) CSS03-Idea, Intent, No Plan-P6M Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you had these thoughts and had some intention of acting on them? (Past 6 Months). C-SSRS Baseline/Screening Version Phase 1 Study - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Past 6 Months) CSS03-Idea, No Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of active suicidal ideation with any methods (not plan) without intent to act. C-SSRS Baseline/Screening Version Phase 1 Study - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Lifetime) CSS03-Idea, No Intent, No Plan-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you been thinking about how you might do this? (Lifetime). C-SSRS Baseline/Screening Version Phase 1 Study - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Lifetime) CSS03-Idea, No Intent, No Plan-P6M Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you been thinking about how you might do this? (Past 6 Months). C-SSRS Baseline/Screening Version Phase 1 Study - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Past 6 Months) CSS03-Idea, Plan, Intent, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of active suicidal ideation with specific plan and intent. C-SSRS Baseline/Screening Version Phase 1 Study - Description of Active Suicidal Ideation with Specific Plan and Intent (Lifetime) CSS03-Idea, Plan, Intent-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Lifetime). C-SSRS Baseline/Screening Version Phase 1 Study - Active Suicidal Ideation with Specific Plan and Intent (Lifetime) CSS03-Idea, Plan, Intent-P6M Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Past 6 Months). C-SSRS Baseline/Screening Version Phase 1 Study - Active Suicidal Ideation with Specific Plan and Intent (Past 6 Months) CSS03-Interrupted Attempt Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Has there been a time when you started to do something to end your life but someone or something stopped you before you actually did anything? C-SSRS Baseline/Screening Version Phase 1 Study - Interrupted Suicide Attempt CSS03-Interrupted Attempt, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of interrupted attempt. C-SSRS Baseline/Screening Version Phase 1 Study - Description of Interrupted Suicide Attempt CSS03-Most Lethal Attempt Damage Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most lethal attempt actual lethality/medical damage. C-SSRS Baseline/Screening Version Phase 1 Study - Most Lethal Suicide Attempt Actual Lethality/Medical Damage CSS03-Most Lethal Attempt Date Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most lethal attempt date. C-SSRS Baseline/Screening Version Phase 1 Study - Most Lethal Suicide Attempt Date CSS03-Most Lethal Attempt Potential Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most lethal attempt potential lethality. C-SSRS Baseline/Screening Version Phase 1 Study - Most Lethal Suicide Attempt Potential Lethality CSS03-Most Recent Attempt Damage Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most recent attempt actual lethality/medical damage. C-SSRS Baseline/Screening Version Phase 1 Study - Most Recent Suicide Attempt Actual Lethality/Medical Damage CSS03-Most Recent Attempt Date Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most recent attempt date. C-SSRS Baseline/Screening Version Phase 1 Study - Most Recent Suicide Attempt Date CSS03-Most Recent Attempt Potential Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most recent attempt potential lethality. C-SSRS Baseline/Screening Version Phase 1 Study - Most Recent Suicide Attempt Potential Lethality CSS03-Most Severe Idea, Control-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Lifetime). C-SSRS Baseline/Screening Version Phase 1 Study - Controllability of Most Severe Ideation (Lifetime) CSS03-Most Severe Idea, Control-P6M Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Past 6 Months). C-SSRS Baseline/Screening Version Phase 1 Study - Controllability of Most Severe Ideation (Past 6 Months) CSS03-Most Severe Idea, Desc-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of most severe ideation. (Lifetime). C-SSRS Baseline/Screening Version Phase 1 Study - Describe Most Severe Ideation (Lifetime) CSS03-Most Severe Idea, Desc-P6M Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of most severe ideation. (Past 6 Months). C-SSRS Baseline/Screening Version Phase 1 Study - Describe Most Severe Ideation (Past 6 Months) CSS03-Most Severe Idea, Deterrents-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Are there things-anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Lifetime). C-SSRS Baseline/Screening Version Phase 1 Study - Deterrents to Most Severe Ideation (Lifetime) CSS03-Most Severe Idea, Deterrents-P6M Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Are there things-anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Past 6 Months). C-SSRS Baseline/Screening Version Phase 1 Study - Deterrents to Most Severe Ideation (Past 6 Months) CSS03-Most Severe Idea, Duration-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - When you have the thoughts how long do they last? (Lifetime). C-SSRS Baseline/Screening Version Phase 1 Study - Duration of Most Severe Ideation (Lifetime) CSS03-Most Severe Idea, Duration-P6M Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - When you have the thoughts how long do they last? (Past 6 Months). C-SSRS Baseline/Screening Version Phase 1 Study - Duration of Most Severe Ideation (Past 6 Months) CSS03-Most Severe Idea, Frequency-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - How many times have you had these thoughts? (Lifetime). C-SSRS Baseline/Screening Version Phase 1 Study - Frequency of Most Severe Ideation (Lifetime) CSS03-Most Severe Idea, Frequency-P6M Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - How many times have you had these thoughts? (Past 6 Months). C-SSRS Baseline/Screening Version Phase 1 Study - Frequency of Most Severe Ideation (Past 6 Months) CSS03-Most Severe Idea, Reasons-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Lifetime). C-SSRS Baseline/Screening Version Phase 1 Study - Reasons for Most Severe Ideation (Lifetime) CSS03-Most Severe Idea, Reasons-P6M Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Past 6 Months). C-SSRS Baseline/Screening Version Phase 1 Study - Reasons for Most Severe Ideation (Past 6 Months) CSS03-Most Severe Idea-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most severe ideation. (Lifetime). C-SSRS Baseline/Screening Version Phase 1 Study - Most Severe Ideation (Lifetime) CSS03-Most Severe Idea-P6M Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most severe ideation. (Past 6 Months). C-SSRS Baseline/Screening Version Phase 1 Study - Most Severe Ideation (Past 6 Months) CSS03-Non-Spec Suicid Thought, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of non-specific active suicidal thoughts. C-SSRS Baseline/Screening Version Phase 1 Study - Description of Non-Specific Active Suicidal Thoughts (Lifetime) CSS03-Non-Spec Suicid Thought-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you actually had any thoughts of killing yourself? (Lifetime). C-SSRS Baseline/Screening Version Phase 1 Study - Non-Specific Active Suicidal Thoughts (Lifetime) CSS03-Non-Spec Suicid Thought-P6M Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you actually had any thoughts of killing yourself? (Past 6 Months). C-SSRS Baseline/Screening Version Phase 1 Study - Non-Specific Active Suicidal Thoughts (Past 6 Months) CSS03-Non-suicidal Self-injurious Behav Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Has the subject engaged in non-suicidal self-injurious behavior. C-SSRS Baseline/Screening Version Phase 1 Study - Non-suicidal Self-injurious Behavior CSS03-Number of Aborted Attempts Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Total number of aborted attempts. C-SSRS Baseline/Screening Version Phase 1 Study - Number of Aborted Suicide Attempts CSS03-Number of Actual Attempts Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Total number of actual attempts. C-SSRS Baseline/Screening Version Phase 1 Study - Number of Actual Suicide Attempts CSS03-Number of Interrupted Attempts Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Total number of interrupted attempts. C-SSRS Baseline/Screening Version Phase 1 Study - Number of Interrupted Suicide Attempts CSS03-Preparatory Acts/Behavior Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? C-SSRS Baseline/Screening Version Phase 1 Study - Preparatory Acts or Behaviors Toward Suicide Attempt CSS03-Preparatory Acts/Behavior, Descr Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of preparatory acts or behavior. C-SSRS Baseline/Screening Version Phase 1 Study - Description of Preparatory Acts or Behaviors Toward Suicide Attempt CSS03-Suicidal Behavior Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Suicidal behavior was present during the assessment period? C-SSRS Baseline/Screening Version Phase 1 Study - Suicidal Behavior CSS03-Wish to be Dead, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of wishing to be dead. C-SSRS Baseline/Screening Version Phase 1 Study - Description of Wish to be Dead (Lifetime) CSS03-Wish to be Dead-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you wished you were dead or wished you could go to sleep and not wake up? (Lifetime). C-SSRS Baseline/Screening Version Phase 1 Study - Wish to be Dead (Lifetime) CSS03-Wish to be Dead-P6M Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you wished you were dead or wished you could go to sleep and not wake up? (Past 6 Months). C-SSRS Baseline/Screening Version Phase 1 Study - Wish to be Dead (Past 6 Months) CSS03TN Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study Questionnaire Test Name CDISC Questionnaire C-SSRS Baseline/Screening Version Phase 1 Study Version 1/14/09 Test Name Terminology Columbia-Suicide Severity Rating Scale Baseline/Screening Version test code. CSS04-Wish to be Dead-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you wished you were dead or wished you could go to sleep and not wake up? (Lifetime). C-SSRS Baseline/Screening Version - Wish to be Dead (Lifetime) CSS04-Wish to be Dead-P_M Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you wished you were dead or wished you could go to sleep and not wake up? (Past _ Months). C-SSRS Baseline/Screening Version - Wish to be Dead (Past X Months) CSS04-Wish to be Dead, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of wishing to be dead. C-SSRS Baseline/Screening Version - Description of Wish to be Dead CSS04-Non-Spec Suicid Thought-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you actually had any thoughts of killing yourself? (Lifetime). C-SSRS Baseline/Screening Version - Non-Specific Active Suicidal Thoughts (Lifetime) CSS04-Non-Spec Suicid Thought-P_M Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you actually had any thoughts of killing yourself? (Past _ Months). C-SSRS Baseline/Screening Version - Non-Specific Active Suicidal Thoughts (Past X Months) CSS04-Non-Spec Suicid Thought, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of non-specific active suicidal thoughts. C-SSRS Baseline/Screening Version - Description of Non-Specific Active Suicidal Thoughts CSS04-Idea, No Intent, No Plan-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you been thinking about how you might do this? (Lifetime). C-SSRS Baseline/Screening Version - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Lifetime) CSS04-Idea, No Intent, No Plan-P_M Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you been thinking about how you might do this? (Past _ Months). C-SSRS Baseline/Screening Version - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Past X Months) CSS04-Idea, No Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of active suicidal ideation with any methods (not plan) without intent to act. C-SSRS Baseline/Screening Version - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act CSS04-Idea, Intent, No Plan-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you had these thoughts and had some intention of acting on them? (Lifetime). C-SSRS Baseline/Screening Version - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Lifetime) CSS04-Idea, Intent, No Plan-P_M Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you had these thoughts and had some intention of acting on them? (Past _ Months). C-SSRS Baseline/Screening Version - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Past X Months) CSS04-Idea, Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of active suicidal ideation with some intent to act, without specific plan. C-SSRS Baseline/Screening Version - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan CSS04-Idea, Plan, Intent-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Lifetime). C-SSRS Baseline/Screening Version - Active Suicidal Ideation with Specific Plan and Intent (Lifetime) CSS04-Idea, Plan, Intent-P_M Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Past _ Months). C-SSRS Baseline/Screening Version - Active Suicidal Ideation with Specific Plan and Intent (Past X Months) CSS04-Idea, Plan, Intent, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of active suicidal ideation with specific plan and intent. C-SSRS Baseline/Screening Version - Description of Active Suicidal Ideation with Specific Plan and Intent CSS04-Most Severe Idea-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most severe ideation. (Lifetime). C-SSRS Baseline/Screening Version - Most Severe Ideation (Lifetime) CSS04-Most Severe Idea, Desc-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of most severe ideation. (Lifetime). C-SSRS Baseline/Screening Version - Describe Most Severe Ideation (Lifetime) CSS04-Most Severe Idea-P_M Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most severe ideation. (Past _ Months). C-SSRS Baseline/Screening Version - Most Severe Ideation (Past X Months) CSS04-Most Severe Idea, Desc-P_M Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of most severe ideation. (Past _ Months). C-SSRS Baseline/Screening Version - Describe Most Severe Ideation (Past X Months) CSS04-Most Severe Idea, Frequency-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - How many times have you had these thoughts? (Lifetime). C-SSRS Baseline/Screening Version - Frequency of Most Severe Ideation (Lifetime) CSS04-Most Severe Idea, Frequency-P_M Columbia-Suicide Severity Rating Scale Baseline/Screening Version - How many times have you had these thoughts? (Past _ Months). C-SSRS Baseline/Screening Version - Frequency of Most Severe Ideation (Past X Months) CSS04-Most Severe Idea, Duration-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - When you have the thoughts how long do they last? (Lifetime). C-SSRS Baseline/Screening Version - Duration of Most Severe Ideation (Lifetime) CSS04-Most Severe Idea, Duration-P_M Columbia-Suicide Severity Rating Scale Baseline/Screening Version - When you have the thoughts how long do they last? (Past _ Months). C-SSRS Baseline/Screening Version - Duration of Most Severe Ideation (Past X Months) CSS04-Most Severe Idea, Control-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Lifetime). C-SSRS Baseline/Screening Version - Controllability of Most Severe Ideation (Lifetime) CSS04-Most Severe Idea, Control-P_M Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Past _ Months). C-SSRS Baseline/Screening Version - Controllability of Most Severe Ideation (Past X Months) CSS04-Most Severe Idea, Deterrents-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Are there things-anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Lifetime). C-SSRS Baseline/Screening Version - Deterrents to Most Severe Ideation (Lifetime) CSS04-Most Severe Idea, Deterrents-P_M Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Are there things-anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Past _ Months). C-SSRS Baseline/Screening Version - Deterrents to Most Severe Ideation (Past X Months) CSS04-Most Severe Idea, Reasons-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Lifetime). C-SSRS Baseline/Screening Version - Reasons for Most Severe Ideation (Lifetime) CSS04-Most Severe Idea, Reasons-P_M Columbia-Suicide Severity Rating Scale Baseline/Screening Version - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Past _ Months). C-SSRS Baseline/Screening Version - Reasons for Most Severe Ideation (Past X Months) CSS04-Actual Attempt-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? (Lifetime). C-SSRS Baseline/Screening Version - Actual Suicide Attempt (Lifetime) CSS04-Actual Attempt-P_Y Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? (Past _ Years). C-SSRS Baseline/Screening Version - Actual Suicide Attempt (Past X Years) CSS04-Number of Actual Attempts-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Total number of actual attempts. (Lifetime). C-SSRS Baseline/Screening Version - Number of Actual Suicide Attempts (Lifetime) CSS04-Number of Actual Attempts-P_Y Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Total number of actual attempts. (Past _ Years). C-SSRS Baseline/Screening Version - Number of Actual Suicide Attempts (Past X Years) CSS04-Actual Attempt, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of actual attempt. C-SSRS Baseline/Screening Version - Description of Actual Suicide Attempt CSS04-Non-suicidal Self-injur Behav-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Has the subject engaged in non-suicidal self-injurious behavior. (Lifetime). C-SSRS Baseline/Screening Version - Non-suicidal Self-injurious Behavior (Lifetime) CSS04-Non-suicidal Self-injur Behav-P_Y Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Has the subject engaged in non-suicidal self-injurious behavior. (Past _ Years). C-SSRS Baseline/Screening Version - Non-suicidal Self-injurious Behavior (Past X Years) CSS04-Interrupted Attempt-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Has there been a time when you started to do something to end your life but someone or something stopped you before you actually did anything? (Lifetime). C-SSRS Baseline/Screening Version - Interrupted Suicide Attempt (Lifetime) CSS04-Interrupted Attempt-P_Y Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Has there been a time when you started to do something to end your life but someone or something stopped you before you actually did anything? (Past _ Years). C-SSRS Baseline/Screening Version - Interrupted Suicide Attempt (Past X Years) CSS04-Number of Interrupt Attempts-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Total number of interrupted attempts. (Lifetime). C-SSRS Baseline/Screening Version - Number of Interrupted Suicide Attempts (Lifetime) CSS04-Number of Interrupt Attempts-P_Y Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Total number of interrupted attempts. (Past _ Years). C-SSRS Baseline/Screening Version - Number of Interrupted Suicide Attempts (Past X Years) CSS04-Interrupted Attempt, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of interrupted attempt. C-SSRS Baseline/Screening Version - Description of Interrupted Suicide Attempt CSS04-Aborted Attempt-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? (Lifetime). C-SSRS Baseline/Screening Version - Aborted Suicide Attempt (Lifetime) CSS04-Aborted Attempt-P_Y Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? (Past _ Years). C-SSRS Baseline/Screening Version - Aborted Suicide Attempt (Past X Years) CSS04-Number of Aborted Attempts-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Total number of aborted attempts. (Lifetime). C-SSRS Baseline/Screening Version - Number of Aborted Suicide Attempts (Lifetime) CSS04-Number of Aborted Attempts-P_Y Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Total number of aborted attempts. (Past _ Years). C-SSRS Baseline/Screening Version - Number of Aborted Suicide Attempts (Past X Years) CSS04-Aborted Attempt, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of aborted attempt. C-SSRS Baseline/Screening Version - Description of Aborted Suicide Attempt CSS04-Preparatory Acts/Behavior-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? (Lifetime). C-SSRS Baseline/Screening Version - Preparatory Acts or Behaviors Toward Suicide Attempt (Lifetime) CSS04-Preparatory Acts/Behavior-P_Y Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? (Past _ Years). C-SSRS Baseline/Screening Version - Preparatory Acts or Behaviors Toward Suicide Attempt (Past X Years) CSS04-Preparatory Acts/Behav, Descr Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of preparatory acts or behavior. C-SSRS Baseline/Screening Version - Description of Preparatory Acts or Behaviors Toward Suicide Attempt CSS04-Suicidal Behavior-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Suicidal behavior was present during the assessment period? (Lifetime). C-SSRS Baseline/Screening Version - Suicidal Behavior (Lifetime) CSS04-Suicidal Behavior-P_Y Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Suicidal behavior was present during the assessment period? (Past _ Years). C-SSRS Baseline/Screening Version - Suicidal Behavior (Past X Years) CSS04-Most Recent Attempt Date Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most recent attempt date. C-SSRS Baseline/Screening Version - Most Recent Suicide Attempt Date CSS04-Most Recent Attempt Damage Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most recent attempt actual lethality/medical damage. C-SSRS Baseline/Screening Version - Most Recent Suicide Attempt Actual Lethality/Medical Damage CSS04-Most Recent Attempt Potential Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most recent attempt potential lethality. C-SSRS Baseline/Screening Version - Most Recent Suicide Attempt Potential Lethality CSS04-Most Lethal Attempt Date Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most lethal attempt date. C-SSRS Baseline/Screening Version - Most Lethal Suicide Attempt Date CSS04-Most Lethal Attempt Damage Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most lethal attempt actual lethality/medical damage. C-SSRS Baseline/Screening Version - Most Lethal Suicide Attempt Actual Lethality/Medical Damage CSS04-Most Lethal Attempt Potential Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most lethal attempt potential lethality. C-SSRS Baseline/Screening Version - Most Lethal Suicide Attempt Potential Lethality CSS04-First Attempt Date Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Initial/first attempt date. C-SSRS Baseline/Screening Version - First Suicide Attempt Date CSS04-First Attempt Damage Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Initial/first attempt actual lethality/medical damage. C-SSRS Baseline/Screening Version - First Suicide Attempt Actual Lethality/Medical Damage CSS04-First Attempt Potential Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Initial/first attempt potential lethality. C-SSRS Baseline/Screening Version - First Suicide Attempt Potential Lethality CSS04TC Columbia-Suicide Severity Rating Scale Baseline/Screening Version Questionnaire Test Code CDISC Questionnaire C-SSRS Baseline/Screening Version Test Code Terminology Columbia-Suicide Severity Rating Scale Baseline/Screening Version test name. CSS04-Aborted Attempt, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of aborted attempt. C-SSRS Baseline/Screening Version - Description of Aborted Suicide Attempt CSS04-Aborted Attempt-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? (Lifetime). C-SSRS Baseline/Screening Version - Aborted Suicide Attempt (Lifetime) CSS04-Aborted Attempt-P_Y Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? (Past _ Years). C-SSRS Baseline/Screening Version - Aborted Suicide Attempt (Past X Years) CSS04-Actual Attempt, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of actual attempt. C-SSRS Baseline/Screening Version - Description of Actual Suicide Attempt CSS04-Actual Attempt-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? (Lifetime). C-SSRS Baseline/Screening Version - Actual Suicide Attempt (Lifetime) CSS04-Actual Attempt-P_Y Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? (Past _ Years). C-SSRS Baseline/Screening Version - Actual Suicide Attempt (Past X Years) CSS04-First Attempt Damage Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Initial/first attempt actual lethality/medical damage. C-SSRS Baseline/Screening Version - First Suicide Attempt Actual Lethality/Medical Damage CSS04-First Attempt Date Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Initial/first attempt date. C-SSRS Baseline/Screening Version - First Suicide Attempt Date CSS04-First Attempt Potential Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Initial/first attempt potential lethality. C-SSRS Baseline/Screening Version - First Suicide Attempt Potential Lethality CSS04-Idea, Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of active suicidal ideation with some intent to act, without specific plan. C-SSRS Baseline/Screening Version - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan CSS04-Idea, Intent, No Plan-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you had these thoughts and had some intention of acting on them? (Lifetime). C-SSRS Baseline/Screening Version - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Lifetime) CSS04-Idea, Intent, No Plan-P_M Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you had these thoughts and had some intention of acting on them? (Past _ Months). C-SSRS Baseline/Screening Version - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Past X Months) CSS04-Idea, No Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of active suicidal ideation with any methods (not plan) without intent to act. C-SSRS Baseline/Screening Version - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act CSS04-Idea, No Intent, No Plan-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you been thinking about how you might do this? (Lifetime). C-SSRS Baseline/Screening Version - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Lifetime) CSS04-Idea, No Intent, No Plan-P_M Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you been thinking about how you might do this? (Past _ Months). C-SSRS Baseline/Screening Version - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Past X Months) CSS04-Idea, Plan, Intent, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of active suicidal ideation with specific plan and intent. C-SSRS Baseline/Screening Version - Description of Active Suicidal Ideation with Specific Plan and Intent CSS04-Idea, Plan, Intent-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Lifetime). C-SSRS Baseline/Screening Version - Active Suicidal Ideation with Specific Plan and Intent (Lifetime) CSS04-Idea, Plan, Intent-P_M Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Past _ Months). C-SSRS Baseline/Screening Version - Active Suicidal Ideation with Specific Plan and Intent (Past X Months) CSS04-Interrupted Attempt, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of interrupted attempt. C-SSRS Baseline/Screening Version - Description of Interrupted Suicide Attempt CSS04-Interrupted Attempt-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Has there been a time when you started to do something to end your life but someone or something stopped you before you actually did anything? (Lifetime). C-SSRS Baseline/Screening Version - Interrupted Suicide Attempt (Lifetime) CSS04-Interrupted Attempt-P_Y Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Has there been a time when you started to do something to end your life but someone or something stopped you before you actually did anything? (Past _ Years). C-SSRS Baseline/Screening Version - Interrupted Suicide Attempt (Past X Years) CSS04-Most Lethal Attempt Damage Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most lethal attempt actual lethality/medical damage. C-SSRS Baseline/Screening Version - Most Lethal Suicide Attempt Actual Lethality/Medical Damage CSS04-Most Lethal Attempt Date Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most lethal attempt date. C-SSRS Baseline/Screening Version - Most Lethal Suicide Attempt Date CSS04-Most Lethal Attempt Potential Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most lethal attempt potential lethality. C-SSRS Baseline/Screening Version - Most Lethal Suicide Attempt Potential Lethality CSS04-Most Recent Attempt Damage Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most recent attempt actual lethality/medical damage. C-SSRS Baseline/Screening Version - Most Recent Suicide Attempt Actual Lethality/Medical Damage CSS04-Most Recent Attempt Date Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most recent attempt date. C-SSRS Baseline/Screening Version - Most Recent Suicide Attempt Date CSS04-Most Recent Attempt Potential Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most recent attempt potential lethality. C-SSRS Baseline/Screening Version - Most Recent Suicide Attempt Potential Lethality CSS04-Most Severe Idea, Control-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Lifetime). C-SSRS Baseline/Screening Version - Controllability of Most Severe Ideation (Lifetime) CSS04-Most Severe Idea, Control-P_M Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Past _ Months). C-SSRS Baseline/Screening Version - Controllability of Most Severe Ideation (Past X Months) CSS04-Most Severe Idea, Desc-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of most severe ideation. (Lifetime). C-SSRS Baseline/Screening Version - Describe Most Severe Ideation (Lifetime) CSS04-Most Severe Idea, Desc-P_M Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of most severe ideation. (Past _ Months). C-SSRS Baseline/Screening Version - Describe Most Severe Ideation (Past X Months) CSS04-Most Severe Idea, Deterrents-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Are there things-anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Lifetime). C-SSRS Baseline/Screening Version - Deterrents to Most Severe Ideation (Lifetime) CSS04-Most Severe Idea, Deterrents-P_M Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Are there things-anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Past _ Months). C-SSRS Baseline/Screening Version - Deterrents to Most Severe Ideation (Past X Months) CSS04-Most Severe Idea, Duration-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - When you have the thoughts how long do they last? (Lifetime). C-SSRS Baseline/Screening Version - Duration of Most Severe Ideation (Lifetime) CSS04-Most Severe Idea, Duration-P_M Columbia-Suicide Severity Rating Scale Baseline/Screening Version - When you have the thoughts how long do they last? (Past _ Months). C-SSRS Baseline/Screening Version - Duration of Most Severe Ideation (Past X Months) CSS04-Most Severe Idea, Frequency-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - How many times have you had these thoughts? (Lifetime). C-SSRS Baseline/Screening Version - Frequency of Most Severe Ideation (Lifetime) CSS04-Most Severe Idea, Frequency-P_M Columbia-Suicide Severity Rating Scale Baseline/Screening Version - How many times have you had these thoughts? (Past _ Months). C-SSRS Baseline/Screening Version - Frequency of Most Severe Ideation (Past X Months) CSS04-Most Severe Idea, Reasons-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Lifetime). C-SSRS Baseline/Screening Version - Reasons for Most Severe Ideation (Lifetime) CSS04-Most Severe Idea, Reasons-P_M Columbia-Suicide Severity Rating Scale Baseline/Screening Version - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Past _ Months). C-SSRS Baseline/Screening Version - Reasons for Most Severe Ideation (Past X Months) CSS04-Most Severe Idea-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most severe ideation. (Lifetime). C-SSRS Baseline/Screening Version - Most Severe Ideation (Lifetime) CSS04-Most Severe Idea-P_M Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most severe ideation. (Past _ Months). C-SSRS Baseline/Screening Version - Most Severe Ideation (Past X Months) CSS04-Non-Spec Suicid Thought, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of non-specific active suicidal thoughts. C-SSRS Baseline/Screening Version - Description of Non-Specific Active Suicidal Thoughts CSS04-Non-Spec Suicid Thought-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you actually had any thoughts of killing yourself? (Lifetime). C-SSRS Baseline/Screening Version - Non-Specific Active Suicidal Thoughts (Lifetime) CSS04-Non-Spec Suicid Thought-P_M Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you actually had any thoughts of killing yourself? (Past _ Months). C-SSRS Baseline/Screening Version - Non-Specific Active Suicidal Thoughts (Past X Months) CSS04-Non-suicidal Self-injur Behav-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Has the subject engaged in non-suicidal self-injurious behavior. (Lifetime). C-SSRS Baseline/Screening Version - Non-suicidal Self-injurious Behavior (Lifetime) CSS04-Non-suicidal Self-injur Behav-P_Y Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Has the subject engaged in non-suicidal self-injurious behavior. (Past _ Years). C-SSRS Baseline/Screening Version - Non-suicidal Self-injurious Behavior (Past X Years) CSS04-Number of Aborted Attempts-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Total number of aborted attempts. (Lifetime). C-SSRS Baseline/Screening Version - Number of Aborted Suicide Attempts (Lifetime) CSS04-Number of Aborted Attempts-P_Y Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Total number of aborted attempts. (Past _ Years). C-SSRS Baseline/Screening Version - Number of Aborted Suicide Attempts (Past X Years) CSS04-Number of Actual Attempts-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Total number of actual attempts. (Lifetime). C-SSRS Baseline/Screening Version - Number of Actual Suicide Attempts (Lifetime) CSS04-Number of Actual Attempts-P_Y Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Total number of actual attempts. (Past _ Years). C-SSRS Baseline/Screening Version - Number of Actual Suicide Attempts (Past X Years) CSS04-Number of Interrupt Attempts-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Total number of interrupted attempts. (Lifetime). C-SSRS Baseline/Screening Version - Number of Interrupted Suicide Attempts (Lifetime) CSS04-Number of Interrupt Attempts-P_Y Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Total number of interrupted attempts. (Past _ Years). C-SSRS Baseline/Screening Version - Number of Interrupted Suicide Attempts (Past X Years) CSS04-Preparatory Acts/Behav, Descr Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of preparatory acts or behavior. C-SSRS Baseline/Screening Version - Description of Preparatory Acts or Behaviors Toward Suicide Attempt CSS04-Preparatory Acts/Behavior-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? (Lifetime). C-SSRS Baseline/Screening Version - Preparatory Acts or Behaviors Toward Suicide Attempt (Lifetime) CSS04-Preparatory Acts/Behavior-P_Y Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? (Past _ Years). C-SSRS Baseline/Screening Version - Preparatory Acts or Behaviors Toward Suicide Attempt (Past X Years) CSS04-Suicidal Behavior-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Suicidal behavior was present during the assessment period? (Lifetime). C-SSRS Baseline/Screening Version - Suicidal Behavior (Lifetime) CSS04-Suicidal Behavior-P_Y Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Suicidal behavior was present during the assessment period? (Past _ Years). C-SSRS Baseline/Screening Version - Suicidal Behavior (Past X Years) CSS04-Wish to be Dead, Describe Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of wishing to be dead. C-SSRS Baseline/Screening Version - Description of Wish to be Dead CSS04-Wish to be Dead-Life Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you wished you were dead or wished you could go to sleep and not wake up? (Lifetime). C-SSRS Baseline/Screening Version - Wish to be Dead (Lifetime) CSS04-Wish to be Dead-P_M Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you wished you were dead or wished you could go to sleep and not wake up? (Past _ Months). C-SSRS Baseline/Screening Version - Wish to be Dead (Past X Months) CSS04TN Columbia-Suicide Severity Rating Scale Baseline/Screening Version Questionnaire Test Name CDISC Questionnaire C-SSRS Baseline/Screening Version Test Name Terminology Columbia-Suicide Severity Rating Scale Children's Baseline test code. CSS06-Wish to be Dead Columbia-Suicide Severity Rating Scale Children's Baseline - Have you thought about being dead or what it would be like to be dead? Have you wished you were dead or wished you could go to sleep and never wake up? Do you ever wish you weren't alive anymore? C-SSRS Children's Baseline - Wish to be Dead CSS06-Wish to be Dead, Describe Columbia-Suicide Severity Rating Scale Children's Baseline - Description of wishing to be dead. C-SSRS Children's Baseline - Description of Wish to be Dead CSS06-Non-Specific Suicidal Thought Columbia-Suicide Severity Rating Scale Children's Baseline - Have you thought about doing something to make yourself not alive anymore? Have you had any thoughts about killing yourself? C-SSRS Children's Baseline - Non-Specific Active Suicidal Thoughts CSS06-Non-Specific Suicid Thought, Descr Columbia-Suicide Severity Rating Scale Children's Baseline - Description of non-specific active suicidal thoughts. C-SSRS Children's Baseline - Description of Non-Specific Active Suicidal Thoughts CSS06-Idea, No Intent, No Plan Columbia-Suicide Severity Rating Scale Children's Baseline - Have you thought about how you would do that or how you would make yourself not alive anymore (kill yourself)? What did you think about? C-SSRS Children's Baseline - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act CSS06-Idea, No Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Children's Baseline - Description of active suicidal ideation with any methods (not plan) without intent to act. C-SSRS Children's Baseline - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act CSS06-Ideation With Intent, No Plan Columbia-Suicide Severity Rating Scale Children's Baseline - When you thought about making yourself not alive anymore (or killing yourself), did you think that this was something you might actually do? This is different from (as opposed to) having the thoughts but knowing you wouldn't do anything about it. C-SSRS Children's Baseline - Active Suicidal Ideation with Some Intent to Act, without Specific Plan CSS06-Ideation With Intent No Plan Descr Columbia-Suicide Severity Rating Scale Children's Baseline - Description of active suicidal ideation with some intent to act, without specific plan. C-SSRS Children's Baseline - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan CSS06-Ideation With Plan/Intent Columbia-Suicide Severity Rating Scale Children's Baseline - Have you ever decided how or when you would make yourself not alive anymore/kill yourself? Have you ever planned out (worked out the details of) how you would do it? What was your plan? When you made this plan (or worked out these details), was any part of you thinking about actually doing it? C-SSRS Children's Baseline - Active Suicidal Ideation with Specific Plan and Intent CSS06-Ideation With Plan/Intent, Descr Columbia-Suicide Severity Rating Scale Children's Baseline - Description of active suicidal ideation with specific plan and intent. C-SSRS Children's Baseline - Description of Active Suicidal Ideation with Specific Plan and Intent CSS06-Most Severe Ideation Columbia-Suicide Severity Rating Scale Children's Baseline - Most severe ideation. C-SSRS Children's Baseline - Most Severe Ideation CSS06-Most Severe Ideation, Description Columbia-Suicide Severity Rating Scale Children's Baseline - Description of most severe ideation. C-SSRS Children's Baseline - Describe Most Severe Ideation CSS06-Most Severe Ideation, Frequency Columbia-Suicide Severity Rating Scale Children's Baseline - How many times have you had these thoughts? C-SSRS Children's Baseline - Frequency of Most Severe Ideation CSS06-Frequency, Write Response Columbia-Suicide Severity Rating Scale Children's Baseline - Frequency, write response. C-SSRS Children's Baseline - Frequency, Write Response CSS06-Actual Attempt Columbia-Suicide Severity Rating Scale Children's Baseline - Did you ever do anything to try to kill yourself or make yourself not alive anymore? What did you do? Did you ever hurt yourself on purpose? Why did you do that? C-SSRS Children's Baseline - Actual Suicide Attempt CSS06-Number of Actual Attempts Columbia-Suicide Severity Rating Scale Children's Baseline - Total number of actual attempts. C-SSRS Children's Baseline - Number of Actual Suicide Attempts CSS06-Actual Attempt, Describe Columbia-Suicide Severity Rating Scale Children's Baseline - Description of actual attempt. C-SSRS Children's Baseline - Description of Actual Suicide Attempt CSS06-Non-suicidal Self-injurious Behav Columbia-Suicide Severity Rating Scale Children's Baseline - Has subject engaged in non-suicidal self-injurious behavior? C-SSRS Children's Baseline - Non-suicidal Self-injurious Behavior CSS06-Self-injur Behav, Intent Unknown Columbia-Suicide Severity Rating Scale Children's Baseline - Has subject engaged in self-injurious behavior, intent unknown? C-SSRS Children's Baseline - Self-injurious Behavior, Intent Unknown CSS06-Interrupted Attempt Columbia-Suicide Severity Rating Scale Children's Baseline - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but someone or something stopped you before you actually did anything? What did you do? C-SSRS Children's Baseline - Interrupted Suicide Attempt CSS06-Number of Interrupt Attempts Columbia-Suicide Severity Rating Scale Children's Baseline - Total number of interrupted attempts. C-SSRS Children's Baseline - Number of Interrupted Suicide Attempts CSS06-Interrupted Attempt, Describe Columbia-Suicide Severity Rating Scale Children's Baseline - Description of interrupted attempt. C-SSRS Children's Baseline - Description of Interrupted Suicide Attempt CSS06-Aborted Attempt Columbia-Suicide Severity Rating Scale Children's Baseline - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but you changed your mind (stopped yourself) before you actually did anything? What did you do? C-SSRS Children's Baseline - Aborted Suicide Attempt CSS06-Number of Aborted Attempts Columbia-Suicide Severity Rating Scale Children's Baseline - Total number of aborted attempts. C-SSRS Children's Baseline - Number of Aborted Suicide Attempts CSS06-Aborted Attempt, Describe Columbia-Suicide Severity Rating Scale Children's Baseline - Description of aborted attempt. C-SSRS Children's Baseline - Description of Aborted Suicide Attempt CSS06-Preparatory Acts/Behavior Columbia-Suicide Severity Rating Scale Children's Baseline - Have you done anything to get ready to make yourself not alive anymore (to end your life or kill yourself) - like giving things away, writing a goodbye note, getting things you need to kill yourself? C-SSRS Children's Baseline - Preparatory Acts or Behaviors Toward Suicide Attempt CSS06-Preparatory Acts/Behavior, Descr Columbia-Suicide Severity Rating Scale Children's Baseline - Description of preparatory acts or behavior. C-SSRS Children's Baseline - Description of Preparatory Acts or Behaviors Toward Suicide Attempt CSS06-Suicidal Behavior Columbia-Suicide Severity Rating Scale Children's Baseline - Suicidal behavior was present during the assessment period? C-SSRS Children's Baseline - Suicidal Behavior CSS06-Most Recent Attempt Date Columbia-Suicide Severity Rating Scale Children's Baseline - Most recent attempt date. C-SSRS Children's Baseline - Most Recent Suicide Attempt Date CSS06-Most Recent Attempt Damage Columbia-Suicide Severity Rating Scale Children's Baseline - Most recent attempt actual lethality/medical damage. C-SSRS Children's Baseline - Most Recent Suicide Attempt Actual Lethality/Medical Damage CSS06-Most Recent Attempt Potential Columbia-Suicide Severity Rating Scale Children's Baseline - Most recent attempt potential lethality. C-SSRS Children's Baseline - Most Recent Suicide Attempt Potential Lethality CSS06-Most Lethal Attempt Date Columbia-Suicide Severity Rating Scale Children's Baseline - Most lethal attempt date. C-SSRS Children's Baseline - Most Lethal Suicide Attempt Date CSS06-Most Lethal Attempt Damage Columbia-Suicide Severity Rating Scale Children's Baseline - Most lethal attempt actual lethality/medical damage. C-SSRS Children's Baseline - Most Lethal Suicide Attempt Actual Lethality/Medical Damage CSS06-Most Lethal Attempt Potential Columbia-Suicide Severity Rating Scale Children's Baseline - Most lethal attempt potential lethality. C-SSRS Children's Baseline - Most Lethal Suicide Attempt Potential Lethality CSS06-First Attempt Date Columbia-Suicide Severity Rating Scale Children's Baseline - Initial/first attempt date. C-SSRS Children's Baseline - First Suicide Attempt Date CSS06-First Attempt Damage Columbia-Suicide Severity Rating Scale Children's Baseline - Initial/first attempt actual lethality/medical damage. C-SSRS Children's Baseline - First Suicide Attempt Actual Lethality/Medical Damage CSS06-First Attempt Potential Columbia-Suicide Severity Rating Scale Children's Baseline - Initial/first attempt potential lethality. C-SSRS Children's Baseline - First Suicide Attempt Potential Lethality CSS06TC Columbia-Suicide Severity Rating Scale Children's Baseline Questionnaire Test Code CDISC Questionnaire C-SSRS Children's Baseline Test Code Terminology Columbia-Suicide Severity Rating Scale Children's Baseline test name. CSS06-Aborted Attempt Columbia-Suicide Severity Rating Scale Children's Baseline - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but you changed your mind (stopped yourself) before you actually did anything? What did you do? C-SSRS Children's Baseline - Aborted Suicide Attempt CSS06-Aborted Attempt, Describe Columbia-Suicide Severity Rating Scale Children's Baseline - Description of aborted attempt. C-SSRS Children's Baseline - Description of Aborted Suicide Attempt CSS06-Actual Attempt Columbia-Suicide Severity Rating Scale Children's Baseline - Did you ever do anything to try to kill yourself or make yourself not alive anymore? What did you do? Did you ever hurt yourself on purpose? Why did you do that? C-SSRS Children's Baseline - Actual Suicide Attempt CSS06-Actual Attempt, Describe Columbia-Suicide Severity Rating Scale Children's Baseline - Description of actual attempt. C-SSRS Children's Baseline - Description of Actual Suicide Attempt CSS06-First Attempt Damage Columbia-Suicide Severity Rating Scale Children's Baseline - Initial/first attempt actual lethality/medical damage. C-SSRS Children's Baseline - First Suicide Attempt Actual Lethality/Medical Damage CSS06-First Attempt Date Columbia-Suicide Severity Rating Scale Children's Baseline - Initial/first attempt date. C-SSRS Children's Baseline - First Suicide Attempt Date CSS06-First Attempt Potential Columbia-Suicide Severity Rating Scale Children's Baseline - Initial/first attempt potential lethality. C-SSRS Children's Baseline - First Suicide Attempt Potential Lethality CSS06-Frequency, Write Response Columbia-Suicide Severity Rating Scale Children's Baseline - Frequency, write response. C-SSRS Children's Baseline - Frequency, Write Response CSS06-Idea, No Intent, No Plan Columbia-Suicide Severity Rating Scale Children's Baseline - Have you thought about how you would do that or how you would make yourself not alive anymore (kill yourself)? What did you think about? C-SSRS Children's Baseline - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act CSS06-Idea, No Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Children's Baseline - Description of active suicidal ideation with any methods (not plan) without intent to act. C-SSRS Children's Baseline - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act CSS06-Ideation With Intent No Plan Descr Columbia-Suicide Severity Rating Scale Children's Baseline - Description of active suicidal ideation with some intent to act, without specific plan. C-SSRS Children's Baseline - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan CSS06-Ideation With Intent, No Plan Columbia-Suicide Severity Rating Scale Children's Baseline - When you thought about making yourself not alive anymore (or killing yourself), did you think that this was something you might actually do? This is different from (as opposed to) having the thoughts but knowing you wouldn't do anything about it. C-SSRS Children's Baseline - Active Suicidal Ideation with Some Intent to Act, without Specific Plan CSS06-Ideation With Plan/Intent Columbia-Suicide Severity Rating Scale Children's Baseline - Have you ever decided how or when you would make yourself not alive anymore/kill yourself? Have you ever planned out (worked out the details of) how you would do it? What was your plan? When you made this plan (or worked out these details), was any part of you thinking about actually doing it? C-SSRS Children's Baseline - Active Suicidal Ideation with Specific Plan and Intent CSS06-Ideation With Plan/Intent, Descr Columbia-Suicide Severity Rating Scale Children's Baseline - Description of active suicidal ideation with specific plan and intent. C-SSRS Children's Baseline - Description of Active Suicidal Ideation with Specific Plan and Intent CSS06-Interrupted Attempt Columbia-Suicide Severity Rating Scale Children's Baseline - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but someone or something stopped you before you actually did anything? What did you do? C-SSRS Children's Baseline - Interrupted Suicide Attempt CSS06-Interrupted Attempt, Describe Columbia-Suicide Severity Rating Scale Children's Baseline - Description of interrupted attempt. C-SSRS Children's Baseline - Description of Interrupted Suicide Attempt CSS06-Most Lethal Attempt Damage Columbia-Suicide Severity Rating Scale Children's Baseline - Most lethal attempt actual lethality/medical damage. C-SSRS Children's Baseline - Most Lethal Suicide Attempt Actual Lethality/Medical Damage CSS06-Most Lethal Attempt Date Columbia-Suicide Severity Rating Scale Children's Baseline - Most lethal attempt date. C-SSRS Children's Baseline - Most Lethal Suicide Attempt Date CSS06-Most Lethal Attempt Potential Columbia-Suicide Severity Rating Scale Children's Baseline - Most lethal attempt potential lethality. C-SSRS Children's Baseline - Most Lethal Suicide Attempt Potential Lethality CSS06-Most Recent Attempt Damage Columbia-Suicide Severity Rating Scale Children's Baseline - Most recent attempt actual lethality/medical damage. C-SSRS Children's Baseline - Most Recent Suicide Attempt Actual Lethality/Medical Damage CSS06-Most Recent Attempt Date Columbia-Suicide Severity Rating Scale Children's Baseline - Most recent attempt date. C-SSRS Children's Baseline - Most Recent Suicide Attempt Date CSS06-Most Recent Attempt Potential Columbia-Suicide Severity Rating Scale Children's Baseline - Most recent attempt potential lethality. C-SSRS Children's Baseline - Most Recent Suicide Attempt Potential Lethality CSS06-Most Severe Ideation Columbia-Suicide Severity Rating Scale Children's Baseline - Most severe ideation. C-SSRS Children's Baseline - Most Severe Ideation CSS06-Most Severe Ideation, Description Columbia-Suicide Severity Rating Scale Children's Baseline - Description of most severe ideation. C-SSRS Children's Baseline - Describe Most Severe Ideation CSS06-Most Severe Ideation, Frequency Columbia-Suicide Severity Rating Scale Children's Baseline - How many times have you had these thoughts? C-SSRS Children's Baseline - Frequency of Most Severe Ideation CSS06-Non-Specific Suicid Thought, Descr Columbia-Suicide Severity Rating Scale Children's Baseline - Description of non-specific active suicidal thoughts. C-SSRS Children's Baseline - Description of Non-Specific Active Suicidal Thoughts CSS06-Non-Specific Suicidal Thought Columbia-Suicide Severity Rating Scale Children's Baseline - Have you thought about doing something to make yourself not alive anymore? Have you had any thoughts about killing yourself? C-SSRS Children's Baseline - Non-Specific Active Suicidal Thoughts CSS06-Non-suicidal Self-injurious Behav Columbia-Suicide Severity Rating Scale Children's Baseline - Has subject engaged in non-suicidal self-injurious behavior? C-SSRS Children's Baseline - Non-suicidal Self-injurious Behavior CSS06-Number of Aborted Attempts Columbia-Suicide Severity Rating Scale Children's Baseline - Total number of aborted attempts. C-SSRS Children's Baseline - Number of Aborted Suicide Attempts CSS06-Number of Actual Attempts Columbia-Suicide Severity Rating Scale Children's Baseline - Total number of actual attempts. C-SSRS Children's Baseline - Number of Actual Suicide Attempts CSS06-Number of Interrupt Attempts Columbia-Suicide Severity Rating Scale Children's Baseline - Total number of interrupted attempts. C-SSRS Children's Baseline - Number of Interrupted Suicide Attempts CSS06-Preparatory Acts/Behavior Columbia-Suicide Severity Rating Scale Children's Baseline - Have you done anything to get ready to make yourself not alive anymore (to end your life or kill yourself) - like giving things away, writing a goodbye note, getting things you need to kill yourself? C-SSRS Children's Baseline - Preparatory Acts or Behaviors Toward Suicide Attempt CSS06-Preparatory Acts/Behavior, Descr Columbia-Suicide Severity Rating Scale Children's Baseline - Description of preparatory acts or behavior. C-SSRS Children's Baseline - Description of Preparatory Acts or Behaviors Toward Suicide Attempt CSS06-Self-injur Behav, Intent Unknown Columbia-Suicide Severity Rating Scale Children's Baseline - Has subject engaged in self-injurious behavior, intent unknown? C-SSRS Children's Baseline - Self-injurious Behavior, Intent Unknown CSS06-Suicidal Behavior Columbia-Suicide Severity Rating Scale Children's Baseline - Suicidal behavior was present during the assessment period? C-SSRS Children's Baseline - Suicidal Behavior CSS06-Wish to be Dead Columbia-Suicide Severity Rating Scale Children's Baseline - Have you thought about being dead or what it would be like to be dead? Have you wished you were dead or wished you could go to sleep and never wake up? Do you ever wish you weren't alive anymore? C-SSRS Children's Baseline - Wish to be Dead CSS06-Wish to be Dead, Describe Columbia-Suicide Severity Rating Scale Children's Baseline - Description of wishing to be dead. C-SSRS Children's Baseline - Description of Wish to be Dead CSS06TN Columbia-Suicide Severity Rating Scale Children's Baseline Questionnaire Test Name CDISC Questionnaire C-SSRS Children's Baseline Test Name Terminology Columbia-Suicide Severity Rating Scale Children's Baseline/Screening test code. CSS07-Wish to be Dead-Life Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you thought about being dead or what it would be like to be dead? Have you wished you were dead or wished you could go to sleep and never wake up? Do you ever wish you weren't alive anymore? (Lifetime). C-SSRS Children's Baseline/Screening - Wish to be Dead (Lifetime) CSS07-Wish to be Dead-P6M Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you thought about being dead or what it would be like to be dead? Have you wished you were dead or wished you could go to sleep and never wake up? Do you ever wish you weren't alive anymore? (Past 6 Months). C-SSRS Children's Baseline/Screening - Wish to be Dead (Past 6 Months) CSS07-Wish to be Dead, Describe Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of wishing to be dead. C-SSRS Children's Baseline/Screening - Description of Wish to be Dead CSS07-Non-Spec Suicid Thought-Life Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you thought about doing something to make yourself not alive anymore? Have you had any thoughts about killing yourself? (Lifetime). C-SSRS Children's Baseline/Screening - Non-Specific Active Suicidal Thoughts (Lifetime) CSS07-Non-Spec Suicid Thought-P6M Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you thought about doing something to make yourself not alive anymore? Have you had any thoughts about killing yourself? (Past 6 Months). C-SSRS Children's Baseline/Screening - Non-Specific Active Suicidal Thoughts (Past 6 Months) CSS07-Non-Spec Suicid Thought, Describe Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of non-specific active suicidal thoughts. C-SSRS Children's Baseline/Screening - Description of Non-Specific Active Suicidal Thoughts CSS07-Idea, No Intent, No Plan-Life Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you thought about how you would do that or how you would make yourself not alive anymore (kill yourself)? What did you think about? (Lifetime). C-SSRS Children's Baseline/Screening - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Lifetime) CSS07-Idea, No Intent, No Plan-P6M Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you thought about how you would do that or how you would make yourself not alive anymore (kill yourself)? What did you think about? (Past 6 Months). C-SSRS Children's Baseline/Screening - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Past 6 Months) CSS07-Idea, No Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of active suicidal ideation with any methods (not plan) without intent to act. C-SSRS Children's Baseline/Screening - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act CSS07-Idea, Intent, No Plan-Life Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - When you thought about making yourself not alive anymore (or killing yourself), did you think that this was something you might actually do? This is different from (as opposed to) having the thoughts but knowing you wouldn't do anything about it. (Lifetime). C-SSRS Children's Baseline/Screening - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Lifetime) CSS07-Idea, Intent, No Plan-P6M Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - When you thought about making yourself not alive anymore (or killing yourself), did you think that this was something you might actually do? This is different from (as opposed to) having the thoughts but knowing you wouldn't do anything about it. (Past 6 Months). C-SSRS Children's Baseline/Screening - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Past 6 Months) CSS07-Idea, Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of active suicidal ideation with some intent to act, without specific plan. C-SSRS Children's Baseline/Screening - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan CSS07-Idea, Plan, Intent-Life Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you ever decided how or when you would make yourself not alive anymore/kill yourself? Have you ever planned out (worked out the details of) how you would do it? What was your plan? When you made this plan (or worked out these details), was any part of you thinking about actually doing it? (Lifetime). C-SSRS Children's Baseline/Screening - Active Suicidal Ideation with Specific Plan and Intent (Lifetime) CSS07-Idea, Plan, Intent-P6M Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you ever decided how or when you would make yourself not alive anymore/kill yourself? Have you ever planned out (worked out the details of) how you would do it? What was your plan? When you made this plan (or worked out these details), was any part of you thinking about actually doing it? (Past 6 Months). C-SSRS Children's Baseline/Screening - Active Suicidal Ideation with Specific Plan and Intent (Past 6 Months) CSS07-Idea, Plan, Intent, Describe Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of active suicidal ideation with specific plan and intent. C-SSRS Children's Baseline/Screening - Description of Active Suicidal Ideation with Specific Plan and Intent CSS07-Most Severe Idea Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Most severe ideation. C-SSRS Children's Baseline/Screening - Most Severe Ideation CSS07-Most Severe Idea, Desc Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of most severe ideation. C-SSRS Children's Baseline/Screening - Describe Most Severe Ideation CSS07-Most Severe Idea, Frequency-Life Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - How many times have you had these thoughts? (Lifetime). C-SSRS Children's Baseline/Screening - Frequency of Most Severe Ideation (Lifetime) CSS07-Most Severe Idea, Frequency-P6M Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - How many times have you had these thoughts? (Past 6 Months). C-SSRS Children's Baseline/Screening - Frequency of Most Severe Ideation (Past 6 Months) CSS07-Frequency, Write Response Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Frequency, write response. C-SSRS Children's Baseline/Screening - Frequency, Write Response CSS07-Actual Attempt Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Did you ever do anything to try to kill yourself or make yourself not alive anymore? What did you do? Did you ever hurt yourself on purpose? Why did you do that? C-SSRS Children's Baseline/Screening - Actual Suicide Attempt CSS07-Number of Actual Attempts Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Total number of actual attempts. C-SSRS Children's Baseline/Screening - Number of Actual Suicide Attempts CSS07-Actual Attempt, Describe Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of actual attempt. C-SSRS Children's Baseline/Screening - Description of Actual Suicide Attempt CSS07-Non-suicidal Self-injur Behav Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Has subject engaged in non-suicidal self-injurious behavior? C-SSRS Children's Baseline/Screening - Non-suicidal Self-injurious Behavior CSS07-Self-injur Behav, Intent Unknown Columbia-Suicide Severity Rating Scale Children's Baseline - Has subject engaged in self-injurious behavior, intent unknown? C-SSRS Children's Baseline/Screening - Self-injurious Behavior, Intent Unknown CSS07-Interrupted Attempt Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but someone or something stopped you before you actually did anything? What did you do? C-SSRS Children's Baseline/Screening - Interrupted Suicide Attempt CSS07-Number of Interrupt Attempts Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Total number of interrupted attempts. C-SSRS Children's Baseline/Screening - Number of Interrupted Suicide Attempts CSS07-Interrupted Attempt, Describe Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of interrupted attempt. C-SSRS Children's Baseline/Screening - Description of Interrupted Suicide Attempt CSS07-Aborted Attempt Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but you changed your mind (stopped yourself) before you actually did anything? What did you do? C-SSRS Children's Baseline/Screening - Aborted Suicide Attempt CSS07-Number of Aborted Attempts Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Total number of aborted attempts. C-SSRS Children's Baseline/Screening - Number of Aborted Suicide Attempts CSS07-Aborted Attempt, Describe Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of aborted attempt. C-SSRS Children's Baseline/Screening - Description of Aborted Suicide Attempt CSS07-Preparatory Acts/Behavior Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you done anything to get ready to make yourself not alive anymore (to end your life or kill yourself) - like giving things away, writing a goodbye note, getting things you need to kill yourself? C-SSRS Children's Baseline/Screening - Preparatory Acts or Behaviors Toward Suicide Attempt CSS07-Preparatory Acts/Behavior, Descr Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of preparatory acts or behavior. C-SSRS Children's Baseline/Screening - Description of Preparatory Acts or Behaviors Toward Suicide Attempt CSS07-Suicidal Behavior Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Suicidal behavior was present during the assessment period? C-SSRS Children's Baseline/Screening - Suicidal Behavior CSS07-Most Recent Attempt Date Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Most recent attempt date. C-SSRS Children's Baseline/Screening - Most Recent Suicide Attempt Date CSS07-Most Recent Attempt Damage Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Most recent attempt actual lethality/medical damage. C-SSRS Children's Baseline/Screening - Most Recent Suicide Attempt Actual Lethality/Medical Damage CSS07-Most Recent Attempt Potential Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Most recent attempt potential lethality. C-SSRS Children's Baseline/Screening - Most Recent Suicide Attempt Potential Lethality CSS07-Most Lethal Attempt Date Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Most lethal attempt date. C-SSRS Children's Baseline/Screening - Most Lethal Suicide Attempt Date CSS07-Most Lethal Attempt Damage Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Most lethal attempt actual lethality/medical damage. C-SSRS Children's Baseline/Screening - Most Lethal Suicide Attempt Actual Lethality/Medical Damage CSS07-Most Lethal Attempt Potential Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Most lethal attempt potential lethality. C-SSRS Children's Baseline/Screening - Most Lethal Suicide Attempt Potential Lethality CSS07-First Attempt Date Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Initial/first attempt date. C-SSRS Children's Baseline/Screening - First Suicide Attempt Date CSS07-First Attempt Damage Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Initial/first attempt actual lethality/medical damage. C-SSRS Children's Baseline/Screening - First Suicide Attempt Actual Lethality/Medical Damage CSS07-First Attempt Potential Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Initial/first attempt potential lethality. C-SSRS Children's Baseline/Screening - First Suicide Attempt Potential Lethality CSS07TC Columbia-Suicide Severity Rating Scale Children's Baseline/Screening Questionnaire Test Code CDISC Questionnaire C-SSRS Children's Baseline/Screening Test Code Terminology Columbia-Suicide Severity Rating Scale Children's Baseline/Screening test name. CSS07-Aborted Attempt Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but you changed your mind (stopped yourself) before you actually did anything? What did you do? C-SSRS Children's Baseline/Screening - Aborted Suicide Attempt CSS07-Aborted Attempt, Describe Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of aborted attempt. C-SSRS Children's Baseline/Screening - Description of Aborted Suicide Attempt CSS07-Actual Attempt Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Did you ever do anything to try to kill yourself or make yourself not alive anymore? What did you do? Did you ever hurt yourself on purpose? Why did you do that? C-SSRS Children's Baseline/Screening - Actual Suicide Attempt CSS07-Actual Attempt, Describe Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of actual attempt. C-SSRS Children's Baseline/Screening - Description of Actual Suicide Attempt CSS07-First Attempt Damage Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Initial/first attempt actual lethality/medical damage. C-SSRS Children's Baseline/Screening - First Suicide Attempt Actual Lethality/Medical Damage CSS07-First Attempt Date Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Initial/first attempt date. C-SSRS Children's Baseline/Screening - First Suicide Attempt Date CSS07-First Attempt Potential Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Initial/first attempt potential lethality. C-SSRS Children's Baseline/Screening - First Suicide Attempt Potential Lethality CSS07-Frequency, Write Response Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Frequency, write response. C-SSRS Children's Baseline/Screening - Frequency, Write Response CSS07-Idea, Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of active suicidal ideation with some intent to act, without specific plan. C-SSRS Children's Baseline/Screening - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan CSS07-Idea, Intent, No Plan-Life Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - When you thought about making yourself not alive anymore (or killing yourself), did you think that this was something you might actually do? This is different from (as opposed to) having the thoughts but knowing you wouldn't do anything about it. (Lifetime). C-SSRS Children's Baseline/Screening - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Lifetime) CSS07-Idea, Intent, No Plan-P6M Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - When you thought about making yourself not alive anymore (or killing yourself), did you think that this was something you might actually do? This is different from (as opposed to) having the thoughts but knowing you wouldn't do anything about it. (Past 6 Months). C-SSRS Children's Baseline/Screening - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Past 6 Months) CSS07-Idea, No Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of active suicidal ideation with any methods (not plan) without intent to act. C-SSRS Children's Baseline/Screening - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act CSS07-Idea, No Intent, No Plan-Life Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you thought about how you would do that or how you would make yourself not alive anymore (kill yourself)? What did you think about? (Lifetime). C-SSRS Children's Baseline/Screening - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Lifetime) CSS07-Idea, No Intent, No Plan-P6M Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you thought about how you would do that or how you would make yourself not alive anymore (kill yourself)? What did you think about? (Past 6 Months). C-SSRS Children's Baseline/Screening - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Past 6 Months) CSS07-Idea, Plan, Intent, Describe Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of active suicidal ideation with specific plan and intent. C-SSRS Children's Baseline/Screening - Description of Active Suicidal Ideation with Specific Plan and Intent CSS07-Idea, Plan, Intent-Life Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you ever decided how or when you would make yourself not alive anymore/kill yourself? Have you ever planned out (worked out the details of) how you would do it? What was your plan? When you made this plan (or worked out these details), was any part of you thinking about actually doing it? (Lifetime). C-SSRS Children's Baseline/Screening - Active Suicidal Ideation with Specific Plan and Intent (Lifetime) CSS07-Idea, Plan, Intent-P6M Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you ever decided how or when you would make yourself not alive anymore/kill yourself? Have you ever planned out (worked out the details of) how you would do it? What was your plan? When you made this plan (or worked out these details), was any part of you thinking about actually doing it? (Past 6 Months). C-SSRS Children's Baseline/Screening - Active Suicidal Ideation with Specific Plan and Intent (Past 6 Months) CSS07-Interrupted Attempt Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but someone or something stopped you before you actually did anything? What did you do? C-SSRS Children's Baseline/Screening - Interrupted Suicide Attempt CSS07-Interrupted Attempt, Describe Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of interrupted attempt. C-SSRS Children's Baseline/Screening - Description of Interrupted Suicide Attempt CSS07-Most Lethal Attempt Damage Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Most lethal attempt actual lethality/medical damage. C-SSRS Children's Baseline/Screening - Most Lethal Suicide Attempt Actual Lethality/Medical Damage CSS07-Most Lethal Attempt Date Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Most lethal attempt date. C-SSRS Children's Baseline/Screening - Most Lethal Suicide Attempt Date CSS07-Most Lethal Attempt Potential Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Most lethal attempt potential lethality. C-SSRS Children's Baseline/Screening - Most Lethal Suicide Attempt Potential Lethality CSS07-Most Recent Attempt Damage Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Most recent attempt actual lethality/medical damage. C-SSRS Children's Baseline/Screening - Most Recent Suicide Attempt Actual Lethality/Medical Damage CSS07-Most Recent Attempt Date Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Most recent attempt date. C-SSRS Children's Baseline/Screening - Most Recent Suicide Attempt Date CSS07-Most Recent Attempt Potential Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Most recent attempt potential lethality. C-SSRS Children's Baseline/Screening - Most Recent Suicide Attempt Potential Lethality CSS07-Most Severe Idea Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Most severe ideation. C-SSRS Children's Baseline/Screening - Most Severe Ideation CSS07-Most Severe Idea, Desc Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of most severe ideation. C-SSRS Children's Baseline/Screening - Describe Most Severe Ideation CSS07-Most Severe Idea, Frequency-Life Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - How many times have you had these thoughts? (Lifetime). C-SSRS Children's Baseline/Screening - Frequency of Most Severe Ideation (Lifetime) CSS07-Most Severe Idea, Frequency-P6M Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - How many times have you had these thoughts? (Past 6 Months). C-SSRS Children's Baseline/Screening - Frequency of Most Severe Ideation (Past 6 Months) CSS07-Non-Spec Suicid Thought, Describe Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of non-specific active suicidal thoughts. C-SSRS Children's Baseline/Screening - Description of Non-Specific Active Suicidal Thoughts CSS07-Non-Spec Suicid Thought-Life Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you thought about doing something to make yourself not alive anymore? Have you had any thoughts about killing yourself? (Lifetime). C-SSRS Children's Baseline/Screening - Non-Specific Active Suicidal Thoughts (Lifetime) CSS07-Non-Spec Suicid Thought-P6M Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you thought about doing something to make yourself not alive anymore? Have you had any thoughts about killing yourself? (Past 6 Months). C-SSRS Children's Baseline/Screening - Non-Specific Active Suicidal Thoughts (Past 6 Months) CSS07-Non-suicidal Self-injur Behav Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Has subject engaged in non-suicidal self-injurious behavior? C-SSRS Children's Baseline/Screening - Non-suicidal Self-injurious Behavior CSS07-Number of Aborted Attempts Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Total number of aborted attempts. C-SSRS Children's Baseline/Screening - Number of Aborted Suicide Attempts CSS07-Number of Actual Attempts Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Total number of actual attempts. C-SSRS Children's Baseline/Screening - Number of Actual Suicide Attempts CSS07-Number of Interrupt Attempts Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Total number of interrupted attempts. C-SSRS Children's Baseline/Screening - Number of Interrupted Suicide Attempts CSS07-Preparatory Acts/Behavior Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you done anything to get ready to make yourself not alive anymore (to end your life or kill yourself) - like giving things away, writing a goodbye note, getting things you need to kill yourself? C-SSRS Children's Baseline/Screening - Preparatory Acts or Behaviors Toward Suicide Attempt CSS07-Preparatory Acts/Behavior, Descr Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of preparatory acts or behavior. C-SSRS Children's Baseline/Screening - Description of Preparatory Acts or Behaviors Toward Suicide Attempt CSS07-Self-injur Behav, Intent Unknown Columbia-Suicide Severity Rating Scale Children's Baseline - Has subject engaged in self-injurious behavior, intent unknown? C-SSRS Children's Baseline/Screening - Self-injurious Behavior, Intent Unknown CSS07-Suicidal Behavior Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Suicidal behavior was present during the assessment period? C-SSRS Children's Baseline/Screening - Suicidal Behavior CSS07-Wish to be Dead, Describe Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of wishing to be dead. C-SSRS Children's Baseline/Screening - Description of Wish to be Dead CSS07-Wish to be Dead-Life Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you thought about being dead or what it would be like to be dead? Have you wished you were dead or wished you could go to sleep and never wake up? Do you ever wish you weren't alive anymore? (Lifetime). C-SSRS Children's Baseline/Screening - Wish to be Dead (Lifetime) CSS07-Wish to be Dead-P6M Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you thought about being dead or what it would be like to be dead? Have you wished you were dead or wished you could go to sleep and never wake up? Do you ever wish you weren't alive anymore? (Past 6 Months). C-SSRS Children's Baseline/Screening - Wish to be Dead (Past 6 Months) CSS07TN Columbia-Suicide Severity Rating Scale Children's Baseline/Screening Questionnaire Test Name CDISC Questionnaire C-SSRS Children's Baseline/Screening Test Name Terminology Columbia-Suicide Severity Rating Scale Children's Since Last Visit test code. CSS08-Wish to be Dead Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Have you thought about being dead or what it would be like to be dead? Have you wished you were dead or wished you could go to sleep and never wake up? Do you ever wish you weren't alive anymore? C-SSRS Children's Since Last Visit - Wish to be Dead CSS08-Wish to be Dead, Describe Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of wishing to be dead. C-SSRS Children's Since Last Visit - Description of Wish to be Dead CSS08-Non-Specific Suicidal Thought Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Have you thought about doing something to make yourself not alive anymore? Have you had any thoughts about killing yourself? C-SSRS Children's Since Last Visit - Non-Specific Active Suicidal Thoughts CSS08-Non-Specific Suicid Thought, Descr Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of non-specific active suicidal thoughts. C-SSRS Children's Since Last Visit - Description of Non-Specific Active Suicidal Thoughts CSS08-Idea, No Intent, No Plan Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Have you thought about how you would do that or how you would make yourself not alive anymore (kill yourself)? What did you think about? C-SSRS Children's Since Last Visit - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act CSS08-Idea, No Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of active suicidal ideation with any methods (not plan) without intent to act. C-SSRS Children's Since Last Visit - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act CSS08-Ideation With Intent, No Plan Columbia-Suicide Severity Rating Scale Children's Since Last Visit - When you thought about making yourself not alive anymore (or killing yourself), did you think that this was something you might actually do? This is different from (as opposed to) having the thoughts but knowing you wouldn't do anything about it. C-SSRS Children's Since Last Visit - Active Suicidal Ideation with Some Intent to Act, without Specific Plan CSS08-Ideation With Intent No Plan Descr Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of active suicidal ideation with some intent to act, without specific plan. C-SSRS Children's Since Last Visit - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan CSS08-Ideation With Plan/Intent Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Have you decided how or when you would make yourself not alive anymore/kill yourself? Have you planned out (worked out the details of) how you would do it? What was your plan? When you made this plan (or worked out these details), was any part of you thinking about actually doing it? C-SSRS Children's Since Last Visit - Active Suicidal Ideation with Specific Plan and Intent CSS08-Ideation With Plan/Intent, Descr Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of active suicidal ideation with specific plan and intent. C-SSRS Children's Since Last Visit - Description of Active Suicidal Ideation with Specific Plan and Intent CSS08-Most Severe Ideation Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Most severe ideation. C-SSRS Children's Since Last Visit - Most Severe Ideation CSS08-Most Severe Ideation, Description Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of most severe ideation. C-SSRS Children's Since Last Visit - Describe Most Severe Ideation CSS08-Most Severe Ideation, Frequency Columbia-Suicide Severity Rating Scale Children's Since Last Visit - How many times have you had these thoughts? C-SSRS Children's Since Last Visit - Frequency of Most Severe Ideation CSS08-Frequency, Write Response Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Frequency, write response. C-SSRS Children's Since Last Visit - Frequency, Write Response CSS08-Actual Attempt Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Did you do anything to try to kill yourself or make yourself not alive anymore? What did you do? Did you hurt yourself on purpose? Why did you do that? C-SSRS Children's Since Last Visit - Actual Suicide Attempt CSS08-Number of Actual Attempts Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Total number of actual attempts. C-SSRS Children's Since Last Visit - Number of Actual Suicide Attempts CSS08-Actual Attempt, Describe Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of actual attempt. C-SSRS Children's Since Last Visit - Description of Actual Suicide Attempt CSS08-Non-suicidal Self-injurious Behav Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Has subject engaged in non-suicidal self-injurious behavior? C-SSRS Children's Since Last Visit - Non-suicidal Self-injurious Behavior CSS08-Self-injur Behav, Intent Unknown Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Has subject engaged in self-injurious behavior, intent unknown? C-SSRS Children's Since Last Visit - Self-injurious Behavior, Intent Unknown CSS08-Interrupted Attempt Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but someone or something stopped you before you actually did anything? What did you do? C-SSRS Children's Since Last Visit - Interrupted Suicide Attempt CSS08-Number of Interrupt Attempts Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Total number of interrupted attempts. C-SSRS Children's Since Last Visit - Number of Interrupted Suicide Attempts CSS08-Interrupted Attempt, Describe Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of interrupted attempt. C-SSRS Children's Since Last Visit - Description of Interrupted Suicide Attempt CSS08-Aborted/Self-Interrupted Attempt Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but you changed your mind (stopped yourself) before you actually did anything? What did you do? C-SSRS Children's Since Last Visit - Aborted or Self-interrupted Suicide Attempt CSS08-Number of Aborted Attempts Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Total number of aborted or self-interrupted attempts. C-SSRS Children's Since Last Visit - Number of Aborted or Self-interrupted Suicide Attempts CSS08-Aborted Attempt, Describe Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of aborted attempt or self-interrupted attempt. C-SSRS Children's Since Last Visit - Description of Aborted or Self-interrupted Suicide Attempt CSS08-Preparatory Acts/Behavior Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Have you done anything to get ready to make yourself not alive anymore (to end your life or kill yourself) - like giving things away, writing a goodbye note, getting things you need to kill yourself? C-SSRS Children's Since Last Visit - Preparatory Acts or Behaviors Toward Suicide Attempt CSS08-Preparatory Acts/Behavior, Descr Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of preparatory acts or behavior. C-SSRS Children's Since Last Visit - Description of Preparatory Acts or Behaviors Toward Suicide Attempt CSS08-Suicidal Behavior Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Suicidal behavior was present during the assessment period? C-SSRS Children's Since Last Visit - Suicidal Behavior CSS08-Suicide Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Suicide. C-SSRS Children's Since Last Visit - Suicide CSS08-Most Lethal Attempt Date Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Most lethal attempt date. C-SSRS Children's Since Last Visit - Most Lethal Suicide Attempt Date CSS08-Most Lethal Attempt Damage Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Most lethal attempt actual lethality/medical damage. C-SSRS Children's Since Last Visit - Most Lethal Suicide Attempt Actual Lethality/Medical Damage CSS08-Most Lethal Attempt Potential Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Most lethal attempt potential lethality. C-SSRS Children's Since Last Visit - Most Lethal Suicide Attempt Potential Lethality CSS08TC Columbia-Suicide Severity Rating Scale Children's Since Last Visit Questionnaire Test Code CDISC Questionnaire C-SSRS Children's Since Last Visit Test Code Terminology Columbia-Suicide Severity Rating Scale Children's Since Last Visit test name. CSS08-Aborted Attempt, Describe Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of aborted attempt or self-interrupted attempt. C-SSRS Children's Since Last Visit - Description of Aborted or Self-interrupted Suicide Attempt CSS08-Aborted/Self-Interrupted Attempt Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but you changed your mind (stopped yourself) before you actually did anything? What did you do? C-SSRS Children's Since Last Visit - Aborted or Self-interrupted Suicide Attempt CSS08-Actual Attempt Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Did you do anything to try to kill yourself or make yourself not alive anymore? What did you do? Did you hurt yourself on purpose? Why did you do that? C-SSRS Children's Since Last Visit - Actual Suicide Attempt CSS08-Actual Attempt, Describe Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of actual attempt. C-SSRS Children's Since Last Visit - Description of Actual Suicide Attempt CSS08-Frequency, Write Response Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Frequency, write response. C-SSRS Children's Since Last Visit - Frequency, Write Response CSS08-Idea, No Intent, No Plan Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Have you thought about how you would do that or how you would make yourself not alive anymore (kill yourself)? What did you think about? C-SSRS Children's Since Last Visit - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act CSS08-Idea, No Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of active suicidal ideation with any methods (not plan) without intent to act. C-SSRS Children's Since Last Visit - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act CSS08-Ideation With Intent No Plan Descr Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of active suicidal ideation with some intent to act, without specific plan. C-SSRS Children's Since Last Visit - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan CSS08-Ideation With Intent, No Plan Columbia-Suicide Severity Rating Scale Children's Since Last Visit - When you thought about making yourself not alive anymore (or killing yourself), did you think that this was something you might actually do? This is different from (as opposed to) having the thoughts but knowing you wouldn't do anything about it. C-SSRS Children's Since Last Visit - Active Suicidal Ideation with Some Intent to Act, without Specific Plan CSS08-Ideation With Plan/Intent Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Have you decided how or when you would make yourself not alive anymore/kill yourself? Have you planned out (worked out the details of) how you would do it? What was your plan? When you made this plan (or worked out these details), was any part of you thinking about actually doing it? C-SSRS Children's Since Last Visit - Active Suicidal Ideation with Specific Plan and Intent CSS08-Ideation With Plan/Intent, Descr Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of active suicidal ideation with specific plan and intent. C-SSRS Children's Since Last Visit - Description of Active Suicidal Ideation with Specific Plan and Intent CSS08-Interrupted Attempt Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but someone or something stopped you before you actually did anything? What did you do? C-SSRS Children's Since Last Visit - Interrupted Suicide Attempt CSS08-Interrupted Attempt, Describe Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of interrupted attempt. C-SSRS Children's Since Last Visit - Description of Interrupted Suicide Attempt CSS08-Most Lethal Attempt Damage Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Most lethal attempt actual lethality/medical damage. C-SSRS Children's Since Last Visit - Most Lethal Suicide Attempt Actual Lethality/Medical Damage CSS08-Most Lethal Attempt Date Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Most lethal attempt date. C-SSRS Children's Since Last Visit - Most Lethal Suicide Attempt Date CSS08-Most Lethal Attempt Potential Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Most lethal attempt potential lethality. C-SSRS Children's Since Last Visit - Most Lethal Suicide Attempt Potential Lethality CSS08-Most Severe Ideation Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Most severe ideation. C-SSRS Children's Since Last Visit - Most Severe Ideation CSS08-Most Severe Ideation, Description Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of most severe ideation. C-SSRS Children's Since Last Visit - Describe Most Severe Ideation CSS08-Most Severe Ideation, Frequency Columbia-Suicide Severity Rating Scale Children's Since Last Visit - How many times have you had these thoughts? C-SSRS Children's Since Last Visit - Frequency of Most Severe Ideation CSS08-Non-Specific Suicid Thought, Descr Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of non-specific active suicidal thoughts. C-SSRS Children's Since Last Visit - Description of Non-Specific Active Suicidal Thoughts CSS08-Non-Specific Suicidal Thought Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Have you thought about doing something to make yourself not alive anymore? Have you had any thoughts about killing yourself? C-SSRS Children's Since Last Visit - Non-Specific Active Suicidal Thoughts CSS08-Non-suicidal Self-injurious Behav Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Has subject engaged in non-suicidal self-injurious behavior? C-SSRS Children's Since Last Visit - Non-suicidal Self-injurious Behavior CSS08-Number of Aborted Attempts Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Total number of aborted or self-interrupted attempts. C-SSRS Children's Since Last Visit - Number of Aborted or Self-interrupted Suicide Attempts CSS08-Number of Actual Attempts Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Total number of actual attempts. C-SSRS Children's Since Last Visit - Number of Actual Suicide Attempts CSS08-Number of Interrupt Attempts Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Total number of interrupted attempts. C-SSRS Children's Since Last Visit - Number of Interrupted Suicide Attempts CSS08-Preparatory Acts/Behavior Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Have you done anything to get ready to make yourself not alive anymore (to end your life or kill yourself) - like giving things away, writing a goodbye note, getting things you need to kill yourself? C-SSRS Children's Since Last Visit - Preparatory Acts or Behaviors Toward Suicide Attempt CSS08-Preparatory Acts/Behavior, Descr Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of preparatory acts or behavior. C-SSRS Children's Since Last Visit - Description of Preparatory Acts or Behaviors Toward Suicide Attempt CSS08-Self-injur Behav, Intent Unknown Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Has subject engaged in self-injurious behavior, intent unknown? C-SSRS Children's Since Last Visit - Self-injurious Behavior, Intent Unknown CSS08-Suicidal Behavior Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Suicidal behavior was present during the assessment period? C-SSRS Children's Since Last Visit - Suicidal Behavior CSS08-Suicide Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Suicide. C-SSRS Children's Since Last Visit - Suicide CSS08-Wish to be Dead Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Have you thought about being dead or what it would be like to be dead? Have you wished you were dead or wished you could go to sleep and never wake up? Do you ever wish you weren't alive anymore? C-SSRS Children's Since Last Visit - Wish to be Dead CSS08-Wish to be Dead, Describe Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of wishing to be dead. C-SSRS Children's Since Last Visit - Description of Wish to be Dead CSS08TN Columbia-Suicide Severity Rating Scale Children's Since Last Visit Questionnaire Test Name CDISC Questionnaire C-SSRS Children's Since Last Visit Test Name Terminology Columbia-Suicide Severity Rating Scale Lifetime/Recent Version test code. CSS11-Wish to be Dead-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you wished you were dead or wished you could go to sleep and not wake up? (Lifetime). C-SSRS Lifetime/Recent Version - Wish to be Dead (Lifetime) CSS11-Wish to be Dead-P1M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you wished you were dead or wished you could go to sleep and not wake up? (Past 1 Month). C-SSRS Lifetime/Recent Version - Wish to be Dead (Past 1 Month) CSS11-Wish to be Dead, Describe Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of wishing to be dead. C-SSRS Lifetime/Recent Version - Description of Wish to be Dead CSS11-Non-Spec Suicid Thought-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you actually had any thoughts of killing yourself? (Lifetime). C-SSRS Lifetime/Recent Version - Non-Specific Active Suicidal Thoughts (Lifetime) CSS11-Non-Spec Suicid Thought-P1M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you actually had any thoughts of killing yourself? (Past 1 Month). C-SSRS Lifetime/Recent Version - Non-Specific Active Suicidal Thoughts (Past 1 Months) CSS11-Non-Spec Suicid Thought, Describe Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of non-specific active suicidal thoughts. C-SSRS Lifetime/Recent Version - Description of Non-Specific Active Suicidal Thoughts CSS11-Idea, No Intent, No Plan-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you been thinking about how you might do this? (Lifetime). C-SSRS Lifetime/Recent Version - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Lifetime) CSS11-Idea, No Intent, No Plan-P1M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you been thinking about how you might do this? (Past 1 Month). C-SSRS Lifetime/Recent Version - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Past 1 Month) CSS11-Idea, No Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of active suicidal ideation with any methods (not plan) without intent to act. C-SSRS Lifetime/Recent Version - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act CSS11-Idea, Intent, No Plan-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you had these thoughts and had some intention of acting on them? (Lifetime). C-SSRS Lifetime/Recent Version - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Lifetime) CSS11-Idea, Intent, No Plan-P1M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you had these thoughts and had some intention of acting on them? (Past 1 Month). C-SSRS Lifetime/Recent Version - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Past 1 Month) CSS11-Idea, Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of active suicidal ideation with some intent to act, without specific plan. C-SSRS Lifetime/Recent Version - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan CSS11-Idea, Plan, Intent-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Lifetime). C-SSRS Lifetime/Recent Version - Active Suicidal Ideation with Specific Plan and Intent (Lifetime) CSS11-Idea, Plan, Intent-P1M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Past 1 Month). C-SSRS Lifetime/Recent Version - Active Suicidal Ideation with Specific Plan and Intent (Past 1 Month) CSS11-Idea, Plan, Intent, Describe Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of active suicidal ideation with specific plan and intent. C-SSRS Lifetime/Recent Version - Description of Active Suicidal Ideation with Specific Plan and Intent CSS11-Most Severe Idea-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most severe ideation. (Lifetime). C-SSRS Lifetime/Recent Version - Most Severe Ideation (Lifetime) CSS11-Most Severe Idea, Desc-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of most severe ideation. (Lifetime). C-SSRS Lifetime/Recent Version - Describe Most Severe Ideation (Lifetime) CSS11-Most Severe Idea-Recent-P1M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most severe ideation. (Recent - Past 1 Month). C-SSRS Lifetime/Recent Version - Recent Most Severe Ideation (Past 1 Month) CSS11-Most Severe Idea, Desc-Recent-P1M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of most severe ideation. (Recent - Past 1 Month). C-SSRS Lifetime/Recent Version - Describe Recent Most Severe Ideation (Past 1 Month) CSS11-Most Severe Idea, Frequency-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - How many times have you had these thoughts? (Lifetime). C-SSRS Lifetime/Recent Version - Frequency of Most Severe Ideation (Lifetime) CSS11-Most Severe Idea, Frequency-P1M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - How many times have you had these thoughts? (Past 1 Month). C-SSRS Lifetime/Recent Version - Frequency of Most Severe Ideation (Past 1 Month) CSS11-Most Severe Idea, Duration-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - When you have the thoughts how long do they last? (Lifetime). C-SSRS Lifetime/Recent Version - Duration of Most Severe Ideation (Lifetime) CSS11-Most Severe Idea, Duration-P1M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - When you have the thoughts how long do they last? (Past 1 Month). C-SSRS Lifetime/Recent Version - Duration of Most Severe Ideation (Past 1 Month) CSS11-Most Severe Idea, Control-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Lifetime). C-SSRS Lifetime/Recent Version - Controllability of Most Severe Ideation (Lifetime) CSS11-Most Severe Idea, Control-P1M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Past 1 Month). C-SSRS Lifetime/Recent Version - Controllability of Most Severe Ideation (Past 1 Month) CSS11-Most Severe Idea, Deterrents-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Are there things - anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Lifetime). C-SSRS Lifetime/Recent Version - Deterrents to Most Severe Ideation (Lifetime) CSS11-Most Severe Idea, Deterrents-P1M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Are there things - anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Past 1 Month). C-SSRS Lifetime/Recent Version - Deterrents to Most Severe Ideation (Past 1 Month) CSS11-Most Severe Idea, Reasons-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Lifetime). C-SSRS Lifetime/Recent Version - Reasons for Most Severe Ideation (Lifetime) CSS11-Most Severe Idea, Reasons-P1M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Past 1 Month). C-SSRS Lifetime/Recent Version - Reasons for Most Severe Ideation (Past 1 Month) CSS11-Actual Attempt-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? (Lifetime). C-SSRS Lifetime/Recent Version - Actual Suicide Attempt (Lifetime) CSS11-Actual Attempt-P3M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? (Past 3 Months). C-SSRS Lifetime/Recent Version - Actual Suicide Attempt (Past 3 Months) CSS11-Number of Actual Attempts-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Total number of actual attempts. (Lifetime). C-SSRS Lifetime/Recent Version - Number of Actual Suicide Attempts (Lifetime) CSS11-Number of Actual Attempts-P3M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Total number of actual attempts. (Past 3 Months). C-SSRS Lifetime/Recent Version - Number of Actual Suicide Attempts (Past 3 Months) CSS11-Actual Attempt, Describe Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of actual attempt. C-SSRS Lifetime/Recent Version - Description of Actual Suicide Attempt CSS11-Non-suicid Self-injur Behav-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Has subject engaged in non-suicidal self-injurious behavior? (Lifetime). C-SSRS Lifetime/Recent Version - Non-suicidal Self-injurious Behavior (Lifetime) CSS11-Non-suicid Self-injur Behav-P3M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Has subject engaged in non-suicidal self-injurious behavior? (Past 3 Months). C-SSRS Lifetime/Recent Version - Non-suicidal Self-injurious Behavior (Past 3 Months) CSS11-Interrupted Attempt-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Has there been a time when you started to do something to end your life but someone or something stopped you before you actually did anything? (Lifetime). C-SSRS Lifetime/Recent Version - Interrupted Suicide Attempt (Lifetime) CSS11-Interrupted Attempt-P3M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Has there been a time when you started to do something to end your life but someone or something stopped you before you actually did anything? (Past 3 Months). C-SSRS Lifetime/Recent Version - Interrupted Suicide Attempt (Past 3 Months) CSS11-Num of Interrupted Attempts-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Total number of interrupted attempts. (Lifetime). C-SSRS Lifetime/Recent Version - Number of Interrupted Suicide Attempts (Lifetime) CSS11-Num of Interrupted Attempts-P3M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Total number of interrupted attempts. (Past 3 Months). C-SSRS Lifetime/Recent Version - Number of Interrupted Suicide Attempts (Past 3 Months) CSS11-Interrupted Attempt, Describe Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of interrupted attempt. C-SSRS Lifetime/Recent Version - Description of Interrupted Suicide Attempt CSS11-Aborted Attempt-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? (Lifetime). C-SSRS Lifetime/Recent Version - Aborted Suicide Attempt (Lifetime) CSS11-Aborted Attempt-P3M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? (Past 3 Months). C-SSRS Lifetime/Recent Version - Aborted Suicide Attempt (Past 3 Months) CSS11-Number of Aborted Attempts-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Total number of aborted or self-interrupted attempts. (Lifetime). C-SSRS Lifetime/Recent Version - Number of Aborted Suicide Attempts (Lifetime) CSS11-Number of Aborted Attempts-P3M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Total number of aborted or self-interrupted attempts. (Past 3 Months). C-SSRS Lifetime/Recent Version - Number of Aborted Suicide Attempts (Past 3 Months) CSS11-Aborted Attempt, Describe Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of aborted or self-interrupted attempt. C-SSRS Lifetime/Recent Version - Description of Aborted Suicide Attempt CSS11-Preparatory Acts/Behavior-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? (Lifetime). C-SSRS Lifetime/Recent Version - Preparatory Acts or Behaviors Toward Suicide Attempt (Lifetime) CSS11-Preparatory Acts/Behavior-P3M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? (Past 3 Months). C-SSRS Lifetime/Recent Version - Preparatory Acts or Behaviors Toward Suicide Attempt (Past 3 Months) CSS11-Preparatory Acts/Behavior, Descr Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of preparatory acts or behavior. C-SSRS Lifetime/Recent Version - Description of Preparatory Acts or Behaviors Toward Suicide Attempt CSS11-Suicidal Behavior-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Suicidal behavior was present during the assessment period? (Lifetime). C-SSRS Lifetime/Recent Version - Suicidal Behavior (Lifetime) CSS11-Suicidal Behavior-P3M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Suicidal behavior was present during the assessment period? (Past 3 Months). C-SSRS Lifetime/Recent Version - Suicidal Behavior (Past 3 Months) CSS11-Most Recent Attempt Date Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most recent attempt date. C-SSRS Lifetime/Recent Version - Most Recent Suicide Attempt Date CSS11-Most Recent Attempt Damage Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most recent attempt actual lethality/medical damage. C-SSRS Lifetime/Recent Version - Most Recent Suicide Attempt Actual Lethality/Medical Damage CSS11-Most Recent Attempt Potential Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most recent attempt potential lethality. C-SSRS Lifetime/Recent Version - Most Recent Suicide Attempt Potential Lethality CSS11-Most Lethal Attempt Date Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most lethal attempt date. C-SSRS Lifetime/Recent Version - Most Lethal Suicide Attempt Date CSS11-Most Lethal Attempt Damage Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most lethal attempt actual lethality/medical damage. C-SSRS Lifetime/Recent Version - Most Lethal Suicide Attempt Actual Lethality/Medical Damage CSS11-Most Lethal Attempt Potential Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most lethal attempt potential lethality. C-SSRS Lifetime/Recent Version - Most Lethal Suicide Attempt Potential Lethality CSS11-First Attempt Date Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Initial/first attempt date. C-SSRS Lifetime/Recent Version - First Suicide Attempt Date CSS11-First Attempt Damage Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Initial/first attempt actual lethality/medical damage. C-SSRS Lifetime/Recent Version - First Suicide Attempt Actual Lethality/Medical Damage CSS11-First Attempt Potential Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Initial/first attempt potential lethality. C-SSRS Lifetime/Recent Version - First Suicide Attempt Potential Lethality CSS11TC Columbia-Suicide Severity Rating Scale Lifetime/Recent Version Questionnaire Test Code CDISC Questionnaire C-SSRS Lifetime/Recent Version Test Code Terminology Columbia-Suicide Severity Rating Scale Lifetime/Recent Version test name. CSS11-Aborted Attempt, Describe Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of aborted or self-interrupted attempt. C-SSRS Lifetime/Recent Version - Description of Aborted Suicide Attempt CSS11-Aborted Attempt-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? (Lifetime). C-SSRS Lifetime/Recent Version - Aborted Suicide Attempt (Lifetime) CSS11-Aborted Attempt-P3M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? (Past 3 Months). C-SSRS Lifetime/Recent Version - Aborted Suicide Attempt (Past 3 Months) CSS11-Actual Attempt, Describe Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of actual attempt. C-SSRS Lifetime/Recent Version - Description of Actual Suicide Attempt CSS11-Actual Attempt-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? (Lifetime). C-SSRS Lifetime/Recent Version - Actual Suicide Attempt (Lifetime) CSS11-Actual Attempt-P3M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? (Past 3 Months). C-SSRS Lifetime/Recent Version - Actual Suicide Attempt (Past 3 Months) CSS11-First Attempt Damage Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Initial/first attempt actual lethality/medical damage. C-SSRS Lifetime/Recent Version - First Suicide Attempt Actual Lethality/Medical Damage CSS11-First Attempt Date Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Initial/first attempt date. C-SSRS Lifetime/Recent Version - First Suicide Attempt Date CSS11-First Attempt Potential Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Initial/first attempt potential lethality. C-SSRS Lifetime/Recent Version - First Suicide Attempt Potential Lethality CSS11-Idea, Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of active suicidal ideation with some intent to act, without specific plan. C-SSRS Lifetime/Recent Version - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan CSS11-Idea, Intent, No Plan-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you had these thoughts and had some intention of acting on them? (Lifetime). C-SSRS Lifetime/Recent Version - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Lifetime) CSS11-Idea, Intent, No Plan-P1M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you had these thoughts and had some intention of acting on them? (Past 1 Month). C-SSRS Lifetime/Recent Version - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Past 1 Month) CSS11-Idea, No Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of active suicidal ideation with any methods (not plan) without intent to act. C-SSRS Lifetime/Recent Version - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act CSS11-Idea, No Intent, No Plan-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you been thinking about how you might do this? (Lifetime). C-SSRS Lifetime/Recent Version - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Lifetime) CSS11-Idea, No Intent, No Plan-P1M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you been thinking about how you might do this? (Past 1 Month). C-SSRS Lifetime/Recent Version - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Past 1 Month) CSS11-Idea, Plan, Intent, Describe Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of active suicidal ideation with specific plan and intent. C-SSRS Lifetime/Recent Version - Description of Active Suicidal Ideation with Specific Plan and Intent CSS11-Idea, Plan, Intent-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Lifetime). C-SSRS Lifetime/Recent Version - Active Suicidal Ideation with Specific Plan and Intent (Lifetime) CSS11-Idea, Plan, Intent-P1M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Past 1 Month). C-SSRS Lifetime/Recent Version - Active Suicidal Ideation with Specific Plan and Intent (Past 1 Month) CSS11-Interrupted Attempt, Describe Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of interrupted attempt. C-SSRS Lifetime/Recent Version - Description of Interrupted Suicide Attempt CSS11-Interrupted Attempt-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Has there been a time when you started to do something to end your life but someone or something stopped you before you actually did anything? (Lifetime). C-SSRS Lifetime/Recent Version - Interrupted Suicide Attempt (Lifetime) CSS11-Interrupted Attempt-P3M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Has there been a time when you started to do something to end your life but someone or something stopped you before you actually did anything? (Past 3 Months). C-SSRS Lifetime/Recent Version - Interrupted Suicide Attempt (Past 3 Months) CSS11-Most Lethal Attempt Damage Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most lethal attempt actual lethality/medical damage. C-SSRS Lifetime/Recent Version - Most Lethal Suicide Attempt Actual Lethality/Medical Damage CSS11-Most Lethal Attempt Date Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most lethal attempt date. C-SSRS Lifetime/Recent Version - Most Lethal Suicide Attempt Date CSS11-Most Lethal Attempt Potential Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most lethal attempt potential lethality. C-SSRS Lifetime/Recent Version - Most Lethal Suicide Attempt Potential Lethality CSS11-Most Recent Attempt Damage Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most recent attempt actual lethality/medical damage. C-SSRS Lifetime/Recent Version - Most Recent Suicide Attempt Actual Lethality/Medical Damage CSS11-Most Recent Attempt Date Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most recent attempt date. C-SSRS Lifetime/Recent Version - Most Recent Suicide Attempt Date CSS11-Most Recent Attempt Potential Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most recent attempt potential lethality. C-SSRS Lifetime/Recent Version - Most Recent Suicide Attempt Potential Lethality CSS11-Most Severe Idea, Control-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Lifetime). C-SSRS Lifetime/Recent Version - Controllability of Most Severe Ideation (Lifetime) CSS11-Most Severe Idea, Control-P1M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Past 1 Month). C-SSRS Lifetime/Recent Version - Controllability of Most Severe Ideation (Past 1 Month) CSS11-Most Severe Idea, Desc-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of most severe ideation. (Lifetime). C-SSRS Lifetime/Recent Version - Describe Most Severe Ideation (Lifetime) CSS11-Most Severe Idea, Desc-Recent-P1M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of most severe ideation. (Recent - Past 1 Month). C-SSRS Lifetime/Recent Version - Describe Recent Most Severe Ideation (Past 1 Month) CSS11-Most Severe Idea, Deterrents-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Are there things - anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Lifetime). C-SSRS Lifetime/Recent Version - Deterrents to Most Severe Ideation (Lifetime) CSS11-Most Severe Idea, Deterrents-P1M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Are there things - anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Past 1 Month). C-SSRS Lifetime/Recent Version - Deterrents to Most Severe Ideation (Past 1 Month) CSS11-Most Severe Idea, Duration-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - When you have the thoughts how long do they last? (Lifetime). C-SSRS Lifetime/Recent Version - Duration of Most Severe Ideation (Lifetime) CSS11-Most Severe Idea, Duration-P1M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - When you have the thoughts how long do they last? (Past 1 Month). C-SSRS Lifetime/Recent Version - Duration of Most Severe Ideation (Past 1 Month) CSS11-Most Severe Idea, Frequency-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - How many times have you had these thoughts? (Lifetime). C-SSRS Lifetime/Recent Version - Frequency of Most Severe Ideation (Lifetime) CSS11-Most Severe Idea, Frequency-P1M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - How many times have you had these thoughts? (Past 1 Month). C-SSRS Lifetime/Recent Version - Frequency of Most Severe Ideation (Past 1 Month) CSS11-Most Severe Idea, Reasons-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Lifetime). C-SSRS Lifetime/Recent Version - Reasons for Most Severe Ideation (Lifetime) CSS11-Most Severe Idea, Reasons-P1M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Past 1 Month). C-SSRS Lifetime/Recent Version - Reasons for Most Severe Ideation (Past 1 Month) CSS11-Most Severe Idea-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most severe ideation. (Lifetime). C-SSRS Lifetime/Recent Version - Most Severe Ideation (Lifetime) CSS11-Most Severe Idea-Recent-P1M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most severe ideation. (Recent - Past 1 Month). C-SSRS Lifetime/Recent Version - Recent Most Severe Ideation (Past 1 Month) CSS11-Non-Spec Suicid Thought, Describe Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of non-specific active suicidal thoughts. C-SSRS Lifetime/Recent Version - Description of Non-Specific Active Suicidal Thoughts CSS11-Non-Spec Suicid Thought-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you actually had any thoughts of killing yourself? (Lifetime). C-SSRS Lifetime/Recent Version - Non-Specific Active Suicidal Thoughts (Lifetime) CSS11-Non-Spec Suicid Thought-P1M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you actually had any thoughts of killing yourself? (Past 1 Month). C-SSRS Lifetime/Recent Version - Non-Specific Active Suicidal Thoughts (Past 1 Months) CSS11-Non-suicid Self-injur Behav-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Has subject engaged in non-suicidal self-injurious behavior? (Lifetime). C-SSRS Lifetime/Recent Version - Non-suicidal Self-injurious Behavior (Lifetime) CSS11-Non-suicid Self-injur Behav-P3M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Has subject engaged in non-suicidal self-injurious behavior? (Past 3 Months). C-SSRS Lifetime/Recent Version - Non-suicidal Self-injurious Behavior (Past 3 Months) CSS11-Num of Interrupted Attempts-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Total number of interrupted attempts. (Lifetime). C-SSRS Lifetime/Recent Version - Number of Interrupted Suicide Attempts (Lifetime) CSS11-Num of Interrupted Attempts-P3M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Total number of interrupted attempts. (Past 3 Months). C-SSRS Lifetime/Recent Version - Number of Interrupted Suicide Attempts (Past 3 Months) CSS11-Number of Aborted Attempts-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Total number of aborted or self-interrupted attempts. (Lifetime). C-SSRS Lifetime/Recent Version - Number of Aborted Suicide Attempts (Lifetime) CSS11-Number of Aborted Attempts-P3M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Total number of aborted or self-interrupted attempts. (Past 3 Months). C-SSRS Lifetime/Recent Version - Number of Aborted Suicide Attempts (Past 3 Months) CSS11-Number of Actual Attempts-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Total number of actual attempts. (Lifetime). C-SSRS Lifetime/Recent Version - Number of Actual Suicide Attempts (Lifetime) CSS11-Number of Actual Attempts-P3M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Total number of actual attempts. (Past 3 Months). C-SSRS Lifetime/Recent Version - Number of Actual Suicide Attempts (Past 3 Months) CSS11-Preparatory Acts/Behavior, Descr Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of preparatory acts or behavior. C-SSRS Lifetime/Recent Version - Description of Preparatory Acts or Behaviors Toward Suicide Attempt CSS11-Preparatory Acts/Behavior-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? (Lifetime). C-SSRS Lifetime/Recent Version - Preparatory Acts or Behaviors Toward Suicide Attempt (Lifetime) CSS11-Preparatory Acts/Behavior-P3M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? (Past 3 Months). C-SSRS Lifetime/Recent Version - Preparatory Acts or Behaviors Toward Suicide Attempt (Past 3 Months) CSS11-Suicidal Behavior-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Suicidal behavior was present during the assessment period? (Lifetime). C-SSRS Lifetime/Recent Version - Suicidal Behavior (Lifetime) CSS11-Suicidal Behavior-P3M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Suicidal behavior was present during the assessment period? (Past 3 Months). C-SSRS Lifetime/Recent Version - Suicidal Behavior (Past 3 Months) CSS11-Wish to be Dead, Describe Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of wishing to be dead. C-SSRS Lifetime/Recent Version - Description of Wish to be Dead CSS11-Wish to be Dead-Life Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you wished you were dead or wished you could go to sleep and not wake up? (Lifetime). C-SSRS Lifetime/Recent Version - Wish to be Dead (Lifetime) CSS11-Wish to be Dead-P1M Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you wished you were dead or wished you could go to sleep and not wake up? (Past 1 Month). C-SSRS Lifetime/Recent Version - Wish to be Dead (Past 1 Month) CSS11TN Columbia-Suicide Severity Rating Scale Lifetime/Recent Version Questionnaire Test Name CDISC Questionnaire C-SSRS Lifetime/Recent Version Test Name Terminology Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent test code. CSS10-Wish to be Dead-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you thought about being dead or what it would be like to be dead? Have you wished you were dead or wished you could go to sleep and never wake up? Do you ever wish you weren't alive anymore? (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Wish to be Dead (Lifetime) CSS10-Wish to be Dead-P1M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you thought about being dead or what it would be like to be dead? Have you wished you were dead or wished you could go to sleep and never wake up? Do you ever wish you weren't alive anymore? (Past 1 Month). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Wish to be Dead (Past 1 Month) CSS10-Wish to be Dead, Describe Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of wishing to be dead. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Wish to be Dead CSS10-Non-Spec Suicid Thought-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you thought about doing something to make yourself not alive anymore? Have you had any thoughts about killing yourself? (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Non-Specific Active Suicidal Thoughts (Lifetime) CSS10-Non-Spec Suicid Thought-P1M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you thought about doing something to make yourself not alive anymore? Have you had any thoughts about killing yourself? (Past 1 Month). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Non-Specific Active Suicidal Thoughts (Past 1 Month) CSS10-Non-Spec Suicid Thought, Describe Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of non-specific active suicidal thoughts. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Non-Specific Active Suicidal Thoughts CSS10-Idea, No Intent, No Plan-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you thought about how you would do that or how you would make yourself not alive anymore (kill yourself)? What did you think about? (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Active Suicidal Ideation With Any Methods (Not Plan) Without Intent to Act (Lifetime) CSS10-Idea, No Intent, No Plan-P1M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you thought about how you would do that or how you would make yourself not alive anymore (kill yourself)? What did you think about? (Past 1 Month). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Active Suicidal Ideation With Any Methods (Not Plan) Without Intent to Act (Past 1 Month) CSS10-Idea, No Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of active suicidal ideation with any methods (not plan) without intent to act. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Active Suicidal Ideation With Any Methods (Not Plan) Without Intent to Act CSS10-Idea, Intent, No Plan-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - When you thought about making yourself not alive anymore (or killing yourself), did you think that this was something you might actually do? This is different from (as opposed to) having the thoughts but knowing you wouldn't do anything about it. (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Active Suicidal Ideation With Some Intent to Act, Without Specific Plan (Lifetime) CSS10-Idea, Intent, No Plan-P1M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - When you thought about making yourself not alive anymore (or killing yourself), did you think that this was something you might actually do? This is different from (as opposed to) having the thoughts but knowing you wouldn't do anything about it. (Past 1 Month). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Active Suicidal Ideation With Some Intent to Act, Without Specific Plan (Past 1 Month) CSS10-Idea, Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of active suicidal ideation with some intent to act, without specific plan. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Active Suicidal Ideation With Some Intent to Act, Without Specific Plan CSS10-Idea, Plan, Intent-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you ever decided how or when you would make yourself not alive anymore/kill yourself? Have you ever planned out (worked out the details of) how you would do it? What was your plan? When you made this plan (or worked out these details), was any part of you thinking about actually doing it? (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Active Suicidal Ideation With Specific Plan and Intent (Lifetime) CSS10-Idea, Plan, Intent-P1M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you ever decided how or when you would make yourself not alive anymore/kill yourself? Have you ever planned out (worked out the details of) how you would do it? What was your plan? When you made this plan (or worked out these details), was any part of you thinking about actually doing it? (Past 1 Month). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Active Suicidal Ideation With Specific Plan and Intent (Past 1 Month) CSS10-Idea, Plan, Intent, Describe Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of active suicidal ideation with specific plan and intent. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Active Suicidal Ideation With Specific Plan and Intent CSS10-Most Severe Idea-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most severe ideation. (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Severe Ideation (Lifetime) CSS10-Most Severe Idea, Desc-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of most severe ideation. (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Describe Most Severe Ideation (Lifetime) CSS10-Most Severe Idea-P1M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most severe ideation. (Past 1 Month). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Severe Ideation (Past 1 Month) CSS10-Most Severe Idea, Desc-P1M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of most severe ideation. (Past 1 Month). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Describe Most Severe Ideation (Past 1 Month) CSS10-Most Severe Idea, Frequency-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - How many times have you had these thoughts? (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Frequency (Lifetime) CSS10-Most Severe Idea, Frequency-P1M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - How many times have you had these thoughts? (Past 1 Month). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Frequency (Past 1 Month) CSS10-Frequency, Write Response Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Frequency, write response. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Frequency Write Response CSS10-Actual Attempt-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Did you ever do anything to try to kill yourself or make yourself not alive anymore? What did you do? Did you ever hurt yourself on purpose? Why did you do that? (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Actual Suicide Attempt (Lifetime) CSS10-Actual Attempt-P3M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Did you ever do anything to try to kill yourself or make yourself not alive anymore? What did you do? Did you ever hurt yourself on purpose? Why did you do that? (Past 3 Months). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Actual Suicide Attempt (Past 3 Month) CSS10-Number of Actual Attempts-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Total number of actual attempts. (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Actual Suicide Attempts (Lifetime) CSS10-Number of Actual Attempts-P3M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Total number of actual attempts. (Past 3 Months). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Actual Suicide Attempts (Past 3 Months) CSS10-Actual Attempt, Describe Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of actual attempt. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Actual Suicide Attempt CSS10-Non-suicidal Self-injur Behav-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has subject engaged in non-suicidal self-injurious behavior? (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Non-suicidal Self-injurious Behavior (Lifetime) CSS10-Non-suicidal Self-injur Behav-P3M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has subject engaged in non-suicidal self-injurious behavior? (Past 3 Months). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Non-suicidal Self-injurious Behavior (Past 3 Months) CSS10-Self-injur Behav, Intent Unk-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has subject engaged in self-injurious behavior, intent unknown? (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Self-injurious Behavior, Intent Unknown (Lifetime) CSS10-Self-injur Behav, Intent Unk-P3M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has subject engaged in self-injurious behavior, intent unknown? (Past 3 Months). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Self-injurious Behavior, Intent Unknown (Past 3 Months) CSS10-Interrupted Attempt-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but someone or something stopped you before you actually did anything? What did you do? (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Interrupted Suicide Attempt (Lifetime) CSS10-Interrupted Attempt-P3M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but someone or something stopped you before you actually did anything? What did you do? (Past 3 Months). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Interrupted Suicide Attempt (Past 3 Months) CSS10-Number of Interrupt Attempts-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Total number of interrupted attempts. (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Interrupted Suicide Attempts (Lifetime) CSS10-Number of Interrupt Attempts-P3M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Total number of interrupted attempts. (Past 3 Months). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Interrupted Suicide Attempts (Past 3 Months) CSS10-Interrupted Attempt, Describe Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of interrupted attempt. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Interrupted Suicide Attempt CSS10-Aborted Attempt-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but you changed your mind (stopped yourself) before you actually did anything? What did you do? (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Aborted or Self-interrupted Suicide Attempt (Lifetime) CSS10-Aborted Attempt-P3M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but you changed your mind (stopped yourself) before you actually did anything? What did you do? (Past 3 Months). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Aborted or Self-interrupted Suicide Attempt (Past 3 Months) CSS10-Number of Aborted Attempts-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Total number of aborted or self-interrupted attempts. (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Aborted or Self-interrupted Suicide Attempt (Lifetime) CSS10-Number of Aborted Attempts-P3M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Total number of aborted or self-interrupted attempts. (Past 3 Months). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Aborted or Self-interrupted Suicide Attempt (Past 3 Months) CSS10-Aborted Attempt, Describe Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of aborted or self-interrupted attempt. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Aborted Suicide Attempt CSS10-Preparatory Acts/Behavior-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you done anything to get ready to make yourself not alive anymore (to end your life or kill yourself) - like giving things away, writing a goodbye note, getting things you need to kill yourself? (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Preparatory Acts or Behaviors Toward Suicide Attempt (Lifetime) CSS10-Preparatory Acts/Behavior-P3M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you done anything to get ready to make yourself not alive anymore (to end your life or kill yourself) - like giving things away, writing a goodbye note, getting things you need to kill yourself? (Past 3 Months). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Preparatory Acts or Behaviors Toward Suicide Attempt (Past 3 Months) CSS10-Preparatory Acts/Behavior, Descr Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of preparatory acts or behavior. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Preparatory Acts or Behaviors Toward Suicide Attempt CSS10-Suicidal Behavior-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Suicidal behavior was present during the assessment period? (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Suicidal Behavior (Lifetime) CSS10-Suicidal Behavior-P3M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Suicidal behavior was present during the assessment period? (Past 3 Months). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Suicidal Behavior (Past 3 Months) CSS10-Most Recent Attempt Date Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most recent attempt date. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Recent Suicide Attempt Date CSS10-Most Recent Attempt Damage Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most recent attempt actual lethality/medical damage. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Recent Suicide Attempt Actual Lethality/Medical Damage CSS10-Most Recent Attempt Potential Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most recent attempt potential lethality. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Recent Suicide Attempt Potential Lethality CSS10-Most Lethal Attempt Date Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most lethal attempt date. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Lethal Suicide Attempt Date CSS10-Most Lethal Attempt Damage Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most lethal attempt actual lethality/medical damage. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Lethal Suicide Attempt Actual Lethality/Medical Damage CSS10-Most Lethal Attempt Potential Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most lethal attempt potential lethality. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Lethal Suicide Attempt Potential Lethality CSS10-First Attempt Date Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Initial/first attempt date. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - First Suicide Attempt Date CSS10-First Attempt Damage Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Initial/first attempt actual lethality/medical damage. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - First Suicide Attempt Actual Lethality/Medical Damage CSS10-First Attempt Potential Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Initial/first attempt potential lethality. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - First Suicide Attempt Potential Lethality CSS10TC Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent Questionnaire Test Code CDISC Questionnaire C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent Test Code Terminology Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent test name. CSS10-Aborted Attempt, Describe Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of aborted or self-interrupted attempt. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Aborted Suicide Attempt CSS10-Aborted Attempt-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but you changed your mind (stopped yourself) before you actually did anything? What did you do? (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Aborted or Self-interrupted Suicide Attempt (Lifetime) CSS10-Aborted Attempt-P3M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but you changed your mind (stopped yourself) before you actually did anything? What did you do? (Past 3 Months). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Aborted or Self-interrupted Suicide Attempt (Past 3 Months) CSS10-Actual Attempt, Describe Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of actual attempt. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Actual Suicide Attempt CSS10-Actual Attempt-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Did you ever do anything to try to kill yourself or make yourself not alive anymore? What did you do? Did you ever hurt yourself on purpose? Why did you do that? (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Actual Suicide Attempt (Lifetime) CSS10-Actual Attempt-P3M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Did you ever do anything to try to kill yourself or make yourself not alive anymore? What did you do? Did you ever hurt yourself on purpose? Why did you do that? (Past 3 Months). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Actual Suicide Attempt (Past 3 Month) CSS10-First Attempt Damage Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Initial/first attempt actual lethality/medical damage. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - First Suicide Attempt Actual Lethality/Medical Damage CSS10-First Attempt Date Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Initial/first attempt date. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - First Suicide Attempt Date CSS10-First Attempt Potential Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Initial/first attempt potential lethality. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - First Suicide Attempt Potential Lethality CSS10-Frequency, Write Response Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Frequency, write response. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Frequency Write Response CSS10-Idea, Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of active suicidal ideation with some intent to act, without specific plan. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Active Suicidal Ideation With Some Intent to Act, Without Specific Plan CSS10-Idea, Intent, No Plan-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - When you thought about making yourself not alive anymore (or killing yourself), did you think that this was something you might actually do? This is different from (as opposed to) having the thoughts but knowing you wouldn't do anything about it. (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Active Suicidal Ideation With Some Intent to Act, Without Specific Plan (Lifetime) CSS10-Idea, Intent, No Plan-P1M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - When you thought about making yourself not alive anymore (or killing yourself), did you think that this was something you might actually do? This is different from (as opposed to) having the thoughts but knowing you wouldn't do anything about it. (Past 1 Month). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Active Suicidal Ideation With Some Intent to Act, Without Specific Plan (Past 1 Month) CSS10-Idea, No Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of active suicidal ideation with any methods (not plan) without intent to act. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Active Suicidal Ideation With Any Methods (Not Plan) Without Intent to Act CSS10-Idea, No Intent, No Plan-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you thought about how you would do that or how you would make yourself not alive anymore (kill yourself)? What did you think about? (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Active Suicidal Ideation With Any Methods (Not Plan) Without Intent to Act (Lifetime) CSS10-Idea, No Intent, No Plan-P1M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you thought about how you would do that or how you would make yourself not alive anymore (kill yourself)? What did you think about? (Past 1 Month). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Active Suicidal Ideation With Any Methods (Not Plan) Without Intent to Act (Past 1 Month) CSS10-Idea, Plan, Intent, Describe Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of active suicidal ideation with specific plan and intent. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Active Suicidal Ideation With Specific Plan and Intent CSS10-Idea, Plan, Intent-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you ever decided how or when you would make yourself not alive anymore/kill yourself? Have you ever planned out (worked out the details of) how you would do it? What was your plan? When you made this plan (or worked out these details), was any part of you thinking about actually doing it? (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Active Suicidal Ideation With Specific Plan and Intent (Lifetime) CSS10-Idea, Plan, Intent-P1M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you ever decided how or when you would make yourself not alive anymore/kill yourself? Have you ever planned out (worked out the details of) how you would do it? What was your plan? When you made this plan (or worked out these details), was any part of you thinking about actually doing it? (Past 1 Month). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Active Suicidal Ideation With Specific Plan and Intent (Past 1 Month) CSS10-Interrupted Attempt, Describe Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of interrupted attempt. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Interrupted Suicide Attempt CSS10-Interrupted Attempt-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but someone or something stopped you before you actually did anything? What did you do? (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Interrupted Suicide Attempt (Lifetime) CSS10-Interrupted Attempt-P3M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but someone or something stopped you before you actually did anything? What did you do? (Past 3 Months). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Interrupted Suicide Attempt (Past 3 Months) CSS10-Most Lethal Attempt Damage Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most lethal attempt actual lethality/medical damage. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Lethal Suicide Attempt Actual Lethality/Medical Damage CSS10-Most Lethal Attempt Date Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most lethal attempt date. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Lethal Suicide Attempt Date CSS10-Most Lethal Attempt Potential Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most lethal attempt potential lethality. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Lethal Suicide Attempt Potential Lethality CSS10-Most Recent Attempt Damage Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most recent attempt actual lethality/medical damage. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Recent Suicide Attempt Actual Lethality/Medical Damage CSS10-Most Recent Attempt Date Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most recent attempt date. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Recent Suicide Attempt Date CSS10-Most Recent Attempt Potential Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most recent attempt potential lethality. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Recent Suicide Attempt Potential Lethality CSS10-Most Severe Idea, Desc-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of most severe ideation. (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Describe Most Severe Ideation (Lifetime) CSS10-Most Severe Idea, Desc-P1M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of most severe ideation. (Past 1 Month). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Describe Most Severe Ideation (Past 1 Month) CSS10-Most Severe Idea, Frequency-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - How many times have you had these thoughts? (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Frequency (Lifetime) CSS10-Most Severe Idea, Frequency-P1M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - How many times have you had these thoughts? (Past 1 Month). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Frequency (Past 1 Month) CSS10-Most Severe Idea-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most severe ideation. (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Severe Ideation (Lifetime) CSS10-Most Severe Idea-P1M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most severe ideation. (Past 1 Month). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Severe Ideation (Past 1 Month) CSS10-Non-Spec Suicid Thought, Describe Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of non-specific active suicidal thoughts. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Non-Specific Active Suicidal Thoughts CSS10-Non-Spec Suicid Thought-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you thought about doing something to make yourself not alive anymore? Have you had any thoughts about killing yourself? (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Non-Specific Active Suicidal Thoughts (Lifetime) CSS10-Non-Spec Suicid Thought-P1M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you thought about doing something to make yourself not alive anymore? Have you had any thoughts about killing yourself? (Past 1 Month). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Non-Specific Active Suicidal Thoughts (Past 1 Month) CSS10-Non-suicidal Self-injur Behav-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has subject engaged in non-suicidal self-injurious behavior? (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Non-suicidal Self-injurious Behavior (Lifetime) CSS10-Non-suicidal Self-injur Behav-P3M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has subject engaged in non-suicidal self-injurious behavior? (Past 3 Months). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Non-suicidal Self-injurious Behavior (Past 3 Months) CSS10-Number of Aborted Attempts-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Total number of aborted or self-interrupted attempts. (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Aborted or Self-interrupted Suicide Attempt (Lifetime) CSS10-Number of Aborted Attempts-P3M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Total number of aborted or self-interrupted attempts. (Past 3 Months). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Aborted or Self-interrupted Suicide Attempt (Past 3 Months) CSS10-Number of Actual Attempts-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Total number of actual attempts. (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Actual Suicide Attempts (Lifetime) CSS10-Number of Actual Attempts-P3M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Total number of actual attempts. (Past 3 Months). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Actual Suicide Attempts (Past 3 Months) CSS10-Number of Interrupt Attempts-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Total number of interrupted attempts. (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Interrupted Suicide Attempts (Lifetime) CSS10-Number of Interrupt Attempts-P3M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Total number of interrupted attempts. (Past 3 Months). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Interrupted Suicide Attempts (Past 3 Months) CSS10-Preparatory Acts/Behavior, Descr Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of preparatory acts or behavior. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Preparatory Acts or Behaviors Toward Suicide Attempt CSS10-Preparatory Acts/Behavior-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you done anything to get ready to make yourself not alive anymore (to end your life or kill yourself) - like giving things away, writing a goodbye note, getting things you need to kill yourself? (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Preparatory Acts or Behaviors Toward Suicide Attempt (Lifetime) CSS10-Preparatory Acts/Behavior-P3M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you done anything to get ready to make yourself not alive anymore (to end your life or kill yourself) - like giving things away, writing a goodbye note, getting things you need to kill yourself? (Past 3 Months). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Preparatory Acts or Behaviors Toward Suicide Attempt (Past 3 Months) CSS10-Self-injur Behav, Intent Unk-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has subject engaged in self-injurious behavior, intent unknown? (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Self-injurious Behavior, Intent Unknown (Lifetime) CSS10-Self-injur Behav, Intent Unk-P3M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has subject engaged in self-injurious behavior, intent unknown? (Past 3 Months). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Self-injurious Behavior, Intent Unknown (Past 3 Months) CSS10-Suicidal Behavior-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Suicidal behavior was present during the assessment period? (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Suicidal Behavior (Lifetime) CSS10-Suicidal Behavior-P3M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Suicidal behavior was present during the assessment period? (Past 3 Months). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Suicidal Behavior (Past 3 Months) CSS10-Wish to be Dead, Describe Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of wishing to be dead. C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Wish to be Dead CSS10-Wish to be Dead-Life Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you thought about being dead or what it would be like to be dead? Have you wished you were dead or wished you could go to sleep and never wake up? Do you ever wish you weren't alive anymore? (Lifetime). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Wish to be Dead (Lifetime) CSS10-Wish to be Dead-P1M Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you thought about being dead or what it would be like to be dead? Have you wished you were dead or wished you could go to sleep and never wake up? Do you ever wish you weren't alive anymore? (Past 1 Month). C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Wish to be Dead (Past 1 Month) CSS10TN Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent Questionnaire Test Name CDISC Questionnaire C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent Test Name Terminology Columbia-Suicide Severity Rating Scale Screening test code. CSS09-Wish to be Dead Columbia-Suicide Severity Rating Scale Screening - Have you wished you were dead or wished you could go to sleep and not wake up? C-SSRS Screening - Wish to be Dead CSS09-Wish to be Dead, Describe Columbia-Suicide Severity Rating Scale Screening - Description of wishing to be dead. C-SSRS Screening - Description of Wish to be Dead CSS09-Non-Spec Suicid Thought Columbia-Suicide Severity Rating Scale Screening - Have you actually had any thoughts of killing yourself? C-SSRS Screening - Non-Specific Active Suicidal Thoughts CSS09-Non-Spec Suicid Thought, Describe Columbia-Suicide Severity Rating Scale Screening - Description of non-specific active suicidal thoughts. C-SSRS Screening - Description of Non-Specific Active Suicidal Thoughts CSS09-Idea, No Intent, No Plan Columbia-Suicide Severity Rating Scale Screening - Have you been thinking about how you might do this? C-SSRS Screening - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act CSS09-Idea, No Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Screening - Description of active suicidal ideation with any methods (not plan) without intent to act. C-SSRS Screening - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act CSS09-Idea, Intent, No Plan Columbia-Suicide Severity Rating Scale Screening - Have you had these thoughts and had some intention of acting on them? C-SSRS Screening - Active Suicidal Ideation with Some Intent to Act, without Specific Plan CSS09-Idea, Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Screening - Description of active suicidal ideation with some intent to act, without specific plan. C-SSRS Screening - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan CSS09-Idea, Plan, Intent Columbia-Suicide Severity Rating Scale Screening - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? C-SSRS Screening - Active Suicidal Ideation with Specific Plan and Intent CSS09-Idea, Plan, Intent, Describe Columbia-Suicide Severity Rating Scale Screening - Description of active suicidal ideation with specific plan and intent. C-SSRS Screening - Description of Active Suicidal Ideation with Specific Plan and Intent CSS09-Most Severe Idea Columbia-Suicide Severity Rating Scale Screening - Most severe ideation. C-SSRS Screening - Most Severe Ideation CSS09-Most Severe Idea, Desc Columbia-Suicide Severity Rating Scale Screening - Description of most severe ideation. C-SSRS Screening - Describe Most Severe Ideation CSS09-Most Severe Idea, Frequency Columbia-Suicide Severity Rating Scale Screening - How many times have you had these thoughts? C-SSRS Screening - Frequency of Most Severe Ideation CSS09-Most Severe Idea, Duration Columbia-Suicide Severity Rating Scale Screening - When you have the thoughts, how long do they last? C-SSRS Screening - Duration of Most Severe Ideation CSS09-Most Severe Idea, Controllability Columbia-Suicide Severity Rating Scale Screening - Could/can you stop thinking about killing yourself or wanting to die if you want to? C-SSRS Screening - Controllability of Most Severe Ideation CSS09-Most Severe Idea, Deterrents Columbia-Suicide Severity Rating Scale Screening - Are there things-anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? C-SSRS Screening - Deterrents to Most Severe Ideation CSS09-Most Severe Idea, Reasons Columbia-Suicide Severity Rating Scale Screening - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? C-SSRS Screening - Reasons for Most Severe Ideation CSS09-Actual Attempt Columbia-Suicide Severity Rating Scale Screening - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? C-SSRS Screening - Actual Suicide Attempt CSS09-Number of Actual Attempts Columbia-Suicide Severity Rating Scale Screening - Total number of actual attempts. C-SSRS Screening - Number of Actual Suicide Attempts CSS09-Actual Attempt, Describe Columbia-Suicide Severity Rating Scale Screening - Description of actual attempt. C-SSRS Screening - Description of Actual Suicide Attempt CSS09-Non-suicidal Self-injur Behav Columbia-Suicide Severity Rating Scale Screening - Has subject engaged in non-suicidal self-injurious behavior? C-SSRS Screening - Non-suicidal Self-injurious Behavior CSS09-Interrupted Attempt Columbia-Suicide Severity Rating Scale Screening - Has there been a time when you started to do something to end your life but someone or something stopped you before you actually did anything? C-SSRS Screening - Interrupted Suicide Attempt CSS09-Number of Interrupt Attempts Columbia-Suicide Severity Rating Scale Screening - Total number of interrupted attempts. C-SSRS Screening - Number of Interrupted Suicide Attempts CSS09-Interrupted Attempt, Describe Columbia-Suicide Severity Rating Scale Screening - Description of interrupted attempt. C-SSRS Screening - Description of Interrupted Suicide Attempt CSS09-Aborted Attempt Columbia-Suicide Severity Rating Scale Screening - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? C-SSRS Screening - Aborted Suicide Attempt CSS09-Number of Aborted Attempts Columbia-Suicide Severity Rating Scale Screening - Total number of aborted attempts. C-SSRS Screening - Number of Aborted Suicide Attempts CSS09-Aborted Attempt, Describe Columbia-Suicide Severity Rating Scale Screening - Description of aborted attempt. C-SSRS Screening - Description of Aborted Suicide Attempt CSS09-Preparatory Acts/Behavior Columbia-Suicide Severity Rating Scale Screening - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? C-SSRS Screening - Preparatory Acts or Behaviors Toward Suicide Attempt CSS09-Preparatory Acts/Behavior, Descr Columbia-Suicide Severity Rating Scale Screening - Description of preparatory acts or behavior. C-SSRS Screening - Description of Preparatory Acts or Behaviors Toward Suicide Attempt CSS09-Suicidal Behavior Columbia-Suicide Severity Rating Scale Screening - Suicidal behavior was present during the assessment period? C-SSRS Screening - Suicidal Behavior CSS09-Most Recent Attempt Date Columbia-Suicide Severity Rating Scale Screening - Most recent attempt date. C-SSRS Screening - Most Recent Suicide Attempt Date CSS09-Most Recent Attempt Damage Columbia-Suicide Severity Rating Scale Screening - Most recent attempt actual lethality/medical damage. C-SSRS Screening - Most Recent Suicide Attempt Actual Lethality/Medical Damage CSS09-Most Recent Attempt Potential Columbia-Suicide Severity Rating Scale Screening - Most recent attempt potential lethality. C-SSRS Screening - Most Recent Suicide Attempt Potential Lethality CSS09-Most Lethal Attempt Date Columbia-Suicide Severity Rating Scale Screening - Most lethal attempt date. C-SSRS Screening - Most Lethal Suicide Attempt Date CSS09-Most Lethal Attempt Damage Columbia-Suicide Severity Rating Scale Screening - Most lethal attempt actual lethality/medical damage. C-SSRS Screening - Most Lethal Suicide Attempt Actual Lethality/Medical Damage CSS09-Most Lethal Attempt Potential Columbia-Suicide Severity Rating Scale Screening - Most lethal attempt potential lethality. C-SSRS Screening - Most Lethal Suicide Attempt Potential Lethality CSS09-First Attempt Date Columbia-Suicide Severity Rating Scale Screening - Initial/first attempt date. C-SSRS Screening - First Suicide Attempt Date CSS09-First Attempt Damage Columbia-Suicide Severity Rating Scale Screening - Initial/first attempt actual lethality/medical damage. C-SSRS Screening - First Suicide Attempt Actual Lethality/Medical Damage CSS09-First Attempt Potential Columbia-Suicide Severity Rating Scale Screening - Initial/first attempt potential lethality. C-SSRS Screening - First Suicide Attempt Potential Lethality CSS09TC Columbia-Suicide Severity Rating Scale Screening Questionnaire Test Code CDISC Questionnaire C-SSRS Screening Test Code Terminology Columbia-Suicide Severity Rating Scale Screening test name. CSS09-Aborted Attempt Columbia-Suicide Severity Rating Scale Screening - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? C-SSRS Screening - Aborted Suicide Attempt CSS09-Aborted Attempt, Describe Columbia-Suicide Severity Rating Scale Screening - Description of aborted attempt. C-SSRS Screening - Description of Aborted Suicide Attempt CSS09-Actual Attempt Columbia-Suicide Severity Rating Scale Screening - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? C-SSRS Screening - Actual Suicide Attempt CSS09-Actual Attempt, Describe Columbia-Suicide Severity Rating Scale Screening - Description of actual attempt. C-SSRS Screening - Description of Actual Suicide Attempt CSS09-First Attempt Damage Columbia-Suicide Severity Rating Scale Screening - Initial/first attempt actual lethality/medical damage. C-SSRS Screening - First Suicide Attempt Actual Lethality/Medical Damage CSS09-First Attempt Date Columbia-Suicide Severity Rating Scale Screening - Initial/first attempt date. C-SSRS Screening - First Suicide Attempt Date CSS09-First Attempt Potential Columbia-Suicide Severity Rating Scale Screening - Initial/first attempt potential lethality. C-SSRS Screening - First Suicide Attempt Potential Lethality CSS09-Idea, Intent, No Plan Columbia-Suicide Severity Rating Scale Screening - Have you had these thoughts and had some intention of acting on them? C-SSRS Screening - Active Suicidal Ideation with Some Intent to Act, without Specific Plan CSS09-Idea, Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Screening - Description of active suicidal ideation with some intent to act, without specific plan. C-SSRS Screening - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan CSS09-Idea, No Intent, No Plan Columbia-Suicide Severity Rating Scale Screening - Have you been thinking about how you might do this? C-SSRS Screening - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act CSS09-Idea, No Intent, No Plan, Describe Columbia-Suicide Severity Rating Scale Screening - Description of active suicidal ideation with any methods (not plan) without intent to act. C-SSRS Screening - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act CSS09-Idea, Plan, Intent Columbia-Suicide Severity Rating Scale Screening - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? C-SSRS Screening - Active Suicidal Ideation with Specific Plan and Intent CSS09-Idea, Plan, Intent, Describe Columbia-Suicide Severity Rating Scale Screening - Description of active suicidal ideation with specific plan and intent. C-SSRS Screening - Description of Active Suicidal Ideation with Specific Plan and Intent CSS09-Interrupted Attempt Columbia-Suicide Severity Rating Scale Screening - Has there been a time when you started to do something to end your life but someone or something stopped you before you actually did anything? C-SSRS Screening - Interrupted Suicide Attempt CSS09-Interrupted Attempt, Describe Columbia-Suicide Severity Rating Scale Screening - Description of interrupted attempt. C-SSRS Screening - Description of Interrupted Suicide Attempt CSS09-Most Lethal Attempt Damage Columbia-Suicide Severity Rating Scale Screening - Most lethal attempt actual lethality/medical damage. C-SSRS Screening - Most Lethal Suicide Attempt Actual Lethality/Medical Damage CSS09-Most Lethal Attempt Date Columbia-Suicide Severity Rating Scale Screening - Most lethal attempt date. C-SSRS Screening - Most Lethal Suicide Attempt Date CSS09-Most Lethal Attempt Potential Columbia-Suicide Severity Rating Scale Screening - Most lethal attempt potential lethality. C-SSRS Screening - Most Lethal Suicide Attempt Potential Lethality CSS09-Most Recent Attempt Damage Columbia-Suicide Severity Rating Scale Screening - Most recent attempt actual lethality/medical damage. C-SSRS Screening - Most Recent Suicide Attempt Actual Lethality/Medical Damage CSS09-Most Recent Attempt Date Columbia-Suicide Severity Rating Scale Screening - Most recent attempt date. C-SSRS Screening - Most Recent Suicide Attempt Date CSS09-Most Recent Attempt Potential Columbia-Suicide Severity Rating Scale Screening - Most recent attempt potential lethality. C-SSRS Screening - Most Recent Suicide Attempt Potential Lethality CSS09-Most Severe Idea Columbia-Suicide Severity Rating Scale Screening - Most severe ideation. C-SSRS Screening - Most Severe Ideation CSS09-Most Severe Idea, Controllability Columbia-Suicide Severity Rating Scale Screening - Could/can you stop thinking about killing yourself or wanting to die if you want to? C-SSRS Screening - Controllability of Most Severe Ideation CSS09-Most Severe Idea, Desc Columbia-Suicide Severity Rating Scale Screening - Description of most severe ideation. C-SSRS Screening - Describe Most Severe Ideation CSS09-Most Severe Idea, Deterrents Columbia-Suicide Severity Rating Scale Screening - Are there things-anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? C-SSRS Screening - Deterrents to Most Severe Ideation CSS09-Most Severe Idea, Duration Columbia-Suicide Severity Rating Scale Screening - When you have the thoughts, how long do they last? C-SSRS Screening - Duration of Most Severe Ideation CSS09-Most Severe Idea, Frequency Columbia-Suicide Severity Rating Scale Screening - How many times have you had these thoughts? C-SSRS Screening - Frequency of Most Severe Ideation CSS09-Most Severe Idea, Reasons Columbia-Suicide Severity Rating Scale Screening - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? C-SSRS Screening - Reasons for Most Severe Ideation CSS09-Non-Spec Suicid Thought Columbia-Suicide Severity Rating Scale Screening - Have you actually had any thoughts of killing yourself? C-SSRS Screening - Non-Specific Active Suicidal Thoughts CSS09-Non-Spec Suicid Thought, Describe Columbia-Suicide Severity Rating Scale Screening - Description of non-specific active suicidal thoughts. C-SSRS Screening - Description of Non-Specific Active Suicidal Thoughts CSS09-Non-suicidal Self-injur Behav Columbia-Suicide Severity Rating Scale Screening - Has subject engaged in non-suicidal self-injurious behavior? C-SSRS Screening - Non-suicidal Self-injurious Behavior CSS09-Number of Aborted Attempts Columbia-Suicide Severity Rating Scale Screening - Total number of aborted attempts. C-SSRS Screening - Number of Aborted Suicide Attempts CSS09-Number of Actual Attempts Columbia-Suicide Severity Rating Scale Screening - Total number of actual attempts. C-SSRS Screening - Number of Actual Suicide Attempts CSS09-Number of Interrupt Attempts Columbia-Suicide Severity Rating Scale Screening - Total number of interrupted attempts. C-SSRS Screening - Number of Interrupted Suicide Attempts CSS09-Preparatory Acts/Behavior Columbia-Suicide Severity Rating Scale Screening - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? C-SSRS Screening - Preparatory Acts or Behaviors Toward Suicide Attempt CSS09-Preparatory Acts/Behavior, Descr Columbia-Suicide Severity Rating Scale Screening - Description of preparatory acts or behavior. C-SSRS Screening - Description of Preparatory Acts or Behaviors Toward Suicide Attempt CSS09-Suicidal Behavior Columbia-Suicide Severity Rating Scale Screening - Suicidal behavior was present during the assessment period? C-SSRS Screening - Suicidal Behavior CSS09-Wish to be Dead Columbia-Suicide Severity Rating Scale Screening - Have you wished you were dead or wished you could go to sleep and not wake up? C-SSRS Screening - Wish to be Dead CSS09-Wish to be Dead, Describe Columbia-Suicide Severity Rating Scale Screening - Description of wishing to be dead. C-SSRS Screening - Description of Wish to be Dead CSS09TN Columbia-Suicide Severity Rating Scale Screening Questionnaire Test Name CDISC Questionnaire C-SSRS Screening Test Name Terminology Columbia-Suicide Severity Rating Scale Since Last Visit test code. CSS02-Wish to be Dead Columbia-Suicide Severity Rating Scale Since Last Visit - Have you wished you were dead or wished you could go to sleep and not wake up? C-SSRS Since Last Visit - Wish to be Dead or go to Sleep and not Wake Up CSS02-Wish to be Dead, Describe Columbia-Suicide Severity Rating Scale Since Last Visit - Description of wishing to be dead. C-SSRS Since Last Visit - Description of Wish to be Dead CSS02-Non-Specific Suicidal Thought Columbia-Suicide Severity Rating Scale Since Last Visit - Have you actually had any thoughts of killing yourself? C-SSRS Since Last Visit - Non-Specific Suicidal Thought CSS02-Non-Specific Suicid Thought, Descr Columbia-Suicide Severity Rating Scale Since Last Visit - Description of non-specific active suicidal thoughts. C-SSRS Since Last Visit - Description of Non-Specific Suicide Thought CSS02-Suicidal Ideation-No Intent Columbia-Suicide Severity Rating Scale Since Last Visit - Have you been thinking about how you might do this? C-SSRS Since Last Visit - Suicidal Ideation-No Intent CSS02-Suicidal Ideation-No Intent, Descr Columbia-Suicide Severity Rating Scale Since Last Visit - Description of active suicidal ideation with any methods (not plan) without intent to act. C-SSRS Since Last Visit - Description of Suicidal Ideation-No Intent CSS02-Ideation With Intent, No Plan Columbia-Suicide Severity Rating Scale Since Last Visit - Have you had these thoughts and had some intention of acting on them? C-SSRS Since Last Visit - Ideation With Intent, No Plan CSS02-Ideation With Intent No Plan Descr Columbia-Suicide Severity Rating Scale Since Last Visit - Description of active suicidal ideation with some intent to act, without specific plan. C-SSRS Since Last Visit - Description of Ideation With Intent, No Plan CSS02-Ideation With Plan/Intent Columbia-Suicide Severity Rating Scale Since Last Visit - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? C-SSRS Since Last Visit - Ideation With Plan/Intent CSS02-Ideation With Plan/Intent, Descr Columbia-Suicide Severity Rating Scale Since Last Visit - Description of active suicidal ideation with specific plan and intent. C-SSRS Since Last Visit - Description of Ideation With Plan and Intent CSS02-Most Severe Ideation Columbia-Suicide Severity Rating Scale Since Last Visit - Most severe ideation. C-SSRS Since Last Visit - Most Severe Ideation CSS02-Most Severe Ideation, Description Columbia-Suicide Severity Rating Scale Since Last Visit - Description of most severe ideation. C-SSRS Since Last Visit - Describe Most Severe Ideation CSS02-Most Severe Ideation, Frequency Columbia-Suicide Severity Rating Scale Since Last Visit - How many times have you had these thoughts? C-SSRS Since Last Visit - Frequency of Most Severe Ideation CSS02-Most Severe Ideation, Duration Columbia-Suicide Severity Rating Scale Since Last Visit - When you have the thoughts, how long do they last? C-SSRS Since Last Visit - Duration of Most Severe Ideation CSS02-Most Severe Ideation, Control Columbia-Suicide Severity Rating Scale Since Last Visit - Could/can you stop thinking about killing yourself or wanting to die if you want to? C-SSRS Since Last Visit - Control over Most Severe Ideation CSS02-Most Severe Ideation, Deterrents Columbia-Suicide Severity Rating Scale Since Last Visit - Are there things - anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? C-SSRS Since Last Visit - Deterrents to Most Severe Ideation CSS02-Most Severe Ideation, Reasons Columbia-Suicide Severity Rating Scale Since Last Visit - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? C-SSRS Since Last Visit - Reasons for Most Severe Ideation CSS02-Actual Attempt Columbia-Suicide Severity Rating Scale Since Last Visit - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? C-SSRS Since Last Visit - Actual Suicide Attempt CSS02-Number of Actual Attempts Columbia-Suicide Severity Rating Scale Since Last Visit - Total number of actual attempts. C-SSRS Since Last Visit - Number of Actual Suicide Attempts CSS02-Actual Attempt, Describe Columbia-Suicide Severity Rating Scale Since Last Visit - Description of actual attempt. C-SSRS Since Last Visit - Description of Actual Suicide Attempts CSS02-Non-suicidal Self-injurious Behav Columbia-Suicide Severity Rating Scale Since Last Visit - Has the subject engaged in non-suicidal self-injurious behavior. C-SSRS Since Last Visit - Non-suicidal Self-injurious Behavior CSS02-Interrupted Attempt Columbia-Suicide Severity Rating Scale Since Last Visit - Has there been a time when you started to do something to end your life but someone or something stopped you before you actually did anything? C-SSRS Since Last Visit - Interrupted Suicide Attempt CSS02-Number of Interrupted Attempts Columbia-Suicide Severity Rating Scale Since Last Visit - Total number of interrupted attempts. C-SSRS Since Last Visit - Number of Interrupted Suicide Attempts CSS02-Interrupted Attempt, Describe Columbia-Suicide Severity Rating Scale Since Last Visit - Description of interrupted attempt. C-SSRS Since Last Visit - Description of Interrupted Suicide Attempt CSS02-Aborted Attempt Columbia-Suicide Severity Rating Scale Since Last Visit - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? C-SSRS Since Last Visit - Aborted Suicide Attempt CSS02-Number of Aborted Attempts Columbia-Suicide Severity Rating Scale Since Last Visit - Total number of aborted attempts. C-SSRS Since Last Visit - Number of Aborted Suicide Attempts CSS02-Aborted Attempt, Describe Columbia-Suicide Severity Rating Scale Since Last Visit - Description of aborted attempt. C-SSRS Since Last Visit - Description of Aborted Suicide Attempt CSS02-Preparatory Acts/Behavior Columbia-Suicide Severity Rating Scale Since Last Visit - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? C-SSRS Since Last Visit - Preparatory Acts or Behaviors Toward Suicide Attempt CSS02-Preparatory Acts/Behavior, Descr Columbia-Suicide Severity Rating Scale Since Last Visit - Description of preparatory acts or behavior. C-SSRS Since Last Visit - Description of Preparatory Acts or Behaviors Toward Suicide Attempt CSS02-Suicidal Behavior Columbia-Suicide Severity Rating Scale Since Last Visit - Suicidal behavior was present during the assessment period? C-SSRS Since Last Visit - Suicidal Behavior CSS02-Suicide Columbia-Suicide Severity Rating Scale Since Last Visit - Suicide. C-SSRS Since Last Visit - Suicide CSS02-Most Lethal Attempt Date Columbia-Suicide Severity Rating Scale Since Last Visit - Most lethal attempt date. C-SSRS Since Last Visit - Most Lethal Attempt Date CSS02-Most Lethal Attempt Damage Columbia-Suicide Severity Rating Scale Since Last Visit - Most lethal attempt actual lethality/medical damage. C-SSRS Since Last Visit - Most Lethal Actual Attempt Lethality/Medical Damage CSS02-Most Lethal Attempt Potential Columbia-Suicide Severity Rating Scale Since Last Visit - Most lethal attempt potential lethality. C-SSRS Since Last Visit - Most Lethal Actual Attempt Potential Lethality CSS02TC Columbia-Suicide Severity Rating Scale Since Last Visit Questionnaire Test Code CDISC Questionnaire C-SSRS Since Last Visit Test Code Terminology Columbia-Suicide Severity Rating Scale Since Last Visit test name. CSS02-Aborted Attempt Columbia-Suicide Severity Rating Scale Since Last Visit - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? C-SSRS Since Last Visit - Aborted Suicide Attempt CSS02-Aborted Attempt, Describe Columbia-Suicide Severity Rating Scale Since Last Visit - Description of aborted attempt. C-SSRS Since Last Visit - Description of Aborted Suicide Attempt CSS02-Actual Attempt Columbia-Suicide Severity Rating Scale Since Last Visit - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? C-SSRS Since Last Visit - Actual Suicide Attempt CSS02-Actual Attempt, Describe Columbia-Suicide Severity Rating Scale Since Last Visit - Description of actual attempt. C-SSRS Since Last Visit - Description of Actual Suicide Attempts CSS02-Ideation With Intent No Plan Descr Columbia-Suicide Severity Rating Scale Since Last Visit - Description of active suicidal ideation with some intent to act, without specific plan. C-SSRS Since Last Visit - Description of Ideation With Intent, No Plan CSS02-Ideation With Intent, No Plan Columbia-Suicide Severity Rating Scale Since Last Visit - Have you had these thoughts and had some intention of acting on them? C-SSRS Since Last Visit - Ideation With Intent, No Plan CSS02-Ideation With Plan/Intent Columbia-Suicide Severity Rating Scale Since Last Visit - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? C-SSRS Since Last Visit - Ideation With Plan/Intent CSS02-Ideation With Plan/Intent, Descr Columbia-Suicide Severity Rating Scale Since Last Visit - Description of active suicidal ideation with specific plan and intent. C-SSRS Since Last Visit - Description of Ideation With Plan and Intent CSS02-Interrupted Attempt Columbia-Suicide Severity Rating Scale Since Last Visit - Has there been a time when you started to do something to end your life but someone or something stopped you before you actually did anything? C-SSRS Since Last Visit - Interrupted Suicide Attempt CSS02-Interrupted Attempt, Describe Columbia-Suicide Severity Rating Scale Since Last Visit - Description of interrupted attempt. C-SSRS Since Last Visit - Description of Interrupted Suicide Attempt CSS02-Most Lethal Attempt Damage Columbia-Suicide Severity Rating Scale Since Last Visit - Most lethal attempt actual lethality/medical damage. C-SSRS Since Last Visit - Most Lethal Actual Attempt Lethality/Medical Damage CSS02-Most Lethal Attempt Date Columbia-Suicide Severity Rating Scale Since Last Visit - Most lethal attempt date. C-SSRS Since Last Visit - Most Lethal Attempt Date CSS02-Most Lethal Attempt Potential Columbia-Suicide Severity Rating Scale Since Last Visit - Most lethal attempt potential lethality. C-SSRS Since Last Visit - Most Lethal Actual Attempt Potential Lethality CSS02-Most Severe Ideation Columbia-Suicide Severity Rating Scale Since Last Visit - Most severe ideation. C-SSRS Since Last Visit - Most Severe Ideation CSS02-Most Severe Ideation, Control Columbia-Suicide Severity Rating Scale Since Last Visit - Could/can you stop thinking about killing yourself or wanting to die if you want to? C-SSRS Since Last Visit - Control over Most Severe Ideation CSS02-Most Severe Ideation, Description Columbia-Suicide Severity Rating Scale Since Last Visit - Description of most severe ideation. C-SSRS Since Last Visit - Describe Most Severe Ideation CSS02-Most Severe Ideation, Deterrents Columbia-Suicide Severity Rating Scale Since Last Visit - Are there things - anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? C-SSRS Since Last Visit - Deterrents to Most Severe Ideation CSS02-Most Severe Ideation, Duration Columbia-Suicide Severity Rating Scale Since Last Visit - When you have the thoughts, how long do they last? C-SSRS Since Last Visit - Duration of Most Severe Ideation CSS02-Most Severe Ideation, Frequency Columbia-Suicide Severity Rating Scale Since Last Visit - How many times have you had these thoughts? C-SSRS Since Last Visit - Frequency of Most Severe Ideation CSS02-Most Severe Ideation, Reasons Columbia-Suicide Severity Rating Scale Since Last Visit - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? C-SSRS Since Last Visit - Reasons for Most Severe Ideation CSS02-Non-Specific Suicid Thought, Descr Columbia-Suicide Severity Rating Scale Since Last Visit - Description of non-specific active suicidal thoughts. C-SSRS Since Last Visit - Description of Non-Specific Suicide Thought CSS02-Non-Specific Suicidal Thought Columbia-Suicide Severity Rating Scale Since Last Visit - Have you actually had any thoughts of killing yourself? C-SSRS Since Last Visit - Non-Specific Suicidal Thought CSS02-Non-suicidal Self-injurious Behav Columbia-Suicide Severity Rating Scale Since Last Visit - Has the subject engaged in non-suicidal self-injurious behavior. C-SSRS Since Last Visit - Non-suicidal Self-injurious Behavior CSS02-Number of Aborted Attempts Columbia-Suicide Severity Rating Scale Since Last Visit - Total number of aborted attempts. C-SSRS Since Last Visit - Number of Aborted Suicide Attempts CSS02-Number of Actual Attempts Columbia-Suicide Severity Rating Scale Since Last Visit - Total number of actual attempts. C-SSRS Since Last Visit - Number of Actual Suicide Attempts CSS02-Number of Interrupted Attempts Columbia-Suicide Severity Rating Scale Since Last Visit - Total number of interrupted attempts. C-SSRS Since Last Visit - Number of Interrupted Suicide Attempts CSS02-Preparatory Acts/Behavior Columbia-Suicide Severity Rating Scale Since Last Visit - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? C-SSRS Since Last Visit - Preparatory Acts or Behaviors Toward Suicide Attempt CSS02-Preparatory Acts/Behavior, Descr Columbia-Suicide Severity Rating Scale Since Last Visit - Description of preparatory acts or behavior. C-SSRS Since Last Visit - Description of Preparatory Acts or Behaviors Toward Suicide Attempt CSS02-Suicidal Behavior Columbia-Suicide Severity Rating Scale Since Last Visit - Suicidal behavior was present during the assessment period? C-SSRS Since Last Visit - Suicidal Behavior CSS02-Suicidal Ideation-No Intent Columbia-Suicide Severity Rating Scale Since Last Visit - Have you been thinking about how you might do this? C-SSRS Since Last Visit - Suicidal Ideation-No Intent CSS02-Suicidal Ideation-No Intent, Descr Columbia-Suicide Severity Rating Scale Since Last Visit - Description of active suicidal ideation with any methods (not plan) without intent to act. C-SSRS Since Last Visit - Description of Suicidal Ideation-No Intent CSS02-Suicide Columbia-Suicide Severity Rating Scale Since Last Visit - Suicide. C-SSRS Since Last Visit - Suicide CSS02-Wish to be Dead Columbia-Suicide Severity Rating Scale Since Last Visit - Have you wished you were dead or wished you could go to sleep and not wake up? C-SSRS Since Last Visit - Wish to be Dead or go to Sleep and not Wake Up CSS02-Wish to be Dead, Describe Columbia-Suicide Severity Rating Scale Since Last Visit - Description of wishing to be dead. C-SSRS Since Last Visit - Description of Wish to be Dead CSS02TN Columbia-Suicide Severity Rating Scale Since Last Visit Questionnaire Test Name CDISC Questionnaire C-SSRS Since Last Visit Test Name Terminology Combat Exposure Scale original result for CES0101 test and test code. CES0101-1-3 times Combat Exposure Scale original result for CES0101-1-3 times. Combat Exposure Scale CES0101 Original Result - 1-3 Times CES0101-13-50 times Combat Exposure Scale original result for CES0101-13-50 times. Combat Exposure Scale CES0101 Original Result - 13-50 Times CES0101-4-12 times Combat Exposure Scale original result for CES0101-4-12 times. Combat Exposure Scale CES0101 Original Result - 4-12 Times CES0101-51+times Combat Exposure Scale original result for CES0101-51+times. Combat Exposure Scale CES0101 Original Result - 51+ Times CES0101-No Combat Exposure Scale original result for CES0101-No. Combat Exposure Scale CES0101 Original Result - No CES0101OR Combat Exposure Scale Questionnaire ORRES for CES0101 TN/TC CDISC Questionnaire Combat Exposure Scale CES0101 Original Response Terminology Combat Exposure Scale original result for CES0102 test and test code. CES0102-1-3 months Combat Exposure Scale original result for CES0102-1-3 months. Combat Exposure Scale CES0102 Original Result - 1-3 Months CES0102-4-6 months Combat Exposure Scale original result for CES0102-4-6 months. Combat Exposure Scale CES0102 Original Result - 4-6 Months CES0102-7+ months Combat Exposure Scale original result for CES0102-7+ months. Combat Exposure Scale CES0102 Original Result - 7+ Months CES0102-<1 month Combat Exposure Scale original result for CES0102-<1 month. Combat Exposure Scale CES0102 Original Result - <1 Month CES0102-Never Combat Exposure Scale original result for CES0102-Never. Combat Exposure Scale CES0102 Original Result - Never CES0102OR Combat Exposure Scale Questionnaire ORRES for CES0102 TN/TC CDISC Questionnaire Combat Exposure Scale CES0102 Original Response Terminology Combat Exposure Scale original result for CES0103 test and test code. CES0103-1-2 times Combat Exposure Scale original result for CES0103-1-2 times. Combat Exposure Scale CES0103 Original Result - 1-2 Times CES0103-13-25 times Combat Exposure Scale original result for CES0103-13-25 times. Combat Exposure Scale CES0103 Original Result - 13-25 Times CES0103-26+times Combat Exposure Scale original result for CES0103-26+times. Combat Exposure Scale CES0103 Original Result - 26+ Times CES0103-3-12 times Combat Exposure Scale original result for CES0103-3-12 times. Combat Exposure Scale CES0103 Original Result - 3-12 Times CES0103-No Combat Exposure Scale original result for CES0103-No. Combat Exposure Scale CES0103 Original Result - No CES0103OR Combat Exposure Scale Questionnaire ORRES for CES0103 TN/TC CDISC Questionnaire Combat Exposure Scale CES0103 Original Response Terminology Combat Exposure Scale original result for CES0104 test and test code. CES0104-1-25% Combat Exposure Scale original result for CES0104-1-25%. Combat Exposure Scale CES0104 Original Result - 1-25% CES0104-26-50% Combat Exposure Scale original result for CES0104-26-50%. Combat Exposure Scale CES0104 Original Result - 26-50% CES0104-51-75% Combat Exposure Scale original result for CES0104-51-75%. Combat Exposure Scale CES0104 Original Result - 51-75% CES0104-76% or more Combat Exposure Scale original result for CES0104-76% or more. Combat Exposure Scale CES0104 Original Result - 76% or More CES0104-None Combat Exposure Scale original result for CES0104-None. Combat Exposure Scale CES0104 Original Result - None CES0104OR Combat Exposure Scale Questionnaire ORRES for CES0104 TN/TC CDISC Questionnaire Combat Exposure Scale CES0104 Original Response Terminology Combat Exposure Scale original result for CES0105 through CES0107 test and test code. CES0105 through CES0107-1-2 times Combat Exposure Scale original result for CES0105 through CES0107-1-2 times. Combat Exposure Scale CES0105 Through CES0107 Original Result - 1-2 Times CES0105 through CES0107-13-50 times Combat Exposure Scale original result for CES0105 through CES0107-13-50 times. Combat Exposure Scale CES0105 Through CES0107 Original Result - 13-50 Times CES0105 through CES0107-3-12 times Combat Exposure Scale original result for CES0105 through CES0107-3-12 times. Combat Exposure Scale CES0105 Through CES0107 Original Result - 3-12 Times CES0105 through CES0107-51+ times Combat Exposure Scale original result for CES0105 through CES0107-51+ times. Combat Exposure Scale CES0105 Through CES0107 Original Result - 51+ Times CES0105 through CES0107-Never Combat Exposure Scale original result for CES0105 through CES0107-Never. Combat Exposure Scale CES0105 Through CES0107 Original Result - Never CES0105T07OR Combat Exposure Scale Questionnaire ORRES for CES0105 Through CES0107 TN/TC CDISC Questionnaire Combat Exposure Scale CES0105 Through CES0107 Original Response Terminology Combat Exposure Scale standardized character result for CES0101 test and test code. CES0101-1 Combat Exposure Scale standardized character result for CES0101-No. Combat Exposure Scale CES0101 Standardized Character Result 1 CES0101-2 Combat Exposure Scale standardized character result for CES0101-1-3 times. Combat Exposure Scale CES0101 Standardized Character Result 2 CES0101-3 Combat Exposure Scale standardized character result for CES0101-4-12 times. Combat Exposure Scale CES0101 Standardized Character Result 3 CES0101-4 Combat Exposure Scale standardized character result for CES0101-13-50 times. Combat Exposure Scale CES0101 Standardized Character Result 4 CES0101-5 Combat Exposure Scale standardized character result for CES0101-51+times. Combat Exposure Scale CES0101 Standardized Character Result 5 CES0101STR Combat Exposure Scale Questionnaire STRESC for CES0101 TN/TC CDISC Questionnaire Combat Exposure Scale CES0101 Standardized Character Response Terminology Combat Exposure Scale standardized character result for CES0102 test and test code. CES0102-1 Combat Exposure Scale standardized character result for CES0102-Never. Combat Exposure Scale CES0102 Standardized Character Result 1 CES0102-2 Combat Exposure Scale standardized character result for CES0102-<1 month. Combat Exposure Scale CES0102 Standardized Character Result 2 CES0102-3 Combat Exposure Scale standardized character result for CES0102-1-3 months. Combat Exposure Scale CES0102 Standardized Character Result 3 CES0102-4 Combat Exposure Scale standardized character result for CES0102-4-6 months. Combat Exposure Scale CES0102 Standardized Character Result 4 CES0102-5 Combat Exposure Scale standardized character result for CES0102-7+ months. Combat Exposure Scale CES0102 Standardized Character Result 5 CES0102STR Combat Exposure Scale Questionnaire STRESC for CES0102 TN/TC CDISC Questionnaire Combat Exposure Scale CES0102 Standardized Character Response Terminology Combat Exposure Scale standardized character result for CES0103 test and test code. CES0103-1 Combat Exposure Scale standardized character result for CES0103-No. Combat Exposure Scale CES0103 Standardized Character Result 1 CES0103-2 Combat Exposure Scale standardized character result for CES0103-1-2 times. Combat Exposure Scale CES0103 Standardized Character Result 2 CES0103-3 Combat Exposure Scale standardized character result for CES0103-3-12 times. Combat Exposure Scale CES0103 Standardized Character Result 3 CES0103-4 Combat Exposure Scale standardized character result for CES0103-13-25 times. Combat Exposure Scale CES0103 Standardized Character Result 4 CES0103-5 Combat Exposure Scale standardized character result for CES0103-26+times. Combat Exposure Scale CES0103 Standardized Character Result 5 CES0103STR Combat Exposure Scale Questionnaire STRESC for CES0103 TN/TC CDISC Questionnaire Combat Exposure Scale CES0103 Standardized Character Response Terminology Combat Exposure Scale standardized character result for CES0104 test and test code. CES0104-1 Combat Exposure Scale standardized character result for CES0104-None. Combat Exposure Scale CES0104 Standardized Character Result 1 CES0104-2 Combat Exposure Scale standardized character result for CES0104-1-25%. Combat Exposure Scale CES0104 Standardized Character Result 2 CES0104-3 Combat Exposure Scale standardized character result for CES0104-26-50%. Combat Exposure Scale CES0104 Standardized Character Result 3 CES0104-4 Combat Exposure Scale standardized character result for CES0104-51-75%. Combat Exposure Scale CES0104 Standardized Character Result 4 CES0104-5 Combat Exposure Scale standardized character result for CES0104-76% or more. Combat Exposure Scale CES0104 Standardized Character Result 5 CES0104STR Combat Exposure Scale Questionnaire STRESC for CES0104 TN/TC CDISC Questionnaire Combat Exposure Scale CES0104 Standardized Character Response Terminology Combat Exposure Scale standardized character result for CES0105 through CES0107 test and test code. CES0105 through CES0107-1 Combat Exposure Scale standardized character result for CES0105 through CES0107-Never. Combat Exposure Scale CES0105 Through CES0107 Standardized Character Result 1 CES0105 through CES0107-2 Combat Exposure Scale standardized character result for CES0105 through CES0107-1-2 times. Combat Exposure Scale CES0105 Through CES0107 Standardized Character Result 2 CES0105 through CES0107-3 Combat Exposure Scale standardized character result for CES0105 through CES0107-3-12 times. Combat Exposure Scale CES0105 Through CES0107 Standardized Character Result 3 CES0105 through CES0107-4 Combat Exposure Scale standardized character result for CES0105 through CES0107-13-50 times. Combat Exposure Scale CES0105 Through CES0107 Standardized Character Result 4 CES0105 through CES0107-5 Combat Exposure Scale standardized character result for CES0105 through CES0107-51+ times. Combat Exposure Scale CES0105 Through CES0107 Standardized Character Result 5 CES0105T07STR Combat Exposure Scale Questionnaire STRESC for CES0105 Through CES0107 TN/TC CDISC Questionnaire Combat Exposure Scale CES0105 Through CES0107 Standardized Character Response Terminology Combat Exposure Scale test code. CES01-Ever Combat Patrols/Dangerous Duty Combat Exposure Scale - Did you ever go on combat patrols or have other dangerous duty? CES - Ever Combat Patrols or Dangerous Duty CES01-Were You Ever Under Enemy Fire Combat Exposure Scale - Were you ever under enemy fire? CES - Were You Ever Under Enemy Fire CES01-Ever Surrounded by the Enemy Combat Exposure Scale - Were you ever surrounded by the enemy? CES - Ever Surrounded by the Enemy CES01-Soldiers in Unit KIA, Wounded, MIA Combat Exposure Scale - What percentage of the soldiers in your unit were killed (KIA), wounded or missing in action (MIA)? CES - Soldiers in Unit Killed (KIA), Wounded, Missing (MIA) CES01-How Often Fire Rounds at Enemy Combat Exposure Scale - How often did you fire rounds at the enemy? CES - How Often Fire Rounds at Enemy CES01-See Someone Hit by Rounds Combat Exposure Scale - How often did you see someone hit by incoming or outgoing rounds? CES - See Someone Hit by Rounds CES01-In Danger of Being Injured/Killed Combat Exposure Scale - How often were you in danger of being injured or killed (i.e., being pinned down, overrun, ambushed, near miss, etc.)? CES - In Danger of Being Injured or Killed CES01TC Combat Exposure Scale Questionnaire Test Code CDISC Questionnaire CES Test Code Terminology Combat Exposure Scale test name. CES01-Ever Combat Patrols/Dangerous Duty Combat Exposure Scale - Did you ever go on combat patrols or have other dangerous duty? CES - Ever Combat Patrols or Dangerous Duty CES01-Ever Surrounded by the Enemy Combat Exposure Scale - Were you ever surrounded by the enemy? CES - Ever Surrounded by the Enemy CES01-How Often Fire Rounds at Enemy Combat Exposure Scale - How often did you fire rounds at the enemy? CES - How Often Fire Rounds at Enemy CES01-In Danger of Being Injured/Killed Combat Exposure Scale - How often were you in danger of being injured or killed (i.e., being pinned down, overrun, ambushed, near miss, etc.)? CES - In Danger of Being Injured or Killed CES01-See Someone Hit by Rounds Combat Exposure Scale - How often did you see someone hit by incoming or outgoing rounds? CES - See Someone Hit by Rounds CES01-Soldiers in Unit KIA, Wounded, MIA Combat Exposure Scale - What percentage of the soldiers in your unit were killed (KIA), wounded or missing in action (MIA)? CES - Soldiers in Unit Killed (KIA), Wounded, Missing (MIA) CES01-Were You Ever Under Enemy Fire Combat Exposure Scale - Were you ever under enemy fire? CES - Were You Ever Under Enemy Fire CES01TN Combat Exposure Scale Questionnaire Test Name CDISC Questionnaire CES Test Name Terminology Comfort Behavior Scale test code. CBS01-Alertness Comfort Behavior Scale Assessment - Alertness. Comfort-B - Alertness CBS01-Calmness/Agitation Comfort Behavior Scale Assessment - Calmness/Agitation. Comfort-B - Calmness/Agitation CBS01-Respiratory Response Comfort Behavior Scale Assessment - Respiratory response (only in mechanically ventilated children). Comfort-B - Respiratory Response CBS01-Crying Comfort Behavior Scale Assessment - Crying (only in spontaneously breathing children). Comfort-B - Crying CBS01-Physical Movement Comfort Behavior Scale Assessment - Physical movement. Comfort-B - Physical Movement CBS01-Muscle Tone Comfort Behavior Scale Assessment - Muscle tone. Comfort-B - Muscle Tone CBS01-Facial Tension Comfort Behavior Scale Assessment - Facial tension. Comfort-B - Facial Tension CBS01-Total Score Comfort Behavior Scale Assessment - Total score. Comfort-B - Total Score CBS01-NRS Pain Comfort Behavior Scale Assessment - NRS pain. Comfort-B - NRS Pain CBS01-NISS Comfort Behavior Scale Assessment - NISS (nurse interpretation of sedation sale). Comfort-B - NISS CBS01-Details Sedatives/Analgesics Comfort Behavior Scale Assessment - Details sedatives/analgesics. Comfort-B - Details Sedatives/Analgesics CBS01-Reason Assessment Comfort Behavior Scale Assessment - Reason assessment. Comfort-B - Reason Assessment CBS01TC Comfort Behavior Scale Clinical Classification Test Code CDISC Clinical Classification Comfort Behavior Scale Test Code Terminology Comfort Behavior Scale test name. CBS01-Alertness Comfort Behavior Scale Assessment - Alertness. Comfort-B - Alertness CBS01-Calmness/Agitation Comfort Behavior Scale Assessment - Calmness/Agitation. Comfort-B - Calmness/Agitation CBS01-Crying Comfort Behavior Scale Assessment - Crying (only in spontaneously breathing children). Comfort-B - Crying CBS01-Details Sedatives/Analgesics Comfort Behavior Scale Assessment - Details sedatives/analgesics. Comfort-B - Details Sedatives/Analgesics CBS01-Facial Tension Comfort Behavior Scale Assessment - Facial tension. Comfort-B - Facial Tension CBS01-Muscle Tone Comfort Behavior Scale Assessment - Muscle tone. Comfort-B - Muscle Tone CBS01-NISS Comfort Behavior Scale Assessment - NISS (nurse interpretation of sedation sale). Comfort-B - NISS CBS01-NRS Pain Comfort Behavior Scale Assessment - NRS pain. Comfort-B - NRS Pain CBS01-Physical Movement Comfort Behavior Scale Assessment - Physical movement. Comfort-B - Physical Movement CBS01-Reason Assessment Comfort Behavior Scale Assessment - Reason assessment. Comfort-B - Reason Assessment CBS01-Respiratory Response Comfort Behavior Scale Assessment - Respiratory response (only in mechanically ventilated children). Comfort-B - Respiratory Response CBS01-Total Score Comfort Behavior Scale Assessment - Total score. Comfort-B - Total Score CBS01TN Comfort Behavior Scale Clinical Classification Test Name CDISC Clinical Classification Comfort Behavior Scale Test Name Terminology A terminology codelist relevant to the state or condition of the sponsor as pertains to whether the sponsor is considered a commercial entity. A person or organization that takes responsibility for a trial which is part of the development program for a marketing authorization of a medicinal product at the time of the application. (EUDRACT) Commercial Clinical Trial Sponsor A person or organization that takes responsibility for a trial that is not part of the development program for a marketing authorization of a medicinal product at the time of the application. (EUDRACT) Non-commercial Clinical Trial Sponsor CMSPSTAT Commercial Sponsor Status Response CDISC SDTM Commercial Sponsor Status Response Terminology The status of the subject's completion of the study or a segment of the study, or the reason the subject discontinued the study or segment of the study. Any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. An adverse event (AE) can therefore be any unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal (investigational) product, whether or not related to the medicinal (investigational) product. (CDISC Glossary) Adverse Event An indication that an approved drug is available for use for the disease indication. Approved Drug Available For Indication To possess every necessary or normal part or component or step; having come or been brought to a conclusion. (NCI) Complete Died The absence of life or state of being dead. (NCI) Dead Recurrent Disease The return of a disease after a period of remission. Recurrent Disease An indication that the subject has not been able to meet protocol-defined continuation criteria and will not continue to participate in the clinical trial. Failure To Meet Continuation Criteria An indication that the subject has been unable to fulfill/satisfy the criteria required for assignment into a randomized group. Failure to Meet Randomization Criteria A position, opinion or judgment reached after consideration by the study investigator, as pertains to the subject. Investigator Decision The lack of expected or desired effect related to a therapy. (NCI) Lack of Efficacy A problem with some logistical aspect of a clinical study, either on the part of the participant or the site. Logistical Problem With Clinical Study The loss or lack of continuation of a subject to follow-up. Lost To Follow-Up Passed Screening But Not Needed Qualified But Not Needed Reserve, Not Used An indication that the subject met inclusion/exclusion criteria but was not needed in the trial. Subject Met Eligibility Criteria But Was Not Needed An indication that a subject has not ever been dosed with the study treatment or investigational product. Never Dosed NLCB An indication that a treatment or therapy was changed or discontinued because it is no longer clinically beneficial to the subject or patient, based on the primary therapeutic objective for which it is being administered and assessed. (Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3. Scher HI, Morris MJ, Stadler WM, et al.; Prostate Cancer Clinical Trials Working Group 3. J Clin Oncol. 2016 Apr 20;34(12):1402-18.) No Longer Clinically Benefiting An indication that a subject has not followed the instructions related to a device that is not under study. Non-Compliance With Non-Study Device An indication that a subject has not followed the instructions related to a device under study. Non-Compliance With Study Device An indication that a subject has not agreed with or followed the instructions related to the study medication. (NCI) Non-Compliance With Study Drug An indication that a subject has not followed the schedule of study activities. Non-Compliance With Study Schedule Failure of a study subject to comply with an aspect of the study. Subject Noncompliance An indication that the study subject's partner is pregnant. Partner Pregnancy A position, opinion or judgment reached after consideration by a physician with reference to subject. (NCI) Physician Decision Subject Pregnancy An indication that the subject is pregnant. Pregnant Subject Disease Progression Progressive Disease A disease process that is increasing in extent or severity. (NCI) Progressive Disease A variation from processes or procedures defined in a protocol. Deviations usually do not preclude the overall evaluability of subject data for either efficacy or safety, and are often acknowledged and accepted in advance by the sponsor. NOTE: Good clinical practice recommends that deviations be summarized by site and by category as part of the report of study results so that the possible importance of the deviations to the findings of the study can be assessed. Compare to protocol violation. [See ICH E3] (CDISC Glossary) Protocol Deviation A significant departure from processes or procedures that were required by the protocol. Violations often result in data that are not deemed evaluable for a per-protocol analysis, and may require that the subject(s) who violate the protocol be discontinued from the study. Compare to protocol deviation. (CDISC Glossary) Protocol Violation An indication that the patient has met one or multiple protocol-specified withdrawal criteria and has been removed from the study or from one or more segments of the study. Protocol-Specified Withdrawal Criterion Met An indication that the subject was randomized but should not have been and study treatment was received in error. Randomized By Mistake With Study Treatment An indication that the subject was randomized but should not have been however no study treatment was received. Randomized By Mistake Without Study Treatment Randomized in Error An indication that the subject was randomized but should not have been. Randomized By Mistake A healing process and/or an outcome implying relative health. The term is typically used in the context of direct and indirect effects of sickness or injury. (NCI) Recovery An indication that the study subject needs to be treated with a medication that is prohibited per the protocol. Requires Prohibited Medication An indication that the study subject needs to be treated with a procedure that is prohibited per the protocol. Requires Prohibited Procedure Failure to Meet Inclusion/Exclusion Criteria The potential subject who does not meet eligibility (inclusion/exclusion) criteria during the screening period. Trial Screen Failure An indication that the subject did not complete the screening process. Screening Not Completed Adverse event that: results in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/ incapacity, or is a congenital anomaly/ birth defect. NOTE: For further information, see the ICH Guideline for Clinical safety Data Management: Definitions and standards for expedited Reporting. [After ICH E2A, ICH E2B] Serious Adverse Event An indication that a clinical study was stopped at a particular site by its sponsor. (NCI) Trial Site Terminated by Sponsor An indication that the study subject was removed from the study or from one or more segments of the study (e.g., treatment epoch, long-term follow-up epoch) at the sponsor's request. Subject Removed at Sponsor Request An indication that a clinical study was stopped by its sponsor. (NCI) Study Terminated By Sponsor A problem with some technical aspect of a clinical study, usually related to an instrument. (NCI) Technical Problem An indication that the study subject underwent a procedure that is prohibited per the protocol. Underwent Prohibited Procedure An indication that the study subject used a medication that is prohibited per the protocol. Used Prohibited Medication Indicator An indication that a study participant has been removed from the study or from one or more segments of the study by the parent or legal guardian. Study Subject Withdrawal by Parent or Guardian Dropout The subject-initiated act of discontinuing participation in the study as a whole or one or more aspects of the study (e.g., a study period or use of biospecimens). Withdrawal by Subject Informed Assent Withdrawn An indication that the assent to participate in the study, or one or more components of the study, has been revoked. Withdrawal of Assent Informed Consent Withdrawn An indication that the consent to participate in the study, or one or more components of the study, has been revoked. Study Consent Withdrawn NCOMPLT Completion/Reason for Non-Completion CDISC SDTM Reason for Non-Completion Terminology Terminology related to the sense of awareness of self and of the environment. Conscious State A level of awareness that can be described as being alert. (NCI) Conscious State Depressed Level of Consciousness A neurologic state characterized by decreased ability to perceive and respond. (NCI) Depressed Level Of Consciousness Semi-conscious State A level of awareness that can be described as varied and intermittent periods of consciousness and unconsciousness. Semi-conscious Loss of Consciousness Unconscious State The neurologic status characterized by the occurrence of a loss of the ability to perceive and respond. Loss of Consciousness Unspecified State of Consciousness The state of consciousness is not controlled. The possibility exists for having multiple conscious states over a period of time. (NCI) Unspecified State of Consciousness CSTATE Consciousness State CDISC SEND Consciousness State Terminology A terminology codelist relevant to the identification and clinical investigation of disease contacts. A way of contracting a disease through everyday interactions (nonsexual) with an infected person. Casual Contact A way of contracting a disease by interacting with an individual that has been exposed to the disease while undergoing a medical procedure. Contact With Exposure During Medical Procedure A way of contracting a disease by physically associating with an infected group of individuals. Contact With Exposure In Crowd Setting A way of contracting a disease by interacting with an individual that is considered at high risk for having the disease. Contact With Medical Risk Factor A way of contracting a disease through interactions with an infected person in the same residence. Household Contact CCINVTYP Contact Case Investigation Contact Type CDISC SDTM Contact Case Investigation Contact Type Terminology The terminology relevant to the role that the responsible individual or entity plays with respect to being a contact for the study. The person responsible for the competent authority application. Competent Authority Applicant The secondary contact person providing centralized, coordinated recruitment information for the entire study. (clinicaltrials.gov) Central Contact for Recruitment Backup The contact person providing centralized, coordinated recruitment information for the entire study. (clinicaltrials.gov) Central Contact for Recruitment The main or principal contact person for the clinical investigator network. Clinical Investigator Network Contact The study contact person who is responsible for questions from the public. Public Queries Study Contact The study contact person who is responsible for questions from the scientific community. Scientific Queries Study Contact The secondary contact person at the facility. Facility Contact Backup The main or principal contact person at the facility. Facility Contact The contact person responsible for disseminating additional information about the study. Study Further Information Contact The person responsible for the independent ethics committee application. Independent Ethics Committee Applicant A person responsible for the conduct of the study, ensuring adherence to the protocol and good clinical practices. (CDISC Glossary) Investigator An individual with expertise in the law who provides legal counsel and representation for a study. Legal Representative for the Study The main or principal contact person for the study. Primary Study Contact The study investigator who has the primary responsibility for the conduct of a study and for the study-related personnel at the participating site(s). Principal Investigator Study Director A person who has overall responsibility for the technical conduct of a study, as well as for the interpretation, analysis, documentation and reporting of results, and represents the single point of study control. (FDA) Study Chair The main or principal contact person for the subcontractor or subcontracting organization. Subcontractor Contact Any member of the clinical trial team designated and supervised by the investigator at a trial site to perform critical trial-related procedures and/or to make important trial-related decisions (e.g., associates, residents, research fellows). (ICH) Subinvestigator CONROL Contact Role for Clinical Study CDISC SDTM Contact Role for Clinical Study Terminology A terminology codelist relevant to a comparator against which the study treatment is evaluated. Active Control A type of control, which has a demonstrated effect, administered as a comparator to subjects in a clinical trial. [From ICH E10] Active Control A type of control using different doses or regimens of the same treatment across the treatment arms. Dose Response Control No person or thing, nobody, not any. (NCI) None Placebo Placebo Control An inactive, identical-appearing drug or treatment that does not contain the test product. Placebo Control Sham Control A type of negative control in which a procedure is performed that mimics the procedure under study but does not include investigational processes or components. Sham Control TCNTRL Control Type Response CDISC SDTM Control Type Terminology Controlled Oral Word Association Test test code. COWAT1-Another Word That Begins With R Controlled Oral Word Association Test - Can you tell me another word that begins with R? COWAT - Another Word That Begins With R COWAT1-Number Correct Words: C Controlled Oral Word Association Test - Number correct words: Now I'm going to give you another letter, and again, say all words beginning with that letter that you can think of. You will have a minute for each one. The first letter is C. COWAT - Number Correct Words: C COWAT1-Number Correct Words: F Controlled Oral Word Association Test - Number correct words: Now I am going to give another letter. Tell me as many words as you can that begin with F. Tell me as many words as quickly as you can that begin with F. COWAT - Number Correct Words: F COWAT1-Number Correct Words: L Controlled Oral Word Association Test - Number correct words: Now I am going to give another letter. Tell me as many words as you can that begin with L. Tell me as many words as quickly as you can that begin with L. COWAT - Number Correct Words: L COWAT1TC Controlled Oral Word Association Test Functional Test Test Code CDISC Functional Test COWAT Test Code Terminology Controlled Oral Word Association Test test name. COWAT1-Another Word That Begins With R Controlled Oral Word Association Test - Can you tell me another word that begins with R? COWAT - Another Word That Begins With R COWAT1-Number Correct Words: C Controlled Oral Word Association Test - Number correct words: Now I'm going to give you another letter, and again, say all words beginning with that letter that you can think of. You will have a minute for each one. The first letter is C. COWAT - Number Correct Words: C COWAT1-Number Correct Words: F Controlled Oral Word Association Test - Number correct words: Now I am going to give another letter. Tell me as many words as you can that begin with F. Tell me as many words as quickly as you can that begin with F. COWAT - Number Correct Words: F COWAT1-Number Correct Words: L Controlled Oral Word Association Test - Number correct words: Now I am going to give another letter. Tell me as many words as you can that begin with L. Tell me as many words as quickly as you can that begin with L. COWAT - Number Correct Words: L COWAT1TN Controlled Oral Word Association Test Functional Test Test Name CDISC Functional Test COWAT Test Name Terminology Terminology relevant to the test codes that describe findings about a COPD event or intervention. Cumulative Exposure The total amount that a subject is exposed to over time. Cumulative Exposure Number of Mild Episodes The number of times an event, which is classified as mild, occurred. Number of Mild Episodes Number of Moderate Episodes The number of times an event, which is classified as moderate, occurred. Number of Moderate Episodes Number of Severe Episodes The number of times an event, which is classified as severe, occurred. Number of Severe Episodes CPFATSCD COPD Findings About Test Code CDISC SDTM COPD Findings About Test Code Terminology Terminology relevant to the test names that describe findings about a COPD event or intervention. Cumulative Exposure The total amount that a subject is exposed to over time. Cumulative Exposure Number of Mild Episodes The number of times an event, which is classified as mild, occurred. Number of Mild Episodes Number of Moderate Episodes The number of times an event, which is classified as moderate, occurred. Number of Moderate Episodes Number of Severe Episodes The number of times an event, which is classified as severe, occurred. Number of Severe Episodes CPFATS COPD Findings About Test Name CDISC SDTM COPD Findings About Test Name Terminology A terminology codelist associated with coronary artery disease presentation. NON-STEMI NSTEMI A myocardial infarction that does not produce elevation in the ST segments of the ECG. Non-ST Elevation Myocardial Infarction by ECG Finding STEMI A myocardial infarction that produces elevation in the ST segments of the ECG. ST Elevation Myocardial Infarction by ECG Finding Angina pectoris which has not recently changed in frequency, duration or intensity. Stable angina pectoris is relieved by rest or administration of oral, sublingual or transdermal antianginal medications. Stable Angina Angina pectoris (or equivalent type of ischemic discomfort) which has recently changed in frequency, duration, intensity, or occurs at rest. Unstable Angina A variant form of angina pectoris caused by coronary artery vasospasm, usually occurring spontaneously and frequently associated with ST segment elevation. Variant Angina CADPRSN Coronary Artery Disease Presentation CDISC SDTM Coronary Artery Disease Presentation Terminology A terminology codelist to describe the relative risk of coronary artery disease. High Coronary Artery Disease Risk The likelihood an individual will develop coronary artery disease is almost certain or greater than 90%. (Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL Jr. ACC/AHA 2002 guideline update for exercise testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). 2002. American College of Cardiology Web site. Available at: www.acc.org/clinical/guidelines/exercise/dirIndex.htm.) High Coronary Artery Disease Risk Intermediate Coronary Artery Disease Risk The likelihood an individual will develop coronary artery disease (CAD) is moderate or between 10% and 90%. (Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL Jr. ACC/AHA 2002 guideline update for exercise testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). 2002. American College of Cardiology Web site. Available at: www.acc.org/clinical/guidelines/exercise/dirIndex.htm.) Intermediate Coronary Artery Disease Risk Known Coronary Artery Disease The individual has coronary artery disease (CAD). (Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL Jr. ACC/AHA 2002 guideline update for exercise testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). 2002. American College of Cardiology Web site. Available at: www.acc.org/clinical/guidelines/exercise/dirIndex.htm.) Known Coronary Artery Disease Low Coronary Artery Disease Risk The likelihood an individual will develop coronary artery disease (CAD) is minimal or less than10%.(Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL Jr. ACC/AHA 2002 guideline update for exercise testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). 2002. American College of Cardiology Web site. Available at: www.acc.org/clinical/guidelines/exercise/dirIndex.htm.) Low Coronary Artery Disease Risk CADRISK Coronary Artery Disease Risk CDISC SDTM Coronary Artery Disease Risk Terminology A terminology codelist that contains symptoms associated with coronary artery disease. Sharp stabbing chest pain or reproduction of pain on palpation. Less common isolated presentations, primarily in older adults, include nausea and vomiting, diaphoresis, and unexplained fatigue. J Am Coll Cardiol, 2007; 50:1-157, doi:10.1016/j.jacc.2007.02.013 (Published online 6 August 2007). Atypical Coronary Artery Disease Symptom The finding of no indications of a particular disease or injury. Asymptomatic A discomfort in the chest area that is not related to the heart. Non-Cardiac Chest Pain Deep, poorly localized chest or arm discomfort that is reproducibly associated with physical exertion or emotional stress and is relieved promptly (ie, in less than 5 minutes) with rest and/or the use of sublingual nitroglycerin. Some patients may have no chest discomfort but present solely with jaw, neck, ear, arm, shoulder, back, or epigastric discomfort or with unexplained dyspnea without discomfort. If these symptoms have a clear relationship to exertion or stress or are relieved promptly with nitrates, they should be considered equivalent to angina. J Am Coll Cardiol, 2007; 50:1-157, doi:10.1016/j.jacc.2007.02.013 (Published online 6 August 2007). Typical Coronary Artery Disease Symptom CADSYMP Coronary Artery Disease Symptoms CDISC SDTM Coronary Artery Disease Symptoms Terminology Coronary Artery Dissection NHLBI Grade test code. CADG01-Coronary Dissection NHLBI Grade Coronary Artery Dissection NHLBI Grade - A grading system to describe coronary artery dissection per the NHLBI, American College of Cardiology, American Heart Association. NHLBI CAD Grade - Coronary Artery Dissection NHLBI Grade CADG01TC Coronary Artery Dissection NHLBI Grade Clinical Classification Test Code CDISC Clinical Classification NHLBI CAD Grade Test Code Terminology Coronary Artery Dissection NHLBI Grade test name. CADG01-Coronary Dissection NHLBI Grade Coronary Artery Dissection NHLBI Grade - A grading system to describe coronary artery dissection per the NHLBI, American College of Cardiology, American Heart Association. NHLBI CAD Grade - Coronary Artery Dissection NHLBI Grade CADG01TN Coronary Artery Dissection NHLBI Grade Clinical Classification Test Name CDISC Clinical Classification NHLBI CAD Grade Test Name Terminology A terminology codelist relevant to the National Heart, Lung, and Blood Institute grade for coronary artery dissection and perforation. Minor radiolucencies within the lumen during contrast injection with no persistence after dye clearance. (Adapted from: Coronary artery angiographic changes after PTCA: Manual of Operations NHLBI PTCA Registry 1985-6:9) NHLBI Coronary Artery Dissection Type A Parallel tracts or double lumen separated by a radiolucent area during contrast injection with no persistence after dye clearance. (Adapted from: Coronary artery angiographic changes after PTCA: Manual of Operations NHLBI PTCA Registry 1985-6:9) NHLBI Coronary Artery Dissection Type B Extraluminal cap with persistence of contrast after dye clearance from the lumen. (Adapted from: Coronary artery angiographic changes after PTCA: Manual of Operations NHLBI PTCA Registry 1985-6:9) NHLBI Coronary Artery Dissection Type C Spiral luminal filling defect with delayed but complete distal flow. (Adapted from: Coronary artery angiographic changes after PTCA: Manual of Operations NHLBI PTCA Registry 1985-6:9) NHLBI Coronary Artery Dissection Type D New persistent filling defect with delayed antegrade flow. May represent thrombus. (Adapted from: Coronary artery angiographic changes after PTCA: Manual of Operations NHLBI PTCA Registry 1985-6:9) NHLBI Coronary Artery Dissection Type E Non-A-E types with total coronary occlusion and no distal antegrade flow. May represent thrombus. (Adapted from: Coronary artery angiographic changes after PTCA: Manual of Operations NHLBI PTCA Registry 1985-6:9) NHLBI Coronary Artery Dissection Type F CADGRS Coronary Artery Dissection NHLBI Grade Responses CDISC SDTM NHLBI Coronary Artery Dissection Grade Responses Terminology A codelist to describe the pattern of the epicardial vessels supplying the posterior descending artery and the posterolateral branches. The right coronary artery supplies the posterior descending artery and the circumflex supplies the posterolateral branches. Co-Dominant Artery The left circumflex artery supplies the posterior descending artery and the posterolateral branches. Left Cardiac Artery Dominance The right coronary artery supplies the posterior descending artery and the posterolateral branches. Coronary Artery Right Dominance CARTDOM Coronary Artery Dominance CDISC SDTM Coronary Artery Dominance Terminology Coronary Thrombus TIMI Grade test code. TIMG01-Coronary Thrombus TIMI Grade Coronary Thrombus TIMI Grade - Grade corresponding to thrombus development as defined in the grading system by the Thrombolysis in the Myocardial Infarction Group. TIMI Thrombus Grade - Coronary Thrombus TIMI Grade TIMG01TC Coronary Thrombus TIMI Grade Clinical Classification Test Code CDISC Clinical Classification TIMI Thrombus Grade Test Code Terminology Coronary Thrombus TIMI Grade test name. TIMG01-Coronary Thrombus TIMI Grade Coronary Thrombus TIMI Grade - Grade corresponding to thrombus development as defined in the grading system by the Thrombolysis in the Myocardial Infarction Group. TIMI Thrombus Grade - Coronary Thrombus TIMI Grade TIMG01TN Coronary Thrombus TIMI Grade Clinical Classification Test Name CDISC Clinical Classification TIMI Thrombus Grade Test Name Terminology A terminology codelist relevant to the Thrombolysis in Myocardial Infarction group grade for the description of coronary thrombus as visualized during angiography. Possible thrombus present - angiography demonstrates characteristics such as reduced contrast density, haziness, irregular lesion contour or a smooth convex 'meniscus' at the site of total occlusion suggestive but not diagnostic of thrombus. (Gibson, C. M., de Lemos, J. A., Murphy, S. A., Marble, S. J., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy Circulation. 2001;103(21):2550-4.) TIMI Coronary Thrombus Grade 1 Small size definite thrombus, with greatest dimensions less than or equal to 1/2 vessel diameter. (Gibson, C. M., de Lemos, J. A., Murphy, S. A., Marble, S. J., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy Circulation. 2001;103(21):2550-4.) TIMI Coronary Thrombus Grade 2 Moderate size definite thrombus, with greatest linear dimension greater than 1/2 but less than 2 vessel diameters. (Gibson, C. M., de Lemos, J. A., Murphy, S. A., Marble, S. J., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy Circulation. 2001;103(21):2550-4.) TIMI Coronary Thrombus Grade 3 Large size definite thrombus, with the largest dimension greater than or equal to 2 vessel diameters. (Gibson, C. M., de Lemos, J. A., Murphy, S. A., Marble, S. J., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy Circulation. 2001;103(21):2550-4.) TIMI Coronary Thrombus Grade 4 Total vessel occlusion. (Gibson, C. M., de Lemos, J. A., Murphy, S. A., Marble, S. J., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy Circulation. 2001;103(21):2550-4.) TIMI Coronary Thrombus Grade 5 CTTIMIRS Coronary Thrombus TIMI Grade Responses CDISC SDTM Coronary Thrombus TIMI Grade Responses Terminology A terminology codelist to describe the extent of coronary artery disease. Inconclusive Cannot distinguish between two or more possible values in the current context. (NCI) Indeterminate A finding of stenosis of less than 70 percent reduction in diameter (or 50 percent reduction in cross-sectional area) in a major epicardial vessel, without stenosis of greater than or equal to 70 percent reduction in diameter (or 50 percent reduction in cross-sectional area) in any major epicardial vessel. (NCI) Insignificant Disease by ECG Finding There was no stenosis in any coronary artery or branch vessel. No Evidence of Coronary Artery Disease There was stenosis of greater than or equal to 70 percent reduction in diameter (or 50 percent reduction in cross-sectional area) in one major epicardial vessel or its major branches. One Vessel Coronary Disease There was one of the following: Stenosis of greater than or equal to 70 percent reduction in diameter (or 50 percent reduction in cross-sectional area) in all three major epicardial vessels (anterior descending, posterior descending, circumflex) or their major branches; Stenosis of greater than or equal to 50 percent reduction in diameter of the left main and greater than or equal to 70 percent reduction in diameter, or 50 percent reduction in cross-sectional area of the right coronary artery with a right dominant or co-dominant circulation; Stenosis of greater than or equal to 50 percent reduction in diameter of the left main with a left dominant circulation. Three Vessel Coronary Disease There was one of the following: Stenosis of greater than or equal to 70 percent reduction in diameter (or 50 percent reduction in cross-sectional area) in two major epicardial vessels or their major branches; Stenosis of greater than or equal to 50 percent reduction in diameter of the left main with a right dominant or co-dominant circulation, and no stenosis of greater than or equal to 70 percent reduction in diameter, or 50 percent reduction in cross-sectional area in the right coronary artery. Two Vessel Coronary Disease U UNK Unknown Not known, not observed, not recorded, or refused. (NCI) Unknown CVSLDEXT Coronary Vessel Disease Extent CDISC SDTM Coronary Vessel Disease Extent Terminology Covi Anxiety Scale test code. COVI01-Verbal Report Covi Anxiety Scale - Verbal report. COVI - Verbal Report COVI01-Behavior Covi Anxiety Scale - Behavior. COVI - Behavior COVI01-Somatic Symptoms of Anxiety Covi Anxiety Scale - Somatic symptoms of anxiety. COVI - Somatic Symptoms of Anxiety COVI01-Total Score Covi Anxiety Scale - Total score. COVI - Total Score COVI01TC Covi Anxiety Scale Clinical Classification Test Code CDISC Clinical Classification COVI Test Code Terminology Covi Anxiety Scale test name. COVI01-Behavior Covi Anxiety Scale - Behavior. COVI - Behavior COVI01-Somatic Symptoms of Anxiety Covi Anxiety Scale - Somatic symptoms of anxiety. COVI - Somatic Symptoms of Anxiety COVI01-Total Score Covi Anxiety Scale - Total score. COVI - Total Score COVI01-Verbal Report Covi Anxiety Scale - Verbal report. COVI - Verbal Report COVI01TN Covi Anxiety Scale Clinical Classification Test Name CDISC Clinical Classification COVI Test Name Terminology Terminology relevant to the test codes that describe findings about COVID-19 related events or interventions. Contrast Enhancement Phase The phase of the contrast agent distribution within the body after its administration. Contrast Agent Enhancement Phase Number of Episodes The total number of episodes that have occurred for the condition. Number of Episodes Occurrence Indicator An indication as to whether something has happened, such as an event or incident. Occurrence Indicator Severity/Intensity The degree of something undesirable. Severity C19FATCD COVID-19 Findings About Test Code CDISC SDTM COVID-19 Findings About Test Code Terminology Terminology relevant to the test names that describe findings about COVID-19 related events or interventions. Contrast Enhancement Phase The phase of the contrast agent distribution within the body after its administration. Contrast Agent Enhancement Phase Number of Episodes The total number of episodes that have occurred for the condition. Number of Episodes Occurrence Indicator An indication as to whether something has happened, such as an event or incident. Occurrence Indicator Severity/Intensity The degree of something undesirable. Severity C19FAT COVID-19 Findings About Test Name CDISC SDTM COVID-19 Findings About Test Name Terminology Craig Handicap Assessment and Reporting Technique - Short Form Interview Version test code. CHSF1-Paid Personal Care per Day Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours in a typical 24-hour day do you have someone with you to provide physical assistance for personal care activities such as eating, bathing, dressing, toileting and mobility? (hours paid assistance). CHART-SF Interview Version - Paid Personal Care per Day CHSF1-Unpaid Personal Care per Day Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours in a typical 24-hour day do you have someone with you to provide physical assistance for personal care activities such as eating, bathing, dressing, toileting and mobility? hours unpaid (family, others). CHART-SF Interview Version - Unpaid Personal Care per Day CHSF1-Home Cognitive Assistance per Day Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How much time is someone with you in your home to assist you with activities that require remembering, decision making, or judgment? CHART-SF Interview Version - Cognitive Assistance at Home per Day CHSF1-Away Cognitive Assistance per Day Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How much of the time is someone with you to help you with remembering, decision making, or judgment when you go away from your home? CHART-SF Interview Version - Cognitive Assistance Away From Home per Day CHSF1-Hours Out of Bed per Day Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - On a typical day, how many hours are you out of bed? CHART-SF Interview Version - Hours Out of Bed per Day CHSF1-Days Out of the House per Week Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - In a typical week, how many days do you get out of your house and go somewhere? CHART-SF Interview Version - Days Out of the House per Week CHSF1-Nights Away From Home Last Year Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - In the last year, how many nights have you spent away from your home? CHART-SF Interview Version - Nights Away From Home Last Year CHSF1-Hours of Paid Work per Week Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours per week do you spend working in a job for which you get paid? CHART-SF Interview Version - Hours of Paid Work per Week CHSF1-Occupation of Paid Work Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours per week do you spend working in a job for which you get paid? (occupation). CHART-SF Interview Version - Occupation of Paid Work CHSF1-Hours of Schoolwork per Week Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours per week do you spend in school working toward a degree or in an accredited technical training program? CHART-SF Interview Version - Hours of Schoolwork per Week CHSF1-Hours of Homemaking per Week Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours per week do you spend in active homemaking including parenting, housekeeping, and food preparation? CHART-SF Interview Version - Hours of Homemaking per Week CHSF1-Hours of Home Maintenance per Week Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours per week do you spend in home maintenance activities such as gardening, house repairs or home improvement? CHART-SF Interview Version - Hours of Home Maintenance per Week CHSF1-Hours of Recreation per Week Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours per week do you spend in recreational activities such as sports, exercise, playing cards, or going to movies? CHART-SF Interview Version - Hours of Recreational Activities per Week CHSF1-Number of People You Live With Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many people do you live with? CHART-SF Interview Version - Number of People You Live With CHSF1-Live With Spouse or Signif Other Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Is one of them your spouse or significant other? CHART-SF Interview Version - Live With Spouse or Significant Other CHSF1-Number of Relatives You Live With Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Of the people you live with how many are relatives? CHART-SF Interview Version - Number of Relatives You Live With CHSF1-Associates Contacted per Month Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many business or organizational associates do you visit, phone, or write to at least once a month? CHART-SF Interview Version - Associates Contacted per Month CHSF1-Friends Contacted per Month Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many friends do you visit, phone, or write to at least once a month? CHART-SF Interview Version - Friends Contacted per Month CHSF1-Strangers Spoke with Last Month Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - With how many strangers have you initiated a conversation in the last month? CHART-SF Interview Version - Initiated Conversation With Strangers Last Month CHSF1-Combined Household Income Last Yr Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Approximately what was the combined annual income, in the last year, of all family members in your household? CHART-SF Interview Version - Combined Annual Household Income Last Year CHSF1-Medical Care Expenses Last Year Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Approximately how much did you pay last year for medical care expenses? CHART-SF Interview Version - Medical Care Expense Last Year CHSF1-Physical Independence Subscore Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Physical independence subscore. CHART-SF Interview Version - Physical Independence Subscore CHSF1-Cognitive Independence Subscore Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Cognitive independence subscore. CHART-SF Interview Version - Cognitive Independence Subscore CHSF1-Mobility Subscore Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Mobility subscore. CHART-SF Interview Version - Mobility Subscore CHSF1-Occupation Subscore Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Occupation subscore. CHART-SF Interview Version - Occupation Subscore CHSF1-Social Integration Subscore Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Social integration subscore. CHART-SF Interview Version - Social Integration Subscore CHSF1-Economic Self-Sufficiency Subscore Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Economic self-sufficiency subscore. CHART-SF Interview Version - Economic Self-Sufficiency Subscore CHSF1-Total Score Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Total score. CHART-SF Interview Version - Total Score CHSF1TC Craig Handicap Assessment and Reporting Technique - Short Form Interview Version Questionnaire Test Code CDISC Questionnaire CHART-SF Interview Version Test Code Terminology Craig Handicap Assessment and Reporting Technique - Short Form Interview Version test name. CHSF1-Associates Contacted per Month Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many business or organizational associates do you visit, phone, or write to at least once a month? CHART-SF Interview Version - Associates Contacted per Month CHSF1-Away Cognitive Assistance per Day Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How much of the time is someone with you to help you with remembering, decision making, or judgment when you go away from your home? CHART-SF Interview Version - Cognitive Assistance Away From Home per Day CHSF1-Cognitive Independence Subscore Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Cognitive independence subscore. CHART-SF Interview Version - Cognitive Independence Subscore CHSF1-Combined Household Income Last Yr Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Approximately what was the combined annual income, in the last year, of all family members in your household? CHART-SF Interview Version - Combined Annual Household Income Last Year CHSF1-Days Out of the House per Week Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - In a typical week, how many days do you get out of your house and go somewhere? CHART-SF Interview Version - Days Out of the House per Week CHSF1-Economic Self-Sufficiency Subscore Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Economic self-sufficiency subscore. CHART-SF Interview Version - Economic Self-Sufficiency Subscore CHSF1-Friends Contacted per Month Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many friends do you visit, phone, or write to at least once a month? CHART-SF Interview Version - Friends Contacted per Month CHSF1-Home Cognitive Assistance per Day Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How much time is someone with you in your home to assist you with activities that require remembering, decision making, or judgment? CHART-SF Interview Version - Cognitive Assistance at Home per Day CHSF1-Hours of Home Maintenance per Week Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours per week do you spend in home maintenance activities such as gardening, house repairs or home improvement? CHART-SF Interview Version - Hours of Home Maintenance per Week CHSF1-Hours of Homemaking per Week Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours per week do you spend in active homemaking including parenting, housekeeping, and food preparation? CHART-SF Interview Version - Hours of Homemaking per Week CHSF1-Hours of Paid Work per Week Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours per week do you spend working in a job for which you get paid? CHART-SF Interview Version - Hours of Paid Work per Week CHSF1-Hours of Recreation per Week Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours per week do you spend in recreational activities such as sports, exercise, playing cards, or going to movies? CHART-SF Interview Version - Hours of Recreational Activities per Week CHSF1-Hours of Schoolwork per Week Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours per week do you spend in school working toward a degree or in an accredited technical training program? CHART-SF Interview Version - Hours of Schoolwork per Week CHSF1-Hours Out of Bed per Day Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - On a typical day, how many hours are you out of bed? CHART-SF Interview Version - Hours Out of Bed per Day CHSF1-Live With Spouse or Signif Other Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Is one of them your spouse or significant other? CHART-SF Interview Version - Live With Spouse or Significant Other CHSF1-Medical Care Expenses Last Year Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Approximately how much did you pay last year for medical care expenses? CHART-SF Interview Version - Medical Care Expense Last Year CHSF1-Mobility Subscore Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Mobility subscore. CHART-SF Interview Version - Mobility Subscore CHSF1-Nights Away From Home Last Year Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - In the last year, how many nights have you spent away from your home? CHART-SF Interview Version - Nights Away From Home Last Year CHSF1-Number of People You Live With Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many people do you live with? CHART-SF Interview Version - Number of People You Live With CHSF1-Number of Relatives You Live With Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Of the people you live with how many are relatives? CHART-SF Interview Version - Number of Relatives You Live With CHSF1-Occupation of Paid Work Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours per week do you spend working in a job for which you get paid? (occupation). CHART-SF Interview Version - Occupation of Paid Work CHSF1-Occupation Subscore Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Occupation subscore. CHART-SF Interview Version - Occupation Subscore CHSF1-Paid Personal Care per Day Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours in a typical 24-hour day do you have someone with you to provide physical assistance for personal care activities such as eating, bathing, dressing, toileting and mobility? (hours paid assistance). CHART-SF Interview Version - Paid Personal Care per Day CHSF1-Physical Independence Subscore Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Physical independence subscore. CHART-SF Interview Version - Physical Independence Subscore CHSF1-Social Integration Subscore Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Social integration subscore. CHART-SF Interview Version - Social Integration Subscore CHSF1-Strangers Spoke with Last Month Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - With how many strangers have you initiated a conversation in the last month? CHART-SF Interview Version - Initiated Conversation With Strangers Last Month CHSF1-Total Score Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Total score. CHART-SF Interview Version - Total Score CHSF1-Unpaid Personal Care per Day Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours in a typical 24-hour day do you have someone with you to provide physical assistance for personal care activities such as eating, bathing, dressing, toileting and mobility? hours unpaid (family, others). CHART-SF Interview Version - Unpaid Personal Care per Day CHSF1TN Craig Handicap Assessment and Reporting Technique - Short Form Interview Version Questionnaire Test Name CDISC Questionnaire CHART-SF Interview Version Test Name Terminology Craig Handicap Assessment and Reporting Technique - Short Form Paper Version test code. CHSF2-Paid Personal Care per Day Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours in a typical 24-hour day do you have someone with you to provide physical assistance for personal care activities such as eating, bathing, dressing, toileting and mobility? (hours paid assistance). CHART-SF Paper Version - Paid Personal Care per Day CHSF2-Unpaid Personal Care per Day Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours in a typical 24-hour day do you have someone with you to provide physical assistance for personal care activities such as eating, bathing, dressing, toileting and mobility? hours unpaid (family, others). CHART-SF Paper Version - Unpaid Personal Care per Day CHSF2-Home Cognitive Assistance per Day Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How much time is someone with you in your home to assist you with activities that require remembering, decision making, or judgment? CHART-SF Paper Version - Cognitive Assistance at Home per Day CHSF2-Away Cognitive Assistance per Day Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How much of the time is someone with you to help you with remembering, decision making, or judgment when you go away from your home? CHART-SF Paper Version - Cognitive Assistance Away From Home per Day CHSF2-Hours Out of Bed per Day Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - On a typical day, how many hours are you out of bed? CHART-SF Paper Version - Hours Out of Bed per Day CHSF2-Days Out of the House per Week Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - In a typical week, how many days do you get out of your house and go somewhere? CHART-SF Paper Version - Days Out of the House per Week CHSF2-Nights Away From Home Last Year Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - In the last year, how many nights have you spent away from your home? CHART-SF Paper Version - Nights Away From Home Last Year CHSF2-Hours of Paid Work per Week Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours per week do you spend working in a job for which you get paid? CHART-SF Paper Version - Hours of Paid Work per Week CHSF2-Occupation of Paid Work Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours per week do you spend working in a job for which you get paid? (occupation). CHART-SF Paper Version - Occupation of Paid Work CHSF2-Hours of Schoolwork per Week Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours per week do you spend in school working toward a degree or in an accredited technical training program? CHART-SF Paper Version - Hours of Schoolwork per Week CHSF2-Hours of Homemaking per Week Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours per week do you spend in active homemaking including parenting, housekeeping, and food preparation? CHART-SF Paper Version - Hours of Homemaking per Week CHSF2-Hours of Home Maintenance per Week Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours per week do you spend in home maintenance activities such as gardening, house repairs or home improvement? CHART-SF Paper Version - Hours of Home Maintenance per Week CHSF2-Hours of Recreation per Week Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours per week do you spend in recreational activities such as sports, exercise, playing cards, or going to movies? CHART-SF Paper Version - Hours of Recreational Activities per Week CHSF2-Number of People You Live With Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many people do you live with? CHART-SF Paper Version - Number of People You Live With CHSF2-Live With Spouse or Signif Other Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Is one of them your spouse or significant other? CHART-SF Paper Version - Live With Spouse or Significant Other CHSF2-Number of Relatives You Live With Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Of the people you live with how many are relatives? CHART-SF Paper Version - Number of Relatives You Live With CHSF2-Associates Contacted per Month Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many business or organizational associates do you visit, phone, or write to at least once a month? CHART-SF Paper Version - Associates Contacted per Month CHSF2-Friends Contacted per Month Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many friends do you visit, phone, or write to at least once a month? CHART-SF Paper Version - Friends Contacted per Month CHSF2-Strangers Spoke with Last Month Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - With how many strangers have you initiated a conversation in the last month? CHART-SF Paper Version - Initiated Conversation With Strangers Last Month CHSF2-Combined Household Income Last Yr Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Approximately what was the combined annual income, in the last year, of all family members in your household? CHART-SF Paper Version - Combined Annual Household Income Last Year CHSF2-Medical Care Expenses Last Year Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Approximately how much did you pay last year for medical care expenses? CHART-SF Paper Version - Medical Care Expense Last Year CHSF2-Physical Independence Subscore Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Physical independence subscore. CHART-SF Paper Version - Physical Independence Subscore CHSF2-Cognitive Independence Subscore Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Cognitive independence subscore. CHART-SF Paper Version - Cognitive Independence Subscore CHSF2-Mobility Subscore Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Mobility subscore. CHART-SF Paper Version - Mobility Subscore CHSF2-Occupation Subscore Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Occupation subscore. CHART-SF Paper Version - Occupation Subscore CHSF2-Social Integration Subscore Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Social integration subscore. CHART-SF Paper Version - Social Integration Subscore CHSF2-Economic Self-sufficiency Subscore Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Economic self-sufficiency subscore. CHART-SF Paper Version - Economic Self-sufficiency Subscore CHSF2-Total Score Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Total score. CHART-SF Paper Version - Total Score CHSF2TC Craig Handicap Assessment and Reporting Technique - Short Form Paper Version Questionnaire Test Code CDISC Questionnaire CHART-SF Paper Version Test Code Terminology Craig Handicap Assessment and Reporting Technique - Short Form Paper Version test name. CHSF2-Associates Contacted per Month Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many business or organizational associates do you visit, phone, or write to at least once a month? CHART-SF Paper Version - Associates Contacted per Month CHSF2-Away Cognitive Assistance per Day Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How much of the time is someone with you to help you with remembering, decision making, or judgment when you go away from your home? CHART-SF Paper Version - Cognitive Assistance Away From Home per Day CHSF2-Cognitive Independence Subscore Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Cognitive independence subscore. CHART-SF Paper Version - Cognitive Independence Subscore CHSF2-Combined Household Income Last Yr Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Approximately what was the combined annual income, in the last year, of all family members in your household? CHART-SF Paper Version - Combined Annual Household Income Last Year CHSF2-Days Out of the House per Week Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - In a typical week, how many days do you get out of your house and go somewhere? CHART-SF Paper Version - Days Out of the House per Week CHSF2-Economic Self-sufficiency Subscore Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Economic self-sufficiency subscore. CHART-SF Paper Version - Economic Self-sufficiency Subscore CHSF2-Friends Contacted per Month Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many friends do you visit, phone, or write to at least once a month? CHART-SF Paper Version - Friends Contacted per Month CHSF2-Home Cognitive Assistance per Day Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How much time is someone with you in your home to assist you with activities that require remembering, decision making, or judgment? CHART-SF Paper Version - Cognitive Assistance at Home per Day CHSF2-Hours of Home Maintenance per Week Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours per week do you spend in home maintenance activities such as gardening, house repairs or home improvement? CHART-SF Paper Version - Hours of Home Maintenance per Week CHSF2-Hours of Homemaking per Week Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours per week do you spend in active homemaking including parenting, housekeeping, and food preparation? CHART-SF Paper Version - Hours of Homemaking per Week CHSF2-Hours of Paid Work per Week Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours per week do you spend working in a job for which you get paid? CHART-SF Paper Version - Hours of Paid Work per Week CHSF2-Hours of Recreation per Week Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours per week do you spend in recreational activities such as sports, exercise, playing cards, or going to movies? CHART-SF Paper Version - Hours of Recreational Activities per Week CHSF2-Hours of Schoolwork per Week Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours per week do you spend in school working toward a degree or in an accredited technical training program? CHART-SF Paper Version - Hours of Schoolwork per Week CHSF2-Hours Out of Bed per Day Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - On a typical day, how many hours are you out of bed? CHART-SF Paper Version - Hours Out of Bed per Day CHSF2-Live With Spouse or Signif Other Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Is one of them your spouse or significant other? CHART-SF Paper Version - Live With Spouse or Significant Other CHSF2-Medical Care Expenses Last Year Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Approximately how much did you pay last year for medical care expenses? CHART-SF Paper Version - Medical Care Expense Last Year CHSF2-Mobility Subscore Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Mobility subscore. CHART-SF Paper Version - Mobility Subscore CHSF2-Nights Away From Home Last Year Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - In the last year, how many nights have you spent away from your home? CHART-SF Paper Version - Nights Away From Home Last Year CHSF2-Number of People You Live With Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many people do you live with? CHART-SF Paper Version - Number of People You Live With CHSF2-Number of Relatives You Live With Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Of the people you live with how many are relatives? CHART-SF Paper Version - Number of Relatives You Live With CHSF2-Occupation of Paid Work Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours per week do you spend working in a job for which you get paid? (occupation). CHART-SF Paper Version - Occupation of Paid Work CHSF2-Occupation Subscore Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Occupation subscore. CHART-SF Paper Version - Occupation Subscore CHSF2-Paid Personal Care per Day Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours in a typical 24-hour day do you have someone with you to provide physical assistance for personal care activities such as eating, bathing, dressing, toileting and mobility? (hours paid assistance). CHART-SF Paper Version - Paid Personal Care per Day CHSF2-Physical Independence Subscore Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Physical independence subscore. CHART-SF Paper Version - Physical Independence Subscore CHSF2-Social Integration Subscore Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Social integration subscore. CHART-SF Paper Version - Social Integration Subscore CHSF2-Strangers Spoke with Last Month Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - With how many strangers have you initiated a conversation in the last month? CHART-SF Paper Version - Initiated Conversation With Strangers Last Month CHSF2-Total Score Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Total score. CHART-SF Paper Version - Total Score CHSF2-Unpaid Personal Care per Day Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours in a typical 24-hour day do you have someone with you to provide physical assistance for personal care activities such as eating, bathing, dressing, toileting and mobility? hours unpaid (family, others). CHART-SF Paper Version - Unpaid Personal Care per Day CHSF2TN Craig Handicap Assessment and Reporting Technique - Short Form Paper Version Questionnaire Test Name CDISC Questionnaire CHART-SF Paper Version Test Name Terminology Crohn's Disease Activity Index Version 1 test code. CDAI01-Weight Crohn's Disease Activity Index Version 1 - Weight. CDAI Version 1 - Weight CDAI01-Standard Body Weight Crohn's Disease Activity Index Version 1 - Standard body weight. CDAI Version 1 - Standard Body Weight CDAI01-Daily Number of Stools Crohn's Disease Activity Index Version 1 - Daily number of very soft/liquid stools in the last 7 days. CDAI Version 1 - Daily Number of Stools CDAI01-Daily Average Abdominal Pain Crohn's Disease Activity Index Version 1 - Daily average abdominal pain (average daily rating for each of the past 7 days). CDAI Version 1 - Daily Average Abdominal Pain CDAI01-Daily Average General Well-being Crohn's Disease Activity Index Version 1 - Daily average general well-being (average daily rating for each of the past 7 days). CDAI Version 1 - Daily Average General Well-being CDAI01-Anti-diarrhea/Opiate Use Crohn's Disease Activity Index Version 1 - Anti-diarrhea/opiate use during past 7 days. CDAI Version 1 - Anti-diarrhea/Opiate Use CDAI01-Abdominal Mass Crohn's Disease Activity Index Version 1 - Abdominal mass. CDAI Version 1 - Abdominal Mass CDAI01-Hematocrit Crohn's Disease Activity Index Version 1 - Hematocrit. CDAI Version 1 - Hematocrit CDAI01-Arthritis/Arthralgia Crohn's Disease Activity Index Version 1 - Arthritis/arthralgia. CDAI Version 1 - Arthritis/Arthralgia CDAI01-Iritis/Uveitis Crohn's Disease Activity Index Version 1 - Iritis/uveitis. CDAI Version 1 - Iritis/Uveitis CDAI01-Erythema Nodosum Crohn's Disease Activity Index Version 1 - Erythema nodosum, pyoderma gangrenosum, or aphthous stomatitis. CDAI Version 1 - Erythema Nodosum CDAI01-Anal Fissure/Fistula/Abscess Crohn's Disease Activity Index Version 1 - Anal fissure, fistula, or abscess. CDAI Version 1 - Anal Fissure, Fistula or Abscess CDAI01-Other Fistula Crohn's Disease Activity Index Version 1 - Other fistula. CDAI Version 1 - Other Fistula CDAI01-Fever Crohn's Disease Activity Index Version 1 - Fever/temperature > 100F/37.8C during the past 7 days. CDAI Version 1 - Fever CDAI01-Weight Subscore Crohn's Disease Activity Index Version 1 - Weight subscore. CDAI Version 1 - Weight Subscore CDAI01-Total Number Stools Subscore Crohn's Disease Activity Index Version 1 - Total number of very soft/liquid stools in the last 7 days: Subscore. CDAI Version 1 - Total Number Stools Subscore CDAI01-Abdominal Pain Subscore Crohn's Disease Activity Index Version 1 - Abdominal pain (daily rating for the past 7 days): Subscore. CDAI Version 1 - Abdominal Pain Subscore CDAI01-General Well-being Subscore Crohn's Disease Activity Index Version 1 - General well-being (daily rating for the past 7 days): Subscore. CDAI Version 1 - General Well-being Subscore CDAI01-Anti-diarrhea/Opiate Use Subscore Crohn's Disease Activity Index Version 1 - Anti-diarrhea/opiate use subscore. CDAI Version 1 - Anti-diarrhea/Opiate Use Subscore CDAI01-Abdominal Mass Subscore Crohn's Disease Activity Index Version 1 - Abdominal mass subscore. CDAI Version 1 - Abdominal Mass Subscore CDAI01-Hematocrit Subscore Crohn's Disease Activity Index Version 1 - Hematocrit subscore. CDAI Version 1 - Hematocrit Subscore CDAI01-Symptoms Manifested Subscore Crohn's Disease Activity Index Version 1 - Arthritis/arthralgia; iritis/uveitis; erythema nodosum, pyoderma gangrenosum, or aphthous stomatitis; anal fissure, fistula, or abscess; other fistula; fever subscore. CDAI Version 1 - Symptoms Manifested Subscore CDAI01-CDAI Total Score Crohn's Disease Activity Index Version 1 - CDAI total score. CDAI Version 1 - CDAI Total Score CDAI01TC Crohn's Disease Activity Index Version 1 Questionnaire Test Code CDISC Questionnaire CDAI Version 1 Test Code Terminology Crohn's Disease Activity Index Version 1 test name. CDAI01-Abdominal Mass Subscore Crohn's Disease Activity Index Version 1 - Abdominal mass subscore. CDAI Version 1 - Abdominal Mass Subscore CDAI01-Abdominal Mass Crohn's Disease Activity Index Version 1 - Abdominal mass. CDAI Version 1 - Abdominal Mass CDAI01-Abdominal Pain Subscore Crohn's Disease Activity Index Version 1 - Abdominal pain (daily rating for the past 7 days): Subscore. CDAI Version 1 - Abdominal Pain Subscore CDAI01-Anal Fissure/Fistula/Abscess Crohn's Disease Activity Index Version 1 - Anal fissure, fistula, or abscess. CDAI Version 1 - Anal Fissure, Fistula or Abscess CDAI01-Anti-diarrhea/Opiate Use Subscore Crohn's Disease Activity Index Version 1 - Anti-diarrhea/opiate use subscore. CDAI Version 1 - Anti-diarrhea/Opiate Use Subscore CDAI01-Anti-diarrhea/Opiate Use Crohn's Disease Activity Index Version 1 - Anti-diarrhea/opiate use during past 7 days. CDAI Version 1 - Anti-diarrhea/Opiate Use CDAI01-Arthritis/Arthralgia Crohn's Disease Activity Index Version 1 - Arthritis/arthralgia. CDAI Version 1 - Arthritis/Arthralgia CDAI01-CDAI Total Score Crohn's Disease Activity Index Version 1 - CDAI total score. CDAI Version 1 - CDAI Total Score CDAI01-Daily Average Abdominal Pain Crohn's Disease Activity Index Version 1 - Daily average abdominal pain (average daily rating for each of the past 7 days). CDAI Version 1 - Daily Average Abdominal Pain CDAI01-Daily Average General Well-being Crohn's Disease Activity Index Version 1 - Daily average general well-being (average daily rating for each of the past 7 days). CDAI Version 1 - Daily Average General Well-being CDAI01-Daily Number of Stools Crohn's Disease Activity Index Version 1 - Daily number of very soft/liquid stools in the last 7 days. CDAI Version 1 - Daily Number of Stools CDAI01-Erythema Nodosum Crohn's Disease Activity Index Version 1 - Erythema nodosum, pyoderma gangrenosum, or aphthous stomatitis. CDAI Version 1 - Erythema Nodosum CDAI01-Fever Crohn's Disease Activity Index Version 1 - Fever/temperature > 100F/37.8C during the past 7 days. CDAI Version 1 - Fever CDAI01-General Well-being Subscore Crohn's Disease Activity Index Version 1 - General well-being (daily rating for the past 7 days): Subscore. CDAI Version 1 - General Well-being Subscore CDAI01-Hematocrit Subscore Crohn's Disease Activity Index Version 1 - Hematocrit subscore. CDAI Version 1 - Hematocrit Subscore CDAI01-Hematocrit Crohn's Disease Activity Index Version 1 - Hematocrit. CDAI Version 1 - Hematocrit CDAI01-Iritis/Uveitis Crohn's Disease Activity Index Version 1 - Iritis/uveitis. CDAI Version 1 - Iritis/Uveitis CDAI01-Other Fistula Crohn's Disease Activity Index Version 1 - Other fistula. CDAI Version 1 - Other Fistula CDAI01-Standard Body Weight Crohn's Disease Activity Index Version 1 - Standard body weight. CDAI Version 1 - Standard Body Weight CDAI01-Symptoms Manifested Subscore Crohn's Disease Activity Index Version 1 - Arthritis/arthralgia; iritis/uveitis; erythema nodosum, pyoderma gangrenosum, or aphthous stomatitis; anal fissure, fistula, or abscess; other fistula; fever subscore. CDAI Version 1 - Symptoms Manifested Subscore CDAI01-Total Number Stools Subscore Crohn's Disease Activity Index Version 1 - Total number of very soft/liquid stools in the last 7 days: Subscore. CDAI Version 1 - Total Number Stools Subscore CDAI01-Weight Subscore Crohn's Disease Activity Index Version 1 - Weight subscore. CDAI Version 1 - Weight Subscore CDAI01-Weight Crohn's Disease Activity Index Version 1 - Weight. CDAI Version 1 - Weight CDAI01TN Crohn's Disease Activity Index Version 1 Questionnaire Test Name CDISC Questionnaire CDAI Version 1 Test Name Terminology Terminology relevant to the test codes that describe findings about Crohn's Disease event or intervention. Number of Abscesses The number of abscesses observed. Number of Abscesses Age Symptoms Started The age at which illness-specific symptoms first began. Age Symptom Started Biopsy Specimen Taken Indicator An indication as to whether a biopsy specimen was collected. Biopsy Specimen Taken Indicator Number of Biopsy Specimens Taken The total number of biopsy specimens collected. Number of Biopsy Specimens Taken Pathologic Appearance of Biopsy Site A description of the appearance of the anatomical site from which a biopsy specimen has been collected. Pathologic Appearance of Biopsy Site Unable to Discon Dependent Indicator Unable to Discontinue Dependent Indicator An indication as to whether an individual is unable to discontinue the use of a substance due to dependence. Unable to Discontinue Use Due to Dependence Indicator Number of Devices Present A determination of the number of devices within a subject. Number of Devices Present Number of Devices Inserted The number of devices inserted into an individual. Number of Devices Inserted Expected Efficacious Treatment Reg Ind Expected Efficacious Treatment Regimen Indicator An indication as to whether the subject has been on a treatment regimen which, based on defined criteria, is expected to be efficacious. Expected Efficacious Treatment Regimen Indicator Extent of Resection A description of the relative amount of tissue, blood vessel, or organ that has been removed. Extent of Resection Fistula Anatomical Type A classification based on the anatomical location(s) of the fistula. Fistula Anatomical Site Number of Fistulas The number of fistulas observed. Number of Fistulas Final Dose Amount A determination of the final amount of a substance taken as a dose by a subject. Final Dose Amount Frequency of Final Dose Amount A determination of how often a subject takes a substance at the final dose amount. Frequency of Final Dose Amount Ileocecal Junction Removed Indicator An indication as to whether the ileocecal junction was removed. Ileocecal Junction Removed Indicator Length of Resection A measurement of the total length of the removed tissue, blood vessel, or organ. Length of Resection Number of Lesions The number of lesions observed. Number of Lesions Maximum Dose Amount A determination of the maximum amount of a substance taken as a dose by a subject. Maximum Dose Amount Frequency of Maximum Dose Amount A determination of how often a subject takes a substance at the maximum dose amount. Frequency of Maximum Dose Amount Largest Diameter of Primary Lesion Longest Diameter of Primary Lesion The longest diameter of the lesion that has been determined to be the primary lesion. Longest Diameter of Primary Lesion Anatomical Location of Primary Lesion The anatomical location of the lesion that has been determined to be the primary lesion. Anatomical Location of Primary Lesion Number of Procedures Performed The number of procedures performed on or in an individual. Number of Procedures Performed Relapse after Discon Dependent Indicator Relapse after Discontinue Dependent Indicator An indication as to whether an individual has had a relapse after discontinuation of a substance due to dependence. Relapse after Discontinuation Because of Dependence Indicator Substance Dependence Indicator An indication as to whether an individual has become dependent on a substance. Substance Dependence Indicator Severity/Intensity The degree of something undesirable. Severity Sign/Symptom Leading to Discontinuation The signs and/or symptoms that result in the discontinuation of treatment or intervention. Sign or Symptom Leading to Discontinuation Number of Strictures The number of anatomical strictures observed. Number of Strictures Unable to Taper Dependent Indicator An indication as to whether an individual is incapable of reducing or tapering the amount of a substance taken due to dependence. Unable to Taper Dependent Indicator CRFATSCD Crohn's Disease Findings About Test Code CDISC SDTM Crohn's Disease Findings About Test Code Terminology Terminology relevant to the test names that describe findings about Crohn's Disease event or intervention. Age Symptoms Started The age at which illness-specific symptoms first began. Age Symptom Started Anatomical Location of Primary Lesion The anatomical location of the lesion that has been determined to be the primary lesion. Anatomical Location of Primary Lesion Biopsy Specimen Taken Indicator An indication as to whether a biopsy specimen was collected. Biopsy Specimen Taken Indicator Expected Efficacious Treatment Reg Ind Expected Efficacious Treatment Regimen Indicator An indication as to whether the subject has been on a treatment regimen which, based on defined criteria, is expected to be efficacious. Expected Efficacious Treatment Regimen Indicator Extent of Resection A description of the relative amount of tissue, blood vessel, or organ that has been removed. Extent of Resection Final Dose Amount A determination of the final amount of a substance taken as a dose by a subject. Final Dose Amount Fistula Anatomical Type A classification based on the anatomical location(s) of the fistula. Fistula Anatomical Site Frequency of Final Dose Amount A determination of how often a subject takes a substance at the final dose amount. Frequency of Final Dose Amount Frequency of Maximum Dose Amount A determination of how often a subject takes a substance at the maximum dose amount. Frequency of Maximum Dose Amount Ileocecal Junction Removed Indicator An indication as to whether the ileocecal junction was removed. Ileocecal Junction Removed Indicator Length of Resection A measurement of the total length of the removed tissue, blood vessel, or organ. Length of Resection Largest Diameter of Primary Lesion Longest Diameter of Primary Lesion The longest diameter of the lesion that has been determined to be the primary lesion. Longest Diameter of Primary Lesion Maximum Dose Amount A determination of the maximum amount of a substance taken as a dose by a subject. Maximum Dose Amount Number of Abscesses The number of abscesses observed. Number of Abscesses Number of Biopsy Specimens Taken The total number of biopsy specimens collected. Number of Biopsy Specimens Taken Number of Devices Inserted The number of devices inserted into an individual. Number of Devices Inserted Number of Devices Present A determination of the number of devices within a subject. Number of Devices Present Number of Fistulas The number of fistulas observed. Number of Fistulas Number of Lesions The number of lesions observed. Number of Lesions Number of Procedures Performed The number of procedures performed on or in an individual. Number of Procedures Performed Number of Strictures The number of anatomical strictures observed. Number of Strictures Pathologic Appearance of Biopsy Site A description of the appearance of the anatomical site from which a biopsy specimen has been collected. Pathologic Appearance of Biopsy Site Relapse after Discon Dependent Indicator Relapse after Discontinue Dependent Indicator An indication as to whether an individual has had a relapse after discontinuation of a substance due to dependence. Relapse after Discontinuation Because of Dependence Indicator Severity/Intensity The degree of something undesirable. Severity Sign/Symptom Leading to Discontinuation The signs and/or symptoms that result in the discontinuation of treatment or intervention. Sign or Symptom Leading to Discontinuation Substance Dependence Indicator An indication as to whether an individual has become dependent on a substance. Substance Dependence Indicator Unable to Discon Dependent Indicator Unable to Discontinue Dependent Indicator An indication as to whether an individual is unable to discontinue the use of a substance due to dependence. Unable to Discontinue Use Due to Dependence Indicator Unable to Taper Dependent Indicator An indication as to whether an individual is incapable of reducing or tapering the amount of a substance taken due to dependence. Unable to Taper Dependent Indicator CRFATS Crohn's Disease Findings About Test Name CDISC SDTM Crohn's Disease Findings About Test Name Terminology Terminology relevant to the type of medium used to culture a specimen. A solid growth medium mainly consisting of peptones, sodium chloride, meat extracts, and mammalian blood, which is developed for the cultivation of fastidious organisms. The blood in the formulation promotes the presence and visualization of hemolytic reactions, enabling the detection and differentiation of hemolytic bacteria. Blood Agar Growth Medium A solid growth medium mainly consisting of various peptones, taurocholate and a chromogenic substrate which is developed primarily for the isolation and cultivation of Clostridium difficile. Chromogenic Selective Medium CCFA A solid growth medium mainly consisting of proteose peptone, fructose, cycloserine, cefoxitin, fructose, and egg yolk, which is developed primarily for the isolation and cultivation of Clostridium difficile. Cycloserine-Cefoxitin Fructose Agar A liquid growth medium mainly consisting of sodium dihydrogen phosphate, potassium dihydrogen phosphate, magnesium sulphate, trisodium citrate, L-asparagine and phenol red, which is developed for the culture and recovery of Mycobacteria. Kirchner Growth Medium LJ medium A growth medium mainly consisting of malachite green, glycerol, asparagine, coagulated eggs, and mineral salts which is developed especially for the cultivation of mycobacterium. Lowenstein-Jensen Medium A liquid and selective growth medium that is modified based on the Kirchner medium by the addition of a mixture of antimicrobial agents (typically polymyxin B, amphotericin B, carbenicillin, and trimethoprim) and colorless tetrazolium salt as a growth indicator, which is developed for the cultivation of mycobacterium. MB Redox Broth Growth Medium A solid growth medium mainly consisting of oleic acid-albumin enrichment, glycerol, dextrose and inorganic compounds, which is developed especially for the primary and secondary cultivation of mycobacterium. Middlebrook 7H10 Growth Medium Middlebrook 7H10 Selective Agar A solid and selective growth medium that is modified based on the Middlebrook 7H10 agar by the addition of four antimicrobial agents: polymyxin B, carbenicillin, amphotericin B and trimethoprim lactate. Middlebrook 7H10S Growth Medium A solid growth medium that is modified based on the Middlebrook 7H10 agar by the addition of pancreatic digest of casein. Middlebrook 7H11 Growth Medium Middlebrook 7H11 Selective Agar A solid and selective growth medium that is modified based on the Middlebrook 7H11 agar by the addition of four antimicrobial agents: polymyxin B, carbenicillin, amphotericin B and trimethoprim lactate. Middlebrook 7H11S Growth Medium A liquid growth medium that is modified based on the Middlebrook 7H9 broth by the addition of bovine serum albumin, casein hydrolysate, catalase and 14C-labelled palmitic acid. Middlebrook 7H12 Growth Medium A liquid growth medium mainly consisting of albumin, glycerol, dextrose and inorganic compounds, which is developed especially for the primary and secondary cultivation of mycobacterium. Middlebrook 7H9 Growth Medium CLTMDTYP Culture Medium Type CDISC SDTM Culture Medium Type Terminology Current Opioid Misuse Measure test code. COMM1-Trouble Thinking Clearly/Memory Current Opioid Misuse Measure - In the past 30 days, how often have you had trouble with thinking clearly or had memory problems? COMM - Trouble Thinking Clearly or Memory Problems COMM1-Complaints Not Completing Tasks Current Opioid Misuse Measure - In the past 30 days, how often do people complain that you are not completing necessary tasks? (i.e., doing things that need to be done, such as going to class, work or appointments) COMM - Complaints Not Completing Tasks COMM1-Other Sources For Pain Medication Current Opioid Misuse Measure - In the past 30 days, how often have you had to go to someone other than your prescribing physician to get sufficient pain relief from medications? (i.e., another doctor, the Emergency Room, friends, street source) COMM - Other Sources for Pain Medication COMM1-Taken Meds Other Than Prescribed Current Opioid Misuse Measure - In the past 30 days, how often have you taken your medications differently from how they are prescribed? COMM - Taken Medications Other Than Prescribed COMM1-Seriously Thought of Hurting Self Current Opioid Misuse Measure - In the past 30 days, how often have you seriously thought about hurting yourself? COMM - Seriously Thought of Hurting Self COMM1-Time Spent Thinking About Opioids Current Opioid Misuse Measure - In the past 30 days, how much of your time was spent thinking about opioid medications (having enough, taking them, dosing schedule, etc.)? COMM - Time Spent Thinking About Opioids COMM1-Been in an Argument Current Opioid Misuse Measure - In the past 30 days, how often have you been in an argument? COMM - Been in an Argument COMM1-Trouble Controlling Anger Current Opioid Misuse Measure - In the past 30 days, how often have you had trouble controlling your anger (e.g., road rage, screaming, etc.)? COMM - Trouble Controlling Anger COMM1-Take Meds Belonging to Others Current Opioid Misuse Measure - In the past 30 days, how often have you needed to take pain medications belonging to someone else? COMM - Take Medications Belonging to Others COMM1-Worry About Handling Meds Current Opioid Misuse Measure - In the past 30 days, how often have you been worried about how you're handling your medications? COMM - Worry About Handling Medications COMM1-Others Worry About Your Meds Current Opioid Misuse Measure - In the past 30 days, how often have others been worried about how you're handling your medications? COMM - Others Worry About Your Medications COMM1-Emergency Phone Call/Clinic Visit Current Opioid Misuse Measure - In the past 30 days, how often have you had to make an emergency phone call or show up at the clinic without an appointment? COMM - Emergency Phone Call or Clinic Visit COMM1-Gotten Angry With People Current Opioid Misuse Measure - In the past 30 days, how often have you gotten angry with people? COMM - Gotten Angry With People COMM1-Take More Meds Than Prescribed Current Opioid Misuse Measure - In the past 30 days, how often have you had to take more of your medication than prescribed? COMM - Take More Medication Than Prescribed COMM1-Borrowed Meds From Others Current Opioid Misuse Measure - In the past 30 days, how often have you borrowed pain medication from someone else? COMM - Borrowed Medication From Others COMM1-Used Pain Meds For Other Symptoms Current Opioid Misuse Measure - In the past 30 days, how often have you used your pain medicine for symptoms other than for pain (e.g., to help you sleep, improve your mood, or relieve stress)? COMM - Used Pain Medicine For Other Symptoms COMM1-Visit Emergency Room Current Opioid Misuse Measure - In the past 30 days, how often have you had to visit the Emergency Room? COMM - Visit Emergency Room COMM1-Score Current Opioid Misuse Measure - Score. COMM - Score COMM1TC Current Opioid Misuse Measure Questionnaire Test Code CDISC Questionnaire COMM Test Code Terminology Current Opioid Misuse Measure test name. COMM1-Been in an Argument Current Opioid Misuse Measure - In the past 30 days, how often have you been in an argument? COMM - Been in an Argument COMM1-Borrowed Meds From Others Current Opioid Misuse Measure - In the past 30 days, how often have you borrowed pain medication from someone else? COMM - Borrowed Medication From Others COMM1-Complaints Not Completing Tasks Current Opioid Misuse Measure - In the past 30 days, how often do people complain that you are not completing necessary tasks? (i.e., doing things that need to be done, such as going to class, work or appointments) COMM - Complaints Not Completing Tasks COMM1-Emergency Phone Call/Clinic Visit Current Opioid Misuse Measure - In the past 30 days, how often have you had to make an emergency phone call or show up at the clinic without an appointment? COMM - Emergency Phone Call or Clinic Visit COMM1-Gotten Angry With People Current Opioid Misuse Measure - In the past 30 days, how often have you gotten angry with people? COMM - Gotten Angry With People COMM1-Other Sources For Pain Medication Current Opioid Misuse Measure - In the past 30 days, how often have you had to go to someone other than your prescribing physician to get sufficient pain relief from medications? (i.e., another doctor, the Emergency Room, friends, street source) COMM - Other Sources for Pain Medication COMM1-Others Worry About Your Meds Current Opioid Misuse Measure - In the past 30 days, how often have others been worried about how you're handling your medications? COMM - Others Worry About Your Medications COMM1-Score Current Opioid Misuse Measure - Score. COMM - Score COMM1-Seriously Thought of Hurting Self Current Opioid Misuse Measure - In the past 30 days, how often have you seriously thought about hurting yourself? COMM - Seriously Thought of Hurting Self COMM1-Take Meds Belonging to Others Current Opioid Misuse Measure - In the past 30 days, how often have you needed to take pain medications belonging to someone else? COMM - Take Medications Belonging to Others COMM1-Take More Meds Than Prescribed Current Opioid Misuse Measure - In the past 30 days, how often have you had to take more of your medication than prescribed? COMM - Take More Medication Than Prescribed COMM1-Taken Meds Other Than Prescribed Current Opioid Misuse Measure - In the past 30 days, how often have you taken your medications differently from how they are prescribed? COMM - Taken Medications Other Than Prescribed COMM1-Time Spent Thinking About Opioids Current Opioid Misuse Measure - In the past 30 days, how much of your time was spent thinking about opioid medications (having enough, taking them, dosing schedule, etc.)? COMM - Time Spent Thinking About Opioids COMM1-Trouble Controlling Anger Current Opioid Misuse Measure - In the past 30 days, how often have you had trouble controlling your anger (e.g., road rage, screaming, etc.)? COMM - Trouble Controlling Anger COMM1-Trouble Thinking Clearly/Memory Current Opioid Misuse Measure - In the past 30 days, how often have you had trouble with thinking clearly or had memory problems? COMM - Trouble Thinking Clearly or Memory Problems COMM1-Used Pain Meds For Other Symptoms Current Opioid Misuse Measure - In the past 30 days, how often have you used your pain medicine for symptoms other than for pain (e.g., to help you sleep, improve your mood, or relieve stress)? COMM - Used Pain Medicine For Other Symptoms COMM1-Visit Emergency Room Current Opioid Misuse Measure - In the past 30 days, how often have you had to visit the Emergency Room? COMM - Visit Emergency Room COMM1-Worry About Handling Meds Current Opioid Misuse Measure - In the past 30 days, how often have you been worried about how you're handling your medications? COMM - Worry About Handling Medications COMM1TN Current Opioid Misuse Measure Questionnaire Test Name CDISC Questionnaire COMM Test Name Terminology Alcohol Use Disorder Identification Test: Self-Report Version test code. DSQ1-Dead Feeling Exercise Freq DePaul Post Exertional Malaise Questionnaire 2018 - Frequency: throughout the past 6 months, how often have you had this symptom? Dead, heavy feeling after starting to exercise. DSQ-PEM 2018 - Dead Feeling Exercise Frequency DSQ1-Dead Feeling Exercise Sev DePaul Post Exertional Malaise Questionnaire 2018 - Severity: throughout the past 6 months, how much has this symptom bothered you? Dead, heavy feeling after starting to exercise. DSQ-PEM 2018 - Dead Feeling Exercise Severity DSQ1-Soreness After Activities Freq DePaul Post Exertional Malaise Questionnaire 2018 - Frequency: throughout the past 6 months, how often have you had this symptom? Next day soreness or fatigue after non-strenuous, everyday activities. DSQ-PEM 2018 - Soreness After Activities Frequency DSQ1-Soreness After Activities Sev DePaul Post Exertional Malaise Questionnaire 2018 - Severity: throughout the past 6 months, how much has this symptom bothered you? Next day soreness or fatigue after non-strenuous, everyday activities. DSQ-PEM 2018 - Soreness After Activities Severity DSQ1-Mentally Tired After Effort Freq DePaul Post Exertional Malaise Questionnaire 2018 - Frequency: throughout the past 6 months, how often have you had this symptom? Mentally tired after the slightest effort. DSQ-PEM 2018 - Mentally Tired After Effort Frequency DSQ1-Mentally Tired After Effort Sev DePaul Post Exertional Malaise Questionnaire 2018 - Severity: throughout the past 6 months, how much has this symptom bothered you? Mentally tired after the slightest effort. DSQ-PEM 2018 - Mentally Tired After Effort Severity DSQ1-Minimum Exercise Makes Tired Freq DePaul Post Exertional Malaise Questionnaire 2018 - Frequency: throughout the past 6 months, how often have you had this symptom? Minimum exercise makes you physically tired. DSQ-PEM 2018 - Minimum Exercise Makes Tired Frequency DSQ1-Minimum Exercise Makes Tired Sev DePaul Post Exertional Malaise Questionnaire 2018 - Severity: throughout the past 6 months, how much has this symptom bothered you? Minimum exercise makes you physically tired. DSQ-PEM 2018 - Minimum Exercise Makes Tired Severity DSQ1-Drained After Mild Activity Freq DePaul Post Exertional Malaise Questionnaire 2018 - Frequency: throughout the past 6 months, how often have you had this symptom? Physically drained or sick after mild activity. DSQ-PEM 2018 - Drained After Mild Activity Frequency DSQ1-Drained After Mild Activity Sev DePaul Post Exertional Malaise Questionnaire 2018 - Severity: throughout the past 6 months, how much has this symptom bothered you? Physically drained or sick after mild activity. DSQ-PEM 2018 - Drained After Mild Activity Severity DSQ1-Recover 1 to 2 Hour After Activity DePaul Post Exertional Malaise Questionnaire 2018 - If you were to become exhausted after actively participating in extracurricular activities, sports, or outings with friends, would you recover within an hour or two after the activity ended? DSQ-PEM 2018 - Recover 1 to 2 Hour After Activity DSQ1-Worsening Fatigue Physical Effort DePaul Post Exertional Malaise Questionnaire 2018 - Do you experience a worsening of your fatigue/energy related illness after engaging in minimal physical effort? DSQ-PEM 2018 - Worsening Fatigue Physical Effort DSQ1-Worsening Fatigue Mental Effort DePaul Post Exertional Malaise Questionnaire 2018 - Do you experience a worsening of your fatigue/energy related illness after engaging in mental effort? DSQ-PEM 2018 - Worsening Fatigue Mental Effort DSQ1-Feel Worse Activities How Long Last DePaul Post Exertional Malaise Questionnaire 2018 - If you feel worse after activities, how long does this last? DSQ-PEM 2018 - Feel Worse Activities How Long Last DSQ1-Do Not Exercise Make Symptoms Worse DePaul Post Exertional Malaise Questionnaire 2018 - If you do not exercise, is it because exercise makes your symptoms worse? DSQ-PEM 2018 - Do Not Exercise Make Symptoms Worse DSQ1TC DePaul Symptom Questionnaire - Post Exertional Malaise 2018 Version - 10 Item Questionnaire Test Code CDISC Questionnaire DSQ1 Test Code Terminology Alcohol Use Disorder Identification Test: Self-Report Version test name. DSQ1-Dead Feeling Exercise Freq DePaul Post Exertional Malaise Questionnaire 2018 - Frequency: throughout the past 6 months, how often have you had this symptom? Dead, heavy feeling after starting to exercise. DSQ-PEM 2018 - Dead Feeling Exercise Frequency DSQ1-Dead Feeling Exercise Sev DePaul Post Exertional Malaise Questionnaire 2018 - Severity: throughout the past 6 months, how much has this symptom bothered you? Dead, heavy feeling after starting to exercise. DSQ-PEM 2018 - Dead Feeling Exercise Severity DSQ1-Do Not Exercise Make Symptoms Worse DePaul Post Exertional Malaise Questionnaire 2018 - If you do not exercise, is it because exercise makes your symptoms worse? DSQ-PEM 2018 - Do Not Exercise Make Symptoms Worse DSQ1-Drained After Mild Activity Freq DePaul Post Exertional Malaise Questionnaire 2018 - Frequency: throughout the past 6 months, how often have you had this symptom? Physically drained or sick after mild activity. DSQ-PEM 2018 - Drained After Mild Activity Frequency DSQ1-Drained After Mild Activity Sev DePaul Post Exertional Malaise Questionnaire 2018 - Severity: throughout the past 6 months, how much has this symptom bothered you? Physically drained or sick after mild activity. DSQ-PEM 2018 - Drained After Mild Activity Severity DSQ1-Feel Worse Activities How Long Last DePaul Post Exertional Malaise Questionnaire 2018 - If you feel worse after activities, how long does this last? DSQ-PEM 2018 - Feel Worse Activities How Long Last DSQ1-Mentally Tired After Effort Freq DePaul Post Exertional Malaise Questionnaire 2018 - Frequency: throughout the past 6 months, how often have you had this symptom? Mentally tired after the slightest effort. DSQ-PEM 2018 - Mentally Tired After Effort Frequency DSQ1-Mentally Tired After Effort Sev DePaul Post Exertional Malaise Questionnaire 2018 - Severity: throughout the past 6 months, how much has this symptom bothered you? Mentally tired after the slightest effort. DSQ-PEM 2018 - Mentally Tired After Effort Severity DSQ1-Minimum Exercise Makes Tired Freq DePaul Post Exertional Malaise Questionnaire 2018 - Frequency: throughout the past 6 months, how often have you had this symptom? Minimum exercise makes you physically tired. DSQ-PEM 2018 - Minimum Exercise Makes Tired Frequency DSQ1-Minimum Exercise Makes Tired Sev DePaul Post Exertional Malaise Questionnaire 2018 - Severity: throughout the past 6 months, how much has this symptom bothered you? Minimum exercise makes you physically tired. DSQ-PEM 2018 - Minimum Exercise Makes Tired Severity DSQ1-Recover 1 to 2 Hour After Activity DePaul Post Exertional Malaise Questionnaire 2018 - If you were to become exhausted after actively participating in extracurricular activities, sports, or outings with friends, would you recover within an hour or two after the activity ended? DSQ-PEM 2018 - Recover 1 to 2 Hour After Activity DSQ1-Soreness After Activities Freq DePaul Post Exertional Malaise Questionnaire 2018 - Frequency: throughout the past 6 months, how often have you had this symptom? Next day soreness or fatigue after non-strenuous, everyday activities. DSQ-PEM 2018 - Soreness After Activities Frequency DSQ1-Soreness After Activities Sev DePaul Post Exertional Malaise Questionnaire 2018 - Severity: throughout the past 6 months, how much has this symptom bothered you? Next day soreness or fatigue after non-strenuous, everyday activities. DSQ-PEM 2018 - Soreness After Activities Severity DSQ1-Worsening Fatigue Mental Effort DePaul Post Exertional Malaise Questionnaire 2018 - Do you experience a worsening of your fatigue/energy related illness after engaging in mental effort? DSQ-PEM 2018 - Worsening Fatigue Mental Effort DSQ1-Worsening Fatigue Physical Effort DePaul Post Exertional Malaise Questionnaire 2018 - Do you experience a worsening of your fatigue/energy related illness after engaging in minimal physical effort? DSQ-PEM 2018 - Worsening Fatigue Physical Effort DSQ1TN DePaul Symptom Questionnaire - Post Exertional Malaise 2018 Version - 10 Item Questionnaire Test Name CDISC Questionnaire DSQ1 Test Name Terminology Deployment Risk and Resilience Inventory-2 test code. DRRI1-A: Someone Close to Me Died Deployment Risk & Resilience Inventory-2 - Before deployment: someone close to me died. DRRI-2 - A: Someone Close to Me Died DRRI1-A: Went Through Divorce/Was Left Deployment Risk & Resilience Inventory-2 - Before deployment: I went through a divorce or was left by a significant other. DRRI-2 - A: Went Through Divorce/Was Left DRRI1-A: Robbed/Had My Home Broken Into Deployment Risk & Resilience Inventory-2 - Before deployment: I was robbed or had my home broken into. DRRI-2 - A: Robbed/Had My Home Broken Into DRRI1-A: Saw/Heard Physical Fight Parent Deployment Risk & Resilience Inventory-2 - Before deployment: I saw or heard physical fighting between my parents or caregivers. DRRI-2 - A: Saw/Heard Physical Fight Parent DRRI1-A: Physically Punished by Parent Deployment Risk & Resilience Inventory-2 - Before deployment: I was physically punished by a parent or primary caregiver. DRRI-2 - A: Physically Punished by Parent DRRI1-A: Unwanted Sex Activity Childhood Deployment Risk & Resilience Inventory-2 - Before deployment: I experienced unwanted sexual activity as a result of force, threat of harm, or manipulation during childhood (before age 18). DRRI-2 - A: Unwanted Sex Activity Childhood DRRI1-A: Unwanted Sex Activity Adulthood Deployment Risk & Resilience Inventory-2 - Before deployment: I experienced unwanted sexual activity as a result of force, threat of harm, or manipulation during adulthood (age 18 or later). DRRI-2 - A: Unwanted Sex Activity Adulthood DRRI1-A: Experienced Natural Disaster Deployment Risk & Resilience Inventory-2 - Before deployment: I experienced a natural disaster (for example, a hurricane), a fire, or an accident in which I or someone close to me was hurt or had serious property damage. DRRI-2 - A: Experienced Natural Disaster DRRI1-A: Someone Close Serious Illness Deployment Risk & Resilience Inventory-2 - Before deployment: someone close to me experienced a serious illness, injury, or mental health problem (for example, cancer, alcohol/drug problem). DRRI-2 - A: Someone Close Serious Illness DRRI1-A: Witnessed Someone Assaulted Deployment Risk & Resilience Inventory-2 - Before deployment: I witnessed someone being seriously assaulted or killed. DRRI-2 - A: Witnessed Someone Assaulted DRRI1-A: Lost My Job/Trouble Finding Job Deployment Risk & Resilience Inventory-2 - Before deployment: I lost my job or had serious trouble finding a job. DRRI-2 - A: Lost My Job/Trouble Finding Job DRRI1-A: Emotionally Mistreated Deployment Risk & Resilience Inventory-2 - Before deployment: I was emotionally mistreated (for example, ignored or repeatedly told I was no good). DRRI-2 - A: Emotionally Mistreated DRRI1-A: Serious Financial Problems Deployment Risk & Resilience Inventory-2 - Before deployment: I experienced serious financial problems. DRRI-2 - A: Serious Financial Problems DRRI1-A: Serious Physical Health Problem Deployment Risk & Resilience Inventory-2 - Before deployment: I experienced serious physical or mental health problems. DRRI-2 - A: Serious Physical Health Problem DRRI1-A: Dangerous Military Duties Deployment Risk & Resilience Inventory-2 - Before deployment: I participated in dangerous military duties. DRRI-2 - A: Dangerous Military Duties DRRI1-A: Injured by Person - Childhood Deployment Risk & Resilience Inventory-2 - Before deployment: I was seriously physically injured by another person (for example, hit or beaten up) during childhood (before age 18). DRRI-2 - A: Injured by Person - Childhood DRRI1-A: Injured by Person - Adulthood Deployment Risk & Resilience Inventory-2 - Before deployment: I was seriously physically injured by another person (for example, hit or beaten up) during adulthood (age 18 or later). DRRI-2 - A: Injured by Person - Adulthood DRRI1-A: Stressful Legal Problems Deployment Risk & Resilience Inventory-2 - Before deployment: I experienced stressful legal problems (for example, being sued, suing someone else, or being in a custody battle). DRRI-2 - A: Stressful Legal Problems DRRI1-B: Got Along Well With My Family Deployment Risk & Resilience Inventory-2 - During childhood: I got along well with my family members. DRRI-2 - B: Got Along Well With My Family DRRI1-B: Felt Like I Fit in With Family Deployment Risk & Resilience Inventory-2 - During childhood: I felt like I fit in with my family. DRRI-2 - B: Felt Like I Fit in With Family DRRI1-B: Family Knew What I Thought/Felt Deployment Risk & Resilience Inventory-2 - During childhood: family members knew what I thought and how I felt about things. DRRI-2 - B: Family Knew What I Thought/Felt DRRI1-B: Contribution Family Appreciated Deployment Risk & Resilience Inventory-2 - During childhood: I felt like my contributions to my family were appreciated. DRRI-2 - B: Contribution Family Appreciated DRRI1-B: Shared Interests With Family Deployment Risk & Resilience Inventory-2 - During childhood: I shared many common interests and activities with family members. DRRI-2 - B: Shared Interests With Family DRRI1-B: Opinions Were Valued by Family Deployment Risk & Resilience Inventory-2 - During childhood: my opinions were valued by other family members. DRRI-2 - B: Opinions Were Valued by Family DRRI1-B: I Was Affectionate With Family Deployment Risk & Resilience Inventory-2 - During childhood: I was affectionate with family members. DRRI-2 - B: I Was Affectionate With Family DRRI1-B: Played Important Role in Family Deployment Risk & Resilience Inventory-2 - During childhood: I played an important role in my family. DRRI-2 - B: Played Important Role in Family DRRI1-B: Spent My Free Time With Family Deployment Risk & Resilience Inventory-2 - During childhood: I spent as much of my free time with family members as possible. DRRI-2 - B: Spent My Free Time With Family DRRI1-B: Family Told Me When Problem Deployment Risk & Resilience Inventory-2 - During childhood: family members told me when they were having a problem. DRRI-2 - B: Family Told Me When Problem DRRI1-B: I Could Be Myself Around Family Deployment Risk & Resilience Inventory-2 - During childhood: I could be myself around family members. DRRI-2 - B: I Could Be Myself Around Family DRRI1-B: Input Sought Family Decisions Deployment Risk & Resilience Inventory-2 - During childhood: my input was sought on important family decisions. DRRI-2 - B: Input Sought Family Decisions DRRI1-C: Climate Was Uncomfortable Deployment Risk & Resilience Inventory-2 - During deployment: the climate was uncomfortable. DRRI-2 - C: Climate Was Uncomfortable DRRI1-C: Deal With Annoying Animals Deployment Risk & Resilience Inventory-2 - During deployment: I had to deal with annoying animals, insects, or plants. DRRI-2 - C: Deal With Annoying Animals DRRI1-C: Food Was of Very Poor Quality Deployment Risk & Resilience Inventory-2 - During deployment: the food I had to eat was of very poor quality (for example, bad or old MREs). DRRI-2 - C: Food Was of Very Poor Quality DRRI1-C: Conditions Extremely Unsanitary Deployment Risk & Resilience Inventory-2 - During deployment: the conditions I lived in were extremely unsanitary. DRRI-2 - C: Conditions Extremely Unsanitary DRRI1-C: Didn't Have Bathrooms Deployment Risk & Resilience Inventory-2 - During deployment: I didn't have access to bathrooms or showers when I needed them. DRRI-2 - C: Didn't Have Bathrooms DRRI1-C: Wasn't Able to Get Privacy Deployment Risk & Resilience Inventory-2 - During deployment: I wasn't able to get as much privacy as I needed. DRRI-2 - C: Wasn't Able to Get Privacy DRRI1-C: I Was Exposed to Awful Smells Deployment Risk & Resilience Inventory-2 - During deployment: I was exposed to awful smells. DRRI-2 - C: I Was Exposed to Awful Smells DRRI1-C: I Was Subjected to Loud Noises Deployment Risk & Resilience Inventory-2 - During deployment: I was subjected to loud noises. DRRI-2 - C: I Was Subjected to Loud Noises DRRI1-C: Restricted Because Local Custom Deployment Risk & Resilience Inventory-2 - During deployment: my daily activities were restricted because of local religious or ethnic customs. DRRI-2 - C: Restricted Because Local Custom DRRI1-C: Wasn't Able to Rest Deployment Risk & Resilience Inventory-2 - During deployment: I wasn't able to get rest when I needed it. DRRI-2 - C: Wasn't Able to Rest DRRI1-C: Wasn't Able to Contact Home Deployment Risk & Resilience Inventory-2 - During deployment: I wasn't able to contact home when I needed to. DRRI-2 - C: Wasn't Able to Contact Home DRRI1-C: Hassle With Heavy/Annoying Gear Deployment Risk & Resilience Inventory-2 - During deployment: I had to hassle with putting on and taking off heavy or annoying gear. DRRI-2 - C: Hassle With Heavy/Annoying Gear DRRI1-C: Not Allowed to Get Job Done Deployment Risk & Resilience Inventory-2 - During deployment: I was not allowed to do the things I needed to do to get my job done. DRRI-2 - C: Not Allowed to Get Job Done DRRI1-C: Not Have Adequate Shelter Deployment Risk & Resilience Inventory-2 - During deployment: I did not have adequate shelter from uncomfortable living conditions (for example, heat, cold, wet, etc.). DRRI-2 - C: Not Have Adequate Shelter DRRI1-D: Went on Combat Patrols/Missions Deployment Risk & Resilience Inventory-2 - During deployment: I went on combat patrols or missions. DRRI-2 - D: Went on Combat Patrols/Missions DRRI1-D: Assault on Entrenched Positions Deployment Risk & Resilience Inventory-2 - During deployment: I took part in an assault on entrenched or fortified positions that involved naval and/or land forces. DRRI-2 - D: Assault on Entrenched Positions DRRI1-D: Witnessed Someone Unit Wounded Deployment Risk & Resilience Inventory-2 - During deployment: I personally witnessed someone from my unit or an ally unit being seriously wounded or killed. DRRI-2 - D: Witnessed Someone Unit Wounded DRRI1-D: Encountered Land Mines Deployment Risk & Resilience Inventory-2 - During deployment: I encountered land or water mines, booby traps, or roadside bombs (for example, IEDs). DRRI-2 - D: Encountered Land Mines DRRI1-D: Exposed Hostile Incoming Fire Deployment Risk & Resilience Inventory-2 - During deployment: I was exposed to hostile incoming fire. DRRI-2 - D: Exposed Hostile Incoming Fire DRRI1-D: Exposed to Friendly Fire Deployment Risk & Resilience Inventory-2 - During deployment: I was exposed to "friendly" fire. DRRI-2 - D: Exposed to Friendly Fire DRRI1-D: Vehicle/Part of Convoy Attacked Deployment Risk & Resilience Inventory-2 - During deployment: I was in a vehicle (for example, a "humvee", helicopter, or boat) or part of a convoy that was attacked. DRRI-2 - D: Vehicle/Part of Convoy Attacked DRRI1-D: Part of Unit Fired on Enemy Deployment Risk & Resilience Inventory-2 - During deployment: I was part of a land or naval artillery unit that fired on enemy combatants. DRRI-2 - D: Part of Unit Fired on Enemy DRRI1-D: Witnessed Enemy Wounded/Killed Deployment Risk & Resilience Inventory-2 - During deployment: I personally witnessed enemy combatants being seriously wounded or killed. DRRI-2 - D: Witnessed Enemy Wounded/Killed DRRI1-D: Witnessed Civilians Wounded Deployment Risk & Resilience Inventory-2 - During deployment: I personally witnessed civilians (for example, women and children) being seriously wounded or killed. DRRI-2 - D: Witnessed Civilians Wounded DRRI1-D: Injured Combat-Related Incident Deployment Risk & Resilience Inventory-2 - During deployment: I was injured in a combat-related incident. DRRI-2 - D: Injured Combat-Related Incident DRRI1-D: Fired My Weapon Enemy Combatant Deployment Risk & Resilience Inventory-2 - During deployment: I fired my weapon at enemy combatants. DRRI-2 - D: Fired My Weapon Enemy Combatant DRRI1-D: Think I Wounded/Killed Someone Deployment Risk & Resilience Inventory-2 - During deployment: I think I wounded or killed someone during combat operations. DRRI-2 - D: Think I Wounded/Killed Someone DRRI1-D: Locating Explosive Devices Deployment Risk & Resilience Inventory-2 - During deployment: I was involved in locating or disarming explosive devices. DRRI-2 - D: Locating Explosive Devices DRRI1-D: Searching Homes/Buildings Deployment Risk & Resilience Inventory-2 - During deployment: I was involved in searching or clearing homes, buildings, or other locations. DRRI-2 - D: Searching Homes/Buildings DRRI1-D: Participate Hand-to-hand Combat Deployment Risk & Resilience Inventory-2 - During deployment: I participated in hand-to-hand combat. DRRI-2 - D: Participate Hand-to-hand Combat DRRI1-D: Search/Disarm Potential Enemy Deployment Risk & Resilience Inventory-2 - During deployment: I was involved in searching and/or disarming potential enemy combatants. DRRI-2 - D: Search/Disarm Potential Enemy DRRI1-E: Saw People Begging for Food Deployment Risk & Resilience Inventory-2 - During deployment: I saw people begging for food. DRRI-2 - E: Saw People Begging for Food DRRI1-E: Saw Refugees Who Had Lost Homes Deployment Risk & Resilience Inventory-2 - During deployment: I saw refugees who had lost their homes or belongings. DRRI-2 - E: Saw Refugees Who Had Lost Homes DRRI1-E: Observed Homes Been Destroyed Deployment Risk & Resilience Inventory-2 - During deployment: I observed homes or communities that had been destroyed. DRRI-2 - E: Observed Homes Been Destroyed DRRI1-E: Took Care Injured/Dying People Deployment Risk & Resilience Inventory-2 - During deployment: I took care of injured or dying people. DRRI-2 - E: Took Care Injured/Dying People DRRI1-E: Saw Civilians After Wounded Deployment Risk & Resilience Inventory-2 - During deployment: I saw civilians after they had been severely wounded or disfigured. DRRI-2 - E: Saw Civilians After Wounded DRRI1-E: Saw Combatants Had Been Wounded Deployment Risk & Resilience Inventory-2 - During deployment: I saw enemy combatants after they had been severely wounded or disfigured. DRRI-2 - E: Saw Combatants Had Been Wounded DRRI1-E: Saw Americans Had Been Wounded Deployment Risk & Resilience Inventory-2 - During deployment: I saw Americans or allies after they had been severely wounded or disfigured. DRRI-2 - E: Saw Americans Had Been Wounded DRRI1-E: Saw Bodies of Dead Enemy Deployment Risk & Resilience Inventory-2 - During deployment: I saw the bodies of dead enemy combatants. DRRI-2 - E: Saw Bodies of Dead Enemy DRRI1-E: Saw Bodies of Dead Americans Deployment Risk & Resilience Inventory-2 - During deployment: I saw the bodies of dead Americans or allies. DRRI-2 - E: Saw Bodies of Dead Americans DRRI1-E: Saw Bodies of Dead Civilians Deployment Risk & Resilience Inventory-2 - During deployment: I saw the bodies of dead civilians. DRRI-2 - E: Saw Bodies of Dead Civilians DRRI1-E: Interacted With Detainees Deployment Risk & Resilience Inventory-2 - During deployment: I interacted with detainees or prisoners of war. DRRI-2 - E: Interacted With Detainees DRRI1-E: Sight/Sound/Smell Dead Animals Deployment Risk & Resilience Inventory-2 - During deployment: I was exposed to the sight, sound, or smell of dead or dying animals. DRRI-2 - E: Sight/Sound/Smell Dead Animals DRRI1-E: Involved Handling Human Remains Deployment Risk & Resilience Inventory-2 - During deployment: I was involved in handling human remains. DRRI-2 - E: Involved Handling Human Remains DRRI1-F: Took Preventative Pills Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I took preventative pills (for example, to protect against nerve gas). DRRI-2 - F: Took Preventative Pills DRRI1-F: Received Vaccinations Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I received preventative vaccinations by injection (for example, to prevent anthrax or botulism). DRRI-2 - F: Received Vaccinations DRRI1-F: Exposed to Nerve Gas Agents Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to nerve gas agents (for example, sarin). DRRI-2 - F: Exposed to Nerve Gas Agents DRRI1-F: Exposed to Mustard Gas Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to mustard gas or other blistering agents. DRRI-2 - F: Exposed to Mustard Gas DRRI1-F: Exposed Government-issued DEET Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to government-issued DEET-containing insect repellents. DRRI-2 - F: Exposed Government-issued DEET DRRI1-F: Exposed to Other Pesticides Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to other pesticides (for example, in flea collars, uniforms, or the environment). DRRI-2 - F: Exposed to Other Pesticides DRRI1-F: Exposed to Smoke/Air Pollution Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to smoke or other air pollution. DRRI-2 - F: Exposed to Smoke/Air Pollution DRRI1-F: Exposed to Diesel/Fuel on Skin Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to diesel or other petrochemical fuel on my skin. DRRI-2 - F: Exposed to Diesel/Fuel on Skin DRRI1-F: Exposed to Fumes From Heaters Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to fumes or exhaust from heaters or generators, including heaters in tents. DRRI-2 - F: Exposed to Fumes From Heaters DRRI1-F: Exposed to Depleted Uranium Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to depleted uranium in munitions. DRRI-2 - F: Exposed to Depleted Uranium DRRI1-F: Exposed to Burning Trash/Feces Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to burning trash or burning feces. DRRI-2 - F: Exposed to Burning Trash/Feces DRRI1-F: Exposed to Chlorine Gas Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to chlorine gas. DRRI-2 - F: Exposed to Chlorine Gas DRRI1-F: Exposed to Nuclear Weapons Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to nuclear, biological, or chemical weapons. DRRI-2 - F: Exposed to Nuclear Weapons DRRI1-G: Concerned Infectious Disease Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned about getting an infectious disease. DRRI-2 - G: Concerned Infectious Disease DRRI1-G: Health Might Suffer NBC Agents Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned that my health might suffer due to exposure to nuclear, biological, or chemical (NBC) agents. DRRI-2 - G: Health Might Suffer NBC Agents DRRI1-G: Felt in Danger of Being Wounded Deployment Risk & Resilience Inventory-2 - During deployment: I felt I was in great danger of being wounded (for example, losing a limb). DRRI-2 - G: Felt in Danger of Being Wounded DRRI1-G: Concerned Medicine Make Me Sick Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned that the medicine I was given to protect me from illness would make me sick. DRRI-2 - G: Concerned Medicine Make Me Sick DRRI1-G: Concerned Encounter Explosive Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned that I would encounter an explosive device (for example, a roadside bomb, mine, or booby trap). DRRI-2 - G: Concerned Encounter Explosive DRRI1-G: Feared Sick From Pesticides Deployment Risk & Resilience Inventory-2 - During deployment: I feared that I would become sick from pesticides (for example, bug spray) or other routinely used chemicals. DRRI-2 - G: Feared Sick From Pesticides DRRI1-G: Concern Rocket/Mortar Would Hit Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned that a rocket or mortar would hit our living quarters. DRRI-2 - G: Concern Rocket/Mortar Would Hit DRRI1-G: Concerned Depleted Uranium Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned that I might be exposed to depleted uranium in munitions. DRRI-2 - G: Concerned Depleted Uranium DRRI1-G: Thought I Would Never Survive Deployment Risk & Resilience Inventory-2 - During deployment: I thought I would never survive. DRRI-2 - G: Thought I Would Never Survive DRRI1-G: Concerned Taken Hostage Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned that I might be taken hostage. DRRI-2 - G: Concerned Taken Hostage DRRI1-G: Concerned Locals Against Us Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned that the locals who were supposed to be helping us were actually working against us. DRRI-2 - G: Concerned Locals Against Us DRRI1-G: Concerned Trapped in Crossfire Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned about being trapped in the crossfire of rival factions. DRRI-2 - G: Concerned Trapped in Crossfire DRRI1-H: Had All Supplies Needed Deployment Risk & Resilience Inventory-2 - In preparation for deployment: I had all the supplies and equipment needed to get my job done. DRRI-2 - H: Had All Supplies Needed DRRI1-H: Confident Ability Use Equipment Deployment Risk & Resilience Inventory-2 - In preparation for deployment: the training I received made me feel confident in my ability to use my equipment. DRRI-2 - H: Confident Ability Use Equipment DRRI1-H: Prepared to Deal With Climate Deployment Risk & Resilience Inventory-2 - In preparation for deployment: the training I received prepared me to deal with the region's climate. DRRI-2 - H: Prepared to Deal With Climate DRRI1-H: Accurately Informed About Role Deployment Risk & Resilience Inventory-2 - In preparation for deployment: I was accurately informed about the role my unit was expected to play in the deployment. DRRI-2 - H: Accurately Informed About Role DRRI1-H: Had Enough Gear in Case Attack Deployment Risk & Resilience Inventory-2 - In preparation for deployment: I had enough gear to protect myself in case of an attack. DRRI-2 - H: Had Enough Gear in Case Attack DRRI1-H: Training for Deployment Deployment Risk & Resilience Inventory-2 - In preparation for deployment: I received appropriate training for the nature of the deployment I experienced. DRRI-2 - H: Training for Deployment DRRI1-H: Military Duties What I Expected Deployment Risk & Resilience Inventory-2 - In preparation for deployment: my military duties and assignments were what I expected. DRRI-2 - H: Military Duties What I Expected DRRI1-H: Prepared to Operate as Team Deployment Risk & Resilience Inventory-2 - In preparation for deployment: my unit was well-prepared to operate as a team during deployment. DRRI-2 - H: Prepared to Operate as Team DRRI1-H: Confident to Perform Tasks Deployment Risk & Resilience Inventory-2 - In preparation for deployment: the training I received made me feel confident in my ability to perform tasks assigned to me during deployment. DRRI-2 - H: Confident to Perform Tasks DRRI1-H: Taught Me Everything I Needed Deployment Risk & Resilience Inventory-2 - In preparation for deployment: the training I received taught me everything I needed to know for deployment. DRRI-2 - H: Taught Me Everything I Needed DRRI1-I: Family Sincerely Interested Deployment Risk & Resilience Inventory-2 - During deployment: family members and/or friends at home were sincerely interested in hearing what was going on with me. DRRI-2 - I: Family Sincerely Interested DRRI1-I: Had Family I Could Talk To Deployment Risk & Resilience Inventory-2 - During deployment: I had family members or friends at home I could talk to when I had a problem. DRRI-2 - I: Had Family I Could Talk To DRRI1-I: Could Count on Family Advice Deployment Risk & Resilience Inventory-2 - During deployment: I could count on my family members or friends at home for good advice. DRRI-2 - I: Could Count on Family Advice DRRI1-I: Relatives Look Out for Family Deployment Risk & Resilience Inventory-2 - During deployment: relatives or friends at home could be counted on to look out for the well-being of my family or other dependents (including pets). DRRI-2 - I: Relatives Look Out for Family DRRI1-I: Relatives Take Care of Finances Deployment Risk & Resilience Inventory-2 - During deployment: relatives or friends at home could be counted on to take care of my finances, property, or belongings if needed. DRRI-2 - I: Relatives Take Care of Finances DRRI1-I: Happy Communication From Home Deployment Risk & Resilience Inventory-2 - During deployment: I was happy with the amount of communication I received from people at home. DRRI-2 - I: Happy Communication From Home DRRI1-I: Happy With Support From Home Deployment Risk & Resilience Inventory-2 - During deployment: I was happy with the amount of support I received from people at home. DRRI-2 - I: Happy With Support From Home DRRI1-I: People at Home Show They Cared Deployment Risk & Resilience Inventory-2 - During deployment: people at home did things to show they cared about me. DRRI-2 - I: People at Home Show They Cared DRRI1-J: My Unit Was Like Family to Me Deployment Risk & Resilience Inventory-2 - During deployment: my unit was like family to me. DRRI-2 - J: My Unit Was Like Family to Me DRRI1-J: People in Unit Were Trustworthy Deployment Risk & Resilience Inventory-2 - During deployment: people in my unit were trustworthy. DRRI-2 - J: People in Unit Were Trustworthy DRRI1-J: Fellow Unit Appreciated Efforts Deployment Risk & Resilience Inventory-2 - During deployment: my fellow unit members appreciated my efforts. DRRI-2 - J: Fellow Unit Appreciated Efforts DRRI1-J: Felt Valued Fellow Unit Members Deployment Risk & Resilience Inventory-2 - During deployment: I felt valued by my fellow unit members. DRRI-2 - J: Felt Valued Fellow Unit Members DRRI1-J: Unit Interested My Well-being Deployment Risk & Resilience Inventory-2 - During deployment: members of my unit were interested in my well-being. DRRI-2 - J: Unit Interested My Well-being DRRI1-J: Unit Interested What I Thought Deployment Risk & Resilience Inventory-2 - During deployment: my fellow unit members were interested in what I thought and how I felt about things. DRRI-2 - J: Unit Interested What I Thought DRRI1-J: Leader Interested What Thought Deployment Risk & Resilience Inventory-2 - During deployment: my unit leader(s) were interested in what I thought and how I felt about things. DRRI-2 - J: Leader Interested What Thought DRRI1-J: Felt Like My Efforts Counted Deployment Risk & Resilience Inventory-2 - During deployment: I felt like my efforts really counted to the leaders in my unit. DRRI-2 - J: Felt Like My Efforts Counted DRRI1-J: Service Appreciated by Leaders Deployment Risk & Resilience Inventory-2 - During deployment: my service was appreciated by the leaders in my unit. DRRI-2 - J: Service Appreciated by Leaders DRRI1-J: Could Go to Leaders If Problem Deployment Risk & Resilience Inventory-2 - During deployment: I could go to unit leaders for help if I had a problem or concern. DRRI-2 - J: Could Go to Leaders If Problem DRRI1-J: Leaders Interested in Welfare Deployment Risk & Resilience Inventory-2 - During deployment: the leaders of my unit were interested in my personal welfare. DRRI-2 - J: Leaders Interested in Welfare DRRI1-J: Felt Valued by Leaders of Unit Deployment Risk & Resilience Inventory-2 - During deployment: I felt valued by the leaders of my unit. DRRI-2 - J: Felt Valued by Leaders of Unit DRRI1-K: Treated in Overly Critical Way Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: treated me in an overly critical way. DRRI-2 - K: Treated in Overly Critical Way DRRI1-K: Uncooperative Working With Me Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: behaved in way that was uncooperative when working with me. DRRI-2 - K: Uncooperative Working With Me DRRI1-K: Had to Work Harder Prove Myself Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: treated me as if I had to work harder than others to prove myself. DRRI-2 - K: Had to Work Harder Prove Myself DRRI1-K: Questioned My Abilities Perform Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: questioned my abilities or commitment to perform my job effectively. DRRI-2 - K: Questioned My Abilities Perform DRRI1-K: My Mistakes Worse Than Others Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: acted as though my mistakes were worse than others'. DRRI-2 - K: My Mistakes Worse Than Others DRRI1-K: Make My Job More Difficult Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: tried to make my job more difficult to do. DRRI-2 - K: Make My Job More Difficult DRRI1-K: Put Me Down Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: "put me down" or treated me in a condescending way. DRRI-2 - K: Put Me Down DRRI1-K: Threatened My Physical Safety Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: threatened my physical safety. DRRI-2 - K: Threatened My Physical Safety DRRI1-K: Made Crude Sexual Remarks at Me Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: made crude and offensive sexual remarks directed at me, either publicly or privately. DRRI-2 - K: Made Crude Sexual Remarks at Me DRRI1-K: Spread Rumors Sexual Activities Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: spread negative rumors about my sexual activities. DRRI-2 - K: Spread Rumors Sexual Activities DRRI1-K: Tried to Talk into Sexual Acts Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: tried to talk me into participating in sexual acts when I didn't want to. DRRI-2 - K: Tried to Talk into Sexual Acts DRRI1-K: Authority Pressure Unwanted Sex Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: used a position of authority to pressure me into unwanted sexual activity. DRRI-2 - K: Authority Pressure Unwanted Sex DRRI1-K: Offered Reward Take Part in Sex Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: offered me a specific reward or special treatment to take part in sexual behavior. DRRI-2 - K: Offered Reward Take Part in Sex DRRI1-K: Threatened Me If Not Sex Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: threatened me with some sort of retaliation if I was not sexually cooperative (for example, the threat of negative review or physical violence). DRRI-2 - K: Threatened Me If Not Sex DRRI1-K: Touched Sexual Way Against Will Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: touched me in a sexual way against my will. DRRI-2 - K: Touched Sexual Way Against Will DRRI1-K: Physically Forced to Have Sex Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: physically forced me to have sex. DRRI-2 - K: Physically Forced to Have Sex DRRI1-L: Effect Deployment Relationship Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: the effect of the deployment on my relationship with my spouse or significant other. DRRI-2 - L: Effect Deployment Relationship DRRI1-L: Missing Out on Children Growth Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: missing out on my children's growth and development. DRRI-2 - L: Missing Out on Children Growth DRRI1-L: Missing Family Events at Home Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: missing important family events at home such as birthdays, weddings, funerals, graduations, etc. DRRI-2 - L: Missing Family Events at Home DRRI1-L: Safety and Well-being of Spouse Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: the safety and well-being of my spouse or significant other. DRRI-2 - L: Safety and Well-being of Spouse DRRI1-L: Safety and Well-being of Child Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: the safety and well-being of my child(ren). DRRI-2 - L: Safety and Well-being of Child DRRI1-L: Unable to Help Family If Crisis Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: being unable to help my family if there was some kind of crisis or emergency. DRRI-2 - L: Unable to Help Family If Crisis DRRI1-L: Inability Manage Family Affairs Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: my inability to directly manage or control family affairs. DRRI-2 - L: Inability Manage Family Affairs DRRI1-L: Damaging Career Because Deploy Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: damaging my career because of the deployment. DRRI-2 - L: Damaging Career Because Deploy DRRI1-L: Care Child/Dependents Receiving Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: the care that my child(ren) or other dependents were receiving. DRRI-2 - L: Care Child/Dependents Receiving DRRI1-L: Being Cheated on by My Spouse Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: being cheated on by my spouse or significant other. DRRI-2 - L: Being Cheated on by My Spouse DRRI1-L: Family Ability Cope With Stress Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: my family's ability to cope with the stress of the deployment. DRRI-2 - L: Family Ability Cope With Stress DRRI1-L: Spouse Ability Manage Household Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: my spouse or significant other's ability to manage the household (for example, chores, bills, home repairs, etc.). DRRI-2 - L: Spouse Ability Manage Household DRRI1-L: Losing My Civilian Job Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: losing my civilian job because of the deployment. DRRI-2 - L: Losing My Civilian Job DRRI1-L: Effect Relationship My Children Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: the effect of the deployment on my relationship with my child(ren). DRRI-2 - L: Effect Relationship My Children DRRI1-L: My Family Financial Situation Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: my family's financial situation. DRRI-2 - L: My Family Financial Situation DRRI1-M: Problems Get in Touch Family Deployment Risk & Resilience Inventory-2 - During deployment: I had problems getting in touch with a family member or other loved one. DRRI-2 - M: Problems Get in Touch Family DRRI1-M: Someone Close Serious Illness Deployment Risk & Resilience Inventory-2 - During deployment: someone close to me experienced a serious illness, injury, or mental health problem (for example, cancer, alcohol/drug problem). DRRI-2 - M: Someone Close Serious Illness DRRI1-M: Family Member Passed Away Deployment Risk & Resilience Inventory-2 - During deployment: a family member or other loved one passed away. DRRI-2 - M: Family Member Passed Away DRRI1-M: My Family Had Money Problems Deployment Risk & Resilience Inventory-2 - During deployment: my family had money problems. DRRI-2 - M: My Family Had Money Problems DRRI1-M: Spouse Cheated on Me Deployment Risk & Resilience Inventory-2 - During deployment: a spouse or significant other cheated on me. DRRI-2 - M: Spouse Cheated on Me DRRI1-M: Spouse Suspected I Cheated Deployment Risk & Resilience Inventory-2 - During deployment: a spouse or significant other suspected that I had cheated on him/her. DRRI-2 - M: Spouse Suspected I Cheated DRRI1-M: Relationship With Spouse Ended Deployment Risk & Resilience Inventory-2 - During deployment: my relationship with a spouse or significant other ended. DRRI-2 - M: Relationship With Spouse Ended DRRI1-M: Had Major Conflict With Family Deployment Risk & Resilience Inventory-2 - During deployment: I had a major conflict with a family member or other loved one. DRRI-2 - M: Had Major Conflict With Family DRRI1-M: Family Had Difficulty Adjusting Deployment Risk & Resilience Inventory-2 - During deployment: a family member or other loved one had serious difficulty adjusting to my absence. DRRI-2 - M: Family Had Difficulty Adjusting DRRI1-M: My Home Was Robbed Deployment Risk & Resilience Inventory-2 - During deployment: my home was robbed and/or my belongings were stolen. DRRI-2 - M: My Home Was Robbed DRRI1-M: Family Member Wasted Money Deployment Risk & Resilience Inventory-2 - During deployment: a family member or other person I trusted wasted or mismanaged my money. DRRI-2 - M: Family Member Wasted Money DRRI1-M: Loved One Things I Disapproved Deployment Risk & Resilience Inventory-2 - During deployment: I learned that a loved one was doing things I disapproved of. DRRI-2 - M: Loved One Things I Disapproved DRRI1-M: Fam Dangerous Military Duties Deployment Risk & Resilience Inventory-2 - During deployment: a family member or other loved one participated in dangerous military duties. DRRI-2 - M: Fam Dangerous Military Duties DRRI1-M: Family Got Into Trouble Deployment Risk & Resilience Inventory-2 - During deployment: a family member got into trouble at home, at school, or in the community. DRRI-2 - M: Family Got Into Trouble DRRI1-N: Robbed/Had My Home Broken Into Deployment Risk & Resilience Inventory-2 - Since returning: I was robbed or had my home broken into. DRRI-2 - N: Robbed/Had My Home Broken Into DRRI1-N: Unwanted Sexual Activity Deployment Risk & Resilience Inventory-2 - Since returning: I experienced unwanted sexual activity as a result of force, threat or harm, or manipulation. DRRI-2 - N: Unwanted Sexual Activity DRRI1-N: Went Through Divorce/Was Left Deployment Risk & Resilience Inventory-2 - Since returning: I went through a divorce or have been left by a partner or significant other. DRRI-2 - N: Went Through Divorce/Was Left DRRI1-N: Problems Getting Healthcare Deployment Risk & Resilience Inventory-2 - Since returning: I had problems getting access to adequate healthcare. DRRI-2 - N: Problems Getting Healthcare DRRI1-N: Experienced Natural Disaster Deployment Risk & Resilience Inventory-2 - Since returning: I experienced a natural disaster (for example, a hurricane), a fire, or an accident in which I or someone close to me was hurt or had serious property damage. DRRI-2 - N: Experienced Natural Disaster DRRI1-N: Someone Close Serious Illness Deployment Risk & Resilience Inventory-2 - Since returning: someone close to me has experienced a serious illness, injury, or mental health problem (for example, cancer, alcohol/drug problem). DRRI-2 - N: Someone Close Serious Illness DRRI1-N: Witnessed Someone Assaulted Deployment Risk & Resilience Inventory-2 - Since returning: I have witnessed someone being seriously assaulted or killed. DRRI-2 - N: Witnessed Someone Assaulted DRRI1-N: Lost My Job/Trouble Finding Job Deployment Risk & Resilience Inventory-2 - Since returning: I lost my job or had serious trouble finding a job. DRRI-2 - N: Lost My Job/Trouble Finding Job DRRI1-N: Emotionally Mistreated Deployment Risk & Resilience Inventory-2 - Since returning: I have been emotionally mistreated (for example, ignored or repeatedly told I was no good). DRRI-2 - N: Emotionally Mistreated DRRI1-N: Serious Financial Problems Deployment Risk & Resilience Inventory-2 - Since returning: I have experienced serious financial problems. DRRI-2 - N: Serious Financial Problems DRRI1-N: Serious Physical Health Problem Deployment Risk & Resilience Inventory-2 - Since returning: I have experienced serious physical or mental health problems. DRRI-2 - N: Serious Physical Health Problem DRRI1-N: Stressful Legal Problems Deployment Risk & Resilience Inventory-2 - Since returning: I have experienced stressful legal problems (for example, being sued, suing someone else, or being in a custody battle). DRRI-2 - N: Stressful Legal Problems DRRI1-N: Injured by Another Person Deployment Risk & Resilience Inventory-2 - Since returning: I have been seriously physically injured by another person (for example, hit or beaten up). DRRI-2 - N: Injured by Another Person DRRI1-N: Someone Close to Me Has Died Deployment Risk & Resilience Inventory-2 - Since returning: someone close to me has died. DRRI-2 - N: Someone Close to Me Has Died DRRI1-O: People Made Me Feel at Home Deployment Risk & Resilience Inventory-2 - Since returning: the American people made me feel at home. DRRI-2 - O: People Made Me Feel at Home DRRI1-O: People Made Me Feel Proud Deployment Risk & Resilience Inventory-2 - Since returning: people made me feel proud to have served my country in the Armed Forces. DRRI-2 - O: People Made Me Feel Proud DRRI1-O: Family Make Me Better When Down Deployment Risk & Resilience Inventory-2 - Since returning: my family members and/or friends make me feel better when I am down. DRRI-2 - O: Family Make Me Better When Down DRRI1-O: Go to Family When Need Advice Deployment Risk & Resilience Inventory-2 - Since returning: I can go to family members or friends when I need good advice. DRRI-2 - O: Go to Family When Need Advice DRRI1-O: Family/Friends Understand Deployment Risk & Resilience Inventory-2 - Since returning: my family and friends understand what I have been through in the Armed Forces. DRRI-2 - O: Family/Friends Understand DRRI1-O: I Can Talk About My Deployment Deployment Risk & Resilience Inventory-2 - Since returning: there are family and/or friends with whom I can talk about my deployment experiences. DRRI-2 - O: I Can Talk About My Deployment DRRI1-O: Family Would Lend Money Deployment Risk & Resilience Inventory-2 - Since returning: my family members or friends would lend me money if I needed it. DRRI-2 - O: Family Would Lend Money DRRI1-O: Family Would Help Move Deployment Risk & Resilience Inventory-2 - Since returning: my family members or friends would help me move my belongings if I needed help. DRRI-2 - O: Family Would Help Move DRRI1-O: Someone Would Help With Tasks Deployment Risk & Resilience Inventory-2 - Since returning: if I were unable to attend to daily chores, there is someone who would help me with these tasks. DRRI-2 - O: Someone Would Help With Tasks DRRI1-O: When Ill Family Will Help Out Deployment Risk & Resilience Inventory-2 - Since returning: when I am ill, family members or friends will help out until I am well. DRRI-2 - O: When Ill Family Will Help Out DRRI1-P: Input Sought Family Decisions Deployment Risk & Resilience Inventory-2 - Since returning: my input is sought on important family decisions. DRRI-2 - P: Input Sought Family Decisions DRRI1-P: Feel Like I Fit in With Family Deployment Risk & Resilience Inventory-2 - Since returning: I feel like I fit in with my family. DRRI-2 - P: Feel Like I Fit in With Family DRRI1-P: Family Know What I Think/Feel Deployment Risk & Resilience Inventory-2 - Since returning: family members know what I think and how I feel about things. DRRI-2 - P: Family Know What I Think/Feel DRRI1-P: Contribution Family Appreciated Deployment Risk & Resilience Inventory-2 - Since returning: I feel like my contributions to my family are appreciated. DRRI-2 - P: Contribution Family Appreciated DRRI1-P: Share Interests With Family Deployment Risk & Resilience Inventory-2 - Since returning: I share many common interests and activities with family members. DRRI-2 - P: Share Interests With Family DRRI1-P: Opinions Valued by Family Deployment Risk & Resilience Inventory-2 - Since returning: my opinions are valued by other family members. DRRI-2 - P: Opinions Valued by Family DRRI1-P: I am Affectionate With Family Deployment Risk & Resilience Inventory-2 - Since returning: I am affectionate with family members. DRRI-2 - P: I am Affectionate With Family DRRI1-P: Play Important Role in Family Deployment Risk & Resilience Inventory-2 - Since returning: I play an important role in my family. DRRI-2 - P: Play Important Role in Family DRRI1-P: Spend My Free Time With Family Deployment Risk & Resilience Inventory-2 - Since returning: I spend as much of my free time with family members as possible. DRRI-2 - P: Spend My Free Time With Family DRRI1-P: Family Tell Me When Problem Deployment Risk & Resilience Inventory-2 - Since returning: family members tell me when they are having a problem. DRRI-2 - P: Family Tell Me When Problem DRRI1-P: Can Be Myself Around Family Deployment Risk & Resilience Inventory-2 - Since returning: I can be myself around family members. DRRI-2 - P: Can Be Myself Around Family DRRI1-P: I Get Along Well With My Family Deployment Risk & Resilience Inventory-2 - Since returning: I get along well with my family members. DRRI-2 - P: I Get Along Well With My Family DRRI1TC Deployment Risk and Resilience Inventory-2 Questionnaire Test Code CDISC Questionnaire DRRI-2 Test Code Terminology Deployment Risk and Resilience Inventory-2 test name. DRRI1-A: Dangerous Military Duties Deployment Risk & Resilience Inventory-2 - Before deployment: I participated in dangerous military duties. DRRI-2 - A: Dangerous Military Duties DRRI1-A: Emotionally Mistreated Deployment Risk & Resilience Inventory-2 - Before deployment: I was emotionally mistreated (for example, ignored or repeatedly told I was no good). DRRI-2 - A: Emotionally Mistreated DRRI1-A: Experienced Natural Disaster Deployment Risk & Resilience Inventory-2 - Before deployment: I experienced a natural disaster (for example, a hurricane), a fire, or an accident in which I or someone close to me was hurt or had serious property damage. DRRI-2 - A: Experienced Natural Disaster DRRI1-A: Injured by Person - Adulthood Deployment Risk & Resilience Inventory-2 - Before deployment: I was seriously physically injured by another person (for example, hit or beaten up) during adulthood (age 18 or later). DRRI-2 - A: Injured by Person - Adulthood DRRI1-A: Injured by Person - Childhood Deployment Risk & Resilience Inventory-2 - Before deployment: I was seriously physically injured by another person (for example, hit or beaten up) during childhood (before age 18). DRRI-2 - A: Injured by Person - Childhood DRRI1-A: Lost My Job/Trouble Finding Job Deployment Risk & Resilience Inventory-2 - Before deployment: I lost my job or had serious trouble finding a job. DRRI-2 - A: Lost My Job/Trouble Finding Job DRRI1-A: Physically Punished by Parent Deployment Risk & Resilience Inventory-2 - Before deployment: I was physically punished by a parent or primary caregiver. DRRI-2 - A: Physically Punished by Parent DRRI1-A: Robbed/Had My Home Broken Into Deployment Risk & Resilience Inventory-2 - Before deployment: I was robbed or had my home broken into. DRRI-2 - A: Robbed/Had My Home Broken Into DRRI1-A: Saw/Heard Physical Fight Parent Deployment Risk & Resilience Inventory-2 - Before deployment: I saw or heard physical fighting between my parents or caregivers. DRRI-2 - A: Saw/Heard Physical Fight Parent DRRI1-A: Serious Financial Problems Deployment Risk & Resilience Inventory-2 - Before deployment: I experienced serious financial problems. DRRI-2 - A: Serious Financial Problems DRRI1-A: Serious Physical Health Problem Deployment Risk & Resilience Inventory-2 - Before deployment: I experienced serious physical or mental health problems. DRRI-2 - A: Serious Physical Health Problem DRRI1-A: Someone Close Serious Illness Deployment Risk & Resilience Inventory-2 - Before deployment: someone close to me experienced a serious illness, injury, or mental health problem (for example, cancer, alcohol/drug problem). DRRI-2 - A: Someone Close Serious Illness DRRI1-A: Someone Close to Me Died Deployment Risk & Resilience Inventory-2 - Before deployment: someone close to me died. DRRI-2 - A: Someone Close to Me Died DRRI1-A: Stressful Legal Problems Deployment Risk & Resilience Inventory-2 - Before deployment: I experienced stressful legal problems (for example, being sued, suing someone else, or being in a custody battle). DRRI-2 - A: Stressful Legal Problems DRRI1-A: Unwanted Sex Activity Adulthood Deployment Risk & Resilience Inventory-2 - Before deployment: I experienced unwanted sexual activity as a result of force, threat of harm, or manipulation during adulthood (age 18 or later). DRRI-2 - A: Unwanted Sex Activity Adulthood DRRI1-A: Unwanted Sex Activity Childhood Deployment Risk & Resilience Inventory-2 - Before deployment: I experienced unwanted sexual activity as a result of force, threat of harm, or manipulation during childhood (before age 18). DRRI-2 - A: Unwanted Sex Activity Childhood DRRI1-A: Went Through Divorce/Was Left Deployment Risk & Resilience Inventory-2 - Before deployment: I went through a divorce or was left by a significant other. DRRI-2 - A: Went Through Divorce/Was Left DRRI1-A: Witnessed Someone Assaulted Deployment Risk & Resilience Inventory-2 - Before deployment: I witnessed someone being seriously assaulted or killed. DRRI-2 - A: Witnessed Someone Assaulted DRRI1-B: Contribution Family Appreciated Deployment Risk & Resilience Inventory-2 - During childhood: I felt like my contributions to my family were appreciated. DRRI-2 - B: Contribution Family Appreciated DRRI1-B: Family Knew What I Thought/Felt Deployment Risk & Resilience Inventory-2 - During childhood: family members knew what I thought and how I felt about things. DRRI-2 - B: Family Knew What I Thought/Felt DRRI1-B: Family Told Me When Problem Deployment Risk & Resilience Inventory-2 - During childhood: family members told me when they were having a problem. DRRI-2 - B: Family Told Me When Problem DRRI1-B: Felt Like I Fit in With Family Deployment Risk & Resilience Inventory-2 - During childhood: I felt like I fit in with my family. DRRI-2 - B: Felt Like I Fit in With Family DRRI1-B: Got Along Well With My Family Deployment Risk & Resilience Inventory-2 - During childhood: I got along well with my family members. DRRI-2 - B: Got Along Well With My Family DRRI1-B: I Could Be Myself Around Family Deployment Risk & Resilience Inventory-2 - During childhood: I could be myself around family members. DRRI-2 - B: I Could Be Myself Around Family DRRI1-B: I Was Affectionate With Family Deployment Risk & Resilience Inventory-2 - During childhood: I was affectionate with family members. DRRI-2 - B: I Was Affectionate With Family DRRI1-B: Input Sought Family Decisions Deployment Risk & Resilience Inventory-2 - During childhood: my input was sought on important family decisions. DRRI-2 - B: Input Sought Family Decisions DRRI1-B: Opinions Were Valued by Family Deployment Risk & Resilience Inventory-2 - During childhood: my opinions were valued by other family members. DRRI-2 - B: Opinions Were Valued by Family DRRI1-B: Played Important Role in Family Deployment Risk & Resilience Inventory-2 - During childhood: I played an important role in my family. DRRI-2 - B: Played Important Role in Family DRRI1-B: Shared Interests With Family Deployment Risk & Resilience Inventory-2 - During childhood: I shared many common interests and activities with family members. DRRI-2 - B: Shared Interests With Family DRRI1-B: Spent My Free Time With Family Deployment Risk & Resilience Inventory-2 - During childhood: I spent as much of my free time with family members as possible. DRRI-2 - B: Spent My Free Time With Family DRRI1-C: Climate Was Uncomfortable Deployment Risk & Resilience Inventory-2 - During deployment: the climate was uncomfortable. DRRI-2 - C: Climate Was Uncomfortable DRRI1-C: Conditions Extremely Unsanitary Deployment Risk & Resilience Inventory-2 - During deployment: the conditions I lived in were extremely unsanitary. DRRI-2 - C: Conditions Extremely Unsanitary DRRI1-C: Deal With Annoying Animals Deployment Risk & Resilience Inventory-2 - During deployment: I had to deal with annoying animals, insects, or plants. DRRI-2 - C: Deal With Annoying Animals DRRI1-C: Didn't Have Bathrooms Deployment Risk & Resilience Inventory-2 - During deployment: I didn't have access to bathrooms or showers when I needed them. DRRI-2 - C: Didn't Have Bathrooms DRRI1-C: Food Was of Very Poor Quality Deployment Risk & Resilience Inventory-2 - During deployment: the food I had to eat was of very poor quality (for example, bad or old MREs). DRRI-2 - C: Food Was of Very Poor Quality DRRI1-C: Hassle With Heavy/Annoying Gear Deployment Risk & Resilience Inventory-2 - During deployment: I had to hassle with putting on and taking off heavy or annoying gear. DRRI-2 - C: Hassle With Heavy/Annoying Gear DRRI1-C: I Was Exposed to Awful Smells Deployment Risk & Resilience Inventory-2 - During deployment: I was exposed to awful smells. DRRI-2 - C: I Was Exposed to Awful Smells DRRI1-C: I Was Subjected to Loud Noises Deployment Risk & Resilience Inventory-2 - During deployment: I was subjected to loud noises. DRRI-2 - C: I Was Subjected to Loud Noises DRRI1-C: Not Allowed to Get Job Done Deployment Risk & Resilience Inventory-2 - During deployment: I was not allowed to do the things I needed to do to get my job done. DRRI-2 - C: Not Allowed to Get Job Done DRRI1-C: Not Have Adequate Shelter Deployment Risk & Resilience Inventory-2 - During deployment: I did not have adequate shelter from uncomfortable living conditions (for example, heat, cold, wet, etc.). DRRI-2 - C: Not Have Adequate Shelter DRRI1-C: Restricted Because Local Custom Deployment Risk & Resilience Inventory-2 - During deployment: my daily activities were restricted because of local religious or ethnic customs. DRRI-2 - C: Restricted Because Local Custom DRRI1-C: Wasn't Able to Contact Home Deployment Risk & Resilience Inventory-2 - During deployment: I wasn't able to contact home when I needed to. DRRI-2 - C: Wasn't Able to Contact Home DRRI1-C: Wasn't Able to Get Privacy Deployment Risk & Resilience Inventory-2 - During deployment: I wasn't able to get as much privacy as I needed. DRRI-2 - C: Wasn't Able to Get Privacy DRRI1-C: Wasn't Able to Rest Deployment Risk & Resilience Inventory-2 - During deployment: I wasn't able to get rest when I needed it. DRRI-2 - C: Wasn't Able to Rest DRRI1-D: Assault on Entrenched Positions Deployment Risk & Resilience Inventory-2 - During deployment: I took part in an assault on entrenched or fortified positions that involved naval and/or land forces. DRRI-2 - D: Assault on Entrenched Positions DRRI1-D: Encountered Land Mines Deployment Risk & Resilience Inventory-2 - During deployment: I encountered land or water mines, booby traps, or roadside bombs (for example, IEDs). DRRI-2 - D: Encountered Land Mines DRRI1-D: Exposed Hostile Incoming Fire Deployment Risk & Resilience Inventory-2 - During deployment: I was exposed to hostile incoming fire. DRRI-2 - D: Exposed Hostile Incoming Fire DRRI1-D: Exposed to Friendly Fire Deployment Risk & Resilience Inventory-2 - During deployment: I was exposed to "friendly" fire. DRRI-2 - D: Exposed to Friendly Fire DRRI1-D: Fired My Weapon Enemy Combatant Deployment Risk & Resilience Inventory-2 - During deployment: I fired my weapon at enemy combatants. DRRI-2 - D: Fired My Weapon Enemy Combatant DRRI1-D: Injured Combat-Related Incident Deployment Risk & Resilience Inventory-2 - During deployment: I was injured in a combat-related incident. DRRI-2 - D: Injured Combat-Related Incident DRRI1-D: Locating Explosive Devices Deployment Risk & Resilience Inventory-2 - During deployment: I was involved in locating or disarming explosive devices. DRRI-2 - D: Locating Explosive Devices DRRI1-D: Part of Unit Fired on Enemy Deployment Risk & Resilience Inventory-2 - During deployment: I was part of a land or naval artillery unit that fired on enemy combatants. DRRI-2 - D: Part of Unit Fired on Enemy DRRI1-D: Participate Hand-to-hand Combat Deployment Risk & Resilience Inventory-2 - During deployment: I participated in hand-to-hand combat. DRRI-2 - D: Participate Hand-to-hand Combat DRRI1-D: Search/Disarm Potential Enemy Deployment Risk & Resilience Inventory-2 - During deployment: I was involved in searching and/or disarming potential enemy combatants. DRRI-2 - D: Search/Disarm Potential Enemy DRRI1-D: Searching Homes/Buildings Deployment Risk & Resilience Inventory-2 - During deployment: I was involved in searching or clearing homes, buildings, or other locations. DRRI-2 - D: Searching Homes/Buildings DRRI1-D: Think I Wounded/Killed Someone Deployment Risk & Resilience Inventory-2 - During deployment: I think I wounded or killed someone during combat operations. DRRI-2 - D: Think I Wounded/Killed Someone DRRI1-D: Vehicle/Part of Convoy Attacked Deployment Risk & Resilience Inventory-2 - During deployment: I was in a vehicle (for example, a "humvee", helicopter, or boat) or part of a convoy that was attacked. DRRI-2 - D: Vehicle/Part of Convoy Attacked DRRI1-D: Went on Combat Patrols/Missions Deployment Risk & Resilience Inventory-2 - During deployment: I went on combat patrols or missions. DRRI-2 - D: Went on Combat Patrols/Missions DRRI1-D: Witnessed Civilians Wounded Deployment Risk & Resilience Inventory-2 - During deployment: I personally witnessed civilians (for example, women and children) being seriously wounded or killed. DRRI-2 - D: Witnessed Civilians Wounded DRRI1-D: Witnessed Enemy Wounded/Killed Deployment Risk & Resilience Inventory-2 - During deployment: I personally witnessed enemy combatants being seriously wounded or killed. DRRI-2 - D: Witnessed Enemy Wounded/Killed DRRI1-D: Witnessed Someone Unit Wounded Deployment Risk & Resilience Inventory-2 - During deployment: I personally witnessed someone from my unit or an ally unit being seriously wounded or killed. DRRI-2 - D: Witnessed Someone Unit Wounded DRRI1-E: Interacted With Detainees Deployment Risk & Resilience Inventory-2 - During deployment: I interacted with detainees or prisoners of war. DRRI-2 - E: Interacted With Detainees DRRI1-E: Involved Handling Human Remains Deployment Risk & Resilience Inventory-2 - During deployment: I was involved in handling human remains. DRRI-2 - E: Involved Handling Human Remains DRRI1-E: Observed Homes Been Destroyed Deployment Risk & Resilience Inventory-2 - During deployment: I observed homes or communities that had been destroyed. DRRI-2 - E: Observed Homes Been Destroyed DRRI1-E: Saw Americans Had Been Wounded Deployment Risk & Resilience Inventory-2 - During deployment: I saw Americans or allies after they had been severely wounded or disfigured. DRRI-2 - E: Saw Americans Had Been Wounded DRRI1-E: Saw Bodies of Dead Americans Deployment Risk & Resilience Inventory-2 - During deployment: I saw the bodies of dead Americans or allies. DRRI-2 - E: Saw Bodies of Dead Americans DRRI1-E: Saw Bodies of Dead Civilians Deployment Risk & Resilience Inventory-2 - During deployment: I saw the bodies of dead civilians. DRRI-2 - E: Saw Bodies of Dead Civilians DRRI1-E: Saw Bodies of Dead Enemy Deployment Risk & Resilience Inventory-2 - During deployment: I saw the bodies of dead enemy combatants. DRRI-2 - E: Saw Bodies of Dead Enemy DRRI1-E: Saw Civilians After Wounded Deployment Risk & Resilience Inventory-2 - During deployment: I saw civilians after they had been severely wounded or disfigured. DRRI-2 - E: Saw Civilians After Wounded DRRI1-E: Saw Combatants Had Been Wounded Deployment Risk & Resilience Inventory-2 - During deployment: I saw enemy combatants after they had been severely wounded or disfigured. DRRI-2 - E: Saw Combatants Had Been Wounded DRRI1-E: Saw People Begging for Food Deployment Risk & Resilience Inventory-2 - During deployment: I saw people begging for food. DRRI-2 - E: Saw People Begging for Food DRRI1-E: Saw Refugees Who Had Lost Homes Deployment Risk & Resilience Inventory-2 - During deployment: I saw refugees who had lost their homes or belongings. DRRI-2 - E: Saw Refugees Who Had Lost Homes DRRI1-E: Sight/Sound/Smell Dead Animals Deployment Risk & Resilience Inventory-2 - During deployment: I was exposed to the sight, sound, or smell of dead or dying animals. DRRI-2 - E: Sight/Sound/Smell Dead Animals DRRI1-E: Took Care Injured/Dying People Deployment Risk & Resilience Inventory-2 - During deployment: I took care of injured or dying people. DRRI-2 - E: Took Care Injured/Dying People DRRI1-F: Exposed Government-issued DEET Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to government-issued DEET-containing insect repellents. DRRI-2 - F: Exposed Government-issued DEET DRRI1-F: Exposed to Burning Trash/Feces Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to burning trash or burning feces. DRRI-2 - F: Exposed to Burning Trash/Feces DRRI1-F: Exposed to Chlorine Gas Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to chlorine gas. DRRI-2 - F: Exposed to Chlorine Gas DRRI1-F: Exposed to Depleted Uranium Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to depleted uranium in munitions. DRRI-2 - F: Exposed to Depleted Uranium DRRI1-F: Exposed to Diesel/Fuel on Skin Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to diesel or other petrochemical fuel on my skin. DRRI-2 - F: Exposed to Diesel/Fuel on Skin DRRI1-F: Exposed to Fumes From Heaters Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to fumes or exhaust from heaters or generators, including heaters in tents. DRRI-2 - F: Exposed to Fumes From Heaters DRRI1-F: Exposed to Mustard Gas Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to mustard gas or other blistering agents. DRRI-2 - F: Exposed to Mustard Gas DRRI1-F: Exposed to Nerve Gas Agents Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to nerve gas agents (for example, sarin). DRRI-2 - F: Exposed to Nerve Gas Agents DRRI1-F: Exposed to Nuclear Weapons Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to nuclear, biological, or chemical weapons. DRRI-2 - F: Exposed to Nuclear Weapons DRRI1-F: Exposed to Other Pesticides Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to other pesticides (for example, in flea collars, uniforms, or the environment). DRRI-2 - F: Exposed to Other Pesticides DRRI1-F: Exposed to Smoke/Air Pollution Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to smoke or other air pollution. DRRI-2 - F: Exposed to Smoke/Air Pollution DRRI1-F: Received Vaccinations Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I received preventative vaccinations by injection (for example, to prevent anthrax or botulism). DRRI-2 - F: Received Vaccinations DRRI1-F: Took Preventative Pills Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I took preventative pills (for example, to protect against nerve gas). DRRI-2 - F: Took Preventative Pills DRRI1-G: Concern Rocket/Mortar Would Hit Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned that a rocket or mortar would hit our living quarters. DRRI-2 - G: Concern Rocket/Mortar Would Hit DRRI1-G: Concerned Depleted Uranium Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned that I might be exposed to depleted uranium in munitions. DRRI-2 - G: Concerned Depleted Uranium DRRI1-G: Concerned Encounter Explosive Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned that I would encounter an explosive device (for example, a roadside bomb, mine, or booby trap). DRRI-2 - G: Concerned Encounter Explosive DRRI1-G: Concerned Infectious Disease Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned about getting an infectious disease. DRRI-2 - G: Concerned Infectious Disease DRRI1-G: Concerned Locals Against Us Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned that the locals who were supposed to be helping us were actually working against us. DRRI-2 - G: Concerned Locals Against Us DRRI1-G: Concerned Medicine Make Me Sick Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned that the medicine I was given to protect me from illness would make me sick. DRRI-2 - G: Concerned Medicine Make Me Sick DRRI1-G: Concerned Taken Hostage Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned that I might be taken hostage. DRRI-2 - G: Concerned Taken Hostage DRRI1-G: Concerned Trapped in Crossfire Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned about being trapped in the crossfire of rival factions. DRRI-2 - G: Concerned Trapped in Crossfire DRRI1-G: Feared Sick From Pesticides Deployment Risk & Resilience Inventory-2 - During deployment: I feared that I would become sick from pesticides (for example, bug spray) or other routinely used chemicals. DRRI-2 - G: Feared Sick From Pesticides DRRI1-G: Felt in Danger of Being Wounded Deployment Risk & Resilience Inventory-2 - During deployment: I felt I was in great danger of being wounded (for example, losing a limb). DRRI-2 - G: Felt in Danger of Being Wounded DRRI1-G: Health Might Suffer NBC Agents Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned that my health might suffer due to exposure to nuclear, biological, or chemical (NBC) agents. DRRI-2 - G: Health Might Suffer NBC Agents DRRI1-G: Thought I Would Never Survive Deployment Risk & Resilience Inventory-2 - During deployment: I thought I would never survive. DRRI-2 - G: Thought I Would Never Survive DRRI1-H: Accurately Informed About Role Deployment Risk & Resilience Inventory-2 - In preparation for deployment: I was accurately informed about the role my unit was expected to play in the deployment. DRRI-2 - H: Accurately Informed About Role DRRI1-H: Confident Ability Use Equipment Deployment Risk & Resilience Inventory-2 - In preparation for deployment: the training I received made me feel confident in my ability to use my equipment. DRRI-2 - H: Confident Ability Use Equipment DRRI1-H: Confident to Perform Tasks Deployment Risk & Resilience Inventory-2 - In preparation for deployment: the training I received made me feel confident in my ability to perform tasks assigned to me during deployment. DRRI-2 - H: Confident to Perform Tasks DRRI1-H: Had All Supplies Needed Deployment Risk & Resilience Inventory-2 - In preparation for deployment: I had all the supplies and equipment needed to get my job done. DRRI-2 - H: Had All Supplies Needed DRRI1-H: Had Enough Gear in Case Attack Deployment Risk & Resilience Inventory-2 - In preparation for deployment: I had enough gear to protect myself in case of an attack. DRRI-2 - H: Had Enough Gear in Case Attack DRRI1-H: Military Duties What I Expected Deployment Risk & Resilience Inventory-2 - In preparation for deployment: my military duties and assignments were what I expected. DRRI-2 - H: Military Duties What I Expected DRRI1-H: Prepared to Deal With Climate Deployment Risk & Resilience Inventory-2 - In preparation for deployment: the training I received prepared me to deal with the region's climate. DRRI-2 - H: Prepared to Deal With Climate DRRI1-H: Prepared to Operate as Team Deployment Risk & Resilience Inventory-2 - In preparation for deployment: my unit was well-prepared to operate as a team during deployment. DRRI-2 - H: Prepared to Operate as Team DRRI1-H: Taught Me Everything I Needed Deployment Risk & Resilience Inventory-2 - In preparation for deployment: the training I received taught me everything I needed to know for deployment. DRRI-2 - H: Taught Me Everything I Needed DRRI1-H: Training for Deployment Deployment Risk & Resilience Inventory-2 - In preparation for deployment: I received appropriate training for the nature of the deployment I experienced. DRRI-2 - H: Training for Deployment DRRI1-I: Could Count on Family Advice Deployment Risk & Resilience Inventory-2 - During deployment: I could count on my family members or friends at home for good advice. DRRI-2 - I: Could Count on Family Advice DRRI1-I: Family Sincerely Interested Deployment Risk & Resilience Inventory-2 - During deployment: family members and/or friends at home were sincerely interested in hearing what was going on with me. DRRI-2 - I: Family Sincerely Interested DRRI1-I: Had Family I Could Talk To Deployment Risk & Resilience Inventory-2 - During deployment: I had family members or friends at home I could talk to when I had a problem. DRRI-2 - I: Had Family I Could Talk To DRRI1-I: Happy Communication From Home Deployment Risk & Resilience Inventory-2 - During deployment: I was happy with the amount of communication I received from people at home. DRRI-2 - I: Happy Communication From Home DRRI1-I: Happy With Support From Home Deployment Risk & Resilience Inventory-2 - During deployment: I was happy with the amount of support I received from people at home. DRRI-2 - I: Happy With Support From Home DRRI1-I: People at Home Show They Cared Deployment Risk & Resilience Inventory-2 - During deployment: people at home did things to show they cared about me. DRRI-2 - I: People at Home Show They Cared DRRI1-I: Relatives Look Out for Family Deployment Risk & Resilience Inventory-2 - During deployment: relatives or friends at home could be counted on to look out for the well-being of my family or other dependents (including pets). DRRI-2 - I: Relatives Look Out for Family DRRI1-I: Relatives Take Care of Finances Deployment Risk & Resilience Inventory-2 - During deployment: relatives or friends at home could be counted on to take care of my finances, property, or belongings if needed. DRRI-2 - I: Relatives Take Care of Finances DRRI1-J: Could Go to Leaders If Problem Deployment Risk & Resilience Inventory-2 - During deployment: I could go to unit leaders for help if I had a problem or concern. DRRI-2 - J: Could Go to Leaders If Problem DRRI1-J: Fellow Unit Appreciated Efforts Deployment Risk & Resilience Inventory-2 - During deployment: my fellow unit members appreciated my efforts. DRRI-2 - J: Fellow Unit Appreciated Efforts DRRI1-J: Felt Like My Efforts Counted Deployment Risk & Resilience Inventory-2 - During deployment: I felt like my efforts really counted to the leaders in my unit. DRRI-2 - J: Felt Like My Efforts Counted DRRI1-J: Felt Valued by Leaders of Unit Deployment Risk & Resilience Inventory-2 - During deployment: I felt valued by the leaders of my unit. DRRI-2 - J: Felt Valued by Leaders of Unit DRRI1-J: Felt Valued Fellow Unit Members Deployment Risk & Resilience Inventory-2 - During deployment: I felt valued by my fellow unit members. DRRI-2 - J: Felt Valued Fellow Unit Members DRRI1-J: Leader Interested What Thought Deployment Risk & Resilience Inventory-2 - During deployment: my unit leader(s) were interested in what I thought and how I felt about things. DRRI-2 - J: Leader Interested What Thought DRRI1-J: Leaders Interested in Welfare Deployment Risk & Resilience Inventory-2 - During deployment: the leaders of my unit were interested in my personal welfare. DRRI-2 - J: Leaders Interested in Welfare DRRI1-J: My Unit Was Like Family to Me Deployment Risk & Resilience Inventory-2 - During deployment: my unit was like family to me. DRRI-2 - J: My Unit Was Like Family to Me DRRI1-J: People in Unit Were Trustworthy Deployment Risk & Resilience Inventory-2 - During deployment: people in my unit were trustworthy. DRRI-2 - J: People in Unit Were Trustworthy DRRI1-J: Service Appreciated by Leaders Deployment Risk & Resilience Inventory-2 - During deployment: my service was appreciated by the leaders in my unit. DRRI-2 - J: Service Appreciated by Leaders DRRI1-J: Unit Interested My Well-being Deployment Risk & Resilience Inventory-2 - During deployment: members of my unit were interested in my well-being. DRRI-2 - J: Unit Interested My Well-being DRRI1-J: Unit Interested What I Thought Deployment Risk & Resilience Inventory-2 - During deployment: my fellow unit members were interested in what I thought and how I felt about things. DRRI-2 - J: Unit Interested What I Thought DRRI1-K: Authority Pressure Unwanted Sex Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: used a position of authority to pressure me into unwanted sexual activity. DRRI-2 - K: Authority Pressure Unwanted Sex DRRI1-K: Had to Work Harder Prove Myself Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: treated me as if I had to work harder than others to prove myself. DRRI-2 - K: Had to Work Harder Prove Myself DRRI1-K: Made Crude Sexual Remarks at Me Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: made crude and offensive sexual remarks directed at me, either publicly or privately. DRRI-2 - K: Made Crude Sexual Remarks at Me DRRI1-K: Make My Job More Difficult Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: tried to make my job more difficult to do. DRRI-2 - K: Make My Job More Difficult DRRI1-K: My Mistakes Worse Than Others Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: acted as though my mistakes were worse than others'. DRRI-2 - K: My Mistakes Worse Than Others DRRI1-K: Offered Reward Take Part in Sex Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: offered me a specific reward or special treatment to take part in sexual behavior. DRRI-2 - K: Offered Reward Take Part in Sex DRRI1-K: Physically Forced to Have Sex Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: physically forced me to have sex. DRRI-2 - K: Physically Forced to Have Sex DRRI1-K: Put Me Down Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: "put me down" or treated me in a condescending way. DRRI-2 - K: Put Me Down DRRI1-K: Questioned My Abilities Perform Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: questioned my abilities or commitment to perform my job effectively. DRRI-2 - K: Questioned My Abilities Perform DRRI1-K: Spread Rumors Sexual Activities Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: spread negative rumors about my sexual activities. DRRI-2 - K: Spread Rumors Sexual Activities DRRI1-K: Threatened Me If Not Sex Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: threatened me with some sort of retaliation if I was not sexually cooperative (for example, the threat of negative review or physical violence). DRRI-2 - K: Threatened Me If Not Sex DRRI1-K: Threatened My Physical Safety Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: threatened my physical safety. DRRI-2 - K: Threatened My Physical Safety DRRI1-K: Touched Sexual Way Against Will Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: touched me in a sexual way against my will. DRRI-2 - K: Touched Sexual Way Against Will DRRI1-K: Treated in Overly Critical Way Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: treated me in an overly critical way. DRRI-2 - K: Treated in Overly Critical Way DRRI1-K: Tried to Talk into Sexual Acts Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: tried to talk me into participating in sexual acts when I didn't want to. DRRI-2 - K: Tried to Talk into Sexual Acts DRRI1-K: Uncooperative Working With Me Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: behaved in way that was uncooperative when working with me. DRRI-2 - K: Uncooperative Working With Me DRRI1-L: Being Cheated on by My Spouse Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: being cheated on by my spouse or significant other. DRRI-2 - L: Being Cheated on by My Spouse DRRI1-L: Care Child/Dependents Receiving Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: the care that my child(ren) or other dependents were receiving. DRRI-2 - L: Care Child/Dependents Receiving DRRI1-L: Damaging Career Because Deploy Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: damaging my career because of the deployment. DRRI-2 - L: Damaging Career Because Deploy DRRI1-L: Effect Deployment Relationship Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: the effect of the deployment on my relationship with my spouse or significant other. DRRI-2 - L: Effect Deployment Relationship DRRI1-L: Effect Relationship My Children Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: the effect of the deployment on my relationship with my child(ren). DRRI-2 - L: Effect Relationship My Children DRRI1-L: Family Ability Cope With Stress Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: my family's ability to cope with the stress of the deployment. DRRI-2 - L: Family Ability Cope With Stress DRRI1-L: Inability Manage Family Affairs Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: my inability to directly manage or control family affairs. DRRI-2 - L: Inability Manage Family Affairs DRRI1-L: Losing My Civilian Job Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: losing my civilian job because of the deployment. DRRI-2 - L: Losing My Civilian Job DRRI1-L: Missing Family Events at Home Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: missing important family events at home such as birthdays, weddings, funerals, graduations, etc. DRRI-2 - L: Missing Family Events at Home DRRI1-L: Missing Out on Children Growth Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: missing out on my children's growth and development. DRRI-2 - L: Missing Out on Children Growth DRRI1-L: My Family Financial Situation Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: my family's financial situation. DRRI-2 - L: My Family Financial Situation DRRI1-L: Safety and Well-being of Child Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: the safety and well-being of my child(ren). DRRI-2 - L: Safety and Well-being of Child DRRI1-L: Safety and Well-being of Spouse Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: the safety and well-being of my spouse or significant other. DRRI-2 - L: Safety and Well-being of Spouse DRRI1-L: Spouse Ability Manage Household Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: my spouse or significant other's ability to manage the household (for example, chores, bills, home repairs, etc.). DRRI-2 - L: Spouse Ability Manage Household DRRI1-L: Unable to Help Family If Crisis Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: being unable to help my family if there was some kind of crisis or emergency. DRRI-2 - L: Unable to Help Family If Crisis DRRI1-M: Fam Dangerous Military Duties Deployment Risk & Resilience Inventory-2 - During deployment: a family member or other loved one participated in dangerous military duties. DRRI-2 - M: Fam Dangerous Military Duties DRRI1-M: Family Got Into Trouble Deployment Risk & Resilience Inventory-2 - During deployment: a family member got into trouble at home, at school, or in the community. DRRI-2 - M: Family Got Into Trouble DRRI1-M: Family Had Difficulty Adjusting Deployment Risk & Resilience Inventory-2 - During deployment: a family member or other loved one had serious difficulty adjusting to my absence. DRRI-2 - M: Family Had Difficulty Adjusting DRRI1-M: Family Member Passed Away Deployment Risk & Resilience Inventory-2 - During deployment: a family member or other loved one passed away. DRRI-2 - M: Family Member Passed Away DRRI1-M: Family Member Wasted Money Deployment Risk & Resilience Inventory-2 - During deployment: a family member or other person I trusted wasted or mismanaged my money. DRRI-2 - M: Family Member Wasted Money DRRI1-M: Had Major Conflict With Family Deployment Risk & Resilience Inventory-2 - During deployment: I had a major conflict with a family member or other loved one. DRRI-2 - M: Had Major Conflict With Family DRRI1-M: Loved One Things I Disapproved Deployment Risk & Resilience Inventory-2 - During deployment: I learned that a loved one was doing things I disapproved of. DRRI-2 - M: Loved One Things I Disapproved DRRI1-M: My Family Had Money Problems Deployment Risk & Resilience Inventory-2 - During deployment: my family had money problems. DRRI-2 - M: My Family Had Money Problems DRRI1-M: My Home Was Robbed Deployment Risk & Resilience Inventory-2 - During deployment: my home was robbed and/or my belongings were stolen. DRRI-2 - M: My Home Was Robbed DRRI1-M: Problems Get in Touch Family Deployment Risk & Resilience Inventory-2 - During deployment: I had problems getting in touch with a family member or other loved one. DRRI-2 - M: Problems Get in Touch Family DRRI1-M: Relationship With Spouse Ended Deployment Risk & Resilience Inventory-2 - During deployment: my relationship with a spouse or significant other ended. DRRI-2 - M: Relationship With Spouse Ended DRRI1-M: Someone Close Serious Illness Deployment Risk & Resilience Inventory-2 - During deployment: someone close to me experienced a serious illness, injury, or mental health problem (for example, cancer, alcohol/drug problem). DRRI-2 - M: Someone Close Serious Illness DRRI1-M: Spouse Cheated on Me Deployment Risk & Resilience Inventory-2 - During deployment: a spouse or significant other cheated on me. DRRI-2 - M: Spouse Cheated on Me DRRI1-M: Spouse Suspected I Cheated Deployment Risk & Resilience Inventory-2 - During deployment: a spouse or significant other suspected that I had cheated on him/her. DRRI-2 - M: Spouse Suspected I Cheated DRRI1-N: Emotionally Mistreated Deployment Risk & Resilience Inventory-2 - Since returning: I have been emotionally mistreated (for example, ignored or repeatedly told I was no good). DRRI-2 - N: Emotionally Mistreated DRRI1-N: Experienced Natural Disaster Deployment Risk & Resilience Inventory-2 - Since returning: I experienced a natural disaster (for example, a hurricane), a fire, or an accident in which I or someone close to me was hurt or had serious property damage. DRRI-2 - N: Experienced Natural Disaster DRRI1-N: Injured by Another Person Deployment Risk & Resilience Inventory-2 - Since returning: I have been seriously physically injured by another person (for example, hit or beaten up). DRRI-2 - N: Injured by Another Person DRRI1-N: Lost My Job/Trouble Finding Job Deployment Risk & Resilience Inventory-2 - Since returning: I lost my job or had serious trouble finding a job. DRRI-2 - N: Lost My Job/Trouble Finding Job DRRI1-N: Problems Getting Healthcare Deployment Risk & Resilience Inventory-2 - Since returning: I had problems getting access to adequate healthcare. DRRI-2 - N: Problems Getting Healthcare DRRI1-N: Robbed/Had My Home Broken Into Deployment Risk & Resilience Inventory-2 - Since returning: I was robbed or had my home broken into. DRRI-2 - N: Robbed/Had My Home Broken Into DRRI1-N: Serious Financial Problems Deployment Risk & Resilience Inventory-2 - Since returning: I have experienced serious financial problems. DRRI-2 - N: Serious Financial Problems DRRI1-N: Serious Physical Health Problem Deployment Risk & Resilience Inventory-2 - Since returning: I have experienced serious physical or mental health problems. DRRI-2 - N: Serious Physical Health Problem DRRI1-N: Someone Close Serious Illness Deployment Risk & Resilience Inventory-2 - Since returning: someone close to me has experienced a serious illness, injury, or mental health problem (for example, cancer, alcohol/drug problem). DRRI-2 - N: Someone Close Serious Illness DRRI1-N: Someone Close to Me Has Died Deployment Risk & Resilience Inventory-2 - Since returning: someone close to me has died. DRRI-2 - N: Someone Close to Me Has Died DRRI1-N: Stressful Legal Problems Deployment Risk & Resilience Inventory-2 - Since returning: I have experienced stressful legal problems (for example, being sued, suing someone else, or being in a custody battle). DRRI-2 - N: Stressful Legal Problems DRRI1-N: Unwanted Sexual Activity Deployment Risk & Resilience Inventory-2 - Since returning: I experienced unwanted sexual activity as a result of force, threat or harm, or manipulation. DRRI-2 - N: Unwanted Sexual Activity DRRI1-N: Went Through Divorce/Was Left Deployment Risk & Resilience Inventory-2 - Since returning: I went through a divorce or have been left by a partner or significant other. DRRI-2 - N: Went Through Divorce/Was Left DRRI1-N: Witnessed Someone Assaulted Deployment Risk & Resilience Inventory-2 - Since returning: I have witnessed someone being seriously assaulted or killed. DRRI-2 - N: Witnessed Someone Assaulted DRRI1-O: Family Make Me Better When Down Deployment Risk & Resilience Inventory-2 - Since returning: my family members and/or friends make me feel better when I am down. DRRI-2 - O: Family Make Me Better When Down DRRI1-O: Family Would Help Move Deployment Risk & Resilience Inventory-2 - Since returning: my family members or friends would help me move my belongings if I needed help. DRRI-2 - O: Family Would Help Move DRRI1-O: Family Would Lend Money Deployment Risk & Resilience Inventory-2 - Since returning: my family members or friends would lend me money if I needed it. DRRI-2 - O: Family Would Lend Money DRRI1-O: Family/Friends Understand Deployment Risk & Resilience Inventory-2 - Since returning: my family and friends understand what I have been through in the Armed Forces. DRRI-2 - O: Family/Friends Understand DRRI1-O: Go to Family When Need Advice Deployment Risk & Resilience Inventory-2 - Since returning: I can go to family members or friends when I need good advice. DRRI-2 - O: Go to Family When Need Advice DRRI1-O: I Can Talk About My Deployment Deployment Risk & Resilience Inventory-2 - Since returning: there are family and/or friends with whom I can talk about my deployment experiences. DRRI-2 - O: I Can Talk About My Deployment DRRI1-O: People Made Me Feel at Home Deployment Risk & Resilience Inventory-2 - Since returning: the American people made me feel at home. DRRI-2 - O: People Made Me Feel at Home DRRI1-O: People Made Me Feel Proud Deployment Risk & Resilience Inventory-2 - Since returning: people made me feel proud to have served my country in the Armed Forces. DRRI-2 - O: People Made Me Feel Proud DRRI1-O: Someone Would Help With Tasks Deployment Risk & Resilience Inventory-2 - Since returning: if I were unable to attend to daily chores, there is someone who would help me with these tasks. DRRI-2 - O: Someone Would Help With Tasks DRRI1-O: When Ill Family Will Help Out Deployment Risk & Resilience Inventory-2 - Since returning: when I am ill, family members or friends will help out until I am well. DRRI-2 - O: When Ill Family Will Help Out DRRI1-P: Can Be Myself Around Family Deployment Risk & Resilience Inventory-2 - Since returning: I can be myself around family members. DRRI-2 - P: Can Be Myself Around Family DRRI1-P: Contribution Family Appreciated Deployment Risk & Resilience Inventory-2 - Since returning: I feel like my contributions to my family are appreciated. DRRI-2 - P: Contribution Family Appreciated DRRI1-P: Family Know What I Think/Feel Deployment Risk & Resilience Inventory-2 - Since returning: family members know what I think and how I feel about things. DRRI-2 - P: Family Know What I Think/Feel DRRI1-P: Family Tell Me When Problem Deployment Risk & Resilience Inventory-2 - Since returning: family members tell me when they are having a problem. DRRI-2 - P: Family Tell Me When Problem DRRI1-P: Feel Like I Fit in With Family Deployment Risk & Resilience Inventory-2 - Since returning: I feel like I fit in with my family. DRRI-2 - P: Feel Like I Fit in With Family DRRI1-P: I am Affectionate With Family Deployment Risk & Resilience Inventory-2 - Since returning: I am affectionate with family members. DRRI-2 - P: I am Affectionate With Family DRRI1-P: I Get Along Well With My Family Deployment Risk & Resilience Inventory-2 - Since returning: I get along well with my family members. DRRI-2 - P: I Get Along Well With My Family DRRI1-P: Input Sought Family Decisions Deployment Risk & Resilience Inventory-2 - Since returning: my input is sought on important family decisions. DRRI-2 - P: Input Sought Family Decisions DRRI1-P: Opinions Valued by Family Deployment Risk & Resilience Inventory-2 - Since returning: my opinions are valued by other family members. DRRI-2 - P: Opinions Valued by Family DRRI1-P: Play Important Role in Family Deployment Risk & Resilience Inventory-2 - Since returning: I play an important role in my family. DRRI-2 - P: Play Important Role in Family DRRI1-P: Share Interests With Family Deployment Risk & Resilience Inventory-2 - Since returning: I share many common interests and activities with family members. DRRI-2 - P: Share Interests With Family DRRI1-P: Spend My Free Time With Family Deployment Risk & Resilience Inventory-2 - Since returning: I spend as much of my free time with family members as possible. DRRI-2 - P: Spend My Free Time With Family DRRI1TN Deployment Risk and Resilience Inventory-2 Questionnaire Test Name CDISC Questionnaire DRRI-2 Test Name Terminology Dermatology Life Quality Index test code. DLQI1-How Itchy, Sore, Painful, Stinging Dermatology Life Quality Index - Over the last week, how itchy, sore, painful or stinging has your skin been? DLQI - Itchy, Sore, Painful or Stinging Skin DLQI1-How Embarrassed, Self Conscious Dermatology Life Quality Index - Over the last week, how embarrassed or self conscious have you been because of your skin? DLQI - Embarrassed Because of Skin DLQI1-Interfered Shopping, Home, Yard Dermatology Life Quality Index - Over the last week, how much has your skin interfered with you going shopping or looking after your home or yard? DLQI - Skin Interfere With Shopping, Looking After Home or Yard DLQI1-Influenced Clothes You Wear Dermatology Life Quality Index - Over the last week, how much has your skin influenced the clothes you wear? DLQI - Skin Influence Clothes You Wear DLQI1-Affected Social, Leisure Activity Dermatology Life Quality Index - Over the last week, how much has your skin affected any social or leisure activities? DLQI - Skin Affect Social or Leisure Activities DLQI1-Made It Difficult to Do Any Sports Dermatology Life Quality Index - Over the last week, how much has your skin made it difficult for you to do any sport? DLQI - Skin Made Difficult to Do Sport DLQI1-Prevented Working or Studying Dermatology Life Quality Index - Over the last week, has your skin prevented you from working or studying? DLQI - Skin Prevent Work or Study DLQI1-Problem at Work or Studying Dermatology Life Quality Index - If 'No', over the last week how much has your skin been a problem at work or studying? DLQI - Skin Has Been a Problem at Work or Study DLQI1-Problem Partner, Friends, Relative Dermatology Life Quality Index - Over the last week, how much has your skin created problems with your partner or any of your close friends or relatives? DLQI - Skin Create Problem With Partner, Friends or Relatives DLQI1-Caused Any Sexual Difficulties Dermatology Life Quality Index - Over the last week, how much has your skin caused any sexual difficulties? DLQI - Skin Cause Sexual Difficulties DLQI1-How Much a Problem is Treatment Dermatology Life Quality Index - Over the last week, how much of a problem has the treatment for your skin been, for example by making your home messy, or by taking up time? DLQI - Treatment for Skin Make Home Messy DLQI1-Score Dermatology Life Quality Index - Score. DLQI - Score DLQI1-Symptoms and Feelings Subscore Dermatology Life Quality Index - Symptoms and feelings subscore. DLQI - Symptoms and Feelings Subscore DLQI1-Daily Activities Subscore Dermatology Life Quality Index - Daily activities subscore. DLQI - Daily Activities Subscore DLQI1-Leisure Subscore Dermatology Life Quality Index - Leisure subscore. DLQI - Leisure Subscore DLQI1-Work and School Subscore Dermatology Life Quality Index - Work and school subscore. DLQI - Work and School Subscore DLQI1-Personal Relationships Subscore Dermatology Life Quality Index - Personal relationships subscore. DLQI - Personal Relationships Subscore DLQI1-Treatment Subscore Dermatology Life Quality Index - Treatment subscore. DLQI - Treatment Subscore DLQI1TC Dermatology Life Quality Index Questionnaire Test Code CDISC Questionnaire DLQI Test Code Terminology Dermatology Life Quality Index test name. DLQI1-Affected Social, Leisure Activity Dermatology Life Quality Index - Over the last week, how much has your skin affected any social or leisure activities? DLQI - Skin Affect Social or Leisure Activities DLQI1-Caused Any Sexual Difficulties Dermatology Life Quality Index - Over the last week, how much has your skin caused any sexual difficulties? DLQI - Skin Cause Sexual Difficulties DLQI1-Daily Activities Subscore Dermatology Life Quality Index - Daily activities subscore. DLQI - Daily Activities Subscore DLQI1-How Embarrassed, Self Conscious Dermatology Life Quality Index - Over the last week, how embarrassed or self conscious have you been because of your skin? DLQI - Embarrassed Because of Skin DLQI1-How Itchy, Sore, Painful, Stinging Dermatology Life Quality Index - Over the last week, how itchy, sore, painful or stinging has your skin been? DLQI - Itchy, Sore, Painful or Stinging Skin DLQI1-How Much a Problem is Treatment Dermatology Life Quality Index - Over the last week, how much of a problem has the treatment for your skin been, for example by making your home messy, or by taking up time? DLQI - Treatment for Skin Make Home Messy DLQI1-Influenced Clothes You Wear Dermatology Life Quality Index - Over the last week, how much has your skin influenced the clothes you wear? DLQI - Skin Influence Clothes You Wear DLQI1-Interfered Shopping, Home, Yard Dermatology Life Quality Index - Over the last week, how much has your skin interfered with you going shopping or looking after your home or yard? DLQI - Skin Interfere With Shopping, Looking After Home or Yard DLQI1-Leisure Subscore Dermatology Life Quality Index - Leisure subscore. DLQI - Leisure Subscore DLQI1-Made It Difficult to Do Any Sports Dermatology Life Quality Index - Over the last week, how much has your skin made it difficult for you to do any sport? DLQI - Skin Made Difficult to Do Sport DLQI1-Personal Relationships Subscore Dermatology Life Quality Index - Personal relationships subscore. DLQI - Personal Relationships Subscore DLQI1-Prevented Working or Studying Dermatology Life Quality Index - Over the last week, has your skin prevented you from working or studying? DLQI - Skin Prevent Work or Study DLQI1-Problem at Work or Studying Dermatology Life Quality Index - If 'No', over the last week how much has your skin been a problem at work or studying? DLQI - Skin Has Been a Problem at Work or Study DLQI1-Problem Partner, Friends, Relative Dermatology Life Quality Index - Over the last week, how much has your skin created problems with your partner or any of your close friends or relatives? DLQI - Skin Create Problem With Partner, Friends or Relatives DLQI1-Score Dermatology Life Quality Index - Score. DLQI - Score DLQI1-Symptoms and Feelings Subscore Dermatology Life Quality Index - Symptoms and feelings subscore. DLQI - Symptoms and Feelings Subscore DLQI1-Treatment Subscore Dermatology Life Quality Index - Treatment subscore. DLQI - Treatment Subscore DLQI1-Work and School Subscore Dermatology Life Quality Index - Work and school subscore. DLQI - Work and School Subscore DLQI1TN Dermatology Life Quality Index Questionnaire Test Name CDISC Questionnaire DLQI Test Name Terminology A terminology codelist based on the action taken with respect to the device. The act of checking or adjusting (by comparison with a standard) the accuracy of a measuring instrument. (NCI) Calibration The act of taking out, extracting, or withdrawing an entity from a location. Extraction The act of rewriting program code or application software. (NCI) Reprogram DEACNDEV Device Events Action Taken with Device CDISC SDTM Device Events Action Taken with Device Terminology A terminology codelist for the long name of the identifier characteristic of the device. Batch Identifier Batch Number A distinctive alpha-numeric identification code assigned by the manufacturer or distributor to a specific quantity of manufactured material or product that is produced in a manner that is expected to render it homogeneous. Batch Number Catalog Number A unique manufacturer-assigned identifier used to distinguish a specific product from others in a catalog of products offered. Catalog Number Device Type Generic category of medical device within the device classification established by a regulatory authority. Type of Device FDA Unique Device Identification A UDI is a unique numeric or alphanumeric code that includes a device identifier, which is specific to a device model, and a production identifier, which includes the current production information for that specific device, such as the lot or batch number, the serial number and/or expiration date. (FDA) FDA Unique Device Identifier Lot Identifier Lot Number A short sequence of characters assigned by the manufacturer or distributor to a specific quantity of manufactured material or product. Lot Number Manufacturer The organization defined as being responsible for creating the product as stated on the package in which the product is supplied. (BRIDG) Manufacturer Model Identifier Model Number The identifier assigned to a particular design of a device, usually an alphanumeric text string. Model Number Secure Lead Type The type of locking device used to securely fasten the electrical leads to the device. (NCI) Electrical Lead Locking Type Serial Number A unique identifier assigned to an individual object. Serial Number Sponsor Device Description The free-text description of the characteristics of a device provided by a sponsor. Sponsor Device Description Stereotactic Surgery Frame Type The classification of the cage structure used to immobilize the head or other body part in preparation for stereotactic surgery. (NCI) Stereotactic Surgery Frame Type Trade Name A commercial name granted by a naming authority for use in marketing a drug/device product. (CDISC Glossary) Proprietary Name DIPARM Device Identifier Long Name CDISC SDTM Device Identifier Parameter Long Name Terminology A terminology codelist for the short name of the identifier characteristic of the device. Batch Identifier Batch Number A distinctive alpha-numeric identification code assigned by the manufacturer or distributor to a specific quantity of manufactured material or product that is produced in a manner that is expected to render it homogeneous. Batch Number Catalog Number A unique manufacturer-assigned identifier used to distinguish a specific product from others in a catalog of products offered. Catalog Number Device Type Generic category of medical device within the device classification established by a regulatory authority. Type of Device FDA Unique Device Identification A UDI is a unique numeric or alphanumeric code that includes a device identifier, which is specific to a device model, and a production identifier, which includes the current production information for that specific device, such as the lot or batch number, the serial number and/or expiration date. (FDA) FDA Unique Device Identifier Lot Identifier Lot Number A short sequence of characters assigned by the manufacturer or distributor to a specific quantity of manufactured material or product. Lot Number Manufacturer The organization defined as being responsible for creating the product as stated on the package in which the product is supplied. (BRIDG) Manufacturer Model Identifier Model Number The identifier assigned to a particular design of a device, usually an alphanumeric text string. Model Number Secure Lead Type The type of locking device used to securely fasten the electrical leads to the device. (NCI) Electrical Lead Locking Type Serial Number A unique identifier assigned to an individual object. Serial Number Stereotactic Surgery Frame Type The classification of the cage structure used to immobilize the head or other body part in preparation for stereotactic surgery. (NCI) Stereotactic Surgery Frame Type Sponsor Device Description The free-text description of the characteristics of a device provided by a sponsor. Sponsor Device Description Trade Name A commercial name granted by a naming authority for use in marketing a drug/device product. (CDISC Glossary) Proprietary Name DIPARMCD Device Identifier Short Name CDISC SDTM Device Identifier Parameter Short Name Terminology A terminology codelist based on the test code used to obtain the device property. Number of Bulbs Number of Light Bulbs The total number of light bulbs associated with the entity. Number of Bulbs Composition The materials from which something is made. Composition Digital Sampling Rate The number of digital samples taken or recorded per unit of time. Digital Sampling Rate Dinucleotide Marker Names The literal identifier of the dinucleotide markers present in an assay kit. Dinucleotide Marker Name Device Output Blinding Status The blinding condition or state of the information generated and provided by a device. Device Data Blinded Status Electrical Current Sensor Type A description of the sensor used to detect electrical current. Type of Electrical Current Sensor FDA Device Classification The class of medical device as determined by the US Food and Drug Administration, based upon the level of control necessary to ensure safety and effectiveness (21 CFR 860). FDA Device Classification Indication for Use Trial Disease/Condition Indication Trial Disease/Condition Indication Description A narrative representation of the condition, disease or disorder that the clinical trial is intended to investigate or address. Trial Indication Internal Orifice Area The extent of a 2-dimensional surface enclosed within the boundary of an internal orifice. Internal Orifice Area Luminescence Type A classification of light emission. Luminescence Type Magnetic Field Strength A measurement of the force of magnetism that acts in the region around a magnetic material or a moving electrical charge. Magnetic Field Strength Mononucleotide Marker Names The literal identifier of the mononucleotide markers present in an assay kit. Mononucleotide Marker Name MRI Coil Type The classification of the coil that is used in an magnetic resonance imaging procedure. Usually refers to the anatomical location for where the coil is placed such as head, body or breast. MRI Coil Type Multiplex Probe Parameter A descriptor referring to the number of unique molecular probes contained in each assay component from which results are obtained, such as each well in a 96-well plate. Multiplex Probe Parameter Pentanucleotide Marker Names The literal identifier of the pentanucleotide markers present in an assay kit. Pentanucleotide Marker Name Pore Size A quantitative or qualitative measurement of the physical dimensions of the pores in a material. Material Pore Size Reagent Lot The lot number of the reagent. Reagent Lot Number Scintillation Crystal Type The classification of the crystalline material, which emits light in response to radiation exposure, used in the imaging procedure. Scintillation Crystal Type Section Thickness A measurement of the thickness of a sectioned slice (of tissue or mineral or other substance). Section Thickness Software Name The literal identifier of the software program. Software Name Software Version A form or variant of software; one of a sequence of copies of a software program, each incorporating new modifications. (NCI) Software Version Shelf Life The period during which a medical product retains its properties and stated performance within specified limits if stored under defined conditions. The stability period is determined from the date the product was manufactured. Medical Product Shelf Life Size The physical magnitude of something. (NCI) Size Surgical Mesh Open Area A quantitative or qualitative measurement of the physical dimensions of the open spaces in a loosely woven sheet of inorganic or biological materials, which is used to physically support organs or tissue during a surgical procedure. Surgical Mesh Open Area Temperature The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI) Temperature Thickness The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. Thickness Cp Number Crossing point Number Ct Ct Number Cycle Threshold Cycle Threshold # Cycle Threshold Number Elbow Value Take-off Point Number Threshold Cycle Threshold Cycle Number TOP Number The cycle number where the fluorescence of the target is detected above the background signal or a pre-set threshold. This value may be used for the computation of the concentration of a target in a polymerase chain reaction (PCR). Threshold Cycle Treatment Amount The concentration or quantity of the treatment. Treatment Amount Wavelength The distance (measured in the direction of propagation) between two points in the same phase in consecutive cycles of a wave. (NCI) Wavelength DOTESTCD Device Properties Test Code CDISC SDTM Device Properties Test Code Terminology A terminology codelist based on the test name used to obtain the device property. Composition The materials from which something is made. Composition Device Output Blinding Status The blinding condition or state of the information generated and provided by a device. Device Data Blinded Status Digital Sampling Rate The number of digital samples taken or recorded per unit of time. Digital Sampling Rate Dinucleotide Marker Names The literal identifier of the dinucleotide markers present in an assay kit. Dinucleotide Marker Name Electrical Current Sensor Type A description of the sensor used to detect electrical current. Type of Electrical Current Sensor FDA Device Classification The class of medical device as determined by the US Food and Drug Administration, based upon the level of control necessary to ensure safety and effectiveness (21 CFR 860). FDA Device Classification Indication for Use Trial Disease/Condition Indication Trial Disease/Condition Indication Description A narrative representation of the condition, disease or disorder that the clinical trial is intended to investigate or address. Trial Indication Internal Orifice Area The extent of a 2-dimensional surface enclosed within the boundary of an internal orifice. Internal Orifice Area Luminescence Type A classification of light emission. Luminescence Type Magnetic Field Strength A measurement of the force of magnetism that acts in the region around a magnetic material or a moving electrical charge. Magnetic Field Strength Mononucleotide Marker Names The literal identifier of the mononucleotide markers present in an assay kit. Mononucleotide Marker Name MRI Coil Type The classification of the coil that is used in an magnetic resonance imaging procedure. Usually refers to the anatomical location for where the coil is placed such as head, body or breast. MRI Coil Type Multiplex Probe Parameter A descriptor referring to the number of unique molecular probes contained in each assay component from which results are obtained, such as each well in a 96-well plate. Multiplex Probe Parameter Number of Bulbs Number of Light Bulbs The total number of light bulbs associated with the entity. Number of Bulbs Pentanucleotide Marker Names The literal identifier of the pentanucleotide markers present in an assay kit. Pentanucleotide Marker Name Pore Size A quantitative or qualitative measurement of the physical dimensions of the pores in a material. Material Pore Size Reagent Lot The lot number of the reagent. Reagent Lot Number Scintillation Crystal Type The classification of the crystalline material, which emits light in response to radiation exposure, used in the imaging procedure. Scintillation Crystal Type Section Thickness A measurement of the thickness of a sectioned slice (of tissue or mineral or other substance). Section Thickness Shelf Life The period during which a medical product retains its properties and stated performance within specified limits if stored under defined conditions. The stability period is determined from the date the product was manufactured. Medical Product Shelf Life Size The physical magnitude of something. (NCI) Size Software Name The literal identifier of the software program. Software Name Software Version A form or variant of software; one of a sequence of copies of a software program, each incorporating new modifications. (NCI) Software Version Surgical Mesh Open Area A quantitative or qualitative measurement of the physical dimensions of the open spaces in a loosely woven sheet of inorganic or biological materials, which is used to physically support organs or tissue during a surgical procedure. Surgical Mesh Open Area Temperature The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI) Temperature Thickness The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. Thickness Cp Number Crossing point Number Ct Ct Number Cycle Threshold Cycle Threshold # Cycle Threshold Number Elbow Value Take-off Point Number Threshold Cycle Threshold Cycle Number TOP Number The cycle number where the fluorescence of the target is detected above the background signal or a pre-set threshold. This value may be used for the computation of the concentration of a target in a polymerase chain reaction (PCR). Threshold Cycle Treatment Amount The concentration or quantity of the treatment. Treatment Amount Wavelength The distance (measured in the direction of propagation) between two points in the same phase in consecutive cycles of a wave. (NCI) Wavelength DOTEST Device Properties Test Name CDISC SDTM Device Properties Test Name Terminology A terminology codelist based on the standardized or preprinted name of the device tracking and disposition event that occurs. A status indicating that the entity is ready to be transported or conveyed back to a responsible party. Available For Return Harmed Impaired A status indicating that the entity has been physically altered or corrupted in a way that reduces its value, operation, usefulness, or reputation. Damage A status indicating that the entity has been positioned, put into use, and/or made available for operation. Deploy The act of demolishing an item to make it unusable or unanalyzable. Destruction A status indicating that the entity has been disposed of. Discarded A status indicating that the entity has been removed from a location on or in the body. Explantation A status indicating that the entity has been placed in a location on or in the body. Surgical Implantation A status indicating that an entity was placed for use but did not meet its intended goal and was removed. Intended But Not Used A status indicating that the entity is no longer held or possessed; incapable of being recovered or regained. Lost A status indicating that the entity comes into one's possession after conveyance from a sender. Receive A status indicating that the entity has been transported or conveyed back to a responsible party. Return Being transported or conveyed by an intermediary to a destination, from the sender to the intended receiver. Shipping DTDECOD Device Tracking and Disposition Event Dictionary Derived Term CDISC SDTM Device Tracking and Disposition Event Dictionary Derived Term Terminology A terminology codelist relevant to the device-in-use responses. An ultrasound imaging setting that uses a probe with two 2-dimensional (2D) planes set perpendicularly to each other, allowing for better detection and localization of objects/structures. 2-Dimensional Biplane Ultrasound Mode An ultrasound imaging setting that uses a linear pattern of beams to produce a standard, 2-dimensional (2-D) image. 2-Dimensional Single Plane Ultrasound Mode An ultrasound imaging setting that reconstructs planar ultrasound data into three dimensional images of the structure being scanned. 3-Dimensional Ultrasound Mode Color Flow Tissue Doppler Mode An ultrasound imaging setting that uses pulsed wave Doppler signals to depict tissue motion direction and velocity in color images that are superimposed over normal, 2-dimensional (2-D) images. Color Tissue Doppler Ultrasound Mode Continuous Doppler Mode CW Doppler An ultrasound imaging setting that uses Doppler signals that are continuously sent and received along a single line to measure both direction and velocity of blood flow. Continuous-Wave Doppler Ultrasound Mode Motion Mode An ultrasound imaging setting that uses a single ultrasound beam to provide high temporal resolution of tissue motion. M-Mode Ultrasound Mode Pulsed Doppler Mode PW Doppler An ultrasound imaging setting that uses intermittent Doppler signals to measure both direction and velocity of blood flow. Pulsed-Wave Doppler Ultrasound Mode Pulsed Tissue Doppler Mode An ultrasound imaging setting that uses pulsed wave Doppler signals to measure velocity of tissue movement. Pulsed-Wave Tissue Doppler Ultrasound Mode An ultrasound imaging setting that uses intermittent Doppler signals to measure velocity of tissue movement. Tissue Doppler Ultrasound Mode DURS Device-In-Use Response CDISC SDTM Device-In-Use Response Terminology A terminology codelist for the test code of the test or examination used to obtain the measurement or finding of the device in use. Anatomical Plane The position and orientation of the image slice relative to the patient-based coordinate system. (NCI) Image Plane Image Acquisition Matrix Size A measurement of the number of data fields, pixels or data points assigned to each linear dimension in a digital image. (NCI) Image Acquisition Matrix Size Attenuation Correction Type The adjustment for the effect of tissue thicknesses through which gamma's travel from an activity concentration origin to the scanner's detectors. The count rates of a detector are adjusted to values as if there were no attenuation along the gamma's path. This makes possible accurate quantitation in image analysis. (NCI) Attenuation Correction Continuous Audio Recording Indicator An indication as to whether a continuous audio recording is made during the assessment. Continuous Audio Recording Made Indicator Carbohydrate to Insulin Ratio Setting A setting on a device that specifies the ratio of the carbohydrates to insulin in the administered product. Carbohydrate to Insulin Ratio Device Setting Checkerboard Square Size A visual stimulus that uses a checkerboard pattern which reverses every half-second (or other specified frequency). The check size can be changed to allow for testing of specific segments of the visual pathway. Checkerboard Square Size Number of Coil Channels The number of channels, or elements, in the coil component of the device. Number of Coil Channels Coil Strength The maximum voltage allowable to pass through an electromagnetic coil. (NCI) Coil Strength Decay Correction Indicator An indication as to whether the image reconstruction took into account the time-activity curve during which the radiolabeled tracer decayed as it spread through the body during the image acquisition. Decay Correction Indicator Number of ECG Electrodes Number of EKG Electrodes Number of Electrocardiogram Electrodes The number of electrocardiogram electrodes used in the assessment. Number of Electrocardiogram Electrodes Echo Time The time in milliseconds between the application of the excitation pulse and the recording of the peak echo signal. (NCI) Echo Time Number of EEG Electrodes Number of Electroencephalogram Electrodes The number of electroencephalogram electrodes used in the assessment. Number of Electroencephalogram Electrodes Number of Electromyogram Electrodes Number of EMG Electrodes The number of electromyogram electrodes used in the assessment. Number of Electromyogram Electrodes Number of Electrooculogram Electrodes Number of EOG Electrodes The number of electrooculogram electrodes used in the assessment. Number of Electrooculogram Electrodes Field of View The extent of an area that is visible. (NCI) Field of View Flip Angle In magnetic resonance imaging, the rotation of the average axis of the protons, relative to the main magnetic field direction, induced by radiofrequency signals. (NCI) Flip Angle Glucose Alert Threshold A setting on a device that triggers the onset of an alarm when a pre-specified value of glucose level has been reached. Glucose Alert Threshold Glucose Target Level A setting on a device where one can set and adjust the target value of blood glucose level. Glucose Target Level Water Signal Suppression Method The technique used to mitigate the signal that is generated from body water during imaging. Water Signal Suppression Method Image Acquisition Dimensionality The number of dimensions that the acquired image(s) are presented in. Image Acquisition Dimensionality Image Weighting Type A classification of the technique used to enhance image contrast based on differences in magnetic resonance tissue properties. This can be achieved by changing the echo time or repetition time after the tissue has returned to its equilibrium state. Image Weighting Type Insulin Delivery Automation Mode The setting on a device that will allow the delivery of insulin to a subject, either automatically or manually, in response to the glucose levels within the subject. (NCI) Insulin Delivery Automation Mode Interslice Distance A measurement of the distance between slices within an image sequence, calculated by subtracting the nominal slice thickness from the couch increment. Interslice Distance Measurement Inversion Time The time between the inversion and excitation pulses in an inversion recovery pulse sequence. Inversion Time Max Bolus Maximum Bolus A setting and safety feature on a device to control the maximum amount of a substance delivered in a single bolus. Maximum Bolus Device Setting Missed Bolus Reminder Status The status of a setting that enables alerts if a bolus is not delivered during a pre-specified time period. (NCI) Missed Bolus Reminder Status Number of Slices The number of planar cross-sections in an imaging sequence; each slice corresponds to a single image. Number of Slices PEEP Setting Positive End Expiratory Pressure Setting A device setting that determines and regulates the amount of pressure delivered to the lungs to ensure alveolar pressure is above atmospheric pressure (i.e. positive pressure remains in the airways) at the end of exhalation. Positive End Expiratory Pressure Device Setting X-axis Pixel Spacing A measurement of the distance between the centers of two adjacent pixels located along the X-axis. Horizontal Pixel Spacing Y-axis Pixel Spacing A measurement of the distance between the centers of two adjacent pixels located along the Y-axis. Vertical Pixel Spacing Pressure Support Setting A device setting that regulates and provides a consistent inspiratory pressure to enable partially or fully supported spontaneous breaths in a subject. Pressure Support Device Setting Puff Block A device setting that determines and regulates the relative measurement (percentage) of the amount of filter vents that are blocked to total filter vents on an inhalational smoking device during a puff event. Puff Block Device Setting Puff Duration A device setting that determines and regulates the length of time over which an inhalational puff occurs. Puff Duration Device Setting Puff Interval A device setting that determines and regulates the number of inhalational puffs that can occur per unit of time. Puff Interval Device Setting Number of Puffs Total Number of Puffs A device setting that determines and regulates the total number of inhalational puffs taken. Number of Puffs Device Setting Puff Pause A device setting that determines and regulates the time of temporary cessation of inhalational puffs after the completion of a predetermined set of inhalational puffs. Puff Pause Device Setting Puff Pause Interval A device setting that determines and regulates the number of inhalational puffs that can be taken before a puff pause occurs. Puff Pause Interval Device Setting Puff Profile A device setting that determines and regulates the pattern describing a characteristic inhalational puffing behavior described by measures such as puff volume, duration, frequency, flow, and interpuff intervals. Puff Profile Device Setting Puff Range Puff Range of Sample Collection A device setting that determines and regulates the upper and lower limit of a range of puffs over which specimen or sample collection occurs. Puff Range Device Setting Puff Volume A device setting that determines and regulates the volume leaving the device and made available for each inhalation puff. Puff Volume Device Setting Pulse Oximeter Indicator An indication as to whether a pulse oximeter is used in the assessment. Pulse Oximeter Use Indicator Pulse Sequence A serially recurrent arrangement of radiofrequency pulses that are applied to the sample. (NCI) Pulse Sequence Randoms Correction Indicator An indication as to whether the device was set to correct for random noise generated by deflected positrons. Randoms Correction Indicator Receiver Bandwidth The range between the minimum and maximum cut-off frequencies for a particular receiver, commonly measured in Hertz. (NCI) Receiver Bandwidth Reconstruction Filter Type A classification of the reconstruction filter used to suppress noise, enhance edges, resolution recovery and smooth an image. Reconstruction Filter Type Reconstruction of Raw Data Type The type of mathematical process used to produce the displayed image from the raw k-space data obtained from the receiver circuitry. (NCI) Reconstruction of Raw Data Type Reference Equation A mathematical formula to predict measured outcomes based on values of associated parameters determined to be related to a test. Reference equations are typically derived via regression analysis of parameters postulated to be relevant to the outcome over sample cohorts from large populations, and verified by comparing measured outcomes to predictions over out-of-sample cohorts. Reference Equation Repetition Time The amount of time in milliseconds between successive pulse sequences applied to the same slice. Repetition Time Respiratory Rate Setting RR Setting A device setting that determines and regulates the rate of breathing (inhalation and exhalation) within a unit of time. Respiratory Rate Device Setting Software Version A form or variant of software; one of a sequence of copies of a software program, each incorporating new modifications. (NCI) Software Version Signal Amplitude A measurement of the height of the signal. Signal Amplitude Signal Frequency A measurement of the number of cycles of a periodic wave or pulse per unit of time. Signal Frequency Signal Width A measurement of the range of values seen in the time interval between the beginning and end of the pulse wave. Signal Width Slice Number The numeric identifier used to identify an image slice. (NCI) Slice Number Spectral Width The width of the wavelength interval at half maximum amplitude. Spectral Width STEAM Pulse Sequence Mixing Time Stimulated Echo Acquisition Mode Pulse Sequence Mixing Time The time elapsed between the second and third pulses of the stimulated echo acquisition mode (STEAM) pulse sequence. STEAM Pulse Sequence Mixing Time Slice Thickness The dimension between two surfaces of an imaging plane. (NCI) Image Slice Thickness Stimulation Parameter The type of electrode (monopolar or bipolar) used on the subject during electrical stimulation of the body or organ. Electrical Stimulation Electrode Type Treatment Amount The concentration or quantity of the treatment. Treatment Amount Tidal Volume Setting VT Setting A device setting that determines and regulates the volume of air delivered to the lungs per breath. Tidal Volume Device Setting Ultrasound Mode The image acquisition settings of an ultrasound-based imaging modality, based on parameters including transducer design, ultrasound frequency, and ultrasound signal processing. Ultrasound Mode Number of Unsuppressed Water Averages The number of averages of the unsuppressed water spectrum signal that are captured during imaging. Number of Unsuppressed Water Averages Mode of Ventilation Ventilator Mode The ventilatory settings that determine, either partially or fully, when the mechanical breaths are to be provided to a patient from a ventilator, and thusly determine the breathing pattern of the patient during mechanical ventilation. Ventilator Mode X-Axis Voxel Dimension The linear measurement of a voxel along the X-axis. X-Axis Voxel Dimension Y-Axis Voxel Dimension The linear measurement of a voxel along the Y-axis. Y-Axis Voxel Dimension Z-Axis Voxel Dimension The linear measurement of a voxel along the Z-axis. Z-Axis Voxel Dimension Voxel Angle Voxel Orientation The angle of the voxel relative to the coordinate system of the scanner. Voxel Orientation DUTESTCD Device-In-Use Test Code CDISC SDTM Device-In-Use Test Code Terminology A terminology codelist for the test name of the test or examination used to obtain the measurement or finding of the device in use. Anatomical Plane The position and orientation of the image slice relative to the patient-based coordinate system. (NCI) Image Plane Attenuation Correction Type The adjustment for the effect of tissue thicknesses through which gamma's travel from an activity concentration origin to the scanner's detectors. The count rates of a detector are adjusted to values as if there were no attenuation along the gamma's path. This makes possible accurate quantitation in image analysis. (NCI) Attenuation Correction Carbohydrate to Insulin Ratio Setting A setting on a device that specifies the ratio of the carbohydrates to insulin in the administered product. Carbohydrate to Insulin Ratio Device Setting Checkerboard Square Size A visual stimulus that uses a checkerboard pattern which reverses every half-second (or other specified frequency). The check size can be changed to allow for testing of specific segments of the visual pathway. Checkerboard Square Size Coil Strength The maximum voltage allowable to pass through an electromagnetic coil. (NCI) Coil Strength Continuous Audio Recording Indicator An indication as to whether a continuous audio recording is made during the assessment. Continuous Audio Recording Made Indicator Decay Correction Indicator An indication as to whether the image reconstruction took into account the time-activity curve during which the radiolabeled tracer decayed as it spread through the body during the image acquisition. Decay Correction Indicator Echo Time The time in milliseconds between the application of the excitation pulse and the recording of the peak echo signal. (NCI) Echo Time Field of View The extent of an area that is visible. (NCI) Field of View Flip Angle In magnetic resonance imaging, the rotation of the average axis of the protons, relative to the main magnetic field direction, induced by radiofrequency signals. (NCI) Flip Angle Glucose Alert Threshold A setting on a device that triggers the onset of an alarm when a pre-specified value of glucose level has been reached. Glucose Alert Threshold Glucose Target Level A setting on a device where one can set and adjust the target value of blood glucose level. Glucose Target Level Image Acquisition Dimensionality The number of dimensions that the acquired image(s) are presented in. Image Acquisition Dimensionality Image Acquisition Matrix Size A measurement of the number of data fields, pixels or data points assigned to each linear dimension in a digital image. (NCI) Image Acquisition Matrix Size Image Weighting Type A classification of the technique used to enhance image contrast based on differences in magnetic resonance tissue properties. This can be achieved by changing the echo time or repetition time after the tissue has returned to its equilibrium state. Image Weighting Type Insulin Delivery Automation Mode The setting on a device that will allow the delivery of insulin to a subject, either automatically or manually, in response to the glucose levels within the subject. (NCI) Insulin Delivery Automation Mode Interslice Distance A measurement of the distance between slices within an image sequence, calculated by subtracting the nominal slice thickness from the couch increment. Interslice Distance Measurement Inversion Time The time between the inversion and excitation pulses in an inversion recovery pulse sequence. Inversion Time Max Bolus Maximum Bolus A setting and safety feature on a device to control the maximum amount of a substance delivered in a single bolus. Maximum Bolus Device Setting Missed Bolus Reminder Status The status of a setting that enables alerts if a bolus is not delivered during a pre-specified time period. (NCI) Missed Bolus Reminder Status Number of Coil Channels The number of channels, or elements, in the coil component of the device. Number of Coil Channels Number of ECG Electrodes Number of EKG Electrodes Number of Electrocardiogram Electrodes The number of electrocardiogram electrodes used in the assessment. Number of Electrocardiogram Electrodes Number of EEG Electrodes Number of Electroencephalogram Electrodes The number of electroencephalogram electrodes used in the assessment. Number of Electroencephalogram Electrodes Number of Electromyogram Electrodes Number of EMG Electrodes The number of electromyogram electrodes used in the assessment. Number of Electromyogram Electrodes Number of Electrooculogram Electrodes Number of EOG Electrodes The number of electrooculogram electrodes used in the assessment. Number of Electrooculogram Electrodes Number of Puffs Total Number of Puffs A device setting that determines and regulates the total number of inhalational puffs taken. Number of Puffs Device Setting Number of Slices The number of planar cross-sections in an imaging sequence; each slice corresponds to a single image. Number of Slices Number of Unsuppressed Water Averages The number of averages of the unsuppressed water spectrum signal that are captured during imaging. Number of Unsuppressed Water Averages PEEP Setting Positive End Expiratory Pressure Setting A device setting that determines and regulates the amount of pressure delivered to the lungs to ensure alveolar pressure is above atmospheric pressure (i.e. positive pressure remains in the airways) at the end of exhalation. Positive End Expiratory Pressure Device Setting Pressure Support Setting A device setting that regulates and provides a consistent inspiratory pressure to enable partially or fully supported spontaneous breaths in a subject. Pressure Support Device Setting Puff Block A device setting that determines and regulates the relative measurement (percentage) of the amount of filter vents that are blocked to total filter vents on an inhalational smoking device during a puff event. Puff Block Device Setting Puff Duration A device setting that determines and regulates the length of time over which an inhalational puff occurs. Puff Duration Device Setting Puff Interval A device setting that determines and regulates the number of inhalational puffs that can occur per unit of time. Puff Interval Device Setting Puff Pause Interval A device setting that determines and regulates the number of inhalational puffs that can be taken before a puff pause occurs. Puff Pause Interval Device Setting Puff Pause A device setting that determines and regulates the time of temporary cessation of inhalational puffs after the completion of a predetermined set of inhalational puffs. Puff Pause Device Setting Puff Profile A device setting that determines and regulates the pattern describing a characteristic inhalational puffing behavior described by measures such as puff volume, duration, frequency, flow, and interpuff intervals. Puff Profile Device Setting Puff Range Puff Range of Sample Collection A device setting that determines and regulates the upper and lower limit of a range of puffs over which specimen or sample collection occurs. Puff Range Device Setting Puff Volume A device setting that determines and regulates the volume leaving the device and made available for each inhalation puff. Puff Volume Device Setting Pulse Oximeter Indicator An indication as to whether a pulse oximeter is used in the assessment. Pulse Oximeter Use Indicator Pulse Sequence A serially recurrent arrangement of radiofrequency pulses that are applied to the sample. (NCI) Pulse Sequence Randoms Correction Indicator An indication as to whether the device was set to correct for random noise generated by deflected positrons. Randoms Correction Indicator Receiver Bandwidth The range between the minimum and maximum cut-off frequencies for a particular receiver, commonly measured in Hertz. (NCI) Receiver Bandwidth Reconstruction Filter Type A classification of the reconstruction filter used to suppress noise, enhance edges, resolution recovery and smooth an image. Reconstruction Filter Type Reconstruction of Raw Data Type The type of mathematical process used to produce the displayed image from the raw k-space data obtained from the receiver circuitry. (NCI) Reconstruction of Raw Data Type Reference Equation A mathematical formula to predict measured outcomes based on values of associated parameters determined to be related to a test. Reference equations are typically derived via regression analysis of parameters postulated to be relevant to the outcome over sample cohorts from large populations, and verified by comparing measured outcomes to predictions over out-of-sample cohorts. Reference Equation Repetition Time The amount of time in milliseconds between successive pulse sequences applied to the same slice. Repetition Time Respiratory Rate Setting RR Setting A device setting that determines and regulates the rate of breathing (inhalation and exhalation) within a unit of time. Respiratory Rate Device Setting Signal Amplitude A measurement of the height of the signal. Signal Amplitude Signal Frequency A measurement of the number of cycles of a periodic wave or pulse per unit of time. Signal Frequency Signal Width A measurement of the range of values seen in the time interval between the beginning and end of the pulse wave. Signal Width Slice Number The numeric identifier used to identify an image slice. (NCI) Slice Number Slice Thickness The dimension between two surfaces of an imaging plane. (NCI) Image Slice Thickness Software Version A form or variant of software; one of a sequence of copies of a software program, each incorporating new modifications. (NCI) Software Version Spectral Width The width of the wavelength interval at half maximum amplitude. Spectral Width STEAM Pulse Sequence Mixing Time Stimulated Echo Acquisition Mode Pulse Sequence Mixing Time The time elapsed between the second and third pulses of the stimulated echo acquisition mode (STEAM) pulse sequence. STEAM Pulse Sequence Mixing Time Stimulation Parameter The type of electrode (monopolar or bipolar) used on the subject during electrical stimulation of the body or organ. Electrical Stimulation Electrode Type Tidal Volume Setting VT Setting A device setting that determines and regulates the volume of air delivered to the lungs per breath. Tidal Volume Device Setting Treatment Amount The concentration or quantity of the treatment. Treatment Amount Ultrasound Mode The image acquisition settings of an ultrasound-based imaging modality, based on parameters including transducer design, ultrasound frequency, and ultrasound signal processing. Ultrasound Mode Mode of Ventilation Ventilator Mode The ventilatory settings that determine, either partially or fully, when the mechanical breaths are to be provided to a patient from a ventilator, and thusly determine the breathing pattern of the patient during mechanical ventilation. Ventilator Mode Voxel Angle Voxel Orientation The angle of the voxel relative to the coordinate system of the scanner. Voxel Orientation Water Signal Suppression Method The technique used to mitigate the signal that is generated from body water during imaging. Water Signal Suppression Method X-axis Pixel Spacing A measurement of the distance between the centers of two adjacent pixels located along the X-axis. Horizontal Pixel Spacing X-Axis Voxel Dimension The linear measurement of a voxel along the X-axis. X-Axis Voxel Dimension Y-axis Pixel Spacing A measurement of the distance between the centers of two adjacent pixels located along the Y-axis. Vertical Pixel Spacing Y-Axis Voxel Dimension The linear measurement of a voxel along the Y-axis. Y-Axis Voxel Dimension Z-Axis Voxel Dimension The linear measurement of a voxel along the Z-axis. Z-Axis Voxel Dimension DUTEST Device-In-Use Test Name CDISC SDTM Device-In-Use Test Name Terminology Diabetes Distress Scale for Adults with Type 1 Diabetes test code. DDS01-Not Skilled at Managing Diabetes Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I am not as skilled at managing diabetes as I should be. T1-DDS - Not Skilled at Managing Diabetes DDS01-I Don't Eat Carefully as I Should Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I don't eat as carefully as I probably should. T1-DDS - I Don't Eat Carefully as I Should DDS01-Don't Notice Signs of Hypoglycemia Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I don't notice the warning signs of hypoglycemia as well as I used to. T1-DDS - Don't Notice Signs of Hypoglycemia DDS01-People Treat Me Differently Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that people treat me differently when they find out I have diabetes. T1-DDS - People Treat Me Differently DDS01-Discouraged See High Blood Glucose Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling discouraged when I see high blood glucose numbers that I can't explain. T1-DDS - Discouraged See High Blood Glucose DDS01-Family Make Bigger Deal Diabetes Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that my family and friends make a bigger deal out of diabetes than they should. T1-DDS - Family Make Bigger Deal Diabetes DDS01-Can't Tell Doctor What on My Mind Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I can't tell my diabetes doctor what is really on my mind. T1-DDS - Can't Tell Doctor What on My Mind DDS01-Not Taking Insulin as I Should Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I am not taking as much insulin as I should. T1-DDS - Not Taking Insulin as I Should DDS01-Too Much Diabetes Equipment w/Me Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that there is too much diabetes equipment and stuff I must always have with me. T1-DDS - Too Much Diabetes Equipment With Me DDS01-Have to Hide My Diabetes Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling like I have to hide my diabetes from other people. T1-DDS - Have to Hide My Diabetes DDS01-Family Worry About Hypoglycemia Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that my friends and family worry more about hypoglycemia than I want them to. T1-DDS - Family Worry About Hypoglycemia DDS01-Don't Check Glucose as I Should Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I don't check my blood glucose level as often as I probably should. T1-DDS - Don't Check Glucose as I Should DDS01-Worried Develop Complications Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling worried that I will develop serious long-term complications, no matter how hard I try. T1-DDS - Worried Develop Complications DDS01-Don't Get Help From Doctor Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I don't get help I really need from my diabetes doctor about managing diabetes. T1-DDS - Don't Get Help From Doctor DDS01-Hypoglycemic Event When Asleep Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling frightened that I could have a serious hypoglycemic event when I'm asleep. T1-DDS - Hypoglycemic Event When Asleep DDS01-Food and Eating Control My Life Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that thoughts about food and eating control my life. T1-DDS - Food and Eating Control My Life DDS01-Family Treat Me More Fragile Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that my friends or family treat me as if I were more fragile or sicker than I really am. T1-DDS - Family Treat Me More Fragile DDS01-Doctor Doesn't Understand Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that my diabetes doctor doesn't really understand what it's like to have diabetes. T1-DDS - Doctor Doesn't Understand DDS01-Less Attractive to Employers Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling concerned that diabetes may make me less attractive to employers. T1-DDS - Less Attractive to Employers DDS01-Family Act Like Diabetes Police Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that my friends or family act like 'diabetes police' (bother me too much). T1-DDS - Family Act Like Diabetes Police DDS01-Be Perfect w/Diabetes Management Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I've got to be perfect with my diabetes management. T1-DDS - Be Perfect With Diabetes Management DDS01-Hypoglycemic Event While Driving Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling frightened that I could have a serious hypoglycemic event while driving. T1-DDS - Hypoglycemic Event While Driving DDS01-Eating Is Out of Control Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that my eating is out of control. T1-DDS - Eating Is Out of Control DDS01-People Think Less of Me Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that people will think less of me if they knew I had diabetes. T1-DDS - People Think Less of Me DDS01-Never Be Good Enough Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that no matter how hard I try with my diabetes, it will never be good enough. T1-DDS - Never Be Good Enough DDS01-Doctor Doesn't Know Enough Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that my diabetes doctor doesn't know enough about diabetes and diabetes care. T1-DDS - Doctor Doesn't Know Enough DDS01-Be Safe From Hypoglycemic Event Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I can't ever be safe from the possibility of a serious hypoglycemic event. T1-DDS - Be Safe From Hypoglycemic Event DDS01-Don't Give Diabetes Attention Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I don't give my diabetes as much attention as I probably should. T1-DDS - Don't Give Diabetes Attention DDS01-Total Scale Diabetes Distress Scale for Adults with Type 1 Diabetes - Total scale. T1-DDS - Total Scale DDS01-Subscale 1: Powerlessness Diabetes Distress Scale for Adults with Type 1 Diabetes - Subscale 1 - Powerlessness. T1-DDS - Subscale 1: Powerlessness DDS01-Subscale 2: Management Distress Diabetes Distress Scale for Adults with Type 1 Diabetes - Subscale 2 - Management distress. T1-DDS - Subscale 2: Management Distress DDS01-Subscale 3: Hypoglycemia Distress Diabetes Distress Scale for Adults with Type 1 Diabetes - Subscale 3 - Hypoglycemia distress. T1-DDS - Subscale 3: Hypoglycemia Distress DDS01-Subscale 4: Neg Social Perceptions Diabetes Distress Scale for Adults with Type 1 Diabetes - Subscale 4 - Negative social perceptions. T1-DDS - Subscale 4: Negative Social Perceptions DDS01-Subscale 5: Eating Distress Diabetes Distress Scale for Adults with Type 1 Diabetes - Subscale 5 - Eating distress. T1-DDS - Subscale 5: Eating Distress DDS01-Subscale 6: Physician Distress Diabetes Distress Scale for Adults with Type 1 Diabetes - Subscale 6 - Physician distress. T1-DDS - Subscale 6: Physician Distress DDS01-Subscale 7: Friend/Family Distress Diabetes Distress Scale for Adults with Type 1 Diabetes - Subscale 7 - Friend/family distress. T1-DDS - Subscale 7: Friend/Family Distress DDS01TC Diabetes Distress Scale for Adults with Type 1 Diabetes Questionnaire Test Code CDISC Questionnaire T1-DDS Test Code Terminology Diabetes Distress Scale for Adults with Type 1 Diabetes test name. DDS01-Be Perfect w/Diabetes Management Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I've got to be perfect with my diabetes management. T1-DDS - Be Perfect With Diabetes Management DDS01-Be Safe From Hypoglycemic Event Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I can't ever be safe from the possibility of a serious hypoglycemic event. T1-DDS - Be Safe From Hypoglycemic Event DDS01-Can't Tell Doctor What on My Mind Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I can't tell my diabetes doctor what is really on my mind. T1-DDS - Can't Tell Doctor What on My Mind DDS01-Discouraged See High Blood Glucose Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling discouraged when I see high blood glucose numbers that I can't explain. T1-DDS - Discouraged See High Blood Glucose DDS01-Doctor Doesn't Know Enough Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that my diabetes doctor doesn't know enough about diabetes and diabetes care. T1-DDS - Doctor Doesn't Know Enough DDS01-Doctor Doesn't Understand Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that my diabetes doctor doesn't really understand what it's like to have diabetes. T1-DDS - Doctor Doesn't Understand DDS01-Don't Check Glucose as I Should Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I don't check my blood glucose level as often as I probably should. T1-DDS - Don't Check Glucose as I Should DDS01-Don't Get Help From Doctor Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I don't get help I really need from my diabetes doctor about managing diabetes. T1-DDS - Don't Get Help From Doctor DDS01-Don't Give Diabetes Attention Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I don't give my diabetes as much attention as I probably should. T1-DDS - Don't Give Diabetes Attention DDS01-Don't Notice Signs of Hypoglycemia Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I don't notice the warning signs of hypoglycemia as well as I used to. T1-DDS - Don't Notice Signs of Hypoglycemia DDS01-Eating Is Out of Control Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that my eating is out of control. T1-DDS - Eating Is Out of Control DDS01-Family Act Like Diabetes Police Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that my friends or family act like 'diabetes police' (bother me too much). T1-DDS - Family Act Like Diabetes Police DDS01-Family Make Bigger Deal Diabetes Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that my family and friends make a bigger deal out of diabetes than they should. T1-DDS - Family Make Bigger Deal Diabetes DDS01-Family Treat Me More Fragile Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that my friends or family treat me as if I were more fragile or sicker than I really am. T1-DDS - Family Treat Me More Fragile DDS01-Family Worry About Hypoglycemia Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that my friends and family worry more about hypoglycemia than I want them to. T1-DDS - Family Worry About Hypoglycemia DDS01-Food and Eating Control My Life Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that thoughts about food and eating control my life. T1-DDS - Food and Eating Control My Life DDS01-Have to Hide My Diabetes Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling like I have to hide my diabetes from other people. T1-DDS - Have to Hide My Diabetes DDS01-Hypoglycemic Event When Asleep Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling frightened that I could have a serious hypoglycemic event when I'm asleep. T1-DDS - Hypoglycemic Event When Asleep DDS01-Hypoglycemic Event While Driving Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling frightened that I could have a serious hypoglycemic event while driving. T1-DDS - Hypoglycemic Event While Driving DDS01-I Don't Eat Carefully as I Should Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I don't eat as carefully as I probably should. T1-DDS - I Don't Eat Carefully as I Should DDS01-Less Attractive to Employers Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling concerned that diabetes may make me less attractive to employers. T1-DDS - Less Attractive to Employers DDS01-Never Be Good Enough Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that no matter how hard I try with my diabetes, it will never be good enough. T1-DDS - Never Be Good Enough DDS01-Not Skilled at Managing Diabetes Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I am not as skilled at managing diabetes as I should be. T1-DDS - Not Skilled at Managing Diabetes DDS01-Not Taking Insulin as I Should Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I am not taking as much insulin as I should. T1-DDS - Not Taking Insulin as I Should DDS01-People Think Less of Me Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that people will think less of me if they knew I had diabetes. T1-DDS - People Think Less of Me DDS01-People Treat Me Differently Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that people treat me differently when they find out I have diabetes. T1-DDS - People Treat Me Differently DDS01-Subscale 1: Powerlessness Diabetes Distress Scale for Adults with Type 1 Diabetes - Subscale 1 - Powerlessness. T1-DDS - Subscale 1: Powerlessness DDS01-Subscale 2: Management Distress Diabetes Distress Scale for Adults with Type 1 Diabetes - Subscale 2 - Management distress. T1-DDS - Subscale 2: Management Distress DDS01-Subscale 3: Hypoglycemia Distress Diabetes Distress Scale for Adults with Type 1 Diabetes - Subscale 3 - Hypoglycemia distress. T1-DDS - Subscale 3: Hypoglycemia Distress DDS01-Subscale 4: Neg Social Perceptions Diabetes Distress Scale for Adults with Type 1 Diabetes - Subscale 4 - Negative social perceptions. T1-DDS - Subscale 4: Negative Social Perceptions DDS01-Subscale 5: Eating Distress Diabetes Distress Scale for Adults with Type 1 Diabetes - Subscale 5 - Eating distress. T1-DDS - Subscale 5: Eating Distress DDS01-Subscale 6: Physician Distress Diabetes Distress Scale for Adults with Type 1 Diabetes - Subscale 6 - Physician distress. T1-DDS - Subscale 6: Physician Distress DDS01-Subscale 7: Friend/Family Distress Diabetes Distress Scale for Adults with Type 1 Diabetes - Subscale 7 - Friend/family distress. T1-DDS - Subscale 7: Friend/Family Distress DDS01-Too Much Diabetes Equipment w/Me Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that there is too much diabetes equipment and stuff I must always have with me. T1-DDS - Too Much Diabetes Equipment With Me DDS01-Total Scale Diabetes Distress Scale for Adults with Type 1 Diabetes - Total scale. T1-DDS - Total Scale DDS01-Worried Develop Complications Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling worried that I will develop serious long-term complications, no matter how hard I try. T1-DDS - Worried Develop Complications DDS01TN Diabetes Distress Scale for Adults with Type 1 Diabetes Questionnaire Test Name CDISC Questionnaire T1-DDS Test Name Terminology Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes test code. DDS02-Don't Work Well Together Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling that my teen and I just don't work well together when it comes to diabetes. PARENT-DDS - Don't Work Well Together DDS02-Unappreciated for Ways I Help Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling unappreciated for all the ways I try to help my teen manage diabetes. PARENT-DDS - Unappreciated for Ways I Help DDS02-Trust Teen Take Care of Diabetes Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling that I can't trust my teen to take good care of his/her diabetes. PARENT-DDS - Trust Teen Take Care of Diabetes DDS02-Low Blood Sugars Away From Home Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying about my teen's low blood sugars when he/she is away from home. PARENT-DDS - Low Blood Sugars Away From Home DDS02-Teen Ignore/Forget Diabetes Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying that my teen will ignore or forget diabetes if I don't keep reminding him/her. PARENT-DDS - Teen Ignore or Forget Diabetes DDS02-Taking Too Much of My Energy Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling that diabetes is taking up too much of my mental and physical energy every day. PARENT-DDS - Taking Too Much of My Energy DDS02-Help Teen Is a Battle Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling that trying to help my teen with his/her diabetes is always a battle. PARENT-DDS - Help Teen Is a Battle DDS02-Low Blood Sugars When Sleeping Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying about my teen's low blood sugars when he/she is sleeping. PARENT-DDS - Low Blood Sugars When Sleeping DDS02-No One Notices Diabetes Hard on Me Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling that no one notices that diabetes is hard on me, not just on my teen. PARENT-DDS - No One Notices Diabetes Hard on Me DDS02-Doesn't Do Enough Manage Diabetes Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling that my teen doesn't do enough to manage his/her diabetes. PARENT-DDS - Doesn't Do Enough Manage Diabetes DDS02-Teen Doesn't Have Right Doctor Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying that my teen doesn't have the right doctor for him/her. PARENT-DDS - Teen Doesn't Have Right Doctor DDS02-Blame Me If Not Well-controlled Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying that others will blame me if my teen's diabetes is not well-controlled. PARENT-DDS - Blame Me If Not Well-controlled DDS02-Leave Home and Cannot Protect Him Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying that my teen will soon leave home and I cannot protect him. PARENT-DDS - Leave Home and Cannot Protect Him DDS02-Teen Ignores My Suggestions Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Frustrated because my teen ignores my suggestions about diabetes. PARENT-DDS - Teen Ignores My Suggestions DDS02-Lack Support From Friends/Family Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Frustrated by the lack of understanding and support for diabetes I get from friends and family members. PARENT-DDS - Lack Support From Friends and Family DDS02-Doesn't Get Expert Medical Help Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying that my teen doesn't get all of the expert medical help he/she needs. PARENT-DDS - Doesn't Get Expert Medical Help DDS02-Motivate Teen Take Care Diabetes Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling uncertain about how to motivate my teen to take better care of his/her diabetes. PARENT-DDS - Motivate Teen Take Care Diabetes DDS02-Teen Not Prepared Once Adult Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Concerned that my teen is not prepared to deal with the world of insurance and doctors once he/she is an adult. PARENT-DDS - Teen Not Prepared Once Adult DDS02-Only One Takes Responsibility Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Frustrated that I am the only one who takes responsibility for helping my teen manage diabetes. PARENT-DDS - Only One Takes Responsibility DDS02-My Nagging Hurting Relationship Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying that my nagging about diabetes is hurting my relationship with my teen. PARENT-DDS - My Nagging Hurting Relationship DDS02-Total DDS Score: Sum Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Total DDS score: Sum of 20 item scores. PARENT-DDS - Total DDS Score: Sum DDS02-Total DDS Score: Mean Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Total DDS score: Mean item score. PARENT-DDS - Total DDS Score: Mean DDS02-Total DDS Score: Moderate Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Total DDS score: Moderate distress or greater? (mean score > 2). PARENT-DDS - Total DDS Score: Moderate DDS02-Personal Distress: Sum Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Personal distress: Sum of 6 items (2, 6, 9, 12, 15, 19). PARENT-DDS - Personal Distress: Sum DDS02-Personal Distress: Mean Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Personal distress: Mean item score. PARENT-DDS - Personal Distress: Mean DDS02-Personal Distress: Moderate Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Personal distress: Moderate distress or greater? (mean score > 2). PARENT-DDS - Personal Distress: Moderate DDS02-Teen Management Distress: Sum Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Teen management distress: Sum of 4 items (4, 8, 13, 18). PARENT-DDS - Teen Management Distress: Sum DDS02-Teen Management Distress: Mean Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Teen management distress: Mean item score. PARENT-DDS - Teen Management Distress: Mean DDS02-Teen Management Distress: Moderate Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Teen management distress: Moderate distress or greater? (mean score > 2). PARENT-DDS - Teen Management Distress: Moderate DDS02-Parent/Teen Rel Distress: Sum Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Parent/teen relationship distress: Sum of 8 items (1, 3, 5, 7, 10, 14, 17, 20). PARENT-DDS - Parent/Teen Relationship Distress: Sum DDS02-Parent/Teen Rel Distress: Mean Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Parent/teen relationship distress: Mean item score. PARENT-DDS - Parent/Teen Relationship Distress: Mean DDS02-Parent/Teen Rel Distress: Moderate Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Parent/teen relationship distress: Moderate distress or greater? (mean score > 2). PARENT-DDS - Parent/Teen Relationship Distress: Moderate DDS02-Healthcare Team Distress: Sum Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Healthcare team distress: Sum of 2 items (11, 16). PARENT-DDS - Healthcare Team Distress: Sum DDS02-Healthcare Team Distress: Mean Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Healthcare team distress: Mean item score. PARENT-DDS - Healthcare Team Distress: Mean DDS02-Healthcare Team Distress: Moderate Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Healthcare team distress: Moderate distress or greater? (mean score > 2). PARENT-DDS - Healthcare Team Distress: Moderate DDS02TC Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes Questionnaire Test Code CDISC Questionnaire PARENT-DDS Test Code Terminology Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes test name. DDS02-Blame Me If Not Well-controlled Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying that others will blame me if my teen's diabetes is not well-controlled. PARENT-DDS - Blame Me If Not Well-controlled DDS02-Doesn't Do Enough Manage Diabetes Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling that my teen doesn't do enough to manage his/her diabetes. PARENT-DDS - Doesn't Do Enough Manage Diabetes DDS02-Doesn't Get Expert Medical Help Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying that my teen doesn't get all of the expert medical help he/she needs. PARENT-DDS - Doesn't Get Expert Medical Help DDS02-Don't Work Well Together Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling that my teen and I just don't work well together when it comes to diabetes. PARENT-DDS - Don't Work Well Together DDS02-Healthcare Team Distress: Mean Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Healthcare team distress: Mean item score. PARENT-DDS - Healthcare Team Distress: Mean DDS02-Healthcare Team Distress: Moderate Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Healthcare team distress: Moderate distress or greater? (mean score > 2). PARENT-DDS - Healthcare Team Distress: Moderate DDS02-Healthcare Team Distress: Sum Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Healthcare team distress: Sum of 2 items (11, 16). PARENT-DDS - Healthcare Team Distress: Sum DDS02-Help Teen Is a Battle Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling that trying to help my teen with his/her diabetes is always a battle. PARENT-DDS - Help Teen Is a Battle DDS02-Lack Support From Friends/Family Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Frustrated by the lack of understanding and support for diabetes I get from friends and family members. PARENT-DDS - Lack Support From Friends and Family DDS02-Leave Home and Cannot Protect Him Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying that my teen will soon leave home and I cannot protect him. PARENT-DDS - Leave Home and Cannot Protect Him DDS02-Low Blood Sugars Away From Home Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying about my teen's low blood sugars when he/she is away from home. PARENT-DDS - Low Blood Sugars Away From Home DDS02-Low Blood Sugars When Sleeping Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying about my teen's low blood sugars when he/she is sleeping. PARENT-DDS - Low Blood Sugars When Sleeping DDS02-Motivate Teen Take Care Diabetes Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling uncertain about how to motivate my teen to take better care of his/her diabetes. PARENT-DDS - Motivate Teen Take Care Diabetes DDS02-My Nagging Hurting Relationship Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying that my nagging about diabetes is hurting my relationship with my teen. PARENT-DDS - My Nagging Hurting Relationship DDS02-No One Notices Diabetes Hard on Me Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling that no one notices that diabetes is hard on me, not just on my teen. PARENT-DDS - No One Notices Diabetes Hard on Me DDS02-Only One Takes Responsibility Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Frustrated that I am the only one who takes responsibility for helping my teen manage diabetes. PARENT-DDS - Only One Takes Responsibility DDS02-Parent/Teen Rel Distress: Mean Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Parent/teen relationship distress: Mean item score. PARENT-DDS - Parent/Teen Relationship Distress: Mean DDS02-Parent/Teen Rel Distress: Moderate Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Parent/teen relationship distress: Moderate distress or greater? (mean score > 2). PARENT-DDS - Parent/Teen Relationship Distress: Moderate DDS02-Parent/Teen Rel Distress: Sum Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Parent/teen relationship distress: Sum of 8 items (1, 3, 5, 7, 10, 14, 17, 20). PARENT-DDS - Parent/Teen Relationship Distress: Sum DDS02-Personal Distress: Mean Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Personal distress: Mean item score. PARENT-DDS - Personal Distress: Mean DDS02-Personal Distress: Moderate Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Personal distress: Moderate distress or greater? (mean score > 2). PARENT-DDS - Personal Distress: Moderate DDS02-Personal Distress: Sum Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Personal distress: Sum of 6 items (2, 6, 9, 12, 15, 19). PARENT-DDS - Personal Distress: Sum DDS02-Taking Too Much of My Energy Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling that diabetes is taking up too much of my mental and physical energy every day. PARENT-DDS - Taking Too Much of My Energy DDS02-Teen Doesn't Have Right Doctor Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying that my teen doesn't have the right doctor for him/her. PARENT-DDS - Teen Doesn't Have Right Doctor DDS02-Teen Ignore/Forget Diabetes Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying that my teen will ignore or forget diabetes if I don't keep reminding him/her. PARENT-DDS - Teen Ignore or Forget Diabetes DDS02-Teen Ignores My Suggestions Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Frustrated because my teen ignores my suggestions about diabetes. PARENT-DDS - Teen Ignores My Suggestions DDS02-Teen Management Distress: Mean Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Teen management distress: Mean item score. PARENT-DDS - Teen Management Distress: Mean DDS02-Teen Management Distress: Moderate Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Teen management distress: Moderate distress or greater? (mean score > 2). PARENT-DDS - Teen Management Distress: Moderate DDS02-Teen Management Distress: Sum Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Teen management distress: Sum of 4 items (4, 8, 13, 18). PARENT-DDS - Teen Management Distress: Sum DDS02-Teen Not Prepared Once Adult Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Concerned that my teen is not prepared to deal with the world of insurance and doctors once he/she is an adult. PARENT-DDS - Teen Not Prepared Once Adult DDS02-Total DDS Score: Mean Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Total DDS score: Mean item score. PARENT-DDS - Total DDS Score: Mean DDS02-Total DDS Score: Moderate Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Total DDS score: Moderate distress or greater? (mean score > 2). PARENT-DDS - Total DDS Score: Moderate DDS02-Total DDS Score: Sum Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Total DDS score: Sum of 20 item scores. PARENT-DDS - Total DDS Score: Sum DDS02-Trust Teen Take Care of Diabetes Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling that I can't trust my teen to take good care of his/her diabetes. PARENT-DDS - Trust Teen Take Care of Diabetes DDS02-Unappreciated for Ways I Help Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling unappreciated for all the ways I try to help my teen manage diabetes. PARENT-DDS - Unappreciated for Ways I Help DDS02TN Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes Questionnaire Test Name CDISC Questionnaire PARENT-DDS Test Name Terminology Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes test code. DDS03-Worry About Low Blood Sugars Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Worrying about my partner's low blood sugars. PARTNER-DDS - Worry About Low Blood Sugars DDS03-How Involved Managing Diabetes Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling unclear about exactly how much I should be involved in managing my partner's diabetes. PARTNER-DDS - How Involved Managing Diabetes DDS03-Partner Shuts Me Out Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Frustrated that my partner shuts me out of his/her diabetes. PARTNER-DDS - Partner Shuts Me Out DDS03-Partner Doesn't Try Hard Enough Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling that my partner doesn't try hard enough to manage his/her diabetes. PARTNER-DDS - Partner Doesn't Try Hard Enough DDS03-Overwhelmed by Constant Demands Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling overwhelmed by the constant demands of my partner's diabetes. PARTNER-DDS - Overwhelmed by Constant Demands DDS03-How to Best Help Partner Manage Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Worrying that don't know how to best help my partner manage diabetes. PARTNER-DDS - How to Best Help Partner Manage DDS03-Silent About My Partner's Diabetes Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling that I stay silent about my partner's diabetes more than I really should. PARTNER-DDS - Silent About My Partner's Diabetes DDS03-Taking Too Much of My Energy Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling that diabetes is taking up too much of my mental and physical energy every day. PARTNER-DDS - Taking Too Much of My Energy DDS03-No One Notices Diabetes Hard On Me Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling that no one notices that diabetes is hard on me, not just on my partner. PARTNER-DDS - No One Notices Diabetes Hard On Me DDS03-More I Try The Worse Things Get Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Frustrated that the more I try to help my partner manage his/her diabetes, the worse things get between us. PARTNER-DDS - More I Try The Worse Things Get DDS03-Guilty Not Doing Enough to Help Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling guilty about not doing enough to help my partner with diabetes. PARTNER-DDS - Guilty Not Doing Enough to Help DDS03-Can't Get Partner Improve Attitude Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Frustrated that I can't get my partner to improve his/her attitude about diabetes. PARTNER-DDS - Can't Get Partner Improve Attitude DDS03-Failing to Help Partner Manage Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Worrying that I am failing to help my partner manage diabetes more successfully. PARTNER-DDS - Failing to Help Partner Manage DDS03-Help My Partner Always a Battle Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling that trying to help my partner with his/her diabetes is always a battle. PARTNER-DDS - Help My Partner Always a Battle DDS03-Partner Ignores My Suggestions Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Frustrated because my partner ignores my suggestions about diabetes. PARTNER-DDS - Partner Ignores My Suggestions DDS03-Diabetes Often Interrupts Plans Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Frustrated that diabetes often interrupts our plans. PARTNER-DDS - Diabetes Often Interrupts Plans DDS03-Low Blood Sugars When Sleeping Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Worrying about my partner's low blood sugars when he/she is sleeping. PARTNER-DDS - Low Blood Sugars When Sleeping DDS03-Partner Driving Low Blood Sugars Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Worrying about my partner's driving because of possible low blood sugars. PARTNER-DDS - Partner Driving Low Blood Sugars DDS03-Leaving Alone Low Blood Sugars Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Worrying about leaving my partner alone because of the possible danger of low blood sugars. PARTNER-DDS - Leaving Alone Low Blood Sugars DDS03-Not Working Well Together Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Concerned that my partner and I are not working well together when it comes to diabetes. PARTNER-DDS - Not Working Well Together DDS03-Never Get a Break From Worrying Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling that I never get a break from worrying about my partner's diabetes. PARTNER-DDS - Never Get a Break From Worrying DDS03-Total DDS Score: Sum Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Total DDS score: Sum of 21 item scores. PARTNER-DDS - Total DDS Score: Sum DDS03-Total DDS Score: Mean Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Total DDS score: Mean item score. PARTNER-DDS - Total DDS Score: Mean DDS03-Total DDS Score: Moderate Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Total DDS score: Moderate distress or greater? (mean score > 2). PARTNER-DDS - Total DDS Score: Moderate DDS03-Partner Diabetes Management: Sum Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - My partner's diabetes management: Sum of 7 items (3, 4, 10, 12, 14, 15, 20). PARTNER-DDS - Partner Diabetes Management: Sum DDS03-Partner Diabetes Management: Mean Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - My partner's diabetes management: Mean item score. PARTNER-DDS - Partner Diabetes Management: Mean DDS03-Partner Diabetes Manage: Moderate Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - My partner's diabetes management: Moderate distress or greater? (mean score > 2). PARTNER-DDS - Partner Diabetes Manage: Moderate DDS03-How Best to Help: Sum Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - How best to help: Sum of 5 items (2, 6, 7, 11, 13). PARTNER-DDS - How Best to Help: Sum DDS03-How Best to Help: Mean Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - How best to help: Mean item score. PARTNER-DDS - How Best to Help: Mean DDS03-How Best to Help: Moderate Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - How best to help: Moderate distress or greater? (mean score > 2). PARTNER-DDS - How Best to Help: Moderate DDS03-Diabetes and Me: Sum Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Diabetes and me: Sum of 5 items (5, 8, 9, 16, 21). PARTNER-DDS - Diabetes and Me: Sum DDS03-Diabetes and Me: Mean Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Diabetes and me: Mean item score. PARTNER-DDS - Diabetes and Me: Mean DDS03-Diabetes and Me: Moderate Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Diabetes and me: Moderate distress or greater? (mean score > 2). PARTNER-DDS - Diabetes and Me: Moderate DDS03-Hypoglycemia: Sum Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Hypoglycemia: Sum of 4 items (1, 17, 18, 19). PARTNER-DDS - Hypoglycemia: Sum DDS03-Hypoglycemia: Mean Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Hypoglycemia: Mean item score. PARTNER-DDS - Hypoglycemia: Mean DDS03-Hypoglycemia: Moderate Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Hypoglycemia: Moderate distress or greater? (mean score > 2). PARTNER-DDS - Hypoglycemia: Moderate DDS03TC Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes Questionnaire Test Code CDISC Questionnaire PARTNER-DDS Test Code Terminology Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes test name. DDS03-Can't Get Partner Improve Attitude Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Frustrated that I can't get my partner to improve his/her attitude about diabetes. PARTNER-DDS - Can't Get Partner Improve Attitude DDS03-Diabetes and Me: Mean Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Diabetes and me: Mean item score. PARTNER-DDS - Diabetes and Me: Mean DDS03-Diabetes and Me: Moderate Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Diabetes and me: Moderate distress or greater? (mean score > 2). PARTNER-DDS - Diabetes and Me: Moderate DDS03-Diabetes and Me: Sum Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Diabetes and me: Sum of 5 items (5, 8, 9, 16, 21). PARTNER-DDS - Diabetes and Me: Sum DDS03-Diabetes Often Interrupts Plans Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Frustrated that diabetes often interrupts our plans. PARTNER-DDS - Diabetes Often Interrupts Plans DDS03-Failing to Help Partner Manage Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Worrying that I am failing to help my partner manage diabetes more successfully. PARTNER-DDS - Failing to Help Partner Manage DDS03-Guilty Not Doing Enough to Help Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling guilty about not doing enough to help my partner with diabetes. PARTNER-DDS - Guilty Not Doing Enough to Help DDS03-Help My Partner Always a Battle Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling that trying to help my partner with his/her diabetes is always a battle. PARTNER-DDS - Help My Partner Always a Battle DDS03-How Best to Help: Mean Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - How best to help: Mean item score. PARTNER-DDS - How Best to Help: Mean DDS03-How Best to Help: Moderate Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - How best to help: Moderate distress or greater? (mean score > 2). PARTNER-DDS - How Best to Help: Moderate DDS03-How Best to Help: Sum Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - How best to help: Sum of 5 items (2, 6, 7, 11, 13). PARTNER-DDS - How Best to Help: Sum DDS03-How Involved Managing Diabetes Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling unclear about exactly how much I should be involved in managing my partner's diabetes. PARTNER-DDS - How Involved Managing Diabetes DDS03-How to Best Help Partner Manage Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Worrying that don't know how to best help my partner manage diabetes. PARTNER-DDS - How to Best Help Partner Manage DDS03-Hypoglycemia: Mean Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Hypoglycemia: Mean item score. PARTNER-DDS - Hypoglycemia: Mean DDS03-Hypoglycemia: Moderate Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Hypoglycemia: Moderate distress or greater? (mean score > 2). PARTNER-DDS - Hypoglycemia: Moderate DDS03-Hypoglycemia: Sum Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Hypoglycemia: Sum of 4 items (1, 17, 18, 19). PARTNER-DDS - Hypoglycemia: Sum DDS03-Leaving Alone Low Blood Sugars Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Worrying about leaving my partner alone because of the possible danger of low blood sugars. PARTNER-DDS - Leaving Alone Low Blood Sugars DDS03-Low Blood Sugars When Sleeping Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Worrying about my partner's low blood sugars when he/she is sleeping. PARTNER-DDS - Low Blood Sugars When Sleeping DDS03-More I Try The Worse Things Get Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Frustrated that the more I try to help my partner manage his/her diabetes, the worse things get between us. PARTNER-DDS - More I Try The Worse Things Get DDS03-Never Get a Break From Worrying Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling that I never get a break from worrying about my partner's diabetes. PARTNER-DDS - Never Get a Break From Worrying DDS03-No One Notices Diabetes Hard On Me Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling that no one notices that diabetes is hard on me, not just on my partner. PARTNER-DDS - No One Notices Diabetes Hard On Me DDS03-Not Working Well Together Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Concerned that my partner and I are not working well together when it comes to diabetes. PARTNER-DDS - Not Working Well Together DDS03-Overwhelmed by Constant Demands Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling overwhelmed by the constant demands of my partner's diabetes. PARTNER-DDS - Overwhelmed by Constant Demands DDS03-Partner Diabetes Manage: Moderate Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - My partner's diabetes management: Moderate distress or greater? (mean score > 2). PARTNER-DDS - Partner Diabetes Manage: Moderate DDS03-Partner Diabetes Management: Mean Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - My partner's diabetes management: Mean item score. PARTNER-DDS - Partner Diabetes Management: Mean DDS03-Partner Diabetes Management: Sum Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - My partner's diabetes management: Sum of 7 items (3, 4, 10, 12, 14, 15, 20). PARTNER-DDS - Partner Diabetes Management: Sum DDS03-Partner Doesn't Try Hard Enough Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling that my partner doesn't try hard enough to manage his/her diabetes. PARTNER-DDS - Partner Doesn't Try Hard Enough DDS03-Partner Driving Low Blood Sugars Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Worrying about my partner's driving because of possible low blood sugars. PARTNER-DDS - Partner Driving Low Blood Sugars DDS03-Partner Ignores My Suggestions Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Frustrated because my partner ignores my suggestions about diabetes. PARTNER-DDS - Partner Ignores My Suggestions DDS03-Partner Shuts Me Out Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Frustrated that my partner shuts me out of his/her diabetes. PARTNER-DDS - Partner Shuts Me Out DDS03-Silent About My Partner's Diabetes Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling that I stay silent about my partner's diabetes more than I really should. PARTNER-DDS - Silent About My Partner's Diabetes DDS03-Taking Too Much of My Energy Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling that diabetes is taking up too much of my mental and physical energy every day. PARTNER-DDS - Taking Too Much of My Energy DDS03-Total DDS Score: Mean Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Total DDS score: Mean item score. PARTNER-DDS - Total DDS Score: Mean DDS03-Total DDS Score: Moderate Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Total DDS score: Moderate distress or greater? (mean score > 2). PARTNER-DDS - Total DDS Score: Moderate DDS03-Total DDS Score: Sum Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Total DDS score: Sum of 21 item scores. PARTNER-DDS - Total DDS Score: Sum DDS03-Worry About Low Blood Sugars Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Worrying about my partner's low blood sugars. PARTNER-DDS - Worry About Low Blood Sugars DDS03TN Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes Questionnaire Test Name CDISC Questionnaire PARTNER-DDS Test Name Terminology A terminology codelist that describes the treatment method for diabetes. A form of therapy which includes dietary approaches and special diets. Special Diet Therapy A synthetic or animal-derived form of insulin used in the treatment of diabetes mellitus. Therapeutic Insulin No treatment for diabetes. No Treatment for Diabetes A pharmacological medication intended for administration through the mouth. Oral Medication DIABTHPY Diabetes Therapy CDISC SDTM Diabetes Therapy Terminology Terminology relevant to the test codes that describe findings about a diabetic kidney disease event or intervention. Number of Events The total number of events that have occurred. Number of Events DKFATSCD Diabetic Kidney Disease Findings About Test Code CDISC SDTM Diabetic Kidney Findings About Test Code Terminology Terminology relevant to the test names that describe findings about a diabetic kidney disease event or intervention. Number of Events The total number of events that have occurred. Number of Events DKFATS Diabetic Kidney Disease Findings About Test Name CDISC SDTM Diabetic Kidney Findings About Test Name Terminology Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 test code. DIBC01-Rate Worst Abdominal Pain Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - How would you rate your worst abdominal pain in the past 24 hours? DIBSS-C Version 1.0 - Rate Worst Abdominal Pain DIBC01-Rate Worst Abdominal Discomfort Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - How would you rate your worst abdominal discomfort in the past 24 hours? DIBSS-C Version 1.0 - Rate Worst Abdominal Discomfort DIBC01-Rate Worst Abdominal Bloating Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - How would you rate your worst abdominal bloating in the past 24 hours? DIBSS-C Version 1.0 - Rate Worst Abdominal Bloating DIBC01-Other Bowel Movements to Report Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - Do you have any other bowel movements to report? DIBSS-C Version 1.0 - Other Bowel Movements to Report DIBC01-Completely Emptied Bowels Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - Did you feel like you completely emptied your bowels after your bowel movement? DIBSS-C Version 1.0 - Completely Emptied Bowels DIBC01-How Much Did You Strain Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - How much did you strain during your bowel movement? DIBSS-C Version 1.0 - How Much Did You Strain DIBC01-Describe Consistency of Stool Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - How would you describe the consistency of your stool? DIBSS-C Version 1.0 - Describe Consistency of Stool DIBC01-Stool Frequency Weekly Total Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - Stool frequency: weekly score, total number of BMs across days on which no laxative, enema, or suppository use was reported. DIBSS-C Version 1.0 - Stool Frequency Weekly Total DIBC01-Stool Frequency Weekly Complete Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - Stool frequency: weekly score, the weekly total score minus any BMs reported as not complete. DIBSS-C Version 1.0 - Stool Frequency Weekly Complete DIBC01-Abdominal Symptom Subscale Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - Abdominal symptom subscale. DIBSS-C Version 1.0 - Abdominal Symptom Subscale DIBC01TC Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 Questionnaire Test Code CDISC Questionnaire DIBSS-C Version 1.0 Test Code Terminology Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 test name. DIBC01-Abdominal Symptom Subscale Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - Abdominal symptom subscale. DIBSS-C Version 1.0 - Abdominal Symptom Subscale DIBC01-Completely Emptied Bowels Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - Did you feel like you completely emptied your bowels after your bowel movement? DIBSS-C Version 1.0 - Completely Emptied Bowels DIBC01-Describe Consistency of Stool Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - How would you describe the consistency of your stool? DIBSS-C Version 1.0 - Describe Consistency of Stool DIBC01-How Much Did You Strain Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - How much did you strain during your bowel movement? DIBSS-C Version 1.0 - How Much Did You Strain DIBC01-Other Bowel Movements to Report Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - Do you have any other bowel movements to report? DIBSS-C Version 1.0 - Other Bowel Movements to Report DIBC01-Rate Worst Abdominal Bloating Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - How would you rate your worst abdominal bloating in the past 24 hours? DIBSS-C Version 1.0 - Rate Worst Abdominal Bloating DIBC01-Rate Worst Abdominal Discomfort Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - How would you rate your worst abdominal discomfort in the past 24 hours? DIBSS-C Version 1.0 - Rate Worst Abdominal Discomfort DIBC01-Rate Worst Abdominal Pain Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - How would you rate your worst abdominal pain in the past 24 hours? DIBSS-C Version 1.0 - Rate Worst Abdominal Pain DIBC01-Stool Frequency Weekly Complete Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - Stool frequency: weekly score, the weekly total score minus any BMs reported as not complete. DIBSS-C Version 1.0 - Stool Frequency Weekly Complete DIBC01-Stool Frequency Weekly Total Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - Stool frequency: weekly score, total number of BMs across days on which no laxative, enema, or suppository use was reported. DIBSS-C Version 1.0 - Stool Frequency Weekly Total DIBC01TN Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 Questionnaire Test Name CDISC Questionnaire DIBSS-C Version 1.0 Test Name Terminology Terminology relevant to the names given to a reference source that lists words and gives their meaning. CDISC Controlled Terminology Clinical Data Interchange Standards Consortium Controlled Terminology A standard terminology developed and maintained by Clinical Data Interchange Standards Consortium (CDISC) and the National Cancer Institute Enterprise Vocabulary Services (NCI-EVS) to support CDISC models, domains and specifications for data representation in regulated research. Clinical Data Interchange Standards Consortium Controlled Terminology An electronic registry and results database of clinical trial information submitted by sponsors, which informs users about ongoing clinical trials in the US. ClinicalTrials.gov Coding Symbols for a Thesaurus of Adverse Reaction Terms A terminology developed and used by the Food and Drug Administration (FDA) for the coding, filing and retrieving of post marketing adverse reaction reports. (NCI) Thesaurus of Adverse Reaction Term Coding Symbols Common Terminology Criteria for Adverse Events A standard terminology developed and maintained by the National Cancer Institute to report adverse events occurring in cancer clinical trials. The CTCAE contains a grading scale for each adverse event term representing the severity of the event. (NCI) Common Terminology Criteria for Adverse Events EMA Clinical Trials Information System An electronic registry database of clinical trial information submitted by sponsors, which informs users about ongoing clinical trials in European Union (EU) member states and European Economic Area (EEA) countries. EMA Clinical Trials Information System Data Universal Number System DUNS Numbers A proprietary system developed and regulated by Dun & Bradstreet that assigns a unique nine digit numeric identifier to a single business entity location. Data Universal Numbering System European Union Drug Regulating Authorities Clinical Trials Database The European Union's electronic database of clinical trials, which contains information submitted by sponsors and informs users about ongoing clinical trials in EU Member States and European Economic Area countries. European Union Drug Regulating Authorities Clinical Trials Database EudraVigilance The system for managing and analysing information on suspected adverse reactions to medicines which have been authorised or being studied in clinical trials in the European Economic Area (EEA). The European Medicines Agency (EMA) operates the system on behalf of the European Union (EU) medicines regulatory network. (EMA) EudraVigilance Geopolitical Entities, Names, and Codes Codes for the representation of names of countries and their subdivisions that have been approved by the US Board on Geographic Names. Geopolitical Entities, Names, and Codes International Classification of Diseases A system of categories to which morbid entries are assigned according to established criteria. Included is the entire range of conditions in a manageable number of categories, grouped to facilitate mortality reporting. It is produced by the World Health Organization (from ICD-10, p1). The Clinical Modifications, produced by the United States Dept. of Health and Human Services, are larger extensions used for morbidity and general epidemiological purposes, primarily in the U.S. (MSH2005_2004_10_12) International Classification of Diseases International Classification of Diseases for Oncology A World Health Organization (WHO) multi-axial classification of the site, morphology, behaviour, and grading of neoplasms. International Classification of Diseases for Oncology An international standard for harmonized data types for information interchange, developed and maintained by the International Organization for Standards (ISO). ISO 21090 An international standard for country and subdivision codes, developed and maintained by the International Organization for Standards (ISO). ISO 3166 Japan Registry for Clinical Trials Japan Registry of Clinical Trials An electronic registry database of clinical trial information submitted by sponsors, which informs users about ongoing clinical trials in Japan. Japan Registry of Clinical Trials Logical Observation Identifiers Names and Codes Published by The Regenstrief Institute, the Logical Observation Identifiers Names and Codes covers clinical and clinical laboratory terminology. (NCI) Logical Observation Identifiers Names and Codes Medication Reference Terminology NDF-RT A standard terminology developed and maintained by the Veterans Health Administration (VHA) that includes terminology to support the mechanism of action, physiologic effect, and asserted pharmacologic classification relationships of medications. MED-RT incorporates terminology from RxNORM, MeSH, and SNOMED CT. Medication Reference Terminology Medical Dictionary for Regulatory Activities An international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information, particularly to regulatory authorities. MedDRA Medical Subject Headings The US National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed. It consists of sets of terms and descriptions in a hierarchical structure that permits searching at various levels of specificity. Medical Subject Headings A web application from the US National Library of Medicine (NLM) that provides a single query interface for biomedical journal articles. PubMed Systematized Nomenclature of Medicine A structured nomenclature and classification of the terminology used in human and veterinary medicine developed by the College of Pathologists and American Veterinary Medical Association. (CDISC Glossary) Systematized Nomenclature of Medicine SRS-UNII Substance Registration System-Unique Ingredient Identifier A standard terminology developed and maintained by the Department of Veterans Affairs/Veterans Health Administration designated federal collaborative Structured Product Labeling Interagency Expert Panel (SPLIEP). It contains terminology to support the mechanism of action, physiologic effect, and asserted pharmacologic classification relationships of drug ingredients and food allergens. Substance Registration System-Unique Ingredient Identifier Anatomical Therapeutic Chemical Classification System A World Health Organization (WHO) classification system, developed and maintained by the WHO Collaborating Centre for Drug Statistics Methodology, for medicinal substances where active substances are divided into different groups according to the organ or system on which they act and their therapeutic, pharmacological, and chemical properties. Anatomical Therapeutic Chemical Classification System World Health Organization Adverse Reaction Terms A terminology implemented by the World Health Organization to describe adverse reactions to a prescribed medication or treatment regimen. (NCI) World Health Organization Adverse Reaction Terminology UMC Drug Dictionary UMCDD Uppsala Monitoring Centre Drug Dictionary WHODrug Global World Health Organization Drug Dictionary A reference source of drugs and drug associated information maintained by the World Health Organization. (NCI) World Health Organization Drug Dictionary DICTNAM Dictionary Name CDISC Dictionary Name Terminology CDISC terminology for anatomical location or specimen further detailing directionality. Of, or pertaining to, a point furthest from the center; belonging to the distal ends of the extremities. Acral Denoting the front portion of the body or a structure. Anterior Denoting the area of the body in front of and away from the middle line. Anterolateral Denoting the front portion of the body towards the median plane. Anteromedial Directed from front to back. Anteroposterior Orientation Denoting the front portion of the body toward the temple. Anterotemporal Of, or pertaining to, an apex. Apical Relating to or located at the lowest portion of a structure. Basal Toward the tail in a body. Caudal A point or area that is approximately central within some larger region or structure. (NCI) Center Toward the head in a body. Cranial Pertaining to an anatomical plane extending between the cranial (towards the head) and caudal (towards the tail) portions of a body. Craniocaudal Plane Extending relatively far inward. (NCI) Deep Pertaining to the farthest portion from the palm side of a hand or the sole side of a foot. Distal Volar Situated farthest from a point of reference. Distal Pertaining to the back or upper surface of the body. Dorsal Toward the back and side of a body. Dorsolateral Of, or related to, or in the direction of the face. (NCI) Facial Of or involving the front of a main body. (NCI) Fore Of, or related to, or in the direction of the front of the body, structure, or object. (NCI) Frontal Of or involving the back of a main body. (NCI) Hind Pertaining to a point below a given reference point. Inferior Inside or closer to the inside of the body or object. (NCI) Inner Located between two points or extremes. Intermediate Situated at or extending to the side. Lateral Pertaining to the lower portion of the surface on the opposite side of the joint when it bends. Lower Extensor Surface Pertaining to the lower portion of the surface on the same side of the joint when it bends. Lower Flexor Surface Denoting the lower portion of the body towards the median plane. Lower Medial The bottom one of two. (NCI) Lower Toward the middle or in a limb toward the median plane. Medial A medial line, especially the medial line or medial plane of the body (or some part of the body). Midline Of, or related to, or in the direction of the nose. Nasal Of, or related to, or in the direction of the occiput, or back of the head. (NCI) Occipital Being on or toward the outside of the body or object. (NCI) Outer Palm-Side Of, or pertaining to the palm side of the hand. Palmar Of, or related to, the area of the body where the parietal and occipital lobes of the brain meet. Parieto-Occipital On or near an edge or constituting an outer boundary; the outer area. (NCI) Peripheral Of, or pertaining to, the area surrounding the ventricles of the brain. Periventricular Denoting the back portion of the body or a structure. Posterior Situated in the back and middle of the body or structure. Posteromedial Pertaining to the nearest portion from the palm side of a hand or the sole side of a foot. Proximal Volar Situated nearest to a point of reference. Proximal Toward the muzzle in the head. Rostral Of, or related to, or in the direction of, an anatomical septum. Septal Denoting the area below a cortex. Subcortical Of or pertaining to the exterior surface. (NCI) Superficial Pertaining to a point above a given reference point. Superior The extended two-dimensional outer layer or area of a three-dimensional object. (NCI) Surface Of, or related to, or in the direction of the anatomic sites that are located in the temple. Temporal Anatomic Qualifier The pointed end of a structure. Tip Pertaining to the upper portion of the surface on the opposite side of the joint when it bends. Upper Extensor Surface Pertaining to the upper portion of the surface on the same side of the joint when it bends. Upper Flexor Surface The top one of two. Upper Pertaining to the front or lower surface of the body. Ventral Of or pertaining to the front and side of a main body. (NCI) Ventrolateral Pertaining to the palm side of a hand and the sole side of a foot. Volar DIR Directionality CDISC SDTM Directionality Terminology Disability Assessment for Dementia test code. DAD01-Decide to Wash Disability Assessment for Dementia - Decide to wash himself/herself or to take a bath or shower? DAD - Decide to Wash or Take a Bath or Shower DAD01-Decide to Brush Teeth Dentures Disability Assessment for Dementia - Decide to brush his/her teeth or care for his/her dentures? DAD - Decide to Brush Teeth or Care for Dentures DAD01-Decide to Care For Hair Disability Assessment for Dementia - Decide to care for his/her hair (wash and comb)? DAD - Decide to Care for His/Her Hair DAD01-Prepare For Washing Bath Shower Disability Assessment for Dementia - Prepare the water, towels, and soap for washing, taking a bath or a shower? DAD - Prepare the Water, Towels, and Soap for Washing, Taking a Bath or Shower DAD01-Wash and Dry Body Safely Disability Assessment for Dementia - Wash and dry all parts of his/her body safely and completely? DAD - Wash and Dry All Parts of Body Safely and Completely DAD01-Brush Teeth Take Care of Dentures Disability Assessment for Dementia - Brush his/her teeth or take care of his/her dentures appropriately? DAD - Brush Teeth or Take Care of Dentures Appropriately DAD01-Take Care of Hair Disability Assessment for Dementia - Take care of his/her hair (wash and comb)? DAD - Take Care of His/Her Hair DAD01-Decide to Dress Disability Assessment for Dementia - Decide to dress himself/herself? DAD - Decide to Dress Himself/Herself DAD01-Choose Appropriate Clothing Disability Assessment for Dementia - Choose appropriate clothing (with regard to the occasion, neatness, the weather and color combination)? DAD - Choose Appropriate Clothing DAD01-Dress in Appropriate Order Disability Assessment for Dementia - Dress himself/herself in the appropriate order (undergarments, pant/dress, shoes)? DAD - Dress in the Appropriate Order DAD01-Dress Completely Disability Assessment for Dementia - Dress himself/herself completely? DAD - Dress Himself/Herself Completely DAD01-Undress Completely Disability Assessment for Dementia - Undress himself/herself completely? DAD - Undress Himself/Herself Completely DAD01-Use Toilet at Appropriate Times Disability Assessment for Dementia - Decide to use the toilet at appropriate times? DAD - Decide to Use the Toilet at Appropriate Times DAD01-Use Toilet Without Accidents Disability Assessment for Dementia - Use the toilet without 'accidents'? DAD - Use the Toilet Without Accidents DAD01-Decide That He/She Needs to Eat Disability Assessment for Dementia - Decide that he/she needs to eat? DAD - Decide That He/She Needs to Eat DAD01-Choose Appropriate Utensils Disability Assessment for Dementia - Choose appropriate utensils and seasonings when eating? DAD - Choose Appropriate Utensils and Seasonings When Eating DAD01-Eat at Normal Pace With Manners Disability Assessment for Dementia - Eat his/her meals at a normal pace and with appropriate manners? DAD - Eat Meals at a Normal Pace and with Appropriate Manners DAD01-Decide to Prepare Meal Snack Disability Assessment for Dementia - Decide to prepare a light meal or snack for himself/herself? DAD - Decide to Prepare a Light Meal or Snack for Himself/Herself DAD01-Adequately Plan Light Meal Snack Disability Assessment for Dementia - Adequately plan a light meal or snack (ingredients, cookware)? DAD - Adequately Plan a Light Meal or Snack DAD01-Prepare or Cook Light Meal Snack Disability Assessment for Dementia - Prepare or cook a light meal or a snack safely? DAD - Safely Prepare or Cook a Light Meal or Snack DAD01-Telephone Someone at Suitable Time Disability Assessment for Dementia - Attempt to telephone someone at a suitable time? DAD - Attempt to Telephone Someone at a Suitable Time DAD01-Find and Dial Telephone Number Disability Assessment for Dementia - Find and dial a telephone number correctly? DAD - Find and Dial a Telephone Number Correctly DAD01-Carry Out Telephone Conversation Disability Assessment for Dementia - Carry out an appropriate telephone conversation? DAD - Carry Out an Appropriate Telephone Conversation DAD01-Write Convey Telephone Message Disability Assessment for Dementia - Write and convey a telephone message adequately? DAD - Write and Convey a Telephone Message Adequately DAD01-Decide to Go Out Disability Assessment for Dementia - Decide to go out (walk, visit, shop) at an appropriate time? DAD - Decide to Go Out at an Appropriate Time DAD01-Adequately Organize an Outing Disability Assessment for Dementia - Adequately organize an outing with respect to transportation, keys, destination, weather, necessary money, shopping list? DAD - Adequately Organize an Outing with Respect to Transportation, Keys, Destination, Weather, Money, Shopping List DAD01-Go Out Without Getting Lost Disability Assessment for Dementia - Go out and reach a familiar destination without getting lost? DAD - Go Out and Reach a Familiar Destination Without Getting Lost DAD01-Safely Take Transportation Disability Assessment for Dementia - Safely take the adequate mode of transportation (car, bus, taxi)? DAD - Safely Take the Adequate Mode of Transportation DAD01-Return From Store With Items Disability Assessment for Dementia - Return from the store with the appropriate items? DAD - Return From the Store with Appropriate Items DAD01-Show Interest in Personal Affairs Disability Assessment for Dementia - Show an interest in his/her personal affairs such as his/her finances and written correspondence? DAD - Show an Interest in Personal Affairs such as Finances and Written Correspondence DAD01-Organize Finances to Pay Bills Disability Assessment for Dementia - Organize his/her finances to pay his/her bills (checks, bank statement, bills)? DAD - Organize Finances to Pay Bills DAD01-Adequately Organize Correspondence Disability Assessment for Dementia - Adequately organize his/her correspondence with respect to stationery, address, stamps? DAD - Adequately Organize Correspondence DAD01-Handle Money Adequately Disability Assessment for Dementia - Handle his/her money adequately (deal with cash)? DAD - Handle Money Adequately DAD01-Take Medications at Correct Time Disability Assessment for Dementia - Decide to take his/her medications at the correct time? DAD - Decide to Take Medications at the Correct Time DAD01-Take Medications as Prescribed Disability Assessment for Dementia - Take his/her medications as prescribed (according to the right dosage)? DAD - Take Medications as Prescribed DAD01-Show Interest in Leisure Activity Disability Assessment for Dementia - Show an interest in leisure activity(ies)? DAD - Show an Interest in Leisure Activities DAD01-Take Interest in Household Chores Disability Assessment for Dementia - Take an interest in household chores that he/she used to perform in the past? DAD - Take an Interest in Household Chores as in the Past DAD01-Plan Organize Household Chores Disability Assessment for Dementia - Plan and organize adequately household chores that he/she used to perform in the past? DAD - Plan and Organize Adequately Household Chores as in the Past DAD01-Complete Household Chores Disability Assessment for Dementia - Complete household chores adequately as he/she used to perform in the past? DAD - Complete Household Chores Adequately as in the Past DAD01-Stay Safely at Home When Needed Disability Assessment for Dementia - Stay safely at home by himself/herself when needed? DAD - Stay Safely at Home When Needed DAD01-Sub-Total Initiation Disability Assessment for Dementia - Sub-Total Initiation. DAD - Sub-Total Initiation DAD01-Initiation Num Applic Items Disability Assessment for Dementia - Sub-Total Initiation Number of Applicable Items. DAD - Total Initiation Number of Applicable Items DAD01-Sub-Total Planning & Organization Disability Assessment for Dementia - Sub-Total Planning & Organization. DAD - Sub-Total Planning and Organization DAD01-Plan & Org Num Applic Items Disability Assessment for Dementia - Sub-Total Planning & Organization Number of Applicable Items. DAD - Plan and Organize Number of Applicable Items DAD01-Sub-Total Effective Performance Disability Assessment for Dementia - Sub-Total Effective Performance. DAD - Sub-Total Effective Performance DAD01-Effective Perf Num Applic Items Disability Assessment for Dementia - Sub-Total Effective Performance Number of Applicable Items. DAD - Sub-Total Effective Performance Number of Applicable Items DAD01-Total Score Disability Assessment for Dementia - Total Score. DAD - Total Score DAD01-Total Num of Applic Items Disability Assessment for Dementia - Total Number of Applicable Items. DAD - Total Number of Applicable Items DAD01-Total % Disability Assessment for Dementia - Total %. DAD - Total Percent DAD01TC Disability Assessment for Dementia Questionnaire Test Code CDISC Questionnaire DAD Test Code Terminology Disability Assessment for Dementia test name. DAD01-Adequately Organize an Outing Disability Assessment for Dementia - Adequately organize an outing with respect to transportation, keys, destination, weather, necessary money, shopping list? DAD - Adequately Organize an Outing with Respect to Transportation, Keys, Destination, Weather, Money, Shopping List DAD01-Adequately Organize Correspondence Disability Assessment for Dementia - Adequately organize his/her correspondence with respect to stationery, address, stamps? DAD - Adequately Organize Correspondence DAD01-Adequately Plan Light Meal Snack Disability Assessment for Dementia - Adequately plan a light meal or snack (ingredients, cookware)? DAD - Adequately Plan a Light Meal or Snack DAD01-Brush Teeth Take Care of Dentures Disability Assessment for Dementia - Brush his/her teeth or take care of his/her dentures appropriately? DAD - Brush Teeth or Take Care of Dentures Appropriately DAD01-Carry Out Telephone Conversation Disability Assessment for Dementia - Carry out an appropriate telephone conversation? DAD - Carry Out an Appropriate Telephone Conversation DAD01-Choose Appropriate Clothing Disability Assessment for Dementia - Choose appropriate clothing (with regard to the occasion, neatness, the weather and color combination)? DAD - Choose Appropriate Clothing DAD01-Choose Appropriate Utensils Disability Assessment for Dementia - Choose appropriate utensils and seasonings when eating? DAD - Choose Appropriate Utensils and Seasonings When Eating DAD01-Complete Household Chores Disability Assessment for Dementia - Complete household chores adequately as he/she used to perform in the past? DAD - Complete Household Chores Adequately as in the Past DAD01-Decide That He/She Needs to Eat Disability Assessment for Dementia - Decide that he/she needs to eat? DAD - Decide That He/She Needs to Eat DAD01-Decide to Brush Teeth Dentures Disability Assessment for Dementia - Decide to brush his/her teeth or care for his/her dentures? DAD - Decide to Brush Teeth or Care for Dentures DAD01-Decide to Care For Hair Disability Assessment for Dementia - Decide to care for his/her hair (wash and comb)? DAD - Decide to Care for His/Her Hair DAD01-Decide to Dress Disability Assessment for Dementia - Decide to dress himself/herself? DAD - Decide to Dress Himself/Herself DAD01-Decide to Go Out Disability Assessment for Dementia - Decide to go out (walk, visit, shop) at an appropriate time? DAD - Decide to Go Out at an Appropriate Time DAD01-Decide to Prepare Meal Snack Disability Assessment for Dementia - Decide to prepare a light meal or snack for himself/herself? DAD - Decide to Prepare a Light Meal or Snack for Himself/Herself DAD01-Decide to Wash Disability Assessment for Dementia - Decide to wash himself/herself or to take a bath or shower? DAD - Decide to Wash or Take a Bath or Shower DAD01-Dress Completely Disability Assessment for Dementia - Dress himself/herself completely? DAD - Dress Himself/Herself Completely DAD01-Dress in Appropriate Order Disability Assessment for Dementia - Dress himself/herself in the appropriate order (undergarments, pant/dress, shoes)? DAD - Dress in the Appropriate Order DAD01-Eat at Normal Pace With Manners Disability Assessment for Dementia - Eat his/her meals at a normal pace and with appropriate manners? DAD - Eat Meals at a Normal Pace and with Appropriate Manners DAD01-Effective Perf Num Applic Items Disability Assessment for Dementia - Sub-Total Effective Performance Number of Applicable Items. DAD - Sub-Total Effective Performance Number of Applicable Items DAD01-Find and Dial Telephone Number Disability Assessment for Dementia - Find and dial a telephone number correctly? DAD - Find and Dial a Telephone Number Correctly DAD01-Go Out Without Getting Lost Disability Assessment for Dementia - Go out and reach a familiar destination without getting lost? DAD - Go Out and Reach a Familiar Destination Without Getting Lost DAD01-Handle Money Adequately Disability Assessment for Dementia - Handle his/her money adequately (deal with cash)? DAD - Handle Money Adequately DAD01-Initiation Num Applic Items Disability Assessment for Dementia - Sub-Total Initiation Number of Applicable Items. DAD - Total Initiation Number of Applicable Items DAD01-Organize Finances to Pay Bills Disability Assessment for Dementia - Organize his/her finances to pay his/her bills (checks, bank statement, bills)? DAD - Organize Finances to Pay Bills DAD01-Plan & Org Num Applic Items Disability Assessment for Dementia - Sub-Total Planning & Organization Number of Applicable Items. DAD - Plan and Organize Number of Applicable Items DAD01-Plan Organize Household Chores Disability Assessment for Dementia - Plan and organize adequately household chores that he/she used to perform in the past? DAD - Plan and Organize Adequately Household Chores as in the Past DAD01-Prepare For Washing Bath Shower Disability Assessment for Dementia - Prepare the water, towels, and soap for washing, taking a bath or a shower? DAD - Prepare the Water, Towels, and Soap for Washing, Taking a Bath or Shower DAD01-Prepare or Cook Light Meal Snack Disability Assessment for Dementia - Prepare or cook a light meal or a snack safely? DAD - Safely Prepare or Cook a Light Meal or Snack DAD01-Return From Store With Items Disability Assessment for Dementia - Return from the store with the appropriate items? DAD - Return From the Store with Appropriate Items DAD01-Safely Take Transportation Disability Assessment for Dementia - Safely take the adequate mode of transportation (car, bus, taxi)? DAD - Safely Take the Adequate Mode of Transportation DAD01-Show Interest in Leisure Activity Disability Assessment for Dementia - Show an interest in leisure activity(ies)? DAD - Show an Interest in Leisure Activities DAD01-Show Interest in Personal Affairs Disability Assessment for Dementia - Show an interest in his/her personal affairs such as his/her finances and written correspondence? DAD - Show an Interest in Personal Affairs such as Finances and Written Correspondence DAD01-Stay Safely at Home When Needed Disability Assessment for Dementia - Stay safely at home by himself/herself when needed? DAD - Stay Safely at Home When Needed DAD01-Sub-Total Effective Performance Disability Assessment for Dementia - Sub-Total Effective Performance. DAD - Sub-Total Effective Performance DAD01-Sub-Total Initiation Disability Assessment for Dementia - Sub-Total Initiation. DAD - Sub-Total Initiation DAD01-Sub-Total Planning & Organization Disability Assessment for Dementia - Sub-Total Planning & Organization. DAD - Sub-Total Planning and Organization DAD01-Take Care of Hair Disability Assessment for Dementia - Take care of his/her hair (wash and comb)? DAD - Take Care of His/Her Hair DAD01-Take Interest in Household Chores Disability Assessment for Dementia - Take an interest in household chores that he/she used to perform in the past? DAD - Take an Interest in Household Chores as in the Past DAD01-Take Medications as Prescribed Disability Assessment for Dementia - Take his/her medications as prescribed (according to the right dosage)? DAD - Take Medications as Prescribed DAD01-Take Medications at Correct Time Disability Assessment for Dementia - Decide to take his/her medications at the correct time? DAD - Decide to Take Medications at the Correct Time DAD01-Telephone Someone at Suitable Time Disability Assessment for Dementia - Attempt to telephone someone at a suitable time? DAD - Attempt to Telephone Someone at a Suitable Time DAD01-Total % Disability Assessment for Dementia - Total %. DAD - Total Percent DAD01-Total Num of Applic Items Disability Assessment for Dementia - Total Number of Applicable Items. DAD - Total Number of Applicable Items DAD01-Total Score Disability Assessment for Dementia - Total Score. DAD - Total Score DAD01-Undress Completely Disability Assessment for Dementia - Undress himself/herself completely? DAD - Undress Himself/Herself Completely DAD01-Use Toilet at Appropriate Times Disability Assessment for Dementia - Decide to use the toilet at appropriate times? DAD - Decide to Use the Toilet at Appropriate Times DAD01-Use Toilet Without Accidents Disability Assessment for Dementia - Use the toilet without 'accidents'? DAD - Use the Toilet Without Accidents DAD01-Wash and Dry Body Safely Disability Assessment for Dementia - Wash and dry all parts of his/her body safely and completely? DAD - Wash and Dry All Parts of Body Safely and Completely DAD01-Write Convey Telephone Message Disability Assessment for Dementia - Write and convey a telephone message adequately? DAD - Write and Convey a Telephone Message Adequately DAD01TN Disability Assessment for Dementia Questionnaire Test Name CDISC Questionnaire DAD Test Name Terminology Disability Rating Scale test code. DRS01-Eye Opening Disability Rating Scale - Eye opening. DRS - Eye Opening DRS01-Communication Ability Disability Rating Scale - Communication ability. DRS - Communication Ability DRS01-Motor Response Disability Rating Scale - Motor response. DRS - Motor Response DRS01-Feeding Disability Rating Scale - Feeding (cognitive ability only). DRS - Feeding DRS01-Toileting Disability Rating Scale - Toileting (cognitive ability only). DRS - Toileting DRS01-Grooming Disability Rating Scale - Grooming (cognitive ability only). DRS - Grooming DRS01-Level of Functioning Disability Rating Scale - Level of functioning (physical, mental, emotional or social function). DRS - Level of Functioning DRS01-Employability Disability Rating Scale - Employability (as a full time worker, homemaker, or student). DRS - Employability DRS01-Total Score Disability Rating Scale - Total score. DRS - Total Score DRS01TC Disability Rating Scale Clinical Classification Test Code CDISC Clinical Classification DRS Test Code Terminology Disability Rating Scale test name. DRS01-Communication Ability Disability Rating Scale - Communication ability. DRS - Communication Ability DRS01-Employability Disability Rating Scale - Employability (as a full time worker, homemaker, or student). DRS - Employability DRS01-Eye Opening Disability Rating Scale - Eye opening. DRS - Eye Opening DRS01-Feeding Disability Rating Scale - Feeding (cognitive ability only). DRS - Feeding DRS01-Grooming Disability Rating Scale - Grooming (cognitive ability only). DRS - Grooming DRS01-Level of Functioning Disability Rating Scale - Level of functioning (physical, mental, emotional or social function). DRS - Level of Functioning DRS01-Motor Response Disability Rating Scale - Motor response. DRS - Motor Response DRS01-Toileting Disability Rating Scale - Toileting (cognitive ability only). DRS - Toileting DRS01-Total Score Disability Rating Scale - Total score. DRS - Total Score DRS01TN Disability Rating Scale Clinical Classification Test Name CDISC Clinical Classification DRS Test Name Terminology The destination or circumstance at the time of discharge. The patient died while in a medical center such as a hospital, skilled nursing facility (SNF), intermediate care facility (ICF), or a freestanding hospice center. Died in a Medical Facility Indicator Died The absence of life or state of being dead. (NCI) Dead The patient will be admitted to a medical center that is funded by the federal government (e.g. Veterans Affairs Hospital). Federal Health Care Facility The patient will return home but personal health maintenance will be administered and monitored by a member of a healthcare organization that is eligible to receive Medicare funding. Home Under Care of Organized Home Health Service Organization in Anticipation of Covered Skilled Care The patient will receive end-of-life care which will be administered in the patient's home. Home Hospice The patient will receive professional nursing care provided within the home of the patient. Home Health Nursing A routine discharge where personal health maintenance will be administered and monitored by the patient while under directed isolation in their home. Discharge to Home Quarantine A routine discharge where personal health maintenance will be administered and monitored by the patient from their home. Home Care The patient will receive end-of-life care which will be administered in a medical center. Hospice Care at Medical Facility The patient will be admitted into a medical center and receive a type of hospital bed that will be paid for by Medicare. Hospital with Medicare Approved Swing Bed The patient will be admitted full time into a free standing rehabilitation center or a rehabilitation center within a general medical facility. Inpatient Rehabilitation Facility Including Rehabilitation distinct Part Units of a Hospital The patient will be admitted into an alternative facility not listed. Institution Not Defined Non-Hospital Intermediate Care Facility The patient will be admitted to an intermediate care facility. Intermediate Care Facility The patient vacated the medical center or ceased medical care contrary to the recommendation of a trained healthcare provider. Left Against Medical Advice The patient will be admitted into a hospital equipped and staffed to provide prolonged care to patients. Long Term Care Hospital The patient will be admitted to a long-term nursing care facility. Long-Term Care Nursing The patient will be admitted into a Medicare funded medical center for a considerable length of time. Medicare Certified Long Term Care Hospital The patient will be admitted into a medical center which is eligible to receive funding from Medicaid but not Medicare. Nursing Facility Certified Under Medicaid but Not Certified Under Medicare The patient will be admitted into a free standing medical facility or a unit within a general medical facility used for the treatment of mental health disorders. Psychiatric Facility The patient will be admitted to a rehabilitation facility designed for improving, maintaining, or restoring physical strength, cognition, speech, or mobility. Rehabilitation Center The patient will remain in a basic hospital environment for a brief time. Short Term General Hospitalization The patient will be admitted into a medical center equipped with a trained nursing staff that is eligible to receive Medicare funding. Skilled Nursing Facility with Medicare Certification in Anticipation of Covered Skilled Care DISCHDX Discharge Disposition CDISC SDTM Discharge Disposition Terminology Terminology relevant to the measurable result or effect of treatment on a disease. There are no indicators of bacterial infection in an individual who previously had an infection. Bacteriological Cure There are indicators of bacterial infection in the individual who previously had an infection. Bacteriological Failure There are no signs or symptoms of disease in the individual who previously had a disease. Clinical Cure There are still signs or symptoms of disease in the individual who previously had an infection. Clinical Failure Recurrent Disease The return of a disease after a period of remission. Recurrent Disease DSSOUT Disease Outcome CDISC SDTM Disease Outcome Terminology Terminology relevant to the symptoms and/or clinical manifestation of a disease. A lesion that demonstrates both cystic and solid components; the solid components can range from thin walls (septae) to a solid tissue mass. Complex Cystic Lesion Abnormal collection of fluid in a body cavity. Effusion Ascites Abnormal collection of fluid in the peritoneal cavity. Peritoneal Effusion A malignant neoplasm that has spread from its original site to the arachnoid mater and the pia mater, the two innermost layers of tissue that cover the brain and spinal cord. Leptomeningeal Neoplasm DSPRTYP Disease Presentation Type CDISC SDTM Disease Presentation Type Terminology Disease Steps test code. DS01-Disease Steps Classification Disease Steps - Methods: For Disease Steps, classification of a patient is determined by history and neurologic examination as well as course of MS. DS - Disease Steps Classification DS01TC Disease Steps Clinical Classification Test Code CDISC Clinical Classification DS Test Code Terminology Disease Steps test name. DS01-Disease Steps Classification Disease Steps - Methods: For Disease Steps, classification of a patient is determined by history and neurologic examination as well as course of MS. DS - Disease Steps Classification DS01TN Disease Steps Clinical Classification Test Name CDISC Clinical Classification DS Test Name Terminology A terminology codelist relevant to the physical form of the administered drug, substance, or product. aer A product that is packaged under pressure and contains therapeutically active ingredients that are released upon activation of an appropriate valve system; it is intended for topical application to the skin as well as local application into the nose (nasal aerosols), mouth (lingual aerosols), or lungs (inhalation aerosols). Aerosol Dosage Form A dosage form containing one or more active ingredients, surfactants, aqueous or non-aqueous liquids, and the propellants; if the propellant is in the internal (discontinuous) phase (i.e., of the oil-in-water type), a stable foam is discharged, and if the propellant is in the external (continuous) phase (i.e., of the water-in-oil type), a spray or a quick-breaking foam is discharged. Aerosol Foam Dosage Form A pressurized dosage form consisting of metered dose valves which allow for the delivery of a uniform quantity of spray upon each activation. (NCI) Metered Aerosol Dosage Form A product that is packaged under pressure and contains therapeutically active ingredients, in the form of a powder, that are released upon activation of an appropriate valve system. (NCI) Powder Aerosol Dosage Form An aerosol product which utilizes a compressed gas as the propellant to provide the force necessary to expel the product as a wet spray; it is applicable to solutions of medicinal agents in aqueous solvents. (NCI) Aerosol Spray Dosage Form A solid dosage form usually in the form of a rectangle that is meant to be chewed. (NCI) Chewable Bar Dosage Form A solid dosage form in the shape of a small ball. (NCI) Bead Dosage Form A small sterile solid mass consisting of a highly purified drug intended for implantation in the body which would allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form. (NCI) Extended Release Bead Implant Dosage Form Solid dosage form, usually in the shape of a square or rectangle. (NCI) Block Dosage Form A solid dosage form in which a tablet has been compacted into capsule shape. Caplet Dosage Form cap A solid pharmaceutical dosage form that contains medicinal agent within either a hard or soft soluble container or shell, usually used for the oral administration of medicine. The shells are made of a suitable form of gelatin or other substance. (NCI) Capsule Dosage Form A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or 'shell' made from a suitable form of gelatin; the drug itself is in the form of granules to which varying amounts of coating have been applied. (NCI) Coated Pellet in Capsule Dosage Form A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or "shell" made from a suitable form of gelatin; additionally, the capsule is covered in a designated coating. Coated Capsule Dosage Form A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or "shell" made from a suitable form of gelatin; additionally, the capsule is covered in a designated coating, and which releases a drug (or drugs) in such a manner to allow at least a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. Extended Release Coated Capsule Dosage Form A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or "shell" made from a suitable form of gelatin; the drug itself is in the form of granules to which enteric coating has been applied, thus delaying release of the drug until its passage into the intestines. Delayed Release Pellet in Capsule Dosage Form A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI) Delayed Release Capsule Dosage Form A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI) Extended Release Capsule Dosage Form A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or 'shell' made from a suitable form of gelatin; additionally, the capsule is covered in a designated film coating, and which releases a drug (or drugs) in such a manner to allow at least a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. Extended Release Film Coated Capsule Dosage Form A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin; through a banding process, the capsule is coated with additional layers of gelatin so as to form a complete seal. (NCI) Gelatin Coated Capsule Dosage Form A capsule, covered with a rigid outer shell, that is designed to release active and/or inert ingredient(s) at a controlled, prolonged rate so as to reduce dosing frequency. Extended Release Capsule, Hard Dosage Form A solid dosage form in which the drug is enclosed within either a hard or soft soluble container, which is designed to release its active and/or inert ingredient(s) immediately upon administration. Immediate Release Capsule Dosage Form A solid dosage form in which the drug is enclosed within a soluble, gelatin shell which is plasticized by the addition of a polyol, such as sorbitol or glycerin, and is therefore of a somewhat thicker consistency than that of a hard shell capsule; typically, the active ingredients are dissolved or suspended in a liquid vehicle. (NCI) Liquid Filled Capsule Dosage Form A capsule, covered with a soft gelatin shell and containing a liquid, suspension, or semisolid, that is designed to release active and/or inert ingredient(s). Capsule Softgel Pharmaceutical Dosage Form A capsule, covered with a soft gelatin shell and containing a liquid, suspension, or semisolid, that is designed to release active and/or inert ingredient(s) at a controlled, prolonged rate so as to reduce dosing frequency. Extended Release Capsule, Softgel Dosage Form A substance that serves to produce solid union between two surfaces. (NCI) Cement Dosage Form A dosage form containing finely cut tobacco leaves, with or without additives, that are rolled in a paper wrapper and burned, releasing smoke that is inhaled. Cigarette Dosage Form A large piece of relatively flat, absorbent material that contains a drug. It is typically used for applying medication or for cleansing. Cloth Dosage Form A liquid preparation of increased strength and reduced volume which is usually diluted prior to administration. (NCI) Concentrated Dosage Form A solid dosage form bounded by a circular base and the surface formed by line segments joining every point of the boundary of the base to a common vertex. A cone (usually containing antibiotics) is normally placed below the gingiva after a dental extraction. (NCI) Cone Dosage Form An ocular system placed in the eye from which the drug diffuses through a membrane at a constant rate over a specified period. (NCI) Extended Release Core Dosage Form A semisolid emulsion of either the oil-in-water or the water-in-oil type, ordinarily intended for topical use. (NCI) Cream Dosage Form A cream dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. Augmented Cream Dosage Form A naturally produced angular solid of definite form in which the ultimate units from which it is built up are systematically arranged; they are usually evenly spaced on a regular space lattice. Crystal Dosage Form The propagation of microorganisms or of living tissue cells in special media conducive to their growth. (NCI) Culture Dosage Form Depot Extended Release Dosage Form Parenteral sustained-release systems of microparticles, implants, or biodegradable polymer-excipients designed to release their active pharmaceutical ingredient over a prolonged period of time. Extended Release Depot Dosage Form A device usually dome-shaped, worn during copulation over the cervical mouth for prevention of conception or infection. (NCI) Vaginal Diaphragm Dosage Form A circular plate-like organ or structure. Disc Dosage Form A liquid preparation, intended for the irrigative cleansing of the vagina, that is prepared from powders, liquid solutions, or liquid concentrates and contains one or more chemical substances dissolved in a suitable solvent or mutually miscible solvents. (NCI) Douche Dosage Form The application of various materials for protecting a wound. Dressing Dosage Form Modern technology, distributed with or as a part of a drug product that allows for the uniform release or targeting of drugs to the body. Drug Delivery System A clear, pleasantly flavored, sweetened hydroalcoholic liquid containing dissolved medicinal agents; it is intended for oral use. (NCI) Elixir Dosage Form A dosage form consisting of a two-phase system comprised of at least two immiscible liquids (1), one of which is dispersed as droplets (internal or dispersed phase) within the other liquid (external or continuous phase), generally stabilized with one or more emulsifying agents. Note 1: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. Note 2: Emulsion is used as a dosage form term unless a more specific term is applicable, e.g. cream, lotion, ointment. (NCI) Emulsion Dosage Form A rectal preparation for therapeutic, diagnostic, or nutritive purposes. (NCI) Enema Dosage Form A concentrated preparation of vegetable or animal drugs obtained by removal of the active constituents of the respective drugs with a suitable menstrua, evaporation of all or nearly all of the solvent, and adjustment of the residual masses or powders to the prescribed standards. (NCI) Extract Dosage Form A slender and elongated solid thread-like substance that delivers drug in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. Extended Release Fiber Dosage Form A thin layer or coating. (NCI) Film Dosage Form A drug delivery system in the form of a film that releases the drug over an extended period in such a way as to maintain constant drug levels in the blood or target tissue. (NCI) Extended Release Film Dosage Form A thin layer or coating which is susceptible to being dissolved when in contact with a liquid. (NCI) Soluble Film Dosage Form A product, usually a solid, intended for solution prior to administration. Dosage Form for Solution A product, usually a solid, intended for suspension prior to administration. Dosage Form for Suspension A product, usually a solid, intended for suspension prior to administration; once the suspension is administered, the drug will be released at a constant rate over a specified period. Extended Release Dosage Form for Suspension Any elastic aeriform fluid in which the molecules are separated from one another and have free paths. (NCI) Gas Dosage Form A semisolid (1) dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion (2). A gel may contain suspended particles. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: A colloidal dispersion is a system in which particles of colloidal dimension (i.e., typically between 1 nm and 1 micrometer) are distributed uniformly throughout a liquid. Gel Dosage Form Gummie Gummy A formed or molded oral gel dosage form that maintains its shape, is elastic, and yields to mastication. (NCI) Chewable Gel Dosage Form A combination of a dentifrice (formulation intended to clean and/or polish the teeth, and which may contain certain additional agents), and a gel. It is used with a toothbrush for the purpose of cleaning and polishing the teeth. (NCI) Dentifrice Gel Dosage Form A gel preparation, with metered dose valves, which allow for the delivery of a uniform quantity of gel upon each activation. Metered Gel Dosage Form An apparatus for the formation of vapor or gas from a liquid or solid by heat or chemical action. The term GENERATOR also applies to radioactive columns from which radionuclides are provided. (NCI) Generator Dosage Form Also called pellets or pilules, are made of pure sucrose, lactose, or other polysaccharides. They are formed into small globular masses of various sizes, and are medicated by placing them in a vial and adding the liquid drug attenuation in the proportion not less than one percent (v/w). After shaking, the medicated globules are dried at temperatures not to exceed 40 degrees Centigrade. (NCI) Globule Dosage Form A slip of skin or of other tissue for implantation. (NCI) Graft Dosage Form A small particle or grain. (NCI) Granule Dosage Form A small medicinal particle or grain that is covered in a designated coating. Coated Granules Dosage Form A small medicinal particle or grain to which an enteric or other coating has been applied, thus delaying release of the drug until its passage into the intestines. (NCI) Delayed Release Granules Dosage Form A small particle or grain containing a medicinal agent in a dry mixture usually composed of sodium bicarbonate, citric acid, and tartaric acid which, when in contact with water, has the capability to release gas, resulting in effervescence. (NCI) Effervescent Granules Dosage Form A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavorants, and any other desired pharmaceutic ingredient. (NCI) Granule for Solution Dosage Form A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavorants, and any other desired pharmaceutic ingredient. (NCI) Granule for Suspension Dosage Form A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the extended release system achieves slow release of the drug over an extended period of time and maintains constant drug levels in the blood or target tissue. (NCI) Extended Release Granule for Suspension Dosage Form A mucilaginous excretion from various plants. (NCI) Gum Dosage Form A sweetened and flavored insoluble plastic material of various shapes which when chewed, releases a drug substance into the oral cavity. (NCI) Chewing Gum Dosage Form Natural mixture of gum and resin, usually obtained as exudations from plants. (NCI) Resin Gum Dosage Form A material containing drug intended to be inserted securely and deeply in a living site for growth, slow release, or formation of an organic union. (NCI) Implant Dosage Form A special class of inhalations consisting of a drug or combination of drugs, that by virtue of their high vapor pressure, can be carried by an air current into the nasal passage where they exert their effect; the container from which the inhalant generally is administered is known as an inhaler. (NCI) Inhalant Dosage Form Capsule for Inhalation Solid preparation consisting of a capsule formulation intended for generation of vapor to be inhaled to obtain a local effect. The vapor is usually generated by adding the whole capsule or the capsule contents to hot water. (EDQM) Inhalation Vapor, Capsule Dosage Form An injection, which either consists of or forms liposomes (a lipid bilayer vesicle usually composed of phospholipids which is used to encapsulate an active drug substance). Liposomal Injection Dosage Form A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP. (NCI) Injectable Dosage Form An emulsion consisting of a sterile, pyrogen-free preparation intended to be administered parenterally. Emulsion for Injection Dosage Form A substance composed of complexed active and/or inert ingredient(s) with natural or synthetic lipids that is intended for injection. (NCI) Injectable Lipid Complex Dosage Form A sterile preparation intended for reconstitution to form a solution for parenteral use. (NCI) Powder for Injectable Solution Dosage Form A sterile preparation intended for reconstitution to form a suspension for parenteral use. (NCI) Powder for Injectable Suspension Dosage Form A dried preparation intended for reconstitution to form a suspension for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution). Powder for Injectable Extended Release Suspension Dosage Form A sterile freeze dried preparation intended for reconstitution for parenteral use which has been formulated in a manner that would allow liposomes (a lipid bilayer vesicle usually composed of phospholipids which is used to encapsulate an active drug substance, either within a lipid bilayer or in an aqueous space) to be formed upon reconstitution. (NCI) Lyophilized Powder for Injectable Liposomal Suspension Dosage Form A dosage form intended for the solution prepared by lyophilization ('freeze drying'), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections. (NCI) Lyophilized Powder for Injectable Solution Dosage Form A liquid preparation, intended for parenteral use, that contains solids suspended in a suitable fluid medium and conforms in all respects to the requirements for Sterile Suspensions; the medicinal agents intended for the suspension are prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures. Lyophilized Powder for Injectable Suspension Dosage Form A sterile freeze dried preparation intended for reconstitution for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution). (NCI) Lyophilized Powder for Extended Release Injectable Suspension Dosage Form A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection. (NCI) Injectable Solution Dosage Form A sterile preparation for parenteral use which, upon the addition of suitable solvents, yields a solution conforming in all respects to the requirements for Injections. (NCI) Concentrated Injectable Solution Dosage Form A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. It can also consist of an oil phase dispersed throughout an aqueous phase, or vice-versa. (NCI) Injectable Suspension Dosage Form A sterile preparation intended for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution or a prompt drug-releasing, conventional solid dosage form). (NCI) Injectable Extended Release Suspension Dosage Form A liquid parenteral pharmaceutical dosage form structured as a multilamellar composition of concentric phospholipid spheres that encapsulate the drug (drug delivery systems) separated by layers of water. Drug release is facilitated and controlled by in vivo erosion of the liposomes. To further increase the in vivo circulation time, liposomes in some preparations are covalently derivatized with PEG to produce PEGylated or stealth liposomes. Covalent attachment of drugs to the outer surface of liposomes can potentially serve as a delayed-release product. (NCI) Injectable Liposomal Suspension Dosage Form A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. In addition, the product is sonicated while a gas is bubbled through the suspension, and this results in the formation of microspheres by the solid particles. (NCI) Injectable Sonicated Suspension Dosage Form A specially formulated and shaped non-encapsulated solid preparation intended to be placed into a non-rectal orifice of the body, where drug is released, generally for localized effects. Insert Dosage Form A specially formulated and shaped solid preparation (e.g., ring, tablet, or stick) intended to be placed in the vagina by special inserters, where the medication is released, generally for localized effects; the extended release preparation is designed to allow a reduction in dosing frequency. (NCI) Extended Release Insert Dosage Form A device inserted and left in the uterus to prevent effective conception. (NCI) Intrauterine Device Dosage Form A sterile solution intended to bathe or flush open wounds or body cavities; they're used topically, never parenterally. (NCI) Irrigant Dosage Form A class of gels--semisolid systems which consist of suspensions made up of either small inorganic particles or large organic molecules interpenetrated by a liquid--in which the structural coherent matrix contains a high portion of liquid, usually water. (NCI) Jelly Dosage Form A packaged collection of related material. (NCI) Kit Dosage Form A material applied to the inside of the dental cavity, for protection or insulation of the surface. Dental Liner Dosage Form A solution or mixture of various substances in oil, alcoholic solutions of soap, or emulsions intended for external application. (NCI) Liniment Dosage Form A waxy solid, usually colored cosmetic, in stick form for the lips. (NCI) Lipstick Dosage Form A dosage form consisting of a pure chemical in its liquid state. This dosage form term should not be applied to solutions. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. Liquid Dosage Form A liquid that delivers a drug in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. Extended Release Liquid Dosage Form An emulsion, liquid (1) dosage form. This dosage form is generally for external application to the skin (2). Note 1: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. Note 2: Previously the definition of a lotion was: The term lotion has been used to categorize many topical suspensions, solutions, and emulsions intended for application to the skin. The current definition of a lotion is restricted to an emulsion. Lotion Dosage Form A lotion dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. Augmented Lotion Dosage Form A lotion dosage form which has a soap or detergent that is usually used to clean the hair and scalp; it is often used as a vehicle for dermatologic agents. Lotion Shampoo Dosage Form A solid preparation containing one or more medicaments, usually in a flavored, sweetened base which is intended to dissolve or disintegrate slowly in the mouth. A lollipop is a lozenge on a stick. Lozenge Dosage Form An aqueous solution which is most often used for its deodorant, refreshing, or antiseptic effect. (NCI) Mouthwash Dosage Form Nanoparticle Suspension A dosage form that contains nano-sized solid particles dispersed in a liquid vehicle. Nanosuspension Dosage Form The use of a dosage form term is not relevant or appropriate. (NCI) Dosage Form Not Applicable An unctuous, combustible substance which is liquid, or easily liquefiable, on warming, and is soluble in ether but insoluble in water. Such substances, depending on their origin, are classified as animal, mineral, or vegetable oils. (NCI) Oil Dosage Form oint A suspension or emulsion, semisolid (1) dosage form, usually containing less than 20 percent water and volatiles (2) and greater than 50 percent hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: Percent water and volatiles are measured by a loss on drying test in which the sample is heated at 105 degrees C until constant weight is achieved. Ointment Dosage Form An ointment dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. Augmented Ointment Dosage Form A material, usually covered by or impregnated with a drug, that is inserted into a body cavity or between the tooth enamel and the gingival margin. Packing Dosage Form A semisolid dosage form, containing a large proportion (20 - 50%) of solids finely dispersed in a fatty vehicle. This dosage form is generally for external application to the skin or mucous membranes. Note: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. (NCI) Paste Dosage Form A paste formulation intended to clean and/or polish the teeth, and which may contain certain additional agents. (NCI) Dentifrice Paste Dosage Form An aromatic preparation, often with a pleasing flavor, usually intended to dissolve in the mouth. Pastille Dosage Form A drug delivery system that often contains an adhesive backing that is usually applied to an external site on the body. Its ingredients either passively diffuse from, or are actively transported from, some portion of the patch. Depending upon the patch, the ingredients are either delivered to the outer surface of the body or into the body. A patch is sometimes synonymous with the terms Extended Release Film and System. Patch Dosage Form A drug delivery system in the form of a patch that releases the drug in such a manner that a reduction in dosing frequency compared to that drug presented as a conventional dosage form (e.g., a solution or a prompt drug-releasing, conventional solid dosage form). (NCI) Extended Release Patch Dosage Form A drug delivery system in the form of a patch which is controlled by an electric current that releases the drug in such a manner that a reduction in dosing frequency compared to that drug presented as a conventional dosage form (e.g., a solution or a prompt drug-releasing, conventional solid dosage form). (NCI) Electrically Controlled Extended Release Patch Dosage Form A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding. (NCI) Pellet Dosage Form A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding; they are intended for implantation in the body (usually subcutaneously) for the purpose of providing continuous release of the drug over long periods of time. Implantable Pellet Dosage Form A solid dosage form in which the drug itself is in the form of granules to which varying amounts of coating have been applied, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI) Extended Release Coated Pellet Dosage Form A dose of medicine in the form of a small pellet. (NCI) Pill Dosage Form Substance intended for external application made of such materials and of such consistency as to adhere to the skin and attach to a dressing; plasters are intended to afford protection and support and/or to furnish an occlusion and macerating action and to bring medication into close contact with the skin. Plaster Dosage Form A soft, moist mass of meal, herbs, seed, etc., usually applied hot in cloth that consists of gruel-like consistency. (NCI) Poultice Dosage Form An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use. (NCI) Powder Dosage Form A powder formulation intended to clean and/or polish the teeth, and which may contain certain additional agents. (NCI) Dentifrice Powder Dosage Form An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a solution. (NCI) Powder for Solution Dosage Form An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a suspension (a liquid preparation containing the solid particles dispersed in the liquid vehicle). (NCI) Powder for Suspension Dosage Form An intimate mixture of dry, finely divided drugs and/or chemicals that is lyophilized. Lyophilized Powder Dosage Form A powder dosage form that is situated inside a container that has a mechanism to deliver a specified quantity. (NCI) Metered Powder Dosage Form A small circular object with a vacant circular center that is usually intended to be placed in the body by special inserters, where the medication is released, generally for localized effects. Ring Dosage Form A liquid used to cleanse by flushing. (NCI) Rinse Dosage Form A thick ointment or cerate (a fat or wax based preparation with a consistency between an ointment and a plaster). (NCI) Salve Dosage Form A liquid soap or detergent used to clean the hair and scalp and is often used as a vehicle for dermatologic agents. (NCI) Shampoo Dosage Form A liquid soap or detergent containing one or more solid, insoluble substances dispersed in a liquid vehicle that is used to clean the hair and scalp and is often used as a vehicle for dermatologic agents. (NCI) Shampoo Suspension Dosage Form Any compound of one or more fatty acids, or their equivalents, with an alkali; soap is detergent and is much employed in liniments, enemas, and in making pills. It is also a mild aperient, antacid and antiseptic. (NCI) Soap Dosage Form A substance having definite shape and volume manufactured for the administration of active and/or inert ingredient(s). Solids may include, but are not limited to, tablets, capsules, powders, granules, and certain suppositories. Solid Dosage Form A clear, homogeneous liquid dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. Solution Dosage Form A liquid preparation (i.e., a substance that flows readily in its natural state) that contains a drug dissolved in a suitable solvent or mixture of mutually miscible solvents; the drug has been strengthened by the evaporation of its non-active parts. (NCI) Concentrated Solution Dosage Form A solution for the preparation of an iced saline slush, which is administered by irrigation and used to induce regional hypothermia (in conditions such as certain open heart and kidney surgical procedures) by its direct application. (NCI) Solution for Slush Dosage Form A solution, which after usually being administered in a drop-wise fashion, forms a gel. Gel Forming Drop Solution Dosage Form A solution that forms a gel when it comes in contact with ocular fluid, and which allows at least a reduction in dosing frequency. Extended Release Gel Forming Solution Dosage Form A solution which is usually administered in a drop-wise fashion. Drop Solution Dosage Form A porous, interlacing, absorbent material that contains a drug. It is typically used for applying or introducing medication, or for cleansing. A sponge usually retains its shape. Sponge Dosage Form A liquid minutely divided as by a jet of air or steam. (NCI) Spray Dosage Form A non-pressurized dosage form consisting of valves which allow the dispensing of a specified quantity of spray upon each activation. (NCI) Metered Spray Dosage Form A liquid preparation containing solid particles dispersed in a liquid vehicle and in the form of coarse droplets or as finely divided solids to be applied locally, most usually to the nasal-pharyngeal tract, or topically to the skin. (NCI) Spray Suspension Dosage Form A dosage form prepared in a relatively long and slender often cylindrical form. (NCI) Stick Dosage Form A long narrow piece of material. Strip Dosage Form supp A solid body of various weights and shapes, adapted for introduction into the rectal, vaginal, or urethral orifice of the human body; they usually melt, soften, or dissolve at body temperature. Suppository Dosage Form A drug delivery system in the form of a suppository that allows at least a reduction in dosing frequency. (NCI) Extended Release Suppository Dosage Form Ready to Use Suspension susp A dosage form that contains solid particles dispersed in a liquid vehicle. Suspension Dosage Form A liquid preparation consisting of solid particles dispersed throughout a liquid phase in which the particles are not soluble; the suspension has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution or a prompt drug-releasing, conventional solid dosage form). (NCI) Extended Release Suspension Dosage Form A suspension which is usually administered in a dropwise fashion. Drop Suspension Dosage Form A strand or fiber used to hold wound edges in apposition during healing. (NCI) Suture Dosage Form A small piece of relatively flat absorbent material that contains a drug. A swab may also be attached to one end of a small stick. A swab is typically used for applying medication or for cleansing. Swab Dosage Form An oral solution containing high concentrations of sucrose or other sugars; the term has also been used to include any other liquid dosage form prepared in a sweet and viscid vehicle, including oral suspensions. (NCI) Syrup Dosage Form tab A solid dosage form containing medicinal substances with or without suitable diluents. (NCI) Tablet Dosage Form A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste. (NCI) Chewable Tablet Dosage Form A solid dosage form containing a conglomerate of medicinal particles that have each been covered with a coating. Tablet Coated Particle Dosage Form A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating. (NCI) Coated Tablet Dosage Form A solid dosage form containing medicinal substances with or without suitable diluents that is crushed prior to administration. Crushed Tablet Dosage Form A solid dosage form containing a conglomerate of medicinal particles that have been covered with a coating which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI) Delayed Release Particle Tablet Dosage Form Tablet, Gastro-Resistant A solid dosage form which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI) Delayed Release Tablet Dosage Form A solid dosage form containing mixtures of acids (e.g., citric acid, tartaric acid) and sodium bicarbonate, which release carbon dioxide when dissolved in water; it is intended to be dissolved or dispersed in water before administration. Effervescent Tablet Dosage Form Tablet, Prolonged Release A solid dosage form containing a drug which allows at least a reduction in dosing frequency as compared to that drug presented in conventional dosage form. (NCI) Extended Release Tablet Dosage Form A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer. (NCI) Film Coated Tablet Dosage Form A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer; the tablet is formulated in such manner as to make the contained medicament available over an extended period of time following ingestion. Film Coated Extended Release Tablet Dosage Form A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer; the tablet is designed to release its active and/or inert ingredient(s) immediately upon administration. Film Coated Immediate Release Tablet Dosage Form A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer that is crushed prior to administration. The tablet is designed to release its active and/or inert ingredient(s) immediately upon administration. Film Coated Immediate Release Crushed Tablet Dosage Form A tablet that forms a solution when placed in a liquid. Tablet for Solution Dosage Form A tablet that forms a suspension when placed in a liquid (formerly referred to as a Dispersible Tablet). Tablet for Suspension Dosage Form TABLET, GASTRO-RETENTIVE A solid dosage form containing medicinal substances with or without suitable diluents, which is designed to remain in the stomach for a prolonged period of time. Gastroretentive Tablet Dosage Form A solid dosage form containing medicinal substances with or without suitable diluents, which is designed to release its active and/or inert ingredient(s) immediately upon administration. Immediate Release Tablet Dosage Form A solid dosage form containing one or more active pharmaceutical ingredient which can be dispersed in a carrier at solid state, and immediately released upon administration. (NCI) Solid Dispersion Immediate Release Tablet Dosage Form A solid dosage form exhibiting an altered inherent rate of release of active and/or inert ingredient(s). Modified Release Tablet Dosage Form A solid dosage form containing medicinal substances that have been compressed to form a two-layered tablet with a 1:1 ratio of immediate release and modified release components and exhibiting an altered inherent rate of release of active and/or inert ingredient(s). Modified Release Bilayer Tablet 1:1 Dosage Form A solid dosage form containing medicinal substances that have been compressed to form a two-layered tablet with a 1:2 ratio of immediate release and modified release components and exhibiting an altered inherent rate of release of active and/or inert ingredient(s). Modified Release Bilayer Tablet 1:2 Dosage Form A solid dosage form containing medicinal substances that have been compressed to form a two-layered tablet of immediate release and modified release components and exhibiting an altered inherent rate of release of active and/or inert ingredient(s). Modified Release Bilayer Tablet Dosage Form Tablet, Modified Release, ECS A solid dosage form exhibiting an altered inherent rate of release of active and/or inert ingredient(s) from an extrudable core system. Modified Release Extrudable Core System Tablet Dosage Form A solid dosage form exhibiting an altered inherent rate of release of active and/or inert ingredient(s) that is classified as long. Long Modified Release Tablet Dosage Form A solid dosage form exhibiting an altered inherent rate of release of active and/or inert ingredient(s) from a polymer matrix system. Modified Release Matrix Tablet Dosage Form A solid dosage form exhibiting an altered inherent rate of release of active and/or inert ingredient(s) that is classified as short. Short Modified Release Tablet Dosage Form A solid dosage form containing medicinal substances that have been compressed to form a multiple-layered tablet or a tablet-within-a-tablet, the inner tablet being the core and the outer portion being the shell. (NCI) Multilayered Tablet Dosage Form A solid dosage form containing medicinal substances that have been compressed to form a multiple-layered tablet or a tablet-within-a-tablet, the inner tablet being the core and the outer portion being the shell, which, additionally, is covered in a designated coating; the tablet is formulated in such manner as to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form. (NCI) Multilayered Extended Release Tablet Dosage Form A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue. (NCI) Orally Disintegrating Tablet Dosage Form A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue, but which releases a drug (or drugs) at a time other than promptly after administration. Orally Disintegrating Delayed Release Tablet Dosage Form A solid dosage form that contains medicinal substances with or without suitable diluents and possesses the ability to dissolve in fluids. (NCI) Soluble Tablet Dosage Form A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a colored or an uncolored water-soluble sugar. (NCI) Sugar Coated Tablet Dosage Form A plug made of cotton, sponge, or oakum variously used in surgery to plug the nose, vagina, etc., for the control of hemorrhage or the absorption of secretions. (NCI) Tampon Dosage Form A narrow woven fabric, or a narrow extruded synthetic (such as plastic), usually with an adhesive on one or both sides. (NCI) Tape Dosage Form An alcoholic or hydroalcoholic solution prepared from vegetable materials or from chemical substances. (NCI) Tincture Dosage Form A discoid-shaped solid containing the medicinal agent in a suitably flavored base; troches are placed in the mouth where they slowly dissolve, liberating the active ingredients. (NCI) Troche Dosage Form A dosage form has yet to be assigned. (NCI) Unassigned Dosage Form The type of pharmaceutical dose form is unknown, or has unspecified or variable physical characteristics. (EDQM) Unknown Dosage Form Category A ring composed of active and/or inert ingredient(s), intended for administration in or around the vagina. Vaginal Ring Dosage Form A thin slice of material containing a medicinal agent. (NCI) Wafer Dosage Form FRM Dosage Form CDISC SDTM Dosage Form Terminology The short name, or code, of the test for the drug accountability assessment. Dispensed Amount The quantity of a product that has been dispensed. (NCI) Dispensed Amount Expected Remaining Amount The quantity of a product that is expected to remain after dosing, consumption, or use. Expected Remaining Amount Lost Amount The quantity of a product reported as lost. Lost Amount Prepared Amount The quantity of a product that has been made ready for use. Prepared Amount Remaining Amount The quantity of a product that remains after dosing, consumption, or use. Remaining Amount Returned Amount The quantity of a product that has been returned. (NCI) Returned Amount DATESTCD Drug Accountability Test Code CDISC SDTM Drug Accountability Test Code Terminology The name of the test for the drug accountability assessment. Dispensed Amount The quantity of a product that has been dispensed. (NCI) Dispensed Amount Expected Remaining Amount The quantity of a product that is expected to remain after dosing, consumption, or use. Expected Remaining Amount Lost Amount The quantity of a product reported as lost. Lost Amount Prepared Amount The quantity of a product that has been made ready for use. Prepared Amount Remaining Amount The quantity of a product that remains after dosing, consumption, or use. Remaining Amount Returned Amount The quantity of a product that has been returned. (NCI) Returned Amount DATEST Drug Accountability Test Name CDISC SDTM Drug Accountability Test Name Terminology A terminology codelist relevant to the state or condition of the microbe or lesion to indicate whether it is resistant to drugs normally used in treatment. XDR Resistance to nearly all known drugs, particularly the most efficacious or non-first line drugs, used in the treatment of a particular disease. Extensively Drug Resistance Process MDR Simultaneous resistance to a spectrum of unrelated drugs following exposure to a single agent. Mechanisms involve expression of multidrug efflux pumps (p-glycoprotein), altered glutathione metabolism, decreased topoisomerase II activity, and changes in various cellular proteins. Multidrug Resistance Process Susceptible The growth of microorganisms are inhibited by the usually achievable concentrations of antimicrobial agent when the recommended dosage is used for the site of infection. Antimicrobial Susceptibility Result DRSTAT Drug Resistance Status CDISC SDTM Drug Resistance Status Terminology Terminology relevant to the test codes that describe findings about a Duchenne muscular dystrophy event or intervention. Age at Full-Time Use The age at which the full-time use of a pre-specified object first occurred. Age at Full-Time Use DMFATSCD Duchenne Muscular Dystrophy Findings About Test Code CDISC SDTM Duchenne Muscular Dystrophy Findings About Test Code Terminology Terminology relevant to the test names that describe findings about a Duchenne muscular dystrophy event or intervention. Age at Full-Time Use The age at which the full-time use of a pre-specified object first occurred. Age at Full-Time Use DMFATS Duchenne Muscular Dystrophy Findings About Test Name CDISC SDTM Duchenne Muscular Dystrophy Findings About Test Name Terminology Eastern Cooperative Oncology Group Performance Status original result for ECOG101 test and test code. ECOG101-Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours Eastern Cooperative Oncology Group Performance Status original result for ECOG101-Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours. Eastern Cooperative Oncology Group Performance Status ECOG101 Original Result - Ambulatory And Capable Of All Selfcare But Unable To Carry Out Any Work Activities. Up And About More Than 50% Of Waking Hours ECOG101-Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours Eastern Cooperative Oncology Group Performance Status original result for ECOG101-Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours. Eastern Cooperative Oncology Group Performance Status ECOG101 Original Result - Capable Of Only Limited Selfcare, Confined To Bed Or Chair More Than 50% Of Waking Hours ECOG101-Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair Eastern Cooperative Oncology Group Performance Status original result for ECOG101-Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair. Eastern Cooperative Oncology Group Performance Status ECOG101 Original Result - Completely Disabled. Cannot Carry On Any Selfcare. Totally Confined To Bed Or Chair ECOG101-Dead Eastern Cooperative Oncology Group Performance Status original result for ECOG101-Dead. Eastern Cooperative Oncology Group Performance Status ECOG101 Original Result - Dead ECOG101-Fully active, able to carry on all pre-disease performance without restriction Eastern Cooperative Oncology Group Performance Status original result for ECOG101-Fully active, able to carry on all pre-disease performance without restriction. Eastern Cooperative Oncology Group Performance Status ECOG101 Original Result - Fully Active, Able To Carry On All Pre-Disease Performance Without Restriction ECOG101-Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work Eastern Cooperative Oncology Group Performance Status original result for ECOG101-Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work. Eastern Cooperative Oncology Group Performance Status ECOG101 Original Result - Restricted In Physically Strenuous Activity But Ambulatory And Able To Carry Out Work Of A Light Or Sedentary Nature, E.G., Light House Work, Office Work ECOG101OR Eastern Cooperative Oncology Group Performance Status Clinical Classification ORRES for ECOG101 TN/TC CDISC Clinical Classification Eastern Cooperative Oncology Group Performance Status ECOG101 Original Response Terminology Eastern Cooperative Oncology Group Performance Status standardized character result for ECOG101 test and test code. ECOG101-0 Eastern Cooperative Oncology Group Performance Status standardized character result for ECOG101-Fully active, able to carry on all pre-disease performance without restriction. Eastern Cooperative Oncology Group Performance Status ECOG101 Standardized Character Result 0 ECOG101-1 Eastern Cooperative Oncology Group Performance Status standardized character result for ECOG101-Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work. Eastern Cooperative Oncology Group Performance Status ECOG101 Standardized Character Result 1 ECOG101-2 Eastern Cooperative Oncology Group Performance Status standardized character result for ECOG101-Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours. Eastern Cooperative Oncology Group Performance Status ECOG101 Standardized Character Result 2 ECOG101-3 Eastern Cooperative Oncology Group Performance Status standardized character result for ECOG101-Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours. Eastern Cooperative Oncology Group Performance Status ECOG101 Standardized Character Result 3 ECOG101-4 Eastern Cooperative Oncology Group Performance Status standardized character result for ECOG101-Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair. Eastern Cooperative Oncology Group Performance Status ECOG101 Standardized Character Result 4 ECOG101-5 Eastern Cooperative Oncology Group Performance Status standardized character result for ECOG101-Dead. Eastern Cooperative Oncology Group Performance Status ECOG101 Standardized Character Result 5 ECOG101STR Eastern Cooperative Oncology Group Performance Status Clinical Classification STRESC for ECOG101 TN/TC CDISC Clinical Classification Eastern Cooperative Oncology Group Performance Status ECOG101 Standardized Character Response Terminology Eastern Cooperative Oncology Group Performance Status test code. ECOG1-Performance Status ECOG Performance Status - Performance Status. ECOG - Performance Status ECOG1TC Eastern Cooperative Oncology Group Performance Status Clinical Classification Test Code CDISC Clinical Classification ECOG Test Code Terminology Eastern Cooperative Oncology Group Performance Status test name. ECOG1-Performance Status ECOG Performance Status - Performance Status. ECOG - Performance Status ECOG1TN Eastern Cooperative Oncology Group Performance Status Clinical Classification Test Name CDISC Clinical Classification ECOG Test Name Terminology Terminology relevant to the test codes that describe findings about an Ebola virus infection event or intervention. Diameter The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) Diameter Occurrence Indicator An indication as to whether something has happened, such as an event or incident. Occurrence Indicator Severity/Intensity The degree of something undesirable. Severity EBFATSCD Ebola Virus Findings About Test Code CDISC SDTM Ebola Virus Findings About Test Code Terminology Terminology relevant to the test names that describe findings about an Ebola virus infection event or intervention. Diameter The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) Diameter Occurrence Indicator An indication as to whether something has happened, such as an event or incident. Occurrence Indicator Severity/Intensity The degree of something undesirable. Severity EBFATS Ebola Virus Findings About Test Name CDISC SDTM Ebola Virus Findings About Test Name Terminology Terminology relevant to the analytical method associated with ECG recording. An electrocardiographic measurement methodology in which the measurement is performed using derived (median) beats which are calculated from multiple complexes (beats) in a single lead. The measurement is performed on the summation of the absolute values of the individual median beats from multiple leads. Global Median Beat Method An electrocardiographic measurement methodology in which the mean is calculated from measurements performed on single recorded complexes (beats) from a single ECG lead. Mean Single Beat Single Lead Method An electrocardiographic measurement methodology in which the mean is calculated from measurements performed on the superimposition of the same single recorded complexes (beats) from multiple leads. Mean Single Beat Superimposed Leads Method An electrocardiographic measurement methodology in which the measurement is performed on a derived (median) beat that is calculated using multiple complexes (beats) in one lead. Median Beat Single Lead Method An electrocardiographic measurement methodology in which the measurement is performed using derived (median) beats which are calculated from multiple complexes (beats) in a single lead. The measurement is performed on the superimposition of those median beats from multiple leads. Median Beat Superimposed Leads Method An electrocardiographic measurement methodology in which the median is calculated from measurements performed on single recorded complexes (beats) from a single ECG lead. Median Single Beat Single Lead Method An electrocardiographic measurement methodology in which the median is calculated from measurements performed on the superimposition of the same single recorded complexes (beats) from multiple leads. Median Single Beat Superimposed Leads Method An electrocardiographic measurement methodology in which the measurement is performed on a single complex (beat) that is created by summation of the absolute values of individual leads of the same complex. Single Beat Global Beat Method An electrocardiographic measurement methodology in which the measurement is performed on a single recorded complex (beat) from a single ECG lead. Single Beat Single Lead Method An electrocardiographic measurement methodology in which the measurement is performed on the superimposition of the same single recorded complex (beat) from multiple leads. Single Beat Superimposed Leads Method EGANMET ECG Analysis Method CDISC SDTM ECG Analysis Method Terminology Terminology related to electrocardiogram lead names. An augmented unipolar lead placed at the sixth intercostal space on the midaxillary line. (NCI) Lead Site aV6 An augmented unipolar electrocardiogram limb lead in which the positive (red) electrode is situated on the left pelvic limb and the negative electrode is a combination of the right thoracic limb (white) electrode and the left thoracic limb (black) electrode. Measures the electrical activity of the electrode on the left pelvic limb. Augmented Vector Foot An augmented unipolar electrocardiogram limb lead in which the positive electrode is situated at the hindquarters proximal to the sacrum and the negative electrode is a combination of the electrode behind the right ear near the right mastoid process and the electrode near the apex of the heart (located in the ICS of left 5-6 rib close to the sternum). Lead Site aVF-Ventral An augmented unipolar electrocardiogram limb lead in which the positive (black) electrode is situated on the left thoracic limb and the negative electrode is a combination of the right thoracic limb (white) electrode and the left pelvic limb (red) electrode. Measures the electrical activity of the electrode on the left thoracic limb. (NCI) Augmented Vector Left An augmented unipolar electrocardiogram limb lead in which the positive electrode is near the apex of the heart (located in the ICS of left 5-6 rib close to the sternum) and the negative electrode is a combination of the electrode behind the right ear near the right mastoid process and the electrode on hindquarters proximal to the sacrum. Lead Site aVL-Axial An augmented unipolar electrocardiogram limb lead in which the positive (white) electrode is situated on the right thoracic limb and the negative electrode is a combination of the left thoracic limb (black) electrode and the left pelvic limb (red) electrode. Measures the electrical activity of the electrode on the right thoracic limb. (NCI) Augmented Vector Right An augmented unipolar electrocardiogram limb lead in which the positive electrode is behind the right ear near the right mastoid process and the negative electrode is a combination of the electrode at the hindquarters proximal to the sacrum and the electrode near the apex of the heart (located in the ICS of left 5-6 rib close to the sternum). Lead Site aVR-Dorsal A bipolar electrocardiogram limb lead which records the voltage between the positive electrode near the apex of the heart (located in the ICS of left 5-6 rib close to the sternum) and the negative electrode behind the right ear near the right mastoid process. Lead Site Axial A bipolar electrocardiogram lead with the right thoracic limb electrode placed on the manubrium and left thoracic limb electrode placed at the surface marking of the V5 position (just above the 5th interspace in the anterior axillary line). The left pelvic limb lead acts as a neutral and may be placed anywhere. The C refers to 'clavicle' where it is often placed. (NCI) Lead Site CM5 A unipolar chest lead used mostly in large animals. Placed on the sixth ICS on the right side of the thorax along a line parallel to the level of the point of the humeralradial joint. Lead Site CV5RL V1 electrode (+) placed in the 6th intercostal space on the left side of the thorax along a line parallel to the level of the point of the humeralradial joint. Lead Site CV6LL V2 electrode (+) placed in the 6th intercostal space on the left side of the thorax along a line parallel to the level of the point of the shoulder. (NCI) Lead Site CV6LU A bipolar electrocardiogram limb lead which records the voltage between the negative electrode behind the right ear near the right mastoid process and the positive electrode on the hindquarters proximal to the sacrum. Lead Site Dorsal A bipolar electrocardiogram limb lead which records the voltage between the negative electrode on the right thoracic limb and the positive electrode on the left thoracic limb. (NCI) Lead Site I A bipolar electrocardiogram limb lead which records the voltage between the negative electrode on the right thoracic limb and the positive electrode on the left pelvic limb. (NCI) Lead Site II A bipolar electrocardiogram limb lead which records the voltage between the negative electrode on the left thoracic limb and the positive electrode on the left pelvic limb. (NCI) Lead Site III A unipolar precordial lead placed at the second intercostal space to the left of the sternum. (NCI) Lead Site rV2 Lead C1 A unipolar electrocardiogram lead site; the electrode is placed at the fourth intercostal space on the anterior chest wall (between ribs 4 and 5) to the right of the sternal border. In small animals, it is placed at the right fifth intercostal space near the sternum. (NCI) Lead Site V1 A unipolar chest lead at which the electrode is placed over the dorsal spinous process of 7th thoracic vertebra. (NCI) Lead Site V10 Lead C2 A unipolar electrocardiogram lead site; the electrode is placed on the anterior chest wall at the fourth intercostal space (between ribs 4 and 5) to the left of the sternal border. In small animals it corresponds to V2-V3 where it is placed at the 6th left intercostal space near the sternum. In large animals it is placed over the 6th rib at the level of the costochondral junction on the left side of the thorax. Lead Site V2 Lead C3 A unipolar electrocardiogram lead site; the electrode is placed on the anterior chest wall midway between leads V2 and V4. In large and small animals, it is placed over the dorsal spinous process of the 7th thoracic vertebra. (NCI) Lead Site V3 Lead C4 A unipolar electrocardiogram lead site; the electrode is placed at the fifth intercostal space on the anterior chest wall (between ribs 5 and 6) at the left midclavicular line. In small animals it corresponds to V4-V6 where it is placed at the 6th left intercostal space near the costochondral junction. In large animals it is placed over the 6th rib at the level of a horizontal line drawn through the scapulohumeral articulation on the left side of the thorax. (NCI) Lead Site V4 Lead C5 A unipolar electrocardiogram lead site; the electrode is placed on the anterior chest wall level with lead V4 at the left anterior axillary line. In large animals it is placed on the sixth ICS on the right side of the thorax along a line parallel to the level of the point of the shoulder corresponding to the electrical center of the heart (central terminal). (NCI) Lead Site V5 Lead C6 A unipolar electrocardiogram lead site at which the electrode is placed on the anterior chest wall level with lead V5 at the left midaxillary line . Lead Site V6 A bipolar electrocardiogram limb lead which records the voltage with the positive electrode on the hindquarters proximal to the sacrum and the negative electrode near the apex of the heart (located in the ICS of left 5-6 rib close to the sternum). Lead Site Ventral Global Median Beat Superimposition of Multiple Leads Measurement methodology using multiple leads for the determination of an ECG parameter. This is often visually represented as a superimposition of the median beats from multiple leads. Superimposition of Multiple Leads EGLEAD ECG Lead CDISC SDTM Electrocardiogram Lead Terminology A terminology codelist relevant to the degree of automation involved in assessing the ECGs for the study. Of or related to a process performed without human intervention. Automatic Of or related to a process performed by hand. Manual Of or related to a process performed using a combination of manual and automatic means. Semi-Automatic EGRDMETH ECG Read Method Response CDISC SDTM ECG Read Method Response Terminology Terminology codelist used with ECG Findings and Abnormalities within CDISC. 1st degree AV block PR Prolongation Prolonged PR interval An electrocardiographic finding of prolonged PR interval. AV Block First Degree by ECG Finding 2:1 AV block An electrocardiographic finding of a supraventricular rhythm where the ratio of impulses generated above the atrioventricular node to the number of impulses conducted through to the ventricles is 2:1. This is manifest on the ECG as 2 P waves per QRS complex. 2:1 Atrioventricular Block by ECG Finding Second Degree AV Block An electrocardiographic finding of intermittent failure of atrial electrical impulse conduction to the ventricles. This is manifest on the ECG by regular P waves which intermittently are not followed by QRS complexes. AV Block Second Degree by ECG Finding 3rd Degree Heart Block AV block, complete (third-degree) Complete Heart Block An electrocardiographic finding of complete failure of atrial electrical impulse conduction to the ventricles. This is manifest on the ECG by disassociation of atrial and ventricular rhythms. The atrial rate must be faster than the ventricular rate. AV Block Third Degree by ECG Finding 50 Hz Artifact 50 Hz Noise An electrocardiographic recording showing power line interference with the electrocardiographic signal. The artifact amplitude modulation has the same frequency as the AC power system present (50 Hz). 50 Hertz Noise by ECG Finding 60 Hz Artifact 60 Hz Noise An electrocardiographic recording showing power line interference with the electrocardiographic signal. The artifact amplitude modulation has the same frequency as the AC power system present (60 Hz). 60 Hertz Noise by ECG Finding Aberrantly Conducted Beats An electrocardiographic finding of an abnormally wide QRS complex(es) of supraventricular origin with prolonged QRS duration due to aberrant AV conduction. Aberrantly Conducted Complexes by ECG Finding AC Noise An electrocardiographic recording showing power line interference with the electrocardiographic signal. The artifact amplitude modulation has the same frequency as the AC power system present (usually 50 Hz or 60 Hz). Alternating Current Noise by ECG Finding Accelerated idioventricular rhythm An electrocardiographic finding of idioventricular rhythm with a rate greater than 50 beats per minute. Accelerated Idioventricular Rhythm by ECG Finding Acute Anterior MI Acute Anterior Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V3 and V4, which is suggestive of acute myocardial infarction of the anterior wall of the left ventricle. Acute Anterior Myocardial Infarction by ECG Finding Acute Anterolateral Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V3 through V6, which is suggestive of acute myocardial infarction of the anterolateral wall of the left ventricle. Acute Anterolateral Myocardial Infarction by ECG Finding Acute anteroseptal MI Acute Anteroseptal Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V1 through V4, which is suggestive of acute myocardial infarction of the anteroseptal wall of the left ventricle. Acute Anteroseptal Myocardial Infarction by ECG Finding An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V1 to V6, I and aVL, which is suggestive of acute myocardial infarction involving the anterior and anterolateral walls of the left ventricle. Acute Extensive Anterior Wall Myocardial Infarction by ECG Finding Acute High Lateral Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads I and aVL, which is suggestive of acute myocardial infarction of the high lateral wall of the left ventricle. Acute High Lateral Myocardial Infarction by ECG Finding Acute Inferior MI Acute Inferior Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads III, aVF and often II, which is suggestive of acute myocardial infarction of the inferior wall of the left ventricle. Acute Inferior Myocardial Infarction by ECG Finding Acute Lateral MI Acute Lateral Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V5, V6, I and aVL, which is suggestive of acute myocardial infarction of the lateral wall of the left ventricle. Acute Lateral Myocardial Infarction by ECG Finding Acute Myocardial Infarction An electrocardiographic finding showing a current of injury with ST elevation. No specification is provided for localization. Acute Myocardial Infarction by ECG Finding Acute Posterior MI Acute Posterior Wall Myocardial Infarction An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, upright T wave, with accompanying ST elevation, which is suggestive of acute myocardial infarction of the posterior wall of the left ventricle. Evidence of inferior or lateral myocardial infarction is usually also present. Acute Posterior Myocardial Infarction by ECG Finding Acute Right ventricular MI Acute Right Ventricular Wall Myocardial Infarction An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, upright T wave, with accompanying ST elevation, which is suggestive of acute myocardial infarction of the ventricular wall of the left ventricle. Evidence of inferior or lateral myocardial infarction is usually also present. Additional criteria include ST elevation > 100 microvolts in the right precordial leads V4R through V6R. Acute Right Ventricular Myocardial Infarction by ECG Finding Acute Septal Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V1, V2 and often V3, which is suggestive of acute myocardial infarction of the intraventricular septum. Acute Septal Myocardial Infarction by ECG Finding Advanced/High Grade AV Block An electrocardiographic finding of intermittent failure of atrial electrical impulse conduction to the ventricles, characterized by two or more consecutive non-conducted P waves. High Grade Atrioventricular Block by ECG Finding An electrocardiographic recording in which all precordial electrodes are disconnected resulting in missing waveforms (flat line) of all leads V1 - V6. All Precordial Electrodes Are Disconnected by ECG Finding Anterior MI Anterior Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V3 and V4, which is suggestive of myocardial infarction of the anterior wall of the left ventricle. Anterior Myocardial Infarction by ECG Finding Anterolateral Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V3 through V6, which is suggestive of myocardial infarction of the anterolateral wall of the left ventricle. Anterolateral Myocardial Infarction by ECG Finding Anteroseptal MI Anteroseptal Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V1 through V4, which is suggestive of myocardial infarction of the anteroseptal wall of the left ventricle. Anteroseptal Myocardial Infarction by ECG Finding An electrocardiographic recording in which one or more leads display extraneous signals which do not represent cardiac electrical activity. Artifact Lead Signal by ECG Finding An electrocardiographic finding showing no cardiac electrical activity on the ECG for the entire duration of the recording. Asystole by ECG Finding An electrocardiographic finding of a sinus beat followed by a premature atrial complex for three or more consecutive cycles; a regularly irregular rhythm of normal and abnormal P waves in a 1-1 ratio. Atrial Bigeminy by ECG Finding Atrial Couplets An electrocardiographic finding in which two premature atrial complexes occur sequentially; there may be one or more occurrences during an electrocardiographic recording. Atrial Couplet by ECG Finding Atrial Enlargement An electrocardiographic finding which comprises left, right or bilateral atrial enlargement. This is may be characterized by prolonged P wave duration, increased P wave amplitude, or multi-component P waves. Atrial Enlargement by ECG Finding Atrial fibrillation An electrocardiographic finding of a supraventricular arrhythmia characterized by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape and timing and are accompanied by an irregularly irregular ventricular response. Atrial Fibrillation by ECG Finding Atrial flutter An electrocardiographic finding of an organized, regular atrial rhythm. Multiple P waves typically appear in the inferior leads in a saw tooth like pattern between the QRS complexes. Atrial Flutter by ECG Finding An electrocardiographic finding of an atrial tachycardia which does not display 1:1 AV conduction. Atrial Tachycardia With AV Block by ECG Finding Atrial tachycardia An electrocardiographic finding of an organized, regular atrial rhythm. The P wave morphology must be distinct from the sinus P wave morphology. Atrial Tachycardia by ECG Finding Atrial Trigeminy An electrocardiographic finding of two sinus beats followed by a premature atrial complex for 3 or more consecutive cycles; a regularly irregular rhythm of normal and abnormal P waves in a 2-1 ratio. Atrial Trigeminy by ECG Finding Atrioventricular dissociation AV Dissociation An electrocardiographic finding in which the electrical activity of the atria and ventricles are independent of one another. Atrioventricular Dissociation by ECG Finding AV Mobitz I Mobitz I Second Degree AV Block Second degree AV block- Mobitz type I Second-degree AV block, Mobitz type I (Wenckebach) Type 1 2nd degree AV Block Wenckebach An electrocardiographic finding of intermittent failure of atrial electrical impulse conduction to the ventricles, characterized by a progressively lengthening PR interval prior to the block of an atrial impulse. AV Block Second Degree Mobitz Type I by ECG Finding Mobitz II AV Block Mobitz II Second Degree AV Block Type 2 2nd degree AV Block An electrocardiographic finding of intermittent failure of atrial electrical impulse conduction to the ventricles, characterized by a relatively constant PR interval prior to the block of an atrial impulse. AV Block Second Degree Mobitz Type II by ECG Finding AV Node Reentrant Supraventricular Tachycardia An electrocardiographic finding of a regular supraventricular tachycardia due to reentry within the AV node. It is characterized by P waves which typically occurs nearly simultaneously with the QRS complex, resulting in a P wave which is obscured by the QRS, merged with the QRS or which may follow the QRS. Atrioventricular Nodal Reentry Tachycardia by ECG Finding AV Reentrant Supraventricular Tachycardia An electrocardiographic finding of a regular supraventricular tachycardia which utilizes an atrioventricular bypass tract as its retrograde limb (orthodromic tachycardia) or as its antegrade limb (antidromic tachycardia). QRS complexes during sinus rhythm may show preexcitation. During orthodromic tachycardia the preexcitation is not present and a retrograde P wave may appear after the QRS complex. During antidromic tachycardia the QRS complex is preexcited. Atrioventricular Reentrant Tachycardia by ECG Finding An electrocardiographic recording in which the isoelectric line in one or more leads is vertically displaced resulting in low frequency upward and downward movements of the signal with varying amplitudes. Baseline Wander by ECG Finding Bifascicular block An electrocardiographic finding comprising right bundle branch block and left anterior fascicular block, or right bundle branch block and left posterior fascicular block. Defects occurring in two of the three divisions of the conduction system of the heart are considered bifascicular blocks. Technically left bundle branch block may be considered a bifascicular block. (NCI) Bifascicular Block by ECG Finding An electrocardiographic finding suggestive of enlargement or thickening of both ventricles, with a combination of findings which are related to LVH and RVH, such as voltage criteria for LVH in the presence of marked right axis deviation. Biventricular Hypertrophy by ECG Finding Borderline QTcB An electrocardiographic finding in which the QT interval corrected for heart rate using Bazett's formula is slightly prolonged. Thresholds for different age, sex, and patient populations exist. Borderline QTcB Borderline QTcF An electrocardiographic finding in which the QT interval corrected for heart rate using Fridericia's formula is slightly prolonged. Thresholds for different age, sex, and patient populations exist. Borderline QTcF Bradycardia An electrocardiographic finding of abnormally slow heart rate. Bradycardia by ECG Finding An electrocardiographic finding of complete or incomplete right bundle branch block accompanied by ST elevation in leads V1-V3. This may be noted at rest or can be provoked by medication challenge. Brugada Syndrome Pattern by ECG Finding An electrocardiographic finding, in the absence of left ventricular hypertrophy (LVH) and left bundle branch block pattern on ECG, of either a) new (or presumed new) ST elevation at the J point in two contiguous leads with the following cut-points: greater than or equal to 0.1 mV in all leads other than leads V2-V3 where the following cut points apply: greater than or equal to 0.2 mV in men greater than or equal to 40 years; greater than or equal to 0.25 mV in men less than 40 years, or greater than or equal to 0.15 mV in women; or b) new (or presumed new) horizontal or down-sloping ST depression greater than or equal to 0.05 mV in two contiguous leads and/or T inversion greater than or equal to 0.1 mV in two contiguous leads with prominent R wave or R/S ratio greater than 1. (Thygesen K, Alpert JS, Jaffe AS, Simoons ML, et al.; Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012 Oct 16;60(16):1581-98). ACC/AHA Ischemic ECG Changes Delta wave An electrocardiographic finding of initial slurring (delta wave) of the QRS complex due to the presence of an accessory pathway. This characteristic ECG pattern is typically seen in Wolff-Parkinson-White syndrome. Delta Wave by ECG Finding Dextrocardia An electrocardiographic finding suggestive of dextrocardia with situs inversus, characterized by reversal of normal anterior R wave progression and the appearance of reversal of the right and left arm electrodes. Dextrocardia by ECG Finding Early R Wave Progression Early R Wave Transition An electrocardiographic finding where the amplitude of the R wave becomes greater than the amplitude of the S wave in the QRS complex at an unusually early point in the precordial leads, usually in leads V1 or V2. Early R Wave Transition by ECG Finding Early Repolarization An electrocardiographic finding of J point and ST segment elevation. Early Repolarization An electrocardiographic recording in which the precordial electrodes have been placed over the right chest and record a right sided ECG. ECG Acquired with Precordial Electrodes Placed on the Right Chest A digital electrocardiographic recording which is corrupted (i.e. ECG signal cannot be restored) such that measurements and/or interpretation cannot be performed. ECG Evaluation Not Performed Due to Corrupted Digital ECG File A printed electrocardiographic recording with poor printout quality (e.g. a faded paper ECG tracing or ECG with inconsistent printing speed) such that measurements and/or interpretation cannot be performed. ECG Evaluation Not Performed Due to Poor Quality of Printed ECG An electrocardiographic recording in which measurements and/or interpretation are not performed because the ECG amplitude gain and/or recording speed are not known. ECG Evaluation Not Performed Due to Unknown ECG Amplitude Gain or Recording Speed Ectopic Supraventricular Rhythm An electrocardiographic finding of a regular atrial rhythm that does not originate in the sinus node, and which is characterized by P waves whose morphology differs from the P wave morphology during sinus rhythm. Ectopic Atrial Rhythm by ECG Finding Ectopic ventricular rhythm An electrocardiographic finding of three or more consecutive complexes of ventricular origin. The QRS complexes are wide and have an abnormal morphology. Ectopic Ventricular Rhythm by ECG Finding Electrical alternans An electrocardiographic finding in which there is an alternating pattern of any of the waveform components. (NCI) Electrical Alternans by ECG Finding An electrocardiographic finding of pathologic Q waves in leads V1 to V6, I and aVL, which is suggestive of myocardial infarction involving the anterior and anterolateral walls of the left ventricle. Extensive Anterior Wall Myocardial Infarction by ECG Finding Fusion Beat Fusion Complexes An electrocardiographic finding that occurs when electrical activation of the atria or ventricles occurs from two separate sites. This results in a P wave or QRS complex that displays merged characteristics of beats originating from the two different sites; there may be one or more occurrences during an electrocardiographic recording. Fusion Complex High Lateral Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads I and aVL, which is suggestive of myocardial infarction of the high lateral wall of the left ventricle. High Lateral Myocardial Infarction by ECG Finding Idioventricular Rhythm An electrocardiographic finding of three or more consecutive complexes of ventricular origin with a rate less than a certain threshold. The QRS complexes are wide and have an abnormal morphology. Idioventricular Rhythm An electrocardiographic recording which is limited in duration or which does not display all of the expected leads. Incomplete ECG Incomplete left bundle branch block An electrocardiographic finding of a wide QRS complex with evidence of delayed conduction to the left ventricle. Incomplete Left Bundle Branch Block by ECG Finding An electrocardiographic recording in which measurements (particularly of QRS amplitudes) and/or interpretations are not performed because QRS complexes have been truncated. Incomplete ECG Measurements Due to Truncation of QRS Complexes Incomplete right bundle branch block Incomplete right bundle-branch block An electrocardiographic finding of a wide QRS complex with evidence of delayed conduction to the right ventricle. Incomplete Right Bundle Branch Block by ECG Finding A digital electrocardiographic recording which was digitized from paper ECG tracings and which does not contain all leads present on the original paper printout. Incompletely Digitized ECG Leads An electrocardiographic recording in which the ECG signal is not displayed at the indicated recording speed and/or amplitude resolution. Incorrectly Scaled ECG Indeterminate Axis Indeterminate QRS Axis QRS Axis Indeterminate An electrocardiographic finding in which the frontal plane QRS axis cannot be calculated. QRS Axis Indeterminate Inferior MI Inferior Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads III, aVF and often II, which is suggestive of myocardial infarction of the inferior wall of the left ventricle. Inferior Myocardial Infarction by ECG Finding An electrocardiographic recording in which fewer than the required number of cardiac complexes are available for measurement and/or interpretation due to a shorter than planned recording or due to cardiac complexes which are present but are not suitable for measurement and/or interpretation. Insufficient Number of Beats for Complete ECG Evaluation Intraatrial Conduction Delay An electrocardiographic finding of a delay in impulse propagation through the atria. This is characterized by broad P waves which are often biphasic in V1. Intra-Atrial Conduction Delay by ECG Finding Intraventricular Conduction Defect Intraventricular conduction delay An electrocardiographic finding of a widened QRS duration. Nonspecific Intraventricular Conduction Delay by ECG Finding An electrocardiographic recording for which the displayed leads do not represent the individual's true ECG lead information. Invalid ECG Waveforms Isorhythmic dissociation An electrocardiographic finding of a type of atrioventricular dissociation characterized by the atria (P waves) and ventricles (QRS complexes) beating at similar rates, although independently. Isorhythmic Atrioventricular Dissociation J point elevation An electrocardiographic finding of a significant elevation above the baseline of the J point. J Point Elevation Junctional bradycardia An electrocardiographic finding of a junctional rhythm with a heart rate which is abnormally low. Junctional Bradycardia by ECG Finding Junctional Escape Beat Junctional Escape Complex An electrocardiographic finding of an escape beat following a pause which originates in the AV junction. This is manifest as a QRS complex of supraventricular origin not preceded by a P wave; there may be one or more occurrences during an electrocardiographic recording. Junctional Escape Complexes by ECG Finding An electrocardiographic finding of a junctional rhythm that arises as a physiologic response to extreme slowing or arrest of sinus node activity. In this setting, a faster junctional rhythm may be a normal response to a very slow or absent sinus rate. Junctional Escape Rhythm by ECG Finding Junctional Extra Beat Junctional Premature Complexes An electrocardiographic finding of an ectopic impulse originating in the AV junction presenting as a QRS complex of supraventricular origin which is not preceded by a P wave; there may be one or more occurrences during an electrocardiographic recording. Junctional Premature Complex by ECG Finding Junctional rhythm An electrocardiographic finding of a rhythm which originates in the AV junction and results in a normal heart rate. It is characterized by retrograde P waves which may be obscured by or may follow the QRS complexes. The QRS complexes may be narrow or may demonstrate aberration. Junctional Rhythm by ECG Finding Junctional tachycardia An electrocardiographic finding of a junctional rhythm with a heart rate which is abnormally elevated. Junctional Tachycardia by ECG Finding Late R Wave Transition An electrocardiographic finding where the amplitude of the R wave does not become greater than the amplitude of the S wave until an unusually late point in the precordial leads, usually in leads V4 to V6. Late R Wave Transition by ECG Finding Lateral MI Lateral Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V5, V6, I and aVL, which is suggestive of myocardial infarction of the lateral wall of the left ventricle. Lateral Myocardial Infarction by ECG Finding Left anterior fascicular block Left Anterior Hemiblock An electrocardiographic finding of a slightly widened QRS duration with leftward frontal plane QRS axis and typically small Q waves. Left Anterior Fascicular Block by ECG Finding Left Atrial Enlargement P-mitrale An electrocardiographic finding suggesting underlying hypertrophy or dilatation of the left atrium. Electrocardiographic criteria used for the diagnosis of left atrial abnormality may include a bifid p wave, a biphasic p wave and/or a p wave duration of greater than 0.12 seconds. (NCI) P-mitrale by ECG Finding Complete LBBB Left bundle branch block Left bundle-branch block An electrocardiographic finding of a wide QRS complex with evidence of delayed conduction to the left ventricle, manifest as a widened initial portion of the QRS complex. Left Bundle Branch Block by ECG Finding Left posterior fascicular block Left Posterior Hemiblock An electrocardiographic finding of an S1Q3 pattern and QRS axis greater than or equal to 120 degrees. It is usually seen in association with other abnormalities (e.g. RBBB or RVH). Left Posterior Fascicular Block by ECG Finding Left Ventricular Conduction Delay An electrocardiographic finding in which there is evidence that electrical transmission through the left ventricle is impaired. Left Ventricular Conduction Delay by ECG Finding Left Ventricular Hypertrophy With Strain An electrocardiographic finding suggestive of a hypertrophied left ventricle, characterized by large QRS amplitudes, ST depression and T wave inversion. Left Ventricular Hypertrophy with Strain by ECG Finding Left Ventricular Hypertrophy An electrocardiographic finding suggestive of a hypertrophied left ventricle, characterized by large QRS amplitudes and secondary findings of left atrial enlargement, left axis deviation, or typical pattern of ST depression and T wave inversion. Left Ventricular Hypertrophy by ECG Finding An electrocardiographic recording in which one or more of the limb electrodes are disconnected resulting in missing waveforms (often flat lines) of the respective leads. Disconnected Limb Electrodes by ECG Finding Limb Lead Reversal An electrocardiographic recording in which two or more of the limb electrodes are switched resulting in improper representation of the affected leads. Interchanged Limb Electrodes by ECG Finding Low Amplitude QRS Complex An electrocardiographic recording showing smaller than usual QRS complexes in one or more leads. This may represent a technical issue with the ECG acquisition or characteristics of the individual. Low Amplitude QRS Complex by ECG Finding Low QRS voltage An electrocardiographic finding of a QRS amplitude less than or equal to 0.5 mV in the limb leads or QRS amplitude less than or equal to 1 mV in the precordial leads. Low QRS Voltage by ECG Finding An electrocardiographic finding of small QRS amplitudes (less than 500 microvolts) in all limb leads. Low Voltage in Limb Leads Only by ECG Finding Multifocal atrial tachycardia An electrocardiographic finding of a supraventricular arrhythmia characterized by 3 or more distinct P wave morphologies with an isoelectric baseline, variable PR intervals and no predominant atrial rhythm. Multifocal Atrial Tachycardia by ECG Finding An electrocardiographic recording with intermittent mid to high frequency artifact in one or more leads due to muscular tremor or movement rather than cardiac activity. Muscle Tremor Artifact Myocardial Infarction An electrocardiographic finding of pathologic Q waves, which is suggestive of myocardial infarction of one or more regions of the heart. No specification is provided for localization. Myocardial Infarction by ECG Finding New Anterior MI New Anterior Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V3 and V4, which is suggestive of myocardial infarction of the anterior wall of the left ventricle and which is new compared to prior ECGs. New Anterior Myocardial Infarction by ECG Finding New Anterolateral Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V3 through V6, which is suggestive of myocardial infarction of the anterolateral wall of the left ventricle and which is new compared to prior ECGs. New Anterolateral Myocardial Infarction by ECG Finding New Anteroseptal Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V1 through V4, which is suggestive of myocardial infarction of the anteroseptal wall of the left ventricle and which is new compared to prior ECGs. New Anteroseptal Myocardial Infarction by ECG Finding New Extensive Anterior Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V1 to V6, I and aVL, which is suggestive of myocardial infarction involving the anterior and anterolateral walls of the left ventricle and which is new compared to prior ECGs. New Extensive Anterior Myocardial Infarction by ECG Finding New High Lateral Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads I and aVL, which is suggestive of myocardial infarction of the high lateral wall of the left ventricle and which is new compared to prior ECGs. New High Lateral Myocardial Infarction by ECG Finding New Inferior Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads III, aVF and often II, which is suggestive of myocardial infarction of the inferior wall of the left ventricle and which is new compared to prior ECGs. New Inferior Myocardial Infarction by ECG Finding New Lateral Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V5, V6, I and aVL, which is suggestive of myocardial infarction of the lateral wall of the left ventricle and which is new compared to prior ECGs. New Lateral Myocardial Infarction by ECG Finding New Myocardial Infarction An electrocardiographic finding of pathologic Q waves, which is suggestive of myocardial infarction of one or more regions of the heart and which is new compared to prior ECGs. No specification is provided for localization. New Myocardial Infarction by ECG Finding An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, and upright T wave, which is suggestive of myocardial infarction of the posterior wall of the left ventricle, and which is new compared to prior ECGs. Evidence of inferior or lateral myocardial infarction is usually also present. New Posterior Wall Myocardial Infarction by ECG Finding New Septal Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V1, V2 and often V3, which is suggestive of myocardial infarction of the intraventricular septum and which is new compared to prior ECGs. New Septal Myocardial Infarction by ECG Finding An electrocardiographic recording that displays flat lines (no waveforms are visible) in all leads present. ECG Waveforms Not Present Non Q Wave Myocardial Infarction An electrocardiographic finding of ST and T wave abnormalities in the absence of pathologic Q waves, which is suggestive of myocardial infarction in one or more regions of the heart. Non Q Wave Myocardial Infarction by ECG Finding An electrocardiographic finding of Q waves which are insufficient for the diagnosis of myocardial infarction. In such cases a myocardial infarction may be suspected, even though ECG criteria are not met. Non-Diagnostic Q Waves by ECG Finding Non-specific ST-T changes An electrocardiographic finding of changes in the ST segment and T wave that do not meet criteria for ischemia or infarction. (NCI) Non-Specific ST-T Changes by ECG Finding An electrocardiographic finding of idioventricular rhythm with a rate greater than 50 beats per minute that terminates in less than 30 seconds. Non-Sustained Accelerated Idioventricular Rhythm by ECG Finding Non-Sustained Atrial Tachycardia An electrocardiographic finding of an atrial tachycardia which terminates in less than 30 seconds. Non-Sustained Atrial Tachycardia by ECG Finding Non-sustained ventricular tachycardia Ventricular tachycardia, unsustained An electrocardiographic finding of ventricular tachycardia less than 30 seconds in duration. (NCI) Non-Sustained Ventricular Tachycardia by ECG Finding An electrocardiographic finding of a P wave that does not conduct to the ventricle or result in ventricular activation. Nonconducted P Wave Physiology Not Defined by ECG Finding Normal Sinus Rhythm An electrocardiographic finding of an atrial rhythm which originates from the sinoatrial node that is considered normal. There are no extra beats or conduction abnormalities. Normal Sinus Rhythm Northwest Axis Right superior axis An electrocardiographic finding of a frontal plane QRS axis from -90 to +180 degrees. Extreme Right Axis Deviation Notched T Waves An electrocardiographic finding of an irregular, u or v shaped deflection within the contour of the T wave. T Wave Notched by ECG Finding Old Or Age Indeterminate Anterior Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V3 and V4, which is suggestive of myocardial infarction of the anterior wall of the left ventricle, without evidence of current or ongoing acute infarction. Old or Age Indeterminate Anterior Myocardial Infarction by ECG Finding Old Or Age Indeterminate Anterolateral Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V3 through V6, which is suggestive of myocardial infarction of the anterolateral wall of the left ventricle, without evidence of current or ongoing acute infarction. Old or Age Indeterminate Anterolateral Myocardial Infarction by ECG Finding Old Or Age Indeterminate Anteroseptal Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V1 through V4, which is suggestive of myocardial infarction of the anteroseptal wall of the left ventricle, without evidence of current or ongoing acute infarction. Old or Age Indeterminate Anteroseptal Myocardial Infarction by ECG Finding Old Or Age Indeterminate Extensive Anterior Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V1 to V6, I and aVL, which is suggestive of myocardial infarction involving the anterior and anterolateral walls of the left ventricle, without evidence of current or ongoing acute infarction. Old or Age Indeterminate Extensive Anterior Myocardial Infarction by ECG Finding Old Or Age Indeterminate High Lateral Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads I and aVL, which is suggestive of myocardial infarction of the high lateral wall of the left ventricle, without evidence of current or ongoing acute infarction. Old or Age Indeterminate High Lateral Myocardial Infarction by ECG Finding Old Or Age Indeterminate Inferior Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads III, aVF and often II, which is suggestive of myocardial infarction of the inferior wall of the left ventricle, without evidence of current or ongoing acute infarction. Old or Age Indeterminate Inferior Myocardial Infarction by ECG Finding Old Or Age Indeterminate Lateral Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V5, V6, I and aVL, which is suggestive of myocardial infarction of the lateral wall of the left ventricle, without evidence of current or ongoing acute infarction. Old or Age Indeterminate Lateral Myocardial Infarction by ECG Finding Old Or Age Indeterminate Posterior Wall Myocardial Infarction An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, and upright T wave, which is suggestive of myocardial infarction of the posterior wall of the left ventricle, without evidence of current or ongoing acute infarction. Evidence of inferior or lateral myocardial infarction is usually also present. Old or Age Indeterminate Posterior Myocardial Infarction by ECG Finding Old Or Age Indeterminate Septal Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V1, V2 and often V3, which is suggestive of myocardial infarction of the intraventricular septum, without evidence of current or ongoing acute infarction. Old or Age Indeterminate Septal Myocardial Infarction by ECG Finding Old Or Age Indeterminate Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves, which is suggestive of myocardial infarction of one or more regions of the heart, without evidence of current or ongoing acute infarction. No specification is provided for localization. Old Myocardial Infarction by ECG Finding An electrocardiographic finding, in the presence of an old or age indeterminate inferior wall myocardial infarction, of Q waves greater than or equal to 40 ms in duration in the right ventricular leads V4R through V6R. Old or Age Indeterminate Right Ventricular Myocardial Infarction by ECG Finding An electrocardiographic recording in which one or more electrodes are incorrectly placed but further details are not provided. Other Incorrect Electrode Placement P Wave Abnormality An electrocardiographic finding for the P wave that is atypical either for the shape, duration, amplitude, axis or polarity. Abnormality of the P wave signifies aberrant propagation of the electrical impulse through the atria. (NCI) P Wave Abnormality by ECG Finding P Wave Notched An electrocardiographic finding of P waves with two peaks longer in duration than normal and amplitude greater than normal. P Wave Notched by ECG Finding AV dual-paced complex(es) or rhythm Paced Atrial And Ventricular Rhythm An electrocardiographic finding in which both the atrial and ventricular rhythm are controlled by an electrical impulse from an artificial cardiac pacemaker. Paced Atrial And Ventricular Rhythm Atrial-paced complex(es) or rhythm Paced Atrial Rhythm An electrocardiographic finding in which the atrial rhythm is controlled by an electrical impulse from an artificial cardiac pacemaker. Paced Atrial Rhythm Atrial and/or Ventricular Paced Rhythm Paced Rhythm An electrocardiographic finding in which the cardiac rhythm is controlled by an electrical impulse from an artificial cardiac pacemaker. Paced Rhythm Paced Ventricular Rhythm Ventricular-paced complex(es) or rhythm An electrocardiographic finding in which the ventricular rhythm is controlled by an electrical impulse from an artificial cardiac pacemaker. Paced Ventricular Rhythm Paroxysmal AV block An electrocardiographic finding of the sudden onset of transient AV block. Paroxysmal Atrioventricular Block by ECG Finding Paroxysmal Ventricular Tachycardia An episodic form of ventricular tachycardia, with abrupt onset and termination. (NCI) Paroxysmal Ventricular Tachycardia by ECG Finding An electrocardiographic finding of an RR interval with duration greater than 3.0 seconds, regardless of the underlying rhythm. Pause Greater Than Three Seconds by ECG Finding An electrocardiographic finding of an RR interval which exceeds a predefined duration threshold, regardless of the underlying rhythm. Pause by ECG Finding An electrocardiographic recording that does not show proper quality for reasons that are not otherwise described. Poor Quality ECG Poor R Wave Progression An electrocardiographic finding of a lack of progression of R wave height across precordial leads. Poor R Wave Progression by ECG Finding Posterior MI Posterior Wall Myocardial Infarction An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, and upright T wave, which is suggestive of myocardial infarction of the posterior wall of the left ventricle. Evidence of inferior or lateral myocardial infarction is usually also present. Posterior Myocardial Infarction by ECG Finding PR Depression An electrocardiographic finding of PR segment depression below the iso-electric line in multiple precordial and/or limb leads. PR Segment Depression by ECG Finding Pre-excitation Ventricular preexcitation An electrocardiographic finding characterized by a premature activation of the whole or some part of the ventricle. Pre-Excitation Syndrome An electrocardiographic recording in which the electrode for lead V1 is disconnected resulting in missing waveforms (flat line) for lead V1. Disconnected Precordial Electrode V1 by ECG Finding An electrocardiographic recording in which the electrode for lead V2 is disconnected resulting in missing waveforms (flat line) for lead V2. Disconnected Precordial Electrode V2 by ECG Finding An electrocardiographic recording in which the electrode for lead V3 is disconnected resulting in missing waveforms (flat line) for lead V3. Disconnected Precordial Electrode V3 by ECG Finding An electrocardiographic recording in which the electrode for lead V4 is disconnected resulting in missing waveforms (flat line) for lead V4. Disconnected Precordial Electrode V4 by ECG Finding An electrocardiographic recording in which the electrode for lead V5 is disconnected resulting in missing waveforms (flat line) for lead V5. Disconnected Precordial Electrode V5 by ECG Finding An electrocardiographic recording in which the electrode for lead V6 is disconnected resulting in missing waveforms (flat line) for lead V6. Disconnected Precordial Electrode V6 by ECG Finding An electrocardiographic recording in which one or more precordial electrodes are placed incorrectly with respect to the standard chest electrode positions resulting in improper representation of the affected leads. Incorrectly Positioned Precordial Electrodes by ECG Finding Precordial Lead Reversal An electrocardiographic recording in which two or more of the precordial electrodes are switched resulting in improper representation of the affected leads. Interchanged Precordial Electrodes by ECG Finding Atrial premature complexes, nonconducted Non-conducted SVE Premature Atrial Complex Blocked Premature Atrial Complexes Non-conducted An electrocardiographic finding of a premature atrial complexes that are is not conducted to the ventricles, and that are is not followed by a QRS complex; there may be one or more occurrences during an electrocardiographic recording. Blocked Atrial Premature Complex by ECG Finding Multifocal Supraventricular Extra Beats Multifocal SVE Premature Atrial Complex Multifocal Premature Atrial Complexes Multiform An electrocardiographic finding of premature atrial complexes which have 2 or more distinct morphologies, suggesting origin at more than one atrial site. Multifocal Atrial Premature Complex by ECG Finding Premature Atrial Complex Unifocal An electrocardiographic finding of premature atrial complexes which have a single distinct morphology, suggesting origin at one atrial site. Unifocal Atrial Premature Complex by ECG Finding APC Atrial premature complex(es) PAC Premature atrial complex Supraventricular Extra Beat Supraventricular Premature Beat SVE An electrocardiographic finding of an ectopic impulse originating in the atria and not specifically in the sinus node. The P wave morphology of these complexes is often different from a sinus P wave and the RR intervals preceding these complexes is also shorter than those of the regular beats; there may be one or more occurrences during an electrocardiographic recording. Atrial Premature Complex by ECG Finding Interpolated VE Interpolated Ventricular Extra Beat Interpolated VES Interpolated VPC Premature Ventricular Complexes Interpolated An electrocardiographic finding of a premature ventricular complex which occurs between two normal QRS complexes which have normal timing; there may be one or more occurrences during an electrocardiographic recording. Interpolated Premature Ventricular Complex by ECG Finding Premature Ventricular Complexes PVC VE Ventricular Extra Beat Ventricular Premature Complexes VES VPC An electrocardiographic finding of an ectopic impulse originating in the ventricles. The QRS morphology of these complexes is different from those of supraventricular origin. The QRS duration is often longer and the RR interval preceding the complexes is usually shorter than that of supraventricular beats; there may be one or more occurrences during an electrocardiographic recording. Ventricular Premature Complex by ECG Finding Multifocal Ventricular Extra Beats Multifocal VES Multifocal VPCS Premature Ventricular Complex Multifocal An electrocardiographic finding of premature ventricular complexes which have two or more distinct morphologies, suggesting origin at more than one ventricular site. Multifocal Ventricular Premature Complex by ECG Finding Premature Ventricular Complex Unifocal Unifocal Ventricular Extra Beats Unifocal VES Unifocal VPCS An electrocardiographic finding of premature ventricular complexes which have a single distinct morphology, suggesting origin at one ventricular site. Unifocal Ventricular Premature Complex by ECG Finding Prolonged QT Prolonged QT interval An electrocardiographic finding in which the QT interval not corrected for heart rate is prolonged. Prolonged QT Interval by ECG Finding An electrocardiographic finding of a prolonged ST segment, resulting in a long QT interval, without lengthening of the T wave duration. Prolonged ST Segment by ECG Finding Left-axis deviation Q Axis, Left axis deviation QRS axis, left axis deviation An electrocardiographic finding of a frontal plane QRS axis from -30 to -90 degrees. Q Axis Left Axis Deviation Q Axis, Right axis deviation QRS axis, right axis deviation Right-axis deviation An electrocardiographic finding of a frontal plane QRS axis from +90 to +180 degrees. Q Axis Right Axis Deviation QRS Complex Abnormality An electrocardiographic finding of a non-specific abnormality of the QRS complex, which is atypical in shape, duration, amplitude, axis or polarity. QRS Complex Abnormality by ECG Finding QTc Prolongation An electrocardiographic finding in which the QTc interval corrected for heart rate is prolonged. Corrected Prolonged QT Interval by ECG Finding PROLONGED QTcB An electrocardiographic finding in which the QT interval corrected for heart rate using Bazett's formula is prolonged. QTcB Prolongation PROLONGED QTcF An electrocardiographic finding in which the QT interval corrected for heart rate using Fridericia's formula is prolonged. QTcF Prolongation Unknown Quality Problem An electrocardiographic artifact or recording error with unknown origin or which is not described otherwise. Quality Problem Not Otherwise Specified by ECG Finding R on T phenomenon An electrocardiographic finding in which the R wave of a premature ventricular complex occurs on top of the T wave of the preceding beat. R On T Phenomenon by ECG Finding R Wave Notched An electrocardiographic finding of an R wave variant in which there is a small deflection of the R wave, with changing polarity, within the QRS complex. (NCI) R Wave Notched by ECG Finding Repolarization Abnormality Secondary To Ventricular Hypertrophy ST-T change due to ventricular hypertrophy An electrocardiographic finding of ST depression and T wave inversion in the presence of increased QRS amplitude which are thought to be due to left ventricular hypertrophy. Repolarization Abnormality Secondary To Ventricular Hypertrophy Repolarization Abnormality An electrocardiographic finding of an abnormality of T wave duration or morphology or of early repolarization. Ventricular Repolarization Abnormality P-pulmonale Right Atrial Enlargement An electrocardiographic finding suggesting underlying hypertrophy or dilatation of the right atrium. Electrocardiographic criteria used for the diagnosis of right atrial abnormality may include a peaked p wave greater than 2.5 millimeters in amplitude in the inferior leads. (NCI) P-pulmonale by ECG Finding Complete RBBB Right bundle branch block Right bundle-branch block An electrocardiographic finding of a wide QRS complex with evidence of delayed conduction to the right ventricle, manifest by a widened initial portion of the QRS. Right Bundle Branch Block by ECG Finding Right Ventricular Conduction Delay Right Ventricular Delay An electrocardiographic finding in which there is evidence that electrical transmission through the right ventricle is impaired. Right Ventricular Conduction Delay by ECG Finding Right ventricular Hypertrophy An electrocardiographic finding suggestive of a hypertrophied right ventricle, characterized by large R wave amplitudes in the right precordial leads and secondary findings of right atrial enlargement, right axis deviation, and typical pattern of ST depression and T wave inversion in the right precordial leads. Right Ventricular Hypertrophy by ECG Finding RSR' An electrocardiographic finding in which there are two R waves, which are two deflections above the baseline resulting from a single ventricular depolarization. The first upward deflection in the complex is the R wave. The S is the first downward deflection. A second upward deflection is called the R-prime wave. RSR' by ECG Finding Septal myocardial infarction An electrocardiographic finding suggesting an infarction in the anatomic location of the cardiac septum. (NCI) Septal Myocardial Infarction by ECG Finding Short PR interval An electrocardiographic finding of an abnormally short PR interval. Short PR Interval by ECG Finding Short QTc Interval An electrocardiographic finding of a QT interval corrected for heart rate that is shorter than the lower limit of normal. Short QTc Interval An electrocardiographic finding in which the QT interval corrected for heart rate using Bazett's formula is shortened. QTcB Shortened An electrocardiographic finding in which the QT interval corrected for heart rate using Fridericia's formula is shortened. QTcF Shortened An electrocardiographic finding of a short or absent ST segment, resulting in a short QT interval, without changes in T wave morphology. Short ST Segment by ECG Finding SA Block Sinoatrial Block Sinoatrial exit block An electrocardiographic finding in which impaired conduction or automaticity within the sinus node results in the failure of impulse transmission from the sinoatrial node. This is manifest as dropped P waves during sinus rhythm. Exit Block by ECG Finding Sinus arrest/pause Sinus pause or arrest An electrocardiographic finding in which a failure of impulse formation or conduction in the sinus node produces prolongation of the P-P interval or dropped P waves. Sinus Arrest by ECG Finding Respiratory Sinus Arrhythmia Sinus arrhythmia An electrocardiographic finding in which the sinus rate fluctuates. Sinus Arrhythmia by ECG Finding Sinus bradycardia An electrocardiographic finding of abnormally slow heart rate with its origin in the sinus node. Sinus Bradycardia by ECG Finding Sinus Rhythm An electrocardiographic finding of an atrial rhythm which originates from the sinoatrial node that is considered normal for the population. Sinus Rhythm Sinus tachycardia An electrocardiographic finding of abnormally rapid heart rate with its origin in the sinus node. Sinus Tachycardia by ECG Finding ST depression An electrocardiographic finding of ST segment depression below the baseline, often described as up sloping, down sloping or horizontal. (NCI) ST Segment Depression by ECG Finding ST elevation pericarditis An electrocardiographic finding of ST elevation which is concave upwards, and which is often accompanied by PR segment depression. ST Elevation Pericarditis by ECG Finding ST elevation An electrocardiographic finding of ST segment elevation above the baseline. (NCI) ST Segment Elevation by ECG Finding An electrocardiographic finding of a supraventricular QRS complex followed by a premature supraventricular complex for 3 or more consecutive cycles; a regularly irregular rhythm of normal and abnormal QRS complexes in a 1-1 ratio. Supraventricular Bigeminy by ECG Finding An electrocardiographic finding in which two premature atrial complexes occur sequentially. Supraventricular Couplet by ECG Finding Supraventricular Escape Complex Supraventricular Escape Complexes An electrocardiographic finding of a compensatory supraventricular complex that occurs following a prolonged RR interval. Supraventricular Escape Beat by ECG Finding Supraventricular Premature Complexes, Origin Unknown An electrocardiographic finding of an ectopic impulse originating from the atria or AV junction for which the site of origin cannot be determined from the surface electrocardiographic recording; there may be one or more occurrences during an electrocardiographic recording. Supraventricular Premature Complex With Unknown Origin by ECG Finding An electrocardiographic finding of three or more consecutive beats of supraventricular origin without reference to rate. Supraventricular Run by ECG Finding Supraventricular tachycardia An electrocardiographic finding of a tachycardia which does not originate in the ventricles or His Purkinje system. There is an abnormally high heart rate and QRS complexes are typically narrow, but aberration or preexcitation may be present. Supraventricular Tachycardia by ECG Finding An electrocardiographic finding of two supraventricular QRS complexes followed by a premature supraventricular complex for 3 or more consecutive cycles; a regularly irregular rhythm of normal and abnormal QRS complexes in a 2-1 ratio. Supraventricular Trigeminy by ECG Finding An electrocardiographic recording in which an interchange of one or more limb lead electrodes is suspected, but for which an interpretation is performed as though the lead placement is correct. Suspicion of Limb Electrodes Reversal But Interpretation Assumes No Reversal by ECG Finding An electrocardiographic recording in which an interchange of one or more limb lead electrodes is suspected, and for which an interpretation is performed as though the leads have in fact been interchanged. Suspicion of Limb Electrodes Reversal But Interpretation Assumes Reversal by ECG Finding An electrocardiographic finding of idioventricular rhythm with a rate greater than 50 beats per minute that lasts 30 seconds or longer. Sustained Accelerated Idioventricular Rhythm by ECG Finding An electrocardiographic finding of an atrial tachycardia that lasts 30 seconds or longer. Sustained Atrial Tachycardia by ECG Finding Sustained ventricular tachycardia An electrocardiographic finding of ventricular tachycardia with longer than normal duration. Sustained Ventricular Tachycardia by ECG Finding T Wave Alternans An electrocardiographic finding in which there are variations in the shape, amplitude, or direction of the T wave from one beat to the next. T Wave Alternans by ECG Finding T Wave Inversion An electrocardiographic finding of an inversion of the T wave from the expected axis. (NCI) T Wave Inversion by ECG Finding T wave peaked An electrocardiographic finding in which the T wave appears increased in amplitude and cresting at a point. (NCI) T Wave Peaked by ECG Finding T waves biphasic An electrocardiographic finding of a T wave with both positive and negative components. T Waves Biphasic by ECG Finding T waves flat An electrocardiographic finding in which the T wave appears decreased in amplitude. (NCI) T Waves Flat by ECG Finding Tachycardia An electrocardiographic finding of abnormally rapid heart rate. Tachycardia by ECG Finding Torsades de pointes Ventricular tachycardia, torsades de pointes An electrocardiographic finding of an atypical rapid polymorphic ventricular tachycardia with a characteristic rotation of the QRS complex around the isoelectric baseline, occurring in the setting of a prolonged QT interval. In addition, the QRS complex displays a periodic waxing and waning of amplitude on the electrogram. Torsades De Pointes by ECG Finding Abnormal U Wave An electrocardiographic finding of U waves which have increased amplitude, are inverted, or merged with the preceding T wave. U Wave Abnormality by ECG Finding A statement indicating the inability to digitize a paper ECG. Inability to Digitize ECG Leads An electrocardiographic finding of a cardiac rhythm whose mechanism cannot be determined from the ECG. Undetermined Rhythm by ECG Finding An electrocardiographic finding of a rhythm which does not originate in the ventricles or His Purkinje system, but whose specific electrophysiologic mechanism cannot be determined from the ECG. The QRS complexes are typically narrow, but aberration or preexcitation may be present. Undetermined Supraventricular Rhythm by ECG Finding Bigeminy An electrocardiographic finding of a normal QRS complex followed by a premature ventricular complex for 3 or more consecutive cycles; a regularly irregular rhythm of normal and abnormal QRS complexes in a 1-1 ratio. Ventricular Bigeminy by ECG Finding Ventricular Couplets Ventricular Pair An electrocardiographic finding in which two premature ventricular complexes occur sequentially; there may be one or more occurrences during an electrocardiographic recording. Ventricular Couplet by ECG Finding Ventricular Escape Beats Ventricular Escape Complex Ventricular Escape Complexes An electrocardiographic finding of a compensatory ventricular complex that occurs following a prolonged RR interval; there may be one or more occurrences during an electrocardiographic recording. Ventricular Escape Beat by ECG Finding Ventricular fibrillation An electrocardiographic finding of a rapid grossly irregular ventricular rhythm with marked variability in QRS cycle length, morphology, and amplitude. Ventricular Fibrillation by ECG Finding Ventricular flutter A ventricular tachyarrhythmia characterized by a high ventricular rate with a regular rhythm. The electrocardiogram shows large oscillating sine wave-like complexes occurring as a result of QRS complexes and T waves being merged. The P wave is not visible. (NCI) Ventricular Flutter by ECG Finding Parasystole Ventricular Parasystole An electrocardiographic finding of normal sinus rhythm coexisting with a regular ectopic ventricular rhythm. Ventricular Parasystole by ECG Finding An electrocardiographic finding of three or more consecutive beats of ventricular origin without reference to rate. Ventricular Run by ECG Finding Ventricular tachycardia An electrocardiographic finding of three or more consecutive complexes of ventricular organ with a rate greater than a certain threshold. The QRS complexes are wide and have an abnormal morphology. Ventricular Tachycardia by ECG Finding Ventricular tachycardia, monomorphic An electrocardiographic finding of a ventricular tachycardia in which the QRS complexes have a uniform morphology. Monomorphic Ventricular Tachycardia by ECG Finding Ventricular tachycardia, polymorphic Ventricular tachycardia, polymorphous An electrocardiographic finding of a ventricular tachycardia in which the QRS complexes have a variable morphology and often rate. Polymorphic Ventricular Tachycardia by ECG Finding Trigeminy An electrocardiographic finding of two normal QRS complexes followed by a premature ventricular complex for 3 or more consecutive cycles; a regularly irregular rhythm of normal and abnormal QRS complexes in a 2-1 ratio. Ventricular Trigeminy by ECG Finding An electrocardiographic finding of large QRS amplitudes which may indicate left ventricular hypertrophy, but in the absence of any of the secondary findings which are typical of this diagnosis (left atrial enlargement, left axis deviation, or typical pattern of ST depression and T wave inversion). Voltage Criteria Suggesting Left Ventricular Hypertrophy, Without Secondary ECG Findings Wandering atrial pacemaker An electrocardiographic finding of a supraventricular arrhythmia characterized by 3 or more distinct P wave morphologies with an isoelectric baseline, variable PR intervals and no predominant atrial rhythm. The ventricular rate is typically below 100 beats per minute. Wandering Atrial Pacemaker by ECG Finding Wide QRS tachycardia Wide-QRS tachycardia An electrocardiographic finding of three or more consecutive wide QRS complexes of uncertain origin with a rate greater than a certain threshold. Wide QRS Tachycardia by ECG Finding Wolff-Parkinson-White syndrome WPW An electrocardiographic finding of ventricular pre-excitation. The syndrome is characterized by a short PR interval and a long QRS interval with a delta wave. Wolff-Parkinson-White Syndrome EGSTRESC ECG Result CDISC SDTM ECG Finding Terminology A terminology codelist relevant to the methods used to determine the end of an ECG T wave. Slope Method A method to determine the end of the T wave. A tangent is drawn to the steepest descending slope of the T wave between its summit and the notch; the end of the T-wave is defined as the point of intersection of this tangent with the base line. (Lepeschkin E, Surawicz B. The measurement of the Q-T interval of the electrocardiogram. Circulation 1952; 6: 378-88). Tangent Method A method to determine the end of the T wave. A line parallel to the isoelectric line at a fraction (e.g. 5%) of the maximum T wave amplitue is constructed. The intercept of the descending limb of the T wave with this line is then defined as the end of the T wave. Threshold Method TWOFFMTH ECG T Wave Offset Method Response CDISC SDTM ECG T Wave Offset Method Response Terminology Terminology codelist used with ECG Tests within CDISC. Acute Myocardial Ischemia ECG Change An electrocardiographic finding assessment of new or presumed new significant ST-segment-T wave (ST-T) changes or new left bundle branch block consistent with acute myocardial ischemia. (Thygesen K, Alpert JS, Jaffe AS, Simoons ML, et al.; Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012 Oct 16;60(16):1581-98). Acute Myocardial Ischemia by ECG Assessment Atrioventricular Conduction An electrocardiographic assessment of cardiac atrioventricular conduction. Atrioventricular Conduction ECG Assessment Axis and Voltage An electrocardiographic assessment of mean cardiac electrical vector and the ECG voltage. Axis and Voltage ECG Assessment Chamber Hypertrophy or Enlargement An electrocardiographic assessment of chamber hypertrophy or enlargement. Chamber Hypertrophy or Enlargement ECG Assessment ECG Maximum Atrial Rate An electrocardiographic measurement of the maximum rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute. Maximum Atrial Rate by Electrocardiogram ECG Median Atrial Rate An electrocardiographic measurement of the median rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute. Median Atrial Rate by Electrocardiogram ECG Minimum Atrial Rate An electrocardiographic measurement of the minimum rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute. Minimum Atrial Rate by Electrocardiogram ECG Mean Atrial Rate An electrocardiographic measurement of the average rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute. Mean Atrial Rate by Electrocardiogram Comparison to a Prior ECG A comparative interpretation of an ECG relative to a previous (comparator) ECG. The definition of the comparator ECG may be specified elsewhere. Common comparator result values include improved, no change, deteriorated. Comparison to a Prior ECG ECG Maximum Heart Rate An electrocardiographic measurement of the maximum rate of depolarization of the heart during an interval of time. Maximum Heart Rate by Electrocardiogram ECG Median Heart Rate An electrocardiographic measurement of the median rate of depolarization of a specific region of the heart during an interval of time, usually expressed in beats per minute. Unless otherwise specified, this is usually the median ventricular rate. ECG Median Heart Rate ECG Minimum Heart Rate An electrocardiographic measurement of the minimum rate of depolarization of the heart during an interval of time. Minimum Heart Rate by Electrocardiogram ECG Mean Heart Rate An electrocardiographic measurement of the average rate of depolarization of the heart during an interval of time. Mean Heart Rate by Electrocardiogram Single RR Heart Rate An electrocardiographic measurement of a heart rate derived from a single RR interval (interval between two consecutive QRS complexes). Single Beat RR Extrapolated Heart Rate by ECG Assessment ECG Maximum Ventricular Rate An electrocardiographic measurement of the maximum rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute. Maximum Ventricular Rate by Electrocardiogram ECG Median Ventricular Rate An electrocardiographic measurement of the median rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute. Median Ventricular Rate by Electrocardiogram ECG Minimum Ventricular Rate An electrocardiographic measurement of the minimum rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute. Minimum Ventricular Rate by Electrocardiogram ECG Mean Ventricular Rate An electrocardiographic measurement of the average rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute. Mean Ventricular Rate by Electrocardiogram Interpretation An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. Interpretation Intraventricular-Intraatrial Conduction An electrocardiographic assessment of intraventricular and intra-atrial conduction. Intraventricular and Intraatrial Conduction ECG Assessment JT Interval, Aggregate An aggregate JT value based on the measurement of JT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate JT Interval JTcB Interval, Aggregate A JT aggregate interval that is corrected for heart rate using Bazett's formula, based on the measurement of QT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate JTCB Interval JTcB Interval, Single Beat A JT single beat interval that is corrected for heart rate using Bazett's formula, based on a QT interval measured on a single beat utilizing one or more ECG leads. Single Beat JTCB Interval JTcF Interval, Aggregate A JT aggregate interval that is corrected for heart rate using Fridericia's formula, based on the measurement of QT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate JTCF Interval JTcF Interval, Single Beat A JT single beat interval that is corrected for heart rate using Fridericia's formula, based on a QT interval measured on a single beat utilizing one or more ECG leads. Single Beat JTCF Interval Summary (Max) JT Interval The maximum duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end of the T wave (representing the end of ventricular repolarization). (NCI) Maximum JT Duration Summary (Min) JT Interval The minimum duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end of the T wave (representing the end of ventricular repolarization). (NCI) Minimum JT Duration J-Tpeak Interval, Aggregate An aggregate J-Tpeak value based on the measurement of J-Tpeak intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate J-T Peak Interval J-Tpeak Interval, Single Beat An electrocardiographic interval measured from the J point to the peak of the T wave of a single beat utilizing one or more leads. Single Beat J-T Peak Interval JT Interval, Single Beat An electrocardiographic interval measured from the J point to the offset of the T wave of a single beat utilizing one or more leads. Single Beat JT Interval Myocardial Infarction An electrocardiographic assessment of findings suggestive of myocardial infarction. Myocardial Infarction ECG Assessment New Q Wave An electrocardiographic finding assessment of new or presumed new pathologic Q waves suggestive of myocardial infarction. (Thygesen K, Alpert JS, Jaffe AS, Simoons ML, et al.; Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012 Oct 16;60(16):1581-98). New Q Wave P Wave Axis A numerical representation of the electrocardiographic vector assessed at maximum deviation of the P wave from the isoelectric baseline, usually reported for the frontal plane. P Wave Axis Pacemaker An electrocardiographic assessment of presence of artificial electronic pacing. Pacemaker ECG Assessment PP Interval, Aggregate An aggregate PP value based on the measurement of PP intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate PP Interval PP Interval, Single Measurement An electrocardiographic measurement of the interval between the onsets of two consecutive P waves. Single Measurement PP Interval PQ Interval, Aggregate PQAG PR Interval, Aggregate An aggregate PR value based on the measurement of PR intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate PR Interval Summary (Max) PR Duration The maximum duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave. (NCI) Maximum PR Duration Summary (Min) PR Duration The minimum duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave. (NCI) Minimum PR Duration PQ Interval, Single Beat PQSB PR Interval, Single Beat An electrocardiographic interval measured from the onset of the P wave to the onset of the QRS complex of a single beat utilizing one or more leads. Single Beat PR Interval PR Segment, Aggregate An aggregate PR segment value based on the measurement of PR segment intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate PR Segment PR Segment, Single Beat An electrocardiographic interval measured from the end of the P wave to the onset of the QRS complex of a single beat utilizing one or more leads. Single Beat PR Segment P Wave Duration, Aggregate An aggregate P wave duration value based on the measurement of P wave duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate P Wave Duration P Wave Duration, Single Beat An electrocardiographic interval measured from the onset of the P wave to the offset of the P wave of a single beat utilizing one or more leads. Single Beat P Wave Duration P Wave Amplitude, Aggregate An aggregate P wave amplitude value based on the measurement of P wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate P Wave Amplitude P Wave Amplitude, Single Beat An electrocardiographic measurement of the mean amplitude (usually measured in mm) of the P wave measured from the isoelectric baseline to the peak of the P wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement is reported in millivolt. Single Beat P Wave Amplitude Summary (Max) QA Interval The maximum time interval between the Q wave on an ECG and the onset of the aortic blood pressure pulse. Maximum QA Interval Summary (Mean) QA Interval The mean time interval between the Q wave on an ECG and the onset of the aortic blood pressure pulse. Mean QA Interval Summary (Median) QA Interval The median time interval between the Q wave on an ECG and the onset of the aortic blood pressure pulse. Median QA Interval Summary (Min) QA Interval The minimum time interval between the Q wave on an ECG and the onset of the aortic blood pressure pulse. Minimum QA Interval QRS Axis A numerical representation of the electrocardiographic vector assessed at maximum deviation of the QRS complex from the isoelectric baseline, usually reported for the frontal plane. QRS Axis QRS Duration, Aggregate An aggregate QRS value based on the measurement of QRS intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate QRS Duration QRS Duration, Single Beat An electrocardiographic interval measured from the onset of the QRS complex to the offset of the QRS complex of a single beat utilizing one or more leads. Single Beat QRS Duration QRS Duration, Ventr. Paced, Aggregate An aggregate paced QRS duration value based on the measurement of paced QRS duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Paced Ventricular Aggregate QRS Duration QRS Duration, Ventr. Paced, Single Beat An electrocardiographic interval measured from the onset of the paced QRS complex to the offset of the QRS complex of a single beat utilizing one or more leads. Paced Ventricular Single Beat QRS Duration QT Interval, Aggregate An aggregate QT value based on the measurement of QT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate QT Interval QTca Interval, Aggregate A QT Aggregate interval that is corrected for heart rate using individual probabilistic QT/RR slopes for each subject, based on the measurement of QT intervals from multiple beats within a single ECG or period of a continuous ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate QTca Interval QTca Interval, Single Beat A QT interval that is corrected for heart rate using individual probabilistic QT/RR slopes for each subject, based on a QT interval measured on a single beat utilizing one or more ECG leads. Single Beat QTca Interval QTcB Interval, Aggregate A QT aggregate interval that is corrected for heart rate using Bazett's formula, based on the measurement of QT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate QTCB Interval QTcB Interval, Single Beat A QT single beat interval that is corrected for heart rate using Bazett's formula, based on a QT interval measured on a single beat utilizing one or more ECG leads. Single Beat QTCB Interval QTcF Interval, Aggregate A QT aggregate interval that is corrected for heart rate using Fridericia's formula, based on the measurement of QT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate QTCF Interval QTcF Interval, Single Beat A QT single beat interval that is corrected for heart rate using Fridericia's formula, based on a QT interval measured on a single beat utilizing one or more ECG leads. Single Beat QTCF Interval QTcL Interval, Aggregate A QT aggregate interval corrected for heart rate using a linear correction formula. Aggregate QTcL Interval QTcL Interval, Single Beat A QT single beat interval corrected for heart rate using a linear correction formula. Single Beat QTcL Interval QTc Correction Method Unspecified A QT interval that is corrected for heart rate by unspecified correction method, or by non-standard correction methods. Corrected QT Interval QTc Corr Method Unspecified, Aggregate QTc Correction Method Unspecified, Aggregate A QT aggregate interval that is corrected for heart rate by unspecified correction method, or by non-standard correction methods. QTc Correction Method Unspecified, Aggregate QTc Corr Method Unspecified, Single Beat QTc Correction Method Unspecified, Single Beat A QT interval that is corrected for heart rate by unspecified correction method, or by non-standard correction methods, based on a QT interval measured on a single beat utilizing one or more ECG leads. QTc Correction Method Unspecified, Single Beat QTcV Interval, Aggregate A QT aggregate interval corrected for heart rate using the Van der Water's correction formula. Aggregate QTcV Interval QTcV Interval, Single Beat A QT single beat interval corrected for heart rate using the Van der Water's correction formula. Single Beat QTcV Interval Summary (Max) QT Duration The maximum duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave. (NCI) Maximum QT Duration Summary (Min) QT Duration The minimum duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave. (NCI) Minimum QT Duration QT Interval, Single Beat An electrocardiographic interval measured from the onset of the QRS complex to the offset of the T wave of a single beat utilizing one or more leads. Single Beat QT Interval Q Wave Amplitude, Aggregate An aggregate Q wave amplitude value based on the measurement of Q wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate Q Wave Amplitude Q Wave Amplitude, Single Beat An electrocardiographic measurement of the mean amplitude (usually measured in mm) of the Q wave measured from the isoelectric baseline to the peak of the Q wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in millivolt. Single Beat Q Wave Amplitude Rhythm Not Otherwise Specified An electrocardiographic assessment of cardiac rhythm not otherwise specified. Rhythm Not Otherwise Specified ECG Assessment RR Interval, Aggregate An aggregate RR value based on the measurement of RR intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate RR Interval Summary (Max) RR Duration The maximum duration (time) between successive peaks of R waves in a particular set of RR intervals. (NCI) Maximum RR Duration Summary (Min) RR Duration The minimum duration (time) between successive peaks of R waves in a particular set of RR intervals. (NCI) Minimum RR Duration RR Interval, Single Measurement An electrocardiographic measurement of the interval between two consecutive R waves. If R waves are not present, this measurement may utilize the interval between the most easily identified components of the QRS complex within two consecutive beats. RR Interval Single Measurement RS Wave Amplitude, Aggregate An aggregate RS wave amplitude value based on measurements from multiple beats from a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. RS Wave Amplitude Aggregate RS Wave Amplitude, Single Beat An electrocardiographic measurement of the sum of the amplitudes of the R and S waves, obtained from a single beat in one particular lead or set of leads. RS Wave Amplitude Single Beat R Wave Amplitude, Aggregate An aggregate R wave amplitude value based on the measurement of R wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. R Wave Amplitude Aggregate R Wave Amplitude, Single Beat An electrocardiographic measurement of the mean amplitude (usually measured in mm) of the R wave measured from the isoelectric baseline to the peak of the R wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement is reported in millivolt. R Wave Amplitude Single Beat Sinus Node Rhythms and Arrhythmias An electrocardiographic assessment of sinus node rhythms and arrhythmias. Sinus Node Rhythm and Arrhythmia ECG Assessment Supraventricular Arrhythmias An electrocardiographic assessment of supraventricular arrhythmias excluding tachycardias. Supraventricular Arrhythmia ECG Assessment Supraventricular Tachyarrhythmias An electrocardiographic assessment of supraventricular tachyarrhythmias. Supraventricular Tachyarrhythmia ECG Assessment ST Segment Depression, Aggregate An aggregate ST segment depression value based on the measurement of ST segment depression from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. ST Segment Depression Aggregate Summary (Max) ST Depression The maximum depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. This is usually expressed in millivolt. Maximum ST Segment Depression by ECG Finding Summary (Min) ST Depression The minimum depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. This is usually expressed in millivolt. Minimum ST Segment Depression by ECG Finding ST Segment Depression, Single Beat An electrocardiographic measurement of the mean amplitude (usually measured in mm) of the ST segment depression below the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in millivolt. ST Segment Depression Single Beat ST Segment Deviation, Aggregate An aggregate ST segment deviation value based on the measurement of ST segment deviation from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. ST Segment Deviation Aggregate Summary (Max) ST Deviation The maximum deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. This is usually expressed in millivolt. Maximum ST Deviation Summary (Min) ST Deviation The minimum deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. This is usually expressed in millivolt. Minimum ST Deviation ST Segment Deviation, Single Beat An electrocardiographic measurement of the mean amplitude (usually measured in mm) of the ST segment deviation above or below the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the recording gain, this measurement is reported in millivolt. ST Segment Deviation Single Beat ST Segment Elevation, Aggregate An aggregate ST segment elevation value based on the measurement of ST segment elevation from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. ST Segment Elevation Aggregate Summary (Max) ST Elevation The maximum elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. This is usually reported in millivolt. Maximum ST Segment Elevation Summary (Min) ST Elevation The minimum elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. This is usually reported in millivolt. Minimum ST Segment Elevation ST Segment Elevation, Single Beat An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the ST segment elevation above the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm. ST Segment Elevation Single Beat ST Segment Duration, Aggregate An aggregate ST segment duration value based on the measurement of ST segment duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. ST Segment Duration Aggregate ST Segment Duration, Single Beat An electrocardiographic interval measured from the J point to the onset of the T wave of a single beat utilizing one or more leads. ST Segment Duration Single Beat ST Segment, T wave, and U wave An electrocardiographic assessment of the characteristics of the ST segment, T wave, and U wave. ST Segment, T wave, and U wave ECG Assessment S Wave Amplitude, Aggregate An aggregate S wave amplitude value based on the measurement of S wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. S Wave Amplitude Aggregate S Wave Amplitude, Single Beat An electrocardiographic measurement of the mean amplitude (usually measured in mm) of the S wave measured from the isoelectric baseline to the peak of the S wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement is reported in millivolt. S Wave Amplitude Single Beat T Wave Axis A numerical representation of the electrocardiographic vector assessed at maximum deviation of the T wave from the isoelectric baseline, usually reported for the frontal plane. T Wave Axis Technical Quality A statement about an electrocardiographic recording describing technical issues or interference during the recording, processing, or transmission of the data. This does not represent an electrocardiographic diagnosis. ECG Technical Quality Tpeak-Tend Interval, Aggregate An aggregate Tpeak-Tend value based on the measurement of Tpeak-Tend from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. T Peak-T End Interval Aggregate Tpeak-Tend Interval, Single Beat An electrocardiographic interval measured from the peak of the T wave to the offset of the T wave of a single beat utilizing one or more leads. T Peak-T End Interval Single Beat T Wave Area, Aggregate An aggregate T wave area value based on the measurement of T wave areas from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. T Wave Area Aggregate T Wave Area, Single Beat An electrocardiographic measurement of the area of the T wave of a single beat utilizing one or more leads. T Wave Area Single Beat T Wave Duration, Aggregate An aggregate T wave duration value based on the measurement of T wave duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. T Wave Duration Aggregate T Wave Duration, Single Beat An electrocardiographic interval measured from the onset of the T wave to the offset of the T wave of a single beat utilizing one or more leads. T Wave Duration Single Beat T Wave Amplitude, Aggregate An aggregate T wave amplitude value based on the measurement of T wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. T Wave Amplitude Aggregate T Wave Amplitude, Single Beat An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the T wave measured from the isoelectric baseline to the peak of the T wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm. T Wave Amplitude Single Beat Ventricular Arrhythmias An electrocardiographic assessment of ventricular arrhythmias excluding tachycardias. Ventricular Arrhythmia ECG Assessment Ventricular Tachyarrhythmias An electrocardiographic assessment of ventricular tachyarrhythmias. Ventricular Tachyarrhythmia ECG Assessment EGTESTCD ECG Test Code CDISC SDTM ECG Test Code Terminology Terminology codelist used with ECG Test Methods within CDISC. 10 Lead Standard An electrocardiogram lead placement on the subject using a ten electrode lead set to synthesize standard 12 lead electrocardiograph data to elicit an electrical view of the heart. 10 Lead Standard 12 Lead 1 Lead Missing An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but one standard lead position is missing therefore requiring a Mortara source consistency filter. (NCI) 12 Lead Placement 1 Lead Missing 12 Lead Cabrera An electrocardiogram (ECG) lead placement whereby the display of the 12 standard ECG leads is in an orderly sequence in a single horizontal display of: aVL, I, -aVR, II, aVF, III, V1 to V6. In the Cabrera display the limb lead aVR is inverted (-aVR) to obtain the same positive leftward orientation as the other 5 limbs. (NCI) 12 Lead Placement Cabrera A continuous electrocardiographic (ECG) recording utilizing 12 leads. The positioning of the electrodes may vary from the standard 12 lead ECG placement. Examples include but are not limited to 12 lead Holter with modified Mason-Likar lead placements, 12 lead exercise ECGs, and 12 lead telemetry systems. 12 Lead Continuous ECG 12 Lead EASI Dower Transformation An electrocardiogram (ECG) lead placement whereby 4 chest electrodes and 1 reference electrode are used to allow for continuous monitoring at the clinical level. This placement creates a 12 lead ECG that allows the acquisition of simultaneous events in the frontal, horizontal and sagittal heart planes with the linear transformation of vectors. This system provides a three-dimensional portrayal of the heart and uses mathematical and fixed coefficients for each lead. (NCI) Lead Placement EASI Dower Transformation A standard duration (typically 10 seconds) 12 lead electrocardiogram (ECG) extracted from a 12 lead continuous ECG. 12 Lead ECG Extracted From 12 Lead Continuous ECG Recording 12 Lead Mason Likar An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the standard lead positions have been modified for ECG recording during exercise. Exercise stress testing requires moving the limb electrodes to more central positions on the thorax. The electrodes are placed in bony prominences close to the bases of the respective limbs in order to avoid skeletal muscle artifact, provide stability for recording electrodes and to record waveforms similar to the standard limb sites. (NCI) 12 Lead Placement Mason Likar 12 Lead Modified Mason Likar An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the Mason Likar lead positions have been modified so that V1 to V6 on the chest are part of a single electrode pad. In addition, lead CM5 is substituted for lead aVR. (NCI) 12 Lead Placement Mason Likar Modified 12 Lead Non-Standard An electrocardiogram (ECG) lead placement whereby the limb leads are placed on the torso for easier and faster application in emergency situations. (NCI) 12 Lead Placement Non-Standard 12 Lead Right-sided Precordial Leads Right-sided Chest Leads An electrocardiogram (ECG) lead placement whereby the precordial leads are intentionally placed on the right side of the chest. 12 Lead Placement Right-sided Precordial Leads 12 Lead Single Pad An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the standard lead positions have been modified so that all leads on the chest are part of a single electrode pad. (NCI) 12 Lead Placement Chest 12 Lead Standard An electrocardiogram (ECG) lead placement whereby 12 leads are recorded, with each lead representing an electrical view of the heart. The six leads recorded in the frontal plane are derived from the placement of 3 electrodes (RA or Right Arm, LA, or Left Arm, and LL or Left Leg). These bipolar frontal leads form the basis of Einthoven's triangle, and are represented by leads I, II, and III. Three other derived (or augmented) bipolar frontal vectors are also recorded on a standard 12-lead EKG, aVR, aVF, and aVL. 6 unipolar leads, corresponding to V1 - V6 measure the electrical activity in the horizontal plane. The placement for the V leads is as follows: V1: right 4th intercostal space,V2: left 4th intercostal space, V3: halfway between V2 and V4, V4: left 5th intercostal space, mid-clavicular line, V5: horizontal to V4, anterior axillary line, V6: horizontal to V5, mid-axillary line. (NCI) 12 Lead Placement Standard 12 Lead Unspecified An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the position of the leads is unspecified. (NCI) 12 Lead Placement Unspecified 12-lead extended to the right by V5R, V4R, V3R A 12-lead electrocardiogram (ECG) lead placement whereby the standard lead placement is modified by having leads V3R, V4R and V5R. The V3R through V5R leads are recorded by using a standard 12-lead ECG machine and substituting lead cables V4 for V3R, V5 for V4R, and V6 for V5R. The positions of these right-sided leads V3R to V5R are opposite to the positions of V3-V5 on the right side of the chest. 12 Lead Placement Standard Extended Right An electrocardiogram (ECG) lead placement whereby 15 lead points are recorded using the standard 12 lead ECG positions and 3 additional leads placed on the right side of the chest. The positions of these right-sided leads V3R to V5R are opposite to the positions of V3-V5 on the right side of the chest. 15 Lead Placement Including V3R-V5R An electrocardiogram (ECG) lead placement whereby 15 lead points are recorded using the standard 12 lead ECG positions and 3 additional leads placed on the back of the chest. The positions of these posterior leads V7 to V9 are at the same vertical level as V6 and at the horizontal positions of the left posterior axillary line (V7), left scapular line (V8), and left paravertebral line (V9). 15 Lead Placement Including V7-V9 An electrocardiogram (ECG) lead configuration that is primarily used to record ECGs in non-human animals, and which uses six (6) electrodes to generate eight (8) ECG leads (ECG wave forms). The six electrode configuration includes the following: four (4) limb electrodes, which are placed analogous to an Einthoven configuration in humans, and two (2) chest electrodes. The eight (8) ECG leads recorded comprise three standard limb leads (leads I, II, and III), three augmented leads (Leads aVR, aVF, and aVL), and two chest leads, which are generated using two unipolar chest leads, typically CV5RL [rV2] and CV6LL [V2] for canines, or MV1 and MV2 for primates. 6 Lead NEHB-SPORI 6 Lead Standard An electrocardiogram lead placement on the subject using a six electrode lead set with three standard leads and three augmented derived leads to elicit an electrical view of the heart. 6 Lead Standard An electrocardiogram lead placement for non-human species using a five electrode lead set to monitor and/or record 7 ECG leads, analogous to the standard and augmented human limb leads and one chest lead. 7 Lead Placement Standard for Non-Human Subjects An electrocardiogram (ECG) recorded using 6 electrodes to generate 8 ECG leads (ECG wave forms). The 6 electrode configuration includes 4 limb electrodes in an Einthoven configuration and two chest electrodes. The 8 ECG leads recorded consist of three standard limb leads (leads I, II, and III), three augmented leads (leads aVR, aVF, and aVL), and two chest leads (which are generated using two unipolar chest leads (typically CV5RL [rV2] and CV6LL [V2] for canines or MV1 and MV2 for non-human primates). This lead configuration is typically used to record ECGs in non-human animals. 8 Lead Standard Bipolar uncorrected XYZ lead system An electrocardiogram (ECG) lead placement whereby the X+ lead is placed at the right mid-axillary line ate the 4th intercostal space, X- at the left mid-axillary line at he 4th intercostal space, Y+ at the proximal left leg, Y- at the superior aspect of the manubrium, Z+ at the direct posterior to Z- and Z- at the 4th intercostal space at the left sternal margin. (NCI) Lead Placement Bipolar Uncorrected XYZ A continuous electrocardiographic (ECG) recording utilizing 1 or more leads that records and stores data directly to the device. The subject need not be restricted to a medical facility, and may be able to participate in their customary activities of daily living. Continuous Ambulatory ECG A continuous electrocardiographic (ECG) recording utilizing one or more implanted leads in a non-human species. Continuous ECG Recording for Non-human Species Using Implanted Leads A continuous electrocardiographic (ECG) recording utilizing one or more surface leads in a non-human species. Continuous Surface ECG Recording for Non-human Species Cube lead system An electrocardiogram (ECG) lead placement that is a type of uncorrected vectorcardiograph. This lead system is based on a rectangular body axis. It uses an extra number of electrodes to make it three-dimensional. (NCI) Lead Placement Cube Frank lead system An electrocardiogram (ECG) lead placement for determining 3 orthogonal components X (right to left direction), Y (foot to head direction) and Z (back to front direction) of the heart. For this method a minimum of 4 electrodes are needed that represent the right arm, left arm, left leg and back. However, usually 7 electrodes are used to avoid dependence on the dipole location and facilitate interpretation. (NCI) Lead Placement Frank An electrocardiographic method for collecting continuous ECG waveforms with a variable number of discrete leads with duration longer than the standard 10 second ECG. Holter recording may be performed in patients who are ambulatory, and may collect data for 24 hours or longer. Holter Monitoring McFee-Parungao lead system An electrocardiogram (ECG) lead placement for determining 3 orthogonal components X (back to front), Y (right to left) and Z (foot to head) of the heart. This system places the electrodes closer to the heart to achieve better orthogonality and a homogeneous lead field. (NCI) Lead Placement McFee-Parungao Pseudo-orthogonal XYZ lead system An electrocardiogram (ECG) lead placement that allows monitoring and recording of cardiac electrical activity. A V1-type lead is used whose positive electrode is localized in the 4th intercostal space, 2.5cm from the sternum. Its negative electrode is placed below the left clavicle. An addition of lead V5 and aVF can be made to facilitate interpretation. (NCI) Lead Placement Pseudo Orthogonal XYZ Standard 12-lead and CC5-CM5-ML An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the standard lead positions have been modified so that the negative reference is at CM5 and the active electrode is at the left leg position. (NCI) 12 Lead Placement Standard And CC5-CM5-ML Standard 12-lead and CM5-CC5-CH5 An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the standard lead positions have been modified so that the bipolar lead groups place the negative of the reference electrode over the manubrium (CM5), the right scapula (CB5), V5R (CC5) or on the forehead (CH5) and the active electrode at V5. (NCI) 12 Lead Placement Standard And CC5-CM5-CH5 Standard 12-lead extended to the left by V7, V8, V9 A 12-lead electrocardiogram (ECG) lead placement whereby the standard lead placement is modified by having leads V7, V8 and V9. The V7 through V9 leads are recorded by using a standard 12-lead ECG machine and substituting lead cables V4 for V7, V5 for V8, and V6 for V9. The positions of these posterior leads V7 to V9 are at the same vertical level as V6 and at the horizontal positions of the left posterior axillary line (V7), left scapular line (V8), and left paravertebral line (V9). 12 Lead Placement Standard Extended Left Limb leads on the back (shoulder and on the hips). (NCI) Lead Placement Bicycle Standard leads one intercostal space higher An electrocardiographic lead placement schema in which the V leads are placed one intercostal space cephalad to the position they would have in the standard lead placement schema. (NCI) Lead Placement Standard Intercostal Space Higher Vectorcardiograph Corrected A recording of the electrical activity of the heart displayed in the form of a vector loop, corrected for anatomic inconsistencies. (NCI) Vectorcardiograph Corrected Vectorcardiograph Uncorrected A recording of the electrical activity of the heart displayed in the form of a vector loop, uncorrected for anatomic inconsistencies. (NCI) Vectorcardiograph Uncorrected EGMETHOD ECG Test Method CDISC SDTM ECG Test Method Terminology Terminology codelist used with ECG Test Names within CDISC. Acute Myocardial Ischemia ECG Change An electrocardiographic finding assessment of new or presumed new significant ST-segment-T wave (ST-T) changes or new left bundle branch block consistent with acute myocardial ischemia. (Thygesen K, Alpert JS, Jaffe AS, Simoons ML, et al.; Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012 Oct 16;60(16):1581-98). Acute Myocardial Ischemia by ECG Assessment Atrioventricular Conduction An electrocardiographic assessment of cardiac atrioventricular conduction. Atrioventricular Conduction ECG Assessment Axis and Voltage An electrocardiographic assessment of mean cardiac electrical vector and the ECG voltage. Axis and Voltage ECG Assessment Chamber Hypertrophy or Enlargement An electrocardiographic assessment of chamber hypertrophy or enlargement. Chamber Hypertrophy or Enlargement ECG Assessment Comparison to a Prior ECG A comparative interpretation of an ECG relative to a previous (comparator) ECG. The definition of the comparator ECG may be specified elsewhere. Common comparator result values include improved, no change, deteriorated. Comparison to a Prior ECG ECG Maximum Atrial Rate An electrocardiographic measurement of the maximum rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute. Maximum Atrial Rate by Electrocardiogram ECG Maximum Heart Rate An electrocardiographic measurement of the maximum rate of depolarization of the heart during an interval of time. Maximum Heart Rate by Electrocardiogram ECG Maximum Ventricular Rate An electrocardiographic measurement of the maximum rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute. Maximum Ventricular Rate by Electrocardiogram ECG Mean Atrial Rate An electrocardiographic measurement of the average rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute. Mean Atrial Rate by Electrocardiogram ECG Mean Heart Rate An electrocardiographic measurement of the average rate of depolarization of the heart during an interval of time. Mean Heart Rate by Electrocardiogram ECG Mean Ventricular Rate An electrocardiographic measurement of the average rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute. Mean Ventricular Rate by Electrocardiogram ECG Median Atrial Rate An electrocardiographic measurement of the median rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute. Median Atrial Rate by Electrocardiogram ECG Median Heart Rate An electrocardiographic measurement of the median rate of depolarization of a specific region of the heart during an interval of time, usually expressed in beats per minute. Unless otherwise specified, this is usually the median ventricular rate. ECG Median Heart Rate ECG Median Ventricular Rate An electrocardiographic measurement of the median rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute. Median Ventricular Rate by Electrocardiogram ECG Minimum Atrial Rate An electrocardiographic measurement of the minimum rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute. Minimum Atrial Rate by Electrocardiogram ECG Minimum Heart Rate An electrocardiographic measurement of the minimum rate of depolarization of the heart during an interval of time. Minimum Heart Rate by Electrocardiogram ECG Minimum Ventricular Rate An electrocardiographic measurement of the minimum rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute. Minimum Ventricular Rate by Electrocardiogram Interpretation An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. Interpretation Intraventricular-Intraatrial Conduction An electrocardiographic assessment of intraventricular and intra-atrial conduction. Intraventricular and Intraatrial Conduction ECG Assessment J-Tpeak Interval, Aggregate An aggregate J-Tpeak value based on the measurement of J-Tpeak intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate J-T Peak Interval J-Tpeak Interval, Single Beat An electrocardiographic interval measured from the J point to the peak of the T wave of a single beat utilizing one or more leads. Single Beat J-T Peak Interval JT Interval, Aggregate An aggregate JT value based on the measurement of JT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate JT Interval JT Interval, Single Beat An electrocardiographic interval measured from the J point to the offset of the T wave of a single beat utilizing one or more leads. Single Beat JT Interval JTcB Interval, Aggregate A JT aggregate interval that is corrected for heart rate using Bazett's formula, based on the measurement of QT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate JTCB Interval JTcB Interval, Single Beat A JT single beat interval that is corrected for heart rate using Bazett's formula, based on a QT interval measured on a single beat utilizing one or more ECG leads. Single Beat JTCB Interval JTcF Interval, Aggregate A JT aggregate interval that is corrected for heart rate using Fridericia's formula, based on the measurement of QT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate JTCF Interval JTcF Interval, Single Beat A JT single beat interval that is corrected for heart rate using Fridericia's formula, based on a QT interval measured on a single beat utilizing one or more ECG leads. Single Beat JTCF Interval Myocardial Infarction An electrocardiographic assessment of findings suggestive of myocardial infarction. Myocardial Infarction ECG Assessment New Q Wave An electrocardiographic finding assessment of new or presumed new pathologic Q waves suggestive of myocardial infarction. (Thygesen K, Alpert JS, Jaffe AS, Simoons ML, et al.; Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012 Oct 16;60(16):1581-98). New Q Wave P Wave Amplitude, Aggregate An aggregate P wave amplitude value based on the measurement of P wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate P Wave Amplitude P Wave Amplitude, Single Beat An electrocardiographic measurement of the mean amplitude (usually measured in mm) of the P wave measured from the isoelectric baseline to the peak of the P wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement is reported in millivolt. Single Beat P Wave Amplitude P Wave Axis A numerical representation of the electrocardiographic vector assessed at maximum deviation of the P wave from the isoelectric baseline, usually reported for the frontal plane. P Wave Axis P Wave Duration, Aggregate An aggregate P wave duration value based on the measurement of P wave duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate P Wave Duration P Wave Duration, Single Beat An electrocardiographic interval measured from the onset of the P wave to the offset of the P wave of a single beat utilizing one or more leads. Single Beat P Wave Duration Pacemaker An electrocardiographic assessment of presence of artificial electronic pacing. Pacemaker ECG Assessment PP Interval, Aggregate An aggregate PP value based on the measurement of PP intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate PP Interval PP Interval, Single Measurement An electrocardiographic measurement of the interval between the onsets of two consecutive P waves. Single Measurement PP Interval PQ Interval, Aggregate PQAG PR Interval, Aggregate An aggregate PR value based on the measurement of PR intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate PR Interval PQ Interval, Single Beat PQSB PR Interval, Single Beat An electrocardiographic interval measured from the onset of the P wave to the onset of the QRS complex of a single beat utilizing one or more leads. Single Beat PR Interval PR Segment, Aggregate An aggregate PR segment value based on the measurement of PR segment intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate PR Segment PR Segment, Single Beat An electrocardiographic interval measured from the end of the P wave to the onset of the QRS complex of a single beat utilizing one or more leads. Single Beat PR Segment Q Wave Amplitude, Aggregate An aggregate Q wave amplitude value based on the measurement of Q wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate Q Wave Amplitude Q Wave Amplitude, Single Beat An electrocardiographic measurement of the mean amplitude (usually measured in mm) of the Q wave measured from the isoelectric baseline to the peak of the Q wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in millivolt. Single Beat Q Wave Amplitude QRS Axis A numerical representation of the electrocardiographic vector assessed at maximum deviation of the QRS complex from the isoelectric baseline, usually reported for the frontal plane. QRS Axis QRS Duration, Aggregate An aggregate QRS value based on the measurement of QRS intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate QRS Duration QRS Duration, Single Beat An electrocardiographic interval measured from the onset of the QRS complex to the offset of the QRS complex of a single beat utilizing one or more leads. Single Beat QRS Duration QRS Duration, Ventr. Paced, Aggregate An aggregate paced QRS duration value based on the measurement of paced QRS duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Paced Ventricular Aggregate QRS Duration QRS Duration, Ventr. Paced, Single Beat An electrocardiographic interval measured from the onset of the paced QRS complex to the offset of the QRS complex of a single beat utilizing one or more leads. Paced Ventricular Single Beat QRS Duration QT Interval, Aggregate An aggregate QT value based on the measurement of QT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate QT Interval QT Interval, Single Beat An electrocardiographic interval measured from the onset of the QRS complex to the offset of the T wave of a single beat utilizing one or more leads. Single Beat QT Interval QTc Corr Method Unspecified, Aggregate QTc Correction Method Unspecified, Aggregate A QT aggregate interval that is corrected for heart rate by unspecified correction method, or by non-standard correction methods. QTc Correction Method Unspecified, Aggregate QTc Corr Method Unspecified, Single Beat QTc Correction Method Unspecified, Single Beat A QT interval that is corrected for heart rate by unspecified correction method, or by non-standard correction methods, based on a QT interval measured on a single beat utilizing one or more ECG leads. QTc Correction Method Unspecified, Single Beat QTc Correction Method Unspecified A QT interval that is corrected for heart rate by unspecified correction method, or by non-standard correction methods. Corrected QT Interval QTca Interval, Aggregate A QT Aggregate interval that is corrected for heart rate using individual probabilistic QT/RR slopes for each subject, based on the measurement of QT intervals from multiple beats within a single ECG or period of a continuous ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate QTca Interval QTca Interval, Single Beat A QT interval that is corrected for heart rate using individual probabilistic QT/RR slopes for each subject, based on a QT interval measured on a single beat utilizing one or more ECG leads. Single Beat QTca Interval QTcB Interval, Aggregate A QT aggregate interval that is corrected for heart rate using Bazett's formula, based on the measurement of QT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate QTCB Interval QTcB Interval, Single Beat A QT single beat interval that is corrected for heart rate using Bazett's formula, based on a QT interval measured on a single beat utilizing one or more ECG leads. Single Beat QTCB Interval QTcF Interval, Aggregate A QT aggregate interval that is corrected for heart rate using Fridericia's formula, based on the measurement of QT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate QTCF Interval QTcF Interval, Single Beat A QT single beat interval that is corrected for heart rate using Fridericia's formula, based on a QT interval measured on a single beat utilizing one or more ECG leads. Single Beat QTCF Interval QTcL Interval, Aggregate A QT aggregate interval corrected for heart rate using a linear correction formula. Aggregate QTcL Interval QTcL Interval, Single Beat A QT single beat interval corrected for heart rate using a linear correction formula. Single Beat QTcL Interval QTcV Interval, Aggregate A QT aggregate interval corrected for heart rate using the Van der Water's correction formula. Aggregate QTcV Interval QTcV Interval, Single Beat A QT single beat interval corrected for heart rate using the Van der Water's correction formula. Single Beat QTcV Interval R Wave Amplitude, Aggregate An aggregate R wave amplitude value based on the measurement of R wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. R Wave Amplitude Aggregate R Wave Amplitude, Single Beat An electrocardiographic measurement of the mean amplitude (usually measured in mm) of the R wave measured from the isoelectric baseline to the peak of the R wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement is reported in millivolt. R Wave Amplitude Single Beat Rhythm Not Otherwise Specified An electrocardiographic assessment of cardiac rhythm not otherwise specified. Rhythm Not Otherwise Specified ECG Assessment RR Interval, Aggregate An aggregate RR value based on the measurement of RR intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. Aggregate RR Interval RR Interval, Single Measurement An electrocardiographic measurement of the interval between two consecutive R waves. If R waves are not present, this measurement may utilize the interval between the most easily identified components of the QRS complex within two consecutive beats. RR Interval Single Measurement RS Wave Amplitude, Aggregate An aggregate RS wave amplitude value based on measurements from multiple beats from a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. RS Wave Amplitude Aggregate RS Wave Amplitude, Single Beat An electrocardiographic measurement of the sum of the amplitudes of the R and S waves, obtained from a single beat in one particular lead or set of leads. RS Wave Amplitude Single Beat S Wave Amplitude, Aggregate An aggregate S wave amplitude value based on the measurement of S wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. S Wave Amplitude Aggregate S Wave Amplitude, Single Beat An electrocardiographic measurement of the mean amplitude (usually measured in mm) of the S wave measured from the isoelectric baseline to the peak of the S wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement is reported in millivolt. S Wave Amplitude Single Beat Single RR Heart Rate An electrocardiographic measurement of a heart rate derived from a single RR interval (interval between two consecutive QRS complexes). Single Beat RR Extrapolated Heart Rate by ECG Assessment Sinus Node Rhythms and Arrhythmias An electrocardiographic assessment of sinus node rhythms and arrhythmias. Sinus Node Rhythm and Arrhythmia ECG Assessment ST Segment Depression, Aggregate An aggregate ST segment depression value based on the measurement of ST segment depression from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. ST Segment Depression Aggregate ST Segment Depression, Single Beat An electrocardiographic measurement of the mean amplitude (usually measured in mm) of the ST segment depression below the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in millivolt. ST Segment Depression Single Beat ST Segment Deviation, Aggregate An aggregate ST segment deviation value based on the measurement of ST segment deviation from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. ST Segment Deviation Aggregate ST Segment Deviation, Single Beat An electrocardiographic measurement of the mean amplitude (usually measured in mm) of the ST segment deviation above or below the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the recording gain, this measurement is reported in millivolt. ST Segment Deviation Single Beat ST Segment Duration, Aggregate An aggregate ST segment duration value based on the measurement of ST segment duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. ST Segment Duration Aggregate ST Segment Duration, Single Beat An electrocardiographic interval measured from the J point to the onset of the T wave of a single beat utilizing one or more leads. ST Segment Duration Single Beat ST Segment Elevation, Aggregate An aggregate ST segment elevation value based on the measurement of ST segment elevation from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. ST Segment Elevation Aggregate ST Segment Elevation, Single Beat An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the ST segment elevation above the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm. ST Segment Elevation Single Beat ST Segment, T wave, and U wave An electrocardiographic assessment of the characteristics of the ST segment, T wave, and U wave. ST Segment, T wave, and U wave ECG Assessment Summary (Max) JT Interval The maximum duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end of the T wave (representing the end of ventricular repolarization). (NCI) Maximum JT Duration Summary (Max) PR Duration The maximum duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave. (NCI) Maximum PR Duration Summary (Max) QA Interval The maximum time interval between the Q wave on an ECG and the onset of the aortic blood pressure pulse. Maximum QA Interval Summary (Max) QT Duration The maximum duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave. (NCI) Maximum QT Duration Summary (Max) RR Duration The maximum duration (time) between successive peaks of R waves in a particular set of RR intervals. (NCI) Maximum RR Duration Summary (Max) ST Depression The maximum depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. This is usually expressed in millivolt. Maximum ST Segment Depression by ECG Finding Summary (Max) ST Deviation The maximum deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. This is usually expressed in millivolt. Maximum ST Deviation Summary (Max) ST Elevation The maximum elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. This is usually reported in millivolt. Maximum ST Segment Elevation Summary (Mean) QA Interval The mean time interval between the Q wave on an ECG and the onset of the aortic blood pressure pulse. Mean QA Interval Summary (Median) QA Interval The median time interval between the Q wave on an ECG and the onset of the aortic blood pressure pulse. Median QA Interval Summary (Min) JT Interval The minimum duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end of the T wave (representing the end of ventricular repolarization). (NCI) Minimum JT Duration Summary (Min) PR Duration The minimum duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave. (NCI) Minimum PR Duration Summary (Min) QA Interval The minimum time interval between the Q wave on an ECG and the onset of the aortic blood pressure pulse. Minimum QA Interval Summary (Min) QT Duration The minimum duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave. (NCI) Minimum QT Duration Summary (Min) RR Duration The minimum duration (time) between successive peaks of R waves in a particular set of RR intervals. (NCI) Minimum RR Duration Summary (Min) ST Depression The minimum depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. This is usually expressed in millivolt. Minimum ST Segment Depression by ECG Finding Summary (Min) ST Deviation The minimum deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. This is usually expressed in millivolt. Minimum ST Deviation Summary (Min) ST Elevation The minimum elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. This is usually reported in millivolt. Minimum ST Segment Elevation Supraventricular Arrhythmias An electrocardiographic assessment of supraventricular arrhythmias excluding tachycardias. Supraventricular Arrhythmia ECG Assessment Supraventricular Tachyarrhythmias An electrocardiographic assessment of supraventricular tachyarrhythmias. Supraventricular Tachyarrhythmia ECG Assessment T Wave Amplitude, Aggregate An aggregate T wave amplitude value based on the measurement of T wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. T Wave Amplitude Aggregate T Wave Amplitude, Single Beat An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the T wave measured from the isoelectric baseline to the peak of the T wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm. T Wave Amplitude Single Beat T Wave Area, Aggregate An aggregate T wave area value based on the measurement of T wave areas from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. T Wave Area Aggregate T Wave Area, Single Beat An electrocardiographic measurement of the area of the T wave of a single beat utilizing one or more leads. T Wave Area Single Beat T Wave Axis A numerical representation of the electrocardiographic vector assessed at maximum deviation of the T wave from the isoelectric baseline, usually reported for the frontal plane. T Wave Axis T Wave Duration, Aggregate An aggregate T wave duration value based on the measurement of T wave duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. T Wave Duration Aggregate T Wave Duration, Single Beat An electrocardiographic interval measured from the onset of the T wave to the offset of the T wave of a single beat utilizing one or more leads. T Wave Duration Single Beat Technical Quality A statement about an electrocardiographic recording describing technical issues or interference during the recording, processing, or transmission of the data. This does not represent an electrocardiographic diagnosis. ECG Technical Quality Tpeak-Tend Interval, Aggregate An aggregate Tpeak-Tend value based on the measurement of Tpeak-Tend from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. T Peak-T End Interval Aggregate Tpeak-Tend Interval, Single Beat An electrocardiographic interval measured from the peak of the T wave to the offset of the T wave of a single beat utilizing one or more leads. T Peak-T End Interval Single Beat Ventricular Arrhythmias An electrocardiographic assessment of ventricular arrhythmias excluding tachycardias. Ventricular Arrhythmia ECG Assessment Ventricular Tachyarrhythmias An electrocardiographic assessment of ventricular tachyarrhythmias. Ventricular Tachyarrhythmia ECG Assessment EGTEST ECG Test Name CDISC SDTM ECG Test Name Terminology Edinburgh Postnatal Depression Scale test code. EPDS01-Able to Laugh and See Funny Side Edinburgh Postnatal Depression Scale - I have been able to laugh and see the funny side of things. EPDS - Able to Laugh and See Funny Side EPDS01-Looked Forward With Enjoyment Edinburgh Postnatal Depression Scale - I have looked forward with enjoyment to things. EPDS - Looked Forward With Enjoyment EPDS01-Blamed Myself Unnecessarily Edinburgh Postnatal Depression Scale - I have blamed myself unnecessarily when things went wrong. EPDS - Blamed Myself Unnecessarily EPDS01-Anxious/Worried No Good Reason Edinburgh Postnatal Depression Scale - I have been anxious or worried for no good reason. EPDS - Anxious or Worried No Good Reason EPDS01-Scared/Panicky for No Good Reason Edinburgh Postnatal Depression Scale - I have felt scared or panicky for no very good reason. EPDS - Scared or Panicky for No Good Reason EPDS01-Things Getting on Top of Me Edinburgh Postnatal Depression Scale - Things have been getting on top of me. EPDS - Things Getting on Top of Me EPDS01-Unhappy Had Difficulty Sleeping Edinburgh Postnatal Depression Scale - I have been so unhappy that I have had difficulty sleeping. EPDS - Unhappy Had Difficulty Sleeping EPDS01-I Have Felt Sad or Miserable Edinburgh Postnatal Depression Scale - I have felt sad or miserable. EPDS - I Have Felt Sad or Miserable EPDS01-So Unhappy I Have Been Crying Edinburgh Postnatal Depression Scale - I have been so unhappy that I have been crying. EPDS - So Unhappy I Have Been Crying EPDS01-Thought of Harming Myself Edinburgh Postnatal Depression Scale - The thought of harming myself has occurred to me. EPDS - Thought of Harming Myself EPDS01TC Edinburgh Postnatal Depression Scale Questionnaire Test Code CDISC Questionnaire EPDS Test Code Terminology Edinburgh Postnatal Depression Scale test name. EPDS01-Able to Laugh and See Funny Side Edinburgh Postnatal Depression Scale - I have been able to laugh and see the funny side of things. EPDS - Able to Laugh and See Funny Side EPDS01-Anxious/Worried No Good Reason Edinburgh Postnatal Depression Scale - I have been anxious or worried for no good reason. EPDS - Anxious or Worried No Good Reason EPDS01-Blamed Myself Unnecessarily Edinburgh Postnatal Depression Scale - I have blamed myself unnecessarily when things went wrong. EPDS - Blamed Myself Unnecessarily EPDS01-I Have Felt Sad or Miserable Edinburgh Postnatal Depression Scale - I have felt sad or miserable. EPDS - I Have Felt Sad or Miserable EPDS01-Looked Forward With Enjoyment Edinburgh Postnatal Depression Scale - I have looked forward with enjoyment to things. EPDS - Looked Forward With Enjoyment EPDS01-Scared/Panicky for No Good Reason Edinburgh Postnatal Depression Scale - I have felt scared or panicky for no very good reason. EPDS - Scared or Panicky for No Good Reason EPDS01-So Unhappy I Have Been Crying Edinburgh Postnatal Depression Scale - I have been so unhappy that I have been crying. EPDS - So Unhappy I Have Been Crying EPDS01-Things Getting on Top of Me Edinburgh Postnatal Depression Scale - Things have been getting on top of me. EPDS - Things Getting on Top of Me EPDS01-Thought of Harming Myself Edinburgh Postnatal Depression Scale - The thought of harming myself has occurred to me. EPDS - Thought of Harming Myself EPDS01-Unhappy Had Difficulty Sleeping Edinburgh Postnatal Depression Scale - I have been so unhappy that I have had difficulty sleeping. EPDS - Unhappy Had Difficulty Sleeping EPDS01TN Edinburgh Postnatal Depression Scale Questionnaire Test Name CDISC Questionnaire EPDS Test Name Terminology Emory Treatment Resistance Interview for PTSD test code. ETRP01-Medication Total Points Emory Treatment Resistance Interview for PTSD - Medication total points. E-TRIP - Medication Total Points ETRP01-Psychotherapy Total Points Emory Treatment Resistance Interview for PTSD - Psychotherapy total points. E-TRIP - Psychotherapy Total Points ETRP01-Total Points Emory Treatment Resistance Interview for PTSD - Total points. E-TRIP - Total Points ETRP01TC Emory Treatment Resistance Interview for PTSD Clinical Classification Test Code CDISC Clinical Classification E-TRIP Test Code Terminology Emory Treatment Resistance Interview for PTSD test name. ETRP01-Medication Total Points Emory Treatment Resistance Interview for PTSD - Medication total points. E-TRIP - Medication Total Points ETRP01-Psychotherapy Total Points Emory Treatment Resistance Interview for PTSD - Psychotherapy total points. E-TRIP - Psychotherapy Total Points ETRP01-Total Points Emory Treatment Resistance Interview for PTSD - Total points. E-TRIP - Total Points ETRP01TN Emory Treatment Resistance Interview for PTSD Clinical Classification Test Name CDISC Clinical Classification E-TRIP Test Name Terminology Emotion Recognition test code. EMO1-Total Stimuli Expected Emotion Recognition - Total number of stimuli (face images) expected to be administered in the task. ERT - Total Stimuli Expected EMO1-Total Stimuli Administered Emotion Recognition - Total number of stimuli (face images) actually administered in the task. ERT - Total Stimuli Administered EMO1-Total Stimuli Completed Emotion Recognition - Total number of stimuli (face images) actually completed in the task. ERT - Total Stimuli Completed EMO1-Total Stimuli Response Correct Emotion Recognition - Total number of stimuli (face images) for which the participant's response was correct. ERT - Total Stimuli Response Correct EMO1-Total Stimuli Response Incorrect Emotion Recognition - Total number of stimuli (face images) for which the participant's response was incorrect. ERT - Total Stimuli Response Incorrect EMO1-Total Stimuli Not Responded Emotion Recognition - Total number of stimuli (face images) for which the participant has not responded. ERT - Total Stimuli Not Responded EMO1-Total Negative Stimuli Expected Emotion Recognition - Total number of negative emotion stimuli (face images) expected to be administered in the task. ERT - Total Negative Stimuli Expected EMO1-Total Negative Stimuli Administered Emotion Recognition - Total number of negative emotion stimuli (face images) actually administered in the task. ERT - Total Negative Stimuli Administered EMO1-Total Negative Stimuli Completed Emotion Recognition - Total number of negative emotion stimuli (face images) actually completed in the task. ERT - Total Negative Stimuli Completed EMO1-Total Negative Stimuli Correct Emotion Recognition - Total number of negative emotion stimuli (face images) for which the participant's response was correct. ERT - Total Negative Stimuli Correct EMO1-Total Negative Stimuli Incorrect Emotion Recognition - Total number of negative emotion stimuli (face images) for which the participant's response was incorrect. ERT - Total Negative Stimuli Incorrect EMO1-Total Negative Stimuli Not Respond Emotion Recognition - Total number of negative emotion stimuli (face images) for which the participant has not responded. ERT - Total Negative Stimuli Not Respond EMO1-Number Stimuli Portraying Anger Emotion Recognition - Number of stimuli defined as portraying anger. ERT - Number Stimuli Portraying Anger EMO1-Anger Responded as Anger Emotion Recognition - Number of anger stimuli responded to as anger. ERT - Anger Responded as Anger EMO1-Anger Responded as Disgust Emotion Recognition - Number of anger stimuli responded to as disgust. ERT - Anger Responded as Disgust EMO1-Anger Responded as Fear Emotion Recognition - Number of anger stimuli responded to as fear. ERT - Anger Responded as Fear EMO1-Anger Responded as Happiness Emotion Recognition - Number of anger stimuli responded to as happiness. ERT - Anger Responded as Happiness EMO1-Anger Responded as Neutral Emotion Recognition - Number of anger stimuli responded to as neutral. ERT - Anger Responded as Neutral EMO1-Anger Responded as Sadness Emotion Recognition - Number of anger stimuli responded to as sadness. ERT - Anger Responded as Sadness EMO1-Anger Responded as Surprise Emotion Recognition - Number of anger stimuli responded to as surprise. ERT - Anger Responded as Surprise EMO1-Number Stimuli Portraying Disgust Emotion Recognition - Number of stimuli defined as portraying disgust. ERT - Number Stimuli Portraying Disgust EMO1-Disgust Responded as Anger Emotion Recognition - Number of disgust stimuli responded to as anger. ERT - Disgust Responded as Anger EMO1-Disgust Responded as Disgust Emotion Recognition - Number of disgust stimuli responded to as disgust. ERT - Disgust Responded as Disgust EMO1-Disgust Responded as Fear Emotion Recognition - Number of disgust stimuli responded to as fear. ERT - Disgust Responded as Fear EMO1-Disgust Responded as Happiness Emotion Recognition - Number of disgust stimuli responded to as happiness. ERT - Disgust Responded as Happiness EMO1-Disgust Responded as Neutral Emotion Recognition - Number of disgust stimuli responded to as neutral. ERT - Disgust Responded as Neutral EMO1-Disgust Responded as Sadness Emotion Recognition - Number of disgust stimuli responded to as sadness. ERT - Disgust Responded as Sadness EMO1-Disgust Responded as Surprise Emotion Recognition - Number of disgust stimuli responded to as surprise. ERT - Disgust Responded as Surprise EMO1-Number Stimuli Portraying Fear Emotion Recognition - Number of stimuli defined as portraying fear. ERT - Number Stimuli Portraying Fear EMO1-Fear Responded as Anger Emotion Recognition - Number of fear stimuli responded to as anger. ERT - Fear Responded as Anger EMO1-Fear Responded as Disgust Emotion Recognition - Number of fear stimuli responded to as disgust. ERT - Fear Responded as Disgust EMO1-Fear Responded as Fear Emotion Recognition - Number of fear stimuli responded to as fear. ERT - Fear Responded as Fear EMO1-Fear Responded as Happiness Emotion Recognition - Number of fear stimuli responded to as happiness. ERT - Fear Responded as Happiness EMO1-Fear Responded as Neutral Emotion Recognition - Number of fear stimuli responded to as neutral. ERT - Fear Responded as Neutral EMO1-Fear Responded as Sadness Emotion Recognition - Number of fear stimuli responded to as sadness. ERT - Fear Responded as Sadness EMO1-Fear Responded as Surprise Emotion Recognition - Number of fear stimuli responded to as surprise. ERT - Fear Responded as Surprise EMO1-Number Stimuli Portraying Happiness Emotion Recognition - Number of stimuli defined as portraying happiness. ERT - Number Stimuli Portraying Happiness EMO1-Happiness Responded as Anger Emotion Recognition - Number of happiness stimuli responded to as anger. ERT - Happiness Responded as Anger EMO1-Happiness Responded as Disgust Emotion Recognition - Number of happiness stimuli responded to as disgust. ERT - Happiness Responded as Disgust EMO1-Happiness Responded as Fear Emotion Recognition - Number of happiness stimuli responded to as fear. ERT - Happiness Responded as Fear EMO1-Happiness Responded as Happiness Emotion Recognition - Number of happiness stimuli responded to as happiness. ERT - Happiness Responded as Happiness EMO1-Happiness Responded as Neutral Emotion Recognition - Number of happiness stimuli responded to as neutral. ERT - Happiness Responded as Neutral EMO1-Happiness Responded as Sadness Emotion Recognition - Number of happiness stimuli responded to as sadness. ERT - Happiness Responded as Sadness EMO1-Happiness Responded as Surprise Emotion Recognition - Number of happiness stimuli responded to as surprise. ERT - Happiness Responded as Surprise EMO1-Number Stimuli Portraying Neutral Emotion Recognition - Number of stimuli defined as portraying a neutral expression. ERT - Number Stimuli Portraying Neutral EMO1-Neutral Responded as Anger Emotion Recognition - Number of neutral stimuli responded to as anger. ERT - Neutral Responded as Anger EMO1-Neutral Responded as Disgust Emotion Recognition - Number of neutral stimuli responded to as disgust. ERT - Neutral Responded as Disgust EMO1-Neutral Responded as Fear Emotion Recognition - Number of neutral stimuli responded to as fear. ERT - Neutral Responded as Fear EMO1-Neutral Responded as Happiness Emotion Recognition - Number of neutral stimuli responded to as happiness. ERT - Neutral Responded as Happiness EMO1-Neutral Responded as Neutral Emotion Recognition - Number of neutral stimuli responded to as neutral. ERT - Neutral Responded as Neutral EMO1-Neutral Responded as Sadness Emotion Recognition - Number of neutral stimuli responded to as sadness. ERT - Neutral Responded as Sadness EMO1-Neutral Responded as Surprise Emotion Recognition - Number of neutral stimuli responded to as surprise. ERT - Neutral Responded as Surprise EMO1-Number Stimuli Portraying Sadness Emotion Recognition - Number of stimuli defined as portraying sadness. ERT - Number Stimuli Portraying Sadness EMO1-Sadness Responded as Anger Emotion Recognition - Number of sadness stimuli responded to as anger. ERT - Sadness Responded as Anger EMO1-Sadness Responded as Disgust Emotion Recognition - Number of sadness stimuli responded to as disgust. ERT - Sadness Responded as Disgust EMO1-Sadness Responded as Fear Emotion Recognition - Number of sadness stimuli responded to as fear. ERT - Sadness Responded as Fear EMO1-Sadness Responded as Happiness Emotion Recognition - Number of sadness stimuli responded to as happiness. ERT - Sadness Responded as Happiness EMO1-Sadness Responded as Neutral Emotion Recognition - Number of sadness stimuli responded to as neutral. ERT - Sadness Responded as Neutral EMO1-Sadness Responded as Sadness Emotion Recognition - Number of sadness stimuli responded to as sadness. ERT - Sadness Responded as Sadness EMO1-Sadness Responded as Surprise Emotion Recognition - Number of sadness stimuli responded to as surprise. ERT - Sadness Responded as Surprise EMO1-Number Stimuli Portraying Surprise Emotion Recognition - Number of stimuli defined as portraying surprise. ERT - Number Stimuli Portraying Surprise EMO1-Surprise Responded as Anger Emotion Recognition - Number of surprise stimuli responded to as anger. ERT - Surprise Responded as Anger EMO1-Surprise Responded as Disgust Emotion Recognition - Number of surprise stimuli responded to as disgust. ERT - Surprise Responded as Disgust EMO1-Surprise Responded as Fear Emotion Recognition - Number of surprise stimuli responded to as fear. ERT - Surprise Responded as Fear EMO1-Surprise Responded as Happiness Emotion Recognition - Number of surprise stimuli responded to as happiness. ERT - Surprise Responded as Happiness EMO1-Surprise Responded as Neutral Emotion Recognition - Number of surprise stimuli responded to as neutral. ERT - Surprise Responded as Neutral EMO1-Surprise Responded as Sadness Emotion Recognition - Number of surprise stimuli responded to as sadness. ERT - Surprise Responded as Sadness EMO1-Surprise Responded as Surprise Emotion Recognition - Number of surprise stimuli responded to as surprise. ERT - Surprise Responded as Surprise EMO1TC Emotion Recognition Functional Test Test Code CDISC Functional Test ERT Test Code Terminology Emotion Recognition test name. EMO1-Anger Responded as Anger Emotion Recognition - Number of anger stimuli responded to as anger. ERT - Anger Responded as Anger EMO1-Anger Responded as Disgust Emotion Recognition - Number of anger stimuli responded to as disgust. ERT - Anger Responded as Disgust EMO1-Anger Responded as Fear Emotion Recognition - Number of anger stimuli responded to as fear. ERT - Anger Responded as Fear EMO1-Anger Responded as Happiness Emotion Recognition - Number of anger stimuli responded to as happiness. ERT - Anger Responded as Happiness EMO1-Anger Responded as Neutral Emotion Recognition - Number of anger stimuli responded to as neutral. ERT - Anger Responded as Neutral EMO1-Anger Responded as Sadness Emotion Recognition - Number of anger stimuli responded to as sadness. ERT - Anger Responded as Sadness EMO1-Anger Responded as Surprise Emotion Recognition - Number of anger stimuli responded to as surprise. ERT - Anger Responded as Surprise EMO1-Disgust Responded as Anger Emotion Recognition - Number of disgust stimuli responded to as anger. ERT - Disgust Responded as Anger EMO1-Disgust Responded as Disgust Emotion Recognition - Number of disgust stimuli responded to as disgust. ERT - Disgust Responded as Disgust EMO1-Disgust Responded as Fear Emotion Recognition - Number of disgust stimuli responded to as fear. ERT - Disgust Responded as Fear EMO1-Disgust Responded as Happiness Emotion Recognition - Number of disgust stimuli responded to as happiness. ERT - Disgust Responded as Happiness EMO1-Disgust Responded as Neutral Emotion Recognition - Number of disgust stimuli responded to as neutral. ERT - Disgust Responded as Neutral EMO1-Disgust Responded as Sadness Emotion Recognition - Number of disgust stimuli responded to as sadness. ERT - Disgust Responded as Sadness EMO1-Disgust Responded as Surprise Emotion Recognition - Number of disgust stimuli responded to as surprise. ERT - Disgust Responded as Surprise EMO1-Fear Responded as Anger Emotion Recognition - Number of fear stimuli responded to as anger. ERT - Fear Responded as Anger EMO1-Fear Responded as Disgust Emotion Recognition - Number of fear stimuli responded to as disgust. ERT - Fear Responded as Disgust EMO1-Fear Responded as Fear Emotion Recognition - Number of fear stimuli responded to as fear. ERT - Fear Responded as Fear EMO1-Fear Responded as Happiness Emotion Recognition - Number of fear stimuli responded to as happiness. ERT - Fear Responded as Happiness EMO1-Fear Responded as Neutral Emotion Recognition - Number of fear stimuli responded to as neutral. ERT - Fear Responded as Neutral EMO1-Fear Responded as Sadness Emotion Recognition - Number of fear stimuli responded to as sadness. ERT - Fear Responded as Sadness EMO1-Fear Responded as Surprise Emotion Recognition - Number of fear stimuli responded to as surprise. ERT - Fear Responded as Surprise EMO1-Happiness Responded as Anger Emotion Recognition - Number of happiness stimuli responded to as anger. ERT - Happiness Responded as Anger EMO1-Happiness Responded as Disgust Emotion Recognition - Number of happiness stimuli responded to as disgust. ERT - Happiness Responded as Disgust EMO1-Happiness Responded as Fear Emotion Recognition - Number of happiness stimuli responded to as fear. ERT - Happiness Responded as Fear EMO1-Happiness Responded as Happiness Emotion Recognition - Number of happiness stimuli responded to as happiness. ERT - Happiness Responded as Happiness EMO1-Happiness Responded as Neutral Emotion Recognition - Number of happiness stimuli responded to as neutral. ERT - Happiness Responded as Neutral EMO1-Happiness Responded as Sadness Emotion Recognition - Number of happiness stimuli responded to as sadness. ERT - Happiness Responded as Sadness EMO1-Happiness Responded as Surprise Emotion Recognition - Number of happiness stimuli responded to as surprise. ERT - Happiness Responded as Surprise EMO1-Neutral Responded as Anger Emotion Recognition - Number of neutral stimuli responded to as anger. ERT - Neutral Responded as Anger EMO1-Neutral Responded as Disgust Emotion Recognition - Number of neutral stimuli responded to as disgust. ERT - Neutral Responded as Disgust EMO1-Neutral Responded as Fear Emotion Recognition - Number of neutral stimuli responded to as fear. ERT - Neutral Responded as Fear EMO1-Neutral Responded as Happiness Emotion Recognition - Number of neutral stimuli responded to as happiness. ERT - Neutral Responded as Happiness EMO1-Neutral Responded as Neutral Emotion Recognition - Number of neutral stimuli responded to as neutral. ERT - Neutral Responded as Neutral EMO1-Neutral Responded as Sadness Emotion Recognition - Number of neutral stimuli responded to as sadness. ERT - Neutral Responded as Sadness EMO1-Neutral Responded as Surprise Emotion Recognition - Number of neutral stimuli responded to as surprise. ERT - Neutral Responded as Surprise EMO1-Number Stimuli Portraying Anger Emotion Recognition - Number of stimuli defined as portraying anger. ERT - Number Stimuli Portraying Anger EMO1-Number Stimuli Portraying Disgust Emotion Recognition - Number of stimuli defined as portraying disgust. ERT - Number Stimuli Portraying Disgust EMO1-Number Stimuli Portraying Fear Emotion Recognition - Number of stimuli defined as portraying fear. ERT - Number Stimuli Portraying Fear EMO1-Number Stimuli Portraying Happiness Emotion Recognition - Number of stimuli defined as portraying happiness. ERT - Number Stimuli Portraying Happiness EMO1-Number Stimuli Portraying Neutral Emotion Recognition - Number of stimuli defined as portraying a neutral expression. ERT - Number Stimuli Portraying Neutral EMO1-Number Stimuli Portraying Sadness Emotion Recognition - Number of stimuli defined as portraying sadness. ERT - Number Stimuli Portraying Sadness EMO1-Number Stimuli Portraying Surprise Emotion Recognition - Number of stimuli defined as portraying surprise. ERT - Number Stimuli Portraying Surprise EMO1-Sadness Responded as Anger Emotion Recognition - Number of sadness stimuli responded to as anger. ERT - Sadness Responded as Anger EMO1-Sadness Responded as Disgust Emotion Recognition - Number of sadness stimuli responded to as disgust. ERT - Sadness Responded as Disgust EMO1-Sadness Responded as Fear Emotion Recognition - Number of sadness stimuli responded to as fear. ERT - Sadness Responded as Fear EMO1-Sadness Responded as Happiness Emotion Recognition - Number of sadness stimuli responded to as happiness. ERT - Sadness Responded as Happiness EMO1-Sadness Responded as Neutral Emotion Recognition - Number of sadness stimuli responded to as neutral. ERT - Sadness Responded as Neutral EMO1-Sadness Responded as Sadness Emotion Recognition - Number of sadness stimuli responded to as sadness. ERT - Sadness Responded as Sadness EMO1-Sadness Responded as Surprise Emotion Recognition - Number of sadness stimuli responded to as surprise. ERT - Sadness Responded as Surprise EMO1-Surprise Responded as Anger Emotion Recognition - Number of surprise stimuli responded to as anger. ERT - Surprise Responded as Anger EMO1-Surprise Responded as Disgust Emotion Recognition - Number of surprise stimuli responded to as disgust. ERT - Surprise Responded as Disgust EMO1-Surprise Responded as Fear Emotion Recognition - Number of surprise stimuli responded to as fear. ERT - Surprise Responded as Fear EMO1-Surprise Responded as Happiness Emotion Recognition - Number of surprise stimuli responded to as happiness. ERT - Surprise Responded as Happiness EMO1-Surprise Responded as Neutral Emotion Recognition - Number of surprise stimuli responded to as neutral. ERT - Surprise Responded as Neutral EMO1-Surprise Responded as Sadness Emotion Recognition - Number of surprise stimuli responded to as sadness. ERT - Surprise Responded as Sadness EMO1-Surprise Responded as Surprise Emotion Recognition - Number of surprise stimuli responded to as surprise. ERT - Surprise Responded as Surprise EMO1-Total Negative Stimuli Administered Emotion Recognition - Total number of negative emotion stimuli (face images) actually administered in the task. ERT - Total Negative Stimuli Administered EMO1-Total Negative Stimuli Completed Emotion Recognition - Total number of negative emotion stimuli (face images) actually completed in the task. ERT - Total Negative Stimuli Completed EMO1-Total Negative Stimuli Correct Emotion Recognition - Total number of negative emotion stimuli (face images) for which the participant's response was correct. ERT - Total Negative Stimuli Correct EMO1-Total Negative Stimuli Expected Emotion Recognition - Total number of negative emotion stimuli (face images) expected to be administered in the task. ERT - Total Negative Stimuli Expected EMO1-Total Negative Stimuli Incorrect Emotion Recognition - Total number of negative emotion stimuli (face images) for which the participant's response was incorrect. ERT - Total Negative Stimuli Incorrect EMO1-Total Negative Stimuli Not Respond Emotion Recognition - Total number of negative emotion stimuli (face images) for which the participant has not responded. ERT - Total Negative Stimuli Not Respond EMO1-Total Stimuli Administered Emotion Recognition - Total number of stimuli (face images) actually administered in the task. ERT - Total Stimuli Administered EMO1-Total Stimuli Completed Emotion Recognition - Total number of stimuli (face images) actually completed in the task. ERT - Total Stimuli Completed EMO1-Total Stimuli Expected Emotion Recognition - Total number of stimuli (face images) expected to be administered in the task. ERT - Total Stimuli Expected EMO1-Total Stimuli Not Responded Emotion Recognition - Total number of stimuli (face images) for which the participant has not responded. ERT - Total Stimuli Not Responded EMO1-Total Stimuli Response Correct Emotion Recognition - Total number of stimuli (face images) for which the participant's response was correct. ERT - Total Stimuli Response Correct EMO1-Total Stimuli Response Incorrect Emotion Recognition - Total number of stimuli (face images) for which the participant's response was incorrect. ERT - Total Stimuli Response Incorrect EMO1TN Emotion Recognition Functional Test Test Name CDISC Functional Test ERT Test Name Terminology A terminology codelist relevant to the state or condition of an individual's employment. The state of being engaged in an activity or service for wages or salary. Employed Employment involving the standard or customary working time. Full Time Employment The state of not having a job. Unemployed Employment involving less than the standard or customary working time. Part Time Employment The state of being intentionally unemployed after a period of employment. Retirement EMPSTAT Employment Status CDISC SDTM Employment Status Terminology A terminology codelist relevant to the surroundings or environment. An establishment that provides care for infants and children. Childcare Center A health care facility where subjects or patients may receive assessments, procedures, or treatments that are provided by physicians and other healthcare providers. Clinic A tract of land cultivated for the purpose of agricultural production or devoted to the raising and breeding of domestic animals. Farm A setting outside the clinic or a comparable health care facility, e.g. a doctor's office, the subject's home or workplace, a school, a public park, or a restaurant. In the Field The buildings and organizations where healthcare services are provided. Healthcare Facility A person's place of residence. Home An institution that provides medical, surgical, or psychiatric care and treatment for the sick or the injured. Hospital The area in which an individual lives. Household Environment An established society, corporation, foundation or other organization founded and united for a specific purpose, e.g. for health-related research; also used to refer to a building or buildings occupied or used by such organization. Institution A motorized conveyance for people and goods. Motor Vehicle An area outside of that in which an individual lives. Non-household Environment Any environmental setting outside of a clinic. Not In Clinic A medical care center that provides healthcare services on an outpatient basis. Ambulatory Care Facility An institution where persons are confined for punishment and to protect the public. Correctional Institution An educational institution. School Temporary housing for displaced or at-risk persons. Shelter The surroundings or environment in which social activities occur. Social Setting Place or physical location of work or employment. Worksite SETTING Environmental Setting CDISC SDTM Environmental Setting Terminology A terminology codelist relevant to the codes for environmental storage condition parameters. Humidity A measure of the water vapor content of air. Humidity Temperature The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI) Temperature ESPARMCD Environmental Storage Conditions Parameter Code CDISC SDTM Environmental Storage Conditions Parameter Code Terminology A terminology codelist relevant to the name for environmental storage condition parameters. Humidity A measure of the water vapor content of air. Humidity Temperature The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI) Temperature ESPARM Environmental Storage Conditions Parameter Name CDISC SDTM Environmental Storage Conditions Parameter Name Terminology The name of the EPOCH. A period in a clinical study after eligibility has been met and before the start of treatment, at which baseline measurements are collected. Baseline Epoch A period in a clinical study during which subjects receive blinded therapeutic treatment. Blinded Treatment Epoch Continuation Phase A period in a clinical study during which subjects receive continuation treatment. Continuation Therapy Epoch A period in a clinical study during which information about the health status of an individual is obtained after study interventions have concluded. Follow-Up Epoch Induction Phase Intensive Phase A period in a clinical study during which subjects receive induction treatment. Induction Therapy Epoch A period in a study during which subjects are receiving investigational intervention(s). Investigational Intervention Epoch A period in a clinical study during which information about the health status of an individual is obtained long after study interventions have concluded. Long-term Follow-up Epoch A period in a clinical study during which subjects are observed, without any planned intervention. Observation Study Epoch A period in a clinical study during which subjects receive open label therapeutic treatment. Open Label Treatment Epoch A period in a clinical study during which subjects are evaluated prior to entering the full screening period. Pre-Screening Epoch A period in a clinical study during which subjects are exposed to the product. Product Exposure Epoch A period in a clinical study that occurs after screening and before randomization, during which the subject is further evaluated and/or prepared for the commencement of the clinical study investigation. Run-in Period A period in a clinical study during which subjects are evaluated for participation in the study. Screening Epoch A period in a study during which subjects are receiving investigational therapy or treatment. Treatment Epoch The interval of time that a participant enrolled in a study must not receive a specified treatment(s) before starting a study intervention(s). (CDISC Glossary) Washout Period EPOCH Epoch CDISC SDTM Epoch Terminology Epworth Sleepiness Scale test code. ESS01-Sitting and Reading Epworth Sleepiness Scale - Sitting and reading. ESS - Sitting and Reading ESS01-Watching TV Epworth Sleepiness Scale - Watching TV. ESS - Watching TV ESS01-Sitting Inactive in a Public Place Epworth Sleepiness Scale - Sitting, inactive in a public place (e.g. a theatre or a meeting). ESS - Sitting, Inactive in a Public Place ESS01-Passenger for Hour Without Break Epworth Sleepiness Scale - As a passenger in a car for an hour without a break. ESS - As a Passenger in a Car for an Hour Without a Break ESS01-Lying Down to Rest In Afternoon Epworth Sleepiness Scale - Lying down to rest in the afternoon when circumstances permit. ESS - Lying Down to Rest in the Afternoon When Circumstances Permit ESS01-Sitting and Talking to Someone Epworth Sleepiness Scale - Sitting and talking to someone. ESS - Sitting and Talking to Someone ESS01-Sitting Quietly After Lunch Epworth Sleepiness Scale - Sitting quietly after a lunch without alcohol. ESS - Sitting Quietly After a Lunch without Alcohol ESS01-In Car Stopped Few Minutes Traffic Epworth Sleepiness Scale - In a car, while stopped for a few minutes in the traffic. ESS - In a car, While Stopped for a Few Minutes in the Traffic ESS01-Total Score Epworth Sleepiness Scale - Total score. ESS - Total Score ESS01TC Epworth Sleepiness Scale Questionnaire Test Code CDISC Questionnaire ESS Test Code Terminology Epworth Sleepiness Scale test name. ESS01-In Car Stopped Few Minutes Traffic Epworth Sleepiness Scale - In a car, while stopped for a few minutes in the traffic. ESS - In a car, While Stopped for a Few Minutes in the Traffic ESS01-Lying Down to Rest In Afternoon Epworth Sleepiness Scale - Lying down to rest in the afternoon when circumstances permit. ESS - Lying Down to Rest in the Afternoon When Circumstances Permit ESS01-Passenger for Hour Without Break Epworth Sleepiness Scale - As a passenger in a car for an hour without a break. ESS - As a Passenger in a Car for an Hour Without a Break ESS01-Sitting and Reading Epworth Sleepiness Scale - Sitting and reading. ESS - Sitting and Reading ESS01-Sitting and Talking to Someone Epworth Sleepiness Scale - Sitting and talking to someone. ESS - Sitting and Talking to Someone ESS01-Sitting Inactive in a Public Place Epworth Sleepiness Scale - Sitting, inactive in a public place (e.g. a theatre or a meeting). ESS - Sitting, Inactive in a Public Place ESS01-Sitting Quietly After Lunch Epworth Sleepiness Scale - Sitting quietly after a lunch without alcohol. ESS - Sitting Quietly After a Lunch without Alcohol ESS01-Total Score Epworth Sleepiness Scale - Total score. ESS - Total Score ESS01-Watching TV Epworth Sleepiness Scale - Watching TV. ESS - Watching TV ESS01TN Epworth Sleepiness Scale Questionnaire Test Name CDISC Questionnaire ESS Test Name Terminology A terminology codelist relevant to the ethnicity of an individual as collected on the case report form. AC A Chinese person from the Achang ethnic group. Achang Chinese Black Latino A person of African and Latino descent. Afro-Latino A person of Ashkenazi Jewish descent. Ashkenazi Jew BA A Chinese person from the Bai ethnic group. Bai Chinese BL A Chinese person from the Blang ethnic group. Blang Chinese BN A Chinese person from the Bonan ethnic group. Bonan Chinese BY A Chinese person from the Buyei ethnic group. Buyei Chinese A person of Central American descent. Central American CS A Chinese person from the Chosen ethnic group. Chosen Chinese A person of Cuban and American descent. Cuban or Cuban American A person of Cuban descent. Cuban DA A Chinese person from the Dai (including several different Tai-speaking groups historically referred to as Bai-yi) ethnic group. Dai Chinese DU A Chinese person from the Daur ethnic group. Daur Chinese DE A Chinese person from the Deang ethnic group. Deang Chinese DR A Chinese person from the Derung ethnic group. Derung Chinese DO A Chinese person from the Dong ethnic group. Dong Chinese DX A Chinese person from the Dongxiang ethnic group. Dongxiang Chinese EW A Chinese person from the Ewenki ethnic group. Ewenki Chinese GS A Chinese person from the Gaoshan ethnic group. Gaoshan Chinese GL A Chinese person from the Gelao ethnic group. Gelao Chinese GI A Chinese person from the Gin ethnic group. Gin Chinese HA A Chinese person from the Han ethnic group (including Chuanqing). Han Chinese HN A Chinese person from the Hani (including Sangkong) ethnic group. Hani Chinese HZ A Chinese person from the Hezhen ethnic group. Hezhen Chinese A person of Mexican, Puerto Rican, Cuban, Central or South American or other Spanish culture or origin, regardless of race. (NCI) Hispanic or Latino Any of the peoples in the Americas and Spain who speak Spanish or are descended from Spanish-speaking communities. Hispanic HU A Chinese person from the Hui (including Utsuls of Hainan, descended from Cham refugees) ethnic group. Hui Chinese JP A Chinese person from the Jingpo ethnic group. Jingpo Chinese JN A Chinese person from the Jino ethnic group. Jino Chinese KZ A Chinese person from the Kazak ethnic group. Kazak Chinese KG A Chinese person from the Kirgiz ethnic group. Kirgiz Chinese A person from the Kurdish ethnic group. Kurdish LH A Chinese person from the Lahu ethnic group. Lahu Chinese A person of Latin American descent. Latin American Latina LatinX A person with origins from anywhere in Latin America (Mexico, South and Central America) and/or the Caribbean. Latino Latin Caribbean A person of Latino and Caribbean descent. Latino-Caribbean LB A Chinese person from the Lhoba ethnic group. Lhoba Chinese LI A Chinese person from the Li ethnic group. Li Chinese LS A Chinese person from the Lisu ethnic group. Lisu Chinese MA A Chinese person from the Man ethnic group. Man Chinese MN A Chinese person from the Maonan (including the Then) ethnic group. Maonan Chinese A person of Mexican and American descent. Mexican American A person of Mexican descent. Mexican MH A Chinese person from the Miao (Including Hmong) ethnic group. Miao Chinese MB A Chinese person from the Monba ethnic group. Monba Chinese MG A Chinese person from the Mongol ethnic group. Mongol Chinese ML A Chinese person from the Mulao (including the Qago) ethnic group. Mulao Chinese NX A Chinese person from the Naxi (including Mosuo) ethnic group. Naxi Chinese A person not of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race. An arbitrary ethnic classification. (NCI) Not Hispanic or Latino Not reported Not provided or available. Not Reported NU A Chinese person from the Nu ethnic group. Nu Chinese OR A Chinese person from the Oroqen ethnic group. Oroqen Chinese A person of Puerto Rican descent. Puerto Rican PM A Chinese person from the Pumi ethnic group. Pumi Chinese QI A Chinese person from the Qiang ethnic group. Qiang Chinese RS A Chinese person from the Russ ethnic group. Russ Chinese SL A Chinese person from the Salar ethnic group. Salar Chinese A person of Sephardic Jewish descent. Sephardic Jew SH A Chinese person from the She ethnic group. She Chinese A person of South American descent. South American Spaniard A person from Spain or of Spanish descent. Spanish SU A Chinese person from the Sui ethnic group. Sui Chinese TA A Chinese person from the Tajik ethnic group. Tajik Chinese TT A Chinese person from the Tatar ethnic group. Tatar Chinese TU A Chinese person from the Tu ethnic group. Tu Chinese TJ A Chinese person from the Tujia ethnic group. Tujia Chinese U UNK Unknown Not known, not observed, not recorded, or refused. (NCI) Unknown UG A Chinese person from the Uygur ethnic group. Uygur Chinese UZ A Chinese person from the Uzbek ethnic group. Uzbek Chinese VA A Chinese person from the Va ethnic group. Va Chinese XB A Chinese person from the Xibe ethnic group. Xibe Chinese YA A Chinese person from the Yao ethnic group. Yao Chinese YI A Chinese person from the Yi ethnic group. Yi Chinese YG A Chinese person from the Yugur ethnic group. Yugur Chinese ZA A Chinese person from the Zang (including Amdowa, Khampa and some Pumi speakers) ethnic group. Zang Chinese ZH A Chinese person from the Zhuang ethnic group. Zhuang Chinese ETHNICC Ethnicity As Collected CDISC SDTM Collected Ethnicity Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 test code. EOR06-Urinate Frequently During Day European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Did you urinate frequently during the day? EORTC QLQ-CR29 Version 2.1 - Urinate Frequently During Day EOR06-Urinate Frequently During Night European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Did you urinate frequently during the night? EORTC QLQ-CR29 Version 2.1 - Urinate Frequently During Night EOR06-Unintentional Release of Urine European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you had any unintentional release (leakage) of urine? EORTC QLQ-CR29 Version 2.1 - Unintentional Release of Urine EOR06-Pain When You Urinated European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Did you have pain when you urinated? EORTC QLQ-CR29 Version 2.1 - Pain When You Urinated EOR06-Did You Have Abdominal Pain European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Did you have abdominal pain? EORTC QLQ-CR29 Version 2.1 - Did You Have Abdominal Pain EOR06-Pain in Buttocks/Anal Area/Rectum European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Did you have pain in your buttocks/anal area/rectum? EORTC QLQ-CR29 Version 2.1 - Pain in Buttocks/Anal Area/Rectum EOR06-Bloated Feeling in Your Abdomen European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Did you have a bloated feeling in your abdomen? EORTC QLQ-CR29 Version 2.1 - Bloated Feeling in Your Abdomen EOR06-Have You Had Blood in Your Stools European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you had blood in your stools? EORTC QLQ-CR29 Version 2.1 - Have You Had Blood in Your Stools EOR06-Have You Had Mucus in Your Stools European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you had mucus in your stools? EORTC QLQ-CR29 Version 2.1 - Have You Had Mucus in Your Stools EOR06-Did You Have a Dry Mouth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Did you have a dry mouth? EORTC QLQ-CR29 Version 2.1 - Did You Have a Dry Mouth EOR06-Lost Hair as Result of Treatment European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you lost hair as a result of your treatment? EORTC QLQ-CR29 Version 2.1 - Lost Hair as Result of Treatment EOR06-Problems With Your Sense of Taste European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you had problems with your sense of taste? EORTC QLQ-CR29 Version 2.1 - Problems With Your Sense of Taste EOR06-Worried About Your Health Future European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Were you worried about your health in the future? EORTC QLQ-CR29 Version 2.1 - Worried About Your Health Future EOR06-Worried About Your Weight European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you worried about your weight? EORTC QLQ-CR29 Version 2.1 - Worried About Your Weight EOR06-Felt Physically Less Attractive European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you felt physically less attractive as a result of your disease or treatment? EORTC QLQ-CR29 Version 2.1 - Felt Physically Less Attractive EOR06-Feeling Less Feminine/Masculine European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you been feeling less feminine/masculine as a result of your disease or treatment? EORTC QLQ-CR29 Version 2.1 - Feeling Less Feminine/Masculine EOR06-Been Dissatisfied With Your Body European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you been dissatisfied with your body? EORTC QLQ-CR29 Version 2.1 - Been Dissatisfied With Your Body EOR06-Do You Have Stoma Bag European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Do you have a stoma bag (colostomy/ileostomy)? EORTC QLQ-CR29 Version 2.1 - Do You Have Stoma Bag EOR06-Unintentional Gas From Stoma Bag European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you had unintentional release of gas/flatulence from your stoma bag? EORTC QLQ-CR29 Version 2.1 - Unintentional Gas From Stoma Bag EOR06-Unintentional Gas Back Passage European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you had unintentional release of gas/flatulence from your back passage? EORTC QLQ-CR29 Version 2.1 - Unintentional Gas Back Passage EOR06-Leakage of Stools From Stoma Bag European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you had leakage of stools from your stoma bag? EORTC QLQ-CR29 Version 2.1 - Leakage of Stools From Stoma Bag EOR06-Leakage of Stools Back Passage European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you had leakage of stools from your back passage? EORTC QLQ-CR29 Version 2.1 - Leakage of Stools Back Passage EOR06-Sore Skin Around Your Stoma European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you had sore skin around your stoma? EORTC QLQ-CR29 Version 2.1 - Sore Skin Around Your Stoma EOR06-Sore Skin Around Your Anal Area European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you had sore skin around your anal area? EORTC QLQ-CR29 Version 2.1 - Sore Skin Around Your Anal Area EOR06-Frequent Bag Changes During Day European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Did frequent bag changes occur during the day? EORTC QLQ-CR29 Version 2.1 - Frequent Bag Changes During Day EOR06-Frequent Bowel Movements Day European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Did frequent bowel movements occur during the day? EORTC QLQ-CR29 Version 2.1 - Frequent Bowel Movements Day EOR06-Frequent Bag Changes During Night European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Did frequent bag changes occur during the night? EORTC QLQ-CR29 Version 2.1 - Frequent Bag Changes During Night EOR06-Frequent Bowel Movements Night European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Did frequent bowel movements occur during the night? EORTC QLQ-CR29 Version 2.1 - Frequent Bowel Movements Night EOR06-Feel Embarrassed Because of Stoma European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Did you feel embarrassed because of your stoma? EORTC QLQ-CR29 Version 2.1 - Feel Embarrassed Because of Stoma EOR06-Embarrassed Because Bowel Movement European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Did you feel embarrassed because of your bowel movement? EORTC QLQ-CR29 Version 2.1 - Embarrassed Because Bowel Movement EOR06-Problems Caring for Your Stoma European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Did you have problems caring for your stoma? EORTC QLQ-CR29 Version 2.1 - Problems Caring for Your Stoma EOR06-Men: Extent Interested in Sex European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past 4 weeks: For men only: To what extent were you interested in sex? EORTC QLQ-CR29 Version 2.1 - Men: Extent Interested in Sex EOR06-Men: Difficulty Getting Erection European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past 4 weeks: For men only: Did you have difficulty getting or maintaining an erection? EORTC QLQ-CR29 Version 2.1 - Men: Difficulty Getting Erection EOR06-Women: Extent Interested in Sex European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past 4 weeks: For women only: To what extent were you interested in sex? EORTC QLQ-CR29 Version 2.1 - Women: Extent Interested in Sex EOR06-Women: Pain/Discomfort Intercourse European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past 4 weeks: For women only: Did you have pain or discomfort during intercourse? EORTC QLQ-CR29 Version 2.1 - Women: Pain or Discomfort Intercourse EOR06TC European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items Questionnaire Test Code CDISC Questionnaire EORTC QLQ-CR29 Version 2.1 Test Code Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 test name. EOR06-Been Dissatisfied With Your Body European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you been dissatisfied with your body? EORTC QLQ-CR29 Version 2.1 - Been Dissatisfied With Your Body EOR06-Bloated Feeling in Your Abdomen European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Did you have a bloated feeling in your abdomen? EORTC QLQ-CR29 Version 2.1 - Bloated Feeling in Your Abdomen EOR06-Did You Have a Dry Mouth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Did you have a dry mouth? EORTC QLQ-CR29 Version 2.1 - Did You Have a Dry Mouth EOR06-Did You Have Abdominal Pain European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Did you have abdominal pain? EORTC QLQ-CR29 Version 2.1 - Did You Have Abdominal Pain EOR06-Do You Have Stoma Bag European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Do you have a stoma bag (colostomy/ileostomy)? EORTC QLQ-CR29 Version 2.1 - Do You Have Stoma Bag EOR06-Embarrassed Because Bowel Movement European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Did you feel embarrassed because of your bowel movement? EORTC QLQ-CR29 Version 2.1 - Embarrassed Because Bowel Movement EOR06-Feel Embarrassed Because of Stoma European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Did you feel embarrassed because of your stoma? EORTC QLQ-CR29 Version 2.1 - Feel Embarrassed Because of Stoma EOR06-Feeling Less Feminine/Masculine European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you been feeling less feminine/masculine as a result of your disease or treatment? EORTC QLQ-CR29 Version 2.1 - Feeling Less Feminine/Masculine EOR06-Felt Physically Less Attractive European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you felt physically less attractive as a result of your disease or treatment? EORTC QLQ-CR29 Version 2.1 - Felt Physically Less Attractive EOR06-Frequent Bag Changes During Day European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Did frequent bag changes occur during the day? EORTC QLQ-CR29 Version 2.1 - Frequent Bag Changes During Day EOR06-Frequent Bag Changes During Night European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Did frequent bag changes occur during the night? EORTC QLQ-CR29 Version 2.1 - Frequent Bag Changes During Night EOR06-Frequent Bowel Movements Day European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Did frequent bowel movements occur during the day? EORTC QLQ-CR29 Version 2.1 - Frequent Bowel Movements Day EOR06-Frequent Bowel Movements Night European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Did frequent bowel movements occur during the night? EORTC QLQ-CR29 Version 2.1 - Frequent Bowel Movements Night EOR06-Have You Had Blood in Your Stools European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you had blood in your stools? EORTC QLQ-CR29 Version 2.1 - Have You Had Blood in Your Stools EOR06-Have You Had Mucus in Your Stools European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you had mucus in your stools? EORTC QLQ-CR29 Version 2.1 - Have You Had Mucus in Your Stools EOR06-Leakage of Stools Back Passage European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you had leakage of stools from your back passage? EORTC QLQ-CR29 Version 2.1 - Leakage of Stools Back Passage EOR06-Leakage of Stools From Stoma Bag European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you had leakage of stools from your stoma bag? EORTC QLQ-CR29 Version 2.1 - Leakage of Stools From Stoma Bag EOR06-Lost Hair as Result of Treatment European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you lost hair as a result of your treatment? EORTC QLQ-CR29 Version 2.1 - Lost Hair as Result of Treatment EOR06-Men: Difficulty Getting Erection European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past 4 weeks: For men only: Did you have difficulty getting or maintaining an erection? EORTC QLQ-CR29 Version 2.1 - Men: Difficulty Getting Erection EOR06-Men: Extent Interested in Sex European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past 4 weeks: For men only: To what extent were you interested in sex? EORTC QLQ-CR29 Version 2.1 - Men: Extent Interested in Sex EOR06-Pain in Buttocks/Anal Area/Rectum European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Did you have pain in your buttocks/anal area/rectum? EORTC QLQ-CR29 Version 2.1 - Pain in Buttocks/Anal Area/Rectum EOR06-Pain When You Urinated European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Did you have pain when you urinated? EORTC QLQ-CR29 Version 2.1 - Pain When You Urinated EOR06-Problems Caring for Your Stoma European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Did you have problems caring for your stoma? EORTC QLQ-CR29 Version 2.1 - Problems Caring for Your Stoma EOR06-Problems With Your Sense of Taste European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you had problems with your sense of taste? EORTC QLQ-CR29 Version 2.1 - Problems With Your Sense of Taste EOR06-Sore Skin Around Your Anal Area European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you had sore skin around your anal area? EORTC QLQ-CR29 Version 2.1 - Sore Skin Around Your Anal Area EOR06-Sore Skin Around Your Stoma European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you had sore skin around your stoma? EORTC QLQ-CR29 Version 2.1 - Sore Skin Around Your Stoma EOR06-Unintentional Gas Back Passage European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you had unintentional release of gas/flatulence from your back passage? EORTC QLQ-CR29 Version 2.1 - Unintentional Gas Back Passage EOR06-Unintentional Gas From Stoma Bag European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you had unintentional release of gas/flatulence from your stoma bag? EORTC QLQ-CR29 Version 2.1 - Unintentional Gas From Stoma Bag EOR06-Unintentional Release of Urine European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you had any unintentional release (leakage) of urine? EORTC QLQ-CR29 Version 2.1 - Unintentional Release of Urine EOR06-Urinate Frequently During Day European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Did you urinate frequently during the day? EORTC QLQ-CR29 Version 2.1 - Urinate Frequently During Day EOR06-Urinate Frequently During Night European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Did you urinate frequently during the night? EORTC QLQ-CR29 Version 2.1 - Urinate Frequently During Night EOR06-Women: Extent Interested in Sex European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past 4 weeks: For women only: To what extent were you interested in sex? EORTC QLQ-CR29 Version 2.1 - Women: Extent Interested in Sex EOR06-Women: Pain/Discomfort Intercourse European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past 4 weeks: For women only: Did you have pain or discomfort during intercourse? EORTC QLQ-CR29 Version 2.1 - Women: Pain or Discomfort Intercourse EOR06-Worried About Your Health Future European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Were you worried about your health in the future? EORTC QLQ-CR29 Version 2.1 - Worried About Your Health Future EOR06-Worried About Your Weight European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items - During the past week: Have you worried about your weight? EORTC QLQ-CR29 Version 2.1 - Worried About Your Weight EOR06TN European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Version 2.1 29 Items Questionnaire Test Name CDISC Questionnaire EORTC QLQ-CR29 Version 2.1 Test Name Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 test code. EOR01-Trouble Doing Strenuous Activities European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Do you have any trouble doing strenuous activities, like carrying a heavy shopping bag or a suitcase? EORTC QLQ-C30 Version 3 - Trouble Doing Strenuous Activities EOR01-Trouble Taking Long Walk European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Do you have any trouble taking a long walk? EORTC QLQ-C30 Version 3 - Trouble Taking Long Walk EOR01-Trouble Taking Short Walk Outside European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Do you have any trouble taking a short walk outside of the house? EORTC QLQ-C30 Version 3 - Trouble Taking Short Walk Outside EOR01-Stay in Bed/Chair During the Day European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Do you need to stay in bed or a chair during the day? EORTC QLQ-C30 Version 3 - Stay in Bed or Chair During the Day EOR01-Need Help Eating/Dressing/Washing European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Do you need help with eating, dressing, washing yourself or using the toilet? EORTC QLQ-C30 Version 3 - Need Help Eating, Dressing, Washing EOR01-Limited in Work/Daily Activities European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Were you limited in doing either your work or other daily activities? EORTC QLQ-C30 Version 3 - Limited in Work or Daily Activities EOR01-Limited Hobbies/Leisure Activities European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Were you limited in pursuing your hobbies or other leisure time activities? EORTC QLQ-C30 Version 3 - Limited Hobbies or Leisure Activities EOR01-Were You Short of Breath European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Were you short of breath? EORTC QLQ-C30 Version 3 - Were You Short of Breath EOR01-Have You Had Pain European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you had pain? EORTC QLQ-C30 Version 3 - Have You Had Pain EOR01-Did You Need to Rest European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Did you need to rest? EORTC QLQ-C30 Version 3 - Did You Need to Rest EOR01-Have You Had Trouble Sleeping European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you had trouble sleeping? EORTC QLQ-C30 Version 3 - Have You Had Trouble Sleeping EOR01-Have You Felt Weak European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you felt weak? EORTC QLQ-C30 Version 3 - Have You Felt Weak EOR01-Have You Lacked Appetite European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you lacked appetite? EORTC QLQ-C30 Version 3 - Have You Lacked Appetite EOR01-Have You Felt Nauseated European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you felt nauseated? EORTC QLQ-C30 Version 3 - Have You Felt Nauseated EOR01-Have You Vomited European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you vomited? EORTC QLQ-C30 Version 3 - Have You Vomited EOR01-Have You Been Constipated European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you been constipated? EORTC QLQ-C30 Version 3 - Have You Been Constipated EOR01-Have You Had Diarrhea European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you had diarrhea? EORTC QLQ-C30 Version 3 - Have You Had Diarrhea EOR01-Were You Tired European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Were you tired? EORTC QLQ-C30 Version 3 - Were You Tired EOR01-Pain Interfere Daily Activities European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Did pain interfere with your daily activities? EORTC QLQ-C30 Version 3 - Pain Interfere Daily Activities EOR01-Difficulty Concentrating on Things European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you had difficulty in concentrating on things, like reading a newspaper or watching television? EORTC QLQ-C30 Version 3 - Difficulty Concentrating on Things EOR01-Did You Feel Tense European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Did you feel tense? EORTC QLQ-C30 Version 3 - Did You Feel Tense EOR01-Did You Worry European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Did you worry? EORTC QLQ-C30 Version 3 - Did You Worry EOR01-Did You Feel Irritable European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Did you feel irritable? EORTC QLQ-C30 Version 3 - Did You Feel Irritable EOR01-Did You Feel Depressed European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Did you feel depressed? EORTC QLQ-C30 Version 3 - Did You Feel Depressed EOR01-Had Difficulty Remembering Things European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you had difficulty remembering things? EORTC QLQ-C30 Version 3 - Had Difficulty Remembering Things EOR01-Condition Interfered Family Life European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Has your physical condition or medical treatment interfered with your family life? EORTC QLQ-C30 Version 3 - Condition Interfered Family Life EOR01-Condition Interfered Social Activ European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Has your physical condition or medical treatment interfered with your social activities? EORTC QLQ-C30 Version 3 - Condition Interfered Social Activities EOR01-Condition Caused Financial Diff European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Has your physical condition or medical treatment caused you financial difficulties? EORTC QLQ-C30 Version 3 - Condition Caused Financial Difficulties EOR01-Rate Your Overall Health European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - How would you rate your overall health during the past week? EORTC QLQ-C30 Version 3 - Rate Your Overall Health EOR01-Rate Your Overall Quality of Life European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - How would you rate your overall quality of life during the past week? EORTC QLQ-C30 Version 3 - Rate Your Overall Quality of Life EOR01-Global Health Status/QoL European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Global health status/QoL. EORTC QLQ-C30 Version 3 - EOR01-Global Health Status/QoL EOR01-FS:Physical Functioning European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Functional scale: physical functioning. EORTC QLQ-C30 Version 3 - EOR01-FS:Physical Functioning EOR01-FS:Role Functioning European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Functional scale: role functioning. EORTC QLQ-C30 Version 3 - EOR01-FS:Role Functioning EOR01-FS:Emotional Functioning European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Functional scale: emotional functioning. EORTC QLQ-C30 Version 3 - EOR01-FS:Emotional Functioning EOR01-FS:Cognitive Functioning European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Functional scale: cognitive functioning. EORTC QLQ-C30 Version 3 - EOR01-FS:Cognitive Functioning EOR01-FS:Social Functioning European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Functional scale: social functioning. EORTC QLQ-C30 Version 3 - EOR01-FS:Social Functioning EOR01-SS:Fatigue European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: fatigue. EORTC QLQ-C30 Version 3 - EOR01-SS:Fatigue EOR01-SS:Nausea and Vomiting European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: nausea and vomiting. EORTC QLQ-C30 Version 3 - EOR01-SS:Nausea and Vomiting EOR01-SS:Pain European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: pain. EORTC QLQ-C30 Version 3 - EOR01-SS:Pain EOR01-SS:Dyspnoea European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: dyspnoea. EORTC QLQ-C30 Version 3 - EOR01-SS:Dyspnoea EOR01-SS:Insomnia European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: insomnia. EORTC QLQ-C30 Version 3 - EOR01-SS:Insomnia EOR01-SS:Appetite Loss European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: appetite loss. EORTC QLQ-C30 Version 3 - EOR01-SS:Appetite Loss EOR01-SS:Constipation European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: constipation. EORTC QLQ-C30 Version 3 - EOR01-SS:Constipation EOR01-SS:Diarrhoea European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: diarrhoea. EORTC QLQ-C30 Version 3 - EOR01-SS:Diarrhoea EOR01-SS:Financial Difficulties European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: financial difficulties. EORTC QLQ-C30 Version 3 - EOR01-SS:Financial Difficulties EOR01TC European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 Questionnaire Test Code CDISC Questionnaire EORTC QLQ-C30 Version 3 Test Code Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 test name. EOR01-Condition Caused Financial Diff European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Has your physical condition or medical treatment caused you financial difficulties? EORTC QLQ-C30 Version 3 - Condition Caused Financial Difficulties EOR01-Condition Interfered Family Life European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Has your physical condition or medical treatment interfered with your family life? EORTC QLQ-C30 Version 3 - Condition Interfered Family Life EOR01-Condition Interfered Social Activ European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Has your physical condition or medical treatment interfered with your social activities? EORTC QLQ-C30 Version 3 - Condition Interfered Social Activities EOR01-Did You Feel Depressed European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Did you feel depressed? EORTC QLQ-C30 Version 3 - Did You Feel Depressed EOR01-Did You Feel Irritable European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Did you feel irritable? EORTC QLQ-C30 Version 3 - Did You Feel Irritable EOR01-Did You Feel Tense European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Did you feel tense? EORTC QLQ-C30 Version 3 - Did You Feel Tense EOR01-Did You Need to Rest European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Did you need to rest? EORTC QLQ-C30 Version 3 - Did You Need to Rest EOR01-Did You Worry European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Did you worry? EORTC QLQ-C30 Version 3 - Did You Worry EOR01-Difficulty Concentrating on Things European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you had difficulty in concentrating on things, like reading a newspaper or watching television? EORTC QLQ-C30 Version 3 - Difficulty Concentrating on Things EOR01-FS:Cognitive Functioning European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Functional scale: cognitive functioning. EORTC QLQ-C30 Version 3 - EOR01-FS:Cognitive Functioning EOR01-FS:Emotional Functioning European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Functional scale: emotional functioning. EORTC QLQ-C30 Version 3 - EOR01-FS:Emotional Functioning EOR01-FS:Physical Functioning European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Functional scale: physical functioning. EORTC QLQ-C30 Version 3 - EOR01-FS:Physical Functioning EOR01-FS:Role Functioning European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Functional scale: role functioning. EORTC QLQ-C30 Version 3 - EOR01-FS:Role Functioning EOR01-FS:Social Functioning European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Functional scale: social functioning. EORTC QLQ-C30 Version 3 - EOR01-FS:Social Functioning EOR01-Global Health Status/QoL European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Global health status/QoL. EORTC QLQ-C30 Version 3 - EOR01-Global Health Status/QoL EOR01-Had Difficulty Remembering Things European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you had difficulty remembering things? EORTC QLQ-C30 Version 3 - Had Difficulty Remembering Things EOR01-Have You Been Constipated European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you been constipated? EORTC QLQ-C30 Version 3 - Have You Been Constipated EOR01-Have You Felt Nauseated European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you felt nauseated? EORTC QLQ-C30 Version 3 - Have You Felt Nauseated EOR01-Have You Felt Weak European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you felt weak? EORTC QLQ-C30 Version 3 - Have You Felt Weak EOR01-Have You Had Diarrhea European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you had diarrhea? EORTC QLQ-C30 Version 3 - Have You Had Diarrhea EOR01-Have You Had Pain European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you had pain? EORTC QLQ-C30 Version 3 - Have You Had Pain EOR01-Have You Had Trouble Sleeping European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you had trouble sleeping? EORTC QLQ-C30 Version 3 - Have You Had Trouble Sleeping EOR01-Have You Lacked Appetite European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you lacked appetite? EORTC QLQ-C30 Version 3 - Have You Lacked Appetite EOR01-Have You Vomited European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you vomited? EORTC QLQ-C30 Version 3 - Have You Vomited EOR01-Limited Hobbies/Leisure Activities European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Were you limited in pursuing your hobbies or other leisure time activities? EORTC QLQ-C30 Version 3 - Limited Hobbies or Leisure Activities EOR01-Limited in Work/Daily Activities European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Were you limited in doing either your work or other daily activities? EORTC QLQ-C30 Version 3 - Limited in Work or Daily Activities EOR01-Need Help Eating/Dressing/Washing European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Do you need help with eating, dressing, washing yourself or using the toilet? EORTC QLQ-C30 Version 3 - Need Help Eating, Dressing, Washing EOR01-Pain Interfere Daily Activities European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Did pain interfere with your daily activities? EORTC QLQ-C30 Version 3 - Pain Interfere Daily Activities EOR01-Rate Your Overall Health European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - How would you rate your overall health during the past week? EORTC QLQ-C30 Version 3 - Rate Your Overall Health EOR01-Rate Your Overall Quality of Life European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - How would you rate your overall quality of life during the past week? EORTC QLQ-C30 Version 3 - Rate Your Overall Quality of Life EOR01-SS:Appetite Loss European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: appetite loss. EORTC QLQ-C30 Version 3 - EOR01-SS:Appetite Loss EOR01-SS:Constipation European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: constipation. EORTC QLQ-C30 Version 3 - EOR01-SS:Constipation EOR01-SS:Diarrhoea European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: diarrhoea. EORTC QLQ-C30 Version 3 - EOR01-SS:Diarrhoea EOR01-SS:Dyspnoea European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: dyspnoea. EORTC QLQ-C30 Version 3 - EOR01-SS:Dyspnoea EOR01-SS:Fatigue European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: fatigue. EORTC QLQ-C30 Version 3 - EOR01-SS:Fatigue EOR01-SS:Financial Difficulties European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: financial difficulties. EORTC QLQ-C30 Version 3 - EOR01-SS:Financial Difficulties EOR01-SS:Insomnia European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: insomnia. EORTC QLQ-C30 Version 3 - EOR01-SS:Insomnia EOR01-SS:Nausea and Vomiting European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: nausea and vomiting. EORTC QLQ-C30 Version 3 - EOR01-SS:Nausea and Vomiting EOR01-SS:Pain European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: pain. EORTC QLQ-C30 Version 3 - EOR01-SS:Pain EOR01-Stay in Bed/Chair During the Day European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Do you need to stay in bed or a chair during the day? EORTC QLQ-C30 Version 3 - Stay in Bed or Chair During the Day EOR01-Trouble Doing Strenuous Activities European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Do you have any trouble doing strenuous activities, like carrying a heavy shopping bag or a suitcase? EORTC QLQ-C30 Version 3 - Trouble Doing Strenuous Activities EOR01-Trouble Taking Long Walk European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Do you have any trouble taking a long walk? EORTC QLQ-C30 Version 3 - Trouble Taking Long Walk EOR01-Trouble Taking Short Walk Outside European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Do you have any trouble taking a short walk outside of the house? EORTC QLQ-C30 Version 3 - Trouble Taking Short Walk Outside EOR01-Were You Short of Breath European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Were you short of breath? EORTC QLQ-C30 Version 3 - Were You Short of Breath EOR01-Were You Tired European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Were you tired? EORTC QLQ-C30 Version 3 - Were You Tired EOR01TN European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 Questionnaire Test Name CDISC Questionnaire EORTC QLQ-C30 Version 3 Test Name Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module test code. EOR18-How Much Did You Cough European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - How much did you cough? EORTC QLQ-LC13 - How Much Did You Cough EOR18-Did You Cough Up Blood European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - Did you cough up blood? EORTC QLQ-LC13 - Did You Cough Up Blood EOR18-Short of Breath When Rested European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - Were you short of breath when you rested? EORTC QLQ-LC13 - Short of Breath When Rested EOR18-Short of Breath When Walked European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - Were you short of breath when you walked? EORTC QLQ-LC13 - Short of Breath When Walked EOR18-Short of Breath Climbed Stairs European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - Were you short of breath when you climbed stairs? EORTC QLQ-LC13 - Short of Breath Climbed Stairs EOR18-Had a Sore Mouth or Tongue European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - Have you had a sore mouth or tongue? EORTC QLQ-LC13 - Had a Sore Mouth or Tongue EOR18-Have You Had Trouble Swallowing European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - Have you had trouble swallowing? EORTC QLQ-LC13 - Have You Had Trouble Swallowing EOR18-Had Tingling Hands or Feet European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - Have you had tingling hands or feet? EORTC QLQ-LC13 - Had Tingling Hands or Feet EOR18-Have You Had Hair Loss European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - Have you had hair loss? EORTC QLQ-LC13 - Have You Had Hair Loss EOR18-Have You Had Pain in Your Chest European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - Have you had pain in your chest? EORTC QLQ-LC13 - Have You Had Pain in Your Chest EOR18-Had Pain in Your Arm or Shoulder European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - Have you had pain in your arm or shoulder? EORTC QLQ-LC13 - Had Pain in Your Arm or Shoulder EOR18-Had Pain in Other Parts of Body European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - Have you had pain in other parts of your body? EORTC QLQ-LC13 - Had Pain in Other Parts of Body EOR18-If Yes, Where European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - If yes, where. EORTC QLQ-LC13 - If Yes, Where EOR18-Did You Take Any Medicine for Pain European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - Did you take any medicine for pain? EORTC QLQ-LC13 - Did You Take Any Medicine for Pain EOR18-If Yes, How Much Did It Help European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - If yes, how much did it help? EORTC QLQ-LC13 - If Yes, How Much Did It Help EOR18TC European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items Questionnaire Test Code CDISC Questionnaire EORTC QLQ-LC13 Test Code Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module test name. EOR18-Did You Cough Up Blood European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - Did you cough up blood? EORTC QLQ-LC13 - Did You Cough Up Blood EOR18-Did You Take Any Medicine for Pain European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - Did you take any medicine for pain? EORTC QLQ-LC13 - Did You Take Any Medicine for Pain EOR18-Had a Sore Mouth or Tongue European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - Have you had a sore mouth or tongue? EORTC QLQ-LC13 - Had a Sore Mouth or Tongue EOR18-Had Pain in Other Parts of Body European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - Have you had pain in other parts of your body? EORTC QLQ-LC13 - Had Pain in Other Parts of Body EOR18-Had Pain in Your Arm or Shoulder European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - Have you had pain in your arm or shoulder? EORTC QLQ-LC13 - Had Pain in Your Arm or Shoulder EOR18-Had Tingling Hands or Feet European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - Have you had tingling hands or feet? EORTC QLQ-LC13 - Had Tingling Hands or Feet EOR18-Have You Had Hair Loss European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - Have you had hair loss? EORTC QLQ-LC13 - Have You Had Hair Loss EOR18-Have You Had Pain in Your Chest European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - Have you had pain in your chest? EORTC QLQ-LC13 - Have You Had Pain in Your Chest EOR18-Have You Had Trouble Swallowing European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - Have you had trouble swallowing? EORTC QLQ-LC13 - Have You Had Trouble Swallowing EOR18-How Much Did You Cough European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - How much did you cough? EORTC QLQ-LC13 - How Much Did You Cough EOR18-If Yes, How Much Did It Help European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - If yes, how much did it help? EORTC QLQ-LC13 - If Yes, How Much Did It Help EOR18-If Yes, Where European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - If yes, where. EORTC QLQ-LC13 - If Yes, Where EOR18-Short of Breath Climbed Stairs European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - Were you short of breath when you climbed stairs? EORTC QLQ-LC13 - Short of Breath Climbed Stairs EOR18-Short of Breath When Rested European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - Were you short of breath when you rested? EORTC QLQ-LC13 - Short of Breath When Rested EOR18-Short of Breath When Walked European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items - Were you short of breath when you walked? EORTC QLQ-LC13 - Short of Breath When Walked EOR18TN European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer 13 Items Questionnaire Test Name CDISC Questionnaire EORTC QLQ-LC13 Test Name Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 test code. EOR02-Trouble Taking Short Walk Outside European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - Do you have any trouble taking a short walk outside of the house? EORTC QLQ-C15-PAL Version 1 - Trouble Taking Short Walk Outside EOR02-Stay in Bed/Chair During the Day European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - Do you need to stay in bed or a chair during the day? EORTC QLQ-C15-PAL Version 1 - Stay in Bed or Chair During the Day EOR02-Need Help Eating/Dressing/Washing European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - Do you need help with eating, dressing, washing yourself or using the toilet? EORTC QLQ-C15-PAL Version 1 - Need Help Eating, Dressing, Washing EOR02-Were You Short of Breath European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Were you short of breath? EORTC QLQ-C15-PAL Version 1 - Were You Short of Breath EOR02-Have You Had Pain European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Have you had pain? EORTC QLQ-C15-PAL Version 1 - Have You Had Pain EOR02-Have You Had Trouble Sleeping European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Have you had trouble sleeping? EORTC QLQ-C15-PAL Version 1 - Have You Had Trouble Sleeping EOR02-Have You Felt Weak European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Have you felt weak? EORTC QLQ-C15-PAL Version 1 - Have You Felt Weak EOR02-Have You Lacked Appetite European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Have you lacked appetite? EORTC QLQ-C15-PAL Version 1 - Have You Lacked Appetite EOR02-Have You Felt Nauseated European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Have you felt nauseated? EORTC QLQ-C15-PAL Version 1 - Have You Felt Nauseated EOR02-Have You Been Constipated European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Have you been constipated? EORTC QLQ-C15-PAL Version 1 - Have You Been Constipated EOR02-Were You Tired European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Were you tired? EORTC QLQ-C15-PAL Version 1 - Were You Tired EOR02-Pain Interfere Daily Activities European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Did pain interfere with your daily activities? EORTC QLQ-C15-PAL Version 1 - Pain Interfere Daily Activities EOR02-Did You Feel Tense European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Did you feel tense? EORTC QLQ-C15-PAL Version 1 - Did You Feel Tense EOR02-Did You Feel Depressed European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Did you feel depressed? EORTC QLQ-C15-PAL Version 1 - Did You Feel Depressed EOR02-Rate Your Overall Quality of Life European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - How would you rate your overall quality of life during the past week? EORTC QLQ-C15-PAL Version 1 - Rate Your Overall Quality of Life EOR02TC European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 Questionnaire Test Code CDISC Questionnaire EORTC QLQ-C15-PAL Version 1 Test Code Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 test name. EOR02-Did You Feel Depressed European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Did you feel depressed? EORTC QLQ-C15-PAL Version 1 - Did You Feel Depressed EOR02-Did You Feel Tense European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Did you feel tense? EORTC QLQ-C15-PAL Version 1 - Did You Feel Tense EOR02-Have You Been Constipated European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Have you been constipated? EORTC QLQ-C15-PAL Version 1 - Have You Been Constipated EOR02-Have You Felt Nauseated European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Have you felt nauseated? EORTC QLQ-C15-PAL Version 1 - Have You Felt Nauseated EOR02-Have You Felt Weak European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Have you felt weak? EORTC QLQ-C15-PAL Version 1 - Have You Felt Weak EOR02-Have You Had Pain European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Have you had pain? EORTC QLQ-C15-PAL Version 1 - Have You Had Pain EOR02-Have You Had Trouble Sleeping European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Have you had trouble sleeping? EORTC QLQ-C15-PAL Version 1 - Have You Had Trouble Sleeping EOR02-Have You Lacked Appetite European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Have you lacked appetite? EORTC QLQ-C15-PAL Version 1 - Have You Lacked Appetite EOR02-Need Help Eating/Dressing/Washing European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - Do you need help with eating, dressing, washing yourself or using the toilet? EORTC QLQ-C15-PAL Version 1 - Need Help Eating, Dressing, Washing EOR02-Pain Interfere Daily Activities European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Did pain interfere with your daily activities? EORTC QLQ-C15-PAL Version 1 - Pain Interfere Daily Activities EOR02-Rate Your Overall Quality of Life European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - How would you rate your overall quality of life during the past week? EORTC QLQ-C15-PAL Version 1 - Rate Your Overall Quality of Life EOR02-Stay in Bed/Chair During the Day European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - Do you need to stay in bed or a chair during the day? EORTC QLQ-C15-PAL Version 1 - Stay in Bed or Chair During the Day EOR02-Trouble Taking Short Walk Outside European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - Do you have any trouble taking a short walk outside of the house? EORTC QLQ-C15-PAL Version 1 - Trouble Taking Short Walk Outside EOR02-Were You Short of Breath European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Were you short of breath? EORTC QLQ-C15-PAL Version 1 - Were You Short of Breath EOR02-Were You Tired European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Were you tired? EORTC QLQ-C15-PAL Version 1 - Were You Tired EOR02TN European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 Questionnaire Test Name CDISC Questionnaire EORTC QLQ-C15-PAL Version 1 Test Name Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items test code. EOR30-Leakage Stools/Mucus Anal Opening European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past week: Have you had leakage of stools or mucus from your anal opening (back passage)? EORTC QLQ-ANL27 - Leakage Stools or Mucus Anal Opening EOR30-Frequent Bowel Movements European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past week: Have you experienced frequent bowel movements? EORTC QLQ-ANL27 - Frequent Bowel Movements EOR30-Bowel Movements Been Painful European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past week: Have your bowel movements been painful? EORTC QLQ-ANL27 - Bowel Movements Been Painful EOR30-Pain/Discomfort Anal Opening European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past week: Have you had pain/discomfort around your anal opening (back passage)? EORTC QLQ-ANL27 - Pain or Discomfort Anal Opening EOR30-Pain While Sitting European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past week: Have you had pain while sitting? EORTC QLQ-ANL27 - Pain While Sitting EOR30-Uncomfortable in Certain Positions European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past week: Have you been uncomfortable in certain positions (e.g. lying down)? EORTC QLQ-ANL27 - Uncomfortable in Certain Positions EOR30-Soreness in Areas Treated European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past week: Have you had soreness in the areas that have been treated? EORTC QLQ-ANL27 - Soreness in Areas Treated EOR30-Itchy/Irritated Skin Areas Treated European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past week: Have you had itchy or irritated skin in the areas that have been treated? EORTC QLQ-ANL27 - Itchy or Irritated Skin Areas Treated EOR30-Urinate Frequently European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past week: Have you had to urinate frequently? EORTC QLQ-ANL27 - Urinate Frequently EOR30-Swelling in Legs/Ankles European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past week: Have you had swelling in your legs or ankles? EORTC QLQ-ANL27 - Swelling in Legs or Ankles EOR30-Problems Going Out Need Toilet European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past week: Have you had problems going out of the house because you needed to be close to a toilet? EORTC QLQ-ANL27 - Problems Going Out Need Toilet EOR30-Clean Yourself More Often European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past week: Have you had to clean yourself more often? EORTC QLQ-ANL27 - Clean Yourself More Often EOR30-Problems Planning Activities European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past week: Have you had problems planning activities in advance (e.g. meeting friends)? EORTC QLQ-ANL27 - Problems Planning Activities EOR30-No Stoma: Problems With Gas European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - Only if you do not have a stoma bag: During the past week: Have you had problems with gas (flatulence)? EORTC QLQ-ANL27 - No Stoma: Problems With Gas EOR30-No Stoma: Move Bowels Hurry Toilet European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - Only if you do not have a stoma bag: During the past week: When you felt the urge to move your bowels, did you have to hurry to get to the toilet? EORTC QLQ-ANL27 - No Stoma: Move Bowels Hurry Toilet EOR30-No Stoma: Unable to Empty Bowels European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - Only if you do not have a stoma bag: During the past week: Have you had the feeling of being unable to completely empty your bowels? EORTC QLQ-ANL27 - No Stoma: Unable to Empty Bowels EOR30-Stoma: Sore Skin Around Stoma European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - Only if you have a stoma bag: During the past week: Have you had sore skin around your stoma? EORTC QLQ-ANL27 - Stoma: Sore Skin Around Stoma EOR30-Stoma: Leakage of Stools Stoma Bag European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - Only if you have a stoma bag: During the past week: Have you had leakage of stools from your stoma bag? EORTC QLQ-ANL27 - Stoma: Leakage of Stools Stoma Bag EOR30-Stoma: Unintentional Gas Stoma Bag European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - Only if you have a stoma bag: During the past week: Have you had unintentional release of gas/flatulence from your stoma bag? EORTC QLQ-ANL27 - Stoma: Unintentional Gas Stoma Bag EOR30-Sexually Active European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past 4 weeks: Have you been sexually active? EORTC QLQ-ANL27 - Sexually Active EOR30-Extent Interested in Sex European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past 4 weeks: To what extent have you been interested in sex? EORTC QLQ-ANL27 - Extent Interested in Sex EOR30-Disease/Treatment Affect Sex Life European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past 4 weeks: Has the disease or treatment affected your sex life (for the worse)? EORTC QLQ-ANL27 - Disease or Treatment Affect Sex Life EOR30-Pain During Intercourse European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past 4 weeks: Have you had pain during intercourse? EORTC QLQ-ANL27 - Pain During Intercourse EOR30-Men: Difficulty Getting Erection European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - For men only: During the past 4 weeks: Have you had difficulty getting or maintaining an erection? EORTC QLQ-ANL27 - Men: Difficulty Getting Erection EOR30-Women: Vagina Felt Dry European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - For women only: During the past 4 weeks: Has your vagina felt dry? EORTC QLQ-ANL27 - Women: Vagina Felt Dry EOR30-Women: Vagina Felt Narrow/Tight European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - For women only: During the past 4 weeks: Has your vagina felt narrow/tight? EORTC QLQ-ANL27 - Women: Vagina Felt Narrow or Tight EOR30-Women: Vagina Been Painful European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - For women only: During the past 4 weeks: Has your vagina been painful? EORTC QLQ-ANL27 - Women: Vagina Been Painful EOR30TC European Organization for the Research and Treatment of Cancer Quality of Life - Anal Cancer 27 Items Questionnaire Test Code CDISC Questionnaire European Organization for the Research and Treatment of Cancer Quality of Life - Anal Cancer 27 Items Test Code Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items test name. EOR30-Bowel Movements Been Painful European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past week: Have your bowel movements been painful? EORTC QLQ-ANL27 - Bowel Movements Been Painful EOR30-Clean Yourself More Often European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past week: Have you had to clean yourself more often? EORTC QLQ-ANL27 - Clean Yourself More Often EOR30-Disease/Treatment Affect Sex Life European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past 4 weeks: Has the disease or treatment affected your sex life (for the worse)? EORTC QLQ-ANL27 - Disease or Treatment Affect Sex Life EOR30-Extent Interested in Sex European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past 4 weeks: To what extent have you been interested in sex? EORTC QLQ-ANL27 - Extent Interested in Sex EOR30-Frequent Bowel Movements European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past week: Have you experienced frequent bowel movements? EORTC QLQ-ANL27 - Frequent Bowel Movements EOR30-Itchy/Irritated Skin Areas Treated European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past week: Have you had itchy or irritated skin in the areas that have been treated? EORTC QLQ-ANL27 - Itchy or Irritated Skin Areas Treated EOR30-Leakage Stools/Mucus Anal Opening European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past week: Have you had leakage of stools or mucus from your anal opening (back passage)? EORTC QLQ-ANL27 - Leakage Stools or Mucus Anal Opening EOR30-Men: Difficulty Getting Erection European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - For men only: During the past 4 weeks: Have you had difficulty getting or maintaining an erection? EORTC QLQ-ANL27 - Men: Difficulty Getting Erection EOR30-No Stoma: Move Bowels Hurry Toilet European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - Only if you do not have a stoma bag: During the past week: When you felt the urge to move your bowels, did you have to hurry to get to the toilet? EORTC QLQ-ANL27 - No Stoma: Move Bowels Hurry Toilet EOR30-No Stoma: Problems With Gas European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - Only if you do not have a stoma bag: During the past week: Have you had problems with gas (flatulence)? EORTC QLQ-ANL27 - No Stoma: Problems With Gas EOR30-No Stoma: Unable to Empty Bowels European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - Only if you do not have a stoma bag: During the past week: Have you had the feeling of being unable to completely empty your bowels? EORTC QLQ-ANL27 - No Stoma: Unable to Empty Bowels EOR30-Pain During Intercourse European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past 4 weeks: Have you had pain during intercourse? EORTC QLQ-ANL27 - Pain During Intercourse EOR30-Pain While Sitting European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past week: Have you had pain while sitting? EORTC QLQ-ANL27 - Pain While Sitting EOR30-Pain/Discomfort Anal Opening European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past week: Have you had pain/discomfort around your anal opening (back passage)? EORTC QLQ-ANL27 - Pain or Discomfort Anal Opening EOR30-Problems Going Out Need Toilet European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past week: Have you had problems going out of the house because you needed to be close to a toilet? EORTC QLQ-ANL27 - Problems Going Out Need Toilet EOR30-Problems Planning Activities European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past week: Have you had problems planning activities in advance (e.g. meeting friends)? EORTC QLQ-ANL27 - Problems Planning Activities EOR30-Sexually Active European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past 4 weeks: Have you been sexually active? EORTC QLQ-ANL27 - Sexually Active EOR30-Soreness in Areas Treated European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past week: Have you had soreness in the areas that have been treated? EORTC QLQ-ANL27 - Soreness in Areas Treated EOR30-Stoma: Leakage of Stools Stoma Bag European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - Only if you have a stoma bag: During the past week: Have you had leakage of stools from your stoma bag? EORTC QLQ-ANL27 - Stoma: Leakage of Stools Stoma Bag EOR30-Stoma: Sore Skin Around Stoma European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - Only if you have a stoma bag: During the past week: Have you had sore skin around your stoma? EORTC QLQ-ANL27 - Stoma: Sore Skin Around Stoma EOR30-Stoma: Unintentional Gas Stoma Bag European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - Only if you have a stoma bag: During the past week: Have you had unintentional release of gas/flatulence from your stoma bag? EORTC QLQ-ANL27 - Stoma: Unintentional Gas Stoma Bag EOR30-Swelling in Legs/Ankles European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past week: Have you had swelling in your legs or ankles? EORTC QLQ-ANL27 - Swelling in Legs or Ankles EOR30-Uncomfortable in Certain Positions European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past week: Have you been uncomfortable in certain positions (e.g. lying down)? EORTC QLQ-ANL27 - Uncomfortable in Certain Positions EOR30-Urinate Frequently European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - During the past week: Have you had to urinate frequently? EORTC QLQ-ANL27 - Urinate Frequently EOR30-Women: Vagina Been Painful European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - For women only: During the past 4 weeks: Has your vagina been painful? EORTC QLQ-ANL27 - Women: Vagina Been Painful EOR30-Women: Vagina Felt Dry European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - For women only: During the past 4 weeks: Has your vagina felt dry? EORTC QLQ-ANL27 - Women: Vagina Felt Dry EOR30-Women: Vagina Felt Narrow/Tight European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer 27 Items - For women only: During the past 4 weeks: Has your vagina felt narrow/tight? EORTC QLQ-ANL27 - Women: Vagina Felt Narrow or Tight EOR30TN European Organization for the Research and Treatment of Cancer Quality of Life - Anal Cancer 27 Items Questionnaire Test Name CDISC Questionnaire European Organization for the Research and Treatment of Cancer Quality of Life - Anal Cancer 27 Items Test Name Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items test code. EOR03-Pain in Back European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week have you had pain in any of the following parts of your body? in your back? EORTC QLQ-BM22 - Pain in Back EOR03-Pain in Leg/Hip European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week have you had pain in any of the following parts of your body? in your leg(s) or hip(s)? EORTC QLQ-BM22 - Pain in Leg or Hip EOR03-Pain in Arm/Shoulder European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week have you had pain in any of the following parts of your body? in your arm(s) or shoulder(s)? EORTC QLQ-BM22 - Pain in Arm or Shoulder EOR03-Pain in Chest/Rib European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week have you had pain in any of the following parts of your body? in your chest or rib(s)? EORTC QLQ-BM22 - Pain in Chest or Rib EOR03-Pain in Buttock European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week have you had pain in any of the following parts of your body? in your buttock(s)? EORTC QLQ-BM22 - Pain in Buttock EOR03-Constant Pain European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you had constant pain? EORTC QLQ-BM22 - Constant Pain EOR03-Intermittent Pain European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you had intermittent pain? EORTC QLQ-BM22 - Intermittent Pain EOR03-Pain Not Relieved by Medications European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you had pain not relieved by pain medications? EORTC QLQ-BM22 - Pain Not Relieved by Medications EOR03-Pain While Lying Down European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you had pain while lying down? EORTC QLQ-BM22 - Pain While Lying Down EOR03-Pain While Sitting European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you had pain while sitting? EORTC QLQ-BM22 - Pain While Sitting EOR03-Pain When Trying to Stand Up European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you had pain when trying to stand up? EORTC QLQ-BM22 - Pain When Trying to Stand Up EOR03-Pain While Walking European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you had pain while walking? EORTC QLQ-BM22 - Pain While Walking EOR03-Pain With Activities European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you had pain with activities such as bending or climbing stairs? EORTC QLQ-BM22 - Pain With Activities EOR03-Pain With Strenuous Activity European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you had pain with strenuous activity (e.g. exercise, lifting)? EORTC QLQ-BM22 - Pain With Strenuous Activity EOR03-Pain Interfered Sleeping at Night European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Has pain interfered with your sleeping at night? EORTC QLQ-BM22 - Pain Interfered Sleeping at Night EOR03-Modify Daily Activities European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you had to modify your daily activities because of your illness? EORTC QLQ-BM22 - Modify Daily Activities EOR03-Isolated From Those Close to You European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you felt isolated from those close to you (e.g. family, friends)? EORTC QLQ-BM22 - Isolated From Those Close to You EOR03-Worried About Loss of Mobility European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you worried about loss of mobility because of your illness? EORTC QLQ-BM22 - Worried About Loss of Mobility EOR03-Worried Becoming Dependent Illness European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you worried about becoming dependent on others because of your illness? EORTC QLQ-BM22 - Worried Becoming Dependent Illness EOR03-Worried About Health in Future European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you worried about your health in the future? EORTC QLQ-BM22 - Worried About Health in Future EOR03-Hopeful Pain Will Get Better European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you felt hopeful your pain will get better? EORTC QLQ-BM22 - Hopeful Pain Will Get Better EOR03-Felt Positive About Health European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you felt positive about your health? EORTC QLQ-BM22 - Felt Positive About Health EOR03TC European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items Test Code CDISC Questionnaire European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items Test Code Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items test name. EOR03-Constant Pain European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you had constant pain? EORTC QLQ-BM22 - Constant Pain EOR03-Felt Positive About Health European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you felt positive about your health? EORTC QLQ-BM22 - Felt Positive About Health EOR03-Hopeful Pain Will Get Better European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you felt hopeful your pain will get better? EORTC QLQ-BM22 - Hopeful Pain Will Get Better EOR03-Intermittent Pain European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you had intermittent pain? EORTC QLQ-BM22 - Intermittent Pain EOR03-Isolated From Those Close to You European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you felt isolated from those close to you (e.g. family, friends)? EORTC QLQ-BM22 - Isolated From Those Close to You EOR03-Modify Daily Activities European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you had to modify your daily activities because of your illness? EORTC QLQ-BM22 - Modify Daily Activities EOR03-Pain in Arm/Shoulder European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week have you had pain in any of the following parts of your body? in your arm(s) or shoulder(s)? EORTC QLQ-BM22 - Pain in Arm or Shoulder EOR03-Pain in Back European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week have you had pain in any of the following parts of your body? in your back? EORTC QLQ-BM22 - Pain in Back EOR03-Pain in Buttock European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week have you had pain in any of the following parts of your body? in your buttock(s)? EORTC QLQ-BM22 - Pain in Buttock EOR03-Pain in Chest/Rib European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week have you had pain in any of the following parts of your body? in your chest or rib(s)? EORTC QLQ-BM22 - Pain in Chest or Rib EOR03-Pain in Leg/Hip European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week have you had pain in any of the following parts of your body? in your leg(s) or hip(s)? EORTC QLQ-BM22 - Pain in Leg or Hip EOR03-Pain Interfered Sleeping at Night European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Has pain interfered with your sleeping at night? EORTC QLQ-BM22 - Pain Interfered Sleeping at Night EOR03-Pain Not Relieved by Medications European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you had pain not relieved by pain medications? EORTC QLQ-BM22 - Pain Not Relieved by Medications EOR03-Pain When Trying to Stand Up European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you had pain when trying to stand up? EORTC QLQ-BM22 - Pain When Trying to Stand Up EOR03-Pain While Lying Down European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you had pain while lying down? EORTC QLQ-BM22 - Pain While Lying Down EOR03-Pain While Sitting European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you had pain while sitting? EORTC QLQ-BM22 - Pain While Sitting EOR03-Pain While Walking European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you had pain while walking? EORTC QLQ-BM22 - Pain While Walking EOR03-Pain With Activities European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you had pain with activities such as bending or climbing stairs? EORTC QLQ-BM22 - Pain With Activities EOR03-Pain With Strenuous Activity European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you had pain with strenuous activity (e.g. exercise, lifting)? EORTC QLQ-BM22 - Pain With Strenuous Activity EOR03-Worried About Health in Future European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you worried about your health in the future? EORTC QLQ-BM22 - Worried About Health in Future EOR03-Worried About Loss of Mobility European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you worried about loss of mobility because of your illness? EORTC QLQ-BM22 - Worried About Loss of Mobility EOR03-Worried Becoming Dependent Illness European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items - During the past week: Have you worried about becoming dependent on others because of your illness? EORTC QLQ-BM22 - Worried Becoming Dependent Illness EOR03TN European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items Test Name CDISC Questionnaire European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases 22 Items Test Name Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items test code. EOR35-Dry Mouth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had a dry mouth? EORTC QLQ-BR42 - Dry Mouth EOR35-Food & Drink Taste Different European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have food and drink tasted different than usual? EORTC QLQ-BR42 - Food & Drink Taste Different EOR35-Eyes Painful/Irritated/Watery European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have your eyes been painful, irritated or watery? EORTC QLQ-BR42 - Eyes Painful or Irritated or Watery EOR35-Lost Any Hair European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you lost any hair? EORTC QLQ-BR42 - Lost Any Hair EOR35-Lost Hair: Upset by Loss of Hair European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: only if you have lost any hair: Have you been upset by the loss of your hair? EORTC QLQ-BR42 - Lost Hair: Upset by Loss of Hair EOR35-Felt Ill/Unwell European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you felt ill or unwell? EORTC QLQ-BR42 - Felt Ill or Unwell EOR35-Hot Flushes European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had hot flushes? EORTC QLQ-BR42 - Hot Flushes EOR35-Headaches European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had headaches? EORTC QLQ-BR42 - Headaches EOR35-Felt Physically Less Attractive European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you felt physically less attractive as a result of your disease or treatment? EORTC QLQ-BR42 - Felt Physically Less Attractive EOR35-Felt Less Feminine European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you felt less feminine as a result of your disease or treatment? EORTC QLQ-BR42 - Felt Less Feminine EOR35-Problems Looking at Yourself Naked European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had problems looking at yourself naked? EORTC QLQ-BR42 - Problems Looking at Yourself Naked EOR35-Dissatisfied With Body European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you been dissatisfied with your body? EORTC QLQ-BR42 - Dissatisfied With Body EOR35-Worried About Health in Future European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you worried about your health in the future? EORTC QLQ-BR42 - Worried About Health in Future EOR35-Interested in Sex European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past four weeks: Have you been interested in sex? EORTC QLQ-BR42 - Interested in Sex EOR35-Sexually Active European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past four weeks: Have you been sexually active (with or without intercourse)? EORTC QLQ-BR42 - Sexually Active EOR35-Sex Enjoyable European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past four weeks: Has sex been enjoyable for you? EORTC QLQ-BR42 - Sex Enjoyable EOR35-Pain in Arm/Shoulder European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had any pain in your arm or shoulder? EORTC QLQ-BR42 - Pain in Arm or Shoulder EOR35-Swollen Arm/Hand European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had a swollen arm or hand? EORTC QLQ-BR42 - Swollen Arm or Hand EOR35-Prob Raising Arm/Moving Sideways European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had problems raising your arm or moving it sideways? EORTC QLQ-BR42 - Problem Raising Arm or Moving Sideways EOR35-Pain in Affected Breast European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had any pain in the area of your affected breast? EORTC QLQ-BR42 - Pain in Affected Breast EOR35-Affected Breast Swollen European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Has the area of your affected breast been swollen? EORTC QLQ-BR42 - Affected Breast Swollen EOR35-Affected Breast Oversensitive European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Has the area of your affected breast been oversensitive? EORTC QLQ-BR42 - Affected Breast Oversensitive EOR35-Skin Problems on Affected Breast European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had skin problems on or in the area of your affected breast (e.g., itchy, dry, flaky)? EORTC QLQ-BR42 - Skin Problems on Affected Breast EOR35-Sweated Excessively European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you sweated excessively? EORTC QLQ-BR42 - Sweated Excessively EOR35-Mood Swings European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had mood swings? EORTC QLQ-BR42 - Mood Swings EOR35-Dizzy European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you been dizzy? EORTC QLQ-BR42 - Dizzy EOR35-Soreness in Mouth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had soreness in your mouth? EORTC QLQ-BR42 - Soreness in Mouth EOR35-Redness in Mouth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had any redness in your mouth? EORTC QLQ-BR42 - Redness in Mouth EOR35-Pain in Hands/Feet European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had pain in your hands or feet? EORTC QLQ-BR42 - Pain in Hands or Feet EOR35-Redness on Hands/Feet European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had any redness on your hands or feet? EORTC QLQ-BR42 - Redness on Hands or Feet EOR35-Tingling in Fingers/Toes European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had tingling in your fingers or toes? EORTC QLQ-BR42 - Tingling in Fingers or Toes EOR35-Numbness in Fingers/Toes European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had numbness in your fingers or toes? EORTC QLQ-BR42 - Numbness in Fingers or Toes EOR35-Problems With Joints European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had problems with your joints? EORTC QLQ-BR42 - Problems With Joints EOR35-Stiffness in Joints European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had stiffness in your joints? EORTC QLQ-BR42 - Stiffness in Joints EOR35-Pain in Joints European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had pain in your joints? EORTC QLQ-BR42 - Pain in Joints EOR35-Aches/Pains in Bones European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had aches or pains in your bones? EORTC QLQ-BR42 - Aches or Pains in Bones EOR35-Gained Weight European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you gained weight? EORTC QLQ-BR42 - Gained Weight EOR35-Discomfort in Vagina European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past four weeks: Have you had discomfort in your vagina? EORTC QLQ-BR42 - Discomfort in Vagina EOR35-Sexual: Pain in Vagina During Sex European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past four weeks: only if you have been sexually active: Have you had pain in your vagina during sexual activity? EORTC QLQ-BR42 - Sexual: Pain in Vagina During Sex EOR35-Sexual: Dry Vagina During Sex European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past four weeks: only if you have been sexually active: Have you experienced a dry vagina during sexual activity? EORTC QLQ-BR42 - Sexual: Dry Vagina During Sex EOR35-Satisfied With Cosmetic Result European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you been satisfied with the cosmetic result of the surgery? EORTC QLQ-BR42 - Satisfied With Cosmetic Result EOR35-Satisfied With Appearance of Skin European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you been satisfied with the appearance of the skin of your affected breast (thoracic area)? EORTC QLQ-BR42 - Satisfied With Appearance of Skin EOR35TC European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items Test Code CDISC Questionnaire European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items Test Code Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items test name. EOR35-Aches/Pains in Bones European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had aches or pains in your bones? EORTC QLQ-BR42 - Aches or Pains in Bones EOR35-Affected Breast Oversensitive European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Has the area of your affected breast been oversensitive? EORTC QLQ-BR42 - Affected Breast Oversensitive EOR35-Affected Breast Swollen European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Has the area of your affected breast been swollen? EORTC QLQ-BR42 - Affected Breast Swollen EOR35-Discomfort in Vagina European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past four weeks: Have you had discomfort in your vagina? EORTC QLQ-BR42 - Discomfort in Vagina EOR35-Dissatisfied With Body European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you been dissatisfied with your body? EORTC QLQ-BR42 - Dissatisfied With Body EOR35-Dizzy European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you been dizzy? EORTC QLQ-BR42 - Dizzy EOR35-Dry Mouth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had a dry mouth? EORTC QLQ-BR42 - Dry Mouth EOR35-Eyes Painful/Irritated/Watery European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have your eyes been painful, irritated or watery? EORTC QLQ-BR42 - Eyes Painful or Irritated or Watery EOR35-Felt Ill/Unwell European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you felt ill or unwell? EORTC QLQ-BR42 - Felt Ill or Unwell EOR35-Felt Less Feminine European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you felt less feminine as a result of your disease or treatment? EORTC QLQ-BR42 - Felt Less Feminine EOR35-Felt Physically Less Attractive European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you felt physically less attractive as a result of your disease or treatment? EORTC QLQ-BR42 - Felt Physically Less Attractive EOR35-Food & Drink Taste Different European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have food and drink tasted different than usual? EORTC QLQ-BR42 - Food & Drink Taste Different EOR35-Gained Weight European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you gained weight? EORTC QLQ-BR42 - Gained Weight EOR35-Headaches European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had headaches? EORTC QLQ-BR42 - Headaches EOR35-Hot Flushes European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had hot flushes? EORTC QLQ-BR42 - Hot Flushes EOR35-Interested in Sex European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past four weeks: Have you been interested in sex? EORTC QLQ-BR42 - Interested in Sex EOR35-Lost Any Hair European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you lost any hair? EORTC QLQ-BR42 - Lost Any Hair EOR35-Lost Hair: Upset by Loss of Hair European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: only if you have lost any hair: Have you been upset by the loss of your hair? EORTC QLQ-BR42 - Lost Hair: Upset by Loss of Hair EOR35-Mood Swings European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had mood swings? EORTC QLQ-BR42 - Mood Swings EOR35-Numbness in Fingers/Toes European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had numbness in your fingers or toes? EORTC QLQ-BR42 - Numbness in Fingers or Toes EOR35-Pain in Affected Breast European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had any pain in the area of your affected breast? EORTC QLQ-BR42 - Pain in Affected Breast EOR35-Pain in Arm/Shoulder European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had any pain in your arm or shoulder? EORTC QLQ-BR42 - Pain in Arm or Shoulder EOR35-Pain in Hands/Feet European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had pain in your hands or feet? EORTC QLQ-BR42 - Pain in Hands or Feet EOR35-Pain in Joints European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had pain in your joints? EORTC QLQ-BR42 - Pain in Joints EOR35-Prob Raising Arm/Moving Sideways European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had problems raising your arm or moving it sideways? EORTC QLQ-BR42 - Problem Raising Arm or Moving Sideways EOR35-Problems Looking at Yourself Naked European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had problems looking at yourself naked? EORTC QLQ-BR42 - Problems Looking at Yourself Naked EOR35-Problems With Joints European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had problems with your joints? EORTC QLQ-BR42 - Problems With Joints EOR35-Redness in Mouth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had any redness in your mouth? EORTC QLQ-BR42 - Redness in Mouth EOR35-Redness on Hands/Feet European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had any redness on your hands or feet? EORTC QLQ-BR42 - Redness on Hands or Feet EOR35-Satisfied With Appearance of Skin European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you been satisfied with the appearance of the skin of your affected breast (thoracic area)? EORTC QLQ-BR42 - Satisfied With Appearance of Skin EOR35-Satisfied With Cosmetic Result European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you been satisfied with the cosmetic result of the surgery? EORTC QLQ-BR42 - Satisfied With Cosmetic Result EOR35-Sex Enjoyable European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past four weeks: Has sex been enjoyable for you? EORTC QLQ-BR42 - Sex Enjoyable EOR35-Sexual: Dry Vagina During Sex European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past four weeks: only if you have been sexually active: Have you experienced a dry vagina during sexual activity? EORTC QLQ-BR42 - Sexual: Dry Vagina During Sex EOR35-Sexual: Pain in Vagina During Sex European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past four weeks: only if you have been sexually active: Have you had pain in your vagina during sexual activity? EORTC QLQ-BR42 - Sexual: Pain in Vagina During Sex EOR35-Sexually Active European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past four weeks: Have you been sexually active (with or without intercourse)? EORTC QLQ-BR42 - Sexually Active EOR35-Skin Problems on Affected Breast European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had skin problems on or in the area of your affected breast (e.g., itchy, dry, flaky)? EORTC QLQ-BR42 - Skin Problems on Affected Breast EOR35-Soreness in Mouth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had soreness in your mouth? EORTC QLQ-BR42 - Soreness in Mouth EOR35-Stiffness in Joints European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had stiffness in your joints? EORTC QLQ-BR42 - Stiffness in Joints EOR35-Sweated Excessively European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you sweated excessively? EORTC QLQ-BR42 - Sweated Excessively EOR35-Swollen Arm/Hand European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had a swollen arm or hand? EORTC QLQ-BR42 - Swollen Arm or Hand EOR35-Tingling in Fingers/Toes European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you had tingling in your fingers or toes? EORTC QLQ-BR42 - Tingling in Fingers or Toes EOR35-Worried About Health in Future European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items - During the past week: Have you worried about your health in the future? EORTC QLQ-BR42 - Worried About Health in Future EOR35TN European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items Test Name CDISC Questionnaire European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer 42 Items Test Name Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items test code. EOR24-Trouble Eating European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you had trouble with eating? EORTC QLQ-BIL21 - Trouble Eating EOR24-Felt Full Too Quickly European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you felt full up too quickly after beginning to eat? EORTC QLQ-BIL21 - Felt Full Too Quickly EOR24-Problems With Sense of Taste European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you had problems with your sense of taste? EORTC QLQ-BIL21 - Problems With Sense of Taste EOR24-Restricted in Types of Food European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Were you restricted in the types of food you can eat as a result of your disease or treatment? EORTC QLQ-BIL21 - Restricted in Types of Food EOR24-Skin/Eyes Been Yellow European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have your skin or eyes been yellow (jaundiced)? EORTC QLQ-BIL21 - Skin or Eyes Been Yellow EOR24-Itching European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you had itching? EORTC QLQ-BIL21 - Itching EOR24-Worried About Skin Being Yellow European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you been worried about your skin being yellow? EORTC QLQ-BIL21 - Worried About Skin Being Yellow EOR24-Less Active Than You Like European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you been less active than you would like to be? EORTC QLQ-BIL21 - Less Active Than You Like EOR24-Felt Slowed Down European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you felt "slowed down"? EORTC QLQ-BIL21 - Felt Slowed Down EOR24-Felt Lacking in Energy European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you felt lacking in energy? EORTC QLQ-BIL21 - Felt Lacking in Energy EOR24-Pain During the Night European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Did you have pain during the night? EORTC QLQ-BIL21 - Pain During the Night EOR24-Pain in Stomach Area European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you had pain in your stomach area? EORTC QLQ-BIL21 - Pain in Stomach Area EOR24-Pain in Back European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you had pain in your back? EORTC QLQ-BIL21 - Pain in Back EOR24-Bloated Feeling in Abdomen European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Did you have a bloated feeling in your abdomen? EORTC QLQ-BIL21 - Bloated Feeling in Abdomen EOR24-Felt Stressed European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you felt stressed? EORTC QLQ-BIL21 - Felt Stressed EOR24-Felt Less Able to Enjoy Yourself European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you felt less able to enjoy yourself? EORTC QLQ-BIL21 - Felt Less Able to Enjoy Yourself EOR24-Worried About Health in Future European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you worried about your health in the future? EORTC QLQ-BIL21 - Worried About Health in Future EOR24-Worried About Family in Future European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Were you worried about your family in the future? EORTC QLQ-BIL21 - Worried About Family in Future EOR24-Extent Troubled With Side-effects European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: To what extent have you been troubled with side-effects from your treatment? EORTC QLQ-BIL21 - Extent Troubled With Side-effects EOR24-Difficulties Drainage Tubes/Bags European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you had difficulties with drainage tubes/bags? EORTC QLQ-BIL21 - Difficulties Drainage Tubes/Bags EOR24-Worried About Losing Weight European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you worried about losing weight? EORTC QLQ-BIL21 - Worried About Losing Weight EOR24TC European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items Questionnaire Test Code CDISC Questionnaire European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items Test Code Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items test name. EOR24-Bloated Feeling in Abdomen European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Did you have a bloated feeling in your abdomen? EORTC QLQ-BIL21 - Bloated Feeling in Abdomen EOR24-Difficulties Drainage Tubes/Bags European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you had difficulties with drainage tubes/bags? EORTC QLQ-BIL21 - Difficulties Drainage Tubes/Bags EOR24-Extent Troubled With Side-effects European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: To what extent have you been troubled with side-effects from your treatment? EORTC QLQ-BIL21 - Extent Troubled With Side-effects EOR24-Felt Full Too Quickly European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you felt full up too quickly after beginning to eat? EORTC QLQ-BIL21 - Felt Full Too Quickly EOR24-Felt Lacking in Energy European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you felt lacking in energy? EORTC QLQ-BIL21 - Felt Lacking in Energy EOR24-Felt Less Able to Enjoy Yourself European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you felt less able to enjoy yourself? EORTC QLQ-BIL21 - Felt Less Able to Enjoy Yourself EOR24-Felt Slowed Down European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you felt "slowed down"? EORTC QLQ-BIL21 - Felt Slowed Down EOR24-Felt Stressed European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you felt stressed? EORTC QLQ-BIL21 - Felt Stressed EOR24-Itching European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you had itching? EORTC QLQ-BIL21 - Itching EOR24-Less Active Than You Like European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you been less active than you would like to be? EORTC QLQ-BIL21 - Less Active Than You Like EOR24-Pain During the Night European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Did you have pain during the night? EORTC QLQ-BIL21 - Pain During the Night EOR24-Pain in Back European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you had pain in your back? EORTC QLQ-BIL21 - Pain in Back EOR24-Pain in Stomach Area European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you had pain in your stomach area? EORTC QLQ-BIL21 - Pain in Stomach Area EOR24-Problems With Sense of Taste European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you had problems with your sense of taste? EORTC QLQ-BIL21 - Problems With Sense of Taste EOR24-Restricted in Types of Food European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Were you restricted in the types of food you can eat as a result of your disease or treatment? EORTC QLQ-BIL21 - Restricted in Types of Food EOR24-Skin/Eyes Been Yellow European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have your skin or eyes been yellow (jaundiced)? EORTC QLQ-BIL21 - Skin or Eyes Been Yellow EOR24-Trouble Eating European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you had trouble with eating? EORTC QLQ-BIL21 - Trouble Eating EOR24-Worried About Family in Future European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Were you worried about your family in the future? EORTC QLQ-BIL21 - Worried About Family in Future EOR24-Worried About Health in Future European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you worried about your health in the future? EORTC QLQ-BIL21 - Worried About Health in Future EOR24-Worried About Losing Weight European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you worried about losing weight? EORTC QLQ-BIL21 - Worried About Losing Weight EOR24-Worried About Skin Being Yellow European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items - During the past week: Have you been worried about your skin being yellow? EORTC QLQ-BIL21 - Worried About Skin Being Yellow EOR24TN European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items Questionnaire Test Name CDISC Questionnaire European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer 21 Items Test Name Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items test code. EOR29-Muscle Weakness European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you had muscle weakness? EORTC QLQ-CLL17 - Muscle Weakness EOR29-Aches/Pains in Muscles/Joints European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you had aches or pains in your muscles or joints? EORTC QLQ-CLL17 - Aches or Pains in Muscles or Joints EOR29-Aches/Pain in Bones European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you had aches or pain in your bones? EORTC QLQ-CLL17 - Aches or Pain in Bones EOR29-Dry Mouth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you had a dry mouth? EORTC QLQ-CLL17 - Dry Mouth EOR29-Felt Ill/Unwell European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you felt ill or unwell? EORTC QLQ-CLL17 - Felt Ill or Unwell EOR29-Night Sweats European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you had night sweats? EORTC QLQ-CLL17 - Night Sweats EOR29-Shortness of Breath on Exertion European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you had shortness of breath on exertion? EORTC QLQ-CLL17 - Shortness of Breath on Exertion EOR29-Lack of Energy European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you had a lack of energy? EORTC QLQ-CLL17 - Lack of Energy EOR29-Felt Drowsy European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you felt drowsy? EORTC QLQ-CLL17 - Felt Drowsy EOR29-Sudden Tiredness European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you had sudden tiredness? EORTC QLQ-CLL17 - Sudden Tiredness EOR29-Worried About Health in Future European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you worried about your health in the future? EORTC QLQ-CLL17 - Worried About Health in Future EOR29-Worried About Recurrence Disease European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you worried about recurrence of your disease? EORTC QLQ-CLL17 - Worried About Recurrence Disease EOR29-Worried About Becoming Dependent European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you worried about becoming dependent on others? EORTC QLQ-CLL17 - Worried About Becoming Dependent EOR29-Worried About Get Another Cancer European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you worried about getting another type of cancer? EORTC QLQ-CLL17 - Worried About Get Another Cancer EOR29-Worried Treatment Caus Future Prob European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you worried about your treatment causing future health problems? EORTC QLQ-CLL17 - Worried Treatment Cause Future Problems EOR29-Problems at Work Due to Disease European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - If applicable: Have you had problems at your work or place of study due to the disease? EORTC QLQ-CLL17 - Problems at Work Due to Disease EOR29-Worried Not Able Continue Working European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - If applicable: Have you worried about not being able to continue working or your education? EORTC QLQ-CLL17 - Worried Not Able Continue Working EOR29TC European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items Test Code CDISC Questionnaire European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukemia 17 Items Test Code Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items test name. EOR29-Aches/Pain in Bones European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you had aches or pain in your bones? EORTC QLQ-CLL17 - Aches or Pain in Bones EOR29-Aches/Pains in Muscles/Joints European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you had aches or pains in your muscles or joints? EORTC QLQ-CLL17 - Aches or Pains in Muscles or Joints EOR29-Dry Mouth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you had a dry mouth? EORTC QLQ-CLL17 - Dry Mouth EOR29-Felt Drowsy European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you felt drowsy? EORTC QLQ-CLL17 - Felt Drowsy EOR29-Felt Ill/Unwell European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you felt ill or unwell? EORTC QLQ-CLL17 - Felt Ill or Unwell EOR29-Lack of Energy European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you had a lack of energy? EORTC QLQ-CLL17 - Lack of Energy EOR29-Muscle Weakness European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you had muscle weakness? EORTC QLQ-CLL17 - Muscle Weakness EOR29-Night Sweats European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you had night sweats? EORTC QLQ-CLL17 - Night Sweats EOR29-Problems at Work Due to Disease European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - If applicable: Have you had problems at your work or place of study due to the disease? EORTC QLQ-CLL17 - Problems at Work Due to Disease EOR29-Shortness of Breath on Exertion European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you had shortness of breath on exertion? EORTC QLQ-CLL17 - Shortness of Breath on Exertion EOR29-Sudden Tiredness European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you had sudden tiredness? EORTC QLQ-CLL17 - Sudden Tiredness EOR29-Worried About Becoming Dependent European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you worried about becoming dependent on others? EORTC QLQ-CLL17 - Worried About Becoming Dependent EOR29-Worried About Get Another Cancer European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you worried about getting another type of cancer? EORTC QLQ-CLL17 - Worried About Get Another Cancer EOR29-Worried About Health in Future European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you worried about your health in the future? EORTC QLQ-CLL17 - Worried About Health in Future EOR29-Worried About Recurrence Disease European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you worried about recurrence of your disease? EORTC QLQ-CLL17 - Worried About Recurrence Disease EOR29-Worried Not Able Continue Working European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - If applicable: Have you worried about not being able to continue working or your education? EORTC QLQ-CLL17 - Worried Not Able Continue Working EOR29-Worried Treatment Caus Future Prob European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items - Have you worried about your treatment causing future health problems? EORTC QLQ-CLL17 - Worried Treatment Cause Future Problems EOR29TN European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia 17 Items Test Name CDISC Questionnaire European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukemia 17 Items Test Name Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items test code. EOR12-Trouble Eating European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you had trouble with eating? EORTC QLQ-LMC21 - Trouble Eating EOR12-Felt Full Too Quickly European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you felt full up too quickly after beginning to eat? EORTC QLQ-LMC21 - Felt Full Too Quickly EOR12-Worried About Losing Weight European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you worried about losing weight? EORTC QLQ-LMC21 - Worried About Losing Weight EOR12-Problems With Sense of Taste European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you had problems with your sense of taste? EORTC QLQ-LMC21 - Problems With Sense of Taste EOR12-Dry Mouth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you had a dry mouth? EORTC QLQ-LMC21 - Dry Mouth EOR12-Sore Mouth/Tongue European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you had a sore mouth or tongue? EORTC QLQ-LMC21 - Sore Mouth or Tongue EOR12-Less Active Than You Like European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you been less active than you would like to be? EORTC QLQ-LMC21 - Less Active Than You Like EOR12-Tingling Hands/Feet European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you had tingling hands or feet? EORTC QLQ-LMC21 - Tingling Hands or Feet EOR12-Pain in Stomach Area European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you had pain in your stomach area? EORTC QLQ-LMC21 - Pain in Stomach Area EOR12-Discomfort in Stomach Area European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you had discomfort in your stomach area? EORTC QLQ-LMC21 - Discomfort in Stomach Area EOR12-Skin/Eyes Been Yellow European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have your skin or eyes been yellow (jaundiced)? EORTC QLQ-LMC21 - Skin or Eyes Been Yellow EOR12-Pain in Back European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you had pain in your back? EORTC QLQ-LMC21 - Pain in Back EOR12-Felt Slowed Down European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you felt slowed down? EORTC QLQ-LMC21 - Felt Slowed Down EOR12-Felt Lacking in Energy European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you felt lacking in energy? EORTC QLQ-LMC21 - Felt Lacking in Energy EOR12-Trouble Social Contact Friends European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you had trouble having social contact with friends? EORTC QLQ-LMC21 - Trouble Social Contact Friends EOR12-Trouble Talking About Feelings European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you had trouble talking about your feelings to your family or friends? EORTC QLQ-LMC21 - Trouble Talking About Feelings EOR12-Felt Stressed European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you felt stressed? EORTC QLQ-LMC21 - Felt Stressed EOR12-Felt Less Able to Enjoy Yourself European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you felt less able to enjoy yourself? EORTC QLQ-LMC21 - Felt Less Able to Enjoy Yourself EOR12-Worried About Health in Future European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you worried about your health in the future? EORTC QLQ-LMC21 - Worried About Health in Future EOR12-Worried About Family in Future European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Were you worried about your family in the future? EORTC QLQ-LMC21 - Worried About Family in Future EOR12-Disease/Treatment Affect Sex Life European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past four weeks: Has the disease or treatment affected your sex life (for the worse)? EORTC QLQ-LMC21 - Disease or Treatment Affect Sex Life EOR12TC European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items Test Code CDISC Questionnaire European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items Test Code Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items test name. EOR12-Discomfort in Stomach Area European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you had discomfort in your stomach area? EORTC QLQ-LMC21 - Discomfort in Stomach Area EOR12-Disease/Treatment Affect Sex Life European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past four weeks: Has the disease or treatment affected your sex life (for the worse)? EORTC QLQ-LMC21 - Disease or Treatment Affect Sex Life EOR12-Dry Mouth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you had a dry mouth? EORTC QLQ-LMC21 - Dry Mouth EOR12-Felt Full Too Quickly European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you felt full up too quickly after beginning to eat? EORTC QLQ-LMC21 - Felt Full Too Quickly EOR12-Felt Lacking in Energy European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you felt lacking in energy? EORTC QLQ-LMC21 - Felt Lacking in Energy EOR12-Felt Less Able to Enjoy Yourself European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you felt less able to enjoy yourself? EORTC QLQ-LMC21 - Felt Less Able to Enjoy Yourself EOR12-Felt Slowed Down European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you felt slowed down? EORTC QLQ-LMC21 - Felt Slowed Down EOR12-Felt Stressed European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you felt stressed? EORTC QLQ-LMC21 - Felt Stressed EOR12-Less Active Than You Like European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you been less active than you would like to be? EORTC QLQ-LMC21 - Less Active Than You Like EOR12-Pain in Back European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you had pain in your back? EORTC QLQ-LMC21 - Pain in Back EOR12-Pain in Stomach Area European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you had pain in your stomach area? EORTC QLQ-LMC21 - Pain in Stomach Area EOR12-Problems With Sense of Taste European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you had problems with your sense of taste? EORTC QLQ-LMC21 - Problems With Sense of Taste EOR12-Skin/Eyes Been Yellow European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have your skin or eyes been yellow (jaundiced)? EORTC QLQ-LMC21 - Skin or Eyes Been Yellow EOR12-Sore Mouth/Tongue European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you had a sore mouth or tongue? EORTC QLQ-LMC21 - Sore Mouth or Tongue EOR12-Tingling Hands/Feet European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you had tingling hands or feet? EORTC QLQ-LMC21 - Tingling Hands or Feet EOR12-Trouble Eating European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you had trouble with eating? EORTC QLQ-LMC21 - Trouble Eating EOR12-Trouble Social Contact Friends European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you had trouble having social contact with friends? EORTC QLQ-LMC21 - Trouble Social Contact Friends EOR12-Trouble Talking About Feelings European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you had trouble talking about your feelings to your family or friends? EORTC QLQ-LMC21 - Trouble Talking About Feelings EOR12-Worried About Family in Future European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Were you worried about your family in the future? EORTC QLQ-LMC21 - Worried About Family in Future EOR12-Worried About Health in Future European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you worried about your health in the future? EORTC QLQ-LMC21 - Worried About Health in Future EOR12-Worried About Losing Weight European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items - During the past week: Have you worried about losing weight? EORTC QLQ-LMC21 - Worried About Losing Weight EOR12TN European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items Test Name CDISC Questionnaire European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases 21 Items Test Name Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Esophago-Gastric Cancer Phase IV Module Version 25 Items test code. EOR21-Problems Eating Solid Foods European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had problems eating solid foods? EORTC QLQ-OG25 Phase IV Module Version - Problems Eating Solid Foods EOR21-Problems Eat Liquidised/Soft Foods European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had problems eating liquidised or soft foods? EORTC QLQ-OG25 Phase IV Module Version - Problems Eat Liquidized or Soft Foods EOR21-Problems Drinking Liquids European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had problems drinking liquids? EORTC QLQ-OG25 Phase IV Module Version - Problems Drinking Liquids EOR21-Trouble Enjoying Meals European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had trouble enjoying your meals? EORTC QLQ-OG25 Phase IV Module Version - Trouble Enjoying Meals EOR21-Felt Full Too Quickly European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you felt full up too quickly after beginning to eat? EORTC QLQ-OG25 Phase IV Module Version - Felt Full Too Quickly EOR21-Taken Long Time Complete Meals European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Has it taken you a long time to complete your meals? EORTC QLQ-OG25 Phase IV Module Version - Taken Long Time Complete Meals EOR21-Difficulty Eating European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had difficulty eating? EORTC QLQ-OG25 Phase IV Module Version - Difficulty Eating EOR21-Acid Indigestion/Heartburn European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had acid indigestion or heartburn? EORTC QLQ-OG25 Phase IV Module Version - Acid Indigestion or Heartburn EOR21-Acid/Bile Into Mouth Problem European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Has acid or bile coming into your mouth been a problem? EORTC QLQ-OG25 Phase IV Module Version - Acid or Bile Into Mouth Problem EOR21-Discomfort When Eating European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had discomfort when eating? EORTC QLQ-OG25 Phase IV Module Version - Discomfort When Eating EOR21-Pain When Eat European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had pain when you eat? EORTC QLQ-OG25 Phase IV Module Version - Pain When Eat EOR21-Pain in Stomach Area European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had pain in your stomach area? EORTC QLQ-OG25 Phase IV Module Version - Pain in Stomach Area EOR21-Discomfort in Stomach Area European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had discomfort in your stomach area? EORTC QLQ-OG25 Phase IV Module Version - Discomfort in Stomach Area EOR21-Thinking About Illness European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you been thinking about your illness? EORTC QLQ-OG25 Phase IV Module Version - Thinking About Illness EOR21-Worried About Health in Future European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you worried about your health in the future? EORTC QLQ-OG25 Phase IV Module Version - Worried About Health in Future EOR21-Trouble Eating in Front of People European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had trouble with eating in front of other people? EORTC QLQ-OG25 Phase IV Module Version - Trouble Eating in Front of People EOR21-Dry Mouth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had a dry mouth? EORTC QLQ-OG25 Phase IV Module Version - Dry Mouth EOR21-Problems With Sense of Taste European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had problems with your sense of taste? EORTC QLQ-OG25 Phase IV Module Version - Problems With Sense of Taste EOR21-Felt Physically Less Attractive European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you felt physically less attractive as a result of your disease or treatment? EORTC QLQ-OG25 Phase IV Module Version - Felt Physically Less Attractive EOR21-Difficulty Swallowing Saliva European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had difficulty swallowing your saliva? EORTC QLQ-OG25 Phase IV Module Version - Difficulty Swallowing Saliva EOR21-Choked When Swallowing European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you choked when swallowing? EORTC QLQ-OG25 Phase IV Module Version - Choked When Swallowing EOR21-Coughed European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you coughed? EORTC QLQ-OG25 Phase IV Module Version - Coughed EOR21-Difficulty Talking European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had difficulty talking? EORTC QLQ-OG25 Phase IV Module Version - Difficulty Talking EOR21-Worried Weight Too Low European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you worried about your weight being too low? EORTC QLQ-OG25 Phase IV Module Version - Worried Weight Too Low EOR21-Lost Hair: Upset by Loss of Hair European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: only if you lost any hair: If so, were you upset by the loss of your hair? EORTC QLQ-OG25 Phase IV Module Version - Lost Hair: Upset by Loss of Hair EOR21TC European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Esophago-Gastric Cancer Phase IV Module Version 25 Items Test Code CDISC Questionnaire European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Esophago-Gastric Cancer Phase IV Module Version 25 Items Test Code Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Esophago-Gastric Cancer Phase IV Module Version 25 Items test name. EOR21-Acid Indigestion/Heartburn European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had acid indigestion or heartburn? EORTC QLQ-OG25 Phase IV Module Version - Acid Indigestion or Heartburn EOR21-Acid/Bile Into Mouth Problem European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Has acid or bile coming into your mouth been a problem? EORTC QLQ-OG25 Phase IV Module Version - Acid or Bile Into Mouth Problem EOR21-Choked When Swallowing European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you choked when swallowing? EORTC QLQ-OG25 Phase IV Module Version - Choked When Swallowing EOR21-Coughed European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you coughed? EORTC QLQ-OG25 Phase IV Module Version - Coughed EOR21-Difficulty Eating European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had difficulty eating? EORTC QLQ-OG25 Phase IV Module Version - Difficulty Eating EOR21-Difficulty Swallowing Saliva European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had difficulty swallowing your saliva? EORTC QLQ-OG25 Phase IV Module Version - Difficulty Swallowing Saliva EOR21-Difficulty Talking European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had difficulty talking? EORTC QLQ-OG25 Phase IV Module Version - Difficulty Talking EOR21-Discomfort in Stomach Area European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had discomfort in your stomach area? EORTC QLQ-OG25 Phase IV Module Version - Discomfort in Stomach Area EOR21-Discomfort When Eating European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had discomfort when eating? EORTC QLQ-OG25 Phase IV Module Version - Discomfort When Eating EOR21-Dry Mouth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had a dry mouth? EORTC QLQ-OG25 Phase IV Module Version - Dry Mouth EOR21-Felt Full Too Quickly European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you felt full up too quickly after beginning to eat? EORTC QLQ-OG25 Phase IV Module Version - Felt Full Too Quickly EOR21-Felt Physically Less Attractive European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you felt physically less attractive as a result of your disease or treatment? EORTC QLQ-OG25 Phase IV Module Version - Felt Physically Less Attractive EOR21-Lost Hair: Upset by Loss of Hair European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: only if you lost any hair: If so, were you upset by the loss of your hair? EORTC QLQ-OG25 Phase IV Module Version - Lost Hair: Upset by Loss of Hair EOR21-Pain in Stomach Area European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had pain in your stomach area? EORTC QLQ-OG25 Phase IV Module Version - Pain in Stomach Area EOR21-Pain When Eat European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had pain when you eat? EORTC QLQ-OG25 Phase IV Module Version - Pain When Eat EOR21-Problems Drinking Liquids European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had problems drinking liquids? EORTC QLQ-OG25 Phase IV Module Version - Problems Drinking Liquids EOR21-Problems Eat Liquidised/Soft Foods European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had problems eating liquidised or soft foods? EORTC QLQ-OG25 Phase IV Module Version - Problems Eat Liquidized or Soft Foods EOR21-Problems Eating Solid Foods European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had problems eating solid foods? EORTC QLQ-OG25 Phase IV Module Version - Problems Eating Solid Foods EOR21-Problems With Sense of Taste European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had problems with your sense of taste? EORTC QLQ-OG25 Phase IV Module Version - Problems With Sense of Taste EOR21-Taken Long Time Complete Meals European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Has it taken you a long time to complete your meals? EORTC QLQ-OG25 Phase IV Module Version - Taken Long Time Complete Meals EOR21-Thinking About Illness European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you been thinking about your illness? EORTC QLQ-OG25 Phase IV Module Version - Thinking About Illness EOR21-Trouble Eating in Front of People European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had trouble with eating in front of other people? EORTC QLQ-OG25 Phase IV Module Version - Trouble Eating in Front of People EOR21-Trouble Enjoying Meals European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you had trouble enjoying your meals? EORTC QLQ-OG25 Phase IV Module Version - Trouble Enjoying Meals EOR21-Worried About Health in Future European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you worried about your health in the future? EORTC QLQ-OG25 Phase IV Module Version - Worried About Health in Future EOR21-Worried Weight Too Low European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Cancer Phase IV Module 25 Items - During the past week: Have you worried about your weight being too low? EORTC QLQ-OG25 Phase IV Module Version - Worried Weight Too Low EOR21TN European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Esophago-Gastric Cancer Phase IV Module Version 25 Items Test Name CDISC Questionnaire European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Esophago-Gastric Cancer Phase IV Module Version 25 Items Test Name Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module Version 43 Items test code. EOR36-Pain in Mouth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had pain in your mouth? EORTC QLQ-H and N43 Phase IV Module Version - Pain in Mouth EOR36-Pain in Jaw European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had pain in your jaw? EORTC QLQ-H and N43 Phase IV Module Version - Pain in Jaw EOR36-Soreness in Mouth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had soreness in your mouth? EORTC QLQ-H and N43 Phase IV Module Version - Soreness in Mouth EOR36-Pain in Throat European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had pain in your throat? EORTC QLQ-H and N43 Phase IV Module Version - Pain in Throat EOR36-Problems Swallowing Liquids European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems swallowing liquids? EORTC QLQ-H and N43 Phase IV Module Version - Problems Swallowing Liquids EOR36-Problems Swallowing Pureed Food European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems swallowing pureed food? EORTC QLQ-H and N43 Phase IV Module Version - Problems Swallowing Pureed Food EOR36-Problems Swallowing Solid Food European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems swallowing solid food? EORTC QLQ-H and N43 Phase IV Module Version - Problems Swallowing Solid Food EOR36-Choked When Swallowing European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you choked when swallowing? EORTC QLQ-H and N43 Phase IV Module Version - Choked When Swallowing EOR36-Problems With Teeth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems with your teeth? EORTC QLQ-H and N43 Phase IV Module Version - Problems With Teeth EOR36-Problems Because Losing Teeth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems because of losing some teeth? EORTC QLQ-H and N43 Phase IV Module Version - Problems Because Losing Teeth EOR36-Problems Opening Mouth Wide European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems opening your mouth wide? EORTC QLQ-H and N43 Phase IV Module Version - Problems Opening Mouth Wide EOR36-Dry Mouth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had a dry mouth? EORTC QLQ-H and N43 Phase IV Module Version - Dry Mouth EOR36-Sticky Saliva European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had sticky saliva? EORTC QLQ-H and N43 Phase IV Module Version - Sticky Saliva EOR36-Problems With Sense of Smell European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems with your sense of smell? EORTC QLQ-H and N43 Phase IV Module Version - Problems With Sense of Smell EOR36-Problems With Sense of Taste European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems with your sense of taste? EORTC QLQ-H and N43 Phase IV Module Version - Problems With Sense of Taste EOR36-Problems With Coughing European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems with coughing? EORTC QLQ-H and N43 Phase IV Module Version - Problems With Coughing EOR36-Problems With Hoarseness European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems with hoarseness? EORTC QLQ-H and N43 Phase IV Module Version - Problems With Hoarseness EOR36-Problems With Appearance European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems with your appearance? EORTC QLQ-H and N43 Phase IV Module Version - Problems With Appearance EOR36-Felt Less Physically Attractive European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you felt less physically attractive as a result of your disease or treatment? EORTC QLQ-H and N43 Phase IV Module Version - Felt Less Physically Attractive EOR36-Dissatisfied With Body European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you felt dissatisfied with your body? EORTC QLQ-H and N43 Phase IV Module Version - Dissatisfied With Body EOR36-Problems Eating European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems eating? EORTC QLQ-H and N43 Phase IV Module Version - Problems Eating EOR36-Problems Eating in Front of Family European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems eating in front of your family? EORTC QLQ-H and N43 Phase IV Module Version - Problems Eating in Front of Family EOR36-Problems Eating in Front of People European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems eating in front of other people? EORTC QLQ-H and N43 Phase IV Module Version - Problems Eating in Front of People EOR36-Problems Enjoying Meals European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems enjoying your meals? EORTC QLQ-H and N43 Phase IV Module Version - Problems Enjoying Meals EOR36-Problems Talking to Other People European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems talking to other people? EORTC QLQ-H and N43 Phase IV Module Version - Problems Talking to Other People EOR36-Problems Talking on Telephone European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems talking on the telephone? EORTC QLQ-H and N43 Phase IV Module Version - Problems Talking on Telephone EOR36-Problems Talking Noisy Environment European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems talking in a noisy environment? EORTC QLQ-H and N43 Phase IV Module Version - Problems Talking Noisy Environment EOR36-Problems Speaking Clearly European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems speaking clearly? EORTC QLQ-H and N43 Phase IV Module Version - Problems Speaking Clearly EOR36-Problems Going Out in Public European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems going out in public? EORTC QLQ-H and N43 Phase IV Module Version - Problems Going Out in Public EOR36-Less Interest in Sex European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you felt less interest in sex? EORTC QLQ-H and N43 Phase IV Module Version - Less Interest in Sex EOR36-Less Sexual Enjoyment European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you felt less sexual enjoyment? EORTC QLQ-H and N43 Phase IV Module Version - Less Sexual Enjoyment EOR36-Prob Raising Arm/Moving Sideways European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems raising your arm or moving it sideways? EORTC QLQ-H and N43 Phase IV Module Version - Prob Raising Arm or Moving Sideways EOR36-Pain in Shoulder European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had pain in your shoulder? EORTC QLQ-H and N43 Phase IV Module Version - Pain in Shoulder EOR36-Swelling in Neck European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had swelling in your neck? EORTC QLQ-H and N43 Phase IV Module Version - Swelling in Neck EOR36-Skin Problems European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had skin problems (e.g. itchy, dry)? EORTC QLQ-H and N43 Phase IV Module Version - Skin Problems EOR36-Rash European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had a rash? EORTC QLQ-H and N43 Phase IV Module Version - Rash EOR36-Skin Changed Colour European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Has your skin changed colour? EORTC QLQ-H and N43 Phase IV Module Version - Skin Changed Color EOR36-Worried Weight Too Low European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you worried that your weight is too low? EORTC QLQ-H and N43 Phase IV Module Version - Worried Weight Too Low EOR36-Worried About Results Exam & Tests European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you worried about the results of examinations and tests? EORTC QLQ-H and N43 Phase IV Module Version - Worried About Results Exam & Tests EOR36-Worried About Health in Future European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you worried about your health in the future? EORTC QLQ-H and N43 Phase IV Module Version - Worried About Health in Future EOR36-Problems With Wounds Healing European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems with wounds healing? EORTC QLQ-H and N43 Phase IV Module Version - Problems With Wounds Healing EOR36-Tingling/Numbness in Hands/Feet European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had tingling or numbness in your hands or feet? EORTC QLQ-H and N43 Phase IV Module Version - Tingling or Numbness in Hands or Feet EOR36-Problems Chewing European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems chewing? EORTC QLQ-H and N43 Phase IV Module Version - Problems Chewing EOR36TC European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module Version 43 Items Test Code CDISC Questionnaire European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module Version 43 Items Test Code Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module Version 43 Items test name. EOR36-Choked When Swallowing European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you choked when swallowing? EORTC QLQ-H and N43 Phase IV Module Version - Choked When Swallowing EOR36-Dissatisfied With Body European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you felt dissatisfied with your body? EORTC QLQ-H and N43 Phase IV Module Version - Dissatisfied With Body EOR36-Dry Mouth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had a dry mouth? EORTC QLQ-H and N43 Phase IV Module Version - Dry Mouth EOR36-Felt Less Physically Attractive European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you felt less physically attractive as a result of your disease or treatment? EORTC QLQ-H and N43 Phase IV Module Version - Felt Less Physically Attractive EOR36-Less Interest in Sex European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you felt less interest in sex? EORTC QLQ-H and N43 Phase IV Module Version - Less Interest in Sex EOR36-Less Sexual Enjoyment European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you felt less sexual enjoyment? EORTC QLQ-H and N43 Phase IV Module Version - Less Sexual Enjoyment EOR36-Pain in Jaw European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had pain in your jaw? EORTC QLQ-H and N43 Phase IV Module Version - Pain in Jaw EOR36-Pain in Mouth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had pain in your mouth? EORTC QLQ-H and N43 Phase IV Module Version - Pain in Mouth EOR36-Pain in Shoulder European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had pain in your shoulder? EORTC QLQ-H and N43 Phase IV Module Version - Pain in Shoulder EOR36-Pain in Throat European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had pain in your throat? EORTC QLQ-H and N43 Phase IV Module Version - Pain in Throat EOR36-Prob Raising Arm/Moving Sideways European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems raising your arm or moving it sideways? EORTC QLQ-H and N43 Phase IV Module Version - Prob Raising Arm or Moving Sideways EOR36-Problems Because Losing Teeth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems because of losing some teeth? EORTC QLQ-H and N43 Phase IV Module Version - Problems Because Losing Teeth EOR36-Problems Chewing European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems chewing? EORTC QLQ-H and N43 Phase IV Module Version - Problems Chewing EOR36-Problems Eating in Front of Family European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems eating in front of your family? EORTC QLQ-H and N43 Phase IV Module Version - Problems Eating in Front of Family EOR36-Problems Eating in Front of People European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems eating in front of other people? EORTC QLQ-H and N43 Phase IV Module Version - Problems Eating in Front of People EOR36-Problems Eating European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems eating? EORTC QLQ-H and N43 Phase IV Module Version - Problems Eating EOR36-Problems Enjoying Meals European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems enjoying your meals? EORTC QLQ-H and N43 Phase IV Module Version - Problems Enjoying Meals EOR36-Problems Going Out in Public European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems going out in public? EORTC QLQ-H and N43 Phase IV Module Version - Problems Going Out in Public EOR36-Problems Opening Mouth Wide European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems opening your mouth wide? EORTC QLQ-H and N43 Phase IV Module Version - Problems Opening Mouth Wide EOR36-Problems Speaking Clearly European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems speaking clearly? EORTC QLQ-H and N43 Phase IV Module Version - Problems Speaking Clearly EOR36-Problems Swallowing Liquids European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems swallowing liquids? EORTC QLQ-H and N43 Phase IV Module Version - Problems Swallowing Liquids EOR36-Problems Swallowing Pureed Food European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems swallowing pureed food? EORTC QLQ-H and N43 Phase IV Module Version - Problems Swallowing Pureed Food EOR36-Problems Swallowing Solid Food European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems swallowing solid food? EORTC QLQ-H and N43 Phase IV Module Version - Problems Swallowing Solid Food EOR36-Problems Talking Noisy Environment European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems talking in a noisy environment? EORTC QLQ-H and N43 Phase IV Module Version - Problems Talking Noisy Environment EOR36-Problems Talking on Telephone European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems talking on the telephone? EORTC QLQ-H and N43 Phase IV Module Version - Problems Talking on Telephone EOR36-Problems Talking to Other People European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems talking to other people? EORTC QLQ-H and N43 Phase IV Module Version - Problems Talking to Other People EOR36-Problems With Appearance European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems with your appearance? EORTC QLQ-H and N43 Phase IV Module Version - Problems With Appearance EOR36-Problems With Coughing European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems with coughing? EORTC QLQ-H and N43 Phase IV Module Version - Problems With Coughing EOR36-Problems With Hoarseness European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems with hoarseness? EORTC QLQ-H and N43 Phase IV Module Version - Problems With Hoarseness EOR36-Problems With Sense of Smell European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems with your sense of smell? EORTC QLQ-H and N43 Phase IV Module Version - Problems With Sense of Smell EOR36-Problems With Sense of Taste European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems with your sense of taste? EORTC QLQ-H and N43 Phase IV Module Version - Problems With Sense of Taste EOR36-Problems With Teeth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems with your teeth? EORTC QLQ-H and N43 Phase IV Module Version - Problems With Teeth EOR36-Problems With Wounds Healing European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had problems with wounds healing? EORTC QLQ-H and N43 Phase IV Module Version - Problems With Wounds Healing EOR36-Rash European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had a rash? EORTC QLQ-H and N43 Phase IV Module Version - Rash EOR36-Skin Changed Colour European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Has your skin changed colour? EORTC QLQ-H and N43 Phase IV Module Version - Skin Changed Color EOR36-Skin Problems European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had skin problems (e.g. itchy, dry)? EORTC QLQ-H and N43 Phase IV Module Version - Skin Problems EOR36-Soreness in Mouth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had soreness in your mouth? EORTC QLQ-H and N43 Phase IV Module Version - Soreness in Mouth EOR36-Sticky Saliva European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had sticky saliva? EORTC QLQ-H and N43 Phase IV Module Version - Sticky Saliva EOR36-Swelling in Neck European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had swelling in your neck? EORTC QLQ-H and N43 Phase IV Module Version - Swelling in Neck EOR36-Tingling/Numbness in Hands/Feet European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you had tingling or numbness in your hands or feet? EORTC QLQ-H and N43 Phase IV Module Version - Tingling or Numbness in Hands or Feet EOR36-Worried About Health in Future European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you worried about your health in the future? EORTC QLQ-H and N43 Phase IV Module Version - Worried About Health in Future EOR36-Worried About Results Exam & Tests European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you worried about the results of examinations and tests? EORTC QLQ-H and N43 Phase IV Module Version - Worried About Results Exam & Tests EOR36-Worried Weight Too Low European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module 43 Items - During the past week: Have you worried that your weight is too low? EORTC QLQ-H and N43 Phase IV Module Version - Worried Weight Too Low EOR36TN European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module Version 43 Items Test Name CDISC Questionnaire European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Head and Neck Cancer Phase IV Module Version 43 Items Test Name Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items test code. EOR17-Diagnosis of Disease European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: The diagnosis of your disease? EORTC QLQ-INFO25 - Diagnosis of Disease EOR17-Extent of Disease European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: The extent (spread) of your disease? EORTC QLQ-INFO25 - Extent of Disease EOR17-Possible Causes of Disease European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: The possible causes of your disease? EORTC QLQ-INFO25 - Possible Causes of Disease EOR17-Whether Disease is Under Control European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Whether the disease is under control? EORTC QLQ-INFO25 - Whether Disease is Under Control EOR17-Purpose of Medical Tests European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: The purpose of any medical tests you have had or may undergo? EORTC QLQ-INFO25 - Purpose of Medical Tests EOR17-Procedures of Medical Tests European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: The procedures of the medical tests? EORTC QLQ-INFO25 - Procedures of Medical Tests EOR17-Results of Medical Tests European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: The results of the medical tests you have already received? EORTC QLQ-INFO25 - Results of Medical Tests EOR17-Medical Treatment European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: The medical treatment (chemotherapy, radiotherapy, surgery or other treatment modality)? EORTC QLQ-INFO25 - Medical Treatment EOR17-Expected Benefit of Treatment European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: The expected benefit of the treatment? EORTC QLQ-INFO25 - Expected Benefit of Treatment EOR17-Possible Side-effects of Treatment European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: The possible side-effects of your treatment? EORTC QLQ-INFO25 - Possible Side-effects of Treatment EOR17-Effects of Treatment on Symptoms European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: The expected effects of the treatment on disease symptoms? EORTC QLQ-INFO25 - Effects of Treatment on Symptoms EOR17-Effects Treatment on Social Life European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: The effects of the treatment on social and family life? EORTC QLQ-INFO25 - Effects Treatment on Social Life EOR17-Effects Treatment on Sexual Activ European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: The effects of the treatment on sexual activity? EORTC QLQ-INFO25 - Effects Treatment on Sexual Activity EOR17-Help Outside Hospital European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Additional help outside the hospital (e.g. help with daily activities, self help groups, district nurses)? EORTC QLQ-INFO25 - Help Outside Hospital EOR17-Rehabilitation Services European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Rehabilitation services (e. g. physiotherapy, occupational therapy)? EORTC QLQ-INFO25 - Rehabilitation Services EOR17-Managing Illness at Home European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Aspects of managing your illness at home? EORTC QLQ-INFO25 - Managing Illness at Home EOR17-Professional Psychological Support European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Possible professional psychological support? EORTC QLQ-INFO25 - Professional Psychological Support EOR17-Different Places of Care European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Different places of care (hospitals/outpatient services/home)? EORTC QLQ-INFO25 - Different Places of Care EOR17-Things to Help Yourself Get Well European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Things that you can do to help yourself get well (e.g. rest, contact with others)? EORTC QLQ-INFO25 - Things to Help Yourself Get Well EOR17-Received Written Information European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Have you received written information? EORTC QLQ-INFO25 - Received Written Information EOR17-Received Information CD/Tape/Video European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Have you received information on CD or tape/video? EORTC QLQ-INFO25 - Received Information CD or Tape or Video EOR17-Satisfied Amount of Information European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Were you satisfied with the amount of information you received? EORTC QLQ-INFO25 - Satisfied Amount of Information EOR17-Wish to Receive More Information European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Do you wish to receive more information? EORTC QLQ-INFO25 - Wish to Receive More Information EOR17-More Information Specify Topics European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Do you wish to receive more information? If yes, please specify on which topics? EORTC QLQ-INFO25 - More Information Specify Topics EOR17-Wish You Received Less Information European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Do you wish that you had received less information? EORTC QLQ-INFO25 - Wish You Received Less Information EOR17-Less Information Specify Topics European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Do you wish that you had received less information? If yes, please specify on which topics? EORTC QLQ-INFO25 - Less Information Specify Topics EOR17-Overall Information Helpful European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Overall has the information you have received been helpful? EORTC QLQ-INFO25 - Overall Information Helpful EOR17TC European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items Test Code CDISC Questionnaire European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items Test Code Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items test name. EOR17-Diagnosis of Disease European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: The diagnosis of your disease? EORTC QLQ-INFO25 - Diagnosis of Disease EOR17-Different Places of Care European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Different places of care (hospitals/outpatient services/home)? EORTC QLQ-INFO25 - Different Places of Care EOR17-Effects of Treatment on Symptoms European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: The expected effects of the treatment on disease symptoms? EORTC QLQ-INFO25 - Effects of Treatment on Symptoms EOR17-Effects Treatment on Sexual Activ European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: The effects of the treatment on sexual activity? EORTC QLQ-INFO25 - Effects Treatment on Sexual Activity EOR17-Effects Treatment on Social Life European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: The effects of the treatment on social and family life? EORTC QLQ-INFO25 - Effects Treatment on Social Life EOR17-Expected Benefit of Treatment European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: The expected benefit of the treatment? EORTC QLQ-INFO25 - Expected Benefit of Treatment EOR17-Extent of Disease European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: The extent (spread) of your disease? EORTC QLQ-INFO25 - Extent of Disease EOR17-Help Outside Hospital European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Additional help outside the hospital (e.g. help with daily activities, self help groups, district nurses)? EORTC QLQ-INFO25 - Help Outside Hospital EOR17-Less Information Specify Topics European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Do you wish that you had received less information? If yes, please specify on which topics? EORTC QLQ-INFO25 - Less Information Specify Topics EOR17-Managing Illness at Home European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Aspects of managing your illness at home? EORTC QLQ-INFO25 - Managing Illness at Home EOR17-Medical Treatment European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: The medical treatment (chemotherapy, radiotherapy, surgery or other treatment modality)? EORTC QLQ-INFO25 - Medical Treatment EOR17-More Information Specify Topics European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Do you wish to receive more information? If yes, please specify on which topics? EORTC QLQ-INFO25 - More Information Specify Topics EOR17-Overall Information Helpful European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Overall has the information you have received been helpful? EORTC QLQ-INFO25 - Overall Information Helpful EOR17-Possible Causes of Disease European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: The possible causes of your disease? EORTC QLQ-INFO25 - Possible Causes of Disease EOR17-Possible Side-effects of Treatment European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: The possible side-effects of your treatment? EORTC QLQ-INFO25 - Possible Side-effects of Treatment EOR17-Procedures of Medical Tests European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: The procedures of the medical tests? EORTC QLQ-INFO25 - Procedures of Medical Tests EOR17-Professional Psychological Support European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Possible professional psychological support? EORTC QLQ-INFO25 - Professional Psychological Support EOR17-Purpose of Medical Tests European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: The purpose of any medical tests you have had or may undergo? EORTC QLQ-INFO25 - Purpose of Medical Tests EOR17-Received Information CD/Tape/Video European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Have you received information on CD or tape/video? EORTC QLQ-INFO25 - Received Information CD or Tape or Video EOR17-Received Written Information European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Have you received written information? EORTC QLQ-INFO25 - Received Written Information EOR17-Rehabilitation Services European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Rehabilitation services (e. g. physiotherapy, occupational therapy)? EORTC QLQ-INFO25 - Rehabilitation Services EOR17-Results of Medical Tests European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: The results of the medical tests you have already received? EORTC QLQ-INFO25 - Results of Medical Tests EOR17-Satisfied Amount of Information European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Were you satisfied with the amount of information you received? EORTC QLQ-INFO25 - Satisfied Amount of Information EOR17-Things to Help Yourself Get Well European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Things that you can do to help yourself get well (e.g. rest, contact with others)? EORTC QLQ-INFO25 - Things to Help Yourself Get Well EOR17-Whether Disease is Under Control European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Whether the disease is under control? EORTC QLQ-INFO25 - Whether Disease is Under Control EOR17-Wish to Receive More Information European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Do you wish to receive more information? EORTC QLQ-INFO25 - Wish to Receive More Information EOR17-Wish You Received Less Information European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items - During your current disease or treatment, how much information have you received on: Do you wish that you had received less information? EORTC QLQ-INFO25 - Wish You Received Less Information EOR17TN European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items Test Name CDISC Questionnaire European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Information 25 Items Test Name Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items test code. EOR19-Bone Aches/Pain European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Have you had bone aches or pain? EORTC QLQ-MY20 - Bone Aches or Pain EOR19-Pain in Back European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Have you had pain in your back? EORTC QLQ-MY20 - Pain in Back EOR19-Pain in Hip European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Have you had pain in your hip? EORTC QLQ-MY20 - Pain in Hip EOR19-Pain in Arm/Shoulder European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Have you had pain in your arm or shoulder? EORTC QLQ-MY20 - Pain in Arm or Shoulder EOR19-Pain in Chest European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Have you had pain in your chest? EORTC QLQ-MY20 - Pain in Chest EOR19-Pain Increase With Activity European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: If you had pain did it increase with activity? EORTC QLQ-MY20 - Pain Increase With Activity EOR19-Feel Drowsy European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Did you feel drowsy? EORTC QLQ-MY20 - Feel Drowsy EOR19-Feel Thirsty European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Did you feel thirsty? EORTC QLQ-MY20 - Feel Thirsty EOR19-Felt Ill European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Have you felt ill? EORTC QLQ-MY20 - Felt Ill EOR19-Dry Mouth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Have you had a dry mouth? EORTC QLQ-MY20 - Dry Mouth EOR19-Lost Any Hair European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Have you lost any hair? EORTC QLQ-MY20 - Lost Any Hair EOR19-Lost Hair: Upset by Loss of Hair European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: only if you lost any hair: Were you upset by the loss of your hair? EORTC QLQ-MY20 - Lost Hair: Upset by Loss of Hair EOR19-Tingling Hands/Feet European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Did you have tingling hands or feet? EORTC QLQ-MY20 - Tingling Hands or Feet EOR19-Feel Restless/Agitated European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Did you feel restless or agitated? EORTC QLQ-MY20 - Feel Restless or Agitated EOR19-Acid Indigestion/Heartburn European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Have you had acid indigestion or heartburn? EORTC QLQ-MY20 - Acid Indigestion or Heartburn EOR19-Burning/Sore Eyes European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Have you had burning or sore eyes? EORTC QLQ-MY20 - Burning or Sore Eyes EOR19-Felt Physically Less Attractive European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Have you felt physically less attractive as a result of your disease or treatment? EORTC QLQ-MY20 - Felt Physically Less Attractive EOR19-Thinking About Illness European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Have you been thinking about your illness? EORTC QLQ-MY20 - Thinking About Illness EOR19-Worried About Dying European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Have you been worried about dying? EORTC QLQ-MY20 - Worried About Dying EOR19-Worried About Health in Future European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Have you worried about your health in the future? EORTC QLQ-MY20 - Worried About Health in Future EOR19TC European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items Test Code CDISC Questionnaire European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items Test Code Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items test name. EOR19-Acid Indigestion/Heartburn European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Have you had acid indigestion or heartburn? EORTC QLQ-MY20 - Acid Indigestion or Heartburn EOR19-Bone Aches/Pain European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Have you had bone aches or pain? EORTC QLQ-MY20 - Bone Aches or Pain EOR19-Burning/Sore Eyes European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Have you had burning or sore eyes? EORTC QLQ-MY20 - Burning or Sore Eyes EOR19-Dry Mouth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Have you had a dry mouth? EORTC QLQ-MY20 - Dry Mouth EOR19-Feel Drowsy European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Did you feel drowsy? EORTC QLQ-MY20 - Feel Drowsy EOR19-Feel Restless/Agitated European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Did you feel restless or agitated? EORTC QLQ-MY20 - Feel Restless or Agitated EOR19-Feel Thirsty European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Did you feel thirsty? EORTC QLQ-MY20 - Feel Thirsty EOR19-Felt Ill European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Have you felt ill? EORTC QLQ-MY20 - Felt Ill EOR19-Felt Physically Less Attractive European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Have you felt physically less attractive as a result of your disease or treatment? EORTC QLQ-MY20 - Felt Physically Less Attractive EOR19-Lost Any Hair European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Have you lost any hair? EORTC QLQ-MY20 - Lost Any Hair EOR19-Lost Hair: Upset by Loss of Hair European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: only if you lost any hair: Were you upset by the loss of your hair? EORTC QLQ-MY20 - Lost Hair: Upset by Loss of Hair EOR19-Pain in Arm/Shoulder European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Have you had pain in your arm or shoulder? EORTC QLQ-MY20 - Pain in Arm or Shoulder EOR19-Pain in Back European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Have you had pain in your back? EORTC QLQ-MY20 - Pain in Back EOR19-Pain in Chest European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Have you had pain in your chest? EORTC QLQ-MY20 - Pain in Chest EOR19-Pain in Hip European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Have you had pain in your hip? EORTC QLQ-MY20 - Pain in Hip EOR19-Pain Increase With Activity European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: If you had pain did it increase with activity? EORTC QLQ-MY20 - Pain Increase With Activity EOR19-Thinking About Illness European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Have you been thinking about your illness? EORTC QLQ-MY20 - Thinking About Illness EOR19-Tingling Hands/Feet European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Did you have tingling hands or feet? EORTC QLQ-MY20 - Tingling Hands or Feet EOR19-Worried About Dying European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Have you been worried about dying? EORTC QLQ-MY20 - Worried About Dying EOR19-Worried About Health in Future European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items - During the past week: Have you worried about your health in the future? EORTC QLQ-MY20 - Worried About Health in Future EOR19TN European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items Test Name CDISC Questionnaire European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma 20 Items Test Name Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items test code. EOR28-Had to Urinate Freq During Day European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Have you had to urinate frequently during the day? EORTC QLQ-NMIBC24 - Had to Urinate Frequently During Day EOR28-Urinate Frequently at Night European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Have you had to urinate frequently at night? EORTC QLQ-NMIBC24 - Urinate Frequently at Night EOR28-Pass Urine Hurry to Get to Toilet European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: When you felt the urge to pass urine, did you have to hurry to get to the toilet? EORTC QLQ-NMIBC24 - Pass Urine Hurry to Get to Toilet EOR28-Difficult Sleep Frequently Urinate European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Was it difficult for you to get enough sleep, because you needed to get up frequently at night to urinate? EORTC QLQ-NMIBC24 - Difficult Sleep Frequently Urinate EOR28-Difficulty Going Out Need Toilet European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Have you had difficulty going out of the house, because you needed to be close to a toilet? EORTC QLQ-NMIBC24 - Difficulty Going Out Need Toilet EOR28-Unintentional Release of Urine European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Have you had any unintentional release (leakage) of urine? EORTC QLQ-NMIBC24 - Unintentional Release of Urine EOR28-Pain/Burning When Urinating European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Have you had pain or a burning feeling when urinating? EORTC QLQ-NMIBC24 - Pain or Burning When Urinating EOR28-Fever European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Did you have a fever? EORTC QLQ-NMIBC24 - Fever EOR28-Feel Ill/Unwell European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Did you feel ill or unwell? EORTC QLQ-NMIBC24 - Feel Ill or Unwell EOR28-Trouble Arranging Life Appointment European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Did you have trouble arranging your life around the repeated bladder treatment appointments (cystoscopies or instillations)? EORTC QLQ-NMIBC24 - Trouble Arranging Life Appointment EOR28-Worry About Repeated Treatments European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Did you worry about having repeated bladder treatments (cystoscopies or instillations)? EORTC QLQ-NMIBC24 - Worry About Repeated Treatments EOR28-Worried About Health in Future European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Were you worried about your health in the future? EORTC QLQ-NMIBC24 - Worried About Health in Future EOR28-Worry About Results Exam & Tests European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Did you worry about the results of examinations and tests? EORTC QLQ-NMIBC24 - Worry About Results Examinations and Tests EOR28-Worry About Future Treatments European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Did you worry about possible future treatments? EORTC QLQ-NMIBC24 - Worry About Future Treatments EOR28-Bloated Feeling in Abdomen European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Did you have a bloated feeling in your abdomen? EORTC QLQ-NMIBC24 - Bloated Feeling in Abdomen EOR28-Flatulence/Gas European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Have you had flatulence or gas? EORTC QLQ-NMIBC24 - Flatulence or Gas EOR28-Extent Interested in Sex European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past 4 weeks: To what extent were you interested in sex? EORTC QLQ-NMIBC24 - Extent Interested in Sex EOR28-Extent Sexually Active European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past 4 weeks: To what extent were you sexually active (with or without sexual intercourse)? EORTC QLQ-NMIBC24 - Extent Sexually Active EOR28-Men: Diff Gain/Maintain Erection European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past 4 weeks: For men only: Did you have difficulty gaining or maintaining an erection? EORTC QLQ-NMIBC24 - Men: Difficulty Gain or Maintain Erection EOR28-Men: Ejaculation Problems European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past 4 weeks: For men only: Did you have ejaculation problems (e.g. dry ejaculation)? EORTC QLQ-NMIBC24 - Men: Ejaculation Problems EOR28-Sexual: Uncomfortable Sex Intimate European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - If you have been sexually active during the past 4 weeks: Have you felt uncomfortable about being sexually intimate? EORTC QLQ-NMIBC24 - Sexual: Uncomfortable Sex Intimate EOR28-Sexual:Worried Contaminate Partner European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - If you have been sexually active during the past 4 weeks: Have you worried that you may contaminate your partner during sexual contact with the bladder treatment you have been receiving? EORTC QLQ-NMIBC24 - Sexual: Worried Contaminate Partner EOR28-Sexual: Extent Sex Enjoyable European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - If you have been sexually active during the past 4 weeks: To what extent was sex enjoyable for you? EORTC QLQ-NMIBC24 - Sexual: Extent Sex Enjoyable EOR28-Sexual Women:Dry Vagina Intercours European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - If you have been sexually active during the past 4 weeks: For women only: Did you have a dry vagina or other problems during intercourse? EORTC QLQ-NMIBC24 - Sexual Women: Dry Vagina Intercourse EOR28TC European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items Test Code CDISC Questionnaire European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items Test Code Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items test name. EOR28-Bloated Feeling in Abdomen European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Did you have a bloated feeling in your abdomen? EORTC QLQ-NMIBC24 - Bloated Feeling in Abdomen EOR28-Difficult Sleep Frequently Urinate European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Was it difficult for you to get enough sleep, because you needed to get up frequently at night to urinate? EORTC QLQ-NMIBC24 - Difficult Sleep Frequently Urinate EOR28-Difficulty Going Out Need Toilet European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Have you had difficulty going out of the house, because you needed to be close to a toilet? EORTC QLQ-NMIBC24 - Difficulty Going Out Need Toilet EOR28-Extent Interested in Sex European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past 4 weeks: To what extent were you interested in sex? EORTC QLQ-NMIBC24 - Extent Interested in Sex EOR28-Extent Sexually Active European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past 4 weeks: To what extent were you sexually active (with or without sexual intercourse)? EORTC QLQ-NMIBC24 - Extent Sexually Active EOR28-Feel Ill/Unwell European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Did you feel ill or unwell? EORTC QLQ-NMIBC24 - Feel Ill or Unwell EOR28-Fever European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Did you have a fever? EORTC QLQ-NMIBC24 - Fever EOR28-Flatulence/Gas European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Have you had flatulence or gas? EORTC QLQ-NMIBC24 - Flatulence or Gas EOR28-Had to Urinate Freq During Day European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Have you had to urinate frequently during the day? EORTC QLQ-NMIBC24 - Had to Urinate Frequently During Day EOR28-Men: Diff Gain/Maintain Erection European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past 4 weeks: For men only: Did you have difficulty gaining or maintaining an erection? EORTC QLQ-NMIBC24 - Men: Difficulty Gain or Maintain Erection EOR28-Men: Ejaculation Problems European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past 4 weeks: For men only: Did you have ejaculation problems (e.g. dry ejaculation)? EORTC QLQ-NMIBC24 - Men: Ejaculation Problems EOR28-Pain/Burning When Urinating European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Have you had pain or a burning feeling when urinating? EORTC QLQ-NMIBC24 - Pain or Burning When Urinating EOR28-Pass Urine Hurry to Get to Toilet European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: When you felt the urge to pass urine, did you have to hurry to get to the toilet? EORTC QLQ-NMIBC24 - Pass Urine Hurry to Get to Toilet EOR28-Sexual Women:Dry Vagina Intercours European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - If you have been sexually active during the past 4 weeks: For women only: Did you have a dry vagina or other problems during intercourse? EORTC QLQ-NMIBC24 - Sexual Women: Dry Vagina Intercourse EOR28-Sexual: Extent Sex Enjoyable European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - If you have been sexually active during the past 4 weeks: To what extent was sex enjoyable for you? EORTC QLQ-NMIBC24 - Sexual: Extent Sex Enjoyable EOR28-Sexual: Uncomfortable Sex Intimate European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - If you have been sexually active during the past 4 weeks: Have you felt uncomfortable about being sexually intimate? EORTC QLQ-NMIBC24 - Sexual: Uncomfortable Sex Intimate EOR28-Sexual:Worried Contaminate Partner European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - If you have been sexually active during the past 4 weeks: Have you worried that you may contaminate your partner during sexual contact with the bladder treatment you have been receiving? EORTC QLQ-NMIBC24 - Sexual: Worried Contaminate Partner EOR28-Trouble Arranging Life Appointment European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Did you have trouble arranging your life around the repeated bladder treatment appointments (cystoscopies or instillations)? EORTC QLQ-NMIBC24 - Trouble Arranging Life Appointment EOR28-Unintentional Release of Urine European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Have you had any unintentional release (leakage) of urine? EORTC QLQ-NMIBC24 - Unintentional Release of Urine EOR28-Urinate Frequently at Night European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Have you had to urinate frequently at night? EORTC QLQ-NMIBC24 - Urinate Frequently at Night EOR28-Worried About Health in Future European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Were you worried about your health in the future? EORTC QLQ-NMIBC24 - Worried About Health in Future EOR28-Worry About Future Treatments European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Did you worry about possible future treatments? EORTC QLQ-NMIBC24 - Worry About Future Treatments EOR28-Worry About Repeated Treatments European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Did you worry about having repeated bladder treatments (cystoscopies or instillations)? EORTC QLQ-NMIBC24 - Worry About Repeated Treatments EOR28-Worry About Results Exam & Tests European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items - During the past week: Did you worry about the results of examinations and tests? EORTC QLQ-NMIBC24 - Worry About Results Examinations and Tests EOR28TN European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items Test Name CDISC Questionnaire European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer 24 Items Test Name Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items test code. EOR20-Eat Solid Food European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Could you eat solid food? EORTC QLQ-OES18 - Eat Solid Food EOR20-Eat Liquidised/Soft Food European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Could you eat liquidised or soft food? EORTC QLQ-OES18 - Eat Liquidized or Soft Food EOR20-Drink Liquids European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Could you drink liquids? EORTC QLQ-OES18 - Drink Liquids EOR20-Trouble Swallowing Saliva European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Have you had trouble with swallowing your saliva? EORTC QLQ-OES18 - Trouble Swallowing Saliva EOR20-Choked When Swallowing European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Have you choked when swallowing? EORTC QLQ-OES18 - Choked When Swallowing EOR20-Trouble Enjoying Meals European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Have you had trouble enjoying your meals? EORTC QLQ-OES18 - Trouble Enjoying Meals EOR20-Felt Full Too Quickly European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Have you felt full up too quickly? EORTC QLQ-OES18 - Felt Full Too Quickly EOR20-Trouble Eating European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Have you had trouble with eating? EORTC QLQ-OES18 - Trouble Eating EOR20-Trouble Eating in Front of People European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Have you had trouble with eating in front of other people? EORTC QLQ-OES18 - Trouble Eating in Front of People EOR20-Dry Mouth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Have you had a dry mouth? EORTC QLQ-OES18 - Dry Mouth EOR20-Food & Drink Taste Different European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Did food and drink taste different from usual? EORTC QLQ-OES18 - Food and Drink Taste Different EOR20-Trouble With Coughing European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Have you had trouble with coughing? EORTC QLQ-OES18 - Trouble With Coughing EOR20-Trouble With Talking European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Have you had trouble with talking? EORTC QLQ-OES18 - Trouble With Talking EOR20-Acid Indigestion/Heartburn European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Have you had acid indigestion or heartburn? EORTC QLQ-OES18 - Acid Indigestion or Heartburn EOR20-Trouble Acid/Bile Into Mouth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Have you had trouble with acid or bile coming into your mouth? EORTC QLQ-OES18 - Trouble Acid or Bile Into Mouth EOR20-Pain When Eat European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Have you had pain when you eat? EORTC QLQ-OES18 - Pain When Eat EOR20-Pain in Chest European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Have you had pain in your chest? EORTC QLQ-OES18 - Pain in Chest EOR20-Pain in Stomach European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Have you had pain in your stomach? EORTC QLQ-OES18 - Pain in Stomach EOR20TC European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items Test Code CDISC Questionnaire European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Esophageal Cancer 18 Items Test Code Terminology European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items test name. EOR20-Acid Indigestion/Heartburn European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Have you had acid indigestion or heartburn? EORTC QLQ-OES18 - Acid Indigestion or Heartburn EOR20-Choked When Swallowing European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Have you choked when swallowing? EORTC QLQ-OES18 - Choked When Swallowing EOR20-Drink Liquids European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Could you drink liquids? EORTC QLQ-OES18 - Drink Liquids EOR20-Dry Mouth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Have you had a dry mouth? EORTC QLQ-OES18 - Dry Mouth EOR20-Eat Liquidised/Soft Food European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Could you eat liquidised or soft food? EORTC QLQ-OES18 - Eat Liquidized or Soft Food EOR20-Eat Solid Food European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Could you eat solid food? EORTC QLQ-OES18 - Eat Solid Food EOR20-Felt Full Too Quickly European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Have you felt full up too quickly? EORTC QLQ-OES18 - Felt Full Too Quickly EOR20-Food & Drink Taste Different European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Did food and drink taste different from usual? EORTC QLQ-OES18 - Food and Drink Taste Different EOR20-Pain in Chest European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Have you had pain in your chest? EORTC QLQ-OES18 - Pain in Chest EOR20-Pain in Stomach European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Have you had pain in your stomach? EORTC QLQ-OES18 - Pain in Stomach EOR20-Pain When Eat European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Have you had pain when you eat? EORTC QLQ-OES18 - Pain When Eat EOR20-Trouble Acid/Bile Into Mouth European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Have you had trouble with acid or bile coming into your mouth? EORTC QLQ-OES18 - Trouble Acid or Bile Into Mouth EOR20-Trouble Eating in Front of People European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Have you had trouble with eating in front of other people? EORTC QLQ-OES18 - Trouble Eating in Front of People EOR20-Trouble Eating European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Have you had trouble with eating? EORTC QLQ-OES18 - Trouble Eating EOR20-Trouble Enjoying Meals European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Have you had trouble enjoying your meals? EORTC QLQ-OES18 - Trouble Enjoying Meals EOR20-Trouble Swallowing Saliva European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Have you had trouble with swallowing your saliva? EORTC QLQ-OES18 - Trouble Swallowing Saliva EOR20-Trouble With Coughing European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Have you had trouble with coughing? EORTC QLQ-OES18 - Trouble With Coughing EOR20-Trouble With Talking European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items - During the past week: Have you had trouble with talking? EORTC QLQ-OES18 - Trouble With Talking EOR20TN European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal Cancer 18 Items Test Name CDISC Questionnaire European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Esophageal Cancer 18 Items Test Name Terminology European Quality of Life Five Dimension Five Level Scale test code. EQ5D02-Mobility European Quality of Life Five Dimension Five Level Scale - Check the one box that best describes your health today: Mobility. EQ-5D-5L - Mobility EQ5D02-Self-Care European Quality of Life Five Dimension Five Level Scale - Check the one box that best describes your health today: Self-care. EQ-5D-5L - Self-Care EQ5D02-Usual Activities European Quality of Life Five Dimension Five Level Scale - Check the one box that best describes your health today: Usual activities. EQ-5D-5L - Usual Activities EQ5D02-Pain/Discomfort European Quality of Life Five Dimension Five Level Scale - Check the one box that best describes your health today: Pain/discomfort. EQ-5D-5L - Pain or Discomfort EQ5D02-Anxiety/Depression European Quality of Life Five Dimension Five Level Scale - Check the one box that best describes your health today: Anxiety/depression. EQ-5D-5L - Anxiety or Depression EQ5D02-EQ VAS Score European Quality of Life Five Dimension Five Level Scale - Indicate how your health is today. EQ-5D-5L - EQ VAS Score EQ5D02TC European Quality of Life Five Dimension Five Level Scale Questionnaire Test Code CDISC Questionnaire EQ-5D-5L Test Code Terminology European Quality of Life Five Dimension Five Level Scale test name. EQ5D02-Anxiety/Depression European Quality of Life Five Dimension Five Level Scale - Check the one box that best describes your health today: Anxiety/depression. EQ-5D-5L - Anxiety or Depression EQ5D02-EQ VAS Score European Quality of Life Five Dimension Five Level Scale - Indicate how your health is today. EQ-5D-5L - EQ VAS Score EQ5D02-Mobility European Quality of Life Five Dimension Five Level Scale - Check the one box that best describes your health today: Mobility. EQ-5D-5L - Mobility EQ5D02-Pain/Discomfort European Quality of Life Five Dimension Five Level Scale - Check the one box that best describes your health today: Pain/discomfort. EQ-5D-5L - Pain or Discomfort EQ5D02-Self-Care European Quality of Life Five Dimension Five Level Scale - Check the one box that best describes your health today: Self-care. EQ-5D-5L - Self-Care EQ5D02-Usual Activities European Quality of Life Five Dimension Five Level Scale - Check the one box that best describes your health today: Usual activities. EQ-5D-5L - Usual Activities EQ5D02TN European Quality of Life Five Dimension Five Level Scale Questionnaire Test Name CDISC Questionnaire EQ-5D-5L Test Name Terminology European Quality of Life Five Dimension Three Level Scale test code. EQ5D01-Mobility European Quality of Life Five Dimension Three Level Scale - Indicate which statements best describe your own health state today: Mobility. EQ-5D-3L - Mobility EQ5D01-Self-Care European Quality of Life Five Dimension Three Level Scale - Indicate which statements best describe your own health state today: Self-care. EQ-5D-3L - Self-Care EQ5D01-Usual Activities European Quality of Life Five Dimension Three Level Scale - Indicate which statements best describe your own health state today: Usual activities. EQ-5D-3L - Usual Activities EQ5D01-Pain/Discomfort European Quality of Life Five Dimension Three Level Scale - Indicate which statements best describe your own health state today: Pain/discomfort. EQ-5D-3L - Pain or Discomfort EQ5D01-Anxiety/Depression European Quality of Life Five Dimension Three Level Scale - Indicate which statements best describe your own health state today: Anxiety/depression. EQ-5D-3L - Anxiety or Depression EQ5D01-EQ VAS Score European Quality of Life Five Dimension Three Level Scale - Indicate on this scale how good or bad your own health is today, in your opinion. EQ-5D-3L - EQ VAS Score EQ5D01TC European Quality of Life Five Dimension Three Level Scale Questionnaire Test Code CDISC Questionnaire EQ-5D-3L Test Code Terminology European Quality of Life Five Dimension Three Level Scale test name. EQ5D01-Anxiety/Depression European Quality of Life Five Dimension Three Level Scale - Indicate which statements best describe your own health state today: Anxiety/depression. EQ-5D-3L - Anxiety or Depression EQ5D01-EQ VAS Score European Quality of Life Five Dimension Three Level Scale - Indicate on this scale how good or bad your own health is today, in your opinion. EQ-5D-3L - EQ VAS Score EQ5D01-Mobility European Quality of Life Five Dimension Three Level Scale - Indicate which statements best describe your own health state today: Mobility. EQ-5D-3L - Mobility EQ5D01-Pain/Discomfort European Quality of Life Five Dimension Three Level Scale - Indicate which statements best describe your own health state today: Pain/discomfort. EQ-5D-3L - Pain or Discomfort EQ5D01-Self-Care European Quality of Life Five Dimension Three Level Scale - Indicate which statements best describe your own health state today: Self-care. EQ-5D-3L - Self-Care EQ5D01-Usual Activities European Quality of Life Five Dimension Three Level Scale - Indicate which statements best describe your own health state today: Usual activities. EQ-5D-3L - Usual Activities EQ5D01TN European Quality of Life Five Dimension Three Level Scale Questionnaire Test Name CDISC Questionnaire EQ-5D-3L Test Name Terminology Terminology relevant to the role of the person(s) providing an evaluation, appraisal, or interpretation. An external committee whose purpose is to evaluate study data and decide whether a study endpoint or other criterion has been met. (NCI) Adjudication Committee An individual that presides over and arbitrates between individuals or organizations. Adjudicator A healthcare professional trained in the diagnosis and treatment of hearing loss and other auditory and balance disorders. Audiologist A physician who specializes in the diagnosis and treatment of heart disorders. Cardiologist Caregiver Carer Caretaker The primary person in charge of the care of a patient, usually a family member or a designated health care professional. (NCI) Caregiver A person authorized through certification to perform an evaluation or assessment. Certified Assessor A biological or non-biological first generation offspring, including but not limited to biological children (including those born outside of marriage), adopted children, step children, and foster children. (NCI) Child Relation A physician specializing in medical diagnosis based on laboratory analysis and the macroscopic and the microscopic changes to tissues and organs caused by disease. Clinical Pathologist Research Associate Person employed by a study sponsor or by a contract research organization (CRO) acting on a sponsor's behalf, who monitors the status, data integrity, and protocol adherence of investigator sites participating in a clinical study. (CDISC Glossary) Clinical Research Associate CRC A qualified study staff member who manages the participation of subjects according to the study protocol. Clinical Coordinator Clinical Study Sponsor Sponsor Study Sponsor An individual, company, institution, or organization that takes responsibility for the initiation, management, and/or financing of a clinical study. [After ICH E6, WHO, 21 CFR 50.3 (e), and after IDMP] Clinical Study Sponsor A doctor who specializes in diagnosis and treatment of skin conditions. Dermatologist A pediatrician who specializes in diagnosing and treating developmental and behavioral disorders in children. Developmental Behavioral Pediatrician A psychologist who specializes in diagnosing and treating emotional and behavioral problems associated with developmental delay or disability. Developmental Psychologist Domestic Partner Person declares that a domestic partnership relationship exists. (HL7) Domestic Partnership A physician who specializes in diagnosing and treating conditions affecting the endocrine system. Endocrinologist A healthcare professional that specializes in the study of the causes, incidence, and distribution of disease in the population and its application for prevention or control. Epidemiologist Family Member Any of the individuals who are descended from a common progenitor, related by marriage or other legal tie. Family Member A physician specializing in comprehensive care for all ages, and who often serves as a primary care doctor. General Practitioner A physician specializing in the diagnosis of both the cause of death and the manner of death of another human being. Forensic Pathologist A person whom an individual knows, likes, and trusts. (NCI) Friend An individual who is authorized under applicable law to be legally responsible for the care and keeping of an individual who is not responsible for their own care. Guardian A physician who specializes in women's healthcare, including diagnosing and treating diseases and disorders of the female reproductive organs. Gynecologist A person qualified to be engaged in activity directed at preservation of mental and physical health by diseases prevention and treatment as a source of livelihood. (NCI) Health Care Professional A doctor who specializes in diagnosing and treating diseases and disorders of the blood and blood-forming organs. (NCI) Hematologist An individual qualified to perform an evaluation who is masked from a subject's data in order to minimize bias or maximize consistency and quality. (NCI) Independent Rater A physician who specializes in internal medicine. Internal Medicine Physician The person who manages an interview and asks the questions. Interviewer A person responsible for the conduct of the study, ensuring adherence to the protocol and good clinical practices. (CDISC Glossary) Investigator A health care professional trained in the visualization of structures too small to be seen by the naked eye, using various microscopic techniques. Microscopist A health professional educated in the discipline of midwifery, including care of women during pregnancy, child birth, and post-partum care. Midwife A physician who specializes in diagnosing and treating diseases and disorders of the nervous system. Neurologist A physician trained in oncology who specializes in tumors of the central nervous system. Neuro-oncologist A radiologist who specializes in diagnosing and treating conditions affecting the nervous system. Neuroradiologist Any individual other than a health care professional. Non-Healthcare Professional A type of radiologist who specializes in procedures using radioactive materials to diagnose and/or treat patients. Nuclear Medicine Physician Advanced Practice Registered Nurse APRN NP A licensed, professional healthcare provider who has graduated from a nursing program with a master's degree and advanced training, and who can, for example, assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, prescribe medications, formulate treatment plans, and additional tasks related to an area of expertise. Nurse Practitioner A physician who specializes in the treatment of women as it relates to pregnancy, child birth, and post-partum care. Obstetrician A physician who specializes in diagnosing and treating cancer. (NCI) Oncologist A physician with a Doctor of Medicine or Doctor of Osteopathic Medicine degree (or analogous) who specializes in diagnosing and treating eye disorders, including more complex disorders that require surgery. (NCI) Ophthalmologist A physician with a Doctor of Optometry degree (or analogous) who specializes in the diagnosis and treatment of eye disorders. Optometrist Ear, Nose, and Throat Doctor ENT Doctor ENT Specialist Otorhinolaryngologist A doctor who specializes in treating diseases of the ear, nose, and throat. (NCI) Otolaryngologist A person with a biological or adoptive relationship to a child and has a role as that child's parent. Parent A physician who specializes in the science of pathology. Pathologist A pediatrician who specializes in the diagnosis and treatment of heart disorders in children. Pediatric Cardiologist A pediatrician who specializes in the diagnosis and treatment of nervous system disorders in children. Pediatric Neurologist A physician who specializes in the care of infants, children, adolescents, and young adults. Pediatrician A scientist who studies and/or works in the field of pharmacokinetics. Pharmacokineticist Physical Therapist A healthcare professional trained and certified to apply knowledge of the concepts, principles, and practices of physical therapy for the treatment or prevention of physical disability or disease. Physical Therapist PCP A physician who provides, coordinates, or helps a patient access a range of health care services. Primary Care Provider The study investigator who has the primary responsibility for the conduct of a study and for the study-related personnel at the participating site(s). Principal Investigator A type of directive that gives a person the authority to make decisions for or provide responses on behalf of another individual. Proxy A physician who specializes in the diagnostic and/or therapeutic uses of radiation. (NCI) Radiologist An individual qualified to perform an assessment. Rater An individual who takes non-quantifiable data and provides quantifiable assessments for that data. Reader A person's brother or sister. Sibling SO A gender-neutral term for a person's partner in an intimate or romantic relationship without disclosing or presuming marital status or sexual orientation. [The NCI Thesaurus contains biomedical terminologies that NCI does not own or control. This concept contains gender-related content that does not comply with Executive Order 14168.] Significant Other A health professional educated in the discipline of ultrasonography. Sonographer Spouse A person's partner in marriage. (NCI) Spouse A professional who specializes in applying statistical principles to experimental design and data analysis. Statistician Study Doctor Any physician that is associated with clinical trial. Clinical Trial Physician An individual who is observed, analyzed, examined, investigated, experimented upon, or/and treated in the course of a particular study. Study Subject Any member of the clinical trial team designated and supervised by the investigator at a trial site to perform critical trial-related procedures and/or to make important trial-related decisions (e.g., associates, residents, research fellows). (ICH) Subinvestigator A doctor who specializes in diseases of the urinary organs in females and the genitourinary organs in males. Urologist A person or agency that promotes or exchanges goods or services for money. (NCI) Vendor EVAL Evaluator CDISC SDTM Evaluator Terminology Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome test code. EXACT1-Chest Feel Congested Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Did your chest feel congested today? EXACT - Chest Feel Congested EXACT1-How Often Cough Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - How often did you cough today? EXACT - How Often Cough Today EXACT1-Bring Up Mucus When Coughing Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - How much mucus (phlegm) did you bring up when coughing today? EXACT - Bring Up Mucus When Coughing EXACT1-Difficult to Bring Up Mucus Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - How difficult was it to bring up mucus (phlegm) today? EXACT - Difficult to Bring Up Mucus EXACT1-Chest Discomfort Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Did you have chest discomfort today? EXACT - Have Chest Discomfort EXACT1-Chest Feel Tight Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Did your chest feel tight today? EXACT - Chest Feel Tight EXACT1-Breathless Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Were you breathless today? EXACT - Were You Breathless EXACT1-Describe How Breathless Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Describe how breathless you were today. EXACT - Describe How Breathless EXACT1-Short Breath Personal Care Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Were you short of breath today when performing your usual personal care activities like washing or dressing? EXACT - Short of Breath When Performing Usual Personal Care EXACT1-Short Breath Indoor Activities Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Were you short of breath today when performing your usual indoor activities like cleaning or household work? EXACT - Short of Breath When Performing Usual Indoor Activities EXACT1-Short Breath Outside Activities Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Were you short of breath today when performing your usual activities outside the home such as yard work or errands? EXACT - Short of Breath When Performing Usual Activities Outside EXACT1-Tired or Weak Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Were you tired or weak today? EXACT - Tired or Weak EXACT1-Night Sleep Disturbed Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Last night, was your sleep disturbed? EXACT - Night Sleep Disturbed EXACT1-Worried About Lung Problems Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - How scared or worried were you about your lung problems today? EXACT - Worried About Lung Problems EXACT1-Breathlessness Raw Score Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Breathlessness raw score. EXACT - Breathlessness Raw Score EXACT1-Cough & Sputum Raw Score Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Cough & sputum raw score. EXACT - Cough & Sputum Raw Score EXACT1-Chest Symptoms Raw Score Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Chest symptoms raw score. EXACT - Chest Symptoms Raw Score EXACT1-EXACT Total Raw Score Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Exact total raw score. EXACT - EXACT Total Raw Score EXACT1-Breathlessness Domain Score Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Breathlessness domain score. EXACT - Breathlessness Domain Score EXACT1-Cough & Sputum Domain Score Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Cough & sputum domain score. EXACT - Cough & Sputum Domain Score EXACT1-Chest Symptoms Domain Score Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Chest symptoms domain score. EXACT - Chest Symptoms Domain Score EXACT1-EXACT Total Score Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Exact total domain score. EXACT - EXACT Total Score EXACT1TC Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome Questionnaire Test Code CDISC Questionnaire EXACT Test Code Terminology Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome test name. EXACT1-Breathless Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Were you breathless today? EXACT - Were You Breathless EXACT1-Breathlessness Domain Score Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Breathlessness domain score. EXACT - Breathlessness Domain Score EXACT1-Breathlessness Raw Score Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Breathlessness raw score. EXACT - Breathlessness Raw Score EXACT1-Bring Up Mucus When Coughing Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - How much mucus (phlegm) did you bring up when coughing today? EXACT - Bring Up Mucus When Coughing EXACT1-Chest Discomfort Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Did you have chest discomfort today? EXACT - Have Chest Discomfort EXACT1-Chest Feel Congested Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Did your chest feel congested today? EXACT - Chest Feel Congested EXACT1-Chest Feel Tight Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Did your chest feel tight today? EXACT - Chest Feel Tight EXACT1-Chest Symptoms Domain Score Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Chest symptoms domain score. EXACT - Chest Symptoms Domain Score EXACT1-Chest Symptoms Raw Score Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Chest symptoms raw score. EXACT - Chest Symptoms Raw Score EXACT1-Cough & Sputum Domain Score Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Cough & sputum domain score. EXACT - Cough & Sputum Domain Score EXACT1-Cough & Sputum Raw Score Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Cough & sputum raw score. EXACT - Cough & Sputum Raw Score EXACT1-Describe How Breathless Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Describe how breathless you were today. EXACT - Describe How Breathless EXACT1-Difficult to Bring Up Mucus Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - How difficult was it to bring up mucus (phlegm) today? EXACT - Difficult to Bring Up Mucus EXACT1-EXACT Total Raw Score Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Exact total raw score. EXACT - EXACT Total Raw Score EXACT1-EXACT Total Score Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Exact total domain score. EXACT - EXACT Total Score EXACT1-How Often Cough Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - How often did you cough today? EXACT - How Often Cough Today EXACT1-Night Sleep Disturbed Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Last night, was your sleep disturbed? EXACT - Night Sleep Disturbed EXACT1-Short Breath Indoor Activities Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Were you short of breath today when performing your usual indoor activities like cleaning or household work? EXACT - Short of Breath When Performing Usual Indoor Activities EXACT1-Short Breath Outside Activities Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Were you short of breath today when performing your usual activities outside the home such as yard work or errands? EXACT - Short of Breath When Performing Usual Activities Outside EXACT1-Short Breath Personal Care Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Were you short of breath today when performing your usual personal care activities like washing or dressing? EXACT - Short of Breath When Performing Usual Personal Care EXACT1-Tired or Weak Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Were you tired or weak today? EXACT - Tired or Weak EXACT1-Worried About Lung Problems Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - How scared or worried were you about your lung problems today? EXACT - Worried About Lung Problems EXACT1TN Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome Questionnaire Test Name CDISC Questionnaire EXACT Test Name Terminology Expanded Disability Rating Scale - Postacute Interview Caregiver Version test code. ED1-Able to Communicate Clearly Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Is [name] able to communicate with you in a way that you and others clearly understand? Expanded DRS-PI Caregiver Version - Able to Communicate Clearly ED1-How They Communicate Primarily Expanded Disability Rating Scale - Postacute Interview Caregiver Version - How do they communicate primarily? Expanded DRS-PI Caregiver Version - How They Communicate Primarily ED1-Correct Date and Time Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Is [name] able to give the correct date and time within a few seconds of being asked? Expanded DRS-PI Caregiver Version - Give Correct Date and Time When Asked ED1-Few Words or Random Answers/Shouting Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] have only a few words that [s/he] uses over and over or does [s/he] express him/herself only through random answers, shouting or swearing? Expanded DRS-PI Caregiver Version - Use Few Words or Random Shouting ED1-Moan/Groan/Sounds Not Understandable Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] only moan, groan or make other sounds that are not understandable? Expanded DRS-PI Caregiver Version - Make Sounds Not Understandable ED1-Feed Independently Without Help Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Can [name] feed him/herself independently or manage tube feedings appropriately without help or reminders? Expanded DRS-PI Caregiver Version - Feed Independently Without Help ED1-Understand Feeding Utensils Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] understand what eating or feeding utensils or equipment are for and how they should be used? Expanded DRS-PI Caregiver Version - Understand Feeding Utensils ED1-Know Meal Times Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] know when meal or feeding times are? Expanded DRS-PI Caregiver Version - Know Meal Times ED1-Use Toilet Independently Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Can [name] use the toilet or manage their bowel and bladder routine independently and appropriately without help or reminders? Expanded DRS-PI Caregiver Version - Use Toilet Independently ED1-Manage Clothing When Toileting Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] understand how to manage their clothing or special equipment when toileting or in bowel and bladder management? Expanded DRS-PI Caregiver Version - Manage Clothing When Toileting ED1-Know When to Use Toilet Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] know when to use the toilet or to conduct bowel and bladder management? Expanded DRS-PI Caregiver Version - Know When to Use Toilet ED1-Can Dress/Groom Independently Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Can [name] dress and groom him/herself independently and appropriately or direct someone else in these activities without help or reminders? Expanded DRS-PI Caregiver Version - Can Dress and Groom Self Independently ED1-Know How to Bathe/Wash Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [s/he] know how to bathe and wash? Expanded DRS-PI Caregiver Version - Know How to Bathe and Wash ED1-Understand How to Get Dressed Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [s/he] understand how to get dressed? Expanded DRS-PI Caregiver Version - Understand How to Get Dressed ED1-Start/Finish Grooming Activities Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Can [s/he] start and finish these grooming activities without prompting? Expanded DRS-PI Caregiver Version - Start and Finish Grooming Activities ED1-Function Completely Independently Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] function completely independently? That is, [s/he] does not require any physical assistance, supervision, equipment, devices or reminders for cognitive, social, behavioral, emotional, and physical function? Expanded DRS-PI Caregiver Version - Function Completely Independently ED1-Require Specific Aids/Equipment Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] REQUIRE special aids or equipment such as a brace, walker, wheelchair, memory notebook, day planner, verbal reminders, prompts, cues, or alarm watch because of a disability? Expanded DRS-PI Caregiver Version - Require Special Aids or Equipment ED1-Require Physical Assistance Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] require physical assistance from another person to meet daily needs? Expanded DRS-PI Caregiver Version - Require Physical Assistance ED1-Require Assistance Thinking Tasks Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [s/he] require assistance from another person in tasks that require thinking abilities? Expanded DRS-PI Caregiver Version - Require Assistance Thinking Tasks ED1-Require Assistance Managing Emotions Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [s/he] require assistance from another person to manage emotions and behavior? Expanded DRS-PI Caregiver Version - Require Assistance Managing Emotions ED1-Need a Helper Always Close By Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [s/he] take care of some of their needs but also need a helper who is always close by? Expanded DRS-PI Caregiver Version - Need a Helper Always Close By ED1-Need Help With All Major Activities Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [s/he] need help with all major activities and the assistance of another person all the time? Expanded DRS-PI Caregiver Version - Need Help With All Major Activities ED1-Need 24-Hour Care Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [s/he] need 24-hour care and is not able to help with their own care at all? Expanded DRS-PI Caregiver Version - Need 24-Hour Care ED1-Independent Work/Social Situations Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Can [name] function with complete independence in work or social situations? Expanded DRS-PI Caregiver Version - Function With Independent Work or Social Situations ED1-Understand/Follow Directions Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Can [name] understand, remember, and follow directions? Expanded DRS-PI Caregiver Version - Understand and Follow Directions ED1-Keep Track of Time/Schedules Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Can [name] keep track of time, schedules and appointments? Expanded DRS-PI Caregiver Version - Keep Track of Time ED1-Perform Jobs, Manage Home/School Expanded Disability Rating Scale - Postacute Interview Caregiver Version - How certain are you that [name] can perform in a wide variety of jobs of [his/her] choosing or manage a home independently or participate in school full-time? Expanded DRS-PI Caregiver Version - Perform Jobs or Manage a Home Independently ED1-Successful With Accommodations Expanded Disability Rating Scale - Postacute Interview Caregiver Version - How certain are you that [name] can be successful at work, school or in home management with some reduction in the work load or with other accommodations due to disabilities? Expanded DRS-PI Caregiver Version - Successful With Accommodations ED1-Successful With Limited Choices Expanded Disability Rating Scale - Postacute Interview Caregiver Version - How certain are you that [name] can be successful at work, school or in home management but with limited choices in jobs or school courses due to disabilities? Expanded DRS-PI Caregiver Version - Successful With Limited Choices ED1-Work With Frequent Support Expanded Disability Rating Scale - Postacute Interview Caregiver Version - How certain are you that [name] can be able to work at home or in a special setting like a sheltered workshop in which the work is very routine and there is very frequent supervision and support? Expanded DRS-PI Caregiver Version - Work With Frequent Supervision and Support ED1TC Expanded Disability Rating Scale - Postacute Interview Caregiver Version Questionnaire Test Code CDISC Questionnaire Expanded DRS-PI Caregiver Version Test Code Terminology Expanded Disability Rating Scale - Postacute Interview Caregiver Version test name. ED1-Able to Communicate Clearly Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Is [name] able to communicate with you in a way that you and others clearly understand? Expanded DRS-PI Caregiver Version - Able to Communicate Clearly ED1-Can Dress/Groom Independently Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Can [name] dress and groom him/herself independently and appropriately or direct someone else in these activities without help or reminders? Expanded DRS-PI Caregiver Version - Can Dress and Groom Self Independently ED1-Correct Date and Time Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Is [name] able to give the correct date and time within a few seconds of being asked? Expanded DRS-PI Caregiver Version - Give Correct Date and Time When Asked ED1-Feed Independently Without Help Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Can [name] feed him/herself independently or manage tube feedings appropriately without help or reminders? Expanded DRS-PI Caregiver Version - Feed Independently Without Help ED1-Few Words or Random Answers/Shouting Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] have only a few words that [s/he] uses over and over or does [s/he] express him/herself only through random answers, shouting or swearing? Expanded DRS-PI Caregiver Version - Use Few Words or Random Shouting ED1-Function Completely Independently Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] function completely independently? That is, [s/he] does not require any physical assistance, supervision, equipment, devices or reminders for cognitive, social, behavioral, emotional, and physical function? Expanded DRS-PI Caregiver Version - Function Completely Independently ED1-How They Communicate Primarily Expanded Disability Rating Scale - Postacute Interview Caregiver Version - How do they communicate primarily? Expanded DRS-PI Caregiver Version - How They Communicate Primarily ED1-Independent Work/Social Situations Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Can [name] function with complete independence in work or social situations? Expanded DRS-PI Caregiver Version - Function With Independent Work or Social Situations ED1-Keep Track of Time/Schedules Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Can [name] keep track of time, schedules and appointments? Expanded DRS-PI Caregiver Version - Keep Track of Time ED1-Know How to Bathe/Wash Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [s/he] know how to bathe and wash? Expanded DRS-PI Caregiver Version - Know How to Bathe and Wash ED1-Know Meal Times Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] know when meal or feeding times are? Expanded DRS-PI Caregiver Version - Know Meal Times ED1-Know When to Use Toilet Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] know when to use the toilet or to conduct bowel and bladder management? Expanded DRS-PI Caregiver Version - Know When to Use Toilet ED1-Manage Clothing When Toileting Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] understand how to manage their clothing or special equipment when toileting or in bowel and bladder management? Expanded DRS-PI Caregiver Version - Manage Clothing When Toileting ED1-Moan/Groan/Sounds Not Understandable Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] only moan, groan or make other sounds that are not understandable? Expanded DRS-PI Caregiver Version - Make Sounds Not Understandable ED1-Need 24-Hour Care Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [s/he] need 24-hour care and is not able to help with their own care at all? Expanded DRS-PI Caregiver Version - Need 24-Hour Care ED1-Need a Helper Always Close By Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [s/he] take care of some of their needs but also need a helper who is always close by? Expanded DRS-PI Caregiver Version - Need a Helper Always Close By ED1-Need Help With All Major Activities Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [s/he] need help with all major activities and the assistance of another person all the time? Expanded DRS-PI Caregiver Version - Need Help With All Major Activities ED1-Perform Jobs, Manage Home/School Expanded Disability Rating Scale - Postacute Interview Caregiver Version - How certain are you that [name] can perform in a wide variety of jobs of [his/her] choosing or manage a home independently or participate in school full-time? Expanded DRS-PI Caregiver Version - Perform Jobs or Manage a Home Independently ED1-Require Assistance Managing Emotions Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [s/he] require assistance from another person to manage emotions and behavior? Expanded DRS-PI Caregiver Version - Require Assistance Managing Emotions ED1-Require Assistance Thinking Tasks Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [s/he] require assistance from another person in tasks that require thinking abilities? Expanded DRS-PI Caregiver Version - Require Assistance Thinking Tasks ED1-Require Physical Assistance Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] require physical assistance from another person to meet daily needs? Expanded DRS-PI Caregiver Version - Require Physical Assistance ED1-Require Specific Aids/Equipment Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] REQUIRE special aids or equipment such as a brace, walker, wheelchair, memory notebook, day planner, verbal reminders, prompts, cues, or alarm watch because of a disability? Expanded DRS-PI Caregiver Version - Require Special Aids or Equipment ED1-Start/Finish Grooming Activities Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Can [s/he] start and finish these grooming activities without prompting? Expanded DRS-PI Caregiver Version - Start and Finish Grooming Activities ED1-Successful With Accommodations Expanded Disability Rating Scale - Postacute Interview Caregiver Version - How certain are you that [name] can be successful at work, school or in home management with some reduction in the work load or with other accommodations due to disabilities? Expanded DRS-PI Caregiver Version - Successful With Accommodations ED1-Successful With Limited Choices Expanded Disability Rating Scale - Postacute Interview Caregiver Version - How certain are you that [name] can be successful at work, school or in home management but with limited choices in jobs or school courses due to disabilities? Expanded DRS-PI Caregiver Version - Successful With Limited Choices ED1-Understand Feeding Utensils Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] understand what eating or feeding utensils or equipment are for and how they should be used? Expanded DRS-PI Caregiver Version - Understand Feeding Utensils ED1-Understand How to Get Dressed Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [s/he] understand how to get dressed? Expanded DRS-PI Caregiver Version - Understand How to Get Dressed ED1-Understand/Follow Directions Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Can [name] understand, remember, and follow directions? Expanded DRS-PI Caregiver Version - Understand and Follow Directions ED1-Use Toilet Independently Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Can [name] use the toilet or manage their bowel and bladder routine independently and appropriately without help or reminders? Expanded DRS-PI Caregiver Version - Use Toilet Independently ED1-Work With Frequent Support Expanded Disability Rating Scale - Postacute Interview Caregiver Version - How certain are you that [name] can be able to work at home or in a special setting like a sheltered workshop in which the work is very routine and there is very frequent supervision and support? Expanded DRS-PI Caregiver Version - Work With Frequent Supervision and Support ED1TN Expanded Disability Rating Scale - Postacute Interview Caregiver Version Questionnaire Test Name CDISC Questionnaire Expanded DRS-PI Caregiver Version Test Name Terminology Expanded Disability Rating Scale - Postacute Interview Survivor Version test code. ED2-Correct Date and Time Expanded Disability Rating Scale - Postacute Interview Survivor Version - Are you able to give the correct date and time within a few seconds of being asked? Expanded DRS-PI Survivor Version - Give Correct Date and Time When Asked ED2-Feed Independently Without Help Expanded Disability Rating Scale - Postacute Interview Survivor Version - Can you feed yourself independently or manage tube feedings appropriately without help or reminders? Expanded DRS-PI Survivor Version - Feed Yourself Independently Without Help ED2-Understand Feeding Utensils Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you understand what eating or feeding utensils or equipment are for and how they should be used? Expanded DRS-PI Survivor Version - Understand Feeding Utensils ED2-Know Meal Times Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you know when meal or feeding times are? Expanded DRS-PI Survivor Version - Know Meal Times ED2-Use Toilet Independently Expanded Disability Rating Scale - Postacute Interview Survivor Version - Can you use the toilet or manage your bowel and bladder routine independently and appropriately without help or reminders? Expanded DRS-PI Survivor Version - Use Toilet Independently ED2-Manage Clothing When Toileting Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you understand how to manage your clothing or special equipment when toileting or in bowel and bladder management? Expanded DRS-PI Survivor Version - Manage Clothing When Toileting ED2-Know When to Use Toilet Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you know when to use the toilet or to conduct bowel and bladder management? Expanded DRS-PI Survivor Version - Know When to Use Toilet ED2-Can Dress/Groom Independently Expanded Disability Rating Scale - Postacute Interview Survivor Version - Can you dress and groom yourself independently and appropriately or direct someone else in these activities without help or reminders? Expanded DRS-PI Survivor Version - Can Dress and Groom Self Independently ED2-Know How to Bathe/Wash Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you know how to bathe and wash? Expanded DRS-PI Survivor Version - Know How to Bathe and Wash ED2-Understand How to Get Dressed Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you understand how to get dressed? Expanded DRS-PI Survivor Version - Understand How to Get Dressed ED2-Start/Finish Grooming Activities Expanded Disability Rating Scale - Postacute Interview Survivor Version - Can you start and finish these grooming activities without prompting? Expanded DRS-PI Survivor Version - Start and Finish Grooming Activities ED2-Function Completely Independently Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you function completely independently? That is, you do not require any physical assistance, supervision, equipment, devices, or reminders for cognitive, social, behavioral, emotional, and physical function? Expanded DRS-PI Survivor Version - Function Completely Independently ED2-Require Specific Aids/Equipment Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you REQUIRE special aids or equipment, such as, a brace, walker, wheelchair, memory notebook, day planner, verbal reminders, prompts, cues, or alarm watch because of a disability? Expanded DRS-PI Survivor Version - Require Special Aids or Equipment ED2-Require Physical Assistance Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you require physical assistance from another person to meet daily needs? Expanded DRS-PI Survivor Version - Require Physical Assistance ED2-Require Assistance Thinking Tasks Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you require assistance from another person in tasks that require thinking abilities? Expanded DRS-PI Survivor Version - Require Assistance Thinking Tasks ED2-Require Assistance Managing Emotions Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you require assistance from another person to manage emotions and behavior? Expanded DRS-PI Survivor Version - Require Assistance Managing Emotions ED2-Need a Helper Always Close By Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you take care of some of your needs but also need a helper who is always close by? Expanded DRS-PI Survivor Version - Need a Helper Always Close By ED2-Need Help With All Major Activities Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you need help with all major activities and the assistance of another person all the time? Expanded DRS-PI Survivor Version - Need Help With All Major Activities ED2-Need 24-Hour Care Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you need 24-hour care and are not able to help with your own care at all? Expanded DRS-PI Survivor Version - Need 24-Hour Care ED2-Independent Work/Social Situations Expanded Disability Rating Scale - Postacute Interview Survivor Version - Can you function with complete independence in work or social situations? Expanded DRS-PI Survivor Version - Function With Independent Work or Social Situations ED2-Understand/Follow Directions Expanded Disability Rating Scale - Postacute Interview Survivor Version - Can you understand, remember, and follow directions? Expanded DRS-PI Survivor Version - Understand and Follow Directions ED2-Keep Track of Time/Schedules Expanded Disability Rating Scale - Postacute Interview Survivor Version - Can you keep track of time, schedules and appointments? Expanded DRS-PI Survivor Version - Keep Track of Time ED2-Perform Jobs, Manage Home/School Expanded Disability Rating Scale - Postacute Interview Survivor Version - How certain are you that you can perform in a wide variety of jobs of your choosing or manage a home independently or participate in school full-time? Expanded DRS-PI Survivor Version - Perform Jobs or Manage a Home Independently ED2-Successful With Accommodations Expanded Disability Rating Scale - Postacute Interview Survivor Version - How certain are you that you can be successful at work, school or in home management with some reduction in the work load or with other accommodations due to disabilities? Expanded DRS-PI Survivor Version - Successful With Accommodations ED2-Successful With Limited Choices Expanded Disability Rating Scale - Postacute Interview Survivor Version - How certain are you that you can be successful at work, school or in home management but with limited choices in jobs or school courses due to disabilities? Expanded DRS-PI Survivor Version - Successful With Limited Choices ED2-Work With Frequent Support Expanded Disability Rating Scale - Postacute Interview Survivor Version - How certain are you that you can be able to work at home or in a special setting like a sheltered workshop in which the work is very routine and there is very frequent supervision and support? Expanded DRS-PI Survivor Version - Work With Frequent Supervision and Support ED2TC Expanded Disability Rating Scale - Postacute Interview Survivor Version Questionnaire Test Code CDISC Questionnaire Expanded DRS-PI Survivor Version Test Code Terminology Expanded Disability Rating Scale - Postacute Interview Survivor Version test name. ED2-Can Dress/Groom Independently Expanded Disability Rating Scale - Postacute Interview Survivor Version - Can you dress and groom yourself independently and appropriately or direct someone else in these activities without help or reminders? Expanded DRS-PI Survivor Version - Can Dress and Groom Self Independently ED2-Correct Date and Time Expanded Disability Rating Scale - Postacute Interview Survivor Version - Are you able to give the correct date and time within a few seconds of being asked? Expanded DRS-PI Survivor Version - Give Correct Date and Time When Asked ED2-Feed Independently Without Help Expanded Disability Rating Scale - Postacute Interview Survivor Version - Can you feed yourself independently or manage tube feedings appropriately without help or reminders? Expanded DRS-PI Survivor Version - Feed Yourself Independently Without Help ED2-Function Completely Independently Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you function completely independently? That is, you do not require any physical assistance, supervision, equipment, devices, or reminders for cognitive, social, behavioral, emotional, and physical function? Expanded DRS-PI Survivor Version - Function Completely Independently ED2-Independent Work/Social Situations Expanded Disability Rating Scale - Postacute Interview Survivor Version - Can you function with complete independence in work or social situations? Expanded DRS-PI Survivor Version - Function With Independent Work or Social Situations ED2-Keep Track of Time/Schedules Expanded Disability Rating Scale - Postacute Interview Survivor Version - Can you keep track of time, schedules and appointments? Expanded DRS-PI Survivor Version - Keep Track of Time ED2-Know How to Bathe/Wash Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you know how to bathe and wash? Expanded DRS-PI Survivor Version - Know How to Bathe and Wash ED2-Know Meal Times Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you know when meal or feeding times are? Expanded DRS-PI Survivor Version - Know Meal Times ED2-Know When to Use Toilet Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you know when to use the toilet or to conduct bowel and bladder management? Expanded DRS-PI Survivor Version - Know When to Use Toilet ED2-Manage Clothing When Toileting Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you understand how to manage your clothing or special equipment when toileting or in bowel and bladder management? Expanded DRS-PI Survivor Version - Manage Clothing When Toileting ED2-Need 24-Hour Care Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you need 24-hour care and are not able to help with your own care at all? Expanded DRS-PI Survivor Version - Need 24-Hour Care ED2-Need a Helper Always Close By Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you take care of some of your needs but also need a helper who is always close by? Expanded DRS-PI Survivor Version - Need a Helper Always Close By ED2-Need Help With All Major Activities Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you need help with all major activities and the assistance of another person all the time? Expanded DRS-PI Survivor Version - Need Help With All Major Activities ED2-Perform Jobs, Manage Home/School Expanded Disability Rating Scale - Postacute Interview Survivor Version - How certain are you that you can perform in a wide variety of jobs of your choosing or manage a home independently or participate in school full-time? Expanded DRS-PI Survivor Version - Perform Jobs or Manage a Home Independently ED2-Require Assistance Managing Emotions Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you require assistance from another person to manage emotions and behavior? Expanded DRS-PI Survivor Version - Require Assistance Managing Emotions ED2-Require Assistance Thinking Tasks Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you require assistance from another person in tasks that require thinking abilities? Expanded DRS-PI Survivor Version - Require Assistance Thinking Tasks ED2-Require Physical Assistance Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you require physical assistance from another person to meet daily needs? Expanded DRS-PI Survivor Version - Require Physical Assistance ED2-Require Specific Aids/Equipment Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you REQUIRE special aids or equipment, such as, a brace, walker, wheelchair, memory notebook, day planner, verbal reminders, prompts, cues, or alarm watch because of a disability? Expanded DRS-PI Survivor Version - Require Special Aids or Equipment ED2-Start/Finish Grooming Activities Expanded Disability Rating Scale - Postacute Interview Survivor Version - Can you start and finish these grooming activities without prompting? Expanded DRS-PI Survivor Version - Start and Finish Grooming Activities ED2-Successful With Accommodations Expanded Disability Rating Scale - Postacute Interview Survivor Version - How certain are you that you can be successful at work, school or in home management with some reduction in the work load or with other accommodations due to disabilities? Expanded DRS-PI Survivor Version - Successful With Accommodations ED2-Successful With Limited Choices Expanded Disability Rating Scale - Postacute Interview Survivor Version - How certain are you that you can be successful at work, school or in home management but with limited choices in jobs or school courses due to disabilities? Expanded DRS-PI Survivor Version - Successful With Limited Choices ED2-Understand Feeding Utensils Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you understand what eating or feeding utensils or equipment are for and how they should be used? Expanded DRS-PI Survivor Version - Understand Feeding Utensils ED2-Understand How to Get Dressed Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you understand how to get dressed? Expanded DRS-PI Survivor Version - Understand How to Get Dressed ED2-Understand/Follow Directions Expanded Disability Rating Scale - Postacute Interview Survivor Version - Can you understand, remember, and follow directions? Expanded DRS-PI Survivor Version - Understand and Follow Directions ED2-Use Toilet Independently Expanded Disability Rating Scale - Postacute Interview Survivor Version - Can you use the toilet or manage your bowel and bladder routine independently and appropriately without help or reminders? Expanded DRS-PI Survivor Version - Use Toilet Independently ED2-Work With Frequent Support Expanded Disability Rating Scale - Postacute Interview Survivor Version - How certain are you that you can be able to work at home or in a special setting like a sheltered workshop in which the work is very routine and there is very frequent supervision and support? Expanded DRS-PI Survivor Version - Work With Frequent Supervision and Support ED2TN Expanded Disability Rating Scale - Postacute Interview Survivor Version Questionnaire Test Name CDISC Questionnaire Expanded DRS-PI Survivor Version Test Name Terminology Extended Glasgow Outcome Scale test code. GOSE1-Obey Simple Commands or Say Words Extended Glasgow Outcome Scale - Is the head injured person able to obey simple commands, or say any words? GOSE - Consciousness: Obey Simple Commands GOSE1-Daily Assistance at Home Essential Extended Glasgow Outcome Scale - Is the assistance of another person at home essential every day for some activities of daily living? GOSE - Independence in the Home: Assistance Essential for Daily Living GOSE1-Need Frequent Help at Home Extended Glasgow Outcome Scale - Do they need frequent help or someone to be around at home most of the time? GOSE - Independence in the Home: Need Frequent Help at Home GOSE1-Assistance at Home Before Injury Extended Glasgow Outcome Scale - Was assistance at home essential before the injury? GOSE - Independence in the Home: Assistance at Home Before Injury GOSE1-Shop Without Assistance Extended Glasgow Outcome Scale - Are they able to shop without assistance? GOSE - Independence Outside the Home: Able to Shop Without Assistance GOSE1-Shop Without Assist Before Injury Extended Glasgow Outcome Scale - Were they able to shop without assistance before the injury? GOSE - Independence Outside the Home: Able to Shop Without Assistance Before Injury GOSE1-Travel Locally Without Assistance Extended Glasgow Outcome Scale - Are they able to travel locally without assistance? GOSE - Independence Outside the Home: Travel Locally Without Assistance GOSE1-Travel Without Assist Before Inj Extended Glasgow Outcome Scale - Were they able to travel without assistance before the injury? GOSE - Independence Outside the Home: Travel Locally Without Assistance Before Injury GOSE1-Able to Work to Previous Capacity Extended Glasgow Outcome Scale - Are they currently able to work to their previous capacity? GOSE - Work: Able to Work to Previous Capacity GOSE1-How Restricted Are They Extended Glasgow Outcome Scale - How restricted are they? GOSE - Work: How Restricted Are They GOSE1-Working Before Injury Extended Glasgow Outcome Scale - Were they either working or seeking employment before the injury (answer 'yes') or were they doing neither (answer 'no')? GOSE - Work: Working or Seeking Employment Before the Injury GOSE1-Resume Social/Leisure Outside Home Extended Glasgow Outcome Scale - Are they able to resume regular social and leisure activities outside home? GOSE - Social and Leisure Activities: Resume Regular Social and Leisure Activities GOSE1-Extent Social/Leisure Restriction Extended Glasgow Outcome Scale - What is the extent of restriction on their social and leisure activities? GOSE - Social and Leisure Activities: Extent of Restriction on Social and Leisure Activities GOSE1-Engage Social/Leisure Before Inj Extended Glasgow Outcome Scale - Did they engage in regular social and leisure activities outside home before the injury? GOSE - Social and Leisure Activities: Engage Regular Social and Leisure Activities Before Injury GOSE1-Disruptive Psychological Problems Extended Glasgow Outcome Scale - Have there been psychological problems which have resulted in ongoing family disruption or disruption to friendships? GOSE - Family and Friendships: Disruptive Psychological Problems GOSE1-Extent of Disruption Extended Glasgow Outcome Scale - What has been the extent of disruption or strain? GOSE - Family and Friendships: Extent of Disruption or Strain GOSE1-Family/Friends Probs Before Injury Extended Glasgow Outcome Scale - Were there problems with family or friends before the injury? GOSE - Family and Friendships: Problems with Family or Friends Before Injury GOSE1-Other Problems Related to Injury Extended Glasgow Outcome Scale - Are there any other current problems relating to the injury which affect daily life? GOSE - Return to Normal Life: Other Current Problems Relating to Injury GOSE1-Similar Problems Before Injury Extended Glasgow Outcome Scale - Were similar problems present before the injury? GOSE - Return to Normal Life: Similar Problems Before Injury GOSE1-Since Injury Any Epileptic Fits Extended Glasgow Outcome Scale - Since the injury has the head injured person had any epileptic fits? GOSE - Epilepsy: Since Injury Any Epileptic Fits GOSE1-At Risk of Developing Epilepsy Extended Glasgow Outcome Scale - Have they been told that they are currently at risk of developing epilepsy? GOSE - Epilepsy: At Risk of Developing Epilepsy GOSE1-Most Important Factor in Outcome Extended Glasgow Outcome Scale - What is the most important factor in outcome? GOSE - Epilepsy: Most Important Factor in Outcome GOSE1-GOSE Overall Score Extended Glasgow Outcome Scale - Scoring: The patient's overall rating is based on the lowest outcome category indicated on the scale. GOSE - GOSE Overall Score GOSE1TC Extended Glasgow Outcome Scale Questionnaire Test Code CDISC Questionnaire GOSE Test Code Terminology Extended Glasgow Outcome Scale test name. GOSE1-Able to Work to Previous Capacity Extended Glasgow Outcome Scale - Are they currently able to work to their previous capacity? GOSE - Work: Able to Work to Previous Capacity GOSE1-Assistance at Home Before Injury Extended Glasgow Outcome Scale - Was assistance at home essential before the injury? GOSE - Independence in the Home: Assistance at Home Before Injury GOSE1-At Risk of Developing Epilepsy Extended Glasgow Outcome Scale - Have they been told that they are currently at risk of developing epilepsy? GOSE - Epilepsy: At Risk of Developing Epilepsy GOSE1-Daily Assistance at Home Essential Extended Glasgow Outcome Scale - Is the assistance of another person at home essential every day for some activities of daily living? GOSE - Independence in the Home: Assistance Essential for Daily Living GOSE1-Disruptive Psychological Problems Extended Glasgow Outcome Scale - Have there been psychological problems which have resulted in ongoing family disruption or disruption to friendships? GOSE - Family and Friendships: Disruptive Psychological Problems GOSE1-Engage Social/Leisure Before Inj Extended Glasgow Outcome Scale - Did they engage in regular social and leisure activities outside home before the injury? GOSE - Social and Leisure Activities: Engage Regular Social and Leisure Activities Before Injury GOSE1-Extent of Disruption Extended Glasgow Outcome Scale - What has been the extent of disruption or strain? GOSE - Family and Friendships: Extent of Disruption or Strain GOSE1-Extent Social/Leisure Restriction Extended Glasgow Outcome Scale - What is the extent of restriction on their social and leisure activities? GOSE - Social and Leisure Activities: Extent of Restriction on Social and Leisure Activities GOSE1-Family/Friends Probs Before Injury Extended Glasgow Outcome Scale - Were there problems with family or friends before the injury? GOSE - Family and Friendships: Problems with Family or Friends Before Injury GOSE1-GOSE Overall Score Extended Glasgow Outcome Scale - Scoring: The patient's overall rating is based on the lowest outcome category indicated on the scale. GOSE - GOSE Overall Score GOSE1-How Restricted Are They Extended Glasgow Outcome Scale - How restricted are they? GOSE - Work: How Restricted Are They GOSE1-Most Important Factor in Outcome Extended Glasgow Outcome Scale - What is the most important factor in outcome? GOSE - Epilepsy: Most Important Factor in Outcome GOSE1-Need Frequent Help at Home Extended Glasgow Outcome Scale - Do they need frequent help or someone to be around at home most of the time? GOSE - Independence in the Home: Need Frequent Help at Home GOSE1-Obey Simple Commands or Say Words Extended Glasgow Outcome Scale - Is the head injured person able to obey simple commands, or say any words? GOSE - Consciousness: Obey Simple Commands GOSE1-Other Problems Related to Injury Extended Glasgow Outcome Scale - Are there any other current problems relating to the injury which affect daily life? GOSE - Return to Normal Life: Other Current Problems Relating to Injury GOSE1-Resume Social/Leisure Outside Home Extended Glasgow Outcome Scale - Are they able to resume regular social and leisure activities outside home? GOSE - Social and Leisure Activities: Resume Regular Social and Leisure Activities GOSE1-Shop Without Assist Before Injury Extended Glasgow Outcome Scale - Were they able to shop without assistance before the injury? GOSE - Independence Outside the Home: Able to Shop Without Assistance Before Injury GOSE1-Shop Without Assistance Extended Glasgow Outcome Scale - Are they able to shop without assistance? GOSE - Independence Outside the Home: Able to Shop Without Assistance GOSE1-Similar Problems Before Injury Extended Glasgow Outcome Scale - Were similar problems present before the injury? GOSE - Return to Normal Life: Similar Problems Before Injury GOSE1-Since Injury Any Epileptic Fits Extended Glasgow Outcome Scale - Since the injury has the head injured person had any epileptic fits? GOSE - Epilepsy: Since Injury Any Epileptic Fits GOSE1-Travel Locally Without Assistance Extended Glasgow Outcome Scale - Are they able to travel locally without assistance? GOSE - Independence Outside the Home: Travel Locally Without Assistance GOSE1-Travel Without Assist Before Inj Extended Glasgow Outcome Scale - Were they able to travel without assistance before the injury? GOSE - Independence Outside the Home: Travel Locally Without Assistance Before Injury GOSE1-Working Before Injury Extended Glasgow Outcome Scale - Were they either working or seeking employment before the injury (answer 'yes') or were they doing neither (answer 'no')? GOSE - Work: Working or Seeking Employment Before the Injury GOSE1TN Extended Glasgow Outcome Scale Questionnaire Test Name CDISC Questionnaire GOSE Test Name Terminology Extrapyramidal Symptom Rating Scale-Abbreviated test code. ESRSA1-Rigidity: Upper Limbs Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Rigidity: Upper limbs. ESRS-A - Rigidity: Upper Limbs ESRSA1-Rigidity: Lower Limbs Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Rigidity: Lower limbs. ESRS-A - Rigidity: Lower Limbs ESRSA1-Rigidity: Neck Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Rigidity: Neck. ESRS-A - Rigidity: Neck ESRSA1-Tremor: Face/Jaw/Chin/Lips/Head Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Tremor: Face, jaw/chin, lips, head. ESRS-A - Tremor: Face/Jaw/Chin/Lips/Head ESRSA1-Tremor: Upper Limbs/Hands Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Tremor: Upper limbs/hands. ESRS-A - Tremor: Upper Limbs/Hands ESRSA1-Tremor: Lower Limbs/Feet Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Tremor: Lower limbs/feet. ESRS-A - Tremor: Lower Limbs/Feet ESRSA1-Reduced Facial Expression/Speech Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Reduced facial expression/speech. ESRS-A - Reduced Facial Expression/Speech ESRSA1-Impaired Gait/Posture Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Impaired gait/posture. ESRS-A - Impaired Gait/Posture ESRSA1-Postural Instability Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Postural instability. ESRS-A - Postural Instability ESRSA1-Bradykinesia/Hypokinesia Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Bradykinesia/hypokinesia. ESRS-A - Bradykinesia/Hypokinesia ESRSA1-Dystonia: Tongue Extrapyramidal Symptom Rating Scale-Abbreviated - Dystonia: Tongue. ESRS-A - Dystonia: Tongue ESRSA1-Dystonia: Jaw Extrapyramidal Symptom Rating Scale-Abbreviated - Dystonia: Jaw. ESRS-A - Dystonia: Jaw ESRSA1-Dystonia: Eyes/Face/Larynx Extrapyramidal Symptom Rating Scale-Abbreviated - Dystonia: Eyes, upper face, lower face, larynx. ESRS-A - Dystonia: Eyes/Upper and Lower Face/Larynx ESRSA1-Dystonia: Shoulder/Up Limb/Hand Extrapyramidal Symptom Rating Scale-Abbreviated - Dystonia: Shoulders, upper limbs, hands. ESRS-A - Dystonia: Shoulder/Upper Limbs/Hands ESRSA1-Dystonia: Hips/Lower Limbs/Feet Extrapyramidal Symptom Rating Scale-Abbreviated - Dystonia: Hips, lower limbs, feet. ESRS-A - Dystonia: Hips/Lower Limbs/Feet ESRSA1-Dystonia: Trunk/Neck Extrapyramidal Symptom Rating Scale-Abbreviated - Dystonia: Trunk, neck. ESRS-A - Dystonia: Trunk/Neck ESRSA1-Dyskinesia: Tongue Extrapyramidal Symptom Rating Scale-Abbreviated - Dyskinesia: Tongue. ESRS-A - Dyskinesia: Tongue ESRSA1-Dyskinesia: Jaw Extrapyramidal Symptom Rating Scale-Abbreviated - Dyskinesia: Jaw. ESRS-A - Dyskinesia: Jaw ESRSA1-Dyskinesia: Eyes/Up Face/Low Face Extrapyramidal Symptom Rating Scale-Abbreviated - Dyskinesia: Eyes, upper face, lower face. ESRS-A - Dyskinesia: Eyes/Upper Face/Lower Face ESRSA1-Dyskinesia: Shoulder/Up Limb/Hand Extrapyramidal Symptom Rating Scale-Abbreviated - Dyskinesia: Shoulders, upper limbs, hands. ESRS-A - Dyskinesia: Shoulder/Upper Limbs/Hands ESRSA1-Dyskinesia: Hips/Lower Limbs/Feet Extrapyramidal Symptom Rating Scale-Abbreviated - Dyskinesia: Hips, lower limbs, feet. ESRS-A - Dyskinesia: Hips/Lower Limbs/Feet ESRSA1-Dyskinesia: Trunk/Neck Extrapyramidal Symptom Rating Scale-Abbreviated - Dyskinesia: Trunk, neck. ESRS-A - Dyskinesia: Trunk/Neck ESRSA1-Akathisia: Subjective Extrapyramidal Symptom Rating Scale-Abbreviated - Akathisia: Subjective. ESRS-A - Akathisia: Subjective ESRSA1-Akathisia: Objective Extrapyramidal Symptom Rating Scale-Abbreviated - Akathisia: Objective. ESRS-A - Akathisia: Objective ESRSA1-CGI-S Parkinsonism Extrapyramidal Symptom Rating Scale-Abbreviated - Clinical Global Impression (CGI-S): Parkinsonism. ESRS-A - CGI-S Parkinsonism ESRSA1-CGI-S Dystonia Extrapyramidal Symptom Rating Scale-Abbreviated - Clinical Global Impression (CGI-S): Dystonia. ESRS-A - CGI-S Dystonia ESRSA1-CGI-S Dyskinesia Extrapyramidal Symptom Rating Scale-Abbreviated - Clinical Global Impression (CGI-S): Dyskinesia. ESRS-A - CGI-S Dyskinesia ESRSA1-CGI-S Akathisia Extrapyramidal Symptom Rating Scale-Abbreviated - Clinical Global Impression (CGI-S): Akathisia. ESRS-A - CGI-S Akathisia ESRSA1TC Extrapyramidal Symptom Rating Scale-Abbreviated Clinical Classification Test Code CDISC Clinical Classification ESRS-A Test Code Terminology Extrapyramidal Symptom Rating Scale-Abbreviated test name. ESRSA1-Akathisia: Objective Extrapyramidal Symptom Rating Scale-Abbreviated - Akathisia: Objective. ESRS-A - Akathisia: Objective ESRSA1-Akathisia: Subjective Extrapyramidal Symptom Rating Scale-Abbreviated - Akathisia: Subjective. ESRS-A - Akathisia: Subjective ESRSA1-Bradykinesia/Hypokinesia Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Bradykinesia/hypokinesia. ESRS-A - Bradykinesia/Hypokinesia ESRSA1-CGI-S Akathisia Extrapyramidal Symptom Rating Scale-Abbreviated - Clinical Global Impression (CGI-S): Akathisia. ESRS-A - CGI-S Akathisia ESRSA1-CGI-S Dyskinesia Extrapyramidal Symptom Rating Scale-Abbreviated - Clinical Global Impression (CGI-S): Dyskinesia. ESRS-A - CGI-S Dyskinesia ESRSA1-CGI-S Dystonia Extrapyramidal Symptom Rating Scale-Abbreviated - Clinical Global Impression (CGI-S): Dystonia. ESRS-A - CGI-S Dystonia ESRSA1-CGI-S Parkinsonism Extrapyramidal Symptom Rating Scale-Abbreviated - Clinical Global Impression (CGI-S): Parkinsonism. ESRS-A - CGI-S Parkinsonism ESRSA1-Dyskinesia: Eyes/Up Face/Low Face Extrapyramidal Symptom Rating Scale-Abbreviated - Dyskinesia: Eyes, upper face, lower face. ESRS-A - Dyskinesia: Eyes/Upper Face/Lower Face ESRSA1-Dyskinesia: Hips/Lower Limbs/Feet Extrapyramidal Symptom Rating Scale-Abbreviated - Dyskinesia: Hips, lower limbs, feet. ESRS-A - Dyskinesia: Hips/Lower Limbs/Feet ESRSA1-Dyskinesia: Jaw Extrapyramidal Symptom Rating Scale-Abbreviated - Dyskinesia: Jaw. ESRS-A - Dyskinesia: Jaw ESRSA1-Dyskinesia: Shoulder/Up Limb/Hand Extrapyramidal Symptom Rating Scale-Abbreviated - Dyskinesia: Shoulders, upper limbs, hands. ESRS-A - Dyskinesia: Shoulder/Upper Limbs/Hands ESRSA1-Dyskinesia: Tongue Extrapyramidal Symptom Rating Scale-Abbreviated - Dyskinesia: Tongue. ESRS-A - Dyskinesia: Tongue ESRSA1-Dyskinesia: Trunk/Neck Extrapyramidal Symptom Rating Scale-Abbreviated - Dyskinesia: Trunk, neck. ESRS-A - Dyskinesia: Trunk/Neck ESRSA1-Dystonia: Eyes/Face/Larynx Extrapyramidal Symptom Rating Scale-Abbreviated - Dystonia: Eyes, upper face, lower face, larynx. ESRS-A - Dystonia: Eyes/Upper and Lower Face/Larynx ESRSA1-Dystonia: Hips/Lower Limbs/Feet Extrapyramidal Symptom Rating Scale-Abbreviated - Dystonia: Hips, lower limbs, feet. ESRS-A - Dystonia: Hips/Lower Limbs/Feet ESRSA1-Dystonia: Jaw Extrapyramidal Symptom Rating Scale-Abbreviated - Dystonia: Jaw. ESRS-A - Dystonia: Jaw ESRSA1-Dystonia: Shoulder/Up Limb/Hand Extrapyramidal Symptom Rating Scale-Abbreviated - Dystonia: Shoulders, upper limbs, hands. ESRS-A - Dystonia: Shoulder/Upper Limbs/Hands ESRSA1-Dystonia: Tongue Extrapyramidal Symptom Rating Scale-Abbreviated - Dystonia: Tongue. ESRS-A - Dystonia: Tongue ESRSA1-Dystonia: Trunk/Neck Extrapyramidal Symptom Rating Scale-Abbreviated - Dystonia: Trunk, neck. ESRS-A - Dystonia: Trunk/Neck ESRSA1-Impaired Gait/Posture Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Impaired gait/posture. ESRS-A - Impaired Gait/Posture ESRSA1-Postural Instability Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Postural instability. ESRS-A - Postural Instability ESRSA1-Reduced Facial Expression/Speech Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Reduced facial expression/speech. ESRS-A - Reduced Facial Expression/Speech ESRSA1-Rigidity: Lower Limbs Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Rigidity: Lower limbs. ESRS-A - Rigidity: Lower Limbs ESRSA1-Rigidity: Neck Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Rigidity: Neck. ESRS-A - Rigidity: Neck ESRSA1-Rigidity: Upper Limbs Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Rigidity: Upper limbs. ESRS-A - Rigidity: Upper Limbs ESRSA1-Tremor: Face/Jaw/Chin/Lips/Head Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Tremor: Face, jaw/chin, lips, head. ESRS-A - Tremor: Face/Jaw/Chin/Lips/Head ESRSA1-Tremor: Lower Limbs/Feet Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Tremor: Lower limbs/feet. ESRS-A - Tremor: Lower Limbs/Feet ESRSA1-Tremor: Upper Limbs/Hands Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Tremor: Upper limbs/hands. ESRS-A - Tremor: Upper Limbs/Hands ESRSA1TN Extrapyramidal Symptom Rating Scale-Abbreviated Clinical Classification Test Name CDISC Clinical Classification ESRS-A Test Name Terminology Faces Pain Scale - Revised test code. FPSR1-How Much Do You Hurt Faces Pain Scale - Revised - Point to the face that shows how much you hurt [right now]. FPSR - How Much Do You Hurt FPSR1TC Faces Pain Scale - Revised Questionnaire Test Code CDISC Questionnaire FPSR Test Code Terminology Faces Pain Scale - Revised test name. FPSR1-How Much Do You Hurt Faces Pain Scale - Revised - Point to the face that shows how much you hurt [right now]. FPSR - How Much Do You Hurt FPSR1TN Faces Pain Scale - Revised Questionnaire Test Name CDISC Questionnaire FPSR Test Name Terminology Fagerstrom Test for Cigarette Dependence test code. FTCD01-How Soon After Wake Smoke Fagerstrom Test for Cigarette Dependence - How soon after you wake up do you smoke your first cigarette? FTCD - How Soon After Wake Smoke FTCD01-Difficult to Refrain in Places Fagerstrom Test for Cigarette Dependence - Do you find it difficult to refrain from smoking in places where it is forbidden (e.g., in church, at the library, in the cinema)? FTCD - Difficult to Refrain in Places FTCD01-Which Cigarette Hate to Give Up Fagerstrom Test for Cigarette Dependence - Which cigarette would you hate most to give up? FTCD - Which Cigarette Hate to Give Up FTCD01-How Many Cigarettes Per Day Smoke Fagerstrom Test for Cigarette Dependence - How many cigarettes per day do you smoke? FTCD - How Many Cigarettes Per Day Smoke FTCD01-Smoke More After Waking Fagerstrom Test for Cigarette Dependence - Do you smoke more frequently during the first hours after waking than during the rest of the day? FTCD - Smoke More After Waking FTCD01-Smoke When Ill in Bed Most Day Fagerstrom Test for Cigarette Dependence - Do you smoke when you are so ill that you are in bed most of the day? FTCD - Smoke When Ill in Bed Most Day FTCD01-Score Fagerstrom Test for Cigarette Dependence - Your score was: (your level of dependence on nicotine is). FTCD - Score FTCD01-Do You Currently Smoke Cigarettes Fagerstrom Test for Cigarette Dependence - Do you currently smoke cigarettes? FTCD - Do You Currently Smoke Cigarettes FTCD01TC Fagerstrom Test for Cigarette Dependence Questionnaire Test Code CDISC Questionnaire Fagerstrom Test for Cigarette Dependence Test Code Terminology Fagerstrom Test for Cigarette Dependence test name. FTCD01-Difficult to Refrain in Places Fagerstrom Test for Cigarette Dependence - Do you find it difficult to refrain from smoking in places where it is forbidden (e.g., in church, at the library, in the cinema)? FTCD - Difficult to Refrain in Places FTCD01-Do You Currently Smoke Cigarettes Fagerstrom Test for Cigarette Dependence - Do you currently smoke cigarettes? FTCD - Do You Currently Smoke Cigarettes FTCD01-How Many Cigarettes Per Day Smoke Fagerstrom Test for Cigarette Dependence - How many cigarettes per day do you smoke? FTCD - How Many Cigarettes Per Day Smoke FTCD01-How Soon After Wake Smoke Fagerstrom Test for Cigarette Dependence - How soon after you wake up do you smoke your first cigarette? FTCD - How Soon After Wake Smoke FTCD01-Score Fagerstrom Test for Cigarette Dependence - Your score was: (your level of dependence on nicotine is). FTCD - Score FTCD01-Smoke More After Waking Fagerstrom Test for Cigarette Dependence - Do you smoke more frequently during the first hours after waking than during the rest of the day? FTCD - Smoke More After Waking FTCD01-Smoke When Ill in Bed Most Day Fagerstrom Test for Cigarette Dependence - Do you smoke when you are so ill that you are in bed most of the day? FTCD - Smoke When Ill in Bed Most Day FTCD01-Which Cigarette Hate to Give Up Fagerstrom Test for Cigarette Dependence - Which cigarette would you hate most to give up? FTCD - Which Cigarette Hate to Give Up FTCD01TN Fagerstrom Test for Cigarette Dependence Questionnaire Test Name CDISC Questionnaire Fagerstrom Test for Cigarette Dependence Test Name Terminology Falls Efficacy Scale test code. FES01-Take a Bath or Shower Falls Efficacy Scale - Take a bath or shower. FES - Take a Bath or Shower FES01-Reach Into Cabinets or Closets Falls Efficacy Scale - Reach into cabinets or closets. FES - Reach Into Cabinets or Closets FES01-Walk Around the House Falls Efficacy Scale - Walk around the house. FES - Walk Around the House FES01-Prepare Meals Not Carrying Objects Falls Efficacy Scale - Prepare meals not requiring carrying heavy or hot objects. FES - Prepare Meals Not Carrying Objects FES01-Get In and Out of Bed Falls Efficacy Scale - Get in and out of bed. FES - Get In and Out of Bed FES01-Answer the Door or Telephone Falls Efficacy Scale - Answer the door or telephone. FES - Answer the Door or Telephone FES01-Get In and Out of Chair Falls Efficacy Scale - Get in and out of a chair. FES - Get In and Out of Chair FES01-Get Dressed and Undressed Falls Efficacy Scale - Get dressed and undressed. FES - Get Dressed and Undressed FES01-Personal Grooming Falls Efficacy Scale - Personal grooming (i.e. washing your face). FES - Personal Grooming FES01-Get On and Off of Toilet Falls Efficacy Scale - Get on and off of the toilet. FES - Get On and Off of Toilet FES01-Total Score Falls Efficacy Scale - Total score. FES - Total Score FES01TC Falls Efficacy Scale Questionnaire Test Code CDISC Questionnaire Falls Efficacy Scale Test Code Terminology Falls Efficacy Scale test name. FES01-Answer the Door or Telephone Falls Efficacy Scale - Answer the door or telephone. FES - Answer the Door or Telephone FES01-Get Dressed and Undressed Falls Efficacy Scale - Get dressed and undressed. FES - Get Dressed and Undressed FES01-Get In and Out of Bed Falls Efficacy Scale - Get in and out of bed. FES - Get In and Out of Bed FES01-Get In and Out of Chair Falls Efficacy Scale - Get in and out of a chair. FES - Get In and Out of Chair FES01-Get On and Off of Toilet Falls Efficacy Scale - Get on and off of the toilet. FES - Get On and Off of Toilet FES01-Personal Grooming Falls Efficacy Scale - Personal grooming (i.e. washing your face). FES - Personal Grooming FES01-Prepare Meals Not Carrying Objects Falls Efficacy Scale - Prepare meals not requiring carrying heavy or hot objects. FES - Prepare Meals Not Carrying Objects FES01-Reach Into Cabinets or Closets Falls Efficacy Scale - Reach into cabinets or closets. FES - Reach Into Cabinets or Closets FES01-Take a Bath or Shower Falls Efficacy Scale - Take a bath or shower. FES - Take a Bath or Shower FES01-Total Score Falls Efficacy Scale - Total score. FES - Total Score FES01-Walk Around the House Falls Efficacy Scale - Walk around the house. FES - Walk Around the House FES01TN Falls Efficacy Scale Questionnaire Test Name CDISC Questionnaire Falls Efficacy Scale Test Name Terminology Fatigue Severity Scale test code. FSS01-Motivation Is Lower When Fatigued Fatigue Severity Scale - My motivation is lower when I am fatigued. FSS - Motivation is Lower When Fatigued FSS01-Exercise Brings on My Fatigue Fatigue Severity Scale - Exercise brings on my fatigue. FSS - Exercise Brings on My Fatigue FSS01-I Am Easily Fatigued Fatigue Severity Scale - I am easily fatigued. FSS - I Am Easily Fatigued FSS01-Interferes With Phys Function Fatigue Severity Scale - Fatigue interferes with my physical functioning. FSS - Fatigue Interferes With Physical Functioning FSS01-Fatigue Causes Frequent Problems Fatigue Severity Scale - Fatigue causes frequent problems for me. FSS - Fatigue Causes Frequent Problems FSS01-Prevents Sustained Phys Function Fatigue Severity Scale - My fatigue prevents sustained physical functioning. FSS - Fatigue Prevents Sustained Physical Functioning FSS01-Fatigue Interferes With Duties Fatigue Severity Scale - Fatigue interferes with carrying out certain duties and responsibilities. FSS - Fatigue Interferes With Carrying Out Duties FSS01-Among My 3 Most Disabling Symptoms Fatigue Severity Scale - Fatigue is among my three most disabling symptoms. FSS - Fatigue is Among Most Disabling Symptoms FSS01-Fatigue Interferes With My Life Fatigue Severity Scale - Fatigue interferes with my work, family, or social life. FSS - Fatigue Interferes With Work FSS01TC Fatigue Severity Scale Questionnaire Test Code CDISC Questionnaire Fatigue Severity Scale Test Code Terminology Fatigue Severity Scale test name. FSS01-Among My 3 Most Disabling Symptoms Fatigue Severity Scale - Fatigue is among my three most disabling symptoms. FSS - Fatigue is Among Most Disabling Symptoms FSS01-Exercise Brings on My Fatigue Fatigue Severity Scale - Exercise brings on my fatigue. FSS - Exercise Brings on My Fatigue FSS01-Fatigue Causes Frequent Problems Fatigue Severity Scale - Fatigue causes frequent problems for me. FSS - Fatigue Causes Frequent Problems FSS01-Fatigue Interferes With Duties Fatigue Severity Scale - Fatigue interferes with carrying out certain duties and responsibilities. FSS - Fatigue Interferes With Carrying Out Duties FSS01-Fatigue Interferes With My Life Fatigue Severity Scale - Fatigue interferes with my work, family, or social life. FSS - Fatigue Interferes With Work FSS01-I Am Easily Fatigued Fatigue Severity Scale - I am easily fatigued. FSS - I Am Easily Fatigued FSS01-Interferes With Phys Function Fatigue Severity Scale - Fatigue interferes with my physical functioning. FSS - Fatigue Interferes With Physical Functioning FSS01-Motivation Is Lower When Fatigued Fatigue Severity Scale - My motivation is lower when I am fatigued. FSS - Motivation is Lower When Fatigued FSS01-Prevents Sustained Phys Function Fatigue Severity Scale - My fatigue prevents sustained physical functioning. FSS - Fatigue Prevents Sustained Physical Functioning FSS01TN Fatigue Severity Scale Questionnaire Test Name CDISC Questionnaire Fatigue Severity Scale Test Name Terminology A terminology codelist relevant to the name and version of the FDA technical specification that is being used in the study submission. Version 1.0 of the FDA Clinical Endpoint BE Studies Technical Specifications Guidance. US FDA Clinical Endpoint BE Studies v1.0 Version 1.0 of the FDA HIV Technical Specifications Guidance. US FDA HIV Technical Specifications Guidance v1.0 Version 4.2.1 of the FDA Study Data Technical Conformance Guide. US FDA Study Data Technical Conformance Guide v4.2.1 Version 4.3 of the FDA Study Data Technical Conformance Guide. FDA Study Data Technical Conformance Guide v4.3 Version 4.4 of the FDA Study Data Technical Conformance Guide. FDA Study Data Technical Conformance Guide v4.4 Version 4.5 of the FDA Study Data Technical Conformance Guide. Study Data Technical Conformance Guide v4.5 Version 4.5.1 of the FDA Study Data Technical Conformance Guide. Study Data Technical Conformance Guide v4.5.1 Version 4.6 of the FDA Study Data Technical Conformance Guide. Study Data Technical Conformance Guide v4.6 Version 4.7 of the FDA Study Data Technical Conformance Guide. Study Data Technical Conformance Guide v4.7 Version 4.8 of the FDA Study Data Technical Conformance Guide. Study Data Technical Conformance Guide v4.8 Version 4.9 of the FDA Study Data Technical Conformance Guide. Study Data Technical Conformance Guide v4.9 Version 5.0 of the FDA Study Data Technical Conformance Guide. Study Data Technical Conformance Guide v5.0 Version 5.1 of the FDA Study Data Technical Conformance Guide. Study Data Technical Conformance Guide v5.1 Version 5.2 of the FDA Study Data Technical Conformance Guide. Study Data Technical Conformance Guide v5.2 Version 5.3 of the FDA Study Data Technical Conformance Guide. Study Data Technical Conformance Guide v5.3 Version 5.4 of the FDA Study Data Technical Conformance Guide. Study Data Technical Conformance Guide v5.4 Version 5.5 of the FDA Study Data Technical Conformance Guide. Study Data Technical Conformance Guide v5.5 Version 5.6 of the FDA Study Data Technical Conformance Guide. Study Data Technical Conformance Guide v5.6 Version 5.7 of the FDA Study Data Technical Conformance Guide. Study Data Technical Conformance Guide v5.7 Version 5.8 of the FDA Study Data Technical Conformance Guide. FDA Study Data Technical Conformance Guide v5.8 Version 5.9 of the FDA Study Data Technical Conformance Guide. FDA Study Data Technical Conformance Guide v5.9 Version 6.0 of the FDA Study Data Technical Conformance Guide. FDA Study Data Technical Conformance Guide v6.0 Version 1.0 of the FDA Vaccines Technical Specifications Guidance. US FDA Vaccines Technical Specification Guidance v1.0 FDATSRS FDA Technical Specification Response CDISC SDTM FDA Technical Specification Response Terminology A terminology codelist to describe the test code for findings about an adjudicated event. Event Classification A grouping of the event, as described in the object of observation, according to a set of criteria. Classification of Event Start Date/Time of Event The start date or date and time of an event, as described in the object of observation, represented in a standardized character format. Event Start Date Time Event Type A characterization or classification of the event, as described in the object of observation. Type of Event Occurrence Indicator An indication as to whether something has happened, such as an event or incident. Occurrence Indicator Relation to Study Treatment or Product An assessment of the likelihood that the study treatment or product was the cause of the event. Relationship to Study Treatment or Product EATESTCD Findings About Adjudicated Event Test Code CDISC SDTM Findings About Adjudicated Event Test Code Terminology A terminology codelist to describe the test name for findings about an adjudicated event. Event Classification A grouping of the event, as described in the object of observation, according to a set of criteria. Classification of Event Event Type A characterization or classification of the event, as described in the object of observation. Type of Event Occurrence Indicator An indication as to whether something has happened, such as an event or incident. Occurrence Indicator Relation to Study Treatment or Product An assessment of the likelihood that the study treatment or product was the cause of the event. Relationship to Study Treatment or Product Start Date/Time of Event The start date or date and time of an event, as described in the object of observation, represented in a standardized character format. Event Start Date Time EATEST Findings About Adjudicated Event Test Name CDISC SDTM Findings About Adjudicated Event Test Name Terminology Terminology relevant to the test codes that describe findings about an event or intervention. Number of Abscesses The number of abscesses observed. Number of Abscesses Acute Myocardial Infarction Type Categorization of the type of acute myocardial infarction. Acute Myocardial Infarction Type Action Taken With Device An action taken with a device as the result of the event. Action Taken with Device Action Taken With Subject Action taken with respect to a subject in a study. Action Taken With Subject Most Severe Acute Stressor The agent, stimulus, activity, or event that causes stress with an acute frequency, which has the highest level of severity. Most Severe Acute Stressor AE Improve/Resolve with Dechallenge Ind AE Improve/Resolve with Dechallenge Indicator An indication as to whether an adverse event improves or disappears after stopping a study treatment. Positive Dechallenge Reaction Indicator AE Reappear/Worsen with Rechallenge Ind AE Reappear/Worsen with Rechallenge Indicator An indication as to whether an adverse event reappears or worsens after restarting a study treatment. Positive Rechallenge Indicator Age At Disease Onset The age at which disease began or were first noted. Age At Disease Onset Age At First Episode The age at which the first episode occurred. Age at First Episode Age at Full-Time Use The age at which the full-time use of a pre-specified object first occurred. Age at Full-Time Use Age At First Hospitalization The age at which the first hospitalization event occurred. Age at First Hospitalization Age Symptoms Started The age at which illness-specific symptoms first began. Age Symptom Started Age At First Treatment The age at which the first treatment for the condition occurred. Age at First Treatment Number of Alcoholic Drinks The total number of alcoholic drinks. Number of Alcoholic Drinks Measurement Aper Appearance The outward or visible aspect of an entity. Appearance Allergen Skin Response Index A relative measurement (ratio or percentage) of the allergen wheal size to the positive control wheal size in an allergen skin test. Allergen Skin Response Index Measurement Allergen Skin Response Intensity A semi-quantitative assessment of the intensity of the wheal and flare reaction. Allergen Skin Response Intensity Measurement Biopsy Specimen Taken Indicator An indication as to whether a biopsy specimen was collected. Biopsy Specimen Taken Indicator Number of Biopsy Specimens Taken The total number of biopsy specimens collected. Number of Biopsy Specimens Taken Blistering Indicator An indication as to whether blistering occurred. Blistering Indicator Pathologic Appearance of Biopsy Site A description of the appearance of the anatomical site from which a biopsy specimen has been collected. Pathologic Appearance of Biopsy Site Calories Burned A measurement of the number of calories expended. Calories Burned Coronary Artery Thrombosis Method Ident The method by which the coronary artery thrombosis event is determined or diagnosed. Coronary Artery Thrombosis Method of Identification Most Severe Chronic Stressor The agent, stimulus, activity, or event that causes stress with a chronic frequency, which has the highest level of severity. Most Severe Chronic Stressor Clinic Stay Indicator An indication as to whether the subject was admitted to a healthcare clinic. Clinic Stay Indicator Clinical Status of Disease A characterization of the state of a subject's disease or condition, as evaluated by a clinician or other healthcare provider. Clinical Status Contrast Enhancement Phase The phase of the contrast agent distribution within the body after its administration. Contrast Agent Enhancement Phase Cumulative Exposure The total amount that a subject is exposed to over time. Cumulative Exposure Dietary Alpha Carotene A determination of the alpha carotene in a nutritional product or meal, or a portion thereof. Dietary Alpha Carotene Measurement Dietary Added Sugar A determination of the total added sugars in a nutritional product or meal, or a portion thereof. Dietary Added Sugar Measurement Dietary Alcohol Dietary Ethanol A determination of the total amount of alcohol in a nutritional product or meal, or a portion thereof. Dietary Alcohol Measurement Dietary 20:4 Arachidonate Dietary 20:4 Arachidonic Acid Dietary Arachidonic Acid A determination of the total 20:4 arachidonic acid in a nutritional product or meal, or a portion thereof. Dietary Arachidonic Acid Measurement Dietary Alpha Tocopherol A determination of the alpha tocopherol in a nutritional product or meal, or a portion thereof. Dietary Alpha Tocopherol Measurement Dietary Added Vitamin B12 A determination of the total added vitamin B12 in a nutritional product or meal, or a portion thereof. Dietary Added Vitamin B12 Measurement Dietary Added Vitamin E A determination of the total added vitamin E in a nutritional product or meal, or a portion thereof. Dietary Added Vitamin E Measurement Dietary Beta Carotene A determination of the beta carotene in a nutritional product or meal, or a portion thereof. Dietary Beta Carotene Measurement Dietary Beans and Peas A determination of the total beans and peas in a nutritional product or meal, or a portion thereof. Dietary Beans and Peas Measurement Dietary 4:0 Butyrate Dietary 4:0 Butyric Acid Dietary Butyric Acid A determination of the total 4:0 butyric acid in a nutritional product or meal, or a portion thereof. Dietary Butyric Acid Measurement Dietary Calcium A determination of the total calcium in a nutritional product or meal, or a portion thereof. Dietary Calcium Measurement Dietary Caffeine A determination of the caffeine in a nutritional product or meal, or a portion thereof. Dietary Caffeine Measurement Dietary Calories A determination of the total dietary calories in a nutritional product or meal, or a portion thereof. Dietary Calories Measurement Dietary 6:0 Caproate Dietary 6:0 Caproic Acid Dietary Caproic Acid A determination of the total 6:0 caproic acid in a nutritional product or meal, or a portion thereof. Dietary Caproic Acid Measurement Dietary 10:0 Caprate Dietary 10:0 Capric Acid Dietary Capric Acid A determination of the total 10:0 capric acid in a nutritional product or meal, or a portion thereof. Dietary Capric Acid Measurement Dietary 8:0 Caprylate Dietary 8:0 Caprylic Acid Dietary Caprylic Acid A determination of the total 8:0 caprylic acid in a nutritional product or meal, or a portion thereof. Dietary Caprylic Acid Measurement Dietary Total Carbohydrate A determination of the total carbohydrate in a nutritional product or meal, or a portion thereof. Total Dietary Carbohydrate Measurement Unable to Discon Dependent Indicator Unable to Discontinue Dependent Indicator An indication as to whether an individual is unable to discontinue the use of a substance due to dependence. Unable to Discontinue Use Due to Dependence Indicator Dietary Cheese A determination of the total cheese in a nutritional product or meal, or a portion thereof. Dietary Cheese Measurement Dietary Cholesterol A determination of the total cholesterol in a nutritional product or meal, or a portion thereof. Dietary Cholesterol Measurement Dietary Choline A determination of the choline in a nutritional product or meal, or a portion thereof. Dietary Choline Measurement Dietary Citrus, Melons, and Berries A determination of the total citrus, melons, and berries in a nutritional product or meal, or a portion thereof. Dietary Citrus, Melons, and Berries Measurement Dietary 22:5 Clupanodonate Dietary 22:5 Clupanodonic Acid Dietary Clupanodonic Acid A determination of the total 22:5 clupanodonic acid in a nutritional product or meal, or a portion thereof. Dietary Clupanodonic Acid Measurement Dietary Beta-Cryptoxanthin A determination of the beta-cryptoxanthin in a nutritional product or meal, or a portion thereof. Dietary Beta-Cryptoxanthin Measurement Dietary Copper A determination of the total copper in a nutritional product or meal, or a portion thereof. Dietary Copper Measurement Dietary Total Dairy A determination of the total dairy (food products produced from or containing milk) in a nutritional product or meal, or a portion thereof. Dietary Dairy Measurement Dietary 22:6 Docosahexaenoate Dietary 22:6 Docosahexaenoic Acid Dietary Docosahexaenoic Acid A determination of the total 22:6 docosahexaenoic acid in a nutritional product or meal, or a portion thereof. Dietary Docosahexaenoic Acid Measurement Dietary Eggs A determination of the eggs in a nutritional product or meal, or a portion thereof. Dietary Eggs Measurement Dietary 22:1 Erucate Dietary 22:1 Erucic Acid Dietary Erucic Acid A determination of the total 22:1 erucic acid in a nutritional product or meal, or a portion thereof. Dietary Erucic Acid Measurement Number of Devices Present A determination of the number of devices within a subject. Number of Devices Present Dietary Fat, Monounsaturated A determination of the total monounsaturated fat in a nutritional product or meal, or a portion thereof. Dietary Monounsaturated Fat Measurement Dietary Fat, Polyunsaturated A determination of the total polyunsaturated fat in a nutritional product or meal, or a portion thereof. Dietary Polyunsaturated Fat Measurement Dietary Fat, Saturated A determination of the total saturated fat in a nutritional product or meal, or a portion thereof. Dietary Saturated Fat Measurement Dietary Fat, Total A determination of the total fat in a nutritional product or meal, or a portion thereof. Total Dietary Fat Measurement Dietary Iron A determination of the total iron in a nutritional product or meal, or a portion thereof. Dietary Iron Measurement DFE Dietary Folate Equivalents The sum of food folate and normalized folic acid (as food folate equivalents) in a nutritional product or meal, or a portion thereof. Dietary Folate Equivalents Measurement Dietary Fiber A determination of the total fiber in a nutritional product or meal, or a portion thereof. Dietary Fiber Measurement Dietary Food Folate A determination of the naturally occurring folate in a nutritional product or meal, or a portion thereof. Dietary Food Folate Measurement Dietary Folic Acid A determination of the folic acid in a nutritional product or meal, or a portion thereof. Dietary Folic Acid Measurement Dietary Total Folate A determination of the total folate (supplemental folic acid + food folate) in a nutritional product or meal, or a portion thereof. Dietary Total Folate Measurement Dietary Fruit Juice A determination of the fruit juice in a nutritional product or meal, or a portion thereof. Dietary Fruit Juice Measurement Dietary Fruit A determination of the total fruit in a nutritional product or meal, or a portion thereof. Dietary Fruit Measurement Dietary 20:1 Gadoleate Dietary 20:1 Gadoleic Acid Dietary Gadoleic Acid A determination of the total 20:1 gadoleic acid in a nutritional product or meal, or a portion thereof. Dietary Gadoleic Acid Measurement Dietary Grain A determination of the total grain in a nutritional product or meal, or a portion thereof. Dietary Grain Measurement Dietary Grain, Refined A determination of the total refined grains in a nutritional product or meal, or a portion thereof. Dietary Grain, Refined Measurement Dietary Whole Grains A determination of the whole grains in a nutritional product or meal, or a portion thereof. Dietary Whole Grains Measurement Diameter The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) Diameter Dispensed Amount The quantity of a product that has been dispensed. (NCI) Dispensed Amount Distance The actual or calculated span between two points (real or virtual). Distance Distribution A description of the arrangement or dissemination of a finding within an area of focus. Distribution Pattern Finding Description Dietary Potassium A determination of the total potassium in a nutritional product or meal, or a portion thereof. Dietary Potassium Measurement Dietary 12:0 Laurate Dietary 12:0 Lauric Acid Dietary Lauric Acid A determination of the total 12:0 lauric acid in a nutritional product or meal, or a portion thereof. Dietary Lauric Acid Measurement Dietary 18:2 Linoleate Dietary 18:2 Linoleic Acid Dietary Linoleic Acid A determination of the total 18:2 linoleic acid in a nutritional product or meal, or a portion thereof. Dietary Linoleic Acid Measurement Dietary 18:3 Linolenate Dietary 18:3 Linolenic Acid Dietary Linolenic Acid A determination of the total 18:3 linolenic acid in a nutritional product or meal, or a portion thereof. Dietary Linolenic Acid Measurement Dietary Lutein and Zeaxanthin A determination of the lutein and zeaxanthin in a nutritional product or meal, or a portion thereof. Dietary Lutein and Zeaxanthin Measurement Dietary Lycopene A determination of the lycopene in a nutritional product or meal, or a portion thereof. Dietary Lycopene Measurement Dietary Meat A determination of the total meat in a nutritional product or meal, or a portion thereof. Dietary Meat Measurement Dietary Meat, Cured A determination of the cured meat in a nutritional product or meal, or a portion thereof. Dietary Meat, Cured Measurement Dietary Meat, Organ A determination of the organ meat in a nutritional product or meal, or a portion thereof. Dietary Meat, Organ Measurement Dietary Meat, Poultry, and Seafood A determination of the total meat, poultry, and seafood in a nutritional product or meal, or a portion thereof. Dietary Meat, Poultry, and Seafood Measurement Dietary Magnesium A determination of the total magnesium in a nutritional product or meal, or a portion thereof. Dietary Magnesium Measurement Dietary Milk A determination of the milk in a nutritional product or meal, or a portion thereof. Dietary Milk Measurement Dietary Moisture A determination of the moisture content in a nutritional product or meal, or a portion thereof. Dietary Moisture Measurement Dietary 14:0 Myristate Dietary 14:0 Myristic Acid Dietary Myristic Acid A determination of the total 14:0 myristic acid in a nutritional product or meal, or a portion thereof. Dietary Myristic Acid Measurement Dietary Sodium A determination of the total sodium in a nutritional product or meal, or a portion thereof. Dietary Sodium Measurement Dietary Niacin Dietary Vitamin B3 A determination of the niacin in a nutritional product or meal, or a portion thereof. Dietary Niacin Measurement Dietary Nuts and Seeds A determination of the total nuts and seeds in a nutritional product or meal, or a portion thereof. Dietary Nuts and Seeds Measurement Dietary Oils A determination of the oils in a nutritional product or meal, or a portion thereof. Dietary Oils Measurement Dietary 18:1 Oleate Dietary 18:1 Oleic Acid Dietary Oleic Acid A determination of the total 18:1 oleic acid in a nutritional product or meal, or a portion thereof. Dietary Oleic Acid Measurement Dietary Phosphorus A determination of the phosphorus in a nutritional product or meal, or a portion thereof. Dietary Phosphorus Measurement Dietary 16:0 Palmitate Dietary 16:0 Palmitic Acid Dietary Palmitic Acid A determination of the total 16:0 palmitic acid in a nutritional product or meal, or a portion thereof. Dietary Palmitic Acid Measurement Dietary 16:1 Palmitoleate Dietary 16:1 Palmitoleic Acid Dietary Palmitoleic Acid A determination of the total 16:1 palmitoleic acid in a nutritional product or meal, or a portion thereof. Dietary Palmitoleic Acid Measurement Dietary 18:4 Parinarate Dietary 18:4 Parinaric Acid Dietary Parinaric Acid A determination of the total 18:4 parinaric acid in a nutritional product or meal, or a portion thereof. Dietary Parinaric Acid Measurement Dietary Potatoes A determination of the potatoes in a nutritional product or meal, or a portion thereof. Dietary Potatoes Measurement Dietary Poultry A determination of the poultry in a nutritional product or meal, or a portion thereof. Dietary Poultry Measurement Dietary Protein A determination of the total protein in a nutritional product or meal, or a portion thereof. Dietary Protein Measurement Dietary Protein Foods A determination of the protein-rich food in a nutritional product or meal, or a portion thereof. Dietary Protein Foods Measurement Dietary Retinol Dietary Vitamin A A determination of the retinol in a nutritional product or meal, or a portion thereof. Dietary Retinol Measurement Dietary Riboflavin Dietary Vitamin B2 A determination of the riboflavin in a nutritional product or meal, or a portion thereof. Dietary Riboflavin Measurement Drug Resistance Status The state or condition of not responding to a pharmacological agent. Drug Resistance Status Dietary Selenium A determination of the total selenium in a nutritional product or meal, or a portion thereof. Dietary Selenium Measurement Dietary Seafood High in n-3 Fatty Acids A determination of the seafood high in n-3 fatty acids in a nutritional product or meal, or a portion thereof. Dietary Seafood High in n-3 Fatty Acids Measurement Dietary Seafood Low in n-3 Fatty Acids A determination of the seafood low in n-3 fatty acids in a nutritional product or meal, or a portion thereof. Dietary Seafood Low in n-3 Fatty Acids Measurement Dietary Solid Fats A determination of the solid fats in a nutritional product or meal, or a portion thereof. Dietary Solid Fats Measurement Dietary Soy Products A determination of the soy-containing products in a nutritional product or meal, or a portion thereof. Dietary Soy Products Measurement Disease Stage A characterization or classification of disease progression based on clinical measures of severity, etiology, and pathophysiology. Disease Stage Qualifier Dietary 18:0 Stearate Dietary 18:0 Stearic Acid Dietary Stearic Acid A determination of the total 18:0 stearic acid in a nutritional product or meal, or a portion thereof. Dietary Stearic Acid Measurement Dietary Total Sugars A determination of the total sugars in a nutritional product or meal, or a portion thereof. Dietary Sugar Measurement Dietary Theobromine A determination of the theobromine in a nutritional product or meal, or a portion thereof. Dietary Theobromine Measurement Dietary Thiamin Dietary Thiamine Dietary Vitamin B1 A determination of the thiamine in a nutritional product or meal, or a portion thereof. Dietary Thiamine Measurement Dietary 20:5 Timnodonate Dietary 20:5 Timnodonic Acid Dietary Timnodonic Acid A determination of the total 20:5 timnodonic acid in a nutritional product or meal, or a portion thereof. Dietary Timnodonic Acid Measurement Dietary Tomatoes A determination of the tomatoes in a nutritional product or meal, or a portion thereof. Dietary Tomatoes Measurement Number of Devices Inserted The number of devices inserted into an individual. Number of Devices Inserted Dietary Vegetable A determination of the total vegetables in a nutritional product or meal, or a portion thereof. Dietary Vegetable Measurement Dietary Vegetables, Dark Green A determination of the total dark green vegetables in a nutritional product or meal, or a portion thereof. Dietary Vegetables, Dark Green Measurement Dietary Vegetables, Red and Orange A determination of the total red and orange vegetables in a nutritional product or meal, or a portion thereof. Dietary Vegetables, Red and Orange Measurement Dietary Vegetables, Starchy A determination of the total starchy vegetables in a nutritional product or meal, or a portion thereof. Dietary Vegetables, Starchy Measurement Dietary Vitamin A A determination of the total vitamin A in a nutritional product or meal, or a portion thereof. Dietary Vitamin A Measurement Dietary Vitamin B12 A determination of the total vitamin B12 in a nutritional product or meal, or a portion thereof. Dietary Vitamin B12 Measurement Dietary Vitamin B6 A determination of the total vitamin B6 in a nutritional product or meal, or a portion thereof. Dietary Vitamin B6 Measurement Dietary Vitamin C A determination of the total vitamin C in a nutritional product or meal, or a portion thereof. Dietary Vitamin C Measurement Dietary Vitamin D A determination of the total vitamin D in a nutritional product or meal, or a portion thereof. Dietary Vitamin D Measurement Dietary Vitamin K A determination of the total vitamin K in a nutritional product or meal, or a portion thereof. Dietary Vitamin K Measurement Diagnostic Criteria Met A description of the diagnostic criteria that the subject fulfilled in order to establish a medical diagnosis. Which Diagnostic Criteria Met Dietary Yogurt A determination of the yogurt in a nutritional product or meal, or a portion thereof. Dietary Yogurt Measurement Dietary Zinc A determination of the total Zinc in a nutritional product or meal, or a portion thereof. Dietary Zinc Measurement Endpoint Event Indicator An indication as to whether the event meets the criteria for being a clinical endpoint. Endpoint Event Indicator Number of Mild Episodes The number of times an event, which is classified as mild, occurred. Number of Mild Episodes Number of Moderate Episodes The number of times an event, which is classified as moderate, occurred. Number of Moderate Episodes Number of Episodes The total number of episodes that have occurred for the condition. Number of Episodes Number of Severe Episodes The number of times an event, which is classified as severe, occurred. Number of Severe Episodes Estimated Entity Weight Estimated Weight An approximate determination of the weight of the entity. Estimated Weight Event Frequency The number of times an event occurs within a given time period. Temporal Frequency Number of Events The total number of events that have occurred. Number of Events Event Related to Incr Phys Activity Ind Event Related to Increased Physical Activity Indicator An indication as to whether the event of interest is related to increased physical activity. Event Related to Increased Physical Activity Indicator Exercise Duration The length of time an individual spends exercising. Exercise Duration Exercise Intensity A determination or assessment of the degree or magnitude of an individual's exertion during physical activity. Exercise Intensity Exercise Compliance A determination or assessment of the extent to which an individual adheres to a fitness program. Exercise Compliance Expected Efficacious Treatment Reg Ind Expected Efficacious Treatment Regimen Indicator An indication as to whether the subject has been on a treatment regimen which, based on defined criteria, is expected to be efficacious. Expected Efficacious Treatment Regimen Indicator Extent of Resection A description of the relative amount of tissue, blood vessel, or organ that has been removed. Extent of Resection Fistula Anatomical Type A classification based on the anatomical location(s) of the fistula. Fistula Anatomical Site Number of Fistulas The number of fistulas observed. Number of Fistulas Flare Size The size of the area of redness that forms around the site of an antigenic challenge to the skin. Antigenic Skin Flare Size Measurement Flare Longest Diameter The longest diameter of the area of redness that forms at the site of an antigenic skin response. Antigenic Skin Flare Longest Diameter Measurement Flare Mean Diameter The mean diameter of the area of redness that forms around the site of an antigenic challenge to the skin. Antigenic Skin Flare Mean Diameter Measurement Final Dose Amount A determination of the final amount of a substance taken as a dose by a subject. Final Dose Amount Frequency of Final Dose Amount A determination of how often a subject takes a substance at the final dose amount. Frequency of Final Dose Amount Greatest Circ at Point of Interest Greatest Circumference at Point of Interest Largest Circumference at Point of Interest The circumferential measurement of an entity or object of interest at its widest point. Greatest Circumference at Point of Interest Healthcare Encounter Type Categorization of the type of healthcare encounter. Healthcare Encounter Type Heart Failure New/Worsening Lab Findings Categorization of the type(s) of new and/or worsening laboratory findings of heart failure present at the time of patient presentation. Lab Findings of New or Worsening Heart Failure Heart Failure New/Worsening PE Findings Categorization of the type(s) of new and/or worsening physical exam findings of heart failure present at the time of patient presentation. Physical Examination Findings of New or Worsening Heart Failure Heart Failure Therapy, Intensification Categorization of the type(s) of new and/or intensified treatment administered for heart failure management. Heart Failure Therapy Intensification Type Number Of Hospitalizations The total number of hospitalization events that have occurred for the condition. Number of Hospitalizations Ileocecal Junction Removed Indicator An indication as to whether the ileocecal junction was removed. Ileocecal Junction Removed Indicator Induration Longest Diameter The longest diameter of an area of hardness in the skin. (NCI) Induration Longest Diameter Interpretation An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. Interpretation Ischemic Discomfort Indicator An indicator as to whether the subject has symptoms of ischemic discomfort. Ischemic Discomfort Indicator Ischemic Evidence Type Categorization of the type of objective evidence of new or worsening ischemia. Ischemic Evidence Type Number of Laps Completed The number of laps completed around a course or circuit. Number of Laps Completed Longest Diameter The longest possible length of a straight line passing through the center of a circular or spheroid object that connects two points on the circumference. Longest Diameter Length of Resection A measurement of the total length of the removed tissue, blood vessel, or organ. Length of Resection Number of Lesions The number of lesions observed. Number of Lesions Localization of Onset The anatomical location of the beginning or early stages of a disease. Location of Disease Onset Longitudinal Course A description of the series of events, including signs and symptoms, that define the course of a chronic disease over time. Clinical Course of Disease Exclusion of Type 1 and Type 2 MI An indication of whether a Type 1 and Type 2 myocardial infarction is excluded as a diagnosis. Exclusion of Type 1 and Type 2 Myocardial Infarction Diagnosis Indicator Maximum Dose Amount A determination of the maximum amount of a substance taken as a dose by a subject. Maximum Dose Amount Frequency of Maximum Dose Amount A determination of how often a subject takes a substance at the maximum dose amount. Frequency of Maximum Dose Amount Needle Gauge A number representing the outer diameter of a needle. (NCI) Needle Gauge Nearest Joint The anatomical joint in closest proximity to the entity or object of interest. Nearest Joint Non-Invasive Imaging Change A description of the clinical change to the subject after a non-invasive imaging procedure. Clinical Change by Non-Invasive Imaging Procedure New or Worsening Symptoms A description of the new or worsening symptoms related to a clinical event. New or Worsening Symptom Number of Objects The number of objects observed. Number of Objects Type of Object The type of object observed. Type of Object Occurrence Indicator An indication as to whether something has happened, such as an event or incident. Occurrence Indicator Origin of Cancer Known Ind Origin of Cancer Known Indicator An indication as to whether the primary site of cancer is known. Cancer Primary Site Known Indicator Focus of Onset Onset Unifocal or Multifocal A characterization of the focality of the lesion at the time of disease diagnosis. Focality of Disease Onset PCI Acute Angiographic Complication Categorization of the type of acute PCI angiographic complication resulting in acute myocardial ischemia. Acute Myocardial Infarction From PCI Complication Type Prevents Daily Activities Indicator An indication as to whether the event or intervention prevents or has prevented the performance of daily activities. Prevents Daily Activities Indicator Largest Diameter of Primary Lesion Longest Diameter of Primary Lesion The longest diameter of the lesion that has been determined to be the primary lesion. Longest Diameter of Primary Lesion Anatomical Location of Primary Lesion The anatomical location of the lesion that has been determined to be the primary lesion. Anatomical Location of Primary Lesion Precipitating Factor The factor that causes or triggers the onset of an occurrence. Precipitating Factor Prepared Amount The quantity of a product that has been made ready for use. Prepared Amount Number of Procedures Performed The number of procedures performed on or in an individual. Number of Procedures Performed Procedure Success Indicator An indication as to whether the procedure is considered successful. Procedure Success Indicator Pruritus Indicator An indicator as to whether the subject has symptoms of itchiness. Pruritus Indicator Procedure Urgency Status Type The degree of urgency in which a medical procedure must be performed. Triage Status Primary Site of Tumor Origin The anatomical location of the primary tumor site of disease. Primary Tumor Site QOL Impact Quality of Life Impact The effect or consequence of an event or condition on an individual's sense of well-being and ability to enjoy life. Quality of Life Impact Reaction Grade The position on a scale to assess the degree of the response to a stimulus or intervention. Reaction Grade Remaining Amount The quantity of a product that remains after dosing, consumption, or use. Remaining Amount Resected Tumor Ind Resected Tumor Indicator An indication as to whether the tumor has been resected. Tumor Resected Indicator Returned Amount The quantity of a product that has been returned. (NCI) Returned Amount Relapse after Discon Dependent Indicator Relapse after Discontinue Dependent Indicator An indication as to whether an individual has had a relapse after discontinuation of a substance due to dependence. Relapse after Discontinuation Because of Dependence Indicator Relationship to Device An assessment of the likelihood that the device was the cause of the event. Relationship to Device Substance Dependence Indicator An indication as to whether an individual has become dependent on a substance. Substance Dependence Indicator Severity/Intensity The degree of something undesirable. Severity Speed A scalar measure of the rate of movement of the object expressed as the distance traveled divided by the elapsed time. Speed Sign/Symptom Leading to Discontinuation The signs and/or symptoms that result in the discontinuation of treatment or intervention. Sign or Symptom Leading to Discontinuation Stent Thrombosis, Coronary, ARC Timing Categorization of the timing of coronary stent thrombosis occurrence per the classification schema described by the Academic Research Consortium (ARC). Academic Research Council Coronary Stent Thrombosis Timing Number of Steps Taken The number of footsteps taken by an individual. Number of Steps Taken Number of Strictures The number of anatomical strictures observed. Number of Strictures Stroke Type Categorization of the type of stroke. Stroke Type Symptom Indicator An indication as to whether the subject had symptoms related to the clinical event. Symptom Indicator Symptom Onset Date The date time of the onset of symptoms of the clinical event. Symptom Onset Date Total Number A measurement of the total number of entities. Total Number Toxicity Grade A standardized categorical classification of the severity of an event or finding. Toxicity Grade Unable to Taper Dependent Indicator An indication as to whether an individual is incapable of reducing or tapering the amount of a substance taken due to dependence. Unable to Taper Dependent Indicator Treatment Environmental Setting Treatment Setting The surroundings or environment within which the subject receives therapeutic treatment for the condition. Treatment Environmental Setting Total Time Paused The total amount of time during which an event, operation or activity has been interrupted or stopped. Total Time Paused Total Time Physically Active The total amount of time during which an individual was actively engaged in physical activity. Total Time Physically Active Vessel Occlusion After CABG 48 Ind An indication as to whether vessel occlusion, in the native or bypass graft, occurred within 48 hours after the coronary artery bypass graft procedure. Vessel Occlusion 48 Hours after CABG Indicator Volume A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. Volume Measurement Wheal Size A semi-quantitative size assessment of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin. Wheal Size Measurement Wheal Diameter Interpretation The process of evaluating the wheal diameter in response to an allergen, based on a threshold size. Wheal Diameter Interpretation Wheal Longest Diameter The longest diameter of the flat, circular, slightly raised area that forms at the site of an antigenic skin response. Wheal Longest Diameter Wheal Mean Diameter The mean diameter of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin. Wheal Mean Diameter FATESTCD Findings About Test Code CDISC SDTM Findings About Test Code Terminology Terminology relevant to the test names that describe findings about an event or intervention. Action Taken With Device An action taken with a device as the result of the event. Action Taken with Device Action Taken With Subject Action taken with respect to a subject in a study. Action Taken With Subject Acute Myocardial Infarction Type Categorization of the type of acute myocardial infarction. Acute Myocardial Infarction Type AE Improve/Resolve with Dechallenge Ind AE Improve/Resolve with Dechallenge Indicator An indication as to whether an adverse event improves or disappears after stopping a study treatment. Positive Dechallenge Reaction Indicator AE Reappear/Worsen with Rechallenge Ind AE Reappear/Worsen with Rechallenge Indicator An indication as to whether an adverse event reappears or worsens after restarting a study treatment. Positive Rechallenge Indicator Age At Disease Onset The age at which disease began or were first noted. Age At Disease Onset Age At First Episode The age at which the first episode occurred. Age at First Episode Age At First Hospitalization The age at which the first hospitalization event occurred. Age at First Hospitalization Age At First Treatment The age at which the first treatment for the condition occurred. Age at First Treatment Age at Full-Time Use The age at which the full-time use of a pre-specified object first occurred. Age at Full-Time Use Age Symptoms Started The age at which illness-specific symptoms first began. Age Symptom Started Allergen Skin Response Index A relative measurement (ratio or percentage) of the allergen wheal size to the positive control wheal size in an allergen skin test. Allergen Skin Response Index Measurement Allergen Skin Response Intensity A semi-quantitative assessment of the intensity of the wheal and flare reaction. Allergen Skin Response Intensity Measurement Anatomical Location of Primary Lesion The anatomical location of the lesion that has been determined to be the primary lesion. Anatomical Location of Primary Lesion Aper Appearance The outward or visible aspect of an entity. Appearance Biopsy Specimen Taken Indicator An indication as to whether a biopsy specimen was collected. Biopsy Specimen Taken Indicator Blistering Indicator An indication as to whether blistering occurred. Blistering Indicator Calories Burned A measurement of the number of calories expended. Calories Burned Clinic Stay Indicator An indication as to whether the subject was admitted to a healthcare clinic. Clinic Stay Indicator Clinical Status of Disease A characterization of the state of a subject's disease or condition, as evaluated by a clinician or other healthcare provider. Clinical Status Contrast Enhancement Phase The phase of the contrast agent distribution within the body after its administration. Contrast Agent Enhancement Phase Coronary Artery Thrombosis Method Ident The method by which the coronary artery thrombosis event is determined or diagnosed. Coronary Artery Thrombosis Method of Identification Cumulative Exposure The total amount that a subject is exposed to over time. Cumulative Exposure Diagnostic Criteria Met A description of the diagnostic criteria that the subject fulfilled in order to establish a medical diagnosis. Which Diagnostic Criteria Met Diameter The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) Diameter Dietary Added Sugar A determination of the total added sugars in a nutritional product or meal, or a portion thereof. Dietary Added Sugar Measurement Dietary Added Vitamin B12 A determination of the total added vitamin B12 in a nutritional product or meal, or a portion thereof. Dietary Added Vitamin B12 Measurement Dietary Added Vitamin E A determination of the total added vitamin E in a nutritional product or meal, or a portion thereof. Dietary Added Vitamin E Measurement Dietary Alcohol Dietary Ethanol A determination of the total amount of alcohol in a nutritional product or meal, or a portion thereof. Dietary Alcohol Measurement Dietary Alpha Carotene A determination of the alpha carotene in a nutritional product or meal, or a portion thereof. Dietary Alpha Carotene Measurement Dietary Alpha Tocopherol A determination of the alpha tocopherol in a nutritional product or meal, or a portion thereof. Dietary Alpha Tocopherol Measurement Dietary 20:4 Arachidonate Dietary 20:4 Arachidonic Acid Dietary Arachidonic Acid A determination of the total 20:4 arachidonic acid in a nutritional product or meal, or a portion thereof. Dietary Arachidonic Acid Measurement Dietary Beans and Peas A determination of the total beans and peas in a nutritional product or meal, or a portion thereof. Dietary Beans and Peas Measurement Dietary Beta Carotene A determination of the beta carotene in a nutritional product or meal, or a portion thereof. Dietary Beta Carotene Measurement Dietary Beta-Cryptoxanthin A determination of the beta-cryptoxanthin in a nutritional product or meal, or a portion thereof. Dietary Beta-Cryptoxanthin Measurement Dietary 4:0 Butyrate Dietary 4:0 Butyric Acid Dietary Butyric Acid A determination of the total 4:0 butyric acid in a nutritional product or meal, or a portion thereof. Dietary Butyric Acid Measurement Dietary Caffeine A determination of the caffeine in a nutritional product or meal, or a portion thereof. Dietary Caffeine Measurement Dietary Calcium A determination of the total calcium in a nutritional product or meal, or a portion thereof. Dietary Calcium Measurement Dietary Calories A determination of the total dietary calories in a nutritional product or meal, or a portion thereof. Dietary Calories Measurement Dietary 10:0 Caprate Dietary 10:0 Capric Acid Dietary Capric Acid A determination of the total 10:0 capric acid in a nutritional product or meal, or a portion thereof. Dietary Capric Acid Measurement Dietary 6:0 Caproate Dietary 6:0 Caproic Acid Dietary Caproic Acid A determination of the total 6:0 caproic acid in a nutritional product or meal, or a portion thereof. Dietary Caproic Acid Measurement Dietary 8:0 Caprylate Dietary 8:0 Caprylic Acid Dietary Caprylic Acid A determination of the total 8:0 caprylic acid in a nutritional product or meal, or a portion thereof. Dietary Caprylic Acid Measurement Dietary Cheese A determination of the total cheese in a nutritional product or meal, or a portion thereof. Dietary Cheese Measurement Dietary Cholesterol A determination of the total cholesterol in a nutritional product or meal, or a portion thereof. Dietary Cholesterol Measurement Dietary Choline A determination of the choline in a nutritional product or meal, or a portion thereof. Dietary Choline Measurement Dietary Citrus, Melons, and Berries A determination of the total citrus, melons, and berries in a nutritional product or meal, or a portion thereof. Dietary Citrus, Melons, and Berries Measurement Dietary 22:5 Clupanodonate Dietary 22:5 Clupanodonic Acid Dietary Clupanodonic Acid A determination of the total 22:5 clupanodonic acid in a nutritional product or meal, or a portion thereof. Dietary Clupanodonic Acid Measurement Dietary Copper A determination of the total copper in a nutritional product or meal, or a portion thereof. Dietary Copper Measurement Dietary 22:6 Docosahexaenoate Dietary 22:6 Docosahexaenoic Acid Dietary Docosahexaenoic Acid A determination of the total 22:6 docosahexaenoic acid in a nutritional product or meal, or a portion thereof. Dietary Docosahexaenoic Acid Measurement Dietary Eggs A determination of the eggs in a nutritional product or meal, or a portion thereof. Dietary Eggs Measurement Dietary 22:1 Erucate Dietary 22:1 Erucic Acid Dietary Erucic Acid A determination of the total 22:1 erucic acid in a nutritional product or meal, or a portion thereof. Dietary Erucic Acid Measurement Dietary Fat, Monounsaturated A determination of the total monounsaturated fat in a nutritional product or meal, or a portion thereof. Dietary Monounsaturated Fat Measurement Dietary Fat, Polyunsaturated A determination of the total polyunsaturated fat in a nutritional product or meal, or a portion thereof. Dietary Polyunsaturated Fat Measurement Dietary Fat, Saturated A determination of the total saturated fat in a nutritional product or meal, or a portion thereof. Dietary Saturated Fat Measurement Dietary Fat, Total A determination of the total fat in a nutritional product or meal, or a portion thereof. Total Dietary Fat Measurement Dietary Fiber A determination of the total fiber in a nutritional product or meal, or a portion thereof. Dietary Fiber Measurement DFE Dietary Folate Equivalents The sum of food folate and normalized folic acid (as food folate equivalents) in a nutritional product or meal, or a portion thereof. Dietary Folate Equivalents Measurement Dietary Folic Acid A determination of the folic acid in a nutritional product or meal, or a portion thereof. Dietary Folic Acid Measurement Dietary Food Folate A determination of the naturally occurring folate in a nutritional product or meal, or a portion thereof. Dietary Food Folate Measurement Dietary Fruit Juice A determination of the fruit juice in a nutritional product or meal, or a portion thereof. Dietary Fruit Juice Measurement Dietary Fruit A determination of the total fruit in a nutritional product or meal, or a portion thereof. Dietary Fruit Measurement Dietary 20:1 Gadoleate Dietary 20:1 Gadoleic Acid Dietary Gadoleic Acid A determination of the total 20:1 gadoleic acid in a nutritional product or meal, or a portion thereof. Dietary Gadoleic Acid Measurement Dietary Grain A determination of the total grain in a nutritional product or meal, or a portion thereof. Dietary Grain Measurement Dietary Grain, Refined A determination of the total refined grains in a nutritional product or meal, or a portion thereof. Dietary Grain, Refined Measurement Dietary Iron A determination of the total iron in a nutritional product or meal, or a portion thereof. Dietary Iron Measurement Dietary 12:0 Laurate Dietary 12:0 Lauric Acid Dietary Lauric Acid A determination of the total 12:0 lauric acid in a nutritional product or meal, or a portion thereof. Dietary Lauric Acid Measurement Dietary 18:2 Linoleate Dietary 18:2 Linoleic Acid Dietary Linoleic Acid A determination of the total 18:2 linoleic acid in a nutritional product or meal, or a portion thereof. Dietary Linoleic Acid Measurement Dietary 18:3 Linolenate Dietary 18:3 Linolenic Acid Dietary Linolenic Acid A determination of the total 18:3 linolenic acid in a nutritional product or meal, or a portion thereof. Dietary Linolenic Acid Measurement Dietary Lutein and Zeaxanthin A determination of the lutein and zeaxanthin in a nutritional product or meal, or a portion thereof. Dietary Lutein and Zeaxanthin Measurement Dietary Lycopene A determination of the lycopene in a nutritional product or meal, or a portion thereof. Dietary Lycopene Measurement Dietary Magnesium A determination of the total magnesium in a nutritional product or meal, or a portion thereof. Dietary Magnesium Measurement Dietary Meat A determination of the total meat in a nutritional product or meal, or a portion thereof. Dietary Meat Measurement Dietary Meat, Cured A determination of the cured meat in a nutritional product or meal, or a portion thereof. Dietary Meat, Cured Measurement Dietary Meat, Organ A determination of the organ meat in a nutritional product or meal, or a portion thereof. Dietary Meat, Organ Measurement Dietary Meat, Poultry, and Seafood A determination of the total meat, poultry, and seafood in a nutritional product or meal, or a portion thereof. Dietary Meat, Poultry, and Seafood Measurement Dietary Milk A determination of the milk in a nutritional product or meal, or a portion thereof. Dietary Milk Measurement Dietary Moisture A determination of the moisture content in a nutritional product or meal, or a portion thereof. Dietary Moisture Measurement Dietary 14:0 Myristate Dietary 14:0 Myristic Acid Dietary Myristic Acid A determination of the total 14:0 myristic acid in a nutritional product or meal, or a portion thereof. Dietary Myristic Acid Measurement Dietary Niacin Dietary Vitamin B3 A determination of the niacin in a nutritional product or meal, or a portion thereof. Dietary Niacin Measurement Dietary Nuts and Seeds A determination of the total nuts and seeds in a nutritional product or meal, or a portion thereof. Dietary Nuts and Seeds Measurement Dietary Oils A determination of the oils in a nutritional product or meal, or a portion thereof. Dietary Oils Measurement Dietary 18:1 Oleate Dietary 18:1 Oleic Acid Dietary Oleic Acid A determination of the total 18:1 oleic acid in a nutritional product or meal, or a portion thereof. Dietary Oleic Acid Measurement Dietary 16:0 Palmitate Dietary 16:0 Palmitic Acid Dietary Palmitic Acid A determination of the total 16:0 palmitic acid in a nutritional product or meal, or a portion thereof. Dietary Palmitic Acid Measurement Dietary 16:1 Palmitoleate Dietary 16:1 Palmitoleic Acid Dietary Palmitoleic Acid A determination of the total 16:1 palmitoleic acid in a nutritional product or meal, or a portion thereof. Dietary Palmitoleic Acid Measurement Dietary 18:4 Parinarate Dietary 18:4 Parinaric Acid Dietary Parinaric Acid A determination of the total 18:4 parinaric acid in a nutritional product or meal, or a portion thereof. Dietary Parinaric Acid Measurement Dietary Phosphorus A determination of the phosphorus in a nutritional product or meal, or a portion thereof. Dietary Phosphorus Measurement Dietary Potassium A determination of the total potassium in a nutritional product or meal, or a portion thereof. Dietary Potassium Measurement Dietary Potatoes A determination of the potatoes in a nutritional product or meal, or a portion thereof. Dietary Potatoes Measurement Dietary Poultry A determination of the poultry in a nutritional product or meal, or a portion thereof. Dietary Poultry Measurement Dietary Protein Foods A determination of the protein-rich food in a nutritional product or meal, or a portion thereof. Dietary Protein Foods Measurement Dietary Protein A determination of the total protein in a nutritional product or meal, or a portion thereof. Dietary Protein Measurement Dietary Retinol Dietary Vitamin A A determination of the retinol in a nutritional product or meal, or a portion thereof. Dietary Retinol Measurement Dietary Riboflavin Dietary Vitamin B2 A determination of the riboflavin in a nutritional product or meal, or a portion thereof. Dietary Riboflavin Measurement Dietary Seafood High in n-3 Fatty Acids A determination of the seafood high in n-3 fatty acids in a nutritional product or meal, or a portion thereof. Dietary Seafood High in n-3 Fatty Acids Measurement Dietary Seafood Low in n-3 Fatty Acids A determination of the seafood low in n-3 fatty acids in a nutritional product or meal, or a portion thereof. Dietary Seafood Low in n-3 Fatty Acids Measurement Dietary Selenium A determination of the total selenium in a nutritional product or meal, or a portion thereof. Dietary Selenium Measurement Dietary Sodium A determination of the total sodium in a nutritional product or meal, or a portion thereof. Dietary Sodium Measurement Dietary Solid Fats A determination of the solid fats in a nutritional product or meal, or a portion thereof. Dietary Solid Fats Measurement Dietary Soy Products A determination of the soy-containing products in a nutritional product or meal, or a portion thereof. Dietary Soy Products Measurement Dietary 18:0 Stearate Dietary 18:0 Stearic Acid Dietary Stearic Acid A determination of the total 18:0 stearic acid in a nutritional product or meal, or a portion thereof. Dietary Stearic Acid Measurement Dietary Theobromine A determination of the theobromine in a nutritional product or meal, or a portion thereof. Dietary Theobromine Measurement Dietary Thiamin Dietary Thiamine Dietary Vitamin B1 A determination of the thiamine in a nutritional product or meal, or a portion thereof. Dietary Thiamine Measurement Dietary 20:5 Timnodonate Dietary 20:5 Timnodonic Acid Dietary Timnodonic Acid A determination of the total 20:5 timnodonic acid in a nutritional product or meal, or a portion thereof. Dietary Timnodonic Acid Measurement Dietary Tomatoes A determination of the tomatoes in a nutritional product or meal, or a portion thereof. Dietary Tomatoes Measurement Dietary Total Carbohydrate A determination of the total carbohydrate in a nutritional product or meal, or a portion thereof. Total Dietary Carbohydrate Measurement Dietary Total Dairy A determination of the total dairy (food products produced from or containing milk) in a nutritional product or meal, or a portion thereof. Dietary Dairy Measurement Dietary Total Folate A determination of the total folate (supplemental folic acid + food folate) in a nutritional product or meal, or a portion thereof. Dietary Total Folate Measurement Dietary Total Sugars A determination of the total sugars in a nutritional product or meal, or a portion thereof. Dietary Sugar Measurement Dietary Vegetable A determination of the total vegetables in a nutritional product or meal, or a portion thereof. Dietary Vegetable Measurement Dietary Vegetables, Dark Green A determination of the total dark green vegetables in a nutritional product or meal, or a portion thereof. Dietary Vegetables, Dark Green Measurement Dietary Vegetables, Red and Orange A determination of the total red and orange vegetables in a nutritional product or meal, or a portion thereof. Dietary Vegetables, Red and Orange Measurement Dietary Vegetables, Starchy A determination of the total starchy vegetables in a nutritional product or meal, or a portion thereof. Dietary Vegetables, Starchy Measurement Dietary Vitamin A A determination of the total vitamin A in a nutritional product or meal, or a portion thereof. Dietary Vitamin A Measurement Dietary Vitamin B12 A determination of the total vitamin B12 in a nutritional product or meal, or a portion thereof. Dietary Vitamin B12 Measurement Dietary Vitamin B6 A determination of the total vitamin B6 in a nutritional product or meal, or a portion thereof. Dietary Vitamin B6 Measurement Dietary Vitamin C A determination of the total vitamin C in a nutritional product or meal, or a portion thereof. Dietary Vitamin C Measurement Dietary Vitamin D A determination of the total vitamin D in a nutritional product or meal, or a portion thereof. Dietary Vitamin D Measurement Dietary Vitamin K A determination of the total vitamin K in a nutritional product or meal, or a portion thereof. Dietary Vitamin K Measurement Dietary Whole Grains A determination of the whole grains in a nutritional product or meal, or a portion thereof. Dietary Whole Grains Measurement Dietary Yogurt A determination of the yogurt in a nutritional product or meal, or a portion thereof. Dietary Yogurt Measurement Dietary Zinc A determination of the total Zinc in a nutritional product or meal, or a portion thereof. Dietary Zinc Measurement Disease Stage A characterization or classification of disease progression based on clinical measures of severity, etiology, and pathophysiology. Disease Stage Qualifier Dispensed Amount The quantity of a product that has been dispensed. (NCI) Dispensed Amount Distance The actual or calculated span between two points (real or virtual). Distance Distribution A description of the arrangement or dissemination of a finding within an area of focus. Distribution Pattern Finding Description Drug Resistance Status The state or condition of not responding to a pharmacological agent. Drug Resistance Status Endpoint Event Indicator An indication as to whether the event meets the criteria for being a clinical endpoint. Endpoint Event Indicator Estimated Entity Weight Estimated Weight An approximate determination of the weight of the entity. Estimated Weight Event Frequency The number of times an event occurs within a given time period. Temporal Frequency Event Related to Incr Phys Activity Ind Event Related to Increased Physical Activity Indicator An indication as to whether the event of interest is related to increased physical activity. Event Related to Increased Physical Activity Indicator Exclusion of Type 1 and Type 2 MI An indication of whether a Type 1 and Type 2 myocardial infarction is excluded as a diagnosis. Exclusion of Type 1 and Type 2 Myocardial Infarction Diagnosis Indicator Exercise Compliance A determination or assessment of the extent to which an individual adheres to a fitness program. Exercise Compliance Exercise Duration The length of time an individual spends exercising. Exercise Duration Exercise Intensity A determination or assessment of the degree or magnitude of an individual's exertion during physical activity. Exercise Intensity Expected Efficacious Treatment Reg Ind Expected Efficacious Treatment Regimen Indicator An indication as to whether the subject has been on a treatment regimen which, based on defined criteria, is expected to be efficacious. Expected Efficacious Treatment Regimen Indicator Extent of Resection A description of the relative amount of tissue, blood vessel, or organ that has been removed. Extent of Resection Final Dose Amount A determination of the final amount of a substance taken as a dose by a subject. Final Dose Amount Fistula Anatomical Type A classification based on the anatomical location(s) of the fistula. Fistula Anatomical Site Flare Longest Diameter The longest diameter of the area of redness that forms at the site of an antigenic skin response. Antigenic Skin Flare Longest Diameter Measurement Flare Mean Diameter The mean diameter of the area of redness that forms around the site of an antigenic challenge to the skin. Antigenic Skin Flare Mean Diameter Measurement Flare Size The size of the area of redness that forms around the site of an antigenic challenge to the skin. Antigenic Skin Flare Size Measurement Frequency of Final Dose Amount A determination of how often a subject takes a substance at the final dose amount. Frequency of Final Dose Amount Frequency of Maximum Dose Amount A determination of how often a subject takes a substance at the maximum dose amount. Frequency of Maximum Dose Amount Greatest Circ at Point of Interest Greatest Circumference at Point of Interest Largest Circumference at Point of Interest The circumferential measurement of an entity or object of interest at its widest point. Greatest Circumference at Point of Interest Healthcare Encounter Type Categorization of the type of healthcare encounter. Healthcare Encounter Type Heart Failure New/Worsening Lab Findings Categorization of the type(s) of new and/or worsening laboratory findings of heart failure present at the time of patient presentation. Lab Findings of New or Worsening Heart Failure Heart Failure New/Worsening PE Findings Categorization of the type(s) of new and/or worsening physical exam findings of heart failure present at the time of patient presentation. Physical Examination Findings of New or Worsening Heart Failure Heart Failure Therapy, Intensification Categorization of the type(s) of new and/or intensified treatment administered for heart failure management. Heart Failure Therapy Intensification Type Ileocecal Junction Removed Indicator An indication as to whether the ileocecal junction was removed. Ileocecal Junction Removed Indicator Induration Longest Diameter The longest diameter of an area of hardness in the skin. (NCI) Induration Longest Diameter Interpretation An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. Interpretation Ischemic Discomfort Indicator An indicator as to whether the subject has symptoms of ischemic discomfort. Ischemic Discomfort Indicator Ischemic Evidence Type Categorization of the type of objective evidence of new or worsening ischemia. Ischemic Evidence Type Length of Resection A measurement of the total length of the removed tissue, blood vessel, or organ. Length of Resection Localization of Onset The anatomical location of the beginning or early stages of a disease. Location of Disease Onset Largest Diameter of Primary Lesion Longest Diameter of Primary Lesion The longest diameter of the lesion that has been determined to be the primary lesion. Longest Diameter of Primary Lesion Longest Diameter The longest possible length of a straight line passing through the center of a circular or spheroid object that connects two points on the circumference. Longest Diameter Longitudinal Course A description of the series of events, including signs and symptoms, that define the course of a chronic disease over time. Clinical Course of Disease Maximum Dose Amount A determination of the maximum amount of a substance taken as a dose by a subject. Maximum Dose Amount Most Severe Acute Stressor The agent, stimulus, activity, or event that causes stress with an acute frequency, which has the highest level of severity. Most Severe Acute Stressor Most Severe Chronic Stressor The agent, stimulus, activity, or event that causes stress with a chronic frequency, which has the highest level of severity. Most Severe Chronic Stressor Nearest Joint The anatomical joint in closest proximity to the entity or object of interest. Nearest Joint Needle Gauge A number representing the outer diameter of a needle. (NCI) Needle Gauge New or Worsening Symptoms A description of the new or worsening symptoms related to a clinical event. New or Worsening Symptom Non-Invasive Imaging Change A description of the clinical change to the subject after a non-invasive imaging procedure. Clinical Change by Non-Invasive Imaging Procedure Number of Abscesses The number of abscesses observed. Number of Abscesses Number of Alcoholic Drinks The total number of alcoholic drinks. Number of Alcoholic Drinks Measurement Number of Biopsy Specimens Taken The total number of biopsy specimens collected. Number of Biopsy Specimens Taken Number of Devices Inserted The number of devices inserted into an individual. Number of Devices Inserted Number of Devices Present A determination of the number of devices within a subject. Number of Devices Present Number of Episodes The total number of episodes that have occurred for the condition. Number of Episodes Number of Events The total number of events that have occurred. Number of Events Number of Fistulas The number of fistulas observed. Number of Fistulas Number Of Hospitalizations The total number of hospitalization events that have occurred for the condition. Number of Hospitalizations Number of Laps Completed The number of laps completed around a course or circuit. Number of Laps Completed Number of Lesions The number of lesions observed. Number of Lesions Number of Mild Episodes The number of times an event, which is classified as mild, occurred. Number of Mild Episodes Number of Moderate Episodes The number of times an event, which is classified as moderate, occurred. Number of Moderate Episodes Number of Objects The number of objects observed. Number of Objects Number of Procedures Performed The number of procedures performed on or in an individual. Number of Procedures Performed Number of Severe Episodes The number of times an event, which is classified as severe, occurred. Number of Severe Episodes Number of Steps Taken The number of footsteps taken by an individual. Number of Steps Taken Number of Strictures The number of anatomical strictures observed. Number of Strictures Occurrence Indicator An indication as to whether something has happened, such as an event or incident. Occurrence Indicator Focus of Onset Onset Unifocal or Multifocal A characterization of the focality of the lesion at the time of disease diagnosis. Focality of Disease Onset Origin of Cancer Known Ind Origin of Cancer Known Indicator An indication as to whether the primary site of cancer is known. Cancer Primary Site Known Indicator Pathologic Appearance of Biopsy Site A description of the appearance of the anatomical site from which a biopsy specimen has been collected. Pathologic Appearance of Biopsy Site PCI Acute Angiographic Complication Categorization of the type of acute PCI angiographic complication resulting in acute myocardial ischemia. Acute Myocardial Infarction From PCI Complication Type Precipitating Factor The factor that causes or triggers the onset of an occurrence. Precipitating Factor Prepared Amount The quantity of a product that has been made ready for use. Prepared Amount Prevents Daily Activities Indicator An indication as to whether the event or intervention prevents or has prevented the performance of daily activities. Prevents Daily Activities Indicator Primary Site of Tumor Origin The anatomical location of the primary tumor site of disease. Primary Tumor Site Procedure Success Indicator An indication as to whether the procedure is considered successful. Procedure Success Indicator Procedure Urgency Status Type The degree of urgency in which a medical procedure must be performed. Triage Status Pruritus Indicator An indicator as to whether the subject has symptoms of itchiness. Pruritus Indicator QOL Impact Quality of Life Impact The effect or consequence of an event or condition on an individual's sense of well-being and ability to enjoy life. Quality of Life Impact Reaction Grade The position on a scale to assess the degree of the response to a stimulus or intervention. Reaction Grade Relapse after Discon Dependent Indicator Relapse after Discontinue Dependent Indicator An indication as to whether an individual has had a relapse after discontinuation of a substance due to dependence. Relapse after Discontinuation Because of Dependence Indicator Relationship to Device An assessment of the likelihood that the device was the cause of the event. Relationship to Device Remaining Amount The quantity of a product that remains after dosing, consumption, or use. Remaining Amount Resected Tumor Ind Resected Tumor Indicator An indication as to whether the tumor has been resected. Tumor Resected Indicator Returned Amount The quantity of a product that has been returned. (NCI) Returned Amount Severity/Intensity The degree of something undesirable. Severity Sign/Symptom Leading to Discontinuation The signs and/or symptoms that result in the discontinuation of treatment or intervention. Sign or Symptom Leading to Discontinuation Speed A scalar measure of the rate of movement of the object expressed as the distance traveled divided by the elapsed time. Speed Stent Thrombosis, Coronary, ARC Timing Categorization of the timing of coronary stent thrombosis occurrence per the classification schema described by the Academic Research Consortium (ARC). Academic Research Council Coronary Stent Thrombosis Timing Stroke Type Categorization of the type of stroke. Stroke Type Substance Dependence Indicator An indication as to whether an individual has become dependent on a substance. Substance Dependence Indicator Symptom Indicator An indication as to whether the subject had symptoms related to the clinical event. Symptom Indicator Symptom Onset Date The date time of the onset of symptoms of the clinical event. Symptom Onset Date Total Number A measurement of the total number of entities. Total Number Total Time Paused The total amount of time during which an event, operation or activity has been interrupted or stopped. Total Time Paused Total Time Physically Active The total amount of time during which an individual was actively engaged in physical activity. Total Time Physically Active Toxicity Grade A standardized categorical classification of the severity of an event or finding. Toxicity Grade Treatment Environmental Setting Treatment Setting The surroundings or environment within which the subject receives therapeutic treatment for the condition. Treatment Environmental Setting Type of Object The type of object observed. Type of Object Unable to Discon Dependent Indicator Unable to Discontinue Dependent Indicator An indication as to whether an individual is unable to discontinue the use of a substance due to dependence. Unable to Discontinue Use Due to Dependence Indicator Unable to Taper Dependent Indicator An indication as to whether an individual is incapable of reducing or tapering the amount of a substance taken due to dependence. Unable to Taper Dependent Indicator Vessel Occlusion After CABG 48 Ind An indication as to whether vessel occlusion, in the native or bypass graft, occurred within 48 hours after the coronary artery bypass graft procedure. Vessel Occlusion 48 Hours after CABG Indicator Volume A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. Volume Measurement Wheal Diameter Interpretation The process of evaluating the wheal diameter in response to an allergen, based on a threshold size. Wheal Diameter Interpretation Wheal Longest Diameter The longest diameter of the flat, circular, slightly raised area that forms at the site of an antigenic skin response. Wheal Longest Diameter Wheal Mean Diameter The mean diameter of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin. Wheal Mean Diameter Wheal Size A semi-quantitative size assessment of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin. Wheal Size Measurement FATEST Findings About Test Name CDISC SDTM Findings About Test Name Terminology A terminology codelist relevant to the classification system used to categorize the sensitivity of a subject's skin to sunlight. (Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871.) TYPE1 Individuals who never tan and always sunburn if exposed to any appreciable amount of sunlight, primarily red headed individuals and lightly complected blondes. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871) Fitzpatrick Skin Type I TYPE2 Individuals who frequently burn but are able to tan to a small degree after extended sun exposure. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871) Fitzpatrick Skin Type II TYPE3 Individuals who burn infrequently and tan readily. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871) Fitzpatrick Skin Type III TYPE4 Individuals who rarely burn and tan heavily with moderate sun exposures, especially individuals of Asian, American Indian, Mediterranean and Latin American descent. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871) Fitzpatrick Skin Type IV TYPE5 Individuals who have dark constitutive pigmentation but become noticeably darker with sun exposure, especially light complected black individuals, those of Indian descent. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871) Fitzpatrick Skin Type V TYPE6 Individuals who have the heaviest constitutive pigmentation, especially dark skinned black individuals. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871) Fitzpatrick Skin Type VI SKINCLAS Fitzpatrick Skin Classification Response CDISC SDTM Skin Classification Terminology Framingham Heart Study Cardiovascular Disease 10-Year Risk Score test code. FCVD1-Framingham CVD 10-Year Risk Score Framingham Heart Study Cardiovascular Disease 10-Year Risk Score - Cardiovascular disease 10-year risk score. FHS CVD 10-Year Risk Score - Risk Score FCVD1TC Framingham Heart Study Cardiovascular Disease 10-Year Risk Score Clinical Classification Test Code CDISC Clinical Classification FHS CVD 10-Year Risk Score Test Code Terminology Framingham Heart Study Cardiovascular Disease 10-Year Risk Score test name. FCVD1-Framingham CVD 10-Year Risk Score Framingham Heart Study Cardiovascular Disease 10-Year Risk Score - Cardiovascular disease 10-year risk score. FHS CVD 10-Year Risk Score - Risk Score FCVD1TN Framingham Heart Study Cardiovascular Disease 10-Year Risk Score Clinical Classification Test Name CDISC Clinical Classification FHS CVD 10-Year Risk Score Test Name Terminology The terminology that includes terms pertaining to frequency within CDISC. One Time Per Week One time per week. (NCI) Once Weekly 10 Days Monthly Ten days per month. (NCI) Ten Days Per Month Two times per cycle. Two Times Per Cycle BIS Twice per week Two times per week. (NCI) Twice Weekly 2 Times Per Year Two times per year. (NCI) Two Times Yearly Three times per cycle. Three Times Per Cycle 3 Times Per Month Three times per month. (NCI) Three Times Monthly Three times a week TIS Three times per week. (NCI) Three Times Weekly 3 Times Per Year Three times per year. (NCI) Three Times Yearly 4 Times Per Month Four times per month. (NCI) Four Times Monthly 4 times per week QIS Four times per week. (NCI) Four Times Weekly 4 Times Per Year Four times per year. (NCI) Four Times Yearly 5 Times Daily Five times per day. (NCI) Five Times Daily 5 Times Per Month Five times per month. (NCI) Five Times Monthly 5 Times Per Week Five times per week. (NCI) Five Times Weekly 5 Times Per Year Five times per year. (NCI) Five Times Yearly 6 Times Daily Six times per day. (NCI) Six Times Daily 6 Times Per Month Six times per month. (NCI) Six Times Monthly 6 Times Per Week Six times per week. (NCI) Six Times Weekly 6 Times Per Year Six times per year. (NCI) Six Times Yearly 7 Times Daily Seven times per day. (NCI) Seven Times Per Day 7 Times Per Week Seven times per week. (NCI) Seven Times Weekly 8 Times Daily Eight times per day. (NCI) Eight Times Per Day 9 Times Daily Nine times per day. (NCI) Nine Times Per Day Ad Libitum As much as desired. As Much as Desired BD Twice per day Two times per day, at unspecified times. (NCI) Twice Daily Twice per month Twice per month. (NCI) Twice Per Month Continuous Remain in force or carry on without letup; keep or maintain in unaltered condition; exist in time or space without stop or interruption. (NCI) Continue Every 10 Weeks Q10S Every 10 weeks. Every Ten Weeks Every 10 years. Every Ten Years Q12S Every twelve weeks. Every Twelve Weeks Every 13 Weeks Q13S Every 13 weeks. Every Thirteen Weeks Q16S Every sixteen weeks. Every Sixteen Weeks Every 2 weeks Q2S Every two weeks. (NCI) Every Two Weeks Every 3 weeks Q3S Every three weeks. (NCI) Every Three Weeks Every three years. Every Three Years Every 4 weeks Q4S Every four weeks. (NCI) Every Four Weeks Every four years. Every Four Years Every 5 weeks Q5S Every five weeks. (NCI) Every Five Weeks Every five years. Every Five Years Every 6 Weeks Q6S Every six weeks. (NCI) Every Six Weeks Every 7 weeks Q7S Every seven weeks. Every Seven Weeks Every 8 weeks Q8S Every eight weeks. (NCI) Every Eight Weeks Every eight years. Every Eight Years Every afternoon. Every Afternoon Every evening. Every Evening Every week Per Week QS Every week. (NCI) Weekly Intermittent Periodically stopping and starting. (NCI) Intermittent Occasional Not occurring regularly or at short intervals. Infrequent One time. Once /Year Every Year Per Annum Per Year A frequency rate of occurrences of something within a period of time equal to three hundred sixty-five days. Per Year As needed As needed. (NCI) As Needed Every 10 hours Every ten hours. (NCI) Every Ten Hours Every 11 hours Every eleven hours. (NCI) Every Eleven Hours Every 12 hours Every twelve hours. (NCI) Every Twelve Hours Every 13 hours Every thirteen hours. (NCI) Every Thirteen Hours Every 14 hours Every fourteen hours. (NCI) Every Fourteen Hours Every 15 hours Every fifteen hours. (NCI) Every Fifteen Hours Every 16 hours Every sixteen hours. (NCI) Every Sixteen Hours Every 17 hours Every seventeen hours. (NCI) Every Seventeen Hours Every 18 hours Every eighteen hours. (NCI) Every Eighteen Hours Every 19 hours Every nineteen hours. (NCI) Every Nineteen Hours Every 20 hours Every twenty hours. (NCI) Every Twenty Hours Every 21 hours Every twenty-one hours. (NCI) Every Twenty-One Hours Every 22 hours Every twenty-two hours. (NCI) Every Twenty-Two Hours Every 23 hours Every twenty-three hours. (NCI) Every Twenty-Three Hours Every 24 hours Every twenty-four hours. (NCI) Every Twenty-Four Hours Every 2 hours Every two hours. (NCI) Every Two Hours Every two months Every two months. (NCI) Every Two Months Every 36 Hours Every thirty-six hours. (NCI) Every Thirty-six Hours Every 3 days Every three days. (NCI) Every Three Days Every 3 hours Every three hours. (NCI) Every Three Hours Every 3 months Every three months. (NCI) Every Three Months Every 45 Minutes Every forty-five minutes. (NCI) Every Forty-Five Minutes Every 48 Hours Every forty-eight hours. (NCI) Every Forty-eight Hours Every 4 days Every four days. (NCI) Every Four Days Every 4 hours Every four hours. (NCI) Every Four Hours Every 4 months Every four months. (NCI) Every Four Months Every 5 days Every five days. (NCI) Every Five Days Every 5 hours Every five hours. (NCI) Every Five Hours Every six days. Every Six Days Every 6 hours Every six hours. (NCI) Every Six Hours Every 6 Months Every six months. (NCI) Every Six Months Every 72 hours Every seventy-two hours. Every Seventy Two Hours Every 7 Days Every seven days. (NCI) Every Seven Days Every 7 hours Every seven hours. (NCI) Every Seven Hours Every 8 hours Every eight hours. (NCI) Every Eight Hours Every 96 Hours Every 96 hours. Every Ninety-Six Hours Every 9 hours Every nine hours. (NCI) Every Nine Hours Every Morning Every morning. (NCI) QAM /day Daily Per Day A rate of occurrences within a period of time equal to one day. Daily Every hour Every hour. (NCI) Every Hour Every day at bedtime. Hour of Sleep 4 times per day Four times per day. (NCI) Four Times Daily Every Month Per Month Every month. (NCI) Monthly Every night. Every Night Every other day Every Second Day Every Two Days Q2D Every other day. (NCI) Every Other Day Every day, on or after 12:00 pm. QPM Three times. Thrice 3 times per day Three times per day. (NCI) Three Times Daily Two times. (NCI) Twice U UNK Unknown Not known, not observed, not recorded, or refused. (NCI) Unknown FREQ Frequency CDISC SDTM Frequency Terminology Functional Activities Questionnaire test code. FAQ01-Write Checks/Pay Bills/Checkbook Functional Activities Questionnaire - Writing checks, paying bills, balancing checkbook. FAQ - Write checks, Pay bills, Balance checkbook FAQ01-Assembling Functional Activities Questionnaire - Assembling tax records, business affairs, or papers. FAQ - Assemble FAQ01-Shopping Alone Functional Activities Questionnaire - Shopping alone for clothes, household necessities, or groceries. FAQ - Shop Alone FAQ01-Playing a Game of Skill Functional Activities Questionnaire - Playing a game of skill, working on a hobby. FAQ - Play Game of Skill, Work on Hobby FAQ01-Heat Water/Make Coffee/Stove Off Functional Activities Questionnaire - Heating water, making a cup of coffee, turning off stove after use. FAQ - Heat water, Make Coffee, Turn Off Stove FAQ01-Preparing a Balanced Meal Functional Activities Questionnaire - Preparing a balanced meal. FAQ - Prepare a Meal FAQ01-Keeping Track of Current Events Functional Activities Questionnaire - Keeping track of current events. FAQ - Keep Track of Current Events FAQ01-Paying Attention Functional Activities Questionnaire - Paying attention to, understanding, discussing TV, book, magazine. FAQ - Pay Attention, Understand, Discuss FAQ01-Remembering Functional Activities Questionnaire - Remembering appointments, family occasions, holidays, medications. FAQ - Remember FAQ01-Traveling Functional Activities Questionnaire - Traveling out of neighborhood, driving, arranging to take buses. FAQ - Travel FAQ01-Total Score Functional Activities Questionnaire - Total Score. FAQ - Total Score FAQ01TC Functional Activities Questionnaire Clinical Classification Test Code CDISC Clinical Classification FAQ Test Code Terminology Functional Activities Questionnaire test name. FAQ01-Assembling Functional Activities Questionnaire - Assembling tax records, business affairs, or papers. FAQ - Assemble FAQ01-Heat Water/Make Coffee/Stove Off Functional Activities Questionnaire - Heating water, making a cup of coffee, turning off stove after use. FAQ - Heat water, Make Coffee, Turn Off Stove FAQ01-Keeping Track of Current Events Functional Activities Questionnaire - Keeping track of current events. FAQ - Keep Track of Current Events FAQ01-Paying Attention Functional Activities Questionnaire - Paying attention to, understanding, discussing TV, book, magazine. FAQ - Pay Attention, Understand, Discuss FAQ01-Playing a Game of Skill Functional Activities Questionnaire - Playing a game of skill, working on a hobby. FAQ - Play Game of Skill, Work on Hobby FAQ01-Preparing a Balanced Meal Functional Activities Questionnaire - Preparing a balanced meal. FAQ - Prepare a Meal FAQ01-Remembering Functional Activities Questionnaire - Remembering appointments, family occasions, holidays, medications. FAQ - Remember FAQ01-Shopping Alone Functional Activities Questionnaire - Shopping alone for clothes, household necessities, or groceries. FAQ - Shop Alone FAQ01-Total Score Functional Activities Questionnaire - Total Score. FAQ - Total Score FAQ01-Traveling Functional Activities Questionnaire - Traveling out of neighborhood, driving, arranging to take buses. FAQ - Travel FAQ01-Write Checks/Pay Bills/Checkbook Functional Activities Questionnaire - Writing checks, paying bills, balancing checkbook. FAQ - Write checks, Pay bills, Balance checkbook FAQ01TN Functional Activities Questionnaire Clinical Classification Test Name CDISC Clinical Classification FAQ Test Name Terminology Functional Assessment of Anorexia/Cachexia Treatment Version 4 test code. FAC065-I Have a Lack of Energy Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have a lack of energy. FAACT Version 4 - I Have a Lack of Energy FAC065-I Have Nausea Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have nausea. FAACT Version 4 - I Have Nausea FAC065-Trouble Meeting Needs of Family Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Because of my physical condition, I have trouble meeting the needs of my family. FAACT Version 4 - Trouble Meeting Needs of Family FAC065-I Have Pain Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have pain. FAACT Version 4 - I Have Pain FAC065-Bothered by Treatment Side Effect Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am bothered by side effects of treatment. FAACT Version 4 - Bothered by Treatment Side Effect FAC065-I Feel Ill Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I feel ill. FAACT Version 4 - I Feel Ill FAC065-I Am Forced to Spend Time in Bed Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am forced to spend time in bed. FAACT Version 4 - I Am Forced to Spend Time in Bed FAC065-I Feel Close to My Friends Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I feel close to my friends. FAACT Version 4 - I Feel Close to My Friends FAC065-Get Emotional Support From Family Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I get emotional support from my family. FAACT Version 4 - Get Emotional Support From Family FAC065-I Get Support From My Friends Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I get support from my friends. FAACT Version 4 - I Get Support From My Friends FAC065-My Family Has Accepted My Illness Functional Assessment of Anorexia/Cachexia Treatment Version 4 - My family accepts my illness. FAACT Version 4 - My Family Has Accepted My Illness FAC065-Satisfied Communication Illness Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am satisfied with family communication about my illness. FAACT Version 4 - Satisfied Communication Illness FAC065-I Feel Close to My Partner Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I feel close to my partner (or the person who is my main support). FAACT Version 4 - I Feel Close to My Partner FAC065-I Am Satisfied With My Sex Life Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am satisfied with my sex life. FAACT Version 4 - I Am Satisfied With My Sex Life FAC065-I Feel Sad Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I feel sad. FAACT Version 4 - I Feel Sad FAC065-Satisfied With How I Am Coping Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am satisfied with how I am coping with my illness. FAACT Version 4 - Satisfied With How I Am Coping FAC065-Losing Hope Against Illness Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am losing hope in the fight against my illness. FAACT Version 4 - Losing Hope Against Illness FAC065-I Feel Nervous Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I feel nervous. FAACT Version 4 - I Feel Nervous FAC065-I Worry About Dying Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I worry about dying. FAACT Version 4 - I Worry About Dying FAC065-Worry My Condition Will Get Worse Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I worry that my condition will get worse. FAACT Version 4 - Worry My Condition Will Get Worse FAC065-I Am Able to Work Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am able to work (include work at home). FAACT Version 4 - I Am Able to Work FAC065-My Work Is Fulfilling Functional Assessment of Anorexia/Cachexia Treatment Version 4 - My work (include work at home) is fulfilling. FAACT Version 4 - My Work Is Fulfilling FAC065-I Am Able to Enjoy Life Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am able to enjoy life. FAACT Version 4 - I Am Able to Enjoy Life FAC065-I Have Accepted My Illness Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have accepted my illness. FAACT Version 4 - I Have Accepted My Illness FAC065-I Am Sleeping Well Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am sleeping well. FAACT Version 4 - I Am Sleeping Well FAC065-Enjoy Things I Usually Do for Fun Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am enjoying the things I usually do for fun. FAACT Version 4 - Enjoy Things I Usually Do for Fun FAC065-Content With Quality of My Life Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am content with the quality of my life right now. FAACT Version 4 - Content With Quality of My Life FAC065-I Have a Good Appetite Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have a good appetite. FAACT Version 4 - I Have a Good Appetite FAC065-Amount I Eat Is Sufficient Functional Assessment of Anorexia/Cachexia Treatment Version 4 - The amount I eat is sufficient to meet my needs. FAACT Version 4 - Amount I Eat Is Sufficient FAC065-I Am Worried About My Weight Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am worried about my weight. FAACT Version 4 - I Am Worried About My Weight FAC065-Most Food Tastes Unpleasant to Me Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Most food tastes unpleasant to me. FAACT Version 4 - Most Food Tastes Unpleasant to Me FAC065-I Am Concerned How Thin I Look Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am concerned about how thin I look. FAACT Version 4 - I Am Concerned How Thin I Look FAC065-Interest in Food Drops Try to Eat Functional Assessment of Anorexia/Cachexia Treatment Version 4 - My interest in food drops as soon as I try to eat. FAACT Version 4 - Interest in Food Drops Try to Eat FAC065-Have Difficulty Eating Rich Foods Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have difficulty eating rich or "heavy" foods. FAACT Version 4 - Have Difficulty Eating Rich Foods FAC065-My Family Pressuring Me to Eat Functional Assessment of Anorexia/Cachexia Treatment Version 4 - My family or friends are pressuring me to eat. FAACT Version 4 - My Family Pressuring Me to Eat FAC065-I Have Been Vomiting Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have been vomiting. FAACT Version 4 - I Have Been Vomiting FAC065-I Seem to Get Full Quickly Functional Assessment of Anorexia/Cachexia Treatment Version 4 - When I eat, I seem to get full quickly. FAACT Version 4 - I Seem to Get Full Quickly FAC065-I Have Pain in My Stomach Area Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have pain in my stomach area. FAACT Version 4 - I Have Pain in My Stomach Area FAC065-My General Health Is Improving Functional Assessment of Anorexia/Cachexia Treatment Version 4 - My general health is improving. FAACT Version 4 - My General Health Is Improving FAC065-Physical Subscale Score Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Physical Well-Being: Subscale score. FAACT Version 4 - Physical Subscale Score FAC065-Social/Family Subscale Score Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Social/Family Well-Being: Subscale score. FAACT Version 4 - Social/Family Subscale Score FAC065-Emotional Subscale Score Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Emotional Well-Being: Subscale score. FAACT Version 4 - Emotional Subscale Score FAC065-Functional Subscale Score Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Functional Well-Being: Subscale score. FAACT Version 4 - Functional Subscale Score FAC065-Additional Concern Subscale Score Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Additional Concerns: Well-Being subscale score. FAACT Version 4 - Additional Concern Subscale Score FAC065-Trial Outcome Index Score Functional Assessment of Anorexia/Cachexia Treatment Version 4 - FAACT trial outcome index. FAACT Version 4 - Trial Outcome Index Score FAC065-FACT-G Total Score Functional Assessment of Anorexia/Cachexia Treatment Version 4 - FACT-G total score. FAACT Version 4 - FACT-G Total Score FAC065-Total Score Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Total score. FAACT Version 4 - Total Score FAC065TC Functional Assessment of Anorexia/Cachexia Treatment Version 4 Questionnaire Test Code CDISC Questionnaire FAACT Version 4 Test Code Terminology Functional Assessment of Anorexia/Cachexia Treatment Version 4 test name. FAC065-Additional Concern Subscale Score Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Additional Concerns: Well-Being subscale score. FAACT Version 4 - Additional Concern Subscale Score FAC065-Amount I Eat Is Sufficient Functional Assessment of Anorexia/Cachexia Treatment Version 4 - The amount I eat is sufficient to meet my needs. FAACT Version 4 - Amount I Eat Is Sufficient FAC065-Bothered by Treatment Side Effect Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am bothered by side effects of treatment. FAACT Version 4 - Bothered by Treatment Side Effect FAC065-Content With Quality of My Life Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am content with the quality of my life right now. FAACT Version 4 - Content With Quality of My Life FAC065-Emotional Subscale Score Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Emotional Well-Being: Subscale score. FAACT Version 4 - Emotional Subscale Score FAC065-Enjoy Things I Usually Do for Fun Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am enjoying the things I usually do for fun. FAACT Version 4 - Enjoy Things I Usually Do for Fun FAC065-FACT-G Total Score Functional Assessment of Anorexia/Cachexia Treatment Version 4 - FACT-G total score. FAACT Version 4 - FACT-G Total Score FAC065-Functional Subscale Score Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Functional Well-Being: Subscale score. FAACT Version 4 - Functional Subscale Score FAC065-Get Emotional Support From Family Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I get emotional support from my family. FAACT Version 4 - Get Emotional Support From Family FAC065-Have Difficulty Eating Rich Foods Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have difficulty eating rich or "heavy" foods. FAACT Version 4 - Have Difficulty Eating Rich Foods FAC065-I Am Able to Enjoy Life Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am able to enjoy life. FAACT Version 4 - I Am Able to Enjoy Life FAC065-I Am Able to Work Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am able to work (include work at home). FAACT Version 4 - I Am Able to Work FAC065-I Am Concerned How Thin I Look Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am concerned about how thin I look. FAACT Version 4 - I Am Concerned How Thin I Look FAC065-I Am Forced to Spend Time in Bed Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am forced to spend time in bed. FAACT Version 4 - I Am Forced to Spend Time in Bed FAC065-I Am Satisfied With My Sex Life Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am satisfied with my sex life. FAACT Version 4 - I Am Satisfied With My Sex Life FAC065-I Am Sleeping Well Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am sleeping well. FAACT Version 4 - I Am Sleeping Well FAC065-I Am Worried About My Weight Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am worried about my weight. FAACT Version 4 - I Am Worried About My Weight FAC065-I Feel Close to My Friends Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I feel close to my friends. FAACT Version 4 - I Feel Close to My Friends FAC065-I Feel Close to My Partner Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I feel close to my partner (or the person who is my main support). FAACT Version 4 - I Feel Close to My Partner FAC065-I Feel Ill Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I feel ill. FAACT Version 4 - I Feel Ill FAC065-I Feel Nervous Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I feel nervous. FAACT Version 4 - I Feel Nervous FAC065-I Feel Sad Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I feel sad. FAACT Version 4 - I Feel Sad FAC065-I Get Support From My Friends Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I get support from my friends. FAACT Version 4 - I Get Support From My Friends FAC065-I Have a Good Appetite Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have a good appetite. FAACT Version 4 - I Have a Good Appetite FAC065-I Have a Lack of Energy Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have a lack of energy. FAACT Version 4 - I Have a Lack of Energy FAC065-I Have Accepted My Illness Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have accepted my illness. FAACT Version 4 - I Have Accepted My Illness FAC065-I Have Been Vomiting Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have been vomiting. FAACT Version 4 - I Have Been Vomiting FAC065-I Have Nausea Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have nausea. FAACT Version 4 - I Have Nausea FAC065-I Have Pain in My Stomach Area Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have pain in my stomach area. FAACT Version 4 - I Have Pain in My Stomach Area FAC065-I Have Pain Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have pain. FAACT Version 4 - I Have Pain FAC065-I Seem to Get Full Quickly Functional Assessment of Anorexia/Cachexia Treatment Version 4 - When I eat, I seem to get full quickly. FAACT Version 4 - I Seem to Get Full Quickly FAC065-I Worry About Dying Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I worry about dying. FAACT Version 4 - I Worry About Dying FAC065-Interest in Food Drops Try to Eat Functional Assessment of Anorexia/Cachexia Treatment Version 4 - My interest in food drops as soon as I try to eat. FAACT Version 4 - Interest in Food Drops Try to Eat FAC065-Losing Hope Against Illness Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am losing hope in the fight against my illness. FAACT Version 4 - Losing Hope Against Illness FAC065-Most Food Tastes Unpleasant to Me Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Most food tastes unpleasant to me. FAACT Version 4 - Most Food Tastes Unpleasant to Me FAC065-My Family Has Accepted My Illness Functional Assessment of Anorexia/Cachexia Treatment Version 4 - My family accepts my illness. FAACT Version 4 - My Family Has Accepted My Illness FAC065-My Family Pressuring Me to Eat Functional Assessment of Anorexia/Cachexia Treatment Version 4 - My family or friends are pressuring me to eat. FAACT Version 4 - My Family Pressuring Me to Eat FAC065-My General Health Is Improving Functional Assessment of Anorexia/Cachexia Treatment Version 4 - My general health is improving. FAACT Version 4 - My General Health Is Improving FAC065-My Work Is Fulfilling Functional Assessment of Anorexia/Cachexia Treatment Version 4 - My work (include work at home) is fulfilling. FAACT Version 4 - My Work Is Fulfilling FAC065-Physical Subscale Score Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Physical Well-Being: Subscale score. FAACT Version 4 - Physical Subscale Score FAC065-Satisfied Communication Illness Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am satisfied with family communication about my illness. FAACT Version 4 - Satisfied Communication Illness FAC065-Satisfied With How I Am Coping Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am satisfied with how I am coping with my illness. FAACT Version 4 - Satisfied With How I Am Coping FAC065-Social/Family Subscale Score Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Social/Family Well-Being: Subscale score. FAACT Version 4 - Social/Family Subscale Score FAC065-Total Score Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Total score. FAACT Version 4 - Total Score FAC065-Trial Outcome Index Score Functional Assessment of Anorexia/Cachexia Treatment Version 4 - FAACT trial outcome index. FAACT Version 4 - Trial Outcome Index Score FAC065-Trouble Meeting Needs of Family Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Because of my physical condition, I have trouble meeting the needs of my family. FAACT Version 4 - Trouble Meeting Needs of Family FAC065-Worry My Condition Will Get Worse Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I worry that my condition will get worse. FAACT Version 4 - Worry My Condition Will Get Worse FAC065TN Functional Assessment of Anorexia/Cachexia Treatment Version 4 Questionnaire Test Name CDISC Questionnaire FAACT Version 4 Test Name Terminology Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 test code. FAC062-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Physical Well-Being: I have a lack of energy. FACT-BRM Version 4 - I Have a Lack of Energy FAC062-I Have Nausea Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Physical Well-Being: I have nausea. FACT-BRM Version 4 - I Have Nausea FAC062-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. FACT-BRM Version 4 - Trouble Meeting Needs of Family FAC062-I Have Pain Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Physical Well-Being: I have pain. FACT-BRM Version 4 - I Have Pain FAC062-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Physical Well-Being: I am bothered by side effects of treatment. FACT-BRM Version 4 - Bothered by Treatment Side Effect FAC062-I Feel Ill Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Physical Well-Being: I feel ill. FACT-BRM Version 4 - I Feel Ill FAC062-I Am Forced to Spend Time in Bed Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Physical Well-Being: I am forced to spend time in bed. FACT-BRM Version 4 - I Am Forced to Spend Time in Bed FAC062-I Feel Close to My Friends Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Social/Family Well-Being: I feel close to my friends. FACT-BRM Version 4 - I Feel Close to My Friends FAC062-Get Emotional Support From Family Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Social/Family Well-Being: I get emotional support from my family. FACT-BRM Version 4 - Get Emotional Support From Family FAC062-I Get Support From My Friends Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Social/Family Well-Being: I get support from my friends. FACT-BRM Version 4 - I Get Support From My Friends FAC062-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Social/Family Well-Being: My family has accepted my illness. FACT-BRM Version 4 - My Family Has Accepted My Illness FAC062-Satisfied Communication Illness Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. FACT-BRM Version 4 - Satisfied Communication Illness FAC062-I Feel Close to My Partner Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). FACT-BRM Version 4 - I Feel Close to My Partner FAC062-I Am Satisfied With My Sex Life Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Social/Family Well-Being: I am satisfied with my sex life. FACT-BRM Version 4 - I Am Satisfied With My Sex Life FAC062-I Feel Sad Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Emotional Well-Being: I feel sad. FACT-BRM Version 4 - I Feel Sad FAC062-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. FACT-BRM Version 4 - Satisfied With How I Am Coping FAC062-Losing Hope Against Illness Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. FACT-BRM Version 4 - Losing Hope Against Illness FAC062-I Feel Nervous Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Emotional Well-Being: I feel nervous. FACT-BRM Version 4 - I Feel Nervous FAC062-I Worry About Dying Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Emotional Well-Being: I worry about dying. FACT-BRM Version 4 - I Worry About Dying FAC062-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Emotional Well-Being: I worry that my condition will get worse. FACT-BRM Version 4 - Worry My Condition Will Get Worse FAC062-I Am Able to Work Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Functional Well-Being: I am able to work (include work at home). FACT-BRM Version 4 - I Am Able to Work FAC062-My Work Is Fulfilling Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. FACT-BRM Version 4 - My Work Is Fulfilling FAC062-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Functional Well-Being: I am able to enjoy life. FACT-BRM Version 4 - I Am Able to Enjoy Life FAC062-I Have Accepted My Illness Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Functional Well-Being: I have accepted my illness. FACT-BRM Version 4 - I Have Accepted My Illness FAC062-I Am Sleeping Well Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Functional Well-Being: I am sleeping well. FACT-BRM Version 4 - I Am Sleeping Well FAC062-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. FACT-BRM Version 4 - Enjoy Things I Usually Do for Fun FAC062-Content With Quality of My Life Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Functional Well-Being: I am content with the quality of my life right now. FACT-BRM Version 4 - Content With Quality of My Life FAC062-I Get Tired Easily Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Physical: I get tired easily. FACT-BRM Version 4 - I Get Tired Easily FAC062-I Feel Weak All Over Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Physical: I feel weak all over. FACT-BRM Version 4 - I Feel Weak All Over FAC062-I Have a Good Appetite Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Physical: I have a good appetite. FACT-BRM Version 4 - I Have a Good Appetite FAC062-I Have Pain in My Joints Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Physical: I have pain in my joints. FACT-BRM Version 4 - I Have Pain in My Joints FAC062-I Am Bothered by the Chills Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Physical: I am bothered by the chills. FACT-BRM Version 4 - I Am Bothered by the Chills FAC062-I Am Bothered by Fevers Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Physical: I am bothered by fevers (episodes of high body temperature). FACT-BRM Version 4 - I Am Bothered by Fevers FAC062-I Am Bothered by Sweating Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Physical: I am bothered by sweating. FACT-BRM Version 4 - I Am Bothered by Sweating FAC062-I Have Trouble Concentrating Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Mental: I have trouble concentrating. FACT-BRM Version 4 - I Have Trouble Concentrating FAC062-I Have Trouble Remembering Things Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Mental: I have trouble remembering things. FACT-BRM Version 4 - I Have Trouble Remembering Things FAC062-I Get Depressed Easily Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Mental: I get depressed easily. FACT-BRM Version 4 - I Get Depressed Easily FAC062-I Get Annoyed Easily Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Mental: I get annoyed easily. FACT-BRM Version 4 - I Get Annoyed Easily FAC062-I Have Emotional Ups and Downs Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Mental: I have emotional ups and downs. FACT-BRM Version 4 - I Have Emotional Ups and Downs FAC062-I Feel Motivated to Do Things Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Mental: I feel motivated to do things. FACT-BRM Version 4 - I Feel Motivated to Do Things FAC062TC Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 Questionnaire Test Code CDISC Questionnaire FACT-BRM Version 4 Test Code Terminology Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 test name. FAC062-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Physical Well-Being: I am bothered by side effects of treatment. FACT-BRM Version 4 - Bothered by Treatment Side Effect FAC062-Content With Quality of My Life Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Functional Well-Being: I am content with the quality of my life right now. FACT-BRM Version 4 - Content With Quality of My Life FAC062-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. FACT-BRM Version 4 - Enjoy Things I Usually Do for Fun FAC062-Get Emotional Support From Family Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Social/Family Well-Being: I get emotional support from my family. FACT-BRM Version 4 - Get Emotional Support From Family FAC062-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Functional Well-Being: I am able to enjoy life. FACT-BRM Version 4 - I Am Able to Enjoy Life FAC062-I Am Able to Work Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Functional Well-Being: I am able to work (include work at home). FACT-BRM Version 4 - I Am Able to Work FAC062-I Am Bothered by Fevers Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Physical: I am bothered by fevers (episodes of high body temperature). FACT-BRM Version 4 - I Am Bothered by Fevers FAC062-I Am Bothered by Sweating Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Physical: I am bothered by sweating. FACT-BRM Version 4 - I Am Bothered by Sweating FAC062-I Am Bothered by the Chills Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Physical: I am bothered by the chills. FACT-BRM Version 4 - I Am Bothered by the Chills FAC062-I Am Forced to Spend Time in Bed Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Physical Well-Being: I am forced to spend time in bed. FACT-BRM Version 4 - I Am Forced to Spend Time in Bed FAC062-I Am Satisfied With My Sex Life Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Social/Family Well-Being: I am satisfied with my sex life. FACT-BRM Version 4 - I Am Satisfied With My Sex Life FAC062-I Am Sleeping Well Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Functional Well-Being: I am sleeping well. FACT-BRM Version 4 - I Am Sleeping Well FAC062-I Feel Close to My Friends Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Social/Family Well-Being: I feel close to my friends. FACT-BRM Version 4 - I Feel Close to My Friends FAC062-I Feel Close to My Partner Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). FACT-BRM Version 4 - I Feel Close to My Partner FAC062-I Feel Ill Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Physical Well-Being: I feel ill. FACT-BRM Version 4 - I Feel Ill FAC062-I Feel Motivated to Do Things Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Mental: I feel motivated to do things. FACT-BRM Version 4 - I Feel Motivated to Do Things FAC062-I Feel Nervous Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Emotional Well-Being: I feel nervous. FACT-BRM Version 4 - I Feel Nervous FAC062-I Feel Sad Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Emotional Well-Being: I feel sad. FACT-BRM Version 4 - I Feel Sad FAC062-I Feel Weak All Over Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Physical: I feel weak all over. FACT-BRM Version 4 - I Feel Weak All Over FAC062-I Get Annoyed Easily Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Mental: I get annoyed easily. FACT-BRM Version 4 - I Get Annoyed Easily FAC062-I Get Depressed Easily Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Mental: I get depressed easily. FACT-BRM Version 4 - I Get Depressed Easily FAC062-I Get Support From My Friends Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Social/Family Well-Being: I get support from my friends. FACT-BRM Version 4 - I Get Support From My Friends FAC062-I Get Tired Easily Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Physical: I get tired easily. FACT-BRM Version 4 - I Get Tired Easily FAC062-I Have a Good Appetite Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Physical: I have a good appetite. FACT-BRM Version 4 - I Have a Good Appetite FAC062-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Physical Well-Being: I have a lack of energy. FACT-BRM Version 4 - I Have a Lack of Energy FAC062-I Have Accepted My Illness Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Functional Well-Being: I have accepted my illness. FACT-BRM Version 4 - I Have Accepted My Illness FAC062-I Have Emotional Ups and Downs Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Mental: I have emotional ups and downs. FACT-BRM Version 4 - I Have Emotional Ups and Downs FAC062-I Have Nausea Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Physical Well-Being: I have nausea. FACT-BRM Version 4 - I Have Nausea FAC062-I Have Pain in My Joints Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Physical: I have pain in my joints. FACT-BRM Version 4 - I Have Pain in My Joints FAC062-I Have Pain Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Physical Well-Being: I have pain. FACT-BRM Version 4 - I Have Pain FAC062-I Have Trouble Concentrating Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Mental: I have trouble concentrating. FACT-BRM Version 4 - I Have Trouble Concentrating FAC062-I Have Trouble Remembering Things Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Mental: I have trouble remembering things. FACT-BRM Version 4 - I Have Trouble Remembering Things FAC062-I Worry About Dying Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Emotional Well-Being: I worry about dying. FACT-BRM Version 4 - I Worry About Dying FAC062-Losing Hope Against Illness Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. FACT-BRM Version 4 - Losing Hope Against Illness FAC062-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Social/Family Well-Being: My family has accepted my illness. FACT-BRM Version 4 - My Family Has Accepted My Illness FAC062-My Work Is Fulfilling Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. FACT-BRM Version 4 - My Work Is Fulfilling FAC062-Satisfied Communication Illness Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. FACT-BRM Version 4 - Satisfied Communication Illness FAC062-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. FACT-BRM Version 4 - Satisfied With How I Am Coping FAC062-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. FACT-BRM Version 4 - Trouble Meeting Needs of Family FAC062-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Emotional Well-Being: I worry that my condition will get worse. FACT-BRM Version 4 - Worry My Condition Will Get Worse FAC062TN Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 Questionnaire Test Name CDISC Questionnaire FACT-BRM Version 4 Test Name Terminology Functional Assessment of Cancer Therapy-Bladder Version 4 test code. FAC006-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: I have a lack of energy. FACT-BL Version 4 - I Have a Lack of Energy FAC006-I Have Nausea Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: I have nausea. FACT-BL Version 4 - I Have Nausea FAC006-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. FACT-BL Version 4 - Trouble Meeting Needs of Family FAC006-I Have Pain Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: I have pain. FACT-BL Version 4 - I Have Pain FAC006-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: I am bothered by side effects of treatment. FACT-BL Version 4 - Bothered by Treatment Side Effect FAC006-I Feel Ill Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: I feel ill. FACT-BL Version 4 - I Feel Ill FAC006-I Am Forced to Spend Time in Bed Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: I am forced to spend time in bed. FACT-BL Version 4 - I Am Forced to Spend Time in Bed FAC006-I Feel Close to My Friends Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: I feel close to my friends. FACT-BL Version 4 - I Feel Close to My Friends FAC006-Get Emotional Support From Family Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: I get emotional support from my family. FACT-BL Version 4 - Get Emotional Support From Family FAC006-I Get Support From My Friends Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: I get support from my friends. FACT-BL Version 4 - I Get Support From My Friends FAC006-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: My family has accepted my illness. FACT-BL Version 4 - My Family Has Accepted My Illness FAC006-Satisfied Communication Illness Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. FACT-BL Version 4 - Satisfied Communication Illness FAC006-I Feel Close to My Partner Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). FACT-BL Version 4 - I Feel Close to My Partner FAC006-I Am Satisfied With My Sex Life Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: I am satisfied with my sex life. FACT-BL Version 4 - I Am Satisfied With My Sex Life FAC006-I Feel Sad Functional Assessment of Cancer Therapy-Bladder Version 4 - Emotional Well-Being: I feel sad. FACT-BL Version 4 - I Feel Sad FAC006-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy-Bladder Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. FACT-BL Version 4 - Satisfied With How I Am Coping FAC006-Losing Hope Against Illness Functional Assessment of Cancer Therapy-Bladder Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. FACT-BL Version 4 - Losing Hope Against Illness FAC006-I Feel Nervous Functional Assessment of Cancer Therapy-Bladder Version 4 - Emotional Well-Being: I feel nervous. FACT-BL Version 4 - I Feel Nervous FAC006-I Worry About Dying Functional Assessment of Cancer Therapy-Bladder Version 4 - Emotional Well-Being: I worry about dying. FACT-BL Version 4 - I Worry About Dying FAC006-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Bladder Version 4 - Emotional Well-Being: I worry that my condition will get worse. FACT-BL Version 4 - Worry My Condition Will Get Worse FAC006-I Am Able to Work Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: I am able to work (include work at home). FACT-BL Version 4 - I Am Able to Work FAC006-My Work Is Fulfilling Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. FACT-BL Version 4 - My Work Is Fulfilling FAC006-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: I am able to enjoy life. FACT-BL Version 4 - I Am Able to Enjoy Life FAC006-I Have Accepted My Illness Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: I have accepted my illness. FACT-BL Version 4 - I Have Accepted My Illness FAC006-I Am Sleeping Well Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: I am sleeping well. FACT-BL Version 4 - I Am Sleeping Well FAC006-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. FACT-BL Version 4 - Enjoy Things I Usually Do for Fun FAC006-Content With Quality of My Life Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: I am content with the quality of my life right now. FACT-BL Version 4 - Content With Quality of My Life FAC006-Trouble Controlling My Urine Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I have trouble controlling my urine. FACT-BL Version 4 - Trouble Controlling My Urine FAC006-I Am Losing Weight Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I am losing weight. FACT-BL Version 4 - I Am Losing Weight FAC006-I Have Control of My Bowels Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I have control of my bowels. FACT-BL Version 4 - I Have Control of My Bowels FAC006-I Urinate More Frequently Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I urinate more frequently than usual. FACT-BL Version 4 - I Urinate More Frequently FAC006-I Have Diarrhea Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I have diarrhea (diarrhoea). FACT-BL Version 4 - I Have Diarrhea FAC006-I Have a Good Appetite Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I have a good appetite. FACT-BL Version 4 - I Have a Good Appetite FAC006-I Like the Appearance of My Body Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I like the appearance of my body. FACT-BL Version 4 - I Like the Appearance of My Body FAC006-It Burns When I Urinate Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: It burns when I urinate. FACT-BL Version 4 - It Burns When I Urinate FAC006-I Am Interested in Sex Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I am interested in sex. FACT-BL Version 4 - I Am Interested in Sex FAC006-Able to Have/Maintain Erection Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: (For men only) I am able to have and maintain an erection. FACT-BL Version 4 - Able to Have/Maintain Erection FAC006-Do You Have an Ostomy Appliance Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: Do you have an ostomy appliance? FACT-BL Version 4 - Do You Have an Ostomy Appliance FAC006-Embarrassed by Ostomy Appliance Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I am embarrassed by my ostomy appliance. FACT-BL Version 4 - Embarrassed by Ostomy Appliance FAC006-Caring for Ostomy Is Difficult Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: Caring for my ostomy appliance is difficult. FACT-BL Version 4 - Caring for Ostomy Appliance Is Difficult FAC006-Physical Subscale Score Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: Subscale score. FACT-BL Version 4 - Physical Subscale Score FAC006-Social/Family Subscale Score Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: Subscale score. FACT-BL Version 4 - Social/Family Subscale Score FAC006-Emotional Subscale Score Functional Assessment of Cancer Therapy-Bladder Version 4 - Emotional Well-Being: Subscale score. FACT-BL Version 4 - Emotional Subscale Score FAC006-Functional Subscale Score Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: Subscale score. FACT-BL Version 4 - Functional Subscale Score FAC006-Additional Concern Subscale Score Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: Subscale score. FACT-BL Version 4 - Additional Concern Subscale Score FAC006-Trial Outcome Index Score Functional Assessment of Cancer Therapy-Bladder Version 4 - Trial outcome index score. FACT-BL Version 4 - Trial Outcome Index Score FAC006-FACT-G Total Score Functional Assessment of Cancer Therapy-Bladder Version 4 - FACT-G total score. FACT-BL Version 4 - FACT-G Total Score FAC006-Total Score Functional Assessment of Cancer Therapy-Bladder Version 4 - Total score. FACT-BL Version 4 - Total Score FAC006TC Functional Assessment of Cancer Therapy-Bladder Version 4 Questionnaire Test Code CDISC Questionnaire FACT-BL Version 4 Test Code Terminology Functional Assessment of Cancer Therapy-Bladder Version 4 test name. FAC006-Able to Have/Maintain Erection Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: (For men only) I am able to have and maintain an erection. FACT-BL Version 4 - Able to Have/Maintain Erection FAC006-Additional Concern Subscale Score Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: Subscale score. FACT-BL Version 4 - Additional Concern Subscale Score FAC006-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: I am bothered by side effects of treatment. FACT-BL Version 4 - Bothered by Treatment Side Effect FAC006-Caring for Ostomy Is Difficult Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: Caring for my ostomy appliance is difficult. FACT-BL Version 4 - Caring for Ostomy Appliance Is Difficult FAC006-Content With Quality of My Life Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: I am content with the quality of my life right now. FACT-BL Version 4 - Content With Quality of My Life FAC006-Do You Have an Ostomy Appliance Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: Do you have an ostomy appliance? FACT-BL Version 4 - Do You Have an Ostomy Appliance FAC006-Embarrassed by Ostomy Appliance Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I am embarrassed by my ostomy appliance. FACT-BL Version 4 - Embarrassed by Ostomy Appliance FAC006-Emotional Subscale Score Functional Assessment of Cancer Therapy-Bladder Version 4 - Emotional Well-Being: Subscale score. FACT-BL Version 4 - Emotional Subscale Score FAC006-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. FACT-BL Version 4 - Enjoy Things I Usually Do for Fun FAC006-FACT-G Total Score Functional Assessment of Cancer Therapy-Bladder Version 4 - FACT-G total score. FACT-BL Version 4 - FACT-G Total Score FAC006-Functional Subscale Score Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: Subscale score. FACT-BL Version 4 - Functional Subscale Score FAC006-Get Emotional Support From Family Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: I get emotional support from my family. FACT-BL Version 4 - Get Emotional Support From Family FAC006-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: I am able to enjoy life. FACT-BL Version 4 - I Am Able to Enjoy Life FAC006-I Am Able to Work Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: I am able to work (include work at home). FACT-BL Version 4 - I Am Able to Work FAC006-I Am Forced to Spend Time in Bed Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: I am forced to spend time in bed. FACT-BL Version 4 - I Am Forced to Spend Time in Bed FAC006-I Am Interested in Sex Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I am interested in sex. FACT-BL Version 4 - I Am Interested in Sex FAC006-I Am Losing Weight Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I am losing weight. FACT-BL Version 4 - I Am Losing Weight FAC006-I Am Satisfied With My Sex Life Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: I am satisfied with my sex life. FACT-BL Version 4 - I Am Satisfied With My Sex Life FAC006-I Am Sleeping Well Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: I am sleeping well. FACT-BL Version 4 - I Am Sleeping Well FAC006-I Feel Close to My Friends Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: I feel close to my friends. FACT-BL Version 4 - I Feel Close to My Friends FAC006-I Feel Close to My Partner Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). FACT-BL Version 4 - I Feel Close to My Partner FAC006-I Feel Ill Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: I feel ill. FACT-BL Version 4 - I Feel Ill FAC006-I Feel Nervous Functional Assessment of Cancer Therapy-Bladder Version 4 - Emotional Well-Being: I feel nervous. FACT-BL Version 4 - I Feel Nervous FAC006-I Feel Sad Functional Assessment of Cancer Therapy-Bladder Version 4 - Emotional Well-Being: I feel sad. FACT-BL Version 4 - I Feel Sad FAC006-I Get Support From My Friends Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: I get support from my friends. FACT-BL Version 4 - I Get Support From My Friends FAC006-I Have a Good Appetite Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I have a good appetite. FACT-BL Version 4 - I Have a Good Appetite FAC006-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: I have a lack of energy. FACT-BL Version 4 - I Have a Lack of Energy FAC006-I Have Accepted My Illness Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: I have accepted my illness. FACT-BL Version 4 - I Have Accepted My Illness FAC006-I Have Control of My Bowels Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I have control of my bowels. FACT-BL Version 4 - I Have Control of My Bowels FAC006-I Have Diarrhea Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I have diarrhea (diarrhoea). FACT-BL Version 4 - I Have Diarrhea FAC006-I Have Nausea Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: I have nausea. FACT-BL Version 4 - I Have Nausea FAC006-I Have Pain Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: I have pain. FACT-BL Version 4 - I Have Pain FAC006-I Like the Appearance of My Body Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I like the appearance of my body. FACT-BL Version 4 - I Like the Appearance of My Body FAC006-I Urinate More Frequently Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I urinate more frequently than usual. FACT-BL Version 4 - I Urinate More Frequently FAC006-I Worry About Dying Functional Assessment of Cancer Therapy-Bladder Version 4 - Emotional Well-Being: I worry about dying. FACT-BL Version 4 - I Worry About Dying FAC006-It Burns When I Urinate Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: It burns when I urinate. FACT-BL Version 4 - It Burns When I Urinate FAC006-Losing Hope Against Illness Functional Assessment of Cancer Therapy-Bladder Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. FACT-BL Version 4 - Losing Hope Against Illness FAC006-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: My family has accepted my illness. FACT-BL Version 4 - My Family Has Accepted My Illness FAC006-My Work Is Fulfilling Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. FACT-BL Version 4 - My Work Is Fulfilling FAC006-Physical Subscale Score Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: Subscale score. FACT-BL Version 4 - Physical Subscale Score FAC006-Satisfied Communication Illness Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. FACT-BL Version 4 - Satisfied Communication Illness FAC006-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy-Bladder Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. FACT-BL Version 4 - Satisfied With How I Am Coping FAC006-Social/Family Subscale Score Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: Subscale score. FACT-BL Version 4 - Social/Family Subscale Score FAC006-Total Score Functional Assessment of Cancer Therapy-Bladder Version 4 - Total score. FACT-BL Version 4 - Total Score FAC006-Trial Outcome Index Score Functional Assessment of Cancer Therapy-Bladder Version 4 - Trial outcome index score. FACT-BL Version 4 - Trial Outcome Index Score FAC006-Trouble Controlling My Urine Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I have trouble controlling my urine. FACT-BL Version 4 - Trouble Controlling My Urine FAC006-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. FACT-BL Version 4 - Trouble Meeting Needs of Family FAC006-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Bladder Version 4 - Emotional Well-Being: I worry that my condition will get worse. FACT-BL Version 4 - Worry My Condition Will Get Worse FAC006TN Functional Assessment of Cancer Therapy-Bladder Version 4 Questionnaire Test Name CDISC Questionnaire FACT-BL Version 4 Test Name Terminology Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 test code. FAC061-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have a lack of energy. FACT-BMT Version 4 - I Have a Lack of Energy FAC061-I Have Nausea Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have nausea. FACT-BMT Version 4 - I Have Nausea FAC061-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - Because of my physical condition, I have trouble meeting the needs of my family. FACT-BMT Version 4 - Trouble Meeting Needs of Family FAC061-I Have Pain Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have pain. FACT-BMT Version 4 - I Have Pain FAC061-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am bothered by side effects of treatment. FACT-BMT Version 4 - Bothered by Treatment Side Effect FAC061-I Feel Ill Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I feel ill. FACT-BMT Version 4 - I Feel Ill FAC061-I Am Forced to Spend Time in Bed Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am forced to spend time in bed. FACT-BMT Version 4 - I Am Forced to Spend Time in Bed FAC061-I Feel Close to My Friends Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I feel close to my friends. FACT-BMT Version 4 - I Feel Close to My Friends FAC061-Get Emotional Support From Family Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I get emotional support from my family. FACT-BMT Version 4 - Get Emotional Support From Family FAC061-I Get Support From My Friends Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I get support from my friends. FACT-BMT Version 4 - I Get Support From My Friends FAC061-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - My family has accepted my illness. FACT-BMT Version 4 - My Family Has Accepted My Illness FAC061-Satisfied Communication Illness Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am satisfied with family communication about my illness. FACT-BMT Version 4 - Satisfied Communication Illness FAC061-I Feel Close to My Partner Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I feel close to my partner (or the person who is my main support). FACT-BMT Version 4 - I Feel Close to My Partner FAC061-I Am Satisfied With My Sex Life Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am satisfied with my sex life. FACT-BMT Version 4 - I Am Satisfied With My Sex Life FAC061-I Feel Sad Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I feel sad. FACT-BMT Version 4 - I Feel Sad FAC061-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am satisfied with how I am coping with my illness. FACT-BMT Version 4 - Satisfied With How I Am Coping FAC061-Losing Hope Against Illness Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am losing hope in the fight against my illness. FACT-BMT Version 4 - Losing Hope Against Illness FAC061-I Feel Nervous Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I feel nervous. FACT-BMT Version 4 - I Feel Nervous FAC061-I Worry About Dying Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I worry about dying. FACT-BMT Version 4 - I Worry About Dying FAC061-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I worry that my condition will get worse. FACT-BMT Version 4 - Worry My Condition Will Get Worse FAC061-I Am Able to Work Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am able to work (include work at home). FACT-BMT Version 4 - I Am Able to Work FAC061-My Work Is Fulfilling Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - My work (include work at home) is fulfilling. FACT-BMT Version 4 - My Work Is Fulfilling FAC061-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am able to enjoy life. FACT-BMT Version 4 - I Am Able to Enjoy Life FAC061-I Have Accepted My Illness Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have accepted my illness. FACT-BMT Version 4 - I Have Accepted My Illness FAC061-I Am Sleeping Well Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am sleeping well. FACT-BMT Version 4 - I Am Sleeping Well FAC061-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am enjoying the things I usually do for fun. FACT-BMT Version 4 - Enjoy Things I Usually Do for Fun FAC061-Content With Quality of My Life Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am content with the quality of my life right now. FACT-BMT Version 4 - Content With Quality of My Life FAC061-I Am Concerned About Keeping Job Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am concerned about keeping my job (include work at home). FACT-BMT Version 4 - I Am Concerned About Keeping Job FAC061-I Feel Distant From Other People Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I feel distant from other people. FACT-BMT Version 4 - I Feel Distant From Other People FAC061-I Worry Transplant Will Not Work Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I worry that the transplant will not work. FACT-BMT Version 4 - I Worry Transplant Will Not Work FAC061-Side Effect of Treatment Worse Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - The side effects of treatment are worse than I had imagined. FACT-BMT Version 4 - Side Effect of Treatment Worse FAC061-I Have a Good Appetite Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have a good appetite. FACT-BMT Version 4 - I Have a Good Appetite FAC061-I Like the Appearance of My Body Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I like the appearance of my body. FACT-BMT Version 4 - I Like the Appearance of My Body FAC061-I Am Able to Get Around by Myself Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am able to get around by myself. FACT-BMT Version 4 - I Am Able to Get Around by Myself FAC061-I Get Tired Easily Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I get tired easily. FACT-BMT Version 4 - I Get Tired Easily FAC061-I Am Interested in Sex Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am interested in sex. FACT-BMT Version 4 - I Am Interested in Sex FAC061-Concerns Ability to Have Children Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have concerns about my ability to have children. FACT-BMT Version 4 - Concerns Ability to Have Children FAC061-Confidence in My Nurse(s) Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have confidence in my nurse(s). FACT-BMT Version 4 - Confidence in My Nurse(s) FAC061-I Regret Bone Marrow Transplant Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I regret having the bone marrow transplant. FACT-BMT Version 4 - I Regret Bone Marrow Transplant FAC061-I Can Remember Things Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I can remember things. FACT-BMT Version 4 - I Can Remember Things FAC061-I Am Able to Concentrate Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am able to concentrate. FACT-BMT Version 4 - I Am Able to Concentrate FAC061-I Have Frequent Colds/Infections Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have frequent colds/infections. FACT-BMT Version 4 - I Have Frequent Colds/Infections FAC061-My Eyesight Is Blurry Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - My eyesight is blurry. FACT-BMT Version 4 - My Eyesight Is Blurry FAC061-Bothered by Change in Food Tastes Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am bothered by a change in the way food tastes. FACT-BMT Version 4 - Bothered by Change in Food Tastes FAC061-I Have Tremors Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have tremors. FACT-BMT Version 4 - I Have Tremors FAC061-I Have Been Short of Breath Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have been short of breath. FACT-BMT Version 4 - I Have Been Short of Breath FAC061-I Am Bothered by Skin Problems Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am bothered by skin problems. FACT-BMT Version 4 - I Am Bothered by Skin Problems FAC061-I Have Trouble With My Bowels Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have trouble with my bowels. FACT-BMT Version 4 - I Have Trouble With My Bowels FAC061-Illness Is Hardship for My Family Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - My illness is a personal hardship for my close family members. FACT-BMT Version 4 - Illness Is Hardship for My Family FAC061-Cost of Treatment Is Burden on Me Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - The cost of my treatment is a burden on me or my family. FACT-BMT Version 4 - Cost of Treatment Is Burden on Me FAC061TC Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 Questionnaire Test Code CDISC Questionnaire FACT-BMT Version 4 Test Code Terminology Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 test name. FAC061-Bothered by Change in Food Tastes Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am bothered by a change in the way food tastes. FACT-BMT Version 4 - Bothered by Change in Food Tastes FAC061-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am bothered by side effects of treatment. FACT-BMT Version 4 - Bothered by Treatment Side Effect FAC061-Concerns Ability to Have Children Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have concerns about my ability to have children. FACT-BMT Version 4 - Concerns Ability to Have Children FAC061-Confidence in My Nurse(s) Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have confidence in my nurse(s). FACT-BMT Version 4 - Confidence in My Nurse(s) FAC061-Content With Quality of My Life Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am content with the quality of my life right now. FACT-BMT Version 4 - Content With Quality of My Life FAC061-Cost of Treatment Is Burden on Me Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - The cost of my treatment is a burden on me or my family. FACT-BMT Version 4 - Cost of Treatment Is Burden on Me FAC061-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am enjoying the things I usually do for fun. FACT-BMT Version 4 - Enjoy Things I Usually Do for Fun FAC061-Get Emotional Support From Family Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I get emotional support from my family. FACT-BMT Version 4 - Get Emotional Support From Family FAC061-I Am Able to Concentrate Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am able to concentrate. FACT-BMT Version 4 - I Am Able to Concentrate FAC061-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am able to enjoy life. FACT-BMT Version 4 - I Am Able to Enjoy Life FAC061-I Am Able to Get Around by Myself Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am able to get around by myself. FACT-BMT Version 4 - I Am Able to Get Around by Myself FAC061-I Am Able to Work Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am able to work (include work at home). FACT-BMT Version 4 - I Am Able to Work FAC061-I Am Bothered by Skin Problems Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am bothered by skin problems. FACT-BMT Version 4 - I Am Bothered by Skin Problems FAC061-I Am Concerned About Keeping Job Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am concerned about keeping my job (include work at home). FACT-BMT Version 4 - I Am Concerned About Keeping Job FAC061-I Am Forced to Spend Time in Bed Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am forced to spend time in bed. FACT-BMT Version 4 - I Am Forced to Spend Time in Bed FAC061-I Am Interested in Sex Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am interested in sex. FACT-BMT Version 4 - I Am Interested in Sex FAC061-I Am Satisfied With My Sex Life Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am satisfied with my sex life. FACT-BMT Version 4 - I Am Satisfied With My Sex Life FAC061-I Am Sleeping Well Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am sleeping well. FACT-BMT Version 4 - I Am Sleeping Well FAC061-I Can Remember Things Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I can remember things. FACT-BMT Version 4 - I Can Remember Things FAC061-I Feel Close to My Friends Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I feel close to my friends. FACT-BMT Version 4 - I Feel Close to My Friends FAC061-I Feel Close to My Partner Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I feel close to my partner (or the person who is my main support). FACT-BMT Version 4 - I Feel Close to My Partner FAC061-I Feel Distant From Other People Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I feel distant from other people. FACT-BMT Version 4 - I Feel Distant From Other People FAC061-I Feel Ill Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I feel ill. FACT-BMT Version 4 - I Feel Ill FAC061-I Feel Nervous Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I feel nervous. FACT-BMT Version 4 - I Feel Nervous FAC061-I Feel Sad Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I feel sad. FACT-BMT Version 4 - I Feel Sad FAC061-I Get Support From My Friends Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I get support from my friends. FACT-BMT Version 4 - I Get Support From My Friends FAC061-I Get Tired Easily Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I get tired easily. FACT-BMT Version 4 - I Get Tired Easily FAC061-I Have a Good Appetite Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have a good appetite. FACT-BMT Version 4 - I Have a Good Appetite FAC061-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have a lack of energy. FACT-BMT Version 4 - I Have a Lack of Energy FAC061-I Have Accepted My Illness Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have accepted my illness. FACT-BMT Version 4 - I Have Accepted My Illness FAC061-I Have Been Short of Breath Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have been short of breath. FACT-BMT Version 4 - I Have Been Short of Breath FAC061-I Have Frequent Colds/Infections Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have frequent colds/infections. FACT-BMT Version 4 - I Have Frequent Colds/Infections FAC061-I Have Nausea Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have nausea. FACT-BMT Version 4 - I Have Nausea FAC061-I Have Pain Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have pain. FACT-BMT Version 4 - I Have Pain FAC061-I Have Tremors Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have tremors. FACT-BMT Version 4 - I Have Tremors FAC061-I Have Trouble With My Bowels Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have trouble with my bowels. FACT-BMT Version 4 - I Have Trouble With My Bowels FAC061-I Like the Appearance of My Body Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I like the appearance of my body. FACT-BMT Version 4 - I Like the Appearance of My Body FAC061-I Regret Bone Marrow Transplant Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I regret having the bone marrow transplant. FACT-BMT Version 4 - I Regret Bone Marrow Transplant FAC061-I Worry About Dying Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I worry about dying. FACT-BMT Version 4 - I Worry About Dying FAC061-I Worry Transplant Will Not Work Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I worry that the transplant will not work. FACT-BMT Version 4 - I Worry Transplant Will Not Work FAC061-Illness Is Hardship for My Family Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - My illness is a personal hardship for my close family members. FACT-BMT Version 4 - Illness Is Hardship for My Family FAC061-Losing Hope Against Illness Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am losing hope in the fight against my illness. FACT-BMT Version 4 - Losing Hope Against Illness FAC061-My Eyesight Is Blurry Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - My eyesight is blurry. FACT-BMT Version 4 - My Eyesight Is Blurry FAC061-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - My family has accepted my illness. FACT-BMT Version 4 - My Family Has Accepted My Illness FAC061-My Work Is Fulfilling Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - My work (include work at home) is fulfilling. FACT-BMT Version 4 - My Work Is Fulfilling FAC061-Satisfied Communication Illness Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am satisfied with family communication about my illness. FACT-BMT Version 4 - Satisfied Communication Illness FAC061-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am satisfied with how I am coping with my illness. FACT-BMT Version 4 - Satisfied With How I Am Coping FAC061-Side Effect of Treatment Worse Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - The side effects of treatment are worse than I had imagined. FACT-BMT Version 4 - Side Effect of Treatment Worse FAC061-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - Because of my physical condition, I have trouble meeting the needs of my family. FACT-BMT Version 4 - Trouble Meeting Needs of Family FAC061-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I worry that my condition will get worse. FACT-BMT Version 4 - Worry My Condition Will Get Worse FAC061TN Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 Questionnaire Test Name CDISC Questionnaire FACT-BMT Version 4 Test Name Terminology Functional Assessment of Cancer Therapy-Bone Pain Version 4 test code. FAC074-How Many Places in Body Felt Pain Functional Assessment of Cancer Therapy - BP: for patients with bone pain: In how many places in your body have you felt bone pain. FACT-BP Version 4 - How Many Places in Body Felt Pain FAC074-Certain Parts of Body Have Pain Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I have certain parts of my body where I experience pain. FACT-BP Version 4 - Certain Parts of Body Have Pain FAC074-I Have Bone Pain Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I have bone pain. FACT-BP Version 4 - I Have Bone Pain FAC074-Hurts When Put Weight/Pressure on Functional Assessment of Cancer Therapy - BP: for patients with bone pain: It hurts when I put weight or pressure on the place where I have bone pain. FACT-BP Version 4 - Hurts When Put Weight/Pressure on FAC074-Bone Pain Even When I Sit Still Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I have bone pain even when I sit stil. FACT-BP Version 4 - Bone Pain Even When I Sit Still FAC074-Need Help Doing Usual Activities Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I need help doing my usual activities because of bone pain. FACT-BP Version 4 - Need Help Doing Usual Activities FAC074-Rest During Day Due to Bone Pain Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I am forced to rest during the day due to bone pain. FACT-BP Version 4 - Rest During Day Due to Bone Pain FAC074-Trouble Walking Because Bone Pain Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I have trouble walking because of bone pain. FACT-BP Version 4 - Trouble Walking Because Bone Pain FAC074-Bone Pain Interferes Care Myself Functional Assessment of Cancer Therapy - BP: for patients with bone pain: Bone pain interferes with my ability to care for myself (bathing, dressing, eating, etc.). FACT-BP Version 4 - Bone Pain Interferes Care Myself FAC074-Bone Pain Interferes w/Social Functional Assessment of Cancer Therapy - BP: for patients with bone pain: Bone pain interferes with my social activities. FACT-BP Version 4 - Bone Pain Interferes w/Social FAC074-Bone Pain Interferes w/My Sleep Functional Assessment of Cancer Therapy - BP: for patients with bone pain: Bone pain interferes with my sleep. FACT-BP Version 4 - Bone Pain Interferes w/My Sleep FAC074-I am Frustrated by My Bone Pain Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I am frustrated by my bone pain. FACT-BP Version 4 - I am Frustrated by My Bone Pain FAC074-I Feel Depressed about Bone Pain Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I feel depressed about my bone pain. FACT-BP Version 4 - I Feel Depressed about Bone Pain FAC074-I Worry Bone Pain Will Get Worse Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I worry that my bone pain will get worse. FACT-BP Version 4 - I Worry Bone Pain Will Get Worse FAC074-Bone Pain Interferes w/My Family Functional Assessment of Cancer Therapy - BP: for patients with bone pain: My bone pain interferes with my family life. FACT-BP Version 4 - Bone Pain Interferes w/My Family FAC074-Pain Interferes Vigorous Activity Functional Assessment of Cancer Therapy - BP: for patients with bone pain: Bone pain interferes with my ability to do vigorous activity (exercise, heavy lifting, etc.). FACT-BP Version 4 - Pain Interferes Vigorous Activity FAC074-Trouble Concentrating Due to Pain Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I have trouble concentrating due to my bone pain. FACT-BP Version 4 - Trouble Concentrating Due to Pain FAC074-Difficulty Coping w/My Bone Pain Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I have difficulty coping with my bone pain. FACT-BP Version 4 - Difficulty Coping w/My Bone Pain FAC074-Difficulty Working Due to Pain Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I have difficulty working due to my bone pain (including work at home) FACT-BP Version 4 - Difficulty Working Due to Pain FAC074-Content With Quality of My Life Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I am content with the quality of my life right now. FACT-BP Version 4 - Content With Quality of My Life FAC074-Total Score Functional Assessment of Cancer therapy - BP: BP subscale score. FACT-BP Version 4 - Total Score FAC074TC Functional Assessment of Cancer Therapy-Bone Pain Version 4 Questionnaire Test Code CDISC Questionnaire FACT-BP Version 4 Test Code Terminology Functional Assessment of Cancer Therapy-Bone Pain Version 4 test name. FAC074-Bone Pain Even When I Sit Still Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I have bone pain even when I sit stil. FACT-BP Version 4 - Bone Pain Even When I Sit Still FAC074-Bone Pain Interferes Care Myself Functional Assessment of Cancer Therapy - BP: for patients with bone pain: Bone pain interferes with my ability to care for myself (bathing, dressing, eating, etc.). FACT-BP Version 4 - Bone Pain Interferes Care Myself FAC074-Bone Pain Interferes w/My Family Functional Assessment of Cancer Therapy - BP: for patients with bone pain: My bone pain interferes with my family life. FACT-BP Version 4 - Bone Pain Interferes w/My Family FAC074-Bone Pain Interferes w/My Sleep Functional Assessment of Cancer Therapy - BP: for patients with bone pain: Bone pain interferes with my sleep. FACT-BP Version 4 - Bone Pain Interferes w/My Sleep FAC074-Bone Pain Interferes w/Social Functional Assessment of Cancer Therapy - BP: for patients with bone pain: Bone pain interferes with my social activities. FACT-BP Version 4 - Bone Pain Interferes w/Social FAC074-Certain Parts of Body Have Pain Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I have certain parts of my body where I experience pain. FACT-BP Version 4 - Certain Parts of Body Have Pain FAC074-Content With Quality of My Life Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I am content with the quality of my life right now. FACT-BP Version 4 - Content With Quality of My Life FAC074-Difficulty Coping w/My Bone Pain Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I have difficulty coping with my bone pain. FACT-BP Version 4 - Difficulty Coping w/My Bone Pain FAC074-Difficulty Working Due to Pain Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I have difficulty working due to my bone pain (including work at home) FACT-BP Version 4 - Difficulty Working Due to Pain FAC074-How Many Places in Body Felt Pain Functional Assessment of Cancer Therapy - BP: for patients with bone pain: In how many places in your body have you felt bone pain. FACT-BP Version 4 - How Many Places in Body Felt Pain FAC074-Hurts When Put Weight/Pressure on Functional Assessment of Cancer Therapy - BP: for patients with bone pain: It hurts when I put weight or pressure on the place where I have bone pain. FACT-BP Version 4 - Hurts When Put Weight/Pressure on FAC074-I am Frustrated by My Bone Pain Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I am frustrated by my bone pain. FACT-BP Version 4 - I am Frustrated by My Bone Pain FAC074-I Feel Depressed about Bone Pain Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I feel depressed about my bone pain. FACT-BP Version 4 - I Feel Depressed about Bone Pain FAC074-I Have Bone Pain Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I have bone pain. FACT-BP Version 4 - I Have Bone Pain FAC074-I Worry Bone Pain Will Get Worse Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I worry that my bone pain will get worse. FACT-BP Version 4 - I Worry Bone Pain Will Get Worse FAC074-Need Help Doing Usual Activities Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I need help doing my usual activities because of bone pain. FACT-BP Version 4 - Need Help Doing Usual Activities FAC074-Pain Interferes Vigorous Activity Functional Assessment of Cancer Therapy - BP: for patients with bone pain: Bone pain interferes with my ability to do vigorous activity (exercise, heavy lifting, etc.). FACT-BP Version 4 - Pain Interferes Vigorous Activity FAC074-Rest During Day Due to Bone Pain Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I am forced to rest during the day due to bone pain. FACT-BP Version 4 - Rest During Day Due to Bone Pain FAC074-Total Score Functional Assessment of Cancer therapy - BP: BP subscale score. FACT-BP Version 4 - Total Score FAC074-Trouble Concentrating Due to Pain Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I have trouble concentrating due to my bone pain. FACT-BP Version 4 - Trouble Concentrating Due to Pain FAC074-Trouble Walking Because Bone Pain Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I have trouble walking because of bone pain. FACT-BP Version 4 - Trouble Walking Because Bone Pain FAC074TN Functional Assessment of Cancer Therapy-Bone Pain Version 4 Questionnaire Test Name CDISC Questionnaire FACT-BP Version 4 Test Name Terminology Functional Assessment of Cancer Therapy-Brain Symptom Index test code. FAC029-I Get Headaches Functional Assessment of Cancer Therapy-Brain Symptom Index - I get headaches. FBRSI - I Get Headaches FAC029-I Have Had Seizures Functional Assessment of Cancer Therapy-Brain Symptom Index - I have had seizures (convulsions). FBRSI - I Have Had Seizures FAC029-Have Weakness in My Arms or Legs Functional Assessment of Cancer Therapy-Brain Symptom Index - I have weakness in my arms or legs. FBRSI - Have Weakness in My Arms or Legs FAC029-I Need Help in Caring for Myself Functional Assessment of Cancer Therapy-Brain Symptom Index - I need help in caring for myself (bathing, dressing, eating, etc.). FBRSI - I Need Help in Caring for Myself FAC029-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Brain Symptom Index - I have a lack of energy. FBRSI - I Have a Lack of Energy FAC029-Difficulty Expressing My Thoughts Functional Assessment of Cancer Therapy-Brain Symptom Index - I have difficulty expressing my thoughts. FBRSI - Difficulty Expressing My Thoughts FAC029-I Have Trouble With Coordination Functional Assessment of Cancer Therapy-Brain Symptom Index - I have trouble with coordination. FBRSI - I Have Trouble With Coordination FAC029-Frustrated I Cannot Do Things Functional Assessment of Cancer Therapy-Brain Symptom Index - I get frustrated that I cannot do things I used to. FBRSI - Frustrated I Cannot Do Things FAC029-I Have Nausea Functional Assessment of Cancer Therapy-Brain Symptom Index - I have nausea. FBRSI - I Have Nausea FAC029-Able to Find the Right Words Functional Assessment of Cancer Therapy-Brain Symptom Index - I am able to find the right word(s) to say what I mean. FBRSI - Able to Find the Right Words FAC029-Losing Hope Against Illness Functional Assessment of Cancer Therapy-Brain Symptom Index - I am losing hope in the fight against my illness. FBRSI - Losing Hope Against Illness FAC029-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-Brain Symptom Index - Because of my physical condition, I have trouble meeting the needs of my family. FBRSI - Trouble Meeting Needs of Family FAC029-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Brain Symptom Index - I worry that my condition will get worse. FBRSI - Worry My Condition Will Get Worse FAC029-I Am Afraid of Having a Seizure Functional Assessment of Cancer Therapy-Brain Symptom Index - I am afraid of having a seizure (convulsion). FBRSI - I Am Afraid of Having a Seizure FAC029-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-Brain Symptom Index - I am able to enjoy life. FBRSI - I Am Able to Enjoy Life FAC029TC Functional Assessment of Cancer Therapy-Brain Symptom Index Questionnaire Test Code CDISC Questionnaire FBRSI Test Code Terminology Functional Assessment of Cancer Therapy-Brain Symptom Index test name. FAC029-Able to Find the Right Words Functional Assessment of Cancer Therapy-Brain Symptom Index - I am able to find the right word(s) to say what I mean. FBRSI - Able to Find the Right Words FAC029-Difficulty Expressing My Thoughts Functional Assessment of Cancer Therapy-Brain Symptom Index - I have difficulty expressing my thoughts. FBRSI - Difficulty Expressing My Thoughts FAC029-Frustrated I Cannot Do Things Functional Assessment of Cancer Therapy-Brain Symptom Index - I get frustrated that I cannot do things I used to. FBRSI - Frustrated I Cannot Do Things FAC029-Have Weakness in My Arms or Legs Functional Assessment of Cancer Therapy-Brain Symptom Index - I have weakness in my arms or legs. FBRSI - Have Weakness in My Arms or Legs FAC029-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-Brain Symptom Index - I am able to enjoy life. FBRSI - I Am Able to Enjoy Life FAC029-I Am Afraid of Having a Seizure Functional Assessment of Cancer Therapy-Brain Symptom Index - I am afraid of having a seizure (convulsion). FBRSI - I Am Afraid of Having a Seizure FAC029-I Get Headaches Functional Assessment of Cancer Therapy-Brain Symptom Index - I get headaches. FBRSI - I Get Headaches FAC029-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Brain Symptom Index - I have a lack of energy. FBRSI - I Have a Lack of Energy FAC029-I Have Had Seizures Functional Assessment of Cancer Therapy-Brain Symptom Index - I have had seizures (convulsions). FBRSI - I Have Had Seizures FAC029-I Have Nausea Functional Assessment of Cancer Therapy-Brain Symptom Index - I have nausea. FBRSI - I Have Nausea FAC029-I Have Trouble With Coordination Functional Assessment of Cancer Therapy-Brain Symptom Index - I have trouble with coordination. FBRSI - I Have Trouble With Coordination FAC029-I Need Help in Caring for Myself Functional Assessment of Cancer Therapy-Brain Symptom Index - I need help in caring for myself (bathing, dressing, eating, etc.). FBRSI - I Need Help in Caring for Myself FAC029-Losing Hope Against Illness Functional Assessment of Cancer Therapy-Brain Symptom Index - I am losing hope in the fight against my illness. FBRSI - Losing Hope Against Illness FAC029-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-Brain Symptom Index - Because of my physical condition, I have trouble meeting the needs of my family. FBRSI - Trouble Meeting Needs of Family FAC029-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Brain Symptom Index - I worry that my condition will get worse. FBRSI - Worry My Condition Will Get Worse FAC029TN Functional Assessment of Cancer Therapy-Brain Symptom Index Questionnaire Test Name CDISC Questionnaire FBRSI Test Name Terminology Functional Assessment of Cancer Therapy-Breast Version 4 test code. FAC005-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: I have a lack of energy. FACT-B Version 4 - I Have a Lack of Energy FAC005-I Have Nausea Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: I have nausea. FACT-B Version 4 - I Have Nausea FAC005-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. FACT-B Version 4 - Trouble Meeting Needs of Family FAC005-I Have Pain Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: I have pain. FACT-B Version 4 - I Have Pain FAC005-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: I am bothered by side effects of treatment. FACT-B Version 4 - Bothered by Treatment Side Effect FAC005-I Feel Ill Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: I feel ill. FACT-B Version 4 - I Feel Ill FAC005-I Am Forced to Spend Time in Bed Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: I am forced to spend time in bed. FACT-B Version 4 - I Am Forced to Spend Time in Bed FAC005-I Feel Close to My Friends Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: I feel close to my friends. FACT-B Version 4 - I Feel Close to My Friends FAC005-Get Emotional Support From Family Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: I get emotional support from my family. FACT-B Version 4 - Get Emotional Support From Family FAC005-I Get Support From My Friends Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: I get support from my friends. FACT-B Version 4 - I Get Support From My Friends FAC005-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: My family has accepted my illness. FACT-B Version 4 - My Family Has Accepted My Illness FAC005-Satisfied Communication Illness Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. FACT-B Version 4 - Satisfied Family Communication of Illness FAC005-I Feel Close to My Partner Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). FACT-B Version 4 - I Feel Close to My Partner FAC005-I Am Satisfied With My Sex Life Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: I am satisfied with my sex life. FACT-B Version 4 - I Am Satisfied With My Sex Life FAC005-I Feel Sad Functional Assessment of Cancer Therapy-Breast Version 4 - Emotional Well-Being: I feel sad. FACT-B Version 4 - I Feel Sad FAC005-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy-Breast Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. FACT-B Version 4 - Satisfied With How I Am Coping FAC005-Losing Hope Against Illness Functional Assessment of Cancer Therapy-Breast Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. FACT-B Version 4 - Losing Hope Against Illness FAC005-I Feel Nervous Functional Assessment of Cancer Therapy-Breast Version 4 - Emotional Well-Being: I feel nervous. FACT-B Version 4 - I Feel Nervous FAC005-I Worry About Dying Functional Assessment of Cancer Therapy-Breast Version 4 - Emotional Well-Being: I worry about dying. FACT-B Version 4 - I Worry About Dying FAC005-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Breast Version 4 - Emotional Well-Being: I worry that my condition will get worse. FACT-B Version 4 - Worry My Condition Will Get Worse FAC005-I Am Able to Work Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: I am able to work (include work at home). FACT-B Version 4 - I Am Able to Work FAC005-My Work Is Fulfilling Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. FACT-B Version 4 - My Work Is Fulfilling FAC005-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: I am able to enjoy life. FACT-B Version 4 - I Am Able to Enjoy Life FAC005-I Have Accepted My Illness Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: I have accepted my illness. FACT-B Version 4 - I Have Accepted My Illness FAC005-I Am Sleeping Well Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: I am sleeping well. FACT-B Version 4 - I Am Sleeping Well FAC005-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. FACT-B Version 4 - Enjoy Things I Usually Do for Fun FAC005-Content With Quality of My Life Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: I am content with the quality of my life right now. FACT-B Version 4 - Content With Quality of My Life FAC005-I Have Been Short of Breath Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I have been short of breath. FACT-B Version 4 - I Have Been Short of Breath FAC005-Self-conscious About Way I Dress Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I am self-conscious about the way I dress. FACT-B Version 4 - Self-conscious About Way I Dress FAC005-One/Both Arms Are Swollen/Tender Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: One or both of my arms are swollen or tender. FACT-B Version 4 - One or Both Arms Are Swollen or Tender FAC005-I Feel Sexually Attractive Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I feel sexually attractive. FACT-B Version 4 - I Feel Sexually Attractive FAC005-I Am Bothered by Hair Loss Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I am bothered by hair loss. FACT-B Version 4 - I Am Bothered by Hair Loss FAC005-Worry Family Will Get Illness Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I worry that other members of my family might someday get the same illness I have. FACT-B Version 4 - Worry Family Will Get Illness FAC005-Worry About the Effect of Stress Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I worry about the effect of stress on my illness. FACT-B Version 4 - Worry About the Effect of Stress FAC005-I Am Bothered by Change in Weight Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I am bothered by a change in weight. FACT-B Version 4 - I Am Bothered by Change in Weight FAC005-I Am Able to Feel Like a Woman Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I am able to feel like a woman. FACT-B Version 4 - I Am Able to Feel Like a Woman FAC005-Certain Parts of Body Have Pain Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I have certain parts of my body where I experience pain. FACT-B Version 4 - Certain Parts of Body Have Pain FAC005-Physical Subscale Score Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: Subscale score. FACT-B Version 4 - Physical Subscale Score FAC005-Social/Family Subscale Score Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: Subscale score. FACT-B Version 4 - Social/Family Subscale Score FAC005-Emotional Subscale Score Functional Assessment of Cancer Therapy-Breast Version 4 - Emotional Well-Being: Subscale score. FACT-B Version 4 - Emotional Subscale Score FAC005-Functional Subscale Score Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: Subscale score. FACT-B Version 4 - Functional Subscale Score FAC005-Additional Concern Subscale Score Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: Subscale score. FACT-B Version 4 - Additional Concern Subscale Score FAC005-Trial Outcome Index Score Functional Assessment of Cancer Therapy-Breast Version 4 - Trial outcome index score. FACT-B Version 4 - Trial Outcome Index Score FAC005-FACT-G Total Score Functional Assessment of Cancer Therapy-Breast Version 4 - FACT-G total score. FACT-B Version 4 - FACT-G Total Score FAC005-Total Score Functional Assessment of Cancer Therapy-Breast Version 4 - Total score. FACT-B Version 4 - Total Score FAC005TC Functional Assessment of Cancer Therapy-Breast Version 4 Questionnaire Test Code CDISC Questionnaire FACT-B Version 4 Test Code Terminology Functional Assessment of Cancer Therapy-Breast Version 4 test name. FAC005-Additional Concern Subscale Score Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: Subscale score. FACT-B Version 4 - Additional Concern Subscale Score FAC005-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: I am bothered by side effects of treatment. FACT-B Version 4 - Bothered by Treatment Side Effect FAC005-Certain Parts of Body Have Pain Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I have certain parts of my body where I experience pain. FACT-B Version 4 - Certain Parts of Body Have Pain FAC005-Content With Quality of My Life Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: I am content with the quality of my life right now. FACT-B Version 4 - Content With Quality of My Life FAC005-Emotional Subscale Score Functional Assessment of Cancer Therapy-Breast Version 4 - Emotional Well-Being: Subscale score. FACT-B Version 4 - Emotional Subscale Score FAC005-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. FACT-B Version 4 - Enjoy Things I Usually Do for Fun FAC005-FACT-G Total Score Functional Assessment of Cancer Therapy-Breast Version 4 - FACT-G total score. FACT-B Version 4 - FACT-G Total Score FAC005-Functional Subscale Score Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: Subscale score. FACT-B Version 4 - Functional Subscale Score FAC005-Get Emotional Support From Family Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: I get emotional support from my family. FACT-B Version 4 - Get Emotional Support From Family FAC005-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: I am able to enjoy life. FACT-B Version 4 - I Am Able to Enjoy Life FAC005-I Am Able to Feel Like a Woman Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I am able to feel like a woman. FACT-B Version 4 - I Am Able to Feel Like a Woman FAC005-I Am Able to Work Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: I am able to work (include work at home). FACT-B Version 4 - I Am Able to Work FAC005-I Am Bothered by Change in Weight Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I am bothered by a change in weight. FACT-B Version 4 - I Am Bothered by Change in Weight FAC005-I Am Bothered by Hair Loss Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I am bothered by hair loss. FACT-B Version 4 - I Am Bothered by Hair Loss FAC005-I Am Forced to Spend Time in Bed Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: I am forced to spend time in bed. FACT-B Version 4 - I Am Forced to Spend Time in Bed FAC005-I Am Satisfied With My Sex Life Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: I am satisfied with my sex life. FACT-B Version 4 - I Am Satisfied With My Sex Life FAC005-I Am Sleeping Well Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: I am sleeping well. FACT-B Version 4 - I Am Sleeping Well FAC005-I Feel Close to My Friends Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: I feel close to my friends. FACT-B Version 4 - I Feel Close to My Friends FAC005-I Feel Close to My Partner Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). FACT-B Version 4 - I Feel Close to My Partner FAC005-I Feel Ill Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: I feel ill. FACT-B Version 4 - I Feel Ill FAC005-I Feel Nervous Functional Assessment of Cancer Therapy-Breast Version 4 - Emotional Well-Being: I feel nervous. FACT-B Version 4 - I Feel Nervous FAC005-I Feel Sad Functional Assessment of Cancer Therapy-Breast Version 4 - Emotional Well-Being: I feel sad. FACT-B Version 4 - I Feel Sad FAC005-I Feel Sexually Attractive Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I feel sexually attractive. FACT-B Version 4 - I Feel Sexually Attractive FAC005-I Get Support From My Friends Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: I get support from my friends. FACT-B Version 4 - I Get Support From My Friends FAC005-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: I have a lack of energy. FACT-B Version 4 - I Have a Lack of Energy FAC005-I Have Accepted My Illness Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: I have accepted my illness. FACT-B Version 4 - I Have Accepted My Illness FAC005-I Have Been Short of Breath Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I have been short of breath. FACT-B Version 4 - I Have Been Short of Breath FAC005-I Have Nausea Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: I have nausea. FACT-B Version 4 - I Have Nausea FAC005-I Have Pain Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: I have pain. FACT-B Version 4 - I Have Pain FAC005-I Worry About Dying Functional Assessment of Cancer Therapy-Breast Version 4 - Emotional Well-Being: I worry about dying. FACT-B Version 4 - I Worry About Dying FAC005-Losing Hope Against Illness Functional Assessment of Cancer Therapy-Breast Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. FACT-B Version 4 - Losing Hope Against Illness FAC005-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: My family has accepted my illness. FACT-B Version 4 - My Family Has Accepted My Illness FAC005-My Work Is Fulfilling Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. FACT-B Version 4 - My Work Is Fulfilling FAC005-One/Both Arms Are Swollen/Tender Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: One or both of my arms are swollen or tender. FACT-B Version 4 - One or Both Arms Are Swollen or Tender FAC005-Physical Subscale Score Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: Subscale score. FACT-B Version 4 - Physical Subscale Score FAC005-Satisfied Communication Illness Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. FACT-B Version 4 - Satisfied Family Communication of Illness FAC005-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy-Breast Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. FACT-B Version 4 - Satisfied With How I Am Coping FAC005-Self-conscious About Way I Dress Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I am self-conscious about the way I dress. FACT-B Version 4 - Self-conscious About Way I Dress FAC005-Social/Family Subscale Score Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: Subscale score. FACT-B Version 4 - Social/Family Subscale Score FAC005-Total Score Functional Assessment of Cancer Therapy-Breast Version 4 - Total score. FACT-B Version 4 - Total Score FAC005-Trial Outcome Index Score Functional Assessment of Cancer Therapy-Breast Version 4 - Trial outcome index score. FACT-B Version 4 - Trial Outcome Index Score FAC005-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. FACT-B Version 4 - Trouble Meeting Needs of Family FAC005-Worry About the Effect of Stress Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I worry about the effect of stress on my illness. FACT-B Version 4 - Worry About the Effect of Stress FAC005-Worry Family Will Get Illness Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I worry that other members of my family might someday get the same illness I have. FACT-B Version 4 - Worry Family Will Get Illness FAC005-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Breast Version 4 - Emotional Well-Being: I worry that my condition will get worse. FACT-B Version 4 - Worry My Condition Will Get Worse FAC005TN Functional Assessment of Cancer Therapy-Breast Version 4 Questionnaire Test Name CDISC Questionnaire FACT-B Version 4 Test Name Terminology Functional Assessment of Cancer Therapy-Cognitive Function Version 3 test code. FAC075-I Have Trouble Forming Thoughts Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble forming thoughts. FACT-COG Version 3 - I Have Trouble Forming Thoughts FAC075-My Thinking Has Been Slow Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: My thinking has been slow. FACT-COG Version 3 - My Thinking Has Been Slow FAC075-I Have Had Trouble Concentrating Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble concentrating. FACT-COG Version 3 - I Have Had Trouble Concentrating FAC075-Trouble Finding Familiar Place Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble finding my way to a familiar place. FACT-COG Version 3 - Trouble Finding Familiar Place FAC075-Trouble Remember Where Put Things Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble remembering where I put things, like my keys or my wallet. FACT-COG Version 3 - Trouble Remember Where Put Things FAC075-Trouble Remembering New Info Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble remembering new information, like phone numbers or simple instructions. FACT-COG Version 3 - Trouble Remembering New Info FAC075-Trouble Recalling Name of Object Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble recalling the name of an object while talking to someone. FACT-COG Version 3 - Trouble Recalling Name of Object FAC075-Trouble Finding Right Words Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble finding the right word(s) to express myself. FACT-COG Version 3 - Trouble Finding Right Words FAC075-Used Wrong Word When Refer Object Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have used the wrong word when I referred to an object. FACT-COG Version 3 - Used Wrong Word When Refer Object FAC075-Trouble Saying What I Mean Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble saying what I mean in conversations with others. FACT-COG Version 3 - Trouble Saying What I Mean FAC075-Walked Into a Room and Forgotten Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have walked into a room and forgotten what I meant to get or do there. FACT-COG Version 3 - Walked Into a Room and Forgotten FAC075-Work Hard to Pay Attention Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had to work really hard to pay attention or I would make a mistake. FACT-COG Version 3 - Work Hard to Pay Attention FAC075-Forgotten Names After Introduced Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have forgotten names of people soon after being introduced. FACT-COG Version 3 - Forgotten Names After Introduced FAC075-Reaction Everyday Situations Slow Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: My reactions in everyday situations have been slow. FACT-COG Version 3 - Reaction Everyday Situations Slow FAC075-Work Harder Than Usual to Track Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had to work harder than usual to keep track of what I was doing. FACT-COG Version 3 - Work Harder Than Usual to Track FAC075-My Thinking Slower Than Usual Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: My thinking has been slower than usual. FACT-COG Version 3 - My Thinking Slower Than Usual FAC075-Work Harder Than Usual to Express Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had to work harder than usual to express myself clearly. FACT-COG Version 3 - Work Harder Than Usual to Express FAC075-Use Written Lists More Often Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had to use written lists more often than usual so I would not forget things. FACT-COG Version 3 - Use Written Lists More Often FAC075-Trouble Keeping Track Interrupted Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have trouble keeping track of what I am doing if I am interrupted. FACT-COG Version 3 - Trouble Keeping Track Interrupted FAC075-Trouble Shifting Back and Forth Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have trouble shifting back and forth between different activities that require thinking. FACT-COG Version 3 - Trouble Shifting Back and Forth FAC075-Told Me Trouble Remembering Info Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Comments From Others: Other people have told me I seemed to have trouble remembering information. FACT-COG Version 3 - Told Me Trouble Remembering Info FAC075-Told Me Trouble Speaking Clearly Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Comments From Others: Other people have told me I seemed to have trouble speaking clearly. FACT-COG Version 3 - Told Me Trouble Speaking Clearly FAC075-Told Me Trouble Thinking Clearly Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Comments From Others: Other people have told me I seemed to have trouble thinking clearly. FACT-COG Version 3 - Told Me Trouble Thinking Clearly FAC075-People Told Me I Seemed Confused Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Comments From Others: Other people have told me I seemed confused. FACT-COG Version 3 - People Told Me I Seemed Confused FAC075-I Have Been Able to Concentrate Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: I have been able to concentrate. FACT-COG Version 3 - I Have Been Able to Concentrate FAC075-Able to Bring to Mind Words Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: I have been able to bring to mind words that I wanted to use while talking to someone. FACT-COG Version 3 - Able to Bring to Mind Words FAC075-Able Remember Things Where Left Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: I have been able to remember things, like where I left my keys or wallet. FACT-COG Version 3 - Able Remember Things Where Left FAC075-Able Remember to Do Things Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: I have been able to remember to do things, like take medicine or buy something I needed. FACT-COG Version 3 - Able Remember to Do Things FAC075-Able to Pay Attention w/o Effort Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: I am able to pay attention and keep track of what I am doing without extra effort. FACT-COG Version 3 - Able to Pay Attention Without Effort FAC075-Mind Is as Sharp as Always Been Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: My mind is as sharp as it has always been. FACT-COG Version 3 - Mind Is as Sharp as Always Been FAC075-Memory Is as Good as Always Been Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: My memory is as good as it has always been. FACT-COG Version 3 - Memory Is as Good as Always Been FAC075-Able to Shift Between Activities Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: I am able to shift back and forth between two activities that require thinking. FACT-COG Version 3 - Able to Shift Between Activities FAC075-Able to Track What I Am Doing Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: I am able to keep track of what I am doing, even if I am interrupted. FACT-COG Version 3 - Able to Track What I Am Doing FAC075-Been Upset about These Problems Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Impact on Quality of Life: I have been upset about these problems. FACT-COG Version 3 - Been Upset about These Problems FAC075-Problems Interfered Ability Work Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Impact on Quality of Life: These problems have interfered with my ability to work. FACT-COG Version 3 - Problems Interfered Ability Work FAC075-Problems Interfered Ability Enjoy Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Impact on Quality of Life: These problems have interfered with my ability to do things I enjoy. FACT-COG Version 3 - Problems Interfered Ability Enjoy FAC075-Problems Interfered Quality Life Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Impact on Quality of Life: These problems have interfered with the quality of my life. FACT-COG Version 3 - Problems Interfered Quality Life FAC075-Cognitive Impairments Score Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: Subscale score. FACT-COG Version 3 - Cognitive Impairments Score FAC075-Comments From Others Score Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Comments From Others: Subscale score. FACT-COG Version 3 - Comments From Others Score FAC075-Cognitive Abilities Score Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: Subscale score. FACT-COG Version 3 - Cognitive Abilities Score FAC075-Impact on Quality of Life Score Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Impact on Quality of Life: Subscale score. FACT-COG Version 3 - Impact on Quality of Life Score FAC075TC Functional Assessment of Cancer Therapy-Cognitive Function Version 3 Questionnaire Test Code CDISC Questionnaire FACT-COG Version 3 Test Code Terminology Functional Assessment of Cancer Therapy-Cognitive Function Version 3 test name. FAC075-Able Remember Things Where Left Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: I have been able to remember things, like where I left my keys or wallet. FACT-COG Version 3 - Able Remember Things Where Left FAC075-Able Remember to Do Things Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: I have been able to remember to do things, like take medicine or buy something I needed. FACT-COG Version 3 - Able Remember to Do Things FAC075-Able to Bring to Mind Words Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: I have been able to bring to mind words that I wanted to use while talking to someone. FACT-COG Version 3 - Able to Bring to Mind Words FAC075-Able to Pay Attention w/o Effort Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: I am able to pay attention and keep track of what I am doing without extra effort. FACT-COG Version 3 - Able to Pay Attention Without Effort FAC075-Able to Shift Between Activities Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: I am able to shift back and forth between two activities that require thinking. FACT-COG Version 3 - Able to Shift Between Activities FAC075-Able to Track What I Am Doing Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: I am able to keep track of what I am doing, even if I am interrupted. FACT-COG Version 3 - Able to Track What I Am Doing FAC075-Been Upset about These Problems Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Impact on Quality of Life: I have been upset about these problems. FACT-COG Version 3 - Been Upset about These Problems FAC075-Cognitive Abilities Score Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: Subscale score. FACT-COG Version 3 - Cognitive Abilities Score FAC075-Cognitive Impairments Score Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: Subscale score. FACT-COG Version 3 - Cognitive Impairments Score FAC075-Comments From Others Score Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Comments From Others: Subscale score. FACT-COG Version 3 - Comments From Others Score FAC075-Forgotten Names After Introduced Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have forgotten names of people soon after being introduced. FACT-COG Version 3 - Forgotten Names After Introduced FAC075-I Have Been Able to Concentrate Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: I have been able to concentrate. FACT-COG Version 3 - I Have Been Able to Concentrate FAC075-I Have Had Trouble Concentrating Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble concentrating. FACT-COG Version 3 - I Have Had Trouble Concentrating FAC075-I Have Trouble Forming Thoughts Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble forming thoughts. FACT-COG Version 3 - I Have Trouble Forming Thoughts FAC075-Impact on Quality of Life Score Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Impact on Quality of Life: Subscale score. FACT-COG Version 3 - Impact on Quality of Life Score FAC075-Memory Is as Good as Always Been Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: My memory is as good as it has always been. FACT-COG Version 3 - Memory Is as Good as Always Been FAC075-Mind Is as Sharp as Always Been Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: My mind is as sharp as it has always been. FACT-COG Version 3 - Mind Is as Sharp as Always Been FAC075-My Thinking Has Been Slow Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: My thinking has been slow. FACT-COG Version 3 - My Thinking Has Been Slow FAC075-My Thinking Slower Than Usual Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: My thinking has been slower than usual. FACT-COG Version 3 - My Thinking Slower Than Usual FAC075-People Told Me I Seemed Confused Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Comments From Others: Other people have told me I seemed confused. FACT-COG Version 3 - People Told Me I Seemed Confused FAC075-Problems Interfered Ability Enjoy Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Impact on Quality of Life: These problems have interfered with my ability to do things I enjoy. FACT-COG Version 3 - Problems Interfered Ability Enjoy FAC075-Problems Interfered Ability Work Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Impact on Quality of Life: These problems have interfered with my ability to work. FACT-COG Version 3 - Problems Interfered Ability Work FAC075-Problems Interfered Quality Life Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Impact on Quality of Life: These problems have interfered with the quality of my life. FACT-COG Version 3 - Problems Interfered Quality Life FAC075-Reaction Everyday Situations Slow Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: My reactions in everyday situations have been slow. FACT-COG Version 3 - Reaction Everyday Situations Slow FAC075-Told Me Trouble Remembering Info Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Comments From Others: Other people have told me I seemed to have trouble remembering information. FACT-COG Version 3 - Told Me Trouble Remembering Info FAC075-Told Me Trouble Speaking Clearly Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Comments From Others: Other people have told me I seemed to have trouble speaking clearly. FACT-COG Version 3 - Told Me Trouble Speaking Clearly FAC075-Told Me Trouble Thinking Clearly Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Comments From Others: Other people have told me I seemed to have trouble thinking clearly. FACT-COG Version 3 - Told Me Trouble Thinking Clearly FAC075-Trouble Finding Familiar Place Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble finding my way to a familiar place. FACT-COG Version 3 - Trouble Finding Familiar Place FAC075-Trouble Finding Right Words Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble finding the right word(s) to express myself. FACT-COG Version 3 - Trouble Finding Right Words FAC075-Trouble Keeping Track Interrupted Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have trouble keeping track of what I am doing if I am interrupted. FACT-COG Version 3 - Trouble Keeping Track Interrupted FAC075-Trouble Recalling Name of Object Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble recalling the name of an object while talking to someone. FACT-COG Version 3 - Trouble Recalling Name of Object FAC075-Trouble Remember Where Put Things Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble remembering where I put things, like my keys or my wallet. FACT-COG Version 3 - Trouble Remember Where Put Things FAC075-Trouble Remembering New Info Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble remembering new information, like phone numbers or simple instructions. FACT-COG Version 3 - Trouble Remembering New Info FAC075-Trouble Saying What I Mean Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble saying what I mean in conversations with others. FACT-COG Version 3 - Trouble Saying What I Mean FAC075-Trouble Shifting Back and Forth Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have trouble shifting back and forth between different activities that require thinking. FACT-COG Version 3 - Trouble Shifting Back and Forth FAC075-Use Written Lists More Often Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had to use written lists more often than usual so I would not forget things. FACT-COG Version 3 - Use Written Lists More Often FAC075-Used Wrong Word When Refer Object Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have used the wrong word when I referred to an object. FACT-COG Version 3 - Used Wrong Word When Refer Object FAC075-Walked Into a Room and Forgotten Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have walked into a room and forgotten what I meant to get or do there. FACT-COG Version 3 - Walked Into a Room and Forgotten FAC075-Work Hard to Pay Attention Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had to work really hard to pay attention or I would make a mistake. FACT-COG Version 3 - Work Hard to Pay Attention FAC075-Work Harder Than Usual to Express Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had to work harder than usual to express myself clearly. FACT-COG Version 3 - Work Harder Than Usual to Express FAC075-Work Harder Than Usual to Track Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had to work harder than usual to keep track of what I was doing. FACT-COG Version 3 - Work Harder Than Usual to Track FAC075TN Functional Assessment of Cancer Therapy-Cognitive Function Version 3 Questionnaire Test Name CDISC Questionnaire FACT-COG Version 3 Test Name Terminology Functional Assessment of Cancer Therapy-Colorectal Version 4 test code. FAC008-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: I have a lack of energy. FACT-C Version 4 - I Have a Lack of Energy FAC008-I Have Nausea Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: I have nausea. FACT-C Version 4 - I Have Nausea FAC008-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. FACT-C Version 4 - Trouble Meeting Needs of Family FAC008-I Have Pain Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: I have pain. FACT-C Version 4 - I Have Pain FAC008-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: I am bothered by side effects of treatment. FACT-C Version 4 - Bothered by Treatment Side Effect FAC008-I Feel Ill Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: I feel ill. FACT-C Version 4 - I Feel Ill FAC008-I Am Forced to Spend Time in Bed Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: I am forced to spend time in bed. FACT-C Version 4 - I Am Forced to Spend Time in Bed FAC008-I Feel Close to My Friends Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: I feel close to my friends. FACT-C Version 4 - I Feel Close to My Friends FAC008-Get Emotional Support From Family Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: I get emotional support from my family. FACT-C Version 4 - Get Emotional Support From Family FAC008-I Get Support From My Friends Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: I get support from my friends. FACT-C Version 4 - I Get Support From My Friends FAC008-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: My family has accepted my illness. FACT-C Version 4 - My Family Has Accepted My Illness FAC008-Satisfied Communication Illness Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. FACT-C Version 4 - Satisfied Communication Illness FAC008-I Feel Close to My Partner Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). FACT-C Version 4 - I Feel Close to My Partner FAC008-I Am Satisfied With My Sex Life Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: I am satisfied with my sex life. FACT-C Version 4 - I Am Satisfied With My Sex Life FAC008-I Feel Sad Functional Assessment of Cancer Therapy-Colorectal Version 4 - Emotional Well-Being: I feel sad. FACT-C Version 4 - I Feel Sad FAC008-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy-Colorectal Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. FACT-C Version 4 - Satisfied With How I Am Coping FAC008-Losing Hope Against Illness Functional Assessment of Cancer Therapy-Colorectal Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. FACT-C Version 4 - Losing Hope Against Illness FAC008-I Feel Nervous Functional Assessment of Cancer Therapy-Colorectal Version 4 - Emotional Well-Being: I feel nervous. FACT-C Version 4 - I Feel Nervous FAC008-I Worry About Dying Functional Assessment of Cancer Therapy-Colorectal Version 4 - Emotional Well-Being: I worry about dying. FACT-C Version 4 - I Worry About Dying FAC008-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Colorectal Version 4 - Emotional Well-Being: I worry that my condition will get worse. FACT-C Version 4 - Worry My Condition Will Get Worse FAC008-I Am Able to Work Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: I am able to work (include work at home). FACT-C Version 4 - I Am Able to Work FAC008-My Work Is Fulfilling Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. FACT-C Version 4 - My Work Is Fulfilling FAC008-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: I am able to enjoy life. FACT-C Version 4 - I Am Able to Enjoy Life FAC008-I Have Accepted My Illness Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: I have accepted my illness. FACT-C Version 4 - I Have Accepted My Illness FAC008-I Am Sleeping Well Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: I am sleeping well. FACT-C Version 4 - I Am Sleeping Well FAC008-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. FACT-C Version 4 - Enjoy Things I Usually Do for Fun FAC008-Content With Quality of My Life Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: I am content with the quality of my life right now. FACT-C Version 4 - Content With Quality of My Life FAC008-Swelling/Cramps in Stomach Area Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I have swelling or cramps in my stomach area. FACT-C Version 4 - Swelling/Cramps in Stomach Area FAC008-I Am Losing Weight Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I am losing weight. FACT-C Version 4 - I Am Losing Weight FAC008-I Have Control of My Bowels Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I have control of my bowels. FACT-C Version 4 - I Have Control of My Bowels FAC008-I Can Digest My Food Well Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I can digest my food well. FACT-C Version 4 - I Can Digest My Food Well FAC008-I Have Diarrhea Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I have diarrhea (diarrhoea). FACT-C Version 4 - I Have Diarrhea FAC008-I Have a Good Appetite Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I have a good appetite. FACT-C Version 4 - I Have a Good Appetite FAC008-I Like the Appearance of My Body Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I like the appearance of my body. FACT-C Version 4 - I Like the Appearance of My Body FAC008-Do You Have an Ostomy Appliance Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: Do you have an ostomy appliance? FACT-C Version 4 - Do You Have an Ostomy Appliance FAC008-Embarrassed by Ostomy Appliance Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I am embarrassed by my ostomy appliance. FACT-C Version 4 - Embarrassed by Ostomy Appliance FAC008-Caring for Ostomy Is Difficult Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: Caring for my ostomy appliance is difficult. FACT-C Version 4 - Caring for Ostomy Is Difficult FAC008-Physical Subscale Score Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: Subscale score. FACT-C Version 4 - Physical Subscale Score FAC008-Social/Family Subscale Score Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: Subscale score. FACT-C Version 4 - Social/Family Subscale Score FAC008-Emotional Subscale Score Functional Assessment of Cancer Therapy-Colorectal Version 4 - Emotional Well-Being: Subscale score. FACT-C Version 4 - Emotional Subscale Score FAC008-Functional Subscale Score Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: Subscale score. FACT-C Version 4 - Functional Subscale Score FAC008-Additional Concern Subscale Score Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: Subscale score. FACT-C Version 4 - Additional Concern Subscale Score FAC008-Trial Outcome Index Score Functional Assessment of Cancer Therapy-Colorectal Version 4 - Trial outcome index score. FACT-C Version 4 - Trial Outcome Index Score FAC008-FACT-G Total Score Functional Assessment of Cancer Therapy-Colorectal Version 4 - FACT-G total score. FACT-C Version 4 - FACT-G Total Score FAC008-Total Score Functional Assessment of Cancer Therapy-Colorectal Version 4 - Total score. FACT-C Version 4 - Total Score FAC008TC Functional Assessment of Cancer Therapy-Colorectal Version 4 Questionnaire Test Code CDISC Questionnaire FACT-C Version 4 Test Code Terminology Functional Assessment of Cancer Therapy-Colorectal Version 4 test name. FAC008-Additional Concern Subscale Score Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: Subscale score. FACT-C Version 4 - Additional Concern Subscale Score FAC008-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: I am bothered by side effects of treatment. FACT-C Version 4 - Bothered by Treatment Side Effect FAC008-Caring for Ostomy Is Difficult Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: Caring for my ostomy appliance is difficult. FACT-C Version 4 - Caring for Ostomy Is Difficult FAC008-Content With Quality of My Life Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: I am content with the quality of my life right now. FACT-C Version 4 - Content With Quality of My Life FAC008-Do You Have an Ostomy Appliance Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: Do you have an ostomy appliance? FACT-C Version 4 - Do You Have an Ostomy Appliance FAC008-Embarrassed by Ostomy Appliance Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I am embarrassed by my ostomy appliance. FACT-C Version 4 - Embarrassed by Ostomy Appliance FAC008-Emotional Subscale Score Functional Assessment of Cancer Therapy-Colorectal Version 4 - Emotional Well-Being: Subscale score. FACT-C Version 4 - Emotional Subscale Score FAC008-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. FACT-C Version 4 - Enjoy Things I Usually Do for Fun FAC008-FACT-G Total Score Functional Assessment of Cancer Therapy-Colorectal Version 4 - FACT-G total score. FACT-C Version 4 - FACT-G Total Score FAC008-Functional Subscale Score Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: Subscale score. FACT-C Version 4 - Functional Subscale Score FAC008-Get Emotional Support From Family Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: I get emotional support from my family. FACT-C Version 4 - Get Emotional Support From Family FAC008-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: I am able to enjoy life. FACT-C Version 4 - I Am Able to Enjoy Life FAC008-I Am Able to Work Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: I am able to work (include work at home). FACT-C Version 4 - I Am Able to Work FAC008-I Am Forced to Spend Time in Bed Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: I am forced to spend time in bed. FACT-C Version 4 - I Am Forced to Spend Time in Bed FAC008-I Am Losing Weight Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I am losing weight. FACT-C Version 4 - I Am Losing Weight FAC008-I Am Satisfied With My Sex Life Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: I am satisfied with my sex life. FACT-C Version 4 - I Am Satisfied With My Sex Life FAC008-I Am Sleeping Well Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: I am sleeping well. FACT-C Version 4 - I Am Sleeping Well FAC008-I Can Digest My Food Well Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I can digest my food well. FACT-C Version 4 - I Can Digest My Food Well FAC008-I Feel Close to My Friends Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: I feel close to my friends. FACT-C Version 4 - I Feel Close to My Friends FAC008-I Feel Close to My Partner Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). FACT-C Version 4 - I Feel Close to My Partner FAC008-I Feel Ill Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: I feel ill. FACT-C Version 4 - I Feel Ill FAC008-I Feel Nervous Functional Assessment of Cancer Therapy-Colorectal Version 4 - Emotional Well-Being: I feel nervous. FACT-C Version 4 - I Feel Nervous FAC008-I Feel Sad Functional Assessment of Cancer Therapy-Colorectal Version 4 - Emotional Well-Being: I feel sad. FACT-C Version 4 - I Feel Sad FAC008-I Get Support From My Friends Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: I get support from my friends. FACT-C Version 4 - I Get Support From My Friends FAC008-I Have a Good Appetite Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I have a good appetite. FACT-C Version 4 - I Have a Good Appetite FAC008-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: I have a lack of energy. FACT-C Version 4 - I Have a Lack of Energy FAC008-I Have Accepted My Illness Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: I have accepted my illness. FACT-C Version 4 - I Have Accepted My Illness FAC008-I Have Control of My Bowels Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I have control of my bowels. FACT-C Version 4 - I Have Control of My Bowels FAC008-I Have Diarrhea Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I have diarrhea (diarrhoea). FACT-C Version 4 - I Have Diarrhea FAC008-I Have Nausea Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: I have nausea. FACT-C Version 4 - I Have Nausea FAC008-I Have Pain Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: I have pain. FACT-C Version 4 - I Have Pain FAC008-I Like the Appearance of My Body Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I like the appearance of my body. FACT-C Version 4 - I Like the Appearance of My Body FAC008-I Worry About Dying Functional Assessment of Cancer Therapy-Colorectal Version 4 - Emotional Well-Being: I worry about dying. FACT-C Version 4 - I Worry About Dying FAC008-Losing Hope Against Illness Functional Assessment of Cancer Therapy-Colorectal Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. FACT-C Version 4 - Losing Hope Against Illness FAC008-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: My family has accepted my illness. FACT-C Version 4 - My Family Has Accepted My Illness FAC008-My Work Is Fulfilling Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. FACT-C Version 4 - My Work Is Fulfilling FAC008-Physical Subscale Score Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: Subscale score. FACT-C Version 4 - Physical Subscale Score FAC008-Satisfied Communication Illness Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. FACT-C Version 4 - Satisfied Communication Illness FAC008-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy-Colorectal Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. FACT-C Version 4 - Satisfied With How I Am Coping FAC008-Social/Family Subscale Score Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: Subscale score. FACT-C Version 4 - Social/Family Subscale Score FAC008-Swelling/Cramps in Stomach Area Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I have swelling or cramps in my stomach area. FACT-C Version 4 - Swelling/Cramps in Stomach Area FAC008-Total Score Functional Assessment of Cancer Therapy-Colorectal Version 4 - Total score. FACT-C Version 4 - Total Score FAC008-Trial Outcome Index Score Functional Assessment of Cancer Therapy-Colorectal Version 4 - Trial outcome index score. FACT-C Version 4 - Trial Outcome Index Score FAC008-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. FACT-C Version 4 - Trouble Meeting Needs of Family FAC008-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Colorectal Version 4 - Emotional Well-Being: I worry that my condition will get worse. FACT-C Version 4 - Worry My Condition Will Get Worse FAC008TN Functional Assessment of Cancer Therapy-Colorectal Version 4 Questionnaire Test Name CDISC Questionnaire FACT-C Version 4 Test Name Terminology Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 test code. FAC015-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: I have a lack of energy. FACT-HEP Version 4 - I Have a Lack of Energy FAC015-I Have Nausea Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: I have nausea. FACT-HEP Version 4 - I Have Nausea FAC015-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. FACT-HEP Version 4 - Trouble Meeting Needs of Family FAC015-I Have Pain Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: I have pain. FACT-HEP Version 4 - I Have Pain FAC015-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: I am bothered by side effects of treatment. FACT-HEP Version 4 - Bothered by Treatment Side Effect FAC015-I Feel Ill Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: I feel ill. FACT-HEP Version 4 - I Feel Ill FAC015-I Am Forced to Spend Time in Bed Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: I am forced to spend time in bed. FACT-HEP Version 4 - I Am Forced to Spend Time in Bed FAC015-I Feel Close to My Friends Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: I feel close to my friends. FACT-HEP Version 4 - I Feel Close to My Friends FAC015-Get Emotional Support From Family Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: I get emotional support from my family. FACT-HEP Version 4 - Get Emotional Support From Family FAC015-I Get Support From My Friends Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: I get support from my friends. FACT-HEP Version 4 - I Get Support From My Friends FAC015-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: My family has accepted my illness. FACT-HEP Version 4 - My Family Has Accepted My Illness FAC015-Satisfied Communication Illness Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. FACT-HEP Version 4 - Satisfied With Communication About Illness FAC015-I Feel Close to My Partner Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). FACT-HEP Version 4 - I Feel Close to My Partner FAC015-I Am Satisfied With My Sex Life Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: I am satisfied with my sex life. FACT-HEP Version 4 - I Am Satisfied With My Sex Life FAC015-I Feel Sad Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Emotional Well-Being: I feel sad. FACT-HEP Version 4 - I Feel Sad FAC015-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. FACT-HEP Version 4 - Satisfied With How I Am Coping FAC015-Losing Hope Against Illness Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. FACT-HEP Version 4 - Losing Hope Against Illness FAC015-I Feel Nervous Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Emotional Well-Being: I feel nervous. FACT-HEP Version 4 - I Feel Nervous FAC015-I Worry About Dying Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Emotional Well-Being: I worry about dying. FACT-HEP Version 4 - I Worry About Dying FAC015-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Emotional Well-Being: I worry that my condition will get worse. FACT-HEP Version 4 - Worry My Condition Will Get Worse FAC015-I Am Able to Work Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: I am able to work (include work at home). FACT-HEP Version 4 - I Am Able to Work FAC015-My Work Is Fulfilling Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. FACT-HEP Version 4 - My Work Is Fulfilling FAC015-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: I am able to enjoy life. FACT-HEP Version 4 - I Am Able to Enjoy Life FAC015-I Have Accepted My Illness Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: I have accepted my illness. FACT-HEP Version 4 - I Have Accepted My Illness FAC015-I Am Sleeping Well Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: I am sleeping well. FACT-HEP Version 4 - I Am Sleeping Well FAC015-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. FACT-HEP Version 4 - Enjoy Things I Usually Do for Fun FAC015-Content With Quality of My Life Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: I am content with the quality of my life right now. FACT-HEP Version 4 - Content With Quality of My Life FAC015-Swelling/Cramps in Stomach Area Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have swelling or cramps in my stomach area. FACT-HEP Version 4 - Swelling or Cramps in Stomach Area FAC015-I Am Losing Weight Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I am losing weight. FACT-HEP Version 4 - I Am Losing Weight FAC015-I Have Control of My Bowels Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have control of my bowels. FACT-HEP Version 4 - I Have Control of My Bowels FAC015-I Can Digest My Food Well Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I can digest my food well. FACT-HEP Version 4 - I Can Digest My Food Well FAC015-I Have Diarrhea Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have diarrhea (diarrhoea). FACT-HEP Version 4 - I Have Diarrhea FAC015-I Have a Good Appetite Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have a good appetite. FACT-HEP Version 4 - I Have a Good Appetite FAC015-Unhappy About Change in My Appear Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I am unhappy about a change in my appearance. FACT-HEP Version 4 - Unhappy About Change in My Appearance FAC015-I Have Pain in My Back Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have pain in my back. FACT-HEP Version 4 - I Have Pain in My Back FAC015-I Am Bothered by Constipation Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I am bothered by constipation. FACT-HEP Version 4 - I Am Bothered by Constipation FAC015-I Feel Fatigued Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I feel fatigued. FACT-HEP Version 4 - I Feel Fatigued FAC015-Able to Do My Usual Activities Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I am able to do my usual activities. FACT-HEP Version 4 - Able to Do My Usual Activities FAC015-Bothered by Jaundice/Yellow Skin Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I am bothered by jaundice or yellow color to my skin. FACT-HEP Version 4 - Bothered by Jaundice or Yellow Skin FAC015-I Have Had Fevers Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have had fevers (episodes of high body temperature). FACT-HEP Version 4 - I Have Had Fevers FAC015-I Have Had Itching Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have had itching. FACT-HEP Version 4 - I Have Had Itching FAC015-Had Change in the Way Food Tastes Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have had a change in the way food tastes. FACT-HEP Version 4 - Had Change in the Way Food Tastes FAC015-I Have Had Chills Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have had chills. FACT-HEP Version 4 - I Have Had Chills FAC015-My Mouth Is Dry Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: My mouth is dry. FACT-HEP Version 4 - My Mouth Is Dry FAC015-Discomfort/Pain in Stomach Area Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have discomfort or pain in my stomach area. FACT-HEP Version 4 - Discomfort or Pain in Stomach Area FAC015-Physical Subscale Score Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: Subscale score. FACT-HEP Version 4 - Physical Subscale Score FAC015-Social/Family Subscale Score Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: Subscale score. FACT-HEP Version 4 - Social/Family Subscale Score FAC015-Emotional Subscale Score Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Emotional Well-Being: Subscale score. FACT-HEP Version 4 - Emotional Subscale Score FAC015-Functional Subscale Score Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: Subscale score. FACT-HEP Version 4 - Functional Subscale Score FAC015-Additional Concern Subscale Score Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: Subscale score. FACT-HEP Version 4 - Additional Concern Subscale Score FAC015-Trial Outcome Index Score Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Trial outcome index score. FACT-HEP Version 4 - Trial Outcome Index Score FAC015-FACT-G Total Score Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - FACT-G total score. FACT-HEP Version 4 - FACT-G Total Score FAC015-Total Score Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Total score. FACT-HEP Version 4 - Total Score FAC015TC Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 Questionnaire Test Code CDISC Questionnaire FACT-HEP Version 4 Test Code Terminology Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 test name. FAC015-Able to Do My Usual Activities Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I am able to do my usual activities. FACT-HEP Version 4 - Able to Do My Usual Activities FAC015-Additional Concern Subscale Score Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: Subscale score. FACT-HEP Version 4 - Additional Concern Subscale Score FAC015-Bothered by Jaundice/Yellow Skin Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I am bothered by jaundice or yellow color to my skin. FACT-HEP Version 4 - Bothered by Jaundice or Yellow Skin FAC015-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: I am bothered by side effects of treatment. FACT-HEP Version 4 - Bothered by Treatment Side Effect FAC015-Content With Quality of My Life Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: I am content with the quality of my life right now. FACT-HEP Version 4 - Content With Quality of My Life FAC015-Discomfort/Pain in Stomach Area Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have discomfort or pain in my stomach area. FACT-HEP Version 4 - Discomfort or Pain in Stomach Area FAC015-Emotional Subscale Score Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Emotional Well-Being: Subscale score. FACT-HEP Version 4 - Emotional Subscale Score FAC015-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. FACT-HEP Version 4 - Enjoy Things I Usually Do for Fun FAC015-FACT-G Total Score Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - FACT-G total score. FACT-HEP Version 4 - FACT-G Total Score FAC015-Functional Subscale Score Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: Subscale score. FACT-HEP Version 4 - Functional Subscale Score FAC015-Get Emotional Support From Family Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: I get emotional support from my family. FACT-HEP Version 4 - Get Emotional Support From Family FAC015-Had Change in the Way Food Tastes Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have had a change in the way food tastes. FACT-HEP Version 4 - Had Change in the Way Food Tastes FAC015-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: I am able to enjoy life. FACT-HEP Version 4 - I Am Able to Enjoy Life FAC015-I Am Able to Work Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: I am able to work (include work at home). FACT-HEP Version 4 - I Am Able to Work FAC015-I Am Bothered by Constipation Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I am bothered by constipation. FACT-HEP Version 4 - I Am Bothered by Constipation FAC015-I Am Forced to Spend Time in Bed Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: I am forced to spend time in bed. FACT-HEP Version 4 - I Am Forced to Spend Time in Bed FAC015-I Am Losing Weight Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I am losing weight. FACT-HEP Version 4 - I Am Losing Weight FAC015-I Am Satisfied With My Sex Life Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: I am satisfied with my sex life. FACT-HEP Version 4 - I Am Satisfied With My Sex Life FAC015-I Am Sleeping Well Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: I am sleeping well. FACT-HEP Version 4 - I Am Sleeping Well FAC015-I Can Digest My Food Well Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I can digest my food well. FACT-HEP Version 4 - I Can Digest My Food Well FAC015-I Feel Close to My Friends Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: I feel close to my friends. FACT-HEP Version 4 - I Feel Close to My Friends FAC015-I Feel Close to My Partner Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). FACT-HEP Version 4 - I Feel Close to My Partner FAC015-I Feel Fatigued Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I feel fatigued. FACT-HEP Version 4 - I Feel Fatigued FAC015-I Feel Ill Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: I feel ill. FACT-HEP Version 4 - I Feel Ill FAC015-I Feel Nervous Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Emotional Well-Being: I feel nervous. FACT-HEP Version 4 - I Feel Nervous FAC015-I Feel Sad Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Emotional Well-Being: I feel sad. FACT-HEP Version 4 - I Feel Sad FAC015-I Get Support From My Friends Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: I get support from my friends. FACT-HEP Version 4 - I Get Support From My Friends FAC015-I Have a Good Appetite Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have a good appetite. FACT-HEP Version 4 - I Have a Good Appetite FAC015-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: I have a lack of energy. FACT-HEP Version 4 - I Have a Lack of Energy FAC015-I Have Accepted My Illness Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: I have accepted my illness. FACT-HEP Version 4 - I Have Accepted My Illness FAC015-I Have Control of My Bowels Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have control of my bowels. FACT-HEP Version 4 - I Have Control of My Bowels FAC015-I Have Diarrhea Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have diarrhea (diarrhoea). FACT-HEP Version 4 - I Have Diarrhea FAC015-I Have Had Chills Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have had chills. FACT-HEP Version 4 - I Have Had Chills FAC015-I Have Had Fevers Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have had fevers (episodes of high body temperature). FACT-HEP Version 4 - I Have Had Fevers FAC015-I Have Had Itching Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have had itching. FACT-HEP Version 4 - I Have Had Itching FAC015-I Have Nausea Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: I have nausea. FACT-HEP Version 4 - I Have Nausea FAC015-I Have Pain in My Back Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have pain in my back. FACT-HEP Version 4 - I Have Pain in My Back FAC015-I Have Pain Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: I have pain. FACT-HEP Version 4 - I Have Pain FAC015-I Worry About Dying Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Emotional Well-Being: I worry about dying. FACT-HEP Version 4 - I Worry About Dying FAC015-Losing Hope Against Illness Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. FACT-HEP Version 4 - Losing Hope Against Illness FAC015-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: My family has accepted my illness. FACT-HEP Version 4 - My Family Has Accepted My Illness FAC015-My Mouth Is Dry Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: My mouth is dry. FACT-HEP Version 4 - My Mouth Is Dry FAC015-My Work Is Fulfilling Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. FACT-HEP Version 4 - My Work Is Fulfilling FAC015-Physical Subscale Score Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: Subscale score. FACT-HEP Version 4 - Physical Subscale Score FAC015-Satisfied Communication Illness Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. FACT-HEP Version 4 - Satisfied With Communication About Illness FAC015-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. FACT-HEP Version 4 - Satisfied With How I Am Coping FAC015-Social/Family Subscale Score Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: Subscale score. FACT-HEP Version 4 - Social/Family Subscale Score FAC015-Swelling/Cramps in Stomach Area Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have swelling or cramps in my stomach area. FACT-HEP Version 4 - Swelling or Cramps in Stomach Area FAC015-Total Score Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Total score. FACT-HEP Version 4 - Total Score FAC015-Trial Outcome Index Score Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Trial outcome index score. FACT-HEP Version 4 - Trial Outcome Index Score FAC015-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. FACT-HEP Version 4 - Trouble Meeting Needs of Family FAC015-Unhappy About Change in My Appear Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I am unhappy about a change in my appearance. FACT-HEP Version 4 - Unhappy About Change in My Appearance FAC015-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Emotional Well-Being: I worry that my condition will get worse. FACT-HEP Version 4 - Worry My Condition Will Get Worse FAC015TN Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 Questionnaire Test Name CDISC Questionnaire FACT-HEP Version 4 Test Name Terminology Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4 Questionnaire - 52 Item test code. FAC104-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I have a lack of energy. FACT-ICM V4 - I Have a Lack of Energy FAC104-I Have Nausea Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I have nausea. FACT-ICM V4 - I Have Nausea FAC104-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: Because of my physical condition, I have trouble meeting the needs of my family. FACT-ICM V4 - Trouble Meeting Needs of Family FAC104-I Have Pain Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I have pain. FACT-ICM V4 - I Have Pain FAC104-Bothered by Side Effect Treatment Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am bothered by side effects of treatment. FACT-ICM V4 - Bothered by Side Effect Treatment FAC104-I Feel Ill Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I feel ill. FACT-ICM V4 - I Feel Ill FAC104-Forced to Spend Time in Bed Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am forced to spend time in bed. FACT-ICM V4 - Forced to Spend Time in Bed FAC104-I Feel Close to My Friends Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I feel close to my friends. FACT-ICM V4 - I Feel Close to My Friends FAC104-Emotional Support From My Family Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I get emotional support from my family. FACT-ICM V4 - Emotional Support From My Family FAC104-I Get Support From My Friends Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I get support from my friends. FACT-ICM V4 - I Get Support From My Friends FAC104-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: My family has accepted my illness. FACT-ICM V4 - My Family Has Accepted My Illness FAC104-Satisfied Communication Illness Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am satisfied with family communication about my illness. FACT-ICM V4 - Satisfied Communication Illness FAC104-I Feel Close to My Partner Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I feel close to my partner (or the person who is my main support). FACT-ICM V4 - I Feel Close to My Partner FAC104-Satisfied With My Sex Life Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am satisfied with my sex life. FACT-ICM V4 - Satisfied With My Sex Life FAC104-I Feel Sad Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I feel sad. FACT-ICM V4 - I Feel Sad FAC104-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am satisfied with how I am coping with my illness. FACT-ICM V4 - Satisfied With How I Am Coping FAC104-Losing Hope Fight Against Illness Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am losing hope in the fight against my illness. FACT-ICM V4 - Losing Hope Fight Against Illness FAC104-I Feel Nervous Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I feel nervous. FACT-ICM V4 - I Feel Nervous FAC104-I Worry About Dying Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I worry about dying. FACT-ICM V4 - I Worry About Dying FAC104-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I worry that my condition will get worse. FACT-ICM V4 - Worry My Condition Will Get Worse FAC104-Able to Work Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am able to work (include work at home). FACT-ICM V4 - Able to Work FAC104-My Work Is Fulfilling Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: My work (include work at home) is fulfilling. FACT-ICM V4 - My Work Is Fulfilling FAC104-Able to Enjoy Life Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am able to enjoy life. FACT-ICM V4 - Able to Enjoy Life FAC104-I Have Accepted My Illness Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I have accepted my illness. FACT-ICM V4 - I Have Accepted My Illness FAC104-Sleeping Well Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am sleeping well. FACT-ICM V4 - Sleeping Well FAC104-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am enjoying the things I usually do for fun. FACT-ICM V4 - Enjoy Things I Usually Do for Fun FAC104-Content With Quality of My Life Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am content with the quality of my life right now. FACT-ICM V4 - Content With Quality of My Life FAC104-Fatigue Keeps Me From Doing Thing Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: My fatigue keeps me from doing the things I want to do. FACT-ICM V4 - Fatigue Keeps Me From Doing Thing FAC104-I Have Been Bothered by Diarrhea Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I have been bothered by diarrhea (diarrhoea). FACT-ICM V4 - I Have Been Bothered by Diarrhea FAC104-Discomfort/Pain in Stomach Area Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I have discomfort or pain in my stomach area. FACT-ICM V4 - Discomfort/Pain in Stomach Area FAC104-Bothered by Constipation Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am bothered by constipation. FACT-ICM V4 - Bothered by Constipation FAC104-Bothered by a Skin Rash Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am bothered by a skin rash. FACT-ICM V4 - Bothered by a Skin Rash FAC104-Bothered by Itching Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am bothered by itching. FACT-ICM V4 - Bothered by Itching FAC104-Bothered by Dry Skin Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am bothered by dry skin. FACT-ICM V4 - Bothered by Dry Skin FAC104-Bothered by Vitiligo Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am bothered by vitiligo (white patches appearing on my skin). FACT-ICM V4 - Bothered by Vitiligo FAC104-Have Weakness in My Arms or Legs Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I have weakness in my arms or legs. FACT-ICM V4 - Have Weakness in My Arms or Legs FAC104-Pain/Soreness/Aches Some Muscles Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I feel pain, soreness or aches in some of my muscles. FACT-ICM V4 - Pain/Soreness/Aches Some Muscles FAC104-I Have Pain in My Joints Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I have pain in my joints. FACT-ICM V4 - I Have Pain in My Joints FAC104-Bothered by Swelling Certain Area Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am bothered by swelling in certain areas of my body. FACT-ICM V4 - Bothered by Swelling Certain Area FAC104-Bothered by Change in Food Tastes Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am bothered by a change in the way food tastes. FACT-ICM V4 - Bothered by Change in Food Tastes FAC104-I Have a Loss of Appetite Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I have a loss of appetite. FACT-ICM V4 - I Have a Loss of Appetite FAC104-I Have Been Vomiting Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I have been vomiting. FACT-ICM V4 - I Have Been Vomiting FAC104-I Have Been Short of Breath Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I have been short of breath. FACT-ICM V4 - I Have Been Short of Breath FAC104-I Have Been Coughing Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I have been coughing. FACT-ICM V4 - I Have Been Coughing FAC104-Bothered by Fevers Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am bothered by fevers (episodes of high body temperature). FACT-ICM V4 - Bothered by Fevers FAC104-Bothered by Headaches Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am bothered by headaches. FACT-ICM V4 - Bothered by Headaches FAC104-I Have Trouble Sleeping at Night Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I have trouble sleeping at night. FACT-ICM V4 - I Have Trouble Sleeping at Night FAC104-Bothered by Dry Mouth Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am bothered by dry mouth. FACT-ICM V4 - Bothered by Dry Mouth FAC104-Bothered by Worsening Eyesight Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am bothered by worsening eyesight. FACT-ICM V4 - Bothered by Worsening Eyesight FAC104-Bothered by Short-term Reactions Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am bothered by short-term treatment reactions that I experience immediately after, or within 24 hours of, an infusion (such as chills, dizziness, hives, rashes lasting no more than 24 hours). FACT-ICM V4 - Bothered by Short-term Reactions FAC104-Troubled Not Knowing Side Effects Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am troubled by not knowing when exactly my side effects will happen, how long they will last and how bad they will be. FACT-ICM V4 - Troubled Not Knowing Side Effects FAC104-Worry Neg Impacts Longterm Health Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I worry about negative impacts that my treatment may have upon my long-term health. FACT-ICM V4 - Worry Neg Impacts Longterm Health FACT104TC Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4 Questionnaire - 52 Item Test Code CDISC Questionnaire FACT-ICM Version 4 Test Code Terminology Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4 Questionnaire - 52 Item test name. FAC104-Able to Enjoy Life Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am able to enjoy life. FACT-ICM V4 - Able to Enjoy Life FAC104-Able to Work Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am able to work (include work at home). FACT-ICM V4 - Able to Work FAC104-Bothered by a Skin Rash Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am bothered by a skin rash. FACT-ICM V4 - Bothered by a Skin Rash FAC104-Bothered by Change in Food Tastes Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am bothered by a change in the way food tastes. FACT-ICM V4 - Bothered by Change in Food Tastes FAC104-Bothered by Constipation Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am bothered by constipation. FACT-ICM V4 - Bothered by Constipation FAC104-Bothered by Dry Mouth Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am bothered by dry mouth. FACT-ICM V4 - Bothered by Dry Mouth FAC104-Bothered by Dry Skin Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am bothered by dry skin. FACT-ICM V4 - Bothered by Dry Skin FAC104-Bothered by Fevers Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am bothered by fevers (episodes of high body temperature). FACT-ICM V4 - Bothered by Fevers FAC104-Bothered by Headaches Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am bothered by headaches. FACT-ICM V4 - Bothered by Headaches FAC104-Bothered by Itching Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am bothered by itching. FACT-ICM V4 - Bothered by Itching FAC104-Bothered by Short-term Reactions Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am bothered by short-term treatment reactions that I experience immediately after, or within 24 hours of, an infusion (such as chills, dizziness, hives, rashes lasting no more than 24 hours). FACT-ICM V4 - Bothered by Short-term Reactions FAC104-Bothered by Side Effect Treatment Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am bothered by side effects of treatment. FACT-ICM V4 - Bothered by Side Effect Treatment FAC104-Bothered by Swelling Certain Area Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am bothered by swelling in certain areas of my body. FACT-ICM V4 - Bothered by Swelling Certain Area FAC104-Bothered by Vitiligo Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am bothered by vitiligo (white patches appearing on my skin). FACT-ICM V4 - Bothered by Vitiligo FAC104-Bothered by Worsening Eyesight Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am bothered by worsening eyesight. FACT-ICM V4 - Bothered by Worsening Eyesight FAC104-Content With Quality of My Life Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am content with the quality of my life right now. FACT-ICM V4 - Content With Quality of My Life FAC104-Discomfort/Pain in Stomach Area Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I have discomfort or pain in my stomach area. FACT-ICM V4 - Discomfort/Pain in Stomach Area FAC104-Emotional Support From My Family Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I get emotional support from my family. FACT-ICM V4 - Emotional Support From My Family FAC104-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am enjoying the things I usually do for fun. FACT-ICM V4 - Enjoy Things I Usually Do for Fun FAC104-Fatigue Keeps Me From Doing Thing Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: My fatigue keeps me from doing the things I want to do. FACT-ICM V4 - Fatigue Keeps Me From Doing Thing FAC104-Forced to Spend Time in Bed Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am forced to spend time in bed. FACT-ICM V4 - Forced to Spend Time in Bed FAC104-Have Weakness in My Arms or Legs Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I have weakness in my arms or legs. FACT-ICM V4 - Have Weakness in My Arms or Legs FAC104-I Feel Close to My Friends Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I feel close to my friends. FACT-ICM V4 - I Feel Close to My Friends FAC104-I Feel Close to My Partner Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I feel close to my partner (or the person who is my main support). FACT-ICM V4 - I Feel Close to My Partner FAC104-I Feel Ill Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I feel ill. FACT-ICM V4 - I Feel Ill FAC104-I Feel Nervous Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I feel nervous. FACT-ICM V4 - I Feel Nervous FAC104-I Feel Sad Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I feel sad. FACT-ICM V4 - I Feel Sad FAC104-I Get Support From My Friends Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I get support from my friends. FACT-ICM V4 - I Get Support From My Friends FAC104-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I have a lack of energy. FACT-ICM V4 - I Have a Lack of Energy FAC104-I Have a Loss of Appetite Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I have a loss of appetite. FACT-ICM V4 - I Have a Loss of Appetite FAC104-I Have Accepted My Illness Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I have accepted my illness. FACT-ICM V4 - I Have Accepted My Illness FAC104-I Have Been Bothered by Diarrhea Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I have been bothered by diarrhea (diarrhoea). FACT-ICM V4 - I Have Been Bothered by Diarrhea FAC104-I Have Been Coughing Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I have been coughing. FACT-ICM V4 - I Have Been Coughing FAC104-I Have Been Short of Breath Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I have been short of breath. FACT-ICM V4 - I Have Been Short of Breath FAC104-I Have Been Vomiting Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I have been vomiting. FACT-ICM V4 - I Have Been Vomiting FAC104-I Have Nausea Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I have nausea. FACT-ICM V4 - I Have Nausea FAC104-I Have Pain in My Joints Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I have pain in my joints. FACT-ICM V4 - I Have Pain in My Joints FAC104-I Have Pain Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I have pain. FACT-ICM V4 - I Have Pain FAC104-I Have Trouble Sleeping at Night Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I have trouble sleeping at night. FACT-ICM V4 - I Have Trouble Sleeping at Night FAC104-I Worry About Dying Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I worry about dying. FACT-ICM V4 - I Worry About Dying FAC104-Losing Hope Fight Against Illness Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am losing hope in the fight against my illness. FACT-ICM V4 - Losing Hope Fight Against Illness FAC104-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: My family has accepted my illness. FACT-ICM V4 - My Family Has Accepted My Illness FAC104-My Work Is Fulfilling Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: My work (include work at home) is fulfilling. FACT-ICM V4 - My Work Is Fulfilling FAC104-Pain/Soreness/Aches Some Muscles Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I feel pain, soreness or aches in some of my muscles. FACT-ICM V4 - Pain/Soreness/Aches Some Muscles FAC104-Satisfied Communication Illness Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am satisfied with family communication about my illness. FACT-ICM V4 - Satisfied Communication Illness FAC104-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am satisfied with how I am coping with my illness. FACT-ICM V4 - Satisfied With How I Am Coping FAC104-Satisfied With My Sex Life Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am satisfied with my sex life. FACT-ICM V4 - Satisfied With My Sex Life FAC104-Sleeping Well Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am sleeping well. FACT-ICM V4 - Sleeping Well FAC104-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: Because of my physical condition, I have trouble meeting the needs of my family. FACT-ICM V4 - Trouble Meeting Needs of Family FAC104-Troubled Not Knowing Side Effects Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I am troubled by not knowing when exactly my side effects will happen, how long they will last and how bad they will be. FACT-ICM V4 - Troubled Not Knowing Side Effects FAC104-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I worry that my condition will get worse. FACT-ICM V4 - Worry My Condition Will Get Worse FAC104-Worry Neg Impacts Longterm Health Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4: I worry about negative impacts that my treatment may have upon my long-term health. FACT-ICM V4 - Worry Neg Impacts Longterm Health FACT104TN Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator Version 4 Questionnaire - 52 Item Test Name CDISC Questionnaire FACT-ICM Version 4 Test Name Terminology Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 test code. FAC039-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I have a lack of energy. FKSI-15 - I Have a Lack of Energy FAC039-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I am bothered by side effects of treatment. FKSI-15 - Bothered by Treatment Side Effect FAC039-I Have Pain Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I have pain. FKSI-15 - I Have Pain FAC039-I Am Losing Weight Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I am losing weight. FKSI-15 - I Am Losing Weight FAC039-I Have Bone Pain Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I have bone pain. FKSI-15 - I Have Bone Pain FAC039-I Feel Fatigued Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I feel fatigued. FKSI-15 - I Feel Fatigued FAC039-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I am able to enjoy life. FKSI-15 - I Am Able to Enjoy Life FAC039-I Have Been Short of Breath Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I have been short of breath. FKSI-15 - I Have Been Short of Breath FAC039-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I worry that my condition will get worse. FKSI-15 - Worry My Condition Will Get Worse FAC039-I Have a Good Appetite Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I have a good appetite. FKSI-15 - I Have a Good Appetite FAC039-I Have Been Coughing Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I have been coughing. FKSI-15 - I Have Been Coughing FAC039-I Am Bothered by Fevers Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I am bothered by fevers (episodes of high body temperature). FKSI-15 - I Am Bothered by Fevers FAC039-I Am Able to Work Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I am able to work (include work at home). FKSI-15 - I Am Able to Work FAC039-I Have Had Blood in My Urine Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I have had blood in my urine. FKSI-15 - I Have Had Blood in My Urine FAC039-I Am Sleeping Well Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I am sleeping well. FKSI-15 - I Am Sleeping Well FAC039TC Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 Questionnaire Test Code CDISC Questionnaire FKSI-15 Test Code Terminology Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 test name. FAC039-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I am bothered by side effects of treatment. FKSI-15 - Bothered by Treatment Side Effect FAC039-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I am able to enjoy life. FKSI-15 - I Am Able to Enjoy Life FAC039-I Am Able to Work Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I am able to work (include work at home). FKSI-15 - I Am Able to Work FAC039-I Am Bothered by Fevers Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I am bothered by fevers (episodes of high body temperature). FKSI-15 - I Am Bothered by Fevers FAC039-I Am Losing Weight Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I am losing weight. FKSI-15 - I Am Losing Weight FAC039-I Am Sleeping Well Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I am sleeping well. FKSI-15 - I Am Sleeping Well FAC039-I Feel Fatigued Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I feel fatigued. FKSI-15 - I Feel Fatigued FAC039-I Have a Good Appetite Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I have a good appetite. FKSI-15 - I Have a Good Appetite FAC039-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I have a lack of energy. FKSI-15 - I Have a Lack of Energy FAC039-I Have Been Coughing Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I have been coughing. FKSI-15 - I Have Been Coughing FAC039-I Have Been Short of Breath Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I have been short of breath. FKSI-15 - I Have Been Short of Breath FAC039-I Have Bone Pain Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I have bone pain. FKSI-15 - I Have Bone Pain FAC039-I Have Had Blood in My Urine Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I have had blood in my urine. FKSI-15 - I Have Had Blood in My Urine FAC039-I Have Pain Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I have pain. FKSI-15 - I Have Pain FAC039-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I worry that my condition will get worse. FKSI-15 - Worry My Condition Will Get Worse FAC039TN Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 Questionnaire Test Name CDISC Questionnaire FKSI-15 Test Name Terminology Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 test code. FAC041-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I have a lack of energy. FKSI-DRS Version 4 - I Have a Lack of Energy FAC041-I Have Pain Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I have pain. FKSI-DRS Version 4 - I Have Pain FAC041-I Am Losing Weight Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I am losing weight. FKSI-DRS Version 4 - I Am Losing Weight FAC041-I Have Bone Pain Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I have bone pain. FKSI-DRS Version 4 - I Have Bone Pain FAC041-I Feel Fatigued Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I feel fatigued. FKSI-DRS Version 4 - I Feel Fatigued FAC041-I Have Been Short of Breath Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I have been short of breath. FKSI-DRS Version 4 - I Have Been Short of Breath FAC041-I Have Been Coughing Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I have been coughing. FKSI-DRS Version 4 - I Have Been Coughing FAC041-I Am Bothered by Fevers Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I am bothered by fevers (episodes of high body temperature). FKSI-DRS Version 4 - I Am Bothered by Fevers FAC041-I Have Had Blood in My Urine Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I have had blood in my urine. FKSI-DRS Version 4 - I Have Had Blood in My Urine FAC041TC Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 Questionnaire Test Code CDISC Questionnaire FKSI-DRS Version 4 Test Code Terminology Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 test name. FAC041-I Am Bothered by Fevers Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I am bothered by fevers (episodes of high body temperature). FKSI-DRS Version 4 - I Am Bothered by Fevers FAC041-I Am Losing Weight Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I am losing weight. FKSI-DRS Version 4 - I Am Losing Weight FAC041-I Feel Fatigued Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I feel fatigued. FKSI-DRS Version 4 - I Feel Fatigued FAC041-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I have a lack of energy. FKSI-DRS Version 4 - I Have a Lack of Energy FAC041-I Have Been Coughing Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I have been coughing. FKSI-DRS Version 4 - I Have Been Coughing FAC041-I Have Been Short of Breath Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I have been short of breath. FKSI-DRS Version 4 - I Have Been Short of Breath FAC041-I Have Bone Pain Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I have bone pain. FKSI-DRS Version 4 - I Have Bone Pain FAC041-I Have Had Blood in My Urine Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I have had blood in my urine. FKSI-DRS Version 4 - I Have Had Blood in My Urine FAC041-I Have Pain Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I have pain. FKSI-DRS Version 4 - I Have Pain FAC041TN Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 Questionnaire Test Name CDISC Questionnaire FKSI-DRS Version 4 Test Name Terminology Functional Assessment of Cancer Therapy-Leukemia Version 4 test code. FAC017-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Leukemia Version 4 - Physical Well-Being: I have a lack of energy. FACT-LEU Version 4 - I Have a Lack of Energy FAC017-I Have Nausea Functional Assessment of Cancer Therapy-Leukemia Version 4 - Physical Well-Being: I have nausea. FACT-LEU Version 4 - I Have Nausea FAC017-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-Leukemia Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. FACT-LEU Version 4 - Trouble Meeting Needs of Family FAC017-I Have Pain Functional Assessment of Cancer Therapy-Leukemia Version 4 - Physical Well-Being: I have pain. FACT-LEU Version 4 - I Have Pain FAC017-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy-Leukemia Version 4 - Physical Well-Being: I am bothered by side effects of treatment. FACT-LEU Version 4 - Bothered by Treatment Side Effect FAC017-I Feel Ill Functional Assessment of Cancer Therapy-Leukemia Version 4 - Physical Well-Being: I feel ill. FACT-LEU Version 4 - I Feel Ill FAC017-I Am Forced to Spend Time in Bed Functional Assessment of Cancer Therapy-Leukemia Version 4 - Physical Well-Being: I am forced to spend time in bed. FACT-LEU Version 4 - I Am Forced to Spend Time in Bed FAC017-I Feel Close to My Friends Functional Assessment of Cancer Therapy-Leukemia Version 4 - Social/Family Well-Being: I feel close to my friends. FACT-LEU Version 4 - I Feel Close to My Friends FAC017-Get Emotional Support From Family Functional Assessment of Cancer Therapy-Leukemia Version 4 - Social/Family Well-Being: I get emotional support from my family. FACT-LEU Version 4 - Get Emotional Support From Family FAC017-I Get Support From My Friends Functional Assessment of Cancer Therapy-Leukemia Version 4 - Social/Family Well-Being: I get support from my friends. FACT-LEU Version 4 - I Get Support From My Friends FAC017-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy-Leukemia Version 4 - Social/Family Well-Being: My family has accepted my illness. FACT-LEU Version 4 - My Family Has Accepted My Illness FAC017-Satisfied Communication Illness Functional Assessment of Cancer Therapy-Leukemia Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. FACT-LEU Version 4 - Satisfied Communication Illness FAC017-I Feel Close to My Partner Functional Assessment of Cancer Therapy-Leukemia Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). FACT-LEU Version 4 - I Feel Close to My Partner FAC017-I Am Satisfied With My Sex Life Functional Assessment of Cancer Therapy-Leukemia Version 4 - Social/Family Well-Being: I am satisfied with my sex life. FACT-LEU Version 4 - I Am Satisfied With My Sex Life FAC017-I Feel Sad Functional Assessment of Cancer Therapy-Leukemia Version 4 - Emotional Well-Being: I feel sad. FACT-LEU Version 4 - I Feel Sad FAC017-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy-Leukemia Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. FACT-LEU Version 4 - Satisfied With How I Am Coping FAC017-Losing Hope Against Illness Functional Assessment of Cancer Therapy-Leukemia Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. FACT-LEU Version 4 - Losing Hope Against Illness FAC017-I Feel Nervous Functional Assessment of Cancer Therapy-Leukemia Version 4 - Emotional Well-Being: I feel nervous. FACT-LEU Version 4 - I Feel Nervous FAC017-I Worry About Dying Functional Assessment of Cancer Therapy-Leukemia Version 4 - Emotional Well-Being: I worry about dying. FACT-LEU Version 4 - I Worry About Dying FAC017-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Leukemia Version 4 - Emotional Well-Being: I worry that my condition will get worse. FACT-LEU Version 4 - Worry My Condition Will Get Worse FAC017-I Am Able to Work Functional Assessment of Cancer Therapy-Leukemia Version 4 - Functional Well-Being: I am able to work (include work at home). FACT-LEU Version 4 - I Am Able to Work FAC017-My Work Is Fulfilling Functional Assessment of Cancer Therapy-Leukemia Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. FACT-LEU Version 4 - My Work Is Fulfilling FAC017-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-Leukemia Version 4 - Functional Well-Being: I am able to enjoy life. FACT-LEU Version 4 - I Am Able to Enjoy Life FAC017-I Have Accepted My Illness Functional Assessment of Cancer Therapy-Leukemia Version 4 - Functional Well-Being: I have accepted my illness. FACT-LEU Version 4 - I Have Accepted My Illness FAC017-I Am Sleeping Well Functional Assessment of Cancer Therapy-Leukemia Version 4 - Functional Well-Being: I am sleeping well. FACT-LEU Version 4 - I Am Sleeping Well FAC017-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy-Leukemia Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. FACT-LEU Version 4 - Enjoy Things I Usually Do for Fun FAC017-Content With Quality of My Life Functional Assessment of Cancer Therapy-Leukemia Version 4 - Functional Well-Being: I am content with the quality of my life right now. FACT-LEU Version 4 - Content With Quality of My Life FAC017-I Am Bothered by Fevers Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I am bothered by fevers (episodes of high body temperature). FACT-LEU Version 4 - I Am Bothered by Fevers FAC017-Certain Parts of Body Have Pain Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I have certain parts of my body where I experience pain. FACT-LEU Version 4 - Certain Parts of Body Have Pain FAC017-I Am Bothered by the Chills Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I am bothered by the chills. FACT-LEU Version 4 - I Am Bothered by the Chills FAC017-I Have Night Sweats Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I have night sweats. FACT-LEU Version 4 - I Have Night Sweats FAC017-Bothered by Lumps or Swelling Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I am bothered by lumps or swelling in certain parts of my body (e.g., neck, armpits, or groin). FACT-LEU Version 4 - Bothered by Lumps or Swelling FAC017-I Bleed Easily Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I bleed easily. FACT-LEU Version 4 - I Bleed Easily FAC017-I Bruise Easily Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I bruise easily. FACT-LEU Version 4 - I Bruise Easily FAC017-I Feel Weak All Over Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I feel weak all over. FACT-LEU Version 4 - I Feel Weak All Over FAC017-I Get Tired Easily Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I get tired easily. FACT-LEU Version 4 - I Get Tired Easily FAC017-I Am Losing Weight Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I am losing weight. FACT-LEU Version 4 - I Am Losing Weight FAC017-I Have a Good Appetite Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I have a good appetite. FACT-LEU Version 4 - I Have a Good Appetite FAC017-Able to Do My Usual Activities Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I am able to do my usual activities. FACT-LEU Version 4 - Able to Do My Usual Activities FAC017-I Worry About Getting Infections Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I worry about getting infections. FACT-LEU Version 4 - I Worry About Getting Infections FAC017-Uncertain About My Future Health Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I feel uncertain about my future health. FACT-LEU Version 4 - Uncertain About My Future Health FAC017-Worry I Might Get New Symptoms Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I worry that I might get new symptoms of my illness. FACT-LEU Version 4 - Worry I Might Get New Symptoms FAC017-I Have Emotional Ups and Downs Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I have emotional ups and downs. FACT-LEU Version 4 - I Have Emotional Ups and Downs FAC017-Feel Isolated Because of Illness Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I feel isolated from others because of my illness or treatment. FACT-LEU Version 4 - Feel Isolated Because of Illness FAC017TC Functional Assessment of Cancer Therapy-Leukemia Version 4 Questionnaire Test Code CDISC Questionnaire FACT-LEU Version 4 Test Code Terminology Functional Assessment of Cancer Therapy-Leukemia Version 4 test name. FAC017-Able to Do My Usual Activities Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I am able to do my usual activities. FACT-LEU Version 4 - Able to Do My Usual Activities FAC017-Bothered by Lumps or Swelling Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I am bothered by lumps or swelling in certain parts of my body (e.g., neck, armpits, or groin). FACT-LEU Version 4 - Bothered by Lumps or Swelling FAC017-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy-Leukemia Version 4 - Physical Well-Being: I am bothered by side effects of treatment. FACT-LEU Version 4 - Bothered by Treatment Side Effect FAC017-Certain Parts of Body Have Pain Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I have certain parts of my body where I experience pain. FACT-LEU Version 4 - Certain Parts of Body Have Pain FAC017-Content With Quality of My Life Functional Assessment of Cancer Therapy-Leukemia Version 4 - Functional Well-Being: I am content with the quality of my life right now. FACT-LEU Version 4 - Content With Quality of My Life FAC017-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy-Leukemia Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. FACT-LEU Version 4 - Enjoy Things I Usually Do for Fun FAC017-Feel Isolated Because of Illness Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I feel isolated from others because of my illness or treatment. FACT-LEU Version 4 - Feel Isolated Because of Illness FAC017-Get Emotional Support From Family Functional Assessment of Cancer Therapy-Leukemia Version 4 - Social/Family Well-Being: I get emotional support from my family. FACT-LEU Version 4 - Get Emotional Support From Family FAC017-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-Leukemia Version 4 - Functional Well-Being: I am able to enjoy life. FACT-LEU Version 4 - I Am Able to Enjoy Life FAC017-I Am Able to Work Functional Assessment of Cancer Therapy-Leukemia Version 4 - Functional Well-Being: I am able to work (include work at home). FACT-LEU Version 4 - I Am Able to Work FAC017-I Am Bothered by Fevers Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I am bothered by fevers (episodes of high body temperature). FACT-LEU Version 4 - I Am Bothered by Fevers FAC017-I Am Bothered by the Chills Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I am bothered by the chills. FACT-LEU Version 4 - I Am Bothered by the Chills FAC017-I Am Forced to Spend Time in Bed Functional Assessment of Cancer Therapy-Leukemia Version 4 - Physical Well-Being: I am forced to spend time in bed. FACT-LEU Version 4 - I Am Forced to Spend Time in Bed FAC017-I Am Losing Weight Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I am losing weight. FACT-LEU Version 4 - I Am Losing Weight FAC017-I Am Satisfied With My Sex Life Functional Assessment of Cancer Therapy-Leukemia Version 4 - Social/Family Well-Being: I am satisfied with my sex life. FACT-LEU Version 4 - I Am Satisfied With My Sex Life FAC017-I Am Sleeping Well Functional Assessment of Cancer Therapy-Leukemia Version 4 - Functional Well-Being: I am sleeping well. FACT-LEU Version 4 - I Am Sleeping Well FAC017-I Bleed Easily Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I bleed easily. FACT-LEU Version 4 - I Bleed Easily FAC017-I Bruise Easily Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I bruise easily. FACT-LEU Version 4 - I Bruise Easily FAC017-I Feel Close to My Friends Functional Assessment of Cancer Therapy-Leukemia Version 4 - Social/Family Well-Being: I feel close to my friends. FACT-LEU Version 4 - I Feel Close to My Friends FAC017-I Feel Close to My Partner Functional Assessment of Cancer Therapy-Leukemia Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). FACT-LEU Version 4 - I Feel Close to My Partner FAC017-I Feel Ill Functional Assessment of Cancer Therapy-Leukemia Version 4 - Physical Well-Being: I feel ill. FACT-LEU Version 4 - I Feel Ill FAC017-I Feel Nervous Functional Assessment of Cancer Therapy-Leukemia Version 4 - Emotional Well-Being: I feel nervous. FACT-LEU Version 4 - I Feel Nervous FAC017-I Feel Sad Functional Assessment of Cancer Therapy-Leukemia Version 4 - Emotional Well-Being: I feel sad. FACT-LEU Version 4 - I Feel Sad FAC017-I Feel Weak All Over Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I feel weak all over. FACT-LEU Version 4 - I Feel Weak All Over FAC017-I Get Support From My Friends Functional Assessment of Cancer Therapy-Leukemia Version 4 - Social/Family Well-Being: I get support from my friends. FACT-LEU Version 4 - I Get Support From My Friends FAC017-I Get Tired Easily Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I get tired easily. FACT-LEU Version 4 - I Get Tired Easily FAC017-I Have a Good Appetite Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I have a good appetite. FACT-LEU Version 4 - I Have a Good Appetite FAC017-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Leukemia Version 4 - Physical Well-Being: I have a lack of energy. FACT-LEU Version 4 - I Have a Lack of Energy FAC017-I Have Accepted My Illness Functional Assessment of Cancer Therapy-Leukemia Version 4 - Functional Well-Being: I have accepted my illness. FACT-LEU Version 4 - I Have Accepted My Illness FAC017-I Have Emotional Ups and Downs Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I have emotional ups and downs. FACT-LEU Version 4 - I Have Emotional Ups and Downs FAC017-I Have Nausea Functional Assessment of Cancer Therapy-Leukemia Version 4 - Physical Well-Being: I have nausea. FACT-LEU Version 4 - I Have Nausea FAC017-I Have Night Sweats Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I have night sweats. FACT-LEU Version 4 - I Have Night Sweats FAC017-I Have Pain Functional Assessment of Cancer Therapy-Leukemia Version 4 - Physical Well-Being: I have pain. FACT-LEU Version 4 - I Have Pain FAC017-I Worry About Dying Functional Assessment of Cancer Therapy-Leukemia Version 4 - Emotional Well-Being: I worry about dying. FACT-LEU Version 4 - I Worry About Dying FAC017-I Worry About Getting Infections Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I worry about getting infections. FACT-LEU Version 4 - I Worry About Getting Infections FAC017-Losing Hope Against Illness Functional Assessment of Cancer Therapy-Leukemia Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. FACT-LEU Version 4 - Losing Hope Against Illness FAC017-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy-Leukemia Version 4 - Social/Family Well-Being: My family has accepted my illness. FACT-LEU Version 4 - My Family Has Accepted My Illness FAC017-My Work Is Fulfilling Functional Assessment of Cancer Therapy-Leukemia Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. FACT-LEU Version 4 - My Work Is Fulfilling FAC017-Satisfied Communication Illness Functional Assessment of Cancer Therapy-Leukemia Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. FACT-LEU Version 4 - Satisfied Communication Illness FAC017-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy-Leukemia Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. FACT-LEU Version 4 - Satisfied With How I Am Coping FAC017-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-Leukemia Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. FACT-LEU Version 4 - Trouble Meeting Needs of Family FAC017-Uncertain About My Future Health Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I feel uncertain about my future health. FACT-LEU Version 4 - Uncertain About My Future Health FAC017-Worry I Might Get New Symptoms Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I worry that I might get new symptoms of my illness. FACT-LEU Version 4 - Worry I Might Get New Symptoms FAC017-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Leukemia Version 4 - Emotional Well-Being: I worry that my condition will get worse. FACT-LEU Version 4 - Worry My Condition Will Get Worse FAC017TN Functional Assessment of Cancer Therapy-Leukemia Version 4 Questionnaire Test Name CDISC Questionnaire FACT-LEU Version 4 Test Name Terminology Functional Assessment of Cancer Therapy-Lung Symptom Index test code. FAC043-I Have Been Short of Breath Functional Assessment of Cancer Therapy-Lung Symptom Index - I have been short of breath. FLSI - I Have Been Short of Breath FAC043-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Lung Symptom Index - I have a lack of energy. FLSI - I Have a Lack of Energy FAC043-I Have Pain Functional Assessment of Cancer Therapy-Lung Symptom Index - I have pain. FLSI - I Have Pain FAC043-I Am Losing Weight Functional Assessment of Cancer Therapy-Lung Symptom Index - I am losing weight. FLSI - I Am Losing Weight FAC043-I Have Been Coughing Functional Assessment of Cancer Therapy-Lung Symptom Index - I have been coughing. FLSI - I Have Been Coughing FAC043-Certain Parts of Body Have Pain Functional Assessment of Cancer Therapy-Lung Symptom Index - I have certain parts of my body where I experience pain. FLSI - Certain Parts of Body Have Pain FAC043TC Functional Assessment of Cancer Therapy-Lung Symptom Index Questionnaire Test Code CDISC Questionnaire FLSI Test Code Terminology Functional Assessment of Cancer Therapy-Lung Symptom Index test name. FAC043-Certain Parts of Body Have Pain Functional Assessment of Cancer Therapy-Lung Symptom Index - I have certain parts of my body where I experience pain. FLSI - Certain Parts of Body Have Pain FAC043-I Am Losing Weight Functional Assessment of Cancer Therapy-Lung Symptom Index - I am losing weight. FLSI - I Am Losing Weight FAC043-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Lung Symptom Index - I have a lack of energy. FLSI - I Have a Lack of Energy FAC043-I Have Been Coughing Functional Assessment of Cancer Therapy-Lung Symptom Index - I have been coughing. FLSI - I Have Been Coughing FAC043-I Have Been Short of Breath Functional Assessment of Cancer Therapy-Lung Symptom Index - I have been short of breath. FLSI - I Have Been Short of Breath FAC043-I Have Pain Functional Assessment of Cancer Therapy-Lung Symptom Index - I have pain. FLSI - I Have Pain FAC043TN Functional Assessment of Cancer Therapy-Lung Symptom Index Questionnaire Test Name CDISC Questionnaire FLSI Test Name Terminology Functional Assessment of Cancer Therapy-Lung Version 4 test code. FAC016-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Lung Version 4 - Physical Well-Being: I have a lack of energy. FACT-L Version 4 - I Have a Lack of Energy FAC016-I Have Nausea Functional Assessment of Cancer Therapy-Lung Version 4 - Physical Well-Being: I have nausea. FACT-L Version 4 - I Have Nausea FAC016-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-Lung Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. FACT-L Version 4 - Trouble Meeting Needs of Family FAC016-I Have Pain Functional Assessment of Cancer Therapy-Lung Version 4 - Physical Well-Being: I have pain. FACT-L Version 4 - I Have Pain FAC016-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy-Lung Version 4 - Physical Well-Being: I am bothered by side effects of treatment. FACT-L Version 4 - Bothered by Treatment Side Effect FAC016-I Feel Ill Functional Assessment of Cancer Therapy-Lung Version 4 - Physical Well-Being: I feel ill. FACT-L Version 4 - I Feel Ill FAC016-I am Forced to Spend Time in Bed Functional Assessment of Cancer Therapy-Lung Version 4 - Physical Well-Being: I am forced to spend time in bed. FACT-L Version 4 - I am Forced to Spend Time in Bed FAC016-I Feel Close to My Friends Functional Assessment of Cancer Therapy-Lung Version 4 - Social/Family Well-Being: I feel close to my friends. FACT-L Version 4 - I Feel Close to My Friends FAC016-Get Emotional Support From Family Functional Assessment of Cancer Therapy-Lung Version 4 - Social/Family Well-Being: I get emotional support from my family. FACT-L Version 4 - Get Emotional Support From Family FAC016-I Get Support From My Friends Functional Assessment of Cancer Therapy-Lung Version 4 - Social/Family Well-Being: I get support from my friends. FACT-L Version 4 - I Get Support From My Friends FAC016-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy-Lung Version 4 - Social/Family Well-Being: My family has accepted my illness. FACT-L Version 4 - My Family Has Accepted My Illness FAC016-Satisfied Communication Illness Functional Assessment of Cancer Therapy-Lung Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. FACT-L Version 4 - Satisfied Communication Illness FAC016-I Feel Close to My Partner Functional Assessment of Cancer Therapy-Lung Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). FACT-L Version 4 - I Feel Close to My Partner FAC016-I Am Satisfied With My Sex Life Functional Assessment of Cancer Therapy-Lung Version 4 - Social/Family Well-Being: I am satisfied with my sex life. FACT-L Version 4 - I Am Satisfied With My Sex Life FAC016-I Feel Sad Functional Assessment of Cancer Therapy-Lung Version 4 - Emotional Well-Being: I feel sad. FACT-L Version 4 - I Feel Sad FAC016-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy-Lung Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. FACT-L Version 4 - Satisfied With How I Am Coping FAC016-Losing Hope Against Illness Functional Assessment of Cancer Therapy-Lung Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. FACT-L Version 4 - Losing Hope Against Illness FAC016-I Feel Nervous Functional Assessment of Cancer Therapy-Lung Version 4 - Emotional Well-Being: I feel nervous. FACT-L Version 4 - I Feel Nervous FAC016-I Worry About Dying Functional Assessment of Cancer Therapy-Lung Version 4 - Emotional Well-Being: I worry about dying. FACT-L Version 4 - I Worry About Dying FAC016-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Lung Version 4 - Emotional Well-Being: I worry that my condition will get worse. FACT-L Version 4 - Worry My Condition Will Get Worse FAC016-I Am Able to Work Functional Assessment of Cancer Therapy-Lung Version 4 - Functional Well-Being: I am able to work (include work at home). FACT-L Version 4 - I Am Able to Work FAC016-My Work Is Fulfilling Functional Assessment of Cancer Therapy-Lung Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. FACT-L Version 4 - My Work Is Fulfilling FAC016-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-Lung Version 4 - Functional Well-Being: I am able to enjoy life. FACT-L Version 4 - I Am Able to Enjoy Life FAC016-I Have Accepted My Illness Functional Assessment of Cancer Therapy-Lung Version 4 - Functional Well-Being: I have accepted my illness. FACT-L Version 4 - I Have Accepted My Illness FAC016-I Am Sleeping Well Functional Assessment of Cancer Therapy-Lung Version 4 - Functional Well-Being: I am sleeping well. FACT-L Version 4 - I Am Sleeping Well FAC016-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy-Lung Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. FACT-L Version 4 - Enjoy Things I Usually Do for Fun FAC016-Content With Quality of My Life Functional Assessment of Cancer Therapy-Lung Version 4 - Functional Well-Being: I am content with the quality of my life right now. FACT-L Version 4 - Content With Quality of My Life FAC016-I Have Been Short of Breath Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: I have been short of breath. FACT-L Version 4 - I Have Been Short of Breath FAC016-I Am Losing Weight Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: I am losing weight. FACT-L Version 4 - I Am Losing Weight FAC016-My Thinking Is Clear Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: My thinking is clear. FACT-L Version 4 - My Thinking Is Clear FAC016-I Have Been Coughing Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: I have been coughing. FACT-L Version 4 - I Have Been Coughing FAC016-I Am Bothered by Hair Loss Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: I am bothered by hair loss. FACT-L Version 4 - I Am Bothered by Hair Loss FAC016-I Have a Good Appetite Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: I have a good appetite. FACT-L Version 4 - I Have a Good Appetite FAC016-I Feel Tightness in My Chest Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: I feel tightness in my chest. FACT-L Version 4 - I Feel Tightness in My Chest FAC016-Breathing Is Easy for Me Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: Breathing is easy for me. FACT-L Version 4 - Breathing Is Easy for Me FAC016-Have You Ever Smoked Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: Have you ever smoked? FACT-L Version 4 - Have You Ever Smoked FAC016-I Regret My Smoking Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: I regret my smoking. FACT-L Version 4 - I Regret My Smoking FAC016TC Functional Assessment of Cancer Therapy-Lung Version 4 Questionnaire Test Code CDISC Questionnaire FACT-L Version 4 Test Code Terminology Functional Assessment of Cancer Therapy-Lung Version 4 test name. FAC016-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy-Lung Version 4 - Physical Well-Being: I am bothered by side effects of treatment. FACT-L Version 4 - Bothered by Treatment Side Effect FAC016-Breathing Is Easy for Me Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: Breathing is easy for me. FACT-L Version 4 - Breathing Is Easy for Me FAC016-Content With Quality of My Life Functional Assessment of Cancer Therapy-Lung Version 4 - Functional Well-Being: I am content with the quality of my life right now. FACT-L Version 4 - Content With Quality of My Life FAC016-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy-Lung Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. FACT-L Version 4 - Enjoy Things I Usually Do for Fun FAC016-Get Emotional Support From Family Functional Assessment of Cancer Therapy-Lung Version 4 - Social/Family Well-Being: I get emotional support from my family. FACT-L Version 4 - Get Emotional Support From Family FAC016-Have You Ever Smoked Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: Have you ever smoked? FACT-L Version 4 - Have You Ever Smoked FAC016-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-Lung Version 4 - Functional Well-Being: I am able to enjoy life. FACT-L Version 4 - I Am Able to Enjoy Life FAC016-I Am Able to Work Functional Assessment of Cancer Therapy-Lung Version 4 - Functional Well-Being: I am able to work (include work at home). FACT-L Version 4 - I Am Able to Work FAC016-I Am Bothered by Hair Loss Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: I am bothered by hair loss. FACT-L Version 4 - I Am Bothered by Hair Loss FAC016-I am Forced to Spend Time in Bed Functional Assessment of Cancer Therapy-Lung Version 4 - Physical Well-Being: I am forced to spend time in bed. FACT-L Version 4 - I am Forced to Spend Time in Bed FAC016-I Am Losing Weight Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: I am losing weight. FACT-L Version 4 - I Am Losing Weight FAC016-I Am Satisfied With My Sex Life Functional Assessment of Cancer Therapy-Lung Version 4 - Social/Family Well-Being: I am satisfied with my sex life. FACT-L Version 4 - I Am Satisfied With My Sex Life FAC016-I Am Sleeping Well Functional Assessment of Cancer Therapy-Lung Version 4 - Functional Well-Being: I am sleeping well. FACT-L Version 4 - I Am Sleeping Well FAC016-I Feel Close to My Friends Functional Assessment of Cancer Therapy-Lung Version 4 - Social/Family Well-Being: I feel close to my friends. FACT-L Version 4 - I Feel Close to My Friends FAC016-I Feel Close to My Partner Functional Assessment of Cancer Therapy-Lung Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). FACT-L Version 4 - I Feel Close to My Partner FAC016-I Feel Ill Functional Assessment of Cancer Therapy-Lung Version 4 - Physical Well-Being: I feel ill. FACT-L Version 4 - I Feel Ill FAC016-I Feel Nervous Functional Assessment of Cancer Therapy-Lung Version 4 - Emotional Well-Being: I feel nervous. FACT-L Version 4 - I Feel Nervous FAC016-I Feel Sad Functional Assessment of Cancer Therapy-Lung Version 4 - Emotional Well-Being: I feel sad. FACT-L Version 4 - I Feel Sad FAC016-I Feel Tightness in My Chest Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: I feel tightness in my chest. FACT-L Version 4 - I Feel Tightness in My Chest FAC016-I Get Support From My Friends Functional Assessment of Cancer Therapy-Lung Version 4 - Social/Family Well-Being: I get support from my friends. FACT-L Version 4 - I Get Support From My Friends FAC016-I Have a Good Appetite Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: I have a good appetite. FACT-L Version 4 - I Have a Good Appetite FAC016-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Lung Version 4 - Physical Well-Being: I have a lack of energy. FACT-L Version 4 - I Have a Lack of Energy FAC016-I Have Accepted My Illness Functional Assessment of Cancer Therapy-Lung Version 4 - Functional Well-Being: I have accepted my illness. FACT-L Version 4 - I Have Accepted My Illness FAC016-I Have Been Coughing Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: I have been coughing. FACT-L Version 4 - I Have Been Coughing FAC016-I Have Been Short of Breath Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: I have been short of breath. FACT-L Version 4 - I Have Been Short of Breath FAC016-I Have Nausea Functional Assessment of Cancer Therapy-Lung Version 4 - Physical Well-Being: I have nausea. FACT-L Version 4 - I Have Nausea FAC016-I Have Pain Functional Assessment of Cancer Therapy-Lung Version 4 - Physical Well-Being: I have pain. FACT-L Version 4 - I Have Pain FAC016-I Regret My Smoking Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: I regret my smoking. FACT-L Version 4 - I Regret My Smoking FAC016-I Worry About Dying Functional Assessment of Cancer Therapy-Lung Version 4 - Emotional Well-Being: I worry about dying. FACT-L Version 4 - I Worry About Dying FAC016-Losing Hope Against Illness Functional Assessment of Cancer Therapy-Lung Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. FACT-L Version 4 - Losing Hope Against Illness FAC016-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy-Lung Version 4 - Social/Family Well-Being: My family has accepted my illness. FACT-L Version 4 - My Family Has Accepted My Illness FAC016-My Thinking Is Clear Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: My thinking is clear. FACT-L Version 4 - My Thinking Is Clear FAC016-My Work Is Fulfilling Functional Assessment of Cancer Therapy-Lung Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. FACT-L Version 4 - My Work Is Fulfilling FAC016-Satisfied Communication Illness Functional Assessment of Cancer Therapy-Lung Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. FACT-L Version 4 - Satisfied Communication Illness FAC016-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy-Lung Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. FACT-L Version 4 - Satisfied With How I Am Coping FAC016-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-Lung Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. FACT-L Version 4 - Trouble Meeting Needs of Family FAC016-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Lung Version 4 - Emotional Well-Being: I worry that my condition will get worse. FACT-L Version 4 - Worry My Condition Will Get Worse FAC016TN Functional Assessment of Cancer Therapy-Lung Version 4 Questionnaire Test Name CDISC Questionnaire FACT-L Version 4 Test Name Terminology Functional Assessment of Cancer Therapy-Lymphoma Version 4 test code. FAC018-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Physical Well-Being: I have a lack of energy. FACT-LYM Version 4 - I Have a Lack of Energy FAC018-I Have Nausea Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Physical Well-Being: I have nausea. FACT-LYM Version 4 - I Have Nausea FAC018-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. FACT-LYM Version 4 - Trouble Meeting Needs of Family FAC018-I Have Pain Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Physical Well-Being: I have pain. FACT-LYM Version 4 - I Have Pain FAC018-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Physical Well-Being: I am bothered by side effects of treatment. FACT-LYM Version 4 - Bothered by Treatment Side Effect FAC018-I Feel Ill Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Physical Well-Being: I feel ill. FACT-LYM Version 4 - I Feel Ill FAC018-I Am Forced to Spend Time in Bed Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Physical Well-Being: I am forced to spend time in bed. FACT-LYM Version 4 - I Am Forced to Spend Time in Bed FAC018-I Feel Close to My Friends Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Social/Family Well-Being: I feel close to my friends. FACT-LYM Version 4 - I Feel Close to My Friends FAC018-Get Emotional Support From Family Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Social/Family Well-Being: I get emotional support from my family. FACT-LYM Version 4 - Get Emotional Support From Family FAC018-I Get Support From My Friends Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Social/Family Well-Being: I get support from my friends. FACT-LYM Version 4 - I Get Support From My Friends FAC018-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Social/Family Well-Being: My family has accepted my illness. FACT-LYM Version 4 - My Family Has Accepted My Illness FAC018-Satisfied Communication Illness Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. FACT-LYM Version 4 - Satisfied With Communication About Illness FAC018-I Feel Close to My Partner Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). FACT-LYM Version 4 - I Feel Close to My Partner FAC018-I Am Satisfied With My Sex Life Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Social/Family Well-Being: I am satisfied with my sex life. FACT-LYM Version 4 - I Am Satisfied With My Sex Life FAC018-I Feel Sad Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Emotional Well-Being: I feel sad. FACT-LYM Version 4 - I Feel Sad FAC018-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. FACT-LYM Version 4 - Satisfied With How I Am Coping FAC018-Losing Hope Against Illness Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. FACT-LYM Version 4 - Losing Hope Against Illness FAC018-I Feel Nervous Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Emotional Well-Being: I feel nervous. FACT-LYM Version 4 - I Feel Nervous FAC018-I Worry About Dying Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Emotional Well-Being: I worry about dying. FACT-LYM Version 4 - I Worry About Dying FAC018-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Emotional Well-Being: I worry that my condition will get worse. FACT-LYM Version 4 - Worry My Condition Will Get Worse FAC018-I Am Able to Work Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Functional Well-Being: I am able to work (include work at home). FACT-LYM Version 4 - I Am Able to Work FAC018-My Work Is Fulfilling Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. FACT-LYM Version 4 - My Work Is Fulfilling FAC018-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Functional Well-Being: I am able to enjoy life. FACT-LYM Version 4 - I Am Able to Enjoy Life FAC018-I Have Accepted My Illness Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Functional Well-Being: I have accepted my illness. FACT-LYM Version 4 - I Have Accepted My Illness FAC018-I Am Sleeping Well Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Functional Well-Being: I am sleeping well. FACT-LYM Version 4 - I Am Sleeping Well FAC018-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. FACT-LYM Version 4 - Enjoy Things I Usually Do for Fun FAC018-Content With Quality of My Life Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Functional Well-Being: I am content with the quality of my life right now. FACT-LYM Version 4 - Content With Quality of My Life FAC018-Certain Parts of Body Have Pain Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I have certain parts of my body where I experience pain. FACT-LYM Version 4 - Certain Parts of Body Have Pain FAC018-Bothered by Lumps or Swelling Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I am bothered by lumps or swelling in certain parts of my body (e.g., neck, armpits, or groin). FACT-LYM Version 4 - Bothered by Lumps or Swelling FAC018-I Am Bothered by Fevers Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I am bothered by fevers (episodes of high body temperature). FACT-LYM Version 4 - I Am Bothered by Fevers FAC018-I Have Night Sweats Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I have night sweats. FACT-LYM Version 4 - I Have Night Sweats FAC018-I Am Bothered by Itching Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I am bothered by itching. FACT-LYM Version 4 - I Am Bothered by Itching FAC018-I Have Trouble Sleeping at Night Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I have trouble sleeping at night. FACT-LYM Version 4 - I Have Trouble Sleeping at Night FAC018-I Get Tired Easily Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I get tired easily. FACT-LYM Version 4 - I Get Tired Easily FAC018-I Am Losing Weight Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I am losing weight. FACT-LYM Version 4 - I Am Losing Weight FAC018-I Have a Loss of Appetite Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I have a loss of appetite. FACT-LYM Version 4 - I Have a Loss of Appetite FAC018-I Have Trouble Concentrating Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I have trouble concentrating. FACT-LYM Version 4 - I Have Trouble Concentrating FAC018-I Worry About Getting Infections Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I worry about getting infections. FACT-LYM Version 4 - I Worry About Getting Infections FAC018-Worry I Might Get New Symptoms Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I worry that I might get new symptoms of my illness. FACT-LYM Version 4 - Worry I Might Get New Symptoms FAC018-Feel Isolated Because of Illness Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I feel isolated from others because of my illness or treatment. FACT-LYM Version 4 - Feel Isolated Because of Illness FAC018-I Have Emotional Ups and Downs Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I have emotional ups and downs. FACT-LYM Version 4 - I Have Emotional Ups and Downs FAC018-Difficulty Planning for Future Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: Because of my illness, I have difficulty planning for the future. FACT-LYM Version 4 - Difficulty Planning for Future FAC018TC Functional Assessment of Cancer Therapy-Lymphoma Version 4 Questionnaire Test Code CDISC Questionnaire FACT-LYM Version 4 Test Code Terminology Functional Assessment of Cancer Therapy-Lymphoma Version 4 test name. FAC018-Bothered by Lumps or Swelling Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I am bothered by lumps or swelling in certain parts of my body (e.g., neck, armpits, or groin). FACT-LYM Version 4 - Bothered by Lumps or Swelling FAC018-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Physical Well-Being: I am bothered by side effects of treatment. FACT-LYM Version 4 - Bothered by Treatment Side Effect FAC018-Certain Parts of Body Have Pain Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I have certain parts of my body where I experience pain. FACT-LYM Version 4 - Certain Parts of Body Have Pain FAC018-Content With Quality of My Life Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Functional Well-Being: I am content with the quality of my life right now. FACT-LYM Version 4 - Content With Quality of My Life FAC018-Difficulty Planning for Future Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: Because of my illness, I have difficulty planning for the future. FACT-LYM Version 4 - Difficulty Planning for Future FAC018-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. FACT-LYM Version 4 - Enjoy Things I Usually Do for Fun FAC018-Feel Isolated Because of Illness Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I feel isolated from others because of my illness or treatment. FACT-LYM Version 4 - Feel Isolated Because of Illness FAC018-Get Emotional Support From Family Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Social/Family Well-Being: I get emotional support from my family. FACT-LYM Version 4 - Get Emotional Support From Family FAC018-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Functional Well-Being: I am able to enjoy life. FACT-LYM Version 4 - I Am Able to Enjoy Life FAC018-I Am Able to Work Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Functional Well-Being: I am able to work (include work at home). FACT-LYM Version 4 - I Am Able to Work FAC018-I Am Bothered by Fevers Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I am bothered by fevers (episodes of high body temperature). FACT-LYM Version 4 - I Am Bothered by Fevers FAC018-I Am Bothered by Itching Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I am bothered by itching. FACT-LYM Version 4 - I Am Bothered by Itching FAC018-I Am Forced to Spend Time in Bed Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Physical Well-Being: I am forced to spend time in bed. FACT-LYM Version 4 - I Am Forced to Spend Time in Bed FAC018-I Am Losing Weight Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I am losing weight. FACT-LYM Version 4 - I Am Losing Weight FAC018-I Am Satisfied With My Sex Life Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Social/Family Well-Being: I am satisfied with my sex life. FACT-LYM Version 4 - I Am Satisfied With My Sex Life FAC018-I Am Sleeping Well Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Functional Well-Being: I am sleeping well. FACT-LYM Version 4 - I Am Sleeping Well FAC018-I Feel Close to My Friends Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Social/Family Well-Being: I feel close to my friends. FACT-LYM Version 4 - I Feel Close to My Friends FAC018-I Feel Close to My Partner Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). FACT-LYM Version 4 - I Feel Close to My Partner FAC018-I Feel Ill Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Physical Well-Being: I feel ill. FACT-LYM Version 4 - I Feel Ill FAC018-I Feel Nervous Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Emotional Well-Being: I feel nervous. FACT-LYM Version 4 - I Feel Nervous FAC018-I Feel Sad Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Emotional Well-Being: I feel sad. FACT-LYM Version 4 - I Feel Sad FAC018-I Get Support From My Friends Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Social/Family Well-Being: I get support from my friends. FACT-LYM Version 4 - I Get Support From My Friends FAC018-I Get Tired Easily Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I get tired easily. FACT-LYM Version 4 - I Get Tired Easily FAC018-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Physical Well-Being: I have a lack of energy. FACT-LYM Version 4 - I Have a Lack of Energy FAC018-I Have a Loss of Appetite Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I have a loss of appetite. FACT-LYM Version 4 - I Have a Loss of Appetite FAC018-I Have Accepted My Illness Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Functional Well-Being: I have accepted my illness. FACT-LYM Version 4 - I Have Accepted My Illness FAC018-I Have Emotional Ups and Downs Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I have emotional ups and downs. FACT-LYM Version 4 - I Have Emotional Ups and Downs FAC018-I Have Nausea Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Physical Well-Being: I have nausea. FACT-LYM Version 4 - I Have Nausea FAC018-I Have Night Sweats Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I have night sweats. FACT-LYM Version 4 - I Have Night Sweats FAC018-I Have Pain Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Physical Well-Being: I have pain. FACT-LYM Version 4 - I Have Pain FAC018-I Have Trouble Concentrating Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I have trouble concentrating. FACT-LYM Version 4 - I Have Trouble Concentrating FAC018-I Have Trouble Sleeping at Night Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I have trouble sleeping at night. FACT-LYM Version 4 - I Have Trouble Sleeping at Night FAC018-I Worry About Dying Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Emotional Well-Being: I worry about dying. FACT-LYM Version 4 - I Worry About Dying FAC018-I Worry About Getting Infections Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I worry about getting infections. FACT-LYM Version 4 - I Worry About Getting Infections FAC018-Losing Hope Against Illness Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. FACT-LYM Version 4 - Losing Hope Against Illness FAC018-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Social/Family Well-Being: My family has accepted my illness. FACT-LYM Version 4 - My Family Has Accepted My Illness FAC018-My Work Is Fulfilling Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. FACT-LYM Version 4 - My Work Is Fulfilling FAC018-Satisfied Communication Illness Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. FACT-LYM Version 4 - Satisfied With Communication About Illness FAC018-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. FACT-LYM Version 4 - Satisfied With How I Am Coping FAC018-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. FACT-LYM Version 4 - Trouble Meeting Needs of Family FAC018-Worry I Might Get New Symptoms Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I worry that I might get new symptoms of my illness. FACT-LYM Version 4 - Worry I Might Get New Symptoms FAC018-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Emotional Well-Being: I worry that my condition will get worse. FACT-LYM Version 4 - Worry My Condition Will Get Worse FAC018TN Functional Assessment of Cancer Therapy-Lymphoma Version 4 Questionnaire Test Name CDISC Questionnaire FACT-LYM Version 4 Test Name Terminology Functional Assessment of Cancer Therapy-Melanoma Version 4 test code. FAC019-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Melanoma Version 4 - Physical Well-Being: I have a lack of energy. FACT-M Version 4 - I Have a Lack of Energy FAC019-I Have Nausea Functional Assessment of Cancer Therapy-Melanoma Version 4 - Physical Well-Being: I have nausea. FACT-M Version 4 - I Have Nausea FAC019-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-Melanoma Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. FACT-M Version 4 - Trouble Meeting Needs of Family FAC019-I Have Pain Functional Assessment of Cancer Therapy-Melanoma Version 4 - Physical Well-Being: I have pain. FACT-M Version 4 - I Have Pain FAC019-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy-Melanoma Version 4 - Physical Well-Being: I am bothered by side effects of treatment. FACT-M Version 4 - Bothered by Treatment Side Effect FAC019-I Feel Ill Functional Assessment of Cancer Therapy-Melanoma Version 4 - Physical Well-Being: I feel ill. FACT-M Version 4 - I Feel Ill FAC019-I Am Forced to Spend Time in Bed Functional Assessment of Cancer Therapy-Melanoma Version 4 - Physical Well-Being: I am forced to spend time in bed. FACT-M Version 4 - I Am Forced to Spend Time in Bed FAC019-I Feel Close to My Friends Functional Assessment of Cancer Therapy-Melanoma Version 4 - Social/Family Well-Being: I feel close to my friends. FACT-M Version 4 - I Feel Close to My Friends FAC019-Get Emotional Support From Family Functional Assessment of Cancer Therapy-Melanoma Version 4 - Social/Family Well-Being: I get emotional support from my family. FACT-M Version 4 - Get Emotional Support From Family FAC019-I Get Support From My Friends Functional Assessment of Cancer Therapy-Melanoma Version 4 - Social/Family Well-Being: I get support from my friends. FACT-M Version 4 - I Get Support From My Friends FAC019-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy-Melanoma Version 4 - Social/Family Well-Being: My family has accepted my illness. FACT-M Version 4 - My Family Has Accepted My Illness FAC019-Satisfied Communication Illness Functional Assessment of Cancer Therapy-Melanoma Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. FACT-M Version 4 - Satisfied Communication Illness FAC019-I Feel Close to My Partner Functional Assessment of Cancer Therapy-Melanoma Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). FACT-M Version 4 - I Feel Close to My Partner FAC019-I Am Satisfied With My Sex Life Functional Assessment of Cancer Therapy-Melanoma Version 4 - Social/Family Well-Being: I am satisfied with my sex life. FACT-M Version 4 - I Am Satisfied With My Sex Life FAC019-I Feel Sad Functional Assessment of Cancer Therapy-Melanoma Version 4 - Emotional Well-Being: I feel sad. FACT-M Version 4 - I Feel Sad FAC019-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy-Melanoma Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. FACT-M Version 4 - Satisfied With How I Am Coping FAC019-Losing Hope Against Illness Functional Assessment of Cancer Therapy-Melanoma Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. FACT-M Version 4 - Losing Hope Against Illness FAC019-I Feel Nervous Functional Assessment of Cancer Therapy-Melanoma Version 4 - Emotional Well-Being: I feel nervous. FACT-M Version 4 - I Feel Nervous FAC019-I Worry About Dying Functional Assessment of Cancer Therapy-Melanoma Version 4 - Emotional Well-Being: I worry about dying. FACT-M Version 4 - I Worry About Dying FAC019-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Melanoma Version 4 - Emotional Well-Being: I worry that my condition will get worse. FACT-M Version 4 - Worry My Condition Will Get Worse FAC019-I Am Able to Work Functional Assessment of Cancer Therapy-Melanoma Version 4 - Functional Well-Being: I am able to work (include work at home). FACT-M Version 4 - I Am Able to Work FAC019-My Work Is Fulfilling Functional Assessment of Cancer Therapy-Melanoma Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. FACT-M Version 4 - My Work Is Fulfilling FAC019-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-Melanoma Version 4 - Functional Well-Being: I am able to enjoy life. FACT-M Version 4 - I Am Able to Enjoy Life FAC019-I Have Accepted My Illness Functional Assessment of Cancer Therapy-Melanoma Version 4 - Functional Well-Being: I have accepted my illness. FACT-M Version 4 - I Have Accepted My Illness FAC019-I Am Sleeping Well Functional Assessment of Cancer Therapy-Melanoma Version 4 - Functional Well-Being: I am sleeping well. FACT-M Version 4 - I Am Sleeping Well FAC019-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy-Melanoma Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. FACT-M Version 4 - Enjoy Things I Usually Do for Fun FAC019-Content With Quality of My Life Functional Assessment of Cancer Therapy-Melanoma Version 4 - Functional Well-Being: I am content with the quality of my life right now. FACT-M Version 4 - Content With Quality of My Life FAC019-Pain at My Melanoma/Surgical Site Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I have pain at my melanoma site or surgical site. FACT-M Version 4 - Pain at My Melanoma or Surgical Site FAC019-Noticed New Changes in My Skin Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I have noticed new changes in my skin (lumps, bumps, color (colour)). FACT-M Version 4 - Noticed New Changes in My Skin FAC019-Worry Appearance Surgical Scars Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I worry about the appearance of surgical scars. FACT-M Version 4 - Worry Appearance Surgical Scars FAC019-I Have Been Short of Breath Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I have been short of breath. FACT-M Version 4 - I Have Been Short of Breath FAC019-Limit Physical Activ B/c Cond Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I have to limit my physical activity because of my condition. FACT-M Version 4 - Limit Physical Activity Because Condition FAC019-I Get Headaches Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I get headaches. FACT-M Version 4 - I Get Headaches FAC019-I Have Had Fevers Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I have had fevers (episodes of high body temperature). FACT-M Version 4 - I Have Had Fevers FAC019-Swelling/Cramps in Stomach Area Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I have swelling or cramps in my stomach area. FACT-M Version 4 - Swelling or Cramps in Stomach Area FAC019-I Have a Good Appetite Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I have a good appetite. FACT-M Version 4 - I Have a Good Appetite FAC019-I Have Aches and Pains My Bones Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I have aches and pains in my bones. FACT-M Version 4 - I Have Aches and Pains My Bones FAC019-I Have Noticed Blood in My Stool Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I have noticed blood in my stool. FACT-M Version 4 - I Have Noticed Blood in My Stool FAC019-Limit My Social Activity Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I have to limit my social activity because of my condition. FACT-M Version 4 - Limit My Social Activity FAC019-Feel Overwhelmed by My Condition Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I feel overwhelmed by my condition. FACT-M Version 4 - Feel Overwhelmed by My Condition FAC019-Isolate From Others B/c Condition Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I isolate myself from others because of my condition. FACT-M Version 4 - Isolate From Others Because Condition FAC019-Have Difficulty Thinking Clearly Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I have difficulty thinking clearly (remembering, concentrating). FACT-M Version 4 - Have Difficulty Thinking Clearly FAC019-I Feel Fatigued Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I feel fatigued. FACT-M Version 4 - I Feel Fatigued FAC019-Have Swelling at My Melanoma Site Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: At the site of my melanoma surgery: I have swelling at my melanoma site. FACT-M Version 4 - Have Swelling at My Melanoma Site FAC019-Swelling as a Result of Surgery Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: At the site of my melanoma surgery: I have swelling as a result of surgery. FACT-M Version 4 - Swelling as a Result of Surgery FAC019-Bothered by Amount of Swelling Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: At the site of my melanoma surgery: I am bothered by the amount of swelling. FACT-M Version 4 - Bothered by Amount of Swelling FAC019-Movement of Swollen Area Painful Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: At the site of my melanoma surgery: Movement of my swollen area is painful. FACT-M Version 4 - Movement of Swollen Area Painful FAC019-Swelling Keeps From Doing Things Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: At the site of my melanoma surgery: Swelling keeps me from doing the things I want to do. FACT-M Version 4 - Swelling Keeps From Doing Things FAC019-Swelling Keeps Me From Wearing Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: At the site of my melanoma surgery: Swelling keeps me from wearing clothes or shoes I want to wear. FACT-M Version 4 - Swelling Keeps Me From Wearing FAC019-Feel Numbness at My Surgical Site Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: At the site of my melanoma surgery: I feel numbness at my surgical site. FACT-M Version 4 - Feel Numbness at My Surgical Site FAC019-Good Range of Movement in Arm/Leg Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: At the site of my melanoma surgery: I have good range of movement in my arm or leg. FACT-M Version 4 - Good Range of Movement in Arm or Leg FAC019-Physical Subscale Score Functional Assessment of Cancer Therapy-Melanoma Version 4 - Physical Well-Being: Subscale score. FACT-M Version 4 - Physical Subscale Score FAC019-Social/Family Subscale Score Functional Assessment of Cancer Therapy-Melanoma Version 4 - Social/Family Well-Being: Subscale score. FACT-M Version 4 - Social/Family Subscale Score FAC019-Emotional Subscale Score Functional Assessment of Cancer Therapy-Melanoma Version 4 - Emotional Well-Being: Subscale score. FACT-M Version 4 - Emotional Subscale Score FAC019-Functional Subscale Score Functional Assessment of Cancer Therapy-Melanoma Version 4 - Functional Well-Being: Subscale score. FACT-M Version 4 - Functional Subscale Score FAC019-Additional Concern Subscale Score Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: Subscale score. FACT-M Version 4 - Additional Concern Subscale Score FAC019-Additional Concern Surgery Score Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: Surgery score. FACT-M Version 4 - Additional Concern Surgery Score FAC019-Trial Outcome Index Score Functional Assessment of Cancer Therapy-Melanoma Version 4 - Total outcome index score. FACT-M Version 4 - Trial Outcome Index Score FAC019-FACT-G Total Score Functional Assessment of Cancer Therapy-Melanoma Version 4 - FACT-G total score. FACT-M Version 4 - FACT-G Total Score FAC019-Total Score Functional Assessment of Cancer Therapy-Melanoma Version 4 - Total score. FACT-M Version 4 - Total Score FAC019TC Functional Assessment of Cancer Therapy-Melanoma Version 4 Questionnaire Test Code CDISC Questionnaire Functional Assessment of Cancer Therapy-Melanoma Version 4 Test Code Terminology Functional Assessment of Cancer Therapy-Melanoma Version 4 test name. FAC019-Additional Concern Subscale Score Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: Subscale score. FACT-M Version 4 - Additional Concern Subscale Score FAC019-Additional Concern Surgery Score Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: Surgery score. FACT-M Version 4 - Additional Concern Surgery Score FAC019-Bothered by Amount of Swelling Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: At the site of my melanoma surgery: I am bothered by the amount of swelling. FACT-M Version 4 - Bothered by Amount of Swelling FAC019-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy-Melanoma Version 4 - Physical Well-Being: I am bothered by side effects of treatment. FACT-M Version 4 - Bothered by Treatment Side Effect FAC019-Content With Quality of My Life Functional Assessment of Cancer Therapy-Melanoma Version 4 - Functional Well-Being: I am content with the quality of my life right now. FACT-M Version 4 - Content With Quality of My Life FAC019-Emotional Subscale Score Functional Assessment of Cancer Therapy-Melanoma Version 4 - Emotional Well-Being: Subscale score. FACT-M Version 4 - Emotional Subscale Score FAC019-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy-Melanoma Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. FACT-M Version 4 - Enjoy Things I Usually Do for Fun FAC019-FACT-G Total Score Functional Assessment of Cancer Therapy-Melanoma Version 4 - FACT-G total score. FACT-M Version 4 - FACT-G Total Score FAC019-Feel Numbness at My Surgical Site Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: At the site of my melanoma surgery: I feel numbness at my surgical site. FACT-M Version 4 - Feel Numbness at My Surgical Site FAC019-Feel Overwhelmed by My Condition Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I feel overwhelmed by my condition. FACT-M Version 4 - Feel Overwhelmed by My Condition FAC019-Functional Subscale Score Functional Assessment of Cancer Therapy-Melanoma Version 4 - Functional Well-Being: Subscale score. FACT-M Version 4 - Functional Subscale Score FAC019-Get Emotional Support From Family Functional Assessment of Cancer Therapy-Melanoma Version 4 - Social/Family Well-Being: I get emotional support from my family. FACT-M Version 4 - Get Emotional Support From Family FAC019-Good Range of Movement in Arm/Leg Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: At the site of my melanoma surgery: I have good range of movement in my arm or leg. FACT-M Version 4 - Good Range of Movement in Arm or Leg FAC019-Have Difficulty Thinking Clearly Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I have difficulty thinking clearly (remembering, concentrating). FACT-M Version 4 - Have Difficulty Thinking Clearly FAC019-Have Swelling at My Melanoma Site Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: At the site of my melanoma surgery: I have swelling at my melanoma site. FACT-M Version 4 - Have Swelling at My Melanoma Site FAC019-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-Melanoma Version 4 - Functional Well-Being: I am able to enjoy life. FACT-M Version 4 - I Am Able to Enjoy Life FAC019-I Am Able to Work Functional Assessment of Cancer Therapy-Melanoma Version 4 - Functional Well-Being: I am able to work (include work at home). FACT-M Version 4 - I Am Able to Work FAC019-I Am Forced to Spend Time in Bed Functional Assessment of Cancer Therapy-Melanoma Version 4 - Physical Well-Being: I am forced to spend time in bed. FACT-M Version 4 - I Am Forced to Spend Time in Bed FAC019-I Am Satisfied With My Sex Life Functional Assessment of Cancer Therapy-Melanoma Version 4 - Social/Family Well-Being: I am satisfied with my sex life. FACT-M Version 4 - I Am Satisfied With My Sex Life FAC019-I Am Sleeping Well Functional Assessment of Cancer Therapy-Melanoma Version 4 - Functional Well-Being: I am sleeping well. FACT-M Version 4 - I Am Sleeping Well FAC019-I Feel Close to My Friends Functional Assessment of Cancer Therapy-Melanoma Version 4 - Social/Family Well-Being: I feel close to my friends. FACT-M Version 4 - I Feel Close to My Friends FAC019-I Feel Close to My Partner Functional Assessment of Cancer Therapy-Melanoma Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). FACT-M Version 4 - I Feel Close to My Partner FAC019-I Feel Fatigued Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I feel fatigued. FACT-M Version 4 - I Feel Fatigued FAC019-I Feel Ill Functional Assessment of Cancer Therapy-Melanoma Version 4 - Physical Well-Being: I feel ill. FACT-M Version 4 - I Feel Ill FAC019-I Feel Nervous Functional Assessment of Cancer Therapy-Melanoma Version 4 - Emotional Well-Being: I feel nervous. FACT-M Version 4 - I Feel Nervous FAC019-I Feel Sad Functional Assessment of Cancer Therapy-Melanoma Version 4 - Emotional Well-Being: I feel sad. FACT-M Version 4 - I Feel Sad FAC019-I Get Headaches Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I get headaches. FACT-M Version 4 - I Get Headaches FAC019-I Get Support From My Friends Functional Assessment of Cancer Therapy-Melanoma Version 4 - Social/Family Well-Being: I get support from my friends. FACT-M Version 4 - I Get Support From My Friends FAC019-I Have a Good Appetite Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I have a good appetite. FACT-M Version 4 - I Have a Good Appetite FAC019-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Melanoma Version 4 - Physical Well-Being: I have a lack of energy. FACT-M Version 4 - I Have a Lack of Energy FAC019-I Have Accepted My Illness Functional Assessment of Cancer Therapy-Melanoma Version 4 - Functional Well-Being: I have accepted my illness. FACT-M Version 4 - I Have Accepted My Illness FAC019-I Have Aches and Pains My Bones Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I have aches and pains in my bones. FACT-M Version 4 - I Have Aches and Pains My Bones FAC019-I Have Been Short of Breath Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I have been short of breath. FACT-M Version 4 - I Have Been Short of Breath FAC019-I Have Had Fevers Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I have had fevers (episodes of high body temperature). FACT-M Version 4 - I Have Had Fevers FAC019-I Have Nausea Functional Assessment of Cancer Therapy-Melanoma Version 4 - Physical Well-Being: I have nausea. FACT-M Version 4 - I Have Nausea FAC019-I Have Noticed Blood in My Stool Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I have noticed blood in my stool. FACT-M Version 4 - I Have Noticed Blood in My Stool FAC019-I Have Pain Functional Assessment of Cancer Therapy-Melanoma Version 4 - Physical Well-Being: I have pain. FACT-M Version 4 - I Have Pain FAC019-I Worry About Dying Functional Assessment of Cancer Therapy-Melanoma Version 4 - Emotional Well-Being: I worry about dying. FACT-M Version 4 - I Worry About Dying FAC019-Isolate From Others B/c Condition Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I isolate myself from others because of my condition. FACT-M Version 4 - Isolate From Others Because Condition FAC019-Limit My Social Activity Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I have to limit my social activity because of my condition. FACT-M Version 4 - Limit My Social Activity FAC019-Limit Physical Activ B/c Cond Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I have to limit my physical activity because of my condition. FACT-M Version 4 - Limit Physical Activity Because Condition FAC019-Losing Hope Against Illness Functional Assessment of Cancer Therapy-Melanoma Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. FACT-M Version 4 - Losing Hope Against Illness FAC019-Movement of Swollen Area Painful Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: At the site of my melanoma surgery: Movement of my swollen area is painful. FACT-M Version 4 - Movement of Swollen Area Painful FAC019-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy-Melanoma Version 4 - Social/Family Well-Being: My family has accepted my illness. FACT-M Version 4 - My Family Has Accepted My Illness FAC019-My Work Is Fulfilling Functional Assessment of Cancer Therapy-Melanoma Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. FACT-M Version 4 - My Work Is Fulfilling FAC019-Noticed New Changes in My Skin Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I have noticed new changes in my skin (lumps, bumps, color (colour)). FACT-M Version 4 - Noticed New Changes in My Skin FAC019-Pain at My Melanoma/Surgical Site Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I have pain at my melanoma site or surgical site. FACT-M Version 4 - Pain at My Melanoma or Surgical Site FAC019-Physical Subscale Score Functional Assessment of Cancer Therapy-Melanoma Version 4 - Physical Well-Being: Subscale score. FACT-M Version 4 - Physical Subscale Score FAC019-Satisfied Communication Illness Functional Assessment of Cancer Therapy-Melanoma Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. FACT-M Version 4 - Satisfied Communication Illness FAC019-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy-Melanoma Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. FACT-M Version 4 - Satisfied With How I Am Coping FAC019-Social/Family Subscale Score Functional Assessment of Cancer Therapy-Melanoma Version 4 - Social/Family Well-Being: Subscale score. FACT-M Version 4 - Social/Family Subscale Score FAC019-Swelling as a Result of Surgery Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: At the site of my melanoma surgery: I have swelling as a result of surgery. FACT-M Version 4 - Swelling as a Result of Surgery FAC019-Swelling Keeps From Doing Things Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: At the site of my melanoma surgery: Swelling keeps me from doing the things I want to do. FACT-M Version 4 - Swelling Keeps From Doing Things FAC019-Swelling Keeps Me From Wearing Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: At the site of my melanoma surgery: Swelling keeps me from wearing clothes or shoes I want to wear. FACT-M Version 4 - Swelling Keeps Me From Wearing FAC019-Swelling/Cramps in Stomach Area Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I have swelling or cramps in my stomach area. FACT-M Version 4 - Swelling or Cramps in Stomach Area FAC019-Total Score Functional Assessment of Cancer Therapy-Melanoma Version 4 - Total score. FACT-M Version 4 - Total Score FAC019-Trial Outcome Index Score Functional Assessment of Cancer Therapy-Melanoma Version 4 - Total outcome index score. FACT-M Version 4 - Trial Outcome Index Score FAC019-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-Melanoma Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. FACT-M Version 4 - Trouble Meeting Needs of Family FAC019-Worry Appearance Surgical Scars Functional Assessment of Cancer Therapy-Melanoma Version 4 - Additional Concerns: I worry about the appearance of surgical scars. FACT-M Version 4 - Worry Appearance Surgical Scars FAC019-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Melanoma Version 4 - Emotional Well-Being: I worry that my condition will get worse. FACT-M Version 4 - Worry My Condition Will Get Worse FAC019TN Functional Assessment of Cancer Therapy-Melanoma Version 4 Questionnaire Test Name CDISC Questionnaire Functional Assessment of Cancer Therapy-Melanoma Version 4 Test Name Terminology Functional Assessment of Cancer Therapy-Ovarian Symptom Index test code. FAC049-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I have a lack of energy. FOSI - I Have a Lack of Energy FAC049-I Have Been Vomiting Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I have been vomiting. FOSI - I Have Been Vomiting FAC049-I Have Pain Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I have pain. FOSI - I Have Pain FAC049-I Have Nausea Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I have nausea. FOSI - I Have Nausea FAC049-I Have Swelling in Stomach Area Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I have swelling in my stomach area. FOSI - I Have Swelling in Stomach Area FAC049-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I worry that my condition will get worse. FOSI - Worry My Condition Will Get Worse FAC049-Content With Quality of My Life Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I am content with the quality of my life right now. FOSI - Content With Quality of My Life FAC049-I Have Cramps in My Stomach Area Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I have cramps in my stomach area. FOSI - I Have Cramps in My Stomach Area FAC049TC Functional Assessment of Cancer Therapy-Ovarian Symptom Index Questionnaire Test Code CDISC Questionnaire FOSI Test Code Terminology Functional Assessment of Cancer Therapy-Ovarian Symptom Index test name. FAC049-Content With Quality of My Life Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I am content with the quality of my life right now. FOSI - Content With Quality of My Life FAC049-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I have a lack of energy. FOSI - I Have a Lack of Energy FAC049-I Have Been Vomiting Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I have been vomiting. FOSI - I Have Been Vomiting FAC049-I Have Cramps in My Stomach Area Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I have cramps in my stomach area. FOSI - I Have Cramps in My Stomach Area FAC049-I Have Nausea Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I have nausea. FOSI - I Have Nausea FAC049-I Have Pain Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I have pain. FOSI - I Have Pain FAC049-I Have Swelling in Stomach Area Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I have swelling in my stomach area. FOSI - I Have Swelling in Stomach Area FAC049-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I worry that my condition will get worse. FOSI - Worry My Condition Will Get Worse FAC049TN Functional Assessment of Cancer Therapy-Ovarian Symptom Index Questionnaire Test Name CDISC Questionnaire FOSI Test Name Terminology Functional Assessment of Cancer Therapy-Taxane Version 4 test code. FAC063-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Taxane Version 4 - Physical Well-Being: I have a lack of energy. FACT-Taxane Version 4 - I Have a Lack of Energy FAC063-I Have Nausea Functional Assessment of Cancer Therapy-Taxane Version 4 - Physical Well-Being: I have nausea. FACT-Taxane Version 4 - I Have Nausea FAC063-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-Taxane Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. FACT-Taxane Version 4 - Trouble Meeting Needs of Family FAC063-I Have Pain Functional Assessment of Cancer Therapy-Taxane Version 4 - Physical Well-Being: I have pain. FACT-Taxane Version 4 - I Have Pain FAC063-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy-Taxane Version 4 - Physical Well-Being: I am bothered by side effects of treatment. FACT-Taxane Version 4 - Bothered by Treatment Side Effect FAC063-I Feel Ill Functional Assessment of Cancer Therapy-Taxane Version 4 - Physical Well-Being: I feel ill. FACT-Taxane Version 4 - I Feel Ill FAC063-I Am Forced to Spend Time in Bed Functional Assessment of Cancer Therapy-Taxane Version 4 - Physical Well-Being: I am forced to spend time in bed. FACT-Taxane Version 4 - I Am Forced to Spend Time in Bed FAC063-I Feel Close to My Friends Functional Assessment of Cancer Therapy-Taxane Version 4 - Social/Family Well-Being: I feel close to my friends. FACT-Taxane Version 4 - I Feel Close to My Friends FAC063-Get Emotional Support From Family Functional Assessment of Cancer Therapy-Taxane Version 4 - Social/Family Well-Being: I get emotional support from my family. FACT-Taxane Version 4 - Get Emotional Support From Family FAC063-I Get Support From My Friends Functional Assessment of Cancer Therapy-Taxane Version 4 - Social/Family Well-Being: I get support from my friends. FACT-Taxane Version 4 - I Get Support From My Friends FAC063-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy-Taxane Version 4 - Social/Family Well-Being: My family has accepted my illness. FACT-Taxane Version 4 - My Family Has Accepted My Illness FAC063-Satisfied Communication Illness Functional Assessment of Cancer Therapy-Taxane Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. FACT-Taxane Version 4 - Satisfied Communication Illness FAC063-I Feel Close to My Partner Functional Assessment of Cancer Therapy-Taxane Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). FACT-Taxane Version 4 - I Feel Close to My Partner FAC063-I Am Satisfied With My Sex Life Functional Assessment of Cancer Therapy-Taxane Version 4 - Social/Family Well-Being: I am satisfied with my sex life. FACT-Taxane Version 4 - I Am Satisfied With My Sex Life FAC063-I Feel Sad Functional Assessment of Cancer Therapy-Taxane Version 4 - Emotional Well-Being: I feel sad. FACT-Taxane Version 4 - I Feel Sad FAC063-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy-Taxane Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. FACT-Taxane Version 4 - Satisfied With How I Am Coping FAC063-Losing Hope Against Illness Functional Assessment of Cancer Therapy-Taxane Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. FACT-Taxane Version 4 - Losing Hope Against Illness FAC063-I Feel Nervous Functional Assessment of Cancer Therapy-Taxane Version 4 - Emotional Well-Being: I feel nervous. FACT-Taxane Version 4 - I Feel Nervous FAC063-I Worry About Dying Functional Assessment of Cancer Therapy-Taxane Version 4 - Emotional Well-Being: I worry about dying. FACT-Taxane Version 4 - I Worry About Dying FAC063-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Taxane Version 4 - Emotional Well-Being: I worry that my condition will get worse. FACT-Taxane Version 4 - Worry My Condition Will Get Worse FAC063-I Am Able to Work Functional Assessment of Cancer Therapy-Taxane Version 4 - Functional Well-Being: I am able to work (include work at home). FACT-Taxane Version 4 - I Am Able to Work FAC063-My Work Is Fulfilling Functional Assessment of Cancer Therapy-Taxane Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. FACT-Taxane Version 4 - My Work Is Fulfilling FAC063-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-Taxane Version 4 - Functional Well-Being: I am able to enjoy life. FACT-Taxane Version 4 - I Am Able to Enjoy Life FAC063-I Have Accepted My Illness Functional Assessment of Cancer Therapy-Taxane Version 4 - Functional Well-Being: I have accepted my illness. FACT-Taxane Version 4 - I Have Accepted My Illness FAC063-I Am Sleeping Well Functional Assessment of Cancer Therapy-Taxane Version 4 - Functional Well-Being: I am sleeping well. FACT-Taxane Version 4 - I Am Sleeping Well FAC063-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy-Taxane Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. FACT-Taxane Version 4 - Enjoy Things I Usually Do for Fun FAC063-Content With Quality of My Life Functional Assessment of Cancer Therapy-Taxane Version 4 - Functional Well-Being: I am content with the quality of my life right now. FACT-Taxane Version 4 - Content With Quality of My Life FAC063-Numbness or Tingling in My Hands Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have numbness or tingling in my hands. FACT-Taxane Version 4 - Numbness or Tingling in My Hands FAC063-Numbness or Tingling in My Feet Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have numbness or tingling in my feet. FACT-Taxane Version 4 - Numbness or Tingling in My Feet FAC063-I Feel Discomfort in My Hands Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I feel discomfort in my hands. FACT-Taxane Version 4 - I Feel Discomfort in My Hands FAC063-I Feel Discomfort in My Feet Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I feel discomfort in my feet. FACT-Taxane Version 4 - I Feel Discomfort in My Feet FAC063-Have Joint Pain or Muscle Cramps Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have joint pain or muscle cramps. FACT-Taxane Version 4 - Have Joint Pain or Muscle Cramps FAC063-I Feel Weak All Over Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I feel weak all over. FACT-Taxane Version 4 - I Feel Weak All Over FAC063-I Have Trouble Hearing Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have trouble hearing. FACT-Taxane Version 4 - I Have Trouble Hearing FAC063-Get Ringing or Buzzing in My Ears Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I get a ringing or buzzing in my ears. FACT-Taxane Version 4 - Get Ringing or Buzzing in My Ears FAC063-I Have Trouble Buttoning Buttons Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have trouble buttoning buttons. FACT-Taxane Version 4 - I Have Trouble Buttoning Buttons FAC063-Trouble Feeling Shape of Objects Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have trouble feeling the shape of small objects when they are in my hand. FACT-Taxane Version 4 - Trouble Feeling Shape of Objects FAC063-I Have Trouble Walking Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have trouble walking. FACT-Taxane Version 4 - I Have Trouble Walking FAC063-I Feel Bloated Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I feel bloated. FACT-Taxane Version 4 - I Feel Bloated FAC063-My Hands Are Swollen Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: My hands are swollen. FACT-Taxane Version 4 - My Hands Are Swollen FAC063-My Legs or Feet Are Swollen Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: My legs or feet are swollen. FACT-Taxane Version 4 - My Legs or Feet Are Swollen FAC063-I Have Pain in My Fingertips Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have pain in my fingertips. FACT-Taxane Version 4 - I Have Pain in My Fingertips FAC063-Bothered by My Hands/Nails Look Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I am bothered by the way my hands or nails look. FACT-Taxane Version 4 - Bothered by My Hands/Nails Look FAC063TC Functional Assessment of Cancer Therapy-Taxane Version 4 Questionnaire Test Code CDISC Questionnaire FACT-Taxane Version 4 Test Code Terminology Functional Assessment of Cancer Therapy-Taxane Version 4 test name. FAC063-Bothered by My Hands/Nails Look Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I am bothered by the way my hands or nails look. FACT-Taxane Version 4 - Bothered by My Hands/Nails Look FAC063-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy-Taxane Version 4 - Physical Well-Being: I am bothered by side effects of treatment. FACT-Taxane Version 4 - Bothered by Treatment Side Effect FAC063-Content With Quality of My Life Functional Assessment of Cancer Therapy-Taxane Version 4 - Functional Well-Being: I am content with the quality of my life right now. FACT-Taxane Version 4 - Content With Quality of My Life FAC063-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy-Taxane Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. FACT-Taxane Version 4 - Enjoy Things I Usually Do for Fun FAC063-Get Emotional Support From Family Functional Assessment of Cancer Therapy-Taxane Version 4 - Social/Family Well-Being: I get emotional support from my family. FACT-Taxane Version 4 - Get Emotional Support From Family FAC063-Get Ringing or Buzzing in My Ears Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I get a ringing or buzzing in my ears. FACT-Taxane Version 4 - Get Ringing or Buzzing in My Ears FAC063-Have Joint Pain or Muscle Cramps Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have joint pain or muscle cramps. FACT-Taxane Version 4 - Have Joint Pain or Muscle Cramps FAC063-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-Taxane Version 4 - Functional Well-Being: I am able to enjoy life. FACT-Taxane Version 4 - I Am Able to Enjoy Life FAC063-I Am Able to Work Functional Assessment of Cancer Therapy-Taxane Version 4 - Functional Well-Being: I am able to work (include work at home). FACT-Taxane Version 4 - I Am Able to Work FAC063-I Am Forced to Spend Time in Bed Functional Assessment of Cancer Therapy-Taxane Version 4 - Physical Well-Being: I am forced to spend time in bed. FACT-Taxane Version 4 - I Am Forced to Spend Time in Bed FAC063-I Am Satisfied With My Sex Life Functional Assessment of Cancer Therapy-Taxane Version 4 - Social/Family Well-Being: I am satisfied with my sex life. FACT-Taxane Version 4 - I Am Satisfied With My Sex Life FAC063-I Am Sleeping Well Functional Assessment of Cancer Therapy-Taxane Version 4 - Functional Well-Being: I am sleeping well. FACT-Taxane Version 4 - I Am Sleeping Well FAC063-I Feel Bloated Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I feel bloated. FACT-Taxane Version 4 - I Feel Bloated FAC063-I Feel Close to My Friends Functional Assessment of Cancer Therapy-Taxane Version 4 - Social/Family Well-Being: I feel close to my friends. FACT-Taxane Version 4 - I Feel Close to My Friends FAC063-I Feel Close to My Partner Functional Assessment of Cancer Therapy-Taxane Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). FACT-Taxane Version 4 - I Feel Close to My Partner FAC063-I Feel Discomfort in My Feet Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I feel discomfort in my feet. FACT-Taxane Version 4 - I Feel Discomfort in My Feet FAC063-I Feel Discomfort in My Hands Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I feel discomfort in my hands. FACT-Taxane Version 4 - I Feel Discomfort in My Hands FAC063-I Feel Ill Functional Assessment of Cancer Therapy-Taxane Version 4 - Physical Well-Being: I feel ill. FACT-Taxane Version 4 - I Feel Ill FAC063-I Feel Nervous Functional Assessment of Cancer Therapy-Taxane Version 4 - Emotional Well-Being: I feel nervous. FACT-Taxane Version 4 - I Feel Nervous FAC063-I Feel Sad Functional Assessment of Cancer Therapy-Taxane Version 4 - Emotional Well-Being: I feel sad. FACT-Taxane Version 4 - I Feel Sad FAC063-I Feel Weak All Over Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I feel weak all over. FACT-Taxane Version 4 - I Feel Weak All Over FAC063-I Get Support From My Friends Functional Assessment of Cancer Therapy-Taxane Version 4 - Social/Family Well-Being: I get support from my friends. FACT-Taxane Version 4 - I Get Support From My Friends FAC063-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Taxane Version 4 - Physical Well-Being: I have a lack of energy. FACT-Taxane Version 4 - I Have a Lack of Energy FAC063-I Have Accepted My Illness Functional Assessment of Cancer Therapy-Taxane Version 4 - Functional Well-Being: I have accepted my illness. FACT-Taxane Version 4 - I Have Accepted My Illness FAC063-I Have Nausea Functional Assessment of Cancer Therapy-Taxane Version 4 - Physical Well-Being: I have nausea. FACT-Taxane Version 4 - I Have Nausea FAC063-I Have Pain in My Fingertips Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have pain in my fingertips. FACT-Taxane Version 4 - I Have Pain in My Fingertips FAC063-I Have Pain Functional Assessment of Cancer Therapy-Taxane Version 4 - Physical Well-Being: I have pain. FACT-Taxane Version 4 - I Have Pain FAC063-I Have Trouble Buttoning Buttons Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have trouble buttoning buttons. FACT-Taxane Version 4 - I Have Trouble Buttoning Buttons FAC063-I Have Trouble Hearing Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have trouble hearing. FACT-Taxane Version 4 - I Have Trouble Hearing FAC063-I Have Trouble Walking Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have trouble walking. FACT-Taxane Version 4 - I Have Trouble Walking FAC063-I Worry About Dying Functional Assessment of Cancer Therapy-Taxane Version 4 - Emotional Well-Being: I worry about dying. FACT-Taxane Version 4 - I Worry About Dying FAC063-Losing Hope Against Illness Functional Assessment of Cancer Therapy-Taxane Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. FACT-Taxane Version 4 - Losing Hope Against Illness FAC063-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy-Taxane Version 4 - Social/Family Well-Being: My family has accepted my illness. FACT-Taxane Version 4 - My Family Has Accepted My Illness FAC063-My Hands Are Swollen Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: My hands are swollen. FACT-Taxane Version 4 - My Hands Are Swollen FAC063-My Legs or Feet Are Swollen Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: My legs or feet are swollen. FACT-Taxane Version 4 - My Legs or Feet Are Swollen FAC063-My Work Is Fulfilling Functional Assessment of Cancer Therapy-Taxane Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. FACT-Taxane Version 4 - My Work Is Fulfilling FAC063-Numbness or Tingling in My Feet Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have numbness or tingling in my feet. FACT-Taxane Version 4 - Numbness or Tingling in My Feet FAC063-Numbness or Tingling in My Hands Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have numbness or tingling in my hands. FACT-Taxane Version 4 - Numbness or Tingling in My Hands FAC063-Satisfied Communication Illness Functional Assessment of Cancer Therapy-Taxane Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. FACT-Taxane Version 4 - Satisfied Communication Illness FAC063-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy-Taxane Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. FACT-Taxane Version 4 - Satisfied With How I Am Coping FAC063-Trouble Feeling Shape of Objects Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have trouble feeling the shape of small objects when they are in my hand. FACT-Taxane Version 4 - Trouble Feeling Shape of Objects FAC063-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-Taxane Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. FACT-Taxane Version 4 - Trouble Meeting Needs of Family FAC063-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Taxane Version 4 - Emotional Well-Being: I worry that my condition will get worse. FACT-Taxane Version 4 - Worry My Condition Will Get Worse FAC063TN Functional Assessment of Cancer Therapy-Taxane Version 4 Questionnaire Test Name CDISC Questionnaire FACT-Taxane Version 4 Test Name Terminology Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 test code. FAC102-Numbness or Tingling in My Hands Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 - I have numbness or tingling in my hands. FACT/GOG-NTX Subscale Version 4 - Numbness or Tingling in My Hands FAC102-Numbness or Tingling in My Feet Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 - I have numbness or tingling in my feet. FACT/GOG-NTX Subscale Version 4 - Numbness or Tingling in My Feet FAC102-I Feel Discomfort in My Hands Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 - I feel discomfort in my hands. FACT/GOG-NTX Subscale Version 4 - I Feel Discomfort in My Hands FAC102-I Feel Discomfort in My Feet Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 - I feel discomfort in my feet. FACT/GOG-NTX Subscale Version 4 - I Feel Discomfort in My Feet FAC102-Have Joint Pain or Muscle Cramps Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 - I have joint pain or muscle cramps. FACT/GOG-NTX Subscale Version 4 - Have Joint Pain or Muscle Cramps FAC102-I Feel Weak All Over Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 - I feel weak all over. FACT/GOG-NTX Subscale Version 4 - I Feel Weak All Over FAC102-I Have Trouble Hearing Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 - I have trouble hearing. FACT/GOG-NTX Subscale Version 4 - I Have Trouble Hearing FAC102-Get Ringing or Buzzing in My Ears Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 - I get a ringing or buzzing in my ears. FACT/GOG-NTX Subscale Version 4 - Get Ringing or Buzzing in My Ears FAC102-I Have Trouble Buttoning Buttons Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 - I have trouble buttoning buttons. FACT/GOG-NTX Subscale Version 4 - I Have Trouble Buttoning Buttons FAC102-Trouble Feeling Shape of Objects Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 - I have trouble feeling the shape of small objects when they are in my hand. FACT/GOG-NTX Subscale Version 4 - Trouble Feeling Shape of Objects FAC102-I Have Trouble Walking Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 - I have trouble walking. FACT/GOG-NTX Subscale Version 4 - I Have Trouble Walking FAC102TC Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 Questionnaire Test Code CDISC Questionnaire Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 Test Code Terminology Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 test name. FAC102-Get Ringing or Buzzing in My Ears Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 - I get a ringing or buzzing in my ears. FACT/GOG-NTX Subscale Version 4 - Get Ringing or Buzzing in My Ears FAC102-Have Joint Pain or Muscle Cramps Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 - I have joint pain or muscle cramps. FACT/GOG-NTX Subscale Version 4 - Have Joint Pain or Muscle Cramps FAC102-I Feel Discomfort in My Feet Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 - I feel discomfort in my feet. FACT/GOG-NTX Subscale Version 4 - I Feel Discomfort in My Feet FAC102-I Feel Discomfort in My Hands Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 - I feel discomfort in my hands. FACT/GOG-NTX Subscale Version 4 - I Feel Discomfort in My Hands FAC102-I Feel Weak All Over Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 - I feel weak all over. FACT/GOG-NTX Subscale Version 4 - I Feel Weak All Over FAC102-I Have Trouble Buttoning Buttons Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 - I have trouble buttoning buttons. FACT/GOG-NTX Subscale Version 4 - I Have Trouble Buttoning Buttons FAC102-I Have Trouble Hearing Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 - I have trouble hearing. FACT/GOG-NTX Subscale Version 4 - I Have Trouble Hearing FAC102-I Have Trouble Walking Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 - I have trouble walking. FACT/GOG-NTX Subscale Version 4 - I Have Trouble Walking FAC102-Numbness or Tingling in My Feet Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 - I have numbness or tingling in my feet. FACT/GOG-NTX Subscale Version 4 - Numbness or Tingling in My Feet FAC102-Numbness or Tingling in My Hands Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 - I have numbness or tingling in my hands. FACT/GOG-NTX Subscale Version 4 - Numbness or Tingling in My Hands FAC102-Trouble Feeling Shape of Objects Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 - I have trouble feeling the shape of small objects when they are in my hand. FACT/GOG-NTX Subscale Version 4 - Trouble Feeling Shape of Objects FAC102TN Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 Questionnaire Test Name CDISC Questionnaire Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Subscale Version 4 Test Name Terminology Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 test code. FAC057-I Have a Lack of Energy Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Physical Well-Being: I have a lack of energy. FACT/GOG-NTX Version 4 - I Have a Lack of Energy FAC057-I Have Nausea Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Physical Well-Being: I have nausea. FACT/GOG-NTX Version 4 - I Have Nausea FAC057-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. FACT/GOG-NTX Version 4 - Trouble Meeting Needs of Family FAC057-I Have Pain Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Physical Well-Being: I have pain. FACT/GOG-NTX Version 4 - I Have Pain FAC057-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Physical Well-Being: I am bothered by side effects of treatment. FACT/GOG-NTX Version 4 - Bothered by Treatment Side Effect FAC057-I Feel Ill Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Physical Well-Being: I feel ill. FACT/GOG-NTX Version 4 - I Feel Ill FAC057-I Am Forced to Spend Time in Bed Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Physical Well-Being: I am forced to spend time in bed. FACT/GOG-NTX Version 4 - I Am Forced to Spend Time in Bed FAC057-I Feel Close to My Friends Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Social/Family Well-Being: I feel close to my friends. FACT/GOG-NTX Version 4 - I Feel Close to My Friends FAC057-Get Emotional Support From Family Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Social/Family Well-Being: I get emotional support from my family. FACT/GOG-NTX Version 4 - Get Emotional Support From Family FAC057-I Get Support From My Friends Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Social/Family Well-Being: I get support from my friends. FACT/GOG-NTX Version 4 - I Get Support From My Friends FAC057-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Social/Family Well-Being: My family has accepted my illness. FACT/GOG-NTX Version 4 - My Family Has Accepted My Illness FAC057-Satisfied Communication Illness Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. FACT/GOG-NTX Version 4 - Satisfied Communication Illness FAC057-I Feel Close to My Partner Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). FACT/GOG-NTX Version 4 - I Feel Close to My Partner FAC057-I Am Satisfied With My Sex Life Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Social/Family Well-Being: I am satisfied with my sex life. FACT/GOG-NTX Version 4 - I Am Satisfied With My Sex Life FAC057-I Feel Sad Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Emotional Well-Being: I feel sad. FACT/GOG-NTX Version 4 - I Feel Sad FAC057-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. FACT/GOG-NTX Version 4 - Satisfied With How I Am Coping FAC057-Losing Hope Against Illness Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. FACT/GOG-NTX Version 4 - Losing Hope Against Illness FAC057-I Feel Nervous Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Emotional Well-Being: I feel nervous. FACT/GOG-NTX Version 4 - I Feel Nervous FAC057-I Worry About Dying Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Emotional Well-Being: I worry about dying. FACT/GOG-NTX Version 4 - I Worry About Dying FAC057-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Emotional Well-Being: I worry that my condition will get worse. FACT/GOG-NTX Version 4 - Worry My Condition Will Get Worse FAC057-I Am Able to Work Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Functional Well-Being: I am able to work (include work at home). FACT/GOG-NTX Version 4 - I Am Able to Work FAC057-My Work Is Fulfilling Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. FACT/GOG-NTX Version 4 - My Work Is Fulfilling FAC057-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Functional Well-Being: I am able to enjoy life. FACT/GOG-NTX Version 4 - I Am Able to Enjoy Life FAC057-I Have Accepted My Illness Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Functional Well-Being: I have accepted my illness. FACT/GOG-NTX Version 4 - I Have Accepted My Illness FAC057-I Am Sleeping Well Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Functional Well-Being: I am sleeping well. FACT/GOG-NTX Version 4 - I Am Sleeping Well FAC057-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. FACT/GOG-NTX Version 4 - Enjoy Things I Usually Do for Fun FAC057-Content With Quality of My Life Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Functional Well-Being: I am content with the quality of my life right now. FACT/GOG-NTX Version 4 - Content With Quality of My Life FAC057-Numbness or Tingling in My Hands Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I have numbness or tingling in my hands. FACT/GOG-NTX Version 4 - Numbness or Tingling in My Hands FAC057-Numbness or Tingling in My Feet Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I have numbness or tingling in my feet. FACT/GOG-NTX Version 4 - Numbness or Tingling in My Feet FAC057-I Feel Discomfort in My Hands Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I feel discomfort in my hands. FACT/GOG-NTX Version 4 - I Feel Discomfort in My Hands FAC057-I Feel Discomfort in My Feet Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I feel discomfort in my feet. FACT/GOG-NTX Version 4 - I Feel Discomfort in My Feet FAC057-Have Joint Pain or Muscle Cramps Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I have joint pain or muscle cramps. FACT/GOG-NTX Version 4 - Have Joint Pain or Muscle Cramps FAC057-I Feel Weak All Over Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I feel weak all over. FACT/GOG-NTX Version 4 - I Feel Weak All Over FAC057-I Have Trouble Hearing Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I have trouble hearing. FACT/GOG-NTX Version 4 - I Have Trouble Hearing FAC057-Get Ringing or Buzzing in My Ears Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I get a ringing or buzzing in my ears. FACT/GOG-NTX Version 4 - Get Ringing or Buzzing in My Ears FAC057-I Have Trouble Buttoning Buttons Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I have trouble buttoning buttons. FACT/GOG-NTX Version 4 - I Have Trouble Buttoning Buttons FAC057-Trouble Feeling Shape of Objects Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I have trouble feeling the shape of small objects when they are in my hand. FACT/GOG-NTX Version 4 - Trouble Feeling Shape of Objects FAC057-I Have Trouble Walking Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I have trouble walking. FACT/GOG-NTX Version 4 - I Have Trouble Walking FAC057TC Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 Questionnaire Test Code CDISC Questionnaire FACT/GOG-NTX Version 4 Test Code Terminology Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 test name. FAC057-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Physical Well-Being: I am bothered by side effects of treatment. FACT/GOG-NTX Version 4 - Bothered by Treatment Side Effect FAC057-Content With Quality of My Life Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Functional Well-Being: I am content with the quality of my life right now. FACT/GOG-NTX Version 4 - Content With Quality of My Life FAC057-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. FACT/GOG-NTX Version 4 - Enjoy Things I Usually Do for Fun FAC057-Get Emotional Support From Family Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Social/Family Well-Being: I get emotional support from my family. FACT/GOG-NTX Version 4 - Get Emotional Support From Family FAC057-Get Ringing or Buzzing in My Ears Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I get a ringing or buzzing in my ears. FACT/GOG-NTX Version 4 - Get Ringing or Buzzing in My Ears FAC057-Have Joint Pain or Muscle Cramps Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I have joint pain or muscle cramps. FACT/GOG-NTX Version 4 - Have Joint Pain or Muscle Cramps FAC057-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Functional Well-Being: I am able to enjoy life. FACT/GOG-NTX Version 4 - I Am Able to Enjoy Life FAC057-I Am Able to Work Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Functional Well-Being: I am able to work (include work at home). FACT/GOG-NTX Version 4 - I Am Able to Work FAC057-I Am Forced to Spend Time in Bed Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Physical Well-Being: I am forced to spend time in bed. FACT/GOG-NTX Version 4 - I Am Forced to Spend Time in Bed FAC057-I Am Satisfied With My Sex Life Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Social/Family Well-Being: I am satisfied with my sex life. FACT/GOG-NTX Version 4 - I Am Satisfied With My Sex Life FAC057-I Am Sleeping Well Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Functional Well-Being: I am sleeping well. FACT/GOG-NTX Version 4 - I Am Sleeping Well FAC057-I Feel Close to My Friends Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Social/Family Well-Being: I feel close to my friends. FACT/GOG-NTX Version 4 - I Feel Close to My Friends FAC057-I Feel Close to My Partner Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). FACT/GOG-NTX Version 4 - I Feel Close to My Partner FAC057-I Feel Discomfort in My Feet Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I feel discomfort in my feet. FACT/GOG-NTX Version 4 - I Feel Discomfort in My Feet FAC057-I Feel Discomfort in My Hands Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I feel discomfort in my hands. FACT/GOG-NTX Version 4 - I Feel Discomfort in My Hands FAC057-I Feel Ill Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Physical Well-Being: I feel ill. FACT/GOG-NTX Version 4 - I Feel Ill FAC057-I Feel Nervous Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Emotional Well-Being: I feel nervous. FACT/GOG-NTX Version 4 - I Feel Nervous FAC057-I Feel Sad Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Emotional Well-Being: I feel sad. FACT/GOG-NTX Version 4 - I Feel Sad FAC057-I Feel Weak All Over Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I feel weak all over. FACT/GOG-NTX Version 4 - I Feel Weak All Over FAC057-I Get Support From My Friends Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Social/Family Well-Being: I get support from my friends. FACT/GOG-NTX Version 4 - I Get Support From My Friends FAC057-I Have a Lack of Energy Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Physical Well-Being: I have a lack of energy. FACT/GOG-NTX Version 4 - I Have a Lack of Energy FAC057-I Have Accepted My Illness Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Functional Well-Being: I have accepted my illness. FACT/GOG-NTX Version 4 - I Have Accepted My Illness FAC057-I Have Nausea Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Physical Well-Being: I have nausea. FACT/GOG-NTX Version 4 - I Have Nausea FAC057-I Have Pain Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Physical Well-Being: I have pain. FACT/GOG-NTX Version 4 - I Have Pain FAC057-I Have Trouble Buttoning Buttons Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I have trouble buttoning buttons. FACT/GOG-NTX Version 4 - I Have Trouble Buttoning Buttons FAC057-I Have Trouble Hearing Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I have trouble hearing. FACT/GOG-NTX Version 4 - I Have Trouble Hearing FAC057-I Have Trouble Walking Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I have trouble walking. FACT/GOG-NTX Version 4 - I Have Trouble Walking FAC057-I Worry About Dying Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Emotional Well-Being: I worry about dying. FACT/GOG-NTX Version 4 - I Worry About Dying FAC057-Losing Hope Against Illness Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. FACT/GOG-NTX Version 4 - Losing Hope Against Illness FAC057-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Social/Family Well-Being: My family has accepted my illness. FACT/GOG-NTX Version 4 - My Family Has Accepted My Illness FAC057-My Work Is Fulfilling Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. FACT/GOG-NTX Version 4 - My Work Is Fulfilling FAC057-Numbness or Tingling in My Feet Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I have numbness or tingling in my feet. FACT/GOG-NTX Version 4 - Numbness or Tingling in My Feet FAC057-Numbness or Tingling in My Hands Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I have numbness or tingling in my hands. FACT/GOG-NTX Version 4 - Numbness or Tingling in My Hands FAC057-Satisfied Communication Illness Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. FACT/GOG-NTX Version 4 - Satisfied Communication Illness FAC057-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. FACT/GOG-NTX Version 4 - Satisfied With How I Am Coping FAC057-Trouble Feeling Shape of Objects Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I have trouble feeling the shape of small objects when they are in my hand. FACT/GOG-NTX Version 4 - Trouble Feeling Shape of Objects FAC057-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. FACT/GOG-NTX Version 4 - Trouble Meeting Needs of Family FAC057-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Emotional Well-Being: I worry that my condition will get worse. FACT/GOG-NTX Version 4 - Worry My Condition Will Get Worse FAC057TN Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 Questionnaire Test Name CDISC Questionnaire FACT/GOG-NTX Version 4 Test Name Terminology Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form test code. FAC084-Part I: Dressing Without Help Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Dressing yourself without help. FACIT-Dyspnea 10 Item Short Form - Part I: Dressing Without Help FAC084-Part I: Dressing Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Dressing yourself without help. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea 10 Item Short Form - Part I: Dressing Why Not FAC084-Part I: Walk 50 Steps Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Walking 50 steps/paces on flat ground at a normal speed without stopping. FACIT-Dyspnea 10 Item Short Form - Part I: Walk 50 Steps FAC084-Part I: Walk 50 Steps Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Walking 50 steps/paces on flat ground at a normal speed without stopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea 10 Item Short Form - Part I: Walk 50 Steps Why Not FAC084-Part I: Walk Up 20 Stairs Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 20 stairs (2 flights) without stopping. FACIT-Dyspnea 10 Item Short Form - Part I: Walk Up 20 Stairs FAC084-Part I: Walk Up 20 Stairs Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 20 stairs (2 flights) without stopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea 10 Item Short Form - Part I: Walk Up 20 Stairs Why Not FAC084-Part I: Preparing Meals Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Preparing Meals. FACIT-Dyspnea 10 Item Short Form - Part I: Preparing Meals FAC084-Part I: Preparing Meals Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Preparing Meals. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea 10 Item Short Form - Part I: Preparing Meals Why Not FAC084-Part I: Washing Dishes Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Washing dishes. FACIT-Dyspnea 10 Item Short Form - Part I: Washing Dishes FAC084-Part I: Washing Dishes Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Washing dishes. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea 10 Item Short Form - Part I: Washing Dishes Why Not FAC084-Part I: Sweeping/Mopping Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Sweeping or mopping. FACIT-Dyspnea 10 Item Short Form - Part I: Sweeping/Mopping FAC084-Part I: Sweeping/Mopping Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Sweeping or mopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea 10 Item Short Form - Part I: Sweeping/Mopping Why Not FAC084-Part I: Making a Bed Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Making a bed. FACIT-Dyspnea 10 Item Short Form - Part I: Making a Bed FAC084-Part I: Making a Bed Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Making a bed. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea 10 Item Short Form - Part I: Making a Bed Why Not FAC084-Part I: Lifting 10-20 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries). FACIT-Dyspnea 10 Item Short Form - Part I: Lifting 10-20 Lbs FAC084-Part I: Lifting 10-20 Lbs Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries). Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea 10 Item Short Form - Part I: Lifting 10-20 Lbs Why Not FAC084-Part I: Carry 10-20 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries) from one room to another. FACIT-Dyspnea 10 Item Short Form - Part I: Carry 10-20 Lbs FAC084-Part I: Carry 10-20 Lbs Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries) from one room to another. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea 10 Item Short Form - Part I: Carry 10-20 Lbs Why Not FAC084-Part I: Walk for 1/2 Mile Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping. FACIT-Dyspnea 10 Item Short Form - Part I: Walk for 1/2 Mile FAC084-Part I: Walk for 1/2 Mile Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea 10 Item Short Form - Part I: Walk for 1/2 Mile Why Not FAC084-Part II: Dressing Without Help Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Dressing yourself without help. FACIT-Dyspnea 10 Item Short Form - Part II: Dressing Without Help FAC084-Part II: Walk 50 Steps Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking 50 steps/paces on flat ground at a normal speed without stopping. FACIT-Dyspnea 10 Item Short Form - Part II: Walk 50 Steps FAC084-Part II: Walk Up 20 Stairs Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking up 20 stairs (2 flights) without stopping. FACIT-Dyspnea 10 Item Short Form - Part II: Walk Up 20 Stairs FAC084-Part II: Preparing Meals Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Preparing meals. FACIT-Dyspnea 10 Item Short Form - Part II: Preparing Meals FAC084-Part II: Washing Dishes Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Washing dishes. FACIT-Dyspnea 10 Item Short Form - Part II: Washing Dishes FAC084-Part II: Sweeping/Mopping Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Sweeping or mopping. FACIT-Dyspnea 10 Item Short Form - Part II: Sweeping/Mopping FAC084-Part II: Making a Bed Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Making a bed. FACIT-Dyspnea 10 Item Short Form - Part II: Making a Bed FAC084-Part II: Lifting 10-20 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Lifting something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries). FACIT-Dyspnea 10 Item Short Form - Part II: Lifting 10-20 Lbs FAC084-Part II: Carry 10-20 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Carrying something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries) from one room to another. FACIT-Dyspnea 10 Item Short Form - Part II: Carry 10-20 Lbs FAC084-Part II: Walk for 1/2 Mile Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping. FACIT-Dyspnea 10 Item Short Form - Part II: Walk for 1/2 Mile FAC084TC Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form Questionnaire Test Code CDISC Questionnaire FACIT-Dyspnea 10 Item Short Form Test Code Terminology Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form test name. FAC084-Part I: Carry 10-20 Lbs Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries) from one room to another. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea 10 Item Short Form - Part I: Carry 10-20 Lbs Why Not FAC084-Part I: Carry 10-20 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries) from one room to another. FACIT-Dyspnea 10 Item Short Form - Part I: Carry 10-20 Lbs FAC084-Part I: Dressing Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Dressing yourself without help. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea 10 Item Short Form - Part I: Dressing Why Not FAC084-Part I: Dressing Without Help Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Dressing yourself without help. FACIT-Dyspnea 10 Item Short Form - Part I: Dressing Without Help FAC084-Part I: Lifting 10-20 Lbs Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries). Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea 10 Item Short Form - Part I: Lifting 10-20 Lbs Why Not FAC084-Part I: Lifting 10-20 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries). FACIT-Dyspnea 10 Item Short Form - Part I: Lifting 10-20 Lbs FAC084-Part I: Making a Bed Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Making a bed. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea 10 Item Short Form - Part I: Making a Bed Why Not FAC084-Part I: Making a Bed Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Making a bed. FACIT-Dyspnea 10 Item Short Form - Part I: Making a Bed FAC084-Part I: Preparing Meals Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Preparing Meals. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea 10 Item Short Form - Part I: Preparing Meals Why Not FAC084-Part I: Preparing Meals Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Preparing Meals. FACIT-Dyspnea 10 Item Short Form - Part I: Preparing Meals FAC084-Part I: Sweeping/Mopping Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Sweeping or mopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea 10 Item Short Form - Part I: Sweeping/Mopping Why Not FAC084-Part I: Sweeping/Mopping Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Sweeping or mopping. FACIT-Dyspnea 10 Item Short Form - Part I: Sweeping/Mopping FAC084-Part I: Walk 50 Steps Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Walking 50 steps/paces on flat ground at a normal speed without stopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea 10 Item Short Form - Part I: Walk 50 Steps Why Not FAC084-Part I: Walk 50 Steps Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Walking 50 steps/paces on flat ground at a normal speed without stopping. FACIT-Dyspnea 10 Item Short Form - Part I: Walk 50 Steps FAC084-Part I: Walk for 1/2 Mile Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea 10 Item Short Form - Part I: Walk for 1/2 Mile Why Not FAC084-Part I: Walk for 1/2 Mile Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping. FACIT-Dyspnea 10 Item Short Form - Part I: Walk for 1/2 Mile FAC084-Part I: Walk Up 20 Stairs Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 20 stairs (2 flights) without stopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea 10 Item Short Form - Part I: Walk Up 20 Stairs Why Not FAC084-Part I: Walk Up 20 Stairs Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 20 stairs (2 flights) without stopping. FACIT-Dyspnea 10 Item Short Form - Part I: Walk Up 20 Stairs FAC084-Part I: Washing Dishes Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Washing dishes. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea 10 Item Short Form - Part I: Washing Dishes Why Not FAC084-Part I: Washing Dishes Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Washing dishes. FACIT-Dyspnea 10 Item Short Form - Part I: Washing Dishes FAC084-Part II: Carry 10-20 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Carrying something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries) from one room to another. FACIT-Dyspnea 10 Item Short Form - Part II: Carry 10-20 Lbs FAC084-Part II: Dressing Without Help Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Dressing yourself without help. FACIT-Dyspnea 10 Item Short Form - Part II: Dressing Without Help FAC084-Part II: Lifting 10-20 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Lifting something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries). FACIT-Dyspnea 10 Item Short Form - Part II: Lifting 10-20 Lbs FAC084-Part II: Making a Bed Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Making a bed. FACIT-Dyspnea 10 Item Short Form - Part II: Making a Bed FAC084-Part II: Preparing Meals Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Preparing meals. FACIT-Dyspnea 10 Item Short Form - Part II: Preparing Meals FAC084-Part II: Sweeping/Mopping Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Sweeping or mopping. FACIT-Dyspnea 10 Item Short Form - Part II: Sweeping/Mopping FAC084-Part II: Walk 50 Steps Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking 50 steps/paces on flat ground at a normal speed without stopping. FACIT-Dyspnea 10 Item Short Form - Part II: Walk 50 Steps FAC084-Part II: Walk for 1/2 Mile Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping. FACIT-Dyspnea 10 Item Short Form - Part II: Walk for 1/2 Mile FAC084-Part II: Walk Up 20 Stairs Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking up 20 stairs (2 flights) without stopping. FACIT-Dyspnea 10 Item Short Form - Part II: Walk Up 20 Stairs FAC084-Part II: Washing Dishes Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Washing dishes. FACIT-Dyspnea 10 Item Short Form - Part II: Washing Dishes FAC084TN Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form Questionnaire Test Name CDISC Questionnaire FACIT-Dyspnea 10 Item Short Form Test Name Terminology Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank test code. FAC100-Sev: Dressing Without Help Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Dressing yourself without help. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Dressing Without Help FAC100-Sev: Dressing Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Dressing yourself without help. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Dressing Why Not FAC100-Sev: Walk 50 Steps Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking 50 steps/paces on flat ground at a normal speed without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk 50 Steps FAC100-Sev: Walk 50 Steps Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking 50 steps/paces on flat ground at a normal speed without stopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk 50 Steps Why Not FAC100-Sev: Walk Up 20 Stairs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 20 stairs (2 flights) without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk Up 20 Stairs FAC100-Sev: Walk Up 20 Stairs Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 20 stairs (2 flights) without stopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk Up 20 Stairs Why Not FAC100-Sev: Preparing Meals Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Preparing meals. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Preparing Meals FAC100-Sev: Preparing Meals Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Preparing meals. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Preparing Meals Why Not FAC100-Sev: Washing Dishes Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Washing dishes. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Washing Dishes FAC100-Sev: Washing Dishes Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Washing dishes. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Washing Dishes Why Not FAC100-Sev: Sweeping/Mopping Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Sweeping or mopping. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Sweeping/Mopping FAC100-Sev: Sweeping/Mopping Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Sweeping or mopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Sweeping/Mopping Why Not FAC100-Sev: Making a Bed Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Making a bed. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Making a Bed FAC100-Sev: Making a Bed Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Making a bed. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Making a Bed Why Not FAC100-Sev: Lifting 10-20 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries). FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lifting 10-20 Lbs FAC100-Sev: Lifting 10-20 Lbs Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries). Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lifting 10-20 Lbs Why Not FAC100-Sev: Carry 10-20 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries) from one room to another. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carry 10-20 Lbs FAC100-Sev: Carry 10-20 Lbs Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries) from one room to another. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carry 10-20 Lbs Why Not FAC100-Sev: Walk for 1/2 Mile Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk for 1/2 Mile FAC100-Sev: Walk for 1/2 Mile Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk for 1/2 Mile Why Not FAC100-Sev: Bath Without Help Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Taking a bath without help. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Bath Without Help FAC100-Sev: Bath Without Help Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Taking a bath without help. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Bath Without Help Why Not FAC100-Sev: Taking a Shower Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Taking a shower. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Taking a Shower FAC100-Sev: Taking a Shower Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Taking a shower. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Taking a Shower Why Not FAC100-Sev: Putting on Socks Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Putting on socks or stockings. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Putting on Socks FAC100-Sev: Putting on Socks Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Putting on socks or stockings. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Putting on Socks Why Not FAC100-Sev: Standing 5 Minutes Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Standing for at least 5 minutes. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Standing 5 Minutes FAC100-Sev: Standing 5 Minutes Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Standing for at least 5 minutes. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Standing 5 Minutes Why Not FAC100-Sev: Walking 10 Steps Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking 10 steps/paces on flat ground at a normal speed without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking 10 Steps FAC100-Sev: Walking 10 Steps Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking 10 steps/paces on flat ground at a normal speed without stopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking 10 Steps Why Not FAC100-Sev: Walking 1/2 Mile Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking 1/2 mile (almost 1 km) on flat ground at a normal speed without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking 1/2 Mile FAC100-Sev: Walking 1/2 Mile Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking 1/2 mile (almost 1 km) on flat ground at a normal speed without stopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking 1/2 Mile Why Not FAC100-Sev: Walking Up 5 Stairs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 5 stairs without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 5 Stairs FAC100-Sev: Walking Up 5 Stairs Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 5 stairs without stopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 5 Stairs Why Not FAC100-Sev: Walking Up 10 Stairs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 10 stairs (1 flight) without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 10 Stairs FAC100-Sev: Walking Up 10 Stairs Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 10 stairs (1 flight) without stopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 10 Stairs Why Not FAC100-Sev: Walking Up 30 Stairs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 30 stairs (3 flights) without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 30 Stairs FAC100-Sev: Walking Up 30 Stairs Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 30 stairs (3 flights) without stopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 30 Stairs Why Not FAC100-Sev: Lift Less Than 5 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing less than 5 lbs (about 2 kg, like a houseplant). FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lift Less Than 5 Lbs FAC100-Sev: Lift Less Than 5 Lbs Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing less than 5 lbs (about 2 kg, like a houseplant). Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lift Less Than 5 Lbs Why Not FAC100-Sev: Lifting 5-10 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes). FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lifting 5-10 Lbs FAC100-Sev: Lifting 5-10 Lbs Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes). Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lifting 5-10 Lbs Why Not FAC100-Sev: Lift More Than 20 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing more than 20 lbs (about 9 kg, like a medium-sized suitcase). FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lift More Than 20 Lbs FAC100-Sev: Lift More Than 20 Lb Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing more than 20 lbs (about 9 kg, like a medium-sized suitcase). Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lift More Than 20 Lbs Why Not FAC100-Sev: Carrying Less Than 5 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing less than 5 lbs (about 2 kg, like a houseplant) from one room to another. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carrying Less Than 5 Lbs FAC100-Sev: Carrying Less Than 5 Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing less than 5 lbs (about 2 kg, like a houseplant) from one room to another. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carrying Less Than 5 Why Not FAC100-Sev: Carrying 5-10 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes) from one room to another. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carrying 5-10 Lbs FAC100-Sev: Carrying 5-10 Lbs Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes) from one room to another. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carrying 5-10 Lbs Why Not FAC100-Sev: Get In/Out of a Car Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Getting in or out of a car. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Get In/Out of a Car FAC100-Sev: Get In/Out of a Car Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Getting in or out of a car. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Get In/Out of a Car Why Not FAC100-Sev: Dining Out Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Dining out. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Dining Out FAC100-Sev: Dining Out Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Dining out. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Dining Out Why Not FAC100-Sev: Low-intensity Activ Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Low-intensity leisure activity (gardening, etc.). FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Low-intensity Activity FAC100-Sev: Low-intensity Activ Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Low-intensity leisure activity (gardening, etc.). Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Low-intensity Activity Why Not FAC100-Sev: Moderate Activity Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Moderate-intensity leisure activity (bicycling on level terrain, etc.). FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Moderate Activity FAC100-Sev: Moderate Activity Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Moderate-intensity leisure activity (bicycling on level terrain, etc.). Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Moderate Activity Why Not FAC100-Sev: Walk Fast 50 Steps Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for 50 steps without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk Fast 50 Steps FAC100-Sev: Walk Fast 50 Steps Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for 50 steps without stopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk Fast 50 Steps Why Not FAC100-Sev: Walking Fast 1 Mile Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for at least 1 mile ( a little more than 1.5 km) without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Fast 1 Mile FAC100-Sev: Walking Fast 1 Mile Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for at least 1 mile ( a little more than 1.5 km) without stopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Fast 1 Mile Why Not FAC100-Sev: Singing or Humming Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Singing or humming. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Singing or Humming FAC100-Sev: Singing or Humming Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Singing or humming. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Singing or Humming Why Not FAC100-Sev: Talking While Walking Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Talking while walking. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Talking While Walking FAC100-Sev: Talking While Walk Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Talking while walking. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Talking While Walk Why Not FAC100-Sev: Scrubbing the Floor Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Scrubbing the floor or counter. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Scrubbing the Floor FAC100-Sev: Scrubbing the Floor Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Scrubbing the floor or counter. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Scrubbing the Floor Why Not FAC100-Limit: Dressing Without Help Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Dressing yourself without help. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Dressing Without Help FAC100-Limit: Walk 50 Steps Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking 50 steps/paces on flat ground at a normal speed without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walk 50 Steps FAC100-Limit: Walk Up 20 Stairs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking up 20 stairs (2 flights) without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walk Up 20 Stairs FAC100-Limit: Preparing Meals Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Preparing meals. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Preparing Meals FAC100-Limit: Washing Dishes Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Washing dishes. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Washing Dishes FAC100-Limit: Sweeping/Mopping Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Sweeping or mopping. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Sweeping/Mopping FAC100-Limit: Making a Bed Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Making a bed. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Making a Bed FAC100-Limit: Lifting 10-20 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Lifting something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries). FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Lifting 10-20 Lbs FAC100-Limit: Carry 10-20 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Carrying something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries) from one room to another. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Carry 10-20 Lbs FAC100-Limit: Walk for 1/2 Mile Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walk for 1/2 Mile FAC100-Limit: Taking a Bath Without Help Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Taking a bath without help. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Taking a Bath Without Help FAC100-Limit: Taking a Shower Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Taking a shower. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Taking a Shower FAC100-Limit: Putting on Socks Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Putting on socks or stockings. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Putting on Socks FAC100-Limit: Standing 5 Minutes Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Standing for at least 5 minutes. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Standing 5 Minutes FAC100-Limit: Walking 10 Steps Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking 10 steps/paces on flat ground at a normal speed without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking 10 Steps FAC100-Limit: Walking 1/2 Mile Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking 1/2 mile (almost 1 km) on flat ground at a normal speed without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking 1/2 Mile FAC100-Limit: Walking Up 5 Stairs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking up 5 stairs without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking Up 5 Stairs FAC100-Limit: Walking Up 10 Stairs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking up 10 stairs (1 flight) without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking Up 10 Stairs FAC100-Limit: Walking Up 30 Stairs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking up 30 stairs (3 flights) without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking Up 30 Stairs FAC100-Limit: Scrubbing the Floor Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Scrubbing the floor or counter. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Scrubbing the Floor FAC100-Limit: Lifting Less Than 5 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Lifting something weighing less than 5 lbs (about 2 kg, like a houseplant). FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Lifting Less Than 5 Lbs FAC100-Limit: Lifting 5-10 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Lifting something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes). FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Lifting 5-10 Lbs FAC100-Limit: Lifting More Than 20 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Lifting something weighing more than 20 lbs (about 9 kg, like a medium-sized suitcase). FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Lifting More Than 20 Lbs FAC100-Limit: Carrying Less Than 5 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Carrying something weighing less than 5 lbs (about 2 kg, like a houseplant) from one room to another. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Carrying Less Than 5 Lbs FAC100-Limit: Carrying 5-10 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Carrying something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes) from one room to another. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Carrying 5-10 Lbs FAC100-Limit: Get In/Out of a Car Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Getting in or out of a car. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Get In/Out of a Car FAC100-Limit: Dining Out Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Dining out. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Dining Out FAC100-Limit: Low-intensity Activity Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Low-intensity leisure activity (gardening, etc.). FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Low-intensity Activity FAC100-Limit: Moderate Activity Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Moderate-intensity leisure activity (bicycling on level terrain, etc.). FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Moderate Activity FAC100-Limit: Walk Fast 50 Steps Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking (faster than your usual speed) for 50 steps without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walk Fast 50 Steps FAC100-Limit: Walking Fast 1 Mile Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking (faster than your usual speed) for at least 1 mile (a little more than 1.5 km) without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking Fast 1 Mile FAC100-Limit: Singing or Humming Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Singing or humming. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Singing or Humming FAC100-Limit: Talking While Walking Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Talking while walking. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Talking While Walking FAC100TC Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank Questionnaire Test Code CDISC Questionnaire FACIT-Dyspnea Scale 33 Item Bank Version Test Code Terminology Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank test name. FAC100-Limit: Carry 10-20 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Carrying something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries) from one room to another. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Carry 10-20 Lbs FAC100-Limit: Carrying 5-10 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Carrying something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes) from one room to another. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Carrying 5-10 Lbs FAC100-Limit: Carrying Less Than 5 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Carrying something weighing less than 5 lbs (about 2 kg, like a houseplant) from one room to another. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Carrying Less Than 5 Lbs FAC100-Limit: Dining Out Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Dining out. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Dining Out FAC100-Limit: Dressing Without Help Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Dressing yourself without help. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Dressing Without Help FAC100-Limit: Get In/Out of a Car Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Getting in or out of a car. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Get In/Out of a Car FAC100-Limit: Lifting 10-20 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Lifting something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries). FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Lifting 10-20 Lbs FAC100-Limit: Lifting 5-10 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Lifting something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes). FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Lifting 5-10 Lbs FAC100-Limit: Lifting Less Than 5 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Lifting something weighing less than 5 lbs (about 2 kg, like a houseplant). FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Lifting Less Than 5 Lbs FAC100-Limit: Lifting More Than 20 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Lifting something weighing more than 20 lbs (about 9 kg, like a medium-sized suitcase). FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Lifting More Than 20 Lbs FAC100-Limit: Low-intensity Activity Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Low-intensity leisure activity (gardening, etc.). FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Low-intensity Activity FAC100-Limit: Making a Bed Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Making a bed. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Making a Bed FAC100-Limit: Moderate Activity Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Moderate-intensity leisure activity (bicycling on level terrain, etc.). FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Moderate Activity FAC100-Limit: Preparing Meals Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Preparing meals. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Preparing Meals FAC100-Limit: Putting on Socks Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Putting on socks or stockings. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Putting on Socks FAC100-Limit: Scrubbing the Floor Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Scrubbing the floor or counter. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Scrubbing the Floor FAC100-Limit: Singing or Humming Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Singing or humming. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Singing or Humming FAC100-Limit: Standing 5 Minutes Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Standing for at least 5 minutes. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Standing 5 Minutes FAC100-Limit: Sweeping/Mopping Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Sweeping or mopping. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Sweeping/Mopping FAC100-Limit: Taking a Bath Without Help Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Taking a bath without help. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Taking a Bath Without Help FAC100-Limit: Taking a Shower Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Taking a shower. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Taking a Shower FAC100-Limit: Talking While Walking Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Talking while walking. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Talking While Walking FAC100-Limit: Walk 50 Steps Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking 50 steps/paces on flat ground at a normal speed without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walk 50 Steps FAC100-Limit: Walk Fast 50 Steps Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking (faster than your usual speed) for 50 steps without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walk Fast 50 Steps FAC100-Limit: Walk for 1/2 Mile Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walk for 1/2 Mile FAC100-Limit: Walk Up 20 Stairs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking up 20 stairs (2 flights) without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walk Up 20 Stairs FAC100-Limit: Walking 1/2 Mile Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking 1/2 mile (almost 1 km) on flat ground at a normal speed without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking 1/2 Mile FAC100-Limit: Walking 10 Steps Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking 10 steps/paces on flat ground at a normal speed without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking 10 Steps FAC100-Limit: Walking Fast 1 Mile Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking (faster than your usual speed) for at least 1 mile (a little more than 1.5 km) without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking Fast 1 Mile FAC100-Limit: Walking Up 10 Stairs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking up 10 stairs (1 flight) without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking Up 10 Stairs FAC100-Limit: Walking Up 30 Stairs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking up 30 stairs (3 flights) without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking Up 30 Stairs FAC100-Limit: Walking Up 5 Stairs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking up 5 stairs without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking Up 5 Stairs FAC100-Limit: Washing Dishes Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Washing dishes. FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Washing Dishes FAC100-Sev: Bath Without Help Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Taking a bath without help. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Bath Without Help Why Not FAC100-Sev: Bath Without Help Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Taking a bath without help. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Bath Without Help FAC100-Sev: Carry 10-20 Lbs Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries) from one room to another. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carry 10-20 Lbs Why Not FAC100-Sev: Carry 10-20 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries) from one room to another. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carry 10-20 Lbs FAC100-Sev: Carrying 5-10 Lbs Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes) from one room to another. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carrying 5-10 Lbs Why Not FAC100-Sev: Carrying 5-10 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes) from one room to another. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carrying 5-10 Lbs FAC100-Sev: Carrying Less Than 5 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing less than 5 lbs (about 2 kg, like a houseplant) from one room to another. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carrying Less Than 5 Lbs FAC100-Sev: Carrying Less Than 5 Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing less than 5 lbs (about 2 kg, like a houseplant) from one room to another. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carrying Less Than 5 Why Not FAC100-Sev: Dining Out Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Dining out. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Dining Out Why Not FAC100-Sev: Dining Out Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Dining out. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Dining Out FAC100-Sev: Dressing Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Dressing yourself without help. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Dressing Why Not FAC100-Sev: Dressing Without Help Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Dressing yourself without help. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Dressing Without Help FAC100-Sev: Get In/Out of a Car Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Getting in or out of a car. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Get In/Out of a Car Why Not FAC100-Sev: Get In/Out of a Car Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Getting in or out of a car. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Get In/Out of a Car FAC100-Sev: Lift Less Than 5 Lbs Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing less than 5 lbs (about 2 kg, like a houseplant). Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lift Less Than 5 Lbs Why Not FAC100-Sev: Lift Less Than 5 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing less than 5 lbs (about 2 kg, like a houseplant). FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lift Less Than 5 Lbs FAC100-Sev: Lift More Than 20 Lb Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing more than 20 lbs (about 9 kg, like a medium-sized suitcase). Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lift More Than 20 Lbs Why Not FAC100-Sev: Lift More Than 20 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing more than 20 lbs (about 9 kg, like a medium-sized suitcase). FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lift More Than 20 Lbs FAC100-Sev: Lifting 10-20 Lbs Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries). Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lifting 10-20 Lbs Why Not FAC100-Sev: Lifting 10-20 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries). FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lifting 10-20 Lbs FAC100-Sev: Lifting 5-10 Lbs Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes). Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lifting 5-10 Lbs Why Not FAC100-Sev: Lifting 5-10 Lbs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes). FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lifting 5-10 Lbs FAC100-Sev: Low-intensity Activ Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Low-intensity leisure activity (gardening, etc.). Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Low-intensity Activity Why Not FAC100-Sev: Low-intensity Activ Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Low-intensity leisure activity (gardening, etc.). FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Low-intensity Activity FAC100-Sev: Making a Bed Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Making a bed. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Making a Bed Why Not FAC100-Sev: Making a Bed Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Making a bed. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Making a Bed FAC100-Sev: Moderate Activity Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Moderate-intensity leisure activity (bicycling on level terrain, etc.). Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Moderate Activity Why Not FAC100-Sev: Moderate Activity Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Moderate-intensity leisure activity (bicycling on level terrain, etc.). FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Moderate Activity FAC100-Sev: Preparing Meals Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Preparing meals. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Preparing Meals Why Not FAC100-Sev: Preparing Meals Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Preparing meals. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Preparing Meals FAC100-Sev: Putting on Socks Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Putting on socks or stockings. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Putting on Socks Why Not FAC100-Sev: Putting on Socks Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Putting on socks or stockings. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Putting on Socks FAC100-Sev: Scrubbing the Floor Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Scrubbing the floor or counter. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Scrubbing the Floor Why Not FAC100-Sev: Scrubbing the Floor Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Scrubbing the floor or counter. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Scrubbing the Floor FAC100-Sev: Singing or Humming Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Singing or humming. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Singing or Humming Why Not FAC100-Sev: Singing or Humming Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Singing or humming. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Singing or Humming FAC100-Sev: Standing 5 Minutes Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Standing for at least 5 minutes. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Standing 5 Minutes Why Not FAC100-Sev: Standing 5 Minutes Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Standing for at least 5 minutes. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Standing 5 Minutes FAC100-Sev: Sweeping/Mopping Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Sweeping or mopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Sweeping/Mopping Why Not FAC100-Sev: Sweeping/Mopping Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Sweeping or mopping. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Sweeping/Mopping FAC100-Sev: Taking a Shower Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Taking a shower. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Taking a Shower Why Not FAC100-Sev: Taking a Shower Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Taking a shower. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Taking a Shower FAC100-Sev: Talking While Walk Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Talking while walking. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Talking While Walk Why Not FAC100-Sev: Talking While Walking Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Talking while walking. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Talking While Walking FAC100-Sev: Walk 50 Steps Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking 50 steps/paces on flat ground at a normal speed without stopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk 50 Steps Why Not FAC100-Sev: Walk 50 Steps Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking 50 steps/paces on flat ground at a normal speed without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk 50 Steps FAC100-Sev: Walk Fast 50 Steps Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for 50 steps without stopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk Fast 50 Steps Why Not FAC100-Sev: Walk Fast 50 Steps Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for 50 steps without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk Fast 50 Steps FAC100-Sev: Walk for 1/2 Mile Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk for 1/2 Mile Why Not FAC100-Sev: Walk for 1/2 Mile Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk for 1/2 Mile FAC100-Sev: Walk Up 20 Stairs Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 20 stairs (2 flights) without stopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk Up 20 Stairs Why Not FAC100-Sev: Walk Up 20 Stairs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 20 stairs (2 flights) without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk Up 20 Stairs FAC100-Sev: Walking 1/2 Mile Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking 1/2 mile (almost 1 km) on flat ground at a normal speed without stopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking 1/2 Mile Why Not FAC100-Sev: Walking 1/2 Mile Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking 1/2 mile (almost 1 km) on flat ground at a normal speed without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking 1/2 Mile FAC100-Sev: Walking 10 Steps Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking 10 steps/paces on flat ground at a normal speed without stopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking 10 Steps Why Not FAC100-Sev: Walking 10 Steps Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking 10 steps/paces on flat ground at a normal speed without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking 10 Steps FAC100-Sev: Walking Fast 1 Mile Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for at least 1 mile ( a little more than 1.5 km) without stopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Fast 1 Mile Why Not FAC100-Sev: Walking Fast 1 Mile Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for at least 1 mile ( a little more than 1.5 km) without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Fast 1 Mile FAC100-Sev: Walking Up 10 Stairs Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 10 stairs (1 flight) without stopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 10 Stairs Why Not FAC100-Sev: Walking Up 10 Stairs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 10 stairs (1 flight) without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 10 Stairs FAC100-Sev: Walking Up 30 Stairs Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 30 stairs (3 flights) without stopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 30 Stairs Why Not FAC100-Sev: Walking Up 30 Stairs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 30 stairs (3 flights) without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 30 Stairs FAC100-Sev: Walking Up 5 Stairs Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 5 stairs without stopping. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 5 Stairs Why Not FAC100-Sev: Walking Up 5 Stairs Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 5 stairs without stopping. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 5 Stairs FAC100-Sev: Washing Dishes Why Not Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Washing dishes. Please indicate why you did not do this in the past 7 days. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Washing Dishes Why Not FAC100-Sev: Washing Dishes Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Washing dishes. FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Washing Dishes FAC100TN Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank Questionnaire Test Name CDISC Questionnaire FACIT-Dyspnea Scale 33 Item Bank Version Test Name Terminology Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 test code. FAC070-I Feel Fatigued Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I feel fatigued. FACIT-Fatigue 13-Item Version 4 - I Feel Fatigued FAC070-I Feel Weak All Over Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I feel weak all over. FACIT-Fatigue 13-Item Version 4 - I Feel Weak All Over FAC070-I Feel Listless Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I feel listless ("washed out"). FACIT-Fatigue 13-Item Version 4 - I Feel Listless FAC070-I Feel Tired Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I feel tired. FACIT-Fatigue 13-Item Version 4 - I Feel Tired FAC070-Trouble Starting Things Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I have trouble starting things because I am tired. FACIT-Fatigue 13-Item Version 4 - Trouble Starting Things FAC070-Trouble Finishing Things Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I have trouble finishing things because I am tired. FACIT-Fatigue 13-Item Version 4 - Trouble Finishing Things FAC070-I Have Energy Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I have energy. FACIT-Fatigue 13-Item Version 4 - I Have Energy FAC070-Able to Do My Usual Activities Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I am able to do my usual activities. FACIT-Fatigue 13-Item Version 4 - Able to Do My Usual Activities FAC070-I Need to Sleep During the Day Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I need to sleep during the day. FACIT-Fatigue 13-Item Version 4 - I Need to Sleep During the Day FAC070-I Am Too Tired to Eat Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I am too tired to eat. FACIT-Fatigue 13-Item Version 4 - I Am Too Tired to Eat FAC070-Need Help Doing Usual Activities Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I need help doing my usual activities. FACIT-Fatigue 13-Item Version 4 - Need Help Doing Usual Activities FAC070-Frustrated by Being Too Tired Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I am frustrated by being too tired to do the things I want to do. FACIT-Fatigue 13-Item Version 4 - Frustrated by Being Too Tired FAC070-Limit Social Activity, I am Tired Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I have to limit my social activity because I am tired. FACIT-Fatigue 13-Item Version 4 - Limit Social Activity, I am Tired FAC070-Total Score Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - Total score. FACIT-Fatigue 13-Item Version 4 - Total Score FAC070TC Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 Questionnaire Test Code CDISC Questionnaire FACIT-Fatigue 13-Item Version 4 Test Code Terminology Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 test name. FAC070-Able to Do My Usual Activities Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I am able to do my usual activities. FACIT-Fatigue 13-Item Version 4 - Able to Do My Usual Activities FAC070-Frustrated by Being Too Tired Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I am frustrated by being too tired to do the things I want to do. FACIT-Fatigue 13-Item Version 4 - Frustrated by Being Too Tired FAC070-I Am Too Tired to Eat Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I am too tired to eat. FACIT-Fatigue 13-Item Version 4 - I Am Too Tired to Eat FAC070-I Feel Fatigued Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I feel fatigued. FACIT-Fatigue 13-Item Version 4 - I Feel Fatigued FAC070-I Feel Listless Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I feel listless ("washed out"). FACIT-Fatigue 13-Item Version 4 - I Feel Listless FAC070-I Feel Tired Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I feel tired. FACIT-Fatigue 13-Item Version 4 - I Feel Tired FAC070-I Feel Weak All Over Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I feel weak all over. FACIT-Fatigue 13-Item Version 4 - I Feel Weak All Over FAC070-I Have Energy Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I have energy. FACIT-Fatigue 13-Item Version 4 - I Have Energy FAC070-I Need to Sleep During the Day Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I need to sleep during the day. FACIT-Fatigue 13-Item Version 4 - I Need to Sleep During the Day FAC070-Limit Social Activity, I am Tired Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I have to limit my social activity because I am tired. FACIT-Fatigue 13-Item Version 4 - Limit Social Activity, I am Tired FAC070-Need Help Doing Usual Activities Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I need help doing my usual activities. FACIT-Fatigue 13-Item Version 4 - Need Help Doing Usual Activities FAC070-Total Score Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - Total score. FACIT-Fatigue 13-Item Version 4 - Total Score FAC070-Trouble Finishing Things Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I have trouble finishing things because I am tired. FACIT-Fatigue 13-Item Version 4 - Trouble Finishing Things FAC070-Trouble Starting Things Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I have trouble starting things because I am tired. FACIT-Fatigue 13-Item Version 4 - Trouble Starting Things FAC070TN Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 Questionnaire Test Name CDISC Questionnaire FACIT-Fatigue 13-Item Version 4 Test Name Terminology Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 test code. FAC071-I Have a Lack of Energy Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: I have a lack of energy. FACIT-F Version 4 - I Have a Lack of Energy FAC071-I Have Nausea Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: I have nausea. FACIT-F Version 4 - I Have Nausea FAC071-Trouble Meeting Needs of Family Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. FACIT-F Version 4 - Trouble Meeting Needs of Family FAC071-I Have Pain Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: I have pain. FACIT-F Version 4 - I Have Pain FAC071-Bothered by Treatment Side Effect Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: I am bothered by side effects of treatment. FACIT-F Version 4 - Bothered by Treatment Side Effect FAC071-I Feel Ill Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: I feel ill. FACIT-F Version 4 - I Feel Ill FAC071-I Am Forced to Spend Time in Bed Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: I am forced to spend time in bed. FACIT-F Version 4 - I Am Forced to Spend Time in Bed FAC071-I Feel Close to My Friends Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Social/Family Well-Being: I feel close to my friends. FACIT-F Version 4 - I Feel Close to My Friends FAC071-Get Emotional Support From Family Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Social/Family Well-Being: I get emotional support from my family. FACIT-F Version 4 - Get Emotional Support From Family FAC071-I Get Support From My Friends Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Social/Family Well-Being: I get support from my friends. FACIT-F Version 4 - I Get Support From My Friends FAC071-My Family Has Accepted My Illness Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Social/Family Well-Being: My family has accepted my illness. FACIT-F Version 4 - My Family Has Accepted My Illness FAC071-Satisfied Communication Illness Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. FACIT-F Version 4 - Satisfied Family Communication of Illness FAC071-I Feel Close to My Partner Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). FACIT-F Version 4 - I Feel Close to My Partner FAC071-I Am Satisfied With My Sex Life Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Social/Family Well-Being: I am satisfied with my sex life. FACIT-F Version 4 - I Am Satisfied With My Sex Life FAC071-I Feel Sad Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Emotional Well-Being: I feel sad. FACIT-F Version 4 - I Feel Sad FAC071-Satisfied With How I Am Coping Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. FACIT-F Version 4 - Satisfied With How I Am Coping FAC071-Losing Hope Against Illness Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. FACIT-F Version 4 - Losing Hope Against Illness FAC071-I Feel Nervous Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Emotional Well-Being: I feel nervous. FACIT-F Version 4 - I Feel Nervous FAC071-I Worry About Dying Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Emotional Well-Being: I worry about dying. FACIT-F Version 4 - I Worry About Dying FAC071-Worry My Condition Will Get Worse Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Emotional Well-Being: I worry that my condition will get worse. FACIT-F Version 4 - Worry My Condition Will Get Worse FAC071-I Am Able to Work Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: I am able to work (include work at home). FACIT-F Version 4 - I Am Able to Work FAC071-My Work Is Fulfilling Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. FACIT-F Version 4 - My Work Is Fulfilling FAC071-I Am Able to Enjoy Life Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: I am able to enjoy life. FACIT-F Version 4 - I Am Able to Enjoy Life FAC071-I Have Accepted My Illness Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: I have accepted my illness. FACIT-F Version 4 - I Have Accepted My Illness FAC071-I Am Sleeping Well Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: I am sleeping well. FACIT-F Version 4 - I Am Sleeping Well FAC071-Enjoy Things I Usually Do for Fun Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. FACIT-F Version 4 - Enjoy Things I Usually Do for Fun FAC071-Content With Quality of My Life Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: I am content with the quality of my life right now. FACIT-F Version 4 - Content With Quality of My Life FAC071-I Feel Fatigued Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I feel fatigued. FACIT-F Version 4 - I Feel Fatigued FAC071-I Feel Weak All Over Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I feel weak all over. FACIT-F Version 4 - I Feel Weak All Over FAC071-I Feel Listless Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I feel listless ('washed out'). FACIT-F Version 4 - I Feel Listless FAC071-I Feel Tired Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I feel tired. FACIT-F Version 4 - I Feel Tired FAC071-Trouble Starting Things Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I have trouble starting things because I am tired. FACIT-F Version 4 - Trouble Starting Things FAC071-Trouble Finishing Things Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I have trouble finishing things because I am tired. FACIT-F Version 4 - Trouble Finishing Things FAC071-I Have Energy Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I have energy. FACIT-F Version 4 - I Have Energy FAC071-Able to Do My Usual Activities Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I am able to do my usual activities. FACIT-F Version 4 - Able to Do My Usual Activities FAC071-I Need to Sleep During the Day Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I need to sleep during the day. FACIT-F Version 4 - I Need to Sleep During the Day FAC071-I Am Too Tired to Eat Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I am too tired to eat. FACIT-F Version 4 - I Am Too Tired to Eat FAC071-Need Help Doing Usual Activities Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I need help doing my usual activities. FACIT-F Version 4 - Need Help Doing Usual Activities FAC071-Frustrated by Being Too Tired Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I am frustrated by being too tired to do the things I want to do. FACIT-F Version 4 - Frustrated by Being Too Tired FAC071-Limit Social Activity, I am Tired Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I have to limit my social activity because I am tired. FACIT-F Version 4 - Limit Social Activity, I am Tired FAC071-Physical Subscale Score Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: Subscale score. FACIT-F Version 4 - Physical Subscale Score FAC071-Social/Family Subscale Score Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Socia/Family Well-Being: Subscale score. FACIT-F Version 4 - Social/Family Subscale Score FAC071-Emotional Subscale Score Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Emotional Well-Being: Subscale score. FACIT-F Version 4 - Emotional Subscale Score FAC071-Functional Subscale Score Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: Subscale score. FACIT-F Version 4 - Functional Subscale Score FAC071-Additional Concern Subscale Score Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: Subscale score. FACIT-F Version 4 - Additional Concern Subscale Score FAC071-Trial Outcome Index Score Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Trial outcome index score. FACIT-F Version 4 - Trial Outcome Index Score FAC071-FACT-G Total Score Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - FACT-G total score. FACIT-F Version 4 - FACT-G Total Score FAC071-Total Score Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Total score. FACIT-F Version 4 - Total Score FAC071TC Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 Questionnaire Test Code CDISC Questionnaire FACIT-F Version 4 Test Code Terminology Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 test name. FAC071-Able to Do My Usual Activities Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I am able to do my usual activities. FACIT-F Version 4 - Able to Do My Usual Activities FAC071-Additional Concern Subscale Score Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: Subscale score. FACIT-F Version 4 - Additional Concern Subscale Score FAC071-Bothered by Treatment Side Effect Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: I am bothered by side effects of treatment. FACIT-F Version 4 - Bothered by Treatment Side Effect FAC071-Content With Quality of My Life Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: I am content with the quality of my life right now. FACIT-F Version 4 - Content With Quality of My Life FAC071-Emotional Subscale Score Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Emotional Well-Being: Subscale score. FACIT-F Version 4 - Emotional Subscale Score FAC071-Enjoy Things I Usually Do for Fun Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. FACIT-F Version 4 - Enjoy Things I Usually Do for Fun FAC071-FACT-G Total Score Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - FACT-G total score. FACIT-F Version 4 - FACT-G Total Score FAC071-Frustrated by Being Too Tired Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I am frustrated by being too tired to do the things I want to do. FACIT-F Version 4 - Frustrated by Being Too Tired FAC071-Functional Subscale Score Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: Subscale score. FACIT-F Version 4 - Functional Subscale Score FAC071-Get Emotional Support From Family Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Social/Family Well-Being: I get emotional support from my family. FACIT-F Version 4 - Get Emotional Support From Family FAC071-I Am Able to Enjoy Life Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: I am able to enjoy life. FACIT-F Version 4 - I Am Able to Enjoy Life FAC071-I Am Able to Work Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: I am able to work (include work at home). FACIT-F Version 4 - I Am Able to Work FAC071-I Am Forced to Spend Time in Bed Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: I am forced to spend time in bed. FACIT-F Version 4 - I Am Forced to Spend Time in Bed FAC071-I Am Satisfied With My Sex Life Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Social/Family Well-Being: I am satisfied with my sex life. FACIT-F Version 4 - I Am Satisfied With My Sex Life FAC071-I Am Sleeping Well Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: I am sleeping well. FACIT-F Version 4 - I Am Sleeping Well FAC071-I Am Too Tired to Eat Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I am too tired to eat. FACIT-F Version 4 - I Am Too Tired to Eat FAC071-I Feel Close to My Friends Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Social/Family Well-Being: I feel close to my friends. FACIT-F Version 4 - I Feel Close to My Friends FAC071-I Feel Close to My Partner Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). FACIT-F Version 4 - I Feel Close to My Partner FAC071-I Feel Fatigued Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I feel fatigued. FACIT-F Version 4 - I Feel Fatigued FAC071-I Feel Ill Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: I feel ill. FACIT-F Version 4 - I Feel Ill FAC071-I Feel Listless Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I feel listless ('washed out'). FACIT-F Version 4 - I Feel Listless FAC071-I Feel Nervous Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Emotional Well-Being: I feel nervous. FACIT-F Version 4 - I Feel Nervous FAC071-I Feel Sad Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Emotional Well-Being: I feel sad. FACIT-F Version 4 - I Feel Sad FAC071-I Feel Tired Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I feel tired. FACIT-F Version 4 - I Feel Tired FAC071-I Feel Weak All Over Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I feel weak all over. FACIT-F Version 4 - I Feel Weak All Over FAC071-I Get Support From My Friends Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Social/Family Well-Being: I get support from my friends. FACIT-F Version 4 - I Get Support From My Friends FAC071-I Have a Lack of Energy Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: I have a lack of energy. FACIT-F Version 4 - I Have a Lack of Energy FAC071-I Have Accepted My Illness Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: I have accepted my illness. FACIT-F Version 4 - I Have Accepted My Illness FAC071-I Have Energy Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I have energy. FACIT-F Version 4 - I Have Energy FAC071-I Have Nausea Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: I have nausea. FACIT-F Version 4 - I Have Nausea FAC071-I Have Pain Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: I have pain. FACIT-F Version 4 - I Have Pain FAC071-I Need to Sleep During the Day Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I need to sleep during the day. FACIT-F Version 4 - I Need to Sleep During the Day FAC071-I Worry About Dying Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Emotional Well-Being: I worry about dying. FACIT-F Version 4 - I Worry About Dying FAC071-Limit Social Activity, I am Tired Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I have to limit my social activity because I am tired. FACIT-F Version 4 - Limit Social Activity, I am Tired FAC071-Losing Hope Against Illness Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. FACIT-F Version 4 - Losing Hope Against Illness FAC071-My Family Has Accepted My Illness Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Social/Family Well-Being: My family has accepted my illness. FACIT-F Version 4 - My Family Has Accepted My Illness FAC071-My Work Is Fulfilling Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. FACIT-F Version 4 - My Work Is Fulfilling FAC071-Need Help Doing Usual Activities Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I need help doing my usual activities. FACIT-F Version 4 - Need Help Doing Usual Activities FAC071-Physical Subscale Score Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: Subscale score. FACIT-F Version 4 - Physical Subscale Score FAC071-Satisfied Communication Illness Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. FACIT-F Version 4 - Satisfied Family Communication of Illness FAC071-Satisfied With How I Am Coping Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. FACIT-F Version 4 - Satisfied With How I Am Coping FAC071-Social/Family Subscale Score Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Socia/Family Well-Being: Subscale score. FACIT-F Version 4 - Social/Family Subscale Score FAC071-Total Score Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Total score. FACIT-F Version 4 - Total Score FAC071-Trial Outcome Index Score Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Trial outcome index score. FACIT-F Version 4 - Trial Outcome Index Score FAC071-Trouble Finishing Things Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I have trouble finishing things because I am tired. FACIT-F Version 4 - Trouble Finishing Things FAC071-Trouble Meeting Needs of Family Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. FACIT-F Version 4 - Trouble Meeting Needs of Family FAC071-Trouble Starting Things Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I have trouble starting things because I am tired. FACIT-F Version 4 - Trouble Starting Things FAC071-Worry My Condition Will Get Worse Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Emotional Well-Being: I worry that my condition will get worse. FACIT-F Version 4 - Worry My Condition Will Get Worse FAC071TN Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 Questionnaire Test Name CDISC Questionnaire FACIT-F Version 4 Test Name Terminology Functional Assessment of Chronic Illness Therapy-Item GP5 Version 4 test code. FAC101-Bothered by Treatment Side Effect Functional Assessment of Chronic Illness Therapy-Item GP5 Version 4 - I am bothered by side effects of treatment. FACIT-Item GP5 Version 4 - Bothered by Treatment Side Effect FAC101TC Functional Assessment of Chronic Illness Therapy-Item GP5 Version 4 Questionnaire Test Code CDISC Questionnaire Functional Assessment of Chronic Illness Therapy-Item GP5 Version 4 Test Code Terminology Functional Assessment of Chronic Illness Therapy-Item GP5 Version 4 test name. FAC101-Bothered by Treatment Side Effect Functional Assessment of Chronic Illness Therapy-Item GP5 Version 4 - I am bothered by side effects of treatment. FACIT-Item GP5 Version 4 - Bothered by Treatment Side Effect FAC101TN Functional Assessment of Chronic Illness Therapy-Item GP5 Version 4 Questionnaire Test Name CDISC Questionnaire Functional Assessment of Chronic Illness Therapy-Item GP5 Version 4 Test Name Terminology Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult test code. FSIL-Fatigue Keeps Me From Doing Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My fatigue keeps me from doing the things I want to do. FACIT-Searchable Item Library Adult Version - Fatigue Keeps Me From Doing Things FSIL-Bothered by Swelling Certain Areas Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by swelling in certain areas of my body. FACIT-Searchable Item Library Adult Version - Bothered by Swelling Certain Areas FSIL-Bothered by Mouth Sores/Tenderness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by mouth sores or tenderness. FACIT-Searchable Item Library Adult Version - Bothered by Mouth Sores/Tenderness FSIL-Because of Sores Eating Difficult Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Because of my mouth sores, eating is difficult. FACIT-Searchable Item Library Adult Version - Because of Sores Eating Difficult FSIL-The Skin on My Hands Hurts Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The skin on my hands hurts. FACIT-Searchable Item Library Adult Version - The Skin on My Hands Hurts FSIL-Hand Pain Interferes Daily Activ Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Hand pain or tenderness interferes with my daily activities. FACIT-Searchable Item Library Adult Version - Hand Pain Interferes Daily Activ FSIL-The Skin on My Feet Hurts Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The skin on my feet hurts. FACIT-Searchable Item Library Adult Version - The Skin on My Feet Hurts FSIL-Pain on My Feet Interferes Walking Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Pain on the bottom of my feet interferes with my walking. FACIT-Searchable Item Library Adult Version - Pain on My Feet Interferes Walking FSIL-Limit Activities Because Diarrhea Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my activities because of diarrhea (diarrhoea). FACIT-Searchable Item Library Adult Version - Limit Activities Because Diarrhea FSIL-Bothered by a Skin Rash Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by a skin rash. FACIT-Searchable Item Library Adult Version - Bothered by a Skin Rash FSIL-Amount I Eat Is Sufficient Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The amount I eat is sufficient to meet my needs. FACIT-Searchable Item Library Adult Version - Amount I Eat Is Sufficient FSIL-I Seem to Get Full Quickly Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: When I eat, I seem to get full quickly. FACIT-Searchable Item Library Adult Version - I Seem to Get Full Quickly FSIL-I Have Pain in My Stomach Area Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my stomach area. FACIT-Searchable Item Library Adult Version - I Have Pain in My Stomach Area FSIL-My General Health Is Improving Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My general health is improving. FACIT-Searchable Item Library Adult Version - My General Health Is Improving FSIL-Worried About My Weight Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am worried about my weight. FACIT-Searchable Item Library Adult Version - Worried About My Weight FSIL-Most Food Tastes Unpleasant to Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Most food tastes unpleasant to me. FACIT-Searchable Item Library Adult Version - Most Food Tastes Unpleasant to Me FSIL-Concerned About How Thin I Look Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am concerned about how thin I look. FACIT-Searchable Item Library Adult Version - Concerned About How Thin I Look FSIL-Interest in Food Drops Try to Eat Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My interest in food drops as soon as I try to eat. FACIT-Searchable Item Library Adult Version - Interest in Food Drops Try to Eat FSIL-Have Difficulty Eating Rich Foods Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty eating rich or "heavy" foods. FACIT-Searchable Item Library Adult Version - Have Difficulty Eating Rich Foods FSIL-My Family Pressuring Me to Eat Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My family or friends are pressuring me to eat. FACIT-Searchable Item Library Adult Version - My Family Pressuring Me to Eat FSIL-Stomach Pain Interferes Functioning Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Stomach pain interferes with my daily functioning. FACIT-Searchable Item Library Adult Version - Stomach Pain Interferes Functioning FSIL-I Have Been Emotionally Distressed Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been emotionally distressed. FACIT-Searchable Item Library Adult Version - I Have Been Emotionally Distressed FSIL-I Feel Listless Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel listless ("washed out"). FACIT-Searchable Item Library Adult Version - I Feel Listless FSIL-I Get Headaches Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get headaches. FACIT-Searchable Item Library Adult Version - I Get Headaches FSIL-I Have Pain in My Chest Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my chest. FACIT-Searchable Item Library Adult Version - I Have Pain in My Chest FSIL-Too Tired to Eat Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am too tired to eat. FACIT-Searchable Item Library Adult Version - Too Tired to Eat FSIL-Motivated to Do Activities Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am motivated to do my usual activities. FACIT-Searchable Item Library Adult Version - Motivated to Do Activities FSIL-Need Help Doing Usual Activities Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I need help doing my usual activities. FACIT-Searchable Item Library Adult Version - Need Help Doing Usual Activities FSIL-Frustrated by Being Too Tired Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated by being too tired to do the things I want to do. FACIT-Searchable Item Library Adult Version - Frustrated by Being Too Tired FSIL-Limit Social Activity B/c Tired Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my social activity because I am tired. FACIT-Searchable Item Library Adult Version - Limit Social Activity B/c Tired FSIL-I Feel Tired Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel tired. FACIT-Searchable Item Library Adult Version - I Feel Tired FSIL-Trouble Starting Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble starting things because I am tired. FACIT-Searchable Item Library Adult Version - Trouble Starting Things FSIL-Trouble Finishing Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble finishing things because I am tired. FACIT-Searchable Item Library Adult Version - Trouble Finishing Things FSIL-I Have Energy Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have energy. FACIT-Searchable Item Library Adult Version - I Have Energy FSIL-I Have Trouble Walking Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble walking. FACIT-Searchable Item Library Adult Version - I Have Trouble Walking FSIL-Able to Do My Usual Activities Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to do my usual activities. FACIT-Searchable Item Library Adult Version - Able to Do My Usual Activities FSIL-I Need to Sleep During the Day Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I need to sleep during the day. FACIT-Searchable Item Library Adult Version - I Need to Sleep During the Day FSIL-I Feel Lightheaded Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel lightheaded (dizzy). FACIT-Searchable Item Library Adult Version - I Feel Lightheaded FSIL-I Have Been Short of Breath Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been short of breath. FACIT-Searchable Item Library Adult Version - I Have Been Short of Breath FSIL-Movement of Arm This Side Painful Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Movement of my arm on this side is painful. FACIT-Searchable Item Library Adult Version - Movement of Arm This Side Painful FSIL-Poor Range Arm Movements This Side Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have a poor range of arm movements on this side. FACIT-Searchable Item Library Adult Version - Poor Range Arm Movements This Side FSIL-My Arm on This Side Feels Numb Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My arm on this side feels numb. FACIT-Searchable Item Library Adult Version - My Arm on This Side Feels Numb FSIL-Have Stiffness of Arm on This Side Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have stiffness of my arm on this side. FACIT-Searchable Item Library Adult Version - Have Stiffness of Arm on This Side FSIL-Self-conscious About Way I Dress Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am self-conscious about the way I dress. FACIT-Searchable Item Library Adult Version - Self-conscious About Way I Dress FSIL-One/Both Arms Are Swollen/Tender Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: One or both of my arms are swollen or tender. FACIT-Searchable Item Library Adult Version - One/Both Arms Are Swollen/Tender FSIL-I Feel Sexually Attractive Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel sexually attractive. FACIT-Searchable Item Library Adult Version - I Feel Sexually Attractive FSIL-Bothered by Hair Loss Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by hair loss. FACIT-Searchable Item Library Adult Version - Bothered by Hair Loss FSIL-Worry Family Will Get Illness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that other members of my family might someday get the same illness I have. FACIT-Searchable Item Library Adult Version - Worry Family Will Get Illness FSIL-Worry About the Effect of Stress Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about the effect of stress on my illness. FACIT-Searchable Item Library Adult Version - Worry About the Effect of Stress FSIL-Bothered by Change in Weight Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by a change in weight. FACIT-Searchable Item Library Adult Version - Bothered by Change in Weight FSIL-Able to Feel Like a Woman Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to feel like a woman. FACIT-Searchable Item Library Adult Version - Able to Feel Like a Woman FSIL-Have Trouble Controlling My Urine Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble controlling my urine. FACIT-Searchable Item Library Adult Version - Have Trouble Controlling My Urine FSIL-I Urinate More Frequently Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I urinate more frequently than usual. FACIT-Searchable Item Library Adult Version - I Urinate More Frequently FSIL-It Burns When I Urinate Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: It burns when I urinate. FACIT-Searchable Item Library Adult Version - It Burns When I Urinate FSIL-Interested in Sex Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am interested in sex. FACIT-Searchable Item Library Adult Version - Interested in Sex FSIL-Able to Have/Maintain Erection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to have and maintain an erection. (For men only) FACIT-Searchable Item Library Adult Version - Able to Have/Maintain Erection FSIL-Concerned About Keeping My Job Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am concerned about keeping my job (include work at home). FACIT-Searchable Item Library Adult Version - Concerned About Keeping My Job FSIL-I Can Remember Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I can remember things. FACIT-Searchable Item Library Adult Version - I Can Remember Things FSIL-I Have Frequent Colds/Infections Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have frequent colds/infections. FACIT-Searchable Item Library Adult Version - I Have Frequent Colds/Infections FSIL-My Eyesight Is Blurry Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My eyesight is blurry. FACIT-Searchable Item Library Adult Version - My Eyesight Is Blurry FSIL-Bothered by Change in Food Tastes Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by a change in the way food tastes. FACIT-Searchable Item Library Adult Version - Bothered by Change in Food Tastes FSIL-I Have Tremors Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have tremors. FACIT-Searchable Item Library Adult Version - I Have Tremors FSIL-Bothered by Skin Problems Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by skin problems. FACIT-Searchable Item Library Adult Version - Bothered by Skin Problems FSIL-I Have Trouble With My Bowels Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble with my bowels. FACIT-Searchable Item Library Adult Version - I Have Trouble With My Bowels FSIL-Illness Is Hardship for My Family Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My illness is a personal hardship for my close family members. FACIT-Searchable Item Library Adult Version - Illness Is Hardship for My Family FSIL-Cost of Treatment Is Burden on Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The cost of my treatment is a burden on me or my family. FACIT-Searchable Item Library Adult Version - Cost of Treatment Is Burden on Me FSIL-I Feel Distant From Other People Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel distant from other people. FACIT-Searchable Item Library Adult Version - I Feel Distant From Other People FSIL-I Worry Transplant Will Not Work Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that the transplant will not work. FACIT-Searchable Item Library Adult Version - I Worry Transplant Will Not Work FSIL-Side Effects of Treatment Worse Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The side effects of treatment are worse than I had imagined. FACIT-Searchable Item Library Adult Version - Side Effects of Treatment Worse FSIL-Able to Get Around by Myself Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to get around by myself. FACIT-Searchable Item Library Adult Version - Able to Get Around by Myself FSIL-I Get Tired Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get tired easily. FACIT-Searchable Item Library Adult Version - I Get Tired Easily FSIL-Concerns Ability to Have Children Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have concerns about my ability to have children. FACIT-Searchable Item Library Adult Version - Concerns Ability to Have Children FSIL-Confidence in My Nurse(s) Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have confidence in my nurse(s). FACIT-Searchable Item Library Adult Version - Confidence in My Nurse(s) FSIL-I Regret Bone Marrow Transplant Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I regret having the bone marrow transplant. FACIT-Searchable Item Library Adult Version - I Regret Bone Marrow Transplant FSIL-I Have Bone Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have bone pain. FACIT-Searchable Item Library Adult Version - I Have Bone Pain FSIL-Frustrated by My Bone Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated by my bone pain. FACIT-Searchable Item Library Adult Version - Frustrated by My Bone Pain FSIL-I Feel Depressed about Bone Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel depressed about my bone pain. FACIT-Searchable Item Library Adult Version - I Feel Depressed about Bone Pain FSIL-I Worry Bone Pain Will Get Worse Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that my bone pain will get worse. FACIT-Searchable Item Library Adult Version - I Worry Bone Pain Will Get Worse FSIL-Family Trouble Understand Bone Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My family has trouble understanding when my bone pain interferes with my activity. FACIT-Searchable Item Library Adult Version - Family Trouble Understand Bone Pain FSIL-Hurts When Put Weight/Pressure on Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: It hurts when I put weight or pressure on the place where I have bone pain. FACIT-Searchable Item Library Adult Version - Hurts When Put Weight/Pressure on FSIL-Bone Pain Even When I Sit/Lie Still Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have bone pain even when I sit or lie still. FACIT-Searchable Item Library Adult Version - Bone Pain Even When I Sit/Lie Still FSIL-Need Help Doing Activ B/c Bone Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I need help doing my usual activities because of bone pain. FACIT-Searchable Item Library Adult Version - Need Help Doing Activ B/c Bone Pain FSIL-Rest During Day B/c of Bone Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am forced to rest during the day because of bone pain. FACIT-Searchable Item Library Adult Version - Rest During Day B/c of Bone Pain FSIL-Trouble Walking Because Bone Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble walking because of bone pain. FACIT-Searchable Item Library Adult Version - Trouble Walking Because Bone Pain FSIL-Bone Pain Interferes Care Myself Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Bone pain interferes with my ability to care for myself (bathing, dressing, eating, etc.). FACIT-Searchable Item Library Adult Version - Bone Pain Interferes Care Myself FSIL-Bone Pain Interferes w/Social Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Bone pain interferes with my social activities. FACIT-Searchable Item Library Adult Version - Bone Pain Interferes w/Social FSIL-Bone Pain Wakes Me Up at Night Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Bone pain wakes me up at night. FACIT-Searchable Item Library Adult Version - Bone Pain Wakes Me Up at Night FSIL-Able to Concentrate Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to concentrate. FACIT-Searchable Item Library Adult Version - Able to Concentrate FSIL-Bothered by Change in Personality Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by a change in my personality. FACIT-Searchable Item Library Adult Version - Bothered by Change in Personality FSIL-Make Decisions Take Responsibility Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to make decisions and take responsibility. FACIT-Searchable Item Library Adult Version - Make Decisions Take Responsibility FSIL-Bothered by Drop in My Contribution Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by the drop in my contribution to the family. FACIT-Searchable Item Library Adult Version - Bothered by Drop in My Contribution FSIL-Able to Put My Thoughts Together Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to put my thoughts together. FACIT-Searchable Item Library Adult Version - Able to Put My Thoughts Together FSIL-I Need Help in Caring for Myself Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I need help in caring for myself (bathing, dressing, eating, etc.). FACIT-Searchable Item Library Adult Version - I Need Help in Caring for Myself FSIL-Able to Put My thoughts Into Action Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to put my thoughts into action. FACIT-Searchable Item Library Adult Version - Able to Put My thoughts Into Action FSIL-Able to Read Like I Used to Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to read like I used to. FACIT-Searchable Item Library Adult Version - Able to Read Like I Used to FSIL-Able to Write Like I Used to Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to write like I used to. FACIT-Searchable Item Library Adult Version - Able to Write Like I Used to FSIL-Able to Drive a Vehicle Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to drive a vehicle (my car, truck, etc.). FACIT-Searchable Item Library Adult Version - Able to Drive a Vehicle FSIL-Trouble Feeling Arm/Hands/Legs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble feeling sensations in my arm, hands or legs. FACIT-Searchable Item Library Adult Version - Trouble Feeling Arm/Hands/Legs FSIL-I Have Had Seizures Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had seizures (convulsions). FACIT-Searchable Item Library Adult Version - I Have Had Seizures FSIL-Have Weakness in My Arms or Legs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have weakness in my arms or legs. FACIT-Searchable Item Library Adult Version - Have Weakness in My Arms or Legs FSIL-I Have Trouble With Coordination Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble with coordination. FACIT-Searchable Item Library Adult Version - I Have Trouble With Coordination FSIL-I Can Remember New Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I can remember new things. FACIT-Searchable Item Library Adult Version - I Can Remember New Things FSIL-Frustrated I Cannot Do Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get frustrated that I cannot do things I used to. FACIT-Searchable Item Library Adult Version - Frustrated I Cannot Do Things FSIL-Afraid of Having a Seizure Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am afraid of having a seizure (convulsion). FACIT-Searchable Item Library Adult Version - Afraid of Having a Seizure FSIL-I Have Trouble With My Eyesight Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble with my eyesight. FACIT-Searchable Item Library Adult Version - I Have Trouble With My Eyesight FSIL-I Feel Independent Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel independent. FACIT-Searchable Item Library Adult Version - I Feel Independent FSIL-Able to Find the Right Words Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to find the right word(s) to say what I mean. FACIT-Searchable Item Library Adult Version - Able to Find the Right Words FSIL-Difficulty Expressing My Thoughts Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty expressing my thoughts. FACIT-Searchable Item Library Adult Version - Difficulty Expressing My Thoughts FSIL-I Have Pain in My Joints Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my joints. FACIT-Searchable Item Library Adult Version - I Have Pain in My Joints FSIL-Bothered by Sweating Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by sweating. FACIT-Searchable Item Library Adult Version - Bothered by Sweating FSIL-Bothered by the Chills Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by the chills. FACIT-Searchable Item Library Adult Version - Bothered by the Chills FSIL-Bothered by Fevers Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by fevers (episodes of high body temperature). FACIT-Searchable Item Library Adult Version - Bothered by Fevers FSIL-Bothered by Dry Mouth Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by dry mouth. FACIT-Searchable Item Library Adult Version - Bothered by Dry Mouth FSIL-I Get Depressed Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get depressed easily. FACIT-Searchable Item Library Adult Version - I Get Depressed Easily FSIL-I Get Annoyed Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get annoyed easily. FACIT-Searchable Item Library Adult Version - I Get Annoyed Easily FSIL-I Have Emotional Ups and Downs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have emotional ups and downs. FACIT-Searchable Item Library Adult Version - I Have Emotional Ups and Downs FSIL-Treatment Bone Disease Takes Time Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Treatment for bone disease takes up my time. FACIT-Searchable Item Library Adult Version - Treatment Bone Disease Takes Time FSIL-Bothered by Effects Treatment Bone Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by side effects of treatment for bone disease. FACIT-Searchable Item Library Adult Version - Bothered by Effects Treatment Bone FSIL-Satisfied With Results of Treatment Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Are you satisfied with the results of the treatment for your bone disease so far? FACIT-Searchable Item Library Adult Version - Satisfied With Results of Treatment FSIL-Treatment Bone Disease to Others Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you recommend this treatment for bone disease to others with your illness? FACIT-Searchable Item Library Adult Version - Treatment Bone Disease to Others FSIL-Choose This Treatment Bone Again Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you choose this treatment for bone disease again? FACIT-Searchable Item Library Adult Version - Choose This Treatment Bone Again FSIL-Treatment Takes Up My Family's Time Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My treatment for bone disease takes up my family's time. FACIT-Searchable Item Library Adult Version - Treatment Takes Up My Family's Time FSIL-Worry About Side Effects Treatment Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about side effects from treatment for bone disease. FACIT-Searchable Item Library Adult Version - Worry About Side Effects Treatment FSIL-Taking Drug Infusion Inconvenient Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Taking the drug by infusion is inconvenient. FACIT-Searchable Item Library Adult Version - Taking Drug Infusion Inconvenient FSIL-Infusion Causes Me Physical Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The infusion for my bone treatment causes me physical pain. FACIT-Searchable Item Library Adult Version - Infusion Causes Me Physical Pain FSIL-Treatment Causes Me Physical Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My treatment for bone disease causes me physical pain. FACIT-Searchable Item Library Adult Version - Treatment Causes Me Physical Pain FSIL-Receiving Treatment Is Inconvenient Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Receiving treatment for bone disease is inconvenient. FACIT-Searchable Item Library Adult Version - Receiving Treatment Is Inconvenient FSIL-Waiting Breakfast Is Inconvenient Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Waiting up to 60 minutes before eating breakfast in the morning is inconvenient. FACIT-Searchable Item Library Adult Version - Waiting Breakfast Is Inconvenient FSIL-Having Blood Drawn Is Inconvenient Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Having my blood drawn is inconvenient. FACIT-Searchable Item Library Adult Version - Having Blood Drawn Is Inconvenient FSIL-Worry Treatment Not Effective Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that my treatment for bone disease will not be effective. FACIT-Searchable Item Library Adult Version - Worry Treatment Not Effective FSIL-Treatment Seems Harmful to Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Treatment for bone disease seems harmful to me. FACIT-Searchable Item Library Adult Version - Treatment Seems Harmful to Me FSIL-Treatment Schedule Stressful to Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My treatment schedule for bone disease is stressful to me. FACIT-Searchable Item Library Adult Version - Treatment Schedule Stressful to Me FSIL-Treatment Schedule Stressful Family Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My treatment schedule for bone disease is stressful to my family. FACIT-Searchable Item Library Adult Version - Treatment Schedule Stressful Family FSIL-Believe Treatment Will Take Up Time Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that treatment for bone disease will take up my time. FACIT-Searchable Item Library Adult Version - Believe Treatment Will Take Up Time FSIL-Believe Will Be Bothered by Effects Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that I will be bothered by side effects of treatment for bone disease. FACIT-Searchable Item Library Adult Version - Believe Will Be Bothered by Effects FSIL-Believe Eating Will Be Inconvenient Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that waiting up to 60 minutes before eating breakfast in the morning will be inconvenient. FACIT-Searchable Item Library Adult Version - Believe Eating Will Be Inconvenient FSIL-Believe Infusion Will Cause Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that an infusion for my bone treatment will cause me physical pain. FACIT-Searchable Item Library Adult Version - Believe Infusion Will Cause Pain FSIL-Believe Blood Will Be Inconvenient Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that having my blood drawn will be inconvenient. FACIT-Searchable Item Library Adult Version - Believe Blood Will Be Inconvenient FSIL-Believe Treatment Take Family Time Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that my treatment for bone disease will take up my family's time. FACIT-Searchable Item Library Adult Version - Believe Treatment Take Family Time FSIL-Believe Treatment Will Cause Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that my treatment for bone disease will cause me physical pain. FACIT-Searchable Item Library Adult Version - Believe Treatment Will Cause Pain FSIL-Believe Treatment Inconvenient Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that receiving treatment for bone disease will be inconvenient. FACIT-Searchable Item Library Adult Version - Believe Treatment Inconvenient FSIL-Believe Treatment Will Be Harmful Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that treatment for bone disease will be harmful to me. FACIT-Searchable Item Library Adult Version - Believe Treatment Will Be Harmful FSIL-Believe Schedule Stressful to Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that my treatment schedule for bone disease will be stressful to me. FACIT-Searchable Item Library Adult Version - Believe Schedule Stressful to Me FSIL-Believe Schedule Stressful Family Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that my treatment schedule for bone disease will be stressful to my family. FACIT-Searchable Item Library Adult Version - Believe Schedule Stressful Family FSIL-Swelling/Cramps in Stomach Area Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have swelling or cramps in my stomach area. FACIT-Searchable Item Library Adult Version - Swelling/Cramps in Stomach Area FSIL-Losing Weight Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am losing weight. FACIT-Searchable Item Library Adult Version - Losing Weight FSIL-I Have Control of My Bowels Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have control of my bowels. FACIT-Searchable Item Library Adult Version - I Have Control of My Bowels FSIL-I Can Digest My Food Well Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I can digest my food well. FACIT-Searchable Item Library Adult Version - I Can Digest My Food Well FSIL-I Have Diarrhea Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have diarrhea (diarrhoea). FACIT-Searchable Item Library Adult Version - I Have Diarrhea FSIL-I Have a Good Appetite Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have a good appetite. FACIT-Searchable Item Library Adult Version - I Have a Good Appetite FSIL-I Like the Appearance of My Body Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I like the appearance of my body. FACIT-Searchable Item Library Adult Version - I Like the Appearance of My Body FSIL-Embarrassed by Ostomy Appliance Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am embarrassed by my ostomy appliance. FACIT-Searchable Item Library Adult Version - Embarrassed by Ostomy Appliance FSIL-Caring for Ostomy Is Difficult Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Caring for my ostomy appliance is difficult. FACIT-Searchable Item Library Adult Version - Caring for Ostomy Is Difficult FSIL-Bothered by Hot Flashes Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by hot flashes. FACIT-Searchable Item Library Adult Version - Bothered by Hot Flashes FSIL-My Breasts Are Swollen Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My breasts are swollen. FACIT-Searchable Item Library Adult Version - My Breasts Are Swollen FSIL-My Breasts Are Painful Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My breasts are painful. FACIT-Searchable Item Library Adult Version - My Breasts Are Painful FSIL-Discomfort in My Pelvic Area Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have discomfort in my pelvic area. FACIT-Searchable Item Library Adult Version - Discomfort in My Pelvic Area FSIL-Accepted I Have This Infection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have accepted that I have this infection. FACIT-Searchable Item Library Adult Version - Accepted I Have This Infection FSIL-Worry Infection Will Get Worse Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that the infection will get worse. FACIT-Searchable Item Library Adult Version - Worry Infection Will Get Worse FSIL-Hidden Problem Others Not Notice Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have hidden this problem so others will not notice. FACIT-Searchable Item Library Adult Version - Hidden Problem Others Not Notice FSIL-Concerns Ability Become Pregnant Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have concerns about my ability to become pregnant. FACIT-Searchable Item Library Adult Version - Concerns Ability Become Pregnant FSIL-Worry About Attitudes Towards Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about other people's attitudes towards me. FACIT-Searchable Item Library Adult Version - Worry About Attitudes Towards Me FSIL-Embarrassed About the Infection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel embarrassed about the infection. FACIT-Searchable Item Library Adult Version - Embarrassed About the Infection FSIL-Blame Myself for the Infection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I tend to blame myself for the infection. FACIT-Searchable Item Library Adult Version - Blame Myself for the Infection FSIL-Careful Who I told About Infection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I was careful who I told about the infection. FACIT-Searchable Item Library Adult Version - Careful Who I told About Infection FSIL-Difficulty Telling Partner/Spouse Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had difficulty telling my partner/spouse about the infection. FACIT-Searchable Item Library Adult Version - Difficulty Telling Partner/Spouse FSIL-Frustrated by the Infection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated by the infection. FACIT-Searchable Item Library Adult Version - Frustrated by the Infection FSIL-I Have Pain in My Pelvic Area Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my pelvic area. FACIT-Searchable Item Library Adult Version - I Have Pain in My Pelvic Area FSIL-Depressed About the Infection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am depressed about the infection. FACIT-Searchable Item Library Adult Version - Depressed About the Infection FSIL-Get Emotional Support Partner Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get emotional support from my partner/spouse. FACIT-Searchable Item Library Adult Version - Get Emotional Support Partner FSIL-Emotional Support Family Members Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get emotional support from family members. FACIT-Searchable Item Library Adult Version - Emotional Support Family Members FSIL-I Have Cramping in My Pelvic Area Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have cramping in my pelvic area. FACIT-Searchable Item Library Adult Version - I Have Cramping in My Pelvic Area FSIL-Limit My Sexual Activity Infection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my sexual activity because of the infection. FACIT-Searchable Item Library Adult Version - Limit My Sexual Activity Infection FSIL-Worry About Spreading the Infection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about spreading the infection. FACIT-Searchable Item Library Adult Version - Worry About Spreading the Infection FSIL-Received Treatment That Was Right Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel that I received the treatment that was right for me. FACIT-Searchable Item Library Adult Version - Received Treatment That Was Right FSIL-Doctor Gave Explanations Understand Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My doctor gave me explanations that I could understand. FACIT-Searchable Item Library Adult Version - Doctor Gave Explanations Understand FSIL-Doctor Explained Possible Benefits Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My doctor explained the possible benefits of my treatment. FACIT-Searchable Item Library Adult Version - Doctor Explained Possible Benefits FSIL-Can Manage Things Around Infection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel that I can manage things that come up around this infection. FACIT-Searchable Item Library Adult Version - Can Manage Things Around Infection FSIL-Able to Maintain My Balance Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to maintain my balance. FACIT-Searchable Item Library Adult Version - Able to Maintain My Balance FSIL-Able to Walk Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to walk. FACIT-Searchable Item Library Adult Version - Able to Walk FSIL-I Have Strength in My Arm(s) Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have strength in my arm(s). FACIT-Searchable Item Library Adult Version - I Have Strength in My Arm(s) FSIL-I Have Strength in My Legs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have strength in my legs. FACIT-Searchable Item Library Adult Version - I Have Strength in My Legs FSIL-I Have Numbness in My Legs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have numbness in my legs. FACIT-Searchable Item Library Adult Version - I Have Numbness in My Legs FSIL-I Have Pain in My Back Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my back. FACIT-Searchable Item Library Adult Version - I Have Pain in My Back FSIL-I Have Trouble Forming Thoughts Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble forming thoughts. FACIT-Searchable Item Library Adult Version - I Have Trouble Forming Thoughts FSIL-My Thinking Has Been Slow Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My thinking has been slow. FACIT-Searchable Item Library Adult Version - My Thinking Has Been Slow FSIL-Work Harder Than Usual to Track Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had to work harder than usual to keep track of what I was doing. FACIT-Searchable Item Library Adult Version - Work Harder Than Usual to Track FSIL-My Thinking Slower Than Usual Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My thinking has been slower than usual. FACIT-Searchable Item Library Adult Version - My Thinking Slower Than Usual FSIL-Work Harder Than Usual to Express Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had to work harder than usual to express myself clearly. FACIT-Searchable Item Library Adult Version - Work Harder Than Usual to Express FSIL-Use Written Lists More Often Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had to use written lists more often than usual so I would not forget things. FACIT-Searchable Item Library Adult Version - Use Written Lists More Often FSIL-I Have Had Trouble Concentrating Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble concentrating. FACIT-Searchable Item Library Adult Version - I Have Had Trouble Concentrating FSIL-Walked Into a Room and Forgotten Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have walked into a room and forgotten what I meant to get or do there. FACIT-Searchable Item Library Adult Version - Walked Into a Room and Forgotten FSIL-Work Hard to Pay Attention Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had to work really hard to pay attention or I would make a mistake. FACIT-Searchable Item Library Adult Version - Work Hard to Pay Attention FSIL-Forgotten Names After Introduced Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have forgotten names of people soon after being introduced. FACIT-Searchable Item Library Adult Version - Forgotten Names After Introduced FSIL-Reaction Everyday Situations Slow Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My reactions in everyday situations have been slow. FACIT-Searchable Item Library Adult Version - Reaction Everyday Situations Slow FSIL-Trouble Remember Where Put Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble remembering where I put things, like my keys or my wallet. FACIT-Searchable Item Library Adult Version - Trouble Remember Where Put Things FSIL-Trouble Remembering New Info Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble remembering new information, like phone numbers or simple instructions. FACIT-Searchable Item Library Adult Version - Trouble Remembering New Info FSIL-Trouble Finding Familiar Place Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble finding my way to a familiar place. FACIT-Searchable Item Library Adult Version - Trouble Finding Familiar Place FSIL-Trouble Keeping Track Interrupted Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble keeping track of what I am doing if I am interrupted. FACIT-Searchable Item Library Adult Version - Trouble Keeping Track Interrupted FSIL-Trouble Shifting Back and Forth Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble shifting back and forth between different activities that require thinking. FACIT-Searchable Item Library Adult Version - Trouble Shifting Back and Forth FSIL-Told Me Trouble Remembering Info Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Other people have told me I seemed to have trouble remembering information. FACIT-Searchable Item Library Adult Version - Told Me Trouble Remembering Info FSIL-Told Me Trouble Speaking Clearly Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Other people have told me I seemed to have trouble speaking clearly. FACIT-Searchable Item Library Adult Version - Told Me Trouble Speaking Clearly FSIL-Told Me Trouble Thinking Clearly Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Other people have told me I seemed to have trouble thinking clearly. FACIT-Searchable Item Library Adult Version - Told Me Trouble Thinking Clearly FSIL-People Told Me I Seemed Confused Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Other people have told me I seemed confused. FACIT-Searchable Item Library Adult Version - People Told Me I Seemed Confused FSIL-I Have Been Able to Concentrate Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been able to concentrate. FACIT-Searchable Item Library Adult Version - I Have Been Able to Concentrate FSIL-Mind Is as Sharp as Always Been Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My mind is as sharp as it has always been. FACIT-Searchable Item Library Adult Version - Mind Is as Sharp as Always Been FSIL-Memory Is as Good as Always Been Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My memory is as good as it has always been. FACIT-Searchable Item Library Adult Version - Memory Is as Good as Always Been FSIL-Able to Pay Attention w/o Effort Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to pay attention and keep track of what I am doing without extra effort. FACIT-Searchable Item Library Adult Version - Able to Pay Attention w/o Effort FSIL-Able Remember Things Where Left Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been able to remember things, like where I left my keys or wallet. FACIT-Searchable Item Library Adult Version - Able Remember Things Where Left FSIL-Able Remember to Do Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been able to remember to do things, like take medicine or buy something I needed. FACIT-Searchable Item Library Adult Version - Able Remember to Do Things FSIL-Able to Shift Between Activities Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to shift back and forth between two activities that require thinking. FACIT-Searchable Item Library Adult Version - Able to Shift Between Activities FSIL-Able to Track What I Am Doing Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to keep track of what I am doing, even if I am interrupted. FACIT-Searchable Item Library Adult Version - Able to Track What I Am Doing FSIL-Able to Bring to Mind Words Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been able to bring to mind words that I wanted to use while talking to someone. FACIT-Searchable Item Library Adult Version - Able to Bring to Mind Words FSIL-I Have Been Upset About Problems Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been upset about these problems. FACIT-Searchable Item Library Adult Version - I Have Been Upset About Problems FSIL-Problems Interfered Ability Work Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: These problems have interfered with my ability to work. FACIT-Searchable Item Library Adult Version - Problems Interfered Ability Work FSIL-Problems Interfered Ability Enjoy Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: These problems have interfered with my ability to do things I enjoy. FACIT-Searchable Item Library Adult Version - Problems Interfered Ability Enjoy FSIL-Problems Interfered Quality Life Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: These problems have interfered with the quality of my life. FACIT-Searchable Item Library Adult Version - Problems Interfered Quality Life FSIL-Trouble Recalling Name of Object Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble recalling the name of an object while talking to someone. FACIT-Searchable Item Library Adult Version - Trouble Recalling Name of Object FSIL-Trouble Finding Right Words Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble finding the right word(s) to express myself. FACIT-Searchable Item Library Adult Version - Trouble Finding Right Words FSIL-Used Wrong Word When Refer Object Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have used the wrong word when I referred to an object. FACIT-Searchable Item Library Adult Version - Used Wrong Word When Refer Object FSIL-Trouble Saying What I Mean Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble saying what I mean in conversations with others. FACIT-Searchable Item Library Adult Version - Trouble Saying What I Mean FSIL-Chemo Treatment Takes Up My Time Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Chemotherapy treatment takes up my time. FACIT-Searchable Item Library Adult Version - Chemo Treatment Takes Up My Time FSIL-Satisfied With Results Chemo Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Are you satisfied with the current results of your chemotherapy? FACIT-Searchable Item Library Adult Version - Satisfied With Results Chemo FSIL-Recommend Chemo to Others Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you recommend this chemotherapy to others with your illness? FACIT-Searchable Item Library Adult Version - Recommend Chemo to Others FSIL-Choose This Chemo Again Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you choose this chemotherapy again? FACIT-Searchable Item Library Adult Version - Choose This Chemo Again FSIL-Rate This Chemo Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: How would you rate this chemotherapy? FACIT-Searchable Item Library Adult Version - Rate This Chemo FSIL-Chemo Takes Family Time Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My chemotherapy treatment takes up my family's time. FACIT-Searchable Item Library Adult Version - Chemo Takes Family Time FSIL-Worry Side Effects From Chemo Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about side effects from chemotherapy treatment. FACIT-Searchable Item Library Adult Version - Worry Side Effects From Chemo FSIL-Chemo Causes Physical Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My chemotherapy treatment causes me physical pain. FACIT-Searchable Item Library Adult Version - Chemo Causes Physical Pain FSIL-Receiving Chemo Inconvenient Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Receiving chemotherapy is inconvenient. FACIT-Searchable Item Library Adult Version - Receiving Chemo Inconvenient FSIL-Worry Chemo Not Effective Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that my chemotherapy will not be effective. FACIT-Searchable Item Library Adult Version - Worry Chemo Not Effective FSIL-Chemo Seems Harmful Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Chemotherapy treatment seems harmful to me. FACIT-Searchable Item Library Adult Version - Chemo Seems Harmful FSIL-Chemo Schedule Is Stressful Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My chemotherapy schedule is stressful to me. FACIT-Searchable Item Library Adult Version - Chemo Schedule Is Stressful Me FSIL-Chemo Schedule Is Stressful Family Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My chemotherapy schedule is stressful to my family. FACIT-Searchable Item Library Adult Version - Chemo Schedule Is Stressful Family FSIL-Believe Chemo Take Up My Time Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe chemotherapy treatment will take up my time. FACIT-Searchable Item Library Adult Version - Believe Chemo Take Up My Time FSIL-Believe Chemo Cause Physical Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe my chemotherapy treatment will cause me physical pain. FACIT-Searchable Item Library Adult Version - Believe Chemo Cause Physical Pain FSIL-Believe Chemo Inconvenient Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe receiving chemotherapy will be inconvenient. FACIT-Searchable Item Library Adult Version - Believe Chemo Inconvenient FSIL-Believe Chemo Harmful to Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe chemotherapy treatment will be harmful to me. FACIT-Searchable Item Library Adult Version - Believe Chemo Harmful to Me FSIL-Believe Chemo Schedule Stressful Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe my chemotherapy schedule will be stressful to me. FACIT-Searchable Item Library Adult Version - Believe Chemo Schedule Stressful Me FSIL-Believe Chemo Sched Stress Family Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe my chemotherapy schedule will be stressful to my family. FACIT-Searchable Item Library Adult Version - Believe Chemo Sched Stress Family FSIL-My Skin Itches Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin itches. FACIT-Searchable Item Library Adult Version - My Skin Itches FSIL-Trouble Sleeping B/c Skin Condition Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble sleeping because of my skin condition. FACIT-Searchable Item Library Adult Version - Trouble Sleeping B/c Skin Condition FSIL-Family Bothered by Skin Condition Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My family is bothered by my skin condition. FACIT-Searchable Item Library Adult Version - Family Bothered by Skin Condition FSIL-Difficulty Doing Things B/c of Skin Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty doing things with my hands because of the condition of my skin. FACIT-Searchable Item Library Adult Version - Difficulty Doing Things B/c of Skin FSIL-Difficulty Walking B/c of Skin Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty walking because of my skin condition. FACIT-Searchable Item Library Adult Version - Difficulty Walking B/c of Skin FSIL-Bothered Red/Pink Appearance Skin Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by the red or pink appearance of my skin. FACIT-Searchable Item Library Adult Version - Bothered Red/Pink Appearance Skin FSIL-Bothered by Uncertainty Prognosis Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by uncertainty about my prognosis. FACIT-Searchable Item Library Adult Version - Bothered by Uncertainty Prognosis FSIL-Tired Dealing With Skin Condition Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am tired of dealing with my skin condition. FACIT-Searchable Item Library Adult Version - Tired Dealing With Skin Condition FSIL-Painful Lesions/Tumors on My Skin Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have painful lesions or tumors on my skin. FACIT-Searchable Item Library Adult Version - Painful Lesions/Tumors on My Skin FSIL-Bothered Inconvenience Treat Skin Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by the inconvenience of treatment for my skin condition. FACIT-Searchable Item Library Adult Version - Bothered Inconvenience Treat Skin FSIL-Skin Feels Sensitive or Raw Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin feels sensitive or "raw". FACIT-Searchable Item Library Adult Version - Skin Feels Sensitive or Raw FSIL-Painful Cracks Skin on Hands/Feet Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have painful cracks in the skin on my hands or feet. FACIT-Searchable Item Library Adult Version - Painful Cracks Skin on Hands/Feet FSIL-My Skin Feels Irritated Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin feels irritated. FACIT-Searchable Item Library Adult Version - My Skin Feels Irritated FSIL-Worry Skin condition Get Worse Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that my skin condition may get worse. FACIT-Searchable Item Library Adult Version - Worry Skin condition Get Worse FSIL-Embarrassed by Appearance of Skin Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am embarrassed by the appearance of my skin. FACIT-Searchable Item Library Adult Version - Embarrassed by Appearance of Skin FSIL-Frustrated by My Skin Condition Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated by my skin condition. FACIT-Searchable Item Library Adult Version - Frustrated by My Skin Condition FSIL-Skin Is Dry or Flaky Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin is dry or "flaky". FACIT-Searchable Item Library Adult Version - Skin Is Dry or Flaky FSIL-Bothered Discharge/Bleeding Vagina Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by discharge or bleeding from my vagina. FACIT-Searchable Item Library Adult Version - Bothered Discharge/Bleeding Vagina FSIL-Bothered by Odor From Vagina Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by odor coming from my vagina. FACIT-Searchable Item Library Adult Version - Bothered by Odor From Vagina FSIL-Afraid to Have Sex Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am afraid to have sex. FACIT-Searchable Item Library Adult Version - Afraid to Have Sex FSIL-Vagina Feels Too Narrow/Short Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My vagina feels too narrow or short. FACIT-Searchable Item Library Adult Version - Vagina Feels Too Narrow/Short FSIL-Afraid Treatment May Harm Body Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am afraid the treatment may harm my body. FACIT-Searchable Item Library Adult Version - Afraid Treatment May Harm Body FSIL-Bothered by Constipation Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by constipation. FACIT-Searchable Item Library Adult Version - Bothered by Constipation FSIL-I Have Discomfort When I Urinate Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have discomfort when I urinate. FACIT-Searchable Item Library Adult Version - I Have Discomfort When I Urinate FSIL-Limit Social Activity B/c Diarrhea Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my social activity because of diarrhea (diarrhoea). FACIT-Searchable Item Library Adult Version - Limit Social Activity B/c Diarrhea FSIL-Limit Physical Activ B/c Diarrhea Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my physical activity because of diarrhea (diarrhoea). FACIT-Searchable Item Library Adult Version - Limit Physical Activ B/c Diarrhea FSIL-Limit Sexual Activity B/c Diarrhea Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my sexual activity because of diarrhea (diarrhoea). FACIT-Searchable Item Library Adult Version - Limit Sexual Activity B/c Diarrhea FSIL-Embarrassed by Having Diarrhea Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am embarrassed by having diarrhea (diarrhoea). FACIT-Searchable Item Library Adult Version - Embarrassed by Having Diarrhea FSIL-Abdominal Cramps Diarrhea Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have abdominal cramps or discomfort due to my diarrhea (diarrhoea). FACIT-Searchable Item Library Adult Version - Abdominal Cramps Diarrhea FSIL-Diarrhea Keeps/Wakes Me Up at Night Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My problem with diarrhea (diarrhoea) keeps/wakes me up at night. FACIT-Searchable Item Library Adult Version - Diarrhea Keeps/Wakes Me Up at Night FSIL-Dressing Yourself Without Help Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Dressing yourself without help. FACIT-Searchable Item Library Adult Version - Dressing Yourself Without Help FSIL-Walking 50 Steps Flat Normal Speed Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Walking 50 steps/paces on flat ground at a normal speed without stopping. FACIT-Searchable Item Library Adult Version - Walking 50 Steps Flat Normal Speed FSIL-Walking Up 20 Stairs w/o Stopping Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Walking up 20 stairs (2 flights) without stopping. FACIT-Searchable Item Library Adult Version - Walking Up 20 Stairs w/o Stopping FSIL-Preparing Meals Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Preparing meals. FACIT-Searchable Item Library Adult Version - Preparing Meals FSIL-Washing Dishes Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Washing dishes. FACIT-Searchable Item Library Adult Version - Washing Dishes FSIL-Sweeping/Mopping Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Sweeping or mopping. FACIT-Searchable Item Library Adult Version - Sweeping/Mopping FSIL-Making a Bed Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Making a bed. FACIT-Searchable Item Library Adult Version - Making a Bed FSIL-Lifting 10-20 Lbs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Lifting something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries). FACIT-Searchable Item Library Adult Version - Lifting 10-20 Lbs FSIL-Carrying 10-20 Lbs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Carrying something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries) from one room to another. FACIT-Searchable Item Library Adult Version - Carrying 10-20 Lbs FSIL-Walking for 1/2 Mile w/o Stopping Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping. FACIT-Searchable Item Library Adult Version - Walking for 1/2 Mile w/o Stopping FSIL-Difficulty Swallowing Solid Foods Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty swallowing solid foods. FACIT-Searchable Item Library Adult Version - Difficulty Swallowing Solid Foods FSIL-Difficulty Swallowing Soft Foods Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty swallowing soft or mashed foods. FACIT-Searchable Item Library Adult Version - Difficulty Swallowing Soft Foods FSIL-Difficulty Swallowing Liquids Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty swallowing liquids. FACIT-Searchable Item Library Adult Version - Difficulty Swallowing Liquids FSIL-Pain in My Chest When I Swallow Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my chest when I swallow. FACIT-Searchable Item Library Adult Version - Pain in My Chest When I Swallow FSIL-I Choke When I Swallow Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I choke when I swallow. FACIT-Searchable Item Library Adult Version - I Choke When I Swallow FSIL-Enjoy Meals With Family/Friends Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to enjoy meals with family or friends. FACIT-Searchable Item Library Adult Version - Enjoy Meals With Family/Friends FSIL-Wake at Night Because of Coughing Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I wake at night because of coughing. FACIT-Searchable Item Library Adult Version - Wake at Night Because of Coughing FSIL-Pleasant Feel Fullness Tube Feeding Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I experience a pleasant feeling of fullness during or after my tube feeding. FACIT-Searchable Item Library Adult Version - Pleasant Feel Fullness Tube Feeding FSIL-I Have the Desire to Eat Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have the desire to eat. FACIT-Searchable Item Library Adult Version - I Have the Desire to Eat FSIL-Worry Feeding Tube Health Is Worse Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that having a feeding tube means my health is worse. FACIT-Searchable Item Library Adult Version - Worry Feeding Tube Health Is Worse FSIL-Worry Tube Coming Out by Accident Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about the tube coming out by accident. FACIT-Searchable Item Library Adult Version - Worry Tube Coming Out by Accident FSIL-Worry Tube Getting Plugged/Blocked Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about the tube getting plugged or blocked. FACIT-Searchable Item Library Adult Version - Worry Tube Getting Plugged/Blocked FSIL-Worry Infection From Feeding Tube Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about getting an infection from the feeding tube. FACIT-Searchable Item Library Adult Version - Worry Infection From Feeding Tube FSIL-Worry Losing Weight Feeding Tube Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about losing weight because I have a feeding tube. FACIT-Searchable Item Library Adult Version - Worry Losing Weight Feeding Tube FSIL-Lost Food Choices Feeding Tube Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel that I have lost control of my food choices because I have a feeding tube. FACIT-Searchable Item Library Adult Version - Lost Food Choices Feeding Tube FSIL-Dependent on Others Feeding Tube Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel dependent on others because I have a feeding tube. FACIT-Searchable Item Library Adult Version - Dependent on Others Feeding Tube FSIL-Left Out When Others Are Eating Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel left out when others are eating. FACIT-Searchable Item Library Adult Version - Left Out When Others Are Eating FSIL-Confident Nutrition Feeding Tube Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am more confident about my nutrition because of my feeding tube. FACIT-Searchable Item Library Adult Version - Confident Nutrition Feeding Tube FSIL-Uncomfortably Full Tube Feeding Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel uncomfortably full during or after my tube feeding. FACIT-Searchable Item Library Adult Version - Uncomfortably Full Tube Feeding FSIL-Feeding Tube Was Right Decision Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Getting a feeding tube was the right decision for me. FACIT-Searchable Item Library Adult Version - Feeding Tube Was Right Decision FSIL-Constipation Dur/After Tube Feeding Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have constipation during or after my tube feeding. FACIT-Searchable Item Library Adult Version - Constipation Dur/After Tube Feeding FSIL-Vomiting Dur/After Tube Feeding Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I experience vomiting during or after my tube feeding. FACIT-Searchable Item Library Adult Version - Vomiting Dur/After Tube Feeding FSIL-Tube Feed Limits Do Inside House Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Tube feeding limits what I can do inside the house (for example housework, watching TV or reading). FACIT-Searchable Item Library Adult Version - Tube Feed Limits Do Inside House FSIL-Tube Feeding Limits Do Outside Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Tube feeding limits what I can do outside of the house (for example shopping, driving or yard work). FACIT-Searchable Item Library Adult Version - Tube Feeding Limits Do Outside FSIL-Tube Feeding Limits Activities Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Tube feeding limits my activities with my friends. FACIT-Searchable Item Library Adult Version - Tube Feeding Limits Activities FSIL-Dur Tube Feeding Eat/Drink by Mouth Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: During the use of tube feeding, I can eat and drink by mouth. FACIT-Searchable Item Library Adult Version - Dur Tube Feeding Eat/Drink by Mouth FSIL-Miss Food/Drink Mouth Feeding Tube Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I miss being able to take more food or drink by mouth now that I have a feeding tube. FACIT-Searchable Item Library Adult Version - Miss Food/Drink Mouth Feeding Tube FSIL-Trouble Digesting Food Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble digesting food. FACIT-Searchable Item Library Adult Version - Trouble Digesting Food FSIL-Discomfort/Pain in My Pelvic Area Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have discomfort or pain in my pelvic area. FACIT-Searchable Item Library Adult Version - Discomfort/Pain in My Pelvic Area FSIL-I Have Hot Flashes/Hot Flushes Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have hot flashes/hot flushes. FACIT-Searchable Item Library Adult Version - I Have Hot Flashes/Hot Flushes FSIL-I Have Gained Weight Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have gained weight. FACIT-Searchable Item Library Adult Version - I Have Gained Weight FSIL-Have Breast Sensitivity/Tenderness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have breast sensitivity/tenderness. FACIT-Searchable Item Library Adult Version - Have Breast Sensitivity/Tenderness FSIL-I Have Mood Swings Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have mood swings. FACIT-Searchable Item Library Adult Version - I Have Mood Swings FSIL-Irritable Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am irritable. FACIT-Searchable Item Library Adult Version - Irritable FSIL-I Have Cold Sweats Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have cold sweats. FACIT-Searchable Item Library Adult Version - I Have Cold Sweats FSIL-I Have Night Sweats Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have night sweats. FACIT-Searchable Item Library Adult Version - I Have Night Sweats FSIL-I Have Vaginal Discharge Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have vaginal discharge. FACIT-Searchable Item Library Adult Version - I Have Vaginal Discharge FSIL-I Have Vaginal Itching/Irritation Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have vaginal itching/irritation. FACIT-Searchable Item Library Adult Version - I Have Vaginal Itching/Irritation FSIL-I Have Vaginal Bleeding or Spotting Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have vaginal bleeding or spotting. FACIT-Searchable Item Library Adult Version - I Have Vaginal Bleeding or Spotting FSIL-I Have Vaginal Dryness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have vaginal dryness. FACIT-Searchable Item Library Adult Version - I Have Vaginal Dryness FSIL-Have Pain/Discomfort w/Intercourse Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain or discomfort with intercourse. FACIT-Searchable Item Library Adult Version - Have Pain/Discomfort w/Intercourse FSIL-I Have Lost Interest in Sex Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have lost interest in sex. FACIT-Searchable Item Library Adult Version - I Have Lost Interest in Sex FSIL-Enough Money to Cover Treatment Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I know that I have enough money in savings, retirement, or assets to cover the costs of my treatment. FACIT-Searchable Item Library Adult Version - Enough Money to Cover Treatment FSIL-Reduced Satisfaction Financial Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My cancer or treatment has reduced my satisfaction with my present financial situation. FACIT-Searchable Item Library Adult Version - Reduced Satisfaction Financial FSIL-In control of Financial Situation Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel in control of my financial situation. FACIT-Searchable Item Library Adult Version - In control of Financial Situation FSIL-Illness a Financial Hardship Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My illness has been a financial hardship to my family and me. FACIT-Searchable Item Library Adult Version - Illness a Financial Hardship FSIL-Medical Expense More Than I Thought Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My out-of-pocket medical expenses are more than I thought they would be. FACIT-Searchable Item Library Adult Version - Medical Expense More Than I Thought FSIL-Worry Financial Problems in Future Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about the financial problems I will have in the future as a result of my illness or treatment. FACIT-Searchable Item Library Adult Version - Worry Financial Problems in Future FSIL-No Choice Money Spend on Care Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel I have no choice about the amount of money I spend on care. FACIT-Searchable Item Library Adult Version - No Choice Money Spend on Care FSIL-Frustrated Cannot Work as Usual Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated that I cannot work or contribute as much as I usually do. FACIT-Searchable Item Library Adult Version - Frustrated Cannot Work as Usual FSIL-Satisfied With Financial Situation Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am satisfied with my current financial situation. FACIT-Searchable Item Library Adult Version - Satisfied With Financial Situation FSIL-Able to Meet My Monthly Expenses Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to meet my monthly expenses. FACIT-Searchable Item Library Adult Version - Able to Meet My Monthly Expenses FSIL-Feel Financially Stressed Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel financially stressed. FACIT-Searchable Item Library Adult Version - Feel Financially Stressed FSIL-Concerned Keeping My Job and Income Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am concerned about keeping my job and income, including work at home. FACIT-Searchable Item Library Adult Version - Concerned Keeping My Job and Income FSIL-I Have a Loss of Appetite Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have a loss of appetite. FACIT-Searchable Item Library Adult Version - I Have a Loss of Appetite FSIL-Digestive Problems Interfere Activ Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My digestive problems interfere with my usual activities. FACIT-Searchable Item Library Adult Version - Digestive Problems Interfere Activ FSIL-Have Trouble Swallowing Food Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble swallowing food. FACIT-Searchable Item Library Adult Version - Have Trouble Swallowing Food FSIL-Bothered by Gas Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by gas (flatulence). FACIT-Searchable Item Library Adult Version - Bothered by Gas FSIL-Bothered by Reflux or Heartburn Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by reflux or heartburn. FACIT-Searchable Item Library Adult Version - Bothered by Reflux or Heartburn FSIL-Bothered by Change in Eating Habits Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by a change in my eating habits. FACIT-Searchable Item Library Adult Version - Bothered by Change in Eating Habits FSIL-Fullness/Heaviness in Stomach Area Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have a feeling of fullness or heaviness in my stomach area. FACIT-Searchable Item Library Adult Version - Fullness/Heaviness in Stomach Area FSIL-Discomfort or Pain When I Eat Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have discomfort or pain when I eat. FACIT-Searchable Item Library Adult Version - Discomfort or Pain When I Eat FSIL-Stomach Problems That Worry Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have stomach problems that worry me. FACIT-Searchable Item Library Adult Version - Stomach Problems That Worry Me FSIL-Avoid Going Out to Eat B/c Illness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I avoid going out to eat because of my illness. FACIT-Searchable Item Library Adult Version - Avoid Going Out to Eat B/c Illness FSIL-I Feel Sad Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel sad. FACIT-Searchable Item Library Adult Version - I Feel Sad FSIL-Satisfied With How I Am Coping Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am satisfied with how I am coping with my illness. FACIT-Searchable Item Library Adult Version - Satisfied With How I Am Coping FSIL-Losing Hope Fight Against Illness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am losing hope in the fight against my illness. FACIT-Searchable Item Library Adult Version - Losing Hope Fight Against Illness FSIL-I Feel Nervous Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel nervous. FACIT-Searchable Item Library Adult Version - I Feel Nervous FSIL-I Worry About Dying Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about dying. FACIT-Searchable Item Library Adult Version - I Worry About Dying FSIL-Worry My Condition Will Get Worse Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that my condition will get worse. FACIT-Searchable Item Library Adult Version - Worry My Condition Will Get Worse FSIL-Able to Work Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to work (include work at home). FACIT-Searchable Item Library Adult Version - Able to Work FSIL-My Work Is Fulfilling Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My work (include work at home) is fulfilling. FACIT-Searchable Item Library Adult Version - My Work Is Fulfilling FSIL-Able to Enjoy Life Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to enjoy life. FACIT-Searchable Item Library Adult Version - Able to Enjoy Life FSIL-I Have Accepted My Illness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have accepted my illness. FACIT-Searchable Item Library Adult Version - I Have Accepted My Illness FSIL-Sleeping Well Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am sleeping well. FACIT-Searchable Item Library Adult Version - Sleeping Well FSIL-Enjoy Things I Usually Do for Fun Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am enjoying the things I usually do for fun. FACIT-Searchable Item Library Adult Version - Enjoy Things I Usually Do for Fun FSIL-Content With Quality of My Life Now Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am content with the quality of my life right now. FACIT-Searchable Item Library Adult Version - Content With Quality of My Life Now FSIL-I Have a Lack of Energy Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have a lack of energy. FACIT-Searchable Item Library Adult Version - I Have a Lack of Energy FSIL-I Have Nausea Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have nausea. FACIT-Searchable Item Library Adult Version - I Have Nausea FSIL-Trouble Meeting Needs of Family Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Because of my physical condition, I have trouble meeting the needs of my family. FACIT-Searchable Item Library Adult Version - Trouble Meeting Needs of Family FSIL-I Have Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain. FACIT-Searchable Item Library Adult Version - I Have Pain FSIL-Bothered by Side Effects Treatment Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by side effects of treatment. FACIT-Searchable Item Library Adult Version - Bothered by Side Effects Treatment FSIL-I Feel Ill Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel ill. FACIT-Searchable Item Library Adult Version - I Feel Ill FSIL-Forced to Spend Time in Bed Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am forced to spend time in bed. FACIT-Searchable Item Library Adult Version - Forced to Spend Time in Bed FSIL-Believe Bothered by Side Effects Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe I will be bothered by side effects of treatment. FACIT-Searchable Item Library Adult Version - Believe Bothered by Side Effects FSIL-I Have Confidence in My Doctor(s) Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have confidence in my doctor(s). FACIT-Searchable Item Library Adult Version - I Have Confidence in My Doctor(s) FSIL-Doctor Available Answer Questions Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My doctor is available to answer my questions. FACIT-Searchable Item Library Adult Version - Doctor Available Answer Questions FSIL-I Feel Close to My Friends Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel close to my friends. FACIT-Searchable Item Library Adult Version - I Feel Close to My Friends FSIL-Emotional Support From My Family Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get emotional support from my family. FACIT-Searchable Item Library Adult Version - Emotional Support From My Family FSIL-I Get Support From My Friends Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get support from my friends. FACIT-Searchable Item Library Adult Version - I Get Support From My Friends FSIL-My Family Has Accepted My Illness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My family has accepted my illness. FACIT-Searchable Item Library Adult Version - My Family Has Accepted My Illness FSIL-Satisfied Communication Illness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am satisfied with family communication about my illness. FACIT-Searchable Item Library Adult Version - Satisfied Communication Illness FSIL-I Feel Close to My Partner Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel close to my partner (or the person who is my main support). FACIT-Searchable Item Library Adult Version - I Feel Close to My Partner FSIL-Satisfied With My Sex Life Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am satisfied with my sex life. FACIT-Searchable Item Library Adult Version - Satisfied With My Sex Life FSIL-I Feel Close to My Family Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel close to my family. FACIT-Searchable Item Library Adult Version - I Feel Close to My Family FSIL-Family Is Well Despite My Illness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My family is doing well despite my illness. FACIT-Searchable Item Library Adult Version - Family Is Well Despite My Illness FSIL-Illness Caused Problems w/ Sex Life Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My illness or treatment has caused problems with my sex life. FACIT-Searchable Item Library Adult Version - Illness Caused Problems w/ Sex Life FSIL-Unhappy About Change in My Appear Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am unhappy about a change in my appearance. FACIT-Searchable Item Library Adult Version - Unhappy About Change in My Appear FSIL-Bothered by Jaundice/Yellow Skin Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by jaundice or yellow color to my skin. FACIT-Searchable Item Library Adult Version - Bothered by Jaundice/Yellow Skin FSIL-I Have Had Fevers Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had fevers (episodes of high body temperature). FACIT-Searchable Item Library Adult Version - I Have Had Fevers FSIL-I Have Had Itching Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had itching. FACIT-Searchable Item Library Adult Version - I Have Had Itching FSIL-Had Change in the Way Food Tastes Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had a change in the way food tastes. FACIT-Searchable Item Library Adult Version - Had Change in the Way Food Tastes FSIL-I Have Had Chills Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had chills. FACIT-Searchable Item Library Adult Version - I Have Had Chills FSIL-Discomfort/Pain in Stomach Area Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have discomfort or pain in my stomach area. FACIT-Searchable Item Library Adult Version - Discomfort/Pain in Stomach Area FSIL-Unhappy With My Appearance Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am unhappy with my appearance. FACIT-Searchable Item Library Adult Version - Unhappy With My Appearance FSIL-Embarrassed by My Illness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am embarrassed by my illness. FACIT-Searchable Item Library Adult Version - Embarrassed by My Illness FSIL-Hopeful About the Future Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am hopeful about the future. FACIT-Searchable Item Library Adult Version - Hopeful About the Future FSIL-I Feel Weak All Over Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel weak all over. FACIT-Searchable Item Library Adult Version - I Feel Weak All Over FSIL-Hard to Tell People About Infection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: It is hard to tell other people about my infection. FACIT-Searchable Item Library Adult Version - Hard to Tell People About Infection FSIL-Have People to Help Me if I Need It Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have people to help me if I need it. FACIT-Searchable Item Library Adult Version - Have People to Help Me if I Need It FSIL-Worry About Spreading My Infection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about spreading my infection. FACIT-Searchable Item Library Adult Version - Worry About Spreading My Infection FSIL-Concerned What the Future Holds Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am concerned about what the future holds for me. FACIT-Searchable Item Library Adult Version - Concerned What the Future Holds FSIL-I Feel Motivated to Do Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel motivated to do things. FACIT-Searchable Item Library Adult Version - I Feel Motivated to Do Things FSIL-I Feel Fatigued Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel fatigued. FACIT-Searchable Item Library Adult Version - I Feel Fatigued FSIL-I Have Trouble Concentrating Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble concentrating. FACIT-Searchable Item Library Adult Version - I Have Trouble Concentrating FSIL-I Have Trouble Remembering Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble remembering things. FACIT-Searchable Item Library Adult Version - I Have Trouble Remembering Things FSIL-Able to Eat the Foods That I Like Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to eat the foods that I like. FACIT-Searchable Item Library Adult Version - Able to Eat the Foods That I Like FSIL-Able to Communicate With Others Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to communicate with others. FACIT-Searchable Item Library Adult Version - Able to Communicate With Others FSIL-I Can Eat Solid Foods Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I can eat solid foods. FACIT-Searchable Item Library Adult Version - I Can Eat Solid Foods FSIL-Pain in My Mouth, Throat or Neck Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my mouth, throat or neck. FACIT-Searchable Item Library Adult Version - Pain in My Mouth, Throat or Neck FSIL-My Mouth Is Dry Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My mouth is dry. FACIT-Searchable Item Library Adult Version - My Mouth Is Dry FSIL-I Have Trouble Breathing Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble breathing. FACIT-Searchable Item Library Adult Version - I Have Trouble Breathing FSIL-Voice Has Usual Quality & Strength Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My voice has its usual quality and strength. FACIT-Searchable Item Library Adult Version - Voice Has Usual Quality & Strength FSIL-Able to Eat as Much Food as I Want Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to eat as much food as I want. FACIT-Searchable Item Library Adult Version - Able to Eat as Much Food as I Want FSIL-Unhappy With How Face & Neck Look Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am unhappy with how my face and neck look. FACIT-Searchable Item Library Adult Version - Unhappy With How Face & Neck Look FSIL-Can Swallow Naturally and Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I can swallow naturally and easily. FACIT-Searchable Item Library Adult Version - Can Swallow Naturally and Easily FSIL-Smoke Cigarettes/Other Tobacco Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I smoke cigarettes or other tobacco products. FACIT-Searchable Item Library Adult Version - Smoke Cigarettes/Other Tobacco FSIL-I Drink Alcohol Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I drink alcohol (e.g. beer, wine, etc.). FACIT-Searchable Item Library Adult Version - I Drink Alcohol FSIL-I Have Been Bothered by Diarrhea Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been bothered by diarrhea (diarrhoea). FACIT-Searchable Item Library Adult Version - I Have Been Bothered by Diarrhea FSIL-Bothered by Blistering of My Skin Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by blistering of my skin. FACIT-Searchable Item Library Adult Version - Bothered by Blistering of My Skin FSIL-I Have Been Wheezing Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been wheezing (whistling sound when I breathe). FACIT-Searchable Item Library Adult Version - I Have Been Wheezing FSIL-Stiffness/Tightness in My Joints Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have stiffness or tightness in my joints. FACIT-Searchable Item Library Adult Version - Stiffness/Tightness in My Joints FSIL-Joint Stiffness/Tight Limits Activ Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Joint stiffness or tightness limits my usual activities. FACIT-Searchable Item Library Adult Version - Joint Stiffness/Tight Limits Activ FSIL-Joint Pain Limits My Usual Activ Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Joint pain limits my usual activities. FACIT-Searchable Item Library Adult Version - Joint Pain Limits My Usual Activ FSIL-I Have Episodes of Heart Racing Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have episodes of heart racing. FACIT-Searchable Item Library Adult Version - I Have Episodes of Heart Racing FSIL-My Eyes Feel Sandy or Gritty Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My eyes feel sandy or gritty. FACIT-Searchable Item Library Adult Version - My Eyes Feel Sandy or Gritty FSIL-I Have Pain in My Sinus Area Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my sinus area. FACIT-Searchable Item Library Adult Version - I Have Pain in My Sinus Area FSIL-Bothered by Dry Skin Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by dry skin. FACIT-Searchable Item Library Adult Version - Bothered by Dry Skin FSIL-Bothered by Vitiligo Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by vitiligo (white patches appearing on my skin). FACIT-Searchable Item Library Adult Version - Bothered by Vitiligo FSIL-Pain/Soreness/Aches in Some Muscles Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel pain, soreness or aches in some of my muscles. FACIT-Searchable Item Library Adult Version - Pain/Soreness/Aches in Some Muscles FSIL-Worry Neg Impacts Long-term Health Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about negative impacts that my treatment may have upon my long-term health. FACIT-Searchable Item Library Adult Version - Worry Neg Impacts Long-term Health FSIL-Bothered by Short-term Reactions Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by short-term treatment reactions that I experience immediately after, or within 24 hours of, an infusion (such as chills, dizziness, hives, rashes lasting no more than 24 hours). FACIT-Searchable Item Library Adult Version - Bothered by Short-term Reactions FSIL-Troubled Not Knowing Side Effects Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am troubled by not knowing when exactly my side effects will happen, how long they will last and how bad they will be. FACIT-Searchable Item Library Adult Version - Troubled Not Knowing Side Effects FSIL-Bothered New Allergy-like Reactions Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by new allergy-like reactions (e.g., to foods, insects, pollen). FACIT-Searchable Item Library Adult Version - Bothered New Allergy-like Reactions FSIL-Bothered by Cracking/Peeling Skin Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by cracking or peeling of my skin. FACIT-Searchable Item Library Adult Version - Bothered by Cracking/Peeling Skin FSIL-Move My Bowels More Than Usual Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I move my bowels more frequently than usual. FACIT-Searchable Item Library Adult Version - Move My Bowels More Than Usual FSIL-Condition Wakes/Keeps Me Up Night Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My condition wakes or keeps me up at night. FACIT-Searchable Item Library Adult Version - Condition Wakes/Keeps Me Up Night FSIL-Move Bowels Freq to Avoid Accidents Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I must move my bowels frequently to avoid accidents. FACIT-Searchable Item Library Adult Version - Move Bowels Freq to Avoid Accidents FSIL-Far From Home/Work W/o Fear Soilage Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I can be far from home/work without fearing soilage. FACIT-Searchable Item Library Adult Version - Far From Home/Work W/o Fear Soilage FSIL-Wear Pads/Protect Prevent Soiling Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I wear pads or protection to prevent soiling my underwear. FACIT-Searchable Item Library Adult Version - Wear Pads/Protect Prevent Soiling FSIL-Comfortable Discuss Cond w/Friends Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am comfortable discussing my condition with friends. FACIT-Searchable Item Library Adult Version - Comfortable Discuss Cond w/Friends FSIL-Afraid to Be Far From a Toilet Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am afraid to be far from a toilet. FACIT-Searchable Item Library Adult Version - Afraid to Be Far From a Toilet FSIL-Limit My Social Activity Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my social activity because of my condition. FACIT-Searchable Item Library Adult Version - Limit My Social Activity FSIL-Limit Physical Activ B/c Condition Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my physical activity because of my condition. FACIT-Searchable Item Library Adult Version - Limit Physical Activ B/c Condition FSIL-Limit Sexual Activ B/c Condition Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my sexual activity because of my condition. FACIT-Searchable Item Library Adult Version - Limit Sexual Activ B/c Condition FSIL-Embarrassed by My Condition Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am embarrassed by my condition. FACIT-Searchable Item Library Adult Version - Embarrassed by My Condition FSIL-My Condition Wakes Me Up at Night Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My condition wakes me up at night. FACIT-Searchable Item Library Adult Version - My Condition Wakes Me Up at Night FSIL-Urinate Frequently to Avoid Leaking Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I must urinate frequently to avoid leaking. FACIT-Searchable Item Library Adult Version - Urinate Frequently to Avoid Leaking FSIL-Wear Protection Leakage of Urine Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I wear protection for leakage of urine. FACIT-Searchable Item Library Adult Version - Wear Protection Leakage of Urine FSIL-My Thinking Is Clear Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My thinking is clear. FACIT-Searchable Item Library Adult Version - My Thinking Is Clear FSIL-I Have Been Coughing Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been coughing. FACIT-Searchable Item Library Adult Version - I Have Been Coughing FSIL-I Feel Tightness in My Chest Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel tightness in my chest. FACIT-Searchable Item Library Adult Version - I Feel Tightness in My Chest FSIL-Breathing Is Easy for Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Breathing is easy for me. FACIT-Searchable Item Library Adult Version - Breathing Is Easy for Me FSIL-I Regret My Smoking Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I regret my smoking. FACIT-Searchable Item Library Adult Version - I Regret My Smoking FSIL-Bothered by Lumps or Swelling Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by lumps or swelling in certain parts of my body (e.g., neck, armpits, or groin). FACIT-Searchable Item Library Adult Version - Bothered by Lumps or Swelling FSIL-Frustrated Unable Do Things I Want Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated by being unable to do the things I want to do. FACIT-Searchable Item Library Adult Version - Frustrated Unable Do Things I Want FSIL-I Feel Discouraged About My Illness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel discouraged about my illness. FACIT-Searchable Item Library Adult Version - I Feel Discouraged About My Illness FSIL-Difficulty Planning for Future Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Because of my illness, I have difficulty planning for the future. FACIT-Searchable Item Library Adult Version - Difficulty Planning for Future FSIL-Uncertain About My Future Health Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel uncertain about my future health. FACIT-Searchable Item Library Adult Version - Uncertain About My Future Health FSIL-Worry I Might Get New Symptoms Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that I might get new symptoms of my illness. FACIT-Searchable Item Library Adult Version - Worry I Might Get New Symptoms FSIL-Feel Isolated Because of Illness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel isolated from others because of my illness or treatment. FACIT-Searchable Item Library Adult Version - Feel Isolated Because of Illness FSIL-Worry Support Myself/Family Illness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about being able to support myself or my family due to my illness. FACIT-Searchable Item Library Adult Version - Worry Support Myself/Family Illness FSIL-Bothered by Itching Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by itching. FACIT-Searchable Item Library Adult Version - Bothered by Itching FSIL-I Have Trouble Sleeping at Night Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble sleeping at night. FACIT-Searchable Item Library Adult Version - I Have Trouble Sleeping at Night FSIL-Nervous Making Decisions Treatment Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get nervous about making decisions regarding treatment. FACIT-Searchable Item Library Adult Version - Nervous Making Decisions Treatment FSIL-Pain at My Melanoma/Surgical Site Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain at my melanoma site or surgical site. FACIT-Searchable Item Library Adult Version - Pain at My Melanoma/Surgical Site FSIL-I Have Swelling at My Melanoma Site Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have swelling at my melanoma site. FACIT-Searchable Item Library Adult Version - I Have Swelling at My Melanoma Site FSIL-Swelling as a Result of Surgery Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have swelling as a result of surgery. FACIT-Searchable Item Library Adult Version - Swelling as a Result of Surgery FSIL-Bothered by the Amount of Swelling Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by the amount of swelling. FACIT-Searchable Item Library Adult Version - Bothered by the Amount of Swelling FSIL-Movement of Swollen Area Is Painful Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Movement of my swollen area is painful. FACIT-Searchable Item Library Adult Version - Movement of Swollen Area Is Painful FSIL-Swelling Keeps Me From Doing Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Swelling keeps me from doing the things I want to do. FACIT-Searchable Item Library Adult Version - Swelling Keeps Me From Doing Things FSIL-Swelling Keeps Me From Wearing Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Swelling keeps me from wearing clothes or shoes I want to wear. FACIT-Searchable Item Library Adult Version - Swelling Keeps Me From Wearing FSIL-I Feel Numbness at My Surgical Site Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel numbness at my surgical site. FACIT-Searchable Item Library Adult Version - I Feel Numbness at My Surgical Site FSIL-Good Range of Movement in Arm/Leg Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have good range of movement in my arm or leg. FACIT-Searchable Item Library Adult Version - Good Range of Movement in Arm/Leg FSIL-Noticed New Changes in My Skin Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have noticed new changes in my skin (lumps, bumps, color (colour)). FACIT-Searchable Item Library Adult Version - Noticed New Changes in My Skin FSIL-Worry Appearance of Surgical Scars Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about the appearance of surgical scars. FACIT-Searchable Item Library Adult Version - Worry Appearance of Surgical Scars FSIL-I Have Aches and Pains in My Bones Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have aches and pains in my bones. FACIT-Searchable Item Library Adult Version - I Have Aches and Pains in My Bones FSIL-I Have Noticed Blood in My Stool Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have noticed blood in my stool. FACIT-Searchable Item Library Adult Version - I Have Noticed Blood in My Stool FSIL-Isolate From Others B/c Condition Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I isolate myself from others because of my condition. FACIT-Searchable Item Library Adult Version - Isolate From Others B/c Condition FSIL-I Have Difficulty Thinking Clearly Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty thinking clearly (remembering, concentrating). FACIT-Searchable Item Library Adult Version - I Have Difficulty Thinking Clearly FSIL-Trouble Walking Because of Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble walking because of pain. FACIT-Searchable Item Library Adult Version - Trouble Walking Because of Pain FSIL-Trouble Getting Around in Public Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble getting around in public places. FACIT-Searchable Item Library Adult Version - Trouble Getting Around in Public FSIL-I Need to Rest During the Day Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I need to rest during the day. FACIT-Searchable Item Library Adult Version - I Need to Rest During the Day FSIL-My Thinking Is Slower Than Before Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My thinking is slower than before. FACIT-Searchable Item Library Adult Version - My Thinking Is Slower Than Before FSIL-I Have Trouble Learning New Tasks Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble learning new tasks or directions. FACIT-Searchable Item Library Adult Version - I Have Trouble Learning New Tasks FSIL-Family Trouble Understand Worse Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My family has trouble understanding when my condition gets worse. FACIT-Searchable Item Library Adult Version - Family Trouble Understand Worse FSIL-I Feel Left Out of Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel "left out" of things. FACIT-Searchable Item Library Adult Version - I Feel Left Out of Things FSIL-Heat Worsens My Symptoms Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Heat worsens my symptoms. FACIT-Searchable Item Library Adult Version - Heat Worsens My Symptoms FSIL-Bothered by Muscle Spasms Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by muscle spasms. FACIT-Searchable Item Library Adult Version - Bothered by Muscle Spasms FSIL-Take My Condition Into Account Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to take my condition into account when making plans. FACIT-Searchable Item Library Adult Version - Take My Condition Into Account FSIL-Bothered by Headaches Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by headaches. FACIT-Searchable Item Library Adult Version - Bothered by Headaches FSIL-Bothered by Muscle Pains Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by muscle pains. FACIT-Searchable Item Library Adult Version - Bothered by Muscle Pains FSIL-I Feel Trapped by My Condition Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel trapped by my condition. FACIT-Searchable Item Library Adult Version - I Feel Trapped by My Condition FSIL-Depressed About My Condition Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am depressed about my condition. FACIT-Searchable Item Library Adult Version - Depressed About My Condition FSIL-I Feel Useless Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel useless. FACIT-Searchable Item Library Adult Version - I Feel Useless FSIL-Feel Overwhelmed by My Condition Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel overwhelmed by my condition. FACIT-Searchable Item Library Adult Version - Feel Overwhelmed by My Condition FSIL-Frustrated by My Condition Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated by my condition. FACIT-Searchable Item Library Adult Version - Frustrated by My Condition FSIL-Worry Getting Sick Low Blood Counts Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about getting sick due to low blood counts. FACIT-Searchable Item Library Adult Version - Worry Getting Sick Low Blood Counts FSIL-Avoid Public Places Fear Infection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I avoid public places for fear of getting an infection. FACIT-Searchable Item Library Adult Version - Avoid Public Places Fear Infection FSIL-I Worry About Getting Infections Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about getting infections. FACIT-Searchable Item Library Adult Version - I Worry About Getting Infections FSIL-Worry Not improve Treatment Delayed Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry my condition will not improve if my treatment is delayed. FACIT-Searchable Item Library Adult Version - Worry Not improve Treatment Delayed FSIL-I Have Mouth Sores Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have mouth sores. FACIT-Searchable Item Library Adult Version - I Have Mouth Sores FSIL-Partner Worries My Blood Counts Low Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My partner worries about me when my blood counts are low. FACIT-Searchable Item Library Adult Version - Partner Worries My Blood Counts Low FSIL-Low Blood Counts Interfere Relation Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My low blood counts interfere with my intimate relationships. FACIT-Searchable Item Library Adult Version - Low Blood Counts Interfere Relation FSIL-I Have Weakness in My Legs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have weakness in my legs. FACIT-Searchable Item Library Adult Version - I Have Weakness in My Legs FSIL-Diff Moving Neck & Shoulders Stiff Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty moving my neck and shoulders because of stiffness. FACIT-Searchable Item Library Adult Version - Diff Moving Neck & Shoulders Stiff FSIL-Bothered by Ringing in My Ear Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by ringing in my ear(s). FACIT-Searchable Item Library Adult Version - Bothered by Ringing in My Ear FSIL-Bothered by Worsening Eyesight Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by worsening eyesight. FACIT-Searchable Item Library Adult Version - Bothered by Worsening Eyesight FSIL-I Have Trouble Smelling Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble smelling. FACIT-Searchable Item Library Adult Version - I Have Trouble Smelling FSIL-I Can Enjoy the Taste of Food Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I can enjoy the taste of food. FACIT-Searchable Item Library Adult Version - I Can Enjoy the Taste of Food FSIL-Bothered by Having a Blocked Nose Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by having a blocked nose. FACIT-Searchable Item Library Adult Version - Bothered by Having a Blocked Nose FSIL-Numbness or Tingling in My Hands Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have numbness or tingling in my hands. FACIT-Searchable Item Library Adult Version - Numbness or Tingling in My Hands FSIL-Pain in Hands/Feet Exposed to Cold Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my hands or feet when I am exposed to cold temperatures. FACIT-Searchable Item Library Adult Version - Pain in Hands/Feet Exposed to Cold FSIL-Difficulty Breathing Exposed Cold Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty breathing when I am exposed to cold temperatures. FACIT-Searchable Item Library Adult Version - Difficulty Breathing Exposed Cold FSIL-Numbness or Tingling in My Feet Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have numbness or tingling in my feet. FACIT-Searchable Item Library Adult Version - Numbness or Tingling in My Feet FSIL-I Feel Discomfort in My Hands Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel discomfort in my hands. FACIT-Searchable Item Library Adult Version - I Feel Discomfort in My Hands FSIL-I Feel Discomfort in My Feet Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel discomfort in my feet. FACIT-Searchable Item Library Adult Version - I Feel Discomfort in My Feet FSIL-Have Joint Pain or Muscle Cramps Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have joint pain or muscle cramps. FACIT-Searchable Item Library Adult Version - Have Joint Pain or Muscle Cramps FSIL-I Have Trouble Hearing Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble hearing. FACIT-Searchable Item Library Adult Version - I Have Trouble Hearing FSIL-Get Ringing or Buzzing in My Ears Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get a ringing or buzzing in my ears. FACIT-Searchable Item Library Adult Version - Get Ringing or Buzzing in My Ears FSIL-I Have Trouble Buttoning Buttons Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble buttoning buttons. FACIT-Searchable Item Library Adult Version - I Have Trouble Buttoning Buttons FSIL-Trouble Feeling Shape of Objects Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble feeling the shape of small objects when they are in my hand. FACIT-Searchable Item Library Adult Version - Trouble Feeling Shape of Objects FSIL-I Have Swelling in Stomach Area Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have swelling in my stomach area. FACIT-Searchable Item Library Adult Version - I Have Swelling in Stomach Area FSIL-I Have Been Vomiting Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been vomiting. FACIT-Searchable Item Library Adult Version - I Have Been Vomiting FSIL-I Have Cramps in My Stomach Area Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have cramps in my stomach area. FACIT-Searchable Item Library Adult Version - I Have Cramps in My Stomach Area FSIL-I Have Aches/Pains That Bother Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have aches and pains that bother me. FACIT-Searchable Item Library Adult Version - I Have Aches/Pains That Bother Me FSIL-Certain Parts of Body Have Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have certain parts of my body where I experience pain. FACIT-Searchable Item Library Adult Version - Certain Parts of Body Have Pain FSIL-Pain Keeps Me From Doing Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My pain keeps me from doing things I want to do. FACIT-Searchable Item Library Adult Version - Pain Keeps Me From Doing Things FSIL-Satisfied With Comfort Level Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am satisfied with my present comfort level. FACIT-Searchable Item Library Adult Version - Satisfied With Comfort Level FSIL-Able to Feel Like a Man Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to feel like a man. FACIT-Searchable Item Library Adult Version - Able to Feel Like a Man FSIL-I Have Trouble Moving My Bowels Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble moving my bowels. FACIT-Searchable Item Library Adult Version - I Have Trouble Moving My Bowels FSIL-I Have Difficulty Urinating Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty urinating. FACIT-Searchable Item Library Adult Version - I Have Difficulty Urinating FSIL-Problem Urinating Limits Activity Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My problems with urinating limit my activities. FACIT-Searchable Item Library Adult Version - Problem Urinating Limits Activity FSIL-I Maintain Contact With My Friends Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I maintain contact with my friends. FACIT-Searchable Item Library Adult Version - I Maintain Contact With My Friends FSIL-I Have Peace of Mind Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have peace of mind. FACIT-Searchable Item Library Adult Version - I Have Peace of Mind FSIL-Able to Make Decisions Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to make decisions. FACIT-Searchable Item Library Adult Version - Able to Make Decisions FSIL-Able to Reconcile With Other People Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been able to reconcile (make peace) with other people. FACIT-Searchable Item Library Adult Version - Able to Reconcile With Other People FSIL-Discuss Concerns w/ People Closest Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to openly discuss my concerns with the people closest to me. FACIT-Searchable Item Library Adult Version - Discuss Concerns w/ People Closest FSIL-Family Who Take My Responsibilities Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have family members who will take on my responsibilities. FACIT-Searchable Item Library Adult Version - Family Who Take My Responsibilities FSIL-Feel That My Family Appreciates Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel that my family appreciates me. FACIT-Searchable Item Library Adult Version - Feel That My Family Appreciates Me FSIL-I Feel Like a Burden to My Family Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel like a burden to my family. FACIT-Searchable Item Library Adult Version - I Feel Like a Burden to My Family FSIL-Constipated Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am constipated. FACIT-Searchable Item Library Adult Version - Constipated FSIL-Have Swelling in Parts of My Body Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have swelling in parts of my body. FACIT-Searchable Item Library Adult Version - Have Swelling in Parts of My Body FSIL-My Mouth and Throat Are Dry Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My mouth and throat are dry. FACIT-Searchable Item Library Adult Version - My Mouth and Throat Are Dry FSIL-I Feel Useful Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel useful. FACIT-Searchable Item Library Adult Version - I Feel Useful FSIL-I Make Each Day Count Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I make each day count. FACIT-Searchable Item Library Adult Version - I Make Each Day Count FSIL-Told Family Members About Infection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have told family members about my infection. FACIT-Searchable Item Library Adult Version - Told Family Members About Infection FSIL-Do You Have an Ostomy Appliance Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Do you have an ostomy appliance? FACIT-Searchable Item Library Adult Version - Do You Have an Ostomy Appliance FSIL-Have You Ever Smoked Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Have you ever smoked? FACIT-Searchable Item Library Adult Version - Have You Ever Smoked FSIL-Which Side Was Breast Operation Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: On which side was your breast operation? FACIT-Searchable Item Library Adult Version - Which Side Was Breast Operation FSIL-How Many Places in Body Felt Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: In how many places in your body have you felt bone pain? FACIT-Searchable Item Library Adult Version - How Many Places in Body Felt Pain FSIL-Told Partner/Spouse About Infection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have told my partner/spouse about my infection. FACIT-Searchable Item Library Adult Version - Told Partner/Spouse About Infection FSIL-I Have Had Blood in My Urine Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had blood in my urine. FACIT-Searchable Item Library Adult Version - I Have Had Blood in My Urine FSIL-Inconvenient to Come for Radiation Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: It is inconvenient for me to come for my radiation treatments. FACIT-Searchable Item Library Adult Version - Inconvenient to Come for Radiation FSIL-I Have Difficultly Raising My Arm Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficultly raising my arm. FACIT-Searchable Item Library Adult Version - I Have Difficultly Raising My Arm FSIL-Difficulty Moving My Arm Sideways Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty moving my arm sideways. FACIT-Searchable Item Library Adult Version - Difficulty Moving My Arm Sideways FSIL-Numbness/Tingling in Arm/Shoulder Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have numbness or tingling in my arm, shoulder, or breast. FACIT-Searchable Item Library Adult Version - Numbness/Tingling in Arm/Shoulder FSIL-I Have Difficulty Breathing Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty breathing. FACIT-Searchable Item Library Adult Version - I Have Difficulty Breathing FSIL-Bothered by Appearance Skin Breast Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by the appearance of the skin in my breast area. FACIT-Searchable Item Library Adult Version - Bothered by Appearance Skin Breast FSIL-I Have Pain in My Breast Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my breast. FACIT-Searchable Item Library Adult Version - I Have Pain in My Breast FSIL-I Have Pain in Arm and/or Shoulder Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my arm and/or shoulder. FACIT-Searchable Item Library Adult Version - I Have Pain in Arm and/or Shoulder FSIL-My Chest Area Is Sore Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My chest area (not including the breast itself) is sore. FACIT-Searchable Item Library Adult Version - My Chest Area Is Sore FSIL-Bothered by Swelling in My Breast Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by swelling in my breast. FACIT-Searchable Item Library Adult Version - Bothered by Swelling in My Breast FSIL-My Breast Is Sensitive/Tender Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My breast is sensitive/tender. FACIT-Searchable Item Library Adult Version - My Breast Is Sensitive/Tender FSIL-My Underarm Area Sensitive/Tender Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My underarm area is sensitive/tender. FACIT-Searchable Item Library Adult Version - My Underarm Area Sensitive/Tender FSIL-Skin in Breast Area Itchy/Flaky/Dry Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The skin in my breast area is itchy, flaky or dry. FACIT-Searchable Item Library Adult Version - Skin in Breast Area Itchy/Flaky/Dry FSIL-Bothered by Skin Problems Underarm Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by skin problems in my underarm area. FACIT-Searchable Item Library Adult Version - Bothered by Skin Problems Underarm FSIL-I Feel Peaceful Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel peaceful. FACIT-Searchable Item Library Adult Version - I Feel Peaceful FSIL-Strength in Faith/Spiritual Beliefs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I find strength in my faith or spiritual beliefs. FACIT-Searchable Item Library Adult Version - Strength in Faith/Spiritual Beliefs FSIL-Illness Strengthen Faith/Spiritual Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My illness has strengthened my faith or spiritual beliefs. FACIT-Searchable Item Library Adult Version - Illness Strengthen Faith/Spiritual FSIL-Whatever Happens Illness Will Be OK Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I know that whatever happens with my illness, things will be okay. FACIT-Searchable Item Library Adult Version - Whatever Happens Illness Will Be OK FSIL-I Feel Connected to Higher Power Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel connected to a higher power (or God). FACIT-Searchable Item Library Adult Version - I Feel Connected to Higher Power FSIL-I Feel Connected to Other People Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel connected to other people. FACIT-Searchable Item Library Adult Version - I Feel Connected to Other People FSIL-I Feel Loved Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel loved. FACIT-Searchable Item Library Adult Version - I Feel Loved FSIL-I Feel Love for Others Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel love for others. FACIT-Searchable Item Library Adult Version - I Feel Love for Others FSIL-Forgive Others for Harm Caused Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to forgive others for any harm they have ever caused me. FACIT-Searchable Item Library Adult Version - Forgive Others for Harm Caused Me FSIL-Feel Forgiven for Harm I Caused Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel forgiven for any harm I may have ever caused. FACIT-Searchable Item Library Adult Version - Feel Forgiven for Harm I Caused FSIL-Feel Sense of Thankfulness for Life Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Throughout the course of my day, I feel a sense of thankfulness for my life. FACIT-Searchable Item Library Adult Version - Feel Sense of Thankfulness for Life FSIL-I Have a Reason for Living Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have a reason for living. FACIT-Searchable Item Library Adult Version - I Have a Reason for Living FSIL-Thankfulness Others Bring to Life Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Throughout the course of my day, I feel a sense of thankfulness for what others bring to my life. FACIT-Searchable Item Library Adult Version - Thankfulness Others Bring to Life FSIL-I Feel Hopeful Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel hopeful. FACIT-Searchable Item Library Adult Version - I Feel Hopeful FSIL-Appreciation for Beauty of Nature Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel a sense of appreciation for the beauty of nature. FACIT-Searchable Item Library Adult Version - Appreciation for Beauty of Nature FSIL-Compassion for Others Difficulties Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel compassion for others in the difficulties they are facing. FACIT-Searchable Item Library Adult Version - Compassion for Others Difficulties FSIL-My Life Has Been Productive Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My life has been productive. FACIT-Searchable Item Library Adult Version - My Life Has Been Productive FSIL-Have Trouble Feeling Peace of Mind Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble feeling peace of mind. FACIT-Searchable Item Library Adult Version - Have Trouble Feeling Peace of Mind FSIL-Feel Sense of Purpose in My Life Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel a sense of purpose in my life. FACIT-Searchable Item Library Adult Version - Feel Sense of Purpose in My Life FSIL-Reach Into Myself for Comfort Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to reach down deep into myself for comfort. FACIT-Searchable Item Library Adult Version - Reach Into Myself for Comfort FSIL-Feel Sense of Harmony Within Myself Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel a sense of harmony within myself. FACIT-Searchable Item Library Adult Version - Feel Sense of Harmony Within Myself FSIL-My Life Lacks Meaning and Purpose Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My life lacks meaning and purpose. FACIT-Searchable Item Library Adult Version - My Life Lacks Meaning and Purpose FSIL-Comfort in Faith/Spiritual Beliefs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I find comfort in my faith or spiritual beliefs. FACIT-Searchable Item Library Adult Version - Comfort in Faith/Spiritual Beliefs FSIL-Difficult Times Strengthened Faith Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Difficult times have strengthened my faith or spiritual beliefs. FACIT-Searchable Item Library Adult Version - Difficult Times Strengthened Faith FSIL-During Difficult Times Things Be OK Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Even during difficult times, I know that things will be okay. FACIT-Searchable Item Library Adult Version - During Difficult Times Things Be OK FSIL-Bothered by Increased Facial Hair Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by increased facial hair. FACIT-Searchable Item Library Adult Version - Bothered by Increased Facial Hair FSIL-Bothered by Sensitivity Fingernails Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by sensitivity around my fingernails or toenails. FACIT-Searchable Item Library Adult Version - Bothered by Sensitivity Fingernails FSIL-My Eyes Are Dry Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My eyes are dry. FACIT-Searchable Item Library Adult Version - My Eyes Are Dry FSIL-Skin Cond Interferes w/ Social Life Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin condition interferes with my social life. FACIT-Searchable Item Library Adult Version - Skin Cond Interferes w/ Social Life FSIL-My Skin Condition Affects My Mood Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin condition affects my mood. FACIT-Searchable Item Library Adult Version - My Skin Condition Affects My Mood FSIL-Embarrassed by My Skin Condition Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am embarrassed by my skin condition. FACIT-Searchable Item Library Adult Version - Embarrassed by My Skin Condition FSIL-Unattractive B/c How My Skin Looks Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel unattractive because of how my skin looks. FACIT-Searchable Item Library Adult Version - Unattractive B/c How My Skin Looks FSIL-Sensitivity Fingernails Diff Tasks Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Sensitivity around my fingernails makes it difficult to perform household tasks. FACIT-Searchable Item Library Adult Version - Sensitivity Fingernails Diff Tasks FSIL-Skin Condition Interferes w/ Sleep Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin condition interferes with my ability to sleep. FACIT-Searchable Item Library Adult Version - Skin Condition Interferes w/ Sleep FSIL-Skin Condition Make Life Difficult Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Changes in my skin condition make daily life difficult. FACIT-Searchable Item Library Adult Version - Skin Condition Make Life Difficult FSIL-Avoid Public B/c How My Skin Looks Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I avoid going out in public because of how my skin looks. FACIT-Searchable Item Library Adult Version - Avoid Public B/c How My Skin Looks FSIL-Skin Side Effects Interfered Tasks Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The skin side effects from treatment have interfered with household tasks. FACIT-Searchable Item Library Adult Version - Skin Side Effects Interfered Tasks FSIL-My Skin or Scalp Feels Irritated Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin or scalp feels irritated. FACIT-Searchable Item Library Adult Version - My Skin or Scalp Feels Irritated FSIL-My Skin or Scalp Is Dry or Flaky Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin or scalp is dry or "flaky". FACIT-Searchable Item Library Adult Version - My Skin or Scalp Is Dry or Flaky FSIL-My Skin or Scalp Itches Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin or scalp itches. FACIT-Searchable Item Library Adult Version - My Skin or Scalp Itches FSIL-My Skin Bleeds Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin bleeds easily. FACIT-Searchable Item Library Adult Version - My Skin Bleeds Easily FSIL-Bothered by Skin Sensitivity to Sun Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by a change in my skin's sensitivity to the sun. FACIT-Searchable Item Library Adult Version - Bothered by Skin Sensitivity to Sun FSIL-Pharmacist Advises Use of Medicines Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My pharmacist advises me on the proper use of my medicines. FACIT-Searchable Item Library Adult Version - Pharmacist Advises Use of Medicines FSIL-Pharmacist Advises Adverse Effects Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My pharmacist advises me on the adverse (side) effects of my medicines. FACIT-Searchable Item Library Adult Version - Pharmacist Advises Adverse Effects FSIL-I Have Confidence in My Pharmacist Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have confidence in my pharmacist(s). FACIT-Searchable Item Library Adult Version - I Have Confidence in My Pharmacist FSIL-Pharmacist Available Questions Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My pharmacist is available to answer my questions. FACIT-Searchable Item Library Adult Version - Pharmacist Available Questions FSIL-Helps Arrangements Obtain Medicines Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My pharmacist helps with the arrangements necessary to obtain my medicines. FACIT-Searchable Item Library Adult Version - Helps Arrangements Obtain Medicines FSIL-Pharmacist Aware Treatment Needs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My pharmacist is aware of my treatment-related needs. FACIT-Searchable Item Library Adult Version - Pharmacist Aware Treatment Needs FSIL-Pharmacist Responds Treatment Needs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My pharmacist responds to my treatment-related needs. FACIT-Searchable Item Library Adult Version - Pharmacist Responds Treatment Needs FSIL-I Feel Bloated Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel bloated. FACIT-Searchable Item Library Adult Version - I Feel Bloated FSIL-My Hands Are Swollen Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My hands are swollen. FACIT-Searchable Item Library Adult Version - My Hands Are Swollen FSIL-My Legs or Feet Are Swollen Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My legs or feet are swollen. FACIT-Searchable Item Library Adult Version - My Legs or Feet Are Swollen FSIL-I Have Pain in My Fingertips Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my fingertips. FACIT-Searchable Item Library Adult Version - I Have Pain in My Fingertips FSIL-Bothered by My Hands/Nails Look Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by the way my hands or nails look. FACIT-Searchable Item Library Adult Version - Bothered by My Hands/Nails Look FSIL-I Bleed Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I bleed easily. FACIT-Searchable Item Library Adult Version - I Bleed Easily FSIL-Avoid or Limit Physical Activity Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I avoid or limit physical activity (because of concern with bleeding or bruising). FACIT-Searchable Item Library Adult Version - Avoid or Limit Physical Activity FSIL-Avoid or Limit Social Activity Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I avoid or limit social activity (because of concern with bleeding or bruising). FACIT-Searchable Item Library Adult Version - Avoid or Limit Social Activity FSIL-Frustrated Not Do Usual Activities Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated by not being able to do my usual activities. FACIT-Searchable Item Library Adult Version - Frustrated Not Do Usual Activities FSIL-Worry Treatment Will Be Delayed Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that my treatment will be delayed (because of low blood counts). FACIT-Searchable Item Library Adult Version - Worry Treatment Will Be Delayed FSIL-Worry Treatment Dose Will Reduced Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that my treatment dose will be reduced (because of low blood counts). FACIT-Searchable Item Library Adult Version - Worry Treatment Dose Will Reduced FSIL-Women: Bothered by Vaginal Bleeding Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: For women only: I am bothered by vaginal bleeding. FACIT-Searchable Item Library Adult Version - Women: Bothered by Vaginal Bleeding FSIL-I Bruise Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I bruise easily. FACIT-Searchable Item Library Adult Version - I Bruise Easily FSIL-Worry Problems Bruising/Bleeding Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about problems with bruising or bleeding. FACIT-Searchable Item Library Adult Version - Worry Problems Bruising/Bleeding FSIL-Worry About Serious Bleeding Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about the possibility of serious bleeding. FACIT-Searchable Item Library Adult Version - Worry About Serious Bleeding FSIL-Bothered by Nosebleeds Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by nosebleeds. FACIT-Searchable Item Library Adult Version - Bothered by Nosebleeds FSIL-Bothered by Bleeding in Gums/Mouth Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by bleeding in my gums or mouth. FACIT-Searchable Item Library Adult Version - Bothered by Bleeding in Gums/Mouth FSIL-Bothered by Bruising Beneath Skin Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by pinpoint bruising beneath my skin. FACIT-Searchable Item Library Adult Version - Bothered by Bruising Beneath Skin FSIL-Bothered by Blood in My Urine/Stool Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by blood in my urine or stool. FACIT-Searchable Item Library Adult Version - Bothered by Blood in My Urine/Stool FSIL-Inconvenienced Platelet Transfusion Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am inconvenienced by platelet transfusions. FACIT-Searchable Item Library Adult Version - Inconvenienced Platelet Transfusion FSIL-Effectiveness of Treatment So Far Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Compared to what you expected, how do you rate the effectiveness of the treatment so far? FACIT-Searchable Item Library Adult Version - Effectiveness of Treatment So Far FSIL-Doctor Explain Benefits Treatment Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) explain the possible benefits of your treatment? FACIT-Searchable Item Library Adult Version - Doctor Explain Benefits Treatment FSIL-Doctor Explain Side Effects/Risks Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) explain the possible side effects or risks of your treatment? FACIT-Searchable Item Library Adult Version - Doctor Explain Side Effects/Risks FSIL-Have Opportunity to Ask Questions Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you have an opportunity to ask questions? FACIT-Searchable Item Library Adult Version - Have Opportunity to Ask Questions FSIL-Get to Say Things Important to You Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you get to say the things that were important to you? FACIT-Searchable Item Library Adult Version - Get to Say Things Important to You FSIL-Doctor Understand Important to You Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) seem to understand what was important to you? FACIT-Searchable Item Library Adult Version - Doctor Understand Important to You FSIL-Doctor Show Genuine Concern for You Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) show genuine concern for you? FACIT-Searchable Item Library Adult Version - Doctor Show Genuine Concern for You FSIL-Doctor Seem Understand Your Needs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) seem to understand your needs? FACIT-Searchable Item Library Adult Version - Doctor Seem Understand Your Needs FSIL-Able to Talk to Doctor When Needed Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Were you able to talk to your doctor(s) when you needed to? FACIT-Searchable Item Library Adult Version - Able to Talk to Doctor When Needed FSIL-Treatment Staff Discuss Work Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did the treatment staff discuss how your health and treatment may affect your normal work (including housework)? FACIT-Searchable Item Library Adult Version - Treatment Staff Discuss Work FSIL-Side Effects of Treatment So Far Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Compared to what you expected, how do you rate the side effects of treatment so far? FACIT-Searchable Item Library Adult Version - Side Effects of Treatment So Far FSIL-Treatment Staff Discuss Activities Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did the treatment staff discuss how your health and treatment may affect your normal daily activities? FACIT-Searchable Item Library Adult Version - Treatment Staff Discuss Activities FSIL-Treatment Staff Discuss Relation Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did the treatment staff discuss how your health and treatment may affect your personal relationships? FACIT-Searchable Item Library Adult Version - Treatment Staff Discuss Relation FSIL-Treatment Staff Discuss Emotionally Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did the treatment staff discuss how your health and treatment may affect you emotionally? FACIT-Searchable Item Library Adult Version - Treatment Staff Discuss Emotionally FSIL-Doctor Experience Treating Illness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you feel your doctor(s) had experience treating your illness? FACIT-Searchable Item Library Adult Version - Doctor Experience Treating Illness FSIL-Doctor Knew Medical Developments Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you feel your doctor(s) knew about the latest medical developments for your illness? FACIT-Searchable Item Library Adult Version - Doctor Knew Medical Developments FSIL-Treatment Staff Thorough Examining Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Was the treatment staff thorough in examining and treating you? FACIT-Searchable Item Library Adult Version - Treatment Staff Thorough Examining FSIL-Participate Decisions Health Care Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Were you encouraged to participate in decisions about your health care? FACIT-Searchable Item Library Adult Version - Participate Decisions Health Care FSIL-Have Enough Time to Make Decisions Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you have enough time to make decisions about your health care? FACIT-Searchable Item Library Adult Version - Have Enough Time to Make Decisions FSIL-Doctor Evaluate Effects Treatment Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) help you evaluate the effects of your treatment so far? FACIT-Searchable Item Library Adult Version - Doctor Evaluate Effects Treatment FSIL-Doctor Seem Respect Your Opinions Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) seem to respect your opinions? FACIT-Searchable Item Library Adult Version - Doctor Seem Respect Your Opinions FSIL-Nurse Explanations You Understand Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your nurse(s) give explanations that you could understand? FACIT-Searchable Item Library Adult Version - Nurse Explanations You Understand FSIL-Nurse Show Genuine Concern for You Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your nurse(s) show genuine concern for you? FACIT-Searchable Item Library Adult Version - Nurse Show Genuine Concern for You FSIL-Nurse Seem to Understand Your Needs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your nurse(s) seem to understand your needs? FACIT-Searchable Item Library Adult Version - Nurse Seem to Understand Your Needs FSIL-Treatment Staff Answered Honestly Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you feel that the treatment staff answered your questions honestly? FACIT-Searchable Item Library Adult Version - Treatment Staff Answered Honestly FSIL-Treatment Staff Respect Privacy Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did the treatment staff respect your privacy? FACIT-Searchable Item Library Adult Version - Treatment Staff Respect Privacy FSIL-Have Confidence in Your Doctor Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you have confidence in your doctor(s)? FACIT-Searchable Item Library Adult Version - Have Confidence in Your Doctor FSIL-Trust Doctor Suggestions Treatment Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you trust your doctor(s)' suggestions for treatment? FACIT-Searchable Item Library Adult Version - Trust Doctor Suggestions Treatment FSIL-Recommend Clinic/Office to Others Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you recommend this clinic or office to others? FACIT-Searchable Item Library Adult Version - Recommend Clinic/Office to Others FSIL-Choose This Clinic/Office Again Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you choose this clinic or office again? FACIT-Searchable Item Library Adult Version - Choose This Clinic/Office Again FSIL-Received Treatment Right for You Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Do you feel you received the treatment that was right for you? FACIT-Searchable Item Library Adult Version - Received Treatment Right for You FSIL-Rate the Care You Received Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: How do you rate the care you received? FACIT-Searchable Item Library Adult Version - Rate the Care You Received FSIL-Satisfied With Effects of Treatment Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Are you satisfied with the effects of this treatment so far? FACIT-Searchable Item Library Adult Version - Satisfied With Effects of Treatment FSIL-Recommend This Treatment to Others Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you recommend this treatment to others with your illness? FACIT-Searchable Item Library Adult Version - Recommend This Treatment to Others FSIL-Choose This Treatment Again Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you choose this treatment again? FACIT-Searchable Item Library Adult Version - Choose This Treatment Again FSIL-Rate This Treatment Overall Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: How do you rate this treatment overall? FACIT-Searchable Item Library Adult Version - Rate This Treatment Overall FSIL-Doctor Explanations You Understand Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) give explanations that you could understand? FACIT-Searchable Item Library Adult Version - Doctor Explanations You Understand FSIL-Bothered by Discharge From Vulva Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by discharge or bleeding from my vulva. FACIT-Searchable Item Library Adult Version - Bothered by Discharge From Vulva FSIL-Bothered by Odor From Vulva Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by odor coming from my vulva. FACIT-Searchable Item Library Adult Version - Bothered by Odor From Vulva FSIL-Bothered by Swelling/Fluid in Legs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by swelling/fluid in my legs. FACIT-Searchable Item Library Adult Version - Bothered by Swelling/Fluid in Legs FSIL-Bothered by Discomfort Groin/Legs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by discomfort in my groin or legs. FACIT-Searchable Item Library Adult Version - Bothered by Discomfort Groin/Legs FSIL-Bothered by Itching/Burning Vulva Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by itching/burning in my vulva area. FACIT-Searchable Item Library Adult Version - Bothered by Itching/Burning Vulva FSIL-Bothered by Pain/Numbness in Vulva Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by pain or numbness in my vulva area. FACIT-Searchable Item Library Adult Version - Bothered by Pain/Numbness in Vulva FSIL-I Have Trouble Bending Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble bending. FACIT-Searchable Item Library Adult Version - I Have Trouble Bending FSIL-I Have Discomfort When I Am Sitting Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have discomfort when I am sitting. FACIT-Searchable Item Library Adult Version - I Have Discomfort When I Am Sitting FSIL-Bothered by Compression Stockings Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by wearing compression stockings. FACIT-Searchable Item Library Adult Version - Bothered by Compression Stockings FSIL-Satisfied With Urinary Condition Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am satisfied with my urinary condition. FACIT-Searchable Item Library Adult Version - Satisfied With Urinary Condition FSIL-Caring Urinary Condition Difficult Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Caring for my urinary condition is difficult. FACIT-Searchable Item Library Adult Version - Caring Urinary Condition Difficult FSILTC Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult Questionnaire Test Code CDISC Questionnaire FACIT-Searchable Item Library Adult Version Test Code Terminology Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult test name. FSIL-Abdominal Cramps Diarrhea Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have abdominal cramps or discomfort due to my diarrhea (diarrhoea). FACIT-Searchable Item Library Adult Version - Abdominal Cramps Diarrhea FSIL-Able Remember Things Where Left Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been able to remember things, like where I left my keys or wallet. FACIT-Searchable Item Library Adult Version - Able Remember Things Where Left FSIL-Able Remember to Do Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been able to remember to do things, like take medicine or buy something I needed. FACIT-Searchable Item Library Adult Version - Able Remember to Do Things FSIL-Able to Bring to Mind Words Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been able to bring to mind words that I wanted to use while talking to someone. FACIT-Searchable Item Library Adult Version - Able to Bring to Mind Words FSIL-Able to Communicate With Others Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to communicate with others. FACIT-Searchable Item Library Adult Version - Able to Communicate With Others FSIL-Able to Concentrate Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to concentrate. FACIT-Searchable Item Library Adult Version - Able to Concentrate FSIL-Able to Do My Usual Activities Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to do my usual activities. FACIT-Searchable Item Library Adult Version - Able to Do My Usual Activities FSIL-Able to Drive a Vehicle Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to drive a vehicle (my car, truck, etc.). FACIT-Searchable Item Library Adult Version - Able to Drive a Vehicle FSIL-Able to Eat as Much Food as I Want Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to eat as much food as I want. FACIT-Searchable Item Library Adult Version - Able to Eat as Much Food as I Want FSIL-Able to Eat the Foods That I Like Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to eat the foods that I like. FACIT-Searchable Item Library Adult Version - Able to Eat the Foods That I Like FSIL-Able to Enjoy Life Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to enjoy life. FACIT-Searchable Item Library Adult Version - Able to Enjoy Life FSIL-Able to Feel Like a Man Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to feel like a man. FACIT-Searchable Item Library Adult Version - Able to Feel Like a Man FSIL-Able to Feel Like a Woman Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to feel like a woman. FACIT-Searchable Item Library Adult Version - Able to Feel Like a Woman FSIL-Able to Find the Right Words Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to find the right word(s) to say what I mean. FACIT-Searchable Item Library Adult Version - Able to Find the Right Words FSIL-Able to Get Around by Myself Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to get around by myself. FACIT-Searchable Item Library Adult Version - Able to Get Around by Myself FSIL-Able to Have/Maintain Erection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to have and maintain an erection. (For men only) FACIT-Searchable Item Library Adult Version - Able to Have/Maintain Erection FSIL-Able to Maintain My Balance Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to maintain my balance. FACIT-Searchable Item Library Adult Version - Able to Maintain My Balance FSIL-Able to Make Decisions Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to make decisions. FACIT-Searchable Item Library Adult Version - Able to Make Decisions FSIL-Able to Meet My Monthly Expenses Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to meet my monthly expenses. FACIT-Searchable Item Library Adult Version - Able to Meet My Monthly Expenses FSIL-Able to Pay Attention w/o Effort Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to pay attention and keep track of what I am doing without extra effort. FACIT-Searchable Item Library Adult Version - Able to Pay Attention w/o Effort FSIL-Able to Put My thoughts Into Action Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to put my thoughts into action. FACIT-Searchable Item Library Adult Version - Able to Put My thoughts Into Action FSIL-Able to Put My Thoughts Together Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to put my thoughts together. FACIT-Searchable Item Library Adult Version - Able to Put My Thoughts Together FSIL-Able to Read Like I Used to Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to read like I used to. FACIT-Searchable Item Library Adult Version - Able to Read Like I Used to FSIL-Able to Reconcile With Other People Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been able to reconcile (make peace) with other people. FACIT-Searchable Item Library Adult Version - Able to Reconcile With Other People FSIL-Able to Shift Between Activities Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to shift back and forth between two activities that require thinking. FACIT-Searchable Item Library Adult Version - Able to Shift Between Activities FSIL-Able to Talk to Doctor When Needed Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Were you able to talk to your doctor(s) when you needed to? FACIT-Searchable Item Library Adult Version - Able to Talk to Doctor When Needed FSIL-Able to Track What I Am Doing Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to keep track of what I am doing, even if I am interrupted. FACIT-Searchable Item Library Adult Version - Able to Track What I Am Doing FSIL-Able to Walk Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to walk. FACIT-Searchable Item Library Adult Version - Able to Walk FSIL-Able to Work Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to work (include work at home). FACIT-Searchable Item Library Adult Version - Able to Work FSIL-Able to Write Like I Used to Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to write like I used to. FACIT-Searchable Item Library Adult Version - Able to Write Like I Used to FSIL-Accepted I Have This Infection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have accepted that I have this infection. FACIT-Searchable Item Library Adult Version - Accepted I Have This Infection FSIL-Afraid of Having a Seizure Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am afraid of having a seizure (convulsion). FACIT-Searchable Item Library Adult Version - Afraid of Having a Seizure FSIL-Afraid to Be Far From a Toilet Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am afraid to be far from a toilet. FACIT-Searchable Item Library Adult Version - Afraid to Be Far From a Toilet FSIL-Afraid to Have Sex Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am afraid to have sex. FACIT-Searchable Item Library Adult Version - Afraid to Have Sex FSIL-Afraid Treatment May Harm Body Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am afraid the treatment may harm my body. FACIT-Searchable Item Library Adult Version - Afraid Treatment May Harm Body FSIL-Amount I Eat Is Sufficient Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The amount I eat is sufficient to meet my needs. FACIT-Searchable Item Library Adult Version - Amount I Eat Is Sufficient FSIL-Appreciation for Beauty of Nature Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel a sense of appreciation for the beauty of nature. FACIT-Searchable Item Library Adult Version - Appreciation for Beauty of Nature FSIL-Avoid Going Out to Eat B/c Illness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I avoid going out to eat because of my illness. FACIT-Searchable Item Library Adult Version - Avoid Going Out to Eat B/c Illness FSIL-Avoid or Limit Physical Activity Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I avoid or limit physical activity (because of concern with bleeding or bruising). FACIT-Searchable Item Library Adult Version - Avoid or Limit Physical Activity FSIL-Avoid or Limit Social Activity Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I avoid or limit social activity (because of concern with bleeding or bruising). FACIT-Searchable Item Library Adult Version - Avoid or Limit Social Activity FSIL-Avoid Public B/c How My Skin Looks Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I avoid going out in public because of how my skin looks. FACIT-Searchable Item Library Adult Version - Avoid Public B/c How My Skin Looks FSIL-Avoid Public Places Fear Infection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I avoid public places for fear of getting an infection. FACIT-Searchable Item Library Adult Version - Avoid Public Places Fear Infection FSIL-Because of Sores Eating Difficult Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Because of my mouth sores, eating is difficult. FACIT-Searchable Item Library Adult Version - Because of Sores Eating Difficult FSIL-Believe Blood Will Be Inconvenient Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that having my blood drawn will be inconvenient. FACIT-Searchable Item Library Adult Version - Believe Blood Will Be Inconvenient FSIL-Believe Bothered by Side Effects Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe I will be bothered by side effects of treatment. FACIT-Searchable Item Library Adult Version - Believe Bothered by Side Effects FSIL-Believe Chemo Cause Physical Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe my chemotherapy treatment will cause me physical pain. FACIT-Searchable Item Library Adult Version - Believe Chemo Cause Physical Pain FSIL-Believe Chemo Harmful to Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe chemotherapy treatment will be harmful to me. FACIT-Searchable Item Library Adult Version - Believe Chemo Harmful to Me FSIL-Believe Chemo Inconvenient Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe receiving chemotherapy will be inconvenient. FACIT-Searchable Item Library Adult Version - Believe Chemo Inconvenient FSIL-Believe Chemo Sched Stress Family Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe my chemotherapy schedule will be stressful to my family. FACIT-Searchable Item Library Adult Version - Believe Chemo Sched Stress Family FSIL-Believe Chemo Schedule Stressful Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe my chemotherapy schedule will be stressful to me. FACIT-Searchable Item Library Adult Version - Believe Chemo Schedule Stressful Me FSIL-Believe Chemo Take Up My Time Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe chemotherapy treatment will take up my time. FACIT-Searchable Item Library Adult Version - Believe Chemo Take Up My Time FSIL-Believe Eating Will Be Inconvenient Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that waiting up to 60 minutes before eating breakfast in the morning will be inconvenient. FACIT-Searchable Item Library Adult Version - Believe Eating Will Be Inconvenient FSIL-Believe Infusion Will Cause Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that an infusion for my bone treatment will cause me physical pain. FACIT-Searchable Item Library Adult Version - Believe Infusion Will Cause Pain FSIL-Believe Schedule Stressful Family Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that my treatment schedule for bone disease will be stressful to my family. FACIT-Searchable Item Library Adult Version - Believe Schedule Stressful Family FSIL-Believe Schedule Stressful to Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that my treatment schedule for bone disease will be stressful to me. FACIT-Searchable Item Library Adult Version - Believe Schedule Stressful to Me FSIL-Believe Treatment Inconvenient Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that receiving treatment for bone disease will be inconvenient. FACIT-Searchable Item Library Adult Version - Believe Treatment Inconvenient FSIL-Believe Treatment Take Family Time Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that my treatment for bone disease will take up my family's time. FACIT-Searchable Item Library Adult Version - Believe Treatment Take Family Time FSIL-Believe Treatment Will Be Harmful Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that treatment for bone disease will be harmful to me. FACIT-Searchable Item Library Adult Version - Believe Treatment Will Be Harmful FSIL-Believe Treatment Will Cause Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that my treatment for bone disease will cause me physical pain. FACIT-Searchable Item Library Adult Version - Believe Treatment Will Cause Pain FSIL-Believe Treatment Will Take Up Time Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that treatment for bone disease will take up my time. FACIT-Searchable Item Library Adult Version - Believe Treatment Will Take Up Time FSIL-Believe Will Be Bothered by Effects Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that I will be bothered by side effects of treatment for bone disease. FACIT-Searchable Item Library Adult Version - Believe Will Be Bothered by Effects FSIL-Blame Myself for the Infection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I tend to blame myself for the infection. FACIT-Searchable Item Library Adult Version - Blame Myself for the Infection FSIL-Bone Pain Even When I Sit/Lie Still Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have bone pain even when I sit or lie still. FACIT-Searchable Item Library Adult Version - Bone Pain Even When I Sit/Lie Still FSIL-Bone Pain Interferes Care Myself Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Bone pain interferes with my ability to care for myself (bathing, dressing, eating, etc.). FACIT-Searchable Item Library Adult Version - Bone Pain Interferes Care Myself FSIL-Bone Pain Interferes w/Social Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Bone pain interferes with my social activities. FACIT-Searchable Item Library Adult Version - Bone Pain Interferes w/Social FSIL-Bone Pain Wakes Me Up at Night Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Bone pain wakes me up at night. FACIT-Searchable Item Library Adult Version - Bone Pain Wakes Me Up at Night FSIL-Bothered by a Skin Rash Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by a skin rash. FACIT-Searchable Item Library Adult Version - Bothered by a Skin Rash FSIL-Bothered by Appearance Skin Breast Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by the appearance of the skin in my breast area. FACIT-Searchable Item Library Adult Version - Bothered by Appearance Skin Breast FSIL-Bothered by Bleeding in Gums/Mouth Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by bleeding in my gums or mouth. FACIT-Searchable Item Library Adult Version - Bothered by Bleeding in Gums/Mouth FSIL-Bothered by Blistering of My Skin Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by blistering of my skin. FACIT-Searchable Item Library Adult Version - Bothered by Blistering of My Skin FSIL-Bothered by Blood in My Urine/Stool Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by blood in my urine or stool. FACIT-Searchable Item Library Adult Version - Bothered by Blood in My Urine/Stool FSIL-Bothered by Bruising Beneath Skin Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by pinpoint bruising beneath my skin. FACIT-Searchable Item Library Adult Version - Bothered by Bruising Beneath Skin FSIL-Bothered by Change in Eating Habits Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by a change in my eating habits. FACIT-Searchable Item Library Adult Version - Bothered by Change in Eating Habits FSIL-Bothered by Change in Food Tastes Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by a change in the way food tastes. FACIT-Searchable Item Library Adult Version - Bothered by Change in Food Tastes FSIL-Bothered by Change in Personality Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by a change in my personality. FACIT-Searchable Item Library Adult Version - Bothered by Change in Personality FSIL-Bothered by Change in Weight Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by a change in weight. FACIT-Searchable Item Library Adult Version - Bothered by Change in Weight FSIL-Bothered by Compression Stockings Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by wearing compression stockings. FACIT-Searchable Item Library Adult Version - Bothered by Compression Stockings FSIL-Bothered by Constipation Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by constipation. FACIT-Searchable Item Library Adult Version - Bothered by Constipation FSIL-Bothered by Cracking/Peeling Skin Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by cracking or peeling of my skin. FACIT-Searchable Item Library Adult Version - Bothered by Cracking/Peeling Skin FSIL-Bothered by Discharge From Vulva Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by discharge or bleeding from my vulva. FACIT-Searchable Item Library Adult Version - Bothered by Discharge From Vulva FSIL-Bothered by Discomfort Groin/Legs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by discomfort in my groin or legs. FACIT-Searchable Item Library Adult Version - Bothered by Discomfort Groin/Legs FSIL-Bothered by Drop in My Contribution Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by the drop in my contribution to the family. FACIT-Searchable Item Library Adult Version - Bothered by Drop in My Contribution FSIL-Bothered by Dry Mouth Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by dry mouth. FACIT-Searchable Item Library Adult Version - Bothered by Dry Mouth FSIL-Bothered by Dry Skin Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by dry skin. FACIT-Searchable Item Library Adult Version - Bothered by Dry Skin FSIL-Bothered by Effects Treatment Bone Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by side effects of treatment for bone disease. FACIT-Searchable Item Library Adult Version - Bothered by Effects Treatment Bone FSIL-Bothered by Fevers Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by fevers (episodes of high body temperature). FACIT-Searchable Item Library Adult Version - Bothered by Fevers FSIL-Bothered by Gas Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by gas (flatulence). FACIT-Searchable Item Library Adult Version - Bothered by Gas FSIL-Bothered by Hair Loss Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by hair loss. FACIT-Searchable Item Library Adult Version - Bothered by Hair Loss FSIL-Bothered by Having a Blocked Nose Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by having a blocked nose. FACIT-Searchable Item Library Adult Version - Bothered by Having a Blocked Nose FSIL-Bothered by Headaches Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by headaches. FACIT-Searchable Item Library Adult Version - Bothered by Headaches FSIL-Bothered by Hot Flashes Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by hot flashes. FACIT-Searchable Item Library Adult Version - Bothered by Hot Flashes FSIL-Bothered by Increased Facial Hair Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by increased facial hair. FACIT-Searchable Item Library Adult Version - Bothered by Increased Facial Hair FSIL-Bothered by Itching Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by itching. FACIT-Searchable Item Library Adult Version - Bothered by Itching FSIL-Bothered by Itching/Burning Vulva Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by itching/burning in my vulva area. FACIT-Searchable Item Library Adult Version - Bothered by Itching/Burning Vulva FSIL-Bothered by Jaundice/Yellow Skin Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by jaundice or yellow color to my skin. FACIT-Searchable Item Library Adult Version - Bothered by Jaundice/Yellow Skin FSIL-Bothered by Lumps or Swelling Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by lumps or swelling in certain parts of my body (e.g., neck, armpits, or groin). FACIT-Searchable Item Library Adult Version - Bothered by Lumps or Swelling FSIL-Bothered by Mouth Sores/Tenderness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by mouth sores or tenderness. FACIT-Searchable Item Library Adult Version - Bothered by Mouth Sores/Tenderness FSIL-Bothered by Muscle Pains Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by muscle pains. FACIT-Searchable Item Library Adult Version - Bothered by Muscle Pains FSIL-Bothered by Muscle Spasms Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by muscle spasms. FACIT-Searchable Item Library Adult Version - Bothered by Muscle Spasms FSIL-Bothered by My Hands/Nails Look Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by the way my hands or nails look. FACIT-Searchable Item Library Adult Version - Bothered by My Hands/Nails Look FSIL-Bothered by Nosebleeds Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by nosebleeds. FACIT-Searchable Item Library Adult Version - Bothered by Nosebleeds FSIL-Bothered by Odor From Vagina Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by odor coming from my vagina. FACIT-Searchable Item Library Adult Version - Bothered by Odor From Vagina FSIL-Bothered by Odor From Vulva Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by odor coming from my vulva. FACIT-Searchable Item Library Adult Version - Bothered by Odor From Vulva FSIL-Bothered by Pain/Numbness in Vulva Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by pain or numbness in my vulva area. FACIT-Searchable Item Library Adult Version - Bothered by Pain/Numbness in Vulva FSIL-Bothered by Reflux or Heartburn Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by reflux or heartburn. FACIT-Searchable Item Library Adult Version - Bothered by Reflux or Heartburn FSIL-Bothered by Ringing in My Ear Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by ringing in my ear(s). FACIT-Searchable Item Library Adult Version - Bothered by Ringing in My Ear FSIL-Bothered by Sensitivity Fingernails Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by sensitivity around my fingernails or toenails. FACIT-Searchable Item Library Adult Version - Bothered by Sensitivity Fingernails FSIL-Bothered by Short-term Reactions Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by short-term treatment reactions that I experience immediately after, or within 24 hours of, an infusion (such as chills, dizziness, hives, rashes lasting no more than 24 hours). FACIT-Searchable Item Library Adult Version - Bothered by Short-term Reactions FSIL-Bothered by Side Effects Treatment Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by side effects of treatment. FACIT-Searchable Item Library Adult Version - Bothered by Side Effects Treatment FSIL-Bothered by Skin Problems Underarm Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by skin problems in my underarm area. FACIT-Searchable Item Library Adult Version - Bothered by Skin Problems Underarm FSIL-Bothered by Skin Problems Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by skin problems. FACIT-Searchable Item Library Adult Version - Bothered by Skin Problems FSIL-Bothered by Skin Sensitivity to Sun Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by a change in my skin's sensitivity to the sun. FACIT-Searchable Item Library Adult Version - Bothered by Skin Sensitivity to Sun FSIL-Bothered by Sweating Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by sweating. FACIT-Searchable Item Library Adult Version - Bothered by Sweating FSIL-Bothered by Swelling Certain Areas Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by swelling in certain areas of my body. FACIT-Searchable Item Library Adult Version - Bothered by Swelling Certain Areas FSIL-Bothered by Swelling in My Breast Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by swelling in my breast. FACIT-Searchable Item Library Adult Version - Bothered by Swelling in My Breast FSIL-Bothered by Swelling/Fluid in Legs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by swelling/fluid in my legs. FACIT-Searchable Item Library Adult Version - Bothered by Swelling/Fluid in Legs FSIL-Bothered by the Amount of Swelling Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by the amount of swelling. FACIT-Searchable Item Library Adult Version - Bothered by the Amount of Swelling FSIL-Bothered by the Chills Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by the chills. FACIT-Searchable Item Library Adult Version - Bothered by the Chills FSIL-Bothered by Uncertainty Prognosis Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by uncertainty about my prognosis. FACIT-Searchable Item Library Adult Version - Bothered by Uncertainty Prognosis FSIL-Bothered by Vitiligo Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by vitiligo (white patches appearing on my skin). FACIT-Searchable Item Library Adult Version - Bothered by Vitiligo FSIL-Bothered by Worsening Eyesight Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by worsening eyesight. FACIT-Searchable Item Library Adult Version - Bothered by Worsening Eyesight FSIL-Bothered Discharge/Bleeding Vagina Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by discharge or bleeding from my vagina. FACIT-Searchable Item Library Adult Version - Bothered Discharge/Bleeding Vagina FSIL-Bothered Inconvenience Treat Skin Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by the inconvenience of treatment for my skin condition. FACIT-Searchable Item Library Adult Version - Bothered Inconvenience Treat Skin FSIL-Bothered New Allergy-like Reactions Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by new allergy-like reactions (e.g., to foods, insects, pollen). FACIT-Searchable Item Library Adult Version - Bothered New Allergy-like Reactions FSIL-Bothered Red/Pink Appearance Skin Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by the red or pink appearance of my skin. FACIT-Searchable Item Library Adult Version - Bothered Red/Pink Appearance Skin FSIL-Breathing Is Easy for Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Breathing is easy for me. FACIT-Searchable Item Library Adult Version - Breathing Is Easy for Me FSIL-Can Manage Things Around Infection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel that I can manage things that come up around this infection. FACIT-Searchable Item Library Adult Version - Can Manage Things Around Infection FSIL-Can Swallow Naturally and Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I can swallow naturally and easily. FACIT-Searchable Item Library Adult Version - Can Swallow Naturally and Easily FSIL-Careful Who I told About Infection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I was careful who I told about the infection. FACIT-Searchable Item Library Adult Version - Careful Who I told About Infection FSIL-Caring for Ostomy Is Difficult Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Caring for my ostomy appliance is difficult. FACIT-Searchable Item Library Adult Version - Caring for Ostomy Is Difficult FSIL-Caring Urinary Condition Difficult Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Caring for my urinary condition is difficult. FACIT-Searchable Item Library Adult Version - Caring Urinary Condition Difficult FSIL-Carrying 10-20 Lbs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Carrying something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries) from one room to another. FACIT-Searchable Item Library Adult Version - Carrying 10-20 Lbs FSIL-Certain Parts of Body Have Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have certain parts of my body where I experience pain. FACIT-Searchable Item Library Adult Version - Certain Parts of Body Have Pain FSIL-Chemo Causes Physical Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My chemotherapy treatment causes me physical pain. FACIT-Searchable Item Library Adult Version - Chemo Causes Physical Pain FSIL-Chemo Schedule Is Stressful Family Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My chemotherapy schedule is stressful to my family. FACIT-Searchable Item Library Adult Version - Chemo Schedule Is Stressful Family FSIL-Chemo Schedule Is Stressful Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My chemotherapy schedule is stressful to me. FACIT-Searchable Item Library Adult Version - Chemo Schedule Is Stressful Me FSIL-Chemo Seems Harmful Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Chemotherapy treatment seems harmful to me. FACIT-Searchable Item Library Adult Version - Chemo Seems Harmful FSIL-Chemo Takes Family Time Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My chemotherapy treatment takes up my family's time. FACIT-Searchable Item Library Adult Version - Chemo Takes Family Time FSIL-Chemo Treatment Takes Up My Time Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Chemotherapy treatment takes up my time. FACIT-Searchable Item Library Adult Version - Chemo Treatment Takes Up My Time FSIL-Choose This Chemo Again Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you choose this chemotherapy again? FACIT-Searchable Item Library Adult Version - Choose This Chemo Again FSIL-Choose This Clinic/Office Again Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you choose this clinic or office again? FACIT-Searchable Item Library Adult Version - Choose This Clinic/Office Again FSIL-Choose This Treatment Again Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you choose this treatment again? FACIT-Searchable Item Library Adult Version - Choose This Treatment Again FSIL-Choose This Treatment Bone Again Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you choose this treatment for bone disease again? FACIT-Searchable Item Library Adult Version - Choose This Treatment Bone Again FSIL-Comfort in Faith/Spiritual Beliefs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I find comfort in my faith or spiritual beliefs. FACIT-Searchable Item Library Adult Version - Comfort in Faith/Spiritual Beliefs FSIL-Comfortable Discuss Cond w/Friends Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am comfortable discussing my condition with friends. FACIT-Searchable Item Library Adult Version - Comfortable Discuss Cond w/Friends FSIL-Compassion for Others Difficulties Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel compassion for others in the difficulties they are facing. FACIT-Searchable Item Library Adult Version - Compassion for Others Difficulties FSIL-Concerned About How Thin I Look Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am concerned about how thin I look. FACIT-Searchable Item Library Adult Version - Concerned About How Thin I Look FSIL-Concerned About Keeping My Job Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am concerned about keeping my job (include work at home). FACIT-Searchable Item Library Adult Version - Concerned About Keeping My Job FSIL-Concerned Keeping My Job and Income Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am concerned about keeping my job and income, including work at home. FACIT-Searchable Item Library Adult Version - Concerned Keeping My Job and Income FSIL-Concerned What the Future Holds Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am concerned about what the future holds for me. FACIT-Searchable Item Library Adult Version - Concerned What the Future Holds FSIL-Concerns Ability Become Pregnant Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have concerns about my ability to become pregnant. FACIT-Searchable Item Library Adult Version - Concerns Ability Become Pregnant FSIL-Concerns Ability to Have Children Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have concerns about my ability to have children. FACIT-Searchable Item Library Adult Version - Concerns Ability to Have Children FSIL-Condition Wakes/Keeps Me Up Night Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My condition wakes or keeps me up at night. FACIT-Searchable Item Library Adult Version - Condition Wakes/Keeps Me Up Night FSIL-Confidence in My Nurse(s) Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have confidence in my nurse(s). FACIT-Searchable Item Library Adult Version - Confidence in My Nurse(s) FSIL-Confident Nutrition Feeding Tube Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am more confident about my nutrition because of my feeding tube. FACIT-Searchable Item Library Adult Version - Confident Nutrition Feeding Tube FSIL-Constipated Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am constipated. FACIT-Searchable Item Library Adult Version - Constipated FSIL-Constipation Dur/After Tube Feeding Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have constipation during or after my tube feeding. FACIT-Searchable Item Library Adult Version - Constipation Dur/After Tube Feeding FSIL-Content With Quality of My Life Now Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am content with the quality of my life right now. FACIT-Searchable Item Library Adult Version - Content With Quality of My Life Now FSIL-Cost of Treatment Is Burden on Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The cost of my treatment is a burden on me or my family. FACIT-Searchable Item Library Adult Version - Cost of Treatment Is Burden on Me FSIL-Dependent on Others Feeding Tube Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel dependent on others because I have a feeding tube. FACIT-Searchable Item Library Adult Version - Dependent on Others Feeding Tube FSIL-Depressed About My Condition Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am depressed about my condition. FACIT-Searchable Item Library Adult Version - Depressed About My Condition FSIL-Depressed About the Infection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am depressed about the infection. FACIT-Searchable Item Library Adult Version - Depressed About the Infection FSIL-Diarrhea Keeps/Wakes Me Up at Night Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My problem with diarrhea (diarrhoea) keeps/wakes me up at night. FACIT-Searchable Item Library Adult Version - Diarrhea Keeps/Wakes Me Up at Night FSIL-Diff Moving Neck & Shoulders Stiff Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty moving my neck and shoulders because of stiffness. FACIT-Searchable Item Library Adult Version - Diff Moving Neck & Shoulders Stiff FSIL-Difficult Times Strengthened Faith Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Difficult times have strengthened my faith or spiritual beliefs. FACIT-Searchable Item Library Adult Version - Difficult Times Strengthened Faith FSIL-Difficulty Breathing Exposed Cold Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty breathing when I am exposed to cold temperatures. FACIT-Searchable Item Library Adult Version - Difficulty Breathing Exposed Cold FSIL-Difficulty Doing Things B/c of Skin Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty doing things with my hands because of the condition of my skin. FACIT-Searchable Item Library Adult Version - Difficulty Doing Things B/c of Skin FSIL-Difficulty Expressing My Thoughts Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty expressing my thoughts. FACIT-Searchable Item Library Adult Version - Difficulty Expressing My Thoughts FSIL-Difficulty Moving My Arm Sideways Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty moving my arm sideways. FACIT-Searchable Item Library Adult Version - Difficulty Moving My Arm Sideways FSIL-Difficulty Planning for Future Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Because of my illness, I have difficulty planning for the future. FACIT-Searchable Item Library Adult Version - Difficulty Planning for Future FSIL-Difficulty Swallowing Liquids Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty swallowing liquids. FACIT-Searchable Item Library Adult Version - Difficulty Swallowing Liquids FSIL-Difficulty Swallowing Soft Foods Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty swallowing soft or mashed foods. FACIT-Searchable Item Library Adult Version - Difficulty Swallowing Soft Foods FSIL-Difficulty Swallowing Solid Foods Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty swallowing solid foods. FACIT-Searchable Item Library Adult Version - Difficulty Swallowing Solid Foods FSIL-Difficulty Telling Partner/Spouse Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had difficulty telling my partner/spouse about the infection. FACIT-Searchable Item Library Adult Version - Difficulty Telling Partner/Spouse FSIL-Difficulty Walking B/c of Skin Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty walking because of my skin condition. FACIT-Searchable Item Library Adult Version - Difficulty Walking B/c of Skin FSIL-Digestive Problems Interfere Activ Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My digestive problems interfere with my usual activities. FACIT-Searchable Item Library Adult Version - Digestive Problems Interfere Activ FSIL-Discomfort in My Pelvic Area Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have discomfort in my pelvic area. FACIT-Searchable Item Library Adult Version - Discomfort in My Pelvic Area FSIL-Discomfort or Pain When I Eat Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have discomfort or pain when I eat. FACIT-Searchable Item Library Adult Version - Discomfort or Pain When I Eat FSIL-Discomfort/Pain in My Pelvic Area Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have discomfort or pain in my pelvic area. FACIT-Searchable Item Library Adult Version - Discomfort/Pain in My Pelvic Area FSIL-Discomfort/Pain in Stomach Area Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have discomfort or pain in my stomach area. FACIT-Searchable Item Library Adult Version - Discomfort/Pain in Stomach Area FSIL-Discuss Concerns w/ People Closest Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to openly discuss my concerns with the people closest to me. FACIT-Searchable Item Library Adult Version - Discuss Concerns w/ People Closest FSIL-Do You Have an Ostomy Appliance Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Do you have an ostomy appliance? FACIT-Searchable Item Library Adult Version - Do You Have an Ostomy Appliance FSIL-Doctor Available Answer Questions Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My doctor is available to answer my questions. FACIT-Searchable Item Library Adult Version - Doctor Available Answer Questions FSIL-Doctor Evaluate Effects Treatment Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) help you evaluate the effects of your treatment so far? FACIT-Searchable Item Library Adult Version - Doctor Evaluate Effects Treatment FSIL-Doctor Experience Treating Illness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you feel your doctor(s) had experience treating your illness? FACIT-Searchable Item Library Adult Version - Doctor Experience Treating Illness FSIL-Doctor Explain Benefits Treatment Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) explain the possible benefits of your treatment? FACIT-Searchable Item Library Adult Version - Doctor Explain Benefits Treatment FSIL-Doctor Explain Side Effects/Risks Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) explain the possible side effects or risks of your treatment? FACIT-Searchable Item Library Adult Version - Doctor Explain Side Effects/Risks FSIL-Doctor Explained Possible Benefits Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My doctor explained the possible benefits of my treatment. FACIT-Searchable Item Library Adult Version - Doctor Explained Possible Benefits FSIL-Doctor Explanations You Understand Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) give explanations that you could understand? FACIT-Searchable Item Library Adult Version - Doctor Explanations You Understand FSIL-Doctor Gave Explanations Understand Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My doctor gave me explanations that I could understand. FACIT-Searchable Item Library Adult Version - Doctor Gave Explanations Understand FSIL-Doctor Knew Medical Developments Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you feel your doctor(s) knew about the latest medical developments for your illness? FACIT-Searchable Item Library Adult Version - Doctor Knew Medical Developments FSIL-Doctor Seem Respect Your Opinions Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) seem to respect your opinions? FACIT-Searchable Item Library Adult Version - Doctor Seem Respect Your Opinions FSIL-Doctor Seem Understand Your Needs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) seem to understand your needs? FACIT-Searchable Item Library Adult Version - Doctor Seem Understand Your Needs FSIL-Doctor Show Genuine Concern for You Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) show genuine concern for you? FACIT-Searchable Item Library Adult Version - Doctor Show Genuine Concern for You FSIL-Doctor Understand Important to You Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) seem to understand what was important to you? FACIT-Searchable Item Library Adult Version - Doctor Understand Important to You FSIL-Dressing Yourself Without Help Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Dressing yourself without help. FACIT-Searchable Item Library Adult Version - Dressing Yourself Without Help FSIL-Dur Tube Feeding Eat/Drink by Mouth Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: During the use of tube feeding, I can eat and drink by mouth. FACIT-Searchable Item Library Adult Version - Dur Tube Feeding Eat/Drink by Mouth FSIL-During Difficult Times Things Be OK Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Even during difficult times, I know that things will be okay. FACIT-Searchable Item Library Adult Version - During Difficult Times Things Be OK FSIL-Effectiveness of Treatment So Far Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Compared to what you expected, how do you rate the effectiveness of the treatment so far? FACIT-Searchable Item Library Adult Version - Effectiveness of Treatment So Far FSIL-Embarrassed About the Infection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel embarrassed about the infection. FACIT-Searchable Item Library Adult Version - Embarrassed About the Infection FSIL-Embarrassed by Appearance of Skin Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am embarrassed by the appearance of my skin. FACIT-Searchable Item Library Adult Version - Embarrassed by Appearance of Skin FSIL-Embarrassed by Having Diarrhea Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am embarrassed by having diarrhea (diarrhoea). FACIT-Searchable Item Library Adult Version - Embarrassed by Having Diarrhea FSIL-Embarrassed by My Condition Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am embarrassed by my condition. FACIT-Searchable Item Library Adult Version - Embarrassed by My Condition FSIL-Embarrassed by My Illness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am embarrassed by my illness. FACIT-Searchable Item Library Adult Version - Embarrassed by My Illness FSIL-Embarrassed by My Skin Condition Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am embarrassed by my skin condition. FACIT-Searchable Item Library Adult Version - Embarrassed by My Skin Condition FSIL-Embarrassed by Ostomy Appliance Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am embarrassed by my ostomy appliance. FACIT-Searchable Item Library Adult Version - Embarrassed by Ostomy Appliance FSIL-Emotional Support Family Members Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get emotional support from family members. FACIT-Searchable Item Library Adult Version - Emotional Support Family Members FSIL-Emotional Support From My Family Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get emotional support from my family. FACIT-Searchable Item Library Adult Version - Emotional Support From My Family FSIL-Enjoy Meals With Family/Friends Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to enjoy meals with family or friends. FACIT-Searchable Item Library Adult Version - Enjoy Meals With Family/Friends FSIL-Enjoy Things I Usually Do for Fun Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am enjoying the things I usually do for fun. FACIT-Searchable Item Library Adult Version - Enjoy Things I Usually Do for Fun FSIL-Enough Money to Cover Treatment Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I know that I have enough money in savings, retirement, or assets to cover the costs of my treatment. FACIT-Searchable Item Library Adult Version - Enough Money to Cover Treatment FSIL-Family Bothered by Skin Condition Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My family is bothered by my skin condition. FACIT-Searchable Item Library Adult Version - Family Bothered by Skin Condition FSIL-Family Is Well Despite My Illness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My family is doing well despite my illness. FACIT-Searchable Item Library Adult Version - Family Is Well Despite My Illness FSIL-Family Trouble Understand Bone Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My family has trouble understanding when my bone pain interferes with my activity. FACIT-Searchable Item Library Adult Version - Family Trouble Understand Bone Pain FSIL-Family Trouble Understand Worse Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My family has trouble understanding when my condition gets worse. FACIT-Searchable Item Library Adult Version - Family Trouble Understand Worse FSIL-Family Who Take My Responsibilities Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have family members who will take on my responsibilities. FACIT-Searchable Item Library Adult Version - Family Who Take My Responsibilities FSIL-Far From Home/Work W/o Fear Soilage Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I can be far from home/work without fearing soilage. FACIT-Searchable Item Library Adult Version - Far From Home/Work W/o Fear Soilage FSIL-Fatigue Keeps Me From Doing Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My fatigue keeps me from doing the things I want to do. FACIT-Searchable Item Library Adult Version - Fatigue Keeps Me From Doing Things FSIL-Feeding Tube Was Right Decision Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Getting a feeding tube was the right decision for me. FACIT-Searchable Item Library Adult Version - Feeding Tube Was Right Decision FSIL-Feel Financially Stressed Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel financially stressed. FACIT-Searchable Item Library Adult Version - Feel Financially Stressed FSIL-Feel Forgiven for Harm I Caused Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel forgiven for any harm I may have ever caused. FACIT-Searchable Item Library Adult Version - Feel Forgiven for Harm I Caused FSIL-Feel Isolated Because of Illness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel isolated from others because of my illness or treatment. FACIT-Searchable Item Library Adult Version - Feel Isolated Because of Illness FSIL-Feel Overwhelmed by My Condition Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel overwhelmed by my condition. FACIT-Searchable Item Library Adult Version - Feel Overwhelmed by My Condition FSIL-Feel Sense of Harmony Within Myself Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel a sense of harmony within myself. FACIT-Searchable Item Library Adult Version - Feel Sense of Harmony Within Myself FSIL-Feel Sense of Purpose in My Life Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel a sense of purpose in my life. FACIT-Searchable Item Library Adult Version - Feel Sense of Purpose in My Life FSIL-Feel Sense of Thankfulness for Life Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Throughout the course of my day, I feel a sense of thankfulness for my life. FACIT-Searchable Item Library Adult Version - Feel Sense of Thankfulness for Life FSIL-Feel That My Family Appreciates Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel that my family appreciates me. FACIT-Searchable Item Library Adult Version - Feel That My Family Appreciates Me FSIL-Forced to Spend Time in Bed Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am forced to spend time in bed. FACIT-Searchable Item Library Adult Version - Forced to Spend Time in Bed FSIL-Forgive Others for Harm Caused Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to forgive others for any harm they have ever caused me. FACIT-Searchable Item Library Adult Version - Forgive Others for Harm Caused Me FSIL-Forgotten Names After Introduced Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have forgotten names of people soon after being introduced. FACIT-Searchable Item Library Adult Version - Forgotten Names After Introduced FSIL-Frustrated by Being Too Tired Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated by being too tired to do the things I want to do. FACIT-Searchable Item Library Adult Version - Frustrated by Being Too Tired FSIL-Frustrated by My Bone Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated by my bone pain. FACIT-Searchable Item Library Adult Version - Frustrated by My Bone Pain FSIL-Frustrated by My Condition Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated by my condition. FACIT-Searchable Item Library Adult Version - Frustrated by My Condition FSIL-Frustrated by My Skin Condition Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated by my skin condition. FACIT-Searchable Item Library Adult Version - Frustrated by My Skin Condition FSIL-Frustrated by the Infection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated by the infection. FACIT-Searchable Item Library Adult Version - Frustrated by the Infection FSIL-Frustrated Cannot Work as Usual Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated that I cannot work or contribute as much as I usually do. FACIT-Searchable Item Library Adult Version - Frustrated Cannot Work as Usual FSIL-Frustrated I Cannot Do Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get frustrated that I cannot do things I used to. FACIT-Searchable Item Library Adult Version - Frustrated I Cannot Do Things FSIL-Frustrated Not Do Usual Activities Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated by not being able to do my usual activities. FACIT-Searchable Item Library Adult Version - Frustrated Not Do Usual Activities FSIL-Frustrated Unable Do Things I Want Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated by being unable to do the things I want to do. FACIT-Searchable Item Library Adult Version - Frustrated Unable Do Things I Want FSIL-Fullness/Heaviness in Stomach Area Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have a feeling of fullness or heaviness in my stomach area. FACIT-Searchable Item Library Adult Version - Fullness/Heaviness in Stomach Area FSIL-Get Emotional Support Partner Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get emotional support from my partner/spouse. FACIT-Searchable Item Library Adult Version - Get Emotional Support Partner FSIL-Get Ringing or Buzzing in My Ears Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get a ringing or buzzing in my ears. FACIT-Searchable Item Library Adult Version - Get Ringing or Buzzing in My Ears FSIL-Get to Say Things Important to You Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you get to say the things that were important to you? FACIT-Searchable Item Library Adult Version - Get to Say Things Important to You FSIL-Good Range of Movement in Arm/Leg Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have good range of movement in my arm or leg. FACIT-Searchable Item Library Adult Version - Good Range of Movement in Arm/Leg FSIL-Had Change in the Way Food Tastes Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had a change in the way food tastes. FACIT-Searchable Item Library Adult Version - Had Change in the Way Food Tastes FSIL-Hand Pain Interferes Daily Activ Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Hand pain or tenderness interferes with my daily activities. FACIT-Searchable Item Library Adult Version - Hand Pain Interferes Daily Activ FSIL-Hard to Tell People About Infection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: It is hard to tell other people about my infection. FACIT-Searchable Item Library Adult Version - Hard to Tell People About Infection FSIL-Have Breast Sensitivity/Tenderness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have breast sensitivity/tenderness. FACIT-Searchable Item Library Adult Version - Have Breast Sensitivity/Tenderness FSIL-Have Confidence in Your Doctor Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you have confidence in your doctor(s)? FACIT-Searchable Item Library Adult Version - Have Confidence in Your Doctor FSIL-Have Difficulty Eating Rich Foods Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty eating rich or "heavy" foods. FACIT-Searchable Item Library Adult Version - Have Difficulty Eating Rich Foods FSIL-Have Enough Time to Make Decisions Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you have enough time to make decisions about your health care? FACIT-Searchable Item Library Adult Version - Have Enough Time to Make Decisions FSIL-Have Joint Pain or Muscle Cramps Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have joint pain or muscle cramps. FACIT-Searchable Item Library Adult Version - Have Joint Pain or Muscle Cramps FSIL-Have Opportunity to Ask Questions Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you have an opportunity to ask questions? FACIT-Searchable Item Library Adult Version - Have Opportunity to Ask Questions FSIL-Have Pain/Discomfort w/Intercourse Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain or discomfort with intercourse. FACIT-Searchable Item Library Adult Version - Have Pain/Discomfort w/Intercourse FSIL-Have People to Help Me if I Need It Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have people to help me if I need it. FACIT-Searchable Item Library Adult Version - Have People to Help Me if I Need It FSIL-Have Stiffness of Arm on This Side Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have stiffness of my arm on this side. FACIT-Searchable Item Library Adult Version - Have Stiffness of Arm on This Side FSIL-Have Swelling in Parts of My Body Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have swelling in parts of my body. FACIT-Searchable Item Library Adult Version - Have Swelling in Parts of My Body FSIL-Have Trouble Controlling My Urine Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble controlling my urine. FACIT-Searchable Item Library Adult Version - Have Trouble Controlling My Urine FSIL-Have Trouble Feeling Peace of Mind Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble feeling peace of mind. FACIT-Searchable Item Library Adult Version - Have Trouble Feeling Peace of Mind FSIL-Have Trouble Swallowing Food Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble swallowing food. FACIT-Searchable Item Library Adult Version - Have Trouble Swallowing Food FSIL-Have Weakness in My Arms or Legs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have weakness in my arms or legs. FACIT-Searchable Item Library Adult Version - Have Weakness in My Arms or Legs FSIL-Have You Ever Smoked Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Have you ever smoked? FACIT-Searchable Item Library Adult Version - Have You Ever Smoked FSIL-Having Blood Drawn Is Inconvenient Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Having my blood drawn is inconvenient. FACIT-Searchable Item Library Adult Version - Having Blood Drawn Is Inconvenient FSIL-Heat Worsens My Symptoms Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Heat worsens my symptoms. FACIT-Searchable Item Library Adult Version - Heat Worsens My Symptoms FSIL-Helps Arrangements Obtain Medicines Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My pharmacist helps with the arrangements necessary to obtain my medicines. FACIT-Searchable Item Library Adult Version - Helps Arrangements Obtain Medicines FSIL-Hidden Problem Others Not Notice Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have hidden this problem so others will not notice. FACIT-Searchable Item Library Adult Version - Hidden Problem Others Not Notice FSIL-Hopeful About the Future Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am hopeful about the future. FACIT-Searchable Item Library Adult Version - Hopeful About the Future FSIL-How Many Places in Body Felt Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: In how many places in your body have you felt bone pain? FACIT-Searchable Item Library Adult Version - How Many Places in Body Felt Pain FSIL-Hurts When Put Weight/Pressure on Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: It hurts when I put weight or pressure on the place where I have bone pain. FACIT-Searchable Item Library Adult Version - Hurts When Put Weight/Pressure on FSIL-I Bleed Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I bleed easily. FACIT-Searchable Item Library Adult Version - I Bleed Easily FSIL-I Bruise Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I bruise easily. FACIT-Searchable Item Library Adult Version - I Bruise Easily FSIL-I Can Digest My Food Well Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I can digest my food well. FACIT-Searchable Item Library Adult Version - I Can Digest My Food Well FSIL-I Can Eat Solid Foods Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I can eat solid foods. FACIT-Searchable Item Library Adult Version - I Can Eat Solid Foods FSIL-I Can Enjoy the Taste of Food Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I can enjoy the taste of food. FACIT-Searchable Item Library Adult Version - I Can Enjoy the Taste of Food FSIL-I Can Remember New Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I can remember new things. FACIT-Searchable Item Library Adult Version - I Can Remember New Things FSIL-I Can Remember Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I can remember things. FACIT-Searchable Item Library Adult Version - I Can Remember Things FSIL-I Choke When I Swallow Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I choke when I swallow. FACIT-Searchable Item Library Adult Version - I Choke When I Swallow FSIL-I Drink Alcohol Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I drink alcohol (e.g. beer, wine, etc.). FACIT-Searchable Item Library Adult Version - I Drink Alcohol FSIL-I Feel Bloated Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel bloated. FACIT-Searchable Item Library Adult Version - I Feel Bloated FSIL-I Feel Close to My Family Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel close to my family. FACIT-Searchable Item Library Adult Version - I Feel Close to My Family FSIL-I Feel Close to My Friends Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel close to my friends. FACIT-Searchable Item Library Adult Version - I Feel Close to My Friends FSIL-I Feel Close to My Partner Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel close to my partner (or the person who is my main support). FACIT-Searchable Item Library Adult Version - I Feel Close to My Partner FSIL-I Feel Connected to Higher Power Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel connected to a higher power (or God). FACIT-Searchable Item Library Adult Version - I Feel Connected to Higher Power FSIL-I Feel Connected to Other People Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel connected to other people. FACIT-Searchable Item Library Adult Version - I Feel Connected to Other People FSIL-I Feel Depressed about Bone Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel depressed about my bone pain. FACIT-Searchable Item Library Adult Version - I Feel Depressed about Bone Pain FSIL-I Feel Discomfort in My Feet Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel discomfort in my feet. FACIT-Searchable Item Library Adult Version - I Feel Discomfort in My Feet FSIL-I Feel Discomfort in My Hands Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel discomfort in my hands. FACIT-Searchable Item Library Adult Version - I Feel Discomfort in My Hands FSIL-I Feel Discouraged About My Illness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel discouraged about my illness. FACIT-Searchable Item Library Adult Version - I Feel Discouraged About My Illness FSIL-I Feel Distant From Other People Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel distant from other people. FACIT-Searchable Item Library Adult Version - I Feel Distant From Other People FSIL-I Feel Fatigued Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel fatigued. FACIT-Searchable Item Library Adult Version - I Feel Fatigued FSIL-I Feel Hopeful Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel hopeful. FACIT-Searchable Item Library Adult Version - I Feel Hopeful FSIL-I Feel Ill Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel ill. FACIT-Searchable Item Library Adult Version - I Feel Ill FSIL-I Feel Independent Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel independent. FACIT-Searchable Item Library Adult Version - I Feel Independent FSIL-I Feel Left Out of Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel "left out" of things. FACIT-Searchable Item Library Adult Version - I Feel Left Out of Things FSIL-I Feel Lightheaded Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel lightheaded (dizzy). FACIT-Searchable Item Library Adult Version - I Feel Lightheaded FSIL-I Feel Like a Burden to My Family Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel like a burden to my family. FACIT-Searchable Item Library Adult Version - I Feel Like a Burden to My Family FSIL-I Feel Listless Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel listless ("washed out"). FACIT-Searchable Item Library Adult Version - I Feel Listless FSIL-I Feel Love for Others Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel love for others. FACIT-Searchable Item Library Adult Version - I Feel Love for Others FSIL-I Feel Loved Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel loved. FACIT-Searchable Item Library Adult Version - I Feel Loved FSIL-I Feel Motivated to Do Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel motivated to do things. FACIT-Searchable Item Library Adult Version - I Feel Motivated to Do Things FSIL-I Feel Nervous Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel nervous. FACIT-Searchable Item Library Adult Version - I Feel Nervous FSIL-I Feel Numbness at My Surgical Site Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel numbness at my surgical site. FACIT-Searchable Item Library Adult Version - I Feel Numbness at My Surgical Site FSIL-I Feel Peaceful Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel peaceful. FACIT-Searchable Item Library Adult Version - I Feel Peaceful FSIL-I Feel Sad Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel sad. FACIT-Searchable Item Library Adult Version - I Feel Sad FSIL-I Feel Sexually Attractive Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel sexually attractive. FACIT-Searchable Item Library Adult Version - I Feel Sexually Attractive FSIL-I Feel Tightness in My Chest Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel tightness in my chest. FACIT-Searchable Item Library Adult Version - I Feel Tightness in My Chest FSIL-I Feel Tired Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel tired. FACIT-Searchable Item Library Adult Version - I Feel Tired FSIL-I Feel Trapped by My Condition Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel trapped by my condition. FACIT-Searchable Item Library Adult Version - I Feel Trapped by My Condition FSIL-I Feel Useful Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel useful. FACIT-Searchable Item Library Adult Version - I Feel Useful FSIL-I Feel Useless Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel useless. FACIT-Searchable Item Library Adult Version - I Feel Useless FSIL-I Feel Weak All Over Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel weak all over. FACIT-Searchable Item Library Adult Version - I Feel Weak All Over FSIL-I Get Annoyed Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get annoyed easily. FACIT-Searchable Item Library Adult Version - I Get Annoyed Easily FSIL-I Get Depressed Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get depressed easily. FACIT-Searchable Item Library Adult Version - I Get Depressed Easily FSIL-I Get Headaches Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get headaches. FACIT-Searchable Item Library Adult Version - I Get Headaches FSIL-I Get Support From My Friends Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get support from my friends. FACIT-Searchable Item Library Adult Version - I Get Support From My Friends FSIL-I Get Tired Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get tired easily. FACIT-Searchable Item Library Adult Version - I Get Tired Easily FSIL-I Have a Good Appetite Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have a good appetite. FACIT-Searchable Item Library Adult Version - I Have a Good Appetite FSIL-I Have a Lack of Energy Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have a lack of energy. FACIT-Searchable Item Library Adult Version - I Have a Lack of Energy FSIL-I Have a Loss of Appetite Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have a loss of appetite. FACIT-Searchable Item Library Adult Version - I Have a Loss of Appetite FSIL-I Have a Reason for Living Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have a reason for living. FACIT-Searchable Item Library Adult Version - I Have a Reason for Living FSIL-I Have Accepted My Illness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have accepted my illness. FACIT-Searchable Item Library Adult Version - I Have Accepted My Illness FSIL-I Have Aches and Pains in My Bones Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have aches and pains in my bones. FACIT-Searchable Item Library Adult Version - I Have Aches and Pains in My Bones FSIL-I Have Aches/Pains That Bother Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have aches and pains that bother me. FACIT-Searchable Item Library Adult Version - I Have Aches/Pains That Bother Me FSIL-I Have Been Able to Concentrate Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been able to concentrate. FACIT-Searchable Item Library Adult Version - I Have Been Able to Concentrate FSIL-I Have Been Bothered by Diarrhea Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been bothered by diarrhea (diarrhoea). FACIT-Searchable Item Library Adult Version - I Have Been Bothered by Diarrhea FSIL-I Have Been Coughing Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been coughing. FACIT-Searchable Item Library Adult Version - I Have Been Coughing FSIL-I Have Been Emotionally Distressed Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been emotionally distressed. FACIT-Searchable Item Library Adult Version - I Have Been Emotionally Distressed FSIL-I Have Been Short of Breath Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been short of breath. FACIT-Searchable Item Library Adult Version - I Have Been Short of Breath FSIL-I Have Been Upset About Problems Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been upset about these problems. FACIT-Searchable Item Library Adult Version - I Have Been Upset About Problems FSIL-I Have Been Vomiting Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been vomiting. FACIT-Searchable Item Library Adult Version - I Have Been Vomiting FSIL-I Have Been Wheezing Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been wheezing (whistling sound when I breathe). FACIT-Searchable Item Library Adult Version - I Have Been Wheezing FSIL-I Have Bone Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have bone pain. FACIT-Searchable Item Library Adult Version - I Have Bone Pain FSIL-I Have Cold Sweats Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have cold sweats. FACIT-Searchable Item Library Adult Version - I Have Cold Sweats FSIL-I Have Confidence in My Doctor(s) Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have confidence in my doctor(s). FACIT-Searchable Item Library Adult Version - I Have Confidence in My Doctor(s) FSIL-I Have Confidence in My Pharmacist Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have confidence in my pharmacist(s). FACIT-Searchable Item Library Adult Version - I Have Confidence in My Pharmacist FSIL-I Have Control of My Bowels Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have control of my bowels. FACIT-Searchable Item Library Adult Version - I Have Control of My Bowels FSIL-I Have Cramping in My Pelvic Area Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have cramping in my pelvic area. FACIT-Searchable Item Library Adult Version - I Have Cramping in My Pelvic Area FSIL-I Have Cramps in My Stomach Area Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have cramps in my stomach area. FACIT-Searchable Item Library Adult Version - I Have Cramps in My Stomach Area FSIL-I Have Diarrhea Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have diarrhea (diarrhoea). FACIT-Searchable Item Library Adult Version - I Have Diarrhea FSIL-I Have Difficultly Raising My Arm Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficultly raising my arm. FACIT-Searchable Item Library Adult Version - I Have Difficultly Raising My Arm FSIL-I Have Difficulty Breathing Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty breathing. FACIT-Searchable Item Library Adult Version - I Have Difficulty Breathing FSIL-I Have Difficulty Thinking Clearly Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty thinking clearly (remembering, concentrating). FACIT-Searchable Item Library Adult Version - I Have Difficulty Thinking Clearly FSIL-I Have Difficulty Urinating Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty urinating. FACIT-Searchable Item Library Adult Version - I Have Difficulty Urinating FSIL-I Have Discomfort When I Am Sitting Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have discomfort when I am sitting. FACIT-Searchable Item Library Adult Version - I Have Discomfort When I Am Sitting FSIL-I Have Discomfort When I Urinate Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have discomfort when I urinate. FACIT-Searchable Item Library Adult Version - I Have Discomfort When I Urinate FSIL-I Have Emotional Ups and Downs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have emotional ups and downs. FACIT-Searchable Item Library Adult Version - I Have Emotional Ups and Downs FSIL-I Have Energy Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have energy. FACIT-Searchable Item Library Adult Version - I Have Energy FSIL-I Have Episodes of Heart Racing Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have episodes of heart racing. FACIT-Searchable Item Library Adult Version - I Have Episodes of Heart Racing FSIL-I Have Frequent Colds/Infections Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have frequent colds/infections. FACIT-Searchable Item Library Adult Version - I Have Frequent Colds/Infections FSIL-I Have Gained Weight Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have gained weight. FACIT-Searchable Item Library Adult Version - I Have Gained Weight FSIL-I Have Had Blood in My Urine Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had blood in my urine. FACIT-Searchable Item Library Adult Version - I Have Had Blood in My Urine FSIL-I Have Had Chills Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had chills. FACIT-Searchable Item Library Adult Version - I Have Had Chills FSIL-I Have Had Fevers Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had fevers (episodes of high body temperature). FACIT-Searchable Item Library Adult Version - I Have Had Fevers FSIL-I Have Had Itching Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had itching. FACIT-Searchable Item Library Adult Version - I Have Had Itching FSIL-I Have Had Seizures Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had seizures (convulsions). FACIT-Searchable Item Library Adult Version - I Have Had Seizures FSIL-I Have Had Trouble Concentrating Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble concentrating. FACIT-Searchable Item Library Adult Version - I Have Had Trouble Concentrating FSIL-I Have Hot Flashes/Hot Flushes Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have hot flashes/hot flushes. FACIT-Searchable Item Library Adult Version - I Have Hot Flashes/Hot Flushes FSIL-I Have Lost Interest in Sex Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have lost interest in sex. FACIT-Searchable Item Library Adult Version - I Have Lost Interest in Sex FSIL-I Have Mood Swings Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have mood swings. FACIT-Searchable Item Library Adult Version - I Have Mood Swings FSIL-I Have Mouth Sores Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have mouth sores. FACIT-Searchable Item Library Adult Version - I Have Mouth Sores FSIL-I Have Nausea Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have nausea. FACIT-Searchable Item Library Adult Version - I Have Nausea FSIL-I Have Night Sweats Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have night sweats. FACIT-Searchable Item Library Adult Version - I Have Night Sweats FSIL-I Have Noticed Blood in My Stool Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have noticed blood in my stool. FACIT-Searchable Item Library Adult Version - I Have Noticed Blood in My Stool FSIL-I Have Numbness in My Legs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have numbness in my legs. FACIT-Searchable Item Library Adult Version - I Have Numbness in My Legs FSIL-I Have Pain in Arm and/or Shoulder Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my arm and/or shoulder. FACIT-Searchable Item Library Adult Version - I Have Pain in Arm and/or Shoulder FSIL-I Have Pain in My Back Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my back. FACIT-Searchable Item Library Adult Version - I Have Pain in My Back FSIL-I Have Pain in My Breast Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my breast. FACIT-Searchable Item Library Adult Version - I Have Pain in My Breast FSIL-I Have Pain in My Chest Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my chest. FACIT-Searchable Item Library Adult Version - I Have Pain in My Chest FSIL-I Have Pain in My Fingertips Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my fingertips. FACIT-Searchable Item Library Adult Version - I Have Pain in My Fingertips FSIL-I Have Pain in My Joints Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my joints. FACIT-Searchable Item Library Adult Version - I Have Pain in My Joints FSIL-I Have Pain in My Pelvic Area Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my pelvic area. FACIT-Searchable Item Library Adult Version - I Have Pain in My Pelvic Area FSIL-I Have Pain in My Sinus Area Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my sinus area. FACIT-Searchable Item Library Adult Version - I Have Pain in My Sinus Area FSIL-I Have Pain in My Stomach Area Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my stomach area. FACIT-Searchable Item Library Adult Version - I Have Pain in My Stomach Area FSIL-I Have Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain. FACIT-Searchable Item Library Adult Version - I Have Pain FSIL-I Have Peace of Mind Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have peace of mind. FACIT-Searchable Item Library Adult Version - I Have Peace of Mind FSIL-I Have Strength in My Arm(s) Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have strength in my arm(s). FACIT-Searchable Item Library Adult Version - I Have Strength in My Arm(s) FSIL-I Have Strength in My Legs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have strength in my legs. FACIT-Searchable Item Library Adult Version - I Have Strength in My Legs FSIL-I Have Swelling at My Melanoma Site Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have swelling at my melanoma site. FACIT-Searchable Item Library Adult Version - I Have Swelling at My Melanoma Site FSIL-I Have Swelling in Stomach Area Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have swelling in my stomach area. FACIT-Searchable Item Library Adult Version - I Have Swelling in Stomach Area FSIL-I Have the Desire to Eat Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have the desire to eat. FACIT-Searchable Item Library Adult Version - I Have the Desire to Eat FSIL-I Have Tremors Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have tremors. FACIT-Searchable Item Library Adult Version - I Have Tremors FSIL-I Have Trouble Bending Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble bending. FACIT-Searchable Item Library Adult Version - I Have Trouble Bending FSIL-I Have Trouble Breathing Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble breathing. FACIT-Searchable Item Library Adult Version - I Have Trouble Breathing FSIL-I Have Trouble Buttoning Buttons Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble buttoning buttons. FACIT-Searchable Item Library Adult Version - I Have Trouble Buttoning Buttons FSIL-I Have Trouble Concentrating Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble concentrating. FACIT-Searchable Item Library Adult Version - I Have Trouble Concentrating FSIL-I Have Trouble Forming Thoughts Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble forming thoughts. FACIT-Searchable Item Library Adult Version - I Have Trouble Forming Thoughts FSIL-I Have Trouble Hearing Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble hearing. FACIT-Searchable Item Library Adult Version - I Have Trouble Hearing FSIL-I Have Trouble Learning New Tasks Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble learning new tasks or directions. FACIT-Searchable Item Library Adult Version - I Have Trouble Learning New Tasks FSIL-I Have Trouble Moving My Bowels Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble moving my bowels. FACIT-Searchable Item Library Adult Version - I Have Trouble Moving My Bowels FSIL-I Have Trouble Remembering Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble remembering things. FACIT-Searchable Item Library Adult Version - I Have Trouble Remembering Things FSIL-I Have Trouble Sleeping at Night Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble sleeping at night. FACIT-Searchable Item Library Adult Version - I Have Trouble Sleeping at Night FSIL-I Have Trouble Smelling Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble smelling. FACIT-Searchable Item Library Adult Version - I Have Trouble Smelling FSIL-I Have Trouble Walking Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble walking. FACIT-Searchable Item Library Adult Version - I Have Trouble Walking FSIL-I Have Trouble With Coordination Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble with coordination. FACIT-Searchable Item Library Adult Version - I Have Trouble With Coordination FSIL-I Have Trouble With My Bowels Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble with my bowels. FACIT-Searchable Item Library Adult Version - I Have Trouble With My Bowels FSIL-I Have Trouble With My Eyesight Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble with my eyesight. FACIT-Searchable Item Library Adult Version - I Have Trouble With My Eyesight FSIL-I Have Vaginal Bleeding or Spotting Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have vaginal bleeding or spotting. FACIT-Searchable Item Library Adult Version - I Have Vaginal Bleeding or Spotting FSIL-I Have Vaginal Discharge Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have vaginal discharge. FACIT-Searchable Item Library Adult Version - I Have Vaginal Discharge FSIL-I Have Vaginal Dryness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have vaginal dryness. FACIT-Searchable Item Library Adult Version - I Have Vaginal Dryness FSIL-I Have Vaginal Itching/Irritation Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have vaginal itching/irritation. FACIT-Searchable Item Library Adult Version - I Have Vaginal Itching/Irritation FSIL-I Have Weakness in My Legs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have weakness in my legs. FACIT-Searchable Item Library Adult Version - I Have Weakness in My Legs FSIL-I Like the Appearance of My Body Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I like the appearance of my body. FACIT-Searchable Item Library Adult Version - I Like the Appearance of My Body FSIL-I Maintain Contact With My Friends Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I maintain contact with my friends. FACIT-Searchable Item Library Adult Version - I Maintain Contact With My Friends FSIL-I Make Each Day Count Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I make each day count. FACIT-Searchable Item Library Adult Version - I Make Each Day Count FSIL-I Need Help in Caring for Myself Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I need help in caring for myself (bathing, dressing, eating, etc.). FACIT-Searchable Item Library Adult Version - I Need Help in Caring for Myself FSIL-I Need to Rest During the Day Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I need to rest during the day. FACIT-Searchable Item Library Adult Version - I Need to Rest During the Day FSIL-I Need to Sleep During the Day Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I need to sleep during the day. FACIT-Searchable Item Library Adult Version - I Need to Sleep During the Day FSIL-I Regret Bone Marrow Transplant Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I regret having the bone marrow transplant. FACIT-Searchable Item Library Adult Version - I Regret Bone Marrow Transplant FSIL-I Regret My Smoking Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I regret my smoking. FACIT-Searchable Item Library Adult Version - I Regret My Smoking FSIL-I Seem to Get Full Quickly Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: When I eat, I seem to get full quickly. FACIT-Searchable Item Library Adult Version - I Seem to Get Full Quickly FSIL-I Urinate More Frequently Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I urinate more frequently than usual. FACIT-Searchable Item Library Adult Version - I Urinate More Frequently FSIL-I Worry About Dying Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about dying. FACIT-Searchable Item Library Adult Version - I Worry About Dying FSIL-I Worry About Getting Infections Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about getting infections. FACIT-Searchable Item Library Adult Version - I Worry About Getting Infections FSIL-I Worry Bone Pain Will Get Worse Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that my bone pain will get worse. FACIT-Searchable Item Library Adult Version - I Worry Bone Pain Will Get Worse FSIL-I Worry Transplant Will Not Work Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that the transplant will not work. FACIT-Searchable Item Library Adult Version - I Worry Transplant Will Not Work FSIL-Illness a Financial Hardship Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My illness has been a financial hardship to my family and me. FACIT-Searchable Item Library Adult Version - Illness a Financial Hardship FSIL-Illness Caused Problems w/ Sex Life Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My illness or treatment has caused problems with my sex life. FACIT-Searchable Item Library Adult Version - Illness Caused Problems w/ Sex Life FSIL-Illness Is Hardship for My Family Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My illness is a personal hardship for my close family members. FACIT-Searchable Item Library Adult Version - Illness Is Hardship for My Family FSIL-Illness Strengthen Faith/Spiritual Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My illness has strengthened my faith or spiritual beliefs. FACIT-Searchable Item Library Adult Version - Illness Strengthen Faith/Spiritual FSIL-In control of Financial Situation Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel in control of my financial situation. FACIT-Searchable Item Library Adult Version - In control of Financial Situation FSIL-Inconvenienced Platelet Transfusion Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am inconvenienced by platelet transfusions. FACIT-Searchable Item Library Adult Version - Inconvenienced Platelet Transfusion FSIL-Inconvenient to Come for Radiation Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: It is inconvenient for me to come for my radiation treatments. FACIT-Searchable Item Library Adult Version - Inconvenient to Come for Radiation FSIL-Infusion Causes Me Physical Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The infusion for my bone treatment causes me physical pain. FACIT-Searchable Item Library Adult Version - Infusion Causes Me Physical Pain FSIL-Interest in Food Drops Try to Eat Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My interest in food drops as soon as I try to eat. FACIT-Searchable Item Library Adult Version - Interest in Food Drops Try to Eat FSIL-Interested in Sex Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am interested in sex. FACIT-Searchable Item Library Adult Version - Interested in Sex FSIL-Irritable Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am irritable. FACIT-Searchable Item Library Adult Version - Irritable FSIL-Isolate From Others B/c Condition Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I isolate myself from others because of my condition. FACIT-Searchable Item Library Adult Version - Isolate From Others B/c Condition FSIL-It Burns When I Urinate Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: It burns when I urinate. FACIT-Searchable Item Library Adult Version - It Burns When I Urinate FSIL-Joint Pain Limits My Usual Activ Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Joint pain limits my usual activities. FACIT-Searchable Item Library Adult Version - Joint Pain Limits My Usual Activ FSIL-Joint Stiffness/Tight Limits Activ Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Joint stiffness or tightness limits my usual activities. FACIT-Searchable Item Library Adult Version - Joint Stiffness/Tight Limits Activ FSIL-Left Out When Others Are Eating Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel left out when others are eating. FACIT-Searchable Item Library Adult Version - Left Out When Others Are Eating FSIL-Lifting 10-20 Lbs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Lifting something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries). FACIT-Searchable Item Library Adult Version - Lifting 10-20 Lbs FSIL-Limit Activities Because Diarrhea Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my activities because of diarrhea (diarrhoea). FACIT-Searchable Item Library Adult Version - Limit Activities Because Diarrhea FSIL-Limit My Sexual Activity Infection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my sexual activity because of the infection. FACIT-Searchable Item Library Adult Version - Limit My Sexual Activity Infection FSIL-Limit My Social Activity Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my social activity because of my condition. FACIT-Searchable Item Library Adult Version - Limit My Social Activity FSIL-Limit Physical Activ B/c Condition Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my physical activity because of my condition. FACIT-Searchable Item Library Adult Version - Limit Physical Activ B/c Condition FSIL-Limit Physical Activ B/c Diarrhea Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my physical activity because of diarrhea (diarrhoea). FACIT-Searchable Item Library Adult Version - Limit Physical Activ B/c Diarrhea FSIL-Limit Sexual Activ B/c Condition Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my sexual activity because of my condition. FACIT-Searchable Item Library Adult Version - Limit Sexual Activ B/c Condition FSIL-Limit Sexual Activity B/c Diarrhea Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my sexual activity because of diarrhea (diarrhoea). FACIT-Searchable Item Library Adult Version - Limit Sexual Activity B/c Diarrhea FSIL-Limit Social Activity B/c Diarrhea Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my social activity because of diarrhea (diarrhoea). FACIT-Searchable Item Library Adult Version - Limit Social Activity B/c Diarrhea FSIL-Limit Social Activity B/c Tired Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my social activity because I am tired. FACIT-Searchable Item Library Adult Version - Limit Social Activity B/c Tired FSIL-Losing Hope Fight Against Illness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am losing hope in the fight against my illness. FACIT-Searchable Item Library Adult Version - Losing Hope Fight Against Illness FSIL-Losing Weight Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am losing weight. FACIT-Searchable Item Library Adult Version - Losing Weight FSIL-Lost Food Choices Feeding Tube Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel that I have lost control of my food choices because I have a feeding tube. FACIT-Searchable Item Library Adult Version - Lost Food Choices Feeding Tube FSIL-Low Blood Counts Interfere Relation Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My low blood counts interfere with my intimate relationships. FACIT-Searchable Item Library Adult Version - Low Blood Counts Interfere Relation FSIL-Make Decisions Take Responsibility Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to make decisions and take responsibility. FACIT-Searchable Item Library Adult Version - Make Decisions Take Responsibility FSIL-Making a Bed Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Making a bed. FACIT-Searchable Item Library Adult Version - Making a Bed FSIL-Medical Expense More Than I Thought Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My out-of-pocket medical expenses are more than I thought they would be. FACIT-Searchable Item Library Adult Version - Medical Expense More Than I Thought FSIL-Memory Is as Good as Always Been Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My memory is as good as it has always been. FACIT-Searchable Item Library Adult Version - Memory Is as Good as Always Been FSIL-Mind Is as Sharp as Always Been Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My mind is as sharp as it has always been. FACIT-Searchable Item Library Adult Version - Mind Is as Sharp as Always Been FSIL-Miss Food/Drink Mouth Feeding Tube Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I miss being able to take more food or drink by mouth now that I have a feeding tube. FACIT-Searchable Item Library Adult Version - Miss Food/Drink Mouth Feeding Tube FSIL-Most Food Tastes Unpleasant to Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Most food tastes unpleasant to me. FACIT-Searchable Item Library Adult Version - Most Food Tastes Unpleasant to Me FSIL-Motivated to Do Activities Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am motivated to do my usual activities. FACIT-Searchable Item Library Adult Version - Motivated to Do Activities FSIL-Move Bowels Freq to Avoid Accidents Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I must move my bowels frequently to avoid accidents. FACIT-Searchable Item Library Adult Version - Move Bowels Freq to Avoid Accidents FSIL-Move My Bowels More Than Usual Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I move my bowels more frequently than usual. FACIT-Searchable Item Library Adult Version - Move My Bowels More Than Usual FSIL-Movement of Arm This Side Painful Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Movement of my arm on this side is painful. FACIT-Searchable Item Library Adult Version - Movement of Arm This Side Painful FSIL-Movement of Swollen Area Is Painful Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Movement of my swollen area is painful. FACIT-Searchable Item Library Adult Version - Movement of Swollen Area Is Painful FSIL-My Arm on This Side Feels Numb Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My arm on this side feels numb. FACIT-Searchable Item Library Adult Version - My Arm on This Side Feels Numb FSIL-My Breast Is Sensitive/Tender Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My breast is sensitive/tender. FACIT-Searchable Item Library Adult Version - My Breast Is Sensitive/Tender FSIL-My Breasts Are Painful Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My breasts are painful. FACIT-Searchable Item Library Adult Version - My Breasts Are Painful FSIL-My Breasts Are Swollen Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My breasts are swollen. FACIT-Searchable Item Library Adult Version - My Breasts Are Swollen FSIL-My Chest Area Is Sore Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My chest area (not including the breast itself) is sore. FACIT-Searchable Item Library Adult Version - My Chest Area Is Sore FSIL-My Condition Wakes Me Up at Night Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My condition wakes me up at night. FACIT-Searchable Item Library Adult Version - My Condition Wakes Me Up at Night FSIL-My Eyes Are Dry Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My eyes are dry. FACIT-Searchable Item Library Adult Version - My Eyes Are Dry FSIL-My Eyes Feel Sandy or Gritty Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My eyes feel sandy or gritty. FACIT-Searchable Item Library Adult Version - My Eyes Feel Sandy or Gritty FSIL-My Eyesight Is Blurry Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My eyesight is blurry. FACIT-Searchable Item Library Adult Version - My Eyesight Is Blurry FSIL-My Family Has Accepted My Illness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My family has accepted my illness. FACIT-Searchable Item Library Adult Version - My Family Has Accepted My Illness FSIL-My Family Pressuring Me to Eat Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My family or friends are pressuring me to eat. FACIT-Searchable Item Library Adult Version - My Family Pressuring Me to Eat FSIL-My General Health Is Improving Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My general health is improving. FACIT-Searchable Item Library Adult Version - My General Health Is Improving FSIL-My Hands Are Swollen Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My hands are swollen. FACIT-Searchable Item Library Adult Version - My Hands Are Swollen FSIL-My Legs or Feet Are Swollen Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My legs or feet are swollen. FACIT-Searchable Item Library Adult Version - My Legs or Feet Are Swollen FSIL-My Life Has Been Productive Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My life has been productive. FACIT-Searchable Item Library Adult Version - My Life Has Been Productive FSIL-My Life Lacks Meaning and Purpose Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My life lacks meaning and purpose. FACIT-Searchable Item Library Adult Version - My Life Lacks Meaning and Purpose FSIL-My Mouth and Throat Are Dry Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My mouth and throat are dry. FACIT-Searchable Item Library Adult Version - My Mouth and Throat Are Dry FSIL-My Mouth Is Dry Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My mouth is dry. FACIT-Searchable Item Library Adult Version - My Mouth Is Dry FSIL-My Skin Bleeds Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin bleeds easily. FACIT-Searchable Item Library Adult Version - My Skin Bleeds Easily FSIL-My Skin Condition Affects My Mood Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin condition affects my mood. FACIT-Searchable Item Library Adult Version - My Skin Condition Affects My Mood FSIL-My Skin Feels Irritated Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin feels irritated. FACIT-Searchable Item Library Adult Version - My Skin Feels Irritated FSIL-My Skin Itches Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin itches. FACIT-Searchable Item Library Adult Version - My Skin Itches FSIL-My Skin or Scalp Feels Irritated Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin or scalp feels irritated. FACIT-Searchable Item Library Adult Version - My Skin or Scalp Feels Irritated FSIL-My Skin or Scalp Is Dry or Flaky Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin or scalp is dry or "flaky". FACIT-Searchable Item Library Adult Version - My Skin or Scalp Is Dry or Flaky FSIL-My Skin or Scalp Itches Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin or scalp itches. FACIT-Searchable Item Library Adult Version - My Skin or Scalp Itches FSIL-My Thinking Has Been Slow Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My thinking has been slow. FACIT-Searchable Item Library Adult Version - My Thinking Has Been Slow FSIL-My Thinking Is Clear Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My thinking is clear. FACIT-Searchable Item Library Adult Version - My Thinking Is Clear FSIL-My Thinking Is Slower Than Before Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My thinking is slower than before. FACIT-Searchable Item Library Adult Version - My Thinking Is Slower Than Before FSIL-My Thinking Slower Than Usual Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My thinking has been slower than usual. FACIT-Searchable Item Library Adult Version - My Thinking Slower Than Usual FSIL-My Underarm Area Sensitive/Tender Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My underarm area is sensitive/tender. FACIT-Searchable Item Library Adult Version - My Underarm Area Sensitive/Tender FSIL-My Work Is Fulfilling Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My work (include work at home) is fulfilling. FACIT-Searchable Item Library Adult Version - My Work Is Fulfilling FSIL-Need Help Doing Activ B/c Bone Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I need help doing my usual activities because of bone pain. FACIT-Searchable Item Library Adult Version - Need Help Doing Activ B/c Bone Pain FSIL-Need Help Doing Usual Activities Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I need help doing my usual activities. FACIT-Searchable Item Library Adult Version - Need Help Doing Usual Activities FSIL-Nervous Making Decisions Treatment Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get nervous about making decisions regarding treatment. FACIT-Searchable Item Library Adult Version - Nervous Making Decisions Treatment FSIL-No Choice Money Spend on Care Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel I have no choice about the amount of money I spend on care. FACIT-Searchable Item Library Adult Version - No Choice Money Spend on Care FSIL-Noticed New Changes in My Skin Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have noticed new changes in my skin (lumps, bumps, color (colour)). FACIT-Searchable Item Library Adult Version - Noticed New Changes in My Skin FSIL-Numbness or Tingling in My Feet Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have numbness or tingling in my feet. FACIT-Searchable Item Library Adult Version - Numbness or Tingling in My Feet FSIL-Numbness or Tingling in My Hands Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have numbness or tingling in my hands. FACIT-Searchable Item Library Adult Version - Numbness or Tingling in My Hands FSIL-Numbness/Tingling in Arm/Shoulder Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have numbness or tingling in my arm, shoulder, or breast. FACIT-Searchable Item Library Adult Version - Numbness/Tingling in Arm/Shoulder FSIL-Nurse Explanations You Understand Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your nurse(s) give explanations that you could understand? FACIT-Searchable Item Library Adult Version - Nurse Explanations You Understand FSIL-Nurse Seem to Understand Your Needs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your nurse(s) seem to understand your needs? FACIT-Searchable Item Library Adult Version - Nurse Seem to Understand Your Needs FSIL-Nurse Show Genuine Concern for You Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your nurse(s) show genuine concern for you? FACIT-Searchable Item Library Adult Version - Nurse Show Genuine Concern for You FSIL-One/Both Arms Are Swollen/Tender Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: One or both of my arms are swollen or tender. FACIT-Searchable Item Library Adult Version - One/Both Arms Are Swollen/Tender FSIL-Pain at My Melanoma/Surgical Site Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain at my melanoma site or surgical site. FACIT-Searchable Item Library Adult Version - Pain at My Melanoma/Surgical Site FSIL-Pain in Hands/Feet Exposed to Cold Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my hands or feet when I am exposed to cold temperatures. FACIT-Searchable Item Library Adult Version - Pain in Hands/Feet Exposed to Cold FSIL-Pain in My Chest When I Swallow Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my chest when I swallow. FACIT-Searchable Item Library Adult Version - Pain in My Chest When I Swallow FSIL-Pain in My Mouth, Throat or Neck Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my mouth, throat or neck. FACIT-Searchable Item Library Adult Version - Pain in My Mouth, Throat or Neck FSIL-Pain Keeps Me From Doing Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My pain keeps me from doing things I want to do. FACIT-Searchable Item Library Adult Version - Pain Keeps Me From Doing Things FSIL-Pain on My Feet Interferes Walking Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Pain on the bottom of my feet interferes with my walking. FACIT-Searchable Item Library Adult Version - Pain on My Feet Interferes Walking FSIL-Pain/Soreness/Aches in Some Muscles Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel pain, soreness or aches in some of my muscles. FACIT-Searchable Item Library Adult Version - Pain/Soreness/Aches in Some Muscles FSIL-Painful Cracks Skin on Hands/Feet Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have painful cracks in the skin on my hands or feet. FACIT-Searchable Item Library Adult Version - Painful Cracks Skin on Hands/Feet FSIL-Painful Lesions/Tumors on My Skin Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have painful lesions or tumors on my skin. FACIT-Searchable Item Library Adult Version - Painful Lesions/Tumors on My Skin FSIL-Participate Decisions Health Care Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Were you encouraged to participate in decisions about your health care? FACIT-Searchable Item Library Adult Version - Participate Decisions Health Care FSIL-Partner Worries My Blood Counts Low Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My partner worries about me when my blood counts are low. FACIT-Searchable Item Library Adult Version - Partner Worries My Blood Counts Low FSIL-People Told Me I Seemed Confused Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Other people have told me I seemed confused. FACIT-Searchable Item Library Adult Version - People Told Me I Seemed Confused FSIL-Pharmacist Advises Adverse Effects Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My pharmacist advises me on the adverse (side) effects of my medicines. FACIT-Searchable Item Library Adult Version - Pharmacist Advises Adverse Effects FSIL-Pharmacist Advises Use of Medicines Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My pharmacist advises me on the proper use of my medicines. FACIT-Searchable Item Library Adult Version - Pharmacist Advises Use of Medicines FSIL-Pharmacist Available Questions Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My pharmacist is available to answer my questions. FACIT-Searchable Item Library Adult Version - Pharmacist Available Questions FSIL-Pharmacist Aware Treatment Needs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My pharmacist is aware of my treatment-related needs. FACIT-Searchable Item Library Adult Version - Pharmacist Aware Treatment Needs FSIL-Pharmacist Responds Treatment Needs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My pharmacist responds to my treatment-related needs. FACIT-Searchable Item Library Adult Version - Pharmacist Responds Treatment Needs FSIL-Pleasant Feel Fullness Tube Feeding Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I experience a pleasant feeling of fullness during or after my tube feeding. FACIT-Searchable Item Library Adult Version - Pleasant Feel Fullness Tube Feeding FSIL-Poor Range Arm Movements This Side Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have a poor range of arm movements on this side. FACIT-Searchable Item Library Adult Version - Poor Range Arm Movements This Side FSIL-Preparing Meals Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Preparing meals. FACIT-Searchable Item Library Adult Version - Preparing Meals FSIL-Problem Urinating Limits Activity Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My problems with urinating limit my activities. FACIT-Searchable Item Library Adult Version - Problem Urinating Limits Activity FSIL-Problems Interfered Ability Enjoy Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: These problems have interfered with my ability to do things I enjoy. FACIT-Searchable Item Library Adult Version - Problems Interfered Ability Enjoy FSIL-Problems Interfered Ability Work Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: These problems have interfered with my ability to work. FACIT-Searchable Item Library Adult Version - Problems Interfered Ability Work FSIL-Problems Interfered Quality Life Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: These problems have interfered with the quality of my life. FACIT-Searchable Item Library Adult Version - Problems Interfered Quality Life FSIL-Rate the Care You Received Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: How do you rate the care you received? FACIT-Searchable Item Library Adult Version - Rate the Care You Received FSIL-Rate This Chemo Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: How would you rate this chemotherapy? FACIT-Searchable Item Library Adult Version - Rate This Chemo FSIL-Rate This Treatment Overall Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: How do you rate this treatment overall? FACIT-Searchable Item Library Adult Version - Rate This Treatment Overall FSIL-Reach Into Myself for Comfort Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to reach down deep into myself for comfort. FACIT-Searchable Item Library Adult Version - Reach Into Myself for Comfort FSIL-Reaction Everyday Situations Slow Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My reactions in everyday situations have been slow. FACIT-Searchable Item Library Adult Version - Reaction Everyday Situations Slow FSIL-Received Treatment Right for You Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Do you feel you received the treatment that was right for you? FACIT-Searchable Item Library Adult Version - Received Treatment Right for You FSIL-Received Treatment That Was Right Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel that I received the treatment that was right for me. FACIT-Searchable Item Library Adult Version - Received Treatment That Was Right FSIL-Receiving Chemo Inconvenient Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Receiving chemotherapy is inconvenient. FACIT-Searchable Item Library Adult Version - Receiving Chemo Inconvenient FSIL-Receiving Treatment Is Inconvenient Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Receiving treatment for bone disease is inconvenient. FACIT-Searchable Item Library Adult Version - Receiving Treatment Is Inconvenient FSIL-Recommend Chemo to Others Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you recommend this chemotherapy to others with your illness? FACIT-Searchable Item Library Adult Version - Recommend Chemo to Others FSIL-Recommend Clinic/Office to Others Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you recommend this clinic or office to others? FACIT-Searchable Item Library Adult Version - Recommend Clinic/Office to Others FSIL-Recommend This Treatment to Others Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you recommend this treatment to others with your illness? FACIT-Searchable Item Library Adult Version - Recommend This Treatment to Others FSIL-Reduced Satisfaction Financial Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My cancer or treatment has reduced my satisfaction with my present financial situation. FACIT-Searchable Item Library Adult Version - Reduced Satisfaction Financial FSIL-Rest During Day B/c of Bone Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am forced to rest during the day because of bone pain. FACIT-Searchable Item Library Adult Version - Rest During Day B/c of Bone Pain FSIL-Satisfied Communication Illness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am satisfied with family communication about my illness. FACIT-Searchable Item Library Adult Version - Satisfied Communication Illness FSIL-Satisfied With Comfort Level Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am satisfied with my present comfort level. FACIT-Searchable Item Library Adult Version - Satisfied With Comfort Level FSIL-Satisfied With Effects of Treatment Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Are you satisfied with the effects of this treatment so far? FACIT-Searchable Item Library Adult Version - Satisfied With Effects of Treatment FSIL-Satisfied With Financial Situation Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am satisfied with my current financial situation. FACIT-Searchable Item Library Adult Version - Satisfied With Financial Situation FSIL-Satisfied With How I Am Coping Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am satisfied with how I am coping with my illness. FACIT-Searchable Item Library Adult Version - Satisfied With How I Am Coping FSIL-Satisfied With My Sex Life Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am satisfied with my sex life. FACIT-Searchable Item Library Adult Version - Satisfied With My Sex Life FSIL-Satisfied With Results Chemo Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Are you satisfied with the current results of your chemotherapy? FACIT-Searchable Item Library Adult Version - Satisfied With Results Chemo FSIL-Satisfied With Results of Treatment Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Are you satisfied with the results of the treatment for your bone disease so far? FACIT-Searchable Item Library Adult Version - Satisfied With Results of Treatment FSIL-Satisfied With Urinary Condition Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am satisfied with my urinary condition. FACIT-Searchable Item Library Adult Version - Satisfied With Urinary Condition FSIL-Self-conscious About Way I Dress Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am self-conscious about the way I dress. FACIT-Searchable Item Library Adult Version - Self-conscious About Way I Dress FSIL-Sensitivity Fingernails Diff Tasks Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Sensitivity around my fingernails makes it difficult to perform household tasks. FACIT-Searchable Item Library Adult Version - Sensitivity Fingernails Diff Tasks FSIL-Side Effects of Treatment So Far Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Compared to what you expected, how do you rate the side effects of treatment so far? FACIT-Searchable Item Library Adult Version - Side Effects of Treatment So Far FSIL-Side Effects of Treatment Worse Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The side effects of treatment are worse than I had imagined. FACIT-Searchable Item Library Adult Version - Side Effects of Treatment Worse FSIL-Skin Cond Interferes w/ Social Life Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin condition interferes with my social life. FACIT-Searchable Item Library Adult Version - Skin Cond Interferes w/ Social Life FSIL-Skin Condition Interferes w/ Sleep Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin condition interferes with my ability to sleep. FACIT-Searchable Item Library Adult Version - Skin Condition Interferes w/ Sleep FSIL-Skin Condition Make Life Difficult Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Changes in my skin condition make daily life difficult. FACIT-Searchable Item Library Adult Version - Skin Condition Make Life Difficult FSIL-Skin Feels Sensitive or Raw Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin feels sensitive or "raw". FACIT-Searchable Item Library Adult Version - Skin Feels Sensitive or Raw FSIL-Skin in Breast Area Itchy/Flaky/Dry Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The skin in my breast area is itchy, flaky or dry. FACIT-Searchable Item Library Adult Version - Skin in Breast Area Itchy/Flaky/Dry FSIL-Skin Is Dry or Flaky Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin is dry or "flaky". FACIT-Searchable Item Library Adult Version - Skin Is Dry or Flaky FSIL-Skin Side Effects Interfered Tasks Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The skin side effects from treatment have interfered with household tasks. FACIT-Searchable Item Library Adult Version - Skin Side Effects Interfered Tasks FSIL-Sleeping Well Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am sleeping well. FACIT-Searchable Item Library Adult Version - Sleeping Well FSIL-Smoke Cigarettes/Other Tobacco Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I smoke cigarettes or other tobacco products. FACIT-Searchable Item Library Adult Version - Smoke Cigarettes/Other Tobacco FSIL-Stiffness/Tightness in My Joints Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have stiffness or tightness in my joints. FACIT-Searchable Item Library Adult Version - Stiffness/Tightness in My Joints FSIL-Stomach Pain Interferes Functioning Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Stomach pain interferes with my daily functioning. FACIT-Searchable Item Library Adult Version - Stomach Pain Interferes Functioning FSIL-Stomach Problems That Worry Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have stomach problems that worry me. FACIT-Searchable Item Library Adult Version - Stomach Problems That Worry Me FSIL-Strength in Faith/Spiritual Beliefs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I find strength in my faith or spiritual beliefs. FACIT-Searchable Item Library Adult Version - Strength in Faith/Spiritual Beliefs FSIL-Sweeping/Mopping Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Sweeping or mopping. FACIT-Searchable Item Library Adult Version - Sweeping/Mopping FSIL-Swelling as a Result of Surgery Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have swelling as a result of surgery. FACIT-Searchable Item Library Adult Version - Swelling as a Result of Surgery FSIL-Swelling Keeps Me From Doing Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Swelling keeps me from doing the things I want to do. FACIT-Searchable Item Library Adult Version - Swelling Keeps Me From Doing Things FSIL-Swelling Keeps Me From Wearing Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Swelling keeps me from wearing clothes or shoes I want to wear. FACIT-Searchable Item Library Adult Version - Swelling Keeps Me From Wearing FSIL-Swelling/Cramps in Stomach Area Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have swelling or cramps in my stomach area. FACIT-Searchable Item Library Adult Version - Swelling/Cramps in Stomach Area FSIL-Take My Condition Into Account Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to take my condition into account when making plans. FACIT-Searchable Item Library Adult Version - Take My Condition Into Account FSIL-Taking Drug Infusion Inconvenient Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Taking the drug by infusion is inconvenient. FACIT-Searchable Item Library Adult Version - Taking Drug Infusion Inconvenient FSIL-Thankfulness Others Bring to Life Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Throughout the course of my day, I feel a sense of thankfulness for what others bring to my life. FACIT-Searchable Item Library Adult Version - Thankfulness Others Bring to Life FSIL-The Skin on My Feet Hurts Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The skin on my feet hurts. FACIT-Searchable Item Library Adult Version - The Skin on My Feet Hurts FSIL-The Skin on My Hands Hurts Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The skin on my hands hurts. FACIT-Searchable Item Library Adult Version - The Skin on My Hands Hurts FSIL-Tired Dealing With Skin Condition Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am tired of dealing with my skin condition. FACIT-Searchable Item Library Adult Version - Tired Dealing With Skin Condition FSIL-Told Family Members About Infection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have told family members about my infection. FACIT-Searchable Item Library Adult Version - Told Family Members About Infection FSIL-Told Me Trouble Remembering Info Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Other people have told me I seemed to have trouble remembering information. FACIT-Searchable Item Library Adult Version - Told Me Trouble Remembering Info FSIL-Told Me Trouble Speaking Clearly Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Other people have told me I seemed to have trouble speaking clearly. FACIT-Searchable Item Library Adult Version - Told Me Trouble Speaking Clearly FSIL-Told Me Trouble Thinking Clearly Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Other people have told me I seemed to have trouble thinking clearly. FACIT-Searchable Item Library Adult Version - Told Me Trouble Thinking Clearly FSIL-Told Partner/Spouse About Infection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have told my partner/spouse about my infection. FACIT-Searchable Item Library Adult Version - Told Partner/Spouse About Infection FSIL-Too Tired to Eat Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am too tired to eat. FACIT-Searchable Item Library Adult Version - Too Tired to Eat FSIL-Treatment Bone Disease Takes Time Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Treatment for bone disease takes up my time. FACIT-Searchable Item Library Adult Version - Treatment Bone Disease Takes Time FSIL-Treatment Bone Disease to Others Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you recommend this treatment for bone disease to others with your illness? FACIT-Searchable Item Library Adult Version - Treatment Bone Disease to Others FSIL-Treatment Causes Me Physical Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My treatment for bone disease causes me physical pain. FACIT-Searchable Item Library Adult Version - Treatment Causes Me Physical Pain FSIL-Treatment Schedule Stressful Family Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My treatment schedule for bone disease is stressful to my family. FACIT-Searchable Item Library Adult Version - Treatment Schedule Stressful Family FSIL-Treatment Schedule Stressful to Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My treatment schedule for bone disease is stressful to me. FACIT-Searchable Item Library Adult Version - Treatment Schedule Stressful to Me FSIL-Treatment Seems Harmful to Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Treatment for bone disease seems harmful to me. FACIT-Searchable Item Library Adult Version - Treatment Seems Harmful to Me FSIL-Treatment Staff Answered Honestly Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you feel that the treatment staff answered your questions honestly? FACIT-Searchable Item Library Adult Version - Treatment Staff Answered Honestly FSIL-Treatment Staff Discuss Activities Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did the treatment staff discuss how your health and treatment may affect your normal daily activities? FACIT-Searchable Item Library Adult Version - Treatment Staff Discuss Activities FSIL-Treatment Staff Discuss Emotionally Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did the treatment staff discuss how your health and treatment may affect you emotionally? FACIT-Searchable Item Library Adult Version - Treatment Staff Discuss Emotionally FSIL-Treatment Staff Discuss Relation Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did the treatment staff discuss how your health and treatment may affect your personal relationships? FACIT-Searchable Item Library Adult Version - Treatment Staff Discuss Relation FSIL-Treatment Staff Discuss Work Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did the treatment staff discuss how your health and treatment may affect your normal work (including housework)? FACIT-Searchable Item Library Adult Version - Treatment Staff Discuss Work FSIL-Treatment Staff Respect Privacy Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did the treatment staff respect your privacy? FACIT-Searchable Item Library Adult Version - Treatment Staff Respect Privacy FSIL-Treatment Staff Thorough Examining Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Was the treatment staff thorough in examining and treating you? FACIT-Searchable Item Library Adult Version - Treatment Staff Thorough Examining FSIL-Treatment Takes Up My Family's Time Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My treatment for bone disease takes up my family's time. FACIT-Searchable Item Library Adult Version - Treatment Takes Up My Family's Time FSIL-Trouble Digesting Food Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble digesting food. FACIT-Searchable Item Library Adult Version - Trouble Digesting Food FSIL-Trouble Feeling Arm/Hands/Legs Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble feeling sensations in my arm, hands or legs. FACIT-Searchable Item Library Adult Version - Trouble Feeling Arm/Hands/Legs FSIL-Trouble Feeling Shape of Objects Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble feeling the shape of small objects when they are in my hand. FACIT-Searchable Item Library Adult Version - Trouble Feeling Shape of Objects FSIL-Trouble Finding Familiar Place Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble finding my way to a familiar place. FACIT-Searchable Item Library Adult Version - Trouble Finding Familiar Place FSIL-Trouble Finding Right Words Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble finding the right word(s) to express myself. FACIT-Searchable Item Library Adult Version - Trouble Finding Right Words FSIL-Trouble Finishing Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble finishing things because I am tired. FACIT-Searchable Item Library Adult Version - Trouble Finishing Things FSIL-Trouble Getting Around in Public Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble getting around in public places. FACIT-Searchable Item Library Adult Version - Trouble Getting Around in Public FSIL-Trouble Keeping Track Interrupted Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble keeping track of what I am doing if I am interrupted. FACIT-Searchable Item Library Adult Version - Trouble Keeping Track Interrupted FSIL-Trouble Meeting Needs of Family Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Because of my physical condition, I have trouble meeting the needs of my family. FACIT-Searchable Item Library Adult Version - Trouble Meeting Needs of Family FSIL-Trouble Recalling Name of Object Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble recalling the name of an object while talking to someone. FACIT-Searchable Item Library Adult Version - Trouble Recalling Name of Object FSIL-Trouble Remember Where Put Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble remembering where I put things, like my keys or my wallet. FACIT-Searchable Item Library Adult Version - Trouble Remember Where Put Things FSIL-Trouble Remembering New Info Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble remembering new information, like phone numbers or simple instructions. FACIT-Searchable Item Library Adult Version - Trouble Remembering New Info FSIL-Trouble Saying What I Mean Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble saying what I mean in conversations with others. FACIT-Searchable Item Library Adult Version - Trouble Saying What I Mean FSIL-Trouble Shifting Back and Forth Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble shifting back and forth between different activities that require thinking. FACIT-Searchable Item Library Adult Version - Trouble Shifting Back and Forth FSIL-Trouble Sleeping B/c Skin Condition Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble sleeping because of my skin condition. FACIT-Searchable Item Library Adult Version - Trouble Sleeping B/c Skin Condition FSIL-Trouble Starting Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble starting things because I am tired. FACIT-Searchable Item Library Adult Version - Trouble Starting Things FSIL-Trouble Walking Because Bone Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble walking because of bone pain. FACIT-Searchable Item Library Adult Version - Trouble Walking Because Bone Pain FSIL-Trouble Walking Because of Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble walking because of pain. FACIT-Searchable Item Library Adult Version - Trouble Walking Because of Pain FSIL-Troubled Not Knowing Side Effects Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am troubled by not knowing when exactly my side effects will happen, how long they will last and how bad they will be. FACIT-Searchable Item Library Adult Version - Troubled Not Knowing Side Effects FSIL-Trust Doctor Suggestions Treatment Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you trust your doctor(s)' suggestions for treatment? FACIT-Searchable Item Library Adult Version - Trust Doctor Suggestions Treatment FSIL-Tube Feed Limits Do Inside House Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Tube feeding limits what I can do inside the house (for example housework, watching TV or reading). FACIT-Searchable Item Library Adult Version - Tube Feed Limits Do Inside House FSIL-Tube Feeding Limits Activities Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Tube feeding limits my activities with my friends. FACIT-Searchable Item Library Adult Version - Tube Feeding Limits Activities FSIL-Tube Feeding Limits Do Outside Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Tube feeding limits what I can do outside of the house (for example shopping, driving or yard work). FACIT-Searchable Item Library Adult Version - Tube Feeding Limits Do Outside FSIL-Unattractive B/c How My Skin Looks Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel unattractive because of how my skin looks. FACIT-Searchable Item Library Adult Version - Unattractive B/c How My Skin Looks FSIL-Uncertain About My Future Health Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel uncertain about my future health. FACIT-Searchable Item Library Adult Version - Uncertain About My Future Health FSIL-Uncomfortably Full Tube Feeding Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel uncomfortably full during or after my tube feeding. FACIT-Searchable Item Library Adult Version - Uncomfortably Full Tube Feeding FSIL-Unhappy About Change in My Appear Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am unhappy about a change in my appearance. FACIT-Searchable Item Library Adult Version - Unhappy About Change in My Appear FSIL-Unhappy With How Face & Neck Look Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am unhappy with how my face and neck look. FACIT-Searchable Item Library Adult Version - Unhappy With How Face & Neck Look FSIL-Unhappy With My Appearance Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am unhappy with my appearance. FACIT-Searchable Item Library Adult Version - Unhappy With My Appearance FSIL-Urinate Frequently to Avoid Leaking Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I must urinate frequently to avoid leaking. FACIT-Searchable Item Library Adult Version - Urinate Frequently to Avoid Leaking FSIL-Use Written Lists More Often Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had to use written lists more often than usual so I would not forget things. FACIT-Searchable Item Library Adult Version - Use Written Lists More Often FSIL-Used Wrong Word When Refer Object Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have used the wrong word when I referred to an object. FACIT-Searchable Item Library Adult Version - Used Wrong Word When Refer Object FSIL-Vagina Feels Too Narrow/Short Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My vagina feels too narrow or short. FACIT-Searchable Item Library Adult Version - Vagina Feels Too Narrow/Short FSIL-Voice Has Usual Quality & Strength Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My voice has its usual quality and strength. FACIT-Searchable Item Library Adult Version - Voice Has Usual Quality & Strength FSIL-Vomiting Dur/After Tube Feeding Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I experience vomiting during or after my tube feeding. FACIT-Searchable Item Library Adult Version - Vomiting Dur/After Tube Feeding FSIL-Waiting Breakfast Is Inconvenient Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Waiting up to 60 minutes before eating breakfast in the morning is inconvenient. FACIT-Searchable Item Library Adult Version - Waiting Breakfast Is Inconvenient FSIL-Wake at Night Because of Coughing Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I wake at night because of coughing. FACIT-Searchable Item Library Adult Version - Wake at Night Because of Coughing FSIL-Walked Into a Room and Forgotten Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have walked into a room and forgotten what I meant to get or do there. FACIT-Searchable Item Library Adult Version - Walked Into a Room and Forgotten FSIL-Walking 50 Steps Flat Normal Speed Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Walking 50 steps/paces on flat ground at a normal speed without stopping. FACIT-Searchable Item Library Adult Version - Walking 50 Steps Flat Normal Speed FSIL-Walking for 1/2 Mile w/o Stopping Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping. FACIT-Searchable Item Library Adult Version - Walking for 1/2 Mile w/o Stopping FSIL-Walking Up 20 Stairs w/o Stopping Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Walking up 20 stairs (2 flights) without stopping. FACIT-Searchable Item Library Adult Version - Walking Up 20 Stairs w/o Stopping FSIL-Washing Dishes Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Washing dishes. FACIT-Searchable Item Library Adult Version - Washing Dishes FSIL-Wear Pads/Protect Prevent Soiling Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I wear pads or protection to prevent soiling my underwear. FACIT-Searchable Item Library Adult Version - Wear Pads/Protect Prevent Soiling FSIL-Wear Protection Leakage of Urine Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I wear protection for leakage of urine. FACIT-Searchable Item Library Adult Version - Wear Protection Leakage of Urine FSIL-Whatever Happens Illness Will Be OK Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I know that whatever happens with my illness, things will be okay. FACIT-Searchable Item Library Adult Version - Whatever Happens Illness Will Be OK FSIL-Which Side Was Breast Operation Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: On which side was your breast operation? FACIT-Searchable Item Library Adult Version - Which Side Was Breast Operation FSIL-Women: Bothered by Vaginal Bleeding Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: For women only: I am bothered by vaginal bleeding. FACIT-Searchable Item Library Adult Version - Women: Bothered by Vaginal Bleeding FSIL-Work Hard to Pay Attention Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had to work really hard to pay attention or I would make a mistake. FACIT-Searchable Item Library Adult Version - Work Hard to Pay Attention FSIL-Work Harder Than Usual to Express Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had to work harder than usual to express myself clearly. FACIT-Searchable Item Library Adult Version - Work Harder Than Usual to Express FSIL-Work Harder Than Usual to Track Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had to work harder than usual to keep track of what I was doing. FACIT-Searchable Item Library Adult Version - Work Harder Than Usual to Track FSIL-Worried About My Weight Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am worried about my weight. FACIT-Searchable Item Library Adult Version - Worried About My Weight FSIL-Worry About Attitudes Towards Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about other people's attitudes towards me. FACIT-Searchable Item Library Adult Version - Worry About Attitudes Towards Me FSIL-Worry About Serious Bleeding Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about the possibility of serious bleeding. FACIT-Searchable Item Library Adult Version - Worry About Serious Bleeding FSIL-Worry About Side Effects Treatment Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about side effects from treatment for bone disease. FACIT-Searchable Item Library Adult Version - Worry About Side Effects Treatment FSIL-Worry About Spreading My Infection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about spreading my infection. FACIT-Searchable Item Library Adult Version - Worry About Spreading My Infection FSIL-Worry About Spreading the Infection Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about spreading the infection. FACIT-Searchable Item Library Adult Version - Worry About Spreading the Infection FSIL-Worry About the Effect of Stress Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about the effect of stress on my illness. FACIT-Searchable Item Library Adult Version - Worry About the Effect of Stress FSIL-Worry Appearance of Surgical Scars Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about the appearance of surgical scars. FACIT-Searchable Item Library Adult Version - Worry Appearance of Surgical Scars FSIL-Worry Chemo Not Effective Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that my chemotherapy will not be effective. FACIT-Searchable Item Library Adult Version - Worry Chemo Not Effective FSIL-Worry Family Will Get Illness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that other members of my family might someday get the same illness I have. FACIT-Searchable Item Library Adult Version - Worry Family Will Get Illness FSIL-Worry Feeding Tube Health Is Worse Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that having a feeding tube means my health is worse. FACIT-Searchable Item Library Adult Version - Worry Feeding Tube Health Is Worse FSIL-Worry Financial Problems in Future Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about the financial problems I will have in the future as a result of my illness or treatment. FACIT-Searchable Item Library Adult Version - Worry Financial Problems in Future FSIL-Worry Getting Sick Low Blood Counts Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about getting sick due to low blood counts. FACIT-Searchable Item Library Adult Version - Worry Getting Sick Low Blood Counts FSIL-Worry I Might Get New Symptoms Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that I might get new symptoms of my illness. FACIT-Searchable Item Library Adult Version - Worry I Might Get New Symptoms FSIL-Worry Infection From Feeding Tube Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about getting an infection from the feeding tube. FACIT-Searchable Item Library Adult Version - Worry Infection From Feeding Tube FSIL-Worry Infection Will Get Worse Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that the infection will get worse. FACIT-Searchable Item Library Adult Version - Worry Infection Will Get Worse FSIL-Worry Losing Weight Feeding Tube Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about losing weight because I have a feeding tube. FACIT-Searchable Item Library Adult Version - Worry Losing Weight Feeding Tube FSIL-Worry My Condition Will Get Worse Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that my condition will get worse. FACIT-Searchable Item Library Adult Version - Worry My Condition Will Get Worse FSIL-Worry Neg Impacts Long-term Health Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about negative impacts that my treatment may have upon my long-term health. FACIT-Searchable Item Library Adult Version - Worry Neg Impacts Long-term Health FSIL-Worry Not improve Treatment Delayed Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry my condition will not improve if my treatment is delayed. FACIT-Searchable Item Library Adult Version - Worry Not improve Treatment Delayed FSIL-Worry Problems Bruising/Bleeding Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about problems with bruising or bleeding. FACIT-Searchable Item Library Adult Version - Worry Problems Bruising/Bleeding FSIL-Worry Side Effects From Chemo Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about side effects from chemotherapy treatment. FACIT-Searchable Item Library Adult Version - Worry Side Effects From Chemo FSIL-Worry Skin condition Get Worse Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that my skin condition may get worse. FACIT-Searchable Item Library Adult Version - Worry Skin condition Get Worse FSIL-Worry Support Myself/Family Illness Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about being able to support myself or my family due to my illness. FACIT-Searchable Item Library Adult Version - Worry Support Myself/Family Illness FSIL-Worry Treatment Dose Will Reduced Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that my treatment dose will be reduced (because of low blood counts). FACIT-Searchable Item Library Adult Version - Worry Treatment Dose Will Reduced FSIL-Worry Treatment Not Effective Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that my treatment for bone disease will not be effective. FACIT-Searchable Item Library Adult Version - Worry Treatment Not Effective FSIL-Worry Treatment Will Be Delayed Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that my treatment will be delayed (because of low blood counts). FACIT-Searchable Item Library Adult Version - Worry Treatment Will Be Delayed FSIL-Worry Tube Coming Out by Accident Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about the tube coming out by accident. FACIT-Searchable Item Library Adult Version - Worry Tube Coming Out by Accident FSIL-Worry Tube Getting Plugged/Blocked Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about the tube getting plugged or blocked. FACIT-Searchable Item Library Adult Version - Worry Tube Getting Plugged/Blocked FSILTN Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult Questionnaire Test Name CDISC Questionnaire FACIT-Searchable Item Library Adult Version Test Name Terminology Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric test code. FSLP-C: I Eat as Much as I Want Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I eat as much as I want. FACIT-Searchable Item Library Pediatric Version Child - I Eat as Much as I Want FSLP-P: Child Eats as Much as S/He Wants Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child eats as much as s/he wants. FACIT-Searchable Item Library Pediatric Version Parent - Child Eats as Much as S/He Wants FSLP-C: I Seem to Get Full Quickly Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - When I eat, I seem to get full quickly. FACIT-Searchable Item Library Pediatric Version Child - I Seem to Get Full Quickly FSLP-P: Child Seems to Get Full Quickly Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - When my child eats, s/he seems to get full quickly. FACIT-Searchable Item Library Pediatric Version Parent - Child Seems to Get Full Quickly FSLP-C: I Have Pain in My Stomach Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I have pain in my stomach. FACIT-Searchable Item Library Pediatric Version Child - I Have Pain in My Stomach FSLP-P: Child Has Pain His/Her Stomach Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child has pain in his/her stomach. FACIT-Searchable Item Library Pediatric Version Parent - Child Has Pain His/Her Stomach FSLP-C: I Feel Like I Am Getting Better Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I feel like I am getting better. FACIT-Searchable Item Library Pediatric Version Child - I Feel Like I Am Getting Better FSLP-P: Child Feel Like Getting Better Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child feels like s/he is getting better. FACIT-Searchable Item Library Pediatric Version Parent - Child Feel Like Getting Better FSLP-C: I Eat Enough to Do Need to Do Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I eat enough food for me to do whatever I need to do. FACIT-Searchable Item Library Pediatric Version Child - I Eat Enough to Do Need to Do FSLP-P: Child Eats Enough to Do Needs Do Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child eats enough to do whatever s/he needs to do. FACIT-Searchable Item Library Pediatric Version Parent - Child Eats Enough to Do Needs Do FSLP-C: I Am Worried About My Weight Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I am worried about my weight. FACIT-Searchable Item Library Pediatric Version Child - I Am Worried About My Weight FSLP-P: Child Worried About Weight Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child is worried about his/her weight. FACIT-Searchable Item Library Pediatric Version Parent - Child Worried About Weight FSLP-C: Most Food Tastes Bad to Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - Most food tastes bad to me. FACIT-Searchable Item Library Pediatric Version Child - Most Food Tastes Bad to Me FSLP-P: Most Food Tastes Bad to My Child Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - Most food tastes bad to my child. FACIT-Searchable Item Library Pediatric Version Parent - Most Food Tastes Bad to My Child FSLP-C: I Am Worried About How Thin I Am Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I am worried about how thin I am. FACIT-Searchable Item Library Pediatric Version Child - I Am Worried About How Thin I Am FSLP-P: Child Worried About How Thin Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child is worried about how thin s/he is. FACIT-Searchable Item Library Pediatric Version Parent - Child Worried About How Thin FSLP-C: Start Eating Feel Like Stopping Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - As soon as I start eating, I feel like stopping. FACIT-Searchable Item Library Pediatric Version Child - Start Eating Feel Like Stopping FSLP-P: Child Starts Eating Feels Stop Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - As soon as my child starts eating, s/he feels like stopping. FACIT-Searchable Item Library Pediatric Version Parent - Child Starts Eating Feels Stop FSLP-C: I Afraid to Eat It Make Me Sick Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I am afraid to eat because it may make me sick. FACIT-Searchable Item Library Pediatric Version Child - I Afraid to Eat It Make Me Sick FSLP-P: Child Afraid to Eat It Make Sick Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child is afraid to eat because it may make her/him sick. FACIT-Searchable Item Library Pediatric Version Parent - Child Afraid to Eat It Make Sick FSLP-C: Family/Friends Get Me Eat More Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - My family or friends try to get me to eat more. FACIT-Searchable Item Library Pediatric Version Child - Family or Friends Get Me Eat More FSLP-P: Family/Friends Child Eat More Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - Family or friends try to get my child to eat more. FACIT-Searchable Item Library Pediatric Version Parent - Family or Friends Child Eat More FSLP-C: I Have Been Throwing Up Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I have been throwing up. FACIT-Searchable Item Library Pediatric Version Child - I Have Been Throwing Up FSLP-P: Child Has Been Throwing Up Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child has been throwing up. FACIT-Searchable Item Library Pediatric Version Parent - Child Has Been Throwing Up FSLP-C: Am Bothered Shorter Than People Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I am bothered by being shorter than other people. FACIT-Searchable Item Library Pediatric Version Child - Am Bothered Shorter Than People FSLP-P: Child Bothered Shorter Than Peer Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child is bothered by being shorter than his/her peers. FACIT-Searchable Item Library Pediatric Version Parent - Child Bothered Shorter Than Peer FSLP-C: I Read Things Several Times Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I have to read things several times so I can understand them. FACIT-Searchable Item Library Pediatric Version Child - I Read Things Several Times FSLP-P: Child Read Things Several Times Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child has to read things several times so s/he can understand them. FACIT-Searchable Item Library Pediatric Version Parent - Child Read Things Several Times FSLP-C: React More Slowly People My Age Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - When I play games or sports, I react more slowly than most people my age. FACIT-Searchable Item Library Pediatric Version Child - React More Slowly People My Age FSLP-P: Child Reacts More Slowly Peers Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - When my child plays games or sports, s/he reacts more slowly than his/her peers. FACIT-Searchable Item Library Pediatric Version Parent - Child Reacts More Slowly Peers FSLP-C: Hard for Me to Find Right Words Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - It is hard for me to find the right words to say what I mean. FACIT-Searchable Item Library Pediatric Version Child - Hard for Me to Find Right Words FSLP-P: Child Difficult Using Right Word Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child has difficulty using the right words. FACIT-Searchable Item Library Pediatric Version Parent - Child Difficult Using Right Word FSLP-C: I Am Bothered Unable to See Well Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I am bothered by being unable to see well. FACIT-Searchable Item Library Pediatric Version Child - I Am Bothered Unable to See Well FSLP-P: Child Is Bothered by Poor Vision Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child is bothered by poor vision. FACIT-Searchable Item Library Pediatric Version Parent - Child Is Bothered by Poor Vision FSLP-C: Am Bothered Unable to Hear Well Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I am bothered by being unable to hear well. FACIT-Searchable Item Library Pediatric Version Child - Am Bothered Unable to Hear Well FSLP-P: Child Bothered by Poor Hearing Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child is bothered by poor hearing. FACIT-Searchable Item Library Pediatric Version Parent - Child Bothered by Poor Hearing FSLP-C: I Am Bothered by Headaches Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I am bothered by headaches. FACIT-Searchable Item Library Pediatric Version Child - I Am Bothered by Headaches FSLP-P: My Child Bothered by Headaches Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child is bothered by headaches. FACIT-Searchable Item Library Pediatric Version Parent - My Child Bothered by Headaches FSLP-C: Speak People Trouble Understand Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - When I speak, people have trouble understanding me. FACIT-Searchable Item Library Pediatric Version Child - Speak People Trouble Understand FSLP-P: Child Speech Hard to Understand Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child's speech is hard for others to understand. FACIT-Searchable Item Library Pediatric Version Parent - Child Speech Hard to Understand FSLP-C: Work Harder Other People School Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I need to work harder than other people to get my school work done. FACIT-Searchable Item Library Pediatric Version Child - Work Harder Other People School FSLP-P: Child Work Harder Than Peers Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child needs to work harder than his/her peers to get work done. FACIT-Searchable Item Library Pediatric Version Parent - Child Work Harder Than Peers FSLP-C: My Grades Worse Than Before Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - My grades are worse than they were before I was sick. FACIT-Searchable Item Library Pediatric Version Child - My Grades Worse Than Before FSLP-P: Child Performance Worse Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child's school performance is worse than it was before s/he was diagnosed. FACIT-Searchable Item Library Pediatric Version Parent - Child Performance Worse FSLP-C: I Forget Things Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I forget things easily. FACIT-Searchable Item Library Pediatric Version Child - I Forget Things Easily FSLP-P: My Child Forgets Things Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child forgets things easily. FACIT-Searchable Item Library Pediatric Version Parent - My Child Forgets Things Easily FSLP-C: Hard for Me Concentrate School Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - It is hard for me to concentrate in school. FACIT-Searchable Item Library Pediatric Version Child - Hard for Me Concentrate School FSLP-P: Hard Child Concentrate School Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - It is hard for my child to concentrate in school. FACIT-Searchable Item Library Pediatric Version Parent - Hard Child Concentrate School FSLP-C: I Feel Happy Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I feel happy. FACIT-Searchable Item Library Pediatric Version Child - I Feel Happy FSLP-P: Child Seems Happy Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child seems happy. FACIT-Searchable Item Library Pediatric Version Parent - Child Seems Happy FSLP-C: Worry About Good Life in Future Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I worry about having a good life in the future. FACIT-Searchable Item Library Pediatric Version Child - Worry About Good Life in Future FSLP-P: Child Worries Good Life Future Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child worries about having a good life in the future. FACIT-Searchable Item Library Pediatric Version Parent - Child Worries Good Life Future FSLP-C: I Worry Able to Have Girlfriend Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I worry about being able to have a girlfriend or boyfriend because of my illness. FACIT-Searchable Item Library Pediatric Version Child - I Worry Able to Have Girlfriend FSLP-C: I Worry Able to Date Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I worry about being able to date because of my illness. FACIT-Searchable Item Library Pediatric Version Child - I Worry Able to Date FSLP-P: Child Worries Have Girlfriend Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child worries about being able to have a girlfriend or boyfriend because of his/her illness. FACIT-Searchable Item Library Pediatric Version Parent - Child Worries Have Girlfriend FSLP-C: I Worry Able to Go to College Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I worry about being able to go to college because of my illness. FACIT-Searchable Item Library Pediatric Version Child - I Worry Able to Go to College FSLP-P: Child Worries to Go to College Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child worries about being able to go to college because of his/her illness. FACIT-Searchable Item Library Pediatric Version Parent - Child Worries to Go to College FSLP-C: I Worry About Getting a Job Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I worry about getting a job because of my illness. FACIT-Searchable Item Library Pediatric Version Child - I Worry About Getting a Job FSLP-C: Worry Getting Job Support Myself Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I worry about getting a job to support myself because of my illness history. FACIT-Searchable Item Library Pediatric Version Child - Worry Getting Job Support Myself FSLP-P: Child Worries About Getting Job Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child worries about getting a job because of his/her illness. FACIT-Searchable Item Library Pediatric Version Parent - Child Worries About Getting Job FSLP-C: I Believe I Will Do Well Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - When I try to do something, I usually believe I will do it well. FACIT-Searchable Item Library Pediatric Version Child - I Believe I Will Do Well FSLP-P: Child Believes S/He Will Do Well Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - When my child tries to do something, s/he usually believes s/he will do it well. FACIT-Searchable Item Library Pediatric Version Parent - Child Believes S/He Will Do Well FSLP-C: Tumor Makes Me Stronger Person Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - The cancer/tumor experience makes me a stronger person. FACIT-Searchable Item Library Pediatric Version Child - Tumor Makes Me Stronger Person FSLP-P: Tumor Make Child Stronger Person Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - The cancer/tumor experience makes my child a stronger person. FACIT-Searchable Item Library Pediatric Version Parent - Tumor Make Child Stronger Person FSLP-C: Tumor Taught Me Appreciate Life Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - The cancer/tumor experience has taught me to appreciate life. FACIT-Searchable Item Library Pediatric Version Child - Tumor Taught Me Appreciate Life FSLP-P: Tumor Taught Child Appreciate Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - The cancer/tumor experience has taught my child to appreciate life. FACIT-Searchable Item Library Pediatric Version Parent - Tumor Taught Child Appreciate FSLP-C: Feel Other Child Better Than Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I often feel that other children are better than me. FACIT-Searchable Item Library Pediatric Version Child - Feel Other Child Better Than Me FSLP-P: Child Feels Inferior Children Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child often feels inferior to other children. FACIT-Searchable Item Library Pediatric Version Parent - Child Feels Inferior Children FSLP-C: Feel Other People Better Than Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I often feel that other people are better than me. FACIT-Searchable Item Library Pediatric Version Child - Feel Other People Better Than Me FSLP-P: Child Feel Inferior Other People Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child often feels inferior to other people. FACIT-Searchable Item Library Pediatric Version Parent - Child Feel Inferior Other People FSLP-C: I Worry Getting Another Tumor Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I worry about getting another cancer/tumor. FACIT-Searchable Item Library Pediatric Version Child - I Worry Getting Another Tumor FSLP-P: Child Worries Get Another Tumor Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child worries about getting another cancer/tumor. FACIT-Searchable Item Library Pediatric Version Parent - Child Worries Get Another Tumor FSLP-C: I Switch From Good to Bad Moods Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I often switch from good moods to bad moods. FACIT-Searchable Item Library Pediatric Version Child - I Switch From Good to Bad Moods FSLP-P: Child Is Moody or Irritable Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child is moody or irritable. FACIT-Searchable Item Library Pediatric Version Parent - Child Is Moody or Irritable FSLP-C: I Worry When I Go to Hospital Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I worry when I go back to the hospital or clinic. FACIT-Searchable Item Library Pediatric Version Child - I Worry When I Go to Hospital FSLP-P: Child Worries When Go Hospital Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child worries when we go back to the hospital or clinic. FACIT-Searchable Item Library Pediatric Version Parent - Child Worries When Go Hospital FSLP-C: I Get Nervous/Frightened Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I get nervous (frightened) easily. FACIT-Searchable Item Library Pediatric Version Child - I Get Nervous Frightened Easily FSLP-P: Child Get Nervous Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child gets nervous (frightened) easily. FACIT-Searchable Item Library Pediatric Version Parent - Child Get Nervous Easily FSLP-C: I Feel Tired Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I feel tired. FACIT-Searchable Item Library Pediatric Version Child - I Feel Tired FSLP-C: I Feel Weak Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I feel weak. FACIT-Searchable Item Library Pediatric Version Child - I Feel Weak FSLP-C: I Was Too Tired to Eat Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I was too tired to eat. FACIT-Searchable Item Library Pediatric Version Child - I Was Too Tired to Eat FSLP-C: Being Tired Made Me Sad Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - Being tired made me sad. FACIT-Searchable Item Library Pediatric Version Child - Being Tired Made Me Sad FSLP-C: Being Tired Made Me Mad Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - Being tired made me mad (angry). FACIT-Searchable Item Library Pediatric Version Child - Being Tired Made Me Mad FSLP-C: I Have Energy Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I have energy (or strength). FACIT-Searchable Item Library Pediatric Version Child - I Have Energy FSLP-C: Could Do My Usual Things at Home Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I could do my usual things at home. FACIT-Searchable Item Library Pediatric Version Child - Could Do My Usual Things at Home FSLP-C: Trouble Starting Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I had trouble starting things because I was too tired. FACIT-Searchable Item Library Pediatric Version Child - Trouble Starting Things FSLP-C: Trouble Finishing Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I had trouble finishing things because I was too tired. FACIT-Searchable Item Library Pediatric Version Child - Trouble Finishing Things FSLP-C: I Needed to Sleep During the Day Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I needed to sleep during the day. FACIT-Searchable Item Library Pediatric Version Child - I Needed to Sleep During the Day FSLP-C: Upset by Being Too Tired Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I got upset by being too tired to do things I wanted to do. FACIT-Searchable Item Library Pediatric Version Child - Upset by Being Too Tired FSLP-C: I Have Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I have pain. FACIT-Searchable Item Library Pediatric Version Child - I Have Pain FSLP-P: My Child Has Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child has pain. FACIT-Searchable Item Library Pediatric Version Parent - My Child Has Pain FSLP-C: Hard for Me to Play With Friends Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - Being tired made it hard for me to play or go out with my friends as much as I'd like. FACIT-Searchable Item Library Pediatric Version Child - Hard for Me to Play With Friends FSLP-C: Needed Help Doing Usual Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I needed help doing my usual things at home. FACIT-Searchable Item Library Pediatric Version Child - Needed Help Doing Usual Things FSLP-P: Child Loses Balance/Falls Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child loses balance or falls down easily. FACIT-Searchable Item Library Pediatric Version Parent - Child Loses Balance or Falls Easily FSLP-C: I Lose Balance/Fall Down Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I lose balance or fall down easily. FACIT-Searchable Item Library Pediatric Version Child - I Lose Balance or Fall Down Easily FSLP-C: Have Trouble Get Myself Dressed Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I have trouble getting myself dressed. FACIT-Searchable Item Library Pediatric Version Child - Have Trouble Get Myself Dressed FSLP-P: Child Trouble Get Dressed Own Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child has trouble getting dressed on his/her own. FACIT-Searchable Item Library Pediatric Version Parent - Child Trouble Get Dressed Own FSLP-C: Trouble Run Like Other Children Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I have trouble running like other children. FACIT-Searchable Item Library Pediatric Version Child - Trouble Run Like Other Children FSLP-P: Child Trouble Run Like Children Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child has trouble running like other children. FACIT-Searchable Item Library Pediatric Version Parent - Child Trouble Run Like Children FSLP-C: I Trouble Run Like Other People Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I have trouble running like other people. FACIT-Searchable Item Library Pediatric Version Child - I Trouble Run Like Other People FSLP-P: Child Trouble Run Like People Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child has trouble running like other people. FACIT-Searchable Item Library Pediatric Version Parent - Child Trouble Run Like People FSLP-C: I Get Tired Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I get tired easily. FACIT-Searchable Item Library Pediatric Version Child - I Get Tired Easily FSLP-P: Child Gets Tired Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child gets tired easily. FACIT-Searchable Item Library Pediatric Version Parent - Child Gets Tired Easily FSLP-C: My Arms or Legs Feel Weak Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - My arms or legs feel weak. FACIT-Searchable Item Library Pediatric Version Child - My Arms or Legs Feel Weak FSLP-P: Child Arms or Legs Seem Weak Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child's arms or legs seem weak. FACIT-Searchable Item Library Pediatric Version Parent - Child Arms or Legs Seem Weak FSLP-C: I Get Ill Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I get ill easily. FACIT-Searchable Item Library Pediatric Version Child - I Get Ill Easily FSLP-P: Child Gets Ill Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child gets ill easily. FACIT-Searchable Item Library Pediatric Version Parent - Child Gets Ill Easily FSLP-C: I Have Trouble Writing w/ a Pen Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I have trouble writing with a pen or pencil. FACIT-Searchable Item Library Pediatric Version Child - I Have Trouble Writing With a Pen FSLP-P: Child Has Trouble Writing w/Pen Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child has trouble writing with a pen or pencil. FACIT-Searchable Item Library Pediatric Version Parent - Child Has Trouble Writing With Pen FSLP-C: Other Children Pick on Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - Other children pick on (tease) me. FACIT-Searchable Item Library Pediatric Version Child - Other Children Pick on Me FSLP-P: Other Children Pick on My Child Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - Other children pick on (tease) my child. FACIT-Searchable Item Library Pediatric Version Parent - Other Children Pick on My Child FSLP-C: Other People Pick on Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - Other people pick on (tease) me. FACIT-Searchable Item Library Pediatric Version Child - Other People Pick on Me FSLP-P: Other People Pick on My Child Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - Other people pick on (tease) my child. FACIT-Searchable Item Library Pediatric Version Parent - Other People Pick on My Child FSLP-C: Have Fewer Friends Than Children Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I think I have fewer friends than other children. FACIT-Searchable Item Library Pediatric Version Child - Have Fewer Friends Than Children FSLP-P: Child Fewer Friend Than Children Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child has fewer friends than other children. FACIT-Searchable Item Library Pediatric Version Parent - Child Fewer Friend Than Children FSLP-C: I Have Fewer Friends Than Others Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I think I have fewer friends than others. FACIT-Searchable Item Library Pediatric Version Child - I Have Fewer Friends Than Others FSLP-P: Child Fewer Friends Than Others Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child has fewer friends than others. FACIT-Searchable Item Library Pediatric Version Parent - Child Fewer Friends Than Others FSLP-C: Children Avoid Play With Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - Other children avoid playing with me because I am different. FACIT-Searchable Item Library Pediatric Version Child - Children Avoid Play With Me FSLP-P: Children Avoid Play w/My Child Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - Other children avoid playing with my child because s/he is different. FACIT-Searchable Item Library Pediatric Version Parent - Children Avoid Play With My Child FSLP-C: People Avoid Hang Out With Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - Other people avoid hanging out with me because I am different. FACIT-Searchable Item Library Pediatric Version Child - People Avoid Hang Out With Me FSLP-P: People Avoid Hang Out w/My Child Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - Other people avoid hanging out with my child because s/he is different. FACIT-Searchable Item Library Pediatric Version Parent - People Avoid Hang Out With My Child FSLP-C: I Feel Lonely Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I feel lonely. FACIT-Searchable Item Library Pediatric Version Child - I Feel Lonely FSLP-P: My Child Seems Lonely Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child seems lonely. FACIT-Searchable Item Library Pediatric Version Parent - My Child Seems Lonely FSLP-C: Play Alone Than w/Other Children Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I would rather play alone than with other children. FACIT-Searchable Item Library Pediatric Version Child - Play Alone Than With Other Children FSLP-P: My Child Prefers to Play Alone Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child prefers to play alone. FACIT-Searchable Item Library Pediatric Version Parent - My Child Prefers to Play Alone FSLP-C: Do by Myself Than w/Other People Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I would rather do something by myself than with other people. FACIT-Searchable Item Library Pediatric Version Child - Do by Myself Than With Other People FSLP-P: Child Prefers Do Something Alone Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child prefers to do something alone. FACIT-Searchable Item Library Pediatric Version Parent - Child Prefers Do Something Alone FSLP-C: Parents Worry Too Much About Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - My parents worry too much about me. FACIT-Searchable Item Library Pediatric Version Child - Parents Worry Too Much About Me FSLP-P: Child Thinks Worry About Him/Her Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child thinks I worry too much about him/her. FACIT-Searchable Item Library Pediatric Version Parent - Child Thinks Worry About Him/Her FSLP-C: My Parents Spoil Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - My parents spoil me. FACIT-Searchable Item Library Pediatric Version Child - My Parents Spoil Me FSLP-P: My Child Thinks I Spoil Him/Her Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child thinks I spoil him/her. FACIT-Searchable Item Library Pediatric Version Parent - My Child Thinks I Spoil Him/Her FSLPTC Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric Questionnaire Test Code CDISC Questionnaire FACIT-Searchable Item Library Pediatric Version Test Code Terminology Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric test name. FSLP-C: Am Bothered Shorter Than People Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I am bothered by being shorter than other people. FACIT-Searchable Item Library Pediatric Version Child - Am Bothered Shorter Than People FSLP-C: Am Bothered Unable to Hear Well Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I am bothered by being unable to hear well. FACIT-Searchable Item Library Pediatric Version Child - Am Bothered Unable to Hear Well FSLP-C: Being Tired Made Me Mad Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - Being tired made me mad (angry). FACIT-Searchable Item Library Pediatric Version Child - Being Tired Made Me Mad FSLP-C: Being Tired Made Me Sad Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - Being tired made me sad. FACIT-Searchable Item Library Pediatric Version Child - Being Tired Made Me Sad FSLP-C: Children Avoid Play With Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - Other children avoid playing with me because I am different. FACIT-Searchable Item Library Pediatric Version Child - Children Avoid Play With Me FSLP-C: Could Do My Usual Things at Home Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I could do my usual things at home. FACIT-Searchable Item Library Pediatric Version Child - Could Do My Usual Things at Home FSLP-C: Do by Myself Than w/Other People Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I would rather do something by myself than with other people. FACIT-Searchable Item Library Pediatric Version Child - Do by Myself Than With Other People FSLP-C: Family/Friends Get Me Eat More Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - My family or friends try to get me to eat more. FACIT-Searchable Item Library Pediatric Version Child - Family or Friends Get Me Eat More FSLP-C: Feel Other Child Better Than Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I often feel that other children are better than me. FACIT-Searchable Item Library Pediatric Version Child - Feel Other Child Better Than Me FSLP-C: Feel Other People Better Than Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I often feel that other people are better than me. FACIT-Searchable Item Library Pediatric Version Child - Feel Other People Better Than Me FSLP-C: Hard for Me Concentrate School Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - It is hard for me to concentrate in school. FACIT-Searchable Item Library Pediatric Version Child - Hard for Me Concentrate School FSLP-C: Hard for Me to Find Right Words Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - It is hard for me to find the right words to say what I mean. FACIT-Searchable Item Library Pediatric Version Child - Hard for Me to Find Right Words FSLP-C: Hard for Me to Play With Friends Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - Being tired made it hard for me to play or go out with my friends as much as I'd like. FACIT-Searchable Item Library Pediatric Version Child - Hard for Me to Play With Friends FSLP-C: Have Fewer Friends Than Children Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I think I have fewer friends than other children. FACIT-Searchable Item Library Pediatric Version Child - Have Fewer Friends Than Children FSLP-C: Have Trouble Get Myself Dressed Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I have trouble getting myself dressed. FACIT-Searchable Item Library Pediatric Version Child - Have Trouble Get Myself Dressed FSLP-C: I Afraid to Eat It Make Me Sick Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I am afraid to eat because it may make me sick. FACIT-Searchable Item Library Pediatric Version Child - I Afraid to Eat It Make Me Sick FSLP-C: I Am Bothered by Headaches Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I am bothered by headaches. FACIT-Searchable Item Library Pediatric Version Child - I Am Bothered by Headaches FSLP-C: I Am Bothered Unable to See Well Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I am bothered by being unable to see well. FACIT-Searchable Item Library Pediatric Version Child - I Am Bothered Unable to See Well FSLP-C: I Am Worried About How Thin I Am Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I am worried about how thin I am. FACIT-Searchable Item Library Pediatric Version Child - I Am Worried About How Thin I Am FSLP-C: I Am Worried About My Weight Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I am worried about my weight. FACIT-Searchable Item Library Pediatric Version Child - I Am Worried About My Weight FSLP-C: I Believe I Will Do Well Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - When I try to do something, I usually believe I will do it well. FACIT-Searchable Item Library Pediatric Version Child - I Believe I Will Do Well FSLP-C: I Eat as Much as I Want Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I eat as much as I want. FACIT-Searchable Item Library Pediatric Version Child - I Eat as Much as I Want FSLP-C: I Eat Enough to Do Need to Do Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I eat enough food for me to do whatever I need to do. FACIT-Searchable Item Library Pediatric Version Child - I Eat Enough to Do Need to Do FSLP-C: I Feel Happy Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I feel happy. FACIT-Searchable Item Library Pediatric Version Child - I Feel Happy FSLP-C: I Feel Like I Am Getting Better Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I feel like I am getting better. FACIT-Searchable Item Library Pediatric Version Child - I Feel Like I Am Getting Better FSLP-C: I Feel Lonely Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I feel lonely. FACIT-Searchable Item Library Pediatric Version Child - I Feel Lonely FSLP-C: I Feel Tired Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I feel tired. FACIT-Searchable Item Library Pediatric Version Child - I Feel Tired FSLP-C: I Feel Weak Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I feel weak. FACIT-Searchable Item Library Pediatric Version Child - I Feel Weak FSLP-C: I Forget Things Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I forget things easily. FACIT-Searchable Item Library Pediatric Version Child - I Forget Things Easily FSLP-C: I Get Ill Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I get ill easily. FACIT-Searchable Item Library Pediatric Version Child - I Get Ill Easily FSLP-C: I Get Nervous/Frightened Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I get nervous (frightened) easily. FACIT-Searchable Item Library Pediatric Version Child - I Get Nervous Frightened Easily FSLP-C: I Get Tired Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I get tired easily. FACIT-Searchable Item Library Pediatric Version Child - I Get Tired Easily FSLP-C: I Have Been Throwing Up Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I have been throwing up. FACIT-Searchable Item Library Pediatric Version Child - I Have Been Throwing Up FSLP-C: I Have Energy Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I have energy (or strength). FACIT-Searchable Item Library Pediatric Version Child - I Have Energy FSLP-C: I Have Fewer Friends Than Others Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I think I have fewer friends than others. FACIT-Searchable Item Library Pediatric Version Child - I Have Fewer Friends Than Others FSLP-C: I Have Pain in My Stomach Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I have pain in my stomach. FACIT-Searchable Item Library Pediatric Version Child - I Have Pain in My Stomach FSLP-C: I Have Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I have pain. FACIT-Searchable Item Library Pediatric Version Child - I Have Pain FSLP-C: I Have Trouble Writing w/ a Pen Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I have trouble writing with a pen or pencil. FACIT-Searchable Item Library Pediatric Version Child - I Have Trouble Writing With a Pen FSLP-C: I Lose Balance/Fall Down Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I lose balance or fall down easily. FACIT-Searchable Item Library Pediatric Version Child - I Lose Balance or Fall Down Easily FSLP-C: I Needed to Sleep During the Day Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I needed to sleep during the day. FACIT-Searchable Item Library Pediatric Version Child - I Needed to Sleep During the Day FSLP-C: I Read Things Several Times Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I have to read things several times so I can understand them. FACIT-Searchable Item Library Pediatric Version Child - I Read Things Several Times FSLP-C: I Seem to Get Full Quickly Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - When I eat, I seem to get full quickly. FACIT-Searchable Item Library Pediatric Version Child - I Seem to Get Full Quickly FSLP-C: I Switch From Good to Bad Moods Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I often switch from good moods to bad moods. FACIT-Searchable Item Library Pediatric Version Child - I Switch From Good to Bad Moods FSLP-C: I Trouble Run Like Other People Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I have trouble running like other people. FACIT-Searchable Item Library Pediatric Version Child - I Trouble Run Like Other People FSLP-C: I Was Too Tired to Eat Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I was too tired to eat. FACIT-Searchable Item Library Pediatric Version Child - I Was Too Tired to Eat FSLP-C: I Worry Able to Date Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I worry about being able to date because of my illness. FACIT-Searchable Item Library Pediatric Version Child - I Worry Able to Date FSLP-C: I Worry Able to Go to College Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I worry about being able to go to college because of my illness. FACIT-Searchable Item Library Pediatric Version Child - I Worry Able to Go to College FSLP-C: I Worry Able to Have Girlfriend Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I worry about being able to have a girlfriend or boyfriend because of my illness. FACIT-Searchable Item Library Pediatric Version Child - I Worry Able to Have Girlfriend FSLP-C: I Worry About Getting a Job Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I worry about getting a job because of my illness. FACIT-Searchable Item Library Pediatric Version Child - I Worry About Getting a Job FSLP-C: I Worry Getting Another Tumor Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I worry about getting another cancer/tumor. FACIT-Searchable Item Library Pediatric Version Child - I Worry Getting Another Tumor FSLP-C: I Worry When I Go to Hospital Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I worry when I go back to the hospital or clinic. FACIT-Searchable Item Library Pediatric Version Child - I Worry When I Go to Hospital FSLP-C: Most Food Tastes Bad to Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - Most food tastes bad to me. FACIT-Searchable Item Library Pediatric Version Child - Most Food Tastes Bad to Me FSLP-C: My Arms or Legs Feel Weak Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - My arms or legs feel weak. FACIT-Searchable Item Library Pediatric Version Child - My Arms or Legs Feel Weak FSLP-C: My Grades Worse Than Before Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - My grades are worse than they were before I was sick. FACIT-Searchable Item Library Pediatric Version Child - My Grades Worse Than Before FSLP-C: My Parents Spoil Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - My parents spoil me. FACIT-Searchable Item Library Pediatric Version Child - My Parents Spoil Me FSLP-C: Needed Help Doing Usual Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I needed help doing my usual things at home. FACIT-Searchable Item Library Pediatric Version Child - Needed Help Doing Usual Things FSLP-C: Other Children Pick on Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - Other children pick on (tease) me. FACIT-Searchable Item Library Pediatric Version Child - Other Children Pick on Me FSLP-C: Other People Pick on Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - Other people pick on (tease) me. FACIT-Searchable Item Library Pediatric Version Child - Other People Pick on Me FSLP-C: Parents Worry Too Much About Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - My parents worry too much about me. FACIT-Searchable Item Library Pediatric Version Child - Parents Worry Too Much About Me FSLP-C: People Avoid Hang Out With Me Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - Other people avoid hanging out with me because I am different. FACIT-Searchable Item Library Pediatric Version Child - People Avoid Hang Out With Me FSLP-C: Play Alone Than w/Other Children Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I would rather play alone than with other children. FACIT-Searchable Item Library Pediatric Version Child - Play Alone Than With Other Children FSLP-C: React More Slowly People My Age Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - When I play games or sports, I react more slowly than most people my age. FACIT-Searchable Item Library Pediatric Version Child - React More Slowly People My Age FSLP-C: Speak People Trouble Understand Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - When I speak, people have trouble understanding me. FACIT-Searchable Item Library Pediatric Version Child - Speak People Trouble Understand FSLP-C: Start Eating Feel Like Stopping Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - As soon as I start eating, I feel like stopping. FACIT-Searchable Item Library Pediatric Version Child - Start Eating Feel Like Stopping FSLP-C: Trouble Finishing Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I had trouble finishing things because I was too tired. FACIT-Searchable Item Library Pediatric Version Child - Trouble Finishing Things FSLP-C: Trouble Run Like Other Children Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I have trouble running like other children. FACIT-Searchable Item Library Pediatric Version Child - Trouble Run Like Other Children FSLP-C: Trouble Starting Things Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I had trouble starting things because I was too tired. FACIT-Searchable Item Library Pediatric Version Child - Trouble Starting Things FSLP-C: Tumor Makes Me Stronger Person Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - The cancer/tumor experience makes me a stronger person. FACIT-Searchable Item Library Pediatric Version Child - Tumor Makes Me Stronger Person FSLP-C: Tumor Taught Me Appreciate Life Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - The cancer/tumor experience has taught me to appreciate life. FACIT-Searchable Item Library Pediatric Version Child - Tumor Taught Me Appreciate Life FSLP-C: Upset by Being Too Tired Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I got upset by being too tired to do things I wanted to do. FACIT-Searchable Item Library Pediatric Version Child - Upset by Being Too Tired FSLP-C: Work Harder Other People School Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I need to work harder than other people to get my school work done. FACIT-Searchable Item Library Pediatric Version Child - Work Harder Other People School FSLP-C: Worry About Good Life in Future Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I worry about having a good life in the future. FACIT-Searchable Item Library Pediatric Version Child - Worry About Good Life in Future FSLP-C: Worry Getting Job Support Myself Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Child - I worry about getting a job to support myself because of my illness history. FACIT-Searchable Item Library Pediatric Version Child - Worry Getting Job Support Myself FSLP-P: Child Afraid to Eat It Make Sick Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child is afraid to eat because it may make her/him sick. FACIT-Searchable Item Library Pediatric Version Parent - Child Afraid to Eat It Make Sick FSLP-P: Child Arms or Legs Seem Weak Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child's arms or legs seem weak. FACIT-Searchable Item Library Pediatric Version Parent - Child Arms or Legs Seem Weak FSLP-P: Child Believes S/He Will Do Well Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - When my child tries to do something, s/he usually believes s/he will do it well. FACIT-Searchable Item Library Pediatric Version Parent - Child Believes S/He Will Do Well FSLP-P: Child Bothered by Poor Hearing Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child is bothered by poor hearing. FACIT-Searchable Item Library Pediatric Version Parent - Child Bothered by Poor Hearing FSLP-P: Child Bothered Shorter Than Peer Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child is bothered by being shorter than his/her peers. FACIT-Searchable Item Library Pediatric Version Parent - Child Bothered Shorter Than Peer FSLP-P: Child Difficult Using Right Word Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child has difficulty using the right words. FACIT-Searchable Item Library Pediatric Version Parent - Child Difficult Using Right Word FSLP-P: Child Eats as Much as S/He Wants Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child eats as much as s/he wants. FACIT-Searchable Item Library Pediatric Version Parent - Child Eats as Much as S/He Wants FSLP-P: Child Eats Enough to Do Needs Do Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child eats enough to do whatever s/he needs to do. FACIT-Searchable Item Library Pediatric Version Parent - Child Eats Enough to Do Needs Do FSLP-P: Child Feel Inferior Other People Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child often feels inferior to other people. FACIT-Searchable Item Library Pediatric Version Parent - Child Feel Inferior Other People FSLP-P: Child Feel Like Getting Better Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child feels like s/he is getting better. FACIT-Searchable Item Library Pediatric Version Parent - Child Feel Like Getting Better FSLP-P: Child Feels Inferior Children Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child often feels inferior to other children. FACIT-Searchable Item Library Pediatric Version Parent - Child Feels Inferior Children FSLP-P: Child Fewer Friend Than Children Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child has fewer friends than other children. FACIT-Searchable Item Library Pediatric Version Parent - Child Fewer Friend Than Children FSLP-P: Child Fewer Friends Than Others Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child has fewer friends than others. FACIT-Searchable Item Library Pediatric Version Parent - Child Fewer Friends Than Others FSLP-P: Child Get Nervous Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child gets nervous (frightened) easily. FACIT-Searchable Item Library Pediatric Version Parent - Child Get Nervous Easily FSLP-P: Child Gets Ill Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child gets ill easily. FACIT-Searchable Item Library Pediatric Version Parent - Child Gets Ill Easily FSLP-P: Child Gets Tired Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child gets tired easily. FACIT-Searchable Item Library Pediatric Version Parent - Child Gets Tired Easily FSLP-P: Child Has Been Throwing Up Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child has been throwing up. FACIT-Searchable Item Library Pediatric Version Parent - Child Has Been Throwing Up FSLP-P: Child Has Pain His/Her Stomach Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child has pain in his/her stomach. FACIT-Searchable Item Library Pediatric Version Parent - Child Has Pain His/Her Stomach FSLP-P: Child Has Trouble Writing w/Pen Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child has trouble writing with a pen or pencil. FACIT-Searchable Item Library Pediatric Version Parent - Child Has Trouble Writing With Pen FSLP-P: Child Is Bothered by Poor Vision Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child is bothered by poor vision. FACIT-Searchable Item Library Pediatric Version Parent - Child Is Bothered by Poor Vision FSLP-P: Child Is Moody or Irritable Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child is moody or irritable. FACIT-Searchable Item Library Pediatric Version Parent - Child Is Moody or Irritable FSLP-P: Child Loses Balance/Falls Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child loses balance or falls down easily. FACIT-Searchable Item Library Pediatric Version Parent - Child Loses Balance or Falls Easily FSLP-P: Child Performance Worse Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child's school performance is worse than it was before s/he was diagnosed. FACIT-Searchable Item Library Pediatric Version Parent - Child Performance Worse FSLP-P: Child Prefers Do Something Alone Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child prefers to do something alone. FACIT-Searchable Item Library Pediatric Version Parent - Child Prefers Do Something Alone FSLP-P: Child Reacts More Slowly Peers Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - When my child plays games or sports, s/he reacts more slowly than his/her peers. FACIT-Searchable Item Library Pediatric Version Parent - Child Reacts More Slowly Peers FSLP-P: Child Read Things Several Times Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child has to read things several times so s/he can understand them. FACIT-Searchable Item Library Pediatric Version Parent - Child Read Things Several Times FSLP-P: Child Seems Happy Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child seems happy. FACIT-Searchable Item Library Pediatric Version Parent - Child Seems Happy FSLP-P: Child Seems to Get Full Quickly Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - When my child eats, s/he seems to get full quickly. FACIT-Searchable Item Library Pediatric Version Parent - Child Seems to Get Full Quickly FSLP-P: Child Speech Hard to Understand Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child's speech is hard for others to understand. FACIT-Searchable Item Library Pediatric Version Parent - Child Speech Hard to Understand FSLP-P: Child Starts Eating Feels Stop Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - As soon as my child starts eating, s/he feels like stopping. FACIT-Searchable Item Library Pediatric Version Parent - Child Starts Eating Feels Stop FSLP-P: Child Thinks Worry About Him/Her Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child thinks I worry too much about him/her. FACIT-Searchable Item Library Pediatric Version Parent - Child Thinks Worry About Him/Her FSLP-P: Child Trouble Get Dressed Own Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child has trouble getting dressed on his/her own. FACIT-Searchable Item Library Pediatric Version Parent - Child Trouble Get Dressed Own FSLP-P: Child Trouble Run Like Children Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child has trouble running like other children. FACIT-Searchable Item Library Pediatric Version Parent - Child Trouble Run Like Children FSLP-P: Child Trouble Run Like People Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child has trouble running like other people. FACIT-Searchable Item Library Pediatric Version Parent - Child Trouble Run Like People FSLP-P: Child Work Harder Than Peers Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child needs to work harder than his/her peers to get work done. FACIT-Searchable Item Library Pediatric Version Parent - Child Work Harder Than Peers FSLP-P: Child Worried About How Thin Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child is worried about how thin s/he is. FACIT-Searchable Item Library Pediatric Version Parent - Child Worried About How Thin FSLP-P: Child Worried About Weight Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child is worried about his/her weight. FACIT-Searchable Item Library Pediatric Version Parent - Child Worried About Weight FSLP-P: Child Worries About Getting Job Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child worries about getting a job because of his/her illness. FACIT-Searchable Item Library Pediatric Version Parent - Child Worries About Getting Job FSLP-P: Child Worries Get Another Tumor Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child worries about getting another cancer/tumor. FACIT-Searchable Item Library Pediatric Version Parent - Child Worries Get Another Tumor FSLP-P: Child Worries Good Life Future Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child worries about having a good life in the future. FACIT-Searchable Item Library Pediatric Version Parent - Child Worries Good Life Future FSLP-P: Child Worries Have Girlfriend Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child worries about being able to have a girlfriend or boyfriend because of his/her illness. FACIT-Searchable Item Library Pediatric Version Parent - Child Worries Have Girlfriend FSLP-P: Child Worries to Go to College Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child worries about being able to go to college because of his/her illness. FACIT-Searchable Item Library Pediatric Version Parent - Child Worries to Go to College FSLP-P: Child Worries When Go Hospital Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child worries when we go back to the hospital or clinic. FACIT-Searchable Item Library Pediatric Version Parent - Child Worries When Go Hospital FSLP-P: Children Avoid Play w/My Child Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - Other children avoid playing with my child because s/he is different. FACIT-Searchable Item Library Pediatric Version Parent - Children Avoid Play With My Child FSLP-P: Family/Friends Child Eat More Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - Family or friends try to get my child to eat more. FACIT-Searchable Item Library Pediatric Version Parent - Family or Friends Child Eat More FSLP-P: Hard Child Concentrate School Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - It is hard for my child to concentrate in school. FACIT-Searchable Item Library Pediatric Version Parent - Hard Child Concentrate School FSLP-P: Most Food Tastes Bad to My Child Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - Most food tastes bad to my child. FACIT-Searchable Item Library Pediatric Version Parent - Most Food Tastes Bad to My Child FSLP-P: My Child Bothered by Headaches Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child is bothered by headaches. FACIT-Searchable Item Library Pediatric Version Parent - My Child Bothered by Headaches FSLP-P: My Child Forgets Things Easily Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child forgets things easily. FACIT-Searchable Item Library Pediatric Version Parent - My Child Forgets Things Easily FSLP-P: My Child Has Pain Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child has pain. FACIT-Searchable Item Library Pediatric Version Parent - My Child Has Pain FSLP-P: My Child Prefers to Play Alone Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child prefers to play alone. FACIT-Searchable Item Library Pediatric Version Parent - My Child Prefers to Play Alone FSLP-P: My Child Seems Lonely Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child seems lonely. FACIT-Searchable Item Library Pediatric Version Parent - My Child Seems Lonely FSLP-P: My Child Thinks I Spoil Him/Her Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - My child thinks I spoil him/her. FACIT-Searchable Item Library Pediatric Version Parent - My Child Thinks I Spoil Him/Her FSLP-P: Other Children Pick on My Child Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - Other children pick on (tease) my child. FACIT-Searchable Item Library Pediatric Version Parent - Other Children Pick on My Child FSLP-P: Other People Pick on My Child Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - Other people pick on (tease) my child. FACIT-Searchable Item Library Pediatric Version Parent - Other People Pick on My Child FSLP-P: People Avoid Hang Out w/My Child Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - Other people avoid hanging out with my child because s/he is different. FACIT-Searchable Item Library Pediatric Version Parent - People Avoid Hang Out With My Child FSLP-P: Tumor Make Child Stronger Person Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - The cancer/tumor experience makes my child a stronger person. FACIT-Searchable Item Library Pediatric Version Parent - Tumor Make Child Stronger Person FSLP-P: Tumor Taught Child Appreciate Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric-Parent - The cancer/tumor experience has taught my child to appreciate life. FACIT-Searchable Item Library Pediatric Version Parent - Tumor Taught Child Appreciate FSLPTN Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric Questionnaire Test Name CDISC Questionnaire FACIT-Searchable Item Library Pediatric Version Test Name Terminology Functional Assessment of Multiple Sclerosis Version 4 test code. FAMS01-Trouble Meeting Needs of Family Functional Assessment of Multiple Sclerosis - Mobility: Because of my physical condition, I have trouble meeting the needs of my family. FAMS - Have Trouble Meeting Needs of Family Because of My Condition FAMS01-I Am Able to Work Functional Assessment of Multiple Sclerosis - Mobility: I am able to work (include work at home). FAMS - I Am Able to Work FAMS01-I Have Trouble Walking Functional Assessment of Multiple Sclerosis - Mobility: I have trouble walking. FAMS - I Have Trouble Walking FAMS01-Limit My Social Activity Functional Assessment of Multiple Sclerosis - Mobility: I have to limit my social activity because of my condition. FAMS - Limit Social Activity Because of Condition FAMS01-I Have Strength in My Legs Functional Assessment of Multiple Sclerosis - Mobility: I have strength in my legs. FAMS - I Have Strength in My Legs FAMS01-Trouble Getting Around in Public Functional Assessment of Multiple Sclerosis - Mobility: I have trouble getting around in public places. FAMS - Trouble Getting Around in Public Places FAMS01-Take My Condition Into Account Functional Assessment of Multiple Sclerosis - Mobility: I have to take my condition into account when making plans. FAMS - Have to Take Condition Into Account When Making Plans FAMS01-I Have Nausea Functional Assessment of Multiple Sclerosis - Symptoms: I have nausea. FAMS - I Have Nausea FAMS01-I Have Pain Functional Assessment of Multiple Sclerosis - Symptoms: I have pain. FAMS - I Have Pain FAMS01-I Feel Ill Functional Assessment of Multiple Sclerosis - Symptoms: I feel ill. FAMS - I Feel Ill FAMS01-I Feel Weak All Over Functional Assessment of Multiple Sclerosis - Symptoms: I feel weak all over. FAMS - I Feel Weak All Over FAMS01-I Have Pain in My Joints Functional Assessment of Multiple Sclerosis - Symptoms: I have pain in my joints. FAMS - I Have Pain in My Joints FAMS01-I Am Bothered by Headaches Functional Assessment of Multiple Sclerosis - Symptoms: I am bothered by headaches. FAMS - Bothered by Headaches FAMS01-I Am Bothered by Muscle Pains Functional Assessment of Multiple Sclerosis - Symptoms: I am bothered by muscle pains. FAMS - Bothered by Muscle Pains FAMS01-I Feel Sad Functional Assessment of Multiple Sclerosis - Emotional Well-Being: I feel sad. FAMS - I Feel Sad FAMS01-Losing Hope Against Illness Functional Assessment of Multiple Sclerosis - Emotional Well-Being: I am losing hope in the fight against my illness. FAMS - Losing Hope in Fight Against My Illness FAMS01-I Am Able to Enjoy Life Functional Assessment of Multiple Sclerosis - Emotional Well-Being: I am able to enjoy life. FAMS - I Am Able to Enjoy Life FAMS01-I Feel Trapped by My Condition Functional Assessment of Multiple Sclerosis - Emotional Well-Being: I feel trapped by my condition. FAMS - Feel Trapped by My Condition FAMS01-I Am Depressed About My Condition Functional Assessment of Multiple Sclerosis - Emotional Well-Being: I am depressed about my condition. FAMS - Depressed About My Condition FAMS01-I Feel Useless Functional Assessment of Multiple Sclerosis - Emotional Well-Being: I feel useless. FAMS - I Feel Useless FAMS01-Feel Overwhelmed by My Condition Functional Assessment of Multiple Sclerosis - Emotional Well-Being: I feel overwhelmed by my condition. FAMS - Feel Overwhelmed by My Condition FAMS01-My Work Is Fulfilling Functional Assessment of Multiple Sclerosis - General Contentment: My work (include work at home) is fulfilling. FAMS - My Work is Fulfilling FAMS01-I Have Accepted My Illness Functional Assessment of Multiple Sclerosis - General Contentment: I have accepted my illness. FAMS - I Have Accepted My Illness FAMS01-Enjoy Things I Usually Do for Fun Functional Assessment of Multiple Sclerosis - General Contentment: I am enjoying the things I usually do for fun. FAMS - Enjoying Things I Usually Do for Fun FAMS01-Content With Quality of My Life Functional Assessment of Multiple Sclerosis - General Contentment: I am content with the quality of my life right now. FAMS - Content With Quality of My Life Now FAMS01-I Am Frustrated by My Condition Functional Assessment of Multiple Sclerosis - General Contentment: I am frustrated by my condition. FAMS - I Am Frustrated by My Condition FAMS01-Feel Sense of Purpose in My Life Functional Assessment of Multiple Sclerosis - General Contentment: I feel a sense of purpose in my life. FAMS - Feel Sense of Purpose in My Life FAMS01-I Feel Motivated to Do Things Functional Assessment of Multiple Sclerosis - General Contentment: I feel motivated to do things. FAMS - Feel Motivated to Do Things FAMS01-I Have a Lack of Energy Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I have a lack of energy. FAMS - Have a Lack of Energy FAMS01-I Feel Tired Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I feel tired. FAMS - I Feel Tired FAMS01-Trouble Starting Things Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I have trouble starting things because I am tired. FAMS - Trouble Starting Things Because I Am Tired FAMS01-Trouble Finishing Things Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I have trouble finishing things because I am tired. FAMS - Trouble Finishing Things Because I Am Tired FAMS01-I Need to Rest During the Day Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I need to rest during the day. FAMS - Need to Rest During the Day FAMS01-I Have Trouble Remembering Things Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I have trouble remembering things. FAMS - Trouble Remembering Things FAMS01-I Have Trouble Concentrating Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I have trouble concentrating. FAMS - Trouble Concentrating FAMS01-My Thinking Is Slower Than Before Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: My thinking is slower than before. FAMS - My Thinking is Slower Than Before FAMS01-I Have Trouble Learning New Tasks Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I have trouble learning new tasks or directions. FAMS - Trouble Learning New Tasks or Directions FAMS01-I Feel Close to My Friends Functional Assessment of Multiple Sclerosis - Family/Social Well-Being: I feel close to my friends. FAMS - Feel Close to My Friends FAMS01-Get Emotional Support From Family Functional Assessment of Multiple Sclerosis - Family/Social Well-Being: I get emotional support from my family. FAMS - Get Emotional Support From Family FAMS01-I Get Support From My Friends Functional Assessment of Multiple Sclerosis - Family/Social Well-Being: I get support from my friends. FAMS - Get Support From Friends FAMS01-My Family Has Accepted My Illness Functional Assessment of Multiple Sclerosis - Family/Social Well-Being: My family has accepted my illness. FAMS - Family Has Accepted My Illness FAMS01-Satisfied Communication Illness Functional Assessment of Multiple Sclerosis - Family/Social Well-Being: I am satisfied with family communication about my illness. FAMS - Satisfied With Family Communication About My Illness FAMS01-Trouble Understanding Worsening Functional Assessment of Multiple Sclerosis - Family/Social Well-Being: My family has trouble understanding when my condition gets worse. FAMS - Family Has Trouble Understanding When My Condition Gets Worse FAMS01-I Feel Left Out of Things Functional Assessment of Multiple Sclerosis - Family/Social Well-Being: I feel 'left out' of things. FAMS - Feel Left Out of Things FAMS01-Bothered by Treatment Side Effect Functional Assessment of Multiple Sclerosis - Additional Concerns: I am bothered by side effects of treatment. FAMS - Bothered by Side Effects of Treatment FAMS01-I Am Forced to Spend Time in Bed Functional Assessment of Multiple Sclerosis - Additional Concerns: I am forced to spend time in bed. FAMS - Forced to Spend Time in Bed FAMS01-I Feel Close to My Partner Functional Assessment of Multiple Sclerosis - Additional Concerns: I feel close to my partner (or the person who is my main support). FAMS - Feel Close to My Partner FAMS01-I Am Satisfied With My Sex Life Functional Assessment of Multiple Sclerosis - Additional Concerns: I am satisfied with my sex life. FAMS - Satisfied With My Sex Life FAMS01-Satisfied With How I Am Coping Functional Assessment of Multiple Sclerosis - Additional Concerns: I am satisfied with how I am coping with my illness. FAMS - Satisfied With How I Am Coping With Illness FAMS01-I Feel Nervous Functional Assessment of Multiple Sclerosis - Additional Concerns: I feel nervous. FAMS - I Feel Nervous FAMS01-Worry My Condition Will Get Worse Functional Assessment of Multiple Sclerosis - Additional Concerns: I worry that my condition will get worse. FAMS - Worry My Condition Will Get Worse FAMS01-I Am Sleeping Well Functional Assessment of Multiple Sclerosis - Additional Concerns: I am sleeping well. FAMS - I Am Sleeping Well FAMS01-Heat Worsens My Symptoms Functional Assessment of Multiple Sclerosis - Additional Concerns: Heat worsens my symptoms. FAMS - Heat Worsens My Symptoms FAMS01-Have Trouble Controlling My Urine Functional Assessment of Multiple Sclerosis - Additional Concerns: I have trouble controlling my urine. FAMS - Trouble Controlling My Urine FAMS01-I Urinate More Frequently Functional Assessment of Multiple Sclerosis - Additional Concerns: I urinate more frequently than usual. FAMS - Urinate More Frequently Than Usual FAMS01-I Am Bothered by the Chills Functional Assessment of Multiple Sclerosis - Additional Concerns: I am bothered by the chills. FAMS - Bothered by Chills FAMS01-I Am Bothered by Fevers Functional Assessment of Multiple Sclerosis - Additional Concerns: I am bothered by fevers (episodes of high body temperature). FAMS - Bothered by Fevers FAMS01-I Am Bothered by Muscle Spasms Functional Assessment of Multiple Sclerosis - Additional Concerns: I am bothered by muscle spasms. FAMS - Bothered by Muscle Spasms FAMS01TC Functional Assessment of Multiple Sclerosis Version 4 Questionnaire Test Code CDISC Questionnaire FAMS Test Code Terminology Functional Assessment of Multiple Sclerosis Version 4 test name. FAMS01-Bothered by Treatment Side Effect Functional Assessment of Multiple Sclerosis - Additional Concerns: I am bothered by side effects of treatment. FAMS - Bothered by Side Effects of Treatment FAMS01-Content With Quality of My Life Functional Assessment of Multiple Sclerosis - General Contentment: I am content with the quality of my life right now. FAMS - Content With Quality of My Life Now FAMS01-Enjoy Things I Usually Do for Fun Functional Assessment of Multiple Sclerosis - General Contentment: I am enjoying the things I usually do for fun. FAMS - Enjoying Things I Usually Do for Fun FAMS01-Feel Overwhelmed by My Condition Functional Assessment of Multiple Sclerosis - Emotional Well-Being: I feel overwhelmed by my condition. FAMS - Feel Overwhelmed by My Condition FAMS01-Feel Sense of Purpose in My Life Functional Assessment of Multiple Sclerosis - General Contentment: I feel a sense of purpose in my life. FAMS - Feel Sense of Purpose in My Life FAMS01-Get Emotional Support From Family Functional Assessment of Multiple Sclerosis - Family/Social Well-Being: I get emotional support from my family. FAMS - Get Emotional Support From Family FAMS01-Have Trouble Controlling My Urine Functional Assessment of Multiple Sclerosis - Additional Concerns: I have trouble controlling my urine. FAMS - Trouble Controlling My Urine FAMS01-Heat Worsens My Symptoms Functional Assessment of Multiple Sclerosis - Additional Concerns: Heat worsens my symptoms. FAMS - Heat Worsens My Symptoms FAMS01-I Am Able to Enjoy Life Functional Assessment of Multiple Sclerosis - Emotional Well-Being: I am able to enjoy life. FAMS - I Am Able to Enjoy Life FAMS01-I Am Able to Work Functional Assessment of Multiple Sclerosis - Mobility: I am able to work (include work at home). FAMS - I Am Able to Work FAMS01-I Am Bothered by Fevers Functional Assessment of Multiple Sclerosis - Additional Concerns: I am bothered by fevers (episodes of high body temperature). FAMS - Bothered by Fevers FAMS01-I Am Bothered by Headaches Functional Assessment of Multiple Sclerosis - Symptoms: I am bothered by headaches. FAMS - Bothered by Headaches FAMS01-I Am Bothered by Muscle Pains Functional Assessment of Multiple Sclerosis - Symptoms: I am bothered by muscle pains. FAMS - Bothered by Muscle Pains FAMS01-I Am Bothered by Muscle Spasms Functional Assessment of Multiple Sclerosis - Additional Concerns: I am bothered by muscle spasms. FAMS - Bothered by Muscle Spasms FAMS01-I Am Bothered by the Chills Functional Assessment of Multiple Sclerosis - Additional Concerns: I am bothered by the chills. FAMS - Bothered by Chills FAMS01-I Am Depressed About My Condition Functional Assessment of Multiple Sclerosis - Emotional Well-Being: I am depressed about my condition. FAMS - Depressed About My Condition FAMS01-I Am Forced to Spend Time in Bed Functional Assessment of Multiple Sclerosis - Additional Concerns: I am forced to spend time in bed. FAMS - Forced to Spend Time in Bed FAMS01-I Am Frustrated by My Condition Functional Assessment of Multiple Sclerosis - General Contentment: I am frustrated by my condition. FAMS - I Am Frustrated by My Condition FAMS01-I Am Satisfied With My Sex Life Functional Assessment of Multiple Sclerosis - Additional Concerns: I am satisfied with my sex life. FAMS - Satisfied With My Sex Life FAMS01-I Am Sleeping Well Functional Assessment of Multiple Sclerosis - Additional Concerns: I am sleeping well. FAMS - I Am Sleeping Well FAMS01-I Feel Close to My Friends Functional Assessment of Multiple Sclerosis - Family/Social Well-Being: I feel close to my friends. FAMS - Feel Close to My Friends FAMS01-I Feel Close to My Partner Functional Assessment of Multiple Sclerosis - Additional Concerns: I feel close to my partner (or the person who is my main support). FAMS - Feel Close to My Partner FAMS01-I Feel Ill Functional Assessment of Multiple Sclerosis - Symptoms: I feel ill. FAMS - I Feel Ill FAMS01-I Feel Left Out of Things Functional Assessment of Multiple Sclerosis - Family/Social Well-Being: I feel 'left out' of things. FAMS - Feel Left Out of Things FAMS01-I Feel Motivated to Do Things Functional Assessment of Multiple Sclerosis - General Contentment: I feel motivated to do things. FAMS - Feel Motivated to Do Things FAMS01-I Feel Nervous Functional Assessment of Multiple Sclerosis - Additional Concerns: I feel nervous. FAMS - I Feel Nervous FAMS01-I Feel Sad Functional Assessment of Multiple Sclerosis - Emotional Well-Being: I feel sad. FAMS - I Feel Sad FAMS01-I Feel Tired Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I feel tired. FAMS - I Feel Tired FAMS01-I Feel Trapped by My Condition Functional Assessment of Multiple Sclerosis - Emotional Well-Being: I feel trapped by my condition. FAMS - Feel Trapped by My Condition FAMS01-I Feel Useless Functional Assessment of Multiple Sclerosis - Emotional Well-Being: I feel useless. FAMS - I Feel Useless FAMS01-I Feel Weak All Over Functional Assessment of Multiple Sclerosis - Symptoms: I feel weak all over. FAMS - I Feel Weak All Over FAMS01-I Get Support From My Friends Functional Assessment of Multiple Sclerosis - Family/Social Well-Being: I get support from my friends. FAMS - Get Support From Friends FAMS01-I Have a Lack of Energy Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I have a lack of energy. FAMS - Have a Lack of Energy FAMS01-I Have Accepted My Illness Functional Assessment of Multiple Sclerosis - General Contentment: I have accepted my illness. FAMS - I Have Accepted My Illness FAMS01-I Have Nausea Functional Assessment of Multiple Sclerosis - Symptoms: I have nausea. FAMS - I Have Nausea FAMS01-I Have Pain in My Joints Functional Assessment of Multiple Sclerosis - Symptoms: I have pain in my joints. FAMS - I Have Pain in My Joints FAMS01-I Have Pain Functional Assessment of Multiple Sclerosis - Symptoms: I have pain. FAMS - I Have Pain FAMS01-I Have Strength in My Legs Functional Assessment of Multiple Sclerosis - Mobility: I have strength in my legs. FAMS - I Have Strength in My Legs FAMS01-I Have Trouble Concentrating Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I have trouble concentrating. FAMS - Trouble Concentrating FAMS01-I Have Trouble Learning New Tasks Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I have trouble learning new tasks or directions. FAMS - Trouble Learning New Tasks or Directions FAMS01-I Have Trouble Remembering Things Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I have trouble remembering things. FAMS - Trouble Remembering Things FAMS01-I Have Trouble Walking Functional Assessment of Multiple Sclerosis - Mobility: I have trouble walking. FAMS - I Have Trouble Walking FAMS01-I Need to Rest During the Day Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I need to rest during the day. FAMS - Need to Rest During the Day FAMS01-I Urinate More Frequently Functional Assessment of Multiple Sclerosis - Additional Concerns: I urinate more frequently than usual. FAMS - Urinate More Frequently Than Usual FAMS01-Limit My Social Activity Functional Assessment of Multiple Sclerosis - Mobility: I have to limit my social activity because of my condition. FAMS - Limit Social Activity Because of Condition FAMS01-Losing Hope Against Illness Functional Assessment of Multiple Sclerosis - Emotional Well-Being: I am losing hope in the fight against my illness. FAMS - Losing Hope in Fight Against My Illness FAMS01-My Family Has Accepted My Illness Functional Assessment of Multiple Sclerosis - Family/Social Well-Being: My family has accepted my illness. FAMS - Family Has Accepted My Illness FAMS01-My Thinking Is Slower Than Before Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: My thinking is slower than before. FAMS - My Thinking is Slower Than Before FAMS01-My Work Is Fulfilling Functional Assessment of Multiple Sclerosis - General Contentment: My work (include work at home) is fulfilling. FAMS - My Work is Fulfilling FAMS01-Satisfied Communication Illness Functional Assessment of Multiple Sclerosis - Family/Social Well-Being: I am satisfied with family communication about my illness. FAMS - Satisfied With Family Communication About My Illness FAMS01-Satisfied With How I Am Coping Functional Assessment of Multiple Sclerosis - Additional Concerns: I am satisfied with how I am coping with my illness. FAMS - Satisfied With How I Am Coping With Illness FAMS01-Take My Condition Into Account Functional Assessment of Multiple Sclerosis - Mobility: I have to take my condition into account when making plans. FAMS - Have to Take Condition Into Account When Making Plans FAMS01-Trouble Finishing Things Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I have trouble finishing things because I am tired. FAMS - Trouble Finishing Things Because I Am Tired FAMS01-Trouble Getting Around in Public Functional Assessment of Multiple Sclerosis - Mobility: I have trouble getting around in public places. FAMS - Trouble Getting Around in Public Places FAMS01-Trouble Meeting Needs of Family Functional Assessment of Multiple Sclerosis - Mobility: Because of my physical condition, I have trouble meeting the needs of my family. FAMS - Have Trouble Meeting Needs of Family Because of My Condition FAMS01-Trouble Starting Things Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I have trouble starting things because I am tired. FAMS - Trouble Starting Things Because I Am Tired FAMS01-Trouble Understanding Worsening Functional Assessment of Multiple Sclerosis - Family/Social Well-Being: My family has trouble understanding when my condition gets worse. FAMS - Family Has Trouble Understanding When My Condition Gets Worse FAMS01-Worry My Condition Will Get Worse Functional Assessment of Multiple Sclerosis - Additional Concerns: I worry that my condition will get worse. FAMS - Worry My Condition Will Get Worse FAMS01TN Functional Assessment of Multiple Sclerosis Version 4 Questionnaire Test Name CDISC Questionnaire FAMS Test Name Terminology Functional Assessment Questionnaire-NACC UDS V2.0 test code. FAQNA1-Write Checks/Pay Bills/Checkbook Functional Assessment Questionnaire-NACC UDS V2.0 - Writing checks, paying bills, or balancing a checkbook. FAQ-NACC UDS Version 2.0 - Write checks, Pay bills, Balance checkbook FAQNA1-Assembling Functional Assessment Questionnaire-NACC UDS V2.0 - Assembling tax records, business affairs, or other papers. FAQ-NACC UDS Version 2.0 - Assemble FAQNA1-Shopping Alone Functional Assessment Questionnaire-NACC UDS V2.0 - Shopping alone for clothes, household necessities, or groceries. FAQ-NACC UDS Version 2.0 - Shop Alone FAQNA1-Playing a Game of Skill Functional Assessment Questionnaire-NACC UDS V2.0 - Playing a game of skill such as bridge or chess, working on a hobby. FAQ-NACC UDS Version 2.0 - Play Game of Skill, Work on Hobby FAQNA1-Heat Water/Make Coffee/Stove Off Functional Assessment Questionnaire-NACC UDS V2.0 - Heating water, making a cup of coffee, turning off the stove. FAQ-NACC UDS Version 2.0 - Heat water, Make Coffee, Turn Off Stove FAQNA1-Preparing a Balanced Meal Functional Assessment Questionnaire-NACC UDS V2.0 - Preparing a balanced meal. FAQ-NACC UDS Version 2.0 - Prepare a Meal FAQNA1-Keeping Track of Current Events Functional Assessment Questionnaire-NACC UDS V2.0 - Keeping track of current events. FAQ-NACC UDS Version 2.0 - Keep Track of Current Events FAQNA1-Paying Attention Functional Assessment Questionnaire-NACC UDS V2.0 - Paying attention to and understanding a TV program, book, or magazine. FAQ-NACC UDS Version 2.0 - Pay Attention, Understand, Discuss FAQNA1-Remembering Functional Assessment Questionnaire-NACC UDS V2.0 - Remembering appointments, family occasions, holidays, medications. FAQ-NACC UDS Version 2.0 - Remember FAQNA1-Traveling Functional Assessment Questionnaire-NACC UDS V2.0 - Traveling out of the neighborhood, driving, or arranging to take public transportation. FAQ-NACC UDS Version 2.0 - Travel FAQNA1TC Functional Assessment Questionnaire-NACC UDS V2.0 Clinical Classification Test Code CDISC Clinical Classification FAQ-NACC UDS Version 2.0 Test Code Terminology Functional Assessment Questionnaire-NACC UDS V2.0 test name. FAQNA1-Assembling Functional Assessment Questionnaire-NACC UDS V2.0 - Assembling tax records, business affairs, or other papers. FAQ-NACC UDS Version 2.0 - Assemble FAQNA1-Heat Water/Make Coffee/Stove Off Functional Assessment Questionnaire-NACC UDS V2.0 - Heating water, making a cup of coffee, turning off the stove. FAQ-NACC UDS Version 2.0 - Heat water, Make Coffee, Turn Off Stove FAQNA1-Keeping Track of Current Events Functional Assessment Questionnaire-NACC UDS V2.0 - Keeping track of current events. FAQ-NACC UDS Version 2.0 - Keep Track of Current Events FAQNA1-Paying Attention Functional Assessment Questionnaire-NACC UDS V2.0 - Paying attention to and understanding a TV program, book, or magazine. FAQ-NACC UDS Version 2.0 - Pay Attention, Understand, Discuss FAQNA1-Playing a Game of Skill Functional Assessment Questionnaire-NACC UDS V2.0 - Playing a game of skill such as bridge or chess, working on a hobby. FAQ-NACC UDS Version 2.0 - Play Game of Skill, Work on Hobby FAQNA1-Preparing a Balanced Meal Functional Assessment Questionnaire-NACC UDS V2.0 - Preparing a balanced meal. FAQ-NACC UDS Version 2.0 - Prepare a Meal FAQNA1-Remembering Functional Assessment Questionnaire-NACC UDS V2.0 - Remembering appointments, family occasions, holidays, medications. FAQ-NACC UDS Version 2.0 - Remember FAQNA1-Shopping Alone Functional Assessment Questionnaire-NACC UDS V2.0 - Shopping alone for clothes, household necessities, or groceries. FAQ-NACC UDS Version 2.0 - Shop Alone FAQNA1-Traveling Functional Assessment Questionnaire-NACC UDS V2.0 - Traveling out of the neighborhood, driving, or arranging to take public transportation. FAQ-NACC UDS Version 2.0 - Travel FAQNA1-Write Checks/Pay Bills/Checkbook Functional Assessment Questionnaire-NACC UDS V2.0 - Writing checks, paying bills, or balancing a checkbook. FAQ-NACC UDS Version 2.0 - Write checks, Pay bills, Balance checkbook FAQNA1TN Functional Assessment Questionnaire-NACC UDS V2.0 Clinical Classification Test Name CDISC Clinical Classification FAQ-NACC UDS Version 2.0 Test Name Terminology Functional Assessment Scale-NACC UDS Version 3.0 test code. FASNA1-Writing Checks, Paying Bills Functional Assessment Scale-NACC UDS V3.0 - Writing checks, paying bills, or balancing a checkbook. FAS-NACC UDS Version 3.0 - Writing Checks, Paying Bills FASNA1-Assembling Tax Records Functional Assessment Scale-NACC UDS V3.0 - Assembling tax records, business affairs, or other papers. FAS-NACC UDS Version 3.0 - Assembling Tax Records FASNA1-Shopping Alone for Clothes Functional Assessment Scale-NACC UDS V3.0 - Shopping alone for clothes, household necessities, or groceries. FAS-NACC UDS Version 3.0 - Shopping Alone for Clothes FASNA1-Playing a Game of Skill Functional Assessment Scale-NACC UDS V3.0 - Playing a game of skill such as bridge or chess, working on a hobby. FAS-NACC UDS Version 3.0 - Playing a Game of Skill FASNA1-Heating Water, Making Coffee Functional Assessment Scale-NACC UDS V3.0 - Heating water, making a cup of coffee, turning off the stove. FAS-NACC UDS Version 3.0 - Heating Water, Making Coffee FASNA1-Preparing a Balanced Meal Functional Assessment Scale-NACC UDS V3.0 - Preparing a balanced meal. FAS-NACC UDS Version 3.0 - Preparing a Balanced Meal FASNA1-Keeping Track of Current Events Functional Assessment Scale-NACC UDS V3.0 - Keeping track of current events. FAS-NACC UDS Version 3.0 - Keeping Track of Current Events FASNA1-Paying Attention/Understanding TV Functional Assessment Scale-NACC UDS V3.0 - Paying attention to and understanding a TV program, book, or magazine. FAS-NACC UDS Version 3.0 - Paying Attention and Understanding TV FASNA1-Remembering Appointments Functional Assessment Scale-NACC UDS V3.0 - Remembering appointments, family occasions, holidays, medications. FAS-NACC UDS Version 3.0 - Remembering Appointments FASNA1-Traveling Out of the Neighborhood Functional Assessment Scale-NACC UDS V3.0 - Traveling out of the neighborhood, driving, or arranging to take public transportation. FAS-NACC UDS Version 3.0 - Traveling Out of the Neighborhood FASNA1TC Functional Assessment Scale-NACC UDS Version 3.0 Clinical Classification Test Code CDISC Clinical Classification FAS-NACC UDS Version 3.0 Test Code Terminology Functional Assessment Scale-NACC UDS Version 3.0 test name. FASNA1-Assembling Tax Records Functional Assessment Scale-NACC UDS V3.0 - Assembling tax records, business affairs, or other papers. FAS-NACC UDS Version 3.0 - Assembling Tax Records FASNA1-Heating Water, Making Coffee Functional Assessment Scale-NACC UDS V3.0 - Heating water, making a cup of coffee, turning off the stove. FAS-NACC UDS Version 3.0 - Heating Water, Making Coffee FASNA1-Keeping Track of Current Events Functional Assessment Scale-NACC UDS V3.0 - Keeping track of current events. FAS-NACC UDS Version 3.0 - Keeping Track of Current Events FASNA1-Paying Attention/Understanding TV Functional Assessment Scale-NACC UDS V3.0 - Paying attention to and understanding a TV program, book, or magazine. FAS-NACC UDS Version 3.0 - Paying Attention and Understanding TV FASNA1-Playing a Game of Skill Functional Assessment Scale-NACC UDS V3.0 - Playing a game of skill such as bridge or chess, working on a hobby. FAS-NACC UDS Version 3.0 - Playing a Game of Skill FASNA1-Preparing a Balanced Meal Functional Assessment Scale-NACC UDS V3.0 - Preparing a balanced meal. FAS-NACC UDS Version 3.0 - Preparing a Balanced Meal FASNA1-Remembering Appointments Functional Assessment Scale-NACC UDS V3.0 - Remembering appointments, family occasions, holidays, medications. FAS-NACC UDS Version 3.0 - Remembering Appointments FASNA1-Shopping Alone for Clothes Functional Assessment Scale-NACC UDS V3.0 - Shopping alone for clothes, household necessities, or groceries. FAS-NACC UDS Version 3.0 - Shopping Alone for Clothes FASNA1-Traveling Out of the Neighborhood Functional Assessment Scale-NACC UDS V3.0 - Traveling out of the neighborhood, driving, or arranging to take public transportation. FAS-NACC UDS Version 3.0 - Traveling Out of the Neighborhood FASNA1-Writing Checks, Paying Bills Functional Assessment Scale-NACC UDS V3.0 - Writing checks, paying bills, or balancing a checkbook. FAS-NACC UDS Version 3.0 - Writing Checks, Paying Bills FASNA1TN Functional Assessment Scale-NACC UDS Version 3.0 Clinical Classification Test Name CDISC Clinical Classification FAS-NACC UDS Version 3.0 Test Name Terminology A terminology codelist based on the test codes for physiological findings related to the gastrointestinal system. Bowel Obstruction Indicator An indication as to whether bowel obstruction has occurred. Bowel Obstruction Indicator Bowel Perforation Indicator An indication as to whether bowel perforation has occurred. Bowel Perforation Indicator Diameter The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) Diameter Elasticity A quantitative measurement of an organ's ability to deform in response to physiological force and return to its normal shape by passive elastic recoil. Organ Elasticity Esophageal Obstruction Indicator An indication as to whether esophageal obstruction has occurred. Esophageal Obstruction Indicator Gastrointestinal System Examination An observation, assessment or examination of the gastrointestinal system. Gastrointestinal System Examination Lymphovascular Invasion Indicator An indication as to whether lymphovascular invasion by tumor cells has occurred. Lymphovascular Invasion Indicator Percent Area Covered By Ulcers A measurement of the percentage of area examined that is covered by ulcerations. Percent Ulcer Area Proton Density Fat Fraction An estimated measurement of the fat in a targeted tissue through proton density assessments via magnetic resonance imaging. Proton Density Fat Fraction Rectal Tumor to Anal Verge Distance A measurement of the distance between the rectal tumor and the anal margin. Rectal Tumor to Anal Verge Distance Stiffness A quantitative measurement of an organ's ability to resist deformation in response to physiological force. Organ Stiffness Measurement Number of Strictures The number of anatomical strictures observed. Number of Strictures Steatosis Extent Steatosis Grade An evaluation of the amount or degree of steatosis (fatty tissue) in a biological specimen. Steatosis Extent Thickness The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. Thickness Volume A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. Volume Measurement GASTROCD Gastrointestinal Test Code CDISC SDTM Gastrointestinal Test Code Terminology A terminology codelist based on the test names for physiological findings related to the gastrointestinal system. Bowel Obstruction Indicator An indication as to whether bowel obstruction has occurred. Bowel Obstruction Indicator Bowel Perforation Indicator An indication as to whether bowel perforation has occurred. Bowel Perforation Indicator Diameter The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) Diameter Elasticity A quantitative measurement of an organ's ability to deform in response to physiological force and return to its normal shape by passive elastic recoil. Organ Elasticity Esophageal Obstruction Indicator An indication as to whether esophageal obstruction has occurred. Esophageal Obstruction Indicator Gastrointestinal System Examination An observation, assessment or examination of the gastrointestinal system. Gastrointestinal System Examination Lymphovascular Invasion Indicator An indication as to whether lymphovascular invasion by tumor cells has occurred. Lymphovascular Invasion Indicator Number of Strictures The number of anatomical strictures observed. Number of Strictures Percent Area Covered By Ulcers A measurement of the percentage of area examined that is covered by ulcerations. Percent Ulcer Area Proton Density Fat Fraction An estimated measurement of the fat in a targeted tissue through proton density assessments via magnetic resonance imaging. Proton Density Fat Fraction Rectal Tumor to Anal Verge Distance A measurement of the distance between the rectal tumor and the anal margin. Rectal Tumor to Anal Verge Distance Steatosis Extent Steatosis Grade An evaluation of the amount or degree of steatosis (fatty tissue) in a biological specimen. Steatosis Extent Stiffness A quantitative measurement of an organ's ability to resist deformation in response to physiological force. Organ Stiffness Measurement Thickness The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. Thickness Volume A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. Volume Measurement GASTRO Gastrointestinal Test Name CDISC SDTM Gastrointestinal Test Name Terminology A terminology codelist relevant to a person's internally held sense of their gender. [The NCI Thesaurus contains biomedical terminologies that NCI does not own or control. This concept contains gender-related content that does not comply with Executive Order 14168.] Describes a person who identifies as having no gender, or who does not experience gender as a primary identity component. (Fenway Health) [The NCI Thesaurus contains biomedical terminologies that NCI does not own or control. This concept contains gender-related content that does not comply with Executive Order 14168.] Agender Identity Cisgender Male/Man/Boy A male person whose gender identity is consistent in a traditional sense with their sex assigned at birth; a person assigned male sex at birth whose gender identity is man/boy. The term cisgender comes from the Latin prefix cis, meaning "on the same side of." (After Fenway Health) [The NCI Thesaurus contains biomedical terminologies that NCI does not own or control. This concept contains gender-related content that does not comply with Executive Order 14168.] Cisgender Man Cisgender Female/Woman/Girl A female person whose gender identity is consistent in a traditional sense with their sex assigned at birth; a person assigned female sex at birth whose gender identity is woman/female. The term cisgender comes from the Latin prefix cis, meaning "on the same side of." (After Fenway Health) [The NCI Thesaurus contains biomedical terminologies that NCI does not own or control. This concept contains gender-related content that does not comply with Executive Order 14168.] Cisgender Woman Gender-Fluid Genderfluid Describes a person whose gender identity is not fixed. A person who is gender fluid may always feel like a mix of more than one gender, but may feel more aligned with a certain gender some of the time, another gender at other times, both genders sometimes, and sometimes no gender at all. (Fenway Health) [The NCI Thesaurus contains biomedical terminologies that NCI does not own or control. This concept contains gender-related content that does not comply with Executive Order 14168.] Gender Fluid Gender Expansive Genderqueer An umbrella term that describes a person whose gender identity falls outside the traditional gender binary of male and female. (Fenway Health) [The NCI Thesaurus contains biomedical terminologies that NCI does not own or control. This concept contains gender-related content that does not comply with Executive Order 14168.] Genderqueer enby Gender Non-Conforming NB Describes a person whose gender identity falls outside of the traditional gender binary structure of girl/woman and boy/man. Sometimes abbreviated as NB or enby. (Fenway Health) [The NCI Thesaurus contains biomedical terminologies that NCI does not own or control. This concept contains gender-related content that does not comply with Executive Order 14168.] Non-Binary Gender Identity Not reported Not provided or available. Not Reported Transgender Male/Man/Boy A transgender person whose gender identity is boy/man/male may use these terms to describe themselves. Some will use the term man. The term transgender comes from the Latin prefix trans, meaning "on the other side of." (Fenway Health) [The NCI Thesaurus contains biomedical terminologies that NCI does not own or control. This concept contains gender-related content that does not comply with Executive Order 14168.] Transgender Man Transgender Female/Woman/Girl A transgender person whose gender identity is girl/woman/female may use these terms to describe themselves. Some will use the term woman. The term transgender comes from the Latin prefix trans, meaning "on the other side of." (Fenway Health) [The NCI Thesaurus contains biomedical terminologies that NCI does not own or control. This concept contains gender-related content that does not comply with Executive Order 14168.] Transgender Woman U UNK Unknown Not known, not observed, not recorded, or refused. (NCI) Unknown GENIDENT Gender Identity Response CDISC SDTM Gender Identity Response Terminology General Clinical Global Impressions test code. GCGI01-Global Severity of Pain General Clinical Global Impressions - Global severity of pain. GCGI - Global Severity of Pain GCGI01-Global Improvement of Pain General Clinical Global Impressions - Global improvement of pain. GCGI - Global Improvement of Pain GCGI01-Global Disease Status of Pain General Clinical Global Impressions - Global disease status of pain. GCGI - Global Disease Status of Pain GCGI01-Pain Treatment Preference General Clinical Global Impressions - Pain treatment preference. GCGI - Pain Treatment Preference GCGI01-Global Rating of Pain Medication General Clinical Global Impressions - Global rating of pain medication. GCGI - Global Rating of Pain Medication GCGI01TC General Clinical Global Impressions Questionnaire Test Code CDISC Questionnaire GCGI v1 Test Code Terminology General Clinical Global Impressions test name. GCGI01-Global Disease Status of Pain General Clinical Global Impressions - Global disease status of pain. GCGI - Global Disease Status of Pain GCGI01-Global Improvement of Pain General Clinical Global Impressions - Global improvement of pain. GCGI - Global Improvement of Pain GCGI01-Global Rating of Pain Medication General Clinical Global Impressions - Global rating of pain medication. GCGI - Global Rating of Pain Medication GCGI01-Global Severity of Pain General Clinical Global Impressions - Global severity of pain. GCGI - Global Severity of Pain GCGI01-Pain Treatment Preference General Clinical Global Impressions - Pain treatment preference. GCGI - Pain Treatment Preference GCGI01TN General Clinical Global Impressions Questionnaire Test Name CDISC Questionnaire GCGI v1 Test Name Terminology Generalized Anxiety Disorder - 7 test code. GAD01-Feeling Nervous Anxious or On Edge Generalized Anxiety Disorder - 7 - Feeling nervous, anxious or on edge. GAD-7 - Feeling Nervous Anxious or On Edge GAD01-Not Able to Stop/Control Worrying Generalized Anxiety Disorder - 7 - Not being able to stop or control worrying. GAD-7 - Not Being Able to Stop or Control Worrying GAD01-Worrying Too Much About Things Generalized Anxiety Disorder - 7 - Worrying too much about different things. GAD-7 - Worrying Too Much About Different Things GAD01-Trouble Relaxing Generalized Anxiety Disorder - 7 - Trouble relaxing. GAD-7 - Trouble Relaxing GAD01-Being Restless Hard to Sit Still Generalized Anxiety Disorder - 7 - Being so restless that it is hard to sit still. GAD-7 - Being so Restless That it is Hard to Sit Still GAD01-Becoming Easily Annoyed/Irritable Generalized Anxiety Disorder - 7 - Becoming easily annoyed or irritable. GAD-7 - Becoming Easily Annoyed or Irritable GAD01-Feel Afraid/Something Awful Happen Generalized Anxiety Disorder - 7 - Feeling afraid as if something awful might happen. GAD-7 - Feel Afraid as if Something Awful Might Happen GAD01-Difficult to Work/Take Care Things Generalized Anxiety Disorder - 7 - If you checked off any problems, how difficult have these problems made it for you to do your work, take care of things at home, or get along with other people? GAD-7 - Problems Made it Difficult to Work, Take Care of Things, or Get Along with Other People GAD01-Total Score Generalized Anxiety Disorder - 7 - Total score. GAD-7 - Total Score GAD01TC Generalized Anxiety Disorder - 7 Questionnaire Test Code CDISC Questionnaire GAD-7 Test Code Terminology Generalized Anxiety Disorder - 7 test name. GAD01-Becoming Easily Annoyed/Irritable Generalized Anxiety Disorder - 7 - Becoming easily annoyed or irritable. GAD-7 - Becoming Easily Annoyed or Irritable GAD01-Being Restless Hard to Sit Still Generalized Anxiety Disorder - 7 - Being so restless that it is hard to sit still. GAD-7 - Being so Restless That it is Hard to Sit Still GAD01-Difficult to Work/Take Care Things Generalized Anxiety Disorder - 7 - If you checked off any problems, how difficult have these problems made it for you to do your work, take care of things at home, or get along with other people? GAD-7 - Problems Made it Difficult to Work, Take Care of Things, or Get Along with Other People GAD01-Feel Afraid/Something Awful Happen Generalized Anxiety Disorder - 7 - Feeling afraid as if something awful might happen. GAD-7 - Feel Afraid as if Something Awful Might Happen GAD01-Feeling Nervous Anxious or On Edge Generalized Anxiety Disorder - 7 - Feeling nervous, anxious or on edge. GAD-7 - Feeling Nervous Anxious or On Edge GAD01-Not Able to Stop/Control Worrying Generalized Anxiety Disorder - 7 - Not being able to stop or control worrying. GAD-7 - Not Being Able to Stop or Control Worrying GAD01-Total Score Generalized Anxiety Disorder - 7 - Total score. GAD-7 - Total Score GAD01-Trouble Relaxing Generalized Anxiety Disorder - 7 - Trouble relaxing. GAD-7 - Trouble Relaxing GAD01-Worrying Too Much About Things Generalized Anxiety Disorder - 7 - Worrying too much about different things. GAD-7 - Worrying Too Much About Different Things GAD01TN Generalized Anxiety Disorder - 7 Questionnaire Test Name CDISC Questionnaire GAD-7 Test Name Terminology Generalized Anxiety Disorder - 7 Version 2 test code. GAD02-Feeling Nervous Anxious or On Edge Generalized Anxiety Disorder - 7 Version 2 - Feeling nervous, anxious or on edge. GAD-7 Version 2 - Feeling Nervous Anxious or On Edge GAD02-Not Able to Stop/Control Worrying Generalized Anxiety Disorder - 7 Version 2 - Not being able to stop or control worrying. GAD-7 Version 2 - Not Able to Stop or Control Worrying GAD02-Worrying Too Much About Things Generalized Anxiety Disorder - 7 Version 2 - Worrying too much about different things. GAD-7 Version 2 - Worrying Too Much About Things GAD02-Trouble Relaxing Generalized Anxiety Disorder - 7 Version 2 - Trouble relaxing. GAD-7 Version 2 - Trouble Relaxing GAD02-Being Restless Hard to Sit Still Generalized Anxiety Disorder - 7 Version 2 - Being so restless that it is hard to sit still. GAD-7 Version 2 - Being Restless Hard to Sit Still GAD02-Becoming Easily Annoyed/Irritable Generalized Anxiety Disorder - 7 Version 2 - Becoming easily annoyed or irritable. GAD-7 Version 2 - Becoming Easily Annoyed or Irritable GAD02-Feel Afraid/Something Awful Happen Generalized Anxiety Disorder - 7 Version 2 - Feeling afraid as if something awful might happen. GAD-7 Version 2 - Feel Afraid If Something Awful Happen GAD02-Total Score Generalized Anxiety Disorder - 7 Version 2 - Total score. GAD-7 Version 2 - Total Score GAD02TC Generalized Anxiety Disorder - 7 Version 2 Questionnaire Test Code CDISC Questionnaire GAD-7 Version 2 Test Code Terminology Generalized Anxiety Disorder - 7 Version 2 test name. GAD02-Becoming Easily Annoyed/Irritable Generalized Anxiety Disorder - 7 Version 2 - Becoming easily annoyed or irritable. GAD-7 Version 2 - Becoming Easily Annoyed or Irritable GAD02-Being Restless Hard to Sit Still Generalized Anxiety Disorder - 7 Version 2 - Being so restless that it is hard to sit still. GAD-7 Version 2 - Being Restless Hard to Sit Still GAD02-Feel Afraid/Something Awful Happen Generalized Anxiety Disorder - 7 Version 2 - Feeling afraid as if something awful might happen. GAD-7 Version 2 - Feel Afraid If Something Awful Happen GAD02-Feeling Nervous Anxious or On Edge Generalized Anxiety Disorder - 7 Version 2 - Feeling nervous, anxious or on edge. GAD-7 Version 2 - Feeling Nervous Anxious or On Edge GAD02-Not Able to Stop/Control Worrying Generalized Anxiety Disorder - 7 Version 2 - Not being able to stop or control worrying. GAD-7 Version 2 - Not Able to Stop or Control Worrying GAD02-Total Score Generalized Anxiety Disorder - 7 Version 2 - Total score. GAD-7 Version 2 - Total Score GAD02-Trouble Relaxing Generalized Anxiety Disorder - 7 Version 2 - Trouble relaxing. GAD-7 Version 2 - Trouble Relaxing GAD02-Worrying Too Much About Things Generalized Anxiety Disorder - 7 Version 2 - Worrying too much about different things. GAD-7 Version 2 - Worrying Too Much About Things GAD02TN Generalized Anxiety Disorder - 7 Version 2 Questionnaire Test Name CDISC Questionnaire GAD-7 Version 2 Test Name Terminology Terminology relevant to the type of nucleic acid which was derived from the collected sample. 7SK Small Nuclear RNA 7SK snRNA 7SK small nuclear RNA is encoded by the human RN7SK gene. This oligoribonucleotide may play a role in the regulation of the enzymatic activity of RNA polymerase II. 7SK Small Nuclear RNA Complementary DNA Single-stranded DNA that is complementary to messenger RNA or DNA that has been synthesized from messenger RNA by reverse transcriptase. cDNA Cell Free Circulating DNA Cell Free DNA Circulating Cell Free DNA DNA in blood plasma and other body fluids that has been released from a cell due to a biological process. Circulating Cell-Free DNA Chloroplast DNA The DNA that is located in the photosynthetic, chlorophyll-containing organelle in the cells of young leaves and stems of higher plants. (NCI) Chloroplast DNA Cell-Free Circulating Tumor DNA Circulating Tumor DNA A type of cell-free DNA composed of small fragments of tumor DNA that are released by tumor cells into the bloodstream of the host. Circulating Tumor-Derived DNA Deoxyribonucleic Acid Double-stranded DNA ds-DNA dsDNA A long linear double-stranded polymer formed from nucleotides attached to a deoxyribose backbone; associated with the transmission of genetic information. DNA Double-stranded RNA An RNA complex consisting of two base-paired strands of complementary RNA. Double-Stranded RNA Genomic DNA The DNA that is part of the normal chromosomal complement of an organism. Genomic DNA The DNA that is found in gametes (i.e., oocyte or spermatozoon). Germline DNA Guide RNA A small RNA involved in post-transcriptional mitochondrial RNA modification (RNA editing) in kinetoplastids. Guide RNA Heterogeneous Nuclear RNA A diverse assortment of nascent, immature, unprocessed RNA transcripts synthesized from DNA templates that are found in eukaryotic nuclei before post-transcriptional modifications. hnRNA MicroRNA miRNA A sequence of single-stranded RNA which is typically 20-25 nucleotides in length and may regulate the expression of other genes. miRNAs are transcribed from DNA, but are not translated into proteins. MicroRNA Messenger RNA A class of RNA molecule containing protein-coding information in its nucleotide sequence that can be translated into the amino acid sequence of a protein. Messenger RNA Multicopy Single-stranded DNA A DNA/RNA chimera comprised of a single-stranded DNA molecule covalently bound to an internal guanosine of a RNA molecule. (NCI) Multicopy Single-stranded DNA MSR The RNA portion of the msDNA molecule, which contains two stem-loop structures and varies widely in length across bacterial species. (NCI) msdRNA mDNA Mitochondrial DNA Typically small, circular, intronless, and maternally inherited, mitochondrial DNA (mtDNA) is the multicopy deoxyribonucleic acid genome of mitochondria, intracellular organelles responsible for vital respiratory chain and oxidative phosphorylation reactions in higher eukaryotes. Replicated and transcribed by a separate enzymatic machinery from that of nuclear DNA, mtDNA encodes only a subset of mitochondrial functions. Mitochondrial DNA Nuclear DNA The DNA that is normally located in the nucleus of a eukaryotic cell. Nuclear DNA Plasmid Plasmid DNA A small cellular inclusion consisting of a ring of DNA that is not in a chromosome but is capable of autonomous replication. Plasmid piRNA Piwi-Interacting RNA Single-stranded RNA molecules that are expressed in animal cells and form complexes with Piwi proteins. They are involved in transcriptional gene silencing. Piwi-Interacting RNA Precursor mRNA A primary RNA transcript synthesized from a DNA template in eukaryotic nuclei which is post-transcriptionally modified and spliced to produce a mature mRNA. (NCI) Precursor mRNA Pri-microRNA Pri-MIR Pri-miRNA Primary MicroRNA The pri-miRNA is a primary transcript derived from a gene whose sole products are miRNA(s). A unique pathway involving the nuclear microprocessor complex participates in the cleavage of such transcripts, which can be substantially longer than the 65-110 nt pre-miRNA. Pri-miRNA Ribosomal DNA Ribosomal RNA Genes The genomic sequences that code for ribosomal RNA molecules. Ribosomal RNA Gene Catalytic RNA Ribonucleic Enzyme RNA that contains an intron sequence which has an enzyme-like catalytic activity. This intron sequence can function like an enzyme in reactions with other RNA molecules and thus synthesize new molecules even in the absence of protein. Ribozyme Ribonucleic Acid Single-stranded long chain of nucleotides containing ribose. It is the end product of DNA transcription by the enzyme RNA polymerase. It is essential in protein synthesis. Ribonucleic Acid Ribosomal RNA rRNA An RNA molecule that associates with multiple proteins to form ribosomes. Ribosomal RNA siRNA Small Interfering RNA A 20 to 25-nucleotide double-stranded RNA which is involved in a sequence-specific messenger RNA degradation process known as RNA interference. Small Interfering RNA Small Nucleolar RNA snoRNA A small RNA molecule located in the cell nucleolus that associates with proteins to form small nucleolar ribonucleoprotein particles that are involved in modification of other RNAs. Small Nucleolar RNA Small Nuclear Ribonucleic Acid Small Nuclear RNA snRNA U-RNA A small RNA molecule (100-300 nucleotides) located in the cell nucleus that is involved in RNA splicing, transcriptional regulation, telomere maintenance and rRNA modification. Small Nuclear RNA 7SL RNA Signal Recognition Particle RNA SRP RNA srpRNA A non-coding RNA that is part of the signal recognition particle. It is involved in the co-translational targeting of proteins to membranes. Signal Recognition Particle RNA Single-stranded DNA A long linear single-stranded polymer formed from nucleotides attached to a deoxyribose backbone. (NCI) Single-stranded DNA 10Sa RNA SsrA Transfer-Messenger RNA An RNA encoded by the bacterial ssrA gene. It is involved in the recycling of stalled ribosomes and the targeting of both defective mRNA molecules and incomplete nascent proteins for degradation. Transfer-Messenger RNA Jumping Gene Jumping Genes Transposable Element A class of mobile genetic elements that can move from one genomic position to another. Transposon Transfer RNA Triplet Codon-Amino Acid Adaptor tRNA A class of short adaptor RNAs that transfers a specific amino acid to a growing polypeptide chain at the ribosomal site of protein synthesis during translation. Transfer RNA GENSMP Genetic Sample Type CDISC SDTM Genetic Sample Type Terminology Terminology relevant to the formula names associated with a genomic findings test calculation. Unique pattern of nucleotide variation of genes that are involved in drug absorption, distribution, metabolism, and excretion (ADME). ADME Variant Profile An algorithm for classifying non-small cell lung cancer as EGFR FISH-positive or FISH-negative, published by Varella-Garcia et al in 2006. (Varella-Garcia M. Stratification of non-small cell lung cancer patients for therapy with epidermal growth factor receptor inhibitors: the EGFR fluorescence in situ hybridization assay. Diagn Pathol. 2006 Aug 15;1:19.) Colorado Scoring Method for EGFR Gene Amplification 2006 Algorithm An algorithm for classifying non-small cell lung cancer as EGFR FISH-positive or FISH-negative, published by Varella-Garcia et al in 2009. (Varella-Garcia M, Diebold J, Eberhard DA, Geenen K, Hirschmann A, Kockx M, Nagelmeier I, Ruschoff J, Schmitt M, Arbogast S, Cappuzzo F. EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer. J Clin Pathol. 2009 Nov;62(11):970-7.) Colorado Scoring Method for EGFR Gene Amplification 2009 Algorithm CPM A mathematical formula that normalizes transcript fragment counts based on the total number of transcript fragments that are sequenced. CPM equals the number of reads divided by the number of sequenced transcript fragments, and multiplied by 1,000,000. Transcript Fragment Count per Million Formula A mathematical formula that compares gene expression by calculating the log2 fold difference between two gene expression intensities, or 2^(Value 2 Intensity - Value 1 Intensity). Differences Of Log2 Intensities Formula FPKM A mathematical formula that calculates the number of fragments per million fragments sampled (calculated by dividing the fragment counts by a per million scaling factor, which is derived by taking the total fragments in the sample and dividing by 1,000,000) divided by the length of the gene, in kilobases. Fragments are represented by either paired or single end reads. Fragments Per Kilobase Million Formula A unique pattern of gene transcription of one to many combinations of genes that is associated with type 1 interferon activity. IFN-1 Gene Signature RPKM A mathematical formula that calculates the number of fragments per million fragments sampled (calculated by dividing the fragment counts by a per million scaling factor, which is derived by taking the total fragments in the sample and dividing by 1,000,000) divided by the length of the gene, in kilobases. Fragments are represented by single end reads. Reads Per Kilobase Million Formula TPM A mathematical formula that identifies the reads per kilobase (RPK, derived by dividing the read counts by the length of each gene, in kilobases) divided by a per million scaling factor (which is the count of RPK values in a sample divided by 1,000,000). Transcripts Per Million Formula GFANMET Genomic Findings Analytical Method Calculation Formula CDISC SDTM Genomic Findings Analytical Method Calculation Formula Terminology Terminology relevant to the test codes that describe genomic findings. Copy Number Amplification Gene Copy Number Amplification An assessment of the increase in the number of replicas of a gene within a genome. Copy Number Amplification Assessment Copy Number Variation Gene Copy Number Variation An assessment of the variability in the number of replicas of a gene within a genome. Copy Number Variation Assessment Gene Expression Signature Gene Signature An assessment of the unique pattern of gene expression of one to many genes associated with a normal or abnormal biological process. Gene Signature Assessment Microsatellite Instability An assessment of the variability in length of microsatellite sequences. Microsatellite Instability Length Assessment Sequence Rearrangement Any product of a process affecting a nucleic acid sequence that results in the gain, loss, inversion, or translocation of nucleic acid. Sequence Rearrangement Short Variation An assessment of the variability in a short sequence of nucleotides (generally defined as 50 base pairs or less), when compared to a reference sequence. Short Variation Assessment Single Nucleotide Variation An assessment of the variability in a nucleotide found within a specified position of the genome, when compared to a reference nucleotide. Single Nucleotide Variation Assessment Tumor Mutation Burden Tumor Mutational Burden A quantitative or qualitative assessment of the number of genomic alterations found in genetic material from tumor cells, when compared to a reference sequence. Tumor Mutation Burden Assessment Transcription An assessment of transcribed RNA molecules in a biological specimen. Transcription Variant Profile An assessment of the unique pattern of sequence variation of one to many loci associated with a normal or abnormal biological process. Variant Profile Assessment Tandem Repeat Variation Variable Nucleotide Tandem Repeats Variable Number Tandem Repeats An assessment of the variations in the number of tandem repeat nucleotide sequences, which are end-to-end adjacent copies of a short (2 to 60 nucleotides) DNA sequence. Variable Number Tandem Repeats Assessment GFTESTCD Genomic Findings Test Code CDISC SDTM Genomic Findings Test Code Terminology Terminology relevant to the reportable qualifying the genomic assessment. The determination of the nucleotide sequence of the allele at a specific locus. Allele Sequence Analysis A characterization or classification of the allele. Allele Type The sum of the number of centromere-specific signals (e.g., fluorescent) within the cells examined. Number of Centromere Signals An interpretive summary of the number of replicas of a gene or gene segment within a genome, as compared to a reference or assumed state. Copy Number Alteration Interpretation A relative measurement (ratio) of the number of altered copies in the sample to the number of copies in the reference sequence. Copy Number Ratio The determination of presence or absence of an entity in a specimen. Biological Detection Test The determination of the nucleotide sequence of linked marker alleles for a given region of DNA on homologous chromosome pairs. Diplotype The absolute number of fragments of genetic material that were detected. Fragment Count An indication as to whether a genetic sequence is transcribed into RNA. Genetic Transcription Indicator An interpretive summary of the pattern of genetic transcription. Genetic Transcription Interpretation The sum of the number of genome-specific target signals (e.g., fluorescent) within the cells examined. Number of Genome-Specific Target Signals The determination of the nucleotide sequence of the genetic material at a specific locus. Genotyping The combination of linked marker alleles for a given region of DNA on a single chromosome. (Glossary of Genomics Terms. JAMA. 2013 Apr 10; 309(14):1533-35.) Haplotype Microsatellite Instability Overall Stat MSIOSTAT The overall state or condition of the variability in length of multiple, assessed microsatellite sequences. Microsatellite Instability Overall Status A value that is adjusted via a formula or calculation, to facilitate comparison. Normalized Level A quantitative assessment of the number of sequence variants within a region of interest, which has been normalized. Number of Normalized Sequence Variants Assessment The sequence of nucleotides within a genetic region of interest. Nucleotide Sequence The number of affected exons as compared to the reference sequence. Number of Altered Exons A quantitative assessment of the number of repeating genetic sequences made up of cytosine, adenine, and guanine trinucleotides. Number of CAG Repeats Gene Copy Number The number of replicas of a particular gene sequence in a genome. Number of Gene Copies A quantitative assessment of the number of sequence variants within a region of interest. Number of Sequence Variants A relative ranking of the percent of total that the entity would equal or exceed. Percentile Rank Inferred Amino Acid Change An inferred amino acid modification, based on sequence analysis of a genetic variation. Predicted Amino Acid Change Inferred Coding Sequence Change An inferred coding sequence modification, based on sequence analysis of a genetic variation. Predicted Coding Sequence Change Inferred Diplotype Predicted Haplotype Pair A description of the inferred nucleotide sequence at one or more paired loci. Predicted Diplotype An indication as to whether the genomic variation product retains the original reading frame, as inferred from the coding sequence. Predicted In-Frame Indicator An inferred number of repeating genetic sequences made up of cytosine, adenine, and guanine trinucleotides. Predicted Number of CAG Repeats The observable characteristics as inferred from changes in the underlying genomic material. Predicted Phenotype Depth of Coverage Total Mapped Reads Total Read Depth The total number of times a particular locus (site, nucleotide, amplicon, region) was sequenced. Read Depth The first or primary gene involved in the sequence rearrangement. Rearrangement Gene 1 Symbol The second gene involved in the sequence rearrangement. Rearrangement Gene 2 Symbol A categorization of the phenotypic or clinical significance of the genetic rearrangement. Genetic Rearrangement Functional Impact Classification The characterization or classification of the structural changes to the gene(s) as a consequence of the rearrangement. Rearrangement Type Classification Score A value (e.g., number, numeric range, ratio) that assesses and orders a result or response for purposes of comparison. Score A categorization of the phenotypic or clinical significance of the genomic variation. Genetic Variation Functional Impact Classification Variant Mapped Reads The number of times a particular variant within a locus (site, nucleotide, amplicon, region) was sequenced. Variant Read Depth Variant Mapped Reads/Total Mapped Reads Variant Read Depth/Total Read Depth A relative measurement (ratio or percentage) of the variant read depth to total read depth. Variant Read Depth to Read Depth An interpretive summary of the magnitude of the variant burden within the tumor. Variant Sequence Tumor Burden Interpretation GFTSDTL Genomic Findings Test Detail CDISC SDTM Genomic Findings Test Detail Terminology Terminology relevant to the test names that describe genomic findings. Copy Number Amplification Gene Copy Number Amplification An assessment of the increase in the number of replicas of a gene within a genome. Copy Number Amplification Assessment Copy Number Variation Gene Copy Number Variation An assessment of the variability in the number of replicas of a gene within a genome. Copy Number Variation Assessment Gene Expression Signature Gene Signature An assessment of the unique pattern of gene expression of one to many genes associated with a normal or abnormal biological process. Gene Signature Assessment Microsatellite Instability An assessment of the variability in length of microsatellite sequences. Microsatellite Instability Length Assessment Sequence Rearrangement Any product of a process affecting a nucleic acid sequence that results in the gain, loss, inversion, or translocation of nucleic acid. Sequence Rearrangement Short Variation An assessment of the variability in a short sequence of nucleotides (generally defined as 50 base pairs or less), when compared to a reference sequence. Short Variation Assessment Single Nucleotide Variation An assessment of the variability in a nucleotide found within a specified position of the genome, when compared to a reference nucleotide. Single Nucleotide Variation Assessment Transcription An assessment of transcribed RNA molecules in a biological specimen. Transcription Tumor Mutation Burden Tumor Mutational Burden A quantitative or qualitative assessment of the number of genomic alterations found in genetic material from tumor cells, when compared to a reference sequence. Tumor Mutation Burden Assessment Tandem Repeat Variation Variable Nucleotide Tandem Repeats Variable Number Tandem Repeats An assessment of the variations in the number of tandem repeat nucleotide sequences, which are end-to-end adjacent copies of a short (2 to 60 nucleotides) DNA sequence. Variable Number Tandem Repeats Assessment Variant Profile An assessment of the unique pattern of sequence variation of one to many loci associated with a normal or abnormal biological process. Variant Profile Assessment GFTEST Genomic Findings Test Name CDISC SDTM Genomic Findings Test Name Terminology Terminology relevant to whether the variation can be passed to the next generation. Any inheritable variation in the DNA that is transmitted to the progeny with some frequency. Germline Variation Any inheritable variation that appears in mitochondrial DNA that is transmitted to the progeny with some frequency. Mitochondrial DNA Variation Any non-inheritable variation in the DNA that is not transmitted to the progeny but will be maintained during any mitosis within the individual. Somatic Variation INHERTGF Genomic Inheritability Type Response CDISC SDTM Genomic Inheritability Type Response Terminology Terminology relevant to the type of genomic entity that is represented by the published gene symbol. circRNA A sequence of single-stranded RNA that forms a covalently closed continuous loop. Circular RNA Integrated retroviral elements that are transmitted through the germline. (HGNC) Endogenous Retrovirus A heritable locus on a chromosome that is prone to DNA breakage. (HGNC) Chromosome Fragile Site A protein-coding gene (the protein may be predicted or of unknown function). (HGNC) Protein-Encoding Gene lncRNA A non-coding transcript typically greater than 200bp in length. (Ensembl) LincRNA MicroRNA miRNA A sequence of single-stranded RNA which is typically 20-25 nucleotides in length and may regulate the expression of other genes. miRNAs are transcribed from DNA, but are not translated into proteins. MicroRNA A transcript with a premature stop codon considered likely to be subjected to targeted degradation. (Ensembl) Non-Sense Mediated Decay Mutation piRNA Piwi-Interacting RNA Single-stranded RNA molecules that are expressed in animal cells and form complexes with Piwi proteins. They are involved in transcriptional gene silencing. Piwi-Interacting RNA A transcript that doesn't contain an open reading frame (ORF). (Ensembl) Processed Transcript Genomic DNA sequences that are similar to protein-coding genes but do not encode a functional protein. (HGNC) Pseudogene A naturally occurring transcript containing coding sequences from two or more genes that can also be transcribed individually. (HGNC) Readthrough Transcript An alternatively spliced transcript believed to contain intronic sequence relative to other, coding, transcripts of the same gene. (Ensembl) Retained Intron Ribosomal RNA rRNA An RNA molecule that associates with multiple proteins to form ribosomes. Ribosomal RNA scRNA Non-protein coding genes that encode small cytoplasmic RNAs (scRNAs). (HGNC) Small Cytoplasmic RNA siRNA Small Interfering RNA A 20 to 25-nucleotide double-stranded RNA which is involved in a sequence-specific messenger RNA degradation process known as RNA interference. Small Interfering RNA Small ncRNA A non-coding transcript typically less than 200bp in length. Small Non-Coding RNA Small Nuclear Ribonucleic Acid Small Nuclear RNA snRNA U-RNA A small RNA molecule (100-300 nucleotides) located in the cell nucleus that is involved in RNA splicing, transcriptional regulation, telomere maintenance and rRNA modification. Small Nuclear RNA Small Nucleolar RNA snoRNA A small RNA molecule located in the cell nucleolus that associates with proteins to form small nucleolar ribonucleoprotein particles that are involved in modification of other RNAs. Small Nucleolar RNA A transcript containing a stop codon that is translated, and termination occurs instead at a canonical stop codon further downstream. (Ensembl) Stop Codon Readthrough Transcript Transfer RNA Triplet Codon-Amino Acid Adaptor tRNA A class of short adaptor RNAs that transfers a specific amino acid to a growing polypeptide chain at the ribosomal site of protein synthesis during translation. Transfer RNA Jumping Gene Jumping Genes Transposable Element A class of mobile genetic elements that can move from one genomic position to another. Transposon vaultRNA vtRNA Small, untranslated RNAs associated with vault complexes. Vault RNA Viral Integration Site Sequence VIS Target sequence for the integration of viral DNA into the genome. (HGNC) Virus Integration Site SYMTYPGF Genomic Symbol Type Response CDISC SDTM Genomic Symbol Type Response Terminology Geriatric Depression Scale test code. GDS01-Satisfied With Life Geriatric Depression Scale - Are you basically satisfied with your life? GDS - Basically Satisfied With Life GDS01-Dropped Activities and Interests Geriatric Depression Scale - Have you dropped many of your activities and interests? GDS - Dropped Activities and Interests GDS01-Life Is Empty Geriatric Depression Scale - Do you feel that your life is empty? GDS - Feel Life Is Empty GDS01-Bored Often Geriatric Depression Scale - Do you often get bored? GDS - Often Get Bored GDS01-Hopeful About Future Geriatric Depression Scale - Are you hopeful about the future? GDS - Hopeful About Future GDS01-Bothered by Thoughts Geriatric Depression Scale - Are you bothered by thoughts you can't get out of your head? GDS - Bothered by Thoughts GDS01-Good Spirits Most of Time Geriatric Depression Scale - Are you in good spirits most of the time? GDS - Good Spirits Most of Time GDS01-Afraid of Something Bad Happening Geriatric Depression Scale - Are you afraid that something bad is going to happen to you? GDS - Afraid of Something Bad Happening GDS01-Feel Happy Most of Time Geriatric Depression Scale - Do you feel happy most of the time? GDS - Feel Happy Most of Time GDS01-Often Feel Helpless Geriatric Depression Scale - Do you often feel helpless? GDS - Often Feel Helpless GDS01-Get Restless and Fidgety Geriatric Depression Scale - Do you often get restless and fidgety? GDS - Get Restless and Fidgety GDS01-Prefer to Stay Home Geriatric Depression Scale - Do you prefer to stay at home, rather than going out and doing new things? GDS - Prefer to Stay Home GDS01-Worry About Future Geriatric Depression Scale - Do you frequently worry about the future? GDS - Frequently Worry About Future GDS01-Memory Problems Geriatric Depression Scale - Do you feel you have more problems with memory than most? GDS - More Memory Problems Than Most GDS01-Wonderful to Be Alive Geriatric Depression Scale - Do you think it is wonderful to be alive now? GDS - Think Wonderful to Be Alive GDS01-Feel Downhearted and Blue Geriatric Depression Scale - Do you often feel downhearted and blue? GDS - Feel Downhearted and Blue GDS01-Feel Worthless Geriatric Depression Scale - Do you feel pretty worthless the way you are now? GDS - Feel Worthless GDS01-Worry About the Past Geriatric Depression Scale - Do you worry a lot about the past? GDS - Worry About the Past GDS01-Find Life Exciting Geriatric Depression Scale - Do you find life very exciting? GDS - Find Life Exciting GDS01-Hard to Start New Projects Geriatric Depression Scale - Is it hard for you to get started on new projects? GDS - Hard to Start New Projects GDS01-Feel Full of Energy Geriatric Depression Scale - Do you feel full of energy? GDS - Feel Full of Energy GDS01-Feel Hopeless Geriatric Depression Scale - Do you feel that your situation is hopeless? GDS - Feel Situation Is Hopeless GDS01-Most People Better Off Than You Geriatric Depression Scale - Do you think that most people are better off than you are? GDS - Think Most People Better Off Than You GDS01-Often Upset Over Little Things Geriatric Depression Scale -Do you frequently get upset over little things? GDS - Often Upset Over Little Things GDS01-Frequently Feel Like Crying Geriatric Depression Scale - Do you frequently feel like crying? GDS - Frequently Feel Like Crying GDS01-Trouble Concentrating Geriatric Depression Scale - Do you have trouble concentrating? GDS - Have Trouble Concentrating GDS01-Enjoy Getting Up in the Morning Geriatric Depression Scale - Do you enjoy getting up in the morning? GDS - Enjoy Getting Up in the Morning GDS01-Avoid Social Gatherings Geriatric Depression Scale - Do you prefer to avoid social gatherings? GDS - Prefer to Avoid Social Gatherings GDS01-Easy to Make Decisions Geriatric Depression Scale - Is it easy for you to make decisions? GDS - Easy to Make Decisions GDS01-Mind as Clear as It Used to Be Geriatric Depression Scale - Is your mind as clear as it used to be? GDS - Mind as Clear as It Used to Be GDS01-Total Score Geriatric Depression Scale - Total score. GDS - Total Score GDS01TC Geriatric Depression Scale Questionnaire Test Code CDISC Questionnaire GDS Test Code Terminology Geriatric Depression Scale test name. GDS01-Afraid of Something Bad Happening Geriatric Depression Scale - Are you afraid that something bad is going to happen to you? GDS - Afraid of Something Bad Happening GDS01-Avoid Social Gatherings Geriatric Depression Scale - Do you prefer to avoid social gatherings? GDS - Prefer to Avoid Social Gatherings GDS01-Bored Often Geriatric Depression Scale - Do you often get bored? GDS - Often Get Bored GDS01-Bothered by Thoughts Geriatric Depression Scale - Are you bothered by thoughts you can't get out of your head? GDS - Bothered by Thoughts GDS01-Dropped Activities and Interests Geriatric Depression Scale - Have you dropped many of your activities and interests? GDS - Dropped Activities and Interests GDS01-Easy to Make Decisions Geriatric Depression Scale - Is it easy for you to make decisions? GDS - Easy to Make Decisions GDS01-Enjoy Getting Up in the Morning Geriatric Depression Scale - Do you enjoy getting up in the morning? GDS - Enjoy Getting Up in the Morning GDS01-Feel Downhearted and Blue Geriatric Depression Scale - Do you often feel downhearted and blue? GDS - Feel Downhearted and Blue GDS01-Feel Full of Energy Geriatric Depression Scale - Do you feel full of energy? GDS - Feel Full of Energy GDS01-Feel Happy Most of Time Geriatric Depression Scale - Do you feel happy most of the time? GDS - Feel Happy Most of Time GDS01-Feel Hopeless Geriatric Depression Scale - Do you feel that your situation is hopeless? GDS - Feel Situation Is Hopeless GDS01-Feel Worthless Geriatric Depression Scale - Do you feel pretty worthless the way you are now? GDS - Feel Worthless GDS01-Find Life Exciting Geriatric Depression Scale - Do you find life very exciting? GDS - Find Life Exciting GDS01-Frequently Feel Like Crying Geriatric Depression Scale - Do you frequently feel like crying? GDS - Frequently Feel Like Crying GDS01-Get Restless and Fidgety Geriatric Depression Scale - Do you often get restless and fidgety? GDS - Get Restless and Fidgety GDS01-Good Spirits Most of Time Geriatric Depression Scale - Are you in good spirits most of the time? GDS - Good Spirits Most of Time GDS01-Hard to Start New Projects Geriatric Depression Scale - Is it hard for you to get started on new projects? GDS - Hard to Start New Projects GDS01-Hopeful About Future Geriatric Depression Scale - Are you hopeful about the future? GDS - Hopeful About Future GDS01-Life Is Empty Geriatric Depression Scale - Do you feel that your life is empty? GDS - Feel Life Is Empty GDS01-Memory Problems Geriatric Depression Scale - Do you feel you have more problems with memory than most? GDS - More Memory Problems Than Most GDS01-Mind as Clear as It Used to Be Geriatric Depression Scale - Is your mind as clear as it used to be? GDS - Mind as Clear as It Used to Be GDS01-Most People Better Off Than You Geriatric Depression Scale - Do you think that most people are better off than you are? GDS - Think Most People Better Off Than You GDS01-Often Feel Helpless Geriatric Depression Scale - Do you often feel helpless? GDS - Often Feel Helpless GDS01-Often Upset Over Little Things Geriatric Depression Scale -Do you frequently get upset over little things? GDS - Often Upset Over Little Things GDS01-Prefer to Stay Home Geriatric Depression Scale - Do you prefer to stay at home, rather than going out and doing new things? GDS - Prefer to Stay Home GDS01-Satisfied With Life Geriatric Depression Scale - Are you basically satisfied with your life? GDS - Basically Satisfied With Life GDS01-Total Score Geriatric Depression Scale - Total score. GDS - Total Score GDS01-Trouble Concentrating Geriatric Depression Scale - Do you have trouble concentrating? GDS - Have Trouble Concentrating GDS01-Wonderful to Be Alive Geriatric Depression Scale - Do you think it is wonderful to be alive now? GDS - Think Wonderful to Be Alive GDS01-Worry About Future Geriatric Depression Scale - Do you frequently worry about the future? GDS - Frequently Worry About Future GDS01-Worry About the Past Geriatric Depression Scale - Do you worry a lot about the past? GDS - Worry About the Past GDS01TN Geriatric Depression Scale Questionnaire Test Name CDISC Questionnaire GDS Test Name Terminology Geriatric Depression Scale Short Form test code. GDS02-Satisfied With Life Geriatric Depression Scale Short Form - Are you basically satisfied with your life? GDS-SF - Basically Satisfied With Life GDS02-Dropped Activities and Interests Geriatric Depression Scale Short Form - Have you dropped many of your activities and interests? GDS-SF - Dropped Activities and Interests GDS02-Life Is Empty Geriatric Depression Scale Short Form - Do you feel that your life is empty? GDS-SF - Feel Life Is Empty GDS02-Bored Often Geriatric Depression Scale Short Form - Do you often get bored? GDS-SF - Often Get Bored GDS02-Good Spirits Most of Time Geriatric Depression Scale Short Form - Are you in good spirits most of the time? GDS-SF - Good Spirits Most of Time GDS02-Afraid of Something Bad Happening Geriatric Depression Scale Short Form - Are you afraid that something bad is going to happen to you? GDS-SF - Afraid of Something Bad Happening GDS02-Feel Happy Most of Time Geriatric Depression Scale Short Form - Do you feel happy most of the time? GDS-SF - Feel Happy Most of Time GDS02-Often Feel Helpless Geriatric Depression Scale Short Form - Do you often feel helpless? GDS-SF - Often Feel Helpless GDS02-Prefer to Stay Home Geriatric Depression Scale Short Form - Do you prefer to stay at home rather than going out and doing new things? GDS-SF - Prefer to Stay Home GDS02-Memory Problems Geriatric Depression Scale Short Form - Do you feel you have more problems with memory than most? GDS-SF - More Memory Problems Than Most GDS02-Wonderful to Be Alive Geriatric Depression Scale Short Form - Do you think it is wonderful to be alive now? GDS-SF - Think Wonderful to Be Alive GDS02-Feel Worthless Geriatric Depression Scale Short Form - Do you feel pretty worthless the way you are now? GDS-SF - Feel Worthless GDS02-Feel Full of Energy Geriatric Depression Scale Short Form - Do you feel full of energy? GDS-SF - Feel Full of Energy GDS02-Feel Hopeless Geriatric Depression Scale Short Form - Do you feel that your situation is hopeless? GDS-SF - Feel Situation is Hopeless GDS02-Most People Better Off Than You Geriatric Depression Scale Short Form - Do you think that most people are better off than you are? GDS-SF - Think Most People Better Off Than You GDS02-Total Score Geriatric Depression Scale Short Form - Total score. GDS-SF - Total Score GDS02TC Geriatric Depression Scale Short Form Questionnaire Test Code CDISC Questionnaire GDS-SF Test Code Terminology Geriatric Depression Scale Short Form test name. GDS02-Afraid of Something Bad Happening Geriatric Depression Scale Short Form - Are you afraid that something bad is going to happen to you? GDS-SF - Afraid of Something Bad Happening GDS02-Bored Often Geriatric Depression Scale Short Form - Do you often get bored? GDS-SF - Often Get Bored GDS02-Dropped Activities and Interests Geriatric Depression Scale Short Form - Have you dropped many of your activities and interests? GDS-SF - Dropped Activities and Interests GDS02-Feel Full of Energy Geriatric Depression Scale Short Form - Do you feel full of energy? GDS-SF - Feel Full of Energy GDS02-Feel Happy Most of Time Geriatric Depression Scale Short Form - Do you feel happy most of the time? GDS-SF - Feel Happy Most of Time GDS02-Feel Hopeless Geriatric Depression Scale Short Form - Do you feel that your situation is hopeless? GDS-SF - Feel Situation is Hopeless GDS02-Feel Worthless Geriatric Depression Scale Short Form - Do you feel pretty worthless the way you are now? GDS-SF - Feel Worthless GDS02-Good Spirits Most of Time Geriatric Depression Scale Short Form - Are you in good spirits most of the time? GDS-SF - Good Spirits Most of Time GDS02-Life Is Empty Geriatric Depression Scale Short Form - Do you feel that your life is empty? GDS-SF - Feel Life Is Empty GDS02-Memory Problems Geriatric Depression Scale Short Form - Do you feel you have more problems with memory than most? GDS-SF - More Memory Problems Than Most GDS02-Most People Better Off Than You Geriatric Depression Scale Short Form - Do you think that most people are better off than you are? GDS-SF - Think Most People Better Off Than You GDS02-Often Feel Helpless Geriatric Depression Scale Short Form - Do you often feel helpless? GDS-SF - Often Feel Helpless GDS02-Prefer to Stay Home Geriatric Depression Scale Short Form - Do you prefer to stay at home rather than going out and doing new things? GDS-SF - Prefer to Stay Home GDS02-Satisfied With Life Geriatric Depression Scale Short Form - Are you basically satisfied with your life? GDS-SF - Basically Satisfied With Life GDS02-Total Score Geriatric Depression Scale Short Form - Total score. GDS-SF - Total Score GDS02-Wonderful to Be Alive Geriatric Depression Scale Short Form - Do you think it is wonderful to be alive now? GDS-SF - Think Wonderful to Be Alive GDS02TN Geriatric Depression Scale Short Form Questionnaire Test Name CDISC Questionnaire GDS-SF Test Name Terminology Glasgow Coma Scale NINDS Version 1.0 test code. GCS01-Best Eye Response Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - Best eye response. Glasgow Coma Scale-NINDS Version 1.0 - Best Eye Response GCS01-Motor Response Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - Motor response. Glasgow Coma Scale-NINDS Version 1.0 - Motor Response GCS01-Verbal Response Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - Verbal response. Glasgow Coma Scale-NINDS Version 1.0 - Verbal Response GCS01-Total Score Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - Total score. Glasgow Coma Scale-NINDS Version 1.0 - Total Score GCS01-Confounder: GCS Accurate Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: GCS accurate. Glasgow Coma Scale-NINDS Version 1.0 - Confounder: GCS Accurate GCS01-Confounder: Paralytic Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: paralytic. Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Paralytic GCS01-Confounder: Alcohol/Drug of Abuse Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: alcohol/drugs of abuse. Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Alcohol or Drug of Abuse GCS01-Confounder: C-Spine Injury Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: C-spine injury. Glasgow Coma Scale-NINDS Version 1.0 - Confounder: C-Spine Injury GCS01-Confounder: Hypoxia/Hypotension Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: hypoxia/hypotension. Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Hypoxia or Hypotension GCS01-Confounder: Hypothermia Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: hypothermia. Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Hypothermia GCS01-Confounder: Sedation Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: sedation. Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Sedation GCS01-Confounder: Unknown Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: unknown. Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Unknown GCS01TC Glasgow Coma Scale NINDS Version 1.0 Clinical Classification Test Code CDISC Clinical Classification Glasgow Coma Scale-NINDS Version 1.0 Test Code Terminology Glasgow Coma Scale NINDS Version 1.0 test name. GCS01-Best Eye Response Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - Best eye response. Glasgow Coma Scale-NINDS Version 1.0 - Best Eye Response GCS01-Confounder: Alcohol/Drug of Abuse Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: alcohol/drugs of abuse. Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Alcohol or Drug of Abuse GCS01-Confounder: C-Spine Injury Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: C-spine injury. Glasgow Coma Scale-NINDS Version 1.0 - Confounder: C-Spine Injury GCS01-Confounder: GCS Accurate Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: GCS accurate. Glasgow Coma Scale-NINDS Version 1.0 - Confounder: GCS Accurate GCS01-Confounder: Hypothermia Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: hypothermia. Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Hypothermia GCS01-Confounder: Hypoxia/Hypotension Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: hypoxia/hypotension. Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Hypoxia or Hypotension GCS01-Confounder: Paralytic Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: paralytic. Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Paralytic GCS01-Confounder: Sedation Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: sedation. Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Sedation GCS01-Confounder: Unknown Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: unknown. Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Unknown GCS01-Motor Response Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - Motor response. Glasgow Coma Scale-NINDS Version 1.0 - Motor Response GCS01-Total Score Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - Total score. Glasgow Coma Scale-NINDS Version 1.0 - Total Score GCS01-Verbal Response Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - Verbal response. Glasgow Coma Scale-NINDS Version 1.0 - Verbal Response GCS01TN Glasgow Coma Scale NINDS Version 1.0 Clinical Classification Test Name CDISC Clinical Classification Glasgow Coma Scale-NINDS Version 1.0 Test Name Terminology A terminology codelist relevant to the type of graft implanted in the subject. A vessel graft comprised of an artery that has been completely detached from its original location. (NCI) Free Arterial Graft A vessel graft comprised of an artery whose origin remains intact. In Situ Arterial Graft A vessel graft comprised of a vein harvested from a different anatomical location. Autologous Vein Graft An arterial graft harvested from a cadaver. (NCI) Cadaveric Arterial Graft A venous graft harvested from a cadaver. (NCI) Cadaveric Venous Graft A vessel graft comprised of two or more conduit materials. Composite Vessel Graft SVG A vessel graft comprised of the saphenous vein. Saphenous Vein Graft A vessel graft comprised of non-biological material. Synthetic Vessel Graft GRAFTTYP Graft Type CDISC SDTM Graft Type Terminology Hamilton Anxiety Rating Scale original result for HAMA101 through HAMA114 test and test code. HAMA101 through HAMA114-Mild Hamilton Anxiety Rating Scale original result for HAMA101 through HAMA114-Mild. Hamilton Anxiety Rating Scale HAMA101 Through HAMA114 Original Result - Mild HAMA101 through HAMA114-Moderate Hamilton Anxiety Rating Scale original result for HAMA101 through HAMA114-Moderate. Hamilton Anxiety Rating Scale HAMA101 Through HAMA114 Original Result - Moderate HAMA101 through HAMA114-Not present Hamilton Anxiety Rating Scale original result for HAMA101 through HAMA114-Not present. Hamilton Anxiety Rating Scale HAMA101 Through HAMA114 Original Result - Not present HAMA101 through HAMA114-Severe Hamilton Anxiety Rating Scale original result for HAMA101 through HAMA114-Severe. Hamilton Anxiety Rating Scale HAMA101 Through HAMA114 Original Result - Severe HAMA101 through HAMA114-Very severe Hamilton Anxiety Rating Scale original result for HAMA101 through HAMA114-Very severe. Hamilton Anxiety Rating Scale HAMA101 Through HAMA114 Original Result - Very severe HAMA101T14OR Hamilton Anxiety Rating Scale Clinical Classification ORRES for HAMA101 Through HAMA114 TN/TC CDISC Clinical Classification Hamilton Anxiety Rating Scale HAMA101 Through HAMA114 Original Response Terminology Hamilton Anxiety Rating Scale standardized character result for HAMA101 through HAMA114 test and test code. HAMA101 through HAMA114-0 Hamilton Anxiety Rating Scale standard character result for HAMA101 through HAMA114-Not present. Hamilton Anxiety Rating Scale HAMA101 Through HAMA114 Standardized Character Result 0 HAMA101 through HAMA114-1 Hamilton Anxiety Rating Scale standard character result for HAMA101 through HAMA114-Mild. Hamilton Anxiety Rating Scale HAMA101 Through HAMA114 Standardized Character Result 1 HAMA101 through HAMA114-2 Hamilton Anxiety Rating Scale standard character result for HAMA101 through HAMA114-Moderate. Hamilton Anxiety Rating Scale HAMA101 Through HAMA114 Standardized Character Result 2 HAMA101 through HAMA114-3 Hamilton Anxiety Rating Scale standard character result for HAMA101 through HAMA114-Severe. Hamilton Anxiety Rating Scale HAMA101 Through HAMA114 Standardized Character Result 3 HAMA101 through HAMA114-4 Hamilton Anxiety Rating Scale standard character result for HAMA101 through HAMA114-Very severe. Hamilton Anxiety Rating Scale HAMA101 Through HAMA114 Standardized Character Result 4 HAMA101T14STR Hamilton Anxiety Rating Scale Clinical Classification STRESC for HAMA101 Through HAMA114 TN/TC CDISC Clinical Classification Hamilton Anxiety Rating Scale HAMA101 Through HAMA114 Standardized Character Response Terminology Hamilton Anxiety Rating Scale test code. HAMA1-Anxious Mood Hamilton Anxiety Rating Scale - Anxious mood: worries, anticipation of the worst, fearful anticipation, irritability. HAMA - Anxious Mood HAMA1-Tension Hamilton Anxiety Rating Scale - Tension: feelings of tension, fatigability, startle response, moved to tears easily, trembling, feelings of restlessness, inability to relax. HAMA - Tension HAMA1-Fears Hamilton Anxiety Rating Scale - Fears: of dark, of strangers, of being left alone, of animals, of traffic, of crowds. HAMA - Fears HAMA1-Insomnia Hamilton Anxiety Rating Scale - Insomnia: difficulty falling asleep, broken sleep, unsatisfying sleep and fatigue on waking, dreams, nightmares, night terrors. HAMA - Insomnia HAMA1-Intellectual Hamilton Anxiety Rating Scale - Intellectual: difficulty in concentration, poor memory. HAMA - Intellectual HAMA1-Depressed Mood Hamilton Anxiety Rating Scale - Depressed mood: loss of interest, lack of pleasure in hobbies, depression, early waking, diurnal swing. HAMA - Depressed Mood HAMA1-Somatic (Muscular) Hamilton Anxiety Rating Scale - Somatic (muscular): pains and aches, twitching, stiffness, myoclonic jerks, grinding of teeth, unsteady voice, increased muscular tone. HAMA - Somatic (Muscular) HAMA1-Somatic (Sensory) Hamilton Anxiety Rating Scale - Somatic (sensory): tinnitus, blurring of vision, hot and cold flushes, feelings of weakness, pricking sensation. HAMA - Somatic (Sensory) HAMA1-Cardiovascular Symptoms Hamilton Anxiety Rating Scale - Cardiovascular symptoms: tachycardia, palpitations, pain in chest, throbbing of vessels, fainting feelings, missing beat. HAMA - Cardiovascular Symptoms HAMA1-Respiratory Symptoms Hamilton Anxiety Rating Scale - Respiratory symptoms: pressure or constriction in chest, choking feelings, sighing, dyspnea. HAMA - Respiratory Symptoms HAMA1-Gastrointestinal Symptoms Hamilton Anxiety Rating Scale - Gastrointestinal symptoms: difficulty swallowing, wind abdominal pain, burning sensations, abdominal fullness, nausea, vomiting, borborygmi, looseness of bowels, loss of weight, constipation. HAMA - Gastrointestinal Symptoms HAMA1-Genitourinary Symptoms Hamilton Anxiety Rating Scale - Genitourinary symptoms: frequency of micturition, urgency of micturition, amenorrhea, menorrhagia, development of frigidity, premature ejaculation, loss of libido, impotence. HAMA - Genitourinary Symptoms HAMA1-Autonomic Symptoms Hamilton Anxiety Rating Scale - Autonomic symptoms: dry mouth, flushing, pallor, tendency to sweat, giddiness, tension, headache, raising of hair. HAMA - Autonomic Symptoms HAMA1-Behavior at Interview Hamilton Anxiety Rating Scale - Behavior at interview: fidgeting, restlessness or pacing, tremor of hands, furrowed brow, strained face, sighing or rapid respiration, facial pallor, swallowing, etc. HAMA - Behavior at Interview HAMA1-Total Score Hamilton Anxiety Rating Scale - Total score. HAMA - Total Score HAMA1TC Hamilton Anxiety Rating Scale Clinical Classification Test Code CDISC Clinical Classification HAMA Test Code Terminology Hamilton Anxiety Rating Scale test name. HAMA1-Anxious Mood Hamilton Anxiety Rating Scale - Anxious mood: worries, anticipation of the worst, fearful anticipation, irritability. HAMA - Anxious Mood HAMA1-Autonomic Symptoms Hamilton Anxiety Rating Scale - Autonomic symptoms: dry mouth, flushing, pallor, tendency to sweat, giddiness, tension, headache, raising of hair. HAMA - Autonomic Symptoms HAMA1-Behavior at Interview Hamilton Anxiety Rating Scale - Behavior at interview: fidgeting, restlessness or pacing, tremor of hands, furrowed brow, strained face, sighing or rapid respiration, facial pallor, swallowing, etc. HAMA - Behavior at Interview HAMA1-Cardiovascular Symptoms Hamilton Anxiety Rating Scale - Cardiovascular symptoms: tachycardia, palpitations, pain in chest, throbbing of vessels, fainting feelings, missing beat. HAMA - Cardiovascular Symptoms HAMA1-Depressed Mood Hamilton Anxiety Rating Scale - Depressed mood: loss of interest, lack of pleasure in hobbies, depression, early waking, diurnal swing. HAMA - Depressed Mood HAMA1-Fears Hamilton Anxiety Rating Scale - Fears: of dark, of strangers, of being left alone, of animals, of traffic, of crowds. HAMA - Fears HAMA1-Gastrointestinal Symptoms Hamilton Anxiety Rating Scale - Gastrointestinal symptoms: difficulty swallowing, wind abdominal pain, burning sensations, abdominal fullness, nausea, vomiting, borborygmi, looseness of bowels, loss of weight, constipation. HAMA - Gastrointestinal Symptoms HAMA1-Genitourinary Symptoms Hamilton Anxiety Rating Scale - Genitourinary symptoms: frequency of micturition, urgency of micturition, amenorrhea, menorrhagia, development of frigidity, premature ejaculation, loss of libido, impotence. HAMA - Genitourinary Symptoms HAMA1-Insomnia Hamilton Anxiety Rating Scale - Insomnia: difficulty falling asleep, broken sleep, unsatisfying sleep and fatigue on waking, dreams, nightmares, night terrors. HAMA - Insomnia HAMA1-Intellectual Hamilton Anxiety Rating Scale - Intellectual: difficulty in concentration, poor memory. HAMA - Intellectual HAMA1-Respiratory Symptoms Hamilton Anxiety Rating Scale - Respiratory symptoms: pressure or constriction in chest, choking feelings, sighing, dyspnea. HAMA - Respiratory Symptoms HAMA1-Somatic (Muscular) Hamilton Anxiety Rating Scale - Somatic (muscular): pains and aches, twitching, stiffness, myoclonic jerks, grinding of teeth, unsteady voice, increased muscular tone. HAMA - Somatic (Muscular) HAMA1-Somatic (Sensory) Hamilton Anxiety Rating Scale - Somatic (sensory): tinnitus, blurring of vision, hot and cold flushes, feelings of weakness, pricking sensation. HAMA - Somatic (Sensory) HAMA1-Tension Hamilton Anxiety Rating Scale - Tension: feelings of tension, fatigability, startle response, moved to tears easily, trembling, feelings of restlessness, inability to relax. HAMA - Tension HAMA1-Total Score Hamilton Anxiety Rating Scale - Total score. HAMA - Total Score HAMA1TN Hamilton Anxiety Rating Scale Clinical Classification Test Name CDISC Clinical Classification HAMA Test Name Terminology The Hamilton Depression Rating Scale - 17 Item test code. HAMD1-Depressed Mood Hamilton Depression Rating Scale 17 Item - Depressed mood. HAMD-17 - Depressed Mood HAMD1-Feelings of Guilt Hamilton Depression Rating Scale 17 Item - Feelings of guilt. HAMD-17 - Feelings of Guilt HAMD1-Suicide Hamilton Depression Rating Scale 17 Item - Suicide. HAMD-17 - Suicide HAMD1-Insomnia Early - Early Night Hamilton Depression Rating Scale 17 Item - Insomnia: early in the night. HAMD-17 - Insomnia - Early Night HAMD1-Insomnia Middle - Middle Night Hamilton Depression Rating Scale 17 Item - Insomnia: middle of the night. HAMD-17 - Insomnia - Middle Night HAMD1-Insomnia Early Hours - Morning Hamilton Depression Rating Scale 17 Item - Insomnia: early hours of the morning. HAMD-17 - Insomnia - Early Morning HAMD1-Work and Activities Hamilton Depression Rating Scale 17 Item - Work and activities. HAMD-17 - Work and Activities HAMD1-Retardation Hamilton Depression Rating Scale 17 Item - Retardation. HAMD-17 - Retardation HAMD1-Agitation Hamilton Depression Rating Scale 17 Item - Agitation. HAMD-17 - Agitation HAMD1-Anxiety Psychic Hamilton Depression Rating Scale 17 Item - Anxiety psychic. HAMD-17 - Psychic Anxiety HAMD1-Anxiety Somatic Hamilton Depression Rating Scale 17 Item - Anxiety somatic: physiological concomitants of anxiety. HAMD-17 - Somatic Anxiety HAMD1-Somatic Symptoms Gastrointestinal Hamilton Depression Rating Scale 17 Item - Somatic symptoms gastrointestinal. HAMD-17 - Somatic Symptoms Gastrointestinal HAMD1-General Somatic Symptoms Hamilton Depression Rating Scale 17 Item - General somatic symptoms. HAMD-17 - General Somatic Symptoms HAMD1-Genital Symptoms Hamilton Depression Rating Scale 17 Item - Genital symptoms. HAMD-17 - Genital Symptoms HAMD1-Hypochondriasis Hamilton Depression Rating Scale 17 Item - Hypochondriasis. HAMD-17 - Hypochondriasis HAMD1-Loss of WT According to Patient Hamilton Depression Rating Scale 17 Item - Loss of weight according to the patient. HAMD-17 - Loss of Weight According to Patient HAMD1-Loss of WT According to WK Meas Hamilton Depression Rating Scale 17 Item - Loss of weight according to weekly measurements. HAMD-17 - Loss of Weight According to Weekly Measurements HAMD1-Insight Hamilton Depression Rating Scale 17 Item - Insight. HAMD-17 - Insight HAMD1-Total Score Hamilton Depression Rating Scale 17 Item - Total Score. HAMD-17 - Total Score HAMD1TC Hamilton Depression Rating Scale - 17 Item Clinical Classification Test Code CDISC Clinical Classification HAMD 17 Test Code Terminology The Hamilton Depression Rating Scale - 17 Item test name. HAMD1-Agitation Hamilton Depression Rating Scale 17 Item - Agitation. HAMD-17 - Agitation HAMD1-Anxiety Psychic Hamilton Depression Rating Scale 17 Item - Anxiety psychic. HAMD-17 - Psychic Anxiety HAMD1-Anxiety Somatic Hamilton Depression Rating Scale 17 Item - Anxiety somatic: physiological concomitants of anxiety. HAMD-17 - Somatic Anxiety HAMD1-Depressed Mood Hamilton Depression Rating Scale 17 Item - Depressed mood. HAMD-17 - Depressed Mood HAMD1-Feelings of Guilt Hamilton Depression Rating Scale 17 Item - Feelings of guilt. HAMD-17 - Feelings of Guilt HAMD1-General Somatic Symptoms Hamilton Depression Rating Scale 17 Item - General somatic symptoms. HAMD-17 - General Somatic Symptoms HAMD1-Genital Symptoms Hamilton Depression Rating Scale 17 Item - Genital symptoms. HAMD-17 - Genital Symptoms HAMD1-Hypochondriasis Hamilton Depression Rating Scale 17 Item - Hypochondriasis. HAMD-17 - Hypochondriasis HAMD1-Insight Hamilton Depression Rating Scale 17 Item - Insight. HAMD-17 - Insight HAMD1-Insomnia Early - Early Night Hamilton Depression Rating Scale 17 Item - Insomnia: early in the night. HAMD-17 - Insomnia - Early Night HAMD1-Insomnia Early Hours - Morning Hamilton Depression Rating Scale 17 Item - Insomnia: early hours of the morning. HAMD-17 - Insomnia - Early Morning HAMD1-Insomnia Middle - Middle Night Hamilton Depression Rating Scale 17 Item - Insomnia: middle of the night. HAMD-17 - Insomnia - Middle Night HAMD1-Loss of WT According to Patient Hamilton Depression Rating Scale 17 Item - Loss of weight according to the patient. HAMD-17 - Loss of Weight According to Patient HAMD1-Loss of WT According to WK Meas Hamilton Depression Rating Scale 17 Item - Loss of weight according to weekly measurements. HAMD-17 - Loss of Weight According to Weekly Measurements HAMD1-Retardation Hamilton Depression Rating Scale 17 Item - Retardation. HAMD-17 - Retardation HAMD1-Somatic Symptoms Gastrointestinal Hamilton Depression Rating Scale 17 Item - Somatic symptoms gastrointestinal. HAMD-17 - Somatic Symptoms Gastrointestinal HAMD1-Suicide Hamilton Depression Rating Scale 17 Item - Suicide. HAMD-17 - Suicide HAMD1-Total Score Hamilton Depression Rating Scale 17 Item - Total Score. HAMD-17 - Total Score HAMD1-Work and Activities Hamilton Depression Rating Scale 17 Item - Work and activities. HAMD-17 - Work and Activities HAMD1TN Hamilton Depression Rating Scale - 17 Item Clinical Classification Test Name CDISC Clinical Classification HAMD 17 Test Name Terminology Hamilton Depression Rating Scale - 24 Item test code. HAMD3-Depressed Mood Hamilton Depression Rating Scale 24 Item - Depressed mood. HAMD 24 - Depressed Mood HAMD3-Low Self-Esteem, Guilt Hamilton Depression Rating Scale 24 Item - Low self-esteem, guilt. HAMD 24 - Low Self-esteem, Guilt HAMD3-Suicidal Thoughts Hamilton Depression Rating Scale 24 Item - Suicidal thoughts. HAMD 24 - Suicidal Thoughts HAMD3-Insomnia - Initial Hamilton Depression Rating Scale 24 Item - Insomnia - initial. HAMD 24 - Insomnia - Initial HAMD3-Insomnia - Middle Hamilton Depression Rating Scale 24 Item - Insomnia - middle. HAMD 24 - Insomnia - Middle HAMD3-Insomnia - Late Hamilton Depression Rating Scale 24 Item - Insomnia - late. HAMD 24 - Insomnia - Late HAMD3-Work and Interests Hamilton Depression Rating Scale 24 Item - Work and interests. HAMD 24 - Work and Interests HAMD3-Psychomotor Retardation Hamilton Depression Rating Scale 24 Item - Psychomotor retardation. HAMD 24 - Psychomotor Retardation HAMD3-Psychomotor Agitation Hamilton Depression Rating Scale 24 Item - Psychomotor agitation. HAMD 24 - Psychomotor Agitation HAMD3-Anxiety - Psychic Hamilton Depression Rating Scale 24 Item - Anxiety - psychic. HAMD 24 - Anxiety, Psychic HAMD3-Anxiety - Somatic Hamilton Depression Rating Scale 24 Item - Anxiety - somatic. HAMD 24 - Anxiety, Somatic HAMD3-GI Symptoms (Appetite) Hamilton Depression Rating Scale 24 Item - Gastrointestinal symptoms (appetite). HAMD 24 - Gastrointestinal Symptoms (Appetite) HAMD3-Somatic Symptoms - General Hamilton Depression Rating Scale 24 Item - Somatic symptoms - general. HAMD 24 - Somatic Symptoms, General HAMD3-Sexual Disturbances Hamilton Depression Rating Scale 24 Item - Sexual disturbances. HAMD 24 - Sexual Disturbances HAMD3-Hypochondriasis (Somatisation) Hamilton Depression Rating Scale 24 Item - Hypochondriasis (somatisation). HAMD 24 - Hypochondriasis (Somatisation) HAMD3-Insight Hamilton Depression Rating Scale 24 Item - Insight. HAMD 24 - Insight HAMD3-Weight Loss Hamilton Depression Rating Scale 24 Item - Weight loss. HAMD 24 - Weight Loss HAMD3-Diurnal Variation Hamilton Depression Rating Scale 24 Item - Diurnal variation. HAMD 24 - Diurnal Variation HAMD3-Depersonalization/Derealization Hamilton Depression Rating Scale 24 Item - Depersonalization/derealization. HAMD 24 - Depersonalization and Derealisation HAMD3-Paranoid Symptoms Hamilton Depression Rating Scale 24 Item - Paranoid symptoms. HAMD 24 - Paranoid Symptoms HAMD3-Observational/Compulsive Symptoms Hamilton Depression Rating Scale 24 Item - Observational/compulsive symptoms. HAMD 24 - Obsessional and Compulsive Symptoms HAMD3-Helplessness Hamilton Depression Rating Scale 24 Item - Helplessness. HAMD 24 - Helplessness HAMD3-Hopelessness Hamilton Depression Rating Scale 24 Item - Hopelessness. HAMD 24 - Hopelessness HAMD3-Worthlessness Hamilton Depression Rating Scale 24 Item - Worthlessness. HAMD 24 - Worthlessness HAMD3-Total Score Hamilton Depression Rating Scale 24 Item - Total score. HAMD 24 - Total Score HAMD3TC Hamilton Depression Rating Scale - 24 Item Clinical Classification Test Code CDISC Clinical Classification HAMD 24 Test Code Terminology Hamilton Depression Rating Scale - 24 Item test name. HAMD3-Anxiety - Psychic Hamilton Depression Rating Scale 24 Item - Anxiety - psychic. HAMD 24 - Anxiety, Psychic HAMD3-Anxiety - Somatic Hamilton Depression Rating Scale 24 Item - Anxiety - somatic. HAMD 24 - Anxiety, Somatic HAMD3-Depersonalization/Derealization Hamilton Depression Rating Scale 24 Item - Depersonalization/derealization. HAMD 24 - Depersonalization and Derealisation HAMD3-Depressed Mood Hamilton Depression Rating Scale 24 Item - Depressed mood. HAMD 24 - Depressed Mood HAMD3-Diurnal Variation Hamilton Depression Rating Scale 24 Item - Diurnal variation. HAMD 24 - Diurnal Variation HAMD3-GI Symptoms (Appetite) Hamilton Depression Rating Scale 24 Item - Gastrointestinal symptoms (appetite). HAMD 24 - Gastrointestinal Symptoms (Appetite) HAMD3-Helplessness Hamilton Depression Rating Scale 24 Item - Helplessness. HAMD 24 - Helplessness HAMD3-Hopelessness Hamilton Depression Rating Scale 24 Item - Hopelessness. HAMD 24 - Hopelessness HAMD3-Hypochondriasis (Somatisation) Hamilton Depression Rating Scale 24 Item - Hypochondriasis (somatisation). HAMD 24 - Hypochondriasis (Somatisation) HAMD3-Insight Hamilton Depression Rating Scale 24 Item - Insight. HAMD 24 - Insight HAMD3-Insomnia - Initial Hamilton Depression Rating Scale 24 Item - Insomnia - initial. HAMD 24 - Insomnia - Initial HAMD3-Insomnia - Late Hamilton Depression Rating Scale 24 Item - Insomnia - late. HAMD 24 - Insomnia - Late HAMD3-Insomnia - Middle Hamilton Depression Rating Scale 24 Item - Insomnia - middle. HAMD 24 - Insomnia - Middle HAMD3-Low Self-Esteem, Guilt Hamilton Depression Rating Scale 24 Item - Low self-esteem, guilt. HAMD 24 - Low Self-esteem, Guilt HAMD3-Observational/Compulsive Symptoms Hamilton Depression Rating Scale 24 Item - Observational/compulsive symptoms. HAMD 24 - Obsessional and Compulsive Symptoms HAMD3-Paranoid Symptoms Hamilton Depression Rating Scale 24 Item - Paranoid symptoms. HAMD 24 - Paranoid Symptoms HAMD3-Psychomotor Agitation Hamilton Depression Rating Scale 24 Item - Psychomotor agitation. HAMD 24 - Psychomotor Agitation HAMD3-Psychomotor Retardation Hamilton Depression Rating Scale 24 Item - Psychomotor retardation. HAMD 24 - Psychomotor Retardation HAMD3-Sexual Disturbances Hamilton Depression Rating Scale 24 Item - Sexual disturbances. HAMD 24 - Sexual Disturbances HAMD3-Somatic Symptoms - General Hamilton Depression Rating Scale 24 Item - Somatic symptoms - general. HAMD 24 - Somatic Symptoms, General HAMD3-Suicidal Thoughts Hamilton Depression Rating Scale 24 Item - Suicidal thoughts. HAMD 24 - Suicidal Thoughts HAMD3-Total Score Hamilton Depression Rating Scale 24 Item - Total score. HAMD 24 - Total Score HAMD3-Weight Loss Hamilton Depression Rating Scale 24 Item - Weight loss. HAMD 24 - Weight Loss HAMD3-Work and Interests Hamilton Depression Rating Scale 24 Item - Work and interests. HAMD 24 - Work and Interests HAMD3-Worthlessness Hamilton Depression Rating Scale 24 Item - Worthlessness. HAMD 24 - Worthlessness HAMD3TN Hamilton Depression Rating Scale - 24 Item Clinical Classification Test Name CDISC Clinical Classification HAMD 24 Test Name Terminology Hamilton Depression Rating Scale - 6 Clinician Version test code. HAMD4-Depressed Mood The Hamilton Depression Rating Scale 6 - Clinician Version - Depressed mood. HAM-D6 - Clinician Version - Depressed Mood HAMD4-Low Self-esteem and Guilt The Hamilton Depression Rating Scale 6 - Clinician Version - Low self-esteem and guilt. HAM-D6 - Clinician Version - Low Self-esteem and Guilt HAMD4-Social Life Activities/Interests The Hamilton Depression Rating Scale 6 - Clinician Version - Social life activities and interests. HAM-D6 - Clinician Version - Social Life Activities or Interests HAMD4-Psychomotor Retardation, General The Hamilton Depression Rating Scale 6 - Clinician Version - Psychomotor retardation, general. HAM-D6 - Clinician Version - Psychomotor Retardation, General HAMD4-Psychic Anxiety The Hamilton Depression Rating Scale 6 - Clinician Version - Psychic anxiety. HAM-D6 - Clinician Version - Psychic Anxiety HAMD4-Tiredness and Pains The Hamilton Depression Rating Scale 6 - Clinician Version - Tiredness and pains. HAM-D6 - Clinician Version - Tiredness and Pains HAMD4-Total Score The Hamilton Depression Rating Scale 6 - Clinician Version - Total score. HAM-D6 - Clinician Version - Total Score HAMD4TC Hamilton Depression Rating Scale - 6 Clinician Version Clinical Classification Test Code CDISC Clinical Classification HAM-D6 Clinician Version Test Code Terminology Hamilton Depression Rating Scale - 6 Clinician Version test name. HAMD4-Depressed Mood The Hamilton Depression Rating Scale 6 - Clinician Version - Depressed mood. HAM-D6 - Clinician Version - Depressed Mood HAMD4-Low Self-esteem and Guilt The Hamilton Depression Rating Scale 6 - Clinician Version - Low self-esteem and guilt. HAM-D6 - Clinician Version - Low Self-esteem and Guilt HAMD4-Psychic Anxiety The Hamilton Depression Rating Scale 6 - Clinician Version - Psychic anxiety. HAM-D6 - Clinician Version - Psychic Anxiety HAMD4-Psychomotor Retardation, General The Hamilton Depression Rating Scale 6 - Clinician Version - Psychomotor retardation, general. HAM-D6 - Clinician Version - Psychomotor Retardation, General HAMD4-Social Life Activities/Interests The Hamilton Depression Rating Scale 6 - Clinician Version - Social life activities and interests. HAM-D6 - Clinician Version - Social Life Activities or Interests HAMD4-Tiredness and Pains The Hamilton Depression Rating Scale 6 - Clinician Version - Tiredness and pains. HAM-D6 - Clinician Version - Tiredness and Pains HAMD4-Total Score The Hamilton Depression Rating Scale 6 - Clinician Version - Total score. HAM-D6 - Clinician Version - Total Score HAMD4TN Hamilton Depression Rating Scale - 6 Clinician Version Clinical Classification Test Name CDISC Clinical Classification HAM-D6 Clinician Version Test Name Terminology Hamilton Depression Rating Scale - 6 Self-Report test code. HAMDS1-Depressed Mood Hamilton Depression Rating Scale 6 - Self-Report Version - (1)=Depressed mood per clinician version: How you have been feeling over the past three days, including today. HAM-D6 Self-Report Version - Depressed Mood HAMDS1-Low Self-esteem and Guilt Hamilton Depression Rating Scale 6 - Self-Report Version - (2)=Low self-esteem and guilt per clinician version: How you have been feeling over the past three days, including today. HAM-D6 Self-Report Version - Low Self-esteem and Guilt HAMDS1-Social Life Activities/Interests Hamilton Depression Rating Scale 6 - Self-Report Version - (3)=Social life activities and interests per clinician version: How you have been feeling over the past three days, including today. HAM-D6 Self-Report Version - Social Life Activities or Interests HAMDS1-Psychomotor Retardation, General Hamilton Depression Rating Scale 6 - Self-Report Version - (4)=Psychomotor retardation, general per clinician version: How you have been feeling over the past three days, including today. HAM-D6 Self-Report Version - Psychomotor Retardation HAMDS1-Psychic Anxiety Hamilton Depression Rating Scale 6 - Self-Report Version - (5)=Psychic anxiety per clinician version: How you have been feeling over the past three days, including today. HAM-D6 Self-Report Version - Psychic Anxiety HAMDS1-Tiredness and Pains Hamilton Depression Rating Scale 6 - Self-Report Version - (6)=Tiredness and pains per clinician version: How you have been feeling over the past three days, including today. HAM-D6 Self-Report Version - Tiredness and Pains HAMDS1TC Hamilton Depression Rating Scale - 6 Self-Report Questionnaire Test Code CDISC Questionnaire HAM-D6 Self-Report Version Test Code Terminology Hamilton Depression Rating Scale - 6 Self-Report test name. HAMDS1-Depressed Mood Hamilton Depression Rating Scale 6 - Self-Report Version - (1)=Depressed mood per clinician version: How you have been feeling over the past three days, including today. HAM-D6 Self-Report Version - Depressed Mood HAMDS1-Low Self-esteem and Guilt Hamilton Depression Rating Scale 6 - Self-Report Version - (2)=Low self-esteem and guilt per clinician version: How you have been feeling over the past three days, including today. HAM-D6 Self-Report Version - Low Self-esteem and Guilt HAMDS1-Psychic Anxiety Hamilton Depression Rating Scale 6 - Self-Report Version - (5)=Psychic anxiety per clinician version: How you have been feeling over the past three days, including today. HAM-D6 Self-Report Version - Psychic Anxiety HAMDS1-Psychomotor Retardation, General Hamilton Depression Rating Scale 6 - Self-Report Version - (4)=Psychomotor retardation, general per clinician version: How you have been feeling over the past three days, including today. HAM-D6 Self-Report Version - Psychomotor Retardation HAMDS1-Social Life Activities/Interests Hamilton Depression Rating Scale 6 - Self-Report Version - (3)=Social life activities and interests per clinician version: How you have been feeling over the past three days, including today. HAM-D6 Self-Report Version - Social Life Activities or Interests HAMDS1-Tiredness and Pains Hamilton Depression Rating Scale 6 - Self-Report Version - (6)=Tiredness and pains per clinician version: How you have been feeling over the past three days, including today. HAM-D6 Self-Report Version - Tiredness and Pains HAMDS1TN Hamilton Depression Rating Scale - 6 Self-Report Questionnaire Test Name CDISC Questionnaire HAM-D6 Self-Report Version Test Name Terminology Hamilton Depression Rating Scale 21-Item test code. HAMD2-Depressed Mood Hamilton Depression Rating Scale 21 Item - Depressed mood: sadness, hopeless, helpless, worthless. HAMD-21 - Depressed Mood HAMD2-Feelings of Guilt Hamilton Depression Rating Scale 21 Item - Feelings of guilt. HAMD-21 - Feelings of Guilt HAMD2-Suicide Hamilton Depression Rating Scale 21 Item - Suicide. HAMD-21 - Suicide HAMD2-Insomnia Early Hamilton Depression Rating Scale 21 Item - Insomnia early. HAMD-21 - Insomnia Early HAMD2-Insomnia Middle Hamilton Depression Rating Scale 21 Item - Insomnia middle. HAMD-21 - Insomnia Middle HAMD2-Insomnia Late Hamilton Depression Rating Scale 21 Item - Insomnia late. HAMD-21 - Insomnia Late HAMD2-Work and Activities Hamilton Depression Rating Scale 21 Item - Work and activities. HAMD-21 - Work and Activities HAMD2-Retardation Hamilton Depression Rating Scale 21 Item - Retardation: psychomotor (slowness of thought and speech; impaired ability to concentrate; decreased motor activity). HAMD-21 - Retardation HAMD2-Agitation Hamilton Depression Rating Scale 21 Item - Agitation. HAMD-21 - Agitation HAMD2-Anxiety Psychological Hamilton Depression Rating Scale 21 Item - Anxiety Psychological. HAMD-21 - Anxiety Psychological HAMD2-Anxiety Somatic Hamilton Depression Rating Scale 21 Item - Anxiety somatic: physiological concomitants of anxiety, (i.e., effects of autonomic overactivity, 'butterflies,' indigestion, stomach cramps, belching, diarrhea, palpitations, hyperventilation, paresthesia, sweating, flushing, tremor, headache, urinary frequency). HAMD-21 - Anxiety Somatic HAMD2-Somatic Symptoms Gastro-intestinal Hamilton Depression Rating Scale 21 Item - Somatic symptoms gastro-intestinal. HAMD-21 - Somatic Symptoms Gastro-intestinal HAMD2-Somatic Symptoms General Hamilton Depression Rating Scale 21 Item - Somatic symptoms general. HAMD-21 - Somatic Symptoms General HAMD2-Genital Symptoms Hamilton Depression Rating Scale 21 Item - Genital symptoms: symptoms such as: loss of libido; impaired sexual performance; menstrual disturbances. HAMD-21 - Genital Symptoms HAMD2-Hypochondriasis Hamilton Depression Rating Scale 21 Item - Hypochondriasis. HAMD-21 - Hypochondriasis HAMD2-Loss of Weight by History Hamilton Depression Rating Scale 21 Item - Loss of weight when rating by history. HAMD-21 - Loss of Weight by History HAMD2-Loss of Weight Measured Hamilton Depression Rating Scale 21 Item - Loss of weight on weekly ratings by war psychiatrist, when actual weight changes are measured. HAMD-21 - Loss of Weight Measured HAMD2-Insight Hamilton Depression Rating Scale 21 Item - Insight. HAMD-21 - Insight HAMD2-Diurnal Variation Hamilton Depression Rating Scale 21 Item - Diurnal variation. HAMD-21 - Diurnal Variation HAMD2-Diurnal Variation Severity Hamilton Depression Rating Scale 21 Item - Diurnal variation severity. HAMD-21 - Diurnal Variation Severity HAMD2-Depersonalization/Derealization Hamilton Depression Rating Scale 21 Item - Depersonalization and derealization: such as feelings of unreality; nihilistic ideas. HAMD-21 - Depersonalization and Derealization HAMD2-Paranoid Symptoms Hamilton Depression Rating Scale 21 Item - Paranoid symptoms. HAMD-21 - Paranoid Symptoms HAMD2-Obsessional/Compulsive Symptoms Hamilton Depression Rating Scale 21 Item - Obsessional and compulsive symptoms. HAMD-21 - Obsessional and Compulsive Symptoms HAMD2-Total Score Hamilton Depression Rating Scale 21 Item - Total score. HAMD-21 - Total Score HAMD2TC Hamilton Depression Rating Scale 21-Item Clinical Classification Test Code CDISC Clinical Classification HAMD 21 Test Code Terminology Hamilton Depression Rating Scale 21-Item test name. HAMD2-Agitation Hamilton Depression Rating Scale 21 Item - Agitation. HAMD-21 - Agitation HAMD2-Anxiety Psychological Hamilton Depression Rating Scale 21 Item - Anxiety Psychological. HAMD-21 - Anxiety Psychological HAMD2-Anxiety Somatic Hamilton Depression Rating Scale 21 Item - Anxiety somatic: physiological concomitants of anxiety, (i.e., effects of autonomic overactivity, 'butterflies,' indigestion, stomach cramps, belching, diarrhea, palpitations, hyperventilation, paresthesia, sweating, flushing, tremor, headache, urinary frequency). HAMD-21 - Anxiety Somatic HAMD2-Depersonalization/Derealization Hamilton Depression Rating Scale 21 Item - Depersonalization and derealization: such as feelings of unreality; nihilistic ideas. HAMD-21 - Depersonalization and Derealization HAMD2-Depressed Mood Hamilton Depression Rating Scale 21 Item - Depressed mood: sadness, hopeless, helpless, worthless. HAMD-21 - Depressed Mood HAMD2-Diurnal Variation Severity Hamilton Depression Rating Scale 21 Item - Diurnal variation severity. HAMD-21 - Diurnal Variation Severity HAMD2-Diurnal Variation Hamilton Depression Rating Scale 21 Item - Diurnal variation. HAMD-21 - Diurnal Variation HAMD2-Feelings of Guilt Hamilton Depression Rating Scale 21 Item - Feelings of guilt. HAMD-21 - Feelings of Guilt HAMD2-Genital Symptoms Hamilton Depression Rating Scale 21 Item - Genital symptoms: symptoms such as: loss of libido; impaired sexual performance; menstrual disturbances. HAMD-21 - Genital Symptoms HAMD2-Hypochondriasis Hamilton Depression Rating Scale 21 Item - Hypochondriasis. HAMD-21 - Hypochondriasis HAMD2-Insight Hamilton Depression Rating Scale 21 Item - Insight. HAMD-21 - Insight HAMD2-Insomnia Early Hamilton Depression Rating Scale 21 Item - Insomnia early. HAMD-21 - Insomnia Early HAMD2-Insomnia Late Hamilton Depression Rating Scale 21 Item - Insomnia late. HAMD-21 - Insomnia Late HAMD2-Insomnia Middle Hamilton Depression Rating Scale 21 Item - Insomnia middle. HAMD-21 - Insomnia Middle HAMD2-Loss of Weight by History Hamilton Depression Rating Scale 21 Item - Loss of weight when rating by history. HAMD-21 - Loss of Weight by History HAMD2-Loss of Weight Measured Hamilton Depression Rating Scale 21 Item - Loss of weight on weekly ratings by war psychiatrist, when actual weight changes are measured. HAMD-21 - Loss of Weight Measured HAMD2-Obsessional/Compulsive Symptoms Hamilton Depression Rating Scale 21 Item - Obsessional and compulsive symptoms. HAMD-21 - Obsessional and Compulsive Symptoms HAMD2-Paranoid Symptoms Hamilton Depression Rating Scale 21 Item - Paranoid symptoms. HAMD-21 - Paranoid Symptoms HAMD2-Retardation Hamilton Depression Rating Scale 21 Item - Retardation: psychomotor (slowness of thought and speech; impaired ability to concentrate; decreased motor activity). HAMD-21 - Retardation HAMD2-Somatic Symptoms Gastro-intestinal Hamilton Depression Rating Scale 21 Item - Somatic symptoms gastro-intestinal. HAMD-21 - Somatic Symptoms Gastro-intestinal HAMD2-Somatic Symptoms General Hamilton Depression Rating Scale 21 Item - Somatic symptoms general. HAMD-21 - Somatic Symptoms General HAMD2-Suicide Hamilton Depression Rating Scale 21 Item - Suicide. HAMD-21 - Suicide HAMD2-Total Score Hamilton Depression Rating Scale 21 Item - Total score. HAMD-21 - Total Score HAMD2-Work and Activities Hamilton Depression Rating Scale 21 Item - Work and activities. HAMD-21 - Work and Activities HAMD2TN Hamilton Depression Rating Scale 21-Item Clinical Classification Test Name CDISC Clinical Classification HAMD 21 Test Name Terminology Harvey-Bradshaw Index original result for HBI0101 test and test code. HBI0101-poor Harvey-Bradshaw Index original result for HBI0101-Poor. Harvey-Bradshaw Index HBI0101 Original Result - Poor HBI0101-slightly below par Harvey-Bradshaw Index original result for HBI0101-Slightly below par. Harvey-Bradshaw Index HBI0101 Original Result - Slightly Below Par HBI0101-terrible Harvey-Bradshaw Index original result for HBI0101-Terrible. Harvey-Bradshaw Index HBI0101 Original Result - Terrible HBI0101-very poor Harvey-Bradshaw Index original result for HBI0101-Very poor. Harvey-Bradshaw Index HBI0101 Original Result - Very Poor HBI0101-very well Harvey-Bradshaw Index original result for HBI0101-Very well. Harvey-Bradshaw Index HBI0101 Original Result - Very Well HBI0101OR Harvey-Bradshaw Index Clinical Classification ORRES for HBI0101 TN/TC CDISC Clinical Classification Harvey-Bradshaw Index HBI0101 Original Response Terminology Harvey-Bradshaw Index original result for HBI0102 test and test code. HBI0102-mild Harvey-Bradshaw Index original result for HBI0102-Mild. Harvey-Bradshaw Index HBI0102 Original Result - Mild HBI0102-moderate Harvey-Bradshaw Index original result for HBI0102-Moderate. Harvey-Bradshaw Index HBI0102 Original Result - Moderate HBI0102-none Harvey-Bradshaw Index original result for HBI0102-None. Harvey-Bradshaw Index HBI0102 Original Result - None HBI0102-severe Harvey-Bradshaw Index original result for HBI0102-Severe. Harvey-Bradshaw Index HBI0102 Original Result - Severe HBI0102OR Harvey-Bradshaw Index Clinical Classification ORRES for HBI0102 TN/TC CDISC Clinical Classification Harvey-Bradshaw Index HBI0102 Original Response Terminology Harvey-Bradshaw Index original result for HBI0104 test and test code. HBI0104-definite and tender Harvey-Bradshaw Index original result for HBI0104-Definite and tender. Harvey-Bradshaw Index HBI0104 Original Result - Definite and Tender HBI0104-definite Harvey-Bradshaw Index original result for HBI0104-Definite. Harvey-Bradshaw Index HBI0104 Original Result - Definite HBI0104-dubious Harvey-Bradshaw Index original result for HBI0104-Dubious. Harvey-Bradshaw Index HBI0104 Original Result - Dubious HBI0104-none Harvey-Bradshaw Index original result for HBI0104-None. Harvey-Bradshaw Index HBI0104 Original Result - None HBI0104OR Harvey-Bradshaw Index Clinical Classification ORRES for HBI0104 TN/TC CDISC Clinical Classification Harvey-Bradshaw Index HBI0104 Original Response Terminology Harvey-Bradshaw Index original result for HBI0105A through HBI0105H test and test code. HBI0105A through HBI0105H-no Harvey-Bradshaw Index original result for HBI0105A through HBI0105H-No. Harvey-Bradshaw Index HBI0105A Through HBI0105H Original Result - No HBI0105A through HBI0105H-yes Harvey-Bradshaw Index original result for HBI0105A through HBI0105H-Yes. Harvey-Bradshaw Index HBI0105A Through HBI0105H Original Result - Yes HBI0105AT05HOR Harvey-Bradshaw Index Clinical Classification ORRES for HBI0105A Through HBI0105H TN/TC CDISC Clinical Classification Harvey-Bradshaw Index HBI0105A Through HBI0105H Original Response Terminology Harvey-Bradshaw Index standardized character result for HBI0101 test and test code. HBI0101-0 Harvey-Bradshaw Index standardized character result for HBI0101-Very well. Harvey-Bradshaw Index HBI0101 Standardized Character Result 0 HBI0101-1 Harvey-Bradshaw Index standardized character result for HBI0101-Slightly below par. Harvey-Bradshaw Index HBI0101 Standardized Character Result 1 HBI0101-2 Harvey-Bradshaw Index standardized character result for HBI0101-Poor. Harvey-Bradshaw Index HBI0101 Standardized Character Result 2 HBI0101-3 Harvey-Bradshaw Index standardized character result for HBI0101-Very poor. Harvey-Bradshaw Index HBI0101 Standardized Character Result 3 HBI0101-4 Harvey-Bradshaw Index standardized character result for HBI0101-Terrible. Harvey-Bradshaw Index HBI0101 Standardized Character Result 4 HBI0101STR Harvey-Bradshaw Index Clinical Classification STRESC for HBI0101 TN/TC CDISC Clinical Classification Harvey-Bradshaw Index HBI0101 Standardized Character Response Terminology Harvey-Bradshaw Index standardized character result for HBI0102 test and test code. HBI0102-0 Harvey-Bradshaw Index standardized character result for HBI0102-None. Harvey-Bradshaw Index HBI0102 Standardized Character Result 0 HBI0102-1 Harvey-Bradshaw Index standardized character result for HBI0102-Mild. Harvey-Bradshaw Index HBI0102 Standardized Character Result 1 HBI0102-2 Harvey-Bradshaw Index standardized character result for HBI0102-Moderate. Harvey-Bradshaw Index HBI0102 Standardized Character Result 2 HBI0102-3 Harvey-Bradshaw Index standardized character result for HBI0102-Severe. Harvey-Bradshaw Index HBI0102 Standardized Character Result 3 HBI0102STR Harvey-Bradshaw Index Clinical Classification STRESC for HBI0102 TN/TC CDISC Clinical Classification Harvey-Bradshaw Index HBI0102 Standardized Character Response Terminology Harvey-Bradshaw Index standardized character result for HBI0104 test and test code. HBI0104-0 Harvey-Bradshaw Index standardized character result for HBI0104-None. Harvey-Bradshaw Index HBI0104 Standardized Character Result 0 HBI0104-1 Harvey-Bradshaw Index standardized character result for HBI0104-Dubious. Harvey-Bradshaw Index HBI0104 Standardized Character Result 1 HBI0104-2 Harvey-Bradshaw Index standardized character result for HBI0104-Definite. Harvey-Bradshaw Index HBI0104 Standardized Character Result 2 HBI0104-3 Harvey-Bradshaw Index standardized character result for HBI0104-Definite and tender. Harvey-Bradshaw Index HBI0104 Standardized Character Result 3 HBI0104STR Harvey-Bradshaw Index Clinical Classification STRESC for HBI0104 TN/TC CDISC Clinical Classification Harvey-Bradshaw Index HBI0104 Standardized Character Response Terminology Harvey-Bradshaw Index standardized character result for HBI0105A through HBI0105H test and test code. HBI0105A through HBI0105H-0 Harvey-Bradshaw Index standardized character result for HBI0105A through HBI0105H-No. Harvey-Bradshaw Index HBI0105A Through HBI0105H Standardized Character Result 0 HBI0105A through HBI0105H-1 Harvey-Bradshaw Index standardized character result for HBI0105A through HBI0105H-Yes. Harvey-Bradshaw Index HBI0105A Through HBI0105H Standardized Character Result 1 HBI0105AT05HSTR Harvey-Bradshaw Index Clinical Classification STRESC for HBI0105A Through HBI0105H TN/TC CDISC Clinical Classification Harvey-Bradshaw Index HBI0105A Through HBI0105H Standardized Character Response Terminology Harvey-Bradshaw Index test code. HBI01-General Well-being Harvey-Bradshaw Index - Patient's general well-being (for the previous day). HBI - General Well-being HBI01-Abdominal Pain Harvey-Bradshaw Index - Abdominal pain (for the previous day). HBI - Abdominal Pain HBI01-Number Liquid Stools Harvey-Bradshaw Index - Number of liquid stools (for the previous day). HBI - Number Liquid Stools HBI01-Abdominal Mass Harvey-Bradshaw Index - Abdominal mass. HBI - Abdominal Mass HBI01-Complication: Arthralgia Harvey-Bradshaw Index - Complication: Arthralgia. HBI - Complication: Arthralgia HBI01-Complication: Uveitis Harvey-Bradshaw Index - Complication: Uveitis. HBI - Complication: Uveitis HBI01-Complication: Erythema Nodosum Harvey-Bradshaw Index - Complication: Erythema nodosum. HBI - Complication: Erythema Nodosum HBI01-Complication: Aphthous Ulcers Harvey-Bradshaw Index - Complication: Aphthous ulcers. HBI - Complication: Aphthous Ulcers HBI01-Complication: Pyoderma Gangrenosum Harvey-Bradshaw Index - Complication: Pyoderma gangrenosum. HBI - Complication: Pyoderma Gangrenosum HBI01-Complication: Anal Fissures Harvey-Bradshaw Index - Complication: Anal fissures. HBI - Complication: Anal Fissures HBI01-Complication: New Fistula Harvey-Bradshaw Index - Complication: New fistula. HBI - Complication: New Fistula HBI01-Complication: Abscess Harvey-Bradshaw Index - Complication: Abscess. HBI - Complication: Abscess HBI01-Total Score Harvey-Bradshaw Index - Total score. HBI - Total Score HBI01TC Harvey-Bradshaw Index Clinical Classification Test Code CDISC Clinical Classification Harvey-Bradshaw Index Test Code Terminology Harvey-Bradshaw Index test name. HBI01-Abdominal Mass Harvey-Bradshaw Index - Abdominal mass. HBI - Abdominal Mass HBI01-Abdominal Pain Harvey-Bradshaw Index - Abdominal pain (for the previous day). HBI - Abdominal Pain HBI01-Complication: Abscess Harvey-Bradshaw Index - Complication: Abscess. HBI - Complication: Abscess HBI01-Complication: Anal Fissures Harvey-Bradshaw Index - Complication: Anal fissures. HBI - Complication: Anal Fissures HBI01-Complication: Aphthous Ulcers Harvey-Bradshaw Index - Complication: Aphthous ulcers. HBI - Complication: Aphthous Ulcers HBI01-Complication: Arthralgia Harvey-Bradshaw Index - Complication: Arthralgia. HBI - Complication: Arthralgia HBI01-Complication: Erythema Nodosum Harvey-Bradshaw Index - Complication: Erythema nodosum. HBI - Complication: Erythema Nodosum HBI01-Complication: New Fistula Harvey-Bradshaw Index - Complication: New fistula. HBI - Complication: New Fistula HBI01-Complication: Pyoderma Gangrenosum Harvey-Bradshaw Index - Complication: Pyoderma gangrenosum. HBI - Complication: Pyoderma Gangrenosum HBI01-Complication: Uveitis Harvey-Bradshaw Index - Complication: Uveitis. HBI - Complication: Uveitis HBI01-General Well-being Harvey-Bradshaw Index - Patient's general well-being (for the previous day). HBI - General Well-being HBI01-Number Liquid Stools Harvey-Bradshaw Index - Number of liquid stools (for the previous day). HBI - Number Liquid Stools HBI01-Total Score Harvey-Bradshaw Index - Total score. HBI - Total Score HBI01TN Harvey-Bradshaw Index Clinical Classification Test Name CDISC Clinical Classification Harvey-Bradshaw Index Test Name Terminology HAS-BLED Bleeding Risk Score test code. HSB01-Hypertension HAS-BLED Bleeding Risk Score - Hypertension. HAS-BLED - Hypertension HSB01-Abnormal Renal and Liver Function HAS-BLED Bleeding Risk Score - Abnormal renal and liver function. HAS-BLED - Abnormal Renal and Liver Function HSB01-Stroke HAS-BLED Bleeding Risk Score - Stroke. HAS-BLED - Stroke HSB01-Bleeding HAS-BLED Bleeding Risk Score - Bleeding. HAS-BLED - Bleeding HSB01-Labile INRs HAS-BLED Bleeding Risk Score - Labile INRs. HAS-BLED - Labile INRs HSB01-Elderly HAS-BLED Bleeding Risk Score - Elderly. HAS-BLED - Elderly HSB01-Drugs or Alcohol HAS-BLED Bleeding Risk Score - Drugs or alcohol. HAS-BLED - Drugs or Alcohol HSB01TC HAS-BLED Bleeding Risk Score Clinical Classification Test Code CDISC Clinical Classification HAS-BLED Test Code Terminology HAS-BLED Bleeding Risk Score test name. HSB01-Abnormal Renal and Liver Function HAS-BLED Bleeding Risk Score - Abnormal renal and liver function. HAS-BLED - Abnormal Renal and Liver Function HSB01-Bleeding HAS-BLED Bleeding Risk Score - Bleeding. HAS-BLED - Bleeding HSB01-Drugs or Alcohol HAS-BLED Bleeding Risk Score - Drugs or alcohol. HAS-BLED - Drugs or Alcohol HSB01-Elderly HAS-BLED Bleeding Risk Score - Elderly. HAS-BLED - Elderly HSB01-Hypertension HAS-BLED Bleeding Risk Score - Hypertension. HAS-BLED - Hypertension HSB01-Labile INRs HAS-BLED Bleeding Risk Score - Labile INRs. HAS-BLED - Labile INRs HSB01-Stroke HAS-BLED Bleeding Risk Score - Stroke. HAS-BLED - Stroke HSB01TN HAS-BLED Bleeding Risk Score Clinical Classification Test Name CDISC Clinical Classification HAS-BLED Test Name Terminology Hauser Ambulation Index test code. HAI01-Ambulation Index Hauser Ambulation Index - Ambulation index. HAI - Ambulation Index HAI01TC Hauser Ambulation Index Functional Test Test Code CDISC Functional Test HAI Test Code Terminology Hauser Ambulation Index test name. HAI01-Ambulation Index Hauser Ambulation Index - Ambulation index. HAI - Ambulation Index HAI01TN Hauser Ambulation Index Functional Test Test Name CDISC Functional Test HAI Test Name Terminology Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale test code. HAQ01-Dress Yourself Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Dressing & Grooming: Are you able to dress yourself, including tying shoelaces and doing buttons? HAQ-DI With VAS - Able to Dress Yourself HAQ01-Shampoo Your Hair Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Dressing & Grooming: Are you able to shampoo your hair? HAQ-DI With VAS - Able to Shampoo Hair HAQ01-Stand Up From a Straight Chair Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Arising: Are you able to stand up from a straight chair? HAQ-DI With VAS - Able to Stand Up From Chair HAQ01-Get In and Out of Bed Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Arising: Are you able to get in and out of bed? HAQ-DI With VAS - Able to Get In and Out of Bed HAQ01-Cut Your Meat Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Eating: Are you able to cut your meat? HAQ-DI With VAS - Able to Cut Meat HAQ01-Lift a Full Cup or Glass to Mouth Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Eating: Are you able to lift a full cup or glass to your mouth? HAQ-DI With VAS - Able to Lift Cup or Glass to Mouth HAQ01-Open a New Milk Carton Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Eating: Are you able to open a new milk carton? HAQ-DI With VAS - Able to Open Milk Carton HAQ01-Walk Outdoors on Flat Ground Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Walking: Are you able to walk outdoors on flat ground? HAQ-DI With VAS - Able to Walk Outdoors On Flat Ground HAQ01-Climb Up Five Steps Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Walking: Are you able to climb up five steps? HAQ-DI With VAS - Able to Climb Up Steps HAQ01-Aid: Cane Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Cane. HAQ-DI With VAS - Aids or Devices - Cane HAQ01-Aid: Walker Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Walker. HAQ-DI With VAS - Aids or Devices - Walker HAQ01-Aid: Crutches Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Crutches. HAQ-DI With VAS - Aids or Devices - Crutches HAQ01-Aid: Wheelchair Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Wheelchair. HAQ-DI With VAS - Aids or Devices - Wheelchair HAQ01-Aid: Devices Used for Dressing Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Devices used for dressing (button hook, zipper pull, long-handled shoe horn, etc.). HAQ-DI With VAS - Aids or Devices - Used For Dressing HAQ01-Aid: Built Up or Special Utensils Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Built up or special utensils. HAQ-DI With VAS - Aids or Devices - Built Up or Special Utensils HAQ01-Aid: Special or Built Up Chair Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Special or built up chair. HAQ-DI With VAS - Aids or Devices - Special or Built Up Chair HAQ01-Othr Aid (Dress/Arising/Eat/Walk) Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other. HAQ-DI With VAS - Aids or Devices For Dress/Arising/Eat/Walk-Other HAQ01-Spec Aid (Dress/Arising/Eat/Walk) Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other (specify). HAQ-DI With VAS - Aids or Devices For Dress/Arising/Eat/Walk-Specify HAQ01-Help: Dressing and Grooming Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Dressing and grooming. HAQ-DI With VAS - Help From Another Person - Dressing and Grooming HAQ01-Help: Arising Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Arising. HAQ-DI With VAS - Help From Another Person - Arising HAQ01-Help: Eating Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Eating. HAQ-DI With VAS - Help From Another Person - Eating HAQ01-Help: Walking Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Walking. HAQ-DI With VAS - Help From Another Person - Walking HAQ01-Wash and Dry Your Body Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Hygiene: Are you able to wash and dry your body? HAQ-DI With VAS - Able to Wash and Dry Body HAQ01-Take a Tub Bath Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Hygiene: Are you able to take a tub bath? HAQ-DI With VAS - Able to Take Tub Bath HAQ01-Get On and Off The Toilet Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Hygiene: Are you able to get on and off the toilet? HAQ-DI With VAS - Able to Get On and Off Toilet HAQ01-Reach-Get Down 5 Lb Obj Above Head Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Reach: Are you able to reach and get down a 5 pound object (such as a bag of sugar) from just above your head? HAQ-DI With VAS - Able to Reach and Get Down Object From Above Head HAQ01-Bend Down Pick Up Clothing - Floor Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Reach: Are you able to bend down to pick up clothing from the floor? HAQ-DI With VAS - Able to Bend Down and Pick Up Clothing From Floor HAQ01-Open Car Doors Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Grip: Are you able to open car doors? HAQ-DI With VAS - Able to Open Car Doors HAQ01-Open Jars Previously Opened Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Grip: Are you able to open jars which have been previously opened? HAQ-DI With VAS - Able to Open Previously Opened Jars HAQ01-Turn Faucets On And Off Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Grip: Are you able to turn faucets on and off? HAQ-DI With VAS - Able to Turn Faucets On and Off HAQ01-Run Errands and Shop Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Activities: Are you able to run errands and shop? HAQ-DI With VAS - Able to Run Errands and Shop HAQ01-Get In and Out of a Car Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Activities: Are you able to get in and out of a car? HAQ-DI With VAS - Able to Get In and Out of Car HAQ01-Able to Do Chores Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Activities: Are you able to do chores such as vacuuming or yardwork? HAQ-DI With VAS - Able to Do Chores - Vacuuming or Yardwork HAQ01-Aid: Raised Toilet Seat Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Raised toilet seat. HAQ-DI With VAS - Aids or Devices - Raised Toilet Seat HAQ01-Aid: Bathtub Seat Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Bathtub seat. HAQ-DI With VAS - Aids or Devices - Bathtub Seat HAQ01-Aid: Jar Opener (Previously Open) Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Jar opener (for jars previously opened). HAQ-DI With VAS - Aids or Devices - Jar Opener (Jars Previously Opened) HAQ01-Aid: Bathtub Bar Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Bathtub bar. HAQ-DI With VAS - Aids or Devices - Bathtub Bar HAQ01-Aid: Long-Handled Appl Reach Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Long-handled appliances for reach. HAQ-DI With VAS - Aids or Devices - Long-Handled Appliances for Reach HAQ01-Aid: Long-Handled Appl Bathroom Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Long-handled appliances in bathroom. HAQ-DI With VAS - Aids or Devices - Long-Handled Appliances in Bathroom HAQ01-Othr Aid (Hygiene/Reach/Grip/Act) Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other. HAQ-DI With VAS - Aids or Devices For Hygiene/Reach/Grip/Act-Other HAQ01-Spec Aid (Hygiene/Reach/Grip/Act) Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other (specify). HAQ-DI With VAS - Aids or Devices For Hygiene/Reach/Grip/Act-Specify HAQ01-Help: Hygiene Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Hygiene. HAQ-DI With VAS - Help From Another Person - Hygiene HAQ01-Help: Reach Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Reach. HAQ-DI With VAS - Help From Another Person - Reach HAQ01-Help: Gripping and Opening Things Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Gripping and opening things. HAQ-DI With VAS - Help From Another Person - Gripping and Opening Things HAQ01-Help: Errands and Chores Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Errands and chores. HAQ-DI With VAS - Help From Another Person - Errands and Chores HAQ01-Severity of Pain Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - How much pain have you had because of your illness in the past week? HAQ-DI With VAS - Severity of Pain in the Past Week HAQ01TC Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale Questionnaire Test Code CDISC Questionnaire HAQ-DI With VAS Test Code Terminology Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale test name. HAQ01-Able to Do Chores Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Activities: Are you able to do chores such as vacuuming or yardwork? HAQ-DI With VAS - Able to Do Chores - Vacuuming or Yardwork HAQ01-Aid: Bathtub Bar Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Bathtub bar. HAQ-DI With VAS - Aids or Devices - Bathtub Bar HAQ01-Aid: Bathtub Seat Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Bathtub seat. HAQ-DI With VAS - Aids or Devices - Bathtub Seat HAQ01-Aid: Built Up or Special Utensils Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Built up or special utensils. HAQ-DI With VAS - Aids or Devices - Built Up or Special Utensils HAQ01-Aid: Cane Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Cane. HAQ-DI With VAS - Aids or Devices - Cane HAQ01-Aid: Crutches Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Crutches. HAQ-DI With VAS - Aids or Devices - Crutches HAQ01-Aid: Devices Used for Dressing Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Devices used for dressing (button hook, zipper pull, long-handled shoe horn, etc.). HAQ-DI With VAS - Aids or Devices - Used For Dressing HAQ01-Aid: Jar Opener (Previously Open) Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Jar opener (for jars previously opened). HAQ-DI With VAS - Aids or Devices - Jar Opener (Jars Previously Opened) HAQ01-Aid: Long-Handled Appl Bathroom Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Long-handled appliances in bathroom. HAQ-DI With VAS - Aids or Devices - Long-Handled Appliances in Bathroom HAQ01-Aid: Long-Handled Appl Reach Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Long-handled appliances for reach. HAQ-DI With VAS - Aids or Devices - Long-Handled Appliances for Reach HAQ01-Aid: Raised Toilet Seat Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Raised toilet seat. HAQ-DI With VAS - Aids or Devices - Raised Toilet Seat HAQ01-Aid: Special or Built Up Chair Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Special or built up chair. HAQ-DI With VAS - Aids or Devices - Special or Built Up Chair HAQ01-Aid: Walker Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Walker. HAQ-DI With VAS - Aids or Devices - Walker HAQ01-Aid: Wheelchair Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Wheelchair. HAQ-DI With VAS - Aids or Devices - Wheelchair HAQ01-Bend Down Pick Up Clothing - Floor Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Reach: Are you able to bend down to pick up clothing from the floor? HAQ-DI With VAS - Able to Bend Down and Pick Up Clothing From Floor HAQ01-Climb Up Five Steps Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Walking: Are you able to climb up five steps? HAQ-DI With VAS - Able to Climb Up Steps HAQ01-Cut Your Meat Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Eating: Are you able to cut your meat? HAQ-DI With VAS - Able to Cut Meat HAQ01-Dress Yourself Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Dressing & Grooming: Are you able to dress yourself, including tying shoelaces and doing buttons? HAQ-DI With VAS - Able to Dress Yourself HAQ01-Get In and Out of a Car Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Activities: Are you able to get in and out of a car? HAQ-DI With VAS - Able to Get In and Out of Car HAQ01-Get In and Out of Bed Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Arising: Are you able to get in and out of bed? HAQ-DI With VAS - Able to Get In and Out of Bed HAQ01-Get On and Off The Toilet Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Hygiene: Are you able to get on and off the toilet? HAQ-DI With VAS - Able to Get On and Off Toilet HAQ01-Help: Arising Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Arising. HAQ-DI With VAS - Help From Another Person - Arising HAQ01-Help: Dressing and Grooming Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Dressing and grooming. HAQ-DI With VAS - Help From Another Person - Dressing and Grooming HAQ01-Help: Eating Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Eating. HAQ-DI With VAS - Help From Another Person - Eating HAQ01-Help: Errands and Chores Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Errands and chores. HAQ-DI With VAS - Help From Another Person - Errands and Chores HAQ01-Help: Gripping and Opening Things Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Gripping and opening things. HAQ-DI With VAS - Help From Another Person - Gripping and Opening Things HAQ01-Help: Hygiene Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Hygiene. HAQ-DI With VAS - Help From Another Person - Hygiene HAQ01-Help: Reach Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Reach. HAQ-DI With VAS - Help From Another Person - Reach HAQ01-Help: Walking Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Walking. HAQ-DI With VAS - Help From Another Person - Walking HAQ01-Lift a Full Cup or Glass to Mouth Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Eating: Are you able to lift a full cup or glass to your mouth? HAQ-DI With VAS - Able to Lift Cup or Glass to Mouth HAQ01-Open a New Milk Carton Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Eating: Are you able to open a new milk carton? HAQ-DI With VAS - Able to Open Milk Carton HAQ01-Open Car Doors Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Grip: Are you able to open car doors? HAQ-DI With VAS - Able to Open Car Doors HAQ01-Open Jars Previously Opened Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Grip: Are you able to open jars which have been previously opened? HAQ-DI With VAS - Able to Open Previously Opened Jars HAQ01-Othr Aid (Dress/Arising/Eat/Walk) Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other. HAQ-DI With VAS - Aids or Devices For Dress/Arising/Eat/Walk-Other HAQ01-Othr Aid (Hygiene/Reach/Grip/Act) Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other. HAQ-DI With VAS - Aids or Devices For Hygiene/Reach/Grip/Act-Other HAQ01-Reach-Get Down 5 Lb Obj Above Head Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Reach: Are you able to reach and get down a 5 pound object (such as a bag of sugar) from just above your head? HAQ-DI With VAS - Able to Reach and Get Down Object From Above Head HAQ01-Run Errands and Shop Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Activities: Are you able to run errands and shop? HAQ-DI With VAS - Able to Run Errands and Shop HAQ01-Severity of Pain Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - How much pain have you had because of your illness in the past week? HAQ-DI With VAS - Severity of Pain in the Past Week HAQ01-Shampoo Your Hair Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Dressing & Grooming: Are you able to shampoo your hair? HAQ-DI With VAS - Able to Shampoo Hair HAQ01-Spec Aid (Dress/Arising/Eat/Walk) Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other (specify). HAQ-DI With VAS - Aids or Devices For Dress/Arising/Eat/Walk-Specify HAQ01-Spec Aid (Hygiene/Reach/Grip/Act) Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other (specify). HAQ-DI With VAS - Aids or Devices For Hygiene/Reach/Grip/Act-Specify HAQ01-Stand Up From a Straight Chair Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Arising: Are you able to stand up from a straight chair? HAQ-DI With VAS - Able to Stand Up From Chair HAQ01-Take a Tub Bath Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Hygiene: Are you able to take a tub bath? HAQ-DI With VAS - Able to Take Tub Bath HAQ01-Turn Faucets On And Off Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Grip: Are you able to turn faucets on and off? HAQ-DI With VAS - Able to Turn Faucets On and Off HAQ01-Walk Outdoors on Flat Ground Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Walking: Are you able to walk outdoors on flat ground? HAQ-DI With VAS - Able to Walk Outdoors On Flat Ground HAQ01-Wash and Dry Your Body Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Hygiene: Are you able to wash and dry your body? HAQ-DI With VAS - Able to Wash and Dry Body HAQ01TN Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale Questionnaire Test Name CDISC Questionnaire HAQ-DI With VAS Test Name Terminology Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale test code. HAQ02-Dress Yourself Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Dressing & Grooming: Are you able to dress yourself, including tying shoelaces and doing buttons? HAQ-DI Without VAS - Dress Yourself HAQ02-Shampoo Your Hair Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Dressing & Grooming: Are you able to shampoo your hair? HAQ-DI Without VAS - Shampoo Your Hair HAQ02-Stand Up From a Straight Chair Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Arising: Are you able to stand up from a straight chair? HAQ-DI Without VAS - Stand Up From a Straight Chair HAQ02-Get In and Out of Bed Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Arising: Are you able to get in and out of bed? HAQ-DI Without VAS - Get In and Out of Bed HAQ02-Cut Your Meat Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Eating: Are you able to cut your meat? HAQ-DI Without VAS - Cut Your Meat HAQ02-Lift a Full Cup or Glass to Mouth Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Eating: Are you able to lift a full cup or glass to your mouth? HAQ-DI Without VAS - Lift a Full Cup or Glass to Mouth HAQ02-Open a New Milk Carton Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Eating: Are you able to open a new milk carton? HAQ-DI Without VAS - Open a New Milk Carton HAQ02-Walk Outdoors on Flat Ground Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Walking: Are you able to walk outdoors on flat ground? HAQ-DI Without VAS - Walk Outdoors on Flat Ground HAQ02-Climb Up Five Steps Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Walking: Are you able to climb up five steps? HAQ-DI Without VAS - Climb Up Five Steps HAQ02-Aid: Cane Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Cane. HAQ-DI Without VAS - Aid: Cane HAQ02-Aid: Walker Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Walker. HAQ-DI Without VAS - Aid: Walker HAQ02-Aid: Crutches Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Crutches. HAQ-DI Without VAS - Aid: Crutches HAQ02-Aid: Wheelchair Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Wheelchair. HAQ-DI Without VAS - Aid: Wheelchair HAQ02-Aid: Devices Used for Dressing Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Devices used for Dressing (button hook, zipper pull, long-handled shoe horn, etc.). HAQ-DI Without VAS - Aid: Devices Used for Dressing HAQ02-Aid: Built Up or Special Utensils Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Built up or special utensils. HAQ-DI Without VAS - Aid: Built Up or Special Utensils HAQ02-Aid: Special or Built Up Chair Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Special or built up chair. HAQ-DI Without VAS - Aid: Special or Built Up Chair HAQ02-Othr Aid (Dress/Arising/Eat/Walk) Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other. HAQ-DI Without VAS - Other Aid (Dress or Arising or Eat or Walk) HAQ02-Spec Aid (Dress/Arising/Eat/Walk) Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other (specify). HAQ-DI Without VAS - Special Aid (Dress or Arising or Eat or Walk) HAQ02-Help: Dressing and Grooming Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Dressing and grooming. HAQ-DI Without VAS - Help: Dressing and Grooming HAQ02-Help: Arising Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Arising. HAQ-DI Without VAS - Help: Arising HAQ02-Help: Eating Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Eating. HAQ-DI Without VAS - Help: Eating HAQ02-Help: Walking Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Walking. HAQ-DI Without VAS - Help: Walking HAQ02-Wash and Dry Your Body Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Hygiene: Are you able to wash and dry your body? HAQ-DI Without VAS - Wash and Dry Your Body HAQ02-Take a Tub Bath Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Hygiene: Are you able to take a tub bath? HAQ-DI Without VAS - Take a Tub Bath HAQ02-Get On and Off The Toilet Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Hygiene: Are you able to get on and off the toilet? HAQ-DI Without VAS - Get On and Off The Toilet HAQ02-Reach-Get Down 5 Lb Obj Above Head Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Reach: Are you able to reach and get down a 5-pound object (such as a bag of sugar) from just above your head? HAQ-DI Without VAS - Reach-Get Down 5 Lb Object Above Head HAQ02-Bend Down Pick Up Clothing - Floor Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Reach: Are you able to bend down to pick up clothing from the floor? HAQ-DI Without VAS - Bend Down Pick Up Clothing - Floor HAQ02-Open Car Doors Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Grip: Are you able to open car doors? HAQ-DI Without VAS - Open Car Doors HAQ02-Open Jars Previously Opened Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Grip: Are you able to open jars which have been previously opened? HAQ-DI Without VAS - Open Jars Previously Opened HAQ02-Turn Faucets On And Off Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Grip: Are you able to turn faucets on and off? HAQ-DI Without VAS - Turn Faucets On And Off HAQ02-Run Errands and Shop Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Activities: Are you able to run errands and shop? HAQ-DI Without VAS - Run Errands and Shop HAQ02-Get In and Out of a Car Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Activities: Are you able to get in and out of a car? HAQ-DI Without VAS - Get In and Out of a Car HAQ02-Able to Do Chores Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Activities: Are you able to do chores such as vacuuming or yardwork? HAQ-DI Without VAS - Able to Do Chores HAQ02-Aid: Raised Toilet Seat Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Raised toilet seat. HAQ-DI Without VAS - Aid: Raised Toilet Seat HAQ02-Aid: Bathtub Seat Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Bathtub seat. HAQ-DI Without VAS - Aid: Bathtub Seat HAQ02-Aid: Jar Opener (Previously Open) Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Jar opener (for jars previously opened). HAQ-DI Without VAS - Aid: Jar Opener (Previously Open) HAQ02-Aid: Bathtub Bar Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Bathtub bar. HAQ-DI Without VAS - Aid: Bathtub Bar HAQ02-Aid: Long-Handled Appl Reach Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Long-handled appliances for reach. HAQ-DI Without VAS - Aid: Long-Handled Appliances Reach HAQ02-Aid: Long-Handled Appl Bathroom Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Long-handled appliances in bathroom. HAQ-DI Without VAS - Aid: Long-Handled Appliances Bathroom HAQ02-Othr Aid (Hygiene/Reach/Grip/Act) Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other. HAQ-DI Without VAS - Other Aid (Hygiene or Reach or Grip or Act) HAQ02-Spec Aid (Hygiene/Reach/Grip/Act) Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other (specify). HAQ-DI Without VAS - Special Aid (Hygiene or Reach or Grip or Act) HAQ02-Help: Hygiene Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Hygiene. HAQ-DI Without VAS - Help: Hygiene HAQ02-Help: Reach Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Reach. HAQ-DI Without VAS - Help: Reach HAQ02-Help: Gripping and Opening Things Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Gripping and opening things. HAQ-DI Without VAS - Help: Gripping and Opening Things HAQ02-Help: Errands and Chores Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Errands and chores. HAQ-DI Without VAS - Help: Errands and Chores HAQ02TC Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale Questionnaire Test Code CDISC Questionnaire HAQ-DI Without VAS Test Code Terminology Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale test name. HAQ02-Able to Do Chores Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Activities: Are you able to do chores such as vacuuming or yardwork? HAQ-DI Without VAS - Able to Do Chores HAQ02-Aid: Bathtub Bar Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Bathtub bar. HAQ-DI Without VAS - Aid: Bathtub Bar HAQ02-Aid: Bathtub Seat Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Bathtub seat. HAQ-DI Without VAS - Aid: Bathtub Seat HAQ02-Aid: Built Up or Special Utensils Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Built up or special utensils. HAQ-DI Without VAS - Aid: Built Up or Special Utensils HAQ02-Aid: Cane Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Cane. HAQ-DI Without VAS - Aid: Cane HAQ02-Aid: Crutches Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Crutches. HAQ-DI Without VAS - Aid: Crutches HAQ02-Aid: Devices Used for Dressing Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Devices used for Dressing (button hook, zipper pull, long-handled shoe horn, etc.). HAQ-DI Without VAS - Aid: Devices Used for Dressing HAQ02-Aid: Jar Opener (Previously Open) Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Jar opener (for jars previously opened). HAQ-DI Without VAS - Aid: Jar Opener (Previously Open) HAQ02-Aid: Long-Handled Appl Bathroom Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Long-handled appliances in bathroom. HAQ-DI Without VAS - Aid: Long-Handled Appliances Bathroom HAQ02-Aid: Long-Handled Appl Reach Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Long-handled appliances for reach. HAQ-DI Without VAS - Aid: Long-Handled Appliances Reach HAQ02-Aid: Raised Toilet Seat Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Raised toilet seat. HAQ-DI Without VAS - Aid: Raised Toilet Seat HAQ02-Aid: Special or Built Up Chair Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Special or built up chair. HAQ-DI Without VAS - Aid: Special or Built Up Chair HAQ02-Aid: Walker Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Walker. HAQ-DI Without VAS - Aid: Walker HAQ02-Aid: Wheelchair Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Wheelchair. HAQ-DI Without VAS - Aid: Wheelchair HAQ02-Bend Down Pick Up Clothing - Floor Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Reach: Are you able to bend down to pick up clothing from the floor? HAQ-DI Without VAS - Bend Down Pick Up Clothing - Floor HAQ02-Climb Up Five Steps Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Walking: Are you able to climb up five steps? HAQ-DI Without VAS - Climb Up Five Steps HAQ02-Cut Your Meat Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Eating: Are you able to cut your meat? HAQ-DI Without VAS - Cut Your Meat HAQ02-Dress Yourself Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Dressing & Grooming: Are you able to dress yourself, including tying shoelaces and doing buttons? HAQ-DI Without VAS - Dress Yourself HAQ02-Get In and Out of a Car Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Activities: Are you able to get in and out of a car? HAQ-DI Without VAS - Get In and Out of a Car HAQ02-Get In and Out of Bed Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Arising: Are you able to get in and out of bed? HAQ-DI Without VAS - Get In and Out of Bed HAQ02-Get On and Off The Toilet Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Hygiene: Are you able to get on and off the toilet? HAQ-DI Without VAS - Get On and Off The Toilet HAQ02-Help: Arising Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Arising. HAQ-DI Without VAS - Help: Arising HAQ02-Help: Dressing and Grooming Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Dressing and grooming. HAQ-DI Without VAS - Help: Dressing and Grooming HAQ02-Help: Eating Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Eating. HAQ-DI Without VAS - Help: Eating HAQ02-Help: Errands and Chores Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Errands and chores. HAQ-DI Without VAS - Help: Errands and Chores HAQ02-Help: Gripping and Opening Things Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Gripping and opening things. HAQ-DI Without VAS - Help: Gripping and Opening Things HAQ02-Help: Hygiene Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Hygiene. HAQ-DI Without VAS - Help: Hygiene HAQ02-Help: Reach Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Reach. HAQ-DI Without VAS - Help: Reach HAQ02-Help: Walking Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Walking. HAQ-DI Without VAS - Help: Walking HAQ02-Lift a Full Cup or Glass to Mouth Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Eating: Are you able to lift a full cup or glass to your mouth? HAQ-DI Without VAS - Lift a Full Cup or Glass to Mouth HAQ02-Open a New Milk Carton Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Eating: Are you able to open a new milk carton? HAQ-DI Without VAS - Open a New Milk Carton HAQ02-Open Car Doors Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Grip: Are you able to open car doors? HAQ-DI Without VAS - Open Car Doors HAQ02-Open Jars Previously Opened Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Grip: Are you able to open jars which have been previously opened? HAQ-DI Without VAS - Open Jars Previously Opened HAQ02-Othr Aid (Dress/Arising/Eat/Walk) Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other. HAQ-DI Without VAS - Other Aid (Dress or Arising or Eat or Walk) HAQ02-Othr Aid (Hygiene/Reach/Grip/Act) Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other. HAQ-DI Without VAS - Other Aid (Hygiene or Reach or Grip or Act) HAQ02-Reach-Get Down 5 Lb Obj Above Head Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Reach: Are you able to reach and get down a 5-pound object (such as a bag of sugar) from just above your head? HAQ-DI Without VAS - Reach-Get Down 5 Lb Object Above Head HAQ02-Run Errands and Shop Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Activities: Are you able to run errands and shop? HAQ-DI Without VAS - Run Errands and Shop HAQ02-Shampoo Your Hair Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Dressing & Grooming: Are you able to shampoo your hair? HAQ-DI Without VAS - Shampoo Your Hair HAQ02-Spec Aid (Dress/Arising/Eat/Walk) Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other (specify). HAQ-DI Without VAS - Special Aid (Dress or Arising or Eat or Walk) HAQ02-Spec Aid (Hygiene/Reach/Grip/Act) Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other (specify). HAQ-DI Without VAS - Special Aid (Hygiene or Reach or Grip or Act) HAQ02-Stand Up From a Straight Chair Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Arising: Are you able to stand up from a straight chair? HAQ-DI Without VAS - Stand Up From a Straight Chair HAQ02-Take a Tub Bath Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Hygiene: Are you able to take a tub bath? HAQ-DI Without VAS - Take a Tub Bath HAQ02-Turn Faucets On And Off Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Grip: Are you able to turn faucets on and off? HAQ-DI Without VAS - Turn Faucets On And Off HAQ02-Walk Outdoors on Flat Ground Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Walking: Are you able to walk outdoors on flat ground? HAQ-DI Without VAS - Walk Outdoors on Flat Ground HAQ02-Wash and Dry Your Body Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Hygiene: Are you able to wash and dry your body? HAQ-DI Without VAS - Wash and Dry Your Body HAQ02TN Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale Questionnaire Test Name CDISC Questionnaire HAQ-DI Without VAS Test Name Terminology A terminology codelist based on the standardized or preprinted name of the healthcare encounter that occurs. The subject or patient has interacted with a healthcare professional at an adult daycare facility. Adult Daycare Facility Visit The subject or patient has interacted with a healthcare professional at a cardiac catheterization unit. Cardiac Catheterization Laboratory Visit CICU Stay Coronary Intensive Care Unit Stay The subject or patient has been admitted as an inpatient to a cardiac intensive care unit in a hospital. Cardiac Intensive Care Unit Stay The subject or patient has interacted with a healthcare professional at a cardiology unit in a hospital. Cardiology Unit Visit The subject or patient has interacted with a healthcare professional at a day hospital. Day Hospital Visit The subject or patient has interacted with a dietary specialist. Dietary Specialist Visit The subject or patient has interacted with a healthcare professional at an emergency room. Emergency Room Visit General Medical Unit Stay The subject or patient has been admitted as an inpatient to a general medical unit of a hospital. General Ward Stay Doctor's Office Visit Physician's Office Visit The subject or patient has interacted with a healthcare professional at their office. Healthcare Professional Office Visit The subject or patient has interacted with a healthcare professional. Healthcare Professional Visit The subject or patient has interacted with a healthcare professional within a residence. Home Healthcare Visit The subject or patient has interacted with a hospice aide at home. Home Hospice Visit The subject or patient has been admitted as an inpatient to a hospice facility. Hospice Facility Stay Inpatient Hospital Stay Inpatient Hospitalization The subject or patient has been admitted as an inpatient to a hospital. Hospital Stay Imaging Facility Visit The subject or patient has interacted with a healthcare professional at an imaging center. Imaging Center Encounter The subject or patient has interacted with a healthcare professional at an infusion center. Infusion Center Visit ICU Stay The subject or patient has been admitted as an inpatient to a intensive care unit in a hospital. Intensive Care Unit Stay The subject or patient has interacted with a healthcare professional in a laboratory. Laboratory Encounter The subject or patient has been admitted as an inpatient to a long term acute care facility. Long Term Acute Care Stay The subject or patient has been admitted as an inpatient to a long term subacute care facility. Long Term Subacute Care Stay The subject or patient has interacted with a mental health specialist. Mental Health Specialist Visit Neuro-ICU Stay Neuro-Trauma ICU Stay The subject or patient has been admitted as an inpatient to a neuro-intensive care unit in a hospital. Neuro Intensive Care Unit Stay The subject or patient has been admitted as an inpatient to a nursing home. Nursing Home Stay OR Visit The subject or patient has interacted with a healthcare professional in an operating room. Operating Room Visit Ambulatory Care Clinic Visit Ambulatory Care Facility Visit Ambulatory Center Visit The subject or patient has interacted with a healthcare professional at an outpatient clinic. Ambulatory Visit The subject or patient has been admitted as an inpatient to a palliative care unit. Palliative Care Unit Stay The subject or patient has interacted with a healthcare professional at a physical therapy facility. Physical Therapy Facility Visit PACU Visit Recovery Room Visit The subject or patient has interacted with a healthcare professional in a post-anesthesia care unit. Post-Anesthesia Care Unit Visit The subject or patient has interacted with a primary care physician at their office. Primary Care Physician's Office Visit The subject or patient has been admitted as an inpatient to a psychiatric ward. Psychiatric Ward Stay The subject or patient has been admitted as an inpatient to a rehabilitation facility. Rehabilitation Facility Stay The subject or patient has been admitted as an inpatient to a short term acute care facility. Short Term Acute Care Stay The subject or patient has been admitted as an inpatient to a skilled nursing facility. Skilled Nursing Facility Stay The subject or patient has interacted with a specialty care physician at their office. Specialty Care Physician's Office Visit SICU Stay The subject or patient has been admitted as an inpatient to a surgical intensive care unit in a hospital. Surgical Intensive Care Unit Stay The subject or patient has interacted with a healthcare professional in a surgical unit. Surgical Unit Visit The subject or patient has interacted with a healthcare professional at an urgent care center. Urgent Care Center Visit The subject or patient has interacted with a healthcare professional remotely, using telecommunications technology. Virtual Patient Encounter The subject or patient has interacted with a healthcare professional remotely, using a telephone. Phone Virtual Visit HODECOD Health Care Encounters Dictionary Derived Term CDISC SDTM Health Care Encounters Dictionary Derived Term Terminology Terminology relevant to the method for how the Holter ECG is read, with respect to how much human intervention is involved. Of or related to a process performed without human intervention. Automatic Of or related to a process performed by hand. Manual Of or related to a process performed using a combination of manual and automatic means. Semi-Automatic HEGRDMTH Holter ECG Read Method Response CDISC SDTM Holter ECG Read Method Response Terminology Terminology relevant to the responses that describe Holter ECG interpretative findings. 1st degree AV block PR Prolongation Prolonged PR interval An electrocardiographic finding of prolonged PR interval. AV Block First Degree by ECG Finding 2:1 AV block An electrocardiographic finding of a supraventricular rhythm where the ratio of impulses generated above the atrioventricular node to the number of impulses conducted through to the ventricles is 2:1. This is manifest on the ECG as 2 P waves per QRS complex. 2:1 Atrioventricular Block by ECG Finding Second Degree AV Block An electrocardiographic finding of intermittent failure of atrial electrical impulse conduction to the ventricles. This is manifest on the ECG by regular P waves which intermittently are not followed by QRS complexes. AV Block Second Degree by ECG Finding 3rd Degree Heart Block AV block, complete (third-degree) Complete Heart Block An electrocardiographic finding of complete failure of atrial electrical impulse conduction to the ventricles. This is manifest on the ECG by disassociation of atrial and ventricular rhythms. The atrial rate must be faster than the ventricular rate. AV Block Third Degree by ECG Finding 50 Hz Artifact 50 Hz Noise An electrocardiographic recording showing power line interference with the electrocardiographic signal. The artifact amplitude modulation has the same frequency as the AC power system present (50 Hz). 50 Hertz Noise by ECG Finding 60 Hz Artifact 60 Hz Noise An electrocardiographic recording showing power line interference with the electrocardiographic signal. The artifact amplitude modulation has the same frequency as the AC power system present (60 Hz). 60 Hertz Noise by ECG Finding Aberrantly Conducted Beats An electrocardiographic finding of an abnormally wide QRS complex(es) of supraventricular origin with prolonged QRS duration due to aberrant AV conduction. Aberrantly Conducted Complexes by ECG Finding AC Noise An electrocardiographic recording showing power line interference with the electrocardiographic signal. The artifact amplitude modulation has the same frequency as the AC power system present (usually 50 Hz or 60 Hz). Alternating Current Noise by ECG Finding Accelerated idioventricular rhythm An electrocardiographic finding of idioventricular rhythm with a rate greater than 50 beats per minute. Accelerated Idioventricular Rhythm by ECG Finding Acute Anterior MI Acute Anterior Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V3 and V4, which is suggestive of acute myocardial infarction of the anterior wall of the left ventricle. Acute Anterior Myocardial Infarction by ECG Finding Acute Anterolateral Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V3 through V6, which is suggestive of acute myocardial infarction of the anterolateral wall of the left ventricle. Acute Anterolateral Myocardial Infarction by ECG Finding Acute anteroseptal MI Acute Anteroseptal Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V1 through V4, which is suggestive of acute myocardial infarction of the anteroseptal wall of the left ventricle. Acute Anteroseptal Myocardial Infarction by ECG Finding An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V1 to V6, I and aVL, which is suggestive of acute myocardial infarction involving the anterior and anterolateral walls of the left ventricle. Acute Extensive Anterior Wall Myocardial Infarction by ECG Finding Acute High Lateral Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads I and aVL, which is suggestive of acute myocardial infarction of the high lateral wall of the left ventricle. Acute High Lateral Myocardial Infarction by ECG Finding Acute Inferior MI Acute Inferior Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads III, aVF and often II, which is suggestive of acute myocardial infarction of the inferior wall of the left ventricle. Acute Inferior Myocardial Infarction by ECG Finding Acute Lateral MI Acute Lateral Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V5, V6, I and aVL, which is suggestive of acute myocardial infarction of the lateral wall of the left ventricle. Acute Lateral Myocardial Infarction by ECG Finding Acute Myocardial Infarction An electrocardiographic finding showing a current of injury with ST elevation. No specification is provided for localization. Acute Myocardial Infarction by ECG Finding Acute Posterior MI Acute Posterior Wall Myocardial Infarction An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, upright T wave, with accompanying ST elevation, which is suggestive of acute myocardial infarction of the posterior wall of the left ventricle. Evidence of inferior or lateral myocardial infarction is usually also present. Acute Posterior Myocardial Infarction by ECG Finding Acute Right ventricular MI Acute Right Ventricular Wall Myocardial Infarction An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, upright T wave, with accompanying ST elevation, which is suggestive of acute myocardial infarction of the ventricular wall of the left ventricle. Evidence of inferior or lateral myocardial infarction is usually also present. Additional criteria include ST elevation > 100 microvolts in the right precordial leads V4R through V6R. Acute Right Ventricular Myocardial Infarction by ECG Finding Acute Septal Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V1, V2 and often V3, which is suggestive of acute myocardial infarction of the intraventricular septum. Acute Septal Myocardial Infarction by ECG Finding Advanced/High Grade AV Block An electrocardiographic finding of intermittent failure of atrial electrical impulse conduction to the ventricles, characterized by two or more consecutive non-conducted P waves. High Grade Atrioventricular Block by ECG Finding An electrocardiographic recording in which all precordial electrodes are disconnected resulting in missing waveforms (flat line) of all leads V1 - V6. All Precordial Electrodes Are Disconnected by ECG Finding Anterior MI Anterior Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V3 and V4, which is suggestive of myocardial infarction of the anterior wall of the left ventricle. Anterior Myocardial Infarction by ECG Finding Anterolateral Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V3 through V6, which is suggestive of myocardial infarction of the anterolateral wall of the left ventricle. Anterolateral Myocardial Infarction by ECG Finding Anteroseptal MI Anteroseptal Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V1 through V4, which is suggestive of myocardial infarction of the anteroseptal wall of the left ventricle. Anteroseptal Myocardial Infarction by ECG Finding An electrocardiographic recording in which one or more leads display extraneous signals which do not represent cardiac electrical activity. Artifact Lead Signal by ECG Finding An electrocardiographic finding showing no cardiac electrical activity on the ECG for the entire duration of the recording. Asystole by ECG Finding An electrocardiographic finding of a sinus beat followed by a premature atrial complex for three or more consecutive cycles; a regularly irregular rhythm of normal and abnormal P waves in a 1-1 ratio. Atrial Bigeminy by ECG Finding Atrial Couplets An electrocardiographic finding in which two premature atrial complexes occur sequentially; there may be one or more occurrences during an electrocardiographic recording. Atrial Couplet by ECG Finding Atrial Enlargement An electrocardiographic finding which comprises left, right or bilateral atrial enlargement. This is may be characterized by prolonged P wave duration, increased P wave amplitude, or multi-component P waves. Atrial Enlargement by ECG Finding Atrial fibrillation An electrocardiographic finding of a supraventricular arrhythmia characterized by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape and timing and are accompanied by an irregularly irregular ventricular response. Atrial Fibrillation by ECG Finding Atrial flutter An electrocardiographic finding of an organized, regular atrial rhythm. Multiple P waves typically appear in the inferior leads in a saw tooth like pattern between the QRS complexes. Atrial Flutter by ECG Finding An electrocardiographic finding of an atrial tachycardia which does not display 1:1 AV conduction. Atrial Tachycardia With AV Block by ECG Finding Atrial tachycardia An electrocardiographic finding of an organized, regular atrial rhythm. The P wave morphology must be distinct from the sinus P wave morphology. Atrial Tachycardia by ECG Finding Atrial Trigeminy An electrocardiographic finding of two sinus beats followed by a premature atrial complex for 3 or more consecutive cycles; a regularly irregular rhythm of normal and abnormal P waves in a 2-1 ratio. Atrial Trigeminy by ECG Finding Atrioventricular dissociation AV Dissociation An electrocardiographic finding in which the electrical activity of the atria and ventricles are independent of one another. Atrioventricular Dissociation by ECG Finding AV Mobitz I Mobitz I Second Degree AV Block Second degree AV block- Mobitz type I Second-degree AV block, Mobitz type I (Wenckebach) Type 1 2nd degree AV Block Wenckebach An electrocardiographic finding of intermittent failure of atrial electrical impulse conduction to the ventricles, characterized by a progressively lengthening PR interval prior to the block of an atrial impulse. AV Block Second Degree Mobitz Type I by ECG Finding Mobitz II AV Block Mobitz II Second Degree AV Block Type 2 2nd degree AV Block An electrocardiographic finding of intermittent failure of atrial electrical impulse conduction to the ventricles, characterized by a relatively constant PR interval prior to the block of an atrial impulse. AV Block Second Degree Mobitz Type II by ECG Finding AV Node Reentrant Supraventricular Tachycardia An electrocardiographic finding of a regular supraventricular tachycardia due to reentry within the AV node. It is characterized by P waves which typically occurs nearly simultaneously with the QRS complex, resulting in a P wave which is obscured by the QRS, merged with the QRS or which may follow the QRS. Atrioventricular Nodal Reentry Tachycardia by ECG Finding AV Reentrant Supraventricular Tachycardia An electrocardiographic finding of a regular supraventricular tachycardia which utilizes an atrioventricular bypass tract as its retrograde limb (orthodromic tachycardia) or as its antegrade limb (antidromic tachycardia). QRS complexes during sinus rhythm may show preexcitation. During orthodromic tachycardia the preexcitation is not present and a retrograde P wave may appear after the QRS complex. During antidromic tachycardia the QRS complex is preexcited. Atrioventricular Reentrant Tachycardia by ECG Finding An electrocardiographic recording in which the isoelectric line in one or more leads is vertically displaced resulting in low frequency upward and downward movements of the signal with varying amplitudes. Baseline Wander by ECG Finding Bifascicular block An electrocardiographic finding comprising right bundle branch block and left anterior fascicular block, or right bundle branch block and left posterior fascicular block. Defects occurring in two of the three divisions of the conduction system of the heart are considered bifascicular blocks. Technically left bundle branch block may be considered a bifascicular block. (NCI) Bifascicular Block by ECG Finding An electrocardiographic finding suggestive of enlargement or thickening of both ventricles, with a combination of findings which are related to LVH and RVH, such as voltage criteria for LVH in the presence of marked right axis deviation. Biventricular Hypertrophy by ECG Finding Borderline QTcB An electrocardiographic finding in which the QT interval corrected for heart rate using Bazett's formula is slightly prolonged. Thresholds for different age, sex, and patient populations exist. Borderline QTcB Borderline QTcF An electrocardiographic finding in which the QT interval corrected for heart rate using Fridericia's formula is slightly prolonged. Thresholds for different age, sex, and patient populations exist. Borderline QTcF Bradycardia An electrocardiographic finding of abnormally slow heart rate. Bradycardia by ECG Finding An electrocardiographic finding of complete or incomplete right bundle branch block accompanied by ST elevation in leads V1-V3. This may be noted at rest or can be provoked by medication challenge. Brugada Syndrome Pattern by ECG Finding An electrocardiographic finding of an artifact generated by an external or internal cardioversion or defibrillation shock. Defibrillator Discharge by ECG Finding Delta wave An electrocardiographic finding of initial slurring (delta wave) of the QRS complex due to the presence of an accessory pathway. This characteristic ECG pattern is typically seen in Wolff-Parkinson-White syndrome. Delta Wave by ECG Finding Dextrocardia An electrocardiographic finding suggestive of dextrocardia with situs inversus, characterized by reversal of normal anterior R wave progression and the appearance of reversal of the right and left arm electrodes. Dextrocardia by ECG Finding Early R Wave Progression Early R Wave Transition An electrocardiographic finding where the amplitude of the R wave becomes greater than the amplitude of the S wave in the QRS complex at an unusually early point in the precordial leads, usually in leads V1 or V2. Early R Wave Transition by ECG Finding Early Repolarization An electrocardiographic finding of J point and ST segment elevation. Early Repolarization An electrocardiographic recording in which the precordial electrodes have been placed over the right chest and record a right sided ECG. ECG Acquired with Precordial Electrodes Placed on the Right Chest A digital electrocardiographic recording which is corrupted (i.e. ECG signal cannot be restored) such that measurements and/or interpretation cannot be performed. ECG Evaluation Not Performed Due to Corrupted Digital ECG File Ectopic Supraventricular Rhythm An electrocardiographic finding of a regular atrial rhythm that does not originate in the sinus node, and which is characterized by P waves whose morphology differs from the P wave morphology during sinus rhythm. Ectopic Atrial Rhythm by ECG Finding Ectopic ventricular rhythm An electrocardiographic finding of three or more consecutive complexes of ventricular origin. The QRS complexes are wide and have an abnormal morphology. Ectopic Ventricular Rhythm by ECG Finding Electrical alternans An electrocardiographic finding in which there is an alternating pattern of any of the waveform components. (NCI) Electrical Alternans by ECG Finding An electrocardiographic finding of pathologic Q waves in leads V1 to V6, I and aVL, which is suggestive of myocardial infarction involving the anterior and anterolateral walls of the left ventricle. Extensive Anterior Wall Myocardial Infarction by ECG Finding An electrocardiographic finding during a continuous recording in which the frequency of atrial premature complexes exceeds the normal threshold. Note that different thresholds may apply to different patient populations. Frequent Premature Atrial Complexes by ECG Finding An electrocardiographic finding during a continuous recording in which the frequency of ventricular premature complexes exceeds the normal threshold. Note that different thresholds may apply to different patient populations. Frequent Premature Ventricular Complexes by ECG Finding Fusion Beat Fusion Complexes An electrocardiographic finding that occurs when electrical activation of the atria or ventricles occurs from two separate sites. This results in a P wave or QRS complex that displays merged characteristics of beats originating from the two different sites; there may be one or more occurrences during an electrocardiographic recording. Fusion Complex High Lateral Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads I and aVL, which is suggestive of myocardial infarction of the high lateral wall of the left ventricle. High Lateral Myocardial Infarction by ECG Finding A continuous, ambulatory electrocardiographic recording during which one or more electrodes are disconnected, at least temporarily, resulting in one or more invalid ECG waveforms. Holter Lead Fail by ECG Finding Idioventricular Rhythm An electrocardiographic finding of three or more consecutive complexes of ventricular origin with a rate less than a certain threshold. The QRS complexes are wide and have an abnormal morphology. Idioventricular Rhythm Incomplete left bundle branch block An electrocardiographic finding of a wide QRS complex with evidence of delayed conduction to the left ventricle. Incomplete Left Bundle Branch Block by ECG Finding Incomplete right bundle branch block Incomplete right bundle-branch block An electrocardiographic finding of a wide QRS complex with evidence of delayed conduction to the right ventricle. Incomplete Right Bundle Branch Block by ECG Finding Indeterminate Axis Indeterminate QRS Axis QRS Axis Indeterminate An electrocardiographic finding in which the frontal plane QRS axis cannot be calculated. QRS Axis Indeterminate Inferior MI Inferior Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads III, aVF and often II, which is suggestive of myocardial infarction of the inferior wall of the left ventricle. Inferior Myocardial Infarction by ECG Finding Intraatrial Conduction Delay An electrocardiographic finding of a delay in impulse propagation through the atria. This is characterized by broad P waves which are often biphasic in V1. Intra-Atrial Conduction Delay by ECG Finding Intraventricular Conduction Defect Intraventricular conduction delay An electrocardiographic finding of a widened QRS duration. Nonspecific Intraventricular Conduction Delay by ECG Finding Isorhythmic dissociation An electrocardiographic finding of a type of atrioventricular dissociation characterized by the atria (P waves) and ventricles (QRS complexes) beating at similar rates, although independently. Isorhythmic Atrioventricular Dissociation J point elevation An electrocardiographic finding of a significant elevation above the baseline of the J point. J Point Elevation Junctional bradycardia An electrocardiographic finding of a junctional rhythm with a heart rate which is abnormally low. Junctional Bradycardia by ECG Finding Junctional Escape Beat Junctional Escape Complex An electrocardiographic finding of an escape beat following a pause which originates in the AV junction. This is manifest as a QRS complex of supraventricular origin not preceded by a P wave; there may be one or more occurrences during an electrocardiographic recording. Junctional Escape Complexes by ECG Finding An electrocardiographic finding of a junctional rhythm that arises as a physiologic response to extreme slowing or arrest of sinus node activity. In this setting, a faster junctional rhythm may be a normal response to a very slow or absent sinus rate. Junctional Escape Rhythm by ECG Finding Junctional Extra Beat Junctional Premature Complexes An electrocardiographic finding of an ectopic impulse originating in the AV junction presenting as a QRS complex of supraventricular origin which is not preceded by a P wave; there may be one or more occurrences during an electrocardiographic recording. Junctional Premature Complex by ECG Finding Junctional rhythm An electrocardiographic finding of a rhythm which originates in the AV junction and results in a normal heart rate. It is characterized by retrograde P waves which may be obscured by or may follow the QRS complexes. The QRS complexes may be narrow or may demonstrate aberration. Junctional Rhythm by ECG Finding Junctional tachycardia An electrocardiographic finding of a junctional rhythm with a heart rate which is abnormally elevated. Junctional Tachycardia by ECG Finding Late R Wave Transition An electrocardiographic finding where the amplitude of the R wave does not become greater than the amplitude of the S wave until an unusually late point in the precordial leads, usually in leads V4 to V6. Late R Wave Transition by ECG Finding Lateral MI Lateral Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V5, V6, I and aVL, which is suggestive of myocardial infarction of the lateral wall of the left ventricle. Lateral Myocardial Infarction by ECG Finding Left anterior fascicular block Left Anterior Hemiblock An electrocardiographic finding of a slightly widened QRS duration with leftward frontal plane QRS axis and typically small Q waves. Left Anterior Fascicular Block by ECG Finding Left Atrial Enlargement P-mitrale An electrocardiographic finding suggesting underlying hypertrophy or dilatation of the left atrium. Electrocardiographic criteria used for the diagnosis of left atrial abnormality may include a bifid p wave, a biphasic p wave and/or a p wave duration of greater than 0.12 seconds. (NCI) P-mitrale by ECG Finding Complete LBBB Left bundle branch block Left bundle-branch block An electrocardiographic finding of a wide QRS complex with evidence of delayed conduction to the left ventricle, manifest as a widened initial portion of the QRS complex. Left Bundle Branch Block by ECG Finding Left posterior fascicular block Left Posterior Hemiblock An electrocardiographic finding of an S1Q3 pattern and QRS axis greater than or equal to 120 degrees. It is usually seen in association with other abnormalities (e.g. RBBB or RVH). Left Posterior Fascicular Block by ECG Finding Left Ventricular Conduction Delay An electrocardiographic finding in which there is evidence that electrical transmission through the left ventricle is impaired. Left Ventricular Conduction Delay by ECG Finding Left Ventricular Hypertrophy With Strain An electrocardiographic finding suggestive of a hypertrophied left ventricle, characterized by large QRS amplitudes, ST depression and T wave inversion. Left Ventricular Hypertrophy with Strain by ECG Finding Left Ventricular Hypertrophy An electrocardiographic finding suggestive of a hypertrophied left ventricle, characterized by large QRS amplitudes and secondary findings of left atrial enlargement, left axis deviation, or typical pattern of ST depression and T wave inversion. Left Ventricular Hypertrophy by ECG Finding An electrocardiographic recording in which one or more of the limb electrodes are disconnected resulting in missing waveforms (often flat lines) of the respective leads. Disconnected Limb Electrodes by ECG Finding Limb Lead Reversal An electrocardiographic recording in which two or more of the limb electrodes are switched resulting in improper representation of the affected leads. Interchanged Limb Electrodes by ECG Finding Low Amplitude QRS Complex An electrocardiographic recording showing smaller than usual QRS complexes in one or more leads. This may represent a technical issue with the ECG acquisition or characteristics of the individual. Low Amplitude QRS Complex by ECG Finding Low QRS voltage An electrocardiographic finding of a QRS amplitude less than or equal to 0.5 mV in the limb leads or QRS amplitude less than or equal to 1 mV in the precordial leads. Low QRS Voltage by ECG Finding An electrocardiographic finding of small QRS amplitudes (less than 500 microvolts) in all limb leads. Low Voltage in Limb Leads Only by ECG Finding An electrocardiographic finding of sinus bradycardia with a heart rate below a threshold of clinical concern. Note that different thresholds (for rate and/or duration) may apply to different patient populations. Marked Sinus Bradycardia by ECG Finding Multifocal atrial tachycardia An electrocardiographic finding of a supraventricular arrhythmia characterized by 3 or more distinct P wave morphologies with an isoelectric baseline, variable PR intervals and no predominant atrial rhythm. Multifocal Atrial Tachycardia by ECG Finding An electrocardiographic recording with intermittent mid to high frequency artifact in one or more leads due to muscular tremor or movement rather than cardiac activity. Muscle Tremor Artifact Myocardial Infarction An electrocardiographic finding of pathologic Q waves, which is suggestive of myocardial infarction of one or more regions of the heart. No specification is provided for localization. Myocardial Infarction by ECG Finding New Anterior MI New Anterior Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V3 and V4, which is suggestive of myocardial infarction of the anterior wall of the left ventricle and which is new compared to prior ECGs. New Anterior Myocardial Infarction by ECG Finding New Anterolateral Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V3 through V6, which is suggestive of myocardial infarction of the anterolateral wall of the left ventricle and which is new compared to prior ECGs. New Anterolateral Myocardial Infarction by ECG Finding New Anteroseptal Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V1 through V4, which is suggestive of myocardial infarction of the anteroseptal wall of the left ventricle and which is new compared to prior ECGs. New Anteroseptal Myocardial Infarction by ECG Finding New Extensive Anterior Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V1 to V6, I and aVL, which is suggestive of myocardial infarction involving the anterior and anterolateral walls of the left ventricle and which is new compared to prior ECGs. New Extensive Anterior Myocardial Infarction by ECG Finding New High Lateral Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads I and aVL, which is suggestive of myocardial infarction of the high lateral wall of the left ventricle and which is new compared to prior ECGs. New High Lateral Myocardial Infarction by ECG Finding New Inferior Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads III, aVF and often II, which is suggestive of myocardial infarction of the inferior wall of the left ventricle and which is new compared to prior ECGs. New Inferior Myocardial Infarction by ECG Finding New Lateral Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V5, V6, I and aVL, which is suggestive of myocardial infarction of the lateral wall of the left ventricle and which is new compared to prior ECGs. New Lateral Myocardial Infarction by ECG Finding New Myocardial Infarction An electrocardiographic finding of pathologic Q waves, which is suggestive of myocardial infarction of one or more regions of the heart and which is new compared to prior ECGs. No specification is provided for localization. New Myocardial Infarction by ECG Finding An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, and upright T wave, which is suggestive of myocardial infarction of the posterior wall of the left ventricle, and which is new compared to prior ECGs. Evidence of inferior or lateral myocardial infarction is usually also present. New Posterior Wall Myocardial Infarction by ECG Finding New Septal Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V1, V2 and often V3, which is suggestive of myocardial infarction of the intraventricular septum and which is new compared to prior ECGs. New Septal Myocardial Infarction by ECG Finding An electrocardiographic recording that displays flat lines (no waveforms are visible) in all leads present. ECG Waveforms Not Present Non Q Wave Myocardial Infarction An electrocardiographic finding of ST and T wave abnormalities in the absence of pathologic Q waves, which is suggestive of myocardial infarction in one or more regions of the heart. Non Q Wave Myocardial Infarction by ECG Finding An electrocardiographic finding of Q waves which are insufficient for the diagnosis of myocardial infarction. In such cases a myocardial infarction may be suspected, even though ECG criteria are not met. Non-Diagnostic Q Waves by ECG Finding Non-specific ST-T changes An electrocardiographic finding of changes in the ST segment and T wave that do not meet criteria for ischemia or infarction. (NCI) Non-Specific ST-T Changes by ECG Finding An electrocardiographic finding of idioventricular rhythm with a rate greater than 50 beats per minute that terminates in less than 30 seconds. Non-Sustained Accelerated Idioventricular Rhythm by ECG Finding Non-Sustained Atrial Tachycardia An electrocardiographic finding of an atrial tachycardia which terminates in less than 30 seconds. Non-Sustained Atrial Tachycardia by ECG Finding Non-sustained ventricular tachycardia Ventricular tachycardia, unsustained An electrocardiographic finding of ventricular tachycardia less than 30 seconds in duration. (NCI) Non-Sustained Ventricular Tachycardia by ECG Finding An electrocardiographic finding of a P wave that does not conduct to the ventricle or result in ventricular activation. Nonconducted P Wave Physiology Not Defined by ECG Finding An electrocardiographic finding of a supraventricular tachycardia with duration shorter than 30 seconds (though other duration thresholds may be applied). Nonsustained Supraventricular Tachycardia by ECG Finding Normal Sinus Rhythm An electrocardiographic finding of an atrial rhythm which originates from the sinoatrial node that is considered normal. There are no extra beats or conduction abnormalities. Normal Sinus Rhythm Northwest Axis Right superior axis An electrocardiographic finding of a frontal plane QRS axis from -90 to +180 degrees. Extreme Right Axis Deviation Notched T Waves An electrocardiographic finding of an irregular, u or v shaped deflection within the contour of the T wave. T Wave Notched by ECG Finding Old Or Age Indeterminate Anterior Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V3 and V4, which is suggestive of myocardial infarction of the anterior wall of the left ventricle, without evidence of current or ongoing acute infarction. Old or Age Indeterminate Anterior Myocardial Infarction by ECG Finding Old Or Age Indeterminate Anterolateral Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V3 through V6, which is suggestive of myocardial infarction of the anterolateral wall of the left ventricle, without evidence of current or ongoing acute infarction. Old or Age Indeterminate Anterolateral Myocardial Infarction by ECG Finding Old Or Age Indeterminate Anteroseptal Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V1 through V4, which is suggestive of myocardial infarction of the anteroseptal wall of the left ventricle, without evidence of current or ongoing acute infarction. Old or Age Indeterminate Anteroseptal Myocardial Infarction by ECG Finding Old Or Age Indeterminate Extensive Anterior Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V1 to V6, I and aVL, which is suggestive of myocardial infarction involving the anterior and anterolateral walls of the left ventricle, without evidence of current or ongoing acute infarction. Old or Age Indeterminate Extensive Anterior Myocardial Infarction by ECG Finding Old Or Age Indeterminate High Lateral Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads I and aVL, which is suggestive of myocardial infarction of the high lateral wall of the left ventricle, without evidence of current or ongoing acute infarction. Old or Age Indeterminate High Lateral Myocardial Infarction by ECG Finding Old Or Age Indeterminate Inferior Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads III, aVF and often II, which is suggestive of myocardial infarction of the inferior wall of the left ventricle, without evidence of current or ongoing acute infarction. Old or Age Indeterminate Inferior Myocardial Infarction by ECG Finding Old Or Age Indeterminate Lateral Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V5, V6, I and aVL, which is suggestive of myocardial infarction of the lateral wall of the left ventricle, without evidence of current or ongoing acute infarction. Old or Age Indeterminate Lateral Myocardial Infarction by ECG Finding Old Or Age Indeterminate Posterior Wall Myocardial Infarction An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, and upright T wave, which is suggestive of myocardial infarction of the posterior wall of the left ventricle, without evidence of current or ongoing acute infarction. Evidence of inferior or lateral myocardial infarction is usually also present. Old or Age Indeterminate Posterior Myocardial Infarction by ECG Finding Old Or Age Indeterminate Septal Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves in leads V1, V2 and often V3, which is suggestive of myocardial infarction of the intraventricular septum, without evidence of current or ongoing acute infarction. Old or Age Indeterminate Septal Myocardial Infarction by ECG Finding Old Or Age Indeterminate Wall Myocardial Infarction An electrocardiographic finding of pathologic Q waves, which is suggestive of myocardial infarction of one or more regions of the heart, without evidence of current or ongoing acute infarction. No specification is provided for localization. Old Myocardial Infarction by ECG Finding An electrocardiographic finding, in the presence of an old or age indeterminate inferior wall myocardial infarction, of Q waves greater than or equal to 40 ms in duration in the right ventricular leads V4R through V6R. Old or Age Indeterminate Right Ventricular Myocardial Infarction by ECG Finding An electrocardiographic recording in which one or more electrodes are incorrectly placed but further details are not provided. Other Incorrect Electrode Placement P Wave Abnormality An electrocardiographic finding for the P wave that is atypical either for the shape, duration, amplitude, axis or polarity. Abnormality of the P wave signifies aberrant propagation of the electrical impulse through the atria. (NCI) P Wave Abnormality by ECG Finding P Wave Notched An electrocardiographic finding of P waves with two peaks longer in duration than normal and amplitude greater than normal. P Wave Notched by ECG Finding AV dual-paced complex(es) or rhythm Paced Atrial And Ventricular Rhythm An electrocardiographic finding in which both the atrial and ventricular rhythm are controlled by an electrical impulse from an artificial cardiac pacemaker. Paced Atrial And Ventricular Rhythm Atrial-paced complex(es) or rhythm Paced Atrial Rhythm An electrocardiographic finding in which the atrial rhythm is controlled by an electrical impulse from an artificial cardiac pacemaker. Paced Atrial Rhythm Atrial and/or Ventricular Paced Rhythm Paced Rhythm An electrocardiographic finding in which the cardiac rhythm is controlled by an electrical impulse from an artificial cardiac pacemaker. Paced Rhythm Paced Ventricular Rhythm Ventricular-paced complex(es) or rhythm An electrocardiographic finding in which the ventricular rhythm is controlled by an electrical impulse from an artificial cardiac pacemaker. Paced Ventricular Rhythm An electrocardiographic finding of atrial fibrillation which occurs intermittently during the recording. Other rhythms which may be present are sinus rhythm, junctional rhythm, or an atrial paced rhythm. Paroxysmal Atrial Fibrillation by ECG Finding An electrocardiographic finding of atrial flutter which occurs intermittently during the recording. Other rhythms which may be present are sinus rhythm, junctional rhythm, or an atrial paced rhythm. Paroxysmal Atrial Flutter Paroxysmal AV block An electrocardiographic finding of the sudden onset of transient AV block. Paroxysmal Atrioventricular Block by ECG Finding Paroxysmal Ventricular Tachycardia An episodic form of ventricular tachycardia, with abrupt onset and termination. (NCI) Paroxysmal Ventricular Tachycardia by ECG Finding An electrocardiographic finding of an RR interval with duration greater than 3.0 seconds, regardless of the underlying rhythm. Pause Greater Than Three Seconds by ECG Finding An electrocardiographic finding of an RR interval which exceeds a predefined duration threshold, regardless of the underlying rhythm. Pause by ECG Finding An electrocardiographic finding of atrial fibrillation which is present during the entire recording. Persistent Atrial Fibrillation by ECG Finding An electrocardiographic finding of atrial flutter which is present during the entire recording. Persistent Atrial Flutter An electrocardiographic recording that does not show proper quality for reasons that are not otherwise described. Poor Quality ECG Poor R Wave Progression An electrocardiographic finding of a lack of progression of R wave height across precordial leads. Poor R Wave Progression by ECG Finding Posterior MI Posterior Wall Myocardial Infarction An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, and upright T wave, which is suggestive of myocardial infarction of the posterior wall of the left ventricle. Evidence of inferior or lateral myocardial infarction is usually also present. Posterior Myocardial Infarction by ECG Finding PR Depression An electrocardiographic finding of PR segment depression below the iso-electric line in multiple precordial and/or limb leads. PR Segment Depression by ECG Finding Pre-excitation Ventricular preexcitation An electrocardiographic finding characterized by a premature activation of the whole or some part of the ventricle. Pre-Excitation Syndrome An electrocardiographic recording in which the electrode for lead V1 is disconnected resulting in missing waveforms (flat line) for lead V1. Disconnected Precordial Electrode V1 by ECG Finding An electrocardiographic recording in which the electrode for lead V2 is disconnected resulting in missing waveforms (flat line) for lead V2. Disconnected Precordial Electrode V2 by ECG Finding An electrocardiographic recording in which the electrode for lead V3 is disconnected resulting in missing waveforms (flat line) for lead V3. Disconnected Precordial Electrode V3 by ECG Finding An electrocardiographic recording in which the electrode for lead V4 is disconnected resulting in missing waveforms (flat line) for lead V4. Disconnected Precordial Electrode V4 by ECG Finding An electrocardiographic recording in which the electrode for lead V5 is disconnected resulting in missing waveforms (flat line) for lead V5. Disconnected Precordial Electrode V5 by ECG Finding An electrocardiographic recording in which the electrode for lead V6 is disconnected resulting in missing waveforms (flat line) for lead V6. Disconnected Precordial Electrode V6 by ECG Finding An electrocardiographic recording in which one or more precordial electrodes are placed incorrectly with respect to the standard chest electrode positions resulting in improper representation of the affected leads. Incorrectly Positioned Precordial Electrodes by ECG Finding Precordial Lead Reversal An electrocardiographic recording in which two or more of the precordial electrodes are switched resulting in improper representation of the affected leads. Interchanged Precordial Electrodes by ECG Finding Atrial premature complexes, nonconducted Non-conducted SVE Premature Atrial Complex Blocked Premature Atrial Complexes Non-conducted An electrocardiographic finding of a premature atrial complexes that are is not conducted to the ventricles, and that are is not followed by a QRS complex; there may be one or more occurrences during an electrocardiographic recording. Blocked Atrial Premature Complex by ECG Finding Multifocal Supraventricular Extra Beats Multifocal SVE Premature Atrial Complex Multifocal Premature Atrial Complexes Multiform An electrocardiographic finding of premature atrial complexes which have 2 or more distinct morphologies, suggesting origin at more than one atrial site. Multifocal Atrial Premature Complex by ECG Finding Premature Atrial Complex Unifocal An electrocardiographic finding of premature atrial complexes which have a single distinct morphology, suggesting origin at one atrial site. Unifocal Atrial Premature Complex by ECG Finding APC Atrial premature complex(es) PAC Premature atrial complex Supraventricular Extra Beat Supraventricular Premature Beat SVE An electrocardiographic finding of an ectopic impulse originating in the atria and not specifically in the sinus node. The P wave morphology of these complexes is often different from a sinus P wave and the RR intervals preceding these complexes is also shorter than those of the regular beats; there may be one or more occurrences during an electrocardiographic recording. Atrial Premature Complex by ECG Finding Interpolated VE Interpolated Ventricular Extra Beat Interpolated VES Interpolated VPC Premature Ventricular Complexes Interpolated An electrocardiographic finding of a premature ventricular complex which occurs between two normal QRS complexes which have normal timing; there may be one or more occurrences during an electrocardiographic recording. Interpolated Premature Ventricular Complex by ECG Finding Premature Ventricular Complexes PVC VE Ventricular Extra Beat Ventricular Premature Complexes VES VPC An electrocardiographic finding of an ectopic impulse originating in the ventricles. The QRS morphology of these complexes is different from those of supraventricular origin. The QRS duration is often longer and the RR interval preceding the complexes is usually shorter than that of supraventricular beats; there may be one or more occurrences during an electrocardiographic recording. Ventricular Premature Complex by ECG Finding Multifocal Ventricular Extra Beats Multifocal VES Multifocal VPCS Premature Ventricular Complex Multifocal An electrocardiographic finding of premature ventricular complexes which have two or more distinct morphologies, suggesting origin at more than one ventricular site. Multifocal Ventricular Premature Complex by ECG Finding Premature Ventricular Complex Unifocal Unifocal Ventricular Extra Beats Unifocal VES Unifocal VPCS An electrocardiographic finding of premature ventricular complexes which have a single distinct morphology, suggesting origin at one ventricular site. Unifocal Ventricular Premature Complex by ECG Finding Prolonged QT Prolonged QT interval An electrocardiographic finding in which the QT interval not corrected for heart rate is prolonged. Prolonged QT Interval by ECG Finding An electrocardiographic finding of a prolonged ST segment, resulting in a long QT interval, without lengthening of the T wave duration. Prolonged ST Segment by ECG Finding Left-axis deviation Q Axis, Left axis deviation QRS axis, left axis deviation An electrocardiographic finding of a frontal plane QRS axis from -30 to -90 degrees. Q Axis Left Axis Deviation Q Axis, Right axis deviation QRS axis, right axis deviation Right-axis deviation An electrocardiographic finding of a frontal plane QRS axis from +90 to +180 degrees. Q Axis Right Axis Deviation QRS Complex Abnormality An electrocardiographic finding of a non-specific abnormality of the QRS complex, which is atypical in shape, duration, amplitude, axis or polarity. QRS Complex Abnormality by ECG Finding QTc Prolongation An electrocardiographic finding in which the QTc interval corrected for heart rate is prolonged. Corrected Prolonged QT Interval by ECG Finding PROLONGED QTcB An electrocardiographic finding in which the QT interval corrected for heart rate using Bazett's formula is prolonged. QTcB Prolongation PROLONGED QTcF An electrocardiographic finding in which the QT interval corrected for heart rate using Fridericia's formula is prolonged. QTcF Prolongation Unknown Quality Problem An electrocardiographic artifact or recording error with unknown origin or which is not described otherwise. Quality Problem Not Otherwise Specified by ECG Finding R on T phenomenon An electrocardiographic finding in which the R wave of a premature ventricular complex occurs on top of the T wave of the preceding beat. R On T Phenomenon by ECG Finding R Wave Notched An electrocardiographic finding of an R wave variant in which there is a small deflection of the R wave, with changing polarity, within the QRS complex. (NCI) R Wave Notched by ECG Finding Repolarization Abnormality Secondary To Ventricular Hypertrophy ST-T change due to ventricular hypertrophy An electrocardiographic finding of ST depression and T wave inversion in the presence of increased QRS amplitude which are thought to be due to left ventricular hypertrophy. Repolarization Abnormality Secondary To Ventricular Hypertrophy Repolarization Abnormality An electrocardiographic finding of an abnormality of T wave duration or morphology or of early repolarization. Ventricular Repolarization Abnormality P-pulmonale Right Atrial Enlargement An electrocardiographic finding suggesting underlying hypertrophy or dilatation of the right atrium. Electrocardiographic criteria used for the diagnosis of right atrial abnormality may include a peaked p wave greater than 2.5 millimeters in amplitude in the inferior leads. (NCI) P-pulmonale by ECG Finding Complete RBBB Right bundle branch block Right bundle-branch block An electrocardiographic finding of a wide QRS complex with evidence of delayed conduction to the right ventricle, manifest by a widened initial portion of the QRS. Right Bundle Branch Block by ECG Finding Right Ventricular Conduction Delay Right Ventricular Delay An electrocardiographic finding in which there is evidence that electrical transmission through the right ventricle is impaired. Right Ventricular Conduction Delay by ECG Finding Right ventricular Hypertrophy An electrocardiographic finding suggestive of a hypertrophied right ventricle, characterized by large R wave amplitudes in the right precordial leads and secondary findings of right atrial enlargement, right axis deviation, and typical pattern of ST depression and T wave inversion in the right precordial leads. Right Ventricular Hypertrophy by ECG Finding RSR' An electrocardiographic finding in which there are two R waves, which are two deflections above the baseline resulting from a single ventricular depolarization. The first upward deflection in the complex is the R wave. The S is the first downward deflection. A second upward deflection is called the R-prime wave. RSR' by ECG Finding Septal myocardial infarction An electrocardiographic finding suggesting an infarction in the anatomic location of the cardiac septum. (NCI) Septal Myocardial Infarction by ECG Finding Short PR interval An electrocardiographic finding of an abnormally short PR interval. Short PR Interval by ECG Finding Short QTc Interval An electrocardiographic finding of a QT interval corrected for heart rate that is shorter than the lower limit of normal. Short QTc Interval An electrocardiographic finding in which the QT interval corrected for heart rate using Bazett's formula is shortened. QTcB Shortened An electrocardiographic finding in which the QT interval corrected for heart rate using Fridericia's formula is shortened. QTcF Shortened An electrocardiographic finding of a short or absent ST segment, resulting in a short QT interval, without changes in T wave morphology. Short ST Segment by ECG Finding SA Block Sinoatrial Block Sinoatrial exit block An electrocardiographic finding in which impaired conduction or automaticity within the sinus node results in the failure of impulse transmission from the sinoatrial node. This is manifest as dropped P waves during sinus rhythm. Exit Block by ECG Finding Sinus arrest/pause Sinus pause or arrest An electrocardiographic finding in which a failure of impulse formation or conduction in the sinus node produces prolongation of the P-P interval or dropped P waves. Sinus Arrest by ECG Finding Respiratory Sinus Arrhythmia Sinus arrhythmia An electrocardiographic finding in which the sinus rate fluctuates. Sinus Arrhythmia by ECG Finding Sinus bradycardia An electrocardiographic finding of abnormally slow heart rate with its origin in the sinus node. Sinus Bradycardia by ECG Finding Sinus Rhythm An electrocardiographic finding of an atrial rhythm which originates from the sinoatrial node that is considered normal for the population. Sinus Rhythm An electrocardiographic finding in which slowing of the sinus rate and AV block occur simultaneously. Sinus Slowing With AV Block by ECG Finding Sinus tachycardia An electrocardiographic finding of abnormally rapid heart rate with its origin in the sinus node. Sinus Tachycardia by ECG Finding ST depression An electrocardiographic finding of ST segment depression below the baseline, often described as up sloping, down sloping or horizontal. (NCI) ST Segment Depression by ECG Finding ST elevation pericarditis An electrocardiographic finding of ST elevation which is concave upwards, and which is often accompanied by PR segment depression. ST Elevation Pericarditis by ECG Finding ST elevation An electrocardiographic finding of ST segment elevation above the baseline. (NCI) ST Segment Elevation by ECG Finding An electrocardiographic finding of a supraventricular QRS complex followed by a premature supraventricular complex for 3 or more consecutive cycles; a regularly irregular rhythm of normal and abnormal QRS complexes in a 1-1 ratio. Supraventricular Bigeminy by ECG Finding An electrocardiographic finding in which two premature atrial complexes occur sequentially. Supraventricular Couplet by ECG Finding Supraventricular Escape Complex Supraventricular Escape Complexes An electrocardiographic finding of a compensatory supraventricular complex that occurs following a prolonged RR interval. Supraventricular Escape Beat by ECG Finding Supraventricular Premature Complexes, Origin Unknown An electrocardiographic finding of an ectopic impulse originating from the atria or AV junction for which the site of origin cannot be determined from the surface electrocardiographic recording; there may be one or more occurrences during an electrocardiographic recording. Supraventricular Premature Complex With Unknown Origin by ECG Finding An electrocardiographic finding of three or more consecutive beats of supraventricular origin without reference to rate. Supraventricular Run by ECG Finding Supraventricular tachycardia An electrocardiographic finding of a tachycardia which does not originate in the ventricles or His Purkinje system. There is an abnormally high heart rate and QRS complexes are typically narrow, but aberration or preexcitation may be present. Supraventricular Tachycardia by ECG Finding An electrocardiographic finding of two supraventricular QRS complexes followed by a premature supraventricular complex for 3 or more consecutive cycles; a regularly irregular rhythm of normal and abnormal QRS complexes in a 2-1 ratio. Supraventricular Trigeminy by ECG Finding An electrocardiographic recording in which an interchange of one or more limb lead electrodes is suspected, but for which an interpretation is performed as though the lead placement is correct. Suspicion of Limb Electrodes Reversal But Interpretation Assumes No Reversal by ECG Finding An electrocardiographic recording in which an interchange of one or more limb lead electrodes is suspected, and for which an interpretation is performed as though the leads have in fact been interchanged. Suspicion of Limb Electrodes Reversal But Interpretation Assumes Reversal by ECG Finding An electrocardiographic finding of idioventricular rhythm with a rate greater than 50 beats per minute that lasts 30 seconds or longer. Sustained Accelerated Idioventricular Rhythm by ECG Finding An electrocardiographic finding of an atrial tachycardia that lasts 30 seconds or longer. Sustained Atrial Tachycardia by ECG Finding An electrocardiographic finding of a supraventricular tachycardia with duration greater than 30 seconds (though other duration thresholds may be applied). Sustained Supraventricular Tachycardia by ECG Finding Sustained ventricular tachycardia An electrocardiographic finding of ventricular tachycardia with longer than normal duration. Sustained Ventricular Tachycardia by ECG Finding T Wave Alternans An electrocardiographic finding in which there are variations in the shape, amplitude, or direction of the T wave from one beat to the next. T Wave Alternans by ECG Finding T Wave Inversion An electrocardiographic finding of an inversion of the T wave from the expected axis. (NCI) T Wave Inversion by ECG Finding T wave peaked An electrocardiographic finding in which the T wave appears increased in amplitude and cresting at a point. (NCI) T Wave Peaked by ECG Finding T waves biphasic An electrocardiographic finding of a T wave with both positive and negative components. T Waves Biphasic by ECG Finding T waves flat An electrocardiographic finding in which the T wave appears decreased in amplitude. (NCI) T Waves Flat by ECG Finding Tachycardia An electrocardiographic finding of abnormally rapid heart rate. Tachycardia by ECG Finding Torsades de pointes Ventricular tachycardia, torsades de pointes An electrocardiographic finding of an atypical rapid polymorphic ventricular tachycardia with a characteristic rotation of the QRS complex around the isoelectric baseline, occurring in the setting of a prolonged QT interval. In addition, the QRS complex displays a periodic waxing and waning of amplitude on the electrogram. Torsades De Pointes by ECG Finding Abnormal U Wave An electrocardiographic finding of U waves which have increased amplitude, are inverted, or merged with the preceding T wave. U Wave Abnormality by ECG Finding An electrocardiographic finding of a cardiac rhythm whose mechanism cannot be determined from the ECG. Undetermined Rhythm by ECG Finding An electrocardiographic finding of a rhythm which does not originate in the ventricles or His Purkinje system, but whose specific electrophysiologic mechanism cannot be determined from the ECG. The QRS complexes are typically narrow, but aberration or preexcitation may be present. Undetermined Supraventricular Rhythm by ECG Finding Bigeminy An electrocardiographic finding of a normal QRS complex followed by a premature ventricular complex for 3 or more consecutive cycles; a regularly irregular rhythm of normal and abnormal QRS complexes in a 1-1 ratio. Ventricular Bigeminy by ECG Finding Ventricular Couplets Ventricular Pair An electrocardiographic finding in which two premature ventricular complexes occur sequentially; there may be one or more occurrences during an electrocardiographic recording. Ventricular Couplet by ECG Finding Ventricular Escape Beats Ventricular Escape Complex Ventricular Escape Complexes An electrocardiographic finding of a compensatory ventricular complex that occurs following a prolonged RR interval; there may be one or more occurrences during an electrocardiographic recording. Ventricular Escape Beat by ECG Finding Ventricular fibrillation An electrocardiographic finding of a rapid grossly irregular ventricular rhythm with marked variability in QRS cycle length, morphology, and amplitude. Ventricular Fibrillation by ECG Finding Ventricular flutter A ventricular tachyarrhythmia characterized by a high ventricular rate with a regular rhythm. The electrocardiogram shows large oscillating sine wave-like complexes occurring as a result of QRS complexes and T waves being merged. The P wave is not visible. (NCI) Ventricular Flutter by ECG Finding Parasystole Ventricular Parasystole An electrocardiographic finding of normal sinus rhythm coexisting with a regular ectopic ventricular rhythm. Ventricular Parasystole by ECG Finding An electrocardiographic finding of three normal QRS complexes followed by a premature ventricular complex for three or more consecutive cycles; a regularly irregular rhythm of normal and abnormal QRS complexes in a 3-1 ratio. Ventricular Quadrigeminy by ECG Finding An electrocardiographic finding of three or more consecutive beats of ventricular origin without reference to rate. Ventricular Run by ECG Finding Ventricular tachycardia An electrocardiographic finding of three or more consecutive complexes of ventricular organ with a rate greater than a certain threshold. The QRS complexes are wide and have an abnormal morphology. Ventricular Tachycardia by ECG Finding Ventricular tachycardia, monomorphic An electrocardiographic finding of a ventricular tachycardia in which the QRS complexes have a uniform morphology. Monomorphic Ventricular Tachycardia by ECG Finding Ventricular tachycardia, polymorphic Ventricular tachycardia, polymorphous An electrocardiographic finding of a ventricular tachycardia in which the QRS complexes have a variable morphology and often rate. Polymorphic Ventricular Tachycardia by ECG Finding Trigeminy An electrocardiographic finding of two normal QRS complexes followed by a premature ventricular complex for 3 or more consecutive cycles; a regularly irregular rhythm of normal and abnormal QRS complexes in a 2-1 ratio. Ventricular Trigeminy by ECG Finding An electrocardiographic finding of large QRS amplitudes which may indicate left ventricular hypertrophy, but in the absence of any of the secondary findings which are typical of this diagnosis (left atrial enlargement, left axis deviation, or typical pattern of ST depression and T wave inversion). Voltage Criteria Suggesting Left Ventricular Hypertrophy, Without Secondary ECG Findings Wandering atrial pacemaker An electrocardiographic finding of a supraventricular arrhythmia characterized by 3 or more distinct P wave morphologies with an isoelectric baseline, variable PR intervals and no predominant atrial rhythm. The ventricular rate is typically below 100 beats per minute. Wandering Atrial Pacemaker by ECG Finding Wide QRS tachycardia Wide-QRS tachycardia An electrocardiographic finding of three or more consecutive wide QRS complexes of uncertain origin with a rate greater than a certain threshold. Wide QRS Tachycardia by ECG Finding Wolff-Parkinson-White syndrome WPW An electrocardiographic finding of ventricular pre-excitation. The syndrome is characterized by a short PR interval and a long QRS interval with a delta wave. Wolff-Parkinson-White Syndrome HESTRESC Holter ECG Results CDISC SDTM Holter ECG Results Terminology Terminology relevant to the test codes that describe Holter ECG interpretative findings. Atrioventricular Conduction An electrocardiographic assessment of cardiac atrioventricular conduction. Atrioventricular Conduction ECG Assessment Axis and Voltage An electrocardiographic assessment of mean cardiac electrical vector and the ECG voltage. Axis and Voltage ECG Assessment Chamber Hypertrophy or Enlargement An electrocardiographic assessment of chamber hypertrophy or enlargement. Chamber Hypertrophy or Enlargement ECG Assessment Comparison to a Prior ECG A comparative interpretation of an ECG relative to a previous (comparator) ECG. The definition of the comparator ECG may be specified elsewhere. Common comparator result values include improved, no change, deteriorated. Comparison to a Prior ECG Interpretation An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. Interpretation Intraventricular-Intraatrial Conduction An electrocardiographic assessment of intraventricular and intra-atrial conduction. Intraventricular and Intraatrial Conduction ECG Assessment Myocardial Infarction An electrocardiographic assessment of findings suggestive of myocardial infarction. Myocardial Infarction ECG Assessment Pacemaker An electrocardiographic assessment of presence of artificial electronic pacing. Pacemaker ECG Assessment Rhythm Not Otherwise Specified An electrocardiographic assessment of cardiac rhythm not otherwise specified. Rhythm Not Otherwise Specified ECG Assessment Sinus Node Rhythms and Arrhythmias An electrocardiographic assessment of sinus node rhythms and arrhythmias. Sinus Node Rhythm and Arrhythmia ECG Assessment Supraventricular Arrhythmias An electrocardiographic assessment of supraventricular arrhythmias excluding tachycardias. Supraventricular Arrhythmia ECG Assessment Supraventricular Tachyarrhythmias An electrocardiographic assessment of supraventricular tachyarrhythmias. Supraventricular Tachyarrhythmia ECG Assessment ST Segment, T wave, and U wave An electrocardiographic assessment of the characteristics of the ST segment, T wave, and U wave. ST Segment, T wave, and U wave ECG Assessment Technical Quality A statement about an electrocardiographic recording describing technical issues or interference during the recording, processing, or transmission of the data. This does not represent an electrocardiographic diagnosis. ECG Technical Quality Ventricular Arrhythmias An electrocardiographic assessment of ventricular arrhythmias excluding tachycardias. Ventricular Arrhythmia ECG Assessment Ventricular Tachyarrhythmias An electrocardiographic assessment of ventricular tachyarrhythmias. Ventricular Tachyarrhythmia ECG Assessment HETESTCD Holter ECG Test Code CDISC SDTM Holter ECG Test Code Terminology Terminology relevant to the test names that describe Holter ECG interpretative findings. Atrioventricular Conduction An electrocardiographic assessment of cardiac atrioventricular conduction. Atrioventricular Conduction ECG Assessment Axis and Voltage An electrocardiographic assessment of mean cardiac electrical vector and the ECG voltage. Axis and Voltage ECG Assessment Chamber Hypertrophy or Enlargement An electrocardiographic assessment of chamber hypertrophy or enlargement. Chamber Hypertrophy or Enlargement ECG Assessment Comparison to a Prior ECG A comparative interpretation of an ECG relative to a previous (comparator) ECG. The definition of the comparator ECG may be specified elsewhere. Common comparator result values include improved, no change, deteriorated. Comparison to a Prior ECG Interpretation An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. Interpretation Intraventricular-Intraatrial Conduction An electrocardiographic assessment of intraventricular and intra-atrial conduction. Intraventricular and Intraatrial Conduction ECG Assessment Myocardial Infarction An electrocardiographic assessment of findings suggestive of myocardial infarction. Myocardial Infarction ECG Assessment Pacemaker An electrocardiographic assessment of presence of artificial electronic pacing. Pacemaker ECG Assessment Rhythm Not Otherwise Specified An electrocardiographic assessment of cardiac rhythm not otherwise specified. Rhythm Not Otherwise Specified ECG Assessment Sinus Node Rhythms and Arrhythmias An electrocardiographic assessment of sinus node rhythms and arrhythmias. Sinus Node Rhythm and Arrhythmia ECG Assessment ST Segment, T wave, and U wave An electrocardiographic assessment of the characteristics of the ST segment, T wave, and U wave. ST Segment, T wave, and U wave ECG Assessment Supraventricular Arrhythmias An electrocardiographic assessment of supraventricular arrhythmias excluding tachycardias. Supraventricular Arrhythmia ECG Assessment Supraventricular Tachyarrhythmias An electrocardiographic assessment of supraventricular tachyarrhythmias. Supraventricular Tachyarrhythmia ECG Assessment Technical Quality A statement about an electrocardiographic recording describing technical issues or interference during the recording, processing, or transmission of the data. This does not represent an electrocardiographic diagnosis. ECG Technical Quality Ventricular Arrhythmias An electrocardiographic assessment of ventricular arrhythmias excluding tachycardias. Ventricular Arrhythmia ECG Assessment Ventricular Tachyarrhythmias An electrocardiographic assessment of ventricular tachyarrhythmias. Ventricular Tachyarrhythmia ECG Assessment HETEST Holter ECG Test Name CDISC SDTM Holter ECG Test Name Terminology Hospital Anxiety and Depression Scale test code. HADS01-I Feel Tense or Wound Up Hospital Anxiety and Depression Scale - I feel tense or 'wound up.' HADS - I Feel Tense or Wound Up HADS01-Enjoy the Things I Used to Enjoy Hospital Anxiety and Depression Scale - I still enjoy the things I used to enjoy. HADS - I Still Enjoy the Things I Used to Enjoy HADS01-Something Awful About to Happen Hospital Anxiety and Depression Scale - I get a sort of frightened feeling as if something awful is about to happen. HADS - I Get a Frightened Feeling Something Awful is About to Happen HADS01-I Can Laugh and See Funny Side Hospital Anxiety and Depression Scale - I can laugh and see the funny side of things. HADS - I Can Laugh and See Funny Side of Things HADS01-Worrying Thoughts Go Through Mind Hospital Anxiety and Depression Scale - Worrying thoughts go through my mind. HADS - Worrying Thoughts Go Through My Mind HADS01-I Feel Cheerful Hospital Anxiety and Depression Scale - I feel cheerful. HADS - I Feel Cheerful HADS01-Sit at Ease and Feel Relaxed Hospital Anxiety and Depression Scale - I can sit at ease and feel relaxed. HADS - I Can Sit at Ease and Feel Relaxed HADS01-I Feel as if I am Slowed Down Hospital Anxiety and Depression Scale - I feel as if I am slowed down. HADS - I Feel as if I am Slowed Down HADS01-Butterflies in the Stomach Hospital Anxiety and Depression Scale - I get a sort of frightened feeling like 'butterflies' in the stomach. HADS - I Get Frightened Feeling Like Butterflies in the Stomach HADS01-Lost Interest in My Appearance Hospital Anxiety and Depression Scale - I have lost interest in my appearance. HADS - I Have Lost Interest in My Appearance HADS01-Feel Restless be on the Move Hospital Anxiety and Depression Scale - I feel restless as if I have to be on the move. HADS - I Feel Restless as if I Have to be on the Move HADS01-Look Forward with Enjoyment Hospital Anxiety and Depression Scale - I look forward with enjoyment to things. HADS - I Look Forward with Enjoyment to Things HADS01-I Get Sudden Feelings of Panic Hospital Anxiety and Depression Scale - I get sudden feelings of panic. HADS - I Get Sudden Feelings of Panic HADS01-Enjoy Good Book/Radio/Television Hospital Anxiety and Depression Scale - I can enjoy a good book or radio or television programme. HADS - I Can Enjoy a Good Book or Radio or Television Programme HADS01-Total Score Anxiety Hospital Anxiety and Depression Scale - Total score anxiety. HADS - Total Score Anxiety HADS01-Total Score Depression Hospital Anxiety and Depression Scale - Total score depression. HADS - Total Score Depression HADS01TC Hospital Anxiety and Depression Scale Questionnaire Test Code CDISC Questionnaire HADS Test Code Terminology Hospital Anxiety and Depression Scale test name. HADS01-Butterflies in the Stomach Hospital Anxiety and Depression Scale - I get a sort of frightened feeling like 'butterflies' in the stomach. HADS - I Get Frightened Feeling Like Butterflies in the Stomach HADS01-Enjoy Good Book/Radio/Television Hospital Anxiety and Depression Scale - I can enjoy a good book or radio or television programme. HADS - I Can Enjoy a Good Book or Radio or Television Programme HADS01-Enjoy the Things I Used to Enjoy Hospital Anxiety and Depression Scale - I still enjoy the things I used to enjoy. HADS - I Still Enjoy the Things I Used to Enjoy HADS01-Feel Restless be on the Move Hospital Anxiety and Depression Scale - I feel restless as if I have to be on the move. HADS - I Feel Restless as if I Have to be on the Move HADS01-I Can Laugh and See Funny Side Hospital Anxiety and Depression Scale - I can laugh and see the funny side of things. HADS - I Can Laugh and See Funny Side of Things HADS01-I Feel as if I am Slowed Down Hospital Anxiety and Depression Scale - I feel as if I am slowed down. HADS - I Feel as if I am Slowed Down HADS01-I Feel Cheerful Hospital Anxiety and Depression Scale - I feel cheerful. HADS - I Feel Cheerful HADS01-I Feel Tense or Wound Up Hospital Anxiety and Depression Scale - I feel tense or 'wound up.' HADS - I Feel Tense or Wound Up HADS01-I Get Sudden Feelings of Panic Hospital Anxiety and Depression Scale - I get sudden feelings of panic. HADS - I Get Sudden Feelings of Panic HADS01-Look Forward with Enjoyment Hospital Anxiety and Depression Scale - I look forward with enjoyment to things. HADS - I Look Forward with Enjoyment to Things HADS01-Lost Interest in My Appearance Hospital Anxiety and Depression Scale - I have lost interest in my appearance. HADS - I Have Lost Interest in My Appearance HADS01-Sit at Ease and Feel Relaxed Hospital Anxiety and Depression Scale - I can sit at ease and feel relaxed. HADS - I Can Sit at Ease and Feel Relaxed HADS01-Something Awful About to Happen Hospital Anxiety and Depression Scale - I get a sort of frightened feeling as if something awful is about to happen. HADS - I Get a Frightened Feeling Something Awful is About to Happen HADS01-Total Score Anxiety Hospital Anxiety and Depression Scale - Total score anxiety. HADS - Total Score Anxiety HADS01-Total Score Depression Hospital Anxiety and Depression Scale - Total score depression. HADS - Total Score Depression HADS01-Worrying Thoughts Go Through Mind Hospital Anxiety and Depression Scale - Worrying thoughts go through my mind. HADS - Worrying Thoughts Go Through My Mind HADS01TN Hospital Anxiety and Depression Scale Questionnaire Test Name CDISC Questionnaire HADS Test Name Terminology Huntington's Disease Cognitive Assessment Battery test code. HDCAB1-Paced Tapping Huntington's Disease Cognitive Assessment Battery - Paced Tapping key variable for composite score: 1/SD of the inter-tap interval for the self-paced taps. HD-CAB - Paced Tapping HDCAB1-Emotion Recognition Huntington's Disease Cognitive Assessment Battery - Emotion Recognition key variable for composite score: Number of correct responses to the negative expressions (anger, fear, sadness, disgust) out of 24 possible. HD-CAB - Emotion Recognition HDCAB1-One Touch Stockings of Cambridge Huntington's Disease Cognitive Assessment Battery - One Touch Stockings of Cambridge key variable for composite score: Mean time to correct response (sec) averaged across all 10 trials (reverse scored). HD-CAB - One Touch Stockings of Cambridge HDCAB1-Symbol Digit Modalities Test Huntington's Disease Cognitive Assessment Battery - Symbol Digit Modalities Test key variable for composite score: Number of correct responses in 90 seconds out of 110 possible responses. HD-CAB - Symbol Digit Modalities Test HDCAB1-Hopkins Verbal Learning Test Rev Huntington's Disease Cognitive Assessment Battery - Hopkins Verbal Learning Test - Revised key variable for composite score: Total number of words correctly recalled over Trials 1-4 out of 48 possible. HD-CAB - Hopkins Verbal Learning Test Revised HDCAB1-Trail Making Test-B Huntington's Disease Cognitive Assessment Battery - Trail Making Test-B key variable for composite score: Time to completion (sec) of TMT Part B with upper time limit of 240 seconds (reverse scored). HD-CAB - Trail Making Test-B HDCAB1-HD-CAB Total Score Huntington's Disease Cognitive Assessment Battery - HD-CAB total score. HD-CAB - HD-CAB Total Score HDCAB1TC Huntington's Disease Cognitive Assessment Battery Functional Test Test Code CDISC Functional Test HD-CAB Test Code Terminology Huntington's Disease Cognitive Assessment Battery test name. HDCAB1-Emotion Recognition Huntington's Disease Cognitive Assessment Battery - Emotion Recognition key variable for composite score: Number of correct responses to the negative expressions (anger, fear, sadness, disgust) out of 24 possible. HD-CAB - Emotion Recognition HDCAB1-HD-CAB Total Score Huntington's Disease Cognitive Assessment Battery - HD-CAB total score. HD-CAB - HD-CAB Total Score HDCAB1-Hopkins Verbal Learning Test Rev Huntington's Disease Cognitive Assessment Battery - Hopkins Verbal Learning Test - Revised key variable for composite score: Total number of words correctly recalled over Trials 1-4 out of 48 possible. HD-CAB - Hopkins Verbal Learning Test Revised HDCAB1-One Touch Stockings of Cambridge Huntington's Disease Cognitive Assessment Battery - One Touch Stockings of Cambridge key variable for composite score: Mean time to correct response (sec) averaged across all 10 trials (reverse scored). HD-CAB - One Touch Stockings of Cambridge HDCAB1-Paced Tapping Huntington's Disease Cognitive Assessment Battery - Paced Tapping key variable for composite score: 1/SD of the inter-tap interval for the self-paced taps. HD-CAB - Paced Tapping HDCAB1-Symbol Digit Modalities Test Huntington's Disease Cognitive Assessment Battery - Symbol Digit Modalities Test key variable for composite score: Number of correct responses in 90 seconds out of 110 possible responses. HD-CAB - Symbol Digit Modalities Test HDCAB1-Trail Making Test-B Huntington's Disease Cognitive Assessment Battery - Trail Making Test-B key variable for composite score: Time to completion (sec) of TMT Part B with upper time limit of 240 seconds (reverse scored). HD-CAB - Trail Making Test-B HDCAB1TN Huntington's Disease Cognitive Assessment Battery Functional Test Test Name CDISC Functional Test HD-CAB Test Name Terminology Hypoglycemic Confidence Scale test code. HCS01-When You Are Exercising Hypoglycemic Confidence Scale - How confident are you that you can stay safe from serious problems with hypoglycemia: When you are exercising? HCS - When You Are Exercising HCS01-When You Are Sleeping Hypoglycemic Confidence Scale - How confident are you that you can stay safe from serious problems with hypoglycemia: When you are sleeping? HCS - When You Are Sleeping HCS01-When You Are Driving Hypoglycemic Confidence Scale - How confident are you that you can stay safe from serious problems with hypoglycemia: When you are driving? HCS - When You Are Driving HCS01-When You Are in Social Situations Hypoglycemic Confidence Scale - How confident are you that you can stay safe from serious problems with hypoglycemia: When you are in social situations? HCS - When You Are in Social Situations HCS01-When You Are Alone Hypoglycemic Confidence Scale - How confident are you that you can stay safe from serious problems with hypoglycemia: When you are alone? HCS - When You Are Alone HCS01-Avoid Serious Problems Hypoglycemic Confidence Scale - In general, how confident are you that you can: Avoid serious problems due to hypoglycemia? HCS - Avoid Serious Problems HCS01-Catch Before Sugars Get Too Low Hypoglycemic Confidence Scale - In general, how confident are you that you can: Catch and respond to hypoglycemia before your blood sugars get too low? HCS - Catch Before Sugars Get Too Low HCS01-Continue to Do Things Really Want Hypoglycemic Confidence Scale - In general, how confident are you that you can: Continue to do the things you really want to do in your life, despite the risks of hypoglycemia? HCS - Continue to Do Things Really Want HCS01-Your Ability to Avoid Problems Hypoglycemic Confidence Scale - If you have a spouse or partner: What is your best guess about how confident your spouse or partner feels about your ability to avoid serious problems due to hypoglycemia? HCS - Your Ability to Avoid Problems HCS01-Mean HCS Score Hypoglycemic Confidence Scale - Mean HCS score. HCS - Mean HCS Score HCS01TC Hypoglycemic Confidence Scale Questionnaire Test Code CDISC Questionnaire HCS Test Code Terminology Hypoglycemic Confidence Scale test name. HCS01-Avoid Serious Problems Hypoglycemic Confidence Scale - In general, how confident are you that you can: Avoid serious problems due to hypoglycemia? HCS - Avoid Serious Problems HCS01-Catch Before Sugars Get Too Low Hypoglycemic Confidence Scale - In general, how confident are you that you can: Catch and respond to hypoglycemia before your blood sugars get too low? HCS - Catch Before Sugars Get Too Low HCS01-Continue to Do Things Really Want Hypoglycemic Confidence Scale - In general, how confident are you that you can: Continue to do the things you really want to do in your life, despite the risks of hypoglycemia? HCS - Continue to Do Things Really Want HCS01-Mean HCS Score Hypoglycemic Confidence Scale - Mean HCS score. HCS - Mean HCS Score HCS01-When You Are Alone Hypoglycemic Confidence Scale - How confident are you that you can stay safe from serious problems with hypoglycemia: When you are alone? HCS - When You Are Alone HCS01-When You Are Driving Hypoglycemic Confidence Scale - How confident are you that you can stay safe from serious problems with hypoglycemia: When you are driving? HCS - When You Are Driving HCS01-When You Are Exercising Hypoglycemic Confidence Scale - How confident are you that you can stay safe from serious problems with hypoglycemia: When you are exercising? HCS - When You Are Exercising HCS01-When You Are in Social Situations Hypoglycemic Confidence Scale - How confident are you that you can stay safe from serious problems with hypoglycemia: When you are in social situations? HCS - When You Are in Social Situations HCS01-When You Are Sleeping Hypoglycemic Confidence Scale - How confident are you that you can stay safe from serious problems with hypoglycemia: When you are sleeping? HCS - When You Are Sleeping HCS01-Your Ability to Avoid Problems Hypoglycemic Confidence Scale - If you have a spouse or partner: What is your best guess about how confident your spouse or partner feels about your ability to avoid serious problems due to hypoglycemia? HCS - Your Ability to Avoid Problems HCS01TN Hypoglycemic Confidence Scale Questionnaire Test Name CDISC Questionnaire HCS Test Name Terminology Terminology relevant to the immunogenicity specimen test codes of the CDISC Study Data Tabulation Model. Antibody-secreting Cells A measurement of the antibody-secreting cells in a biological specimen. Antibody-secreting Cells Measurement Binding Antidrug Antibody A measurement of the binding antidrug antibody in a biological specimen. A binding antidrug antibody is an antibody that binds to a test article, and/or portion(s) of the test article. Binding Antidrug Antibody Measurement Neutralizing Binding Antidrug Antibody A measurement of the neutralizing binding antidrug antibody in a biological specimen. A neutralizing binding antidrug antibody is a type of ADA that binds to the functional portion of a test article leading to diminished or negated pharmacological activity. Neutralizing Binding Antidrug Antibody Measurement Neutraliz Cross-React Bind Antidrug AB Neutralizing Cross-Reactive Binding Antidrug Antibody A measurement of the neutralizing cross-reactive binding antidrug antibody in a biological specimen. A neutralizing cross-reactive binding antidrug antibody is a type of ADA that binds to an endogenous molecule that is structurally similar to an analogue test article and diminishes or negates its function. Neutralizing Cross-Reacting Binding Antidrug Antibody Measurement Cross-Reactive Binding Antidrug Antibody A measurement of the cross-reactive binding antidrug antibody in a biological specimen. A cross-reactive binding antidrug antibody is a type of ADA that binds to the endogenous molecule that is structurally similar to an analogue test article. Cross-Reactive Binding Antidrug Antibody Measurement Binding Antidrug IgA Antibody A measurement of the binding antidrug IgA antibody in a biological specimen. Binding Antidrug IgA Antibody Measurement Binding Antidrug IgE Antibody A measurement of the binding antidrug IgE antibody in a biological specimen. Binding Antidrug IgE Antibody Measurement Binding Antidrug IgG Antibody A measurement of the binding antidrug IgG antibody in a biological specimen. Binding Antidrug IgG Antibody Measurement Binding Antidrug IgG1 Antibody A measurement of the binding antidrug IgG1 antibody in a biological specimen. Binding Antidrug IgG1 Antibody Measurement Binding Antidrug IgG2 Antibody A measurement of the binding antidrug IgG2 antibody in a biological specimen. Binding Antidrug IgG2 Antibody Measurement Binding Antidrug IgG3 Antibody A measurement of the binding antidrug IgG3 antibody in a biological specimen. Binding Antidrug IgG3 Antibody Measurement Binding Antidrug IgG4 Antibody A measurement of the binding antidrug IgG4 antibody in a biological specimen. Binding Antidrug IgG4 Antibody Measurement Binding Antidrug IgG/IgM Antibody A measurement of the binding antidrug IgG and/or IgM antibody in a biological specimen. Binding Antidrug IgG/IgM Antibody Measurement Binding Antidrug IgM Antibody A measurement of the binding antidrug IgM antibody in a biological specimen. Binding Antidrug IgM Antibody Measurement Cross-Reactive Binding Antidrug IgA AB Cross-Reactive Binding Antidrug IgA Antibody A measurement of the cross-reactive binding antidrug IgA antibody in a biological specimen. Cross-Reactive Binding Antidrug IgA Antibody Measurement Cross-Reactive Binding Antidrug IgE AB Cross-Reactive Binding Antidrug IgE Antibody A measurement of the cross-reactive binding antidrug IgE antibody in a biological specimen. Cross-Reactive Binding Antidrug IgE Antibody Measurement Cross-Reactive Binding Antidrug IgG AB Cross-Reactive Binding Antidrug IgG Antibody A measurement of the cross-reactive binding antidrug IgG antibody in a biological specimen. Cross-Reactive Binding Antidrug IgG Antibody Measurement Cross-Reactive Binding Antidrug IgG1 AB Cross-Reactive Binding Antidrug IgG1 Antibody A measurement of the cross-reactive binding antidrug IgG1 antibody in a biological specimen. Cross-Reactive Binding Antidrug IgG1 Antibody Measurement Cross-Reactive Binding Antidrug IgG2 AB Cross-Reactive Binding Antidrug IgG2 Antibody A measurement of the cross-reactive binding antidrug IgG2 antibody in a biological specimen. Cross-Reactive Binding Antidrug IgG2 Antibody Measurement Cross-Reactive Binding Antidrug IgG3 AB Cross-Reactive Binding Antidrug IgG3 Antibody A measurement of the cross-reactive binding antidrug IgG3 antibody in a biological specimen. Cross-Reactive Binding Antidrug IgG3 Antibody Measurement Cross-Reactive Binding Antidrug IgG4 AB Cross-Reactive Binding Antidrug IgG4 Antibody A measurement of the cross-reactive binding antidrug IgG4 antibody in a biological specimen. Cross-Reactive Binding Antidrug IgG4 Antibody Measurement Cross-Reactive Binding ADA IgG/IgM Cross-Reactive Binding Antidrug IgG/IgM Antibody A measurement of the cross-reactive binding antidrug IgG and/or IgM antibody in a biological specimen. Cross-Reactive Binding Antidrug Antibody IgG/IgM Measurement Cross-Reactive Binding Antidrug IgM AB Cross-Reactive Binding Antidrug IgM Antibody A measurement of the cross-reactive binding antidrug IgM antibody in a biological specimen. Cross-Reactive Binding Antidrug IgM Antibody Measurement Neutralizing Binding Antidrug IgA AB Neutralizing Binding Antidrug IgA Antibody A measurement of the neutralizing binding antidrug IgA antibody in a biological specimen. Neutralizing Binding Antidrug IgA Antibody Measurement Neutralizing Binding Antidrug IgE AB Neutralizing Binding Antidrug IgE Antibody A measurement of the neutralizing binding antidrug IgE antibody in a biological specimen. Neutralizing Binding Antidrug IgE Antibody Measurement Neutralizing Binding Antidrug IgG AB Neutralizing Binding Antidrug IgG Antibody A measurement of the neutralizing binding antidrug IgG antibody in a biological specimen. Neutralizing Binding Antidrug IgG Antibody Measurement Neutralizing Binding Antidrug IgG1 AB Neutralizing Binding Antidrug IgG1 Antibody A measurement of the neutralizing binding antidrug IgG1 antibody in a biological specimen. Neutralizing Binding Antidrug IgG1 Antibody Measurement Neutralizing Binding Antidrug IgG2 AB Neutralizing Binding Antidrug IgG2 Antibody A measurement of the neutralizing binding antidrug IgG2 antibody in a biological specimen. Neutralizing Binding Antidrug IgG2 Antibody Measurement Neutralizing Binding Antidrug IgG3 AB Neutralizing Binding Antidrug IgG3 Antibody A measurement of the neutralizing binding antidrug IgG3 antibody in a biological specimen. Neutralizing Binding Antidrug IgG3 Antibody Measurement Neutralizing Binding Antidrug IgG4 AB Neutralizing Binding Antidrug IgG4 Antibody A measurement of the neutralizing binding antidrug IgG4 antibody in a biological specimen. Neutralizing Binding Antidrug IgG4 Antibody Measurement Neutralizing Binding Antidrug IgG/IgM AB A measurement of the neutralizing binding antidrug IgG and/or IgM antibody in a biological specimen. Neutralizing Binding Antidrug IgG/IgM Antibody Measurement Neutralizing Binding Antidrug IgM AB Neutralizing Binding Antidrug IgM Antibody A measurement of the neutralizing binding antidrug IgM antibody in a biological specimen. Neutralizing Binding Antidrug IgM Antibody Measurement Neut Cross-Reactive Binding ADA IgA Neutralizing Cross-Reactive Binding Antidrug IgA Antibody A measurement of the neutralizing cross-reactive binding antidrug IgA antibody in a biological specimen. Neutralizing Cross-Reactive Binding Antidrug Antibody IgA Measurement Neut Cross-Reactive Binding ADA IgE Neutralizing Cross-Reactive Binding Antidrug IgE Antibody A measurement of the neutralizing cross-reactive binding antidrug IgE antibody in a biological specimen. Neutralizing Cross-Reactive Binding Antidrug Antibody IgE Measurement Neut Cross-Reactive Binding ADA IgG Neutralizing Cross-Reactive Binding Antidrug IgG Antibody A measurement of the neutralizing cross-reactive binding antidrug IgG antibody in a biological specimen. Neutralizing Cross-Reactive Binding Antidrug Antibody IgG Measurement Neut Cross-Reactive Binding ADA IgG1 Neutralizing Cross-Reactive Binding Antidrug IgG1 Antibody A measurement of the neutralizing cross-reactive binding antidrug IgG1 antibody in a biological specimen. Neutralizing Cross-Reactive Binding Antidrug Antibody IgG1 Measurement Neut Cross-Reactive Binding ADA IgG2 Neutralizing Cross-Reactive Binding Antidrug IgG2 Antibody A measurement of the neutralizing cross-reactive binding antidrug IgG2 antibody in a biological specimen. Neutralizing Cross-Reactive Binding Antidrug Antibody IgG2 Measurement Neut Cross-Reactive Binding ADA IgG3 Neutralizing Cross-Reactive Binding Antidrug IgG3 Antibody A measurement of the neutralizing cross-reactive binding antidrug IgG3 antibody in a biological specimen. Neutralizing Cross-Reactive Binding Antidrug Antibody IgG3 Measurement Neut Cross-Reactive Binding ADA IgG4 Neutralizing Cross-Reactive Binding Antidrug IgG4 Antibody A measurement of the neutralizing cross-reactive binding antidrug IgG4 antibody in a biological specimen. Neutralizing Cross-Reactive Binding Antidrug Antibody IgG4 Measurement Neut Cross-Reactive Binding ADA IgG/IgM Neutralizing Cross-Reactive Binding Antidrug IgG/IgM Antibody A measurement of the neutralizing cross-reactive binding antidrug IgG and/or IgM antibody in a biological specimen. Neutralizing Cross-Reactive Binding Antidrug Antibody IgG/IgM Measurement Neut Cross-Reactive Binding ADA IgM Neutralizing Cross-Reactive Binding Antidrug IgM Antibody A measurement of the neutralizing cross-reactive binding antidrug IgM antibody in a biological specimen. Neutralizing Cross-Reactive Binding Antidrug Antibody IgM Measurement Alloantibody A measurement of the binding alloantibody in a biological specimen. Alloantibody Measurement IgG Alloantibody A measurement of the binding IgG alloantibody in a biological specimen. IgG Alloantibody Measurement Anti-Neutrophil Antibody Anti-Neutrophil Autoantibody A measurement of the total anti-neutrophil antibody in a biological specimen. Anti-Neutrophil Antibody Measurement Anti-Neutrophil Cytoplasmic Antibody Anti-Neutrophil Cytoplasmic Autoantibody A measurement of the anti-neutrophil cytoplasmic antibody in a biological specimen. Anti-Neutrophil Cytoplasmic Antibody Measurement Anti-Neutrophil Cytoplasmic IgG Antibody Anti-Neutrophil Cytoplasmic IgG Autoantibody A measurement of the anti-neutrophil cytoplasmic IgG antibody in a biological specimen. Anti-Neutrophil Cytoplasmic IgG Antibody Measurement Allergen-induced Antibody A measurement of the binding allergen-induced antibody in a biological specimen. Allergen-induced Antibody Measurement Allergen-induced IgA Antibody A measurement of the binding allergen-induced IgA antibody in a biological specimen. Allergen-induced IgA Antibody Measurement Allergen-induced IgE Antibody A measurement of the binding allergen-induced IgE antibody in a biological specimen. Allergen-induced IgE Antibody Measurement Allergen-induced IgG4 Antibody A measurement of the binding allergen-induced IgG4 antibody in a biological specimen. Allergen-induced IgG4 Antibody Measurement Allergen-induced IgG Antibody A measurement of the binding allergen-induced IgG antibody in a biological specimen. Allergen-induced IgG Antibody Measurement Allergen-induced IgM Antibody A measurement of the binding allergen-induced IgM antibody in a biological specimen. Allergen-induced IgM Antibody Measurement Autoantibody A measurement of the binding autoantibody in a biological specimen. Autoantibody Measurement IgA Autoantibody A measurement of the binding IgA autoantibody in a biological specimen. IgA Autoantibody Measurement IgG1 Autoantibody A measurement of the binding IgG1 autoantibody in a biological specimen. IgG1 Autoantibody Measurement IgG2 Autoantibody A measurement of the binding IgG2 autoantibody in a biological specimen. IgG2 Autoantibody Measurement IgG3 Autoantibody A measurement of the binding IgG3 autoantibody in a biological specimen. IgG3 Autoantibody Measurement IgG Autoantibody A measurement of the binding IgG autoantibody in a biological specimen. IgG Autoantibody Measurement IgM Autoantibody A measurement of the binding IgM autoantibody in a biological specimen. IgM Autoantibody Measurement CTL-Mediated Cytolysis Cytotoxic T Cell-Mediated Cytolysis Cytotoxic T Lymphocyte-Mediated Cytolysis A measurement of the lysis of target cells mediated by cytotoxic T cells in a biological specimen. Cytotoxic T Cell-Mediated Cytolysis Assessment Cytokine-secreting Cells A measurement of the cytokine-secreting cells in a biological specimen. Cytokine-secreting Cells Measurement Cytokine-Secreting T Cells A measurement of the cytokine-secreting T lymphocytes in a biological specimen. Cytokine-Secreting T Lymphocyte Count Epstein-Barr Virus Antibody Profile Epstein-Barr Virus Infection Status Epstein-Barr Virus Panel An assessment of Epstein-Barr virus infection based on a panel of EBV antigen antibody tests. Epstein-Barr Virus Infection Status Alloantibody, Factor VIII Inhibitor Factor VIII Antibody A measurement of the factor VIII inhibitor (antibody) in a biological specimen. Factor VIII Inhibitor Measurement Alloantibody, Factor IX Inhibitor Factor IX Antibody A measurement of the factor IX inhibitor (antibody) in a biological specimen. Factor IX Inhibitor Measurement Human Anti-Human Antibody A measurement of the total human anti-human antibody in a biological specimen. Human Anti-Human Antibody Measurement HAMA Human Anti-Mouse Antibody A measurement of the human anti-mouse antibody in a biological specimen. Human Anti-Mouse Antibody Measurement Human Anti-Sheep IgE Antibody A measurement of the human anti-sheep IgE antibodies in a biological specimen. Human Anti-Sheep IgE Antibody Measurement Human Anti-Sheep IgG Antibody A measurement of the human anti-sheep IgG antibodies in a biological specimen. Human Anti-Sheep IgG Antibody Measurement Human Anti-Sheep IgM Antibody A measurement of the human anti-sheep IgM antibodies in a biological specimen. Human Anti-Sheep IgM Antibody Measurement HIV-1 Seroreactivity A measurement of the HIV-1 seroreactivity in a biological specimen. HIV-1 Seroreactivity Measurement HIV-2 Seroreactivity A measurement of the HIV-2 seroreactivity in a biological specimen. HIV-2 Seroreactivity Measurement HLA Class II Panel Reactive Antibody A measurement of the panel reactive antibody (the reactivity between host immune cells and donor) human leukocyte antigen class II in a biological specimen. HLA Class II Panel Reactive Antibody Measurement HLA Class I Panel Reactive Antibody A measurement of the panel reactive antibody (the reactivity between host immune cells and donor) human leukocyte antigen class I in a biological specimen. HLA Class I Panel Reactive Antibody Measurement Heterophile Antibodies A measurement of the heterophile antibodies in a biological specimen. Heterophile Antibody Measurement Interferon Gamma A measurement of the interferon gamma in a biological specimen. Interferon Gamma Measurement Modulating Autoab/Total Autoab Modulating Autoantibody/Total Autoantibody A relative measurement (ratio or percentage) of the modulating autoantibody to total autoantibody in a biological specimen. Modulating Autoantibody to Autoantibody Ratio Measurement Microbial-induced Antibody A measurement of the binding microbial-induced antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection, vaccination and/or viral vector-based therapy using a whole microbe or component(s) of a microbe. Microbial-induced Antibody Measurement Functional Microbial-induced Antibody A measurement of the functional binding microbial-induced antibody in a biological specimen. A functional microbial-induced antibody is defined as antibodies that have agonist or antagonist effects on pathogens or their toxins in the presence of other effector molecules or cells. For example, the effects of functional antibodies can include neutralization, phagocytosis, antibody-dependent cellular cytotoxicity, and complement-mediated lysis. The production of this antibody may be triggered by naturally occurring infection, vaccination and/or viral vector-based therapy using a whole microbe or component(s) of a microbe. Functional Microbial-induced Antibody Measurement Microbial-induced IgA/IgM Antibody A measurement of the binding microbial-induced IgA and/or IgM antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection, vaccination and/or viral vector-based therapy using a whole microbe or component(s) of a microbe. Microbial-induced IgA and/or IgM Antibody Measurement Microbial-induced IgG + IgM Antibody A measurement of the binding microbial-induced IgG and IgM antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection, vaccination and/or viral vector-based therapy using a whole microbe or component(s) of a microbe. Microbial-induced IgG and IgM Antibody Measurement Microbial-induced IgA Antibody A measurement of the binding microbial-induced IgA antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection, vaccination and/or viral vector-based therapy using a whole microbe or component(s) of a microbe. Microbial-induced IgA Antibody Measurement Microbial-induced IgE Antibody A measurement of the binding microbial-induced IgE antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection, vaccination and/or viral vector-based therapy using a whole microbe or component(s) of a microbe. Microbial-induced IgE Antibody Measurement Microbial-induced IgG Antibody A measurement of the binding microbial-induced IgG antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection, vaccination and/or viral vector-based therapy using a whole microbe or component(s) of a microbe. Microbial-induced IgG Antibody Measurement Microbial-induced IgG/IgM Antibody A measurement of the binding microbial-induced IgG and/or IgM antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection, vaccination and/or viral vector-based therapy using a whole microbe or component(s) of a microbe. Microbial-induced IgG and/or IgM Antibody Measurement Microbial-induced IgM Antibody A measurement of the binding microbial-induced IgM antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection, vaccination and/or viral vector-based therapy using a whole microbe or component(s) of a microbe. Microbial-induced IgM Antibody Measurement Microbial-induced IgM/IgA/IgG Antibody A measurement of the binding microbial-induced IgM, IgA and/or IgG antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection, vaccination and/or viral vector-based therapy using a whole microbe or component(s) of a microbe. Microbial-induced IgM, IgA, and/or IgG Antibody Measurement Neutralizing Microbial-induced Antibody A measurement of the neutralizing binding microbial-induced antibody in a biological specimen. A neutralizing microbial-induced antibody is a type of functional antibody that's defined as antibodies that bind to, block and prevent microbes from infecting cells. The production of this antibody may be triggered by naturally occurring infection, vaccination and/or viral vector-based therapy using a whole microbe or component(s) of a microbe. Neutralizing Microbial-induced Antibody Measurement Natural Killer Cell-Mediated Cytolysis NK Cell-Mediated Cytolysis A measurement of the lysis of target cells mediated by natural killer cells in a biological specimen. Natural Killer Cell-Mediated Cytolysis Assessment Panel Reactive Antibody Percent Reactive Antibody PRA Score A measurement of the panel reactive antibody that is achieved by mixing and assessing the reactivity between the recipient's immune cells and the donor's human leukocyte antigen, in which anti-HLA class I and class II antibody specificities are measured separately in a biological specimen. Panel Reactive Antibody Test Calculated Panel Reactive Antibody A measurement of the calculated panel reactive antibody, which is based on the number/type of unacceptable HLA antigens to which an organ recipient has been sensitized, and which algorithmically estimates the level of sensitization in the recipient. The CPRA is computed from HLA antigen frequencies in a given donor population using both anti-HLA class I and class II antibody specificities; it also represents the percentage of actual organ donors that express one or more unacceptable HLA antigens to which a recipient may react adversely. Calculated Panel Reactive Antibody Measurement Rapid Plasma Reagin Reagin Antibody RPR VDRL Venereal Disease Research Laboratory Test A measurement of the non-specific Treponemal antibodies produced in response to cellular damage caused by Treponema pallidum (syphilis) in a biological specimen. Rapid Plasma Reagin Measurement Autoantibody, Rheumatoid Factor A measurement of any of the rheumatoid factor autoantibodies in a biological specimen. Rheumatoid Factor Autoantibody Measurement IgA Autoantibody, Rheumatoid Factor A measurement of the rheumatoid factor IgA autoantibody in a biological specimen. Rheumatoid Factor IgA Autoantibody Measurement IgG Autoantibody, Rheumatoid Factor A measurement of the rheumatoid factor IgG autoantibody in a biological specimen. Rheumatoid Factor IgG Autoantibody Measurement IgM Autoantibody, Rheumatoid Factor A measurement of the rheumatoid factor IgM autoantibody in a biological specimen. Rheumatoid Factor IgM Autoantibody Measurement Autoantibody, TBII Autoantibody, Thyrotropin Binding Inhibitory Immunoglobulin A measurement of the thyrotropin binding inhibitory immunoglobulin autoantibody in a biological specimen. Thyrotropin Binding Inhibitory Immunoglobulin Autoantibody Measurement T-Lymphocyte Proliferation Index A relative measurement (ratio or percentage) of T-lymphocyte proliferation due to stimulation by an antigen of interest to a non-stimulated T-lymphocyte proliferation control. T-Lymphocyte Proliferation Index Autoantibody, Thyroid Stimulating Immunoglobulin Autoantibody, TSI A measurement of the thyroid stimulating immunoglobulin autoantibody in a biological specimen. Thyroid Stimulating Immunoglobulin Autoantibody Measurement Thyroid Stimulating Immunoglobulin Actual/Control Thyroid Stimulating Immunoglobulin Actual/Normal TSI Actual/Control A relative measurement (ratio or percentage) of the thyroid stimulating immunoglobulin in a subject's specimen when compared to a control specimen. Thyroid Stimulating Immunoglobulin Actual to Control Ratio Measurement ISTESTCD Immunogenicity Specimen Assessments Test Code CDISC SDTM Immunogenicity Specimen Assessments Test Code Terminology Terminology relevant to the immunogenicity specimen test names of the CDISC Study Data Tabulation Model. Allergen-induced Antibody A measurement of the binding allergen-induced antibody in a biological specimen. Allergen-induced Antibody Measurement Allergen-induced IgA Antibody A measurement of the binding allergen-induced IgA antibody in a biological specimen. Allergen-induced IgA Antibody Measurement Allergen-induced IgE Antibody A measurement of the binding allergen-induced IgE antibody in a biological specimen. Allergen-induced IgE Antibody Measurement Allergen-induced IgG Antibody A measurement of the binding allergen-induced IgG antibody in a biological specimen. Allergen-induced IgG Antibody Measurement Allergen-induced IgG4 Antibody A measurement of the binding allergen-induced IgG4 antibody in a biological specimen. Allergen-induced IgG4 Antibody Measurement Allergen-induced IgM Antibody A measurement of the binding allergen-induced IgM antibody in a biological specimen. Allergen-induced IgM Antibody Measurement Alloantibody A measurement of the binding alloantibody in a biological specimen. Alloantibody Measurement Anti-Neutrophil Antibody Anti-Neutrophil Autoantibody A measurement of the total anti-neutrophil antibody in a biological specimen. Anti-Neutrophil Antibody Measurement Anti-Neutrophil Cytoplasmic Antibody Anti-Neutrophil Cytoplasmic Autoantibody A measurement of the anti-neutrophil cytoplasmic antibody in a biological specimen. Anti-Neutrophil Cytoplasmic Antibody Measurement Anti-Neutrophil Cytoplasmic IgG Antibody Anti-Neutrophil Cytoplasmic IgG Autoantibody A measurement of the anti-neutrophil cytoplasmic IgG antibody in a biological specimen. Anti-Neutrophil Cytoplasmic IgG Antibody Measurement Antibody-secreting Cells A measurement of the antibody-secreting cells in a biological specimen. Antibody-secreting Cells Measurement Autoantibody A measurement of the binding autoantibody in a biological specimen. Autoantibody Measurement Autoantibody, Rheumatoid Factor A measurement of any of the rheumatoid factor autoantibodies in a biological specimen. Rheumatoid Factor Autoantibody Measurement Autoantibody, TBII Autoantibody, Thyrotropin Binding Inhibitory Immunoglobulin A measurement of the thyrotropin binding inhibitory immunoglobulin autoantibody in a biological specimen. Thyrotropin Binding Inhibitory Immunoglobulin Autoantibody Measurement Autoantibody, Thyroid Stimulating Immunoglobulin Autoantibody, TSI A measurement of the thyroid stimulating immunoglobulin autoantibody in a biological specimen. Thyroid Stimulating Immunoglobulin Autoantibody Measurement Binding Antidrug Antibody A measurement of the binding antidrug antibody in a biological specimen. A binding antidrug antibody is an antibody that binds to a test article, and/or portion(s) of the test article. Binding Antidrug Antibody Measurement Binding Antidrug IgA Antibody A measurement of the binding antidrug IgA antibody in a biological specimen. Binding Antidrug IgA Antibody Measurement Binding Antidrug IgE Antibody A measurement of the binding antidrug IgE antibody in a biological specimen. Binding Antidrug IgE Antibody Measurement Binding Antidrug IgG Antibody A measurement of the binding antidrug IgG antibody in a biological specimen. Binding Antidrug IgG Antibody Measurement Binding Antidrug IgG/IgM Antibody A measurement of the binding antidrug IgG and/or IgM antibody in a biological specimen. Binding Antidrug IgG/IgM Antibody Measurement Binding Antidrug IgG1 Antibody A measurement of the binding antidrug IgG1 antibody in a biological specimen. Binding Antidrug IgG1 Antibody Measurement Binding Antidrug IgG2 Antibody A measurement of the binding antidrug IgG2 antibody in a biological specimen. Binding Antidrug IgG2 Antibody Measurement Binding Antidrug IgG3 Antibody A measurement of the binding antidrug IgG3 antibody in a biological specimen. Binding Antidrug IgG3 Antibody Measurement Binding Antidrug IgG4 Antibody A measurement of the binding antidrug IgG4 antibody in a biological specimen. Binding Antidrug IgG4 Antibody Measurement Binding Antidrug IgM Antibody A measurement of the binding antidrug IgM antibody in a biological specimen. Binding Antidrug IgM Antibody Measurement Calculated Panel Reactive Antibody A measurement of the calculated panel reactive antibody, which is based on the number/type of unacceptable HLA antigens to which an organ recipient has been sensitized, and which algorithmically estimates the level of sensitization in the recipient. The CPRA is computed from HLA antigen frequencies in a given donor population using both anti-HLA class I and class II antibody specificities; it also represents the percentage of actual organ donors that express one or more unacceptable HLA antigens to which a recipient may react adversely. Calculated Panel Reactive Antibody Measurement Cross-Reactive Binding ADA IgG/IgM Cross-Reactive Binding Antidrug IgG/IgM Antibody A measurement of the cross-reactive binding antidrug IgG and/or IgM antibody in a biological specimen. Cross-Reactive Binding Antidrug Antibody IgG/IgM Measurement Cross-Reactive Binding Antidrug Antibody A measurement of the cross-reactive binding antidrug antibody in a biological specimen. A cross-reactive binding antidrug antibody is a type of ADA that binds to the endogenous molecule that is structurally similar to an analogue test article. Cross-Reactive Binding Antidrug Antibody Measurement Cross-Reactive Binding Antidrug IgA AB Cross-Reactive Binding Antidrug IgA Antibody A measurement of the cross-reactive binding antidrug IgA antibody in a biological specimen. Cross-Reactive Binding Antidrug IgA Antibody Measurement Cross-Reactive Binding Antidrug IgE AB Cross-Reactive Binding Antidrug IgE Antibody A measurement of the cross-reactive binding antidrug IgE antibody in a biological specimen. Cross-Reactive Binding Antidrug IgE Antibody Measurement Cross-Reactive Binding Antidrug IgG AB Cross-Reactive Binding Antidrug IgG Antibody A measurement of the cross-reactive binding antidrug IgG antibody in a biological specimen. Cross-Reactive Binding Antidrug IgG Antibody Measurement Cross-Reactive Binding Antidrug IgG1 AB Cross-Reactive Binding Antidrug IgG1 Antibody A measurement of the cross-reactive binding antidrug IgG1 antibody in a biological specimen. Cross-Reactive Binding Antidrug IgG1 Antibody Measurement Cross-Reactive Binding Antidrug IgG2 AB Cross-Reactive Binding Antidrug IgG2 Antibody A measurement of the cross-reactive binding antidrug IgG2 antibody in a biological specimen. Cross-Reactive Binding Antidrug IgG2 Antibody Measurement Cross-Reactive Binding Antidrug IgG3 AB Cross-Reactive Binding Antidrug IgG3 Antibody A measurement of the cross-reactive binding antidrug IgG3 antibody in a biological specimen. Cross-Reactive Binding Antidrug IgG3 Antibody Measurement Cross-Reactive Binding Antidrug IgG4 AB Cross-Reactive Binding Antidrug IgG4 Antibody A measurement of the cross-reactive binding antidrug IgG4 antibody in a biological specimen. Cross-Reactive Binding Antidrug IgG4 Antibody Measurement Cross-Reactive Binding Antidrug IgM AB Cross-Reactive Binding Antidrug IgM Antibody A measurement of the cross-reactive binding antidrug IgM antibody in a biological specimen. Cross-Reactive Binding Antidrug IgM Antibody Measurement Cytokine-secreting Cells A measurement of the cytokine-secreting cells in a biological specimen. Cytokine-secreting Cells Measurement Cytokine-Secreting T Cells A measurement of the cytokine-secreting T lymphocytes in a biological specimen. Cytokine-Secreting T Lymphocyte Count CTL-Mediated Cytolysis Cytotoxic T Cell-Mediated Cytolysis Cytotoxic T Lymphocyte-Mediated Cytolysis A measurement of the lysis of target cells mediated by cytotoxic T cells in a biological specimen. Cytotoxic T Cell-Mediated Cytolysis Assessment Epstein-Barr Virus Antibody Profile Epstein-Barr Virus Infection Status Epstein-Barr Virus Panel An assessment of Epstein-Barr virus infection based on a panel of EBV antigen antibody tests. Epstein-Barr Virus Infection Status Alloantibody, Factor IX Inhibitor Factor IX Antibody A measurement of the factor IX inhibitor (antibody) in a biological specimen. Factor IX Inhibitor Measurement Alloantibody, Factor VIII Inhibitor Factor VIII Antibody A measurement of the factor VIII inhibitor (antibody) in a biological specimen. Factor VIII Inhibitor Measurement Functional Microbial-induced Antibody A measurement of the functional binding microbial-induced antibody in a biological specimen. A functional microbial-induced antibody is defined as antibodies that have agonist or antagonist effects on pathogens or their toxins in the presence of other effector molecules or cells. For example, the effects of functional antibodies can include neutralization, phagocytosis, antibody-dependent cellular cytotoxicity, and complement-mediated lysis. The production of this antibody may be triggered by naturally occurring infection, vaccination and/or viral vector-based therapy using a whole microbe or component(s) of a microbe. Functional Microbial-induced Antibody Measurement Heterophile Antibodies A measurement of the heterophile antibodies in a biological specimen. Heterophile Antibody Measurement HIV-1 Seroreactivity A measurement of the HIV-1 seroreactivity in a biological specimen. HIV-1 Seroreactivity Measurement HIV-2 Seroreactivity A measurement of the HIV-2 seroreactivity in a biological specimen. HIV-2 Seroreactivity Measurement HLA Class I Panel Reactive Antibody A measurement of the panel reactive antibody (the reactivity between host immune cells and donor) human leukocyte antigen class I in a biological specimen. HLA Class I Panel Reactive Antibody Measurement HLA Class II Panel Reactive Antibody A measurement of the panel reactive antibody (the reactivity between host immune cells and donor) human leukocyte antigen class II in a biological specimen. HLA Class II Panel Reactive Antibody Measurement Human Anti-Human Antibody A measurement of the total human anti-human antibody in a biological specimen. Human Anti-Human Antibody Measurement HAMA Human Anti-Mouse Antibody A measurement of the human anti-mouse antibody in a biological specimen. Human Anti-Mouse Antibody Measurement Human Anti-Sheep IgE Antibody A measurement of the human anti-sheep IgE antibodies in a biological specimen. Human Anti-Sheep IgE Antibody Measurement Human Anti-Sheep IgG Antibody A measurement of the human anti-sheep IgG antibodies in a biological specimen. Human Anti-Sheep IgG Antibody Measurement Human Anti-Sheep IgM Antibody A measurement of the human anti-sheep IgM antibodies in a biological specimen. Human Anti-Sheep IgM Antibody Measurement IgA Autoantibody A measurement of the binding IgA autoantibody in a biological specimen. IgA Autoantibody Measurement IgA Autoantibody, Rheumatoid Factor A measurement of the rheumatoid factor IgA autoantibody in a biological specimen. Rheumatoid Factor IgA Autoantibody Measurement IgG Alloantibody A measurement of the binding IgG alloantibody in a biological specimen. IgG Alloantibody Measurement IgG Autoantibody A measurement of the binding IgG autoantibody in a biological specimen. IgG Autoantibody Measurement IgG Autoantibody, Rheumatoid Factor A measurement of the rheumatoid factor IgG autoantibody in a biological specimen. Rheumatoid Factor IgG Autoantibody Measurement IgG1 Autoantibody A measurement of the binding IgG1 autoantibody in a biological specimen. IgG1 Autoantibody Measurement IgG2 Autoantibody A measurement of the binding IgG2 autoantibody in a biological specimen. IgG2 Autoantibody Measurement IgG3 Autoantibody A measurement of the binding IgG3 autoantibody in a biological specimen. IgG3 Autoantibody Measurement IgM Autoantibody A measurement of the binding IgM autoantibody in a biological specimen. IgM Autoantibody Measurement IgM Autoantibody, Rheumatoid Factor A measurement of the rheumatoid factor IgM autoantibody in a biological specimen. Rheumatoid Factor IgM Autoantibody Measurement Interferon Gamma A measurement of the interferon gamma in a biological specimen. Interferon Gamma Measurement Microbial-induced Antibody A measurement of the binding microbial-induced antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection, vaccination and/or viral vector-based therapy using a whole microbe or component(s) of a microbe. Microbial-induced Antibody Measurement Microbial-induced IgA Antibody A measurement of the binding microbial-induced IgA antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection, vaccination and/or viral vector-based therapy using a whole microbe or component(s) of a microbe. Microbial-induced IgA Antibody Measurement Microbial-induced IgA/IgM Antibody A measurement of the binding microbial-induced IgA and/or IgM antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection, vaccination and/or viral vector-based therapy using a whole microbe or component(s) of a microbe. Microbial-induced IgA and/or IgM Antibody Measurement Microbial-induced IgE Antibody A measurement of the binding microbial-induced IgE antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection, vaccination and/or viral vector-based therapy using a whole microbe or component(s) of a microbe. Microbial-induced IgE Antibody Measurement Microbial-induced IgG + IgM Antibody A measurement of the binding microbial-induced IgG and IgM antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection, vaccination and/or viral vector-based therapy using a whole microbe or component(s) of a microbe. Microbial-induced IgG and IgM Antibody Measurement Microbial-induced IgG Antibody A measurement of the binding microbial-induced IgG antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection, vaccination and/or viral vector-based therapy using a whole microbe or component(s) of a microbe. Microbial-induced IgG Antibody Measurement Microbial-induced IgG/IgM Antibody A measurement of the binding microbial-induced IgG and/or IgM antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection, vaccination and/or viral vector-based therapy using a whole microbe or component(s) of a microbe. Microbial-induced IgG and/or IgM Antibody Measurement Microbial-induced IgM Antibody A measurement of the binding microbial-induced IgM antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection, vaccination and/or viral vector-based therapy using a whole microbe or component(s) of a microbe. Microbial-induced IgM Antibody Measurement Microbial-induced IgM/IgA/IgG Antibody A measurement of the binding microbial-induced IgM, IgA and/or IgG antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection, vaccination and/or viral vector-based therapy using a whole microbe or component(s) of a microbe. Microbial-induced IgM, IgA, and/or IgG Antibody Measurement Modulating Autoab/Total Autoab Modulating Autoantibody/Total Autoantibody A relative measurement (ratio or percentage) of the modulating autoantibody to total autoantibody in a biological specimen. Modulating Autoantibody to Autoantibody Ratio Measurement Natural Killer Cell-Mediated Cytolysis NK Cell-Mediated Cytolysis A measurement of the lysis of target cells mediated by natural killer cells in a biological specimen. Natural Killer Cell-Mediated Cytolysis Assessment Neut Cross-Reactive Binding ADA IgA Neutralizing Cross-Reactive Binding Antidrug IgA Antibody A measurement of the neutralizing cross-reactive binding antidrug IgA antibody in a biological specimen. Neutralizing Cross-Reactive Binding Antidrug Antibody IgA Measurement Neut Cross-Reactive Binding ADA IgE Neutralizing Cross-Reactive Binding Antidrug IgE Antibody A measurement of the neutralizing cross-reactive binding antidrug IgE antibody in a biological specimen. Neutralizing Cross-Reactive Binding Antidrug Antibody IgE Measurement Neut Cross-Reactive Binding ADA IgG Neutralizing Cross-Reactive Binding Antidrug IgG Antibody A measurement of the neutralizing cross-reactive binding antidrug IgG antibody in a biological specimen. Neutralizing Cross-Reactive Binding Antidrug Antibody IgG Measurement Neut Cross-Reactive Binding ADA IgG/IgM Neutralizing Cross-Reactive Binding Antidrug IgG/IgM Antibody A measurement of the neutralizing cross-reactive binding antidrug IgG and/or IgM antibody in a biological specimen. Neutralizing Cross-Reactive Binding Antidrug Antibody IgG/IgM Measurement Neut Cross-Reactive Binding ADA IgG1 Neutralizing Cross-Reactive Binding Antidrug IgG1 Antibody A measurement of the neutralizing cross-reactive binding antidrug IgG1 antibody in a biological specimen. Neutralizing Cross-Reactive Binding Antidrug Antibody IgG1 Measurement Neut Cross-Reactive Binding ADA IgG2 Neutralizing Cross-Reactive Binding Antidrug IgG2 Antibody A measurement of the neutralizing cross-reactive binding antidrug IgG2 antibody in a biological specimen. Neutralizing Cross-Reactive Binding Antidrug Antibody IgG2 Measurement Neut Cross-Reactive Binding ADA IgG3 Neutralizing Cross-Reactive Binding Antidrug IgG3 Antibody A measurement of the neutralizing cross-reactive binding antidrug IgG3 antibody in a biological specimen. Neutralizing Cross-Reactive Binding Antidrug Antibody IgG3 Measurement Neut Cross-Reactive Binding ADA IgG4 Neutralizing Cross-Reactive Binding Antidrug IgG4 Antibody A measurement of the neutralizing cross-reactive binding antidrug IgG4 antibody in a biological specimen. Neutralizing Cross-Reactive Binding Antidrug Antibody IgG4 Measurement Neut Cross-Reactive Binding ADA IgM Neutralizing Cross-Reactive Binding Antidrug IgM Antibody A measurement of the neutralizing cross-reactive binding antidrug IgM antibody in a biological specimen. Neutralizing Cross-Reactive Binding Antidrug Antibody IgM Measurement Neutraliz Cross-React Bind Antidrug AB Neutralizing Cross-Reactive Binding Antidrug Antibody A measurement of the neutralizing cross-reactive binding antidrug antibody in a biological specimen. A neutralizing cross-reactive binding antidrug antibody is a type of ADA that binds to an endogenous molecule that is structurally similar to an analogue test article and diminishes or negates its function. Neutralizing Cross-Reacting Binding Antidrug Antibody Measurement Neutralizing Binding Antidrug Antibody A measurement of the neutralizing binding antidrug antibody in a biological specimen. A neutralizing binding antidrug antibody is a type of ADA that binds to the functional portion of a test article leading to diminished or negated pharmacological activity. Neutralizing Binding Antidrug Antibody Measurement Neutralizing Binding Antidrug IgA AB Neutralizing Binding Antidrug IgA Antibody A measurement of the neutralizing binding antidrug IgA antibody in a biological specimen. Neutralizing Binding Antidrug IgA Antibody Measurement Neutralizing Binding Antidrug IgE AB Neutralizing Binding Antidrug IgE Antibody A measurement of the neutralizing binding antidrug IgE antibody in a biological specimen. Neutralizing Binding Antidrug IgE Antibody Measurement Neutralizing Binding Antidrug IgG AB Neutralizing Binding Antidrug IgG Antibody A measurement of the neutralizing binding antidrug IgG antibody in a biological specimen. Neutralizing Binding Antidrug IgG Antibody Measurement Neutralizing Binding Antidrug IgG/IgM AB A measurement of the neutralizing binding antidrug IgG and/or IgM antibody in a biological specimen. Neutralizing Binding Antidrug IgG/IgM Antibody Measurement Neutralizing Binding Antidrug IgG1 AB Neutralizing Binding Antidrug IgG1 Antibody A measurement of the neutralizing binding antidrug IgG1 antibody in a biological specimen. Neutralizing Binding Antidrug IgG1 Antibody Measurement Neutralizing Binding Antidrug IgG2 AB Neutralizing Binding Antidrug IgG2 Antibody A measurement of the neutralizing binding antidrug IgG2 antibody in a biological specimen. Neutralizing Binding Antidrug IgG2 Antibody Measurement Neutralizing Binding Antidrug IgG3 AB Neutralizing Binding Antidrug IgG3 Antibody A measurement of the neutralizing binding antidrug IgG3 antibody in a biological specimen. Neutralizing Binding Antidrug IgG3 Antibody Measurement Neutralizing Binding Antidrug IgG4 AB Neutralizing Binding Antidrug IgG4 Antibody A measurement of the neutralizing binding antidrug IgG4 antibody in a biological specimen. Neutralizing Binding Antidrug IgG4 Antibody Measurement Neutralizing Binding Antidrug IgM AB Neutralizing Binding Antidrug IgM Antibody A measurement of the neutralizing binding antidrug IgM antibody in a biological specimen. Neutralizing Binding Antidrug IgM Antibody Measurement Neutralizing Microbial-induced Antibody A measurement of the neutralizing binding microbial-induced antibody in a biological specimen. A neutralizing microbial-induced antibody is a type of functional antibody that's defined as antibodies that bind to, block and prevent microbes from infecting cells. The production of this antibody may be triggered by naturally occurring infection, vaccination and/or viral vector-based therapy using a whole microbe or component(s) of a microbe. Neutralizing Microbial-induced Antibody Measurement Panel Reactive Antibody Percent Reactive Antibody PRA Score A measurement of the panel reactive antibody that is achieved by mixing and assessing the reactivity between the recipient's immune cells and the donor's human leukocyte antigen, in which anti-HLA class I and class II antibody specificities are measured separately in a biological specimen. Panel Reactive Antibody Test Rapid Plasma Reagin Reagin Antibody RPR VDRL Venereal Disease Research Laboratory Test A measurement of the non-specific Treponemal antibodies produced in response to cellular damage caused by Treponema pallidum (syphilis) in a biological specimen. Rapid Plasma Reagin Measurement T-Lymphocyte Proliferation Index A relative measurement (ratio or percentage) of T-lymphocyte proliferation due to stimulation by an antigen of interest to a non-stimulated T-lymphocyte proliferation control. T-Lymphocyte Proliferation Index Thyroid Stimulating Immunoglobulin Actual/Control Thyroid Stimulating Immunoglobulin Actual/Normal TSI Actual/Control A relative measurement (ratio or percentage) of the thyroid stimulating immunoglobulin in a subject's specimen when compared to a control specimen. Thyroid Stimulating Immunoglobulin Actual to Control Ratio Measurement ISTEST Immunogenicity Specimen Assessments Test Name CDISC SDTM Immunogenicity Specimen Assessments Test Name Terminology Terminology relevant to the additional descriptions of the test being performed to produce the immunogenicity specimen test findings. FRNT50 The reciprocal of the highest sample dilution level that results in a 50% or greater reduction in the formation of viral foci. This should be reported as a titer from a focus reduction neutralization assay. Fifty Percent Focus Reduction Neutralization Titer 50% Inhibitory Concentration Half-maximal Inhibitory Concentration IC50 The concentration of the inhibitory molecule that results in a 50% or greater reduction in infectivity, biological, or biochemical function. Fifty Percent Inhibitory Concentration NF50 The quotient of the test sample ED50 value divided by the reference sample ED50 value. ED50 is the dilution of sample containing neutralizing antibody that is able to neutralize and reduce 50% of infectivity, biological or biochemical function, or total cell cytotoxicity. 50% Neutralization Factor Half-maximal Neutralization Titer NT50 The reciprocal of the highest sample dilution level that results in a 50% or greater reduction in infectivity, biological or biochemical function. This should be reported as a titer. 50 Percent Neutralization Endpoint Titer PRNT50 The reciprocal of the highest sample dilution level that results in a 50% or greater reduction in the formation of viral plaques. This should be reported as a titer from a plaque reduction neutralization assay. Fifty Percent Plaque Reduction Neutralization Endpoint Titer The concentration of the inhibitory molecule that results in a 80% or greater reduction in infectivity, biological or biochemical function. This should be reported as mass or arbitrary unit per volume. Eighty Percent Inhibitory Concentration 80% Neutralizing Titer The reciprocal of the highest sample dilution level that results in a 80% or greater reduction in infectivity, biological or biochemical function. This should be reported as a titer. Eighty Percent Neutralization Endpoint Titer IC90 The concentration of the inhibitory molecule that results in a 90% or greater reduction in infectivity, biological or biochemical function. This should be reported as mass or arbitrary unit per volume. Ninety Percent Inhibitory Concentration 90% Neutralizing Titer NT90 The reciprocal of the highest sample dilution level that results in a 90% or greater reduction in infectivity, biological or biochemical function. This should be reported as a titer. 90 Percent Neutralization Endpoint Titer Immunoblot Band Pattern A determination of the relative location an entity migrates to and settles on a immunoblot, which also indicates the specific molecular weight of that entity. Immunoblot Band Pattern Analysis Interpretation An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. Interpretation MAST 5-Grade A 5-class (0, 1, 2, 3, and 4) system used to evaluate the severity of allergic reaction by measuring the amount of circulating allergen-specific antibody, using the multiple-allergosorbent test. MAST 5-Grade MAST 7-Grade A 7-class (0, 1, 2, 3, 4, 5, and 6) system used to evaluate the severity of allergic reaction by measuring the amount of circulating allergen-specific antibody, using the multiple-allergosorbent test. MAST 7-Grade OI Opsonic Index A measurement that compares the phagocytic activity of an infected individual's blood for a particular microorganism to that of a normal person. The opsonic index is the ratio of the phagocytic index of infected or immune serum divided by the phagocytic index of normal serum. Opsonization Index Phagocytic Score An arbitrary measure of phagocytic activity (by phagocytes) that is assessed by counting the average number of ingested microorganisms per phagocyte after a period of incubation. It is calculated by counting the number of microorganisms ingested by phagocytes in a suspension of microorganisms, phagocytes, and serum (either normal or immune). Phagocytic Index RAST Class RAST Rating A score system used to evaluate the severity of allergy by measuring the amount of circulating allergen-specific antibody, using the radioallergosorbent test. RAST Score S/Co Signal/Cutoff A relative measurement (ratio) of the signal strength of a pre-specified analyte in a specimen to the signal strength of an internal cutoff standard. Signal to Cutoff Ratio Measurement Stain Pattern A determination of the distribution pattern of a stained entity. Staining Distribution Pattern ISFTSDTL Immunogenicity Specimen Test Details CDISC SDTM Immunogenicity Specimen Test Details Terminology Impact of Visual Impairment Scale test code. IVIS01-Read or Access Personal Letters Impact of Visual Impairment Scale - During the past 4 weeks, how difficult did you find it to read or access personal letters or notes? IVIS - Read or Access Personal Letters IVIS01-Read or Access Printed Materials Impact of Visual Impairment Scale - During the past 4 weeks, how difficult did you find it to read or access printed materials, such as books, magazines, newspaper, etc.? IVIS - Read or Access Printed Materials IVIS01-Read or Access Dials Impact of Visual Impairment Scale - During the past 4 weeks, how difficult did you find it to read or access dials, such as on stoves, thermostats, etc.? IVIS - Read or Access Dials IVIS01-Watch TV/ID Faces From Distance Impact of Visual Impairment Scale - During the past 4 weeks, how difficult did you find it to watch television or identify faces from a distance? IVIS - Watch TV or Identify Faces From Distance IVIS01-Identify House Number/Street Sign Impact of Visual Impairment Scale - During the past 4 weeks, how difficult did you find it to identify house numbers, street signs, etc.? IVIS - Identify House Numbers or Street Signs IVIS01TC Impact of Visual Impairment Scale Questionnaire Test Code CDISC Questionnaire Impact of Visual Impairment Scale Test Code Terminology Impact of Visual Impairment Scale test name. IVIS01-Identify House Number/Street Sign Impact of Visual Impairment Scale - During the past 4 weeks, how difficult did you find it to identify house numbers, street signs, etc.? IVIS - Identify House Numbers or Street Signs IVIS01-Read or Access Dials Impact of Visual Impairment Scale - During the past 4 weeks, how difficult did you find it to read or access dials, such as on stoves, thermostats, etc.? IVIS - Read or Access Dials IVIS01-Read or Access Personal Letters Impact of Visual Impairment Scale - During the past 4 weeks, how difficult did you find it to read or access personal letters or notes? IVIS - Read or Access Personal Letters IVIS01-Read or Access Printed Materials Impact of Visual Impairment Scale - During the past 4 weeks, how difficult did you find it to read or access printed materials, such as books, magazines, newspaper, etc.? IVIS - Read or Access Printed Materials IVIS01-Watch TV/ID Faces From Distance Impact of Visual Impairment Scale - During the past 4 weeks, how difficult did you find it to watch television or identify faces from a distance? IVIS - Watch TV or Identify Faces From Distance IVIS01TN Impact of Visual Impairment Scale Questionnaire Test Name CDISC Questionnaire Impact of Visual Impairment Scale Test Name Terminology A terminology codelist relevant to the complexity of the ingredients within a product. An ingredient comprising more than one single ingredient, which could include flavoring or multiple single types of leaf tobacco. (FDA CTP) Complex Ingredient An individual chemical substance (e.g., sodium chloride, ammonium hydroxide) which may be purchased or prepared in-house and purified and is to be uniquely identified by using a unique scientific name or code, such as the FDA UNII (Unique Ingredient Identifiers) code, Chemical Abstracts Service (CAS) number, or International Union of Pure and Applied Chemistry (IUPAC) name; or a tobacco ingredient that is not a complex ingredient (e.g., burley leaf). (FDA CTP) Single Ingredient IGDCMPLX Ingredient Complexity Response CDISC SDTM Ingredient Complexity Response Terminology A terminology codelist to describe the test codes for examinations of the integumentary system. Affected Body Surface Area/Total Body Surface Area Affected BSA/Total BSA A relative measurement (ratio or percentage) of the affected body surface area to total body surface area. Affected Body Surface Area to Total Body Surface Area Ratio Measurement Integumentary System Examination An observation, assessment or examination of the integumentary system. Integumentary System Examination Skin Type A distinctive characteristic of the skin marked by the amount of sebum secreted by sebaceous glands. Skin Type INTEGUCD Integumentary System Test Code CDISC SDTM Integumentary System Test Code Terminology A terminology codelist to describe the test names for examinations of the integumentary system. Affected Body Surface Area/Total Body Surface Area Affected BSA/Total BSA A relative measurement (ratio or percentage) of the affected body surface area to total body surface area. Affected Body Surface Area to Total Body Surface Area Ratio Measurement Integumentary System Examination An observation, assessment or examination of the integumentary system. Integumentary System Examination Skin Type A distinctive characteristic of the skin marked by the amount of sebum secreted by sebaceous glands. Skin Type INTEGU Integumentary System Test Name CDISC SDTM Integumentary System Test Name Terminology International Index of Erectile Function test code. IIEF01-Erection During Sexual Activity IIEF01-Erection Frequency International Index of Erectile Function - Over the past four weeks how often were you able to get an erection during sexual activity? IIEF - Able to Get an Erection During Sexual Activity IIEF01-Erection Firmness IIEF01-Erection Hard Enough to Penetrate International Index of Erectile Function - Over the past four weeks when you had erections with sexual stimulation, how often were your erections hard enough for penetration? IIEF - Erections Hard Enough for Penetration IIEF01-Able to Penetrate Your Partner IIEF01-Penetration Ability International Index of Erectile Function - Over the past four weeks when you attempted sexual intercourse, how often were you able to penetrate (enter) your partner? IIEF - Able to Penetrate Your Partner IIEF01-Maintain Erection After Penetrate IIEF01-Maintenance Frequency International Index of Erectile Function - Over the past four weeks during sexual intercourse, how often were you able to maintain your erection after you had penetrated (entered) your partner? IIEF - Able to Maintain Your Erection After You Had Penetrated Your Partner IIEF01-Maintain Erection to Completion IIEF01-Maintenance Ability International Index of Erectile Function - Over the past four weeks during sexual intercourse, how difficult was it to maintain your erection to completion of intercourse? IIEF - Maintain Your Erection to Completion of Intercourse IIEF01-Intercourse Frequency IIEF01-Times Attempted Sexual Intercours International Index of Erectile Function - Over the past four weeks how many times have you attempted sexual intercourse? IIEF - How Many Times Have You Attempted Sexual Intercourse IIEF01-How Often was it Satisfactory IIEF01-Intercourse Satisfaction International Index of Erectile Function - Over the past four weeks when you attempted sexual intercourse, how often was it satisfactory for you? IIEF - How Often was it Satisfactory for You IIEF01-Enjoyed Sexual Intercourse IIEF01-Intercourse Enjoyment International Index of Erectile Function - Over the past four weeks how much have you enjoyed sexual intercourse? IIEF - How Much Have You Enjoyed Sexual Intercourse IIEF01-Ejaculation Frequency IIEF01-How Often Did You Ejaculate International Index of Erectile Function - Over the past four weeks when you had sexual stimulation or intercourse, how often did you ejaculate? IIEF - How Often Did You Ejaculate IIEF01-Did You Have Feeling of Orgasm IIEF01-Orgasm Frequency International Index of Erectile Function - Over the past four weeks when you had sexual stimulation or intercourse, how often did you have the feeling of orgasm with our without ejaculation? IIEF - Did You Have Feeling of Orgasm With or Without Ejaculation IIEF01-Desire Frequency IIEF01-Have You Felt Sexual Desire International Index of Erectile Function - Over the past four weeks how often have you felt sexual desire? IIEF - How Often Have You Felt Sexual Desire IIEF01-Desire Level IIEF01-Rate Your Level of Sexual Desire International Index of Erectile Function - Over the past four weeks how would you rate your level of sexual desire? IIEF - Rate Your Level of Sexual Desire IIEF01-Overall Satisfaction IIEF01-Satisfied with Overall Sex Life International Index of Erectile Function - Over the past four weeks how satisfied have you been with your overall sex life? IIEF - Satisfied with Overall Sex Life IIEF01-Relationship Satisfaction IIEF01-Satisfy with Sexual Relationship International Index of Erectile Function - Over the past four weeks how satisfied have you been with your sexual relationship with your partner? IIEF - Satisfied with Your Sexual Relationship with Your Partner IIEF01-Confidence to Get/Keep Erection IIEF01-Erection Confidence International Index of Erectile Function - Over the past four weeks how do you rate your confidence that you could get and keep an erection? IIEF - Your Confidence to Get and Keep an Erection IIEF01TC International Index of Erectile Function Questionnaire Test Code CDISC Questionnaire IIEF Test Code Terminology International Index of Erectile Function test name. IIEF01-Able to Penetrate Your Partner IIEF01-Penetration Ability International Index of Erectile Function - Over the past four weeks when you attempted sexual intercourse, how often were you able to penetrate (enter) your partner? IIEF - Able to Penetrate Your Partner IIEF01-Confidence to Get/Keep Erection IIEF01-Erection Confidence International Index of Erectile Function - Over the past four weeks how do you rate your confidence that you could get and keep an erection? IIEF - Your Confidence to Get and Keep an Erection IIEF01-Did You Have Feeling of Orgasm IIEF01-Orgasm Frequency International Index of Erectile Function - Over the past four weeks when you had sexual stimulation or intercourse, how often did you have the feeling of orgasm with our without ejaculation? IIEF - Did You Have Feeling of Orgasm With or Without Ejaculation IIEF01-Enjoyed Sexual Intercourse IIEF01-Intercourse Enjoyment International Index of Erectile Function - Over the past four weeks how much have you enjoyed sexual intercourse? IIEF - How Much Have You Enjoyed Sexual Intercourse IIEF01-Erection During Sexual Activity IIEF01-Erection Frequency International Index of Erectile Function - Over the past four weeks how often were you able to get an erection during sexual activity? IIEF - Able to Get an Erection During Sexual Activity IIEF01-Erection Firmness IIEF01-Erection Hard Enough to Penetrate International Index of Erectile Function - Over the past four weeks when you had erections with sexual stimulation, how often were your erections hard enough for penetration? IIEF - Erections Hard Enough for Penetration IIEF01-Desire Frequency IIEF01-Have You Felt Sexual Desire International Index of Erectile Function - Over the past four weeks how often have you felt sexual desire? IIEF - How Often Have You Felt Sexual Desire IIEF01-Ejaculation Frequency IIEF01-How Often Did You Ejaculate International Index of Erectile Function - Over the past four weeks when you had sexual stimulation or intercourse, how often did you ejaculate? IIEF - How Often Did You Ejaculate IIEF01-How Often was it Satisfactory IIEF01-Intercourse Satisfaction International Index of Erectile Function - Over the past four weeks when you attempted sexual intercourse, how often was it satisfactory for you? IIEF - How Often was it Satisfactory for You IIEF01-Maintain Erection After Penetrate IIEF01-Maintenance Frequency International Index of Erectile Function - Over the past four weeks during sexual intercourse, how often were you able to maintain your erection after you had penetrated (entered) your partner? IIEF - Able to Maintain Your Erection After You Had Penetrated Your Partner IIEF01-Maintain Erection to Completion IIEF01-Maintenance Ability International Index of Erectile Function - Over the past four weeks during sexual intercourse, how difficult was it to maintain your erection to completion of intercourse? IIEF - Maintain Your Erection to Completion of Intercourse IIEF01-Desire Level IIEF01-Rate Your Level of Sexual Desire International Index of Erectile Function - Over the past four weeks how would you rate your level of sexual desire? IIEF - Rate Your Level of Sexual Desire IIEF01-Overall Satisfaction IIEF01-Satisfied with Overall Sex Life International Index of Erectile Function - Over the past four weeks how satisfied have you been with your overall sex life? IIEF - Satisfied with Overall Sex Life IIEF01-Relationship Satisfaction IIEF01-Satisfy with Sexual Relationship International Index of Erectile Function - Over the past four weeks how satisfied have you been with your sexual relationship with your partner? IIEF - Satisfied with Your Sexual Relationship with Your Partner IIEF01-Intercourse Frequency IIEF01-Times Attempted Sexual Intercours International Index of Erectile Function - Over the past four weeks how many times have you attempted sexual intercourse? IIEF - How Many Times Have You Attempted Sexual Intercourse IIEF01TN International Index of Erectile Function Questionnaire Test Name CDISC Questionnaire IIEF Test Name Terminology International Physical Activity Questionnaire (August 2002) Short Last 7 Days Self-Administered Format test code. IPA04-Days Vigorous Physical Activities International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do vigorous physical activities like heavy lifting, digging, aerobics, or fast bicycling?: days per week. IPAQ Short Last 7 Days Self-administered Format Version - Days Vigorous Physical Activities IPA04-Vigorous Physical Hr & Min per Day International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Self-Administered Format - How much time did you usually spend doing vigorous physical activities on one of those days?: hours and minutes per day. IPAQ Short Last 7 Days Self-administered Format Version - Vigorous Physical Hr and Min per Day IPA04-Days Moderate Physical Activities International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do moderate physical activities like carrying light loads, bicycling at a regular pace, or doubles tennis?: days per week. IPAQ Short Last 7 Days Self-administered Format Version - Days Moderate Physical Activities IPA04-Moderate Physical Hr & Min per Day International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Self-Administered Format - How much time did you usually spend doing moderate physical activities on one of those days?: hours and minutes per day. IPAQ Short Last 7 Days Self-administered Format Version - Moderate Physical Hr and Min per Day IPA04-Days Walk at Least 10 Minutes International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you walk for at least 10 minutes at a time?: days per week. IPAQ Short Last 7 Days Self-administered Format Version - Days Walk at Least 10 Minutes IPA04-Walking Hr & Min per Day International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Self-Administered Format - How much time did you usually spend walking on one of those days?: hours and minutes per day. IPAQ Short Last 7 Days Self-administered Format Version - Walking Hr and Min per Day IPA04-Sitting Weekday Hr & Min per Day International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Self-Administered Format - During the last 7 days, how much time did you spend sitting on a weekday?: hours and minutes per day. IPAQ Short Last 7 Days Self-administered Format Version - Sitting Weekday Hr and Min per Day IPAQ04TC International Physical Activity Questionnaire (August 2002) Short Last 7 Days Self-Administered Format Questionnaire Test Code CDISC Questionnaire IPAQ Short Last 7 Days Self-administered Format Version Test Code Terminology International Physical Activity Questionnaire (August 2002) Short Last 7 Days Self-Administered Format test name. IPA04-Days Moderate Physical Activities International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do moderate physical activities like carrying light loads, bicycling at a regular pace, or doubles tennis?: days per week. IPAQ Short Last 7 Days Self-administered Format Version - Days Moderate Physical Activities IPA04-Days Vigorous Physical Activities International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do vigorous physical activities like heavy lifting, digging, aerobics, or fast bicycling?: days per week. IPAQ Short Last 7 Days Self-administered Format Version - Days Vigorous Physical Activities IPA04-Days Walk at Least 10 Minutes International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you walk for at least 10 minutes at a time?: days per week. IPAQ Short Last 7 Days Self-administered Format Version - Days Walk at Least 10 Minutes IPA04-Moderate Physical Hr & Min per Day International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Self-Administered Format - How much time did you usually spend doing moderate physical activities on one of those days?: hours and minutes per day. IPAQ Short Last 7 Days Self-administered Format Version - Moderate Physical Hr and Min per Day IPA04-Sitting Weekday Hr & Min per Day International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Self-Administered Format - During the last 7 days, how much time did you spend sitting on a weekday?: hours and minutes per day. IPAQ Short Last 7 Days Self-administered Format Version - Sitting Weekday Hr and Min per Day IPA04-Vigorous Physical Hr & Min per Day International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Self-Administered Format - How much time did you usually spend doing vigorous physical activities on one of those days?: hours and minutes per day. IPAQ Short Last 7 Days Self-administered Format Version - Vigorous Physical Hr and Min per Day IPA04-Walking Hr & Min per Day International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Self-Administered Format - How much time did you usually spend walking on one of those days?: hours and minutes per day. IPAQ Short Last 7 Days Self-administered Format Version - Walking Hr and Min per Day IPAQ04TN International Physical Activity Questionnaire (August 2002) Short Last 7 Days Self-Administered Format Questionnaire Test Name CDISC Questionnaire IPAQ Short Last 7 Days Self-administered Format Version Test Name Terminology International Physical Activity Questionnaire (August 2002) Short Last 7 Days Telephone Format test code. IPA01-Days Vigorous Physical Activities International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - During the last 7 days, on how many days did you do vigorous physical activities? IPAQ Short Last 7 Days Telephone Format Version - Days Vigorous Physical Activities IPA01-Vigorous Physical Hr & Min per Day International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - How much time did you usually spend doing vigorous physical activities on one of those days?: Hours and minutes per day. IPAQ Short Last 7 Days Telephone Format Version - Vigorous Physical Hr and Min per Day IPA01-Total Vigorous Hr & Min per Week International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - How much time in total would you spend over the last 7 days doing vigorous physical activities?: Hours and minutes per week. IPAQ Short Last 7 Days Telephone Format Version - Total Vigorous Hr and Min per Week IPA01-Days Moderate Physical Activities International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - During the last 7 days, on how many days did you do moderate physical activities? IPAQ Short Last 7 Days Telephone Format Version - Days Moderate Physical Activities IPA01-Moderate Physical Hr & Min per Day International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - How much time did you usually spend doing moderate physical activities on one of those days?: Hours and minutes per day. IPAQ Short Last 7 Days Telephone Format Version - Moderate Physical Hr and Min per Day IPA01-Total Moderate Hr & Min per Week International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing moderate physical activities?: Hours and minutes per week. IPAQ Short Last 7 Days Telephone Format Version - Total Moderate Hr and Min per Week IPA01-Days Walk at Least 10 Minutes International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - During the last 7 days, on how many days did you walk for at least 10 minutes at a time? IPAQ Short Last 7 Days Telephone Format Version - Days Walk at Least 10 Minutes IPA01-Walking Hr & Min per Day International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - How much time did you usually spend walking on one of those days?: Hours and minutes per day. IPAQ Short Last 7 Days Telephone Format Version - Walking Hr and Min per Day IPA01-Total Walking Hr & Min per Week International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - What is the total amount of time you spent walking over the last 7 days?: Hours and minutes per week. IPAQ Short Last 7 Days Telephone Format Version - Total Walking Hr and Min per Week IPA01-Sitting Hr & Min per Weekday International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - During the last 7 days, how much time did you usually spend sitting on a weekday?: Hours and minutes per weekday. IPAQ Short Last 7 Days Telephone Format Version - Sitting Hr and Min per Weekday IPA01-Total Sitting Hr & Min Wednesday International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - What is the total amount of time you spent sitting last Wednesday?: Hours and minutes on Wednesday. IPAQ Short Last 7 Days Telephone Format Version - Total Sitting Hr and Min Wednesday IPAQ01TC International Physical Activity Questionnaire (August 2002) Short Last 7 Days Telephone Format Questionnaire Test Code CDISC Questionnaire IPAQ Short Last 7 Days Telephone Format Version Test Code Terminology International Physical Activity Questionnaire (August 2002) Short Last 7 Days Telephone Format test name. IPA01-Days Moderate Physical Activities International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - During the last 7 days, on how many days did you do moderate physical activities? IPAQ Short Last 7 Days Telephone Format Version - Days Moderate Physical Activities IPA01-Days Vigorous Physical Activities International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - During the last 7 days, on how many days did you do vigorous physical activities? IPAQ Short Last 7 Days Telephone Format Version - Days Vigorous Physical Activities IPA01-Days Walk at Least 10 Minutes International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - During the last 7 days, on how many days did you walk for at least 10 minutes at a time? IPAQ Short Last 7 Days Telephone Format Version - Days Walk at Least 10 Minutes IPA01-Moderate Physical Hr & Min per Day International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - How much time did you usually spend doing moderate physical activities on one of those days?: Hours and minutes per day. IPAQ Short Last 7 Days Telephone Format Version - Moderate Physical Hr and Min per Day IPA01-Sitting Hr & Min per Weekday International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - During the last 7 days, how much time did you usually spend sitting on a weekday?: Hours and minutes per weekday. IPAQ Short Last 7 Days Telephone Format Version - Sitting Hr and Min per Weekday IPA01-Total Moderate Hr & Min per Week International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing moderate physical activities?: Hours and minutes per week. IPAQ Short Last 7 Days Telephone Format Version - Total Moderate Hr and Min per Week IPA01-Total Sitting Hr & Min Wednesday International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - What is the total amount of time you spent sitting last Wednesday?: Hours and minutes on Wednesday. IPAQ Short Last 7 Days Telephone Format Version - Total Sitting Hr and Min Wednesday IPA01-Total Vigorous Hr & Min per Week International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - How much time in total would you spend over the last 7 days doing vigorous physical activities?: Hours and minutes per week. IPAQ Short Last 7 Days Telephone Format Version - Total Vigorous Hr and Min per Week IPA01-Total Walking Hr & Min per Week International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - What is the total amount of time you spent walking over the last 7 days?: Hours and minutes per week. IPAQ Short Last 7 Days Telephone Format Version - Total Walking Hr and Min per Week IPA01-Vigorous Physical Hr & Min per Day International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - How much time did you usually spend doing vigorous physical activities on one of those days?: Hours and minutes per day. IPAQ Short Last 7 Days Telephone Format Version - Vigorous Physical Hr and Min per Day IPA01-Walking Hr & Min per Day International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - How much time did you usually spend walking on one of those days?: Hours and minutes per day. IPAQ Short Last 7 Days Telephone Format Version - Walking Hr and Min per Day IPAQ01TN International Physical Activity Questionnaire (August 2002) Short Last 7 Days Telephone Format Questionnaire Test Name CDISC Questionnaire IPAQ Short Last 7 Days Telephone Format Version Test Name Terminology International Physical Activity Questionnaire (November 2002) Long Last 7 Days Telephone Format test code. IPA02-Currently Have Job or Unpaid Work International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - Do you currently have a job or do any unpaid work outside your home? IPAQ Long Last 7 Days Telephone Format Version - Currently Have Job or Unpaid Work IPA02-Days Vigorous as Part of Work International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you do vigorous physical activities as part of your work? IPAQ Long Last 7 Days Telephone Format Version - Days Vigorous as Part of Work IPA02-Vigorous Work Hr & Min per Day International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days doing vigorous physical activities as part of your work?: Hours and minutes per day. IPAQ Long Last 7 Days Telephone Format Version - Vigorous Work Hr and Min per Day IPA02-Vigorous Work Hr & Min per Week International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing vigorous physical activities as part of your work?: Hours and minutes per week. IPAQ Long Last 7 Days Telephone Format Version - Vigorous Work Hr and Min per Week IPA02-Days Moderate as Part of Work International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you do moderate physical activities as part of your work? IPAQ Long Last 7 Days Telephone Format Version - Days Moderate as Part of Work IPA02-Moderate Work Hr & Min per Day International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days doing moderate physical activities as part of your work?: Hours and minutes per day. IPAQ Long Last 7 Days Telephone Format Version - Moderate Work Hr and Min per Day IPA02-Moderate Work Hr & Min per Week International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing moderate physical activities as part of your work?: Hours and minutes per week. IPAQ Long Last 7 Days Telephone Format Version - Moderate Work Hr and Min per Week IPA02-Days Walk as Part of Your Work International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you walk as part of your work? IPAQ Long Last 7 Days Telephone Format Version - Days Walk as Part of Your Work IPA02-Walking Work Hr & Min per Day International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days walking as part of your work?: Hours and minutes per day. IPAQ Long Last 7 Days Telephone Format Version - Walking Work Hr and Min per Day IPA02-Walking Work Hr & Min per Week International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent walking over the last 7 days as part of your work?: Hours and minutes per week. IPAQ Long Last 7 Days Telephone Format Version - Walking Work Hr and Min per Week IPA02-Days Travel in a Motor Vehicle International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you travel in a motor vehicle like a train, bus, car or tram? IPAQ Long Last 7 Days Telephone Format Version - Days Travel in a Motor Vehicle IPA02-Traveling Hr & Min per Day International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days traveling in a car, bus, train or other kind of motor vehicle?: Hours and minutes per day. IPAQ Long Last 7 Days Telephone Format Version - Traveling Hr and Min per Day IPA02-Traveling Hr & Min per Week International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days traveling in a motor vehicle?: Hours and minutes per week. IPAQ Long Last 7 Days Telephone Format Version - Traveling Hr and Min per Week IPA02-Days Bicycle Place to Place International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you bicycle to go from place to place? IPAQ Long Last 7 Days Telephone Format Version - Days Bicycle Place to Place IPA02-Bicycle Hr & Min per Day International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days to bicycle from place to place?: Hours and minutes per day. IPAQ Long Last 7 Days Telephone Format Version - Bicycle Hr and Min per Day IPA02-Bicycling Hr & Min per Week International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent bicycling over the last 7 days to travel from place to place?: Hours and minutes per week. IPAQ Long Last 7 Days Telephone Format Version - Bicycling Hr and Min per Week IPA02-Days Walk Place to Place International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you walk to go from place to place? IPAQ Long Last 7 Days Telephone Format Version - Days Walk Place to Place IPA02-Walking Place Hr & Min per Day International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days walking from place to place?: Hours and minutes per day. IPAQ Long Last 7 Days Telephone Format Version - Walking Place Hr and Min per Day IPA02-Walking Place Hr & Min per Week International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days walking from place to place?: Hours and minutes per week. IPAQ Long Last 7 Days Telephone Format Version - Walking Place Hr and Min per Week IPA02-Days Vigorous in the Garden/Yard International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you do vigorous physical activities in the garden or yard? IPAQ Long Last 7 Days Telephone Format Version - Days Vigorous in the Garden/Yard IPA02-Vigorous Garden Hr & Min per Day International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days doing vigorous physical activities in the garden or yard?: Hours and minutes per day. IPAQ Long Last 7 Days Telephone Format Version - Vigorous Garden Hr and Min per Day IPA02-Vigorous Garden Hr & Min per Week International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing vigorous physical activities in the garden or yard?: Hours and minutes per week. IPAQ Long Last 7 Days Telephone Format Version - Vigorous Garden Hr and Min per Week IPA02-Days Moderate in the Garden/Yard International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you do moderate activities in the garden or yard? IPAQ Long Last 7 Days Telephone Format Version - Days Moderate in the Garden/Yard IPA02-Moderate Garden Hr & Min per Day International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days doing moderate physical activities in the garden or yard?: Hours and minutes per day. IPAQ Long Last 7 Days Telephone Format Version - Moderate Garden Hr and Min per Day IPA02-Moderate Garden Hr & Min per Week International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing moderate physical activities in the garden or yard?: Hours and minutes per week. IPAQ Long Last 7 Days Telephone Format Version - Moderate Garden Hr and Min per Week IPA02-Days Moderate Inside Your Home International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you do moderate activities inside your home? IPAQ Long Last 7 Days Telephone Format Version - Days Moderate Inside Your Home IPA02-Moderate Home Hr & Min per Day International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days doing moderate physical activities inside your home?: Hours and minutes per day. IPAQ Long Last 7 Days Telephone Format Version - Moderate Home Hr and Min per Day IPA02-Moderate Home Hr & Min per Week International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing moderate physical activities inside your home?: Hours and minutes per week. IPAQ Long Last 7 Days Telephone Format Version - Moderate Home Hr and Min per Week IPA02-Days Walk in Your Leisure Time International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - Not counting any walking you have already mentioned, during the last 7 days, on how many days did you walk for at least 10 minutes at a time in your leisure time? IPAQ Long Last 7 Days Telephone Format Version - Days Walk in Your Leisure Time IPA02-Walking Leisure Hr & Min per Day International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days walking in your leisure time?: Hours and minutes per day. IPAQ Long Last 7 Days Telephone Format Version - Walking Leisure Hr and Min per Day IPA02-Walking Leisure Hr & Min per Week International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days walking in your leisure time?: Hours and minutes per week. IPAQ Long Last 7 Days Telephone Format Version - Walking Leisure Hr and Min per Week IPA02-Days Vigorous in Your Leisure Time International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you do vigorous physical activities in your leisure time? IPAQ Long Last 7 Days Telephone Format Version - Days Vigorous in Your Leisure Time IPA02-Vigorous Leisure Hr & Min per Day International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days doing vigorous physical activities in your leisure time?: Hours and minutes per day. IPAQ Long Last 7 Days Telephone Format Version - Vigorous Leisure Hr and Min per Day IPA02-Vigorous Leisure Hr & Min per Week International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing vigorous physical activities in your leisure time?: Hours and minutes per week. IPAQ Long Last 7 Days Telephone Format Version - Vigorous Leisure Hr and Min per Week IPA02-Days Moderate in Your Leisure Time International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you do moderate physical activities in your leisure time? IPAQ Long Last 7 Days Telephone Format Version - Days Moderate in Your Leisure Time IPA02-Moderate Leisure Hr & Min per Day International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days doing moderate physical activities in your leisure time?: Hours and minutes per day. IPAQ Long Last 7 Days Telephone Format Version - Moderate Leisure Hr and Min per Day IPA02-Moderate Leisure Hr & Min per Week International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing moderate physical activities in your leisure time?: Hours and minutes per week. IPAQ Long Last 7 Days Telephone Format Version - Moderate Leisure Hr and Min per Week IPA02-Sitting Weekday Hr & Min per Day International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, how much time did you usually spend sitting on a weekday?: Hours and minutes per day. IPAQ Long Last 7 Days Telephone Format Version - Sitting Weekday Hr and Min per Day IPA02-Sitting Hr & Min on Wednesday International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time in total did you spend sitting on Wednesday?: Hours and minutes on Wednesday. IPAQ Long Last 7 Days Telephone Format Version - Sitting Hr and Min on Wednesday IPA02-Sitting Weekend Hr & Min per Day International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, how much time did you usually spend sitting on a weekend day?: Hours and minutes per day. IPAQ Long Last 7 Days Telephone Format Version - Sitting Weekend Hr and Min per Day IPA02-Sitting Hr & Min on Saturday International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time in total did you spend sitting on Saturday?: Hours and minutes on Saturday. IPAQ Long Last 7 Days Telephone Format Version - Sitting Hr and Min on Saturday IPAQ02TC International Physical Activity Questionnaire (November 2002) Long Last 7 Days Telephone Format Questionnaire Test Code CDISC Questionnaire IPAQ Long Last 7 Days Telephone Format Version Test Code Terminology International Physical Activity Questionnaire (November 2002) Long Last 7 Days Telephone Format test name. IPA02-Bicycle Hr & Min per Day International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days to bicycle from place to place?: Hours and minutes per day. IPAQ Long Last 7 Days Telephone Format Version - Bicycle Hr and Min per Day IPA02-Bicycling Hr & Min per Week International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent bicycling over the last 7 days to travel from place to place?: Hours and minutes per week. IPAQ Long Last 7 Days Telephone Format Version - Bicycling Hr and Min per Week IPA02-Currently Have Job or Unpaid Work International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - Do you currently have a job or do any unpaid work outside your home? IPAQ Long Last 7 Days Telephone Format Version - Currently Have Job or Unpaid Work IPA02-Days Bicycle Place to Place International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you bicycle to go from place to place? IPAQ Long Last 7 Days Telephone Format Version - Days Bicycle Place to Place IPA02-Days Moderate as Part of Work International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you do moderate physical activities as part of your work? IPAQ Long Last 7 Days Telephone Format Version - Days Moderate as Part of Work IPA02-Days Moderate in the Garden/Yard International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you do moderate activities in the garden or yard? IPAQ Long Last 7 Days Telephone Format Version - Days Moderate in the Garden/Yard IPA02-Days Moderate in Your Leisure Time International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you do moderate physical activities in your leisure time? IPAQ Long Last 7 Days Telephone Format Version - Days Moderate in Your Leisure Time IPA02-Days Moderate Inside Your Home International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you do moderate activities inside your home? IPAQ Long Last 7 Days Telephone Format Version - Days Moderate Inside Your Home IPA02-Days Travel in a Motor Vehicle International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you travel in a motor vehicle like a train, bus, car or tram? IPAQ Long Last 7 Days Telephone Format Version - Days Travel in a Motor Vehicle IPA02-Days Vigorous as Part of Work International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you do vigorous physical activities as part of your work? IPAQ Long Last 7 Days Telephone Format Version - Days Vigorous as Part of Work IPA02-Days Vigorous in the Garden/Yard International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you do vigorous physical activities in the garden or yard? IPAQ Long Last 7 Days Telephone Format Version - Days Vigorous in the Garden/Yard IPA02-Days Vigorous in Your Leisure Time International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you do vigorous physical activities in your leisure time? IPAQ Long Last 7 Days Telephone Format Version - Days Vigorous in Your Leisure Time IPA02-Days Walk as Part of Your Work International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you walk as part of your work? IPAQ Long Last 7 Days Telephone Format Version - Days Walk as Part of Your Work IPA02-Days Walk in Your Leisure Time International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - Not counting any walking you have already mentioned, during the last 7 days, on how many days did you walk for at least 10 minutes at a time in your leisure time? IPAQ Long Last 7 Days Telephone Format Version - Days Walk in Your Leisure Time IPA02-Days Walk Place to Place International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you walk to go from place to place? IPAQ Long Last 7 Days Telephone Format Version - Days Walk Place to Place IPA02-Moderate Garden Hr & Min per Day International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days doing moderate physical activities in the garden or yard?: Hours and minutes per day. IPAQ Long Last 7 Days Telephone Format Version - Moderate Garden Hr and Min per Day IPA02-Moderate Garden Hr & Min per Week International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing moderate physical activities in the garden or yard?: Hours and minutes per week. IPAQ Long Last 7 Days Telephone Format Version - Moderate Garden Hr and Min per Week IPA02-Moderate Home Hr & Min per Day International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days doing moderate physical activities inside your home?: Hours and minutes per day. IPAQ Long Last 7 Days Telephone Format Version - Moderate Home Hr and Min per Day IPA02-Moderate Home Hr & Min per Week International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing moderate physical activities inside your home?: Hours and minutes per week. IPAQ Long Last 7 Days Telephone Format Version - Moderate Home Hr and Min per Week IPA02-Moderate Leisure Hr & Min per Day International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days doing moderate physical activities in your leisure time?: Hours and minutes per day. IPAQ Long Last 7 Days Telephone Format Version - Moderate Leisure Hr and Min per Day IPA02-Moderate Leisure Hr & Min per Week International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing moderate physical activities in your leisure time?: Hours and minutes per week. IPAQ Long Last 7 Days Telephone Format Version - Moderate Leisure Hr and Min per Week IPA02-Moderate Work Hr & Min per Day International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days doing moderate physical activities as part of your work?: Hours and minutes per day. IPAQ Long Last 7 Days Telephone Format Version - Moderate Work Hr and Min per Day IPA02-Moderate Work Hr & Min per Week International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing moderate physical activities as part of your work?: Hours and minutes per week. IPAQ Long Last 7 Days Telephone Format Version - Moderate Work Hr and Min per Week IPA02-Sitting Hr & Min on Saturday International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time in total did you spend sitting on Saturday?: Hours and minutes on Saturday. IPAQ Long Last 7 Days Telephone Format Version - Sitting Hr and Min on Saturday IPA02-Sitting Hr & Min on Wednesday International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time in total did you spend sitting on Wednesday?: Hours and minutes on Wednesday. IPAQ Long Last 7 Days Telephone Format Version - Sitting Hr and Min on Wednesday IPA02-Sitting Weekday Hr & Min per Day International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, how much time did you usually spend sitting on a weekday?: Hours and minutes per day. IPAQ Long Last 7 Days Telephone Format Version - Sitting Weekday Hr and Min per Day IPA02-Sitting Weekend Hr & Min per Day International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, how much time did you usually spend sitting on a weekend day?: Hours and minutes per day. IPAQ Long Last 7 Days Telephone Format Version - Sitting Weekend Hr and Min per Day IPA02-Traveling Hr & Min per Day International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days traveling in a car, bus, train or other kind of motor vehicle?: Hours and minutes per day. IPAQ Long Last 7 Days Telephone Format Version - Traveling Hr and Min per Day IPA02-Traveling Hr & Min per Week International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days traveling in a motor vehicle?: Hours and minutes per week. IPAQ Long Last 7 Days Telephone Format Version - Traveling Hr and Min per Week IPA02-Vigorous Garden Hr & Min per Day International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days doing vigorous physical activities in the garden or yard?: Hours and minutes per day. IPAQ Long Last 7 Days Telephone Format Version - Vigorous Garden Hr and Min per Day IPA02-Vigorous Garden Hr & Min per Week International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing vigorous physical activities in the garden or yard?: Hours and minutes per week. IPAQ Long Last 7 Days Telephone Format Version - Vigorous Garden Hr and Min per Week IPA02-Vigorous Leisure Hr & Min per Day International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days doing vigorous physical activities in your leisure time?: Hours and minutes per day. IPAQ Long Last 7 Days Telephone Format Version - Vigorous Leisure Hr and Min per Day IPA02-Vigorous Leisure Hr & Min per Week International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing vigorous physical activities in your leisure time?: Hours and minutes per week. IPAQ Long Last 7 Days Telephone Format Version - Vigorous Leisure Hr and Min per Week IPA02-Vigorous Work Hr & Min per Day International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days doing vigorous physical activities as part of your work?: Hours and minutes per day. IPAQ Long Last 7 Days Telephone Format Version - Vigorous Work Hr and Min per Day IPA02-Vigorous Work Hr & Min per Week International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing vigorous physical activities as part of your work?: Hours and minutes per week. IPAQ Long Last 7 Days Telephone Format Version - Vigorous Work Hr and Min per Week IPA02-Walking Leisure Hr & Min per Day International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days walking in your leisure time?: Hours and minutes per day. IPAQ Long Last 7 Days Telephone Format Version - Walking Leisure Hr and Min per Day IPA02-Walking Leisure Hr & Min per Week International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days walking in your leisure time?: Hours and minutes per week. IPAQ Long Last 7 Days Telephone Format Version - Walking Leisure Hr and Min per Week IPA02-Walking Place Hr & Min per Day International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days walking from place to place?: Hours and minutes per day. IPAQ Long Last 7 Days Telephone Format Version - Walking Place Hr and Min per Day IPA02-Walking Place Hr & Min per Week International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days walking from place to place?: Hours and minutes per week. IPAQ Long Last 7 Days Telephone Format Version - Walking Place Hr and Min per Week IPA02-Walking Work Hr & Min per Day International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days walking as part of your work?: Hours and minutes per day. IPAQ Long Last 7 Days Telephone Format Version - Walking Work Hr and Min per Day IPA02-Walking Work Hr & Min per Week International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent walking over the last 7 days as part of your work?: Hours and minutes per week. IPAQ Long Last 7 Days Telephone Format Version - Walking Work Hr and Min per Week IPAQ02TN International Physical Activity Questionnaire (November 2002) Long Last 7 Days Telephone Format Questionnaire Test Name CDISC Questionnaire IPAQ Long Last 7 Days Telephone Format Version Test Name Terminology International Physical Activity Questionnaire (October 2002) Long Last 7 Days Self-Administered Format test code. IPA03-Currently Have Job or Unpaid Work International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - Do you currently have a job or do any unpaid work outside your home? IPAQ Long Last 7 Days Self-Administered Format Version - Currently Have Job or Unpaid Work IPA03-Days Vigorous as Part of Work International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do vigorous physical activities like heavy lifting, digging, heavy construction, or climbing up stairs as part of your work?: days per week. IPAQ Long Last 7 Days Self-Administered Format Version - Days Vigorous as Part of Work IPA03-Vigorous Work Hr & Min per Day International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days doing vigorous physical activities as part of your work?: hours and minutes per day. IPAQ Long Last 7 Days Self-Administered Format Version - Vigorous Work Hr and Min per Day IPA03-Days Moderate as Part of Work International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do moderate physical activities like carrying light loads as part of your work?: days per week. IPAQ Long Last 7 Days Self-Administered Format Version - Days Moderate as Part of Work IPA03-Moderate Work Hr & Min per Day International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days doing moderate physical activities as part of your work?: hours and minutes per day. IPAQ Long Last 7 Days Self-Administered Format Version - Moderate Work Hr and Min per Day IPA03-Days Walk as Part of Your Work International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you walk for at least 10 minutes at a time as part of your work?: days per week. IPAQ Long Last 7 Days Self-Administered Format Version - Days Walk as Part of Your Work IPA03-Walking Work Hr & Min per Day International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days walking as part of your work?: hours and minutes per day. IPAQ Long Last 7 Days Self-Administered Format Version - Walking Work Hr and Min per Day IPA03-Days Travel in a Motor Vehicle International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you travel in a motor vehicle like a train, bus, car or tram?: days per week. IPAQ Long Last 7 Days Self-Administered Format Version - Days Travel in a Motor Vehicle IPA03-Traveling Hr & Min per Day International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days traveling in a train, bus, car, tram, or other kind of motor vehicle?: hours and minutes per day. IPAQ Long Last 7 Days Self-Administered Format Version - Traveling Hr and Min per Day IPA03-Days Bicycle Place to Place International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you bicycle for at least 10 minutes at a time to go from place to place?: days per week. IPAQ Long Last 7 Days Self-Administered Format Version - Days Bicycle Place to Place IPA03-Bicycle Hr & Min per Day International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days to bicycle from place to place?: hours and minutes per day. IPAQ Long Last 7 Days Self-Administered Format Version - Bicycle Hr and Min per Day IPA03-Days Walk Place to Place International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you walk for at least 10 minutes at a time to go from place to place?: days per week. IPAQ Long Last 7 Days Self-Administered Format Version - Days Walk Place to Place IPA03-Walking Place Hr & Min per Day International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days walking from place to place?: hours and minutes per day. IPAQ Long Last 7 Days Self-Administered Format Version - Walking Place Hr and Min per Day IPA03-Days Vigorous in the Garden/Yard International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do vigorous physical activities like heavy lifting, chopping wood, shoveling snow, or digging in the garden or yard?: days per week. IPAQ Long Last 7 Days Self-Administered Format Version - Days Vigorous in the Garden/Yard IPA03-Vigorous Garden Hr & Min per Day International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days doing vigorous physical activities in the garden or yard?: hours and minutes per day. IPAQ Long Last 7 Days Self-Administered Format Version - Vigorous Garden Hr and Min per Day IPA03-Days Moderate in the Garden/Yard International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do moderate activities like carrying light loads, sweeping, washing windows, and raking in the garden or yard?: days per week. IPAQ Long Last 7 Days Self-Administered Format Version - Days Moderate in the Garden/Yard IPA03-Moderate Garden Hr & Min per Day International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days doing moderate physical activities in the garden or yard?: hours and minutes per day. IPAQ Long Last 7 Days Self-Administered Format Version - Moderate Garden Hr and Min per Day IPA03-Days Moderate Inside Home International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do moderate activities like carrying light loads, washing windows, scrubbing floors and sweeping inside your home?: days per week. IPAQ Long Last 7 Days Self-Administered Format Version - Days Moderate Inside Home IPA03-Moderate Home Hr & Min per Day International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days doing moderate physical activities inside your home?: hours and minutes per day. IPAQ Long Last 7 Days Self-Administered Format Version - Moderate Home Hr and Min per Day IPA03-Days Walk in Leisure Time International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you walk for at least 10 minutes at a time in your leisure time?: days per week. IPAQ Long Last 7 Days Self-Administered Format Version - Days Walk in Leisure Time IPA03-Walking Leisure Hr & Min per Day International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days walking in your leisure time?: hours and minutes per day. IPAQ Long Last 7 Days Self-Administered Format Version - Walking Leisure Hr and Min per Day IPA03-Days Vigorous in Leisure Time International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do vigorous physical activities like aerobics, running, fast bicycling, or fast swimming in your leisure time?: days per week. IPAQ Long Last 7 Days Self-Administered Format Version - Days Vigorous in Leisure Time IPA03-Vigorous Leisure Hr & Min per Day International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days doing vigorous physical activities in your leisure time?: hours and minutes per day. IPAQ Long Last 7 Days Self-Administered Format Version - Vigorous Leisure Hr and Min per Day IPA03-Days Moderate in Leisure Time International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do moderate physical activities like bicycling at a regular pace, swimming at a regular pace, and doubles tennis in your leisure time?: days per week. IPAQ Long Last 7 Days Self-Administered Format Version - Days Moderate in Leisure Time IPA03-Moderate Leisure Hr & Min per Day International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days doing moderate physical activities in your leisure time?: hours and minutes per day. IPAQ Long Last 7 Days Self-Administered Format Version - Moderate Leisure Hr and Min per Day IPA03-Sitting Weekday Hr & Min per Day International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, how much time did you usually spend sitting on a weekday?: hours and minutes per day. IPAQ Long Last 7 Days Self-Administered Format Version - Sitting Weekday Hr and Min per Day IPA03-Sitting Weekend Hr & Min per Day International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, how much time did you usually spend sitting on a weekend day?: hours and minutes per day. IPAQ Long Last 7 Days Self-Administered Format Version - Sitting Weekend Hr and Min per Day IPAQ03TC International Physical Activity Questionnaire (October 2002) Long Last 7 Days Self-Administered Format Questionnaire Test Code CDISC Questionnaire IPAQ Long Last 7 Days Self-Administered Format Version Test Code Terminology International Physical Activity Questionnaire (October 2002) Long Last 7 Days Self-Administered Format test name. IPA03-Bicycle Hr & Min per Day International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days to bicycle from place to place?: hours and minutes per day. IPAQ Long Last 7 Days Self-Administered Format Version - Bicycle Hr and Min per Day IPA03-Currently Have Job or Unpaid Work International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - Do you currently have a job or do any unpaid work outside your home? IPAQ Long Last 7 Days Self-Administered Format Version - Currently Have Job or Unpaid Work IPA03-Days Bicycle Place to Place International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you bicycle for at least 10 minutes at a time to go from place to place?: days per week. IPAQ Long Last 7 Days Self-Administered Format Version - Days Bicycle Place to Place IPA03-Days Moderate as Part of Work International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do moderate physical activities like carrying light loads as part of your work?: days per week. IPAQ Long Last 7 Days Self-Administered Format Version - Days Moderate as Part of Work IPA03-Days Moderate in Leisure Time International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do moderate physical activities like bicycling at a regular pace, swimming at a regular pace, and doubles tennis in your leisure time?: days per week. IPAQ Long Last 7 Days Self-Administered Format Version - Days Moderate in Leisure Time IPA03-Days Moderate in the Garden/Yard International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do moderate activities like carrying light loads, sweeping, washing windows, and raking in the garden or yard?: days per week. IPAQ Long Last 7 Days Self-Administered Format Version - Days Moderate in the Garden/Yard IPA03-Days Moderate Inside Home International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do moderate activities like carrying light loads, washing windows, scrubbing floors and sweeping inside your home?: days per week. IPAQ Long Last 7 Days Self-Administered Format Version - Days Moderate Inside Home IPA03-Days Travel in a Motor Vehicle International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you travel in a motor vehicle like a train, bus, car or tram?: days per week. IPAQ Long Last 7 Days Self-Administered Format Version - Days Travel in a Motor Vehicle IPA03-Days Vigorous as Part of Work International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do vigorous physical activities like heavy lifting, digging, heavy construction, or climbing up stairs as part of your work?: days per week. IPAQ Long Last 7 Days Self-Administered Format Version - Days Vigorous as Part of Work IPA03-Days Vigorous in Leisure Time International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do vigorous physical activities like aerobics, running, fast bicycling, or fast swimming in your leisure time?: days per week. IPAQ Long Last 7 Days Self-Administered Format Version - Days Vigorous in Leisure Time IPA03-Days Vigorous in the Garden/Yard International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do vigorous physical activities like heavy lifting, chopping wood, shoveling snow, or digging in the garden or yard?: days per week. IPAQ Long Last 7 Days Self-Administered Format Version - Days Vigorous in the Garden/Yard IPA03-Days Walk as Part of Your Work International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you walk for at least 10 minutes at a time as part of your work?: days per week. IPAQ Long Last 7 Days Self-Administered Format Version - Days Walk as Part of Your Work IPA03-Days Walk in Leisure Time International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you walk for at least 10 minutes at a time in your leisure time?: days per week. IPAQ Long Last 7 Days Self-Administered Format Version - Days Walk in Leisure Time IPA03-Days Walk Place to Place International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you walk for at least 10 minutes at a time to go from place to place?: days per week. IPAQ Long Last 7 Days Self-Administered Format Version - Days Walk Place to Place IPA03-Moderate Garden Hr & Min per Day International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days doing moderate physical activities in the garden or yard?: hours and minutes per day. IPAQ Long Last 7 Days Self-Administered Format Version - Moderate Garden Hr and Min per Day IPA03-Moderate Home Hr & Min per Day International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days doing moderate physical activities inside your home?: hours and minutes per day. IPAQ Long Last 7 Days Self-Administered Format Version - Moderate Home Hr and Min per Day IPA03-Moderate Leisure Hr & Min per Day International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days doing moderate physical activities in your leisure time?: hours and minutes per day. IPAQ Long Last 7 Days Self-Administered Format Version - Moderate Leisure Hr and Min per Day IPA03-Moderate Work Hr & Min per Day International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days doing moderate physical activities as part of your work?: hours and minutes per day. IPAQ Long Last 7 Days Self-Administered Format Version - Moderate Work Hr and Min per Day IPA03-Sitting Weekday Hr & Min per Day International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, how much time did you usually spend sitting on a weekday?: hours and minutes per day. IPAQ Long Last 7 Days Self-Administered Format Version - Sitting Weekday Hr and Min per Day IPA03-Sitting Weekend Hr & Min per Day International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, how much time did you usually spend sitting on a weekend day?: hours and minutes per day. IPAQ Long Last 7 Days Self-Administered Format Version - Sitting Weekend Hr and Min per Day IPA03-Traveling Hr & Min per Day International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days traveling in a train, bus, car, tram, or other kind of motor vehicle?: hours and minutes per day. IPAQ Long Last 7 Days Self-Administered Format Version - Traveling Hr and Min per Day IPA03-Vigorous Garden Hr & Min per Day International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days doing vigorous physical activities in the garden or yard?: hours and minutes per day. IPAQ Long Last 7 Days Self-Administered Format Version - Vigorous Garden Hr and Min per Day IPA03-Vigorous Leisure Hr & Min per Day International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days doing vigorous physical activities in your leisure time?: hours and minutes per day. IPAQ Long Last 7 Days Self-Administered Format Version - Vigorous Leisure Hr and Min per Day IPA03-Vigorous Work Hr & Min per Day International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days doing vigorous physical activities as part of your work?: hours and minutes per day. IPAQ Long Last 7 Days Self-Administered Format Version - Vigorous Work Hr and Min per Day IPA03-Walking Leisure Hr & Min per Day International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days walking in your leisure time?: hours and minutes per day. IPAQ Long Last 7 Days Self-Administered Format Version - Walking Leisure Hr and Min per Day IPA03-Walking Place Hr & Min per Day International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days walking from place to place?: hours and minutes per day. IPAQ Long Last 7 Days Self-Administered Format Version - Walking Place Hr and Min per Day IPA03-Walking Work Hr & Min per Day International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days walking as part of your work?: hours and minutes per day. IPAQ Long Last 7 Days Self-Administered Format Version - Walking Work Hr and Min per Day IPAQ03TN International Physical Activity Questionnaire (October 2002) Long Last 7 Days Self-Administered Format Questionnaire Test Name CDISC Questionnaire IPAQ Long Last 7 Days Self-Administered Format Version Test Name Terminology International Prostate Symptom Score original result for IPS0101 through IPS0106 test and test code. IPS0101 through IPS0106-About Half the Time International Prostate Symptom Score original result for IPS0101 through IPS0106-About half the time. International Prostate Symptom Score IPS0101 Through IPS0106 Original Result - About Half the Time IPS0101 through IPS0106-Almost Always International Prostate Symptom Score original result for IPS0101 through IPS0106-Almost always. International Prostate Symptom Score IPS0101 Through IPS0106 Original Result - Almost Always IPS0101 through IPS0106-Less Than 1 Time in 5 International Prostate Symptom Score original result for IPS0101 through IPS0106-Less than 1 time in 5. International Prostate Symptom Score IPS0101 Through IPS0106 Original Result - Less Than 1 Time in 5 IPS0101 through IPS0106-Less Than Half the Time International Prostate Symptom Score original result for IPS0101 through IPS0106-Less than half the time. International Prostate Symptom Score IPS0101 Through IPS0106 Original Result - Less Than Half the Time IPS0101 through IPS0106-More Than Half the Time International Prostate Symptom Score original result for IPS0101 through IPS0106-More than half the time. International Prostate Symptom Score IPS0101 Through IPS0106 Original Result - More Than Half the Time IPS0101 through IPS0106-Not at All International Prostate Symptom Score original result for IPS0101 through IPS0106-Not at all. International Prostate Symptom Score IPS0101 Through IPS0106 Original Result - Not at All IPS0101T06OR International Prostate Symptom Score Questionnaire ORRES for IPS0101 Through IPS0106 TN/TC CDISC Questionnaire International Prostate Symptom Score IPS0101 Through IPS0106 Original Response Terminology International Prostate Symptom Score original result for IPS0107 test and test code. IPS0107-1 Time International Prostate Symptom Score original result for IPS0107-1 time. International Prostate Symptom Score IPS0107 Original Result - 1 Time IPS0107-2 Times International Prostate Symptom Score original result for IPS0107-2 times. International Prostate Symptom Score IPS0107 Original Result - 2 Times IPS0107-3 Times International Prostate Symptom Score original result for IPS0107-3 times. International Prostate Symptom Score IPS0107 Original Result - 3 Times IPS0107-4 Times International Prostate Symptom Score original result for IPS0107-4 times. International Prostate Symptom Score IPS0107 Original Result - 4 Times IPS0107-5 or More Times International Prostate Symptom Score original result for IPS0107-5 or more times. International Prostate Symptom Score IPS0107 Original Result - 5 or More Times IPS0107-None International Prostate Symptom Score original result for IPS0107-None. International Prostate Symptom Score IPS0107 Original Result - None IPS0107OR International Prostate Symptom Score Questionnaire ORRES for IPS0107 TN/TC CDISC Questionnaire International Prostate Symptom Score IPS0107 Original Response Terminology International Prostate Symptom Score original result for IPS0109 test and test code. IPS0109-Delighted International Prostate Symptom Score original result for IPS0109-Delighted. International Prostate Symptom Score IPS0109 Original Result - Delighted IPS0109-Mixed (about equally satisfied and dissatisfied) International Prostate Symptom Score original result for IPS0109-Mixed (about equally satisfied and dissatisfied). International Prostate Symptom Score IPS0109 Original Result - Mixed (about equally satisfied and dissatisfied) IPS0109-Mostly dissatisfied International Prostate Symptom Score original result for IPS0109-Mostly dissatisfied. International Prostate Symptom Score IPS0109 Original Result - Mostly dissatisfied IPS0109-Mostly satisfied International Prostate Symptom Score original result for IPS0109-Mostly satisfied. International Prostate Symptom Score IPS0109 Original Result - Mostly satisfied IPS0109-Pleased International Prostate Symptom Score original result for IPS0109-Pleased. International Prostate Symptom Score IPS0109 Original Result - Pleased IPS0109-Terrible International Prostate Symptom Score original result for IPS0109-Terrible. International Prostate Symptom Score IPS0109 Original Result - Terrible IPS0109-Unhappy International Prostate Symptom Score original result for IPS0109-Unhappy. International Prostate Symptom Score IPS0109 Original Result - Unhappy IPS0109OR International Prostate Symptom Score Questionnaire ORRES for IPS0109 TN/TC CDISC Questionnaire International Prostate Symptom Score IPS0109 Original Response Terminology International Prostate Symptom Score standardized character result for IPS0101 Through IPS0106 test and test code. IPS0101 through IPS0106-0 International Prostate Symptom Score standardized character result for IPS0101 through IPS0106-Not at all. International Prostate Symptom Score IPS0101 Through IPS0106 Standardized Character Result 0 IPS0101 through IPS0106-1 International Prostate Symptom Score standardized character result for IPS0101 through IPS0106-Less than 1 time in 5. International Prostate Symptom Score IPS0101 Through IPS0106 Standardized Character Result 1 IPS0101 through IPS0106-2 International Prostate Symptom Score standardized character result for IPS0101 through IPS0106-Less than half the time. International Prostate Symptom Score IPS0101 Through IPS0106 Standardized Character Result 2 IPS0101 through IPS0106-3 International Prostate Symptom Score standardized character result for IPS0101 through IPS0106-About half the time. International Prostate Symptom Score IPS0101 Through IPS0106 Standardized Character Result 3 IPS0101 through IPS0106-4 International Prostate Symptom Score standardized character result for IPS0101 through IPS0106-More than half the time. International Prostate Symptom Score IPS0101 Through IPS0106 Standardized Character Result 4 IPS0101 through IPS0106-5 International Prostate Symptom Score standardized character result for IPS0101 through IPS0106-Almost always. International Prostate Symptom Score IPS0101 Through IPS0106 Standardized Character Result 5 IPS0101T06STR International Prostate Symptom Score Questionnaire STRESC for IPS0101 Through IPS0106 TN/TC CDISC Questionnaire International Prostate Symptom Score IPS0101 Through IPS0106 Standardized Character Response Terminology International Prostate Symptom Score standardized character result for IPS0107 test and test code. IPS0107-0 International Prostate Symptom Score standardized character result for IPS0107-None. International Prostate Symptom Score IPS0107 Standardized Character Result 0 IPS0107-1 International Prostate Symptom Score standardized character result for IPS0107-1 time. International Prostate Symptom Score IPS0107 Standardized Character Result 1 IPS0107-2 International Prostate Symptom Score standardized character result for IPS0107-2 times. International Prostate Symptom Score IPS0107 Standardized Character Result 2 IPS0107-3 International Prostate Symptom Score standardized character result for IPS0107-3 times. International Prostate Symptom Score IPS0107 Standardized Character Result 3 IPS0107-4 International Prostate Symptom Score standardized character result for IPS0107-4 times. International Prostate Symptom Score IPS0107 Standardized Character Result 4 IPS0107-5 International Prostate Symptom Score standardized character result for IPS0107-5 or more times. International Prostate Symptom Score IPS0107 Standardized Character Result 5 IPS0107STR International Prostate Symptom Score Questionnaire STRESC for IPS0107 TN/TC CDISC Questionnaire International Prostate Symptom Score IPS0107 Standardized Character Response Terminology International Prostate Symptom Score standardized character result for IPS0109 test and test code. IPS0109-0 International Prostate Symptom Score standardized character result for IPS0109-Delighted. International Prostate Symptom Score IPS0109 Standardized Character Result 0 IPS0109-1 International Prostate Symptom Score standardized character result for IPS0109-Pleased. International Prostate Symptom Score IPS0109 Standardized Character Result 1 IPS0109-2 International Prostate Symptom Score standardized character result for IPS0109-Mostly satisfied. International Prostate Symptom Score IPS0109 Standardized Character Result 2 IPS0109-3 International Prostate Symptom Score standardized character result for IPS0109-Mixed (about equally satisfied and dissatisfied). International Prostate Symptom Score IPS0109 Standardized Character Result 3 IPS0109-4 International Prostate Symptom Score standardized character result for IPS0109-Mostly dissatisfied. International Prostate Symptom Score IPS0109 Standardized Character Result 4 IPS0109-5 International Prostate Symptom Score standardized character result for IPS0109-Unhappy. International Prostate Symptom Score IPS0109 Standardized Character Result 5 IPS0109-6 International Prostate Symptom Score standardized character result for IPS0109-Terrible. International Prostate Symptom Score IPS0109 Standardized Character Result 6 IPS0109STR International Prostate Symptom Score Questionnaire STRESC for IPS0109 TN/TC CDISC Questionnaire International Prostate Symptom Score IPS0109 Standardized Character Response Terminology International Prostate Symptom Score test code. IPS01-Sensation of Not Emptying Bladder International Prostate Symptom Score - During the last month or so, how often have you had a sensation of not emptying your bladder completely after you finished urinating? IPSS - Sensation of Not Emptying Bladder IPS01-Urinate Again Less Than 2 Hours International Prostate Symptom Score - During the last month or so, how often have you had to urinate again less than 2 hours after you finished urinating? IPSS - Urinate Again Less Than 2 Hours IPS01-Stop Start Several Times Urinated International Prostate Symptom Score - During the last month or so, how often have you found you stopped and started again several times when you urinated? IPSS - Stop Start Several Times Urinated IPS01-Difficult to Postpone Urination International Prostate Symptom Score - During the last month or so, how often have you found it difficult to postpone urination? IPSS - Difficult to Postpone Urination IPS01-Had Weak Urinary Stream International Prostate Symptom Score - During the last month or so, how often have you had a weak urinary stream? IPSS - Had Weak Urinary Stream IPS01-Push or Strain to Begin Urination International Prostate Symptom Score - During the last month or so, how often have you had to push or strain to begin urination? IPSS - Push or Strain to Begin Urination IPS01-Times Get Up to Urinate at Night International Prostate Symptom Score - During the last month, how many times did you most typically get up to urinate from the time you went to bed at night until the time you got up in the morning? IPSS - Times Get Up to Urinate at Night IPS01-Total Score International Prostate Symptom Score - AUA symptom total score. IPSS - Total Score IPS01-Life With Symptoms Feel About It International Prostate Symptom Score - If you were to spend the rest of your life with your prostate symptoms just as they are now, how would you feel about that? IPSS - Life With Symptoms Feel About It IPS01TC International Prostate Symptom Score Questionnaire Test Code CDISC Questionnaire IPSS Test Code Terminology International Prostate Symptom Score test name. IPS01-Difficult to Postpone Urination International Prostate Symptom Score - During the last month or so, how often have you found it difficult to postpone urination? IPSS - Difficult to Postpone Urination IPS01-Had Weak Urinary Stream International Prostate Symptom Score - During the last month or so, how often have you had a weak urinary stream? IPSS - Had Weak Urinary Stream IPS01-Life With Symptoms Feel About It International Prostate Symptom Score - If you were to spend the rest of your life with your prostate symptoms just as they are now, how would you feel about that? IPSS - Life With Symptoms Feel About It IPS01-Push or Strain to Begin Urination International Prostate Symptom Score - During the last month or so, how often have you had to push or strain to begin urination? IPSS - Push or Strain to Begin Urination IPS01-Sensation of Not Emptying Bladder International Prostate Symptom Score - During the last month or so, how often have you had a sensation of not emptying your bladder completely after you finished urinating? IPSS - Sensation of Not Emptying Bladder IPS01-Stop Start Several Times Urinated International Prostate Symptom Score - During the last month or so, how often have you found you stopped and started again several times when you urinated? IPSS - Stop Start Several Times Urinated IPS01-Times Get Up to Urinate at Night International Prostate Symptom Score - During the last month, how many times did you most typically get up to urinate from the time you went to bed at night until the time you got up in the morning? IPSS - Times Get Up to Urinate at Night IPS01-Total Score International Prostate Symptom Score - AUA symptom total score. IPSS - Total Score IPS01-Urinate Again Less Than 2 Hours International Prostate Symptom Score - During the last month or so, how often have you had to urinate again less than 2 hours after you finished urinating? IPSS - Urinate Again Less Than 2 Hours IPS01TN International Prostate Symptom Score Questionnaire Test Name CDISC Questionnaire IPSS Test Name Terminology A terminology codelist relevant to the responses as to whether the participant or subject has been diagnosed as intersex. No The non-affirmative response to a question. (NCI) No Not reported Not provided or available. Not Reported U UNK Unknown Not known, not observed, not recorded, or refused. (NCI) Unknown Yes The affirmative response to a question. (NCI) Yes ISXDXRS Intersex Diagnosis Indicator Response CDISC SDTM Intersex Diagnosis Indicator Response Terminology A terminology codelist relevant to the general design of the strategy for assigning interventions to participants in a clinical study. A trial design in which subjects function as their own control and are assigned to receive an investigational product(s) and control(s) in an order determined by randomization, with or without a washout period between the interventions. (CDISC Glossary) Crossover Study Two or more interventions, each alone or in combination, are evaluated in parallel against a control group. This study design allows for the comparison of active drug to placebo, presence of drug-drug interactions, and comparison of active drugs against each other. Factorial Study A trial design in which subjects are randomised to one of two or more arms, with each arm being allocated a different intervention for the duration of the study. Parallel Study A type of adaptive trial design that allows successive interim analyses of the data at particular time points or after a pre-defined number of patients have been enrolled. (CDISC Glossary) Group Sequential Design All trial participants are assigned to a single treatment group for the duration of the study. Single Group Study INTMODEL Intervention Model Response CDISC SDTM Intervention Model Terminology A terminology codelist relevant to the kind of product or procedure studied in a trial. A technique used to change the behavior of a subject (e.g., psychotherapy, lifestyle counseling, or hypnosis). Behavioral Intervention A product of biological origin applicable to the prevention, treatment, or cure of a disease or condition, for example: virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, or analogous product. (FDA 21 CFR 600.3) Biological Agent A product composed of two or more different types of medical products (i.e., a combination of a drug, device, and/or biological product with one another and are referred to as "constituent parts" of the combination product). NOTE: A combination product might be a single-entity product, a co-packaged product or a cross-labeled product. [After 21 CFR 3.2 (e)] (CDISC Glossary) Combination Product Medical Device Any instrument, apparatus, implement, machine, appliance, implant, reagent for in vitro use, software, material or other similar or related article, intended by the manufacturer to be used, alone or in combination for, one or more specific medical purpose(s). [After REGULATION (EU) 2017/745 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 5 April 2017 on medical devices] Medical Device Any procedure or test used to diagnose a disease or disorder. Diagnostic Procedure Preparations containing ingredient(s) intended to supplement the diet. Dietary Supplement An active natural, synthetic or semi-synthetic ingredient including endogenous body substance that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient (21 CFR 314.3(b)). Pharmacologic Substance Gene Therapy Ex vivo or in vivo gene modification of cells in order to correct or treat an inherited or acquired disease or condition. (CDISC Glossary) Gene Therapy A medical procedure that produces an effect, or that is intended to alter the course of a disease in a patient or population, which is not considered a surgical procedure. Non-Surgical Procedure Medical Procedure Any activity performed by manual and/or instrumental means for the purpose of diagnosis, assessment, therapy, prevention, or palliative care. Physical Medical Procedure Radiation Therapy Radiotherapy Use of targeted or whole body radiation to treat a disease. Radiation Therapy Surgical Procedure A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery. Surgical Procedure A medicinal product inducing immunity against disease, most often to prevent occurrence of a disease, (e.g., a preventative vaccine against infectious disease), but also to treat a disease, (e.g., a therapeutic vaccine against cancer). (CDISC Glossary) Vaccine INTTYPE Intervention Type Response CDISC SDTM Intervention Type Terminology Inventory of Depressive Symptomatology Clinician-Rated Version test code. IDSC1-Sleep Onset Insomnia Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Sleep onset insomnia. IDS-C - Sleep Onset Insomnia IDSC1-Mid-Nocturnal Insomnia Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Mid-nocturnal insomnia. IDS-C - Mid-Nocturnal Insomnia IDSC1-Early Morning Insomnia Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Early morning insomnia. IDS-C - Early Morning Insomnia IDSC1-Hypersomnia Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Hypersomnia. IDS-C - Hypersomnia IDSC1-Mood (Sad) Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Mood (sad). IDS-C - Mood (Sad) IDSC1-Mood (Irritable) Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Mood (irritable). IDS-C - Mood (Irritable) IDSC1-Mood (Anxious) Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Mood (anxious). IDS-C - Mood (Anxious) IDSC1-Reactivity of Mood Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Reactivity of mood. IDS-C - Reactivity of Mood IDSC1-Mood Variation Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Mood variation. IDS-C - Mood Variation IDSC1-Mood Worse Morn/Afternoon/Night Inventory of Depressive Symptomatology - Clinician-Rated - Is mood typically worse in morning, afternoon, or night. IDS-C - Mood Worse in Morning, Afternoon, or Night IDSC1-Mood Attributed to Environment Inventory of Depressive Symptomatology - Clinician-Rated - Is mood variation attributed to environment by the patient? IDS-C - Mood Variation Attributed to Environment IDSC1-Quality of Mood Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Quality of mood. IDS-C - Quality of Mood IDSC1-Appetite (Decreased) Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Appetite (decreased). IDS-C - Appetite (Decreased) IDSC1-Appetite (Increased) Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Appetite (increased). IDS-C - Appetite (Increased) IDSC1-Weight (Decrease) Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Weight (decrease) within the last two weeks. IDS-C - Weight (Decrease) IDSC1-Weight (Increase) Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Weight (increase) within the last two weeks. IDS-C - Weight (Increase) IDSC1-Concentration/Decision Making Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Concentration/decision making. IDS-C - Concentration or Decision Making IDSC1-Outlook (Self) Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Outlook (self). IDS-C - Outlook (Self) IDSC1-Outlook (Future) Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Outlook (future). IDS-C - Outlook (Future) IDSC1-Suicidal Ideation Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Suicidal ideation. IDS-C - Suicidal Ideation IDSC1-Involvement Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Involvement. IDS-C - Involvement IDSC1-Energy/Fatiguability Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Energy/fatiguability. IDS-C - Energy or Fatiguability IDSC1-Pleasure/Enjoyment (Exclude Sex) Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Pleasure/enjoyment (exclude sexual activities). IDS-C - Pleasure or Enjoyment IDSC1-Sexual Interest Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Sexual interest. IDS-C - Sexual Interest IDSC1-Psychomotor Slowing Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Psychomotor slowing. IDS-C - Psychomotor Slowing IDSC1-Psychomotor Agitation Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Psychomotor agitation. IDS-C - Psychomotor Agitation IDSC1-Somatic Complaints Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Somatic complaints. IDS-C - Somatic Complaints IDSC1-Sympathetic Arousal Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Sympathetic arousal. IDS-C - Sympathetic Arousal IDSC1-Panic/Phobic Symptoms Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Panic/phobic symptoms. IDS-C - Panic or Phobic Symptoms IDSC1-Gastrointestinal Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Gastrointestinal. IDS-C - Gastrointestinal IDSC1-Interpersonal Sensitivity Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Interpersonal sensitivity. IDS-C - Interpersonal Sensitivity IDSC1-Leaden Paralysis/Physical Energy Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Leaden paralysis/physical energy. IDS-C - Leaden Paralysis or Physical Energy IDSC1-Score Inventory of Depressive Symptomatology - Clinician-Rated - Score. IDS-C - Score IDSC1TC Inventory of Depressive Symptomatology Clinician-Rated Version Clinical Classification Test Code CDISC Clinical Classification IDS-C Test Code Terminology Inventory of Depressive Symptomatology Clinician-Rated Version test name. IDSC1-Appetite (Decreased) Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Appetite (decreased). IDS-C - Appetite (Decreased) IDSC1-Appetite (Increased) Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Appetite (increased). IDS-C - Appetite (Increased) IDSC1-Concentration/Decision Making Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Concentration/decision making. IDS-C - Concentration or Decision Making IDSC1-Early Morning Insomnia Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Early morning insomnia. IDS-C - Early Morning Insomnia IDSC1-Energy/Fatiguability Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Energy/fatiguability. IDS-C - Energy or Fatiguability IDSC1-Gastrointestinal Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Gastrointestinal. IDS-C - Gastrointestinal IDSC1-Hypersomnia Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Hypersomnia. IDS-C - Hypersomnia IDSC1-Interpersonal Sensitivity Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Interpersonal sensitivity. IDS-C - Interpersonal Sensitivity IDSC1-Involvement Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Involvement. IDS-C - Involvement IDSC1-Leaden Paralysis/Physical Energy Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Leaden paralysis/physical energy. IDS-C - Leaden Paralysis or Physical Energy IDSC1-Mid-Nocturnal Insomnia Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Mid-nocturnal insomnia. IDS-C - Mid-Nocturnal Insomnia IDSC1-Mood (Anxious) Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Mood (anxious). IDS-C - Mood (Anxious) IDSC1-Mood (Irritable) Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Mood (irritable). IDS-C - Mood (Irritable) IDSC1-Mood (Sad) Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Mood (sad). IDS-C - Mood (Sad) IDSC1-Mood Attributed to Environment Inventory of Depressive Symptomatology - Clinician-Rated - Is mood variation attributed to environment by the patient? IDS-C - Mood Variation Attributed to Environment IDSC1-Mood Variation Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Mood variation. IDS-C - Mood Variation IDSC1-Mood Worse Morn/Afternoon/Night Inventory of Depressive Symptomatology - Clinician-Rated - Is mood typically worse in morning, afternoon, or night. IDS-C - Mood Worse in Morning, Afternoon, or Night IDSC1-Outlook (Future) Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Outlook (future). IDS-C - Outlook (Future) IDSC1-Outlook (Self) Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Outlook (self). IDS-C - Outlook (Self) IDSC1-Panic/Phobic Symptoms Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Panic/phobic symptoms. IDS-C - Panic or Phobic Symptoms IDSC1-Pleasure/Enjoyment (Exclude Sex) Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Pleasure/enjoyment (exclude sexual activities). IDS-C - Pleasure or Enjoyment IDSC1-Psychomotor Agitation Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Psychomotor agitation. IDS-C - Psychomotor Agitation IDSC1-Psychomotor Slowing Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Psychomotor slowing. IDS-C - Psychomotor Slowing IDSC1-Quality of Mood Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Quality of mood. IDS-C - Quality of Mood IDSC1-Reactivity of Mood Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Reactivity of mood. IDS-C - Reactivity of Mood IDSC1-Score Inventory of Depressive Symptomatology - Clinician-Rated - Score. IDS-C - Score IDSC1-Sexual Interest Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Sexual interest. IDS-C - Sexual Interest IDSC1-Sleep Onset Insomnia Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Sleep onset insomnia. IDS-C - Sleep Onset Insomnia IDSC1-Somatic Complaints Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Somatic complaints. IDS-C - Somatic Complaints IDSC1-Suicidal Ideation Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Suicidal ideation. IDS-C - Suicidal Ideation IDSC1-Sympathetic Arousal Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Sympathetic arousal. IDS-C - Sympathetic Arousal IDSC1-Weight (Decrease) Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Weight (decrease) within the last two weeks. IDS-C - Weight (Decrease) IDSC1-Weight (Increase) Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Weight (increase) within the last two weeks. IDS-C - Weight (Increase) IDSC1TN Inventory of Depressive Symptomatology Clinician-Rated Version Clinical Classification Test Name CDISC Clinical Classification IDS-C Test Name Terminology Inventory of Depressive Symptomatology Self-Report Version test code. IDSR1-Falling Asleep Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Falling asleep. IDS-SR - Falling Asleep IDSR1-Sleep During the Night Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Sleep during the night. IDS-SR - Sleep During the Night IDSR1-Waking Up Too Early Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Waking up too early. IDS-SR - Waking Up Too Early IDSR1-Sleeping Too Much Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Sleeping too much. IDS-SR - Sleeping Too Much IDSR1-Feeling Sad Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling sad. IDS-SR - Feeling Sad IDSR1-Feeling Irritable Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling irritable. IDS-SR - Feeling Irritable IDSR1-Feeling Anxious or Tense Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling anxious or tense. IDS-SR - Feeling Anxious or Tense IDSR1-Your Mood to Good/Desired Events Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Response of your mood to good or desired events. IDS-SR - Response of Your Mood to Good or Desired Events IDSR1-Mood in Relation to Time of Day Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Mood in relation to the time of day. IDS-SR - Mood in Relation to the Time of Day IDSR1-Mood Worse Morn/Afternoon/Night Inventory of Depressive Symptomatology - Self-Report - Is your mood typically worse in the morning, afternoon or night? IDS-SR - Mood Worse in Morning, Afternoon, or Night IDSR1-Mood Attributed to Environment Inventory of Depressive Symptomatology - Self-Report - Is your mood variation attributed to the environment? IDS-SR - Mood Variation Attributed to Environment IDSR1-Quality of Your Mood Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: The quality of your mood. IDS-SR - The Quality of Your Mood IDSR1-Decreased Appetite Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Decreased appetite. IDS-SR - Decreased Appetite IDSR1-Increased Appetite Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Increased appetite. IDS-SR - Increased Appetite IDSR1-Weight (Decrease) Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: within the last two weeks: Weight (decrease). IDS-SR - Weight (Decrease) IDSR1-Weight (Increase) Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: within the last two weeks: Weight (increase). IDS-SR - Weight (Increase) IDSR1-Concentration/Decision Making Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Concentration/decision making. IDS-SR - Concentration or Decision Making IDSR1-View of Myself Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: View of myself. IDS-SR - View of Myself IDSR1-View of My Future Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: View of my future. IDS-SR - View of My Future IDSR1-Thoughts of Death or Suicide Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Thoughts of death or suicide. IDS-SR - Thoughts of Death or Suicide IDSR1-General Interest Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: General interest. IDS-SR - General Interest IDSR1-Energy Level Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Energy level. IDS-SR - Energy Level IDSR1-Pleasure/Enjoyment (Exclude Sex) Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Capacity for pleasure or enjoyment (excluding sex). IDS-SR - Capacity for Pleasure or Enjoyment IDSR1-Interest in Sex Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Interest in sex. IDS-SR - Interest in Sex IDSR1-Feeling Slowed Down Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling slowed down. IDS-SR - Feeling Slowed Down IDSR1-Feeling Restless Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling restless. IDS-SR - Feeling Restless IDSR1-Aches and Pains Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Aches and pains. IDS-SR - Aches and Pains IDSR1-Other Bodily Symptoms Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Other bodily symptoms. IDS-SR - Other Bodily Symptoms IDSR1-Panic/Phobic Symptoms Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Panic/phobic symptoms. IDS-SR - Panic or Phobic Symptoms IDSR1-Constipation/Diarrhea Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Constipation/diarrhea. IDS-SR - Constipation or Diarrhea IDSR1-Interpersonal Sensitivity Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Interpersonal sensitivity. IDS-SR - Interpersonal Sensitivity IDSR1-Leaden Paralysis/Physical Energy Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Leaden paralysis/physical energy. IDS-SR - Leaden Paralysis or Physical Energy IDSR1-Score Inventory of Depressive Symptomatology - Self-Report - Score. IDS-SR - Score IDSR1TC Inventory of Depressive Symptomatology Self-Report Version Questionnaire Test Code CDISC Questionnaire IDS-SR Test Code Terminology Inventory of Depressive Symptomatology Self-Report Version test name. IDSR1-Aches and Pains Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Aches and pains. IDS-SR - Aches and Pains IDSR1-Concentration/Decision Making Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Concentration/decision making. IDS-SR - Concentration or Decision Making IDSR1-Constipation/Diarrhea Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Constipation/diarrhea. IDS-SR - Constipation or Diarrhea IDSR1-Decreased Appetite Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Decreased appetite. IDS-SR - Decreased Appetite IDSR1-Energy Level Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Energy level. IDS-SR - Energy Level IDSR1-Falling Asleep Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Falling asleep. IDS-SR - Falling Asleep IDSR1-Feeling Anxious or Tense Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling anxious or tense. IDS-SR - Feeling Anxious or Tense IDSR1-Feeling Irritable Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling irritable. IDS-SR - Feeling Irritable IDSR1-Feeling Restless Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling restless. IDS-SR - Feeling Restless IDSR1-Feeling Sad Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling sad. IDS-SR - Feeling Sad IDSR1-Feeling Slowed Down Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling slowed down. IDS-SR - Feeling Slowed Down IDSR1-General Interest Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: General interest. IDS-SR - General Interest IDSR1-Increased Appetite Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Increased appetite. IDS-SR - Increased Appetite IDSR1-Interest in Sex Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Interest in sex. IDS-SR - Interest in Sex IDSR1-Interpersonal Sensitivity Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Interpersonal sensitivity. IDS-SR - Interpersonal Sensitivity IDSR1-Leaden Paralysis/Physical Energy Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Leaden paralysis/physical energy. IDS-SR - Leaden Paralysis or Physical Energy IDSR1-Mood Attributed to Environment Inventory of Depressive Symptomatology - Self-Report - Is your mood variation attributed to the environment? IDS-SR - Mood Variation Attributed to Environment IDSR1-Mood in Relation to Time of Day Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Mood in relation to the time of day. IDS-SR - Mood in Relation to the Time of Day IDSR1-Mood Worse Morn/Afternoon/Night Inventory of Depressive Symptomatology - Self-Report - Is your mood typically worse in the morning, afternoon or night? IDS-SR - Mood Worse in Morning, Afternoon, or Night IDSR1-Other Bodily Symptoms Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Other bodily symptoms. IDS-SR - Other Bodily Symptoms IDSR1-Panic/Phobic Symptoms Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Panic/phobic symptoms. IDS-SR - Panic or Phobic Symptoms IDSR1-Pleasure/Enjoyment (Exclude Sex) Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Capacity for pleasure or enjoyment (excluding sex). IDS-SR - Capacity for Pleasure or Enjoyment IDSR1-Quality of Your Mood Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: The quality of your mood. IDS-SR - The Quality of Your Mood IDSR1-Score Inventory of Depressive Symptomatology - Self-Report - Score. IDS-SR - Score IDSR1-Sleep During the Night Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Sleep during the night. IDS-SR - Sleep During the Night IDSR1-Sleeping Too Much Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Sleeping too much. IDS-SR - Sleeping Too Much IDSR1-Thoughts of Death or Suicide Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Thoughts of death or suicide. IDS-SR - Thoughts of Death or Suicide IDSR1-View of My Future Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: View of my future. IDS-SR - View of My Future IDSR1-View of Myself Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: View of myself. IDS-SR - View of Myself IDSR1-Waking Up Too Early Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Waking up too early. IDS-SR - Waking Up Too Early IDSR1-Weight (Decrease) Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: within the last two weeks: Weight (decrease). IDS-SR - Weight (Decrease) IDSR1-Weight (Increase) Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: within the last two weeks: Weight (increase). IDS-SR - Weight (Increase) IDSR1-Your Mood to Good/Desired Events Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Response of your mood to good or desired events. IDS-SR - Response of Your Mood to Good or Desired Events IDSR1TN Inventory of Depressive Symptomatology Self-Report Version Questionnaire Test Name CDISC Questionnaire IDS-SR Test Name Terminology JFK Coma Recovery Scale-Revised test code. CRSR01-Diagnosis JFK Coma Recovery Scale-Revised - Diagnosis. CRS-R - Diagnosis CRSR01-Etiology JFK Coma Recovery Scale-Revised - Etiology. CRS-R - Etiology CRSR01-Date of Onset JFK Coma Recovery Scale-Revised - Date of onset. CRS-R - Date of Onset CRSR01-Date of Admission JFK Coma Recovery Scale-Revised - Date of admission. CRS-R - Date of Admission CRSR01-Auditory Function Scale JFK Coma Recovery Scale-Revised - Auditory function scale. CRS-R - Auditory Function Scale CRSR01-Visual Function Scale JFK Coma Recovery Scale-Revised - Visual function scale. CRS-R - Visual Function Scale CRSR01-Motor Function Scale JFK Coma Recovery Scale-Revised - Motor function scale. CRS-R - Motor Function Scale CRSR01-Oromotor/Verbal Function JFK Coma Recovery Scale-Revised - Oromotor/verbal function scale. CRS-R - Oromotor/Verbal Function CRSR01-Communication Scale JFK Coma Recovery Scale-Revised - Communication scale. CRS-R - Communication Scale CRSR01-Arousal Scale JFK Coma Recovery Scale-Revised - Arousal scale. CRS-R - Arousal Scale CRSR01-Total Score JFK Coma Recovery Scale-Revised - Total score. CRS-R - Total Score CRSR01TC JFK Coma Recovery Scale-Revised Clinical Classification Test Code CDISC Clinical Classification CRS-R Test Code Terminology JFK Coma Recovery Scale-Revised test name. CRSR01-Arousal Scale JFK Coma Recovery Scale-Revised - Arousal scale. CRS-R - Arousal Scale CRSR01-Auditory Function Scale JFK Coma Recovery Scale-Revised - Auditory function scale. CRS-R - Auditory Function Scale CRSR01-Communication Scale JFK Coma Recovery Scale-Revised - Communication scale. CRS-R - Communication Scale CRSR01-Date of Admission JFK Coma Recovery Scale-Revised - Date of admission. CRS-R - Date of Admission CRSR01-Date of Onset JFK Coma Recovery Scale-Revised - Date of onset. CRS-R - Date of Onset CRSR01-Diagnosis JFK Coma Recovery Scale-Revised - Diagnosis. CRS-R - Diagnosis CRSR01-Etiology JFK Coma Recovery Scale-Revised - Etiology. CRS-R - Etiology CRSR01-Motor Function Scale JFK Coma Recovery Scale-Revised - Motor function scale. CRS-R - Motor Function Scale CRSR01-Oromotor/Verbal Function JFK Coma Recovery Scale-Revised - Oromotor/verbal function scale. CRS-R - Oromotor/Verbal Function CRSR01-Total Score JFK Coma Recovery Scale-Revised - Total score. CRS-R - Total Score CRSR01-Visual Function Scale JFK Coma Recovery Scale-Revised - Visual function scale. CRS-R - Visual Function Scale CRSR01TN JFK Coma Recovery Scale-Revised Clinical Classification Test Name CDISC Clinical Classification CRS-R Test Name Terminology Karnofsky Performance Status Scale original result for KPSS0101 test and test code. KPSS0101-Able to carry on normal activity minor signs or symptoms of disease Karnofsky Performance Status Scale original result for KPSS0101-Able to carry on normal activity; minor signs or symptoms of disease. Karnofsky Performance Status Scale KPSS0101 Original Result - Able to carry on normal activity; minor signs or symptoms of disease KPSS0101-Cares for self unable to carry on normal activity or to do active work Karnofsky Performance Status Scale original result for KPSS0101-Cares for self; unable to carry on normal activity or to do active work. Karnofsky Performance Status Scale KPSS0101 Original Result - Cares for self; unable to carry on normal activity or to do active work KPSS0101-Dead Karnofsky Performance Status Scale original result for KPSS0101-Dead. Karnofsky Performance Status Scale KPSS0101 Original Result - Dead KPSS0101-Disabled requires special care and assistance Karnofsky Performance Status Scale original result for KPSS0101-Disabled; requires special care and assistance. Karnofsky Performance Status Scale KPSS0101 Original Result - Disabled; requires special care and assistance KPSS0101-Moribund fatal processes progressing rapidly Karnofsky Performance Status Scale original result for KPSS0101-Moribund; fatal processes progressing rapidly. Karnofsky Performance Status Scale KPSS0101 Original Result - Moribund; fatal processes progressing rapidly KPSS0101-Normal activity with effort some signs or symptoms of disease Karnofsky Performance Status Scale original result for KPSS0101-Normal activity with effort; some signs or symptoms of disease. Karnofsky Performance Status Scale KPSS0101 Original Result - Normal activity with effort; some signs or symptoms of disease KPSS0101-Normal no complaints no evidence of disease Karnofsky Performance Status Scale original result for KPSS0101-Normal no complaints; no evidence of disease. Karnofsky Performance Status Scale KPSS0101 Original Result - Normal no complaints; no evidence of disease KPSS0101-Requires considerable assistance and frequent medical care Karnofsky Performance Status Scale original result for KPSS0101-Requires considerable assistance and frequent medical care. Karnofsky Performance Status Scale KPSS0101 Original Result - Requires considerable assistance and frequent medical care KPSS0101-Requires occasional assistance, but is able to care for most of his personal needs Karnofsky Performance Status Scale original result for KPSS0101-Requires occasional assistance, but is able to care for most of his personal needs. Karnofsky Performance Status Scale KPSS0101 Original Result - Requires occasional assistance, but is able to care for most of his personal needs KPSS0101-Severely disabled hospital admission is indicated although death not imminent Karnofsky Performance Status Scale original result for KPSS0101-Severely disabled; hospital admission is indicated although death not imminent. Karnofsky Performance Status Scale KPSS0101 Original Result - Severely disabled; hospital admission is indicated although death not imminent KPSS0101-Very sick hospital admission necessary active supportive treatment necessary Karnofsky Performance Status Scale original result for KPSS0101-Very sick; hospital admission necessary; active supportive treatment necessary. Karnofsky Performance Status Scale KPSS0101 Original Result - Very sick; hospital admission necessary; active supportive treatment necessary KPSS0101OR Karnofsky Performance Status Scale Clinical Classification ORRES for KPSS0101 TN/TC CDISC Clinical Classification Karnofsky Performance Status Scale KPSS0101 Original Response Terminology Karnofsky Performance Status Scale standardized character result for KPSS0101 test and test code. KPSS0101-0 Karnofsky Performance Status Scale standardized character result for KPSS0101-Dead. Karnofsky Performance Status Scale KPSS0101 Standardized Character Result 0 KPSS0101-10 Karnofsky Performance Status Scale standardized character result for KPSS0101-Moribund; fatal processes progressing rapidly. Karnofsky Performance Status Scale KPSS0101 Standardized Character Result 10 KPSS0101-100 Karnofsky Performance Status Scale standardized character result for KPSS0101-Normal no complaints; no evidence of disease. Karnofsky Performance Status Scale KPSS0101 Standardized Character Result 100 KPSS0101-20 Karnofsky Performance Status Scale standardized character result for KPSS0101-Very sick; hospital admission necessary; active supportive treatment necessary. Karnofsky Performance Status Scale KPSS0101 Standardized Character Result 20 KPSS0101-30 Karnofsky Performance Status Scale standardized character result for KPSS0101-Severely disabled; hospital admission is indicated although death not imminent. Karnofsky Performance Status Scale KPSS0101 Standardized Character Result 30 KPSS0101-40 Karnofsky Performance Status Scale standardized character result for KPSS0101-Disabled; requires special care and assistance. Karnofsky Performance Status Scale KPSS0101 Standardized Character Result 40 KPSS0101-50 Karnofsky Performance Status Scale standardized character result for KPSS0101-Requires considerable assistance and frequent medical care. Karnofsky Performance Status Scale KPSS0101 Standardized Character Result 50 KPSS0101-60 Karnofsky Performance Status Scale standardized character result for KPSS0101-Requires occasional assistance, but is able to care for most of his personal needs. Karnofsky Performance Status Scale KPSS0101 Standardized Character Result 60 KPSS0101-70 Karnofsky Performance Status Scale standardized character result for KPSS0101-Cares for self; unable to carry on normal activity or to do active work. Karnofsky Performance Status Scale KPSS0101 Standardized Character Result 70 KPSS0101-80 Karnofsky Performance Status Scale standardized character result for KPSS0101-Normal activity with effort; some signs or symptoms of disease. Karnofsky Performance Status Scale KPSS0101 Standardized Character Result 80 KPSS0101-90 Karnofsky Performance Status Scale standardized character result for KPSS0101-Able to carry on normal activity; minor signs or symptoms of disease. Karnofsky Performance Status Scale KPSS0101 Standardized Character Result 90 KPSS0101STR Karnofsky Performance Status Scale Clinical Classification STRESC for KPSS0101 TN/TC CDISC Clinical Classification Karnofsky Performance Status Scale KPSS0101 Standardized Character Response Terminology Karnofsky Performance Status Scale test code. KPSS01-Karnofsky Performance Status Karnofsky Performance Status Scale - Karnofsky Performance Status. KPS Scale - Karnofsky Performance Status KPSS01TC Karnofsky Performance Status Scale Clinical Classification Test Code CDISC Clinical Classification KPS Scale Test Code Terminology Karnofsky Performance Status Scale test name. KPSS01-Karnofsky Performance Status Karnofsky Performance Status Scale - Karnofsky Performance Status. KPS Scale - Karnofsky Performance Status KPSS01TN Karnofsky Performance Status Scale Clinical Classification Test Name CDISC Clinical Classification KPS Scale Test Name Terminology Kidney Disease and Quality of Life-36 Version 1 test code. KDQ1-In General You Say Your Health Is Kidney Disease and Quality of Life-36 Version 1 - In general, would you say your health is. KDQOL-36 Version 1 - In General You Say Your Health Is KDQ1-Limit Moderate Activities Kidney Disease and Quality of Life-36 Version 1 - Does your health now limit you in these activities? If so, how much: Moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. KDQOL-36 Version 1 - Limit Moderate Activities KDQ1-Limit Climbing Several Flights Kidney Disease and Quality of Life-36 Version 1 - Does your health now limit you in these activities? If so, how much: Climbing several flights of stairs. KDQOL-36 Version 1 - Limit Climbing Several Flights KDQ1-Physical: Accomplished Less Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Accomplished less than you would like. KDQOL-36 Version 1 - Physical: Accomplished Less KDQ1-Physical: Limited Kind of Work Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Were limited in the kind of work or other activities. KDQOL-36 Version 1 - Physical: Limited Kind of Work KDQ1-Emotional: Accomplished Less Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious): Accomplished less than you would like. KDQOL-36 Version 1 - Emotional: Accomplished Less KDQ1-Emotional: Did Work Less Carefully Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious): Didn't do work or other activities as carefully as usual. KDQOL-36 Version 1 - Emotional: Did Work Less Carefully KDQ1-Pain Interfere With Normal Work Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the home and housework)? KDQOL-36 Version 1 - Pain Interfere With Normal Work KDQ1-Have You Felt Calm and Peaceful Kidney Disease and Quality of Life-36 Version 1 - How much of the time during the past 4 weeks: Have you felt calm and peaceful? KDQOL-36 Version 1 - Have You Felt Calm and Peaceful KDQ1-Did You Have a Lot of Energy Kidney Disease and Quality of Life-36 Version 1 - How much of the time during the past 4 weeks: Did you have a lot of energy? KDQOL-36 Version 1 - Did You Have a Lot of Energy KDQ1-You Felt Downhearted and Blue Kidney Disease and Quality of Life-36 Version 1 - How much of the time during the past 4 weeks: Have you felt downhearted and blue? KDQOL-36 Version 1 - You Felt Downhearted and Blue KDQ1-Time Phys/Emotional Interfered Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting with friends, relatives, etc.)? KDQOL-36 Version 1 - Time Physical or Emotional Interfered KDQ1-Kidney Disease Interferes w/ Life Kidney Disease and Quality of Life-36 Version 1 - How true or false is each of the following statements for you: My kidney disease interferes too much with my life. KDQOL-36 Version 1 - Kidney Disease Interferes With Life KDQ1-Time Spent Deal w/ Kidney Disease Kidney Disease and Quality of Life-36 Version 1 - How true or false is each of the following statements for you: Too much of my time is spent dealing with my kidney disease. KDQOL-36 Version 1 - Time Spent Deal With Kidney Disease KDQ1-Frustrated Deal w/ Kidney Disease Kidney Disease and Quality of Life-36 Version 1 - How true or false is each of the following statements for you: I feel frustrated dealing with my kidney disease. KDQOL-36 Version 1 - Frustrated Deal With Kidney Disease KDQ1-I Feel Like a Burden on My Family Kidney Disease and Quality of Life-36 Version 1 - How true or false is each of the following statements for you: I feel like a burden on my family. KDQOL-36 Version 1 - I Feel Like a Burden on My Family KDQ1-Bothered by Soreness in Muscles Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Soreness in your muscles? KDQOL-36 Version 1 - Bothered by Soreness in Muscles KDQ1-Bothered by Chest Pain Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Chest pain? KDQOL-36 Version 1 - Bothered by Chest Pain KDQ1-Bothered by Cramps Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Cramps? KDQOL-36 Version 1 - Bothered by Cramps KDQ1-Bothered by Itchy Skin Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Itchy skin? KDQOL-36 Version 1 - Bothered by Itchy Skin KDQ1-Bothered by Dry Skin Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Dry skin? KDQOL-36 Version 1 - Bothered by Dry Skin KDQ1-Bothered by Shortness of Breath Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Shortness of breath? KDQOL-36 Version 1 - Bothered by Shortness of Breath KDQ1-Bothered by Faintness or Dizziness Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Faintness or dizziness? KDQOL-36 Version 1 - Bothered by Faintness or Dizziness KDQ1-Bothered by Lack of Appetite Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Lack of appetite? KDQOL-36 Version 1 - Bothered by Lack of Appetite KDQ1-Bothered by Washed Out or Drained Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Washed out or drained? KDQOL-36 Version 1 - Bothered by Washed Out or Drained KDQ1-Bothered by Numbness in Hands/Feet Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Numbness in hands or feet? KDQOL-36 Version 1 - Bothered by Numbness in Hands or Feet KDQ1-Bothered by Nausea/Upset Stomach Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Nausea or upset stomach? KDQOL-36 Version 1 - Bothered by Nausea or Upset Stomach KDQ1-Bothered by Problems w/ Access Site Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: (Hemodialysis patient only) Problems with your access site? KDQOL-36 Version 1 - Bothered by Problems With Access Site KDQ1-Bothered by Problems Catheter Site Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: (Peritoneal dialysis patient only) Problems with your catheter site? KDQOL-36 Version 1 - Bothered by Problems Catheter Site KDQ1-Bother Fluid Restriction Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Fluid restriction? KDQOL-36 Version 1 - Bother Fluid Restriction KDQ1-Bother Dietary Restriction Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Dietary restriction? KDQOL-36 Version 1 - Bother Dietary Restriction KDQ1-Bother Ability to Work Around House Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Your ability to work around the house? KDQOL-36 Version 1 - Bother Ability to Work Around House KDQ1-Bother Your Ability to Travel Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Your ability to travel? KDQOL-36 Version 1 - Bother Your Ability to Travel KDQ1-Bother Dependent on Doctors/Staff Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Being dependent on doctors and other medical staff? KDQOL-36 Version 1 - Bother Dependent on Doctors and Staff KDQ1-Bother Stress Caused by Disease Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Stress or worries caused by kidney disease? KDQOL-36 Version 1 - Bother Stress Caused by Disease KDQ1-Bother Your Sex Life Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Your sex life? KDQOL-36 Version 1 - Bother Your Sex Life KDQ1-Bother Your Personal Appearance Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Your personal appearance? KDQOL-36 Version 1 - Bother Your Personal Appearance KDQ1TC Kidney Disease and Quality of Life-36 Version 1 Questionnaire Test Code CDISC Questionnaire Kidney Disease and Quality of Life-36 Version 1 Test Code Terminology Kidney Disease and Quality of Life-36 Version 1 test name. KDQ1-Bother Ability to Work Around House Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Your ability to work around the house? KDQOL-36 Version 1 - Bother Ability to Work Around House KDQ1-Bother Dependent on Doctors/Staff Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Being dependent on doctors and other medical staff? KDQOL-36 Version 1 - Bother Dependent on Doctors and Staff KDQ1-Bother Dietary Restriction Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Dietary restriction? KDQOL-36 Version 1 - Bother Dietary Restriction KDQ1-Bother Fluid Restriction Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Fluid restriction? KDQOL-36 Version 1 - Bother Fluid Restriction KDQ1-Bother Stress Caused by Disease Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Stress or worries caused by kidney disease? KDQOL-36 Version 1 - Bother Stress Caused by Disease KDQ1-Bother Your Ability to Travel Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Your ability to travel? KDQOL-36 Version 1 - Bother Your Ability to Travel KDQ1-Bother Your Personal Appearance Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Your personal appearance? KDQOL-36 Version 1 - Bother Your Personal Appearance KDQ1-Bother Your Sex Life Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Your sex life? KDQOL-36 Version 1 - Bother Your Sex Life KDQ1-Bothered by Chest Pain Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Chest pain? KDQOL-36 Version 1 - Bothered by Chest Pain KDQ1-Bothered by Cramps Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Cramps? KDQOL-36 Version 1 - Bothered by Cramps KDQ1-Bothered by Dry Skin Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Dry skin? KDQOL-36 Version 1 - Bothered by Dry Skin KDQ1-Bothered by Faintness or Dizziness Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Faintness or dizziness? KDQOL-36 Version 1 - Bothered by Faintness or Dizziness KDQ1-Bothered by Itchy Skin Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Itchy skin? KDQOL-36 Version 1 - Bothered by Itchy Skin KDQ1-Bothered by Lack of Appetite Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Lack of appetite? KDQOL-36 Version 1 - Bothered by Lack of Appetite KDQ1-Bothered by Nausea/Upset Stomach Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Nausea or upset stomach? KDQOL-36 Version 1 - Bothered by Nausea or Upset Stomach KDQ1-Bothered by Numbness in Hands/Feet Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Numbness in hands or feet? KDQOL-36 Version 1 - Bothered by Numbness in Hands or Feet KDQ1-Bothered by Problems Catheter Site Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: (Peritoneal dialysis patient only) Problems with your catheter site? KDQOL-36 Version 1 - Bothered by Problems Catheter Site KDQ1-Bothered by Problems w/ Access Site Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: (Hemodialysis patient only) Problems with your access site? KDQOL-36 Version 1 - Bothered by Problems With Access Site KDQ1-Bothered by Shortness of Breath Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Shortness of breath? KDQOL-36 Version 1 - Bothered by Shortness of Breath KDQ1-Bothered by Soreness in Muscles Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Soreness in your muscles? KDQOL-36 Version 1 - Bothered by Soreness in Muscles KDQ1-Bothered by Washed Out or Drained Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Washed out or drained? KDQOL-36 Version 1 - Bothered by Washed Out or Drained KDQ1-Did You Have a Lot of Energy Kidney Disease and Quality of Life-36 Version 1 - How much of the time during the past 4 weeks: Did you have a lot of energy? KDQOL-36 Version 1 - Did You Have a Lot of Energy KDQ1-Emotional: Accomplished Less Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious): Accomplished less than you would like. KDQOL-36 Version 1 - Emotional: Accomplished Less KDQ1-Emotional: Did Work Less Carefully Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious): Didn't do work or other activities as carefully as usual. KDQOL-36 Version 1 - Emotional: Did Work Less Carefully KDQ1-Frustrated Deal w/ Kidney Disease Kidney Disease and Quality of Life-36 Version 1 - How true or false is each of the following statements for you: I feel frustrated dealing with my kidney disease. KDQOL-36 Version 1 - Frustrated Deal With Kidney Disease KDQ1-Have You Felt Calm and Peaceful Kidney Disease and Quality of Life-36 Version 1 - How much of the time during the past 4 weeks: Have you felt calm and peaceful? KDQOL-36 Version 1 - Have You Felt Calm and Peaceful KDQ1-I Feel Like a Burden on My Family Kidney Disease and Quality of Life-36 Version 1 - How true or false is each of the following statements for you: I feel like a burden on my family. KDQOL-36 Version 1 - I Feel Like a Burden on My Family KDQ1-In General You Say Your Health Is Kidney Disease and Quality of Life-36 Version 1 - In general, would you say your health is. KDQOL-36 Version 1 - In General You Say Your Health Is KDQ1-Kidney Disease Interferes w/ Life Kidney Disease and Quality of Life-36 Version 1 - How true or false is each of the following statements for you: My kidney disease interferes too much with my life. KDQOL-36 Version 1 - Kidney Disease Interferes With Life KDQ1-Limit Climbing Several Flights Kidney Disease and Quality of Life-36 Version 1 - Does your health now limit you in these activities? If so, how much: Climbing several flights of stairs. KDQOL-36 Version 1 - Limit Climbing Several Flights KDQ1-Limit Moderate Activities Kidney Disease and Quality of Life-36 Version 1 - Does your health now limit you in these activities? If so, how much: Moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. KDQOL-36 Version 1 - Limit Moderate Activities KDQ1-Pain Interfere With Normal Work Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the home and housework)? KDQOL-36 Version 1 - Pain Interfere With Normal Work KDQ1-Physical: Accomplished Less Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Accomplished less than you would like. KDQOL-36 Version 1 - Physical: Accomplished Less KDQ1-Physical: Limited Kind of Work Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Were limited in the kind of work or other activities. KDQOL-36 Version 1 - Physical: Limited Kind of Work KDQ1-Time Phys/Emotional Interfered Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting with friends, relatives, etc.)? KDQOL-36 Version 1 - Time Physical or Emotional Interfered KDQ1-Time Spent Deal w/ Kidney Disease Kidney Disease and Quality of Life-36 Version 1 - How true or false is each of the following statements for you: Too much of my time is spent dealing with my kidney disease. KDQOL-36 Version 1 - Time Spent Deal With Kidney Disease KDQ1-You Felt Downhearted and Blue Kidney Disease and Quality of Life-36 Version 1 - How much of the time during the past 4 weeks: Have you felt downhearted and blue? KDQOL-36 Version 1 - You Felt Downhearted and Blue KDQ1TN Kidney Disease and Quality of Life-36 Version 1 Questionnaire Test Name CDISC Questionnaire Kidney Disease and Quality of Life-36 Version 1 Test Name Terminology Kidney Disease Improving Global Outcomes Staging For Acute Kidney Injury test code. KDIGO1-KDIGO AKI Stage Kidney Disease: Improving Global Outcomes Staging For Acute Kidney Injury - KDIGO AKI stage. KDIGO-AKI - KDIGO AKI Stage KDIGO1TC Kidney Disease Improving Global Outcomes Staging For Acute Kidney Injury Clinical Classification Test Code CDISC Clinical Classification KDIGO-AKI Test Code Terminology Kidney Disease Improving Global Outcomes Staging For Acute Kidney Injury test name. KDIGO1-KDIGO AKI Stage Kidney Disease: Improving Global Outcomes Staging For Acute Kidney Injury - KDIGO AKI stage. KDIGO-AKI - KDIGO AKI Stage KDIGO1TN Kidney Disease Improving Global Outcomes Staging For Acute Kidney Injury Clinical Classification Test Name CDISC Clinical Classification KDIGO-AKI Test Name Terminology Kidney Donor Profile Index test code. KDPI01-KDPI Score Kidney Donor Profile Index - KDPI score. KDPI - KDPI Score KDPI01TC Kidney Donor Profile Index Clinical Classification Test Code CDISC Clinical Classification KDPI Test Code Terminology Kidney Donor Profile Index test name. KDPI01-KDPI Score Kidney Donor Profile Index - KDPI score. KDPI - KDPI Score KDPI01TN Kidney Donor Profile Index Clinical Classification Test Name CDISC Clinical Classification KDPI Test Name Terminology A terminology codelist based on the classification developed by Killip and Kimball, which classifies patients with myocardial infarction based on routine physical examination parameters, such as the presence or absence of rales, or a decreased systolic blood pressure. The absence of rales over the lung fields and absence of third heart sound (S3). (ACC/AHA) Killip Class I The presence of rales over 50% or less of the lung fields or the presence of a third heart sound (S3).(ACC/AHA) Killip Class II The presence of rales over more than 50% of the lung fields. (ACC/AHA) Killip Class III The presence of cardiogenic shock (systolic BP less than 90 mm Hg) for greater than 30 minutes, not responsive to fluid resuscitation alone, and felt to be secondary to cardiac dysfunction. (ACC/AHA) Killip Class IV KILLIPC Killip Class Responses CDISC SDTM Killip Class Responses Terminology Kurtzke Expanded Disability Status Scale test code. EDSS01-Expanded Disability Score Kurtzke Expanded Disability Status Scale - Expanded disability score. EDSS - Expanded Disability Score EDSS01TC Kurtzke Expanded Disability Status Scale Clinical Classification Test Code CDISC Clinical Classification EDSS Test Code Terminology Kurtzke Expanded Disability Status Scale test name. EDSS01-Expanded Disability Score Kurtzke Expanded Disability Status Scale - Expanded disability score. EDSS - Expanded Disability Score EDSS01TN Kurtzke Expanded Disability Status Scale Clinical Classification Test Name CDISC Clinical Classification EDSS Test Name Terminology Kurtzke Functional System Scores original result for KFSS101 test and test code. KFSS101-Abnormal signs without disability Kurtzke Functional System Scores original result for KFSS101-Abnormal signs without disability. Kurtzke Functional System Scores KFSS101 Original Result - Abnormal signs without disability KFSS101-Marked paraparesis or hemiparesis moderate quadriparesis or monoplegia Kurtzke Functional System Scores original result for KFSS101-Marked paraparesis or hemiparesis; moderate quadriparesis; or monoplegia. Kurtzke Functional System Scores KFSS101 Original Result - Marked paraparesis or hemiparesis; moderate quadriparesis; or monoplegia KFSS101-Mild or moderate paraparesis or hemiparesis severe monoparesis Kurtzke Functional System Scores original result for KFSS101-Mild or moderate paraparesis or hemiparesis; severe monoparesis. Kurtzke Functional System Scores KFSS101 Original Result - Mild or moderate paraparesis or hemiparesis; severe monoparesis KFSS101-Minimal disability Kurtzke Functional System Scores original result for KFSS101-Minimal disability. Kurtzke Functional System Scores KFSS101 Original Result - Minimal disability KFSS101-Normal Kurtzke Functional System Scores original result for KFSS101-Normal. Kurtzke Functional System Scores KFSS101 Original Result - Normal KFSS101-Paraplegia, hemiplegia, or marked quadriparesis Kurtzke Functional System Scores original result for KFSS101-Paraplegia, hemiplegia, or marked quadriparesis. Kurtzke Functional System Scores KFSS101 Original Result - Paraplegia, hemiplegia, or marked quadriparesis KFSS101-Quadriplegia Kurtzke Functional System Scores original result for KFSS101-Quadriplegia. Kurtzke Functional System Scores KFSS101 Original Result - Quadriplegia KFSS101-Unknown Kurtzke Functional System Scores original result for KFSS101-Unknown. Kurtzke Functional System Scores KFSS101 Original Result - Unknown KFSS101OR Kurtzke Functional System Scores Clinical Classification ORRES for KFSS101 TN/TC CDISC Clinical Classification Kurtzke Functional System Scores KFSS101 Original Response Terminology Kurtzke Functional System Scores original result for KFSS102 test and test code. KFSS102-Abnormal signs without disability Kurtzke Functional System Scores original result for KFSS102-Abnormal signs without disability. Kurtzke Functional System Scores KFSS102 Original Result - Abnormal signs without disability KFSS102-Mild ataxia Kurtzke Functional System Scores original result for KFSS102-Mild ataxia. Kurtzke Functional System Scores KFSS102 Original Result - Mild ataxia KFSS102-Moderate truncal or limb ataxias Kurtzke Functional System Scores original result for KFSS102-Moderate truncal or limb ataxia. Kurtzke Functional System Scores KFSS102 Original Result - Moderate truncal or limb ataxia KFSS102-Normal Kurtzke Functional System Scores original result for KFSS102-Normal. Kurtzke Functional System Scores KFSS102 Original Result - Normal KFSS102-Severe ataxia, all limbs Kurtzke Functional System Scores original result for KFSS102-Severe ataxia, all limbs. Kurtzke Functional System Scores KFSS102 Original Result - Severe ataxia, all limbs KFSS102-Unable to perform coordinated movements due to ataxia Kurtzke Functional System Scores original result for KFSS102-Unable to perform coordinated movements due to ataxia. Kurtzke Functional System Scores KFSS102 Original Result - Unable to perform coordinated movements due to ataxia KFSS102-Unknown Kurtzke Functional System Scores original result for KFSS102-Unknown. Kurtzke Functional System Scores KFSS102 Original Result - Unknown KFSS102OR Kurtzke Functional System Scores Clinical Classification ORRES for KFSS102 TN/TC CDISC Clinical Classification Kurtzke Functional System Scores KFSS102 Original Response Terminology Kurtzke Functional System Scores original result for KFSS103 test and test code. KFSS103-Inability to swallow or speak Kurtzke Functional System Scores original result for KFSS103-Inability to swallow or speak. Kurtzke Functional System Scores KFSS103 Original Result - Inability to swallow or speak KFSS103-Marked dysarthria or other marked disability Kurtzke Functional System Scores original result for KFSS103-Marked dysarthria or other marked disability. Kurtzke Functional System Scores KFSS103 Original Result - Marked dysarthria or other marked disability KFSS103-Moderate nystagmus or other mild disability Kurtzke Functional System Scores original result for KFSS103-Moderate nystagmus or other mild disability. Kurtzke Functional System Scores KFSS103 Original Result - Moderate nystagmus or other mild disability KFSS103-Normal. Kurtzke Functional System Scores original result for KFSS103-Normal. Kurtzke Functional System Scores KFSS103 Original Result - Normal KFSS103-Severe nystagmus, marked extraocular weakness, or moderate disability of other cranial nerves Kurtzke Functional System Scores original result for KFSS103-Severe nystagmus, marked extraocular weakness, or moderate disability of other cranial nerves. Kurtzke Functional System Scores KFSS103 Original Result - Severe nystagmus, marked extraocular weakness, or moderate disability of other cranial nerves KFSS103-Signs only Kurtzke Functional System Scores original result for KFSS103-Signs only. Kurtzke Functional System Scores KFSS103 Original Result - Signs only KFSS103-Unknown Kurtzke Functional System Scores original result for KFSS103-Unknown. Kurtzke Functional System Scores KFSS103 Original Result - Unknown KFSS103OR Kurtzke Functional System Scores Clinical Classification ORRES for KFSS103 TN/TC CDISC Clinical Classification Kurtzke Functional System Scores KFSS103 Original Response Terminology Kurtzke Functional System Scores original result for KFSS104 test and test code. KFSS104-Loss (essentially) of sensation in one or two limbs or moderate decrease in touch or pain and/or loss of proprioception for most of the body below the head Kurtzke Functional System Scores original result for KFSS104-Loss (essentially) of sensation in one or two limbs; or moderate decrease in touch or pain and/or loss of proprioception for most of the body below the head. Kurtzke Functional System Scores KFSS104 Original Result - Loss (essentially) of sensation in one or two limbs; or moderate decrease in touch or pain and/or loss of proprioception for most of the body below the head KFSS104-Marked decrease in touch or pain or loss of proprioception, alone or combined, in one or two limbs or moderate decrease in touch or pain and/or severe proprioceptive decrease in more than two limbs Kurtzke Functional System Scores original result for KFSS104-Marked decrease in touch or pain or loss of proprioception, alone or combined, in one or two limbs; or moderate decrease in touch or pain and/or severe proprioceptive decrease in more than two limbs. Kurtzke Functional System Scores KFSS104 Original Result - Marked decrease in touch or pain or loss of proprioception, alone or combined, in one or two limbs; or moderate decrease in touch or pain and/or severe proprioceptive decrease in more than two limbs KFSS104-Mild decrease in touch or pain or position sense, and/or moderate decrease in vibration in one or two limbs or vibratory (c/s figure writing) decrease alone in three or four limbs Kurtzke Functional System Scores original result for KFSS104-Mild decrease in touch or pain or position sense, and/or moderate decrease in vibration in one or two limbs; or vibratory (c/s figure writing) decrease alone in three or four limbs. Kurtzke Functional System Scores KFSS104 Original Result - Mild decrease in touch or pain or position sense, and/or moderate decrease in vibration in one or two limbs; or vibratory (c/s figure writing) decrease alone in three or four limbs KFSS104-Moderate decrease in touch or pain or position sense, and/or lost vibration in 1 or 2 limbs or mild decrease in touch or pain and/or moderate decrease in all proprioceptive tests in 3 or 4 limbs Kurtzke Functional System Scores original result for KFSS104-Moderate decrease in touch or pain or position sense, and/or lost vibration in 1 or 2 limbs; or mild decrease in touch or pain and/or moderate decrease in all proprioceptive tests in 3 or 4 limbs. Kurtzke Functional System Scores KFSS104 Original Result - Moderate decrease in touch or pain or position sense, and/or lost vibration in 1 or 2 limbs; or mild decrease in touch or pain and/or moderate decrease in all proprioceptive tests in 3 or 4 limbs KFSS104-Normal Kurtzke Functional System Scores original result for KFSS104-Normal. Kurtzke Functional System Scores KFSS104 Original Result - Normal KFSS104-Sensation essentially lost below the head Kurtzke Functional System Scores original result for KFSS104-Sensation essentially lost below the head. Kurtzke Functional System Scores KFSS104 Original Result - Sensation essentially lost below the head KFSS104-Unknown Kurtzke Functional System Scores original result for KFSS104-Unknown. Kurtzke Functional System Scores KFSS104 Original Result - Unknown KFSS104-Vibration or figure-writing decrease only, in one or two limbs Kurtzke Functional System Scores original result for KFSS104-Vibration or figure-writing decrease only, in one or two limbs. Kurtzke Functional System Scores KFSS104 Original Result - Vibration or figure-writing decrease only, in one or two limbs KFSS104OR Kurtzke Functional System Scores Clinical Classification ORRES for KFSS104 TN/TC CDISC Clinical Classification Kurtzke Functional System Scores KFSS104 Original Response Terminology Kurtzke Functional System Scores original result for KFSS105 test and test code. KFSS105-Frequent urinary incontinence Kurtzke Functional System Scores original result for KFSS105-Frequent urinary incontinence. Kurtzke Functional System Scores KFSS105 Original Result - Frequent urinary incontinence KFSS105-In need of almost constant catheterization Kurtzke Functional System Scores original result for KFSS105-In need of almost constant catheterization. Kurtzke Functional System Scores KFSS105 Original Result - In need of almost constant catheterization KFSS105-Loss of bladder function Kurtzke Functional System Scores original result for KFSS105-Loss of bladder function. Kurtzke Functional System Scores KFSS105 Original Result - Loss of bladder function KFSS105-Loss of bowel and bladder function Kurtzke Functional System Scores original result for KFSS105-Loss of bowel and bladder function. Kurtzke Functional System Scores KFSS105 Original Result - Loss of bowel and bladder function KFSS105-Mild urinary hesitancy, urgency, or retention Kurtzke Functional System Scores original result for KFSS105-Mild urinary hesitancy, urgency, or retention. Kurtzke Functional System Scores KFSS105 Original Result - Mild urinary hesitancy, urgency, or retention KFSS105-Moderate hesitancy, urgency, retention of bowel or bladder, or rare urinary incontinence Kurtzke Functional System Scores original result for KFSS105-Moderate hesitancy, urgency, retention of bowel or bladder, or rare urinary incontinences. Kurtzke Functional System Scores KFSS105 Original Result - Moderate hesitancy, urgency, retention of bowel or bladder, or rare urinary incontinence KFSS105-Normal Kurtzke Functional System Scores original result for KFSS105-Normal. Kurtzke Functional System Scores KFSS105 Original Result - Normal KFSS105-Unknown Kurtzke Functional System Scores original result for KFSS105-Unknown. Kurtzke Functional System Scores KFSS105 Original Result - Unknown KFSS105OR Kurtzke Functional System Scores Clinical Classification ORRES for KFSS105 TN/TC CDISC Clinical Classification Kurtzke Functional System Scores KFSS105 Original Response Terminology Kurtzke Functional System Scores original result for KFSS106 test and test code. KFSS106-Grade 5 plus maximal visual acuity of better eye of 20/60 or less Kurtzke Functional System Scores original result for KFSS106-Grade 5 plus maximal visual acuity of better eye of 20/60 or less. Kurtzke Functional System Scores KFSS106 Original Result - Grade 5 plus maximal visual acuity of better eye of 20/60 or less KFSS106-Normal Kurtzke Functional System Scores original result for KFSS106-Normal. Kurtzke Functional System Scores KFSS106 Original Result - Normal KFSS106-Scotoma with visual acuity (corrected) better than 20/30 Kurtzke Functional System Scores original result for KFSS106-Scotoma with visual acuity (corrected) better than 20/30. Kurtzke Functional System Scores KFSS106 Original Result - Scotoma with visual acuity (corrected) better than 20/30 KFSS106-Unknown Kurtzke Functional System Scores original result for KFSS106-Unknown. Kurtzke Functional System Scores KFSS106 Original Result - Unknown KFSS106-Worse eye with large scotoma, or moderate decrease in fields, but with maximal visual acuity (corrected) of 20/60 to 20/99 Kurtzke Functional System Scores original result for KFSS106-Worse eye with large scotoma, or moderate decrease in fields, but with maximal visual acuity (corrected) of 20/60 to 20/99. Kurtzke Functional System Scores KFSS106 Original Result - Worse eye with large scotoma, or moderate decrease in fields, but with maximal visual acuity (corrected) of 20/60 to 20/99 KFSS106-Worse eye with marked decrease of fields and maximal visual acuity (corrected) of 20/100 to 20/200 grade 3 plus maximal acuity of better eye of 20/60 or less Kurtzke Functional System Scores original result for KFSS106-Worse eye with marked decrease of fields and maximal visual acuity (corrected) of 20/100 to 20/200; grade 3 plus maximal acuity of better eye of 20/60 or less. Kurtzke Functional System Scores KFSS106 Original Result - Worse eye with marked decrease of fields and maximal visual acuity (corrected) of 20/100 to 20/200; grade 3 plus maximal acuity of better eye of 20/60 or less KFSS106-Worse eye with maximal visual acuity (corrected) less than 20/200 grade 4 plus maximal acuity of better eye of 20/60 or less Kurtzke Functional System Scores original result for KFSS106-Worse eye with maximal visual acuity (corrected) less than 20/200; grade 4 plus maximal acuity of better eye of 20/60 or less. Kurtzke Functional System Scores KFSS106 Original Result - Worse eye with maximal visual acuity (corrected) less than 20/200; grade 4 plus maximal acuity of better eye of 20/60 or less KFSS106-Worse eye with scotoma with maximal visual acuity (corrected) of 20/30 to 20/59 Kurtzke Functional System Scores original result for KFSS106-Worse eye with scotoma with maximal visual acuity (corrected) of 20/30 to 20/59. Kurtzke Functional System Scores KFSS106 Original Result - Worse eye with scotoma with maximal visual acuity (corrected) of 20/30 to 20/59 KFSS106OR Kurtzke Functional System Scores Clinical Classification ORRES for KFSS106 TN/TC CDISC Clinical Classification Kurtzke Functional System Scores KFSS106 Original Response Terminology Kurtzke Functional System Scores original result for KFSS107 test and test code. KFSS107-Dementia or chronic brain syndrome - severe or incompetent Kurtzke Functional System Scores original result for KFSS107-Dementia or chronic brain syndrome - severe or incompetent. Kurtzke Functional System Scores KFSS107 Original Result - Dementia or chronic brain syndrome - severe or incompetent KFSS107-Marked decrease in mentation (chronic brain syndrome - moderate) Kurtzke Functional System Scores original result for KFSS107-Marked decrease in mentation (chronic brain syndrome - moderate). Kurtzke Functional System Scores KFSS107 Original Result - Marked decrease in mentation (chronic brain syndrome - moderate) KFSS107-Mild decrease in mentation Kurtzke Functional System Scores original result for KFSS107-Mild decrease in mentation. Kurtzke Functional System Scores KFSS107 Original Result - Mild decrease in mentation KFSS107-Moderate decrease in mentation Kurtzke Functional System Scores original result for KFSS107-Moderate decrease in mentation. Kurtzke Functional System Scores KFSS107 Original Result - Moderate decrease in mentation KFSS107-Mood alteration only (does not affect DSS score) Kurtzke Functional System Scores original result for KFSS107-Mood alteration only (does not affect DSS score). Kurtzke Functional System Scores KFSS107 Original Result - Mood alteration only (does not affect DSS score) KFSS107-Normal Kurtzke Functional System Scores original result for KFSS107-Normal. Kurtzke Functional System Scores KFSS107 Original Result - Normal KFSS107-Unknown Kurtzke Functional System Scores original result for KFSS107-Unknown. Kurtzke Functional System Scores KFSS107 Original Result - Unknown KFSS107OR Kurtzke Functional System Scores Clinical Classification ORRES for KFSS107 TN/TC CDISC Clinical Classification Kurtzke Functional System Scores KFSS107 Original Response Terminology Kurtzke Functional System Scores original result for KFSS108 test and test code. KFSS108-Any other neurologic findings attributed to MS (specify) Kurtzke Functional System Scores original result for KFSS108-Any other neurologic findings attributed to MS (specify). Kurtzke Functional System Scores KFSS108 Original Result - Any other neurologic findings attributed to MS (specify) KFSS108-None Kurtzke Functional System Scores original result for KFSS108-None. Kurtzke Functional System Scores KFSS108 Original Result - None KFSS108-Unknown Kurtzke Functional System Scores original result for KFSS108-Unknown. Kurtzke Functional System Scores KFSS108 Original Result - Unknown KFSS108OR Kurtzke Functional System Scores Clinical Classification ORRES for KFSS108 TN/TC CDISC Clinical Classification Kurtzke Functional System Scores KFSS108 Original Response Terminology Kurtzke Functional System Scores original result for KFSS102A and KFSS106A test and test code. KFSS1SET1-CHECKED Kurtzke Functional System Scores original result for KFSS102 and KFSS106A-Checked. Kurtzke Functional System Scores KFSS1SET1 Original Result - Checked KFSS1SET1-NOT CHECKED Kurtzke Functional System Scores original result for KFSS102 and KFSS106A-Not checked. Kurtzke Functional System Scores KFSS1SET1 Original Result - Not Checked KFSS1SET1OR Kurtzke Functional System Scores Clinical Classification ORRES the Same as KFSS102A TN/TC CDISC Clinical Classification Kurtzke Functional System Scores KFSS1SET1 Original Response Terminology Kurtzke Functional System Scores standardized character result for KFSS101 test and test code. KFSS101-0 Kurtzke Functional System Scores standardized character result for KFSS101-Normal. Kurtzke Functional System Scores KFSS101 Standardized Character Result 0 KFSS101-1 Kurtzke Functional System Scores standardized character result for KFSS101-Abnormal signs without disability. Kurtzke Functional System Scores KFSS101 Standardized Character Result 1 KFSS101-2 Kurtzke Functional System Scores standardized character result for KFSS101-Minimal disability. Kurtzke Functional System Scores KFSS101 Standardized Character Result 2 KFSS101-3 Kurtzke Functional System Scores standardized character result for KFSS101-Mild or moderate paraparesis or hemiparesis; severe monoparesis. Kurtzke Functional System Scores KFSS101 Standardized Character Result 3 KFSS101-4 Kurtzke Functional System Scores standardized character result for KFSS101-Marked paraparesis or hemiparesis; moderate quadriparesis; or monoplegia. Kurtzke Functional System Scores KFSS101 Standardized Character Result 4 KFSS101-5 Kurtzke Functional System Scores standardized character result for KFSS101-Paraplegia, hemiplegia, or marked quadriparesis. Kurtzke Functional System Scores KFSS101 Standardized Character Result 5 KFSS101-6 Kurtzke Functional System Scores standardized character result for KFSS101-Quadriplegia. Kurtzke Functional System Scores KFSS101 Standardized Character Result 6 KFSS101-Unknown Kurtzke Functional System Scores standardized character result for KFSS101-Unknown. Kurtzke Functional System Scores KFSS101 Standardized Character Result Unknown KFSS101STR Kurtzke Functional System Scores Clinical Classification STRESC for KFSS101 TN/TC CDISC Clinical Classification Kurtzke Functional System Scores KFSS101 Standardized Character Response Terminology Kurtzke Functional System Scores standardized character result for KFSS102 test and test code. KFSS102-0 Kurtzke Functional System Scores standardized character result for KFSS102-Normal. Kurtzke Functional System Scores KFSS102 Standardized Character Result 0 KFSS102-1 Kurtzke Functional System Scores standardized character result for KFSS102-Abnormal signs without disability. Kurtzke Functional System Scores KFSS102 Standardized Character Result 1 KFSS102-2 Kurtzke Functional System Scores standardized character result for KFSS102-Mild ataxia. Kurtzke Functional System Scores KFSS102 Standardized Character Result 2 KFSS102-3 Kurtzke Functional System Scores standardized character result for KFSS102-Moderate truncal or limb ataxia. Kurtzke Functional System Scores KFSS102 Standardized Character Result 3 KFSS102-4 Kurtzke Functional System Scores standardized character result for KFSS102-Severe ataxia, all limbs. Kurtzke Functional System Scores KFSS102 Standardized Character Result 4 KFSS102-5 Kurtzke Functional System Scores standardized character result for KFSS102-Unable to perform coordinated movements due to ataxia. Kurtzke Functional System Scores KFSS102 Standardized Character Result 5 KFSS102-Unknown Kurtzke Functional System Scores standardized character result for KFSS102-Unknown. Kurtzke Functional System Scores KFSS102 Standardized Character Result Unknown KFSS102STR Kurtzke Functional System Scores Clinical Classification STRESC for KFSS102 TN/TC CDISC Clinical Classification Kurtzke Functional System Scores KFSS102 Standardized Character Response Terminology Kurtzke Functional System Scores standardized character result for KFSS103 test and test code. KFSS103-0 Kurtzke Functional System Scores standardized character result for KFSS103-Normal. Kurtzke Functional System Scores KFSS103 Standardized Character Result 0 KFSS103-1 Kurtzke Functional System Scores standardized character result for KFSS103-Signs only. Kurtzke Functional System Scores KFSS103 Standardized Character Result 1 KFSS103-2 Kurtzke Functional System Scores standardized character result for KFSS103-Moderate nystagmus or other mild disability. Kurtzke Functional System Scores KFSS103 Standardized Character Result 2 KFSS103-3 Kurtzke Functional System Scores standardized character result for KFSS103-Severe nystagmus, marked extraocular weakness, or moderate disability of other cranial nerves. Kurtzke Functional System Scores KFSS103 Standardized Character Result 3 KFSS103-4 Kurtzke Functional System Scores standardized character result for KFSS103-Marked dysarthria or other marked disability. Kurtzke Functional System Scores KFSS103 Standardized Character Result 4 KFSS103-5 Kurtzke Functional System Scores standardized character result for KFSS103-Inability to swallow or speak. Kurtzke Functional System Scores KFSS103 Standardized Character Result 5 KFSS103-Unknown Kurtzke Functional System Scores standardized character result for KFSS103-Unknown. Kurtzke Functional System Scores KFSS103 Standardized Character Result Unknown KFSS103STR Kurtzke Functional System Scores Clinical Classification STRESC for KFSS103 TN/TC CDISC Clinical Classification Kurtzke Functional System Scores KFSS103 Standardized Character Response Terminology Kurtzke Functional System Scores standardized character result for KFSS104 test and test code. KFSS104-0 Kurtzke Functional System Scores standardized character result for KFSS104-Normal. Kurtzke Functional System Scores KFSS104 Standardized Character Result 0 KFSS104-1 Kurtzke Functional System Scores standardized character result for KFSS104-Vibration or figure-writing decrease only, in one or two limbs. Kurtzke Functional System Scores KFSS104 Standardized Character Result 1 KFSS104-2 Kurtzke Functional System Scores standardized character result for KFSS104-Mild decrease in touch or pain or position sense, and/or moderate decrease in vibration in one or two limbs; or vibratory (c/s figure writing) decrease alone in three or four limbs. Kurtzke Functional System Scores KFSS104 Standardized Character Result 2 KFSS104-3 Kurtzke Functional System Scores standardized character result for KFSS104-Moderate decrease in touch or pain or position sense, and/or lost vibration in 1 or 2 limbs; or mild decrease in touch or pain and/or moderate decrease in all proprioceptive tests in 3 or 4 limbs. Kurtzke Functional System Scores KFSS104 Standardized Character Result 3 KFSS104-4 Kurtzke Functional System Scores standardized character result for KFSS104-Marked decrease in touch or pain or loss of proprioception, alone or combined, in one or two limbs; or moderate decrease in touch or pain and/or severe proprioceptive decrease in more than two limbs. Kurtzke Functional System Scores KFSS104 Standardized Character Result 4 KFSS104-5 Kurtzke Functional System Scores standardized character result for KFSS104-Loss (essentially) of sensation in one or two limbs; or moderate decrease in touch or pain and/or loss of proprioception for most of the body below the head. Kurtzke Functional System Scores KFSS104 Standardized Character Result 5 KFSS104-6 Kurtzke Functional System Scores standardized character result for KFSS104-Sensation essentially lost below the head. Kurtzke Functional System Scores KFSS104 Standardized Character Result 6 KFSS104-Unknown Kurtzke Functional System Scores standardized character result for KFSS104-Unknown. Kurtzke Functional System Scores KFSS104 Standardized Character Result Unknown KFSS104STR Kurtzke Functional System Scores Clinical Classification STRESC for KFSS104 TN/TC CDISC Clinical Classification Kurtzke Functional System Scores KFSS104 Standardized Character Response Terminology Kurtzke Functional System Scores standardized character result for KFSS105 test and test code. KFSS105-0 Kurtzke Functional System Scores standardized character result for KFSS105-Normal. Kurtzke Functional System Scores KFSS105 Standardized Character Result 0 KFSS105-1 Kurtzke Functional System Scores standardized character result for KFSS105-Mild urinary hesitancy, urgency, or retention. Kurtzke Functional System Scores KFSS105 Standardized Character Result 1 KFSS105-2 Kurtzke Functional System Scores standardized character result for KFSS105-Moderate hesitancy, urgency, retention of bowel or bladder, or rare urinary incontinences. Kurtzke Functional System Scores KFSS105 Standardized Character Result 2 KFSS105-3 Kurtzke Functional System Scores standardized character result for KFSS105-Frequent urinary incontinence. Kurtzke Functional System Scores KFSS105 Standardized Character Result 3 KFSS105-4 Kurtzke Functional System Scores standardized character result for KFSS105-In need of almost constant catheterization. Kurtzke Functional System Scores KFSS105 Standardized Character Result 4 KFSS105-5 Kurtzke Functional System Scores standardized character result for KFSS105-Loss of bladder function. Kurtzke Functional System Scores KFSS105 Standardized Character Result 5 KFSS105-6 Kurtzke Functional System Scores standardized character result for KFSS105-Loss of bowel and bladder function. Kurtzke Functional System Scores KFSS105 Standardized Character Result 6 KFSS105-Unknown Kurtzke Functional System Scores standardized character result for KFSS105-Unknown. Kurtzke Functional System Scores KFSS105 Standardized Character Result Unknown KFSS105STR Kurtzke Functional System Scores Clinical Classification STRESC for KFSS105 TN/TC CDISC Clinical Classification Kurtzke Functional System Scores KFSS105 Standardized Character Response Terminology Kurtzke Functional System Scores standardized character result for KFSS106 test and test code. KFSS106-0 Kurtzke Functional System Scores standardized character result for KFSS106-Normal. Kurtzke Functional System Scores KFSS106 Standardized Character Result 0 KFSS106-1 Kurtzke Functional System Scores standardized character result for KFSS106-Scotoma with visual acuity (corrected) better than 20/30. Kurtzke Functional System Scores KFSS106 Standardized Character Result 1 KFSS106-2 Kurtzke Functional System Scores standardized character result for KFSS106-Worse eye with scotoma with maximal visual acuity (corrected) of 20/30 to 20/59. Kurtzke Functional System Scores KFSS106 Standardized Character Result 2 KFSS106-3 Kurtzke Functional System Scores standardized character result for KFSS106-Worse eye with large scotoma, or moderate decrease in fields, but with maximal visual acuity (corrected) of 20/60 to 20/99. Kurtzke Functional System Scores KFSS106 Standardized Character Result 3 KFSS106-4 Kurtzke Functional System Scores standardized character result for KFSS106-Worse eye with marked decrease of fields and maximal visual acuity (corrected) of 20/100 to 20/200; grade 3 plus maximal acuity of better eye of 20/60 or less. Kurtzke Functional System Scores KFSS106 Standardized Character Result 4 KFSS106-5 Kurtzke Functional System Scores standardized character result for KFSS106-Worse eye with maximal visual acuity (corrected) less than 20/200; grade 4 plus maximal acuity of better eye of 20/60 or less. Kurtzke Functional System Scores KFSS106 Standardized Character Result 5 KFSS106-6 Kurtzke Functional System Scores standardized character result for KFSS106-Grade 5 plus maximal visual acuity of better eye of 20/60 or less. Kurtzke Functional System Scores KFSS106 Standardized Character Result 6 KFSS106-Unknown Kurtzke Functional System Scores standardized character result for KFSS106-Unknown. Kurtzke Functional System Scores KFSS106 Standardized Character Result Unknown KFSS106STR Kurtzke Functional System Scores Clinical Classification STRESC for KFSS106 TN/TC CDISC Clinical Classification Kurtzke Functional System Scores KFSS106 Standardized Character Response Terminology Kurtzke Functional System Scores standardized character result for KFSS107 test and test code. KFSS107-0 Kurtzke Functional System Scores standardized character result for KFSS107-Normal. Kurtzke Functional System Scores KFSS107 Standardized Character Result 0 KFSS107-1 Kurtzke Functional System Scores standardized character result for KFSS107-Mood alteration only (does not affect DSS score). Kurtzke Functional System Scores KFSS107 Standardized Character Result 1 KFSS107-2 Kurtzke Functional System Scores standardized character result for KFSS107-Mild decrease in mentation. Kurtzke Functional System Scores KFSS107 Standardized Character Result 2 KFSS107-3 Kurtzke Functional System Scores standardized character result for KFSS107-Moderate decrease in mentation. Kurtzke Functional System Scores KFSS107 Standardized Character Result 3 KFSS107-4 Kurtzke Functional System Scores standardized character result for KFSS107-Marked decrease in mentation (chronic brain syndrome - moderate). Kurtzke Functional System Scores KFSS107 Standardized Character Result 4 KFSS107-5 Kurtzke Functional System Scores standardized character result for KFSS107-Dementia or chronic brain syndrome - severe or incompetent. Kurtzke Functional System Scores KFSS107 Standardized Character Result 5 KFSS107-Unknown Kurtzke Functional System Scores standardized character result for KFSS107-Unknown. Kurtzke Functional System Scores KFSS107 Standardized Character Result Unknown KFSS107STR Kurtzke Functional System Scores Clinical Classification STRESC for KFSS107 TN/TC CDISC Clinical Classification Kurtzke Functional System Scores KFSS107 Standardized Character Response Terminology Kurtzke Functional System Scores standardized character result for KFSS108 test and test code. KFSS108-0 Kurtzke Functional System Scores standardized character result for KFSS108-None. Kurtzke Functional System Scores KFSS108 Standardized Character Result 0 KFSS108-1 Kurtzke Functional System Scores standardized character result for KFSS108-Any other neurologic findings attributed to MS (specify). Kurtzke Functional System Scores KFSS108 Standardized Character Result 1 KFSS108-Unknown Kurtzke Functional System Scores standardized character result for KFSS108-Unknown. Kurtzke Functional System Scores KFSS108 Standardized Character Result Unknown KFSS108STR Kurtzke Functional System Scores Clinical Classification STRESC for KFSS108 TN/TC CDISC Clinical Classification Kurtzke Functional System Scores KFSS108 Standardized Character Response Terminology Kurtzke Functional System Scores standardized character result for KFSS102A and KFSS106A test and test code. KFSS1SET1-CHECKED Kurtzke Functional System Scores standardized character result for KFSS102A and KFSS106A-Checked. Kurtzke Functional System Scores KFSS1SET1 Standardized Character Result Checked - Checked KFSS1SET1-NOT CHECKED Kurtzke Functional System Scores standardized character result for KFSS102A and KFSS106A-Not checked. Kurtzke Functional System Scores KFSS1SET1 Standardized Character Result Not Checked - Not Checked KFSS1SET1STR Kurtzke Functional System Scores Clinical Classification STRESC the Same as KFSS102A TN/TC CDISC Clinical Classification Kurtzke Functional System Scores KFSS1SET1 Standardized Character Response Terminology Kurtzke Functional Systems Scores test code. KFSS1-Pyramidal Functions Kurtzke Functional Systems Scores - Pyramidal functions. KFSS - Pyramidal Functions KFSS1-Cerebellar Functions Kurtzke Functional Systems Scores - Cerebellar functions. KFSS - Cerebellar Functions KFSS1-Weakness Interferes With Testing Kurtzke Functional Systems Scores - Check here when weakness (grade 3 or more on pyramidal) interferes with testing. KFSS - Weakness Interferes With Testing KFSS1-Brain Stem Functions Kurtzke Functional Systems Scores - Brain stem functions. KFSS - Brain Stem Functions KFSS1-Sensory Functions Kurtzke Functional Systems Scores - Sensory functions. KFSS - Sensory Functions KFSS1-Bowel and Bladder Functions Kurtzke Functional Systems Scores - Bowel and bladder functions. KFSS - Bowel and Bladder Functions KFSS1-Visual or Optic Functions Kurtzke Functional Systems Scores - Visual (or optic) functions. KFSS - Visual (or Optic) Functions KFSS1-Presence of Temporal Pallor Kurtzke Functional Systems Scores - Check here for presence of temporal pallor. KFSS - Presence of Temporal Pallor KFSS1-Cerebral or Mental Functions Kurtzke Functional Systems Scores - Cerebral (or mental) functions. KFSS - Cerebral (or Mental) Functions KFSS1-Other Functions Kurtzke Functional Systems Scores - Other functions. KFSS - Other Functions KFSS1-Other Functions Specify Kurtzke Functional Systems Scores - Any other neurologic findings attributed to MS (specify). KFSS - Other Functions Specify KFSS1TC Kurtzke Functional Systems Scores Clinical Classification Test Code CDISC Clinical Classification KFSS Test Code Terminology Kurtzke Functional Systems Scores test name. KFSS1-Bowel and Bladder Functions Kurtzke Functional Systems Scores - Bowel and bladder functions. KFSS - Bowel and Bladder Functions KFSS1-Brain Stem Functions Kurtzke Functional Systems Scores - Brain stem functions. KFSS - Brain Stem Functions KFSS1-Cerebellar Functions Kurtzke Functional Systems Scores - Cerebellar functions. KFSS - Cerebellar Functions KFSS1-Cerebral or Mental Functions Kurtzke Functional Systems Scores - Cerebral (or mental) functions. KFSS - Cerebral (or Mental) Functions KFSS1-Other Functions Specify Kurtzke Functional Systems Scores - Any other neurologic findings attributed to MS (specify). KFSS - Other Functions Specify KFSS1-Other Functions Kurtzke Functional Systems Scores - Other functions. KFSS - Other Functions KFSS1-Presence of Temporal Pallor Kurtzke Functional Systems Scores - Check here for presence of temporal pallor. KFSS - Presence of Temporal Pallor KFSS1-Pyramidal Functions Kurtzke Functional Systems Scores - Pyramidal functions. KFSS - Pyramidal Functions KFSS1-Sensory Functions Kurtzke Functional Systems Scores - Sensory functions. KFSS - Sensory Functions KFSS1-Visual or Optic Functions Kurtzke Functional Systems Scores - Visual (or optic) functions. KFSS - Visual (or Optic) Functions KFSS1-Weakness Interferes With Testing Kurtzke Functional Systems Scores - Check here when weakness (grade 3 or more on pyramidal) interferes with testing. KFSS - Weakness Interferes With Testing KFSS1TN Kurtzke Functional Systems Scores Clinical Classification Test Name CDISC Clinical Classification KFSS Test Name Terminology Terminology relevant to the formula names associated with a laboratory test calculation. ASH FibroSURE Formula ASH Test A proprietary algorithm derived from the FibroTest liver fibrosis algorithm that is used to measure liver fibrosis, hepatic steatosis, and alcoholic steatohepatitis. It includes ten serum markers: alpha-2-macroglobulin, apolipoprotein A1, total bilirubin, gamma-glutamyltransferase, haptoglobin, alanine aminotransferase, aspartate aminotransferase, glucose, total cholesterol, and triglycerides, and adjusts for age, sex, height, and weight. (NCI) ASH Fibrosure Formula CKD U25 Cystatin C Based 2021 Formula A formula to estimate glomerular filtration rates in children and young adults with chronic kidney disease that takes into account sex, age and serum cystatin C. (Pierce CB, Munoz A, Ng DK, Warady BA, Furth SL, Schwartz GJ. Age- and sex-dependent clinical equations to estimate glomerular filtration rates in children and young adults with chronic kidney disease. Kidney Int. 2021 Apr;99(4):948-956.) CKD U25 Cystatin C Based eGFR 2021 Formula CKD-EPI Creatinine NKF/ASN 2021 Formula CKD-EPI Creatinine Without Race 2021 Formula CKD-EPI Creatinine Without Race NKF/ASN 2021 Formula A formula to estimate glomerular filtration rate that takes into account sex, age, and serum creatinine (SCr). eGFRcr = 142 x min(Scr/k, 1)a x max(Scr/k, 1)-1.200 x 0.9938Age x 1.012 [if female] (Inker LA, Eneanya ND, Coresh J, et al.; Chronic Kidney Disease Epidemiology Collaboration. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. N Engl J Med. 2021 Nov 4;385(19):1737-1749.) CKD-EPI Creatinine 2021 Formula CKD-EPI Creatinine 2009 Formula A mathematical formula to estimate glomerular filtration rate that takes into account sex, age, race, and serum creatinine (SCr). eGFR(mL/min/1.73 m2)=141 x min(SCr/k, 1)^a x max(SCr/k, 1)^-1.209 x 0.993^Age x 1.018 [if female] x 1.159 [if black] where: SCr is in mg/dL; k=0.7 for Female and 0.9 for Male; a=-0.329 for female and -0.411 for male. (Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-612.) CKD-EPI Creatinine Formula CKD-EPI Creatinine-Cystatin C NKF/ASN 2021 Formula CKD-EPI Creatinine-Cystatin C Without Race NKF/ASN 2021 Formula A formula to estimate glomerular filtration rate that takes into account sex, age, serum creatinine (SCr) and serum cystatin C (Scys). eGFR(mL/min/1.73 m2)=135 x min(SCr/k, 1)a x max(SCr/k, 1)-0.544 x min(Scys/0.8, 1)-0.323 x max(Scys/0.8, 1)-0.778 x 0.9961^Age x 0.963 [if female]. (Inker LA, Eneanya ND, Coresh J, et al.; Chronic Kidney Disease Epidemiology Collaboration. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. N Engl J Med. 2021 Nov 4;385(19):1737-1749.) CKD-EPI Creatinine-Cystatine C 2021 Formula CKD-EPI Creatinine-Cystatin C 2012 Formula A mathematical formula to estimate glomerular filtration rate that takes into account sex, age, race, serum creatinine (SCr) and serum cystatin C (Scys). eGFR(mL/min/1.73 m2)=135 x min(SCr/k, 1)a x max(SCr/k, 1)-0.601 x min(Scys/0.8, 1)-0.375 x max(Scys/0.8, 1)-0.711 x 0.995^Age x 0.969 [if female] x 1.08 [if black]. (Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20-29.) CKD-EPI Creatinine-Cystatin C Formula CKD-EPI Cystatin C 2012 Formula A mathematical formula to estimate glomerular filtration rate that takes into account sex, age, race, and serum cystatin C (Scys). eGFR(mL/min/1.73 m2)=133 x min(Scys/0.8, 1)^-0.499 x max (Scys/0.8, 1)^-1.328 x 0.996^Age x 0.932 [if female]. (Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20-29.) CKD-EPI Cystatin C Formula Chronic Kidney Disease Epidemiology Collaboration Formula Unspecified CKD-EPI GFR Formula Unspecified An unspecified CKD-EPI-based mathematical formula to estimate glomerular filtration rate that takes into account factors such as sex, age, race, and biomarker measurements. CKD-EPI Formula A formula to estimate glomerular filtration rate that takes into account sex, age, race, and serum creatinine (SCr). eGFR(mL/min/1.73 m2)=141 x min(SCr/k, 1)^a x max(SCr/k, 1)^-1.209 x 0.993^Age x 1.018 [if female] x 1.159 [if black] where: SCr is in mg/dL; k=0.7 for Female and 0.9 for Male; a=-0.329 for female and -0.411 for male; additional multiplication of the result of the 2009 CKD-EPI formula with the factor 0.813. (M Horio, E Imai et al. Modification of the CKD Epidemiology Collaboration (CKD-EPI) Equation for Japanese: Accuracy and Use for Population Estimates. Am J Kidney Dis 2010; 56:32-38) 2010 Japanese Modification of 2009 CKD-EPI Formula A mathematical formula to estimate creatinine clearance that takes into account sex, age, weight, and serum creatinine (SCr). CCr=(140 - Age) x Wgt (Kg) / 72xCrt (mg/dL) x 1 (if M) or 0.85 (if F), for conventional units. CCr=(140 - Age) x Wgt (Kg) / 72xCrt (MCMOL/L) x 88.4 x 1 (if M) or 0.85 (if F) [If Wgt is in lbs; Wgt (Kg) = Wgt (lbs) x 0.45], for SI units. (Cockcroft, D.W. and M.H. Gault. Prediction of creatinine clearance from serum creatinine. Nephron. 1976. 16(1):31-41.) Cockcroft-Gault Formula A mathematical formula that estimates liver pathology through the assessment of a six-parameter blood test, taking into account subject age. Fibrometer regression function = -0.007 platelets (Giga/L) - 0.049 prothrombin index (%) + 0.012 aspartate aminotransferase (UI/L) + 0.005 alpha2-macroglobulin (mg/dL) + 0.021 hyaluronate (g/L) - 0.270 urea (mmol/L) + 0.027 age (years) + 3.718. (Cales P, Oberti F, Michalak S et al. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology. 2005 Dec;42(6):1373-81.) Fibrometer Formula FIB-4 Formula A mathematical formula that estimates liver pathology through the assessment of a three-parameter blood test, taking into account subject age. FIB-4 = age ([yr] x AST [U/L]) / ((PLT [10(9)/L]) x (ALT [U/L])(1/2)). (Sterling RK, Lissen E, Clumeck N, et. al. Development of a simple noninvasive index to predict significant fibrosis patients with HIV/HCV co-infection. Hepatology 2006;43:1317-1325.) Fibrosis 4 Formula FibroSURE Formula FibroTest Formula FibroTest-HCV Formula FibroTest/FibroSURE Formula A mathematical formula that estimates liver pathology through the assessment of a six-parameter blood test, taking into account subject age and sex. z = 4.467 x log10[Alpha2-Macroglobulin(g/L)] - 1.357 x log10[Haptoglobulin(g/L) + 1.017 x log10[Gamma Glutamyl Transferase (IU/L)] +0.0281 x [Age] + 1.737 x log10[Bilirubin umol/L] - 1.184 x [Apolipoprotein A1(g/L)] + 0.301 x [Sex (female=0, Male=1) - 5.54. (US Patent 6631330) Fibrotest Formula A formula developed by Friedewald et al to estimate the concentration of low density lipoprotein cholesterol defined as (F-LDL-C) = TC - (TG/5 + HDL-C). (Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502.) Friedewald 1972 Formula Glucose Management Indicator % Formula A mathematical formula to calculate the glucose management indicator (GMI) as a percentage. GMI = 3.31 + 0.02392 x [mean glucose in mg/dL]. (Richard M. Bergenstal, Roy W. Beck, Kelly L. Close, et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018 Nov; 41(11): 2275-2280.) Glucose Management Indicator Percentage Formula Glucose Management Indicator mmol/mol Formula A mathematical formula to calculate the glucose management indicator (GMI) in mmol/mol. GMI = 12.71 + 4.70587 x [mean glucose in mmol/L]. (Richard M. Bergenstal, Roy W. Beck, Kelly L. Close, et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018 Nov; 41(11): 2275-2280.) Glucose Management Indicator Mmol/mol Formula Hepatoscore Formula A mathematical formula that estimates liver pathology through the assessment of a four-parameter blood test, taking into account subject age and sex. Hepascore = y/(1 + y) with y = exp (-4.185818 - (0.0249 x age) + (0.7464 x 1 if male, 0 if female) + (1.0039 x a2 macroglobulin) + (0.0302 x hyaluronate) + (0.0691 x bilirubin) - (0.0012 x gamma-glutamyl transferase)). (Adams LA, Bulsara M, Rossi E et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem. 2005 Oct;51(10):1867-73.) Hepascore Formula A formula to estimate glomerular filtration rate in Japanese subjects that takes into account age, sex, and serum creatinine. eGFR (mL/min/1.73 m2) = 0.741 x SCr^-1.154 x 175 x Age^-0.203 x 0.742 (if female). (Enyu Imai, Masaru Horio, Kosaku Nitta, Kunihiro Yamagata, Kunitoshi Iseki, Yusuke Tsukamoto, Sadayoshi Ito, Hirofumi Makino, Akira Hishida, Seiichi Matsuo. Modification of the Modification of Diet in Renal Disease (MDRD) Study Equation for Japan. Am J Kidney Dis. 2007 Dec;50(6):927-37.) IDMS-MDRD Study Equation With JSN-CKDI Coefficient 0.741 Imai et al. 2007 A mathematical formula to estimate glomerular filtration rate that takes into account age, sex, race, and serum creatinine (Scr). eGFR (mL/min/1.73 m2) = 186 x (Scr)^-1.154 x (Age)^-0.203 x (0.742 if female) x (1.210 if African American). (Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-70.) MDRD 4 Variable Formula A mathematical formula to estimate glomerular filtration rate that takes into account age, sex, race, serum creatinine and serum urea nitrogen. eGFR (mL/min/1.73 m = 270 x creatinine (mg/dl)^-1.007 x age^-0.180 x 1.178 (if black) x 0.762 (if female) x serum urea nitrogen^-0.169. (Levey AS, Greene T, Kusek JW, Beck GJ, MDRD study group. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11: A0828.) MDRD 5 Variable Formula A mathematical formula to estimate glomerular filtration rate that takes into account age, sex, race, serum creatinine, serum urea nitrogen, and albumin. eGFR (mL/min/1.73 m2) = 170 x (SCr/88.4)^-0.999 x age^-0.176 x (SU x 2.78)^-0.170 x albumin^0.318 x (0.762, if female) x (1.18, if African American). (Levey AS, Greene T, Kusek JW, Beck GJ, MDRD study group. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11: A0828.) MDRD 6 Variable Formula IDMS MDRD A mathematical formula to estimate glomerular filtration rate that takes into account age, sex, race, and serum creatinine. eGFR (mL/min/1.73 m2)=175 x (serum Cr [conv mg/dL])^-1.154 x (Age)^ -0.203 x (0.742 if female) x (1.212 if black), for conventional units. eGFR=175 x (serum Cr [SI UMOL/L]/88.4)^-1.154 x (Age)^ -0.203 x (0.742 if female) x (1.212 if black), for SI units. (Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-12.) MDRD Enzymatic Formula MDRD Enzymatic Japanese 2007 Formula MDRD Enzymatic Japanese Imai 2007 Formula A mathematical formula to estimate glomerular filtration rate in Japanese subjects that takes into account age, sex, and serum creatinine. eGFR (ml/min/1.73m2) = 194 x PD93 power^-1.094 x Age power^- 0.287 x Sex; where PD93 = Serum Cr (mg/dL), Sex = 1.00 for male and 0.739 for female. (Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S. Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. Am J Kidney Dis. 2007 Dec;50(6):927-37.) MDRD Enzymatic Japanese Formula MDRD GFR Formula Modification of Diet in Renal Disease Formula An unspecified MDRD-based mathematical formula to estimate glomerular filtration rate that takes into account factors such as sex, age, race, and biomarker measurements. Modification of Diet in Renal Disease Formula NASH FibroSURE Formula NASH Test A proprietary algorithm derived from the FibroTest liver fibrosis algorithm that is used to measure liver fibrosis, hepatic steatosis, and non-alcoholic steatohepatitis. It includes ten serum markers: alpha-2-macroglobulin, apolipoprotein A1, total bilirubin, gamma-glutamyltransferase, haptoglobin, alanine aminotransferase, aspartate aminotransferase, glucose, total cholesterol, and triglycerides, and adjusts for age, sex, height, and weight. (NCI) NASH Fibrosure Formula NephroCheck Acute Kidney Injury Risk Formula A proprietary algorithm derived from the NephroCheck test that is used for the risk assessment of moderate or severe acute kidney injury. It includes two urine markers: insulin-like growth factor binding protein 7 (IGFBP-7) and tissue inhibitor of metalloproteinase 2 (TIMP-2). (Kashani K, Al-Khafaji A, Ardiles T, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013 Feb 6;17(1):R25.) NephroCheck AKI Risk 2013 Formula Schwartz Method for Children 1985 Formula A mathematical formula to estimate glomerular filtration rate in children that takes into account age, height, and serum creatinine. eGFR (mL/min/1.73 m2) = k x Height (cm)/Serum creatinine (mg/dL) where k=0.33 for pre-term babies, 0.45 for full-term babies and 0.55 for girls ages 1-13 or 0.70 for boys ages 1-13. (Schwartz GJ, Gauthier B. A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr. 1985 Mar;106(3):522-6.) Schwartz Method For Children Formula LBANMET Laboratory Analytical Method Calculation Formula CDISC SDTM Laboratory Analytical Method Calculation Formula Terminology Terminology used for laboratory test codes of the CDISC Study Data Tabulation Model. Alpha-1 Acid Glycoprotein A measurement of the alpha-1 acid glycoprotein in a biological specimen. Alpha-1 Acid Glycoprotein Measurement Alpha-1 Antitrypsin, Functional A measurement of the functional alpha-1 antitrypsin in a biological specimen. Functional Alpha-1 Antitrypsin Measurement Alpha-1 Antitrypsin Serum Trypsin Inhibitor A measurement of the alpha-1 antitrypsin in a biological specimen. Alpha-1 Antitrypsin Measurement Alpha-1 Microglobulin Excretion Rate A measurement of the amount of alpha-1 microglobulin being excreted in a biological specimen over a defined amount of time (e.g. one hour). Alpha-1 Microglobulin Excretion Rate Measurement Alpha-1 Microglobulin/Creatinine A relative measurement (ratio or percentage) of the alpha-1 microglobulin to creatinine in a biological specimen. Alpha-1 Microglobulin to Creatinine Ratio Measurement Alpha-1 Microglobulin Protein HC A measurement of the alpha-1 microglobulin in a biological specimen. Alpha-1 Microglobulin Measurement Alpha-2 Macroglobulin A measurement of the alpha-2 macroglobulin in a biological specimen. Alpha-2 Macroglobulin Measurement 7-Alpha hydroxy-4-cholesten-3-one 7-alpha-Hydroxy-4-cholesten-3-one A measurement of the 7-alpha-hydroxy-4-cholesten-3-one in a biological specimen. 7-alpha-Hydroxy-4-cholesten-3-one Measurement Alpha-Aminoadipate Alpha-Aminoadipic Acid A measurement of the alpha-aminoadipic acid in a biological specimen. Alpha-Aminoadipic Acid Measurement Alpha-aminobutyrate Alpha-Aminobutyric Acid Homoalanine A measurement of the alpha-aminobutyric acid in a biological specimen. Alpha-Aminobutyric Acid Measurement Alanine Aminopeptidase A measurement of the alanine aminopeptidase in a biological specimen. Alanine Aminopeptidase Measurement Aggrecan Ala-Arg-Gly-Ser Neoepitope Aggrecan Alanine-Arginine-Glycine-Serine Neoepitope ARGS ARGS-Aggrecan A measurement of the aggrecan alanine-arginine-glycine-serine neoepitope (ARGS) in a biological specimen. Aggrecan Alanine-Arginine-Glycine-Serine Neoepitope Measurement AAT Z-Polymer Alpha-1 Antitrypsin Z-Polymer A measurement of the polymers of Z-variant alpha-1 antitrypsin in a biological specimen. Alpha-1 Antitrypsin Z-Polymer Measurement Amyloid Beta 1-42/Amyloid Beta 1-40 A relative measurement (ratio) of the amyloid beta 1-42 to amyloid beta 1-40 in a biological specimen. Amyloid Beta 1-42 to Amyloid Beta 1-40 Ratio Measurement Activation B7-1 Antigen B-Lymphocyte Activation Antigen B7 CD28 Ligand CD28LG1 CD80 Molecule Soluble CD80 T-Lymphocyte Activation Antigen CD80 A measurement of the activation B7-1 antigen in a biological specimen. Activation B7-1 Antigen Measurement AB-FUBINACA A measurement of the synthetic cannabinoid AB-FUBINACA in a biological specimen. AB-FUBINACA Measurement Abnormal Cells A measurement of the abnormal cells in a biological specimen. Abnormal Cell Count Abnormal Cells/Total Cells A relative measurement (ratio or percentage) of abnormal cells to total cells in a biological specimen. Abnormal Cells to Total Cells Ratio Measurement Abnormal Cells/Leukocytes A relative measurement (ratio or percentage) of abnormal cells to leukocytes in a biological specimen. Abnormal Cells to Leukocytes Ratio Measurement ABO Blood Group The characterization of the blood type of an individual by testing for the presence of A antigen and B antigen on the surface of red blood cells. ABO Blood Group Determination ABO A1 Subtype The characterization of the ABO blood group A1 subtype in an individual. (NCI) ABO A1 Subtype Determination 4-ABP 4-Aminobiphenyl A measurement of the 4-aminobiphenyl in a specimen. 4-Aminobiphenyl Measurement AB-PINACA A measurement of the synthetic cannabinoid AB-PINACA in a biological specimen. AB-PINACA Measurement Acanthocytes A measurement of the acanthocytes in a biological specimen. Acanthocyte Count Acanthocytes/Erythrocytes A relative measurement (ratio or percentage) of acanthocytes to all erythrocytes in a biological specimen. Acanthocyte to Erythrocyte Ratio Measurement ACC Acetyl-CoA Carboxylase A measurement of the total acetyl-CoA carboxylase in a biological specimen. Acetyl-CoA Carboxylase Measurement pACC pAcetyl-CoA Carboxylase Phosphorylated Acetyl-CoA Carboxylase A measurement of the phosphorylated acetyl-CoA carboxylase in a biological specimen. Phosphorylated Acetyl-CoA Carboxylase Measurement pACC/ACC pAcetyl-CoA Carboxylase/ACC Phosphorylated Acetyl-CoA Carboxylase/Acetyl-CoA Carboxylase A relative measurement (ratio or percentage) of the phosphorylated acetyl-CoA carboxylase to total acetyl-CoA carboxylase in a biological specimen. Phosphorylated Acetyl-CoA Carboxylase to Acetyl-CoA Carboxylase Ratio Measurement Angiotensin Converting Enzyme A measurement of the angiotensin converting enzyme in a biological specimen. Angiotensin Converting Enzyme Measurement Acetaminophen Paracetamol A measurement of the acetaminophen in a biological specimen. Acetaminophen Measurement Acetoacetate Acetoacetic Acid A measurement of the acetoacetic acid in a biological specimen. Acetoacetic Acid Measurement Acetone A measurement of the acetone in a specimen. Acetone Measurement Acetylcholine A measurement of the acetylcholine hormone in a biological specimen. Acetylcholine Measurement Acetylcholinesterase A measurement of the acetylcholinesterase in a biological specimen. Acetylcholinesterase Measurement Acid Phosphatase A measurement of the acid phosphatase in a biological specimen. Acid Phosphatase Measurement Acylcarnitine/Carnitine, Free A relative measurement (ratio or percentage) of the acylcarnitine to free carnitine in a biological specimen. Acylcarnitine to Free Carnitine Ratio Measurement Acrolein A measurement of the acrolein in a specimen. Acrolein Measurement Acrylonitrile A measurement of the acrylonitrile in a specimen. Acrylonitrile Measurement Acid Sphingomyelinase A measurement of the acid sphingomyelinase in a biological specimen. Sphingomyelin Phosphodiesterase Measurement Activated Clotting Time Activated Coagulation Time A measurement of the inhibition of blood coagulation in response to anticoagulant therapies. Activated Coagulation Time Acetoacetate Excretion Rate Acetoacetic Acid Excretion Rate A measurement of the amount of acetoacetic acid being excreted in a biological specimen over a defined period of time (e.g. one hour). Acetoacetic Acid Excretion Rate Measurement Acetaldehyde A measurement of the acetaldehyde in a specimen. Acetaldehyde Measurement Actin Beta B-Actin Beta-Actin A measurement of the beta-actin in a biological specimen. Beta-Actin Measurement Adrenocorticotropic Hormone Corticotropin A measurement of the adrenocorticotropic hormone in a biological specimen. Adrenocorticotropic Hormone Measurement Activin A A measurement of the activin A (a homodimer consisting of Inhibin Subunit Beta A) in a biological specimen. Activin A Measurement Activin AB A measurement of the activin AB (a heterodimer consisting of Inhibin Subunit Beta A and Inhibin Subunit Beta B) in a biological specimen. Activin AB Measurement Activin B A measurement of the activin B (a homodimer consisting of Inhibin Subunit Beta B) in a biological specimen. Activin B Measurement Acylcarnitine A measurement of the acylcarnitine in a biological specimen. Acylcarnitine Measurement Acylglycine A measurement of the acylglycine in a biological specimen. Acylglycine Measurement Acyl CoA Oxidase Acyl Coenzyme A Oxidase Fatty Acyl Coenzyme A Oxidase A measurement of the acyl coenzyme A oxidase in a biological specimen. Acyl Coenzyme A Oxidase Measurement A Disintegrin And Metalloproteinase Domain 8 ADAM Metallopeptidase Domain 8 Soluble CD156a A measurement of the ADAM metallopeptidase domain 8 protein in a biological specimen. ADAM Metallopeptidase Domain 8 Measurement A Disintegrin-Like And Metalloprotease (Reprolysin Type) With Thrombospondin Type 1 Motif, 13 ADAM Metallopeptidase With Thrombospondin Type 1 Motif 13 von Willebrand Coagulation Factor Cleaving Protease ADAMTS13 A measurement of the von Willebrand coagulation factor cleaving protease, ADAMTS13, in a biological specimen. von Willebrand Coagulation Factor Cleaving Protease Measurement ADB-PINACA A measurement of the synthetic cannabinoid ADB-PINACA in a biological specimen. ADB-PINACA Measurement Antidiuretic Hormone Vasopressin A measurement of the antidiuretic hormone in a biological specimen. Antidiuretic Hormone Measurement Adrenomedullin A measurement of the adrenomedullin in a biological specimen. Adrenomedullin Measurement Asymmetric Dimethylarginine N,N-dimethylarginine A measurement of asymmetric dimethylarginine in a biological specimen. Asymmetric Dimethylarginine Measurement A Disintegrin-Like And Metalloprotease (Reprolysin Type) With Thrombospondin Type 1 Motif, 13 Activity ADAM Metallopeptidase With Thrombospondin Type 1 Motif 13 Activity ADAMTS13 Activity von Willebrand Coagulation Factor Cleaving Protease ADAMTS13 Activity A measurement of the biological activity of von Willebrand coagulation factor cleaving protease, ADAMTS13, in a biological specimen. von Willebrand Coagulation Factor Cleaving Protease Activity Measurement Adenosine Diphosphate A measurement of the adenosine diphosphate in a biological specimen. Adenosine Diphosphate Measurement Adiponectin A measurement of the total adiponectin hormone in a biological specimen. Adiponectin Measurement Adiponectin, High Molecular Weight A measurement of the high molecular weight adiponectin hormone in a biological specimen. High Molecular Weight Adiponectin Measurement Anti-Factor Xa Activity A measurement of the ability of antithrombin to inactivate activated Factor X in a biological specimen. This test is used to monitor low molecular weight or unfractionated heparin levels in a biological specimen. Anti-Factor Xa Activity Measurement Alpha Fetoprotein Alpha-1-Fetoprotein A measurement of the alpha fetoprotein in a biological specimen. Alpha-fetoprotein Measurement Alpha Fetoprotein Adj for Body Weight A measurement of alpha fetoprotein, which has been adjusted for body weight, in a biological specimen. Alpha Fetoprotein Adjusted for Body Weight Measurement Alpha Fetoprotein L1 A measurement of the alpha fetoprotein L1 in a biological specimen. Alpha Fetoprotein L1 Measurement Alpha Fetoprotein L2 A measurement of the alpha fetoprotein L2 in a biological specimen. Alpha Fetoprotein L2 Measurement Alpha Fetoprotein L3 A measurement of the alpha fetoprotein L3 in a biological specimen. Alpha Fetoprotein L3 Measurement A Fetoprotein L3/A Fetoprotein A relative measurement (ratio or percentage) of alpha fetoprotein L3 to total alpha fetoprotein in a biological specimen. Alpha Fetoprotein L3 to Total Alpha Fetoprotein Ratio Measurement 1,5-Anhydroglucitol A measurement of the 1,5-anhydroglucitol in a biological specimen. 1,5-Anhydroglucitol Measurement Alpha Hydroxybutyrate Dehydrogenase A measurement of the alpha-hydroxybutyrate dehydrogenase in a biological specimen. Alpha Hydroxybutyrate Dehydrogenase Measurement Alpha-Hydroxytriazolam A measurement of the alpha-hydroxytriazolam a biological specimen. Alpha-Hydroxytriazolam Measurement Acute Kidney Injury Risk Score AKI Risk Score A scoring system that evaluates acute kidney injury risk through the assessment of urine test parameter(s), and which may take into account additional factors. Acute Kidney Injury Risk Score Alanine A measurement of the alanine in a biological specimen. Alanine Measurement Apolipoprotein A1/Apolipoprotein B A relative measurement (ratio or percentage) of the Apolipoprotein A1 to Apolipoprotein B in a biological specimen. Apolipoprotein A1 to Apolipoprotein B Ratio Measurement Apolipoprotein A/Apolipoprotein B A relative measurement (ratio) of the total apolipoprotein A to apolipoprotein B in a biological specimen. Apolipoprotein A to Apolipoprotein B Ratio Measurement Albumin Microalbumin A measurement of the albumin protein in a biological specimen. Albumin Measurement Albumin Clearance A measurement of the albumin clearance in a biological specimen. Albumin Clearance Albumin/Creatinine Microalbumin/Creatinine Ratio A relative measurement (ratio) of the albumin to the creatinine in a biological specimen. Albumin to Creatinine Ratio Measurement Albumin Excretion Rate A measurement of the amount of albumin excreted in a biological specimen over a defined period of time (e.g. one hour). Albumin Excretion Rate Glycated Albumin/Albumin A relative measurement (ratio or percentage) of the glycated albumin to total albumin in a biological specimen. Glycated Albumin to Albumin Ratio Measurement Albumin/Globulin The ratio of albumin to globulin in a biological specimen. Albumin to Globulin Ratio Measurement Glycated Albumin A measurement of the glycated albumin present in a biological specimen. Glycated Albumin Measurement Albumin Index A relative measurement (ratio) of the albumin in cerebrospinal fluid to albumin in serum or plasma in a biological specimen. Albumin Index Albumin/Total Protein A relative measurement (ratio or percentage) of the albumin to total protein in a biological specimen. Albumin to Total Protein Ratio Measurement Aldrin Epoxidase A measurement of the aldrin epoxidase in a biological specimen. Aldrin Epoxidase Measurement Aldolase A measurement of the aldolase enzyme in a biological specimen. Aldolase Measurement Aldosterone Excretion Rate A measurement of the amount of aldosterone being excreted in a biological specimen over a defined amount of time (e.g. one hour). Aldosterone Excretion Rate Aldosterone A measurement of the aldosterone hormone in a biological specimen. Aldosterone Measurement Alfentanil A measurement of the alfentanil in a biological specimen. Alfentanil Measurement Alloisoleucine A measurement of the alloisoleucine in a biological specimen. Alloisoleucine Measurement 5-Lipoxygenase 5-LO 5-LOX ALOX5 Arachidonate 5-Lipoxygenase A measurement of the arachidonate 5-lipoxygenase in a biological specimen. Arachidonate 5-Lipoxygenase Measurement Alkaline Phosphatase A measurement of the alkaline phosphatase in a biological specimen. Alkaline Phosphatase Measurement Alk Phos, Bone/Total Alk Phos Alkaline Phosphatase, Bone/Total Alkaline Phosphatase A relative measurement (ratio or percentage) of the bone specific alkaline phosphatase isoform to total alkaline phosphatase in a biological specimen. Bone Alkaline Phosphatase to Total Alkaline Phosphatase Ratio Measurement Alk Phos, Bile/Total Alk Phos Alk Phos, Biliary/Total Alk Phos A relative measurement (ratio or percentage) of the biliary specific alkaline phosphatase isoform to total alkaline phosphatase in a biological specimen. Biliary Alkaline Phosphatase to Alkaline Phosphatase Ratio Measurement Bone Specific Alkaline Phosphatase A measurement of the bone specific alkaline phosphatase isoform in a biological specimen. Bone Specific Alkaline Phosphatase Measurement Alkaline Phosphatase/Creatinine A relative measurement (ratio or percentage) of the alkaline phosphatase to creatinine in a biological specimen. Alkaline Phosphatase to Creatinine Ratio Measurement Alkaline Phosphatase Excretion Rate A measurement of the amount of alkaline phosphatase being excreted in a biological specimen over a defined amount of time (e.g. one hour). Alkaline Phosphatase Excretion Rate Alk Phos, Intestinal/Total Alk Phos Alkaline Phosphatase, Intestinal/Total Alkaline Phosphatase A relative measurement (ratio or percentage) of the intestinal specific alkaline phosphatase isoform to total alkaline phosphatase in a biological specimen. Intestinal Alkaline Phosphatase to Total Alkaline Phosphatase Ratio Measurement Intestinal Specific Alkaline Phosphatase A measurement of the intestinal specific alkaline phosphatase isoform in a biological specimen. Intestinal Specific Alkaline Phosphatase Measurement Alkaline Phosphatase Isoenzyme A measurement of the alkaline phosphatase isoenzyme in a biological specimen. Alkaline Phosphatase Isoenzyme Measurement Alk Phos, Liver/Total Alk Phos Alkaline Phosphatase, Liver/Total Alkaline Phosphatase A relative measurement (ratio or percentage) of the liver specific alkaline phosphatase isoform to total alkaline phosphatase in a biological specimen. Liver Alkaline Phosphatase to Total Alkaline Phosphatase Ratio Measurement Alk Phos, Liver + Bone/Total Alk Phos A relative measurement (ratio or percentage) of the liver and bone specific alkaline phosphatase isoforms to total alkaline phosphatase in a biological specimen. Liver and Bone Specific Alkaline Phosphatase Isoform to Alkaline Phosphatase Ratio Measurement Liver Specific Alkaline Phosphatase A measurement of the liver specific alkaline phosphatase isoform in a biological specimen. Liver Specific Alkaline Phosphatase Measurement Alk Phos, Macro/Total Alk Phos Alk Phos, Macrohepatic/Total Alk Phos A relative measurement (ratio or percentage) of the macrohepatic specific alkaline phosphatase isoform to total alkaline phosphatase in a biological specimen. Macrohepatic Alkaline Phosphatase to Alkaline Phosphatase Ratio Measurement Alk Phos, Placental/Total Alk Phos Alkaline Phosphatase, Placental/Total Alkaline Phosphatase A relative measurement (ratio or percentage) of the placental specific alkaline phosphatase isoform to total alkaline phosphatase in a biological specimen. Placental Alkaline Phosphatase to Total Alkaline Phosphatase Measurement Placental Specific Alkaline Phosphatase A measurement of the placental specific alkaline phosphatase isoform in a biological specimen. Placental Specific Alkaline Phosphatase Measurement Alprazolam A measurement of the alprazolam present in a biological specimen. Alprazolam Measurement Acid Labile Subunit ALS IGFALS Insulin Like Growth Factor Binding Protein Acid Labile Subunit A measurement of the acid labile subunit in a biological specimen. Acid Labile Subunit Measurement Alanine Aminotransferase SGPT A measurement of the alanine aminotransferase in a biological specimen. Alanine Aminotransferase Measurement ALT/AST A relative measurement (ratio or percentage) of the alanine aminotransferase (ALT) to aspartate aminotransferase (AST) present in a sample. Alanine Aminotransferase to Aspartate Aminotransferase Ratio Measurement Alpha Tocopherol A measurement of the alpha tocopherol in a biological specimen. Alpha Tocopherol Measurement Al Aluminum A measurement of aluminum in a biological specimen. Aluminum Measurement AM-2201 AM2201 A measurement of the synthetic cannabinoid AM-2201 in a biological specimen. AM-2201 Measurement AM694 N-5-hydroxypentyl A measurement of the synthetic cannabinoid metabolite AM694 N-5-hydroxypentyl in a biological specimen. AM694 N-5-hydroxypentyl Measurement Alpha-Methylacyl Coenzyme A Racemase A measurement of the alpha-methylacyl coenzyme A racemase in a biological specimen. Alpha-Methylacyl Coenzyme A Racemase Measurement Amobarbital A measurement of the amobarbital present in a biological specimen. Amobarbital Measurement AMACR mRNA A measurement of the alpha-methylacyl coenzyme A racemase mRNA in a biological specimen. Alpha-Methylacyl Coenzyme A Racemase mRNA Measurement Anti-Mullerian Hormone A measurement of the anti-Mullerian hormone in a biological specimen. Anti-Mullerian Hormone Measurement Amitriptyline A measurement of the amitriptyline in a biological specimen. Amitriptyline Measurement Ammonia NH3 A measurement of the ammonia in a specimen. Ammonia Measurement Ammonium Ammonium Ion NH4+ A measurement of the ammonium ion (NH4+) in a biological specimen. Ammonium Measurement Ammonium/Creatinine A relative measurement (ratio) of ammonium to creatinine in a biological specimen. Ammonium to Creatinine Ratio Measurement AA Amino Acids A measurement of the total amino acids in a biological specimen. Amino Acid Measurement 1-Aminonaphthalene 1-Naphthylamine A measurement of the 1-aminonaphthalene in a specimen. 1-Aminonaphthalene Measurement 2-Aminonaphthalene 2-Naphthylamine A measurement of the 2-aminonaphthalene in a specimen. 2-Aminonaphthalene Measurement Amorphous Debris Amorphous Sediment A measurement of the amorphous sediment present in a biological specimen. Amorphous Sediment Measurement Alpha-Methylphenethylamine Amphetamine A measurement of the alpha-methylphenethylamine in a biological specimen. Amphetamine Measurement Amphetamine Amphetamines A measurement of any amphetamine class drug present in a biological specimen. Amphetamine Drug Class Measurement d-amphetamine Dextroamphetamine A measurement of the dextroamphetamine in a biological specimen. Dextroamphetamine Measurement Amylase A measurement of the total enzyme amylase in a biological specimen. Amylase Measurement Macroamylase A measurement of macroamylase in a biological specimen. Macroamylase Measurement Amylase, Pancreatic Pancreatic Amylase Isoenzyme A measurement of the pancreatic enzyme amylase in a biological specimen. Pancreatic Amylase Measurement Amylase, Salivary Salivary Amylase Isoenzyme A measurement of the salivary enzyme amylase in a biological specimen. Salivary Amylase Measurement Amyloid Beta 1-38 Amyloid Beta 38 Amyloid Beta 38 Protein A measurement of amyloid beta protein which is composed of peptides 1 to 38 in a biological specimen. Amyloid Beta 1-38 Measurement Amyloid Beta 1-40 Amyloid Beta 40 Amyloid Beta 40 Protein A measurement of amyloid beta protein which is composed of peptides 1 to 40 in a biological specimen. Amyloid Beta 1-40 Measurement Amyloid Beta 1-41 Amyloid Beta 41 Amyloid Beta 41 Protein A measurement of amyloid beta protein which is composed of peptides 1 to 41 in a biological specimen. Amyloid Beta 1-41 Measurement Amyloid Beta 1-42 Amyloid Beta 42 Amyloid Beta 42 Protein A measurement of amyloid beta protein which is composed of peptides 1 to 42 in a biological specimen. Beta Amyloid 42 Measurement Amyloid A A measurement of the total amyloid A in a biological specimen. Amyloid A Measurement Amyloid, Beta Beta Amyloid A measurement of the total amyloid beta in a biological specimen. Beta Amyloid Measurement Amyloid P Amyloid P Component SAP Serum Amyloid P Component A measurement of the total amyloid P in a biological specimen. Amyloid P Measurement Anabasine A measurement of the anabasine in a specimen. Anabasine Measurement Alpha-N-acetylglucosaminidase A measurement of the alpha-N-acetylglucosaminidase in a biological specimen. Alpha-N-acetylglucosaminidase Measurement Androstenediol A measurement of the androstenediol metabolite in a biological specimen. Androstenediol Metabolite Measurement 4-Androstenedione Androstenedione A measurement of the androstenedione hormone in a biological specimen. Androstenedione Measurement Androsterone A measurement of the androsterone in a biological specimen. Androsterone Measurement Antiglobulin Test, Indirect Indirect Coombs Test A test that uses Coombs' reagent to detect the presence of anti-erythrocyte antibodies in a biological specimen. Indirect Antiglobulin Test Antiglobulin Test Polyspecific, Direct Antiglobulin Test, Direct Direct Coombs Test A measurement of the antibody or complement-coated erythrocytes in a biological specimen in vivo. Direct Antiglobulin Test Angiopoietin 1 A measurement of angiopoietin 1 in a biological specimen. Angiopoietin 1 Measurement ANG2 Angiopoietin 2 A measurement of angiopoietin 2 in a biological specimen. Angiopoietin 2 Measurement ANG-5 Angiopoietin 5 Angiopoietin-Like 3 Angiopoietin-Related Protein 3 ANGPT5 A measurement of the angiopoietin-related protein 3 in a biological specimen. Angiopoietin-Related Protein 3 Measurement Angiopoietin-Related Protein 3/8 Complex ANGPTL3/8 A measurement of the angiopoietin-related protein 3 and angiopoietin-related protein 8 complex in a biological specimen. Angiopoietin-Related Protein 3/8 Complex Measurement Angiopoietin-Like 4 Angiopoietin-Related Protein 4 ARP4 FIAF Hepatic Angiopoietin-Related Protein HFARP PGAR A measurement of the angiopoietin-related protein 4 in a biological specimen. Angiopoietin-Related Protein 4 Measurement Angiopoietin-Like 8 Angiopoietin-Related Protein 8 Betatrophin Lipasin A measurement of the angiopoietin-related protein 8 in a biological specimen. Angiopoietin-Related Protein 8 Measurement Angiotensin I A measurement of the angiotensin I hormone in a biological specimen. Angiotensin I Measurement Angiotensin II A measurement of the angiotensin II hormone in a biological specimen. Angiotensin II Measurement Angiotensin Precursor Angiotensinogen A measurement of the angiotensinogen hormone in a biological specimen. Angiotensinogen Measurement Anion Gap A computed estimate of the unmeasured anions (those other than the chloride and bicarbonate anions) in a biological specimen. Anion Gap Measurement Anion Gap 3 A computed estimate of the unmeasured anions (computed as sodium minus the chloride and bicarbonate) in a biological specimen. Anion Gap 3 Measurement Anion Gap 4 A computed estimate of the unmeasured anions (computed as the difference between the sum of serum sodium + serum potassium and the sum of the serum bicarbonate+ chloride) in a biological specimen. Anion Gap 4 Measurement Anisocytes Anisocytosis A measurement of the variability in the size of the red blood cells in a whole blood specimen. Anisocyte Measurement Anisochromia A measurement of the color variation of erythrocytes in a biological specimen. Anisochromia Measurement Anileridine A measurement of the anileridine in a biological specimen. Anileridine Measurement Atrial Natriuretic Peptide Atriopeptin A measurement of the atrial natriuretic peptide in a biological specimen. Atrial Natriuretic Peptide Measurement Mid-Reg Pro-Atrial Natriuretic Peptide Mid-Regional Pro-Atrial Natriuretic Peptide MR-proANP MRproANP A measurement of the mid-regional pro-atrial natriuretic peptide in a biological specimen. Mid-Regional Pro-Atrial Natriuretic Peptide Measurement N-terminal pro-Atrial Natriuretic Peptide N-Terminal ProA-type Natriuretic Peptide NT proANP II A measurement of the N-terminal proA-type natriuretic peptide in a biological specimen. N-Terminal ProA-type Natriuretic Peptide Measurement Antithrombin Activity Antithrombin III Activity A measurement of the antithrombin activity in a biological specimen. Antithrombin Activity Measurement Antithrombin Antithrombin Antigen Antithrombin III Antithrombin III Antigen A measurement of the antithrombin antigen in a biological specimen. Antithrombin Antigen Measurement Antidepressants A measurement of any antidepressant class drug present in a biological specimen. Antidepressant Measurement Acetaminophen Protein Adduct Acetaminophen-Cysteine Adduct APAP-CYS APAP-Protein A measurement of the acetaminophen-cysteine adducts in a biological specimen. Acetaminophen-Cysteine Adduct Measurement Acetaminophen-Glucuronide Adduct A measurement of the acetaminophen-glucuronide adducts in a biological specimen. Acetaminophen-Glucuronide Adduct Measurement Acetaminophen-Sulfate Adduct A measurement of the acetaminophen-sulfate adducts in a biological specimen. Acetaminophen-Sulfate Adduct Measurement APTT-LA Screen to Confirm Percent Difference PTT-LA Screen to Confirm Pct Difference A measurement to confirm the presence of Lupus anticoagulants, calculated as [(Screen aPTT - Confirm aPTT)/Screen aPTT]x100. APTT-LA Screen to Confirm Percent Difference Alpha-2 Antiplasmin Alpha-2 Plasmin Inhibitor A measurement of the alpha-2 antiplasmin in a biological specimen. Alpha-2 Antiplasmin Measurement Alpha-2 Antiplasmin Activity A measurement of the alpha-2 antiplasmin activity in a biological specimen. Alpha-2 Antiplasmin Activity Measurement Apolipoprotein A A measurement of the total apolipoprotein A in a biological specimen. Apolipoprotein A Measurement Apolipoprotein A1 A measurement of the apolipoprotein A1 in a biological specimen. Apolipoprotein A1 Measurement Apolipoprotein AII A measurement of the apolipoprotein AII in a biological specimen. Apolipoprotein AII Measurement Apolipoprotein A4 A measurement of the apolipoprotein A4 in a biological specimen. Apolipoprotein A4 Measurement Apolipoprotein A5 A measurement of the apolipoprotein A5 in a biological specimen. Apolipoprotein A5 Measurement Apolipoprotein B A measurement of the total apolipoprotein B in a biological specimen. Apolipoprotein B Measurement Apolipoprotein B100 A measurement of the apolipoprotein B100 in a biological specimen. Apolipoprotein B100 Measurement Apolipoprotein B48 A measurement of the apolipoprotein B48 in a biological specimen. Apolipoprotein B48 Measurement Apolipoprotein B/Apolipoprotein A1 A relative measurement (ratio or percentage) of the Apolipoprotein B to Apolipoprotein A1 in a biological specimen. Apolipoprotein B to Apolipoprotein A1 Ratio Measurement Apolipoprotein CI A measurement of the apolipoprotein CI in a biological specimen. Apolipoprotein CI Measurement Apolipoprotein C2 Apolipoprotein CII A measurement of the apolipoprotein C2 in a biological specimen. Apolipoprotein C2 Measurement Apolipoprotein CIII A measurement of the apolipoprotein CIII in a biological specimen. Apolipoprotein CIII Measurement Apolipoprotein D A measurement of the apolipoprotein D in a biological specimen. Apolipoprotein D Measurement Apolipoprotein E A measurement of the apolipoprotein E in a biological specimen. Apolipoprotein E Measurement Apolipoprotein E4 A measurement of the apolipoprotein E4 in a biological specimen. Apolipoprotein E4 Measurement Apolipoprotein H A measurement of the apolipoprotein H in a biological specimen. Apolipoprotein H Measurement Apolipoprotein J Clusterin A measurement of the apolipoprotein J in a biological specimen. Apolipoprotein J Measurement Apolipoprotein J/Creatinine Clusterin/Creatinine A relative measurement (ratio or percentage) of the apolipoprotein J to creatinine in a biological specimen. Apolipoprotein J to Creatinine Ratio Measurement Amyloid Alpha Precursor Protein A measurement of the amyloid alpha precursor protein present in a biological specimen. Amyloid Alpha Precursor Protein Measurement Amyloid Beta Precursor Amyloid Beta Precursor Protein Amyloid Precursor Beta Amyloid Precursor Protein A measurement of the amyloid beta precursor protein present in a biological specimen. Amyloid Beta Precursor Protein Measurement Specimen Appearance The outward or visible aspect of a specimen. Specimen Appearance Assessment Total Amyloid Precursor Protein A measurement of the total amyloid precursor protein present in a biological specimen. Total Amyloid Precursor Protein Measurement Aprobarbital A measurement of the aprobarbital in a biological specimen. Aprobarbital Measurement APRI Score AST to Platelet Ratio Index A calculation that indicates the likely presence of liver cirrhosis and fibrosis, measured as the relative measurement of aspartate aminotransferase (AST) to AST upper limit of normal, divided by the platelet count, and multiplied by 100. Aspartate Aminotransferase to Platelet Ratio Index A Proliferation-Inducing Ligand Soluble CD256 TNFSF13 Tumor Necrosis Factor Ligand Superfamily Member 13 A measurement of the a proliferation-inducing ligand in a biological specimen. A Proliferation-Inducing Ligand Measurement Activated Protein C Resistance Factor V Leiden Screen A measurement of the resistance in the anticoagulation response to activated protein C in a biological specimen. Activated Protein C Resistance Measurement Amyloid Probability Score APS Plasma Amyloid Probability Score A probability score representing the estimated likelihood that the patient is amyloid positive on PET imaging. Amyloid Probability Score Activated Partial Thromboplastin Time A measurement of the length of time that it takes for clotting to occur when activating reagents are added to a biological specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture. Activated Partial Thromboplastin Time APTT-LA Actual/Control Lupus Anticoagulant Sensitive APTT Actual/Control A relative measurement (ratio or percentage) of the Lupus anticoagulant sensitive APTT in a subject's specimen when compared to a control specimen. APTT-LA Actual to Control Ratio Measurement APTT-LA APTTLA Lupus Anticoagulant Sensitive APTT A measurement of the length of time that it takes for clotting to occur when a lupus sensitive reagent is added to a plasma specimen. Lupus Anticoagulant Sensitive APTT Measurement Activated Partial Thromboplastin Time/Standard Thromboplastin Time Activated PTT/Standard Activated PTT/Standard PTT A relative measurement (ratio or percentage) of the subject's activated partial thromboplastin time to a standard or control partial thromboplastin time. Activated PTT/Standard Ratio Measurement Arachidonic Acid A measurement of the arachidonic acid present in a biological specimen. Arachidonic Acid Measurement Amphiregulin Schwannoma-Derived Growth Factor SDGF A measurement of the amphiregulin in a biological specimen. Amphiregulin Measurement Arginine A measurement of the arginine in a biological specimen. Arginine Measurement Argininosuccinate Argininosuccinic Acid A measurement of the argininosuccinic acid in a biological specimen. Argininosuccinic Acid Measurement Aripiprazole A measurement of the aripiprazole in a biological specimen. Aripiprazole Measurement Aldosterone/Renin Activity A relative measurement (ratio) of the aldosterone to renin activity in a biological specimen. Aldosterone to Renin Activity Ratio Measurement Arsenic As A measurement of the arsenic in a specimen. Arsenic Measurement Asenapine A measurement of the asenapine in a biological specimen. Asenapine Measurement Alpha-Actin 2 Alpha-SMA Alpha-Smooth Muscle Actin A measurement of the alpha-smooth muscle actin in a biological specimen. Alpha-Smooth Muscle Actin Measurement Asparagine A measurement of the asparagine in a biological specimen. Asparagine Measurement Aspartate Aspartic Acid A measurement of the aspartic acid in a biological specimen. Aspartic Acid Measurement Anti-Single Stranded DNA IgG A measurement of the anti-single stranded DNA IgG antibody in a biological specimen. Anti-Single Stranded DNA IgG Measurement Aspartate Aminotransferase Aspartate Aminotransferase Antigen SGOT SGOT Antigen A measurement of the aspartate aminotransferase in a biological specimen. Aspartate Aminotransferase Measurement AST/ALT A relative measurement (ratio or percentage) of the aspartate aminotransferase (AST) to alanine aminotransferase (ALT) present in a sample. Aspartate Aminotransferase to Alanine Aminotransferase Ratio Measurement Aspartate Aminotransferase Isoenzyme C Aspartate Aminotransferase Isoenzyme Cytoplasmic C-AST cAspAT Cytoplasmic Isoenzyme of Aspartate Aminotransferase SGOT Isoenzyme C A measurement of the aspartate aminotransferase isoenzyme C in a biological specimen. Aspartate Aminotransferase Isoenzyme C Measurement Aspartate Aminotransferase/CPK Aspartate Aminotransferase/Creatine Kinase AST/Creatine Kinase A relative measurement (ratio) of the aspartate aminotransferase to creatine kinase in a biological specimen. Aspartate Aminotransferase to Creatine Kinase Ratio Measurement Aspartate Aminotransferase/Creatinine A relative measurement (ratio or percentage) of the aspartate aminotransferase to creatinine in a biological specimen. Aspartate Aminotransferase to Creatinine Ratio Measurement 3-Alpha-Androstanediol Glucuronide A measurement of the 3-alpha-androstanediol glucuronide in a biological specimen. 3-Alpha-Androstanediol Glucuronide Measurement Aspartate Aminotransferase Isoenzyme M Aspartate Aminotransferase Isoenzyme Mitochondrial M-AST mAspAT Mitochondrial Isoenzyme of Aspartate Aminotransferase SGOT Isoenzyme M A measurement of the aspartate aminotransferase isoenzyme M in a biological specimen. Aspartate Aminotransferase Isoenzyme M Measurement Alpha Synuclein Protein A measurement of the alpha synuclein protein in a biological specimen. Alpha Synuclein Protein Measurement Antithrombin Activity Actual/Antithrombin Activity Control Antithrombin Activity Actual/Control Antithrombin Activity Actual/Normal A relative measurement (ratio or percentage) of the biological activity of antithrombin in a subject's specimen when compared to the same activity in a control specimen. Antithrombin Activity Actual to Control Ratio Measurement Antithrombin Actual/Control Antithrombin Actual/Normal A relative measurement (ratio or percentage) of the Antithrombin in a subject's specimen when compared to a control specimen. Antithrombin Actual to Control Ratio Measurement AIP Atherogenic Index Atherogenic Index of Plasma A measurement of the base 10 logarithm of the ratio of molar concentration of plasma triglyceride to high density lipoprotein cholesterol in a biological specimen. Atherogenic Index of Plasma ALK1 Antileukoproteinase BLPI Proteinase Inhibitor WAP4 Secretory Leukocyte Peptidase Inhibitor Secretory Leukocyte Protease Inhibitor A measurement of the antileukoproteinase in a biological specimen. Antileukoproteinase Measurement Adenosine Triphosphate A measurement of the adenosine triphosphate in a biological specimen. Adenosine Triphosphate Measurement Alpha Tocopherol/Vitamin E A relative measurement (ratio or percentage) of alpha-tocopherol to the total vitamin E in a biological specimen. Alpha Tocopherol to Vitamin E Ratio Measurement Auer Rods A measurement of the Auer rods (elongated needle structures that are found in the cytoplasm of leukemic blasts and are formed by clumps of azurophilic granular material) in a biological specimen. Auer Rod Measurement ARK AXL Receptor Tyrosine Kinase JTK11 Tyro7 UFO A measurement of the AXL receptor tyrosine kinase in a biological specimen. AXL Receptor Tyrosine Kinase Measurement Azurophilic Granulation Azurophilic Granules An observation of azurophilic granules in a biological specimen. Azurophilic Granule Measurement Beta-1B Glycoprotein Hemopexin HPX A measurement of the beta-1B glycoprotein in a biological specimen. Beta-1B Glycoprotein Measurement Beta-2 Microglobulin/Creatinine A relative measurement (ratio) of the beta-2 microglobulin to creatinine in a biological specimen. Beta-2 Microglobulin to Creatinine Ratio Measurement Beta-2 Microglobulin A measurement of the beta-2 microglobulin in a biological specimen. Beta-2 Microglobulin Measurement Bacteria A measurement of the bacteria in a biological specimen. Bacterial Count B-Cell Activating Factor A measurement of the B-cell activating factor in a biological specimen. B-Cell Activating Factor Measurement Beta Alanine A measurement of the beta alanine in a biological specimen. Beta Alanine Measurement BABA Beta-aminobutyrate Beta-Aminobutyric Acid A measurement of the beta-aminobutyric acid in a biological specimen. Beta-Aminobutyric Acid Measurement Barbiturates A measurement of any barbiturate class drug present in a biological specimen. Barbiturate Drug Class Measurement Base Deficit A measurement of the amount of alkali required to return a biological specimen to a normal pH under standard conditions. Base Deficit Actual Base Excess Base Excess A calculated measurement of the amount of acid required to return blood to a normal pH under standard conditions. Base Excess Measurement Basophils A measurement of the basophils in a biological specimen. Absolute Basophil Count Basophils Band Form A measurement of the banded basophils in a biological specimen. Basophil Band Form Count Basophils Band Form/Leukocytes A relative measurement (ratio or percentage) of the banded basophils to leukocytes in a biological specimen. Basophil Band Form to Leukocytes Ratio Measurement Basophils/Total Cells A relative measurement (ratio or percentage) of the basophils to total cells in a biological specimen (for example a bone marrow specimen). Basophil to Total Cell Ratio Measurement Immature Basophils A measurement of the immature basophils in a biological specimen. Immature Basophil Count Immature Basophils/Leukocytes A relative measurement (ratio or percentage) of immature basophils to total leukocytes in a biological specimen. Immature Basophil to Leukocyte Ratio Measurement Basophils/Leukocytes A relative measurement (ratio or percentage) of the basophils to leukocytes in a biological specimen. Basophil to Leukocyte Ratio Basophilic Metamyelocytes A measurement of the basophilic metamyelocytes in a biological specimen. Basophilic Metamyelocyte Count Basophilic Myelocytes A measurement of the basophilic myelocytes in a biological specimen. Basophilic Myelocyte Count Basophilic Myelocytes/Lymphocytes A relative measurement (ratio or percentage) of the basophilic myelocytes to lymphocytes in a biological specimen (for example a bone marrow specimen). Basophilic Myelocytes to Lymphocytes Ratio Measurement Basophils, Segmented A measurement of the segmented basophils in a biological specimen. Segmented Basophil Count Beta-cell Function A measurement of the beta cell function (insulin production and secretion) in a biological specimen. Beta-Cell Function Measurement Soluble B Cell Maturation Antigen Soluble BCM Soluble BCMA Soluble CD269 Soluble TNF Receptor Superfamily Member 17 Soluble TNFRSF13A A measurement of the soluble B cell maturation antigen in a biological specimen. Soluble B Cell Maturation Antigen Measurement Beta-defensin 2 A measurement of the beta-defensin 2 in a biological specimen. Beta-defensin 2 Measurement Brain-Derived Neurotrophic Factor A measurement of the brain-derived neurotrophic factor in a biological specimen. Brain-Derived Neurotrophic Factor Measurement Benzene A measurement of the benzene in a specimen. Benzene Measurement b-Carotene Beta Carotene Beta Carotin A measurement of the beta carotene in a biological specimen. Beta Carotene Measurement Betaines A measurement of the betaine class compounds in a biological specimen. Betaines Measurement Bufotenine A measurement of the bufotenine in a biological specimen. Bufotenine Measurement Beta and Gamma Tocopherol Beta+Gamma Tocopherol A measurement of the beta and gamma tocopherol in a biological specimen. Beta and Gamma Tocopherol Measurement Beta-Hydroxybutyrate/Acetoacetate A relative measurement (ratio) of the beta-hydroxybutyrate to acetoacetate in a biological specimen. Beta-Hydroxybutyrate to Acetoacetate Ratio Measurement 3-Hydroxybutyrate Excretion Rate B-Hydroxybutyrate Excretion Rate Beta-Hydroxybutyrate Excretion Rate BHB Excretion Rate A measurement of the amount of beta-Hydroxybutyrate being excreted in a biological specimen over a defined period of time (e.g. one hour). Beta-Hydroxybutyrate Excretion Rate Measurement 3-Hydroxybutyrate B-Hydroxybutyrate Beta-Hydroxybutyrate Beta-Hydroxybutyric Acid BHB A measurement of the total Beta-hydroxybutyrate in a biological specimen. Beta-Hydroxybutyrate Measurement Bicarbonate HCO3 A measurement of the bicarbonate in a biological specimen. Bicarbonate Measurement Albumin-Bound Bilirubin Biliprotein Delta Bilirubin Delta Fraction A measurement of the albumin-bound bilirubin in a biological specimen. Delta Bilirubin Measurement Conjugated Bilirubin + Albumin-Bound Bilirubin Conjugated Bilirubin + Delta Bilirubin Direct Bilirubin A measurement of the glucuronidated bilirubin and albumin-bound bilirubin in a biological specimen. Direct Bilirubin Measurement Direct Bilirubin/Bilirubin A relative measurement (ratio or percentage) of the direct bilirubin to total bilirubin in a biological specimen. Direct Bilirubin to Bilirubin Ratio Measurement Bile Acid Bile Acids Bile Salt Bile Salts A measurement of the total bile acids in a biological specimen. Bile Acid Measurement Conjugated Bilirubin Glucuronidated Bilirubin A measurement of the glucuronidated bilirubin (water soluble) in a biological specimen. Glucuronidated Bilirubin Measurement Bilirubin Total Bilirubin A measurement of the total bilirubin in a biological specimen. Total Bilirubin Measurement Indirect Bilirubin Non-Glucuronidated Bilirubin Unconjugated Bilirubin A measurement of the unconjugated or non-water-soluble bilirubin in a biological specimen. Indirect Bilirubin Measurement Bite Cells A measurement of the bite cells (erythrocytes with the appearance of a bite having been removed, due to oxidative hemolysis) in a biological specimen. Bite Cell Count Bence-Jones Protein A measurement of the total Bence-Jones protein in a biological specimen. Bence-Jones Protein Measurement Blasts A measurement of the blast cells in a biological specimen. Blast Count Blasts/Total Cells A relative measurement (ratio or percentage) of the blasts to total cells in a biological specimen. Blasts to Total Cells Ratio Measurement Basophilic Erythroblast A measurement of the basophilic erythroblasts in a biological specimen taken from a non-human organism. Basophilic Erythroblast Count Immunoblastic Lymphocytes Immunoblasts A measurement of the immunoblasts in a biological specimen. Immunoblast Count Blasts/Leukocytes A relative measurement (ratio or percentage) of the blasts to leukocytes in a biological specimen. Blast to Leukocyte Ratio Leukemic Blasts A measurement of the leukemic blasts (lymphoblasts and/or myeloblasts that remain in an immature state even when outside the bone marrow) in a biological specimen. Leukemic Blast Count Proerythroblast Pronormoblast Rubriblast A measurement of the rubriblasts in a biological specimen. Proerythroblast Measurement Bleeding Time Clotting Time Homeostasis A measurement of the time from the start to cessation of an induced bleed. Bleeding Time Blister Cell A measurement of the blister cells in a biological specimen. Blister Cell Count Immunoblasts/Lymphocytes Lymphocytes, Immunoblastic/Lymphocytes A relative measurement (ratio or percentage) of immunoblasts to all lymphocytes present in a sample. Immunoblasts to Lymphocytes Ratio Measurement Leukemic Blasts/Lymphocytes A relative measurement (ratio or percentage) of the leukemic blasts (immature lymphoblasts and/or myeloblasts) to mature lymphocytes in a biological specimen. Leukemic Blast to Lymphocyte Ratio Measurement Lymphoblasts Lymphoid Blasts A measurement of the lymphoblasts (immature cells that differentiate to form lymphocytes) in a biological specimen. Lymphoblast Count Lymphoblasts/Leukocytes A relative measurement (ratio or percentage) of the lymphoblasts to leukocytes in a biological specimen. Lymphoblast to Leukocyte Ratio Measurement Lymphoblasts/Lymphocytes A relative measurement (ratio or percentage) of the lymphoblasts to lymphocytes in a biological specimen. Lymphoblast to Lymphocyte Ratio Measurement Myeloblasts/Total Cells A relative measurement (ratio or percentage) of the myeloblasts to total cells in a biological specimen (for example a bone marrow specimen). Myeloblast to Total Cell Ratio Measurement Megakaryoblasts A measurement of the megakaryoblasts in a biological specimen. Megakaryoblast Cell Count Megakaryoblasts/Total Cells A relative measurement (ratio or percentage) of the megakaryoblasts to total cells in a biological specimen (for example a bone marrow specimen). Megakaryoblast to Total Cell Ratio Measurement Megakaryoblasts/Leukocytes A relative measurement (ratio or percentage) of megakaryoblasts to total leukocytes in a biological specimen. Megakaryoblasts to Leukocytes Ratio Measurement Normoblasts A measurement of the normoblasts in a biological specimen. Normoblast Count Normoblasts/Total Cells A relative measurement (ratio or percentage) of the normoblasts to total cells in a biological specimen (for example a bone marrow specimen). Normoblast to Total Cell Ratio Measurement Proerythroblast/Total Cells Pronormoblasts/Total Cells Rubriblast/Total Cells A relative measurement (ratio or percentage) of the rubriblasts to total cells in a biological specimen (for example a bone marrow specimen). Pronormoblast to Total Cell Ratio Measurement Ringed Sideroblasts A measurement of the ringed sideroblasts (abnormal nucleated erythroblasts with a large number of iron deposits in the perinuclear mitochondria, forming a ring around the nucleus) in a biological specimen. Ring Sideroblast Measurement Sideroblast A measurement of the sideroblasts (nucleated erythroblasts with iron granules in the cytoplasm) in a biological specimen. Sideroblast Measurement B Cells B-Cell Lymphocytes B-Cells B-Lymphocytes A measurement of the B-lymphocytes in a biological specimen. B-Lymphocyte Count B-Lymphocytes/Total Cells A relative measurement (ratio or percentage) of the B-lymphocytes to total cells in a biological specimen. B-Lymphocyte to Total Cells Ratio Measurement B Cells/Leukocytes B-Lymphocytes/Leukocytes BLym/Leuk A relative measurement (ratio or percentage) of B-lymphocytes to leukocytes in a biological specimen. B-Lymphocyte to Leukocyte Ratio Measurement B-Lymphocytes/Lymphocytes A relative measurement (ratio or percentage) of the B-lymphocytes to total lymphocytes in a biological specimen. B-Lymphocyte to Lymphocyte Ratio Measurement B-lymphocyte Crossmatch A measurement to determine human leukocyte antigens (HLA) histocompatibility between the recipient and the donor by examining the presence or absence of the recipient's anti-HLA antibody reactivity towards HLA antigens expressed on the donor B-lymphocytes. B-lymphocyte Crossmatch Measurement B-Type Natriuretic Peptide Brain Natriuretic Peptide A measurement of the brain (B-type) natriuretic peptide in a biological specimen. Brain Natriuretic Peptide Measurement Pro-Brain Natriuretic Peptide ProB-type Natriuretic Peptide proBNP A measurement of the proB-type natriuretic peptide in a biological specimen. ProB-Type Natriuretic Peptide Measurement N-terminal pro-Brain Natriuretic Peptide N-Terminal ProB-type Natriuretic Peptide NT proBNP II A measurement of the N-terminal proB-type natriuretic peptide in a biological specimen. N-Terminal ProB-type Natriuretic Peptide Measurement Benzodiazepine A measurement of any benzodiazepine class drug present in a biological specimen. Benzodiazepine Measurement Benzoylecgonine A measurement of the benzoylecgonine in a biological specimen. Benzoylecgonine Measurement Boldenone A measurement of the boldenone in a biological specimen. Boldenone Measurement Bolasterone A measurement of the bolasterone in a biological specimen. Bolasterone Measurement Barbital A measurement of the barbital in a biological specimen. Barbital Measurement Bromazepam A measurement of the bromazepam in a biological specimen. Bromazepam Measurement Brivaracetam A measurement of the brivaracetam in a biological specimen. Brivaracetam Measurement Brexpiprazole A measurement of the brexpiprazole in a biological specimen. Brexpiprazole Measurement Betacellulin A measurement of the betacellulin in a biological specimen. Betacellulin Measurement Bite Cells/Erythrocytes A relative measurement (ratio or percentage) of bite cells (erythrocytes with the appearance of a bite having been removed, due to oxidative hemolysis) to all erythrocytes in a biological specimen. Bite Cell to Erythrocyte Ratio Measurement Agammaglobulinemia Tyrosine Kinase ATK B-cell Progenitor Kinase Bruton Tyrosine Kinase Bruton's Tyrosine Kinase Tyrosine-protein kinase BTK A measurement of the Bruton's tyrosine kinase in a biological specimen. Bruton's Tyrosine Kinase Measurement Bruton's Tyrosine Kinase, Free A measurement of the free Bruton's tyrosine kinase in a biological specimen. Free Bruton's Tyrosine Kinase Measurement Butabarbital A measurement of the butabarbital in a biological specimen. Butabarbital Measurement Butalbital A measurement of the butalbital present in a biological specimen. Butalbital Measurement Butorphanol A measurement of the butorphanol in a biological specimen. Butorphanol Measurement Acylcholine Acylhydrolase Butyrylcholinesterase Non-neuronal Cholinesterase Plasma Cholinesterase Pseudocholinesterase A measurement of the total butyrylcholinesterase in a biological specimen. Butyrylcholinesterase Measurement Buprenorphine A measurement of the buprenorphine drug present in a biological specimen. Buprenorphine Measurement Bupropion A measurement of the bupropion in a biological specimen. Bupropion Measurement Burr Cells Echinocytes A measurement of the Burr cells (erythrocytes characterized by the presence of small, blunt projections evenly distributed across the cell surface) in a biological specimen. Burr Cell Count 1,3-Butadiene A measurement of the 1,3-butadiene in a specimen. 1,3-Butadiene Measurement Butylone A measurement of the butylone in a biological specimen. Butylone Measurement 3,4-Benzpyrene Benz(a)pyrene Benz[a]pyrene Benzo(a)pyrene Benzo[a]pyrene A measurement of the benzo[a]pyrene in a specimen. Benzo[a]pyrene Measurement 1-benzylpiperazine Benzylpiperazine N-benzylpiperazine A measurement of the benzylpiperazine in a biological specimen. Benzylpiperazine Measurement Complement C1 Esterase Inhibitor A measurement of the complement C1 esterase inhibitor in a biological specimen. Complement C1 Esterase Inhibitor Measurement C1M MMP-Degraded Type I collagen Fragment C1M A measurement of the MMP-degraded type I collagen fragment C1M in a biological specimen. MMP-Degraded Type I Collagen Fragment C1M Measurement Complement C1q A measurement of the complement C1q in a biological specimen. Complement C1q Measurement ARMD14 Complement C2 A measurement of the complement C2 in a biological specimen. Complement C2 Measurement Complement C2, Free A measurement of the free complement C2 in a biological specimen. Free Complement C2 Measurement Complement C2, Free/Complement C2 A relative measurement (ratio or percentage) of the free complement C2 to total complement C2 in a biological specimen. Free Complement C2 to Complement C2 Ratio Measurement C2M MMP-Degraded Type II collagen Fragment C2M A measurement of the MMP-degraded type II collagen fragment C2M in a biological specimen. MMP-Degraded Type II Collagen Fragment C2M Measurement Complement C3 A measurement of the complement C3 in a biological specimen. Complement C3 Measurement Complement C3a A measurement of the complement C3a in a biological specimen. Complement C3a Measurement Acylation-Stimulating Protein ASP Complement C3a DesArg A measurement of the complement C3a DesArg in a biological specimen. Complement C3a DesArg Measurement Complement C3b A measurement of the complement C3b in a biological specimen. Complement C3b Measurement Complement C3c A measurement of the complement C3c in a biological specimen. Complement C3c Measurement Collagen III Neo-Peptide C3M A measurement of the collagen III neo-peptide C3M in a biological specimen. Collagen III Neo-Peptide C3M Measurement Complement C4 A measurement of the complement C4 in a biological specimen. Complement C4 Measurement Complement C4a A measurement of the complement C4a in a biological specimen. Complement C4a Measurement Complement C4d A measurement of the complement C4d in a biological specimen. Complement C4d Measurement C4G MMP-Degraded Type IV collagen Fragment C4G A measurement of the MMP-degraded type IV collagen fragment C4G in a biological specimen. MMP-Degraded Type IV Collagen Fragment C4G Measurement C4M MMP-Degraded Type IV collagen Fragment C4M A measurement of the MMP-degraded type IV collagen fragment C4M in a biological specimen. MMP-Degraded Type IV Collagen Fragment C4M Measurement C4Ma3 MMP-2,9,12 Degraded Type IV Collagen Alpha 3 A measurement of the MMP-2,9,12-degraded type IV collagen alpha 3 fragment C4Ma3 in a biological specimen. MMP 2,9,12-Degraded Type IV Collagen Alpha 3 Fragment C4Ma3 Measurement Complement C5 A measurement of the total complement C5 in a biological specimen. Complement C5 Measurement Complement C5a A measurement of the complement C5a in a biological specimen. Complement C5a Measurement Complement C5b-9 A measurement of the complement C5b-9 in a biological specimen. Complement C5b-9 Measurement sC5b-9 Smac Soluble Complement C5b-9 Soluble MAC Soluble Membrane Attack Complex TCC Terminal Complement Complex A measurement of the soluble complement C5b-9 in a biological specimen. Soluble Complement C5b-9 Measurement Complement C5, Free A measurement of the free complement C5 in a biological specimen. Free Complement C5 Measurement C6M MMP-2 Degraded Type VI Collagen C6M A measurement of the MMP2-degraded type VI collagen fragment C6M in a biological specimen. MMP 2-Degraded Type VI Collagen Fragment C6M Measurement C6Ma3 MMP-2 and MMP-9 Degraded Type VI Collagen alpha-3 subunit C6M A measurement of the MMP-2-egraded Type VI Collagen alpha-3 subunit fragment C6Ma3 in a biological specimen. MMP 2-Degraded Type VI Collagen Alpha-3 Subunit Fragment C6Ma3 Measurement Calcium A measurement of the calcium in a biological specimen. Calcium Measurement CA125 CA125AG Cancer Antigen 125 Carbohydrate Antigen 125 MUC16 Mucin-16 Mucin-16, Cell Surface Associated A measurement of the cancer antigen 125 in a biological specimen. CA-125 Measurement Cancer Antigen 15-3 Carbohydrate Antigen 15-3 A measurement of the cancer antigen 15-3 in a biological specimen. Cancer Antigen 15-3 Measurement Cancer Antigen 19-9 Carbohydrate Antigen 19-9 A measurement of the cancer antigen 19-9 in a biological specimen. Cancer Antigen 19-9 Measurement Cancer Antigen 1 A measurement of the cancer antigen 1 in a biological specimen. Cancer Antigen 1 Measurement Cancer Antigen 242 Carbohydrate Antigen 242 A measurement of the cancer antigen 242 in a biological specimen. Cancer Antigen 242 Measurement Cancer Antigen 27-29 A measurement of the cancer antigen 27-29 in a biological specimen. Cancer Antigen 27-29 Measurement CA50 Cancer Antigen 50 Carbohydrate Antigen 50 A measurement of the cancer antigen 50 in a biological specimen. Cancer Antigen 50 Measurement CA 72-4 Cancer Antigen 72-4 Carbohydrate Antigen 72-4 A measurement of the cancer antigen 72-4 in a biological specimen. Cancer Antigen 72-4 Measurement Cabot Rings A measurement of the Cabot rings (red-purple staining, threadlike, ring or figure 8 shaped filaments in an erythrocyte) in a biological specimen. Cabot Ring Count Calcium Clearance A measurement of the volume of serum or plasma that would be cleared of calcium by excretion of urine for a specified unit of time (e.g. one minute). Calcium Clearance Measurement Calcium Corrected A measurement of calcium, which has been corrected using an unspecified protein, in a biological specimen. Calcium Corrected Measurement Calcium Corrected for Albumin A measurement of calcium, which has been corrected for albumin, in a biological specimen. Albumin Corrected Calcium Measurement Calcium/Creatinine A relative measurement (ratio or percentage) of the calcium to creatinine in a biological specimen. Calcium to Creatinine Ratio Measurement Calcium Corrected for Total Protein A measurement of calcium, which has been corrected for total protein, in a biological specimen. Calcium Corrected for Total Protein Measurement Cadmium A measurement of the cadmium in a specimen. Cadmium Measurement ADP-Ribosyl Cyclase 1 ADP-Ribosyl Cyclase/Cyclic ADP-Ribose Hydrolase 1 ADPRC1 cADPr Hydrolase 1 Cyclic ADP Ribose Hydrolase Cyclic ADP Ribose Hydrolase 1 Soluble CD38 A measurement of the cyclic ADP ribose hydrolase 1 protein in a biological specimen. Cyclic ADP Ribose Hydrolase 1 Measurement Calcium Excretion Rate A measurement of the amount of calcium being excreted in a biological specimen over a defined period of time (e.g. one hour). Calcium Excretion Rate Caffeine A measurement of the caffeine in a biological specimen. Caffeine Measurement Calcium, Ionized A measurement of the ionized calcium in a biological specimen. Ionized Calcium Measurement Calcium, Ionized pH Adjusted A measurement of the pH adjusted ionized calcium in a biological specimen. Ionized pH Adjusted Calcium Measurement Calbindin A measurement of the total calbindin in a biological specimen. Calbindin Measurement Calprotectin A measurement of the calprotectin in a biological specimen. Calprotectin Measurement Cyclic Adenosine 3,5-Monophosphate A measurement of cyclic adenosine 3,5-monophosphate in a biological specimen. Cyclic Adenosine 3,5-Monophosphate Measurement Cyclic Adenosine 3,5-Monophosphate/Creatinine Cyclic Adenosine Monophosphate/Creat Cyclic Adenosine Monophosphate/Creatinine A relative measurement (ratio) of the cyclic adenosine 3,5-monophosphate to creatinine in a biological specimen. Cyclic Adenosine 3,5 Monophosphate to Creatinine Ratio Measurement Coefficient of Nitrogen Absorption A measurement of the coefficient of nitrogen absorption in a biological specimen. Coefficient of Nitrogen Absorption Measurement Cannabinoids A measurement of any cannabinoid class drug present in a biological specimen. Cannabinoid Drug Class Measurement Cannabinoid Metabolites Cannabis Metabolites Marijuana Metabolites A measurement of any cannabinoid drug class metabolite(s) present in a biological specimen. Cannabinoid Metabolite Measurement Cannabinoids, Synthetic A measurement of any synthetic cannabinoid class drug present in a biological specimen. Synthetic Cannabinoid Measurement Calcium Oxalate Excretion Rate A measurement of the amount of calcium oxalate being excreted in a biological specimen over a defined amount of time (e.g. one hour). Calcium Oxalate Excretion Rate Calcium/Phosphate Calcium/Phosphorus A relative measurement (ratio) of the calcium to phosphorus in a biological specimen. Calcium to Phosphorus Ratio Measurement Calcium - Phosphorus Product A measurement of the product of the calcium and phosphate measurements in a biological specimen. Calcium and Phosphorus Product Measurement Carboxyhemoglobin A measurement of the carboxyhemoglobin, carbon monoxide-bound hemoglobin, in a biological specimen. Carboxyhemoglobin Measurement Cariprazine A measurement of the cariprazine in a biological specimen. Cariprazine Measurement Carnitine A measurement of the total carnitine in a biological specimen. Total Carnitine Measurement Carnitine Acetyl Transferase A measurement of the carnitine acetyl transferase in a biological specimen. Carnitine Acetyl Transferase Measurement Carnitine, Free A measurement of the free carnitine in a biological specimen. Free Carnitine Measurement Carnitine Excretion Rate A measurement of the amount of carnitine being excreted in a biological specimen over a defined amount of time (e.g. one hour). Carnitine Excretion Rate CART Cocaine Amphetamine-Reg Transcript Prot Cocaine and Amphetamine-Regulated Transcript Protein A measurement of the cocaine and amphetamine-regulated transcript protein in a biological specimen. Cocaine Amphetamine-Regulated Transcript Protein Measurement Casein A measurement of the casein in a biological specimen. Casein Measurement Casts Casts Absent Indicator An indication that casts were looked for and not found in a biological specimen. Cast Absent Indicator Calcium Sulphate A measurement of the calcium sulphate in a biological specimen. Calcium Sulphate Measurement Cathinone A measurement of the cathinone in a biological specimen. Cathinone Measurement Beta Catenin A measurement of the beta catenin in a biological specimen. Beta Catenin Measurement Ba Fragment of Complement Factor B Ba Fragment of Factor B Complement Ba A measurement of the Ba fragment of complement factor B in a biological specimen. Complement Ba Measurement CA9 CAIX Carbonic Anhydrase 9 A measurement of the carbonic anhydrase 9 in a biological specimen. Carbonic Anhydrase 9 Measurement Bb Fragment of Complement Factor B Bb Fragment of Factor B Complement Bb A measurement of the Bb fragment of complement factor B in a biological specimen. Complement Bb Measurement Cystathionine Beta-Synthase A measurement of the cystathionine beta-synthase in a biological specimen. Cystathionine Beta-Synthase Measurement Cholecystokinin Pancreozymin A measurement of the cholecystokinin hormone in a biological specimen. Cholecystokinin Measurement Chemokine (C-C Motif) Ligand 1 I-309 SCYA1 Small Inducible Cytokine A1 T Lymphocyte-Secreted Protein I-309 A measurement of the CCL1, chemokine (C-C motif) ligand 1, in a biological specimen. Chemokine (C-C Motif) Ligand 1 Measurement Chemokine (C-C Motif) Ligand 12 Monocyte Chemotactic Protein 5 A measurement of the CCL12, chemokine (C-C motif) ligand 12, in a biological specimen. Chemokine (C-C Motif) Ligand 12 Measurement C-C Motif Chemokine Ligand 13 Chemokine (C-C Motif) Ligand 13 CKb10 MCP-4 NCC1 SCYA13 SCYL1 A measurement of the CCL13, chemokine (C-C motif) ligand 13, in a biological specimen. Chemokine (C-C Motif) Ligand 13 Measurement Chemokine (C-C Motif) Ligand 15 Leukotactin 1 Macrophage inflammatory protein-5 MIP-1 Delta MIP1D MIP5 A measurement of the CCL15, chemokine (C-C motif) ligand 15, in a biological specimen. Chemokine (C-C Motif) Ligand 15 Measurement Chemokine (C-C Motif) Ligand 16 Chemokine CC-4 CKb12 HCC-4 ILINCK LCC-1 LEC LMC Mtn-1 NCC4 SCYA16 SCYL4 A measurement of the CCL16, chemokine (C-C motif) ligand 16, in a biological specimen. Chemokine (C-C Motif) Ligand 16 Measurement ABCD-2 Chemokine (C-C Motif) Ligand 17 SCYA17 TARC Thymus and Activation Regulated Chemokine A measurement of the CCL17, chemokine (C-C motif) ligand 17, in a biological specimen. Chemokine (C-C Motif) Ligand 17 Measurement AMAC-1 AMAC1 Chemokine (C-C Motif) Ligand 18 CKB7 DC-CK1 DCCK1 Macrophage inflammatory protein-4 MIP4 PARC Pulmonary and Activation-Regulated Chemokine SCYA18 A measurement of the CCL18, chemokine (C-C motif) ligand 18, in a biological specimen. Chemokine (C-C Motif) Ligand 18 Measurement Chemokine (C-C Motif) Ligand 19 Macrophage Inflammatory Protein 3 Beta MIP3B A measurement of the CCL19, chemokine (C-C motif) ligand 19, in a biological specimen. Chemokine (C-C Motif) Ligand 19 Measurement CCL20 Chemokine (C-C Motif) Ligand 20 LARC Liver Activation Regulated Chemokine Macrophage Inflammatory Protein-3 Alpha MIP3A A measurement of the chemokine (C-C motif) ligand 20 in a biological specimen. Chemokine (C-C Motif) Ligand 20 Measurement 6Ckine Chemokine (C-C Motif) Ligand 21 Secondary Lymphoid Tissue Chemokine A measurement of the CCL21, chemokine (C-C motif) ligand 21, in a biological specimen. Chemokine (C-C Motif) Ligand 21 Measurement Chemokine (C-C Motif) Ligand 23 CK-BETA-8 Ckb-8-1 CKb8 Hmrp-2a MIP3 MPIF-1 SCYA23 A measurement of the CCL23, chemokine (C-C motif) ligand 23, in a biological specimen. Chemokine (C-C Motif) Ligand 23 Measurement Chemokine (C-C Motif) Ligand 25 Ckb15 SCYA25 TECK A measurement of the CCL25, chemokine (C-C motif) ligand 25, in a biological specimen. Chemokine (C-C Motif) Ligand 25 Measurement Chemokine (C-C Motif) Ligand 2 Excr Rate Chemokine (C-C Motif) Ligand 2 Excretion Rate MCP1 Excretion Rate A measurement of the amount of chemokine (C-C Motif) ligand 2 being excreted in a biological specimen over a defined period of time (e.g. one hour). Chemokine (C-C Motif) Ligand 2 Excretion Rate Chemokine (C-C Motif) Ligand 7 MCP3 Monocyte Chemotactic Protein 3 A measurement of the CCL7, chemokine (C-C motif) ligand 7, in a biological specimen. Chemokine (C-C Motif) Ligand 7 Measurement Chemokine (C-C Motif) Ligand 8 HC14 MCP2 SCYA10 SCYA8 A measurement of the CCL8, chemokine (C-C motif) ligand 8, in a biological specimen. Chemokine (C-C Motif) Ligand 8 Measurement C-C Chemokine Receptor Type 5 Soluble CD195 A measurement of the CCR5, chemokine (C-C motif) receptor type 5, in a biological specimen. C-C Chemokine Receptor Type 5 Measurement CD14 Antigen CD14 Molecule Monocyte Differentiation Antigen CD14 My23 Antigen Myeloid Cell-Specific LEU-Rich Glycoprot Myeloid Cell-Specific Leucine-Rich Glycoprotein SCD14 Soluble CD14 A measurement of the myeloid cell-specific leucine-rich glycoprotein in a biological specimen. Myeloid Cell-Specific Leucine-Rich Glycoprotein Measurement CD8 CD8 Complex T-Cell Surface Glycoprotein CD8 A measurement of the T-cell surface glycoprotein CD8 in a biological specimen. T-Cell Surface Glycoprotein CD8 Measurement Chenic Acid Chenocholic Acid Chenodeoxycholate Chenodeoxycholic Acid A measurement of the chenodeoxycholate in a biological specimen. Chenodeoxycholate Measurement Chenodeoxycholate Compounds Chenodeoxycholic Acid Compounds A measurement of the chenodeoxycholic acid, glycochenodeoxycholic acid, and taurochenodeoxycholic acid in a biological specimen. Chenodeoxycholate Compounds Measurement Cadherin 1 Cadherin-1 E-Cadherin Soluble CD324 A measurement of the cadherin 1 in a biological specimen. Cadherin 1 Measurement Carbohydrate-Deficient Transferrin A measurement of transferrin with a reduced number of carbohydrate moieties in a biological specimen. Carbohydrate-Deficient Transferrin Measurement Carb-Deficient Transferrin/Transferrin A relative measurement (ratio or percentage) of the carbohydrate-deficient transferrin to total transferrin in a biological specimen. Carbohydrate-Deficient Transferrin to Transferrin Ratio Measurement Carcinoembryonic Antigen A measurement of the carcinoembryonic antigen in a biological specimen. Carcinoembryonic Antigen Measurement BGP Biliary Glycoprotein Carcinoembryonic Antigen Cell Adhesion Molecule 1 CEA Cell Adhesion Molecule 1 CEA Related Cell Adhesion Molecule 1 Soluble CD66a A measurement of the carcinoembryonic antigen (CEA) cell adhesion molecule 1 in a biological specimen. CEA Cell Adhesion Molecule 1 Measurement Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 CEA Cell Adhesion Molecule 5 Soluble CD66e A measurement of the carcinoembryonic antigen (CEA) cell adhesion molecule 5 in a biological specimen. CEA Cell Adhesion Molecule 5 Measurement Soluble Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 Soluble CD66e Soluble CEA Cell Adhesion Molecule 5 A measurement of the soluble carcinoembryonic antigen (CEA) cell adhesion molecule 5 in a biological specimen. Soluble CEA Cell Adhesion Molecule 5 Measurement Circulating Endothelial Cells A measurement of the circulating endothelial cells in a biological specimen. Circulating Endothelial Cell Count Immature Cells/Total Cells A relative measurement (ratio or percentage) of the immature hematopoietic cells to total cells in a biological specimen. Immature Cell to Total Cell Ratio Measurement Cells Total Cells A measurement of the total nucleated cells in a biological specimen. Cell Count Immature Cells A measurement of the total immature cells in a blood specimen. Immature Cell Count Cellularity Cellularity Grade A measurement of the degree, quality or condition of cells in a biological specimen. Cellularity Measurement Cell Morphology An examination or assessment of the form and structure of cells. Cell Morphology Assessment Cholesteryl Ester Transfer Protein A measurement of the cholesteryl ester transfer protein in a biological specimen. Cholesteryl Ester Transfer Protein Measurement Cholesteryl Ester Transfer Protein Act A measurement of the biological activity of cholesteryl ester transfer protein in a biological specimen. Cholesteryl Ester Transfer Protein Activity Measurement Coefficient of Fat Absorption A measurement of the coefficient of fat absorption in a biological specimen. Coefficient of Fat Absorption Measurement Beta-1-H-Globulin Complement Factor H Factor H H Factor 1 A measurement of the complement factor H in a biological specimen. Complement Factor H Measurement Complement Factor H Related 1 Complement Factor H-Related Protein 1 FHL-1 FHR-1 H Factor-Like Protein 1 H-Factor-Like 1 A measurement of the complement factor H-related Protein 1 in a biological specimen. Complement Factor H-Related Protein 1 Measurement Chromogranin A A measurement of the chromogranin A in a biological specimen. Chromogranin A Measurement Choriogonadotropin Adj for Maternal Wt Choriogonadotropin Adjusted for Maternal Weight A measurement of choriogonadotropin, which has been adjusted for maternal body weight, in a biological specimen. Choriogonadotropin Adjusted for Maternal Weight Measurement Cyclic Guanosine Monophosphate A measurement of the cyclic guanosine 3,5-monophosphate in a biological specimen. Cyclic Guanosine Monophosphate Measurement CH100 Complement CH100 Total Hemolytic Complement CH100 A measurement of the complement required to lyse 100 percent of red blood cells in a biological specimen. Complement CH100 Measurement CH50 Complement CH50 Total Hemolytic Complement CH50 A measurement of the complement required to lyse 50 percent of red blood cells in a biological specimen. CH50 Measurement Corpuscular HGB Concentration Mean A direct measurement of the concentration of hemoglobin within individual erythrocytes in a biological specimen, reported as a mean. Corpuscular Hemoglobin Concentration Mean Ret. Corpuscular HGB Concentration Mean Reticulocyte Corpuscular Hemoglobin Concentration Mean An indirect measurement of the average concentration of hemoglobin per reticulocyte in a biological specimen, calculated as the ratio of hemoglobin to hematocrit. Reticulocyte Corpuscular Hemoglobin Concentration Mean Cellular Hemoglobin Content CH Corpuscular Hemoglobin Content A measurement of the mean erythrocyte hemoglobin content within an individual erythrocyte, calculated as the product of cell volume and cell hemoglobin concentration. Corpuscular Hemoglobin Content 7alpha,25-Dihydroxycholesterol A measurement of the 7alpha,25-dihydroxycholesterol in a biological specimen. 7alpha,25-Dihydroxycholesterol Measurement 7alpha,27-Dihydroxycholesterol A measurement of the 7alpha,27-dihydroxycholesterol in a biological specimen. 7alpha,27-Dihydroxycholesterol Measurement Corpuscular Hemoglobin Concentration Distribution Width Corpuscular HGB Conc Distribution Width A measurement of the standard deviation of hemoglobin concentrations in erythrocytes in a biological specimen, calculated as the standard deviation of hemoglobin content divided by the mean hemoglobin content. Corpuscular Hemoglobin Concentration Distribution Width Ret Corpuscular HGB Conc Distr Width Reticulocyte Corpuscular Hemoglobin Distribution Width A measurement of the standard deviation of hemoglobin concentrations in reticulocytes in a biological specimen, calculated as the standard deviation of hemoglobin content divided by the mean hemoglobin content. Reticulocyte Corpuscular Hemoglobin Distribution Width 24(S),25-Epoxycholesterol A measurement of the 24(S),25-epoxycholesterol in a biological specimen. 24(S),25-Epoxycholesterol Measurement Chitinase 1 Chitotriosidase Chitotriosidase-1 A measurement of the chitotriosidase-1 in a biological specimen. Chitotriosidase-1 Measurement Chylomicrons A measurement of the chylomicrons in a biological specimen. Chylomicrons Measurement Chylomicron Triglyceride A measurement of the chylomicron triglyceride in a biological specimen. Chylomicron Triglyceride Measurement Chloral Hydrate Mickey Finn Trichloroacetaldehyde Monohydrate A measurement of the chloral hydrate in a biological specimen. Chloral Hydrate Measurement Chlorpromazine A measurement of the chlorpromazine in a biological specimen. Chlorpromazine Measurement Cholesterol Total Cholesterol A measurement of the cholesterol in a biological specimen. Cholesterol Measurement Cholate Cholic Acid A measurement of the cholate in a biological specimen. Cholate Measurement Cholate Compounds Cholic Acid Compounds A measurement of the cholic acid, glycocholic acid, hyocholic acid, and taurocholic acid in a biological specimen. Cholate Compounds Measurement Cholesteryl Esters A measurement of the cholesteryl esters in a biological specimen. Cholesteryl Ester Measurement 20(S)-Hydroxycholesterol 20-Alpha-Hydroxycholesterol A measurement of the 20(S)-hydroxycholesterol in a biological specimen. 20(S)-Hydroxycholesterol Measurement 22(R)-Hydroxycholesterol A measurement of the 22(R)-hydroxycholesterol in a biological specimen. 22(R)-Hydroxycholesterol Measurement 22(S)-Hydroxycholesterol A measurement of the 22(S)-hydroxycholesterol in a biological specimen. 22(S)-Hydroxycholesterol Measurement 24(R)-Hydroxycholesterol A measurement of the 24(R)-hydroxycholesterol in a biological specimen. 24(R)-Hydroxycholesterol Measurement 24(S)-Hydroxycholesterol A measurement of the 24(S)-hydroxycholesterol in a biological specimen. 24(S)-Hydroxycholesterol Measurement 25-Hydroxycholesterol A measurement of the 25-hydroxycholesterol in a biological specimen. 25-Hydroxycholesterol Measurement 27-Hydroxycholesterol A measurement of the 27-hydroxycholesterol in a biological specimen. 27-Hydroxycholesterol Measurement 7alpha-Hydroxycholesterol A measurement of the 7alpha-hydroxycholesterol in a biological specimen. 7alpha-Hydroxycholesterol Measurement 7beta-Hydroxycholesterol A measurement of the 7beta-hydroxycholesterol in a biological specimen. 7beta-Hydroxycholesterol Measurement Cholesterol/HDL-Cholesterol A relative measurement (ratio or percentage) of total cholesterol to high-density lipoprotein cholesterol (HDL-C) in a biological specimen. Cholesterol to HDL-Cholesterol Ratio Measurement Cholinesterase A measurement of the cholinesterase in a biological specimen. Cholinesterase Measurement 7-Ketocholesterol 7-Oxocholesterol A measurement of the 7-ketocholesterol in a biological specimen. 7-Ketocholesterol Measurement 4-Beta-Hydroxycholesterol A measurement of the 4-beta-hydroxycholesterol in a biological specimen. 4-Beta-Hydroxycholesterol Measurement 5alpha-Cholestanol Beta-Cholestanol Cholestanol Dehydrocholesterol Zymostanol A measurement of the cholestanol in a biological specimen. Cholestanol Measurement Cholesterol Sulfate A measurement of the cholesterol sulfate in a biological specimen. Cholesterol Sulfate Measurement Chymotrypsin A measurement of the total chymotrypsin in a biological specimen. Chymotrypsin Measurement Circulating Immune Complexes A measurement of the circulating immune complexes in a biological specimen. Circulating Immune Complex Measurement Citrulline A measurement of the citrulline in a biological specimen. Citrulline Measurement Citrate/Creatinine Citric Acid/Creatinine A relative measurement (ratio or percentage) of the citrate to creatinine in a biological specimen. Citrate to Creatinine Ratio Measurement Citrate Citric Acid A measurement of the citrate in a biological specimen. Citrate Measurement Citrate Excretion Rate A measurement of the amount of citrate being excreted in a biological specimen over a defined amount of time (e.g. one hour). Citrate Excretion Rate CPK Creatine Kinase Creatine Phosphokinase A measurement of the total creatine kinase in a biological specimen. Creatine Kinase Measurement Creatine Kinase BB A measurement of the homozygous B-type creatine kinase in a biological specimen. Creatine Kinase BB Measurement Creatine Kinase BB/Total Creatine Kinase A relative measurement (ratio or percentage) of the BB-type creatine kinase to total creatine kinase in a biological specimen. Creatine Kinase BB to Total Creatine Kinase Ratio Measurement Creatine Kinase MB A measurement of the heterozygous MB-type creatine kinase in a biological specimen. Creatine Kinase MB Measurement Creatine Kinase MB/Total Creatine Kinase A relative measurement (ratio or percentage) of the MB-type creatine kinase to total creatine kinase in a biological specimen. Creatine Kinase MB to Total Creatine Kinase Ratio Measurement Creatine Kinase MM A measurement of the homozygous M-type creatine kinase in a biological specimen. Creatine Kinase MM Measurement Creatine Kinase MM/Total Creatine Kinase A relative measurement (ratio or percentage) of the MM-type creatine kinase to total creatine kinase in a biological specimen. Creatine Kinase MM to Total Creatine Kinase Ratio Measurement CK, Macromolecular Type 1/Total CK Creatine Kinase, Macromolecular Type 1/Total Creatine Kinase A relative measurement (ratio or percentage) of the macromolecular type 1 creatine kinase to total creatine kinase in a biological specimen. Macromolecular Type 1 Creatine Kinase to Total Creatine Kinase Ratio Measurement CK, Macromolecular Type 2/Total CK Creatine Kinase, Macromolecular Type 2/Total Creatine Kinase A relative measurement (ratio or percentage) of the macromolecular type 2 creatine kinase to total creatine kinase in a biological specimen. Macromolecular Type 2 Creatine Kinase to Total Creatine Kinase Ratio Measurement Chloride A measurement of the chloride in a biological specimen. Chloride Measurement Clarity A measurement of the transparency of a biological specimen. Clarity Measurement Chloride Clearance A measurement of the volume of serum or plasma that would be cleared of chloride by excretion of urine for a specified unit of time (e.g. one minute). Chloride Clearance Measurement Chloride/Creatinine A relative measurement (ratio or percentage) of the chloride to creatinine in a biological specimen. Chloride to Creatinine Ratio Measurement Calcitonin A measurement of the calcitonin hormone in a biological specimen. Calcitonin Measurement Calcitriol A measurement of the calcitriol hormone in a biological specimen. Calcitriol Measurement Columnar Epi Cells/Non-Squam Epi Cells A relative measurement (ratio or percentage) of the columnar epithelial cells to non-squamous epithelial cells in a biological specimen. Columnar Epithelial Cells to Non-Squamous Epithelial Cells Ratio Measurement Chloride Excretion Rate A measurement of the amount of chloride being excreted in a biological specimen over a defined period of time (e.g. one hour). Chloride Excretion Rate Clonazepam A measurement of the clonazepam present in a biological specimen. Clonazepam Measurement Clobazam cloBAZam A measurement of the clobazam in a biological specimen. Clobazam Measurement Clostebol A measurement of the clostebol in a biological specimen. Clostebol Measurement Alpha Angle Alpha-Angle Clot Formation Alpha Angle A measurement of the angle of incline (tangent at 20mm and the midline) during the rising phase of the thromboelastogram curve, during the clot formation process. Clot Formation Alpha Angle Measurement Clot Amplitude Clot Firmness A measurement of the firmness of a clot. Clot Firmness Measurement Maximum Clot Amplitude Maximum Clot Firmness A measurement of the maximum firmness of a clot. Maximum Clot Firmness Measurement CFT Clot Formation Time A measurement of the elapsed time from the start of clot formation to the point at which the clot reaches a firmness of 20mm. Clot Formation Time Measurement Clot Initiation Time Clotting Time CT A measurement of the elapsed time from the addition of the clot activating agent to the start of clot formation. Clot Initiation Time Measurement Clot LI Clot Lysis Index A relative measurement (percentage) of remaining clot stability in relation to the maximum clot firmness value at some time point after clot initiation time. Clot Lysis Index Maximum Clot Lysis Maximum Lysis A relative measurement (percentage) of the decrease in amplitude of the waveform at rotational thromboelastometry test completion. Maximum Clot Lysis Measurement Clot Retraction Clot Retraction, Qualitative A qualitative assessment of clot retraction in a biological specimen. Qualitative Clot Retraction Measurement Clot Retraction Time A measurement of the amount of time it takes for a clot to retract, or pull away from, the wall of a glass collection container. Clot Retraction Time Measurement Chlorphentermine A measurement of the chlorphentermine in a biological specimen. Chlorphentermine Measurement Chlordiazepoxide A measurement of the chlordiazepoxide present in a biological specimen. Chlordiazepoxide Measurement Clorazepate A measurement of the clorazepate present in a biological specimen. Clorazepate Measurement Clot Lysis Time ECLT ELT Euglobulin Clot Lysis Time Euglobulin Lysis Time A measurement of the amount of time it takes for dissolution of a fibrin clot in a biological specimen. Euglobulin Clot Lysis Time Clue Cells A measurement of the clue cells in a biological specimen. Clue Cell Count Clonazepam and/or Metabolites A measurement of the clonazepam and/or its metabolite(s) present in a biological specimen, for an assay that can measure both clonazepam and its metabolites. Clonazepam and/or Metabolites Measurement Carbon Monoxide A measurement of the carbon monoxide in a specimen. Carbon Monoxide Measurement Cytidine-Uridine Monophosphate Kinase 2 Cytidine/Uridine Monophosphate Kinase 2 A measurement of the cytidine-uridine monophosphate kinase 2 in a biological specimen. Cytidine-Uridine Monophosphate Kinase 2 Measurement Ciliary Neurotrophic Factor A measurement of the ciliary neurotrophic factor in a biological specimen. Ciliary Neurotrophic Factor Measurement Carbon Dioxide A measurement of the carbon dioxide gas in a biological specimen. Carbon Dioxide Measurement CI Coagulation Index A measurement of the efficiency of coagulation of a biological specimen. This is calculated by a mathematical formula that takes into account the R value, K value, angle and maximum amplitude of clot formation. Coagulation Index Measurement Cocaine and/or Metabolites A measurement of the cocaine and/or its metabolite(s) present in a biological specimen, for an assay that can measure both cocaine and its metabolites. Cocaine And/Or Metabolites Measurement Cocaethylene Cocaine Ethyl A measurement of the cocaethylene present in a biological specimen. Cocaethylene Measurement Cocaine A measurement of the cocaine present in a biological specimen. Cocaine Measurement Cocaine Metabolites A measurement of any cocaine drug class metabolite(s) present in a biological specimen. Cocaine Metabolites Measurement Cocaine Benzoylecgonine Ecgonine A measurement of the cocaine, benzoylecgonine, and/or ecgonine in a biological specimen. Cocaine, Benzoylecgonine, and/or Ecgonine Measurement Codeine A measurement of the codeine present in a biological specimen. Codeine Measurement Collagen Type IV A measurement of the collagen type IV in a biological specimen. Collagen Type IV Measurement Color A measurement of the color of a biological specimen. Color Assessment Cartilage Oligomeric Matrix Protein A measurement of the cartilage oligomeric matrix protein in a biological specimen. Cartilage Oligomeric Matrix Protein Measurement Urine Conductivity A measurement of the urine conductivity which is a non-linear function of the electrolyte concentration in the urine. Urine Conductivity Consistency A description about the firmness or make-up of an entity. Consistency Copeptin A measurement of the copeptin in a biological specimen. Copeptin Measurement Copper Cu A measurement of copper in a biological specimen. Copper Measurement Coenzyme Q10 Ubiquinone 10 A measurement of the ubiquinone 10 in a biological specimen. Ubiquinone 10 Measurement Cortisol/Creatinine A relative measurement (ratio or percentage) of the cortisol to creatinine present in a sample. Cortisol to Creatinine Ratio Measurement Cortisol, Free A measurement of the free, unbound cortisol in a biological specimen. Free Cortisol Measurement Cortisol Total Cortisol A measurement of the cortisol in a biological specimen. Cortisol Measurement Alpha Cortol alpha-Cortol A measurement of the alpha cortol in a biological specimen. Alpha Cortol Measurement Alpha Cortolone alpha-Cortolone A measurement of the alpha cortolone in a biological specimen. Alpha Cortolone Measurement Cotinine A measurement of the cotinine in a biological specimen. Cotinine Measurement Cotinine, Free A measurement of the free (unbound) cotinine in a specimen. Free Cotinine Measurement Calprotectin Neo-epitope CPa9-HNE CPa9-HNE Human Neutrophil Elastase-Degraded Calprotectin Neo-epitope CPa9-HNE A measurement of the human neutrophil elastase-degraded calprotectin neo-epitope CPa9-HNE in a biological specimen. Human Neutrophil Elastase-Degraded Calprotectin Neo-epitope CPa9-HNE Measurement Carboxypeptidase B2 CPU PCPB TAFI A measurement of the carboxypeptidase B2 in a biological specimen. Carboxypeptidase B2 Measurement C-peptide/Creatinine A relative measurement (ratio or percentage) of the C-peptide to creatinine in a biological specimen. C-peptide to Creatinine Ratio Measurement C-Peptide Excretion Rate A measurement of the amount of C-peptide being excreted in a biological specimen over a defined amount of time (e.g. one hour). C-Peptide Excretion Rate C-peptide A measurement of the C (connecting) peptide of insulin in a biological specimen. C-peptide Measurement Carbamazepine A measurement of the carbamazepine in a biological specimen. Carbamazepine Measurement Creatinine A measurement of the creatinine in a biological specimen. Creatinine Measurement Creatinine Clearance A measurement of the volume of serum or plasma that would be cleared of creatinine by excretion of urine for a specified unit of time (e.g. one minute). Creatinine Clearance Creatinine Excretion Rate A measurement of the amount of creatinine being excreted in a biological specimen over a defined amount of time (e.g. one hour). Creatinine Excretion Rate Crenated Cells A measurement of the crenated cells in a biological specimen. Crenated Cell Measurement Corticotropin Releasing Factor Corticotropin Releasing Hormone A measurement of the corticotropin releasing hormone in a biological specimen. Corticotropin Releasing Hormone Measurement Caeruloplasmin Ceruloplasmin A measurement of ceruloplasmin in a biological specimen. Ceruloplasmin Measurement Carnitine Esters A measurement of the total carnitine esters in a biological specimen. Carnitine Ester Measurement Crotonaldehyde A measurement of the crotonaldehyde in a specimen. Crotonaldehyde Measurement C Reactive Protein A measurement of the C reactive protein in a biological specimen. C-Reactive Protein Measurement C-Reactive Protein Metabolite CRPM A measurement of the C-reactive protein metabolite, an MMP-generated neoepitope of C-reactive protein (CRP), in a biological specimen. C-Reactive Protein Metabolite Measurement Carisoprodol A measurement of the carisoprodol in a biological specimen. Carisoprodol Measurement Creatinine Clearance Adjusted for BSA A measurement of the volume of serum or plasma that would be cleared of creatinine by excretion of urine for a specified unit of time (e.g. one minute), adjusted for body surface area. Creatinine Clearance Adjusted for BSA Creatinine Clearance, Estimated An estimate of the volume of serum or plasma that would be cleared of creatinine by excretion of urine for a specified unit of time (e.g. one minute). Estimated Creatinine Clearance Corticosterone/Creatinine A relative measurement (ratio or percentage) of the corticosterone to creatinine present in a sample. Corticosterone to Creatinine Ratio Measurement Cortisol, Free Excretion Rate A measurement of the amount of free cortisol being excreted in a biological specimen over a defined amount of time (e.g. one hour). Free Cortisol Excretion Rate Carotene A measurement of the total carotenes in a biological specimen. Carotene Measurement Corticosterone A measurement of corticosterone in a biological specimen. Corticosterone Measurement Cryoglobulin Volume/Serum Volume A relative measurement (ratio or percentage) of the volume of cryoglobulin to total serum volume in a biological specimen. Cryoglobulin Volume to Serum Volume Ratio Measurement Cryofibrinogen A measurement of the cryofibrinogen in a biological specimen. Cryofibrinogen Measurement Cryoglobulin A measurement of cryoglobulin in a biological specimen. Cryoglobulin Measurement Crystals Crystals Absent Indicator An indication that crystals were looked for and not found in a biological specimen. Crystal Absent Indicator Bacterial Casts A measurement of the bacterial casts present in a biological specimen. Bacterial Cast Measurement Broad Casts A measurement of the broad casts in a biological specimen. Broad Casts Measurement Cellular Casts A measurement of the cellular (white blood cell, red blood cell, epithelial and bacterial) casts present in a biological specimen. Cellular Cast Measurement Cylindroid Casts Cylindroid Pseudocasts A measurement of cylindroid casts (casts with a tapering end) in a biological specimen. Cylindroid Cast Measurement Epithelial Casts A measurement of the epithelial cell casts present in a biological specimen. Epithelial-Cast Measurement 846-Epitope Aggrecan Chondroitin Sulfate Epitope 846 Chondroitin Sulfate Epitope 846 Chondroitin Sulfate Proteoglycan 1 Epitope 846 CS846 A measurement of the 846 epitope present on the chondroitin sulfate chains of aggrecan in a biological specimen. Aggrecan Chondroitin Sulfate Epitope 846 Measurement Renal Epithelial Casts A measurement of the renal epithelial cell casts in a biological specimen. Renal Epithelial Casts Measurement Renal Tubular Epithelial Casts A measurement of the renal tubular epithelial cell casts in a biological specimen. Renal Tubular Epithelial Casts Measurement Fatty Casts A measurement of the fatty casts present in a biological specimen. Fatty Cast Measurement CSF IgG Index CSF Index IgG Index A relative measurement (ratio) of the IgG to albumin in cerebrospinal fluid to the IgG to albumin in serum. IgG Index Granular Casts A measurement of the granular (coarse and fine) casts present in a biological specimen. Granular Cast Measurement Granular Coarse Casts A measurement of the coarse granular casts present in a biological specimen. Coarse Granular Cast Measurement Granular Fine Casts A measurement of the fine granular casts present in a biological specimen. Granular Fine Cast Measurement Hyaline Casts A measurement of the hyaline casts present in a biological specimen. Hyaline Cast Measurement Hyalogranular Casts A measurement of the hyalogranular casts in a biological specimen. Hyalogranular Casts Mixed Casts A measurement of the mixed (the cast contains a mixture of cell types) casts present in a biological specimen. Mixed Cast Count Non-Hyalin Casts Non-Hyaline Casts Pathologic Casts A measurement of the pathologic (non-hyaline) casts present in a biological specimen. Pathologic Cast Measurement Pigment Casts Pigmented Casts A measurement of the pigment casts present in a biological specimen. Pigment Cast Measurement Erythrocyte Casts RBC Casts A measurement of the red blood cell casts present in a biological specimen. Red Blood Cell Cast Measurement Unclassified Casts A measurement of the unclassifiable casts present in a biological specimen. Unclassified Cast Measurement Waxy Casts A measurement of the waxy casts present in a biological specimen. Waxy Cell Cast Measurement WBC Casts A measurement of the white blood cell casts present in a biological specimen. White Blood Cell Cast Measurement Circulating Tumor Cells A measurement of the circulating tumor cells in a biological specimen. Circulating Tumor Cell Count Circulating Tumor Cells, Apoptotic A measurement of the apoptotic circulating tumor cells in a biological specimen. Apoptotic Circulating Tumor Cell Count Catecholamines A measurement of the total catecholamines in a biological specimen. Catecholamine Measurement Circulating Tumor Cells, Traditional A measurement of the traditional circulating tumor cells in a biological specimen. Traditional Circulating Tumor Cell Count Cellular Communication Network Factor 2 CN2 Connective Tissue Growth Factor IGFBP8 A measurement of the connective tissue growth factor in a biological specimen. Connective Tissue Growth Factor Measurement Citrulline/Creatinine A relative measurement (ratio or percentage) of the citrulline to creatinine in a biological specimen. Citrulline to Creatinine Ratio Measurement Citalopram A measurement of the citalopram present in a biological specimen. Citalopram Measurement Desmethyl Citalopram Desmethylcitalopram Norcitalopram A measurement of the desmethylcitalopram in a biological specimen. Desmethylcitalopram Measurement Di-Desmethylcitalopram A measurement of the di-desmethylcitalopram in a biological specimen. Di-Desmethylcitalopram Measurement Cotinine Glucuronide Cotinine N-B-D-Glucuronide Cotinine N-beta-D-Glucuronide Cotinine-Glucuronide Cotinine-N-Glucuronide A measurement of the cotinine glucuronide in a specimen. Cotinine Glucuronide Measurement Complement Total Total Hemolytic Complement A measurement of the total complement in a biological specimen. Complement Measurement Cathepsin D A measurement of the cathepsin D in a biological specimen. Cathepsin D Measurement C-Terminal Telopeptide of Type I Collagen Type I Collagen C-Telopeptides Type I Collagen X-linked C-telopeptide A measurement of the type I collagen cross-linked C-telopeptides in a biological specimen. Type I Collagen C-Telopeptide Measurement B-CTx Beta Isomer of C-Terminal Telopeptide of Type I Collagen Beta-CrossLaps Type I Collagen C-Telopeptides Beta A measurement of the beta isomer of type I collagen cross-linked C-telopeptides in a biological specimen. Beta Isomer of C-Terminal Telopeptide of Type I Collagen Measurement Type I Collagen C-Telopeptides/Creat Type I Collagen X-Linked C-Telopeptides/Creatinine A relative measurement (ratio or percentage) of the type I collagen cross-linked C-telopeptides to creatinine in a biological specimen. Type I Collagen C-Telopeptide to Creatinine Ratio Measurement Type II Collagen C-Telopeptides Type II Collagen X-Linked C-Telopeptides A measurement of the type II collagen cross-linked C-telopeptides in a biological specimen. Type II Collagen C-Telopeptide Measurement Type II Collagen C-Telopeptides/Creat Type II Collagen X-Linked C-Telopeptides/Creatinine A relative measurement (ratio or percentage) of the type II collagen cross-linked C-telopeptides to creatinine in a biological specimen. Type II Collagen C-Telopeptides to Creatinine Ratio Measurement Cross-Linked C-telopeptide of Type III Collagen Type III Collagen C-Telopeptides Type III Collagen X-Linked C-Telopeptides A measurement of the type III collagen cross-linked C-telopeptides in a biological specimen. Type III Collagen Cross-Linked C-Telopeptide Measurement Chemokine (C-X3-C motif) Ligand 1 Fractalkine Neurotactin A measurement of the chemokine (C-X3-C motif) ligand 1 in a biological specimen. Chemokine (C-X3-C Motif) Ligand 1 Measurement Chemokine (C-X-C Motif) Ligand 1 GRO Alpha GRO/KC GRO1 GROA Growth-Regulated Alpha Protein Melanoma Growth Stimulating Activity, Alpha A measurement of the CXCL1, chemokine (C-X-C motif) ligand 1, in a biological specimen. Chemokine (C-X-C Motif) Ligand 1 Measurement Chemokine (C-X-C Motif) Ligand 10 Interferon Gamma-induced Protein 10 Interferon-inducible Protein-10 IP-10 Small-inducible Cytokine B10 A measurement of the CXCL10, chemokine (C-X-C motif) ligand 10, in a biological specimen. Chemokine (C-X-C Motif) Ligand 10 Measurement Chemokine (C-X-C Motif) Ligand 11 I-TAC IFN-inducible T Cell Alpha Chemoattractant ITAC A measurement of the chemokine (C-X-C motif) ligand 11 in a biological specimen. Chemokine (C-X-C Motif) Ligand 11 Measurement Chemokine (C-X-C Motif) Ligand 12 IRH PBSF SCYB12 SDF1 SDF1A SDF1B Stromal Cell-Derived Factor-1 Alpha Stromal Cell-Derived Factor-1 Beta TLSF TPAR1 A measurement of the CXCL12, chemokine (C-X-C motif) ligand 12, in a biological specimen. Chemokine (C-X-C Motif) Ligand 12 Measurement B Lymphocyte Chemoattractant Chemokine (C-X-C Motif) Ligand 13 A measurement of the CXCL13, chemokine (C-X-C motif) ligand 13, in a biological specimen. Chemokine (C-X-C Motif) Ligand 13 Measurement Chemokine (C-X-C Motif) Ligand 2 GRO Beta GRO2 MIP2-Alpha A measurement of the CXCL2, chemokine (C-X-C motif) ligand 2, in a biological specimen. Chemokine (C-X-C Motif) Ligand 2 Measurement Chemokine (C-X-C Motif) Ligand 3 GRO Gamma Macrophage Inflammatory Protein 2-Beta MIP2 Beta MIP2B A measurement of the CXCL3, chemokine (C-X-C motif) ligand 3, in a biological specimen. Chemokine (C-X-C Motif) Ligand 3 Measurement Chemokine (C-X-C Motif) Ligand 4 Oncostatin A Platelet Factor 4 PLF4 A measurement of the CXCL4, chemokine (C-X-C motif) ligand 4, in a biological specimen. Chemokine (C-X-C Motif) Ligand 4 Measurement Chemokine (C-X-C Motif) Ligand 6 GCP2 Granulocyte Chemotactic Protein 2 A measurement of the CXCL6, chemokine (C-X-C motif) ligand 6, in a biological specimen. Chemokine (C-X-C Motif) Ligand 6 Measurement B-TG1 Beta-TG Chemokine (C-X-C Motif) Ligand 7 CTAP-III CTAP3 CTAPIII LA-PF4 LDGF MDGF NAP-2 Neutrophil-Activating Peptide 2 PBP PPBP Pro-Platelet Basic Protein SCYB7 TC1 TC2 TGB TGB1 THBGB THBGB1 A measurement of the pro-platelet basic protein in a biological specimen. Chemokine (C-X-C Motif) Ligand 7 Measurement Chemokine (C-X-C Motif) Ligand 9 CMK crg-10 Humig MIG Monokine Induced by Gamma Interferon SCYB9 A measurement of the CXCL9, chemokine (C-X-C motif) ligand 9, in a biological specimen. Chemokine (C-X-C Motif) Ligand 9 Measurement Chemokine (C-X-C Motif) Receptor 3 CXCR3 GPR9 Soluble CD183 A measurement of the CXCR3, chemokine (C-X-C motif) receptor 3, in a biological specimen. Chemokine Receptor CXCR3 Measurement Chemokine (C-X-C Motif) Receptor 4 LPS-Associated Protein 3 Soluble CD184 Stromal Cell-Derived Factor 1 Receptor A measurement of the CXCR4, chemokine (C-X-C motif) receptor 4, in a biological specimen. C-X-C Chemokine Receptor Type 4 Measurement Acid Ammonium Urate Crystals Ammonium Biurate Crystals Ammonium Urate Crystals A measurement of the ammonium biurate crystals present in a biological specimen. Ammonium Biurate Crystals Measurement Ammonium Oxalate Crystals A measurement of the ammonium oxalate crystals in a biological specimen. Ammonium Oxalate Crystal Measurement Amorphous Crystals A measurement of the amorphous (Note: phosphate or urate, depending on pH) crystals present in a biological specimen. Amorphous Crystal Measurement Amorphous Phosphate Crystals A measurement of the amorphous phosphate crystals in a biological specimen. Amorphous Phosphate Crystals Measurement Amorphous Urate Crystals A measurement of the amorphous urate crystals in a biological specimen. Amorphous Urate Crystals Measurement Bilirubin Crystals A measurement of the bilirubin crystals present in a biological specimen. Bilirubin Crystal Measurement Calcium Carbonate Crystals A measurement of the calcium carbonate crystals present in a biological specimen. Calcium Carbonate Crystal Measurement Calcium Oxalate Crystals A measurement of the calcium oxalate crystals present in a biological specimen. Calcium Oxalate Crystal Measurement Calcium Phosphate Crystals A measurement of the calcium phosphate crystals present in a biological specimen. Calcium Phosphate Crystal Measurement Calcium Sulfate Crystals A measurement of the calcium sulfate crystals present in a biological specimen. Calcium Sulfate Crystals Measurement Cholesterol Crystals A measurement of the cholesterol crystals present in a biological specimen. Cholesterol Crystal Measurement Charcot Leyden Crystals Charcot-Leyden Crystals CLC Galectin-10 Crystals A measurement of the Charcot-Leyden crystals present in a biological specimen. Charcot-Leyden Crystal Measurement Cystine Crystals A measurement of the cystine crystals present in a biological specimen. Cystine Crystal Measurement Dicalcium Phosphate Crystals A measurement of dicalcium phosphate crystals in a biological specimen. Dicalcium Phosphate Crystals Measurement Drug Crystals A measurement of the drug crystals in a biological specimen. Drug Crystal Measurement 2-Cyanoethmercapturate 2-Cyanoethyl Mercapturic Acid 2-Cyanoethylmercapturic Acid CEMA A measurement of the 2-cyanoethyl mercapturic acid in a specimen. 2-Cyanoethyl Mercapturic Acid Measurement 2-Cyanoethyl Mercapturate Cysteine 2-Cyanoethyl Mercapturic Acid Cysteine 2-Cyanoethylmercapturic Acid Cysteine 2-CyEMA N-Acetyl-S-(2-Cyanoethyl)-L-Cysteine A measurement of the 2-cyanoethyl mercapturic acid cysteine in a specimen. 2-Cyanoethyl Mercapturic Acid Cysteine Measurement Cytokeratin 18 Fragment A measurement of the cytokeratin 18 fragment in a biological specimen. Cytokeratin 18 Fragment Measurement CYFRA21-1 Cytokeratin 19 Fragment 21-1 A measurement of the cytokeratin 19 fragment 21-1 in a biological specimen. Cytokeratin 19 Fragment 21-1 Measurement Hemoglobin C Crystals A measurement of hemoglobin C crystals in a biological specimen. Hemoglobin C Crystals Measurement Hippurate Crystals Hippuric Acid Crystals A measurement of the hippuric acid crystals present in a biological specimen. Hippuric Acid Crystal Measurement Leucine Crystals A measurement of the leucine crystals present in a biological specimen. Leucine Crystal Measurement Monosodium Urate Crystals Sodium Urate Crystals A measurement of the monosodium urate crystals present in a biological specimen. Monosodium Urate Crystal Measurement Cytochrome P450 2A6 A measurement of the cytochrome P450 2A6 enzyme in a specimen. Cytochrome P450 2A6 Measurement Cytochrome P450 2C9 A measurement of the cytochrome P450 2C9 enzyme in a biological specimen. Cytochrome P450 2C9 Measurement Phosphate Crystals A measurement of the total phosphate crystals in a biological specimen. Phosphate Crystals Measurement Cystatin C/Creatinine A relative measurement (ratio or percentage) of the cystatin C to creatinine present in a sample. Cystatin C to Creatinine Ratio Measurement CysLTR1 Cysteinyl Leukotriene Receptor 1 A measurement of the cysteinyl leukotriene receptor 1 in a biological specimen. Cysteinyl Leukotriene Receptor 1 Measurement Starch Crystals Starch Granules A measurement of the starch crystals in a biological specimen. Starch Crystal Measurement CPI-B Cystatin B A measurement of the cystatin B in a biological specimen. Cystatin B Measurement Cystatin C A measurement of the cystatin C in a biological specimen. Cystatin C Measurement Cysteine A measurement of the cysteine in a biological specimen. Cysteine Measurement Cystathionine A measurement of the cystathionine in a biological specimen. Cystathionine Measurement Cystine A measurement of the cystine in a biological specimen. Cystine Measurement Sulfa Crystals Sulfonamide Crystals A measurement of the sulfa crystals present in a biological specimen. Sulfa Crystal Measurement Ammonium Magnesium Phosphate Crystals Struvite Crystals Triple Phosphate Crystals A measurement of the triple phosphate crystals present in a biological specimen. Triple Phosphate Crystal Measurement Tyrosine Crystals A measurement of the tyrosine crystals present in a biological specimen. Tyrosine Crystal Measurement Unclassified Crystals A measurement of the unclassifiable crystals present in a biological specimen. Unclassified Crystal Measurement Uric Acid Crystals A measurement of the uric acid crystals (including acid urate and urate crystals) present in a biological specimen. Uric Acid Crystal Measurement DAGs Diacylglycerol Diacylglycerols Diglycerides A measurement of the diacylglycerol in a biological specimen. Diacylglycerol Measurement 5-Aminolevulinic Acid 5ALA dALA Delta Aminolevulinate Delta Aminolevulinic Acid A measurement of the delta aminolevulinic acid in a biological specimen. Delta Aminolevulinate Measurement Delta Aminolevulinate/Creatinine A relative measurement (ratio or percentage) of the delta aminolevulinate to creatinine in a biological specimen. Delta Aminolevulinate to Creatinine Ratio Measurement Deoxycholate Deoxycholic Acid A measurement of the deoxycholate in a biological specimen. Deoxycholate Measurement C10 Decanoylcarnitine A measurement of the decanoylcarnitine in a biological specimen. Decanoylcarnitine Measurement D-Dimer A measurement of the d-dimers in a biological specimen. D-Dimer Measurement Anti-Double Stranded DNA IgG A measurement of the double stranded DNA IgG antibody in a biological specimen. Anti-Double Stranded DNA IgG Measurement DEAD Box Protein 58 DExD/H-Box Helicase 58 Probable ATP-Dependent RNA Helicase DDX58 A measurement of the DEAD box protein 58 in a biological specimen. DEAD Box Protein 58 Measurement DCN Decorin A measurement of the decorin in a biological specimen. Decorin Measurement Density A measurement of the compactness of a biological specimen expressed in mass per unit volume. Density Desipramine A measurement of the desipramine in a biological specimen. Desipramine Measurement DES Desmosine A measurement of the desmosine in a specimen. Desmosine Measurement Diethylpropion A measurement of the diethylpropion in a biological specimen. Diethylpropion Measurement DNA Fragmentation Index A measurement of the deoxyribonucleic acid fragmentation within the nucleated cells of a biological specimen. DNA Fragmentation Index Degenerated Leukocytes Degenerated WBC Degenerated White Blood Cells A measurement of the degenerated leukocytes (leukocytes that show deterioration in form or function) in a biological specimen. Degenerated Leukocyte Count Dehydroepiandrosterone Dehydroisoandrosterone A measurement of the dehydroepiandrosterone hormone in a biological specimen. Dehydroepiandrosterone Measurement Dehydroepiandrosterone Sulfate DHEA Sulfate DHEA-S sDHEA A measurement of the sulfated Dehydroepiandrosterone in a biological specimen. Sulfated DHEA Measurement 3,4-Dihydroxyphenylglycol 3.4 Dihydroxyphenylglycol A measurement of the catecholamine metabolite, 3,4-Dihydroxyphenylglycol in a biological specimen. 3,4-Dihydroxyphenylglycol Measurement Androstanolone Dihydrotestosterone A measurement of the dihydrotestosterone hormone in a biological specimen. Dihydrotestosterone Measurement 2,3-dihydroxypropyl Mercapturate 2,3-dihydroxypropyl Mercapturic Acid DHPMA A measurement of the 2,3-dihydroxypropyl mercapturic acid in a specimen. 2,3-dihydroxypropyl Mercapturic Acid Measurement Dihydrocodeine A measurement of the dihydrocodeine present in a biological specimen. Dihydrocodeine Measurement Dickkopf WNT Signaling Pathway Inhibitor 1 DKK-1 SK A measurement of the dickkopf WNT signaling pathway inhibitor 1 in a biological specimen. Dickkopf WNT Signaling Path Inhibitor 1 Measurement Dimethylglycine A measurement of the dimethylglycine in a biological specimen. Dimethylglycine Measurement Dimethyltryptamine DMT N,N-Dimethyltryptamine A measurement of the N,N-dimethyltryptamine in a biological specimen. N,N-Dimethyltryptamine Measurement Deoxyribonucleic Acid A measurement of a targeted deoxyribonucleic acid (DNA) in a biological specimen. Deoxyribonucleic Acid Measurement (+)-Norpseudoephedrine Cathine D-Norpseudoephedrine A measurement of the D-norpseudoephedrine in a biological specimen. D-Norpseudoephedrine Measurement Dohle Bodies A measurement of the Dohle bodies (blue-gray, basophilic, leukocyte inclusions located in the peripheral cytoplasm of neutrophils) in a biological specimen. Dohle Body Measurement 3,4-Dihydroxyphenylacetic Acid A measurement of the 3,4-dihydroxyphenylacetic acid in a biological specimen. 3,4-Dihydroxyphenylacetic Acid Measurement Dopamine Excretion Rate A measurement of the amount of dopamine being excreted in a biological specimen over a defined amount of time (e.g. one hour). Dopamine Excretion Rate Dopamine A measurement of the dopamine hormone in a biological specimen. Dopamine Measurement Desoxymethyltestosterone A measurement of the desoxymethyltestosterone in a biological specimen. Desoxymethyltestosterone Measurement Doxepin A measurement of the doxepin present in a biological specimen. Doxepin Measurement Doxepin and/or Metabolites A measurement of the doxepin and/or its metabolite(s) present in a biological specimen, for an assay that can measure both doxepin and its metabolites. Doxepin And/Or Metabolites Measurement Deoxypyridinoline A measurement of the deoxypyridinoline in a biological specimen. Deoxypyridinoline Measurement Deoxypyridinoline/Creatinine A relative measurement (ratio or percentage) of the deoxypyridinoline to creatinine in a biological specimen. Deoxypyridinoline to Creatinine Ratio Measurement Diphenoxylate A measurement of the diphenoxylate in a biological specimen. Diphenoxylate Measurement Dipipanone A measurement of the dipipanone in a biological specimen. Dipipanone Measurement Dipeptidyl Peptidase-4 A measurement of the dipeptidyl peptidase-4 in a biological specimen. Dipeptidyl Peptidase-4 Measurement Dromostanolone Drostanolone Medrosteron Medrotestron Metholone A measurement of the drostanolone in a biological specimen. Drostanolone Measurement Drug Screen An indication of the presence or absence of recreational drugs or drugs of abuse in a biological specimen. Drug Test dRVVT Screen to Confirm Pct Difference dRVVT Screen to Confirm Percent Difference A measurement to confirm the presence of Lupus anticoagulants, calculated as [(Screen dRVVT - Confirm dRVVT)/Screen dRVVT]x100. dRVVT Screen to Confirm Percent Difference Dilute Russell's Viper Venom Time Lupus Anticoagulant Test A measurement of the time it takes a plasma sample to clot after adding dilute Russell's viper venom. Dilute Russell's Viper Venom Time Measurement Dilute Russell's Viper Venom Time Ratio Lupus Anticoagulant Ratio A relative measurement of the dilute Russell's viper venom time in a subject sample to a control sample. Dilute Russell's Viper Venom Time to Control Ratio Measurement DRVVT Screen to Confirm Ratio A relative measurement (ratio) of the dilute Russell's viper venom time without the presence of excess phospholipid to the dRVVT in the presence of excess phospholipid. Dilute Russell's Viper Venom Time to Confirm Ratio Measurement Desvenlafaxine O-Desmethylvenlafaxine A measurement of the desvenlafaxine present in a biological specimen. Desvenlafaxine Measurement DTPA Clearance A measurement of the volume of serum or plasma that would be cleared of Diethylenetriamine pentaacetate (DTPA) by excretion of urine for a specified unit of time (e.g. one minute). Diethylene Triamine Pentaacetic Acid Clearance Duloxetine A measurement of the duloxetine in a biological specimen. Duloxetine Measurement DU-PAN-2 Duke Pancreatic Monoclonal Antigen Type 2 DUPAN-2 A measurement of the DU-PAN-2 antigen in a biological specimen. Duke Pancreatic Monoclonal Antigen Type 2 Measurement 11-Deoxycorticoids 11-Deoxycorticosteroid 11-Deoxycorticosteroids A measurement of the total 11-deoxycorticosteroids in a biological specimen. 11-Deoxycorticosteroid Measurement 11-Deoxycortisol A measurement of the 11-deoxycortisol in a biological specimen. 11-Deoxycortisol Measurement 21-Deoxycortisol A measurement of the 21-deoxycortisol in a biological specimen. 21-Deoxycortisol Measurement 11-Deoxycorticosterone 21-Hydroxyprogesterone Cortexone Deoxycortone Desoxycortone A measurement of the 11-deoxycorticosterone in a biological specimen. 11-Deoxycorticosterone Measurement 21-Deoxycorticosterone A measurement of the 21-deoxycorticosterone in a biological specimen. 21-Deoxycorticosterone Measurement Dystrophin A measurement of the total dystrophin in a biological specimen. Dystrophin Measurement Dystrophin Actual/Control Dystrophin Actual/Normal A relative measurement (ratio or percentage) of the dystrophin in a subject's specimen when compared to a control specimen. Dystrophin Actual to Control Ratio Measurement Diazepam A measurement of the diazepam present in a biological specimen. Diazepam Measurement E1S Estrone 3-Sulfate Estrone Sulfate A measurement of the estrone sulfate in a biological specimen. Estrone Sulfate Measurement EAG Estimated Average Glucose Glucose, Estimated Glucose, Estimated Average A computed estimate of the blood glucose based on the value of the glycated hemoglobin. Estimated Average Glucose Measurement Eccentrocytes A measurement of the eccentrocytes (erythrocytes in which the hemoglobin is localized to a particular portion of the cell, noticeable as localized staining) in a biological specimen. Eccentrocyte Count Eosinophil Cationic Protein Ribonuclease A Family Member 3 RNase 3 A measurement of the eosinophil cationic protein in a biological specimen. Eosinophil Cationic Protein Measurement Ecarin Clotting Time A measurement of the activity of thrombin inhibitors in a biological specimen based on the generation of meizothrombin. Ecarin Clotting Time Measurement 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine EDDP A measurement of the methadone metabolite 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine present in a biological specimen. EDDP Measurement Eosinophil Protein-X Eosinophil-Derived Neurotoxin RAF3 Ribonuclease A Family Member 2 A measurement of the eosinophil-derived neurotoxin in a biological specimen. Eosinophil-Derived Neurotoxin Measurement EDTA Clearance A measurement of the volume of serum or plasma that would be cleared of Ethylenediamine tetraacetic acid (EDTA) by excretion of urine for a specified unit of time (e.g. one minute). EDTA Clearance Epidermal Growth Factor A measurement of the epidermal growth factor in a biological specimen. Epidermal Growth Factor Measurement Epidermal Growth Factor Receptor ERBB1 HER1 A measurement of the epidermal growth factor receptor in a biological specimen. Epidermal Growth Factor Receptor Measurement Epidermal Growth Factor Receptor, Free A measurement of the free (unbound) epidermal growth factor receptor in a biological specimen. Free Epidermal Growth Factor Receptor Measurement Pancreatic Elastase 1 A measurement of the pancreatic elastase 1 in a biological specimen. Pancreatic Elastase Measurement Pancreatic Elastase 1, Polymorphonuclear A measurement of the polymorphonuclear pancreatic elastase 1 in a biological specimen. Polymorphonuclear Pancreatic Elastase Measurement Neutrophil Elastase A measurement of the neutrophil elastase in a biological specimen. Neutrophil Elastase Measurement Neutrophil Elastase, Polymorphonuclear A measurement of the polymorphonuclear neutrophil elastase in a biological specimen. Polymorphonuclear Neutrophil Elastase Measurement Elastin A measurement of the elastin in a biological specimen. Elastin Measurement Elliptocytes A measurement of the elliptocytes (elliptically shaped cell with blunt ends and a long axis twice the length of its short axis) in a biological specimen. Elliptocyte Count Elongator Acetyltransferase Complex Sub3 Elongator Acetyltransferase Complex Subunit 3 ELP-3 Protein Lysine Acetyltransferase ELP3 Proteinase-3 Degraded Elastin TRNA Uridine(34) Acetyltransferase A measurement of the elongator acetyltransferase complex subunit 3 in a biological specimen. Elongator Acetyltransferase Complex Subunit 3 Measurement Ethylamphetamine Etilamfetamine N-Ethylamphetamine A measurement of the ethylamphetamine in a biological specimen. Ethylamphetamine Measurement Epith Neutrophil-Activating Peptide 78 A measurement of the epithelial neutrophil-activating peptide in a biological specimen. Epithelial Neutrophil-Activating Peptide 78 Measurement Collagen Type XVIII Alpha 1 Chain Endostatin A measurement of the endostatin in a biological specimen. Endostatin Measurement Endothelin-1 A measurement of the endothelin-1 in a biological specimen. Endothelin-1 Measurement Endothelin-3 ET-3 A measurement of the endothelin-3 in a biological specimen. Endothelin-3 Measurement Extracell Newly Ident RAGE Bind Protein S100 Calcium Binding Protein A12 A measurement of the extracellular newly identified RAGE (receptor for advanced glycation end products) binding protein in a biological specimen. Extracell Newly Ident RAGE Bind Protein Measurement Eosinophils A measurement of the eosinophils in a biological specimen. Eosinophil Count Eosinophils Band Form A measurement of the banded eosinophils in a biological specimen. Eosinophil Band Form Count Eosinophils Band Form/Leukocytes A relative measurement (ratio or percentage) of the banded eosinophils to leukocytes in a biological specimen. Eosinophil Band Form to Leukocyte Ratio Eosinophils/Total Cells A relative measurement (ratio or percentage) of the eosinophils to total cells in a biological specimen (for example a bone marrow specimen). Eosinophils to Total Cell Ratio Measurement Immature Eosinophils A measurement of the immature eosinophils in a biological specimen. Immature Eosinophil Count Immature Eosinophils/Leukocytes A relative measurement (ratio or percentage) of immature eosinophils to total leukocytes in a biological specimen. Immature Eosinophil to Leukocyte Ratio Measurement Eosinophils/Leukocytes A relative measurement (ratio or percentage) of the eosinophils to leukocytes in a biological specimen. Eosinophil to Leukocyte Ratio Eosinophilic Metamyelocytes A measurement of the eosinphilic metamyelocytes in a biological specimen. Eosinophilic Metamyelocyte Count Eosinophilic Myelocytes A measurement of the eosinophilic myelocytes in a biological specimen. Eosinophilic Myelocyte Count Eosinophilic Myelocytes/Lymphocytes A relative measurement (ratio or percentage) of the eosinophilic myelocytes to lymphocytes in a biological specimen (for example a bone marrow specimen). Eosinophilic Myelocytes to Lymphocytes Ratio Measurement Eosinophils/Non-Squam Epi Cells A relative measurement (ratio or percentage) of the eosinophils to non-squamous epithelial cells in a biological specimen. Eosinophils to Non-Squamous Epithelial Cells Ratio Measurement Pseudo-Eosinophils A measurement of the pseudo-eosinophils in a biological specimen. Pseudo-Eosinophil Count Pseudo-Eosinophils/Leukocytes A relative measurement (ratio or percentage) of the pseudo-eosinophils to the leukocytes in a biological specimen. Pseudo-Eosinophils to Leukocyte Ratio Measurement Eosinophils, Segmented A measurement of the segmented eosinophils in a biological specimen. Segmented Eosinophil Count Chemokine Ligand 11 Eotaxin-1 A measurement of the eotaxin-1 in a biological specimen. Eotaxin-1 Measurement Chemokine Ligand 24 Eotaxin-2 A measurement of the eotaxin-2 in a biological specimen. Eotaxin-2 Measurement CCL26 Chemokine (C-C Motif) Ligand 26 Chemokine Ligand 26 Eotaxin-3 A measurement of the eotaxin-3 in a biological specimen. Eotaxin-3 Measurement Ephedrine A measurement of the ephedrine in a biological specimen. Ephedrine Measurement Epithelial Cells A measurement of the epithelial cells in a biological specimen. Epithelial Cell Count Epithelial Cells/Total Cells A relative measurement (ratio or percentage) of the epithelial cells to total cells in a biological specimen. Epithelial Cells to Total Cells Ratio Measurement Epithelial Cell Clumps A measurement of the epithelial cell clumps in a biological specimen. Epithelial Cell Clumps Measurement Adrenaline Epinephrine A measurement of the epinephrine hormone in a biological specimen. Epinephrine Measurement Epinephrine Excretion Rate A measurement of the amount of epinephrine being excreted in a biological specimen over a defined amount of time (e.g. one hour). Epinephrine Excretion Rate Non-Squamous Epithelial Cells A measurement of the non-squamous epithelial cells in a biological specimen. Non-Squamous Epithelial Cell Count Epi Cells/Non-Squam Epi Cells A relative measurement (ratio or percentage) of the epithelial cells to non-squamous epithelial cells in a biological specimen. Epithelial Cells to Non-Squamous Epithelial Cells Ratio Measurement Renal Epithelial Cells A measurement of the renal epithelial cells in a biological specimen. Renal Epithelial Cells Measurement Round Epithelial Cells A measurement of the round epithelial cells present in a biological specimen. Round Epithelial Cell Count Squamous Cells/Total Cells Squamous Epithelial Cells/Total Cells A relative measurement (ratio or percentage) of the squamous epithelial cells to total cells in a biological specimen. Squamous Epithelial Cells to Total Cells Ratio Measurement Squamous Cells Squamous Epithelial Cells A measurement of the squamous epithelial cells present in a biological specimen. Squamous Epithelial Cell Count Squamous Transitional Epithelial Cells A measurement of the squamous transitional epithelial cells present in a biological specimen. Squamous Transitional Epithelial Cell Count Transitional Epithelial Cells A measurement of the transitional epithelial cells present in a biological specimen. Transitional Epithelial Cells Measurement Renal Tubular Epithelial Cells Tubular Epithelial Cells A measurement of the tubular epithelial cells present in a biological specimen. Tubular Epithelial Cell Count Erythropoietin Hematopoietin A measurement of the erythropoietin hormone in a biological specimen. Erythropoietin Measurement BRESI1 Epithelial Stromal Interaction Protein 1 A measurement of the epithelial stromal interaction protein 1 in a biological specimen. Epithelial Stromal Interaction 1 Measurement Erythroid Cells A measurement of the erythroid cells in a biological specimen. Erythroid Cell Count Erythroid Cells/Total Cells A relative measurement (ratio or percentage) of the erythroid cells to total cells (total nucleated cells + erythrocytes + reticulocytes) in a biological specimen. Erythroid Cells to Total Cells Ratio Measurement Erythroid Maturation Index A relative measurement (ratio) of the sum of erythroid maturation phase cells (pool) to the sum of erythroid proliferative phase cells (pool) in a biological specimen. Erythroid Maturation Index Erythroid Maturation Pool A measurement of the erythroid maturation phase cells (polychromatic rubricytes, normochromic rubricytes, and metarubricytes) in a biological specimen. Erythroid Maturation Pool Count Erythroid Cells/Nucleated Cells A relative measurement (ratio or percentage) of the erythroid cells to total nucleated cells in a biological specimen. Erythroid Cells to Nucleated Cells Ratio Measurement Erythroid Proliferation Index A relative measurement (ratio) of the sum of erythroid proliferative phase cells (pool) to the sum of erythroid maturation phase cells (pool) in a biological specimen. Erythroid Proliferation Index Erythroid Proliferation Pool A measurement of the erythroid proliferative phase cells (rubriblasts, prorubricytes, and basophilic rubricytes) in a biological specimen. Erythroid Proliferation Pool Count Epiregulin EPR A measurement of the epiregulin in a biological specimen. Epiregulin Measurement Erythroferrone A measurement of the erythroferrone in a biological specimen. Erythroferrone Measurement Erythroid Precursor Cells Erythroid Precursors A measurement of the erythroid precursors in a biological specimen. Erythroid Precursor Cell Count Erythroid Precursor Cells/Total Cells Erythroid Precursors/Total Cells A relative measurement (ratio or percentage) of the erythroid precursors to total cells in a biological specimen. Erythroid Precursor Cells to Total Cells Ratio Measurement Escitalopram A measurement of the escitalopram in a biological specimen. Escitalopram Measurement E-Selectin A measurement of total E-selectin in a biological specimen. E-selectin Measurement sE-selectin Soluble E-Selectin A measurement of the soluble E-Selectin in a biological specimen. Soluble E-Selectin Measurement Biernacki Reaction Erythrocyte Sedimentation Rate The distance (e.g. millimeters) that red blood cells settle in unclotted blood over a specified unit of time (e.g. one hour). Erythrocyte Sedimentation Rate Measurement Estazolam A measurement of the estazolam in a biological specimen. Estazolam Measurement Estradiol, Free A measurement of the unbound estradiol in a biological specimen. Free Estradiol Measurement Estradiol, Free/Estradiol A relative measurement (ratio or percentage) of unbound estradiol to total estradiol in a biological specimen. Free Estradiol to Estradiol Ratio Measurement ER ESR Estrogen Receptor Oestrogen Receptor A measurement of estrogen receptor protein in a biological specimen. Estrogen Receptor Measurement Estradiol Oestradiol A measurement of the estradiol in a biological specimen. Estradiol Measurement Estriol Oestriol A measurement of the estriol hormone in a biological specimen. Estriol Measurement Estriol, Free Unconjugated Estriol A measurement of the free estriol in a biological specimen. Free Estriol Measurement Estrogen Oestrogen A measurement of the estrogen hormone in a biological specimen. Estrogen Measurement Estrone Oestrone A measurement of the estrone hormone in a biological specimen. Estrone Measurement Ethyl Glucuronide A measurement of the ethyl glucuronide in a biological specimen. Ethyl Glucuronide Measurement Ethyl Glucuronide Ethyl Sulfate A measurement of the ethyl glucuronide and/or ethyl sulfate in a biological specimen. Ethyl Glucuronide And Ethyl Sulfate Measurement Alcohol Ethanol A measurement of the ethanol present in a biological specimen. Ethanol Measurement Ethchlorvynol A measurement of the ethchlorvynol in a biological specimen. Ethchlorvynol Measurement Ethylestrenol A measurement of the ethylestrenol in a biological specimen. Ethylestrenol Measurement Ethinamate A measurement of the ethinamate in a biological specimen. Ethinamate Measurement Endogenous Thrombin Potential A measurement of the total concentration of thrombin generated in the presence of a substrate in a plasma or blood sample. Endogenous Thrombin Potential Measurement Endogenous Thrombin Potential Area Under Curve ETP Area Under Curve A measurement of the area under the thrombin generation curve. Endogenous Thrombin Potential Area Under Curve Measurement Endogenous Thrombin Potential Lag Time ETP Lag Time A measurement of time from the start of the thrombin generation test to the point where a predetermined amount of thrombin is generated. Endogenous Thrombin Potential Lag Time Measurement Endogenous Thrombin Potential Lag Time Relative ETP Lag Time Relative A relative measurement (ratio or percentage) of time from the start of the thrombin generation test to the point where a predetermined amount of thrombin is generated. Endogenous Thrombin Potential Lag Time Relative Measurement Endogenous Thrombin Potential Peak Height ETP Peak Height A measurement of the maximum concentration of thrombin generated during a thrombin generation test. Endogenous Thrombin Potential Peak Height Measurement Endogenous Thrombin Potential Peak Height Relative ETP Peak Height Relative A relative (ratio or percentage) of the maximum concentration of thrombin generated during a thrombin generation test. Endogenous Thrombin Potential Peak Height Relative Measurement Endogenous Thrombin Potential Time to Peak ETP Time to Peak A measurement of the time it takes to generate the maximum concentration of thrombin. Endogenous Thrombin Potential Time to Peak Measurement Endogenous Thrombin Potential Time to Peak Relative ETP Time to Peak Relative A relative (ratio or percentage) measurement of the time it takes to generate the maximum concentration of thrombin. Endogenous Thrombin Potential Time to Peak Relative Measurement Ethyl Sulfate A measurement of the ethyl sulfate in a biological specimen. Ethyl Sulfate Measurement Epimerized Ursodeoxycholate Epimerized Ursodeoxycholic Acid A measurement of the epimerized ursodeoxycholate in a biological specimen. Epimerized Ursodeoxycholate Measurement Ezogabine A measurement of the ezogabine in a biological specimen. Ezogabine Measurement FABP1 Fatty Acid Binding Protein 1 L-FABP L-Type Fatty Acid-Binding Protein Liver Fatty Acid-Binding Protein A measurement of the fatty acid binding protein 1 in a biological specimen. Fatty Acid Binding Protein 1 Measurement FABP-11 Fatty Acid Binding Protein 3 Fatty Acid Binding Protein 3, Muscle And Heart Fatty Acid Binding Protein, Heart H-FABP Heart-Type Fatty Acid-Binding Protein M-FABP A measurement of the fatty acid binding protein 3 in a biological specimen. Fatty Acid Binding Protein 3 Measurement A-FABP Adipocyte-Type Fatty Acid-Binding Protein Fatty Acid Binding Protein 4 Fatty Acid-Binding Protein, Adipocyte A measurement of the fatty acid binding protein 4 in a biological specimen. Fatty Acid Binding Protein 4 Measurement Factor II Prothrombin A measurement of the coagulation factor II in a biological specimen. Prothrombin Measurement Factor III Soluble CD142 Tissue Factor, CD142 A measurement of the coagulation factor III in a biological specimen. Factor III Measurement Christmas Factor Factor IX A measurement of the coagulation factor IX in a biological specimen. Factor IX Measurement Christmas Factor Activity Factor IX Activity A measurement of the biological activity of coagulation factor IX in a biological specimen. Factor IX Activity Measurement Factor V Labile Factor A measurement of the coagulation factor V in a biological specimen. Factor V Measurement Factor V Activity Labile Factor Activity A measurement of the biological activity of coagulation factor V in a biological specimen. Factor V Activity Measurement Factor VII Proconvertin Stable Factor A measurement of the coagulation factor VII in a biological specimen. Factor VII Measurement Factor VII Activity Proconvertin Activity Stable Factor Activity A measurement of the biological activity of coagulation factor VII in a biological specimen. Factor VII Activity Measurement Anti-hemophilic Factor Factor VIII A measurement of the coagulation factor VIII in a biological specimen. Factor VIII Measurement Factor V Leiden A measurement of the coagulation factor V Leiden in a biological specimen. Factor V Leiden Measurement von Willebrand Factor von Willebrand Factor Antigen A measurement of the von Willebrand coagulation factor in a biological specimen. von Willebrand Factor Measurement von Willebrand Factor Activity A measurement of the biological activity of von Willebrand coagulation factor in a biological specimen. von Willebrand Factor Activity Measurement von Willebrand Factor Multimers A measurement of the von Willebrand Factor multimers (an aggregate of multiple von Willebrand factor antigens that are held together with non-covalent bonds) in a biological specimen. von Willebrand Factor Multimers Measurement Factor X A measurement of the coagulation factor X in a biological specimen. Factor X Measurement Factor X Activity A measurement of the biological activity of coagulation factor X in a biological specimen. Factor X Activity Measurement Factor XI A measurement of the factor XI in a biological specimen. Factor XI Measurement Factor XI Activity Factor XIa Activity A measurement of the biological activity of coagulation factor XI in a biological specimen. Factor XI Activity Measurement Factor XII A measurement of the factor XII in a biological specimen. Factor XII Measurement Factor XII Activity A measurement of the biological activity of coagulation factor XII in a biological specimen. Factor XII Activity Measurement Factor XIII Fibrin Stabilizing Factor A measurement of the coagulation factor XIII in a biological specimen. Factor XIII Measurement Autoprothrombin IIA Factor XIV Protein C Protein C Antigen Protein C, Inactivator of Coagulation Factors Va and VIIIa A measurement of the coagulation factor XIV in a biological specimen. Factor XIV Measurement Factor XIV Activity Protein C Activity Protein C Function A measurement of the biological activity of coagulation factor XIV in a biological specimen. Factor XIV Activity Measurement Free Androgen Index A measurement of the androgen status in a biological specimen. This is calculated by a mathematical formula that takes into account the total testosterone level, sex hormone binding globulin, and a constant. Free Androgen Index ALPS1A APT1 Fas Cell Surface Death Receptor FAS1 FASTM Soluble CD95 TNF Receptor Superfamily Member 6 TNFRSF6 A measurement of the Fas cell surface death receptor in a biological specimen. Fas Cell Surface Death Receptor Measurement Fas Ligand Soluble CD178 Soluble CD95L Tumor Necrosis Factor Ligand Superfamily Member 6 A measurement of the Fas ligand in a biological specimen. Fas Ligand Measurement Fat A measurement of the fat in a biological specimen. Fat Measurement Free Fatty Acid Non-Esterified Fatty Acid, Free A measurement of the total non-esterified fatty acids in a biological specimen. Non-esterified Fatty Acids Measurement Free Fatty Acid, Saturated Non-esterified Fatty Acid, Saturated A measurement of the saturated non-esterified fatty acids in a biological specimen. Saturated Non-esterified Fatty Acids Measurement Free Fatty Acid, Unsaturated Non-esterified Fatty Acid, Unsaturated A measurement of the unsaturated non-esterified fatty acids in a biological specimen. Unsaturated Non-esterified Fatty Acids Measurement Fatty Acids, Very Long Chain A measurement of the very long chain fatty acids (containing 22 or more carbon atoms) in a biological specimen. Very Long Chain Fatty Acids Measurement Fat Bodies, Oval A measurement of the oval-shaped fat bodies, usually renal proximal tubular cells with lipid aggregates in the cytoplasm, in a biological specimen. Oval Fat Body Measurement Fat Droplet A measurement of the triglyceride aggregates within a biological specimen. Fat Droplet Measurement Fatty Liver Index FLI A calculation that indicates the likely presence of fatty liver disease, taking into account waist circumference, body mass index, triglyceride concentrations, and gamma-glutamyltransferase activity. (Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006 Nov 2;6:33.) Fatty Liver Index Fat/Total Solids A relative measurement (ratio or percentage) of the fat to total solid material in a biological specimen (for example a stool specimen). Fats to Total Solids Ratio Measurement Fibronectin, Cellular Insoluble Fibronectin A measurement of the cellular fibronectin in a biological specimen. Cellular Fibronectin Measurement Fibronectin, Fetal A measurement of the fetal isoform of fibronectin in a biological specimen Fetal Fibronectin Test Fibronectin, Maternal + Fetal A measurement of the maternal plasma fibronectin and fetal fibronectin in a biological specimen. Maternal and Fetal Fibronectin Measurement Fibronectin, Plasma Soluble Fibronectin A measurement of the plasma fibronectin in a biological specimen. Plasma Fibronectin Measurement FibroSURE Score FibroTest Score A biomarker test that measures liver pathology through the assessment of a six-parameter blood test (for Alpha-2-macroglobulin, Haptoglobin, Apolipoprotein A1, Gamma-glutamyl transpeptidase (GGT), Total bilirubin, and Alanine aminotransferase (ALT)), taking into account the age and sex of the patient. FibroTest Score Measurement Factor VIIa Activity A measurement of the biological activity of coagulation factor VIIa in a biological specimen. Factor VIIa Activity Measurement Anti-hemophilic Factor Activity Factor VIII Activity Factor VIII:C A measurement of the biological activity of coagulation factor VIII in a biological specimen. Factor VIII Activity Measurement Factor XIII Activity A measurement of the biological activity of coagulation factor XIII in a biological specimen. Factor XIII Activity Measurement Fibrin Degradation Products A measurement of the fibrin degradation products in a biological specimen. Fibrin Degradation Products Measurement Fractional Calcium Excretion A measurement of the fractional excretion of calcium that is computed based upon the concentrations of calcium and creatinine in both blood and urine. Fractional Excretion of Calcium Fractional Chloride Excretion A measurement of the fractional excretion of chloride that is computed based upon the concentrations of chloride and creatinine in both blood and urine. Fractional Excretion of Chloride Fractional Potassium Excretion A measurement of the fractional excretion of potassium that is computed based upon the concentrations of potassium and creatinine in both blood and urine. Fractional Excretion of Potassium Fractional Magnesium Excretion A measurement of the fractional excretion of magnesium that is computed based upon the concentrations of magnesium and creatinine in both blood and urine. Fractional Excretion of Magnesium 3-Methylfentanyl A measurement of the 3-methylfentanyl in a biological specimen. 3-Methylfentanyl Measurement Fractional Sodium Excretion A measurement of the fractional excretion of sodium that is computed based upon the concentrations of sodium and creatinine in both blood and urine. Fractional Excretion of Sodium Acetyl Fentanyl Acetylfentanyl A measurement of the acetylfentanyl in a biological specimen. Acetylfentanyl Measurement Alpha-Methylfentanyl A measurement of the alpha-methylfentanyl in a biological specimen. Alpha-Methylfentanyl Measurement Beta-Hydroxythiofentanyl A measurement of the beta-hydroxythiofentanyl in a biological specimen. Beta-Hydroxythiofentanyl Measurement Butyrfentanyl Butyryl Fentanyl Butyrylfentanyl A measurement of the butyrylfentanyl in a biological specimen. Butyrylfentanyl Measurement Fencamfamin Fencamfamine A measurement of the fencamfamin in a biological specimen. Fencamfamin Measurement Fenfluramine A measurement of the fenfluramine in a biological specimen. Fenfluramine Measurement Furanyl Fentanyl Furanylfentanyl A measurement of the furanylfentanyl in a biological specimen. Furanylfentanyl Measurement Para-Fluorofentanyl A measurement of the para-fluorofentanyl in a biological specimen. Para-Fluorofentanyl Measurement Fenproporex A measurement of the fenproporex in a biological specimen. Fenproporex Measurement Fentanyl A measurement of the fentanyl in a biological specimen. Fentanyl Measurement Valeryl Fentanyl Valerylfentanyl A measurement of the valerylfentanyl in a biological specimen. Valerylfentanyl Measurement Erythrocyte Protoporphyrin, Free A measurement of the free erythrocyte protoporphyrin (zinc bound plus unbound protoporphyrin) in a biological specimen. Free Erythrocyte Protoporphyrin Measurement Fractional Inorganic Phosphate Excretion Fractional Phosphorus Excretion A measurement of the fractional excretion of phosphorus that is computed based upon the concentrations of phosphorus and creatinine in both blood and urine. Fractional Excretion of Phosphate Ferritin A measurement of the ferritin in a biological specimen. Ferritin Measurement FGF 19 Fibroblast Growth Factor 19 A measurement of the fibroblast growth factor 19 in a biological specimen. Fibroblast Growth Factor 19 Measurement FGF 21 Fibroblast Growth Factor 21 A measurement of the fibroblast growth factor 21 in a biological specimen. Fibroblast Growth Factor 21 Measurement Fibroblast Growth Factor 23 Phosphatonin A measurement of the total fibroblast growth factor 23 in a biological specimen. Fibroblast Growth Factor 23 Measurement Fibroblast Growth Factor 23, C-Terminal A measurement of the C-terminal fibroblast growth factor 23 in a biological specimen. C-Terminal Fibroblast Growth Factor 23 Measurement Fibroblast Growth Factor 23, Intact A measurement of the intact fibroblast growth factor 23 in a biological specimen. Intact Fibroblast Growth Factor 23 Measurement FGF 9 Fibroblast Growth Factor 9 A measurement of the fibroblast growth factor 9 in a biological specimen. Fibroblast Growth Factor 9 Measurement FGF2 Fibroblast Growth Factor Basic Form A measurement of the basic form of fibroblast growth factor in a biological specimen. Fibroblast Growth Factor Basic Form Measurement FIB4 Fibrosis-4 Index A scoring system that evaluates liver pathology through the assessment of multiple blood test parameters, taking into account age, alanine aminotransferase, aspartate aminotransferase, and platelet count. Fibrosis-4 Score Vegetable Fiber Vegetable Fibers A measurement of the vegetable fiber in a biological specimen. Vegetable Fiber Measurement Fibrin Monomer Soluble Fibrin Monomer A measurement of the fibrin monomer in a biological specimen. Fibrin Monomer Measurement Fibrinogen Fibrinogen Antigen A measurement of the total fibrinogen (functional and non-functional) in a biological specimen. Fibrinogen Measurement Fibrinogen, Functional A measurement of the functional fibrinogen (fibrinogen that is capable of being converted to fibrin) in a biological specimen. Functional Fibrinogen Measurement FCN3 Ficolin-3 A measurement of the ficolin-3 in a biological specimen. Ficolin-3 Measurement Fraction of Inspired Oxygen A measurement of the volumetric fraction of oxygen in the inhaled gas. Fraction of Inspired Oxygen Factor IX Activity Actual/Control Factor IX Activity Actual/Factor IX Activity Control Factor IX Activity Actual/Normal A relative measurement (ratio or percentage) of the biological activity of factor IX dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. Factor IX Activity Actual to Control Ratio Measurement Flunitrazepam A measurement of the flunitrazepam present in a biological specimen. Flunitrazepam Measurement Flurazepam A measurement of the flurazepam present in a biological specimen. Flurazepam Measurement FMS-like Receptor Tyrosine Kinase 3 Soluble CD135 A measurement of the FMS-like receptor tyrosine kinase 3 in a biological specimen. FMS-like Receptor Tyrosine Kinase 3 Measurement FMS-like Tyrosine Kinase 3 Ligand A measurement of the FMS-like tyrosine kinase 3 ligand in a biological specimen. FMS-like Tyrosine Kinase 3 Ligand Measurement Fluid Output, Estimated An estimate of the total volume of fluid discharged over a set period of time. Estimated Fluid Output Fluid Output A measurement of the total volume of fluid discharged over a set period of time. Fluid Output Fluoride A measurement of the fluoride in a biological specimen. Fluoride Measurement Fluoxetine A measurement of the fluoxetine drug present in a biological specimen. Fluoxetine Measurement Norfluoxetine A measurement of the norfluoxetine in a biological specimen. Norfluoxetine Measurement Fluphenazine A measurement of the fluphenazine in a biological specimen. Fluphenazine Measurement Fluvoxamine A measurement of the fluvoxamine present in a biological specimen. Fluvoxamine Measurement Fluoxymesterone A measurement of the fluoxymesterone in a biological specimen. Fluoxymesterone Measurement Flunitrazepam and/or Metabolites A measurement of the flunitrazepam and/or its metabolite(s) present in a biological specimen, for an assay that can measure both flunitrazepam and its metabolites. Flunitrazepam and/or Metabolites Measurement Folate Hydrolase mRNA A measurement of the folate hydrolase mRNA in a biological specimen. Folate Hydrolase mRNA Measurement Formaldehyde Formic Aldehyde Methanal A measurement of the formaldehyde in a specimen. Formaldehyde Measurement Protoporphyrin, Free A measurement of the free protoporphyrin (unbound to iron in hemoglobin) in a biological specimen. Free Protoporphyrin Measurement Fractional Iron Absorption A relative measurement (ratio or percentage) of the iron absorbed into tissue or cells to the total available iron. Fractional Iron Absorption Glycated Ferritin A measurement of the glycated ferritin in a biological specimen. Glycated Ferritin Measurement Glycated Ferritin/Ferritin A relative measurement (ratio or percentage) of the glycated ferritin to total ferritin in a biological specimen. Glycated Ferritin to Ferritin Ratio Measurement Glycosylated Ferritin A measurement of the glycosylated ferritin in a biological specimen. Glycosylated Ferritin Measurement Glycosylated Ferritin/Ferritin A relative measurement (ratio or percentage) of the glycosylated ferritin to total ferritin in a biological specimen. Glycosylated Ferritin to Ferritin Ratio Measurement Apoferritin Ferritin Heavy Chain FTH FTH1 A measurement of the ferritin heavy chain in a biological specimen. Ferritin Heavy Chain Measurement Ferritin Light Chain FTL L Apoferritin A measurement of the ferritin light chain in a biological specimen. Ferritin Light Chain Measurement Fructosamine Glycated Serum Protein A measurement of the fructosamine in a biological specimen. Fructosamine Measurement Fructose A measurement of the fructose in a biological specimen. Fructose Measurement Fructosamine Corrected for Total Protein A measurement of fructosamine, which has been corrected for total protein, in a biological specimen. Fructosamine Corrected for Total Protein Measurement Flurazepam and/or Metabolites A measurement of the flurazepam and/or its metabolite(s) present in a biological specimen, for an assay that can measure both flurazepam and its metabolites. Flurazepam and/or Metabolites Measurement Follicle Stimulating Hormone A measurement of the follicle stimulating hormone (FSH) in a biological specimen. Follicle Stimulating Hormone Measurement Fungi Fungus A measurement of the fungi in a biological specimen. Fungi Measurement Fungi, Filamentous A measurement of the filamentous fungi in a biological specimen. Filamentous Fungi Count Fungi, Yeast-Like A measurement of the yeast-like fungi in a biological specimen. Yeast-Like Fungi Count Furazabol A measurement of the furazabol in a biological specimen. Furazabol Measurement Factor V Activity Actual/Control Factor V Activity Actual/Factor V Activity Control Factor V Activity Actual/Normal A relative measurement (ratio or percentage) of the biological activity of factor V dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. Factor V Activity Actual to Control Ratio Measurement Factor VII Activity Actual/Control Factor VII Activity Actual/Factor VII Activity Control Factor VII Activity Actual/Normal A relative measurement (ratio or percentage) of the biological activity of factor VII dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. Factor VII Activity Actual to Control Ratio Measurement Factor VIII Activity Actual/Control Factor VIII Activity Actual/Factor VIII Activity Control Factor VIII Activity Actual/Normal A relative measurement (ratio or percentage) of the biological activity of factor VIII dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. Factor VIII Activity Actual to Control Ratio Measurement Factor X Activity Actual/Control Factor X Activity Actual/Factor X Activity Control Factor X Activity Actual/Normal A relative measurement (ratio or percentage) of the biological activity of factor X dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. Factor X Activity Actual/Control Ratio Measurement Factor X Actual/Control Factor X Actual/Normal A relative measurement (ratio or percentage) of the factor X in a subject's specimen when compared to a control specimen. Factor X Actual to Control Ratio Measurement Factor XIV Activity Actual/Control Factor XIV Activity Actual/Factor XIV Activity Control Factor XIV Activity Actual/Normal Protein C Activity Actual/Control A relative measurement (ratio or percentage) of the biological activity of factor XIV dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. Factor XIV Activity Actual to Control Ratio Measurement Factor XIV Actual/Control Protein C Actual/Control A relative measurement (ratio or percentage) of the factor XIV in a subject's specimen when compared to a control specimen. Factor XIV Actual to Control Ratio Measurement Glucose-6-Phosphate Dehydrogenase A measurement of the glucose-6-phosphate dehydrogenase in a biological specimen. Glucose-6-Phosphate Dehydrogenase Measurement Glucose-6-Phosphate Dehydrogenase Act A measurement of the biological activity of glucose-6-phosphate dehydrogenase in a biological specimen. Glucose-6-Phosphate Dehydrogenase Activity G6PD-Deficient Erythrocytes A measurement of the glucose-6-phosphate dehydrogenase deficient erythrocytes in a biological specimen. G6PD-Deficient Erythrocytes Count G6PD-Deficient Erythrocytes/Erythrocytes A relative measurement (ratio or percentage) of G6PD-deficient erythrocytes to total erythrocytes in a biological specimen. G6PD-Deficient Erythrocytes to Erythrocytes Ratio Measurement Acid Alpha-Glucosidase Acid Maltase Alpha-1,4-glucosidase A measurement of the acid alpha-glucosidase in a biological specimen. Acid Alpha-Glucosidase Measurement Glutamic Acid Decarboxylase 1 Glutamic Acid Decarboxylase 67 A measurement of the glutamic acid decarboxylase 1 in a biological specimen. Glutamic Acid Decarboxylase 1 Measurement Glutamic Acid Decarboxylase 2 Glutamic Acid Decarboxylase 65 A measurement of the glutamic acid decarboxylase 2 in a biological specimen. Glutamic Acid Decarboxylase 2 Measurement Galactose A measurement of the galactose in a biological specimen. Galactose Measurement Galactose-1-Phosphate A measurement of the galactose-1-phosphate in a biological specimen. Galactose-1-Phosphate Measurement G1PUT Galactose 1 Phosphate Uridyl Transferase Galactose-1-Phos Uridylyltransferase Galactose-1-Phosphate Uridylyltransferase GALT A measurement of the galactose-1-phosphate uridyltransferase in a biological specimen. Galactose-1-Phosphate Uridyltransferase Measurement Galanin A measurement of the galanin in a biological specimen. Galanin Measurement Galactose Mutarotase A measurement of the galactose mutarotase in a biological specimen. Galactose Mutarotase Measurement GABA Gamma-aminobutyrate Gamma-Aminobutyric Acid A measurement of the gamma-aminobutyric acid in a biological specimen. Gamma-Aminobutyric Acid Measurement GAPDH Glyceraldehyde 3 Phosphate Dehydrogenase Glyceraldehyde-3-Phosphate Dehydrogenase A measurement of the glyceraldehyde-3-phosphate dehydrogenase in a biological specimen. Glyceraldehyde-3-Phosphate Dehydrogenase Measurement Gastrin A measurement of the gastrin hormone in a biological specimen. Gastrin Measurement Gamma Tocopherol A measurement of the gamma tocopherol in a biological specimen. Gamma Tocopherol Measurement Gb3 GL-3 GL3 Globotriaosylceramide sCD77 Soluble CD77 A measurement of the globotriaosylceramide in a biological specimen. Globotriaosylceramide Measurement Beta-Glucocerebrosidase GBA Glucocerebrosidase Beta Glucosylceramidase Glucosylceramidase Beta A measurement of the glucosylceramidase beta in a biological specimen. Glucosylceramidase Beta Measurement Guanylate Binding Protein 1 A measurement of the guanylate binding protein 1 in a biological specimen. Guanylate Binding Protein 1 Measurement Guanylate Binding Protein 2 A measurement of the guanylate binding protein 2 in a biological specimen. Guanylate Binding Protein 2 Measurement Glycochenodeoxycholate Glycochenodeoxycholic Acid A measurement of the glycochenodeoxycholate in a biological specimen. Glycochenodeoxycholate Measurement Cholylglycine Glycocholate Glycocholic Acid A measurement of the glycocholate in a biological specimen. Glycocholate Measurement Granulocyte Colony Stimulating Factor A measurement of the granulocyte colony stimulating factor in a biological specimen. Granulocyte Colony Stimulating Factor Measurement Ganglioside GD2 Lipoform C16:0 A measurement of the ganglioside GD2 lipoform C16:0 in a biological specimen. Ganglioside GD2 Lipoform C16:0 Measurement Ganglioside GD2 Lipoform C18:0 A measurement of the ganglioside GD2 lipoform C18:0 in a biological specimen. Ganglioside GD2 Lipoform C18:0 Measurement Ganglioside GD2 Lipoform C20:0 A measurement of the ganglioside GD2 lipoform C20:0 in a biological specimen. Ganglioside GD2 Lipoform C20:0 Measurement Ganglioside GD2 Lipoform C22:0 A measurement of the ganglioside GD2 lipoform C22:0 in a biological specimen. Ganglioside GD2 Lipoform C22:0 Measurement Guanase Guanine Aminohydrolase Guanine Deaminase A measurement of the guanine deaminase in a biological specimen. Guanine Deaminase Measurement BMP-11 Bone Morphogenetic Protein 11 Growth Differentiation Factor 11 A measurement of the growth differentiation factor 11 in a biological specimen. Growth Differentiation Factor 11 Measurement GDF-15 Growth Differentiation Factor 15 Macrophage Inhibitory Cytokine-1 MIC-1 A measurement of the growth differentiation factor 15 in a biological specimen. Growth Differentiation Factor 15 Measurement BMP-9 BMP9 Bone Morphogenetic Protein 9 Growth Differentiation Factor 2 Growth/Differentiation Factor 2 A measurement of the growth differentiation factor 2 in a biological specimen. Growth Differentiation Factor 2 Measurement Growth Differentiation Factor 8 Myostatin A measurement of the growth differentiation factor 8 in a biological specimen. Growth Differentiation Factor 8 Measurement Galactose-Deficient IgA1 Gd-IgA1 A measurement of the galactose-deficient IgA1 in a biological specimen. Galactose-Deficient IgA1 Measurement Galactose Elimination Capacity A liver function test that measures galactose elimination capacity in a biological specimen. Galactose Elimination Capacity Glial Fibrillary Acidic Protein A measurement of the glial fibrillary acidic protein in a biological specimen. Glial Fibrillary Acidic Protein Measurement Glomerular Filtration Rate A kidney function test that measures the fluid volume that is filtered from the kidney glomeruli to the Bowman's capsule per unit of time. Glomerular Filtration Rate Glomerular Filtration Rate Adj for BSA A measurement of the glomerular filtration rate adjusted for body surface area. Glomerular Filtration Rate Adjusted for BSA GFR from B-2 Microglobulin Adj for BSA A direct measurement of the glomerular filtration rate (GFR) based on the clearance of beta-2 microglobulin after adjusting it for the standard body surface area value 1.73m2. Direct Glomerular Filtration Rate from Beta-2 Microglobulin Adjusted for Standard BSA Measurement GFR from Beta-Trace Protein Adj for BSA A direct measurement of the glomerular filtration rate (GFR) based on the clearance of beta-trace protein after adjusting it for the standard body surface area value 1.73m2. Direct Glomerular Filtration Rate from Beta-Trace Protein Adjusted for Standard BSA Measurement GFR from Cystatin C and Creat Adj BSA An estimation of the glomerular filtration rate adjusted for standard body surface area (1.73m2) based on cystatin C and creatinine. Estimated Glomeluar Filtration Rate from Cystatin C and Creatinine Adjusted for Standard BSA GFR from Creatinine Adjusted for BSA An estimation of the glomerular filtration rate adjusted for standard body surface area (1.73m2) based on creatinine. Estimated Glomerular Filtration Rate from Creatinine Adjusted for Standard BSA GFR from Creat and UreaN Adj BSA GFR from Creatinine and Urea Nitrogen Adjusted for BSA An estimation of the glomerular filtration rate adjusted for standard body surface area (1.73m2) based on creatinine and urea nitrogen. Estimated Glomerular Filtration Rate from Creatinine and Urea Nitrogen Adjusted for Standard BSA GFR from Creat,UreaN,Alb Adj BSA GFR from Creatinine, Urea Nitrogen and Albumin Adjusted for BSA An estimation of the glomerular filtration rate adjusted for standard body surface area (1.73m2) based on creatinine, urea nitrogen, and albumin. Estimated Glomerular Filtration Rate from Creatinine, Urea Nitrogen, and Albumin Adjusted for Standard BSA GFR from Cystatin C Adjusted for BSA An estimation of the glomerular filtration rate adjusted for standard body surface area (1.73m2) based on cystatin C. Estimated Glomerular Filtration Rate from Cystatin C Adjusted for Standard BSA eGFR Glomerular Filtration Rate, Estimated A kidney function test that estimates the fluid volume that is filtered from the kidney glomeruli to the Bowman's capsule per unit of time, which may or may not be indexed for body surface area. Estimated Glomerular Filtration Rate eGFR, Indexed Estimated Glomerular Filtration Rate Adj for 1.73m2 GFR, Estimated Indexed Indexed eGFR Indexed Estimated Glomerular Filtration Rate An estimated GFR (eGFR) that takes into account a standardized body surface area (BSA) value of 1.73m2. Indexed Estimated Glomerular Filtration Rate Absolute GFR De-Indexed eGFR eGFR, Non-Indexed Estimated Glomerular Filtration Rate Adj for BSA GFR, Estimated Non-Indexed Individual eGFR Non-Indexed eGFR Non-Indexed Estimated Glomerular Filtration Rate An estimated GFR (eGFR) that takes into account the individual's actual body surface area (BSA) value. Non-Indexed Estimated Glomerular Filtration Rate GFR from B-2 Microglobulin Adj for aBSA GFR from B-2 Microglobulin Adjusted for Actual BSA A direct measurement of the glomerular filtration rate (GFR) based on the clearance of beta-2 microglobulin after adjusting it for the individual's actual body surface area value. Glomerular Filtration Rate from B-2 Microglobulin Adjusted for Actual BSA Measurement GFR from Beta-Trace Protein Adj for aBSA GFR from Beta-Trace Protein Adjusted for Actual BSA A direct measurement of the glomerular filtration rate (GFR) based on the clearance of beta-trace protein after adjusting it for the individual's actual body surface area value. Glomerular Filtration Rate from Beta-Trace Protein Adjusted for Actual BSA Measurement GFR from Cystatin C and Creat Adj aBSA An estimation of the glomerular filtration rate adjusted for an individual's actual body surface area based on cystatin C and creatinine. Glomerular Filtration Rate from Cystatin C and Creatinine Adjusted for Actual BSA GFR from Creatinine Adjusted for aBSA GFR from Creatinine Adjusted for Actual BSA An estimation of the glomerular filtration rate adjusted for an individual's actual body surface area based on creatinine. Glomerular Filtration Rate from Creatinine Adjusted for Actual BSA GFR from Creat and UreaN Adj aBSA GFR from Creatinine and Urea Nitrogen Adjusted for Actual BSA An estimation of the glomerular filtration rate adjusted for an individual's actual body surface area based on creatinine and urea nitrogen. Glomerular Filtration Rate from Creatinine and Urea Nitrogen Adjusted for Actual Body Surface Area Measurement GFR from Creat,UreaN,Alb Adj aBSA GFR from Creatinine, Urea Nitrogen and Albumin Adjusted for Actual BSA An estimation of the glomerular filtration rate adjusted for an individual's actual body surface area based on creatinine, urea nitrogen, and albumin. Glomerular Filtration Rate from Creatinine, Urea Nitrogen, and Albumin Adjusted for Actual Body Surface Area Measurement GFR from Cystatin C Adjusted for aBSA GFR from Cystatin C Adjusted for Actual BSA An estimation of the glomerular filtration rate adjusted for an individual's actual body surface area based on cystatin C. Glomerular Filtration Rate from Cystatin C Adjusted for Actual BSA Gamma Glutamyl Transferase A measurement of the gamma glutamyl transferase in a biological specimen. Gamma Glutamyl Transpeptidase Measurement Gamma Glutamyl Transferase/Creatinine A relative measurement (ratio or percentage) of the gamma glutamyl transferase to creatinine in a biological specimen. Gamma Glutamyl Transferase to Creatinine Ratio Measurement Gamma Glutamyl Transferase Excretion Rate A measurement of the amount of gamma glutamyl transferase being excreted in a biological specimen over a defined amount of time (e.g. one hour). Gamma Glutamyl Transferase Excretion Rate 4-Hydroxybutanoic Acid Gamma-Hydroxybutyrate Gamma-Hydroxybutyric Acid A measurement of the gamma-hydroxybutyrate in a biological specimen. Gamma-Hydroxybutyrate Measurement GH Binding Protein Growth Hormone Binding Protein Somatotropin Receptor A measurement of the growth hormone binding protein in a biological specimen. Growth Hormone Binding Protein Measurement Ghrelin Growth Hormone Secretagogue Receptor Ligand Motilin-related Peptide Total Ghrelin A measurement of total ghrelin in a biological specimen. Ghrelin Measurement Active Ghrelin A measurement of active ghrelin in a biological specimen. Active Ghrelin Measurement Glucose-dep Insulinotropic Pep, Intact Intact Gastric Inhibitory Polypeptide Intact GIP Intact Glucose-dependent Insulinotropic Peptide A measurement of the intact (containing amino acids 1-42) glucose-dependent insulinotropic peptide in a biological specimen. Intact Glucose-dependent Insulinotropic Peptide Measurement GL1 Glucocerebroside Glucosylceramide A measurement of the glucosylceramide in a biological specimen. Glucosylceramide Measurement Globulin/Creatinine A relative measurement (ratio or percentage) of the globulin to creatinine in a biological specimen. Globulin to Creatinine Ratio Measurement Glycolithocholate Glycolithocholic Acid A measurement of the glycolithocholate in a biological specimen. Glycolithocholate Measurement Galactose-Specific Lectin 3 Galectin-3 GALIG MAC-2 A measurement of the galectin-3 in a biological specimen. Galectin-3 Measurement Galectin-3 Binding Protein LGALS3BP M2BP Mac-2 Binding Protein A measurement of the galectin-3 binding protein in a biological specimen. Galectin-3 Binding Protein Measurement Glutamate Dehydrogenase A measurement of the glutamate dehydrogenase in a biological specimen. Glutamate Dehydrogenase Measurement Glutamine A measurement of the glutamine in a biological specimen. Glutamine Measurement Alpha Globulin A measurement of the total alpha globulins in a biological specimen. Alpha Globulin Measurement A1-Globulin Alpha-1 Globulin A measurement of the proteins contributing to the alpha 1 fraction in a biological specimen. Alpha-1 Globulin Measurement Alpha-1 Globulin/Total Protein A relative measurement (ratio or percentage) of alpha-1-fraction proteins to total proteins in a biological specimen. Alpha-1 Globulin to Total Protein Ratio Measurement A2-Globulin Alpha-2 Globulin A measurement of the proteins contributing to the alpha 2 fraction in a biological specimen. Alpha-2 Globulin Measurement Alpha-2 Globulin/Total Protein A relative measurement (ratio or percentage) of alpha-2-fraction proteins to total proteins in a biological specimen. Alpha-2 Globulin to Total Protein Ratio Measurement Beta Globulin A measurement of the proteins contributing to the beta fraction in a biological specimen. Beta Globulin Measurement Beta-1 Globulin A measurement of the beta-1 globulin in a biological specimen. Beta-1 Globulin Measurement Beta-1 Globulin/Beta Protein A relative measurement (ratio or percentage) of the beta-1-fraction proteins to the total beta protein fraction in a biological specimen. Beta-1 Globulin to Total Beta Protein Ratio Measurement Beta-1 Globulin/Total Protein A relative measurement (ratio or percentage) of beta-1-fraction proteins to total proteins in a biological specimen. Beta-1 Globulin to Total Protein Ratio Measurement Beta-2 Globulin A measurement of the beta-2 globulin in a biological specimen. Beta-2 Globulin Measurement Beta-2 Globulin/Total Protein A relative measurement (ratio or percentage) of beta-2-fraction proteins to total proteins in a biological specimen. Beta-2 Globulin to Total Protein Ratio Measurement Beta Globulin/Total Protein A relative measurement (ratio or percentage) of beta fraction proteins to total proteins in a biological specimen. Beta Globulin to Total Protein Ratio Measurement Gamma Globulin A measurement of the proteins contributing to the gamma fraction in a biological specimen. Gamma Globulin Measurement Gamma Globulin/Total Protein A relative measurement (ratio or percentage) of gamma fraction proteins to total proteins in a biological specimen. Gamma Globulin to Total Protein Ratio Measurement Globulin A measurement of the globulin protein in a biological specimen. Globulin Protein Measurement Glucagon-Like Peptide-1 Total Glucagon-Like Peptide-1 A measurement of the total glucagon-like peptide-1 in a biological specimen. Glucagon-like Peptide-1 Measurement Glucagon-Like Peptide-1, Active Form A measurement of the active form of glucagon-like peptide-1 in a biological specimen. Active Glucagon-like Peptide-1 Measurement Glucagon-Like Peptide-1, Inactive Form A measurement of the inactive form of glucagon-like peptide-1 in a biological specimen. Inactive Glucagon-Like Peptide-1 Measurement Glitter Cells A measurement of the glitter cells in a biological specimen. Glitter Cell Count Glutethimide A measurement of the glutethimide in a biological specimen. Glutethimide Measurement 1,3-Beta-D-Glucan A measurement of the 1,3-beta-D-glucan in a biological specimen. 1,3-Beta-D-Glucan Measurement Glucose A measurement of the glucose in a biological specimen. Glucose Measurement Glucagon A measurement of the glucagon hormone in a biological specimen. Glucagon Measurement Glucose Clearance A measurement of the volume of serum or plasma that would be cleared of glucose by excretion of urine for a specified unit of time (e.g. one minute). Glucose Clearance Measurement Glucose/Creatinine A relative measurement (ratio or percentage) of the glucose to creatinine in a biological specimen. Glucose to Creatinine Ratio Measurement Glucose Excretion Rate A measurement of the amount of glucose being excreted in a biological specimen over a defined amount of time (e.g. one hour). Glucose Excretion Rate Plasma Equivalent Glucose A measurement of the plasma equivalent glucose in a biological specimen. Plasma Equivalent Glucose Measurement Plasma Equivalent Glucose Distribution A measurement of the plasma equivalent glucose distribution in a biological specimen. Plasma Equivalent Glucose Distribution Measurement Whole Blood Equivalent Glucose A measurement of the whole blood equivalent glucose in a biological specimen. Whole Blood Equivalent Glucose Measurement Glucose, Enriched/Glucose Glucose, Radiolabeled/Glucose A relative measurement (ratio or percentage) of radiolabeled glucose to total glucose in a biological specimen. Radiolabeled Glucose to Glucose Ratio Measurement Glutamate Glutamic Acid A measurement of the glutamate in a biological specimen. Glutamate Measurement GIP Gluten Immunogenic Peptide Gluten Immunogenic Peptides A measurement of gluten immunogenic peptide in a biological specimen. Gluten Immunogenic Peptide Measurement Glycine A measurement of the glycine in a biological specimen. Glycine Measurement GlycA Glycoprotein Acetyls A measurement of the glycoprotein acetyls (i.e., alpha-1-acid glycoprotein, alpha-1-antitrypsin, haptoglobin, alpha-1-antichymotrypsin, and transferrin) in a biological specimen. Glycoprotein Acetyls Measurement Glycine/Creatinine A relative measurement (ratio) of the glycine to the creatinine in a biological specimen. Glycine to Creatinine Ratio Measurement Glycerol A measurement of the total glycerol in a specimen. Glycerol Measurement Free Glycerin Free Glycerol A measurement of the amount of unbound glycerol in a biological specimen. Free Glycerol Measurement Glycogen A measurement of the glycogen in a biological specimen. Glycogen Measurement Ganglioside GM3 Monosialodihexosylganglioside A measurement of the ganglioside GM3 in a biological specimen. Ganglioside GM3 Measurement Granulocyte Macrophage Colony Stm Factor A measurement of the granulocyte macrophage colony stimulating factor in a biological specimen. Granulocyte Macrophage Colony Stm Factor Measurement Glucose Management Indicator An approximate measure (expressed as a % or mmol/mol) of an individual's expected hemoglobin A1c/hemoglobin level, based on the mean glucose measured over a period of at least 10 days by continuous glucose monitoring. Glucose Management Indicator Gonadotropin Releasing Hormone Luteinising Hormone Releasing Hormone A measurement of the gonadotropin releasing hormone in a biological specimen. Gonadotropin Releasing Hormone Measurement Gold A measurement of the gold in a biological specimen. Gold Measurement Glycogen Phosphorylase Isoenzyme BB A measurement of the glycogen phosphorylase isoenzyme BB in a biological specimen. Glycogen Phosphorylase Isoenzyme BB Measurement Glycylproline Dipeptidyl Aminopeptidase GPDA A measurement of the glycylproline dipeptidyl aminopeptidase in a biological specimen. Glycylproline Dipeptidyl Aminopeptidase Measurement Granulocytes Polymorphonuclear Leukocytes A measurement of the granulocytes in a biological specimen. Granulocyte Count Banded Granulocytes Granulocytes Band Form A measurement of the banded granulocytes in a biological specimen. Granulocytes Band Form Count Granulocytes Band Form/Total Cells A relative measurement (ratio or percentage) of the banded granulocytes to total cells in a biological specimen. Band Form Granulocyte to Total Cell Ratio Measurement Granulocytes/Total Cells A relative measurement (ratio or percentage) of the granulocytes to total cells in a biological specimen (for example a bone marrow specimen). Granulocyte to Total Cell Ratio Measurement Immature Granulocytes A measurement of the total immature granulocytes in a biological specimen. Immature Granulocyte Count Immature Granulocytes/Leukocytes A relative measurement (ratio or percentage) of the immature granulocytes to leukocytes in a biological specimen (for example a bone marrow specimen). Immature Granulocytes to Leukocytes Ratio Measurement Gran/Leuk Granulocytes/Leukocytes Polymorphonuclear Leukocytes/Leukocytes A relative measurement (ratio or percentage) of the granulocytes to total leukocytes in a biological specimen. Granulocytes to Leukocytes Ratio Measurement Granulocytes Segmented A measurement of the segmented granulocytes in a biological specimen. Segmented Granulocyte Count Granulocytes Segmented/Total Cells Segmented Granulocytes/Total Cells A relative measurement (ratio or percentage) of the segmented granulocytes to total cells in a biological specimen. Segmented Granulocyte to Total Cell Ratio Measurement Granulin A measurement of the granulin in a biological specimen. Granulin Measurement Progranulin A measurement of the progranulin in a biological specimen. Progranulin Measurement Growth Regulated Oncogene A measurement of the total growth regulated oncogene proteins in a biological specimen. Growth Regulated Oncogene Measurement Growth Hormone Inhibiting Hormone Somatostatin A measurement of the growth hormone inhibiting hormone in a biological specimen. Growth Hormone Inhibiting Hormone Measurement Growth Hormone Releasing Hormone Somatocrinin A measurement of the growth hormone releasing hormone in a biological specimen. Growth Hormone Releasing Hormone Measurement Glutathione S-Transferase, Total A measurement of the total glutathione-s-transferase in a biological specimen. Glutathione-S-Transferase Measurement Alpha Glutathione-S-Transferase A measurement of the alpha form of glutathione S-transferase in a biological specimen. Alpha Glutathione-S-Transferase Measurement Glutathione S-Transferase, Alpha/Creat A relative measurement (ratio or percentage) of the alpha glutathione-S-transferase to creatinine in a biological specimen. Alpha Glutathione-S-Transferase to Creatinine Ratio Measurement Alpha-GST Excretion Rate A measurement of the amount of Alpha Glutathione-S-Transferase being excreted in a biological specimen over a defined period of time (e.g. one hour). Alpha-GST Excretion Rate Glutathione-S-Transferase/Creatinine A relative measurement (ratio or percentage) of the glutathione S-transferase to creatinine in a biological specimen. Glutathione-S-Transferase to Creatinine Ratio Measurement Mu Glutathione-S-Transferase A measurement of the mu form of glutathione S-transferase in a biological specimen. Mu Glutathione-S-Transferase Measurement Mu Glutathione-S-Transferase/Creatinine A relative measurement (ratio or percentage) of the mu gamma glutamyl transpeptidase to creatinine in a biological specimen. Mu Glutathione-S-Transferase to Creatinine Ratio Measurement Glutathione S-Transferase, Pi A measurement of the Pi glutathione-s-transferase in a biological specimen. Pi Glutathione S-Transferase Measurement Pi-GST Excretion Rate A measurement of the amount of Pi Glutathione-S-Transferase being excreted in a biological specimen over a defined period of time (e.g. one hour). Pi-GST Excretion Rate Glutathione S-Transferase, Theta A measurement of the theta glutathione-s-transferase in a biological specimen. Theta Glutathione S-Transferase Measurement Glutathione S-Transferase, Y1 A measurement of the Y1 subunit of glutathione-s-transferase in a biological specimen. Glutathione S-Transferase Y1 Subunit Measurement Glycoursodeoxycholate Glycoursodeoxycholic Acid A measurement of the glycoursodeoxycholate in a biological specimen. Glycoursodeoxycholate Measurement Glucuronidase, Alpha A measurement of the alpha glucuronidase in a biological specimen. Alpha Glucuronidase Measurement Glucuronidase, Beta A measurement of the beta glucuronidase in a biological specimen. Beta Glucuronidase Measurement CTL Tryptase Cytotoxic T-Lymphocyte Proteinase 1 Cytotoxic T-Lymphocyte-Associated Serine Esterase-3 Fragmentin-1 Granzyme A Granzyme-1 Hanukkah Factor A measurement of the granzyme A in a biological specimen. Granzyme A Measurement C11 CCPI CGL1 CSPB CTLA1 CTSGL1 Granzyme B HLP SECT A measurement of the granzyme B in a biological specimen. Granzyme B Measurement 2-Hydroxyethylflurazepam Hydroxyethylflurazepam A measurement of the hydroxyethylflurazepam a biological specimen. Hydroxyethylflurazepam Measurement 6-Alpha Hydroxytetrahydro-11-Dehydrocorticosterone 6a OH-tetrahydro-11-DeH-Corticosterone A measurement of the 6-alpha hydroxytetrahydro-11-dehydrocorticosterone in a biological specimen. 6a OH-tetrahydro-11-DeH-Corticosterone Measurement 6-Alpha Hydroxytetrahydro-11-Deoxycortisol 6a OH-tetrahydro-11-Deoxycortisol A measurement of the 6-alpha hydroxytetrahydro-11-deoxycortisol in a biological specimen. 6a OH-tetrahydro-11-Deoxycortisol Measurement Hairy Cells A measurement of the hairy cells (b-cell lymphocytes with hairy projections from the cytoplasm) in a biological specimen. Hairy Cell Count Hallucinogen A measurement of any hallucinogenic class drug present in a biological specimen. Hallucinogen Measurement Haloperidol A measurement of the haloperidol in a biological specimen. Haloperidol Measurement Alpha-Hydroxyalprazolam A measurement of the alpha-hydroxyalprazolam in a biological specimen. Alpha-Hydroxyalprazolam Measurement Hydroxyalprazolam A measurement of the total hydroxyalprazolam present in a biological specimen. Hydroxyalprazolam Measurement Haptoglobin A measurement of the haptoglobin protein in a biological specimen. Haptoglobin Protein Measurement Glycated Hemoglobin 1A Hemoglobin A1A A measurement of the glycated hemoglobin A1A in a biological specimen. Hemoglobin A1A Measurement Glycated Hemoglobin 1B Hemoglobin A1B A measurement of the glycated hemoglobin A1B in a biological specimen. Hemoglobin A1B Measurement HbA1c Hemoglobin A1C A measurement of the glycated hemoglobin A1C in a biological specimen. Hemoglobin A1C Measurement Glycated Hemoglobin/Hemoglobin HbA1c/Hemoglobin Hemoglobin A1C/Hemoglobin A relative measurement (ratio or percentage) of the glycated hemoglobin A1C to total hemoglobin in a biological specimen. Hemoglobin A1C to Hemoglobin Ratio Measurement Hemoglobin A2 Prime/Total Hemoglobin A relative measurement (ratio or percentage) of the hemoglobin A2 prime to total hemoglobin in a biological specimen. Hemoglobin A2 Prime to Total Hemoglobin Ratio Measurement Hemoglobin Barts/Total Hemoglobin A relative measurement (ratio or percentage) of the hemoglobin Barts to total hemoglobin in a biological specimen. Hemoglobin Barts to Total Hemoglobin Ratio Measurement Carboxyhemoglobin/Total Hemoglobin A relative measurement (ratio or percentage) of the amount of carboxyhemoglobin compared to total hemoglobin in a biological specimen. Carboxyhemoglobin to Total Hemoglobin Ratio Measurement Deoxyhemoglobin/Total Hemoglobin A relative measurement (ratio or percentage) of the deoxyhemoglobin to total hemoglobin in a biological specimen. Deoxyhemoglobin to Hemoglobin Ratio Measurement HB-EGF HEGFL Heparin Binding EGF Like Growth Factor Heparin-Binding EGF-Like Growth Factor Proheparin-Binding EGF-Like Growth Factor A measurement of the heparin binding EGF like growth factor in a biological specimen. Heparin Binding EGF Like Growth Factor Measurement Hemoglobin G Coushatta/Total Hemoglobin A relative measurement (ratio or percentage) of the hemoglobin G Coushatta to total hemoglobin in a biological specimen. Hemoglobin G Coushatta to Total Hemoglobin Ratio Measurement HBH Inclusion Bodies Hemoglobin H Inclusion Bodies HGH Inclusion Bodies A measurement of the hemoglobin H inclusion bodies in a biological specimen. Hemoglobin H Inclusion Bodies Measurement Hemoglobin Lepore/Total Hemoglobin A relative measurement (ratio or percentage) of the Lepore hemoglobin to total hemoglobin in a biological specimen. Hemoglobin Lepore to Total Hemoglobin Ratio Measurement Hemoglobin O-Arab/Total Hemoglobin A relative measurement (ratio or percentage) of the hemoglobin O-Arab to total hemoglobin in a biological specimen. Hemoglobin O-Arab to Total Hemoglobin Ratio Measurement FO2 Hb Fractioned Oxyhemoglobin Oxyhemoglobin/Total Hemoglobin A relative measurement (ratio or percentage) of the amount of oxyhemoglobin compared to total hemoglobin in a biological specimen. Oxyhemoglobin to Total Hemoglobin Ratio Measurement Choriogonadotropin Beta Pregnancy Test A measurement of the Choriogonadotropin Beta in a biological specimen. Choriogonadotropin Beta Measurement Choriogonadotropin Beta, Free A measurement of the free choriogonadotropin beta in a biological specimen. Free Choriogonadotropin Beta Measurement Choriogonadotropin A measurement of the total choriogonadotropin in a biological specimen. Choriogonadotropin Measurement Choriogonadotropin, Intact A measurement of the intact choriogonadotropin in a biological specimen. Intact Choriogonadotropin Measurement H+CH4 Hydrogen+Methane A measurement of the hydrogen and methane in a biological specimen. Hydrogen and Methane Measurement Hyocholate Hyocholic Acid A measurement of the hyocholate in a biological specimen. Hyocholate Measurement 3-HCOA 3-Hydroxy-5-cholestenoic acid 3beta-Hydroxy-5-Cholestenoic Acid A measurement of the 3beta-hydroxy-5-cholestenoic acid in a biological specimen. 3beta-Hydroxy-5-Cholestenoic Acid Measurement Erythrocyte Volume Fraction EVF Hematocrit Packed Cell Volume PCV The percentage of a whole blood specimen that is composed of red blood cells (erythrocytes). Hematocrit Measurement HDL Cholesterol A measurement of the high density lipoprotein cholesterol in a biological specimen. High Density Lipoprotein Cholesterol Measurement HDL-Cholesterol Subclass 2 A measurement of the high-density lipoprotein (HDL) cholesterol subclass 2 in a biological specimen. HDL-Cholesterol Subclass 2 Measurement HDL-Cholesterol Subclass 3 A measurement of the high-density lipoprotein (HDL) cholesterol subclass 3 in a biological specimen. HDL-Cholesterol Subclass 3 Measurement HDL+LDL Cholesterol A measurement of the high density lipoprotein cholesterol and the low density lipoprotein cholesterol in a biological specimen. High Density Lipoprotein Cholesterol and Low Density Lipoprotein Cholesterol Measurement HDL Cholesterol/Total Cholesterol A relative measurement (ratio or percentage) of the amount of HDL cholesterol compared to total cholesterol in a biological specimen. HDL Cholesterol to Total Cholesterol Ratio Measurement HDL Cholesterol/LDL Cholesterol A relative measurement (ratio or percentage) of the amount of HDL cholesterol compared to LDL cholesterol in a biological specimen. HDL Cholesterol to LDL Cholesterol Ratio Measurement HDL Phospholipid HDL-PL A measurement of the high density lipoprotein phospholipid in a biological specimen. HDL Phospholipid Measurement HDL Particle Size A measurement of the average particle size of high-density lipoprotein in a biological specimen. HDL Particle Size Measurement HLA-DR51 Antigen Type The identification of the type of human leukocyte antigen, class II, antigen-D-related 51 (HLA-DR51), in a biological specimen. HLA-DR51 Antigen Measurement HLA-DR52 Antigen Type The identification of the type of human leukocyte antigen, class II, antigen-D-related 52 (HLA-DR52), in a biological specimen. HLA-DR52 Antigen Measurement HLA-DR53 Antigen Type The identification of the type of human leukocyte antigen, class II, antigen-D-related 53 (HLA-DR53), in a biological specimen. HLA-DR53 Antigen Measurement Hemoglobin Concentration Distribution Width Hemoglobin Distribution Width A measurement of the distribution of the hemoglobin concentration in red blood cells. Hemoglobin Distribution Width Measurement Ret Hemoglobin Distribution Width Reticulocyte Hemoglobin Concentration Distribution Width A measurement of the distribution of the hemoglobin concentration in reticulocytes. Reticulocyte Hemoglobin Distribution Width Human Epididymis Protein 4 A measurement of the human epididymis protein 4 in a biological specimen. Human Epididymis Protein 4 Measurement Heinz Bodies Heinz-Erhlich Bodies A measurement of the Heinz bodies (small round inclusions within the body of a red blood cell) in a biological specimen. Heinz-Ehrlich Body Measurement Heinz Bodies/Erythrocytes A relative measurement (ratio or percentage) of the erythrocytes that contain heinz bodies to total erythrocytes in a biological specimen. Heinz Body to Erythrocyte Ratio Measurement Helmet Cells A measurement of the Helmet cells (specialized Keratocytes with two projections on either end that are tapered and hornlike) in a biological specimen. Helmet Cell Count Helicase MOV-10 Protein Moloney Leukemia Virus 10 Protein A measurement of helicase MOV-10 protein in a biological specimen. Helicase MOV-10 Protein Measurement Hemolysis Hemolytic Index A measurement of the destruction of red blood cells in a biological specimen. Hemolytic Index Heparin A measurement of the heparin in a biological specimen. Heparin Measurement Azurocidin CAP37 Cationic Antimicrobial Protein CAP37 HBP Heparin-Binding Protein A measurement of the heparin-binding protein in a biological specimen. Heparin-Binding Protein Measurement Hepcidin A measurement of the total hepcidin in a biological specimen. Hepcidin Measurement HEPS Hepsin Serine Protease Hepsin TMPRSS1 Transmembrane Protease Serine 1 A measurement of the hepsin in a biological specimen. Hepsin Measurement ErbB-2 ERBB2 HER2/NEU Human Epidermal Growth Factor Receptor 2 A measurement of HER2 protein in a biological specimen. Human Epidermal Growth Factor Receptor 2 Measurement HER2 Antigen HER2/NEU Antigen HER2/NEU Shed Antigen Soluble HER2 Soluble HER2/NEU A measurement of the soluble HER2 protein in a biological specimen. Soluble HER2 Antigen Measurement E3 ISG15--Protein Ligase HERC5 HECT and RLD Domain Containing E3 Ubiquitin Protein Ligase 5 Hect Domain and RLD 5 A measurement of the hect domain and RLD 5 in a biological specimen. Hect Domain and RLD 5 Measurement Heterophils A measurement of heterophils (granular leukocytes) in a biological specimen from avian species. Heterophil Measurement Heterophils/Leukocytes A relative measurement (ratio or percentage) of heterophils to leukocytes in a biological specimen from avian species. Heterophils to Leukocytes Ratio Measurement Beta-Hexosaminidase Subunit Alpha Beta-N-Acetylhexosaminidase Subunit Alpha Hexosaminidase A Hexosaminidase Subunit A Hexosaminidase Subunit Alpha N-Acetyl-Beta-Glucosaminidase Subunit Alpha A measurement of the hexosaminidase A in a biological specimen. Hexosaminidase A Measurement Hexokinase A measurement of the hexokinase in a biological specimen. Hexokinase Measurement Hemoglobin Hemoglobin Monomer A measurement of the total erythrocyte associated hemoglobin in a biological specimen. Hemoglobin Measurement Hemoglobin A A measurement of the hemoglobin A in a biological specimen. Hemoglobin A Measurement Hemoglobin A1/Total Hemoglobin A relative measurement (ratio or percentage) of the hemoglobin A1 to total hemoglobin in a biological specimen. Hemoglobin A1 to Total Hemoglobin Ratio Measurement Hemoglobin A2 A measurement of the hemoglobin A2 in a biological specimen. Hemoglobin A2 Measurement Hemoglobin A2/Total Hemoglobin A relative measurement (ratio or percentage) of the hemoglobin A2 to total hemoglobin in a biological specimen. Hemoglobin A2 to Total Hemoglobin Ratio Measurement Hemoglobin A/Total Hemoglobin A relative measurement (ratio or percentage) of the hemoglobin A to total hemoglobin in a biological specimen. Hemoglobin A to Total Hemoglobin Ratio Measurement Hemoglobin B A measurement of the hemoglobin B in a biological specimen. Hemoglobin B Measurement Hemoglobin C A measurement of the hemoglobin C in a biological specimen. Hemoglobin C Measurement Hemoglobin C/Total Hemoglobin A relative measurement (ratio or percentage) of the hemoglobin C to total hemoglobin in a biological specimen. Hemoglobin C to Total Hemoglobin Ratio Measurement Hemoglobin Casts A measurement of the hemoglobin casts present in a biological specimen. Hemoglobin Cast Measurement Hemoglobin D/Total Hemoglobin A relative measurement (ratio or percentage) of the hemoglobin D to total hemoglobin in a biological specimen. Hemoglobin D to Total Hemoglobin Ratio Measurement Deoxyhemoglobin A measurement of the deoxyhemoglobin, hemoglobin without oxygen, in a biological specimen. Deoxyhemoglobin Measurement Hemoglobin E/Total Hemoglobin A relative measurement (ratio or percentage) of the hemoglobin E to total hemoglobin in a biological specimen. Hemoglobin E to Total Hemoglobin Ratio Measurement Fetal Hemoglobin Hemoglobin F A measurement of the hemoglobin F in a biological specimen. Hemoglobin F Measurement Hemoglobin F/Total Hemoglobin A relative measurement (ratio or percentage) of the fetal hemoglobin (hemoglobin F) to total hemoglobin in a biological specimen. Hemoglobin F to Total Hemoglobin Ratio Measurement Hemoglobin Fraction Pattern A description of the hemoglobin fraction pattern in a biological specimen. Hemoglobin Fraction Pattern Hemoglobin, Free A measurement of the hemoglobin external to erythrocytes in a biological specimen. Free Hemoglobin Measurement HB H/Total Hemoglobin Hemoglobin H/Total Hemoglobin A relative measurement (ratio or percentage) of the hemoglobin H to total hemoglobin in a biological specimen. Hemoglobin H to Hemoglobin Ratio Measurement Methemoglobin A measurement of the methemoglobin in a biological specimen. Methemoglobin Measurement FMET HB Fractionated Methemoglobin Methemoglobin/Total Hemoglobin A relative measurement (ratio or percentage) of the amount of methemoglobin compared to total hemoglobin in a biological specimen. Methemoglobin to Total Hemoglobin Ratio Measurement Oxyhemoglobin A measurement of the oxyhemoglobin, oxygen-bound hemoglobin, in a biological specimen. Oxyhemoglobin Measurement Hemoglobin S Sickle Hemoglobin A measurement of the hemoglobin S in a biological specimen. Hemoglobin S Measurement Hemoglobin S/Total Hemoglobin A relative measurement (ratio or percentage) of the hemoglobin S to total hemoglobin in a biological specimen. Hemoglobin S to Total Hemoglobin Ratio Measurement Hemoglobin Tetramer A measurement of the hemoglobin tetramer in a biological specimen. Hemoglobin Tetramer Measurement Hemoglobin Variants A statement that indicates a defined set of hemoglobin variants were looked for in a biological specimen. Hemoglobin Variant Measurement Hepatocyte Growth Factor A measurement of the hepatocyte growth factor in a biological specimen. Hepatocyte Growth Factor Measurement c-Met Hepatocyte Growth Factor Receptor MET Proto-Oncogene, Receptor Tyrosine Kinase Tyrosine-Protein Kinase Met A measurement of the hepatocyte growth factor receptor in a biological specimen. Hepatocyte Growth Factor Receptor Measurement Hepatocyte Growth Factor Receptor, Free A measurement of the free (unbound) hepatocyte growth factor receptor in a biological specimen. Free Hepatocyte Growth Factor Receptor Measurement Hypoxanthine-Guanine Phosphoribosyltransferase Hypoxanthine-Guanine PRT A measurement of the hypoxanthine-guanine phosphoribosyltransferase in a biological specimen. Hypoxanthine-Guanine Phosphoribosyltransferase Measurement Histidine A measurement of the histidine in a biological specimen. Histidine Measurement Histamine A measurement of the histamine in a biological specimen. Histamine Measurement HLA Class IA Antigen A measurement of the HLA class IA antigen in a biological specimen. HLA Class IA Histocompatibility Antigen Measurement HLA A03 Antigen HLA-A03 Antigen A measurement of the HLA A03 antigen in a biological specimen. HLA A03 Histocompatibility Antigen Measurement HLA A2 Antigen HLA-A2 Antigen A measurement of the HLA A2 antigen in a biological specimen. HLA A2 Histocompatibility Antigen Measurement HLA A24 Antigen HLA-A24 Antigen A measurement of the HLA A24 antigen in a biological specimen. HLA A24 Histocompatibility Antigen Measurement HLA A3 Antigen HLA-A3 Antigen A measurement of the HLA A3 antigen in a biological specimen. HLA A3 Histocompatibility Antigen Measurement HLA-A Antigen Type The identification of the type of human leukocyte antigen, class I, group A (HLA-A), in a biological specimen. HLA-A Antigen Type HLA-A Mismatch Count A measurement to determine the number of mismatches between the recipient and the donor for the human leukocyte antigen, class I, group A (HLA-A). HLA-A Mismatch Count HLA Class IB Antigen A measurement of the HLA class IB antigen in a biological specimen. HLA Class IB Histocompatibility Antigen Measurement HLA-B27 Antigen Human Leukocyte Antigen B27 A measurement of the human leukocyte antigen B27 (HLA-B27) in a biological specimen. HLA-B27 Antigen Measurement HLA-B Antigen Type The identification of the type of human leukocyte antigen, class I, group B (HLA-B), in a biological specimen. HLA-B Antigen Type HLA-B Mismatch Count A measurement to determine the number of mismatches between the recipient and the donor for the human leukocyte antigen, class I, group B (HLA-B). HLA-B Mismatch Count HLA Class IC Antigen A measurement of the HLA class IC antigen in a biological specimen. HLA Class IC Histocompatibility Antigen Measurement HLA Cw Antigen HLA-Cw Antigen A measurement of the HLA Cw antigen in a biological specimen. HLA Cw Histocompatibility Antigen Measurement HLA DP Alpha1 Antigen HLA-DP Alpha1 Antigen A measurement of the HLA DP alpha1 antigen in a biological specimen. HLA DP Alpha1 Histocompatibility Antigen Measurement HLA DP Beta Antigen HLA-DP Beta Antigen A measurement of the total HLA DP beta antigen in a biological specimen. HLA DP Beta Histocompatibility Antigen Measurement HLA DP Beta1 Antigen A measurement of the HLA DP beta1 antigen in a biological specimen. HLA DP Beta1 Histocompatibility Antigen Measurement HLA DQ2 Antigen HLA-DQ2 Antigen A measurement of the HLA DQ2 antigen in a biological specimen. HLA DQ2 Antigen Measurement HLA DQ8 Antigen HLA-DQ8 Antigen A measurement of the HLA DQ8 antigen in a biological specimen. HLA DQ8 Antigen Measurement HLA DQ Alpha1 Antigen HLA-DQ Alpha1 Antigen A measurement of the HLA DQ alpha1 antigen in a biological specimen. HLA DQ Alpha1 Histocompatibility Antigen Measurement HLA DQ Beta1 Antigen A measurement of the HLA DQ beta1 antigen in a biological specimen. HLA DQ Beta1 Histocompatibility Antigen Measurement HLA DR Antigen HLA-DR Antigen A measurement of the total HLA DR antigen in a biological specimen. HLA DR Histocompatibility Antigen Measurement HLA DR Alpha Antigen HLA-DR Alpha Antigen A measurement of the total HLA DR alpha antigen in a biological specimen. HLA-DR Alpha Histocompatibility Antigen Measurement HLA-DR Antigen Type The identification of the type of human leukocyte antigen, class II, antigen-D-related (HLA-DR), in a biological specimen. HLA-DR Antigen Type HLA DR Beta Antigen HLA-DR Beta Antigen A measurement of the total HLA DR beta antigen in a biological specimen. HLA DR Beta Histocompatibility Antigen Measurement HLA DR Beta1 Antigen A measurement of the HLA DR beta1 antigen in a biological specimen. HLA DR Beta1 Histocompatibility Antigen Measurement HLA DR Beta2 Antigen HLA-DR Beta2 Antigen A measurement of the HLA DR beta2 antigen in a biological specimen. HLA DR Beta 2 Histocompatibility Antigen Measurement HLA DR Beta3 Antigen HLA-DR Beta3 Antigen A measurement of the HLA DR beta3 antigen in a biological specimen. HLA DR Beta 3 Histocompatibility Antigen Measurement HLA DR Beta4 Antigen HLA-DR Beta4 Antigen A measurement of the HLA DR beta4 antigen in a biological specimen. HLA DR Beta 4 Histocompatibility Antigen Measurement HLA DR Beta5 Antigen HLA-DR Beta5 Antigen A measurement of the HLA DR beta5 antigen in a biological specimen. HLA DR Beta 5 Histocompatibility Antigen Measurement HLA DR Antigen/Total Cells HLA-DR Antigen/Total Cells A relative measurement (ratio or percentage) of the human leukocyte antigen DR (HLA-DR) antigen to total cells in a biological specimen. HLA-DR Antigen to Total Cell Ratio Measurement HLA DR Antigen/Leukocytes HLA-DR Antigen/Leukocytes A relative measurement (ratio or percentage) of the human leukocyte antigen DR (HLA-DR) antigen to leukocytes in a biological specimen. HLA-DR Antigen to Leukocyte Ratio Measurement HLA-DR Mismatch Count A measurement to determine the number of mismatches between the recipient and the donor for the human leukocyte antigen, class II, antigen-D-related (HLA-DR). HLA-DR Mismatch Count HLA Mismatch Count A measurement to determine the number of mismatches between the recipient and the donor for the human leukocyte antigens (HLA). HLA Mismatch Count Halazepam A measurement of the halazepam present in a biological specimen. Halazepam Measurement Hemosiderin A measurement of the hemosiderin complex in a biological specimen. Hemosiderin Measurement (2R)-2-Acetamido-3-((4-hydroxybutan-2-yl)thio)propanoic acid (2R)-HMPMA 3-Hydroxy-1-Methyl-Propylmercapturate 3-Hydroxy-1-Methyl-Propylmercapturic Acid 3-Hydroxy-1-Methyl-PropylmercapturicAcid HMPMA-1 A measurement of the 3-hydroxy-1-methyl-propylmercapturic acid in a specimen. 3-Hydroxy-1-Methyl-Propylmercapturic Acid Measurement Homocitrulline A measurement of the homocitrulline in a biological specimen. Homocitrulline Measurement Homocysteine A measurement of the homocysteine amino acid in a biological specimen. Homocysteine Acid Measurement Hypochromic Erythrocytes/Erythrocytes A relative measurement (ratio or percentage) of the hypochromic erythrocytes to total erythrocytes in a biological specimen. Hypochromic Erythrocytes to Erythrocytes Ratio Measurement Howell-Jolly Bodies A measurement of the Howell-Jolly bodies (spherical, blue-black condensed DNA inclusions within the body of a red blood cell that appear under Wright-stain) in a biological specimen. Howell-Jolly Body Measurement 3-HPMA 3-Hydroxypropyl Mercapturate 3-Hydroxypropyl Mercapturic Acid N-Acetyl-S-(3-Hydroxypropyl)Cysteine A measurement of the 3-hydroxypropyl mercapturic acid in a specimen. 3-Hydroxypropyl Mercapturic Acid Measurement Hypochromia Hypochromic Erythrocytes An observation which indicates that the hemoglobin concentration in a red blood cell specimen has fallen below a specified level. Hypochromia Hyperchromic Erythrocytes/Erythrocytes A relative measurement (ratio or percentage) of the hyperchromic erythrocytes to total erythrocytes in a biological specimen. Hyperchromic Erythrocytes to Erythrocytes Ratio Measurement Hairy Cells/Total Cells A relative measurement (ratio or percentage) of the hairy cells to total cells in a biological specimen. Hairy Cells to Total Cells Ratio Measurement Hairy Cells/Leukocytes A relative measurement (ratio or percentage) of the hairy cells (B-cell lymphocytes with hairy projections from the cytoplasm) to all leukocytes in a biological specimen. Hairy Cells to Leukocytes Ratio Measurement Hairy Cells/Lymphocytes A relative measurement (ratio or percentage) of the hairy cells (b-cell lymphocytes with hairy projections from the cytoplasm) to all lymphocytes in a biological specimen . Hairy Cell to Lymphocyte Ratio Measurement Heat Shock Protein 70 A measurement of the heat shock protein 70 in a biological specimen. Heat Shock Protein 70 Measurement Heat Shock Protein 90 Alpha A measurement of the heat shock protein 90 alpha in a biological specimen. Heat Shock Protein 90 Alpha Measurement Huntingtin Protein Total Huntingtin Protein A measurement of the total huntingtin protein in a biological specimen. Huntingtin Protein Measurement Huntingtin Protein, Mutant A measurement of the mutant huntingtin protein in a biological specimen. Mutant Huntingtin Protein Measurement Huntingtin Protein, Wild Type A measurement of the wild type huntingtin protein in a biological specimen. Wild Type Huntingtin Protein Measurement Homovanillic Acid A measurement of the homovanillic acid metabolite in a biological specimen. Homovanillic Acid Measurement 11-Hydroxyandrostenedione A measurement of the 11-hydroxyandrostenedione in a biological specimen. 11-Hydroxyandrostenedione Measurement 11-Hydroxyandrosterone A measurement of the 11-hydroxyandrosterone in a biological specimen. 11-Hydroxyandrosterone Measurement 6-Hydroxybupropion BW 306U Hydroxybupropion A measurement of the hydroxybupropion in a biological specimen. Hydroxybupropion Measurement 17-Hydroxycorticoid 17-Hydroxycorticosteroid 17-Hydroxycorticosteroids A measurement of the 17-hydroxycorticosteroids in a biological specimen. 17-Hydroxycorticosteroid Measurement 18-Hydroxycortisol A measurement of the 18-hydroxycortisol in a biological specimen. 18-Hydroxycortisol Measurement 18-Hydroxycorticosterone A measurement of the 18-hydroxycorticosterone in a biological specimen. 18-Hydroxycorticosterone Measurement cis-Hexadecenoic Acid Hexadecenoate Cis Hexadecenoic Acid Cis Sapienic Acid A measurement of the hexadecenoate cis in a biological specimen. Hexadecenoate cis Measurement 18-Hydroxydeoxycorticosterone A measurement of the 18-hydroxydeoxycorticosterone in a biological specimen. 18-Hydroxydeoxycorticosterone Measurement 2-Hydroxyethyl Mercapturate 2-Hydroxyethyl Mercapturic Acid HEMA N-Acetyl-S-(2-Hydroxyethyl)Cysteine A measurement of the 2-hydroxyethyl mercapturic acid in a specimen. 2-Hydroxyethyl Mercapturic Acid Measurement 11-Hydroxyetiocholanolone A measurement of the 11-hydroxyetiocholanolone in a biological specimen. 11-Hydroxyetiocholanolone Measurement 2-Hydroxyglutarate 2-Hydroxyglutaric Acid Alpha-Hydroxyglutaric Acid A measurement of the 2-hydroxyglutarate in a biological specimen. 2-Hydroxyglutarate Measurement 4-HNE 4-hydroxy-2-nonenal 4-Hydroxynonenal HNE A measurement of the 4-hydroxynonenal in a biological specimen. 4-Hydroxynonenal Measurement 17-Hydroxypregnenolone A measurement of the 17-hydroxypregnenolone in a biological specimen. 17-Hydroxypregnenolone Measurement Hyaluronic Acid A measurement of hyaluronic acid in a biological specimen. Hyaluronic Acid Measurement Hydrocodone A measurement of the hydrocodone present in a biological specimen. Hydrocodone Measurement 1'-Hydroxymidazolam 1-Hydroxymidazolam Alpha-Hydroxymidazolam A measurement of the 1-Hydroxymidazolam present in a biological specimen. 1-Hydroxymidazolam Measurement 4-Hydroxymidazolam A measurement of the 4-hydroxymidazolam present in a biological specimen. 4-Hydroxymidazolam Measurement Hydromorphone A measurement of the hydromorphone present in a biological specimen. Hydromorphone Measurement Hydrogen A measurement of the hydrogen in a biological specimen. Hydrogen Measurement Hyperchromia Hyperchromic Erythrocytes A measurement of the prevalence of the erthrocytes with an elevated hemoglobin concentration. Hyperchromia Measurement 17-Hydroxyprogesterone 17-OHP A measurement of the 17-Hydroxyprogesterone in a biological specimen. 17-Hydroxyprogesterone Measurement Hydroxyproline A measurement of the total hydroxyproline in a biological specimen. Hydroxyproline Measurement Hypersegmented Cells A measurement of the hypersegmented (more than five lobes) neutrophils in a biological specimen. Hypersegmented Neutrophil Measurement Hydroxylysine A measurement of the hydroxylysine in a biological specimen. Hydroxylysine Measurement 5-Hydroxyindoleacetic Acid Excretion Rate 5-HydroxyindoleaceticAcid Excretion Rate A measurement of the amount of 5-hydroxyindoleacetic acid being excreted in a biological specimen over a defined amount of time (e.g. one hour). 5-Hydroxyindoleacetic Acid Excretion Rate 5-Hydroxyindoleacetate 5-Hydroxyindoleacetic Acid A measurement of 5-hydroxyindoleacetic acid in a biological specimen. 5-Hydroxyindoleacetic Acid Measurement 5-Hydroxyindoleacetic Acid/Creatinine A relative measurement (ratio or percentage) of the 5-hydroxyindoleacetic acid to creatinine in a biological specimen. 5-Hydroxyindoleacetic Acid to Creatinine Ratio Measurement IDL Apolipoprotein B A measurement of the apolipoprotein B in the intermediate density lipoprotein fraction of a biological specimen. IDL Apolipoprotein B Measurement Amylin Islet Amyloid Polypeptide A measurement of the islet amyloid polypeptide in a biological specimen. Islet Amyloid Polypeptide Measurement Total Iron Binding Capacity A measurement of the amount of iron needed to fully saturate the transferrin in a biological specimen. Total Iron Binding Capacity Unsaturated Iron Binding Capacity A measurement of the binding capacity of unsaturated iron in a biological specimen. Unsaturated Iron Binding Capacity Measurement iC3b Complement A measurement of the complement iC3b in a biological specimen. Complement iC3b Measurement Islet Cell 512 Antigen A measurement of the islet cell 512 antigen in a biological specimen. Islet Cell 512 Antigen Measurement Intercellular Adhesion Molecule A measurement of the total intercellular adhesion molecule in a biological specimen. Intercellular Adhesion Molecule Measurement Intercellular Adhesion Molecule 1 Soluble CD54 A measurement of the intercellular adhesion molecule 1 in a biological specimen. Intercellular Adhesion Molecule 1 Measurement Intercellular Adhesion Molecule 3 A measurement of the intercellular adhesion molecule 3 in a biological specimen. Intercellular Adhesion Molecule 3 Measurement Indocyanine Green A measurement of the indocyanine green in a biological specimen. Indocyanine Green Measurement Indocyanine Green Clearance A measurement of the volume of serum or plasma that would be cleared of indocyanine green by excretion for a specified unit of time (e.g. one minute). Indocyanine Green Clearance Measurement Icteric Index Icterus A measurement of the yellow color of a biological specimen, due to the presence of bile pigments. Icteric Index IDL Cholesterol Intermediate Density Lipoprotein A measurement of the intermediate density lipoprotein in a biological specimen. Intermediate Density Lipoprotein Cholesterol Measurement IDL Cholesterol/LDL Cholesterol A relative measurement (ratio) of the amount of intermediate density lipoprotein cholesterol compared to low density lipoprotein cholesterol in a biological specimen. IDL Cholesterol to LDL Cholesterol Ratio Measurement IDL Particles Intermediate Density Lipoproteins Particles A measurement of the concentration of IDL particles in a biological specimen. IDL Particles Measurement IDL Triglyceride A measurement of the intermediate density lipoprotein triglyceride in a biological specimen. IDL Triglyceride Measurement IDL Cholesterol and VLDL Cholesterol Subtype 3 IDL+VLDL Cholesterol Subtype 3 A measurement of the intermediate density lipoprotein cholesterol and the very low density lipoprotein cholesterol subtype 3 in a biological specimen. IDL Cholesterol and VLDL Cholesterol Subtype 3 Measurement Interferon Alpha-Induced Protein 27 Interferon Alpha-Inducible Protein 27 A measurement of the interferon alpha-inducible protein 27 in a biological specimen. Interferon Alpha-Inducible Protein 27 Measurement Interferon-Induced Protein 44 A measurement of the interferon-induced protein 44 in a biological specimen. Interferon-Induced Protein 44 Measurement Interferon-Induced Protein 44-Like A measurement of the interferon-induced protein 44-like in a biological specimen. Interferon-Induced Protein 44-Like Measurement Interferon Alpha-Inducible Protein 6 A measurement of the interferon alpha-inducible protein 6 in a biological specimen. Interferon Alpha-Inducible Protein 6 Measurement Interferon-Induced 56 kDa Protein Interferon-Induced Protein With Tetratricopeptide Repeats 1 A measurement of the interferon-induced 56 KDa protein in a biological specimen. Interferon-Induced 56 kDa Protein Measurement Interferon-Induced 60 kDa Protein Interferon-Induced Protein With Tetratricopeptide Repeats 3 A measurement of the interferon-induced 60 KDa protein in a biological specimen. Interferon-Induced 60 kDa Protein Measurement Interferon Alpha A measurement of the total interferon alpha in a biological specimen. Interferon Alpha Measurement Interferon Alpha Type 1 A measurement of the interferon alpha type 1 in a biological specimen. Interferon Alpha Type 1 Measurement Interferon Alpha Type 2 A measurement of the interferon alpha type 2 in a biological specimen. Interferon Alpha Type 2 Measurement Interferon Beta A measurement of the interferon beta in a biological specimen. Interferon Beta Measurement Interferon Gamma A measurement of the interferon gamma in a biological specimen. Interferon Gamma Measurement Immunoglobulin A A measurement of the total immunoglobulin A in a biological specimen. Immunoglobulin A Measurement Immunoglobulin A Subclass 1 A measurement of the immunoglobulin A subclass 1 in a biological specimen. Immunoglobulin A Subclass 1 Measurement Immunoglobulin A Subclass 2 A measurement of the immunoglobulin A subclass 2 in a biological specimen. Immunoglobulin A Subclass 2 Measurement IgA/C3 IgA/Complement C3 Immunoglobulin A/Complement C3 A relative measurement (ratio) of the immunoglobulin A to complement C3 in a biological specimen. Immunoglobulin A to Complement C3 Measurement IgG IgM IgA Total A measurement of the total IgG, IgM, and IgA in a biological specimen. IgG IgM IgA Total Measurement Immunoglobulin D A measurement of the Immunoglobulin D in a biological specimen. Immunoglobulin D Measurement Immunoglobulin E A measurement of the total Immunoglobulin E in a biological specimen. Immunoglobulin E Measurement Immunoglobulin E, Free A measurement of the free Immunoglobulin E in a biological specimen. Free Immunoglobulin E Measurement Insulin-like Growth Factor-1 A measurement of the insulin-like growth factor-1 in a biological specimen. Insulin Like Growth Factor-1 Measurement Insulin-like Growth Factor-2 A measurement of the insulin-like growth factor-2 in a biological specimen. Insulin Like Growth Factor-2 Measurement Insulin-Like Growth Factor Binding Prot1 Insulin-Like Growth Factor Binding Protein 1 A measurement of the total insulin-like growth factor binding protein 1 in a biological specimen. Insulin-Like Growth Factor Binding Protein 1 Measurement Insulin-Like Growth Factor Binding Prot2 Insulin-Like Growth Factor Binding Protein 2 A measurement of the insulin-like growth factor binding protein 2 in a biological specimen. Insulin-Like Growth Factor Binding Protein 2 Measurement Insulin-Like Growth Factor Binding Prot3 Insulin-Like Growth Factor Binding Protein 3 A measurement of the insulin-like growth factor binding protein 3 in a biological specimen. Insulin-Like Growth Factor Binding Protein 3 Measurement AGM FSTL2 IBP-7 IGFBP-7 IGFBP-7v IGFBPRP1 Insulin-Like Growth Factor Binding Prot7 Insulin-like Growth Factor Binding Protein 7 MAC25 PSF RAMSVPS TAF A measurement of the insulin-like growth factor binding protein 7 in a biological specimen. Insulin-Like Growth Factor Binding Protein 7 Measurement Immunoglobulin G A measurement of the total immunoglobulin G in a biological specimen. Immunoglobulin G Measurement Immunoglobulin G Subclass 1 A measurement of the immunoglobulin G subclass 1 in a biological specimen. Immunoglobulin G Subclass 1 Measurement Immunoglobulin G Subclass 2 A measurement of the immunoglobulin G subclass 2 in a biological specimen. Immunoglobulin G Subclass 2 Measurement Immunoglobulin G Subclass 3 A measurement of the immunoglobulin G subclass 3 in a biological specimen. Immunoglobulin G Subclass 3 Measurement Immunoglobulin G Subclass 4 A measurement of the immunoglobulin G subclass 4 in a biological specimen. Immunoglobulin G Subclass 4 Measurement IgG/Albumin Immunoglobulin G/Albumin A relative measurement (ratio or percentage) of the immunoglobulin G to albumin in a biological specimen. Immunoglobulin G to Albumin Ratio Measurement IgG Clearance A measurement of the IgG clearance in a biological specimen. IgG Clearance IgG Clearance/Albumin Clearance A relative measurement (ratio) of the IgG clearance to albumin clearance in a biological specimen. IgG Clearance to Albumin Clearance Ratio Measurement Immunoglobulin G/Creatinine A relative measurement (ratio or percentage) of the immunoglobulin G to creatinine in a biological specimen. Immunoglobulin G to Creatinine Ratio Measurement IgG Synthesis Rate A measurement of the IgG synthesis rate in a biological specimen. IgG Synthesis Rate Immunoglobulin Heavy Constant Gamma 2 A measurement of the immunoglobulin heavy constant gamma 2 in a biological specimen. Immunoglobulin Heavy Constant Gamma 2 Measurement Immunoglobulin Heavy Constant Gamma 4 A measurement of the immunoglobulin heavy constant gamma 4 in a biological specimen. Immunoglobulin Heavy Constant Gamma 4 Measurement Immunoglobulin M A measurement of the total immunoglobulin M in a biological specimen. Immunoglobulin M Measurement Soluble Immunoglobulin A measurement of the soluble total immunoglobulin in a biological specimen. Soluble Immunoglobulin Measurement Interleukin 12+23 p40 A measurement of the p40 subunit of the interleukins 12 and 23 in a biological specimen. Interleukin 12+23 p40 Measurement Pro-IL-16 Pro-Interleukin 16 A measurement of the pro-interleukin 16 in a biological specimen. Pro-Interleukin 16 Measurement Interleukin 18 Binding Protein A measurement of the interleukin 18 binding protein in a biological specimen. Interleukin 18 Binding Protein Measurement Interleukin 18 Excretion Rate A measurement of the amount of interleukin 18 being excreted in a biological specimen over a defined period of time (e.g. one hour). Interleukin 18 Excretion Rate Interleukin 1 Excretion Rate A measurement of the amount of interleukin 1 being excreted in a biological specimen over a defined period of time (e.g. one hour). Interleukin 1 Excretion Rate Interleukin 1 Receptor Interleukin 1 Receptor Types I+II A measurement of the interleukin 1 receptor (type I and type II) in a biological specimen. Interleukin 1 Receptor Measurement CD121A CD121a Antigen IL-1R-1 IL-1R-Alpha IL-1R1 IL-1RT1 IL1RA Interleukin 1 Receptor Type 1 Interleukin-1 Receptor Alpha A measurement of the interleukin 1 receptor type 1 in a biological specimen. Interleukin-1 Receptor Type 1 Measurement CDw121b IL-1R-2 IL-1RT2 IL1R2c IL1RB Interleukin 1 Receptor Type 2 Soluble CD121b A measurement of the interleukin 1 receptor type 2 in a biological specimen. Interleukin 1 Receptor Type 2 Measurement Interleukin 1 Receptor-Like 1 Protein ST2 sST2 A measurement of the interleukin 1 receptor-like 1 in a biological specimen. Interleukin 1 Receptor-Like 1 Measurement Soluble Interleukin-1 Receptor Type I A measurement of the soluble interleukin-1 receptor type I in a biological specimen. Soluble Interleukin-1 Receptor Type I Measurement IFN-Lambda 3 Interleukin 28B A measurement of the interleukin 28B in a biological specimen. Interleukin 28B Measurement Interleukin 2 Receptor A measurement of the interleukin 2 receptor in a biological specimen. Interleukin 2 Receptor Measurement IL-2Ra Interleukin 2 Receptor Subunit Alpha sCD25 Soluble CD25 A measurement of the interleukin 2 receptor subunit alpha in a biological specimen. Interleukin 2 Receptor Subunit Alpha Measurement IL-2Rb Interleukin 2 Receptor Subunit Beta A measurement of the interleukin 2 receptor subunit beta in a biological specimen. Interleukin 2 Receptor Subunit Beta Measurement Soluble Interleukin 2 Receptor A measurement of the soluble interleukin 2 receptor (including all subunits) in a biological specimen. Soluble Interleukin 2 Receptor Measurement IL-4Ra Interleukin 13 Receptor Interleukin 4 Receptor Interleukin 4 Receptor Subunit Alpha Soluble CD124 A measurement of the interleukin 4 receptor subunit alpha in a biological specimen. Interleukin-4 Receptor Subunit Alpha Measurement Soluble Interleukin 6 Receptor A measurement of the soluble interleukin 6 receptor in a biological specimen. Soluble Interleukin 6 Receptor Measurement Isoleucine A measurement of the isoleucine in a biological specimen. Isoleucine Measurement Iloperidone A measurement of the iloperidone in a biological specimen. Iloperidone Measurement Imipramine A measurement of the imipramine in a biological specimen. Imipramine Measurement Immunoglobulin A measurement of the total immunoglobulin in a biological specimen. Immunoglobulin Measurement Immunoglobulin Light Chains A measurement of the total immunoglobulin (kappa and lambda) light chains in a biological specimen. Immunoglobulin Light Chain Measurement Immunoglobulin Light Chains, Free A measurement of the total free immunoglobulin (kappa and lambda) light chains in a biological specimen. Free Immunoglobulin Light Chain Measurement Inclusion Bodies A measurement of the inclusion bodies in a biological specimen. Inclusion Body Measurement Erythrocyte Inclusion Bodies A measurement of the erythrocyte inclusion bodies in a biological specimen. Erythrocyte Inclusion Bodies Measurement Indican A measurement of the indican present in a biological specimen. Indican Measurement Inhibin A A measurement of the inhibin A (a heterodimer of the Inhibin Subunit Alpha and Inhibin Subunit Beta A) in a biological specimen. Inhibin A Measurement Inhibin B A measurement of the inhibin B (a heterodimer of the Inhibin Subunit Alpha and Inhibin Subunit Beta B) in a biological specimen. Inhibin B Measurement Inulin Clearance A measurement of the volume of serum or plasma that would be cleared of inulin by excretion of urine for a specified unit of time (e.g. one minute). Inulin Clearance Prothrombin Intl. Normalized Ratio A ratio that represents the prothrombin time for a plasma specimen, divided by the result for a control plasma specimen, further standardized for the International Sensitivity Index of the tissue factor (thromboplastin) used in the test. International Normalized Ratio of Prothrombin Time Insulin, Free A measurement of the free insulin in a biological specimen. Free Insulin Measurement Insulin A measurement of the insulin in a biological specimen. Insulin Measurement Insulin, Intact A measurement of the intact insulin in a biological specimen. Intact Insulin Measurement Insulin Resistance A measurement of the insulin resistance (a cell's inability to respond to insulin) in a biological specimen. Insulin Resistance Measurement Insulin Sensitivity A measurement of the insulin sensitivity (cells are stimulated by lower than normal insulin levels) in a biological specimen. Insulin Sensitivity Measurement Interleukin 1 A measurement of the interleukin 1 in a biological specimen. Interleukin 1 Measurement Interleukin 10 A measurement of the interleukin 10 in a biological specimen. Interleukin 10 Measurement Interleukin 11 A measurement of the interleukin 11 in a biological specimen. Interleukin 11 Measurement Interleukin 12 Interleukin 12 p70 A measurement of the interleukin 12 in a biological specimen. Interleukin 12 Measurement Interleukin 12 Beta Interleukin 12 Beta Subunit Interleukin 12 p40 Interleukin 12 p40 Subunit A measurement of p40 subunit of Interleukin 12 in a biological specimen. Interleukin 12 Beta Measurement Interleukin 13 A measurement of the interleukin 13 in a biological specimen. Interleukin 13 Measurement Interleukin 14 A measurement of the interleukin 14 in a biological specimen. Interleukin 14 Measurement Interleukin 15 A measurement of the interleukin 15 in a biological specimen. Interleukin 15 Measurement Interleukin 16 A measurement of the interleukin 16 in a biological specimen. Interleukin 16 Measurement IL-17A Interleukin 17 Interleukin 17A A measurement of the interleukin 17 in a biological specimen. Interleukin 17 Measurement CX2 Cytokine CX2 IL-17C Interleukin 17C A measurement of the interleukin 17C in a biological specimen. Interleukin 17C Measurement IL-17D Interleukin 17D A measurement of the interleukin 17D in a biological specimen. Interleukin 17D Measurement Interleukin 18 A measurement of the interleukin 18 in a biological specimen. Interleukin 18 Measurement Interleukin 19 A measurement of the interleukin 19 in a biological specimen. Interleukin 19 Measurement Interleukin 1 Alpha A measurement of interleukin 1 alpha in a biological specimen. Interleukin 1 Alpha Measurement IL-1B IL1Beta Interleukin 1 Beta Interleukin 1B A measurement of interleukin 1 beta in a biological specimen. Interleukin 1 Beta Measurement IL-1RA Interleukin 1 Receptor Antagonist A measurement of the interleukin 1 receptor antagonist in a biological specimen. Interleukin 1 Receptor Antagonist Measurement Interleukin 2 A measurement of the interleukin 2 in a biological specimen. Interleukin 2 Measurement Interleukin 20 A measurement of the interleukin 20 in a biological specimen. Interleukin 20 Measurement Interleukin 21 A measurement of the interleukin 21 in a biological specimen. Interleukin 21 Measurement Interleukin 22 A measurement of the interleukin 22 in a biological specimen. Interleukin 22 Measurement Interleukin 23 Interleukin 23 p59 A measurement of the interleukin 23 in a biological specimen. Interleukin 23 Measurement Interleukin 24 A measurement of the interleukin 24 in a biological specimen. Interleukin 24 Measurement Interleukin 25 A measurement of the interleukin 25 in a biological specimen. Interleukin 25 Measurement Interleukin 26 A measurement of the interleukin 26 in a biological specimen. Interleukin 26 Measurement Interleukin 27 A measurement of the interleukin 27 in a biological specimen. Interleukin 27 Measurement Interleukin 28 A measurement of the total interleukin 28 in a biological specimen. Interleukin 28 Measurement Interleukin 29 A measurement of the interleukin 29 in a biological specimen. Interleukin 29 Measurement Interleukin 3 A measurement of the interleukin 3 in a biological specimen. Interleukin 3 Measurement Interleukin 30 A measurement of the interleukin 30 in a biological specimen. Interleukin 30 Measurement Interleukin 31 A measurement of the interleukin 31 in a biological specimen. Interleukin 31 Measurement Interleukin 32 A measurement of the interleukin 32 in a biological specimen. Interleukin 32 Measurement Interleukin 33 A measurement of the interleukin 33 in a biological specimen. Interleukin 33 Measurement Interleukin 4 A measurement of the interleukin 4 in a biological specimen. Interleukin 4 Measurement Interleukin 5 A measurement of the interleukin 5 in a biological specimen. Interleukin 5 Measurement Interleukin 6 A measurement of the interleukin 6 in a biological specimen. Interleukin 6 Measurement Interleukin 7 A measurement of the interleukin 7 in a biological specimen. Interleukin 7 Measurement Chemokine (C-X-C Motif) Ligand 8 CXCL8 Interleukin 8 A measurement of the interleukin 8 in a biological specimen. Interleukin 8 Measurement Interleukin 9 A measurement of the interleukin 9 in a biological specimen. Interleukin 9 Measurement Inulin A measurement of the inulin in a biological specimen. Inulin Measurement Iodine A measurement of the total iodine in a biological specimen. Iodine Measurement Iodine, Free A measurement of the free (unbound) iodine in a biological specimen. Free Iodine Measurement Iohexol Clearance A measurement of the volume of serum or plasma that would be cleared of Iohexol by excretion of urine for a specified unit of time (e.g. one minute). Iohexol Clearance Iohexol A measurement of iohexol in a biological specimen. Iohexol Measurement Iothalamate Clearance A measurement of the volume of serum or plasma that would be cleared of iothalamate by excretion of urine for a specified unit of time (e.g. one minute). Iothalamate Clearance Iothalamate Clearance Adjusted for BSA A measurement of the volume of serum or plasma that would be cleared of iothalamate by excretion of urine for a specified unit of time (e.g. one minute), adjusted for body surface area. Iothalamate Clearance Adjusted for BSA Immature Reticulocyte Fraction A measurement of the immature reticulocyte fraction present in a biological specimen. Immature Reticulocyte Fraction Measurement FE Iron A measurement of the iron in a biological specimen. Iron Measurement Iron Excretion Rate A measurement of the amount of iron being excreted in a biological specimen over a defined amount of time (e.g. one hour). Iron Excretion Rate ISG15 Ubiquitin-Like Modifier Ubiquitin-Like Protein ISG15 A measurement of the ubiquitin-like protein ISG15 in a biological specimen. Ubiquitin-Like Protein ISG15 Measurement Isoprene A measurement of the isoprene in a specimen. Isoprene Measurement F2-Isoprostane A measurement of the F2-isoprostane in a biological specimen. F2 Isoprostane Measurement Endothelial Lectin HL-1 Galactofuranose-Binding Lectin Intelectin-1 Intestinal Lactoferrin Receptor ITLN-1 Omentin A measurement of the intelectin-1 in a biological specimen. Intelectin-1 Measurement JWH-018 JWH018 A measurement of the synthetic cannabinoid JWH-018 in a biological specimen. JWH-018 Measurement JWH-073 JWH073 A measurement of the synthetic cannabinoid JWH-073 in a biological specimen. JWH-073 Measurement JWH-081 JWH081 A measurement of the synthetic cannabinoid JWH-081 in a biological specimen. JWH-081 Measurement JWH-122 JWH122 A measurement of the synthetic cannabinoid JWH-122 in a biological specimen. JWH-122 Measurement JWH-200 JWH200 A measurement of the synthetic cannabinoid JWH-200 in a biological specimen. JWH-200 Measurement JWH-250 JWH250 A measurement of the synthetic cannabinoid JWH-250 in a biological specimen. JWH-250 Measurement JWH-398 JWH398 A measurement of the synthetic cannabinoid JWH-398 in a biological specimen. JWH-398 Measurement Potassium A measurement of the potassium in a biological specimen. Potassium Measurement Kappa Light Chain A measurement of the total kappa light chains in a biological specimen. Kappa Light Chain Measurement Ketobemidone A measurement of the ketobemidone in a biological specimen. Ketobemidone Measurement Potassium Clearance A measurement of the volume of serum or plasma that would be cleared of potassium by excretion of urine for a specified unit of time (e.g. one minute). Potassium Clearance Measurement Potassium/Creatinine A relative measurement (ratio or percentage) of the potassium to creatinine in a biological specimen. Potassium to Creatinine Ratio Measurement Keratocyte A measurement of the keratocytes in a biological specimen. Keratocyte Count Ketamine A measurement of the ketamine in a biological specimen. Ketamine Measurement Ketone Bodies A measurement of the ketone bodies (acetone, acetoacetic acid, beta-hydroxybutyric acid, beta-ketopentanoate and beta-hydroxypentanoate) in a biological specimen. Ketone Body Measurement Ketones A measurement of the ketones in a biological specimen. Ketone Measurement Potassium Excretion Rate A measurement of the amount of potassium being excreted in a biological specimen over a defined amount of time (e.g. one hour). Potassium Excretion Rate Ki-67 KI67 MKI67 pKi-67 A measurement of the Ki-67 protein in a biological specimen. Ki67 Measurement Hepatitis A Virus Cellular Receptor 1 Kidney Injury Molecule-1 KIM-1 A measurement of the kidney injury molecule-1 (Kim-1) in a biological specimen. Kidney Injury Molecule-1 Measurement Kidney Injury Molecule-1/Creatinine A relative measurement (ratio or percentage) of the kidney injury molecule-1 to creatinine in a biological specimen. Kidney Injury Molecule-1/Creatinine Ratio Measurement Kidney Injury Molecule-1 Excretion Rate A measurement of the amount of kidney injury molecule-1 being excreted in a biological specimen over a defined amount of time (e.g. one hour). Kidney Injury Molecule-1 Excretion Rate Soluble Hepatitis A Virus Cellular Receptor 1 Soluble Kidney Injury Molecule-1 Soluble KIM-1 A measurement of the soluble kidney injury molecule-1 in a biological specimen. Soluble Kidney Injury Molecule-1 Measurement KL-6 Krebs von den Lungen-6 Antigen A measurement of the Krebs von den Lungen-6 in a biological specimen. Krebs von den Lungen-6 Measurement Bence-Jones, Kappa Kappa Light Chain, Free A measurement of the free kappa light chain in a biological specimen. Free Kappa Light Chain Measurement Kappa Lambda Ratio Kappa Light Chain/Lambda Light Chain A relative measurement (ratio) of the total kappa light chain to total lambda light chain in a biological specimen. Kappa Light Chain to Lambda Light Chain Ratio Measurement Kappa Lt Chain,Free/Lambda Lt Chain,Free A relative measurement (ratio or percentage) of the free kappa light chain to the free lambda light chain in a biological specimen. Free Kappa Light Chain to Free Lambda Light Chain Ratio Measurement Kallikrein-2 A measurement of the kallikrein-2 in a biological specimen. Kallikrein-2 Measurement Kallikrein Related Peptidase 5 Kallikrein-5 Kallikrein-Like Protein 2 KLK-L2 A measurement of the kallikrein-5 in a biological specimen. Kallikrein-5 Measurement Kallikrein Related Peptidase 7 Kallikrein-7 Serine Protease 6 A measurement of the kallikrein-7 in a biological specimen. Kallikrein-7 Measurement Klotho A measurement of the total klotho protein in a biological specimen. Klotho Protein Measurement Megakaryocytes A measurement of the megakaryocytes per unit of a biological specimen. Megakaryocyte Count Megakaryocytes/Total Cells A relative measurement (ratio or percentage) of the megakaryocytes to total cells in a biological specimen (for example a bone marrow specimen). Megakaryocyte to Total Cell Ratio Measurement Megakaryocytes/Leukocytes A relative measurement (ratio or percentage) of the megakaryocytes to leukocytes in a biological specimen. Megakaryocytes to Leukocytes Ratio Measurement Cell Proliferation-Inducing Gene 46 Protein CK-18 CYK18 Cytokeratin 18 K18 Keratin 18 Keratin, Type I Cytoskeletal 18 A measurement of the cytokeratin 18 in a biological specimen. Cytokeratin 18 Measurement 11-Ketoandrosterone A measurement of the 11-ketoandrosterone in a biological specimen. 11-Ketoandrosterone Measurement Ketone Bodies Excretion Rate A measurement of the amount of ketone bodies being excreted in a biological specimen over a defined period of time (e.g. one hour). Ketone Bodies Excretion Rate Measurement 11-Ketoetiocholanolone A measurement of the 11-ketoetiocholanolone in a biological specimen. 11-Ketoetiocholanolone Measurement 17-Ketogenic steroids A measurement of the total 17-ketogenic steroids in a biological specimen. 17-Ketogenic Steroid Measurement Ketoisoleucine A measurement of the ketoisoleucine in a biological specimen. Ketoisoleucine Measurement Ketoleucine A measurement of the ketoleucine in a biological specimen. Ketoleucine Measurement 17-Ketosteroids A measurement of the total 17-ketosteroids in a biological specimen. 17-Ketosteroid Measurement Ketovaline A measurement of the ketovaline in a biological specimen. Ketovaline Measurement Kurloff Cells A measurement of the large secretory granule-containing immune cells in a biological specimen taken from members of certain genera of the Caviidae family. Kurloff Cells Measurement Kynurenine A measurement of the kynurenine in a biological specimen. Kynurenine Measurement Lacosamide A measurement of the lacosamide in a biological specimen. Lacosamide Measurement 2-hydroxypropanoic acid Lactate Lactic Acid A measurement of the lactic acid in a biological specimen. Lactic Acid Measurement Lactose A measurement of the lactose in a biological specimen. Lactose Measurement Lactulose A measurement of the lactulose in a biological specimen. Lactulose Measurement Soluble CD223 Antigen Soluble LAG-3 Soluble Lymphocyte Activation Gene 3 Protein Soluble Lymphocyte Activation Gene-3 A measurement of the soluble lymphocyte activation gene-3 protein in a biological specimen. Soluble Lymphocyte Activation Gene-3 Measurement Lipoarabinomannan A measurement of the lipoarabinomannan in a biological specimen. Lipoarabinomannan Measurement Lysosomal Associated Membrane Protein 2 Lysosomal Membrane Associated Protein 2 Lysosome-Associated Membrane Protein 2 Soluble CD107b A measurement of the lysosomal associated membrane protein 2 present in a biological specimen. Lysosome-Associated Membrane Protein 2 Measurement Cytosol Aminopeptidase LAP3 Leucine Aminopeptidase Leucine Aminopeptidase 3 Leucyl Aminopeptidase A measurement of the total leucine aminopeptidase present in a biological specimen. Leucine Aminopeptidase Measurement LDL Apolipoprotein B A measurement of the apolipoprotein B in the low density lipoprotein fraction of a biological specimen. LDL Fraction Apoliprotein B Measurement Lithocholate Compounds Lithocholic Acid Compounds A measurement of the lithocholic acid, glycolithocholic acid, and taurolithocholic acid in a biological specimen. Lithocholate Compounds Measurement Lithocholate Lithocholic Acid A measurement of the lithocholate in a biological specimen. Lithocholate Measurement Lipocalin-2 Neutrophil Gelatinase-Associated Lipocalin NGAL Oncogene 24p3 A measurement of lipocalin-2 in a biological specimen. Lipocalin-2 Measurement Lipocalin-2/Creatinine Neutrophil Gelatinase-Associated Lipocalin/Creatinine NGAL/Creatinine A relative measurement (ratio or percentage) of the lipocalin-2 to creatinine present in a sample. Lipocalin-2 to Creatinine Ratio Measurement Lecithin/Sphingomyelin LS Ratio A relative measurement (ratio) of the lecithin to sphingomyelin in a biological specimen. Lecithin to Sphingomyelin Ratio Measurement Lactate Dehydrogenase A measurement of the lactate dehydrogenase in a biological specimen. Lactate Dehydrogenase Measurement LDH Isoenzyme 1 A measurement of the lactate dehydrogenase isoenzyme 1 in a biological specimen. Lactate Dehydrogenase Isoenzyme 1 Measurement LDH Isoenzyme 1/LDH A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 1 to total lactate dehydrogenase in a biological specimen. LDH Isoenzyme 1 to LDH Ratio Measurement LDH Isoenzyme 2 A measurement of the lactate dehydrogenase isoenzyme 2 in a biological specimen. Lactate Dehydrogenase Isoenzyme 2 Measurement LDH Isoenzyme 2/LDH A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 2 to total lactate dehydrogenase in a biological specimen. LDH Isoenzyme 2 to LDH Ratio Measurement LDH Isoenzyme 3 A measurement of the lactate dehydrogenase isoenzyme 3 in a biological specimen. Lactate Dehydrogenase Isoenzyme 3 Measurement LDH Isoenzyme 3/LDH A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 3 to total lactate dehydrogenase in a biological specimen. LDH Isoenzyme 3 to LDH Ratio Measurement LDH Isoenzyme 4 A measurement of the lactate dehydrogenase isoenzyme 4 in a biological specimen. Lactate Dehydrogenase Isoenzyme 4 Measurement LDH Isoenzyme 4/LDH A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 4 to total lactate dehydrogenase in a biological specimen. LDH Isoenzyme 4 to LDH Ratio Measurement LDH Isoenzyme 5 A measurement of the lactate dehydrogenase isoenzyme 5 in a biological specimen. Lactate Dehydrogenase Isoenzyme 5 Measurement LDH Isoenzyme 5/LDH A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 5 to total lactate dehydrogenase in a biological specimen. LDH Isoenzyme 5 to LDH Ratio Measurement Lactate Dehydrogenase/Creatinine A relative measurement (ratio or percentage) of the lactate dehydrogenase to creatinine in a biological specimen. Lactate Dehydrogenase to Creatinine Ratio Measurement Lactate Dehydrogenase Excretion Rate A measurement of the amount of lactate dehydrogenase being excreted in a biological specimen over a defined amount of time (e.g. one hour). Lactate Dehydrogenase Excretion Rate LDL Cholesterol A measurement of the low density lipoprotein cholesterol in a biological specimen. Low Density Lipoprotein Cholesterol Measurement LDL Cholesterol/HDL Cholesterol A relative measurement (ratio) of the low density lipoprotein cholesterol to high density lipoprotein cholesterol in a biological specimen. LDL Cholesterol to HDL Cholesterol Ratio Measurement Oxidized LDL Cholesterol A measurement of the oxidized low density lipoprotein cholesterol in a biological specimen. Oxidized LDL Cholesterol Measurement LDL Particles A measurement of the concentration of the total LDL particles in a biological specimen. LDL Particles Measurement LDL Subtype Pattern A description of the low density lipoprotein particle pattern (an interpretation of the amounts of LDL particles based on size and density) in a biological specimen. LDL Subtype Pattern LDL Particle Size A measurement of the average particle size of low-density lipoprotein in a biological specimen. LDL Particle Size Measurement LDL Triglyceride A measurement of the low density lipoprotein triglyceride in a biological specimen. LDL Triglyceride Measurement Lead Pb A measurement of the lead in a specimen. Lead Measurement Immature Leukocytes A measurement of the immature leukocytes in a biological specimen. Immature Leukocyte Count Immature Leukocytes/Leukocytes A relative measurement (ratio or percentage) of the immature leukocytes to leukocytes in a biological specimen. Immature Leukocyte to Leukocytes Ratio Measurement Leptin A measurement of the leptin hormone in a biological specimen. Leptin Measurement CD295 LEP-R LEPR Leptin Receptor OB Receptor A measurement of the leptin receptor in a biological specimen. Leptin Receptor Measurement Leptocytes A measurement of the leptocytes in a biological specimen. Leptocyte Measurement Leucine A measurement of the leucine in a biological specimen. Leucine Measurement Leukocyte Esterase A measurement of the enzyme which indicates the presence of white blood cells in a biological specimen. Leukocyte Esterase Measurement Leukemic Cells Residual Leukemic Cells A measurement of the leukemic cells in a biological specimen. Leukemic Cells Measurement Leukocytes Corrected for Nucleated Erythrocytes Leuks Corrected for Nucl Erythrocytes A measurement of the leukocytes corrected for nucleated erythrocytes in a biological specimen. Leukocytes Corrected for Nucleated Erythrocytes Count Large Unstained Cells/Leukocytes A relative measure (ratio or percentage) of the large unstained cells to leukocytes in a biological specimen. Large Unstained Cells to Leukocytes Ratio Measurement Large Unstained Cells A measurement of the large, peroxidase-negative cells which cannot be further characterized (i.e. as large lymphocytes, virocytes, or stem cells) present in a biological specimen. Large Unstained Cell Count Luteinizing Hormone Lutropin A measurement of the luteinizing hormone in a biological specimen. Luteinizing Hormone Measurement Leukemia Inhibitory Factor A measurement of leukemia inhibitory factor in a biological specimen. Leukemia Inhibitory Factor Measurement Gastric Triacylglycerol Lipase Lipase, Gastric LIPF A measurement of the gastric triacylglycerol lipase in a biological specimen. Gastric Lipase Measurement Hepatic Triacylglycerol Lipase Lipase, Hepatic LIPH A measurement of the hepatic triacylglycerol lipase in a biological specimen. Hepatic Triacylglycerol Lipase Measurement Lipase, Pancreatic Pancreatic Triacylglycerol Lipase PNLIP A measurement of the pancreatic triacylglycerol lipase in a biological specimen. Pancreatic Lipase Measurement Lipase Total Lipase Triacylglycerol Lipase A measurement of the total triacylglycerol lipase in a biological specimen. Lipase Measurement Acid Cholesteryl Ester Hydrolase LAL LIPA Lipase, Lysosomal Acid Lysosomal Lipase A measurement of the lysosomal acid lipase in a biological specimen. Lysosomal Acid Lipase Measurement Lipemia Lipemic Index A measurement of the abnormally high concentration of lipid in a biological specimen. Lipemic Index Lipid Total Lipid A measurement of the total lipids (cholesterol, lipoproteins, and triglycerides) in a biological specimen. Lipid Measurement Liquefaction Time A measurement of the time it takes for a gelatinous or semi-solid substance to change to a liquid. Liquefaction Time Measurement Lithium A measurement of the lithium in a biological specimen. Lithium Measurement Bence-Jones, Lambda Lambda Light Chain, Free A measurement of the free lambda light chain in a biological specimen. Free Lambda Light Chain Measurement Lambda Light Chain A measurement of the total lambda light chains in a biological specimen. Lambda Light Chain Measurement LAMP2/GAPDH Lysosomal Associated Membrane Protein 2/Glyceraldehyde-3-Phosphate Dehydrogenase A relative measurement (ratio) of the lysosomal associated membrane protein 2 to glyceraldehyde-3-phosphate dehydrogenase in a biological specimen. Lysosomal Associated Membrane Protein 2 to Glyceraldehyde-3-Phosphate Dehydrogenase Ratio Measurement Loprazolam A measurement of the loprazolam in a biological specimen. Loprazolam Measurement C-Type Lectin Domain Family 8 Member A CLEC8A Lectin-Like Oxidized LDL Receptor-1 LOX-1 Oxidized LDL Receptor 1 Oxidized Low-Density Lipoprotein Receptor 1 A measurement of the lectin-like oxidized LDL Receptor-1 in a biological specimen. Lectin-Like Oxidized LDL Receptor-1 Measurement Loxapine A measurement of the loxapine in a biological specimen. Loxapine Measurement Lipoprotein-a A measurement of the lipoprotein-a in a biological specimen. Lipoprotein a Measurement Lipoprotein Lipase A measurement of the lipoprotein lipase in a biological specimen. Lipoprotein Lipase Measurement Lipoprotein Associated Phospholipase A2 A measurement of the lipoprotein associated phospholipase A2 in a biological specimen. Lipoprotein Associated Phospholipase A2 Measurement HMFT1766 Leucine Rich Alpha-2-Glycoprotein 1 A measurement of the leucine rich alpha-2-glycoprotein 1 in a biological specimen. Leucine Rich Alpha-2-Glycoprotein 1 Measurement Lormetazepam A measurement of the lormetazepam in a biological specimen. Lormetazepam Measurement Lorazepam A measurement of the lorazepam present in a biological specimen. Lorazepam Measurement Acid Lysergate Diethylamide Lysergic Acid Diethylamide A measurement of the lysergic acid diethylamine (LSD) in a biological specimen. Lysergide Measurement sL-Selectin Soluble CD62L Soluble L-Selectin A measurement of the soluble L-selectin in a biological specimen. Soluble L-Selectin Measurement Lymphotoxin Alpha TNF-beta Tumor Necrosis Factor Beta A measurement of the lymphotoxin alpha in a biological specimen. Lymphotoxin Alpha Measurement Leukotriene B4 A measurement of the leukotriene B4 in a biological specimen. Leukotriene B4 Measurement Leukotriene C4 Synthase A measurement of the leukotriene C4 synthase in a biological specimen. Leukotriene C4 Synthase Measurement Leukotriene D4 A measurement of the leukotriene D4 in a biological specimen. Leukotriene D4 Measurement Leukotriene E4 A measurement of the leukotriene E4 in a biological specimen. Leukotriene E4 Measurement Lactoferrin Lactotransferrin A measurement of the lactoferrin in a biological specimen. Lactoferrin Measurement Lurasidone A measurement of the lurasidone in a biological specimen. Lurasidone Measurement Liver Fibrosis Score A scoring system that evaluates liver pathology through the assessment of multiple blood test parameters, taking into account additional demographic factors such as the age and/or sex of the subject. Liver Fibrosis Score Levorphanol A measurement of the levorphanol in a biological specimen. Levorphanol Measurement Levetiracetam A measurement of the levetiracetam in a biological specimen. Levetiracetam Measurement Lymphocyte Antigen 6 Family Member E Lymphocyte Antigen 6E A measurement of the lymphocyte antigen 6E in a biological specimen. Lymphocyte Antigen 6E Measurement Lymphocytes A measurement of the lymphocytes in a biological specimen. Lymphocyte Count Lymphocytes Activated A measurement of the total activated lymphocytes in a biological specimen. Activated Lymphocytes Measurement Lymphocytes Atypical Lymphocytes, Variant Reactive Lymphocytes A measurement of the atypical lymphocytes in a biological specimen. Atypical Lymphocyte Count Lymphocytes Atypical/Leukocytes Lymphocytes, Variant/Leukocytes Reactive Lymphocytes/Leukocytes A relative measurement (ratio or percentage) of the atypical lymphocytes to leukocytes in a biological specimen. Atypical Lymphocyte to Leukocyte Ratio Measurement Atypical Lymphocytes/Lymphocytes Lymphocytes Atypical/Lymphocytes Reactive Lymphocytes/Lymphocytes Variant Lymphocytes/Lymphocytes A relative measurement (ratio or percentage) of the atypical lymphocytes to all lymphocytes in a biological specimen. Reactive Lymphocyte to Lymphocyte Ratio Measurement Lymphocytes/Total Cells A relative measurement (ratio or percentage) of the lymphocytes to total cells in a biological specimen (for example a bone marrow specimen). Lymphocyte to Total Cell Ratio Measurement Lymphocytes, Clefted A measurement of the clefted lymphocytes in a biological specimen. Clefted Lymphocytes Count Lymphocytes, Clefted/Leukocytes A relative measurement (ratio or percentage) of the clefted lymphocytes to total leukocytes in a biological specimen. Clefted Lymphocytes to Leukocytes Ratio Measurement Immature Lymphocytes A measurement of the immature lymphocytes in a biological specimen. Immature Lymphocytes Measurement Immature Lymphocytes/Leukocytes A relative measurement (ratio or percentage) of the immature lymphocytes to leukocytes in a biological specimen. Immature Lymphocytes to Leukocytes Ratio Measurement Lymphocytes/Leukocytes A relative measurement (ratio or percentage) of the lymphocytes to leukocytes in a biological specimen. Lymphocyte to Leukocyte Ratio Large Lymphocytes A measurement of the large lymphocytes (approximately between 10 um and 20 um in diameter) in a biological specimen. Large Lymphocyte Count Lymphoma Cells A measurement of the malignant lymphocytes in a biological specimen. Lymphoma Cell Count Lymphoma Cells/Total Cells A relative measurement (ratio or percentage) of the lymphoma cells to total cells in a biological specimen. Lymphoma Cell to Total Cell Ratio Measurement Lymphoma Cells/Leukocytes A relative measurement (ratio or percentage) of the malignant lymphocytes to all leukocytes in a biological specimen. Lymphoma Cells to Leukocytes Ratio Measurement Lymphoma Cells/Lymphocytes A relative measurement (ratio or percentage) of the malignant lymphocytes to all lymphocytes in a biological specimen. Lymphoma Cell to Lymphocyte Ratio Measurement Lymphocytes/Neutrophils A relative measurement (ratio) of lymphocytes to neutrophils in a biological specimen. Lymphocyte to Neutrophil Ratio Measurement Lymphocytes/Non-Squam Epi Cells A relative measurement (ratio or percentage) of the lymphocytes to non-squamous epithelial cells in a biological specimen. Lymphocytes to Non-Squamous Epithelial Cells Ratio Measurement Lymphoid Cells A measurement of the total lymphoid lineage cells in a biological specimen. Lymphoid Cell Count Chemokine Ligand 1 Lymphotactin A measurement of the lymphotactin in a biological specimen. Lymphotactin Measurement Plasmacytoid Lymphocytes Plymphocytes A measurement of the plasmacytoid lymphocytes (lymphocytes with peripherally clumped chromatin and often deep blue cytoplasm, and that appear similar to plasma cells) in a biological specimen. Plasmacytoid Lymphocyte Count Plasmacytoid Lymphocytes/Leukocytes A relative measurement (ratio or percentage) of the plasmacytoid lymphocytes to all leukocytes in a biological specimen. Plasmacytoid Lymphocytes to Leukocytes Ratio Measurement Plasmacytoid Lymphocytes/Lymphocytes A relative measurement (ratio or percentage) of the plasmacytoid lymphocytes (lymphocytes with peripherally clumped chromatin and often deep blue cytoplasm, and that appear similar to plasma cells) to all lymphocytes in a biological specimen. Plasmacytoid Lymphocyte to Lymphocyte Ratio Measurement Vacuolated Lymphocytes A measurement of the vacuolated lymphocytes in a biological specimen. Vacuolated Lymphocyte Count Vacuolated Lymphocytes/Leukocytes A relative measurement (ratio or percentage) of the vacuolated lymphocytes to leukocytes in a biological specimen. Vacuolated Lymphocyte to Leukocyte Ratio Measurement Lysine A measurement of the lysine in a biological specimen. Lysine Measurement Globotriaosylsphingosine Lyso-Gb3 Lyso-GL3 A measurement of the globotriaosylsphingosine in a biological specimen. Globotriaosylsphingosine Measurement Glucopsychosine Glucosylsphingosine Lyso-GL1 A measurement of the glucopsychosine in a biological specimen. Glucopsychosine Measurement Lysozyme A measurement of lysozyme in a biological specimen. Lysozyme Measurement Scavenger Rcpt Cys-Rich Type1 Prot M130 Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Soluble CD163 Soluble CD163a A measurement of the scavenger receptor cysteine-rich type 1 protein M130 in a biological specimen. Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement MAB-CHMINACA A measurement of the synthetic cannabinoid MAB-CHMINACA in a biological specimen. MAB-CHMINACA Measurement Macroscopic Blood Visible Blood A measurement of the blood in body products such as a urine or stool sample, and visibly detectable on gross examination. Macroscopic Blood Measurement Macrocytes A measurement of the macrocytes in a biological specimen. Macrocyte Count Mannitol A measurement of the mannitol in a biological specimen. Mannitol Measurement Monoamine Oxidase A measurement of the total monoamine oxidase in a biological specimen. Monoamine Oxidase Measurement Mast Cells Mastocytes A measurement of the mast cells in a biological specimen. Mast Cell Count Mast Cells/Total Cells A relative measurement (ratio or percentage) of the mast cells to total cells in a biological specimen. Mast Cell to Total Cell Ratio Measurement Mast Cells/Leukocytes A relative measurement (ratio or percentage) of mast cells to total leukocytes in a biological specimen. Mast Cells to Leukocytes Ratio Measurement May-Hegglin Anomaly A measurement of the May-Hegglin anomaly in a blood sample. This anomaly is characterized by large, misshapen platelets and the presence of Dohle bodies in leukocytes. May-Hegglin Anomaly Measurement Mazindol A measurement of the mazindol in a biological specimen. Mazindol Measurement Myelin Basic Protein A measurement of the myelin basic protein in a biological specimen. Myelin Basic Protein Measurement 2-Methylcitrate 2-Methylcitric Acid MCA Methylcitrate Methylcitric Acid A measurement of the 2-methylcitrate in a biological specimen. 2-Methylcitrate Measurement Ephedrone Methcathinone A measurement of the methcathinone in a biological specimen. Methcathinone Measurement Ery. Mean Corpuscular Hemoglobin A measurement of the mean amount of hemoglobin per erythrocyte in a biological specimen, calculated as the product of hemoglobin times ten, divided by the number of erythrocytes. Erythrocyte Mean Corpuscular Hemoglobin Ery. Mean Corpuscular HGB Concentration An indirect measurement of the average concentration of hemoglobin per erythrocyte in a biological specimen, calculated as the ratio of hemoglobin to hematocrit. Erythrocyte Mean Corpuscular Hemoglobin Concentration CCL2 Chemokine (C-C Motif) Ligand 2 Monocyte Chemoattractant Protein-1 Monocyte Chemotactic Protein 1 A measurement of the monocyte chemotactic protein 1 in a biological specimen. Monocyte Chemotactic Protein 1 Measurement CCL2/Creatinine Chemokine (C-C Motif) Ligand 2/Creatinine Monocyte Chemotactic Protein 1/Creatinine Monocyte Chemotactic Protein1/Creatinine A relative measurement (ratio or percentage) of the monocyte chemotactic protein 1 to creatinine in a biological specimen. Monocyte Chemotactic Protein 1 to Creatinine Ratio Measurement Macrophages A measurement of the macrophages in a biological specimen. Macrophage Count Macrophages/Total Cells A relative measurement (ratio or percentage) of the macrophages to total cells in a biological specimen. Macrophage to Total Cell Ratio Measurement Macrophages/Leukocytes A relative measurement (ratio or percentage) of the macrophages to leukocytes in a biological specimen. Macrophage to Leukocyte Ratio Macrophages/Non-Squam Epi Cells A relative measurement (ratio or percentage) of the macrophages to non-squamous epithelial cells in a biological specimen. Macrophages to Non-Squamous Epithelial Cells Ratio Measurement Abnormal Gamma Protein Band M Protein M-Spike Paraprotein M-Spike Protein Monoclonal Immunoglobulin Protein Monoclonal Protein Monoclonal Protein Spike Myeloma Protein Paraprotein A measurement of homogenous immunoglobulin resulting from the proliferation of a single clone of plasma cells in a biological specimen. Monoclonal Protein Measurement Macrophage Colony Stimulating Factor A measurement of the macrophage colony stimulating factor in a biological specimen. Macrophage Colony Stimulating Factor Measurement Ery. Mean Corpuscular Volume Erythrocytes Mean Corpuscular Volume RBC Mean Corpuscular Volume A measurement of the mean cellular volume per erythrocyte in a biological specimen. Erythrocyte Mean Corpuscular Volume MCV Reticulocytes MCVr Mean Corpuscular Volume Reticulocytes A measurement of the mean volume of reticulocytes in a biological specimen. Reticulocyte Mean Corpuscular Volume 3,4-methylenedioxyamphetamine A measurement of the 3,4-methylenedioxyamphetamine in a biological specimen. 3,4-methylenedioxyamphetamine Measurement Malondialdehyde MDA A measurement of the malondialdehyde in a biological specimen. Malondialdehyde Measurement C-C Motif Chemokine Ligand 22 CCL22 Chemokine (C-C Motif) Ligand 22 Chemokine Ligand 22 Macrophage-Derived Chemokine A measurement of the macrophage-derived chemokine in a biological specimen. Macrophage-Derived Chemokine Measurement 3,4-methylenedioxy-N-ethylamphetamine Eve MDE A measurement of the 3,4-methylenedioxy-N-ethylamphetamine in a biological specimen. 3,4-methylenedioxy-N-ethylamphetamine Measurement 3,4-methylenedioxymethamphetamine Ecstasy A measurement of the 3,4-methylenedioxymethamphetamine (MDMA) in a biological specimen. 3,4-Methylenedioxymethamphetamine Measurement Monocyte Distribution Width A measurement of the monocyte volume dispersion in a biological specimen. Monocyte Distribution Width Measurement Midazolam A measurement of the midazolam present in a biological specimen. Midazolam Measurement Medazepam A measurement of the medazepam present in a biological specimen. Medazepam Measurement Meconium A measurement of the meconium in a biological specimen. Meconium Measurement Meningeal Cells A measurement of the mengingeal cells in a biological specimen. Meningeal Cell Count Meningeal Cells/Total Cells A relative measurement (ratio or percentage) of the meningeal cells to total cells in a biological specimen. Meningeal Cell to Total Cell Ratio Measurement Meperidine A measurement of the meperidine in a biological specimen. Meperidine Measurement Erythroid Precursors/Total Cells Maturing Erythroid Cells/Total Cells Maturing Erythroid/Total Cells Total Erythroid Precursors/Total Cells A relative measurement (ratio or percentage) of the maturing erythroid cells to total cells in a biological specimen. Maturing Erythroid Cell to Total Cell Ratio Measurement Hg Mercury A measurement of the mercury in a specimen. Mercury Measurement 3,4,5-trimethoxyphenethylamine Mescaline A measurement of the mescaline in a biological specimen. Mescaline Measurement Mesoridazine A measurement of the mesoridazine in a biological specimen. Mesoridazine Measurement Methionine A measurement of the methionine in a biological specimen. Methionine Measurement Metamyelocytes A measurement of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) in a biological specimen. Metamyelocyte Count Metamyelocytes/Total Cells A relative measurement (ratio or percentage ) of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) to total cells in a biological specimen (for example a bone marrow specimen). Metamyelocyte to Total Cell Ratio Measurement Metamyelocytes/Leukocytes A relative measurement (ratio or percentage) of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) to all leukocytes in a biological specimen. Metamyelocyte to Leukocyte Ratio Measurement Metadrenaline Metanephrine A measurement of the metanephrine in a biological specimen. Metanephrine Measurement Metanephrine Excretion Rate A measurement of the amount of metanephrine being excreted in a biological specimen over a defined amount of time (e.g. one hour). Metanephrine Excretion Rate Metarubricyte/Total Cells A relative measurement (ratio or percentage) of the metarubricytes to total cells in a biological specimen. Metarubricyte to Total Cell Ratio Measurement Metarubricytes/Leukocytes A relative measurement (ratio or percentage) of the metarubricytes to leukocytes in a biological specimen. Metarubricyte to Leukocyte Ratio Measurement Acidophilic Erythroblast Metarubricyte Orthochromatophilic Normoblast Orthochromic Erythroblast Orthochromic Normoblast A measurement of the metarubricytes in a biological specimen. Metarubricyte Count Methyltransferase A measurement of the total methyltransferase in a biological specimen. Methyltransferase Measurement Methamphetamine A measurement of the methamphetamine drug present in a biological specimen. Methamphetamine Measurement CH4 Methane A measurement of the methane in a biological specimen. Methane Measurement Methanol A measurement of the methanol in a biological specimen. Methanol Measurement Methadone A measurement of the methadone present in a biological specimen. Methadone Measurement Methylphenidate A measurement of the methylphenidate in a biological specimen. Methylphenidate Measurement Methaqualone A measurement of the methaqualone present in a biological specimen. Methaqualone Measurement Mefenorex A measurement of the mefenorex in a biological specimen. Mefenorex Measurement Magnesium A measurement of the magnesium in a biological specimen. Magnesium Measurement Myoglobin A measurement of myoglobin in a biological specimen. Myoglobin Measurement Myoglobin/Creatinine A relative measurement (ratio or percentage) of the myoglobin to creatinine present in a sample. Myoglobin to Creatinine Ratio Measurement Magnesium/Creatinine A relative measurement (ratio or percentage) of the magnesium to creatinine in a biological specimen. Magnesium to Creatinine Ratio Measurement Magnesium, Ionized A measurement of the ionized magnesium in a biological specimen. Ionized Magnesium Measurement MHBMA Monohydroxy-3-butenyl Mercapturic Acid Monohydroxybutenyl Mercapturate Monohydroxybutenyl Mercapturic Acid A measurement of the monohydroxybutenyl mercapturic acid in a specimen. Monohydroxybutenyl Mercapturic Acid Measurement MHC Class I Chain Related Protein A A measurement of the MHC class I chain related protein A in a biological specimen. MHC Class I Chain Related Protein A Measurement Microcytes A measurement of the microcytes in a biological specimen. Microcyte Count Mid Cell Fraction Mid Cells A measurement of the mid cell fraction, including eosinophils, basophils, monocytes and other precursor white blood cells, in a biological specimen. Mid Cell Fraction Measurement Macrophage Inflammatory Protein 1 A measurement of total macrophage inflammatory protein 1 in a biological specimen. Macrophage Inflammatory Protein 1 Measurement Chemokine Ligand 3 Macrophage Inflammatory Protein 1 Alpha A measurement of the macrophage inflammatory protein 1 alpha in a biological specimen. Macrophage Inflammatory Protein 1 Alpha Measurement Chemokine Ligand 4 Macrophage Inflammatory Protein 1 Beta A measurement of the macrophage inflammatory protein 1 beta in a biological specimen. Macrophage Inflammatory Protein 1 Beta Measurement Macrophage Inflammatory Protein 1 Gamma A measurement of the macrophage inflammatory protein 1 gamma in a biological specimen. Macrophage Inflammatory Protein 1 Gamma Measurement Megakaryocyte and Megakaryoblast Morph Megakaryocyte and Megakaryoblast Morphology An examination or assessment of the form and structure of megakaryoblasts and megakaryocytes. Megakaryocyte and Megakaryoblast Morphology Assessment Melatonin A measurement of the melatonin hormone in a biological specimen. Melatonin Measurement Malignant Cells, NOS A measurement of the malignant cells of all types in a biological specimen. Malignant Cell Count Malignant Cells, NOS/Blood Cells A relative measurement (ratio or percentage) of the malignant cells of all types to all blood cells in a biological specimen. Malignant Cell to Blood Cell Ratio Measurement Milnacipran A measurement of the milnacipran in a biological specimen. Milnacipran Measurement Mixed Leukocyte Reaction Mixed Lymphocyte Reaction A measurement of the histocompatibility at the HL-A locus between two populations of lymphocytes taken from two separate individuals. Mixed Lymphocyte Reaction Test Methylmalonate Methylmalonic Acid A measurement of the methylmalonic acid in a biological specimen. Methylmalonic Acid Measurement Monomethylarginine Tilarginine A measurement of the monomethylarginine in a biological specimen. Monomethylarginine Measurement Macrophage Migration Inhibitory Factor MIF A measurement of the macrophage migration inhibitory factor in a biological specimen. Macrophage Migration Inhibitory Factor Measurement Interstitial Collagenase Matrix Metalloproteinase 1 A measurement of the matrix metalloproteinase 1 in a biological specimen. Matrix Metalloproteinase 1 Measurement Matrix Metalloproteinase 10 Stromelysin 2 A measurement of the matrix metalloproteinase 10 in a specimen. Matrix Metalloproteinase 10 Measurement Macrophage Elastase Macrophage Metalloelastase Matrix Metallopeptidase 12 Matrix Metalloproteinase 12 MME A measurement of the matrix metalloproteinase 12 in a specimen. Matrix Metalloproteinase 12 Measurement CLG3 Collagenase 3 Matrix Metalloproteinase 13 A measurement of the matrix metalloproteinase 13 in a specimen. Matrix Metalloproteinase 13 Measurement Gelatinase A Matrix Metalloproteinase 2 A measurement of the matrix metalloproteinase 2 in a biological specimen. Matrix Metalloproteinase 2 Measurement Matrix Metalloproteinase 3 Stromelysin 1 A measurement of the matrix metalloproteinase 3 in a biological specimen. Matrix Metalloproteinase 3 Measurement Matrilysin Matrix Metalloproteinase 7 A measurement of the matrix metalloproteinase 7 in a biological specimen. Matrix Metalloproteinase 7 Measurement Matrix Metalloproteinase 8 Neutrophil Collagenase A measurement of the matrix metalloproteinase 8 in a biological specimen. Matrix Metalloproteinase 8 Measurement Gelatinase B Matrix Metalloproteinase 9 A measurement of the matrix metalloproteinase 9 in a biological specimen. Matrix Metalloproteinase 9 Measurement Maturing Myeloid/Total Cells A relative measurement (ratio or percentage) of the maturing myeloid cells to total cells in a biological specimen. Maturing Myeloid Cell to Total Cell Ratio Measurement Mononuclear Cells Mononucleated Cells A measurement of the mononuclear cells in a biological specimen. Mononuclear Cell Count Mononuclear Cells Atypical A measurement of the atypical mononuclear cells in a biological specimen. Atypical Mononuclear Cell Count Mononuclear Cells Atypical/Leukocytes A relative measurement (ratio or percentage) of the atypical mononuclear cells to leukocytes in a biological specimen. Atypical Mononuclear Cells to Leukocytes Ratio Measurement Monocytoid Cells A measurement of the monocytoid cells in a biological specimen. Monocytoid Cell Count Monocytoid Cells/Total Cells A relative measurement (ratio or percentage) of the monocytoid cells to total cells in a biological specimen. Monocytoid Cell to Total Cell Ratio Measurement Monocytoid Cells/Leukocytes A relative measurement (ratio or percentage) of the monocytoid cells to leukocytes in a biological specimen. Monocytoid Cells to Leukocytes Ratio Measurement Modafinil A measurement of the modafinil in a biological specimen. Modafinil Measurement Methohexital A measurement of the methohexital in a biological specimen. Methohexital Measurement Molindone A measurement of the molindone in a biological specimen. Molindone Measurement Monocytes and Macrophages/Leukocytes A relative measurement (ratio or percentage) of the monocytes and macrophages to total leukocytes in a biological specimen. Monocytes and Macrophages to Leukocytes Ratio Measurement Monocytes A measurement of the monocytes in a biological specimen. Monocyte Count Monoblasts A measurement of the monoblast cells in a biological specimen. Monoblast Count Monoblasts/Total Cells A relative measurement (ratio or percentage) of the monoblasts to total cells in a biological specimen. Monoblast to Total Cell Ratio Measurement Monoblasts/Leukocytes A relative measurement (ratio or percentage) of the monoblasts to leukocytes in a biological specimen. Monoblast to Leukocyte Ratio Measurement Monocytes/Total Cells A relative measurement (ratio or percentage) of the monocytes to total cells in a biological specimen (for example a bone marrow specimen). Monocytes to Total Cell Ratio Measurement Immature Monocytes A measurement of the immature monocytes in a biological specimen. Immature Monocyte Count Immature Monocytes/Leukocytes A relative measurement (ratio or percentage) of immature monocytes to total leukocytes in a biological specimen. Immature Monocyte to Leukocyte Ratio Measurement Monocytes/Leukocytes A relative measurement (ratio or percentage) of the monocytes to leukocytes in a biological specimen. Monocyte to Leukocyte Ratio Monocytes/Macrocytes A relative measurement (ratio or percentage) of the monocytes to macrocytes present in a sample. Monocytes to Macrocytes Ratio Measurement Monocytes/Non-Squam Epi Cells A relative measurement (ratio or percentage) of the monocytes to non-squamous epithelial cells in a biological specimen. Monocytes to Non-Squamous Epithelial Cells Ratio Measurement M Protein/Total Protein M-Spike Protein/Total Protein Monoclonal Protein Spike/Total Protein Monoclonal Protein/Total Protein Myeloma Protein/Total Protein A relative measurement (ratio or percentage) of the monoclonal protein to total protein in a biological specimen. Monoclonal Protein to Total Protein Ratio Measurement Desomorphine A measurement of the desomorphine in a biological specimen. Desomorphine Measurement Ethylmorphine A measurement of the ethylmorphine in a biological specimen. Ethylmorphine Measurement Morphine A measurement of the morphine present in a biological specimen. Morphine Measurement Nicomorphine A measurement of the nicomorphine in a biological specimen. Nicomorphine Measurement Normorphine A measurement of the normorphine in a biological specimen. Normorphine Measurement Mean Platelet Component A measurement of the mean platelet component (platelet activity) in a blood specimen. Mean Platelet Component Measurement Mephedrone A measurement of the mephedrone in a biological specimen. Mephedrone Measurement Mephobarbital Methylphenobarbital A measurement of the methylphenobarbital in a biological specimen. Mephobarbital Measurement Immunoglobulin Immunofixation Interpretation Monoclonal Prot Immunoglobulin Isotype Monoclonal Protein Immunoglobulin Class Monoclonal Protein Immunoglobulin Isotype The identification of the monoclonal protein immunoglobulin isotype in a biological specimen. Monoclonal Protein Immunoglobulin Isotype Determination Mean Platelet Dry Mass A measurement of the mean platelet dry mass in a biological specimen. Mean Platelet Dry Mass Myeloperoxidase A measurement of the myeloperoxidase in a biological specimen. Myeloperoxidase Measurement Meprobamate A measurement of the meprobamate in a biological specimen. Meprobamate Measurement M Protein Excretion Rate M-Spike Protein Excretion Rate Monoclonal Protein Excretion Rate Monoclonal Protein Spike Excretion Rate Myeloma Protein Excretion Rate A measurement of the amount of Monoclonal Protein being excreted in a biological specimen over a defined amount of time (e.g. one hour). Monoclonal Protein Excretion Rate Monoclonal Protein Band Region Monoclonal Protein Region Monoclonal Protein Spike Region The identification of the protein zone (e.g., alpha-1 globulin, beta globulin, etc.) within which the monoclonal protein is observed. Monoclonal Protein Spike Region Identification Methyprylon A measurement of the methyprylon in a biological specimen. Methyprylon Measurement Mean Platelet Volume A measurement of the average size of the platelets present in a blood sample. Mean Platelet Volume Measurement Myeloperoxidase Index The mean peroxidase activity index or staining intensity of the neutrophil population relative to the archetype. Neutrophil Myeloperoxidase Index Alpha Melanocyte Stimulating Hormone Alpha-MSH A measurement of the alpha melanocyte stimulating hormone in a biological specimen. Alpha Melanocyte Stimulating Hormone Measurement Mesothelial Cells A measurement of the mesothelial cells in a biological specimen. Mesothelial Cells Count Mesothelial Cells/Leukocytes A relative measurement (ratio or percentage) of the mesothelial cells to total leukocytes in a biological specimen. Mesothelial Cells to Leukocytes Ratio Measurement Mesterelone Mesterolone A measurement of the mesterolone in a biological specimen. Mesterolone Measurement Methyltestosterone A measurement of the methyltestosterone in a biological specimen. Methyltestosterone Measurement Methasterone A measurement of the methasterone in a biological specimen. Methasterone Measurement 3-Methoxytyramine A measurement of the total 3-methoxytyramine in a biological specimen. Total 3-Methoxytyramine Measurement 3-Methoxytyramine, Free A measurement of the free 3-methoxytyramine in a biological specimen. Free 3-Methoxytyramine Measurement Metanephrine, Free A measurement of the free metanephrine in a biological specimen. Free Metanephrine Measurement Metanephrine+Normetanephrine Excr Rate Metanephrine+Normetanephrine Excretion Rate A measurement of the amount of metanephrine and normetanephrine being excreted in a biological specimen over a defined amount of time (e.g., one hour). Metanephrine and Normetanephrine Excretion Rate Metanephrine+Normetanephrine A measurement of the metanephrine and normetanephrine in a biological specimen. Metanephrine and Normetanephrine Measurement Mucous Threads A measurement of the mucous threads present in a biological specimen. Mucous Thread Measurement Murinoglobulin A measurement of the murinoglobulin in a biological specimen. Murinoglobulin Measurement Interferon-Induced GTP-Binding Protein Mx1 Interferon-Induced Protein p78 A measurement of the interferon-induced protein P78 in a biological specimen. Interferon-Induced Protein p78 Measurement Myeloblasts Myeloid Blasts A measurement of the myeloblast cells in a biological specimen. Myeloblast Count Myeloblasts/Leukocytes A relative measurement (ratio or percentage) of the myeloblasts to leukocytes in a biological specimen. Myeloblast to Leukocyte Ratio Type I Myeloblasts A measurement of type I myeloblast cells per unit of a biological specimen. Type I Myeloblasts Measurement Type II Myeloblasts A measurement of type II myeloblast cells per unit of a biological specimen. Type II Myeloblasts Measurement Type III Myeloblasts A measurement of type III myeloblast cells per unit of a biological specimen. Type III Myeloblasts Measurement Myeloid Maturation Index A relative measurement (ratio) of the sum of myeloid maturation phase cells (pool) to the sum of myeloid proliferative phase cells (pool) in a biological specimen. Myeloid Maturation Index Myeloid Maturation Pool A measurement of the myeloid maturation phase cells (metamyelocytes, band neutrophils, and segmented neutrophils) in a biological specimen. Myeloid Maturation Pool Count Myeloid Proliferation Index A relative measurement (ratio) of the sum of myeloid proliferative phase cells (pool) to the sum of myeloid maturation phase cells (pool) in a biological specimen. Myeloid Proliferation Index Myeloid Proliferation Pool A measurement of the myeloid proliferative phase cells (myeloblasts, promyelocytes, and myelocytes) in a biological specimen. Myeloid Proliferation Pool Count Myelocytes A measurement of the myelocytes in a biological specimen. Myelocyte Count Myelocytes/Total Cells A relative measurement (ratio or percentage) of the myelocytes to total cells in a biological specimen (for example a bone marrow specimen). Myelocyte to Total Cell Ratio Measurement Myelocytes/Leukocytes A relative measurement (ratio or percentage) of the myelocytes to leukocytes in a biological specimen. Myelocyte to Leukocyte Ratio Cardiac myosin light chain 1 Myosin light chain 1, slow-twitch muscle B/ventricular isoform Myosin Light Chain 3 A measurement of myosin light chain 3 in a biological specimen. Myosin Light Chain 3 Measurement Myeloid Progenitor Cells A measurement of the myeloid progenitor cells in a biological specimen. Myeloid Progenitor Cell Count Myeloid Progenitor Cells/Total Cells A relative measurement (ratio or percentage) of the myeloid progenitor cells to total cells in a biological specimen. Myeloid Progenitor Cell to Total Cell Ratio Measurement Sodium Clearance A measurement of the volume of serum or plasma that would be cleared of sodium by excretion of urine for a specified unit of time (e.g. one minute). Sodium Clearance Measurement Sodium/Creatinine A relative measurement (ratio or percentage) of the sodium to creatinine in a biological specimen. Sodium to Creatinine Ratio Measurement N-Acetyl Glucosamide N-Acetyl Glucosamine A measurement of N-acetyl glucosamide (sugar derivative) in a biological specimen. N-Acetyl Glucosamide Measurement Beta-N-acetyl-D-glucosaminidase N-acetyl-beta-D-glucosaminidase A measurement of the N-acetyl-beta-D-glucosaminidase (enzyme) in a biological specimen. N-acetyl-beta-D-glucosaminidase Measurement N-acetyl-B-D-glucosaminidase/Creatinine A relative measurement (ratio or percentage) of the N-acetyl-beta-D-glucosaminidase to creatinine in a biological specimen. N-acetyl-Beta-D-glucosaminidase to Creatinine Ratio Measurement N-acetyl-beta-D-glucosaminidase Excretion Rate NAGASE Excretion Rate A measurement of the amount of N-acetyl-beta-D-glucosaminidase being excreted in a biological specimen over a defined amount of time (e.g. one hour). N-acetyl-beta-D-glucosaminidase Excretion Rate N-Acetyl Glucosamide/Creatinine A relative measurement (ratio or percentage) of the N-acetyl glucosamide to creatinine in a biological specimen. N-Acetyl Glucosamide to Creatinine Ratio Measurement Sodium/Potassium A relative measurement (ratio or percentage) of the sodium to potassium in a biological specimen. Sodium to Potassium Ratio Measurement Allorphine Antorphine N-allylnormorphine Nalorphine A measurement of the nalorphine in a biological specimen. Nalorphine Measurement Nandrolone Norandrostenolone Nortestosterone A measurement of the nandrolone in a biological specimen. Nandrolone Measurement Naphyrone A measurement of the naphyrone in a biological specimen. Naphyrone Measurement Nociceptin Orphanin FQ A measurement of the nociceptin in a biological specimen. Nociceptin Measurement Norclostebol A measurement of the norclostebol in a biological specimen. Norclostebol Measurement 5 Prime Nucleotidase 5'-Ribonucleotide Phosphohydrolase A measurement of the 5'-nucleotidase in a biological specimen. 5 Prime Nucleotidase Measurement Nicotine Glucuronide Nicotine N-glucuronide Nicotine-Glucuronide A measurement of the nicotine glucuronide in a specimen. Nicotine Glucuronide Measurement Nicotinamide Phosphoribosyltransferase Visfatin A measurement of the nicotinamide phosphoribosyltransferase in a biological specimen. Nicotinamide Phosphoribosyltransferase Measurement Desmethylolanzapine DMO N-Desmethylolanzapine Norolanzapine A measurement of the N-desmethylolanzapine in a biological specimen. N-Desmethylolanzapine Measurement N-Demethylase A measurement of the N-Demethylase in a biological specimen. N-Demethylase Measurement N-Desmethyltramadol N-DSMT A measurement of the N-desmethyltramadol in a biological specimen. N-Desmethyltramadol Measurement Neopterin A measurement of the neopterin in a biological specimen. Neopterin Measurement Nephrin NPHS1 Adhesion Molecule, Nephrin A measurement of the nephrin in a biological specimen. Nephrin Measurement Neutrophilic Myelocytes/Lymphocytes A relative measurement (ratio or percentage) of the neutrophilic myelocytes to lymphocytes in a biological specimen (for example a bone marrow specimen). Neutrophilic Myelocytes to Lymphocytes Ratio Measurement Neutrophils A measurement of the neutrophils in a biological specimen. Absolute Neutrophil Count Agranular Neutrophils A measurement of the agranular neutrophils in a biological specimen. Agranular Neutrophils Measurement Neutrophils Band Form A measurement of the banded neutrophils in a biological specimen. Neutrophil Band Form Count Neutrophils Band Form/Total Cells A relative measurement (ratio or percentage) of the banded neutrophils to total cells in a biological specimen. Neutrophil Band Form to Total Cell Ratio Measurement Neutrophils Band Form/Leukocytes A relative measurement (ratio or percentage) of the banded neutrophils to leukocytes in a biological specimen. Neutrophil Band Form to Leukocyte Ratio Neutrophils Band Form/ Neutrophils A relative measurement (ratio or percentage) of banded neutrophils to total neutrophils in a biological specimen. Neutrophils Band Form to Neutrophils Ratio Measurement Neutrophils/Total Cells A relative measurement (ratio or percentage) of the neutrophils to total cells in a biological specimen (for example a bone marrow specimen). Neutrophil to Total Cell Ratio Measurement Cytoplasmic Basophilia Neutrophil A measurement of the neutrophils in a biological specimen showing a dark staining pattern in the cytoplasm due to increased acidic content. Cytoplasmic Basophilia Neutrophil Count Giant Neutrophils A measurement of the giant neutrophils in a biological specimen. Giant Neutrophil Count Hypogranular Neutrophils A measurement of the hypogranular neutrophils in a biological specimen. Hypogranular Neutrophil Measurement Immature Neutrophils A measurement of the total immature neutrophils in a biological specimen. Immature Neutrophil Count Immature Neutrophils/Leukocytes A relative measurement (ratio or percentage) of the immature neutrophils to leukocytes in a biological specimen. Immature Neutrophils to Leukocytes Ratio Measurement Neutrophils/Leukocytes A relative measurement (ratio or percentage) of the neutrophils to leukocytes in a biological specimen. Neutrophil to Leukocyte Ratio Measurement Left Shift Neutrophils An observation of the above normal incidence of immature neutrophils, including band neutrophils and neutrophil precursors in a biological specimen. Left Shift Neutrophil Measurement Neutrophils/Lymphocytes A relative measurement (ratio) of the neutrophils to lymphocytes in a biological specimen. Neutrophil to Lymphocyte Ratio Measurement Neutrophilic Metamyelocytes A measurement of the neutrophilic metamyelocytes in a biological specimen. Neutrophilic Metamyelocyte Count Neutrophilic Metamyelocytes/Total Cells A relative measurement (ratio or percentage) of the neutrophilic metamyelocytes to total cells in a biological specimen. Neutrophilic Metamyelocyte to Total Cell Ratio Measurement Neutrophilic Myelocytes A measurement of the neutrophilic myelocytes in a biological specimen. Neutrophilic Myelocyte Count Neutrophils/Non-Squam Epi Cells A relative measurement (ratio or percentage) of the neutrophils to non-squamous epithelial cells in a biological specimen. Neutrophils to Non-Squamous Epithelial Cells Ratio Measurement Neutrophils with Pseudo Pelger-Huet Nucleus Pseudo Pelger-Huet Neutrophils A measurement of the neutrophils with a Pelger-Huet-like nucleus (hyposegmented) in a biological specimen. Pseudo Pelger-Huet Neutrophil Count Neutrophils, Segmented A measurement of the segmented neutrophils in a biological specimen. Segmented Neutrophil Count Neutrophils, Segmented + Band Form A measurement of the segmented and band form neutrophils in a biological specimen. Segmented and Band Form Neutrophils Measurement Neutrophils + Immature Neutrophils Neutrophils, Seg + Band Form + Precursor Neutrophils, Segmented + Band Form + Precursors A measurement of the segmented and band form neutrophils, metamyelocytes, myelocytes, promyelocytes, and myeloblasts in a biological specimen. Segmented, Band Form and Precursor Neutrophils Measurement Neutrophils, Segmented/Total Cells A relative measurement (ratio or percentage) of segmented neutrophils to total cells in a biological specimen. Segmented Neutrophil to Total Cell Ratio Measurement Neutrophils, Segmented/Leukocytes A relative measurement (ratio or percentage) of segmented neutrophils to leukocytes in a biological specimen. Segmented Neutrophil to Leukocyte Ratio Measurement Neutrophils, Segmented/Neutrophils A relative measurement (ratio or percentage) of segmented neutrophils to total neutrophils in a biological specimen. Segmented Neutrophils to Neutrophils Ratio Measurement Neutrophilic Toxic Change A measurement of any type of toxic change in cells of the neutrophilic lineage in a biological specimen. Neutrophilic Toxic Change Assessment Vacuolated Neutrophils A measurement of the neutrophils containing small vacuoles in a biological specimen. Vacuolated Neutrophil Count Neurofilament Heavy Chain Neurofilament Heavy Polypeptide Neurofilament Triplet H Protein NF-H A measurement of the neurofilament heavy polypeptide in a biological specimen. Neurofilament Heavy Polypeptide Measurement Phosphorylated Neurofilament Heavy Chain A measurement of the phosphorylated neurofilament heavy chain in a biological specimen. Phosphorylated Neurofilament Heavy Chain Measurement NEFL Neurofilament Light Chain Protein Neurofilament Light Polypeptide NF-L Protein Phosphatase 1, Regulatory Subunit 110 A measurement of the neurofilament light chain protein in a biological specimen. Neurofilament Light Chain Protein Measurement Nerve Growth Factor A measurement of the total nerve growth factor in a biological specimen. Nerve Growth Factor Measurement Nerve Growth Factor Alpha A measurement of the nerve growth factor alpha in a biological specimen. Nerve Growth Factor Alpha Measurement Nerve Growth Factor Beta A measurement of the nerve growth factor beta in a biological specimen. Nerve Growth Factor Beta Measurement Nerve Growth Factor Gamma A measurement of the nerve growth factor gamma in a biological specimen. Nerve Growth Factor Gamma Measurement Neurogranin Protein Kinase C Substrate, RC3 A measurement of the neurogranin in a biological specimen. Neurogranin Measurement Non-HDL Cholesterol/LDL Cholesterol A relative measurement (ratio or percentage) of the non-HDL cholesterol to LDL cholesterol in a biological specimen. Non-HDL Cholesterol to LDL Cholesterol Ratio Measurement Nonhematic Cells A measurement of the cells of nonhematopoietic origin in a biological specimen. Nonhematic Cells Count Nonhematic Cells/Leukocytes A relative measurement (ratio) of the nonhematic cells to total leukocytes in a biological specimen. Nonhematic Cells to Leukocytes Ratio Measurement Norhydrocodone A measurement of the norhydrocodone in a biological specimen. Norhydrocodone Measurement Nicotine A measurement of the nicotine in a specimen. Nicotine Measurement Nicotine and/or Metabolites Nicotine Equivalents TNE Total Nicotine Equivalents A measurement of the nicotine and/or its metabolite(s) present in a specimen, for an assay that can measure both nicotine and its metabolites. Nicotine And/Or Metabolites Measurement Nicotine, Free A measurement of the free (unbound) cotinine in a specimen. Free Nicotine Measurement Nitrate Nitric Acid A measurement of the nitrate in a biological specimen. Nitrate Measurement Nitric Oxide NO A measurement of the nitric oxide in a biological specimen. Nitric Oxide Measurement Nitrite A measurement of the nitrite in a biological specimen. Nitrite Measurement Natural Killer Cells A measurement of the total natural killer cells in a biological specimen. Natural Killer Cell Count Natural Killer Cell Activity Natural Killer Cell Function A measurement of the natural killer cell function in a biological specimen. Natural Killer Cell Activity Measurement Neurokinin A NKA Substance K A measurement of the neurokinin A in a biological specimen. Neurokinin A Measurement Natural Killer Cells/Lymphocytes NK Cells/Lym A relative measurement (ratio or percentage) of the natural killer cells to lymphocytes in a biological specimen. Natural Killer Cells to Lymphocytes Ratio Measurement N-methylhistamine A measurement of the N-methylhistamine in a biological specimen. N-Methylhistamine Measurement Nuclear Matrix Protein 22 Nuclear Mitotic Apparatus Protein 1 NUMA1 A measurement of the nuclear matrix protein 22 in a biological specimen. Nuclear Matrix Protein 22 Measurement 4-(Methylnitrosamino)-4-(3-pyridyl)-1-butanol NNAL A measurement of the total 4-(methylnitrosamino)-4-(3-pyridyl)-1-butanol (NNAL) in a specimen. 4-(Methylnitrosamino)-4-(3-pyridyl)-1-Butanol Measurement 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Nicotine-Derived Nitrosamine Ketone NNK A measurement of the nicotine-derived nitrosamine ketone in a specimen. Nicotine-Derived Nitrosamine Ketone Measurement N-Nitrosonornicotine NNN A measurement of the N-nitrosonornicotine in a specimen. N-Nitrosonornicotine Measurement Non-HDL Cholesterol/HDL Cholesterol A relative measurement (ratio or percentage) of non-high density lipoprotein cholesterol to high density lipoprotein cholesterol in a biological specimen. Non-HDL Cholesterol to HDL Cholesterol Ratio Measurement Non-HDL Cholesterol Non-High Density Lipoprotein A measurement of the non-high density lipoprotein cholesterol in a biological specimen. Non-High Density Lipoprotein Cholesterol Measurement Nordoxepin A measurement of the nordoxepin present in a biological specimen. Nordoxepin Measurement Norepinephrine Excretion Rate A measurement of the amount of norepinephrine being excreted in a biological specimen over a defined amount of time (e.g. one hour). Norepinephrine Excretion Rate Noradrenaline Norepinephrine A measurement of the norepinephrine hormone in a biological specimen. Noradrenaline Measurement Basophilic Normoblast A measurement of the basophilic normoblasts in a biological specimen taken from a non-human organism. Basophilic Normoblast Count Normetanephrine Excretion Rate A measurement of the amount of normetanephrine being excreted in a biological specimen over a defined amount of time (e.g. one hour). Normetanephrine Excretion Rate Normetanephrine A measurement of the normetanephrine in a biological specimen. Normetanephrine Measurement Normetanephrine, Free A measurement of the free normetanephrine in a biological specimen. Free Normetanephrine Measurement Nornicotine A measurement of the nornicotine in a biological specimen. Nornicotine Measurement Nortriptyline A measurement of the nortriptyline in a biological specimen. Nortriptyline Measurement Noroxycodone A measurement of the noroxycodone in a biological specimen. Noroxycodone Measurement Non-Prostatic Acid Phosphatase A measurement of the non-prostatic acid phosphatase in a biological specimen. Non-Prostatic Acid Phosphatase Measurement Normalized Protein Catabolic Rate Normalized Protein Catabolism Rate NPCR nPCR A calculated measurement of the normalized protein catabolism rate in a biological specimen used to assess dietary protein intake in dialysis patients. Normalized Protein Catabolism Rate Neuropeptide Y A measurement of the neuropeptide Y in a biological specimen. Neuropeptide Y Measurement Desmethyldiazepam N-Desmethyldiazepam Nordazepam Nordiazepam A measurement of the nordazepam present in a biological specimen. Nordazepam Measurement Norethandrolone A measurement of the norethandrolone in a biological specimen. Norethandrolone Measurement BDCA4 Neuropilin-1 NP1 NRP Soluble CD304 VEGF165R A measurement of the neuropilin-1 in a biological specimen. Neuropilin-1 Measurement Norpropoxyphene A measurement of the norpropoxyphene in a biological specimen. Norpropoxyphene Measurement Enolase 2 Gamma-enolase Neuron Specific Enolase A measurement of the neuron specific enolase in a biological specimen. Neuron Specific Enolase Measurement Normal Sperm/Total Sperm Sperm Morphology A measurement (ratio or percentage) of the normal spermatozoa to total spermatozoa in a biological specimen. Normal Sperm to Total Sperm Ratio Measurement N-telopeptide/Creatinine A relative measurement (ratio or percentage) of the N-telopeptide to creatinine in a biological specimen. N-telopeptide to Creatinine Ratio Measurement N-telopeptide A measurement of the N-telopeptide in a biological specimen. N-Telopeptide Measurement Neurotensin NTS A measurement of the neurotensin in a biological specimen. Neurotensin Measurement Neutral Fats A measurement of the total neutral fats in a biological specimen. Neutral Fats Measurement Nitrazepam A measurement of the nitrazepam in a biological specimen. Nitrazepam Measurement Type I Collagen N-Telopeptides Type I Collagen X-Linked N-Telopeptides A measurement of the type I collagen cross-linked N-telopeptides in a biological specimen. Type I Collagen N-Telopeptide Measurement T1 Collagen X-link N-Telopeptides/Creat Type I Collagen X-linked N-Telopeptides/Creatinine A relative measurement (ratio or percentage) of the type 1 collagen cross-linked N-telopeptides to creatinine in a biological specimen. Type 1 Collagen X-link N-Telopeptides to Creatinine Ratio Measurement Type II Collagen N-Telopeptides Type II Collagen X-Linked N-Telopeptides A measurement of the type II collagen cross-linked N-telopeptides in a biological specimen. Type II Collagen N-Telopeptide Measurement 3-Nitrotyrosine A measurement of the total 3-nitrotyrosine in a biological specimen. 3-Nitrotyrosine Measurement Nitrazepam and/or Metabolites A measurement of the nitrazepam and/or its metabolite(s) present in a biological specimen, for an assay that can measure both nitrazepam and its metabolites. Nitrazepam and/or Metabolites Measurement Nucleated Cells A measurement of the nucleated cells in a biological specimen. Nucleated Cell Count Nuclear Swelling A measurement of the expansion of the nucleus of the cells in a biological specimen. Nuclear Swelling Measurement Oxygen Content A measurement of the amount of oxygen content in a biological specimen. Oxygen Measurement 2-5-Oligoadenylate Synthase 1 A measurement of the 2-5-oligoadenylate synthase 1 in a biological specimen. 2-5-Oligoadenylate Synthase 1 Measurement 2-5-Oligoadenylate Synthase 2 A measurement of the 2-5-oligoadenylate synthase 2 in a biological specimen. 2-5-Oligoadenylate Synthase 2 Measurement 2-5-Oligoadenylate Synthase 3 A measurement of the 2-5-oligoadenylate synthase 3 in a biological specimen. 2-5-Oligoadenylate Synthase 3 Measurement Occult Blood A measurement of the blood in body products such as a urine or stool sample, not detectable on gross examination. Occult Blood Measurement O-Demethylase A measurement of the O-Demethylase in a biological specimen. O-Demethylase Measurement Desmetramadol O-Desmethyltramadol O-DSMT A measurement of the O-desmethyltramadol in a biological specimen. O-Desmethyltramadol Measurement 8-Hydroxy-2'-Deoxyguanosine 8-oxo-dG A measurement of the 8-hydroxy-2'-deoxyguanosine in a biological specimen. 8-Hydroxy-2'-Deoxyguanosine Measurement 9-Hydroxyrisperidone Paliperidone A measurement of the 9-hydroxyrisperidone in a biological specimen. 9-Hydroxyrisperidone Measurement 8-Hydroxydeoxyguanosine 8-OHdG A measurement of the 8-hydroxydeoxyguanosine in a biological specimen. 8-Hydroxydeoxyguanosine Measurement 6 Beta-Hydrocortisol 6 Beta-Hydroxycortisol 6 beta-OHF A measurement of 6 beta-hydroxycortisol in a biological specimen. 6 Beta-Hydroxycortisol Measurement Olanzapine A measurement of the olanzapine in a biological specimen. Olanzapine Measurement Oligoclonal Bands A measurement of the oligoclonal bands in a biological specimen. Oligoclonal Bands Measurement OCIF Osteoclastogenesis Inhibitory Factor Osteoprotegerin TNFRS11B Tumor Necrosis Factor Receptor Superfamily Member 11b A measurement of the osteoprotegerin in a biological specimen. Osteoprotegerin Measurement Opiate A measurement of any opiate class drug present in a biological specimen. Opiate Measurement Osteopontin A measurement of the osteopontin in a biological specimen. Osteopontin Measurement Osteopontin/Creatinine A relative measurement (ratio or percentage) of the osteopontin to creatinine in a biological specimen. Osteopontin to Creatinine Ratio Measurement Ornithine A measurement of the ornithine in a biological specimen. Ornithine Measurement Oncostatin M A measurement of the oncostatin M in a biological specimen. Oncostatin M Measurement Osmolality A measurement of the osmoles of solute per unit of biological specimen. Osmolality Measurement Osmolarity A measurement of the osmoles of solute per liter of solution. Osmolarity Measurement Osteocalcin A measurement of the osteocalcin in a biological specimen. Osteocalcin Measurement 2-Methylaniline 2-Toluidine o-Toluidine Ortho-Toluidine A measurement of the o-toluidine in a specimen. o-Toluidine Measurement Ovalocytes A measurement of the ovalocytes (oval shaped cell with rounded ends and a long axis less than twice its short axis) in a biological specimen. Ovalocyte Count Oxalate/Creatinine A relative measurement (ratio or percentage) of the oxalate to creatinine in a biological specimen. Oxalate to Creatinine Ratio Measurement Oxalate Excretion Rate A measurement of the amount of oxalate being excreted in a biological specimen over a defined amount of time (e.g. one hour). Oxalate Excretion Rate Ethanedioate Oxalate A measurement of the oxalate in a biological specimen. Oxalate Measurement Ossandrolone Oxandrolone A measurement of the oxandrolone in a biological specimen. Oxandrolone Measurement Oxymorphone A measurement of the Oxymorphone in a biological specimen. Oxymorphone Measurement Oxymesterone A measurement of the oxymesterone in a biological specimen. Oxymesterone Measurement Oxymethalone Oxymethenolone Oxymetholone A measurement of the oxymetholone in a biological specimen. Oxymetholone Measurement Oxygen Capacity A measurement of the maximum amount of oxygen that can be combined chemically with hemoglobin in a volume of blood. Oxygen Capacity Measurement Oxycodone Oxycontin A measurement of the oxycodone present in a biological specimen. Oxycodone Measurement Oxygen Saturation A measurement of the oxygen-hemoglobin saturation of a volume of blood. Oxygen Saturation Measurement Oxytocin Oxytoxin A measurement of the oxytocin hormone in a biological specimen. Oxytocin Measurement Oxazepam A measurement of the oxazepam present in a biological specimen. Oxazepam Measurement Amino-terminal propeptide of type 1 procollagen P1NP Aminoterm Type 1 Procollagen 1 N-Terminal Propeptide A measurement of the procollagen 1 N-terminal propeptide in a biological specimen. Procollagen 1 N-Terminal Propeptide Measurement N-Terminal Type III Collagen Propeptide PIIINP Procollagen 3 N-Terminal Propeptide A measurement of the procollagen 3 N-terminal propeptide in a biological specimen. Procollagen 3 N-Terminal Propeptide Measurement P50 Oxygen A measurement of the partial pressure of oxygen when hemoglobin is half saturated in a biological specimen. P50 Oxygen Measurement PAP Plasmin Alpha-2 Antiplasmin Complex A measurement of the plasmin alpha-2 antiplasmin complex in a biological specimen. Plasmin Alpha-2 Antiplasmin Complex Measurement Para-Aminobenzoate Para-Aminobenzoic Acid A measurement of the para-aminobenzoate in a biological specimen. Para-Aminobenzoate Measurement Platelet Activating Factor A measurement of the platelet activating factor in a biological specimen. Platelet Activating Factor Measurement 4-Aminohippurate P-Amino Hippuric Acid P-Aminohippurate PAH Para Aminohippurate Para Aminohippuric Acid Para-Amino Hippuric Acid Para-Aminohippurate A measurement of the para aminohippurate in a biological specimen. Para Aminohippurate Measurement 4-Aminohippurate Clearance P-Amino Hippuric Acid Clearance P-Aminohippurate Clearance PAH Clearance Para Aminohippurate Clearance Para Aminohippuric Acid Clearance Para-Amino Hippuric Acid Clearance Para-Aminohippurate Clearance A measurement of the volume of serum or plasma that would be cleared of para aminohippurate by excretion of urine for a specified unit of time (e.g. one minute). Para Aminohippurate Clearance Measurement Plasminogen Activator Inhibitor-1 Plasminogen Activator Inhibitor-1 AG Plasminogen Activator Inhibitor-1 Antigen A measurement of the plasminogen activator inhibitor-1 in a biological specimen. Plasminogen Activator Inhibitor-1 Measurement Prostatic Acid Phosphatase A measurement of the prostatic acid phosphatase in a biological specimen. Prostatic Acid Phosphatase Measurement Pregnancy-Associated Plasma Protein-A A measurement of the pregnancy-associated plasma protein-A in a biological specimen. Pregnancy-Associated Plasma Protein-A Measurement Pappenheimer Bodies A measurement of the cells containing Pappenheimer Bodies (violet or blue staining ferritin granules usually found along the periphery of the red blood cells) in a biological specimen. Pappenheimer Body Count Paraldehyde A measurement of the paraldehyde in a biological specimen. Paraldehyde Measurement DJ-1 GATD2 PARK7 Parkinson Disease Protein 7 Parkinsonism Associated Deglycase Protein Deglycase DJ-1 Protein DJ-1 A measurement of the Parkinson disease protein 7 in a biological specimen. Parkinson Disease Protein 7 Measurement Paroxetine A measurement of the paroxetine present in a biological specimen. Paroxetine Measurement PB-22 3-carboxyindole A measurement of the synthetic cannabinoid metabolite PB-22 3-carboxyindole in a biological specimen. PB-22 3-carboxyindole Measurement 5-fluoro PB-22 3-carboxyindole A measurement of the synthetic cannabinoid metabolite 5-fluoro PB-22 3-carboxyindole in a biological specimen. 5-fluoro PB-22 3-carboxyindole Measurement Porphobilinogen A measurement of the porphobilinogen in a biological specimen. Porphobilinogen Measurement Porphobilinogen/Creatinine A relative measurement (ratio or percentage) of the porphobilinogen to creatinine in a biological specimen. Porphobilinogen to Creatinine Ratio Measurement Autosomal Dominant Polycystic Kidney Disease 1 Protein Polycystin 1, Transient Receptor Potential Channel Interacting Polycystin-1 TRPP1 A measurement of the polycystin-1 in a biological specimen. Polycystin-1 Measurement PCA3 mRNA/PSA mRNA A relative measurement (ratio) of the prostate cancer antigen 3 mRNA to prostate specific antigen mRNA in a biological specimen. PCA3 mRNA to PSA mRNA Ratio Measurement Prostate Cancer Antigen 3 mRNA A measurement of the prostate cancer antigen 3 mRNA in a biological specimen. Prostate Cancer Antigen 3 mRNA Measurement Platelet Component Distribution Width A measurement of a marker of platelet shape change in a biological specimen. Platelet Component Distribution Width Measurement Prochlorperazine A measurement of the prochlorperazine in a biological specimen. Prochlorperazine Measurement Cyclin Proliferating Cell Nuclear Antigen A measurement of the proliferating cell nuclear antigen in a biological specimen. Proliferating Cell Nuclear Antigen Measurement Partial Pressure Carbon Dioxide A measurement of the pressure of carbon dioxide in a biological specimen. Partial Pressure of Carbon Dioxide Measurement Partial Pressure Carbon Dioxide Adj Temp A measurement of the pressure of carbon dioxide, which has been adjusted for body temperature, in a biological specimen. Partial Pressure of Carbon Dioxide Adjusted for Body Temperature Measurement Phencyclidine Phenylcyclohexylpiperidine A measurement of the phencyclidine present in a biological specimen. Phencyclidine Measurement Proprotein Convertase Subtilisin/Kexin 9 A measurement of the proprotein convertase subtilisin/kexin type 9 in a biological specimen. Proprotein Convertase Subtilisin/Kexin Type 9 Measurement Proprotein Convertase Subtilisin/Kexin Type 9 Prprot Cnvrtase Subtilisin-Kexin 9, Free A measurement of the free proprotein convertase subtilisin/kexin type 9 in a biological specimen. Free Proprotein Convertase Subtilisin/Kexin Type 9 Measurement Procalcitonin A measurement of the procalcitonin in a biological specimen. Procalcitonin Measurement Soluble CD279 Soluble PD-1 Soluble PD1 Soluble Programmed Cell Death Protein 1 Soluble Programmed Death-1 A measurement of the soluble programmed death-1 protein in a biological specimen. Soluble Programmed Death-1 Measurement PDGF Isoform AA Platelet Derived Growth Factor IsoformAA Platelet Derived Growth Factor-AA Isoform A measurement of the platelet derived growth factor isoform AA in a biological specimen. Platelet Derived Growth Factor Isoform AA Measurement PDGF Isoform AB Platelet Derived Growth Factor IsoformAB Platelet Derived Growth Factor-AB Isoform A measurement of the platelet derived growth factor isoform AB in a biological specimen. Platelet Derived Growth Factor Isoform AB Measurement PDGF Isoform BB Platelet Derived Growth Factor IsoformBB Platelet Derived Growth Factor-BB Isoform Platelet-Derived Growth Factor BB A measurement of the platelet derived growth factor isoform BB in a biological specimen. Platelet Derived Growth Factor Isoform BB Measurement Soluble CD274 Soluble PD-L1 Soluble PDL1 Soluble Programmed Death Ligand 1 A measurement of the soluble programmed death ligand 1 in a biological specimen. Soluble Programmed Death Ligand 1 Measurement Platelet Distribution Width A measurement of the range of platelet sizes in a biological specimen. Platelet Distribution Width CD31 Antigen PECAM PECAM-1 PECAM1 Platelet And Endothelial Cell Adhesion Molecule 1 Platelet Endo Cell Adhesion Molecule 1 Platelet Endothelial Adhesion Molecule Soluble CD31 A measurement of the platelet and endothelial cell adhesion molecule 1 in a biological specimen. Platelet Endothelial Cell Adhesion Molecule 1 Measurement Pelger Huet Anomaly Pelger-Huet Cells PHA A measurement of the Pelger-Huet Anomaly (nuclei of granulocytes appear rod-like, bilobed, peanut, or dumbbell shaped) in a biological specimen. Pelger Huet Anomaly Measurement Pemoline A measurement of the pemoline in a biological specimen. Pemoline Measurement Pentedrone A measurement of the pentedrone in a biological specimen. Pentedrone Measurement Pentylone A measurement of the pentylone in a biological specimen. Pentylone Measurement Pepsinogen A measurement of the pepsinogen in a biological specimen. Pepsinogen Measurement Pepsinogen A Pepsinogen I PGA PGI A measurement of the pepsinogen I in a biological specimen. Pepsinogen I Measurement Pepsinogen C Pepsinogen II PGC PGII A measurement of the pepsinogen II in a biological specimen. Pepsinogen II Measurement Proliferating Erythroid/Total Cells A relative measurement (ratio or percentage) of the proliferating erythroid cells to total cells in a biological specimen. Proliferating Erythroid Cell to Total Cell Ratio Measurement OSF2 Osteoblast Specific Factor 2 Periostin POSTN A measurement of the periostin in a biological specimen. Periostin Measurement Perphenazine A measurement of the perphenazine in a biological specimen. Perphenazine Measurement 8-Iso-PGF2alpha/Creatinine A relative measurement (ratio or percentage) of the prostaglandin F2 alpha isoform 8 to creatinine in a biological specimen. 8-Iso-Prostaglandin F2 Alpha to Creatinine Ratio Measurement PFCT Platelet Function Closure Time A measurement of the platelet function closure time in a biological specimen. Platelet Function Closure Time Measurement Prostaglandin A measurement of the total prostaglandin in a biological specimen. Prostaglandin Measurement Platelet-Granulocyte Agg Platelet-Granulocyte Aggregates A measurement of the aggregates composed of platelets and granulocytes in a biological specimen. Platelet-Granulocyte Aggregate Measurement Prostaglandin D2 A measurement of the prostaglandin D2 in a biological specimen. Prostaglandin D2 Measurement Prostaglandin D2 Receptor 2 A measurement of the prostaglandin D2 receptor 2 in a biological specimen. Prostaglandin D2 Receptor 2 Measurement Beta-Trace Protein Prostaglandin D2 Synthase A measurement of the prostaglandin D2 synthase in a biological specimen. Prostaglandin D2 Synthase Measurement Prostaglandin E1 A measurement of the prostaglandin E1 in a biological specimen. Prostaglandin E1 Measurement Prostaglandin E2 A measurement of the prostaglandin E2 in a biological specimen. Prostaglandin E2 Measurement Prostaglandin E Synthase A measurement of the prostaglandin E synthase in a biological specimen. Prostaglandin E Synthase Measurement Prostaglandin F1 Alpha A measurement of the prostaglandin F1 alpha in a biological specimen. Prostaglandin F1 Alpha Measurement Prostaglandin F2 Alpha A measurement of the prostaglandin F2 alpha in a biological specimen. Prostaglandin F2 Alpha Measurement 8-Iso-Prostaglandin F2 Alpha A measurement of the prostaglandin F2 alpha isoform 8 in a biological specimen. 8-Iso-Prostaglandin F2 Alpha Measurement pH The negative logarithm (base 10) of the concentration of hydronium ions, which is used as a measure of the acidity or alkalinity of a fluid. pH pH Adjusted for Body Temp A measurement of pH, which has been adjusted for body temperature, in a biological specimen. pH Adjusted for Body Temperature Measurement Phenylalanine A measurement of the phenylalanine in a biological specimen. Phenylalanine Measurement Dibenzothiazine Phenothiazine A measurement of the phenothiazine present in a biological specimen. Phenothiazine Measurement Phenytoin A measurement of the phenytoin in a biological specimen. Phenytoin Measurement Phenylalanine/Tyrosine A relative measurement (ratio) of the phenylalanine to tyrosine in a biological specimen. Phenylalanine to Tyrosine Ratio Measurement Phenobarbital A measurement of the phenobarbital present in a biological specimen. Phenobarbital Measurement Phendimetrazine A measurement of the phendimetrazine in a biological specimen. Phendimetrazine Measurement Phenyl Ketones Phenylketones A measurement of the total phenylketones in a biological specimen Phenylketone Measurement Phenmetrazine A measurement of the phenmetrazine in a biological specimen. Phenmetrazine Measurement Phenylpyruvate Phenylpyruvic Acid PPA PPY PPYR A measurement of the phenylpyruvate in a biological specimen. Phenylpyruvate Measurement Phenazocine A measurement of the phenazocine in a biological specimen. Phenazocine Measurement Inorganic Phosphate Phosphate Phosphorus A measurement of the phosphate in a biological specimen. Phosphate Measurement Phosphate Clearance A measurement of the volume of serum or plasma that would be cleared of phosphate by excretion of urine for a specified unit of time (e.g. one minute). Phosphate Clearance Measurement Phosphate/Creatinine A relative measurement (ratio or percentage) of the phosphate to creatinine in a biological specimen. Phosphate to Creatinine Ratio Measurement Phosphorus Excretion Rate A measurement of the amount of phosphorus being excreted in a biological specimen over a defined amount of time (e.g. one hour). Phosphorus Excretion Rate Phospholipid A measurement of the phospholipids in a biological specimen. Phospholipid Measurement Phentermine Phenyl-tertiary-butylamine A measurement of the phentermine in a biological specimen. Phentermine Measurement Procollagen Type I Carboxy Term Peptide A measurement of the procollagen-1 carboxy-terminal peptide in a biological specimen. Procollagen Type I Carboxy Terminal Peptide Measurement Pimozide A measurement of the pimozide in a biological specimen. Pimozide Measurement Pipradrol A measurement of the pipradrol in a biological specimen. Pipradrol Measurement DCP Des-Gammacarboxyprothrombin PIVKA-II Protein Induced by Vitamin K Absence-II Protein Induced by Vitamin K Absence/Antagonist-II A measurement of the protein induced by vitamin K absence-II in a biological specimen. Protein Induced by Vitamin K Absence-II Measurement Pyruvate Kinase Muscle Isozyme A measurement of the total pyruvate kinase muscle isozymes (M1 and M2) in a biological specimen. Pyruvate Kinase Muscle Isozyme Measurement Pyruvate Kinase Isozyme M1 A measurement of the pyruvate kinase isozyme M1 in a biological specimen. Pyruvate Kinase Isozyme M1 Measurement Pyruvate Kinase Isozyme M2 A measurement of the pyruvate kinase isozyme M2 in a biological specimen. Pyruvate Kinase Isozyme M2 Measurement Phospholipase A2 A measurement of the total phospholipase A2 in a biological specimen. Phospholipase A2 Measurement Platelet Aggregation Curve Type The classification of the curve pattern that is formed as a result of platelet aggregation. Platelet Aggregometry Curve Type Platelet Aggregation Mean Amplitude An average of the measurements of the magnitude of the platelet aggregation in a biological specimen. Platelet Aggregometry Mean Amplitude Platelet Aggregation Mean Curve Type The classification of the curve pattern that is formed as the average result of the platelet aggregation curve measurements. Platelet Aggregometry Mean Curve Type Platelets A measurement of the platelets (non-nucleated thrombocytes) in a biological specimen. Platelet Count Platelet Aggregation Platelet Function A measurement of the association of platelets to one another via adhesion molecules in a biological sample. Platelet Aggregation Measurement Platelets, Agranular A measurement of the agranular platelets in a biological specimen. Agranular Platelets Count Bizarre Platelets A measurement of the bizarre platelets (large with abnormal morphology and shape) in a biological specimen. Bizarre Platelet Count Platelet Clumps PLT Clumps A measurement of the platelet clumps in a biological specimen. Platelet Clumps Count Platelets, Estimated An estimated measurement of the platelets (non-nucleated thrombocytes) in a biological specimen. Estimated Platelets Measurement Giant Platelets A measurement of the giant (larger than 7um in diameter) platelets in a biological specimen. Giant Platelet Count Platelet Hematocrit Thrombocytocrit A relative measurement (ratio or percentage) of the proportion of the volume of blood taken up by platelets. Platelet Hematocrit Measurement Immature Platelets Reticulated Platelets A measurement of the immature platelets in a biological specimen. Immature Platelet Count Large Platelets A measurement of the large (between 4 um and 7um in diameter) platelets in a biological specimen. Large Platelet Count Platelet Satellitism An examination or assessment of the platelet satellitism (platelet rosetting around cells) in a biological specimen. Platelet Satellitism Assessment Monocyte Activation Antigen Mo3 Plasminogen Activator Urokinase Receptor Plasminogen Activator, Urokinase Receptor Soluble CD87 UPAR Urokinase Plasminogen Activator Receptor A measurement of the plasminogen activator urokinase receptor in a specimen. Plasminogen Activator Urokinase Receptor Measurement PGF PIGF Placental Growth Factor PLGF A measurement of the placental growth factor in a biological specimen. Placental Growth Factor Measurement Plasminogen A measurement of the plasminogen (antigen) in a biological specimen. Plasminogen Measurement Active Vitamin B6 Pyridoxal Phosphate A measurement of the pyridoxal phosphate in a biological specimen. Pyridoxal Phosphate Measurement Phospholipid Scramblase 1 A measurement of the phospholipid scramblase 1 in a biological specimen. Phospholipid Scramblase 1 Measurement Immature Plasma Cells/Total Cells A relative measurement (ratio or percentage) of the immature plasma cells (plasmacytes) to total cells in a biological specimen. Immature Plasma Cells to Total Cells Ratio Measurement Immature Plasma Cells A measurement of the immature plasma cells in a biological specimen. Immature Plasma Cell Count Immature Plasma Cells/Lymphocytes A relative measurement (ratio or percentage) of immature plasma cells to total lymphocytes in a biological specimen. Immature Plasma Cell to Lymphocyte Ratio Measurement Mature Plasma Cells Plasmacytes Plasmocytes A measurement of the mature plasma cells (plasmacytes) in a biological specimen. Mature Plasma Cell Count Mature Plasma Cells/Total Cells A relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to total cells in a biological specimen (for example a bone marrow specimen). Mature Plasma Cell to Total Cell Ratio Measurement Mature Plasma Cells/Lymphocytes A relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to all lymphocytes in a biological specimen. Mature Plasma Cell to Lymphocyte Ratio Measurement Monoclonal Plasma Cells Monotypic Plasma Cells Neoplastic Plasma Cells A measurement of the neoplastic plasma cells in a biological specimen. Neoplastic Plasma Cell Count Plasmablast Precursor Plasma Cells A measurement of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) in a biological specimen. Precursor Plasma Cell Count Precursor Plasma Cells/Lymphocytes A relative measurement (ratio or percentage) of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) to all lymphocytes in a biological specimen. Precursor Plasma Cell to Lymphocyte Ratio Measurement Total Plasma Cells A measurement of the total plasma cells in a biological specimen. Plasma Cell Count Plasma Cells/Total Cells Total Plasma Cells/Total Cells A relative measurement (ratio or percentage) of the total plasma cells to total cells in a biological specimen. Plasma Cell to Total Cell Ratio Measurement Plasma Cells/Leuk Total Plasma Cells/Leukocytes A relative measurement (ratio or percentage) of the total plasma cells to leukocytes in a biological specimen. Plasma Cells to Leukocytes Ratio Measurement Total Plasma Cells/Lymphocytes A relative measurement (ratio or percentage) of the total plasma cells to lymphocytes in a biological specimen. Plasma Cell to Lymphocyte Ratio Measurement Platelet Aggregation Amplitude A measurement of the magnitude of the platelet aggregation in a biological specimen. Platelet Aggregation Amplitude Measurement Immature Platelet Fraction Immature Platelets/Total Platelets IPF Reticulated Platelets/Total Platelets A relative measurement (ratio or percentage) of immature platelets to total platelets in a biological specimen. Immature Platelets to Total Platelets Ratio Measurement Large Platelets/Total Platelets Platelet Large Cell Ratio PLCR A relative measurement (ratio or percentage) of large platelets to total platelets in a biological specimen. Large Platelets to Total Platelets Ratio Measurement Platelet Morphology An examination or assessment of the form and structure of platelets. Platelet Morphology Measurement Platelet Mass Distribution Width A measurement which represents the variation defined by two standard deviations of the platelet dry mass distribution in a biological specimen. Platelet Mass Distribution Width Proliferating Myeloid Cells/Total Cells A relative measurement (ratio or percentage) of the proliferating myeloid cells to total cells in a biological specimen. Proliferating Myeloid Cell to Total Cell Ratio Measurement Pancreatic Polypeptide A measurement of the pancreatic polypeptide in a biological specimen. Pancreatic Polypeptide Measurement Pentobarbital A measurement of the pentobarbital present in a biological specimen. Pentobarbital Measurement Pentazocine A measurement of the pentazocine in a biological specimen. Pentazocine Measurement PaO2 Partial Pressure Oxygen Po2 pO2 A measurement of the pressure of oxygen in a biological specimen. Partial Pressure of Oxygen Measurement Partial Pressure Oxygen Adj for Temp A measurement of the pressure of oxygen, which has been adjusted for body temperature, in a biological specimen. Partial Pressure of Oxygen Adjusted for Body Temperature Measurement PAO2/FIO2 PP Arterial O2/Fraction Inspired O2 A relative measurement (ratio or percentage) of the force per unit area (pressure) of oxygen dissolved in arterial blood to the percentage oxygen of an inhaled mixture of gasses. Partial Pressure Arterial Oxygen to Fraction Inspired Oxygen Ratio Measurement Poikilocytes A measurement of the odd-shaped erythrocytes in a whole blood specimen. Poikilocyte Measurement Poikilocytes/Erythrocytes A relative measurement (ratio or percentage) of the poikilocytes, or irregularly shaped erythrocytes, to all erythrocytes in a biological specimen. Poikilocyte to Erythrocyte Ratio Measurement Polychromasia A measurement of the blue-staining characteristic of newly generated erythrocytes. Polychromasia Polychromatophilic Erythroblast A measurement of the polychromatophilic erythroblasts in a biological specimen taken from a non-human organism. Polychromatophilic Erythroblast Count Polychromatophilic Normoblast A measurement of the polychromatophilic normoblasts in a biological specimen taken from a non-human organism. Polychromatophilic Normoblast Count Aromatic Esterase 1 Arylesterase 1 Arylesterase B-Type Esterase A Paraoxonase 1 Paraoxonase B-Type Paraoxonase-1 PON 1 A measurement of the paraoxonase 1 in a biological specimen. Paraoxonase 1 Measurement Porphyrin A measurement of the total porphyrin in a biological specimen. Porphyrin Measurement Beta-Hydroxyamphetamine Norephedrine Phenylpropanolamine A measurement of the phenylpropanolamine in a biological specimen. Phenylpropanolamine Measurement Inorganic Pyrophosphate A measurement of the inorganic pyrophosphate in a biological specimen. Inorganic Pyrophosphate Measurement Cyclophilin A CYPA Peptidylprolyl Isomerase A Rotamase A A measurement of the peptidylprolyl isomerase A in a biological specimen. Peptidylprolyl Isomerase A Measurement Phosphatidylcholine/Albumin A relative measurement (ratio or percentage) of the phosphatidylcholine to albumin in a biological specimen. Phosphatidylcholine to Albumin Ratio Measurement PEth Phosphatidylethanol A measurement of the total phosphatidylethanol in a biological specimen. Phosphatidylethanol Measurement Prostate Circulating Tumor Cells A measurement of the prostate circulating tumor cells in a biological specimen. Circulating Prostate Tumor Cell Count Prealbumin Thyroxine-binding Prealbumin Transthyretin A measurement of the prealbumin in a biological specimen. Prealbumin Measurement Pregabalin A measurement of the pregabalin in a biological specimen. Pregabalin Measurement Cytolysin HPLH2 Lymphocyte Pore-Forming Protein Perforin-1 A measurement of the perforin-1 in a biological specimen. Perforin-1 Measurement Pregnenolone A measurement of the pregnenolone in a biological specimen. Pregnenolone Measurement Pregnanediol A measurement of the pregnanediol in a biological specimen. Pregnanediol Measurement Proinsulin/Insulin Ratio A relative measurement (ratio or percentage) of the proinsulin to insulin in a biological specimen. Proinsulin to Insulin Ratio Measurement Prolymphocytes/Leukocytes A relative measurement (ratio or percentage) of prolymphocytes to leukocytes in a biological specimen. Prolymphocyte to Leukocyte Ratio Perampanel A measurement of the perampanel in a biological specimen. Perampanel Measurement Proline A measurement of the proline in a biological specimen. Proline Measurement Cytosol Aminopeptidase V Proline Aminopeptidase Proline Iminopeptidase Prolyl Aminopeptidase A measurement of the proline aminopeptidase in a biological specimen. Proline Aminopeptidase Measurement NC1 Domain Fragment of Type X Collagen Pro-C10 A measurement of the Pro-C10 (a fragment of the NC1 domain of type X collagen) in a biological specimen. Pro-C10 Measurement C-Terminal Propeptide of Type XVI Collagen Pro-C16 A measurement of the Pro-C16 (a C-terminal fragment of type XVI collagen) in a biological specimen. Pro-C16 Measurement PIIBNP Pro-C2 Procollagen IIB N-Terminal Propeptide A measurement of the Pro-C2 (a N-terminal fragment of type IIB procollagen) in a biological specimen. Pro-C2 Measurement C-Terminal Propeptide of Type XXVIII Collagen Pro-C28 A measurement of the Pro-C28 (a C-terminal fragment of type XXVIII collagen) in a biological specimen. Pro-C28 Measurement ADAMTS-2 Degraded N-Terminal Type III Collagen Propeptide ADAMTS-2 Degraded Procollagen 3 N-Terminal Propeptide Pro-C3 A measurement of the Pro-C3 (ADAMTS-2 cleaved N-terminal propeptide of type III collagen) in a biological specimen. Pro-C3 Measurement 7S Domain Fragment Propeptide of Type IV Collagen P4NP7S Pro-C4 Type IV Collage 7S Domain A measurement of the Pro-C4 (a fragment of the internal 7S domain of type IV collagen) in a biological specimen. Pro-C4 Measurement C-Terminal Propeptide of Type V Collagen Pro-C5 A measurement of the Pro-C5 (a C-terminal propeptide of type V collagen) in a biological specimen. Pro-C5 Measurement C-terminal Pro-Peptide of the Alpha 3 Type VI Collagen Chain C-Terminal Propeptide of Type 6a3 Collagen C-Terminal Propeptide of Type VIa3 Collagen Endotrophin Pro-C6 A measurement of the C-terminal propeptide of type VIa3 collagen (pro-C6) in a biological specimen. Pro-C6 Measurement Alphaprodine A measurement of the alphaprodine in a biological specimen. Alphaprodine Measurement Progesterone A measurement of the progesterone hormone in a biological specimen. Progesterone Measurement NR3C3 PGR PgR PR Progesterone Receptor A measurement of the progesterone receptor protein in a biological specimen. Progesterone Receptor Measurement Pro-gastrin Releasing Peptide proGRP A measurement of the pro-gastrin releasing peptide in a biological specimen. Pro-gastrin Releasing Peptide Measurement Proinsulin A measurement of the proinsulin in a biological specimen. Proinsulin Measurement Prolactin A measurement of the prolactin hormone in a biological specimen. Prolactin Measurement Prolymphocytes A measurement of the prolymphocytes in a biological specimen. Prolymphocyte Count Prolymphocytes/Lymphocytes A relative measurement (ratio or percentage) of the prolymphocytes to all lymphocytes in a biological specimen. Prolymphocyte to Lymphocyte Ratio Measurement Promonocytes/Total Cells A relative measurement (ratio or percentage) of the promonocytes to total cells in a biological specimen (for example a bone marrow specimen). Promonocyte to Total Cell Ratio Measurement Promonocytes/Leukocytes A relative measurement (ratio or percentage) of the promonocytes to all leukocytes in a biological specimen. Promonocyte to Lymphocyte Ratio Measurement Promonocytes A measurement of the promonocytes in a biological specimen. Promonocyte Count Promyelocytes A measurement of the promyelocytes (immature myelocytes) in a biological specimen. Promyelocyte Count Promyeloblasts A measurement of the promyeloblasts in a biological specimen. Promyeloblasts Measurement Promyelocytes/Total Cells A relative measurement (ratio or percentage) of the promyelocytes (immature myelocytes) to total cells in a biological specimen (for example a bone marrow specimen). Promyelocyte to Total Cell Ratio Measurement Promyelocytes/Leukocytes A relative measurement (ratio or percentage) of the promyelocytes (immature myelocytes) to all leukocytes in a biological specimen. Promyelocyte to Lymphocyte Ratio Measurement Propoxyphene A measurement of the propoxyphene present in a biological specimen. Propoxyphene Measurement Basophilic Erythroblast Basophilic Normoblast Prorubricyte A measurement of the prorubricytes in a biological specimen. Prorubricyte Count Prorubricyte/Total Cells A relative measurement (ratio or percentage) of the prorubricytes to total cells in a biological specimen. Prorubricyte to Total Cell Ratio Measurement Protein A measurement of the total protein in a biological specimen. Total Protein Measurement Protein/Creatinine A relative measurement (ratio or percentage) of the total protein to creatinine in a biological specimen. Protein to Creatinine Ratio Measurement Protein Excretion Rate A measurement of the amount of total protein being excreted in a biological specimen over a defined amount of time (e.g. one hour). Protein Excretion Rate Protein/Osmolality Protein/Osmolality Ratio A relative measurement (ratio or percentage) of total proteins to the osmolality of a biological specimen. Protein to Osmolality Ratio Measurement Protein Pattern A measurement of the protein band pattern in a biological specimen. Protein Pattern Measurement Protriptyline A measurement of the protriptyline present in a biological specimen. Protriptyline Measurement Protein S A measurement of the total protein S in a biological specimen. Protein S Measurement Protein S, Free A measurement of the unbound protein S in a biological specimen. Free Protein S Measurement Presepsin sCD14-ST Soluble CD14 Subtype A measurement of the presepsin in a biological specimen. Presepsin Measurement Prostanozol A measurement of the prostanozol in a biological specimen. Prostanozol Measurement 1,7-dimethylxanthine Paraxanthine A measurement of the paraxanthine in a specimen. Paraxanthine Measurement Prazepam A measurement of the prazepam present in a biological specimen. Prazepam Measurement Prostate Specific Antigen A measurement of the total prostate specific antigen in a biological specimen. Prostate Specific Antigen Measurement Prostate Specific Antigen, Free A measurement of the unbound prostate-specific antigen in a biological specimen. Free Prostate Specific Antigen Measurement PSA, Free/PSA A relative measurement (percentage) of the free prostate specific antigen to total prostate specific antigen in a biological specimen. Free PSA to Total PSA Ratio Measurement Prostate Specific Antigen mRNA A measurement of the prostate-specific antigen mRNA in a biological specimen. Prostate Specific Antigen mRNA Measurement Pseudoephedrine A measurement of the pseudoephedrine present in a biological specimen. Pseudoephedrine Measurement Phosphatidylglycerol/Lung Surfactant Phosphatidylglycerol/Pulmonary Surfactant A relative measurement (ratio) of the phosphatidylglycerol to total lung surfactant in a biological specimen. Phosphatidylglycerol to Lung Surfactant Ratio Measurement GMP-140 P-Selectin A measurement of total P-selectin in a biological specimen. P-Selectin Measurement Soluble P-Selectin A measurement of the soluble P-selectin in a biological specimen. Soluble P-Selectin Measurement Magic Mushrooms Psilocybin Psilocybine A measurement of the psilocybin in a biological specimen. Psilocybine Measurement Prothrombin Time A blood clotting measurement that evaluates the extrinsic pathway of coagulation. Prothrombin Time Factor II Activity Prothrombin Activity A measurement of the biological activity of coagulation factor prothrombin in a biological specimen. Prothrombin Activity Measurement Prothrombin Time Actual/Control A relative measurement (ratio or percentage) of the prothrombin time in a subject's specimen when compared to a control specimen. Prothrombin Time Actual to Control Ratio Measurement Phosphorylated Tau Prot/Amyloid Beta1-42 Phosphorylated Tau Protein/Amyloid Beta 1-42 A relative measurement (ratio) of the phosphorylated Tau protein to amyloid beta 1-42 in a biological specimen. Phosphorylated Tau Protein to Amyloid Beta1-42 Ratio Measurement Prothrombin Fragment 1 A measurement of the prothrombin fragment 1 in a biological specimen. Prothrombin Fragment 1 Measurement Prothrombin Fragments 1 + 2 A measurement of the prothrombin fragments 1 and 2 in a biological specimen. Prothrombin Fragments 1 and 2 Measurement Prothrombin Fragment 2 A measurement of the prothrombin fragment 2 in a biological specimen. Prothrombin Fragment 2 Measurement Parathyrin Hormone, C-Terminal Parathyroid Hormone, C-Terminal A measurement of the C-terminal fragment of parathyroid hormone in a biological specimen. C-Terminal Parathyroid Hormone Measurement Parathyrin Hormone, Fragmented Parathyroid Hormone, Fragmented A measurement of the fragmented parathyroid hormone in a biological specimen. Fragmented Parathyroid Hormone Measurement Parathyrin, Intact Parathyroid Hormone, Intact A measurement of the intact parathyroid hormone (consisting of amino acids 1-84 or 7-84) in a biological specimen. Intact Parathyroid Hormone Measurement Parathyrin Hormone, Mid-Molecule Parathyroid Hormone, Mid-Molecule A measurement of the mid-molecule fragment of parathyroid hormone in a biological specimen. Mid-Molecule Parathyroid Hormone Measurement Parathyrin Hormone, N-Terminal Parathyroid Hormone, N-Terminal A measurement of the N-terminal fragment of parathyroid hormone in a biological specimen. N-Terminal Parathyroid Hormone Measurement Parathyrin Hormone-related Protein Parathyroid Hormone-related Peptide Parathyroid Hormone-related Protein A measurement of parathyroid hormone-related protein in a biological specimen. Parathyroid Hormone-related Protein Measurement Parathyrin Hormone, Whole Parathyroid Hormone, Whole A measurement of the whole parathyroid hormone (consisting of amino acids 1-84) in a biological specimen. Whole Parathyroid Hormone Measurement Protein S Activity Actual/Control Protein S Activity Actual/Normal Protein S Activity Actual/Protein S Activity Control A relative measurement (ratio or percentage) of the biological activity of protein S in a subject's specimen when compared to the same activity in a control specimen. Protein S Activity Actual to Control Ratio Measurement Protein S Actual/Control A relative measurement (ratio or percentage) of the protein S in a subject's specimen when compared to a control specimen. Protein S Actual to Control Ratio Measurement Protein S Free Activity Actual/Control Protein S Free Activity Actual/Normal Protein S Free Activity Actual/Protein S Free Activity Control A relative measurement (ratio or percentage) of the biological activity of free protein S in a subject's specimen when compared to the same activity in a control specimen. Free Protein S Activity Actual to Control Ratio Measurement Protein S, Free Actual/Control A relative measurement (ratio or percentage) of the free protein S in a subject's specimen when compared to a control specimen. Free Protein S Actual to Control Ratio Measurement Partial Thromboplastin Time A measurement of the length of time that it takes for clotting to occur when no activating reagents are added to a biological specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture. Partial Thromboplastin Time Partial Thromboplastin Time/Standard Thromboplastin Time PTT/Standard PTT/Standard PTT A relative measurement (ratio or percentage) of the subject's partial thromboplastin time to a standard or control partial thromboplastin time. Partial Thromboplastin Time to Standard Thromboplastin Time Ratio Measurement Pus A measurement of the pus in a biological specimen. Pus Measurement Pyridinoline/Creatinine A relative measurement (ratio or percentage) of the pyridinoline to creatinine in a biological specimen. Pyridinoline to Creatinine Ratio Measurement PK Pyruvate Kinase A measurement of the total pyruvate kinase in a biological specimen. Pyruvate Kinase Measurement Karyopyknotic Cells Pyknotic Cells A measurement of the pyknotic cells in a biological specimen. Pyknotic Cell Count Pyocytes A measurement of the pyocytes in a biological specimen. Pyocytes Measurement Pyridinoline A measurement of the pyridinoline in a biological specimen. Pyridinoline Measurement Pyrovalerone A measurement of the pyrovalerone in a biological specimen. Pyrovalerone Measurement Pyruvate Pyruvic Acid A measurement of the pyruvate in a biological specimen. Pyruvate Measurement Peptide Tyrosine Tyrosine Peptide YY A measurement of the peptide YY in a biological specimen. Peptide YY Measurement Quetiapine A measurement of the quetiapine in a biological specimen. Quetiapine Measurement Quazepam A measurement of the quazepam in a biological specimen. Quazepam Measurement Advanced Glycosylation End-Product Specific Receptor AGER Receptor Advanced Glycation Endproducts A measurement of the receptor advanced glycation endproducts in a biological specimen. Receptor Advanced Glycation Endproducts Measurement Receptor Activator Nuclear KappaB Ligand Receptor Activator of Nuclear Kappa-B Ligand A measurement of the receptor activator of nuclear kappa-B ligand in a biological specimen. Receptor Activator Nuclear KappaB Ligand Measurement Chemokine Ligand 5 Reg upon Act Normal T-cell Exprd Secrtd A measurement of the RANTES (regulated on activation, normally, T-cell expressed, and secreted) chemokine in a biological specimen. Reg upon Act Normal T-cell Exprd Secrtd Measurement Erythrocytes Red Blood Cells A measurement of the total erythrocytes in a biological specimen. Erythrocyte Count Autoagglutination Erythrocyte Agglutination RBC Agglutination A measurement of the erythrocyte agglutination in a biological specimen. Erythrocyte Agglutination Measurement Erythrocyte Cell Clumps RBC Aggregates RBC Clumps Red Blood Cell Clumps A measurement of red blood cell clumps in a biological specimen. Erythrocyte Cell Clumps Measurement Erythrocyte Deformability An assessment of a red blood cell's ability to adapt its shape to dynamically changing flow conditions, thus minimizing resistance to flow. Erythrocyte Deformability Measurement Dimorphic Erythrocyte Population Dimorphic RBC Population Examination of a biological specimen to detect the presence of dimorphic erythrocyte population. Dimorphic Erythrocyte Population Dysmorphic Erythrocytes/Erythrocytes A measurement (ratio or percentage) of dysmorphic erythrocytes to total erythrocytes in a biological specimen. Dysmorphic Erythrocytes to Erythrocytes Ratio Measurement Dysmorphic Erythrocytes A measurement of the dysmorphic erythrocytes in a biological specimen. Dysmorphic Erythrocyte Count Erythrocyte Fragment RBC Fragment A measurement of the red blood cell fragments (red cell fragments that have a reticular-like shape with rounded ends and no spicules, differentiating them from schistocytes and acanthocytes) in a biological specimen. Erythrocyte Fragment Measurement Erythrocyte Ghosts RBC Ghosts A measurement of the erythrocyte ghosts (erythrocytes in which hemoglobin has been removed through hemolysis) in a biological specimen. Erythrocyte Ghost Count Erythrocyte Cell Morphology RBC Morphology Red Blood Cell Morphology An examination or assessment of the form and structure of red blood cells. Erythrocyte Cell Morphology Erythrocyte Membrane Rigidity An assessment of the rigidity of the membrane of erythrocytes in a biological specimen. Erythrocyte Membrane Rigidity Measurement Nucleated Erythrocytes Nucleated Red Blood Cells A measurement of the nucleated erythrocytes (large, immature nucleated erythrocytes) in a biological specimen. Nucleated Red Blood Cell Count Nucleated Erythrocytes/Leukocytes A relative measurement (ratio or percentage) of nucleated erythrocytes to leukocytes in a biological specimen. Nucleated Erythrocyte to Leukocyte Ratio Measurement Nucleated Erythrocytes/Erythrocytes Nucleated Red Blood Cells/Erythrocytes A relative measurement (ratio or percentage) of the nucleated erythrocytes (large, immature nucleated erythrocytes) to all erythrocytes in a biological specimen. Nucleated Red Blood Cell to Erythrocyte Ratio Measurement Retinol Binding Protein A measurement of the total retinol binding protein in a biological specimen. Retinol Binding Protein Measurement Retinol Binding Protein 1 A measurement of the retinol binding protein 1 in a biological specimen. Retinol Binding Protein 1 Measurement Retinol Binding Protein 2 A measurement of the retinol binding protein 2 in a biological specimen. Retinol Binding Protein 2 Measurement Retinol Binding Protein 3 A measurement of the retinol binding protein 3 in a biological specimen. Retinol Binding Protein 3 Measurement Retinol Binding Protein 4 A measurement of the retinol binding protein 4 in a biological specimen. Retinol Binding Protein 4 Measurement Retinol Binding Protein/Creatinine A relative measurement (ratio or percentage) of the retinol binding protein to creatinine in a biological specimen. Retinol Binding Protein to Creatinine Ratio Measurement Reducing Substances A measurement of the reducing substances (e.g., sugars, glutathione, creatinine, uric acid, and ascorbic acid) in a biological specimen. Reducing Substance Measurement Reducing Sugars A measurement of the reducing sugars in a biological specimen. Reducing Sugar Measurement Erythrocytes Distribution Width RDW-CV Red Blood Cell Distribution Width Red Cell Volume Distribution Width A relative measurement (ratio or percentage) of the standard deviation of the red blood cell volume to the mean distribution of the red blood cell volume in a biological specimen. Erythrocyte Distribution Width Measurement RDWr Ret Volume Distribution Width Reticulocyte Volume Distribution Width A relative measurement (ratio or percentage) of the standard deviation of the reticulocyte volume to the mean distribution of the reticulocyte volume in a biological specimen. Reticulocyte Volume Distribution Width RDWr-CV Red Cell Volume Distribution Width Coefficient of Variation in Reticulocytes Ret RDW Coefficient of Variation Reticulocyte Volume Distribution Width Coefficient of Variation A measurement of the volume dispersion within a reticulocyte population, calculated as the standard deviation of the mean reticulocyte volume divided by the mean reticulocyte volume, multiplied by 100 to convert to a percentage. Reticulocyte Volume Distribution Width Coefficient of Variation RDWr-SD Red Cell Volume Distribution Width Standard Deviation in Reticulocytes Ret RDW Standard Deviation Reticulocyte Volume Distribution Width Standard Deviation A measurement of the volume dispersion within a reticulocyte population, calculated as the width of the distribution curve at the 20 percent frequency level. Reticulocyte Volume Distribution Width Standard Deviation RDW Standard Deviation RDW-SD Red Cell Volume Distribution Width Standard Deviation A measurement of the volume dispersion within an erythrocyte population, calculated as the width of the distribution curve at the 20 percent frequency level. Red Cell Volume Distribution Width Standard Deviation Active Renin Angiotensinogenase Direct Renin Renin A measurement of the renin in a biological specimen. Renin Measurement Renin Activity A measurement of the renin activity in a biological specimen. Renin Activity Measurement Resistin A measurement of the resistin in a biological specimen. Resistin Measurement HCT Corrected Reticulocytes/Erythrocytes A relative measurement (ratio or percentage) of the hematocrit corrected reticulocytes to erythrocytes in a biological specimen. Hematocrit Corrected Reticulocytes to Erythrocytes Ratio Measurement Reticulocytes A measurement of the reticulocytes in a biological specimen. Reticulocyte Count Reticulocytes/Total Cells A relative measurement (ratio or percentage) of reticulocytes to total cells in a biological specimen. Reticulocyte to Total Cell Ratio Measurement CHr Ret. Corpuscular Hemoglobin Content Reticulocyte Cellular Hemoglobin Content A measurement of the average total amount of hemoglobin per reticulocyte. Reticulocyte Corpuscular Hemoglobin Content High Absorption Reticulocytes A measurement of the high absorption reticulocytes in a biological specimen. High Absorption Reticulocyte Measurement Hematocrit Corrected Reticulocytes A measurement of the hematocrit corrected reticulocytes in a biological specimen. Hematocrit Corrected Reticulocyte Count High Absorption Retic/Reticulocytes A relative measurement (ratio or percentage) of the high absorption reticulocytes to total reticulocytes in a biological specimen. High Absorption Reticulocytes to Total Reticulocytes Ratio Measurement Low Absorption Reticulocytes A measurement of the low absorption reticulocytes in a biological specimen. Low Absorption Reticulocyte Measurement Low Absorption Retic/Reticulocytes A relative measurement (ratio or percentage) of the low absorption reticulocytes to total reticulocytes in a biological specimen. Low Absorption Reticulocytes to Total Reticulocytes Ratio Measurement Medium Absorption Reticulocytes A measurement of the medium absorption reticulocytes in a biological specimen. Medium Absorption Reticulocyte Measurement Medium Absorption Retic/Reticulocytes A relative measurement (ratio or percentage) of the medium absorption reticulocytes to total reticulocytes in a biological specimen. Medium Absorption Reticulocytes to Total Reticulocytes Ratio Measurement Retinoate Retinoic Acid A measurement of the retinoic acid in a biological specimen. Retinoic Acid Measurement Reticulocytes/Erythrocytes A relative measurement (ratio or percentage) of reticulocytes to erythrocytes in a biological specimen. Reticulocyte to Erythrocyte Ratio Retinol Palmitate Retinyl Palmitate Vitamin A Palmitate A measurement of the endogenous retinyl palmitate vitamin A in a biological specimen. Retinyl Palmitate Measurement Rh Factor A measurement of non-specified Rhesus factor antigen(s) in a biological specimen. Rh Factor Measurement RhD Factor A measurement of the Rhesus factor D antigen in a biological specimen. RhD Factor Measurement Ritalinic Acid A measurement of the ritalinic acid in a biological specimen. Ritalinic Acid Measurement RLP Cholesterol A measurement of the cholesterol remnant-like particles in a biological specimen. Remnant-like Particle Cholesterol Measurement Remnant Lipoprotein A measurement of the remnant lipoproteins in a biological specimen. Remnant Lipoprotein Measurement Ribonucleic Acid A measurement of a targeted ribonucleic acid (RNA) in a biological specimen. Ribonucleic Acid Measurement Reactive Oxygen Metabolite A measurement of the reactive oxygen metabolite in a biological specimen. Reactive Oxygen Metabolite Measurement Rouleaux Formation A measurement of the stacking red blood cells in a biological specimen. Rouleaux Formation Count Round Cells A measurement of the round cells (round shaped cells mainly comprised of white blood cells and immature spermatogenic cells) in a biological specimen. Round Cell Count Renal Papillary Antigen 1 A measurement of the renal papillary antigen 1 in a biological specimen. Renal Papillary Antigen 1 Measurement Reptilase Activity Actual/Control Reptilase Activity Actual/Normal Reptilase Activity Actual/Reptilase Activity Control A relative measurement (ratio or percentage) of the biological activity of reptilase dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. Reptilase Activity Actual to Control Ratio Measurement Reptilase Time A measurement of the time it takes a plasma sample to clot after adding the active enzyme reptilase. Reptilase Time Measurement Cytomegalovirus-Induced Gene 5 Protein Radical S-adenosyl Methionine Domain-Containing Protein 2 A measurement of the cytomegalovirus-induced gene 5 protein in a biological specimen. Cytomegalovirus-Induced Gene 5 Protein Measurement Risperidone+9-Hydroxyrisperidone Risperidone+Paliperidone A measurement of the risperidone and 9-hydroxyrisperidone in a biological specimen. Risperidone and 9-Hydroxyrisperidone Measurement Risperidone A measurement of the risperidone in a biological specimen. Risperidone Measurement Triiodothyronine, Reverse A measurement of the reverse triiodothyronine in a biological specimen. Reverse Triiodothyronine Measurement Polychromatophilic Erythroblast Polychromatophilic Normoblast Rubricyte A measurement of the rubricytes in a biological specimen. Rubricyte Count Rubricyte/Total Cells A relative measurement (ratio or percentage) of the rubricytes to total cells in a biological specimen. Rubricyte to Total Cell Ratio Measurement S100 Calcium Binding Protein A8 A measurement of the S100 calcium binding protein A8 in a biological specimen. S100 Calcium Binding Protein A8 Measurement S100 Calcium-Binding Protein B A measure of the S100 calcium-binding protein B in a biological specimen. S100 Calcium-Binding Protein B Measurement Phos-S6 Ribosomal Protein Phosphorylated S6 protein of the 40S ribosomal subunit A measurement of the phosphorylated S6 protein of the 40S ribosomal subunit in a biological specimen. Phosphorylated 40S Ribosomal Protein S6 Measurement PIG4 SAA1 Serum Amyloid A-1 Protein Serum Amyloid A1 A measurement of the serum amyloid A1 in a biological specimen. Serum Amyloid A1 Measurement SAAG Serum-Ascites Albumin Gradient A measurement of the serum-ascites albumin gradient, calculated by subtracting the amount of albumin in ascites fluid from the albumin in serum. Serum-Ascites Albumin Gradient Measurement S-adenosyl-L-homocysteine S-Adenosylhomocysteine SAH A measurement of the S-adenosylhomocysteine in a biological specimen. S-Adenosylhomocysteine Measurement Salicylates A measurement of the salicylates in a biological specimen. Salicylates Measurement S-adenosyl-L-methionine S-Adenosylmethionine SAM-e SAMe SAMMY A measurement of the S-adenosylmethionine in a biological specimen. S-Adenosylmethionine Measurement Oxygen Saturation/Fraction Inspired O2 A relative measurement (ratio or percentage) of the oxygen-hemoglobin saturation of a volume of blood to the volumetric fraction of oxygen in the inhaled gas. Oxygen Saturation/Fraction Inspired O2 N-Methylglycine Sarcosine A measurement of the sarcosine in a biological specimen. Sarcosine Measurement Sibutramine A measurement of the sibutramine in a biological specimen. Sibutramine Measurement N-Acetyl-S-benzyl-L-cysteine S-Benzyl Mercapturic Acid S-Benzylmercapturate S-Benzylmercapturic Acid SBNAC A measurement of the S-benzyl mercapturic acid in a specimen. S-Benzyl Mercapturic Acid Measurement Secobarbital A measurement of the secobarbital present in a biological specimen. Secobarbital Measurement Squamous Cell Carcinoma Antigen A measurement of the squamous cell carcinoma antigen in a biological specimen. Squamous Cell Carcinoma Antigen Measurement KIT Ligand Stem Cell Factor A measurement of the stem cell factor in a biological specimen. Stem Cell Factor Measurement C-Kit CD117 KIT Proto-Oncogene, Receptor Tyrosine Kinase Mast/Stem Cell Growth Factor Rec Kit Mast/Stem Cell Growth Factor Receptor Kit A measurement of the mast/stem cell growth factor receptor kit in a biological specimen. Mast/Stem Cell Growth Factor Receptor Kit Measurement Schistocytes/Erythrocytes A relative measure (ratio or percentage) of schistocytes to erythrocytes in a biological specimen. Schistocyte to Erythrocyte Ratio Measurement Schistocytes A measurement of the schistocytes (fragmented red blood cells) in a biological specimen. Schistocyte Count Sickle Cells/Erythrocytes A relative measurement (ratio or percentage) of the sickle cells (sickle shaped red blood cells) to all erythrocytes in a biological specimen. Sickle Cell to Erythrocyte Ratio Measurement Drepanocytes Sickle Cells A measurement of the sickle cells (sickle shaped red blood cells) in a biological specimen. Sickle Cell Count Thiocyanate A measurement of the thiocyanate in a biological specimen. Thiocyanate Measurement Succinylacetone A measurement of the succinylacetone in a biological specimen. Succinylacetone Measurement Sorbitol Dehydrogenase A measurement of the sorbitol dehydrogenase in a biological specimen. Sorbitol Dehydrogenase Measurement N,N'-dimethylarginine Symmetric Dimethylarginine A measurement of the symmetric dimethylarginine in a biological specimen. Symmetric Dimethylarginine Measurement Selenium A measurement of the selenium in a specimen. Selenium Measurement Secretin A measurement of the secretin hormone in a biological specimen. Secretin Measurement Microscopic Sediment Analysis Sediment Analysis Sediment Examination An observation, assessment or examination of the sediment in a biological specimen. Sediment Analysis Serine A measurement of the serine in a biological specimen. Serine Measurement Sertraline A measurement of the sertraline present in a biological specimen. Sertraline Measurement Norsertraline A measurement of the norsertraline in a biological specimen. Norsertraline Measurement Sezary Cells A measurement of the Sezary cells (atypical lymphocytes with cerebriform nuclei) in a biological specimen. Sezary Cell Count Sezary Cells/Leukocytes A relative measurement (ratio or percentage) of the Sezary cells to all leukocytes in a biological specimen. Sezary Cells to Leukocytes Ratio Measurement Sezary Cells/Lymphocytes A relative measurement (ratio or percentage of the Sezary cells (atypical lymphocytes with cerebriform nuclei) to all lymphocytes in a biological specimen. Sezary Cell to Lymphocyte Ratio Measurement SP-D Surfactant Protein D A measurement of the surfactant protein D in a biological specimen. Surfactant Protein D Measurement DSHP Duncan Disease SH2-Protein EBVS IMD5 LYP MTCP1 SAP SAP/SH2D1A SH2 Domain Containing 1A Protein XLP XLPD XLPD1 A measurement of the SH2 domain containing 1A protein in a biological specimen. SH2 Domain Containing 1A Protein Measurement Sex Hormone Binding Globulin Sex Hormone Binding Protein A measurement of the sex hormone binding (globulin) protein in a biological specimen. Sex Hormone Binding Protein Measurement Sonic Hedgehog A measurement of the sonic hedgehog protein in a biological specimen. Sonic Hedgehog Measurement Soluble Intercell Adhesion Molecule 1 A measurement of the soluble intercellular adhesion molecule 1 in a biological specimen. Soluble Intercellular Adhesion Molecule 1 Measurement Soluble Intercell Adhesion Molecule 4 Soluble Intercellular Adhesion Molecule 4 A measurement of the soluble intercellular adhesion molecule 4 in a biological specimen. Soluble Intercellular Adhesion Molecule 4 Measurement 6-Monoacetylmorphine A measurement of the 6-monoacetylmorphine present in a biological specimen. 6-Monoacetylmorphine Measurement Soluble Transferrin Receptor A measurement of the soluble transferrin receptor in a biological specimen. Soluble Transferrin Receptor Measurement Sialyl Lewis X Antigen Sialyl Lex Sialyl SSEA-1 Antigen Sialyl-CD15 SLeX A measurement of the sialyl stage-specific embryonic antigen-1 in a biological specimen. Sialyl SSEA-1 Antigen Measurement Basket Cells Gumprecht Shadow Cells Shadow Cells Smudge Cells A measurement of the smudge cells (the nuclear remnant of a ruptured white blood cell) in a biological specimen. Smudge Cell Count Basket Cells/Leukocytes Gumprecht Shadow Cells/Leukocytes Shadow Cells/Leukocytes Smudge Cells/Leukocytes A relative measurement (ratio or percentage) of smudge cells to leukocytes in a biological specimen. Smudge Cells to Leukocytes Ratio Measurement Smear Evaluation Smear Examination Specimen Smear Examination An observation, assessment or examination of a smear of a biological specimen. Smear Examination Soluble Mesothelin Related Peptides Soluble Mesothelin Related Proteins A measurement of the soluble mesothelin related peptides in a biological specimen. Soluble Mesothelin Related Peptides Measurement Sulfur Dioxide A measurement of the sulfur dioxide in a biological specimen. Sulfur Dioxide Measurement Sodium A measurement of the sodium in a biological specimen. Sodium Measurement Sodium Excretion Rate A measurement of the amount of sodium being excreted in a biological specimen over a defined amount of time (e.g. one hour). Sodium Excretion Rate Growth Hormone Somatotrophin Somatotropin A measurement of the somatotrophin (growth) hormone in a biological specimen. Somatotrophin Measurement Sclerostin A measurement of the sclerostin in a biological specimen. Sclerostin Measurement S-Pancreas-1 Antigen Sialylated Carbonated Antigen SPAN-1 SPan-1 A measurement of the S-pancreas-1 antigen in a biological specimen. S-Pancreas-1 Antigen Measurement Spermatozoa A measurement of the spermatozoa cells present in a biological specimen. Spermatozoa Cell Count Sperm Motility A measurement of the sperm capable of forward, progressive movement in a semen specimen. Sperm Motility Measurement Spermatozoa, Progressive A measurement of the progressive spermatozoa (motile in a forward direction) in a biological specimen. Progressive Spermatozoa Measurement Specific Gravity A ratio of the density of a fluid to the density of water. Specific Gravity Spherocytes A measurement of the spherocytes (small, sphere-shaped red blood cells) in a biological specimen. Spherocyte Count Pancreatic Secretory Trypsin Inhibitor PSTI Serine Peptidase Inhibitor Kazal Type 1 Spink3 TATI Tumor-Associated Trypsin Inhibitor A measurement of the serine peptidase inhibitor Kazal type 1 in a biological specimen. Serine Peptidase Inhibitor Kazal Type 1 Measurement Type II Secretory Phospholipase A2 A measurement of the type II secretory phospholipase A2 in a biological specimen. Type II Secretory Phospholipase A2 Measurement Sperm Agglutination A measurement of the motile spermatozoa agglutination in a biological specimen. Sperm Agglutination Measurement Sperm Aggregation A measurement of the immotile spermatozoa aggregation in a biological specimen. Sperm Aggregation Measurement Motile Sperm/Total Sperm A relative measurement (ratio or percentage) of the motile sperm to total sperm in a biological specimen. Motile Sperm to Total Sperm Ratio Measurement Spermatozoa, Progressive/Spermatozoa A relative measurement (ratio or percentage) of the progressive spermatozoa to total spermatozoa in a biological specimen. Progressive Spermatozoa to Total Spermatozoa Ratio Measurement Specimen Weight A measurement of the weight of a biological specimen. Specimen Weight Measurement Squalene A measurement of the squalene in a biological specimen. Squalene Measurement OL-64 Serpin A12 Serpin Family A Member 12 Vaspin Visceral Adipose Tissue-Derived Serpin A measurement of the serpin A12 in a biological specimen. Serpin A12 Measurement CBG Corticosteroid Binding Globulin Corticosteroid-binding Globulin Serpin A6 Transcortin A measurement of the serpin A6 in a biological specimen. Serpin A6 Measurement Maspin Peptidase Inhibitor 5 PI-5 PI5 Serpin B5 Serpin Family B Member 5 A measurement of the serpin family B member 5 in a biological specimen. Serpin Family B Member 5 Measurement PEDF Pigment Epithelium Derived Factor Serpin F1 Serpin Family F Member 1 A measurement of the serpin family F member 1 in a biological specimen. Serpin Family F Member 1 Measurement Serotonin A measurement of the serotonin hormone in a biological specimen. Serotonin Measurement Somatostatin Receptor Type 2 SRIF-1 A measurement of the somatostatin receptor type 2 in a biological specimen. Somatostatin Receptor Type 2 Measurement Signal Transducer and Activator of Transcription 3 STAT3 A measurement of the STAT3 (signal transducer and activator of transcription 3) in a biological specimen. STAT3 Measurement Phosphorylated STAT3 pSTAT3 A measurement of the phosphorylated STAT3 (signal transducer and activator of transcription 3) in a biological specimen. Phosphorylated STAT3 Measurement Phosphorylated STAT3/STAT3 pSTAT3/STAT3 A relative measurement (ratio or percentage) of the phosphorylated STAT3 to total STAT3 in a biological specimen. Phosphorylated STAT3 to STAT3 Ratio Measurement Standard Base Excess A calculated measurement of the amount of acid required to return blood with hemoglobin at 5g/dL, which is used as a surrogate for extracellular fluid, to a normal pH under standard conditions. Standard Base Excess Measurement Basophilic Stippling A measurement of the basophilic stippling in a biological specimen. Basophilic Stippling Measurement Deacetylanatrofin Stenbolone A measurement of the stenbolone in a biological specimen. Stenbolone Measurement Stanozolol A measurement of the stanozolol in a biological specimen. Stanozolol Measurement Stomatocytes A measurement of the stomatocytes (red blood cells with an oval or rectangular area of central pallor, producing the appearance of a cell mouth) in a biological specimen. Stomatocyte Count Skeletal Troponin I sTnl A measurement of the total skeletal troponin I in a biological specimen. Skeletal Troponin I Measurement Steroid Sulfatase Steryl-sulfatase A measurement of the steroid sulfatase in a biological specimen. Steroid Sulfatase Measurement Sufentanil A measurement of the sufentanil in a biological specimen. Sufentanil Measurement Sulfate Sulphate A measurement of the sulfate in a biological specimen. Sulfate Measurement Soluble Vasc Cell Adhesion Molecule 1 A measurement of the soluble vascular cell adhesion molecule 1 in a biological specimen. Soluble Vascular Cell Adhesion Molecule 1 Synoviocytes Total Synoviocytes A measurement of the total synoviocytes in a biological specimen. Synoviocytes Cell Count Synoviocytes/Leukocytes Total Synoviocytes/Leukocytes A relative measurement (ratio or percentage) of the synoviocytes to all leukocytes in a biological specimen. Synoviocytes to Leukocytes Ratio Measurement Phosphorylated Tau 217/Amyloid Beta 1-42 Phosphorylated Tau Protein 217/Amyloid Beta 1-42 A relative measurement (ratio) of the phosphorylated Tau protein 217 to amyloid beta 1-42 in a biological specimen. Phosphorylated Tau 217 to Amyloid Beta 1-42 Ratio Measurement Total T3 Triiodothyronine A measurement of the total (free and bound) triiodothyronine in a biological specimen. Triiodothyronine Measurement Free T3 Triiodothyronine, Free A measurement of the free triiodothyronine in a biological specimen. Free Triiodothyronine Measurement 3-HC 3HC Trans-3 Hydroxycotinine A measurement of the total trans-3'- hydroxycotinine in a specimen. Trans-3 Hydroxycotinine Measurement Free 3-HC Free 3HC Trans-3'- Hydroxycotinine, Free A measurement of the free (unbound) trans-3'- hydroxycotinine in a specimen. Free Trans-3'-Hydroxycotinine Measurement 3HC-gluc Trans-3'- Hydroxycotinineglucuronide Trans-3'-Hydroxycotinine-O-glucuronide A measurement of the trans-3'- hydroxycotinineglucuronide in a specimen. Trans-3'-Hydroxycotinineglucuronide Measurement T3RU T3U Triiodothyronine Uptake A measurement of the binding of triiodothyronine to thyroxine binding globulin protein in a biological specimen. Triiodothyronine Uptake Measurement Thyroxine Total T4 A measurement of the total (free and bound) thyroxine in a biological specimen. Total Thyroxine Measurement Free T4 Thyroxine, Free A measurement of the free thyroxine in a biological specimen. Free Thyroxine Measurement Thyroxine, Free Index A measurement of the thyroid status in a biological specimen. This is calculated by a mathematical formula that takes into account the total thyroxine and unbound thyroxine binding globulins. Free Thyroxine Index Thyroxine, Free, Indirect An indirect measurement of the free thyroxine in a biological specimen. Indirect Free Thyroxine Measurement Total Anti-Oxidant Capacity Total Antioxidant Capacity A measurement of the amount and/or activity of antioxidants in a specimen. Total Antioxidant Capacity Measurement Antigen Peptide Transporter 1 Peptide Transporter TAP1 A measurement of the peptide transporter TAP1 in a biological specimen. Peptide Transporter TAP1 Measurement Thrombin/Antithrombin Thrombin/Antithrombin III A relative measurement (ratio or percentage) of the thrombin to antithrombin present in a sample. Thrombin to Antithrombin Ratio Measurement TAT Thrombin Antithrombin Complex Thrombin Antithrombin Complex Antigen A measurement of the thrombin-antithrombin complexes in a biological specimen. Thrombin Antithrombin Complex Measurement Phosphorylated Tau 181 Phosphorylated Tau Protein 181 pTau181 A measurement of the phosphorylated Tau protein 181 in a biological specimen. Phosphorylated Tau Protein 181 Measurement Phosphorylated Tau 212 Phosphorylated Tau Protein 212 pTau212 A measurement of the phosphorylated Tau protein 212 in a biological specimen. Phosphorylated Tau Protein 212 Measurement Phosphorylated Tau 217 Phosphorylated Tau Protein 217 pTau217 A measurement of the phosphorylated Tau protein 217 in a biological specimen. Phosphorylated Tau Protein 217 Measurement Phosphorylated Tau 231 Phosphorylated Tau Protein 231 pTau231 A measurement of the phosphorylated Tau protein 231 in a biological specimen. Phosphorylated Tau Protein 231 Measurement Taurine/Creatinine A relative measurement (ratio) of the taurine to the creatinine in a biological specimen. Taurine to Creatinine Ratio Measurement Tauric Acid Taurine A measurement of the taurine in a biological specimen. Taurine Measurement Thyroxine Binding Globulin A measurement of the thyroxine binding globulin protein in a biological specimen. Thyroxine Binding Globulin Protein Measurement TATA Box Binding Protein TATA-Binding Protein A measurement of the TATA-box binding protein in a biological specimen. TATA Box Binding Protein Measurement Taurochenodeoxycholate Taurochenodeoxycholic Acid A measurement of the taurochenodeoxycholate in a biological specimen. Taurochenodeoxycholate Measurement Taurocholate Taurocholic Acid A measurement of the taurocholate in a biological specimen. Taurocholate Measurement Terminal Deoxynucleotidyl Transferase Ag Terminal Deoxynucleotidyl Transferase Antigen A measurement of the terminal deoxynucleotidyl transferase antigen in a biological specimen. Terminal Deoxynucleotidyl Transferase Antigen Measurement Dacryocytes Tear Shaped Erythrocytes Teardrop Cells A measurement of dacryocytes in a biological specimen. Dacryocyte Analysis Testosterone Total Testosterone A measurement of the total (free and bound) testosterone in a biological specimen. Total Testosterone Measurement Bioavailable Testosterone A measurement of bioavailable testosterone in a biological specimen. Bioavailable Testosterone Measurement Testosterone, Free A measurement of the free testosterone in a biological specimen. Free Testosterone Measurement Testosterone, Weakly Bound A measurement of the weakly bound testosterone (testosterone bound to albumin) in a biological specimen. Weakly Bound Testosterone Measurement Beta-1 Metal-Binding Globulin Serotransferrin Siderophilin Transferrin A measurement of the total transferrin in a biological specimen. Transferrin Measurement Trefoil Factor 3 A measurement of the trefoil factor 3 in a biological specimen. Trefoil Factor 3 Measurement Free Tissue Factor Pathway Inhibitor Antigen Tissue Factor Pathway Inhibitor, Free A measurement of the free tissue factor pathway inhibitor in a biological specimen. Free Tissue Factor Pathway Inhibitor Antigen Measurement P90 Soluble CD71 TfR1 Transferrin Receptor Protein 1 A measurement of the transferrin receptor protein 1 in a biological specimen. Transferrin Receptor Protein 1 Measurement Iron Binding Capacity Saturation Iron Saturation Iron to TIBC Transferrin Saturation A measurement of the iron bound to transferrin in a biological specimen. Transferrin Saturation Measurement Protransforming Growth Factor Alpha TGF-Alpha Transforming Growth Factor Alpha A measurement of the transforming growth factor alpha in a biological specimen. Transforming Growth Factor Alpha Measurement Transforming Growth Factor Beta A measurement of the total transforming growth factor beta in a biological specimen. Transforming Growth Factor Beta Measurement Transforming Growth Factor Beta 1 A measurement of the transforming growth factor beta 1 in a biological specimen. Transforming Growth Factor Beta 1 Measurement G-TSF LDS4 TGF-beta2 Transforming Growth Factor Beta 2 A measurement of the transforming growth factor beta 2 in a biological specimen. Transforming Growth Factor Beta 2 Measurement ARVD ARVD1 LDS5 RNHF TGF-beta3 Transforming Growth Factor Beta 3 A measurement of the transforming growth factor beta 3 in a biological specimen. Transforming Growth Factor Beta 3 Measurement TG Thyroglobulin A measurement of the thyroglobulin in a biological specimen. Thyroglobulin Measurement Thyroglobulin Recovery Rate A measurement of the thyroglobulin recovery rate in a biological specimen obtained by measuring the thyroglobulin concentration before and after a known amount of thyroglobulin has been added to the specimen. Thyroglobulin Recovery Rate BDCA3 Thrombomodulin A measurement of the thrombomodulin in a biological specimen. Thrombomodulin Measurement Delta-9-Tetrahydrocannabinol Tetrahydrocannabinol THC A measurement of the tetrahydrocannabinol in a biological specimen. Tetrahydrocannabinol Measurement 11-Nor-Delta9-THC-9-Carboxylic Acid THC-COOH A measurement of 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid present in a biological specimen. 11-Nor-Delta9-THC-9-Carboxylic Acid Measurement 5-Alpha Tetrahydrocortisol A measurement of the 5-alpha tetrahydrocortisol in a biological specimen. 5-Alpha Tetrahydrocortisol Measurement Thebaine A measurement of the thebaine in a biological specimen. Thebaine Measurement Theophylline A measurement of the Theophylline present in a biological specimen. Theophylline Measurement Tetrahydrogestrinone A measurement of the tetrahydrogestrinone in a biological specimen. Tetrahydrogestrinone Measurement Thiopental A measurement of the thiopental in a biological specimen. Thiopental Measurement Thioridazine A measurement of the thioridazine in a biological specimen. Thioridazine Measurement Thiothixene A measurement of the thiothixene in a biological specimen. Thiothixene Measurement Thrombin Activity Actual/Control Thrombin Activity Actual/Normal Thrombin Activity Actual/Thrombin Activity Control A relative measurement (ratio or percentage) of the biological activity of thrombin dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. Thrombin Activity Actual to Control Ratio Measurement Thiamylal A measurement of the thiamylal in a biological specimen. Thiamylal Measurement Threonine A measurement of the threonine in a biological specimen. Threonine Measurement Threonine/Creatinine A relative measurement (ratio) of the threonine to the creatinine in a biological specimen. Threonine to Creatinine Ratio Measurement Thrombopoietin A measurement of the thrombopoietin hormone in a biological specimen. Thrombopoietin Measurement Nucleated Thrombocytes Thrombocytes A measurement of the nucleated platelets, namely thrombocytes, in a biological specimen. This is typically measured in birds and other non-mammalian vertebrates. Nucleated Thrombocyte Count Thyroid Peroxidase Thyroperoxidase A measurement of the thyroperoxidase in a biological specimen. Thyroperoxidase Measurement Translocase Inner Mitochondrial Membr 10 Translocase of Inner Mitochondrial Membrane 10 A measurement of the translocase of inner mitochondrial membrane 10 in a biological specimen. Translocase Inner Mitochondrial Membrane 10 Measurement TIM Tissue Inhibitor of Metalloproteinase A measurement of the total tissue inhibitor metalloproteinase in a biological specimen. Tissue Inhibitor of Metalloproteinase Measurement EPA Erythroid Potentiating Activity Fibroblast Collagenase Inhibitor Metalloproteinase Inhibitor 1 Tissue Inhibitor of Metalloproteinase 1 A measurement of the tissue inhibitor of metalloproteinase 1 in a biological specimen. Tissue Inhibitor of Metalloproteinase 1 Measurement TIMP1/Creatinine Tissue Inhibitor of Metalloproteinase 1/Creatinine A relative measurement (ratio or percentage) of the tissue inhibitor of metalloproteinase 1 to creatinine present in a sample. Tissue Inhibitor of Metalloproteinase 1 to Creatinine Ratio Measurement CSC-21K Metalloproteinase Inhibitor 2 Tissue Inhibitor of Metalloproteinase 2 A measurement of the tissue inhibitor of metalloproteinase 2 in a biological specimen. Tissue Inhibitor of Metalloproteinase 2 Measurement HSMRK222 K222 K222TA2 Metalloproteinase Inhibitor 3 Protein MIG-5 SFD Tissue Inhibitor of Metalloproteinase 3 A measurement of the tissue inhibitor of metalloproteinase 3 in a biological specimen. Tissue Inhibitor of Metalloproteinase 3 Measurement Thymidine Kinase A measurement of the total thymidine kinase in a biological specimen. Thymidine Kinase Measurement Thymidine Kinase 1 Thymidine Kinase, Cytosolic A measurement of the thymidine kinase 1 in a biological specimen. Thymidine Kinase 1 Measurement Thymidine Kinase 2 Thymidine Kinase, Mitochondrial A measurement of the thymidine kinase 2 in a biological specimen. Thymidine Kinase 2 Measurement T-Kininogen A measurement of the total T-kininogen in a biological specimen. T-Kininogen Measurement Taurolithocholate Taurolithocholic Acid A measurement of the taurolithocholate in a biological specimen. Taurolithocholate Measurement T Cells T-Cell Lymphocytes T-Cells T-Lymphocytes A measurement of the total thymocyte-derived lymphocytes in a biological specimen. T-Lymphocyte Count T-lymphocyte Crossmatch A measurement to determine human leukocyte antigens (HLA) histocompatibility between the recipient and the donor by examining the presence or absence of the recipient's anti-HLA antibody reactivity towards HLA antigens expressed on the donor T-lymphocytes. T-lymphocyte Crossmatch Measurement Trimeperidine A measurement of the trimeperidine in a biological specimen. Trimeperidine Measurement Temazepam A measurement of the temazepam present in a biological specimen. Temazepam Measurement Tenascin C Tenascin-C TN-C A measurement of the tenascin C in a biological specimen. Tenascin C Measurement Tumor Necrosis Factor Tumor Necrosis Factor alpha A measurement of the total tumor necrosis factor (cachexin) cytokine in a biological specimen. Tumor Necrosis Factor Measurement APO2L Soluble CD253 TL2 TNF-Related Apoptosis-Inducing Ligand TNFSF10 TNLG6A TRAIL A measurement of the total tumor necrosis factor superfamily member 10 in a biological specimen. TNF Superfamily Member 10 Measurement CD263 DcR1 TNF Receptor Superfamily Member 10c TNF-Related Apoptosis-Inducing Ligand Receptor 3 TRAIL Receptor 3 TRAILR3 A measurement of the TNF receptor superfamily member 10c in a biological specimen. Tumor Necrosis Factor Receptor Superfamily Member 10c Measurement APO3L DR3LG TNF Superfamily Member 12 TNLG4A TWEAK A measurement of the total tumor necrosis factor superfamily member 12 in a biological specimen. TNF Superfamily Member 12 Measurement TNF Superfamily Member 12 Excretion Rate TWEAK Excretion Rate A measurement of the amount of TNF superfamily member 12 being excreted in a biological specimen over a defined period of time (e.g. one hour). TNF Superfamily Member 12 Excretion Rate Soluble TNF Superfamily Member 12 Soluble TNFSF12 A measurement of soluble tumor necrosis factor superfamily member 12 in a biological specimen. Soluble TNF Superfamily Member 12 Measurement Herpesvirus Entry Mediator Ligand HVEM-L LIGHT Soluble CD258 TNF Ligand Superfamily Member 14 TNF Superfamily Member 14 TNFSF14 Tumor Necrosis Factor (Ligand) Superfamily, Member 14 A measurement of the tumor necrosis factor superfamily member 14 in a biological specimen. Tumor Necrosis Factor Receptor Superfamily Member 14 Measurement Soluble CD154 Soluble CD40 Ligand Soluble CD40L Soluble CD40LG Soluble gp39 Soluble T-BAM Soluble TNF Superfamily Member 5 Soluble TNFSF5 Soluble TRAP A measurement of the soluble tumor necrosis factor superfamily member 5 in a biological specimen. Soluble TNF Superfamily Member 5 Measurement TNF-a Production Inhibition TNF-a Production Inhibitory Activity A measurement of TNF-a production inhibitory activity in a biological specimen. TNF-a Production Inhibitory Activity Measurement Soluble CD120a Tumor Necrosis Factor Receptor 1 A measurement of the tumor necrosis factor receptor 1 (CD120a) in a biological specimen. Tumor Necrosis Factor Receptor 1 Measurement CD120b p75 p75TNFR Soluble CD120b TBPII TNF Receptor 1B TNF-R-II TNF-R75 TNFBR TNFR1B TNFR2 TNFR80 Tumor Necrosis Factor Receptor 2 A measurement of the tumor necrosis factor receptor superfamily member 1B in a biological specimen. TNF Receptor 1B Measurement Soluble CD120b Soluble TNF Receptor 1B Soluble TNF Receptor Type II Soluble TNFR1B Soluble TNFRSF1B Soluble Tumor Necrosis Factor Receptor Superfamily Member 1B A measurement of the soluble tumor necrosis factor receptor superfamily member 1B in a biological specimen. Soluble Tumor Necrosis Factor Receptor Type II Measurement ACT35 Antigen OX40 OX40L Receptor Soluble CD134 Soluble TNF Receptor Superfamily Mem 4 Soluble TNF Receptor Superfamily Member 4 TNFRSF4 A measurement of the soluble tumor necrosis factor receptor superfamily member 4 in a biological specimen. Soluble Tumor Necrosis Factor Receptor Superfamily Member 4 Measurement Soluble B-cell Surface Antigen CD40 Soluble Bp50 Soluble CD40 Soluble CDW40 Soluble p50 Soluble TNF Receptor Superfamily Mem 5 Soluble TNF Receptor Superfamily Member 5 Soluble TNFRSF5 Soluble Tumor Necrosis Factor Receptor Superfamily, Member 5 A measurement of the soluble tumor necrosis factor receptor superfamily member 5 (CD40) in a biological specimen. Soluble TNF Receptor Superfamily Member 5 Measurement Soluble CD27 Soluble CD27 Antigen Soluble CD27 Molecule Soluble TNF Receptor Superfamily Mem 7 Soluble TNFRSF7 Soluble Tumor Necrosis Factor Receptor Superfamily Member 7 A measurement of the soluble tumor necrosis factor receptor superfamily member 7 (CD27) in a biological specimen. Soluble TNF Receptor Superfamily Mem 7 Measurement sCD137 Soluble CD137 Soluble TNF Receptor Superfamily Mem 9 Soluble TNF Receptor Superfamily Member 9 Soluble TNFRSF9 A measurement of the soluble tumor necrosis factor receptor superfamily member 9 (CD137) in a biological specimen. Soluble Tumor Necrosis Factor Receptor Superfamily Member 9 Measurement Soluble Tumor Necrosis Factor Receptor A measurement of the total soluble tumor necrosis factor receptor in a biological specimen. Soluble Tumor Necrosis Factor Receptor Measurement Soluble TNF Receptor Type I A measurement of the soluble tumor necrosis factor receptor type I in a biological specimen. Soluble Tumor Necrosis Factor Receptor Type I Measurement Methylbenzene Phenylmethane Toluene Toluol A measurement of the toluene in a specimen. Toluene Measurement Tomoregulin-2 Transmembrane Protein With EGF-Like And Two Follistatin-Like Domains 2 A measurement of the tomoregulin-2 in a biological specimen. Tomoregulin-2 Measurement Toxic Granulation A measurement of the toxic granulation in granulocytic blood cells. Toxic Granulation Measurement Toxic Vacuolation A measurement of the toxic vacuolation in any of the granulocytic blood cells. Toxic Vacuolation Assessment Tissue Plasminogen Activator Antigen A measurement of the tissue plasminogen activator antigen in a biological specimen. Tissue Plasminogen Activator Measurement Tissue Polypeptide Antigen TPA A measurement of the tissue polypeptide antigen in a biological specimen. Tissue Polypeptide Antigen Measurement Tapentadol A measurement of the tapentadol in a biological specimen. Tapentadol Measurement Non-Phosphorylated Tau Protein A measurement of the non-phosphorylated Tau protein in a biological specimen. Nonphosphorylated Tau Protein Measurement Tau Protein Total Tau Protein A measurement of the total Tau protein in a biological specimen. Tau Protein Measurement Tau Protein, Free A measurement of the free tau protein in a biological specimen. Free Tau Protein Measurement Phosphorylated Tau Protein pTau A measurement of the phosphorylated Tau protein in a biological specimen. Phosphorylated Tau Protein Measurement Tartrate-Resistant Acid Phosphatase 5b TRAP5B A measurement of tartrate-resistant acid phosphatase 5b in a biological specimen. Tartrate-Resistant Acid Phosphatase 5b Measurement Tramadol A measurement of the tramadol present in a biological specimen. Tramadol Measurement TPR and Ankyrin Repeat-Containing Protein 1 TPR-Ankyrin Repeat-Containing Protein 1 A measurement of the TPR-ankyrin repeat-containing protein 1 in a biological specimen. TPR-Ankyrin Repeat-containing Protein 1 Measurement Total Radical-Trap Antioxidant Potential A measurement of the ability of the antioxidants in a biological specimen to buffer free radicals in a suspension. Total Radical-Trap Antioxidant Potential Measurement Tricyclic Antidepressants A measurement of tricyclic antidepressants in a biological specimen. Tricyclic Antidepressant Measurement Soluble CD354 Triggering Rcpt Expressed Myeloid Cell 1 Triggering Receptor Expressed On Monocytes 1 Triggering Receptor Expressed On Myeloid Cells 1 A measurement of the triggering receptor expressed on myeloid cells 1 protein in a biological specimen. Triggering Receptor Expressed On Myeloid Cells 1 Measurement Codocytes Target Cells A measurement of the target cells in a biological specimen. Target Cell Count Thyrotropin Releasing Factor Thyrotropin Releasing Hormone A measurement of the thyrotropin releasing hormone in a biological specimen. Thyrotropin Releasing Hormone Measurement Trichomonas Examination of a biological specimen to detect the presence of any protozoan belonging to the Trichomonas genus. Trichomonas Screening Trifluoperazine A measurement of the trifluoperazine in a biological specimen. Trifluoperazine Measurement Triglycerides A measurement of the triglycerides in a biological specimen. Triglyceride Measurement Triglycerides/HDL Cholesterol A relative measurement (ratio or percentage) of the triglycerides to high density lipoprotein cholesterol in a biological specimen. Triglycerides to HDL Cholesterol Ratio Measurement Triglyceride Sapienate Triglyceride Sapienic Acid A measurement of the total triglyceride sapienate in a biological specimen. Triglyceride Sapienate Measurement E3 Ubiquitin-Protein Ligase TRIM21 Ro(SS-A) Sjogren Syndrome Type A Antigen Tripartite Motif Containing Protein 21 A measurement of the tripartite motif containing protein 21 in a biological specimen. Tripartite Motif Containing Protein 21 Measurement E3 Ubiquitin-Protein Ligase TRIM33 Tripartite Motif Containing 33 A measurement of the E3 ubiquitin-protein ligase TRIM33 in a biological specimen. E3 Ubiquitin-Protein Ligase TRIM33 Measurement Tripartite Motif Containing Protein 38 A measurement of the tripartite motif containing protein 38 in a biological specimen. Tripartite Motif Containing Protein 38 Measurement 17beta-Trenbolone Trenbolone Trienbolone A measurement of the trenbolone in a biological specimen. Trenbolone Measurement Troponin I A measurement of the actin binding troponin in a biological specimen. Troponin I Measurement Slow-Twitch Skeletal Muscle Troponin I ssTnI Troponin I Type 1 A measurement of the troponin I type 1 (slow twitch skeletal muscle) in a biological specimen. Troponin I Type 1 Measurement Fast-Twitch Skeletal Muscle Troponin I fsTnI Troponin I Type 2 A measurement of the troponin I type 2 (fast twitch skeletal muscle) in a biological specimen. Troponin I Type 2 Measurement Cardiac Troponin I cTnI TNNC1 Troponin I Type 3 A measurement of the troponin I type 3 (cardiac muscle) in a biological specimen. Troponin I Type 3 Measurement Troponin A measurement of the total troponin in a biological specimen. Troponin Measurement Troponin T A measurement of the tropomyosin binding troponin in a biological specimen. Troponin T Measurement Tryptophan A measurement of the tryptophan in a biological specimen. Tryptophan Measurement Trypsin 1 and Trypsinogen 1 A measurement of the trypsin 1 and trypsinogen 1 in a biological specimen. Trypsin 1 and Trypsinogen 1 Measurement Tryptophan/Creatinine A relative measurement (ratio or percentage) of the tryptophan to creatinine in a biological specimen. Tryptophan to Creatinine Ratio Measurement Trypsin and Trypsinogen A measurement of the total trypsin and total trypsinogen in a biological specimen. Trypsin and Trypsinogen Measurement Trypsin A measurement of the trypsin in a biological specimen. Trypsin Measurement Tryptase A measurement of the tryptase in a biological specimen. Tryptase Measurement Trazodone A measurement of the trazodone in a biological specimen. Trazodone Measurement Triazolam A measurement of the triazolam in a biological specimen. Triazolam Measurement Thyroid Stimulating Hormone Thyrotropin A measurement of the thyrotropin in a biological specimen. Thyrotropin Measurement Thyroid Stimulating Hormone/Free T4 Thyrotropin/Thyroxine, Free A relative measurement (ratio) of the thyrotropin to free thyroxine in a biological specimen. Thyrotropin to Free Thyroxine Ratio Measurement Thymic Stromal Lymphopoietin A measurement of the thymic stromal lymphopoietin in a biological specimen. Thymic Stromal Lymphopoietin Measurement THBS1 Thrombospondin 1 A measurement of the thrombospondin 1 in a biological specimen. Thrombospondin 1 Measurement BA2 CD9 CD9 Antigen CD9 Molecule MIC3 MRP-1 P24 Soluble CD9 Tetraspanin-29 TSPAN-29 A measurement of the tetraspanin-29 in a biological specimen. Tetraspanin-29 Measurement 11-Ketotestosterone A measurement of the 11-ketotestosterone in a biological specimen. 11-Ketotestosterone Measurement 4-Hydroxytestosterone A measurement of the 4-hydroxytestosterone in a biological specimen. 4-Hydroxytestosterone Measurement Testosterone, Free/Testosterone A relative measurement (ratio or percentage) of the amount of the bioavailable testosterone compared to total testosterone in a biological specimen. Free Testosterone to Testosterone Ratio Measurement Testosterone Free+Weakly Bound/Testost Testosterone, Free and Weakly Bound/Testosterone A relative measurement (ratio or percentage) of the free and weakly bound testosterone to total testosterone in a biological specimen. Free Testosterone and Weakly Bound to Total Testosterone Ratio Measurement Testolactone A measurement of the testolactone in a biological specimen. Testolactone Measurement Testosterone, Free/Total Protein A relative measurement (ratio or percentage) of free testosterone to total proteins in a biological specimen. Free Testosterone to Total Protein Ratio Measurement Thrombin Time A measurement of the time it takes a plasma sample to clot after adding the active enzyme thrombin. (NCI) Thrombin Time Thrombin Time Actual/Control A relative measurement (ratio or percentage) of the thrombin time in a subject's specimen when compared to a control specimen. Thrombin Time Actual to Control Ratio Measurement Tauroursodeoxycholate Tauroursodeoxycholic Acid A measurement of the tauroursodeoxycholate in a biological specimen. Tauroursodeoxycholate Measurement TUM Tumstatin A measurement of the tumstatin in a biological specimen. Tumstatin Measurement Turbidity A measurement of the opacity of a biological specimen. Turbidity Measurement Thromboxane B2 A measurement of the thromboxane B2 in a biological specimen. Thromboxane B2 Measurement 11-Dehydro-Thromboxane B2 A measurement of the 11-dehydro-thromboxane B2 in a biological specimen. 11-Dehydro-Thromboxane B2 Measurement 11-Dehydro-Thromboxane B2 Excretion Rate A measurement of the amount of 11-dehydro-thromboxane B2 being excreted in a biological specimen over a defined amount of time (e.g. one hour). 11-Dehydro-Thromboxane B2 Excretion Rate Tyrosine A measurement of the tyrosine in a biological specimen. Tyrosine Measurement Pink Pinky U-47700 U4 U47700 A measurement of the synthetic cannabinoid U-47700 in a biological specimen. U-47700 Measurement Ubiquitin Protein A measurement of the total ubiquitin protein in a biological specimen. Ubiquitin Protein Measurement Ubiquitin C-Terminal Hydrolase L1 Ubiquitin Carboxy-Terminal Hydrolase L1 UCH-L1 A measurement of the ubiquitin C-terminal hydrolase L1 in a biological specimen. Ubiquitin C-Terminal Hydrolase L1 Measurement Ursodeoxycholate Ursodeoxycholic Acid Ursodiol A measurement of the ursodeoxycholate in a biological specimen. Ursodeoxycholate Measurement Ursodeoxycholate Compounds Ursodeoxycholic Acid Compounds A measurement of the ursodeoxycholic acid, glycoursodeoxycholic acid, tauroursodeoxycholic acid, and epimerized ursodeoxycholic acid in a biological specimen. Ursodeoxycholate Compounds Measurement Tamm-Horsfall Urinary Glycoprotein THP UROM Uromodulin A measurement of the uromodulin in a biological specimen. Uromodulin Measurement Unspecified Cells A measurement of the cells not otherwise identified or specified in a biological specimen. Count of Unspecified Cells Unspecified Cells/Total Cells A relative measurement (ratio or percentage) of the cells not otherwise identified or specified to total cells in a biological specimen. Unspecified Cells to Total Cell Ratio Measurement Unspecified Cells/Leukocytes A relative measurement (ratio or percentage) of the cells not otherwise identified or specified to leukocytes in a biological specimen. Unspecified Cells to Leukocytes Ratio Measurement uPA Urokinase Plasminogen Activator A measurement of the urokinase plasminogen activator in a biological specimen. Urokinase Plasminogen Activator Measurement UR-144 UR144 A measurement of the synthetic cannabinoid UR-144 in a biological specimen. UR-144 Measurement Urate Uric Acid A measurement of the urate in a biological specimen. Urate Measurement Urate/Creatinine A relative measurement (ratio or percentage) of the urate to creatinine in a biological specimen. Urate to Creatinine Ratio Measurement Urate Excretion Rate A measurement of the amount of urate being excreted in a biological specimen over a defined amount of time (e.g. one hour). Urate Excretion Rate Urea A measurement of the urea in a biological specimen. Urea Measurement Urea/Creatinine A relative measurement (ratio or percentage) of the urea to creatinine in a biological specimen. Urea to Creatinine Ratio Measurement Urea Excretion Rate A measurement of the amount of urea excreted in a biological specimen over a defined period of time (e.g. one hour). Urea Excretion Rate Urea Distribution Volume Ratio Urea Kt/V A calculated measurement of the urea distribution volume (ratio) in a biological specimen used to quantify adequacy of dialysis treatment. Urea Distribution Volume Ratio Urea Nitrogen A measurement of the urea nitrogen in a biological specimen. Urea Nitrogen Measurement Urea Nitrogen/Creatinine A relative measurement (ratio or percentage) of the urea nitrogen to creatinine in a biological specimen. Urea Nitrogen to Creatinine Ratio Measurement Urea Nitrogen Excretion Rate A measurement of the amount of urea nitrogen being excreted in a biological specimen over a defined amount of time (e.g. one hour). Urea Nitrogen Excretion Rate Urinalysis Panel Interpretation Urine Panel Analysis Urine Panel Examination Urine Panel Interpretation An interpretation of the results of a panel of urinalysis tests. Urinalysis Panel Interpretation Urobilinogen A measurement of the urobilinogen in a biological specimen. Urobilinogen Measurement Urothelial Cells A measurement of urothelial cells in a biological specimen. Urothelial Cell Count Urea Reduction Ratio A calculated measurement (ratio or percentage) of the proportionate reduction in urea nitrogen over the course of dialysis in a biological specimen. Urea Reduction Ratio 25-Hydroxycalciferol 25-Hydroxyergocalciferol 25-Hydroxyvitamin D2 Ercalcidiol A measurement of the 25-Hydroxyvitamin D2 in a biological specimen. 25-Hydroxyvitamin D2 Measurement 25-Hydroxycholecalciferol 25-Hydroxyvitamin D 25-Hydroxyvitamin D3 Calcidiol Calcifediol Inactive Vitamin D A measurement of the 25-Hydroxyvitamin D3 in a biological specimen. 25-Hydroxyvitamin D3 Measurement Valine A measurement of the valine in a biological specimen. Valine Measurement Valproate Valproic Acid A measurement of the valproate in a biological specimen. Valproate Measurement VLDL Apolipoprotein B A measurement of the apolipoprotein B in the very low density lipoprotein fraction of a biological specimen. VLDL Apolipoprotein B Measurement Live Cells Viable Cells A measurement of the viable cells in a biological specimen. Viable Cell Count Vascular Cell Adhesion Molecule 1 A measurement of the vascular cell adhesion molecule 1 in a biological specimen. Vascular Cell Adhesion Molecule 1 Measurement Vascular Endothelial Growth Factor A measurement of the vascular endothelial growth factor in a biological specimen. Vascular Endothelial Growth Factor Measurement Vascular Endothelial Growth Factor A A measurement of the vascular endothelial growth factor A in a biological specimen. Vascular Endothelial Growth Factor A Measurement Vascular Endothelial Growth Factor C A measurement of the vascular endothelial growth factor C in a biological specimen. Vascular Endothelial Growth Factor C Measurement FIGF Vascular Endothelial Growth Factor D A measurement of the vascular endothelial growth factor D in a biological specimen. Vascular Endothelial Growth Factor D Measurement Soluble Vasc Endoth Growth Factor Rec1 Soluble Vascular Endothelial Growth Factor Receptor 1 A measurement of the soluble vascular endothelial growth factor receptor 1 in a biological specimen. Soluble Vascular Endothelial Growth Factor Receptor Type 1 Measurement Vasc Endothelial Growth Factor Rec 2 Vascular Endothelial Growth Factor Receptor 2 A measurement of the vascular endothelial growth factor receptor 2 in a biological specimen. Vascular Endothelial Growth Factor Receptor 2 Measurement Soluble Vasc Endoth Growth Factor Rec2 Soluble Vascular Endothelial Growth Factor Receptor 2 A measurement of the soluble vascular endothelial growth factor receptor 2 in a biological specimen. Soluble Vascular Endothelial Growth Factor Receptor Type 2 Measurement Soluble Vasc Endoth Growth Factor Rec3 Soluble Vascular Endothelial Growth Factor Receptor 3 A measurement of the soluble vascular endothelial growth factor receptor 3 in a biological specimen. Soluble Vascular Endothelial Growth Factor Receptor Type 3 Measurement Venlafaxine A measurement of the venlafaxine present in a biological specimen. Venlafaxine Measurement Citrullinated and MMP-Degraded Vimentin VICM VICM A measurement of the citrullinated and MMP-degraded vimentin fragment VICM in a biological specimen. Citrullinated and MMP-Degraded Vimentin Measurement Vinbarbital A measurement of the vinbarbital in a biological specimen. Vinbarbital Measurement Vasoactive Intestinal Polypeptide VIP A measurement of vasoactive intestinal polypeptide in a biological specimen. Vasoactive Intestinal Polypeptide Measurement Visc Viscosity The resistance of a liquid to sheer forces and flow. (NCI) Viscosity Retinol Vitamin A A measurement of the Vitamin A in a biological specimen. Vitamin A Measurement Thiamine Vitamin B1 A measurement of the thiamine in a biological specimen. Vitamin B1 Measurement Cobalamin Vitamin B12 A measurement of the Vitamin B12 in a biological specimen. Vitamin B12 Measurement Amygdalin Vitamin B17 A measurement of the Vitamin B17 in a biological specimen. Vitamin B17 Measurement Riboflavin Vitamin B2 A measurement of the riboflavin in a biological specimen. Vitamin B2 Measurement Niacin Vitamin B3 A measurement of the niacin in a biological specimen. Vitamin B3 Measurement Pantothenic Acid Vitamin B5 A measurement of the Vitamin B5 in a biological specimen. Vitamin B5 Measurement Pyridoxine Vitamin B6 A measurement of the Vitamin B6 in a biological specimen. Vitamin B6 Measurement Biotin Vitamin B7 A measurement of the Vitamin B7 in a biological specimen. Vitamin B7 Measurement Folate Folic Acid Vitamin B9 A measurement of the folic acid in a biological specimen. Folic Acid Measurement Ascorbate Ascorbic Acid Vitamin C A measurement of the Vitamin C in a biological specimen. Vitamin C Measurement Calciferol Ergocalciferol Viosterol Vitamin D2 A measurement of the Vitamin D2 in a biological specimen. Vitamin D2 Measurement Calciferol + Cholecalciferol Vitamin D2 + Vitamin D3 A measurement of the vitamin D2 and vitamin D3 in a biological specimen. Vitamin D2 and Vitamin D3 Measurement Vitamin D + Metabolites Vitamin D2 + Vitamin D3 + 25-Hydroxy Vitamin D2 + 25-Hydroxy Vitamin D3 Vitamin D2 D3 25-OH A measurement of the vitamin D2, vitamin D3 and their metabolites in a biological specimen. Vitamin D2 and Vitamin D3 and 25-Hydroxy Vitamin D2 and 25-Hydroxy Vitamin D3 Measurement Calciol Cholecalciferol Colecalciferol Vitamin D Vitamin D3 A measurement of the Vitamin D3 in a biological specimen. Vitamin D3 Measurement DBP GC Vitamin D Binding Protein VDBP Vitamin D Binding Protein A measurement of the vitamin D binding protein in a biological specimen. Vitamin D Binding Protein Measurement Vitamin E A measurement of the Vitamin E in a biological specimen. Vitamin E Measurement Vitamin E/Cholesterol A relative measurement (ratio or percentage) of vitamin E to total cholesterol in a biological specimen. Vitamin E to Cholesterol Ratio Measurement Naphthoquinone Vitamin K A measurement of the total Vitamin K in a biological specimen. Vitamin K Measurement Phylloquinone Phytomenadione Vitamin K1 A measurement of the Vitamin K1 in a biological specimen. Vitamin K1 Measurement VLDL Cholesterol A measurement of the very low density lipoprotein cholesterol in a biological specimen. Very Low Density Lipoprotein Cholesterol Measurement VLDL Cholesterol Subtype 1 A measurement of the very low density lipoprotein cholesterol subtype 1 in a biological specimen. VLDL Cholesterol Subtype 1 Measurement VLDL Cholesterol Subtype 2 A measurement of the very low density lipoprotein cholesterol subtype 2 in a biological specimen. VLDL Cholesterol Subtype 2 Measurement VLDL Cholesterol Subtype 3 A measurement of the very low density lipoprotein cholesterol subtype 3 in a biological specimen. VLDL Cholesterol Subtype 3 Measurement VLDL Particle Size A measurement of the average particle size of very-low-density lipoprotein in a biological specimen. VLDL Particle Size Measurement VLDL Triglyceride A measurement of the very low density lipoprotein triglyceride in a biological specimen. VLDL Triglyceride Measurement VLDL Trig + Chylomicron Trig VLDL Triglyceride + Chylomicron Triglyceride A measurement of the very low density lipoprotein triglyceride and chylomicron triglyceride in a biological specimen. VLDL Triglyceride and Chylomicron Triglyceride Measurement Vilazodone A measurement of the vilazodone in a biological specimen. Vilazodone Measurement Vanillyl Mandelic Acid Vanillylmandelate Vanilmandelic Acid A measurement of the vanillyl mandelic acid metabolite in a biological specimen. Vanillyl Mandelic Acid Measurement Vanillyl Mandelic Acid Excretion Rate A measurement of the amount of vanillyl mandelic acid being excreted in a biological specimen over a defined amount of time (e.g. one hour). Vanillyl Mandelic Acid Excretion Rate Volume A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. Volume Measurement Vortioxetine A measurement of the vortioxetine in a biological specimen. Vortioxetine Measurement 1,25-Dihydroxycalciferol 1,25-Dihydroxyergocalciferol 1,25-Dihydroxyvitamin D2 Ercalcitriol A measurement of the 1,25-dihydroxyvitamin D2 in a biological specimen. 1,25-Dihydroxyvitamin D2 Measurement 1,25-Di(OH)vitamin D2 + 1,25-Di(OH)vitamin D3 1,25-Dihydroxyvitamin D2 + 1,25-Dihydroxyvitamin D3 1,25-DihydroxyvitD2+1,25-DihydroxyvitD3 A measurement of the 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 in a biological specimen. 1,25-Dihydroxyvitamin D2 and 1,25-Dihydroxyvitamin D3 Measurement 25-Hydroxyvit D2 + 25-Hydroxyvit D3 A measurement of the total inactive vitamin D2 and vitamin D3 in a biological specimen. 25-Hydroxyvitamin D2 and 25-Hydroxyvitamin D3 Measurement 1,25-Dihydroxycholecalciferol 1,25-Dihydroxyvitamin D 1,25-Dihydroxyvitamin D3 Calcitriol A measurement of the 1,25-dihydroxyvitamin D3 in a biological specimen. 1,25-Dihydroxyvitamin D3 Measurement 24,25-Dihydroxycholecalciferol 24,25-Dihydroxyvitamin D 24,25-Dihydroxyvitamin D3 A measurement of the 24,25-dihydroxyvitamin D3 in a biological specimen. 24,25-Dihydroxyvitamin D3 Measurement V75 Vitronectin VN VNT VTN A measurement of the vitronectin in a biological specimen. Vitronectin Measurement von Will Factor Act Actual/Control von Willebrand Factor Activity Actual/Normal von Willebrand Factor Activity Actual/von Willebrand Factor Activity Control A relative measurement (ratio or percentage) of the biological activity of the von Willebrand factor dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. von Willebrand Factor Activity Actual to Control Ratio Measurement von Will Factor Actual/Control von Willebrand Factor Actual/Control von Willebrand Factor Actual/Normal von Willebrand Factor Actual/von Willebrand Factor Control A relative measurement (ratio or percentage) of the von Willebrand factor in a subject's specimen when compared to a control specimen. von Willebrand Factor Actual to Control Ratio Measurement Wax Esters A measurement of the wax esters in a biological specimen. Wax Ester Measurement Leukocytes White Blood Cells A measurement of the leukocytes in a biological specimen. Leukocyte Count Leukocytes/Total Cells WBC/Total Cells A relative measurement (ratio or percentage) of the leukocytes to total cells in a biological specimen. Leukocytes to Total Cells Ratio Measurement Leukocyte Cell Clumps WBC Clumps White Blood Cell Clumps A measurement of white blood cell clumps in a biological specimen. Leukocyte Cell Clumps Measurement Leukocyte Cell Differential Leukocyte Cell Fraction Leukocyte Diff An overall assessment of the leukocyte subtype distribution in a biological specimen. Differential Leukocyte Count Leukocyte Cell Morphology WBC Morphology White Blood Cell Morphology An examination or assessment of the form and structure of white blood cells. Leukocyte Cell Morphology CDW2 Macrophage Inflammatory Protein-2 MIP2 WD Repeat-Containing Protein 26 A measurement of the WD repeat-containing protein 26 in a biological specimen. WD Repeat-Containing Protein 26 Measurement Wax Ester Sapienate Wax Ester Sapienic Acid A measurement of the total wax ester sapienate in a biological specimen. Wax Ester Sapienate Measurement Xylose/Xylose Dose A relative measurement (percentage) of the xylose in a biological specimen to an administered dose of xylose. Xylose to Xylose Dose Ratio Measurement Xanthochromia A measurement of the yellowish appearance of a biological specimen due to the presence of bilirubin produced by the degradation of heme from erythrocytes that have entered the biological specimen. Xanthochromia Measurement Xylose A measurement of the xylose in a biological specimen. Xylose Measurement Yeast Cells A measurement of the yeast cells present in a biological specimen. Yeast Cell Measurement Budding Yeast Yeast Budding A measurement of the budding yeast present in a biological specimen. Budding Yeast Measurement Yeast Hyphae A measurement of the yeast hyphae present in a biological specimen. Yeast Hyphae Screening Chitinase-3-Like Protein 1 YKL-40 Protein A measurement of the YKL-40 protein in a biological specimen. YKL-40 Protein Measurement Zaleplon A measurement of the zaleplon in a biological specimen. Zaleplon Measurement Zinc A measurement of the zinc in a biological specimen. Zinc Measurement Ziprasidone A measurement of the ziprasidone in a biological specimen. Ziprasidone Measurement Zolpidem A measurement of the zolpidem in a biological specimen. Zolpidem Measurement Zopiclone A measurement of the zopiclone in a biological specimen. Zopiclone Measurement Zinc Protoporphyrin A measurement of the zinc protoporphyrin (zinc bound protoporphyrin) in a biological specimen. Zinc Protoporphyrin Measurement LBTESTCD Laboratory Test Code CDISC SDTM Laboratory Test Code Terminology Terminology used for laboratory test names of the CDISC Study Data Tabulation Model. 1,25-Dihydroxycalciferol 1,25-Dihydroxyergocalciferol 1,25-Dihydroxyvitamin D2 Ercalcitriol A measurement of the 1,25-dihydroxyvitamin D2 in a biological specimen. 1,25-Dihydroxyvitamin D2 Measurement 1,25-Dihydroxycholecalciferol 1,25-Dihydroxyvitamin D 1,25-Dihydroxyvitamin D3 Calcitriol A measurement of the 1,25-dihydroxyvitamin D3 in a biological specimen. 1,25-Dihydroxyvitamin D3 Measurement 1,25-Di(OH)vitamin D2 + 1,25-Di(OH)vitamin D3 1,25-Dihydroxyvitamin D2 + 1,25-Dihydroxyvitamin D3 1,25-DihydroxyvitD2+1,25-DihydroxyvitD3 A measurement of the 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 in a biological specimen. 1,25-Dihydroxyvitamin D2 and 1,25-Dihydroxyvitamin D3 Measurement 1,3-Beta-D-Glucan A measurement of the 1,3-beta-D-glucan in a biological specimen. 1,3-Beta-D-Glucan Measurement 1,3-Butadiene A measurement of the 1,3-butadiene in a specimen. 1,3-Butadiene Measurement 1,5-Anhydroglucitol A measurement of the 1,5-anhydroglucitol in a biological specimen. 1,5-Anhydroglucitol Measurement 1-Aminonaphthalene 1-Naphthylamine A measurement of the 1-aminonaphthalene in a specimen. 1-Aminonaphthalene Measurement 1'-Hydroxymidazolam 1-Hydroxymidazolam Alpha-Hydroxymidazolam A measurement of the 1-Hydroxymidazolam present in a biological specimen. 1-Hydroxymidazolam Measurement 11-Dehydro-Thromboxane B2 Excretion Rate A measurement of the amount of 11-dehydro-thromboxane B2 being excreted in a biological specimen over a defined amount of time (e.g. one hour). 11-Dehydro-Thromboxane B2 Excretion Rate 11-Dehydro-Thromboxane B2 A measurement of the 11-dehydro-thromboxane B2 in a biological specimen. 11-Dehydro-Thromboxane B2 Measurement 11-Deoxycorticoids 11-Deoxycorticosteroid 11-Deoxycorticosteroids A measurement of the total 11-deoxycorticosteroids in a biological specimen. 11-Deoxycorticosteroid Measurement 11-Deoxycorticosterone 21-Hydroxyprogesterone Cortexone Deoxycortone Desoxycortone A measurement of the 11-deoxycorticosterone in a biological specimen. 11-Deoxycorticosterone Measurement 11-Deoxycortisol A measurement of the 11-deoxycortisol in a biological specimen. 11-Deoxycortisol Measurement 11-Hydroxyandrostenedione A measurement of the 11-hydroxyandrostenedione in a biological specimen. 11-Hydroxyandrostenedione Measurement 11-Hydroxyandrosterone A measurement of the 11-hydroxyandrosterone in a biological specimen. 11-Hydroxyandrosterone Measurement 11-Hydroxyetiocholanolone A measurement of the 11-hydroxyetiocholanolone in a biological specimen. 11-Hydroxyetiocholanolone Measurement 11-Ketoandrosterone A measurement of the 11-ketoandrosterone in a biological specimen. 11-Ketoandrosterone Measurement 11-Ketoetiocholanolone A measurement of the 11-ketoetiocholanolone in a biological specimen. 11-Ketoetiocholanolone Measurement 11-Ketotestosterone A measurement of the 11-ketotestosterone in a biological specimen. 11-Ketotestosterone Measurement 11-Nor-Delta9-THC-9-Carboxylic Acid THC-COOH A measurement of 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid present in a biological specimen. 11-Nor-Delta9-THC-9-Carboxylic Acid Measurement 17-Hydroxycorticoid 17-Hydroxycorticosteroid 17-Hydroxycorticosteroids A measurement of the 17-hydroxycorticosteroids in a biological specimen. 17-Hydroxycorticosteroid Measurement 17-Hydroxypregnenolone A measurement of the 17-hydroxypregnenolone in a biological specimen. 17-Hydroxypregnenolone Measurement 17-Hydroxyprogesterone 17-OHP A measurement of the 17-Hydroxyprogesterone in a biological specimen. 17-Hydroxyprogesterone Measurement 17-Ketogenic steroids A measurement of the total 17-ketogenic steroids in a biological specimen. 17-Ketogenic Steroid Measurement 17-Ketosteroids A measurement of the total 17-ketosteroids in a biological specimen. 17-Ketosteroid Measurement 18-Hydroxycorticosterone A measurement of the 18-hydroxycorticosterone in a biological specimen. 18-Hydroxycorticosterone Measurement 18-Hydroxycortisol A measurement of the 18-hydroxycortisol in a biological specimen. 18-Hydroxycortisol Measurement 18-Hydroxydeoxycorticosterone A measurement of the 18-hydroxydeoxycorticosterone in a biological specimen. 18-Hydroxydeoxycorticosterone Measurement 2,3-dihydroxypropyl Mercapturate 2,3-dihydroxypropyl Mercapturic Acid DHPMA A measurement of the 2,3-dihydroxypropyl mercapturic acid in a specimen. 2,3-dihydroxypropyl Mercapturic Acid Measurement 2-5-Oligoadenylate Synthase 1 A measurement of the 2-5-oligoadenylate synthase 1 in a biological specimen. 2-5-Oligoadenylate Synthase 1 Measurement 2-5-Oligoadenylate Synthase 2 A measurement of the 2-5-oligoadenylate synthase 2 in a biological specimen. 2-5-Oligoadenylate Synthase 2 Measurement 2-5-Oligoadenylate Synthase 3 A measurement of the 2-5-oligoadenylate synthase 3 in a biological specimen. 2-5-Oligoadenylate Synthase 3 Measurement 2-Aminonaphthalene 2-Naphthylamine A measurement of the 2-aminonaphthalene in a specimen. 2-Aminonaphthalene Measurement 2-Cyanoethyl Mercapturate Cysteine 2-Cyanoethyl Mercapturic Acid Cysteine 2-Cyanoethylmercapturic Acid Cysteine 2-CyEMA N-Acetyl-S-(2-Cyanoethyl)-L-Cysteine A measurement of the 2-cyanoethyl mercapturic acid cysteine in a specimen. 2-Cyanoethyl Mercapturic Acid Cysteine Measurement 2-Cyanoethmercapturate 2-Cyanoethyl Mercapturic Acid 2-Cyanoethylmercapturic Acid CEMA A measurement of the 2-cyanoethyl mercapturic acid in a specimen. 2-Cyanoethyl Mercapturic Acid Measurement 2-Hydroxyethyl Mercapturate 2-Hydroxyethyl Mercapturic Acid HEMA N-Acetyl-S-(2-Hydroxyethyl)Cysteine A measurement of the 2-hydroxyethyl mercapturic acid in a specimen. 2-Hydroxyethyl Mercapturic Acid Measurement 2-Hydroxyglutarate 2-Hydroxyglutaric Acid Alpha-Hydroxyglutaric Acid A measurement of the 2-hydroxyglutarate in a biological specimen. 2-Hydroxyglutarate Measurement 2-Methylcitrate 2-Methylcitric Acid MCA Methylcitrate Methylcitric Acid A measurement of the 2-methylcitrate in a biological specimen. 2-Methylcitrate Measurement 20(S)-Hydroxycholesterol 20-Alpha-Hydroxycholesterol A measurement of the 20(S)-hydroxycholesterol in a biological specimen. 20(S)-Hydroxycholesterol Measurement 21-Deoxycorticosterone A measurement of the 21-deoxycorticosterone in a biological specimen. 21-Deoxycorticosterone Measurement 21-Deoxycortisol A measurement of the 21-deoxycortisol in a biological specimen. 21-Deoxycortisol Measurement 22(R)-Hydroxycholesterol A measurement of the 22(R)-hydroxycholesterol in a biological specimen. 22(R)-Hydroxycholesterol Measurement 22(S)-Hydroxycholesterol A measurement of the 22(S)-hydroxycholesterol in a biological specimen. 22(S)-Hydroxycholesterol Measurement 24(R)-Hydroxycholesterol A measurement of the 24(R)-hydroxycholesterol in a biological specimen. 24(R)-Hydroxycholesterol Measurement 24(S),25-Epoxycholesterol A measurement of the 24(S),25-epoxycholesterol in a biological specimen. 24(S),25-Epoxycholesterol Measurement 24(S)-Hydroxycholesterol A measurement of the 24(S)-hydroxycholesterol in a biological specimen. 24(S)-Hydroxycholesterol Measurement 24,25-Dihydroxycholecalciferol 24,25-Dihydroxyvitamin D 24,25-Dihydroxyvitamin D3 A measurement of the 24,25-dihydroxyvitamin D3 in a biological specimen. 24,25-Dihydroxyvitamin D3 Measurement 25-Hydroxycholesterol A measurement of the 25-hydroxycholesterol in a biological specimen. 25-Hydroxycholesterol Measurement 25-Hydroxyvit D2 + 25-Hydroxyvit D3 A measurement of the total inactive vitamin D2 and vitamin D3 in a biological specimen. 25-Hydroxyvitamin D2 and 25-Hydroxyvitamin D3 Measurement 25-Hydroxycalciferol 25-Hydroxyergocalciferol 25-Hydroxyvitamin D2 Ercalcidiol A measurement of the 25-Hydroxyvitamin D2 in a biological specimen. 25-Hydroxyvitamin D2 Measurement 25-Hydroxycholecalciferol 25-Hydroxyvitamin D 25-Hydroxyvitamin D3 Calcidiol Calcifediol Inactive Vitamin D A measurement of the 25-Hydroxyvitamin D3 in a biological specimen. 25-Hydroxyvitamin D3 Measurement 27-Hydroxycholesterol A measurement of the 27-hydroxycholesterol in a biological specimen. 27-Hydroxycholesterol Measurement 3,4-Dihydroxyphenylacetic Acid A measurement of the 3,4-dihydroxyphenylacetic acid in a biological specimen. 3,4-Dihydroxyphenylacetic Acid Measurement 3,4-Dihydroxyphenylglycol 3.4 Dihydroxyphenylglycol A measurement of the catecholamine metabolite, 3,4-Dihydroxyphenylglycol in a biological specimen. 3,4-Dihydroxyphenylglycol Measurement 3,4-methylenedioxy-N-ethylamphetamine Eve MDE A measurement of the 3,4-methylenedioxy-N-ethylamphetamine in a biological specimen. 3,4-methylenedioxy-N-ethylamphetamine Measurement 3,4-methylenedioxyamphetamine A measurement of the 3,4-methylenedioxyamphetamine in a biological specimen. 3,4-methylenedioxyamphetamine Measurement 3,4-methylenedioxymethamphetamine Ecstasy A measurement of the 3,4-methylenedioxymethamphetamine (MDMA) in a biological specimen. 3,4-Methylenedioxymethamphetamine Measurement 3-Alpha-Androstanediol Glucuronide A measurement of the 3-alpha-androstanediol glucuronide in a biological specimen. 3-Alpha-Androstanediol Glucuronide Measurement (2R)-2-Acetamido-3-((4-hydroxybutan-2-yl)thio)propanoic acid (2R)-HMPMA 3-Hydroxy-1-Methyl-Propylmercapturate 3-Hydroxy-1-Methyl-Propylmercapturic Acid 3-Hydroxy-1-Methyl-PropylmercapturicAcid HMPMA-1 A measurement of the 3-hydroxy-1-methyl-propylmercapturic acid in a specimen. 3-Hydroxy-1-Methyl-Propylmercapturic Acid Measurement 3-HPMA 3-Hydroxypropyl Mercapturate 3-Hydroxypropyl Mercapturic Acid N-Acetyl-S-(3-Hydroxypropyl)Cysteine A measurement of the 3-hydroxypropyl mercapturic acid in a specimen. 3-Hydroxypropyl Mercapturic Acid Measurement 3-Methoxytyramine A measurement of the total 3-methoxytyramine in a biological specimen. Total 3-Methoxytyramine Measurement 3-Methoxytyramine, Free A measurement of the free 3-methoxytyramine in a biological specimen. Free 3-Methoxytyramine Measurement 3-Methylfentanyl A measurement of the 3-methylfentanyl in a biological specimen. 3-Methylfentanyl Measurement 3-Nitrotyrosine A measurement of the total 3-nitrotyrosine in a biological specimen. 3-Nitrotyrosine Measurement 3-HCOA 3-Hydroxy-5-cholestenoic acid 3beta-Hydroxy-5-Cholestenoic Acid A measurement of the 3beta-hydroxy-5-cholestenoic acid in a biological specimen. 3beta-Hydroxy-5-Cholestenoic Acid Measurement 4-ABP 4-Aminobiphenyl A measurement of the 4-aminobiphenyl in a specimen. 4-Aminobiphenyl Measurement 4-Beta-Hydroxycholesterol A measurement of the 4-beta-hydroxycholesterol in a biological specimen. 4-Beta-Hydroxycholesterol Measurement 4-Hydroxymidazolam A measurement of the 4-hydroxymidazolam present in a biological specimen. 4-Hydroxymidazolam Measurement 4-HNE 4-hydroxy-2-nonenal 4-Hydroxynonenal HNE A measurement of the 4-hydroxynonenal in a biological specimen. 4-Hydroxynonenal Measurement 4-Hydroxytestosterone A measurement of the 4-hydroxytestosterone in a biological specimen. 4-Hydroxytestosterone Measurement 5 Prime Nucleotidase 5'-Ribonucleotide Phosphohydrolase A measurement of the 5'-nucleotidase in a biological specimen. 5 Prime Nucleotidase Measurement 5-Alpha Tetrahydrocortisol A measurement of the 5-alpha tetrahydrocortisol in a biological specimen. 5-Alpha Tetrahydrocortisol Measurement 5-fluoro PB-22 3-carboxyindole A measurement of the synthetic cannabinoid metabolite 5-fluoro PB-22 3-carboxyindole in a biological specimen. 5-fluoro PB-22 3-carboxyindole Measurement 5-Hydroxyindoleacetate 5-Hydroxyindoleacetic Acid A measurement of 5-hydroxyindoleacetic acid in a biological specimen. 5-Hydroxyindoleacetic Acid Measurement 5-Hydroxyindoleacetic Acid/Creatinine A relative measurement (ratio or percentage) of the 5-hydroxyindoleacetic acid to creatinine in a biological specimen. 5-Hydroxyindoleacetic Acid to Creatinine Ratio Measurement 5-Hydroxyindoleacetic Acid Excretion Rate 5-HydroxyindoleaceticAcid Excretion Rate A measurement of the amount of 5-hydroxyindoleacetic acid being excreted in a biological specimen over a defined amount of time (e.g. one hour). 5-Hydroxyindoleacetic Acid Excretion Rate 6 Beta-Hydrocortisol 6 Beta-Hydroxycortisol 6 beta-OHF A measurement of 6 beta-hydroxycortisol in a biological specimen. 6 Beta-Hydroxycortisol Measurement 6-Monoacetylmorphine A measurement of the 6-monoacetylmorphine present in a biological specimen. 6-Monoacetylmorphine Measurement 6-Alpha Hydroxytetrahydro-11-Dehydrocorticosterone 6a OH-tetrahydro-11-DeH-Corticosterone A measurement of the 6-alpha hydroxytetrahydro-11-dehydrocorticosterone in a biological specimen. 6a OH-tetrahydro-11-DeH-Corticosterone Measurement 6-Alpha Hydroxytetrahydro-11-Deoxycortisol 6a OH-tetrahydro-11-Deoxycortisol A measurement of the 6-alpha hydroxytetrahydro-11-deoxycortisol in a biological specimen. 6a OH-tetrahydro-11-Deoxycortisol Measurement 7-Alpha hydroxy-4-cholesten-3-one 7-alpha-Hydroxy-4-cholesten-3-one A measurement of the 7-alpha-hydroxy-4-cholesten-3-one in a biological specimen. 7-alpha-Hydroxy-4-cholesten-3-one Measurement 7-Ketocholesterol 7-Oxocholesterol A measurement of the 7-ketocholesterol in a biological specimen. 7-Ketocholesterol Measurement 7alpha,25-Dihydroxycholesterol A measurement of the 7alpha,25-dihydroxycholesterol in a biological specimen. 7alpha,25-Dihydroxycholesterol Measurement 7alpha,27-Dihydroxycholesterol A measurement of the 7alpha,27-dihydroxycholesterol in a biological specimen. 7alpha,27-Dihydroxycholesterol Measurement 7alpha-Hydroxycholesterol A measurement of the 7alpha-hydroxycholesterol in a biological specimen. 7alpha-Hydroxycholesterol Measurement 7beta-Hydroxycholesterol A measurement of the 7beta-hydroxycholesterol in a biological specimen. 7beta-Hydroxycholesterol Measurement 8-Hydroxy-2'-Deoxyguanosine 8-oxo-dG A measurement of the 8-hydroxy-2'-deoxyguanosine in a biological specimen. 8-Hydroxy-2'-Deoxyguanosine Measurement 8-Hydroxydeoxyguanosine 8-OHdG A measurement of the 8-hydroxydeoxyguanosine in a biological specimen. 8-Hydroxydeoxyguanosine Measurement 8-Iso-PGF2alpha/Creatinine A relative measurement (ratio or percentage) of the prostaglandin F2 alpha isoform 8 to creatinine in a biological specimen. 8-Iso-Prostaglandin F2 Alpha to Creatinine Ratio Measurement 8-Iso-Prostaglandin F2 Alpha A measurement of the prostaglandin F2 alpha isoform 8 in a biological specimen. 8-Iso-Prostaglandin F2 Alpha Measurement 9-Hydroxyrisperidone Paliperidone A measurement of the 9-hydroxyrisperidone in a biological specimen. 9-Hydroxyrisperidone Measurement A Fetoprotein L3/A Fetoprotein A relative measurement (ratio or percentage) of alpha fetoprotein L3 to total alpha fetoprotein in a biological specimen. Alpha Fetoprotein L3 to Total Alpha Fetoprotein Ratio Measurement A Proliferation-Inducing Ligand Soluble CD256 TNFSF13 Tumor Necrosis Factor Ligand Superfamily Member 13 A measurement of the a proliferation-inducing ligand in a biological specimen. A Proliferation-Inducing Ligand Measurement AB-FUBINACA A measurement of the synthetic cannabinoid AB-FUBINACA in a biological specimen. AB-FUBINACA Measurement AB-PINACA A measurement of the synthetic cannabinoid AB-PINACA in a biological specimen. AB-PINACA Measurement Abnormal Cells A measurement of the abnormal cells in a biological specimen. Abnormal Cell Count Abnormal Cells/Leukocytes A relative measurement (ratio or percentage) of abnormal cells to leukocytes in a biological specimen. Abnormal Cells to Leukocytes Ratio Measurement Abnormal Cells/Total Cells A relative measurement (ratio or percentage) of abnormal cells to total cells in a biological specimen. Abnormal Cells to Total Cells Ratio Measurement ABO A1 Subtype The characterization of the ABO blood group A1 subtype in an individual. (NCI) ABO A1 Subtype Determination ABO Blood Group The characterization of the blood type of an individual by testing for the presence of A antigen and B antigen on the surface of red blood cells. ABO Blood Group Determination Acanthocytes A measurement of the acanthocytes in a biological specimen. Acanthocyte Count Acanthocytes/Erythrocytes A relative measurement (ratio or percentage) of acanthocytes to all erythrocytes in a biological specimen. Acanthocyte to Erythrocyte Ratio Measurement Acetaldehyde A measurement of the acetaldehyde in a specimen. Acetaldehyde Measurement Acetaminophen Paracetamol A measurement of the acetaminophen in a biological specimen. Acetaminophen Measurement Acetaminophen Protein Adduct Acetaminophen-Cysteine Adduct APAP-CYS APAP-Protein A measurement of the acetaminophen-cysteine adducts in a biological specimen. Acetaminophen-Cysteine Adduct Measurement Acetaminophen-Glucuronide Adduct A measurement of the acetaminophen-glucuronide adducts in a biological specimen. Acetaminophen-Glucuronide Adduct Measurement Acetaminophen-Sulfate Adduct A measurement of the acetaminophen-sulfate adducts in a biological specimen. Acetaminophen-Sulfate Adduct Measurement Acetoacetate Excretion Rate Acetoacetic Acid Excretion Rate A measurement of the amount of acetoacetic acid being excreted in a biological specimen over a defined period of time (e.g. one hour). Acetoacetic Acid Excretion Rate Measurement Acetoacetate Acetoacetic Acid A measurement of the acetoacetic acid in a biological specimen. Acetoacetic Acid Measurement Acetone A measurement of the acetone in a specimen. Acetone Measurement ACC Acetyl-CoA Carboxylase A measurement of the total acetyl-CoA carboxylase in a biological specimen. Acetyl-CoA Carboxylase Measurement Acetylcholine A measurement of the acetylcholine hormone in a biological specimen. Acetylcholine Measurement Acetylcholinesterase A measurement of the acetylcholinesterase in a biological specimen. Acetylcholinesterase Measurement Acetyl Fentanyl Acetylfentanyl A measurement of the acetylfentanyl in a biological specimen. Acetylfentanyl Measurement Acid Alpha-Glucosidase Acid Maltase Alpha-1,4-glucosidase A measurement of the acid alpha-glucosidase in a biological specimen. Acid Alpha-Glucosidase Measurement Acid Labile Subunit ALS IGFALS Insulin Like Growth Factor Binding Protein Acid Labile Subunit A measurement of the acid labile subunit in a biological specimen. Acid Labile Subunit Measurement Acid Phosphatase A measurement of the acid phosphatase in a biological specimen. Acid Phosphatase Measurement Acid Sphingomyelinase A measurement of the acid sphingomyelinase in a biological specimen. Sphingomyelin Phosphodiesterase Measurement Acrolein A measurement of the acrolein in a specimen. Acrolein Measurement Acrylonitrile A measurement of the acrylonitrile in a specimen. Acrylonitrile Measurement Activated Clotting Time Activated Coagulation Time A measurement of the inhibition of blood coagulation in response to anticoagulant therapies. Activated Coagulation Time Activated Partial Thromboplastin Time A measurement of the length of time that it takes for clotting to occur when activating reagents are added to a biological specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture. Activated Partial Thromboplastin Time Activated Protein C Resistance Factor V Leiden Screen A measurement of the resistance in the anticoagulation response to activated protein C in a biological specimen. Activated Protein C Resistance Measurement Activated Partial Thromboplastin Time/Standard Thromboplastin Time Activated PTT/Standard Activated PTT/Standard PTT A relative measurement (ratio or percentage) of the subject's activated partial thromboplastin time to a standard or control partial thromboplastin time. Activated PTT/Standard Ratio Measurement Activation B7-1 Antigen B-Lymphocyte Activation Antigen B7 CD28 Ligand CD28LG1 CD80 Molecule Soluble CD80 T-Lymphocyte Activation Antigen CD80 A measurement of the activation B7-1 antigen in a biological specimen. Activation B7-1 Antigen Measurement Active Ghrelin A measurement of active ghrelin in a biological specimen. Active Ghrelin Measurement Activin A A measurement of the activin A (a homodimer consisting of Inhibin Subunit Beta A) in a biological specimen. Activin A Measurement Activin AB A measurement of the activin AB (a heterodimer consisting of Inhibin Subunit Beta A and Inhibin Subunit Beta B) in a biological specimen. Activin AB Measurement Activin B A measurement of the activin B (a homodimer consisting of Inhibin Subunit Beta B) in a biological specimen. Activin B Measurement Acute Kidney Injury Risk Score AKI Risk Score A scoring system that evaluates acute kidney injury risk through the assessment of urine test parameter(s), and which may take into account additional factors. Acute Kidney Injury Risk Score Acyl CoA Oxidase Acyl Coenzyme A Oxidase Fatty Acyl Coenzyme A Oxidase A measurement of the acyl coenzyme A oxidase in a biological specimen. Acyl Coenzyme A Oxidase Measurement Acylcarnitine A measurement of the acylcarnitine in a biological specimen. Acylcarnitine Measurement Acylcarnitine/Carnitine, Free A relative measurement (ratio or percentage) of the acylcarnitine to free carnitine in a biological specimen. Acylcarnitine to Free Carnitine Ratio Measurement Acylglycine A measurement of the acylglycine in a biological specimen. Acylglycine Measurement A Disintegrin And Metalloproteinase Domain 8 ADAM Metallopeptidase Domain 8 Soluble CD156a A measurement of the ADAM metallopeptidase domain 8 protein in a biological specimen. ADAM Metallopeptidase Domain 8 Measurement A Disintegrin-Like And Metalloprotease (Reprolysin Type) With Thrombospondin Type 1 Motif, 13 Activity ADAM Metallopeptidase With Thrombospondin Type 1 Motif 13 Activity ADAMTS13 Activity von Willebrand Coagulation Factor Cleaving Protease ADAMTS13 Activity A measurement of the biological activity of von Willebrand coagulation factor cleaving protease, ADAMTS13, in a biological specimen. von Willebrand Coagulation Factor Cleaving Protease Activity Measurement A Disintegrin-Like And Metalloprotease (Reprolysin Type) With Thrombospondin Type 1 Motif, 13 ADAM Metallopeptidase With Thrombospondin Type 1 Motif 13 von Willebrand Coagulation Factor Cleaving Protease ADAMTS13 A measurement of the von Willebrand coagulation factor cleaving protease, ADAMTS13, in a biological specimen. von Willebrand Coagulation Factor Cleaving Protease Measurement ADB-PINACA A measurement of the synthetic cannabinoid ADB-PINACA in a biological specimen. ADB-PINACA Measurement Adenosine Diphosphate A measurement of the adenosine diphosphate in a biological specimen. Adenosine Diphosphate Measurement Adenosine Triphosphate A measurement of the adenosine triphosphate in a biological specimen. Adenosine Triphosphate Measurement Adiponectin A measurement of the total adiponectin hormone in a biological specimen. Adiponectin Measurement Adiponectin, High Molecular Weight A measurement of the high molecular weight adiponectin hormone in a biological specimen. High Molecular Weight Adiponectin Measurement Adrenocorticotropic Hormone Corticotropin A measurement of the adrenocorticotropic hormone in a biological specimen. Adrenocorticotropic Hormone Measurement Adrenomedullin A measurement of the adrenomedullin in a biological specimen. Adrenomedullin Measurement Aggrecan Ala-Arg-Gly-Ser Neoepitope Aggrecan Alanine-Arginine-Glycine-Serine Neoepitope ARGS ARGS-Aggrecan A measurement of the aggrecan alanine-arginine-glycine-serine neoepitope (ARGS) in a biological specimen. Aggrecan Alanine-Arginine-Glycine-Serine Neoepitope Measurement 846-Epitope Aggrecan Chondroitin Sulfate Epitope 846 Chondroitin Sulfate Epitope 846 Chondroitin Sulfate Proteoglycan 1 Epitope 846 CS846 A measurement of the 846 epitope present on the chondroitin sulfate chains of aggrecan in a biological specimen. Aggrecan Chondroitin Sulfate Epitope 846 Measurement Agranular Neutrophils A measurement of the agranular neutrophils in a biological specimen. Agranular Neutrophils Measurement Alanine Aminopeptidase A measurement of the alanine aminopeptidase in a biological specimen. Alanine Aminopeptidase Measurement Alanine Aminotransferase SGPT A measurement of the alanine aminotransferase in a biological specimen. Alanine Aminotransferase Measurement Alanine A measurement of the alanine in a biological specimen. Alanine Measurement Albumin Clearance A measurement of the albumin clearance in a biological specimen. Albumin Clearance Albumin Excretion Rate A measurement of the amount of albumin excreted in a biological specimen over a defined period of time (e.g. one hour). Albumin Excretion Rate Albumin Index A relative measurement (ratio) of the albumin in cerebrospinal fluid to albumin in serum or plasma in a biological specimen. Albumin Index Albumin Microalbumin A measurement of the albumin protein in a biological specimen. Albumin Measurement Albumin/Creatinine Microalbumin/Creatinine Ratio A relative measurement (ratio) of the albumin to the creatinine in a biological specimen. Albumin to Creatinine Ratio Measurement Albumin/Globulin The ratio of albumin to globulin in a biological specimen. Albumin to Globulin Ratio Measurement Albumin/Total Protein A relative measurement (ratio or percentage) of the albumin to total protein in a biological specimen. Albumin to Total Protein Ratio Measurement Aldolase A measurement of the aldolase enzyme in a biological specimen. Aldolase Measurement Aldosterone Excretion Rate A measurement of the amount of aldosterone being excreted in a biological specimen over a defined amount of time (e.g. one hour). Aldosterone Excretion Rate Aldosterone A measurement of the aldosterone hormone in a biological specimen. Aldosterone Measurement Aldosterone/Renin Activity A relative measurement (ratio) of the aldosterone to renin activity in a biological specimen. Aldosterone to Renin Activity Ratio Measurement Aldrin Epoxidase A measurement of the aldrin epoxidase in a biological specimen. Aldrin Epoxidase Measurement Alfentanil A measurement of the alfentanil in a biological specimen. Alfentanil Measurement Alk Phos, Bile/Total Alk Phos Alk Phos, Biliary/Total Alk Phos A relative measurement (ratio or percentage) of the biliary specific alkaline phosphatase isoform to total alkaline phosphatase in a biological specimen. Biliary Alkaline Phosphatase to Alkaline Phosphatase Ratio Measurement Alk Phos, Bone/Total Alk Phos Alkaline Phosphatase, Bone/Total Alkaline Phosphatase A relative measurement (ratio or percentage) of the bone specific alkaline phosphatase isoform to total alkaline phosphatase in a biological specimen. Bone Alkaline Phosphatase to Total Alkaline Phosphatase Ratio Measurement Alk Phos, Intestinal/Total Alk Phos Alkaline Phosphatase, Intestinal/Total Alkaline Phosphatase A relative measurement (ratio or percentage) of the intestinal specific alkaline phosphatase isoform to total alkaline phosphatase in a biological specimen. Intestinal Alkaline Phosphatase to Total Alkaline Phosphatase Ratio Measurement Alk Phos, Liver + Bone/Total Alk Phos A relative measurement (ratio or percentage) of the liver and bone specific alkaline phosphatase isoforms to total alkaline phosphatase in a biological specimen. Liver and Bone Specific Alkaline Phosphatase Isoform to Alkaline Phosphatase Ratio Measurement Alk Phos, Liver/Total Alk Phos Alkaline Phosphatase, Liver/Total Alkaline Phosphatase A relative measurement (ratio or percentage) of the liver specific alkaline phosphatase isoform to total alkaline phosphatase in a biological specimen. Liver Alkaline Phosphatase to Total Alkaline Phosphatase Ratio Measurement Alk Phos, Macro/Total Alk Phos Alk Phos, Macrohepatic/Total Alk Phos A relative measurement (ratio or percentage) of the macrohepatic specific alkaline phosphatase isoform to total alkaline phosphatase in a biological specimen. Macrohepatic Alkaline Phosphatase to Alkaline Phosphatase Ratio Measurement Alk Phos, Placental/Total Alk Phos Alkaline Phosphatase, Placental/Total Alkaline Phosphatase A relative measurement (ratio or percentage) of the placental specific alkaline phosphatase isoform to total alkaline phosphatase in a biological specimen. Placental Alkaline Phosphatase to Total Alkaline Phosphatase Measurement Alkaline Phosphatase Excretion Rate A measurement of the amount of alkaline phosphatase being excreted in a biological specimen over a defined amount of time (e.g. one hour). Alkaline Phosphatase Excretion Rate Alkaline Phosphatase Isoenzyme A measurement of the alkaline phosphatase isoenzyme in a biological specimen. Alkaline Phosphatase Isoenzyme Measurement Alkaline Phosphatase A measurement of the alkaline phosphatase in a biological specimen. Alkaline Phosphatase Measurement Alkaline Phosphatase/Creatinine A relative measurement (ratio or percentage) of the alkaline phosphatase to creatinine in a biological specimen. Alkaline Phosphatase to Creatinine Ratio Measurement Alloisoleucine A measurement of the alloisoleucine in a biological specimen. Alloisoleucine Measurement Alpha Cortol alpha-Cortol A measurement of the alpha cortol in a biological specimen. Alpha Cortol Measurement Alpha Cortolone alpha-Cortolone A measurement of the alpha cortolone in a biological specimen. Alpha Cortolone Measurement Alpha Fetoprotein Adj for Body Weight A measurement of alpha fetoprotein, which has been adjusted for body weight, in a biological specimen. Alpha Fetoprotein Adjusted for Body Weight Measurement Alpha Fetoprotein L1 A measurement of the alpha fetoprotein L1 in a biological specimen. Alpha Fetoprotein L1 Measurement Alpha Fetoprotein L2 A measurement of the alpha fetoprotein L2 in a biological specimen. Alpha Fetoprotein L2 Measurement Alpha Fetoprotein L3 A measurement of the alpha fetoprotein L3 in a biological specimen. Alpha Fetoprotein L3 Measurement Alpha Fetoprotein Alpha-1-Fetoprotein A measurement of the alpha fetoprotein in a biological specimen. Alpha-fetoprotein Measurement Alpha Globulin A measurement of the total alpha globulins in a biological specimen. Alpha Globulin Measurement Alpha Glutathione-S-Transferase A measurement of the alpha form of glutathione S-transferase in a biological specimen. Alpha Glutathione-S-Transferase Measurement Alpha Hydroxybutyrate Dehydrogenase A measurement of the alpha-hydroxybutyrate dehydrogenase in a biological specimen. Alpha Hydroxybutyrate Dehydrogenase Measurement Alpha Melanocyte Stimulating Hormone Alpha-MSH A measurement of the alpha melanocyte stimulating hormone in a biological specimen. Alpha Melanocyte Stimulating Hormone Measurement Alpha Synuclein Protein A measurement of the alpha synuclein protein in a biological specimen. Alpha Synuclein Protein Measurement Alpha Tocopherol A measurement of the alpha tocopherol in a biological specimen. Alpha Tocopherol Measurement Alpha Tocopherol/Vitamin E A relative measurement (ratio or percentage) of alpha-tocopherol to the total vitamin E in a biological specimen. Alpha Tocopherol to Vitamin E Ratio Measurement Alpha-1 Acid Glycoprotein A measurement of the alpha-1 acid glycoprotein in a biological specimen. Alpha-1 Acid Glycoprotein Measurement AAT Z-Polymer Alpha-1 Antitrypsin Z-Polymer A measurement of the polymers of Z-variant alpha-1 antitrypsin in a biological specimen. Alpha-1 Antitrypsin Z-Polymer Measurement Alpha-1 Antitrypsin Serum Trypsin Inhibitor A measurement of the alpha-1 antitrypsin in a biological specimen. Alpha-1 Antitrypsin Measurement Alpha-1 Antitrypsin, Functional A measurement of the functional alpha-1 antitrypsin in a biological specimen. Functional Alpha-1 Antitrypsin Measurement A1-Globulin Alpha-1 Globulin A measurement of the proteins contributing to the alpha 1 fraction in a biological specimen. Alpha-1 Globulin Measurement Alpha-1 Globulin/Total Protein A relative measurement (ratio or percentage) of alpha-1-fraction proteins to total proteins in a biological specimen. Alpha-1 Globulin to Total Protein Ratio Measurement Alpha-1 Microglobulin Excretion Rate A measurement of the amount of alpha-1 microglobulin being excreted in a biological specimen over a defined amount of time (e.g. one hour). Alpha-1 Microglobulin Excretion Rate Measurement Alpha-1 Microglobulin Protein HC A measurement of the alpha-1 microglobulin in a biological specimen. Alpha-1 Microglobulin Measurement Alpha-1 Microglobulin/Creatinine A relative measurement (ratio or percentage) of the alpha-1 microglobulin to creatinine in a biological specimen. Alpha-1 Microglobulin to Creatinine Ratio Measurement Alpha-2 Antiplasmin Activity A measurement of the alpha-2 antiplasmin activity in a biological specimen. Alpha-2 Antiplasmin Activity Measurement Alpha-2 Antiplasmin Alpha-2 Plasmin Inhibitor A measurement of the alpha-2 antiplasmin in a biological specimen. Alpha-2 Antiplasmin Measurement A2-Globulin Alpha-2 Globulin A measurement of the proteins contributing to the alpha 2 fraction in a biological specimen. Alpha-2 Globulin Measurement Alpha-2 Globulin/Total Protein A relative measurement (ratio or percentage) of alpha-2-fraction proteins to total proteins in a biological specimen. Alpha-2 Globulin to Total Protein Ratio Measurement Alpha-2 Macroglobulin A measurement of the alpha-2 macroglobulin in a biological specimen. Alpha-2 Macroglobulin Measurement Alpha-Aminoadipate Alpha-Aminoadipic Acid A measurement of the alpha-aminoadipic acid in a biological specimen. Alpha-Aminoadipic Acid Measurement Alpha-aminobutyrate Alpha-Aminobutyric Acid Homoalanine A measurement of the alpha-aminobutyric acid in a biological specimen. Alpha-Aminobutyric Acid Measurement Alpha-GST Excretion Rate A measurement of the amount of Alpha Glutathione-S-Transferase being excreted in a biological specimen over a defined period of time (e.g. one hour). Alpha-GST Excretion Rate Alpha-Hydroxyalprazolam A measurement of the alpha-hydroxyalprazolam in a biological specimen. Alpha-Hydroxyalprazolam Measurement Alpha-Hydroxytriazolam A measurement of the alpha-hydroxytriazolam a biological specimen. Alpha-Hydroxytriazolam Measurement Alpha-Methylacyl Coenzyme A Racemase A measurement of the alpha-methylacyl coenzyme A racemase in a biological specimen. Alpha-Methylacyl Coenzyme A Racemase Measurement Alpha-Methylfentanyl A measurement of the alpha-methylfentanyl in a biological specimen. Alpha-Methylfentanyl Measurement Alpha-Methylphenethylamine Amphetamine A measurement of the alpha-methylphenethylamine in a biological specimen. Amphetamine Measurement Alpha-N-acetylglucosaminidase A measurement of the alpha-N-acetylglucosaminidase in a biological specimen. Alpha-N-acetylglucosaminidase Measurement Alpha-Actin 2 Alpha-SMA Alpha-Smooth Muscle Actin A measurement of the alpha-smooth muscle actin in a biological specimen. Alpha-Smooth Muscle Actin Measurement Alphaprodine A measurement of the alphaprodine in a biological specimen. Alphaprodine Measurement Alprazolam A measurement of the alprazolam present in a biological specimen. Alprazolam Measurement ALT/AST A relative measurement (ratio or percentage) of the alanine aminotransferase (ALT) to aspartate aminotransferase (AST) present in a sample. Alanine Aminotransferase to Aspartate Aminotransferase Ratio Measurement Al Aluminum A measurement of aluminum in a biological specimen. Aluminum Measurement AM-2201 AM2201 A measurement of the synthetic cannabinoid AM-2201 in a biological specimen. AM-2201 Measurement AM694 N-5-hydroxypentyl A measurement of the synthetic cannabinoid metabolite AM694 N-5-hydroxypentyl in a biological specimen. AM694 N-5-hydroxypentyl Measurement AMACR mRNA A measurement of the alpha-methylacyl coenzyme A racemase mRNA in a biological specimen. Alpha-Methylacyl Coenzyme A Racemase mRNA Measurement AA Amino Acids A measurement of the total amino acids in a biological specimen. Amino Acid Measurement Amitriptyline A measurement of the amitriptyline in a biological specimen. Amitriptyline Measurement Ammonia NH3 A measurement of the ammonia in a specimen. Ammonia Measurement Acid Ammonium Urate Crystals Ammonium Biurate Crystals Ammonium Urate Crystals A measurement of the ammonium biurate crystals present in a biological specimen. Ammonium Biurate Crystals Measurement Ammonium Oxalate Crystals A measurement of the ammonium oxalate crystals in a biological specimen. Ammonium Oxalate Crystal Measurement Ammonium Ammonium Ion NH4+ A measurement of the ammonium ion (NH4+) in a biological specimen. Ammonium Measurement Ammonium/Creatinine A relative measurement (ratio) of ammonium to creatinine in a biological specimen. Ammonium to Creatinine Ratio Measurement Amobarbital A measurement of the amobarbital present in a biological specimen. Amobarbital Measurement Amorphous Crystals A measurement of the amorphous (Note: phosphate or urate, depending on pH) crystals present in a biological specimen. Amorphous Crystal Measurement Amorphous Phosphate Crystals A measurement of the amorphous phosphate crystals in a biological specimen. Amorphous Phosphate Crystals Measurement Amorphous Debris Amorphous Sediment A measurement of the amorphous sediment present in a biological specimen. Amorphous Sediment Measurement Amorphous Urate Crystals A measurement of the amorphous urate crystals in a biological specimen. Amorphous Urate Crystals Measurement Amphetamine Amphetamines A measurement of any amphetamine class drug present in a biological specimen. Amphetamine Drug Class Measurement Amphiregulin Schwannoma-Derived Growth Factor SDGF A measurement of the amphiregulin in a biological specimen. Amphiregulin Measurement Amylase A measurement of the total enzyme amylase in a biological specimen. Amylase Measurement Amylase, Pancreatic Pancreatic Amylase Isoenzyme A measurement of the pancreatic enzyme amylase in a biological specimen. Pancreatic Amylase Measurement Amylase, Salivary Salivary Amylase Isoenzyme A measurement of the salivary enzyme amylase in a biological specimen. Salivary Amylase Measurement Amyloid A A measurement of the total amyloid A in a biological specimen. Amyloid A Measurement Amyloid Alpha Precursor Protein A measurement of the amyloid alpha precursor protein present in a biological specimen. Amyloid Alpha Precursor Protein Measurement Amyloid Beta 1-38 Amyloid Beta 38 Amyloid Beta 38 Protein A measurement of amyloid beta protein which is composed of peptides 1 to 38 in a biological specimen. Amyloid Beta 1-38 Measurement Amyloid Beta 1-40 Amyloid Beta 40 Amyloid Beta 40 Protein A measurement of amyloid beta protein which is composed of peptides 1 to 40 in a biological specimen. Amyloid Beta 1-40 Measurement Amyloid Beta 1-41 Amyloid Beta 41 Amyloid Beta 41 Protein A measurement of amyloid beta protein which is composed of peptides 1 to 41 in a biological specimen. Amyloid Beta 1-41 Measurement Amyloid Beta 1-42 Amyloid Beta 42 Amyloid Beta 42 Protein A measurement of amyloid beta protein which is composed of peptides 1 to 42 in a biological specimen. Beta Amyloid 42 Measurement Amyloid Beta 1-42/Amyloid Beta 1-40 A relative measurement (ratio) of the amyloid beta 1-42 to amyloid beta 1-40 in a biological specimen. Amyloid Beta 1-42 to Amyloid Beta 1-40 Ratio Measurement Amyloid Beta Precursor Amyloid Beta Precursor Protein Amyloid Precursor Beta Amyloid Precursor Protein A measurement of the amyloid beta precursor protein present in a biological specimen. Amyloid Beta Precursor Protein Measurement Amyloid P Amyloid P Component SAP Serum Amyloid P Component A measurement of the total amyloid P in a biological specimen. Amyloid P Measurement Amyloid Probability Score APS Plasma Amyloid Probability Score A probability score representing the estimated likelihood that the patient is amyloid positive on PET imaging. Amyloid Probability Score Amyloid, Beta Beta Amyloid A measurement of the total amyloid beta in a biological specimen. Beta Amyloid Measurement Anabasine A measurement of the anabasine in a specimen. Anabasine Measurement Androstenediol A measurement of the androstenediol metabolite in a biological specimen. Androstenediol Metabolite Measurement 4-Androstenedione Androstenedione A measurement of the androstenedione hormone in a biological specimen. Androstenedione Measurement Androsterone A measurement of the androsterone in a biological specimen. Androsterone Measurement Angiopoietin 1 A measurement of angiopoietin 1 in a biological specimen. Angiopoietin 1 Measurement ANG2 Angiopoietin 2 A measurement of angiopoietin 2 in a biological specimen. Angiopoietin 2 Measurement ANG-5 Angiopoietin 5 Angiopoietin-Like 3 Angiopoietin-Related Protein 3 ANGPT5 A measurement of the angiopoietin-related protein 3 in a biological specimen. Angiopoietin-Related Protein 3 Measurement Angiopoietin-Related Protein 3/8 Complex ANGPTL3/8 A measurement of the angiopoietin-related protein 3 and angiopoietin-related protein 8 complex in a biological specimen. Angiopoietin-Related Protein 3/8 Complex Measurement Angiopoietin-Like 4 Angiopoietin-Related Protein 4 ARP4 FIAF Hepatic Angiopoietin-Related Protein HFARP PGAR A measurement of the angiopoietin-related protein 4 in a biological specimen. Angiopoietin-Related Protein 4 Measurement Angiopoietin-Like 8 Angiopoietin-Related Protein 8 Betatrophin Lipasin A measurement of the angiopoietin-related protein 8 in a biological specimen. Angiopoietin-Related Protein 8 Measurement Angiotensin Converting Enzyme A measurement of the angiotensin converting enzyme in a biological specimen. Angiotensin Converting Enzyme Measurement Angiotensin I A measurement of the angiotensin I hormone in a biological specimen. Angiotensin I Measurement Angiotensin II A measurement of the angiotensin II hormone in a biological specimen. Angiotensin II Measurement Angiotensin Precursor Angiotensinogen A measurement of the angiotensinogen hormone in a biological specimen. Angiotensinogen Measurement Anileridine A measurement of the anileridine in a biological specimen. Anileridine Measurement Anion Gap 3 A computed estimate of the unmeasured anions (computed as sodium minus the chloride and bicarbonate) in a biological specimen. Anion Gap 3 Measurement Anion Gap 4 A computed estimate of the unmeasured anions (computed as the difference between the sum of serum sodium + serum potassium and the sum of the serum bicarbonate+ chloride) in a biological specimen. Anion Gap 4 Measurement Anion Gap A computed estimate of the unmeasured anions (those other than the chloride and bicarbonate anions) in a biological specimen. Anion Gap Measurement Anisochromia A measurement of the color variation of erythrocytes in a biological specimen. Anisochromia Measurement Anisocytes Anisocytosis A measurement of the variability in the size of the red blood cells in a whole blood specimen. Anisocyte Measurement Anti-Double Stranded DNA IgG A measurement of the double stranded DNA IgG antibody in a biological specimen. Anti-Double Stranded DNA IgG Measurement Anti-Factor Xa Activity A measurement of the ability of antithrombin to inactivate activated Factor X in a biological specimen. This test is used to monitor low molecular weight or unfractionated heparin levels in a biological specimen. Anti-Factor Xa Activity Measurement Anti-Mullerian Hormone A measurement of the anti-Mullerian hormone in a biological specimen. Anti-Mullerian Hormone Measurement Anti-Single Stranded DNA IgG A measurement of the anti-single stranded DNA IgG antibody in a biological specimen. Anti-Single Stranded DNA IgG Measurement Antidepressants A measurement of any antidepressant class drug present in a biological specimen. Antidepressant Measurement Antidiuretic Hormone Vasopressin A measurement of the antidiuretic hormone in a biological specimen. Antidiuretic Hormone Measurement Antiglobulin Test Polyspecific, Direct Antiglobulin Test, Direct Direct Coombs Test A measurement of the antibody or complement-coated erythrocytes in a biological specimen in vivo. Direct Antiglobulin Test Antiglobulin Test, Indirect Indirect Coombs Test A test that uses Coombs' reagent to detect the presence of anti-erythrocyte antibodies in a biological specimen. Indirect Antiglobulin Test ALK1 Antileukoproteinase BLPI Proteinase Inhibitor WAP4 Secretory Leukocyte Peptidase Inhibitor Secretory Leukocyte Protease Inhibitor A measurement of the antileukoproteinase in a biological specimen. Antileukoproteinase Measurement Antithrombin Activity Actual/Antithrombin Activity Control Antithrombin Activity Actual/Control Antithrombin Activity Actual/Normal A relative measurement (ratio or percentage) of the biological activity of antithrombin in a subject's specimen when compared to the same activity in a control specimen. Antithrombin Activity Actual to Control Ratio Measurement Antithrombin Activity Antithrombin III Activity A measurement of the antithrombin activity in a biological specimen. Antithrombin Activity Measurement Antithrombin Actual/Control Antithrombin Actual/Normal A relative measurement (ratio or percentage) of the Antithrombin in a subject's specimen when compared to a control specimen. Antithrombin Actual to Control Ratio Measurement Antithrombin Antithrombin Antigen Antithrombin III Antithrombin III Antigen A measurement of the antithrombin antigen in a biological specimen. Antithrombin Antigen Measurement Apolipoprotein A A measurement of the total apolipoprotein A in a biological specimen. Apolipoprotein A Measurement Apolipoprotein A/Apolipoprotein B A relative measurement (ratio) of the total apolipoprotein A to apolipoprotein B in a biological specimen. Apolipoprotein A to Apolipoprotein B Ratio Measurement Apolipoprotein A1 A measurement of the apolipoprotein A1 in a biological specimen. Apolipoprotein A1 Measurement Apolipoprotein A1/Apolipoprotein B A relative measurement (ratio or percentage) of the Apolipoprotein A1 to Apolipoprotein B in a biological specimen. Apolipoprotein A1 to Apolipoprotein B Ratio Measurement Apolipoprotein A4 A measurement of the apolipoprotein A4 in a biological specimen. Apolipoprotein A4 Measurement Apolipoprotein A5 A measurement of the apolipoprotein A5 in a biological specimen. Apolipoprotein A5 Measurement Apolipoprotein AII A measurement of the apolipoprotein AII in a biological specimen. Apolipoprotein AII Measurement Apolipoprotein B A measurement of the total apolipoprotein B in a biological specimen. Apolipoprotein B Measurement Apolipoprotein B/Apolipoprotein A1 A relative measurement (ratio or percentage) of the Apolipoprotein B to Apolipoprotein A1 in a biological specimen. Apolipoprotein B to Apolipoprotein A1 Ratio Measurement Apolipoprotein B100 A measurement of the apolipoprotein B100 in a biological specimen. Apolipoprotein B100 Measurement Apolipoprotein B48 A measurement of the apolipoprotein B48 in a biological specimen. Apolipoprotein B48 Measurement Apolipoprotein C2 Apolipoprotein CII A measurement of the apolipoprotein C2 in a biological specimen. Apolipoprotein C2 Measurement Apolipoprotein CI A measurement of the apolipoprotein CI in a biological specimen. Apolipoprotein CI Measurement Apolipoprotein CIII A measurement of the apolipoprotein CIII in a biological specimen. Apolipoprotein CIII Measurement Apolipoprotein D A measurement of the apolipoprotein D in a biological specimen. Apolipoprotein D Measurement Apolipoprotein E A measurement of the apolipoprotein E in a biological specimen. Apolipoprotein E Measurement Apolipoprotein E4 A measurement of the apolipoprotein E4 in a biological specimen. Apolipoprotein E4 Measurement Apolipoprotein H A measurement of the apolipoprotein H in a biological specimen. Apolipoprotein H Measurement Apolipoprotein J Clusterin A measurement of the apolipoprotein J in a biological specimen. Apolipoprotein J Measurement Apolipoprotein J/Creatinine Clusterin/Creatinine A relative measurement (ratio or percentage) of the apolipoprotein J to creatinine in a biological specimen. Apolipoprotein J to Creatinine Ratio Measurement Aprobarbital A measurement of the aprobarbital in a biological specimen. Aprobarbital Measurement APTT-LA Actual/Control Lupus Anticoagulant Sensitive APTT Actual/Control A relative measurement (ratio or percentage) of the Lupus anticoagulant sensitive APTT in a subject's specimen when compared to a control specimen. APTT-LA Actual to Control Ratio Measurement APTT-LA Screen to Confirm Percent Difference PTT-LA Screen to Confirm Pct Difference A measurement to confirm the presence of Lupus anticoagulants, calculated as [(Screen aPTT - Confirm aPTT)/Screen aPTT]x100. APTT-LA Screen to Confirm Percent Difference 5-Lipoxygenase 5-LO 5-LOX ALOX5 Arachidonate 5-Lipoxygenase A measurement of the arachidonate 5-lipoxygenase in a biological specimen. Arachidonate 5-Lipoxygenase Measurement Arachidonic Acid A measurement of the arachidonic acid present in a biological specimen. Arachidonic Acid Measurement Arginine A measurement of the arginine in a biological specimen. Arginine Measurement Argininosuccinate Argininosuccinic Acid A measurement of the argininosuccinic acid in a biological specimen. Argininosuccinic Acid Measurement Aripiprazole A measurement of the aripiprazole in a biological specimen. Aripiprazole Measurement Arsenic As A measurement of the arsenic in a specimen. Arsenic Measurement Asenapine A measurement of the asenapine in a biological specimen. Asenapine Measurement Asparagine A measurement of the asparagine in a biological specimen. Asparagine Measurement Aspartate Aminotransferase Isoenzyme C Aspartate Aminotransferase Isoenzyme Cytoplasmic C-AST cAspAT Cytoplasmic Isoenzyme of Aspartate Aminotransferase SGOT Isoenzyme C A measurement of the aspartate aminotransferase isoenzyme C in a biological specimen. Aspartate Aminotransferase Isoenzyme C Measurement Aspartate Aminotransferase Isoenzyme M Aspartate Aminotransferase Isoenzyme Mitochondrial M-AST mAspAT Mitochondrial Isoenzyme of Aspartate Aminotransferase SGOT Isoenzyme M A measurement of the aspartate aminotransferase isoenzyme M in a biological specimen. Aspartate Aminotransferase Isoenzyme M Measurement Aspartate Aminotransferase Aspartate Aminotransferase Antigen SGOT SGOT Antigen A measurement of the aspartate aminotransferase in a biological specimen. Aspartate Aminotransferase Measurement Aspartate Aminotransferase/Creatinine A relative measurement (ratio or percentage) of the aspartate aminotransferase to creatinine in a biological specimen. Aspartate Aminotransferase to Creatinine Ratio Measurement Aspartate Aspartic Acid A measurement of the aspartic acid in a biological specimen. Aspartic Acid Measurement APRI Score AST to Platelet Ratio Index A calculation that indicates the likely presence of liver cirrhosis and fibrosis, measured as the relative measurement of aspartate aminotransferase (AST) to AST upper limit of normal, divided by the platelet count, and multiplied by 100. Aspartate Aminotransferase to Platelet Ratio Index AST/ALT A relative measurement (ratio or percentage) of the aspartate aminotransferase (AST) to alanine aminotransferase (ALT) present in a sample. Aspartate Aminotransferase to Alanine Aminotransferase Ratio Measurement Aspartate Aminotransferase/CPK Aspartate Aminotransferase/Creatine Kinase AST/Creatine Kinase A relative measurement (ratio) of the aspartate aminotransferase to creatine kinase in a biological specimen. Aspartate Aminotransferase to Creatine Kinase Ratio Measurement Asymmetric Dimethylarginine N,N-dimethylarginine A measurement of asymmetric dimethylarginine in a biological specimen. Asymmetric Dimethylarginine Measurement AIP Atherogenic Index Atherogenic Index of Plasma A measurement of the base 10 logarithm of the ratio of molar concentration of plasma triglyceride to high density lipoprotein cholesterol in a biological specimen. Atherogenic Index of Plasma Atrial Natriuretic Peptide Atriopeptin A measurement of the atrial natriuretic peptide in a biological specimen. Atrial Natriuretic Peptide Measurement Atypical Lymphocytes/Lymphocytes Lymphocytes Atypical/Lymphocytes Reactive Lymphocytes/Lymphocytes Variant Lymphocytes/Lymphocytes A relative measurement (ratio or percentage) of the atypical lymphocytes to all lymphocytes in a biological specimen. Reactive Lymphocyte to Lymphocyte Ratio Measurement Auer Rods A measurement of the Auer rods (elongated needle structures that are found in the cytoplasm of leukemic blasts and are formed by clumps of azurophilic granular material) in a biological specimen. Auer Rod Measurement ARK AXL Receptor Tyrosine Kinase JTK11 Tyro7 UFO A measurement of the AXL receptor tyrosine kinase in a biological specimen. AXL Receptor Tyrosine Kinase Measurement Azurophilic Granulation Azurophilic Granules An observation of azurophilic granules in a biological specimen. Azurophilic Granule Measurement B-Cell Activating Factor A measurement of the B-cell activating factor in a biological specimen. B-Cell Activating Factor Measurement B-lymphocyte Crossmatch A measurement to determine human leukocyte antigens (HLA) histocompatibility between the recipient and the donor by examining the presence or absence of the recipient's anti-HLA antibody reactivity towards HLA antigens expressed on the donor B-lymphocytes. B-lymphocyte Crossmatch Measurement B Cells B-Cell Lymphocytes B-Cells B-Lymphocytes A measurement of the B-lymphocytes in a biological specimen. B-Lymphocyte Count B Cells/Leukocytes B-Lymphocytes/Leukocytes BLym/Leuk A relative measurement (ratio or percentage) of B-lymphocytes to leukocytes in a biological specimen. B-Lymphocyte to Leukocyte Ratio Measurement B-Lymphocytes/Lymphocytes A relative measurement (ratio or percentage) of the B-lymphocytes to total lymphocytes in a biological specimen. B-Lymphocyte to Lymphocyte Ratio Measurement B-Lymphocytes/Total Cells A relative measurement (ratio or percentage) of the B-lymphocytes to total cells in a biological specimen. B-Lymphocyte to Total Cells Ratio Measurement Bacteria A measurement of the bacteria in a biological specimen. Bacterial Count Bacterial Casts A measurement of the bacterial casts present in a biological specimen. Bacterial Cast Measurement Barbital A measurement of the barbital in a biological specimen. Barbital Measurement Barbiturates A measurement of any barbiturate class drug present in a biological specimen. Barbiturate Drug Class Measurement Base Deficit A measurement of the amount of alkali required to return a biological specimen to a normal pH under standard conditions. Base Deficit Actual Base Excess Base Excess A calculated measurement of the amount of acid required to return blood to a normal pH under standard conditions. Base Excess Measurement Basophilic Erythroblast A measurement of the basophilic erythroblasts in a biological specimen taken from a non-human organism. Basophilic Erythroblast Count Basophilic Metamyelocytes A measurement of the basophilic metamyelocytes in a biological specimen. Basophilic Metamyelocyte Count Basophilic Myelocytes A measurement of the basophilic myelocytes in a biological specimen. Basophilic Myelocyte Count Basophilic Myelocytes/Lymphocytes A relative measurement (ratio or percentage) of the basophilic myelocytes to lymphocytes in a biological specimen (for example a bone marrow specimen). Basophilic Myelocytes to Lymphocytes Ratio Measurement Basophilic Normoblast A measurement of the basophilic normoblasts in a biological specimen taken from a non-human organism. Basophilic Normoblast Count Basophilic Stippling A measurement of the basophilic stippling in a biological specimen. Basophilic Stippling Measurement Basophils Band Form A measurement of the banded basophils in a biological specimen. Basophil Band Form Count Basophils Band Form/Leukocytes A relative measurement (ratio or percentage) of the banded basophils to leukocytes in a biological specimen. Basophil Band Form to Leukocytes Ratio Measurement Basophils A measurement of the basophils in a biological specimen. Absolute Basophil Count Basophils, Segmented A measurement of the segmented basophils in a biological specimen. Segmented Basophil Count Basophils/Leukocytes A relative measurement (ratio or percentage) of the basophils to leukocytes in a biological specimen. Basophil to Leukocyte Ratio Basophils/Total Cells A relative measurement (ratio or percentage) of the basophils to total cells in a biological specimen (for example a bone marrow specimen). Basophil to Total Cell Ratio Measurement Bence-Jones Protein A measurement of the total Bence-Jones protein in a biological specimen. Bence-Jones Protein Measurement Benzene A measurement of the benzene in a specimen. Benzene Measurement 3,4-Benzpyrene Benz(a)pyrene Benz[a]pyrene Benzo(a)pyrene Benzo[a]pyrene A measurement of the benzo[a]pyrene in a specimen. Benzo[a]pyrene Measurement Benzodiazepine A measurement of any benzodiazepine class drug present in a biological specimen. Benzodiazepine Measurement Benzoylecgonine A measurement of the benzoylecgonine in a biological specimen. Benzoylecgonine Measurement 1-benzylpiperazine Benzylpiperazine N-benzylpiperazine A measurement of the benzylpiperazine in a biological specimen. Benzylpiperazine Measurement Beta Alanine A measurement of the beta alanine in a biological specimen. Beta Alanine Measurement b-Carotene Beta Carotene Beta Carotin A measurement of the beta carotene in a biological specimen. Beta Carotene Measurement Beta Catenin A measurement of the beta catenin in a biological specimen. Beta Catenin Measurement Beta Globulin A measurement of the proteins contributing to the beta fraction in a biological specimen. Beta Globulin Measurement Beta Globulin/Total Protein A relative measurement (ratio or percentage) of beta fraction proteins to total proteins in a biological specimen. Beta Globulin to Total Protein Ratio Measurement Beta and Gamma Tocopherol Beta+Gamma Tocopherol A measurement of the beta and gamma tocopherol in a biological specimen. Beta and Gamma Tocopherol Measurement Beta-1 Globulin A measurement of the beta-1 globulin in a biological specimen. Beta-1 Globulin Measurement Beta-1 Globulin/Beta Protein A relative measurement (ratio or percentage) of the beta-1-fraction proteins to the total beta protein fraction in a biological specimen. Beta-1 Globulin to Total Beta Protein Ratio Measurement Beta-1 Globulin/Total Protein A relative measurement (ratio or percentage) of beta-1-fraction proteins to total proteins in a biological specimen. Beta-1 Globulin to Total Protein Ratio Measurement Beta-1B Glycoprotein Hemopexin HPX A measurement of the beta-1B glycoprotein in a biological specimen. Beta-1B Glycoprotein Measurement Beta-2 Globulin A measurement of the beta-2 globulin in a biological specimen. Beta-2 Globulin Measurement Beta-2 Globulin/Total Protein A relative measurement (ratio or percentage) of beta-2-fraction proteins to total proteins in a biological specimen. Beta-2 Globulin to Total Protein Ratio Measurement Beta-2 Microglobulin A measurement of the beta-2 microglobulin in a biological specimen. Beta-2 Microglobulin Measurement Beta-2 Microglobulin/Creatinine A relative measurement (ratio) of the beta-2 microglobulin to creatinine in a biological specimen. Beta-2 Microglobulin to Creatinine Ratio Measurement Actin Beta B-Actin Beta-Actin A measurement of the beta-actin in a biological specimen. Beta-Actin Measurement BABA Beta-aminobutyrate Beta-Aminobutyric Acid A measurement of the beta-aminobutyric acid in a biological specimen. Beta-Aminobutyric Acid Measurement Beta-cell Function A measurement of the beta cell function (insulin production and secretion) in a biological specimen. Beta-Cell Function Measurement Beta-defensin 2 A measurement of the beta-defensin 2 in a biological specimen. Beta-defensin 2 Measurement 3-Hydroxybutyrate Excretion Rate B-Hydroxybutyrate Excretion Rate Beta-Hydroxybutyrate Excretion Rate BHB Excretion Rate A measurement of the amount of beta-Hydroxybutyrate being excreted in a biological specimen over a defined period of time (e.g. one hour). Beta-Hydroxybutyrate Excretion Rate Measurement 3-Hydroxybutyrate B-Hydroxybutyrate Beta-Hydroxybutyrate Beta-Hydroxybutyric Acid BHB A measurement of the total Beta-hydroxybutyrate in a biological specimen. Beta-Hydroxybutyrate Measurement Beta-Hydroxybutyrate/Acetoacetate A relative measurement (ratio) of the beta-hydroxybutyrate to acetoacetate in a biological specimen. Beta-Hydroxybutyrate to Acetoacetate Ratio Measurement Beta-Hydroxythiofentanyl A measurement of the beta-hydroxythiofentanyl in a biological specimen. Beta-Hydroxythiofentanyl Measurement Betacellulin A measurement of the betacellulin in a biological specimen. Betacellulin Measurement Betaines A measurement of the betaine class compounds in a biological specimen. Betaines Measurement Bicarbonate HCO3 A measurement of the bicarbonate in a biological specimen. Bicarbonate Measurement Bile Acid Bile Acids Bile Salt Bile Salts A measurement of the total bile acids in a biological specimen. Bile Acid Measurement Bilirubin Crystals A measurement of the bilirubin crystals present in a biological specimen. Bilirubin Crystal Measurement Bilirubin Total Bilirubin A measurement of the total bilirubin in a biological specimen. Total Bilirubin Measurement Bioavailable Testosterone A measurement of bioavailable testosterone in a biological specimen. Bioavailable Testosterone Measurement Bite Cells A measurement of the bite cells (erythrocytes with the appearance of a bite having been removed, due to oxidative hemolysis) in a biological specimen. Bite Cell Count Bite Cells/Erythrocytes A relative measurement (ratio or percentage) of bite cells (erythrocytes with the appearance of a bite having been removed, due to oxidative hemolysis) to all erythrocytes in a biological specimen. Bite Cell to Erythrocyte Ratio Measurement Bizarre Platelets A measurement of the bizarre platelets (large with abnormal morphology and shape) in a biological specimen. Bizarre Platelet Count Blasts A measurement of the blast cells in a biological specimen. Blast Count Blasts/Leukocytes A relative measurement (ratio or percentage) of the blasts to leukocytes in a biological specimen. Blast to Leukocyte Ratio Blasts/Total Cells A relative measurement (ratio or percentage) of the blasts to total cells in a biological specimen. Blasts to Total Cells Ratio Measurement Bleeding Time Clotting Time Homeostasis A measurement of the time from the start to cessation of an induced bleed. Bleeding Time Blister Cell A measurement of the blister cells in a biological specimen. Blister Cell Count Bolasterone A measurement of the bolasterone in a biological specimen. Bolasterone Measurement Boldenone A measurement of the boldenone in a biological specimen. Boldenone Measurement Bone Specific Alkaline Phosphatase A measurement of the bone specific alkaline phosphatase isoform in a biological specimen. Bone Specific Alkaline Phosphatase Measurement B-Type Natriuretic Peptide Brain Natriuretic Peptide A measurement of the brain (B-type) natriuretic peptide in a biological specimen. Brain Natriuretic Peptide Measurement Brain-Derived Neurotrophic Factor A measurement of the brain-derived neurotrophic factor in a biological specimen. Brain-Derived Neurotrophic Factor Measurement Brexpiprazole A measurement of the brexpiprazole in a biological specimen. Brexpiprazole Measurement Brivaracetam A measurement of the brivaracetam in a biological specimen. Brivaracetam Measurement Broad Casts A measurement of the broad casts in a biological specimen. Broad Casts Measurement Bromazepam A measurement of the bromazepam in a biological specimen. Bromazepam Measurement Agammaglobulinemia Tyrosine Kinase ATK B-cell Progenitor Kinase Bruton Tyrosine Kinase Bruton's Tyrosine Kinase Tyrosine-protein kinase BTK A measurement of the Bruton's tyrosine kinase in a biological specimen. Bruton's Tyrosine Kinase Measurement Bruton's Tyrosine Kinase, Free A measurement of the free Bruton's tyrosine kinase in a biological specimen. Free Bruton's Tyrosine Kinase Measurement Bufotenine A measurement of the bufotenine in a biological specimen. Bufotenine Measurement Buprenorphine A measurement of the buprenorphine drug present in a biological specimen. Buprenorphine Measurement Bupropion A measurement of the bupropion in a biological specimen. Bupropion Measurement Burr Cells Echinocytes A measurement of the Burr cells (erythrocytes characterized by the presence of small, blunt projections evenly distributed across the cell surface) in a biological specimen. Burr Cell Count Butabarbital A measurement of the butabarbital in a biological specimen. Butabarbital Measurement Butalbital A measurement of the butalbital present in a biological specimen. Butalbital Measurement Butorphanol A measurement of the butorphanol in a biological specimen. Butorphanol Measurement Butylone A measurement of the butylone in a biological specimen. Butylone Measurement Acylcholine Acylhydrolase Butyrylcholinesterase Non-neuronal Cholinesterase Plasma Cholinesterase Pseudocholinesterase A measurement of the total butyrylcholinesterase in a biological specimen. Butyrylcholinesterase Measurement Butyrfentanyl Butyryl Fentanyl Butyrylfentanyl A measurement of the butyrylfentanyl in a biological specimen. Butyrylfentanyl Measurement C Reactive Protein A measurement of the C reactive protein in a biological specimen. C-Reactive Protein Measurement C-C Chemokine Receptor Type 5 Soluble CD195 A measurement of the CCR5, chemokine (C-C motif) receptor type 5, in a biological specimen. C-C Chemokine Receptor Type 5 Measurement C-Peptide Excretion Rate A measurement of the amount of C-peptide being excreted in a biological specimen over a defined amount of time (e.g. one hour). C-Peptide Excretion Rate C-peptide A measurement of the C (connecting) peptide of insulin in a biological specimen. C-peptide Measurement C-peptide/Creatinine A relative measurement (ratio or percentage) of the C-peptide to creatinine in a biological specimen. C-peptide to Creatinine Ratio Measurement C-Reactive Protein Metabolite CRPM A measurement of the C-reactive protein metabolite, an MMP-generated neoepitope of C-reactive protein (CRP), in a biological specimen. C-Reactive Protein Metabolite Measurement C1M MMP-Degraded Type I collagen Fragment C1M A measurement of the MMP-degraded type I collagen fragment C1M in a biological specimen. MMP-Degraded Type I Collagen Fragment C1M Measurement C2M MMP-Degraded Type II collagen Fragment C2M A measurement of the MMP-degraded type II collagen fragment C2M in a biological specimen. MMP-Degraded Type II Collagen Fragment C2M Measurement C4G MMP-Degraded Type IV collagen Fragment C4G A measurement of the MMP-degraded type IV collagen fragment C4G in a biological specimen. MMP-Degraded Type IV Collagen Fragment C4G Measurement C4M MMP-Degraded Type IV collagen Fragment C4M A measurement of the MMP-degraded type IV collagen fragment C4M in a biological specimen. MMP-Degraded Type IV Collagen Fragment C4M Measurement C4Ma3 MMP-2,9,12 Degraded Type IV Collagen Alpha 3 A measurement of the MMP-2,9,12-degraded type IV collagen alpha 3 fragment C4Ma3 in a biological specimen. MMP 2,9,12-Degraded Type IV Collagen Alpha 3 Fragment C4Ma3 Measurement C6M MMP-2 Degraded Type VI Collagen C6M A measurement of the MMP2-degraded type VI collagen fragment C6M in a biological specimen. MMP 2-Degraded Type VI Collagen Fragment C6M Measurement C6Ma3 MMP-2 and MMP-9 Degraded Type VI Collagen alpha-3 subunit C6M A measurement of the MMP-2-egraded Type VI Collagen alpha-3 subunit fragment C6Ma3 in a biological specimen. MMP 2-Degraded Type VI Collagen Alpha-3 Subunit Fragment C6Ma3 Measurement Cabot Rings A measurement of the Cabot rings (red-purple staining, threadlike, ring or figure 8 shaped filaments in an erythrocyte) in a biological specimen. Cabot Ring Count Cadherin 1 Cadherin-1 E-Cadherin Soluble CD324 A measurement of the cadherin 1 in a biological specimen. Cadherin 1 Measurement Cadmium A measurement of the cadmium in a specimen. Cadmium Measurement Caffeine A measurement of the caffeine in a biological specimen. Caffeine Measurement Calbindin A measurement of the total calbindin in a biological specimen. Calbindin Measurement Calcitonin A measurement of the calcitonin hormone in a biological specimen. Calcitonin Measurement Calcitriol A measurement of the calcitriol hormone in a biological specimen. Calcitriol Measurement Calcium - Phosphorus Product A measurement of the product of the calcium and phosphate measurements in a biological specimen. Calcium and Phosphorus Product Measurement Calcium Carbonate Crystals A measurement of the calcium carbonate crystals present in a biological specimen. Calcium Carbonate Crystal Measurement Calcium Clearance A measurement of the volume of serum or plasma that would be cleared of calcium by excretion of urine for a specified unit of time (e.g. one minute). Calcium Clearance Measurement Calcium Corrected for Albumin A measurement of calcium, which has been corrected for albumin, in a biological specimen. Albumin Corrected Calcium Measurement Calcium Corrected for Total Protein A measurement of calcium, which has been corrected for total protein, in a biological specimen. Calcium Corrected for Total Protein Measurement Calcium Corrected A measurement of calcium, which has been corrected using an unspecified protein, in a biological specimen. Calcium Corrected Measurement Calcium Excretion Rate A measurement of the amount of calcium being excreted in a biological specimen over a defined period of time (e.g. one hour). Calcium Excretion Rate Calcium Oxalate Crystals A measurement of the calcium oxalate crystals present in a biological specimen. Calcium Oxalate Crystal Measurement Calcium Oxalate Excretion Rate A measurement of the amount of calcium oxalate being excreted in a biological specimen over a defined amount of time (e.g. one hour). Calcium Oxalate Excretion Rate Calcium Phosphate Crystals A measurement of the calcium phosphate crystals present in a biological specimen. Calcium Phosphate Crystal Measurement Calcium Sulfate Crystals A measurement of the calcium sulfate crystals present in a biological specimen. Calcium Sulfate Crystals Measurement Calcium Sulphate A measurement of the calcium sulphate in a biological specimen. Calcium Sulphate Measurement Calcium A measurement of the calcium in a biological specimen. Calcium Measurement Calcium, Ionized pH Adjusted A measurement of the pH adjusted ionized calcium in a biological specimen. Ionized pH Adjusted Calcium Measurement Calcium, Ionized A measurement of the ionized calcium in a biological specimen. Ionized Calcium Measurement Calcium/Creatinine A relative measurement (ratio or percentage) of the calcium to creatinine in a biological specimen. Calcium to Creatinine Ratio Measurement Calcium/Phosphate Calcium/Phosphorus A relative measurement (ratio) of the calcium to phosphorus in a biological specimen. Calcium to Phosphorus Ratio Measurement Calprotectin A measurement of the calprotectin in a biological specimen. Calprotectin Measurement Cancer Antigen 1 A measurement of the cancer antigen 1 in a biological specimen. Cancer Antigen 1 Measurement CA125 CA125AG Cancer Antigen 125 Carbohydrate Antigen 125 MUC16 Mucin-16 Mucin-16, Cell Surface Associated A measurement of the cancer antigen 125 in a biological specimen. CA-125 Measurement Cancer Antigen 15-3 Carbohydrate Antigen 15-3 A measurement of the cancer antigen 15-3 in a biological specimen. Cancer Antigen 15-3 Measurement Cancer Antigen 19-9 Carbohydrate Antigen 19-9 A measurement of the cancer antigen 19-9 in a biological specimen. Cancer Antigen 19-9 Measurement Cancer Antigen 242 Carbohydrate Antigen 242 A measurement of the cancer antigen 242 in a biological specimen. Cancer Antigen 242 Measurement Cancer Antigen 27-29 A measurement of the cancer antigen 27-29 in a biological specimen. Cancer Antigen 27-29 Measurement CA50 Cancer Antigen 50 Carbohydrate Antigen 50 A measurement of the cancer antigen 50 in a biological specimen. Cancer Antigen 50 Measurement CA 72-4 Cancer Antigen 72-4 Carbohydrate Antigen 72-4 A measurement of the cancer antigen 72-4 in a biological specimen. Cancer Antigen 72-4 Measurement Cannabinoid Metabolites Cannabis Metabolites Marijuana Metabolites A measurement of any cannabinoid drug class metabolite(s) present in a biological specimen. Cannabinoid Metabolite Measurement Cannabinoids A measurement of any cannabinoid class drug present in a biological specimen. Cannabinoid Drug Class Measurement Cannabinoids, Synthetic A measurement of any synthetic cannabinoid class drug present in a biological specimen. Synthetic Cannabinoid Measurement Carb-Deficient Transferrin/Transferrin A relative measurement (ratio or percentage) of the carbohydrate-deficient transferrin to total transferrin in a biological specimen. Carbohydrate-Deficient Transferrin to Transferrin Ratio Measurement Carbamazepine A measurement of the carbamazepine in a biological specimen. Carbamazepine Measurement Carbohydrate-Deficient Transferrin A measurement of transferrin with a reduced number of carbohydrate moieties in a biological specimen. Carbohydrate-Deficient Transferrin Measurement Carbon Dioxide A measurement of the carbon dioxide gas in a biological specimen. Carbon Dioxide Measurement Carbon Monoxide A measurement of the carbon monoxide in a specimen. Carbon Monoxide Measurement CA9 CAIX Carbonic Anhydrase 9 A measurement of the carbonic anhydrase 9 in a biological specimen. Carbonic Anhydrase 9 Measurement Carboxyhemoglobin A measurement of the carboxyhemoglobin, carbon monoxide-bound hemoglobin, in a biological specimen. Carboxyhemoglobin Measurement Carboxyhemoglobin/Total Hemoglobin A relative measurement (ratio or percentage) of the amount of carboxyhemoglobin compared to total hemoglobin in a biological specimen. Carboxyhemoglobin to Total Hemoglobin Ratio Measurement Carboxypeptidase B2 CPU PCPB TAFI A measurement of the carboxypeptidase B2 in a biological specimen. Carboxypeptidase B2 Measurement Carcinoembryonic Antigen A measurement of the carcinoembryonic antigen in a biological specimen. Carcinoembryonic Antigen Measurement Cariprazine A measurement of the cariprazine in a biological specimen. Cariprazine Measurement Carisoprodol A measurement of the carisoprodol in a biological specimen. Carisoprodol Measurement Carnitine Acetyl Transferase A measurement of the carnitine acetyl transferase in a biological specimen. Carnitine Acetyl Transferase Measurement Carnitine Esters A measurement of the total carnitine esters in a biological specimen. Carnitine Ester Measurement Carnitine Excretion Rate A measurement of the amount of carnitine being excreted in a biological specimen over a defined amount of time (e.g. one hour). Carnitine Excretion Rate Carnitine A measurement of the total carnitine in a biological specimen. Total Carnitine Measurement Carnitine, Free A measurement of the free carnitine in a biological specimen. Free Carnitine Measurement Carotene A measurement of the total carotenes in a biological specimen. Carotene Measurement Cartilage Oligomeric Matrix Protein A measurement of the cartilage oligomeric matrix protein in a biological specimen. Cartilage Oligomeric Matrix Protein Measurement Casein A measurement of the casein in a biological specimen. Casein Measurement Casts Casts Absent Indicator An indication that casts were looked for and not found in a biological specimen. Cast Absent Indicator Catecholamines A measurement of the total catecholamines in a biological specimen. Catecholamine Measurement Cathepsin D A measurement of the cathepsin D in a biological specimen. Cathepsin D Measurement Cathinone A measurement of the cathinone in a biological specimen. Cathinone Measurement BGP Biliary Glycoprotein Carcinoembryonic Antigen Cell Adhesion Molecule 1 CEA Cell Adhesion Molecule 1 CEA Related Cell Adhesion Molecule 1 Soluble CD66a A measurement of the carcinoembryonic antigen (CEA) cell adhesion molecule 1 in a biological specimen. CEA Cell Adhesion Molecule 1 Measurement Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 CEA Cell Adhesion Molecule 5 Soluble CD66e A measurement of the carcinoembryonic antigen (CEA) cell adhesion molecule 5 in a biological specimen. CEA Cell Adhesion Molecule 5 Measurement Cell Morphology An examination or assessment of the form and structure of cells. Cell Morphology Assessment Cells Total Cells A measurement of the total nucleated cells in a biological specimen. Cell Count Cellular Casts A measurement of the cellular (white blood cell, red blood cell, epithelial and bacterial) casts present in a biological specimen. Cellular Cast Measurement Cellularity Cellularity Grade A measurement of the degree, quality or condition of cells in a biological specimen. Cellularity Measurement Caeruloplasmin Ceruloplasmin A measurement of ceruloplasmin in a biological specimen. Ceruloplasmin Measurement Charcot Leyden Crystals Charcot-Leyden Crystals CLC Galectin-10 Crystals A measurement of the Charcot-Leyden crystals present in a biological specimen. Charcot-Leyden Crystal Measurement Chemokine (C-C Motif) Ligand 1 I-309 SCYA1 Small Inducible Cytokine A1 T Lymphocyte-Secreted Protein I-309 A measurement of the CCL1, chemokine (C-C motif) ligand 1, in a biological specimen. Chemokine (C-C Motif) Ligand 1 Measurement Chemokine (C-C Motif) Ligand 12 Monocyte Chemotactic Protein 5 A measurement of the CCL12, chemokine (C-C motif) ligand 12, in a biological specimen. Chemokine (C-C Motif) Ligand 12 Measurement C-C Motif Chemokine Ligand 13 Chemokine (C-C Motif) Ligand 13 CKb10 MCP-4 NCC1 SCYA13 SCYL1 A measurement of the CCL13, chemokine (C-C motif) ligand 13, in a biological specimen. Chemokine (C-C Motif) Ligand 13 Measurement Chemokine (C-C Motif) Ligand 15 Leukotactin 1 Macrophage inflammatory protein-5 MIP-1 Delta MIP1D MIP5 A measurement of the CCL15, chemokine (C-C motif) ligand 15, in a biological specimen. Chemokine (C-C Motif) Ligand 15 Measurement Chemokine (C-C Motif) Ligand 16 Chemokine CC-4 CKb12 HCC-4 ILINCK LCC-1 LEC LMC Mtn-1 NCC4 SCYA16 SCYL4 A measurement of the CCL16, chemokine (C-C motif) ligand 16, in a biological specimen. Chemokine (C-C Motif) Ligand 16 Measurement ABCD-2 Chemokine (C-C Motif) Ligand 17 SCYA17 TARC Thymus and Activation Regulated Chemokine A measurement of the CCL17, chemokine (C-C motif) ligand 17, in a biological specimen. Chemokine (C-C Motif) Ligand 17 Measurement AMAC-1 AMAC1 Chemokine (C-C Motif) Ligand 18 CKB7 DC-CK1 DCCK1 Macrophage inflammatory protein-4 MIP4 PARC Pulmonary and Activation-Regulated Chemokine SCYA18 A measurement of the CCL18, chemokine (C-C motif) ligand 18, in a biological specimen. Chemokine (C-C Motif) Ligand 18 Measurement Chemokine (C-C Motif) Ligand 19 Macrophage Inflammatory Protein 3 Beta MIP3B A measurement of the CCL19, chemokine (C-C motif) ligand 19, in a biological specimen. Chemokine (C-C Motif) Ligand 19 Measurement Chemokine (C-C Motif) Ligand 2 Excr Rate Chemokine (C-C Motif) Ligand 2 Excretion Rate MCP1 Excretion Rate A measurement of the amount of chemokine (C-C Motif) ligand 2 being excreted in a biological specimen over a defined period of time (e.g. one hour). Chemokine (C-C Motif) Ligand 2 Excretion Rate CCL20 Chemokine (C-C Motif) Ligand 20 LARC Liver Activation Regulated Chemokine Macrophage Inflammatory Protein-3 Alpha MIP3A A measurement of the chemokine (C-C motif) ligand 20 in a biological specimen. Chemokine (C-C Motif) Ligand 20 Measurement 6Ckine Chemokine (C-C Motif) Ligand 21 Secondary Lymphoid Tissue Chemokine A measurement of the CCL21, chemokine (C-C motif) ligand 21, in a biological specimen. Chemokine (C-C Motif) Ligand 21 Measurement Chemokine (C-C Motif) Ligand 23 CK-BETA-8 Ckb-8-1 CKb8 Hmrp-2a MIP3 MPIF-1 SCYA23 A measurement of the CCL23, chemokine (C-C motif) ligand 23, in a biological specimen. Chemokine (C-C Motif) Ligand 23 Measurement Chemokine (C-C Motif) Ligand 25 Ckb15 SCYA25 TECK A measurement of the CCL25, chemokine (C-C motif) ligand 25, in a biological specimen. Chemokine (C-C Motif) Ligand 25 Measurement Chemokine (C-C Motif) Ligand 7 MCP3 Monocyte Chemotactic Protein 3 A measurement of the CCL7, chemokine (C-C motif) ligand 7, in a biological specimen. Chemokine (C-C Motif) Ligand 7 Measurement Chemokine (C-C Motif) Ligand 8 HC14 MCP2 SCYA10 SCYA8 A measurement of the CCL8, chemokine (C-C motif) ligand 8, in a biological specimen. Chemokine (C-C Motif) Ligand 8 Measurement Chemokine (C-X-C Motif) Ligand 1 GRO Alpha GRO/KC GRO1 GROA Growth-Regulated Alpha Protein Melanoma Growth Stimulating Activity, Alpha A measurement of the CXCL1, chemokine (C-X-C motif) ligand 1, in a biological specimen. Chemokine (C-X-C Motif) Ligand 1 Measurement Chemokine (C-X-C Motif) Ligand 10 Interferon Gamma-induced Protein 10 Interferon-inducible Protein-10 IP-10 Small-inducible Cytokine B10 A measurement of the CXCL10, chemokine (C-X-C motif) ligand 10, in a biological specimen. Chemokine (C-X-C Motif) Ligand 10 Measurement Chemokine (C-X-C Motif) Ligand 11 I-TAC IFN-inducible T Cell Alpha Chemoattractant ITAC A measurement of the chemokine (C-X-C motif) ligand 11 in a biological specimen. Chemokine (C-X-C Motif) Ligand 11 Measurement Chemokine (C-X-C Motif) Ligand 12 IRH PBSF SCYB12 SDF1 SDF1A SDF1B Stromal Cell-Derived Factor-1 Alpha Stromal Cell-Derived Factor-1 Beta TLSF TPAR1 A measurement of the CXCL12, chemokine (C-X-C motif) ligand 12, in a biological specimen. Chemokine (C-X-C Motif) Ligand 12 Measurement B Lymphocyte Chemoattractant Chemokine (C-X-C Motif) Ligand 13 A measurement of the CXCL13, chemokine (C-X-C motif) ligand 13, in a biological specimen. Chemokine (C-X-C Motif) Ligand 13 Measurement Chemokine (C-X-C Motif) Ligand 2 GRO Beta GRO2 MIP2-Alpha A measurement of the CXCL2, chemokine (C-X-C motif) ligand 2, in a biological specimen. Chemokine (C-X-C Motif) Ligand 2 Measurement Chemokine (C-X-C Motif) Ligand 3 GRO Gamma Macrophage Inflammatory Protein 2-Beta MIP2 Beta MIP2B A measurement of the CXCL3, chemokine (C-X-C motif) ligand 3, in a biological specimen. Chemokine (C-X-C Motif) Ligand 3 Measurement Chemokine (C-X-C Motif) Ligand 4 Oncostatin A Platelet Factor 4 PLF4 A measurement of the CXCL4, chemokine (C-X-C motif) ligand 4, in a biological specimen. Chemokine (C-X-C Motif) Ligand 4 Measurement Chemokine (C-X-C Motif) Ligand 6 GCP2 Granulocyte Chemotactic Protein 2 A measurement of the CXCL6, chemokine (C-X-C motif) ligand 6, in a biological specimen. Chemokine (C-X-C Motif) Ligand 6 Measurement B-TG1 Beta-TG Chemokine (C-X-C Motif) Ligand 7 CTAP-III CTAP3 CTAPIII LA-PF4 LDGF MDGF NAP-2 Neutrophil-Activating Peptide 2 PBP PPBP Pro-Platelet Basic Protein SCYB7 TC1 TC2 TGB TGB1 THBGB THBGB1 A measurement of the pro-platelet basic protein in a biological specimen. Chemokine (C-X-C Motif) Ligand 7 Measurement Chemokine (C-X-C Motif) Ligand 9 CMK crg-10 Humig MIG Monokine Induced by Gamma Interferon SCYB9 A measurement of the CXCL9, chemokine (C-X-C motif) ligand 9, in a biological specimen. Chemokine (C-X-C Motif) Ligand 9 Measurement Chemokine (C-X-C Motif) Receptor 3 CXCR3 GPR9 Soluble CD183 A measurement of the CXCR3, chemokine (C-X-C motif) receptor 3, in a biological specimen. Chemokine Receptor CXCR3 Measurement Chemokine (C-X-C Motif) Receptor 4 LPS-Associated Protein 3 Soluble CD184 Stromal Cell-Derived Factor 1 Receptor A measurement of the CXCR4, chemokine (C-X-C motif) receptor 4, in a biological specimen. C-X-C Chemokine Receptor Type 4 Measurement Chemokine (C-X3-C motif) Ligand 1 Fractalkine Neurotactin A measurement of the chemokine (C-X3-C motif) ligand 1 in a biological specimen. Chemokine (C-X3-C Motif) Ligand 1 Measurement Chenodeoxycholate Compounds Chenodeoxycholic Acid Compounds A measurement of the chenodeoxycholic acid, glycochenodeoxycholic acid, and taurochenodeoxycholic acid in a biological specimen. Chenodeoxycholate Compounds Measurement Chenic Acid Chenocholic Acid Chenodeoxycholate Chenodeoxycholic Acid A measurement of the chenodeoxycholate in a biological specimen. Chenodeoxycholate Measurement Chitinase 1 Chitotriosidase Chitotriosidase-1 A measurement of the chitotriosidase-1 in a biological specimen. Chitotriosidase-1 Measurement Chloral Hydrate Mickey Finn Trichloroacetaldehyde Monohydrate A measurement of the chloral hydrate in a biological specimen. Chloral Hydrate Measurement Chlordiazepoxide A measurement of the chlordiazepoxide present in a biological specimen. Chlordiazepoxide Measurement Chloride Clearance A measurement of the volume of serum or plasma that would be cleared of chloride by excretion of urine for a specified unit of time (e.g. one minute). Chloride Clearance Measurement Chloride Excretion Rate A measurement of the amount of chloride being excreted in a biological specimen over a defined period of time (e.g. one hour). Chloride Excretion Rate Chloride A measurement of the chloride in a biological specimen. Chloride Measurement Chloride/Creatinine A relative measurement (ratio or percentage) of the chloride to creatinine in a biological specimen. Chloride to Creatinine Ratio Measurement Chlorphentermine A measurement of the chlorphentermine in a biological specimen. Chlorphentermine Measurement Chlorpromazine A measurement of the chlorpromazine in a biological specimen. Chlorpromazine Measurement Cholate Compounds Cholic Acid Compounds A measurement of the cholic acid, glycocholic acid, hyocholic acid, and taurocholic acid in a biological specimen. Cholate Compounds Measurement Cholate Cholic Acid A measurement of the cholate in a biological specimen. Cholate Measurement Cholecystokinin Pancreozymin A measurement of the cholecystokinin hormone in a biological specimen. Cholecystokinin Measurement 5alpha-Cholestanol Beta-Cholestanol Cholestanol Dehydrocholesterol Zymostanol A measurement of the cholestanol in a biological specimen. Cholestanol Measurement Cholesterol Crystals A measurement of the cholesterol crystals present in a biological specimen. Cholesterol Crystal Measurement Cholesterol Sulfate A measurement of the cholesterol sulfate in a biological specimen. Cholesterol Sulfate Measurement Cholesterol Total Cholesterol A measurement of the cholesterol in a biological specimen. Cholesterol Measurement Cholesterol/HDL-Cholesterol A relative measurement (ratio or percentage) of total cholesterol to high-density lipoprotein cholesterol (HDL-C) in a biological specimen. Cholesterol to HDL-Cholesterol Ratio Measurement Cholesteryl Ester Transfer Protein Act A measurement of the biological activity of cholesteryl ester transfer protein in a biological specimen. Cholesteryl Ester Transfer Protein Activity Measurement Cholesteryl Ester Transfer Protein A measurement of the cholesteryl ester transfer protein in a biological specimen. Cholesteryl Ester Transfer Protein Measurement Cholesteryl Esters A measurement of the cholesteryl esters in a biological specimen. Cholesteryl Ester Measurement Cholinesterase A measurement of the cholinesterase in a biological specimen. Cholinesterase Measurement Choriogonadotropin Adj for Maternal Wt Choriogonadotropin Adjusted for Maternal Weight A measurement of choriogonadotropin, which has been adjusted for maternal body weight, in a biological specimen. Choriogonadotropin Adjusted for Maternal Weight Measurement Choriogonadotropin Beta Pregnancy Test A measurement of the Choriogonadotropin Beta in a biological specimen. Choriogonadotropin Beta Measurement Choriogonadotropin Beta, Free A measurement of the free choriogonadotropin beta in a biological specimen. Free Choriogonadotropin Beta Measurement Choriogonadotropin A measurement of the total choriogonadotropin in a biological specimen. Choriogonadotropin Measurement Choriogonadotropin, Intact A measurement of the intact choriogonadotropin in a biological specimen. Intact Choriogonadotropin Measurement Chromogranin A A measurement of the chromogranin A in a biological specimen. Chromogranin A Measurement Chylomicron Triglyceride A measurement of the chylomicron triglyceride in a biological specimen. Chylomicron Triglyceride Measurement Chylomicrons A measurement of the chylomicrons in a biological specimen. Chylomicrons Measurement Chymotrypsin A measurement of the total chymotrypsin in a biological specimen. Chymotrypsin Measurement Ciliary Neurotrophic Factor A measurement of the ciliary neurotrophic factor in a biological specimen. Ciliary Neurotrophic Factor Measurement Circulating Endothelial Cells A measurement of the circulating endothelial cells in a biological specimen. Circulating Endothelial Cell Count Circulating Immune Complexes A measurement of the circulating immune complexes in a biological specimen. Circulating Immune Complex Measurement Circulating Tumor Cells A measurement of the circulating tumor cells in a biological specimen. Circulating Tumor Cell Count Circulating Tumor Cells, Apoptotic A measurement of the apoptotic circulating tumor cells in a biological specimen. Apoptotic Circulating Tumor Cell Count Circulating Tumor Cells, Traditional A measurement of the traditional circulating tumor cells in a biological specimen. Traditional Circulating Tumor Cell Count Citalopram A measurement of the citalopram present in a biological specimen. Citalopram Measurement Citrate Excretion Rate A measurement of the amount of citrate being excreted in a biological specimen over a defined amount of time (e.g. one hour). Citrate Excretion Rate Citrate Citric Acid A measurement of the citrate in a biological specimen. Citrate Measurement Citrate/Creatinine Citric Acid/Creatinine A relative measurement (ratio or percentage) of the citrate to creatinine in a biological specimen. Citrate to Creatinine Ratio Measurement Citrulline A measurement of the citrulline in a biological specimen. Citrulline Measurement Citrulline/Creatinine A relative measurement (ratio or percentage) of the citrulline to creatinine in a biological specimen. Citrulline to Creatinine Ratio Measurement CK, Macromolecular Type 1/Total CK Creatine Kinase, Macromolecular Type 1/Total Creatine Kinase A relative measurement (ratio or percentage) of the macromolecular type 1 creatine kinase to total creatine kinase in a biological specimen. Macromolecular Type 1 Creatine Kinase to Total Creatine Kinase Ratio Measurement CK, Macromolecular Type 2/Total CK Creatine Kinase, Macromolecular Type 2/Total Creatine Kinase A relative measurement (ratio or percentage) of the macromolecular type 2 creatine kinase to total creatine kinase in a biological specimen. Macromolecular Type 2 Creatine Kinase to Total Creatine Kinase Ratio Measurement Clarity A measurement of the transparency of a biological specimen. Clarity Measurement Clobazam cloBAZam A measurement of the clobazam in a biological specimen. Clobazam Measurement Clonazepam and/or Metabolites A measurement of the clonazepam and/or its metabolite(s) present in a biological specimen, for an assay that can measure both clonazepam and its metabolites. Clonazepam and/or Metabolites Measurement Clonazepam A measurement of the clonazepam present in a biological specimen. Clonazepam Measurement Clorazepate A measurement of the clorazepate present in a biological specimen. Clorazepate Measurement Clostebol A measurement of the clostebol in a biological specimen. Clostebol Measurement Clot Amplitude Clot Firmness A measurement of the firmness of a clot. Clot Firmness Measurement Alpha Angle Alpha-Angle Clot Formation Alpha Angle A measurement of the angle of incline (tangent at 20mm and the midline) during the rising phase of the thromboelastogram curve, during the clot formation process. Clot Formation Alpha Angle Measurement CFT Clot Formation Time A measurement of the elapsed time from the start of clot formation to the point at which the clot reaches a firmness of 20mm. Clot Formation Time Measurement Clot Initiation Time Clotting Time CT A measurement of the elapsed time from the addition of the clot activating agent to the start of clot formation. Clot Initiation Time Measurement Clot LI Clot Lysis Index A relative measurement (percentage) of remaining clot stability in relation to the maximum clot firmness value at some time point after clot initiation time. Clot Lysis Index Clot Lysis Time ECLT ELT Euglobulin Clot Lysis Time Euglobulin Lysis Time A measurement of the amount of time it takes for dissolution of a fibrin clot in a biological specimen. Euglobulin Clot Lysis Time Clot Retraction Time A measurement of the amount of time it takes for a clot to retract, or pull away from, the wall of a glass collection container. Clot Retraction Time Measurement Clot Retraction Clot Retraction, Qualitative A qualitative assessment of clot retraction in a biological specimen. Qualitative Clot Retraction Measurement Clue Cells A measurement of the clue cells in a biological specimen. Clue Cell Count CI Coagulation Index A measurement of the efficiency of coagulation of a biological specimen. This is calculated by a mathematical formula that takes into account the R value, K value, angle and maximum amplitude of clot formation. Coagulation Index Measurement Cocaethylene Cocaine Ethyl A measurement of the cocaethylene present in a biological specimen. Cocaethylene Measurement CART Cocaine Amphetamine-Reg Transcript Prot Cocaine and Amphetamine-Regulated Transcript Protein A measurement of the cocaine and amphetamine-regulated transcript protein in a biological specimen. Cocaine Amphetamine-Regulated Transcript Protein Measurement Cocaine and/or Metabolites A measurement of the cocaine and/or its metabolite(s) present in a biological specimen, for an assay that can measure both cocaine and its metabolites. Cocaine And/Or Metabolites Measurement Cocaine Benzoylecgonine Ecgonine A measurement of the cocaine, benzoylecgonine, and/or ecgonine in a biological specimen. Cocaine, Benzoylecgonine, and/or Ecgonine Measurement Cocaine Metabolites A measurement of any cocaine drug class metabolite(s) present in a biological specimen. Cocaine Metabolites Measurement Cocaine A measurement of the cocaine present in a biological specimen. Cocaine Measurement Codeine A measurement of the codeine present in a biological specimen. Codeine Measurement Coefficient of Fat Absorption A measurement of the coefficient of fat absorption in a biological specimen. Coefficient of Fat Absorption Measurement Coefficient of Nitrogen Absorption A measurement of the coefficient of nitrogen absorption in a biological specimen. Coefficient of Nitrogen Absorption Measurement Collagen III Neo-Peptide C3M A measurement of the collagen III neo-peptide C3M in a biological specimen. Collagen III Neo-Peptide C3M Measurement Collagen Type IV A measurement of the collagen type IV in a biological specimen. Collagen Type IV Measurement Color A measurement of the color of a biological specimen. Color Assessment Columnar Epi Cells/Non-Squam Epi Cells A relative measurement (ratio or percentage) of the columnar epithelial cells to non-squamous epithelial cells in a biological specimen. Columnar Epithelial Cells to Non-Squamous Epithelial Cells Ratio Measurement Ba Fragment of Complement Factor B Ba Fragment of Factor B Complement Ba A measurement of the Ba fragment of complement factor B in a biological specimen. Complement Ba Measurement Bb Fragment of Complement Factor B Bb Fragment of Factor B Complement Bb A measurement of the Bb fragment of complement factor B in a biological specimen. Complement Bb Measurement Complement C1 Esterase Inhibitor A measurement of the complement C1 esterase inhibitor in a biological specimen. Complement C1 Esterase Inhibitor Measurement Complement C1q A measurement of the complement C1q in a biological specimen. Complement C1q Measurement ARMD14 Complement C2 A measurement of the complement C2 in a biological specimen. Complement C2 Measurement Complement C2, Free A measurement of the free complement C2 in a biological specimen. Free Complement C2 Measurement Complement C2, Free/Complement C2 A relative measurement (ratio or percentage) of the free complement C2 to total complement C2 in a biological specimen. Free Complement C2 to Complement C2 Ratio Measurement Complement C3 A measurement of the complement C3 in a biological specimen. Complement C3 Measurement Acylation-Stimulating Protein ASP Complement C3a DesArg A measurement of the complement C3a DesArg in a biological specimen. Complement C3a DesArg Measurement Complement C3a A measurement of the complement C3a in a biological specimen. Complement C3a Measurement Complement C3b A measurement of the complement C3b in a biological specimen. Complement C3b Measurement Complement C3c A measurement of the complement C3c in a biological specimen. Complement C3c Measurement Complement C4 A measurement of the complement C4 in a biological specimen. Complement C4 Measurement Complement C4a A measurement of the complement C4a in a biological specimen. Complement C4a Measurement Complement C4d A measurement of the complement C4d in a biological specimen. Complement C4d Measurement Complement C5 A measurement of the total complement C5 in a biological specimen. Complement C5 Measurement Complement C5, Free A measurement of the free complement C5 in a biological specimen. Free Complement C5 Measurement Complement C5a A measurement of the complement C5a in a biological specimen. Complement C5a Measurement Complement C5b-9 A measurement of the complement C5b-9 in a biological specimen. Complement C5b-9 Measurement CH100 Complement CH100 Total Hemolytic Complement CH100 A measurement of the complement required to lyse 100 percent of red blood cells in a biological specimen. Complement CH100 Measurement CH50 Complement CH50 Total Hemolytic Complement CH50 A measurement of the complement required to lyse 50 percent of red blood cells in a biological specimen. CH50 Measurement Beta-1-H-Globulin Complement Factor H Factor H H Factor 1 A measurement of the complement factor H in a biological specimen. Complement Factor H Measurement Complement Factor H Related 1 Complement Factor H-Related Protein 1 FHL-1 FHR-1 H Factor-Like Protein 1 H-Factor-Like 1 A measurement of the complement factor H-related Protein 1 in a biological specimen. Complement Factor H-Related Protein 1 Measurement Complement Total Total Hemolytic Complement A measurement of the total complement in a biological specimen. Complement Measurement Cellular Communication Network Factor 2 CN2 Connective Tissue Growth Factor IGFBP8 A measurement of the connective tissue growth factor in a biological specimen. Connective Tissue Growth Factor Measurement Consistency A description about the firmness or make-up of an entity. Consistency Copeptin A measurement of the copeptin in a biological specimen. Copeptin Measurement Copper Cu A measurement of copper in a biological specimen. Copper Measurement Cellular Hemoglobin Content CH Corpuscular Hemoglobin Content A measurement of the mean erythrocyte hemoglobin content within an individual erythrocyte, calculated as the product of cell volume and cell hemoglobin concentration. Corpuscular Hemoglobin Content Corpuscular Hemoglobin Concentration Distribution Width Corpuscular HGB Conc Distribution Width A measurement of the standard deviation of hemoglobin concentrations in erythrocytes in a biological specimen, calculated as the standard deviation of hemoglobin content divided by the mean hemoglobin content. Corpuscular Hemoglobin Concentration Distribution Width Corpuscular HGB Concentration Mean A direct measurement of the concentration of hemoglobin within individual erythrocytes in a biological specimen, reported as a mean. Corpuscular Hemoglobin Concentration Mean Corticosterone A measurement of corticosterone in a biological specimen. Corticosterone Measurement Corticosterone/Creatinine A relative measurement (ratio or percentage) of the corticosterone to creatinine present in a sample. Corticosterone to Creatinine Ratio Measurement Corticotropin Releasing Factor Corticotropin Releasing Hormone A measurement of the corticotropin releasing hormone in a biological specimen. Corticotropin Releasing Hormone Measurement Cortisol Total Cortisol A measurement of the cortisol in a biological specimen. Cortisol Measurement Cortisol, Free Excretion Rate A measurement of the amount of free cortisol being excreted in a biological specimen over a defined amount of time (e.g. one hour). Free Cortisol Excretion Rate Cortisol, Free A measurement of the free, unbound cortisol in a biological specimen. Free Cortisol Measurement Cortisol/Creatinine A relative measurement (ratio or percentage) of the cortisol to creatinine present in a sample. Cortisol to Creatinine Ratio Measurement Cotinine Glucuronide Cotinine N-B-D-Glucuronide Cotinine N-beta-D-Glucuronide Cotinine-Glucuronide Cotinine-N-Glucuronide A measurement of the cotinine glucuronide in a specimen. Cotinine Glucuronide Measurement Cotinine A measurement of the cotinine in a biological specimen. Cotinine Measurement Cotinine, Free A measurement of the free (unbound) cotinine in a specimen. Free Cotinine Measurement Calprotectin Neo-epitope CPa9-HNE CPa9-HNE Human Neutrophil Elastase-Degraded Calprotectin Neo-epitope CPa9-HNE A measurement of the human neutrophil elastase-degraded calprotectin neo-epitope CPa9-HNE in a biological specimen. Human Neutrophil Elastase-Degraded Calprotectin Neo-epitope CPa9-HNE Measurement Creatine Kinase BB A measurement of the homozygous B-type creatine kinase in a biological specimen. Creatine Kinase BB Measurement Creatine Kinase BB/Total Creatine Kinase A relative measurement (ratio or percentage) of the BB-type creatine kinase to total creatine kinase in a biological specimen. Creatine Kinase BB to Total Creatine Kinase Ratio Measurement Creatine Kinase MB A measurement of the heterozygous MB-type creatine kinase in a biological specimen. Creatine Kinase MB Measurement Creatine Kinase MB/Total Creatine Kinase A relative measurement (ratio or percentage) of the MB-type creatine kinase to total creatine kinase in a biological specimen. Creatine Kinase MB to Total Creatine Kinase Ratio Measurement Creatine Kinase MM A measurement of the homozygous M-type creatine kinase in a biological specimen. Creatine Kinase MM Measurement Creatine Kinase MM/Total Creatine Kinase A relative measurement (ratio or percentage) of the MM-type creatine kinase to total creatine kinase in a biological specimen. Creatine Kinase MM to Total Creatine Kinase Ratio Measurement CPK Creatine Kinase Creatine Phosphokinase A measurement of the total creatine kinase in a biological specimen. Creatine Kinase Measurement Creatinine Clearance Adjusted for BSA A measurement of the volume of serum or plasma that would be cleared of creatinine by excretion of urine for a specified unit of time (e.g. one minute), adjusted for body surface area. Creatinine Clearance Adjusted for BSA Creatinine Clearance A measurement of the volume of serum or plasma that would be cleared of creatinine by excretion of urine for a specified unit of time (e.g. one minute). Creatinine Clearance Creatinine Clearance, Estimated An estimate of the volume of serum or plasma that would be cleared of creatinine by excretion of urine for a specified unit of time (e.g. one minute). Estimated Creatinine Clearance Creatinine Excretion Rate A measurement of the amount of creatinine being excreted in a biological specimen over a defined amount of time (e.g. one hour). Creatinine Excretion Rate Creatinine A measurement of the creatinine in a biological specimen. Creatinine Measurement Crenated Cells A measurement of the crenated cells in a biological specimen. Crenated Cell Measurement Crotonaldehyde A measurement of the crotonaldehyde in a specimen. Crotonaldehyde Measurement Cryofibrinogen A measurement of the cryofibrinogen in a biological specimen. Cryofibrinogen Measurement Cryoglobulin Volume/Serum Volume A relative measurement (ratio or percentage) of the volume of cryoglobulin to total serum volume in a biological specimen. Cryoglobulin Volume to Serum Volume Ratio Measurement Cryoglobulin A measurement of cryoglobulin in a biological specimen. Cryoglobulin Measurement Crystals Crystals Absent Indicator An indication that crystals were looked for and not found in a biological specimen. Crystal Absent Indicator CSF IgG Index CSF Index IgG Index A relative measurement (ratio) of the IgG to albumin in cerebrospinal fluid to the IgG to albumin in serum. IgG Index Cyclic Adenosine 3,5-Monophosphate A measurement of cyclic adenosine 3,5-monophosphate in a biological specimen. Cyclic Adenosine 3,5-Monophosphate Measurement Cyclic Adenosine 3,5-Monophosphate/Creatinine Cyclic Adenosine Monophosphate/Creat Cyclic Adenosine Monophosphate/Creatinine A relative measurement (ratio) of the cyclic adenosine 3,5-monophosphate to creatinine in a biological specimen. Cyclic Adenosine 3,5 Monophosphate to Creatinine Ratio Measurement ADP-Ribosyl Cyclase 1 ADP-Ribosyl Cyclase/Cyclic ADP-Ribose Hydrolase 1 ADPRC1 cADPr Hydrolase 1 Cyclic ADP Ribose Hydrolase Cyclic ADP Ribose Hydrolase 1 Soluble CD38 A measurement of the cyclic ADP ribose hydrolase 1 protein in a biological specimen. Cyclic ADP Ribose Hydrolase 1 Measurement Cyclic Guanosine Monophosphate A measurement of the cyclic guanosine 3,5-monophosphate in a biological specimen. Cyclic Guanosine Monophosphate Measurement Cylindroid Casts Cylindroid Pseudocasts A measurement of cylindroid casts (casts with a tapering end) in a biological specimen. Cylindroid Cast Measurement Cystathionine Beta-Synthase A measurement of the cystathionine beta-synthase in a biological specimen. Cystathionine Beta-Synthase Measurement Cystathionine A measurement of the cystathionine in a biological specimen. Cystathionine Measurement CPI-B Cystatin B A measurement of the cystatin B in a biological specimen. Cystatin B Measurement Cystatin C A measurement of the cystatin C in a biological specimen. Cystatin C Measurement Cystatin C/Creatinine A relative measurement (ratio or percentage) of the cystatin C to creatinine present in a sample. Cystatin C to Creatinine Ratio Measurement Cysteine A measurement of the cysteine in a biological specimen. Cysteine Measurement CysLTR1 Cysteinyl Leukotriene Receptor 1 A measurement of the cysteinyl leukotriene receptor 1 in a biological specimen. Cysteinyl Leukotriene Receptor 1 Measurement Cystine Crystals A measurement of the cystine crystals present in a biological specimen. Cystine Crystal Measurement Cystine A measurement of the cystine in a biological specimen. Cystine Measurement Cytidine-Uridine Monophosphate Kinase 2 Cytidine/Uridine Monophosphate Kinase 2 A measurement of the cytidine-uridine monophosphate kinase 2 in a biological specimen. Cytidine-Uridine Monophosphate Kinase 2 Measurement Cytochrome P450 2A6 A measurement of the cytochrome P450 2A6 enzyme in a specimen. Cytochrome P450 2A6 Measurement Cytochrome P450 2C9 A measurement of the cytochrome P450 2C9 enzyme in a biological specimen. Cytochrome P450 2C9 Measurement Cytokeratin 18 Fragment A measurement of the cytokeratin 18 fragment in a biological specimen. Cytokeratin 18 Fragment Measurement Cell Proliferation-Inducing Gene 46 Protein CK-18 CYK18 Cytokeratin 18 K18 Keratin 18 Keratin, Type I Cytoskeletal 18 A measurement of the cytokeratin 18 in a biological specimen. Cytokeratin 18 Measurement CYFRA21-1 Cytokeratin 19 Fragment 21-1 A measurement of the cytokeratin 19 fragment 21-1 in a biological specimen. Cytokeratin 19 Fragment 21-1 Measurement Cytomegalovirus-Induced Gene 5 Protein Radical S-adenosyl Methionine Domain-Containing Protein 2 A measurement of the cytomegalovirus-induced gene 5 protein in a biological specimen. Cytomegalovirus-Induced Gene 5 Protein Measurement Cytoplasmic Basophilia Neutrophil A measurement of the neutrophils in a biological specimen showing a dark staining pattern in the cytoplasm due to increased acidic content. Cytoplasmic Basophilia Neutrophil Count D-Dimer A measurement of the d-dimers in a biological specimen. D-Dimer Measurement (+)-Norpseudoephedrine Cathine D-Norpseudoephedrine A measurement of the D-norpseudoephedrine in a biological specimen. D-Norpseudoephedrine Measurement Dacryocytes Tear Shaped Erythrocytes Teardrop Cells A measurement of dacryocytes in a biological specimen. Dacryocyte Analysis DEAD Box Protein 58 DExD/H-Box Helicase 58 Probable ATP-Dependent RNA Helicase DDX58 A measurement of the DEAD box protein 58 in a biological specimen. DEAD Box Protein 58 Measurement C10 Decanoylcarnitine A measurement of the decanoylcarnitine in a biological specimen. Decanoylcarnitine Measurement DCN Decorin A measurement of the decorin in a biological specimen. Decorin Measurement Degenerated Leukocytes Degenerated WBC Degenerated White Blood Cells A measurement of the degenerated leukocytes (leukocytes that show deterioration in form or function) in a biological specimen. Degenerated Leukocyte Count Dehydroepiandrosterone Sulfate DHEA Sulfate DHEA-S sDHEA A measurement of the sulfated Dehydroepiandrosterone in a biological specimen. Sulfated DHEA Measurement Dehydroepiandrosterone Dehydroisoandrosterone A measurement of the dehydroepiandrosterone hormone in a biological specimen. Dehydroepiandrosterone Measurement 5-Aminolevulinic Acid 5ALA dALA Delta Aminolevulinate Delta Aminolevulinic Acid A measurement of the delta aminolevulinic acid in a biological specimen. Delta Aminolevulinate Measurement Delta Aminolevulinate/Creatinine A relative measurement (ratio or percentage) of the delta aminolevulinate to creatinine in a biological specimen. Delta Aminolevulinate to Creatinine Ratio Measurement Albumin-Bound Bilirubin Biliprotein Delta Bilirubin Delta Fraction A measurement of the albumin-bound bilirubin in a biological specimen. Delta Bilirubin Measurement Density A measurement of the compactness of a biological specimen expressed in mass per unit volume. Density Deoxycholate Deoxycholic Acid A measurement of the deoxycholate in a biological specimen. Deoxycholate Measurement Deoxyhemoglobin A measurement of the deoxyhemoglobin, hemoglobin without oxygen, in a biological specimen. Deoxyhemoglobin Measurement Deoxyhemoglobin/Total Hemoglobin A relative measurement (ratio or percentage) of the deoxyhemoglobin to total hemoglobin in a biological specimen. Deoxyhemoglobin to Hemoglobin Ratio Measurement Deoxypyridinoline A measurement of the deoxypyridinoline in a biological specimen. Deoxypyridinoline Measurement Deoxypyridinoline/Creatinine A relative measurement (ratio or percentage) of the deoxypyridinoline to creatinine in a biological specimen. Deoxypyridinoline to Creatinine Ratio Measurement Deoxyribonucleic Acid A measurement of a targeted deoxyribonucleic acid (DNA) in a biological specimen. Deoxyribonucleic Acid Measurement Desipramine A measurement of the desipramine in a biological specimen. Desipramine Measurement Desmethyl Citalopram Desmethylcitalopram Norcitalopram A measurement of the desmethylcitalopram in a biological specimen. Desmethylcitalopram Measurement DES Desmosine A measurement of the desmosine in a specimen. Desmosine Measurement Desomorphine A measurement of the desomorphine in a biological specimen. Desomorphine Measurement Desoxymethyltestosterone A measurement of the desoxymethyltestosterone in a biological specimen. Desoxymethyltestosterone Measurement Desvenlafaxine O-Desmethylvenlafaxine A measurement of the desvenlafaxine present in a biological specimen. Desvenlafaxine Measurement d-amphetamine Dextroamphetamine A measurement of the dextroamphetamine in a biological specimen. Dextroamphetamine Measurement Di-Desmethylcitalopram A measurement of the di-desmethylcitalopram in a biological specimen. Di-Desmethylcitalopram Measurement DAGs Diacylglycerol Diacylglycerols Diglycerides A measurement of the diacylglycerol in a biological specimen. Diacylglycerol Measurement Diazepam A measurement of the diazepam present in a biological specimen. Diazepam Measurement Dicalcium Phosphate Crystals A measurement of dicalcium phosphate crystals in a biological specimen. Dicalcium Phosphate Crystals Measurement Dickkopf WNT Signaling Pathway Inhibitor 1 DKK-1 SK A measurement of the dickkopf WNT signaling pathway inhibitor 1 in a biological specimen. Dickkopf WNT Signaling Path Inhibitor 1 Measurement Diethylpropion A measurement of the diethylpropion in a biological specimen. Diethylpropion Measurement Dihydrocodeine A measurement of the dihydrocodeine present in a biological specimen. Dihydrocodeine Measurement Androstanolone Dihydrotestosterone A measurement of the dihydrotestosterone hormone in a biological specimen. Dihydrotestosterone Measurement Dilute Russell's Viper Venom Time Ratio Lupus Anticoagulant Ratio A relative measurement of the dilute Russell's viper venom time in a subject sample to a control sample. Dilute Russell's Viper Venom Time to Control Ratio Measurement Dilute Russell's Viper Venom Time Lupus Anticoagulant Test A measurement of the time it takes a plasma sample to clot after adding dilute Russell's viper venom. Dilute Russell's Viper Venom Time Measurement Dimethylglycine A measurement of the dimethylglycine in a biological specimen. Dimethylglycine Measurement Dimorphic Erythrocyte Population Dimorphic RBC Population Examination of a biological specimen to detect the presence of dimorphic erythrocyte population. Dimorphic Erythrocyte Population Dipeptidyl Peptidase-4 A measurement of the dipeptidyl peptidase-4 in a biological specimen. Dipeptidyl Peptidase-4 Measurement Diphenoxylate A measurement of the diphenoxylate in a biological specimen. Diphenoxylate Measurement Dipipanone A measurement of the dipipanone in a biological specimen. Dipipanone Measurement Conjugated Bilirubin + Albumin-Bound Bilirubin Conjugated Bilirubin + Delta Bilirubin Direct Bilirubin A measurement of the glucuronidated bilirubin and albumin-bound bilirubin in a biological specimen. Direct Bilirubin Measurement Direct Bilirubin/Bilirubin A relative measurement (ratio or percentage) of the direct bilirubin to total bilirubin in a biological specimen. Direct Bilirubin to Bilirubin Ratio Measurement DNA Fragmentation Index A measurement of the deoxyribonucleic acid fragmentation within the nucleated cells of a biological specimen. DNA Fragmentation Index Dohle Bodies A measurement of the Dohle bodies (blue-gray, basophilic, leukocyte inclusions located in the peripheral cytoplasm of neutrophils) in a biological specimen. Dohle Body Measurement Dopamine Excretion Rate A measurement of the amount of dopamine being excreted in a biological specimen over a defined amount of time (e.g. one hour). Dopamine Excretion Rate Dopamine A measurement of the dopamine hormone in a biological specimen. Dopamine Measurement Doxepin and/or Metabolites A measurement of the doxepin and/or its metabolite(s) present in a biological specimen, for an assay that can measure both doxepin and its metabolites. Doxepin And/Or Metabolites Measurement Doxepin A measurement of the doxepin present in a biological specimen. Doxepin Measurement Dromostanolone Drostanolone Medrosteron Medrotestron Metholone A measurement of the drostanolone in a biological specimen. Drostanolone Measurement Drug Crystals A measurement of the drug crystals in a biological specimen. Drug Crystal Measurement Drug Screen An indication of the presence or absence of recreational drugs or drugs of abuse in a biological specimen. Drug Test dRVVT Screen to Confirm Pct Difference dRVVT Screen to Confirm Percent Difference A measurement to confirm the presence of Lupus anticoagulants, calculated as [(Screen dRVVT - Confirm dRVVT)/Screen dRVVT]x100. dRVVT Screen to Confirm Percent Difference DRVVT Screen to Confirm Ratio A relative measurement (ratio) of the dilute Russell's viper venom time without the presence of excess phospholipid to the dRVVT in the presence of excess phospholipid. Dilute Russell's Viper Venom Time to Confirm Ratio Measurement DTPA Clearance A measurement of the volume of serum or plasma that would be cleared of Diethylenetriamine pentaacetate (DTPA) by excretion of urine for a specified unit of time (e.g. one minute). Diethylene Triamine Pentaacetic Acid Clearance DU-PAN-2 Duke Pancreatic Monoclonal Antigen Type 2 DUPAN-2 A measurement of the DU-PAN-2 antigen in a biological specimen. Duke Pancreatic Monoclonal Antigen Type 2 Measurement Duloxetine A measurement of the duloxetine in a biological specimen. Duloxetine Measurement Dysmorphic Erythrocytes A measurement of the dysmorphic erythrocytes in a biological specimen. Dysmorphic Erythrocyte Count Dysmorphic Erythrocytes/Erythrocytes A measurement (ratio or percentage) of dysmorphic erythrocytes to total erythrocytes in a biological specimen. Dysmorphic Erythrocytes to Erythrocytes Ratio Measurement Dystrophin Actual/Control Dystrophin Actual/Normal A relative measurement (ratio or percentage) of the dystrophin in a subject's specimen when compared to a control specimen. Dystrophin Actual to Control Ratio Measurement Dystrophin A measurement of the total dystrophin in a biological specimen. Dystrophin Measurement E-Selectin A measurement of total E-selectin in a biological specimen. E-selectin Measurement E3 Ubiquitin-Protein Ligase TRIM33 Tripartite Motif Containing 33 A measurement of the E3 ubiquitin-protein ligase TRIM33 in a biological specimen. E3 Ubiquitin-Protein Ligase TRIM33 Measurement Ecarin Clotting Time A measurement of the activity of thrombin inhibitors in a biological specimen based on the generation of meizothrombin. Ecarin Clotting Time Measurement Eccentrocytes A measurement of the eccentrocytes (erythrocytes in which the hemoglobin is localized to a particular portion of the cell, noticeable as localized staining) in a biological specimen. Eccentrocyte Count 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine EDDP A measurement of the methadone metabolite 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine present in a biological specimen. EDDP Measurement EDTA Clearance A measurement of the volume of serum or plasma that would be cleared of Ethylenediamine tetraacetic acid (EDTA) by excretion of urine for a specified unit of time (e.g. one minute). EDTA Clearance Elastin A measurement of the elastin in a biological specimen. Elastin Measurement Elliptocytes A measurement of the elliptocytes (elliptically shaped cell with blunt ends and a long axis twice the length of its short axis) in a biological specimen. Elliptocyte Count Elongator Acetyltransferase Complex Sub3 Elongator Acetyltransferase Complex Subunit 3 ELP-3 Protein Lysine Acetyltransferase ELP3 Proteinase-3 Degraded Elastin TRNA Uridine(34) Acetyltransferase A measurement of the elongator acetyltransferase complex subunit 3 in a biological specimen. Elongator Acetyltransferase Complex Subunit 3 Measurement Endogenous Thrombin Potential A measurement of the total concentration of thrombin generated in the presence of a substrate in a plasma or blood sample. Endogenous Thrombin Potential Measurement Collagen Type XVIII Alpha 1 Chain Endostatin A measurement of the endostatin in a biological specimen. Endostatin Measurement Endothelin-1 A measurement of the endothelin-1 in a biological specimen. Endothelin-1 Measurement Endothelin-3 ET-3 A measurement of the endothelin-3 in a biological specimen. Endothelin-3 Measurement Eosinophil Cationic Protein Ribonuclease A Family Member 3 RNase 3 A measurement of the eosinophil cationic protein in a biological specimen. Eosinophil Cationic Protein Measurement Eosinophil Protein-X Eosinophil-Derived Neurotoxin RAF3 Ribonuclease A Family Member 2 A measurement of the eosinophil-derived neurotoxin in a biological specimen. Eosinophil-Derived Neurotoxin Measurement Eosinophilic Metamyelocytes A measurement of the eosinphilic metamyelocytes in a biological specimen. Eosinophilic Metamyelocyte Count Eosinophilic Myelocytes A measurement of the eosinophilic myelocytes in a biological specimen. Eosinophilic Myelocyte Count Eosinophilic Myelocytes/Lymphocytes A relative measurement (ratio or percentage) of the eosinophilic myelocytes to lymphocytes in a biological specimen (for example a bone marrow specimen). Eosinophilic Myelocytes to Lymphocytes Ratio Measurement Eosinophils Band Form A measurement of the banded eosinophils in a biological specimen. Eosinophil Band Form Count Eosinophils Band Form/Leukocytes A relative measurement (ratio or percentage) of the banded eosinophils to leukocytes in a biological specimen. Eosinophil Band Form to Leukocyte Ratio Eosinophils A measurement of the eosinophils in a biological specimen. Eosinophil Count Eosinophils, Segmented A measurement of the segmented eosinophils in a biological specimen. Segmented Eosinophil Count Eosinophils/Leukocytes A relative measurement (ratio or percentage) of the eosinophils to leukocytes in a biological specimen. Eosinophil to Leukocyte Ratio Eosinophils/Non-Squam Epi Cells A relative measurement (ratio or percentage) of the eosinophils to non-squamous epithelial cells in a biological specimen. Eosinophils to Non-Squamous Epithelial Cells Ratio Measurement Eosinophils/Total Cells A relative measurement (ratio or percentage) of the eosinophils to total cells in a biological specimen (for example a bone marrow specimen). Eosinophils to Total Cell Ratio Measurement Chemokine Ligand 11 Eotaxin-1 A measurement of the eotaxin-1 in a biological specimen. Eotaxin-1 Measurement Chemokine Ligand 24 Eotaxin-2 A measurement of the eotaxin-2 in a biological specimen. Eotaxin-2 Measurement CCL26 Chemokine (C-C Motif) Ligand 26 Chemokine Ligand 26 Eotaxin-3 A measurement of the eotaxin-3 in a biological specimen. Eotaxin-3 Measurement Ephedrine A measurement of the ephedrine in a biological specimen. Ephedrine Measurement Epi Cells/Non-Squam Epi Cells A relative measurement (ratio or percentage) of the epithelial cells to non-squamous epithelial cells in a biological specimen. Epithelial Cells to Non-Squamous Epithelial Cells Ratio Measurement Epidermal Growth Factor Receptor ERBB1 HER1 A measurement of the epidermal growth factor receptor in a biological specimen. Epidermal Growth Factor Receptor Measurement Epidermal Growth Factor Receptor, Free A measurement of the free (unbound) epidermal growth factor receptor in a biological specimen. Free Epidermal Growth Factor Receptor Measurement Epidermal Growth Factor A measurement of the epidermal growth factor in a biological specimen. Epidermal Growth Factor Measurement Epimerized Ursodeoxycholate Epimerized Ursodeoxycholic Acid A measurement of the epimerized ursodeoxycholate in a biological specimen. Epimerized Ursodeoxycholate Measurement Epinephrine Excretion Rate A measurement of the amount of epinephrine being excreted in a biological specimen over a defined amount of time (e.g. one hour). Epinephrine Excretion Rate Adrenaline Epinephrine A measurement of the epinephrine hormone in a biological specimen. Epinephrine Measurement Epiregulin EPR A measurement of the epiregulin in a biological specimen. Epiregulin Measurement Epith Neutrophil-Activating Peptide 78 A measurement of the epithelial neutrophil-activating peptide in a biological specimen. Epithelial Neutrophil-Activating Peptide 78 Measurement Epithelial Casts A measurement of the epithelial cell casts present in a biological specimen. Epithelial-Cast Measurement Epithelial Cell Clumps A measurement of the epithelial cell clumps in a biological specimen. Epithelial Cell Clumps Measurement Epithelial Cells A measurement of the epithelial cells in a biological specimen. Epithelial Cell Count Epithelial Cells/Total Cells A relative measurement (ratio or percentage) of the epithelial cells to total cells in a biological specimen. Epithelial Cells to Total Cells Ratio Measurement BRESI1 Epithelial Stromal Interaction Protein 1 A measurement of the epithelial stromal interaction protein 1 in a biological specimen. Epithelial Stromal Interaction 1 Measurement Ery. Mean Corpuscular Hemoglobin A measurement of the mean amount of hemoglobin per erythrocyte in a biological specimen, calculated as the product of hemoglobin times ten, divided by the number of erythrocytes. Erythrocyte Mean Corpuscular Hemoglobin Ery. Mean Corpuscular HGB Concentration An indirect measurement of the average concentration of hemoglobin per erythrocyte in a biological specimen, calculated as the ratio of hemoglobin to hematocrit. Erythrocyte Mean Corpuscular Hemoglobin Concentration Ery. Mean Corpuscular Volume Erythrocytes Mean Corpuscular Volume RBC Mean Corpuscular Volume A measurement of the mean cellular volume per erythrocyte in a biological specimen. Erythrocyte Mean Corpuscular Volume Autoagglutination Erythrocyte Agglutination RBC Agglutination A measurement of the erythrocyte agglutination in a biological specimen. Erythrocyte Agglutination Measurement Erythrocyte Cell Clumps RBC Aggregates RBC Clumps Red Blood Cell Clumps A measurement of red blood cell clumps in a biological specimen. Erythrocyte Cell Clumps Measurement Erythrocyte Cell Morphology RBC Morphology Red Blood Cell Morphology An examination or assessment of the form and structure of red blood cells. Erythrocyte Cell Morphology Erythrocyte Deformability An assessment of a red blood cell's ability to adapt its shape to dynamically changing flow conditions, thus minimizing resistance to flow. Erythrocyte Deformability Measurement Erythrocyte Fragment RBC Fragment A measurement of the red blood cell fragments (red cell fragments that have a reticular-like shape with rounded ends and no spicules, differentiating them from schistocytes and acanthocytes) in a biological specimen. Erythrocyte Fragment Measurement Erythrocyte Ghosts RBC Ghosts A measurement of the erythrocyte ghosts (erythrocytes in which hemoglobin has been removed through hemolysis) in a biological specimen. Erythrocyte Ghost Count Erythrocyte Inclusion Bodies A measurement of the erythrocyte inclusion bodies in a biological specimen. Erythrocyte Inclusion Bodies Measurement Erythrocyte Membrane Rigidity An assessment of the rigidity of the membrane of erythrocytes in a biological specimen. Erythrocyte Membrane Rigidity Measurement Erythrocyte Protoporphyrin, Free A measurement of the free erythrocyte protoporphyrin (zinc bound plus unbound protoporphyrin) in a biological specimen. Free Erythrocyte Protoporphyrin Measurement Biernacki Reaction Erythrocyte Sedimentation Rate The distance (e.g. millimeters) that red blood cells settle in unclotted blood over a specified unit of time (e.g. one hour). Erythrocyte Sedimentation Rate Measurement Erythrocytes Distribution Width RDW-CV Red Blood Cell Distribution Width Red Cell Volume Distribution Width A relative measurement (ratio or percentage) of the standard deviation of the red blood cell volume to the mean distribution of the red blood cell volume in a biological specimen. Erythrocyte Distribution Width Measurement Erythrocytes Red Blood Cells A measurement of the total erythrocytes in a biological specimen. Erythrocyte Count Erythroferrone A measurement of the erythroferrone in a biological specimen. Erythroferrone Measurement Erythroid Cells A measurement of the erythroid cells in a biological specimen. Erythroid Cell Count Erythroid Cells/Nucleated Cells A relative measurement (ratio or percentage) of the erythroid cells to total nucleated cells in a biological specimen. Erythroid Cells to Nucleated Cells Ratio Measurement Erythroid Cells/Total Cells A relative measurement (ratio or percentage) of the erythroid cells to total cells (total nucleated cells + erythrocytes + reticulocytes) in a biological specimen. Erythroid Cells to Total Cells Ratio Measurement Erythroid Maturation Index A relative measurement (ratio) of the sum of erythroid maturation phase cells (pool) to the sum of erythroid proliferative phase cells (pool) in a biological specimen. Erythroid Maturation Index Erythroid Maturation Pool A measurement of the erythroid maturation phase cells (polychromatic rubricytes, normochromic rubricytes, and metarubricytes) in a biological specimen. Erythroid Maturation Pool Count Erythroid Precursor Cells Erythroid Precursors A measurement of the erythroid precursors in a biological specimen. Erythroid Precursor Cell Count Erythroid Precursor Cells/Total Cells Erythroid Precursors/Total Cells A relative measurement (ratio or percentage) of the erythroid precursors to total cells in a biological specimen. Erythroid Precursor Cells to Total Cells Ratio Measurement Erythroid Proliferation Index A relative measurement (ratio) of the sum of erythroid proliferative phase cells (pool) to the sum of erythroid maturation phase cells (pool) in a biological specimen. Erythroid Proliferation Index Erythroid Proliferation Pool A measurement of the erythroid proliferative phase cells (rubriblasts, prorubricytes, and basophilic rubricytes) in a biological specimen. Erythroid Proliferation Pool Count Erythropoietin Hematopoietin A measurement of the erythropoietin hormone in a biological specimen. Erythropoietin Measurement Escitalopram A measurement of the escitalopram in a biological specimen. Escitalopram Measurement Estazolam A measurement of the estazolam in a biological specimen. Estazolam Measurement Estradiol Oestradiol A measurement of the estradiol in a biological specimen. Estradiol Measurement Estradiol, Free A measurement of the unbound estradiol in a biological specimen. Free Estradiol Measurement Estradiol, Free/Estradiol A relative measurement (ratio or percentage) of unbound estradiol to total estradiol in a biological specimen. Free Estradiol to Estradiol Ratio Measurement Estriol Oestriol A measurement of the estriol hormone in a biological specimen. Estriol Measurement Estriol, Free Unconjugated Estriol A measurement of the free estriol in a biological specimen. Free Estriol Measurement ER ESR Estrogen Receptor Oestrogen Receptor A measurement of estrogen receptor protein in a biological specimen. Estrogen Receptor Measurement Estrogen Oestrogen A measurement of the estrogen hormone in a biological specimen. Estrogen Measurement E1S Estrone 3-Sulfate Estrone Sulfate A measurement of the estrone sulfate in a biological specimen. Estrone Sulfate Measurement Estrone Oestrone A measurement of the estrone hormone in a biological specimen. Estrone Measurement Alcohol Ethanol A measurement of the ethanol present in a biological specimen. Ethanol Measurement Ethchlorvynol A measurement of the ethchlorvynol in a biological specimen. Ethchlorvynol Measurement Ethinamate A measurement of the ethinamate in a biological specimen. Ethinamate Measurement Ethyl Glucuronide Ethyl Sulfate A measurement of the ethyl glucuronide and/or ethyl sulfate in a biological specimen. Ethyl Glucuronide And Ethyl Sulfate Measurement Ethyl Glucuronide A measurement of the ethyl glucuronide in a biological specimen. Ethyl Glucuronide Measurement Ethyl Sulfate A measurement of the ethyl sulfate in a biological specimen. Ethyl Sulfate Measurement Ethylamphetamine Etilamfetamine N-Ethylamphetamine A measurement of the ethylamphetamine in a biological specimen. Ethylamphetamine Measurement Ethylestrenol A measurement of the ethylestrenol in a biological specimen. Ethylestrenol Measurement Ethylmorphine A measurement of the ethylmorphine in a biological specimen. Ethylmorphine Measurement Endogenous Thrombin Potential Area Under Curve ETP Area Under Curve A measurement of the area under the thrombin generation curve. Endogenous Thrombin Potential Area Under Curve Measurement Endogenous Thrombin Potential Lag Time Relative ETP Lag Time Relative A relative measurement (ratio or percentage) of time from the start of the thrombin generation test to the point where a predetermined amount of thrombin is generated. Endogenous Thrombin Potential Lag Time Relative Measurement Endogenous Thrombin Potential Lag Time ETP Lag Time A measurement of time from the start of the thrombin generation test to the point where a predetermined amount of thrombin is generated. Endogenous Thrombin Potential Lag Time Measurement Endogenous Thrombin Potential Peak Height Relative ETP Peak Height Relative A relative (ratio or percentage) of the maximum concentration of thrombin generated during a thrombin generation test. Endogenous Thrombin Potential Peak Height Relative Measurement Endogenous Thrombin Potential Peak Height ETP Peak Height A measurement of the maximum concentration of thrombin generated during a thrombin generation test. Endogenous Thrombin Potential Peak Height Measurement Endogenous Thrombin Potential Time to Peak Relative ETP Time to Peak Relative A relative (ratio or percentage) measurement of the time it takes to generate the maximum concentration of thrombin. Endogenous Thrombin Potential Time to Peak Relative Measurement Endogenous Thrombin Potential Time to Peak ETP Time to Peak A measurement of the time it takes to generate the maximum concentration of thrombin. Endogenous Thrombin Potential Time to Peak Measurement Extracell Newly Ident RAGE Bind Protein S100 Calcium Binding Protein A12 A measurement of the extracellular newly identified RAGE (receptor for advanced glycation end products) binding protein in a biological specimen. Extracell Newly Ident RAGE Bind Protein Measurement Ezogabine A measurement of the ezogabine in a biological specimen. Ezogabine Measurement F2-Isoprostane A measurement of the F2-isoprostane in a biological specimen. F2 Isoprostane Measurement Factor II Prothrombin A measurement of the coagulation factor II in a biological specimen. Prothrombin Measurement Factor III Soluble CD142 Tissue Factor, CD142 A measurement of the coagulation factor III in a biological specimen. Factor III Measurement Factor IX Activity Actual/Control Factor IX Activity Actual/Factor IX Activity Control Factor IX Activity Actual/Normal A relative measurement (ratio or percentage) of the biological activity of factor IX dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. Factor IX Activity Actual to Control Ratio Measurement Christmas Factor Activity Factor IX Activity A measurement of the biological activity of coagulation factor IX in a biological specimen. Factor IX Activity Measurement Christmas Factor Factor IX A measurement of the coagulation factor IX in a biological specimen. Factor IX Measurement Factor V Activity Actual/Control Factor V Activity Actual/Factor V Activity Control Factor V Activity Actual/Normal A relative measurement (ratio or percentage) of the biological activity of factor V dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. Factor V Activity Actual to Control Ratio Measurement Factor V Activity Labile Factor Activity A measurement of the biological activity of coagulation factor V in a biological specimen. Factor V Activity Measurement Factor V Leiden A measurement of the coagulation factor V Leiden in a biological specimen. Factor V Leiden Measurement Factor V Labile Factor A measurement of the coagulation factor V in a biological specimen. Factor V Measurement Factor VII Activity Actual/Control Factor VII Activity Actual/Factor VII Activity Control Factor VII Activity Actual/Normal A relative measurement (ratio or percentage) of the biological activity of factor VII dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. Factor VII Activity Actual to Control Ratio Measurement Factor VII Activity Proconvertin Activity Stable Factor Activity A measurement of the biological activity of coagulation factor VII in a biological specimen. Factor VII Activity Measurement Factor VII Proconvertin Stable Factor A measurement of the coagulation factor VII in a biological specimen. Factor VII Measurement Factor VIIa Activity A measurement of the biological activity of coagulation factor VIIa in a biological specimen. Factor VIIa Activity Measurement Factor VIII Activity Actual/Control Factor VIII Activity Actual/Factor VIII Activity Control Factor VIII Activity Actual/Normal A relative measurement (ratio or percentage) of the biological activity of factor VIII dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. Factor VIII Activity Actual to Control Ratio Measurement Anti-hemophilic Factor Activity Factor VIII Activity Factor VIII:C A measurement of the biological activity of coagulation factor VIII in a biological specimen. Factor VIII Activity Measurement Anti-hemophilic Factor Factor VIII A measurement of the coagulation factor VIII in a biological specimen. Factor VIII Measurement Factor X Activity Actual/Control Factor X Activity Actual/Factor X Activity Control Factor X Activity Actual/Normal A relative measurement (ratio or percentage) of the biological activity of factor X dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. Factor X Activity Actual/Control Ratio Measurement Factor X Activity A measurement of the biological activity of coagulation factor X in a biological specimen. Factor X Activity Measurement Factor X Actual/Control Factor X Actual/Normal A relative measurement (ratio or percentage) of the factor X in a subject's specimen when compared to a control specimen. Factor X Actual to Control Ratio Measurement Factor X A measurement of the coagulation factor X in a biological specimen. Factor X Measurement Factor XI Activity Factor XIa Activity A measurement of the biological activity of coagulation factor XI in a biological specimen. Factor XI Activity Measurement Factor XI A measurement of the factor XI in a biological specimen. Factor XI Measurement Factor XII Activity A measurement of the biological activity of coagulation factor XII in a biological specimen. Factor XII Activity Measurement Factor XII A measurement of the factor XII in a biological specimen. Factor XII Measurement Factor XIII Activity A measurement of the biological activity of coagulation factor XIII in a biological specimen. Factor XIII Activity Measurement Factor XIII Fibrin Stabilizing Factor A measurement of the coagulation factor XIII in a biological specimen. Factor XIII Measurement Factor XIV Activity Actual/Control Factor XIV Activity Actual/Factor XIV Activity Control Factor XIV Activity Actual/Normal Protein C Activity Actual/Control A relative measurement (ratio or percentage) of the biological activity of factor XIV dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. Factor XIV Activity Actual to Control Ratio Measurement Factor XIV Activity Protein C Activity Protein C Function A measurement of the biological activity of coagulation factor XIV in a biological specimen. Factor XIV Activity Measurement Factor XIV Actual/Control Protein C Actual/Control A relative measurement (ratio or percentage) of the factor XIV in a subject's specimen when compared to a control specimen. Factor XIV Actual to Control Ratio Measurement Autoprothrombin IIA Factor XIV Protein C Protein C Antigen Protein C, Inactivator of Coagulation Factors Va and VIIIa A measurement of the coagulation factor XIV in a biological specimen. Factor XIV Measurement ALPS1A APT1 Fas Cell Surface Death Receptor FAS1 FASTM Soluble CD95 TNF Receptor Superfamily Member 6 TNFRSF6 A measurement of the Fas cell surface death receptor in a biological specimen. Fas Cell Surface Death Receptor Measurement Fas Ligand Soluble CD178 Soluble CD95L Tumor Necrosis Factor Ligand Superfamily Member 6 A measurement of the Fas ligand in a biological specimen. Fas Ligand Measurement Fat Bodies, Oval A measurement of the oval-shaped fat bodies, usually renal proximal tubular cells with lipid aggregates in the cytoplasm, in a biological specimen. Oval Fat Body Measurement Fat Droplet A measurement of the triglyceride aggregates within a biological specimen. Fat Droplet Measurement Fat A measurement of the fat in a biological specimen. Fat Measurement Fat/Total Solids A relative measurement (ratio or percentage) of the fat to total solid material in a biological specimen (for example a stool specimen). Fats to Total Solids Ratio Measurement FABP1 Fatty Acid Binding Protein 1 L-FABP L-Type Fatty Acid-Binding Protein Liver Fatty Acid-Binding Protein A measurement of the fatty acid binding protein 1 in a biological specimen. Fatty Acid Binding Protein 1 Measurement FABP-11 Fatty Acid Binding Protein 3 Fatty Acid Binding Protein 3, Muscle And Heart Fatty Acid Binding Protein, Heart H-FABP Heart-Type Fatty Acid-Binding Protein M-FABP A measurement of the fatty acid binding protein 3 in a biological specimen. Fatty Acid Binding Protein 3 Measurement A-FABP Adipocyte-Type Fatty Acid-Binding Protein Fatty Acid Binding Protein 4 Fatty Acid-Binding Protein, Adipocyte A measurement of the fatty acid binding protein 4 in a biological specimen. Fatty Acid Binding Protein 4 Measurement Fatty Acids, Very Long Chain A measurement of the very long chain fatty acids (containing 22 or more carbon atoms) in a biological specimen. Very Long Chain Fatty Acids Measurement Fatty Casts A measurement of the fatty casts present in a biological specimen. Fatty Cast Measurement Fatty Liver Index FLI A calculation that indicates the likely presence of fatty liver disease, taking into account waist circumference, body mass index, triglyceride concentrations, and gamma-glutamyltransferase activity. (Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006 Nov 2;6:33.) Fatty Liver Index Fencamfamin Fencamfamine A measurement of the fencamfamin in a biological specimen. Fencamfamin Measurement Fenfluramine A measurement of the fenfluramine in a biological specimen. Fenfluramine Measurement Fenproporex A measurement of the fenproporex in a biological specimen. Fenproporex Measurement Fentanyl A measurement of the fentanyl in a biological specimen. Fentanyl Measurement Apoferritin Ferritin Heavy Chain FTH FTH1 A measurement of the ferritin heavy chain in a biological specimen. Ferritin Heavy Chain Measurement Ferritin Light Chain FTL L Apoferritin A measurement of the ferritin light chain in a biological specimen. Ferritin Light Chain Measurement Ferritin A measurement of the ferritin in a biological specimen. Ferritin Measurement Fibrin Degradation Products A measurement of the fibrin degradation products in a biological specimen. Fibrin Degradation Products Measurement Fibrin Monomer Soluble Fibrin Monomer A measurement of the fibrin monomer in a biological specimen. Fibrin Monomer Measurement Fibrinogen Fibrinogen Antigen A measurement of the total fibrinogen (functional and non-functional) in a biological specimen. Fibrinogen Measurement Fibrinogen, Functional A measurement of the functional fibrinogen (fibrinogen that is capable of being converted to fibrin) in a biological specimen. Functional Fibrinogen Measurement FGF 19 Fibroblast Growth Factor 19 A measurement of the fibroblast growth factor 19 in a biological specimen. Fibroblast Growth Factor 19 Measurement FGF 21 Fibroblast Growth Factor 21 A measurement of the fibroblast growth factor 21 in a biological specimen. Fibroblast Growth Factor 21 Measurement Fibroblast Growth Factor 23 Phosphatonin A measurement of the total fibroblast growth factor 23 in a biological specimen. Fibroblast Growth Factor 23 Measurement Fibroblast Growth Factor 23, C-Terminal A measurement of the C-terminal fibroblast growth factor 23 in a biological specimen. C-Terminal Fibroblast Growth Factor 23 Measurement Fibroblast Growth Factor 23, Intact A measurement of the intact fibroblast growth factor 23 in a biological specimen. Intact Fibroblast Growth Factor 23 Measurement FGF 9 Fibroblast Growth Factor 9 A measurement of the fibroblast growth factor 9 in a biological specimen. Fibroblast Growth Factor 9 Measurement FGF2 Fibroblast Growth Factor Basic Form A measurement of the basic form of fibroblast growth factor in a biological specimen. Fibroblast Growth Factor Basic Form Measurement Fibronectin, Cellular Insoluble Fibronectin A measurement of the cellular fibronectin in a biological specimen. Cellular Fibronectin Measurement Fibronectin, Fetal A measurement of the fetal isoform of fibronectin in a biological specimen Fetal Fibronectin Test Fibronectin, Maternal + Fetal A measurement of the maternal plasma fibronectin and fetal fibronectin in a biological specimen. Maternal and Fetal Fibronectin Measurement Fibronectin, Plasma Soluble Fibronectin A measurement of the plasma fibronectin in a biological specimen. Plasma Fibronectin Measurement FIB4 Fibrosis-4 Index A scoring system that evaluates liver pathology through the assessment of multiple blood test parameters, taking into account age, alanine aminotransferase, aspartate aminotransferase, and platelet count. Fibrosis-4 Score FibroSURE Score FibroTest Score A biomarker test that measures liver pathology through the assessment of a six-parameter blood test (for Alpha-2-macroglobulin, Haptoglobin, Apolipoprotein A1, Gamma-glutamyl transpeptidase (GGT), Total bilirubin, and Alanine aminotransferase (ALT)), taking into account the age and sex of the patient. FibroTest Score Measurement FCN3 Ficolin-3 A measurement of the ficolin-3 in a biological specimen. Ficolin-3 Measurement Fluid Output A measurement of the total volume of fluid discharged over a set period of time. Fluid Output Fluid Output, Estimated An estimate of the total volume of fluid discharged over a set period of time. Estimated Fluid Output Flunitrazepam and/or Metabolites A measurement of the flunitrazepam and/or its metabolite(s) present in a biological specimen, for an assay that can measure both flunitrazepam and its metabolites. Flunitrazepam and/or Metabolites Measurement Flunitrazepam A measurement of the flunitrazepam present in a biological specimen. Flunitrazepam Measurement Fluoride A measurement of the fluoride in a biological specimen. Fluoride Measurement Fluoxetine A measurement of the fluoxetine drug present in a biological specimen. Fluoxetine Measurement Fluoxymesterone A measurement of the fluoxymesterone in a biological specimen. Fluoxymesterone Measurement Fluphenazine A measurement of the fluphenazine in a biological specimen. Fluphenazine Measurement Flurazepam and/or Metabolites A measurement of the flurazepam and/or its metabolite(s) present in a biological specimen, for an assay that can measure both flurazepam and its metabolites. Flurazepam and/or Metabolites Measurement Flurazepam A measurement of the flurazepam present in a biological specimen. Flurazepam Measurement Fluvoxamine A measurement of the fluvoxamine present in a biological specimen. Fluvoxamine Measurement FMS-like Receptor Tyrosine Kinase 3 Soluble CD135 A measurement of the FMS-like receptor tyrosine kinase 3 in a biological specimen. FMS-like Receptor Tyrosine Kinase 3 Measurement FMS-like Tyrosine Kinase 3 Ligand A measurement of the FMS-like tyrosine kinase 3 ligand in a biological specimen. FMS-like Tyrosine Kinase 3 Ligand Measurement Folate Hydrolase mRNA A measurement of the folate hydrolase mRNA in a biological specimen. Folate Hydrolase mRNA Measurement Follicle Stimulating Hormone A measurement of the follicle stimulating hormone (FSH) in a biological specimen. Follicle Stimulating Hormone Measurement Formaldehyde Formic Aldehyde Methanal A measurement of the formaldehyde in a specimen. Formaldehyde Measurement Fraction of Inspired Oxygen A measurement of the volumetric fraction of oxygen in the inhaled gas. Fraction of Inspired Oxygen Fractional Calcium Excretion A measurement of the fractional excretion of calcium that is computed based upon the concentrations of calcium and creatinine in both blood and urine. Fractional Excretion of Calcium Fractional Chloride Excretion A measurement of the fractional excretion of chloride that is computed based upon the concentrations of chloride and creatinine in both blood and urine. Fractional Excretion of Chloride Fractional Iron Absorption A relative measurement (ratio or percentage) of the iron absorbed into tissue or cells to the total available iron. Fractional Iron Absorption Fractional Magnesium Excretion A measurement of the fractional excretion of magnesium that is computed based upon the concentrations of magnesium and creatinine in both blood and urine. Fractional Excretion of Magnesium Fractional Inorganic Phosphate Excretion Fractional Phosphorus Excretion A measurement of the fractional excretion of phosphorus that is computed based upon the concentrations of phosphorus and creatinine in both blood and urine. Fractional Excretion of Phosphate Fractional Potassium Excretion A measurement of the fractional excretion of potassium that is computed based upon the concentrations of potassium and creatinine in both blood and urine. Fractional Excretion of Potassium Fractional Sodium Excretion A measurement of the fractional excretion of sodium that is computed based upon the concentrations of sodium and creatinine in both blood and urine. Fractional Excretion of Sodium Free Androgen Index A measurement of the androgen status in a biological specimen. This is calculated by a mathematical formula that takes into account the total testosterone level, sex hormone binding globulin, and a constant. Free Androgen Index Free Fatty Acid Non-Esterified Fatty Acid, Free A measurement of the total non-esterified fatty acids in a biological specimen. Non-esterified Fatty Acids Measurement Free Fatty Acid, Saturated Non-esterified Fatty Acid, Saturated A measurement of the saturated non-esterified fatty acids in a biological specimen. Saturated Non-esterified Fatty Acids Measurement Free Fatty Acid, Unsaturated Non-esterified Fatty Acid, Unsaturated A measurement of the unsaturated non-esterified fatty acids in a biological specimen. Unsaturated Non-esterified Fatty Acids Measurement Free Glycerin Free Glycerol A measurement of the amount of unbound glycerol in a biological specimen. Free Glycerol Measurement Fructosamine Corrected for Total Protein A measurement of fructosamine, which has been corrected for total protein, in a biological specimen. Fructosamine Corrected for Total Protein Measurement Fructosamine Glycated Serum Protein A measurement of the fructosamine in a biological specimen. Fructosamine Measurement Fructose A measurement of the fructose in a biological specimen. Fructose Measurement Fungi Fungus A measurement of the fungi in a biological specimen. Fungi Measurement Fungi, Filamentous A measurement of the filamentous fungi in a biological specimen. Filamentous Fungi Count Fungi, Yeast-Like A measurement of the yeast-like fungi in a biological specimen. Yeast-Like Fungi Count Furanyl Fentanyl Furanylfentanyl A measurement of the furanylfentanyl in a biological specimen. Furanylfentanyl Measurement Furazabol A measurement of the furazabol in a biological specimen. Furazabol Measurement G6PD-Deficient Erythrocytes A measurement of the glucose-6-phosphate dehydrogenase deficient erythrocytes in a biological specimen. G6PD-Deficient Erythrocytes Count G6PD-Deficient Erythrocytes/Erythrocytes A relative measurement (ratio or percentage) of G6PD-deficient erythrocytes to total erythrocytes in a biological specimen. G6PD-Deficient Erythrocytes to Erythrocytes Ratio Measurement Galactose Elimination Capacity A liver function test that measures galactose elimination capacity in a biological specimen. Galactose Elimination Capacity Galactose Mutarotase A measurement of the galactose mutarotase in a biological specimen. Galactose Mutarotase Measurement Galactose A measurement of the galactose in a biological specimen. Galactose Measurement G1PUT Galactose 1 Phosphate Uridyl Transferase Galactose-1-Phos Uridylyltransferase Galactose-1-Phosphate Uridylyltransferase GALT A measurement of the galactose-1-phosphate uridyltransferase in a biological specimen. Galactose-1-Phosphate Uridyltransferase Measurement Galactose-1-Phosphate A measurement of the galactose-1-phosphate in a biological specimen. Galactose-1-Phosphate Measurement Galactose-Deficient IgA1 Gd-IgA1 A measurement of the galactose-deficient IgA1 in a biological specimen. Galactose-Deficient IgA1 Measurement Galanin A measurement of the galanin in a biological specimen. Galanin Measurement Galectin-3 Binding Protein LGALS3BP M2BP Mac-2 Binding Protein A measurement of the galectin-3 binding protein in a biological specimen. Galectin-3 Binding Protein Measurement Galactose-Specific Lectin 3 Galectin-3 GALIG MAC-2 A measurement of the galectin-3 in a biological specimen. Galectin-3 Measurement Gamma Globulin A measurement of the proteins contributing to the gamma fraction in a biological specimen. Gamma Globulin Measurement Gamma Globulin/Total Protein A relative measurement (ratio or percentage) of gamma fraction proteins to total proteins in a biological specimen. Gamma Globulin to Total Protein Ratio Measurement Gamma Glutamyl Transferase A measurement of the gamma glutamyl transferase in a biological specimen. Gamma Glutamyl Transpeptidase Measurement Gamma Glutamyl Transferase/Creatinine A relative measurement (ratio or percentage) of the gamma glutamyl transferase to creatinine in a biological specimen. Gamma Glutamyl Transferase to Creatinine Ratio Measurement Gamma Tocopherol A measurement of the gamma tocopherol in a biological specimen. Gamma Tocopherol Measurement GABA Gamma-aminobutyrate Gamma-Aminobutyric Acid A measurement of the gamma-aminobutyric acid in a biological specimen. Gamma-Aminobutyric Acid Measurement 4-Hydroxybutanoic Acid Gamma-Hydroxybutyrate Gamma-Hydroxybutyric Acid A measurement of the gamma-hydroxybutyrate in a biological specimen. Gamma-Hydroxybutyrate Measurement Gamma Glutamyl Transferase Excretion Rate A measurement of the amount of gamma glutamyl transferase being excreted in a biological specimen over a defined amount of time (e.g. one hour). Gamma Glutamyl Transferase Excretion Rate Ganglioside GD2 Lipoform C16:0 A measurement of the ganglioside GD2 lipoform C16:0 in a biological specimen. Ganglioside GD2 Lipoform C16:0 Measurement Ganglioside GD2 Lipoform C18:0 A measurement of the ganglioside GD2 lipoform C18:0 in a biological specimen. Ganglioside GD2 Lipoform C18:0 Measurement Ganglioside GD2 Lipoform C20:0 A measurement of the ganglioside GD2 lipoform C20:0 in a biological specimen. Ganglioside GD2 Lipoform C20:0 Measurement Ganglioside GD2 Lipoform C22:0 A measurement of the ganglioside GD2 lipoform C22:0 in a biological specimen. Ganglioside GD2 Lipoform C22:0 Measurement Ganglioside GM3 Monosialodihexosylganglioside A measurement of the ganglioside GM3 in a biological specimen. Ganglioside GM3 Measurement Gastrin A measurement of the gastrin hormone in a biological specimen. Gastrin Measurement GFR from B-2 Microglobulin Adj for aBSA GFR from B-2 Microglobulin Adjusted for Actual BSA A direct measurement of the glomerular filtration rate (GFR) based on the clearance of beta-2 microglobulin after adjusting it for the individual's actual body surface area value. Glomerular Filtration Rate from B-2 Microglobulin Adjusted for Actual BSA Measurement GFR from B-2 Microglobulin Adj for BSA A direct measurement of the glomerular filtration rate (GFR) based on the clearance of beta-2 microglobulin after adjusting it for the standard body surface area value 1.73m2. Direct Glomerular Filtration Rate from Beta-2 Microglobulin Adjusted for Standard BSA Measurement GFR from Beta-Trace Protein Adj for aBSA GFR from Beta-Trace Protein Adjusted for Actual BSA A direct measurement of the glomerular filtration rate (GFR) based on the clearance of beta-trace protein after adjusting it for the individual's actual body surface area value. Glomerular Filtration Rate from Beta-Trace Protein Adjusted for Actual BSA Measurement GFR from Beta-Trace Protein Adj for BSA A direct measurement of the glomerular filtration rate (GFR) based on the clearance of beta-trace protein after adjusting it for the standard body surface area value 1.73m2. Direct Glomerular Filtration Rate from Beta-Trace Protein Adjusted for Standard BSA Measurement GFR from Creat and UreaN Adj aBSA GFR from Creatinine and Urea Nitrogen Adjusted for Actual BSA An estimation of the glomerular filtration rate adjusted for an individual's actual body surface area based on creatinine and urea nitrogen. Glomerular Filtration Rate from Creatinine and Urea Nitrogen Adjusted for Actual Body Surface Area Measurement GFR from Creat and UreaN Adj BSA GFR from Creatinine and Urea Nitrogen Adjusted for BSA An estimation of the glomerular filtration rate adjusted for standard body surface area (1.73m2) based on creatinine and urea nitrogen. Estimated Glomerular Filtration Rate from Creatinine and Urea Nitrogen Adjusted for Standard BSA GFR from Creat,UreaN,Alb Adj aBSA GFR from Creatinine, Urea Nitrogen and Albumin Adjusted for Actual BSA An estimation of the glomerular filtration rate adjusted for an individual's actual body surface area based on creatinine, urea nitrogen, and albumin. Glomerular Filtration Rate from Creatinine, Urea Nitrogen, and Albumin Adjusted for Actual Body Surface Area Measurement GFR from Creat,UreaN,Alb Adj BSA GFR from Creatinine, Urea Nitrogen and Albumin Adjusted for BSA An estimation of the glomerular filtration rate adjusted for standard body surface area (1.73m2) based on creatinine, urea nitrogen, and albumin. Estimated Glomerular Filtration Rate from Creatinine, Urea Nitrogen, and Albumin Adjusted for Standard BSA GFR from Creatinine Adjusted for aBSA GFR from Creatinine Adjusted for Actual BSA An estimation of the glomerular filtration rate adjusted for an individual's actual body surface area based on creatinine. Glomerular Filtration Rate from Creatinine Adjusted for Actual BSA GFR from Creatinine Adjusted for BSA An estimation of the glomerular filtration rate adjusted for standard body surface area (1.73m2) based on creatinine. Estimated Glomerular Filtration Rate from Creatinine Adjusted for Standard BSA GFR from Cystatin C Adjusted for aBSA GFR from Cystatin C Adjusted for Actual BSA An estimation of the glomerular filtration rate adjusted for an individual's actual body surface area based on cystatin C. Glomerular Filtration Rate from Cystatin C Adjusted for Actual BSA GFR from Cystatin C Adjusted for BSA An estimation of the glomerular filtration rate adjusted for standard body surface area (1.73m2) based on cystatin C. Estimated Glomerular Filtration Rate from Cystatin C Adjusted for Standard BSA GFR from Cystatin C and Creat Adj aBSA An estimation of the glomerular filtration rate adjusted for an individual's actual body surface area based on cystatin C and creatinine. Glomerular Filtration Rate from Cystatin C and Creatinine Adjusted for Actual BSA GFR from Cystatin C and Creat Adj BSA An estimation of the glomerular filtration rate adjusted for standard body surface area (1.73m2) based on cystatin C and creatinine. Estimated Glomeluar Filtration Rate from Cystatin C and Creatinine Adjusted for Standard BSA eGFR, Indexed Estimated Glomerular Filtration Rate Adj for 1.73m2 GFR, Estimated Indexed Indexed eGFR Indexed Estimated Glomerular Filtration Rate An estimated GFR (eGFR) that takes into account a standardized body surface area (BSA) value of 1.73m2. Indexed Estimated Glomerular Filtration Rate Absolute GFR De-Indexed eGFR eGFR, Non-Indexed Estimated Glomerular Filtration Rate Adj for BSA GFR, Estimated Non-Indexed Individual eGFR Non-Indexed eGFR Non-Indexed Estimated Glomerular Filtration Rate An estimated GFR (eGFR) that takes into account the individual's actual body surface area (BSA) value. Non-Indexed Estimated Glomerular Filtration Rate Ghrelin Growth Hormone Secretagogue Receptor Ligand Motilin-related Peptide Total Ghrelin A measurement of total ghrelin in a biological specimen. Ghrelin Measurement Giant Neutrophils A measurement of the giant neutrophils in a biological specimen. Giant Neutrophil Count Giant Platelets A measurement of the giant (larger than 7um in diameter) platelets in a biological specimen. Giant Platelet Count Glial Fibrillary Acidic Protein A measurement of the glial fibrillary acidic protein in a biological specimen. Glial Fibrillary Acidic Protein Measurement Glitter Cells A measurement of the glitter cells in a biological specimen. Glitter Cell Count Gb3 GL-3 GL3 Globotriaosylceramide sCD77 Soluble CD77 A measurement of the globotriaosylceramide in a biological specimen. Globotriaosylceramide Measurement Globotriaosylsphingosine Lyso-Gb3 Lyso-GL3 A measurement of the globotriaosylsphingosine in a biological specimen. Globotriaosylsphingosine Measurement Globulin A measurement of the globulin protein in a biological specimen. Globulin Protein Measurement Globulin/Creatinine A relative measurement (ratio or percentage) of the globulin to creatinine in a biological specimen. Globulin to Creatinine Ratio Measurement Glomerular Filtration Rate Adj for BSA A measurement of the glomerular filtration rate adjusted for body surface area. Glomerular Filtration Rate Adjusted for BSA Glomerular Filtration Rate A kidney function test that measures the fluid volume that is filtered from the kidney glomeruli to the Bowman's capsule per unit of time. Glomerular Filtration Rate eGFR Glomerular Filtration Rate, Estimated A kidney function test that estimates the fluid volume that is filtered from the kidney glomeruli to the Bowman's capsule per unit of time, which may or may not be indexed for body surface area. Estimated Glomerular Filtration Rate Glucagon A measurement of the glucagon hormone in a biological specimen. Glucagon Measurement Glucagon-Like Peptide-1 Total Glucagon-Like Peptide-1 A measurement of the total glucagon-like peptide-1 in a biological specimen. Glucagon-like Peptide-1 Measurement Glucagon-Like Peptide-1, Active Form A measurement of the active form of glucagon-like peptide-1 in a biological specimen. Active Glucagon-like Peptide-1 Measurement Glucagon-Like Peptide-1, Inactive Form A measurement of the inactive form of glucagon-like peptide-1 in a biological specimen. Inactive Glucagon-Like Peptide-1 Measurement Glucopsychosine Glucosylsphingosine Lyso-GL1 A measurement of the glucopsychosine in a biological specimen. Glucopsychosine Measurement Glucose Clearance A measurement of the volume of serum or plasma that would be cleared of glucose by excretion of urine for a specified unit of time (e.g. one minute). Glucose Clearance Measurement Glucose Excretion Rate A measurement of the amount of glucose being excreted in a biological specimen over a defined amount of time (e.g. one hour). Glucose Excretion Rate Glucose Management Indicator An approximate measure (expressed as a % or mmol/mol) of an individual's expected hemoglobin A1c/hemoglobin level, based on the mean glucose measured over a period of at least 10 days by continuous glucose monitoring. Glucose Management Indicator Glucose A measurement of the glucose in a biological specimen. Glucose Measurement EAG Estimated Average Glucose Glucose, Estimated Glucose, Estimated Average A computed estimate of the blood glucose based on the value of the glycated hemoglobin. Estimated Average Glucose Measurement Glucose, Enriched/Glucose Glucose, Radiolabeled/Glucose A relative measurement (ratio or percentage) of radiolabeled glucose to total glucose in a biological specimen. Radiolabeled Glucose to Glucose Ratio Measurement Glucose-6-Phosphate Dehydrogenase Act A measurement of the biological activity of glucose-6-phosphate dehydrogenase in a biological specimen. Glucose-6-Phosphate Dehydrogenase Activity Glucose-6-Phosphate Dehydrogenase A measurement of the glucose-6-phosphate dehydrogenase in a biological specimen. Glucose-6-Phosphate Dehydrogenase Measurement Glucose-dep Insulinotropic Pep, Intact Intact Gastric Inhibitory Polypeptide Intact GIP Intact Glucose-dependent Insulinotropic Peptide A measurement of the intact (containing amino acids 1-42) glucose-dependent insulinotropic peptide in a biological specimen. Intact Glucose-dependent Insulinotropic Peptide Measurement Glucose/Creatinine A relative measurement (ratio or percentage) of the glucose to creatinine in a biological specimen. Glucose to Creatinine Ratio Measurement Beta-Glucocerebrosidase GBA Glucocerebrosidase Beta Glucosylceramidase Glucosylceramidase Beta A measurement of the glucosylceramidase beta in a biological specimen. Glucosylceramidase Beta Measurement GL1 Glucocerebroside Glucosylceramide A measurement of the glucosylceramide in a biological specimen. Glucosylceramide Measurement Glucuronidase, Alpha A measurement of the alpha glucuronidase in a biological specimen. Alpha Glucuronidase Measurement Glucuronidase, Beta A measurement of the beta glucuronidase in a biological specimen. Beta Glucuronidase Measurement Conjugated Bilirubin Glucuronidated Bilirubin A measurement of the glucuronidated bilirubin (water soluble) in a biological specimen. Glucuronidated Bilirubin Measurement Glutamate Dehydrogenase A measurement of the glutamate dehydrogenase in a biological specimen. Glutamate Dehydrogenase Measurement Glutamate Glutamic Acid A measurement of the glutamate in a biological specimen. Glutamate Measurement Glutamic Acid Decarboxylase 1 Glutamic Acid Decarboxylase 67 A measurement of the glutamic acid decarboxylase 1 in a biological specimen. Glutamic Acid Decarboxylase 1 Measurement Glutamic Acid Decarboxylase 2 Glutamic Acid Decarboxylase 65 A measurement of the glutamic acid decarboxylase 2 in a biological specimen. Glutamic Acid Decarboxylase 2 Measurement Glutamine A measurement of the glutamine in a biological specimen. Glutamine Measurement Glutathione S-Transferase, Alpha/Creat A relative measurement (ratio or percentage) of the alpha glutathione-S-transferase to creatinine in a biological specimen. Alpha Glutathione-S-Transferase to Creatinine Ratio Measurement Glutathione S-Transferase, Pi A measurement of the Pi glutathione-s-transferase in a biological specimen. Pi Glutathione S-Transferase Measurement Glutathione S-Transferase, Theta A measurement of the theta glutathione-s-transferase in a biological specimen. Theta Glutathione S-Transferase Measurement Glutathione S-Transferase, Total A measurement of the total glutathione-s-transferase in a biological specimen. Glutathione-S-Transferase Measurement Glutathione S-Transferase, Y1 A measurement of the Y1 subunit of glutathione-s-transferase in a biological specimen. Glutathione S-Transferase Y1 Subunit Measurement Glutathione-S-Transferase/Creatinine A relative measurement (ratio or percentage) of the glutathione S-transferase to creatinine in a biological specimen. Glutathione-S-Transferase to Creatinine Ratio Measurement GIP Gluten Immunogenic Peptide Gluten Immunogenic Peptides A measurement of gluten immunogenic peptide in a biological specimen. Gluten Immunogenic Peptide Measurement Glutethimide A measurement of the glutethimide in a biological specimen. Glutethimide Measurement Glycated Albumin A measurement of the glycated albumin present in a biological specimen. Glycated Albumin Measurement Glycated Albumin/Albumin A relative measurement (ratio or percentage) of the glycated albumin to total albumin in a biological specimen. Glycated Albumin to Albumin Ratio Measurement Glycated Ferritin A measurement of the glycated ferritin in a biological specimen. Glycated Ferritin Measurement Glycated Ferritin/Ferritin A relative measurement (ratio or percentage) of the glycated ferritin to total ferritin in a biological specimen. Glycated Ferritin to Ferritin Ratio Measurement GAPDH Glyceraldehyde 3 Phosphate Dehydrogenase Glyceraldehyde-3-Phosphate Dehydrogenase A measurement of the glyceraldehyde-3-phosphate dehydrogenase in a biological specimen. Glyceraldehyde-3-Phosphate Dehydrogenase Measurement Glycerol A measurement of the total glycerol in a specimen. Glycerol Measurement Glycine A measurement of the glycine in a biological specimen. Glycine Measurement Glycine/Creatinine A relative measurement (ratio) of the glycine to the creatinine in a biological specimen. Glycine to Creatinine Ratio Measurement Glycochenodeoxycholate Glycochenodeoxycholic Acid A measurement of the glycochenodeoxycholate in a biological specimen. Glycochenodeoxycholate Measurement Cholylglycine Glycocholate Glycocholic Acid A measurement of the glycocholate in a biological specimen. Glycocholate Measurement Glycogen Phosphorylase Isoenzyme BB A measurement of the glycogen phosphorylase isoenzyme BB in a biological specimen. Glycogen Phosphorylase Isoenzyme BB Measurement Glycogen A measurement of the glycogen in a biological specimen. Glycogen Measurement Glycolithocholate Glycolithocholic Acid A measurement of the glycolithocholate in a biological specimen. Glycolithocholate Measurement GlycA Glycoprotein Acetyls A measurement of the glycoprotein acetyls (i.e., alpha-1-acid glycoprotein, alpha-1-antitrypsin, haptoglobin, alpha-1-antichymotrypsin, and transferrin) in a biological specimen. Glycoprotein Acetyls Measurement Glycosylated Ferritin A measurement of the glycosylated ferritin in a biological specimen. Glycosylated Ferritin Measurement Glycosylated Ferritin/Ferritin A relative measurement (ratio or percentage) of the glycosylated ferritin to total ferritin in a biological specimen. Glycosylated Ferritin to Ferritin Ratio Measurement Glycoursodeoxycholate Glycoursodeoxycholic Acid A measurement of the glycoursodeoxycholate in a biological specimen. Glycoursodeoxycholate Measurement Glycylproline Dipeptidyl Aminopeptidase GPDA A measurement of the glycylproline dipeptidyl aminopeptidase in a biological specimen. Glycylproline Dipeptidyl Aminopeptidase Measurement Gold A measurement of the gold in a biological specimen. Gold Measurement Gonadotropin Releasing Hormone Luteinising Hormone Releasing Hormone A measurement of the gonadotropin releasing hormone in a biological specimen. Gonadotropin Releasing Hormone Measurement Granular Casts A measurement of the granular (coarse and fine) casts present in a biological specimen. Granular Cast Measurement Granular Coarse Casts A measurement of the coarse granular casts present in a biological specimen. Coarse Granular Cast Measurement Granular Fine Casts A measurement of the fine granular casts present in a biological specimen. Granular Fine Cast Measurement Granulin A measurement of the granulin in a biological specimen. Granulin Measurement Granulocyte Colony Stimulating Factor A measurement of the granulocyte colony stimulating factor in a biological specimen. Granulocyte Colony Stimulating Factor Measurement Granulocyte Macrophage Colony Stm Factor A measurement of the granulocyte macrophage colony stimulating factor in a biological specimen. Granulocyte Macrophage Colony Stm Factor Measurement Banded Granulocytes Granulocytes Band Form A measurement of the banded granulocytes in a biological specimen. Granulocytes Band Form Count Granulocytes Band Form/Total Cells A relative measurement (ratio or percentage) of the banded granulocytes to total cells in a biological specimen. Band Form Granulocyte to Total Cell Ratio Measurement Granulocytes Segmented A measurement of the segmented granulocytes in a biological specimen. Segmented Granulocyte Count Granulocytes Segmented/Total Cells Segmented Granulocytes/Total Cells A relative measurement (ratio or percentage) of the segmented granulocytes to total cells in a biological specimen. Segmented Granulocyte to Total Cell Ratio Measurement Granulocytes Polymorphonuclear Leukocytes A measurement of the granulocytes in a biological specimen. Granulocyte Count Gran/Leuk Granulocytes/Leukocytes Polymorphonuclear Leukocytes/Leukocytes A relative measurement (ratio or percentage) of the granulocytes to total leukocytes in a biological specimen. Granulocytes to Leukocytes Ratio Measurement Granulocytes/Total Cells A relative measurement (ratio or percentage) of the granulocytes to total cells in a biological specimen (for example a bone marrow specimen). Granulocyte to Total Cell Ratio Measurement CTL Tryptase Cytotoxic T-Lymphocyte Proteinase 1 Cytotoxic T-Lymphocyte-Associated Serine Esterase-3 Fragmentin-1 Granzyme A Granzyme-1 Hanukkah Factor A measurement of the granzyme A in a biological specimen. Granzyme A Measurement C11 CCPI CGL1 CSPB CTLA1 CTSGL1 Granzyme B HLP SECT A measurement of the granzyme B in a biological specimen. Granzyme B Measurement BMP-11 Bone Morphogenetic Protein 11 Growth Differentiation Factor 11 A measurement of the growth differentiation factor 11 in a biological specimen. Growth Differentiation Factor 11 Measurement GDF-15 Growth Differentiation Factor 15 Macrophage Inhibitory Cytokine-1 MIC-1 A measurement of the growth differentiation factor 15 in a biological specimen. Growth Differentiation Factor 15 Measurement BMP-9 BMP9 Bone Morphogenetic Protein 9 Growth Differentiation Factor 2 Growth/Differentiation Factor 2 A measurement of the growth differentiation factor 2 in a biological specimen. Growth Differentiation Factor 2 Measurement Growth Differentiation Factor 8 Myostatin A measurement of the growth differentiation factor 8 in a biological specimen. Growth Differentiation Factor 8 Measurement GH Binding Protein Growth Hormone Binding Protein Somatotropin Receptor A measurement of the growth hormone binding protein in a biological specimen. Growth Hormone Binding Protein Measurement Growth Hormone Inhibiting Hormone Somatostatin A measurement of the growth hormone inhibiting hormone in a biological specimen. Growth Hormone Inhibiting Hormone Measurement Growth Hormone Releasing Hormone Somatocrinin A measurement of the growth hormone releasing hormone in a biological specimen. Growth Hormone Releasing Hormone Measurement Growth Regulated Oncogene A measurement of the total growth regulated oncogene proteins in a biological specimen. Growth Regulated Oncogene Measurement Guanase Guanine Aminohydrolase Guanine Deaminase A measurement of the guanine deaminase in a biological specimen. Guanine Deaminase Measurement Guanylate Binding Protein 1 A measurement of the guanylate binding protein 1 in a biological specimen. Guanylate Binding Protein 1 Measurement Guanylate Binding Protein 2 A measurement of the guanylate binding protein 2 in a biological specimen. Guanylate Binding Protein 2 Measurement Hairy Cells A measurement of the hairy cells (b-cell lymphocytes with hairy projections from the cytoplasm) in a biological specimen. Hairy Cell Count Hairy Cells/Leukocytes A relative measurement (ratio or percentage) of the hairy cells (B-cell lymphocytes with hairy projections from the cytoplasm) to all leukocytes in a biological specimen. Hairy Cells to Leukocytes Ratio Measurement Hairy Cells/Lymphocytes A relative measurement (ratio or percentage) of the hairy cells (b-cell lymphocytes with hairy projections from the cytoplasm) to all lymphocytes in a biological specimen . Hairy Cell to Lymphocyte Ratio Measurement Hairy Cells/Total Cells A relative measurement (ratio or percentage) of the hairy cells to total cells in a biological specimen. Hairy Cells to Total Cells Ratio Measurement Halazepam A measurement of the halazepam present in a biological specimen. Halazepam Measurement Hallucinogen A measurement of any hallucinogenic class drug present in a biological specimen. Hallucinogen Measurement Haloperidol A measurement of the haloperidol in a biological specimen. Haloperidol Measurement Haptoglobin A measurement of the haptoglobin protein in a biological specimen. Haptoglobin Protein Measurement HCT Corrected Reticulocytes/Erythrocytes A relative measurement (ratio or percentage) of the hematocrit corrected reticulocytes to erythrocytes in a biological specimen. Hematocrit Corrected Reticulocytes to Erythrocytes Ratio Measurement HDL Cholesterol A measurement of the high density lipoprotein cholesterol in a biological specimen. High Density Lipoprotein Cholesterol Measurement HDL Cholesterol/LDL Cholesterol A relative measurement (ratio or percentage) of the amount of HDL cholesterol compared to LDL cholesterol in a biological specimen. HDL Cholesterol to LDL Cholesterol Ratio Measurement HDL Cholesterol/Total Cholesterol A relative measurement (ratio or percentage) of the amount of HDL cholesterol compared to total cholesterol in a biological specimen. HDL Cholesterol to Total Cholesterol Ratio Measurement HDL Particle Size A measurement of the average particle size of high-density lipoprotein in a biological specimen. HDL Particle Size Measurement HDL Phospholipid HDL-PL A measurement of the high density lipoprotein phospholipid in a biological specimen. HDL Phospholipid Measurement HDL+LDL Cholesterol A measurement of the high density lipoprotein cholesterol and the low density lipoprotein cholesterol in a biological specimen. High Density Lipoprotein Cholesterol and Low Density Lipoprotein Cholesterol Measurement HDL-Cholesterol Subclass 2 A measurement of the high-density lipoprotein (HDL) cholesterol subclass 2 in a biological specimen. HDL-Cholesterol Subclass 2 Measurement HDL-Cholesterol Subclass 3 A measurement of the high-density lipoprotein (HDL) cholesterol subclass 3 in a biological specimen. HDL-Cholesterol Subclass 3 Measurement Heat Shock Protein 70 A measurement of the heat shock protein 70 in a biological specimen. Heat Shock Protein 70 Measurement Heat Shock Protein 90 Alpha A measurement of the heat shock protein 90 alpha in a biological specimen. Heat Shock Protein 90 Alpha Measurement E3 ISG15--Protein Ligase HERC5 HECT and RLD Domain Containing E3 Ubiquitin Protein Ligase 5 Hect Domain and RLD 5 A measurement of the hect domain and RLD 5 in a biological specimen. Hect Domain and RLD 5 Measurement Heinz Bodies Heinz-Erhlich Bodies A measurement of the Heinz bodies (small round inclusions within the body of a red blood cell) in a biological specimen. Heinz-Ehrlich Body Measurement Heinz Bodies/Erythrocytes A relative measurement (ratio or percentage) of the erythrocytes that contain heinz bodies to total erythrocytes in a biological specimen. Heinz Body to Erythrocyte Ratio Measurement Helicase MOV-10 Protein Moloney Leukemia Virus 10 Protein A measurement of helicase MOV-10 protein in a biological specimen. Helicase MOV-10 Protein Measurement Helmet Cells A measurement of the Helmet cells (specialized Keratocytes with two projections on either end that are tapered and hornlike) in a biological specimen. Helmet Cell Count Hematocrit Corrected Reticulocytes A measurement of the hematocrit corrected reticulocytes in a biological specimen. Hematocrit Corrected Reticulocyte Count Erythrocyte Volume Fraction EVF Hematocrit Packed Cell Volume PCV The percentage of a whole blood specimen that is composed of red blood cells (erythrocytes). Hematocrit Measurement Hemoglobin A A measurement of the hemoglobin A in a biological specimen. Hemoglobin A Measurement Hemoglobin A/Total Hemoglobin A relative measurement (ratio or percentage) of the hemoglobin A to total hemoglobin in a biological specimen. Hemoglobin A to Total Hemoglobin Ratio Measurement Hemoglobin A1/Total Hemoglobin A relative measurement (ratio or percentage) of the hemoglobin A1 to total hemoglobin in a biological specimen. Hemoglobin A1 to Total Hemoglobin Ratio Measurement Glycated Hemoglobin 1A Hemoglobin A1A A measurement of the glycated hemoglobin A1A in a biological specimen. Hemoglobin A1A Measurement Glycated Hemoglobin 1B Hemoglobin A1B A measurement of the glycated hemoglobin A1B in a biological specimen. Hemoglobin A1B Measurement HbA1c Hemoglobin A1C A measurement of the glycated hemoglobin A1C in a biological specimen. Hemoglobin A1C Measurement Glycated Hemoglobin/Hemoglobin HbA1c/Hemoglobin Hemoglobin A1C/Hemoglobin A relative measurement (ratio or percentage) of the glycated hemoglobin A1C to total hemoglobin in a biological specimen. Hemoglobin A1C to Hemoglobin Ratio Measurement Hemoglobin A2 Prime/Total Hemoglobin A relative measurement (ratio or percentage) of the hemoglobin A2 prime to total hemoglobin in a biological specimen. Hemoglobin A2 Prime to Total Hemoglobin Ratio Measurement Hemoglobin A2 A measurement of the hemoglobin A2 in a biological specimen. Hemoglobin A2 Measurement Hemoglobin A2/Total Hemoglobin A relative measurement (ratio or percentage) of the hemoglobin A2 to total hemoglobin in a biological specimen. Hemoglobin A2 to Total Hemoglobin Ratio Measurement Hemoglobin B A measurement of the hemoglobin B in a biological specimen. Hemoglobin B Measurement Hemoglobin Barts/Total Hemoglobin A relative measurement (ratio or percentage) of the hemoglobin Barts to total hemoglobin in a biological specimen. Hemoglobin Barts to Total Hemoglobin Ratio Measurement Hemoglobin C Crystals A measurement of hemoglobin C crystals in a biological specimen. Hemoglobin C Crystals Measurement Hemoglobin C A measurement of the hemoglobin C in a biological specimen. Hemoglobin C Measurement Hemoglobin C/Total Hemoglobin A relative measurement (ratio or percentage) of the hemoglobin C to total hemoglobin in a biological specimen. Hemoglobin C to Total Hemoglobin Ratio Measurement Hemoglobin Casts A measurement of the hemoglobin casts present in a biological specimen. Hemoglobin Cast Measurement Hemoglobin D/Total Hemoglobin A relative measurement (ratio or percentage) of the hemoglobin D to total hemoglobin in a biological specimen. Hemoglobin D to Total Hemoglobin Ratio Measurement Hemoglobin Concentration Distribution Width Hemoglobin Distribution Width A measurement of the distribution of the hemoglobin concentration in red blood cells. Hemoglobin Distribution Width Measurement Hemoglobin E/Total Hemoglobin A relative measurement (ratio or percentage) of the hemoglobin E to total hemoglobin in a biological specimen. Hemoglobin E to Total Hemoglobin Ratio Measurement Fetal Hemoglobin Hemoglobin F A measurement of the hemoglobin F in a biological specimen. Hemoglobin F Measurement Hemoglobin F/Total Hemoglobin A relative measurement (ratio or percentage) of the fetal hemoglobin (hemoglobin F) to total hemoglobin in a biological specimen. Hemoglobin F to Total Hemoglobin Ratio Measurement Hemoglobin Fraction Pattern A description of the hemoglobin fraction pattern in a biological specimen. Hemoglobin Fraction Pattern Hemoglobin G Coushatta/Total Hemoglobin A relative measurement (ratio or percentage) of the hemoglobin G Coushatta to total hemoglobin in a biological specimen. Hemoglobin G Coushatta to Total Hemoglobin Ratio Measurement HBH Inclusion Bodies Hemoglobin H Inclusion Bodies HGH Inclusion Bodies A measurement of the hemoglobin H inclusion bodies in a biological specimen. Hemoglobin H Inclusion Bodies Measurement HB H/Total Hemoglobin Hemoglobin H/Total Hemoglobin A relative measurement (ratio or percentage) of the hemoglobin H to total hemoglobin in a biological specimen. Hemoglobin H to Hemoglobin Ratio Measurement Hemoglobin Lepore/Total Hemoglobin A relative measurement (ratio or percentage) of the Lepore hemoglobin to total hemoglobin in a biological specimen. Hemoglobin Lepore to Total Hemoglobin Ratio Measurement Hemoglobin O-Arab/Total Hemoglobin A relative measurement (ratio or percentage) of the hemoglobin O-Arab to total hemoglobin in a biological specimen. Hemoglobin O-Arab to Total Hemoglobin Ratio Measurement Hemoglobin S Sickle Hemoglobin A measurement of the hemoglobin S in a biological specimen. Hemoglobin S Measurement Hemoglobin S/Total Hemoglobin A relative measurement (ratio or percentage) of the hemoglobin S to total hemoglobin in a biological specimen. Hemoglobin S to Total Hemoglobin Ratio Measurement Hemoglobin Tetramer A measurement of the hemoglobin tetramer in a biological specimen. Hemoglobin Tetramer Measurement Hemoglobin Variants A statement that indicates a defined set of hemoglobin variants were looked for in a biological specimen. Hemoglobin Variant Measurement Hemoglobin Hemoglobin Monomer A measurement of the total erythrocyte associated hemoglobin in a biological specimen. Hemoglobin Measurement Hemoglobin, Free A measurement of the hemoglobin external to erythrocytes in a biological specimen. Free Hemoglobin Measurement Hemolysis Hemolytic Index A measurement of the destruction of red blood cells in a biological specimen. Hemolytic Index Hemosiderin A measurement of the hemosiderin complex in a biological specimen. Hemosiderin Measurement HB-EGF HEGFL Heparin Binding EGF Like Growth Factor Heparin-Binding EGF-Like Growth Factor Proheparin-Binding EGF-Like Growth Factor A measurement of the heparin binding EGF like growth factor in a biological specimen. Heparin Binding EGF Like Growth Factor Measurement Heparin A measurement of the heparin in a biological specimen. Heparin Measurement Azurocidin CAP37 Cationic Antimicrobial Protein CAP37 HBP Heparin-Binding Protein A measurement of the heparin-binding protein in a biological specimen. Heparin-Binding Protein Measurement c-Met Hepatocyte Growth Factor Receptor MET Proto-Oncogene, Receptor Tyrosine Kinase Tyrosine-Protein Kinase Met A measurement of the hepatocyte growth factor receptor in a biological specimen. Hepatocyte Growth Factor Receptor Measurement Hepatocyte Growth Factor Receptor, Free A measurement of the free (unbound) hepatocyte growth factor receptor in a biological specimen. Free Hepatocyte Growth Factor Receptor Measurement Hepatocyte Growth Factor A measurement of the hepatocyte growth factor in a biological specimen. Hepatocyte Growth Factor Measurement Hepcidin A measurement of the total hepcidin in a biological specimen. Hepcidin Measurement HEPS Hepsin Serine Protease Hepsin TMPRSS1 Transmembrane Protease Serine 1 A measurement of the hepsin in a biological specimen. Hepsin Measurement Heterophils A measurement of heterophils (granular leukocytes) in a biological specimen from avian species. Heterophil Measurement Heterophils/Leukocytes A relative measurement (ratio or percentage) of heterophils to leukocytes in a biological specimen from avian species. Heterophils to Leukocytes Ratio Measurement cis-Hexadecenoic Acid Hexadecenoate Cis Hexadecenoic Acid Cis Sapienic Acid A measurement of the hexadecenoate cis in a biological specimen. Hexadecenoate cis Measurement Hexokinase A measurement of the hexokinase in a biological specimen. Hexokinase Measurement Beta-Hexosaminidase Subunit Alpha Beta-N-Acetylhexosaminidase Subunit Alpha Hexosaminidase A Hexosaminidase Subunit A Hexosaminidase Subunit Alpha N-Acetyl-Beta-Glucosaminidase Subunit Alpha A measurement of the hexosaminidase A in a biological specimen. Hexosaminidase A Measurement High Absorption Retic/Reticulocytes A relative measurement (ratio or percentage) of the high absorption reticulocytes to total reticulocytes in a biological specimen. High Absorption Reticulocytes to Total Reticulocytes Ratio Measurement High Absorption Reticulocytes A measurement of the high absorption reticulocytes in a biological specimen. High Absorption Reticulocyte Measurement Hippurate Crystals Hippuric Acid Crystals A measurement of the hippuric acid crystals present in a biological specimen. Hippuric Acid Crystal Measurement Histamine A measurement of the histamine in a biological specimen. Histamine Measurement Histidine A measurement of the histidine in a biological specimen. Histidine Measurement HLA A03 Antigen HLA-A03 Antigen A measurement of the HLA A03 antigen in a biological specimen. HLA A03 Histocompatibility Antigen Measurement HLA A2 Antigen HLA-A2 Antigen A measurement of the HLA A2 antigen in a biological specimen. HLA A2 Histocompatibility Antigen Measurement HLA A24 Antigen HLA-A24 Antigen A measurement of the HLA A24 antigen in a biological specimen. HLA A24 Histocompatibility Antigen Measurement HLA A3 Antigen HLA-A3 Antigen A measurement of the HLA A3 antigen in a biological specimen. HLA A3 Histocompatibility Antigen Measurement HLA Class IA Antigen A measurement of the HLA class IA antigen in a biological specimen. HLA Class IA Histocompatibility Antigen Measurement HLA Class IB Antigen A measurement of the HLA class IB antigen in a biological specimen. HLA Class IB Histocompatibility Antigen Measurement HLA Class IC Antigen A measurement of the HLA class IC antigen in a biological specimen. HLA Class IC Histocompatibility Antigen Measurement HLA Cw Antigen HLA-Cw Antigen A measurement of the HLA Cw antigen in a biological specimen. HLA Cw Histocompatibility Antigen Measurement HLA DP Alpha1 Antigen HLA-DP Alpha1 Antigen A measurement of the HLA DP alpha1 antigen in a biological specimen. HLA DP Alpha1 Histocompatibility Antigen Measurement HLA DP Beta Antigen HLA-DP Beta Antigen A measurement of the total HLA DP beta antigen in a biological specimen. HLA DP Beta Histocompatibility Antigen Measurement HLA DP Beta1 Antigen A measurement of the HLA DP beta1 antigen in a biological specimen. HLA DP Beta1 Histocompatibility Antigen Measurement HLA DQ Alpha1 Antigen HLA-DQ Alpha1 Antigen A measurement of the HLA DQ alpha1 antigen in a biological specimen. HLA DQ Alpha1 Histocompatibility Antigen Measurement HLA DQ Beta1 Antigen A measurement of the HLA DQ beta1 antigen in a biological specimen. HLA DQ Beta1 Histocompatibility Antigen Measurement HLA DQ2 Antigen HLA-DQ2 Antigen A measurement of the HLA DQ2 antigen in a biological specimen. HLA DQ2 Antigen Measurement HLA DQ8 Antigen HLA-DQ8 Antigen A measurement of the HLA DQ8 antigen in a biological specimen. HLA DQ8 Antigen Measurement HLA DR Alpha Antigen HLA-DR Alpha Antigen A measurement of the total HLA DR alpha antigen in a biological specimen. HLA-DR Alpha Histocompatibility Antigen Measurement HLA DR Antigen HLA-DR Antigen A measurement of the total HLA DR antigen in a biological specimen. HLA DR Histocompatibility Antigen Measurement HLA DR Beta Antigen HLA-DR Beta Antigen A measurement of the total HLA DR beta antigen in a biological specimen. HLA DR Beta Histocompatibility Antigen Measurement HLA DR Beta1 Antigen A measurement of the HLA DR beta1 antigen in a biological specimen. HLA DR Beta1 Histocompatibility Antigen Measurement HLA DR Beta2 Antigen HLA-DR Beta2 Antigen A measurement of the HLA DR beta2 antigen in a biological specimen. HLA DR Beta 2 Histocompatibility Antigen Measurement HLA DR Beta3 Antigen HLA-DR Beta3 Antigen A measurement of the HLA DR beta3 antigen in a biological specimen. HLA DR Beta 3 Histocompatibility Antigen Measurement HLA DR Beta4 Antigen HLA-DR Beta4 Antigen A measurement of the HLA DR beta4 antigen in a biological specimen. HLA DR Beta 4 Histocompatibility Antigen Measurement HLA DR Beta5 Antigen HLA-DR Beta5 Antigen A measurement of the HLA DR beta5 antigen in a biological specimen. HLA DR Beta 5 Histocompatibility Antigen Measurement HLA Mismatch Count A measurement to determine the number of mismatches between the recipient and the donor for the human leukocyte antigens (HLA). HLA Mismatch Count HLA-A Antigen Type The identification of the type of human leukocyte antigen, class I, group A (HLA-A), in a biological specimen. HLA-A Antigen Type HLA-A Mismatch Count A measurement to determine the number of mismatches between the recipient and the donor for the human leukocyte antigen, class I, group A (HLA-A). HLA-A Mismatch Count HLA-B Antigen Type The identification of the type of human leukocyte antigen, class I, group B (HLA-B), in a biological specimen. HLA-B Antigen Type HLA-B Mismatch Count A measurement to determine the number of mismatches between the recipient and the donor for the human leukocyte antigen, class I, group B (HLA-B). HLA-B Mismatch Count HLA-B27 Antigen Human Leukocyte Antigen B27 A measurement of the human leukocyte antigen B27 (HLA-B27) in a biological specimen. HLA-B27 Antigen Measurement HLA-DR Antigen Type The identification of the type of human leukocyte antigen, class II, antigen-D-related (HLA-DR), in a biological specimen. HLA-DR Antigen Type HLA DR Antigen/Leukocytes HLA-DR Antigen/Leukocytes A relative measurement (ratio or percentage) of the human leukocyte antigen DR (HLA-DR) antigen to leukocytes in a biological specimen. HLA-DR Antigen to Leukocyte Ratio Measurement HLA DR Antigen/Total Cells HLA-DR Antigen/Total Cells A relative measurement (ratio or percentage) of the human leukocyte antigen DR (HLA-DR) antigen to total cells in a biological specimen. HLA-DR Antigen to Total Cell Ratio Measurement HLA-DR Mismatch Count A measurement to determine the number of mismatches between the recipient and the donor for the human leukocyte antigen, class II, antigen-D-related (HLA-DR). HLA-DR Mismatch Count HLA-DR51 Antigen Type The identification of the type of human leukocyte antigen, class II, antigen-D-related 51 (HLA-DR51), in a biological specimen. HLA-DR51 Antigen Measurement HLA-DR52 Antigen Type The identification of the type of human leukocyte antigen, class II, antigen-D-related 52 (HLA-DR52), in a biological specimen. HLA-DR52 Antigen Measurement HLA-DR53 Antigen Type The identification of the type of human leukocyte antigen, class II, antigen-D-related 53 (HLA-DR53), in a biological specimen. HLA-DR53 Antigen Measurement Homocitrulline A measurement of the homocitrulline in a biological specimen. Homocitrulline Measurement Homocysteine A measurement of the homocysteine amino acid in a biological specimen. Homocysteine Acid Measurement Homovanillic Acid A measurement of the homovanillic acid metabolite in a biological specimen. Homovanillic Acid Measurement Howell-Jolly Bodies A measurement of the Howell-Jolly bodies (spherical, blue-black condensed DNA inclusions within the body of a red blood cell that appear under Wright-stain) in a biological specimen. Howell-Jolly Body Measurement ErbB-2 ERBB2 HER2/NEU Human Epidermal Growth Factor Receptor 2 A measurement of HER2 protein in a biological specimen. Human Epidermal Growth Factor Receptor 2 Measurement Human Epididymis Protein 4 A measurement of the human epididymis protein 4 in a biological specimen. Human Epididymis Protein 4 Measurement Huntingtin Protein Total Huntingtin Protein A measurement of the total huntingtin protein in a biological specimen. Huntingtin Protein Measurement Huntingtin Protein, Mutant A measurement of the mutant huntingtin protein in a biological specimen. Mutant Huntingtin Protein Measurement Huntingtin Protein, Wild Type A measurement of the wild type huntingtin protein in a biological specimen. Wild Type Huntingtin Protein Measurement Hyaline Casts A measurement of the hyaline casts present in a biological specimen. Hyaline Cast Measurement Hyalogranular Casts A measurement of the hyalogranular casts in a biological specimen. Hyalogranular Casts Hyaluronic Acid A measurement of hyaluronic acid in a biological specimen. Hyaluronic Acid Measurement Hydrocodone A measurement of the hydrocodone present in a biological specimen. Hydrocodone Measurement Hydrogen A measurement of the hydrogen in a biological specimen. Hydrogen Measurement H+CH4 Hydrogen+Methane A measurement of the hydrogen and methane in a biological specimen. Hydrogen and Methane Measurement Hydromorphone A measurement of the hydromorphone present in a biological specimen. Hydromorphone Measurement Hydroxyalprazolam A measurement of the total hydroxyalprazolam present in a biological specimen. Hydroxyalprazolam Measurement 6-Hydroxybupropion BW 306U Hydroxybupropion A measurement of the hydroxybupropion in a biological specimen. Hydroxybupropion Measurement 2-Hydroxyethylflurazepam Hydroxyethylflurazepam A measurement of the hydroxyethylflurazepam a biological specimen. Hydroxyethylflurazepam Measurement Hydroxylysine A measurement of the hydroxylysine in a biological specimen. Hydroxylysine Measurement Hydroxyproline A measurement of the total hydroxyproline in a biological specimen. Hydroxyproline Measurement Hyocholate Hyocholic Acid A measurement of the hyocholate in a biological specimen. Hyocholate Measurement Hyperchromia Hyperchromic Erythrocytes A measurement of the prevalence of the erthrocytes with an elevated hemoglobin concentration. Hyperchromia Measurement Hyperchromic Erythrocytes/Erythrocytes A relative measurement (ratio or percentage) of the hyperchromic erythrocytes to total erythrocytes in a biological specimen. Hyperchromic Erythrocytes to Erythrocytes Ratio Measurement Hypersegmented Cells A measurement of the hypersegmented (more than five lobes) neutrophils in a biological specimen. Hypersegmented Neutrophil Measurement Hypochromia Hypochromic Erythrocytes An observation which indicates that the hemoglobin concentration in a red blood cell specimen has fallen below a specified level. Hypochromia Hypochromic Erythrocytes/Erythrocytes A relative measurement (ratio or percentage) of the hypochromic erythrocytes to total erythrocytes in a biological specimen. Hypochromic Erythrocytes to Erythrocytes Ratio Measurement Hypogranular Neutrophils A measurement of the hypogranular neutrophils in a biological specimen. Hypogranular Neutrophil Measurement Hypoxanthine-Guanine Phosphoribosyltransferase Hypoxanthine-Guanine PRT A measurement of the hypoxanthine-guanine phosphoribosyltransferase in a biological specimen. Hypoxanthine-Guanine Phosphoribosyltransferase Measurement iC3b Complement A measurement of the complement iC3b in a biological specimen. Complement iC3b Measurement Icteric Index Icterus A measurement of the yellow color of a biological specimen, due to the presence of bile pigments. Icteric Index IDL Apolipoprotein B A measurement of the apolipoprotein B in the intermediate density lipoprotein fraction of a biological specimen. IDL Apolipoprotein B Measurement IDL Cholesterol Intermediate Density Lipoprotein A measurement of the intermediate density lipoprotein in a biological specimen. Intermediate Density Lipoprotein Cholesterol Measurement IDL Cholesterol/LDL Cholesterol A relative measurement (ratio) of the amount of intermediate density lipoprotein cholesterol compared to low density lipoprotein cholesterol in a biological specimen. IDL Cholesterol to LDL Cholesterol Ratio Measurement IDL Particles Intermediate Density Lipoproteins Particles A measurement of the concentration of IDL particles in a biological specimen. IDL Particles Measurement IDL Triglyceride A measurement of the intermediate density lipoprotein triglyceride in a biological specimen. IDL Triglyceride Measurement IDL Cholesterol and VLDL Cholesterol Subtype 3 IDL+VLDL Cholesterol Subtype 3 A measurement of the intermediate density lipoprotein cholesterol and the very low density lipoprotein cholesterol subtype 3 in a biological specimen. IDL Cholesterol and VLDL Cholesterol Subtype 3 Measurement IgG Clearance A measurement of the IgG clearance in a biological specimen. IgG Clearance IgG Clearance/Albumin Clearance A relative measurement (ratio) of the IgG clearance to albumin clearance in a biological specimen. IgG Clearance to Albumin Clearance Ratio Measurement IgG IgM IgA Total A measurement of the total IgG, IgM, and IgA in a biological specimen. IgG IgM IgA Total Measurement IgG Synthesis Rate A measurement of the IgG synthesis rate in a biological specimen. IgG Synthesis Rate Iloperidone A measurement of the iloperidone in a biological specimen. Iloperidone Measurement Imipramine A measurement of the imipramine in a biological specimen. Imipramine Measurement Immature Basophils A measurement of the immature basophils in a biological specimen. Immature Basophil Count Immature Basophils/Leukocytes A relative measurement (ratio or percentage) of immature basophils to total leukocytes in a biological specimen. Immature Basophil to Leukocyte Ratio Measurement Immature Cells A measurement of the total immature cells in a blood specimen. Immature Cell Count Immature Cells/Total Cells A relative measurement (ratio or percentage) of the immature hematopoietic cells to total cells in a biological specimen. Immature Cell to Total Cell Ratio Measurement Immature Eosinophils A measurement of the immature eosinophils in a biological specimen. Immature Eosinophil Count Immature Eosinophils/Leukocytes A relative measurement (ratio or percentage) of immature eosinophils to total leukocytes in a biological specimen. Immature Eosinophil to Leukocyte Ratio Measurement Immature Granulocytes A measurement of the total immature granulocytes in a biological specimen. Immature Granulocyte Count Immature Granulocytes/Leukocytes A relative measurement (ratio or percentage) of the immature granulocytes to leukocytes in a biological specimen (for example a bone marrow specimen). Immature Granulocytes to Leukocytes Ratio Measurement Immature Leukocytes A measurement of the immature leukocytes in a biological specimen. Immature Leukocyte Count Immature Leukocytes/Leukocytes A relative measurement (ratio or percentage) of the immature leukocytes to leukocytes in a biological specimen. Immature Leukocyte to Leukocytes Ratio Measurement Immature Lymphocytes A measurement of the immature lymphocytes in a biological specimen. Immature Lymphocytes Measurement Immature Lymphocytes/Leukocytes A relative measurement (ratio or percentage) of the immature lymphocytes to leukocytes in a biological specimen. Immature Lymphocytes to Leukocytes Ratio Measurement Immature Monocytes A measurement of the immature monocytes in a biological specimen. Immature Monocyte Count Immature Monocytes/Leukocytes A relative measurement (ratio or percentage) of immature monocytes to total leukocytes in a biological specimen. Immature Monocyte to Leukocyte Ratio Measurement Immature Neutrophils A measurement of the total immature neutrophils in a biological specimen. Immature Neutrophil Count Immature Neutrophils/Leukocytes A relative measurement (ratio or percentage) of the immature neutrophils to leukocytes in a biological specimen. Immature Neutrophils to Leukocytes Ratio Measurement Immature Plasma Cells A measurement of the immature plasma cells in a biological specimen. Immature Plasma Cell Count Immature Plasma Cells/Lymphocytes A relative measurement (ratio or percentage) of immature plasma cells to total lymphocytes in a biological specimen. Immature Plasma Cell to Lymphocyte Ratio Measurement Immature Plasma Cells/Total Cells A relative measurement (ratio or percentage) of the immature plasma cells (plasmacytes) to total cells in a biological specimen. Immature Plasma Cells to Total Cells Ratio Measurement Immature Platelets Reticulated Platelets A measurement of the immature platelets in a biological specimen. Immature Platelet Count Immature Platelet Fraction Immature Platelets/Total Platelets IPF Reticulated Platelets/Total Platelets A relative measurement (ratio or percentage) of immature platelets to total platelets in a biological specimen. Immature Platelets to Total Platelets Ratio Measurement Immature Reticulocyte Fraction A measurement of the immature reticulocyte fraction present in a biological specimen. Immature Reticulocyte Fraction Measurement Immunoblastic Lymphocytes Immunoblasts A measurement of the immunoblasts in a biological specimen. Immunoblast Count Immunoblasts/Lymphocytes Lymphocytes, Immunoblastic/Lymphocytes A relative measurement (ratio or percentage) of immunoblasts to all lymphocytes present in a sample. Immunoblasts to Lymphocytes Ratio Measurement Immunoglobulin A Subclass 1 A measurement of the immunoglobulin A subclass 1 in a biological specimen. Immunoglobulin A Subclass 1 Measurement Immunoglobulin A Subclass 2 A measurement of the immunoglobulin A subclass 2 in a biological specimen. Immunoglobulin A Subclass 2 Measurement Immunoglobulin A A measurement of the total immunoglobulin A in a biological specimen. Immunoglobulin A Measurement IgA/C3 IgA/Complement C3 Immunoglobulin A/Complement C3 A relative measurement (ratio) of the immunoglobulin A to complement C3 in a biological specimen. Immunoglobulin A to Complement C3 Measurement Immunoglobulin D A measurement of the Immunoglobulin D in a biological specimen. Immunoglobulin D Measurement Immunoglobulin E A measurement of the total Immunoglobulin E in a biological specimen. Immunoglobulin E Measurement Immunoglobulin E, Free A measurement of the free Immunoglobulin E in a biological specimen. Free Immunoglobulin E Measurement Immunoglobulin G Subclass 1 A measurement of the immunoglobulin G subclass 1 in a biological specimen. Immunoglobulin G Subclass 1 Measurement Immunoglobulin G Subclass 2 A measurement of the immunoglobulin G subclass 2 in a biological specimen. Immunoglobulin G Subclass 2 Measurement Immunoglobulin G Subclass 3 A measurement of the immunoglobulin G subclass 3 in a biological specimen. Immunoglobulin G Subclass 3 Measurement Immunoglobulin G Subclass 4 A measurement of the immunoglobulin G subclass 4 in a biological specimen. Immunoglobulin G Subclass 4 Measurement Immunoglobulin G A measurement of the total immunoglobulin G in a biological specimen. Immunoglobulin G Measurement IgG/Albumin Immunoglobulin G/Albumin A relative measurement (ratio or percentage) of the immunoglobulin G to albumin in a biological specimen. Immunoglobulin G to Albumin Ratio Measurement Immunoglobulin G/Creatinine A relative measurement (ratio or percentage) of the immunoglobulin G to creatinine in a biological specimen. Immunoglobulin G to Creatinine Ratio Measurement Immunoglobulin Heavy Constant Gamma 2 A measurement of the immunoglobulin heavy constant gamma 2 in a biological specimen. Immunoglobulin Heavy Constant Gamma 2 Measurement Immunoglobulin Heavy Constant Gamma 4 A measurement of the immunoglobulin heavy constant gamma 4 in a biological specimen. Immunoglobulin Heavy Constant Gamma 4 Measurement Immunoglobulin Light Chains A measurement of the total immunoglobulin (kappa and lambda) light chains in a biological specimen. Immunoglobulin Light Chain Measurement Immunoglobulin Light Chains, Free A measurement of the total free immunoglobulin (kappa and lambda) light chains in a biological specimen. Free Immunoglobulin Light Chain Measurement Immunoglobulin M A measurement of the total immunoglobulin M in a biological specimen. Immunoglobulin M Measurement Immunoglobulin A measurement of the total immunoglobulin in a biological specimen. Immunoglobulin Measurement Inclusion Bodies A measurement of the inclusion bodies in a biological specimen. Inclusion Body Measurement Indican A measurement of the indican present in a biological specimen. Indican Measurement Indirect Bilirubin Non-Glucuronidated Bilirubin Unconjugated Bilirubin A measurement of the unconjugated or non-water-soluble bilirubin in a biological specimen. Indirect Bilirubin Measurement Indocyanine Green Clearance A measurement of the volume of serum or plasma that would be cleared of indocyanine green by excretion for a specified unit of time (e.g. one minute). Indocyanine Green Clearance Measurement Indocyanine Green A measurement of the indocyanine green in a biological specimen. Indocyanine Green Measurement Inhibin A A measurement of the inhibin A (a heterodimer of the Inhibin Subunit Alpha and Inhibin Subunit Beta A) in a biological specimen. Inhibin A Measurement Inhibin B A measurement of the inhibin B (a heterodimer of the Inhibin Subunit Alpha and Inhibin Subunit Beta B) in a biological specimen. Inhibin B Measurement Inorganic Pyrophosphate A measurement of the inorganic pyrophosphate in a biological specimen. Inorganic Pyrophosphate Measurement Insulin Resistance A measurement of the insulin resistance (a cell's inability to respond to insulin) in a biological specimen. Insulin Resistance Measurement Insulin Sensitivity A measurement of the insulin sensitivity (cells are stimulated by lower than normal insulin levels) in a biological specimen. Insulin Sensitivity Measurement Insulin A measurement of the insulin in a biological specimen. Insulin Measurement Insulin, Free A measurement of the free insulin in a biological specimen. Free Insulin Measurement Insulin, Intact A measurement of the intact insulin in a biological specimen. Intact Insulin Measurement Insulin-Like Growth Factor Binding Prot1 Insulin-Like Growth Factor Binding Protein 1 A measurement of the total insulin-like growth factor binding protein 1 in a biological specimen. Insulin-Like Growth Factor Binding Protein 1 Measurement Insulin-Like Growth Factor Binding Prot2 Insulin-Like Growth Factor Binding Protein 2 A measurement of the insulin-like growth factor binding protein 2 in a biological specimen. Insulin-Like Growth Factor Binding Protein 2 Measurement Insulin-Like Growth Factor Binding Prot3 Insulin-Like Growth Factor Binding Protein 3 A measurement of the insulin-like growth factor binding protein 3 in a biological specimen. Insulin-Like Growth Factor Binding Protein 3 Measurement AGM FSTL2 IBP-7 IGFBP-7 IGFBP-7v IGFBPRP1 Insulin-Like Growth Factor Binding Prot7 Insulin-like Growth Factor Binding Protein 7 MAC25 PSF RAMSVPS TAF A measurement of the insulin-like growth factor binding protein 7 in a biological specimen. Insulin-Like Growth Factor Binding Protein 7 Measurement Insulin-like Growth Factor-1 A measurement of the insulin-like growth factor-1 in a biological specimen. Insulin Like Growth Factor-1 Measurement Insulin-like Growth Factor-2 A measurement of the insulin-like growth factor-2 in a biological specimen. Insulin Like Growth Factor-2 Measurement Endothelial Lectin HL-1 Galactofuranose-Binding Lectin Intelectin-1 Intestinal Lactoferrin Receptor ITLN-1 Omentin A measurement of the intelectin-1 in a biological specimen. Intelectin-1 Measurement Intercellular Adhesion Molecule 1 Soluble CD54 A measurement of the intercellular adhesion molecule 1 in a biological specimen. Intercellular Adhesion Molecule 1 Measurement Intercellular Adhesion Molecule 3 A measurement of the intercellular adhesion molecule 3 in a biological specimen. Intercellular Adhesion Molecule 3 Measurement Intercellular Adhesion Molecule A measurement of the total intercellular adhesion molecule in a biological specimen. Intercellular Adhesion Molecule Measurement Interferon Alpha Type 1 A measurement of the interferon alpha type 1 in a biological specimen. Interferon Alpha Type 1 Measurement Interferon Alpha Type 2 A measurement of the interferon alpha type 2 in a biological specimen. Interferon Alpha Type 2 Measurement Interferon Alpha A measurement of the total interferon alpha in a biological specimen. Interferon Alpha Measurement Interferon Alpha-Induced Protein 27 Interferon Alpha-Inducible Protein 27 A measurement of the interferon alpha-inducible protein 27 in a biological specimen. Interferon Alpha-Inducible Protein 27 Measurement Interferon Alpha-Inducible Protein 6 A measurement of the interferon alpha-inducible protein 6 in a biological specimen. Interferon Alpha-Inducible Protein 6 Measurement Interferon Beta A measurement of the interferon beta in a biological specimen. Interferon Beta Measurement Interferon Gamma A measurement of the interferon gamma in a biological specimen. Interferon Gamma Measurement Interferon-Induced 56 kDa Protein Interferon-Induced Protein With Tetratricopeptide Repeats 1 A measurement of the interferon-induced 56 KDa protein in a biological specimen. Interferon-Induced 56 kDa Protein Measurement Interferon-Induced 60 kDa Protein Interferon-Induced Protein With Tetratricopeptide Repeats 3 A measurement of the interferon-induced 60 KDa protein in a biological specimen. Interferon-Induced 60 kDa Protein Measurement Interferon-Induced Protein 44 A measurement of the interferon-induced protein 44 in a biological specimen. Interferon-Induced Protein 44 Measurement Interferon-Induced Protein 44-Like A measurement of the interferon-induced protein 44-like in a biological specimen. Interferon-Induced Protein 44-Like Measurement Interferon-Induced GTP-Binding Protein Mx1 Interferon-Induced Protein p78 A measurement of the interferon-induced protein P78 in a biological specimen. Interferon-Induced Protein p78 Measurement Interleukin 1 Alpha A measurement of interleukin 1 alpha in a biological specimen. Interleukin 1 Alpha Measurement IL-1B IL1Beta Interleukin 1 Beta Interleukin 1B A measurement of interleukin 1 beta in a biological specimen. Interleukin 1 Beta Measurement Interleukin 1 Excretion Rate A measurement of the amount of interleukin 1 being excreted in a biological specimen over a defined period of time (e.g. one hour). Interleukin 1 Excretion Rate IL-1RA Interleukin 1 Receptor Antagonist A measurement of the interleukin 1 receptor antagonist in a biological specimen. Interleukin 1 Receptor Antagonist Measurement CD121A CD121a Antigen IL-1R-1 IL-1R-Alpha IL-1R1 IL-1RT1 IL1RA Interleukin 1 Receptor Type 1 Interleukin-1 Receptor Alpha A measurement of the interleukin 1 receptor type 1 in a biological specimen. Interleukin-1 Receptor Type 1 Measurement CDw121b IL-1R-2 IL-1RT2 IL1R2c IL1RB Interleukin 1 Receptor Type 2 Soluble CD121b A measurement of the interleukin 1 receptor type 2 in a biological specimen. Interleukin 1 Receptor Type 2 Measurement Interleukin 1 Receptor Interleukin 1 Receptor Types I+II A measurement of the interleukin 1 receptor (type I and type II) in a biological specimen. Interleukin 1 Receptor Measurement Interleukin 1 Receptor-Like 1 Protein ST2 sST2 A measurement of the interleukin 1 receptor-like 1 in a biological specimen. Interleukin 1 Receptor-Like 1 Measurement Interleukin 1 A measurement of the interleukin 1 in a biological specimen. Interleukin 1 Measurement Interleukin 10 A measurement of the interleukin 10 in a biological specimen. Interleukin 10 Measurement Interleukin 11 A measurement of the interleukin 11 in a biological specimen. Interleukin 11 Measurement Interleukin 12 Beta Interleukin 12 Beta Subunit Interleukin 12 p40 Interleukin 12 p40 Subunit A measurement of p40 subunit of Interleukin 12 in a biological specimen. Interleukin 12 Beta Measurement Interleukin 12 Interleukin 12 p70 A measurement of the interleukin 12 in a biological specimen. Interleukin 12 Measurement Interleukin 12+23 p40 A measurement of the p40 subunit of the interleukins 12 and 23 in a biological specimen. Interleukin 12+23 p40 Measurement Interleukin 13 A measurement of the interleukin 13 in a biological specimen. Interleukin 13 Measurement Interleukin 14 A measurement of the interleukin 14 in a biological specimen. Interleukin 14 Measurement Interleukin 15 A measurement of the interleukin 15 in a biological specimen. Interleukin 15 Measurement Interleukin 16 A measurement of the interleukin 16 in a biological specimen. Interleukin 16 Measurement IL-17A Interleukin 17 Interleukin 17A A measurement of the interleukin 17 in a biological specimen. Interleukin 17 Measurement CX2 Cytokine CX2 IL-17C Interleukin 17C A measurement of the interleukin 17C in a biological specimen. Interleukin 17C Measurement IL-17D Interleukin 17D A measurement of the interleukin 17D in a biological specimen. Interleukin 17D Measurement Interleukin 18 Binding Protein A measurement of the interleukin 18 binding protein in a biological specimen. Interleukin 18 Binding Protein Measurement Interleukin 18 Excretion Rate A measurement of the amount of interleukin 18 being excreted in a biological specimen over a defined period of time (e.g. one hour). Interleukin 18 Excretion Rate Interleukin 18 A measurement of the interleukin 18 in a biological specimen. Interleukin 18 Measurement Interleukin 19 A measurement of the interleukin 19 in a biological specimen. Interleukin 19 Measurement IL-2Ra Interleukin 2 Receptor Subunit Alpha sCD25 Soluble CD25 A measurement of the interleukin 2 receptor subunit alpha in a biological specimen. Interleukin 2 Receptor Subunit Alpha Measurement IL-2Rb Interleukin 2 Receptor Subunit Beta A measurement of the interleukin 2 receptor subunit beta in a biological specimen. Interleukin 2 Receptor Subunit Beta Measurement Interleukin 2 Receptor A measurement of the interleukin 2 receptor in a biological specimen. Interleukin 2 Receptor Measurement Interleukin 2 A measurement of the interleukin 2 in a biological specimen. Interleukin 2 Measurement Interleukin 20 A measurement of the interleukin 20 in a biological specimen. Interleukin 20 Measurement Interleukin 21 A measurement of the interleukin 21 in a biological specimen. Interleukin 21 Measurement Interleukin 22 A measurement of the interleukin 22 in a biological specimen. Interleukin 22 Measurement Interleukin 23 Interleukin 23 p59 A measurement of the interleukin 23 in a biological specimen. Interleukin 23 Measurement Interleukin 24 A measurement of the interleukin 24 in a biological specimen. Interleukin 24 Measurement Interleukin 25 A measurement of the interleukin 25 in a biological specimen. Interleukin 25 Measurement Interleukin 26 A measurement of the interleukin 26 in a biological specimen. Interleukin 26 Measurement Interleukin 27 A measurement of the interleukin 27 in a biological specimen. Interleukin 27 Measurement Interleukin 28 A measurement of the total interleukin 28 in a biological specimen. Interleukin 28 Measurement IFN-Lambda 3 Interleukin 28B A measurement of the interleukin 28B in a biological specimen. Interleukin 28B Measurement Interleukin 29 A measurement of the interleukin 29 in a biological specimen. Interleukin 29 Measurement Interleukin 3 A measurement of the interleukin 3 in a biological specimen. Interleukin 3 Measurement Interleukin 30 A measurement of the interleukin 30 in a biological specimen. Interleukin 30 Measurement Interleukin 31 A measurement of the interleukin 31 in a biological specimen. Interleukin 31 Measurement Interleukin 32 A measurement of the interleukin 32 in a biological specimen. Interleukin 32 Measurement Interleukin 33 A measurement of the interleukin 33 in a biological specimen. Interleukin 33 Measurement IL-4Ra Interleukin 13 Receptor Interleukin 4 Receptor Interleukin 4 Receptor Subunit Alpha Soluble CD124 A measurement of the interleukin 4 receptor subunit alpha in a biological specimen. Interleukin-4 Receptor Subunit Alpha Measurement Interleukin 4 A measurement of the interleukin 4 in a biological specimen. Interleukin 4 Measurement Interleukin 5 A measurement of the interleukin 5 in a biological specimen. Interleukin 5 Measurement Interleukin 6 A measurement of the interleukin 6 in a biological specimen. Interleukin 6 Measurement Interleukin 7 A measurement of the interleukin 7 in a biological specimen. Interleukin 7 Measurement Chemokine (C-X-C Motif) Ligand 8 CXCL8 Interleukin 8 A measurement of the interleukin 8 in a biological specimen. Interleukin 8 Measurement Interleukin 9 A measurement of the interleukin 9 in a biological specimen. Interleukin 9 Measurement Intestinal Specific Alkaline Phosphatase A measurement of the intestinal specific alkaline phosphatase isoform in a biological specimen. Intestinal Specific Alkaline Phosphatase Measurement Inulin Clearance A measurement of the volume of serum or plasma that would be cleared of inulin by excretion of urine for a specified unit of time (e.g. one minute). Inulin Clearance Inulin A measurement of the inulin in a biological specimen. Inulin Measurement Iodine A measurement of the total iodine in a biological specimen. Iodine Measurement Iodine, Free A measurement of the free (unbound) iodine in a biological specimen. Free Iodine Measurement Iohexol Clearance A measurement of the volume of serum or plasma that would be cleared of Iohexol by excretion of urine for a specified unit of time (e.g. one minute). Iohexol Clearance Iohexol A measurement of iohexol in a biological specimen. Iohexol Measurement Iothalamate Clearance Adjusted for BSA A measurement of the volume of serum or plasma that would be cleared of iothalamate by excretion of urine for a specified unit of time (e.g. one minute), adjusted for body surface area. Iothalamate Clearance Adjusted for BSA Iothalamate Clearance A measurement of the volume of serum or plasma that would be cleared of iothalamate by excretion of urine for a specified unit of time (e.g. one minute). Iothalamate Clearance Iron Excretion Rate A measurement of the amount of iron being excreted in a biological specimen over a defined amount of time (e.g. one hour). Iron Excretion Rate FE Iron A measurement of the iron in a biological specimen. Iron Measurement Amylin Islet Amyloid Polypeptide A measurement of the islet amyloid polypeptide in a biological specimen. Islet Amyloid Polypeptide Measurement Islet Cell 512 Antigen A measurement of the islet cell 512 antigen in a biological specimen. Islet Cell 512 Antigen Measurement Isoleucine A measurement of the isoleucine in a biological specimen. Isoleucine Measurement Isoprene A measurement of the isoprene in a specimen. Isoprene Measurement JWH-018 JWH018 A measurement of the synthetic cannabinoid JWH-018 in a biological specimen. JWH-018 Measurement JWH-073 JWH073 A measurement of the synthetic cannabinoid JWH-073 in a biological specimen. JWH-073 Measurement JWH-081 JWH081 A measurement of the synthetic cannabinoid JWH-081 in a biological specimen. JWH-081 Measurement JWH-122 JWH122 A measurement of the synthetic cannabinoid JWH-122 in a biological specimen. JWH-122 Measurement JWH-200 JWH200 A measurement of the synthetic cannabinoid JWH-200 in a biological specimen. JWH-200 Measurement JWH-250 JWH250 A measurement of the synthetic cannabinoid JWH-250 in a biological specimen. JWH-250 Measurement JWH-398 JWH398 A measurement of the synthetic cannabinoid JWH-398 in a biological specimen. JWH-398 Measurement Kallikrein-2 A measurement of the kallikrein-2 in a biological specimen. Kallikrein-2 Measurement Kallikrein Related Peptidase 5 Kallikrein-5 Kallikrein-Like Protein 2 KLK-L2 A measurement of the kallikrein-5 in a biological specimen. Kallikrein-5 Measurement Kallikrein Related Peptidase 7 Kallikrein-7 Serine Protease 6 A measurement of the kallikrein-7 in a biological specimen. Kallikrein-7 Measurement Kappa Light Chain A measurement of the total kappa light chains in a biological specimen. Kappa Light Chain Measurement Bence-Jones, Kappa Kappa Light Chain, Free A measurement of the free kappa light chain in a biological specimen. Free Kappa Light Chain Measurement Kappa Lambda Ratio Kappa Light Chain/Lambda Light Chain A relative measurement (ratio) of the total kappa light chain to total lambda light chain in a biological specimen. Kappa Light Chain to Lambda Light Chain Ratio Measurement Kappa Lt Chain,Free/Lambda Lt Chain,Free A relative measurement (ratio or percentage) of the free kappa light chain to the free lambda light chain in a biological specimen. Free Kappa Light Chain to Free Lambda Light Chain Ratio Measurement Keratocyte A measurement of the keratocytes in a biological specimen. Keratocyte Count Ketamine A measurement of the ketamine in a biological specimen. Ketamine Measurement Ketobemidone A measurement of the ketobemidone in a biological specimen. Ketobemidone Measurement Ketoisoleucine A measurement of the ketoisoleucine in a biological specimen. Ketoisoleucine Measurement Ketoleucine A measurement of the ketoleucine in a biological specimen. Ketoleucine Measurement Ketone Bodies Excretion Rate A measurement of the amount of ketone bodies being excreted in a biological specimen over a defined period of time (e.g. one hour). Ketone Bodies Excretion Rate Measurement Ketone Bodies A measurement of the ketone bodies (acetone, acetoacetic acid, beta-hydroxybutyric acid, beta-ketopentanoate and beta-hydroxypentanoate) in a biological specimen. Ketone Body Measurement Ketones A measurement of the ketones in a biological specimen. Ketone Measurement Ketovaline A measurement of the ketovaline in a biological specimen. Ketovaline Measurement Ki-67 KI67 MKI67 pKi-67 A measurement of the Ki-67 protein in a biological specimen. Ki67 Measurement Kidney Injury Molecule-1 Excretion Rate A measurement of the amount of kidney injury molecule-1 being excreted in a biological specimen over a defined amount of time (e.g. one hour). Kidney Injury Molecule-1 Excretion Rate Hepatitis A Virus Cellular Receptor 1 Kidney Injury Molecule-1 KIM-1 A measurement of the kidney injury molecule-1 (Kim-1) in a biological specimen. Kidney Injury Molecule-1 Measurement Kidney Injury Molecule-1/Creatinine A relative measurement (ratio or percentage) of the kidney injury molecule-1 to creatinine in a biological specimen. Kidney Injury Molecule-1/Creatinine Ratio Measurement Klotho A measurement of the total klotho protein in a biological specimen. Klotho Protein Measurement KL-6 Krebs von den Lungen-6 Antigen A measurement of the Krebs von den Lungen-6 in a biological specimen. Krebs von den Lungen-6 Measurement Kurloff Cells A measurement of the large secretory granule-containing immune cells in a biological specimen taken from members of certain genera of the Caviidae family. Kurloff Cells Measurement Kynurenine A measurement of the kynurenine in a biological specimen. Kynurenine Measurement Lacosamide A measurement of the lacosamide in a biological specimen. Lacosamide Measurement Lactate Dehydrogenase Excretion Rate A measurement of the amount of lactate dehydrogenase being excreted in a biological specimen over a defined amount of time (e.g. one hour). Lactate Dehydrogenase Excretion Rate Lactate Dehydrogenase A measurement of the lactate dehydrogenase in a biological specimen. Lactate Dehydrogenase Measurement Lactate Dehydrogenase/Creatinine A relative measurement (ratio or percentage) of the lactate dehydrogenase to creatinine in a biological specimen. Lactate Dehydrogenase to Creatinine Ratio Measurement 2-hydroxypropanoic acid Lactate Lactic Acid A measurement of the lactic acid in a biological specimen. Lactic Acid Measurement Lactoferrin Lactotransferrin A measurement of the lactoferrin in a biological specimen. Lactoferrin Measurement Lactose A measurement of the lactose in a biological specimen. Lactose Measurement Lactulose A measurement of the lactulose in a biological specimen. Lactulose Measurement Lambda Light Chain A measurement of the total lambda light chains in a biological specimen. Lambda Light Chain Measurement Bence-Jones, Lambda Lambda Light Chain, Free A measurement of the free lambda light chain in a biological specimen. Free Lambda Light Chain Measurement LAMP2/GAPDH Lysosomal Associated Membrane Protein 2/Glyceraldehyde-3-Phosphate Dehydrogenase A relative measurement (ratio) of the lysosomal associated membrane protein 2 to glyceraldehyde-3-phosphate dehydrogenase in a biological specimen. Lysosomal Associated Membrane Protein 2 to Glyceraldehyde-3-Phosphate Dehydrogenase Ratio Measurement Large Lymphocytes A measurement of the large lymphocytes (approximately between 10 um and 20 um in diameter) in a biological specimen. Large Lymphocyte Count Large Platelets A measurement of the large (between 4 um and 7um in diameter) platelets in a biological specimen. Large Platelet Count Large Platelets/Total Platelets Platelet Large Cell Ratio PLCR A relative measurement (ratio or percentage) of large platelets to total platelets in a biological specimen. Large Platelets to Total Platelets Ratio Measurement Large Unstained Cells A measurement of the large, peroxidase-negative cells which cannot be further characterized (i.e. as large lymphocytes, virocytes, or stem cells) present in a biological specimen. Large Unstained Cell Count Large Unstained Cells/Leukocytes A relative measure (ratio or percentage) of the large unstained cells to leukocytes in a biological specimen. Large Unstained Cells to Leukocytes Ratio Measurement LDH Isoenzyme 1 A measurement of the lactate dehydrogenase isoenzyme 1 in a biological specimen. Lactate Dehydrogenase Isoenzyme 1 Measurement LDH Isoenzyme 1/LDH A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 1 to total lactate dehydrogenase in a biological specimen. LDH Isoenzyme 1 to LDH Ratio Measurement LDH Isoenzyme 2 A measurement of the lactate dehydrogenase isoenzyme 2 in a biological specimen. Lactate Dehydrogenase Isoenzyme 2 Measurement LDH Isoenzyme 2/LDH A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 2 to total lactate dehydrogenase in a biological specimen. LDH Isoenzyme 2 to LDH Ratio Measurement LDH Isoenzyme 3 A measurement of the lactate dehydrogenase isoenzyme 3 in a biological specimen. Lactate Dehydrogenase Isoenzyme 3 Measurement LDH Isoenzyme 3/LDH A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 3 to total lactate dehydrogenase in a biological specimen. LDH Isoenzyme 3 to LDH Ratio Measurement LDH Isoenzyme 4 A measurement of the lactate dehydrogenase isoenzyme 4 in a biological specimen. Lactate Dehydrogenase Isoenzyme 4 Measurement LDH Isoenzyme 4/LDH A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 4 to total lactate dehydrogenase in a biological specimen. LDH Isoenzyme 4 to LDH Ratio Measurement LDH Isoenzyme 5 A measurement of the lactate dehydrogenase isoenzyme 5 in a biological specimen. Lactate Dehydrogenase Isoenzyme 5 Measurement LDH Isoenzyme 5/LDH A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 5 to total lactate dehydrogenase in a biological specimen. LDH Isoenzyme 5 to LDH Ratio Measurement LDL Apolipoprotein B A measurement of the apolipoprotein B in the low density lipoprotein fraction of a biological specimen. LDL Fraction Apoliprotein B Measurement LDL Cholesterol A measurement of the low density lipoprotein cholesterol in a biological specimen. Low Density Lipoprotein Cholesterol Measurement LDL Cholesterol/HDL Cholesterol A relative measurement (ratio) of the low density lipoprotein cholesterol to high density lipoprotein cholesterol in a biological specimen. LDL Cholesterol to HDL Cholesterol Ratio Measurement LDL Particle Size A measurement of the average particle size of low-density lipoprotein in a biological specimen. LDL Particle Size Measurement LDL Particles A measurement of the concentration of the total LDL particles in a biological specimen. LDL Particles Measurement LDL Subtype Pattern A description of the low density lipoprotein particle pattern (an interpretation of the amounts of LDL particles based on size and density) in a biological specimen. LDL Subtype Pattern LDL Triglyceride A measurement of the low density lipoprotein triglyceride in a biological specimen. LDL Triglyceride Measurement Lead Pb A measurement of the lead in a specimen. Lead Measurement Lecithin/Sphingomyelin LS Ratio A relative measurement (ratio) of the lecithin to sphingomyelin in a biological specimen. Lecithin to Sphingomyelin Ratio Measurement C-Type Lectin Domain Family 8 Member A CLEC8A Lectin-Like Oxidized LDL Receptor-1 LOX-1 Oxidized LDL Receptor 1 Oxidized Low-Density Lipoprotein Receptor 1 A measurement of the lectin-like oxidized LDL Receptor-1 in a biological specimen. Lectin-Like Oxidized LDL Receptor-1 Measurement Left Shift Neutrophils An observation of the above normal incidence of immature neutrophils, including band neutrophils and neutrophil precursors in a biological specimen. Left Shift Neutrophil Measurement CD295 LEP-R LEPR Leptin Receptor OB Receptor A measurement of the leptin receptor in a biological specimen. Leptin Receptor Measurement Leptin A measurement of the leptin hormone in a biological specimen. Leptin Measurement Leptocytes A measurement of the leptocytes in a biological specimen. Leptocyte Measurement Cytosol Aminopeptidase LAP3 Leucine Aminopeptidase Leucine Aminopeptidase 3 Leucyl Aminopeptidase A measurement of the total leucine aminopeptidase present in a biological specimen. Leucine Aminopeptidase Measurement Leucine Crystals A measurement of the leucine crystals present in a biological specimen. Leucine Crystal Measurement HMFT1766 Leucine Rich Alpha-2-Glycoprotein 1 A measurement of the leucine rich alpha-2-glycoprotein 1 in a biological specimen. Leucine Rich Alpha-2-Glycoprotein 1 Measurement Leucine A measurement of the leucine in a biological specimen. Leucine Measurement Leukemia Inhibitory Factor A measurement of leukemia inhibitory factor in a biological specimen. Leukemia Inhibitory Factor Measurement Leukemic Blasts A measurement of the leukemic blasts (lymphoblasts and/or myeloblasts that remain in an immature state even when outside the bone marrow) in a biological specimen. Leukemic Blast Count Leukemic Blasts/Lymphocytes A relative measurement (ratio or percentage) of the leukemic blasts (immature lymphoblasts and/or myeloblasts) to mature lymphocytes in a biological specimen. Leukemic Blast to Lymphocyte Ratio Measurement Leukemic Cells Residual Leukemic Cells A measurement of the leukemic cells in a biological specimen. Leukemic Cells Measurement Leukocyte Cell Clumps WBC Clumps White Blood Cell Clumps A measurement of white blood cell clumps in a biological specimen. Leukocyte Cell Clumps Measurement Leukocyte Cell Differential Leukocyte Cell Fraction Leukocyte Diff An overall assessment of the leukocyte subtype distribution in a biological specimen. Differential Leukocyte Count Leukocyte Cell Morphology WBC Morphology White Blood Cell Morphology An examination or assessment of the form and structure of white blood cells. Leukocyte Cell Morphology Leukocyte Esterase A measurement of the enzyme which indicates the presence of white blood cells in a biological specimen. Leukocyte Esterase Measurement Leukocytes White Blood Cells A measurement of the leukocytes in a biological specimen. Leukocyte Count Leukocytes/Total Cells WBC/Total Cells A relative measurement (ratio or percentage) of the leukocytes to total cells in a biological specimen. Leukocytes to Total Cells Ratio Measurement Leukotriene B4 A measurement of the leukotriene B4 in a biological specimen. Leukotriene B4 Measurement Leukotriene C4 Synthase A measurement of the leukotriene C4 synthase in a biological specimen. Leukotriene C4 Synthase Measurement Leukotriene D4 A measurement of the leukotriene D4 in a biological specimen. Leukotriene D4 Measurement Leukotriene E4 A measurement of the leukotriene E4 in a biological specimen. Leukotriene E4 Measurement Leukocytes Corrected for Nucleated Erythrocytes Leuks Corrected for Nucl Erythrocytes A measurement of the leukocytes corrected for nucleated erythrocytes in a biological specimen. Leukocytes Corrected for Nucleated Erythrocytes Count Levetiracetam A measurement of the levetiracetam in a biological specimen. Levetiracetam Measurement Levorphanol A measurement of the levorphanol in a biological specimen. Levorphanol Measurement Lipase Total Lipase Triacylglycerol Lipase A measurement of the total triacylglycerol lipase in a biological specimen. Lipase Measurement Gastric Triacylglycerol Lipase Lipase, Gastric LIPF A measurement of the gastric triacylglycerol lipase in a biological specimen. Gastric Lipase Measurement Hepatic Triacylglycerol Lipase Lipase, Hepatic LIPH A measurement of the hepatic triacylglycerol lipase in a biological specimen. Hepatic Triacylglycerol Lipase Measurement Acid Cholesteryl Ester Hydrolase LAL LIPA Lipase, Lysosomal Acid Lysosomal Lipase A measurement of the lysosomal acid lipase in a biological specimen. Lysosomal Acid Lipase Measurement Lipase, Pancreatic Pancreatic Triacylglycerol Lipase PNLIP A measurement of the pancreatic triacylglycerol lipase in a biological specimen. Pancreatic Lipase Measurement Lipemia Lipemic Index A measurement of the abnormally high concentration of lipid in a biological specimen. Lipemic Index Lipid Total Lipid A measurement of the total lipids (cholesterol, lipoproteins, and triglycerides) in a biological specimen. Lipid Measurement Lipoarabinomannan A measurement of the lipoarabinomannan in a biological specimen. Lipoarabinomannan Measurement Lipocalin-2 Neutrophil Gelatinase-Associated Lipocalin NGAL Oncogene 24p3 A measurement of lipocalin-2 in a biological specimen. Lipocalin-2 Measurement Lipocalin-2/Creatinine Neutrophil Gelatinase-Associated Lipocalin/Creatinine NGAL/Creatinine A relative measurement (ratio or percentage) of the lipocalin-2 to creatinine present in a sample. Lipocalin-2 to Creatinine Ratio Measurement Lipoprotein Associated Phospholipase A2 A measurement of the lipoprotein associated phospholipase A2 in a biological specimen. Lipoprotein Associated Phospholipase A2 Measurement Lipoprotein Lipase A measurement of the lipoprotein lipase in a biological specimen. Lipoprotein Lipase Measurement Lipoprotein-a A measurement of the lipoprotein-a in a biological specimen. Lipoprotein a Measurement Liquefaction Time A measurement of the time it takes for a gelatinous or semi-solid substance to change to a liquid. Liquefaction Time Measurement Lithium A measurement of the lithium in a biological specimen. Lithium Measurement Lithocholate Compounds Lithocholic Acid Compounds A measurement of the lithocholic acid, glycolithocholic acid, and taurolithocholic acid in a biological specimen. Lithocholate Compounds Measurement Lithocholate Lithocholic Acid A measurement of the lithocholate in a biological specimen. Lithocholate Measurement Liver Fibrosis Score A scoring system that evaluates liver pathology through the assessment of multiple blood test parameters, taking into account additional demographic factors such as the age and/or sex of the subject. Liver Fibrosis Score Liver Specific Alkaline Phosphatase A measurement of the liver specific alkaline phosphatase isoform in a biological specimen. Liver Specific Alkaline Phosphatase Measurement Loprazolam A measurement of the loprazolam in a biological specimen. Loprazolam Measurement Lorazepam A measurement of the lorazepam present in a biological specimen. Lorazepam Measurement Lormetazepam A measurement of the lormetazepam in a biological specimen. Lormetazepam Measurement Low Absorption Retic/Reticulocytes A relative measurement (ratio or percentage) of the low absorption reticulocytes to total reticulocytes in a biological specimen. Low Absorption Reticulocytes to Total Reticulocytes Ratio Measurement Low Absorption Reticulocytes A measurement of the low absorption reticulocytes in a biological specimen. Low Absorption Reticulocyte Measurement Loxapine A measurement of the loxapine in a biological specimen. Loxapine Measurement APTT-LA APTTLA Lupus Anticoagulant Sensitive APTT A measurement of the length of time that it takes for clotting to occur when a lupus sensitive reagent is added to a plasma specimen. Lupus Anticoagulant Sensitive APTT Measurement Lurasidone A measurement of the lurasidone in a biological specimen. Lurasidone Measurement Luteinizing Hormone Lutropin A measurement of the luteinizing hormone in a biological specimen. Luteinizing Hormone Measurement Lymphoblasts Lymphoid Blasts A measurement of the lymphoblasts (immature cells that differentiate to form lymphocytes) in a biological specimen. Lymphoblast Count Lymphoblasts/Leukocytes A relative measurement (ratio or percentage) of the lymphoblasts to leukocytes in a biological specimen. Lymphoblast to Leukocyte Ratio Measurement Lymphoblasts/Lymphocytes A relative measurement (ratio or percentage) of the lymphoblasts to lymphocytes in a biological specimen. Lymphoblast to Lymphocyte Ratio Measurement Lymphocyte Antigen 6 Family Member E Lymphocyte Antigen 6E A measurement of the lymphocyte antigen 6E in a biological specimen. Lymphocyte Antigen 6E Measurement Lymphocytes Activated A measurement of the total activated lymphocytes in a biological specimen. Activated Lymphocytes Measurement Lymphocytes Atypical Lymphocytes, Variant Reactive Lymphocytes A measurement of the atypical lymphocytes in a biological specimen. Atypical Lymphocyte Count Lymphocytes Atypical/Leukocytes Lymphocytes, Variant/Leukocytes Reactive Lymphocytes/Leukocytes A relative measurement (ratio or percentage) of the atypical lymphocytes to leukocytes in a biological specimen. Atypical Lymphocyte to Leukocyte Ratio Measurement Lymphocytes A measurement of the lymphocytes in a biological specimen. Lymphocyte Count Lymphocytes, Clefted A measurement of the clefted lymphocytes in a biological specimen. Clefted Lymphocytes Count Lymphocytes, Clefted/Leukocytes A relative measurement (ratio or percentage) of the clefted lymphocytes to total leukocytes in a biological specimen. Clefted Lymphocytes to Leukocytes Ratio Measurement Lymphocytes/Leukocytes A relative measurement (ratio or percentage) of the lymphocytes to leukocytes in a biological specimen. Lymphocyte to Leukocyte Ratio Lymphocytes/Neutrophils A relative measurement (ratio) of lymphocytes to neutrophils in a biological specimen. Lymphocyte to Neutrophil Ratio Measurement Lymphocytes/Non-Squam Epi Cells A relative measurement (ratio or percentage) of the lymphocytes to non-squamous epithelial cells in a biological specimen. Lymphocytes to Non-Squamous Epithelial Cells Ratio Measurement Lymphocytes/Total Cells A relative measurement (ratio or percentage) of the lymphocytes to total cells in a biological specimen (for example a bone marrow specimen). Lymphocyte to Total Cell Ratio Measurement Lymphoid Cells A measurement of the total lymphoid lineage cells in a biological specimen. Lymphoid Cell Count Lymphoma Cells A measurement of the malignant lymphocytes in a biological specimen. Lymphoma Cell Count Lymphoma Cells/Leukocytes A relative measurement (ratio or percentage) of the malignant lymphocytes to all leukocytes in a biological specimen. Lymphoma Cells to Leukocytes Ratio Measurement Lymphoma Cells/Lymphocytes A relative measurement (ratio or percentage) of the malignant lymphocytes to all lymphocytes in a biological specimen. Lymphoma Cell to Lymphocyte Ratio Measurement Lymphoma Cells/Total Cells A relative measurement (ratio or percentage) of the lymphoma cells to total cells in a biological specimen. Lymphoma Cell to Total Cell Ratio Measurement Chemokine Ligand 1 Lymphotactin A measurement of the lymphotactin in a biological specimen. Lymphotactin Measurement Lymphotoxin Alpha TNF-beta Tumor Necrosis Factor Beta A measurement of the lymphotoxin alpha in a biological specimen. Lymphotoxin Alpha Measurement Acid Lysergate Diethylamide Lysergic Acid Diethylamide A measurement of the lysergic acid diethylamine (LSD) in a biological specimen. Lysergide Measurement Lysine A measurement of the lysine in a biological specimen. Lysine Measurement Lysosomal Associated Membrane Protein 2 Lysosomal Membrane Associated Protein 2 Lysosome-Associated Membrane Protein 2 Soluble CD107b A measurement of the lysosomal associated membrane protein 2 present in a biological specimen. Lysosome-Associated Membrane Protein 2 Measurement Lysozyme A measurement of lysozyme in a biological specimen. Lysozyme Measurement MAB-CHMINACA A measurement of the synthetic cannabinoid MAB-CHMINACA in a biological specimen. MAB-CHMINACA Measurement Macroamylase A measurement of macroamylase in a biological specimen. Macroamylase Measurement Macrocytes A measurement of the macrocytes in a biological specimen. Macrocyte Count Macrophage Colony Stimulating Factor A measurement of the macrophage colony stimulating factor in a biological specimen. Macrophage Colony Stimulating Factor Measurement Chemokine Ligand 3 Macrophage Inflammatory Protein 1 Alpha A measurement of the macrophage inflammatory protein 1 alpha in a biological specimen. Macrophage Inflammatory Protein 1 Alpha Measurement Chemokine Ligand 4 Macrophage Inflammatory Protein 1 Beta A measurement of the macrophage inflammatory protein 1 beta in a biological specimen. Macrophage Inflammatory Protein 1 Beta Measurement Macrophage Inflammatory Protein 1 Gamma A measurement of the macrophage inflammatory protein 1 gamma in a biological specimen. Macrophage Inflammatory Protein 1 Gamma Measurement Macrophage Inflammatory Protein 1 A measurement of total macrophage inflammatory protein 1 in a biological specimen. Macrophage Inflammatory Protein 1 Measurement Macrophage Migration Inhibitory Factor MIF A measurement of the macrophage migration inhibitory factor in a biological specimen. Macrophage Migration Inhibitory Factor Measurement C-C Motif Chemokine Ligand 22 CCL22 Chemokine (C-C Motif) Ligand 22 Chemokine Ligand 22 Macrophage-Derived Chemokine A measurement of the macrophage-derived chemokine in a biological specimen. Macrophage-Derived Chemokine Measurement Macrophages A measurement of the macrophages in a biological specimen. Macrophage Count Macrophages/Leukocytes A relative measurement (ratio or percentage) of the macrophages to leukocytes in a biological specimen. Macrophage to Leukocyte Ratio Macrophages/Non-Squam Epi Cells A relative measurement (ratio or percentage) of the macrophages to non-squamous epithelial cells in a biological specimen. Macrophages to Non-Squamous Epithelial Cells Ratio Measurement Macrophages/Total Cells A relative measurement (ratio or percentage) of the macrophages to total cells in a biological specimen. Macrophage to Total Cell Ratio Measurement Macroscopic Blood Visible Blood A measurement of the blood in body products such as a urine or stool sample, and visibly detectable on gross examination. Macroscopic Blood Measurement Magnesium A measurement of the magnesium in a biological specimen. Magnesium Measurement Magnesium, Ionized A measurement of the ionized magnesium in a biological specimen. Ionized Magnesium Measurement Magnesium/Creatinine A relative measurement (ratio or percentage) of the magnesium to creatinine in a biological specimen. Magnesium to Creatinine Ratio Measurement Malignant Cells, NOS A measurement of the malignant cells of all types in a biological specimen. Malignant Cell Count Malignant Cells, NOS/Blood Cells A relative measurement (ratio or percentage) of the malignant cells of all types to all blood cells in a biological specimen. Malignant Cell to Blood Cell Ratio Measurement Malondialdehyde MDA A measurement of the malondialdehyde in a biological specimen. Malondialdehyde Measurement Mannitol A measurement of the mannitol in a biological specimen. Mannitol Measurement Mast Cells Mastocytes A measurement of the mast cells in a biological specimen. Mast Cell Count Mast Cells/Leukocytes A relative measurement (ratio or percentage) of mast cells to total leukocytes in a biological specimen. Mast Cells to Leukocytes Ratio Measurement Mast Cells/Total Cells A relative measurement (ratio or percentage) of the mast cells to total cells in a biological specimen. Mast Cell to Total Cell Ratio Measurement C-Kit CD117 KIT Proto-Oncogene, Receptor Tyrosine Kinase Mast/Stem Cell Growth Factor Rec Kit Mast/Stem Cell Growth Factor Receptor Kit A measurement of the mast/stem cell growth factor receptor kit in a biological specimen. Mast/Stem Cell Growth Factor Receptor Kit Measurement Interstitial Collagenase Matrix Metalloproteinase 1 A measurement of the matrix metalloproteinase 1 in a biological specimen. Matrix Metalloproteinase 1 Measurement Matrix Metalloproteinase 10 Stromelysin 2 A measurement of the matrix metalloproteinase 10 in a specimen. Matrix Metalloproteinase 10 Measurement Macrophage Elastase Macrophage Metalloelastase Matrix Metallopeptidase 12 Matrix Metalloproteinase 12 MME A measurement of the matrix metalloproteinase 12 in a specimen. Matrix Metalloproteinase 12 Measurement CLG3 Collagenase 3 Matrix Metalloproteinase 13 A measurement of the matrix metalloproteinase 13 in a specimen. Matrix Metalloproteinase 13 Measurement Gelatinase A Matrix Metalloproteinase 2 A measurement of the matrix metalloproteinase 2 in a biological specimen. Matrix Metalloproteinase 2 Measurement Matrix Metalloproteinase 3 Stromelysin 1 A measurement of the matrix metalloproteinase 3 in a biological specimen. Matrix Metalloproteinase 3 Measurement Matrilysin Matrix Metalloproteinase 7 A measurement of the matrix metalloproteinase 7 in a biological specimen. Matrix Metalloproteinase 7 Measurement Matrix Metalloproteinase 8 Neutrophil Collagenase A measurement of the matrix metalloproteinase 8 in a biological specimen. Matrix Metalloproteinase 8 Measurement Gelatinase B Matrix Metalloproteinase 9 A measurement of the matrix metalloproteinase 9 in a biological specimen. Matrix Metalloproteinase 9 Measurement Mature Plasma Cells Plasmacytes Plasmocytes A measurement of the mature plasma cells (plasmacytes) in a biological specimen. Mature Plasma Cell Count Mature Plasma Cells/Lymphocytes A relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to all lymphocytes in a biological specimen. Mature Plasma Cell to Lymphocyte Ratio Measurement Mature Plasma Cells/Total Cells A relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to total cells in a biological specimen (for example a bone marrow specimen). Mature Plasma Cell to Total Cell Ratio Measurement Erythroid Precursors/Total Cells Maturing Erythroid Cells/Total Cells Maturing Erythroid/Total Cells Total Erythroid Precursors/Total Cells A relative measurement (ratio or percentage) of the maturing erythroid cells to total cells in a biological specimen. Maturing Erythroid Cell to Total Cell Ratio Measurement Maturing Myeloid/Total Cells A relative measurement (ratio or percentage) of the maturing myeloid cells to total cells in a biological specimen. Maturing Myeloid Cell to Total Cell Ratio Measurement Maximum Clot Amplitude Maximum Clot Firmness A measurement of the maximum firmness of a clot. Maximum Clot Firmness Measurement Maximum Clot Lysis Maximum Lysis A relative measurement (percentage) of the decrease in amplitude of the waveform at rotational thromboelastometry test completion. Maximum Clot Lysis Measurement May-Hegglin Anomaly A measurement of the May-Hegglin anomaly in a blood sample. This anomaly is characterized by large, misshapen platelets and the presence of Dohle bodies in leukocytes. May-Hegglin Anomaly Measurement Mazindol A measurement of the mazindol in a biological specimen. Mazindol Measurement MCV Reticulocytes MCVr Mean Corpuscular Volume Reticulocytes A measurement of the mean volume of reticulocytes in a biological specimen. Reticulocyte Mean Corpuscular Volume Mean Platelet Component A measurement of the mean platelet component (platelet activity) in a blood specimen. Mean Platelet Component Measurement Mean Platelet Dry Mass A measurement of the mean platelet dry mass in a biological specimen. Mean Platelet Dry Mass Mean Platelet Volume A measurement of the average size of the platelets present in a blood sample. Mean Platelet Volume Measurement Meconium A measurement of the meconium in a biological specimen. Meconium Measurement Medazepam A measurement of the medazepam present in a biological specimen. Medazepam Measurement Medium Absorption Retic/Reticulocytes A relative measurement (ratio or percentage) of the medium absorption reticulocytes to total reticulocytes in a biological specimen. Medium Absorption Reticulocytes to Total Reticulocytes Ratio Measurement Medium Absorption Reticulocytes A measurement of the medium absorption reticulocytes in a biological specimen. Medium Absorption Reticulocyte Measurement Mefenorex A measurement of the mefenorex in a biological specimen. Mefenorex Measurement Megakaryoblasts A measurement of the megakaryoblasts in a biological specimen. Megakaryoblast Cell Count Megakaryoblasts/Leukocytes A relative measurement (ratio or percentage) of megakaryoblasts to total leukocytes in a biological specimen. Megakaryoblasts to Leukocytes Ratio Measurement Megakaryoblasts/Total Cells A relative measurement (ratio or percentage) of the megakaryoblasts to total cells in a biological specimen (for example a bone marrow specimen). Megakaryoblast to Total Cell Ratio Measurement Megakaryocyte and Megakaryoblast Morph Megakaryocyte and Megakaryoblast Morphology An examination or assessment of the form and structure of megakaryoblasts and megakaryocytes. Megakaryocyte and Megakaryoblast Morphology Assessment Megakaryocytes A measurement of the megakaryocytes per unit of a biological specimen. Megakaryocyte Count Megakaryocytes/Leukocytes A relative measurement (ratio or percentage) of the megakaryocytes to leukocytes in a biological specimen. Megakaryocytes to Leukocytes Ratio Measurement Megakaryocytes/Total Cells A relative measurement (ratio or percentage) of the megakaryocytes to total cells in a biological specimen (for example a bone marrow specimen). Megakaryocyte to Total Cell Ratio Measurement Melatonin A measurement of the melatonin hormone in a biological specimen. Melatonin Measurement Meningeal Cells A measurement of the mengingeal cells in a biological specimen. Meningeal Cell Count Meningeal Cells/Total Cells A relative measurement (ratio or percentage) of the meningeal cells to total cells in a biological specimen. Meningeal Cell to Total Cell Ratio Measurement Meperidine A measurement of the meperidine in a biological specimen. Meperidine Measurement Mephedrone A measurement of the mephedrone in a biological specimen. Mephedrone Measurement Meprobamate A measurement of the meprobamate in a biological specimen. Meprobamate Measurement Hg Mercury A measurement of the mercury in a specimen. Mercury Measurement 3,4,5-trimethoxyphenethylamine Mescaline A measurement of the mescaline in a biological specimen. Mescaline Measurement Mesoridazine A measurement of the mesoridazine in a biological specimen. Mesoridazine Measurement Mesothelial Cells A measurement of the mesothelial cells in a biological specimen. Mesothelial Cells Count Mesothelial Cells/Leukocytes A relative measurement (ratio or percentage) of the mesothelial cells to total leukocytes in a biological specimen. Mesothelial Cells to Leukocytes Ratio Measurement Mesterelone Mesterolone A measurement of the mesterolone in a biological specimen. Mesterolone Measurement Metamyelocytes A measurement of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) in a biological specimen. Metamyelocyte Count Metamyelocytes/Leukocytes A relative measurement (ratio or percentage) of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) to all leukocytes in a biological specimen. Metamyelocyte to Leukocyte Ratio Measurement Metamyelocytes/Total Cells A relative measurement (ratio or percentage ) of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) to total cells in a biological specimen (for example a bone marrow specimen). Metamyelocyte to Total Cell Ratio Measurement Metanephrine Excretion Rate A measurement of the amount of metanephrine being excreted in a biological specimen over a defined amount of time (e.g. one hour). Metanephrine Excretion Rate Metadrenaline Metanephrine A measurement of the metanephrine in a biological specimen. Metanephrine Measurement Metanephrine+Normetanephrine Excr Rate Metanephrine+Normetanephrine Excretion Rate A measurement of the amount of metanephrine and normetanephrine being excreted in a biological specimen over a defined amount of time (e.g., one hour). Metanephrine and Normetanephrine Excretion Rate Metanephrine+Normetanephrine A measurement of the metanephrine and normetanephrine in a biological specimen. Metanephrine and Normetanephrine Measurement Metanephrine, Free A measurement of the free metanephrine in a biological specimen. Free Metanephrine Measurement Acidophilic Erythroblast Metarubricyte Orthochromatophilic Normoblast Orthochromic Erythroblast Orthochromic Normoblast A measurement of the metarubricytes in a biological specimen. Metarubricyte Count Metarubricyte/Total Cells A relative measurement (ratio or percentage) of the metarubricytes to total cells in a biological specimen. Metarubricyte to Total Cell Ratio Measurement Metarubricytes/Leukocytes A relative measurement (ratio or percentage) of the metarubricytes to leukocytes in a biological specimen. Metarubricyte to Leukocyte Ratio Measurement Methadone A measurement of the methadone present in a biological specimen. Methadone Measurement Methamphetamine A measurement of the methamphetamine drug present in a biological specimen. Methamphetamine Measurement CH4 Methane A measurement of the methane in a biological specimen. Methane Measurement Methanol A measurement of the methanol in a biological specimen. Methanol Measurement Methaqualone A measurement of the methaqualone present in a biological specimen. Methaqualone Measurement Methasterone A measurement of the methasterone in a biological specimen. Methasterone Measurement Ephedrone Methcathinone A measurement of the methcathinone in a biological specimen. Methcathinone Measurement Methemoglobin A measurement of the methemoglobin in a biological specimen. Methemoglobin Measurement FMET HB Fractionated Methemoglobin Methemoglobin/Total Hemoglobin A relative measurement (ratio or percentage) of the amount of methemoglobin compared to total hemoglobin in a biological specimen. Methemoglobin to Total Hemoglobin Ratio Measurement Methionine A measurement of the methionine in a biological specimen. Methionine Measurement Methohexital A measurement of the methohexital in a biological specimen. Methohexital Measurement Methylmalonate Methylmalonic Acid A measurement of the methylmalonic acid in a biological specimen. Methylmalonic Acid Measurement Methylphenidate A measurement of the methylphenidate in a biological specimen. Methylphenidate Measurement Mephobarbital Methylphenobarbital A measurement of the methylphenobarbital in a biological specimen. Mephobarbital Measurement Methyltestosterone A measurement of the methyltestosterone in a biological specimen. Methyltestosterone Measurement Methyltransferase A measurement of the total methyltransferase in a biological specimen. Methyltransferase Measurement Methyprylon A measurement of the methyprylon in a biological specimen. Methyprylon Measurement MHC Class I Chain Related Protein A A measurement of the MHC class I chain related protein A in a biological specimen. MHC Class I Chain Related Protein A Measurement Microcytes A measurement of the microcytes in a biological specimen. Microcyte Count Mid Cell Fraction Mid Cells A measurement of the mid cell fraction, including eosinophils, basophils, monocytes and other precursor white blood cells, in a biological specimen. Mid Cell Fraction Measurement Mid-Reg Pro-Atrial Natriuretic Peptide Mid-Regional Pro-Atrial Natriuretic Peptide MR-proANP MRproANP A measurement of the mid-regional pro-atrial natriuretic peptide in a biological specimen. Mid-Regional Pro-Atrial Natriuretic Peptide Measurement Midazolam A measurement of the midazolam present in a biological specimen. Midazolam Measurement Milnacipran A measurement of the milnacipran in a biological specimen. Milnacipran Measurement Mixed Casts A measurement of the mixed (the cast contains a mixture of cell types) casts present in a biological specimen. Mixed Cast Count Mixed Leukocyte Reaction Mixed Lymphocyte Reaction A measurement of the histocompatibility at the HL-A locus between two populations of lymphocytes taken from two separate individuals. Mixed Lymphocyte Reaction Test Modafinil A measurement of the modafinil in a biological specimen. Modafinil Measurement Molindone A measurement of the molindone in a biological specimen. Molindone Measurement Monoamine Oxidase A measurement of the total monoamine oxidase in a biological specimen. Monoamine Oxidase Measurement Monoblasts A measurement of the monoblast cells in a biological specimen. Monoblast Count Monoblasts/Leukocytes A relative measurement (ratio or percentage) of the monoblasts to leukocytes in a biological specimen. Monoblast to Leukocyte Ratio Measurement Monoblasts/Total Cells A relative measurement (ratio or percentage) of the monoblasts to total cells in a biological specimen. Monoblast to Total Cell Ratio Measurement Immunoglobulin Immunofixation Interpretation Monoclonal Prot Immunoglobulin Isotype Monoclonal Protein Immunoglobulin Class Monoclonal Protein Immunoglobulin Isotype The identification of the monoclonal protein immunoglobulin isotype in a biological specimen. Monoclonal Protein Immunoglobulin Isotype Determination M Protein Excretion Rate M-Spike Protein Excretion Rate Monoclonal Protein Excretion Rate Monoclonal Protein Spike Excretion Rate Myeloma Protein Excretion Rate A measurement of the amount of Monoclonal Protein being excreted in a biological specimen over a defined amount of time (e.g. one hour). Monoclonal Protein Excretion Rate Monoclonal Protein Band Region Monoclonal Protein Region Monoclonal Protein Spike Region The identification of the protein zone (e.g., alpha-1 globulin, beta globulin, etc.) within which the monoclonal protein is observed. Monoclonal Protein Spike Region Identification Abnormal Gamma Protein Band M Protein M-Spike Paraprotein M-Spike Protein Monoclonal Immunoglobulin Protein Monoclonal Protein Monoclonal Protein Spike Myeloma Protein Paraprotein A measurement of homogenous immunoglobulin resulting from the proliferation of a single clone of plasma cells in a biological specimen. Monoclonal Protein Measurement M Protein/Total Protein M-Spike Protein/Total Protein Monoclonal Protein Spike/Total Protein Monoclonal Protein/Total Protein Myeloma Protein/Total Protein A relative measurement (ratio or percentage) of the monoclonal protein to total protein in a biological specimen. Monoclonal Protein to Total Protein Ratio Measurement CCL2 Chemokine (C-C Motif) Ligand 2 Monocyte Chemoattractant Protein-1 Monocyte Chemotactic Protein 1 A measurement of the monocyte chemotactic protein 1 in a biological specimen. Monocyte Chemotactic Protein 1 Measurement CCL2/Creatinine Chemokine (C-C Motif) Ligand 2/Creatinine Monocyte Chemotactic Protein 1/Creatinine Monocyte Chemotactic Protein1/Creatinine A relative measurement (ratio or percentage) of the monocyte chemotactic protein 1 to creatinine in a biological specimen. Monocyte Chemotactic Protein 1 to Creatinine Ratio Measurement Monocyte Distribution Width A measurement of the monocyte volume dispersion in a biological specimen. Monocyte Distribution Width Measurement Monocytes and Macrophages/Leukocytes A relative measurement (ratio or percentage) of the monocytes and macrophages to total leukocytes in a biological specimen. Monocytes and Macrophages to Leukocytes Ratio Measurement Monocytes A measurement of the monocytes in a biological specimen. Monocyte Count Monocytes/Leukocytes A relative measurement (ratio or percentage) of the monocytes to leukocytes in a biological specimen. Monocyte to Leukocyte Ratio Monocytes/Macrocytes A relative measurement (ratio or percentage) of the monocytes to macrocytes present in a sample. Monocytes to Macrocytes Ratio Measurement Monocytes/Non-Squam Epi Cells A relative measurement (ratio or percentage) of the monocytes to non-squamous epithelial cells in a biological specimen. Monocytes to Non-Squamous Epithelial Cells Ratio Measurement Monocytes/Total Cells A relative measurement (ratio or percentage) of the monocytes to total cells in a biological specimen (for example a bone marrow specimen). Monocytes to Total Cell Ratio Measurement Monocytoid Cells A measurement of the monocytoid cells in a biological specimen. Monocytoid Cell Count Monocytoid Cells/Leukocytes A relative measurement (ratio or percentage) of the monocytoid cells to leukocytes in a biological specimen. Monocytoid Cells to Leukocytes Ratio Measurement Monocytoid Cells/Total Cells A relative measurement (ratio or percentage) of the monocytoid cells to total cells in a biological specimen. Monocytoid Cell to Total Cell Ratio Measurement MHBMA Monohydroxy-3-butenyl Mercapturic Acid Monohydroxybutenyl Mercapturate Monohydroxybutenyl Mercapturic Acid A measurement of the monohydroxybutenyl mercapturic acid in a specimen. Monohydroxybutenyl Mercapturic Acid Measurement Monomethylarginine Tilarginine A measurement of the monomethylarginine in a biological specimen. Monomethylarginine Measurement Mononuclear Cells Atypical A measurement of the atypical mononuclear cells in a biological specimen. Atypical Mononuclear Cell Count Mononuclear Cells Atypical/Leukocytes A relative measurement (ratio or percentage) of the atypical mononuclear cells to leukocytes in a biological specimen. Atypical Mononuclear Cells to Leukocytes Ratio Measurement Mononuclear Cells Mononucleated Cells A measurement of the mononuclear cells in a biological specimen. Mononuclear Cell Count Monosodium Urate Crystals Sodium Urate Crystals A measurement of the monosodium urate crystals present in a biological specimen. Monosodium Urate Crystal Measurement Morphine A measurement of the morphine present in a biological specimen. Morphine Measurement Motile Sperm/Total Sperm A relative measurement (ratio or percentage) of the motile sperm to total sperm in a biological specimen. Motile Sperm to Total Sperm Ratio Measurement Mu Glutathione-S-Transferase A measurement of the mu form of glutathione S-transferase in a biological specimen. Mu Glutathione-S-Transferase Measurement Mu Glutathione-S-Transferase/Creatinine A relative measurement (ratio or percentage) of the mu gamma glutamyl transpeptidase to creatinine in a biological specimen. Mu Glutathione-S-Transferase to Creatinine Ratio Measurement Mucous Threads A measurement of the mucous threads present in a biological specimen. Mucous Thread Measurement Murinoglobulin A measurement of the murinoglobulin in a biological specimen. Murinoglobulin Measurement Myelin Basic Protein A measurement of the myelin basic protein in a biological specimen. Myelin Basic Protein Measurement Myeloblasts Myeloid Blasts A measurement of the myeloblast cells in a biological specimen. Myeloblast Count Myeloblasts/Leukocytes A relative measurement (ratio or percentage) of the myeloblasts to leukocytes in a biological specimen. Myeloblast to Leukocyte Ratio Myeloblasts/Total Cells A relative measurement (ratio or percentage) of the myeloblasts to total cells in a biological specimen (for example a bone marrow specimen). Myeloblast to Total Cell Ratio Measurement Myelocytes A measurement of the myelocytes in a biological specimen. Myelocyte Count Myelocytes/Leukocytes A relative measurement (ratio or percentage) of the myelocytes to leukocytes in a biological specimen. Myelocyte to Leukocyte Ratio Myelocytes/Total Cells A relative measurement (ratio or percentage) of the myelocytes to total cells in a biological specimen (for example a bone marrow specimen). Myelocyte to Total Cell Ratio Measurement CD14 Antigen CD14 Molecule Monocyte Differentiation Antigen CD14 My23 Antigen Myeloid Cell-Specific LEU-Rich Glycoprot Myeloid Cell-Specific Leucine-Rich Glycoprotein SCD14 Soluble CD14 A measurement of the myeloid cell-specific leucine-rich glycoprotein in a biological specimen. Myeloid Cell-Specific Leucine-Rich Glycoprotein Measurement Myeloid Maturation Index A relative measurement (ratio) of the sum of myeloid maturation phase cells (pool) to the sum of myeloid proliferative phase cells (pool) in a biological specimen. Myeloid Maturation Index Myeloid Maturation Pool A measurement of the myeloid maturation phase cells (metamyelocytes, band neutrophils, and segmented neutrophils) in a biological specimen. Myeloid Maturation Pool Count Myeloid Progenitor Cells A measurement of the myeloid progenitor cells in a biological specimen. Myeloid Progenitor Cell Count Myeloid Progenitor Cells/Total Cells A relative measurement (ratio or percentage) of the myeloid progenitor cells to total cells in a biological specimen. Myeloid Progenitor Cell to Total Cell Ratio Measurement Myeloid Proliferation Index A relative measurement (ratio) of the sum of myeloid proliferative phase cells (pool) to the sum of myeloid maturation phase cells (pool) in a biological specimen. Myeloid Proliferation Index Myeloid Proliferation Pool A measurement of the myeloid proliferative phase cells (myeloblasts, promyelocytes, and myelocytes) in a biological specimen. Myeloid Proliferation Pool Count Myeloperoxidase Index The mean peroxidase activity index or staining intensity of the neutrophil population relative to the archetype. Neutrophil Myeloperoxidase Index Myeloperoxidase A measurement of the myeloperoxidase in a biological specimen. Myeloperoxidase Measurement Myoglobin A measurement of myoglobin in a biological specimen. Myoglobin Measurement Myoglobin/Creatinine A relative measurement (ratio or percentage) of the myoglobin to creatinine present in a sample. Myoglobin to Creatinine Ratio Measurement Cardiac myosin light chain 1 Myosin light chain 1, slow-twitch muscle B/ventricular isoform Myosin Light Chain 3 A measurement of myosin light chain 3 in a biological specimen. Myosin Light Chain 3 Measurement Dimethyltryptamine DMT N,N-Dimethyltryptamine A measurement of the N,N-dimethyltryptamine in a biological specimen. N,N-Dimethyltryptamine Measurement N-Acetyl Glucosamide N-Acetyl Glucosamine A measurement of N-acetyl glucosamide (sugar derivative) in a biological specimen. N-Acetyl Glucosamide Measurement N-Acetyl Glucosamide/Creatinine A relative measurement (ratio or percentage) of the N-acetyl glucosamide to creatinine in a biological specimen. N-Acetyl Glucosamide to Creatinine Ratio Measurement N-acetyl-B-D-glucosaminidase/Creatinine A relative measurement (ratio or percentage) of the N-acetyl-beta-D-glucosaminidase to creatinine in a biological specimen. N-acetyl-Beta-D-glucosaminidase to Creatinine Ratio Measurement Beta-N-acetyl-D-glucosaminidase N-acetyl-beta-D-glucosaminidase A measurement of the N-acetyl-beta-D-glucosaminidase (enzyme) in a biological specimen. N-acetyl-beta-D-glucosaminidase Measurement N-Demethylase A measurement of the N-Demethylase in a biological specimen. N-Demethylase Measurement Desmethylolanzapine DMO N-Desmethylolanzapine Norolanzapine A measurement of the N-desmethylolanzapine in a biological specimen. N-Desmethylolanzapine Measurement N-Desmethyltramadol N-DSMT A measurement of the N-desmethyltramadol in a biological specimen. N-Desmethyltramadol Measurement N-methylhistamine A measurement of the N-methylhistamine in a biological specimen. N-Methylhistamine Measurement N-Nitrosonornicotine NNN A measurement of the N-nitrosonornicotine in a specimen. N-Nitrosonornicotine Measurement N-telopeptide A measurement of the N-telopeptide in a biological specimen. N-Telopeptide Measurement N-telopeptide/Creatinine A relative measurement (ratio or percentage) of the N-telopeptide to creatinine in a biological specimen. N-telopeptide to Creatinine Ratio Measurement N-terminal pro-Atrial Natriuretic Peptide N-Terminal ProA-type Natriuretic Peptide NT proANP II A measurement of the N-terminal proA-type natriuretic peptide in a biological specimen. N-Terminal ProA-type Natriuretic Peptide Measurement N-terminal pro-Brain Natriuretic Peptide N-Terminal ProB-type Natriuretic Peptide NT proBNP II A measurement of the N-terminal proB-type natriuretic peptide in a biological specimen. N-Terminal ProB-type Natriuretic Peptide Measurement N-acetyl-beta-D-glucosaminidase Excretion Rate NAGASE Excretion Rate A measurement of the amount of N-acetyl-beta-D-glucosaminidase being excreted in a biological specimen over a defined amount of time (e.g. one hour). N-acetyl-beta-D-glucosaminidase Excretion Rate Allorphine Antorphine N-allylnormorphine Nalorphine A measurement of the nalorphine in a biological specimen. Nalorphine Measurement Nandrolone Norandrostenolone Nortestosterone A measurement of the nandrolone in a biological specimen. Nandrolone Measurement Naphyrone A measurement of the naphyrone in a biological specimen. Naphyrone Measurement Natural Killer Cell Activity Natural Killer Cell Function A measurement of the natural killer cell function in a biological specimen. Natural Killer Cell Activity Measurement Natural Killer Cells A measurement of the total natural killer cells in a biological specimen. Natural Killer Cell Count Monoclonal Plasma Cells Monotypic Plasma Cells Neoplastic Plasma Cells A measurement of the neoplastic plasma cells in a biological specimen. Neoplastic Plasma Cell Count Neopterin A measurement of the neopterin in a biological specimen. Neopterin Measurement Nephrin NPHS1 Adhesion Molecule, Nephrin A measurement of the nephrin in a biological specimen. Nephrin Measurement Nerve Growth Factor Alpha A measurement of the nerve growth factor alpha in a biological specimen. Nerve Growth Factor Alpha Measurement Nerve Growth Factor Beta A measurement of the nerve growth factor beta in a biological specimen. Nerve Growth Factor Beta Measurement Nerve Growth Factor Gamma A measurement of the nerve growth factor gamma in a biological specimen. Nerve Growth Factor Gamma Measurement Nerve Growth Factor A measurement of the total nerve growth factor in a biological specimen. Nerve Growth Factor Measurement Neurofilament Heavy Chain Neurofilament Heavy Polypeptide Neurofilament Triplet H Protein NF-H A measurement of the neurofilament heavy polypeptide in a biological specimen. Neurofilament Heavy Polypeptide Measurement NEFL Neurofilament Light Chain Protein Neurofilament Light Polypeptide NF-L Protein Phosphatase 1, Regulatory Subunit 110 A measurement of the neurofilament light chain protein in a biological specimen. Neurofilament Light Chain Protein Measurement Neurogranin Protein Kinase C Substrate, RC3 A measurement of the neurogranin in a biological specimen. Neurogranin Measurement Neurokinin A NKA Substance K A measurement of the neurokinin A in a biological specimen. Neurokinin A Measurement Enolase 2 Gamma-enolase Neuron Specific Enolase A measurement of the neuron specific enolase in a biological specimen. Neuron Specific Enolase Measurement Neuropeptide Y A measurement of the neuropeptide Y in a biological specimen. Neuropeptide Y Measurement BDCA4 Neuropilin-1 NP1 NRP Soluble CD304 VEGF165R A measurement of the neuropilin-1 in a biological specimen. Neuropilin-1 Measurement Neurotensin NTS A measurement of the neurotensin in a biological specimen. Neurotensin Measurement Neutral Fats A measurement of the total neutral fats in a biological specimen. Neutral Fats Measurement Neutrophil Elastase A measurement of the neutrophil elastase in a biological specimen. Neutrophil Elastase Measurement Neutrophil Elastase, Polymorphonuclear A measurement of the polymorphonuclear neutrophil elastase in a biological specimen. Polymorphonuclear Neutrophil Elastase Measurement Neutrophilic Metamyelocytes A measurement of the neutrophilic metamyelocytes in a biological specimen. Neutrophilic Metamyelocyte Count Neutrophilic Metamyelocytes/Total Cells A relative measurement (ratio or percentage) of the neutrophilic metamyelocytes to total cells in a biological specimen. Neutrophilic Metamyelocyte to Total Cell Ratio Measurement Neutrophilic Myelocytes A measurement of the neutrophilic myelocytes in a biological specimen. Neutrophilic Myelocyte Count Neutrophilic Myelocytes/Lymphocytes A relative measurement (ratio or percentage) of the neutrophilic myelocytes to lymphocytes in a biological specimen (for example a bone marrow specimen). Neutrophilic Myelocytes to Lymphocytes Ratio Measurement Neutrophilic Toxic Change A measurement of any type of toxic change in cells of the neutrophilic lineage in a biological specimen. Neutrophilic Toxic Change Assessment Neutrophils Band Form A measurement of the banded neutrophils in a biological specimen. Neutrophil Band Form Count Neutrophils Band Form/ Neutrophils A relative measurement (ratio or percentage) of banded neutrophils to total neutrophils in a biological specimen. Neutrophils Band Form to Neutrophils Ratio Measurement Neutrophils Band Form/Leukocytes A relative measurement (ratio or percentage) of the banded neutrophils to leukocytes in a biological specimen. Neutrophil Band Form to Leukocyte Ratio Neutrophils Band Form/Total Cells A relative measurement (ratio or percentage) of the banded neutrophils to total cells in a biological specimen. Neutrophil Band Form to Total Cell Ratio Measurement Neutrophils A measurement of the neutrophils in a biological specimen. Absolute Neutrophil Count Neutrophils + Immature Neutrophils Neutrophils, Seg + Band Form + Precursor Neutrophils, Segmented + Band Form + Precursors A measurement of the segmented and band form neutrophils, metamyelocytes, myelocytes, promyelocytes, and myeloblasts in a biological specimen. Segmented, Band Form and Precursor Neutrophils Measurement Neutrophils, Segmented + Band Form A measurement of the segmented and band form neutrophils in a biological specimen. Segmented and Band Form Neutrophils Measurement Neutrophils, Segmented A measurement of the segmented neutrophils in a biological specimen. Segmented Neutrophil Count Neutrophils, Segmented/Leukocytes A relative measurement (ratio or percentage) of segmented neutrophils to leukocytes in a biological specimen. Segmented Neutrophil to Leukocyte Ratio Measurement Neutrophils, Segmented/Neutrophils A relative measurement (ratio or percentage) of segmented neutrophils to total neutrophils in a biological specimen. Segmented Neutrophils to Neutrophils Ratio Measurement Neutrophils, Segmented/Total Cells A relative measurement (ratio or percentage) of segmented neutrophils to total cells in a biological specimen. Segmented Neutrophil to Total Cell Ratio Measurement Neutrophils/Leukocytes A relative measurement (ratio or percentage) of the neutrophils to leukocytes in a biological specimen. Neutrophil to Leukocyte Ratio Measurement Neutrophils/Lymphocytes A relative measurement (ratio) of the neutrophils to lymphocytes in a biological specimen. Neutrophil to Lymphocyte Ratio Measurement Neutrophils/Non-Squam Epi Cells A relative measurement (ratio or percentage) of the neutrophils to non-squamous epithelial cells in a biological specimen. Neutrophils to Non-Squamous Epithelial Cells Ratio Measurement Neutrophils/Total Cells A relative measurement (ratio or percentage) of the neutrophils to total cells in a biological specimen (for example a bone marrow specimen). Neutrophil to Total Cell Ratio Measurement Niacin Vitamin B3 A measurement of the niacin in a biological specimen. Vitamin B3 Measurement Nicomorphine A measurement of the nicomorphine in a biological specimen. Nicomorphine Measurement Nicotinamide Phosphoribosyltransferase Visfatin A measurement of the nicotinamide phosphoribosyltransferase in a biological specimen. Nicotinamide Phosphoribosyltransferase Measurement Nicotine and/or Metabolites Nicotine Equivalents TNE Total Nicotine Equivalents A measurement of the nicotine and/or its metabolite(s) present in a specimen, for an assay that can measure both nicotine and its metabolites. Nicotine And/Or Metabolites Measurement Nicotine Glucuronide Nicotine N-glucuronide Nicotine-Glucuronide A measurement of the nicotine glucuronide in a specimen. Nicotine Glucuronide Measurement Nicotine A measurement of the nicotine in a specimen. Nicotine Measurement Nicotine, Free A measurement of the free (unbound) cotinine in a specimen. Free Nicotine Measurement 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Nicotine-Derived Nitrosamine Ketone NNK A measurement of the nicotine-derived nitrosamine ketone in a specimen. Nicotine-Derived Nitrosamine Ketone Measurement Nitrate Nitric Acid A measurement of the nitrate in a biological specimen. Nitrate Measurement Nitrazepam and/or Metabolites A measurement of the nitrazepam and/or its metabolite(s) present in a biological specimen, for an assay that can measure both nitrazepam and its metabolites. Nitrazepam and/or Metabolites Measurement Nitrazepam A measurement of the nitrazepam in a biological specimen. Nitrazepam Measurement Nitric Oxide NO A measurement of the nitric oxide in a biological specimen. Nitric Oxide Measurement Nitrite A measurement of the nitrite in a biological specimen. Nitrite Measurement Natural Killer Cells/Lymphocytes NK Cells/Lym A relative measurement (ratio or percentage) of the natural killer cells to lymphocytes in a biological specimen. Natural Killer Cells to Lymphocytes Ratio Measurement 4-(Methylnitrosamino)-4-(3-pyridyl)-1-butanol NNAL A measurement of the total 4-(methylnitrosamino)-4-(3-pyridyl)-1-butanol (NNAL) in a specimen. 4-(Methylnitrosamino)-4-(3-pyridyl)-1-Butanol Measurement Nociceptin Orphanin FQ A measurement of the nociceptin in a biological specimen. Nociceptin Measurement Non-HDL Cholesterol Non-High Density Lipoprotein A measurement of the non-high density lipoprotein cholesterol in a biological specimen. Non-High Density Lipoprotein Cholesterol Measurement Non-HDL Cholesterol/HDL Cholesterol A relative measurement (ratio or percentage) of non-high density lipoprotein cholesterol to high density lipoprotein cholesterol in a biological specimen. Non-HDL Cholesterol to HDL Cholesterol Ratio Measurement Non-HDL Cholesterol/LDL Cholesterol A relative measurement (ratio or percentage) of the non-HDL cholesterol to LDL cholesterol in a biological specimen. Non-HDL Cholesterol to LDL Cholesterol Ratio Measurement Non-Phosphorylated Tau Protein A measurement of the non-phosphorylated Tau protein in a biological specimen. Nonphosphorylated Tau Protein Measurement Non-Prostatic Acid Phosphatase A measurement of the non-prostatic acid phosphatase in a biological specimen. Non-Prostatic Acid Phosphatase Measurement Non-Squamous Epithelial Cells A measurement of the non-squamous epithelial cells in a biological specimen. Non-Squamous Epithelial Cell Count Nonhematic Cells A measurement of the cells of nonhematopoietic origin in a biological specimen. Nonhematic Cells Count Nonhematic Cells/Leukocytes A relative measurement (ratio) of the nonhematic cells to total leukocytes in a biological specimen. Nonhematic Cells to Leukocytes Ratio Measurement Norclostebol A measurement of the norclostebol in a biological specimen. Norclostebol Measurement Desmethyldiazepam N-Desmethyldiazepam Nordazepam Nordiazepam A measurement of the nordazepam present in a biological specimen. Nordazepam Measurement Nordoxepin A measurement of the nordoxepin present in a biological specimen. Nordoxepin Measurement Norepinephrine Excretion Rate A measurement of the amount of norepinephrine being excreted in a biological specimen over a defined amount of time (e.g. one hour). Norepinephrine Excretion Rate Noradrenaline Norepinephrine A measurement of the norepinephrine hormone in a biological specimen. Noradrenaline Measurement Norethandrolone A measurement of the norethandrolone in a biological specimen. Norethandrolone Measurement Norfluoxetine A measurement of the norfluoxetine in a biological specimen. Norfluoxetine Measurement Norhydrocodone A measurement of the norhydrocodone in a biological specimen. Norhydrocodone Measurement Normal Sperm/Total Sperm Sperm Morphology A measurement (ratio or percentage) of the normal spermatozoa to total spermatozoa in a biological specimen. Normal Sperm to Total Sperm Ratio Measurement Normalized Protein Catabolic Rate Normalized Protein Catabolism Rate NPCR nPCR A calculated measurement of the normalized protein catabolism rate in a biological specimen used to assess dietary protein intake in dialysis patients. Normalized Protein Catabolism Rate Normetanephrine Excretion Rate A measurement of the amount of normetanephrine being excreted in a biological specimen over a defined amount of time (e.g. one hour). Normetanephrine Excretion Rate Normetanephrine A measurement of the normetanephrine in a biological specimen. Normetanephrine Measurement Normetanephrine, Free A measurement of the free normetanephrine in a biological specimen. Free Normetanephrine Measurement Normoblasts A measurement of the normoblasts in a biological specimen. Normoblast Count Normoblasts/Total Cells A relative measurement (ratio or percentage) of the normoblasts to total cells in a biological specimen (for example a bone marrow specimen). Normoblast to Total Cell Ratio Measurement Normorphine A measurement of the normorphine in a biological specimen. Normorphine Measurement Nornicotine A measurement of the nornicotine in a biological specimen. Nornicotine Measurement Noroxycodone A measurement of the noroxycodone in a biological specimen. Noroxycodone Measurement Norpropoxyphene A measurement of the norpropoxyphene in a biological specimen. Norpropoxyphene Measurement Norsertraline A measurement of the norsertraline in a biological specimen. Norsertraline Measurement Nortriptyline A measurement of the nortriptyline in a biological specimen. Nortriptyline Measurement Nuclear Matrix Protein 22 Nuclear Mitotic Apparatus Protein 1 NUMA1 A measurement of the nuclear matrix protein 22 in a biological specimen. Nuclear Matrix Protein 22 Measurement Nuclear Swelling A measurement of the expansion of the nucleus of the cells in a biological specimen. Nuclear Swelling Measurement Nucleated Cells A measurement of the nucleated cells in a biological specimen. Nucleated Cell Count Nucleated Erythrocytes Nucleated Red Blood Cells A measurement of the nucleated erythrocytes (large, immature nucleated erythrocytes) in a biological specimen. Nucleated Red Blood Cell Count Nucleated Erythrocytes/Erythrocytes Nucleated Red Blood Cells/Erythrocytes A relative measurement (ratio or percentage) of the nucleated erythrocytes (large, immature nucleated erythrocytes) to all erythrocytes in a biological specimen. Nucleated Red Blood Cell to Erythrocyte Ratio Measurement Nucleated Erythrocytes/Leukocytes A relative measurement (ratio or percentage) of nucleated erythrocytes to leukocytes in a biological specimen. Nucleated Erythrocyte to Leukocyte Ratio Measurement O-Demethylase A measurement of the O-Demethylase in a biological specimen. O-Demethylase Measurement Desmetramadol O-Desmethyltramadol O-DSMT A measurement of the O-desmethyltramadol in a biological specimen. O-Desmethyltramadol Measurement 2-Methylaniline 2-Toluidine o-Toluidine Ortho-Toluidine A measurement of the o-toluidine in a specimen. o-Toluidine Measurement Occult Blood A measurement of the blood in body products such as a urine or stool sample, not detectable on gross examination. Occult Blood Measurement Olanzapine A measurement of the olanzapine in a biological specimen. Olanzapine Measurement Oligoclonal Bands A measurement of the oligoclonal bands in a biological specimen. Oligoclonal Bands Measurement Oncostatin M A measurement of the oncostatin M in a biological specimen. Oncostatin M Measurement Opiate A measurement of any opiate class drug present in a biological specimen. Opiate Measurement Ornithine A measurement of the ornithine in a biological specimen. Ornithine Measurement Osmolality A measurement of the osmoles of solute per unit of biological specimen. Osmolality Measurement Osmolarity A measurement of the osmoles of solute per liter of solution. Osmolarity Measurement Osteocalcin A measurement of the osteocalcin in a biological specimen. Osteocalcin Measurement Osteopontin A measurement of the osteopontin in a biological specimen. Osteopontin Measurement Osteopontin/Creatinine A relative measurement (ratio or percentage) of the osteopontin to creatinine in a biological specimen. Osteopontin to Creatinine Ratio Measurement OCIF Osteoclastogenesis Inhibitory Factor Osteoprotegerin TNFRS11B Tumor Necrosis Factor Receptor Superfamily Member 11b A measurement of the osteoprotegerin in a biological specimen. Osteoprotegerin Measurement Ovalocytes A measurement of the ovalocytes (oval shaped cell with rounded ends and a long axis less than twice its short axis) in a biological specimen. Ovalocyte Count Oxalate Excretion Rate A measurement of the amount of oxalate being excreted in a biological specimen over a defined amount of time (e.g. one hour). Oxalate Excretion Rate Ethanedioate Oxalate A measurement of the oxalate in a biological specimen. Oxalate Measurement Oxalate/Creatinine A relative measurement (ratio or percentage) of the oxalate to creatinine in a biological specimen. Oxalate to Creatinine Ratio Measurement Ossandrolone Oxandrolone A measurement of the oxandrolone in a biological specimen. Oxandrolone Measurement Oxazepam A measurement of the oxazepam present in a biological specimen. Oxazepam Measurement Oxidized LDL Cholesterol A measurement of the oxidized low density lipoprotein cholesterol in a biological specimen. Oxidized LDL Cholesterol Measurement Oxycodone Oxycontin A measurement of the oxycodone present in a biological specimen. Oxycodone Measurement Oxygen Capacity A measurement of the maximum amount of oxygen that can be combined chemically with hemoglobin in a volume of blood. Oxygen Capacity Measurement Oxygen Content A measurement of the amount of oxygen content in a biological specimen. Oxygen Measurement Oxygen Saturation A measurement of the oxygen-hemoglobin saturation of a volume of blood. Oxygen Saturation Measurement Oxygen Saturation/Fraction Inspired O2 A relative measurement (ratio or percentage) of the oxygen-hemoglobin saturation of a volume of blood to the volumetric fraction of oxygen in the inhaled gas. Oxygen Saturation/Fraction Inspired O2 Oxyhemoglobin A measurement of the oxyhemoglobin, oxygen-bound hemoglobin, in a biological specimen. Oxyhemoglobin Measurement FO2 Hb Fractioned Oxyhemoglobin Oxyhemoglobin/Total Hemoglobin A relative measurement (ratio or percentage) of the amount of oxyhemoglobin compared to total hemoglobin in a biological specimen. Oxyhemoglobin to Total Hemoglobin Ratio Measurement Oxymesterone A measurement of the oxymesterone in a biological specimen. Oxymesterone Measurement Oxymethalone Oxymethenolone Oxymetholone A measurement of the oxymetholone in a biological specimen. Oxymetholone Measurement Oxymorphone A measurement of the Oxymorphone in a biological specimen. Oxymorphone Measurement Oxytocin Oxytoxin A measurement of the oxytocin hormone in a biological specimen. Oxytocin Measurement GMP-140 P-Selectin A measurement of total P-selectin in a biological specimen. P-Selectin Measurement P50 Oxygen A measurement of the partial pressure of oxygen when hemoglobin is half saturated in a biological specimen. P50 Oxygen Measurement pACC/ACC pAcetyl-CoA Carboxylase/ACC Phosphorylated Acetyl-CoA Carboxylase/Acetyl-CoA Carboxylase A relative measurement (ratio or percentage) of the phosphorylated acetyl-CoA carboxylase to total acetyl-CoA carboxylase in a biological specimen. Phosphorylated Acetyl-CoA Carboxylase to Acetyl-CoA Carboxylase Ratio Measurement Pancreatic Elastase 1 A measurement of the pancreatic elastase 1 in a biological specimen. Pancreatic Elastase Measurement Pancreatic Elastase 1, Polymorphonuclear A measurement of the polymorphonuclear pancreatic elastase 1 in a biological specimen. Polymorphonuclear Pancreatic Elastase Measurement Pancreatic Polypeptide A measurement of the pancreatic polypeptide in a biological specimen. Pancreatic Polypeptide Measurement Pappenheimer Bodies A measurement of the cells containing Pappenheimer Bodies (violet or blue staining ferritin granules usually found along the periphery of the red blood cells) in a biological specimen. Pappenheimer Body Count 4-Aminohippurate Clearance P-Amino Hippuric Acid Clearance P-Aminohippurate Clearance PAH Clearance Para Aminohippurate Clearance Para Aminohippuric Acid Clearance Para-Amino Hippuric Acid Clearance Para-Aminohippurate Clearance A measurement of the volume of serum or plasma that would be cleared of para aminohippurate by excretion of urine for a specified unit of time (e.g. one minute). Para Aminohippurate Clearance Measurement 4-Aminohippurate P-Amino Hippuric Acid P-Aminohippurate PAH Para Aminohippurate Para Aminohippuric Acid Para-Amino Hippuric Acid Para-Aminohippurate A measurement of the para aminohippurate in a biological specimen. Para Aminohippurate Measurement Para-Aminobenzoate Para-Aminobenzoic Acid A measurement of the para-aminobenzoate in a biological specimen. Para-Aminobenzoate Measurement Para-Fluorofentanyl A measurement of the para-fluorofentanyl in a biological specimen. Para-Fluorofentanyl Measurement Paraldehyde A measurement of the paraldehyde in a biological specimen. Paraldehyde Measurement Aromatic Esterase 1 Arylesterase 1 Arylesterase B-Type Esterase A Paraoxonase 1 Paraoxonase B-Type Paraoxonase-1 PON 1 A measurement of the paraoxonase 1 in a biological specimen. Paraoxonase 1 Measurement Parathyrin Hormone, C-Terminal Parathyroid Hormone, C-Terminal A measurement of the C-terminal fragment of parathyroid hormone in a biological specimen. C-Terminal Parathyroid Hormone Measurement Parathyrin Hormone, Fragmented Parathyroid Hormone, Fragmented A measurement of the fragmented parathyroid hormone in a biological specimen. Fragmented Parathyroid Hormone Measurement Parathyrin, Intact Parathyroid Hormone, Intact A measurement of the intact parathyroid hormone (consisting of amino acids 1-84 or 7-84) in a biological specimen. Intact Parathyroid Hormone Measurement Parathyrin Hormone, Mid-Molecule Parathyroid Hormone, Mid-Molecule A measurement of the mid-molecule fragment of parathyroid hormone in a biological specimen. Mid-Molecule Parathyroid Hormone Measurement Parathyrin Hormone, N-Terminal Parathyroid Hormone, N-Terminal A measurement of the N-terminal fragment of parathyroid hormone in a biological specimen. N-Terminal Parathyroid Hormone Measurement Parathyrin Hormone, Whole Parathyroid Hormone, Whole A measurement of the whole parathyroid hormone (consisting of amino acids 1-84) in a biological specimen. Whole Parathyroid Hormone Measurement Parathyrin Hormone-related Protein Parathyroid Hormone-related Peptide Parathyroid Hormone-related Protein A measurement of parathyroid hormone-related protein in a biological specimen. Parathyroid Hormone-related Protein Measurement 1,7-dimethylxanthine Paraxanthine A measurement of the paraxanthine in a specimen. Paraxanthine Measurement DJ-1 GATD2 PARK7 Parkinson Disease Protein 7 Parkinsonism Associated Deglycase Protein Deglycase DJ-1 Protein DJ-1 A measurement of the Parkinson disease protein 7 in a biological specimen. Parkinson Disease Protein 7 Measurement Paroxetine A measurement of the paroxetine present in a biological specimen. Paroxetine Measurement Partial Pressure Carbon Dioxide Adj Temp A measurement of the pressure of carbon dioxide, which has been adjusted for body temperature, in a biological specimen. Partial Pressure of Carbon Dioxide Adjusted for Body Temperature Measurement Partial Pressure Carbon Dioxide A measurement of the pressure of carbon dioxide in a biological specimen. Partial Pressure of Carbon Dioxide Measurement Partial Pressure Oxygen Adj for Temp A measurement of the pressure of oxygen, which has been adjusted for body temperature, in a biological specimen. Partial Pressure of Oxygen Adjusted for Body Temperature Measurement PaO2 Partial Pressure Oxygen Po2 pO2 A measurement of the pressure of oxygen in a biological specimen. Partial Pressure of Oxygen Measurement Partial Thromboplastin Time A measurement of the length of time that it takes for clotting to occur when no activating reagents are added to a biological specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture. Partial Thromboplastin Time Non-Hyalin Casts Non-Hyaline Casts Pathologic Casts A measurement of the pathologic (non-hyaline) casts present in a biological specimen. Pathologic Cast Measurement PB-22 3-carboxyindole A measurement of the synthetic cannabinoid metabolite PB-22 3-carboxyindole in a biological specimen. PB-22 3-carboxyindole Measurement PCA3 mRNA/PSA mRNA A relative measurement (ratio) of the prostate cancer antigen 3 mRNA to prostate specific antigen mRNA in a biological specimen. PCA3 mRNA to PSA mRNA Ratio Measurement Pelger Huet Anomaly Pelger-Huet Cells PHA A measurement of the Pelger-Huet Anomaly (nuclei of granulocytes appear rod-like, bilobed, peanut, or dumbbell shaped) in a biological specimen. Pelger Huet Anomaly Measurement Pemoline A measurement of the pemoline in a biological specimen. Pemoline Measurement Pentazocine A measurement of the pentazocine in a biological specimen. Pentazocine Measurement Pentedrone A measurement of the pentedrone in a biological specimen. Pentedrone Measurement Pentobarbital A measurement of the pentobarbital present in a biological specimen. Pentobarbital Measurement Pentylone A measurement of the pentylone in a biological specimen. Pentylone Measurement Pepsinogen A Pepsinogen I PGA PGI A measurement of the pepsinogen I in a biological specimen. Pepsinogen I Measurement Pepsinogen C Pepsinogen II PGC PGII A measurement of the pepsinogen II in a biological specimen. Pepsinogen II Measurement Pepsinogen A measurement of the pepsinogen in a biological specimen. Pepsinogen Measurement Antigen Peptide Transporter 1 Peptide Transporter TAP1 A measurement of the peptide transporter TAP1 in a biological specimen. Peptide Transporter TAP1 Measurement Peptide Tyrosine Tyrosine Peptide YY A measurement of the peptide YY in a biological specimen. Peptide YY Measurement Cyclophilin A CYPA Peptidylprolyl Isomerase A Rotamase A A measurement of the peptidylprolyl isomerase A in a biological specimen. Peptidylprolyl Isomerase A Measurement Perampanel A measurement of the perampanel in a biological specimen. Perampanel Measurement Cytolysin HPLH2 Lymphocyte Pore-Forming Protein Perforin-1 A measurement of the perforin-1 in a biological specimen. Perforin-1 Measurement OSF2 Osteoblast Specific Factor 2 Periostin POSTN A measurement of the periostin in a biological specimen. Periostin Measurement Perphenazine A measurement of the perphenazine in a biological specimen. Perphenazine Measurement pH Adjusted for Body Temp A measurement of pH, which has been adjusted for body temperature, in a biological specimen. pH Adjusted for Body Temperature Measurement pH The negative logarithm (base 10) of the concentration of hydronium ions, which is used as a measure of the acidity or alkalinity of a fluid. pH Phenazocine A measurement of the phenazocine in a biological specimen. Phenazocine Measurement Phencyclidine Phenylcyclohexylpiperidine A measurement of the phencyclidine present in a biological specimen. Phencyclidine Measurement Phendimetrazine A measurement of the phendimetrazine in a biological specimen. Phendimetrazine Measurement Phenmetrazine A measurement of the phenmetrazine in a biological specimen. Phenmetrazine Measurement Phenobarbital A measurement of the phenobarbital present in a biological specimen. Phenobarbital Measurement Dibenzothiazine Phenothiazine A measurement of the phenothiazine present in a biological specimen. Phenothiazine Measurement Phentermine Phenyl-tertiary-butylamine A measurement of the phentermine in a biological specimen. Phentermine Measurement Phenylalanine A measurement of the phenylalanine in a biological specimen. Phenylalanine Measurement Phenylalanine/Tyrosine A relative measurement (ratio) of the phenylalanine to tyrosine in a biological specimen. Phenylalanine to Tyrosine Ratio Measurement Phenyl Ketones Phenylketones A measurement of the total phenylketones in a biological specimen Phenylketone Measurement Beta-Hydroxyamphetamine Norephedrine Phenylpropanolamine A measurement of the phenylpropanolamine in a biological specimen. Phenylpropanolamine Measurement Phenylpyruvate Phenylpyruvic Acid PPA PPY PPYR A measurement of the phenylpyruvate in a biological specimen. Phenylpyruvate Measurement Phenytoin A measurement of the phenytoin in a biological specimen. Phenytoin Measurement Phos-S6 Ribosomal Protein Phosphorylated S6 protein of the 40S ribosomal subunit A measurement of the phosphorylated S6 protein of the 40S ribosomal subunit in a biological specimen. Phosphorylated 40S Ribosomal Protein S6 Measurement Phosphate Clearance A measurement of the volume of serum or plasma that would be cleared of phosphate by excretion of urine for a specified unit of time (e.g. one minute). Phosphate Clearance Measurement Phosphate Crystals A measurement of the total phosphate crystals in a biological specimen. Phosphate Crystals Measurement Inorganic Phosphate Phosphate Phosphorus A measurement of the phosphate in a biological specimen. Phosphate Measurement Phosphate/Creatinine A relative measurement (ratio or percentage) of the phosphate to creatinine in a biological specimen. Phosphate to Creatinine Ratio Measurement Phosphatidylcholine/Albumin A relative measurement (ratio or percentage) of the phosphatidylcholine to albumin in a biological specimen. Phosphatidylcholine to Albumin Ratio Measurement PEth Phosphatidylethanol A measurement of the total phosphatidylethanol in a biological specimen. Phosphatidylethanol Measurement Phosphatidylglycerol/Lung Surfactant Phosphatidylglycerol/Pulmonary Surfactant A relative measurement (ratio) of the phosphatidylglycerol to total lung surfactant in a biological specimen. Phosphatidylglycerol to Lung Surfactant Ratio Measurement Phospholipase A2 A measurement of the total phospholipase A2 in a biological specimen. Phospholipase A2 Measurement Phospholipid Scramblase 1 A measurement of the phospholipid scramblase 1 in a biological specimen. Phospholipid Scramblase 1 Measurement Phospholipid A measurement of the phospholipids in a biological specimen. Phospholipid Measurement Phosphorus Excretion Rate A measurement of the amount of phosphorus being excreted in a biological specimen over a defined amount of time (e.g. one hour). Phosphorus Excretion Rate pACC pAcetyl-CoA Carboxylase Phosphorylated Acetyl-CoA Carboxylase A measurement of the phosphorylated acetyl-CoA carboxylase in a biological specimen. Phosphorylated Acetyl-CoA Carboxylase Measurement Phosphorylated Neurofilament Heavy Chain A measurement of the phosphorylated neurofilament heavy chain in a biological specimen. Phosphorylated Neurofilament Heavy Chain Measurement Phosphorylated STAT3 pSTAT3 A measurement of the phosphorylated STAT3 (signal transducer and activator of transcription 3) in a biological specimen. Phosphorylated STAT3 Measurement Phosphorylated STAT3/STAT3 pSTAT3/STAT3 A relative measurement (ratio or percentage) of the phosphorylated STAT3 to total STAT3 in a biological specimen. Phosphorylated STAT3 to STAT3 Ratio Measurement Phosphorylated Tau 217/Amyloid Beta 1-42 Phosphorylated Tau Protein 217/Amyloid Beta 1-42 A relative measurement (ratio) of the phosphorylated Tau protein 217 to amyloid beta 1-42 in a biological specimen. Phosphorylated Tau 217 to Amyloid Beta 1-42 Ratio Measurement Phosphorylated Tau Prot/Amyloid Beta1-42 Phosphorylated Tau Protein/Amyloid Beta 1-42 A relative measurement (ratio) of the phosphorylated Tau protein to amyloid beta 1-42 in a biological specimen. Phosphorylated Tau Protein to Amyloid Beta1-42 Ratio Measurement Phosphorylated Tau 181 Phosphorylated Tau Protein 181 pTau181 A measurement of the phosphorylated Tau protein 181 in a biological specimen. Phosphorylated Tau Protein 181 Measurement Phosphorylated Tau 212 Phosphorylated Tau Protein 212 pTau212 A measurement of the phosphorylated Tau protein 212 in a biological specimen. Phosphorylated Tau Protein 212 Measurement Phosphorylated Tau 217 Phosphorylated Tau Protein 217 pTau217 A measurement of the phosphorylated Tau protein 217 in a biological specimen. Phosphorylated Tau Protein 217 Measurement Phosphorylated Tau 231 Phosphorylated Tau Protein 231 pTau231 A measurement of the phosphorylated Tau protein 231 in a biological specimen. Phosphorylated Tau Protein 231 Measurement Phosphorylated Tau Protein pTau A measurement of the phosphorylated Tau protein in a biological specimen. Phosphorylated Tau Protein Measurement Pi-GST Excretion Rate A measurement of the amount of Pi Glutathione-S-Transferase being excreted in a biological specimen over a defined period of time (e.g. one hour). Pi-GST Excretion Rate Pigment Casts Pigmented Casts A measurement of the pigment casts present in a biological specimen. Pigment Cast Measurement Pimozide A measurement of the pimozide in a biological specimen. Pimozide Measurement Pipradrol A measurement of the pipradrol in a biological specimen. Pipradrol Measurement PGF PIGF Placental Growth Factor PLGF A measurement of the placental growth factor in a biological specimen. Placental Growth Factor Measurement Placental Specific Alkaline Phosphatase A measurement of the placental specific alkaline phosphatase isoform in a biological specimen. Placental Specific Alkaline Phosphatase Measurement Plasma Equivalent Glucose Distribution A measurement of the plasma equivalent glucose distribution in a biological specimen. Plasma Equivalent Glucose Distribution Measurement Plasma Equivalent Glucose A measurement of the plasma equivalent glucose in a biological specimen. Plasma Equivalent Glucose Measurement Plasmacytoid Lymphocytes Plymphocytes A measurement of the plasmacytoid lymphocytes (lymphocytes with peripherally clumped chromatin and often deep blue cytoplasm, and that appear similar to plasma cells) in a biological specimen. Plasmacytoid Lymphocyte Count Plasmacytoid Lymphocytes/Leukocytes A relative measurement (ratio or percentage) of the plasmacytoid lymphocytes to all leukocytes in a biological specimen. Plasmacytoid Lymphocytes to Leukocytes Ratio Measurement Plasmacytoid Lymphocytes/Lymphocytes A relative measurement (ratio or percentage) of the plasmacytoid lymphocytes (lymphocytes with peripherally clumped chromatin and often deep blue cytoplasm, and that appear similar to plasma cells) to all lymphocytes in a biological specimen. Plasmacytoid Lymphocyte to Lymphocyte Ratio Measurement PAP Plasmin Alpha-2 Antiplasmin Complex A measurement of the plasmin alpha-2 antiplasmin complex in a biological specimen. Plasmin Alpha-2 Antiplasmin Complex Measurement Plasminogen Activator Inhibitor-1 Plasminogen Activator Inhibitor-1 AG Plasminogen Activator Inhibitor-1 Antigen A measurement of the plasminogen activator inhibitor-1 in a biological specimen. Plasminogen Activator Inhibitor-1 Measurement Monocyte Activation Antigen Mo3 Plasminogen Activator Urokinase Receptor Plasminogen Activator, Urokinase Receptor Soluble CD87 UPAR Urokinase Plasminogen Activator Receptor A measurement of the plasminogen activator urokinase receptor in a specimen. Plasminogen Activator Urokinase Receptor Measurement Plasminogen A measurement of the plasminogen (antigen) in a biological specimen. Plasminogen Measurement Platelet Activating Factor A measurement of the platelet activating factor in a biological specimen. Platelet Activating Factor Measurement Platelet Aggregation Amplitude A measurement of the magnitude of the platelet aggregation in a biological specimen. Platelet Aggregation Amplitude Measurement Platelet Aggregation Curve Type The classification of the curve pattern that is formed as a result of platelet aggregation. Platelet Aggregometry Curve Type Platelet Aggregation Mean Amplitude An average of the measurements of the magnitude of the platelet aggregation in a biological specimen. Platelet Aggregometry Mean Amplitude Platelet Aggregation Mean Curve Type The classification of the curve pattern that is formed as the average result of the platelet aggregation curve measurements. Platelet Aggregometry Mean Curve Type Platelet Aggregation Platelet Function A measurement of the association of platelets to one another via adhesion molecules in a biological sample. Platelet Aggregation Measurement Platelet Clumps PLT Clumps A measurement of the platelet clumps in a biological specimen. Platelet Clumps Count Platelet Component Distribution Width A measurement of a marker of platelet shape change in a biological specimen. Platelet Component Distribution Width Measurement PDGF Isoform AA Platelet Derived Growth Factor IsoformAA Platelet Derived Growth Factor-AA Isoform A measurement of the platelet derived growth factor isoform AA in a biological specimen. Platelet Derived Growth Factor Isoform AA Measurement PDGF Isoform AB Platelet Derived Growth Factor IsoformAB Platelet Derived Growth Factor-AB Isoform A measurement of the platelet derived growth factor isoform AB in a biological specimen. Platelet Derived Growth Factor Isoform AB Measurement PDGF Isoform BB Platelet Derived Growth Factor IsoformBB Platelet Derived Growth Factor-BB Isoform Platelet-Derived Growth Factor BB A measurement of the platelet derived growth factor isoform BB in a biological specimen. Platelet Derived Growth Factor Isoform BB Measurement Platelet Distribution Width A measurement of the range of platelet sizes in a biological specimen. Platelet Distribution Width CD31 Antigen PECAM PECAM-1 PECAM1 Platelet And Endothelial Cell Adhesion Molecule 1 Platelet Endo Cell Adhesion Molecule 1 Platelet Endothelial Adhesion Molecule Soluble CD31 A measurement of the platelet and endothelial cell adhesion molecule 1 in a biological specimen. Platelet Endothelial Cell Adhesion Molecule 1 Measurement PFCT Platelet Function Closure Time A measurement of the platelet function closure time in a biological specimen. Platelet Function Closure Time Measurement Platelet Hematocrit Thrombocytocrit A relative measurement (ratio or percentage) of the proportion of the volume of blood taken up by platelets. Platelet Hematocrit Measurement Platelet Mass Distribution Width A measurement which represents the variation defined by two standard deviations of the platelet dry mass distribution in a biological specimen. Platelet Mass Distribution Width Platelet Morphology An examination or assessment of the form and structure of platelets. Platelet Morphology Measurement Platelet Satellitism An examination or assessment of the platelet satellitism (platelet rosetting around cells) in a biological specimen. Platelet Satellitism Assessment Platelet-Granulocyte Agg Platelet-Granulocyte Aggregates A measurement of the aggregates composed of platelets and granulocytes in a biological specimen. Platelet-Granulocyte Aggregate Measurement Platelets A measurement of the platelets (non-nucleated thrombocytes) in a biological specimen. Platelet Count Platelets, Agranular A measurement of the agranular platelets in a biological specimen. Agranular Platelets Count Platelets, Estimated An estimated measurement of the platelets (non-nucleated thrombocytes) in a biological specimen. Estimated Platelets Measurement Poikilocytes A measurement of the odd-shaped erythrocytes in a whole blood specimen. Poikilocyte Measurement Poikilocytes/Erythrocytes A relative measurement (ratio or percentage) of the poikilocytes, or irregularly shaped erythrocytes, to all erythrocytes in a biological specimen. Poikilocyte to Erythrocyte Ratio Measurement Polychromasia A measurement of the blue-staining characteristic of newly generated erythrocytes. Polychromasia Polychromatophilic Erythroblast A measurement of the polychromatophilic erythroblasts in a biological specimen taken from a non-human organism. Polychromatophilic Erythroblast Count Polychromatophilic Normoblast A measurement of the polychromatophilic normoblasts in a biological specimen taken from a non-human organism. Polychromatophilic Normoblast Count Autosomal Dominant Polycystic Kidney Disease 1 Protein Polycystin 1, Transient Receptor Potential Channel Interacting Polycystin-1 TRPP1 A measurement of the polycystin-1 in a biological specimen. Polycystin-1 Measurement Porphobilinogen A measurement of the porphobilinogen in a biological specimen. Porphobilinogen Measurement Porphobilinogen/Creatinine A relative measurement (ratio or percentage) of the porphobilinogen to creatinine in a biological specimen. Porphobilinogen to Creatinine Ratio Measurement Porphyrin A measurement of the total porphyrin in a biological specimen. Porphyrin Measurement Potassium Clearance A measurement of the volume of serum or plasma that would be cleared of potassium by excretion of urine for a specified unit of time (e.g. one minute). Potassium Clearance Measurement Potassium Excretion Rate A measurement of the amount of potassium being excreted in a biological specimen over a defined amount of time (e.g. one hour). Potassium Excretion Rate Potassium A measurement of the potassium in a biological specimen. Potassium Measurement Potassium/Creatinine A relative measurement (ratio or percentage) of the potassium to creatinine in a biological specimen. Potassium to Creatinine Ratio Measurement PAO2/FIO2 PP Arterial O2/Fraction Inspired O2 A relative measurement (ratio or percentage) of the force per unit area (pressure) of oxygen dissolved in arterial blood to the percentage oxygen of an inhaled mixture of gasses. Partial Pressure Arterial Oxygen to Fraction Inspired Oxygen Ratio Measurement Prazepam A measurement of the prazepam present in a biological specimen. Prazepam Measurement Prealbumin Thyroxine-binding Prealbumin Transthyretin A measurement of the prealbumin in a biological specimen. Prealbumin Measurement Plasmablast Precursor Plasma Cells A measurement of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) in a biological specimen. Precursor Plasma Cell Count Precursor Plasma Cells/Lymphocytes A relative measurement (ratio or percentage) of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) to all lymphocytes in a biological specimen. Precursor Plasma Cell to Lymphocyte Ratio Measurement Pregabalin A measurement of the pregabalin in a biological specimen. Pregabalin Measurement Pregnancy-Associated Plasma Protein-A A measurement of the pregnancy-associated plasma protein-A in a biological specimen. Pregnancy-Associated Plasma Protein-A Measurement Pregnanediol A measurement of the pregnanediol in a biological specimen. Pregnanediol Measurement Pregnenolone A measurement of the pregnenolone in a biological specimen. Pregnenolone Measurement Presepsin sCD14-ST Soluble CD14 Subtype A measurement of the presepsin in a biological specimen. Presepsin Measurement NC1 Domain Fragment of Type X Collagen Pro-C10 A measurement of the Pro-C10 (a fragment of the NC1 domain of type X collagen) in a biological specimen. Pro-C10 Measurement C-Terminal Propeptide of Type XVI Collagen Pro-C16 A measurement of the Pro-C16 (a C-terminal fragment of type XVI collagen) in a biological specimen. Pro-C16 Measurement PIIBNP Pro-C2 Procollagen IIB N-Terminal Propeptide A measurement of the Pro-C2 (a N-terminal fragment of type IIB procollagen) in a biological specimen. Pro-C2 Measurement C-Terminal Propeptide of Type XXVIII Collagen Pro-C28 A measurement of the Pro-C28 (a C-terminal fragment of type XXVIII collagen) in a biological specimen. Pro-C28 Measurement ADAMTS-2 Degraded N-Terminal Type III Collagen Propeptide ADAMTS-2 Degraded Procollagen 3 N-Terminal Propeptide Pro-C3 A measurement of the Pro-C3 (ADAMTS-2 cleaved N-terminal propeptide of type III collagen) in a biological specimen. Pro-C3 Measurement 7S Domain Fragment Propeptide of Type IV Collagen P4NP7S Pro-C4 Type IV Collage 7S Domain A measurement of the Pro-C4 (a fragment of the internal 7S domain of type IV collagen) in a biological specimen. Pro-C4 Measurement C-Terminal Propeptide of Type V Collagen Pro-C5 A measurement of the Pro-C5 (a C-terminal propeptide of type V collagen) in a biological specimen. Pro-C5 Measurement C-terminal Pro-Peptide of the Alpha 3 Type VI Collagen Chain C-Terminal Propeptide of Type 6a3 Collagen C-Terminal Propeptide of Type VIa3 Collagen Endotrophin Pro-C6 A measurement of the C-terminal propeptide of type VIa3 collagen (pro-C6) in a biological specimen. Pro-C6 Measurement Pro-gastrin Releasing Peptide proGRP A measurement of the pro-gastrin releasing peptide in a biological specimen. Pro-gastrin Releasing Peptide Measurement Pro-IL-16 Pro-Interleukin 16 A measurement of the pro-interleukin 16 in a biological specimen. Pro-Interleukin 16 Measurement Pro-Brain Natriuretic Peptide ProB-type Natriuretic Peptide proBNP A measurement of the proB-type natriuretic peptide in a biological specimen. ProB-Type Natriuretic Peptide Measurement Procalcitonin A measurement of the procalcitonin in a biological specimen. Procalcitonin Measurement Prochlorperazine A measurement of the prochlorperazine in a biological specimen. Prochlorperazine Measurement Amino-terminal propeptide of type 1 procollagen P1NP Aminoterm Type 1 Procollagen 1 N-Terminal Propeptide A measurement of the procollagen 1 N-terminal propeptide in a biological specimen. Procollagen 1 N-Terminal Propeptide Measurement N-Terminal Type III Collagen Propeptide PIIINP Procollagen 3 N-Terminal Propeptide A measurement of the procollagen 3 N-terminal propeptide in a biological specimen. Procollagen 3 N-Terminal Propeptide Measurement Procollagen Type I Carboxy Term Peptide A measurement of the procollagen-1 carboxy-terminal peptide in a biological specimen. Procollagen Type I Carboxy Terminal Peptide Measurement NR3C3 PGR PgR PR Progesterone Receptor A measurement of the progesterone receptor protein in a biological specimen. Progesterone Receptor Measurement Progesterone A measurement of the progesterone hormone in a biological specimen. Progesterone Measurement Progranulin A measurement of the progranulin in a biological specimen. Progranulin Measurement Proinsulin A measurement of the proinsulin in a biological specimen. Proinsulin Measurement Proinsulin/Insulin Ratio A relative measurement (ratio or percentage) of the proinsulin to insulin in a biological specimen. Proinsulin to Insulin Ratio Measurement Prolactin A measurement of the prolactin hormone in a biological specimen. Prolactin Measurement Cyclin Proliferating Cell Nuclear Antigen A measurement of the proliferating cell nuclear antigen in a biological specimen. Proliferating Cell Nuclear Antigen Measurement Proliferating Erythroid/Total Cells A relative measurement (ratio or percentage) of the proliferating erythroid cells to total cells in a biological specimen. Proliferating Erythroid Cell to Total Cell Ratio Measurement Proliferating Myeloid Cells/Total Cells A relative measurement (ratio or percentage) of the proliferating myeloid cells to total cells in a biological specimen. Proliferating Myeloid Cell to Total Cell Ratio Measurement Cytosol Aminopeptidase V Proline Aminopeptidase Proline Iminopeptidase Prolyl Aminopeptidase A measurement of the proline aminopeptidase in a biological specimen. Proline Aminopeptidase Measurement Proline A measurement of the proline in a biological specimen. Proline Measurement Prolymphocytes A measurement of the prolymphocytes in a biological specimen. Prolymphocyte Count Prolymphocytes/Leukocytes A relative measurement (ratio or percentage) of prolymphocytes to leukocytes in a biological specimen. Prolymphocyte to Leukocyte Ratio Prolymphocytes/Lymphocytes A relative measurement (ratio or percentage) of the prolymphocytes to all lymphocytes in a biological specimen. Prolymphocyte to Lymphocyte Ratio Measurement Promonocytes A measurement of the promonocytes in a biological specimen. Promonocyte Count Promonocytes/Leukocytes A relative measurement (ratio or percentage) of the promonocytes to all leukocytes in a biological specimen. Promonocyte to Lymphocyte Ratio Measurement Promonocytes/Total Cells A relative measurement (ratio or percentage) of the promonocytes to total cells in a biological specimen (for example a bone marrow specimen). Promonocyte to Total Cell Ratio Measurement Promyeloblasts A measurement of the promyeloblasts in a biological specimen. Promyeloblasts Measurement Promyelocytes A measurement of the promyelocytes (immature myelocytes) in a biological specimen. Promyelocyte Count Promyelocytes/Leukocytes A relative measurement (ratio or percentage) of the promyelocytes (immature myelocytes) to all leukocytes in a biological specimen. Promyelocyte to Lymphocyte Ratio Measurement Promyelocytes/Total Cells A relative measurement (ratio or percentage) of the promyelocytes (immature myelocytes) to total cells in a biological specimen (for example a bone marrow specimen). Promyelocyte to Total Cell Ratio Measurement Propoxyphene A measurement of the propoxyphene present in a biological specimen. Propoxyphene Measurement Proprotein Convertase Subtilisin/Kexin 9 A measurement of the proprotein convertase subtilisin/kexin type 9 in a biological specimen. Proprotein Convertase Subtilisin/Kexin Type 9 Measurement Basophilic Erythroblast Basophilic Normoblast Prorubricyte A measurement of the prorubricytes in a biological specimen. Prorubricyte Count Prorubricyte/Total Cells A relative measurement (ratio or percentage) of the prorubricytes to total cells in a biological specimen. Prorubricyte to Total Cell Ratio Measurement Prostaglandin D2 Receptor 2 A measurement of the prostaglandin D2 receptor 2 in a biological specimen. Prostaglandin D2 Receptor 2 Measurement Beta-Trace Protein Prostaglandin D2 Synthase A measurement of the prostaglandin D2 synthase in a biological specimen. Prostaglandin D2 Synthase Measurement Prostaglandin D2 A measurement of the prostaglandin D2 in a biological specimen. Prostaglandin D2 Measurement Prostaglandin E Synthase A measurement of the prostaglandin E synthase in a biological specimen. Prostaglandin E Synthase Measurement Prostaglandin E1 A measurement of the prostaglandin E1 in a biological specimen. Prostaglandin E1 Measurement Prostaglandin E2 A measurement of the prostaglandin E2 in a biological specimen. Prostaglandin E2 Measurement Prostaglandin F1 Alpha A measurement of the prostaglandin F1 alpha in a biological specimen. Prostaglandin F1 Alpha Measurement Prostaglandin F2 Alpha A measurement of the prostaglandin F2 alpha in a biological specimen. Prostaglandin F2 Alpha Measurement Prostaglandin A measurement of the total prostaglandin in a biological specimen. Prostaglandin Measurement Prostanozol A measurement of the prostanozol in a biological specimen. Prostanozol Measurement Prostate Cancer Antigen 3 mRNA A measurement of the prostate cancer antigen 3 mRNA in a biological specimen. Prostate Cancer Antigen 3 mRNA Measurement Prostate Circulating Tumor Cells A measurement of the prostate circulating tumor cells in a biological specimen. Circulating Prostate Tumor Cell Count Prostate Specific Antigen mRNA A measurement of the prostate-specific antigen mRNA in a biological specimen. Prostate Specific Antigen mRNA Measurement Prostate Specific Antigen A measurement of the total prostate specific antigen in a biological specimen. Prostate Specific Antigen Measurement Prostate Specific Antigen, Free A measurement of the unbound prostate-specific antigen in a biological specimen. Free Prostate Specific Antigen Measurement Prostatic Acid Phosphatase A measurement of the prostatic acid phosphatase in a biological specimen. Prostatic Acid Phosphatase Measurement Protein Excretion Rate A measurement of the amount of total protein being excreted in a biological specimen over a defined amount of time (e.g. one hour). Protein Excretion Rate DCP Des-Gammacarboxyprothrombin PIVKA-II Protein Induced by Vitamin K Absence-II Protein Induced by Vitamin K Absence/Antagonist-II A measurement of the protein induced by vitamin K absence-II in a biological specimen. Protein Induced by Vitamin K Absence-II Measurement Protein Pattern A measurement of the protein band pattern in a biological specimen. Protein Pattern Measurement Protein S Activity Actual/Control Protein S Activity Actual/Normal Protein S Activity Actual/Protein S Activity Control A relative measurement (ratio or percentage) of the biological activity of protein S in a subject's specimen when compared to the same activity in a control specimen. Protein S Activity Actual to Control Ratio Measurement Protein S Actual/Control A relative measurement (ratio or percentage) of the protein S in a subject's specimen when compared to a control specimen. Protein S Actual to Control Ratio Measurement Protein S Free Activity Actual/Control Protein S Free Activity Actual/Normal Protein S Free Activity Actual/Protein S Free Activity Control A relative measurement (ratio or percentage) of the biological activity of free protein S in a subject's specimen when compared to the same activity in a control specimen. Free Protein S Activity Actual to Control Ratio Measurement Protein S A measurement of the total protein S in a biological specimen. Protein S Measurement Protein S, Free Actual/Control A relative measurement (ratio or percentage) of the free protein S in a subject's specimen when compared to a control specimen. Free Protein S Actual to Control Ratio Measurement Protein S, Free A measurement of the unbound protein S in a biological specimen. Free Protein S Measurement Protein A measurement of the total protein in a biological specimen. Total Protein Measurement Protein/Creatinine A relative measurement (ratio or percentage) of the total protein to creatinine in a biological specimen. Protein to Creatinine Ratio Measurement Protein/Osmolality Protein/Osmolality Ratio A relative measurement (ratio or percentage) of total proteins to the osmolality of a biological specimen. Protein to Osmolality Ratio Measurement Factor II Activity Prothrombin Activity A measurement of the biological activity of coagulation factor prothrombin in a biological specimen. Prothrombin Activity Measurement Prothrombin Fragment 1 A measurement of the prothrombin fragment 1 in a biological specimen. Prothrombin Fragment 1 Measurement Prothrombin Fragment 2 A measurement of the prothrombin fragment 2 in a biological specimen. Prothrombin Fragment 2 Measurement Prothrombin Fragments 1 + 2 A measurement of the prothrombin fragments 1 and 2 in a biological specimen. Prothrombin Fragments 1 and 2 Measurement Prothrombin Intl. Normalized Ratio A ratio that represents the prothrombin time for a plasma specimen, divided by the result for a control plasma specimen, further standardized for the International Sensitivity Index of the tissue factor (thromboplastin) used in the test. International Normalized Ratio of Prothrombin Time Prothrombin Time Actual/Control A relative measurement (ratio or percentage) of the prothrombin time in a subject's specimen when compared to a control specimen. Prothrombin Time Actual to Control Ratio Measurement Prothrombin Time A blood clotting measurement that evaluates the extrinsic pathway of coagulation. Prothrombin Time Protoporphyrin, Free A measurement of the free protoporphyrin (unbound to iron in hemoglobin) in a biological specimen. Free Protoporphyrin Measurement Protriptyline A measurement of the protriptyline present in a biological specimen. Protriptyline Measurement Proprotein Convertase Subtilisin/Kexin Type 9 Prprot Cnvrtase Subtilisin-Kexin 9, Free A measurement of the free proprotein convertase subtilisin/kexin type 9 in a biological specimen. Free Proprotein Convertase Subtilisin/Kexin Type 9 Measurement PSA, Free/PSA A relative measurement (percentage) of the free prostate specific antigen to total prostate specific antigen in a biological specimen. Free PSA to Total PSA Ratio Measurement Neutrophils with Pseudo Pelger-Huet Nucleus Pseudo Pelger-Huet Neutrophils A measurement of the neutrophils with a Pelger-Huet-like nucleus (hyposegmented) in a biological specimen. Pseudo Pelger-Huet Neutrophil Count Pseudo-Eosinophils A measurement of the pseudo-eosinophils in a biological specimen. Pseudo-Eosinophil Count Pseudo-Eosinophils/Leukocytes A relative measurement (ratio or percentage) of the pseudo-eosinophils to the leukocytes in a biological specimen. Pseudo-Eosinophils to Leukocyte Ratio Measurement Pseudoephedrine A measurement of the pseudoephedrine present in a biological specimen. Pseudoephedrine Measurement Magic Mushrooms Psilocybin Psilocybine A measurement of the psilocybin in a biological specimen. Psilocybine Measurement Partial Thromboplastin Time/Standard Thromboplastin Time PTT/Standard PTT/Standard PTT A relative measurement (ratio or percentage) of the subject's partial thromboplastin time to a standard or control partial thromboplastin time. Partial Thromboplastin Time to Standard Thromboplastin Time Ratio Measurement Pus A measurement of the pus in a biological specimen. Pus Measurement Karyopyknotic Cells Pyknotic Cells A measurement of the pyknotic cells in a biological specimen. Pyknotic Cell Count Pyocytes A measurement of the pyocytes in a biological specimen. Pyocytes Measurement Pyridinoline A measurement of the pyridinoline in a biological specimen. Pyridinoline Measurement Pyridinoline/Creatinine A relative measurement (ratio or percentage) of the pyridinoline to creatinine in a biological specimen. Pyridinoline to Creatinine Ratio Measurement Active Vitamin B6 Pyridoxal Phosphate A measurement of the pyridoxal phosphate in a biological specimen. Pyridoxal Phosphate Measurement Pyrovalerone A measurement of the pyrovalerone in a biological specimen. Pyrovalerone Measurement Pyruvate Kinase Isozyme M1 A measurement of the pyruvate kinase isozyme M1 in a biological specimen. Pyruvate Kinase Isozyme M1 Measurement Pyruvate Kinase Isozyme M2 A measurement of the pyruvate kinase isozyme M2 in a biological specimen. Pyruvate Kinase Isozyme M2 Measurement Pyruvate Kinase Muscle Isozyme A measurement of the total pyruvate kinase muscle isozymes (M1 and M2) in a biological specimen. Pyruvate Kinase Muscle Isozyme Measurement PK Pyruvate Kinase A measurement of the total pyruvate kinase in a biological specimen. Pyruvate Kinase Measurement Pyruvate Pyruvic Acid A measurement of the pyruvate in a biological specimen. Pyruvate Measurement Quazepam A measurement of the quazepam in a biological specimen. Quazepam Measurement Quetiapine A measurement of the quetiapine in a biological specimen. Quetiapine Measurement Erythrocyte Casts RBC Casts A measurement of the red blood cell casts present in a biological specimen. Red Blood Cell Cast Measurement RDW Standard Deviation RDW-SD Red Cell Volume Distribution Width Standard Deviation A measurement of the volume dispersion within an erythrocyte population, calculated as the width of the distribution curve at the 20 percent frequency level. Red Cell Volume Distribution Width Standard Deviation Reactive Oxygen Metabolite A measurement of the reactive oxygen metabolite in a biological specimen. Reactive Oxygen Metabolite Measurement Receptor Activator Nuclear KappaB Ligand Receptor Activator of Nuclear Kappa-B Ligand A measurement of the receptor activator of nuclear kappa-B ligand in a biological specimen. Receptor Activator Nuclear KappaB Ligand Measurement Advanced Glycosylation End-Product Specific Receptor AGER Receptor Advanced Glycation Endproducts A measurement of the receptor advanced glycation endproducts in a biological specimen. Receptor Advanced Glycation Endproducts Measurement Reducing Substances A measurement of the reducing substances (e.g., sugars, glutathione, creatinine, uric acid, and ascorbic acid) in a biological specimen. Reducing Substance Measurement Reducing Sugars A measurement of the reducing sugars in a biological specimen. Reducing Sugar Measurement Chemokine Ligand 5 Reg upon Act Normal T-cell Exprd Secrtd A measurement of the RANTES (regulated on activation, normally, T-cell expressed, and secreted) chemokine in a biological specimen. Reg upon Act Normal T-cell Exprd Secrtd Measurement Remnant Lipoprotein A measurement of the remnant lipoproteins in a biological specimen. Remnant Lipoprotein Measurement Renal Epithelial Casts A measurement of the renal epithelial cell casts in a biological specimen. Renal Epithelial Casts Measurement Renal Epithelial Cells A measurement of the renal epithelial cells in a biological specimen. Renal Epithelial Cells Measurement Renal Papillary Antigen 1 A measurement of the renal papillary antigen 1 in a biological specimen. Renal Papillary Antigen 1 Measurement Renal Tubular Epithelial Casts A measurement of the renal tubular epithelial cell casts in a biological specimen. Renal Tubular Epithelial Casts Measurement Renin Activity A measurement of the renin activity in a biological specimen. Renin Activity Measurement Active Renin Angiotensinogenase Direct Renin Renin A measurement of the renin in a biological specimen. Renin Measurement Reptilase Activity Actual/Control Reptilase Activity Actual/Normal Reptilase Activity Actual/Reptilase Activity Control A relative measurement (ratio or percentage) of the biological activity of reptilase dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. Reptilase Activity Actual to Control Ratio Measurement Reptilase Time A measurement of the time it takes a plasma sample to clot after adding the active enzyme reptilase. Reptilase Time Measurement Resistin A measurement of the resistin in a biological specimen. Resistin Measurement Ret Corpuscular HGB Conc Distr Width Reticulocyte Corpuscular Hemoglobin Distribution Width A measurement of the standard deviation of hemoglobin concentrations in reticulocytes in a biological specimen, calculated as the standard deviation of hemoglobin content divided by the mean hemoglobin content. Reticulocyte Corpuscular Hemoglobin Distribution Width Ret Hemoglobin Distribution Width Reticulocyte Hemoglobin Concentration Distribution Width A measurement of the distribution of the hemoglobin concentration in reticulocytes. Reticulocyte Hemoglobin Distribution Width RDWr-CV Red Cell Volume Distribution Width Coefficient of Variation in Reticulocytes Ret RDW Coefficient of Variation Reticulocyte Volume Distribution Width Coefficient of Variation A measurement of the volume dispersion within a reticulocyte population, calculated as the standard deviation of the mean reticulocyte volume divided by the mean reticulocyte volume, multiplied by 100 to convert to a percentage. Reticulocyte Volume Distribution Width Coefficient of Variation RDWr-SD Red Cell Volume Distribution Width Standard Deviation in Reticulocytes Ret RDW Standard Deviation Reticulocyte Volume Distribution Width Standard Deviation A measurement of the volume dispersion within a reticulocyte population, calculated as the width of the distribution curve at the 20 percent frequency level. Reticulocyte Volume Distribution Width Standard Deviation RDWr Ret Volume Distribution Width Reticulocyte Volume Distribution Width A relative measurement (ratio or percentage) of the standard deviation of the reticulocyte volume to the mean distribution of the reticulocyte volume in a biological specimen. Reticulocyte Volume Distribution Width CHr Ret. Corpuscular Hemoglobin Content Reticulocyte Cellular Hemoglobin Content A measurement of the average total amount of hemoglobin per reticulocyte. Reticulocyte Corpuscular Hemoglobin Content Ret. Corpuscular HGB Concentration Mean Reticulocyte Corpuscular Hemoglobin Concentration Mean An indirect measurement of the average concentration of hemoglobin per reticulocyte in a biological specimen, calculated as the ratio of hemoglobin to hematocrit. Reticulocyte Corpuscular Hemoglobin Concentration Mean Reticulocytes A measurement of the reticulocytes in a biological specimen. Reticulocyte Count Reticulocytes/Erythrocytes A relative measurement (ratio or percentage) of reticulocytes to erythrocytes in a biological specimen. Reticulocyte to Erythrocyte Ratio Reticulocytes/Total Cells A relative measurement (ratio or percentage) of reticulocytes to total cells in a biological specimen. Reticulocyte to Total Cell Ratio Measurement Retinoate Retinoic Acid A measurement of the retinoic acid in a biological specimen. Retinoic Acid Measurement Retinol Binding Protein 1 A measurement of the retinol binding protein 1 in a biological specimen. Retinol Binding Protein 1 Measurement Retinol Binding Protein 2 A measurement of the retinol binding protein 2 in a biological specimen. Retinol Binding Protein 2 Measurement Retinol Binding Protein 3 A measurement of the retinol binding protein 3 in a biological specimen. Retinol Binding Protein 3 Measurement Retinol Binding Protein 4 A measurement of the retinol binding protein 4 in a biological specimen. Retinol Binding Protein 4 Measurement Retinol Binding Protein A measurement of the total retinol binding protein in a biological specimen. Retinol Binding Protein Measurement Retinol Binding Protein/Creatinine A relative measurement (ratio or percentage) of the retinol binding protein to creatinine in a biological specimen. Retinol Binding Protein to Creatinine Ratio Measurement Retinol Palmitate Retinyl Palmitate Vitamin A Palmitate A measurement of the endogenous retinyl palmitate vitamin A in a biological specimen. Retinyl Palmitate Measurement Rh Factor A measurement of non-specified Rhesus factor antigen(s) in a biological specimen. Rh Factor Measurement RhD Factor A measurement of the Rhesus factor D antigen in a biological specimen. RhD Factor Measurement Riboflavin Vitamin B2 A measurement of the riboflavin in a biological specimen. Vitamin B2 Measurement Ribonucleic Acid A measurement of a targeted ribonucleic acid (RNA) in a biological specimen. Ribonucleic Acid Measurement Ringed Sideroblasts A measurement of the ringed sideroblasts (abnormal nucleated erythroblasts with a large number of iron deposits in the perinuclear mitochondria, forming a ring around the nucleus) in a biological specimen. Ring Sideroblast Measurement Risperidone A measurement of the risperidone in a biological specimen. Risperidone Measurement Risperidone+9-Hydroxyrisperidone Risperidone+Paliperidone A measurement of the risperidone and 9-hydroxyrisperidone in a biological specimen. Risperidone and 9-Hydroxyrisperidone Measurement Ritalinic Acid A measurement of the ritalinic acid in a biological specimen. Ritalinic Acid Measurement RLP Cholesterol A measurement of the cholesterol remnant-like particles in a biological specimen. Remnant-like Particle Cholesterol Measurement Rouleaux Formation A measurement of the stacking red blood cells in a biological specimen. Rouleaux Formation Count Round Cells A measurement of the round cells (round shaped cells mainly comprised of white blood cells and immature spermatogenic cells) in a biological specimen. Round Cell Count Round Epithelial Cells A measurement of the round epithelial cells present in a biological specimen. Round Epithelial Cell Count Proerythroblast Pronormoblast Rubriblast A measurement of the rubriblasts in a biological specimen. Proerythroblast Measurement Proerythroblast/Total Cells Pronormoblasts/Total Cells Rubriblast/Total Cells A relative measurement (ratio or percentage) of the rubriblasts to total cells in a biological specimen (for example a bone marrow specimen). Pronormoblast to Total Cell Ratio Measurement Polychromatophilic Erythroblast Polychromatophilic Normoblast Rubricyte A measurement of the rubricytes in a biological specimen. Rubricyte Count Rubricyte/Total Cells A relative measurement (ratio or percentage) of the rubricytes to total cells in a biological specimen. Rubricyte to Total Cell Ratio Measurement S-adenosyl-L-homocysteine S-Adenosylhomocysteine SAH A measurement of the S-adenosylhomocysteine in a biological specimen. S-Adenosylhomocysteine Measurement S-adenosyl-L-methionine S-Adenosylmethionine SAM-e SAMe SAMMY A measurement of the S-adenosylmethionine in a biological specimen. S-Adenosylmethionine Measurement N-Acetyl-S-benzyl-L-cysteine S-Benzyl Mercapturic Acid S-Benzylmercapturate S-Benzylmercapturic Acid SBNAC A measurement of the S-benzyl mercapturic acid in a specimen. S-Benzyl Mercapturic Acid Measurement S-Pancreas-1 Antigen Sialylated Carbonated Antigen SPAN-1 SPan-1 A measurement of the S-pancreas-1 antigen in a biological specimen. S-Pancreas-1 Antigen Measurement S100 Calcium Binding Protein A8 A measurement of the S100 calcium binding protein A8 in a biological specimen. S100 Calcium Binding Protein A8 Measurement S100 Calcium-Binding Protein B A measure of the S100 calcium-binding protein B in a biological specimen. S100 Calcium-Binding Protein B Measurement Salicylates A measurement of the salicylates in a biological specimen. Salicylates Measurement N-Methylglycine Sarcosine A measurement of the sarcosine in a biological specimen. Sarcosine Measurement Scavenger Rcpt Cys-Rich Type1 Prot M130 Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Soluble CD163 Soluble CD163a A measurement of the scavenger receptor cysteine-rich type 1 protein M130 in a biological specimen. Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement Schistocytes A measurement of the schistocytes (fragmented red blood cells) in a biological specimen. Schistocyte Count Schistocytes/Erythrocytes A relative measure (ratio or percentage) of schistocytes to erythrocytes in a biological specimen. Schistocyte to Erythrocyte Ratio Measurement Sclerostin A measurement of the sclerostin in a biological specimen. Sclerostin Measurement Secobarbital A measurement of the secobarbital present in a biological specimen. Secobarbital Measurement Secretin A measurement of the secretin hormone in a biological specimen. Secretin Measurement Microscopic Sediment Analysis Sediment Analysis Sediment Examination An observation, assessment or examination of the sediment in a biological specimen. Sediment Analysis Selenium A measurement of the selenium in a specimen. Selenium Measurement Pancreatic Secretory Trypsin Inhibitor PSTI Serine Peptidase Inhibitor Kazal Type 1 Spink3 TATI Tumor-Associated Trypsin Inhibitor A measurement of the serine peptidase inhibitor Kazal type 1 in a biological specimen. Serine Peptidase Inhibitor Kazal Type 1 Measurement Serine A measurement of the serine in a biological specimen. Serine Measurement Serotonin A measurement of the serotonin hormone in a biological specimen. Serotonin Measurement OL-64 Serpin A12 Serpin Family A Member 12 Vaspin Visceral Adipose Tissue-Derived Serpin A measurement of the serpin A12 in a biological specimen. Serpin A12 Measurement CBG Corticosteroid Binding Globulin Corticosteroid-binding Globulin Serpin A6 Transcortin A measurement of the serpin A6 in a biological specimen. Serpin A6 Measurement Maspin Peptidase Inhibitor 5 PI-5 PI5 Serpin B5 Serpin Family B Member 5 A measurement of the serpin family B member 5 in a biological specimen. Serpin Family B Member 5 Measurement PEDF Pigment Epithelium Derived Factor Serpin F1 Serpin Family F Member 1 A measurement of the serpin family F member 1 in a biological specimen. Serpin Family F Member 1 Measurement Sertraline A measurement of the sertraline present in a biological specimen. Sertraline Measurement PIG4 SAA1 Serum Amyloid A-1 Protein Serum Amyloid A1 A measurement of the serum amyloid A1 in a biological specimen. Serum Amyloid A1 Measurement SAAG Serum-Ascites Albumin Gradient A measurement of the serum-ascites albumin gradient, calculated by subtracting the amount of albumin in ascites fluid from the albumin in serum. Serum-Ascites Albumin Gradient Measurement Sex Hormone Binding Globulin Sex Hormone Binding Protein A measurement of the sex hormone binding (globulin) protein in a biological specimen. Sex Hormone Binding Protein Measurement Sezary Cells A measurement of the Sezary cells (atypical lymphocytes with cerebriform nuclei) in a biological specimen. Sezary Cell Count Sezary Cells/Leukocytes A relative measurement (ratio or percentage) of the Sezary cells to all leukocytes in a biological specimen. Sezary Cells to Leukocytes Ratio Measurement Sezary Cells/Lymphocytes A relative measurement (ratio or percentage of the Sezary cells (atypical lymphocytes with cerebriform nuclei) to all lymphocytes in a biological specimen. Sezary Cell to Lymphocyte Ratio Measurement DSHP Duncan Disease SH2-Protein EBVS IMD5 LYP MTCP1 SAP SAP/SH2D1A SH2 Domain Containing 1A Protein XLP XLPD XLPD1 A measurement of the SH2 domain containing 1A protein in a biological specimen. SH2 Domain Containing 1A Protein Measurement Sialyl Lewis X Antigen Sialyl Lex Sialyl SSEA-1 Antigen Sialyl-CD15 SLeX A measurement of the sialyl stage-specific embryonic antigen-1 in a biological specimen. Sialyl SSEA-1 Antigen Measurement Sibutramine A measurement of the sibutramine in a biological specimen. Sibutramine Measurement Drepanocytes Sickle Cells A measurement of the sickle cells (sickle shaped red blood cells) in a biological specimen. Sickle Cell Count Sickle Cells/Erythrocytes A relative measurement (ratio or percentage) of the sickle cells (sickle shaped red blood cells) to all erythrocytes in a biological specimen. Sickle Cell to Erythrocyte Ratio Measurement Sideroblast A measurement of the sideroblasts (nucleated erythroblasts with iron granules in the cytoplasm) in a biological specimen. Sideroblast Measurement Skeletal Troponin I sTnl A measurement of the total skeletal troponin I in a biological specimen. Skeletal Troponin I Measurement Smear Evaluation Smear Examination Specimen Smear Examination An observation, assessment or examination of a smear of a biological specimen. Smear Examination Basket Cells Gumprecht Shadow Cells Shadow Cells Smudge Cells A measurement of the smudge cells (the nuclear remnant of a ruptured white blood cell) in a biological specimen. Smudge Cell Count Basket Cells/Leukocytes Gumprecht Shadow Cells/Leukocytes Shadow Cells/Leukocytes Smudge Cells/Leukocytes A relative measurement (ratio or percentage) of smudge cells to leukocytes in a biological specimen. Smudge Cells to Leukocytes Ratio Measurement Sodium Clearance A measurement of the volume of serum or plasma that would be cleared of sodium by excretion of urine for a specified unit of time (e.g. one minute). Sodium Clearance Measurement Sodium Excretion Rate A measurement of the amount of sodium being excreted in a biological specimen over a defined amount of time (e.g. one hour). Sodium Excretion Rate Sodium A measurement of the sodium in a biological specimen. Sodium Measurement Sodium/Creatinine A relative measurement (ratio or percentage) of the sodium to creatinine in a biological specimen. Sodium to Creatinine Ratio Measurement Sodium/Potassium A relative measurement (ratio or percentage) of the sodium to potassium in a biological specimen. Sodium to Potassium Ratio Measurement Soluble B Cell Maturation Antigen Soluble BCM Soluble BCMA Soluble CD269 Soluble TNF Receptor Superfamily Member 17 Soluble TNFRSF13A A measurement of the soluble B cell maturation antigen in a biological specimen. Soluble B Cell Maturation Antigen Measurement Soluble Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 Soluble CD66e Soluble CEA Cell Adhesion Molecule 5 A measurement of the soluble carcinoembryonic antigen (CEA) cell adhesion molecule 5 in a biological specimen. Soluble CEA Cell Adhesion Molecule 5 Measurement sC5b-9 Smac Soluble Complement C5b-9 Soluble MAC Soluble Membrane Attack Complex TCC Terminal Complement Complex A measurement of the soluble complement C5b-9 in a biological specimen. Soluble Complement C5b-9 Measurement sE-selectin Soluble E-Selectin A measurement of the soluble E-Selectin in a biological specimen. Soluble E-Selectin Measurement HER2 Antigen HER2/NEU Antigen HER2/NEU Shed Antigen Soluble HER2 Soluble HER2/NEU A measurement of the soluble HER2 protein in a biological specimen. Soluble HER2 Antigen Measurement Soluble Immunoglobulin A measurement of the soluble total immunoglobulin in a biological specimen. Soluble Immunoglobulin Measurement Soluble Intercell Adhesion Molecule 1 A measurement of the soluble intercellular adhesion molecule 1 in a biological specimen. Soluble Intercellular Adhesion Molecule 1 Measurement Soluble Intercell Adhesion Molecule 4 Soluble Intercellular Adhesion Molecule 4 A measurement of the soluble intercellular adhesion molecule 4 in a biological specimen. Soluble Intercellular Adhesion Molecule 4 Measurement Soluble Interleukin 2 Receptor A measurement of the soluble interleukin 2 receptor (including all subunits) in a biological specimen. Soluble Interleukin 2 Receptor Measurement Soluble Interleukin 6 Receptor A measurement of the soluble interleukin 6 receptor in a biological specimen. Soluble Interleukin 6 Receptor Measurement Soluble Interleukin-1 Receptor Type I A measurement of the soluble interleukin-1 receptor type I in a biological specimen. Soluble Interleukin-1 Receptor Type I Measurement Soluble Hepatitis A Virus Cellular Receptor 1 Soluble Kidney Injury Molecule-1 Soluble KIM-1 A measurement of the soluble kidney injury molecule-1 in a biological specimen. Soluble Kidney Injury Molecule-1 Measurement sL-Selectin Soluble CD62L Soluble L-Selectin A measurement of the soluble L-selectin in a biological specimen. Soluble L-Selectin Measurement Soluble CD223 Antigen Soluble LAG-3 Soluble Lymphocyte Activation Gene 3 Protein Soluble Lymphocyte Activation Gene-3 A measurement of the soluble lymphocyte activation gene-3 protein in a biological specimen. Soluble Lymphocyte Activation Gene-3 Measurement Soluble Mesothelin Related Peptides Soluble Mesothelin Related Proteins A measurement of the soluble mesothelin related peptides in a biological specimen. Soluble Mesothelin Related Peptides Measurement Soluble P-Selectin A measurement of the soluble P-selectin in a biological specimen. Soluble P-Selectin Measurement Soluble CD274 Soluble PD-L1 Soluble PDL1 Soluble Programmed Death Ligand 1 A measurement of the soluble programmed death ligand 1 in a biological specimen. Soluble Programmed Death Ligand 1 Measurement Soluble CD279 Soluble PD-1 Soluble PD1 Soluble Programmed Cell Death Protein 1 Soluble Programmed Death-1 A measurement of the soluble programmed death-1 protein in a biological specimen. Soluble Programmed Death-1 Measurement Soluble CD120b Soluble TNF Receptor 1B Soluble TNF Receptor Type II Soluble TNFR1B Soluble TNFRSF1B Soluble Tumor Necrosis Factor Receptor Superfamily Member 1B A measurement of the soluble tumor necrosis factor receptor superfamily member 1B in a biological specimen. Soluble Tumor Necrosis Factor Receptor Type II Measurement ACT35 Antigen OX40 OX40L Receptor Soluble CD134 Soluble TNF Receptor Superfamily Mem 4 Soluble TNF Receptor Superfamily Member 4 TNFRSF4 A measurement of the soluble tumor necrosis factor receptor superfamily member 4 in a biological specimen. Soluble Tumor Necrosis Factor Receptor Superfamily Member 4 Measurement Soluble B-cell Surface Antigen CD40 Soluble Bp50 Soluble CD40 Soluble CDW40 Soluble p50 Soluble TNF Receptor Superfamily Mem 5 Soluble TNF Receptor Superfamily Member 5 Soluble TNFRSF5 Soluble Tumor Necrosis Factor Receptor Superfamily, Member 5 A measurement of the soluble tumor necrosis factor receptor superfamily member 5 (CD40) in a biological specimen. Soluble TNF Receptor Superfamily Member 5 Measurement Soluble CD27 Soluble CD27 Antigen Soluble CD27 Molecule Soluble TNF Receptor Superfamily Mem 7 Soluble TNFRSF7 Soluble Tumor Necrosis Factor Receptor Superfamily Member 7 A measurement of the soluble tumor necrosis factor receptor superfamily member 7 (CD27) in a biological specimen. Soluble TNF Receptor Superfamily Mem 7 Measurement sCD137 Soluble CD137 Soluble TNF Receptor Superfamily Mem 9 Soluble TNF Receptor Superfamily Member 9 Soluble TNFRSF9 A measurement of the soluble tumor necrosis factor receptor superfamily member 9 (CD137) in a biological specimen. Soluble Tumor Necrosis Factor Receptor Superfamily Member 9 Measurement Soluble TNF Receptor Type I A measurement of the soluble tumor necrosis factor receptor type I in a biological specimen. Soluble Tumor Necrosis Factor Receptor Type I Measurement Soluble TNF Superfamily Member 12 Soluble TNFSF12 A measurement of soluble tumor necrosis factor superfamily member 12 in a biological specimen. Soluble TNF Superfamily Member 12 Measurement Soluble CD154 Soluble CD40 Ligand Soluble CD40L Soluble CD40LG Soluble gp39 Soluble T-BAM Soluble TNF Superfamily Member 5 Soluble TNFSF5 Soluble TRAP A measurement of the soluble tumor necrosis factor superfamily member 5 in a biological specimen. Soluble TNF Superfamily Member 5 Measurement Soluble Transferrin Receptor A measurement of the soluble transferrin receptor in a biological specimen. Soluble Transferrin Receptor Measurement Soluble Tumor Necrosis Factor Receptor A measurement of the total soluble tumor necrosis factor receptor in a biological specimen. Soluble Tumor Necrosis Factor Receptor Measurement Soluble Vasc Cell Adhesion Molecule 1 A measurement of the soluble vascular cell adhesion molecule 1 in a biological specimen. Soluble Vascular Cell Adhesion Molecule 1 Soluble Vasc Endoth Growth Factor Rec1 Soluble Vascular Endothelial Growth Factor Receptor 1 A measurement of the soluble vascular endothelial growth factor receptor 1 in a biological specimen. Soluble Vascular Endothelial Growth Factor Receptor Type 1 Measurement Soluble Vasc Endoth Growth Factor Rec2 Soluble Vascular Endothelial Growth Factor Receptor 2 A measurement of the soluble vascular endothelial growth factor receptor 2 in a biological specimen. Soluble Vascular Endothelial Growth Factor Receptor Type 2 Measurement Soluble Vasc Endoth Growth Factor Rec3 Soluble Vascular Endothelial Growth Factor Receptor 3 A measurement of the soluble vascular endothelial growth factor receptor 3 in a biological specimen. Soluble Vascular Endothelial Growth Factor Receptor Type 3 Measurement Somatostatin Receptor Type 2 SRIF-1 A measurement of the somatostatin receptor type 2 in a biological specimen. Somatostatin Receptor Type 2 Measurement Growth Hormone Somatotrophin Somatotropin A measurement of the somatotrophin (growth) hormone in a biological specimen. Somatotrophin Measurement Sonic Hedgehog A measurement of the sonic hedgehog protein in a biological specimen. Sonic Hedgehog Measurement Sorbitol Dehydrogenase A measurement of the sorbitol dehydrogenase in a biological specimen. Sorbitol Dehydrogenase Measurement Specific Gravity A ratio of the density of a fluid to the density of water. Specific Gravity Specimen Appearance The outward or visible aspect of a specimen. Specimen Appearance Assessment Specimen Weight A measurement of the weight of a biological specimen. Specimen Weight Measurement Sperm Agglutination A measurement of the motile spermatozoa agglutination in a biological specimen. Sperm Agglutination Measurement Sperm Aggregation A measurement of the immotile spermatozoa aggregation in a biological specimen. Sperm Aggregation Measurement Sperm Motility A measurement of the sperm capable of forward, progressive movement in a semen specimen. Sperm Motility Measurement Spermatozoa A measurement of the spermatozoa cells present in a biological specimen. Spermatozoa Cell Count Spermatozoa, Progressive A measurement of the progressive spermatozoa (motile in a forward direction) in a biological specimen. Progressive Spermatozoa Measurement Spermatozoa, Progressive/Spermatozoa A relative measurement (ratio or percentage) of the progressive spermatozoa to total spermatozoa in a biological specimen. Progressive Spermatozoa to Total Spermatozoa Ratio Measurement Spherocytes A measurement of the spherocytes (small, sphere-shaped red blood cells) in a biological specimen. Spherocyte Count Squalene A measurement of the squalene in a biological specimen. Squalene Measurement Squamous Cell Carcinoma Antigen A measurement of the squamous cell carcinoma antigen in a biological specimen. Squamous Cell Carcinoma Antigen Measurement Squamous Cells Squamous Epithelial Cells A measurement of the squamous epithelial cells present in a biological specimen. Squamous Epithelial Cell Count Squamous Cells/Total Cells Squamous Epithelial Cells/Total Cells A relative measurement (ratio or percentage) of the squamous epithelial cells to total cells in a biological specimen. Squamous Epithelial Cells to Total Cells Ratio Measurement Squamous Transitional Epithelial Cells A measurement of the squamous transitional epithelial cells present in a biological specimen. Squamous Transitional Epithelial Cell Count Standard Base Excess A calculated measurement of the amount of acid required to return blood with hemoglobin at 5g/dL, which is used as a surrogate for extracellular fluid, to a normal pH under standard conditions. Standard Base Excess Measurement Stanozolol A measurement of the stanozolol in a biological specimen. Stanozolol Measurement Starch Crystals Starch Granules A measurement of the starch crystals in a biological specimen. Starch Crystal Measurement Signal Transducer and Activator of Transcription 3 STAT3 A measurement of the STAT3 (signal transducer and activator of transcription 3) in a biological specimen. STAT3 Measurement KIT Ligand Stem Cell Factor A measurement of the stem cell factor in a biological specimen. Stem Cell Factor Measurement Deacetylanatrofin Stenbolone A measurement of the stenbolone in a biological specimen. Stenbolone Measurement Steroid Sulfatase Steryl-sulfatase A measurement of the steroid sulfatase in a biological specimen. Steroid Sulfatase Measurement Stomatocytes A measurement of the stomatocytes (red blood cells with an oval or rectangular area of central pallor, producing the appearance of a cell mouth) in a biological specimen. Stomatocyte Count Succinylacetone A measurement of the succinylacetone in a biological specimen. Succinylacetone Measurement Sufentanil A measurement of the sufentanil in a biological specimen. Sufentanil Measurement Sulfa Crystals Sulfonamide Crystals A measurement of the sulfa crystals present in a biological specimen. Sulfa Crystal Measurement Sulfate Sulphate A measurement of the sulfate in a biological specimen. Sulfate Measurement Sulfur Dioxide A measurement of the sulfur dioxide in a biological specimen. Sulfur Dioxide Measurement SP-D Surfactant Protein D A measurement of the surfactant protein D in a biological specimen. Surfactant Protein D Measurement N,N'-dimethylarginine Symmetric Dimethylarginine A measurement of the symmetric dimethylarginine in a biological specimen. Symmetric Dimethylarginine Measurement Synoviocytes Total Synoviocytes A measurement of the total synoviocytes in a biological specimen. Synoviocytes Cell Count Synoviocytes/Leukocytes Total Synoviocytes/Leukocytes A relative measurement (ratio or percentage) of the synoviocytes to all leukocytes in a biological specimen. Synoviocytes to Leukocytes Ratio Measurement CD8 CD8 Complex T-Cell Surface Glycoprotein CD8 A measurement of the T-cell surface glycoprotein CD8 in a biological specimen. T-Cell Surface Glycoprotein CD8 Measurement T-Kininogen A measurement of the total T-kininogen in a biological specimen. T-Kininogen Measurement T-lymphocyte Crossmatch A measurement to determine human leukocyte antigens (HLA) histocompatibility between the recipient and the donor by examining the presence or absence of the recipient's anti-HLA antibody reactivity towards HLA antigens expressed on the donor T-lymphocytes. T-lymphocyte Crossmatch Measurement T Cells T-Cell Lymphocytes T-Cells T-Lymphocytes A measurement of the total thymocyte-derived lymphocytes in a biological specimen. T-Lymphocyte Count T1 Collagen X-link N-Telopeptides/Creat Type I Collagen X-linked N-Telopeptides/Creatinine A relative measurement (ratio or percentage) of the type 1 collagen cross-linked N-telopeptides to creatinine in a biological specimen. Type 1 Collagen X-link N-Telopeptides to Creatinine Ratio Measurement Tapentadol A measurement of the tapentadol in a biological specimen. Tapentadol Measurement Codocytes Target Cells A measurement of the target cells in a biological specimen. Target Cell Count Tartrate-Resistant Acid Phosphatase 5b TRAP5B A measurement of tartrate-resistant acid phosphatase 5b in a biological specimen. Tartrate-Resistant Acid Phosphatase 5b Measurement TATA Box Binding Protein TATA-Binding Protein A measurement of the TATA-box binding protein in a biological specimen. TATA Box Binding Protein Measurement Tau Protein Total Tau Protein A measurement of the total Tau protein in a biological specimen. Tau Protein Measurement Tau Protein, Free A measurement of the free tau protein in a biological specimen. Free Tau Protein Measurement Tauric Acid Taurine A measurement of the taurine in a biological specimen. Taurine Measurement Taurine/Creatinine A relative measurement (ratio) of the taurine to the creatinine in a biological specimen. Taurine to Creatinine Ratio Measurement Taurochenodeoxycholate Taurochenodeoxycholic Acid A measurement of the taurochenodeoxycholate in a biological specimen. Taurochenodeoxycholate Measurement Taurocholate Taurocholic Acid A measurement of the taurocholate in a biological specimen. Taurocholate Measurement Taurolithocholate Taurolithocholic Acid A measurement of the taurolithocholate in a biological specimen. Taurolithocholate Measurement Tauroursodeoxycholate Tauroursodeoxycholic Acid A measurement of the tauroursodeoxycholate in a biological specimen. Tauroursodeoxycholate Measurement Temazepam A measurement of the temazepam present in a biological specimen. Temazepam Measurement Tenascin C Tenascin-C TN-C A measurement of the tenascin C in a biological specimen. Tenascin C Measurement Terminal Deoxynucleotidyl Transferase Ag Terminal Deoxynucleotidyl Transferase Antigen A measurement of the terminal deoxynucleotidyl transferase antigen in a biological specimen. Terminal Deoxynucleotidyl Transferase Antigen Measurement Testolactone A measurement of the testolactone in a biological specimen. Testolactone Measurement Testosterone Free+Weakly Bound/Testost Testosterone, Free and Weakly Bound/Testosterone A relative measurement (ratio or percentage) of the free and weakly bound testosterone to total testosterone in a biological specimen. Free Testosterone and Weakly Bound to Total Testosterone Ratio Measurement Testosterone Total Testosterone A measurement of the total (free and bound) testosterone in a biological specimen. Total Testosterone Measurement Testosterone, Free A measurement of the free testosterone in a biological specimen. Free Testosterone Measurement Testosterone, Free/Testosterone A relative measurement (ratio or percentage) of the amount of the bioavailable testosterone compared to total testosterone in a biological specimen. Free Testosterone to Testosterone Ratio Measurement Testosterone, Free/Total Protein A relative measurement (ratio or percentage) of free testosterone to total proteins in a biological specimen. Free Testosterone to Total Protein Ratio Measurement Testosterone, Weakly Bound A measurement of the weakly bound testosterone (testosterone bound to albumin) in a biological specimen. Weakly Bound Testosterone Measurement Delta-9-Tetrahydrocannabinol Tetrahydrocannabinol THC A measurement of the tetrahydrocannabinol in a biological specimen. Tetrahydrocannabinol Measurement Tetrahydrogestrinone A measurement of the tetrahydrogestrinone in a biological specimen. Tetrahydrogestrinone Measurement BA2 CD9 CD9 Antigen CD9 Molecule MIC3 MRP-1 P24 Soluble CD9 Tetraspanin-29 TSPAN-29 A measurement of the tetraspanin-29 in a biological specimen. Tetraspanin-29 Measurement Thebaine A measurement of the thebaine in a biological specimen. Thebaine Measurement Theophylline A measurement of the Theophylline present in a biological specimen. Theophylline Measurement Thiamine Vitamin B1 A measurement of the thiamine in a biological specimen. Vitamin B1 Measurement Thiamylal A measurement of the thiamylal in a biological specimen. Thiamylal Measurement Thiocyanate A measurement of the thiocyanate in a biological specimen. Thiocyanate Measurement Thiopental A measurement of the thiopental in a biological specimen. Thiopental Measurement Thioridazine A measurement of the thioridazine in a biological specimen. Thioridazine Measurement Thiothixene A measurement of the thiothixene in a biological specimen. Thiothixene Measurement Threonine A measurement of the threonine in a biological specimen. Threonine Measurement Threonine/Creatinine A relative measurement (ratio) of the threonine to the creatinine in a biological specimen. Threonine to Creatinine Ratio Measurement Thrombin Activity Actual/Control Thrombin Activity Actual/Normal Thrombin Activity Actual/Thrombin Activity Control A relative measurement (ratio or percentage) of the biological activity of thrombin dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. Thrombin Activity Actual to Control Ratio Measurement TAT Thrombin Antithrombin Complex Thrombin Antithrombin Complex Antigen A measurement of the thrombin-antithrombin complexes in a biological specimen. Thrombin Antithrombin Complex Measurement Thrombin Time Actual/Control A relative measurement (ratio or percentage) of the thrombin time in a subject's specimen when compared to a control specimen. Thrombin Time Actual to Control Ratio Measurement Thrombin Time A measurement of the time it takes a plasma sample to clot after adding the active enzyme thrombin. (NCI) Thrombin Time Thrombin/Antithrombin Thrombin/Antithrombin III A relative measurement (ratio or percentage) of the thrombin to antithrombin present in a sample. Thrombin to Antithrombin Ratio Measurement Nucleated Thrombocytes Thrombocytes A measurement of the nucleated platelets, namely thrombocytes, in a biological specimen. This is typically measured in birds and other non-mammalian vertebrates. Nucleated Thrombocyte Count BDCA3 Thrombomodulin A measurement of the thrombomodulin in a biological specimen. Thrombomodulin Measurement Thrombopoietin A measurement of the thrombopoietin hormone in a biological specimen. Thrombopoietin Measurement THBS1 Thrombospondin 1 A measurement of the thrombospondin 1 in a biological specimen. Thrombospondin 1 Measurement Thromboxane B2 A measurement of the thromboxane B2 in a biological specimen. Thromboxane B2 Measurement Thymic Stromal Lymphopoietin A measurement of the thymic stromal lymphopoietin in a biological specimen. Thymic Stromal Lymphopoietin Measurement Thymidine Kinase 1 Thymidine Kinase, Cytosolic A measurement of the thymidine kinase 1 in a biological specimen. Thymidine Kinase 1 Measurement Thymidine Kinase 2 Thymidine Kinase, Mitochondrial A measurement of the thymidine kinase 2 in a biological specimen. Thymidine Kinase 2 Measurement Thymidine Kinase A measurement of the total thymidine kinase in a biological specimen. Thymidine Kinase Measurement Thyroglobulin Recovery Rate A measurement of the thyroglobulin recovery rate in a biological specimen obtained by measuring the thyroglobulin concentration before and after a known amount of thyroglobulin has been added to the specimen. Thyroglobulin Recovery Rate TG Thyroglobulin A measurement of the thyroglobulin in a biological specimen. Thyroglobulin Measurement Thyroid Peroxidase Thyroperoxidase A measurement of the thyroperoxidase in a biological specimen. Thyroperoxidase Measurement Thyrotropin Releasing Factor Thyrotropin Releasing Hormone A measurement of the thyrotropin releasing hormone in a biological specimen. Thyrotropin Releasing Hormone Measurement Thyroid Stimulating Hormone Thyrotropin A measurement of the thyrotropin in a biological specimen. Thyrotropin Measurement Thyroid Stimulating Hormone/Free T4 Thyrotropin/Thyroxine, Free A relative measurement (ratio) of the thyrotropin to free thyroxine in a biological specimen. Thyrotropin to Free Thyroxine Ratio Measurement Thyroxine Binding Globulin A measurement of the thyroxine binding globulin protein in a biological specimen. Thyroxine Binding Globulin Protein Measurement Thyroxine Total T4 A measurement of the total (free and bound) thyroxine in a biological specimen. Total Thyroxine Measurement Thyroxine, Free Index A measurement of the thyroid status in a biological specimen. This is calculated by a mathematical formula that takes into account the total thyroxine and unbound thyroxine binding globulins. Free Thyroxine Index Free T4 Thyroxine, Free A measurement of the free thyroxine in a biological specimen. Free Thyroxine Measurement Thyroxine, Free, Indirect An indirect measurement of the free thyroxine in a biological specimen. Indirect Free Thyroxine Measurement TIMP1/Creatinine Tissue Inhibitor of Metalloproteinase 1/Creatinine A relative measurement (ratio or percentage) of the tissue inhibitor of metalloproteinase 1 to creatinine present in a sample. Tissue Inhibitor of Metalloproteinase 1 to Creatinine Ratio Measurement Free Tissue Factor Pathway Inhibitor Antigen Tissue Factor Pathway Inhibitor, Free A measurement of the free tissue factor pathway inhibitor in a biological specimen. Free Tissue Factor Pathway Inhibitor Antigen Measurement EPA Erythroid Potentiating Activity Fibroblast Collagenase Inhibitor Metalloproteinase Inhibitor 1 Tissue Inhibitor of Metalloproteinase 1 A measurement of the tissue inhibitor of metalloproteinase 1 in a biological specimen. Tissue Inhibitor of Metalloproteinase 1 Measurement CSC-21K Metalloproteinase Inhibitor 2 Tissue Inhibitor of Metalloproteinase 2 A measurement of the tissue inhibitor of metalloproteinase 2 in a biological specimen. Tissue Inhibitor of Metalloproteinase 2 Measurement HSMRK222 K222 K222TA2 Metalloproteinase Inhibitor 3 Protein MIG-5 SFD Tissue Inhibitor of Metalloproteinase 3 A measurement of the tissue inhibitor of metalloproteinase 3 in a biological specimen. Tissue Inhibitor of Metalloproteinase 3 Measurement TIM Tissue Inhibitor of Metalloproteinase A measurement of the total tissue inhibitor metalloproteinase in a biological specimen. Tissue Inhibitor of Metalloproteinase Measurement Tissue Plasminogen Activator Antigen A measurement of the tissue plasminogen activator antigen in a biological specimen. Tissue Plasminogen Activator Measurement Tissue Polypeptide Antigen TPA A measurement of the tissue polypeptide antigen in a biological specimen. Tissue Polypeptide Antigen Measurement CD120b p75 p75TNFR Soluble CD120b TBPII TNF Receptor 1B TNF-R-II TNF-R75 TNFBR TNFR1B TNFR2 TNFR80 Tumor Necrosis Factor Receptor 2 A measurement of the tumor necrosis factor receptor superfamily member 1B in a biological specimen. TNF Receptor 1B Measurement CD263 DcR1 TNF Receptor Superfamily Member 10c TNF-Related Apoptosis-Inducing Ligand Receptor 3 TRAIL Receptor 3 TRAILR3 A measurement of the TNF receptor superfamily member 10c in a biological specimen. Tumor Necrosis Factor Receptor Superfamily Member 10c Measurement APO2L Soluble CD253 TL2 TNF-Related Apoptosis-Inducing Ligand TNFSF10 TNLG6A TRAIL A measurement of the total tumor necrosis factor superfamily member 10 in a biological specimen. TNF Superfamily Member 10 Measurement TNF Superfamily Member 12 Excretion Rate TWEAK Excretion Rate A measurement of the amount of TNF superfamily member 12 being excreted in a biological specimen over a defined period of time (e.g. one hour). TNF Superfamily Member 12 Excretion Rate APO3L DR3LG TNF Superfamily Member 12 TNLG4A TWEAK A measurement of the total tumor necrosis factor superfamily member 12 in a biological specimen. TNF Superfamily Member 12 Measurement Herpesvirus Entry Mediator Ligand HVEM-L LIGHT Soluble CD258 TNF Ligand Superfamily Member 14 TNF Superfamily Member 14 TNFSF14 Tumor Necrosis Factor (Ligand) Superfamily, Member 14 A measurement of the tumor necrosis factor superfamily member 14 in a biological specimen. Tumor Necrosis Factor Receptor Superfamily Member 14 Measurement TNF-a Production Inhibition TNF-a Production Inhibitory Activity A measurement of TNF-a production inhibitory activity in a biological specimen. TNF-a Production Inhibitory Activity Measurement Methylbenzene Phenylmethane Toluene Toluol A measurement of the toluene in a specimen. Toluene Measurement Tomoregulin-2 Transmembrane Protein With EGF-Like And Two Follistatin-Like Domains 2 A measurement of the tomoregulin-2 in a biological specimen. Tomoregulin-2 Measurement Total Amyloid Precursor Protein A measurement of the total amyloid precursor protein present in a biological specimen. Total Amyloid Precursor Protein Measurement Total Anti-Oxidant Capacity Total Antioxidant Capacity A measurement of the amount and/or activity of antioxidants in a specimen. Total Antioxidant Capacity Measurement Total Iron Binding Capacity A measurement of the amount of iron needed to fully saturate the transferrin in a biological specimen. Total Iron Binding Capacity Total Plasma Cells A measurement of the total plasma cells in a biological specimen. Plasma Cell Count Plasma Cells/Leuk Total Plasma Cells/Leukocytes A relative measurement (ratio or percentage) of the total plasma cells to leukocytes in a biological specimen. Plasma Cells to Leukocytes Ratio Measurement Total Plasma Cells/Lymphocytes A relative measurement (ratio or percentage) of the total plasma cells to lymphocytes in a biological specimen. Plasma Cell to Lymphocyte Ratio Measurement Plasma Cells/Total Cells Total Plasma Cells/Total Cells A relative measurement (ratio or percentage) of the total plasma cells to total cells in a biological specimen. Plasma Cell to Total Cell Ratio Measurement Total Radical-Trap Antioxidant Potential A measurement of the ability of the antioxidants in a biological specimen to buffer free radicals in a suspension. Total Radical-Trap Antioxidant Potential Measurement Toxic Granulation A measurement of the toxic granulation in granulocytic blood cells. Toxic Granulation Measurement Toxic Vacuolation A measurement of the toxic vacuolation in any of the granulocytic blood cells. Toxic Vacuolation Assessment TPR and Ankyrin Repeat-Containing Protein 1 TPR-Ankyrin Repeat-Containing Protein 1 A measurement of the TPR-ankyrin repeat-containing protein 1 in a biological specimen. TPR-Ankyrin Repeat-containing Protein 1 Measurement Tramadol A measurement of the tramadol present in a biological specimen. Tramadol Measurement 3-HC 3HC Trans-3 Hydroxycotinine A measurement of the total trans-3'- hydroxycotinine in a specimen. Trans-3 Hydroxycotinine Measurement Free 3-HC Free 3HC Trans-3'- Hydroxycotinine, Free A measurement of the free (unbound) trans-3'- hydroxycotinine in a specimen. Free Trans-3'-Hydroxycotinine Measurement 3HC-gluc Trans-3'- Hydroxycotinineglucuronide Trans-3'-Hydroxycotinine-O-glucuronide A measurement of the trans-3'- hydroxycotinineglucuronide in a specimen. Trans-3'-Hydroxycotinineglucuronide Measurement P90 Soluble CD71 TfR1 Transferrin Receptor Protein 1 A measurement of the transferrin receptor protein 1 in a biological specimen. Transferrin Receptor Protein 1 Measurement Iron Binding Capacity Saturation Iron Saturation Iron to TIBC Transferrin Saturation A measurement of the iron bound to transferrin in a biological specimen. Transferrin Saturation Measurement Beta-1 Metal-Binding Globulin Serotransferrin Siderophilin Transferrin A measurement of the total transferrin in a biological specimen. Transferrin Measurement Protransforming Growth Factor Alpha TGF-Alpha Transforming Growth Factor Alpha A measurement of the transforming growth factor alpha in a biological specimen. Transforming Growth Factor Alpha Measurement Transforming Growth Factor Beta 1 A measurement of the transforming growth factor beta 1 in a biological specimen. Transforming Growth Factor Beta 1 Measurement G-TSF LDS4 TGF-beta2 Transforming Growth Factor Beta 2 A measurement of the transforming growth factor beta 2 in a biological specimen. Transforming Growth Factor Beta 2 Measurement ARVD ARVD1 LDS5 RNHF TGF-beta3 Transforming Growth Factor Beta 3 A measurement of the transforming growth factor beta 3 in a biological specimen. Transforming Growth Factor Beta 3 Measurement Transforming Growth Factor Beta A measurement of the total transforming growth factor beta in a biological specimen. Transforming Growth Factor Beta Measurement Transitional Epithelial Cells A measurement of the transitional epithelial cells present in a biological specimen. Transitional Epithelial Cells Measurement Translocase Inner Mitochondrial Membr 10 Translocase of Inner Mitochondrial Membrane 10 A measurement of the translocase of inner mitochondrial membrane 10 in a biological specimen. Translocase Inner Mitochondrial Membrane 10 Measurement Trazodone A measurement of the trazodone in a biological specimen. Trazodone Measurement Trefoil Factor 3 A measurement of the trefoil factor 3 in a biological specimen. Trefoil Factor 3 Measurement 17beta-Trenbolone Trenbolone Trienbolone A measurement of the trenbolone in a biological specimen. Trenbolone Measurement Triazolam A measurement of the triazolam in a biological specimen. Triazolam Measurement Trichomonas Examination of a biological specimen to detect the presence of any protozoan belonging to the Trichomonas genus. Trichomonas Screening Tricyclic Antidepressants A measurement of tricyclic antidepressants in a biological specimen. Tricyclic Antidepressant Measurement Trifluoperazine A measurement of the trifluoperazine in a biological specimen. Trifluoperazine Measurement Soluble CD354 Triggering Rcpt Expressed Myeloid Cell 1 Triggering Receptor Expressed On Monocytes 1 Triggering Receptor Expressed On Myeloid Cells 1 A measurement of the triggering receptor expressed on myeloid cells 1 protein in a biological specimen. Triggering Receptor Expressed On Myeloid Cells 1 Measurement Triglyceride Sapienate Triglyceride Sapienic Acid A measurement of the total triglyceride sapienate in a biological specimen. Triglyceride Sapienate Measurement Triglycerides A measurement of the triglycerides in a biological specimen. Triglyceride Measurement Triglycerides/HDL Cholesterol A relative measurement (ratio or percentage) of the triglycerides to high density lipoprotein cholesterol in a biological specimen. Triglycerides to HDL Cholesterol Ratio Measurement T3RU T3U Triiodothyronine Uptake A measurement of the binding of triiodothyronine to thyroxine binding globulin protein in a biological specimen. Triiodothyronine Uptake Measurement Total T3 Triiodothyronine A measurement of the total (free and bound) triiodothyronine in a biological specimen. Triiodothyronine Measurement Free T3 Triiodothyronine, Free A measurement of the free triiodothyronine in a biological specimen. Free Triiodothyronine Measurement Triiodothyronine, Reverse A measurement of the reverse triiodothyronine in a biological specimen. Reverse Triiodothyronine Measurement Trimeperidine A measurement of the trimeperidine in a biological specimen. Trimeperidine Measurement E3 Ubiquitin-Protein Ligase TRIM21 Ro(SS-A) Sjogren Syndrome Type A Antigen Tripartite Motif Containing Protein 21 A measurement of the tripartite motif containing protein 21 in a biological specimen. Tripartite Motif Containing Protein 21 Measurement Tripartite Motif Containing Protein 38 A measurement of the tripartite motif containing protein 38 in a biological specimen. Tripartite Motif Containing Protein 38 Measurement Ammonium Magnesium Phosphate Crystals Struvite Crystals Triple Phosphate Crystals A measurement of the triple phosphate crystals present in a biological specimen. Triple Phosphate Crystal Measurement Slow-Twitch Skeletal Muscle Troponin I ssTnI Troponin I Type 1 A measurement of the troponin I type 1 (slow twitch skeletal muscle) in a biological specimen. Troponin I Type 1 Measurement Fast-Twitch Skeletal Muscle Troponin I fsTnI Troponin I Type 2 A measurement of the troponin I type 2 (fast twitch skeletal muscle) in a biological specimen. Troponin I Type 2 Measurement Cardiac Troponin I cTnI TNNC1 Troponin I Type 3 A measurement of the troponin I type 3 (cardiac muscle) in a biological specimen. Troponin I Type 3 Measurement Troponin I A measurement of the actin binding troponin in a biological specimen. Troponin I Measurement Troponin T A measurement of the tropomyosin binding troponin in a biological specimen. Troponin T Measurement Troponin A measurement of the total troponin in a biological specimen. Troponin Measurement Trypsin 1 and Trypsinogen 1 A measurement of the trypsin 1 and trypsinogen 1 in a biological specimen. Trypsin 1 and Trypsinogen 1 Measurement Trypsin and Trypsinogen A measurement of the total trypsin and total trypsinogen in a biological specimen. Trypsin and Trypsinogen Measurement Trypsin A measurement of the trypsin in a biological specimen. Trypsin Measurement Tryptase A measurement of the tryptase in a biological specimen. Tryptase Measurement Tryptophan A measurement of the tryptophan in a biological specimen. Tryptophan Measurement Tryptophan/Creatinine A relative measurement (ratio or percentage) of the tryptophan to creatinine in a biological specimen. Tryptophan to Creatinine Ratio Measurement Renal Tubular Epithelial Cells Tubular Epithelial Cells A measurement of the tubular epithelial cells present in a biological specimen. Tubular Epithelial Cell Count Soluble CD120a Tumor Necrosis Factor Receptor 1 A measurement of the tumor necrosis factor receptor 1 (CD120a) in a biological specimen. Tumor Necrosis Factor Receptor 1 Measurement Tumor Necrosis Factor Tumor Necrosis Factor alpha A measurement of the total tumor necrosis factor (cachexin) cytokine in a biological specimen. Tumor Necrosis Factor Measurement TUM Tumstatin A measurement of the tumstatin in a biological specimen. Tumstatin Measurement Turbidity A measurement of the opacity of a biological specimen. Turbidity Measurement B-CTx Beta Isomer of C-Terminal Telopeptide of Type I Collagen Beta-CrossLaps Type I Collagen C-Telopeptides Beta A measurement of the beta isomer of type I collagen cross-linked C-telopeptides in a biological specimen. Beta Isomer of C-Terminal Telopeptide of Type I Collagen Measurement C-Terminal Telopeptide of Type I Collagen Type I Collagen C-Telopeptides Type I Collagen X-linked C-telopeptide A measurement of the type I collagen cross-linked C-telopeptides in a biological specimen. Type I Collagen C-Telopeptide Measurement Type I Collagen C-Telopeptides/Creat Type I Collagen X-Linked C-Telopeptides/Creatinine A relative measurement (ratio or percentage) of the type I collagen cross-linked C-telopeptides to creatinine in a biological specimen. Type I Collagen C-Telopeptide to Creatinine Ratio Measurement Type I Collagen N-Telopeptides Type I Collagen X-Linked N-Telopeptides A measurement of the type I collagen cross-linked N-telopeptides in a biological specimen. Type I Collagen N-Telopeptide Measurement Type I Myeloblasts A measurement of type I myeloblast cells per unit of a biological specimen. Type I Myeloblasts Measurement Type II Collagen C-Telopeptides Type II Collagen X-Linked C-Telopeptides A measurement of the type II collagen cross-linked C-telopeptides in a biological specimen. Type II Collagen C-Telopeptide Measurement Type II Collagen C-Telopeptides/Creat Type II Collagen X-Linked C-Telopeptides/Creatinine A relative measurement (ratio or percentage) of the type II collagen cross-linked C-telopeptides to creatinine in a biological specimen. Type II Collagen C-Telopeptides to Creatinine Ratio Measurement Type II Collagen N-Telopeptides Type II Collagen X-Linked N-Telopeptides A measurement of the type II collagen cross-linked N-telopeptides in a biological specimen. Type II Collagen N-Telopeptide Measurement Type II Myeloblasts A measurement of type II myeloblast cells per unit of a biological specimen. Type II Myeloblasts Measurement Type II Secretory Phospholipase A2 A measurement of the type II secretory phospholipase A2 in a biological specimen. Type II Secretory Phospholipase A2 Measurement Cross-Linked C-telopeptide of Type III Collagen Type III Collagen C-Telopeptides Type III Collagen X-Linked C-Telopeptides A measurement of the type III collagen cross-linked C-telopeptides in a biological specimen. Type III Collagen Cross-Linked C-Telopeptide Measurement Type III Myeloblasts A measurement of type III myeloblast cells per unit of a biological specimen. Type III Myeloblasts Measurement Tyrosine Crystals A measurement of the tyrosine crystals present in a biological specimen. Tyrosine Crystal Measurement Tyrosine A measurement of the tyrosine in a biological specimen. Tyrosine Measurement Pink Pinky U-47700 U4 U47700 A measurement of the synthetic cannabinoid U-47700 in a biological specimen. U-47700 Measurement Coenzyme Q10 Ubiquinone 10 A measurement of the ubiquinone 10 in a biological specimen. Ubiquinone 10 Measurement Ubiquitin C-Terminal Hydrolase L1 Ubiquitin Carboxy-Terminal Hydrolase L1 UCH-L1 A measurement of the ubiquitin C-terminal hydrolase L1 in a biological specimen. Ubiquitin C-Terminal Hydrolase L1 Measurement Ubiquitin Protein A measurement of the total ubiquitin protein in a biological specimen. Ubiquitin Protein Measurement ISG15 Ubiquitin-Like Modifier Ubiquitin-Like Protein ISG15 A measurement of the ubiquitin-like protein ISG15 in a biological specimen. Ubiquitin-Like Protein ISG15 Measurement Unclassified Casts A measurement of the unclassifiable casts present in a biological specimen. Unclassified Cast Measurement Unclassified Crystals A measurement of the unclassifiable crystals present in a biological specimen. Unclassified Crystal Measurement Unsaturated Iron Binding Capacity A measurement of the binding capacity of unsaturated iron in a biological specimen. Unsaturated Iron Binding Capacity Measurement Unspecified Cells A measurement of the cells not otherwise identified or specified in a biological specimen. Count of Unspecified Cells Unspecified Cells/Leukocytes A relative measurement (ratio or percentage) of the cells not otherwise identified or specified to leukocytes in a biological specimen. Unspecified Cells to Leukocytes Ratio Measurement Unspecified Cells/Total Cells A relative measurement (ratio or percentage) of the cells not otherwise identified or specified to total cells in a biological specimen. Unspecified Cells to Total Cell Ratio Measurement UR-144 UR144 A measurement of the synthetic cannabinoid UR-144 in a biological specimen. UR-144 Measurement Urate Excretion Rate A measurement of the amount of urate being excreted in a biological specimen over a defined amount of time (e.g. one hour). Urate Excretion Rate Urate Uric Acid A measurement of the urate in a biological specimen. Urate Measurement Urate/Creatinine A relative measurement (ratio or percentage) of the urate to creatinine in a biological specimen. Urate to Creatinine Ratio Measurement Urea Distribution Volume Ratio Urea Kt/V A calculated measurement of the urea distribution volume (ratio) in a biological specimen used to quantify adequacy of dialysis treatment. Urea Distribution Volume Ratio Urea Excretion Rate A measurement of the amount of urea excreted in a biological specimen over a defined period of time (e.g. one hour). Urea Excretion Rate Urea Nitrogen Excretion Rate A measurement of the amount of urea nitrogen being excreted in a biological specimen over a defined amount of time (e.g. one hour). Urea Nitrogen Excretion Rate Urea Nitrogen A measurement of the urea nitrogen in a biological specimen. Urea Nitrogen Measurement Urea Nitrogen/Creatinine A relative measurement (ratio or percentage) of the urea nitrogen to creatinine in a biological specimen. Urea Nitrogen to Creatinine Ratio Measurement Urea Reduction Ratio A calculated measurement (ratio or percentage) of the proportionate reduction in urea nitrogen over the course of dialysis in a biological specimen. Urea Reduction Ratio Urea A measurement of the urea in a biological specimen. Urea Measurement Urea/Creatinine A relative measurement (ratio or percentage) of the urea to creatinine in a biological specimen. Urea to Creatinine Ratio Measurement Uric Acid Crystals A measurement of the uric acid crystals (including acid urate and urate crystals) present in a biological specimen. Uric Acid Crystal Measurement Urinalysis Panel Interpretation Urine Panel Analysis Urine Panel Examination Urine Panel Interpretation An interpretation of the results of a panel of urinalysis tests. Urinalysis Panel Interpretation Urine Conductivity A measurement of the urine conductivity which is a non-linear function of the electrolyte concentration in the urine. Urine Conductivity Urobilinogen A measurement of the urobilinogen in a biological specimen. Urobilinogen Measurement uPA Urokinase Plasminogen Activator A measurement of the urokinase plasminogen activator in a biological specimen. Urokinase Plasminogen Activator Measurement Tamm-Horsfall Urinary Glycoprotein THP UROM Uromodulin A measurement of the uromodulin in a biological specimen. Uromodulin Measurement Urothelial Cells A measurement of urothelial cells in a biological specimen. Urothelial Cell Count Ursodeoxycholate Compounds Ursodeoxycholic Acid Compounds A measurement of the ursodeoxycholic acid, glycoursodeoxycholic acid, tauroursodeoxycholic acid, and epimerized ursodeoxycholic acid in a biological specimen. Ursodeoxycholate Compounds Measurement Ursodeoxycholate Ursodeoxycholic Acid Ursodiol A measurement of the ursodeoxycholate in a biological specimen. Ursodeoxycholate Measurement Vacuolated Lymphocytes A measurement of the vacuolated lymphocytes in a biological specimen. Vacuolated Lymphocyte Count Vacuolated Lymphocytes/Leukocytes A relative measurement (ratio or percentage) of the vacuolated lymphocytes to leukocytes in a biological specimen. Vacuolated Lymphocyte to Leukocyte Ratio Measurement Vacuolated Neutrophils A measurement of the neutrophils containing small vacuoles in a biological specimen. Vacuolated Neutrophil Count Valeryl Fentanyl Valerylfentanyl A measurement of the valerylfentanyl in a biological specimen. Valerylfentanyl Measurement Valine A measurement of the valine in a biological specimen. Valine Measurement Valproate Valproic Acid A measurement of the valproate in a biological specimen. Valproate Measurement Vanillyl Mandelic Acid Excretion Rate A measurement of the amount of vanillyl mandelic acid being excreted in a biological specimen over a defined amount of time (e.g. one hour). Vanillyl Mandelic Acid Excretion Rate Vanillyl Mandelic Acid Vanillylmandelate Vanilmandelic Acid A measurement of the vanillyl mandelic acid metabolite in a biological specimen. Vanillyl Mandelic Acid Measurement Vasc Endothelial Growth Factor Rec 2 Vascular Endothelial Growth Factor Receptor 2 A measurement of the vascular endothelial growth factor receptor 2 in a biological specimen. Vascular Endothelial Growth Factor Receptor 2 Measurement Vascular Cell Adhesion Molecule 1 A measurement of the vascular cell adhesion molecule 1 in a biological specimen. Vascular Cell Adhesion Molecule 1 Measurement Vascular Endothelial Growth Factor A A measurement of the vascular endothelial growth factor A in a biological specimen. Vascular Endothelial Growth Factor A Measurement Vascular Endothelial Growth Factor C A measurement of the vascular endothelial growth factor C in a biological specimen. Vascular Endothelial Growth Factor C Measurement FIGF Vascular Endothelial Growth Factor D A measurement of the vascular endothelial growth factor D in a biological specimen. Vascular Endothelial Growth Factor D Measurement Vascular Endothelial Growth Factor A measurement of the vascular endothelial growth factor in a biological specimen. Vascular Endothelial Growth Factor Measurement Vasoactive Intestinal Polypeptide VIP A measurement of vasoactive intestinal polypeptide in a biological specimen. Vasoactive Intestinal Polypeptide Measurement Vegetable Fiber Vegetable Fibers A measurement of the vegetable fiber in a biological specimen. Vegetable Fiber Measurement Venlafaxine A measurement of the venlafaxine present in a biological specimen. Venlafaxine Measurement Live Cells Viable Cells A measurement of the viable cells in a biological specimen. Viable Cell Count Citrullinated and MMP-Degraded Vimentin VICM VICM A measurement of the citrullinated and MMP-degraded vimentin fragment VICM in a biological specimen. Citrullinated and MMP-Degraded Vimentin Measurement Vilazodone A measurement of the vilazodone in a biological specimen. Vilazodone Measurement Vinbarbital A measurement of the vinbarbital in a biological specimen. Vinbarbital Measurement Visc Viscosity The resistance of a liquid to sheer forces and flow. (NCI) Viscosity Retinol Vitamin A A measurement of the Vitamin A in a biological specimen. Vitamin A Measurement Cobalamin Vitamin B12 A measurement of the Vitamin B12 in a biological specimen. Vitamin B12 Measurement Amygdalin Vitamin B17 A measurement of the Vitamin B17 in a biological specimen. Vitamin B17 Measurement Pantothenic Acid Vitamin B5 A measurement of the Vitamin B5 in a biological specimen. Vitamin B5 Measurement Pyridoxine Vitamin B6 A measurement of the Vitamin B6 in a biological specimen. Vitamin B6 Measurement Biotin Vitamin B7 A measurement of the Vitamin B7 in a biological specimen. Vitamin B7 Measurement Folate Folic Acid Vitamin B9 A measurement of the folic acid in a biological specimen. Folic Acid Measurement Ascorbate Ascorbic Acid Vitamin C A measurement of the Vitamin C in a biological specimen. Vitamin C Measurement DBP GC Vitamin D Binding Protein VDBP Vitamin D Binding Protein A measurement of the vitamin D binding protein in a biological specimen. Vitamin D Binding Protein Measurement Calciferol + Cholecalciferol Vitamin D2 + Vitamin D3 A measurement of the vitamin D2 and vitamin D3 in a biological specimen. Vitamin D2 and Vitamin D3 Measurement Vitamin D + Metabolites Vitamin D2 + Vitamin D3 + 25-Hydroxy Vitamin D2 + 25-Hydroxy Vitamin D3 Vitamin D2 D3 25-OH A measurement of the vitamin D2, vitamin D3 and their metabolites in a biological specimen. Vitamin D2 and Vitamin D3 and 25-Hydroxy Vitamin D2 and 25-Hydroxy Vitamin D3 Measurement Calciferol Ergocalciferol Viosterol Vitamin D2 A measurement of the Vitamin D2 in a biological specimen. Vitamin D2 Measurement Calciol Cholecalciferol Colecalciferol Vitamin D Vitamin D3 A measurement of the Vitamin D3 in a biological specimen. Vitamin D3 Measurement Vitamin E A measurement of the Vitamin E in a biological specimen. Vitamin E Measurement Vitamin E/Cholesterol A relative measurement (ratio or percentage) of vitamin E to total cholesterol in a biological specimen. Vitamin E to Cholesterol Ratio Measurement Naphthoquinone Vitamin K A measurement of the total Vitamin K in a biological specimen. Vitamin K Measurement Phylloquinone Phytomenadione Vitamin K1 A measurement of the Vitamin K1 in a biological specimen. Vitamin K1 Measurement V75 Vitronectin VN VNT VTN A measurement of the vitronectin in a biological specimen. Vitronectin Measurement VLDL Apolipoprotein B A measurement of the apolipoprotein B in the very low density lipoprotein fraction of a biological specimen. VLDL Apolipoprotein B Measurement VLDL Cholesterol Subtype 1 A measurement of the very low density lipoprotein cholesterol subtype 1 in a biological specimen. VLDL Cholesterol Subtype 1 Measurement VLDL Cholesterol Subtype 2 A measurement of the very low density lipoprotein cholesterol subtype 2 in a biological specimen. VLDL Cholesterol Subtype 2 Measurement VLDL Cholesterol Subtype 3 A measurement of the very low density lipoprotein cholesterol subtype 3 in a biological specimen. VLDL Cholesterol Subtype 3 Measurement VLDL Cholesterol A measurement of the very low density lipoprotein cholesterol in a biological specimen. Very Low Density Lipoprotein Cholesterol Measurement VLDL Particle Size A measurement of the average particle size of very-low-density lipoprotein in a biological specimen. VLDL Particle Size Measurement VLDL Trig + Chylomicron Trig VLDL Triglyceride + Chylomicron Triglyceride A measurement of the very low density lipoprotein triglyceride and chylomicron triglyceride in a biological specimen. VLDL Triglyceride and Chylomicron Triglyceride Measurement VLDL Triglyceride A measurement of the very low density lipoprotein triglyceride in a biological specimen. VLDL Triglyceride Measurement Volume A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. Volume Measurement von Will Factor Act Actual/Control von Willebrand Factor Activity Actual/Normal von Willebrand Factor Activity Actual/von Willebrand Factor Activity Control A relative measurement (ratio or percentage) of the biological activity of the von Willebrand factor dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. von Willebrand Factor Activity Actual to Control Ratio Measurement von Will Factor Actual/Control von Willebrand Factor Actual/Control von Willebrand Factor Actual/Normal von Willebrand Factor Actual/von Willebrand Factor Control A relative measurement (ratio or percentage) of the von Willebrand factor in a subject's specimen when compared to a control specimen. von Willebrand Factor Actual to Control Ratio Measurement von Willebrand Factor Activity A measurement of the biological activity of von Willebrand coagulation factor in a biological specimen. von Willebrand Factor Activity Measurement von Willebrand Factor Multimers A measurement of the von Willebrand Factor multimers (an aggregate of multiple von Willebrand factor antigens that are held together with non-covalent bonds) in a biological specimen. von Willebrand Factor Multimers Measurement von Willebrand Factor von Willebrand Factor Antigen A measurement of the von Willebrand coagulation factor in a biological specimen. von Willebrand Factor Measurement Vortioxetine A measurement of the vortioxetine in a biological specimen. Vortioxetine Measurement Wax Ester Sapienate Wax Ester Sapienic Acid A measurement of the total wax ester sapienate in a biological specimen. Wax Ester Sapienate Measurement Wax Esters A measurement of the wax esters in a biological specimen. Wax Ester Measurement Waxy Casts A measurement of the waxy casts present in a biological specimen. Waxy Cell Cast Measurement WBC Casts A measurement of the white blood cell casts present in a biological specimen. White Blood Cell Cast Measurement CDW2 Macrophage Inflammatory Protein-2 MIP2 WD Repeat-Containing Protein 26 A measurement of the WD repeat-containing protein 26 in a biological specimen. WD Repeat-Containing Protein 26 Measurement Whole Blood Equivalent Glucose A measurement of the whole blood equivalent glucose in a biological specimen. Whole Blood Equivalent Glucose Measurement Xanthochromia A measurement of the yellowish appearance of a biological specimen due to the presence of bilirubin produced by the degradation of heme from erythrocytes that have entered the biological specimen. Xanthochromia Measurement Xylose A measurement of the xylose in a biological specimen. Xylose Measurement Xylose/Xylose Dose A relative measurement (percentage) of the xylose in a biological specimen to an administered dose of xylose. Xylose to Xylose Dose Ratio Measurement Budding Yeast Yeast Budding A measurement of the budding yeast present in a biological specimen. Budding Yeast Measurement Yeast Cells A measurement of the yeast cells present in a biological specimen. Yeast Cell Measurement Yeast Hyphae A measurement of the yeast hyphae present in a biological specimen. Yeast Hyphae Screening Chitinase-3-Like Protein 1 YKL-40 Protein A measurement of the YKL-40 protein in a biological specimen. YKL-40 Protein Measurement Zaleplon A measurement of the zaleplon in a biological specimen. Zaleplon Measurement Zinc Protoporphyrin A measurement of the zinc protoporphyrin (zinc bound protoporphyrin) in a biological specimen. Zinc Protoporphyrin Measurement Zinc A measurement of the zinc in a biological specimen. Zinc Measurement Ziprasidone A measurement of the ziprasidone in a biological specimen. Ziprasidone Measurement Zolpidem A measurement of the zolpidem in a biological specimen. Zolpidem Measurement Zopiclone A measurement of the zopiclone in a biological specimen. Zopiclone Measurement LBTEST Laboratory Test Name CDISC SDTM Laboratory Test Name Terminology Lansky Play-Performance Status Scale test code. LPPSS1-Lansky Play-Performance Status Lansky Play-Performance Status Scale - Lansky play-performance status. LPSS - Lansky Play-Performance Status LPPSS1TC Lansky Play-Performance Status Scale Clinical Classification Test Code CDISC Clinical Classification LPSS Test Code Terminology Lansky Play-Performance Status Scale test name. LPPSS1-Lansky Play-Performance Status Lansky Play-Performance Status Scale - Lansky play-performance status. LPSS - Lansky Play-Performance Status LPPSS1TN Lansky Play-Performance Status Scale Clinical Classification Test Name CDISC Clinical Classification LPSS Test Name Terminology CDISC terminology for anatomical location or specimen further detailing the side(s) of interest. Affecting both sides of the body, or a pair of organs. Bilateral Having to do with the opposite side of the body, in relation to a pre-existing reference point. Contralateral Having to do with the same side of the body, in relation to a pre-existing reference point. Ipsilateral Situated at or extending to the side. Lateral Being or located on or directed toward the side of the body to the west when facing north. Left Being or located on or directed toward the side of the body to the east when facing north. Right Affecting one side of the body or one of a pair of organs. Unilateral LAT Laterality CDISC SDTM Laterality Terminology Terminology related to the complications of cardiac lead systems. Conductor failure manifests by high lead impedance either absolutely (above manufacturer's product specifications) or by a significant increase from previously stable chronic values. Cardiac Device Conductor Failure The cardiac lead is not performing as expected with issues such as oversensing with or without shock or ATP, or failed shocks or inadequate DFT safety margins defibrillation activity. Cardiac Defibrillator Issue This manifests as stimulation by the lead of non-cardiac structures such as the diaphragm, chest wall, or pectoral muscle. Extracardiac Stimulation The cardiac lead failed to administer a shock and had an inadequate defibrillator threshold safety margin. Failure to Shock with Inadequate Defibrillator Threshold Safety Margin Failure to capture manifests as a high pacing threshold that results in either intermittent failure to capture at maximal programmed output or excessive battery drain leading to premature battery exhaustion. Failure to Capture with Acceptable Safety Margin Failure to pace manifests as absence of pacemaker stimulation artifacts on electrocardiographic recordings despite rates below pacemaker programmed rate. Failure of Cardiac Pacemaker to Pace Insulation failure manifests as low lead impedance either absolutely (below manufacturer's product specifications) or by a significant decrease from previously stable chronic values. Cardiac Lead Insulation Failure The movement (macroscopic or microscopic) of an existing lead within the heart or vascular tree away from the original implantation site. Cardiac Lead Dislodgement Requiring Reposition/Reoperation This manifests as sensing of non-cardiac depolarization signals that met arrhythmia detection criteria and elicited programmed tachyarrhythmia therapy. Cardiac Device Oversensing with Shock or Anti-Tachycardia Pacing This manifests as sensing of non-cardiac depolarization signals that did not meet arrhythmia detection criteria and do not elicit programmed tachyarrhythmia therapy. Cardiac Device Oversensing without Shock or Anti-Tachycardia Pacing Oversensing manifests as sensing of electrical signals not related to cardiac depolarization of the lead chamber that cannot be resolved acceptably by device reprogramming. Cardiac Device Oversensing The pacing and/or sensing problem associated with high impedance due to a poor connection between a lead and generator caused by a loose set screw. Cardiac Device Set Screw Problem Undersensing manifests as failure to sense appropriate cardiac depolarizations that cannot be resolved with reprogramming. Cardiac Device Undersensing LEADABN Lead Abnormality CDISC SDTM Lead Abnormality Terminology The status of the lead. The lead has been left in situ but is not in use. Abandoned Lead The lead has been removed from the body. Extracted Lead The lead has been left in situ and reused. Reused Lead LEADSTAT Lead Status CDISC SDTM Lead Status Terminology Terminology for results of left ventricular ejection fraction assessments. A pathologically high percentage of blood that is forced from the heart ventricle to produce cardiac output. This is often the result of ventricular dilation due to hypertrophic cardiomyopathy. Quantitatively, the ejection fraction is considered higher than 70%. Hyperdynamic Ventricular Ejection Fraction Slightly less than normal amount of blood that is forced from the heart ventricle to produce cardiac output. Quantitatively, the ejection fraction is considered between 41% to 49%. Mildly Abnormal Ejection Fraction Moderately less than normal amount of blood that is forced from the heart ventricle to produce cardiac output. Quantitatively, the ejection fraction is considered between 30% to 40%. Moderately Abnormal Ejection Fraction The usual amount of blood that is forced from the heart ventricle to produce cardiac output. Quantitatively, the ejection fraction is considered between 50% to 70%. Normal Ventricular Ejection Fraction Severely less than normal amount of blood that is forced from the heart ventricle to produce cardiac output. Quantitatively, the ejection fraction is considered less than 30%. Severely Abnormal Ventricular Ejection Fraction LVEFMRE Left Ventricular Ejection Fraction Measurement Result CDISC SDTM Left Ventricular Ejection Fraction Measurement Result Terminology Terminology related to the risk of percutaneous coronary intervention for a particular lesion. Low Risk Discrete (less than 10 mm length) and concentric and readily accessible and non-angulated segment less than 45 degrees and smooth contour and little or no calcification and less than totally occlusive and not ostial in location and no major branch involvement and absence of thrombus. American College of Cardiology/American Heart Association Lesion Complexity Score A Medium Risk Tubular (10-20 mm length) or eccentric or moderate tortuosity of proximal segment or moderately angulated segment, 45-90 degrees or irregular contour or moderate to heavy calcification or ostial in location or bifurcation lesions requiring double guidewires or some thrombus present or total occlusion less than3 months old. American College of Cardiology/American Heart Association Lesion Complexity Score B High Risk Diffuse (length greater than 2cm) or excessive tortuosity of proximal segment or extremely angulated segments greater than 90 degrees or total occlusions greater than 3 months old and/or bridging collaterals or inability to protect major side branches or degenerated vein grafts with friable lesions. American College of Cardiology/American Heart Association Lesion Complexity Score C LSNCMPX Lesion Complexity CDISC SDTM Lesion Complexity Terminology Life Events Checklist for DSM-5 Standard Version test code. LEC01-Natural Disaster: Happened Life Events Checklist for DSM-5, Standard Version - Natural disaster (for example, flood, hurricane, tornado, earthquake): Happened to me. LEC-5 Standard Version - Natural Disaster: Happened LEC01-Natural Disaster: Witnessed Life Events Checklist for DSM-5, Standard Version - Natural disaster (for example, flood, hurricane, tornado, earthquake): Witnessed it. LEC-5 Standard Version - Natural Disaster: Witnessed LEC01-Natural Disaster: Learned Life Events Checklist for DSM-5, Standard Version - Natural disaster (for example, flood, hurricane, tornado, earthquake): Learned about it. LEC-5 Standard Version - Natural Disaster: Learned LEC01-Natural Disaster: Job Life Events Checklist for DSM-5, Standard Version - Natural disaster (for example, flood, hurricane, tornado, earthquake): Part of my job. LEC-5 Standard Version - Natural Disaster: Job LEC01-Natural Disaster: Not Sure Life Events Checklist for DSM-5, Standard Version - Natural disaster (for example, flood, hurricane, tornado, earthquake): Not sure. LEC-5 Standard Version - Natural Disaster: Not Sure LEC01-Natural Disaster: Not Apply Life Events Checklist for DSM-5, Standard Version - Natural disaster (for example, flood, hurricane, tornado, earthquake): Doesn't apply. LEC-5 Standard Version - Natural Disaster: Not Apply LEC01-Fire or Explosion: Happened Life Events Checklist for DSM-5, Standard Version - Fire or explosion: Happened to me. LEC-5 Standard Version - Fire or Explosion: Happened LEC01-Fire or Explosion: Witnessed Life Events Checklist for DSM-5, Standard Version - Fire or explosion: Witnessed it. LEC-5 Standard Version - Fire or Explosion: Witnessed LEC01-Fire or Explosion: Learned Life Events Checklist for DSM-5, Standard Version - Fire or explosion: Learned about it. LEC-5 Standard Version - Fire or Explosion: Learned LEC01-Fire or Explosion: Job Life Events Checklist for DSM-5, Standard Version - Fire or explosion: Part of my job. LEC-5 Standard Version - Fire or Explosion: Job LEC01-Fire or Explosion: Not Sure Life Events Checklist for DSM-5, Standard Version - Fire or explosion: Not sure. LEC-5 Standard Version - Fire or Explosion: Not Sure LEC01-Fire or Explosion: Not Apply Life Events Checklist for DSM-5, Standard Version - Fire or explosion: Doesn't apply. LEC-5 Standard Version - Fire or Explosion: Not Apply LEC01-Transportation Accident: Happened Life Events Checklist for DSM-5, Standard Version - Transportation accident (for example, car accident, boat accident, train wreck, plane crash): Happened to me. LEC-5 Standard Version - Transportation Accident: Happened LEC01-Transportation Accident: Witnessed Life Events Checklist for DSM-5, Standard Version - Transportation accident (for example, car accident, boat accident, train wreck, plane crash): Witnessed it. LEC-5 Standard Version - Transportation Accident: Witnessed LEC01-Transportation Accident: Learned Life Events Checklist for DSM-5, Standard Version - Transportation accident (for example, car accident, boat accident, train wreck, plane crash): Learned about it. LEC-5 Standard Version - Transportation Accident: Learned LEC01-Transportation Accident: Job Life Events Checklist for DSM-5, Standard Version - Transportation accident (for example, car accident, boat accident, train wreck, plane crash): Part of my job. LEC-5 Standard Version - Transportation Accident: Job LEC01-Transportation Accident: Not Sure Life Events Checklist for DSM-5, Standard Version - Transportation accident (for example, car accident, boat accident, train wreck, plane crash): Not sure. LEC-5 Standard Version - Transportation Accident: Not Sure LEC01-Transportation Accident: Not Apply Life Events Checklist for DSM-5, Standard Version - Transportation accident (for example, car accident, boat accident, train wreck, plane crash): Doesn't apply. LEC-5 Standard Version - Transportation Accident: Not Apply LEC01-Serious Accident: Happened Life Events Checklist for DSM-5, Standard Version - Serious accident at work, home, or during recreational activity: Happened to me. LEC-5 Standard Version - Serious Accident: Happened LEC01-Serious Accident: Witnessed Life Events Checklist for DSM-5, Standard Version - Serious accident at work, home, or during recreational activity: Witnessed it. LEC-5 Standard Version - Serious Accident: Witnessed LEC01-Serious Accident: Learned Life Events Checklist for DSM-5, Standard Version - Serious accident at work, home, or during recreational activity: Learned about it. LEC-5 Standard Version - Serious Accident: Learned LEC01-Serious Accident: Job Life Events Checklist for DSM-5, Standard Version - Serious accident at work, home, or during recreational activity: Part of my job. LEC-5 Standard Version - Serious Accident: Job LEC01-Serious Accident: Not Sure Life Events Checklist for DSM-5, Standard Version - Serious accident at work, home, or during recreational activity: Not sure. LEC-5 Standard Version - Serious Accident: Not Sure LEC01-Serious Accident: Not Apply Life Events Checklist for DSM-5, Standard Version - Serious accident at work, home, or during recreational activity: Doesn't apply. LEC-5 Standard Version - Serious Accident: Not Apply LEC01-Toxic Substance: Happened Life Events Checklist for DSM-5, Standard Version - Exposure to toxic substance (for example, dangerous chemicals, radiation): Happened to me. LEC-5 Standard Version - Toxic Substance: Happened LEC01-Toxic Substance: Witnessed Life Events Checklist for DSM-5, Standard Version - Exposure to toxic substance (for example, dangerous chemicals, radiation): Witnessed it. LEC-5 Standard Version - Toxic Substance: Witnessed LEC01-Toxic Substance: Learned Life Events Checklist for DSM-5, Standard Version - Exposure to toxic substance (for example, dangerous chemicals, radiation): Learned about it. LEC-5 Standard Version - Toxic Substance: Learned LEC01-Toxic Substance: Job Life Events Checklist for DSM-5, Standard Version - Exposure to toxic substance (for example, dangerous chemicals, radiation): Part of my job. LEC-5 Standard Version - Toxic Substance: Job LEC01-Toxic Substance: Not Sure Life Events Checklist for DSM-5, Standard Version - Exposure to toxic substance (for example, dangerous chemicals, radiation): Not sure. LEC-5 Standard Version - Toxic Substance: Not Sure LEC01-Toxic Substance: Not Apply Life Events Checklist for DSM-5, Standard Version - Exposure to toxic substance (for example, dangerous chemicals, radiation): Doesn't apply. LEC-5 Standard Version - Toxic Substance: Not Apply LEC01-Physical Assault: Happened Life Events Checklist for DSM-5, Standard Version - Physical assault (for example, being attacked, hit, slapped, kicked, beaten up): Happened to me. LEC-5 Standard Version - Physical Assault: Happened LEC01-Physical Assault: Witnessed Life Events Checklist for DSM-5, Standard Version - Physical assault (for example, being attacked, hit, slapped, kicked, beaten up): Witnessed it. LEC-5 Standard Version - Physical Assault: Witnessed LEC01-Physical Assault: Learned Life Events Checklist for DSM-5, Standard Version - Physical assault (for example, being attacked, hit, slapped, kicked, beaten up): Learned about it. LEC-5 Standard Version - Physical Assault: Learned LEC01-Physical Assault: Job Life Events Checklist for DSM-5, Standard Version - Physical assault (for example, being attacked, hit, slapped, kicked, beaten up): Part of my job. LEC-5 Standard Version - Physical Assault: Job LEC01-Physical Assault: Not Sure Life Events Checklist for DSM-5, Standard Version - Physical assault (for example, being attacked, hit, slapped, kicked, beaten up): Not sure. LEC-5 Standard Version - Physical Assault: Not Sure LEC01-Physical Assault: Not Apply Life Events Checklist for DSM-5, Standard Version - Physical assault (for example, being attacked, hit, slapped, kicked, beaten up): Doesn't apply. LEC-5 Standard Version - Physical Assault: Not Apply LEC01-Assault With a Weapon: Happened Life Events Checklist for DSM-5, Standard Version - Assault with a weapon (for example, being shot, stabbed, threatened with a knife, gun, bomb): Happened to me. LEC-5 Standard Version - Assault With a Weapon: Happened LEC01-Assault With a Weapon: Witnessed Life Events Checklist for DSM-5, Standard Version - Assault with a weapon (for example, being shot, stabbed, threatened with a knife, gun, bomb): Witnessed it. LEC-5 Standard Version - Assault With a Weapon: Witnessed LEC01-Assault With a Weapon: Learned Life Events Checklist for DSM-5, Standard Version - Assault with a weapon (for example, being shot, stabbed, threatened with a knife, gun, bomb): Learned about it. LEC-5 Standard Version - Assault With a Weapon: Learned LEC01-Assault With a Weapon: Job Life Events Checklist for DSM-5, Standard Version - Assault with a weapon (for example, being shot, stabbed, threatened with a knife, gun, bomb): Part of my job. LEC-5 Standard Version - Assault With a Weapon: Job LEC01-Assault With a Weapon: Not Sure Life Events Checklist for DSM-5, Standard Version - Assault with a weapon (for example, being shot, stabbed, threatened with a knife, gun, bomb): Not sure. LEC-5 Standard Version - Assault With a Weapon: Not Sure LEC01-Assault With a Weapon: Not Apply Life Events Checklist for DSM-5, Standard Version - Assault with a weapon (for example, being shot, stabbed, threatened with a knife, gun, bomb): Doesn't apply. LEC-5 Standard Version - Assault With a Weapon: Not Apply LEC01-Sexual Assault: Happened Life Events Checklist for DSM-5, Standard Version - Sexual assault (rape, attempted rape, made to perform any type of sexual act through force or threat of harm): Happened to me. LEC-5 Standard Version - Sexual Assault: Happened LEC01-Sexual Assault: Witnessed Life Events Checklist for DSM-5, Standard Version - Sexual assault (rape, attempted rape, made to perform any type of sexual act through force or threat of harm): Witnessed it. LEC-5 Standard Version - Sexual Assault: Witnessed LEC01-Sexual Assault: Learned Life Events Checklist for DSM-5, Standard Version - Sexual assault (rape, attempted rape, made to perform any type of sexual act through force or threat of harm): Learned about it. LEC-5 Standard Version - Sexual Assault: Learned LEC01-Sexual Assault: Job Life Events Checklist for DSM-5, Standard Version - Sexual assault (rape, attempted rape, made to perform any type of sexual act through force or threat of harm): Part of my job. LEC-5 Standard Version - Sexual Assault: Job LEC01-Sexual Assault: Not Sure Life Events Checklist for DSM-5, Standard Version - Sexual assault (rape, attempted rape, made to perform any type of sexual act through force or threat of harm): Not sure. LEC-5 Standard Version - Sexual Assault: Not Sure LEC01-Sexual Assault: Not Apply Life Events Checklist for DSM-5, Standard Version - Sexual assault (rape, attempted rape, made to perform any type of sexual act through force or threat of harm): Doesn't apply. LEC-5 Standard Version - Sexual Assault: Not Apply LEC01-Unwanted Sex Experience: Happened Life Events Checklist for DSM-5, Standard Version - Other unwanted or uncomfortable sexual experience: Happened to me. LEC-5 Standard Version - Unwanted Sex Experience: Happened LEC01-Unwanted Sex Experience: Witnessed Life Events Checklist for DSM-5, Standard Version - Other unwanted or uncomfortable sexual experience: Witnessed it. LEC-5 Standard Version - Unwanted Sex Experience: Witnessed LEC01-Unwanted Sex Experience: Learned Life Events Checklist for DSM-5, Standard Version - Other unwanted or uncomfortable sexual experience: Learned about it. LEC-5 Standard Version - Unwanted Sex Experience: Learned LEC01-Unwanted Sex Experience: Job Life Events Checklist for DSM-5, Standard Version - Other unwanted or uncomfortable sexual experience: Part of my job. LEC-5 Standard Version - Unwanted Sex Experience: Job LEC01-Unwanted Sex Experience: Not Sure Life Events Checklist for DSM-5, Standard Version - Other unwanted or uncomfortable sexual experience: Not sure. LEC-5 Standard Version - Unwanted Sex Experience: Not Sure LEC01-Unwanted Sex Experience: Not Apply Life Events Checklist for DSM-5, Standard Version - Other unwanted or uncomfortable sexual experience: Doesn't apply. LEC-5 Standard Version - Unwanted Sex Experience: Not Apply LEC01-Combat/Exp to War-Zone: Happened Life Events Checklist for DSM-5, Standard Version - Combat or exposure to a war-zone (in the military or as a civilian): Happened to me. LEC-5 Standard Version - Combat or Exposure to War-Zone: Happened LEC01-Combat/Exp to War-Zone: Witnessed Life Events Checklist for DSM-5, Standard Version - Combat or exposure to a war-zone (in the military or as a civilian): Witnessed it. LEC-5 Standard Version - Combat or Exposure to War-Zone: Witnessed LEC01-Combat/Exp to War-Zone: Learned Life Events Checklist for DSM-5, Standard Version - Combat or exposure to a war-zone (in the military or as a civilian): Learned about it. LEC-5 Standard Version - Combat or Exposure to War-Zone: Learned LEC01-Combat/Exp to War-Zone: Job Life Events Checklist for DSM-5, Standard Version - Combat or exposure to a war-zone (in the military or as a civilian): Part of my job. LEC-5 Standard Version - Combat or Exposure to War-Zone: Job LEC01-Combat/Exp to War-Zone: Not Sure Life Events Checklist for DSM-5, Standard Version - Combat or exposure to a war-zone (in the military or as a civilian): Not sure. LEC-5 Standard Version - Combat or Exposure to War-Zone: Not Sure LEC01-Combat/Exp to War-Zone: Not Apply Life Events Checklist for DSM-5, Standard Version - Combat or exposure to a war-zone (in the military or as a civilian): Doesn't apply. LEC-5 Standard Version - Combat or Exposure to War-Zone: Not Apply LEC01-Captivity: Happened Life Events Checklist for DSM-5, Standard Version - Captivity (for example, being kidnapped, abducted, held hostage, prisoner of war): Happened to me. LEC-5 Standard Version - Captivity: Happened LEC01-Captivity: Witnessed Life Events Checklist for DSM-5, Standard Version - Captivity (for example, being kidnapped, abducted, held hostage, prisoner of war): Witnessed it. LEC-5 Standard Version - Captivity: Witnessed LEC01-Captivity: Learned Life Events Checklist for DSM-5, Standard Version - Captivity (for example, being kidnapped, abducted, held hostage, prisoner of war): Learned about it. LEC-5 Standard Version - Captivity: Learned LEC01-Captivity: Job Life Events Checklist for DSM-5, Standard Version - Captivity (for example, being kidnapped, abducted, held hostage, prisoner of war): Part of my job. LEC-5 Standard Version - Captivity: Job LEC01-Captivity: Not Sure Life Events Checklist for DSM-5, Standard Version - Captivity (for example, being kidnapped, abducted, held hostage, prisoner of war): Not sure. LEC-5 Standard Version - Captivity: Not Sure LEC01-Captivity: Not Apply Life Events Checklist for DSM-5, Standard Version - Captivity (for example, being kidnapped, abducted, held hostage, prisoner of war): Doesn't apply. LEC-5 Standard Version - Captivity: Not Apply LEC01-Life-threatening Illness: Happened Life Events Checklist for DSM-5, Standard Version - Life-threatening illness or injury: Happened to me. LEC-5 Standard Version - Life-threatening Illness: Happened LEC01-Life-threatening Illness: Witness Life Events Checklist for DSM-5, Standard Version - Life-threatening illness or injury: Witnessed it. LEC-5 Standard Version - Life-threatening Illness: Witnessed LEC01-Life-threatening Illness: Learned Life Events Checklist for DSM-5, Standard Version - Life-threatening illness or injury: Learned about it. LEC-5 Standard Version - Life-threatening Illness: Learned LEC01-Life-threatening Illness: Job Life Events Checklist for DSM-5, Standard Version - Life-threatening illness or injury: Part of my job. LEC-5 Standard Version - Life-threatening Illness: Job LEC01-Life-threatening Illness: Not Sure Life Events Checklist for DSM-5, Standard Version - Life-threatening illness or injury: Not sure. LEC-5 Standard Version - Life-threatening Illness: Not Sure LEC01-Life-threatening Illness: No Apply Life Events Checklist for DSM-5, Standard Version - Life-threatening illness or injury: Doesn't apply. LEC-5 Standard Version - Life-threatening Illness: Not Apply LEC01-Severe Human Suffering: Happened Life Events Checklist for DSM-5, Standard Version - Severe human suffering: Happened to me. LEC-5 Standard Version - Severe Human Suffering: Happened LEC01-Severe Human Suffering: Witnessed Life Events Checklist for DSM-5, Standard Version - Severe human suffering: Witnessed it. LEC-5 Standard Version - Severe Human Suffering: Witnessed LEC01-Severe Human Suffering: Learned Life Events Checklist for DSM-5, Standard Version - Severe human suffering: Learned about it. LEC-5 Standard Version - Severe Human Suffering: Learned LEC01-Severe Human Suffering: Job Life Events Checklist for DSM-5, Standard Version - Severe human suffering: Part of my job. LEC-5 Standard Version - Severe Human Suffering: Job LEC01-Severe Human Suffering: Not Sure Life Events Checklist for DSM-5, Standard Version - Severe human suffering: Not sure. LEC-5 Standard Version - Severe Human Suffering: Not Sure LEC01-Severe Human Suffering: Not Apply Life Events Checklist for DSM-5, Standard Version - Severe human suffering: Doesn't apply. LEC-5 Standard Version - Severe Human Suffering: Not Apply LEC01-Sudden Violent Death: Happened Life Events Checklist for DSM-5, Standard Version - Sudden violent death (for example, homicide, suicide): Happened to me. LEC-5 Standard Version - Sudden Violent Death: Happened LEC01-Sudden Violent Death: Witnessed Life Events Checklist for DSM-5, Standard Version - Sudden violent death (for example, homicide, suicide): Witnessed it. LEC-5 Standard Version - Sudden Violent Death: Witnessed LEC01-Sudden Violent Death: Learned Life Events Checklist for DSM-5, Standard Version - Sudden violent death (for example, homicide, suicide): Learned about it. LEC-5 Standard Version - Sudden Violent Death: Learned LEC01-Sudden Violent Death: Job Life Events Checklist for DSM-5, Standard Version - Sudden violent death (for example, homicide, suicide): Part of my job. LEC-5 Standard Version - Sudden Violent Death: Job LEC01-Sudden Violent Death: Not Sure Life Events Checklist for DSM-5, Standard Version - Sudden violent death (for example, homicide, suicide): Not sure. LEC-5 Standard Version - Sudden Violent Death: Not Sure LEC01-Sudden Violent Death: Not Apply Life Events Checklist for DSM-5, Standard Version - Sudden violent death (for example, homicide, suicide): Doesn't apply. LEC-5 Standard Version - Sudden Violent Death: Not Apply LEC01-Sudden Accidental Death: Happened Life Events Checklist for DSM-5, Standard Version - Sudden accidental death: Happened to me. LEC-5 Standard Version - Sudden Accidental Death: Happened LEC01-Sudden Accidental Death: Witnessed Life Events Checklist for DSM-5, Standard Version - Sudden accidental death: Witnessed it. LEC-5 Standard Version - Sudden Accidental Death: Witnessed LEC01-Sudden Accidental Death: Learned Life Events Checklist for DSM-5, Standard Version - Sudden accidental death: Learned about it. LEC-5 Standard Version - Sudden Accidental Death: Learned LEC01-Sudden Accidental Death: Job Life Events Checklist for DSM-5, Standard Version - Sudden accidental death: Part of my job. LEC-5 Standard Version - Sudden Accidental Death: Job LEC01-Sudden Accidental Death: Not Sure Life Events Checklist for DSM-5, Standard Version - Sudden accidental death: Not sure. LEC-5 Standard Version - Sudden Accidental Death: Not Sure LEC01-Sudden Accidental Death: Not Apply Life Events Checklist for DSM-5, Standard Version - Sudden accidental death: Doesn't apply. LEC-5 Standard Version - Sudden Accidental Death: Not Apply LEC01-Serious Injury Caused: Happened Life Events Checklist for DSM-5, Standard Version - Serious injury, harm, or death you caused to someone else: Happened to me. LEC-5 Standard Version - Serious Injury Caused: Happened LEC01-Serious Injury Caused: Witnessed Life Events Checklist for DSM-5, Standard Version - Serious injury, harm, or death you caused to someone else: Witnessed it. LEC-5 Standard Version - Serious Injury Caused: Witnessed LEC01-Serious Injury Caused: Learned Life Events Checklist for DSM-5, Standard Version - Serious injury, harm, or death you caused to someone else: Learned about it. LEC-5 Standard Version - Serious Injury Caused: Learned LEC01-Serious Injury Caused: Job Life Events Checklist for DSM-5, Standard Version - Serious injury, harm, or death you caused to someone else: Part of my job. LEC-5 Standard Version - Serious Injury Caused: Job LEC01-Serious Injury Caused: Not Sure Life Events Checklist for DSM-5, Standard Version - Serious injury, harm, or death you caused to someone else: Not sure. LEC-5 Standard Version - Serious Injury Caused: Not Sure LEC01-Serious Injury Caused: Not Apply Life Events Checklist for DSM-5, Standard Version - Serious injury, harm, or death you caused to someone else: Doesn't apply. LEC-5 Standard Version - Serious Injury Caused: Not Apply LEC01-Other Stressful Event: Happened Life Events Checklist for DSM-5, Standard Version - Any other very stressful event or experience: Happened to me. LEC-5 Standard Version - Other Stressful Event: Happened LEC01-Other Stressful Event: Witnessed Life Events Checklist for DSM-5, Standard Version - Any other very stressful event or experience: Witnessed it. LEC-5 Standard Version - Other Stressful Event: Witnessed LEC01-Other Stressful Event: Learned Life Events Checklist for DSM-5, Standard Version - Any other very stressful event or experience: Learned about it. LEC-5 Standard Version - Other Stressful Event: Learned LEC01-Other Stressful Event: Job Life Events Checklist for DSM-5, Standard Version - Any other very stressful event or experience: Part of my job. LEC-5 Standard Version - Other Stressful Event: Job LEC01-Other Stressful Event: Not Sure Life Events Checklist for DSM-5, Standard Version - Any other very stressful event or experience: Not sure. LEC-5 Standard Version - Other Stressful Event: Not Sure LEC01-Other Stressful Event: Not Apply Life Events Checklist for DSM-5, Standard Version - Any other very stressful event or experience: Doesn't apply. LEC-5 Standard Version - Other Stressful Event: Not Apply LEC01TC Life Events Checklist for DSM-5 Standard Version Questionnaire Test Code CDISC Questionnaire LEC-5 Standard Version Test Code Terminology Life Events Checklist for DSM-5 Standard Version test name. LEC01-Assault With a Weapon: Happened Life Events Checklist for DSM-5, Standard Version - Assault with a weapon (for example, being shot, stabbed, threatened with a knife, gun, bomb): Happened to me. LEC-5 Standard Version - Assault With a Weapon: Happened LEC01-Assault With a Weapon: Job Life Events Checklist for DSM-5, Standard Version - Assault with a weapon (for example, being shot, stabbed, threatened with a knife, gun, bomb): Part of my job. LEC-5 Standard Version - Assault With a Weapon: Job LEC01-Assault With a Weapon: Learned Life Events Checklist for DSM-5, Standard Version - Assault with a weapon (for example, being shot, stabbed, threatened with a knife, gun, bomb): Learned about it. LEC-5 Standard Version - Assault With a Weapon: Learned LEC01-Assault With a Weapon: Not Apply Life Events Checklist for DSM-5, Standard Version - Assault with a weapon (for example, being shot, stabbed, threatened with a knife, gun, bomb): Doesn't apply. LEC-5 Standard Version - Assault With a Weapon: Not Apply LEC01-Assault With a Weapon: Not Sure Life Events Checklist for DSM-5, Standard Version - Assault with a weapon (for example, being shot, stabbed, threatened with a knife, gun, bomb): Not sure. LEC-5 Standard Version - Assault With a Weapon: Not Sure LEC01-Assault With a Weapon: Witnessed Life Events Checklist for DSM-5, Standard Version - Assault with a weapon (for example, being shot, stabbed, threatened with a knife, gun, bomb): Witnessed it. LEC-5 Standard Version - Assault With a Weapon: Witnessed LEC01-Captivity: Happened Life Events Checklist for DSM-5, Standard Version - Captivity (for example, being kidnapped, abducted, held hostage, prisoner of war): Happened to me. LEC-5 Standard Version - Captivity: Happened LEC01-Captivity: Job Life Events Checklist for DSM-5, Standard Version - Captivity (for example, being kidnapped, abducted, held hostage, prisoner of war): Part of my job. LEC-5 Standard Version - Captivity: Job LEC01-Captivity: Learned Life Events Checklist for DSM-5, Standard Version - Captivity (for example, being kidnapped, abducted, held hostage, prisoner of war): Learned about it. LEC-5 Standard Version - Captivity: Learned LEC01-Captivity: Not Apply Life Events Checklist for DSM-5, Standard Version - Captivity (for example, being kidnapped, abducted, held hostage, prisoner of war): Doesn't apply. LEC-5 Standard Version - Captivity: Not Apply LEC01-Captivity: Not Sure Life Events Checklist for DSM-5, Standard Version - Captivity (for example, being kidnapped, abducted, held hostage, prisoner of war): Not sure. LEC-5 Standard Version - Captivity: Not Sure LEC01-Captivity: Witnessed Life Events Checklist for DSM-5, Standard Version - Captivity (for example, being kidnapped, abducted, held hostage, prisoner of war): Witnessed it. LEC-5 Standard Version - Captivity: Witnessed LEC01-Combat/Exp to War-Zone: Happened Life Events Checklist for DSM-5, Standard Version - Combat or exposure to a war-zone (in the military or as a civilian): Happened to me. LEC-5 Standard Version - Combat or Exposure to War-Zone: Happened LEC01-Combat/Exp to War-Zone: Job Life Events Checklist for DSM-5, Standard Version - Combat or exposure to a war-zone (in the military or as a civilian): Part of my job. LEC-5 Standard Version - Combat or Exposure to War-Zone: Job LEC01-Combat/Exp to War-Zone: Learned Life Events Checklist for DSM-5, Standard Version - Combat or exposure to a war-zone (in the military or as a civilian): Learned about it. LEC-5 Standard Version - Combat or Exposure to War-Zone: Learned LEC01-Combat/Exp to War-Zone: Not Apply Life Events Checklist for DSM-5, Standard Version - Combat or exposure to a war-zone (in the military or as a civilian): Doesn't apply. LEC-5 Standard Version - Combat or Exposure to War-Zone: Not Apply LEC01-Combat/Exp to War-Zone: Not Sure Life Events Checklist for DSM-5, Standard Version - Combat or exposure to a war-zone (in the military or as a civilian): Not sure. LEC-5 Standard Version - Combat or Exposure to War-Zone: Not Sure LEC01-Combat/Exp to War-Zone: Witnessed Life Events Checklist for DSM-5, Standard Version - Combat or exposure to a war-zone (in the military or as a civilian): Witnessed it. LEC-5 Standard Version - Combat or Exposure to War-Zone: Witnessed LEC01-Fire or Explosion: Happened Life Events Checklist for DSM-5, Standard Version - Fire or explosion: Happened to me. LEC-5 Standard Version - Fire or Explosion: Happened LEC01-Fire or Explosion: Job Life Events Checklist for DSM-5, Standard Version - Fire or explosion: Part of my job. LEC-5 Standard Version - Fire or Explosion: Job LEC01-Fire or Explosion: Learned Life Events Checklist for DSM-5, Standard Version - Fire or explosion: Learned about it. LEC-5 Standard Version - Fire or Explosion: Learned LEC01-Fire or Explosion: Not Apply Life Events Checklist for DSM-5, Standard Version - Fire or explosion: Doesn't apply. LEC-5 Standard Version - Fire or Explosion: Not Apply LEC01-Fire or Explosion: Not Sure Life Events Checklist for DSM-5, Standard Version - Fire or explosion: Not sure. LEC-5 Standard Version - Fire or Explosion: Not Sure LEC01-Fire or Explosion: Witnessed Life Events Checklist for DSM-5, Standard Version - Fire or explosion: Witnessed it. LEC-5 Standard Version - Fire or Explosion: Witnessed LEC01-Life-threatening Illness: Happened Life Events Checklist for DSM-5, Standard Version - Life-threatening illness or injury: Happened to me. LEC-5 Standard Version - Life-threatening Illness: Happened LEC01-Life-threatening Illness: Job Life Events Checklist for DSM-5, Standard Version - Life-threatening illness or injury: Part of my job. LEC-5 Standard Version - Life-threatening Illness: Job LEC01-Life-threatening Illness: Learned Life Events Checklist for DSM-5, Standard Version - Life-threatening illness or injury: Learned about it. LEC-5 Standard Version - Life-threatening Illness: Learned LEC01-Life-threatening Illness: No Apply Life Events Checklist for DSM-5, Standard Version - Life-threatening illness or injury: Doesn't apply. LEC-5 Standard Version - Life-threatening Illness: Not Apply LEC01-Life-threatening Illness: Not Sure Life Events Checklist for DSM-5, Standard Version - Life-threatening illness or injury: Not sure. LEC-5 Standard Version - Life-threatening Illness: Not Sure LEC01-Life-threatening Illness: Witness Life Events Checklist for DSM-5, Standard Version - Life-threatening illness or injury: Witnessed it. LEC-5 Standard Version - Life-threatening Illness: Witnessed LEC01-Natural Disaster: Happened Life Events Checklist for DSM-5, Standard Version - Natural disaster (for example, flood, hurricane, tornado, earthquake): Happened to me. LEC-5 Standard Version - Natural Disaster: Happened LEC01-Natural Disaster: Job Life Events Checklist for DSM-5, Standard Version - Natural disaster (for example, flood, hurricane, tornado, earthquake): Part of my job. LEC-5 Standard Version - Natural Disaster: Job LEC01-Natural Disaster: Learned Life Events Checklist for DSM-5, Standard Version - Natural disaster (for example, flood, hurricane, tornado, earthquake): Learned about it. LEC-5 Standard Version - Natural Disaster: Learned LEC01-Natural Disaster: Not Apply Life Events Checklist for DSM-5, Standard Version - Natural disaster (for example, flood, hurricane, tornado, earthquake): Doesn't apply. LEC-5 Standard Version - Natural Disaster: Not Apply LEC01-Natural Disaster: Not Sure Life Events Checklist for DSM-5, Standard Version - Natural disaster (for example, flood, hurricane, tornado, earthquake): Not sure. LEC-5 Standard Version - Natural Disaster: Not Sure LEC01-Natural Disaster: Witnessed Life Events Checklist for DSM-5, Standard Version - Natural disaster (for example, flood, hurricane, tornado, earthquake): Witnessed it. LEC-5 Standard Version - Natural Disaster: Witnessed LEC01-Other Stressful Event: Happened Life Events Checklist for DSM-5, Standard Version - Any other very stressful event or experience: Happened to me. LEC-5 Standard Version - Other Stressful Event: Happened LEC01-Other Stressful Event: Job Life Events Checklist for DSM-5, Standard Version - Any other very stressful event or experience: Part of my job. LEC-5 Standard Version - Other Stressful Event: Job LEC01-Other Stressful Event: Learned Life Events Checklist for DSM-5, Standard Version - Any other very stressful event or experience: Learned about it. LEC-5 Standard Version - Other Stressful Event: Learned LEC01-Other Stressful Event: Not Apply Life Events Checklist for DSM-5, Standard Version - Any other very stressful event or experience: Doesn't apply. LEC-5 Standard Version - Other Stressful Event: Not Apply LEC01-Other Stressful Event: Not Sure Life Events Checklist for DSM-5, Standard Version - Any other very stressful event or experience: Not sure. LEC-5 Standard Version - Other Stressful Event: Not Sure LEC01-Other Stressful Event: Witnessed Life Events Checklist for DSM-5, Standard Version - Any other very stressful event or experience: Witnessed it. LEC-5 Standard Version - Other Stressful Event: Witnessed LEC01-Physical Assault: Happened Life Events Checklist for DSM-5, Standard Version - Physical assault (for example, being attacked, hit, slapped, kicked, beaten up): Happened to me. LEC-5 Standard Version - Physical Assault: Happened LEC01-Physical Assault: Job Life Events Checklist for DSM-5, Standard Version - Physical assault (for example, being attacked, hit, slapped, kicked, beaten up): Part of my job. LEC-5 Standard Version - Physical Assault: Job LEC01-Physical Assault: Learned Life Events Checklist for DSM-5, Standard Version - Physical assault (for example, being attacked, hit, slapped, kicked, beaten up): Learned about it. LEC-5 Standard Version - Physical Assault: Learned LEC01-Physical Assault: Not Apply Life Events Checklist for DSM-5, Standard Version - Physical assault (for example, being attacked, hit, slapped, kicked, beaten up): Doesn't apply. LEC-5 Standard Version - Physical Assault: Not Apply LEC01-Physical Assault: Not Sure Life Events Checklist for DSM-5, Standard Version - Physical assault (for example, being attacked, hit, slapped, kicked, beaten up): Not sure. LEC-5 Standard Version - Physical Assault: Not Sure LEC01-Physical Assault: Witnessed Life Events Checklist for DSM-5, Standard Version - Physical assault (for example, being attacked, hit, slapped, kicked, beaten up): Witnessed it. LEC-5 Standard Version - Physical Assault: Witnessed LEC01-Serious Accident: Happened Life Events Checklist for DSM-5, Standard Version - Serious accident at work, home, or during recreational activity: Happened to me. LEC-5 Standard Version - Serious Accident: Happened LEC01-Serious Accident: Job Life Events Checklist for DSM-5, Standard Version - Serious accident at work, home, or during recreational activity: Part of my job. LEC-5 Standard Version - Serious Accident: Job LEC01-Serious Accident: Learned Life Events Checklist for DSM-5, Standard Version - Serious accident at work, home, or during recreational activity: Learned about it. LEC-5 Standard Version - Serious Accident: Learned LEC01-Serious Accident: Not Apply Life Events Checklist for DSM-5, Standard Version - Serious accident at work, home, or during recreational activity: Doesn't apply. LEC-5 Standard Version - Serious Accident: Not Apply LEC01-Serious Accident: Not Sure Life Events Checklist for DSM-5, Standard Version - Serious accident at work, home, or during recreational activity: Not sure. LEC-5 Standard Version - Serious Accident: Not Sure LEC01-Serious Accident: Witnessed Life Events Checklist for DSM-5, Standard Version - Serious accident at work, home, or during recreational activity: Witnessed it. LEC-5 Standard Version - Serious Accident: Witnessed LEC01-Serious Injury Caused: Happened Life Events Checklist for DSM-5, Standard Version - Serious injury, harm, or death you caused to someone else: Happened to me. LEC-5 Standard Version - Serious Injury Caused: Happened LEC01-Serious Injury Caused: Job Life Events Checklist for DSM-5, Standard Version - Serious injury, harm, or death you caused to someone else: Part of my job. LEC-5 Standard Version - Serious Injury Caused: Job LEC01-Serious Injury Caused: Learned Life Events Checklist for DSM-5, Standard Version - Serious injury, harm, or death you caused to someone else: Learned about it. LEC-5 Standard Version - Serious Injury Caused: Learned LEC01-Serious Injury Caused: Not Apply Life Events Checklist for DSM-5, Standard Version - Serious injury, harm, or death you caused to someone else: Doesn't apply. LEC-5 Standard Version - Serious Injury Caused: Not Apply LEC01-Serious Injury Caused: Not Sure Life Events Checklist for DSM-5, Standard Version - Serious injury, harm, or death you caused to someone else: Not sure. LEC-5 Standard Version - Serious Injury Caused: Not Sure LEC01-Serious Injury Caused: Witnessed Life Events Checklist for DSM-5, Standard Version - Serious injury, harm, or death you caused to someone else: Witnessed it. LEC-5 Standard Version - Serious Injury Caused: Witnessed LEC01-Severe Human Suffering: Happened Life Events Checklist for DSM-5, Standard Version - Severe human suffering: Happened to me. LEC-5 Standard Version - Severe Human Suffering: Happened LEC01-Severe Human Suffering: Job Life Events Checklist for DSM-5, Standard Version - Severe human suffering: Part of my job. LEC-5 Standard Version - Severe Human Suffering: Job LEC01-Severe Human Suffering: Learned Life Events Checklist for DSM-5, Standard Version - Severe human suffering: Learned about it. LEC-5 Standard Version - Severe Human Suffering: Learned LEC01-Severe Human Suffering: Not Apply Life Events Checklist for DSM-5, Standard Version - Severe human suffering: Doesn't apply. LEC-5 Standard Version - Severe Human Suffering: Not Apply LEC01-Severe Human Suffering: Not Sure Life Events Checklist for DSM-5, Standard Version - Severe human suffering: Not sure. LEC-5 Standard Version - Severe Human Suffering: Not Sure LEC01-Severe Human Suffering: Witnessed Life Events Checklist for DSM-5, Standard Version - Severe human suffering: Witnessed it. LEC-5 Standard Version - Severe Human Suffering: Witnessed LEC01-Sexual Assault: Happened Life Events Checklist for DSM-5, Standard Version - Sexual assault (rape, attempted rape, made to perform any type of sexual act through force or threat of harm): Happened to me. LEC-5 Standard Version - Sexual Assault: Happened LEC01-Sexual Assault: Job Life Events Checklist for DSM-5, Standard Version - Sexual assault (rape, attempted rape, made to perform any type of sexual act through force or threat of harm): Part of my job. LEC-5 Standard Version - Sexual Assault: Job LEC01-Sexual Assault: Learned Life Events Checklist for DSM-5, Standard Version - Sexual assault (rape, attempted rape, made to perform any type of sexual act through force or threat of harm): Learned about it. LEC-5 Standard Version - Sexual Assault: Learned LEC01-Sexual Assault: Not Apply Life Events Checklist for DSM-5, Standard Version - Sexual assault (rape, attempted rape, made to perform any type of sexual act through force or threat of harm): Doesn't apply. LEC-5 Standard Version - Sexual Assault: Not Apply LEC01-Sexual Assault: Not Sure Life Events Checklist for DSM-5, Standard Version - Sexual assault (rape, attempted rape, made to perform any type of sexual act through force or threat of harm): Not sure. LEC-5 Standard Version - Sexual Assault: Not Sure LEC01-Sexual Assault: Witnessed Life Events Checklist for DSM-5, Standard Version - Sexual assault (rape, attempted rape, made to perform any type of sexual act through force or threat of harm): Witnessed it. LEC-5 Standard Version - Sexual Assault: Witnessed LEC01-Sudden Accidental Death: Happened Life Events Checklist for DSM-5, Standard Version - Sudden accidental death: Happened to me. LEC-5 Standard Version - Sudden Accidental Death: Happened LEC01-Sudden Accidental Death: Job Life Events Checklist for DSM-5, Standard Version - Sudden accidental death: Part of my job. LEC-5 Standard Version - Sudden Accidental Death: Job LEC01-Sudden Accidental Death: Learned Life Events Checklist for DSM-5, Standard Version - Sudden accidental death: Learned about it. LEC-5 Standard Version - Sudden Accidental Death: Learned LEC01-Sudden Accidental Death: Not Apply Life Events Checklist for DSM-5, Standard Version - Sudden accidental death: Doesn't apply. LEC-5 Standard Version - Sudden Accidental Death: Not Apply LEC01-Sudden Accidental Death: Not Sure Life Events Checklist for DSM-5, Standard Version - Sudden accidental death: Not sure. LEC-5 Standard Version - Sudden Accidental Death: Not Sure LEC01-Sudden Accidental Death: Witnessed Life Events Checklist for DSM-5, Standard Version - Sudden accidental death: Witnessed it. LEC-5 Standard Version - Sudden Accidental Death: Witnessed LEC01-Sudden Violent Death: Happened Life Events Checklist for DSM-5, Standard Version - Sudden violent death (for example, homicide, suicide): Happened to me. LEC-5 Standard Version - Sudden Violent Death: Happened LEC01-Sudden Violent Death: Job Life Events Checklist for DSM-5, Standard Version - Sudden violent death (for example, homicide, suicide): Part of my job. LEC-5 Standard Version - Sudden Violent Death: Job LEC01-Sudden Violent Death: Learned Life Events Checklist for DSM-5, Standard Version - Sudden violent death (for example, homicide, suicide): Learned about it. LEC-5 Standard Version - Sudden Violent Death: Learned LEC01-Sudden Violent Death: Not Apply Life Events Checklist for DSM-5, Standard Version - Sudden violent death (for example, homicide, suicide): Doesn't apply. LEC-5 Standard Version - Sudden Violent Death: Not Apply LEC01-Sudden Violent Death: Not Sure Life Events Checklist for DSM-5, Standard Version - Sudden violent death (for example, homicide, suicide): Not sure. LEC-5 Standard Version - Sudden Violent Death: Not Sure LEC01-Sudden Violent Death: Witnessed Life Events Checklist for DSM-5, Standard Version - Sudden violent death (for example, homicide, suicide): Witnessed it. LEC-5 Standard Version - Sudden Violent Death: Witnessed LEC01-Toxic Substance: Happened Life Events Checklist for DSM-5, Standard Version - Exposure to toxic substance (for example, dangerous chemicals, radiation): Happened to me. LEC-5 Standard Version - Toxic Substance: Happened LEC01-Toxic Substance: Job Life Events Checklist for DSM-5, Standard Version - Exposure to toxic substance (for example, dangerous chemicals, radiation): Part of my job. LEC-5 Standard Version - Toxic Substance: Job LEC01-Toxic Substance: Learned Life Events Checklist for DSM-5, Standard Version - Exposure to toxic substance (for example, dangerous chemicals, radiation): Learned about it. LEC-5 Standard Version - Toxic Substance: Learned LEC01-Toxic Substance: Not Apply Life Events Checklist for DSM-5, Standard Version - Exposure to toxic substance (for example, dangerous chemicals, radiation): Doesn't apply. LEC-5 Standard Version - Toxic Substance: Not Apply LEC01-Toxic Substance: Not Sure Life Events Checklist for DSM-5, Standard Version - Exposure to toxic substance (for example, dangerous chemicals, radiation): Not sure. LEC-5 Standard Version - Toxic Substance: Not Sure LEC01-Toxic Substance: Witnessed Life Events Checklist for DSM-5, Standard Version - Exposure to toxic substance (for example, dangerous chemicals, radiation): Witnessed it. LEC-5 Standard Version - Toxic Substance: Witnessed LEC01-Transportation Accident: Happened Life Events Checklist for DSM-5, Standard Version - Transportation accident (for example, car accident, boat accident, train wreck, plane crash): Happened to me. LEC-5 Standard Version - Transportation Accident: Happened LEC01-Transportation Accident: Job Life Events Checklist for DSM-5, Standard Version - Transportation accident (for example, car accident, boat accident, train wreck, plane crash): Part of my job. LEC-5 Standard Version - Transportation Accident: Job LEC01-Transportation Accident: Learned Life Events Checklist for DSM-5, Standard Version - Transportation accident (for example, car accident, boat accident, train wreck, plane crash): Learned about it. LEC-5 Standard Version - Transportation Accident: Learned LEC01-Transportation Accident: Not Apply Life Events Checklist for DSM-5, Standard Version - Transportation accident (for example, car accident, boat accident, train wreck, plane crash): Doesn't apply. LEC-5 Standard Version - Transportation Accident: Not Apply LEC01-Transportation Accident: Not Sure Life Events Checklist for DSM-5, Standard Version - Transportation accident (for example, car accident, boat accident, train wreck, plane crash): Not sure. LEC-5 Standard Version - Transportation Accident: Not Sure LEC01-Transportation Accident: Witnessed Life Events Checklist for DSM-5, Standard Version - Transportation accident (for example, car accident, boat accident, train wreck, plane crash): Witnessed it. LEC-5 Standard Version - Transportation Accident: Witnessed LEC01-Unwanted Sex Experience: Happened Life Events Checklist for DSM-5, Standard Version - Other unwanted or uncomfortable sexual experience: Happened to me. LEC-5 Standard Version - Unwanted Sex Experience: Happened LEC01-Unwanted Sex Experience: Job Life Events Checklist for DSM-5, Standard Version - Other unwanted or uncomfortable sexual experience: Part of my job. LEC-5 Standard Version - Unwanted Sex Experience: Job LEC01-Unwanted Sex Experience: Learned Life Events Checklist for DSM-5, Standard Version - Other unwanted or uncomfortable sexual experience: Learned about it. LEC-5 Standard Version - Unwanted Sex Experience: Learned LEC01-Unwanted Sex Experience: Not Apply Life Events Checklist for DSM-5, Standard Version - Other unwanted or uncomfortable sexual experience: Doesn't apply. LEC-5 Standard Version - Unwanted Sex Experience: Not Apply LEC01-Unwanted Sex Experience: Not Sure Life Events Checklist for DSM-5, Standard Version - Other unwanted or uncomfortable sexual experience: Not sure. LEC-5 Standard Version - Unwanted Sex Experience: Not Sure LEC01-Unwanted Sex Experience: Witnessed Life Events Checklist for DSM-5, Standard Version - Other unwanted or uncomfortable sexual experience: Witnessed it. LEC-5 Standard Version - Unwanted Sex Experience: Witnessed LEC01TN Life Events Checklist for DSM-5 Standard Version Questionnaire Test Name CDISC Questionnaire LEC-5 Standard Version Test Name Terminology Terminology used to describe the part of the graft that is most severely stenotic. The connection where the graft joins the aorta usually less than or equal to 3 mm from insertion point. Aortic Anastomosis of Graft The portion of the graft that lies between its anastomoses. Body of Graft Coronary Graft Anastomoses The connection where the graft joins the coronary artery usually less than or equal to 3 mm from insertion point. Coronary Graft Anastomoses GRSTNLOC Location of Most Severe Stenosis Within a Graft CDISC SDTM Location of Most Severe Stenosis Within a Graft Terminology Terminology relevant to the scores from the London Deaville criteria published in 2014. (Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014 Sep 20;32(27):3048-58.) PET Score 1 No uptake. (Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014 Sep 20;32(27):3048-58.) London Deauville Criteria Point Scale 1 PET Score 2 Uptake less than or equal to mediastinum. (Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014 Sep 20;32(27):3048-58.) London Deauville Criteria Point Scale 2 PET Score 3 Uptake greater than mediastinum but less than or equal to liver. (Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014 Sep 20;32(27):3048-58.) London Deauville Criteria Point Scale 3 PET Score 4 Uptake moderately higher than liver. (Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014 Sep 20;32(27):3048-58.) London Deauville Criteria Point Scale 4 PET Score 5 Uptake markedly higher than liver and/or new lesions. (Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014 Sep 20;32(27):3048-58.) London Deauville Criteria Point Scale 5 PET Score X New areas of uptake unlikely to be related to lymphoma. (Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014 Sep 20;32(27):3048-58.) London Deauville Criteria Point Scale X DPETSCRS London Deauville Criteria Point Scale 2014 CDISC SDTM London Deauville Criteria Point Scale 2014 Response Terminology Terminology relevant to the test codes that describe findings about a lung cancer event or intervention. Origin of Cancer Known Ind Origin of Cancer Known Indicator An indication as to whether the primary site of cancer is known. Cancer Primary Site Known Indicator Resected Tumor Ind Resected Tumor Indicator An indication as to whether the tumor has been resected. Tumor Resected Indicator LUFATSCD Lung Cancer Findings About Test Code CDISC SDTM Lung Cancer Findings About Test Code Terminology Terminology relevant to the test names that describe findings about a lung cancer event or intervention. Origin of Cancer Known Ind Origin of Cancer Known Indicator An indication as to whether the primary site of cancer is known. Cancer Primary Site Known Indicator Resected Tumor Ind Resected Tumor Indicator An indication as to whether the tumor has been resected. Tumor Resected Indicator LUFATS Lung Cancer Findings About Test Name CDISC SDTM Lung Cancer Findings About Test Name Terminology Terminology relevant to the test codes that describe findings about a malaria event or intervention. Occurrence Indicator An indication as to whether something has happened, such as an event or incident. Occurrence Indicator Severity/Intensity The degree of something undesirable. Severity MRFATSCD Malaria Findings About Test Code CDISC SDTM Malaria Findings About Test Code Terminology Terminology relevant to the test names that describe findings about a malaria event or intervention. Occurrence Indicator An indication as to whether something has happened, such as an event or incident. Occurrence Indicator Severity/Intensity The degree of something undesirable. Severity MRFATS Malaria Findings About Test Name CDISC SDTM Malaria Findings About Test Name Terminology A terminology codelist relevant to the state or condition of a person's matrimonial status. Marriage contract has been declared null and to not have existed. (HL7) Annulled Marriage contract has been declared dissolved and inactive. (HL7) Divorced Domestic Partner Person declares that a domestic partnership relationship exists. (HL7) Domestic Partnership Temporary order issued during the course of litigation. (HL7) Interlocutory Marital Status A person living apart from his/her spouse by legal arrangement. (HL7) Legally Separated A current marriage contract is active. (HL7) Married No marriage contract has ever been entered. (HL7) Never Married More than 1 current spouse. (HL7) Polygamous A person who is separated from their spouse, whether or not there is a legal arrangement. Separated The spouse has died. (HL7) Widowed MARISTAT Marital Status Response CDISC SDTM Marital Status Terminology Mayo-Portland Adaptability Inventory-4 test code. MPAI1-Mobility Mayo-Portland Adaptability Inventory-4 - Problems walking or moving; balance problems that interfere with moving about. MPAI-4 - Abilities: Mobility MPAI1-Use of Hands Mayo-Portland Adaptability Inventory-4 - Impaired strength or coordination in one or both hands. MPAI-4 - Abilities: Use of Hands MPAI1-Vision Mayo-Portland Adaptability Inventory-4 - Problems seeing; double vision; eye, brain, or nerve injuries that interfere with seeing. MPAI-4 - Abilities: Vision MPAI1-Audition Mayo-Portland Adaptability Inventory-4 - Problems hearing; ringing in the ears. MPAI-4 - Abilities: Audition MPAI1-Dizziness Mayo-Portland Adaptability Inventory-4 - Feeling unsteady, dizzy, light-headed. MPAI-4 - Abilities: Dizziness MPAI1-Motor Speech Mayo-Portland Adaptability Inventory-4 - Abnormal clearness or rate of speech; stuttering. MPAI-4 - Abilities: Motor Speech MPAI1-Verbal Communication Mayo-Portland Adaptability Inventory-4 - Problems expressing or understanding language. MPAI-4 - Abilities: Verbal Communication MPAI1-Nonverbal Communication Mayo-Portland Adaptability Inventory-4 - Restricted or unusual gestures or facial expressions; talking too much or not enough; missing nonverbal cues from others. MPAI-4 - Abilities: Nonverbal Communication MPAI1-Attention/Concentration Mayo-Portland Adaptability Inventory-4 - Problems ignoring distractions, shifting attention, keeping more than one thing in mind at a time. MPAI-4 - Abilities: Attention or Concentration MPAI1-Memory Mayo-Portland Adaptability Inventory-4 - Problems learning and recalling new information. MPAI-4 - Abilities: Memory MPAI1-Fund of Information Mayo-Portland Adaptability Inventory-4 - Problems remembering information learned in school or on the job; difficulty remembering information about self and family from years ago. MPAI-4 - Abilities: Fund of Information MPAI1-Novel Problem-Solving Mayo-Portland Adaptability Inventory-4 - Problems thinking up solutions or picking the best solution to new problems. MPAI-4 - Abilities: Novel Problem-Solving MPAI1-Visuospatial Abilities Mayo-Portland Adaptability Inventory-4 - Problems drawing, assembling things, route-finding, being visually aware on both the left and right sides. MPAI-4 - Abilities: Visuospatial Abilities MPAI1-Anxiety Mayo-Portland Adaptability Inventory-4 - Tense, nervous, fearful, phobias, nightmares, flashbacks of stressful events. MPAI-4 - Adjustment: Anxiety MPAI1-Depression Mayo-Portland Adaptability Inventory-4 - Sad, blue, hopeless, poor appetite, poor sleep, worry, self-criticism. MPAI-4 - Adjustment: Depression MPAI1-Irritablity, Anger, Aggression Mayo-Portland Adaptability Inventory-4 - Verbal or physical expressions of anger. MPAI-4 - Adjustment: Irritability, Anger, Aggression MPAI1-Pain and Headache Mayo-Portland Adaptability Inventory-4 - Verbal and nonverbal expressions of pain; activities limited by pain. MPAI-4 - Adjustment: Pain and Headache MPAI1-Fatigue Mayo-Portland Adaptability Inventory-4 - Feeling tired; lack of energy; tiring easily. MPAI-4 - Adjustment: Fatigue MPAI1-Sensitivity to Mild Symptoms Mayo-Portland Adaptability Inventory-4 - Focusing on thinking, physical or emotional problems attributed to brain injury; rate only how concern or worry about these symptoms affects current functioning over and above the effects of the symptoms themselves. MPAI-4 - Adjustment: Sensitivity to Mild Symptoms MPAI1-Inappropriate Social Interaction Mayo-Portland Adaptability Inventory-4 - Acting childish, silly, rude, behavior not fitting for time and place. MPAI-4 - Adjustment: Inappropriate Social Interaction MPAI1-Impaired Self-Awareness Mayo-Portland Adaptability Inventory-4 - Lack of recognition of personal limitations and disabilities and how they interfere with everyday activities and work or school. MPAI-4 - Adjustment: Impaired Self-Awareness MPAI1-Family/Significant Relationships Mayo-Portland Adaptability Inventory-4 - Interactions with close others; describe stress within the family or those closest to the person with brain injury; 'family functioning' means cooperating to accomplish those tasks that need to be done to keep the household running. MPAI-4 - Adjustment: Family or Significant Relationships MPAI1-Initiation Mayo-Portland Adaptability Inventory-4 - Problems getting started on activities without prompting. MPAI-4 - Participation: Initiation MPAI1-Social Contact-Friends/Coworkers Mayo-Portland Adaptability Inventory-4 - Social contact with friends, work associates, and other people who are not family, significant others, or professionals. MPAI-4 - Participation: Social Contact with Fiends, Work Associates and Others MPAI1-Leisure and Recreation Activities Mayo-Portland Adaptability Inventory-4 - Leisure and recreational activities. MPAI-4 - Participation: Leisure and Recreational Activities MPAI1-Self-Care Mayo-Portland Adaptability Inventory-4 - Eating, dressing, bathing, hygiene. MPAI-4 - Participation: Self-Care MPAI1-Residence Mayo-Portland Adaptability Inventory-4 - Responsibilities of independent living and homemaking (such as meal preparation, home repairs and maintenance, personal health maintenance beyond basic hygiene including medication management) but not including managing money. MPAI-4 - Participation: Residence MPAI1-Transportation Mayo-Portland Adaptability Inventory-4 - Transportation. MPAI-4 - Participation: Transportation MPAI1-Paid Employment Mayo-Portland Adaptability Inventory-4 - Hours per week at paid employment when primary desired social role is paid employment. 'Support' means special help from another person with responsibilities (such as, a job coach or shadow, tutor, helper) or reduced responsibilities. Modifications to the physical environment that facilitate employment are not considered as support. MPAI-4 - Participation: Paid Employment MPAI1-Other Employment Mayo-Portland Adaptability Inventory-4 - Hours per week involved in constructive, role-appropriate activity other than paid employment when primary desired social role is not paid employment. 'Support' means special help from another person with responsibilities (such as, a job coach or shadow, tutor, helper) or reduced responsibilities. Modifications to the physical environment that facilitate employment are not considered as support. MPAI-4 - Participation: Other Employment MPAI1-Other Employment-Social Role Mayo-Portland Adaptability Inventory-4 - Primary social role when paid employment is not primary desired social role. MPAI-4 - Participation: Other Employment-Social Role MPAI1-Managing Money and Finances Mayo-Portland Adaptability Inventory-4 - Shopping, keeping a check book or other bank account, managing personal income and investments. MPAI-4 - Participation: Managing Money and Finances MPAI1-Alcohol Use-Pre-Injury Mayo-Portland Adaptability Inventory-4 - Pre-injury use of alcoholic beverages. MPAI-4 - Alcohol Use Pre-Injury MPAI1-Alcohol Use-Post-Injury Mayo-Portland Adaptability Inventory-4 - Post-injury use of alcoholic beverages. MPAI-4 - Alcohol Use Post-Injury MPAI1-Drug Use-Pre-Injury Mayo-Portland Adaptability Inventory-4 - Pre-injury use of illegal drugs or abuse of prescription drugs. MPAI-4 - Drug Use Pre-Injury MPAI1-Drug Use-Post-Injury Mayo-Portland Adaptability Inventory-4 - Post-injury use of illegal drugs or abuse of prescription drugs. MPAI-4 - Drug Use Post-Injury MPAI1-Psychotic Symptoms-Pre-Injury Mayo-Portland Adaptability Inventory-4 - Pre-injury hallucinations, delusions, other persistent severely distorted perceptions of reality. MPAI-4 - Psychotic Symptoms Pre-Injury MPAI1-Psychotic Symptoms-Post-Injury Mayo-Portland Adaptability Inventory-4 - Post-injury hallucinations, delusions, other persistent severely distorted perceptions of reality. MPAI-4 - Psychotic Symptoms Post-Injury MPAI1-Law Violations-Pre-Injury Mayo-Portland Adaptability Inventory-4 - Pre-injury history before and after injury. MPAI-4 - Law Violations Pre-Injury MPAI1-Law Violations-Post-Injury Mayo-Portland Adaptability Inventory-4 - Post-injury history before and after injury. MPAI-4 - Law Violations Post-Injury MPAI1-Other Physical Cond-Pre-Injury Mayo-Portland Adaptability Inventory-4 - Pre-injury physical disability due to medical conditions other than brain injury, such as, spinal cord injury, amputation. MPAI-4 - Other Condition Causing Physical Impairment Pre-Injury MPAI1-Other Physical Cond-Post-Injury Mayo-Portland Adaptability Inventory-4 - Post-injury physical disability due to medical conditions other than brain injury, such as, spinal cord injury, amputation. MPAI-4 - Other Condition Causing Physical Impairment Post-Injury MPAI1-Other Cognitive Cond-Pre-Injury Mayo-Portland Adaptability Inventory-4 - Pre-injury cognitive disability due to nonpsychiatric medical conditions other than brain injury, such as, dementia, stroke, developmental disability. MPAI-4 - Other Condition Causing Cognitive Impairment Pre-Injury MPAI1-Other Cognitive Cond-Post-Injury Mayo-Portland Adaptability Inventory-4 - Post-injury cognitive disability due to nonpsychiatric medical conditions other than brain injury, such as, dementia, stroke, developmental disability. MPAI-4 - Other Condition Causing Cognitive Impairment Post-Injury MPAI1TC Mayo-Portland Adaptability Inventory-4 Questionnaire Test Code CDISC Questionnaire MPAI-4 Test Code Terminology Mayo-Portland Adaptability Inventory-4 test name. MPAI1-Alcohol Use-Post-Injury Mayo-Portland Adaptability Inventory-4 - Post-injury use of alcoholic beverages. MPAI-4 - Alcohol Use Post-Injury MPAI1-Alcohol Use-Pre-Injury Mayo-Portland Adaptability Inventory-4 - Pre-injury use of alcoholic beverages. MPAI-4 - Alcohol Use Pre-Injury MPAI1-Anxiety Mayo-Portland Adaptability Inventory-4 - Tense, nervous, fearful, phobias, nightmares, flashbacks of stressful events. MPAI-4 - Adjustment: Anxiety MPAI1-Attention/Concentration Mayo-Portland Adaptability Inventory-4 - Problems ignoring distractions, shifting attention, keeping more than one thing in mind at a time. MPAI-4 - Abilities: Attention or Concentration MPAI1-Audition Mayo-Portland Adaptability Inventory-4 - Problems hearing; ringing in the ears. MPAI-4 - Abilities: Audition MPAI1-Depression Mayo-Portland Adaptability Inventory-4 - Sad, blue, hopeless, poor appetite, poor sleep, worry, self-criticism. MPAI-4 - Adjustment: Depression MPAI1-Dizziness Mayo-Portland Adaptability Inventory-4 - Feeling unsteady, dizzy, light-headed. MPAI-4 - Abilities: Dizziness MPAI1-Drug Use-Post-Injury Mayo-Portland Adaptability Inventory-4 - Post-injury use of illegal drugs or abuse of prescription drugs. MPAI-4 - Drug Use Post-Injury MPAI1-Drug Use-Pre-Injury Mayo-Portland Adaptability Inventory-4 - Pre-injury use of illegal drugs or abuse of prescription drugs. MPAI-4 - Drug Use Pre-Injury MPAI1-Family/Significant Relationships Mayo-Portland Adaptability Inventory-4 - Interactions with close others; describe stress within the family or those closest to the person with brain injury; 'family functioning' means cooperating to accomplish those tasks that need to be done to keep the household running. MPAI-4 - Adjustment: Family or Significant Relationships MPAI1-Fatigue Mayo-Portland Adaptability Inventory-4 - Feeling tired; lack of energy; tiring easily. MPAI-4 - Adjustment: Fatigue MPAI1-Fund of Information Mayo-Portland Adaptability Inventory-4 - Problems remembering information learned in school or on the job; difficulty remembering information about self and family from years ago. MPAI-4 - Abilities: Fund of Information MPAI1-Impaired Self-Awareness Mayo-Portland Adaptability Inventory-4 - Lack of recognition of personal limitations and disabilities and how they interfere with everyday activities and work or school. MPAI-4 - Adjustment: Impaired Self-Awareness MPAI1-Inappropriate Social Interaction Mayo-Portland Adaptability Inventory-4 - Acting childish, silly, rude, behavior not fitting for time and place. MPAI-4 - Adjustment: Inappropriate Social Interaction MPAI1-Initiation Mayo-Portland Adaptability Inventory-4 - Problems getting started on activities without prompting. MPAI-4 - Participation: Initiation MPAI1-Irritablity, Anger, Aggression Mayo-Portland Adaptability Inventory-4 - Verbal or physical expressions of anger. MPAI-4 - Adjustment: Irritability, Anger, Aggression MPAI1-Law Violations-Post-Injury Mayo-Portland Adaptability Inventory-4 - Post-injury history before and after injury. MPAI-4 - Law Violations Post-Injury MPAI1-Law Violations-Pre-Injury Mayo-Portland Adaptability Inventory-4 - Pre-injury history before and after injury. MPAI-4 - Law Violations Pre-Injury MPAI1-Leisure and Recreation Activities Mayo-Portland Adaptability Inventory-4 - Leisure and recreational activities. MPAI-4 - Participation: Leisure and Recreational Activities MPAI1-Managing Money and Finances Mayo-Portland Adaptability Inventory-4 - Shopping, keeping a check book or other bank account, managing personal income and investments. MPAI-4 - Participation: Managing Money and Finances MPAI1-Memory Mayo-Portland Adaptability Inventory-4 - Problems learning and recalling new information. MPAI-4 - Abilities: Memory MPAI1-Mobility Mayo-Portland Adaptability Inventory-4 - Problems walking or moving; balance problems that interfere with moving about. MPAI-4 - Abilities: Mobility MPAI1-Motor Speech Mayo-Portland Adaptability Inventory-4 - Abnormal clearness or rate of speech; stuttering. MPAI-4 - Abilities: Motor Speech MPAI1-Nonverbal Communication Mayo-Portland Adaptability Inventory-4 - Restricted or unusual gestures or facial expressions; talking too much or not enough; missing nonverbal cues from others. MPAI-4 - Abilities: Nonverbal Communication MPAI1-Novel Problem-Solving Mayo-Portland Adaptability Inventory-4 - Problems thinking up solutions or picking the best solution to new problems. MPAI-4 - Abilities: Novel Problem-Solving MPAI1-Other Cognitive Cond-Post-Injury Mayo-Portland Adaptability Inventory-4 - Post-injury cognitive disability due to nonpsychiatric medical conditions other than brain injury, such as, dementia, stroke, developmental disability. MPAI-4 - Other Condition Causing Cognitive Impairment Post-Injury MPAI1-Other Cognitive Cond-Pre-Injury Mayo-Portland Adaptability Inventory-4 - Pre-injury cognitive disability due to nonpsychiatric medical conditions other than brain injury, such as, dementia, stroke, developmental disability. MPAI-4 - Other Condition Causing Cognitive Impairment Pre-Injury MPAI1-Other Employment Mayo-Portland Adaptability Inventory-4 - Hours per week involved in constructive, role-appropriate activity other than paid employment when primary desired social role is not paid employment. 'Support' means special help from another person with responsibilities (such as, a job coach or shadow, tutor, helper) or reduced responsibilities. Modifications to the physical environment that facilitate employment are not considered as support. MPAI-4 - Participation: Other Employment MPAI1-Other Employment-Social Role Mayo-Portland Adaptability Inventory-4 - Primary social role when paid employment is not primary desired social role. MPAI-4 - Participation: Other Employment-Social Role MPAI1-Other Physical Cond-Post-Injury Mayo-Portland Adaptability Inventory-4 - Post-injury physical disability due to medical conditions other than brain injury, such as, spinal cord injury, amputation. MPAI-4 - Other Condition Causing Physical Impairment Post-Injury MPAI1-Other Physical Cond-Pre-Injury Mayo-Portland Adaptability Inventory-4 - Pre-injury physical disability due to medical conditions other than brain injury, such as, spinal cord injury, amputation. MPAI-4 - Other Condition Causing Physical Impairment Pre-Injury MPAI1-Paid Employment Mayo-Portland Adaptability Inventory-4 - Hours per week at paid employment when primary desired social role is paid employment. 'Support' means special help from another person with responsibilities (such as, a job coach or shadow, tutor, helper) or reduced responsibilities. Modifications to the physical environment that facilitate employment are not considered as support. MPAI-4 - Participation: Paid Employment MPAI1-Pain and Headache Mayo-Portland Adaptability Inventory-4 - Verbal and nonverbal expressions of pain; activities limited by pain. MPAI-4 - Adjustment: Pain and Headache MPAI1-Psychotic Symptoms-Post-Injury Mayo-Portland Adaptability Inventory-4 - Post-injury hallucinations, delusions, other persistent severely distorted perceptions of reality. MPAI-4 - Psychotic Symptoms Post-Injury MPAI1-Psychotic Symptoms-Pre-Injury Mayo-Portland Adaptability Inventory-4 - Pre-injury hallucinations, delusions, other persistent severely distorted perceptions of reality. MPAI-4 - Psychotic Symptoms Pre-Injury MPAI1-Residence Mayo-Portland Adaptability Inventory-4 - Responsibilities of independent living and homemaking (such as meal preparation, home repairs and maintenance, personal health maintenance beyond basic hygiene including medication management) but not including managing money. MPAI-4 - Participation: Residence MPAI1-Self-Care Mayo-Portland Adaptability Inventory-4 - Eating, dressing, bathing, hygiene. MPAI-4 - Participation: Self-Care MPAI1-Sensitivity to Mild Symptoms Mayo-Portland Adaptability Inventory-4 - Focusing on thinking, physical or emotional problems attributed to brain injury; rate only how concern or worry about these symptoms affects current functioning over and above the effects of the symptoms themselves. MPAI-4 - Adjustment: Sensitivity to Mild Symptoms MPAI1-Social Contact-Friends/Coworkers Mayo-Portland Adaptability Inventory-4 - Social contact with friends, work associates, and other people who are not family, significant others, or professionals. MPAI-4 - Participation: Social Contact with Fiends, Work Associates and Others MPAI1-Transportation Mayo-Portland Adaptability Inventory-4 - Transportation. MPAI-4 - Participation: Transportation MPAI1-Use of Hands Mayo-Portland Adaptability Inventory-4 - Impaired strength or coordination in one or both hands. MPAI-4 - Abilities: Use of Hands MPAI1-Verbal Communication Mayo-Portland Adaptability Inventory-4 - Problems expressing or understanding language. MPAI-4 - Abilities: Verbal Communication MPAI1-Vision Mayo-Portland Adaptability Inventory-4 - Problems seeing; double vision; eye, brain, or nerve injuries that interfere with seeing. MPAI-4 - Abilities: Vision MPAI1-Visuospatial Abilities Mayo-Portland Adaptability Inventory-4 - Problems drawing, assembling things, route-finding, being visually aware on both the left and right sides. MPAI-4 - Abilities: Visuospatial Abilities MPAI1TN Mayo-Portland Adaptability Inventory-4 Questionnaire Test Name CDISC Questionnaire MPAI-4 Test Name Terminology A terminology codelist to describe the timing of mechanical circulatory support placement. In Place at Start of Procedure Mechanical Circulatory Support was in place at the start of the procedure. Mechanical Circulatory Support in Place at Start of Procedure Inserted during a Non PCI Procedure Mechanical Circulatory Support was inserted during a non-Percutaneous Coronary Intervention (PCI) procedure. Inserted During a Non-Percutaneous Coronary Intervention Inserted during Procedure and after PCI Started Mechanical Circulatory Support was inserted during the procedure after Percutaneous Coronary Intervention (PCI) started. Inserted During Procedure and After Percutaneous Coronary Intervention Began Inserted during Procedure but Prior to PCI Mechanical Circulatory Support was inserted during the procedure prior to percutaneous coronary intervention (PCI). Inserted During a Procedure but Prior to Percutaneous Coronary Intervention MCRCSPTM Mechanical Circulatory Support Placement Timing CDISC SDTM Mechanical Circulatory Support Placement Timing Terminology A terminology codelist containing identifiers used to uniquely distinguish multiple evaluators with the same role. An adjudicator performing the assessment who is given the designation of one. Adjudicator 1 An adjudicator performing the assessment who is given the designation of two. Adjudicator 2 An adjudicator performing the assessment who is given the designation of three. Adjudicator 3 A cardiologist performing the assessment who is given the designation of one. Cardiologist 1 A cardiologist performing the assessment who is given the designation of two. Cardiologist 2 A certified assessor performing the assessment who is given the designation of one. Certified Assessor 1 A clinical pathologist performing the assessment who is given the designation of one. Clinical Pathologist 1 A clinical pathologist performing the assessment who is given the designation of two. Clinical Pathologist 2 A dermatologist performing the assessment who is given the designation of one. Dermatologist 1 A dermatologist performing the assessment who is given the designation of two. Dermatologist 2 A developmental behavioral pediatrician performing the assessment who is given the designation of one. Developmental Behavioral Pediatrician 1 A developmental behavioral pediatrician performing the assessment who is given the designation of two. Developmental Behavioral Pediatrician 2 A developmental psychologist performing the assessment who is given the designation of one. Developmental Psychologist 1 A developmental psychologist performing the assessment who is given the designation of two. Developmental Psychologist 2 An endocrinologist performing the assessment who is given the designation of one. Endocrinologist 1 An endocrinologist performing the assessment who is given the designation of two. Endocrinologist 2 A forensic pathologist performing the assessment who is given the designation of one. Forensic Pathologist 1 A forensic pathologist performing the assessment who is given the designation of two. Forensic Pathologist 2 A hematologist performing the assessment who is given the designation of one. Hematologist 1 A hematologist performing the assessment who is given the designation of two. Hematologist 2 An internist performing the assessment who is given the designation of one. Internist 1 An internist performing the assessment who is given the designation of two. Internist 2 A microscopist performing the assessment who is given the designation of one. Microscopist 1 A microscopist performing the assessment who is given the designation of two. Microscopist 2 A microscopist performing the assessment who is given the designation of three. Microscopist 3 A neurologist performing the assessment who is given the designation of one. Neurologist 1 A neurologist performing the assessment who is given the designation of two. Neurologist 2 A neurooncologist performing the assessment who is given the designation of one. Neuro-oncologist 1 A neuroradiologist performing the assessment who is given the designation of one. Neuroradiologist 1 A neuroradiologist performing the assessment who is given the designation of two. Neuroradiologist 2 A nuclear medicine physician performing the assessment who is given the designation of one. Nuclear Medicine Physician 1 An oncologist performing the assessment who is given the designation of one. Oncologist 1 An oncologist performing the assessment who is given the designation of two. Oncologist 2 An ophthalmologist performing the assessment who is given the designation of one. Ophthalmologist 1 An ophthalmologist performing the assessment who is given the designation of two. Ophthalmologist 2 An optometrist performing the assessment who is given the designation of one. Optometrist 1 An optometrist performing the assessment who is given the designation of two. Optometrist 2 A otolaryngologist performing the assessment who is given the designation of one. Otolaryngologist 1 A otolaryngologist performing the assessment who is given the designation of two. Otolaryngologist 2 A pathologist performing the assessment who is given the designation of one. Pathologist 1 A pathologist performing the assessment who is given the designation of two. Pathologist 2 A pediatric neurologist performing the assessment who is given the designation of one. Pediatric Neurologist 1 A pediatric neurologist performing the assessment who is given the designation of two. Pediatric Neurologist 2 A pharmacokineticist performing the assessment who is given the designation of one. Pharmacokineticist 1 A physiotherapist performing the assessment who is given the designation of one. Physiotherapist 1 A physiotherapist performing the assessment who is given the designation of two. Physiotherapist 2 A radiologist performing the assessment who is given the designation of one. Radiologist 1 A radiologist performing the assessment who is given the designation of two. Radiologist 2 A radiologist performing the assessment who is given the designation of three. Radiologist 3 A rater performing the assessment who is given the designation of one. Rater 1 A rater performing the assessment who is given the designation of two. Rater 2 A reader performing the assessment who is given the designation of one. Reader 1 A reader performing the assessment who is given the designation of two. Reader 2 A reader performing the assessment who is given the designation of three. Reader 3 An urologist performing the assessment who is given the designation of one. Urologist 1 An urologist performing the assessment who is given the designation of two. Urologist 2 MEDEVAL Medical Evaluator Identifier CDISC SDTM Medical Evaluator Identifier Terminology Terminology relevant to the classification of the medical condition or event by which MHSTDTC is defined. The current compilation of symptoms and/or clinical manifestations of any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected and/or those in contact with the person. Disease Presentation Diagnostic A process to identify the disease, condition, or injury that explains the symptoms and signs occurring in a patient. Diagnosis Assessment A disease has been characterized as advanced. Advanced Disease A disease has been characterized as locally advanced. Locally Advanced Disease A disease that has become metastatic, that is arising at a location apart from the primary lesion. Metastatic Disease Recurrent Disease The return of a disease after a period of remission. Recurrent Disease A conversion from one disease diagnosis to another, which may be considered a progression to a worsening state. Disease Transformation A noteworthy happening that is distinctive in a series of related events. Episode An increase in frequency and/or worsening of a symptom, condition, or disease. Exacerbation Flare Episode A sudden worsening of a disease, condition, or symptom. Flare-up The first diagnosis of the disease. Initial Diagnosis First Recurrence Initial Recurrence The first relapse of the disease. First Relapse Current Diagnosis The latest diagnosis of the disease. Most Recent Diagnosis The latest relapse of the disease. Most Recent Disease Relapse The latest occurrence of an episode. Most Recent Episode The latest exacerbation of the disease. Most Recent Exacerbation Diagnosis based on a pathological assessment. Pathological Diagnosis A disease, condition, or injury that is increasing in extent or severity. Disease Progression A disease staging event that happens after the initial staging event. Restaging The determination of the extent of disease within the context of the expected progression of the disease, and in accordance with pre-defined criteria. Staging The point at which the symptoms began or were first noted. Symptom Onset MHEDTTYP Medical History Event Date Type CDISC SDTM Medical History Event Date Type Terminology Terminology relevant to the responses for the status of a female with respect to menopause. Menopause Transitional Phase The 10 or so years immediately prior to menopause when the subject experiences symptoms of menopause. Perimenopausal The period of time after menopause. Postmenopausal The period of time before perimenopause. Premenopausal MPSTATRS Menopause Status Response CDISC SDTM Menopause Status Response Terminology Method is any technique or procedure (an action) that determines how an observation or clinical finding was made. AMS A type of mass spectrometry in which ions in the sample are accelerated to very high kinetic energies, thus allowing for the separation of rare isotopes from more abundant isotopes. (NCI) Accelerator Mass Spectrometry A microscopy staining method used to examine a specimen for the presence of acid-fast microorganisms, specifically mycobacteria. Acid Fast Bacillae Staining Method A microscopy staining method that utilizes acridine orange, a fluorescent cationic dye that is selective for nucleic acids, to determine the presence of viable cells or microorganisms in a sample. Acridine orange interacts with RNA and DNA and the lysosomal compartment of cells. Acridine Orange Staining Method A method for continuous recording of body movement that uses an actimetry sensor worn by an individual to measure rest/activity (sleep/wake) cycles. Actigraphy A method to track an individual's physical activity using an activity monitor or other tracking device. Activity Tracking A method to determine microbial susceptibility to antibiotics in which test bacteria is inoculated onto agar plates with serial dilutions of know quantities of antibiotics. The minimum inhibitory concentration of antibiotic is assessed. Agar Dilution Method A method that is used to determine microbial susceptibility to antibiotics by evaluating the extent of growth of several dilutions of a standardized inoculum of microorganism in drug-free and drug-containing agar mediums. The number of colony-forming units grown are compared and expressed as a proportion. Agar Proportion An in vitro assay that is used to detect the presence of antibodies or antigens of interest by evaluating whether particles (cells, beads, etc.) clump together in response to the introduction of a specific antibody or complement. Immunoagglutination Assay A form of complement-dependent lymphocytotoxicity assay with the addition of anti-human globulin (AHG) which is a complement fixing antibody to human immunoglobulin. AHG binds to both complement proteins and non-complement-fixing antibodies. AHG-enhanced Complement-dependent Lymphocytotoxicity Assay A microscopy staining method that utilizes periodic acid, an oxoacid of iodine, Schiff reagent, the reaction product of fuchsine and sodium bisulfite, and Alcian blue, a water soluble copper phthalocyanine dye. This staining method is used to differentially stain glycoproteins. Alcian Blue and Periodic Acid Schiff Staining Method A microscopy staining method that utilizes alcian blue, a cationic, water soluble copper-containing phthalocyanine dye to determine the presence of acid mucopolysaccharides and glycosaminoglycans. Alcian Blue Staining Method A diagrammatic method to test visual acuity and presence of macular degeneration, which uses a uniform square grid of lines with a dot in the center. Amsler Grid A high-speed centrifugation-based method that uses an optical detection system to monitor and record data during the centrifugation process. Analytical Ultracentrifugation The X-ray examination of blood vessels or chambers of the heart after introduction of a radiopaque substance. X-ray Angiography A method used to detect organisms that have resistance to a single concentration of antibiotics in an agar matrix. Antibiotic Agar Screening Method ADCC An in vitro assay that is used to measure antibodies in a biological specimen capable of eliciting effector cell-mediated lysis of target cells. Antibody Dependent Cellular Cytotoxicity Assay A method to determine the microbial susceptibility to two or more antibiotics. Numerical result translated into indifference, antagonism, synergism, or additive. Antimicrobial Combination Testing Method A method in which a constant pressure is applied to a surface (e.g., the surface of the cornea or an artery), in order to flatten a prespecified area of the membrane, which is used to calculate pressure within an organ or tissue (e.g., intraocular or arterial pressure). Applanation Tonometry ASL fMRI A noninvasive fMRI technique that uses arterial water as an endogenous tracer to measure cerebral blood flow by magnetically labeling the proton spins of the arterial water prior to reaching the imaged volume. Arterial Spin Labeling Magnetic Resonance Imaging A spectrometric method that determines the type and concentration of metal elements in a sample, based upon the principle that each elemental metal absorbs a particular wavelength of ultraviolet light when exposed to heat. Atomic Absorption Spectroscopy Testing conducted utilizing a manual or microprocessor audiometer to test for hearing loss. Audiometric Test Auramine O A microscopy acid fast staining method that utilizes auramine O, a bright yellow ketonimine dye, which binds to the mycolic acid in the cell walls of acid fast microorganisms. Auramine Staining Method Listening with a device, such as a stethoscope, to anatomical locations that produce audible sounds like the heart, lungs and abdomen. Auscultation Simple Western Assay An automated Western Blot system that uses capillary electrophoresis to separate proteins, followed by western blot. Automated Capillary Electrophoresis Western Blot A technique to determine the number of entities, which is performed by a device. Automated Count Any type of computer-assisted microscopy that uses digital imaging and software to classify and quantify particles. This enables objective, reproducible evaluation by applying algorithms to detect the presence of entities such as protein aggregates, cell counts, and other morphological information. Automated Microscopy An eye examination method in which a computer-controlled electronic optometer is used to automatically measure refractive error. Autorefraction BAC Array-based CGH Bacterial Artificial Chromosome Array-based CGH Bacterial Artificial Chromosome Array-based Comparative Genomic Hybridization A molecular cytogenetic method combining chromosomal comparative genomic hybridization technique and microarray to detect chromosomal aberrations and changes in DNA copy numbers, using bacterial artificial chromosome clones containing target DNA fragments for hybridization. Bacterial Artificial Chromosome Array-based Comparative Genomic Hybridization A technique used to measure the skin induration diameter of intradermal tuberculin tests based on resistance to the movement of a ballpoint pen across the skin. Ballpoint Pen Technique A test that detects beta lactamase produced by Staphylococcus species, Haemophilus species, Moraxella catarrhalis, and Neisseria gonorrhoeae. Beta Lactamase Screening Method A type of spectroscopy that measures resistance to electrical current at a given body location, to assess tissue composition and fluid levels. Bioimpedance Spectroscopy The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis. Biopsy Procedure Biuret Reagent Test Piotrowski's Test A chemical technique where an alkaline solution is treated with Biuret reagent containing copper (II) ions that form complexes with peptide bonds in the solution and create a color change that is proportional in intensity to the number of peptide bonds. Biuret Reaction Method Blood Oxygen Level-Dependent fMRI BOLD fMRI A functional magnetic resonance imaging technique that uses the difference between the magnetic signals of hemoglobin when it is carrying oxygen (oxyhemoglobin) and when it is not carrying oxygen (deoxyhemoglobin) to detect metabolic activity, and hence neurologic activity, in the brain. (NCI) Blood Oxygen Level-Dependent Functional MRI A type of cellular proliferation assay in which bromodeoxyuridine is used as a substitute for thymidine in the DNA of replicating cells. BrdU Cellular Proliferation Assay A technique to assess the presence and/or amount of analyte(s) in breath exhaled into a device. Breath Test A microscopy staining method that utilizes calcofluor, a fluorescent dye that preferentially stains chitin and cellulose on the cell walls of fungi, parasites, and some cysts of the Pneumocystis genus. Calcofluor White Staining Method The procedure or activity of determining a result by mathematical or logical methods. (NCI) Calculation A measurement methodology in which a caliper device is used for measuring the length of dimension, consisting of two hinged legs (that may be inturned or outturned) usually, but not always, attached to a ruled scale, dial, or digital display. Vernier Caliper Measurement Method An electrophoresis procedure, in which a sample is introduced into a capillary tube and the components are separated by the application of high voltage. (NCI) Capillary Electrophoresis A technique for calculating cardiac output in which a catheter (e.g., Swan-Ganz) is inserted into the pulmonary artery through a peripheral vein to measure the change in right ventricular outflow blood temperature after a cold saline solution is injected into the right atrium from a proximal catheter port. Cardiac Output Thermodilution Method A diagrammatic method to test visual acuity that uses a set of cards with familiar pictures placed in either the top or bottom half of the card, and which is used for those individuals who are unable to provide a verbal response to questions, including infants, toddlers, and other non-verbal individuals. Cardiff Acuity Cards An in vitro assay that utilizes live cells to measure the biological activity or potency of a drug, substance, or organism. Cell Based Bioassay An immunoassay in which an antigen of interest and neutralizing antibodies that are specific to the antigen are added to cells in culture that express proteins that are targets of the antigen. Antigen function is then measured to determine the neutralizing effects of the antibodies. Cell Based Neutralizing Antibody Assay CCNA An assay that is used to detect the presence of a toxin in a biological sample by inoculating two sets of tissue cell cultures, one prepared with anti-toxin and one prepared without anti-toxin, followed by assessment for cytopathic effect. Cell Cytotoxicity Neutralization Assay COO Assay An assay that utilizes gene expression profiling of RNA extracted from formalin-fixed, paraffin-embedded tissue biopsies, in order to determine the cell of origin of the tumor. Cell-of-Origin Assay A type of cell-based assay that measures the ability of a biological specimen to inhibit transduction of the target cell line (for example, antibody-dependent inhibition of recombinant adeno-associated virus vector transfection). Cell-based Transduction Inhibition Assay Any method to measure the number of dividing cells in a culture, or to measure the change in the proportion of cells that are dividing. Cell Proliferation Assay Separating and isolating components of different density and size in a specimen using centrifugal force. Centrifugation Any assay in which the analyte is quantified using light emission that is generated from a chemical reaction. Chemiluminescent Assay Chemiluminescent Magnetic Microparticle Immunoassay CMIA A type of chemiluminescent immunoassay that uses paramagnetic microparticles bound to antigen or primary antibodies as a substrate for analyte binding prior to labeling with a luminescent compound. Chemiluminescent Microparticle Immunoassay A technique for the separation of complex mixtures that relies on the differential affinities of substances for a gas or liquid mobile medium and for a stationary adsorbing medium through which they pass. Chromatography An assay in which the reaction product produces a visible color change. Chromogenic Assay A type of angiography in which motion picture camera technology is used to record the passage of dye (usually fluorescent) through blood vessels and the heart. Cineangiography Chromogenic in Situ Hybridization A laboratory procedure that combines the sequence-specific detection aspects of FISH with the simple detection methods of immunohistochemistry. Briefly, sequence-specific probes are hybridized to cells fixed on slides and the sequestered probe is visualized by a peroxidase reaction. It has the advantage of being a less costly assay that does not require fluorescence microscopy with results that are stable over time. Chromogenic In Situ Hybridization An in vitro method to determine the plasma concentration of fibrin, based on the correlation of fibrinogen concentration with the clotting time of diluted plasma mixed with excess thrombin. The method is calibrated using a standard curve based on plasma with decreasing fibrinogen concentrations. Clauss Method An appraisal of a patient's condition by a clinician that is based on a physical exam, medical history, patient's account of symptoms, laboratory assessments, and/or imaging analysis. Clinical Evaluation CLIP-Seq Cross-linking Immunoprecipitation High-throughput Sequencing HITS-CLIP A molecular biology method combining crosslinking-immunoprecipitation and high-throughput sequencing techniques to detect and map RNA-protein interactions. Cross-linking Immunoprecipitation High-throughput Sequencing Cross-Linking and Immunoprecipitation A type of immunoprecipitation protocol that employs UV-light induced covalent cross-linking of molecules (for instance protein and RNA) prior to the immunoprecipitation and purification steps. Cross-Linking and Immunoprecipitation Any of several methods used to detect the presence of or quantify the formation of a thrombus in a specimen. (NCI) Clot Detection An invasive method that provides a direct measurement of fractional oxygen saturation in arterial blood by utilizing spectrophotometry. CO-oximetry A technique that potentially induces the formation of insoluble solids from solution by exposing the specimen to cold temperatures. Cold Precipitation A type of immunoassay in which a solution containing a target antigen is run through a membrane filter to which antibodies specific to the target antigen have been immobilized. Antibodies labeled with colloidal gold nanoparticles are then run through the membrane filter and are used for detection. Colloidal Gold Immunofiltration Assay A method to measure the absorbance of visible wavelengths of light using a colorimeter. Colorimetry A hybridization method in which complementary single-stranded DNA from different sources compete to form complexes with target DNA sequences. Competitive DNA Hybridization Competitive Enzyme-linked Immunosorbent Assay Competitive Immunoassay Inhibition ELISA A type of enzyme-linked immunosorbent assay that uses a reference antigen to competitively bind labeled antibody against an antigen of interest. The strength of the signal interference caused by antibody bound to the reference antigen is used to determine the concentration of the antigen of interest. Competitive Enzyme-linked Immunosorbent Assay An in vitro immunoassay that detects the presence of a specific antibody utilizing complement-hemolytic activity. The complement binds to the antigen-antibody complexes in a biological specimen, leading to the reduction of hemolytic activity. Complement Fixation Assay A method that detects the presence and reaction of complement-fixing alloantibodies to donor lymphocytes, via the addition of complement proteins and lysis of the lymphocytes. Complement-dependent Lymphocytotoxicity Assay CR A type of X-ray based radiography that uses a phosphor imaging plate in a cassette in place of X-ray film. A photomultiplier tube converts visible light to electrical signals, which are then digitally processed to reconstruct an image. Computed Radiography CT Perfusion A computed tomography imaging method used for the evaluation of tissue blood flow, where serial images are acquired after intravenous injection of a bolus of contrast agent, and software is used to analyze perfusion parameters and create color coded perfusion maps. Computed Tomography Perfusion Imaging Computer-Assisted Corneal Topography A non-invasive, computer-assisted method of measuring the shape of the cornea of the eye. Computerized Corneal Topography CPA A type of conditioned audiometry to detect sound, where the child performs a motor activity in response to a specific auditory stimulus. Conditioned Play Audiometry COR Audiometry A type of conditioned audiometry to detect and localize sound, where a delayed visual presentation is used to support a child's reflexive orientation response to an audio signal from one of multiple spatially separated sources. Conditioned Orientation Reflex Audiometry A system of (usually) epifluorescence light microscopy in which a fine laser beam of light is scanned over the object through the objective lens. This technique is particularly good at rejecting light from outside the plane of focus and so produces higher effective resolution than other microscopy techniques. Confocal Microscopy A microscopy staining method that utilizes the Congo red stain, a benzidine derivative dye that stains amyloid and may also be used as a pH indicator. Congo Red Staining Method A type of specular microscopy in which the specular microscope makes contact with the cornea of the eye. Contact Specular Microscopy Contrast Enhanced Computed Tomography CT Scan With Contrast A type of CT scan in which images are enhanced by the addition of contrast agents into the body. Computed Tomography with Contrast A technique that uses radiofrequency waves and a magnet to image the body. The images are enhanced by the addition of contrast agents which selectively intensify anatomical regions to intensify the clarity of the image for diagnostic purposes. (NCI) Contrast-enhanced Magnetic Resonance Imaging PET Scan With Contrast A type of PET scan in which images are enhanced by the addition of contrast agents into the body. Contrast Enhanced PET Scan An imaging technique that utilizes positron emission tomography and computed tomography in a single machine, in which images are enhanced by the addition of contrast agents into the body. Contrast Enhanced PET-CT Scan Spiral CT Scan With Contrast A type of spiral CT scan in which images are enhanced by the addition of contrast agents into the body. Contrast Enhanced Spiral CT Scan A type of transesophageal echocardiography in which images are enhanced by the addition of contrast agents into the body. Transesophageal Echocardiography With Contrast A type of transthoracic echocardiography in which images are enhanced by the addition of contrast agents into the body. Transthoracic Echocardiography With Contrast A type of X-ray in which images are enhanced by the addition of contrast agents into the body. Contrast Enhanced X-ray A procedure in which the catheter is passed into the aortic root or other great vessels for the purpose of angiography of the native coronary arteries or bypass grafts supplying native coronary arteries. Coronary Angiography A titration method in which the titrating agent is generated electrochemically in solution and the magnitude and duration of the current are measured to determine the amount of the substance. Coulometric Titration A method for measuring the molar concentration of a substance in solution by determining the freezing point of the solution. Cryoscopy Computed Tomography Angiography CT Scan Angiography CTA A type of computed tomography that is used to construct images of blood vessels. Computed Tomography Angiography A type of CT scan in which the images are not enhanced by the addition of contrast agents into the body. Computed Tomography without Contrast CAT Scan Computed Axial Tomography Computed Tomography Computerized Tomography CT An imaging technique for examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis. Computed Tomography A method of bladder function testing in which pressure and volume are measured during the filling and voiding phases of micturition. Cystometry Endoscopic examination of the urinary bladder or urethra. Cystoscopy A microscopic technique in which the light that does not come into contact with the structure or details of interest is subtracted from the ocular image. This yields an image in which the structure or details are alight while the areas where the structures or details are absent are dark. Dark Field Microscopy Sheath Flow DC Detection Sheath Flow Direct Current Detection A technique that utilizes hydrodynamic focusing to create a sheath flow in which the direct current impedance signal is measured. Sheath Flow Direct Current Detection Diffusion Tensor Imaging DT-MRI DTI A type of MRI technique that maps the diffusion of water in three dimensions. Diffusion Tensor Imaging Diffusion Weighted Imaging DW-MRI DWI A type of MRI technique in which diffusion-sensitizing gradients are applied to the imaging sequence. Diffusion Weighted Imaging A technique used to deliver high-throughput digital PCR. The digital array partitions a sample premixed with PCR reagents into hundreds of individual PCR reactions, which allows the absolute quantification of target sequences and rare allele detection, as compared to conventional real-time quantitative PCR. Digital Array Digital Polymerase Chain Reaction dPCR A type of polymerase chain reaction technique in which the sample is fractionated, within which individual PCR reactions occur in each fraction. Digital Polymerase Chain Reaction Any type of radiography that creates digitized images for analysis. Digital Radiography A measurement methodology in which a dipstick device is used to detect the presence of an analyte in a liquid by producing a color change. Dipstick Measurement Method Direct Conversion Digital Radiography A type of digital radiography in which X-rays are directly registered by flat panel detector (FPDs), without the need for an intermediate cassette. Direct Digital Radiography A type of enzyme-linked immunosorbent assay that uses a one-step process, where a labeled antibody binds the antigen of interest. Direct Enzyme-linked Immunosorbent Assay A technique used to identify the sequence of individual nucleotides in a single strand of DNA fragment template which does not require subcloning and can be a plasmid insert, genomic DNA or a PCR product. Direct Sequencing Dual-Color Chromogenic in Situ Hybridization Dual-Color CISH A type of chromogenic in situ hybridization that uses a two color hybridization probe, which is visualized by a peroxidase reaction Dual-Color Chromogenic in Situ Hybridization A technique for microbial characterization that assesses the zone edge of susceptible bacteria isolates after disk diffusion with an antimicrobial agent. Penicillin Zone Edge A method to determine microbial susceptibility to antibiotics in which filter paper disks containing known concentrations of antibiotics are placed on the agar surface that has been previously inoculated with the bacteria of interest. Microbial susceptibility is assessed by measuring the area around the disk that is free of microbial growth. Disk Diffusion Method DNA Chip Gene Chip Gene Expression Array An orderly array of DNA samples affixed to a support. The chip is used in various types of hybridization experiments. Used when a more specific microarray methodology is not specified. DNA Microarray Chip A type of echocardiography that uses sound waves applying the Doppler effect to measure characteristics of blood flow, such as direction, velocity, speed, and turbulence. Doppler Echocardiography Test Diagnostic imaging that uses sound waves (ultrasound) applying the Doppler effect, with frequency-shifted ultrasound reflections produced by moving targets (usually red blood cells) in the bloodstream along the ultrasound axis in direct proportion to the velocity of movement of the targets, to determine both direction and velocity of blood flow. Doppler Ultrasound DID Ouchterlony Double Immunodiffusion Passive Double Immunodiffusion A technique used to identify specific antibodies bound to an antigen by the appearance of a precipitation band (precipitin band) formed between wells in an agar gel plate as a result of the interaction of the antigen and antibodies at optimal concentration. Double Immunodiffusion ddPCR A type of digital polymerase chain reaction technique in which the sample is fractionated into thousands of tiny droplets using a water-oil emulsion droplet technology, within which individual PCR reactions occur in each droplet. Droplet Digital PCR Galactography A type of mammography that uses contrast medium to visualize the ducts of the breast. Ductography A method for assessing bleeding time in which a controlled stab incision is made with a lancet on the earlobe or finger and blood is drawn off of the incision site with blotting paper every 30 seconds until bleeding stops. Duke Incision Method DEXA Scan A technique for measuring anatomical densities in which two X-ray beams at different energy levels are aimed at the anatomical location of interest and x-ray absorption is assessed. Dual X-ray Absorptiometry A method of measuring cardiac output by rapidly injecting a known quantity of dye through a central venous catheter and then monitoring arterial blood at fixed time intervals to determine the change in concentration of dye over time. Dye Dilution Method Measurement A type of contrast-enhanced MRI that allows observation of functional properties in addition to structural properties. Dynamic Contrast-Enhanced Magnetic Resonance Imaging Photon Correlation Spectroscopy Quasi-elastic Light Scattering A type of spectroscopy that utilizes a laser beam to irradiate a sample containing particles in suspension, resulting in light scattering. Photon Correlation Spectroscopy DSC-MRI A type of MRI that uses the transient signal reduction induced by the first pass of gadolinium chelate through the brain vessels to calculate cerebral blood flow maps, and to determine the ratio between the cerebral blood volume in the lesion and the cerebral blood volume in normal tissue. Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging A technique that measures the torque, or force, of muscle contraction. Dynamometry Snellen E Optotype Chart Tumbling E Chart A diagrammatic method to test visual acuity that uses the letter 'E' pointing in different directions at 90 degree angles to each other. Snellen E Optotype Chart A procedure that uses high-frequency sound waves (ultrasound) to create an image of the heart. Echocardiography Test ELECTROENCEPHALOGRAPHY A technique used to capture and record spontaneous electrical activity of the brain by the application of electrodes to the scalp. Electroencephalography Enzyme Immunoassay Any of several immunoassay methods that use an enzyme covalently linked to an antigen or antibody as a label; the most common types are enzyme-linked immunosorbent assay (ELISA) and enzyme-multiplied immunoassay technique (EMIT). Enzyme Immunoassay An ultrasound-based imaging technique used to examine the stiffness or elasticity of a tissue by applying mechanical compression or vibration to the tissue being imaged. (NCI) Elastography EIM A non-invasive method of applying and measuring high-frequency, low-intensity electrical currents on the skin over localized muscle or muscle group of interest. Electrical Impedance Myography A method in which electromagnetic radiation, in the form of light emission, is generated from an electrochemical reaction in a solution due to the formation of antigen-antibody complexes. Electrochemiluminescence Immunoassay A method in which electromagnetic radiation, in the form of light emission, is generated from an electrochemical reaction in a solution. (NCI) Electrochemiluminescence A non-invasive technique that utilizes abdominal skin electrodes and computerized spectral analysis to assess gastric myoelectrical activity. Electrogastrography EMG A method to assess skeletal muscle function and nerve control, obtained by recording and studying the intrinsic electrical properties of the muscles. Electromyography A nerve conduction study technique where a brief electrical stimulation is delivered under the skin, and the resulting electrical activity is recorded to assess the conductivity of peripheral nerve impulses. Electroneurography The motion of charged particles in a colloid under the influence of an electric field; particles with a positive charge go to the cathode and negative to the anode. Electrophoresis Enzyme-linked Immunosorbent Assay A type of enzyme immunoassay in which an antigen or antibody is bound to a solid substrate (e.g., microplate or beads) and interacts with an enzyme-linked antibody or antigen in solution. ELISA Enzyme-linked Immunosorbent Spot Assay A highly sensitive immunoassay capable of detecting secreted materials from individuals cells upon activation. If the material of interest is secreted in response to a particular stimulus, then the material will bind to a specific immobilized antibody. Binding is then verified and visualized by applying other antibodies that have been tagged in some way. Enzyme-linked Immunosorbent Spot Assay Enzyme-Linked Lectin Assay An enzyme immunoassay that utilizes enzyme-lectin conjugates to detect specific carbohydrate end groups on immobilized glycoproteins on microtiter plates. Enzyme-Linked Lectin Assay ERCP An imaging technique in which the bile ducts, pancreatic duct, and gallbladder are examined using a combination of endoscopy and fluoroscopy. Endoscopic Retrograde Cholangiopancreatography An endoscopic technique using a specialized endoscope that transmits high frequency sound waves to generate ultrasound images. Endoscopic Ultrasound An examination of the body using an endoscope. Endoscopic Procedure An in vitro cell based assay in which plated host cells are inoculated with serial dilutions of an infective agent and observed for cytotoxic effects in order to calculate the titer. Endpoint Dilution Assay A type of colorimetry that makes use of an enzymatic reaction to induce a color change. (NCI) Enzymatic Colorimetry A spectrophotometry technique that measures the changes in the intensity of the light absorbed or scattered in response to an enzymatic reaction. Enzymatic Spectrophotometry A high-speed centrifugation-based method that uses enzymatic catalytic reaction to quantify a substance. Enzymatic Ultracentrifugation EMIT A type of homogenous immunoassay in which sample is applied to a reagent mixture of enzyme-labeled ligand, antibody, and substrate. Substrate binding to enzyme leads to inactivation and unlabeled-ligand in the sample can be quantified by colorimetric analysis. Enzyme Multiplied Immunoassay Technique A method to determine microbial susceptibility to antibiotics in which a plastic strip impregnated with the antibiotic of interest is placed on an agar plate that has been inoculated with bacteria. The antibiotic diffuses from the strip producing a concentration gradient of drug on the agar. The point at which the elliptical shaped area of growth inhibition meets the strip is the minimum inhibitory concentration of the drug of interest. Epsilometry Spiroergometry An exercise testing method that continuously measures respiratory volume and frequency, oxygen intake, carbon-dioxide output, and heart rate during ergometer exercise to assess integrative cardiopulmonary, musculoskeletal, and metabolic response to physical stress. Ergospirometry The X-ray examination of the esophagus after introduction of a radiopaque substance. Esophagography A diagrammatic method to test visual acuity which incorporates the Bailey-Lovie layout in conjunction with Sloan optotypes. Early Treatment of Diabetic Retinopathy Study Eye Chart A diagrammatic method to test color blindness or deficiencies, which uses 100 colors from the Munsell color system arranged in rows of four color families and containing 25 hues for each color. The subject must put the hues in order based on the anchor colors on the ends of each row. Farnsworth-Munsell 100 Hue Test A type of radioimmunoprecipitation assay that uses ammonium sulfate to precipitate immune complexes formed with radiolabeled antigen. Farr Assay Fluorescence in Situ Hybridization A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping. Fluorescence In Situ Hybridization A type of atomic spectroscopy that qualitatively or quantitatively measures select cations (particularly Na, K, Rb, Cs, Ca, Ba, Cu) by utilizing a low temperature flame capable of exciting a valence electron to an upper energy state which emits light at a wavelength unique to each cation as the electron returns to its ground state. (NCI) Flame Photometry A method in which microscopic particles in suspension aggregate to form observable loosely clumped masses. Flocculation Assay A type of flocculation method in which microscopic charcoal particles are used to enhance the visibility of aggregated masses in suspension. Charcoal Enhanced Flocculation A technique for counting, examining or sorting microscopic particles in which the particles are placed in a fluid (with or without light-sensitive dye) and passed through a beam of light. Flow Cytometry A method of measuring the number of entities in a sample by placing those entities in a fluid and passing them, in a stream, through a special light microscope that can record and analyze images to determine the presence of foreign particles, cell counts, protein aggregates, and morphology information. Flow Microscopy FLAIR MRI A type of magnetic resonance imaging that uses an inversion recovery sequence with a long inversion time to null fluids present in the imaging area, improving clarity of the object of interest. Fluid Attenuated Inversion Recovery A microscopy staining method that utilizes an orange phthalic indicator dye, which emits green fluorescence in the presence of alkaline solutions. Fluorescein Stain An examination technique that uses fluorescent dye and a specialized camera to inspect blood flow within vessels. Fluorescence Angiography Forster Resonance Energy Transfer FRET A process to measure the proximity of two fluorochromes whereby the excitation energy of one fluorochrome is released and absorbed by the second fluorochrome. It is used to study interactions and structure of macromolecules. (NCI) Fluorescence Resonance Energy Transfer FAVN An immunofluorescence assay method that measures the level of virus-specific neutralizing antibodies in a specimen by the detection of fluorescence in susceptible cells incubated with serial dilutions of the specimen and fluorophore-conjugated virus. Fluorescent Antibody Virus Neutralization Assay ELFA Enzyme-linked Fluorescence Assay Enzyme-linked Fluorescent Immunoassay FEIA An assay technique that uses one or more antibodies to detect an analyte, where either the analyte or antibody is labelled with an enzyme. The binding of antibody to analyte is detected by the enzyme converting a substrate to a fluorescent product. Fluorescent Enzyme Immunoassay Fluorescent Antibody Assay Immunofluorescence Assay A bioassay in which fluorescent-coupled antibodies or antigens are used to quantify or qualify a biological response to a stimulus. Fluorescent Antibody Procedure An imaging technique that produces spatially resolved images based on the differences in the excited state decay rates of fluorescent compounds in a sample. Fluorescence Lifetime Imaging Microscopy Microscopy of specimens stained with fluorescent dye or naturally fluorescent materials. Fluorescence Microscopy A method to assess enzymatic activity in which a substrate reagent is incubated with a biological specimen and spotted on filter paper. The spots are then examined for fluorescence, which correlates with enzyme activity. Fluorescent Spot Test Fluorometry An analytical method that utilizes ultraviolet light to excite the sample and detects the fluorescence emitted during the return of the sample to its ground state. (NCI) Fluorimetry An imaging technique that produces real-time, moving images of tissues and deep structures of the body using the fluoroscope, a device that produces an image when X-rays strike a fluorescent screen. Fluoroscopy Virus Focus Forming Assay An assay used to determine viral quantity, where host cells are infected with serially diluted virus and incubated. Conjugated antibodies that bind to the infected cells are then added, leading to the formation of precipitates that can be visualized. Focus Forming Assay Foci Reduction Neutralization Test Focus Reduction Neutralization Test FRNT An assay that is used to determine whether neutralizing antibodies that are present in a biological specimen can block viral infection/proliferation ex vivo, by staining and counting the number of viral foci, which are detected with a colorimetric substrate, such as horseradish peroxidase or fluorescent labels. This assay typically uses live virus. Focus Reduction Neutralization Assay FOT A non-invasive method to evaluate respiratory mechanical properties of the lung and airways using small-amplitude pressure oscillations superimposed on the normal, tidal breathing of a subject. Forced Oscillation Technique The addition of a solute to a solvent that results in a decrease in the temperature at which the solute-solvent mixture (solution) freezes. Freezing Point Depression fMRI A type of MRI that takes a series of images of an organ in quick succession and statistically analyzes the differences between the images. Functional Magnetic Resonance Imaging A method of capturing images of the vitreous, retina, choroid, and optic nerve using a fundus camera, a specialized low power microscope with an attached camera. Eye Fundus Photography Gas Chromatography/Flame Ionization Detector An analytical technique where gas chromatography is coupled with flame ionization detection in order to separate, identify, and quantify substances in a sample. Gas Chromatography and Flame Ionization Detection Gas Chromatography/Mass Spectrometry An analytical technique where gas chromatography is coupled with mass spectrometry in order to separate, identify, and quantify substances in a sample. (NCI) Gas Chromatography Mass Spectrometry An analytical technique where gas chromatography is coupled with chemical ionization mass spectrometry in order to separate, identify, and quantify substances in a sample. Gas Chromatography/Chemical Ionization Mass Spectrometry An analytical technique where gas chromatography is coupled with electron ionization mass spectrometry in order to separate, identify, and quantify substances in a sample. Gas Chromatography/Electron Ionization Mass Spectrometry An analytical technique where gas chromatography is coupled to tandem mass spectrometry in order to separate, identify, and quantify substances in a sample. Gas Chromatography/Tandem Mass Spectrometry A method of separating large molecules (such as DNA fragments or proteins) from a mixture of similar molecules by electrophoretic filtration through a gelatinous matrix. Gel Electrophoresis A microscopy staining method that utilizes Giemsa, a mixture of ethylene blue and eosin, which forms purplish-black crystals when dried. This stain preferentially binds to the phosphate groups of DNA and aggregates at areas with an increase in adenine-thymine binding, thus leading to chromosomal staining patterns that lend themselves to g-banding analysis. Additionally Giemsa can be used as a differential stain to determine microbial cell adherence to human cells as well as in the diagnosis of malaria, spirochete, and protozoal infections. Giemsa Staining Method A method to determine microbial susceptibility to antibiotics in which an agar plate, which has a concentration gradient of the drug within the agar, is streaked with the microorganism of interest. Microbial susceptibility as well as minimum inhibitory concentration of antibiotic is assessed. Gradient Diffusion Method A microscopy staining method for staining and identifying bacteria, based on the differential retention of a crystal violet-iodine complex within the cell membrane. Gram-positive organisms will appear blue-black or purple while Gram-negative organisms will appear red. Gram Staining Method A technique to assess isometric muscle strength using a hand-held dynamometer. Hand-held Dynamometry A microscopy staining method that uses Hansel reagent to differentiate eosinophils and neutrophils in a specimen. (NCI) Hansel Staining Method An in vitro assay that is used to determine the relative concentration of viruses, bacteria, or antibodies in which serial dilutions of solution containing virus, bacteria, or antibody are applied to red blood cells in culture to look for the presence of hemagglutination. Hemagglutination Assay An in vitro assay that is used to determine whether antibodies present in serum samples will inhibit hemagglutination in a cell culture plate containing red blood cells and a hemagglutinating agent. Hemagglutination Inhibition Assay H&E Stain A microscopy staining method that utilizes two separate dyes, one staining the nucleus and the other staining the cytoplasm and connective tissue. Hematoxylin is a dark purplish dye that stains the chromatin (nuclear material) within the nucleus. Eosin is an orangish-pink to red dye that stains the cytoplasmic material including connective tissue and collagen. Hematoxylin and Eosin Staining Method A method that uses a thick glass slide containing a chamber with a defined volume, which is etched with a precisely ruled grid and is used to quantify cells or cell-sized particles in suspension. Hemocytometry A technique for measuring circulating complement in which biological specimens are added to antibody-coated erythrocytes and the percentage of cell lysis is measured. Complement Hemolytic Activity Assay An assay used to verify the presence of anti-HCV antibodies in a blood sample. Serum is incubated with a membrane strip on which four recombinant viral proteins are attached. The immunoblot is considered positive if two or more proteins react, and indeterminate if only one positive band is detected. (NCI) Hepatitis C Virus Recombinant Immunoblot Assay A method to determine microbial susceptibility to high concentrations of aminoglycoside antibiotics. Aminoglycoside Screening Method High Resolution Computed Tomography HRCT A type of computed tomography that utilizes narrow collimated light beams to take thin-slice, high-definition images. High Resolution Computed Tomography A reverse real-time polymerase chain reaction technique in which fluorescently labeled double-stranded DNA is slowly melted apart by increasing temperature. High Resolution Melt Analysis A visual color scale created by Hillman et al in 2004 to enable standardization of urine color in the assessment of hemoglobinuria. Hillmen Color Chart High Performance Liquid Chromatography Frequently referred to simply as HPLC, this form of column chromatography is used frequently in biochemistry. The analyte is forced through a column by liquid at high pressure, which decreases the time the separated components remain on the stationary phase. Less time on the column then translates to narrower peaks in the resulting chromatogram and thence to better selectivity and sensitivity. High Performance Liquid Chromatography High-Performance Liquid Chromatography with Electrochemical Detection HPLC-ECD HPLC-ED An analytical technique where high performance liquid chromatography with an electrochemical detector is used to separate, identify, and quantify substances in a sample. High-Performance Liquid Chromatography with Electrochemical Detection An analytical technique where high performance liquid chromatography with a fluorescence detector is used to separate, identify, and quantify substances in a sample. High-performance Liquid Chromatography-Fluorescence An analytical technique where high performance liquid chromatography with an ultraviolet light detector is used to separate, identify, and quantify substances in a sample. High-performance Liquid Chromatography-UV High Performance Liquid Chromatography/Accelerator Mass Spectrometry An analytical technique wherein high performance liquid chromatography is coupled to accelerator mass spectrometry in order to separate, identify, and quantify substances in a sample. High Performance Liquid Chromatography/Accelerator Mass Spectrometry An analytical technique where high performance liquid chromatography is coupled to ion exchange chromatography in order to separate proteins based on net charge. High-performance Liquid Chromatography/Ion-Exchange Chromatography High Performance Liquid Chromatography/Mass Spectrometry An analytical technique wherein high performance liquid chromatography is coupled to mass spectrometry in order to separate, identify, and quantify substances in a sample. High Performance Liquid Chromatography Mass Spectrometry An analytical technique where high performance liquid chromatography is coupled to tandem mass spectrometry in order to separate, identify, and quantify substances in a sample. High-performance Liquid Chromatography/Tandem Mass Spectrometry Immunocytochemistry A method for the detection of proteins or antigens on samples of cells that are grown in monolayers or in suspension and deposited on slides, using antibodies or other biomolecules that bind the target and can be visualized through a chemical process. Immunocytochemistry A mass spectrometry technique that uses inductively-coupled plasma generated from argon gas to atomize and ionize a sample. The resulting ions are separated and analyzed using a mass spectrometer. Inductively-Coupled Plasma Mass Spectrometry Immunohistochemistry Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen. Immunohistochemistry Staining Method A DNA sequencing technique in which the full array of genes associated with immune cell markers are sequenced. Immune Repertoire Deep Sequencing A next generation sequencing technique in which specific genes associated with immune cell markers are targeted. Immune Repertoire Targeted Sequencing An imaging technique that utilizes positron emission tomography following administration of labeled antibody to confer specificity in the image. Immuno-Positron Emission Tomography Scan An immunological procedure involving the usage of enzyme-antibody or enzyme-antigen conjugates, antienzyme antibodies, or enzyme-antienzyme complexes. Immunoenzyme Procedure A technique for analyzing or identifying proteins immobilized on a filter by complementary reaction with specific antibodies. (NCI) Immunoblot Analysis Chemiluminescence Immunoassay Chemiluminescent Immunoassay CLIA ICMA An immunoassay in which the antigen-antibody complex is quantified using light emission, which is generated from a chemical reaction. Chemiluminescent Immunoassay ICA Immunochromatography Assay A type of chromatography assay in which an antibody-conjugate is passed over an immobilized antigen, or an antigen-conjugate is passed over an immobilized antibody, giving a visual indication of positive or negative result. Immunochromatography A quantitative technique used to detect and estimate the concentration of an antigen by measuring the precipitation which is formed as a result of the interaction of the antigen and an antibody at optimal concentration. Immunodiffusion IFE An enhancement of immunoelectrophoresis in which a series of post-electrophoretic gel slabs are layered with cellulose-acetate gels saturated with specific antibodies. The resulting antigen-antibody complexes fixed on the second gel may then be stained, allowing sensitive and specific qualitative visual identification of proteins by electrophoretic position. Immunofixation A microscopy staining method that utilizes immunofluorescent markers for use with histological applications of preserved cells. Immunofluorescent Staining Method An imaging technique in which fluorescently labeled cells are immunomagnetically selected and imaged by fluorescent microscopy. Immunomagnetic Fluorescence Microscopy Antigen aggregation with antibody, in the right ratios, to cause precipitation. (NCI) Immunoprecipitation IRMA An antibody-excess, non-competition radioimmunometric assay in which ligand is sandwiched between an immobilized antibody on a solid phase and a radiolabeled antibody raised against a different epitope of the ligand. Immunoradiometric Assay Immunoturbidimetric Assay Turbidimetric Immunoassay A method that measures the absorbance of light from a sample which is used for quantifying an amount of analyte based on the level of turbidity produced by the formation and precipitation of an immune complex containing the analyte. (NCI) Immunoturbidimetry A method that measures impedance of conductivity which corrects for the concentrations of conducting ions in the sample. Impedance Conductivity IOS A non-invasive method to measure pulmonary resistance and reactance, and the impedance of the respiratory system, using small pressure oscillation of a regular square wave of pressure 5 times per second. Impulse Oscillometry Use of a DNA or RNA probe to detect the presence of complementary sequences in chromosomes, cells, or tissues. (NCI) In Situ Hybridization A method that detects gene transcription associated with an in vitro cellular stimulus, through detection of the resulting transcribed mRNA or translated protein. In vitro Gene Expression Assay Any method for assessing bleeding time in which a controlled incision is made in the dermis and the time to bleeding cessation is measured. Incision-induced Bleeding Method A microscopy staining method that utilizes India Ink, a water soluble carbon-based black ink, to determine the presence of microorganisms that are surrounded by a gelatinous capsule. This is a negative staining method in which background is stained in black and the microbes and microscopic structures of interest remain white. India Ink Staining Method A type of electrochemiluminescence immunoassay that utilizes primary and secondary antibodies in a two-step binding process. Indirect Binding Electrochemiluminescence Immunoassay Indirect Conversion Digital Radiography A type of digital radiography in which X-rays are converted to visible light by a scintillator and then registered by a detector, without the need for an intermediate cassette. Indirect Digital Radiography A type of enzyme-linked immunosorbent assay that uses a two-step process, where a primary antibody binds the antigen of interest and then a labeled secondary antibody binds to the primary antibody. Indirect Enzyme-linked Immunosorbent Assay Secondary Immunofluorescence A fluorescent antibody technique in which a secondary fluorophore-conjugated antibody is used to detect a primary, unconjugated antibody directed against a target antigen. Indirect Immunofluorescence Microscopy of specimens stained with a secondary fluorophore-conjugated binding agent to detect a primary, unconjugated antibody directed against a target antigen. Indirect Immunofluorescent Microscopy A spectrometric method that determines the type and concentration of elements or chemicals in a sample, based upon the principle that the atoms in a sample will vibrate or rotate at a specific frequency when exposed to infrared light. Infrared Spectrometry IGRA A blood test that exposes a person's T-lymphocytes ex vivo to specific microbial antigen(s) to stimulate the production and release of interferon gamma, which provides an indication that the person has been exposed to a specific microbe. Interferon Gamma Release Assay IReST Test A method for assessing reading performance based on a standardized set of ten equivalent paragraphs of text, based on everyday life reading demands with equivalent levels of difficulty. International Reading Speed Text Test RINT A non-invasive method of measuring airway resistance during which the subject breathes normally while airflow is interrupted at a predetermined rate and volume during the early exhalation phase. Interrupter Technique A method for blood pressure measurement in which the motion of flow within a cannulated peripheral artery is transmitted to a transducer that converts the information into electrical signals. Intra-Arterial Differential Pressure Transduction ICS Intracellular Cytokine Staining A technique that is used with flow cytometry to measure cytokine production in isolated cells. Cells may be stimulated with an antigen or mitogen, and cytokine secretion may be blocked using protein transport inhibitors. The cells are then stained with fluorochrome labeled monoclonal antibodies that target surface markers, fixed and permeabilized, and stained with fluorochrome labeled anti-cytokine monoclonal antibodies prior to analysis by flow cytometry. Intracellular Cytokine Stain Flow Cytometric Assay IVUS An invasive procedure in which sound waves (called ultrasound) are bounced off of vascular tissues from within the vessel and the echoes produce a picture (sonogram). Intravascular Ultrasound IVP An imaging technique in which X-ray images of the renal pelvis and urinary tract are obtained after intravenous injection of a radiopaque substance. Intravenous Pyelography A microscopy staining method that utilizes Iodine, an element belonging to the halogen group, which specifically stains polysaccharides such as cellulose, chitin, glycogen, and starch a blue color. Iodine Staining Method A microscopy staining method that utilizes a mixture of iron and hematoxylin to visualize intracellular structures in a microscopic sample. In this dye system, iron acts as a mordant to hematoxylin rendering it insoluble, thereby allowing irreversible blue-black colored dyeing to the cell nucleus. Iron Hematoxylin Staining Method A diagrammatic method to test color blindness or deficiencies, which uses a circular form composed of multiple size circles in varying colors. A number or symbol is present in the middle and is composed of similar sized circles, which are a different color from those of the outer circular form. Ishihara Color Plates A diverse group of nucleic acid amplification methods that are performed at a constant temperature and utilize a polymerase with strand-displacement activity. Isothermal Amplification An assay that is used to quantify cytotoxic effector cell activity (e.g., cytotoxic T cell (CTL) or natural killer (NK) cell) by measuring target cell lysis. The process involves bathing and labeling the target cells with a radioactive isotope (e.g. Chromium 51 or Indium-111) or fluorescent molecule. The target cells are then mixed with the effector cells (CTL or NK). The killing of the labeled target cells leads to the release of the radioactive isotope into the supernatant after cell lysis. Accumulation of the radioactive isotope is quantified and measured in the supernatant which indicates effector cell-mediated cytolysis. Isotope-release Cytotoxicity Assay A method for assessing bleeding time in which the individual wears a blood pressure cuff inflated to 40mmHg, a controlled incision (10mm long x 1mm deep)is made on the volar surface of the arm, and blood is drawn off of the incision site with blotting paper every 30 seconds until bleeding stops. Ivy Incision Method A diagrammatic method to test visual acuity that uses paragraphs of text in differing font sizes to assess near vision. Jaeger Eye Chart A colorimetric method used to measure creatinine, in which color change is directly related to the amount of creatinine in an alkaline solution containing picric acid. Jaffe Reaction The preparation, analysis, and interpretation of a karyotype, the representation of the chromosome set of a cell sample. Karyotyping A bioassay in which a biological specimen is incubated with a kinetic substrate, followed by optical assessment of color change. Kinetic Chromogenic Assay A type of immunoassay in which the antigen of interest found in a biological specimen competes with a lattice of antigen-antibody complexes. Competing antigen inhibits lattice formation and decreases absorbance in proportion to the amount of antigen present in a biological specimen. (NCI) Kinetic Microparticle Immunoassay A microscopy acid fast staining method that utilizes kinyoun carbol fuchsin, a dye containing basic fuchsin in solution with ethyl alcohol and aqueous phenol. This acid fast staining technique does not require heating during the primary staining step involving the carbol fuchsin. Kinyoun Staining Method A biospecimen collection and staining procedure in which maternal blood smear is prepared and stained using Shepard's staining method, followed by microscopic examination to identify fetal hemoglobin transference to the mother's bloodstream. Kleihauer-Betke Staining Procedure A technique which measures lower limb length using a knemometer, for the assessment of short-term growth and development in childhood. Knemometry LAg-Avidity EIA Limiting Antigen-Avidity Enzyme Immunoassay An enzyme immunoassay technique that limits the amount of antigen available for binding in order to measure antibody avidity, with or without the use of a dissociation buffer. Limiting Antigen-Avidity Enzyme Immunoassay A diagrammatic method to test visual acuity in which a symbol, in the shape of the letter C, is presented to the patient who must identify on which side of the symbol the gap is present. Both the size of the gap and the size of the symbol are reduced until the subject makes a predetermined rate of errors, thus ending the test. (NCI) Landolt Ring A technique used to examine the abdominopelvic region with a laparoscope. Laparoscopy Laser Microdissection LCM LMD A technique used for the highly specific and selective capture and isolation of a cell population from a heterogeneous tissue section, cytological preparation, or live cell culture. This technique uses direct visualization of the cells via microscopy as well as a laser energy source for cutting and extraction of the cells. Laser Capture Microdissection LSCI A noninvasive, non-scanning optical imaging technique that provides full-field visualization of blood flow by illuminating a scattering surface with laser light and measuring the blurring effect of speckle contrast fluctuation due to movement. Laser Speckle Imaging A method for the detection of a target analyte from a sample placed onto a slot found on one end of a testing device or strip. Capillary action, driven by a buffering liquid, draws the sample across zones within the device containing molecules that specifically interact with the analyte. Lateral Flow Assay An analytical technique where liquid chromatography with a fluorescence detector is used to separate, identify, and quantify substances in a sample. Liquid Chromatography-Fluorescence Liquid Chromatography/Mass Spectrometry An analytical technique wherein liquid chromatography is coupled to mass spectrometry in order to separate, identify, and quantify substances in a sample. Liquid Chromatography Mass Spectrometry An analytical technique where liquid chromatography is coupled to tandem mass spectrometry in order to separate, identify, and quantify substances in a sample. Liquid Chromatography/Tandem Mass Spectrometry A diagrammatic method to test visual acuity in individuals that may have difficulty reading letters or numbers, which uses four symbols: house; apple; circle; and square. Lea Symbols Eye Chart A microscopy staining method that utilizes lead citrate, a mixture of lead nitrate and sodium citrate, and has applications for electron microscopy staining. Lead Citrate Staining Method An immunoassay that utilizes the interactions between two molecules, or the binding of molecules to antibodies, to detect and quantify analytes of interest. (NCI) Ligand Binding Assay A form of microscopy that involves passing light transmitted through or reflected from the subject through a series of lenses to be detected directly by the eye, imaged on a photographic plate, or captured digitally. Light Microscopy LiSSP A type of spectroscopy that measures power spectral density of surface morphology by exploiting the tendency of light to disperse into a range of directions as a result of physical interaction. Light-Scattering Spectroscopy LiPA LPA A microbial identification technique in which polymerase chain reaction is used to amplify specific nucleic acid sequences in a biospecimen. The product of this reaction is then applied to a nitrocellulose test strip containing complementary DNA probes. Line Probe Assay Luciferase Immunoprecipitation System Assay An immunoassay method that involves the binding of antibodies to luciferase-labeled antigen, precipitation of the antibody/antigen complex, and analysis of the precipitate through the light-producing interaction of luciferase and luciferin. Luciferase Immunoprecipitation System Assay A method for measuring the amount of ionizing radiation in a liquid substance. Samples are mixed with a mixture of solvent, surfactant and scintillators that can convert beta particles into light energy, which can be measured. Liquid Scintillation Counting A microscopy staining method that utilizes a green, synthetically produced phenyl methane dye that preferentially stains degenerate and dead epithelial cells and stroma. Lissamine Green Stain LAMP A type of nucleic acid amplification test in which sample DNA is exposed to a single temperature in the presence of multiple sets of primers and a polymerase with replication and high strand displacement activity. This test negates the need for thermal cyclers and may be a low cost alternative to PCR. Loop-mediated Isothermal Amplification LCA Luciferase PCA A cell-based assay that utilizes a luciferase complementation reporter mechanism to detect regulated protein-protein interactions in situ. Luciferase Protein Complementation Assay A microscopy staining method that utilizes luxol fast blue, an alcohol soluble copper phthalocyanine dye, and cresyl violet, an organic compound that is commonly used as a counter stain, to determine the presence of myelin as well as helicobacter and campylobacter bacterial species. Luxol Fast Blue and Cresyl Violet Staining Method A type of angiographic procedure that allows for the examination of the lymph nodes and lymphatic vessels following the injection of a radiopaque substance. Lymphangiography A method to determine the minimum inhibitory concentration (MIC) of antibiotics in which growth media is pipetted into a test tube. Each tube contains a known concentration of drug and is inoculated with a known quantity of bacteria. The tubes are incubated for a specified period of time and each is assessed for bacterial cell growth. The drug concentration in the first tube showing no growth is known as the MIC for that antibiotic. Macro Broth Dilution Method A type of flocculation method in which aggregates in suspension are detected with the naked eye. Macroflocculation Assay MRA A type of magnetic resonance imaging that is used to construct images of blood vessels. MRI-Based Angiogram MRCP A type of magnetic resonance imaging that is used to construct images of the intrahepatic and extrahepatic bile ducts, the pancreatic duct, and the surrounding parenchyma. Magnetic Resonance Cholangiopancreatography MRE An imaging technique that combines MRI with ultrasound to assess the mechanical properties of tissues. An MRI machine captures a cross sectional image of the sound waves, produced by ultrasound techniques, which are then processed by computer to produce an image showing the hardness or elasticity of tissues within the cross section. Magnetic Resonance Elastography MRE A magnetic resonance imaging technique that allows for the visualization of the entire small bowel by imaging the abdomen and pelvis during the enteric phase of digestion following oral administration of large volumes of enteric contrast material for bowel distention, followed by intravenous administration of contrast agent. Magnetic Resonance Enterography MEG MEG Scan A non-invasive encephalographic technique used to measure the magnetic fields produced by electrical activity in the brain. Magnetoencephalography Matrix-Assisted Laser Desorption Ionization Mass Spectrometry A mass spectrometric technique that is used for the analysis of large biomolecules. Analyte molecules are embedded in an excess matrix of small organic molecules that show a high resonant absorption at the laser wavelength used. The matrix absorbs the laser energy, thus inducing a soft disintegration of the sample- matrix mixture into free (gas phase) matrix and analyte molecules and molecular ions. In general, only molecular ions of the analyte molecules are produced and almost no fragmentation occurs. This makes the method well suited for molecular weight determinations and mixture analysis. (CHI) Matrix-Assisted Laser Desorption Ionization Mass Spectrometry Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry In MALDI-TOF, a laser pulse is fired into a protein or peptide sample contained in a light-absorbing matrix. A small explosion vaporizes and ionizes the sample. In the presence of a high electric field, peptide ions are accelerated down an evacuated flight tube. Because large particles travel more slowly than small ones, the masses of the ionized particles are determined by measuring their arrival time at the end of the tube. Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry A type of radiography used specifically to examine breast tissue. The procedure utilizes a low-dose of x-rays or radiation to generate an image. Mammography A clot detection method that uses a manual means (visual discernment) to detect the presence and/or quantify the formation of a thrombus in a specimen. (NCI) Manual Clot Detection A technique to determine the number of entities, which is performed by visual inspection. Manual Count Multiplex Amplifiable Probe Hybridization A screening method used to determine changes in complex genomes. This method uses unique short probes which are quantitatively recovered and amplified after hybridization to genomic DNA. Multiplex Amplifiable Probe Hybridization Cytometry by Time-of-Flight Time-of-Flight Cytometry ToF Cytometry A flow cytometry technique that utilizes mass spectrometry to detect antibodies labeled with heavy metal ion tags that are bound to antigens of interest on single cells. Mass Cytometry MassSpec An analytical technique wherein ions are separated according to their ratio of charge to mass. From the mass spectrum produced, the atomic weight of the particle can be deduced. Mass Spectrometry MGG Stain Pappenheim Stain A microscopy staining method that utilizes a combination of May-Grunwald and Giemsa stains and is used to preferentially visualize blood cells and bone marrow cells. May-Grunwald Giemsa Stain MG Stain A microscopy staining method that utilizes the May-Grunwald stain, an alcohol-based composition of methylene blue and eosin, and is preferentially used to visualize blood cells and bone marrow cells. May-Grunwald Stain A clot detection method that uses a mechanical means (electromagnetic mechanical or electromechanical) to detect the presence of or quantify the formation of a thrombus in a specimen. (NCI) Mechanical Clot Detection A technique used to examine the thorax with a mediastinoscope. Mediastinoscopy Micrometabolic inhibition Assay An assay that is used to determine whether neutralizing antibodies that are present in a biological specimen can block microbial infection/proliferation ex vivo, by assessing the amount/level of metabolism (in the form of carbon dioxide production) of surviving cells. Metabolic Inhibition Assay MS-qLNAPCR A modified polymerase chain reaction (PCR) technique in which bisulphite-converted methylated CpG target sequences are amplified in the presence of locked nucleic acid (LNA) modified primers. Methylation-Sensitive Quantitative Locked Nucleic Acid Polymerase Chain Reaction A method to determine the minimum inhibitory concentration (MIC) of antibiotics in which growth media is pipetted into a multi-well plate. Each well contains a known concentration of drug which is inoculated with a known quantity of bacteria. The plate is incubated for a specified period of time and each well is assessed for bacterial cell growth. The drug concentration in the first well showing no growth is known as the MIC for that antibiotic. Micro Broth Dilution Method Latex Agglutination Latex Fixation An immunoassay that involves coating microbeads of latex with antigens or antibodies, mixing them with a fluid specimen, and then observing for any agglutination. Micro-Latex Particle-Mediated Immunoassay A piece of glass or plastic on which different samples have been affixed at separate locations in an ordered manner thus forming a microscopic array. The samples are usually DNA fragments but may also be antibodies, other proteins, or tissues. Microarray Any of a number of biochemical tests performed to identify the genus and/or species of a microorganism. These may include the assessment of gram reaction or metabolic characteristics. Bacterial Typing Procedure Any technique in which a sample is condensed in order to afford greater sensitivity for the detection of microorganisms. Microbial Concentration Method Culture Procedure Any method for growing microorganisms. Microbial Culture Procedure A method for growing microorganisms in liquid culture media. Microbial Liquid Culture A method for growing microorganisms in solid culture media. Microbial Solid Culture A technique for measuring microscopic optical density on exposed film or photographic images through the detection of faint spectral lines. Microdensitometry A type of flocculation method in which aggregates in suspension are detected microscopically. Microflocculation Assay A type of enzyme-linked immunosorbent assay that utilizes microfluidic channels to simultaneously measure analytes of interest. Microfluidic ELISA Any of a number of immunoassay-based techniques that use very small amounts (e.g., on a nanoliter scale) of biological fluids. Microfluidic Immunoassay Virus Neutralization Assay VNA An in vitro assay in microwell plates that is used to determine whether antibodies that can block viral infection are present in a biological specimen. Virus Neutralization Assay MEIA An enzyme immunoassay that uses antigen-coated microparticles as a substrate for antibody binding. Microparticle Enzyme Immunoassay The application of microscope magnification to the study of materials that cannot be properly seen by the unaided eye. (NCI) Microscopy Multiple Inert Gas Elimination Technique A technique that measures the pulmonary exchange of a set of inert gases dissolved together in saline (or dextrose) and infused intravenously. The measurements are then used to compute the distribution of ventilation/perfusion ratios that best describes the exchange of the gases simultaneously. (Wagner PD. The multiple inert gas elimination technique (MIGET). Intensive Care Med. 2008 Jun;34(6):994-1001.) Multiple Inert Gas Elimination Technique A microscopy staining method, that does not utilize heat in the slide preparation, used to examine a specimen for the presence of acid-fast microorganisms, specifically nocardia. Modified Acid Fast Staining Method MPA An assay method that is used for the detection of neutralizing antibodies in subject's serum by determining the ability of the serum to prevent the death of mice that are exposed to a lethal dose of challenge agent. Mouse Protection Assay A technique that uses radiofrequency waves and a magnet to image the body, in which the images are not enhanced by the addition of contrast agents. MRI Without Contrast Magnetic Resonance Imaging MRIs sMRI Structural MRI Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders. Magnetic Resonance Imaging Magnetic Resonance Spectroscopy Magnetic resonance spectroscopy is a noninvasive imaging technique that operates by exciting and recording signals from a range of magnetic resonance frequencies, allowing the identification and quantification of several biologically significant molecules containing proton groups that resonate in the appropriate frequency range. The technique facilitates observation of the spatial distribution of metabolic patterns over a region of interest and surrounding tissue at a high spatial resolution. (NCI) Magnetic Resonance Spectroscopic Imaging Tandem Mass Spectrometry An analytical technique where mass spectrometry is coupled to mass spectrometry in order to separate, identify, and quantify substances in a sample. Tandem Mass Spectrometry Gated Heart Pool Scan Radionuclide Ventriculogram Scan Radionuclide Ventriculography RNV Scan A multi-gated acquisition (MUGA) scan and a form of radionuclide imaging that provides a comprehensive look at blood flow and the function of the lower chambers of the heart ventricles. Multigated Acquisition Scan Multi-Slice Spiral Computed Tomography A type of spiral computed tomography that employs multiple rows of detectors, each capable of producing a simultaneous image (slice). (NCI) Multi-slice Spiral Computed Tomography A test of lung function in which changes in exhaled tracer gas concentration is analyzed for a specified number of tidal expirations, a defined period of time, or a defined index of expired gas volume. Multiple Breath Washout Multiple Complete Digestion A DNA mapping technique based on complete restriction enzyme digestion of a set of overlapping clones that provides highly redundant coverage of the mapping target. Multiple Complete Digest Restriction Fragment Mapping Multiplex IF Multiplexed Immunofluorescence MxIF A method that enables simultaneous measurement of multiple antigens on a single tissue section using immunofluorescence techniques. Multiplexed Immunofluorescence Multiplex IHC Multiplexed Immunohistochemistry MxIHC A method that enables simultaneous measurement of multiple antigens on a single tissue section using immunohistochemistry techniques. Multiplexed Immunohistochemistry MLPA A type of high-throughput, multiplex PCR method that uses a single pair of PCR primers to amplify multiple targets and to determine changes in complex genomes. Multiplex Ligation-dependent Probe Amplification An assay technique that utilizes the polymerase chain reaction (PCR) method to amplify multiple DNA sequences in a single cycle, with the accumulation of amplification product being measured as the reaction progresses. Multiplex Real-time Polymerase Chain Reaction Assay Fluorescent Microsphere Immunoassay FMIA Any type of immunoassay (e.g., solid phase or flow cytometric) that uses microbeads coated with one or more fluorescent reagents that attach to antigens, antibodies, oligonucleotides, enzyme substrates, or receptors, for the simultaneous detection and measurement of multiple analytes within a single sample. Multiplexed Bead Based Immunoassay A type of digital gene expression analysis to detect or quantify targeted RNA transcripts using bar code indexing. Multiplexed Digital Gene Expression Analysis MOPA An assay to assess the opsonophagocytic killing activity of antibodies that measures the functionality of phagocytic immune cells by incubating different dilutions of co-cultured bacteria, sera, and complement, and then quantifying the percent bacterial survival of multiple serotypes relative to serum-negative controls. Multiplexed Opsonophagocytic Killing Assay MPO Stain A microscopy staining method that utilizes hydrogen peroxide and a chromogenic electron donor to stain for the presence of myeloperoxidase. Myeloperoxidase Stain A method to quantify the concentration of particulate matter suspended in a liquid or gas using a nephelometer. Nephelometry Nested PCR An assay technique that utilizes the polymerase chain reaction (PCR) method using two sets of primers, in two sequential runs of amplification, with the second set intended to amplify a target within the first run product. Nested PCR A type of enzyme-based assay that assesses neuraminidase activity in the presence of an enzyme inhibitor. Neuraminidase Inhibition Assay Massively Parallel Sequencing A type of sequencing technology that makes use of high-throughput parallel sequencing of multiple fragments of DNA or RNA. Next Generation Sequencing A type of next generation sequencing in which specific genes or portions of genes are targeted for sequencing using amplicon-based workflow. Next Generation Targeted Sequencing NI The value is exceptional (missing, omitted, incomplete, improper). No information as to the reason for being an exceptional value is provided. This is the most general exceptional value. It is also the default exceptional value. (ISO) No Information Available A type of specular microscopy in which the specular microscope does not make contact with the cornea of the eye. Non-Contact Specular Microscopy A method in which the dielectric tissue properties are measured based on the emission and reflection of low-power electromagnetic signals in between two sensors attached to the body. Non-Invasive Dielectric Sensing A type of spectroscopy that detects and measures the resonant spectra of molecular species in a tissue or sample. Magnetic Resonance Spectroscopy Any type of imaging method that uses radioactive materials. Nuclear Radiology Imaging Procedure NAAT Any of a number of molecular biological techniques that are used to copy nucleic acid sequences within a specimen, leading to an increase in the number of copies of that sequence of interest. These techniques may be used for detection of a particular gene or microorganism of interest. Nucleic Acid Amplification Test Molecular Analysis Molecular Assay Any laboratory methodology that involves the study of tissues, cells, and fluids using DNA/RNA analysis techniques for the identification of characteristics and abnormalities at the molecular level. Molecular Analysis A method in which single stranded nucleic acids are allowed to interact so that complexes, or hybrids, are formed by molecules with sufficiently similar, complementary sequences. By this means the degree of sequence identity can be assessed and specific sequences detected. (From Biology-online) Nucleic Acid Hybridization The process of determining the sequence of purines and pyrimidines in nucleic acids and polynucleotides. Nucleic Acid Sequencing Observing a subject or material to gain information. Observation Activity Oligonucleotide Array-based CGH Oligonucleotide Array-based Comparative Genomic Hybridization A molecular cytogenetic method combining chromosomal comparative genomic hybridization technique and microarray to detect chromosomal aberrations and changes in DNA copy numbers in the genome, using oligonucleotides as targets for hybridization. Oligonucleotide Array-based Comparative Genomic Hybridization Fundoscopy A technique used to examine the fundus and other anatomical structures of the eye with a magnifying instrument. Ophthalmoscopy OPA An assay to assess the opsonophagocytic killing activity of antibodies that measures the functionality of phagocytic immune cells by incubating different dilutions of co-cultured bacteria, sera, and complement, and then quantifying the percent bacterial survival of a single serotype relative to serum-negative controls. Opsonophagocytic Killing Assay OCT-A OCTA An optical coherence tomography imaging method that utilizes motion contrast imaging to capture the patterns of moving red blood cell reflectance across time and create high-resolution, 3D angiograms of vascular networks. Intravascular Optical Coherence Tomography OCT Optical Coherence Tomography (OCT) combines the principles of ultrasound with the imaging performance of a microscope. OCT uses infrared light waves that reflect off the internal microstructure within the biological tissues. The frequencies and bandwidths of infrared light are orders of magnitude higher than medical ultrasound signals, resulting in greatly increased image resolution, 8-25 times greater than any existing modality. In addition to providing high-level resolutions for the evaluation of microanatomic structures OCT is also able to provide information regarding tissue composition. (NCI) Optical Coherence Tomography A quantification of the amount of light that is absorbed by or transmitted through a substance. Optical Density Measurement Optical Map A technique used for constructing the ordered and high-resolution genome or chromosome sized restriction enzyme map of an organism from a single, stained DNA molecule, digested by the restriction enzyme and imaged by an optical microscope. Optical Mapping A method used to measure testicular volume by comparing the size of one's testicles to the beads in a orchidometer, which consists of a string of 12 numbered beads of increasing sizes of 1 to 6, 8, 10, 12, 15, 20, and 25mL. Orchidometry Measurement A technique to measure a motion that repeats itself in a regular cycle around an equilibrium point or mean value. Oscillometry A method for estimating body surface area, in which the individual's hand, with or without digits, accounts for a small proportion of the total body surface. An individual's palm (not including fingers and wrist) accounts for about 0.5% of the individual's total body surface area. The entire palmar surface (including digits) accounts for about 1% of the individuals total body surface area. Palm Method A method of feeling with the hands during a physical examination. The health care provider touches and feels the patient's body to examine the size, consistency, texture, location and tenderness of an organ or body part. Palpation An endoscopic examination of the pharynx, larynx, trachea and esophagus. Panendoscopy Papanicolau Stain A microscopy staining method that utilizes a mixture of dyes including hematoxylin, orange G (OG), and eosin azure, which contains variable portions of Eosin Y, light green SF yellowish, and Bismarck brown Y. This multichromatic staining method is used to differentially stain samples containing mixed cell populations. Papanicolaou Staining Method PENIA A method to quantify the concentration of immunoaggregates suspended in a liquid or gas using a nephelometer. The immunoaggregates are target antigens agglutinated to antigen-specific antibody-coated polystyrene latex-enhanced particles. Particle-Enhanced Nephelometric Immunoassay PETIA A method to quantify the opaqueness of a liquid using a turbidimeter, by measuring the decrease in light intensity due to the scattering effect of suspended immunoaggregates in a liquid sample. The immunoaggregates are target antigens agglutinated to antigen-specific antibody-coated polystyrene latex-enhanced particles. Particle-Enhanced Turbidimetric Immunoassay An appraisal by a pathologist that is based on microscopic and macroscopic structural and functional changes that result from disease processes. Pathologic Examination A method for measuring the flow of air through the bronchi upon expiration. Peak Flowmetry A diagrammatic method to test visual acuity and contrast sensitivity, which uses large letters (at a 20/60 acuity) that decrease in contrast from right to left and top to bottom. Pelli-Robson Contrast Sensitivity Eye Chart A diagnostic test performed on a tooth by tapping on the crown with a dental instrument. Dental Percussion A type of contrast-enhanced magnetic resonance imaging technique that assesses the circulatory perfusion of an anatomical location. Perfusion Magnetic Resonance Imaging A microscopy staining method that utilizes Schiff's reagent, a solution composed of pararosanilin treated with sulfurous acid, which selectively reacts with and stains aldehydes pink to determine the presence of glycogen, mucin, mucoprotein, glycoprotein, as well as fungi. Periodic Acid Schiff staining is useful for outlining tissue structures such as basement membranes, capsules and blood vessels. Periodic Acid Schiff Staining Method A procedure in which the catheter is passed into a peripheral vessel (usually in the groin) for the purpose of angiography of the abdomen, hands, arms, feet and legs. Peripheral Angiography A type of PET scan in which the images are not enhanced by the addition of contrast agents into the body. PET SCAN Without Contrast An imaging technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance. A scanner reveals the tissue location of the metabolically-active substance administered. Positron Emission Tomography An imaging technique that utilizes positron emission tomography and computed tomography in a single machine, in which the images are not enhanced by the addition of contrast agents into the body. PET-CT Scan Without Contrast An imaging technique that utilizes positron emission tomography and computed tomography in a single machine. Positron Emission Tomography and Computed Tomography Scan An imaging technique that utilizes positron emission tomography and magnetic resonance imaging in a single machine. Positron Emission Tomography and Magnetic Resonance Imaging An imaging technique that utilizes positron emission tomography and single-photon emission computed tomography in a single machine. Positron Emission Tomography and Single Photon Emission Computed Tomography Scan A measurement methodology in which a pH meter device is used for measuring the alkalinity or acidity of a liquid or semi-solid substance. pH Meter Measurement Method A microscopic technique in which the amplitude shift that occurs when light passes through a specimen highlights structures or details within the specimen. Phase-Contrast Microscopy PCMR A type of MRI in which a phase shift between flowing tissue and static tissue is generated in order to determine the quantity and velocity of body fluid. Phase-Contrast Magnetic Resonance Imaging A type of solid-phase multiplex assay that uses microbeads coated with recombinant or purified antigens that will identify multiple antibodies. Phenotypic Multiple Antigen Bead-based Multiplex Assay An instrument composed of multiple lenses that refract the light going into the subject's eye, allowing the examiner to determine the refractive error of the eye. Phoropter The process by which an image is acquired by recording light emissions. Photography Optical Density Clot Detection A clot detection method that uses a photometric means (measuring the absorbancy of monochromatic light) to detect the presence and/or quantify the formation of a thrombus in a specimen. (NCI) Photometric Clot Detection Measurement of the properties of light, especially luminous intensity. (NCI) Photometry PPG An optical technique used to detect volumetric changes in blood in peripheral circulation. Using low-intensity infrared light, changes in blood flow can be detected as changes in the intensity of light, with the signal being proportional to the quantity of blood flowing through the blood vessels. Photoplethysmography Physical Exam A systemic evaluation of the body and its functions using visual inspection, palpation, percussion and auscultation. Physical Examination A visual acuity method using a pinhole occluder device, which negates refractive error. Pinhole Occlusion Method Plaque Reduction Neutralization Test PRNT An assay that is used to determine whether neutralizing antibodies that are present in a biological specimen can block viral infection/proliferation ex vivo, by counting the number of cytolytic plaques. This assay typically uses live virus. Plaque Reduction Neutralization Assay Body Box A method used to measure changes in volume, pressure and resistance within an organ or whole body by means of a plethysmograph. Plethysmography A method of simultaneously recording variations in multiple physiological pulsations. Polygraphy PCR A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase. This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample. Polymerase Chain Reaction PSG A group of tests taken during sleep to capture and record brain wave changes, eye movements, breathing rate, blood pressure, heart rate, and the electrical activity of the heart and other muscles. Polysomnography A process by which the individual genomes of most or all of an entire population of a species undergoes a large-scale comparison of the DNA sequences within that population, using probabilistic matching tools. Population Sequencing Ion Selective Electrode Method ISE Method An electroanalytical technique in which the electrical potential of a solution is measured to determine the composition of the sample, by comparing the constant potential of the reference electrode with the actual potential of the indicator electrode. Potentiometry PEA A type of multiplex immunoassay that utilizes pairs of oligonucleotide-labeled antibodies to detect and quantify proteins in a sample. In this assay, the antibodies bind to their target proteins, and when in close proximity, the oligonucleotides are extended and amplified through a polymerase reaction. The resulting DNA products are then quantified using real-time PCR, allowing for sensitive and specific measurement of protein levels in complex biological samples. Proximity Extension Assay PBNA An assay that is used to determine whether neutralizing antibodies that are present in a biological specimen can block pseudoviral infection ex vivo, by counting the number of infected cells. This assay uses a pseudovirus expressing a pathogenic virus antigen of interest. Pseudovirion-Based Neutralization Assay An x-ray imaging technique that involves visualization of the pulmonary vasculature after fluoroscopy-guided catheter placement and injection of an iodinated contrast medium into the pulmonary circulation. Pulmonary Angiography A non-invasive method that provides estimates of arterial hemoglobin oxygen saturation by utilizing selected wavelengths of light. Pulse Oximetry PFGE An electrophoresis method used to separate proteins or high molecular weight linear DNA fragments that are greater than 50 kilobases (kb) in size. Fragments are separated by pulsing an electrical field across an agarose gel rather than applying the constant field used in conventional electrophoresis. Pulsed-Field Gel Electrophoresis A technique used to measure the diameter of a single pupil in response to stimuli. Monocular Pupillometry A DNA sequencing technique that is based on the detection of released pyrophosphate during DNA synthesis. Pyrosequencing QCT A type of computed tomography in which a calibration standard derives quantitative tissue density values from radiodensity measurements. Quantitative Computed Tomography A type of angiographic procedure that allows for direct quantitative assessment of the native coronary arteries or bypass grafts supplying native coronary arteries. Quantitative Coronary Angiography qMSP A modified polymerase chain reaction (PCR) technique in which bisulphite-converted methylated DNA target sequences are amplified in the presence of an excess of unmethylated counterpart sequences. Quantitative Methylation-Specific Polymerase Chain Reaction A type of angiographic procedure that allows for direct quantitative assessment of the vessels of the hands, arms, feet and legs. Quantitative Peripheral Angiography qRT-PCR Real-Time Reverse Transcriptase PCR rRT-PCR A modified polymerase chain reaction (PCR) technique in which RNA sequences are reverse transcribed into complementary DNA (cDNA) transcripts by the enzyme reverse transcriptase. The cDNA is then amplified by a real time PCR reaction. The level of expression of a target gene is calculated using the crossing thresholds (CTs) or crossing points (CPs) which correspond to the numbers of cycles required for a target gene and the housekeeping, internal control gene, to reach a defined fluorescence intensity. Quantitative Reverse Transcriptase PCR A type of ultrasound method in which the velocity and attenuation of ultrasonic sound waves are measured as they pass through tissue. Quantitative Ultrasound Neufeld Reaction A microbiological technique in which bacterial cells are mixed with type-specific antisera, causing the bacterial capsule to swell and become more visible under a microscope. The reaction is based on the binding of antibodies to the polysaccharide capsule, resulting in a characteristic change in refractivity that allows identification and serotyping of encapsulated bacteria. Quellung Reaction A quantitative technique used to detect and estimate the concentration of an antigen by measuring the diameter of the ring of precipitation (precipitin ring) which is formed as a result of the interaction of the antigen and an antibody at optimal concentration. (NCI) Radial Immunodiffusion Any of a number of techniques used to measure radiation exposure. Radiation Dosimetry Radiographic Exam A radiographic procedure using the emission of penetrating energy waves to form an image of the structure. Radiographic Examination RIPA An immunoassay method that involves the binding of antibodies to radiolabeled antigen, precipitation of the antibody/antigen complex using a special reagent, and analysis of the precipitate. Radioimmunoprecipitation Assay Raji Cell Enzyme Immunoassay A type of complement receptor-dependent immune complex assay that uses Raji cells washed with anti-IgA, anti-IgG, anti-IgM, and anti-Ig (A+G+M) conjugated with an enzyme to detect the presence of circulating immune complexes in biologic fluids. (NCI) Raji Cell Enzyme Immunoassay Raji Cell Radioimmunoassay A type of complement receptor-dependent immune complex assay that uses radiolabeled anti-IgA, anti-IgG, or anti-IgM Raji cells to detect the presence of soluble immune complexes in biologic fluids. (NCI) Raji Cell Radioimmunoassay An immunoassay that can quickly detect the presence of specific antigens in a sample and return results within a matter of minutes. Rapid Antigen Test Any of a number of immunoassay-based techniques that can be completed outside a laboratory in less than 30 minutes. Rapid Immunoassay qPCR Quantitative PCR Real Time-PCR A modified polymerase chain reaction (PCR) technique in which DNA amplification is detected and quantified as the PCR reaction progresses, through the use of fluorescent DNA probes in the reaction mixture. Real Time PCR A method in which a probe is bounced off of the surface of the cornea, creating an induction current that is used to calculate intraocular pressure. Rebound Tonometry The spectroscopic analysis of light reflected from a polished sample. Reflectance or Transmission Spectroscopy A method to measure the refractive index (propensity for light to bend) of a sample. (NCI) Refractometry ROMA A genomic microarray-based method that analyzes two restriction enzyme digested full genomes to identify regions in the genome that have undergone large scale variation. Representational Oligonucleotide Microarray Analysis Resting fMRI A type of functional magnetic resonance imaging that is performed on an organ in the absence of a stimulus or task. (NCI) Resting Functional Magnetic Resonance Imaging RFLP Analysis A technique that analyzes restriction fragments of target DNA sequences to detect polymorphisms. Restriction Fragment Length Polymorphism Analysis An imaging technique in which X-ray images of the renal pelvis and urinary tract obtained after injection of a radiopaque substance into the ureter, usually done via a cystoscope. Retrograde Pyelogram RPPA A high-throughput antibody-based functional proteomic microarray that can quantify basal protein expression and characterize as well as quantify post-translational modifications in a series of samples of body fluids or those derived from tissue or cellular lysates. (NCI) Reverse Phase Protein Array Reverse Transcription Polymerase Chain Reaction RT-PCR A molecular biology technique used to recreate and amplify complementary DNA (cDNA) from total RNA or messenger RNA (mRNA), using reverse transcriptase and DNA polymerase. Reverse Transcriptase-Polymerase Chain Reaction Radioimmunoassay Radioimmunoassay (RIA) is an immunological technique, which quantitatively determines antigen and antibody concentrations, using a radioactively labeled substance (radioligand), either directly or indirectly. Radioimmunoassay A technique that assesses auditory function by comparing sound conduction through air versus the mastoid bone, in which a vibrating tuning fork (at 512Hz) is placed on the mastoid bone and the subject indicates when they can no longer hear the vibration, at which point the still vibrating tuning fork is moved 1-2cm from the auditory canal and the subject again indicates when they can no longer hear the fork. Rinne Test Method A microscopy staining method that utilizes both cationic and anionic dyes (typically methylene blue and eosin Y, respectively) for the morphological assessment of cells in a biological specimen. Romanowsky Stain Rotational Thromboelastography ROTEG ROTEM A method to evaluate clotting dynamics and physical properties in which the amplitude of movement of an oscillating pin within a static blood sample is measured over time and analyzed using an optical detection system. Rotational Thromboelastography A standardized method of color vision testing that is a shortened version of the Farnsworth-Munsell 100-Hue test (FM100), using every third of the FM100's 85 color caps that are arranged in rows of four color families. Roth-28 Hue Test A measurement methodology in which a ruler device is used for measuring distance, consisting of an elongated piece of material marked with units of length. Ruler Measurement Method A microscopy staining method that utilizes a modified trichrome stain to determine the presence of microspordial, sporulating species. This staining technique substitutes aniline blue for the fast green counterstain of the original trichrome staining method and decreased levels of phosphotungstic acid in the reagent. Ryan Blue Staining Method A type of enzyme-linked immunosorbent assay that uses separate capture and detection antibodies such that the antigen is bound between the two antibodies. Sandwich Enzyme-linked Immunosorbent Assay A DNA sequencing technique in which a mixture of deoxynucleosidetriphosphates (dNTPs) and chain-terminating dNTPs (which are radioactively or fluorescently labeled) are combined within the reaction mixture. Once the polymerase chain reaction is complete the DNA strands are separated by size and the labeled chain terminating dNTPs can be read in sequence by the investigator or a machine. Dideoxy Chain Termination DNA Sequencing An electron microscopy imaging technique that is utilized to examine structural components of a sample by passing electrons through a specimen that has been coated with a heavy metal. Scanning Electron Microscopy A method to assess tear production in which filter paper is placed inside the lower eyelid for a period of time and moisture content is measured. Schirmer Test Wetting Gamma Scan An imaging technique that uses a small dose of a radioactive chemical (isotope) called a tracer that can detect sites of cancer growth, trauma, infection or degenerative disorders. The tracer, which is either injected into a vein or swallowed, travels through the bloodstream to the target organ, and emits gamma rays, which are detected by a gamma camera and analyzed by a computer to form an image of the target organ. (NCI) Radionuclide Imaging An analytical technique in which a mass spectrometer is used to measure the atomic weight of sputtered ionized atoms (secondary ions) that are ejected from a solid surface after application of a beam of high energy primary ions. Secondary Ion Mass Spectrometry A technique in which one evaluates their own actions or performance. Self Assessment An individual's perspective or subjective interpretation of an event or information. Self-Report sqRT-PCR A type of reverse transcriptase-polymerase chain reaction combined with electrophoresis. After real-time PCR reaction, amplified gene products undergo electrophoretic separation and the level of expression of the target gene is determined by measuring the intensity of the gel bands corresponding to the target gene amplicon normalized to a housekeeping, internal control gene. Semi-Quantitative Reverse Transcriptase Polymerase Chain Reaction PCR-SSP A modified polymerase chain reaction (PCR) technique in which primer pair(s) are used to select a highly specific nucleotide sequence of interest, which will be the only sequence amplified. Allele Specific Primer Polymerase Chain Reaction SBT A method that uses PCR amplification of specific nucleotides to produce templates and primers that are used to provide the entirety of the nucleotide sequence of a specific DNA strand, allowing for reliable and thorough genotyping of the allele in question. Sequence-based Typing PCR-SSOP A modified polymerase chain reaction (PCR) technique that uses distinct probes, specifically synthesized according to the polymorphic region of the gene of interest, to detect nucleotide differences during genotype testing. Sequence-specific Oligonucleotide Probe Polymerase Chain Reaction A process to identify and determine the primary structure of, and the order of constituents in a biopolymer. Used when a more specific sequencing methodology is not specified. Biopolymer Sequencing Complement-Dependent Bactericidal Assay SBA Assay Serum Bactericidal Antibody Assay An assay to evaluate the bactericidal activity of antibodies present in serum by measuring the ability of complement and antibodies to lyse bacteria. This is performed by incubating a defined concentration of bacteria with various dilutions of serum and complement, followed by quantifying the percent bacterial survival relative to serum-negative controls. The assay assesses the functional capacity of antibodies to mediate bacterial killing through complement activation. Serum Bactericidal Assay Secondary Electrospray Ionization High-resolution Mass Spectrometry A method in which a nano-electrospray produces charging agents that collide with analyte molecules in gas-phase, creating an ionized vapor that is then analyzed via high resolution mass spectrometry. Secondary Electrospray Ionization High-resolution Mass Spectrometry A method of screening for sickle cell disease or trait in which sodium dithionite or a similar chemical is used to lyse red blood cells in a blood sample. This allows any hemoglobin S, which does not dissolve easily in plasma, to form crystals that visibly cloud the plasma. Sickle Cell Solubility Test A type of solid-phase multiplex assay that uses microbeads coated with a recombinant or purified antigen that will identify a single antibody. Single Antigen Bead-based Multiplex Assay SiMoA Single Molecule Array Immunoassay A type of enzyme-linked immunoassay in which single molecules can be detected through the use of femtomolar-sized reaction chambers and an excess of fluorescently labeled antibody-bound beads. Single-Molecule Array SNuPE An assay technique where a primer is hybridized adjacent to the interrogated variant site and is extended by deoxyribonucleic acid (DNA) polymerase to incorporate a complementary base that can be labeled for detection. Single-Nucleotide Primer Extension Single-Slice Spiral Computed Tomography A type of spiral computed tomography that employs only one detector and produces one image (slice). (NCI) Single-slice Spiral Computed Tomography PCR-SSCP A modified polymerase chain reaction (PCR) technique followed by electrophoresis such that DNA molecular weights and three-dimensional structures are used to identify mutations. Single-strand Conformation Polymerase Chain Reaction Silver-Enhanced in Situ Hybridization A type of in situ hybridization that uses a hybridization probe linked to an enzyme that elicits neutralization and deposition of silver onto the probe target site. Silver-Enhanced in Situ Hybridization Gel permeation or sieve chromatography that is performed on porous gels that separate solutes on the basis of size. Gel Filtration Chromatography Slit Lamp Biomicrography A method of capturing images using a horizontally mounted microscope with an attached slit lamp. Slit Lamp Photography Slit Lamp Biomicroscopy Slit Lamp Examination A method for examining the anterior segment of the eye using a slit lamp. Slit-lamp Examination A diagrammatic method to test visual acuity that uses the Sloan optotypes and a 1.25% contrast level. Sloan Letter Eye Chart 1.25 Percent A diagrammatic method to test visual acuity that uses the Sloan optotypes and a 100% contrast level. Sloan Letter Eye Chart 100 Percent A diagrammatic method to test visual acuity that uses the Sloan optotypes and a 2.5% contrast level. Sloan Letter Eye Chart 2.5 Percent The action of spreading a thin layer of material across a surface. Smear A technique to assess puffing behavior in smokers, using a smoking topography (ST) device. Smoking Topography Research A diagrammatic method to test visual acuity, which uses a chart containing 11 lines of Sloan optotypes in varying sizes with the largest located at the top of the chart and decreasing in size toward the bottom of the chart. Snellen Eye Chart Genotype Chip Single Nucleotide Polymorphism Array SNP Genotyping SNP Probe A genomic microarray-based method able to detect single nucleotide polymorphisms. Single Nucleotide Polymorphism Array Cyanide-Free SLS Method SLS Hemoglobin Detection Method A hemoglobin estimation technique that utilizes sodium lauryl sulphate, a surfactant that lyses erythrocytes. The released hemoglobin converts to methemoglobin and forms a sodium lauryl sulphate-methemoglobin complex with a characteristic light absorbance spectrum, which is detected by photometry. Sodium Lauryl Sulphate Method A type of tomography in which gamma photon-emitting radionuclides are administered to the patient and then detected by one or more gamma cameras rotated around the patient. From the series of two-dimensional images produced, a three-dimensional image can be created by computer reconstruction. Single Photon Emission Computed Tomography A dual-modality imaging technique that merges data from single-photon emission computed tomography (SPECT) and computed tomography (CT) to provide structural and functional information. Single Photon Tomography and Computed Tomography Scan SD-OCT A type of optical coherence tomography that acquires all information in a single axial scan through the tissue simultaneously by evaluating the frequency spectrum of the interference between the reflected light and a stationary reference mirror. (AAO EyeWiki) Spectral Domain-Optical Coherence Tomography A technique used to calculate the transmittance of light through a material. Spectrophotometry A noninvasive photographic technique used to visualize and examine the corneal endothelium, in which a source of light is projected onto the cornea and the subsequent image reflected from the optical interface between the corneal endothelium and the aqueous humor is captured. Specular Microscopy A type of spiral CT scan in which the images are not enhanced by the addition of contrast agents into the body. Spiral CT Scan Without Contrast Spiral Computed Tomography A method of examining body organs by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis. Spiral CT A method used to measure the breathing capacity of the lung by means of a spirometer. Spirometry An eye examination technique that utilizes test objects with gradually increasing luminance that are positioned at fixed locations across the visual field to determine the threshold of visibility. Static Perimetry An echocardiographic technique in which an image of the heart is produced by ultrasonography under conditions (e.g., exercise, pharmacologic agents or pacing) intended to elicit signs and symptoms of myocardial ischemia. Stress Echocardiography Test A quantum optical-electrical phenomena consisting of an alteration in light reflectance as a result of binding of molecules to a surface from which total internal reflection is occurring. Surface Plasmon Resonance Susceptibility Weighted Imaging SWI SWI MRI SWI-Phase An MRI-based imaging technique that uses phase differences between tissues, due to differences in magnetic susceptibilities, to produce an enhanced contrast magnitude image. Susceptibility Weighted Imaging Sweep VEP A technique that measures an evoked potential caused by a visual stimulus and recorded by an electroencephalogram, and which is used for those individuals who are unable to provide a verbal response to questions, including infants, toddlers, and other non-verbal individuals. Sweep Visual Evoked Potential Single Energy X-Ray Absorptiometry A technique for measuring anatomical densities in which a single X-ray beam, whose low and high energy is separated, is aimed at the anatomical location of interest and x-ray absorption is assessed. Single Energy X-Ray Absorptiometry A DNA sequencing technique in which selected regions of an individual's genome are sequenced. Targeted Genome Sequencing Targeted RNA-Seq An RNA sequencing technique in which selected RNA transcripts of an individual's genome are sequenced. Targeted Transcriptome Sequencing Task fMRI A type of functional magnetic resonance imaging that images dynamic changes in brain tissue while the subject performs a task or experiences a sensory stimulus designed to target specific cognitive processes. Task Functional Magnetic Resonance Imaging A diagrammatic method to test visual acuity that uses a set of cards with parallel lines, used for those individuals who are unable to provide a verbal response to questions, including infants, toddlers, and other non verbal individuals. Teller Acuity Cards A modification of the Ivy method for assessing bleeding time in which the individual wears a blood pressure cuff inflated to 40mmHg, a controlled incision is made using an automatic blade on the volar surface of the arm (thus standardizing the incision size), and blood is drawn off of the incision site with blotting paper every 30 seconds until bleeding stops. Template Incision Method A piece of chemically treated medium designed to react in the presence of specific amounts of a trigger substance. Test Strip Device TIMS A mass spectrometry method in which chemically purified samples are heated to create positively ionized atoms that are then accelerated by an electric field and mass separated by an electromagnet. Thermal Ionization Mass Spectrometry A blood smear technique used to make a thick blood smear on a microscope slide which is generally used to look for blood parasites such as those causing malaria. Thick Smear Technique A blood smear technique used to make a thin blood smear on a microscope slide which is generally used to look for blood parasites such as those causing malaria. Thin Smear Technique A method of testing the efficiency of blood coagulation in which the amplitude of movement of a pin suspended in the center of an oscillating blood sample, or the vertical movement of the meniscus of a vibrating blood sample, is measured over time and analyzed to assess the dynamics and physical properties of blood clot formation in a low shear environment, using an electromagnetic detection system. Thromboelastography A group of methods in which an analyte amount is determined based on its stoichiometric reaction with a reagent of established concentration that is introduced to a sample gradually until the analyte is consumed. (ScienceDirect) Titrimetry A microscopy staining method that utilizes toluidine blue, a solution composed of tolonium chloride, to determine the presence of mast cells, lignin, proteoglycans and glycosaminoglycans. Toluidine Blue Staining Method A method in which pressure is applied to the surface of the cornea in order to flatten a prespecified area of the membrane. Tonometry TBI Whole Body Irradiation A procedure involving irradiation of the whole body. Total-Body Irradiation A diagnostic radiologic test that involves the examination of the entire body in a single procedure. Total Body Radiography Hess Rumpel-Leede A method of assessing capillary fragility that is used in the diagnosis of hemorrhagic fevers. After taking a blood pressure measurement, the cuff is inflated to a point midway between the assessed systolic and diastolic pressures and maintained for five minutes; the cuff is then released and, after two minutes, the number of petechiae below the antecubital fossa are counted. Tourniquet Test TNA An in vitro assay to measure antibody in a biological specimen capable of protecting cells against the effect of a specific toxin. Toxin Neutralization Assay An ultrasound imaging technique in which the ultrasound probe is pressed against the skin of the abdomen in order to create an image of the abdominal organs. Transabdominal Ultrasound A technique used to selectively replicate nucleic acid sequences from RNA templates using reverse transcriptase and RNA polymerase. Transcription-mediated Amplification TEE A cardiac ultrasound performed by passing a specialized probe containing a transducer into the patient's esophagus. Transesophageal Echocardiography Test An electron microscopy imaging technique that is utilized to examine structural components of a sample by passing electrons through the specimen. Transmission Electron Microscopy TTE A non-invasive cardiac ultrasound performed by placing the transducer on the chest. Transthoracic Echocardiography Test A technique in which sound waves are sent out by an ultrasound probe that has been inserted in the vagina and a computer uses the ultrasound echoes to create an image of the female reproductive organs. Transvaginal Ultrasound A microscopy staining method that utilizes two or more colored, acidic dyes of contrasting colors. Masson trichrome is a mixture of three dyes including aniline blue, Beibrich scarlet and Weigert's iron hematoxylin. Other related, modified trichrome staining methods include Lillie's trichrome, Gomori's trichrome and Mallory's trichrome. Trichrome Staining Method A type of magnetic resonance imaging (MRI) in which images are taken during three distinct timing points (phases) following the injection of contrast material: arterial, venous, and delayed. Triple Phase MRI Triple-Phase Spiral Computed Tomography A type of computed tomography (CT) in which images are taken during three distinct timing points (phases) following the injection of contrast material: arterial, venous, and delayed. Triple-Phase Spiral CT A microscopy staining method that utilizes trypan blue, an acid azo dye that can traverse the cell membrane of dead cells and is used to differentiate between living and dead cells. (NCI) Trypan Blue Staining Method A method to quantify the opaqueness of a liquid using a turbidimeter, by measuring the decrease in light intensity due to the scattering effect of suspended particles in the liquid sample. Turbidimetry Dual-channel Microarray Two-channel Expression Array Two-channel Microarray Two-color Microarray-based Gene Expression A genomic microarray-based method using cDNA from two samples, labeled with two separate fluorophores/dyes at different emission wavelengths, and hybridized to a single microarray. The relative fluorescence intensity of each dye is being measured. Two Color Microarray A technique that measures energy transmission through the middle ear using a tympanometer. Tympanometry Assessment An analytical technique where ultra-high performance liquid chromatography is coupled to accelerated mass spectrometry in order to separate, identify, and quantify substances in a sample. Ultra High Performance Liquid Chromatography/Accelerator Mass Spectrometry An analytical technique where ultra-high performance liquid chromatography is coupled to tandem mass spectrometry in order to separate, identify, and quantify substances in a sample. Ultra High-performance Liquid Chromatography/Tandem Mass Spectrometry A noninvasive technique that is used to measure organ or tissue stiffness. An ultrasound wave is passed into the organ or tissue from a small transducer on the end of an ultrasound probe which measures the velocity of the shear wave (in meters per second) as this wave passes through the organ or tissue. The shear wave velocity can then be converted into organ or tissue stiffness. This technique may be used as an alternative to organ or tissue biopsy. Ultrasonographic Elastography A technique in which high-frequency sound waves are bounced off internal organs and the echo pattern is converted into a 2 dimensional picture of the structures beneath the transducer. Ultrasound Imaging A microscopy staining method that utilizes uranyl acetate, a water insoluble yellow crystalline solid, which is used as a negative stain in electron microscopy. Uranyl Acetate Staining Method A chemical titration method described by van de Kamer, et al. in 1949 in which fecal fat is quantitatively measured by conversion of fecal lipids into fatty acids through saponification with ethanolic potassium hydroxide, release of the free fatty acids by the addition of hydrochloric acid and extraction into ether, and titration of the fatty acids against sodium hydroxide. (NCI) Van de Kamer Titration Method VQ SCAN A nuclear imaging test that uses radiopharmaceuticals to produce an image of the blood flow to the lungs. Ventilation Perfusion Scanning An assay that is used to determine viral quantity by infecting monolayers of host cells with serially diluted virus, covering the monolayers with an immobilizing overlay after a period of incubation to restrict the spread of the virus to neighboring cells, and counting the resulting visible plaques of infected cells. Virus Plaque Assay VAS A psychometric response scale to assess subjective characteristics or symptoms, which relies upon a continuum of possible result values in between two fixed end-points. Visual Analog Scale Inspection Manual Visual Inspection Human evaluation of an attribute of a subject or material using visual discernment. Visual Inspection Conditioned Visual Reinforcement Audiometry VRA A type of conditioned audiometry to detect sound, where a delayed visual presentation is used to support a child's reflexive orientation response to a audio signal from a single source. Visual Reinforcement Audiometry VCS Method A type of blood cell analysis that uses impedance, conductivity, and laser scatter to measure cell volume, cell size, chemical composition, nuclear volume, cellular granularity, nuclear structure, and cell surface characteristics. Volume Conductivity Scatter Method A method for estimating body surface area of second and third degree burns, based on assigned percentages for different regions of the body. Wallace Rule of Nines A microscopy staining method that utilizes a modified trichrome stain to determine the presence of microspordial, sporulating species. The staining method utilizes chromotrope 2R, a red acidic dye, the counterstain fast green, and phosphotungstic acid. Weber Green Staining Method A technique that assesses auditory function and/or type of hearing loss, in which a vibrating tuning fork (typically at 256Hz or 512Hz) is placed on top of the head or over the upper lip and the subject reporting whether sound is heard equally in both ears or whether the sound is louder in one ear. Weber Test Method A method that measures the sedimentation rate of an entity in an aqueous solution using a Westergren tube. Westergren Tube Method A method for the detection or identification of proteins or peptides that have been separated by gel electrophoresis and transferred onto nitrocellulose or other type of paper or nylon membrane. The proteins are then detected by reaction with enzymatically labeled or radiolabeled antibody probes. Western Blotting WES A DNA sequencing technique in which all of the exons of an individual's genome are sequenced. Whole Exome Sequencing WGS A DNA sequencing technique in which the entirety of the individual's genome is sequenced. Whole Genome Sequencing RNA-Seq Whole Transcriptome Shotgun Sequencing WTSS An RNA sequencing technique in which all of the RNA transcripts of an individual's genome are sequenced. Whole Transcriptome Sequencing A microscopy staining method that utilizes the Romanowsky stains, eosin and methylene blue, solubilized in methanol. In this staining protocol, methanol is also utilized as a fixative agent prior to staining. Wright Staining Method A microscopy staining method that is a combination of the Wright and Giemsa staining protocols and utilizes the Romanowsky stains, which are mixtures of eosin and thiazine dyes such as methylene blue. It produces darker blue and magenta shades than the giemsa stain alone, which may provide better contrast in microscopy. Wright-Giemsa Staining Method A spectrometric method that determines the type and concentration of elements or chemicals in a sample, based upon the principle that each element emits fluorescent light of a particular wavelength when exposed to an X-ray. X-Ray Fluorescence Spectrometry A type of X-ray in which the images are not enhanced by the addition of contrast agents into the body. X-Ray Without Contrast Static X-Ray A radiographic procedure using the emission of x-rays, a type of penetrating energy wave. X-Ray Imaging A microscopy acid fast staining method that utilizes Ziehl-Neelsen carbol fuchsin, acid alcohol and methylene blue, to determine the presence of acid fast microorganisms. This acid fast staining technique requires heating during the primary staining step involving the carbol fuchsin. Ziehl Neelsen Acid Fast Staining Method METHOD Method CDISC SDTM Method Terminology Michigan Neuropathy Screening Instrument test code. MNSI1-Are Your Legs and/or Feet Numb Michigan Neuropathy Screening Instrument - History: Are your legs and/or feet numb? MNSI - Legs and/or Feet Numb MNSI1-Ever Have Burning Pain Legs/Feet Michigan Neuropathy Screening Instrument - History: Do you ever have any burning pain in your legs and/or feet? MNSI - Burning Pain Legs/Feet MNSI1-Are Feet Too Sensitive to Touch Michigan Neuropathy Screening Instrument - History: Are your feet too sensitive to touch? MNSI - Feet Too Sensitive to Touch MNSI1-Get Muscle Cramps Legs/Feet Michigan Neuropathy Screening Instrument - History: Do you get muscle cramps in your legs and/or feet? MNSI - Muscle Cramps Legs/Feet MNSI1-Ever Prickling Feelings Legs/Feet Michigan Neuropathy Screening Instrument - History: Do you ever have any prickling feelings in your legs or feet? MNSI - Prickling Feelings Legs/Feet MNSI1-Hurt When Bed Covers Touch Skin Michigan Neuropathy Screening Instrument - History: Does it hurt when the bed covers touch your skin? MNSI - Hurt When Bed Covers Touch Skin MNSI1-Able to Tell Hot from Cold Water Michigan Neuropathy Screening Instrument - History: When you get into the tub or shower, are you able to tell the hot water from the cold water? MNSI - Able to Tell Hot from Cold Water MNSI1-Ever Had Open Sore on Foot Michigan Neuropathy Screening Instrument - History: Have you ever had an open sore on your foot? MNSI - Open Sore on Foot MNSI1-Doctor Says Diabetic Neuropathy Michigan Neuropathy Screening Instrument - History: Has your doctor ever told you that you have diabetic neuropathy? MNSI - Doctor Says Diabetic Neuropathy MNSI1-Feel Weak All Over Most Times Michigan Neuropathy Screening Instrument - History: Do you feel weak all over most of the time? MNSI - Feel Weak All Over Most Times MNSI1-Symptoms Worse at Night Michigan Neuropathy Screening Instrument - History: Are your symptoms worse at night? MNSI - Symptoms Worse at Night MNSI1-Legs Hurt When Walking Michigan Neuropathy Screening Instrument - History: Do your legs hurt when you walk? MNSI - Legs Hurt When Walking MNSI1-Able to Sense Feet When Walking Michigan Neuropathy Screening Instrument - History: Are you able to sense your feet when you walk? MNSI - Able to Sense Feet When Walking MNSI1-Skin So Dry That Feet Crack Open Michigan Neuropathy Screening Instrument - History: Is the skin on your feet so dry that it cracks open? MNSI - Skin So Dry That Feet Crack Open MNSI1-Ever Had Amputation Michigan Neuropathy Screening Instrument - History: Have you ever had an amputation? MNSI - Ever Had Amputation MNSI1-Total Michigan Neuropathy Screening Instrument - History: Total. MNSI - History Total MNSI1-Right Foot Appears Normal Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of right foot - normal. MNSI - Right Foot Appears Normal MNSI1-Right Foot Deformities Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of right foot - deformities. MNSI - Right Foot Deformities MNSI1-Right Foot Dry Skin, Callus Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of right foot - dry skin, callus. MNSI - Right Foot Dry Skin, Callus MNSI1-Right Foot Infection Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of right foot - infection. MNSI - Right Foot Infection MNSI1-Right Foot Fissure Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of right foot - fissure. MNSI - Right Foot Fissure MNSI1-Right Foot Other Abnormal Specify Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of right foot - other, specify. MNSI - Right Foot Other Abnormal Specify MNSI1-Left Foot Appears Normal Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of left foot - normal. MNSI - Left Foot Appears Normal MNSI1-Left Foot Deformities Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of left foot - deformities. MNSI - Left Foot Deformities MNSI1-Left Foot Dry Skin, Callus Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of left foot - dry skin, callus. MNSI - Left Foot Dry Skin, Callus MNSI1-Left Foot Infection Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of left foot - infection. MNSI - Left Foot Infection MNSI1-Left Foot Fissure Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of left foot - fissure. MNSI - Left Foot Fissure MNSI1-Left Foot Other Abnormal Specify Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of left foot - other, specify. MNSI - Left Foot Other Abnormal Specify MNSI1-Right Foot Ulceration Michigan Neuropathy Screening Instrument - Physical Assessment: Right foot - ulceration. MNSI - Right Foot Ulceration MNSI1-Left Foot Ulceration Michigan Neuropathy Screening Instrument - Physical Assessment: Left foot - ulceration. MNSI - Left Foot Ulceration MNSI1-Right Ankle Reflexes Michigan Neuropathy Screening Instrument - Physical Assessment: Right ankle reflexes. MNSI - Right Ankle Reflexes MNSI1-Left Ankle Reflexes Michigan Neuropathy Screening Instrument - Physical Assessment: Left ankle reflexes. MNSI - Left Ankle Reflexes MNSI1-Right Foot Vibration Great Toe Michigan Neuropathy Screening Instrument - Physical Assessment: Right foot - vibration perception at great toe. MNSI - Right Foot Vibration Great Toe MNSI1-Left Foot Vibration Great Toe Michigan Neuropathy Screening Instrument - Physical Assessment: Left foot - vibration perception at great toe. MNSI - Left Foot Vibration Great Toe MNSI1-Right Foot Monofilament Michigan Neuropathy Screening Instrument - Physical Assessment: Right foot - monofilament. MNSI - Right Foot Monofilament MNSI1-Left Foot Monofilament Michigan Neuropathy Screening Instrument - Physical Assessment: Left foot - monofilament. MNSI - Left Foot Monofilament MNSI1-Total Score Michigan Neuropathy Screening Instrument - Physical Assessment: Total Score. MNSI - Physical Assessment Total Score MNSI1TC Michigan Neuropathy Screening Instrument Questionnaire Test Code CDISC Questionnaire MNSI Test Code Terminology Michigan Neuropathy Screening Instrument test name. MNSI1-Able to Sense Feet When Walking Michigan Neuropathy Screening Instrument - History: Are you able to sense your feet when you walk? MNSI - Able to Sense Feet When Walking MNSI1-Able to Tell Hot from Cold Water Michigan Neuropathy Screening Instrument - History: When you get into the tub or shower, are you able to tell the hot water from the cold water? MNSI - Able to Tell Hot from Cold Water MNSI1-Are Feet Too Sensitive to Touch Michigan Neuropathy Screening Instrument - History: Are your feet too sensitive to touch? MNSI - Feet Too Sensitive to Touch MNSI1-Are Your Legs and/or Feet Numb Michigan Neuropathy Screening Instrument - History: Are your legs and/or feet numb? MNSI - Legs and/or Feet Numb MNSI1-Doctor Says Diabetic Neuropathy Michigan Neuropathy Screening Instrument - History: Has your doctor ever told you that you have diabetic neuropathy? MNSI - Doctor Says Diabetic Neuropathy MNSI1-Ever Had Amputation Michigan Neuropathy Screening Instrument - History: Have you ever had an amputation? MNSI - Ever Had Amputation MNSI1-Ever Had Open Sore on Foot Michigan Neuropathy Screening Instrument - History: Have you ever had an open sore on your foot? MNSI - Open Sore on Foot MNSI1-Ever Have Burning Pain Legs/Feet Michigan Neuropathy Screening Instrument - History: Do you ever have any burning pain in your legs and/or feet? MNSI - Burning Pain Legs/Feet MNSI1-Ever Prickling Feelings Legs/Feet Michigan Neuropathy Screening Instrument - History: Do you ever have any prickling feelings in your legs or feet? MNSI - Prickling Feelings Legs/Feet MNSI1-Feel Weak All Over Most Times Michigan Neuropathy Screening Instrument - History: Do you feel weak all over most of the time? MNSI - Feel Weak All Over Most Times MNSI1-Get Muscle Cramps Legs/Feet Michigan Neuropathy Screening Instrument - History: Do you get muscle cramps in your legs and/or feet? MNSI - Muscle Cramps Legs/Feet MNSI1-Hurt When Bed Covers Touch Skin Michigan Neuropathy Screening Instrument - History: Does it hurt when the bed covers touch your skin? MNSI - Hurt When Bed Covers Touch Skin MNSI1-Left Ankle Reflexes Michigan Neuropathy Screening Instrument - Physical Assessment: Left ankle reflexes. MNSI - Left Ankle Reflexes MNSI1-Left Foot Appears Normal Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of left foot - normal. MNSI - Left Foot Appears Normal MNSI1-Left Foot Deformities Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of left foot - deformities. MNSI - Left Foot Deformities MNSI1-Left Foot Dry Skin, Callus Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of left foot - dry skin, callus. MNSI - Left Foot Dry Skin, Callus MNSI1-Left Foot Fissure Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of left foot - fissure. MNSI - Left Foot Fissure MNSI1-Left Foot Infection Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of left foot - infection. MNSI - Left Foot Infection MNSI1-Left Foot Monofilament Michigan Neuropathy Screening Instrument - Physical Assessment: Left foot - monofilament. MNSI - Left Foot Monofilament MNSI1-Left Foot Other Abnormal Specify Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of left foot - other, specify. MNSI - Left Foot Other Abnormal Specify MNSI1-Left Foot Ulceration Michigan Neuropathy Screening Instrument - Physical Assessment: Left foot - ulceration. MNSI - Left Foot Ulceration MNSI1-Left Foot Vibration Great Toe Michigan Neuropathy Screening Instrument - Physical Assessment: Left foot - vibration perception at great toe. MNSI - Left Foot Vibration Great Toe MNSI1-Legs Hurt When Walking Michigan Neuropathy Screening Instrument - History: Do your legs hurt when you walk? MNSI - Legs Hurt When Walking MNSI1-Right Ankle Reflexes Michigan Neuropathy Screening Instrument - Physical Assessment: Right ankle reflexes. MNSI - Right Ankle Reflexes MNSI1-Right Foot Appears Normal Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of right foot - normal. MNSI - Right Foot Appears Normal MNSI1-Right Foot Deformities Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of right foot - deformities. MNSI - Right Foot Deformities MNSI1-Right Foot Dry Skin, Callus Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of right foot - dry skin, callus. MNSI - Right Foot Dry Skin, Callus MNSI1-Right Foot Fissure Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of right foot - fissure. MNSI - Right Foot Fissure MNSI1-Right Foot Infection Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of right foot - infection. MNSI - Right Foot Infection MNSI1-Right Foot Monofilament Michigan Neuropathy Screening Instrument - Physical Assessment: Right foot - monofilament. MNSI - Right Foot Monofilament MNSI1-Right Foot Other Abnormal Specify Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of right foot - other, specify. MNSI - Right Foot Other Abnormal Specify MNSI1-Right Foot Ulceration Michigan Neuropathy Screening Instrument - Physical Assessment: Right foot - ulceration. MNSI - Right Foot Ulceration MNSI1-Right Foot Vibration Great Toe Michigan Neuropathy Screening Instrument - Physical Assessment: Right foot - vibration perception at great toe. MNSI - Right Foot Vibration Great Toe MNSI1-Skin So Dry That Feet Crack Open Michigan Neuropathy Screening Instrument - History: Is the skin on your feet so dry that it cracks open? MNSI - Skin So Dry That Feet Crack Open MNSI1-Symptoms Worse at Night Michigan Neuropathy Screening Instrument - History: Are your symptoms worse at night? MNSI - Symptoms Worse at Night MNSI1-Total Score Michigan Neuropathy Screening Instrument - Physical Assessment: Total Score. MNSI - Physical Assessment Total Score MNSI1-Total Michigan Neuropathy Screening Instrument - History: Total. MNSI - History Total MNSI1TN Michigan Neuropathy Screening Instrument Questionnaire Test Name CDISC Questionnaire MNSI Test Name Terminology Terminology relevant to the degree of certainty of the correctness of a microbial identification test result. Supplying or being a final or conclusive settlement or result. Definitive Supplying or being a probable or reasonable settlement or result. Presumptive MCIDCERT Microbial Identification Certainty CDISC SDTM Microbial Identification Certainty Terminology Terminology relevant to the additional descriptions of the test being performed to produce the microbiology finding. A measurement of the total cells of a pre-specified type in a specimen. Specified Cell Count Test A measurement of the total number of microbial colonies of a pre-specified microorganism in a specimen. Specified Colony Count Test The determination of presence or absence of an entity in a specimen. Biological Detection Test The further determination and/or classification of the identity of a pre-specified entity or group of entities in a specimen. In the context of microbiology, this is likely the identification of (but is not limited to) genus, species, strains, variants, serotypes, serogroups, genotypes, etc., of a known microorganism(s). Biologic Entity Classification Interpretation An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. Interpretation Cp Number Crossing point Number Ct Ct Number Cycle Threshold Cycle Threshold # Cycle Threshold Number Elbow Value Take-off Point Number Threshold Cycle Threshold Cycle Number TOP Number The cycle number where the fluorescence of the target is detected above the background signal or a pre-set threshold. This value may be used for the computation of the concentration of a target in a polymerase chain reaction (PCR). Threshold Cycle The determination of the quantity of a pre-specified analyte in a specimen. Quantitation A measurement of the total number of viral particles of a pre-specified virus in a specimen. Specified Viral Load Test MBFTSDTL Microbiology Findings Test Details CDISC SDTM Microbiology Findings Test Details Terminology Terminology relevant to the test codes that define microorganism responses to antimicrobial agents. Diameter of the Kill Zone Diameter of the Zone of Inhibition A measurement of the diameter of the circular region of bacteria growth inhibition that surrounds an antibiotic source on the surface of a cultured plate. Antibiotic Susceptibility Zone Diameter Flagged Mutations Present Indicator An indication as to whether the pre-specified mutations of interest are present in the subject. Flagged Mutations Present Indicator Inhibitory Concentration Net Assessment An indication of reduced or increased susceptibility of a microbial organism, or activity of a biological/biochemical reaction in response to the inhibitory concentration (IC50 and/or IC95) of a specific drug. Inhibitory Concentration Net Assessment Measurement Microbial EC50 Fold Change from Baseline A fold change based on the concentration of a specific drug expected to produce 50 percent inhibition of population growth or replication of a microbial organism. (NCI) Microbial EC50 Fold Change from Baseline Microbial EC50 Fold Change from Ref Microbial EC50 Fold Change from Reference A fold change based on the concentration of a specific drug expected to produce 50 percent inhibition of the population growth or replication of a microbial organism. It is a ratio calculated by the EC50 Subject Result divided by the EC50 Reference Control Result. (NCI) Microbial EC50 Fold Change from Reference Microbial EC50 Reference Control Result A reference control sample response based on the concentration of a specific drug expected to produce 50 percent inhibition of the population growth or replication of a microbial organism. (NCI) Microbial EC50 Reference Control Result Microbial EC50 Subject Result A measurement of titer of a microbial organism that has been exposed to the concentration of a specific drug expected to produce 50 percent inhibition of the population growth or replication of a microbial organism. (NCI) Microbial EC50 Subject Result Minimum Inhibitory Concentration A measurement that specifies the minimum concentration of the agent at which organism growth was inhibited. Minimum Inhibitory Concentration Test Microbial IC50 Fold Change from Baseline A fold change based on the concentration of a specific drug expected to produce 50 percent inhibition on the enzymatic activity of a microbial organism. It is a ratio calculated by the current IC50 Subject Result divided by the IC50 Subject Result from the baseline visit. Microbial IC50 Fold Change from Baseline Microbial IC50 Fold Change from Ref Microbial IC50 Fold Change from Reference A fold change based on the concentration of a specific drug expected to produce 50 percent inhibition on the enzymatic activity of a microbial organism. It is a ratio calculated by the IC50 Subject Result divided by the IC50 Reference Control Result. Microbial IC50 Fold Change from Reference Microbial IC50 Reference Control Result A reference control sample response based on the concentration of a specific drug expected to produce 50 percent inhibition on the enzymatic activity of a microbial organism. Microbial IC50 Reference Control Result Microbial IC50 Subject Result A measurement of biological/biochemical reaction of a microbial organism that has been exposed to the concentration of a specific drug expected to produce 50 percent inhibition on the enzymatic activity of a microbial organism. Microbial IC50 Subject Result IC95 Fold Change from Baseline Microbial IC95 Fold Change from Baseline A fold change based on the concentration of a specific drug expected to produce 95 percent inhibition on the enzymatic activity of a microbial organism. It is a ratio calculated by the current IC95 Subject Result divided by the IC95 Subject Result from the baseline visit. Microbial IC95 Fold Change from Baseline IC95 Fold Change from Reference Microbial IC95 Fold Change from Ref A fold change based on the concentration of a specific drug expected to produce 95 percent inhibition on the enzymatic activity of a microbial organism. It is a ratio calculated by the IC95 Subject Result divided by the IC95 Reference Control Result. Microbial IC95 Fold Change from Ref IC95 Reference Control Result Microbial IC95 Reference Control Result A reference control sample response based on the concentration of a specific drug expected to produce 95 percent inhibition on the enzymatic activity of a microbial organism. Microbial IC95 Reference Control Result IC95 Subject Result Microbial IC95 Subject Result A measurement of biological/biochemical reaction of a microbial organism that has been exposed to the concentration of a specific drug expected to produce 95 percent inhibition on the enzymatic activity of a microbial organism. Microbial IC95 Subject Result Microbial Susceptibility A phenotypic or genotypic assessment of the response of the microbial organism to an antimicrobial agent. Microbial Susceptibility Test Susceptibility Score Mutations Indicator An indication as to whether one or more scored mutations of interest that may confer susceptibility in the microorganism is present. Susceptibility Score Mutations Indicator MSTESTCD Microbiology Susceptibility Test Code CDISC SDTM Microbiology Susceptibility Test Code Terminology Terminology relevant to the test names that define microorganism responses to antimicrobial agents. Diameter of the Kill Zone Diameter of the Zone of Inhibition A measurement of the diameter of the circular region of bacteria growth inhibition that surrounds an antibiotic source on the surface of a cultured plate. Antibiotic Susceptibility Zone Diameter Flagged Mutations Present Indicator An indication as to whether the pre-specified mutations of interest are present in the subject. Flagged Mutations Present Indicator Inhibitory Concentration Net Assessment An indication of reduced or increased susceptibility of a microbial organism, or activity of a biological/biochemical reaction in response to the inhibitory concentration (IC50 and/or IC95) of a specific drug. Inhibitory Concentration Net Assessment Measurement Microbial EC50 Fold Change from Baseline A fold change based on the concentration of a specific drug expected to produce 50 percent inhibition of population growth or replication of a microbial organism. (NCI) Microbial EC50 Fold Change from Baseline Microbial EC50 Fold Change from Ref Microbial EC50 Fold Change from Reference A fold change based on the concentration of a specific drug expected to produce 50 percent inhibition of the population growth or replication of a microbial organism. It is a ratio calculated by the EC50 Subject Result divided by the EC50 Reference Control Result. (NCI) Microbial EC50 Fold Change from Reference Microbial EC50 Reference Control Result A reference control sample response based on the concentration of a specific drug expected to produce 50 percent inhibition of the population growth or replication of a microbial organism. (NCI) Microbial EC50 Reference Control Result Microbial EC50 Subject Result A measurement of titer of a microbial organism that has been exposed to the concentration of a specific drug expected to produce 50 percent inhibition of the population growth or replication of a microbial organism. (NCI) Microbial EC50 Subject Result Microbial IC50 Fold Change from Baseline A fold change based on the concentration of a specific drug expected to produce 50 percent inhibition on the enzymatic activity of a microbial organism. It is a ratio calculated by the current IC50 Subject Result divided by the IC50 Subject Result from the baseline visit. Microbial IC50 Fold Change from Baseline Microbial IC50 Fold Change from Ref Microbial IC50 Fold Change from Reference A fold change based on the concentration of a specific drug expected to produce 50 percent inhibition on the enzymatic activity of a microbial organism. It is a ratio calculated by the IC50 Subject Result divided by the IC50 Reference Control Result. Microbial IC50 Fold Change from Reference Microbial IC50 Reference Control Result A reference control sample response based on the concentration of a specific drug expected to produce 50 percent inhibition on the enzymatic activity of a microbial organism. Microbial IC50 Reference Control Result Microbial IC50 Subject Result A measurement of biological/biochemical reaction of a microbial organism that has been exposed to the concentration of a specific drug expected to produce 50 percent inhibition on the enzymatic activity of a microbial organism. Microbial IC50 Subject Result IC95 Fold Change from Baseline Microbial IC95 Fold Change from Baseline A fold change based on the concentration of a specific drug expected to produce 95 percent inhibition on the enzymatic activity of a microbial organism. It is a ratio calculated by the current IC95 Subject Result divided by the IC95 Subject Result from the baseline visit. Microbial IC95 Fold Change from Baseline IC95 Fold Change from Reference Microbial IC95 Fold Change from Ref A fold change based on the concentration of a specific drug expected to produce 95 percent inhibition on the enzymatic activity of a microbial organism. It is a ratio calculated by the IC95 Subject Result divided by the IC95 Reference Control Result. Microbial IC95 Fold Change from Ref IC95 Reference Control Result Microbial IC95 Reference Control Result A reference control sample response based on the concentration of a specific drug expected to produce 95 percent inhibition on the enzymatic activity of a microbial organism. Microbial IC95 Reference Control Result IC95 Subject Result Microbial IC95 Subject Result A measurement of biological/biochemical reaction of a microbial organism that has been exposed to the concentration of a specific drug expected to produce 95 percent inhibition on the enzymatic activity of a microbial organism. Microbial IC95 Subject Result Microbial Susceptibility A phenotypic or genotypic assessment of the response of the microbial organism to an antimicrobial agent. Microbial Susceptibility Test Minimum Inhibitory Concentration A measurement that specifies the minimum concentration of the agent at which organism growth was inhibited. Minimum Inhibitory Concentration Test Susceptibility Score Mutations Indicator An indication as to whether one or more scored mutations of interest that may confer susceptibility in the microorganism is present. Susceptibility Score Mutations Indicator MSTEST Microbiology Susceptibility Test Name CDISC SDTM Microbiology Susceptibility Test Name Terminology Terminology relevant to the standardized results, in character format, for microbiology susceptibility tests. Inconclusive Cannot distinguish between two or more possible values in the current context. (NCI) Indeterminate Intermediate The growth of microorganisms may be inhibited by antimicrobials that approach usually attainable blood and tissue concentrations. The response rates may be lower than for susceptible isolates. This category also includes a buffer zone, which should prevent small, uncontrolled, technical factors from causing major discrepancies in interpretations, especially for drugs with narrow pharmacotoxicity margins. Antimicrobial Intermediate Susceptibility Result Non Susceptible A category used for microorganisms that have only a susceptible interpretive category, but not an intermediate or resistant interpretive category (i.e., susceptible-only interpretive category). This category may be applied to new antimicrobial agents for which no resistant microorganisms have been encountered at the time the initial interpretive criteria are determined. Microorganisms that test with an MIC above or a zone measurement below the susceptible interpretive criteria are designated as nonsusceptible. A designation of nonsusceptible does not necessarily mean that a resistance mechanism(s) exists in the microorganism. Antimicrobial Nonsusceptibility Result NA Not Applicable Determination of a value is not relevant in the current context. (NCI) Not Applicable The growth of the microorganism is intermediate or resistant to an antimicrobial. This category is used when describing isolates that are above the susceptible interpretive category breakpoint as defined by a standards organization, and, when the "intermediate" breakpoint and the "resistant" breakpoint are defined but not applied; or when "intermediate" and "resistant" interpretive categories are merged/combined. Antimicrobial Not Susceptible Result Resistant The growth of microorganisms are not inhibited by the usually achievable concentrations of the antimicrobial agent with normal dosages, and/or microorganisms demonstrate MICs or zone diameters that fall in the range where specific microbial resistance mechanisms (e.g. Beta-lactamases) are likely, and clinical efficacy of the agent against the microorganism has not been reliably shown in treatment studies. Antimicrobial Resistance Result Susceptible The growth of microorganisms are inhibited by the usually achievable concentrations of antimicrobial agent when the recommended dosage is used for the site of infection. Antimicrobial Susceptibility Result Susceptible-Dose Dependent The growth of microorganisms may be inhibited when higher than normal dosages of an antimicrobial agent are used and maximal possible blood concentration of the antimicrobial agent is achieved. Antimicrobial Dose Dependent Susceptibility Result U UNK Unknown Not known, not observed, not recorded, or refused. (NCI) Unknown MSSTRESC Microbiology Susceptibility Test Standard Character Result CDISC SDTM Microbiology Susceptibility Test Standard Character Result Terminology Terminology relevant to the microbiology test codes of the CDISC Study Data Tabulation Model. Acinetobacter anitratus A measurement of Acinetobacter anitratus in a biological specimen. Acinetobacter anitratus Measurement Acinetobacter baumannii A measurement of Acinetobacter baumannii in a biological specimen. Acinetobacter baumannii Measurement A. calcoaceticus-baumannii Complex Acinetobacter calcoaceticus-baumannii Complex A measurement of the Acinetobacter calcoaceticus-baumannii complex in a biological specimen. Acinetobacter calcoaceticus/baumannii Complex Measurement A. calcoaceticus-baumannii Complex DNA Acinetobacter calcoaceticus-baumannii Complex DNA A measurement of Acinetobacter Calcoaceticus-Baumannii complex DNA in a biological specimen. Acinetobacter calcoaceticus/baumannii Complex DNA Measurement Acinetobacter A measurement of the organisms that are not assigned to the species level but are assigned to the Acinetobacter genus level in a biological specimen. Acinetobacter Measurement Achromobacter denitrificans A measurement of Achromobacter denitrificans in a biological specimen. Achromobacter denitrificans Measurement Adenovirus Antigen A measurement of the Adenovirus antigen in a biological specimen. Adenovirus Antigen Measurement Adenoviridae Adenovirus A measurement of the adenoviridae in a biological specimen. Adenoviridae Measurement Adenovirus DNA A measurement of the DNA from any member of the family Adenoviridae in a biological specimen. Adenovirus DNA Measurement Adenovirus Nucleic Acid A measurement of the nucleic acid from any member of the family Adenoviridae in a biological specimen. Adenovirus Nucleic Acid Measurement Aerobic Bacteria A measurement of the aerobic bacteria in a biological specimen. Aerobic Bacteria Measurement Aeromonas DNA A measurement of the DNA from any member of the genus Aeromonas in a biological specimen. Aeromonas DNA Measurement Aeromonas A measurement of the organisms that are not assigned to the species level but are assigned to the Aeromonas genus level in a biological specimen. Aeromonas Measurement Acid-Fast Bacilli A measurement of any rod-shaped bacteria that resist decolorizing by acid after accepting an aqueous stain solution, due to the mycolic acids in their cell walls. Acid-Fast Bacilli Measurement Aspergillus fumigatus A measurement of the Aspergillus fumigatus in a biological specimen. Aspergillus fumigatus Measurement Acinetobacter johnsonii A measurement of Acinetobacter johnsonii in a biological specimen. Acinetobacter johnsonii Measurement Acinetobacter lactucae A measurement of Acinetobacter lactucae in a biological specimen. Acinetobacter lactucae Measurement Acinetobacter lwoffii A measurement of the Acinetobacter lwoffii in a biological specimen. Acinetobacter Iwoffii Measurement Anaplasma DNA A measurement of the DNA from any member of the genus Anaplasma in a biological specimen. Anaplasma DNA Measurement Anaplasma A measurement of the organisms that are not assigned to the species level but are assigned to the Anaplasma genus level in a biological specimen. Anaplasma Measurement Anaerobic Bacteria A measurement of the anaerobic bacteria in a biological specimen. Anaerobic Bacteria Measurement Aspergillus niger A measurement of the Aspergillus niger in a biological specimen. Aspergillus niger Measurement Acinetobacter pittii A measurement of Acinetobacter pittii in a biological specimen. Acinetobacter pittii Measurement Aspergillus Antigen A measurement of the antigen from any member of the genus Aspergillus in a biological specimen. Aspergillus Antigen Measurement Aspergillus DNA A measurement of the DNA from any member of the genus Aspergillus in a biological specimen. Aspergillus DNA Measurement Aspergillus A measurement of the organisms that are not assigned to the species level but are assigned to the Aspergillus genus level in a biological specimen. Aspergillus Measurement Aerococcus urinae A measurement of Aerococcus urinae in a biological specimen. Aerococcus urinae Measurement Acinetobacter ursingii A measurement of Acinetobacter ursingii in a biological specimen. Acinetobacter ursingii Measurement Achromobacter xylosoxidans A measurement of the Achromobacter xylosoxidans in a biological specimen. Achromobacter xylosoxidans Measurement Human Parvovirus B19 A measurement of the Human Parvovirus B19 in a biological specimen. Human Parvovirus B19 Measurement Human Parvovirus B19 DNA A measurement of the Human Parvovirus B19 DNA in a biological specimen. Human Parvovirus B19 DNA Measurement Babesia DNA A measurement of the DNA from any member of the genus Babesia in a biological specimen. Babesia DNA Measurement Bacterial Beta-lactamase A measurement of the bacterial enzyme beta-lactamase in a biological specimen. Bacterial Beta-lactamase Measurement Bacilli/Leukocytes A relative measurement (ratio or percentage) of the bacilli to leukocytes in a biological specimen. Bacillus to Leukocyte Ratio Measurement Bacilli Rod-shaped Bacteria A measurement of the rod-shaped bacilli in a biological specimen. Bacillus Measurement Bacillota A measurement of the organisms that are not assigned to the species level but are assigned to the Bacillota phylum level in a biological specimen. Bacillota Measurement Bacterial Lipopolysaccharide Antigen A measurement of the lipopolysaccharide antigen from bacteria in a biological specimen. Bacterial Lipopolysaccharide Antigen Measurement Bacteria A measurement of the bacteria in a biological specimen. Bacterial Count Bacteroidia A measurement of the organisms that are not assigned to the species level but are assigned to the Bacteroidia phylum level in a biological specimen. Bacteroidia Measurement Burkholderia ambifaria A measurement of the Burkholderia ambifaria in a biological specimen. Burkholderia ambifaria Measurement Burkholderia anthina A measurement of the Burkholderia anthina in a biological specimen. Burkholderia anthina Measurement Burkholderia cenocepacia A measurement of the Burkholderia cenocepacia in a biological specimen. Burkholderia cenocepacia Measurement B. cepacia Burkholderia cepacia Pseudomonas cepacia A measurement of the Burkholderia cepacia in a biological specimen. Burkholderia cepacia Measurement Bacterial Sialidase A measurement of the bacterial sialidase enzyme in a biological specimen. Bacterial Sialidase Measurement Burkholderia dolosa A measurement of the Burkholderia dolosa in a biological specimen. Burkholderia dolosa Measurement Blastocystis hominis DNA A measurement of the Blastocystis hominis DNA in a biological specimen. Blastocystis hominis DNA Measurement Beta-lactamase Negative Bacteria A measurement of the beta-lactamase negative bacteria in a biological specimen. Beta-lactamase Negative Bacteria Measurement Beta-lactamase Positive Bacteria A measurement of the beta-lactamase positive bacteria in a biological specimen. Beta-lactamase Positive Bacteria Measurement Burkholderia multivorans A measurement of the Burkholderia multivorans in a biological specimen. Burkholderia multivorans Measurement Borrelia DNA A measurement of the DNA from any member of the genus Borrelia in a biological specimen. Borrelia DNA Measurement Bordetella parapertussis A measurement of the Bordetella parapertussis in a biological specimen. Bordetella Parapertussis Measurement Bordetella parapertussis DNA A measurement of the Bordetella parapertussis DNA in a biological specimen. Bordetella Parapertussis DNA Measurement Bordetella pertussis A measurement of the Bordetella pertussis in a biological specimen. Bordetella pertussis Measurement Bordetella pertussis Antigen A measurement of the Bordetella pertussis antigen in a biological specimen. Bordetella pertussis Antigen Measurement Bordetella pertussis DNA A measurement of the Bordetella pertussis DNA in a biological specimen. Bordetella pertussis DNA Measurement Burkholderia pyrrocinia A measurement of the Burkholderia pyrrocinia in a biological specimen. Burkholderia pyrrocinia Measurement Burkholderia stabilis A measurement of the Burkholderia stabilis in a biological specimen. Burkholderia stabilis Measurement Burkholderia A measurement of the organisms that are not assigned to the species level but are assigned to the Burkholderia genus level in a biological specimen. Burkholderia Measurement Burkholderia vietnamiensis A measurement of the Burkholderia vietnamiensis in a biological specimen. Burkholderia vietnamiensis Measurement Clostridium difficile 027/NAP1/BI A measurement of the 027/NAP1/BI strain of Clostridium difficile in a biological specimen. Clostridium difficile 027/NAP1/BI Measurement V. chol/parahaemolyticus/vulnificus DNA Vibrio cholerae/parahaemolyticus/vulnificus DNA A measurement of the Vibrio cholerae and/or Vibrio parahaemolyticus and/or Vibrio vulnificus DNA in a biological specimen. Vibrio cholerae, Vibrio parahaemolyticus, and/or Vibrio vulnificus DNA Measurement Invasion Plasmid Antigen H Gene ipaH gene Shigella species and/or Enteroinvasive Escherichia coli Invasion Plasmid Antigen H DNA Shigella/EIEC ipaH DNA A measurement of the invasion plasmid antigen H DNA from any members of the genus Shigella and/or enteroinvasive Escherichia coli in a biological specimen. Shigella and/or Enteroinvasive Escherichia coli ipaH DNA Measurement Sapovirus Genogroups I/II/IV/V RNA A measurement of the Sapovirus genogroups I, II, IV and/or V RNA in a biological specimen. Sapovirus Genogroups I, II, IV, and/or V RNA Measurement Norovirus genogroup I and/or genogroup II RNA Norovirus GI/GII RNA A measurement of Norovirus genogroup I and/or II RNA in a biological specimen. Norovirus Genogroup I and/or II RNA Measurement Enterotoxigenic Escherichia coli LtA/ST1a/ST1b DNA ETEC LtA/ST1a/ST1b DNA A measurement of the enterotoxigenic Escherichia coli LtA, ST1a and/or ST1b DNA in a biological specimen. Enterotoxigenic Escherichia coli LtA, ST1a, and/or ST1b DNA Measurement Enteropathogenic Escherichia coli eae DNA EPEC eae DNA A measurement of the enteropathogenic Escherichia coli eae DNA in a biological specimen. Enteropathogenic Escherichia coli eae DNA Measurement EAEC pAA Plasmid aggR/aatA DNA Enteroaggregative Escherichia coli pAA Plasmid aggR/aatA DNA A measurement of the enteroaggregative Escherichia coli pAA plasmid aggR and/or aatA DNA in a biological specimen. Enteroaggregative Escherichia coli pAA Plasmid aggR and/or aatA DNA Measurement C. coli/jejuni/upsaliensis DNA Campylobacter coli/jejuni/upsaliensis DNA A measurement of the Campylobacter coli, Campylobacter jejuni and/or Campylobacter upsaliensis DNA in a biological specimen. Campylobacter coli, Campylobacter jejuni and/or Campylobacter upsaliensis DNA Measurement Human astrovirus 1/2/3/4/5/6/7/8 RNA A measurement of the Human astrovirus 1, 2, 3, 4, 5, 6, 7 and/or 8 RNA in a biological specimen. Human astrovirus 1, 2, 3, 4, 5, 6, 7, and/or 8 RNA Measurement Human adenovirus 40/41 DNA Human adenovirus F40/F41 DNA Mastadenovirus 40/41 DNA A measurement of the Human adenovirus type 40 and/or Human adenovirus type 41 DNA in a biological specimen. Human adenovirus 40 and/or Human adenovirus 41 DNA Measurement HCoV-229E Nucleic Acid Human Coronavirus 229E Nucleic Acid A measurement of the Human coronavirus 229E nucleic acid in a biological specimen. Human Coronavirus 229E Nucleic Acid Measurement HCoV-229E RNA Human Coronavirus 229E RNA A measurement of the Human coronavirus 229E RNA in a biological specimen. HCoV-229E RNA Measurement Candida albicans Candida stellatoidea A measurement of the Candida albicans in a biological specimen. Candida albicans Measurement Candida albicans DNA A measurement of the Candida albicans DNA in a biological specimen. Candida albicans DNA Measurement Corynebacterium amycolatum A measurement of Corynebacterium amycolatum in a biological specimen. Corynebacterium amycolatum Measurement Campylobacter DNA A measurement of the DNA from any member of the genus Campylobacter in a biological specimen. Campylobacter DNA Measurement Campylobacter A measurement of the organisms that are not assigned to the species level but are assigned to the Campylobacter genus level in a biological specimen. Campylobacter Measurement Candida Antigen A measurement of the antigen from any member of the genus Candida in a biological specimen. Candida Antigen Measurement Candida A measurement of the organisms that are not assigned to the species level but are assigned to the Candida genus level in a biological specimen. Candida Measurement Corynebacterium aurimucosum A measurement of Corynebacterium aurimucosum in a biological specimen. Corynebacterium aurimucosum Measurement Candida auris Candidozyma auris A measurement of Candidozyma auris in a biological specimen. Candidozyma auris Measurement Clostridium botulinum A measurement of the Clostridium botulinum in a biological specimen. Clostridium botulinum Measurement Citrobacter braakii A measurement of the Citrobacter braakii in a biological specimen. Citrobacter braakii Measurement Cyclospora cayetanensis DNA A measurement of the Cyclospora cayetanensis DNA in a biological specimen. Cyclospora cayetanensis DNA Measurement Campylobacter coli A measurement of the Campylobacter coli in a biological specimen. Campylobacter coli Measurement Clostridium difficile A measurement of the Clostridium difficile in a biological specimen. Clostridium difficile Measurement Clostridium difficile A/B Toxin A measurement of the Clostridium difficile A and/or B toxin in a biological specimen. Clostridium difficile A and/or B Toxin Measurement Clostridium difficile A Toxin A measurement of the Clostridium difficile toxin A in a biological specimen. Clostridium difficile A Toxin Measurement Clostridium difficile B Toxin A measurement of the Clostridium difficile toxin B in a biological specimen. Clostridium difficile B Toxin Measurement Clostridium difficile cdt DNA A measurement of the Clostridium difficile binary toxin (cdt) DNA in a biological specimen. Clostridium difficile cdt DNA Measurement Clostridium difficile DNA A measurement of the Clostridium difficile DNA in a biological specimen. Clostridium difficile DNA Measurement C. difficile Glutamate Dehydrogenase Clostridium difficile Glutamate Dehydrogenase A measurement of the Clostridium difficile glutamate dehydrogenase in a biological specimen. C. difficile Glutamate Dehydrogenase Measurement Clostridium difficile tcdA DNA A measurement of the Clostridium difficile toxin A (tcdA) DNA in a biological specimen. Clostridium difficile tcdA DNA Measurement Clostridium difficile tcdB DNA A measurement of the Clostridium difficile toxin B (tcdB) DNA in a biological specimen. Clostridium difficile tcdB DNA Measurement Clostridium difficile tcdC DNA A measurement of the Clostridium difficile regulatory protein (tcdC) DNA in a biological specimen. Clostridium difficile tcdC DNA Measurement Clostridium difficile Toxin A measurement of the Clostridium difficile toxin in a biological specimen. Clostridium difficile Toxin Measurement Candida dubliniensis A measurement of the Candida dubliniensis in a biological specimen. Candida dubliniensis Measurement Citrobacter freundi A measurement of the Citrobacter freundi in a biological specimen. Citrobacter freundi Measurement Candida glabrata A measurement of the Candida glabrata in a biological specimen. Candida glabrata Measurement Chikungunya Virus RNA A measurement of the Chikungunya virus RNA in a biological specimen. Chikungunya Virus RNA Measurement Chlamydia A measurement of the organisms that are not assigned to the species level but are assigned to the Chlamydia genus level in a biological specimen. Chlamydia Measurement Campylobacter jejuni A measurement of the Campylobacter jejuni in a biological specimen. Campylobacter jejuni Measurement Corynebacterium jeikeium A measurement of Corynebacterium jeikeium in a biological specimen. Corynebacterium jeikeium Measurement Citrobacter koseri A measurement of the Citrobacter koseri in a biological specimen. Citrobacter koseri Measurement Cytomegalovirus A measurement of the organisms that are not assigned to the species level but are assigned to the Cytomegalovirus genus level in a biological specimen. Cytomegalovirus Measurement Cytomegalovirus Antigen A measurement of the Cytomegalovirus antigen in a biological specimen. Cytomegalovirus Antigen Measurement Cytomegalovirus DNA A measurement of the Cytomegalovirus DNA in a biological specimen. Cytomegalovirus DNA Measurement Cytomegalovirus Phosphoprotein 65 Antigen Cytomegalovirus pp65 Antigen A measurement of the Cytomegalovirus phosphoprotein 65 (pp65) antigen in a biological specimen. Cytomegalovirus pp65 Antigen Measurement Cryptococcus neoformans/gattii DNA A measurement of Cryptococcus neoformans and/or Cryptococcus gattii DNA in a biological specimen. Cryptococcus neoformans and/or gattii DNA Measurement Corynebacterium A measurement of the organisms that are not assigned to the species level but are assigned to the Corynebacterium genus level in a biological specimen. Corynebacterium Measurement Candida parapsilosis A measurement of Candida parapsilosis in a biological specimen. Candida parapsilosis Measurement Cryptosporidium parvum Antigen A measurement of the Cryptosporidium parvum antigen in a biological specimen. Cryptosporidium parvum Antigen Measurement Candida parapsilosis Complex A measurement of Candida parapsilosis Complex in a biological specimen. Candida parapsilosis Complex Measurement Chlamydia pneumoniae A measurement of the Chlamydia pneumoniae in a biological specimen. Chlamydia Pneumoniae Measurement Chlamydia pneumoniae DNA A measurement of the Chlamydia pneumoniae DNA in a biological specimen. Chlamydia pneumoniae DNA Measurement Chlamydia pneumoniae Nucleic Acid A measurement of the Chlamydia pneumoniae nucleic acid in a biological specimen. Chlamydia pneumoniae Nucleic Acid Measurement Chlamydophila psittaci DNA A measurement of the Chlamydophila psittaci DNA in a biological specimen. Chlamydophila psittaci DNA Measurement Acinetobacter, Carbapenem-resistant Carbapenem Resistant Acinetobacter A measurement of the organisms that are not assigned to the species level but are assigned to the Enterococcus genus level and are also carbapenem-resistant in a biological specimen. Carbapenem-resistant Acinetobacter Measurement Enterobacterales, Carbapenem-resistant A measurement of the organisms that are not assigned to the species level but are assigned to the Enterobacterales order level and are also carbapenem-resistant in a biological specimen. Carbapenem Resistant Enterobacterales Measurement K. pneumoniae, Carbapenem-resistant Klebsiella pneumoniae, Carbapenem-resistant A measurement of the carbapenem-resistant strain of Klebsiella pneumoniae in a biological specimen. Carbapenem-Resistant Klebsiella pneumoniae Measurement Coronaviridae Coronavirus A measurement of the coronaviridae in a biological specimen. Coronaviridae Measurement Coronavirus RNA A measurement of the RNA from any member of the family Coronaviridae in a biological specimen. Coronavirus RNA Measurement Candida rugosa A measurement of Candida rugosa in a biological specimen. Candida rugosa Measurement Cryptococcus Antigen A measurement of the antigen from any member of the genus Cryptococcus in a biological specimen. Cryptococcus Antigen Measurement Cryptosporidium DNA A measurement of the DNA from any member of the genus Cryptosporidium in a biological specimen. Cryptosporidium DNA Measurement Cryptosporidium Antigen A measurement of the antigen from any member of the genus Cryptosporidium in a biological specimen. Cryptosporidium Antigen Measurement Corynebacterium striatum A measurement of Corynebacterium striatum in a biological specimen. Corynebacterium striatum Measurement Chlamydia trachomatis A measurement of the Chlamydia trachomatis in a biological specimen. Chlamydia trachomatis Measurement Chlamydia trachomatis Antigen A measurement of the Chlamydia trachomatis antigen in a biological specimen. Chlamydia Trachomatis Antigen Measurement Chlamydia trachomatis DNA A measurement of the Chlamydia trachomatis DNA in a biological specimen. Chlamydia trachomatis DNA Measurement Candida tropicalis A measurement of Candida tropicalis in a biological specimen. Candida tropicalis Measurement Chlamydia trachomatis RNA A measurement of the Chlamydia trachomatis RNA in a biological specimen. Chlamydia Trachomatis RNA Measurement Corynebacterium tuberculostearicum A measurement of Corynebacterium tuberculostearicum in a biological specimen. Corynebacterium tuberculostearicum Measurement Corynebacterium urealyticum A measurement of Corynebacterium urealyticum in a biological specimen. Corynebacterium urealyticum Measurement Curved Bacillus Curved Rods A measurement of the curved rod-shaped bacillus in a biological specimen. Curved Bacillus Measurement Cyanobacteria A measurement of the organisms that are not assigned to the species level but are assigned to the Cyanobacteria phylum level in a biological specimen. Cyanobacteria Measurement Dientamoeba fragilis DNA A measurement of the Dientamoeba fragilis DNA in a biological specimen. Dientamoeba fragilis DNA Measurement Dengue Virus 1 RNA A measurement of the dengue virus 1 RNA in a biological specimen. Dengue Virus 1 RNA Measurement Dengue Virus 2 RNA A measurement of the dengue virus 2 RNA in a biological specimen. Dengue Virus 2 RNA Measurement Dengue Virus 3 RNA A measurement of the dengue virus 3 RNA in a biological specimen. Dengue Virus 3 RNA Measurement Dengue Virus 4 RNA A measurement of the dengue virus 4 RNA in a biological specimen. Dengue Virus 4 RNA Measurement Dengue Virus Nonstructural Protein 1 Dengue Virus NS1 Antigen A measurement of the dengue virus NS1 antigen in a biological specimen. Dengue Virus NS1 Antigen Measurement Dengue Virus RNA A measurement of the dengue virus RNA in a biological specimen. Dengue Virus RNA Measurement Dengue Virus 1/2/3/4 RNA A measurement of the RNA from the dengue virus serotype 1, 2, 3 and/or 4 in a biological specimen. Dengue Virus 1, 2, 3, and/or 4 RNA Measurement Enterococcus avium A measurement of Enterococcus avium in a biological specimen. Enterococcus avium Measurement Epstein-Barr DNA Human Herpesvirus 4 DNA A measurement of the Epstein-Barr virus DNA in a biological specimen. Epstein-Barr DNA Measurement Epstein-Barr Early Antigen A measurement of the Epstein-Barr early antigen in a biological specimen. Epstein-Barr Early Antigen Measurement Epstein-Barr Nuclear Antigen A measurement of the Epstein-Barr nuclear antigen in a biological specimen. Epstein-Barr Nuclear Antigen Measurement Ebola Virus A measurement of the Ebola virus in a biological specimen. Ebola Virus Measurement Epstein-Barr Virus A measurement of the Epstein-Barr virus in a biological specimen. Epstein-Barr Virus Measurement Epstein-Barr Virus Latent Membrane Protein 1 Epstein-Barr Virus LMP1 A measurement of the epstein-barr virus latent membrane protein 1 in a biological specimen. Epstein-Barr Virus Latent Membrane Protein 1 Measurement Enterobacter cloacae A measurement of the Enterobacter cloacae in a biological specimen. Enterobacter cloacae Measurement Enterobacter cloacae Complex A measurement of the Enterobacter cloacae complex in a biological specimen. Enterobacter cloacae Complex Measurement Enterobacter cloacae Complex DNA A measurement of the Enterobacter cloacae complex DNA in a biological specimen. Enterobacter cloacae Complex DNA Measurement Escherichia coli Shiga-like Toxin A measurement of the total Escherichia coli shiga-like toxin in a biological specimen. Escherichia coli Shiga-like Toxin Measurement Escherichia coli A measurement of the Escherichia coli in a biological specimen. Escherichia coli Measurement Escherichia coli DNA A measurement of the Escherichia coli DNA in a biological specimen. Escherichia coli DNA Measurement Escherichia coli K1 DNA A measurement of the Escherichia coli K1 DNA in a biological specimen. Escherichia coli K1 DNA Measurement Escherichia coli O Antigen A measurement of the Escherichia coli O antigen in a biological specimen. Escherichia coli O Antigen Measurement Escherichia coli Verotoxin A measurement of the total Escherichia coli verotoxin in a biological specimen. Escherichia coli Verotoxin Measurement Entamoeba dispar A measurement of the Entamoeba dispar in a biological specimen. Entamoeba dispar Measurement Entamoeba dispar DNA A measurement of the Entamoeba dispar DNA in a biological specimen. Entamoeba dispar DNA Measurement Streptococcus faecalis A measurement of the Enterococcus faecalis in a biological specimen. Enterococcus faecalis Measurement Enterococcus faecalis DNA A measurement of the Enterococcus faecalis DNA in a biological specimen. Enterococcus faecalis DNA Measurement Enterococcus faecium A measurement of the Enterococcus faecium in a biological specimen. Enterococcus faecium Measurement Escherichia fergusonii A measurement of Escherichia fergusonii in a biological specimen. Escherichia fergusonii Measurement Enterococcus gallinarum A measurement of Enterococcus gallinarum in a biological specimen. Enterococcus gallinarum Measurement Enterohemorrhagic Escherichia coli A measurement of the enterohemorrhagic Escherichia coli in a biological specimen. Enterohemorrhagic Escherichia coli Measurement Entamoeba histolytica DNA A measurement of the Entamoeba histolytica DNA in a biological specimen. Entamoeba histolytica DNA Measurement Enterobacter hormaechei A measurement of Enterobacter hormaechei in a biological specimen. Enterobacter hormaechei Measurement Ehrlichia DNA A measurement of the DNA from any member of the genus Ehrlichia in a biological specimen. Ehrlichia DNA Measurement E.Coli K1/N.Meningitidis Serogroup B Ag Escherichia coli K1/Neisseria meningitidis Group B Antigen Escherichia coli K1/Neisseria meningitidis Serogroup B Antigen A measurement of the antigen from Escherichia coli K1 and/or Neisseria meningitidis serogroup B in a biological specimen. Escherichia coli K1 and/or Neisseria meningitidis Group B Antigen Measurement Enterobacter A measurement of the organisms that are not assigned to the species level but are assigned to the Enterobacter genus level in a biological specimen. Enterobacter Measurement Enterococcus A measurement of the organisms that are not assigned to the species level but are assigned to the Enterococcus genus level in a biological specimen. Enterococcus Measurement Enterovirus A measurement of the organisms that are not assigned to the species level but are assigned to the Enterovirus genus level in a biological specimen. Enterovirus Measurement Enterovirus RNA A measurement of the RNA from any member of the genus Enterovirus in a biological specimen. Enterovirus RNA Measurement Escherichia coli O157 Antigen A measurement of the Escherichia coli O157 antigen in a biological specimen. Escherichia coli O157 Antigen Measurement Escherichia coli O157 DNA A measurement of the Escherichia coli O157 DNA in a biological specimen. Escherichia coli O157 DNA Measurement Firmicutes/Bacteroidetes Ratio A ratio measurement of the members from the phylum Firmicutes to the members from the phylum Bacteroidetes in a biological specimen. Firmicutes to Bacteroidetes Ratio Measurement Flagellates A measurement of the flagellates (protozoans that possess flagella) in a biological specimen. Flagellates Measurement Fusobacterium nucleatum A measurement of the Fusobacterium nucleatum in a biological specimen. Fusobacterium nucleatum Measurement Fungi Fungus A measurement of the fungi in a biological specimen. Fungi Measurement Fungi, Filamentous A measurement of the filamentous fungi in a biological specimen. Filamentous Fungi Count Fungi, Yeast-Like A measurement of the yeast-like fungi in a biological specimen. Yeast-Like Fungi Count Gardnerella A measurement of the organisms that are not assigned to the species level but are assigned to the Gardnerella genus level in a biological specimen. Gardnerella Measurement Streptococcus Group A A measurement of the Streptococcus group A in a biological specimen. Group A Streptococcus Measurement Streptococcus Group B A measurement of the Streptococcus group B in a biological specimen. Group B Streptococcus Measurement Giardia DNA A measurement of the DNA from any member of the genus Giardia in a biological specimen. Giardia DNA Measurement Giardia lamblia Antigen A measurement of the Giardia lamblia antigen in a biological specimen. Giardia lamblia Antigen Measurement Giardia lamblia/Cryptosporidium Antigen A measurement of the antigen from Giardia lamblia and/or any member of the genus Cryptosporidium in a biological specimen. Giardia lamblia/Cryptosporidium Antigen Measurement Giardia duodenalis DNA Giardia intestinalis DNA Giardia lamblia DNA A measurement of the Giardia lamblia DNA in a biological specimen. Giardia lamblia DNA Measurement Galactomannan Antigen A measurement of the galactomannan antigen in a biological specimen. Galactomannan Antigen Measurement Gram Negative Bacteria A measurement of the gram negative bacteria in a biological specimen. Gram Negative Bacteria Measurement Gram Negative Cocci A measurement of the gram negative cocci-shaped bacteria in a biological specimen. Gram Negative Cocci Measurement Gram Positive Bacteria A measurement of the gram positive bacteria in a biological specimen. Gram Positive Bacteria Measurement Corynebacterium vaginalis Gardnerella vaginalis A measurement of the Gardnerella vaginalis in a biological specimen. Gardnerella vaginalis Measurement Gardnerella vaginalis DNA A measurement of the Gardnerella vaginalis DNA in a biological specimen. Gardnerella vaginalis DNA Measurement H. influenzae Haemophilus influenzae A measurement of the Haemophilus influenza virus in a biological specimen. Haemophilus influenzae Measurement Haemophilus A measurement of the organisms that are not assigned to the species level but are assigned to the Haemophilus genus level in a biological specimen. Haemophilus Measurement HAsAg Hepatitis A Virus Surface Antigen A measurement of the surface antigen reaction of a biological specimen to the Hepatitis A virus. Hepatits A Virus Surface Antigen Measurement Hepatitis A Virus RNA A measurement of the hepatitis A virus RNA in a biological specimen. Hepatitis A Virus RNA Measurement Hepatitis B Virus Core Antigen A measurement of the Hepatitis B virus core antigen in a biological specimen. Hepatitis B Virus Core Antigen Measurement Hepatitis B Virus DNA A measurement of the Hepatitis B virus DNA in a biological specimen. Hepatitis B DNA Measurement Hepatitis B Virus e Antigen A measurement of the hepatitis B e antigen in a biological specimen. Hepatitis B Virus e Antigen Measurement Hepatitis B Virus Nucleic Acid A measurement of the hepatitis B virus nucleic acid in a biological specimen. Hepatitis B Virus Nucleic Acid Measurement Human Bocavirus Antigen A measurement of the Human bocavirus antigen in a biological specimen. Human Bocavirus Antigen Measurement Human bocavirus DNA A measurement of the Human bocavirus DNA in a biological specimen. Human Bocavirus DNA Measurement Human Bocavirus Nucleic Acid A measurement of the Human bocavirus nucleic acid in a biological specimen. Human Bocavirus Nucleic Acid Measurement Hepatitis B Virus RNA A measurement of the Hepatitis B virus RNA in a biological specimen. Hepatitis B Virus RNA Measurement HBsAg Hepatitis B Virus Surface Antigen A measurement of the surface antigen reaction of a biological specimen to the Hepatitis B virus. Hepatitis B Virus Surface Antigen Measurement Hepatitis B Virus A measurement of the hepatitis B virus in a biological specimen. Hepatitis B Virus Measurement Hepatitis C Virus Antigen A measurement of the hepatitis C virus antigen in a biological specimen. Hepatitis C Virus Antigen Measurement Hepatitis C Virus Core Antigen A measurement of the hepatitis C virus core antigen in a biological specimen. Hepatitis C Virus Core Antigen Measurement Hepatitis C Virus Nucleic Acid A measurement of the hepatitis C virus nucleic acid in a biological specimen. Hepatitis C Virus Nucleic Acid Measurement Human Coronavirus 229E A measurement of the Human coronavirus 229E in a biological specimen. Human Coronavirus 229E Measurement Human Coronavirus HKU1 A measurement of the Human coronavirus HKU1 in a biological specimen. Human Coronavirus HKU1 Measurement Human Coronavirus NL63 A measurement of the Human coronavirus NL63 in a biological specimen. Human Coronavirus NL63 Measurement Human Coronavirus OC43 A measurement of the Human coronavirus OC43 in a biological specimen. Human Coronavirus OC43 Measurement Histoplasma capsulatum Antigen A measurement of the Histoplasma capsulatum antigen in a biological specimen. Histoplasma capsulatum Antigen Measurement Hepatitis C Virus RNA A measurement of the Hepatitis C virus RNA in a biological specimen. Hepatitis C Virus RNA Measurement Hepatitis C Virus A measurement of the hepatitis C virus in a biological specimen. Hepatitis C Virus Measurement Hepatitis D Virus RNA A measurement of the hepatitis D virus RNA in a biological specimen. Hepatitis D Virus RNA Measurement Hepatitis E Virus Antigen A measurement of the Hepatitis E virus antigen in a biological specimen. Hepatitis E Virus Antigen Measurement Hemozoin A measurement of hemozoin in a biological specimen. Hemozoin is a breakdown product of hemoglobin and iron-containing pigment that accumulates as cytoplasmic granules in blood-feeding parasites. Hemozoin Measurement Hepatitis E Virus RNA A measurement of the Hepatitis E virus RNA in a biological specimen. Hepatitis E Virus RNA Measurement Human Herpesvirus 6 A measurement of the human herpesvirus 6 in a biological specimen. Human Herpesvirus 6 Measurement Human Herpesvirus 6 DNA A measurement of the human herpesvirus 6 DNA in a biological specimen. Human Herpesvirus 6 DNA Measurement Human Herpesvirus 7 A measurement of the human herpesvirus 7 in a biological specimen. Human Herpesvirus 7 Measurement Human Herpesvirus 7 DNA A measurement of the human herpesvirus 7 DNA in a biological specimen. Human Herpesvirus 7 DNA Measurement Human Herpes Virus 8 Human Herpesvirus 8 A measurement of the human herpes virus 8 in a biological specimen. Human Herpesvirus 8 Measurement Human Herpesvirus 8 DNA A measurement of the human herpesvirus 8 DNA in a biological specimen. Human Herpesvirus 8 DNA Measurement Haemophilus influenzae DNA A measurement of the Haemophilus influenza virus DNA in a biological specimen. Haemophilus influenzae DNA Measurement Human Immunodeficiency Virus A measurement of the Human Immunodeficiency Virus in a biological specimen. Human Immunodeficiency Virus Measurement HIV-1 p24 Antigen A measurement of the HIV-1 p24 antigen in a biological specimen. HIV-1 p24 Antigen Measurement HIV-1/2 Antigen/Antibody A measurement of the HIV-1/HIV-2 antigens and/or HIV-1/HIV-2 antibodies in a biological specimen (to be used when the antigen is not specified). HIV-1/2 Antigen/Antibody Measurement HIV-1/2 Antibody + HIV-1 p24 Antigen A measurement of the antibody reaction of a biological specimen to either the HIV-1 or HIV-2 virus and the measurement of HIV-1 p24 antigen in a biological specimen. HIV-1/2 Antibody and HIV-1 p24 Antigen Measurement HIV-1/2 RNA A measurement of the HIV-1 and/or HIV-2 RNA in a biological specimen. HIV-1/2 RNA Measurement HIV-1 Antibody + HIV-1 p24 Antigen A measurement of the antibody reaction to the HIV-1 virus and the measurement of HIV-1 p24 antigen in a biological specimen. HIV-1 Antibody and HIV-1 p24 Antigen Measurement HIV-1 Antigen A measurement of the HIV-1 antigen in a biological specimen. HIV-1 Antigen Measurement HIV-1 Group M and O Nucleic Acid A measurement of the HIV-1 group M and O nucleic acids in a biological specimen. HIV-1 Group M and O Nucleic Acid Measurement HIV-1 Nucleic Acid A measurement of the HIV-1 nucleic acid in a biological specimen. HIV-1 Nucleic Acid Measurement HIV-1 RNA A measurement of the HIV-1 RNA in a biological specimen. HIV-1 RNA Measurement HIV-2 Antibody + HIV-1 p24 Antigen A measurement of the antibody reaction to the HIV-2 virus and the measurement of HIV-1 p24 antigen in a biological specimen. HIV-2 Antibody And HIV-1 p24 Antigen Measurement HIV-2 Nucleic Acid A measurement of the HIV-2 nucleic acids in a biological specimen. HIV-2 Nucleic Acid Measurement HIV-2 RNA A measurement of the HIV-2 RNA in a biological specimen. HIV-2 RNA Measurement HIV Antigen/Antibody A measurement of the HIV antigens and/or HIV antibodies in a biological specimen. HIV Antigen/Antibody Measurement HCoV-HKU1 Nucleic Acid HCoV-HKU1 RNA Human Coronavirus HKU1 Nucleic Acid A measurement of the Human coronavirus HKU1 nucleic acid in a biological specimen. Human Coronavirus HKU1 Nucleic Acid Measurement HCoV-HKU1 RNA Human Coronavirus HKU1 RNA A measurement of the Human coronavirus HKU1 RNA in a biological specimen. HCoV-HKU1 RNA Measurement Human Metapneumovirus A measurement of the Human metapneumovirus in a biological specimen. Human Metapneumovirus Measurement Human Metapneumovirus Antigen A measurement of the Human metapneumovirus antigen in a biological specimen. Human Metapneumovirus Antigen Measurement Human Metapneumovirus Nucleic Acid A measurement of the Human metapneumovirus nucleic acid in a biological specimen. Human Metapneumovirus Nucleic Acid Measurement Human Metapneumovirus RNA A measurement of the Human Metapneumovirus RNA in a biological specimen. Human Metapneumovirus RNA Measurement Human Parainfluenza Virus 1/2/3/4 RNA A measurement of the RNA from the Human Parainfluenza virus 1, 2, 3 and/or 4 in a biological specimen. Human Parainfluenza Virus 1, 2, 3, and/or 4 RNA Measurement Human Parainfluenza Virus 1/2/3 Antigen A measurement of the Human Parainfluenza virus 1, 2, and/or 3 antigen in a biological specimen. Human Parainfluenza Virus 1, 2, and/or 3 Antigen Measurement Human Parainfluenza Virus 1/2/3 RNA A measurement of the RNA from the Human Parainfluenza virus 1, 2, and/or 3 in a biological specimen. Human Parainfluenza Virus 1, 2, and/or 3 RNA Measurement Haemophilus parahaemolyticus DNA A measurement of the Haemophilus parahaemolyticus DNA in a biological specimen. Haemophilus parahaemolyticus DNA Measurement Human Parainfluenza Virus 1 A measurement of the Human parainfluenza virus 1 in a biological specimen. Human Parainfluenza Virus 1 Measurement Human Parainfluenza Virus 1 Antigen Human Respirovirus 1 Antigen A measurement of the Human parainfluenza virus 1 antigen in a biological specimen. Human Parainfluenza Type 1 Antigen Measurement Human Parainfluenza Virus 1 Nucleic Acid A measurement of the Human parainfluenza virus 1 nucleic acid in a biological specimen. Human Parainfluenza Virus 1 Nucleic Acid Measurement Human Parainfluenza Virus 1 RNA Human Respirovirus 1 RNA A measurement of the Human parainfluenza virus 1 RNA in a biological specimen. Human Parainfluenza Virus 1 RNA Measurement Human Parainfluenza Virus 2 A measurement of the Human parainfluenza virus 2 in a biological specimen. Human Parainfluenza Virus 2 Measurement Human Orthorubulavirus 2 Antigen Human Parainfluenza Virus 2 Antigen A measurement of the Human parainfluenza virus 2 antigen in a biological specimen. Human Parainfluenza Virus 2 Antigen Measurement Human Parainfluenza Virus 2 Nucleic Acid A measurement of the Human parainfluenza virus 2 nucleic acid in a biological specimen. Human Parainfluenza Virus 2 Nucleic Acid Measurement Human Orthorubulavirus 2 RNA Human Parainfluenza Virus 2 RNA A measurement of the Human parainfluenza virus 2 RNA in a biological specimen. Human Parainfluenza Virus 2 RNA Measurement Human Parainfluenza Virus 3 A measurement of the Human parainfluenza virus 3 in a biological specimen. Human Parainfluenza Virus 3 Measurement Human Parainfluenza Virus 3 Antigen Human Respirovirus 3 Antigen A measurement of the Human parainfluenza virus 3 antigen in a biological specimen. Human Parainfluenza Virus 3 Antigen Measurement Human Parainfluenza Virus 3 Nucleic Acid A measurement of the Human parainfluenza virus 3 nucleic acid in a biological specimen. Human Parainfluenza Virus 3 Nucleic Acid Measurement Human Parainfluenza Virus 3 RNA Human Respirovirus 3 RNA A measurement of the Human parainfluenza virus 3 RNA in a biological specimen. Human Parainfluenza Virus 3 RNA Measurement Human Parainfluenza Virus 4 A measurement of the Human parainfluenza virus 4 in a biological specimen. Human Parainfluenza Virus 4 Measurement Human Parainfluenza Virus 4B NC Human Parainfluenza Virus 4B Nucleic Acid A measurement of the Human parainfluenza virus 4b nucleic acid in a biological specimen. Human Parainfluenza Virus 4B Nucleic Acid Measurement Human Parainfluenza Virus 4 Nucleic Acid A measurement of the Human parainfluenza virus 4 nucleic acid in a biological specimen. Human Parainfluenza Virus 4 Nucleic Acid Measurement Human Orthorubulavirus 4 RNA Human Parainfluenza Virus 4 RNA A measurement of the Human parainfluenza virus 4 RNA in a biological specimen. Human Parainfluenza Virus 4 RNA Measurement Human Parainfluenza Antigen A measurement of the Human Parainfluenza antigen in a biological specimen. Human Parainfluenza Antigen Measurement Human Parainfluenza virus RNA A measurement of the Human parainfluenza virus RNA in a biological specimen. Human Parainfluenza virus RNA Measurement Human Papillomavirus A measurement of the Human papillomavirus in a biological specimen. Human Papillomavirus Measurement Human Papillomavirus Type 11 DNA A measurement of the Human papillomavirus type 11 DNA in a biological specimen. Human Papillomavirus Type 11 DNA Measurement Human Papillomavirus Type 16 DNA A measurement of the Human papillomavirus type 16 DNA in a biological specimen. Human Papillomavirus Type 16 DNA Measurement Human Papillomavirus Type 18 DNA A measurement of the Human papillomavirus type 18 DNA in a biological specimen. Human Papillomavirus Type 18 DNA Measurement Human Papillomavirus Type 31 A measurement of the Human papillomavirus type 31 in a biological specimen. Human Papillomavirus Type 31 Measurement Human Papillomavirus Type 31 DNA A measurement of the Human papillomavirus type 31 DNA in a biological specimen. Human Papillomavirus Type 31 DNA Measurement Human Papillomavirus Type 33 A measurement of the Human papillomavirus type 33 in a biological specimen. Human Papillomavirus Type 33 Measurement Human Papillomavirus Type 33 DNA A measurement of the Human papillomavirus type 33 DNA in a biological specimen. Human Papillomavirus Type 33 DNA Measurement Human Papillomavirus Type 34 A measurement of the Human papillomavirus type 34 in a biological specimen. Human Papillomavirus Type 34 Measurement Human Papillomavirus Type 35 A measurement of the Human papillomavirus type 35 in a biological specimen. Human Papillomavirus Type 35 Measurement Human Papillomavirus Type 35 DNA A measurement of the Human papillomavirus type 35 DNA in a biological specimen. Human Papillomavirus Type 35 DNA Measurement Human Papillomavirus Type 39 A measurement of the Human papillomavirus type 39 in a biological specimen. Human Papillomavirus Type 39 Measurement Human Papillomavirus Type 39 DNA A measurement of the Human papillomavirus type 39 DNA in a biological specimen. Human Papillomavirus Type 39 DNA Measurement Human Papillomavirus Type 40 A measurement of the Human papillomavirus type 40 in a biological specimen. Human Papillomavirus Type 40 Measurement Human Papillomavirus Type 42 A measurement of the Human papillomavirus type 42 in a biological specimen. Human Papillomavirus Type 42 Measurement Human Papillomavirus Type 43 A measurement of the Human papillomavirus type 43 in a biological specimen. Human Papillomavirus Type 43 Measurement Human Papillomavirus Type 44 A measurement of the Human papillomavirus type 44 in a biological specimen. Human Papillomavirus Type 44 Measurement Human Papillomavirus Type 45 A measurement of the Human papillomavirus type 45 in a biological specimen. Human Papillomavirus Type 45 Measurement Human Papillomavirus Type 45 DNA A measurement of the Human papillomavirus type 45 DNA in a biological specimen. Human Papillomavirus Type 45 DNA Measurement Human Papillomavirus Type 51 A measurement of the Human papillomavirus type 51 in a biological specimen. Human Papillomavirus Type 51 Measurement Human Papillomavirus Type 51 DNA A measurement of the Human papillomavirus type 51 DNA in a biological specimen. Human Papillomavirus Type 51 DNA Measurement Human Papillomavirus Type 52 A measurement of the Human papillomavirus type 52 in a biological specimen. Human Papillomavirus Type 52 Measurement Human Papillomavirus Type 52 DNA A measurement of the Human papillomavirus type 52 DNA in a biological specimen. Human Papillomavirus Type 52 DNA Measurement Human Papillomavirus Type 53 A measurement of the Human papillomavirus type 53 in a biological specimen. Human Papillomavirus Type 53 Measurement Human Papillomavirus Type 53 DNA A measurement of the Human papillomavirus type 53 DNA in a biological specimen. Human Papillomavirus Type 53 DNA Measurement Human Papillomavirus Type 54 A measurement of the Human papillomavirus type 54 in a biological specimen. Human Papillomavirus Type 54 Measurement Human Papillomavirus Type 56 A measurement of the Human papillomavirus type 56 in a biological specimen. Human Papillomavirus Type 56 Measurement Human Papillomavirus Type 56 DNA A measurement of the Human papillomavirus type 56 DNA in a biological specimen. Human Papillomavirus Type 56 DNA Measurement Human Papillomavirus Type 57 DNA A measurement of the Human papillomavirus type 57 DNA in a biological specimen. Human Papillomavirus Type 57 DNA Measurement Human Papillomavirus Type 58 A measurement of the Human papillomavirus type 58 in a biological specimen. Human Papillomavirus Type 58 Measurement Human Papillomavirus Type 58 DNA A measurement of the Human papillomavirus type 58 DNA in a biological specimen. Human Papillomavirus Type 58 DNA Measurement Human Papillomavirus Type 59 A measurement of the Human papillomavirus type 59 in a biological specimen. Human Papillomavirus Type 59 Measurement Human Papillomavirus Type 59 DNA A measurement of the Human papillomavirus type 59 DNA in a biological specimen. Human Papillomavirus Type 59 DNA Measurement Human Papillomavirus Type 66 A measurement of the Human papillomavirus type 66 in a biological specimen. Human Papillomavirus Type 66 Measurement Human Papillomavirus Type 66 DNA A measurement of the Human papillomavirus type 66 DNA in a biological specimen. Human Papillomavirus Type 66 DNA Measurement Human Papillomavirus Type 67 DNA A measurement of the Human papillomavirus type 67 DNA in a biological specimen. Human Papillomavirus Type 67 DNA Measurement Human Papillomavirus Type 68 A measurement of the Human papillomavirus type 68 in a biological specimen. Human Papillomavirus Type 68 Measurement Human Papillomavirus Type 68 DNA A measurement of the Human papillomavirus type 68 DNA in a biological specimen. Human Papillomavirus Type 68 DNA Measurement Human Papillomavirus Type 69 A measurement of the Human papillomavirus type 69 in a biological specimen. Human Papillomavirus Type 69 Measurement Human Papillomavirus Type 6 DNA A measurement of the Human papillomavirus type 6 DNA in a biological specimen. Human Papillomavirus Type 6 DNA Measurement Human Papillomavirus Type 70 A measurement of the Human papillomavirus type 70 in a biological specimen. Human Papillomavirus Type 70 Measurement Human Papillomavirus Type 74 A measurement of the Human papillomavirus type 74 in a biological specimen. Human Papillomavirus Type 74 Measurement Human Papillomavirus DNA A measurement of the Human papillomavirus DNA in a biological specimen. Human Papillomavirus DNA Measurement Human Papillomavirus E6/E7 Messenger RNA Human Papillomavirus E6/E7 mRNA A measurement of the human papillomavirus E6 and/or E7 protein-making mRNA in a biological specimen. Human Papillomavirus E6/E7 mRNA Measurement Helicobacter pylori A measurement of the Helicobacter pylori in a biological specimen. Helicobacter pylori Measurement Helicobacter pylori Antigen A measurement of the Helicobacter pylori antigen in a biological specimen. Helicobacter pylori Antigen Measurement Helicobacter pylori DNA A measurement of the Helicobacter pylori DNA in a biological specimen. Helicobacter pylori DNA Measurement High Risk Human Papillomavirus Types DNA, Multi-Target High-Risk HPV Types DNA, MLTTRG High-Risk HPV Types DNA, Multi-Target A measurement of high-risk human papillomavirus DNA in a biological specimen. This is a multiple-target test. Multi-Target High Risk Human Papillomavirus Types DNA Measurement High Risk Human Papillomavirus Types mRNA, Multi-Target High-Risk HPV Types mRNA, MLTTRG High-Risk HPV Types mRNA, Multi-Target A measurement of high-risk human papillomavirus mRNA in a biological specimen. This is a multiple-target test. Multi-Target High Risk Human Papillomavirus Types mRNA Measurement Human rhinovirus A measurement of the Human rhinovirus in a biological specimen. Human rhinovirus Measurement HRV A/B/C Human rhinovirus A/B/C A measurement of the Human rhinovirus A, B and/or C in a biological specimen. Human rhinovirus A, B, and/or C Measurement HRV A/B/C Antigen Human rhinovirus A/B/C Antigen A measurement of the Human rhinovirus A, B and/or C antigen in a biological specimen. Human rhinovirus A, B, and/or C Antigen Measurement Herpes Simplex Virus 1 A measurement of the herpes simplex virus 1 in a biological specimen. Herpes Simplex Virus 1 Measurement Herpes Simplex Virus 1/2 A measurement of the herpes simplex virus 1 and/or 2 in a biological specimen. Herpes Simplex Virus 1 and/or 2 Measurement Herpes Simplex Virus 1/2 Antigen HSV 1/2 Antigen A measurement of the herpes simplex virus 1 and/or 2 antigen in a biological specimen. Herpes Simplex Virus 1 and/or 2 Antigen Measurement Herpes Simplex Virus 1/2 DNA HSV 1/2 DNA A measurement of the herpes simplex virus 1 and/or 2 DNA in a biological specimen. Herpes Simplex Virus 1 and/or 2 DNA Measurement Herpes Simplex Virus 1 DNA A measurement of the herpes simplex virus 1 DNA in a biological specimen. Herpes Simplex Virus 1 DNA Measurement Herpes Simplex Virus 2 A measurement of the herpes simplex virus 2 in a biological specimen. Herpes Simplex Virus 2 Measurement Herpes Simplex Virus 2 DNA A measurement of the Herpes simplex virus 2 DNA in a biological specimen. Herpes Simplex Virus 2 DNA Measurement Human T-Lymphotropic Virus RNA A measurement of the Human T-Lymphotropic virus RNA in a biological specimen. Human T-Lymphotropic Virus RNA Measurement Influenza A Virus A measurement of the Influenza A virus an biological specimen. Influenza A Virus Measurement Influenza A Antigen A measurement of the influenza A antigen in a biological specimen. Influenza A Antigen Measurement Influenza A/B Virus A measurement of the influenza A and/or B virus in a biological specimen. Influenza A/B Virus Measurement Influenza A/B Antigen A measurement of the influenza A and/or B antigen in a biological specimen. Influenza A/B Antigen Measurement Influenza A/B RNA A measurement of the influenza A and/or B RNA in a biological specimen. Influenza A and/or B RNA Measurement Influenza A H1 Nucleic Acid A measurement of the Influenza A virus subtype hemagglutinin (HA) 1 nucleic acid in an biological specimen. Influenza A H1 Nucleic Acid Measurement Influenza A H1 RNA A measurement of the Influenza A virus subtype hemagglutinin (HA) 1 RNA in an biological specimen. Influenza A H1 RNA Measurement Influenza A H3 Nucleic Acid A measurement of the Influenza A virus subtype hemagglutinin (HA) 3 nucleic acid in an biological specimen. Influenza A H3 Nucleic Acid Measurement Influenza A H3 RNA A measurement of the Influenza A virus subtype hemagglutinin (HA) 3 RNA in an biological specimen. Influenza A H3 RNA Measurement Influenza A Nucleic Acid A measurement of the Influenza A virus nucleic acid in an biological specimen. Influenza A Nucleic Acid Measurement Influenza A RNA A measurement of the Influenza A virus RNA in a biological specimen. Influenza A RNA Measurement Influenza B Virus A measurement of the Influenza B virus an biological specimen. Influenza B Virus Measurement Influenza B Antigen A measurement of the influenza B antigen in a biological specimen. Influenza B Antigen Measurement Influenza B Nucleic Acid A measurement of the Influenza B virus nucleic acid in an biological specimen. Influenza B Nucleic Acid Measurement Influenza B RNA A measurement of the Influenza B virus RNA in a biological specimen. Influenza B RNA Measurement JC Polyomavirus JC Virus John Cunningham Virus A measurement of the JC virus in a biological specimen. JC Virus Measurement JC Polyomavirus DNA JC Virus DNA JCV DNA John Cunningham Virus DNA A measurement of the JC virus DNA in a biological specimen. JC Virus DNA Measurement Klebsiella aerogenes A measurement of the Klebsiella aerogenes in a biological specimen. Klebsiella aerogenes Measurement Klebsiella aerogenes DNA A measurement of the Klebsiella aerogenes DNA in a biological specimen. Klebsiella aerogenes DNA Measurement Klebsiella A measurement of the organisms that are not assigned to the species level but are assigned to the Klebsiella genus level in a biological specimen. Klebsiella Measurement Klebsiella oxytoca A measurement of the Klebsiella oxytoca in a biological specimen. Klebsiella oxytoca Measurement Klebsiella oxytoca DNA A measurement of the Klebsiella oxytoca DNA in a biological specimen. Klebsiella oxytoca DNA Measurement Klebsiella pneumoniae A measurement of the Klebsiella pneumoniae in a biological specimen. Klebsiella pneumoniae Measurement Klebsiella pneumoniae DNA A measurement of the Klebsiella pneumoniae DNA in a biological specimen. Klebsiella pneumoniae DNA Measurement Klebsiella variicola A measurement of Klebsiella variicola in a biological specimen. Klebsiella variicola Measurement Lactobacillus A measurement of the organisms that are not assigned to the species level but are assigned to the Lactobacillus genus level in a biological specimen. Lactobacillus Measurement Lactobacillus crispatus A measurement of Lactobacillus crispatus in a biological specimen. Lactobacillus crispatus Measurement Lactobacillus crispatus DNA A measurement of the Lactobacillus crispatus DNA in a biological specimen. Lactobacillus crispatus DNA Measurement Lactobacillus jensenii A measurement of Lactobacillus jensenii in a biological specimen. Lactobacillus jensenii Measurement Legionella longbeachae DNA A measurement of the Legionella longbeachae DNA in a biological specimen. Legionella longbeachae DNA Measurement Listeria monocytogenes A measurement of the Listeria monocytogenes in a biological specimen. Listeria monocytogenes Measurement Legionella pneumophila A measurement of the Legionella pneumophila in a biological specimen. Legionella pneumophila Measurement Legionella pneumophila Antigen A measurement of the Legionella pneumophila antigen in a biological specimen. Legionella pneumophila Antigen Measurement Legionella pneumophila DNA A measurement of the Legionella pneumophila DNA in a biological specimen. Legionella pneumophila DNA Measurement Legionella pneumophila Serogroup 1 Antigen Legionella pneumophila Sg 1 Antigen A measurement of the Legionella pneumophila serogroup 1 antigen in a biological specimen. Legionella pneumophila Serogroup 1 Antigen Measurement Listeria monocytogenes DNA A measurement of the Listeria monocytogenes DNA in a biological specimen. Listeria monocytogenes DNA Measurement Mycobacterium abscessus A measurement of the Mycobacterium abscessus in a biological specimen. Mycobacterium abscessus Measurement Mycobacterium avium Complex A measurement of the group of bacterial species that can be assigned to the Mycobacterium avium complex in a biological specimen. Mycobacterium avium Complex Measurement Moraxella catarrhalis A measurement of the Moraxella catarrhalis in a biological specimen. Moraxella catarrhalis Measurement Moraxella catarrhalis DNA A measurement of the Moraxella catarrhalis DNA in a biological specimen. Moraxella catarrhalis DNA Measurement Mycobacterium chelonae A measurement of the Mycobacterium chelonae in a biological specimen. Mycobacterium chelonae Measurement Microbial Organism Identification The identification of the type of a microbial organism in a biological specimen. Microorganism Identification MERS-CoV RNA A measurement of the MERS-CoV RNA in a biological specimen. MERS-CoV RNA Measurement Microfilaria Presence of microfilaria stage of filarial nematodes in smears prepared from whole blood or other body fluids. Microfilaria Measurement Mycobacterium fortuitum A measurement of the Mycobacterium fortuitum in a biological specimen. Mycobacterium fortuitum Measurement Mycoplasma genitalium A measurement of the Mycoplasma genitalium in a biological specimen. Mycoplasma genitalium Measurement Mycoplasma genitalium DNA A measurement of the Mycoplasma genitalium DNA in a biological specimen. Mycoplasma genitalium DNA Measurement Mycoplasma hominis DNA A measurement of the Mycoplasma hominis DNA in a biological specimen. Mycoplasma hominis DNA Measurement Mycobacterium kansasii A measurement of the Mycobacterium kansasii in a biological specimen. Mycobacterium kansasii Measurement Morganella morganii A measurement of the Morganella morganii in a biological specimen. Morganella morganii Measurement Mumps rubulavirus RNA Mumps Virus RNA A measurement of the Mumps rubulavirus RNA in a biological specimen. Mumps Virus RNA Measurement Molluscum Contagiosum Virus DNA A measurement of the molluscum contagiosum virus DNA in a biological specimen. Molluscum contagiosum Virus DNA Measurement Morganella A measurement of the organisms that are not assigned to the species level but are assigned to the Morganella genus level in a biological specimen. Morganella Measurement Mycoplasma pneumoniae A measurement of the Mycoplasma pneumoniae in a biological specimen. Mycoplasma pneumoniae Measurement Mycoplasma pneumoniae DNA A measurement of the Mycoplasma pneumoniae DNA in a biological specimen. Mycoplasma pneumoniae DNA Measurement Mycoplasma pneumoniae Nucleic Acid A measurement of the Mycoplasma pneumoniae nucleic acid in a biological specimen. Mycoplasma pneumoniae Nucleic Acid Measurement Murine Pneumonia Virus A measurement of the Murine pneumonia virus in a biological specimen. Murine Pneumonia Virus Measurement Monkey Pox Virus Monkeypox Virus A measurement of the Monkeypox virus in a biological specimen. Monkeypox Virus Measurement Monkeypox Virus DNA A measurement of the Monkeypox virus DNA in a biological specimen. Monkeypox Virus DNA Measurement S. aureus, Methicillin-Resistant Staphylococcus aureus, Methicillin-Resistant A measurement of the methicillin-resistant strain of Staphylococcus aureus in a biological specimen. Methicillin-resistant Staphylococcus aureus Measurement Mycobacterium simiae A measurement of the Mycobacterium simiae in a biological specimen. Mycobacterium simiae Measurement S. aureus, Methicillin-Susceptible Staphylococcus aureus, Methicillin-Susceptible A measurement of the methicillin-susceptible strain of Staphylococcus aureus in a biological specimen. Methicillin-susceptible Staphylococcus aureus Measurement Mycobacterium tuberculosis A measurement of the organisms that are assigned to the Mycobacterium tuberculosis species in a biological specimen. Mycobacterium Tuberculosis Measurement Mycobacterium tuberculosis Complex A measurement of the organisms assignable to the Mycobacterium tuberculosis complex in a biological specimen. Mycobacterium tuberculosis Complex Measurement M. tuberculosis, Rifampin-resistant Mycobacterium tuberculosis, Rifampin-resistant A measurement of the rifampin-resistant strain of Mycobacterium tuberculosis in a biological specimen. Rifampin-resistant Mycobacterium Measurement Mycobacterium A measurement of the organisms that are not assigned to the species level but are assigned to the Mycobacterium genus level in a biological specimen. Mycobacterium Measurement Mycoplasma A measurement of the organisms that are not assigned to the species level but are assigned to the Mycoplasma genus level in a biological specimen. Mycoplasma Measurement M. tuberculosis IFN Gamma Response Mycobacterium tuberculosis IFN Gamma Response A measurement of the amount of interferon gamma that is released when Mycobacterium tuberculosis antigen is incubated with a biological specimen, usually blood. Increased amounts of interferon gamma suggests a prior or existing M. tuberculosis infection. Mycobacterium tuberculosis Interferon Gamma Response Measurement Mycobacterium tuberculosis Nucleic Acid A measurement of the Mycobacterium tuberculosis nucleic acid in a biological specimen. Mycobacterium tuberculosis Nucleic Acid Measurement HCoV-NL63/HCoV-HKU1 RNA Human Coronavirus NL63/Human Coronavirus HKU1 RNA A measurement of the Human coronavirus NL63 and/or Human coronavirus HKU1 RNA in a biological specimen. Human Coronavirus NL63 and/or Human Coronavirus HKU1 RNA Measurement Nocardia cyriacigeorgica A measurement of the Nocardia cyriacigeorgica in a biological specimen. Nocardia cyriacigeorgica Measurement Neisseria gonorrhoeae A measurement of the Neisseria gonorrhoeae in a biological specimen. Neisseria gonorrhoeae Measurement N. gonorrhoeae, Beta-lactamase Negative A measurement of the beta-lactamase negative strain of Neisseria gonorrhoeae in a biological specimen. Neisseria gonorrhoeae, Beta-lactamase Negative Measurement N. gonorrhoeae, Beta-lactamase Positive A measurement of the beta-lactamase positive strain of Neisseria gonorrhoeae in a biological specimen. Neisseria gonorrhoeae, Beta-lactamase Positive Measurement Neisseria gonorrhoeae DNA A measurement of the Neisseria gonorrhoeae DNA in a biological specimen. Neisseria gonorrhoeae DNA Measurement Neisseria gonorrhoeae RNA A measurement of the Neisseria gonorrhoeae RNA in a biological specimen. Neisseria gonorrhoeae RNA Measurement HCoV-NL63 Nucleic Acid Human Coronavirus NL63 Nucleic Acid A measurement of the Human coronavirus NL63 nucleic acid in a biological specimen. Human Coronavirus NL63 Nucleic Acid Measurement HCoV-NL63 RNA Human Coronavirus NL63 RNA A measurement of the Human coronavirus NL63 RNA in a biological specimen. HCoV-NL63 RNA Measurement Neisseria meningitidis A Antigen A measurement of Neisseria meningitidis A antigen in a biological specimen. Neisseria meningitidis A Antigen Measurement Neisseria meningitidis C Antigen A measurement of Neisseria meningitidis C antigen in a biological specimen. Neisseria meningitidis C Antigen Measurement Neisseria meningitidis DNA A measurement of Neisseria meningitidis DNA in a biological specimen. Neisseria meningitidis DNA Measurement Norovirus A measurement of the organisms that are not assigned to the species level but are assigned to the Norovirus genus level in a biological specimen. Norovirus Measurement Norwalk calicivirus RNA Norwalk virus RNA A measurement of the Norwalk virus RNA in a biological specimen. Norwalk virus RNA Measurement Non-tuberculous mycobacteria Nontuberculous Mycobacteria NTM A measurement of the organisms that are assigned to the Mycobacterium genus but are not tuberculosis or leprosy-causing in a biological specimen. Nontuberculous Mycobacteria Measurement Nontuberculous Mycobacteria Nucleic Acid A measurement of the nucleic acid from any nontuberculous member of the Mycobacterium genus in a biological specimen. Nontuberculous Mycobacteria Nucleic Acid Measurement Human Calicivirus Genogroup 2 RNA Norovirus Genogroup II RNA Norovirus GII RNA A measurement of Norovirus genogroup II RNA in a biological specimen. Norovirus Genogroup II RNA Measurement Human Calicivirus Genogroup 1 RNA Norovirus Genogroup 1 RNA Norovirus GI RNA A measurement of Norovirus genogroup I RNA in a biological specimen. Norovirus Genogroup I RNA Measurement Norovirus RNA A measurement of the RNA from any member of the genus Norovirus in a biological specimen. Norovirus RNA Measurement HCoV-OC43 Nucleic Acid Human Coronavirus OC43 Nucleic Acid A measurement of the Human coronavirus OC43 nucleic acid in a biological specimen. Human Coronavirus OC43 Nucleic Acid Measurement HCoV-OC43 RNA Human Coronavirus OC43 RNA A measurement of the Human coronavirus OC43 RNA in a biological specimen. HCoV-OC43 RNA Measurement Ova and Parasite A measurement of the parasites and ova in a biological specimen. Ova and Parasite Measurement Pseudomonas aeruginosa A measurement of the Pseudomonas aeruginosa in a biological specimen. Pseudomonas aeruginosa Measurement Pseudomonas aeruginosa DNA A measurement of the Pseudomonas aeruginosa DNA in a biological specimen. Pseudomonas aeruginosa DNA Measurement P. aeruginosa, Mucoid Pseudomonas aeruginosa, Mucoid A measurement of the mucoid strain of Pseudomonas aeruginosa in a biological specimen. Mucoid Pseudomonas aeruginosa Measurement P. aeruginosa, Non-Mucoid Pseudomonas aeruginosa, Non-Mucoid A measurement of the non-mucoid strain of Pseudomonas aeruginosa in a biological specimen. Non-Mucoid Pseudomonas aeruginosa Measurement P. aeruginosa, Small-colony Variant Pseudomonas aeruginosa, SCV Pseudomonas aeruginosa, Small-colony Variant A measurement of the small-colony variant strain of Pseudomonas aeruginosa in a biological specimen. Small-Colony Variant Pseudomonas aeruginosa Measurement Plasmodium Antigen, MLTTRG Plasmodium Antigen, Multi-Target A measurement of Plasmodium antigen in a biological specimen. This is a multiple-target test. Plasmodium Antigen Measurement Parechovirus RNA A measurement of the RNA from any member of the genus Parechovirus in a biological specimen. Parechovirus RNA Measurement Prevotella bivia A measurement of the Prevotella bivia in a biological specimen. Prevotella bivia Measurement Peptostreptococcus A measurement of the organisms that are not assigned to the species level but are assigned to the Peptostreptococcus genus level in a biological specimen. Peptostreptococcus Measurement Plasmodium falciparum A measurement of the Plasmodium falciparum in a biological specimen. Plasmodium falciparum Measurement Plasmodium falciparum RNA A measurement of the Plasmodium falciparum RNA in a biological specimen. Plasmodium falciparum RNA Measurement Proteus hauseri A measurement of Proteus hauseri in a biological specimen. Proteus hauseri Measurement Plasmodium Histidine Rich Protein 2 Plasmodium Histidine Rich Protein II A measurement of the Plasmodium histidine rich protein 2 in a biological specimen. Plasmodium Histidine Rich Protein 2 Measurement Pneumocystis jiroveci A measurement of the Pneumocystis jiroveci in a biological specimen. Pneumocystis jiroveci Measurement Pneumocystis jiroveci Antigen A measurement of the Pneumocystis jiroveci antigen in a biological specimen. Pneumocystis jiroveci Antigen Measurement Pneumocystis jiroveci DNA A measurement of the Pneumocystis jiroveci DNA in a biological specimen. Pneumocystis jiroveci DNA Measurement Plasmodium knowlesi, Asexual A measurement of the Plasmodium knowlesi in an asexual replication stage in a biological specimen. Asexual Plasmodium knowlesi Measurement Plasmodium knowlesi, Sexual A measurement of the Plasmodium knowlesi in a sexual replication stage in a biological specimen. Sexual Plasmodium knowlesi Measurement Plasmodium Lactate Dehydrogenase A measurement of the Plasmodium lactate dehydrogenase in a biological specimen. Plasmodium Lactate Dehydrogenase Measurement Malaria Plasmodium Examination of a biological specimen to detect the presence of any protozoan belonging to the Plasmodium genus. Plasmodium Measurement Plasmodium, Asexual A measurement of the Plasmodium genus protozoan in an asexual replication stage in a biological specimen. Asexual Plasmodium Measurement Plasmodium, Sexual A measurement of the Plasmodium genus protozoan in a sexual replication stage in a biological specimen. Sexual Plasmodium Measurement Pseudomonas mendocina A measurement of Pseudomonas mendocina in a biological specimen. Pseudomonas mendocina Measurement Proteus mirabilis A measurement of the Proteus mirabilis in a biological specimen. Proteus mirabilis Measurement Proteus penneri A measurement of Proteus penneri in a biological specimen. Proteus penneri Measurement Pseudomonas putida A measurement of Pseudomonas putida in a biological specimen. Pseudomonas putida Measurement Providencia rettgeri A measurement of the Providencia rettgeri in a biological specimen. Providencia rettgeri Measurement Proteus DNA Proteus Species DNA Proteus spp DNA A measurement of the DNA from any member of the genus Proteus in a biological specimen. Proteus DNA Measurement Protozoa A measurement of protozoa in a biological specimen. Protozoa Measurement Pseudomonas A measurement of the organisms that are not assigned to the species level but are assigned to the Pseudomonas genus level in a biological specimen. Pseudomonas Measurement Plesiomonas shigelloides DNA A measurement of the Plesiomonas shigelloides DNA in a biological specimen. Plesiomonas shigelloides DNA Measurement Providencia stuartii A measurement of the Providencia staurtii in a biological specimen. Providencia stuartee Measurement Proteus vulgaris A measurement of the Proteus vulgaris in a biological specimen. Proteus vulgaris Measurement Measles Virus Antigen A measurement of the Rubeola virus antigen in a biological specimen. Rubeola Antigen Measurement Replication Competent Lentivirus RNA A measurement of the RNA from a replication competent viral vector lentivirus in a biological specimen. Replication Competent Lentivirus RNA Measurement Rickettsia DNA A measurement of the DNA from any member of the genus Rickettsia in a biological specimen. Rickettsia DNA Measurement Raoultella ornithinolytica A measurement of Raoultella ornithinolytica in a biological specimen. Raoultella ornithinolytica Measurement Rotavirus Antigen A measurement of the antigen from any member of the genus Rotavirus in a biological specimen. Rotavirus Antigen Measurement Rotavirus A measurement of the organisms that are not assigned to the species level but are assigned to the Rotavirus genus level in a biological specimen. Rotavirus Measurement Rotavirus RNA A measurement of the RNA from any member of the genus Rotavirus in a biological specimen. Rotavirus RNA Measurement Rotavirus A RNA Rotavirus Group A RNA A measurement of the Rotavirus A RNA in a biological specimen. Rotavirus A RNA Measurement Respiratory Syncytial Virus A measurement of the respiratory syncytial virus in a biological specimen. Respiratory Syncytial Virus Measurement Respiratory Syncytial Virus Type A A measurement of the respiratory syncytial virus type A in a biological specimen. Respiratory Syncytial Virus Type A Measurement Respiratory Syncytial Virus Antigen RSV Antigen A measurement of the respiratory syncytial virus antigen in a biological specimen. Respiratory Syncytial Virus Antigen Measurement Respiratory Syncytial Virus Type A Nucleic Acid RSV Type A Nucleic Acid A measurement of the respiratory syncytial virus type A nucleic acid in a biological specimen. Human Respiratory Syncytial Virus Type A Nucleic Acid Measurement Respiratory Syncytial Virus Type A RNA RSV Type A RNA A measurement of the respiratory syncytial virus type A RNA in a biological specimen. Respiratory Syncytial Virus Type A RNA Measurement Respiratory Syncytial Virus Type B A measurement of the respiratory syncytial virus type B in a biological specimen. Respiratory Syncytial Virus Type B Measurement Respiratory Syncytial Virus Type B Nucleic Acid RSV Type B Nucleic Acid A measurement of the respiratory syncytial virus type B nucleic acid in a biological specimen. Human Respiratory Syncytial Virus Type B Nucleic Acid Measurement Respiratory Syncytial Virus Type B RNA RSV Type B RNA A measurement of the respiratory syncytial virus type B RNA in a biological specimen. Respiratory Syncytial Virus Type B RNA Measurement Respiratory Syncytial Virus RNA A measurement of the respiratory syncytial virus RNA in a biological specimen. Respiratory Syncytial Virus RNA Measurement Human rhinovirus/enterovirus A measurement of the Human rhinovirus and/or Human enterovirus in a biological specimen. Human Rhinovirus and/or Enterovirus Measurement Human rhinovirus/enterovirus Nuc Acid Human rhinovirus/enterovirus Nucleic Acid A measurement of nucleic acid from any member of the Human Rhinovirus species and/or Human Enterovirus species in a biological specimen. Human Rhinovirus and/or Enterovirus Nucleic Acid Measurement Human rhinovirus/enterovirus RNA A measurement of RNA from any member of the Human Rhinovirus species and/or Human Enterovirus species in a biological specimen. Human rhinovirus and/or enterovirus RNA Measurement Streptococcus agalactiae A measurement of the Streptococcus agalactiae in a biological specimen. Streptococcus agalactiae Measurement Streptococcus agalactiae Antigen Streptococcus Group B Antigen A measurement of the Streptococcus agalactiae antigen in a biological specimen. Streptococcus agalactiae Antigen Measurement Streptococcus agalactiae DNA A measurement of the Streptococcus agalactiae DNA in a biological specimen. Streptococcus agalactiae DNA Measurement Salmonella Antigen A measurement of the antigen from any member of the genus Salmonella in a biological specimen. Salmonella Antigen Measurement Salmonella DNA A measurement of the DNA from any member of the genus Salmonella in a biological specimen. Salmonella DNA Measurement Salmonella A measurement of the organisms that are not assigned to the species level but are assigned to the Salmonella genus level in a biological specimen. Salmonella Measurement Streptococcus anginosus A measurement of the Streptococcus anginosus in a biological specimen. Streptococcus anginosus Measurement Streptococcus anginosus Group A measurement of Streptococcus anginosus Group in a biological specimen. Streptococcus anginosus Group Measurement SARS-CoV-1/SARS-CoV-2 Antigen A measurement of the antigens from SARS-CoV-1 and/or SARS-CoV-2 in a biological specimen. SARS-CoV-1/SARS-CoV-2 Antigen Measurement SARS-CoV-2 Antigen A measurement of the SARS-CoV-2 antigen in a biological specimen. SARS-CoV-2 Antigen Measurement SARS-CoV-2 N Protein Antigen A measurement of the SARS-CoV-2 nucleocapsid protein antigen in a biological specimen. SARS-CoV-2 Nucleocapsid Protein Antigen Measurement SARS-CoV-2 RNA A measurement of the SARS-CoV-2 RNA in a biological specimen. SARS-CoV-2 RNA Measurement SARS-CoV-2 S Gene SARS-CoV-2 S RNA SARS-CoV-2 Spike RNA A measurement of the SARS-CoV-2 S RNA in a biological specimen. SARS-CoV-2 S RNA Measurement SARS-related Coronavirus RNA/MERS RNA A measurement of the SARS-related and/or MERS Coronavirus RNA which includes but not limited to SARS-CoV, SARS-CoV-2, other SARS-like Coronavirus, and/or MERS-CoV in a biological specimen. SARS-related Coronavirus RNA/MERS RNA Measurement SARS-CoV SARS-CoV-1 Severe Acute Respiratory Syndrome-Related Coronavirus A measurement of the severe acute respiratory syndrome-related Coronavirus in a biological specimen. Severe Acute Respiratory Syndrome-related Coronavirus Measurement SARS-CoV-2 Severe Acute Resp Syndrome Coronavirus 2 Severe Acute Respiratory Syndrome Coronavirus 2 A measurement of the severe acute respiratory syndrome Coronavirus 2 in a biological specimen. Severe Acute Respiratory Syndrome Coronavirus 2 Measurement SARS-related Coronavirus RNA A measurement of the SARS-related Coronavirus RNA including but not limited to SARS-CoV, SARS-CoV-2, and/or other SARS-like Coronavirus in a biological specimen. SARS-related Coronavirus RNA Measurement Staphylococcus aureus DNA A measurement of the Staphylococcus aureus DNA in a biological specimen. Staphylococcus aureus DNA Measurement S. aureus Staphylococcus aureus A measurement of the Staphylococcus aureus in a biological specimen. Staphylococcus aureus Measurement Salmonella enterica A measurement of the Salmonella enterica in a biological specimen. Salmonella enterica Measurement Salmonella enterica/bongori DNA A measurement of the Salmonella enterica and/or Salmonella bongori DNA in a biological specimen. Salmonella enterica and/or Salmonella bongori DNA Measurement Staphylococcus epidermidis A measurement of the Staphylococcus epidermidis in a biological specimen. Staphylococcus epidermidis Measurement Serratia A measurement of the organisms that are not assigned to the species level but are assigned to the Serratia genus level in a biological specimen. Serratia Measurement Streptococcus gallolyticus A measurement of Streptococcus gallolyticus in a biological specimen. Streptococcus gallolyticus Measurement Staphylococcus haemolyticus A measurement of the Staphylococcus haemolyticus in a biological specimen. Staphylococcus haemolyticus Measurement Shigella Antigen A measurement of the antigen from any member of the genus Shigella in a biological specimen. Shigella Antigen Measurement Shiga Toxin A measurement of the shiga toxin in a biological specimen. Shiga Toxin Measurement Shigella DNA A measurement of the DNA from any member of the genus Shigella in a biological specimen. Shigella DNA Measurement Shigella/EIEC Shigella/Enteroinvasive E. coli Shigella/Enteroinvasive Escherichia coli A measurement of the organisms that are not assigned to the species level but are assigned to the Shigella genus level and/or enteroinvasive Escherichia coli in a biological specimen. Shigella and/or Enteroinvasive Escherichia coli DNA Measurement Shigella A measurement of the organisms that are not assigned to the species level but are assigned to the Shigella genus level in a biological specimen. Shigella Measurement Staphylococcus hominis A measurement of Staphylococcus hominis in a biological specimen. Staphylococcus hominis Measurement Serratia marcescens A measurement of the Serratia marcescens in a biological specimen. Serratia marcescens Measurement Serratia marcescens DNA A measurement of the Serratia marcescens DNA in a biological specimen. Serratia marcescens DNA Measurement Streptococcus mitis A measurement of Streptococcus mitis in a biological specimen. Streptococcus mitis Measurement Spirochaetales Spirochete Bacteria A measurement of the organisms that are not assigned to the species level but are assigned to the Spirochaetales order level in a biological specimen. Spirochaetales Measurement Streptococcus pneumoniae A measurement of the Streptococcus pneumoniae in a biological specimen. Streptococcus pneumoniae Measurement Streptococcus pneumoniae Antigen A measurement of the Streptococcus pneumoniae antigen in a biological specimen. Streptococcus pneumoniae Antigen Measurement Streptococcus pneumoniae DNA A measurement of Streptococcus pneumoniae DNA in a biological specimen. Streptococcus pneumoniae DNA Measurement Streptococcus pyogenes A measurement of the Streptococcus pyogenes in a biological specimen. Streptococcus pyogenes Measurement Streptococcus pyogenes Antigen A measurement of the Streptococcus pyogenes antigen in a biological specimen. Streptococcus pyogenes Antigen Measurement Streptococcus pyogenes DNA A measurement of the Streptococcus pyogenes DNA in a biological specimen. Streptococcus pyogenes DNA Measurement SARS-CoV-2 RdRp Gene SARS-CoV-2 RdRp RNA SARS-CoV-2 RNA-dependent RNA Polymerase RNA A measurement of the SARS-CoV-2 RdRp RNA in a biological specimen. SARS-CoV-2 RdRp RNA Measurement Staphylococcus saprophyticus A measurement of the Staphylococcus saprophyticus in a biological specimen. Staphylococcus saprophyticus Measurement Streptococcus salivarius A measurement of Streptococcus salivarius in a biological specimen. Streptococcus salivarius Measurement Staphylococcus, Coagulase Negative DNA A measurement of the DNA from any coagulase negative Staphylococcus species in a biological specimen. Coagulase Negative Staphylococcus DNA Measurement Staphylococcus, Coagulase Negative A measurement of the coagulase negative Staphylococcus species in a biological specimen. Coagulase Negative Staphylococcus Measurement Staphylococcus, Coagulase Positive A measurement of the coagulase positive Staphylococcus species in a biological specimen. Coagulase Positive Staphylococcus Measurement Stenotrophomonas maltophilia A measurement of the organisms that are assigned to the Stenotrophomonas maltophilia species in a biological specimen. Stenotrophomonas maltophilia Measurement Streptococcus thoraltensis A measurement of Streptococcus thoraltensis in a biological specimen. Streptococcus thoraltensis Measurement Streptococcus beta-hemolytic A measurement of beta-hemolytic Streptococcus in a biological specimen. Beta-Hemolytic Streptococcus Measurement Streptococcus gamma-hemolytic A measurement of gamma-hemolytic Streptococcus in a biological specimen. Gamma-Hemolytic Streptococcus Measurement Streptococcus A measurement of the organisms that are not assigned to the species level but are assigned to the Streptococcus genus level in a biological specimen. Streptococcus Measurement Streptococcus viridans A measurement of Streptococcus viridans in a biological specimen. Streptococcus viridans Measurement Tick-Borne Encephalitis Virus RNA A measurement of the Tick-borne Encephalitis virus RNA in a biological specimen. Tick Borne Encephalitis Virus RNA Measurement Toxoplasma gondii DNA A measurement of the Toxoplasma gondii DNA in a biological specimen. Toxoplasma gondii DNA Measurement Toscana Virus RNA A measurement of the Toscana virus RNA in a biological specimen. Toscana Virus RNA Measurement Toxin B-Producing Clostridium difficile A measurement of the toxin B-producing strain of Clostridium difficile in a biological specimen. Toxin B-Producing Clostridium difficile Measurement Toxigenic Clostridium difficile A measurement of the toxigenic strain of Clostridium difficile in a biological specimen. Toxigenic Clostridium difficile Measurement Treponema pallidum A measurement of the Treponema pallidum in a biological specimen. Treponema pallidum Measurement Treponema pallidum DNA A measurement of the Treponema pallidum DNA in a biological specimen. Treponema pallidum DNA Measurement Trichomonas Examination of a biological specimen to detect the presence of any protozoan belonging to the Trichomonas genus. Trichomonas Screening Trichomonas RNA A measurement of the RNA from any member of the genus Trichomonas in a biological specimen. Trichomonas RNA Measurement Trichomonas vaginalis A measurement of the Trichomonas vaginalis in a biological specimen. Trichomonas vaginalis Measurement Trichomonas vaginalis DNA A measurement of the Trichomonas vaginalis DNA in a biological specimen. Trichomonas vaginalis DNA Measurement Ureaplasma parvum A measurement of the Ureaplasma parvum in a biological specimen. Ureaplasma parvum Measurement Ureaplasma parvum DNA A measurement of the Ureaplasma parvum DNA in a biological specimen. Ureaplasma parvum DNA Measurement Urease A measurement of the microbial urease enzyme in a biological specimen. Urease Measurement Ureaplasma urealyticum A measurement of the Ureaplasma urealyticum in a biological specimen. Ureaplasma urealyticum Measurement Ureaplasma urealyticum DNA A measurement of the Ureaplasma urealyticum DNA in a biological specimen. Ureaplasma urealyticum DNA Measurement Vaccinia Virus A measurement of the Vaccinia virus in a biological specimen. Vaccinia Virus Measurement Vibrio cholerae DNA A measurement of the Vibrio cholerae DNA in a biological specimen. Vibrio cholerae DNA Measurement Vibrio parahaemolyticus DNA A measurement of the Vibrio parahaemolyticus DNA in a biological specimen. Vibrio parahaemolyticus DNA Measurement Enterococcus, Vancomycin-resistant A measurement of the organisms that are vancomycin-resistant, and are not assigned to the species level but are assigned to the Enterococcus genus level in a biological specimen. Vancomycin-resistant Enterococcus Measurement Varicella Zoster Virus A measurement of the varicella zoster virus in a biological specimen. Varicella Zoster Virus Measurement Varicella Zoster Virus DNA A measurement of the Varicella Zoster virus DNA in a biological specimen. Varicella Zoster Virus DNA Measurement West Nile Virus RNA A measurement of the West Nile virus RNA in a biological specimen. West Nile Virus RNA Measurement Yeast Cells A measurement of the yeast cells present in a biological specimen. Yeast Cell Measurement Budding Yeast Yeast Budding A measurement of the budding yeast present in a biological specimen. Budding Yeast Measurement Yeast Hyphae A measurement of the yeast hyphae present in a biological specimen. Yeast Hyphae Screening Yersinia enterocolitica DNA A measurement of the Yersinia enterocolitica DNA in a biological specimen. Yersinia enterocolitica DNA Measurement Yersinia A measurement of the organisms that are not assigned to the species level but are assigned to the Yersinia genus level in a biological specimen. Yersinia Measurement Zaire Ebolavirus A measurement of the Zaire ebolavirus present in a biological specimen. Zaire Ebolavirus Measurement Zika Virus RNA A measurement of the Zika virus RNA in a biological specimen. Zika Virus RNA Measurement MBTESTCD Microbiology Test Code CDISC SDTM Microbiology Test Code Terminology Terminology relevant to the microbiology test names of the CDISC Study Data Tabulation Model. A. calcoaceticus-baumannii Complex DNA Acinetobacter calcoaceticus-baumannii Complex DNA A measurement of Acinetobacter Calcoaceticus-Baumannii complex DNA in a biological specimen. Acinetobacter calcoaceticus/baumannii Complex DNA Measurement A. calcoaceticus-baumannii Complex Acinetobacter calcoaceticus-baumannii Complex A measurement of the Acinetobacter calcoaceticus-baumannii complex in a biological specimen. Acinetobacter calcoaceticus/baumannii Complex Measurement Achromobacter denitrificans A measurement of Achromobacter denitrificans in a biological specimen. Achromobacter denitrificans Measurement Achromobacter xylosoxidans A measurement of the Achromobacter xylosoxidans in a biological specimen. Achromobacter xylosoxidans Measurement Acid-Fast Bacilli A measurement of any rod-shaped bacteria that resist decolorizing by acid after accepting an aqueous stain solution, due to the mycolic acids in their cell walls. Acid-Fast Bacilli Measurement Acinetobacter anitratus A measurement of Acinetobacter anitratus in a biological specimen. Acinetobacter anitratus Measurement Acinetobacter baumannii A measurement of Acinetobacter baumannii in a biological specimen. Acinetobacter baumannii Measurement Acinetobacter johnsonii A measurement of Acinetobacter johnsonii in a biological specimen. Acinetobacter johnsonii Measurement Acinetobacter lactucae A measurement of Acinetobacter lactucae in a biological specimen. Acinetobacter lactucae Measurement Acinetobacter lwoffii A measurement of the Acinetobacter lwoffii in a biological specimen. Acinetobacter Iwoffii Measurement Acinetobacter pittii A measurement of Acinetobacter pittii in a biological specimen. Acinetobacter pittii Measurement Acinetobacter ursingii A measurement of Acinetobacter ursingii in a biological specimen. Acinetobacter ursingii Measurement Acinetobacter A measurement of the organisms that are not assigned to the species level but are assigned to the Acinetobacter genus level in a biological specimen. Acinetobacter Measurement Acinetobacter, Carbapenem-resistant Carbapenem Resistant Acinetobacter A measurement of the organisms that are not assigned to the species level but are assigned to the Enterococcus genus level and are also carbapenem-resistant in a biological specimen. Carbapenem-resistant Acinetobacter Measurement Adenoviridae Adenovirus A measurement of the adenoviridae in a biological specimen. Adenoviridae Measurement Adenovirus Antigen A measurement of the Adenovirus antigen in a biological specimen. Adenovirus Antigen Measurement Adenovirus DNA A measurement of the DNA from any member of the family Adenoviridae in a biological specimen. Adenovirus DNA Measurement Adenovirus Nucleic Acid A measurement of the nucleic acid from any member of the family Adenoviridae in a biological specimen. Adenovirus Nucleic Acid Measurement Aerobic Bacteria A measurement of the aerobic bacteria in a biological specimen. Aerobic Bacteria Measurement Aerococcus urinae A measurement of Aerococcus urinae in a biological specimen. Aerococcus urinae Measurement Aeromonas DNA A measurement of the DNA from any member of the genus Aeromonas in a biological specimen. Aeromonas DNA Measurement Aeromonas A measurement of the organisms that are not assigned to the species level but are assigned to the Aeromonas genus level in a biological specimen. Aeromonas Measurement Anaerobic Bacteria A measurement of the anaerobic bacteria in a biological specimen. Anaerobic Bacteria Measurement Anaplasma DNA A measurement of the DNA from any member of the genus Anaplasma in a biological specimen. Anaplasma DNA Measurement Anaplasma A measurement of the organisms that are not assigned to the species level but are assigned to the Anaplasma genus level in a biological specimen. Anaplasma Measurement Aspergillus Antigen A measurement of the antigen from any member of the genus Aspergillus in a biological specimen. Aspergillus Antigen Measurement Aspergillus DNA A measurement of the DNA from any member of the genus Aspergillus in a biological specimen. Aspergillus DNA Measurement Aspergillus fumigatus A measurement of the Aspergillus fumigatus in a biological specimen. Aspergillus fumigatus Measurement Aspergillus niger A measurement of the Aspergillus niger in a biological specimen. Aspergillus niger Measurement Aspergillus A measurement of the organisms that are not assigned to the species level but are assigned to the Aspergillus genus level in a biological specimen. Aspergillus Measurement Babesia DNA A measurement of the DNA from any member of the genus Babesia in a biological specimen. Babesia DNA Measurement Bacilli Rod-shaped Bacteria A measurement of the rod-shaped bacilli in a biological specimen. Bacillus Measurement Bacilli/Leukocytes A relative measurement (ratio or percentage) of the bacilli to leukocytes in a biological specimen. Bacillus to Leukocyte Ratio Measurement Bacillota A measurement of the organisms that are not assigned to the species level but are assigned to the Bacillota phylum level in a biological specimen. Bacillota Measurement Bacteria A measurement of the bacteria in a biological specimen. Bacterial Count Bacterial Beta-lactamase A measurement of the bacterial enzyme beta-lactamase in a biological specimen. Bacterial Beta-lactamase Measurement Bacterial Lipopolysaccharide Antigen A measurement of the lipopolysaccharide antigen from bacteria in a biological specimen. Bacterial Lipopolysaccharide Antigen Measurement Bacterial Sialidase A measurement of the bacterial sialidase enzyme in a biological specimen. Bacterial Sialidase Measurement Bacteroidia A measurement of the organisms that are not assigned to the species level but are assigned to the Bacteroidia phylum level in a biological specimen. Bacteroidia Measurement Beta-lactamase Negative Bacteria A measurement of the beta-lactamase negative bacteria in a biological specimen. Beta-lactamase Negative Bacteria Measurement Beta-lactamase Positive Bacteria A measurement of the beta-lactamase positive bacteria in a biological specimen. Beta-lactamase Positive Bacteria Measurement Blastocystis hominis DNA A measurement of the Blastocystis hominis DNA in a biological specimen. Blastocystis hominis DNA Measurement Bordetella parapertussis DNA A measurement of the Bordetella parapertussis DNA in a biological specimen. Bordetella Parapertussis DNA Measurement Bordetella parapertussis A measurement of the Bordetella parapertussis in a biological specimen. Bordetella Parapertussis Measurement Bordetella pertussis Antigen A measurement of the Bordetella pertussis antigen in a biological specimen. Bordetella pertussis Antigen Measurement Bordetella pertussis DNA A measurement of the Bordetella pertussis DNA in a biological specimen. Bordetella pertussis DNA Measurement Bordetella pertussis A measurement of the Bordetella pertussis in a biological specimen. Bordetella pertussis Measurement Borrelia DNA A measurement of the DNA from any member of the genus Borrelia in a biological specimen. Borrelia DNA Measurement Burkholderia ambifaria A measurement of the Burkholderia ambifaria in a biological specimen. Burkholderia ambifaria Measurement Burkholderia anthina A measurement of the Burkholderia anthina in a biological specimen. Burkholderia anthina Measurement Burkholderia cenocepacia A measurement of the Burkholderia cenocepacia in a biological specimen. Burkholderia cenocepacia Measurement B. cepacia Burkholderia cepacia Pseudomonas cepacia A measurement of the Burkholderia cepacia in a biological specimen. Burkholderia cepacia Measurement Burkholderia dolosa A measurement of the Burkholderia dolosa in a biological specimen. Burkholderia dolosa Measurement Burkholderia multivorans A measurement of the Burkholderia multivorans in a biological specimen. Burkholderia multivorans Measurement Burkholderia pyrrocinia A measurement of the Burkholderia pyrrocinia in a biological specimen. Burkholderia pyrrocinia Measurement Burkholderia stabilis A measurement of the Burkholderia stabilis in a biological specimen. Burkholderia stabilis Measurement Burkholderia vietnamiensis A measurement of the Burkholderia vietnamiensis in a biological specimen. Burkholderia vietnamiensis Measurement Burkholderia A measurement of the organisms that are not assigned to the species level but are assigned to the Burkholderia genus level in a biological specimen. Burkholderia Measurement C. coli/jejuni/upsaliensis DNA Campylobacter coli/jejuni/upsaliensis DNA A measurement of the Campylobacter coli, Campylobacter jejuni and/or Campylobacter upsaliensis DNA in a biological specimen. Campylobacter coli, Campylobacter jejuni and/or Campylobacter upsaliensis DNA Measurement C. difficile Glutamate Dehydrogenase Clostridium difficile Glutamate Dehydrogenase A measurement of the Clostridium difficile glutamate dehydrogenase in a biological specimen. C. difficile Glutamate Dehydrogenase Measurement Campylobacter coli A measurement of the Campylobacter coli in a biological specimen. Campylobacter coli Measurement Campylobacter DNA A measurement of the DNA from any member of the genus Campylobacter in a biological specimen. Campylobacter DNA Measurement Campylobacter jejuni A measurement of the Campylobacter jejuni in a biological specimen. Campylobacter jejuni Measurement Campylobacter A measurement of the organisms that are not assigned to the species level but are assigned to the Campylobacter genus level in a biological specimen. Campylobacter Measurement Candida albicans DNA A measurement of the Candida albicans DNA in a biological specimen. Candida albicans DNA Measurement Candida albicans Candida stellatoidea A measurement of the Candida albicans in a biological specimen. Candida albicans Measurement Candida Antigen A measurement of the antigen from any member of the genus Candida in a biological specimen. Candida Antigen Measurement Candida dubliniensis A measurement of the Candida dubliniensis in a biological specimen. Candida dubliniensis Measurement Candida glabrata A measurement of the Candida glabrata in a biological specimen. Candida glabrata Measurement Candida parapsilosis Complex A measurement of Candida parapsilosis Complex in a biological specimen. Candida parapsilosis Complex Measurement Candida parapsilosis A measurement of Candida parapsilosis in a biological specimen. Candida parapsilosis Measurement Candida rugosa A measurement of Candida rugosa in a biological specimen. Candida rugosa Measurement Candida tropicalis A measurement of Candida tropicalis in a biological specimen. Candida tropicalis Measurement Candida A measurement of the organisms that are not assigned to the species level but are assigned to the Candida genus level in a biological specimen. Candida Measurement Candida auris Candidozyma auris A measurement of Candidozyma auris in a biological specimen. Candidozyma auris Measurement Chikungunya Virus RNA A measurement of the Chikungunya virus RNA in a biological specimen. Chikungunya Virus RNA Measurement Chlamydia pneumoniae DNA A measurement of the Chlamydia pneumoniae DNA in a biological specimen. Chlamydia pneumoniae DNA Measurement Chlamydia pneumoniae Nucleic Acid A measurement of the Chlamydia pneumoniae nucleic acid in a biological specimen. Chlamydia pneumoniae Nucleic Acid Measurement Chlamydia pneumoniae A measurement of the Chlamydia pneumoniae in a biological specimen. Chlamydia Pneumoniae Measurement Chlamydia trachomatis Antigen A measurement of the Chlamydia trachomatis antigen in a biological specimen. Chlamydia Trachomatis Antigen Measurement Chlamydia trachomatis DNA A measurement of the Chlamydia trachomatis DNA in a biological specimen. Chlamydia trachomatis DNA Measurement Chlamydia trachomatis RNA A measurement of the Chlamydia trachomatis RNA in a biological specimen. Chlamydia Trachomatis RNA Measurement Chlamydia trachomatis A measurement of the Chlamydia trachomatis in a biological specimen. Chlamydia trachomatis Measurement Chlamydia A measurement of the organisms that are not assigned to the species level but are assigned to the Chlamydia genus level in a biological specimen. Chlamydia Measurement Chlamydophila psittaci DNA A measurement of the Chlamydophila psittaci DNA in a biological specimen. Chlamydophila psittaci DNA Measurement Citrobacter braakii A measurement of the Citrobacter braakii in a biological specimen. Citrobacter braakii Measurement Citrobacter freundi A measurement of the Citrobacter freundi in a biological specimen. Citrobacter freundi Measurement Citrobacter koseri A measurement of the Citrobacter koseri in a biological specimen. Citrobacter koseri Measurement Clostridium botulinum A measurement of the Clostridium botulinum in a biological specimen. Clostridium botulinum Measurement Clostridium difficile 027/NAP1/BI A measurement of the 027/NAP1/BI strain of Clostridium difficile in a biological specimen. Clostridium difficile 027/NAP1/BI Measurement Clostridium difficile A Toxin A measurement of the Clostridium difficile toxin A in a biological specimen. Clostridium difficile A Toxin Measurement Clostridium difficile A/B Toxin A measurement of the Clostridium difficile A and/or B toxin in a biological specimen. Clostridium difficile A and/or B Toxin Measurement Clostridium difficile B Toxin A measurement of the Clostridium difficile toxin B in a biological specimen. Clostridium difficile B Toxin Measurement Clostridium difficile cdt DNA A measurement of the Clostridium difficile binary toxin (cdt) DNA in a biological specimen. Clostridium difficile cdt DNA Measurement Clostridium difficile DNA A measurement of the Clostridium difficile DNA in a biological specimen. Clostridium difficile DNA Measurement Clostridium difficile tcdA DNA A measurement of the Clostridium difficile toxin A (tcdA) DNA in a biological specimen. Clostridium difficile tcdA DNA Measurement Clostridium difficile tcdB DNA A measurement of the Clostridium difficile toxin B (tcdB) DNA in a biological specimen. Clostridium difficile tcdB DNA Measurement Clostridium difficile tcdC DNA A measurement of the Clostridium difficile regulatory protein (tcdC) DNA in a biological specimen. Clostridium difficile tcdC DNA Measurement Clostridium difficile Toxin A measurement of the Clostridium difficile toxin in a biological specimen. Clostridium difficile Toxin Measurement Clostridium difficile A measurement of the Clostridium difficile in a biological specimen. Clostridium difficile Measurement Coronaviridae Coronavirus A measurement of the coronaviridae in a biological specimen. Coronaviridae Measurement Coronavirus RNA A measurement of the RNA from any member of the family Coronaviridae in a biological specimen. Coronavirus RNA Measurement Corynebacterium amycolatum A measurement of Corynebacterium amycolatum in a biological specimen. Corynebacterium amycolatum Measurement Corynebacterium aurimucosum A measurement of Corynebacterium aurimucosum in a biological specimen. Corynebacterium aurimucosum Measurement Corynebacterium jeikeium A measurement of Corynebacterium jeikeium in a biological specimen. Corynebacterium jeikeium Measurement Corynebacterium striatum A measurement of Corynebacterium striatum in a biological specimen. Corynebacterium striatum Measurement Corynebacterium tuberculostearicum A measurement of Corynebacterium tuberculostearicum in a biological specimen. Corynebacterium tuberculostearicum Measurement Corynebacterium urealyticum A measurement of Corynebacterium urealyticum in a biological specimen. Corynebacterium urealyticum Measurement Corynebacterium A measurement of the organisms that are not assigned to the species level but are assigned to the Corynebacterium genus level in a biological specimen. Corynebacterium Measurement Cryptococcus Antigen A measurement of the antigen from any member of the genus Cryptococcus in a biological specimen. Cryptococcus Antigen Measurement Cryptococcus neoformans/gattii DNA A measurement of Cryptococcus neoformans and/or Cryptococcus gattii DNA in a biological specimen. Cryptococcus neoformans and/or gattii DNA Measurement Cryptosporidium Antigen A measurement of the antigen from any member of the genus Cryptosporidium in a biological specimen. Cryptosporidium Antigen Measurement Cryptosporidium DNA A measurement of the DNA from any member of the genus Cryptosporidium in a biological specimen. Cryptosporidium DNA Measurement Cryptosporidium parvum Antigen A measurement of the Cryptosporidium parvum antigen in a biological specimen. Cryptosporidium parvum Antigen Measurement Curved Bacillus Curved Rods A measurement of the curved rod-shaped bacillus in a biological specimen. Curved Bacillus Measurement Cyanobacteria A measurement of the organisms that are not assigned to the species level but are assigned to the Cyanobacteria phylum level in a biological specimen. Cyanobacteria Measurement Cyclospora cayetanensis DNA A measurement of the Cyclospora cayetanensis DNA in a biological specimen. Cyclospora cayetanensis DNA Measurement Cytomegalovirus Antigen A measurement of the Cytomegalovirus antigen in a biological specimen. Cytomegalovirus Antigen Measurement Cytomegalovirus DNA A measurement of the Cytomegalovirus DNA in a biological specimen. Cytomegalovirus DNA Measurement Cytomegalovirus Phosphoprotein 65 Antigen Cytomegalovirus pp65 Antigen A measurement of the Cytomegalovirus phosphoprotein 65 (pp65) antigen in a biological specimen. Cytomegalovirus pp65 Antigen Measurement Cytomegalovirus A measurement of the organisms that are not assigned to the species level but are assigned to the Cytomegalovirus genus level in a biological specimen. Cytomegalovirus Measurement Dengue Virus 1 RNA A measurement of the dengue virus 1 RNA in a biological specimen. Dengue Virus 1 RNA Measurement Dengue Virus 1/2/3/4 RNA A measurement of the RNA from the dengue virus serotype 1, 2, 3 and/or 4 in a biological specimen. Dengue Virus 1, 2, 3, and/or 4 RNA Measurement Dengue Virus 2 RNA A measurement of the dengue virus 2 RNA in a biological specimen. Dengue Virus 2 RNA Measurement Dengue Virus 3 RNA A measurement of the dengue virus 3 RNA in a biological specimen. Dengue Virus 3 RNA Measurement Dengue Virus 4 RNA A measurement of the dengue virus 4 RNA in a biological specimen. Dengue Virus 4 RNA Measurement Dengue Virus Nonstructural Protein 1 Dengue Virus NS1 Antigen A measurement of the dengue virus NS1 antigen in a biological specimen. Dengue Virus NS1 Antigen Measurement Dengue Virus RNA A measurement of the dengue virus RNA in a biological specimen. Dengue Virus RNA Measurement Dientamoeba fragilis DNA A measurement of the Dientamoeba fragilis DNA in a biological specimen. Dientamoeba fragilis DNA Measurement E.Coli K1/N.Meningitidis Serogroup B Ag Escherichia coli K1/Neisseria meningitidis Group B Antigen Escherichia coli K1/Neisseria meningitidis Serogroup B Antigen A measurement of the antigen from Escherichia coli K1 and/or Neisseria meningitidis serogroup B in a biological specimen. Escherichia coli K1 and/or Neisseria meningitidis Group B Antigen Measurement EAEC pAA Plasmid aggR/aatA DNA Enteroaggregative Escherichia coli pAA Plasmid aggR/aatA DNA A measurement of the enteroaggregative Escherichia coli pAA plasmid aggR and/or aatA DNA in a biological specimen. Enteroaggregative Escherichia coli pAA Plasmid aggR and/or aatA DNA Measurement Ebola Virus A measurement of the Ebola virus in a biological specimen. Ebola Virus Measurement Ehrlichia DNA A measurement of the DNA from any member of the genus Ehrlichia in a biological specimen. Ehrlichia DNA Measurement Entamoeba dispar DNA A measurement of the Entamoeba dispar DNA in a biological specimen. Entamoeba dispar DNA Measurement Entamoeba dispar A measurement of the Entamoeba dispar in a biological specimen. Entamoeba dispar Measurement Entamoeba histolytica DNA A measurement of the Entamoeba histolytica DNA in a biological specimen. Entamoeba histolytica DNA Measurement Enterobacter cloacae Complex DNA A measurement of the Enterobacter cloacae complex DNA in a biological specimen. Enterobacter cloacae Complex DNA Measurement Enterobacter cloacae Complex A measurement of the Enterobacter cloacae complex in a biological specimen. Enterobacter cloacae Complex Measurement Enterobacter cloacae A measurement of the Enterobacter cloacae in a biological specimen. Enterobacter cloacae Measurement Enterobacter hormaechei A measurement of Enterobacter hormaechei in a biological specimen. Enterobacter hormaechei Measurement Enterobacter A measurement of the organisms that are not assigned to the species level but are assigned to the Enterobacter genus level in a biological specimen. Enterobacter Measurement Enterobacterales, Carbapenem-resistant A measurement of the organisms that are not assigned to the species level but are assigned to the Enterobacterales order level and are also carbapenem-resistant in a biological specimen. Carbapenem Resistant Enterobacterales Measurement Enterococcus avium A measurement of Enterococcus avium in a biological specimen. Enterococcus avium Measurement Enterococcus faecalis DNA A measurement of the Enterococcus faecalis DNA in a biological specimen. Enterococcus faecalis DNA Measurement Streptococcus faecalis A measurement of the Enterococcus faecalis in a biological specimen. Enterococcus faecalis Measurement Enterococcus faecium A measurement of the Enterococcus faecium in a biological specimen. Enterococcus faecium Measurement Enterococcus gallinarum A measurement of Enterococcus gallinarum in a biological specimen. Enterococcus gallinarum Measurement Enterococcus A measurement of the organisms that are not assigned to the species level but are assigned to the Enterococcus genus level in a biological specimen. Enterococcus Measurement Enterococcus, Vancomycin-resistant A measurement of the organisms that are vancomycin-resistant, and are not assigned to the species level but are assigned to the Enterococcus genus level in a biological specimen. Vancomycin-resistant Enterococcus Measurement Enterohemorrhagic Escherichia coli A measurement of the enterohemorrhagic Escherichia coli in a biological specimen. Enterohemorrhagic Escherichia coli Measurement Enterovirus RNA A measurement of the RNA from any member of the genus Enterovirus in a biological specimen. Enterovirus RNA Measurement Enterovirus A measurement of the organisms that are not assigned to the species level but are assigned to the Enterovirus genus level in a biological specimen. Enterovirus Measurement Enteropathogenic Escherichia coli eae DNA EPEC eae DNA A measurement of the enteropathogenic Escherichia coli eae DNA in a biological specimen. Enteropathogenic Escherichia coli eae DNA Measurement Epstein-Barr DNA Human Herpesvirus 4 DNA A measurement of the Epstein-Barr virus DNA in a biological specimen. Epstein-Barr DNA Measurement Epstein-Barr Early Antigen A measurement of the Epstein-Barr early antigen in a biological specimen. Epstein-Barr Early Antigen Measurement Epstein-Barr Nuclear Antigen A measurement of the Epstein-Barr nuclear antigen in a biological specimen. Epstein-Barr Nuclear Antigen Measurement Epstein-Barr Virus Latent Membrane Protein 1 Epstein-Barr Virus LMP1 A measurement of the epstein-barr virus latent membrane protein 1 in a biological specimen. Epstein-Barr Virus Latent Membrane Protein 1 Measurement Epstein-Barr Virus A measurement of the Epstein-Barr virus in a biological specimen. Epstein-Barr Virus Measurement Escherichia coli DNA A measurement of the Escherichia coli DNA in a biological specimen. Escherichia coli DNA Measurement Escherichia coli K1 DNA A measurement of the Escherichia coli K1 DNA in a biological specimen. Escherichia coli K1 DNA Measurement Escherichia coli O Antigen A measurement of the Escherichia coli O antigen in a biological specimen. Escherichia coli O Antigen Measurement Escherichia coli O157 Antigen A measurement of the Escherichia coli O157 antigen in a biological specimen. Escherichia coli O157 Antigen Measurement Escherichia coli O157 DNA A measurement of the Escherichia coli O157 DNA in a biological specimen. Escherichia coli O157 DNA Measurement Escherichia coli Shiga-like Toxin A measurement of the total Escherichia coli shiga-like toxin in a biological specimen. Escherichia coli Shiga-like Toxin Measurement Escherichia coli Verotoxin A measurement of the total Escherichia coli verotoxin in a biological specimen. Escherichia coli Verotoxin Measurement Escherichia coli A measurement of the Escherichia coli in a biological specimen. Escherichia coli Measurement Escherichia fergusonii A measurement of Escherichia fergusonii in a biological specimen. Escherichia fergusonii Measurement Enterotoxigenic Escherichia coli LtA/ST1a/ST1b DNA ETEC LtA/ST1a/ST1b DNA A measurement of the enterotoxigenic Escherichia coli LtA, ST1a and/or ST1b DNA in a biological specimen. Enterotoxigenic Escherichia coli LtA, ST1a, and/or ST1b DNA Measurement Firmicutes/Bacteroidetes Ratio A ratio measurement of the members from the phylum Firmicutes to the members from the phylum Bacteroidetes in a biological specimen. Firmicutes to Bacteroidetes Ratio Measurement Flagellates A measurement of the flagellates (protozoans that possess flagella) in a biological specimen. Flagellates Measurement Fungi Fungus A measurement of the fungi in a biological specimen. Fungi Measurement Fungi, Filamentous A measurement of the filamentous fungi in a biological specimen. Filamentous Fungi Count Fungi, Yeast-Like A measurement of the yeast-like fungi in a biological specimen. Yeast-Like Fungi Count Fusobacterium nucleatum A measurement of the Fusobacterium nucleatum in a biological specimen. Fusobacterium nucleatum Measurement Galactomannan Antigen A measurement of the galactomannan antigen in a biological specimen. Galactomannan Antigen Measurement Gardnerella vaginalis DNA A measurement of the Gardnerella vaginalis DNA in a biological specimen. Gardnerella vaginalis DNA Measurement Corynebacterium vaginalis Gardnerella vaginalis A measurement of the Gardnerella vaginalis in a biological specimen. Gardnerella vaginalis Measurement Gardnerella A measurement of the organisms that are not assigned to the species level but are assigned to the Gardnerella genus level in a biological specimen. Gardnerella Measurement Giardia DNA A measurement of the DNA from any member of the genus Giardia in a biological specimen. Giardia DNA Measurement Giardia lamblia Antigen A measurement of the Giardia lamblia antigen in a biological specimen. Giardia lamblia Antigen Measurement Giardia duodenalis DNA Giardia intestinalis DNA Giardia lamblia DNA A measurement of the Giardia lamblia DNA in a biological specimen. Giardia lamblia DNA Measurement Giardia lamblia/Cryptosporidium Antigen A measurement of the antigen from Giardia lamblia and/or any member of the genus Cryptosporidium in a biological specimen. Giardia lamblia/Cryptosporidium Antigen Measurement Gram Negative Bacteria A measurement of the gram negative bacteria in a biological specimen. Gram Negative Bacteria Measurement Gram Negative Cocci A measurement of the gram negative cocci-shaped bacteria in a biological specimen. Gram Negative Cocci Measurement Gram Positive Bacteria A measurement of the gram positive bacteria in a biological specimen. Gram Positive Bacteria Measurement Haemophilus influenzae DNA A measurement of the Haemophilus influenza virus DNA in a biological specimen. Haemophilus influenzae DNA Measurement H. influenzae Haemophilus influenzae A measurement of the Haemophilus influenza virus in a biological specimen. Haemophilus influenzae Measurement Haemophilus parahaemolyticus DNA A measurement of the Haemophilus parahaemolyticus DNA in a biological specimen. Haemophilus parahaemolyticus DNA Measurement Haemophilus A measurement of the organisms that are not assigned to the species level but are assigned to the Haemophilus genus level in a biological specimen. Haemophilus Measurement HCoV-229E Nucleic Acid Human Coronavirus 229E Nucleic Acid A measurement of the Human coronavirus 229E nucleic acid in a biological specimen. Human Coronavirus 229E Nucleic Acid Measurement HCoV-229E RNA Human Coronavirus 229E RNA A measurement of the Human coronavirus 229E RNA in a biological specimen. HCoV-229E RNA Measurement HCoV-HKU1 Nucleic Acid HCoV-HKU1 RNA Human Coronavirus HKU1 Nucleic Acid A measurement of the Human coronavirus HKU1 nucleic acid in a biological specimen. Human Coronavirus HKU1 Nucleic Acid Measurement HCoV-HKU1 RNA Human Coronavirus HKU1 RNA A measurement of the Human coronavirus HKU1 RNA in a biological specimen. HCoV-HKU1 RNA Measurement HCoV-NL63 Nucleic Acid Human Coronavirus NL63 Nucleic Acid A measurement of the Human coronavirus NL63 nucleic acid in a biological specimen. Human Coronavirus NL63 Nucleic Acid Measurement HCoV-NL63 RNA Human Coronavirus NL63 RNA A measurement of the Human coronavirus NL63 RNA in a biological specimen. HCoV-NL63 RNA Measurement HCoV-NL63/HCoV-HKU1 RNA Human Coronavirus NL63/Human Coronavirus HKU1 RNA A measurement of the Human coronavirus NL63 and/or Human coronavirus HKU1 RNA in a biological specimen. Human Coronavirus NL63 and/or Human Coronavirus HKU1 RNA Measurement HCoV-OC43 Nucleic Acid Human Coronavirus OC43 Nucleic Acid A measurement of the Human coronavirus OC43 nucleic acid in a biological specimen. Human Coronavirus OC43 Nucleic Acid Measurement HCoV-OC43 RNA Human Coronavirus OC43 RNA A measurement of the Human coronavirus OC43 RNA in a biological specimen. HCoV-OC43 RNA Measurement Helicobacter pylori Antigen A measurement of the Helicobacter pylori antigen in a biological specimen. Helicobacter pylori Antigen Measurement Helicobacter pylori DNA A measurement of the Helicobacter pylori DNA in a biological specimen. Helicobacter pylori DNA Measurement Helicobacter pylori A measurement of the Helicobacter pylori in a biological specimen. Helicobacter pylori Measurement Hemozoin A measurement of hemozoin in a biological specimen. Hemozoin is a breakdown product of hemoglobin and iron-containing pigment that accumulates as cytoplasmic granules in blood-feeding parasites. Hemozoin Measurement Hepatitis A Virus RNA A measurement of the hepatitis A virus RNA in a biological specimen. Hepatitis A Virus RNA Measurement HAsAg Hepatitis A Virus Surface Antigen A measurement of the surface antigen reaction of a biological specimen to the Hepatitis A virus. Hepatits A Virus Surface Antigen Measurement Hepatitis B Virus Core Antigen A measurement of the Hepatitis B virus core antigen in a biological specimen. Hepatitis B Virus Core Antigen Measurement Hepatitis B Virus DNA A measurement of the Hepatitis B virus DNA in a biological specimen. Hepatitis B DNA Measurement Hepatitis B Virus e Antigen A measurement of the hepatitis B e antigen in a biological specimen. Hepatitis B Virus e Antigen Measurement Hepatitis B Virus Nucleic Acid A measurement of the hepatitis B virus nucleic acid in a biological specimen. Hepatitis B Virus Nucleic Acid Measurement Hepatitis B Virus RNA A measurement of the Hepatitis B virus RNA in a biological specimen. Hepatitis B Virus RNA Measurement HBsAg Hepatitis B Virus Surface Antigen A measurement of the surface antigen reaction of a biological specimen to the Hepatitis B virus. Hepatitis B Virus Surface Antigen Measurement Hepatitis B Virus A measurement of the hepatitis B virus in a biological specimen. Hepatitis B Virus Measurement Hepatitis C Virus Antigen A measurement of the hepatitis C virus antigen in a biological specimen. Hepatitis C Virus Antigen Measurement Hepatitis C Virus Core Antigen A measurement of the hepatitis C virus core antigen in a biological specimen. Hepatitis C Virus Core Antigen Measurement Hepatitis C Virus Nucleic Acid A measurement of the hepatitis C virus nucleic acid in a biological specimen. Hepatitis C Virus Nucleic Acid Measurement Hepatitis C Virus RNA A measurement of the Hepatitis C virus RNA in a biological specimen. Hepatitis C Virus RNA Measurement Hepatitis C Virus A measurement of the hepatitis C virus in a biological specimen. Hepatitis C Virus Measurement Hepatitis D Virus RNA A measurement of the hepatitis D virus RNA in a biological specimen. Hepatitis D Virus RNA Measurement Hepatitis E Virus Antigen A measurement of the Hepatitis E virus antigen in a biological specimen. Hepatitis E Virus Antigen Measurement Hepatitis E Virus RNA A measurement of the Hepatitis E virus RNA in a biological specimen. Hepatitis E Virus RNA Measurement Herpes Simplex Virus 1 DNA A measurement of the herpes simplex virus 1 DNA in a biological specimen. Herpes Simplex Virus 1 DNA Measurement Herpes Simplex Virus 1 A measurement of the herpes simplex virus 1 in a biological specimen. Herpes Simplex Virus 1 Measurement Herpes Simplex Virus 1/2 Antigen HSV 1/2 Antigen A measurement of the herpes simplex virus 1 and/or 2 antigen in a biological specimen. Herpes Simplex Virus 1 and/or 2 Antigen Measurement Herpes Simplex Virus 1/2 DNA HSV 1/2 DNA A measurement of the herpes simplex virus 1 and/or 2 DNA in a biological specimen. Herpes Simplex Virus 1 and/or 2 DNA Measurement Herpes Simplex Virus 1/2 A measurement of the herpes simplex virus 1 and/or 2 in a biological specimen. Herpes Simplex Virus 1 and/or 2 Measurement Herpes Simplex Virus 2 DNA A measurement of the Herpes simplex virus 2 DNA in a biological specimen. Herpes Simplex Virus 2 DNA Measurement Herpes Simplex Virus 2 A measurement of the herpes simplex virus 2 in a biological specimen. Herpes Simplex Virus 2 Measurement High Risk Human Papillomavirus Types DNA, Multi-Target High-Risk HPV Types DNA, MLTTRG High-Risk HPV Types DNA, Multi-Target A measurement of high-risk human papillomavirus DNA in a biological specimen. This is a multiple-target test. Multi-Target High Risk Human Papillomavirus Types DNA Measurement High Risk Human Papillomavirus Types mRNA, Multi-Target High-Risk HPV Types mRNA, MLTTRG High-Risk HPV Types mRNA, Multi-Target A measurement of high-risk human papillomavirus mRNA in a biological specimen. This is a multiple-target test. Multi-Target High Risk Human Papillomavirus Types mRNA Measurement Histoplasma capsulatum Antigen A measurement of the Histoplasma capsulatum antigen in a biological specimen. Histoplasma capsulatum Antigen Measurement HIV Antigen/Antibody A measurement of the HIV antigens and/or HIV antibodies in a biological specimen. HIV Antigen/Antibody Measurement HIV-1 Antibody + HIV-1 p24 Antigen A measurement of the antibody reaction to the HIV-1 virus and the measurement of HIV-1 p24 antigen in a biological specimen. HIV-1 Antibody and HIV-1 p24 Antigen Measurement HIV-1 Antigen A measurement of the HIV-1 antigen in a biological specimen. HIV-1 Antigen Measurement HIV-1 Group M and O Nucleic Acid A measurement of the HIV-1 group M and O nucleic acids in a biological specimen. HIV-1 Group M and O Nucleic Acid Measurement HIV-1 Nucleic Acid A measurement of the HIV-1 nucleic acid in a biological specimen. HIV-1 Nucleic Acid Measurement HIV-1 p24 Antigen A measurement of the HIV-1 p24 antigen in a biological specimen. HIV-1 p24 Antigen Measurement HIV-1 RNA A measurement of the HIV-1 RNA in a biological specimen. HIV-1 RNA Measurement HIV-1/2 Antibody + HIV-1 p24 Antigen A measurement of the antibody reaction of a biological specimen to either the HIV-1 or HIV-2 virus and the measurement of HIV-1 p24 antigen in a biological specimen. HIV-1/2 Antibody and HIV-1 p24 Antigen Measurement HIV-1/2 Antigen/Antibody A measurement of the HIV-1/HIV-2 antigens and/or HIV-1/HIV-2 antibodies in a biological specimen (to be used when the antigen is not specified). HIV-1/2 Antigen/Antibody Measurement HIV-1/2 RNA A measurement of the HIV-1 and/or HIV-2 RNA in a biological specimen. HIV-1/2 RNA Measurement HIV-2 Antibody + HIV-1 p24 Antigen A measurement of the antibody reaction to the HIV-2 virus and the measurement of HIV-1 p24 antigen in a biological specimen. HIV-2 Antibody And HIV-1 p24 Antigen Measurement HIV-2 Nucleic Acid A measurement of the HIV-2 nucleic acids in a biological specimen. HIV-2 Nucleic Acid Measurement HIV-2 RNA A measurement of the HIV-2 RNA in a biological specimen. HIV-2 RNA Measurement Human adenovirus 40/41 DNA Human adenovirus F40/F41 DNA Mastadenovirus 40/41 DNA A measurement of the Human adenovirus type 40 and/or Human adenovirus type 41 DNA in a biological specimen. Human adenovirus 40 and/or Human adenovirus 41 DNA Measurement Human astrovirus 1/2/3/4/5/6/7/8 RNA A measurement of the Human astrovirus 1, 2, 3, 4, 5, 6, 7 and/or 8 RNA in a biological specimen. Human astrovirus 1, 2, 3, 4, 5, 6, 7, and/or 8 RNA Measurement Human Bocavirus Antigen A measurement of the Human bocavirus antigen in a biological specimen. Human Bocavirus Antigen Measurement Human bocavirus DNA A measurement of the Human bocavirus DNA in a biological specimen. Human Bocavirus DNA Measurement Human Bocavirus Nucleic Acid A measurement of the Human bocavirus nucleic acid in a biological specimen. Human Bocavirus Nucleic Acid Measurement Human Coronavirus 229E A measurement of the Human coronavirus 229E in a biological specimen. Human Coronavirus 229E Measurement Human Coronavirus HKU1 A measurement of the Human coronavirus HKU1 in a biological specimen. Human Coronavirus HKU1 Measurement Human Coronavirus NL63 A measurement of the Human coronavirus NL63 in a biological specimen. Human Coronavirus NL63 Measurement Human Coronavirus OC43 A measurement of the Human coronavirus OC43 in a biological specimen. Human Coronavirus OC43 Measurement Human Herpes Virus 8 Human Herpesvirus 8 A measurement of the human herpes virus 8 in a biological specimen. Human Herpesvirus 8 Measurement Human Herpesvirus 6 DNA A measurement of the human herpesvirus 6 DNA in a biological specimen. Human Herpesvirus 6 DNA Measurement Human Herpesvirus 6 A measurement of the human herpesvirus 6 in a biological specimen. Human Herpesvirus 6 Measurement Human Herpesvirus 7 DNA A measurement of the human herpesvirus 7 DNA in a biological specimen. Human Herpesvirus 7 DNA Measurement Human Herpesvirus 7 A measurement of the human herpesvirus 7 in a biological specimen. Human Herpesvirus 7 Measurement Human Herpesvirus 8 DNA A measurement of the human herpesvirus 8 DNA in a biological specimen. Human Herpesvirus 8 DNA Measurement Human Immunodeficiency Virus A measurement of the Human Immunodeficiency Virus in a biological specimen. Human Immunodeficiency Virus Measurement Human Metapneumovirus Antigen A measurement of the Human metapneumovirus antigen in a biological specimen. Human Metapneumovirus Antigen Measurement Human Metapneumovirus Nucleic Acid A measurement of the Human metapneumovirus nucleic acid in a biological specimen. Human Metapneumovirus Nucleic Acid Measurement Human Metapneumovirus RNA A measurement of the Human Metapneumovirus RNA in a biological specimen. Human Metapneumovirus RNA Measurement Human Metapneumovirus A measurement of the Human metapneumovirus in a biological specimen. Human Metapneumovirus Measurement Human Papillomavirus DNA A measurement of the Human papillomavirus DNA in a biological specimen. Human Papillomavirus DNA Measurement Human Papillomavirus E6/E7 Messenger RNA Human Papillomavirus E6/E7 mRNA A measurement of the human papillomavirus E6 and/or E7 protein-making mRNA in a biological specimen. Human Papillomavirus E6/E7 mRNA Measurement Human Papillomavirus Type 11 DNA A measurement of the Human papillomavirus type 11 DNA in a biological specimen. Human Papillomavirus Type 11 DNA Measurement Human Papillomavirus Type 16 DNA A measurement of the Human papillomavirus type 16 DNA in a biological specimen. Human Papillomavirus Type 16 DNA Measurement Human Papillomavirus Type 18 DNA A measurement of the Human papillomavirus type 18 DNA in a biological specimen. Human Papillomavirus Type 18 DNA Measurement Human Papillomavirus Type 31 DNA A measurement of the Human papillomavirus type 31 DNA in a biological specimen. Human Papillomavirus Type 31 DNA Measurement Human Papillomavirus Type 31 A measurement of the Human papillomavirus type 31 in a biological specimen. Human Papillomavirus Type 31 Measurement Human Papillomavirus Type 33 DNA A measurement of the Human papillomavirus type 33 DNA in a biological specimen. Human Papillomavirus Type 33 DNA Measurement Human Papillomavirus Type 33 A measurement of the Human papillomavirus type 33 in a biological specimen. Human Papillomavirus Type 33 Measurement Human Papillomavirus Type 34 A measurement of the Human papillomavirus type 34 in a biological specimen. Human Papillomavirus Type 34 Measurement Human Papillomavirus Type 35 DNA A measurement of the Human papillomavirus type 35 DNA in a biological specimen. Human Papillomavirus Type 35 DNA Measurement Human Papillomavirus Type 35 A measurement of the Human papillomavirus type 35 in a biological specimen. Human Papillomavirus Type 35 Measurement Human Papillomavirus Type 39 DNA A measurement of the Human papillomavirus type 39 DNA in a biological specimen. Human Papillomavirus Type 39 DNA Measurement Human Papillomavirus Type 39 A measurement of the Human papillomavirus type 39 in a biological specimen. Human Papillomavirus Type 39 Measurement Human Papillomavirus Type 40 A measurement of the Human papillomavirus type 40 in a biological specimen. Human Papillomavirus Type 40 Measurement Human Papillomavirus Type 42 A measurement of the Human papillomavirus type 42 in a biological specimen. Human Papillomavirus Type 42 Measurement Human Papillomavirus Type 43 A measurement of the Human papillomavirus type 43 in a biological specimen. Human Papillomavirus Type 43 Measurement Human Papillomavirus Type 44 A measurement of the Human papillomavirus type 44 in a biological specimen. Human Papillomavirus Type 44 Measurement Human Papillomavirus Type 45 DNA A measurement of the Human papillomavirus type 45 DNA in a biological specimen. Human Papillomavirus Type 45 DNA Measurement Human Papillomavirus Type 45 A measurement of the Human papillomavirus type 45 in a biological specimen. Human Papillomavirus Type 45 Measurement Human Papillomavirus Type 51 DNA A measurement of the Human papillomavirus type 51 DNA in a biological specimen. Human Papillomavirus Type 51 DNA Measurement Human Papillomavirus Type 51 A measurement of the Human papillomavirus type 51 in a biological specimen. Human Papillomavirus Type 51 Measurement Human Papillomavirus Type 52 DNA A measurement of the Human papillomavirus type 52 DNA in a biological specimen. Human Papillomavirus Type 52 DNA Measurement Human Papillomavirus Type 52 A measurement of the Human papillomavirus type 52 in a biological specimen. Human Papillomavirus Type 52 Measurement Human Papillomavirus Type 53 DNA A measurement of the Human papillomavirus type 53 DNA in a biological specimen. Human Papillomavirus Type 53 DNA Measurement Human Papillomavirus Type 53 A measurement of the Human papillomavirus type 53 in a biological specimen. Human Papillomavirus Type 53 Measurement Human Papillomavirus Type 54 A measurement of the Human papillomavirus type 54 in a biological specimen. Human Papillomavirus Type 54 Measurement Human Papillomavirus Type 56 DNA A measurement of the Human papillomavirus type 56 DNA in a biological specimen. Human Papillomavirus Type 56 DNA Measurement Human Papillomavirus Type 56 A measurement of the Human papillomavirus type 56 in a biological specimen. Human Papillomavirus Type 56 Measurement Human Papillomavirus Type 57 DNA A measurement of the Human papillomavirus type 57 DNA in a biological specimen. Human Papillomavirus Type 57 DNA Measurement Human Papillomavirus Type 58 DNA A measurement of the Human papillomavirus type 58 DNA in a biological specimen. Human Papillomavirus Type 58 DNA Measurement Human Papillomavirus Type 58 A measurement of the Human papillomavirus type 58 in a biological specimen. Human Papillomavirus Type 58 Measurement Human Papillomavirus Type 59 DNA A measurement of the Human papillomavirus type 59 DNA in a biological specimen. Human Papillomavirus Type 59 DNA Measurement Human Papillomavirus Type 59 A measurement of the Human papillomavirus type 59 in a biological specimen. Human Papillomavirus Type 59 Measurement Human Papillomavirus Type 6 DNA A measurement of the Human papillomavirus type 6 DNA in a biological specimen. Human Papillomavirus Type 6 DNA Measurement Human Papillomavirus Type 66 DNA A measurement of the Human papillomavirus type 66 DNA in a biological specimen. Human Papillomavirus Type 66 DNA Measurement Human Papillomavirus Type 66 A measurement of the Human papillomavirus type 66 in a biological specimen. Human Papillomavirus Type 66 Measurement Human Papillomavirus Type 67 DNA A measurement of the Human papillomavirus type 67 DNA in a biological specimen. Human Papillomavirus Type 67 DNA Measurement Human Papillomavirus Type 68 DNA A measurement of the Human papillomavirus type 68 DNA in a biological specimen. Human Papillomavirus Type 68 DNA Measurement Human Papillomavirus Type 68 A measurement of the Human papillomavirus type 68 in a biological specimen. Human Papillomavirus Type 68 Measurement Human Papillomavirus Type 69 A measurement of the Human papillomavirus type 69 in a biological specimen. Human Papillomavirus Type 69 Measurement Human Papillomavirus Type 70 A measurement of the Human papillomavirus type 70 in a biological specimen. Human Papillomavirus Type 70 Measurement Human Papillomavirus Type 74 A measurement of the Human papillomavirus type 74 in a biological specimen. Human Papillomavirus Type 74 Measurement Human Papillomavirus A measurement of the Human papillomavirus in a biological specimen. Human Papillomavirus Measurement Human Parainfluenza Antigen A measurement of the Human Parainfluenza antigen in a biological specimen. Human Parainfluenza Antigen Measurement Human Parainfluenza Virus 1 Antigen Human Respirovirus 1 Antigen A measurement of the Human parainfluenza virus 1 antigen in a biological specimen. Human Parainfluenza Type 1 Antigen Measurement Human Parainfluenza Virus 1 Nucleic Acid A measurement of the Human parainfluenza virus 1 nucleic acid in a biological specimen. Human Parainfluenza Virus 1 Nucleic Acid Measurement Human Parainfluenza Virus 1 RNA Human Respirovirus 1 RNA A measurement of the Human parainfluenza virus 1 RNA in a biological specimen. Human Parainfluenza Virus 1 RNA Measurement Human Parainfluenza Virus 1 A measurement of the Human parainfluenza virus 1 in a biological specimen. Human Parainfluenza Virus 1 Measurement Human Parainfluenza Virus 1/2/3 Antigen A measurement of the Human Parainfluenza virus 1, 2, and/or 3 antigen in a biological specimen. Human Parainfluenza Virus 1, 2, and/or 3 Antigen Measurement Human Parainfluenza Virus 1/2/3 RNA A measurement of the RNA from the Human Parainfluenza virus 1, 2, and/or 3 in a biological specimen. Human Parainfluenza Virus 1, 2, and/or 3 RNA Measurement Human Parainfluenza Virus 1/2/3/4 RNA A measurement of the RNA from the Human Parainfluenza virus 1, 2, 3 and/or 4 in a biological specimen. Human Parainfluenza Virus 1, 2, 3, and/or 4 RNA Measurement Human Orthorubulavirus 2 Antigen Human Parainfluenza Virus 2 Antigen A measurement of the Human parainfluenza virus 2 antigen in a biological specimen. Human Parainfluenza Virus 2 Antigen Measurement Human Parainfluenza Virus 2 Nucleic Acid A measurement of the Human parainfluenza virus 2 nucleic acid in a biological specimen. Human Parainfluenza Virus 2 Nucleic Acid Measurement Human Orthorubulavirus 2 RNA Human Parainfluenza Virus 2 RNA A measurement of the Human parainfluenza virus 2 RNA in a biological specimen. Human Parainfluenza Virus 2 RNA Measurement Human Parainfluenza Virus 2 A measurement of the Human parainfluenza virus 2 in a biological specimen. Human Parainfluenza Virus 2 Measurement Human Parainfluenza Virus 3 Antigen Human Respirovirus 3 Antigen A measurement of the Human parainfluenza virus 3 antigen in a biological specimen. Human Parainfluenza Virus 3 Antigen Measurement Human Parainfluenza Virus 3 Nucleic Acid A measurement of the Human parainfluenza virus 3 nucleic acid in a biological specimen. Human Parainfluenza Virus 3 Nucleic Acid Measurement Human Parainfluenza Virus 3 RNA Human Respirovirus 3 RNA A measurement of the Human parainfluenza virus 3 RNA in a biological specimen. Human Parainfluenza Virus 3 RNA Measurement Human Parainfluenza Virus 3 A measurement of the Human parainfluenza virus 3 in a biological specimen. Human Parainfluenza Virus 3 Measurement Human Parainfluenza Virus 4 Nucleic Acid A measurement of the Human parainfluenza virus 4 nucleic acid in a biological specimen. Human Parainfluenza Virus 4 Nucleic Acid Measurement Human Orthorubulavirus 4 RNA Human Parainfluenza Virus 4 RNA A measurement of the Human parainfluenza virus 4 RNA in a biological specimen. Human Parainfluenza Virus 4 RNA Measurement Human Parainfluenza Virus 4 A measurement of the Human parainfluenza virus 4 in a biological specimen. Human Parainfluenza Virus 4 Measurement Human Parainfluenza Virus 4B NC Human Parainfluenza Virus 4B Nucleic Acid A measurement of the Human parainfluenza virus 4b nucleic acid in a biological specimen. Human Parainfluenza Virus 4B Nucleic Acid Measurement Human Parainfluenza virus RNA A measurement of the Human parainfluenza virus RNA in a biological specimen. Human Parainfluenza virus RNA Measurement Human Parvovirus B19 DNA A measurement of the Human Parvovirus B19 DNA in a biological specimen. Human Parvovirus B19 DNA Measurement Human Parvovirus B19 A measurement of the Human Parvovirus B19 in a biological specimen. Human Parvovirus B19 Measurement HRV A/B/C Antigen Human rhinovirus A/B/C Antigen A measurement of the Human rhinovirus A, B and/or C antigen in a biological specimen. Human rhinovirus A, B, and/or C Antigen Measurement HRV A/B/C Human rhinovirus A/B/C A measurement of the Human rhinovirus A, B and/or C in a biological specimen. Human rhinovirus A, B, and/or C Measurement Human rhinovirus A measurement of the Human rhinovirus in a biological specimen. Human rhinovirus Measurement Human rhinovirus/enterovirus Nuc Acid Human rhinovirus/enterovirus Nucleic Acid A measurement of nucleic acid from any member of the Human Rhinovirus species and/or Human Enterovirus species in a biological specimen. Human Rhinovirus and/or Enterovirus Nucleic Acid Measurement Human rhinovirus/enterovirus RNA A measurement of RNA from any member of the Human Rhinovirus species and/or Human Enterovirus species in a biological specimen. Human rhinovirus and/or enterovirus RNA Measurement Human rhinovirus/enterovirus A measurement of the Human rhinovirus and/or Human enterovirus in a biological specimen. Human Rhinovirus and/or Enterovirus Measurement Human T-Lymphotropic Virus RNA A measurement of the Human T-Lymphotropic virus RNA in a biological specimen. Human T-Lymphotropic Virus RNA Measurement Influenza A Antigen A measurement of the influenza A antigen in a biological specimen. Influenza A Antigen Measurement Influenza A H1 Nucleic Acid A measurement of the Influenza A virus subtype hemagglutinin (HA) 1 nucleic acid in an biological specimen. Influenza A H1 Nucleic Acid Measurement Influenza A H1 RNA A measurement of the Influenza A virus subtype hemagglutinin (HA) 1 RNA in an biological specimen. Influenza A H1 RNA Measurement Influenza A H3 Nucleic Acid A measurement of the Influenza A virus subtype hemagglutinin (HA) 3 nucleic acid in an biological specimen. Influenza A H3 Nucleic Acid Measurement Influenza A H3 RNA A measurement of the Influenza A virus subtype hemagglutinin (HA) 3 RNA in an biological specimen. Influenza A H3 RNA Measurement Influenza A Nucleic Acid A measurement of the Influenza A virus nucleic acid in an biological specimen. Influenza A Nucleic Acid Measurement Influenza A RNA A measurement of the Influenza A virus RNA in a biological specimen. Influenza A RNA Measurement Influenza A Virus A measurement of the Influenza A virus an biological specimen. Influenza A Virus Measurement Influenza A/B Antigen A measurement of the influenza A and/or B antigen in a biological specimen. Influenza A/B Antigen Measurement Influenza A/B RNA A measurement of the influenza A and/or B RNA in a biological specimen. Influenza A and/or B RNA Measurement Influenza A/B Virus A measurement of the influenza A and/or B virus in a biological specimen. Influenza A/B Virus Measurement Influenza B Antigen A measurement of the influenza B antigen in a biological specimen. Influenza B Antigen Measurement Influenza B Nucleic Acid A measurement of the Influenza B virus nucleic acid in an biological specimen. Influenza B Nucleic Acid Measurement Influenza B RNA A measurement of the Influenza B virus RNA in a biological specimen. Influenza B RNA Measurement Influenza B Virus A measurement of the Influenza B virus an biological specimen. Influenza B Virus Measurement JC Polyomavirus DNA JC Virus DNA JCV DNA John Cunningham Virus DNA A measurement of the JC virus DNA in a biological specimen. JC Virus DNA Measurement JC Polyomavirus JC Virus John Cunningham Virus A measurement of the JC virus in a biological specimen. JC Virus Measurement K. pneumoniae, Carbapenem-resistant Klebsiella pneumoniae, Carbapenem-resistant A measurement of the carbapenem-resistant strain of Klebsiella pneumoniae in a biological specimen. Carbapenem-Resistant Klebsiella pneumoniae Measurement Klebsiella aerogenes DNA A measurement of the Klebsiella aerogenes DNA in a biological specimen. Klebsiella aerogenes DNA Measurement Klebsiella aerogenes A measurement of the Klebsiella aerogenes in a biological specimen. Klebsiella aerogenes Measurement Klebsiella oxytoca DNA A measurement of the Klebsiella oxytoca DNA in a biological specimen. Klebsiella oxytoca DNA Measurement Klebsiella oxytoca A measurement of the Klebsiella oxytoca in a biological specimen. Klebsiella oxytoca Measurement Klebsiella pneumoniae DNA A measurement of the Klebsiella pneumoniae DNA in a biological specimen. Klebsiella pneumoniae DNA Measurement Klebsiella pneumoniae A measurement of the Klebsiella pneumoniae in a biological specimen. Klebsiella pneumoniae Measurement Klebsiella variicola A measurement of Klebsiella variicola in a biological specimen. Klebsiella variicola Measurement Klebsiella A measurement of the organisms that are not assigned to the species level but are assigned to the Klebsiella genus level in a biological specimen. Klebsiella Measurement Lactobacillus crispatus DNA A measurement of the Lactobacillus crispatus DNA in a biological specimen. Lactobacillus crispatus DNA Measurement Lactobacillus crispatus A measurement of Lactobacillus crispatus in a biological specimen. Lactobacillus crispatus Measurement Lactobacillus jensenii A measurement of Lactobacillus jensenii in a biological specimen. Lactobacillus jensenii Measurement Lactobacillus A measurement of the organisms that are not assigned to the species level but are assigned to the Lactobacillus genus level in a biological specimen. Lactobacillus Measurement Legionella longbeachae DNA A measurement of the Legionella longbeachae DNA in a biological specimen. Legionella longbeachae DNA Measurement Legionella pneumophila Antigen A measurement of the Legionella pneumophila antigen in a biological specimen. Legionella pneumophila Antigen Measurement Legionella pneumophila DNA A measurement of the Legionella pneumophila DNA in a biological specimen. Legionella pneumophila DNA Measurement Legionella pneumophila Serogroup 1 Antigen Legionella pneumophila Sg 1 Antigen A measurement of the Legionella pneumophila serogroup 1 antigen in a biological specimen. Legionella pneumophila Serogroup 1 Antigen Measurement Legionella pneumophila A measurement of the Legionella pneumophila in a biological specimen. Legionella pneumophila Measurement Listeria monocytogenes DNA A measurement of the Listeria monocytogenes DNA in a biological specimen. Listeria monocytogenes DNA Measurement Listeria monocytogenes A measurement of the Listeria monocytogenes in a biological specimen. Listeria monocytogenes Measurement M. tuberculosis IFN Gamma Response Mycobacterium tuberculosis IFN Gamma Response A measurement of the amount of interferon gamma that is released when Mycobacterium tuberculosis antigen is incubated with a biological specimen, usually blood. Increased amounts of interferon gamma suggests a prior or existing M. tuberculosis infection. Mycobacterium tuberculosis Interferon Gamma Response Measurement M. tuberculosis, Rifampin-resistant Mycobacterium tuberculosis, Rifampin-resistant A measurement of the rifampin-resistant strain of Mycobacterium tuberculosis in a biological specimen. Rifampin-resistant Mycobacterium Measurement MERS-CoV RNA A measurement of the MERS-CoV RNA in a biological specimen. MERS-CoV RNA Measurement Microbial Organism Identification The identification of the type of a microbial organism in a biological specimen. Microorganism Identification Microfilaria Presence of microfilaria stage of filarial nematodes in smears prepared from whole blood or other body fluids. Microfilaria Measurement Molluscum Contagiosum Virus DNA A measurement of the molluscum contagiosum virus DNA in a biological specimen. Molluscum contagiosum Virus DNA Measurement Monkeypox Virus DNA A measurement of the Monkeypox virus DNA in a biological specimen. Monkeypox Virus DNA Measurement Monkey Pox Virus Monkeypox Virus A measurement of the Monkeypox virus in a biological specimen. Monkeypox Virus Measurement Moraxella catarrhalis DNA A measurement of the Moraxella catarrhalis DNA in a biological specimen. Moraxella catarrhalis DNA Measurement Moraxella catarrhalis A measurement of the Moraxella catarrhalis in a biological specimen. Moraxella catarrhalis Measurement Morganella morganii A measurement of the Morganella morganii in a biological specimen. Morganella morganii Measurement Morganella A measurement of the organisms that are not assigned to the species level but are assigned to the Morganella genus level in a biological specimen. Morganella Measurement Mumps rubulavirus RNA Mumps Virus RNA A measurement of the Mumps rubulavirus RNA in a biological specimen. Mumps Virus RNA Measurement Murine Pneumonia Virus A measurement of the Murine pneumonia virus in a biological specimen. Murine Pneumonia Virus Measurement Mycobacterium abscessus A measurement of the Mycobacterium abscessus in a biological specimen. Mycobacterium abscessus Measurement Mycobacterium avium Complex A measurement of the group of bacterial species that can be assigned to the Mycobacterium avium complex in a biological specimen. Mycobacterium avium Complex Measurement Mycobacterium chelonae A measurement of the Mycobacterium chelonae in a biological specimen. Mycobacterium chelonae Measurement Mycobacterium fortuitum A measurement of the Mycobacterium fortuitum in a biological specimen. Mycobacterium fortuitum Measurement Mycobacterium kansasii A measurement of the Mycobacterium kansasii in a biological specimen. Mycobacterium kansasii Measurement Mycobacterium simiae A measurement of the Mycobacterium simiae in a biological specimen. Mycobacterium simiae Measurement Mycobacterium tuberculosis Complex A measurement of the organisms assignable to the Mycobacterium tuberculosis complex in a biological specimen. Mycobacterium tuberculosis Complex Measurement Mycobacterium tuberculosis Nucleic Acid A measurement of the Mycobacterium tuberculosis nucleic acid in a biological specimen. Mycobacterium tuberculosis Nucleic Acid Measurement Mycobacterium tuberculosis A measurement of the organisms that are assigned to the Mycobacterium tuberculosis species in a biological specimen. Mycobacterium Tuberculosis Measurement Mycobacterium A measurement of the organisms that are not assigned to the species level but are assigned to the Mycobacterium genus level in a biological specimen. Mycobacterium Measurement Mycoplasma genitalium DNA A measurement of the Mycoplasma genitalium DNA in a biological specimen. Mycoplasma genitalium DNA Measurement Mycoplasma genitalium A measurement of the Mycoplasma genitalium in a biological specimen. Mycoplasma genitalium Measurement Mycoplasma hominis DNA A measurement of the Mycoplasma hominis DNA in a biological specimen. Mycoplasma hominis DNA Measurement Mycoplasma pneumoniae DNA A measurement of the Mycoplasma pneumoniae DNA in a biological specimen. Mycoplasma pneumoniae DNA Measurement Mycoplasma pneumoniae Nucleic Acid A measurement of the Mycoplasma pneumoniae nucleic acid in a biological specimen. Mycoplasma pneumoniae Nucleic Acid Measurement Mycoplasma pneumoniae A measurement of the Mycoplasma pneumoniae in a biological specimen. Mycoplasma pneumoniae Measurement Mycoplasma A measurement of the organisms that are not assigned to the species level but are assigned to the Mycoplasma genus level in a biological specimen. Mycoplasma Measurement N. gonorrhoeae, Beta-lactamase Negative A measurement of the beta-lactamase negative strain of Neisseria gonorrhoeae in a biological specimen. Neisseria gonorrhoeae, Beta-lactamase Negative Measurement N. gonorrhoeae, Beta-lactamase Positive A measurement of the beta-lactamase positive strain of Neisseria gonorrhoeae in a biological specimen. Neisseria gonorrhoeae, Beta-lactamase Positive Measurement Neisseria gonorrhoeae DNA A measurement of the Neisseria gonorrhoeae DNA in a biological specimen. Neisseria gonorrhoeae DNA Measurement Neisseria gonorrhoeae RNA A measurement of the Neisseria gonorrhoeae RNA in a biological specimen. Neisseria gonorrhoeae RNA Measurement Neisseria gonorrhoeae A measurement of the Neisseria gonorrhoeae in a biological specimen. Neisseria gonorrhoeae Measurement Neisseria meningitidis A Antigen A measurement of Neisseria meningitidis A antigen in a biological specimen. Neisseria meningitidis A Antigen Measurement Neisseria meningitidis C Antigen A measurement of Neisseria meningitidis C antigen in a biological specimen. Neisseria meningitidis C Antigen Measurement Neisseria meningitidis DNA A measurement of Neisseria meningitidis DNA in a biological specimen. Neisseria meningitidis DNA Measurement Nocardia cyriacigeorgica A measurement of the Nocardia cyriacigeorgica in a biological specimen. Nocardia cyriacigeorgica Measurement Nontuberculous Mycobacteria Nucleic Acid A measurement of the nucleic acid from any nontuberculous member of the Mycobacterium genus in a biological specimen. Nontuberculous Mycobacteria Nucleic Acid Measurement Non-tuberculous mycobacteria Nontuberculous Mycobacteria NTM A measurement of the organisms that are assigned to the Mycobacterium genus but are not tuberculosis or leprosy-causing in a biological specimen. Nontuberculous Mycobacteria Measurement Human Calicivirus Genogroup 1 RNA Norovirus Genogroup 1 RNA Norovirus GI RNA A measurement of Norovirus genogroup I RNA in a biological specimen. Norovirus Genogroup I RNA Measurement Norovirus genogroup I and/or genogroup II RNA Norovirus GI/GII RNA A measurement of Norovirus genogroup I and/or II RNA in a biological specimen. Norovirus Genogroup I and/or II RNA Measurement Human Calicivirus Genogroup 2 RNA Norovirus Genogroup II RNA Norovirus GII RNA A measurement of Norovirus genogroup II RNA in a biological specimen. Norovirus Genogroup II RNA Measurement Norovirus RNA A measurement of the RNA from any member of the genus Norovirus in a biological specimen. Norovirus RNA Measurement Norovirus A measurement of the organisms that are not assigned to the species level but are assigned to the Norovirus genus level in a biological specimen. Norovirus Measurement Norwalk calicivirus RNA Norwalk virus RNA A measurement of the Norwalk virus RNA in a biological specimen. Norwalk virus RNA Measurement Ova and Parasite A measurement of the parasites and ova in a biological specimen. Ova and Parasite Measurement P. aeruginosa, Mucoid Pseudomonas aeruginosa, Mucoid A measurement of the mucoid strain of Pseudomonas aeruginosa in a biological specimen. Mucoid Pseudomonas aeruginosa Measurement P. aeruginosa, Non-Mucoid Pseudomonas aeruginosa, Non-Mucoid A measurement of the non-mucoid strain of Pseudomonas aeruginosa in a biological specimen. Non-Mucoid Pseudomonas aeruginosa Measurement P. aeruginosa, Small-colony Variant Pseudomonas aeruginosa, SCV Pseudomonas aeruginosa, Small-colony Variant A measurement of the small-colony variant strain of Pseudomonas aeruginosa in a biological specimen. Small-Colony Variant Pseudomonas aeruginosa Measurement Parechovirus RNA A measurement of the RNA from any member of the genus Parechovirus in a biological specimen. Parechovirus RNA Measurement Peptostreptococcus A measurement of the organisms that are not assigned to the species level but are assigned to the Peptostreptococcus genus level in a biological specimen. Peptostreptococcus Measurement Plasmodium Antigen, MLTTRG Plasmodium Antigen, Multi-Target A measurement of Plasmodium antigen in a biological specimen. This is a multiple-target test. Plasmodium Antigen Measurement Plasmodium falciparum RNA A measurement of the Plasmodium falciparum RNA in a biological specimen. Plasmodium falciparum RNA Measurement Plasmodium falciparum A measurement of the Plasmodium falciparum in a biological specimen. Plasmodium falciparum Measurement Plasmodium Histidine Rich Protein 2 Plasmodium Histidine Rich Protein II A measurement of the Plasmodium histidine rich protein 2 in a biological specimen. Plasmodium Histidine Rich Protein 2 Measurement Plasmodium knowlesi, Asexual A measurement of the Plasmodium knowlesi in an asexual replication stage in a biological specimen. Asexual Plasmodium knowlesi Measurement Plasmodium knowlesi, Sexual A measurement of the Plasmodium knowlesi in a sexual replication stage in a biological specimen. Sexual Plasmodium knowlesi Measurement Plasmodium Lactate Dehydrogenase A measurement of the Plasmodium lactate dehydrogenase in a biological specimen. Plasmodium Lactate Dehydrogenase Measurement Malaria Plasmodium Examination of a biological specimen to detect the presence of any protozoan belonging to the Plasmodium genus. Plasmodium Measurement Plasmodium, Asexual A measurement of the Plasmodium genus protozoan in an asexual replication stage in a biological specimen. Asexual Plasmodium Measurement Plasmodium, Sexual A measurement of the Plasmodium genus protozoan in a sexual replication stage in a biological specimen. Sexual Plasmodium Measurement Plesiomonas shigelloides DNA A measurement of the Plesiomonas shigelloides DNA in a biological specimen. Plesiomonas shigelloides DNA Measurement Pneumocystis jiroveci Antigen A measurement of the Pneumocystis jiroveci antigen in a biological specimen. Pneumocystis jiroveci Antigen Measurement Pneumocystis jiroveci DNA A measurement of the Pneumocystis jiroveci DNA in a biological specimen. Pneumocystis jiroveci DNA Measurement Pneumocystis jiroveci A measurement of the Pneumocystis jiroveci in a biological specimen. Pneumocystis jiroveci Measurement Prevotella bivia A measurement of the Prevotella bivia in a biological specimen. Prevotella bivia Measurement Proteus DNA Proteus Species DNA Proteus spp DNA A measurement of the DNA from any member of the genus Proteus in a biological specimen. Proteus DNA Measurement Proteus hauseri A measurement of Proteus hauseri in a biological specimen. Proteus hauseri Measurement Proteus mirabilis A measurement of the Proteus mirabilis in a biological specimen. Proteus mirabilis Measurement Proteus penneri A measurement of Proteus penneri in a biological specimen. Proteus penneri Measurement Proteus vulgaris A measurement of the Proteus vulgaris in a biological specimen. Proteus vulgaris Measurement Protozoa A measurement of protozoa in a biological specimen. Protozoa Measurement Providencia rettgeri A measurement of the Providencia rettgeri in a biological specimen. Providencia rettgeri Measurement Providencia stuartii A measurement of the Providencia staurtii in a biological specimen. Providencia stuartee Measurement Pseudomonas aeruginosa DNA A measurement of the Pseudomonas aeruginosa DNA in a biological specimen. Pseudomonas aeruginosa DNA Measurement Pseudomonas aeruginosa A measurement of the Pseudomonas aeruginosa in a biological specimen. Pseudomonas aeruginosa Measurement Pseudomonas mendocina A measurement of Pseudomonas mendocina in a biological specimen. Pseudomonas mendocina Measurement Pseudomonas putida A measurement of Pseudomonas putida in a biological specimen. Pseudomonas putida Measurement Pseudomonas A measurement of the organisms that are not assigned to the species level but are assigned to the Pseudomonas genus level in a biological specimen. Pseudomonas Measurement Raoultella ornithinolytica A measurement of Raoultella ornithinolytica in a biological specimen. Raoultella ornithinolytica Measurement Replication Competent Lentivirus RNA A measurement of the RNA from a replication competent viral vector lentivirus in a biological specimen. Replication Competent Lentivirus RNA Measurement Respiratory Syncytial Virus Antigen RSV Antigen A measurement of the respiratory syncytial virus antigen in a biological specimen. Respiratory Syncytial Virus Antigen Measurement Respiratory Syncytial Virus RNA A measurement of the respiratory syncytial virus RNA in a biological specimen. Respiratory Syncytial Virus RNA Measurement Respiratory Syncytial Virus Type A RNA RSV Type A RNA A measurement of the respiratory syncytial virus type A RNA in a biological specimen. Respiratory Syncytial Virus Type A RNA Measurement Respiratory Syncytial Virus Type A A measurement of the respiratory syncytial virus type A in a biological specimen. Respiratory Syncytial Virus Type A Measurement Respiratory Syncytial Virus Type B RNA RSV Type B RNA A measurement of the respiratory syncytial virus type B RNA in a biological specimen. Respiratory Syncytial Virus Type B RNA Measurement Respiratory Syncytial Virus Type B A measurement of the respiratory syncytial virus type B in a biological specimen. Respiratory Syncytial Virus Type B Measurement Respiratory Syncytial Virus A measurement of the respiratory syncytial virus in a biological specimen. Respiratory Syncytial Virus Measurement Rickettsia DNA A measurement of the DNA from any member of the genus Rickettsia in a biological specimen. Rickettsia DNA Measurement Rotavirus A RNA Rotavirus Group A RNA A measurement of the Rotavirus A RNA in a biological specimen. Rotavirus A RNA Measurement Rotavirus Antigen A measurement of the antigen from any member of the genus Rotavirus in a biological specimen. Rotavirus Antigen Measurement Rotavirus RNA A measurement of the RNA from any member of the genus Rotavirus in a biological specimen. Rotavirus RNA Measurement Rotavirus A measurement of the organisms that are not assigned to the species level but are assigned to the Rotavirus genus level in a biological specimen. Rotavirus Measurement Respiratory Syncytial Virus Type A Nucleic Acid RSV Type A Nucleic Acid A measurement of the respiratory syncytial virus type A nucleic acid in a biological specimen. Human Respiratory Syncytial Virus Type A Nucleic Acid Measurement Respiratory Syncytial Virus Type B Nucleic Acid RSV Type B Nucleic Acid A measurement of the respiratory syncytial virus type B nucleic acid in a biological specimen. Human Respiratory Syncytial Virus Type B Nucleic Acid Measurement Measles Virus Antigen A measurement of the Rubeola virus antigen in a biological specimen. Rubeola Antigen Measurement S. aureus, Methicillin-Resistant Staphylococcus aureus, Methicillin-Resistant A measurement of the methicillin-resistant strain of Staphylococcus aureus in a biological specimen. Methicillin-resistant Staphylococcus aureus Measurement S. aureus, Methicillin-Susceptible Staphylococcus aureus, Methicillin-Susceptible A measurement of the methicillin-susceptible strain of Staphylococcus aureus in a biological specimen. Methicillin-susceptible Staphylococcus aureus Measurement Salmonella Antigen A measurement of the antigen from any member of the genus Salmonella in a biological specimen. Salmonella Antigen Measurement Salmonella DNA A measurement of the DNA from any member of the genus Salmonella in a biological specimen. Salmonella DNA Measurement Salmonella enterica A measurement of the Salmonella enterica in a biological specimen. Salmonella enterica Measurement Salmonella enterica/bongori DNA A measurement of the Salmonella enterica and/or Salmonella bongori DNA in a biological specimen. Salmonella enterica and/or Salmonella bongori DNA Measurement Salmonella A measurement of the organisms that are not assigned to the species level but are assigned to the Salmonella genus level in a biological specimen. Salmonella Measurement Sapovirus Genogroups I/II/IV/V RNA A measurement of the Sapovirus genogroups I, II, IV and/or V RNA in a biological specimen. Sapovirus Genogroups I, II, IV, and/or V RNA Measurement SARS-CoV-1/SARS-CoV-2 Antigen A measurement of the antigens from SARS-CoV-1 and/or SARS-CoV-2 in a biological specimen. SARS-CoV-1/SARS-CoV-2 Antigen Measurement SARS-CoV-2 Antigen A measurement of the SARS-CoV-2 antigen in a biological specimen. SARS-CoV-2 Antigen Measurement SARS-CoV-2 N Protein Antigen A measurement of the SARS-CoV-2 nucleocapsid protein antigen in a biological specimen. SARS-CoV-2 Nucleocapsid Protein Antigen Measurement SARS-CoV-2 RdRp Gene SARS-CoV-2 RdRp RNA SARS-CoV-2 RNA-dependent RNA Polymerase RNA A measurement of the SARS-CoV-2 RdRp RNA in a biological specimen. SARS-CoV-2 RdRp RNA Measurement SARS-CoV-2 RNA A measurement of the SARS-CoV-2 RNA in a biological specimen. SARS-CoV-2 RNA Measurement SARS-CoV-2 S Gene SARS-CoV-2 S RNA SARS-CoV-2 Spike RNA A measurement of the SARS-CoV-2 S RNA in a biological specimen. SARS-CoV-2 S RNA Measurement SARS-related Coronavirus RNA A measurement of the SARS-related Coronavirus RNA including but not limited to SARS-CoV, SARS-CoV-2, and/or other SARS-like Coronavirus in a biological specimen. SARS-related Coronavirus RNA Measurement SARS-related Coronavirus RNA/MERS RNA A measurement of the SARS-related and/or MERS Coronavirus RNA which includes but not limited to SARS-CoV, SARS-CoV-2, other SARS-like Coronavirus, and/or MERS-CoV in a biological specimen. SARS-related Coronavirus RNA/MERS RNA Measurement Serratia marcescens DNA A measurement of the Serratia marcescens DNA in a biological specimen. Serratia marcescens DNA Measurement Serratia marcescens A measurement of the Serratia marcescens in a biological specimen. Serratia marcescens Measurement Serratia A measurement of the organisms that are not assigned to the species level but are assigned to the Serratia genus level in a biological specimen. Serratia Measurement SARS-CoV SARS-CoV-1 Severe Acute Respiratory Syndrome-Related Coronavirus A measurement of the severe acute respiratory syndrome-related Coronavirus in a biological specimen. Severe Acute Respiratory Syndrome-related Coronavirus Measurement SARS-CoV-2 Severe Acute Resp Syndrome Coronavirus 2 Severe Acute Respiratory Syndrome Coronavirus 2 A measurement of the severe acute respiratory syndrome Coronavirus 2 in a biological specimen. Severe Acute Respiratory Syndrome Coronavirus 2 Measurement Shiga Toxin A measurement of the shiga toxin in a biological specimen. Shiga Toxin Measurement Shigella Antigen A measurement of the antigen from any member of the genus Shigella in a biological specimen. Shigella Antigen Measurement Shigella DNA A measurement of the DNA from any member of the genus Shigella in a biological specimen. Shigella DNA Measurement Shigella A measurement of the organisms that are not assigned to the species level but are assigned to the Shigella genus level in a biological specimen. Shigella Measurement Invasion Plasmid Antigen H Gene ipaH gene Shigella species and/or Enteroinvasive Escherichia coli Invasion Plasmid Antigen H DNA Shigella/EIEC ipaH DNA A measurement of the invasion plasmid antigen H DNA from any members of the genus Shigella and/or enteroinvasive Escherichia coli in a biological specimen. Shigella and/or Enteroinvasive Escherichia coli ipaH DNA Measurement Shigella/EIEC Shigella/Enteroinvasive E. coli Shigella/Enteroinvasive Escherichia coli A measurement of the organisms that are not assigned to the species level but are assigned to the Shigella genus level and/or enteroinvasive Escherichia coli in a biological specimen. Shigella and/or Enteroinvasive Escherichia coli DNA Measurement Spirochaetales Spirochete Bacteria A measurement of the organisms that are not assigned to the species level but are assigned to the Spirochaetales order level in a biological specimen. Spirochaetales Measurement Staphylococcus aureus DNA A measurement of the Staphylococcus aureus DNA in a biological specimen. Staphylococcus aureus DNA Measurement S. aureus Staphylococcus aureus A measurement of the Staphylococcus aureus in a biological specimen. Staphylococcus aureus Measurement Staphylococcus epidermidis A measurement of the Staphylococcus epidermidis in a biological specimen. Staphylococcus epidermidis Measurement Staphylococcus haemolyticus A measurement of the Staphylococcus haemolyticus in a biological specimen. Staphylococcus haemolyticus Measurement Staphylococcus hominis A measurement of Staphylococcus hominis in a biological specimen. Staphylococcus hominis Measurement Staphylococcus saprophyticus A measurement of the Staphylococcus saprophyticus in a biological specimen. Staphylococcus saprophyticus Measurement Staphylococcus, Coagulase Negative DNA A measurement of the DNA from any coagulase negative Staphylococcus species in a biological specimen. Coagulase Negative Staphylococcus DNA Measurement Staphylococcus, Coagulase Negative A measurement of the coagulase negative Staphylococcus species in a biological specimen. Coagulase Negative Staphylococcus Measurement Staphylococcus, Coagulase Positive A measurement of the coagulase positive Staphylococcus species in a biological specimen. Coagulase Positive Staphylococcus Measurement Stenotrophomonas maltophilia A measurement of the organisms that are assigned to the Stenotrophomonas maltophilia species in a biological specimen. Stenotrophomonas maltophilia Measurement Streptococcus agalactiae Antigen Streptococcus Group B Antigen A measurement of the Streptococcus agalactiae antigen in a biological specimen. Streptococcus agalactiae Antigen Measurement Streptococcus agalactiae DNA A measurement of the Streptococcus agalactiae DNA in a biological specimen. Streptococcus agalactiae DNA Measurement Streptococcus agalactiae A measurement of the Streptococcus agalactiae in a biological specimen. Streptococcus agalactiae Measurement Streptococcus anginosus Group A measurement of Streptococcus anginosus Group in a biological specimen. Streptococcus anginosus Group Measurement Streptococcus anginosus A measurement of the Streptococcus anginosus in a biological specimen. Streptococcus anginosus Measurement Streptococcus beta-hemolytic A measurement of beta-hemolytic Streptococcus in a biological specimen. Beta-Hemolytic Streptococcus Measurement Streptococcus gallolyticus A measurement of Streptococcus gallolyticus in a biological specimen. Streptococcus gallolyticus Measurement Streptococcus gamma-hemolytic A measurement of gamma-hemolytic Streptococcus in a biological specimen. Gamma-Hemolytic Streptococcus Measurement Streptococcus Group A A measurement of the Streptococcus group A in a biological specimen. Group A Streptococcus Measurement Streptococcus Group B A measurement of the Streptococcus group B in a biological specimen. Group B Streptococcus Measurement Streptococcus mitis A measurement of Streptococcus mitis in a biological specimen. Streptococcus mitis Measurement Streptococcus pneumoniae Antigen A measurement of the Streptococcus pneumoniae antigen in a biological specimen. Streptococcus pneumoniae Antigen Measurement Streptococcus pneumoniae DNA A measurement of Streptococcus pneumoniae DNA in a biological specimen. Streptococcus pneumoniae DNA Measurement Streptococcus pneumoniae A measurement of the Streptococcus pneumoniae in a biological specimen. Streptococcus pneumoniae Measurement Streptococcus pyogenes Antigen A measurement of the Streptococcus pyogenes antigen in a biological specimen. Streptococcus pyogenes Antigen Measurement Streptococcus pyogenes DNA A measurement of the Streptococcus pyogenes DNA in a biological specimen. Streptococcus pyogenes DNA Measurement Streptococcus pyogenes A measurement of the Streptococcus pyogenes in a biological specimen. Streptococcus pyogenes Measurement Streptococcus salivarius A measurement of Streptococcus salivarius in a biological specimen. Streptococcus salivarius Measurement Streptococcus thoraltensis A measurement of Streptococcus thoraltensis in a biological specimen. Streptococcus thoraltensis Measurement Streptococcus viridans A measurement of Streptococcus viridans in a biological specimen. Streptococcus viridans Measurement Streptococcus A measurement of the organisms that are not assigned to the species level but are assigned to the Streptococcus genus level in a biological specimen. Streptococcus Measurement Tick-Borne Encephalitis Virus RNA A measurement of the Tick-borne Encephalitis virus RNA in a biological specimen. Tick Borne Encephalitis Virus RNA Measurement Toscana Virus RNA A measurement of the Toscana virus RNA in a biological specimen. Toscana Virus RNA Measurement Toxigenic Clostridium difficile A measurement of the toxigenic strain of Clostridium difficile in a biological specimen. Toxigenic Clostridium difficile Measurement Toxin B-Producing Clostridium difficile A measurement of the toxin B-producing strain of Clostridium difficile in a biological specimen. Toxin B-Producing Clostridium difficile Measurement Toxoplasma gondii DNA A measurement of the Toxoplasma gondii DNA in a biological specimen. Toxoplasma gondii DNA Measurement Treponema pallidum DNA A measurement of the Treponema pallidum DNA in a biological specimen. Treponema pallidum DNA Measurement Treponema pallidum A measurement of the Treponema pallidum in a biological specimen. Treponema pallidum Measurement Trichomonas RNA A measurement of the RNA from any member of the genus Trichomonas in a biological specimen. Trichomonas RNA Measurement Trichomonas vaginalis DNA A measurement of the Trichomonas vaginalis DNA in a biological specimen. Trichomonas vaginalis DNA Measurement Trichomonas vaginalis A measurement of the Trichomonas vaginalis in a biological specimen. Trichomonas vaginalis Measurement Trichomonas Examination of a biological specimen to detect the presence of any protozoan belonging to the Trichomonas genus. Trichomonas Screening Ureaplasma parvum DNA A measurement of the Ureaplasma parvum DNA in a biological specimen. Ureaplasma parvum DNA Measurement Ureaplasma parvum A measurement of the Ureaplasma parvum in a biological specimen. Ureaplasma parvum Measurement Ureaplasma urealyticum DNA A measurement of the Ureaplasma urealyticum DNA in a biological specimen. Ureaplasma urealyticum DNA Measurement Ureaplasma urealyticum A measurement of the Ureaplasma urealyticum in a biological specimen. Ureaplasma urealyticum Measurement Urease A measurement of the microbial urease enzyme in a biological specimen. Urease Measurement V. chol/parahaemolyticus/vulnificus DNA Vibrio cholerae/parahaemolyticus/vulnificus DNA A measurement of the Vibrio cholerae and/or Vibrio parahaemolyticus and/or Vibrio vulnificus DNA in a biological specimen. Vibrio cholerae, Vibrio parahaemolyticus, and/or Vibrio vulnificus DNA Measurement Vaccinia Virus A measurement of the Vaccinia virus in a biological specimen. Vaccinia Virus Measurement Varicella Zoster Virus DNA A measurement of the Varicella Zoster virus DNA in a biological specimen. Varicella Zoster Virus DNA Measurement Varicella Zoster Virus A measurement of the varicella zoster virus in a biological specimen. Varicella Zoster Virus Measurement Vibrio cholerae DNA A measurement of the Vibrio cholerae DNA in a biological specimen. Vibrio cholerae DNA Measurement Vibrio parahaemolyticus DNA A measurement of the Vibrio parahaemolyticus DNA in a biological specimen. Vibrio parahaemolyticus DNA Measurement West Nile Virus RNA A measurement of the West Nile virus RNA in a biological specimen. West Nile Virus RNA Measurement Budding Yeast Yeast Budding A measurement of the budding yeast present in a biological specimen. Budding Yeast Measurement Yeast Cells A measurement of the yeast cells present in a biological specimen. Yeast Cell Measurement Yeast Hyphae A measurement of the yeast hyphae present in a biological specimen. Yeast Hyphae Screening Yersinia enterocolitica DNA A measurement of the Yersinia enterocolitica DNA in a biological specimen. Yersinia enterocolitica DNA Measurement Yersinia A measurement of the organisms that are not assigned to the species level but are assigned to the Yersinia genus level in a biological specimen. Yersinia Measurement Zaire Ebolavirus A measurement of the Zaire ebolavirus present in a biological specimen. Zaire Ebolavirus Measurement Zika Virus RNA A measurement of the Zika virus RNA in a biological specimen. Zika Virus RNA Measurement MBTEST Microbiology Test Name CDISC SDTM Microbiology Test Name Terminology Microorganisms, bacteria, fungi and other organisms. Any bacterial organism that can be assigned to the species Abiotrophia defectiva. Abiotrophia defectiva Any bacteria that is not assigned to the species level but can be assigned to the Abiotrophia genus level. Abiotrophia Any fungal organism that is not assigned to the species level but can be assigned to the Absidia genus level. Absidia Any amoebic organism that can be assigned to the species Acanthamoeba astronyxis. Acanthamoeba astronyxis Any amoebic organism that can be assigned to the species Acanthamoeba castellanii. Acanthamoeba castellanii Any amoebic organism that can be assigned to the species Acanthamoeba culbertsoni. Acanthamoeba culbertsoni Any amoebic organism that can be assigned to the species Acanthamoeba griffini. Acanthamoeba griffini Any amoebic organism that can be assigned to the species Acanthamoeba hatchetti. Acanthamoeba hatchetti Any amoebic organism that can be assigned to the species Acanthamoeba lugdunensis. Acanthamoeba lugdunensis Any amoebic organism that can be assigned to the species Acanthamoeba palestinensis. Acanthamoeba palestinensis Any amoebic organism that can be assigned to the species Acanthamoeba polyphaga. Acanthamoeba polyphaga Any amoebic organism that can be assigned to the species Acanthamoeba quina. Acanthamoeba quina Any amoebic organism that can be assigned to the species Acanthamoeba rhysodes. Acanthamoeba rhysodes Any amoebic organism that is not assigned to the species level but can be assigned to the Acanthamoeba genus level. Acanthamoeba Alcaligenes denitrificans Any bacterial organism that can be assigned to the species Achromobacter denitrificans. Achromobacter denitrificans Any bacterial organism that can be assigned to the species Achromobacter piechaudii. Achromobacter piechaudii Alcaligenes ruhlandii Hydrogenomonas ruhlandii Pseudomonas ruhlandii Any bacterial organism that can be assigned to the species Achromobacter ruhlandii. Achromobacter ruhlandii Any bacterial organism that can be assigned to the species Achromobacter spanius. Achromobacter spanius Alcaligenes xylosoxidans Any bacterial organism that can be assigned to the species Achromobacter xylosoxidans. Achromobacter xylosoxidans Any bacteria that is not assigned to the species level but can be assigned to the Achromobacter genus level. Achromobacter Any rod-shaped bacteria with the characteristic of acid fastness that resists decolorization by acids during staining. Acid-fast Bacillus Any bacterial organism that can be assigned to the species Acidaminococcus fermentans. Acidaminococcus fermentans Any bacterial organism that can be assigned to the species Acidaminococcus intestini. Acidaminococcus intestini Any bacteria that is not assigned to the species level but can be assigned to the Acidaminococcus genus level. Acidaminococcus Any bacterial organism that can be assigned to the species Acidovorax delafieldii. Acidovorax delafieldii Any bacterial organism that can be assigned to the species Acidovorax facilis. Acidovorax facilis Any bacterial organism that can be assigned to the species Acidovorax temperans. Acidovorax temperans Any bacteria that is not assigned to the species level but can be assigned to the Acidovorax genus level. Acidovorax Acinetobacter calcoaceticus subsp. anitratus Any bacterial organism that can be assigned to the species Acinetobacter calcoaceticus subspecies anitratus. Acinetobacter anitratus Acinetobacter genomospecies 2 Bacterium anitratum Any bacterial organism that can be assigned to the species Acinetobacter baumannii. Acinetobacter baumannii Carbapenem-resistant Acinetobacter baumannii CRAB Any bacterial organism that can be assigned to the species Acinetobacter baumannii and is resistant to the antibiotic carbapenem. Carbapenem Resistant Acinetobacter baumannii Acinetobacter genospecies 10 Any bacterial organism that can be assigned to the species Acinetobacter bereziniae. Acinetobacter bereziniae Any bacterial organism that can be assigned to the species Acinetobacter calcoaceticus. Acinetobacter calcoaceticus Abc Complex Acb Complex Acinetobacter baumannii-calcoaceticus Complex A bacterial species group that mainly includes Acinetobacter baumannii, Acinetobacter nosocomialis, Acinetobacter pittii, and Acinetobacter calcoaceticus, as well as those that are phenotypically or genetically similar to these species. Acinetobacter calcoaceticus/baumannii Complex Any bacterial organism that can be assigned to the species Acinetobacter haemolyticus. Acinetobacter haemolyticus Any bacterial organism that can be assigned to the species Acinetobacter johnsonii. Acinetobacter johnsonii Any bacterial organism that can be assigned to the species Acinetobacter junii. Acinetobacter junii Acinetobacter dijkshoorniae Acinetobacter genomo sp. NB14 Any bacterial organism that can be assigned to the species Acinetobacter lactucae. Acinetobacter lactucae Acinetobacter calcoaceticus subsp. lwoffii Any bacterial organism that can be assigned to the species Acinetobacter lwoffii. Acinetobacter lwoffii Any bacterial organism that can be assigned to the species Acinetobacter nosocomialis. Acinetobacter nosocomialis Acinetobacter sp. phenon 4 Any bacterial organism that can be assigned to the species Acinetobacter parvus. Acinetobacter parvus Acinetobacter genomosp. 3 g-proteobacteria Any bacterial organism that can be assigned to the species Acinetobacter pittii. Acinetobacter pittii Any bacterial organism that can be assigned to the species Acinetobacter radioresistens. Acinetobacter radioresistens Any bacterial organism that can be assigned to the species Acinetobacter soli. Acinetobacter soli Acinetobacter sp. phenon 1 Any bacterial organism that can be assigned to the species Acinetobacter ursingii. Acinetobacter ursingii Any bacteria that is not assigned to the species level but can be assigned to the Acinetobacter genus level. Acinetobacter Carbapenem-resistant Acinetobacter Any bacterial organism that can be assigned to the genus Acinetobacter and is resistant to the antibiotic carbapenem. Carbapenem Resistant Acinetobacter Gliomastix atrogriseum Phaeoscopulariopsis atrogrisea Any fungal organism that can be assigned to the species Acremonium atrogriseum. Acremonium atrogriseum Any fungal organism that is not assigned to the species level but can be assigned to the Acremonium genus level. Acremonium Any bacterial organism that can be assigned to the species Actinobacillus actinomycetemcomitans. Actinobacillus actinomycetemcomitans Any bacterial organism that can be assigned to the species Actinobacillus equuli. Actinobacillus equuli Any bacterial organism that can be assigned to the species Actinobacillus ligniersii. Actinobacillus lignieresii Haemophilus pleuropneumoniae Any bacterial organism that can be assigned to the species Actinobacillus pleuropneumoniae. Actinobacillus pleuropneumoniae Any bacterial organism that can be assigned to the species Actinobacillus suis. Actinobacillus suis Pasteurella ureae Any bacterial organism that can be assigned to the species Actinobacillus ureae. Actinobacillus ureae Any bacteria that is not assigned to the species level but can be assigned to the Actinobacillus genus level. Actinobacillus Any bacterial organism that can be assigned to the species Actinobaculum schaalii. Actinobaculum schaalii Any bacterial organism that can be assigned to the species Actinomadura madurae. Actinomadura madurae Any bacterial organism that can be assigned to the species Actinomadura pelletieri. Actinomadura pelletieri Any bacteria that is not assigned to the species level but can be assigned to the Actinomadura genus level. Actinomadura Actinocladothrix bovis Cladothrix bovis Discomyces bovis Nocardia bovis Oospora bovis Proactinomyces bovis Sarcomyces bovis Sphaerotilus bovis Streptothrix bovis Any bacterial organism that can be assigned to the species Actinomyces bovis. Actinomyces bovis Any bacterial organism that can be assigned to the species Actinomyces europaeus. Actinomyces europaeus Any bacterial organism that can be assigned to the species Actinomyces israelii. Actinomyces israelii Any bacterial organism that can be assigned to the species Actinomyces meyerii. Actinomyces meyerii Any bacterial organism that can be assigned to the species Actinomyces naseslundii. Actinomyces naeslundii CDC coryneform group 1 Any bacterial organism that can be assigned to the species Actinomyces neuii subspecies neuii. Actinomyces neuii Subspecies neuii Any bacterial organism that can be assigned to the species Actinomyces neuii. Actinomyces neuii Any bacterial organism that can be assigned to the species Actinomyces odontolyticus. Actinomyces odontolyticus Actinomyces naeslundii Genospecies 2 Any bacterial organism that can be assigned to the species Actinomyces oris. Actinomyces oris Any bacterial organism that can be assigned to the species Actinomyces radingae. Actinomyces radingae Any bacterial organism that can be assigned to the species Actinomyces turicensis. Actinomyces turicensis Any bacterial organism that can be assigned to the species Actinomyces viscosus. Actinomyces viscosus Any bacteria that is not assigned to the species level but can be assigned to the Actinomyces genus level. Actinomyces AAV2 Any viral organism that can be assigned to below the species level adeno-associated virus 2. Adeno-Associated Virus Type 2 Adenovirus ADV Any viral organism that can be assigned to the family Adenoviridae. Adenoviridae Adherent Invasive E. coli AIEC Any bacterial organism that can be assigned to the species Escherichia coli, and is considered as the pathotype adherent invasive. AIEC causes Crohn's disease and inflammatory bowel disease. Adherent Invasive Escherichia coli Aerobic Gram-negative Rod Any rod-shaped bacteria with an oxygen-based metabolism and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique. Aerobic Gram Negative Bacillus Gram-negative Aerobe Any bacteria that requires oxygen to grow or respirate, cannot be assigned to a specific genus or species, and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique. Aerobic Gram-Negative Bacteria Any bacterial organism with an oxygen-based metabolism, and is intermediate in morphology between a spherical-shaped coccus and a rod-shaped bacillus that contains low levels of peptidoglycan in its cell wall and stains pink with the Gram staining technique. Aerobic Gram-Negative Coccobacillus Any spherical-shaped bacteria with an oxygen-based metabolism and a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique. Aerobic Gram Negative Coccus Aerobic Gram-positive Rod Any rod-shaped bacteria with an oxygen-based metabolism and has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique. Aerobic Gram Positive Bacillus Gram-positive Aerobe Any bacteria that requires oxygen to grow or respirate, cannot be assigned to a specific genus or species, and has a cell wall that contains high levels of peptidoglycan and stains purple with the Gram staining technique. Aerobic Gram-Positive Bacteria Any spherical-shaped bacteria with an oxygen-based metabolism and a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique. Aerobic Gram Positive Coccus Any bacteria assigned to the genus Streptococcus that requires oxygen to grow or respirate. Aerobic Streptococcus Any bacteria that are not assigned to the species level but can be assigned to the Aerococcaceae family level. Aerococcaceae Any bacterial organism that can be assigned to the species Aerococcus sanguinicola. Aerococcus sanguinicola Any bacterial organism that can be assigned to the species Aerococcus urinae. Aerococcus urinae Any bacterial organism that can be assigned to the species Aerococcus viridans. Aerococcus viridans Any bacteria that is not assigned to the species level but can be assigned to the Aerococcus genus level. Aerococcus Any bacterial organism that can be assigned to the species Aeromonas hydrophila. Aeromonas hydrophila Any bacterial organism that can be assigned to the species Aeromonas jandaei. Aeromonas jandaei Aeromonas caviae Any bacterial organism that can be assigned to the species Aeromonas punctata. Aeromonas punctata Any bacterial organism that can be assigned to the species Aeromonas salmonicida. Aeromonas salmonicida Any bacterial organism that can be assigned to the species Aeromonas schubertii. Aeromonas schubertii Any bacterial organism that can be assigned to the species Aeromonas sobria. Aeromonas sobria Any bacterial organism that can be assigned to the species Aeromonas veronii. Aeromonas veronii Any bacteria that is not assigned to the species level but can be assigned to the Aeromonas genus level. Aeromonas Haemophilus actinomycetemcomitans Any bacterial organism that can be assigned to the species Aggregatibacter actinomycetemcomitans. Aggregatibacter actinomycetemcomitans Haemophilus aphrophilus Haemophilus paraphrophilus Any bacterial organism that can be assigned to the species Aggregatibacter aphrophilus. Aggregatibacter aphrophilus Haemophilus aphrophilus, Beta-lactamase Negative Any bacterial organism that can be assigned to the species Aggregatibacter aphrophilus and is beta-lactamase negative. Aggregatibacter aphrophilus, Beta-lactamase Negative Haemophilus aphrophilus, Beta-lactamase Positive Any bacterial organism that can be assigned to the species Aggregatibacter aphrophilus and is beta-lactamase positive. Aggregatibacter aphrophilus, Beta-lactamase Positive Haemophilus aphrophilus, Penicillinase Negative Any bacterial organism that can be assigned to the species Aggregatibacter aphrophilus and is penicillinase negative. Aggregatibacter aphrophilus, Penicillinase Negative Haemophilus aphrophilus, Penicillinase Positive Any bacterial organism that can be assigned to the species Aggregatibacter aphrophilus and is penicillinase positive. Aggregatibacter aphrophilus, Penicillinase Positive Haemophilus segnis Any bacterial organism that can be assigned to the species Aggregatibacter segnis. Aggregatibacter segnis Any bacteria that is not assigned to the species level but can be assigned to the Aggregatibacter genus level. Aggregatibacter Any bacterial organism that can be assigned to the species Agrobacterium radiobacter. Agrobacterium radiobacter Rhizobium radiobacter Any bacterial organism that can be assigned to the species Agrobacterium tumefaciens. Agrobacterium tumefaciens Any bacteria that is not assigned to the species level but can be assigned to the Agrobacterium genus level. Agrobacterium Any bacteria that are not assigned to the species level but can be assigned to the Alcaligenaceae family level. Alcaligenaceae Alcaligenes odorans Any bacterial organism that can be assigned to the species Alcaligenes faecalis. Alcaligenes faecalis Any bacteria that is not assigned to the species level but can be assigned to the Alcaligenes genus level. Alcaligenes Bacteroides putredinis Any bacterial organism that can be assigned to the species Alistipes putredinis. Alistipes putredinis Any bacterial organism that can be assigned to the species Alistipes shahii. Alistipes shahii Any bacterial organism that is not assigned to the species level but can be assigned to the Alistipes genus level. Alistipes Bacillus clausii Any bacterial organism that can be assigned to the species Alkalihalobacillus clausii. Alkalihalobacillus clausii Alloiococcus otitidis Any bacterial organism that can be assigned to the species Alloiococcus otitis. Alloiococcus otitis Coronavirus Group 1 Any viral organism that is not assigned to the species level but can be assigned to the Alphacoronavirus genus level. Alphacoronavirus Arboviruses Group A Any viral organism that can be assigned to the genus Alphavirus. Alphavirus Alternaria tenuis Any fungal organism that can be assigned to the species Alternaria alternata. Alternaria alternata Any fungal organism that is not assigned to the species level but can be assigned to the Alternaria genus level. Alternaria Ameba Any unicellular, eukaryotic organism that is not assigned to the species level but can be assigned to the Amoeba genus level. Amoeba Anaerobe Any bacterial organism that does not require oxygen to grow or respirate and cannot be assigned to a specific genus or species. Anaerobic Bacteria Any spherical shaped bacterial organism that does not require oxygen to grow or respirate and cannot be assigned to a specific genus or species. Anaerobic Coccus Anaerobic Gram-negative Rod Any rod-shaped bacteria that does not require oxygen to grow or respirate and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique. Anaerobic Gram Negative Bacillus Gram-negative Anaerobe Any bacterial organism that does not require oxygen to grow or respirate, cannot be assigned to a specific genus or species, and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique. Anaerobic Gram-negative Bacteria Any bacterial organism that does not require oxygen to grow or respirate, and is intermediate in morphology between a spherical-shaped coccus and a rod-shaped bacillus that contains low levels of peptidoglycan in its cell wall and stains pink with the Gram staining technique. Anaerobic Gram-Negative Coccobacillus Any spherical-shaped bacteria that does not require oxygen to grow or respirate and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique. Anaerobic Gram Negative Coccus Anaerobic Gram-positive Rod Any rod-shaped bacteria that does not require oxygen to grow or respirate and has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique. Anaerobic Gram Positive Bacillus Gram-positive Anaerobe Any bacterial organism that does not require oxygen to grow or respirate, cannot be assigned to a specific genus or species, and has a cell wall that contains high levels of peptidoglycan and stains purple with the Gram staining technique. Anaerobic Gram Positive Bacteria Any spherical-shaped bacteria that does not require oxygen to grow or respirate and has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique. Anaerobic Gram Positive Coccus Any bacteria assigned to the genus Streptococcus that does not require oxygen to grow or respirate. Anaerobic Streptococcus Peptostreptococcus hydrogenalis Any bacterial organism that can be assigned to the species Anaerococcus hydrogenalis. Anaerococcus hydrogenalis Micrococcus prevotii Peptococcus prevotii Peptostreptococcus prevotii Any bacterial organism that can be assigned to the species Anaerococcus prevotii. Anaerococcus prevotii Gaffkya anaerobia Peptostreptotoccus tetradius Any bacterial organism that can be assigned to the species Anaerococcus tetradius. Anaerococcus tetradius Any bacterial organism that can be assigned to the species Anaerococcus vaginalis. Anaerococcus vaginalis Any bacteria that is not assigned to the species level but can be assigned to the Anaerococcus genus level. Anaerococcus Cytoecetes phagocytophila Ehrlichia equi Rickettsia phagocytophila Any bacterial organism that can be assigned to the species Anaplasma phagocytophilum. Anaplasma phagocytophilum Any bacteria that is not assigned to the species level but can be assigned to the Anaplasma genus level. Anaplasma Ancylostoma ceylanicum Ancylostoma ceylonicum Any nematode parasite that can be assigned to the species Ancylostoma braziliense. Ancylostoma braziliense Dog Hookworm Any nematode parasite that can be assigned to the species Ancylostoma caninum. Ancylostoma caninum European Hookworm Old World Hookworm Any nematode parasite that can be assigned to the species Ancylostoma duodenale. Ancylostoma duodenale Any nematode parasite that is not assigned to the species level but can be assigned to the Ancylostoma genus level. Ancylostoma Hookworms Any nematode parasite that can be assigned to the family of Ancylostomatoidea. Ancylostomatoidea Rat Lungworm Any nematode parasite that can be assigned to the species Angiostrongylus cantonensis. Angiostrongylus cantonensis Any nematode parasite that is not assigned to the species level but can be assigned to the Angiostrongylus genus level. Angiostrongylus Herring Worm Any nematode parasite that can be assigned to the species Anisakis simplex. Anisakis simplex Any nematode parasite that is not assigned to the species level but can be assigned to the Anisakis genus level. Anisakis Any viral organism that can be assigned to the genus Aphthovirus. Aphthovirus Any fungal organism that can be assigned to the species Apophysomyces elegans. Apophysomyces elegans Arthropod-borne Virus A non-taxonomic grouping of viruses that are transmitted through an arthropod vector and replicate in a vertebrate host. Arbovirus Trueperella bernardiae Any bacterial organism that can be assigned to the species Arcanobacterium bernardiae. Arcanobacterium bernardiae Corynebacterium haemolyticum Corynebacterium haemolyticus Any bacterial organism that can be assigned to the species Arcanobacterium haemolyticum. Arcanobacterium haemolyticum Any bacteria that is not assigned to the species level but can be assigned to the Arcanobacterium genus level. Arcanobacterium Campylobacter butzleri Any bacterial organism that can be assigned to the species Arcobacter butzleri. Arcobacter butzleri Campylobacter cryaerophilus Any bacterial organism that can be assigned to the species Arcobacter cryaerophilus. Arcobacter cryaerophilus Any bacteria that is not assigned to the species level but can be assigned to the Arcobacter genus level. Arcobacter Any viral organism that can be assigned to the genus Arenavirus. Arenavirus Any fungal organism that can be assigned to the species Arthrinium phaeospermum. Arthrinium phaeospermum Any bacterial organism that can be assigned to the species Arthrobacter cumminsii. Arthrobacter cumminsii Any bacteria that is not assigned to the species level but can be assigned to the Arthrobacter genus level. Arthrobacter Microsporum fulvum Any fungal organism that can be assigned to the species Arthroderma fulvum. Arthroderma fulvum Microsporum nanum Any fungal organism that can be assigned to the species Arthroderma obtusum. Arthroderma obtusum Microsporum canis Nannizzia otae Any fungal organism that can be assigned to the species Arthroderma otae. Arthroderma otae Trichophyton persicolor Any fungal organism that can be assigned to the species Arthroderma persicolor. Arthroderma persicolor Trichophyton simii Any fungal organism that can be assigned to the species Arthroderma simii. Arthroderma simii Any fungal organism that is not assigned to the species level but can be assigned to the Arthrographis genus level. Arthrographis Giant Roundworm Any nematode parasite that can be assigned to the species Ascaris lumbricoides. Ascaris lumbricoides Any nematode parasite that is not assigned to the species level but can be assigned to the Ascaris genus level. Ascaris A non-taxonomic grouping of fungal species that are morphologically similar to the Aspergillus flavus species. Aspergillus Flavus Complex Any fungal organism that can be assigned to the species Aspergillus flavus. Aspergillus flavus A non-taxonomic grouping of fungal species that are morphologically similar to the Aspergillus fumigatus species. Aspergillus Fumigatus Complex Aspergillus fumigates Any fungal organism that can be assigned to the species Aspergillus fumigatus. Aspergillus fumigatus Any fungal organism that can be assigned to the species Aspergillus niger. Aspergillus niger Any fungal organism that can be assigned to the species Aspergillus niveus. Aspergillus niveus Any fungal organism that can be assigned to the species Aspergillus ochraceus. Aspergillus ochraceus Aspergillus terrestrius Any fungal organism that can be assigned to the species Aspergillus terreus. Aspergillus terreus Sterigmatocystis versicolor Any fungal organism that can be assigned to the species Aspergillus versicolor. Aspergillus versicolor Any fungal organism that is not assigned to the species level but can be assigned to the Aspergillus genus level. Aspergillus Apiotrichum humicola Azymoprocandida humicola Candida humicola Cryptococcus humicola Mycotorula humicola Torula humicola Vanrija humicola Vanrijia humicola Any fungal organism that can be assigned to the species Asterotremella humicola. Asterotremella humicola Any viral organism that can be assigned to the family Astroviridae. Astroviridae Lactobacillus minutis Lactobacillus minutus Any bacterial organism that can be assigned to the species Atopobium minutum. Atopobium minutum Streptococcus parvulus Any bacterial organism that can be assigned to the species Atopobium parvulum. Atopobium parvulum Lactobacillus rimae Any bacterial organism that can be assigned to the species Atopobium rimae. Atopobium rimae Any bacterial organism that can be assigned to the species Atopobium vaginae. Atopobium vaginae Aureobasidium pullulans var. pullulans Any fungal organism that can be assigned to the species Aureobasidium pullulans. Aureobasidium pullulans Haemophilus paragallinarum Any bacterial organism that can be assigned to the species Avibacterium paragallinarum. Avibacterium paragallinarum Any unicellular, eukaryotic organism that can be assigned to the species Babesia divergens. Babesia divergens Any unicellular, eukaryotic organism that can be assigned to the species Babesia microti. Babesia microti Any unicellular, eukaryotic organism that is not assigned to the species level but can be assigned to the Babesia genus level. Babesia Firmicutes Any bacterial organism that can be assigned to the phylum Bacillota. Bacillota Any bacterial organism that can be assigned to the species Bacillus alvei. Bacillus alvei Any bacterial organism that can be assigned to the species Bacillus anthracis. Bacillus anthracis Any bacterial organism that can be assigned to the species Bacillus cereus. Bacillus cereus Any bacterial organism that can be assigned to the species Bacillus lentus. Bacillus lentus Any bacterial organism that can be assigned to the species Bacillus licheniformis. Bacillus licheniformis Any bacterial organism that can be assigned to the species Bacillus megaterium. Bacillus megaterium Any bacterial organism that can be assigned to the species Bacillus mycoides. Bacillus mycoides Any bacterial organism that can be assigned to the species Bacillus polymyxa. Bacillus polymyxa Bacillus aminoglucosidicus Any bacterial organism that can be assigned to the species Bacillus pumilus. Bacillus pumilus Any bacterial organism that can be assigned to the species Bacillus subtilis. Bacillus subtilis Any bacteria that is not assigned to the species level but can be assigned to the Bacillus genus level. Bacillus Bacterium Eubacteria Any organism assigned to the kingdom Bacteria. Bacteria Any bacterial organism that can be assigned to the species Bacteroides caccae. Bacteroides caccae Any bacterial organism that can be assigned to the species Bacteroides capillosus. Bacteroides capillosus Any bacterial organism that can be assigned to the species Bacteroides cellulosolvens. Bacteroides cellulosolvens Any bacterial organism that can be assigned to the species Bacteroides dorei. Bacteroides dorei Any bacterial organism that can be assigned to the species Bacteroides eggerthii. Bacteroides eggerthii Any bacterial organism that can be assigned to the species Bacteroides faecis. Bacteroides faecis A non-taxonomic grouping of bacteria that belongs to the fragilis group of the genus Bacteroides. Bacteroides fragilis Group Any bacterial organism that can be assigned to the species Bacteroides fragilis. Bacteroides fragilis Any bacterial organism that can be assigned to the species Bacteroides intestinalis. Bacteroides intestinalis Any bacterial organism that can be assigned to the species Bacteroides nordii. Bacteroides nordii Any bacterial organism that can be assigned to the species Bacteroides ovatus. Bacteroides ovatus Bacteroides tectum Bacteroides tectus Any bacterial organism that can be assigned to the species Bacteroides pyogenes. Bacteroides tectus Any bacterial organism that can be assigned to the species Bacteroides salyersiae. Bacteroides salyersiae Bacteroides fragilis subsp. A Any bacterial organism that can be assigned to the species Bacteroides stercoris. Bacteroides stercoris Any bacterial organism that can be assigned to the species Bacteroides thetaiotamicron. Bacteroides thetaiotaomicron Any bacterial organism that can be assigned to the species Bacteroides uniformis. Bacteroides uniformis Any bacterial organism that can be assigned to the species Bacteroides vulgatus. Bacteroides vulgatus Any bacterial organism that can be assigned to the species Bacteroides xylanisolvens. Bacteroides xylanisolvens Any bacteria that is not assigned to the species level but can be assigned to the Bacteroides genus level. Bacteroides Any amoebic organism that can be assigned to the species Balamuthia mandrillaris. Balamuthia mandrillaris Any amoebic organism that is not assigned to the species level but can be assigned to the Balamuthia genus level. Balamuthia Paramecium coli Any unicellular, eukaryotic organism that can be assigned to the species Balantidium coli. Balantidium coli Any viral organism that can be assigned to the species Barmah Forest virus. Barmah Forest Virus Rochalimaea elizabethae Any bacterial organism that can be assigned to the species Bartonella elizabethae. Bartonella elizabethae Rochalimaea henselae Any bacterial organism that can be assigned to the species Bartonella henselae. Bartonella henselae Rochalimaea quintana Any bacterial organism that can be assigned to the species Bartonella quintana. Bartonella quintana Any bacteria that is not assigned to the species level but can be assigned to the Bartonella genus level. Bartonella Weeksella zoohelcum Any bacterial organism that can be assigned to the species Bergeyella zoohelcum. Bergeyella zoohelcum Any bacteria that is not assigned to the species level but can be assigned to the Bergeyella genus level. Bergeyella GAS Streptococcus Group A A non-taxonomic grouping of beta-hemolytic species within the Streptococcus genus that are assigned to the A group. Beta-Hemolytic Streptococcus Group A GBS Streptococcus Group B A non-taxonomic grouping of beta-hemolytic species within the Streptococcus genus that are assigned to the B group. Beta-Hemolytic Streptococcus Group B GCS Streptococcus Group C A non-taxonomic grouping of beta-hemolytic species within the Streptococcus genus that are assigned to the C group. Beta-Hemolytic Streptococcus Group C GFS Streptococcus Group F A non-taxonomic grouping of beta-hemolytic species within the Streptococcus genus that are assigned to the F group. Beta-Hemolytic Streptococcus Group F GGS Streptococcus Group G A non-taxonomic grouping of beta-hemolytic species within the Streptococcus genus that are assigned to the G group. Beta-Hemolytic Streptococcus Group G Coronavirus Group 2 Any viral organism that can be assigned to the genus Betacoronavirus. Betacoronavirus Any bacterial organism that can be assigned to the species Bifidobacterium adolescentis. Bifidobacterium adolescentis Any bacterial organism that can be assigned to the species Bifidobacterium angulatum. Bifidobacterium angulatum Any bacterial organism that can be assigned to the species Bifidobacterium animalis. Bifidobacterium animalis Any bacterial organism that can be assigned to the species Bifidobacterium bifidum. Bifidobacterium bifidum Bifidobacterium parvulorum Any bacterial organism that can be assigned to the species Bifidobacterium breve. Bifidobacterium breve Bifidobacterium appendicitis Any bacterial organism that can be assigned to the species Bifidobacterium dentium. Bifidobacterium dentium Any bacterial organism that can be assigned to the species Bifidobacterium longum. Bifidobacterium longum Any bacterial organism that can be assigned to the species Bifidobacterium pseudocatenulatum. Bifidobacterium pseudocatenulatum Any bacteria that is not assigned to the species level but can be assigned to the Bifidobacterium genus level. Bifidobacterium Any bacterial organism that can be assigned to the species Bilophila wadsworthia. Bilophila wadsworthia Any bacteria that is not assigned to the species level but can be assigned to the Bilophila genus level. Bilophila Any fungal organism that is not assigned to the species level but can be assigned to the Bipolaris genus level. Bipolaris BK Virus Any viral organism that can be assigned to the species BK polyomavirus. BK Virus Any unicellular, eukaryotic organism that can be assigned to the species Blastocystis hominis. Blastocystis hominis Ajellomyces dermatitidis Blastomycoides dermatitidis Any fungal organism that can be assigned to the species Blastomyces dermatitidis. Blastomyces dermatitidis Bocavirus Any viral organism that can be assigned to the genus Bocaparvovirus. Bocaparvovirus Any bacterial organism that can be assigned to the species Bordetella avium. Bordetella avium Bordetella bronchicanis Any bacterial organism that can be assigned to the species Bordetella bronchiseptica. Bordetella bronchiseptica Any bacterial organism that can be assigned to the species Bordetella hinzii. Bordetella hinzii CDC Nonoxidizer Group 2 Any bacterial organism that can be assigned to the species Bordetella holmesii. Bordetella holmesii Any bacterial organism that can be assigned to the species Bordetella parapertussis. Bordetella parapertussis Any bacterial organism that can be assigned to the species Bordetella pertussis. Bordetella pertussis Any bacterial organism that can be assigned to the species Bordetella petrii. Bordetella petrii Any bacteria that is not assigned to the species level but can be assigned to the Bordetella genus level. Bordetella Any bacterial organism that can be assigned to the species Borrelia burgdorferi. Borrelia burgdorferi Any bacterial organism that can be assigned to the species Borrelia miyamotoi. Borrelia miyamotoi Any bacteria that is not assigned to the species level but can be assigned to the Borrelia genus level. Borrelia Borrelia mayonii Any bacterial organism that can be assigned to the species Borreliella mayonii. Borreliella mayonii Any bacterial organism that can be assigned to the species Brevibacillus laterosporus. Brevibacillus laterosporus Any bacteria that is not assigned to the species level but can be assigned to the Brevibacillus genus level. Brevibacillus Any bacterial organism that can be assigned to the species Brevibacterium casei. Brevibacterium casei Any bacterial organism that can be assigned to the species Brevibacterium epidermidis. Brevibacterium epidermidis Any bacteria that is not assigned to the species level but can be assigned to the Brevibacterium genus level. Brevibacterium Pseudomonas diminuta Any bacterial organism that can be assigned to the species Brevundimonas diminuta. Brevundimonas diminuta Pseudomonas vesicularis Any bacterial organism that can be assigned to the species Brevundimonas vesicularis. Brevundimonas vesicularis Any bacteria that is not assigned to the species level but can be assigned to the Brevundimonas genus level. Brevundimonas Any bacterial organism that can be assigned to the species Brucella abortus. Brucella abortus Any bacterial organism that can be assigned to the species Brucella canis. Brucella canis Any bacterial organism that can be assigned to the species Brucella melitensis. Brucella melitensis Any bacterial organism that can be assigned to the species Brucella suis. Brucella suis Any bacteria that is not assigned to the species level but can be assigned to the Brucella genus level. Brucella Any bacterial organism that can be assigned to the species Budvicia aquatica. Budvicia aquatica Any bacteria that is not assigned to the species level but can be assigned to the Budvicia genus level. Budvicia Burkholderia cepacia Complex Genomovar VII Any bacterial organism that can be assigned to the species Burkholderia ambifaria. Burkholderia ambifaria Any bacterial organism that can be assigned to the species Burkholderia anthina. Burkholderia anthina Any bacterial organism that can be assigned to the species Burkholderia cenocepacia. Burkholderia cenocepacia A non-taxonomic grouping of bacterial species that are phenotypically or genetically similar to the Burkholderia cepacia species. Burkholderia cepacia Complex Pseudomonas cepacia Any bacterial organism that can be assigned to the species Burkholderia cepacia. Burkholderia cepacia Burkholderia cepacia Genomovar VI Any bacterial organism that can be assigned to the species Burkholderia dolosa. Burkholderia dolosa Pseudomonas gladioli Any bacterial organism that can be assigned to the species Burkholderia gladioli. Burkholderia gladioli Actinobacillus mallei Any bacterial organism that can be assigned to the species Burkholderia mallei. Burkholderia mallei Burkholderia cepacia Genomovar II Any bacterial organism that can be assigned to the species Burkholderia multivorans. Burkholderia multivorans Burkholderia pseudomalle Pseudomonas pseudomallei Any bacterial organism that can be assigned to the species Burkholderia pseudomallei. Burkholderia pseudomallei Pseudomonas pyrrocinia Any bacterial organism that can be assigned to the species Burkholderia pyrrocinia. Burkholderia pyrrocinia Burkholderia cepacia Genomovar IV Any bacterial organism that can be assigned to the species Burkholderia stabilis. Burkholderia stabilis Burkholderia cepacia Genomovar V Any bacterial organism that can be assigned to the species Burkholderia vietnamiensis. Burkholderia vietnamiensis Any bacteria that is not assigned to the species level but can be assigned to the Burkholderia genus level. Burkholderia Any bacterial organism that can be assigned to the species Buttiauxella agrestis. Buttiauxella agrestis CDC Enteric Group 63 Any bacterial organism that can be assigned to the species Buttiauxella ferragutiae. Buttiauxella ferragutiae CDC Enteric Group 64 Any bacterial organism that can be assigned to the species Buttiauxella gaviniae. Buttiauxella gaviniae CDC Enteric Group 59 Any bacterial organism that can be assigned to the species Buttiauxella noackiae. Buttiauxella noackiae Any bacteria that is not assigned to the species level but can be assigned to the Buttiauxella genus level. Buttiauxella Paecilomyces spectabilis Paecilomyces variotii Talaromyces spectabilis Any fungal organism that can be assigned to the species Byssochlamys spectabilis. Byssochlamys spectabilis Any viral organism that can be assigned to the family Caliciviridae. Caliciviridae Capillaria hepatica Any nematode parasite that can be assigned to the species Calodium hepaticum. Calodium hepaticum Any bacterial organism that can be assigned to the species Campylobacter coli. Campylobacter coli Any bacterial organism that can be assigned to the species Campylobacter concisus. Campylobacter concisus Wolinella curva Any bacterial organism that can be assigned to the species Campylobacter curvus. Campylobacter curvus Vibrio fetus Any bacterial organism that can be assigned to the species Campylobacter fetus. Campylobacter fetus Bacteroides gracilis Any bacterial organism that can be assigned to the species Campylobacter gracilis. Campylobacter gracilis Any bacterial organism that can be assigned to the species Campylobacter jejuni. Campylobacter jejuni Campylobacter laridis Any bacterial organism that can be assigned to the species Campylobacter lari. Campylobacter lari Wolinella recta Any bacterial organism that can be assigned to the species Campylobacter rectus. Campylobacter rectus Any bacterial organism that can be assigned to the species Campylobacter upsaliensis. Campylobacter upsaliensis Bacteroides corrodens Bacteroides ureolyticus Any bacterial organism that can be assigned to the species Campylobacter ureolyticus. Bacteroides ureolyticus Any bacteria that is not assigned to the species level but can be assigned to the Campylobacter genus level. Campylobacter Candida stellatoidea Any fungal organism that can be assigned to the species Candida albicans. Candida albicans Hansenula alcolica Any fungal organism that can be assigned to the species Candida boidinii. Candida boidinii Any fungal organism that can be assigned to the species Candida dubliniensis. Candida dubliniensis Any fungal organism that can be assigned to the species Candida famata. Candida famata Torulopsis glabrata Any fungal organism that can be assigned to the species Candida glabrata. Candida glabrata Torulopsis inconspicua Any fungal organism that can be assigned to the species Candida inconspicua. Candida inconspicua Blastodendrion intermedium Blastodendrion intermedius Cryptococcus intermedius Kluyveromyces cellobiovorus Mycotorula intermedia Any fungal organism that can be assigned to the species Candida intermedia. Candida intermedia Candida parapsilosis group II Any fungal organism that can be assigned to the species Candida orthopsilosis. Candida orthopsilosis A non-taxonomic grouping of fungal species that are phenotypically or genetically similar to the Candida parapsilosis species. Candida parapsilosis Complex Any fungal organism that can be assigned to the species Candida parapsilosis. Candida parapsilosis Any fungal organism that can be assigned to the species Candida pararugosa. Candida pararugosa Azymocandida rugosa Diutina rugosa Mycoderma rugosum Any fungal organism that can be assigned to the species Candida rugosa. Candida rugosa Any fungal organism that can be assigned to the species Candida sake. Candida sake Any fungal organism that can be assigned to the species Candida tropicalis. Candida tropicalis Candida krissii Any fungal organism that can be assigned to the species Candida zeylanoides. Candida zeylanoides Any fungal organism that is not assigned to the species level but can be assigned to the Candida genus level. Candida Candida auris Any fungal organism that can be assigned to the species Candidozyma auris. Candidozyma auris Paracapillaria philippinensis Any nematode parasite that can be assigned to the species Capillaria philippinensis. Capillaria philippinensis Hairworm Any nematode parasite that is not assigned to the species level but can be assigned to the Capillaria genus level. Capillaria Any bacterial organism that can be assigned to the species Capnocytophaga canimorsus. Capnocytophaga canimorsus Any bacterial organism that can be assigned to the species Capnocytophaga gingivalis. Capnocytophaga gingivalis Any bacterial organism that can be assigned to the species Capnocytophaga ochracea. Capnocytophaga ochracea Any bacterial organism that can be assigned to the species Capnocytophaga sputigena. Capnocytophaga sputigena Any bacteria that is not assigned to the species level but can be assigned to the Capnocytophaga genus level. Capnocytophaga Any bacterial organism that can be assigned to the species Cardiobacterium hominis. Cardiobacterium hominis Any bacteria that is not assigned to the species level but can be assigned to the Cardiobacterium genus level. Cardiobacterium Any bacterial organism that can be assigned to the species Cedecea davisae. Cedecea davisae Any bacterial organism that can be assigned to the species Cedecea lapagei. Cedecea lapagei Cedecea Species 4 Any bacterial organism that can be assigned to the species Cedecea neteri. Cedecea neteri Any bacteria that is not assigned to the species level but can be assigned to the Cedecea genus level. Cedecea Any bacterial organism that can be assigned to the species Cellulomonas hominis. Cellulomonas hominis Any bacteria that is not assigned to the species level but can be assigned to the Cellulomonas genus level. Cellulomonas Arthrobacter luteus Cellulomonas cellulans Nocardia cellulans Oerskovia xanthineolytica Any bacterial organism that can be assigned to the species Cellulosimicrobium cellulans. Cellulosimicrobium cellulans Any bacteria that is not assigned to the species level but can be assigned to the Cellulosimicrobium genus level. Cellulosimicrobium Tapeworm Any parasitic flatworm that is not assigned to the species level but can be assigned to the Cestoda class level. Cestoda Any fungal organism that is not assigned to the species level but can be assigned to the Chaetomium genus level. Chaetomium Any viral organism that can be assigned to the species Chikungunya virus. Chikungunya Virus Any unicellular, eukaryotic organism that can be assigned to the species Chilomastix mesnili. Chilomastix mesnili Chlamydia pneumoniae Chlamydophila pneumoniae Any bacterial organism that can be assigned to the species Chlamydia pneumoniae. Chlamydia pneumoniae Any bacterial organism that can be assigned to the species Chlamydia trachomatis. Chlamydia trachomatis Any bacteria that is not assigned to the species level but can be assigned to the Chlamydia genus level. Chlamydia Chlamydia psittaci Any bacterial organism that can be assigned to the species Chlamydophila psittaci. Chlamydophila psittaci Any bacteria that is not assigned to the species level but can be assigned to the Chlamydophila genus level. Chlamydophila Any bacterial organism that can be assigned to the species Chromobacterium violaceum. Chromobacterium violaceum Any bacteria that is not assigned to the species level but can be assigned to the Chromobacterium genus level. Chromobacterium Flavobacterium gleum Any bacterial organism that can be assigned to the species Chryseobacterium gleum. Chryseobacterium gleum Flavobacterium indologenes Any bacterial organism that can be assigned to the species Chryseobacterium indologenes. Chryseobacterium indologenes Any bacteria that is not assigned to the species level but can be assigned to the Chryseobacterium genus level. Chryseobacterium Any bacteria that is not assigned to the species level but can be assigned to the Chryseomonas genus level. Chryseomonas Any fungal organism that is not assigned to the species level but can be assigned to the Chrysosporium genus level. Chrysosporium Levinea amalonatica Any bacterial organism that can be assigned to the species Citrobacter amalonaticus. Citrobacter amalonaticus Any bacterial organism that can be assigned to the species Citrobacter braakii. Citrobacter braakii Citrobacter amalonaticus Biogroup 1 Any bacterial organism that can be assigned to the species Citrobacter farmeri. Citrobacter farmeri A non-taxonomic grouping of bacterial species that are phenotypically or genetically similar to the Citrobacter freundii species. Citrobacter freundii Complex Colobactrum freundii Any bacterial organism that can be assigned to the species Citrobacter freundii. Citrobacter freundii Citrobacter diversus Any bacterial organism that can be assigned to the species Citrobacter koseri. Citrobacter koseri Any bacterial organism that can be assigned to the species Citrobacter murliniae. Citrobacter murliniae Citrobacter Genomospecies 7 Any bacterial organism that can be assigned to the species Citrobacter werkmanii. Citrobacter werkmanii Any bacterial organism that can be assigned to the species Citrobacter youngae. Citrobacter youngae Any bacteria that is not assigned to the species level but can be assigned to the Citrobacter genus level. Citrobacter Byssus herbarum Dematium herbarum Any fungal organism that can be assigned to the species Cladosporium herbarum. Cladosporium herbarum Any fungal organism that is not assigned to the species level but can be assigned to the Cladosporium genus level. Cladosporium Candida lusitaniae Any fungal organism that can be assigned to the species Clavispora lusitaniae. Clavispora lusitaniae Oriental liver fluke Any trematode parasite that can be assigned to the species Clonorchis sinensis. Clonorchis sinensis Any bacterial organism that can be assigned to the species Clostridium acetobutylicum. Clostridium acetobutylicum Any bacterial organism that can be assigned to the species Clostridium aldenense. Clostridium aldenense Clostridium barati Any bacterial organism that can be assigned to the species Clostridium baratii. Clostridium baratii Any bacterial organism that can be assigned to the species Clostridium beijerinckii. Clostridium beijerinckii Paraclostridium bifermentans Any bacterial organism that can be assigned to the species Clostridium bifermentans. Clostridium bifermentans Any bacterial organism that can be assigned to the species Clostridium bolteae. Clostridium bolteae Clostridium pseudotetanicum Any bacterial organism that can be assigned to the species Clostridium butyricum. Clostridium butyricum Any bacterial organism that can be assigned to the species Clostridium cadaveris. Clostridium cadaveris Any bacterial organism that can be assigned to the species Clostridium celatum. Clostridium celatum Any bacterial organism that can be assigned to the species Clostridium citroniae. Clostridium citroniae Clostridium clostridiiforme Any bacterial organism that can be assigned to the species Clostridium clostridioforme. Clostridium clostridioforme Any bacterial organism that can be assigned to the species Clostridium cochlearium. Clostridium cochlearium Any bacterial organism that can be assigned to the species Clostridium cocleatum. Clostridium cocleatum Any bacterial organism that can be assigned to the species Clostridium colicanis. Clostridium colicanis Clostridioides difficile Clostridium difficilis Any bacterial organism that can be assigned to the species Clostridium difficile. Clostridium difficile Clostridium pseudofallax Any bacterial organism that can be assigned to the species Clostridium fallax. Clostridium fallax Any bacterial organism that can be assigned to the species Clostridium glycolicum. Clostridium glycolicum Any bacterial organism that can be assigned to the species Clostridium haemolyticum. Clostridium haemolyticum Any bacterial organism that can be assigned to the species Clostridium hathewayi. Clostridium hathewayi Any bacterial organism that can be assigned to the species Clostridium histolyticum. Clostridium histolyticum Any bacterial organism that can be assigned to the species Clostridium innocuum. Clostridium innocuum Any bacterial organism that can be assigned to the species Clostridium limosum. Clostridium limosum Any bacterial organism that can be assigned to the species Clostridium novyi. Clostridium novyi Any bacterial organism that can be assigned to the species Clostridium oceanicum. Clostridium oceanicum Zymobacterium oroticum Any bacterial organism that can be assigned to the species Clostridium oroticum. Clostridium oroticum Any bacterial organism that can be assigned to the species Clostridium paraputrificum. Clostridium paraputrificum Clostridium welchii Any bacterial organism that can be assigned to the species Clostridium perfringens. Clostridium perfringens Botulobacillus botulinus Clostridium botulinum Clostridium lentoputrescens Ermengemillus botulinus Any bacterial organism that can be assigned to the species Clostridium putrificum. Clostridium putrificum Actinomyces ramosus Any bacterial organism that can be assigned to the species Clostridium ramosum. Clostridium ramosum Any bacterial organism that can be assigned to the species Clostridium rectum. Clostridium rectum Any bacterial organism that can be assigned to the species Clostridium sartagoforme. Clostridium sartagoforme Any bacterial organism that can be assigned to the species Clostridium septicum. Clostridium septicum Paeniclostridium sordellii Any bacterial organism that can be assigned to the species Clostridium sordellii. Clostridium sordellii Any bacterial organism that can be assigned to the species Clostridium spiroforme. Clostridium spiroforme Any bacterial organism that can be assigned to the species Clostridium sporogenes. Clostridium sporogenes Any bacterial organism that can be assigned to the species Clostridium subterminale. Clostridium subterminale Bacteroides symbiosus Any bacterial organism that can be assigned to the species Clostridium symbiosum. Clostridium symbiosum Any bacterial organism that can be assigned to the species Clostridium tertium. Clostridium tertium Any bacterial organism that can be assigned to the species Clostridium tetani. Clostridium tetani Any bacterial organism that can be assigned to the species Clostridium tyrobutyricum. Clostridium tyrobutyricum Any bacteria that is not assigned to the species level but can be assigned to the Clostridium genus level. Clostridium CONS Any bacteria assigned to the genus Staphylococcus that does not express the enzyme coagulase. Coagulase-Negative Staphylococcus Any bacteria assigned to the genus Staphylococcus that expresses the enzyme coagulase. Coagulase-Positive Staphylococcus Ascomycete fungi Any fungal organism that can be assigned to the species Coccidioides immitis. Coccidioides immitis Any fungal organism that is not assigned to the species level but can be assigned to the Coccidioides genus level. Coccidioides A non-taxonomic grouping of rod-shaped, gram-negative, non-spore forming bacteria that ferment lactose, producing acid and gas. Coliform Bacteria A non-taxonomic grouping of coliform bacteria that can ferment lactose. Coliform Bacteria, Lactose Fermenting A non-taxonomic grouping of coliform bacteria that cannot ferment lactose. Coliform Bacteria, Non-Lactose Fermenting Eubacterium aerofaciens Any bacterial organism that can be assigned to the species Collinsella aerofaciens. Collinsella aerofaciens Any bacterial organism that can be assigned to the species Collinsella intestinalis. Collinsella intestinalis Any bacteria that is not assigned to the species level but can be assigned to the Collinsella genus level. Collinsella CTFV Any viral organism that can be assigned to the species Colorado tick fever virus. Colorado Tick Fever Virus Any bacterial organism that can be assigned to the species Comamonas terrigena. Comamonas terrigena Pseudomonas testosteroni Any bacterial organism that can be assigned to the species Comamonas testosteroni. Comamonas testosteroni Any bacteria that is not assigned to the species level but can be assigned to the Comamonas genus level. Comamonas Lecythophora Any fungal organism that is not assigned to the species level but can be assigned to the Coniochaeta genus level. Coniochaeta Coprinus radians Any fungal organism that can be assigned to the species Coprinellus radians. Coprinellus radians Any viral organism that can be assigned to the family Coronaviridae. Coronaviridae CDC Coryneform Group G-1 Any bacterial organism that can be assigned to the species Corynebacterium accolens. Corynebacterium accolens Corynebacterium ANF-1 Any bacterial organism that can be assigned to the species Corynebacterium afermentans. Corynebacterium afermentans Any bacterial organism that can be assigned to the species Corynebacterium amycolatum. Corynebacterium amycolatum Any bacterial organism that can be assigned to the species Corynebacterium argentoratense. Corynebacterium argentoratense Corynebacterium nigricans Any bacterial organism that can be assigned to the species Corynebacterium aurimucosum. Corynebacterium aurimucosum Any bacterial organism that can be assigned to the species Corynebacterium auris. Corynebacterium auris Any bacterial organism that can be assigned to the species Corynebacterium bovis. Corynebacterium bovis Any bacterial organism that can be assigned to the species Corynebacterium coyleae. Corynebacterium coyleae Any bacterial organism that can be assigned to the species Corynebacterium diphtheriae subspecies gravis. Corynebacterium diphtheriae bv. gravis Any bacterial organism that can be assigned to the species Corynebacterium diphtheriae subspecies intermedius. Corynebacterium diphtheriae bv. intermedius Any bacterial organism that can be assigned to the species Corynebacterium diphtheriae subspecies mitis. Corynebacterium diphtheriae bv. mitis Any bacterial organism that can be assigned to the species Corynebacterium diphtheriae subspecies belfanti. Corynebacterium diphtheriae bv. belfanti Any bacterial organism that can be assigned to the species Corynebacterium diphtheriae. Corynebacterium diphtheriae Any bacterial organism that can be assigned to the species Corynebacterium genitalium. Corynebacterium genitalium Any bacterial organism that can be assigned to the species Corynebacterium glucuronolyticum. Corynebacterium glucuronolyticum CDC Coryneform Group JK Any bacterial organism that can be assigned to the species Corynebacterium jeikeium. Corynebacterium jeikeium Any bacterial organism that can be assigned to the species Corynebacterium kutscheri. Corynebacterium kutscheri Any bacterial organism that can be assigned to the species Corynebacterium macginleyi. Corynebacterium macginleyi Bacterionema matruchotii Any bacterial organism that can be assigned to the species Corynebacterium matruchotii. Corynebacterium matruchotii Any bacterial organism that can be assigned to the species Corynebacterium minutissimum. Corynebacterium minutissimum Any bacterial organism that can be assigned to the species Corynebacterium mucifaciens. Corynebacterium mucifaciens Any bacterial organism that can be assigned to the species Corynebacterium pilosum. Corynebacterium pilosum Any bacterial organism that can be assigned to the species Corynebacterium propinquum. Corynebacterium propinquum Corynebacterium hofmannii Any bacterial organism that can be assigned to the species Corynebacterium pseudodiphtheriticum. Corynebacterium pseudodiphtheriticum Any bacterial organism that can be assigned to the species Corynebacterium pseudotuberculosis. Corynebacterium pseudotuberculosis Any bacterial organism that can be assigned to the species Corynebacterium renale. Corynebacterium renale Any bacterial organism that can be assigned to the species Corynebacterium simulans. Corynebacterium simulans Any bacterial organism that can be assigned to the species Corynebacterium striatum. Corynebacterium striatum Any bacterial organism that can be assigned to the species Corynebacterium tuberculostearicum. Corynebacterium tuberculostearicum Any bacterial organism that can be assigned to the species Corynebacterium ulcerans. Corynebacterium ulcerans CDC Coryneform Group D-2 Any bacterial organism that can be assigned to the species Corynebacterium urealyticum. Corynebacterium urealyticum Any bacterial organism that can be assigned to the species Corynebacterium xerosis. Corynebacterium xerosis Any bacteria that is not assigned to the species level but can be assigned to the Corynebacterium genus level. Corynebacterium Coryneform Gram-positive Rod Any bacteria whose shape is similar to those bacteria assigned to the Corynebacterium genus and have a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique. Coryneform Gram Positive Bacillus Any bacterial organism that can be assigned to the species Coxiella burnetii. Coxiella burnetii Any bacteria that is not assigned to the species level but can be assigned to the Coxiella genus level. Coxiella Coxsackie Virus A Any viral organism that can be assigned to the Human Enterovirus A, B and/or C species and subtype Coxsackie A virus. Coxsackie A Virus Coxsackie Virus B Any viral organism that can be assigned to the Human Enterovirus B species and subtype Coxsackie B virus. Coxsackie B Virus Human Coxsackievirus Any viral organism that can be classified as a Human Coxsackievirus. Human Coxsackievirus Enterobacter sakazakii Any bacterial organism that can be assigned to the species Cronobacter sakazakii. Cronobacter sakazakii Any fungal organism that can be assigned to the species Cryptococcus albidus variant albidus. Cryptococcus albidus Var. albidus Rhodotorula albida Torula albida Torulopsis albida Torulopsis nadaensis Torulopsis neoformans var. albida Any fungal organism that can be assigned to the species Cryptococcus albidus. Cryptococcus albidus Cryptococcus albidus var. diffluens Cryptococcus diffluens var. diffluens Torulopsis diffluens Any fungal organism that can be assigned to the species Cryptococcus diffluens. Cryptococcus diffluens Cryptococcus bacillisporus Any fungal organism that can be assigned to the species Cryptococcus gattii. Cryptococcus gattii Any fungal organism that can be assigned to the species Cryptococcus laurentii. Cryptococcus laurentii Blastomyces neoformans Debaryomyces neoformans Lipomyces neoformans Saccharomyces neoformans Torula neoformans Torulopsis neoformans Any fungal organism that can be assigned to the species Cryptococcus neoformans. Cryptococcus neoformans Any fungal organism that can be assigned to the species Cryptococcus randhawii. Cryptococcus randhawii Any fungal organism that can be assigned to the species Cryptococcus terreus. Cryptococcus terreus Any fungal organism that is not assigned to the species level but can be assigned to the Cryptococcus genus level. Cryptococcus Any unicellular, eukaryotic organism that can be assigned to the species Cryptosporidium parvum. Cryptosporidium parvum Any unicellular, eukaryotic organism that is not assigned to the species level but can be assigned to the Cryptosporidium genus level. Cryptosporidium CDC Group IVc-2 Ralstonia paucula Wautersia paucula Any bacterial organism that can be assigned to the species Cupriavidus pauculus. Cupriavidus pauculus Any bacteria that is not assigned to the species level but can be assigned to the Cupriavidus genus level. Cupriavidus Curved Rods Any rod-shaped bacteria that also appear curved. Curved Bacillus Any fungal organism that is not assigned to the species level but can be assigned to the Curvularia genus level. Curvularia Blue-Green Algae Cyanobacteriota Cyanophycota Oxygenic Photosynthetic Bacteria Oxyphotobacteria Any bacterial organism that can be assigned to the phylum Cyanobacteria. Cyanobacteria Cyclospora cayetanesis Any unicellular, eukaryotic organism that can be assigned to the species Cyclospora cayetanensis. Cyclospora cayetanensis Any unicellular, eukaryotic organism that is not assigned to the species level but can be assigned to the Cyclospora genus level. Cyclospora Rhodotorula minuta Torula minuta Any fungal organism that can be assigned to the species Cystobasidium minutum. Cystobasidium minutum Isospora belli Any unicellular, eukaryotic organism that can be assigned to the species Cystoisospora belli. Cystoisospora belli Any viral organism that can be assigned to the genus Cytomegalovirus. Cytomegalovirus Comamonas acidovorans Pseudomonas acidovorans Any bacterial organism that can be assigned to the species Delftia acidovorans. Delftia acidovorans Any bacteria that is not assigned to the species level but can be assigned to the Delftia genus level. Delftia Coronavirus Group 3 Any viral organism that can be assigned to the genus Deltacoronavirus. Deltacoronavirus Any viral organism that can be assigned to the genus Deltaretrovirus. Deltaretrovirus DEN-1 Dengue Virus Type 1 DENV-1 Any viral organism that can be assigned to the Dengue virus serotype 1. Dengue Virus 1 DEN-2 Dengue Virus Type 2 DENV-2 Any viral organism that can be assigned to the Dengue virus serotype 2. Dengue Virus 2 DEN-3 Dengue Virus Type 3 DENV-3 Any viral organism that can be assigned to the Dengue virus serotype 3. Dengue Virus 3 DEN-4 Dengue Virus Type 4 DENV-4 Any viral organism that can be assigned to the Dengue virus serotype 4. Dengue Virus 4 Any viral organism that can be assigned to the species Dengue virus. Dengue Virus Any bacterial organism that can be assigned to the species Dermabacter hominis. Dermabacter hominis Any bacteria that is not assigned to the species level but can be assigned to the Dermabacter genus level. Dermabacter Micrococcus nishinomiyaensis Any bacterial organism that can be assigned to the species Dermacoccus nishinomiyaensis. Dermacoccus nishinomiyaensis Any bacterial organism that can be assigned to the species Dermatophilus congolensis. Dermatophilus congolensis Any bacteria that is not assigned to the species level but can be assigned to the Dermatophilus genus level. Dermatophilus Any bacterial organism that can be assigned to the species Desulfovibrio desulfuricans. Desulfovibrio desulfuricans Any bacterial organism that can be assigned to the species Desulfovibrio fairfieldensis. Desulfovibrio fairfieldensis Desulfomonas pigra Any bacterial organism that can be assigned to the species Desulfovibrio piger. Desulfovibrio piger Desulfomonas Any bacteria that is not assigned to the species level but can be assigned to the Desulfovibrio genus level. Desulfovibrio Any bacterial organism that can be assigned to the species Dialister micraerophilus. Dialister micraerophilus Bacillus pneumosintes Bacteroides pneumosintes Any bacterial organism that can be assigned to the species Dialister pneumosintes. Dialister pneumosintes Any bacterial organism that can be assigned to the species Dickeya dadantii. Dickeya dadantii Any unicellular, eukaryotic organism that can be assigned to the species Dientamoeba fragilis. Dientamoeba fragilis DAEC Diffusely Adhering E. coli Any bacterial organism that can be assigned to the species Escherichia coli, and is considered as the pathotype diffusely adhering. DAEC causes urinary tract infections (UTIs), pregnancy complications, and diarrhea in children of ages 18 months to 5 years. Diffusely Adhering Escherichia coli Any nematode parasite that is not assigned to the species level but can be assigned to the Dipetalonema genus level. Dipetalonema Any of a number of rod-shaped bacteria that resemble Corynebacterium diphtheriae, either in morphology or etiology. Diptheroid Bacillus Broad Fish Tapeworm Any cestode parasite that can be assigned to the species Diphyllobothrium latum. Diphyllobothrium latum Cucumber Tapeworm Double-pore Tapeworm Flea Tapeworm Any cestode parasite that can be assigned to the species Dipylidium caninum. Dipylidium caninum Any bacterial organism that can be assigned to the species Dolosigranulum pigrum. Dolosigranulum pigrum Any bacterial organism that can be assigned to the genus Dorea. Dorea Guinea worm Any nematode parasite that can be assigned to the species Dracunculus medinensis. Dracunculus medinensis EBOV Any viral organism that can be assigned to the genus Ebola virus. Ebola Virus Hydatid Worm Hyper Tapeworm Any cestode parasite that can be assigned to the species Echinococcus granulosus. Echinococcus granulosus Any cestode parasite that can be assigned to the species Echinococcus multilocularis. Echinococcus multilocularis Any cestode parasite that can be assigned to the species Echinococcus vogeli. Echinococcus vogeli Any viral organism that can be assigned to the species Echovirus. Echovirus Any bacterial organism that can be assigned to the species Edwardsiella hoshinae. Edwardsiella hoshinae Any bacterial organism that can be assigned to the species Edwardsiella ictaluri. Edwardsiella ictaluri Any bacterial organism that can be assigned to the species Edwardsiella tarda. Edwardsiella tarda Any bacteria that is not assigned to the species level but can be assigned to the Edwardsiella genus level. Edwardsiella Eubacterium lentum Any bacterial organism that can be assigned to the species Eggerthella lenta. Eggerthella lenta Any bacteria that is not assigned to the species level but can be assigned to the Eggerthella genus level. Eggerthella Any bacterial organism that can be assigned to the species Ehrlichia chaffeensis. Ehrlichia chaffeensis Cowdria Kurlovia Nicollea Any bacterial organism that is not assigned to the species level but can be assigned to the Ehrlichia genus level. Ehrlichia Any bacterial organism that can be assigned to the species Eikenella corrodens. Eikenella corrodens Any bacteria that is not assigned to the species level but can be assigned to the Eikenella genus level. Eikenella Elizabethkingia genomospecies 1 Any bacterial organism that can be assigned to the species Elizabethkingia anophelis. Elizabethkingia anophelis Chryseobacterium meningosepticum Flavobacterium meningosepticum Any bacterial organism that can be assigned to the species Elizabethkingia meningoceptica. Elizabethkingia meningoceptica Any bacteria that is not assigned to the species level but can be assigned to the Elizabethkingia genus level. Elizabethkingia Flavobacterium breve Any bacterial organism that can be assigned to the species Empedobacter brevis. Empedobacter brevis Any bacteria that is not assigned to the species level but can be assigned to the Empedobacter genus level. Empedobacter Septata Any fungal organism that is not assigned to the species level but can be assigned to the Encephalitozoon genus level. Encephalitozoon Any unicellular, eukaryotic organism that can be assigned to the species Endolimax nana. Endolimax nana Any unicellular, eukaryotic organism that can be assigned to the species Entamoeba coli. Entamoeba coli Any amoebic organism that can be assigned to the species Entamoeba dispar. Entamoeba dispar Any unicellular, eukaryotic organism that can be assigned to the species Entamoeba hartmanni. Entamoeba hartmanni Any unicellular, eukaryotic organism that can be assigned to the species Entamoeba histolytica. Entamoeba histolytica Any unicellular, eukaryotic organism that can be assigned to the species Entamoeba polecki. Entamoeba polecki Any unicellular, eukaryotic organism that is not assigned to the species level but can be assigned to the Entamoeba genus level. Entamoeba Any rod-shaped bacterial organism that does not require oxygen to grow or respirate, cannot be assigned to a specific genus or species, has a cell wall that stains Gram-negative, and that occurs normally or pathogenically in the intestinal tracts of animals. Enteric Bacteria EAEC Enteroaggregative E. coli Any bacterial organism that can be assigned to the species Escherichia coli, and is considered as the pathotype enteroaggregative. EAEC causes acute or persistent watery diarrhea prevalent in developing countries and in the immunocompromised host. Enteroaggregative Escherichia coli Enterobacter amnigenus I Any bacterial organism that can be assigned to the species Enterobacter amnigenus. Enterobacter amnigenus CDC Enteric Group 17 Any bacterial organism that can be assigned to the species Enterobacter asburiae. Enterobacter asburiae Any bacterial organism that can be assigned to the species Enterobacter bugandensis. Enterobacter bugandensis CDC Enteric Group 19 Enterobacter taylorae Any bacterial organism that can be assigned to the species Enterobacter cancerogenus. Enterobacter cancerogenus A non-taxonomic grouping of bacterial species that are phenotypically or genetically similar to the Enterobacter cloacae species. Enterobacter cloacae Complex Any bacterial organism that can be assigned to the species Enterobacter cloacae. Enterobacter cloacae Any bacterial organism that can be assigned to the species Enterobacter gergoviae. Enterobacter gergoviae CDC Enteric Group 75 Any bacterial organism that can be assigned to the species Enterobacter hormaechei. Enterobacter hormaechei Any bacteria that is not assigned to the species level but can be assigned to the Enterobacter genus level. Enterobacter Carbapenem-resistant Enterobacterales CRE Any bacterial organism that can be assigned to the order Enterobacterales and is resistant to the antibiotic Carbapenem. Carbapenem Resistant Enterobacterales Enterobacteraceae Any bacteria that is not assigned to the species level but can be assigned to the Enterobacteriaceae family level. Enterobacteriaceae Any nematode parasite that can be assigned to the species Enterobius vermicularis. Enterobius vermicularis Streptococcus avium Any bacterial organism that can be assigned to the species Enterococcus avium. Enterococcus avium Any bacterial organism that can be assigned to the species Enterococcus casseliflavus. Enterococcus casseliflavus Any bacterial organism that can be assigned to the species Enterococcus dispar. Enterococcus dispar Streptococcus durans Any bacterial organism that can be assigned to the species Enterococcus durans. Enterococcus durans Streptococcus faecalis Any bacterial organism that can be assigned to the species Enterococcus faecalis. Enterococcus faecalis Streptococcus faecium Any bacterial organism that can be assigned to the species Enterococcus faecium. Enterococcus faecium Any bacterial organism that can be assigned to the species Enterococcus gallinarum. Enterococcus gallinarum Any bacterial organism that can be assigned to the species Enterococcus hirae. Enterococcus hirae Any bacterial organism that can be assigned to the species Enterococcus malodoratus. Enterococcus malodoratus Any bacterial organism that can be assigned to the species Enterococcus mundtii. Enterococcus mundtii Any bacterial organism that can be assigned to the species Enterococcus pseudoavium. Enterococcus pseudoavium Any bacterial organism that can be assigned to the species Enterococcus raffinosus. Enterococcus raffinosus Streptococcus saccharolyticus Any bacterial organism that can be assigned to the species Enterococcus saccharolyticus. Enterococcus saccharolyticus Enterococcus sanguinicola Any bacterial organism that can be assigned to the species Enterococcus thailandicus. Enterococcus thailandicus Any bacteria that is not assigned to the species level but can be assigned to the Enterococcus genus level. Enterococcus Vancomycin-resistant Enterococcus VRE Any bacterial organism that can be assigned to the genus Enterococcus and is resistant to the antibiotic vancomycin. Vancomycin Resistant Enterococcus Any fungal organism that is not assigned to the species level but can be assigned to the Enterocytozoon genus level. Enterocytozoon EHEC Enterohemorrhagic E. coli Any bacterial organism that can be assigned to the species Escherichia coli, and is considered as the pathotype enterohemorrhagic. EHEC is a subset of STEC, produces shiga toxin, and causes hemorrhagic colitis associated with the hemolytic uremic syndrome. Enterohemorrhagic Escherichia coli EIEC Enteroinvasive E. coli Any bacterial organism that can be assigned to the species Escherichia coli, and is considered as the pathotype enterohemorrhagic. EIEC causes dysentery identical to that caused by Shigella sonnei. Enteroinvasive Escherichia coli Any unicellular, eukaryotic organism that can be assigned to the species Enteromonas hominis. Enteromonas hominis Enteropathogenic E. coli EPEC Any bacterial organism that can be assigned to the species Escherichia coli, and is considered as the pathotype enteropathogenic. EPEC causes acute and chronic watery diarrhea in infants and children. Enteropathogenic Escherichia coli Enterotoxigenic E. coli ETEC Any bacterial organism that can be assigned to the species Escherichia coli, and is considered as the pathotype enterotoxigenic. ETEC causes watery diarrhea in infants and travelers. Enterotoxigenic Escherichia coli EV-D68 Human enterovirus 68 Human Enterovirus D68 Any viral organism that can be assigned to the Human enterovirus D68 serotype. Enterovirus D68 Any viral organism that can be assigned to the genus Enterovirus. Enterovirus Any fungal organism that is not assigned to the species level but can be assigned to the Epicoccum genus level. Epicoccum Acrothecium floccosum Epidermophyton floccosum var. nigricans Any fungal organism that can be assigned to the species Epidermophyton floccosum. Epidermophyton floccosum EBV HHV-4 Human Gammaherpesvirus 4 Human Herpesvirus 4 Any viral organism that can be assigned to the species Epstein-Barr virus. Epstein-Barr Virus Any bacterial organism that can be assigned to the species Erysipelothrix rhusiopathiae. Erysipelothrix rhusiopathiae Erysipelothrix insidiosa Any bacteria that is not assigned to the species level but can be assigned to the Erysipelothrix genus level. Erysipelothrix Any bacterial organism that can be assigned to the species Escherichia albertii. Escherichia albertii Any bacterial organism that can be assigned to the species Escherichia blattae. Escherichia blattae Any bacterial organism that can be assigned to the species Escherichia coli and strain K1. Escherichia coli Strain K1 Any bacterial organism that can be assigned to the species Escherichia coli and serogroup O157, but does not include the H7 serotype. Escherichia coli Serogroup O157 Not Including H7 Serotype Any bacterial organism that can be assigned to the species Escherichia coli and serogroup O157. Escherichia coli Strain O157 Any bacterial organism that can be assigned to the species Escherichia coli and serotype O157:H7. Escherichia coli Serotype O157:H7 Any bacterial organism that can be assigned to the species Escherichia coli and serogroup O26. Escherichia coli Serogroup O26 Any bacterial organism that can be assigned to the species Escherichia coli and serogroup O111. Escherichia coli Strain O111 E. coli Any bacterial organism that can be assigned to the species Escherichia coli. Escherichia coli Escherichia coli, Extended-spectrum Beta-lactamases Any bacterial organism that can be assigned to the species Escherichia coli and produces extended-spectrum beta-lactamases (ESBL). Escherichia coli, Extended-spectrum Beta-lactamase Positive CDC Enteric Group 10 Any bacterial organism that can be assigned to the species Escherichia fergusonii. Escherichia fergusonii CDC Enteric Group 11 Any bacterial organism that can be assigned to the species Escherichia hermannii. Escherichia hermannii CDC Enteric Group 1 Any bacterial organism that can be assigned to the species Escherichia vulneris. Escherichia vulneris Any bacteria that is not assigned to the species level but can be assigned to the Escherichia genus level. Escherichia Any bacterial organism that can be assigned to the species Eubacterium adactolyticum. Eubacterium alactolyticum Any bacterial organism that can be assigned to the species Eubacterium contortum. Eubacterium contortum Any bacterial organism that can be assigned to the species Eubacterium limosum. Eubacterium limosum Any bacterial organism that can be assigned to the species Eubacterium nodatum. Eubacterium nodatum Any bacterial organism that can be assigned to the species Eubacterium rectale. Eubacterium rectale Any bacterial organism that can be assigned to the species Eubacterium ventriosum. Eubacterium ventriosum Any bacteria that is not assigned to the species level but can be assigned to the Eubacterium genus level. Eubacterium Aspergillus glaucus Aspergillus herbariorum Any fungal organism that can be assigned to the species Eurotium herbariorum. Eurotium herbariorum Any bacterial organism that can be assigned to the species Ewingella americana. Ewingella americana Any bacteria that is not assigned to the species level but can be assigned to the Ewingella genus level. Ewingella Brevibacterium acetylicum Any bacterial organism that can be assigned to the species Exiguobacterium acetylicum. Exiguobacterium acetylicum Any bacteria that is not assigned to the species level but can be assigned to the Exiguobacterium genus level. Exiguobacterium Wangiella dermatitidis Any fungal organism that can be assigned to the species Exophiala dermatitidis. Exophiala dermatitidis Phialophora jeanselmei Pullularia jeanselmei Torula jeanselmei Any fungal organism that can be assigned to the species Exophiala jeanselmei. Exophiala jeanselmei Any fungal organism that is not assigned to the species level but can be assigned to the Exserohilum genus level. Exserohilum Any bacterial organism that can be assigned to the species Facklamia hominis. Facklamia hominis Any bacteria that is not assigned to the species level but can be assigned to the Facklamia genus level. Facklamia Fusobacterium prausnitzii Any bacterial organism that can be assigned to the species Faecalibacterium prausnitzii. Faecalibacterium prausnitzii Any bacteria that is not assigned to the species level but can be assigned to the Faecalibacterium genus level. Faecalibacterium Sheep liver fluke Any trematode parasite that can be assigned to the species Fasciola hepatica. Fasciola hepatica Any trematode parasite that can be assigned to the species Fasciolopsis buski. Fasciolopsis buski Fermentative Gram-negative Rod Any rod-shaped, anaerobic bacteria that can convert carbohydrates into acids and alcohols and has a cell wall contains low levels of peptidoglycan and stains pink with the Gram staining technique. Fermentative Gram Negative Bacillus Cryptococcus neoformans var. uniguttulatus Cryptococcus uniguttulatus Eutorulopsis uniguttulata Any fungal organism that can be assigned to the species Filobasidium uniguttulatum. Filobasidium uniguttulatum Filovirus Any viral organism that can be assigned to the family Filoviridae. Filoviridae Peptostreptococcus magnus Any bacterial organism that can be assigned to the species Finegoldia magna. Finegoldia magna Any bacteria that is not assigned to the species level but can be assigned to the Finegoldia genus level. Finegoldia Any viral organism that can be assigned to the genus Flavivirus. Flavivirus Any bacteria that is not assigned to the species level but can be assigned to the Flavobacterium genus level. Flavobacterium Any bacterial organism that is not assigned to the species level but can be assigned to the Flavonifractor genus level. Flavonifractor Any fungal organism that is not assigned to the species level but can be assigned to the Fonsecaea genus level. Fonsecaea Pasteurella tularensis Any bacterial organism that can be assigned to the species Francisella tularensis. Francisella tularensis Any bacteria that is not assigned to the species level but can be assigned to the Francisella genus level. Francisella Any organism assigned to the kingdom Fungi. Fungus Any fungal organism that can be assigned to the species Fusarium chlamydosporum. Fusarium chlamydosporum Fusarium pallidoroseum Fusarium semitectum Any fungal organism that can be assigned to the species Fusarium incarnatum. Fusarium incarnatum Any fungal organism that can be assigned to the species Fusarium proliferatum. Fusarium proliferatum Neocosmospora solani Any fungal organism that can be assigned to the species Fusarium solani. Fusarium solani Any fungal organism that is not assigned to the species level but can be assigned to the Fusarium genus level. Fusarium Any bacterial organism that can be assigned to the species Fusobacterium gonidiaformans. Fusobacterium gonidiaformans Any bacterial organism that can be assigned to the species Fusobacterium mortiferum. Fusobacterium mortiferum Bacillus naviformis Fusibacterium naviforme Pseudobacterium naviformis Ristella naviformis Any bacterial organism that can be assigned to the species Fusobacterium naviforme. Fusobacterium naviforme Any bacterial organism that can be assigned to the species Fusobacterium necrogenes. Fusobacterium necrogenes Any bacterial organism that can be assigned to the species Fusobacterium necrophorum. Fusobacterium necrophorum Any bacterial organism that can be assigned to the species Fusobacterium nucleatum. Fusobacterium nucleatum Any bacterial organism that can be assigned to the species Fusobacterium periodonticum. Fusobacterium periodonticum Any bacterial organism that can be assigned to the species Fusobacterium russii. Fusobacterium russii Any bacterial organism that can be assigned to the species Fusobacterium ulcerans. Fusobacterium ulcerans Fusobacterium necrophorum Biovar C Fusobacterium pseudonecrophorum Any bacterial organism that can be assigned to the species Fusobacterium varium. Fusobacterium varium Any bacteria that is not assigned to the species level but can be assigned to the Fusobacterium genus level. Fusobacterium Coronavirus group 3 Any viral organism that is not assigned to the species level but can be assigned to the Gammacoronavirus genus level. Gammacoronavirus Corynebacterium vaginalis Any bacterial organism that can be assigned to the species Gardnerella vaginalis. Gardnerella vaginalis Any bacteria that is not assigned to the species level but can be assigned to the Gardnerella genus level. Gardnerella Any bacterial organism that can be assigned to the species Gemella bergeri. Gemella bergeri Neisseria haemolysans Any bacterial organism that can be assigned to the species Gemella haemolysans. Gemella haemolysans Streptococcus morbillorum Any bacterial organism that can be assigned to the species Gemella morbillorum. Gemella morbillorum Any bacterial organism that can be assigned to the species Gemella sanguinis. Gemella sanguinis Any bacteria that is not assigned to the species level but can be assigned to the Gemella genus level. Gemella Any fungal organism that is not assigned to the species level but can be assigned to the Geomyces genus level. Geomyces Geotrichum penicillatum Trichosporon penicillatum Any fungal organism that can be assigned to the species Geotrichum klebahnii. Geotrichum klebahnii Any fungal organism that is not assigned to the species level but can be assigned to the Geotrichum genus level. Geotrichum Giardia duodenalis Giardia intestinalis Lamblia intestinalis Any unicellular, eukaryotic organism that can be assigned to the species Giardia lamblia. Giardia lamblia Any unicellular, eukaryotic organism that is not assigned to the species level but can be assigned to the Giardia genus level. Giardia Any fungal organism that is not assigned to the species level but can be assigned to the Gliocladium genus level. Gliocladium Globicatella sanguis Any bacterial organism that can be assigned to the species Globicatella sanguinis. Globicatella sanguinis Any bacterial organism that can be assigned to the species Globicatella sulfidifaciens. Globicatella sulfidifaciens Any bacteria that is not assigned to the species level but can be assigned to the Globicatella genus level. Globicatella Any nematode parasite that can be assigned to the species Gnathostoma spinigerum. Gnathostoma spinigerum Any nematode parasite that is not assigned to the species level but can be assigned to the Gnathostoma genus level. Gnathostoma Gordona aichiensis Tsukamurella aichiensis Any bacterial organism that can be assigned to the species Gordonia aichiensis. Gordonia aichiensis Gordona bronchialis Rhodococcus bronchialis Any bacterial organism that can be assigned to the species Gordonia bronchialis. Gordonia bronchialis Gordona rubropertincta Rhodococcus rubripertincta Any bacterial organism that can be assigned to the species Gordonia rubripertincta. Gordonia rubripertincta Gordona sputi Any bacterial organism that can be assigned to the species Gordonia sputi. Gordonia sputi Gordona terrae Rhodococcus terrae Any bacterial organism that can be assigned to the species Gordonia terrae. Gordonia terrae Any bacteria that is not assigned to the species level but can be assigned to the Gordonia genus level. Gordonia Any bacteria that is not assigned to the species level but can be assigned to the Gracilibacillus genus level. Gracilibacillus Gram Negative Rods Any rod-shaped bacteria that contains low levels of peptidoglycan in its cell wall and stains pink with the Gram staining technique. Gram Negative Bacillus Any bacteria intermediate in morphology between a spherical-shaped coccus and a rod-shaped bacillus that contains low levels of peptidoglycan in its cell wall and stains pink with the Gram staining technique. Gram-Negative Coccobacillus Any spherical-shaped bacteria that contains low levels of peptidoglycan in its cell wall and stains pink with the Gram staining technique. Gram Negative Coccus Any spherical-shaped bacteria in the form of two joined cells that contains low levels of peptidoglycan in its cell wall and stains pink with the Gram staining technique. Gram-Negative Diplococcus Any rod-shaped bacteria whose growth requires lower than atmospheric oxygen level and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique. Gram-Negative Microaerophilic Bacillus Any spherical-shaped bacteria whose growth requires lower than atmospheric oxygen level and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique. Gram-Negative Microaerophilic Coccus Any rod-shaped bacteria with the ability to alter its shape or size in response to stimuli and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique. Gram-Negative Pleomorphic Bacillus Any rod-shaped bacteria that has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique. Gram Positive Bacillus Any spherical-shaped bacteria that has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique. Gram Positive Coccus Any spherical-shaped bacteria in the form of two joined cells and has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique. Gram-Positive Diplococcus Any rod-shaped bacteria whose growth requires lower than atmospheric oxygen level and has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique. Gram-Positive Microaerophilic Bacillus Any spherical-shaped bacteria whose growth requires lower than atmospheric oxygen level and has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique. Gram-Positive Microaerophilic Coccus Abiotrophia adjacens Streptococcus adjacens Any bacterial organism that can be assigned to the species Granulicatella adiacens. Granulicatella adiacens Abiotrophia elegans Any bacterial organism that can be assigned to the species Granulicatella elegans. Granulicatella elegans Any bacteria that is not assigned to the species level but can be assigned to the Granulicatella genus level. Granulicatella Vibrio hollisae Any bacterial organism that can be assigned to the species Grimontia hollisae. Grimontia hollisae Basidiotrichosporon pullulans Monilia pullulans Oidium pullulans Oospora pullulans Trichosporon pullulans Any fungal organism that can be assigned to the species Guehomyces pullulans. Guehomyces pullulans Any bacterial organism that can be assigned to the species Haemophilus aegyptius. Haemophilus aegyptius Any bacterial organism that can be assigned to the species Haemophilus haemoglobinophilus. Haemophilus haemoglobinophilus Any bacterial organism that can be assigned to the species Haemophilus haemolyticus. Haemophilus haemolyticus Any bacterial organism that can be assigned to the species Haemophilus haemolyticus and is beta-lactamase negative. Haemophilus haemolyticus, Beta-Lactamase Negative Any bacterial organism that can be assigned to the species Haemophilus haemolyticus and is beta-lactamase positive. Haemophilus haemolyticus, Beta-Lactamase Positive Any bacterial organism that can be assigned to the species Haemophilus haemolyticus and is penicillinase negative. Haemophilus haemolyticus, Penicillinase Negative Any bacterial organism that can be assigned to the species Haemophilus haemolyticus and is penicillinase positive. Haemophilus haemolyticus, Penicillinase Positive H-flu Any bacterial organism that can be assigned to the species Haemophilus influenzae. Haemophilus influenzae Any bacterial organism that can be assigned to the species Haemophilus influenzae and is beta-lactamase negative. Haemophilus influenzae, Beta-Lactamase Negative Any bacterial organism that can be assigned to the species Haemophilus influenzae and is beta-lactamase positive. Haemophilus influenzae, Beta-Lactamase Positive Any bacterial organism that can be assigned to the species Haemophilus influenzae and is penicillinase negative. Haemophilus influenzae, Penicillinase Negative Any bacterial organism that can be assigned to the species Haemophilus influenzae and is penicillinase positive. Haemophilus influenzae, Penicillinase Positive Any bacterial organism that can be assigned to the species Haemophilus parahaemolyticus. Haemophilus parahaemolyticus Any bacterial organism that can be assigned to the species Haemophilus parahaemolyticus and is beta-lactamase negative. Haemophilus parahaemolyticus, Beta-Lactamase Negative Any bacterial organism that can be assigned to the species Haemophilus parahaemolyticus and is beta-lactamase positive. Haemophilus parahaemolyticus, Beta-Lactamase Positive Any bacterial organism that can be assigned to the species Haemophilus parahaemolyticus and is penicillinase negative. Haemophilus parahaemolyticus, Penicillinase Negative Any bacterial organism that can be assigned to the species Haemophilus parahaemolyticus and is penicillinase positive. Haemophilus parahaemolyticus, Penicillinase Positive Hemophilus parainfluenzae Any bacterial organism that can be assigned to the species Haemophilus parainfluenzae. Haemophilus parainfluenzae Any bacterial organism that can be assigned to the species Haemophilus parainfluenzae and is beta-lactamase negative. Haemophilus parainfluenzae, Beta-Lactamase Negative Any bacterial organism that can be assigned to the species Haemophilus parainfluenzae and is beta-lactamase positive. Haemophilus parainfluenzae, Beta-Lactamase Positive Any bacterial organism that can be assigned to the species Haemophilus parainfluenzae and is penicillinase negative. Haemophilus parainfluenzae, Penicillinase Negative Any bacterial organism that can be assigned to the species Haemophilus parainfluenzae and is penicillinase positive. Haemophilus parainfluenzae, Penicillinase Positive Any bacterial organism that can be assigned to the species Haemophilus paraphrohaemolyticus. Haemophilus paraphrohaemolyticus Any bacteria that is not assigned to the species level but can be assigned to the Haemophilus genus level. Haemophilus Enterobacter alvei Any bacterial organism that can be assigned to the species Hafnia alvei. Hafnia alvei Any bacteria that is not assigned to the species level but can be assigned to the Hafnia genus level. Hafnia Any bacteria that is not assigned to the species level but can be assigned to the Halobacillus genus level. Halobacillus Chromotorula luteola Cryptococcus luteolus Hannaella luteolus Rhodotorula luteola Torula luteola Torulopsis luteola Any fungal organism that can be assigned to the species Hannaella luteola. Hannaella luteola Any fungal organism that can be assigned to the species Hanseniaspora guilliermondii. Hanseniaspora guilliermondii Hanseniaspora apiculata Kloeckera apiculata Kloeckeraspora uvarum Any fungal organism that can be assigned to the species Hanseniaspora uvarum. Hanseniaspora uvarum Any fungal organism that can be assigned to the species Hanseniaspora valbyensis. Hanseniaspora valbyensis Any viral organism that can be assigned to the genus Hantavirus. Hantavirus Any bacterial organism that can be assigned to the species Helcococcus kunzii. Helcococcus kunzii Any bacterial organism that can be assigned to the species Helcococcus pyogenes. Helcococcus pyogenes Any bacterial organism that can be assigned to the species Helcococcus sueciensis. Helcococcus sueciensis Any bacteria that is not assigned to the species level but can be assigned to the Helcococcus genus level. Helcococcus Campylobacter cinaedi Any bacterial organism that can be assigned to the species Helicobacter cinaedi. Helicobacter cinaedi Any bacterial organism that can be assigned to the species Helicobacter felis. Helicobacter felis Campylobacter fennelliae Any bacterial organism that can be assigned to the species Helicobacter fennelliae. Helicobacter fennelliae Campylobacter mustelae Any bacterial organism that can be assigned to the species Helicobacter mustelae. Helicobacter mustelae Campylobacter pylori H. pylori Any bacterial organism that can be assigned to the species Helicobacter pylori. Helicobacter pylori Flexispira rappini Any bacterial organism that can be assigned to the species Helicobacter rappini. Helicobacter rappini Any bacteria that is not assigned to the species level but can be assigned to the Helicobacter genus level. Helicobacter Any viral organism that can be assigned to the species Hendra virus. Hendra Virus Any viral organism that can be assigned to the genus Henipavirus. Henipavirus HAV Any viral organism that can be assigned to the species Hepatitis A virus. Hepatitis A Virus HBV Any viral organism that can be assigned to the species Hepatitis B virus. Hepatitis B Virus HCV Any viral organism that can be assigned to the species Hepatitis C virus. Hepatitis C Virus HDV Any viral organism that can be assigned to the species Hepatitis D virus. Hepatitis D Virus HEV Any viral organism that can be assigned to the species Hepatitis E virus. Hepatitis E Virus GBV-C HGV Any viral organism that can be assigned to the species Hepatitis G virus. GB virus C Pseudomonas huttiensis Any bacterial organism that can be assigned to the species Herbaspirillum huttiense. Herbaspirillum huttiense Herpes Simplex Virus Type 1 HHV-1 HSV-1 Human Alphaherpesvirus 1 Human Herpesvirus 1 Any viral organism that can be assigned to the species herpes simplex virus 1. Human Herpesvirus 1 Herpes Simplex Virus Type 2 HHV-2 HSV-2 Human Alphaherpesvirus 2 Human Herpesvirus 2 Any viral organism that can be assigned to the species herpes simplex virus 2. Human Herpesvirus 2 Any trematode parasite that can be assigned to the species Heterophyes heterophyes. Heterophyes heterophyes Haemophilus somnus Any bacterial organism that can be assigned to the species Histophilus somni. Histophilus somni Ajellomyces capsulatus Cryptococcus capsulatus Any fungal organism that can be assigned to the species Histoplasma capsulatum. Histoplasma capsulatum Any fungal organism that can be assigned to the species Histoplasma capsulatum in its mycelial form. Histoplasma capsulatum, Mycelial Phase Any fungal organism that can be assigned to the species Histoplasma capsulatum in its yeast form. Histoplasma capsulatum, Yeast Phase A non-taxonomic grouping of HIV-1 strains that are assigned to the O group. HIV-1 Group O Any bacterial organism that can be assigned to the species Holdemania filiformis. Holdemania filiformis Any bacteria that is not assigned to the species level but can be assigned to the Holdemania genus level. Holdemania Any fungal organism that can be assigned to the species Hortaea werneckii. Hortaea werneckii Any viral organism that can be assigned to the species Human bocavirus. Human Bocavirus Any viral organism that can be classified as a Human coronavirus, but excluding the severe acute respiratory syndrome-related coronavirus (HCoV-SARS). Non-HCoV-SARS Human Coronavirus Coronavirus 229E HCoV-229E Any viral organism that can be assigned to the species Human coronavirus 229E. Human Coronavirus 229E HCoV-HKU1 Any viral organism that can be assigned to the species Human coronavirus HKU1. Human Coronavirus HKU1 Coronavirus NL63 HCoV-NL63 Any viral organism that can be assigned to the species Human coronavirus NL63. Human Coronavirus NL63 HCoV-OC43 Any viral organism that can be assigned to the species Human coronavirus OC43. Human Coronavirus OC43 HCMV HHV-5 Human Betaherpesvirus 5 Human Herpesvirus 5 Any viral organism that can be assigned to the species human cytomegalovirus. Human Herpesvirus 5 HSV Type Human Herpes Simplex Virus Type Any viral organism that can be classified as a Human herpes simplex virus type. This is a non-taxonomic term used to describe the Human herpes simplex virus type 1 or type 2. Human Herpes Simplex Virus Herpes Simplex Virus 6 Herpes Virus 6 HHV-6 Human Betaherpesvirus 6 Any viral organism that can be assigned to the species human herpesvirus 6. Human Herpesvirus 6 Herpes Simplex Virus 7 Herpes Virus 7 HHV-7 Human Betaherpesvirus 7 Any viral organism that can be assigned to the species human herpesvirus 7. Human Herpesvirus 7 Herpes Virus 8 HHV-8 Human Gammaherpesvirus 8 Kaposi's Sarcoma-associated Herpesvirus KSHV Any viral organism that can be assigned to the species human herpesvirus 8. Human Herpesvirus 8 HIV-1 Subtype A Any viral organism that can be assigned to the species Human Immunodeficiency virus 1, group M (major) and subtype/clade A. Human Immunodeficiency Virus 1 Subtype A HIV-1 CRF01_AE Human Immunodeficiency Virus 1 Circulating Recombinant Form AE Any viral organism that can be assigned to the species Human Immunodeficiency virus 1, group M (major), and subtype/clade circulating recombinant form (CRF) AE. Human Immunodeficiency Virus 1 Subtype AE HIV-1 CRF02_AG Human Immunodeficiency Virus 1 Circulating Recombinant Form AG Any viral organism that can be assigned to the species Human Immunodeficiency virus 1, group M (major), and subtype/clade circulating recombinant form (CRF) AG. Human Immunodeficiency Virus 1 Subtype AG HIV-1 Subtype B Any viral organism that can be assigned to the species Human Immunodeficiency virus 1, group M (major) and subtype/clade B. Human Immunodeficiency Virus 1 Subtype B HIV-1 Subtype C Any viral organism that can be assigned to the species Human Immunodeficiency virus 1, group M (major) and subtype/clade C. Human Immunodeficiency Virus 1 Subtype C HIV-1 Subtype D Any viral organism that can be assigned to the species Human Immunodeficiency virus 1, group M (major) and subtype/clade D. Human Immunodeficiency Virus 1 Subtype D HIV-1 Subtype F Any viral organism that can be assigned to the species Human Immunodeficiency virus 1, group M (major) and subtype/clade F. Human Immunodeficiency Virus 1 Subtype F HIV-1 Subtype G Any viral organism that can be assigned to the species Human Immunodeficiency virus 1, group M (major) and subtype/clade G. Human Immunodeficiency Virus 1 Subtype G HIV-1 LAV-1 Any viral organism that can be assigned to the species Human Immunodeficiency virus 1. Human Immunodeficiency Virus 1 HIV-2 LAV-2 Any viral organism that can be assigned to the species Human Immunodeficiency virus 2. Human Immunodeficiency Virus 2 HIV Any viral organism that can be assigned to the species Human Immunodeficiency virus 1 or 2. Human Immunodeficiency Virus An viral species which can be assigned to the species Human metapneumovirus. Human Metapneumovirus HPV 11 Human papillomavirus 11 Any viral organism that can be assigned to the Human papillomavirus virus type 11 serotype. Human Papillomavirus-11 HPV 16 Any viral organism that can be assigned to the Human papillomavirus virus type 16 serotype. Human Papillomavirus-16 HPV 18 Any viral organism that can be assigned to the Human papillomavirus virus type 18 serotype. Human Papillomavirus-18 HPV 31 Human papillomavirus 31 Any viral organism that can be assigned to the Human papillomavirus virus type 31 serotype. Human Papillomavirus-31 HPV 33 Human papillomavirus 33 Any viral organism that can be assigned to the Human papillomavirus virus type 33 serotype. Human Papillomavirus-33 HPV 34 Any viral organism that can be assigned to the Human papillomavirus virus type 34 serotype. Human Papillomavirus-34 HPV 35 Human papillomavirus 35 Any viral organism that can be assigned to the Human papillomavirus virus type 35 serotype. Human Papillomavirus-35 HPV 39 Human papillomavirus 39 Any viral organism that can be assigned to the Human papillomavirus virus type 39 serotype. Human Papillomavirus-39 HPV 40 Human papillomavirus 40 Any viral organism that can be assigned to the Human papillomavirus virus type 40 serotype. Human Papillomavirus-40 HPV 42 Human papillomavirus 42 Any viral organism that can be assigned to the Human papillomavirus virus type 42 serotype. Human Papillomavirus-42 HPV 43 Human papillomavirus 43 Any viral organism that can be assigned to the Human papillomavirus virus type 43 serotype. Human Papillomavirus-43 HPV 44 Human papillomavirus 44 Any viral organism that can be assigned to the Human papillomavirus virus type 44 serotype. Human Papillomavirus-44 HPV 45 Human papillomavirus 45 Any viral organism that can be assigned to the Human papillomavirus virus type 45 serotype. Human Papillomavirus-45 HPV 51 Human papillomavirus 51 Any viral organism that can be assigned to the Human papillomavirus virus type 51 serotype. Human Papillomavirus-51 HPV 52 Human papillomavirus 52 Any viral organism that can be assigned to the Human papillomavirus virus type 52 serotype. Human Papillomavirus-52 HPV 53 Any viral organism that can be assigned to the Human papillomavirus virus type 53 serotype. Human Papillomavirus-53 HPV 54 Human papillomavirus 54 Any viral organism that can be assigned to the Human papillomavirus virus type 54 serotype. Human Papillomavirus-54 HPV 56 Human papillomavirus 56 Any viral organism that can be assigned to the Human papillomavirus virus type 56 serotype. Human Papillomavirus-56 HPV 57 Human papillomavirus 57 Any viral organism that can be assigned to the Human papillomavirus virus type 57 serotype. Human Papillomavirus-57 HPV 58 Human papillomavirus 58 Any viral organism that can be assigned to the Human papillomavirus virus type 58 serotype. Human Papillomavirus-58 HPV 59 Human papillomavirus 59 Any viral organism that can be assigned to the Human papillomavirus virus type 59 serotype. Human Papillomavirus-59 HPV 6 Any viral organism that can be assigned to the Human papillomavirus virus type 6 serotype. Human Papillomavirus-6 HPV 66 Human papillomavirus 66 Any viral organism that can be assigned to the Human papillomavirus virus type 66 serotype. Human Papillomavirus-66 HPV 67 Human papillomavirus 67 Any viral organism that can be assigned to the Human papillomavirus virus type 67 serotype. Human Papillomavirus-67 HPV 68 Human papillomavirus 68 Any viral organism that can be assigned to the Human papillomavirus virus type 68 serotype. Human Papillomavirus-68 HPV 69 Human papillomavirus 69 Any viral organism that can be assigned to the Human papillomavirus virus type 69 serotype. Human Papillomavirus-69 HPV 70 Any viral organism that can be assigned to the Human papillomavirus virus type 70 serotype. Human Papillomavirus-70 HPV 74 Human papillomavirus 74 Any viral organism that can be assigned to the Human papillomavirus virus type 74 serotype. Human Papillomavirus-74 HPV Human Papilloma Virus Any viral organism in humans that can be assigned to the family Papillomaviridae. Human Papillomavirus HPIV-1 Human Parainfluenza Virus Type 1 Human Respirovirus 1 Any viral organism that can be assigned to the species Human Parainfluenza virus 1. Human Parainfluenza Virus 1 HPIV-2 Human orthorubulavirus 2 Human Parainfluenza Virus Type 2 Human Rubulavirus 2 Any viral organism that can be assigned to the species Human Parainfluenza virus 2. Human Parainfluenza Virus 2 HPIV-3 Human Parainfluenza Virus Type 3 Human Respirovirus 3 Any viral organism that can be assigned to the species Human Parainfluenza virus 3. Human Parainfluenza Virus 3 HPIV Type 4 HPIV-4 Human orthorubulavirus 4 Human Parainfluenza Virus Type 4 Human Rubulavirus 4 Any viral organism that can be assigned to the species Human Parainfluenza virus 4. Human Parainfluenza Virus 4 HPIV4b Human Parainfluenza Virus Type 4b Any viral organism that can be assigned to below the species level Human Parainfluenza virus 4b. Human Parainfluenza Virus 4b Any viral organism that can be assigned to the species Human Parainfluenza virus 1, 2, 3 and/or 4. Human Parainfluenza Virus B19 Virus Human Erythrovirus B19 Parvovirus B19 Any viral organism that can be assigned to the species Human Parvovirus B19. Parvovirus B19 Human poliovirus type 1 NC Type 1 Any viral organism that can be assigned to the Human poliovirus serotype 1. Human Poliovirus Type 1 ENC Type 3 Human poliovirus type 3 Any viral organism that can be assigned to the Human poliovirus serotype 3. Human Poliovirus Type 3 hRSV Human RSV RSV Any viral organism that can be classified as a Human respiratory syncytial virus. Human Respiratory Syncytial Virus Adult T-cell Leukemia Lymphoma ATLL Adult T-cell Lymphoma Virus Type 1 HTLV-1 Any viral organism that can be assigned to the Human T-lymphotrophic virus serotype 1. HTLV-1 HTLV-2 HTLV-II Any viral organism that can be assigned to the Human T-lymphotrophic virus serotype 2. HTLV-2 Rat Tapeworm Any cestode parasite that can be assigned to the species Hymenolepis diminuta. Hymenolepis diminuta Dwarf Tapeworm Taenia nana Vampirolepis nana Any cestode parasite that can be assigned to the species Hymenolepis nana. Hymenolepis nana Any viral organism that can be assigned to the Influenza A virus species subtype H1. Influenza A Virus Subtype H1 Any viral organism that can be assigned to the Influenza A species subtype H1N1. Influenza A (H1N1) Virus Any viral organism that can be assigned to the Influenza A virus species subtype H3. Influenza A Virus Subtype H3 Any viral organism that can be assigned to the Influenza A species subtype H3N2. Influenza A Virus Subtype H3N2 Any viral organism that can be assigned to the Influenza A species subtype H5N1. Influenza A (H5N1) Virus FLUAV Influenza Virus Type A Any viral organism that can be assigned to the species Influenza A virus. Influenza A Virus FLUBV Influenza Virus Type B Any viral organism that can be assigned to the species Influenza B virus. Influenza B Virus FLUCV Influenza Virus Type C Any viral organism that can be assigned to the species Influenza C virus. Influenza C Virus Any bacterial organism that can be assigned to the species Inquilinus limosus. Inquilinus limosus Any bacteria that is not assigned to the species level but can be assigned to the Inquilinus genus level. Inquilinus Clostridium bartlettii Any bacterial organism that can be assigned to the species Intestinibacter bartlettii. Intestinibacter bartlettii Any amoebic organism that can be assigned to the species Iodamoeba butschlii. Iodamoeba butschlii Any unicellular, eukaryotic organism that is not assigned to the species level but can be assigned to the Isospora genus level. Isospora JEV Any viral organism that can be assigned to the species Japanese encephalitis virus. Japanese Encephalitis Virus Human polyomavirus (type JC) Polyomavirus hominis 2 polyomavirus JC Any viral organism that can be assigned to the species JC polyomavirus. JC Virus Any bacteria that is not assigned to the species level but can be assigned to the Jeotgalibacillus genus level. Jeotgalibacillus Any bacterial organism that can be assigned to the species Johnsonella ignava. Johnsonella ignava Any bacteria that is not assigned to the species level but can be assigned to the Johnsonella genus level. Johnsonella Any bacterial organism that can be assigned to the species Kerstersia gyiorum. Kerstersia gyiorum Any bacterial organism that can be assigned to the species Kingella denitrificans. Kingella denitrificans Moraxella kingae Any bacterial organism that can be assigned to the species Kingella kingae. Kingella kingae Any bacterial organism that can be assigned to the species Kingella oralis. Kingella oralis Any bacterial organism that can be assigned to the species Kingella potus. Kingella potus Any bacteria that is not assigned to the species level but can be assigned to the Kingella genus level. Kingella Aerobacter aerogenes Enterobacter aerogenes Klebsiella mobilis Any bacterial organism that can be assigned to the species Klebsiella aerogenes. Klebsiella aerogenes Any bacterial organism that can be assigned to the species Klebsiella granulomatis. Klebsiella granulomatis Any bacterial organism that can be assigned to the species Klebsiella oxytoca. Klebsiella oxytoca Klebsiella oxytoca, Extended-Spectrum Beta-Lactamases Any bacterial organism that can be assigned to the species Klebsiella oxytoca and produces extended-spectrum beta-lactamases (ESBL). Extended-spectrum Beta-lactamase Positive Klebsiella oxytoca Klebsiella pneumoniae subsp. ozaenae Any bacterial organism that can be assigned to the species Klebsiella ozaenae. Klebsiella ozaenae Any bacterial organism that can be assigned to the species Klebsiella pneumoniae. Klebsiella pneumoniae CRKP Any bacterial organism that can be assigned to the species Klebsiella pneumoniae and is resistant to the antibiotic carbapenem. Carbapenem-Resistant Klebsiella pneumoniae Klebsiella pneumoniae, Extended-Spectrum Beta-Lactamases Any bacterial organism that can be assigned to the species Klebsiella pneumoniae and produces extended-spectrum beta-lactamases (ESBL). Extended-spectrum Beta-lactamase Positive Klebsiella pneumoniae Klebsiella pneumoniae subsp. rhinoscleromatis Any bacterial organism that can be assigned to the species Klebsiella rhinoscleromatis. Klebsiella rhinoscleromatis Any bacterial organism that can be assigned to the species Klebsiella singaporensis. Klebsiella singaporensis Any bacterial organism that can be assigned to the species Klebsiella variicola. Klebsiella variicola Any bacteria that is not assigned to the species level but can be assigned to the Klebsiella genus level. Klebsiella Any fungal organism that can be assigned to the species Kloeckera japonica. Kloeckera japonica CDC Enteric Group 8 Any bacterial organism that can be assigned to the species Kluyvera ascorbata. Kluyvera ascorbata Any bacterial organism that can be assigned to the species Kluyvera cryocrescens. Kluyvera cryocrescens Any bacterial organism that can be assigned to the species Kluyvera georgiana. Kluyvera georgiana Enterobacter intermedium Enterobacter intermedius Kluyvera cochleae Any bacterial organism that can be assigned to the species Kluyvera intermedia. Kluyvera intermedia Any bacteria that is not assigned to the species level but can be assigned to the Kluyvera genus level. Kluyvera Candida sphaerica Kluyveromyces drosophilarum Kluyveromyces lactis var. drosophilarum Kluyveromyces lactis var. lactis Kluyveromyces marxianus lactis Kluyveromyces marxianus var. drosophilarum Kluyveromyces marxianus var. lactis Any fungal organism that can be assigned to the species Kluyveromyces lactis. Kluyveromyces lactis Candida pseudotropicalis Kluyveromyces cicerisporus Kluyveromyces fragilis Any fungal organism that can be assigned to the species Kluyveromyces marxianus. Kluyveromyces marxianus Any bacteria that is not assigned to the species level but can be assigned to the Knoellia genus level. Knoellia Micrococcus kristinae Any bacterial organism that can be assigned to the species Kocuria kristinae. Kocuria kristinae Any bacterial organism that can be assigned to the species Kocuria rhizophila. Kocuria rhizophila Any bacterial organism that can be assigned to the species Kocuria rosea. Kocuria rosea Any bacterial organism that can be assigned to the species Kocuria varians. Kocuria varians Any bacteria that is not assigned to the species level but can be assigned to the Kocuria genus level. Kocuria Candida guilliermondii var. membranifaciens Pichia ohmeri Yamadazyma ohmeri Any fungal organism that can be assigned to the species Kodamaea ohmeri. Kodamaea ohmeri Any bacteria that is not assigned to the species level but can be assigned to the Kurthia genus level. Kurthia Any bacterial organism that can be assigned to the species Kytococcus sedentarius. Kytococcus sedentarius Any bacteria that is not assigned to the species level but can be assigned to the Kytococcus genus level. Kytococcus Lactobacillus paracasei paracasei Any bacterial organism that can be assigned to Lacticaseibacillus paracasei subspecies paracasei. Lactobacillus paracasei Subspecies paracasei Any bacterial organism that can be assigned to the species Lactobacillus acidophilus. Lactobacillus acidophilus Any bacterial organism that can be assigned to the species Lactobacillus brevis. Lactobacillus brevis Any bacterial organism that can be assigned to the species Lactobacillus casei. Lactobacillus casei Lactobacillus catenaforme Any bacterial organism that can be assigned to the species Lactobacillus catenaformis. Lactobacillus catenaformis Eubacterium crispatum Any bacterial organism that can be assigned to the species Lactobacillus crispatus. Lactobacillus crispatus Lactobacillus cellobiosus Any bacterial organism that can be assigned to the species Lactobacillus fermentum. Lactobacillus fermentum Any bacterial organism that can be assigned to the species Lactobacillus gallinarum. Lactobacillus gallinarum Any bacterial organism that can be assigned to the species Lactobacillus gasseri. Lactobacillus gasseri Any bacterial organism that can be assigned to the species Lactobacillus jensenii. Lactobacillus jensenii Any bacterial organism that can be assigned to the species Lactobacillus johnsonii. Lactobacillus johnsonii Any bacterial organism that can be assigned to the species Lactobacillus oris. Lactobacillus oris Any bacterial organism that can be assigned to the species Lactobacillus paracasei. Lactobacillus paracasei Lactobacillus casei rhamnosus Any bacterial organism that can be assigned to the species Lactobacillus rhamnosus. Lactobacillus rhamnosus Any bacterial organism that can be assigned to the species Lactobacillus salivarius. Lactobacillus salivarius Any bacterial organism that can be assigned to the species Lactobacillus vaginalis. Lactobacillus vaginalis Any bacteria that is not assigned to the species level but can be assigned to the Lactobacillus genus level. Lactobacillus Any bacterial organism that can be assigned to the species Lactococcus garvieae. Lactococcus garvieae Lactococcus cremoris Streptococcus cremoris Streptococcus hollandicus Streptococcus lactis B Any bacterial organism that can be assigned to Lactococcus lactis subspecies cremoris. Lactococcus lactis subsp cremoris Lactobacillus xylosus Streptococcus diacetilactis Any bacterial organism that can be assigned to Lactococcus lactis subspecies lactis. Lactococcus lactis subsp lactis Any bacterial organism that can be assigned to the species Lactococcus lactis. Lactococcus lactis Doederlein bacillus Any bacteria that is not assigned to the species level but can be assigned to the Lactococcus genus level. Lactococcus CDC Enteric Group 41 Any bacterial organism that can be assigned to the species Leclercia adecarboxylata. Leclercia adecarboxylata Any bacteria that is not assigned to the species level but can be assigned to the Leclercia genus level. Leclercia Legionella longbeachae Sg 1 Any bacterial organism that can be assigned to the species Legionella longbeachae serogroup 1. Legionella longbeachae Serogroup 1 Any bacterial organism that can be assigned to the species Legionella longbeachae. Legionella longbeachae Any bacterial organism that can be assigned to the species Legionella pneumophila serogroup 1. Legionella pneumophila Serogroup 1 Any bacterial organism that can be assigned to the species Legionella pneumophila serogroup 2. Legionella pneumophila Serogroup 2 Any bacterial organism that can be assigned to the species Legionella pneumophila serogroup 3. Legionella pneumophila Serogroup 3 Any bacterial organism that can be assigned to the species Legionella pneumophila serogroup 4. Legionella pneumophila Serogroup 4 Any bacterial organism that can be assigned to the species Legionella pneumophila serogroup 5. Legionella pneumophila Serogroup 5 Any bacterial organism that can be assigned to the species Legionella pneumophila serogroup 6. Legionella pneumophila Serogroup 6 Any bacterial organism that can be assigned to the species Legionella pneumophila serogroup 7. Legionella pneumophila Serogroup 7 Any bacterial organism that can be assigned to the species Legionella pneumophila serogroup 8. Legionella pneumophila Serogroup 8 Any bacterial organism that can be assigned to the species Legionella pneumophila serogroup 9. Legionella pneumophila Serogroup 9 Any bacterial organism that can be assigned to the species Legionella pneumophila. Legionella pneumophila Any bacteria that is not assigned to the species level but can be assigned to the Legionella genus level. Legionella Corynebacterium aquaticum Any bacterial organism that can be assigned to the species Leifsonia aquatica. Leifsonia aquatica Any bacteria that is not assigned to the species level but can be assigned to the Leifsonia genus level. Leifsonia Leishmania brasiliensis Leishmania viannia Any unicellular, eukaryotic organism that can be assigned to the species Leishmania braziliensis. Leishmania braziliensis Any unicellular, eukaryotic organism that can be assigned to the species Leishmania donovani. Leishmania donovani Leishmania chagasi Leishmania donovani infantum Any unicellular, eukaryotic organism that can be assigned to the species Leishmania infantum. Leishmania infantum Any unicellular, eukaryotic organism that can be assigned to the species Leishmania mexicana. Leishmania mexicana Leishmania tropica minor Any unicellular, eukaryotic organism that can be assigned to the species Leishmania tropica. Leishmania tropica CDC Enteric Group 57 Any bacterial organism that can be assigned to the species Leminorella grimontii. Leminorella grimontii Any bacterial organism that can be assigned to the species Leminorella richardii. Leminorella richardii Any bacteria that is not assigned to the species level but can be assigned to the Leminorella genus level. Leminorella Lentivirinae Any viral organism that can be assigned to the genus Lentivirus. Lentivirus Any bacteria that is not assigned to the species level but can be assigned to the Leptospira genus level. Leptospira Any bacterial organism that can be assigned to the species Leuconostoc citreum. Leuconostoc citreum Any bacterial organism that can be assigned to the species Leuconostoc lactis. Leuconostoc lactis Any bacterial organism that can be assigned to the species Leuconostoc mesenteroides. Leuconostoc mesenteroides Any bacterial organism that can be assigned to the species Leuconostoc pseudomesenteroides. Leuconostoc pseudomesenteroides Any bacteria that is not assigned to the species level but can be assigned to the Leuconostoc genus level. Leuconostoc Any bacterial organism that can be assigned to the species Listeria grayi. Listeria grayi Any bacterial organism that can be assigned to the species Listeria innocua. Listeria innocua Listeria bulgarica Listeria monocytogenes subsp. perhaemolytica Listeria perhaemolytica Any bacterial organism that can be assigned to the species Listeria ivanovii. Listeria ivanovii Bacterium monocytogenes hominis Corynebacterium infantisepticum Corynebacterium parvulum Listerella hepatolytica Any bacterial organism that can be assigned to the species Listeria monocytogenes. Listeria monocytogenes Any bacterial organism that can be assigned to the species Listeria seeligeri. Listeria seeligeri Any bacterial organism that can be assigned to the species Listeria welshimeri. Listeria welshimeri Any bacteria that is not assigned to the species level but can be assigned to the Listeria genus level. Listeria Eye Worm Any nematode parasite that can be assigned to the species Loa loa. Loa loa Scedosporium inflatum Scedosporium prolificans Any fungal organism that can be assigned to the species Lomentospora prolificans. Scedosporium prolificans Any bacteria that is not assigned to the species level but can be assigned to the Lysinibacillus genus level. Lysinibacillus Any viral organism that can be assigned to the genus Lyssavirus. Lyssavirus Staphylococcus caseolyticus Any bacterial organism that can be assigned to the species Macrococcus caseolyticus. Macrococcus caseolyticus Any bacteria that is not assigned to the species level but can be assigned to the Macrococcus genus level. Macrococcus Madurella ikedae Madurella mycetomi Streptotrix mycetomatis Any fungal organism that can be assigned to the species Madurella mycetomatis. Madurella mycetomatis Blastoschizomyces capitatus Dipodascus capitatus Geotrichum capitatum Saprochaete capitata Trichosporon capitatum Any fungal organism that can be assigned to the species Magnusiomyces capitatus. Magnusiomyces capitatus Pityrosporum orbiculare Pityrosporum ovale Saccharomyces ovalis Any fungal organism that can be assigned to the species Malassezia furfur. Malassezia furfur Pityrosporum pachydermatis Any fungal organism that can be assigned to the species Malassezia pachydermatis. Malassezia pachydermatis Any fungal organism that is not assigned to the species level but can be assigned to the Malassezia genus level. Malassezia Pasteurella haemolytica Any bacterial organism that can be assigned to the species Mannheimia haemolytica. Mannheimia haemolytica Any bacteria that is not assigned to the species level but can be assigned to the Mannheimia genus level. Mannheimia Filaria ozzardi Tetrapetalonema ozzardi Any nematode parasite that can be assigned to the species Mansonella ozzardi. Mansonella ozzardi Dipetalonema perstans Any nematode parasite that can be assigned to the species Mansonella perstans. Mansonella perstans Dipetalonema streptocerca Any nematode parasite that can be assigned to the species Mansonella streptocerca. Mansonella streptocerca Any viral organism that can be assigned to the genus Marburgvirus. Marburgvirus Measles Virus Rougeole Virus Rubeola Virus SSPEV Subacute Sclerosing Panencephalitis Virus Any viral organism that can be assigned to the species Measles morbillivirus. Measles morbillivirus Any bacterial organism that can be assigned to the species Megamonas funiformis. Megamonas funiformis Bacteroides hypermegas Megamonas hypermegas Sphaerophorus hypermegas Any bacterial organism that can be assigned to the species Megamonas hypermegale. Megamonas hypermegale Any bacteria that is not assigned to the species level but can be assigned to the Megamonas genus level. Megamonas Peptostreptococcus elsdenii Any bacterial organism that can be assigned to the species Megasphaera elsdenii. Megasphaera elsdenii Any bacteria that is not assigned to the species level but can be assigned to the Megasphaera genus level. Megasphaera Any trematode parasite that can be assigned to the species Metagonimus yokogawai. Metagonimus yokogawai Any viral organism that can be assigned to the genus Metapneumovirus. Metapneumovirus MSSA Any bacterial organism that can be assigned to the species Staphylococcus aureus and is susceptible to methicillin. Methicillin Susceptible Staphylococcus Aureus Pseudomonas mesophilica Any bacterial organism that can be assigned to the species Methylobacterium mesophilicum. Methylobacterium mesophilicum Any bacteria that is not assigned to the species level but can be assigned to the Methylobacterium genus level. Methylobacterium Candida pulcherrima Any fungal organism that can be assigned to the species Metschnikowia pulcherrima. Metschnikowia pulcherrima Candida guilliermondii Candida guilliermondii var. carpophila Endomyces guilliermondii Pichia guilliermondii Yamadazyma guilliermondii Any fungal organism that can be assigned to the species Meyerozyma guilliermondii. Pichia guilliermondii Any bacterial organism that can be assigned to the species Microbacterium paraoxydans. Microbacterium paraoxydans Any bacteria that is not assigned to the species level but can be assigned to the Microbacterium genus level. Microbacterium Any bacterial organism that can be assigned to the species Micrococcus luteus. Micrococcus luteus Any bacterial organism that can be assigned to the species Micrococcus lylae. Micrococcus lylae Any bacteria that is not assigned to the species level but can be assigned to the Micrococcus genus level. Micrococcus Microspora Microsporea Microsporida Any fungal organism that can be assigned to the phylum Microsporidia. Microsporidia Any fungal organism that can be assigned to the species Microsporum audouinii. Microsporum audouinii Microsporum canis var. distortum Any fungal organism that can be assigned to the species Microsporum distortum. Microsporum distortum Any fungal organism that can be assigned to the species Microsporum equinum. Microsporum equinum Any fungal organism that can be assigned to the species Microsporum ferrugineum. Microsporum ferrugineum Arthroderma gypseum Gymnoascus gypseus Nannizzia gypsea Any fungal organism that can be assigned to the species Microsporum gypseum. Microsporum gypseum MERS Virus MERS-CoV Middle East Respiratory Syndrome-related Coronavirus Any viral organism that can be assigned to the species Middle East respiratory syndrome coronavirus. Middle East Respiratory Syndrome Coronavirus Any bacterial organism that can be assigned to the species Mitsuokella multacida. Mitsuokella multacida Any bacteria that is not assigned to the species level but can be assigned to the Mitsuokella genus level. Mitsuokella The presence of more than one fungal and/or bacterial organism in a culture. (NCI) Mixed Flora Any bacterial organism that can be assigned to the species Mobiluncus curtisii. Mobiluncus curtisii Any bacterial organism that can be assigned to the species Mobiluncus mulieris. Mobiluncus mulieris Any bacteria that is not assigned to the species level but can be assigned to the Mobiluncus genus level. Mobiluncus MVA Any viral organism that can be assigned to below the species level modified vaccinia ankara virus. Modified Vaccinia Ankara Virus CDC Enteric Group 46 Any bacterial organism that can be assigned to the species Moellerella wisconsensis. Moellerella wisconsensis Any bacteria that is not assigned to the species level but can be assigned to the Moellerella genus level. Moellerella Eubacterium timidum Any bacterial organism that can be assigned to the species Mogibacterium timidum. Mogibacterium timidum Any bacteria that is not assigned to the species level but can be assigned to the Mogibacterium genus level. Mogibacterium Filamentous fungus Mould A non-taxonomic grouping of fungi that grow in the form of mycelium of hyphae (vegetative filaments). Mold Molluscipox Virus Any viral organism that can be assigned to the genus Molluscipoxvirus. Molluscipoxvirus MCV MOCV Any viral organism that can be assigned to the species Molluscum contagiosum virus. Molluscum Contagiosum Virus Any fungal organism that can be assigned to the species Monascus ruber. Monascus ruber Monkey Pox Virus Any viral organism that can be assigned to the species Monkeypox virus. Monkeypox Virus Any bacterial organism that can be assigned to the species Moraxella atlantae. Moraxella atlantae Any bacterial organism that can be assigned to the species Moraxella bovis. Moraxella bovis Any bacterial organism that can be assigned to the species Moraxella canis. Moraxella canis Branhamella catarrhalis Any bacterial organism that can be assigned to the species Moraxella catarrhalis. Moraxella catarrhalis Any bacterial organism that can be assigned to the species Moraxella catarrhalis and is beta-lactamase negative. Moraxella catarrhalis, Beta-Lactamase Negative Any bacterial organism that can be assigned to the species Moraxella catarrhalis and is beta-lactamase positive. Moraxella catarrhalis, Beta-Lactamase Positive Any bacterial organism that can be assigned to the species Moraxella catarrhalis and is penicillinase negative. Moraxella catarrhalis, Penicillinase Negative Any bacterial organism that can be assigned to the species Moraxella catarrhalis and is penicillinase positive. Moraxella catarrhalis, Penicillinase Positive Moraxella liquefaciens Any bacterial organism that can be assigned to the species Moraxella lacunata. Moraxella lacunata Any bacterial organism that can be assigned to the species Moraxella lincolnii. Moraxella lincolnii Any bacterial organism that can be assigned to the species Moraxella nonliquefaciens. Moraxella nonliquefaciens Any bacterial organism that can be assigned to the species Moraxella oblonga. Moraxella oblonga Any bacterial organism that can be assigned to the species Moraxella osloensis. Moraxella osloensis Branhamella Any bacteria that is not assigned to the species level but can be assigned to the Moraxella genus level. Moraxella Any viral organism that can be assigned to the genus Morbillivirus. Morbillivirus Proteus morganii Any bacterial organism that can be assigned to the species Morganella morganii. Morganella morganii Any bacterial organism that can be assigned to the species Morganella morganii and is able to metabolize lysine. Morganella morganii, Lysine-Positive Any bacterial organism that can be assigned to the species Morganella morganii and is unable to metabolize ornithine. Morganella morganii, Ornithine-Negative Any bacteria that is not assigned to the species level but can be assigned to the Morganella genus level. Morganella Any fungal organism that can be assigned to the species Mucor racemosus. Mucor racemosus Any fungal organism that can be assigned to the species Mucor ramosissimus. Mucor ramosissimus Any fungal organism that is not assigned to the species level but can be assigned to the Mucor genus level. Mucor Mucoromycotan Fungi Pin Molds Any fungal organism that is not assigned to the species level but can be assigned to the Mucorales order level. Mucorales Mumps orthorubulavirus Mumps Virus Any viral organism that can be assigned to the species Mumps rubulavirus. Mumps Virus M-MuLV Moloney Murine Leukemia Virus M-MuLV MoMuLV Rat Moloney Murine Leukemia Virus MoMuLV Any viral organism that can be assigned to the Murine leukaemia virus species subtype Moloney. Moloney Leukemia Virus Murine Leukemia Virus MLV Murine Leukemia Virus MuLV Any viral organism that can be assigned to the species Murine leukemia virus. Mouse Leukemia Virus Murine orthopneumovirus Any viral organism that can be assigned to the murine pneumonia virus. Murine Pneumonia Virus A non-taxonomic grouping of bacterial species that are phenotypically or genetically similar to the Mycobacterium abscessus species. This grouping may include but is not limited to: M. abscessus subsp. abscessus, M. abscessus subsp. massiliense, and M. abscessus subsp. bolletii. Mycobacterium abscessus Complex Mycobacterium bolletii Any bacterial organism that can be assigned to the species Mycobacterium abscessus subspecies bolletii. Mycobacterium abscessus Subspecies bolletii Mycobacterium massiliense Any bacterial organism that can be assigned to the species Mycobacterium abscessus subspecies massiliense. Mycobacterium abscessus Subspecies massiliense Mycobacterium chelonae subsp. abscessus Any bacterial organism that can be assigned to the species Mycobacterium abscessus. Mycobacterium abscessus Any bacterial organism that can be assigned to the species Mycobacterium africanum. Mycobacterium africanum A non-taxonomic grouping of bacterial species that are phenotypically or genetically similar to the Mycobacterium avium species. Mycobacterium avium complex Any bacterial organism that can be assigned to the species Mycobacterium avium. Mycobacterium avium An attenuated form of Mycobacterium bovis that is used to generate the Bacillus Calmette-Guerin vaccine. Mycobacterium bovis BCG Any bacterial organism that can be assigned to the species Mycobacterium bovis. Mycobacterium bovis Any bacterial organism that can be assigned to the species Mycobacterium canettii. Mycobacterium canetti Mycobacterium chelonae subsp. chelonae Any bacterial organism that can be assigned to the species Mycobacterium chelonae. Mycobacterium chelonae Any bacterial organism that can be assigned to the species Mycobacterium chimaera. Mycolicibacterium chimaera Any bacterial organism that can be assigned to the species Mycobacterium flavescens. Mycobacterium flavescens A non-taxonomic grouping of bacterial species that are phenotypically or genetically similar to the Mycobacterium fortuitum species. Mycobacterium fortuitum Complex Any bacterial organism that can be assigned to the species Mycobacterium fortuitum. Mycobacterium fortuitum Any bacterial organism that can be assigned to the species Mycobacterium gastri. Mycobacterium gastri Mycobacterium aquae Any bacterial organism that can be assigned to the species Mycobacterium gordonae. Mycobacterium gordonae Any bacterial organism that can be assigned to the species Mycobacterium haemophilum. Mycobacterium haemophilum Any bacterial organism that can be assigned to the species Mycobacterium intracellulare. Mycobacterium intracellulare A non-taxonomic grouping of bacterial species that are phenotypically or genetically similar to the Mycobacterium intracellulare and Mycobacterium chimaera species. Mycobacterium intracellulare and chimaera Group Any bacterial organism that can be assigned to the species Mycobacterium kansasii. Mycobacterium kansasii Any bacterial organism that can be assigned to the species Mycobacterium leprae. Mycobacterium leprae Any bacterial organism that can be assigned to the species Mycobacterium malmoense. Mycobacterium malmoense Mycobacterium balnei Any bacterial organism that can be assigned to the species Mycobacterium marinum. Mycobacterium marinum Any bacterial organism that can be assigned to the species Mycobacterium microti. Mycobacterium microti Any bacterial organism that can be assigned to the species Mycobacterium peregrinum. Mycobacterium peregrinum Any bacterial organism that can be assigned to the species Mycobacterium scrofulaceum. Mycobacterium scrofulaceum Mycobacterium habana Any bacterial organism that can be assigned to the species Mycobacterium simiae. Mycobacterium simiae Any bacterial organism that can be assigned to the species Mycobacterium smegmatis. Mycobacterium smegmatis Any bacterial organism that can be assigned to the species Mycobacterium szulgai. Mycobacterium szulgai Any bacterial organism that can be assigned to the species Mycobacterium terrae. Mycobacterium terrae Any bacterial organism that can be assigned to the species Mycobacterium thermoresistibile. Mycobacterium thermoresistibile A non-taxonomic grouping of bacterial species that are phenotypically or genetically similar to the Mycobacterium tuberculosis species. Mycobacterium tuberculosis Complex Any bacterial organism that can be assigned to the species Mycobacterium tuberculosis. Mycobacterium tuberculosis RR-TB Rifampin-resistant Mycobacterium tuberculosis Any bacterial organism that can be assigned to the species Mycobacterium tuberculosis and is resistant to the antibiotic rifampin. Rifampin-Resistant Mycobacterium tuberculosis Mycobacterium buruli Any bacterial organism that can be assigned to the species Mycobacterium ulcerans. Mycobacterium ulcerans Any bacterial organism that can be assigned to the species Mycobacterium xenopi. Mycobacterium xenopi Any bacteria that is not assigned to the species level but can be assigned to the Mycobacterium genus level. Mycobacterium Mycobacterium aubagnense Any bacterial organism that can be assigned to the species Mycolicibacterium aubagnense. Mycolicibacterium aubagnense Mycobacterium mucogenicum Group A non-taxonomic grouping of bacterial species that are phenotypically or genetically similar to the Mycolicibacterium mucogenicum species. This group may include but is not limited to: M. mucogenicum, M. aubagnense, and M. phocaicum. Mycolicibacterium mucogenicum Group Mycobacterium mucogenicum Any bacterial organism that can be assigned to the species Mycolicibacterium mucogenicum. Mycobacterium mucogenicum Mycobacterium phocaicum Any bacterial organism that can be assigned to the species Mycolicibacterium phocaicum. Mycolicibacterium phocaicum Any bacterial organism that can be assigned to the species Mycoplasma hominis. Mycoplasma hominis Any bacterial organism that can be assigned to the species Mycoplasma orale. Mycoplasma orale Any bacterial organism that can be assigned to the species Mycoplasma pneumoniae. Mycoplasma pneumoniae Any bacteria that is not assigned to the species level but can be assigned to the Mycoplasma genus level. Mycoplasma Flavobacterium odoratum Any bacterial organism that can be assigned to the species Myroides odoratus. Myroides odoratus Any bacteria that is not assigned to the species level but can be assigned to the Myroides genus level. Myroides Any unicellular, eukaryotic organism that can be assigned to the species Naegleria fowleri. Naegleria fowleri Any unicellular, eukaryotic organism that is not assigned to the species level but can be assigned to the Naegleria genus level. Naegleria Any viral organism that can be assigned to the genus Nairovirus. Nairovirus Any nematode parasite that can be assigned to the species Necator americanus. Necator americanus Any bacterial organism that can be assigned to the species Neisseria canis. Neisseria canis Micrococcus cinereus Any bacterial organism that can be assigned to the species Neisseria cinerea. Neisseria cinerea CDC Group M-6 Any bacterial organism that can be assigned to the species Neisseria elongata subspecies nitroreducens. Neisseria elongata subsp nitroreducens Any bacterial organism that can be assigned to the species Neisseria elongata. Neisseria elongata Any bacterial organism that can be assigned to the species Neisseria flavescens. Neisseria flavescens A non-taxonomic grouping of bacteria that belongs to the flavescens/subflava group of the genus Neisseria. Neisseria flavescens/subflava Any bacterial organism that can be assigned to the species Neisseria gonorrhoeae and strain 1291. Neisseria gonorrhoeae 1291 Any bacterial organism that can be assigned to the species Neisseria gonorrhoeae. Neisseria gonorrhoeae Any bacterial organism that can be assigned to the species Neisseria gonorrhoeae and is beta-lactamase negative. Neisseria gonorrhoeae, Beta-lactamase Negative Any bacterial organism that can be assigned to the species Neisseria gonorrhoeae and is beta-lactamase positive. Neisseria gonorrhoeae, Beta-lactamase Positive Any bacterial organism that can be assigned to the species Neisseria gonorrhoeae and is penicillinase negative. Neisseria gonorrhoeae, Penicillinase Negative Any bacterial organism that can be assigned to the species Neisseria gonorrhoeae and is penicillinase positive. Neisseria gonorrhoeae, Penicillinase Positive Any bacterial organism that can be assigned to the species Neisseria lactamica. Neisseria lactamica MenB Neisseria meningitidis Group B Any bacterial organism that can be assigned to the Neisseria meningitidis serogroup B. Neisseria meningitidis Serogroup B Any bacterial organism that can be assigned to the species Neisseria meningitidis. Neisseria meningitidis Any bacterial organism that can be assigned to the species Neisseria mucosa. Neisseria mucosa Any bacterial organism that can be assigned to the species Neisseria polysaccharea. Neisseria polysaccharea Any bacterial organism that can be assigned to the species Neisseria sicca. Neisseria sicca Any bacterial organism that can be assigned to the species Neisseria subflava. Neisseria subflava CDC Group M-5 Any bacterial organism that can be assigned to the species Neisseria weaverii. Neisseria weaverii Any bacteria that is not assigned to the species level but can be assigned to the Neisseria genus level. Neisseria Roundworms Any parasitic roundworm that is not assigned to the species level but can be assigned to the Nematoda phylum level. Nematoda Avian Paramyxovirus Type 1 NDV Any viral organism that can be assigned to the species Newcastle disease virus. Newcastle Disease Virus Any fungal organism that is not assigned to the species level but can be assigned to the Nigrospora genus level. Nigrospora NiV Any viral organism that can be assigned to the species Nipah virus. Nipah Virus A non-taxonomic grouping of bacterial species that are phenotypically or genetically similar to the Nocardia asteroides species. Nocardia asteroides Complex Any bacterial organism that can be assigned to the species Nocardia asteroides. Nocardia asteroides Any bacterial organism that can be assigned to the species Nocardia brasiliensis. Nocardia brasiliensis Any bacterial organism that can be assigned to the species Nocardia cyriacigeorgica. Nocardia cyriacigeorgica Any bacterial organism that can be assigned to the species Nocardia dassonvillei. Nocardia dassonvillei Any bacterial organism that can be assigned to the species Nocardia farcinica. Nocardia farcinica Any bacterial organism that can be assigned to the species Nocardia nova. Nocardia nova Nocardia caviae Any bacterial organism that can be assigned to the species Nocardia otitidiscaviarum. Nocardia otitidiscaviarum Any bacteria that is not assigned to the species level but can be assigned to the Nocardia genus level. Nocardia Non-fermentative Gram-negative Rod Any rod-shaped, anaerobic bacteria that cannot convert carbohydrates into acids and alcohols and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique. Non-Fermentative Gram Negative Bacillus The presence of microorganisms that normally reside at an anatomical site and that under normal circumstances do not cause disease. Normal Flora Human calicivirus genogroup 1 Norovirus GI Any viral organism that can be assigned to the Norovirus genogroup I. Norovirus Genogroup I Norovirus GII Any viral organism that can be assigned to the Norovirus genogroup II. Norovirus Genogroup II Norovirus Genogroup GII.4 Norovirus GII.4 Any viral organism that can be assigned to the Norovirus genogroup II.4. Norovirus Genogroup II.4 Norwalk-like virus NoV Any viral organism that can be assigned to the genus Norovirus. Norovirus Norwalk calicivirus NV Any viral organism that can be assigned to the species Norwalk virus. Norwalk Virus Any fungal organism that is not assigned to the species level but can be assigned to the Nosema genus level. Nosema Achromobacter subsp. Biotype 1 Any bacterial organism that can be assigned to the species Ochrobactrum anthropi. Ochrobactrum anthropi Any bacterial organism that can be assigned to the species Ochrobactrum intermedium. Ochrobactrum intermedium Any bacteria that is not assigned to the species level but can be assigned to the Ochrobactrum genus level. Ochrobactrum Bacteroides splanchnicus Any bacterial organism that can be assigned to the species Odoribacter splanchnicus. Bacteroides splanchnicus Any bacterial organism that can be assigned to the species Oerskovia turbata. Oerskovia turbata Any bacteria that is not assigned to the species level but can be assigned to the Oerskovia genus level. Oerskovia Any fungal organism that is not assigned to the species level but can be assigned to the Oidiodendron genus level. Oidiodendron CDC Group Ive Any bacterial organism that can be assigned to the species Oligella ureolytica. Oligella ureolytica Any bacterial organism that can be assigned to the species Oligella urethralis. Oligella urethralis Any bacteria that is not assigned to the species level but can be assigned to the Oligella genus level. Oligella Lactobacillus uli Any bacterial organism that can be assigned to the species Olsenella uli. Olsenella uli Any bacteria that is not assigned to the species level but can be assigned to the Olsenella genus level. Olsenella Any trematode parasite that can be assigned to the species Onchocerca volvulus. Onchocerca volvulus Cat Liver Fluke Any trematode parasite that can be assigned to the species Opisthorchis felineus. Opisthorchis felineus Any viral organism that can be assigned to the genus Orbivirus. Orbivirus Rickettsia akamushi Rickettsia orientalis Any bacterial organism that can be assigned to the species Orientia tsutsugamushi. Orientia tsutsugamushi Bunyavirus Any viral organism that can be assigned to the genus Orthobunyavirus. Orthobunyavirus Any viral organism that can be assigned to the genus Orthopoxvirus. Orthopoxvirus Any fungal organism that is not assigned to the species level but can be assigned to the Paecilomyces genus level. Paecilomyces Bacillus glucanolyticus Any bacterial organism that can be assigned to the species Paenibacillus glucanolyticus. Paenibacillus glucanolyticus Any bacterial organism that can be assigned to the species Paenibacillus phoenicis. Paenibacillus phoenicis Any bacterial organism that can be assigned to the species Paenibacillus provencensis. Paenibacillus provencensis Any bacterial organism that can be assigned to the species Pandoraea apista. Pandoraea apista Any bacterial organism that can be assigned to the species Pandoraea pnomenusa. Pandoraea pnomenusa Any bacterial organism that can be assigned to the species Pandoraea sputorum. Pandoraea sputorum Any bacteria that is not assigned to the species level but can be assigned to the Pandoraea genus level. Pandoraea Achromobacter group B Achromobacter group E Any bacterial organism that can be assigned to the species Pannonibacter phragmitetus. Pannonibacter phragmitetus Enterobacter agglomerans Any bacterial organism that can be assigned to the species Pantoea agglomerans. Pantoea agglomerans Any bacterial organism that can be assigned to the species Pantoea anthophila. Pantoea anthophila Any bacteria that is not assigned to the species level but can be assigned to the Pantoea genus level. Pantoea Bacteroides distasonis Any bacterial organism that can be assigned to the species Parabacteroides distasonis. Parabacteroides distasonis Bacteroides goldsteinii Any bacterial organism that can be assigned to the species Parabacteroides goldsteinii. Parabacteroides goldsteinii Any bacterial organism that can be assigned to the species Parabacteroides johnsonii. Parabacteroides johnsonii Bacteroides fragilis T4-1 Bacteroides merdae Any bacterial organism that can be assigned to the species Parabacteroides merdae. Parabacteroides merdae Any bacteria that is not assigned to the species level but can be assigned to the Parabacteroides genus level. Parabacteroides CDC Group EO-2 Any bacterial organism that can be assigned to the species Paracoccus yeei. Paracoccus yeei Oriental Lung Fluke Any trematode parasite that can be assigned to the species Paragonimus westermani. Paragonimus westermani Any viral organism that can be assigned to the genus Parapoxvirus. Parapoxvirus Any viral organism that is not assigned to the species level but can be assigned to the Parechovirus genus level. Parechovirus Micromonas micros Peptostreptococcus micros Any bacterial organism that can be assigned to the species Parvimonas micra. Parvimonas micra Any bacteria that is not assigned to the species level but can be assigned to the Parvimonas genus level. Parvimonas Any bacterial organism that can be assigned to the species Pasteurella aerogenes. Pasteurella aerogenes Any bacterial organism that can be assigned to the species Pasteurella bettyae. Pasteurella bettyae Pasteurella multocida Biotype 6 Any bacterial organism that can be assigned to the species Pasteurella canis. Pasteurella canis Pasteurella septica Any bacterial organism that can be assigned to the species Pasteurella multocida. Pasteurella multocida Any bacterial organism that can be assigned to the species Pasteurella pneumotropica. Pasteurella pneumotropica Any bacteria that is not assigned to the species level but can be assigned to the Pasteurella genus level. Pasteurella Pediococcus hennebergii Any bacterial organism that can be assigned to the species Pediococcus pentosaceus. Pediococcus pentosaceus Any bacteria that is not assigned to the species level but can be assigned to the Pediococcus genus level. Pediococcus Penicillium notatum Any fungal organism that can be assigned to the species Penicillium chrysogenum. Penicillium chrysogenum Any fungal organism that is not assigned to the species level but can be assigned to the Penicillium genus level. Penicillium Any unicellular, eukaryotic organism that can be assigned to the species Pentatrichomonas hominis. Pentatrichomonas hominis Micrococcus niger Any bacterial organism that can be assigned to the species Peptococcus niger. Peptococcus niger Any bacteria that is not assigned to the species level but can be assigned to the Peptococcus genus level. Peptococcus Peptococcus asaccharolyticus Peptostreptococcus asaccharolyticus Any bacterial organism that can be assigned to the species Peptoniphilus asaccharolyticus. Peptoniphilus asaccharolyticus Peptostreptococcus harei Schleiferella harei Any bacterial organism that can be assigned to the species Peptoniphilus harei. Peptoniphilus harei Peptostreptococcus indolicus Any bacterial organism that can be assigned to the species Peptoniphilus indolicus. Peptoniphilus indolicus Any bacteria that is not assigned to the species level but can be assigned to the Peptoniphilus genus level. Peptoniphilus Any bacterial organism that can be assigned to the species Peptostreptococcus anaerobius. Peptostreptococcus anaerobius Any bacterial organism that can be assigned to the species Peptostreptococcus stomatis. Peptostreptococcus stomatis Any bacteria that is not assigned to the species level but can be assigned to the Peptostreptococcus genus level. Peptostreptococcus Bacillus simplex Any bacterial organism that can be assigned to the species Peribacillus simplex. Peribacillus simplex Any fungal organism that is not assigned to the species level but can be assigned to the Pestalotiopsis genus level. Pestalotiopsis Any fungal organism that can be assigned to the species Phialophora verrucosa. Phialophora verrucosa Any fungal organism that is not assigned to the species level but can be assigned to the Phialophora genus level. Phialophora Any viral organism that can be assigned to the genus Phlebovirus. Phlebovirus Photobacterium damselae subsp. damselae Vibrio damsela Any bacterial organism that can be assigned to the species Photobacterium damselae. Photobacterium damselae Any bacteria that is not assigned to the species level but can be assigned to the Photobacterium genus level. Photobacterium Any bacterial organism that can be assigned to the species Photorhabdus luminescens. Photorhabdus luminescens Any bacteria that is not assigned to the species level but can be assigned to the Photorhabdus genus level. Photorhabdus Candida fimetaria Candida lambica Mycoderma lambica Any fungal organism that can be assigned to the species Pichia fermentans. Pichia fermentans Any fungal organism that can be assigned to the species Pichia kluyveri. Pichia kluyveri Candida krusei Issatchenkia orientalis Any fungal organism that can be assigned to the species Pichia kudriavzevii. Candida krusei Candida mycoderma var. annulata Any fungal organism that can be assigned to the species Pichia norvegensis. Pichia norvegensis Hansenula Any fungal organism that is not assigned to the species level but can be assigned to the Pichia genus level. Pichia Any fungal organism that can be assigned to the species Piedraia hortae. Piedraia hortae Any fungal organism that is not assigned to the species level but can be assigned to the Piedraia genus level. Piedraia Any fungal organism that is not assigned to the species level but can be assigned to the Pithomyces genus level. Pithomyces Any bacteria that is not assigned to the species level but can be assigned to the Planococcus genus level. Planococcus Any unicellular, eukaryotic organism that can be assigned to the species Plasmodium falciparum. Plasmodium falciparum Any unicellular, eukaryotic organism that can be assigned to the species Plasmodium malariae. Plasmodium malariae Any unicellular, eukaryotic organism that can be assigned to the species Plasmodium ovale. Plasmodium ovale Any unicellular, eukaryotic organism that can be assigned to the species Plasmodium vivax. Plasmodium vivax Any fungal organism that is not assigned to the species level but can be assigned to the Pleistophora genus level. Pleistophora Aeromonas shigelloides Any bacterial organism that can be assigned to the species Plesiomonas shigelloides. Plesiomonas shigelloides Any bacteria that is not assigned to the species level but can be assigned to the Plesiomonas genus level. Plesiomonas Any fungal organism that can be assigned to the species Pneumocystis carinii. Pneumocystis carinii Pneumocystis carinii f. sp. Hominis Any fungal organism that can be assigned to the species Pneumocystis jirovecii. Pneumocystis jirovecii Any fungal organism that is not assigned to the species level but can be assigned to the Pneumocystis genus level. Pneumocystis Any viral organism that can be assigned to the genus Pneumovirus. Pneumovirus ENC Enterovirus C Human enterovirus C Any viral organism that can be assigned to the species Poliovirus. Poliovirus Any viral organism that can be assigned to the genus Polyomavirus. Polyomavirus Bacteroides asaccharolyticus Any bacterial organism that can be assigned to the species Porphyromonas asaccharolytica. Porphyromonas asaccharolytica Any bacterial organism that can be assigned to the species Porphyromonas bennonis. Porphyromonas bennonis Any bacterial organism that can be assigned to the species Porphyromonas catoniae. Porphyromonas catoniae Bacteroides endodontalis Any bacterial organism that can be assigned to the species Porphyromonas endodontalis. Porphyromonas endodontalis Bacteroides gingivalis Any bacterial organism that can be assigned to the species Porphyromonas gingivalis. Porphyromonas gingivalis Bacteroides levii Bacteroides melaninogenicus subsp. levii Any bacterial organism that can be assigned to the species Porphyromonas levii. Porphyromonas levii Any bacterial organism that can be assigned to the species Porphyromonas somerae. Porphyromonas somerae Any bacteria that is not assigned to the species level but can be assigned to the Porphyromonas genus level. Porphyromonas Any bacterial organism that can be assigned to the species Prevotella amnii. Prevotella amnii Prevotella Genomospecies E4 Any bacterial organism that can be assigned to the species Prevotella baroniae. Prevotella baroniae Any bacterial organism that can be assigned to the species Prevotella bergensis. Prevotella bergensis Bacteroides bivia Any bacterial organism that can be assigned to the species Prevotella bivia. Prevotella bivia Bacteroides ruminicola subsp. brevis Bacteroides ruminicola subsp. brevus Any bacterial organism that can be assigned to the species Prevotella brevis. Prevotella brevis Bacteroides buccae Any bacterial organism that can be assigned to the species Prevotella buccae. Prevotella buccae Any bacterial organism that can be assigned to the species Prevotella buccalis. Prevotella buccalis Any bacterial organism that can be assigned to the species Prevotella corporis. Prevotella corporis Any bacterial organism that can be assigned to the species Prevotella dentalis. Prevotella dentalis Bacteroides denticola Any bacterial organism that can be assigned to the species Prevotella denticola. Prevotella denticola Bacteroides disiens Any bacterial organism that can be assigned to the species Prevotella disiens. Prevotella disiens Bacteroides heparinolyticus Any bacterial organism that can be assigned to the species Prevotella heparinolytica. Prevotella heparinolytica Any bacterial organism that can be assigned to the species Prevotella histicola. Prevotella histicola Bacteroides intermedia Any bacterial organism that can be assigned to the species Prevotella intermedia. Prevotella intermedia A non-taxonomic grouping of bacteria that belongs to the intermedia/nigrescens group of the genus Prevotella. Prevotella intermedia/nigrescens Group Any bacterial organism that can be assigned to the species Prevotella loescheii. Prevotella loescheii Bacteroides melaninogenicus Any bacterial organism that can be assigned to the species Prevotella melaninogenica. Prevotella melaninogenica Any bacterial organism that can be assigned to the species Prevotella nigrescens. Prevotella nigrescens Bacteroides oralis Any bacterial organism that can be assigned to the species Prevotella oralis. Prevotella oralis Bacteroides oris Any bacterial organism that can be assigned to the species Prevotella oris. Prevotella oris Bacteroides ruminicola Any bacterial organism that can be assigned to the species Prevotella ruminicola. Prevotella ruminicola Any bacterial organism that can be assigned to the species Prevotella tannerae. Prevotella tannerae Any bacterial organism that can be assigned to the species Prevotella timonensis. Prevotella timonensis Any bacterial organism that can be assigned to the species Prevotella veroralis. Prevotella veroralis Any bacteria that is not assigned to the species level but can be assigned to the Prevotella genus level. Prevotella Bacillus acnes Corynebacterium acnes Corynebacterium parvum Cutibacterium acnes Any bacterial organism that can be assigned to the species Propionibacterium acnes. Propionibacterium acnes Any bacterial organism that can be assigned to the species Propionibacterium avidum. Propionibacterium avidum Corynebacterium granulosum Any bacterial organism that can be assigned to the species Propionibacterium granulosum. Propionibacterium granulosum Actinomyces propionicus Any bacterial organism that can be assigned to the species Propionibacterium propionicum. Propionibacterium propionicum Any bacteria that is not assigned to the species level but can be assigned to the Propionibacterium genus level. Propionibacterium Any bacterial organism that can be assigned to the species Proteus hauseri. Proteus hauseri Providencia inconstans Any bacterial organism that can be assigned to the species Proteus inconstans. Proteus inconstans Any bacterial organism that can be assigned to the species Proteus mirabilis. Proteus mirabilis Any bacterial organism that can be assigned to the species Proteus myxofaciens. Proteus myxofaciens Indole Negative Proteus vulgaris Any bacterial organism that can be assigned to the species Proteus penneri. Proteus penneri Any bacterial organism that can be assigned to the species Proteus vulgaris. Proteus vulgaris Any bacteria that is not assigned to the species level but can be assigned to the Proteus genus level. Proteus Prototheca stagnora Any algal organism that can be assigned to the species Prototheca stagnorum. Prototheca stagnora Any algal organism that can be assigned to the species Prototheca wickerhamii. Prototheca wickerhamii Any algal organism that can be assigned to the species Prototheca zopfii. Prototheca zopfii Any bacterial organism that can be assigned to the species Providencia alcalifaciens. Providencia alcalifaciens Any bacterial organism that can be assigned to the species Providencia heimbachae. Providencia heimbachae Any bacterial organism that can be assigned to the species Providencia rettgeri. Proteus rettgeri Providencia alcalifaciens Biogroup 3 Any bacterial organism that can be assigned to the species Providencia rustigianii. Providencia rustigianii Any bacterial organism that can be assigned to the species Providencia stuartii. Providencia stuartii Any bacterial organism that can be assigned to the species Providencia stuartii and is able to metabolize urea. Urea-Positive Providencia stuartii Any bacteria that is not assigned to the species level but can be assigned to the Providencia genus level. Providencia Paravaccinia virus Pseudocowpoxvirus Any viral organism that can be assigned to the species Pseudocowpox virus. Pseudocowpox Virus Any bacterial organism that can be assigned to the species Pseudomonas aeruginosa. Pseudomonas aeruginosa Any bacterial organism that can be assigned to the species Pseudomonas aeruginosa and the mucoid strain. Mucoid Pseudomonas aeruginosa Any bacterial organism that can be assigned to the species Pseudomonas aeruginosa and the non-mucoid strain. Non-Mucoid Pseudomonas aeruginosa Pseudomonas aeruginosa SCV Any bacterial organism that can be assigned to the species Pseudomonas aeruginosa and the small-colony variant strain. Small-Colony Variant Pseudomonas aeruginosa Any bacterial organism that can be assigned to the species Pseudomonas alcaligenes. Pseudomonas alcaligenes Any bacterial organism that can be assigned to the species Pseudomonas chlororaphis. Pseudomonas chlororaphis Bacterium fluorescen Liquidomonas fluorescens Any bacterial organism that can be assigned to the species Pseudomonas fluorescens. Pseudomonas fluorescens A non-taxonomic grouping of bacteria that belongs to the fluorescens/putida group of the genus Pseudomonas. Pseudomonas fluorescens/putida Group Any bacterial organism that can be assigned to the species Pseudomonas fulva. Pseudomonas fulva Any bacterial organism that can be assigned to the species Pseudomonas koreensis. Pseudomonas koreensis Chryseomonas luteola Any bacterial organism that can be assigned to the species Pseudomonas luteola. Pseudomonas luteola Any bacterial organism that can be assigned to the species Pseudomonas mendocina. Pseudomonas mendocina Any bacterial organism that can be assigned to the species Pseudomonas mosselii. Pseudomonas mosselii Pseudomonas azelaica Any bacterial organism that can be assigned to the species Pseudomonas nitroreducens. Pseudomonas nitroreducens Flavimonas oryzihabitans Any bacterial organism that can be assigned to the species Pseudomonas oryzihabitans. Pseudomonas oryzihabitans Any bacterial organism that can be assigned to the species Pseudomonas otitidis. Pseudomonas otitidis Any bacterial organism that can be assigned to the species Pseudomonas plecoglossicida. Pseudomonas plecoglossicida Pseudomonas alcaligenes Biotype B Any bacterial organism that can be assigned to the species Pseudomonas pseudoalcaligenes. Pseudomonas pseudoalcaligenes Any bacterial organism that can be assigned to the species Pseudomonas putida. Pseudomonas putida Any bacterial organism that can be assigned to the species Pseudomonas stutzeri. Pseudomonas stutzeri Any bacteria that is not assigned to the species level but can be assigned to the Pseudomonas genus level. Pseudomonas Codworm Phocanema decipiens Sealworm Any nematode parasite that can be assigned to the species Pseudoterranova decipiens. Pseudoterranova decipiens Any bacterial organism that can be assigned to the species Psychrobacter immobilis. Psychrobacter immobilis Moraxella phenylpyruvica Any bacterial organism that can be assigned to the species Psychrobacter phenylpyruvicus. Psychrobacter phenylpyruvicus Any bacteria that is not assigned to the species level but can be assigned to the Psychrobacter genus level. Psychrobacter Paecilomyces lilacinus Penicillium lilacinum Purpureocillium lilacinus Any fungal organism that can be assigned to the species Purpureocillium lilacinum. Purpureocillium lilacinum Any fungal organism that is not assigned to the species level but can be assigned to the Pyrenochaeta genus level. Pyrenochaeta Any viral organism that can be assigned to the species Rabies virus. Rabies Virus Any bacterial organism that can be assigned to the species Rahnella aquatilis. Rahnella aquatilis Any bacteria that is not assigned to the species level but can be assigned to the Rahnella genus level. Rahnella Any bacterial organism that can be assigned to the species Ralstonia mannitolilytica. Ralstonia mannitolilytica Pseudomonas Group CDC Va-1 Any bacterial organism that can be assigned to the species Pseudomonas pickettii biovariant 1. Ralstonia pickettii Biovariant 1 Burkholderia pickettii Pseudomonas pickettii Any bacterial organism that can be assigned to the species Ralstonia pickettii. Ralstonia pickettii Any bacteria that is not assigned to the species level but can be assigned to the Ralstonia genus level. Ralstonia Klebsiella ornithinolytica Any bacterial organism that can be assigned to the species Raoultella ornithinolytica. Raoultella ornithinolytica Any bacterial organism that can be assigned to the species Raoultella planticola. Raoultella planticola Klebsiella terrigena Any bacterial organism that can be assigned to the species Raoultella terrigena. Raoultella terrigena Any bacteria that is not assigned to the species level but can be assigned to the Raoultella genus level. Raoultella Respiratory Syncytial Virus Subsp. A RSV Type A RSV-A Any viral organism that can be assigned to the species Human Respiratory Syncytial virus type A. Human Respiratory Syncytial Virus Type A Respiratory Syncytial Virus Subsp. B RSV Type B RSV-B Any viral organism that can be assigned to the species Human Respiratory Syncytial virus type B. Human Respiratory Syncytial Virus Type B Paramyxovirus Any viral organism that can be assigned to the genus Paramyxovirus. Paramyxovirus Any unicellular, eukaryotic organism that can be assigned to the species Retortamonas intestinalis. Retortamonas intestinalis Human Rhinovirus A Any viral organism that can be assigned to the species Rhinovirus A. Rhinovirus A Human Rhinovirus B Any viral organism that can be assigned to the species Rhinovirus B. Rhinovirus B Human Rhinovirus C Any viral organism that can be assigned to the species Rhinovirus C. Rhinovirus C Human Rhinovirus Any viral organism that can be classified as a Human rhinovirus. Rhinovirus Any bacteria that is not assigned to the species level but can be assigned to the Rhizobium genus level. Rhizobium Mucor pusillus Any fungal organism that can be assigned to the species Rhizomucor pusillus. Rhizomucor pusillus Any fungal organism that is not assigned to the species level but can be assigned to the Rhizomucor genus level. Rhizomucor Rhizopus arrhizus Rhizopus chiuniang Rhizopus formosaensis Rhizopus hangchow Rhizopus javanicus Y. Takeda Rhizopus liquefaciens Rhizopus peka Rhizopus pseudochinensis Rhizopus suinus Rhizopus tamarii Rhizopus thermosus Rhizopus tritici Any fungal organism that can be assigned to the species Rhizopus oryzae. Rhizopus oryzae Any fungal organism that is not assigned to the species level but can be assigned to the Rhizopus genus level. Rhizopus Corynebacterium equi Any bacterial organism that can be assigned to the species Rhodococcus equi. Rhodococcus equi Any bacteria that is not assigned to the species level but can be assigned to the Rhodococcus genus level. Rhodococcus Any fungal organism that can be assigned to the species Rhodotorula glutinis. Rhodotorula glutinis Rhodotorula pilimanae Rhodotorula rubra Sporobolomyces albo-rubescens Any fungal organism that can be assigned to the species Rhodotorula mucilaginosa. Rhodotorula mucilaginosa Any fungal organism that is not assigned to the species level but can be assigned to the Rhodotorula genus level. Rhodotorula Any bacterial organism that can be assigned to the species Rickettsia africae. Rickettsia africae Any bacterial organism that can be assigned to the species Rickettsia felis. Rickettsia felis Any bacterial organism that can be assigned to the species Rickettsia japonica. Rickettsia japonica Any bacterial organism that can be assigned to the species Rickettsia prowazekii. Rickettsia prowazekii Any bacterial organism that can be assigned to the species Rickettsia rickettsii. Rickettsia rickettsii Any bacterial organism that can be assigned to the species Rickettsia typhi. Rickettsia typhi Any bacteria that is not assigned to the species level but can be assigned to the Rickettsia genus level. Rickettsia Any viral organism that can be assigned to the genus Roseolovirus. Roseolovirus Any bacterial organism that can be assigned to the species Roseomonas gilardii. Roseomonas gilardii Any bacterial organism that can be assigned to the species Roseomonas mucosa. Roseomonas mucosa Any bacteria that is not assigned to the species level but can be assigned to the Roseomonas genus level. Roseomonas RRV Any viral organism that can be assigned to the species Ross River virus. Ross River Virus Any viral organism that can be assigned to the genus Rotavirus. Rotavirus Any bacterial organism that can be assigned to the species Rothia aeria. Rothia aeria Nocardia dentocariosa Any bacterial organism that can be assigned to the species Rothia dentocariosa. Rothia dentocariosa Stomatococcus mucilaginosus Any bacterial organism that can be assigned to the species Rothia mucilaginosa. Rothia mucilaginosa Stomatococcus Any bacteria that is not assigned to the species level but can be assigned to the Rothia genus level. Rothia German Measles Virus Any viral organism that can be assigned to the species Rubella virus. Rubella Virus Any viral organism that can be assigned to the genus Rubivirus. Rubivirus Any viral organism that can be assigned to the genus Rubulavirus. Rubulavirus Any bacterial organism that can be assigned to the species Ruminococcus gnavus. Ruminococcus gnavus Peptostreptococcus productus Any bacterial organism that can be assigned to the species Ruminococcus productus. Ruminococcus productus Any bacteria that is not assigned to the species level but can be assigned to the Ruminococcus genus level. Ruminococcus Micropolyspora internatus Any bacterial organism that can be assigned to the species Saccharomonospora viridis. Saccharomonospora viridis Bakers Yeast Brewers Yeast Saccharomyces capensis Saccharomyces italicus Saccharomyces oviformis Saccharomyces uvarum var. melibiosus Any fungal organism that can be assigned to the species Saccharomyces cerevisiae. Saccharomyces cerevisiae Micropolyspora faeni Micropolyspora rectivirgula Thermopolyspora polyspora Thermopolyspora rectivirgula Any bacterial organism that can be assigned to the species Saccharopolyspora rectivirgula. Saccharopolyspora rectivirgula Any bacterial organism that can be assigned to the species Salmonella bongori. Salmonella bongori Salmonella decatur Any bacterial organism that can be assigned to the species Salmonella choleraesuis variant decatur. Salmonella enterica Serotype choleraesuis var. decatur Arizona arizonae Arizona hinshawii Paracolobactrum arizonae Salmonella arizonae Any bacterial organism that can be assigned to the species Salmonella enterica subspecies arizonae. Salmonella enterica subsp arizonae Any bacterial organism that can be assigned to the species Salmonella enterica subspecies diarizonae. Salmonella enterica subsp diarizonae Bacillus enteritidis Salmonella enteritidis Any bacterial organism that can be assigned to the species Salmonella enterica subspecies enterica serovariant enteritidis. Salmonella enterica subsp. enterica Serovar enteritidis Salmonella gallinarum Any bacterial organism that can be assigned to the species Salmonella enterica subspecies enterica serovariant gallinarum. Salmonella enterica subsp. enterica Serovar gallinarum Salmonella pullorum Any bacterial organism that can be assigned to the species Salmonella enterica subspecies enterica serovariant pullorum. Salmonella enterica subsp. enterica Serovar Pullorum Bacillus typhi Salmonella serotype typhi Salmonella typhi Any bacterial organism that can be assigned to the species Salmonella enterica subspecies enterica serovariant typhi. Salmonella Serotype Typhi Salmonella typhisuis Any bacterial organism that can be assigned to the species Salmonella enterica subspecies enterica serovariant typhisuis. Salmonella enterica subsp. enterica Serovar typhisuis Any bacterial organism that can be assigned to the species Salmonella enterica subspecies enterica. Salmonella enterica subsp enterica Any bacterial organism that can be assigned to the species Salmonella enterica subspecies houtenae. Salmonella enterica subsp houtenae Any bacterial organism that can be assigned to the species Salmonella enterica subspecies indica. Salmonella enterica subsp indica Any bacterial organism that can be assigned to the species Salmonella enterica subspecies salamae. Salmonella enterica subsp salamae Any bacterial organism that can be assigned to the species Salmonella enterica. Salmonella enterica Salmonella enterica subsp. enterica serovar Infantis Any bacterial organism that can be assigned to below the species level serotype Salmonella infantis. Salmonella infantis Any bacterial organism that can be assigned to the genus Salmonella with serotype Choleraesuis. Salmonella Serotype Choleraesuis Any bacterial organism that can be assigned to the genus Salmonella with serotype Dublin. Salmonella Serotype Dublin Any bacterial organism that can be assigned to the genus Salmonella with serotype Enteritidis. Salmonella Serotype Enteritidis Any bacterial organism that can be assigned to the genus Salmonella and serotype group A. Salmonella Serotype Group A Any bacterial organism that can be assigned to the genus Salmonella and serotype group B. Salmonella Serotype Group B Any bacterial organism that can be assigned to the genus Salmonella and serotype group C. Salmonella Serotype Group C Any bacterial organism that can be assigned to the genus Salmonella and serotype group C1. Salmonella Serotype Group C1 Any bacterial organism that can be assigned to the genus Salmonella and serotype group C2. Salmonella Serotype Group C2 Any bacterial organism that can be assigned to the genus Salmonella with serotype Newport. Salmonella Serotype Newport Any bacterial organism that can be assigned to the genus Salmonella with serotype Paratyphi A. Salmonella Serotype Paratyphi A Any bacterial organism that can be assigned to the genus Salmonella with serotype Paratyphi B. Salmonella Serotype Paratyphi B Any bacterial organism that can be assigned to the genus Salmonella with serotype Paratyphi C. Salmonella Serotype Paratyphi C Any bacterial organism that can be assigned to the genus Salmonella with serotype Typhimurium. Salmonella Serotype Typhimurium Any bacteria that is not assigned to the species level but can be assigned to the Salmonella genus level. Salmonella Any viral organism that can be assigned to the genus Sapovirus. Sapovirus Human Calicivirus Sapporo-like Virus Human Calicivirus SLV Any viral organism that can be assigned to the species Sapporo virus. Sapporo Virus Zymosarcina ventriculi Any bacterial organism that can be assigned to the species Sarcina ventriculi. Sarcina ventriculi Any unicellular, eukaryotic organism that can be assigned to the species Sarcocystis hominis. Sarcocystis hominis Any unicellular, eukaryotic organism that can be assigned to the species Sarcocystis suihominis. Sarcocystis suihominis Any unicellular, eukaryotic organism that is not assigned to the species level but can be assigned to the Sarcocystis genus level. Sarcocystis Allescheria boydii Petriellidium boydii Pseudallescheria boydii Any fungal organism that can be assigned to the species Scedosporium boydii. Scedosporium boydii Any trematode parasite that can be assigned to the genus Schistosoma and is in the larval life stage. Schistosoma Cercariae Any trematode parasite that can be assigned to the species Schistosoma haematobium. Schistosoma haematobium Any trematode parasite that can be assigned to the species Schistosoma intercalatum. Schistosoma intercalatum Any trematode parasite that can be assigned to the species Schistosoma japonicum. Schistosoma japonicum Any trematode parasite that can be assigned to the species Schistosoma mansoni. Schistosoma mansoni Any trematode parasite that can be assigned to the species Schistosoma mekongi. Schistosoma mekongi Any fungal organism that is not assigned to the species level but can be assigned to the Schizophyllum genus level. Schizophyllum Any fungal organism that can be assigned to the species Scolecobasidium terreum. Scolecobasidium terreum Microascus brevicaulis Any fungal organism that can be assigned to the species Scopulariopsis brevicaulis. Scopulariopsis brevicaulis Any fungal organism that is not assigned to the species level but can be assigned to the Scopulariopsis genus level. Scopulariopsis Any bacterial organism that can be assigned to the species Selenomonas noxia. Selenomonas noxia Any bacterial organism that can be assigned to the species Selenomonas sputigena. Selenomonas sputigena Any bacteria that is not assigned to the species level but can be assigned to the Selenomonas genus level. Selenomonas Any bacterial organism that can be assigned to the species Serratia ficaria. Serratia ficaria Any bacterial organism that can be assigned to the species Serratia fonticola. Serratia fonticola A non-taxonomic grouping of bacteria that belongs to the liquefaciens group of the genus Serratia. Serratia liquefaciens Group Enterobacter liquefaciens Any bacterial organism that can be assigned to the species Serratia liquefaciens. Serratia liquefaciens Any bacterial organism that can be assigned to the species Serratia marcescens. Serratia marcescens Any bacterial organism that can be assigned to the species Serratia odorifera and biogroup 1. Serratia odorifera Biogroup 1 Any bacterial organism that can be assigned to the species Serratia odorifera and biogroup 2. Serratia odorifera Biogroup 2 Any bacterial organism that can be assigned to the species Serratia odorifera. Serratia odorifera Any bacterial organism that can be assigned to the species Serratia plymuthica. Serratia plymuthica Serratia marinorubra Any bacterial organism that can be assigned to the species Serratia rubidaea. Serratia rubidaea Serratia Any bacteria that is not assigned to the species level but can be assigned to the Serratia genus level. Serratia Exserohilum rostratum Any fungal organism that can be assigned to the species Setosphaeria rostrata. Setosphaeria rostrata 2019-nCoV COVID-19 Virus SARS Coronavirus 2 SARS-CoV-2 SARS2 Any viral organism that can be assigned to the severe acute respiratory syndrome Coronavirus 2. SARS Coronavirus 2 HCoV-SARS SARS SARS-CoV SARS-CoV-1 Severe Acute Respiratory Syndrome Coronavirus Any viral organism that can be assigned to the species SARS coronavirus. SARS Coronavirus Any bacterial organism that can be assigned to the species Shewanella algae. Shewanella algae Alteromonas putrefaciens Pseudomonas putrefaciens Any bacterial organism that can be assigned to the species Shewanella putrefaciens. Shewanella putrefaciens Any bacteria that is not assigned to the species level but can be assigned to the Shewanella genus level. Shewanella Shiga Toxin-producing E. coli Shiga-like Toxin-producing E. coli STEC Any bacterial organism that can be assigned to the species Escherichia coli and produces shiga toxin (also called shiga-like toxin). Shiga Toxin-producing Escherichia coli Any bacterial organism that can be assigned to the species Shigella boydii. Shigella boydii Any bacterial organism that can be assigned to the species Shigella dysenteriae. Shigella dysenteriae Any bacterial organism that can be assigned to the species Shigella flexneri. Shigella flexneri Any bacterial organism that can be assigned to the species Shigella sonnei. Shigella sonnei Any bacteria that is not assigned to the species level but can be assigned to the Shigella genus level. Shigella Any viral organism that can be assigned to the genus Simplexvirus. Simplex Virus Eubacterium exiguum Any bacterial organism that can be assigned to the species Slackia exigua. Slackia exigua Any bacterial organism that can be assigned to the species Solobacterium moorei. Solobacterium moorei Flavobacterium mizutae Any bacterial organism that can be assigned to the species Sphingobacterium mizutaii. Sphingobacterium mizutaii CDC Group IIk-2 Any bacterial organism that can be assigned to the species Sphingobacterium multivorum. Sphingobacterium multivorum Any bacterial organism that can be assigned to the species Sphingobacterium spiritivorum. Sphingobacterium spiritivorum Flavobacterium thalpophilum Any bacterial organism that can be assigned to the species Sphingobacterium thalpophilum. Sphingobacterium thalpophilum Any bacteria that is not assigned to the species level but can be assigned to the Sphingobacterium genus level. Sphingobacterium Pseudomonas paucimobilis Any bacterial organism that can be assigned to the species Sphingomonas paucimobilis. Sphingomonas paucimobilis Any bacteria that is not assigned to the species level but can be assigned to the Sphingomonas genus level. Sphingomonas Any bacterial organism that can be assigned to the species Spirillum minus. Spirillum minus Any bacterial organism that is not assigned to the species level but can be assigned to the Spirillum genus level. Spirillum Spirochetes Any bacteria that is not assigned to the species level but can be assigned to the Spirochaetales order level. Spirochaetales Aessosporon salmonicolor Sporobolomyces salmonicolor Any fungal organism that can be assigned to the species Sporidiobolus salmonicolor. Sporidiobolus salmonicolor Any fungal organism that can be assigned to the species Sporothrix schenckii. Sporothrix schenckii Any bacterial organism that can be assigned to the species Staphylococcus arlettae. Staphylococcus arlettae Staph. aureus Any bacterial organism that can be assigned to the species Staphylococcus aureus. Staphylococcus Aureus Any bacterial organism that can be assigned to the species Staphylococcus aureus and is beta-lactamase negative. Beta-Lactamase Negative Staphylococcus Aureus Any bacterial organism that can be assigned to the species Staphylococcus aureus and is beta-lactamase positive. Beta-Lactamase Positive Staphylococcus Aureus Methicillin-resistant Staphylococcus aureus MRSA Any bacterial organism that can be assigned to the species Staphylococcus aureus and is resistant to methicillin. Methicillin Resistant Staphylococcus Aureus ORSA Oxacillin-resistant Staphylococcus aureus Any bacterial organism that can be assigned to the species Staphylococcus aureus and is resistant to the antibiotic oxacillin. Oxacillin Resistant Staphylococcus aureus Any bacterial organism that can be assigned to the species Staphylococcus aureus and is penicillinase negative. Penicillinase Negative Staphylococcus Aureus Any bacterial organism that can be assigned to the species Staphylococcus aureus and is penicillinase positive. Penicillinase Positive Staphylococcus Aureus Vancomycin-resistant Staphylococcus aureus VRSA Any bacterial organism that can be assigned to the species Staphylococcus aureus and is resistant to the antibiotic vancomycin. Vancomycin Resistant Staphylococcus Aureus Any bacterial organism that can be assigned to the species Staphylococcus auricularis. Staphylococcus auricularis Any bacterial organism that can be assigned to the species Staphylococcus capitis subspecies urealyticus. Staphylococcus capitis Subspecies urealyticus Any bacterial organism that can be assigned to the species Staphylococcus capitis. Staphylococcus capitis Any bacterial organism that can be assigned to the species Staphylococcus caprae. Staphylococcus caprae Any bacterial organism that can be assigned to the species Staphylococcus carnosus. Staphylococcus carnosus Any bacterial organism that can be assigned to the species Staphylococcus chromogenes. Staphylococcus chromogenes Any bacterial organism that can be assigned to the species Staphylococcus cohnii subspecies urealyticus. Staphylococcus cohnii subsp. urealyticus Any bacterial organism that can be assigned to the species Staphylococcus cohnii. Staphylococcus cohnii Staphylococcus albus Any bacterial organism that can be assigned to the species Staphylococcus epidermidis. Staphylococcus epidermidis Any bacterial organism that can be assigned to the species Staphylococcus equorum. Staphylococcus equorum Any bacterial organism that can be assigned to the species Staphylococcus felis. Staphylococcus felis Any bacterial organism that can be assigned to the species Staphylococcus gallinarum. Staphylococcus gallinarum Staph. haemolyticus Any bacterial organism that can be assigned to the species Staphylococcus haemolyticus. Staphylococcus haemolyticus Coagulase Negative Staphylococcus hominis Any bacterial organism that can be assigned to the species Staphylococcus hominis. Staphylococcus hominis Any bacterial organism that can be assigned to the species Staphylococcus hyicus. Staphylococcus hyicus Any bacterial organism that can be assigned to the species Staphylococcus intermedius. Staphylococcus intermedius Any bacterial organism that can be assigned to the species Staphylococcus kloosii. Staphylococcus kloosii Any bacterial organism that can be assigned to the species Staphylococcus lentus. Staphylococcus lentus Any bacterial organism that can be assigned to the species Staphylococcus lugdunensis. Staphylococcus lugdunensis Any bacterial organism that can be assigned to the species Staphylococcus pasteuri. Staphylococcus pasteuri Any bacterial organism that can be assigned to the species Staphylococcus pettenkoferi. Staphylococcus pettenkoferi Peptococcus saccharolyticus Any bacterial organism that can be assigned to the species Staphylococcus saccharolyticus. Staphylococcus saccharolyticus Any bacterial organism that can be assigned to the species Staphylococcus saprophyticus. Staphylococcus saprophyticus Any bacterial organism that can be assigned to the species Staphylococcus schleiferi subspecies coagulans. Staphylococcus schleiferi subsp. coagulans Any bacterial organism that can be assigned to the species Staphylococcus schleiferi. Staphylococcus schleiferi Any bacterial organism that can be assigned to the species Staphylococcus sciuri. Staphylococcus sciuri Any bacterial organism that can be assigned to the species Staphylococcus simulans. Staphylococcus simulans Any bacterial organism that can be assigned to the species Staphylococcus succinus. Staphylococcus succinus Any bacterial organism that can be assigned to the species Staphylococcus warneri. Staphylococcus warneri Any bacterial organism that can be assigned to the species Staphylococcus xylosus. Staphylococcus xylosus Any bacteria that is not assigned to the species level but can be assigned to the Staphylococcus genus level. Staphylococcus Any fungal organism that is not assigned to the species level but can be assigned to the Stemphylium genus level. Stemphylium Any bacterial organism that can be assigned to the species Stenotrophomonas acidaminiphila. Stenotrophomonas acidaminiphila Pseudomonas maltophilia Xanthomonas maltophilia Any bacterial organism that can be assigned to the species Stenotrophomonas maltophilia. Stenotrophomonas maltophilia Stenotrophomonas Any bacteria that is not assigned to the species level but can be assigned to the Stenotrophomonas genus level. Stenotrophomonas Haverhillia multiformis Any bacterial organism that can be assigned to the species Streptobacillus moniliformis. Streptobacillus moniliformis Any bacteria that is not assigned to the species level but can be assigned to the Streptobacillus genus level. Streptobacillus Any bacteria that are not assigned to the species level but can be assigned to the Streptococcaceae family level. Streptococcaceae Any bacterial organism that can be assigned to the species Streptococcus acidominimus. Streptococcus acidominimus STREPT. GP B(AGALACT) Any bacterial organism that can be assigned to the species Streptococcus agalactiae. Streptococcus agalactiae Any bacterial organism that can be assigned to the species Streptococcus alactolyticus. Streptococcus alactolyticus A bacteria that is assigned to the genus Streptococcus that is able to reduce the iron content in hemoglobin in red blood cells, thus producing green-colored colonies on blood agar plates. Alpha-Hemolytic Streptococcus Any bacterial organism that can be assigned to the species group Streptococcus anginosus group. Streptococcus anginosus Group Any bacterial organism that can be assigned to the species Streptococcus anginosus. Streptococcus anginosus A bacteria that is assigned to the genus Streptococcus that is able to facilitate the complete rupturing of red blood cells, thus producing wide, clear, zones around colonies on blood agar plates. Beta-Hemolytic Streptococcus A non-taxonomic grouping of bacteria that belongs to the bovis group of the genus Streptococcus. Streptococcus bovis Group Any bacterial organism that can be assigned to the species Streptococcus bovis. Streptococcus bovis Any bacterial organism that can be assigned to the species Streptococcus canis. Streptococcus canis Any bacterial organism that can be assigned to the species Streptococcus constellatus. Streptococcus constellatus Any bacterial organism that can be assigned to the species Streptococcus cristatus. Streptococcus cristatus Any bacterial organism that can be assigned to the species Streptococcus dysgalactiae subspecies dysgalactiae. Streptococcus dysgalactiae subsp dysgalactiae Streptococcus equisimilis Any bacterial organism that can be assigned to the species Streptococcus dysgalactiae subspecies equisimilis. Streptococcus dysgalactiae subsp equisimilis Any bacterial organism that can be assigned to the species Streptococcus dysgalactiae. Streptococcus dysgalactiae Any bacterial organism that can be assigned to the species Streptococcus equi subspecies zooepidemicus. Streptococcus equi subsp. zooepidemicus Any bacterial organism that can be assigned to the species Streptococcus equi. Streptococcus equi Any bacterial organism that can be assigned to the species Streptococcus equinus. Streptococcus equinus Any bacterial organism that can be assigned to the species Streptococcus gallolyticus. Streptococcus gallolyticus Non-Hemolytic Streptococcus A bacteria that is assigned to the genus Streptococcus that is unable to facilitate red blood cell lysis. Gamma-Hemolytic Streptococcus Any bacterial organism that can be assigned to the species Streptococcus gordonii. Streptococcus gordonii Any bacterial organism that can be assigned to the species Streptococcus infantarius. Streptococcus infantarius Any bacterial organism that can be assigned to the species Streptococcus intermedius. Streptococcus intermedius Any bacterial organism that can be assigned to the species Streptococcus lutetiensis. Streptococcus lutetiensis Any bacterial organism that can be assigned to the species Streptococcus massiliensis. Streptococcus massiliensis A non-taxonomic grouping of bacteria that belongs to the milleri group of the genus Streptococcus. Streptococcus milleri Group Streptococcus milleri I Any bacterial organism that can be assigned to the species Streptococcus milleri. Streptococcus milleri A non-taxonomic grouping of bacteria that belongs to the mitis group of the genus Streptococcus. Streptococcus mitis Group Any bacterial organism that can be assigned to the species Streptococcus mitis. Streptococcus mitis A non-taxonomic grouping of bacteria that belongs to the mutans group of the genus Streptococcus. Streptococcus mutans Group Any bacterial organism that can be assigned to the species Streptococcus mutans. Streptococcus mutans Nutritionally Variant Streptococci NVS Any bacterial organism that can be assigned to a nutritionally variant group in the genus Streptococcus. Nutritionally Variant Streptococcus Any bacterial organism that can be assigned to the species Streptococcus oralis. Streptococcus oralis Streptococcus parasanguis Any bacterial organism that can be assigned to the species Streptococcus parasanguinis. Streptococcus parasanguinis Streptococcus gallolyticus subsp. pasteurianus Any bacterial organism that can be assigned to the species Streptococcus pasteurianus. Streptococcus pasteurianus Any bacterial organism that can be assigned to the species Streptococcus pluranimalium. Streptococcus pluranimalium Streptococcus pneumoniae US Serotype 1 Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 1. Streptococcus pneumoniae Danish Serotype 1 Streptococcus pneumoniae US Serotype 34 Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 10A. Streptococcus pneumoniae Danish Serotype 10A Streptococcus pneumoniae US Serotype 43 Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 11A. Streptococcus pneumoniae Danish Serotype 11A Streptococcus pneumoniae US Serotype 12 Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 12F. Streptococcus pneumoniae Danish Serotype 12F Streptococcus pneumoniae US Serotype 14 Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 14. Streptococcus pneumoniae Danish Serotype 14 Streptococcus pneumoniae US Serotype 54 Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 15B. Streptococcus pneumoniae Danish Serotype 15B Streptococcus pneumoniae US Serotype 17 Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 17F. Streptococcus pneumoniae Danish Serotype 17F Streptococcus pneumoniae US Serotype 56 Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 18C. Streptococcus pneumoniae Danish Serotype 18C Streptococcus pneumoniae US Serotype 57 Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 19A. Streptococcus pneumoniae Danish Serotype 19A Streptococcus pneumoniae US Serotype 19 Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 19F. Streptococcus pneumoniae Danish Serotype 19F Streptococcus pneumoniae US Serotype 2 Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 2. Streptococcus pneumoniae Danish Serotype 2 Streptococcus pneumoniae US Serotype 20 Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 20A. Streptococcus pneumoniae Danish Serotype 20A Streptococcus pneumoniae US Serotype 22 Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 22F. Streptococcus pneumoniae Danish Serotype 22F Streptococcus pneumoniae US Serotype 23 Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 23F. Streptococcus pneumoniae Danish Serotype 23F Streptococcus pneumoniae US Serotype 3 Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 3. Streptococcus pneumoniae Danish Serotype 3 Streptococcus pneumoniae US Serotype 70 Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 33F. Streptococcus pneumoniae Danish Serotype 33F Streptococcus pneumoniae US Serotype 4 Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 4. Streptococcus pneumoniae Danish Serotype 4 Streptococcus pneumoniae US Serotype 5 Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 5. Streptococcus pneumoniae Danish Serotype 5 Streptococcus pneumoniae US Serotype 6 Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 6A. Streptococcus pneumoniae Danish Serotype 6A Streptococcus pneumoniae US Serotype 26 Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 6B. Streptococcus pneumoniae Danish Serotype 6B Streptococcus pneumoniae US Serotype 51 Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 7F. Streptococcus pneumoniae Danish Serotype 7F Streptococcus pneumoniae US Serotype 8 Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 8. Streptococcus pneumoniae Danish Serotype 8 Streptococcus pneumoniae US Serotype 9 Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 9N. Streptococcus pneumoniae Danish Serotype 9N Streptococcus pneumoniae US Serotype 68 Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 9V. Streptococcus pneumoniae Danish Serotype 9V Diplococcus pneumoniae Any bacterial organism that can be assigned to the species Streptococcus pneumoniae. Streptococcus pneumoniae Any bacterial organism that can be assigned to the species Streptococcus porcinus. Streptococcus porcinus Any bacterial organism that can be assigned to the species Streptococcus pseudopneumoniae. Streptococcus pseudopneumoniae Group A Beta-hemolytic Streptococcus pyogenes Micrococcus scarlatinae Streptococcus erysipelatos Streptococcus hemolyticus Streptococcus scarlatinae Any bacterial organism that can be assigned to the species Streptococcus pyogenes. Streptococcus pyogenes A non-taxonomic grouping of bacteria that belongs to the salivarius group of the genus Streptococcus. Streptococcus salivarius Group Any bacterial organism that can be assigned to the species Streptococcus salivarius. Streptococcus salivarius Streptococcus sanguis Any bacterial organism that can be assigned to the species Streptococcus sanguinis. Streptococcus sanguinis Streptococcus Group R Any bacterial organism that can be assigned to the species Streptococcus suis serotype 2. Streptococcus suis serotype 2 Any bacterial organism that can be assigned to the species Streptococcus suis. Streptococcus suis Any bacterial organism that can be assigned to the species Streptococcus thermophilus. Streptococcus thermophilus Any bacterial organism that can be assigned to the species Streptococcus uberis. Streptococcus uberis Any bacterial organism that can be assigned to the species Streptococcus urinalis. Streptococcus urinalis Any bacterial organism that can be assigned to the species Streptococcus vestibularis. Streptococcus vestibularis A non-taxonomic grouping of species within the Streptococcus genus that are alpha-hemolytic and do not express Lancefield antigens. Streptococcus viridans Group Any bacterial organism that can be assigned to the species Streptococcus viridans. Streptococcus viridans Streptococci sp. Any bacteria that is not assigned to the species level but can be assigned to the Streptococcus genus level. Streptococcus Any bacterial organism that can be assigned to the species Streptomyces albus. Streptomyces albus Any bacterial organism that can be assigned to the species Streptomyces griseus. Streptomyces griseus Any bacterial organism that can be assigned to the species Streptomyces paraguayensis. Streptomyces paraguayensis Any bacterial organism that can be assigned to the species Streptomyces somaliensis. Streptomyces somaliensis Any bacteria that is not assigned to the species level but can be assigned to the Streptomyces genus level. Streptomyces Any nematode parasite that can be assigned to the species Strongyloides stercoralis. Strongyloides stercoralis Any nematode parasite that is not assigned to the species level but can be assigned to the Strongyloides genus level. Strongyloides Any bacteria that is not assigned to the species level but can be assigned to the Sutterella genus level. Sutterella Kingella indologenes Any bacterial organism that can be assigned to the species Suttonella indologenes. Suttonella indologenes Any bacteria that is not assigned to the species level but can be assigned to the Suttonella genus level. Suttonella Any fungal organism that is not assigned to the species level but can be assigned to the Syncephalastrum genus level. Syncephalastrum Beef Tapeworm Any cestode parasite that can be assigned to the species Taenia saginata. Taenia saginata Cysticercus cellulosae Pork Tapeworm Any cestode parasite that can be assigned to the species Taenia solium. Taenia solium Any cestode parasite that is not assigned to the species level but can be assigned to the Taenia genus level. Taenia Legionella micdadei Any bacterial organism that can be assigned to the species Legionella micdadei. Tatlockia micdadei CDC Group EF-9 Any bacterial organism that can be assigned to the species Tatumella ptyseos. Tatumella ptyseos Any bacteria that is not assigned to the species level but can be assigned to the Tatumella genus level. Tatumella Enterococcus solitarius Any bacterial organism that can be assigned to the species Tetragenococcus solitarius. Tetragenococcus solitarius Any bacteria that is not assigned to the species level but can be assigned to the Tetragenococcus genus level. Tetragenococcus Thermoactinomyces candidus Any bacterial organism that can be assigned to the species Thermoactinomyces vulgaris. Thermoactinomyces Vulgaris FSME virus TBEV Any viral organism that can be assigned to the species Tick-borne encephalitis virus. Tick-Borne Encephalitis Virus Any bacterial organism that can be assigned to the species Tissierella praeacuta. Tissierella praeacuta Any bacteria that is not assigned to the species level but can be assigned to the Tissierella genus level. Tissierella Any fungal organism that can be assigned to the species Torulaspora delbrueckii. Torulaspora delbrueckii TOSV Any viral organism that can be assigned to below the species level Toscana virus. Toscana virus Dog Roundworm Any nematode parasite that can be assigned to the species Toxocara canis. Toxocara canis Cat Roundworm Feline Roundworm Any nematode parasite that can be assigned to the species Toxocara cati. Toxocara cati Any nematode parasite that is not assigned to the species level but can be assigned to the Toxocara genus level. Toxocara Any unicellular, eukaryotic organism that can be assigned to the species Toxoplasma gondii. Toxoplasma gondii Any unicellular, eukaryotic organism that is not assigned to the species level but can be assigned to the Toxoplasma genus level. Toxoplasma CDC Enteric Group 90 Any bacterial organism that can be assigned to the species Trabulsiella guamensis. Trabulsiella guamensis Any bacteria that is not assigned to the species level but can be assigned to the Trabulsiella genus level. Trabulsiella Any parasitic flatworm that is not assigned to the species level but can be assigned to the Trematoda class level. Trematoda Madurella grisea Any fungal organism that can be assigned to the species Trematosphaeria grisea. Trematosphaeria grisea Any bacterial organism that can be assigned to the species Treponema pallidum subspecies endemicum. Treponema pallidum subsp endemicum Any bacterial organism that can be assigned to the species Treponema pallidum subspecies pallidum. Treponema pallidum subsp pallidum Treponema pertenue Any bacterial organism that can be assigned to the species Treponema pallidum and subspecies pertenue. Treponema pallidum subsp pertenue Any bacterial organism that can be assigned to the species Treponema pallidum. Treponema pallidum Any bacteria that is not assigned to the species level but can be assigned to the Treponema genus level. Treponema Any nematode parasite that can be assigned to the species Trichinella spiralis. Trichinella spiralis Any nematode parasite that is not assigned to the species level but can be assigned to the Trichinella genus level. Trichinella Any fungal organism that is not assigned to the species level but can be assigned to the Trichoderma genus level. Trichoderma Any unicellular, eukaryotic organism that can be assigned to the species Trichomonas vaginalis. Trichomonas vaginalis Any unicellular, eukaryotic organism that is not assigned to the species level but can be assigned to the Trichomonas genus level. Trichomonas Candida ciferrii Stephanoascus ciferrii Any fungal organism that can be assigned to the species Trichomonascus ciferrii. Trichomonascus ciferrii Any fungal organism that can be assigned to the species Trichophyton equinum. Trichophyton equinum Microsporum mentagrophytes Any fungal organism that can be assigned to the species Trichophyton mentagrophytes. Trichophyton mentagrophytes Epidermophyton rubrum Trichophyton fischeri Trichophyton kanei Trichophyton megninii Trichophyton raubitschekii Any fungal organism that can be assigned to the species Trichophyton rubrum. Trichophyton rubrum Any fungal organism that can be assigned to the species Trichophyton schoenleinii. Trichophyton schoenleinii Any fungal organism that can be assigned to the species Trichophyton soudanense. Trichophyton soudanense Any fungal organism that can be assigned to the species Trichophyton tonsurans. Trichophyton tonsurans Any fungal organism that can be assigned to the species Trichophyton verrucosum. Trichophyton verrucosum Any fungal organism that can be assigned to the species Trichophyton violaceum. Trichophyton violaceum Any fungal organism that can be assigned to the species Trichophyton yaoundei. Trichophyton yaoundei Any fungal organism that can be assigned to the species Trichosporon asahii. Trichosporon asahii Any fungal organism that can be assigned to the species Trichosporon beigelii. Trichosporon beigelii Any fungal organism that can be assigned to the species Trichosporon mucoides. Trichosporon mucoides Any fungal organism that is not assigned to the species level but can be assigned to the Trichosporon genus level. Trichosporon Any nematode parasite that can be assigned to the species Trichostrongylus axei. Trichostrongylus axei Any nematode parasite that can be assigned to the species Trichostrongylus colubriformis. Trichostrongylus colubriformis Any nematode parasite that can be assigned to the species Trichostrongylus orientalis. Trichostrongylus orientalis Any nematode parasite that can be assigned to the species Trichostrongylus probolurus. Trichostrongylus probolurus Any nematode parasite that can be assigned to the species Trichostrongylus vitrinus. Trichostrongylus vitrinus Any nematode parasite that is not assigned to the species level but can be assigned to the Trichostrongylus genus level. Trichostrongylus Human Whipworm Any nematode parasite that can be assigned to the species Trichuris trichiura. Trichuris trichiura Any nematode parasite that is not assigned to the species level but can be assigned to the Trichuris genus level. Trichuris Any fungal organism that is not assigned to the species level but can be assigned to the Tritirachium genus level. Tritirachium Any bacterial organism that can be assigned to the species Tropheryma whipplei. Tropheryma whipplei Any bacteria that is not assigned to the species level but can be assigned to the Tropheryma genus level. Tropheryma Actinomyces pyogenes Arcanobacterium pyogenes Corynebacterium pyogenes Any bacterial organism that can be assigned to the species Trueperella pyogenes. Arcanobacterium pyogenes Any unicellular, eukaryotic organism that can be assigned to the species Trypanosoma brucei subspecies gambiense. Trypanosoma brucei gambiense Any unicellular, eukaryotic organism that can be assigned to the species Trypanosoma brucei subspecies rhodesiense. Trypanosoma brucei rhodesiense Any unicellular, eukaryotic organism that can be assigned to the species Trypanosoma cruzi. Trypanosoma cruzi Gordona aurantiaca Any bacterial organism that can be assigned to the species Tsukamurella paurometabolum. Tsukamurella paurometabolum Any bacterial organism that can be assigned to the species Tsukamurella pulmonis. Tsukamurella pulmonis Any bacteria that is not assigned to the species level but can be assigned to the Tsukamurella genus level. Tsukamurella Rhodococcus aurantiazus Any bacterial organism that can be assigned to the species Turicella otitidis. Turicella otitidis Any bacteria that is not assigned to the species level but can be assigned to the Turicella genus level. Turicella Any fungal organism that is not assigned to the species level but can be assigned to the Ulocladium genus level. Ulocladium Ureaplasma urealyticum biovar 1 Any bacterial organism that can be assigned to the species Ureaplasma parvum. Ureaplasma parvum T-mycoplasma Any bacterial organism that can be assigned to the species Ureaplasma urealyticum. Ureaplasma urealyticum Any bacteria that is not assigned to the species level but can be assigned to the Ureaplasma genus level. Ureaplasma Bacillus massiliensis Lysinibacillus massiliensis Any bacterial organism that can be assigned to the species Ureibacillus massiliensis. Ureibacillus massiliensis Any fungal organism that is not assigned to the species level but can be assigned to the Ustilago genus level. Ustilago Any viral organism that can be assigned to below the species level Vaccinia virus Western reserve. Vaccinia Virus Western Reserve VV Any viral organism that can be assigned to the species Vaccinia virus. Vaccinia Virus Any bacteria that is not assigned to the species level but can be assigned to the Vagococcus genus level. Vagococcus VSE Any bacterial organism that can be assigned to the genus Enterococcus and is susceptible to the antibiotic vancomycin. Vancomycin Susceptible Enterococcus Any bacterial organism that can be assigned to the species Varibaculum cambriense. Varibaculum cambriense Any bacteria that is not assigned to the species level but can be assigned to the Varibaculum genus level. Varibaculum HHV-3 Human Alphaherpesvirus 3 Human Herpesvirus 3 Varicella Zoster Virus VZV Any viral organism that can be assigned to the species varicella zoster virus. Varicella Zoster Virus Varicellavirus Any viral organism that can be assigned to the genus Varicellovirus. Varicellovirus Smallpox Virus Variola Virus VAR Any viral organism that can be assigned to the species Variola virus. Variola Virus Veillonella parvula subsp. atypica Any bacterial organism that can be assigned to the species Veillonella atypica. Veillonella atypica Any bacterial organism that can be assigned to the species Veillonella dispar. Veillonella dispar Any bacterial organism that can be assigned to the species Veillonella parvula. Veillonella parvula Any bacteria that is not assigned to the species level but can be assigned to the Veillonella genus level. Veillonella Verotoxin-producing E. coli VETC Any bacterial organism that can be assigned to the species Escherichia coli and produces verotoxin. Verotoxin-producing Escherichia coli Any fungal organism that is not assigned to the species level but can be assigned to the Verticillium genus level. Verticillium Any bacterial organism that can be assigned to the species Vibrio alginolyticus. Vibrio alginolyticus Vibrio comma Any bacterial organism that can be assigned to the species Vibrio cholerae. Vibrio cholerae Any bacterial organism that can be assigned to the species Vibrio fluvialis. Vibrio fluvialis Any bacterial organism that can be assigned to the species Vibrio furnissii. Vibrio furnissii CDC Enteric Group 16 Any bacterial organism that can be assigned to the species Vibrio metschnikovii. Vibrio metschnikovii Any bacterial organism that can be assigned to the species Vibrio mimicus. Vibrio mimicus Any bacterial organism that can be assigned to the species Vibrio parahaemolyticus. Vibrio parahaemolyticus Beneckea vulnifica Any bacterial organism that can be assigned to the species Vibrio vulnificus. Vibrio vulnificus Any bacteria that is not assigned to the species level but can be assigned to the Vibrio genus level. Vibrio Any unicellular, eukaryotic organism that is not assigned to the species level but can be assigned to the Vorticella genus level. Vorticella Any bacterial organism that can be assigned to the species Wautersiella falsenii. Wautersiella falsenii Any bacterial organism that can be assigned to the species Weeksella virosa. Weeksella virosa Any bacteria that is not assigned to the species level but can be assigned to the Weeksella genus level. Weeksella Weissella kimchii Any bacterial organism that can be assigned to the species Weissella cibaria. Weissella cibaria WNV Any viral organism that can be assigned to the species West Nile virus. West Nile Virus Candida pelliculosa Hansenula anomala Pichia anomala Any fungal organism that can be assigned to the species Wickerhamomyces anomalus. Wickerhamomyces anomalus Any bacterial organism that can be assigned to the species Wolinella succinogenes. Wolinella succinogenes Any bacteria that is not assigned to the species level but can be assigned to the Wolinella genus level. Wolinella Filaria bancrofti Any nematode parasite that can be assigned to the species Wuchereria bancrofti. Wuchereria bancrofti Any nematode parasite that is not assigned to the species level but can be assigned to the Wuchereria genus level. Wuchereria Any bacterial organism that is not assigned to the species level but can be assigned to the Xanthomonas genus level. Xanthomonas Candida lipolytica Mycotorula lipolytica Any fungal organism that can be assigned to the species Yarrowia lipolytica. Yarrowia lipolytica Any of various single-celled ascomycetes, basidiomycetes and imperfect fungi with little or no mycelium development that asexually reproduce by budding. They ferment sugars to produce alcohol and carbon dioxide. Yeast Flavivirus febricis YFV Any viral organism that can be assigned to the species Yellow fever virus. Yellow Fever Virus Any bacterial organism that can be assigned to the species Yersinia aldovae. Yersinia aldovae Yersinia enterocolitica Biogroup 3B Any bacterial organism that can be assigned to the species Yersinia bercovieri. Yersinia bercovieri Pasteurella enterocolitica Any bacterial organism that can be assigned to the species Yersinia enterocolitica. Yersinia enterocolitica Any bacterial organism that can be assigned to the species Yersinia frederiksenii. Yersinia frederiksenii Any bacterial organism that can be assigned to the species Yersinia intermedia. Yersinia intermedia Any bacterial organism that can be assigned to the species Yersinia kristensenii. Yersinia kristensenii Yersinia enterocolitica Biogroup 3A Any bacterial organism that can be assigned to the species Yersinia mollaretii. Yersinia mollaretii Pasteurella pestis Any bacterial organism that can be assigned to the species Yersinia pestis. Yersinia pestis Pasteurella pseudotuberculosis Any bacterial organism that can be assigned to the species Yersinia pseudotuberculosis. Yersinia pseudotuberculosis Any bacterial organism that can be assigned to the species Yersinia rohdei. Yersinia rohdei Any bacterial organism that can be assigned to the species Yersinia ruckeri. Yersinia ruckeri Any bacteria that is not assigned to the species level but can be assigned to the Yersinia genus level. Yersinia CDC Enteric Group 45 Any bacterial organism that can be assigned to the species Yokenella regensburgei. Yokenella regensburgei Any bacteria that is not assigned to the species level but can be assigned to the Yokenella genus level. Yokenella Any viral organism that can be assigned to the species Zika virus. Zika Virus Any bacterial organism that can be assigned to the species Zimmermannella alba. Zimmermannella alba Any bacterial organism that can be assigned to the species Zimmermannella bifida. Zimmermannella bifida Any bacteria that is not assigned to the species level but can be assigned to the Zimmermannella genus level. Zimmermannella MICROORG Microorganism CDISC SDTM Microorganism Terminology Terminology relevant to the additional descriptions of the test being performed to produce the microscopic result. A grading system developed by the American Joint Committee on Cancer (AJCC) and assigned based on the degree of cellular differentiation within a tumor sample. AJCC Tumor Grade A score developed by Allred et al. (1998) and assigned based on the percent positivity of cells for a particular analyte (Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998 Feb;11(2):155-68). Allred Proportion Positive Score A score developed by Allred et al. (1998) and assigned based on the average staining intensity of cells for a particular analyte. (Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998 Feb;11(2):155-68) Allred Average Staining Intensity Score The interpretation of the findings of the Allred Total Score, the histopathological evaluation of staining in tissue based on the Allred scoring system. Scores of 0-2 are considered negative expression and scores of 3-8 are considered positive expression. (Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998 Feb;11(2):155-68). Allred Total Score Interpretation The total score within the Allred scoring system developed by Allred et al. (1998) and based on the sum of the proportion positive score and the staining intensity score. (Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998 Feb;11(2):155-68) Allred Total Score Area The extent of a 2-dimensional surface enclosed within a boundary. (NCI) Area Average Shortest Distances to Invasive Margin-Whole Tumor Region Boundary A measurement of the average shortest distances between the cells of interest to the boundary between the invasive margin and whole tumor region. Average Shortest Distances to Invasive Margin-Whole Tumor Region Boundary Measurement A score originally developed by Solez et al. (1993) and assigned based on the histologic evaluation of kidney allograft biopsies according to the Banff Working Classification of Renal Allograft Pathology. Banff Renal Quantitative Criteria Score Batts-Ludwig Fibrosis Score The histopathological evaluation of the liver based on the Batts-Ludwig scoring system. Batts-Ludwig Fibrosis Score A score based on the Bauermeister scale, a 6-point grading system used to rate the extent of myelofibrosis, based on the amount of reticulin and collagen fibers present in the bone marrow. (Bauermeister DE. Quantitation of bone marrow reticulin-a normal range. Am J Clin Pathol. 1971 Jul;56(1):24-31.) Bauermeister Score Breslow Thickness The measurement in millimeters of the vertical thickness of primary cutaneous melanoma. Breslow thickness is measured from the granular layer of the epidermis, or the ulcer base (if ulcerated), to the deepest tumor cells. Breslow Thickness College of American Pathology Tumor Regression Grade A grading system developed by the College of American Pathology to assess a decrease in tumor size or extent in the body. (College of American Pathology) College of American Pathology Tumor Regression Grade Cells Total Cells A measurement of the total nucleated cells in a biological specimen. Cell Count Cell Density A measurement of the number of cells contained in a unit of volume or area. Cell Density A microscopic measurement of the volumetric or area ratios of components (e.g. blood vessel-, macrophage-, or lymphatic vessel density) of tissues or organs. (Chalkley HW. Method for the quantitative morphological analysis of tissues. J Natl Cancer Inst; 4: 47-52) Chalkley Score CPS A relative measurement (percentage) of the number of positive staining cells to the total number of viable tumor cells. Combined Positive Score ELF The histopathological evaluation of the liver based on the enhanced liver fibrosis scoring system. Enhanced Liver Fibrosis Score A morphologic classification system for prostate carcinoma with neuroendocrine differentiation by Epstein et al (2014). (Epstein JI, Amin MB, Beltran H, Lotan TL, Mosquera JM, Reuter VE, Robinson BD, Troncoso P, Rubin MA. Proposed morphologic classification of prostate cancer with neuroendocrine differentiation. Am J Surg Pathol. 2014 Jun;38(6):756-67.) Epstein Prostate Neuroendocrine Carcinoma Classification 2014 A score based on the European Consensus scale, a 4-point grading system for the qualitative and quantitative evaluation of bone marrow fibrosis. (Thiele J, Kvasnicka HM, Facchetti F, Franco V, van der Walt J, Orazi A. European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica. 2005 Aug;90(8):1128-32.) European Consensus Score For Bone Marrow Fibrosis A grading system developed by Evans et al (1992) to assess a decrease in tumor size or extent in the body. (Evans DB, Rich TA, Byrd DR, Cleary KR, Connelly JH, Levin B, et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg. (1992) 127:1335-9.) Evans et al Tumor Regression Grade (1992) French-American-British Classification 1985 A classification for grading and staging of acute leukemias published by the French-American-British (FAB) co-operative group in 1985. (Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med. 1985;103(4):620-625.) FAB Classification 1985 A tumor histopathologic grading system developed by Bhatla et al (2018) for uterine and cervical cancers. (Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri. Int J Gynaecol Obstet 2018;143(Suppl 2):22-36.) FIGO Tumor Grading System Fuhrman Tumor Grade A tumor grading system developed by Fuhrman et al (1982) that evaluates nuclear grade, based on nuclear size, irregularity and nucleolar prominence, in renal cell carcinomas. (Fuhrman SA, Lasky SA, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982 Oct;6(7):655-63.) Fuhrman Nuclear Grade Global Histologic Disease Activity Score A score originally developed by D'Haens et al. (1998) and assigned based on the histologic evaluation of acute and chronic inflammatory changes, epithelial damage, and the extent of inflammation in Crohn's disease mucosal biopsy specimens, according to the Global Histologic Disease Activity Score. (G R D'Haens, K Geboes, M Peeters, F Baert, F Penninckx, P Rutgeerts. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology. 1998 Feb;114(2):262-7). Global Histologic Disease Activity Score The most prevalent Gleason pattern in a prostate biopsy or prostatectomy specimen. (Gleason, D. F. (1977). The Veteran's Administration Cooperative Urologic Research Group: histologic grading and clinical staging of prostatic carcinoma. In Tannenbaum, M. Urologic Pathology: The Prostate. Philadelphia: Lea and Febiger. pp. 171-198.) Primary Gleason Pattern The second most prevalent Gleason pattern in a prostate biopsy or prostatectomy specimen. (Gleason, D. F. (1977). The Veteran's Administration Cooperative Urologic Research Group: histologic grading and clinical staging of prostatic carcinoma. In Tannenbaum, M. Urologic Pathology: The Prostate. Philadelphia: Lea and Febiger. pp. 171-198.) Secondary Gleason Pattern The sum of the primary and secondary Gleason scores. If three patterns are identified, it is the sum of the primary pattern score and the score of the least well-differentiated pattern. (Gleason, D. F. (1977). The Veteran's Administration Cooperative Urologic Research Group: histologic grading and clinical staging of prostatic carcinoma. In Tannenbaum, M. Urologic Pathology: The Prostate. Philadelphia: Lea and Febiger. pp. 171-198.) Total Gleason Score for Prostate Cancer A measurement of the amount or proportion of cells that have a staining intensity of 0, based on the H Score scoring system, in a biological specimen. (McCarty KS Jr, Miller LS, Cox EB, et al. Estrogen receptor analyses: correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med. 1985;109(8):716-721). H Score Staining Intensity 0 A measurement of the amount or proportion of cells that have a staining intensity of 1+, based on the H Score scoring system, in a biological specimen. (McCarty KS Jr, Miller LS, Cox EB, et al. Estrogen receptor analyses: correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med. 1985;109(8):716-721). H Score Staining Intensity 1+ A measurement of the amount or proportion of cells that have a staining intensity of 2+, based on the H Score scoring system, in a biological specimen. (McCarty KS Jr, Miller LS, Cox EB, et al. Estrogen receptor analyses: correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med. 1985;109(8):716-721). H Score Staining Intensity 2+ A measurement of the amount or proportion of cells that have a staining intensity of 3+, based on the H Score scoring system, in a biological specimen. (McCarty KS Jr, Miller LS, Cox EB, et al. Estrogen receptor analyses: correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med. 1985;109(8):716-721). H Score Staining Intensity 3+ The histopathological evaluation of staining in tissue based on the H Score scoring system (McCarty KS Jr, Miller LS, Cox EB, et al. Estrogen receptor analyses: correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med. 1985;109(8):716-721). H Score Total Score A grading system developed by Hartman et al (2012) to assess a decrease in tumor size or extent in the body. (Hartman DJ, Krasinskas AM. Assessing treatment effect in pancreatic cancer. Arch Pathol Lab Med. (2012) 136:100-9.) Hartman et al Tumor Regression Grade (2012) A classification for grading and staging of neuroendocrine neoplasms published by the World Health Organization (WHO) in 2018. (Rindi, G., Klimstra, D.S., Abedi-Ardekani, B. et al. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol 31, 1770-1786 (2018).) IARC and WHO Classification of Tumors of Neuroendocrine Neoplasms 2018 A grading system developed by Dworak et al (1997) to assess a decrease in tumor size or extent in the body. (Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. (1997) 12:19-23.) iDworak et al Tumor Regression Grade (1997) Ishak Fibrosis Score The histopathological evaluation of the liver based on the Ishak scoring system. Ishak Score Epstein ISUP Grade Group A grading system for prostatic adenocarcinoma based on cellular differentiation patterns and Gleason primary and secondary scores (Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA; Grading Committee. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. Am J Surg Pathol. 2016 Feb;40(2):244-52.) International Society of Urological Pathology Gleason Grade Group A classification system for rectal cancer prognosis based on four histomorphologic parameters. (JR Jass, SB Love, JM Northover. A new prognostic classification of rectal cancer. Lancet 1987 Jun 6;1(8545):1303-6.) JASS Rectal Cancer Prognostic Classification 1987 Knodell Fibrosis Score The histopathological evaluation of the liver based on the Knodell scoring system. Knodell Fibrosis Score The Two Histological Main Types Of Gastric Carcinoma: Diffuse And So-Called Intestinal-Type Carcinoma. An Attempt At A Histo-Clinical Classification. (LAUREN P. THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand. 1965;64:31-49.) Lauren Classification A grading system developed by Chatterjee et al (2012) to assess a decrease in tumor size or extent in the body. (Chatterjee D, Katz MH, Rashid A, Wolff RA, Wang H, Lee JE, et al. Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome. Cancer. (2012) 118:3182-90.) MD Anderson Tumor Regression Grade (2012) The mean of the degree or magnitude of staining within a biological specimen. Mean Staining Intensity Metavir Fibrosis Score The histopathological evaluation of the liver based on the Meta-analysis of Histological Data in Viral Hepatitis (Metavir) scoring system. METAVIR Fibrosis Score The histopathological evaluation of MET (Hepatocyte Growth Factor Receptor) staining in tissue based on the METMAB scoring system (Koeppen H, Yu W, Zha J, et al. Biomarker Analyses from a Placebo-Controlled Phase II Study Evaluating Erlotinib +/- Onartuzumab in Advanced Non-Small Cell Lung Cancer: MET Expression Levels Are Predictive of Patient Benefit. Clin Cancer Res. 2014 September 1; 20(17): 4488-4498.) METMAB Score NAS Non-Alcoholic Fatty Liver Disease Activity Score The histopathological evaluation of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) based on the NAFLD activity scoring system (NAS). (Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ; Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005 Jun;41(6):1313-21.) Non-Alcoholic Fatty Liver Disease Activity Score Elston-Ellis modification of Scarff-Bloom-Richardson Grading System A histologic grading system developed by Elston and Ellis as a modification of the Scarff-Bloom-Richardson grading system, based on tubule formation, nuclear pleomorphism, and mitotic counts of invasive adenocarcinomas. (CW Ellston, O Ellis. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991 Nov;19(5):403-10.) Nottingham Grade Count Num Number Count An absolute count of the number of entities. Count Percent Negative Marker Area A measurement of the proportion of area that is negative for a given analyte, characteristic, or feature. Percent Negative Area Percent Positive Marker Area A measurement of the proportion of area that is positive for a given analyte, characteristic, or feature. Percent Positive Area A measurement of the proportion of cells that are positive for a given analyte. Percent of Positive Cells A measurement of the total number of cells that stain positively in a biological specimen. Positive Cell Count The extent of a 2-dimensional surface that contains cells staining positively for a given analyte. Positive Cells Area Cell Proliferation Index An assessment of the amount or extent of proliferating cells in a biological specimen. Proliferative Index An assessment of the status of a biological specimen with regards to a given receptor. Receptor Overall Status Robarts Histopathology Index Score A score developed by Mosli et al. (2017) and assigned based on the histologic evaluation of disease activity in ulcerative colitis. (Mahmoud H Mosli, Brian G Feagan, Guangyong Zou, et al. Development and validation of a histological index for UC. Gut. 2017 Jan;66(1):50-58.) Robarts Histopathology Index Score Scheuer Fibrosis Score The histopathological evaluation of the liver based on the Scheuer scoring system. Scheuer Fibrosis Score A measurement of the amount or proportion of tissue or cells that have a staining intensity of 0. Staining Intensity 0 A measurement of the amount or proportion of tissue or cells that have a staining intensity of 1+. Staining Intensity 1+ A measurement of the amount or proportion of tissue or cells that have a staining intensity of 2+. Staining Intensity 2+ A measurement of the amount or proportion of tissue or cells that have a staining intensity of 3+. Staining Intensity 3+ The degree or magnitude of staining within a biological specimen. Staining Intensity Stain Pattern A determination of the distribution pattern of a stained entity. Staining Distribution Pattern TPS Tumor Proportional Score The percentage of viable tumor cells with partial or complete cell membrane staining. Tumor Proportion Score The tumor grade classification system used in the assessment was not stated explicitly or in detail. Unspecified Tumor Grade Classification A classification for grading and staging of tumors of endocrine organs published by the World Health Organization (WHO) in 2017. (Lloyd RV, Osamura R, Kloppel G, Rosai J. WHO Classification of Tumours of Endocrine Organs. 4th ed. Lyon: IARC Press; 2017.) WHO Classification of Tumors of Endocrine Organs 2017 A classification for grading and staging of tumors of hematopoietic and lymphoid tissue published by the World Health Organization (WHO) in 2017. (WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. WHO Classification of Tumours, Revised 4th Edition, Volume 2. Edited by Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J. 2017) WHO Classification of Tumors of Hematopoietic And Lymphoid Tissue 2017 A classification for grading and staging of tumors of the digestive system published by the World Health Organization (WHO) in 2010. (Bosman F, Carneiro F: World Health Organization Classification of Tumours, Pathology and Genetics of Tumours of the Digestive System., Lyon: IARC Press, 2010.) WHO Classification of Tumors of the Digestive System 2010 A classification for grading and staging of tumors of the digestive system published by the World Health Organization (WHO) in 2019. (Iris D Nagtegaal, Robert D Odze, David Klimstra, Valerie Paradis, Massimo Rugge, Peter Schirmacher, Kay M Washington, Fatima Carneiro, Ian A Cree, and the WHO Classification of Tumours Editorial Board. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020 Jan; 76(2): 182-188.) WHO Classification of Tumors of the Digestive System 2019 WHO/ISUP Tumor Grade A tumor grading system developed by the members of the ISUP Renal Tumor Panel (2013) that evaluates nuclear grade in renal cell carcinomas. (Delahunt B., Cheville J.C., Martignoni G., Humphrey P.A., Magi-Galluzzi C., McKenney J., Egevad L., Algaba F., Moch H., Grignon D.J., Montironi R., Srigley J.R., Members of the ISUP Renal Tumor Panel. International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol. 2013;37:1490-1504.) WHO/ISUP Fuhrman Nuclear Grade MIFTSDTL Microscopic Findings Test Details CDISC SDTM Microscopic Findings Test Detail Terminology Mini-Mental State Examination 2 Standard Version test code. MMS2-Repeat Word 1 Mini-Mental State Examination 2 Standard Version - Now repeat those words back to me: Word 1. MMSE-2 Standard Version - Repeat Word 1 MMS2-Repeat Word 2 Mini-Mental State Examination 2 Standard Version - Now repeat those words back to me: Word 2. MMSE-2 Standard Version - Repeat Word 2 MMS2-Repeat Word 3 Mini-Mental State Examination 2 Standard Version - Now repeat those words back to me: Word 3. MMSE-2 Standard Version - Repeat Word 3 MMS2-What Is the Year Mini-Mental State Examination 2 Standard Version - What is the year? MMSE-2 Standard Version - What Is the Year MMS2-What Is the Season Mini-Mental State Examination 2 Standard Version - What is the season? MMSE-2 Standard Version - What Is the Season MMS2-What Is the Month of Year Mini-Mental State Examination 2 Standard Version - What is the month of the year? MMSE-2 Standard Version - What Is the Month of Year MMS2-What Is the Day of Week Mini-Mental State Examination 2 Standard Version - What is the day of the week? MMSE-2 Standard Version - What Is the Day of Week MMS2-What Is the Date Mini-Mental State Examination 2 Standard Version - What is the date? MMSE-2 Standard Version - What Is the Date MMS2-What Is the State Mini-Mental State Examination 2 Standard Version - Where are we now? What is the state (or province)? MMSE-2 Standard Version - What Is the State MMS2-What Is the County Mini-Mental State Examination 2 Standard Version - Where are we now? What is the county (or city/town)? MMSE-2 Standard Version - What Is the County MMS2-What Is the City/Town Mini-Mental State Examination 2 Standard Version - Where are we now? What is the city/town (or part of city/neighborhood)? MMSE-2 Standard Version - What Is the City/Town MMS2-What Is the Building Mini-Mental State Examination 2 Standard Version - Where are we now? What is the building (name or type)? MMSE-2 Standard Version - What Is the Building MMS2-What Is the Floor Mini-Mental State Examination 2 Standard Version - Where are we now? What is the floor of the building (room number or address)? MMSE-2 Standard Version - What Is the Floor MMS2-Recall Word 1 Mini-Mental State Examination 2 Standard Version - What were those three words I asked you to remember: Word 1? MMSE-2 Standard Version - Recall Word 1 MMS2-Recall Word 2 Mini-Mental State Examination 2 Standard Version - What were those three words I asked you to remember: Word 2? MMSE-2 Standard Version - Recall Word 2 MMS2-Recall Word 3 Mini-Mental State Examination 2 Standard Version - What were those three words I asked you to remember: Word 3? MMSE-2 Standard Version - Recall Word 3 MMS2-What is 100 Take Away 7 Mini-Mental State Examination 2 Standard Version - What is 100 take away 7 [93]? MMSE-2 Standard Version - What is 100 Take Away 7 MMS2-Keep Subtracting 7 Step 2 Mini-Mental State Examination 2 Standard Version - Keep going [86]. MMSE-2 Standard Version - Keep Subtracting 7 Step 2 MMS2-Keep Subtracting 7 Step 3 Mini-Mental State Examination 2 Standard Version - Keep going [79]. MMSE-2 Standard Version - Keep Subtracting 7 Step 3 MMS2-Keep Subtracting 7 Step 4 Mini-Mental State Examination 2 Standard Version - Keep going [72]. MMSE-2 Standard Version - Keep Subtracting 7 Step 4 MMS2-Keep Subtracting 7 Step 5 Mini-Mental State Examination 2 Standard Version - Keep going [65]. MMSE-2 Standard Version - Keep Subtracting 7 Step 5 MMS2-Naming Object 1 Mini-Mental State Examination 2 Standard Version - What is this: Object 1? MMSE-2 Standard Version - Naming Object 1 MMS2-Naming Object 2 Mini-Mental State Examination 2 Standard Version - What is this: Object 2? MMSE-2 Standard Version - Naming Object 2 MMS2-Repeat What I Say Mini-Mental State Examination 2 Standard Version - Now I am going to ask you to repeat what I say. Ready? "It is a lovely, sunny day but too warm." Now you say that. MMSE-2 Standard Version - Repeat What I Say MMS2-Point to the Circle Mini-Mental State Examination 2 Standard Version - Look at these pictures and point to the circle. MMSE-2 Standard Version - Point to the Circle MMS2-Point to the Square Mini-Mental State Examination 2 Standard Version - Then point to the square. MMSE-2 Standard Version - Point to the Square MMS2-Point to the Triangle Mini-Mental State Examination 2 Standard Version - Then point to the triangle. MMSE-2 Standard Version - Point to the Triangle MMS2-Do What This Says to Do Mini-Mental State Examination 2 Standard Version - Please do what this says to do. MMSE-2 Standard Version - Do What This Says to Do MMS2-Write a Sentence Mini-Mental State Examination 2 Standard Version - Please write a sentence. MMSE-2 Standard Version - Write a Sentence MMS2-Copy This Design Mini-Mental State Examination 2 Standard Version - Please copy this design. MMSE-2 Standard Version - Copy This Design MMS2-BV Total Raw Score Mini-Mental State Examination 2 Standard Version - BV (Brief Version) total raw score. MMSE-2 Standard Version - BV Total Raw Score MMS2-SV Total Raw Score Mini-Mental State Examination 2 Standard Version - SV (Standard Version) total raw score. MMSE-2 Standard Version - SV Total Raw Score MMS2-Level of Consciousness Mini-Mental State Examination 2 Standard Version - Assessment of level of consciousness. MMSE-2 Standard Version - Level of Consciousness MMS2TC Mini-Mental State Examination 2 Standard Version Functional Test Test Code CDISC Functional Test MMSE-2 Standard Version Test Code Terminology Mini-Mental State Examination 2 Standard Version test name. MMS2-BV Total Raw Score Mini-Mental State Examination 2 Standard Version - BV (Brief Version) total raw score. MMSE-2 Standard Version - BV Total Raw Score MMS2-Copy This Design Mini-Mental State Examination 2 Standard Version - Please copy this design. MMSE-2 Standard Version - Copy This Design MMS2-Do What This Says to Do Mini-Mental State Examination 2 Standard Version - Please do what this says to do. MMSE-2 Standard Version - Do What This Says to Do MMS2-Keep Subtracting 7 Step 2 Mini-Mental State Examination 2 Standard Version - Keep going [86]. MMSE-2 Standard Version - Keep Subtracting 7 Step 2 MMS2-Keep Subtracting 7 Step 3 Mini-Mental State Examination 2 Standard Version - Keep going [79]. MMSE-2 Standard Version - Keep Subtracting 7 Step 3 MMS2-Keep Subtracting 7 Step 4 Mini-Mental State Examination 2 Standard Version - Keep going [72]. MMSE-2 Standard Version - Keep Subtracting 7 Step 4 MMS2-Keep Subtracting 7 Step 5 Mini-Mental State Examination 2 Standard Version - Keep going [65]. MMSE-2 Standard Version - Keep Subtracting 7 Step 5 MMS2-Level of Consciousness Mini-Mental State Examination 2 Standard Version - Assessment of level of consciousness. MMSE-2 Standard Version - Level of Consciousness MMS2-Naming Object 1 Mini-Mental State Examination 2 Standard Version - What is this: Object 1? MMSE-2 Standard Version - Naming Object 1 MMS2-Naming Object 2 Mini-Mental State Examination 2 Standard Version - What is this: Object 2? MMSE-2 Standard Version - Naming Object 2 MMS2-Point to the Circle Mini-Mental State Examination 2 Standard Version - Look at these pictures and point to the circle. MMSE-2 Standard Version - Point to the Circle MMS2-Point to the Square Mini-Mental State Examination 2 Standard Version - Then point to the square. MMSE-2 Standard Version - Point to the Square MMS2-Point to the Triangle Mini-Mental State Examination 2 Standard Version - Then point to the triangle. MMSE-2 Standard Version - Point to the Triangle MMS2-Recall Word 1 Mini-Mental State Examination 2 Standard Version - What were those three words I asked you to remember: Word 1? MMSE-2 Standard Version - Recall Word 1 MMS2-Recall Word 2 Mini-Mental State Examination 2 Standard Version - What were those three words I asked you to remember: Word 2? MMSE-2 Standard Version - Recall Word 2 MMS2-Recall Word 3 Mini-Mental State Examination 2 Standard Version - What were those three words I asked you to remember: Word 3? MMSE-2 Standard Version - Recall Word 3 MMS2-Repeat What I Say Mini-Mental State Examination 2 Standard Version - Now I am going to ask you to repeat what I say. Ready? "It is a lovely, sunny day but too warm." Now you say that. MMSE-2 Standard Version - Repeat What I Say MMS2-Repeat Word 1 Mini-Mental State Examination 2 Standard Version - Now repeat those words back to me: Word 1. MMSE-2 Standard Version - Repeat Word 1 MMS2-Repeat Word 2 Mini-Mental State Examination 2 Standard Version - Now repeat those words back to me: Word 2. MMSE-2 Standard Version - Repeat Word 2 MMS2-Repeat Word 3 Mini-Mental State Examination 2 Standard Version - Now repeat those words back to me: Word 3. MMSE-2 Standard Version - Repeat Word 3 MMS2-SV Total Raw Score Mini-Mental State Examination 2 Standard Version - SV (Standard Version) total raw score. MMSE-2 Standard Version - SV Total Raw Score MMS2-What is 100 Take Away 7 Mini-Mental State Examination 2 Standard Version - What is 100 take away 7 [93]? MMSE-2 Standard Version - What is 100 Take Away 7 MMS2-What Is the Building Mini-Mental State Examination 2 Standard Version - Where are we now? What is the building (name or type)? MMSE-2 Standard Version - What Is the Building MMS2-What Is the City/Town Mini-Mental State Examination 2 Standard Version - Where are we now? What is the city/town (or part of city/neighborhood)? MMSE-2 Standard Version - What Is the City/Town MMS2-What Is the County Mini-Mental State Examination 2 Standard Version - Where are we now? What is the county (or city/town)? MMSE-2 Standard Version - What Is the County MMS2-What Is the Date Mini-Mental State Examination 2 Standard Version - What is the date? MMSE-2 Standard Version - What Is the Date MMS2-What Is the Day of Week Mini-Mental State Examination 2 Standard Version - What is the day of the week? MMSE-2 Standard Version - What Is the Day of Week MMS2-What Is the Floor Mini-Mental State Examination 2 Standard Version - Where are we now? What is the floor of the building (room number or address)? MMSE-2 Standard Version - What Is the Floor MMS2-What Is the Month of Year Mini-Mental State Examination 2 Standard Version - What is the month of the year? MMSE-2 Standard Version - What Is the Month of Year MMS2-What Is the Season Mini-Mental State Examination 2 Standard Version - What is the season? MMSE-2 Standard Version - What Is the Season MMS2-What Is the State Mini-Mental State Examination 2 Standard Version - Where are we now? What is the state (or province)? MMSE-2 Standard Version - What Is the State MMS2-What Is the Year Mini-Mental State Examination 2 Standard Version - What is the year? MMSE-2 Standard Version - What Is the Year MMS2-Write a Sentence Mini-Mental State Examination 2 Standard Version - Please write a sentence. MMSE-2 Standard Version - Write a Sentence MMS2TN Mini-Mental State Examination 2 Standard Version Functional Test Test Name CDISC Functional Test MMSE-2 Standard Version Test Name Terminology Mini-Mental State Examination test code. MMS1-What Is the Year Mini-Mental State Examination - What is the year? MMSE - What Is the Year MMS1-What Is the Season Mini-Mental State Examination - What is the season? MMSE - What Is the Season MMS1-What Is the Month of Year Mini-Mental State Examination - What is the month of the year? MMSE - What Is the Month of Year MMS1-What Is the Day of Week Mini-Mental State Examination - What is the day of the week? MMSE - What Is the Day of Week MMS1-What Is the Date Mini-Mental State Examination - What is the date? MMSE - What Is the Date MMS1-What Is the State Mini-Mental State Examination - Where are we now? What is the state (province)? MMSE - What Is the State MMS1-What Is the County Mini-Mental State Examination - Where are we now? What is the county (or city/town)? MMSE - What Is the County MMS1-What Is the City/Town Mini-Mental State Examination - Where are we now? What is the city/town (or part of city/neighborhood)? MMSE - What Is the City or Town MMS1-What Is the Building Mini-Mental State Examination - Where are we now? What is the building (name or type)? MMSE - What Is the Building MMS1-What Is the Floor Mini-Mental State Examination - Where are we now? What is the floor of the building (room number or address)? MMSE - What Is the Floor MMS1-Repeat Word 1 Mini-Mental State Examination - Now repeat those words back to me: Word 1. MMSE - Repeat Word 1 MMS1-Repeat Word 2 Mini-Mental State Examination - Now repeat those words back to me: Word 2. MMSE - Repeat Word 2 MMS1-Repeat Word 3 Mini-Mental State Examination - Now repeat those words back to me: Word 3. MMSE - Repeat Word 3 MMS1-Attention and Calculation Subtotal Mini-Mental State Examination - Attention and calculation subtotal. MMSE - Attention and Calculation Subtotal MMS1-What is 100 Take Away 7 Mini-Mental State Examination - What is 100 take away 7 [93]? MMSE - What is 100 Take Away 7 MMS1-Keep Subtracting 7 Step 2 Mini-Mental State Examination - Keep going [86]. MMSE - Keep Subtracting 7 Step 2 MMS1-Keep Subtracting 7 Step 3 Mini-Mental State Examination - Keep going [79]. MMSE - Keep Subtracting 7 Step 3 MMS1-Keep Subtracting 7 Step 4 Mini-Mental State Examination - Keep going [72]. MMSE - Keep Subtracting 7 Step 4 MMS1-Keep Subtracting 7 Step 5 Mini-Mental State Examination - Keep going [65]. MMSE - Keep Subtracting 7 Step 5 MMS1-Spell Backward Letter 1 Mini-Mental State Examination - Spell backward, letter 1. MMSE - Spell Backward Letter 1 MMS1-Spell Backward Letter 2 Mini-Mental State Examination - Spell backward, letter 2. MMSE - Spell Backward Letter 2 MMS1-Spell Backward Letter 3 Mini-Mental State Examination - Spell backward, letter 3. MMSE - Spell Backward Letter 3 MMS1-Spell Backward Letter 4 Mini-Mental State Examination - Spell backward, letter 4. MMSE - Spell Backward Letter 4 MMS1-Spell Backward Letter 5 Mini-Mental State Examination - Spell backward, letter 5. MMSE - Spell Backward Letter 5 MMS1-Recall Word 1 Mini-Mental State Examination - What were those three words I asked you to remember: Word 1? MMSE - Recall Word 1 MMS1-Recall Word 2 Mini-Mental State Examination - What were those three words I asked you to remember: Word 2? MMSE - Recall Word 2 MMS1-Recall Word 3 Mini-Mental State Examination - What were those three words I asked you to remember: Word 3? MMSE - Recall Word 3 MMS1-Naming Object 1 Mini-Mental State Examination - What is this: Object 1? MMSE - Naming Object 1 MMS1-Naming Object 2 Mini-Mental State Examination - What is this: Object 2? MMSE - Naming Object 2 MMS1-Repeat What I Say Mini-Mental State Examination - Now I am going to ask you to repeat what I say. Ready? "No ifs, ands, or buts." Now you say that. MMSE - Repeat What I Say MMS1-Take in Right Hand Mini-Mental State Examination - Listen carefully because I am going to ask you to do something. Take this paper in your right hand. MMSE - Take in Right Hand MMS1-Fold in Half Mini-Mental State Examination - Fold it in half. MMSE - Fold in Half MMS1-Put on Floor (or Table) Mini-Mental State Examination - And put it on the floor (or table). MMSE - Put on Floor or Table MMS1-Read This and Do What It Says Mini-Mental State Examination - Please read this and do what it says. MMSE - Read This and Do What It Says MMS1-Write a Sentence Mini-Mental State Examination - Please write a sentence. MMSE - Write a Sentence MMS1-Copy This Design Mini-Mental State Examination - Please copy this design. MMSE - Copy This Design MMS1-Total Score Mini-Mental State Examination - Total score. MMSE - Total Score MMS1-Level of Consciousness Mini-Mental State Examination - Assessment of level of consciousness. MMSE - Level of Consciousness MMS1TC Mini-Mental State Examination Functional Test Test Code CDISC Functional Test MMSE Test Code Terminology Mini-Mental State Examination test name. MMS1-Attention and Calculation Subtotal Mini-Mental State Examination - Attention and calculation subtotal. MMSE - Attention and Calculation Subtotal MMS1-Copy This Design Mini-Mental State Examination - Please copy this design. MMSE - Copy This Design MMS1-Fold in Half Mini-Mental State Examination - Fold it in half. MMSE - Fold in Half MMS1-Keep Subtracting 7 Step 2 Mini-Mental State Examination - Keep going [86]. MMSE - Keep Subtracting 7 Step 2 MMS1-Keep Subtracting 7 Step 3 Mini-Mental State Examination - Keep going [79]. MMSE - Keep Subtracting 7 Step 3 MMS1-Keep Subtracting 7 Step 4 Mini-Mental State Examination - Keep going [72]. MMSE - Keep Subtracting 7 Step 4 MMS1-Keep Subtracting 7 Step 5 Mini-Mental State Examination - Keep going [65]. MMSE - Keep Subtracting 7 Step 5 MMS1-Level of Consciousness Mini-Mental State Examination - Assessment of level of consciousness. MMSE - Level of Consciousness MMS1-Naming Object 1 Mini-Mental State Examination - What is this: Object 1? MMSE - Naming Object 1 MMS1-Naming Object 2 Mini-Mental State Examination - What is this: Object 2? MMSE - Naming Object 2 MMS1-Put on Floor (or Table) Mini-Mental State Examination - And put it on the floor (or table). MMSE - Put on Floor or Table MMS1-Read This and Do What It Says Mini-Mental State Examination - Please read this and do what it says. MMSE - Read This and Do What It Says MMS1-Recall Word 1 Mini-Mental State Examination - What were those three words I asked you to remember: Word 1? MMSE - Recall Word 1 MMS1-Recall Word 2 Mini-Mental State Examination - What were those three words I asked you to remember: Word 2? MMSE - Recall Word 2 MMS1-Recall Word 3 Mini-Mental State Examination - What were those three words I asked you to remember: Word 3? MMSE - Recall Word 3 MMS1-Repeat What I Say Mini-Mental State Examination - Now I am going to ask you to repeat what I say. Ready? "No ifs, ands, or buts." Now you say that. MMSE - Repeat What I Say MMS1-Repeat Word 1 Mini-Mental State Examination - Now repeat those words back to me: Word 1. MMSE - Repeat Word 1 MMS1-Repeat Word 2 Mini-Mental State Examination - Now repeat those words back to me: Word 2. MMSE - Repeat Word 2 MMS1-Repeat Word 3 Mini-Mental State Examination - Now repeat those words back to me: Word 3. MMSE - Repeat Word 3 MMS1-Spell Backward Letter 1 Mini-Mental State Examination - Spell backward, letter 1. MMSE - Spell Backward Letter 1 MMS1-Spell Backward Letter 2 Mini-Mental State Examination - Spell backward, letter 2. MMSE - Spell Backward Letter 2 MMS1-Spell Backward Letter 3 Mini-Mental State Examination - Spell backward, letter 3. MMSE - Spell Backward Letter 3 MMS1-Spell Backward Letter 4 Mini-Mental State Examination - Spell backward, letter 4. MMSE - Spell Backward Letter 4 MMS1-Spell Backward Letter 5 Mini-Mental State Examination - Spell backward, letter 5. MMSE - Spell Backward Letter 5 MMS1-Take in Right Hand Mini-Mental State Examination - Listen carefully because I am going to ask you to do something. Take this paper in your right hand. MMSE - Take in Right Hand MMS1-Total Score Mini-Mental State Examination - Total score. MMSE - Total Score MMS1-What is 100 Take Away 7 Mini-Mental State Examination - What is 100 take away 7 [93]? MMSE - What is 100 Take Away 7 MMS1-What Is the Building Mini-Mental State Examination - Where are we now? What is the building (name or type)? MMSE - What Is the Building MMS1-What Is the City/Town Mini-Mental State Examination - Where are we now? What is the city/town (or part of city/neighborhood)? MMSE - What Is the City or Town MMS1-What Is the County Mini-Mental State Examination - Where are we now? What is the county (or city/town)? MMSE - What Is the County MMS1-What Is the Date Mini-Mental State Examination - What is the date? MMSE - What Is the Date MMS1-What Is the Day of Week Mini-Mental State Examination - What is the day of the week? MMSE - What Is the Day of Week MMS1-What Is the Floor Mini-Mental State Examination - Where are we now? What is the floor of the building (room number or address)? MMSE - What Is the Floor MMS1-What Is the Month of Year Mini-Mental State Examination - What is the month of the year? MMSE - What Is the Month of Year MMS1-What Is the Season Mini-Mental State Examination - What is the season? MMSE - What Is the Season MMS1-What Is the State Mini-Mental State Examination - Where are we now? What is the state (province)? MMSE - What Is the State MMS1-What Is the Year Mini-Mental State Examination - What is the year? MMSE - What Is the Year MMS1-Write a Sentence Mini-Mental State Examination - Please write a sentence. MMSE - Write a Sentence MMS1TN Mini-Mental State Examination Functional Test Test Name CDISC Functional Test MMSE Test Name Terminology Minnesota Tobacco Withdrawal Scale-Revised original result for MTWSR101 through MTWSR115 test and test code. MTWSR101 through MTWSR115-Mild Minnesota Tobacco Withdrawal Scale-Revised original result for MTWSR101 through MTWSR115-Mild. Minnesota Tobacco Withdrawal Scale-Revised MTWSR101 Through MTWSR115 Original Result - Mild MTWSR101 through MTWSR115-Moderate Minnesota Tobacco Withdrawal Scale-Revised original result for MTWSR101 through MTWSR115-Moderate. Minnesota Tobacco Withdrawal Scale-Revised MTWSR101 Through MTWSR115 Original Result - Moderate MTWSR101 through MTWSR115-None Minnesota Tobacco Withdrawal Scale-Revised original result for MTWSR101 through MTWSR115-None. Minnesota Tobacco Withdrawal Scale-Revised MTWSR101 Through MTWSR115 Original Result - None MTWSR101 through MTWSR115-Severe Minnesota Tobacco Withdrawal Scale-Revised original result for MTWSR101 through MTWSR115-Severe. Minnesota Tobacco Withdrawal Scale-Revised MTWSR101 Through MTWSR115 Original Result - Severe MTWSR101 through MTWSR115-Slight Minnesota Tobacco Withdrawal Scale-Revised original result for MTWSR101 through MTWSR115-Slight. Minnesota Tobacco Withdrawal Scale-Revised MTWSR101 Through MTWSR115 Original Result - Slight MTWSR101T15OR Minnesota Tobacco Withdrawal Scale-Revised Questionnaire ORRES for MTWSR101 Through MTWSR115 TN/TC CDISC Questionnaire Minnesota Tobacco Withdrawal Scale-Revised MTWSR101 Through MTWSR115 Original Response Terminology Minnesota Tobacco Withdrawal Scale-Revised standardized character result for MTWSR101 through MTWSR115 test and test code. MTWSR101 through MTWSR115-0 Minnesota Tobacco Withdrawal Scale-Revised standardized character result for MTWSR101 through MTWSR115-None. Minnesota Tobacco Withdrawal Scale-Revised MTWSR101 Through MTWSR115 Standardized Character Result 0 MTWSR101 through MTWSR115-1 Minnesota Tobacco Withdrawal Scale-Revised standardized character result for MTWSR101 through MTWSR115-Slight. Minnesota Tobacco Withdrawal Scale-Revised MTWSR101 Through MTWSR115 Standardized Character Result 1 MTWSR101 through MTWSR115-2 Minnesota Tobacco Withdrawal Scale-Revised standardized character result for MTWSR101 through MTWSR115-Mild. Minnesota Tobacco Withdrawal Scale-Revised MTWSR101 Through MTWSR115 Standardized Character Result 2 MTWSR101 through MTWSR115-3 Minnesota Tobacco Withdrawal Scale-Revised standardized character result for MTWSR101 through MTWSR115-Moderate. Minnesota Tobacco Withdrawal Scale-Revised MTWSR101 Through MTWSR115 Standardized Character Result 3 MTWSR101 through MTWSR115-4 Minnesota Tobacco Withdrawal Scale-Revised standardized character result for MTWSR101 through MTWSR115-Severe. Minnesota Tobacco Withdrawal Scale-Revised MTWSR101 Through MTWSR115 Standardized Character Result 4 MTWSR101T15STR Minnesota Tobacco Withdrawal Scale-Revised Questionnaire STRESC for MTWSR101 Through MTWSR115 TN/TC CDISC Questionnaire Minnesota Tobacco Withdrawal Scale-Revised MTWSR101 Through MTWSR115 Standardized Character Response Terminology Minnesota Tobacco Withdrawal Scale-Revised test code. MTWSR1-Angry, Irritable, Frustrated Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: angry, irritable, frustrated. MTWS-Revised Version - Angry, Irritable, Frustrated MTWSR1-Anxious, Nervous Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: anxious, nervous. MTWS-Revised Version - Anxious, Nervous MTWSR1-Depressed Mood, Sad Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: depressed mood, sad. MTWS-Revised Version - Depressed Mood, Sad MTWSR1-Difficulty Concentrating Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: difficulty concentrating. MTWS-Revised Version - Difficulty Concentrating MTWSR1-Inc Appetite, Hungry, Weight Gain Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: increased appetite, hungry, weight gain. MTWS-Revised Version - Increased Appetite, Hungry, Weight Gain MTWSR1-Sleep Problems/Awakening at Night Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: insomnia, sleep problems, awakening at night. MTWS-Revised Version - Sleep Problems, Awakening at Night MTWSR1-Restless Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: restless. MTWS-Revised Version - Restless MTWSR1-Impatient Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: impatient behavior. MTWS-Revised Version - Impatient MTWSR1-Craving to Smoke Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: craving to smoke. MTWS-Revised Version - Craving to Smoke MTWSR1-Constipation Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: constipation. MTWS-Revised Version - Constipation MTWSR1-Dizziness Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: dizziness. MTWS-Revised Version - Dizziness MTWSR1-Coughing Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: coughing. MTWS-Revised Version - Coughing MTWSR1-Dreaming or Nightmares Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: dreams or nightmares. MTWS-Revised Version - Dreaming or Nightmares MTWSR1-Nausea Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: nausea. MTWS-Revised Version - Nausea MTWSR1-Sore Throat Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: sore throat. MTWS-Revised Version - Sore Throat MTWSR1-Total Withdrawal Discomfort Score Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Total withdrawal discomfort score. MTWS-Revised Version - Total Withdrawal Discomfort Score MTWSR1TC Minnesota Tobacco Withdrawal Scale-Revised Questionnaire Test Code CDISC Questionnaire Minnesota Tobacco Withdrawal Scale-Revised Test Code Terminology Minnesota Tobacco Withdrawal Scale-Revised test name. MTWSR1-Angry, Irritable, Frustrated Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: angry, irritable, frustrated. MTWS-Revised Version - Angry, Irritable, Frustrated MTWSR1-Anxious, Nervous Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: anxious, nervous. MTWS-Revised Version - Anxious, Nervous MTWSR1-Constipation Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: constipation. MTWS-Revised Version - Constipation MTWSR1-Coughing Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: coughing. MTWS-Revised Version - Coughing MTWSR1-Craving to Smoke Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: craving to smoke. MTWS-Revised Version - Craving to Smoke MTWSR1-Depressed Mood, Sad Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: depressed mood, sad. MTWS-Revised Version - Depressed Mood, Sad MTWSR1-Difficulty Concentrating Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: difficulty concentrating. MTWS-Revised Version - Difficulty Concentrating MTWSR1-Dizziness Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: dizziness. MTWS-Revised Version - Dizziness MTWSR1-Dreaming or Nightmares Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: dreams or nightmares. MTWS-Revised Version - Dreaming or Nightmares MTWSR1-Impatient Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: impatient behavior. MTWS-Revised Version - Impatient MTWSR1-Inc Appetite, Hungry, Weight Gain Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: increased appetite, hungry, weight gain. MTWS-Revised Version - Increased Appetite, Hungry, Weight Gain MTWSR1-Nausea Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: nausea. MTWS-Revised Version - Nausea MTWSR1-Restless Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: restless. MTWS-Revised Version - Restless MTWSR1-Sleep Problems/Awakening at Night Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: insomnia, sleep problems, awakening at night. MTWS-Revised Version - Sleep Problems, Awakening at Night MTWSR1-Sore Throat Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Please rate yourself for items 1-15 below using the following scale of severity: sore throat. MTWS-Revised Version - Sore Throat MTWSR1-Total Withdrawal Discomfort Score Minnesota Tobacco Withdrawal Scale-Revised (MTWS-R) - Total withdrawal discomfort score. MTWS-Revised Version - Total Withdrawal Discomfort Score MTWSR1TN Minnesota Tobacco Withdrawal Scale-Revised Questionnaire Test Name CDISC Questionnaire Minnesota Tobacco Withdrawal Scale-Revised Test Name Terminology A terminology codelist relevant to the mode of delivery of a fetus or neonate. The delivery of a breech-presenting fetus, which is manually pulled through the birth canal. Breech Extraction C-Section Cesarean Delivery Surgical delivery of one or more intrauterine fetuses though an abdominal incision. Cesarean Section Extraction of a fetus through the cervix using destructive surgical techniques. Delivery by Destructive Operation Operative Vaginal Delivery Birth of the fetus through the vagina with the application of vacuum or forceps or any other instrument. Vaginal Assisted Delivery A vaginal birth in a woman with one or more previous cesarean births. (reVITALize) Vaginal Birth after Cesarean Delivery Birth of the fetus through the vagina. Vaginal Delivery MODDLV Mode of Delivery CDISC SDTM Mode of Delivery Terminology The terminology relevant to the mechanism by which a disease is transmitted. The infusion of whole blood or a blood component into the bloodstream. Blood Transfusion The nursing of an infant at the female's breast. Breast Feeding The transmission of a disease from one individual to another within the same species. Horizontal Transmission The use of injection needles that have been previously used. Injection Needle Reuse The exposure to agents that occurs as a result of in utero development. Intrauterine Exposure The process by which a mammal gives birth. Labor and Delivery Process The exposure to agents that occurs as a result of one's occupation. Occupational Exposure Heterosexual Contact Sexual contact with a member of the opposite sex. Heterosexual Contact The exposure to agents that occurs transplacentally or during the labor and delivery process. Perinatal Exposure Homosexual Contact Sexual contact with a member of the same sex. Homosexual Contact Sexual interaction between individuals. Sexual Contact U UNK Unknown Not known, not observed, not recorded, or refused. (NCI) Unknown The transmission of a disease from the mother to the fetus or newborn. Maternal Transmission MODTRN Mode of Disease Transmission CDISC SDTM Mode of Disease Transmission Terminology Terminology relevant to the means by which interaction occurs between the subject and person or entity. Electronic Mail Composing, sending, and receiving messages over electronic communication systems. E-mail In-Person An interaction that takes place in the physical presence of someone else. In Person Interactive Voice Response System A type of automated system in which individuals can access information menus containing pre-recorded or dynamically generated information with voice prompts, without the need for an agent or operator. Interactive Voice Response System A written message addressed to a person or organization. Letter A form of remote communication by audio video technology. Audio-Videoconferencing A form of remote communication by audio technology. Audioconferencing Receipt of shipped material was confirmed by signature. Shipment Confirmed by Signature Communication by way of telephone. Telephone Call A short electronic communication, usually sent and received by a mobile phone. Text Message CNTMODE Mode of Subject Contact CDISC SDTM Mode of Subject Contact Terminology Model for End Stage Liver Disease - Serum Na 2008 test code. MELD02-Score Model for End Stage Liver Disease - Serum Na 2008 - MELDNa Score. MELDNA 2008 - Score MELD02TC Model for End Stage Liver Disease - Serum Na 2008 Clinical Classification Test Code CDISC Clinical Classification Model for End Stage Liver Disease - Serum Na 2008 Test Code Terminology Model for End Stage Liver Disease - Serum Na 2008 test name. MELD02-Score Model for End Stage Liver Disease - Serum Na 2008 - MELDNa Score. MELDNA 2008 - Score MELD02TN Model for End Stage Liver Disease - Serum Na 2008 Clinical Classification Test Name CDISC Clinical Classification Model for End Stage Liver Disease - Serum Na 2008 Test Name Terminology Model for End Stage Liver Disease test code. MELD01-Score Model for End Stage Liver Disease - MELD score. MELD - Score MELD01TC Model for End Stage Liver Disease Clinical Classification Test Code CDISC Clinical Classification MELD Test Code Terminology Model for End Stage Liver Disease test name. MELD01-Score Model for End Stage Liver Disease - MELD score. MELD - Score MELD01TN Model for End Stage Liver Disease Clinical Classification Test Name CDISC Clinical Classification MELD Test Name Terminology Modified Cigarette Evaluation Questionnaire test code. MCEQ01-Was Smoking Satisfying Modified Cigarette Evaluation Questionnaire - Was smoking satisfying? MCEQ - Was Smoking Satisfying MCEQ01-Did Cigarettes Taste Good Modified Cigarette Evaluation Questionnaire - Did cigarettes taste good? MCEQ - Did Cigarettes Taste Good MCEQ01-Did You Enjoy Sensations Throat Modified Cigarette Evaluation Questionnaire - Did you enjoy the sensations in your throat and chest? MCEQ - Did You Enjoy Sensations Throat MCEQ01-Did Smoking Calm You Down Modified Cigarette Evaluation Questionnaire - Did smoking calm you down? MCEQ - Did Smoking Calm You Down MCEQ01-Did Smoking Make Feel More Awake Modified Cigarette Evaluation Questionnaire - Did smoking make you feel more awake? MCEQ - Did Smoking Make Feel More Awake MCEQ01-Did Smoking Feel Less Irritable Modified Cigarette Evaluation Questionnaire - Did smoking make you feel less irritable? MCEQ - Did Smoking Feel Less Irritable MCEQ01-Did Smoking Help You Concentrate Modified Cigarette Evaluation Questionnaire - Did smoking help you concentrate? MCEQ - Did Smoking Help You Concentrate MCEQ01-Did Smoking Reduce Your Hunger Modified Cigarette Evaluation Questionnaire - Did smoking reduce your hunger for food? MCEQ - Did Smoking Reduce Your Hunger MCEQ01-Did Smoking Make You Dizzy Modified Cigarette Evaluation Questionnaire - Did smoking make you dizzy? MCEQ - Did Smoking Make You Dizzy MCEQ01-Did Smoking Make You Nauseous Modified Cigarette Evaluation Questionnaire - Did smoking make you nauseous? MCEQ - Did Smoking Make You Nauseous MCEQ01-Did Smoking Relieve Craving Modified Cigarette Evaluation Questionnaire - Did smoking immediately relieve your craving for a cigarette? MCEQ - Did Smoking Relieve Craving MCEQ01-Did You Enjoy Smoking Modified Cigarette Evaluation Questionnaire - Did you enjoy smoking? MCEQ - Did You Enjoy Smoking MCEQ01-Smoking Satisfaction Score Modified Cigarette Evaluation Questionnaire - Smoking satisfaction subscale score. MCEQ - Smoking Satisfaction Score MCEQ01-Psychological Reward Score Modified Cigarette Evaluation Questionnaire - Psychological reward subscale score. MCEQ - Psychological Reward Score MCEQ01-Enjoy Respiratory Sensation Score Modified Cigarette Evaluation Questionnaire - Enjoyment of respiratory tract sensations subscale score. MCEQ - Enjoy Respiratory Sensation Score MCEQ01-Craving Reduction Score Modified Cigarette Evaluation Questionnaire - Craving reduction subscale score. MCEQ - Craving Reduction Score MCEQ01-Aversion Score Modified Cigarette Evaluation Questionnaire - Aversion subscale score. MCEQ - Aversion Score MCEQ01-Total Score Modified Cigarette Evaluation Questionnaire - Total score. MCEQ - Total Score MCEQ01TC Modified Cigarette Evaluation Questionnaire Test Code CDISC Questionnaire Modified Cigarette Evaluation Questionnaire Test Code Terminology Modified Cigarette Evaluation Questionnaire test name. MCEQ01-Aversion Score Modified Cigarette Evaluation Questionnaire - Aversion subscale score. MCEQ - Aversion Score MCEQ01-Craving Reduction Score Modified Cigarette Evaluation Questionnaire - Craving reduction subscale score. MCEQ - Craving Reduction Score MCEQ01-Did Cigarettes Taste Good Modified Cigarette Evaluation Questionnaire - Did cigarettes taste good? MCEQ - Did Cigarettes Taste Good MCEQ01-Did Smoking Calm You Down Modified Cigarette Evaluation Questionnaire - Did smoking calm you down? MCEQ - Did Smoking Calm You Down MCEQ01-Did Smoking Feel Less Irritable Modified Cigarette Evaluation Questionnaire - Did smoking make you feel less irritable? MCEQ - Did Smoking Feel Less Irritable MCEQ01-Did Smoking Help You Concentrate Modified Cigarette Evaluation Questionnaire - Did smoking help you concentrate? MCEQ - Did Smoking Help You Concentrate MCEQ01-Did Smoking Make Feel More Awake Modified Cigarette Evaluation Questionnaire - Did smoking make you feel more awake? MCEQ - Did Smoking Make Feel More Awake MCEQ01-Did Smoking Make You Dizzy Modified Cigarette Evaluation Questionnaire - Did smoking make you dizzy? MCEQ - Did Smoking Make You Dizzy MCEQ01-Did Smoking Make You Nauseous Modified Cigarette Evaluation Questionnaire - Did smoking make you nauseous? MCEQ - Did Smoking Make You Nauseous MCEQ01-Did Smoking Reduce Your Hunger Modified Cigarette Evaluation Questionnaire - Did smoking reduce your hunger for food? MCEQ - Did Smoking Reduce Your Hunger MCEQ01-Did Smoking Relieve Craving Modified Cigarette Evaluation Questionnaire - Did smoking immediately relieve your craving for a cigarette? MCEQ - Did Smoking Relieve Craving MCEQ01-Did You Enjoy Sensations Throat Modified Cigarette Evaluation Questionnaire - Did you enjoy the sensations in your throat and chest? MCEQ - Did You Enjoy Sensations Throat MCEQ01-Did You Enjoy Smoking Modified Cigarette Evaluation Questionnaire - Did you enjoy smoking? MCEQ - Did You Enjoy Smoking MCEQ01-Enjoy Respiratory Sensation Score Modified Cigarette Evaluation Questionnaire - Enjoyment of respiratory tract sensations subscale score. MCEQ - Enjoy Respiratory Sensation Score MCEQ01-Psychological Reward Score Modified Cigarette Evaluation Questionnaire - Psychological reward subscale score. MCEQ - Psychological Reward Score MCEQ01-Smoking Satisfaction Score Modified Cigarette Evaluation Questionnaire - Smoking satisfaction subscale score. MCEQ - Smoking Satisfaction Score MCEQ01-Total Score Modified Cigarette Evaluation Questionnaire - Total score. MCEQ - Total Score MCEQ01-Was Smoking Satisfying Modified Cigarette Evaluation Questionnaire - Was smoking satisfying? MCEQ - Was Smoking Satisfying MCEQ01TN Modified Cigarette Evaluation Questionnaire Test Name CDISC Questionnaire Modified Cigarette Evaluation Questionnaire Test Name Terminology Modified Fatigue Impact Scale test code. MFIS01-I Have Been Less Alert Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been less alert. MFIS - Have Been Less Alert MFIS01-Have Difficulty Paying Attention Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have had difficulty paying attention for long periods of time. MFIS - Have Difficulty Paying Attention for Long Time MFIS01-Have Been Unable to Think Clearly Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been unable to think clearly. MFIS - Unable to Think Clearly MFIS01-Been Clumsy and Uncoordinated Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been clumsy and uncoordinated. MFIS - Have Been Clumsy and Uncoordinated MFIS01-I Have Been Forgetful Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been forgetful. MFIS - Have Been Forgetful MFIS01-Pace Myself in Physical Activity Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have had to pace myself in my physical activities. MFIS - Pace Myself in Physical Activities MFIS01-Less Motivated, Physical Effort Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been less motivated to do anything that requires physical effort. MFIS - Less Motivated to Do Anything That Requires Physical Effort MFIS01-Less Motivated, Social Activity Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been less motivated to participate in social activities. MFIS - Less Motivated to Participate in Social Activities MFIS01-Limited in Ability Away From Home Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been limited in my ability to do things away from home. MFIS - Limited in My Abilities to Do Things Away From Home MFIS01-Trouble Maintain Physical Effort Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have had trouble maintaining physical effort for long periods. MFIS - Have Trouble Maintain Physical Effort MFIS01-Have Difficulty Making Decisions Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have had difficulty making decisions. MFIS - Have Difficulty Making Decisions MFIS01-Less Motivated, Thinking Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been less motivated to do anything that requires thinking. MFIS - Less Motivated to Do Anything That Requires Thinking MFIS01-My Muscles Have Felt Weak Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks my muscles have felt weak. MFIS - Muscles Have Felt Weak MFIS01-Been Physically Uncomfortable Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been physically uncomfortable. MFIS - Been Physically Uncomfortable MFIS01-Trouble Finishing Thinking Tasks Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have had trouble finishing tasks that require thinking. MFIS - Have Trouble Finishing Tasks That Require Thinking MFIS01-Difficulty Organizing My Thoughts Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have had difficulty organizing my thoughts when doing things at home or at work. MFIS - Difficulty Organizing My Thoughts MFIS01-Less Able Complete Physical Tasks Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been less able to complete tasks that require physical effort. MFIS - Less Able to Complete Tasks That Require Physical Effort MFIS01-My Thinking Has Been Slowed Down Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks my thinking has been slowed down. MFIS - My Thinking Has Been Slowed Down MFIS01-I Have Had Trouble Concentrating Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have had trouble concentrating. MFIS - Have Trouble Concentrating MFIS01-Have Limited My Physical Activity Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have limited my physical activities. MFIS - Have Limited My Physical Activities MFIS01-Need to Rest More Often or Longer Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have needed to rest more often or for longer periods. MFIS - Need to Rest More Often or Longer MFIS01TC Modified Fatigue Impact Scale Questionnaire Test Code CDISC Questionnaire Modified Fatigue Impact Scale Test Code Terminology Modified Fatigue Impact Scale test name. MFIS01-Been Clumsy and Uncoordinated Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been clumsy and uncoordinated. MFIS - Have Been Clumsy and Uncoordinated MFIS01-Been Physically Uncomfortable Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been physically uncomfortable. MFIS - Been Physically Uncomfortable MFIS01-Difficulty Organizing My Thoughts Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have had difficulty organizing my thoughts when doing things at home or at work. MFIS - Difficulty Organizing My Thoughts MFIS01-Have Been Unable to Think Clearly Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been unable to think clearly. MFIS - Unable to Think Clearly MFIS01-Have Difficulty Making Decisions Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have had difficulty making decisions. MFIS - Have Difficulty Making Decisions MFIS01-Have Difficulty Paying Attention Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have had difficulty paying attention for long periods of time. MFIS - Have Difficulty Paying Attention for Long Time MFIS01-Have Limited My Physical Activity Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have limited my physical activities. MFIS - Have Limited My Physical Activities MFIS01-I Have Been Forgetful Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been forgetful. MFIS - Have Been Forgetful MFIS01-I Have Been Less Alert Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been less alert. MFIS - Have Been Less Alert MFIS01-I Have Had Trouble Concentrating Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have had trouble concentrating. MFIS - Have Trouble Concentrating MFIS01-Less Able Complete Physical Tasks Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been less able to complete tasks that require physical effort. MFIS - Less Able to Complete Tasks That Require Physical Effort MFIS01-Less Motivated, Physical Effort Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been less motivated to do anything that requires physical effort. MFIS - Less Motivated to Do Anything That Requires Physical Effort MFIS01-Less Motivated, Social Activity Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been less motivated to participate in social activities. MFIS - Less Motivated to Participate in Social Activities MFIS01-Less Motivated, Thinking Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been less motivated to do anything that requires thinking. MFIS - Less Motivated to Do Anything That Requires Thinking MFIS01-Limited in Ability Away From Home Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been limited in my ability to do things away from home. MFIS - Limited in My Abilities to Do Things Away From Home MFIS01-My Muscles Have Felt Weak Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks my muscles have felt weak. MFIS - Muscles Have Felt Weak MFIS01-My Thinking Has Been Slowed Down Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks my thinking has been slowed down. MFIS - My Thinking Has Been Slowed Down MFIS01-Need to Rest More Often or Longer Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have needed to rest more often or for longer periods. MFIS - Need to Rest More Often or Longer MFIS01-Pace Myself in Physical Activity Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have had to pace myself in my physical activities. MFIS - Pace Myself in Physical Activities MFIS01-Trouble Finishing Thinking Tasks Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have had trouble finishing tasks that require thinking. MFIS - Have Trouble Finishing Tasks That Require Thinking MFIS01-Trouble Maintain Physical Effort Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have had trouble maintaining physical effort for long periods. MFIS - Have Trouble Maintain Physical Effort MFIS01TN Modified Fatigue Impact Scale Questionnaire Test Name CDISC Questionnaire Modified Fatigue Impact Scale Test Name Terminology Modified Hachinski Ischemic Scale-NACC Version test code. MHIS01-Abrupt Onset Modified Hachinski Ischemic Scale-NACC Version - Abrupt onset (re: cognitive status). MHIS-NACC - Abrupt Onset MHIS01-Stepwise Deterioration Modified Hachinski Ischemic Scale-NACC Version - Stepwise deterioration (re: cognitive status). MHIS-NACC - Stepwise Deterioration MHIS01- Somatic Complaints Modified Hachinski Ischemic Scale-NACC Version - Somatic complaints. MHIS-NACC - Somatic Complaints MHIS01-Emotional Incontinence Modified Hachinski Ischemic Scale-NACC Version - Emotional incontinence. MHIS-NACC - Emotional Incontinence MHIS01-History or Presence Hypertension Modified Hachinski Ischemic Scale-NACC Version - History or presence of hypertension. MHIS-NACC - History or Presence of Hypertension MHIS01-History of Stroke Modified Hachinski Ischemic Scale-NACC Version - History of stroke. MHIS-NACC - History of Stroke MHIS01-Focal Neurological Symptoms Modified Hachinski Ischemic Scale-NACC Version - Focal neurological symptoms. MHIS-NACC - Focal Neurological Symptoms MHIS01-Focal Neurological Signs Modified Hachinski Ischemic Scale-NACC Version - Focal neurological signs. MHIS-NACC - Focal Neurological Signs MHIS01-Total Score Modified Hachinski Ischemic Scale-NACC Version - Sum all circled answers for a total score. MHIS-NACC - Total Score MHIS01TC Modified Hachinski Ischemic Scale-NACC Version Questionnaire Test Code CDISC Questionnaire MHIS-NACC Test Code Terminology Modified Hachinski Ischemic Scale-NACC Version test name. MHIS01- Somatic Complaints Modified Hachinski Ischemic Scale-NACC Version - Somatic complaints. MHIS-NACC - Somatic Complaints MHIS01-Abrupt Onset Modified Hachinski Ischemic Scale-NACC Version - Abrupt onset (re: cognitive status). MHIS-NACC - Abrupt Onset MHIS01-Emotional Incontinence Modified Hachinski Ischemic Scale-NACC Version - Emotional incontinence. MHIS-NACC - Emotional Incontinence MHIS01-Focal Neurological Signs Modified Hachinski Ischemic Scale-NACC Version - Focal neurological signs. MHIS-NACC - Focal Neurological Signs MHIS01-Focal Neurological Symptoms Modified Hachinski Ischemic Scale-NACC Version - Focal neurological symptoms. MHIS-NACC - Focal Neurological Symptoms MHIS01-History of Stroke Modified Hachinski Ischemic Scale-NACC Version - History of stroke. MHIS-NACC - History of Stroke MHIS01-History or Presence Hypertension Modified Hachinski Ischemic Scale-NACC Version - History or presence of hypertension. MHIS-NACC - History or Presence of Hypertension MHIS01-Stepwise Deterioration Modified Hachinski Ischemic Scale-NACC Version - Stepwise deterioration (re: cognitive status). MHIS-NACC - Stepwise Deterioration MHIS01-Total Score Modified Hachinski Ischemic Scale-NACC Version - Sum all circled answers for a total score. MHIS-NACC - Total Score MHIS01TN Modified Hachinski Ischemic Scale-NACC Version Questionnaire Test Name CDISC Questionnaire MHIS-NACC Test Name Terminology Modified Medical Research Council Dyspnea Scale test code. MMRC01-Description of Breathlessness Modified Medical Research Council Dyspnea Scale - Description of breathlessness. MMRC - Description of Level of Breathlessness MMRC01TC Modified Medical Research Council Dyspnea Scale Questionnaire Test Code CDISC Questionnaire MMRC Test Code Terminology Modified Medical Research Council Dyspnea Scale test name. MMRC01-Description of Breathlessness Modified Medical Research Council Dyspnea Scale - Description of breathlessness. MMRC - Description of Level of Breathlessness MMRC01TN Modified Medical Research Council Dyspnea Scale Questionnaire Test Name CDISC Questionnaire MMRC Test Name Terminology Modified Rankin Scale test code. MRS01-Modified Rankin Scale Score Modified Rankin Scale - Modified Rankin Scale Score. MRS - Modified Rankin Scale Score MRS01TC Modified Rankin Scale Clinical Classification Test Code CDISC Clinical Classification MRS Test Code Terminology Modified Rankin Scale test name. MRS01-Modified Rankin Scale Score Modified Rankin Scale - Modified Rankin Scale Score. MRS - Modified Rankin Scale Score MRS01TN Modified Rankin Scale Clinical Classification Test Name CDISC Clinical Classification MRS Test Name Terminology Modified Van Assche Index original result for MVAI101 test and test code. MVAI101-Absent Modified Van Assche Index original result for MVAI101-Absent. Modified Van Assche Index MVAI101 Original Result - Absent MVAI101-Horseshoe configuration Modified Van Assche Index original result for MVAI101-Horseshoe configuration. Modified Van Assche Index MVAI101 Original Result - Horseshoe Configuration MVAI101-Infralevatoric Modified Van Assche Index original result for MVAI101-Infralevatoric. Modified Van Assche Index MVAI101 Original Result - Infralevatoric MVAI101-Supralevatoric Modified Van Assche Index original result for MVAI101-Supralevatoric. Modified Van Assche Index MVAI101 Original Result - Supralevatoric MVAI101OR Modified Van Assche Index Clinical Classification ORRES for MVAI101 TN/TC CDISC Clinical Classification Modified Van Assche Index MVAI101 Original Response Terminology Modified Van Assche Index original result for MVAI102 test and test code. MVAI102-Absent Modified Van Assche Index original result for MVAI102-Absent. Modified Van Assche Index MVAI102 Original Result - Absent MVAI102-Mild Modified Van Assche Index original result for MVAI102-Mild. Modified Van Assche Index MVAI102 Original Result - Mild MVAI102-Pronounced Modified Van Assche Index original result for MVAI102-Pronounced. Modified Van Assche Index MVAI102 Original Result - Pronounced MVAI102OR Modified Van Assche Index Clinical Classification ORRES for MVAI102 TN/TC CDISC Clinical Classification Modified Van Assche Index MVAI102 Original Response Terminology Modified Van Assche Index original result for MVAI103 test and test code. MVAI103-Increased signal intensity Modified Van Assche Index original result for MVAI103-Increased signal intensity. Modified Van Assche Index MVAI103 Original Result - Increased Signal Intensity MVAI103-Normal Modified Van Assche Index original result for MVAI103-Normal. Modified Van Assche Index MVAI103 Original Result - Normal MVAI103-Thickened Modified Van Assche Index original result for MVAI103-Thickened. Modified Van Assche Index MVAI103 Original Result - Thickened MVAI103OR Modified Van Assche Index Clinical Classification ORRES for MVAI103 TN/TC CDISC Clinical Classification Modified Van Assche Index MVAI103 Original Response Terminology Modified Van Assche Index original result for MVAI104 test and test code. MVAI104-Absent Modified Van Assche Index original result for MVAI104-Absent. Modified Van Assche Index MVAI104 Original Result - Absent MVAI104-Collection - large Modified Van Assche Index original result for MVAI104-Collection - large. Modified Van Assche Index MVAI104 Original Result - Collection - Large MVAI104-Collection - medium Modified Van Assche Index original result for MVAI104-Collection - medium. Modified Van Assche Index MVAI104 Original Result - Collection - Medium MVAI104-Collection - small Modified Van Assche Index original result for MVAI104-Collection - small. Modified Van Assche Index MVAI104 Original Result - Collection - Small MVAI104-Diffuse Modified Van Assche Index original result for MVAI104-Diffuse. Modified Van Assche Index MVAI104 Original Result - Diffuse MVAI104-Focal Modified Van Assche Index original result for MVAI104-Focal. Modified Van Assche Index MVAI104 Original Result - Focal MVAI104OR Modified Van Assche Index Clinical Classification ORRES for MVAI104 TN/TC CDISC Clinical Classification Modified Van Assche Index MVAI104 Original Response Terminology Modified Van Assche Index original result for MVAI105 test and test code. MVAI105-Fibrous Modified Van Assche Index original result for MVAI105-Fibrous. Modified Van Assche Index MVAI105 Original Result - Fibrous MVAI105-Fluid/pus Modified Van Assche Index original result for MVAI105-Fluid/pus. Modified Van Assche Index MVAI105 Original Result - Fluid/Pus MVAI105-Granulation tissue Modified Van Assche Index original result for MVAI105-Granulation tissue. Modified Van Assche Index MVAI105 Original Result - Granulation Tissue MVAI105OR Modified Van Assche Index Clinical Classification ORRES for MVAI105 TN/TC CDISC Clinical Classification Modified Van Assche Index MVAI105 Original Response Terminology Modified Van Assche Index standardized character result for MVAI101 test and test code. MVAI101-0 Modified Van Assche Index standardized character result for MVAI101-Absent. Modified Van Assche Index MVAI101 Standardized Character Result 0 MVAI101-1 Modified Van Assche Index standardized character result for MVAI101-Infralevatoric. Modified Van Assche Index MVAI101 Standardized Character Result 1 MVAI101-2 Modified Van Assche Index standardized character result for MVAI101-Horseshoe configuration. Modified Van Assche Index MVAI101 Standardized Character Result 2 MVAI101-3 Modified Van Assche Index standardized character result for MVAI101-Supralevatoric. Modified Van Assche Index MVAI101 Standardized Character Result 3 MVAI101STR Modified Van Assche Index Clinical Classification STRESC for MVAI101 TN/TC CDISC Clinical Classification Modified Van Assche Index MVAI101 Standardized Character Response Terminology Modified Van Assche Index standardized character result for MVAI102 test and test code. MVAI102-0 Modified Van Assche Index standardized character result for MVAI102-Absent. Modified Van Assche Index MVAI102 Standardized Character Result 0 MVAI102-1 Modified Van Assche Index standardized character result for MVAI102-Mild. Modified Van Assche Index MVAI102 Standardized Character Result 1 MVAI102-2 Modified Van Assche Index standardized character result for MVAI102-Pronounced. Modified Van Assche Index MVAI102 Standardized Character Result 2 MVAI102STR Modified Van Assche Index Clinical Classification STRESC for MVAI102 TN/TC CDISC Clinical Classification Modified Van Assche Index MVAI102 Standardized Character Response Terminology Modified Van Assche Index standardized character result for MVAI103 test and test code. MVAI103-0 Modified Van Assche Index standardized character result for MVAI103-Normal. Modified Van Assche Index MVAI103 Standardized Character Result 0 MVAI103-1 Modified Van Assche Index standardized character result for MVAI103-Thickened. Modified Van Assche Index MVAI103 Standardized Character Result 1 MVAI103-2 Modified Van Assche Index standardized character result for MVAI103-Increased signal intensity. Modified Van Assche Index MVAI103 Standardized Character Result 2 MVAI103STR Modified Van Assche Index Clinical Classification STRESC for MVAI103 TN/TC CDISC Clinical Classification Modified Van Assche Index MVAI103 Standardized Character Response Terminology Modified Van Assche Index standardized character result for MVAI104 test and test code. MVAI104-0 Modified Van Assche Index standardized character result for MVAI104-Absent. Modified Van Assche Index MVAI104 Standardized Character Result 0 MVAI104-1 Modified Van Assche Index standardized character result for MVAI104-Diffuse. Modified Van Assche Index MVAI104 Standardized Character Result 1 MVAI104-2 Modified Van Assche Index standardized character result for MVAI104-Focal. Modified Van Assche Index MVAI104 Standardized Character Result 2 MVAI104-3 Modified Van Assche Index standardized character result for MVAI104-Collection - small. Modified Van Assche Index MVAI104 Standardized Character Result 3 MVAI104-4 Modified Van Assche Index standardized character result for MVAI104-Collection - medium. Modified Van Assche Index MVAI104 Standardized Character Result 4 MVAI104-5 Modified Van Assche Index standardized character result for MVAI104-Collection - large. Modified Van Assche Index MVAI104 Standardized Character Result 5 MVAI104STR Modified Van Assche Index Clinical Classification STRESC for MVAI104 TN/TC CDISC Clinical Classification Modified Van Assche Index MVAI104 Standardized Character Response Terminology Modified Van Assche Index standardized character result for MVAI105 test and test code. MVAI105-0 Modified Van Assche Index standardized character result for MVAI105-Fibrous. Modified Van Assche Index MVAI105 Standardized Character Result 0 MVAI105-1 Modified Van Assche Index standardized character result for MVAI105-Granulation tissue. Modified Van Assche Index MVAI105 Standardized Character Result 1 MVAI105-2 Modified Van Assche Index standardized character result for MVAI105-Fluid/pus. Modified Van Assche Index MVAI105 Standardized Character Result 2 MVAI105STR Modified Van Assche Index Clinical Classification STRESC for MVAI105 TN/TC CDISC Clinical Classification Modified Van Assche Index MVAI105 Standardized Character Response Terminology Modified Van Assche Index test code. MVAI1-Extension Modified Van Assche Index - Extension. MVAI - Extension MVAI1-Hyperintensity T2-weighted Images Modified Van Assche Index - Hyperintensity T2-weighted images. MVAI - Hyperintensity T2-weighted Images MVAI1-Rectal Wall Involvement Modified Van Assche Index - Rectal wall involvement. MVAI - Rectal Wall Involvement MVAI1-Inflammatory Mass Modified Van Assche Index - Inflammatory mass. MVAI - Inflammatory Mass MVAI1-Dominant Feature Modified Van Assche Index - Dominant feature. MVAI - Dominant Feature MVAI1-Total Score Modified Van Assche Index - Total score. MVAI - Total Score MVAI1TC Modified Van Assche Index Clinical Classification Test Code CDISC Clinical Classification Modified Van Assche Index Test Code Terminology Modified Van Assche Index test name. MVAI1-Dominant Feature Modified Van Assche Index - Dominant feature. MVAI - Dominant Feature MVAI1-Extension Modified Van Assche Index - Extension. MVAI - Extension MVAI1-Hyperintensity T2-weighted Images Modified Van Assche Index - Hyperintensity T2-weighted images. MVAI - Hyperintensity T2-weighted Images MVAI1-Inflammatory Mass Modified Van Assche Index - Inflammatory mass. MVAI - Inflammatory Mass MVAI1-Rectal Wall Involvement Modified Van Assche Index - Rectal wall involvement. MVAI - Rectal Wall Involvement MVAI1-Total Score Modified Van Assche Index - Total score. MVAI - Total Score MVAI1TN Modified Van Assche Index Clinical Classification Test Name CDISC Clinical Classification Modified Van Assche Index Test Name Terminology Montreal Classification for Crohn's Disease test code. MCHR01-Age at Diagnosis Montreal Classification for Crohn's Disease - Age at diagnosis (A). Montreal Classification - Age at Diagnosis MCHR01-Location Montreal Classification for Crohn's Disease - Location (L). Montreal Classification - Location MCHR01-Behavior Montreal Classification for Crohn's Disease - Behavior (B). Montreal Classification - Behavior MCHR01TC Montreal Classification for Crohn's Disease Clinical Classification Test Code CDISC Clinical Classification Montreal Classification for Crohn's Disease Test Code Terminology Montreal Classification for Crohn's Disease test name. MCHR01-Age at Diagnosis Montreal Classification for Crohn's Disease - Age at diagnosis (A). Montreal Classification - Age at Diagnosis MCHR01-Behavior Montreal Classification for Crohn's Disease - Behavior (B). Montreal Classification - Behavior MCHR01-Location Montreal Classification for Crohn's Disease - Location (L). Montreal Classification - Location MCHR01TN Montreal Classification for Crohn's Disease Clinical Classification Test Name CDISC Clinical Classification Montreal Classification for Crohn's Disease Test Name Terminology The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale test code. UPD2-Cognitive Impairment The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week have you had problems remembering things, following conversations, paying attention, thinking clearly, or finding your way around the house or in town? MDS-UPDRS - Cognitive Impairment UPD2-Hallucinations and Psychosis The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week have you seen, heard, smelled or felt things that were not really there? MDS-UPDRS - Hallucinations and Psychosis UPD2-Depressed Mood The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week have you felt low, sad, hopeless or unable to enjoy things? If yes, was this feeling for longer than one day at a time? Did it make it difficult for you carry out your usual activities or to be with people? MDS-UPDRS - Depressed Mood UPD2-Anxious Mood The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week have you felt nervous, worried or tense? If yes, was this feeling for longer than one day at a time? Did it make it difficult for you to follow your usual activities or to be with other people? MDS-UPDRS - Anxious Mood UPD2-Apathy The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you felt indifferent to doing activities or being with people? MDS-UPDRS - Apathy UPD2-Ftrs Dopa Dysregulation Synd The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you had unusually strong urges that are hard to control? Do you feel driven to do or think about something and find it hard to stop? MDS-UPDRS - Features of Dopamine Dysregulation Syndrome UPD2-Sleep Problems The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you had trouble going to sleep at night or staying asleep through the night? MDS-UPDRS - Sleep Problems UPD2-Daytime Sleepiness The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you had trouble staying awake during the daytime? MDS-UPDRS - Daytime Sleepiness UPD2-Pain and other Sensations The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you had uncomfortable feelings in your body like pain, aches tingling or cramps? MDS-UPDRS - Pain and Other Sensations UPD2-Urinary Problems The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you had trouble with urine control? MDS-UPDRS - Urinary Problems UPD2-Constipation Problems The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week have you had constipation troubles that cause you difficulty moving your bowels? MDS-UPDRS - Constipation Problems UPD2-Lightheadedness on Standing The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you felt faint, dizzy or foggy when you stand up after sitting or lying down? MDS-UPDRS - Lightheadedness on Standing UPD2-Fatigue The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually felt fatigued? MDS-UPDRS - Fatigue UPD2-Speech The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you had problems with your speech? MDS-UPDRS - Speech UPD2-Saliva and Drooling The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had too much saliva during when you are awake or when you sleep? MDS-UPDRS - Saliva and Drooling UPD2-Chewing and Swallowing The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had problems swallowing pills or eating meals? MDS-UPDRS - Chewing and Swallowing UPD2-Eating Tasks The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had troubles handling your food and using eating utensils? MDS-UPDRS - Eating Tasks UPD2-Dressing The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had problems dressing? MDS-UPDRS - Dressing UPD2-Hygiene The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually been slow or do you need help with washing, bathing, shaving, brushing teeth, combing your hair or with other personal hygiene? MDS-UPDRS - Hygiene UPD2-Handwriting The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have people usually had trouble reading your handwriting? MDS-UPDRS - Handwriting UPD2-Doing Hobbies/Other Activities The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had trouble doing your hobbies or other things that you like to do? MDS-UPDRS - Doing Hobbies and Other Activities UPD2-Turning in Bed The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, do you usually have trouble turning over in bed? MDS-UPDRS - Turning in Bed UPD2-Tremor The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had shaking or tremor? MDS-UPDRS - Tremor UPD2-Get Out of Bed/Car/Deep Chair The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had trouble getting out of bed, a car seat, or a deep chair? MDS-UPDRS - Get Out of Bed, Car, or Deep Chair UPD2-Walking and Balance The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had problems with balance and walking? MDS-UPDRS - Walking and Balance UPD2-Freezing The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, on your usual day when walking, do you suddenly stop or freeze as if your feet are stuck to the floor? MDS-UPDRS - Freezing UPD2-Speech Problems The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Speech Problems. MDS-UPDRS - Speech Problems UPD2-Facial Expression The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Facial Expression. MDS-UPDRS - Facial Expression UPD2-Rigidity Neck The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rigidity Neck. MDS-UPDRS - Rigidity Neck UPD2-Rigidity RT Upper Extremity The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rigidity Right Upper Extremity. MDS-UPDRS - Rigidity Right Upper Extremity UPD2-Rigidity Left Upper Extremity The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rigidity Left Upper Extremity. MDS-UPDRS - Rigidity Left Upper Extremity UPD2-Rigidity RT Lower Extremity The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rigidity Right Lower Extremity. MDS-UPDRS - Rigidity Right Lower Extremity UPD2-Rigidity Left Lower Extremity The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rigidity Left Lower Extremity. MDS-UPDRS - Rigidity Left Lower Extremity UPD2-Right Finger Tapping The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Right Finger Tapping. MDS-UPDRS - Right Finger Tapping UPD2-Left Finger Tapping The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Left Finger Tapping. MDS-UPDRS - Left Finger Tapping UPD2-Right Hand Movements The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Right Hand Movements. MDS-UPDRS - Right Hand Movements UPD2-Left Hand Movements The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Left Hand Movements. MDS-UPDRS - Left Hand Movements UPD2-Pron/Sup Movement of RT Hand The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Pronation-Supination Movements of Right Hand. MDS-UPDRS - Pronanation-Supination Movement of Right Hand UPD2-Pron/Sup Movement of Left Hand The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Pronation-Supination Movements of Left Hand. MDS-UPDRS - Pronanation-Supination Movement of Left Hand UPD2-Right Toe Tapping The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Right Toe Tapping. MDS-UPDRS - Right Toe Tapping UPD2-Left Toe Tapping The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Left Toe Tapping. MDS-UPDRS - Left Toe Tapping UPD2-Right Leg Agility The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Right Leg Agility. MDS-UPDRS - Right Leg Agility UPD2-Left Leg Agility The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Left Leg Agility. MDS-UPDRS - Left Leg Agility UPD2-Arising from Chair The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Arising from Chair. MDS-UPDRS - Arising from Chair UPD2-Gait The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Gait. MDS-UPDRS - Gait UPD2-Freezing of Gait The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Freezing of Gait. MDS-UPDRS - Freezing of Gait UPD2-Postural Stability The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Postural Stability. MDS-UPDRS - Postural Stability UPD2-Posture The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Posture. MDS-UPDRS - Posture UPD2-Body Bradykinesia The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Global Spontaneity of Movement (Body Bradykinesia). MDS-UPDRS - Body Bradykinesia UPD2-Postural Tremor of Right Hand The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Postural Tremor of the Right Hand. MDS-UPDRS - Postural Tremor of Right Hand UPD2-Postural Tremor of Left Hand The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Postural Tremor of the Left Hand. MDS-UPDRS - Postural Tremor of Left Hand UPD2-Kinetic Tremor of Right Hand The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Kinetic Tremor of the Right Hand. MDS-UPDRS - Kinetic Tremor of Right Hand UPD2-Kinetic Tremor of Left Hand The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Kinetic Tremor of the Left Hand. MDS-UPDRS - Kinetic Tremor of Left Hand UPD2-Rest Tremor Amplitude RUE The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rest Tremor Amplitude Right Upper Extremity. MDS-UPDRS - Rest Tremor Amplitude Right Upper Extremity UPD2-Rest Tremor Amplitude LUE The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rest Tremor Amplitude Left Upper Extremity. MDS-UPDRS - Rest Tremor Amplitude Left Upper Extremity UPD2-Rest Tremor Amplitude RLE The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rest Tremor Amplitude Right Lower Extremity. MDS-UPDRS - Rest Tremor Amplitude Right Lower Extremity UPD2-Rest Tremor Amplitude LLE The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rest Tremor Amplitude Left Lower Extremity. MDS-UPDRS - Rest Tremor Amplitude Left Lower Extremity UPD2-Rest Tremor Amplitude Lip/Jaw The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rest Tremor Amplitude Lip/Jaw. MDS-UPDRS - Rest Tremor Amplitude Lip or Jaw UPD2-Consistency of Rest Tremor The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Consistency of Rest Tremor. MDS-UPDRS - Consistency of Rest Tremor UPD2-Medication for PD The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Is the patient on medication for treating the symptoms of Parkinson's Disease? MDS-UPDRS - Medication for Parkinson's Disease UPD2-Clinical State on Meds The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - If the patient is receiving medication for treating the symptoms of Parkinson's Disease, mark the patient's clinical state. MDS-UPDRS - Clinical State on Medication UPD2-Taking Levodopa The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Is the patient on Levodopa? MDS-UPDRS - Taking Levodopa UPD2-Minutes Since Levodopa Dose The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Minutes since last Levodopa dose. MDS-UPDRS - Minutes Since Levodopa Dose UPD2-Time Spent with Dyskinesias The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Time Spent with Dyskinesias. MDS-UPDRS - Time Spent with Dyskinesias UPD2-Functional Impact Dyskinesias The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Functional Impact of Dyskinesias. MDS-UPDRS - Functional Impact of Dyskinesias UPD2-Time Spent in the Off State The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Time Spent in the Off State. MDS-UPDRS - Time Spent in the Off State UPD2-Functional Impact Fluctuations The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Functional Impact of Fluctuations. MDS-UPDRS - Functional Impact of Fluctuations UPD2-Complexity Motor Fluctuations The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Complexity of Motor Fluctuations. MDS-UPDRS - Complexity of Motor Fluctuations UPD2-Painful Off-state Dystonia The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Painful Off-state Dystonia. MDS-UPDRS - Painful Off-state Dystonia UPD2-Dyskinesias During Exam The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Were dyskinesias (chorea or dystonia) present during examination? MDS-UPDRS - Dyskinesias During Exam UPD2-Movements Interfere Ratings The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - If yes, did these movements interfere with your ratings? MDS-UPDRS - Movements Interfere with Ratings UPD2-Hoehn and Yahr Stage The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Hoehn and Yahr Stage. MDS-UPDRS - Hoehn and Yahr Stage UPD2TC Movement Disorder Society Unified Parkinson's Disease Rating Scale Questionnaire Test Code CDISC Questionnaire MDS-UPDRS Test Code Terminology The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale test name. UPD2-Anxious Mood The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week have you felt nervous, worried or tense? If yes, was this feeling for longer than one day at a time? Did it make it difficult for you to follow your usual activities or to be with other people? MDS-UPDRS - Anxious Mood UPD2-Apathy The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you felt indifferent to doing activities or being with people? MDS-UPDRS - Apathy UPD2-Arising from Chair The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Arising from Chair. MDS-UPDRS - Arising from Chair UPD2-Body Bradykinesia The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Global Spontaneity of Movement (Body Bradykinesia). MDS-UPDRS - Body Bradykinesia UPD2-Chewing and Swallowing The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had problems swallowing pills or eating meals? MDS-UPDRS - Chewing and Swallowing UPD2-Clinical State on Meds The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - If the patient is receiving medication for treating the symptoms of Parkinson's Disease, mark the patient's clinical state. MDS-UPDRS - Clinical State on Medication UPD2-Cognitive Impairment The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week have you had problems remembering things, following conversations, paying attention, thinking clearly, or finding your way around the house or in town? MDS-UPDRS - Cognitive Impairment UPD2-Complexity Motor Fluctuations The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Complexity of Motor Fluctuations. MDS-UPDRS - Complexity of Motor Fluctuations UPD2-Consistency of Rest Tremor The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Consistency of Rest Tremor. MDS-UPDRS - Consistency of Rest Tremor UPD2-Constipation Problems The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week have you had constipation troubles that cause you difficulty moving your bowels? MDS-UPDRS - Constipation Problems UPD2-Daytime Sleepiness The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you had trouble staying awake during the daytime? MDS-UPDRS - Daytime Sleepiness UPD2-Depressed Mood The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week have you felt low, sad, hopeless or unable to enjoy things? If yes, was this feeling for longer than one day at a time? Did it make it difficult for you carry out your usual activities or to be with people? MDS-UPDRS - Depressed Mood UPD2-Doing Hobbies/Other Activities The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had trouble doing your hobbies or other things that you like to do? MDS-UPDRS - Doing Hobbies and Other Activities UPD2-Dressing The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had problems dressing? MDS-UPDRS - Dressing UPD2-Dyskinesias During Exam The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Were dyskinesias (chorea or dystonia) present during examination? MDS-UPDRS - Dyskinesias During Exam UPD2-Eating Tasks The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had troubles handling your food and using eating utensils? MDS-UPDRS - Eating Tasks UPD2-Facial Expression The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Facial Expression. MDS-UPDRS - Facial Expression UPD2-Fatigue The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually felt fatigued? MDS-UPDRS - Fatigue UPD2-Freezing of Gait The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Freezing of Gait. MDS-UPDRS - Freezing of Gait UPD2-Freezing The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, on your usual day when walking, do you suddenly stop or freeze as if your feet are stuck to the floor? MDS-UPDRS - Freezing UPD2-Ftrs Dopa Dysregulation Synd The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you had unusually strong urges that are hard to control? Do you feel driven to do or think about something and find it hard to stop? MDS-UPDRS - Features of Dopamine Dysregulation Syndrome UPD2-Functional Impact Dyskinesias The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Functional Impact of Dyskinesias. MDS-UPDRS - Functional Impact of Dyskinesias UPD2-Functional Impact Fluctuations The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Functional Impact of Fluctuations. MDS-UPDRS - Functional Impact of Fluctuations UPD2-Gait The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Gait. MDS-UPDRS - Gait UPD2-Get Out of Bed/Car/Deep Chair The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had trouble getting out of bed, a car seat, or a deep chair? MDS-UPDRS - Get Out of Bed, Car, or Deep Chair UPD2-Hallucinations and Psychosis The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week have you seen, heard, smelled or felt things that were not really there? MDS-UPDRS - Hallucinations and Psychosis UPD2-Handwriting The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have people usually had trouble reading your handwriting? MDS-UPDRS - Handwriting UPD2-Hoehn and Yahr Stage The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Hoehn and Yahr Stage. MDS-UPDRS - Hoehn and Yahr Stage UPD2-Hygiene The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually been slow or do you need help with washing, bathing, shaving, brushing teeth, combing your hair or with other personal hygiene? MDS-UPDRS - Hygiene UPD2-Kinetic Tremor of Left Hand The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Kinetic Tremor of the Left Hand. MDS-UPDRS - Kinetic Tremor of Left Hand UPD2-Kinetic Tremor of Right Hand The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Kinetic Tremor of the Right Hand. MDS-UPDRS - Kinetic Tremor of Right Hand UPD2-Left Finger Tapping The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Left Finger Tapping. MDS-UPDRS - Left Finger Tapping UPD2-Left Hand Movements The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Left Hand Movements. MDS-UPDRS - Left Hand Movements UPD2-Left Leg Agility The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Left Leg Agility. MDS-UPDRS - Left Leg Agility UPD2-Left Toe Tapping The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Left Toe Tapping. MDS-UPDRS - Left Toe Tapping UPD2-Lightheadedness on Standing The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you felt faint, dizzy or foggy when you stand up after sitting or lying down? MDS-UPDRS - Lightheadedness on Standing UPD2-Medication for PD The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Is the patient on medication for treating the symptoms of Parkinson's Disease? MDS-UPDRS - Medication for Parkinson's Disease UPD2-Minutes Since Levodopa Dose The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Minutes since last Levodopa dose. MDS-UPDRS - Minutes Since Levodopa Dose UPD2-Movements Interfere Ratings The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - If yes, did these movements interfere with your ratings? MDS-UPDRS - Movements Interfere with Ratings UPD2-Pain and other Sensations The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you had uncomfortable feelings in your body like pain, aches tingling or cramps? MDS-UPDRS - Pain and Other Sensations UPD2-Painful Off-state Dystonia The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Painful Off-state Dystonia. MDS-UPDRS - Painful Off-state Dystonia UPD2-Postural Stability The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Postural Stability. MDS-UPDRS - Postural Stability UPD2-Postural Tremor of Left Hand The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Postural Tremor of the Left Hand. MDS-UPDRS - Postural Tremor of Left Hand UPD2-Postural Tremor of Right Hand The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Postural Tremor of the Right Hand. MDS-UPDRS - Postural Tremor of Right Hand UPD2-Posture The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Posture. MDS-UPDRS - Posture UPD2-Pron/Sup Movement of Left Hand The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Pronation-Supination Movements of Left Hand. MDS-UPDRS - Pronanation-Supination Movement of Left Hand UPD2-Pron/Sup Movement of RT Hand The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Pronation-Supination Movements of Right Hand. MDS-UPDRS - Pronanation-Supination Movement of Right Hand UPD2-Rest Tremor Amplitude Lip/Jaw The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rest Tremor Amplitude Lip/Jaw. MDS-UPDRS - Rest Tremor Amplitude Lip or Jaw UPD2-Rest Tremor Amplitude LLE The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rest Tremor Amplitude Left Lower Extremity. MDS-UPDRS - Rest Tremor Amplitude Left Lower Extremity UPD2-Rest Tremor Amplitude LUE The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rest Tremor Amplitude Left Upper Extremity. MDS-UPDRS - Rest Tremor Amplitude Left Upper Extremity UPD2-Rest Tremor Amplitude RLE The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rest Tremor Amplitude Right Lower Extremity. MDS-UPDRS - Rest Tremor Amplitude Right Lower Extremity UPD2-Rest Tremor Amplitude RUE The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rest Tremor Amplitude Right Upper Extremity. MDS-UPDRS - Rest Tremor Amplitude Right Upper Extremity UPD2-Right Finger Tapping The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Right Finger Tapping. MDS-UPDRS - Right Finger Tapping UPD2-Right Hand Movements The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Right Hand Movements. MDS-UPDRS - Right Hand Movements UPD2-Right Leg Agility The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Right Leg Agility. MDS-UPDRS - Right Leg Agility UPD2-Right Toe Tapping The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Right Toe Tapping. MDS-UPDRS - Right Toe Tapping UPD2-Rigidity Left Lower Extremity The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rigidity Left Lower Extremity. MDS-UPDRS - Rigidity Left Lower Extremity UPD2-Rigidity Left Upper Extremity The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rigidity Left Upper Extremity. MDS-UPDRS - Rigidity Left Upper Extremity UPD2-Rigidity Neck The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rigidity Neck. MDS-UPDRS - Rigidity Neck UPD2-Rigidity RT Lower Extremity The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rigidity Right Lower Extremity. MDS-UPDRS - Rigidity Right Lower Extremity UPD2-Rigidity RT Upper Extremity The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rigidity Right Upper Extremity. MDS-UPDRS - Rigidity Right Upper Extremity UPD2-Saliva and Drooling The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had too much saliva during when you are awake or when you sleep? MDS-UPDRS - Saliva and Drooling UPD2-Sleep Problems The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you had trouble going to sleep at night or staying asleep through the night? MDS-UPDRS - Sleep Problems UPD2-Speech Problems The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Speech Problems. MDS-UPDRS - Speech Problems UPD2-Speech The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you had problems with your speech? MDS-UPDRS - Speech UPD2-Taking Levodopa The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Is the patient on Levodopa? MDS-UPDRS - Taking Levodopa UPD2-Time Spent in the Off State The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Time Spent in the Off State. MDS-UPDRS - Time Spent in the Off State UPD2-Time Spent with Dyskinesias The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Time Spent with Dyskinesias. MDS-UPDRS - Time Spent with Dyskinesias UPD2-Tremor The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had shaking or tremor? MDS-UPDRS - Tremor UPD2-Turning in Bed The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, do you usually have trouble turning over in bed? MDS-UPDRS - Turning in Bed UPD2-Urinary Problems The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you had trouble with urine control? MDS-UPDRS - Urinary Problems UPD2-Walking and Balance The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had problems with balance and walking? MDS-UPDRS - Walking and Balance UPD2TN Movement Disorder Society Unified Parkinson's Disease Rating Scale Questionnaire Test Name CDISC Questionnaire MDS-UPDRS Test Name Terminology Terminology relevant to the test codes that describe multiple sclerosis findings. Diagnostic Criteria Met A description of the diagnostic criteria that the subject fulfilled in order to establish a medical diagnosis. Which Diagnostic Criteria Met Localization of Onset The anatomical location of the beginning or early stages of a disease. Location of Disease Onset Focus of Onset Onset Unifocal or Multifocal A characterization of the focality of the lesion at the time of disease diagnosis. Focality of Disease Onset MSFATSCD Multiple Sclerosis Findings About Test Code CDISC SDTM Multiple Sclerosis Findings About Test Code Terminology Terminology relevant to the test names that describe multiple sclerosis findings. Diagnostic Criteria Met A description of the diagnostic criteria that the subject fulfilled in order to establish a medical diagnosis. Which Diagnostic Criteria Met Localization of Onset The anatomical location of the beginning or early stages of a disease. Location of Disease Onset Focus of Onset Onset Unifocal or Multifocal A characterization of the focality of the lesion at the time of disease diagnosis. Focality of Disease Onset MSFATS Multiple Sclerosis Findings About Test Name CDISC SDTM Multiple Sclerosis Findings About Test Name Terminology Multiple Sclerosis Quality of Life-54 Instrument test code. MSQL1-Would You Say Your Health Is Multiple Sclerosis Quality of Life-54 Instrument - In general, would you say your health is: MSQOL-54 - Would You Say Your Health Is MSQL1-Health Now Compared to 1 Year Ago Multiple Sclerosis Quality of Life-54 Instrument - Compared to one year ago, how would you rate your health in general now? MSQOL-54 - Health Now Compared to One Year Ago MSQL1-Health Limit Vigorous Activities Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Vigorous activities, such as running, lifting heavy objects, participating in strenuous sports. MSQOL-54 - Health Limit Vigorous Activities MSQL1-Health Limit Moderate Activities Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. MSQOL-54 - Health Limit Moderate Activities MSQL1-Health Limit Carrying Groceries Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Lifting or carrying groceries. MSQOL-54 - Health Limit Lifting or Carrying Groceries MSQL1-Health Limit Climb Several Flights Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Climbing several flights of stairs. MSQOL-54 - Health Limit Climbing Several Stairs MSQL1-Health Limit Climb One Flight Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Climbing one flight of stairs. MSQOL-54 - Health Limit Climbing One Stair MSQL1-Health Limit Bending or Kneeling Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Bending, kneeling, or stooping. MSQOL-54 - Health Limit Bending, Kneeling or Stooping MSQL1-Health Limit Walk More Than Mile Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Walking more than a mile. MSQOL-54 - Health Limit Walking More than A Mile MSQL1-Health Limit Walk Several Blocks Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Walking several blocks. MSQOL-54 - Health Limit Walking Several Blocks MSQL1-Health Limit Walk One Block Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Walking one block. MSQOL-54 - Health Limit Walking One Block MSQL1-Health Limit Bathing/Dressing Self Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Bathing and dressing yourself. MSQOL-54 - Health Limit Bathing and Dressing Yourself MSQL1-Phys Health: Cut Work Time Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Cut down on the amount of time you could spend on work or other activities. MSQOL-54 - Physical Health Cut Down Time on Work MSQL1-Phys Health: Accomplish Less Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Accomplished less than you would like. MSQOL-54 - Physical Health Accomplish Less MSQL1-Phys Health: Limit Kind of Work Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Were limited in the kind of work or other activities. MSQOL-54 - Physical Health Limited in the Kind of Work MSQL1-Phys Health: Difficulty Performing Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Had difficulty performing the work or other activities. MSQOL-54 - Physical Health Difficulty Perform Work MSQL1-Emotional Problem: Cut Work Time Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems: Cut down on the amount of time you could spend on work or other activities. MSQOL-54 - Emotional Problem Cut Down Time on Work MSQL1-Emotional Problem: Accomplish Less Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems: Accomplished less than you would like. MSQOL-54 - Emotional Problem Accomplish Less MSQL1-Emotional Problem: Less Careful Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems: Didn't do work or other activities as carefully as usual. MSQOL-54 - Emotional Problem Did Not Do Work Carefully MSQL1-Extent Interfered Social Activity Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, to what extent has your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors, or groups? MSQOL-54 - Extend Physical Health or Emotional Problem Interfere With Social Activities MSQL1-How Much Bodily Pain Have You Had Multiple Sclerosis Quality of Life-54 Instrument - How much bodily pain have you had during the past 4 weeks? MSQOL-54 - Bodily Pain MSQL1-Did Pain Interfere With Your Work Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, how much did pain interfere with your normal work? MSQOL-54 - Pain Interfere With Normal Work MSQL1-Did You Feel Full of Pep Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Did you feel full of pep? MSQOL-54 - Feel Full of Pep MSQL1-Have Been a Very Nervous Person Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have you been a very nervous person? MSQOL-54 - Been a Nervous Person MSQL1-Have Felt So Down in the Dumps Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have you felt so down in the dumps that nothing could cheer you up? MSQOL-54 - Felt So Down Nothing Could Cheer You Up MSQL1-Have You Felt Calm and Peaceful Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have you felt calm and peaceful? MSQOL-54 - Felt Calm and Peaceful MSQL1-Did You Have a Lot of Energy Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Did you have a lot of energy? MSQOL-54 - Have a Lot of Energy MSQL1-Have Felt Downhearted and Blue Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have you felt downhearted and blue? MSQOL-54 - Felt Downhearted and Blue MSQL1-Did You Feel Worn Out Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Did you feel worn out? MSQOL-54 - Feel Worn Out MSQL1-Have You Been a Happy Person Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have you been a happy person? MSQOL-54 - Been a Happy Person MSQL1-Did You Feel Tired Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Did you feel tired? MSQOL-54 - Feel Tired MSQL1-Did You Feel Rested on Waking Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Did you feel rested on waking in the morning? MSQOL-54 - Feel Rested Waking in the Morning MSQL1-Amt Time Interfere Social Activity Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities? MSQOL-54 - Time Physical Health or Emotional Problem Interfere With Social Activities MSQL1-Get Sick Easier Than Other People Multiple Sclerosis Quality of Life-54 Instrument - How TRUE or FALSE is each of the following statements for you: I seem to get sick a little easier than other people. MSQOL-54 - Get Sick Easier Than Other MSQL1-I Am as Healthy as Anybody I Know Multiple Sclerosis Quality of Life-54 Instrument - How TRUE or FALSE is each of the following statements for you: I am as healthy as anybody I know. MSQOL-54 - As Healthy as Anybody MSQL1-I Expect My Health to Get Worse Multiple Sclerosis Quality of Life-54 Instrument - How TRUE or FALSE is each of the following statements for you: I expect my health to get worse. MSQOL-54 - Expect Health to Get Worse MSQL1-My Health Is Excellent Multiple Sclerosis Quality of Life-54 Instrument - How TRUE or FALSE is each of the following statements for you: My health is excellent. MSQOL-54 - Health is Excellent MSQL1-Discouraged by Health Problems Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Were you discouraged by your health problems? MSQOL-54 - Discouraged by Health Problem MSQL1-Were Frustrated About Your Health Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Were you frustrated about your health? MSQOL-54 - Frustrated With Health MSQL1-Was Health a Worry in Your Life Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Was your health a worry in your life? MSQOL-54 - Health a Worry in Life MSQL1-Weighed Down by Health Problems Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Did you feel weighed down by your health problems? MSQOL-54 - Feel Weighed Down by Health Problem MSQL1-Difficulty Concentrating/Thinking Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have you had difficulty concentrating and thinking? MSQOL-54 - Difficulty Concentrating and Thinking MSQL1-Trouble Keep Attention for Long Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Did you have trouble keeping your attention on an activity for long? MSQOL-54 - Trouble Keep Attention for Long MSQL1-Have Had Trouble With Your Memory Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have you had trouble with your memory? MSQOL-54 - Trouble With Memory MSQL1-Others Notice Your Memory Trouble Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have others, such as family members or friends, noticed that you have trouble with your memory or problems with your concentration? MSQOL-54 - Others Notice Your Problems With Memory or Concentration MSQL1-Lack of Sexual Interest Multiple Sclerosis Quality of Life-54 Instrument - How much of a problem was each of the following for you during the past 4 weeks: Lack of sexual interest. MSQOL-54 - Lack of Sexual Interest MSQL1-Difficult Getting/Keeping Erection Multiple Sclerosis Quality of Life-54 Instrument - How much of a problem was each of the following for you during the past 4 weeks: Difficulty getting or keeping an erection. MSQOL-54 - Difficulty Keeping an Erection MSQL1-Inadequate Lubrication Multiple Sclerosis Quality of Life-54 Instrument - How much of a problem was each of the following for you during the past 4 weeks: Inadequate lubrication. MSQOL-54 - Inadequate Lubrication MSQL1-Difficulty Having Orgasm Multiple Sclerosis Quality of Life-54 Instrument - How much of a problem was each of the following for you during the past 4 weeks: Difficulty having orgasm. MSQOL-54 - Difficulty Having Orgasm MSQL1-Ability to Satisfy Sexual Partner Multiple Sclerosis Quality of Life-54 Instrument - How much of a problem was each of the following for you during the past 4 weeks: Ability to satisfy sexual partner. MSQOL-54 - Ability to Satisfy Sexual Partner MSQL1-Satisfied With Sexual Function Multiple Sclerosis Quality of Life-54 Instrument - Overall, how satisfied were you with your sexual function during the past 4 weeks? MSQOL-54 - Satisfied With Sexual Function MSQL1-Bowel/Bladder Interfered Activity Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, to what extent have problems with your bowel or bladder function interfered with your normal social activities with family, friends, neighbors, or groups? MSQOL-54 - Bowel or Bladder Function Interfere With Social Activities MSQL1-Pain Interfere Enjoyment of Life Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, how much did pain interfere with your enjoyment of life? MSQOL-54 - Pain Interfere Enjoyment of Life MSQL1-Rate Your Own Quality-of-Life Multiple Sclerosis Quality of Life-54 Instrument - Overall, how would you rate your own quality-of-life? MSQOL-54 - Rate Your Own Quality of Life MSQL1-Describe How Feel About Your Life Multiple Sclerosis Quality of Life-54 Instrument - Which best describes how you feel about your life as a whole? MSQOL-54 - Describe How You Feel About Your Life MSQL1TC Multiple Sclerosis Quality of Life-54 Instrument Questionnaire Test Code CDISC Questionnaire Multiple Sclerosis Quality of Life-54 Instrument Test Code Terminology Multiple Sclerosis Quality of Life-54 Instrument test name. MSQL1-Ability to Satisfy Sexual Partner Multiple Sclerosis Quality of Life-54 Instrument - How much of a problem was each of the following for you during the past 4 weeks: Ability to satisfy sexual partner. MSQOL-54 - Ability to Satisfy Sexual Partner MSQL1-Amt Time Interfere Social Activity Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities? MSQOL-54 - Time Physical Health or Emotional Problem Interfere With Social Activities MSQL1-Bowel/Bladder Interfered Activity Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, to what extent have problems with your bowel or bladder function interfered with your normal social activities with family, friends, neighbors, or groups? MSQOL-54 - Bowel or Bladder Function Interfere With Social Activities MSQL1-Describe How Feel About Your Life Multiple Sclerosis Quality of Life-54 Instrument - Which best describes how you feel about your life as a whole? MSQOL-54 - Describe How You Feel About Your Life MSQL1-Did Pain Interfere With Your Work Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, how much did pain interfere with your normal work? MSQOL-54 - Pain Interfere With Normal Work MSQL1-Did You Feel Full of Pep Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Did you feel full of pep? MSQOL-54 - Feel Full of Pep MSQL1-Did You Feel Rested on Waking Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Did you feel rested on waking in the morning? MSQOL-54 - Feel Rested Waking in the Morning MSQL1-Did You Feel Tired Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Did you feel tired? MSQOL-54 - Feel Tired MSQL1-Did You Feel Worn Out Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Did you feel worn out? MSQOL-54 - Feel Worn Out MSQL1-Did You Have a Lot of Energy Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Did you have a lot of energy? MSQOL-54 - Have a Lot of Energy MSQL1-Difficult Getting/Keeping Erection Multiple Sclerosis Quality of Life-54 Instrument - How much of a problem was each of the following for you during the past 4 weeks: Difficulty getting or keeping an erection. MSQOL-54 - Difficulty Keeping an Erection MSQL1-Difficulty Concentrating/Thinking Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have you had difficulty concentrating and thinking? MSQOL-54 - Difficulty Concentrating and Thinking MSQL1-Difficulty Having Orgasm Multiple Sclerosis Quality of Life-54 Instrument - How much of a problem was each of the following for you during the past 4 weeks: Difficulty having orgasm. MSQOL-54 - Difficulty Having Orgasm MSQL1-Discouraged by Health Problems Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Were you discouraged by your health problems? MSQOL-54 - Discouraged by Health Problem MSQL1-Emotional Problem: Accomplish Less Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems: Accomplished less than you would like. MSQOL-54 - Emotional Problem Accomplish Less MSQL1-Emotional Problem: Cut Work Time Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems: Cut down on the amount of time you could spend on work or other activities. MSQOL-54 - Emotional Problem Cut Down Time on Work MSQL1-Emotional Problem: Less Careful Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems: Didn't do work or other activities as carefully as usual. MSQOL-54 - Emotional Problem Did Not Do Work Carefully MSQL1-Extent Interfered Social Activity Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, to what extent has your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors, or groups? MSQOL-54 - Extend Physical Health or Emotional Problem Interfere With Social Activities MSQL1-Get Sick Easier Than Other People Multiple Sclerosis Quality of Life-54 Instrument - How TRUE or FALSE is each of the following statements for you: I seem to get sick a little easier than other people. MSQOL-54 - Get Sick Easier Than Other MSQL1-Have Been a Very Nervous Person Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have you been a very nervous person? MSQOL-54 - Been a Nervous Person MSQL1-Have Felt Downhearted and Blue Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have you felt downhearted and blue? MSQOL-54 - Felt Downhearted and Blue MSQL1-Have Felt So Down in the Dumps Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have you felt so down in the dumps that nothing could cheer you up? MSQOL-54 - Felt So Down Nothing Could Cheer You Up MSQL1-Have Had Trouble With Your Memory Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have you had trouble with your memory? MSQOL-54 - Trouble With Memory MSQL1-Have You Been a Happy Person Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have you been a happy person? MSQOL-54 - Been a Happy Person MSQL1-Have You Felt Calm and Peaceful Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have you felt calm and peaceful? MSQOL-54 - Felt Calm and Peaceful MSQL1-Health Limit Bathing/Dressing Self Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Bathing and dressing yourself. MSQOL-54 - Health Limit Bathing and Dressing Yourself MSQL1-Health Limit Bending or Kneeling Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Bending, kneeling, or stooping. MSQOL-54 - Health Limit Bending, Kneeling or Stooping MSQL1-Health Limit Carrying Groceries Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Lifting or carrying groceries. MSQOL-54 - Health Limit Lifting or Carrying Groceries MSQL1-Health Limit Climb One Flight Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Climbing one flight of stairs. MSQOL-54 - Health Limit Climbing One Stair MSQL1-Health Limit Climb Several Flights Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Climbing several flights of stairs. MSQOL-54 - Health Limit Climbing Several Stairs MSQL1-Health Limit Moderate Activities Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. MSQOL-54 - Health Limit Moderate Activities MSQL1-Health Limit Vigorous Activities Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Vigorous activities, such as running, lifting heavy objects, participating in strenuous sports. MSQOL-54 - Health Limit Vigorous Activities MSQL1-Health Limit Walk More Than Mile Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Walking more than a mile. MSQOL-54 - Health Limit Walking More than A Mile MSQL1-Health Limit Walk One Block Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Walking one block. MSQOL-54 - Health Limit Walking One Block MSQL1-Health Limit Walk Several Blocks Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Walking several blocks. MSQOL-54 - Health Limit Walking Several Blocks MSQL1-Health Now Compared to 1 Year Ago Multiple Sclerosis Quality of Life-54 Instrument - Compared to one year ago, how would you rate your health in general now? MSQOL-54 - Health Now Compared to One Year Ago MSQL1-How Much Bodily Pain Have You Had Multiple Sclerosis Quality of Life-54 Instrument - How much bodily pain have you had during the past 4 weeks? MSQOL-54 - Bodily Pain MSQL1-I Am as Healthy as Anybody I Know Multiple Sclerosis Quality of Life-54 Instrument - How TRUE or FALSE is each of the following statements for you: I am as healthy as anybody I know. MSQOL-54 - As Healthy as Anybody MSQL1-I Expect My Health to Get Worse Multiple Sclerosis Quality of Life-54 Instrument - How TRUE or FALSE is each of the following statements for you: I expect my health to get worse. MSQOL-54 - Expect Health to Get Worse MSQL1-Inadequate Lubrication Multiple Sclerosis Quality of Life-54 Instrument - How much of a problem was each of the following for you during the past 4 weeks: Inadequate lubrication. MSQOL-54 - Inadequate Lubrication MSQL1-Lack of Sexual Interest Multiple Sclerosis Quality of Life-54 Instrument - How much of a problem was each of the following for you during the past 4 weeks: Lack of sexual interest. MSQOL-54 - Lack of Sexual Interest MSQL1-My Health Is Excellent Multiple Sclerosis Quality of Life-54 Instrument - How TRUE or FALSE is each of the following statements for you: My health is excellent. MSQOL-54 - Health is Excellent MSQL1-Others Notice Your Memory Trouble Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have others, such as family members or friends, noticed that you have trouble with your memory or problems with your concentration? MSQOL-54 - Others Notice Your Problems With Memory or Concentration MSQL1-Pain Interfere Enjoyment of Life Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, how much did pain interfere with your enjoyment of life? MSQOL-54 - Pain Interfere Enjoyment of Life MSQL1-Phys Health: Accomplish Less Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Accomplished less than you would like. MSQOL-54 - Physical Health Accomplish Less MSQL1-Phys Health: Cut Work Time Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Cut down on the amount of time you could spend on work or other activities. MSQOL-54 - Physical Health Cut Down Time on Work MSQL1-Phys Health: Difficulty Performing Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Had difficulty performing the work or other activities. MSQOL-54 - Physical Health Difficulty Perform Work MSQL1-Phys Health: Limit Kind of Work Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Were limited in the kind of work or other activities. MSQOL-54 - Physical Health Limited in the Kind of Work MSQL1-Rate Your Own Quality-of-Life Multiple Sclerosis Quality of Life-54 Instrument - Overall, how would you rate your own quality-of-life? MSQOL-54 - Rate Your Own Quality of Life MSQL1-Satisfied With Sexual Function Multiple Sclerosis Quality of Life-54 Instrument - Overall, how satisfied were you with your sexual function during the past 4 weeks? MSQOL-54 - Satisfied With Sexual Function MSQL1-Trouble Keep Attention for Long Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Did you have trouble keeping your attention on an activity for long? MSQOL-54 - Trouble Keep Attention for Long MSQL1-Was Health a Worry in Your Life Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Was your health a worry in your life? MSQOL-54 - Health a Worry in Life MSQL1-Weighed Down by Health Problems Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Did you feel weighed down by your health problems? MSQOL-54 - Feel Weighed Down by Health Problem MSQL1-Were Frustrated About Your Health Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Were you frustrated about your health? MSQOL-54 - Frustrated With Health MSQL1-Would You Say Your Health Is Multiple Sclerosis Quality of Life-54 Instrument - In general, would you say your health is: MSQOL-54 - Would You Say Your Health Is MSQL1TN Multiple Sclerosis Quality of Life-54 Instrument Questionnaire Test Name CDISC Questionnaire Multiple Sclerosis Quality of Life-54 Instrument Test Name Terminology A terminology codelist to describe the test code for a physiological examination of the musculoskeletal system. Alpha Angle Alpha Angle of the Hip A measurement of the angle between the line from the center of the femoral head to the center of the femoral neck at its narrowest point and the line from the center of the femoral head to a point where the distance from the bone to the center of the head is greater than the radius of the cartilage-covered femoral head. Alpha Angle of the Hip Area The extent of a 2-dimensional surface enclosed within a boundary. (NCI) Area Appendicular Skeletal Muscle Mass ASMM A measurement of the mass of the muscles of the arms and legs. Appendicular Skeletal Muscle Mass Measurement Adipose Tissue-Free Volume Non-Adipose Tissue Volume A measurement of the volume of total tissue distributed within a specific body region or the entire body, excluding adipose tissue. Non-Adipose Tissue Volume Measurement Adipose Tissue Volume Total Adipose Tissue Volume A measurement of the volume of total adipose tissue distributed within a specific body region or the entire body. Adipose Tissue Volume Measurement Beta Angle Beta Angle of the Hip A measurement of the angle formed by the cartilaginous roof to the vertical cortex of the ilium. Beta Angle of the Hip Bone Mass Bone Mineral Content Bone Mineral Mass An assessment of the quantity of minerals within a specific bone(s) or segments. Bone Mineral Content Bone Mineral Density A measurement of the amount of minerals contained in a specified volume or area of bone(s) or segments. Bone Mineral Density Test Bone Mineral Density T-Score The standard deviation of the subject's bone mineral density score in comparison to the normal bone mineral density of a healthy 30-year old adult. Bone Mineral Density T-Score Bone Mineral Density Z-Score A statistical score representing the number of standard deviations above or below what is expected for an individual's bone mineral density based on his age, sex, weight, and race. Bone Mineral Density Z-Score Brooke mMRC MMT Score, Abduction Brooke Modified Medical Research Council Manual Muscle Test Score, Abduction The numerical value that represents the result of a clinical assessment of muscle strength and function during abduction that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). Brooke Modified Medical Research Council Manual Muscle Test Score, Abduction Brooke mMRC MMT Score, Dorsiflexion Brooke Modified Medical Research Council Manual Muscle Test Score, Dorsiflexion The numerical value that represents the result of a clinical assessment of muscle strength and function during dorsiflexion that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). Brooke Modified Medical Research Council Manual Muscle Test Score, Dorsiflexion Brooke mMRC MMT Score, Eversion Brooke Modified Medical Research Council Manual Muscle Test Score, Eversion The numerical value that represents the result of a clinical assessment of muscle strength and function during eversion that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). Brooke Modified Medical Research Council Manual Muscle Test Score, Eversion Brooke mMRC MMT Score, Extension Brooke Modified Medical Research Council Manual Muscle Test Score, Extension The numerical value that represents the result of a clinical assessment of muscle strength and function during extension that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). Brooke Modified Medical Research Council Manual Muscle Test Score, Extension Brooke mMRC MMT Score, Flexion Brooke Modified Medical Research Council Manual Muscle Test Score, Flexion The numerical value that represents the result of a clinical assessment of muscle strength and function during flexion that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). Brooke Modified Medical Research Council Manual Muscle Test Score, Flexion Brooke mMRC MMT Score, Inversion Brooke Modified Medical Research Council Manual Muscle Test Score, Inversion The numerical value that represents the result of a clinical assessment of muscle strength and function during inversion that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). Brooke Modified Medical Research Council Manual Muscle Test Score, Inversion Brooke mMRC MMT Score, Lat. Rotat. Brooke Modified Medical Research Council Manual Muscle Test Score, Lateral Rotation The numerical value that represents the result of a clinical assessment of muscle strength and function during lateral rotation that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). Brooke Modified Medical Research Council Manual Muscle Test Score, Lateral Rotation Brooke mMRC MMT Score, Plantar Flex Brooke Modified Medical Research Council Manual Muscle Test Score, Plantar Flexion The numerical value that represents the result of a clinical assessment of muscle strength and function during plantar flexion that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). Brooke Modified Medical Research Council Manual Muscle Test Score, Plantar Flexion Total Body Fat/Total Body Mass A relative measurement (ratio or percentage) of an individual's total body fat to total body weight. Total Body Fat to Total Body Mass Ratio Measurement EMCL Norm for Phantom Volume EMCL Normalized for Phantom Volume A measurement of extramyocellular lipid normalized for imaging phantom volume, in a biological specimen. Extramyocellular Lipid Normalized for Phantom Volume Measurement EMCL Norm for Tissue Weight EMCL Normalized for Tissue Weight Extramyocellular Lipid Normalized for Tissue Weight A measurement of extramyocellular lipid normalized for tissue weight, in a biological specimen. Extramyocellular Lipid Normalized for Tissue Weight Measurement EMCL Norm for Tissue Water Volume EMCL Normalized for Tissue Water Volume Extramyocellular Lipid Normalized for Tissue Water Volume A measurement of extramyocellular lipid normalized for tissue water volume, in a biological specimen. Extramyocellular Lipid Normalized for Tissue Water Volume Measurement Muscle Endurance A measurement of a muscle's ability to perform repetitive contractions against a force. Muscle Endurance Measurement Fat Mass A measurement of the fat weight associated with a body part or whole body. Fat Mass Fontanelle Closure Indicator An indication as to whether the fontanelle is closed. Fontanelle Closure Indicator Glycogen Norm for Phantom Volume Glycogen Normalized for Phantom Volume A measurement of glycogen normalized for imaging phantom volume, in a biological specimen. Glycogen Normalized for Phantom Volume Measurement Glycogen Norm for Tissue Weight Glycogen Normalized for Tissue Weight A measurement of glycogen normalized for tissue weight, in a biological specimen. Glycogen Normalized for Tissue Weight Measurement Glycogen Norm for Tissue Water Vol Glycogen Normalized for Tissue Water Volume A measurement of glycogen normalized for tissue water volume, in a biological specimen. Glycogen Normalized for Tissue Water Volume Measurement Greulich and Pyle Bone Age Estimation Greulich and Pyle Skeletal Maturity Estimation An estimated assessment of an individual's skeletal maturity (bone age) based on comparison of standard radiographic images of the bones of the hand and wrist. (Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist. The American Journal of the Medical Sciences. 1959;238(3):393.) Greulich and Pyle Bone Age Estimation Grip Strength An assessment of muscle strength that measures that force with which one holds or grasps. Grip Strength IMCL Norm for Phantom Volume IMCL Normalized for Phantom Volume A measurement of intramyocellular lipid normalized for imaging phantom volume, in a biological specimen. Intramyocellular Lipid Normalized for Phantom Volume Measurement IMCL Norm for Tissue Weight IMCL Normalized for Tissue Weight Intramyocellular Lipid Normalized for Tissue Weight A measurement of intramyocellular lipid normalized for tissue weight, in a biological specimen. Intramyocellular Lipid Normalized for Tissue Weight Measurement IMCL Norm for Tissue Water Volume IMCL Normalized for Tissue Water Volume Intramyocellular Lipid Normalized for Tissue Water Volume A measurement of intramyocellular lipid normalized for tissue water volume, in a biological specimen. Intramyocellular Lipid Normalized for Tissue Water Volume Measurement Isometric Muscle Strength, Abduction An assessment of muscle strength that measures the force produced by static muscle contraction during the movement of a body part away from the midline of the body. Isometric Muscle Strength, Abduction Isometric Muscle Strength, Adduction An assessment of muscle strength that measures the force produced by static muscle contraction during the movement of a body part toward the midline of the body. Isometric Muscle Strength, Adduction Isometric Muscle Strength, Dorsiflexion An assessment of muscle strength that measures the force produced by static muscle contraction during the movement of a body part bending upwards towards the dorsal surface of the body. Isometric Muscle Strength, Dorsiflexion Isometric Muscle Strength, Extern Rotat Isometric Muscle Strength, External Rotation An assessment of muscle strength that measures the force produced by static muscle contraction during the rotational movement of a body part outward, away from the body. Isometric Muscle Strength, External Rotation Isometric Muscle Strength, Extension An assessment of muscle strength that measures the force produced by static muscle contraction during the straightening (unbending) movement between body parts. (NCI) Isometric Muscle Strength, Extension Isometric Muscle Strength, Flexion An assessment of muscle strength that measures the force produced by static muscle contraction during the bending movement between body parts. (NCI) Isometric Muscle Strength, Flexion Isometric Muscle Strength, Intern Rotat Isometric Muscle Strength, Internal Rotation An assessment of muscle strength that measures the force produced by static muscle contraction during the rotational movement of a body part inward, toward the body. Isometric Muscle Strength, Internal Rotation Lean Mass A measurement of the weight of a body part or whole body, minus the weight of the fat associated with that body part or whole body. Lean Mass Myoglobin Deoxygenation Rate A measurement of myoglobin deoxygenation per unit of time. Myoglobin Deoxygenation Rate Myoglobin Deoxygenation Time A measurement of the time it takes for myoglobin to fully deoxygenate. Myoglobin Deoxygenation Time Measurement Myoglobin Reoxygenation Time Constant A measurement of the exponential time constant of myoglobin reoxygenation. Myoglobin Reoxygenation Time Constant Measurement Musculoskeletal System Examination An observation, assessment or examination of the musculoskeletal system. Musculoskeletal Examination Medical Research Council Manual Muscle Test Score, Abduction MRC MMT Score, Abduction The numerical value that represents the result of a clinical assessment of muscle strength and function during abduction that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). Medical Research Council Manual Muscle Test Score, Abduction Medical Research Council Manual Muscle Test Score, Dorsiflexion MRC MMT Score, Dorsiflexion The numerical value that represents the result of a clinical assessment of muscle strength and function during dorsiflexion that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). Medical Research Council Manual Muscle Test Score, Dorsiflexion Medical Research Council Manual Muscle Test Score, Eversion MRC MMT Score, Eversion The numerical value that represents the result of a clinical assessment of muscle strength and function during eversion that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). Medical Research Council Manual Muscle Test Score, Eversion Medical Research Council Manual Muscle Test Score, Extension MRC MMT Score, Extension The numerical value that represents the result of a clinical assessment of muscle strength and function during extension that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). Medical Research Council Manual Muscle Test Score, Extension Medical Research Council Manual Muscle Test Score, Flexion MRC MMT Score, Flexion The numerical value that represents the result of a clinical assessment of muscle strength and function during flexion that is based on the Medical Research Council Manual Muscle. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). Medical Research Council Manual Muscle Test Score, Flexion Medical Research Council Manual Muscle Test Score, Inversion MRC MMT Score, Inversion The numerical value that represents the result of a clinical assessment of muscle strength and function during inversion that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). Medical Research Council Manual Muscle Test Score, Inversion Medical Research Council Manual Muscle Test Score, Lateral Rotation MRC MMT Score, Lat. Rotat. The numerical value that represents the result of a clinical assessment of muscle strength and function during lateral rotation that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). Medical Research Council Manual Muscle Test Score, Lateral Rotation Medical Research Council Manual Muscle Test Score, Plantar Flexion MRC MMT Score, Plantar Flex The numerical value that represents the result of a clinical assessment of muscle strength and function during plantar flexion that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). Medical Research Council Manual Muscle Test Score, Plantar Flexion Myoglobin Peak Norm for Phantom Vol Myoglobin Peak Normalized for Phantom Volume A measurement of the peak myoglobin normalized for imaging phantom volume, in a biological specimen. Myoglobin Peak Normalized for Phantom Volume Measurement Myoglobin Peak Norm for Tissue Weight Myoglobin Peak Normalized for Tissue Weight A measurement of the peak myoglobin normalized for tissue weight, in a biological specimen. Myoglobin Peak Normalized for Tissue Weight Measurement Myoglobin Peak Norm for Tissue Water Vol Myoglobin Peak Normalized for Tissue Water Volume A measurement of the peak myoglobin normalized for tissue water volume, in a biological specimen. Myoglobin Peak Normalized for Tissue Water Volume Measurement Pinch Strength An assessment of hand muscle strength that measures the force with which an individual can squeeze or compress an object using his thumb and one or multiple fingers from the same hand. Pinch Strength Range of Motion, Abduction An assessment of joint flexibility that measures the movement of a body part pulling away from the midline of the body, in number of degrees. (NCI) Range of Motion, Abduction Range of Motion, Dorsiflexion An assessment of joint flexibility that measures the movement of a body part bending towards its dorsal surface, in number of degrees. (NCI) Range of Motion, Dorsiflexion Range of Motion, Extension An assessment of joint flexibility that measures the straightening (unbending) movement between body parts, in number of degrees. (NCI) Range of Motion, Extension Subcutaneous Adipose Tissue Volume A measurement of the volume of adipose tissue within the subcutaneous layer of the skin. Subcutaneous Adipose Tissue Volume Measurement Sharp/Genant Bone Erosion Score The numerical value that represents the result of a clinical assessment of bone erosion based on the Genant modification of the Sharp Joint Erosion Assessment (Genant HK. Methods of assessing radiographic change in rheumatoid arthritis. Am J Med. 1983 Dec 30;75(6A):35-47). Sharp Genant Bone Erosion Score Sharp/Genant JSN Score The numerical value that represents the result of a clinical assessment of joint space narrowing based on the Genant modification of the Sharp Joint Space Narrowing Assessment (Genant HK. Methods of assessing radiographic change in rheumatoid arthritis. Am J Med. 1983 Dec 30;75(6A):35-47). Sharp Genant Joint Space Narrowing Score Skeletal Muscle Mass A measurement of the total mass of the skeletal muscle. Skeletal Muscle Mass Measurement Sharp/Van der Heijde Bone Erosion Score The numerical value that represents the result of a clinical assessment of bone erosion based on the Van der Heijde modification of the Sharp Joint Erosion Assessment (Van der Heijde DM, van Riel PL, Nuver-Zwart IH, Gribnau FW, van de Putte LB. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989;1:1036-8). Sharp van der Heijde Bone Erosion Score Sharp/Van der Heijde JSN Score The numerical value that represents the result of a clinical assessment of joint space narrowing based on the Van der Heijde modification of the Sharp Joint Space Narrowing Assessment (Van der Heijde DM, van Riel PL, Nuver-Zwart IH, Gribnau FW, van de Putte LB. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989;1:1036-8). Sharp van der Heijde Joint Space Narrowing Score Swollen Indicator An indication as to whether there are symptoms of swelling. Swollen Indicator Tenderness Indicator An indication as to whether there are symptoms of tenderness. Tenderness Indicator Visceral Adipose Tissue Volume A measurement of the volume of adipose tissue around the internal organs of the body. Visceral Adipose Tissue Volume Measurement MUSCTSCD Musculoskeletal System Finding Test Code CDISC SDTM Musculoskeletal System Finding Test Code Terminology A terminology codelist to describe the test name for a physiological examination of the musculoskeletal system. Adipose Tissue Volume Total Adipose Tissue Volume A measurement of the volume of total adipose tissue distributed within a specific body region or the entire body. Adipose Tissue Volume Measurement Alpha Angle Alpha Angle of the Hip A measurement of the angle between the line from the center of the femoral head to the center of the femoral neck at its narrowest point and the line from the center of the femoral head to a point where the distance from the bone to the center of the head is greater than the radius of the cartilage-covered femoral head. Alpha Angle of the Hip Appendicular Skeletal Muscle Mass ASMM A measurement of the mass of the muscles of the arms and legs. Appendicular Skeletal Muscle Mass Measurement Area The extent of a 2-dimensional surface enclosed within a boundary. (NCI) Area Beta Angle Beta Angle of the Hip A measurement of the angle formed by the cartilaginous roof to the vertical cortex of the ilium. Beta Angle of the Hip Bone Mass Bone Mineral Content Bone Mineral Mass An assessment of the quantity of minerals within a specific bone(s) or segments. Bone Mineral Content Bone Mineral Density T-Score The standard deviation of the subject's bone mineral density score in comparison to the normal bone mineral density of a healthy 30-year old adult. Bone Mineral Density T-Score Bone Mineral Density Z-Score A statistical score representing the number of standard deviations above or below what is expected for an individual's bone mineral density based on his age, sex, weight, and race. Bone Mineral Density Z-Score Bone Mineral Density A measurement of the amount of minerals contained in a specified volume or area of bone(s) or segments. Bone Mineral Density Test Brooke mMRC MMT Score, Abduction Brooke Modified Medical Research Council Manual Muscle Test Score, Abduction The numerical value that represents the result of a clinical assessment of muscle strength and function during abduction that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). Brooke Modified Medical Research Council Manual Muscle Test Score, Abduction Brooke mMRC MMT Score, Dorsiflexion Brooke Modified Medical Research Council Manual Muscle Test Score, Dorsiflexion The numerical value that represents the result of a clinical assessment of muscle strength and function during dorsiflexion that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). Brooke Modified Medical Research Council Manual Muscle Test Score, Dorsiflexion Brooke mMRC MMT Score, Eversion Brooke Modified Medical Research Council Manual Muscle Test Score, Eversion The numerical value that represents the result of a clinical assessment of muscle strength and function during eversion that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). Brooke Modified Medical Research Council Manual Muscle Test Score, Eversion Brooke mMRC MMT Score, Extension Brooke Modified Medical Research Council Manual Muscle Test Score, Extension The numerical value that represents the result of a clinical assessment of muscle strength and function during extension that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). Brooke Modified Medical Research Council Manual Muscle Test Score, Extension Brooke mMRC MMT Score, Flexion Brooke Modified Medical Research Council Manual Muscle Test Score, Flexion The numerical value that represents the result of a clinical assessment of muscle strength and function during flexion that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). Brooke Modified Medical Research Council Manual Muscle Test Score, Flexion Brooke mMRC MMT Score, Inversion Brooke Modified Medical Research Council Manual Muscle Test Score, Inversion The numerical value that represents the result of a clinical assessment of muscle strength and function during inversion that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). Brooke Modified Medical Research Council Manual Muscle Test Score, Inversion Brooke mMRC MMT Score, Lat. Rotat. Brooke Modified Medical Research Council Manual Muscle Test Score, Lateral Rotation The numerical value that represents the result of a clinical assessment of muscle strength and function during lateral rotation that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). Brooke Modified Medical Research Council Manual Muscle Test Score, Lateral Rotation Brooke mMRC MMT Score, Plantar Flex Brooke Modified Medical Research Council Manual Muscle Test Score, Plantar Flexion The numerical value that represents the result of a clinical assessment of muscle strength and function during plantar flexion that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). Brooke Modified Medical Research Council Manual Muscle Test Score, Plantar Flexion EMCL Norm for Phantom Volume EMCL Normalized for Phantom Volume A measurement of extramyocellular lipid normalized for imaging phantom volume, in a biological specimen. Extramyocellular Lipid Normalized for Phantom Volume Measurement EMCL Norm for Tissue Water Volume EMCL Normalized for Tissue Water Volume Extramyocellular Lipid Normalized for Tissue Water Volume A measurement of extramyocellular lipid normalized for tissue water volume, in a biological specimen. Extramyocellular Lipid Normalized for Tissue Water Volume Measurement EMCL Norm for Tissue Weight EMCL Normalized for Tissue Weight Extramyocellular Lipid Normalized for Tissue Weight A measurement of extramyocellular lipid normalized for tissue weight, in a biological specimen. Extramyocellular Lipid Normalized for Tissue Weight Measurement Fat Mass A measurement of the fat weight associated with a body part or whole body. Fat Mass Fontanelle Closure Indicator An indication as to whether the fontanelle is closed. Fontanelle Closure Indicator Glycogen Norm for Phantom Volume Glycogen Normalized for Phantom Volume A measurement of glycogen normalized for imaging phantom volume, in a biological specimen. Glycogen Normalized for Phantom Volume Measurement Glycogen Norm for Tissue Water Vol Glycogen Normalized for Tissue Water Volume A measurement of glycogen normalized for tissue water volume, in a biological specimen. Glycogen Normalized for Tissue Water Volume Measurement Glycogen Norm for Tissue Weight Glycogen Normalized for Tissue Weight A measurement of glycogen normalized for tissue weight, in a biological specimen. Glycogen Normalized for Tissue Weight Measurement Greulich and Pyle Bone Age Estimation Greulich and Pyle Skeletal Maturity Estimation An estimated assessment of an individual's skeletal maturity (bone age) based on comparison of standard radiographic images of the bones of the hand and wrist. (Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist. The American Journal of the Medical Sciences. 1959;238(3):393.) Greulich and Pyle Bone Age Estimation Grip Strength An assessment of muscle strength that measures that force with which one holds or grasps. Grip Strength IMCL Norm for Phantom Volume IMCL Normalized for Phantom Volume A measurement of intramyocellular lipid normalized for imaging phantom volume, in a biological specimen. Intramyocellular Lipid Normalized for Phantom Volume Measurement IMCL Norm for Tissue Water Volume IMCL Normalized for Tissue Water Volume Intramyocellular Lipid Normalized for Tissue Water Volume A measurement of intramyocellular lipid normalized for tissue water volume, in a biological specimen. Intramyocellular Lipid Normalized for Tissue Water Volume Measurement IMCL Norm for Tissue Weight IMCL Normalized for Tissue Weight Intramyocellular Lipid Normalized for Tissue Weight A measurement of intramyocellular lipid normalized for tissue weight, in a biological specimen. Intramyocellular Lipid Normalized for Tissue Weight Measurement Isometric Muscle Strength, Abduction An assessment of muscle strength that measures the force produced by static muscle contraction during the movement of a body part away from the midline of the body. Isometric Muscle Strength, Abduction Isometric Muscle Strength, Adduction An assessment of muscle strength that measures the force produced by static muscle contraction during the movement of a body part toward the midline of the body. Isometric Muscle Strength, Adduction Isometric Muscle Strength, Dorsiflexion An assessment of muscle strength that measures the force produced by static muscle contraction during the movement of a body part bending upwards towards the dorsal surface of the body. Isometric Muscle Strength, Dorsiflexion Isometric Muscle Strength, Extension An assessment of muscle strength that measures the force produced by static muscle contraction during the straightening (unbending) movement between body parts. (NCI) Isometric Muscle Strength, Extension Isometric Muscle Strength, Extern Rotat Isometric Muscle Strength, External Rotation An assessment of muscle strength that measures the force produced by static muscle contraction during the rotational movement of a body part outward, away from the body. Isometric Muscle Strength, External Rotation Isometric Muscle Strength, Flexion An assessment of muscle strength that measures the force produced by static muscle contraction during the bending movement between body parts. (NCI) Isometric Muscle Strength, Flexion Isometric Muscle Strength, Intern Rotat Isometric Muscle Strength, Internal Rotation An assessment of muscle strength that measures the force produced by static muscle contraction during the rotational movement of a body part inward, toward the body. Isometric Muscle Strength, Internal Rotation Lean Mass A measurement of the weight of a body part or whole body, minus the weight of the fat associated with that body part or whole body. Lean Mass Medical Research Council Manual Muscle Test Score, Abduction MRC MMT Score, Abduction The numerical value that represents the result of a clinical assessment of muscle strength and function during abduction that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). Medical Research Council Manual Muscle Test Score, Abduction Medical Research Council Manual Muscle Test Score, Dorsiflexion MRC MMT Score, Dorsiflexion The numerical value that represents the result of a clinical assessment of muscle strength and function during dorsiflexion that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). Medical Research Council Manual Muscle Test Score, Dorsiflexion Medical Research Council Manual Muscle Test Score, Eversion MRC MMT Score, Eversion The numerical value that represents the result of a clinical assessment of muscle strength and function during eversion that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). Medical Research Council Manual Muscle Test Score, Eversion Medical Research Council Manual Muscle Test Score, Extension MRC MMT Score, Extension The numerical value that represents the result of a clinical assessment of muscle strength and function during extension that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). Medical Research Council Manual Muscle Test Score, Extension Medical Research Council Manual Muscle Test Score, Flexion MRC MMT Score, Flexion The numerical value that represents the result of a clinical assessment of muscle strength and function during flexion that is based on the Medical Research Council Manual Muscle. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). Medical Research Council Manual Muscle Test Score, Flexion Medical Research Council Manual Muscle Test Score, Inversion MRC MMT Score, Inversion The numerical value that represents the result of a clinical assessment of muscle strength and function during inversion that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). Medical Research Council Manual Muscle Test Score, Inversion Medical Research Council Manual Muscle Test Score, Lateral Rotation MRC MMT Score, Lat. Rotat. The numerical value that represents the result of a clinical assessment of muscle strength and function during lateral rotation that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). Medical Research Council Manual Muscle Test Score, Lateral Rotation Medical Research Council Manual Muscle Test Score, Plantar Flexion MRC MMT Score, Plantar Flex The numerical value that represents the result of a clinical assessment of muscle strength and function during plantar flexion that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). Medical Research Council Manual Muscle Test Score, Plantar Flexion Muscle Endurance A measurement of a muscle's ability to perform repetitive contractions against a force. Muscle Endurance Measurement Musculoskeletal System Examination An observation, assessment or examination of the musculoskeletal system. Musculoskeletal Examination Myoglobin Deoxygenation Rate A measurement of myoglobin deoxygenation per unit of time. Myoglobin Deoxygenation Rate Myoglobin Deoxygenation Time A measurement of the time it takes for myoglobin to fully deoxygenate. Myoglobin Deoxygenation Time Measurement Myoglobin Peak Norm for Phantom Vol Myoglobin Peak Normalized for Phantom Volume A measurement of the peak myoglobin normalized for imaging phantom volume, in a biological specimen. Myoglobin Peak Normalized for Phantom Volume Measurement Myoglobin Peak Norm for Tissue Water Vol Myoglobin Peak Normalized for Tissue Water Volume A measurement of the peak myoglobin normalized for tissue water volume, in a biological specimen. Myoglobin Peak Normalized for Tissue Water Volume Measurement Myoglobin Peak Norm for Tissue Weight Myoglobin Peak Normalized for Tissue Weight A measurement of the peak myoglobin normalized for tissue weight, in a biological specimen. Myoglobin Peak Normalized for Tissue Weight Measurement Myoglobin Reoxygenation Time Constant A measurement of the exponential time constant of myoglobin reoxygenation. Myoglobin Reoxygenation Time Constant Measurement Adipose Tissue-Free Volume Non-Adipose Tissue Volume A measurement of the volume of total tissue distributed within a specific body region or the entire body, excluding adipose tissue. Non-Adipose Tissue Volume Measurement Pinch Strength An assessment of hand muscle strength that measures the force with which an individual can squeeze or compress an object using his thumb and one or multiple fingers from the same hand. Pinch Strength Range of Motion, Abduction An assessment of joint flexibility that measures the movement of a body part pulling away from the midline of the body, in number of degrees. (NCI) Range of Motion, Abduction Range of Motion, Dorsiflexion An assessment of joint flexibility that measures the movement of a body part bending towards its dorsal surface, in number of degrees. (NCI) Range of Motion, Dorsiflexion Range of Motion, Extension An assessment of joint flexibility that measures the straightening (unbending) movement between body parts, in number of degrees. (NCI) Range of Motion, Extension Sharp/Genant Bone Erosion Score The numerical value that represents the result of a clinical assessment of bone erosion based on the Genant modification of the Sharp Joint Erosion Assessment (Genant HK. Methods of assessing radiographic change in rheumatoid arthritis. Am J Med. 1983 Dec 30;75(6A):35-47). Sharp Genant Bone Erosion Score Sharp/Genant JSN Score The numerical value that represents the result of a clinical assessment of joint space narrowing based on the Genant modification of the Sharp Joint Space Narrowing Assessment (Genant HK. Methods of assessing radiographic change in rheumatoid arthritis. Am J Med. 1983 Dec 30;75(6A):35-47). Sharp Genant Joint Space Narrowing Score Sharp/Van der Heijde Bone Erosion Score The numerical value that represents the result of a clinical assessment of bone erosion based on the Van der Heijde modification of the Sharp Joint Erosion Assessment (Van der Heijde DM, van Riel PL, Nuver-Zwart IH, Gribnau FW, van de Putte LB. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989;1:1036-8). Sharp van der Heijde Bone Erosion Score Sharp/Van der Heijde JSN Score The numerical value that represents the result of a clinical assessment of joint space narrowing based on the Van der Heijde modification of the Sharp Joint Space Narrowing Assessment (Van der Heijde DM, van Riel PL, Nuver-Zwart IH, Gribnau FW, van de Putte LB. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989;1:1036-8). Sharp van der Heijde Joint Space Narrowing Score Skeletal Muscle Mass A measurement of the total mass of the skeletal muscle. Skeletal Muscle Mass Measurement Subcutaneous Adipose Tissue Volume A measurement of the volume of adipose tissue within the subcutaneous layer of the skin. Subcutaneous Adipose Tissue Volume Measurement Swollen Indicator An indication as to whether there are symptoms of swelling. Swollen Indicator Tenderness Indicator An indication as to whether there are symptoms of tenderness. Tenderness Indicator Total Body Fat/Total Body Mass A relative measurement (ratio or percentage) of an individual's total body fat to total body weight. Total Body Fat to Total Body Mass Ratio Measurement Visceral Adipose Tissue Volume A measurement of the volume of adipose tissue around the internal organs of the body. Visceral Adipose Tissue Volume Measurement MUSCTS Musculoskeletal System Finding Test Name CDISC SDTM Musculoskeletal System Finding Test Name Terminology National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 test code. FAC028-I Have Pain National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I have pain. NCCN-FACT FBLSI-18 Version 2 - I Have Pain FAC028-I Am Losing Weight National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I am losing weight. NCCN-FACT FBLSI-18 Version 2 - I Am Losing Weight FAC028-Have Trouble Controlling My Urine National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I have trouble controlling my urine. NCCN-FACT FBLSI-18 Version 2 - Have Trouble Controlling My Urine FAC028-I Feel Weak All Over National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I feel weak all over. NCCN-FACT FBLSI-18 Version 2 - I Feel Weak All Over FAC028-I Feel Light-headed National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I feel light-headed (dizzy). NCCN-FACT FBLSI-18 Version 2 - I Feel Light-headed FAC028-Trouble Meeting Needs of Family National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - Because of my physical condition, I have trouble meeting the needs of my family. NCCN-FACT FBLSI-18 Version 2 - Trouble Meeting Needs of Family FAC028-I Have a Good Appetite National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I have a good appetite. NCCN-FACT FBLSI-18 Version 2 - I Have a Good Appetite FAC028-Able to Have/Maintain Erection National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - (For men only) I am able to have and maintain an erection. NCCN-FACT FBLSI-18 Version 2 - Able to Have, Maintain Erection FAC028-I Am Sleeping Well National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I am sleeping well. NCCN-FACT FBLSI-18 Version 2 - I Am Sleeping Well FAC028-Worry My Condition Will Get Worse National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I worry that my condition will get worse. NCCN-FACT FBLSI-18 Version 2 - Worry My Condition Will Get Worse FAC028-I Feel Sad National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I feel sad. NCCN-FACT FBLSI-18 Version 2 - I Feel Sad FAC028-I Have Nausea National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I have nausea. NCCN-FACT FBLSI-18 Version 2 - I Have Nausea FAC028-I Have a Lack of Energy National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I have a lack of energy. NCCN-FACT FBLSI-18 Version 2 - I Have a Lack of Energy FAC028-I Feel Ill National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I feel ill. NCCN-FACT FBLSI-18 Version 2 - I Feel Ill FAC028-I Have Control of My Bowels National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I have control of my bowels. NCCN-FACT FBLSI-18 Version 2 - I Have Control of My Bowels FAC028-Bothered by Treatment Side Effect National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I am bothered by side effects of treatment. NCCN-FACT FBLSI-18 Version 2 - Bothered by Treatment Side Effect FAC028-I Am Able to Enjoy Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I am able to enjoy life. NCCN-FACT FBLSI-18 Version 2 - I Am Able to Enjoy Life FAC028-Content With Quality of My Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I am content with the quality of my life right now. NCCN-FACT FBLSI-18 Version 2 - Content With Quality of My Life FAC028TC National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 Questionnaire Test Code CDISC Questionnaire NCCN-FACT FBLSI-18 Version 2 Test Code Terminology National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 test name. FAC028-Able to Have/Maintain Erection National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - (For men only) I am able to have and maintain an erection. NCCN-FACT FBLSI-18 Version 2 - Able to Have, Maintain Erection FAC028-Bothered by Treatment Side Effect National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I am bothered by side effects of treatment. NCCN-FACT FBLSI-18 Version 2 - Bothered by Treatment Side Effect FAC028-Content With Quality of My Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I am content with the quality of my life right now. NCCN-FACT FBLSI-18 Version 2 - Content With Quality of My Life FAC028-Have Trouble Controlling My Urine National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I have trouble controlling my urine. NCCN-FACT FBLSI-18 Version 2 - Have Trouble Controlling My Urine FAC028-I Am Able to Enjoy Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I am able to enjoy life. NCCN-FACT FBLSI-18 Version 2 - I Am Able to Enjoy Life FAC028-I Am Losing Weight National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I am losing weight. NCCN-FACT FBLSI-18 Version 2 - I Am Losing Weight FAC028-I Am Sleeping Well National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I am sleeping well. NCCN-FACT FBLSI-18 Version 2 - I Am Sleeping Well FAC028-I Feel Ill National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I feel ill. NCCN-FACT FBLSI-18 Version 2 - I Feel Ill FAC028-I Feel Light-headed National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I feel light-headed (dizzy). NCCN-FACT FBLSI-18 Version 2 - I Feel Light-headed FAC028-I Feel Sad National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I feel sad. NCCN-FACT FBLSI-18 Version 2 - I Feel Sad FAC028-I Feel Weak All Over National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I feel weak all over. NCCN-FACT FBLSI-18 Version 2 - I Feel Weak All Over FAC028-I Have a Good Appetite National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I have a good appetite. NCCN-FACT FBLSI-18 Version 2 - I Have a Good Appetite FAC028-I Have a Lack of Energy National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I have a lack of energy. NCCN-FACT FBLSI-18 Version 2 - I Have a Lack of Energy FAC028-I Have Control of My Bowels National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I have control of my bowels. NCCN-FACT FBLSI-18 Version 2 - I Have Control of My Bowels FAC028-I Have Nausea National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I have nausea. NCCN-FACT FBLSI-18 Version 2 - I Have Nausea FAC028-I Have Pain National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I have pain. NCCN-FACT FBLSI-18 Version 2 - I Have Pain FAC028-Trouble Meeting Needs of Family National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - Because of my physical condition, I have trouble meeting the needs of my family. NCCN-FACT FBLSI-18 Version 2 - Trouble Meeting Needs of Family FAC028-Worry My Condition Will Get Worse National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I worry that my condition will get worse. NCCN-FACT FBLSI-18 Version 2 - Worry My Condition Will Get Worse FAC028TN National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 Questionnaire Test Name CDISC Questionnaire NCCN-FACT FBLSI-18 Version 2 Test Name Terminology National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 test code. FAC030-I Get Headaches National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I get headaches. NCCN-FACT FBRSI-24 Version 2 - I Get Headaches FAC030-I Have Trouble With Coordination National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I have trouble with coordination. NCCN-FACT FBRSI-24 Version 2 - I Have Trouble With Coordination FAC030-I Have Had Seizures National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I have had seizures (convulsions). NCCN-FACT FBRSI-24 Version 2 - I Have Had Seizures FAC030-I Need Help in Caring for Myself National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I need help in caring for myself (bathing, dressing, eating, etc.). NCCN-FACT FBRSI-24 Version 2 - I Need Help in Caring for Myself FAC030-Have Weakness in My Arms or Legs National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I have weakness in my arms or legs. NCCN-FACT FBRSI-24 Version 2 - Have Weakness in My Arms or Legs FAC030-I Am Losing Weight National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am losing weight. NCCN-FACT FBRSI-24 Version 2 - I Am Losing Weight FAC030-Trouble Meeting Needs of Family National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - Because of my physical condition, I have trouble meeting the needs of my family. NCCN-FACT FBRSI-24 Version 2 - Trouble Meeting Needs of Family FAC030-Difficulty Expressing My Thoughts National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I have difficulty expressing my thoughts. NCCN-FACT FBRSI-24 Version 2 - Difficulty Expressing My Thoughts FAC030-I Am Sleeping Well National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am sleeping well. NCCN-FACT FBRSI-24 Version 2 - I Am Sleeping Well FAC030-I Am Able to Concentrate National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am able to concentrate. NCCN-FACT FBRSI-24 Version 2 - I Am Able to Concentrate FAC030-I Can Remember New Things National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I can remember new things. NCCN-FACT FBRSI-24 Version 2 - I Can Remember New Things FAC030-Able to Find the Right Words National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am able to find the right word(s) to say what I mean. NCCN-FACT FBRSI-24 Version 2 - Able to Find the Right Words FAC030-Bothered by Change in Personality National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am bothered by the change in my personality. NCCN-FACT FBRSI-24 Version 2 - Bothered by Change in Personality FAC030-Worry My Condition Will Get Worse National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I worry that my condition will get worse. NCCN-FACT FBRSI-24 Version 2 - Worry My Condition Will Get Worse FAC030-I Am Afraid of Having a Seizure National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am afraid of having a seizure (convulsion). NCCN-FACT FBRSI-24 Version 2 - I Am Afraid of Having a Seizure FAC030-Frustrated I Cannot Do Things National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I get frustrated that I cannot do things I used to. NCCN-FACT FBRSI-24 Version 2 - Frustrated I Cannot Do Things FAC030-Losing Hope Against Illness National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am losing hope in the fight against my illness. NCCN-FACT FBRSI-24 Version 2 - Losing Hope Against Illness FAC030-I Have a Lack of Energy National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I have a lack of energy. NCCN-FACT FBRSI-24 Version 2 - I Have a Lack of Energy FAC030-I Have Nausea National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I have nausea. NCCN-FACT FBRSI-24 Version 2 - I Have Nausea FAC030-Bothered by Treatment Side Effect National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am bothered by side effects of treatment. NCCN-FACT FBRSI-24 Version 2 - Bothered by Treatment Side Effect FAC030-I Feel Fatigued National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I feel fatigued. NCCN-FACT FBRSI-24 Version 2 - I Feel Fatigued FAC030-I Have a Good Appetite National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I have a good appetite. NCCN-FACT FBRSI-24 Version 2 - I Have a Good Appetite FAC030-I Am Able to Enjoy Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am able to enjoy life. NCCN-FACT FBRSI-24 Version 2 - I Am Able to Enjoy Life FAC030-Content With Quality of My Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am content with the quality of my life right now. NCCN-FACT FBRSI-24 Version 2 - Content With Quality of My Life FAC030TC National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 Questionnaire Test Code CDISC Questionnaire NCCN-FACT FBRSI-24 Version 2 Test Code Terminology National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 test name. FAC030-Able to Find the Right Words National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am able to find the right word(s) to say what I mean. NCCN-FACT FBRSI-24 Version 2 - Able to Find the Right Words FAC030-Bothered by Change in Personality National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am bothered by the change in my personality. NCCN-FACT FBRSI-24 Version 2 - Bothered by Change in Personality FAC030-Bothered by Treatment Side Effect National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am bothered by side effects of treatment. NCCN-FACT FBRSI-24 Version 2 - Bothered by Treatment Side Effect FAC030-Content With Quality of My Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am content with the quality of my life right now. NCCN-FACT FBRSI-24 Version 2 - Content With Quality of My Life FAC030-Difficulty Expressing My Thoughts National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I have difficulty expressing my thoughts. NCCN-FACT FBRSI-24 Version 2 - Difficulty Expressing My Thoughts FAC030-Frustrated I Cannot Do Things National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I get frustrated that I cannot do things I used to. NCCN-FACT FBRSI-24 Version 2 - Frustrated I Cannot Do Things FAC030-Have Weakness in My Arms or Legs National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I have weakness in my arms or legs. NCCN-FACT FBRSI-24 Version 2 - Have Weakness in My Arms or Legs FAC030-I Am Able to Concentrate National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am able to concentrate. NCCN-FACT FBRSI-24 Version 2 - I Am Able to Concentrate FAC030-I Am Able to Enjoy Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am able to enjoy life. NCCN-FACT FBRSI-24 Version 2 - I Am Able to Enjoy Life FAC030-I Am Afraid of Having a Seizure National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am afraid of having a seizure (convulsion). NCCN-FACT FBRSI-24 Version 2 - I Am Afraid of Having a Seizure FAC030-I Am Losing Weight National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am losing weight. NCCN-FACT FBRSI-24 Version 2 - I Am Losing Weight FAC030-I Am Sleeping Well National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am sleeping well. NCCN-FACT FBRSI-24 Version 2 - I Am Sleeping Well FAC030-I Can Remember New Things National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I can remember new things. NCCN-FACT FBRSI-24 Version 2 - I Can Remember New Things FAC030-I Feel Fatigued National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I feel fatigued. NCCN-FACT FBRSI-24 Version 2 - I Feel Fatigued FAC030-I Get Headaches National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I get headaches. NCCN-FACT FBRSI-24 Version 2 - I Get Headaches FAC030-I Have a Good Appetite National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I have a good appetite. NCCN-FACT FBRSI-24 Version 2 - I Have a Good Appetite FAC030-I Have a Lack of Energy National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I have a lack of energy. NCCN-FACT FBRSI-24 Version 2 - I Have a Lack of Energy FAC030-I Have Had Seizures National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I have had seizures (convulsions). NCCN-FACT FBRSI-24 Version 2 - I Have Had Seizures FAC030-I Have Nausea National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I have nausea. NCCN-FACT FBRSI-24 Version 2 - I Have Nausea FAC030-I Have Trouble With Coordination National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I have trouble with coordination. NCCN-FACT FBRSI-24 Version 2 - I Have Trouble With Coordination FAC030-I Need Help in Caring for Myself National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I need help in caring for myself (bathing, dressing, eating, etc.). NCCN-FACT FBRSI-24 Version 2 - I Need Help in Caring for Myself FAC030-Losing Hope Against Illness National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am losing hope in the fight against my illness. NCCN-FACT FBRSI-24 Version 2 - Losing Hope Against Illness FAC030-Trouble Meeting Needs of Family National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - Because of my physical condition, I have trouble meeting the needs of my family. NCCN-FACT FBRSI-24 Version 2 - Trouble Meeting Needs of Family FAC030-Worry My Condition Will Get Worse National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I worry that my condition will get worse. NCCN-FACT FBRSI-24 Version 2 - Worry My Condition Will Get Worse FAC030TN National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 Questionnaire Test Name CDISC Questionnaire NCCN-FACT FBRSI-24 Version 2 Test Name Terminology National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index-16 Version 2 Questionnaire test code. FAC032-I Have a Lack of Energy National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I have a lack of energy. NFBSI-16 V2 - I Have a Lack of Energy FAC032-I Have Pain National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I have pain. NFBSI-16 V2 - I Have Pain FAC032-I Feel Ill National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I feel ill. NFBSI-16 V2 - I Feel Ill FAC032-I Have Been Short of Breath National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I have been short of breath. NFBSI-16 V2 - I Have Been Short of Breath FAC032-Trouble Meeting Needs of Family National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: Because of my physical condition, I have trouble meeting the needs of my family. NFBSI-16 V2 - Trouble Meeting Needs of Family FAC032-I Feel Fatigued National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I feel fatigued. NFBSI-16 V2 - I Feel Fatigued FAC032-I Have Bone Pain National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I have bone pain. NFBSI-16 V2 - I Have Bone Pain FAC032-Sleeping Well National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I am sleeping well. NFBSI-16 V2 - Sleeping Well FAC032-Worry My Condition Will Get Worse National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I worry that my condition will get worse. NFBSI-16 V2 - Worry My Condition Will Get Worse FAC032-I Have Nausea National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I have nausea. NFBSI-16 V2 - I Have Nausea FAC032-I Have Mouth Sores National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I have mouth sores. NFBSI-16 V2 - I Have Mouth Sores FAC032-Bothered by Side Effect Treatment National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I am bothered by side effects of treatment. NFBSI-16 V2 - Bothered by Side Effect Treatment FAC032-Bothered by Hair Loss National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I am bothered by hair loss. NFBSI-16 V2 - Bothered by Hair Loss FAC032-Able to Work National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I am able to work (include work at home). NFBSI-16 V2 - Able to Work FAC032-Able to Enjoy Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I am able to enjoy life. NFBSI-16 V2 - Able to Enjoy Life FAC032-Content With Quality of My Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I am content with the quality of my life right now. NFBSI-16 V2 - Content With Quality of My Life FAC032TC National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index-16 Version 2 Questionnaire Test Code CDISC Questionnaire NFBSI-16 Version 2 Test Code Terminology National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index-16 Version 2 Questionnaire test name. FAC032-Able to Enjoy Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I am able to enjoy life. NFBSI-16 V2 - Able to Enjoy Life FAC032-Able to Work National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I am able to work (include work at home). NFBSI-16 V2 - Able to Work FAC032-Bothered by Hair Loss National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I am bothered by hair loss. NFBSI-16 V2 - Bothered by Hair Loss FAC032-Bothered by Side Effect Treatment National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I am bothered by side effects of treatment. NFBSI-16 V2 - Bothered by Side Effect Treatment FAC032-Content With Quality of My Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I am content with the quality of my life right now. NFBSI-16 V2 - Content With Quality of My Life FAC032-I Feel Fatigued National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I feel fatigued. NFBSI-16 V2 - I Feel Fatigued FAC032-I Feel Ill National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I feel ill. NFBSI-16 V2 - I Feel Ill FAC032-I Have a Lack of Energy National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I have a lack of energy. NFBSI-16 V2 - I Have a Lack of Energy FAC032-I Have Been Short of Breath National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I have been short of breath. NFBSI-16 V2 - I Have Been Short of Breath FAC032-I Have Bone Pain National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I have bone pain. NFBSI-16 V2 - I Have Bone Pain FAC032-I Have Mouth Sores National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I have mouth sores. NFBSI-16 V2 - I Have Mouth Sores FAC032-I Have Nausea National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I have nausea. NFBSI-16 V2 - I Have Nausea FAC032-I Have Pain National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I have pain. NFBSI-16 V2 - I Have Pain FAC032-Sleeping Well National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I am sleeping well. NFBSI-16 V2 - Sleeping Well FAC032-Trouble Meeting Needs of Family National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: Because of my physical condition, I have trouble meeting the needs of my family. NFBSI-16 V2 - Trouble Meeting Needs of Family FAC032-Worry My Condition Will Get Worse National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version 2: I worry that my condition will get worse. NFBSI-16 V2 - Worry My Condition Will Get Worse FAC032TN National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index-16 Version 2 Questionnaire Test Name CDISC Questionnaire NFBSI-16 Version 2 Test Name Terminology National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 test code. FAC036-I Have Pain National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have pain. NCCN-FACT FHNSI-22 Version 2 - I Have Pain FAC036-I Am Losing Weight National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am losing weight. NCCN-FACT FHNSI-22 Version 2 - I Am Losing Weight FAC036-I Have Trouble Breathing National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have trouble breathing. NCCN-FACT FHNSI-22 Version 2 - I Have Trouble Breathing FAC036-I Feel Ill National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I feel ill. NCCN-FACT FHNSI-22 Version 2 - I Feel Ill FAC036-Pain in My Mouth, Throat or Neck National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have pain in my mouth, throat or neck. NCCN-FACT FHNSI-22 Version 2 - Pain in My Mouth, Throat or Neck FAC036-Trouble Meeting Needs of Family National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - Because of my physical condition, I have trouble meeting the needs of my family. NCCN-FACT FHNSI-22 Version 2 - Trouble Meeting Needs of Family FAC036-Can Swallow Naturally and Easily National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I can swallow naturally and easily. NCCN-FACT FHNSI-22 Version 2 - Can Swallow Naturally and Easily FAC036-Able to Eat the Foods That I Like National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am able to eat the foods that I like. NCCN-FACT FHNSI-22 Version 2 - Able to Eat the Foods That I Like FAC036-Able to Communicate With Others National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am able to communicate with others. NCCN-FACT FHNSI-22 Version 2 - Able to Communicate With Others FAC036-I Can Eat Solid Foods National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I can eat solid foods. NCCN-FACT FHNSI-22 Version 2 - I Can Eat Solid Foods FAC036-I Am Sleeping Well National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am sleeping well. NCCN-FACT FHNSI-22 Version 2 - I Am Sleeping Well FAC036-Worry My Condition Will Get Worse National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I worry that my condition will get worse. NCCN-FACT FHNSI-22 Version 2 - Worry My Condition Will Get Worse FAC036-I Have a Lack of Energy National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have a lack of energy. NCCN-FACT FHNSI-22 Version 2 - I Have a Lack of Energy FAC036-I Have Nausea National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have nausea. NCCN-FACT FHNSI-22 Version 2 - I Have Nausea FAC036-Had Change in the Way Food Tastes National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have had a change in the way food tastes. NCCN-FACT FHNSI-22 Version 2 - Had Change in the Way Food Tastes FAC036-I Have Mouth Sores National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have mouth sores. NCCN-FACT FHNSI-22 Version 2 - I Have Mouth Sores FAC036-I Am Bothered by Hair Loss National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am bothered by hair loss. NCCN-FACT FHNSI-22 Version 2 - I Am Bothered by Hair Loss FAC036-Bothered by Treatment Side Effect National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am bothered by side effects of treatment. NCCN-FACT FHNSI-22 Version 2 - Bothered by Treatment Side Effect FAC036-I Have a Good Appetite National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have a good appetite. NCCN-FACT FHNSI-22 Version 2 - I Have a Good Appetite FAC036-I Am Able to Work National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am able to work (include work at home). NCCN-FACT FHNSI-22 Version 2 - I Am Able to Work FAC036-I Am Able to Enjoy Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am able to enjoy life. NCCN-FACT FHNSI-22 Version 2 - I Am Able to Enjoy Life FAC036-Content With Quality of My Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am content with the quality of my life right now. NCCN-FACT FHNSI-22 Version 2 - Content With Quality of My Life FAC036TC National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 Questionnaire Test Code CDISC Questionnaire NCCN-FACT FHNSI-22 Version 2 Test Code Terminology National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 test name. FAC036-Able to Communicate With Others National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am able to communicate with others. NCCN-FACT FHNSI-22 Version 2 - Able to Communicate With Others FAC036-Able to Eat the Foods That I Like National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am able to eat the foods that I like. NCCN-FACT FHNSI-22 Version 2 - Able to Eat the Foods That I Like FAC036-Bothered by Treatment Side Effect National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am bothered by side effects of treatment. NCCN-FACT FHNSI-22 Version 2 - Bothered by Treatment Side Effect FAC036-Can Swallow Naturally and Easily National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I can swallow naturally and easily. NCCN-FACT FHNSI-22 Version 2 - Can Swallow Naturally and Easily FAC036-Content With Quality of My Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am content with the quality of my life right now. NCCN-FACT FHNSI-22 Version 2 - Content With Quality of My Life FAC036-Had Change in the Way Food Tastes National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have had a change in the way food tastes. NCCN-FACT FHNSI-22 Version 2 - Had Change in the Way Food Tastes FAC036-I Am Able to Enjoy Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am able to enjoy life. NCCN-FACT FHNSI-22 Version 2 - I Am Able to Enjoy Life FAC036-I Am Able to Work National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am able to work (include work at home). NCCN-FACT FHNSI-22 Version 2 - I Am Able to Work FAC036-I Am Bothered by Hair Loss National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am bothered by hair loss. NCCN-FACT FHNSI-22 Version 2 - I Am Bothered by Hair Loss FAC036-I Am Losing Weight National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am losing weight. NCCN-FACT FHNSI-22 Version 2 - I Am Losing Weight FAC036-I Am Sleeping Well National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am sleeping well. NCCN-FACT FHNSI-22 Version 2 - I Am Sleeping Well FAC036-I Can Eat Solid Foods National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I can eat solid foods. NCCN-FACT FHNSI-22 Version 2 - I Can Eat Solid Foods FAC036-I Feel Ill National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I feel ill. NCCN-FACT FHNSI-22 Version 2 - I Feel Ill FAC036-I Have a Good Appetite National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have a good appetite. NCCN-FACT FHNSI-22 Version 2 - I Have a Good Appetite FAC036-I Have a Lack of Energy National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have a lack of energy. NCCN-FACT FHNSI-22 Version 2 - I Have a Lack of Energy FAC036-I Have Mouth Sores National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have mouth sores. NCCN-FACT FHNSI-22 Version 2 - I Have Mouth Sores FAC036-I Have Nausea National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have nausea. NCCN-FACT FHNSI-22 Version 2 - I Have Nausea FAC036-I Have Pain National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have pain. NCCN-FACT FHNSI-22 Version 2 - I Have Pain FAC036-I Have Trouble Breathing National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have trouble breathing. NCCN-FACT FHNSI-22 Version 2 - I Have Trouble Breathing FAC036-Pain in My Mouth, Throat or Neck National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have pain in my mouth, throat or neck. NCCN-FACT FHNSI-22 Version 2 - Pain in My Mouth, Throat or Neck FAC036-Trouble Meeting Needs of Family National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - Because of my physical condition, I have trouble meeting the needs of my family. NCCN-FACT FHNSI-22 Version 2 - Trouble Meeting Needs of Family FAC036-Worry My Condition Will Get Worse National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I worry that my condition will get worse. NCCN-FACT FHNSI-22 Version 2 - Worry My Condition Will Get Worse FAC036TN National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 Questionnaire Test Name CDISC Questionnaire NCCN-FACT FHNSI-22 Version 2 Test Name Terminology National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 test code. FAC042-I Have a Lack of Energy National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have a lack of energy. NCCN-FACT FKSI-19 Version 2 - I Have a Lack of Energy FAC042-I Have Pain National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have pain. NCCN-FACT FKSI-19 Version 2 - I Have Pain FAC042-I Am Losing Weight National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I am losing weight. NCCN-FACT FKSI-19 Version 2 - I Am Losing Weight FAC042-I Feel Fatigued National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I feel fatigued. NCCN-FACT FKSI-19 Version 2 - I Feel Fatigued FAC042-I Have Been Short of Breath National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have been short of breath. NCCN-FACT FKSI-19 Version 2 - I Have Been Short of Breath FAC042-I Am Bothered by Fevers National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I am bothered by fevers (episodes of high body temperature). NCCN-FACT FKSI-19 Version 2 - I Am Bothered by Fevers FAC042-I Have Bone Pain National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have bone pain. NCCN-FACT FKSI-19 Version 2 - I Have Bone Pain FAC042-I Have Been Coughing National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have been coughing. NCCN-FACT FKSI-19 Version 2 - I Have Been Coughing FAC042-I Feel Weak All Over National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I feel weak all over. NCCN-FACT FKSI-19 Version 2 - I Feel Weak All Over FAC042-I Have Had Blood in My Urine National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have had blood in my urine. NCCN-FACT FKSI-19 Version 2 - I Have Had Blood in My Urine FAC042-I Have a Good Appetite National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have a good appetite. NCCN-FACT FKSI-19 Version 2 - I Have a Good Appetite FAC042-I Am Sleeping Well National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I am sleeping well. NCCN-FACT FKSI-19 Version 2 - I Am Sleeping Well FAC042-Worry My Condition Will Get Worse National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I worry that my condition will get worse. NCCN-FACT FKSI-19 Version 2 - Worry My Condition Will Get Worse FAC042-I Have Nausea National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have nausea. NCCN-FACT FKSI-19 Version 2 - I Have Nausea FAC042-I Have Diarrhea National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have diarrhea (diarrhoea). NCCN-FACT FKSI-19 Version 2 - I Have Diarrhea FAC042-Bothered by Treatment Side Effect National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I am bothered by side effects of treatment. NCCN-FACT FKSI-19 Version 2 - Bothered by Treatment Side Effect FAC042-I Am Able to Work National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I am able to work (include work at home). NCCN-FACT FKSI-19 Version 2 - I Am Able to Work FAC042-I Am Able to Enjoy Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I am able to enjoy life. NCCN-FACT FKSI-19 Version 2 - I Am Able to Enjoy Life FAC042-Content With Quality of My Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I am content with the quality of my life right now. NCCN-FACT FKSI-19 Version 2 - Content With Quality of My Life FAC042TC National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 Questionnaire Test Code CDISC Questionnaire NCCN-FACT FKSI-19 Version 2 Test Code Terminology National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 test name. FAC042-Bothered by Treatment Side Effect National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I am bothered by side effects of treatment. NCCN-FACT FKSI-19 Version 2 - Bothered by Treatment Side Effect FAC042-Content With Quality of My Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I am content with the quality of my life right now. NCCN-FACT FKSI-19 Version 2 - Content With Quality of My Life FAC042-I Am Able to Enjoy Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I am able to enjoy life. NCCN-FACT FKSI-19 Version 2 - I Am Able to Enjoy Life FAC042-I Am Able to Work National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I am able to work (include work at home). NCCN-FACT FKSI-19 Version 2 - I Am Able to Work FAC042-I Am Bothered by Fevers National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I am bothered by fevers (episodes of high body temperature). NCCN-FACT FKSI-19 Version 2 - I Am Bothered by Fevers FAC042-I Am Losing Weight National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I am losing weight. NCCN-FACT FKSI-19 Version 2 - I Am Losing Weight FAC042-I Am Sleeping Well National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I am sleeping well. NCCN-FACT FKSI-19 Version 2 - I Am Sleeping Well FAC042-I Feel Fatigued National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I feel fatigued. NCCN-FACT FKSI-19 Version 2 - I Feel Fatigued FAC042-I Feel Weak All Over National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I feel weak all over. NCCN-FACT FKSI-19 Version 2 - I Feel Weak All Over FAC042-I Have a Good Appetite National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have a good appetite. NCCN-FACT FKSI-19 Version 2 - I Have a Good Appetite FAC042-I Have a Lack of Energy National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have a lack of energy. NCCN-FACT FKSI-19 Version 2 - I Have a Lack of Energy FAC042-I Have Been Coughing National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have been coughing. NCCN-FACT FKSI-19 Version 2 - I Have Been Coughing FAC042-I Have Been Short of Breath National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have been short of breath. NCCN-FACT FKSI-19 Version 2 - I Have Been Short of Breath FAC042-I Have Bone Pain National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have bone pain. NCCN-FACT FKSI-19 Version 2 - I Have Bone Pain FAC042-I Have Diarrhea National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have diarrhea (diarrhoea). NCCN-FACT FKSI-19 Version 2 - I Have Diarrhea FAC042-I Have Had Blood in My Urine National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have had blood in my urine. NCCN-FACT FKSI-19 Version 2 - I Have Had Blood in My Urine FAC042-I Have Nausea National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have nausea. NCCN-FACT FKSI-19 Version 2 - I Have Nausea FAC042-I Have Pain National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have pain. NCCN-FACT FKSI-19 Version 2 - I Have Pain FAC042-Worry My Condition Will Get Worse National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I worry that my condition will get worse. NCCN-FACT FKSI-19 Version 2 - Worry My Condition Will Get Worse FAC042TN National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 Questionnaire Test Name CDISC Questionnaire NCCN-FACT FKSI-19 Version 2 Test Name Terminology National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 test code. FAC050-I Have a Lack of Energy National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I have a lack of energy. NCCN-FACT FOSI-18 Version 2 - I Have a Lack of Energy FAC050-I Have Pain National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I have pain. NCCN-FACT FOSI-18 Version 2 - I Have Pain FAC050-I Feel Ill National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I feel ill. NCCN-FACT FOSI-18 Version 2 - I Feel Ill FAC050-I Have Cramps in My Stomach Area National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I have cramps in my stomach area. NCCN-FACT FOSI-18 Version 2 - I Have Cramps in My Stomach Area FAC050-I Feel Fatigued National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I feel fatigued. NCCN-FACT FOSI-18 Version 2 - I Feel Fatigued FAC050-I Am Bothered by Constipation National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am bothered by constipation. NCCN-FACT FOSI-18 Version 2 - I Am Bothered by Constipation FAC050-I Have Swelling in Stomach Area National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I have swelling in my stomach area. NCCN-FACT FOSI-18 Version 2 - I Have Swelling in Stomach Area FAC050-I Have Control of My Bowels National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I have control of my bowels. NCCN-FACT FOSI-18 Version 2 - I Have Control of My Bowels FAC050-I Am Sleeping Well National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am sleeping well. NCCN-FACT FOSI-18 Version 2 - I Am Sleeping Well FAC050-Worry My Condition Will Get Worse National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I worry that my condition will get worse. NCCN-FACT FOSI-18 Version 2 - Worry My Condition Will Get Worse FAC050-I Have Nausea National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I have nausea. NCCN-FACT FOSI-18 Version 2 - I Have Nausea FAC050-I Am Bothered by Hair Loss National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am bothered by hair loss. NCCN-FACT FOSI-18 Version 2 - I Am Bothered by Hair Loss FAC050-Bothered by Treatment Side Effect National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am bothered by side effects of treatment. NCCN-FACT FOSI-18 Version 2 - Bothered by Treatment Side Effect FAC050-I Have Been Vomiting National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I have been vomiting. NCCN-FACT FOSI-18 Version 2 - I Have Been Vomiting FAC050-I Am Bothered by Skin Problems National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am bothered by skin problems. NCCN-FACT FOSI-18 Version 2 - I Am Bothered by Skin Problems FAC050-I Am Able to Get Around by Myself National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am able to get around by myself. NCCN-FACT FOSI-18 Version 2 - I Am Able to Get Around by Myself FAC050-I Am Able to Enjoy Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am able to enjoy life. NCCN-FACT FOSI-18 Version 2 - I Am Able to Enjoy Life FAC050-Content With Quality of My Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am content with the quality of my life right now. NCCN-FACT FOSI-18 Version 2 - Content With Quality of My Life FAC050TC National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 Questionnaire Test Code CDISC Questionnaire NCCN-FACT FOSI-18 Version 2 Test Code Terminology National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 test name. FAC050-Bothered by Treatment Side Effect National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am bothered by side effects of treatment. NCCN-FACT FOSI-18 Version 2 - Bothered by Treatment Side Effect FAC050-Content With Quality of My Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am content with the quality of my life right now. NCCN-FACT FOSI-18 Version 2 - Content With Quality of My Life FAC050-I Am Able to Enjoy Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am able to enjoy life. NCCN-FACT FOSI-18 Version 2 - I Am Able to Enjoy Life FAC050-I Am Able to Get Around by Myself National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am able to get around by myself. NCCN-FACT FOSI-18 Version 2 - I Am Able to Get Around by Myself FAC050-I Am Bothered by Constipation National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am bothered by constipation. NCCN-FACT FOSI-18 Version 2 - I Am Bothered by Constipation FAC050-I Am Bothered by Hair Loss National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am bothered by hair loss. NCCN-FACT FOSI-18 Version 2 - I Am Bothered by Hair Loss FAC050-I Am Bothered by Skin Problems National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am bothered by skin problems. NCCN-FACT FOSI-18 Version 2 - I Am Bothered by Skin Problems FAC050-I Am Sleeping Well National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am sleeping well. NCCN-FACT FOSI-18 Version 2 - I Am Sleeping Well FAC050-I Feel Fatigued National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I feel fatigued. NCCN-FACT FOSI-18 Version 2 - I Feel Fatigued FAC050-I Feel Ill National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I feel ill. NCCN-FACT FOSI-18 Version 2 - I Feel Ill FAC050-I Have a Lack of Energy National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I have a lack of energy. NCCN-FACT FOSI-18 Version 2 - I Have a Lack of Energy FAC050-I Have Been Vomiting National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I have been vomiting. NCCN-FACT FOSI-18 Version 2 - I Have Been Vomiting FAC050-I Have Control of My Bowels National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I have control of my bowels. NCCN-FACT FOSI-18 Version 2 - I Have Control of My Bowels FAC050-I Have Cramps in My Stomach Area National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I have cramps in my stomach area. NCCN-FACT FOSI-18 Version 2 - I Have Cramps in My Stomach Area FAC050-I Have Nausea National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I have nausea. NCCN-FACT FOSI-18 Version 2 - I Have Nausea FAC050-I Have Pain National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I have pain. NCCN-FACT FOSI-18 Version 2 - I Have Pain FAC050-I Have Swelling in Stomach Area National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I have swelling in my stomach area. NCCN-FACT FOSI-18 Version 2 - I Have Swelling in Stomach Area FAC050-Worry My Condition Will Get Worse National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I worry that my condition will get worse. NCCN-FACT FOSI-18 Version 2 - Worry My Condition Will Get Worse FAC050TN National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 Questionnaire Test Name CDISC Questionnaire NCCN-FACT FOSI-18 Version 2 Test Name Terminology National Early Warning Score 2 test code. NEWS1-Respirations National Early Warning Score 2 - Respirations. NEWS2 - Respirations NEWS1-Oxygen Saturation SpO2 Scale 1 National Early Warning Score 2 - SpO2 Scale 1 oxygen saturation. NEWS2 - Oxygen Saturation SpO2 Scale 1 NEWS1-Oxygen Saturation SpO2 Scale 2 National Early Warning Score 2 - SpO2 Scale 2 oxygen saturation. NEWS2 - Oxygen Saturation SpO2 Scale 2 NEWS1-Air or Oxygen National Early Warning Score 2 - Air or oxygen? NEWS2 - Air or Oxygen NEWS1-Air or Oxygen: Device National Early Warning Score 2 - Air or oxygen: Device. NEWS2 - Air or Oxygen: Device NEWS1-Systolic Blood Pressure National Early Warning Score 2 - Blood pressure. Score uses systolic BP only. NEWS2 - Systolic Blood Pressure NEWS1-Pulse National Early Warning Score 2 - Pulse. NEWS2 - Pulse NEWS1-Consciousness National Early Warning Score 2 - Consciousness. NEWS2 - Consciousness NEWS1-Temperature National Early Warning Score 2 - Temperature. NEWS2 - Temperature NEWS1-NEWS Total National Early Warning Score 2 - NEWS total. NEWS2 - NEWS Total NEWS1-Monitoring Frequency National Early Warning Score 2 - Monitoring frequency. NEWS2 - Monitoring Frequency NEWS1-Escalation of Care National Early Warning Score 2 - Escalation of care. NEWS2 - Escalation of Care NEWS1TC National Early Warning Score 2 Clinical Classification Test Code CDISC Clinical Classification NEWS2 Test Code Terminology National Early Warning Score 2 test name. NEWS1-Air or Oxygen National Early Warning Score 2 - Air or oxygen? NEWS2 - Air or Oxygen NEWS1-Air or Oxygen: Device National Early Warning Score 2 - Air or oxygen: Device. NEWS2 - Air or Oxygen: Device NEWS1-Consciousness National Early Warning Score 2 - Consciousness. NEWS2 - Consciousness NEWS1-Escalation of Care National Early Warning Score 2 - Escalation of care. NEWS2 - Escalation of Care NEWS1-Monitoring Frequency National Early Warning Score 2 - Monitoring frequency. NEWS2 - Monitoring Frequency NEWS1-NEWS Total National Early Warning Score 2 - NEWS total. NEWS2 - NEWS Total NEWS1-Oxygen Saturation SpO2 Scale 1 National Early Warning Score 2 - SpO2 Scale 1 oxygen saturation. NEWS2 - Oxygen Saturation SpO2 Scale 1 NEWS1-Oxygen Saturation SpO2 Scale 2 National Early Warning Score 2 - SpO2 Scale 2 oxygen saturation. NEWS2 - Oxygen Saturation SpO2 Scale 2 NEWS1-Pulse National Early Warning Score 2 - Pulse. NEWS2 - Pulse NEWS1-Respirations National Early Warning Score 2 - Respirations. NEWS2 - Respirations NEWS1-Systolic Blood Pressure National Early Warning Score 2 - Blood pressure. Score uses systolic BP only. NEWS2 - Systolic Blood Pressure NEWS1-Temperature National Early Warning Score 2 - Temperature. NEWS2 - Temperature NEWS1TN National Early Warning Score 2 Clinical Classification Test Name CDISC Clinical Classification NEWS2 Test Name Terminology National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format test code. VFQ1-Your Overall Health Is National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - General Health and Vision: In general, would you say your overall health is: VFQ25-Interviewer Administered Format - Overall Health VFQ1-Eyesight Using Both Eyes Is National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - General Health and Vision: At the present time, would you say your eyesight using both eyes (with glasses or contact lenses, if you wear them) is excellent, good, fair, poor, or very poor or are you completely blind? VFQ25-Interviewer Administered Format - Eyesight Using Both Eyes VFQ1-How Often You Worry About Eyesight National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - General Health and Vision: How much of the time do you worry about your eyesight? VFQ25-Interviewer Administered Format - Time Spent Worry About Eyesight VFQ1-How Much Pain in and Around Eyes National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - General Health and Vision: How much pain or discomfort have you had in and around your eyes (for example, burning, itching, or aching)? Would you say it is: VFQ25-Interviewer Administered Format - Pain or Discomfort You Had in and Around Eyes VFQ1-Difficulty Reading Newspapers National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: How much difficulty do you have reading ordinary print in newspapers? Would you say you have: VFQ25-Interviewer Administered Format - Difficulty Reading Ordinary Print in Newspapers VFQ1-Difficulty Doing Work/Hobbies National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: How much difficulty do you have doing work or hobbies that require you to see well up close, such as cooking, sewing, fixing things around the house, or using hand tools? Would you say: VFQ25-Interviewer Administered Format - Difficulty Doing Work or Hobbies VFQ1-Difficulty Finding on Crowded Shelf National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have finding something on a crowded shelf? VFQ25-Interviewer Administered Format - Difficulty Finding Something On a Shelf VFQ1-Difficulty Reading Street Signs National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: How much difficulty do you have reading street signs or the names of stores? VFQ25-Interviewer Administered Format - Difficulty Reading Street Signs VFQ1-Difficulty Going Down Step at Night National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have going down steps, stairs, or curbs in dim light or at night? VFQ25-Interviewer Administered Format - Difficulty Going Down Steps at Night VFQ1-Difficulty Noticing Objects to Side National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have noticing objects off to the side while you are walking along? VFQ25-Interviewer Administered Format - Difficulty Noticing Objects Off to the Side While Walking VFQ1-Difficulty Seeing How People React National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have seeing how people react to things you say? VFQ25-Interviewer Administered Format - Difficulty Seeing How People React VFQ1-Difficulty Picking Out Own Clothes National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have picking out and matching your own clothes? VFQ25-Interviewer Administered Format - Difficulty Picking Out and Matching Own Clothes VFQ1-Difficulty Visiting With People National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have visiting with people in their homes, at parties, or in restaurants? VFQ25-Interviewer Administered Format - Difficulty Visiting People VFQ1-Difficulty Going Out to See Movies National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have going out to see movies, plays, or sports events? VFQ25-Interviewer Administered Format - Difficulty Going Out to See Movies VFQ1-Are You Currently Driving National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Are you currently driving, at least once in a while? VFQ25-Interviewer Administered Format - Are You Currently Driving VFQ1-Never Driven or Given Up Driving National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: If no, Have you never driven a car or have you given up driving? VFQ25-Interviewer Administered Format - Never Driven or Given Up Driving VFQ1-Main Reason You Gave Up Driving National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: If gave up driving: Was that mainly because of your eyesight, mainly for some other reason, or because of both your eyesight and other reasons? VFQ25-Interviewer Administered Format - Main Reason You Gave Up Driving VFQ1-Difficulty Driving During Daytime National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: If currently driving: How much difficulty do you have driving during the daytime in familiar places? Would you say you have: VFQ25-Interviewer Administered Format - Difficulty Driving During Daytime VFQ1-Difficulty Driving at Night National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: How much difficulty do you have driving at night? Would you say you have: VFQ25-Interviewer Administered Format - Difficulty Driving at Night VFQ1-Driving in Difficult Conditions National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: How much difficulty do you have driving in difficult conditions, such as in bad weather, during rush hour, on the freeway, or in city traffic? Would you say you have: VFQ25-Interviewer Administered Format - Driving in Difficult Condition VFQ1-Accomplish Less Than You Would Like National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: Do you accomplish less than you would like because of your vision? VFQ25-Interviewer Administered Format - Accomplish Less Because of Vision VFQ1-Limited in How Long You Can Work National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: Are you limited in how long you can work or do other activities because of your vision? VFQ25-Interviewer Administered Format - Limited in How Long You Can Work Because of Vision VFQ1-Eye Pain Keep From Doing What Like National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: How much does pain or discomfort in or around your eyes, for example, burning, itching, or aching, keep you from doing what you'd like to be doing? Would you say: VFQ25-Interviewer Administered Format - Pain in Eyes Keep You From Doing What You Like VFQ1-I Stay Home Most of the Time National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: I stay home most of the time because of my eyesight. VFQ25-Interviewer Administered Format - Stay Home Because of Eyesight VFQ1-I Feel Frustrated a Lot of the Time National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: I feel frustrated a lot of the time because of my eyesight. VFQ25-Interviewer Administered Format - Feel Frustrated Because of Eyesight VFQ1-Much Less Control Over What I Do National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: I have much less control over what I do, because of my eyesight. VFQ25-Interviewer Administered Format - Have Less Control Because of Eyesight VFQ1-Rely Too Much on What Others Tell National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: Because of my eyesight, I have to rely too much on what other people tell me. VFQ25-Interviewer Administered Format - Have to Rely On Other People Because of Eyesight VFQ1-I Need a Lot of Help From Others National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: I need a lot of help from others because of my eyesight. VFQ25-Interviewer Administered Format - Need Help From Others Because of Eyesight VFQ1-Worry I'll Do Embarrassing Things National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: I worry about doing things that will embarrass myself or others, because of my eyesight. VFQ25-Interviewer Administered Format - Worry About Embarrass Myself or Others Because of Eyesight VFQ1-Rate Your Overall Health National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - General Health: How would you rate your overall health, on a scale where zero is as bad as death and 10 is best possible health? VFQ25-Interviewer Administered Format - Rate Your Overall Health VFQ1-Rate Your Eyesight Now National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - General Vision: How would you rate your eyesight now (with glasses or contact lens on, if you wear them), on a scale of from 0 to 10, where zero means the worst possible eyesight, as bad or worse than being blind, and 10 means the best possible eyesight? VFQ25-Interviewer Administered Format - Rate Your Eyesight Now VFQ1-Difficulty Reading Small Print National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Near Vision: Wearing glasses, how much difficulty do you have reading the small print in a telephone book, on a medicine bottle, or on legal forms? Would you say: VFQ25-Interviewer Administered Format - Difficulty Reading Small Print VFQ1-Difficulty Figure Out Bill Accuracy National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Near Vision: Because of your eyesight, how much difficulty do you have figuring out whether bills you receive are accurate? VFQ25-Interviewer Administered Format - Difficulty Figure Out Bill Accuracy VFQ1-Difficulty Shaving or Styling Hair National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Near Vision: Because of your eyesight, how much difficulty do you have doing things like shaving, styling your hair, or putting on makeup? VFQ25-Interviewer Administered Format - Difficulty Shaving or Styling Hair or Putting On Makeup VFQ1-Difficulty Recognizing People National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Distance Vision: Because of your eyesight, how much difficulty do you have recognizing people you know from across a room? VFQ25-Interviewer Administered Format - Difficulty Recognizing People You Know VFQ1-Difficulty Taking Part in Sports National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Distance Vision: Because of your eyesight, how much difficulty do you have taking part in active sports or other outdoor activities that you enjoy (like golf, bowling, jogging, or walking)? VFQ25-Interviewer Administered Format - Difficulty Taking Part in Sports or Outdoor Activities VFQ1-Difficulty Seeing Programs on TV National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Distance Vision: Because of your eyesight, how much difficulty do you have seeing and enjoying programs on TV? VFQ25-Interviewer Administered Format - Difficulty Seeing and Enjoying Programs on TV VFQ1-Difficulty Entertaining Friends National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Social Function: Because of your eyesight, how much difficulty do you have entertaining friends and family in your home? VFQ25-Interviewer Administered Format - Difficulty Entertaining Friends and Family in Home VFQ1-Do You Have More Help From Others National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Role Limitations: Do you have more help from others because of your vision? VFQ25-Interviewer Administered Format - Do You Have More Help From Others VFQ1-Limited in Kinds of Things Can Do National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Role Limitations: Are you limited in the kinds of things you can do because of your vision? VFQ25-Interviewer Administered Format - Limited in Kinds of Things Can Do VFQ1-Often Irritable Because Eyesight National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Well-Being/Distress: I am often irritable because of my eyesight. VFQ25-Interviewer Administered Format - Often Irritable Because of Eyesight VFQ1-I Don't Go Out of My Home Alone National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Dependency: I don't go out of my home alone, because of my eyesight. VFQ25-Interviewer Administered Format - Don't Go Out of Home Alone Because of Eyesight VFQ1TC National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format Questionnaire Test Code CDISC Questionnaire VFQ25-Interviewer Administered Format Test Code Terminology National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format test name. VFQ1-Accomplish Less Than You Would Like National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: Do you accomplish less than you would like because of your vision? VFQ25-Interviewer Administered Format - Accomplish Less Because of Vision VFQ1-Are You Currently Driving National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Are you currently driving, at least once in a while? VFQ25-Interviewer Administered Format - Are You Currently Driving VFQ1-Difficulty Doing Work/Hobbies National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: How much difficulty do you have doing work or hobbies that require you to see well up close, such as cooking, sewing, fixing things around the house, or using hand tools? Would you say: VFQ25-Interviewer Administered Format - Difficulty Doing Work or Hobbies VFQ1-Difficulty Driving at Night National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: How much difficulty do you have driving at night? Would you say you have: VFQ25-Interviewer Administered Format - Difficulty Driving at Night VFQ1-Difficulty Driving During Daytime National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: If currently driving: How much difficulty do you have driving during the daytime in familiar places? Would you say you have: VFQ25-Interviewer Administered Format - Difficulty Driving During Daytime VFQ1-Difficulty Entertaining Friends National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Social Function: Because of your eyesight, how much difficulty do you have entertaining friends and family in your home? VFQ25-Interviewer Administered Format - Difficulty Entertaining Friends and Family in Home VFQ1-Difficulty Figure Out Bill Accuracy National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Near Vision: Because of your eyesight, how much difficulty do you have figuring out whether bills you receive are accurate? VFQ25-Interviewer Administered Format - Difficulty Figure Out Bill Accuracy VFQ1-Difficulty Finding on Crowded Shelf National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have finding something on a crowded shelf? VFQ25-Interviewer Administered Format - Difficulty Finding Something On a Shelf VFQ1-Difficulty Going Down Step at Night National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have going down steps, stairs, or curbs in dim light or at night? VFQ25-Interviewer Administered Format - Difficulty Going Down Steps at Night VFQ1-Difficulty Going Out to See Movies National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have going out to see movies, plays, or sports events? VFQ25-Interviewer Administered Format - Difficulty Going Out to See Movies VFQ1-Difficulty Noticing Objects to Side National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have noticing objects off to the side while you are walking along? VFQ25-Interviewer Administered Format - Difficulty Noticing Objects Off to the Side While Walking VFQ1-Difficulty Picking Out Own Clothes National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have picking out and matching your own clothes? VFQ25-Interviewer Administered Format - Difficulty Picking Out and Matching Own Clothes VFQ1-Difficulty Reading Newspapers National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: How much difficulty do you have reading ordinary print in newspapers? Would you say you have: VFQ25-Interviewer Administered Format - Difficulty Reading Ordinary Print in Newspapers VFQ1-Difficulty Reading Small Print National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Near Vision: Wearing glasses, how much difficulty do you have reading the small print in a telephone book, on a medicine bottle, or on legal forms? Would you say: VFQ25-Interviewer Administered Format - Difficulty Reading Small Print VFQ1-Difficulty Reading Street Signs National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: How much difficulty do you have reading street signs or the names of stores? VFQ25-Interviewer Administered Format - Difficulty Reading Street Signs VFQ1-Difficulty Recognizing People National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Distance Vision: Because of your eyesight, how much difficulty do you have recognizing people you know from across a room? VFQ25-Interviewer Administered Format - Difficulty Recognizing People You Know VFQ1-Difficulty Seeing How People React National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have seeing how people react to things you say? VFQ25-Interviewer Administered Format - Difficulty Seeing How People React VFQ1-Difficulty Seeing Programs on TV National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Distance Vision: Because of your eyesight, how much difficulty do you have seeing and enjoying programs on TV? VFQ25-Interviewer Administered Format - Difficulty Seeing and Enjoying Programs on TV VFQ1-Difficulty Shaving or Styling Hair National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Near Vision: Because of your eyesight, how much difficulty do you have doing things like shaving, styling your hair, or putting on makeup? VFQ25-Interviewer Administered Format - Difficulty Shaving or Styling Hair or Putting On Makeup VFQ1-Difficulty Taking Part in Sports National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Distance Vision: Because of your eyesight, how much difficulty do you have taking part in active sports or other outdoor activities that you enjoy (like golf, bowling, jogging, or walking)? VFQ25-Interviewer Administered Format - Difficulty Taking Part in Sports or Outdoor Activities VFQ1-Difficulty Visiting With People National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have visiting with people in their homes, at parties, or in restaurants? VFQ25-Interviewer Administered Format - Difficulty Visiting People VFQ1-Do You Have More Help From Others National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Role Limitations: Do you have more help from others because of your vision? VFQ25-Interviewer Administered Format - Do You Have More Help From Others VFQ1-Driving in Difficult Conditions National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: How much difficulty do you have driving in difficult conditions, such as in bad weather, during rush hour, on the freeway, or in city traffic? Would you say you have: VFQ25-Interviewer Administered Format - Driving in Difficult Condition VFQ1-Eye Pain Keep From Doing What Like National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: How much does pain or discomfort in or around your eyes, for example, burning, itching, or aching, keep you from doing what you'd like to be doing? Would you say: VFQ25-Interviewer Administered Format - Pain in Eyes Keep You From Doing What You Like VFQ1-Eyesight Using Both Eyes Is National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - General Health and Vision: At the present time, would you say your eyesight using both eyes (with glasses or contact lenses, if you wear them) is excellent, good, fair, poor, or very poor or are you completely blind? VFQ25-Interviewer Administered Format - Eyesight Using Both Eyes VFQ1-How Much Pain in and Around Eyes National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - General Health and Vision: How much pain or discomfort have you had in and around your eyes (for example, burning, itching, or aching)? Would you say it is: VFQ25-Interviewer Administered Format - Pain or Discomfort You Had in and Around Eyes VFQ1-How Often You Worry About Eyesight National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - General Health and Vision: How much of the time do you worry about your eyesight? VFQ25-Interviewer Administered Format - Time Spent Worry About Eyesight VFQ1-I Don't Go Out of My Home Alone National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Dependency: I don't go out of my home alone, because of my eyesight. VFQ25-Interviewer Administered Format - Don't Go Out of Home Alone Because of Eyesight VFQ1-I Feel Frustrated a Lot of the Time National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: I feel frustrated a lot of the time because of my eyesight. VFQ25-Interviewer Administered Format - Feel Frustrated Because of Eyesight VFQ1-I Need a Lot of Help From Others National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: I need a lot of help from others because of my eyesight. VFQ25-Interviewer Administered Format - Need Help From Others Because of Eyesight VFQ1-I Stay Home Most of the Time National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: I stay home most of the time because of my eyesight. VFQ25-Interviewer Administered Format - Stay Home Because of Eyesight VFQ1-Limited in How Long You Can Work National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: Are you limited in how long you can work or do other activities because of your vision? VFQ25-Interviewer Administered Format - Limited in How Long You Can Work Because of Vision VFQ1-Limited in Kinds of Things Can Do National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Role Limitations: Are you limited in the kinds of things you can do because of your vision? VFQ25-Interviewer Administered Format - Limited in Kinds of Things Can Do VFQ1-Main Reason You Gave Up Driving National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: If gave up driving: Was that mainly because of your eyesight, mainly for some other reason, or because of both your eyesight and other reasons? VFQ25-Interviewer Administered Format - Main Reason You Gave Up Driving VFQ1-Much Less Control Over What I Do National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: I have much less control over what I do, because of my eyesight. VFQ25-Interviewer Administered Format - Have Less Control Because of Eyesight VFQ1-Never Driven or Given Up Driving National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: If no, Have you never driven a car or have you given up driving? VFQ25-Interviewer Administered Format - Never Driven or Given Up Driving VFQ1-Often Irritable Because Eyesight National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Well-Being/Distress: I am often irritable because of my eyesight. VFQ25-Interviewer Administered Format - Often Irritable Because of Eyesight VFQ1-Rate Your Eyesight Now National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - General Vision: How would you rate your eyesight now (with glasses or contact lens on, if you wear them), on a scale of from 0 to 10, where zero means the worst possible eyesight, as bad or worse than being blind, and 10 means the best possible eyesight? VFQ25-Interviewer Administered Format - Rate Your Eyesight Now VFQ1-Rate Your Overall Health National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - General Health: How would you rate your overall health, on a scale where zero is as bad as death and 10 is best possible health? VFQ25-Interviewer Administered Format - Rate Your Overall Health VFQ1-Rely Too Much on What Others Tell National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: Because of my eyesight, I have to rely too much on what other people tell me. VFQ25-Interviewer Administered Format - Have to Rely On Other People Because of Eyesight VFQ1-Worry I'll Do Embarrassing Things National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: I worry about doing things that will embarrass myself or others, because of my eyesight. VFQ25-Interviewer Administered Format - Worry About Embarrass Myself or Others Because of Eyesight VFQ1-Your Overall Health Is National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - General Health and Vision: In general, would you say your overall health is: VFQ25-Interviewer Administered Format - Overall Health VFQ1TN National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format Questionnaire Test Name CDISC Questionnaire VFQ25-Interviewer Administered Format Test Name Terminology National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format test code. VFQ2-Your Overall Health Is National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - General Health and Vision: In general, would you say your overall health is: VFQ25-Self Administered Format - Overall Health VFQ2-Eyesight Using Both Eyes Is National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - General Health and Vision: At the present time, would you say your eyesight using both eyes (with glasses or contact lenses, if you wear them) is excellent, good, fair, poor, or very poor or are you completely blind? VFQ25-Self Administered Format - Eyesight Using Both Eyes VFQ2-How Often You Worry About Eyesight National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - General Health and Vision: How much of the time do you worry about your eyesight? VFQ25-Self Administered Format - Time Spent Worry About Eyesight VFQ2-How Much Pain in and Around Eyes National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - General Health and Vision: How much pain or discomfort have you had in and around your eyes (for example, burning, itching, or aching)? Would you say it is: VFQ25-Self Administered Format - Pain or Discomfort You Had in and Around Eyes VFQ2-Difficulty Reading Newspapers National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: How much difficulty do you have reading ordinary print in newspapers? Would you say you have: VFQ25-Self Administered Format - Difficulty Reading Ordinary Print in Newspapers VFQ2-Difficulty Doing Work/Hobbies National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: How much difficulty do you have doing work or hobbies that require you to see well up close, such as cooking, sewing, fixing things around the house, or using hand tools? Would you say: VFQ25-Self Administered Format - Difficulty Doing Work or Hobbies VFQ2-Difficulty Finding on Crowded Shelf National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have finding something on a crowded shelf? VFQ25-Self Administered Format - Difficulty Finding Something On a Shelf VFQ2-Difficulty Reading Street Signs National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: How much difficulty do you have reading street signs or the names of stores? VFQ25-Self Administered Format - Difficulty Reading Street Signs VFQ2-Difficulty Going Down Step at Night National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have going down steps, stairs, or curbs in dim light or at night? VFQ25-Self Administered Format - Difficulty Going Down Steps at Night VFQ2-Difficulty Noticing Objects to Side National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have noticing objects off to the side while you are walking along? VFQ25-Self Administered Format - Difficulty Noticing Objects Off to the Side While Walking VFQ2-Difficulty Seeing How People React National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have seeing how people react to things you say? VFQ25-Self Administered Format - Difficulty Seeing How People React VFQ2-Difficulty Picking Out Own Clothes National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have picking out and matching your own clothes? VFQ25-Self Administered Format - Difficulty Picking Out and Matching Own Clothes VFQ2-Difficulty Visiting With People National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have visiting with people in their homes, at parties, or in restaurants? VFQ25-Self Administered Format - Difficulty Visiting People VFQ2-Difficulty Going Out to See Movies National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have going out to see movies, plays, or sports events? VFQ25-Self Administered Format - Difficulty Going Out to See Movies VFQ2-Are You Currently Driving National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Are you currently driving, at least once in a while? VFQ25-Self Administered Format - Are You Currently Driving VFQ2-Never Driven or Given Up Driving National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: If no: Have you never driven a car or have you given up driving? VFQ25-Self Administered Format - Never Driven or Given Up Driving VFQ2-Main Reason You Gave Up Driving National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: If you gave up driving: Was that mainly because of your eyesight, mainly for some other reason, or because of both your eyesight and other reasons? VFQ25-Self Administered Format - Main Reason You Gave Up Driving VFQ2-Difficulty Driving During Daytime National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: If currently driving: How much difficulty do you have driving during the daytime in familiar places? Would you say you have: VFQ25-Self Administered Format - Difficulty Driving During Daytime VFQ2-Difficulty Driving at Night National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: How much difficulty do you have driving at night? Would you say you have: VFQ25-Self Administered Format - Difficulty Driving at Night VFQ2-Driving in Difficult Conditions National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: How much difficulty do you have driving in difficult conditions, such as in bad weather, during rush hour, on the freeway, or in city traffic? Would you say you have: VFQ25-Self Administered Format - Driving in Difficult Condition VFQ2-Accomplish Less Than You Would Like National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: Do you accomplish less than you would like because of your vision? VFQ25-Self Administered Format - Accomplish Less Because of Vision VFQ2-Limited in How Long You Can Work National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: Are you limited in how long you can work or do other activities because of your vision? VFQ25-Self Administered Format - Limited in How Long You Can Work Because of Vision VFQ2-Eye Pain Keep From Doing What Like National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: How much does pain or discomfort in or around your eyes, for example, burning, itching, or aching, keep you from doing what you'd like to be doing? Would you say: VFQ25-Self Administered Format - Pain in Eyes Keep You From Doing What You Like VFQ2-I Stay Home Most of the Time National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: I stay home most of the time because of my eyesight. VFQ25-Self Administered Format - Stay Home Because of Eyesight VFQ2-I Feel Frustrated a Lot of the Time National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: I feel frustrated a lot of the time because of my eyesight. VFQ25-Self Administered Format - Feel Frustrated Because of Eyesight VFQ2-Much Less Control Over What I Do National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: I have much less control over what I do, because of my eyesight. VFQ25-Self Administered Format - Have Less Control Because of Eyesight VFQ2-Rely Too Much on What Others Tell National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: Because of my eyesight, I have to rely too much on what other people tell me. VFQ25-Self Administered Format - Have to Rely On Other People Because of Eyesight VFQ2-I Need a Lot of Help From Others National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: I need a lot of help from others because of my eyesight. VFQ25-Self Administered Format - Need Help From Others Because of Eyesight VFQ2-Worry I'll Do Embarrassing Things National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: I worry about doing things that will embarrass myself or others, because of my eyesight. VFQ25-Self Administered Format - Worry About Embarrass Myself or Others Because of Eyesight VFQ2-Rate Your Overall Health National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - General Health: How would you rate your overall health, on a scale where zero is as bad as death and 10 is best possible health? VFQ25-Self Administered Format - Rate Your Overall Health VFQ2-Rate Your Eyesight Now National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - General Vision: How would you rate your eyesight now (with glasses or contact lens on, if you wear them), on a scale of from 0 to 10, where zero means the worst possible eyesight, as bad or worse than being blind, and 10 means the best possible eyesight? VFQ25-Self Administered Format - Rate Your Eyesight Now VFQ2-Difficulty Reading Small Print National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Near Vision: Wearing glasses, how much difficulty do you have reading the small print in a telephone book, on a medicine bottle, or on legal forms? Would you say: VFQ25-Self Administered Format - Difficulty Reading Small Print VFQ2-Difficulty Figure Out Bill Accuracy National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Near Vision: Because of your eyesight, how much difficulty do you have figuring out whether bills you receive are accurate? VFQ25-Self Administered Format - Difficulty Figure Out Bill Accuracy VFQ2-Difficulty Shaving or Styling Hair National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Near Vision: Because of your eyesight, how much difficulty do you have doing things like shaving, styling your hair, or putting on makeup? VFQ25-Self Administered Format - Difficulty Shaving or Styling Hair or Putting On Makeup VFQ2-Difficulty Recognizing People National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Distance Vision: Because of your eyesight, how much difficulty do you have recognizing people you know from across a room? VFQ25-Self Administered Format - Difficulty Recognizing People You Know VFQ2-Difficulty Taking Part in Sports National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Distance Vision: Because of your eyesight, how much difficulty do you have taking part in active sports or other outdoor activities that you enjoy (like golf, bowling, jogging, or walking)? VFQ25-Self Administered Format - Difficulty Taking Part in Sports or Outdoor Activities VFQ2-Difficulty Seeing Programs on TV National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Distance Vision: Because of your eyesight, how much difficulty do you have seeing and enjoying programs on TV? VFQ25-Self Administered Format - Difficulty Seeing and Enjoying Programs on TV VFQ2-Difficulty Entertaining Friends National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Social Function: Because of your eyesight, how much difficulty do you have entertaining friends and family in your home? VFQ25-Self Administered Format - Difficulty Entertaining Friends and Family in Home VFQ2-Do You Have More Help From Others National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Role Limitations: Do you have more help from others because of your vision? VFQ25-Self Administered Format - Do You Have More Help From Others VFQ2-Limited in Kinds of Things Can Do National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Role Limitations: Are you limited in the kinds of things you can do because of your vision? VFQ25-Self Administered Format - Limited in Kinds of Things Can Do VFQ2-Often Irritable Because Eyesight National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Well-Being/Distress: I am often irritable because of my eyesight. VFQ25-Self Administered Format - Often Irritable Because of Eyesight VFQ2-I Don't Go Out of My Home Alone National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Dependency: I don't go out of my home alone, because of my eyesight. VFQ25-Self Administered Format - Don't Go Out of Home Alone Because of Eyesight VFQ2TC National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format Questionnaire Test Code CDISC Questionnaire VFQ25-Self Administered Format Test Code Terminology National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format test name. VFQ2-Accomplish Less Than You Would Like National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: Do you accomplish less than you would like because of your vision? VFQ25-Self Administered Format - Accomplish Less Because of Vision VFQ2-Are You Currently Driving National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Are you currently driving, at least once in a while? VFQ25-Self Administered Format - Are You Currently Driving VFQ2-Difficulty Doing Work/Hobbies National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: How much difficulty do you have doing work or hobbies that require you to see well up close, such as cooking, sewing, fixing things around the house, or using hand tools? Would you say: VFQ25-Self Administered Format - Difficulty Doing Work or Hobbies VFQ2-Difficulty Driving at Night National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: How much difficulty do you have driving at night? Would you say you have: VFQ25-Self Administered Format - Difficulty Driving at Night VFQ2-Difficulty Driving During Daytime National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: If currently driving: How much difficulty do you have driving during the daytime in familiar places? Would you say you have: VFQ25-Self Administered Format - Difficulty Driving During Daytime VFQ2-Difficulty Entertaining Friends National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Social Function: Because of your eyesight, how much difficulty do you have entertaining friends and family in your home? VFQ25-Self Administered Format - Difficulty Entertaining Friends and Family in Home VFQ2-Difficulty Figure Out Bill Accuracy National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Near Vision: Because of your eyesight, how much difficulty do you have figuring out whether bills you receive are accurate? VFQ25-Self Administered Format - Difficulty Figure Out Bill Accuracy VFQ2-Difficulty Finding on Crowded Shelf National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have finding something on a crowded shelf? VFQ25-Self Administered Format - Difficulty Finding Something On a Shelf VFQ2-Difficulty Going Down Step at Night National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have going down steps, stairs, or curbs in dim light or at night? VFQ25-Self Administered Format - Difficulty Going Down Steps at Night VFQ2-Difficulty Going Out to See Movies National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have going out to see movies, plays, or sports events? VFQ25-Self Administered Format - Difficulty Going Out to See Movies VFQ2-Difficulty Noticing Objects to Side National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have noticing objects off to the side while you are walking along? VFQ25-Self Administered Format - Difficulty Noticing Objects Off to the Side While Walking VFQ2-Difficulty Picking Out Own Clothes National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have picking out and matching your own clothes? VFQ25-Self Administered Format - Difficulty Picking Out and Matching Own Clothes VFQ2-Difficulty Reading Newspapers National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: How much difficulty do you have reading ordinary print in newspapers? Would you say you have: VFQ25-Self Administered Format - Difficulty Reading Ordinary Print in Newspapers VFQ2-Difficulty Reading Small Print National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Near Vision: Wearing glasses, how much difficulty do you have reading the small print in a telephone book, on a medicine bottle, or on legal forms? Would you say: VFQ25-Self Administered Format - Difficulty Reading Small Print VFQ2-Difficulty Reading Street Signs National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: How much difficulty do you have reading street signs or the names of stores? VFQ25-Self Administered Format - Difficulty Reading Street Signs VFQ2-Difficulty Recognizing People National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Distance Vision: Because of your eyesight, how much difficulty do you have recognizing people you know from across a room? VFQ25-Self Administered Format - Difficulty Recognizing People You Know VFQ2-Difficulty Seeing How People React National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have seeing how people react to things you say? VFQ25-Self Administered Format - Difficulty Seeing How People React VFQ2-Difficulty Seeing Programs on TV National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Distance Vision: Because of your eyesight, how much difficulty do you have seeing and enjoying programs on TV? VFQ25-Self Administered Format - Difficulty Seeing and Enjoying Programs on TV VFQ2-Difficulty Shaving or Styling Hair National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Near Vision: Because of your eyesight, how much difficulty do you have doing things like shaving, styling your hair, or putting on makeup? VFQ25-Self Administered Format - Difficulty Shaving or Styling Hair or Putting On Makeup VFQ2-Difficulty Taking Part in Sports National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Distance Vision: Because of your eyesight, how much difficulty do you have taking part in active sports or other outdoor activities that you enjoy (like golf, bowling, jogging, or walking)? VFQ25-Self Administered Format - Difficulty Taking Part in Sports or Outdoor Activities VFQ2-Difficulty Visiting With People National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have visiting with people in their homes, at parties, or in restaurants? VFQ25-Self Administered Format - Difficulty Visiting People VFQ2-Do You Have More Help From Others National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Role Limitations: Do you have more help from others because of your vision? VFQ25-Self Administered Format - Do You Have More Help From Others VFQ2-Driving in Difficult Conditions National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: How much difficulty do you have driving in difficult conditions, such as in bad weather, during rush hour, on the freeway, or in city traffic? Would you say you have: VFQ25-Self Administered Format - Driving in Difficult Condition VFQ2-Eye Pain Keep From Doing What Like National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: How much does pain or discomfort in or around your eyes, for example, burning, itching, or aching, keep you from doing what you'd like to be doing? Would you say: VFQ25-Self Administered Format - Pain in Eyes Keep You From Doing What You Like VFQ2-Eyesight Using Both Eyes Is National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - General Health and Vision: At the present time, would you say your eyesight using both eyes (with glasses or contact lenses, if you wear them) is excellent, good, fair, poor, or very poor or are you completely blind? VFQ25-Self Administered Format - Eyesight Using Both Eyes VFQ2-How Much Pain in and Around Eyes National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - General Health and Vision: How much pain or discomfort have you had in and around your eyes (for example, burning, itching, or aching)? Would you say it is: VFQ25-Self Administered Format - Pain or Discomfort You Had in and Around Eyes VFQ2-How Often You Worry About Eyesight National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - General Health and Vision: How much of the time do you worry about your eyesight? VFQ25-Self Administered Format - Time Spent Worry About Eyesight VFQ2-I Don't Go Out of My Home Alone National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Dependency: I don't go out of my home alone, because of my eyesight. VFQ25-Self Administered Format - Don't Go Out of Home Alone Because of Eyesight VFQ2-I Feel Frustrated a Lot of the Time National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: I feel frustrated a lot of the time because of my eyesight. VFQ25-Self Administered Format - Feel Frustrated Because of Eyesight VFQ2-I Need a Lot of Help From Others National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: I need a lot of help from others because of my eyesight. VFQ25-Self Administered Format - Need Help From Others Because of Eyesight VFQ2-I Stay Home Most of the Time National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: I stay home most of the time because of my eyesight. VFQ25-Self Administered Format - Stay Home Because of Eyesight VFQ2-Limited in How Long You Can Work National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: Are you limited in how long you can work or do other activities because of your vision? VFQ25-Self Administered Format - Limited in How Long You Can Work Because of Vision VFQ2-Limited in Kinds of Things Can Do National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Role Limitations: Are you limited in the kinds of things you can do because of your vision? VFQ25-Self Administered Format - Limited in Kinds of Things Can Do VFQ2-Main Reason You Gave Up Driving National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: If you gave up driving: Was that mainly because of your eyesight, mainly for some other reason, or because of both your eyesight and other reasons? VFQ25-Self Administered Format - Main Reason You Gave Up Driving VFQ2-Much Less Control Over What I Do National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: I have much less control over what I do, because of my eyesight. VFQ25-Self Administered Format - Have Less Control Because of Eyesight VFQ2-Never Driven or Given Up Driving National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: If no: Have you never driven a car or have you given up driving? VFQ25-Self Administered Format - Never Driven or Given Up Driving VFQ2-Often Irritable Because Eyesight National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Well-Being/Distress: I am often irritable because of my eyesight. VFQ25-Self Administered Format - Often Irritable Because of Eyesight VFQ2-Rate Your Eyesight Now National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - General Vision: How would you rate your eyesight now (with glasses or contact lens on, if you wear them), on a scale of from 0 to 10, where zero means the worst possible eyesight, as bad or worse than being blind, and 10 means the best possible eyesight? VFQ25-Self Administered Format - Rate Your Eyesight Now VFQ2-Rate Your Overall Health National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - General Health: How would you rate your overall health, on a scale where zero is as bad as death and 10 is best possible health? VFQ25-Self Administered Format - Rate Your Overall Health VFQ2-Rely Too Much on What Others Tell National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: Because of my eyesight, I have to rely too much on what other people tell me. VFQ25-Self Administered Format - Have to Rely On Other People Because of Eyesight VFQ2-Worry I'll Do Embarrassing Things National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: I worry about doing things that will embarrass myself or others, because of my eyesight. VFQ25-Self Administered Format - Worry About Embarrass Myself or Others Because of Eyesight VFQ2-Your Overall Health Is National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - General Health and Vision: In general, would you say your overall health is: VFQ25-Self Administered Format - Overall Health VFQ2TN National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format Questionnaire Test Name CDISC Questionnaire VFQ25-Self Administered Format Test Name Terminology National Youth Tobacco Survey 2022 test code. NY1-How Old Are You National Youth Tobacco Survey 2022 - How old are you? NYTS 2022 Version - How Old Are You NY1-What Is Your Sex National Youth Tobacco Survey 2022 - What is your sex? NYTS 2022 Version - What Is Your Sex NY1-What Grade Are You In National Youth Tobacco Survey 2022 - What grade are you in? NYTS 2022 Version - What Grade Are You In NY1-Hispanic: No National Youth Tobacco Survey 2022 - Are you Hispanic, Latino, Latina, or of Spanish origin: No, not of Hispanic, Latino, Latina, or Spanish origin. NYTS 2022 Version - Hispanic: No NY1-Hispanic: Yes Mexican National Youth Tobacco Survey 2022 - Are you Hispanic, Latino, Latina, or of Spanish origin: Yes, Mexican, Mexican American, Chicano, or Chicana. NYTS 2022 Version - Hispanic: Yes Mexican NY1-Hispanic: Yes Puerto Rican National Youth Tobacco Survey 2022 - Are you Hispanic, Latino, Latina, or of Spanish origin: Yes, Puerto Rican. NYTS 2022 Version - Hispanic: Yes Puerto Rican NY1-Hispanic: Yes Cuban National Youth Tobacco Survey 2022 - Are you Hispanic, Latino, Latina, or of Spanish origin: Yes, Cuban. NYTS 2022 Version - Hispanic: Yes Cuban NY1-Hispanic: Yes Another Hispanic National Youth Tobacco Survey 2022 - Are you Hispanic, Latino, Latina, or of Spanish origin: Yes, Another Hispanic, Latino, Latina, or Spanish origin. NYTS 2022 Version - Hispanic: Yes Another Hispanic NY1-Race: American Indian/Alaska Native National Youth Tobacco Survey 2022 - What race or races do you consider yourself to be: American Indian or Alaska Native. NYTS 2022 Version - Race: American Indian/Alaska Native NY1-Race: Asian National Youth Tobacco Survey 2022 - What race or races do you consider yourself to be: Asian. NYTS 2022 Version - Race: Asian NY1-Race: Black or African American National Youth Tobacco Survey 2022 - What race or races do you consider yourself to be: Black or African American. NYTS 2022 Version - Race: Black or African American NY1-Race: Native Hawaiian/Other Pacific National Youth Tobacco Survey 2022 - What race or races do you consider yourself to be: Native Hawaiian or Other Pacific Islander. NYTS 2022 Version - Race: Native Hawaiian/Other Pacific NY1-Race: White National Youth Tobacco Survey 2022 - What race or races do you consider yourself to be: White. NYTS 2022 Version - Race: White NY1-Ever Used an E-Cig National Youth Tobacco Survey 2022 - Have you ever used an e-cigarette, even once or twice? NYTS 2022 Version - Ever Used an E-Cig NY1-How Old When First Used E-Cig National Youth Tobacco Survey 2022 - How old were you when you first used an e-cigarette, even once or twice? NYTS 2022 Version - How Old When First Used E-Cig NY1-Days Used E-Cig Life National Youth Tobacco Survey 2022 - In total, on how many days have you used e-cigarettes in your entire life? NYTS 2022 Version - Days Used E-Cig Life NY1-Past 30 Days Use E-Cig National Youth Tobacco Survey 2022 - During the past 30 days, on how many days did you use e-cigarettes? NYTS 2022 Version - Past 30 Days Use E-Cig NY1-Last Time Used E-Cig National Youth Tobacco Survey 2022 - When was the last time you used an e-cigarette, even one or two times? NYTS 2022 Version - Last Time Used E-Cig NY1-Why First E-Cig: Friend National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: A friend used them. NYTS 2022 Version - Why First E-Cig: Friend NY1-Why First E-Cig: Family Member National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: A family member used them. NYTS 2022 Version - Why First E-Cig: Family Member NY1-Why First E-Cig: Try Quit Other National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: To try to quit using other tobacco products, such as cigarettes. NYTS 2022 Version - Why First E-Cig: Try Quit Other NY1-Why First E-Cig: They Cost Less National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: They cost less than other tobacco products, such as cigarettes. NYTS 2022 Version - Why First E-Cig: They Cost Less NY1-Why First E-Cig: Easier to Get National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: They were easier to get than other tobacco products, such as cigarettes. NYTS 2022 Version - Why First E-Cig: Easier to Get NY1-Why First E-Cig: Seen People TV National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: I've seen people on TV, online, or in movies use them. NYTS 2022 Version - Why First E-Cig: Seen People TV NY1-Why First E-Cig: Less Harmful Other National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: They are less harmful than other forms of tobacco, such as cigarettes. NYTS 2022 Version - Why First E-Cig: Less Harmful Other NY1-Why First E-Cig: Available Flavors National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: They were available in flavors, such as menthol, mint, candy, fruit, or chocolate. NYTS 2022 Version - Why First E-Cig: Available Flavors NY1-Why First E-Cig: Unnoticed at Home National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: I could use them unnoticed at home or at school. NYTS 2022 Version - Why First E-Cig: Unnoticed at Home NY1-Why First E-Cig: Could Do Tricks National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: I could use them to do tricks. NYTS 2022 Version - Why First E-Cig: Could Do Tricks NY1-Why First E-Cig: Curious About National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: I was curious about them. NYTS 2022 Version - Why First E-Cig: Curious About NY1-Why First E-Cig: Feeling Anxious National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: I was feeling anxious, stressed, or depressed. NYTS 2022 Version - Why First E-Cig: Feeling Anxious NY1-Why First E-Cig: Get High or Buzz National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: To get a high or buzz from nicotine. NYTS 2022 Version - Why First E-Cig: Get High or Buzz NY1-Why First E-Cig: Other Reason National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: I used them for some other reason. NYTS 2022 Version - Why First E-Cig: Other Reason NY1-Why First E-Cig: Specify National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: I used them for some other reason (specify). NYTS 2022 Version - Why First E-Cig: Specify NY1-Why Curr E-Cig: Friend National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: A friend uses them. NYTS 2022 Version - Why Curr E-Cig: Friend NY1-Why Curr E-Cig: Family Member National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: A family member uses them. NYTS 2022 Version - Why Curr E-Cig: Family Member NY1-Why Curr E-Cig: Try Quit Other National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: To try to quit using other tobacco products, such as cigarettes. NYTS 2022 Version - Why Curr E-Cig: Try Quit Other NY1-Why Curr E-Cig: They Cost Less National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: They cost less than other tobacco products, such as cigarettes. NYTS 2022 Version - Why Curr E-Cig: They Cost Less NY1-Why Curr E-Cig: Easier to Get National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: They are easier to get than other tobacco products, such as cigarettes. NYTS 2022 Version - Why Curr E-Cig: Easier to Get NY1-Why Curr E-Cig: Seen People TV National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: I've seen people on TV, online, or in movies use them. NYTS 2022 Version - Why Curr E-Cig: Seen People TV NY1-Why Curr E-Cig: Less Harmful Other National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: They are less harmful than other forms of tobacco, such as cigarettes. NYTS 2022 Version - Why Curr E-Cig: Less Harmful Other NY1-Why Curr E-Cig: Available Flavors National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: They are available in flavors, such as menthol, mint, candy, fruit, or chocolate. NYTS 2022 Version - Why Curr E-Cig: Available Flavors NY1-Why Curr E-Cig: Unnoticed at Home National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: I can use them unnoticed at home or at school. NYTS 2022 Version - Why Curr E-Cig: Unnoticed at Home NY1-Why Curr E-Cig: Use to Do Tricks National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: I can use them to do tricks. NYTS 2022 Version - Why Curr E-Cig: Use to Do Tricks NY1-Why Curr E-Cig: Curious About Them National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: I am curious about them. NYTS 2022 Version - Why Curr E-Cig: Curious About Them NY1-Why Curr E-Cig: Feeling Anxious National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: Because I feel anxious, stressed, or depressed. NYTS 2022 Version - Why Curr E-Cig: Feeling Anxious NY1-Why Curr E-Cig: Get High or Buzz National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: To get a high or buzz from nicotine. NYTS 2022 Version - Why Curr E-Cig: Get High or Buzz NY1-Why Curr E-Cig: Other Reason National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: I use them for some other reason. NYTS 2022 Version - Why Curr E-Cig: Other Reason NY1-Why Curr E-Cig: Specify National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: I use them for some other reason (specify). NYTS 2022 Version - Why Curr E-Cig: Specify NY1-Type of E-Cig Used National Youth Tobacco Survey 2022 - Which of the following best describes the type of e-cigarette you have used in the past 30 days? If you have used more than one type, please think about the one you use most often. NYTS 2022 Version - Type of E-Cig Used NY1-What E-Cig Brands Use: blu National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: blu. NYTS 2022 Version - What E-Cig Brands Use: blu NY1-What E-Cig Brands Use: Eonsmoke National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: Eonsmoke. NYTS 2022 Version - What E-Cig Brands Use: Eonsmoke NY1-What E-Cig Brands Use: JUUL National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: JUUL. NYTS 2022 Version - What E-Cig Brands Use: JUUL NY1-What E-Cig Brands Use: Leap National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: Leap. NYTS 2022 Version - What E-Cig Brands Use: Leap NY1-What E-Cig Brands Use: Logic National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: Logic. NYTS 2022 Version - What E-Cig Brands Use: Logic NY1-What E-Cig Brands Use: Mojo National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: Mojo. NYTS 2022 Version - What E-Cig Brands Use: Mojo NY1-What E-Cig Brands Use: NJOY National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: NJOY. NYTS 2022 Version - What E-Cig Brands Use: NJOY NY1-What E-Cig Brands Use: Posh National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: Posh. NYTS 2022 Version - What E-Cig Brands Use: Posh NY1-What E-Cig Brands Use: Puff Bar National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: Puff Bar. NYTS 2022 Version - What E-Cig Brands Use: Puff Bar NY1-What E-Cig Brands Use: SMOK National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: SMOK (including NOVO). NYTS 2022 Version - What E-Cig Brands Use: SMOK NY1-What E-Cig Brands Use: STIG National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: STIG. NYTS 2022 Version - What E-Cig Brands Use: STIG NY1-What E-Cig Brands Use: Suorin National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: Suorin. NYTS 2022 Version - What E-Cig Brands Use: Suorin NY1-What E-Cig Brands Use: Vuse National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: Vuse. NYTS 2022 Version - What E-Cig Brands Use: Vuse NY1-What E-Cig Brands Use: Other National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: Some other brand(s) not listed here. NYTS 2022 Version - What E-Cig Brands Use: Other NY1-What E-Cig Brands Use: Not Sure National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: Not sure/I don't know the brand. NYTS 2022 Version - What E-Cig Brands Use: Not Sure NY1-What E-Cig Brands Use: Specify National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: Some other brand(s) not listed here (specify). NYTS 2022 Version - What E-Cig Brands Use: Specify NY1-What Brand E-Cig Usually National Youth Tobacco Survey 2022 - During the past 30 days, what brand of e-cigarettes did you usually use? NYTS 2022 Version - What Brand E-Cig Usually NY1-What Brand E-Cig Usually: Specify National Youth Tobacco Survey 2022 - During the past 30 days, what brand of e-cigarettes did you usually use? Some other brand not listed here (specify). NYTS 2022 Version - What Brand E-Cig Usually: Specify NY1-Any E-Cigs Used Contain Nicotine National Youth Tobacco Survey 2022 - Did any of the e-cigarettes that you used in the past 30 days contain nicotine? NYTS 2022 Version - Any E-Cigs Used Contain Nicotine NY1-Any E-Cigs Used Contain Nic Salt National Youth Tobacco Survey 2022 - Did any of the e-cigarettes that you used in the past 30 days contain nicotine salts? NYTS 2022 Version - Any E-Cigs Used Contain Nic Salt NY1-Any E-Cigs Flavored National Youth Tobacco Survey 2022 - Were any of the e-cigarettes that you used in the past 30 days flavored to taste like menthol, mint, clove or spice, alcoholic drinks, candy, fruit, chocolate, or any other flavor? NYTS 2022 Version - Any E-Cigs Flavored NY1-Any Cigars Flavored National Youth Tobacco Survey 2022 - Were any of the cigars, cigarillos, or little cigars that you used in the past 30 days flavored to taste like menthol, mint, clove or spice, alcoholic drinks, candy, fruit, chocolate, or any other flavor? NYTS 2022 Version - Any Cigars Flavored NY1-Any Dip Flavored National Youth Tobacco Survey 2022 - Was any of the chewing tobacco, snuff, or dip that you used in the past 30 days flavored to taste like menthol, mint, clove or spice, alcoholic drinks, candy, fruit, chocolate, or any other flavor? NYTS 2022 Version - Any Dip Flavored NY1-Any Hookah Flavored National Youth Tobacco Survey 2022 - Was any of the tobacco in a hookah or waterpipe that you used in the past 30 days flavored to taste like menthol, mint, clove or spice, alcoholic drinks, candy, fruit, chocolate, or any other flavor? NYTS 2022 Version - Any Hookah Flavored NY1-Any Pipe Tobacco Flavored National Youth Tobacco Survey 2022 - Were any of the pipes filled with tobacco that you used in the past 30 days flavored to taste like menthol, mint, clove or spice, alcoholic drinks, candy, fruit, chocolate, or any other flavor? NYTS 2022 Version - Any Pipe Tobacco Flavored NY1-Any Snus Flavored National Youth Tobacco Survey 2022 - Was any of the snus that you used in the past 30 days flavored to taste like menthol, mint, clove or spice, alcoholic drinks, candy, fruit, chocolate, or any other flavor? NYTS 2022 Version - Any Snus Flavored NY1-Any Dissolv Tobacco Flavored National Youth Tobacco Survey 2022 - Were any of the dissolvable tobacco products that you used in the past 30 days flavored to taste like menthol, mint, clove or spice, alcoholic drinks, candy, fruit, chocolate, or any other flavor? NYTS 2022 Version - Any Dissolv Tobacco Flavored NY1-Any Bidis Flavored National Youth Tobacco Survey 2022 - Were any of the bidis that you used in the past 30 days flavored to taste like menthol, mint, clove or spice, alcoholic drinks, candy, fruit, chocolate or any other flavor? NYTS 2022 Version - Any Bidis Flavored NY1-Any RYO Cigs Flavored National Youth Tobacco Survey 2022 - Were any of the roll-your-own cigarettes that you used in the past 30 days flavored to taste like menthol, mint, clove or spice, alcoholic drinks, candy, fruit, chocolate, or any other flavor? NYTS 2022 Version - Any RYO Cigs Flavored NY1-Any Heated Tobacco Flavored National Youth Tobacco Survey 2022 - Were any of the heated tobacco products that you used in the past 30 days flavored to taste like menthol, mint, clove or spice, alcoholic drinks, candy, fruit, chocolate, or any other flavor? NYTS 2022 Version - Any Heated Tobacco Flavored NY1-Any Pouches Flavored National Youth Tobacco Survey 2022 - Were any of the nicotine pouches that you used in the past 30 days flavored to taste like menthol, mint, clove or spice, alcoholic drinks, candy, fruit, chocolate, or any other flavor? NYTS 2022 Version - Any Pouches Flavored NY1-Flavors E-Cig: Menthol National Youth Tobacco Survey 2022 - What flavors were the e-cigarettes that you have used in the past 30 days: Menthol. NYTS 2022 Version - Flavors E-Cig: Menthol NY1-Flavors E-Cig: Mint National Youth Tobacco Survey 2022 - What flavors were the e-cigarettes that you have used in the past 30 days: Mint. NYTS 2022 Version - Flavors E-Cig: Mint NY1-Flavors E-Cig: Clove National Youth Tobacco Survey 2022 - What flavors were the e-cigarettes that you have used in the past 30 days: Clove or spice. NYTS 2022 Version - Flavors E-Cig: Clove NY1-Flavors E-Cig: Fruit National Youth Tobacco Survey 2022 - What flavors were the e-cigarettes that you have used in the past 30 days: Fruit. NYTS 2022 Version - Flavors E-Cig: Fruit NY1-Flavors E-Cig: Chocolate National Youth Tobacco Survey 2022 - What flavors were the e-cigarettes that you have used in the past 30 days: Chocolate. NYTS 2022 Version - Flavors E-Cig: Chocolate NY1-Flavors E-Cig: Alcoholic National Youth Tobacco Survey 2022 - What flavors were the e-cigarettes that you have used in the past 30 days: Alcoholic drinks (such as wine, margarita, or other cocktails). NYTS 2022 Version - Flavors E-Cig: Alcoholic NY1-Flavors E-Cig: Candy National Youth Tobacco Survey 2022 - What flavors were the e-cigarettes that you have used in the past 30 days: Candy, desserts, or other sweets. NYTS 2022 Version - Flavors E-Cig: Candy NY1-Flavors E-Cig: Other National Youth Tobacco Survey 2022 - What flavors were the e-cigarettes that you have used in the past 30 days: Some other flavor not listed here. NYTS 2022 Version - Flavors E-Cig: Other NY1-Flavors E-Cig: Specify National Youth Tobacco Survey 2022 - What flavors were the e-cigarettes that you have used in the past 30 days: Some other flavor not listed here (specify). NYTS 2022 Version - Flavors E-Cig: Specify NY1-Flavors Cigars: Menthol National Youth Tobacco Survey 2022 - What flavors were the cigars, cigarillos, or little cigars that you have used in the past 30 days: Menthol. NYTS 2022 Version - Flavors Cigars: Menthol NY1-Flavors Cigars: Mint National Youth Tobacco Survey 2022 - What flavors were the cigars, cigarillos, or little cigars that you have used in the past 30 days: Mint. NYTS 2022 Version - Flavors Cigars: Mint NY1-Flavors Cigars: Clove National Youth Tobacco Survey 2022 - What flavors were the cigars, cigarillos, or little cigars that you have used in the past 30 days: Clove or spice. NYTS 2022 Version - Flavors Cigars: Clove NY1-Flavors Cigars: Fruit National Youth Tobacco Survey 2022 - What flavors were the cigars, cigarillos, or little cigars that you have used in the past 30 days: Fruit. NYTS 2022 Version - Flavors Cigars: Fruit NY1-Flavors Cigars: Chocolate National Youth Tobacco Survey 2022 - What flavors were the cigars, cigarillos, or little cigars that you have used in the past 30 days: Chocolate. NYTS 2022 Version - Flavors Cigars: Chocolate NY1-Flavors Cigars: Alcoholic National Youth Tobacco Survey 2022 - What flavors were the cigars, cigarillos, or little cigars that you have used in the past 30 days: Alcoholic drinks (such as wine, margarita, or other cocktails). NYTS 2022 Version - Flavors Cigars: Alcoholic NY1-Flavors Cigars: Candy National Youth Tobacco Survey 2022 - What flavors were the cigars, cigarillos, or little cigars that you have used in the past 30 days: Candy, desserts, or other sweets. NYTS 2022 Version - Flavors Cigars: Candy NY1-Flavors Cigars: Other National Youth Tobacco Survey 2022 - What flavors were the cigars, cigarillos, or little cigars that you have used in the past 30 days: Some other flavor not listed here. NYTS 2022 Version - Flavors Cigars: Other NY1-Flavors Cigars: Specify National Youth Tobacco Survey 2022 - What flavors were the cigars, cigarillos, or little cigars that you have used in the past 30 days: Some other flavor not listed here (specify). NYTS 2022 Version - Flavors Cigars: Specify NY1-Flavors Dip: Menthol National Youth Tobacco Survey 2022 - What flavors was the chewing tobacco, snuff, or dip that you have used in the past 30 days: Menthol. NYTS 2022 Version - Flavors Dip: Menthol NY1-Flavors Dip: Mint National Youth Tobacco Survey 2022 - What flavors was the chewing tobacco, snuff, or dip that you have used in the past 30 days: Mint. NYTS 2022 Version - Flavors Dip: Mint NY1-Flavors Dip: Clove National Youth Tobacco Survey 2022 - What flavors was the chewing tobacco, snuff, or dip that you have used in the past 30 days: Clove or spice. NYTS 2022 Version - Flavors Dip: Clove NY1-Flavors Dip: Fruit National Youth Tobacco Survey 2022 - What flavors was the chewing tobacco, snuff, or dip that you have used in the past 30 days: Fruit. NYTS 2022 Version - Flavors Dip: Fruit NY1-Flavors Dip: Chocolate National Youth Tobacco Survey 2022 - What flavors was the chewing tobacco, snuff, or dip that you have used in the past 30 days: Chocolate. NYTS 2022 Version - Flavors Dip: Chocolate NY1-Flavors Dip: Alcoholic National Youth Tobacco Survey 2022 - What flavors was the chewing tobacco, snuff, or dip that you have used in the past 30 days: Alcoholic drinks (such as wine, margarita, or other cocktails). NYTS 2022 Version - Flavors Dip: Alcoholic NY1-Flavors Dip: Candy National Youth Tobacco Survey 2022 - What flavors was the chewing tobacco, snuff, or dip that you have used in the past 30 days: Candy, desserts, or other sweets. NYTS 2022 Version - Flavors Dip: Candy NY1-Flavors Dip: Other National Youth Tobacco Survey 2022 - What flavors was the chewing tobacco, snuff, or dip that you have used in the past 30 days: Some other flavor not listed here. NYTS 2022 Version - Flavors Dip: Other NY1-Flavors Dip: Specify National Youth Tobacco Survey 2022 - What flavors was the chewing tobacco, snuff, or dip that you have used in the past 30 days: Some other flavor not listed here (specify). NYTS 2022 Version - Flavors Dip: Specify NY1-Flavors Hookah: Menthol National Youth Tobacco Survey 2022 - What flavors was the tobacco in a hookah or waterpipe that you have used in the past 30 days: Menthol. NYTS 2022 Version - Flavors Hookah: Menthol NY1-Flavors Hookah: Mint National Youth Tobacco Survey 2022 - What flavors was the tobacco in a hookah or waterpipe that you have used in the past 30 days: Mint. NYTS 2022 Version - Flavors Hookah: Mint NY1-Flavors Hookah: Clove National Youth Tobacco Survey 2022 - What flavors was the tobacco in a hookah or waterpipe that you have used in the past 30 days: Clove or spice. NYTS 2022 Version - Flavors Hookah: Clove NY1-Flavors Hookah: Fruit National Youth Tobacco Survey 2022 - What flavors was the tobacco in a hookah or waterpipe that you have used in the past 30 days: Fruit. NYTS 2022 Version - Flavors Hookah: Fruit NY1-Flavors Hookah: Chocolate National Youth Tobacco Survey 2022 - What flavors was the tobacco in a hookah or waterpipe that you have used in the past 30 days: Chocolate. NYTS 2022 Version - Flavors Hookah: Chocolate NY1-Flavors Hookah: Alcoholic National Youth Tobacco Survey 2022 - What flavors was the tobacco in a hookah or waterpipe that you have used in the past 30 days: Alcoholic drinks (such as wine, margarita, or other cocktails). NYTS 2022 Version - Flavors Hookah: Alcoholic NY1-Flavors Hookah: Candy National Youth Tobacco Survey 2022 - What flavors was the tobacco in a hookah or waterpipe that you have used in the past 30 days: Candy, desserts, or other sweets. NYTS 2022 Version - Flavors Hookah: Candy NY1-Flavors Hookah: Other National Youth Tobacco Survey 2022 - What flavors was the tobacco in a hookah or waterpipe that you have used in the past 30 days: Some other flavor not listed here. NYTS 2022 Version - Flavors Hookah: Other NY1-Flavors Hookah: Specify National Youth Tobacco Survey 2022 - What flavors was the tobacco in a hookah or waterpipe that you have used in the past 30 days: Some other flavor not listed here (specify). NYTS 2022 Version - Flavors Hookah: Specify NY1-Flavors Pipe Tobacco: Menthol National Youth Tobacco Survey 2022 - What flavors were the pipes filled with tobacco that you have used in the past 30 days: Menthol. NYTS 2022 Version - Flavors Pipe Tobacco: Menthol NY1-Flavors Pipe Tobacco: Mint National Youth Tobacco Survey 2022 - What flavors were the pipes filled with tobacco that you have used in the past 30 days: Mint. NYTS 2022 Version - Flavors Pipe Tobacco: Mint NY1-Flavors Pipe Tobacco: Clove National Youth Tobacco Survey 2022 - What flavors were the pipes filled with tobacco that you have used in the past 30 days: Clove or spice. NYTS 2022 Version - Flavors Pipe Tobacco: Clove NY1-Flavors Pipe Tobacco: Fruit National Youth Tobacco Survey 2022 - What flavors were the pipes filled with tobacco that you have used in the past 30 days: Fruit. NYTS 2022 Version - Flavors Pipe Tobacco: Fruit NY1-Flavors Pipe Tobacco: Chocolate National Youth Tobacco Survey 2022 - What flavors were the pipes filled with tobacco that you have used in the past 30 days: Chocolate. NYTS 2022 Version - Flavors Pipe Tobacco: Chocolate NY1-Flavors Pipe Tobacco: Alcoholic National Youth Tobacco Survey 2022 - What flavors were the pipes filled with tobacco that you have used in the past 30 days: Alcoholic drinks (such as wine, margarita, or other cocktails). NYTS 2022 Version - Flavors Pipe Tobacco: Alcoholic NY1-Flavors Pipe Tobacco: Candy National Youth Tobacco Survey 2022 - What flavors were the pipes filled with tobacco that you have used in the past 30 days: Candy, desserts, or other sweets. NYTS 2022 Version - Flavors Pipe Tobacco: Candy NY1-Flavors Pipe Tobacco: Other National Youth Tobacco Survey 2022 - What flavors were the pipes filled with tobacco that you have used in the past 30 days: Some other flavor not listed here. NYTS 2022 Version - Flavors Pipe Tobacco: Other NY1-Flavors Pipe Tobacco: Specify National Youth Tobacco Survey 2022 - What flavors were the pipes filled with tobacco that you have used in the past 30 days: Some other flavor not listed here (specify). NYTS 2022 Version - Flavors Pipe Tobacco: Specify NY1-Flavors Snus: Menthol National Youth Tobacco Survey 2022 - What flavors was the snus that you have used in the past 30 days: Menthol. NYTS 2022 Version - Flavors Snus: Menthol NY1-Flavors Snus: Mint National Youth Tobacco Survey 2022 - What flavors was the snus that you have used in the past 30 days: Mint. NYTS 2022 Version - Flavors Snus: Mint NY1-Flavors Snus: Clove National Youth Tobacco Survey 2022 - What flavors was the snus that you have used in the past 30 days: Clove or spice. NYTS 2022 Version - Flavors Snus: Clove NY1-Flavors Snus: Fruit National Youth Tobacco Survey 2022 - What flavors was the snus that you have used in the past 30 days: Fruit. NYTS 2022 Version - Flavors Snus: Fruit NY1-Flavors Snus: Chocolate National Youth Tobacco Survey 2022 - What flavors was the snus that you have used in the past 30 days: Chocolate. NYTS 2022 Version - Flavors Snus: Chocolate NY1-Flavors Snus: Alcoholic National Youth Tobacco Survey 2022 - What flavors was the snus that you have used in the past 30 days: Alcoholic drinks (such as wine, margarita, or other cocktails). NYTS 2022 Version - Flavors Snus: Alcoholic NY1-Flavors Snus: Candy National Youth Tobacco Survey 2022 - What flavors was the snus that you have used in the past 30 days: Candy, desserts, or other sweets. NYTS 2022 Version - Flavors Snus: Candy NY1-Flavors Snus: Other National Youth Tobacco Survey 2022 - What flavors was the snus that you have used in the past 30 days: Some other flavor not listed here. NYTS 2022 Version - Flavors Snus: Other NY1-Flavors Snus: Specify National Youth Tobacco Survey 2022 - What flavors was the snus that you have used in the past 30 days: Some other flavor not listed here (specify). NYTS 2022 Version - Flavors Snus: Specify NY1-Flavors Dissolv: Menthol National Youth Tobacco Survey 2022 - What flavors were the dissolvable tobacco products that you have used in the past 30 days: Menthol. NYTS 2022 Version - Flavors Dissolv: Menthol NY1-Flavors Dissolv: Mint National Youth Tobacco Survey 2022 - What flavors were the dissolvable tobacco products that you have used in the past 30 days: Mint. NYTS 2022 Version - Flavors Dissolv: Mint NY1-Flavors Dissolv: Clove National Youth Tobacco Survey 2022 - What flavors were the dissolvable tobacco products that you have used in the past 30 days: Clove or spice. NYTS 2022 Version - Flavors Dissolv: Clove NY1-Flavors Dissolv: Fruit National Youth Tobacco Survey 2022 - What flavors were the dissolvable tobacco products that you have used in the past 30 days: Fruit. NYTS 2022 Version - Flavors Dissolv: Fruit NY1-Flavors Dissolv: Chocolate National Youth Tobacco Survey 2022 - What flavors were the dissolvable tobacco products that you have used in the past 30 days: Chocolate. NYTS 2022 Version - Flavors Dissolv: Chocolate NY1-Flavors Dissolv: Alcoholic National Youth Tobacco Survey 2022 - What flavors were the dissolvable tobacco products that you have used in the past 30 days: Alcoholic drinks (such as wine, margarita, or other cocktails). NYTS 2022 Version - Flavors Dissolv: Alcoholic NY1-Flavors Dissolv: Candy National Youth Tobacco Survey 2022 - What flavors were the dissolvable tobacco products that you have used in the past 30 days: Candy, desserts, or other sweets. NYTS 2022 Version - Flavors Dissolv: Candy NY1-Flavors Dissolv: Other National Youth Tobacco Survey 2022 - What flavors were the dissolvable tobacco products that you have used in the past 30 days: Some other flavor not listed here. NYTS 2022 Version - Flavors Dissolv: Other NY1-Flavors Dissolv: Specify National Youth Tobacco Survey 2022 - What flavors were the dissolvable tobacco products that you have used in the past 30 days: Some other flavor not listed here (specify). NYTS 2022 Version - Flavors Dissolv: Specify NY1-Flavors Bidis: Menthol National Youth Tobacco Survey 2022 - What flavors were the bidis that you have used in the past 30 days: Menthol. NYTS 2022 Version - Flavors Bidis: Menthol NY1-Flavors Bidis: Mint National Youth Tobacco Survey 2022 - What flavors were the bidis that you have used in the past 30 days: Mint. NYTS 2022 Version - Flavors Bidis: Mint NY1-Flavors Bidis: Clove National Youth Tobacco Survey 2022 - What flavors were the bidis that you have used in the past 30 days: Clove or spice. NYTS 2022 Version - Flavors Bidis: Clove NY1-Flavors Bidis: Fruit National Youth Tobacco Survey 2022 - What flavors were the bidis that you have used in the past 30 days: Fruit. NYTS 2022 Version - Flavors Bidis: Fruit NY1-Flavors Bidis: Chocolate National Youth Tobacco Survey 2022 - What flavors were the bidis that you have used in the past 30 days: Chocolate. NYTS 2022 Version - Flavors Bidis: Chocolate NY1-Flavors Bidis: Alcoholic National Youth Tobacco Survey 2022 - What flavors were the bidis that you have used in the past 30 days: Alcoholic drinks (such as wine, margarita, or other cocktails). NYTS 2022 Version - Flavors Bidis: Alcoholic NY1-Flavors Bidis: Candy National Youth Tobacco Survey 2022 - What flavors were the bidis that you have used in the past 30 days: Candy, desserts, or other sweets. NYTS 2022 Version - Flavors Bidis: Candy NY1-Flavors Bidis: Other National Youth Tobacco Survey 2022 - What flavors were the bidis that you have used in the past 30 days: Some other flavor not listed here. NYTS 2022 Version - Flavors Bidis: Other NY1-Flavors Bidis: Specify National Youth Tobacco Survey 2022 - What flavors were the bidis that you have used in the past 30 days: Some other flavor not listed here (specify). NYTS 2022 Version - Flavors Bidis: Specify NY1-Flavors RYO Cigs: Menthol National Youth Tobacco Survey 2022 - What flavors were the roll-your-own cigarettes that you have used in the past 30 days: Menthol. NYTS 2022 Version - Flavors RYO Cigs: Menthol NY1-Flavors RYO Cigs: Mint National Youth Tobacco Survey 2022 - What flavors were the roll-your-own cigarettes that you have used in the past 30 days: Mint. NYTS 2022 Version - Flavors RYO Cigs: Mint NY1-Flavors RYO Cigs: Clove National Youth Tobacco Survey 2022 - What flavors were the roll-your-own cigarettes that you have used in the past 30 days: Clove or spice. NYTS 2022 Version - Flavors RYO Cigs: Clove NY1-Flavors RYO Cigs: Fruit National Youth Tobacco Survey 2022 - What flavors were the roll-your-own cigarettes that you have used in the past 30 days: Fruit. NYTS 2022 Version - Flavors RYO Cigs: Fruit NY1-Flavors RYO Cigs: Chocolate National Youth Tobacco Survey 2022 - What flavors were the roll-your-own cigarettes that you have used in the past 30 days: Chocolate. NYTS 2022 Version - Flavors RYO Cigs: Chocolate NY1-Flavors RYO Cigs: Alcoholic National Youth Tobacco Survey 2022 - What flavors were the roll-your-own cigarettes that you have used in the past 30 days: Alcoholic drinks (such as wine, margarita, or other cocktails). NYTS 2022 Version - Flavors RYO Cigs: Alcoholic NY1-Flavors RYO Cigs: Candy National Youth Tobacco Survey 2022 - What flavors were the roll-your-own cigarettes that you have used in the past 30 days: Candy, desserts, or other sweets. NYTS 2022 Version - Flavors RYO Cigs: Candy NY1-Flavors RYO Cigs: Other National Youth Tobacco Survey 2022 - What flavors were the roll-your-own cigarettes that you have used in the past 30 days: Some other flavor not listed here. NYTS 2022 Version - Flavors RYO Cigs: Other NY1-Flavors RYO Cigs: Specify National Youth Tobacco Survey 2022 - What flavors were the roll-your-own cigarettes that you have used in the past 30 days: Some other flavor not listed here (specify). NYTS 2022 Version - Flavors RYO Cigs: Specify NY1-Flavors Heated Tobacco: Menthol National Youth Tobacco Survey 2022 - What flavors were the heated tobacco products that you have used in the past 30 days: Menthol. NYTS 2022 Version - Flavors Heated Tobacco: Menthol NY1-Flavors Heated Tobacco: Mint National Youth Tobacco Survey 2022 - What flavors were the heated tobacco products that you have used in the past 30 days: Mint. NYTS 2022 Version - Flavors Heated Tobacco: Mint NY1-Flavors Heated Tobacco: Clove National Youth Tobacco Survey 2022 - What flavors were the heated tobacco products that you have used in the past 30 days: Clove or spice. NYTS 2022 Version - Flavors Heated Tobacco: Clove NY1-Flavors Heated Tobacco: Fruit National Youth Tobacco Survey 2022 - What flavors were the heated tobacco products that you have used in the past 30 days: Fruit. NYTS 2022 Version - Flavors Heated Tobacco: Fruit NY1-Flavors Heated Tobacco: Chocolate National Youth Tobacco Survey 2022 - What flavors were the heated tobacco products that you have used in the past 30 days: Chocolate. NYTS 2022 Version - Flavors Heated Tobacco: Chocolate NY1-Flavors Heated Tobacco: Alcoholic National Youth Tobacco Survey 2022 - What flavors were the heated tobacco products that you have used in the past 30 days: Alcoholic drinks (such as wine, margarita, or other cocktails). NYTS 2022 Version - Flavors Heated Tobacco: Alcoholic NY1-Flavors Heated Tobacco: Candy National Youth Tobacco Survey 2022 - What flavors were the heated tobacco products that you have used in the past 30 days: Candy, desserts, or other sweets. NYTS 2022 Version - Flavors Heated Tobacco: Candy NY1-Flavors Heated Tobacco: Other National Youth Tobacco Survey 2022 - What flavors were the heated tobacco products that you have used in the past 30 days: Some other flavor not listed here. NYTS 2022 Version - Flavors Heated Tobacco: Other NY1-Flavors Heated Tobacco: Specify National Youth Tobacco Survey 2022 - What flavors were the heated tobacco products that you have used in the past 30 days: Some other flavor not listed here (specify). NYTS 2022 Version - Flavors Heated Tobacco: Specify NY1-Flavors Pouches: Menthol National Youth Tobacco Survey 2022 - What flavors were the nicotine pouches that you have used in the past 30 days: Menthol. NYTS 2022 Version - Flavors Pouches: Menthol NY1-Flavors Pouches: Mint National Youth Tobacco Survey 2022 - What flavors were the nicotine pouches that you have used in the past 30 days: Mint. NYTS 2022 Version - Flavors Pouches: Mint NY1-Flavors Pouches: Clove National Youth Tobacco Survey 2022 - What flavors were the nicotine pouches that you have used in the past 30 days: Clove or spice. NYTS 2022 Version - Flavors Pouches: Clove NY1-Flavors Pouches: Fruit National Youth Tobacco Survey 2022 - What flavors were the nicotine pouches that you have used in the past 30 days: Fruit. NYTS 2022 Version - Flavors Pouches: Fruit NY1-Flavors Pouches: Chocolate National Youth Tobacco Survey 2022 - What flavors were the nicotine pouches that you have used in the past 30 days: Chocolate. NYTS 2022 Version - Flavors Pouches: Chocolate NY1-Flavors Pouches: Alcoholic National Youth Tobacco Survey 2022 - What flavors were the nicotine pouches that you have used in the past 30 days: Alcoholic drinks (such as wine, margarita, or other cocktails). NYTS 2022 Version - Flavors Pouches: Alcoholic NY1-Flavors Pouches: Candy National Youth Tobacco Survey 2022 - What flavors were the nicotine pouches that you have used in the past 30 days: Candy, desserts, or other sweets. NYTS 2022 Version - Flavors Pouches: Candy NY1-Flavors Pouches: Other National Youth Tobacco Survey 2022 - What flavors were the nicotine pouches that you have used in the past 30 days: Some other flavor not listed here. NYTS 2022 Version - Flavors Pouches: Other NY1-Flavors Pouches: Specify National Youth Tobacco Survey 2022 - What flavors were the nicotine pouches that you have used in the past 30 days: Some other flavor not listed here (specify). NYTS 2022 Version - Flavors Pouches: Specify NY1-How Get E-Cig: Myself National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your e-cigarette devices, pods, cartridges, or e-liquid refills: I bought them myself. NYTS 2022 Version - How Get E-Cig: Myself NY1-How Get E-Cig: Someone Buy National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your e-cigarette devices, pods, cartridges, or e-liquid refills: I had someone else buy them for me. NYTS 2022 Version - How Get E-Cig: Someone Buy NY1-How Get E-Cig: Asked National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your e-cigarette devices, pods, cartridges, or e-liquid refills: I asked someone to give me some. NYTS 2022 Version - How Get E-Cig: Asked NY1-How Get E-Cig: Offered National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your e-cigarette devices, pods, cartridges, or e-liquid refills: Someone offered them to me. NYTS 2022 Version - How Get E-Cig: Offered NY1-How Get E-Cig: From Friend National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your e-cigarette devices, pods, cartridges, or e-liquid refills: I got them from a friend. NYTS 2022 Version - How Get E-Cig: From Friend NY1-How Get E-Cig: From Family National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your e-cigarette devices, pods, cartridges, or e-liquid refills: I got them from a family member. NYTS 2022 Version - How Get E-Cig: From Family NY1-How Get E-Cig: Took Store National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your e-cigarette devices, pods, cartridges, or e-liquid refills: I took them from a store or another person. NYTS 2022 Version - How Get E-Cig: Took Store NY1-How Get E-Cig: Other National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your e-cigarette devices, pods, cartridges, or e-liquid refills: I got them in some other way. NYTS 2022 Version - How Get E-Cig: Other NY1-How Get E-Cig: Specify National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your e-cigarette devices, pods, cartridges, or e-liquid refills: I got them in some other way (specify). NYTS 2022 Version - How Get E-Cig: Specify NY1-How Get Cig: Myself National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigarettes: I bought them myself. NYTS 2022 Version - How Get Cig: Myself NY1-How Get Cig: Someone Buy National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigarettes: I had someone else buy them for me. NYTS 2022 Version - How Get Cig: Someone Buy NY1-How Get Cig: Asked National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigarettes: I asked someone to give me some. NYTS 2022 Version - How Get Cig: Asked NY1-How Get Cig: Offered National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigarettes: Someone offered them to me. NYTS 2022 Version - How Get Cig: Offered NY1-How Get Cig: From Friend National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigarettes: I got them from a friend. NYTS 2022 Version - How Get Cig: From Friend NY1-How Get Cig: From Family National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigarettes: I got them from a family member. NYTS 2022 Version - How Get Cig: From Family NY1-How Get Cig: Took Store National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigarettes: I took them from a store or another person. NYTS 2022 Version - How Get Cig: Took Store NY1-How Get Cig: Other National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigarettes: I got them in some other way. NYTS 2022 Version - How Get Cig: Other NY1-How Get Cig: Specify National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigarettes: I got them in some other way (specify). NYTS 2022 Version - How Get Cig: Specify NY1-How Get Cigars: Myself National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigars, cigarillos, or little cigars: I bought them myself. NYTS 2022 Version - How Get Cigars: Myself NY1-How Get Cigars: Someone Buy National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigars, cigarillos, or little cigars: I had someone else buy them for me. NYTS 2022 Version - How Get Cigars: Someone Buy NY1-How Get Cigars: Asked National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigars, cigarillos, or little cigars: I asked someone to give me some. NYTS 2022 Version - How Get Cigars: Asked NY1-How Get Cigars: Offered National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigars, cigarillos, or little cigars: Someone offered them to me. NYTS 2022 Version - How Get Cigars: Offered NY1-How Get Cigars: From Friend National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigars, cigarillos, or little cigars: I got them from a friend. NYTS 2022 Version - How Get Cigars: From Friend NY1-How Get Cigars: From Family National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigars, cigarillos, or little cigars: I got them from a family member. NYTS 2022 Version - How Get Cigars: From Family NY1-How Get Cigars: Took Store National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigars, cigarillos, or little cigars: I took them from a store or another person. NYTS 2022 Version - How Get Cigars: Took Store NY1-How Get Cigars: Other National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigars, cigarillos, or little cigars: I got them in some other way. NYTS 2022 Version - How Get Cigars: Other NY1-How Get Cigars: Specify National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigars, cigarillos, or little cigars: I got them in some other way (specify). NYTS 2022 Version - How Get Cigars: Specify NY1-How Get Dip: Myself National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your chewing tobacco, snuff, or dip: I bought it myself. NYTS 2022 Version - How Get Dip: Myself NY1-How Get Dip: Someone Buy National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your chewing tobacco, snuff, or dip: I had someone else buy it for me. NYTS 2022 Version - How Get Dip: Someone Buy NY1-How Get Dip: Asked National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your chewing tobacco, snuff, or dip: I asked someone to give me some. NYTS 2022 Version - How Get Dip: Asked NY1-How Get Dip: Offered National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your chewing tobacco, snuff, or dip: Someone offered it to me. NYTS 2022 Version - How Get Dip: Offered NY1-How Get Dip: From Friend National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your chewing tobacco, snuff, or dip: I got it from a friend. NYTS 2022 Version - How Get Dip: From Friend NY1-How Get Dip: From Family National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your chewing tobacco, snuff, or dip: I got it from a family member. NYTS 2022 Version - How Get Dip: From Family NY1-How Get Dip: Took Store National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your chewing tobacco, snuff, or dip: I took it from a store or another person. NYTS 2022 Version - How Get Dip: Took Store NY1-How Get Dip: Other National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your chewing tobacco, snuff, or dip: I got it in some other way. NYTS 2022 Version - How Get Dip: Other NY1-How Get Dip: Specify National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your chewing tobacco, snuff, or dip: I got it in some other way (specify). NYTS 2022 Version - How Get Dip: Specify NY1-How Get Hookah: Myself National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your hookah tobacco: I bought it myself. NYTS 2022 Version - How Get Hookah: Myself NY1-How Get Hookah: Someone Buy National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your hookah tobacco: I had someone else buy it for me. NYTS 2022 Version - How Get Hookah: Someone Buy NY1-How Get Hookah: Asked National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your hookah tobacco: I asked someone to give me some. NYTS 2022 Version - How Get Hookah: Asked NY1-How Get Hookah: Offered National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your hookah tobacco: Someone offered it to me. NYTS 2022 Version - How Get Hookah: Offered NY1-How Get Hookah: From Friend National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your hookah tobacco: I got it from a friend. NYTS 2022 Version - How Get Hookah: From Friend NY1-How Get Hookah: From Family National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your hookah tobacco: I got it from a family member. NYTS 2022 Version - How Get Hookah: From Family NY1-How Get Hookah: Took Store National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your hookah tobacco: I took it from a store or another person. NYTS 2022 Version - How Get Hookah: Took Store NY1-How Get Hookah: Other National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your hookah tobacco: I got it in some other way. NYTS 2022 Version - How Get Hookah: Other NY1-How Get Hookah: Specify National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your hookah tobacco: I got it in some other way (specify). NYTS 2022 Version - How Get Hookah: Specify NY1-How Get Pipe Tobacco: Myself National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your pipe tobacco: I bought it myself. NYTS 2022 Version - How Get Pipe Tobacco: Myself NY1-How Get Pipe Tobacco: Someone Buy National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your pipe tobacco: I had someone else buy it for me. NYTS 2022 Version - How Get Pipe Tobacco: Someone Buy NY1-How Get Pipe Tobacco: Asked National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your pipe tobacco: I asked someone to give me some. NYTS 2022 Version - How Get Pipe Tobacco: Asked NY1-How Get Pipe Tobacco: Offered National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your pipe tobacco: Someone offered it to me. NYTS 2022 Version - How Get Pipe Tobacco: Offered NY1-How Get Pipe Tobacco: From Friend National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your pipe tobacco: I got it from a friend. NYTS 2022 Version - How Get Pipe Tobacco: From Friend NY1-How Get Pipe Tobacco: From Family National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your pipe tobacco: I got it from a family member. NYTS 2022 Version - How Get Pipe Tobacco: From Family NY1-How Get Pipe Tobacco: Took Store National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your pipe tobacco: I took it from a store or another person. NYTS 2022 Version - How Get Pipe Tobacco: Took Store NY1-How Get Pipe Tobacco: Other National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your pipe tobacco: I got it in some other way. NYTS 2022 Version - How Get Pipe Tobacco: Other NY1-How Get Pipe Tobacco: Specify National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your pipe tobacco: I got it in some other way (specify). NYTS 2022 Version - How Get Pipe Tobacco: Specify NY1-How Get Snus: Myself National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your snus: I bought it myself. NYTS 2022 Version - How Get Snus: Myself NY1-How Get Snus: Someone Buy National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your snus: I had someone else buy it for me. NYTS 2022 Version - How Get Snus: Someone Buy NY1-How Get Snus: Asked National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your snus: I asked someone to give me some. NYTS 2022 Version - How Get Snus: Asked NY1-How Get Snus: Offered National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your snus: Someone offered it to me. NYTS 2022 Version - How Get Snus: Offered NY1-How Get Snus: From Friend National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your snus: I got it from a friend. NYTS 2022 Version - How Get Snus: From Friend NY1-How Get Snus: From Family National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your snus: I got it from a family member. NYTS 2022 Version - How Get Snus: From Family NY1-How Get Snus: Took Store National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your snus: I took it from a store or another person. NYTS 2022 Version - How Get Snus: Took Store NY1-How Get Snus: Other National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your snus: I got it in some other way. NYTS 2022 Version - How Get Snus: Other NY1-How Get Snus: Specify National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your snus: I got it in some other way (specify). NYTS 2022 Version - How Get Snus: Specify NY1-How Get Dissolv: Myself National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your dissolvable tobacco products: I bought them myself. NYTS 2022 Version - How Get Dissolv: Myself NY1-How Get Dissolv: Someone Buy National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your dissolvable tobacco products: I had someone else buy them for me. NYTS 2022 Version - How Get Dissolv: Someone Buy NY1-How Get Dissolv: Asked National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your dissolvable tobacco products: I asked someone to give me some. NYTS 2022 Version - How Get Dissolv: Asked NY1-How Get Dissolv: Offered National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your dissolvable tobacco products: Someone offered them to me. NYTS 2022 Version - How Get Dissolv: Offered NY1-How Get Dissolv: From Friend National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your dissolvable tobacco products: I got them from a friend. NYTS 2022 Version - How Get Dissolv: From Friend NY1-How Get Dissolv: From Family National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your dissolvable tobacco products: I got them from a family member. NYTS 2022 Version - How Get Dissolv: From Family NY1-How Get Dissolv: Took Store National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your dissolvable tobacco products: I took them from a store or another person. NYTS 2022 Version - How Get Dissolv: Took Store NY1-How Get Dissolv: Other National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your dissolvable tobacco products: I got them in some other way. NYTS 2022 Version - How Get Dissolv: Other NY1-How Get Dissolv: Specify National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your dissolvable tobacco products: I got them in some other way (specify). NYTS 2022 Version - How Get Dissolv: Specify NY1-How Get Bidis: Myself National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your bidis: I bought them myself. NYTS 2022 Version - How Get Bidis: Myself NY1-How Get Bidis: Someone Buy National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your bidis: I had someone else buy them for me. NYTS 2022 Version - How Get Bidis: Someone Buy NY1-How Get Bidis: Asked National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your bidis: I asked someone to give me some. NYTS 2022 Version - How Get Bidis: Asked NY1-How Get Bidis: Offered National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your bidis: Someone offered them to me. NYTS 2022 Version - How Get Bidis: Offered NY1-How Get Bidis: From Friend National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your bidis: I got them from a friend. NYTS 2022 Version - How Get Bidis: From Friend NY1-How Get Bidis: From Family National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your bidis: I got them from a family member. NYTS 2022 Version - How Get Bidis: From Family NY1-How Get Bidis: Took Store National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your bidis: I took them from a store or another person. NYTS 2022 Version - How Get Bidis: Took Store NY1-How Get Bidis: Other National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your bidis: I got them in some other way. NYTS 2022 Version - How Get Bidis: Other NY1-How Get Bidis: Specify National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your bidis: I got them in some other way (specify). NYTS 2022 Version - How Get Bidis: Specify NY1-How Get RYO Cigs: Myself National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your roll-your-own cigarettes: I bought them myself. NYTS 2022 Version - How Get RYO Cigs: Myself NY1-How Get RYO Cigs: Someone Buy National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your roll-your-own cigarettes: I had someone else buy them for me. NYTS 2022 Version - How Get RYO Cigs: Someone Buy NY1-How Get RYO Cigs: Asked National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your roll-your-own cigarettes: I asked someone to give me some. NYTS 2022 Version - How Get RYO Cigs: Asked NY1-How Get RYO Cigs: Offered National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your roll-your-own cigarettes: Someone offered them to me. NYTS 2022 Version - How Get RYO Cigs: Offered NY1-How Get RYO Cigs: From Friend National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your roll-your-own cigarettes: I got them from a friend. NYTS 2022 Version - How Get RYO Cigs: From Friend NY1-How Get RYO Cigs: From Family National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your roll-your-own cigarettes: I got them from a family member. NYTS 2022 Version - How Get RYO Cigs: From Family NY1-How Get RYO Cigs: Took Store National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your roll-your-own cigarettes: I took them from a store or another person. NYTS 2022 Version - How Get RYO Cigs: Took Store NY1-How Get RYO Cigs: Other National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your roll-your-own cigarettes: I got them in some other way. NYTS 2022 Version - How Get RYO Cigs: Other NY1-How Get RYO Cigs: Specify National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your roll-your-own cigarettes: I got them in some other way (specify). NYTS 2022 Version - How Get RYO Cigs: Specify NY1-How Get Heated Tobacco: Myself National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your heated tobacco products: I bought them myself. NYTS 2022 Version - How Get Heated Tobacco: Myself NY1-How Get Heated Tobacco: Someone Buy National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your heated tobacco products: I had someone else buy them for me. NYTS 2022 Version - How Get Heated Tobacco: Someone Buy NY1-How Get Heated Tobacco: Asked National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your heated tobacco products: I asked someone to give me some. NYTS 2022 Version - How Get Heated Tobacco: Asked NY1-How Get Heated Tobacco: Offered National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your heated tobacco products: Someone offered them to me. NYTS 2022 Version - How Get Heated Tobacco: Offered NY1-How Get Heated Tobacco: From Friend National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your heated tobacco products: I got them from a friend. NYTS 2022 Version - How Get Heated Tobacco: From Friend NY1-How Get Heated Tobacco: From Family National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your heated tobacco products: I got them from a family member. NYTS 2022 Version - How Get Heated Tobacco: From Family NY1-How Get Heated Tobacco: Took Store National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your heated tobacco products: I took them from a store or another person. NYTS 2022 Version - How Get Heated Tobacco: Took Store NY1-How Get Heated Tobacco: Other National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your heated tobacco products: I got them in some other way. NYTS 2022 Version - How Get Heated Tobacco: Other NY1-How Get Heated Tobacco: Specify National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your heated tobacco products: I got them in some other way (specify). NYTS 2022 Version - How Get Heated Tobacco: Specify NY1-How Get Pouches: Myself National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your nicotine pouches: I bought them myself. NYTS 2022 Version - How Get Pouches: Myself NY1-How Get Pouches: Someone Buy National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your nicotine pouches: I had someone else buy them for me. NYTS 2022 Version - How Get Pouches: Someone Buy NY1-How Get Pouches: Asked National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your nicotine pouches: I asked someone to give me some. NYTS 2022 Version - How Get Pouches: Asked NY1-How Get Pouches: Offered National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your nicotine pouches: Someone offered them to me. NYTS 2022 Version - How Get Pouches: Offered NY1-How Get Pouches: From Friend National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your nicotine pouches: I got them from a friend. NYTS 2022 Version - How Get Pouches: From Friend NY1-How Get Pouches: From Family National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your nicotine pouches: I got them from a family member. NYTS 2022 Version - How Get Pouches: From Family NY1-How Get Pouches: Took Store National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your nicotine pouches: I took them from a store or another person. NYTS 2022 Version - How Get Pouches: Took Store NY1-How Get Pouches: Other National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your nicotine pouches: I got them in some other way. NYTS 2022 Version - How Get Pouches: Other NY1-How Get Pouches: Specify National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your nicotine pouches: I got them in some other way (specify). NYTS 2022 Version - How Get Pouches: Specify NY1-Where Buy E-Cig: Did Not National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your e-cigarette devices, pods, cartridges, or e-liquid refills: I did not buy e-cigarettes during the past 30 days. NYTS 2022 Version - Where Buy E-Cig: Did Not NY1-Where Buy E-Cig: Person National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your e-cigarette devices, pods, cartridges, or e-liquid refills: I bought them from another person (a friend, family member, or someone else). NYTS 2022 Version - Where Buy E-Cig: Person NY1-Where Buy E-Cig: Gas National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your e-cigarette devices, pods, cartridges, or e-liquid refills: A gas station or convenience store. NYTS 2022 Version - Where Buy E-Cig: Gas NY1-Where Buy E-Cig: Grocery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your e-cigarette devices, pods, cartridges, or e-liquid refills: A grocery store. NYTS 2022 Version - Where Buy E-Cig: Grocery NY1-Where Buy E-Cig: Drugstore National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your e-cigarette devices, pods, cartridges, or e-liquid refills: A drugstore. NYTS 2022 Version - Where Buy E-Cig: Drugstore NY1-Where Buy E-Cig: Kiosk National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your e-cigarette devices, pods, cartridges, or e-liquid refills: A mall or shopping center kiosk/stand. NYTS 2022 Version - Where Buy E-Cig: Kiosk NY1-Where Buy E-Cig: Vending National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your e-cigarette devices, pods, cartridges, or e-liquid refills: A vending machine. NYTS 2022 Version - Where Buy E-Cig: Vending NY1-Where Buy E-Cig: Internet National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your e-cigarette devices, pods, cartridges, or e-liquid refills: On the Internet (such as a product website or store website like eBay or Facebook Marketplace). NYTS 2022 Version - Where Buy E-Cig: Internet NY1-Where Buy E-Cig: Mail National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your e-cigarette devices, pods, cartridges, or e-liquid refills: Through the mail. NYTS 2022 Version - Where Buy E-Cig: Mail NY1-Where Buy E-Cig: Delivery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your e-cigarette devices, pods, cartridges, or e-liquid refills: Through a delivery service (such as DoorDash or Postmates). NYTS 2022 Version - Where Buy E-Cig: Delivery NY1-Where Buy E-Cig: Vape Shop National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your e-cigarette devices, pods, cartridges, or e-liquid refills: A vape shop or tobacco shop. NYTS 2022 Version - Where Buy E-Cig: Vape Shop NY1-Where Buy E-Cig: Other National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your e-cigarette devices, pods, cartridges, or e-liquid refills: Some other place not listed here. NYTS 2022 Version - Where Buy E-Cig: Other NY1-Where Buy E-Cig: Specify National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your e-cigarette devices, pods, cartridges, or e-liquid refills: Some other place not listed here (specify). NYTS 2022 Version - Where Buy E-Cig: Specify NY1-Where Buy Cig: Did Not National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigarettes: I did not buy cigarettes during the past 30 days. NYTS 2022 Version - Where Buy Cig: Did Not NY1-Where Buy Cig: Person National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigarettes: I bought them from another person (a friend, family member, or someone else). NYTS 2022 Version - Where Buy Cig: Person NY1-Where Buy Cig: Gas National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigarettes: A gas station or convenience store. NYTS 2022 Version - Where Buy Cig: Gas NY1-Where Buy Cig: Grocery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigarettes: A grocery store. NYTS 2022 Version - Where Buy Cig: Grocery NY1-Where Buy Cig: Drugstore National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigarettes: A drugstore. NYTS 2022 Version - Where Buy Cig: Drugstore NY1-Where Buy Cig: Kiosk National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigarettes: A mall or shopping center kiosk/stand. NYTS 2022 Version - Where Buy Cig: Kiosk NY1-Where Buy Cigs: Vending National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigarettes: A vending machine. NYTS 2022 Version - Where Buy Cigs: Vending NY1-Where Buy Cigs: Internet National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigarettes: On the Internet (such as a product or store website, eBay or Facebook Marketplace). NYTS 2022 Version - Where Buy Cigs: Internet NY1-Where Buy Cig: Mail National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigarettes: Through the mail. NYTS 2022 Version - Where Buy Cig: Mail NY1-Where Buy Cig: Delivery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigarettes: Through a delivery service (such as DoorDash or Postmates). NYTS 2022 Version - Where Buy Cig: Delivery NY1-Where Buy Cig: Vape Shop National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigarettes: A vape shop or tobacco shop. NYTS 2022 Version - Where Buy Cig: Vape Shop NY1-Where Buy Cig: Other National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigarettes: Some other place not listed here. NYTS 2022 Version - Where Buy Cig: Other NY1-Where Buy Cig: Specify National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigarettes: Some other place not listed here (specify). NYTS 2022 Version - Where Buy Cig: Specify NY1-Where Buy Cigars: Did Not National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigars, cigarillos, or little cigars: I did not buy cigars, cigarillos, or little cigars during the past 30 days. NYTS 2022 Version - Where Buy Cigars: Did Not NY1-Where Buy Cigars: Person National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigars, cigarillos, or little cigars: I bought them from another person (a friend, family member, or someone else). NYTS 2022 Version - Where Buy Cigars: Person NY1-Where Buy Cigars: Gas National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigars, cigarillos, or little cigars: A gas station or convenience store. NYTS 2022 Version - Where Buy Cigars: Gas NY1-Where Buy Cigars: Grocery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigars, cigarillos, or little cigars: A grocery store. NYTS 2022 Version - Where Buy Cigars: Grocery NY1-Where Buy Cigars: Drugstore National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigars, cigarillos, or little cigars: A drugstore. NYTS 2022 Version - Where Buy Cigars: Drugstore NY1-Where Buy Cigars: Kiosk National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigars, cigarillos, or little cigars: A mall or shopping center kiosk/stand. NYTS 2022 Version - Where Buy Cigars: Kiosk NY1-Where Buy Cigars: Vending National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigars, cigarillos, or little cigars: A vending machine. NYTS 2022 Version - Where Buy Cigars: Vending NY1-Where Buy Cigars: Internet National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigars, cigarillos, or little cigars: On the Internet (such as a product or store website, eBay, or Facebook Marketplace). NYTS 2022 Version - Where Buy Cigars: Internet NY1-Where Buy Cigars: Mail National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigars, cigarillos, or little cigars: Through the mail. NYTS 2022 Version - Where Buy Cigars: Mail NY1-Where Buy Cigars: Delivery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigars, cigarillos, or little cigars: Through a delivery service (such as DoorDash or Postmates). NYTS 2022 Version - Where Buy Cigars: Delivery NY1-Where Buy Cigars: Vape Shop National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigars, cigarillos, or little cigars: A vape shop or tobacco shop. NYTS 2022 Version - Where Buy Cigars: Vape Shop NY1-Where Buy Cigars: Other National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigars, cigarillos, or little cigars: Some other place not listed here. NYTS 2022 Version - Where Buy Cigars: Other NY1-Where Buy Cigars: Specify National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigars, cigarillos, or little cigars: Some other place not listed here (specify). NYTS 2022 Version - Where Buy Cigars: Specify NY1-Where Buy Dip: Did Not National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your chewing tobacco, snuff, or dip: I did not buy chewing tobacco, snuff, or dip during the past 30 days. NYTS 2022 Version - Where Buy Dip: Did Not NY1-Where Buy Dip: Person National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your chewing tobacco, snuff, or dip: I bought it from another person (a friend, family member, or someone else). NYTS 2022 Version - Where Buy Dip: Person NY1-Where Buy Dip: Gas National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your chewing tobacco, snuff, or dip: A gas station or convenience store. NYTS 2022 Version - Where Buy Dip: Gas NY1-Where Buy Dip: Grocery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your chewing tobacco, snuff, or dip: A grocery store. NYTS 2022 Version - Where Buy Dip: Grocery NY1-Where Buy Dip: Drugstore National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your chewing tobacco, snuff, or dip: A drugstore. NYTS 2022 Version - Where Buy Dip: Drugstore NY1-Where Buy Dip: Kiosk National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your chewing tobacco, snuff, or dip: A mall or shopping center kiosk/stand. NYTS 2022 Version - Where Buy Dip: Kiosk NY1-Where Buy Dip: Vending National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your chewing tobacco, snuff, or dip: A vending machine. NYTS 2022 Version - Where Buy Dip: Vending NY1-Where Buy Dip: Internet National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your chewing tobacco, snuff, or dip: On the Internet (such as a product or store website, eBay, or Facebook Marketplace). NYTS 2022 Version - Where Buy Dip: Internet NY1-Where Buy Dip: Mail National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your chewing tobacco, snuff, or dip: Through the mail. NYTS 2022 Version - Where Buy Dip: Mail NY1-Where Buy Dip: Delivery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your chewing tobacco, snuff, or dip: Through a delivery service (such as DoorDash or Postmates). NYTS 2022 Version - Where Buy Dip: Delivery NY1-Where Buy Dip: Vape Shop National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your chewing tobacco, snuff, or dip: A vape shop or tobacco shop. NYTS 2022 Version - Where Buy Dip: Vape Shop NY1-Where Buy Dip: Other National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your chewing tobacco, snuff, or dip: Some other place not listed here. NYTS 2022 Version - Where Buy Dip: Other NY1-Where Buy Dip: Specify National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your chewing tobacco, snuff, or dip: Some other place not listed here (specify). NYTS 2022 Version - Where Buy Dip: Specify NY1-Where Buy Hookah: Did Not National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your hookah tobacco: I did not buy hookah tobacco during the past 30 days. NYTS 2022 Version - Where Buy Hookah: Did Not NY1-Where Buy Hookah: Person National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your hookah tobacco: I bought it from another person (a friend, family member, or someone else). NYTS 2022 Version - Where Buy Hookah: Person NY1-Where Buy Hookah: Gas National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your hookah tobacco: A gas station or convenience store. NYTS 2022 Version - Where Buy Hookah: Gas NY1-Where Buy Hookah: Grocery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your hookah tobacco: A grocery store. NYTS 2022 Version - Where Buy Hookah: Grocery NY1-Where Buy Hookah: Drugstore National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your hookah tobacco: A drugstore. NYTS 2022 Version - Where Buy Hookah: Drugstore NY1-Where Buy Hookah: Kiosk National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your hookah tobacco: A mall or shopping center kiosk/stand. NYTS 2022 Version - Where Buy Hookah: Kiosk NY1-Where Buy Hookah: Vending National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your hookah tobacco: A vending machine. NYTS 2022 Version - Where Buy Hookah: Vending NY1-Where Buy Hookah: Internet National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your hookah tobacco: On the Internet (such as a product or store website, eBay, or Facebook Marketplace). NYTS 2022 Version - Where Buy Hookah: Internet NY1-Where Buy Hookah: Mail National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your hookah tobacco: Through the mail. NYTS 2022 Version - Where Buy Hookah: Mail NY1-Where Buy Hookah: Delivery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your hookah tobacco: Through a delivery service (such as DoorDash or Postmates). NYTS 2022 Version - Where Buy Hookah: Delivery NY1-Where Buy Hookah: Vape Shop National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your hookah tobacco: A vape shop or tobacco shop. NYTS 2022 Version - Where Buy Hookah: Vape Shop NY1-Where Buy Hookah: Other National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your hookah tobacco: Some other place not listed here. NYTS 2022 Version - Where Buy Hookah: Other NY1-Where Buy Hookah: Specify National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your hookah tobacco: Some other place not listed here (specify). NYTS 2022 Version - Where Buy Hookah: Specify NY1-Where Buy Pipe Tobacco: Did Not National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your pipe tobacco: I did not buy pipe tobacco during the past 30 days. NYTS 2022 Version - Where Buy Pipe Tobacco: Did Not NY1-Where Buy Pipe Tobacco: Person National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your pipe tobacco: I bought it from another person (a friend, family member, or someone else). NYTS 2022 Version - Where Buy Pipe Tobacco: Person NY1-Where Buy Pipe Tobacco: Gas National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your pipe tobacco: A gas station or convenience store. NYTS 2022 Version - Where Buy Pipe Tobacco: Gas NY1-Where Buy Pipe Tobacco: Grocery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your pipe tobacco: A grocery store. NYTS 2022 Version - Where Buy Pipe Tobacco: Grocery NY1-Where Buy Pipe Tobacco: Drugstore National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your pipe tobacco: A drugstore. NYTS 2022 Version - Where Buy Pipe Tobacco: Drugstore NY1-Where Buy Pipe Tobacco: Kiosk National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your pipe tobacco: A mall or shopping center kiosk/stand. NYTS 2022 Version - Where Buy Pipe Tobacco: Kiosk NY1-Where Buy Pipe Tobacco: Vending National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your pipe tobacco: A vending machine. NYTS 2022 Version - Where Buy Pipe Tobacco: Vending NY1-Where Buy Pipe Tobacco: Internet National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your pipe tobacco: On the Internet (such as a product or store website, eBay, or Facebook Marketplace). NYTS 2022 Version - Where Buy Pipe Tobacco: Internet NY1-Where Buy Pipe Tobacco: Mail National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your pipe tobacco: Through the mail. NYTS 2022 Version - Where Buy Pipe Tobacco: Mail NY1-Where Buy Pipe Tobacco: Delivery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your pipe tobacco: Through a delivery service (such as DoorDash or Postmates). NYTS 2022 Version - Where Buy Pipe Tobacco: Delivery NY1-Where Buy Pipe Tobacco: Vape Shop National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your pipe tobacco: A vape shop or tobacco shop. NYTS 2022 Version - Where Buy Pipe Tobacco: Vape Shop NY1-Where Buy Pipe Tobacco: Other National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your pipe tobacco: Some other place not listed here. NYTS 2022 Version - Where Buy Pipe Tobacco: Other NY1-Where Buy Pipe Tobacco: Specify National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your pipe tobacco: Some other place not listed here (specify). NYTS 2022 Version - Where Buy Pipe Tobacco: Specify NY1-Where Buy Snus: Did Not National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your snus: I did not buy snus during the past 30 days. NYTS 2022 Version - Where Buy Snus: Did Not NY1-Where Buy Snus: Person National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your snus: I bought it from another person (a friend, family member, or someone else). NYTS 2022 Version - Where Buy Snus: Person NY1-Where Buy Snus: Gas National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your snus: A gas station or convenience store. NYTS 2022 Version - Where Buy Snus: Gas NY1-Where Buy Snus: Grocery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your snus: A grocery store. NYTS 2022 Version - Where Buy Snus: Grocery NY1-Where Buy Snus: Drugstore National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your snus: A drugstore. NYTS 2022 Version - Where Buy Snus: Drugstore NY1-Where Buy Snus: Kiosk National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your snus: A mall or shopping center kiosk/stand. NYTS 2022 Version - Where Buy Snus: Kiosk NY1-Where Buy Snus: Vending National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your snus: A vending machine. NYTS 2022 Version - Where Buy Snus: Vending NY1-Where Buy Snus: Internet National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your snus: On the Internet (such as a product or store website, eBay, or Facebook Marketplace). NYTS 2022 Version - Where Buy Snus: Internet NY1-Where Buy Snus: Mail National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your snus: Through the mail. NYTS 2022 Version - Where Buy Snus: Mail NY1-Where Buy Snus: Delivery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your snus: Through a delivery service (such as DoorDash or Postmates). NYTS 2022 Version - Where Buy Snus: Delivery NY1-Where Buy Snus: Vape Shop National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your snus: A vape or tobacco shop. NYTS 2022 Version - Where Buy Snus: Vape Shop NY1-Where Buy Snus: Other National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your snus: Some other place not listed here. NYTS 2022 Version - Where Buy Snus: Other NY1-Where Buy Snus: Specify National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your snus: Some other place not listed here (specify). NYTS 2022 Version - Where Buy Snus: Specify NY1-Where Buy Dissolv: Did Not National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your dissolvable tobacco products: I did not buy dissolvable tobacco products during the past 30 days. NYTS 2022 Version - Where Buy Dissolv: Did Not NY1-Where Buy Dissolv: Person National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your dissolvable tobacco products: I bought them from another person (a friend, family member, or someone else). NYTS 2022 Version - Where Buy Dissolv: Person NY1-Where Buy Dissolv: Gas National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your dissolvable tobacco products: A gas station or convenience store. NYTS 2022 Version - Where Buy Dissolv: Gas NY1-Where Buy Dissolv: Grocery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your dissolvable tobacco products: A grocery store. NYTS 2022 Version - Where Buy Dissolv: Grocery NY1-Where Buy Dissolv: Drugstore National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your dissolvable tobacco products: A drugstore. NYTS 2022 Version - Where Buy Dissolv: Drugstore NY1-Where Buy Dissolv: Kiosk National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your dissolvable tobacco products: A mall or shopping center kiosk/stand. NYTS 2022 Version - Where Buy Dissolv: Kiosk NY1-Where Buy Dissolv: Vending National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your dissolvable tobacco products: A vending machine. NYTS 2022 Version - Where Buy Dissolv: Vending NY1-Where Buy Dissolv: Internet National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your dissolvable tobacco products: On the Internet (such as a website or a secondary source, like eBay or Facebook Marketplace). NYTS 2022 Version - Where Buy Dissolv: Internet NY1-Where Buy Dissolv: Mail National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your dissolvable tobacco products: Through the mail. NYTS 2022 Version - Where Buy Dissolv: Mail NY1-Where Buy Dissolv: Delivery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your dissolvable tobacco products: Through a delivery service (such as DoorDash or Postmates). NYTS 2022 Version - Where Buy Dissolv: Delivery NY1-Where Buy Dissolv: Vape Shop National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your dissolvable tobacco products: A vape shop or tobacco shop. NYTS 2022 Version - Where Buy Dissolv: Vape Shop NY1-Where Buy Dissolv: Other National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your dissolvable tobacco products: Some other place not listed here. NYTS 2022 Version - Where Buy Dissolv: Other NY1-Where Buy Dissolv: Specify National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your dissolvable tobacco products: Some other place not listed here (specify). NYTS 2022 Version - Where Buy Dissolv: Specify NY1-Where Buy Bidis: Did Not National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your bidis: I did not buy bidis during the past 30 days. NYTS 2022 Version - Where Buy Bidis: Did Not NY1-Where Buy Bidis: Person National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your bidis: I bought them from another person (a friend, family member, or someone else). NYTS 2022 Version - Where Buy Bidis: Person NY1-Where Buy Bidis: Gas National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your bidis: A gas station or convenience store. NYTS 2022 Version - Where Buy Bidis: Gas NY1-Where Buy Bidis: Grocery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your bidis: A grocery store. NYTS 2022 Version - Where Buy Bidis: Grocery NY1-Where Buy Bidis: Drugstore National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your bidis: A drugstore. NYTS 2022 Version - Where Buy Bidis: Drugstore NY1-Where Buy Bidis: Kiosk National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your bidis: A mall or shopping center kiosk/stand. NYTS 2022 Version - Where Buy Bidis: Kiosk NY1-Where Buy Bidis: Vending National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your bidis: A vending machine. NYTS 2022 Version - Where Buy Bidis: Vending NY1-Where Buy Bidis: Internet National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your bidis: On the Internet (such as a product or store website, eBay, or Facebook Marketplace). NYTS 2022 Version - Where Buy Bidis: Internet NY1-Where Buy Bidis: Mail National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your bidis: Through the mail. NYTS 2022 Version - Where Buy Bidis: Mail NY1-Where Buy Bidis: Delivery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your bidis: Through a delivery service (such as DoorDash or Postmates). NYTS 2022 Version - Where Buy Bidis: Delivery NY1-Where Buy Bidis: Vape Shop National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your bidis: A vape shop or tobacco shop. NYTS 2022 Version - Where Buy Bidis: Vape Shop NY1-Where Buy Bidis: Other National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your bidis: Some other place not listed here. NYTS 2022 Version - Where Buy Bidis: Other NY1-Where Buy Bidis: Specify National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your bidis: Some other place not listed here (specify). NYTS 2022 Version - Where Buy Bidis: Specify NY1-Where Buy RYO Cigs: Did Not National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your roll-your-own cigarettes: I did not buy roll-your-own cigarettes during the past 30 days. NYTS 2022 Version - Where Buy RYO Cigs: Did Not NY1-Where Buy RYO Cigs: Person National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your roll-your-own cigarettes: I bought them from another person (a friend, family member, or someone else). NYTS 2022 Version - Where Buy RYO Cigs: Person NY1-Where Buy RYO Cigs: Gas National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your roll-your-own cigarettes: A gas station or convenience store. NYTS 2022 Version - Where Buy RYO Cigs: Gas NY1-Where Buy RYO Cigs: Grocery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your roll-your-own cigarettes: A grocery store. NYTS 2022 Version - Where Buy RYO Cigs: Grocery NY1-Where Buy RYO Cigs: Drugstore National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your roll-your-own cigarettes: A drugstore. NYTS 2022 Version - Where Buy RYO Cigs: Drugstore NY1-Where Buy RYO Cigs: Kiosk National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your roll-your-own cigarettes: A mall or shopping center kiosk/stand. NYTS 2022 Version - Where Buy RYO Cigs: Kiosk NY1-Where Buy RYO Cigs: Vending National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your roll-your-own cigarettes: A vending machine. NYTS 2022 Version - Where Buy RYO Cigs: Vending NY1-Where Buy RYO Cigs: Internet National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your roll-your-own cigarettes: On the Internet (such as a product or store website, eBay, or Facebook Marketplace). NYTS 2022 Version - Where Buy RYO Cigs: Internet NY1-Where Buy RYO Cigs: Mail National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your roll-your-own cigarettes: Through the mail. NYTS 2022 Version - Where Buy RYO Cigs: Mail NY1-Where Buy RYO Cigs: Delivery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your roll-your-own cigarettes: Through a delivery service (such as DoorDash or Postmates). NYTS 2022 Version - Where Buy RYO Cigs: Delivery NY1-Where Buy RYO Cigs: Vape Shop National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your roll-your-own cigarettes: A vape shop or tobacco shop. NYTS 2022 Version - Where Buy RYO Cigs: Vape Shop NY1-Where Buy RYO Cigs: Other National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your roll-your-own cigarettes: Some other place not listed here. NYTS 2022 Version - Where Buy RYO Cigs: Other NY1-Where Buy RYO Cigs: Specify National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your roll-your-own cigarettes: Some other place not listed here (specify). NYTS 2022 Version - Where Buy RYO Cigs: Specify NY1-Where Buy Heated Tobacco: Did Not National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your heated tobacco products: I did not buy heated tobacco products during the past 30 days. NYTS 2022 Version - Where Buy Heated Tobacco: Did Not NY1-Where Buy Heated Tobacco: Person National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your heated tobacco products: I bought them from another person (a friend, family member, or someone else). NYTS 2022 Version - Where Buy Heated Tobacco: Person NY1-Where Buy Heated Tobacco: Gas National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your heated tobacco products: A gas station or convenience store. NYTS 2022 Version - Where Buy Heated Tobacco: Gas NY1-Where Buy Heated Tobacco: Grocery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your heated tobacco products: A grocery store. NYTS 2022 Version - Where Buy Heated Tobacco: Grocery NY1-Where Buy Heated Tobacco: Drugstore National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your heated tobacco products: A drugstore. NYTS 2022 Version - Where Buy Heated Tobacco: Drugstore NY1-Where Buy Heated Tobacco: Kiosk National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your heated tobacco products: A mall or shopping center kiosk/stand. NYTS 2022 Version - Where Buy Heated Tobacco: Kiosk NY1-Where Buy Heated Tobacco: Vending National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your heated tobacco products: A vending machine. NYTS 2022 Version - Where Buy Heated Tobacco: Vending NY1-Where Buy Heated Tobacco: Internet National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your heated tobacco products: On the Internet (such as a product or store website, eBay, or Facebook Marketplace). NYTS 2022 Version - Where Buy Heated Tobacco: Internet NY1-Where Buy Heated Tobacco: Mail National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your heated tobacco products: Through the mail. NYTS 2022 Version - Where Buy Heated Tobacco: Mail NY1-Where Buy Heated Tobacco: Delivery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your heated tobacco products: Through a delivery service (such as DoorDash or Postmates). NYTS 2022 Version - Where Buy Heated Tobacco: Delivery NY1-Where Buy Heated Tobacco: Vape Shop National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your heated tobacco products: A vape shop or tobacco shop. NYTS 2022 Version - Where Buy Heated Tobacco: Vape Shop NY1-Where Buy Heated Tobacco: Other National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your heated tobacco products: Some other place not listed here. NYTS 2022 Version - Where Buy Heated Tobacco: Other NY1-Where Buy Heated Tobacco: Specify National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your heated tobacco products: Some other place not listed here (specify). NYTS 2022 Version - Where Buy Heated Tobacco: Specify NY1-Where Buy Pouches: Did Not National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your nicotine pouches: I did not buy nicotine pouches during the past 30 days. NYTS 2022 Version - Where Buy Pouches: Did Not NY1-Where Buy Pouches: Person National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your nicotine pouches: I bought them from another person (a friend, family member, or someone else). NYTS 2022 Version - Where Buy Pouches: Person NY1-Where Buy Pouches: Gas National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your nicotine pouches: A gas station or convenience store. NYTS 2022 Version - Where Buy Pouches: Gas NY1-Where Buy Pouches: Grocery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your nicotine pouches: A grocery store. NYTS 2022 Version - Where Buy Pouches: Grocery NY1-Where Buy Pouches: Drugstore National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your nicotine pouches: A drugstore. NYTS 2022 Version - Where Buy Pouches: Drugstore NY1-Where Buy Pouches: Kiosk National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your nicotine pouches: A mall or shopping center kiosk/stand. NYTS 2022 Version - Where Buy Pouches: Kiosk NY1-Where Buy Pouches: Vending National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your nicotine pouches: A vending machine. NYTS 2022 Version - Where Buy Pouches: Vending NY1-Where Buy Pouches: Internet National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your nicotine pouches: On the Internet (such as a product or store website, eBay, or Facebook Marketplace). NYTS 2022 Version - Where Buy Pouches: Internet NY1-Where Buy Pouches: Mail National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your nicotine pouches: Through the mail. NYTS 2022 Version - Where Buy Pouches: Mail NY1-Where Buy Pouches: Delivery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your nicotine pouches: Through a delivery service (such as DoorDash or Postmates). NYTS 2022 Version - Where Buy Pouches: Delivery NY1-Where Buy Pouches: Vape Shop National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your nicotine pouches: A vape shop or tobacco shop. NYTS 2022 Version - Where Buy Pouches: Vape Shop NY1-Where Buy Pouches: Other National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your nicotine pouches: Some other place not listed here. NYTS 2022 Version - Where Buy Pouches: Other NY1-Where Buy Pouches: Specify National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your nicotine pouches: Some other place not listed here (specify). NYTS 2022 Version - Where Buy Pouches: Specify NY1-Got E-Cig How Old Was This Person National Youth Tobacco Survey 2022 - Earlier you answered that you got or bought your e-cigarette devices, pods, cartridges, or e-liquid refills from another person, such as a friend or family member during the past 30 days. How old was this person? NYTS 2022 Version - Got E-Cig How Old Was This Person NY1-E-Cig Get From Person: New E-Cig National Youth Tobacco Survey 2022 - During the past 30 days, which of the following e-cigarette product(s) did you get or buy from another person: A new e-cigarette device (including disposable devices). NYTS 2022 Version - E-Cig Get From Person: New E-Cig NY1-E-Cig Get From Person: A Pod National Youth Tobacco Survey 2022 - During the past 30 days, which of the following e-cigarette product(s) did you get or buy from another person: A pod, cartridge, or e-liquid refill. NYTS 2022 Version - E-Cig Get From Person: A Pod NY1-E-Cig Get From Person: A Hit National Youth Tobacco Survey 2022 - During the past 30 days, which of the following e-cigarette product(s) did you get or buy from another person: A hit or drag from another person's e-cigarette device. NYTS 2022 Version - E-Cig Get From Person: A Hit NY1-E-Cig Get From Person: Something National Youth Tobacco Survey 2022 - During the past 30 days, which of the following e-cigarette product(s) did you get or buy from another person: Something else. NYTS 2022 Version - E-Cig Get From Person: Something NY1-E-Cig Get From Person: Specify National Youth Tobacco Survey 2022 - During the past 30 days, which of the following e-cigarette product(s) did you get or buy from another person: Something else (specify). NYTS 2022 Version - E-Cig Get From Person: Specify NY1-Ever Purchased an E-Cig School National Youth Tobacco Survey 2022 - Have you ever purchased an e-cigarette device (including disposable devices), pod, cartridge, single hit, or e-liquid refill while at school or on school property? NYTS 2022 Version - Ever Purchased an E-Cig School NY1-How Often Use Someone E-Cig National Youth Tobacco Survey 2022 - During the past 30 days, how often did you use someone else's e-cigarette device? NYTS 2022 Version - How Often Use Someone E-Cig NY1-Seriously Thinking Quitting E-Cig National Youth Tobacco Survey 2022 - Are you seriously thinking about quitting e-cigarettes? NYTS 2022 Version - Seriously Thinking Quitting E-Cig NY1-Times Stopped E-Cig Trying Quit National Youth Tobacco Survey 2022 - During the past 12 months, how many times have you stopped using e-cigarettes for one day or longer because you were trying to quit using e-cigarettes for good? NYTS 2022 Version - Times Stopped E-Cig Trying Quit NY1-Tried Quit E-Cig: Not Use Resources National Youth Tobacco Survey 2022 - When you tried to quit using e-cigarettes, did you use any of the following: I did not use any resources. NYTS 2022 Version - Tried Quit E-Cig: Not Use Resources NY1-Tried Quit E-Cig: Help From Parent National Youth Tobacco Survey 2022 - When you tried to quit using e-cigarettes, did you use any of the following: Help or advice from a parent or caregiver. NYTS 2022 Version - Tried Quit E-Cig: Help From Parent NY1-Tried Quit E-Cig: Help From Friend National Youth Tobacco Survey 2022 - When you tried to quit using e-cigarettes, did you use any of the following: Help or advice from a friend or peer. NYTS 2022 Version - Tried Quit E-Cig: Help From Friend NY1-Tried Quit E-Cig: Help From Teacher National Youth Tobacco Survey 2022 - When you tried to quit using e-cigarettes, did you use any of the following: Help or advice from a teacher or coach. NYTS 2022 Version - Tried Quit E-Cig: Help From Teacher NY1-Tried Quit E-Cig: Help from Doctor National Youth Tobacco Survey 2022 - When you tried to quit using e-cigarettes, did you use any of the following: Help, advice, or counseling from a doctor or health care provider. NYTS 2022 Version - Tried Quit E-Cig: Help from Doctor NY1-Tried Quit E-Cig: Treatment Hospital National Youth Tobacco Survey 2022 - When you tried to quit using e-cigarettes, did you use any of the following: Treatment from a hospital, medical center, or some other facility. NYTS 2022 Version - Tried Quit E-Cig: Treatment Hospital NY1-Tried Quit E-Cig: Help on Internet National Youth Tobacco Survey 2022 - When you tried to quit using e-cigarettes, did you use any of the following: Help or advice you found on the Internet. NYTS 2022 Version - Tried Quit E-Cig: Help on Internet NY1-Tried Quit E-Cig: Mobile App National Youth Tobacco Survey 2022 - When you tried to quit using e-cigarettes, did you use any of the following: A mobile app or texting program. NYTS 2022 Version - Tried Quit E-Cig: Mobile App NY1-Tried Quit E-Cig: Helpline National Youth Tobacco Survey 2022 - When you tried to quit using e-cigarettes, did you use any of the following: A telephone helpline or quitline. NYTS 2022 Version - Tried Quit E-Cig: Helpline NY1-Tried Quit E-Cig: Something Else National Youth Tobacco Survey 2022 - When you tried to quit using e-cigarettes, did you use any of the following: Something else. NYTS 2022 Version - Tried Quit E-Cig: Something Else NY1-Tried Quit E-Cig: Specify National Youth Tobacco Survey 2022 - When you tried to quit using e-cigarettes, did you use any of the following: Something else (specify). NYTS 2022 Version - Tried Quit E-Cig: Specify NY1-Curious Using E-Cig National Youth Tobacco Survey 2022 - Have you ever been curious about using an e-cigarette? NYTS 2022 Version - Curious Using E-Cig NY1-Think Will Try E-Cig Soon National Youth Tobacco Survey 2022 - Do you think that you will try an e-cigarette soon? NYTS 2022 Version - Think Will Try E-Cig Soon NY1-Think Will Use E-Cig in Next Year National Youth Tobacco Survey 2022 - Do you think you will use an e-cigarette in the next year? NYTS 2022 Version - Think Will Use E-Cig in Next Year NY1-If Best Friends Offer E-Cig Use National Youth Tobacco Survey 2022 - If one of your best friends were to offer you an e-cigarette, would you use it? NYTS 2022 Version - If Best Friends Offer E-Cig Use NY1-Ever Vaped: Marijuana National Youth Tobacco Survey 2022 - Have you ever vaped any of the following substances (even once): Marijuana (also called pot, weed, or cannabis), including THC, THC concentrates, hash oil, or waxes. NYTS 2022 Version - Ever Vaped: Marijuana NY1-Ever Vaped: CBD or CBD Oils National Youth Tobacco Survey 2022 - Have you ever vaped any of the following substances (even once): CBD or CBD oils. NYTS 2022 Version - Ever Vaped: CBD or CBD Oils NY1-Ever Vaped: Synthetic Marijuana National Youth Tobacco Survey 2022 - Have you ever vaped any of the following substances (even once): Synthetic marijuana or cannabinoids, such as K2 or Spice. NYTS 2022 Version - Ever Vaped: Synthetic Marijuana NY1-Ever Vaped: Another Substance National Youth Tobacco Survey 2022 - Have you ever vaped any of the following substances (even once): Another substance. NYTS 2022 Version - Ever Vaped: Another Substance NY1-Ever Vaped: Specify National Youth Tobacco Survey 2022 - Have you ever vaped any of the following substances (even once): Another substance (specify). NYTS 2022 Version - Ever Vaped: Specify NY1-Vaped 30 Days: Marijuana National Youth Tobacco Survey 2022 - Have you vaped any of the following substances during the past 30 days: Marijuana (also called pot, weed, or cannabis), including THC, THC concentrates, hash oil, or waxes. NYTS 2022 Version - Vaped 30 Days: Marijuana NY1-Vaped 30 Days: CBD or CBD Oils National Youth Tobacco Survey 2022 - Have you vaped any of the following substances during the past 30 days: CBD or CBD oils. NYTS 2022 Version - Vaped 30 Days: CBD or CBD Oils NY1-Vaped 30 Days: Synthetic Marijuana National Youth Tobacco Survey 2022 - Have you vaped any of the following substances during the past 30 days: Synthetic marijuana or cannabinoids, such as K2 or Spice. NYTS 2022 Version - Vaped 30 Days: Synthetic Marijuana NY1-Vaped 30 Days: Another Substance National Youth Tobacco Survey 2022 - Have you vaped any of the following substances during the past 30 days: Another substance. NYTS 2022 Version - Vaped 30 Days: Another Substance NY1-Vaped 30 Days: Specify National Youth Tobacco Survey 2022 - Have you vaped any of the following substances during the past 30 days: Another substance (specify). NYTS 2022 Version - Vaped 30 Days: Specify NY1-Ever Smoked a Cig National Youth Tobacco Survey 2022 - Have you ever smoked a cigarette, even one or two puffs? NYTS 2022 Version - Ever Smoked a Cig NY1-How Old When First Smoked Cig National Youth Tobacco Survey 2022 - How old were you when you first smoked a cigarette, even one or two puffs? NYTS 2022 Version - How Old When First Smoked Cig NY1-How Many Cigs Entire Life National Youth Tobacco Survey 2022 - About how many cigarettes have you smoked in your entire life? NYTS 2022 Version - How Many Cigs Entire Life NY1-How Many Days Smoke Cigs National Youth Tobacco Survey 2022 - During the past 30 days, on how many days did you smoke cigarettes? NYTS 2022 Version - How Many Days Smoke Cigs NY1-Last Time Smoked Cig National Youth Tobacco Survey 2022 - When was the last time you smoked a cigarette, even one or two puffs? NYTS 2022 Version - Last Time Smoked Cig NY1-On Days Smoked How Many Cigs National Youth Tobacco Survey 2022 - During the past 30 days, on the days you smoked, about how many cigarettes did you smoke per day? NYTS 2022 Version - On Days Smoked How Many Cigs NY1-What Brands Cigs Smoke: American National Youth Tobacco Survey 2022 - During the past 30 days, what brands of cigarettes did you smoke: American Spirit. NYTS 2022 Version - What Brands Cigs Smoke: American NY1-What Brands Cigs Smoke: Camel National Youth Tobacco Survey 2022 - During the past 30 days, what brands of cigarettes did you smoke: Camel. NYTS 2022 Version - What Brands Cigs Smoke: Camel NY1-What Brands Cigs Smoke: GPC National Youth Tobacco Survey 2022 - During the past 30 days, what brands of cigarettes did you smoke: GPC, Basic, or Doral. NYTS 2022 Version - What Brands Cigs Smoke: GPC NY1-What Brands Cigs Smoke: Kool National Youth Tobacco Survey 2022 - During the past 30 days, what brands of cigarettes did you smoke: Kool. NYTS 2022 Version - What Brands Cigs Smoke: Kool NY1-What Brands Cigs Smoke: Marlboro National Youth Tobacco Survey 2022 - During the past 30 days, what brands of cigarettes did you smoke: Marlboro. NYTS 2022 Version - What Brands Cigs Smoke: Marlboro NY1-What Brands Cigs Smoke: Maverick National Youth Tobacco Survey 2022 - During the past 30 days, what brands of cigarettes did you smoke: Maverick. NYTS 2022 Version - What Brands Cigs Smoke: Maverick NY1-What Brands Cigs Smoke: Newport National Youth Tobacco Survey 2022 - During the past 30 days, what brands of cigarettes did you smoke: Newport. NYTS 2022 Version - What Brands Cigs Smoke: Newport NY1-What Brands Cigs Smoke: L&M National Youth Tobacco Survey 2022 - During the past 30 days, what brands of cigarettes did you smoke: L&M. NYTS 2022 Version - What Brands Cigs Smoke: L&M NY1-What Brands Cigs Smoke: Pall Mall National Youth Tobacco Survey 2022 - During the past 30 days, what brands of cigarettes did you smoke: Pall Mall. NYTS 2022 Version - What Brands Cigs Smoke: Pall Mall NY1-What Brands Cigs Smoke: Parliament National Youth Tobacco Survey 2022 - During the past 30 days, what brands of cigarettes did you smoke: Parliament. NYTS 2022 Version - What Brands Cigs Smoke: Parliament NY1-What Brands Cigs Smoke: Winston National Youth Tobacco Survey 2022 - During the past 30 days, what brands of cigarettes did you smoke: Winston. NYTS 2022 Version - What Brands Cigs Smoke: Winston NY1-What Brands Cigs Smoke: Other National Youth Tobacco Survey 2022 - During the past 30 days, what brands of cigarettes did you smoke: Some other brand not listed here. NYTS 2022 Version - What Brands Cigs Smoke: Other NY1-What Brands Cigs Smoke: Not Sure National Youth Tobacco Survey 2022 - During the past 30 days, what brands of cigarettes did you smoke: Not sure/I don't know the brand. NYTS 2022 Version - What Brands Cigs Smoke: Not Sure NY1-What Brands Cigs Smoke: Specify National Youth Tobacco Survey 2022 - During the past 30 days, what brands of cigarettes did you smoke: Some other brand not listed here (Please specify). NYTS 2022 Version - What Brands Cigs Smoke: Specify NY1-What Brand Cig Usually National Youth Tobacco Survey 2022 - During the past 30 days, what brand of cigarettes did you usually smoke? NYTS 2022 Version - What Brand Cig Usually NY1-What Brand Cig Usually: Specify National Youth Tobacco Survey 2022 - During the past 30 days, what brand of cigarettes did you usually smoke: Some other brand not listed here (Please specify). NYTS 2022 Version - What Brand Cig Usually: Specify NY1-Past 30 Days Menthol Cig Use National Youth Tobacco Survey 2022 - During the past 30 days, were the cigarettes that you usually smoked menthol? NYTS 2022 Version - Past 30 Days Menthol Cig Use NY1-Got Cig How Old Was This Person National Youth Tobacco Survey 2022 - Earlier you mentioned that you got or bought your cigarettes from another person, such as a friend or family member during the past 30 days. How old was this person? NYTS 2022 Version - Got Cig How Old Was This Person NY1-Seriously Thinking Quitting Cig National Youth Tobacco Survey 2022 - Are you seriously thinking about quitting cigarettes? NYTS 2022 Version - Seriously Thinking Quitting Cig NY1-Times Stopped Cig Trying Quit National Youth Tobacco Survey 2022 - During the past 12 months, how many times have you stopped smoking cigarettes for one day or longer because you were trying to quit smoking cigarettes for good? NYTS 2022 Version - Times Stopped Cig Trying Quit NY1-Ever Curious Smoking Cig National Youth Tobacco Survey 2022 - Have you ever been curious about smoking a cigarette? NYTS 2022 Version - Ever Curious Smoking Cig NY1-Think Will Try Cig Soon National Youth Tobacco Survey 2022 - Do you think that you will try a cigarette soon? NYTS 2022 Version - Think Will Try Cig Soon NY1-Think Will Smoke Cig in Next Year National Youth Tobacco Survey 2022 - Do you think you will smoke a cigarette in the next year? NYTS 2022 Version - Think Will Smoke Cig in Next Year NY1-If Best Friends Offer Cig Smoke National Youth Tobacco Survey 2022 - If one of your best friends were to offer you a cigarette, would you smoke it? NYTS 2022 Version - If Best Friends Offer Cig Smoke NY1-Ever Smoked a Cigar National Youth Tobacco Survey 2022 - Have you ever smoked a cigar, cigarillo, or little cigar, even one or two puffs? NYTS 2022 Version - Ever Smoked a Cigar NY1-How Old When First Smoked Cigar National Youth Tobacco Survey 2022 - How old were you when you first smoked a cigar, cigarillo, or little cigar, even one or two puffs? NYTS 2022 Version - How Old When First Smoked Cigar NY1-How Many Days Smoke Cigars National Youth Tobacco Survey 2022 - During the past 30 days, on how many days did you smoke cigars, cigarillos, or little cigars? NYTS 2022 Version - How Many Days Smoke Cigars NY1-On Days Smoked How Many Cigars National Youth Tobacco Survey 2022 - During the past 30 days, on the days that you smoked, about how many cigars, cigarillos, or little cigars did you smoke per day? NYTS 2022 Version - On Days Smoked How Many Cigars NY1-Type of Cigar Smoked: Regular Cigars National Youth Tobacco Survey 2022 - During the past 30 days, which of the following types of cigars have you smoked: Regular cigars. NYTS 2022 Version - Type of Cigar Smoked: Regular Cigars NY1-Type of Cigar Smoked: Cigarillos National Youth Tobacco Survey 2022 - During the past 30 days, which of the following types of cigars have you smoked: Cigarillos. NYTS 2022 Version - Type of Cigar Smoked: Cigarillos NY1-Type of Cigar Smoked: Little Cigars National Youth Tobacco Survey 2022 - During the past 30 days, which of the following types of cigars have you smoked: Little Cigars. NYTS 2022 Version - Type of Cigar Smoked: Little Cigars NY1-Type of Cigar Smoked: Don't Know National Youth Tobacco Survey 2022 - During the past 30 days, which of the following types of cigars have you smoked: Don't Know. NYTS 2022 Version - Type of Cigar Smoked: Don't Know NY1-Got Cigar How Old Was This Person National Youth Tobacco Survey 2022 - Earlier you mentioned that you got or bought your cigars, cigarillos, or little cigars from another person, such as a friend or family member during the past 30 days. How old was this person? NYTS 2022 Version - Got Cigar How Old Was This Person NY1-Ever Curious Smoking Cigar National Youth Tobacco Survey 2022 - Have you ever been curious about smoking a cigar, cigarillo, or little cigar? NYTS 2022 Version - Ever Curious Smoking Cigar NY1-Think Will Try Cigar Soon National Youth Tobacco Survey 2022 - Do you think you will try a cigar, cigarillo, or little cigar soon? NYTS 2022 Version - Think Will Try Cigar Soon NY1-Think Will Smoke Cigar in Next Year National Youth Tobacco Survey 2022 - Do you think you will smoke a cigar, cigarillo, or little cigar in the next year? NYTS 2022 Version - Think Will Smoke Cigar in Next Year NY1-If Best Friends Offer Cigar Smoke National Youth Tobacco Survey 2022 - If one of your best friends were to offer you a cigar, cigarillo, or little cigar, would you smoke it? NYTS 2022 Version - If Best Friends Offer Cigar Smoke NY1-Ever Smoked Cigar With Marijuana National Youth Tobacco Survey 2022 - Have you ever smoked part or all of a cigar, cigarillo, or little cigar with marijuana in it? NYTS 2022 Version - Ever Smoked Cigar With Marijuana NY1-Ever Used Dip National Youth Tobacco Survey 2022 - Have you ever used chewing tobacco, snuff, or dip, even just a small amount? NYTS 2022 Version - Ever Used Dip NY1-How Old When First Used Dip National Youth Tobacco Survey 2022 - How old were you when you first used chewing tobacco, snuff, or dip, even just a small amount? NYTS 2022 Version - How Old When First Used Dip NY1-How Many Days Use Dip National Youth Tobacco Survey 2022 - During the past 30 days, on how many days did you use chewing tobacco, snuff, or dip? NYTS 2022 Version - How Many Days Use Dip NY1-Got Dip How Old Was This Person National Youth Tobacco Survey 2022 - Earlier you mentioned that you got or bought your chewing tobacco, snuff, or dip from another person, such as a friend or family member. How old was this person? NYTS 2022 Version - Got Dip How Old Was This Person NY1-Curious Using Dip National Youth Tobacco Survey 2022 - Have you ever been curious about using chewing tobacco, snuff, or dip? NYTS 2022 Version - Curious Using Dip NY1-Ever Smoked Hookah National Youth Tobacco Survey 2022 - Have you ever smoked tobacco in a hookah or waterpipe, even one or two puffs? NYTS 2022 Version - Ever Smoked Hookah NY1-How Old When First Smoked Hookah National Youth Tobacco Survey 2022 - How old were you when you first smoked tobacco in a hookah or waterpipe, even one or two puffs? NYTS 2022 Version - How Old When First Smoked Hookah NY1-How Many Days Smoke Hookah National Youth Tobacco Survey 2022 - During the past 30 days, on how many days did you smoke tobacco in a hookah or waterpipe? NYTS 2022 Version - How Many Days Smoke Hookah NY1-Where Smoke Hookah: My House National Youth Tobacco Survey 2022 - During the past 30 days, where did you smoke tobacco in a hookah or waterpipe: At my house. NYTS 2022 Version - Where Smoke Hookah: My House NY1-Where Smoke Hookah: Friend's House National Youth Tobacco Survey 2022 - During the past 30 days, where did you smoke tobacco in a hookah or waterpipe: At a friend's house. NYTS 2022 Version - Where Smoke Hookah: Friend's House NY1-Where Smoke Hookah: Family House National Youth Tobacco Survey 2022 - During the past 30 days, where did you smoke tobacco in a hookah or waterpipe: At a family member's house, other than my house. NYTS 2022 Version - Where Smoke Hookah: Family House NY1-Where Smoke Hookah: Hookah Bar National Youth Tobacco Survey 2022 - During the past 30 days, where did you smoke tobacco in a hookah or waterpipe: At a hookah bar. NYTS 2022 Version - Where Smoke Hookah: Hookah Bar NY1-Where Smoke Hookah: Cafe National Youth Tobacco Survey 2022 - During the past 30 days, where did you smoke tobacco in a hookah or waterpipe: At a cafe or restaurant. NYTS 2022 Version - Where Smoke Hookah: Cafe NY1-Where Smoke Hookah: Other National Youth Tobacco Survey 2022 - During the past 30 days, where did you smoke tobacco in a hookah or waterpipe: Some other place not listed here. NYTS 2022 Version - Where Smoke Hookah: Other NY1-Got Hookah How Old Was This Person National Youth Tobacco Survey 2022 - Earlier you mentioned that you got or bought your hookah tobacco from another person, such as a friend or family member. How old was this person? NYTS 2022 Version - Got Hookah How Old Was This Person NY1-Ever Curious Smoking Hookah National Youth Tobacco Survey 2022 - Have you ever been curious about smoking tobacco in a hookah or waterpipe? NYTS 2022 Version - Ever Curious Smoking Hookah NY1-Ever Smoked RYO Cigs National Youth Tobacco Survey 2022 - Have you ever smoked roll-your-own cigarettes, even just one time? NYTS 2022 Version - Ever Smoked RYO Cigs NY1-How Many Days Smoke RYO Cigs National Youth Tobacco Survey 2022 - During the past 30 days, on how many days did you smoke roll-your-own cigarettes? NYTS 2022 Version - How Many Days Smoke RYO Cigs NY1-Ever Smoked Pipe Tobacco National Youth Tobacco Survey 2022 - Have you ever smoked pipes filled with tobacco (not hookah or waterpipe), even just one time? NYTS 2022 Version - Ever Smoked Pipe Tobacco NY1-How Many Days Smoke Pipe Tobacco National Youth Tobacco Survey 2022 - During the past 30 days, on how many days did you smoke pipes filled with tobacco? NYTS 2022 Version - How Many Days Smoke Pipe Tobacco NY1-Ever Used Snus National Youth Tobacco Survey 2022 - Have you ever used snus, even just one time? NYTS 2022 Version - Ever Used Snus NY1-How Many Days Use Snus National Youth Tobacco Survey 2022 - During the past 30 days, on how many days did you use snus? NYTS 2022 Version - How Many Days Use Snus NY1-Used Dissolv Tobacco National Youth Tobacco Survey 2022 - Have you ever used dissolvable tobacco products, even just one time? NYTS 2022 Version - Used Dissolv Tobacco NY1-How Many Days Use Dissolv Tobacco National Youth Tobacco Survey 2022 - During the past 30 days, on how many days did you use dissolvable tobacco products? NYTS 2022 Version - How Many Days Use Dissolv Tobacco NY1-Smoked Bidis National Youth Tobacco Survey 2022 - Have you ever smoked bidis, even just one time? NYTS 2022 Version - Smoked Bidis NY1-How Many Days Smoke Bidis National Youth Tobacco Survey 2022 - During the past 30 days, on how many days did you smoke bidis? NYTS 2022 Version - How Many Days Smoke Bidis NY1-Have You Heard of Heated Tobacco National Youth Tobacco Survey 2022 - Before today, have you heard of "heated tobacco products"? NYTS 2022 Version - Have You Heard of Heated Tobacco NY1-Ever Used Heated Tobacco National Youth Tobacco Survey 2022 - Have you ever used a "heated tobacco product," even just one time? NYTS 2022 Version - Ever Used Heated Tobacco NY1-How Many Days Use Heated Tobacco National Youth Tobacco Survey 2022 - During the past 30 days, on how many days did you use a "heated tobacco product"? NYTS 2022 Version - How Many Days Use Heated Tobacco NY1-Have You Heard of Pouches National Youth Tobacco Survey 2022 - Before today, have you heard of "nicotine pouches"? NYTS 2022 Version - Have You Heard of Pouches NY1-Ever Used a Pouch National Youth Tobacco Survey 2022 - Have you ever used a "nicotine pouch," even just one time? NYTS 2022 Version - Ever Used a Pouch NY1-How Many Days Use Pouch National Youth Tobacco Survey 2022 - During the past 30 days, on how many days did you use a "nicotine pouch"? NYTS 2022 Version - How Many Days Use Pouch NY1-How Many Days Use Any Tobacco National Youth Tobacco Survey 2022 - During the past 30 days, on how many days did you use any tobacco product(s)? NYTS 2022 Version - How Many Days Use Any Tobacco NY1-Had Strong Craving to Use Tobacco National Youth Tobacco Survey 2022 - During the past 30 days, have you had a strong craving or felt like you really needed to use a tobacco product of any kind? NYTS 2022 Version - Had Strong Craving to Use Tobacco NY1-How Soon Wake Up Want to Use Tobacco National Youth Tobacco Survey 2022 - How soon after you wake up do you want to use a tobacco product of any kind? NYTS 2022 Version - How Soon Wake Up Want to Use Tobacco NY1-Seriously Thinking Quitting Tobacco National Youth Tobacco Survey 2022 - Are you seriously thinking about quitting the use of all tobacco products? NYTS 2022 Version - Seriously Thinking Quitting Tobacco NY1-Times Stopped Tobacco Trying Quit National Youth Tobacco Survey 2022 - During the past 12 months, how many times have you stopped using all tobacco products for one day or longer because you were trying to quit all tobacco products for good? NYTS 2022 Version - Times Stopped Tobacco Trying Quit NY1-Anyone Refuse Sell Tobacco B/c Age National Youth Tobacco Survey 2022 - During the past 30 days, did anyone refuse to sell you any tobacco products because of your age? NYTS 2022 Version - Anyone Refuse Sell Tobacco B/c Age NY1-How Easy Buy Tobacco Store B/c Age National Youth Tobacco Survey 2022 - How easy do you think it is for people your age to buy tobacco products in a store? NYTS 2022 Version - How Easy Buy Tobacco Store B/c Age NY1-How Easy Buy Tobacco Online B/c Age National Youth Tobacco Survey 2022 - How easy do you think it is for people your age to buy tobacco products online? NYTS 2022 Version - How Easy Buy Tobacco Online B/c Age NY1-Visited Doctor Past 12 Months National Youth Tobacco Survey 2022 - Have you visited a doctor, dentist, or nurse in the past 12 months? NYTS 2022 Version - Visited Doctor Past 12 Months NY1-During Visits Asked Used Cigs National Youth Tobacco Survey 2022 - During any of these visits to a doctor, dentist, nurse, or other health professional, were you asked if you used cigarettes? NYTS 2022 Version - During Visits Asked Used Cigs NY1-During Visits Advised Not Cigs National Youth Tobacco Survey 2022 - During any of these visits, were you advised to not use cigarettes? NYTS 2022 Version - During Visits Advised Not Cigs NY1-During Visits Asked E-Cigs National Youth Tobacco Survey 2022 - During any of these visits to a doctor, dentist, nurse, or other health professional, were you asked if you used e-cigarettes? NYTS 2022 Version - During Visits Asked E-Cigs NY1-During Visits Advised Not E-Cigs National Youth Tobacco Survey 2022 - During any of these visits, were you advised to not use e-cigarettes? NYTS 2022 Version - During Visits Advised Not E-Cigs NY1-During Visits Asked Other Tobacco National Youth Tobacco Survey 2022 - During any of these visits to a doctor, dentist, nurse, or other health professional, were you asked if you used any of these other tobacco products? NYTS 2022 Version - During Visits Asked Other Tobacco NY1-During Visits Advised Not Tobacco National Youth Tobacco Survey 2022 - During any of these visits, were you advised to not use any of these other tobacco products? NYTS 2022 Version - During Visits Advised Not Tobacco NY1-How Often Warning Label E-Cig National Youth Tobacco Survey 2022 - During the past 30 days, how often did you see a warning label on an e-cigarette package? NYTS 2022 Version - How Often Warning Label E-Cig NY1-How Often Warning Label Cig National Youth Tobacco Survey 2022 - During the past 30 days, how often did you see a warning label on a cigarette package? NYTS 2022 Version - How Often Warning Label Cig NY1-How Often Warning Label Cigar National Youth Tobacco Survey 2022 - During the past 30 days, how often did you see a warning label on a cigar, cigarillo, or little cigar package? NYTS 2022 Version - How Often Warning Label Cigar NY1-How Often Warning Label Dip National Youth Tobacco Survey 2022 - During the past 30 days, how often did you see a warning label on a package of chewing tobacco, snuff, or dip? NYTS 2022 Version - How Often Warning Label Dip NY1-How Often Warning Label Hookah National Youth Tobacco Survey 2022 - During the past 30 days, how often did you see a warning label on a package of hookah tobacco? NYTS 2022 Version - How Often Warning Label Hookah NY1-Have You Seen The Real Cost Ads National Youth Tobacco Survey 2022 - In the past 12 months, have you seen or heard The Real Cost, on television, the internet, social media, or radio as part of ads about tobacco? NYTS 2022 Version - Have You Seen The Real Cost Ads NY1-Ads Against Tobacco: Truth National Youth Tobacco Survey 2022 - In the past 12 months, have you seen or heard any other ads against tobacco with the following names or slogans on television, the internet, social media, or on the radio: Truth. NYTS 2022 Version - Ads Against Tobacco: Truth NY1-Ads Against Tobacco: Tips National Youth Tobacco Survey 2022 - In the past 12 months, have you seen or heard any other ads against tobacco with the following names or slogans on television, the internet, social media, or on the radio: Tips or Tips From Former Smokers. NYTS 2022 Version - Ads Against Tobacco: Tips NY1-Ads Against Tobacco: Fresh Empire National Youth Tobacco Survey 2022 - In the past 12 months, have you seen or heard any other ads against tobacco with the following names or slogans on television, the internet, social media, or on the radio: Fresh Empire. NYTS 2022 Version - Ads Against Tobacco: Fresh Empire NY1-Ads Against Tobacco: This Free Life National Youth Tobacco Survey 2022 - In the past 12 months, have you seen or heard any other ads against tobacco with the following names or slogans on television, the internet, social media, or on the radio: This Free Life. NYTS 2022 Version - Ads Against Tobacco: This Free Life NY1-Ads Against Tobacco: Other National Youth Tobacco Survey 2022 - In the past 12 months, have you seen or heard any other ads against tobacco with the following names or slogans on television, the internet, social media, or on the radio: Some other ad. NYTS 2022 Version - Ads Against Tobacco: Other NY1-Ads Against Tobacco: Haven't Seen National Youth Tobacco Survey 2022 - In the past 12 months, have you seen or heard any other ads against tobacco with the following names or slogans on television, the internet, social media, or on the radio: I haven't seen or heard of any of these ads. NYTS 2022 Version - Ads Against Tobacco: Haven't Seen NY1-Ads Against Tobacco: Specify National Youth Tobacco Survey 2022 - In the past 12 months, have you seen or heard any other ads against tobacco with the following names or slogans on television, the internet, social media, or on the radio: Some other ad (specify). NYTS 2022 Version - Ads Against Tobacco: Specify NY1-Think People Harm When Smoke Cigs National Youth Tobacco Survey 2022 - How much do you think people harm themselves when they smoke cigarettes some days but not every day? NYTS 2022 Version - Think People Harm When Smoke Cigs NY1-Think People Harm When Smoke Cigar National Youth Tobacco Survey 2022 - How much do you think people harm themselves when they smoke cigars, cigarillos, or little cigars, some days but not every day? NYTS 2022 Version - Think People Harm When Smoke Cigar NY1-Cigars Less/Equally/More Addictive National Youth Tobacco Survey 2022 - Do you believe that cigars, cigarillos, or little cigars are (less addictive, equally addictive, or more addictive) than cigarettes? NYTS 2022 Version - Cigars Less/Equally/More Addictive NY1-People Harm When Use Dip National Youth Tobacco Survey 2022 - How much do you think people harm themselves when they use chewing tobacco, snuff, dip, snus, or dissolvable tobacco products, some days but not every day? NYTS 2022 Version - People Harm When Use Dip NY1-Dip Less/Equally/More Addictive National Youth Tobacco Survey 2022 - Do you believe that chewing tobacco, snuff, dip, snus, or dissolvable tobacco products are (less addictive, equally addictive, or more addictive) than cigarettes? NYTS 2022 Version - Dip Less/Equally/More Addictive NY1-People Harm When Use E-Cigs National Youth Tobacco Survey 2022 - How much do you think people harm themselves when they use e-cigarettes some days but not every day? NYTS 2022 Version - People Harm When Use E-Cigs NY1-E-Cigs Less/Equally/More Addictive National Youth Tobacco Survey 2022 - Do you believe that e-cigarettes are (less addictive, equally addictive, or more addictive) than cigarettes? NYTS 2022 Version - E-Cigs Less/Equally/More Addictive NY1-People Harm When Smoke Hookah National Youth Tobacco Survey 2022 - How much do you think people harm themselves when they smoke tobacco in a hookah or waterpipe some days but not every day? NYTS 2022 Version - People Harm When Smoke Hookah NY1-Hookah Less/Equally/More Addictive National Youth Tobacco Survey 2022 - Do you believe that smoking tobacco in a hookah or waterpipe is (less addictive, equally addictive, or more addictive) than cigarettes? NYTS 2022 Version - Hookah Less/Equally/More Addictive NY1-Think Cig Advertised as Low Nicotine National Youth Tobacco Survey 2022 - Compared to a typical cigarette, would you think that a cigarette advertised as low nicotine would be. NYTS 2022 Version - Think Cig Advertised as Low Nicotine NY1-Think That E-Cigs National Youth Tobacco Survey 2022 - Do you think that e-cigarettes. NYTS 2022 Version - Think That E-Cigs NY1-Agree Statement Tobacco Dangerous National Youth Tobacco Survey 2022 - How strongly do you agree with the statement 'All tobacco products are dangerous'? NYTS 2022 Version - Agree Statement Tobacco Dangerous NY1-Breathing Vapor Other People E-Cigs National Youth Tobacco Survey 2022 - Do you think that breathing the vapor from other people's e-cigarettes causes. NYTS 2022 Version - Breathing Vapor Other People E-Cigs NY1-Breathing Smoke Other People Cigs National Youth Tobacco Survey 2022 - Not including the vapor from e-cigarettes, do you think that breathing smoke from other people's cigarettes or other tobacco products causes. NYTS 2022 Version - Breathing Smoke Other People Cigs NY1-How Many You Think Smoke Cigs National Youth Tobacco Survey 2022 - Out of every 10 students in your grade at school, how many do you think smoke cigarettes? NYTS 2022 Version - How Many You Think Smoke Cigs NY1-How Many You Think Use E-Cigs National Youth Tobacco Survey 2022 - Out of every 10 students in your grade at school, how many do you think use e-cigarettes? NYTS 2022 Version - How Many You Think Use E-Cigs NY1-My Friends Think E-Cig Use Is National Youth Tobacco Survey 2022 - Please complete the following sentence. My friends think that e-cigarette use is. NYTS 2022 Version - My Friends Think E-Cig Use Is NY1-Internet How Often Ads E-Cigs National Youth Tobacco Survey 2022 - When you are using the Internet, how often do you see ads or promotions for e-cigarettes? NYTS 2022 Version - Internet How Often Ads E-Cigs NY1-Magazines How Often Ads E-Cigs National Youth Tobacco Survey 2022 - When you read newspapers or magazines, how often do you see ads or promotions for e-cigarettes? NYTS 2022 Version - Magazines How Often Ads E-Cigs NY1-Store How Often Ads E-Cigs National Youth Tobacco Survey 2022 - When you go to a convenience store, supermarket, gas station, kiosk/storefront, or shopping center, how often do you see ads or promotions for e-cigarettes? NYTS 2022 Version - Store How Often Ads E-Cigs NY1-Watch TV How Often See Ads E-Cigs National Youth Tobacco Survey 2022 - When you watch TV or streaming services (such as Netflix, Hulu, or Amazon Prime), or go to the movies, how often do you see ads or promotions for e-cigarettes? NYTS 2022 Version - Watch TV How Often See Ads E-Cigs NY1-Watch TV See People Using E-Cigs National Youth Tobacco Survey 2022 - When you watch TV or streaming services (such as Netflix, Hulu, or Amazon Prime), or go to the movies, how often do you see people or characters using e-cigarettes? NYTS 2022 Version - Watch TV See People Using E-Cigs NY1-How Often Do You Use Social Media National Youth Tobacco Survey 2022 - How often do you use social media? NYTS 2022 Version - How Often Do You Use Social Media NY1-Social Media See Posts E-Cigs National Youth Tobacco Survey 2022 - When you use social media, how often do you see posts or content (pictures, videos, or text) related to e-cigarettes? NYTS 2022 Version - Social Media See Posts E-Cigs NY1-Sites Seen Posts E-Cigs: Facebook National Youth Tobacco Survey 2022 - On which social media sites have you seen posts or content related to e-cigarettes: Facebook. NYTS 2022 Version - Sites Seen Posts E-Cigs: Facebook NY1-Sites Seen Posts E-Cigs: Instagram National Youth Tobacco Survey 2022 - On which social media sites have you seen posts or content related to e-cigarettes: Instagram. NYTS 2022 Version - Sites Seen Posts E-Cigs: Instagram NY1-Sites Seen Posts E-Cigs: Snapchat National Youth Tobacco Survey 2022 - On which social media sites have you seen posts or content related to e-cigarettes: Snapchat. NYTS 2022 Version - Sites Seen Posts E-Cigs: Snapchat NY1-Sites Seen Posts E-Cigs: TikTok National Youth Tobacco Survey 2022 - On which social media sites have you seen posts or content related to e-cigarettes: TikTok. NYTS 2022 Version - Sites Seen Posts E-Cigs: TikTok NY1-Sites Seen Posts E-Cigs: Twitter National Youth Tobacco Survey 2022 - On which social media sites have you seen posts or content related to e-cigarettes: Twitter. NYTS 2022 Version - Sites Seen Posts E-Cigs: Twitter NY1-Sites Seen Posts E-Cigs: Reddit National Youth Tobacco Survey 2022 - On which social media sites have you seen posts or content related to e-cigarettes: Reddit. NYTS 2022 Version - Sites Seen Posts E-Cigs: Reddit NY1-Sites Seen Posts E-Cigs: YouTube National Youth Tobacco Survey 2022 - On which social media sites have you seen posts or content related to e-cigarettes: YouTube. NYTS 2022 Version - Sites Seen Posts E-Cigs: YouTube NY1-Sites Seen Posts E-Cigs: Other National Youth Tobacco Survey 2022 - On which social media sites have you seen posts or content related to e-cigarettes: Some other site. NYTS 2022 Version - Sites Seen Posts E-Cigs: Other NY1-Sites Seen Posts E-Cigs: Specify National Youth Tobacco Survey 2022 - On which social media sites have you seen posts or content related to e-cigarettes: Some other site (specify). NYTS 2022 Version - Sites Seen Posts E-Cigs: Specify NY1-Post Pictures of Using E-Cigs National Youth Tobacco Survey 2022 - When you use social media, how often do you post pictures or videos of yourself or someone else using e-cigarettes? NYTS 2022 Version - Post Pictures of Using E-Cigs NY1-Social Media Shared Posts E-Cigs National Youth Tobacco Survey 2022 - When you use social media, how often have you liked, commented, or shared posts or content (pictures, videos, or text) related to e-cigarettes? NYTS 2022 Version - Social Media Shared Posts E-Cigs NY1-Who Posted E-Cigs: People I know National Youth Tobacco Survey 2022 - Who usually posted the content related to e-cigarettes on your social media: People I know in real life. NYTS 2022 Version - Who Posted E-Cigs: People I know NY1-Who Posted E-Cigs: Online Friends National Youth Tobacco Survey 2022 - Who usually posted the content related to e-cigarette son your social media: Online friends I have not met in real life. NYTS 2022 Version - Who Posted E-Cigs: Online Friends NY1-Who Posted E-Cigs: Celebrities National Youth Tobacco Survey 2022 - Who usually posted the content related to e-cigarettes on your social media: Celebrities or social media influencers. NYTS 2022 Version - Who Posted E-Cigs: Celebrities NY1-Who Posted E-Cigs: E-Cig Brands National Youth Tobacco Survey 2022 - Who usually posted the content related to e-cigarettes on your social media: E-cigarette brands or sellers. NYTS 2022 Version - Who Posted E-Cigs: E-Cig Brands NY1-Who Posted E-Cigs: News Articles National Youth Tobacco Survey 2022 - Who usually posted the content related to e-cigarettes on your social media: Online news articles. NYTS 2022 Version - Who Posted E-Cigs: News Articles NY1-Who Posted E-Cigs: Public Health National Youth Tobacco Survey 2022 - Who usually posted the content related to e-cigarette son your social media: Public health campaigns (e.g., Truth Initiative, Real Cost). NYTS 2022 Version - Who Posted E-Cigs: Public Health NY1-Who Posted E-Cigs: Other National Youth Tobacco Survey 2022 - Who usually posted the content related to e-cigarette son your social media: Other. NYTS 2022 Version - Who Posted E-Cigs: Other NY1-Who Posted E-Cigs: Specify National Youth Tobacco Survey 2022 - Who usually posted the content related to e-cigarettes on your social media: Other (specify). NYTS 2022 Version - Who Posted E-Cigs: Specify NY1-Internet How Often See Ads Cigs National Youth Tobacco Survey 2022 - When you are using the Internet, how often do you see ads or promotions for cigarettes or other tobacco products? NYTS 2022 Version - Internet How Often See Ads Cigs NY1-Magazines How Often See Ads Cigs National Youth Tobacco Survey 2022 - When you read newspapers or magazines, how often do you see ads or promotions for cigarettes or other tobacco products? NYTS 2022 Version - Magazines How Often See Ads Cigs NY1-Store How Often See Ads Cigs National Youth Tobacco Survey 2022 - When you go to a convenience store, supermarket, gas station, kiosk/storefront, or shopping center, how often do you see ads or promotions for cigarettes or other tobacco products? NYTS 2022 Version - Store How Often See Ads Cigs NY1-Watch TV How Often See Ads Cigs National Youth Tobacco Survey 2022 - When you watch TV or streaming services (such as Netflix, Hulu, or Amazon Prime), or go to the movies, how often do you see ads or promotions for cigarettes or other tobacco products? NYTS 2022 Version - Watch TV How Often See Ads Cigs NY1-Watch TV See People Using Cigs National Youth Tobacco Survey 2022 - When you watch TV or streaming services (such as Netflix, Hulu, or Amazon Prime), or go to the movies, how often do you see people or characters using cigarettes or other tobacco products? NYTS 2022 Version - Watch TV See People Using Cigs NY1-Someone Smoke in Home National Youth Tobacco Survey 2022 - During the past 7 days, on how many days did someone smoke tobacco products in your home while you were there? NYTS 2022 Version - Someone Smoke in Home NY1-Ride in Vehicle Someone Smoking National Youth Tobacco Survey 2022 - During the past 7 days, on how many days did you ride in a vehicle when someone was smoking a tobacco product? NYTS 2022 Version - Ride in Vehicle Someone Smoking NY1-Exposed Smoke Indoor Public Place National Youth Tobacco Survey 2022 - During the past 30 days, on how many days were you exposed to the smoke from someone who was smoking tobacco products in an indoor public place? Examples of indoor public places are school buildings, stores, restaurants, and sports arenas. NYTS 2022 Version - Exposed Smoke Indoor Public Place NY1-Exposed Smoke Outdoor Public Place National Youth Tobacco Survey 2022 - During the past 30 days, on how many days were you exposed to the smoke from someone who was smoking tobacco products in an outdoor public place? Examples of outdoor public places are school grounds, sidewalks, parking lots, stadiums, and parks. NYTS 2022 Version - Exposed Smoke Outdoor Public Place NY1-Someone Use E-Cigs in Home National Youth Tobacco Survey 2022 - During the past 7 days, on how many days did someone use e-cigarettes in your home while you were there? NYTS 2022 Version - Someone Use E-Cigs in Home NY1-Ride in Vehicle Someone Using E-Cig National Youth Tobacco Survey 2022 - During the past 7 days, on how many days did you ride in a vehicle when someone was using an e-cigarette? NYTS 2022 Version - Ride in Vehicle Someone Using E-Cig NY1-Exposed E-Cig Indoor Public Place National Youth Tobacco Survey 2022 - During the past 30 days, on how many days were you exposed to the vapor from someone who was using an e-cigarette in an indoor public place? Examples of indoor public places are school buildings, stores, restaurants, and sports arenas. NYTS 2022 Version - Exposed E-Cig Indoor Public Place NY1-Exposed E-Cig Outdoor Public Place National Youth Tobacco Survey 2022 - During the past 30 days, on how many days were you exposed to the vapor from someone who was using an e-cigarette in an outdoor public place? Examples of outdoor public places are school grounds, sidewalks, parking lots, stadiums, and parks. NYTS 2022 Version - Exposed E-Cig Outdoor Public Place NY1-Using E-Cig at School: No National Youth Tobacco Survey 2022 - Have you ever seen anyone using an e-cigarette, such as JUUL, SMOK, Suorin, Vuse, blu, Puff Bar, or STIG in any locations while at school or on school property: No. NYTS 2022 Version - Using E-Cig at School: No NY1-Using E-Cig at School: Bathroom National Youth Tobacco Survey 2022 - Have you ever seen anyone using an e-cigarette, such as JUUL, SMOK, Suorin, Vuse, blu, Puff Bar, or STIG in any locations while at school or on school property: Yes, inside a school bathroom or locker room. NYTS 2022 Version - Using E-Cig at School: Bathroom NY1-Using E-Cig at School: Classroom National Youth Tobacco Survey 2022 - Have you ever seen anyone using an e-cigarette, such as JUUL, SMOK, Suorin, Vuse, blu, Puff Bar, or STIG in any locations while at school or on school property: Yes, inside a classroom. NYTS 2022 Version - Using E-Cig at School: Classroom NY1-Using E-Cig at School: Inside Other National Youth Tobacco Survey 2022 - Have you ever seen anyone using an e-cigarette, such as JUUL, SMOK, Suorin, Vuse, blu, Puff Bar, or STIG in any locations while at school or on school property: Yes, inside some other area of the school (hallway, cafeteria). NYTS 2022 Version - Using E-Cig at School: Inside Other NY1-Using E-Cig at School: Outside Other National Youth Tobacco Survey 2022 - Have you ever seen anyone using an e-cigarette, such as JUUL, SMOK, Suorin, Vuse, blu, Puff Bar, or STIG in any locations while at school or on school property: Yes, outside of the school, such as in the parking lot, sidewalk, sports field, or other school grounds. NYTS 2022 Version - Using E-Cig at School: Outside Other NY1-Using E-Cig at School: Not Listed National Youth Tobacco Survey 2022 - Have you ever seen anyone using an e-cigarette, such as JUUL, SMOK, Suorin, Vuse, blu, Puff Bar, or STIG in any locations while at school or on school property: Yes, somewhere else not listed here. NYTS 2022 Version - Using E-Cig at School: Not Listed NY1-Using E-Cig at School: Specify National Youth Tobacco Survey 2022 - Have you ever seen anyone using an e-cigarette, such as JUUL, SMOK, Suorin, Vuse, blu, Puff Bar, or STIG in any locations while at school or on school property: Yes, somewhere else not listed here (specify). NYTS 2022 Version - Using E-Cig at School: Specify NY1-Anyone Lives w/You: Use E-Cigs National Youth Tobacco Survey 2022 - Does anyone who lives with you now: Use e-cigarettes. NYTS 2022 Version - Anyone Lives w/You: Use E-Cigs NY1-Anyone Lives w/You: Cigs National Youth Tobacco Survey 2022 - Does anyone who lives with you now: Smoke cigarettes. NYTS 2022 Version - Anyone Lives w/You: Cigs NY1-Anyone Lives w/You: Cigars National Youth Tobacco Survey 2022 - Does anyone who lives with you now: Smoke cigars, cigarillos, or little cigars. NYTS 2022 Version - Anyone Lives w/You: Cigars NY1-Anyone Lives w/You: Use Dip National Youth Tobacco Survey 2022 - Does anyone who lives with you now: Use chewing tobacco, snuff, or dip. NYTS 2022 Version - Anyone Lives w/You: Use Dip NY1-Anyone Lives w/You: Hookah National Youth Tobacco Survey 2022 - Does anyone who lives with you now: Smoke tobacco in a hookah or waterpipe. NYTS 2022 Version - Anyone Lives w/You: Hookah NY1-Anyone Lives w/You: RYO Cigs National Youth Tobacco Survey 2022 - Does anyone who lives with you now: Smoke roll-your-own cigarettes. NYTS 2022 Version - Anyone Lives w/You: RYO Cigs NY1-Anyone Lives w/You: Pipe tobacco National Youth Tobacco Survey 2022 - Does anyone who lives with you now: Smoke pipes filled with tobacco (not hookah or waterpipes). NYTS 2022 Version - Anyone Lives w/You: Pipe tobacco NY1-Anyone Lives w/You: Use Snus National Youth Tobacco Survey 2022 - Does anyone who lives with you now: Use snus. NYTS 2022 Version - Anyone Lives w/You: Use Snus NY1-Anyone Lives w/You: Dissolv Tobacco National Youth Tobacco Survey 2022 - Does anyone who lives with you now: Use dissolvable tobacco products. NYTS 2022 Version - Anyone Lives w/You: Dissolv Tobacco NY1-Anyone Lives w/You: Bidis National Youth Tobacco Survey 2022 - Does anyone who lives with you now: Smoke bidis (small brown cigarettes wrapped in a leaf). NYTS 2022 Version - Anyone Lives w/You: Bidis NY1-Anyone Lives w/You: Heated Tobacco National Youth Tobacco Survey 2022 - Does anyone who lives with you now: Use heated tobacco products. NYTS 2022 Version - Anyone Lives w/You: Heated Tobacco NY1-Anyone Lives w/You: Pouches National Youth Tobacco Survey 2022 - Does anyone who lives with you now: Use nicotine pouches. NYTS 2022 Version - Anyone Lives w/You: Pouches NY1-Anyone Lives w/You: No One National Youth Tobacco Survey 2022 - Does anyone who lives with you now: No one who lives with me now uses any form of tobacco. NYTS 2022 Version - Anyone Lives w/You: No One NY1-Speak Language Other Than English National Youth Tobacco Survey 2022 - Do you speak a language other than English at home? NYTS 2022 Version - Speak Language Other Than English NY1-Which of the Following Describes You National Youth Tobacco Survey 2022 - Which of the following best describes you? NYTS 2022 Version - Which of the Following Describes You NY1-Are You Transgender National Youth Tobacco Survey 2022 - Some people describe themselves as transgender when their sex at birth does not match the way they think or feel about their gender. Are you transgender? [The NCI Thesaurus contains biomedical terminologies that NCI does not own or control. This concept contains gender-related content that does not comply with Executive Order 14168.] NYTS 2022 Version - Are You Transgender NY1-Been Bothered: Little Interest National Youth Tobacco Survey 2022 - During the past two weeks, how often have you been bothered by any of the following problems: Little interest or pleasure in doing things. NYTS 2022 Version - Been Bothered: Little Interest NY1-Been Bothered: Feeling Depressed National Youth Tobacco Survey 2022 - During the past two weeks, how often have you been bothered by any of the following problems: Feeling down, depressed, or hopeless. NYTS 2022 Version - Been Bothered: Feeling Depressed NY1-Been Bothered: Feeling Anxious National Youth Tobacco Survey 2022 - During the past two weeks, how often have you been bothered by any of the following problems: Feeling nervous, anxious, or on edge. NYTS 2022 Version - Been Bothered: Feeling Anxious NY1-Been Bothered: Not Stop Worrying National Youth Tobacco Survey 2022 - During the past two weeks, how often have you been bothered by any of the following problems: Not being able to stop or control worrying. NYTS 2022 Version - Been Bothered: Not Stop Worrying NY1-Does Your Family Own a Vehicle National Youth Tobacco Survey 2022 - Does your family own a vehicle (such as a car, van, or truck). NYTS 2022 Version - Does Your Family Own a Vehicle NY1-Do you Have Your Own Bedroom National Youth Tobacco Survey 2022 - Do you have your own bedroom? NYTS 2022 Version - Do you Have Your Own Bedroom NY1-How Many Computers Family Own National Youth Tobacco Survey 2022 - How many computers (including laptops and tablets, not including game consoles and smartphones) does your family own? NYTS 2022 Version - How Many Computers Family Own NY1-How Many Times Travel With Family National Youth Tobacco Survey 2022 - During the past 12 months, how many times did you travel on vacation with your family? NYTS 2022 Version - How Many Times Travel With Family NY1-Describe Your Grades in School National Youth Tobacco Survey 2022 - During the past 12 months, how would you describe your grades in school? NYTS 2022 Version - Describe Your Grades in School NY1-Do You Have Difficulty Concentrating National Youth Tobacco Survey 2022 - Because of a physical, mental, or emotional condition, do you have serious difficulty concentrating, remembering, or making decisions? NYTS 2022 Version - Do You Have Difficulty Concentrating NY1TC National Youth Tobacco Survey 2022 Questionnaire Test Code CDISC Questionnaire National Youth Tobacco Survey 2022 Version Test Code Terminology National Youth Tobacco Survey 2022 test name. NY1-Ads Against Tobacco: Fresh Empire National Youth Tobacco Survey 2022 - In the past 12 months, have you seen or heard any other ads against tobacco with the following names or slogans on television, the internet, social media, or on the radio: Fresh Empire. NYTS 2022 Version - Ads Against Tobacco: Fresh Empire NY1-Ads Against Tobacco: Haven't Seen National Youth Tobacco Survey 2022 - In the past 12 months, have you seen or heard any other ads against tobacco with the following names or slogans on television, the internet, social media, or on the radio: I haven't seen or heard of any of these ads. NYTS 2022 Version - Ads Against Tobacco: Haven't Seen NY1-Ads Against Tobacco: Other National Youth Tobacco Survey 2022 - In the past 12 months, have you seen or heard any other ads against tobacco with the following names or slogans on television, the internet, social media, or on the radio: Some other ad. NYTS 2022 Version - Ads Against Tobacco: Other NY1-Ads Against Tobacco: Specify National Youth Tobacco Survey 2022 - In the past 12 months, have you seen or heard any other ads against tobacco with the following names or slogans on television, the internet, social media, or on the radio: Some other ad (specify). NYTS 2022 Version - Ads Against Tobacco: Specify NY1-Ads Against Tobacco: This Free Life National Youth Tobacco Survey 2022 - In the past 12 months, have you seen or heard any other ads against tobacco with the following names or slogans on television, the internet, social media, or on the radio: This Free Life. NYTS 2022 Version - Ads Against Tobacco: This Free Life NY1-Ads Against Tobacco: Tips National Youth Tobacco Survey 2022 - In the past 12 months, have you seen or heard any other ads against tobacco with the following names or slogans on television, the internet, social media, or on the radio: Tips or Tips From Former Smokers. NYTS 2022 Version - Ads Against Tobacco: Tips NY1-Ads Against Tobacco: Truth National Youth Tobacco Survey 2022 - In the past 12 months, have you seen or heard any other ads against tobacco with the following names or slogans on television, the internet, social media, or on the radio: Truth. NYTS 2022 Version - Ads Against Tobacco: Truth NY1-Agree Statement Tobacco Dangerous National Youth Tobacco Survey 2022 - How strongly do you agree with the statement 'All tobacco products are dangerous'? NYTS 2022 Version - Agree Statement Tobacco Dangerous NY1-Any Bidis Flavored National Youth Tobacco Survey 2022 - Were any of the bidis that you used in the past 30 days flavored to taste like menthol, mint, clove or spice, alcoholic drinks, candy, fruit, chocolate or any other flavor? NYTS 2022 Version - Any Bidis Flavored NY1-Any Cigars Flavored National Youth Tobacco Survey 2022 - Were any of the cigars, cigarillos, or little cigars that you used in the past 30 days flavored to taste like menthol, mint, clove or spice, alcoholic drinks, candy, fruit, chocolate, or any other flavor? NYTS 2022 Version - Any Cigars Flavored NY1-Any Dip Flavored National Youth Tobacco Survey 2022 - Was any of the chewing tobacco, snuff, or dip that you used in the past 30 days flavored to taste like menthol, mint, clove or spice, alcoholic drinks, candy, fruit, chocolate, or any other flavor? NYTS 2022 Version - Any Dip Flavored NY1-Any Dissolv Tobacco Flavored National Youth Tobacco Survey 2022 - Were any of the dissolvable tobacco products that you used in the past 30 days flavored to taste like menthol, mint, clove or spice, alcoholic drinks, candy, fruit, chocolate, or any other flavor? NYTS 2022 Version - Any Dissolv Tobacco Flavored NY1-Any E-Cigs Flavored National Youth Tobacco Survey 2022 - Were any of the e-cigarettes that you used in the past 30 days flavored to taste like menthol, mint, clove or spice, alcoholic drinks, candy, fruit, chocolate, or any other flavor? NYTS 2022 Version - Any E-Cigs Flavored NY1-Any E-Cigs Used Contain Nic Salt National Youth Tobacco Survey 2022 - Did any of the e-cigarettes that you used in the past 30 days contain nicotine salts? NYTS 2022 Version - Any E-Cigs Used Contain Nic Salt NY1-Any E-Cigs Used Contain Nicotine National Youth Tobacco Survey 2022 - Did any of the e-cigarettes that you used in the past 30 days contain nicotine? NYTS 2022 Version - Any E-Cigs Used Contain Nicotine NY1-Any Heated Tobacco Flavored National Youth Tobacco Survey 2022 - Were any of the heated tobacco products that you used in the past 30 days flavored to taste like menthol, mint, clove or spice, alcoholic drinks, candy, fruit, chocolate, or any other flavor? NYTS 2022 Version - Any Heated Tobacco Flavored NY1-Any Hookah Flavored National Youth Tobacco Survey 2022 - Was any of the tobacco in a hookah or waterpipe that you used in the past 30 days flavored to taste like menthol, mint, clove or spice, alcoholic drinks, candy, fruit, chocolate, or any other flavor? NYTS 2022 Version - Any Hookah Flavored NY1-Any Pipe Tobacco Flavored National Youth Tobacco Survey 2022 - Were any of the pipes filled with tobacco that you used in the past 30 days flavored to taste like menthol, mint, clove or spice, alcoholic drinks, candy, fruit, chocolate, or any other flavor? NYTS 2022 Version - Any Pipe Tobacco Flavored NY1-Any Pouches Flavored National Youth Tobacco Survey 2022 - Were any of the nicotine pouches that you used in the past 30 days flavored to taste like menthol, mint, clove or spice, alcoholic drinks, candy, fruit, chocolate, or any other flavor? NYTS 2022 Version - Any Pouches Flavored NY1-Any RYO Cigs Flavored National Youth Tobacco Survey 2022 - Were any of the roll-your-own cigarettes that you used in the past 30 days flavored to taste like menthol, mint, clove or spice, alcoholic drinks, candy, fruit, chocolate, or any other flavor? NYTS 2022 Version - Any RYO Cigs Flavored NY1-Any Snus Flavored National Youth Tobacco Survey 2022 - Was any of the snus that you used in the past 30 days flavored to taste like menthol, mint, clove or spice, alcoholic drinks, candy, fruit, chocolate, or any other flavor? NYTS 2022 Version - Any Snus Flavored NY1-Anyone Lives w/You: Bidis National Youth Tobacco Survey 2022 - Does anyone who lives with you now: Smoke bidis (small brown cigarettes wrapped in a leaf). NYTS 2022 Version - Anyone Lives w/You: Bidis NY1-Anyone Lives w/You: Cigars National Youth Tobacco Survey 2022 - Does anyone who lives with you now: Smoke cigars, cigarillos, or little cigars. NYTS 2022 Version - Anyone Lives w/You: Cigars NY1-Anyone Lives w/You: Cigs National Youth Tobacco Survey 2022 - Does anyone who lives with you now: Smoke cigarettes. NYTS 2022 Version - Anyone Lives w/You: Cigs NY1-Anyone Lives w/You: Dissolv Tobacco National Youth Tobacco Survey 2022 - Does anyone who lives with you now: Use dissolvable tobacco products. NYTS 2022 Version - Anyone Lives w/You: Dissolv Tobacco NY1-Anyone Lives w/You: Heated Tobacco National Youth Tobacco Survey 2022 - Does anyone who lives with you now: Use heated tobacco products. NYTS 2022 Version - Anyone Lives w/You: Heated Tobacco NY1-Anyone Lives w/You: Hookah National Youth Tobacco Survey 2022 - Does anyone who lives with you now: Smoke tobacco in a hookah or waterpipe. NYTS 2022 Version - Anyone Lives w/You: Hookah NY1-Anyone Lives w/You: No One National Youth Tobacco Survey 2022 - Does anyone who lives with you now: No one who lives with me now uses any form of tobacco. NYTS 2022 Version - Anyone Lives w/You: No One NY1-Anyone Lives w/You: Pipe tobacco National Youth Tobacco Survey 2022 - Does anyone who lives with you now: Smoke pipes filled with tobacco (not hookah or waterpipes). NYTS 2022 Version - Anyone Lives w/You: Pipe tobacco NY1-Anyone Lives w/You: Pouches National Youth Tobacco Survey 2022 - Does anyone who lives with you now: Use nicotine pouches. NYTS 2022 Version - Anyone Lives w/You: Pouches NY1-Anyone Lives w/You: RYO Cigs National Youth Tobacco Survey 2022 - Does anyone who lives with you now: Smoke roll-your-own cigarettes. NYTS 2022 Version - Anyone Lives w/You: RYO Cigs NY1-Anyone Lives w/You: Use Dip National Youth Tobacco Survey 2022 - Does anyone who lives with you now: Use chewing tobacco, snuff, or dip. NYTS 2022 Version - Anyone Lives w/You: Use Dip NY1-Anyone Lives w/You: Use E-Cigs National Youth Tobacco Survey 2022 - Does anyone who lives with you now: Use e-cigarettes. NYTS 2022 Version - Anyone Lives w/You: Use E-Cigs NY1-Anyone Lives w/You: Use Snus National Youth Tobacco Survey 2022 - Does anyone who lives with you now: Use snus. NYTS 2022 Version - Anyone Lives w/You: Use Snus NY1-Anyone Refuse Sell Tobacco B/c Age National Youth Tobacco Survey 2022 - During the past 30 days, did anyone refuse to sell you any tobacco products because of your age? NYTS 2022 Version - Anyone Refuse Sell Tobacco B/c Age NY1-Are You Transgender National Youth Tobacco Survey 2022 - Some people describe themselves as transgender when their sex at birth does not match the way they think or feel about their gender. Are you transgender? [The NCI Thesaurus contains biomedical terminologies that NCI does not own or control. This concept contains gender-related content that does not comply with Executive Order 14168.] NYTS 2022 Version - Are You Transgender NY1-Been Bothered: Feeling Anxious National Youth Tobacco Survey 2022 - During the past two weeks, how often have you been bothered by any of the following problems: Feeling nervous, anxious, or on edge. NYTS 2022 Version - Been Bothered: Feeling Anxious NY1-Been Bothered: Feeling Depressed National Youth Tobacco Survey 2022 - During the past two weeks, how often have you been bothered by any of the following problems: Feeling down, depressed, or hopeless. NYTS 2022 Version - Been Bothered: Feeling Depressed NY1-Been Bothered: Little Interest National Youth Tobacco Survey 2022 - During the past two weeks, how often have you been bothered by any of the following problems: Little interest or pleasure in doing things. NYTS 2022 Version - Been Bothered: Little Interest NY1-Been Bothered: Not Stop Worrying National Youth Tobacco Survey 2022 - During the past two weeks, how often have you been bothered by any of the following problems: Not being able to stop or control worrying. NYTS 2022 Version - Been Bothered: Not Stop Worrying NY1-Breathing Smoke Other People Cigs National Youth Tobacco Survey 2022 - Not including the vapor from e-cigarettes, do you think that breathing smoke from other people's cigarettes or other tobacco products causes. NYTS 2022 Version - Breathing Smoke Other People Cigs NY1-Breathing Vapor Other People E-Cigs National Youth Tobacco Survey 2022 - Do you think that breathing the vapor from other people's e-cigarettes causes. NYTS 2022 Version - Breathing Vapor Other People E-Cigs NY1-Cigars Less/Equally/More Addictive National Youth Tobacco Survey 2022 - Do you believe that cigars, cigarillos, or little cigars are (less addictive, equally addictive, or more addictive) than cigarettes? NYTS 2022 Version - Cigars Less/Equally/More Addictive NY1-Curious Using Dip National Youth Tobacco Survey 2022 - Have you ever been curious about using chewing tobacco, snuff, or dip? NYTS 2022 Version - Curious Using Dip NY1-Curious Using E-Cig National Youth Tobacco Survey 2022 - Have you ever been curious about using an e-cigarette? NYTS 2022 Version - Curious Using E-Cig NY1-Days Used E-Cig Life National Youth Tobacco Survey 2022 - In total, on how many days have you used e-cigarettes in your entire life? NYTS 2022 Version - Days Used E-Cig Life NY1-Describe Your Grades in School National Youth Tobacco Survey 2022 - During the past 12 months, how would you describe your grades in school? NYTS 2022 Version - Describe Your Grades in School NY1-Dip Less/Equally/More Addictive National Youth Tobacco Survey 2022 - Do you believe that chewing tobacco, snuff, dip, snus, or dissolvable tobacco products are (less addictive, equally addictive, or more addictive) than cigarettes? NYTS 2022 Version - Dip Less/Equally/More Addictive NY1-Do You Have Difficulty Concentrating National Youth Tobacco Survey 2022 - Because of a physical, mental, or emotional condition, do you have serious difficulty concentrating, remembering, or making decisions? NYTS 2022 Version - Do You Have Difficulty Concentrating NY1-Do you Have Your Own Bedroom National Youth Tobacco Survey 2022 - Do you have your own bedroom? NYTS 2022 Version - Do you Have Your Own Bedroom NY1-Does Your Family Own a Vehicle National Youth Tobacco Survey 2022 - Does your family own a vehicle (such as a car, van, or truck). NYTS 2022 Version - Does Your Family Own a Vehicle NY1-During Visits Advised Not Cigs National Youth Tobacco Survey 2022 - During any of these visits, were you advised to not use cigarettes? NYTS 2022 Version - During Visits Advised Not Cigs NY1-During Visits Advised Not E-Cigs National Youth Tobacco Survey 2022 - During any of these visits, were you advised to not use e-cigarettes? NYTS 2022 Version - During Visits Advised Not E-Cigs NY1-During Visits Advised Not Tobacco National Youth Tobacco Survey 2022 - During any of these visits, were you advised to not use any of these other tobacco products? NYTS 2022 Version - During Visits Advised Not Tobacco NY1-During Visits Asked E-Cigs National Youth Tobacco Survey 2022 - During any of these visits to a doctor, dentist, nurse, or other health professional, were you asked if you used e-cigarettes? NYTS 2022 Version - During Visits Asked E-Cigs NY1-During Visits Asked Other Tobacco National Youth Tobacco Survey 2022 - During any of these visits to a doctor, dentist, nurse, or other health professional, were you asked if you used any of these other tobacco products? NYTS 2022 Version - During Visits Asked Other Tobacco NY1-During Visits Asked Used Cigs National Youth Tobacco Survey 2022 - During any of these visits to a doctor, dentist, nurse, or other health professional, were you asked if you used cigarettes? NYTS 2022 Version - During Visits Asked Used Cigs NY1-E-Cig Get From Person: A Hit National Youth Tobacco Survey 2022 - During the past 30 days, which of the following e-cigarette product(s) did you get or buy from another person: A hit or drag from another person's e-cigarette device. NYTS 2022 Version - E-Cig Get From Person: A Hit NY1-E-Cig Get From Person: A Pod National Youth Tobacco Survey 2022 - During the past 30 days, which of the following e-cigarette product(s) did you get or buy from another person: A pod, cartridge, or e-liquid refill. NYTS 2022 Version - E-Cig Get From Person: A Pod NY1-E-Cig Get From Person: New E-Cig National Youth Tobacco Survey 2022 - During the past 30 days, which of the following e-cigarette product(s) did you get or buy from another person: A new e-cigarette device (including disposable devices). NYTS 2022 Version - E-Cig Get From Person: New E-Cig NY1-E-Cig Get From Person: Something National Youth Tobacco Survey 2022 - During the past 30 days, which of the following e-cigarette product(s) did you get or buy from another person: Something else. NYTS 2022 Version - E-Cig Get From Person: Something NY1-E-Cig Get From Person: Specify National Youth Tobacco Survey 2022 - During the past 30 days, which of the following e-cigarette product(s) did you get or buy from another person: Something else (specify). NYTS 2022 Version - E-Cig Get From Person: Specify NY1-E-Cigs Less/Equally/More Addictive National Youth Tobacco Survey 2022 - Do you believe that e-cigarettes are (less addictive, equally addictive, or more addictive) than cigarettes? NYTS 2022 Version - E-Cigs Less/Equally/More Addictive NY1-Ever Curious Smoking Cig National Youth Tobacco Survey 2022 - Have you ever been curious about smoking a cigarette? NYTS 2022 Version - Ever Curious Smoking Cig NY1-Ever Curious Smoking Cigar National Youth Tobacco Survey 2022 - Have you ever been curious about smoking a cigar, cigarillo, or little cigar? NYTS 2022 Version - Ever Curious Smoking Cigar NY1-Ever Curious Smoking Hookah National Youth Tobacco Survey 2022 - Have you ever been curious about smoking tobacco in a hookah or waterpipe? NYTS 2022 Version - Ever Curious Smoking Hookah NY1-Ever Purchased an E-Cig School National Youth Tobacco Survey 2022 - Have you ever purchased an e-cigarette device (including disposable devices), pod, cartridge, single hit, or e-liquid refill while at school or on school property? NYTS 2022 Version - Ever Purchased an E-Cig School NY1-Ever Smoked a Cig National Youth Tobacco Survey 2022 - Have you ever smoked a cigarette, even one or two puffs? NYTS 2022 Version - Ever Smoked a Cig NY1-Ever Smoked a Cigar National Youth Tobacco Survey 2022 - Have you ever smoked a cigar, cigarillo, or little cigar, even one or two puffs? NYTS 2022 Version - Ever Smoked a Cigar NY1-Ever Smoked Cigar With Marijuana National Youth Tobacco Survey 2022 - Have you ever smoked part or all of a cigar, cigarillo, or little cigar with marijuana in it? NYTS 2022 Version - Ever Smoked Cigar With Marijuana NY1-Ever Smoked Hookah National Youth Tobacco Survey 2022 - Have you ever smoked tobacco in a hookah or waterpipe, even one or two puffs? NYTS 2022 Version - Ever Smoked Hookah NY1-Ever Smoked Pipe Tobacco National Youth Tobacco Survey 2022 - Have you ever smoked pipes filled with tobacco (not hookah or waterpipe), even just one time? NYTS 2022 Version - Ever Smoked Pipe Tobacco NY1-Ever Smoked RYO Cigs National Youth Tobacco Survey 2022 - Have you ever smoked roll-your-own cigarettes, even just one time? NYTS 2022 Version - Ever Smoked RYO Cigs NY1-Ever Used a Pouch National Youth Tobacco Survey 2022 - Have you ever used a "nicotine pouch," even just one time? NYTS 2022 Version - Ever Used a Pouch NY1-Ever Used an E-Cig National Youth Tobacco Survey 2022 - Have you ever used an e-cigarette, even once or twice? NYTS 2022 Version - Ever Used an E-Cig NY1-Ever Used Dip National Youth Tobacco Survey 2022 - Have you ever used chewing tobacco, snuff, or dip, even just a small amount? NYTS 2022 Version - Ever Used Dip NY1-Ever Used Heated Tobacco National Youth Tobacco Survey 2022 - Have you ever used a "heated tobacco product," even just one time? NYTS 2022 Version - Ever Used Heated Tobacco NY1-Ever Used Snus National Youth Tobacco Survey 2022 - Have you ever used snus, even just one time? NYTS 2022 Version - Ever Used Snus NY1-Ever Vaped: Another Substance National Youth Tobacco Survey 2022 - Have you ever vaped any of the following substances (even once): Another substance. NYTS 2022 Version - Ever Vaped: Another Substance NY1-Ever Vaped: CBD or CBD Oils National Youth Tobacco Survey 2022 - Have you ever vaped any of the following substances (even once): CBD or CBD oils. NYTS 2022 Version - Ever Vaped: CBD or CBD Oils NY1-Ever Vaped: Marijuana National Youth Tobacco Survey 2022 - Have you ever vaped any of the following substances (even once): Marijuana (also called pot, weed, or cannabis), including THC, THC concentrates, hash oil, or waxes. NYTS 2022 Version - Ever Vaped: Marijuana NY1-Ever Vaped: Specify National Youth Tobacco Survey 2022 - Have you ever vaped any of the following substances (even once): Another substance (specify). NYTS 2022 Version - Ever Vaped: Specify NY1-Ever Vaped: Synthetic Marijuana National Youth Tobacco Survey 2022 - Have you ever vaped any of the following substances (even once): Synthetic marijuana or cannabinoids, such as K2 or Spice. NYTS 2022 Version - Ever Vaped: Synthetic Marijuana NY1-Exposed E-Cig Indoor Public Place National Youth Tobacco Survey 2022 - During the past 30 days, on how many days were you exposed to the vapor from someone who was using an e-cigarette in an indoor public place? Examples of indoor public places are school buildings, stores, restaurants, and sports arenas. NYTS 2022 Version - Exposed E-Cig Indoor Public Place NY1-Exposed E-Cig Outdoor Public Place National Youth Tobacco Survey 2022 - During the past 30 days, on how many days were you exposed to the vapor from someone who was using an e-cigarette in an outdoor public place? Examples of outdoor public places are school grounds, sidewalks, parking lots, stadiums, and parks. NYTS 2022 Version - Exposed E-Cig Outdoor Public Place NY1-Exposed Smoke Indoor Public Place National Youth Tobacco Survey 2022 - During the past 30 days, on how many days were you exposed to the smoke from someone who was smoking tobacco products in an indoor public place? Examples of indoor public places are school buildings, stores, restaurants, and sports arenas. NYTS 2022 Version - Exposed Smoke Indoor Public Place NY1-Exposed Smoke Outdoor Public Place National Youth Tobacco Survey 2022 - During the past 30 days, on how many days were you exposed to the smoke from someone who was smoking tobacco products in an outdoor public place? Examples of outdoor public places are school grounds, sidewalks, parking lots, stadiums, and parks. NYTS 2022 Version - Exposed Smoke Outdoor Public Place NY1-Flavors Bidis: Alcoholic National Youth Tobacco Survey 2022 - What flavors were the bidis that you have used in the past 30 days: Alcoholic drinks (such as wine, margarita, or other cocktails). NYTS 2022 Version - Flavors Bidis: Alcoholic NY1-Flavors Bidis: Candy National Youth Tobacco Survey 2022 - What flavors were the bidis that you have used in the past 30 days: Candy, desserts, or other sweets. NYTS 2022 Version - Flavors Bidis: Candy NY1-Flavors Bidis: Chocolate National Youth Tobacco Survey 2022 - What flavors were the bidis that you have used in the past 30 days: Chocolate. NYTS 2022 Version - Flavors Bidis: Chocolate NY1-Flavors Bidis: Clove National Youth Tobacco Survey 2022 - What flavors were the bidis that you have used in the past 30 days: Clove or spice. NYTS 2022 Version - Flavors Bidis: Clove NY1-Flavors Bidis: Fruit National Youth Tobacco Survey 2022 - What flavors were the bidis that you have used in the past 30 days: Fruit. NYTS 2022 Version - Flavors Bidis: Fruit NY1-Flavors Bidis: Menthol National Youth Tobacco Survey 2022 - What flavors were the bidis that you have used in the past 30 days: Menthol. NYTS 2022 Version - Flavors Bidis: Menthol NY1-Flavors Bidis: Mint National Youth Tobacco Survey 2022 - What flavors were the bidis that you have used in the past 30 days: Mint. NYTS 2022 Version - Flavors Bidis: Mint NY1-Flavors Bidis: Other National Youth Tobacco Survey 2022 - What flavors were the bidis that you have used in the past 30 days: Some other flavor not listed here. NYTS 2022 Version - Flavors Bidis: Other NY1-Flavors Bidis: Specify National Youth Tobacco Survey 2022 - What flavors were the bidis that you have used in the past 30 days: Some other flavor not listed here (specify). NYTS 2022 Version - Flavors Bidis: Specify NY1-Flavors Cigars: Alcoholic National Youth Tobacco Survey 2022 - What flavors were the cigars, cigarillos, or little cigars that you have used in the past 30 days: Alcoholic drinks (such as wine, margarita, or other cocktails). NYTS 2022 Version - Flavors Cigars: Alcoholic NY1-Flavors Cigars: Candy National Youth Tobacco Survey 2022 - What flavors were the cigars, cigarillos, or little cigars that you have used in the past 30 days: Candy, desserts, or other sweets. NYTS 2022 Version - Flavors Cigars: Candy NY1-Flavors Cigars: Chocolate National Youth Tobacco Survey 2022 - What flavors were the cigars, cigarillos, or little cigars that you have used in the past 30 days: Chocolate. NYTS 2022 Version - Flavors Cigars: Chocolate NY1-Flavors Cigars: Clove National Youth Tobacco Survey 2022 - What flavors were the cigars, cigarillos, or little cigars that you have used in the past 30 days: Clove or spice. NYTS 2022 Version - Flavors Cigars: Clove NY1-Flavors Cigars: Fruit National Youth Tobacco Survey 2022 - What flavors were the cigars, cigarillos, or little cigars that you have used in the past 30 days: Fruit. NYTS 2022 Version - Flavors Cigars: Fruit NY1-Flavors Cigars: Menthol National Youth Tobacco Survey 2022 - What flavors were the cigars, cigarillos, or little cigars that you have used in the past 30 days: Menthol. NYTS 2022 Version - Flavors Cigars: Menthol NY1-Flavors Cigars: Mint National Youth Tobacco Survey 2022 - What flavors were the cigars, cigarillos, or little cigars that you have used in the past 30 days: Mint. NYTS 2022 Version - Flavors Cigars: Mint NY1-Flavors Cigars: Other National Youth Tobacco Survey 2022 - What flavors were the cigars, cigarillos, or little cigars that you have used in the past 30 days: Some other flavor not listed here. NYTS 2022 Version - Flavors Cigars: Other NY1-Flavors Cigars: Specify National Youth Tobacco Survey 2022 - What flavors were the cigars, cigarillos, or little cigars that you have used in the past 30 days: Some other flavor not listed here (specify). NYTS 2022 Version - Flavors Cigars: Specify NY1-Flavors Dip: Alcoholic National Youth Tobacco Survey 2022 - What flavors was the chewing tobacco, snuff, or dip that you have used in the past 30 days: Alcoholic drinks (such as wine, margarita, or other cocktails). NYTS 2022 Version - Flavors Dip: Alcoholic NY1-Flavors Dip: Candy National Youth Tobacco Survey 2022 - What flavors was the chewing tobacco, snuff, or dip that you have used in the past 30 days: Candy, desserts, or other sweets. NYTS 2022 Version - Flavors Dip: Candy NY1-Flavors Dip: Chocolate National Youth Tobacco Survey 2022 - What flavors was the chewing tobacco, snuff, or dip that you have used in the past 30 days: Chocolate. NYTS 2022 Version - Flavors Dip: Chocolate NY1-Flavors Dip: Clove National Youth Tobacco Survey 2022 - What flavors was the chewing tobacco, snuff, or dip that you have used in the past 30 days: Clove or spice. NYTS 2022 Version - Flavors Dip: Clove NY1-Flavors Dip: Fruit National Youth Tobacco Survey 2022 - What flavors was the chewing tobacco, snuff, or dip that you have used in the past 30 days: Fruit. NYTS 2022 Version - Flavors Dip: Fruit NY1-Flavors Dip: Menthol National Youth Tobacco Survey 2022 - What flavors was the chewing tobacco, snuff, or dip that you have used in the past 30 days: Menthol. NYTS 2022 Version - Flavors Dip: Menthol NY1-Flavors Dip: Mint National Youth Tobacco Survey 2022 - What flavors was the chewing tobacco, snuff, or dip that you have used in the past 30 days: Mint. NYTS 2022 Version - Flavors Dip: Mint NY1-Flavors Dip: Other National Youth Tobacco Survey 2022 - What flavors was the chewing tobacco, snuff, or dip that you have used in the past 30 days: Some other flavor not listed here. NYTS 2022 Version - Flavors Dip: Other NY1-Flavors Dip: Specify National Youth Tobacco Survey 2022 - What flavors was the chewing tobacco, snuff, or dip that you have used in the past 30 days: Some other flavor not listed here (specify). NYTS 2022 Version - Flavors Dip: Specify NY1-Flavors Dissolv: Alcoholic National Youth Tobacco Survey 2022 - What flavors were the dissolvable tobacco products that you have used in the past 30 days: Alcoholic drinks (such as wine, margarita, or other cocktails). NYTS 2022 Version - Flavors Dissolv: Alcoholic NY1-Flavors Dissolv: Candy National Youth Tobacco Survey 2022 - What flavors were the dissolvable tobacco products that you have used in the past 30 days: Candy, desserts, or other sweets. NYTS 2022 Version - Flavors Dissolv: Candy NY1-Flavors Dissolv: Chocolate National Youth Tobacco Survey 2022 - What flavors were the dissolvable tobacco products that you have used in the past 30 days: Chocolate. NYTS 2022 Version - Flavors Dissolv: Chocolate NY1-Flavors Dissolv: Clove National Youth Tobacco Survey 2022 - What flavors were the dissolvable tobacco products that you have used in the past 30 days: Clove or spice. NYTS 2022 Version - Flavors Dissolv: Clove NY1-Flavors Dissolv: Fruit National Youth Tobacco Survey 2022 - What flavors were the dissolvable tobacco products that you have used in the past 30 days: Fruit. NYTS 2022 Version - Flavors Dissolv: Fruit NY1-Flavors Dissolv: Menthol National Youth Tobacco Survey 2022 - What flavors were the dissolvable tobacco products that you have used in the past 30 days: Menthol. NYTS 2022 Version - Flavors Dissolv: Menthol NY1-Flavors Dissolv: Mint National Youth Tobacco Survey 2022 - What flavors were the dissolvable tobacco products that you have used in the past 30 days: Mint. NYTS 2022 Version - Flavors Dissolv: Mint NY1-Flavors Dissolv: Other National Youth Tobacco Survey 2022 - What flavors were the dissolvable tobacco products that you have used in the past 30 days: Some other flavor not listed here. NYTS 2022 Version - Flavors Dissolv: Other NY1-Flavors Dissolv: Specify National Youth Tobacco Survey 2022 - What flavors were the dissolvable tobacco products that you have used in the past 30 days: Some other flavor not listed here (specify). NYTS 2022 Version - Flavors Dissolv: Specify NY1-Flavors E-Cig: Alcoholic National Youth Tobacco Survey 2022 - What flavors were the e-cigarettes that you have used in the past 30 days: Alcoholic drinks (such as wine, margarita, or other cocktails). NYTS 2022 Version - Flavors E-Cig: Alcoholic NY1-Flavors E-Cig: Candy National Youth Tobacco Survey 2022 - What flavors were the e-cigarettes that you have used in the past 30 days: Candy, desserts, or other sweets. NYTS 2022 Version - Flavors E-Cig: Candy NY1-Flavors E-Cig: Chocolate National Youth Tobacco Survey 2022 - What flavors were the e-cigarettes that you have used in the past 30 days: Chocolate. NYTS 2022 Version - Flavors E-Cig: Chocolate NY1-Flavors E-Cig: Clove National Youth Tobacco Survey 2022 - What flavors were the e-cigarettes that you have used in the past 30 days: Clove or spice. NYTS 2022 Version - Flavors E-Cig: Clove NY1-Flavors E-Cig: Fruit National Youth Tobacco Survey 2022 - What flavors were the e-cigarettes that you have used in the past 30 days: Fruit. NYTS 2022 Version - Flavors E-Cig: Fruit NY1-Flavors E-Cig: Menthol National Youth Tobacco Survey 2022 - What flavors were the e-cigarettes that you have used in the past 30 days: Menthol. NYTS 2022 Version - Flavors E-Cig: Menthol NY1-Flavors E-Cig: Mint National Youth Tobacco Survey 2022 - What flavors were the e-cigarettes that you have used in the past 30 days: Mint. NYTS 2022 Version - Flavors E-Cig: Mint NY1-Flavors E-Cig: Other National Youth Tobacco Survey 2022 - What flavors were the e-cigarettes that you have used in the past 30 days: Some other flavor not listed here. NYTS 2022 Version - Flavors E-Cig: Other NY1-Flavors E-Cig: Specify National Youth Tobacco Survey 2022 - What flavors were the e-cigarettes that you have used in the past 30 days: Some other flavor not listed here (specify). NYTS 2022 Version - Flavors E-Cig: Specify NY1-Flavors Heated Tobacco: Alcoholic National Youth Tobacco Survey 2022 - What flavors were the heated tobacco products that you have used in the past 30 days: Alcoholic drinks (such as wine, margarita, or other cocktails). NYTS 2022 Version - Flavors Heated Tobacco: Alcoholic NY1-Flavors Heated Tobacco: Candy National Youth Tobacco Survey 2022 - What flavors were the heated tobacco products that you have used in the past 30 days: Candy, desserts, or other sweets. NYTS 2022 Version - Flavors Heated Tobacco: Candy NY1-Flavors Heated Tobacco: Chocolate National Youth Tobacco Survey 2022 - What flavors were the heated tobacco products that you have used in the past 30 days: Chocolate. NYTS 2022 Version - Flavors Heated Tobacco: Chocolate NY1-Flavors Heated Tobacco: Clove National Youth Tobacco Survey 2022 - What flavors were the heated tobacco products that you have used in the past 30 days: Clove or spice. NYTS 2022 Version - Flavors Heated Tobacco: Clove NY1-Flavors Heated Tobacco: Fruit National Youth Tobacco Survey 2022 - What flavors were the heated tobacco products that you have used in the past 30 days: Fruit. NYTS 2022 Version - Flavors Heated Tobacco: Fruit NY1-Flavors Heated Tobacco: Menthol National Youth Tobacco Survey 2022 - What flavors were the heated tobacco products that you have used in the past 30 days: Menthol. NYTS 2022 Version - Flavors Heated Tobacco: Menthol NY1-Flavors Heated Tobacco: Mint National Youth Tobacco Survey 2022 - What flavors were the heated tobacco products that you have used in the past 30 days: Mint. NYTS 2022 Version - Flavors Heated Tobacco: Mint NY1-Flavors Heated Tobacco: Other National Youth Tobacco Survey 2022 - What flavors were the heated tobacco products that you have used in the past 30 days: Some other flavor not listed here. NYTS 2022 Version - Flavors Heated Tobacco: Other NY1-Flavors Heated Tobacco: Specify National Youth Tobacco Survey 2022 - What flavors were the heated tobacco products that you have used in the past 30 days: Some other flavor not listed here (specify). NYTS 2022 Version - Flavors Heated Tobacco: Specify NY1-Flavors Hookah: Alcoholic National Youth Tobacco Survey 2022 - What flavors was the tobacco in a hookah or waterpipe that you have used in the past 30 days: Alcoholic drinks (such as wine, margarita, or other cocktails). NYTS 2022 Version - Flavors Hookah: Alcoholic NY1-Flavors Hookah: Candy National Youth Tobacco Survey 2022 - What flavors was the tobacco in a hookah or waterpipe that you have used in the past 30 days: Candy, desserts, or other sweets. NYTS 2022 Version - Flavors Hookah: Candy NY1-Flavors Hookah: Chocolate National Youth Tobacco Survey 2022 - What flavors was the tobacco in a hookah or waterpipe that you have used in the past 30 days: Chocolate. NYTS 2022 Version - Flavors Hookah: Chocolate NY1-Flavors Hookah: Clove National Youth Tobacco Survey 2022 - What flavors was the tobacco in a hookah or waterpipe that you have used in the past 30 days: Clove or spice. NYTS 2022 Version - Flavors Hookah: Clove NY1-Flavors Hookah: Fruit National Youth Tobacco Survey 2022 - What flavors was the tobacco in a hookah or waterpipe that you have used in the past 30 days: Fruit. NYTS 2022 Version - Flavors Hookah: Fruit NY1-Flavors Hookah: Menthol National Youth Tobacco Survey 2022 - What flavors was the tobacco in a hookah or waterpipe that you have used in the past 30 days: Menthol. NYTS 2022 Version - Flavors Hookah: Menthol NY1-Flavors Hookah: Mint National Youth Tobacco Survey 2022 - What flavors was the tobacco in a hookah or waterpipe that you have used in the past 30 days: Mint. NYTS 2022 Version - Flavors Hookah: Mint NY1-Flavors Hookah: Other National Youth Tobacco Survey 2022 - What flavors was the tobacco in a hookah or waterpipe that you have used in the past 30 days: Some other flavor not listed here. NYTS 2022 Version - Flavors Hookah: Other NY1-Flavors Hookah: Specify National Youth Tobacco Survey 2022 - What flavors was the tobacco in a hookah or waterpipe that you have used in the past 30 days: Some other flavor not listed here (specify). NYTS 2022 Version - Flavors Hookah: Specify NY1-Flavors Pipe Tobacco: Alcoholic National Youth Tobacco Survey 2022 - What flavors were the pipes filled with tobacco that you have used in the past 30 days: Alcoholic drinks (such as wine, margarita, or other cocktails). NYTS 2022 Version - Flavors Pipe Tobacco: Alcoholic NY1-Flavors Pipe Tobacco: Candy National Youth Tobacco Survey 2022 - What flavors were the pipes filled with tobacco that you have used in the past 30 days: Candy, desserts, or other sweets. NYTS 2022 Version - Flavors Pipe Tobacco: Candy NY1-Flavors Pipe Tobacco: Chocolate National Youth Tobacco Survey 2022 - What flavors were the pipes filled with tobacco that you have used in the past 30 days: Chocolate. NYTS 2022 Version - Flavors Pipe Tobacco: Chocolate NY1-Flavors Pipe Tobacco: Clove National Youth Tobacco Survey 2022 - What flavors were the pipes filled with tobacco that you have used in the past 30 days: Clove or spice. NYTS 2022 Version - Flavors Pipe Tobacco: Clove NY1-Flavors Pipe Tobacco: Fruit National Youth Tobacco Survey 2022 - What flavors were the pipes filled with tobacco that you have used in the past 30 days: Fruit. NYTS 2022 Version - Flavors Pipe Tobacco: Fruit NY1-Flavors Pipe Tobacco: Menthol National Youth Tobacco Survey 2022 - What flavors were the pipes filled with tobacco that you have used in the past 30 days: Menthol. NYTS 2022 Version - Flavors Pipe Tobacco: Menthol NY1-Flavors Pipe Tobacco: Mint National Youth Tobacco Survey 2022 - What flavors were the pipes filled with tobacco that you have used in the past 30 days: Mint. NYTS 2022 Version - Flavors Pipe Tobacco: Mint NY1-Flavors Pipe Tobacco: Other National Youth Tobacco Survey 2022 - What flavors were the pipes filled with tobacco that you have used in the past 30 days: Some other flavor not listed here. NYTS 2022 Version - Flavors Pipe Tobacco: Other NY1-Flavors Pipe Tobacco: Specify National Youth Tobacco Survey 2022 - What flavors were the pipes filled with tobacco that you have used in the past 30 days: Some other flavor not listed here (specify). NYTS 2022 Version - Flavors Pipe Tobacco: Specify NY1-Flavors Pouches: Alcoholic National Youth Tobacco Survey 2022 - What flavors were the nicotine pouches that you have used in the past 30 days: Alcoholic drinks (such as wine, margarita, or other cocktails). NYTS 2022 Version - Flavors Pouches: Alcoholic NY1-Flavors Pouches: Candy National Youth Tobacco Survey 2022 - What flavors were the nicotine pouches that you have used in the past 30 days: Candy, desserts, or other sweets. NYTS 2022 Version - Flavors Pouches: Candy NY1-Flavors Pouches: Chocolate National Youth Tobacco Survey 2022 - What flavors were the nicotine pouches that you have used in the past 30 days: Chocolate. NYTS 2022 Version - Flavors Pouches: Chocolate NY1-Flavors Pouches: Clove National Youth Tobacco Survey 2022 - What flavors were the nicotine pouches that you have used in the past 30 days: Clove or spice. NYTS 2022 Version - Flavors Pouches: Clove NY1-Flavors Pouches: Fruit National Youth Tobacco Survey 2022 - What flavors were the nicotine pouches that you have used in the past 30 days: Fruit. NYTS 2022 Version - Flavors Pouches: Fruit NY1-Flavors Pouches: Menthol National Youth Tobacco Survey 2022 - What flavors were the nicotine pouches that you have used in the past 30 days: Menthol. NYTS 2022 Version - Flavors Pouches: Menthol NY1-Flavors Pouches: Mint National Youth Tobacco Survey 2022 - What flavors were the nicotine pouches that you have used in the past 30 days: Mint. NYTS 2022 Version - Flavors Pouches: Mint NY1-Flavors Pouches: Other National Youth Tobacco Survey 2022 - What flavors were the nicotine pouches that you have used in the past 30 days: Some other flavor not listed here. NYTS 2022 Version - Flavors Pouches: Other NY1-Flavors Pouches: Specify National Youth Tobacco Survey 2022 - What flavors were the nicotine pouches that you have used in the past 30 days: Some other flavor not listed here (specify). NYTS 2022 Version - Flavors Pouches: Specify NY1-Flavors RYO Cigs: Alcoholic National Youth Tobacco Survey 2022 - What flavors were the roll-your-own cigarettes that you have used in the past 30 days: Alcoholic drinks (such as wine, margarita, or other cocktails). NYTS 2022 Version - Flavors RYO Cigs: Alcoholic NY1-Flavors RYO Cigs: Candy National Youth Tobacco Survey 2022 - What flavors were the roll-your-own cigarettes that you have used in the past 30 days: Candy, desserts, or other sweets. NYTS 2022 Version - Flavors RYO Cigs: Candy NY1-Flavors RYO Cigs: Chocolate National Youth Tobacco Survey 2022 - What flavors were the roll-your-own cigarettes that you have used in the past 30 days: Chocolate. NYTS 2022 Version - Flavors RYO Cigs: Chocolate NY1-Flavors RYO Cigs: Clove National Youth Tobacco Survey 2022 - What flavors were the roll-your-own cigarettes that you have used in the past 30 days: Clove or spice. NYTS 2022 Version - Flavors RYO Cigs: Clove NY1-Flavors RYO Cigs: Fruit National Youth Tobacco Survey 2022 - What flavors were the roll-your-own cigarettes that you have used in the past 30 days: Fruit. NYTS 2022 Version - Flavors RYO Cigs: Fruit NY1-Flavors RYO Cigs: Menthol National Youth Tobacco Survey 2022 - What flavors were the roll-your-own cigarettes that you have used in the past 30 days: Menthol. NYTS 2022 Version - Flavors RYO Cigs: Menthol NY1-Flavors RYO Cigs: Mint National Youth Tobacco Survey 2022 - What flavors were the roll-your-own cigarettes that you have used in the past 30 days: Mint. NYTS 2022 Version - Flavors RYO Cigs: Mint NY1-Flavors RYO Cigs: Other National Youth Tobacco Survey 2022 - What flavors were the roll-your-own cigarettes that you have used in the past 30 days: Some other flavor not listed here. NYTS 2022 Version - Flavors RYO Cigs: Other NY1-Flavors RYO Cigs: Specify National Youth Tobacco Survey 2022 - What flavors were the roll-your-own cigarettes that you have used in the past 30 days: Some other flavor not listed here (specify). NYTS 2022 Version - Flavors RYO Cigs: Specify NY1-Flavors Snus: Alcoholic National Youth Tobacco Survey 2022 - What flavors was the snus that you have used in the past 30 days: Alcoholic drinks (such as wine, margarita, or other cocktails). NYTS 2022 Version - Flavors Snus: Alcoholic NY1-Flavors Snus: Candy National Youth Tobacco Survey 2022 - What flavors was the snus that you have used in the past 30 days: Candy, desserts, or other sweets. NYTS 2022 Version - Flavors Snus: Candy NY1-Flavors Snus: Chocolate National Youth Tobacco Survey 2022 - What flavors was the snus that you have used in the past 30 days: Chocolate. NYTS 2022 Version - Flavors Snus: Chocolate NY1-Flavors Snus: Clove National Youth Tobacco Survey 2022 - What flavors was the snus that you have used in the past 30 days: Clove or spice. NYTS 2022 Version - Flavors Snus: Clove NY1-Flavors Snus: Fruit National Youth Tobacco Survey 2022 - What flavors was the snus that you have used in the past 30 days: Fruit. NYTS 2022 Version - Flavors Snus: Fruit NY1-Flavors Snus: Menthol National Youth Tobacco Survey 2022 - What flavors was the snus that you have used in the past 30 days: Menthol. NYTS 2022 Version - Flavors Snus: Menthol NY1-Flavors Snus: Mint National Youth Tobacco Survey 2022 - What flavors was the snus that you have used in the past 30 days: Mint. NYTS 2022 Version - Flavors Snus: Mint NY1-Flavors Snus: Other National Youth Tobacco Survey 2022 - What flavors was the snus that you have used in the past 30 days: Some other flavor not listed here. NYTS 2022 Version - Flavors Snus: Other NY1-Flavors Snus: Specify National Youth Tobacco Survey 2022 - What flavors was the snus that you have used in the past 30 days: Some other flavor not listed here (specify). NYTS 2022 Version - Flavors Snus: Specify NY1-Got Cig How Old Was This Person National Youth Tobacco Survey 2022 - Earlier you mentioned that you got or bought your cigarettes from another person, such as a friend or family member during the past 30 days. How old was this person? NYTS 2022 Version - Got Cig How Old Was This Person NY1-Got Cigar How Old Was This Person National Youth Tobacco Survey 2022 - Earlier you mentioned that you got or bought your cigars, cigarillos, or little cigars from another person, such as a friend or family member during the past 30 days. How old was this person? NYTS 2022 Version - Got Cigar How Old Was This Person NY1-Got Dip How Old Was This Person National Youth Tobacco Survey 2022 - Earlier you mentioned that you got or bought your chewing tobacco, snuff, or dip from another person, such as a friend or family member. How old was this person? NYTS 2022 Version - Got Dip How Old Was This Person NY1-Got E-Cig How Old Was This Person National Youth Tobacco Survey 2022 - Earlier you answered that you got or bought your e-cigarette devices, pods, cartridges, or e-liquid refills from another person, such as a friend or family member during the past 30 days. How old was this person? NYTS 2022 Version - Got E-Cig How Old Was This Person NY1-Got Hookah How Old Was This Person National Youth Tobacco Survey 2022 - Earlier you mentioned that you got or bought your hookah tobacco from another person, such as a friend or family member. How old was this person? NYTS 2022 Version - Got Hookah How Old Was This Person NY1-Had Strong Craving to Use Tobacco National Youth Tobacco Survey 2022 - During the past 30 days, have you had a strong craving or felt like you really needed to use a tobacco product of any kind? NYTS 2022 Version - Had Strong Craving to Use Tobacco NY1-Have You Heard of Heated Tobacco National Youth Tobacco Survey 2022 - Before today, have you heard of "heated tobacco products"? NYTS 2022 Version - Have You Heard of Heated Tobacco NY1-Have You Heard of Pouches National Youth Tobacco Survey 2022 - Before today, have you heard of "nicotine pouches"? NYTS 2022 Version - Have You Heard of Pouches NY1-Have You Seen The Real Cost Ads National Youth Tobacco Survey 2022 - In the past 12 months, have you seen or heard The Real Cost, on television, the internet, social media, or radio as part of ads about tobacco? NYTS 2022 Version - Have You Seen The Real Cost Ads NY1-Hispanic: No National Youth Tobacco Survey 2022 - Are you Hispanic, Latino, Latina, or of Spanish origin: No, not of Hispanic, Latino, Latina, or Spanish origin. NYTS 2022 Version - Hispanic: No NY1-Hispanic: Yes Another Hispanic National Youth Tobacco Survey 2022 - Are you Hispanic, Latino, Latina, or of Spanish origin: Yes, Another Hispanic, Latino, Latina, or Spanish origin. NYTS 2022 Version - Hispanic: Yes Another Hispanic NY1-Hispanic: Yes Cuban National Youth Tobacco Survey 2022 - Are you Hispanic, Latino, Latina, or of Spanish origin: Yes, Cuban. NYTS 2022 Version - Hispanic: Yes Cuban NY1-Hispanic: Yes Mexican National Youth Tobacco Survey 2022 - Are you Hispanic, Latino, Latina, or of Spanish origin: Yes, Mexican, Mexican American, Chicano, or Chicana. NYTS 2022 Version - Hispanic: Yes Mexican NY1-Hispanic: Yes Puerto Rican National Youth Tobacco Survey 2022 - Are you Hispanic, Latino, Latina, or of Spanish origin: Yes, Puerto Rican. NYTS 2022 Version - Hispanic: Yes Puerto Rican NY1-Hookah Less/Equally/More Addictive National Youth Tobacco Survey 2022 - Do you believe that smoking tobacco in a hookah or waterpipe is (less addictive, equally addictive, or more addictive) than cigarettes? NYTS 2022 Version - Hookah Less/Equally/More Addictive NY1-How Easy Buy Tobacco Online B/c Age National Youth Tobacco Survey 2022 - How easy do you think it is for people your age to buy tobacco products online? NYTS 2022 Version - How Easy Buy Tobacco Online B/c Age NY1-How Easy Buy Tobacco Store B/c Age National Youth Tobacco Survey 2022 - How easy do you think it is for people your age to buy tobacco products in a store? NYTS 2022 Version - How Easy Buy Tobacco Store B/c Age NY1-How Get Bidis: Asked National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your bidis: I asked someone to give me some. NYTS 2022 Version - How Get Bidis: Asked NY1-How Get Bidis: From Family National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your bidis: I got them from a family member. NYTS 2022 Version - How Get Bidis: From Family NY1-How Get Bidis: From Friend National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your bidis: I got them from a friend. NYTS 2022 Version - How Get Bidis: From Friend NY1-How Get Bidis: Myself National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your bidis: I bought them myself. NYTS 2022 Version - How Get Bidis: Myself NY1-How Get Bidis: Offered National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your bidis: Someone offered them to me. NYTS 2022 Version - How Get Bidis: Offered NY1-How Get Bidis: Other National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your bidis: I got them in some other way. NYTS 2022 Version - How Get Bidis: Other NY1-How Get Bidis: Someone Buy National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your bidis: I had someone else buy them for me. NYTS 2022 Version - How Get Bidis: Someone Buy NY1-How Get Bidis: Specify National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your bidis: I got them in some other way (specify). NYTS 2022 Version - How Get Bidis: Specify NY1-How Get Bidis: Took Store National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your bidis: I took them from a store or another person. NYTS 2022 Version - How Get Bidis: Took Store NY1-How Get Cig: Asked National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigarettes: I asked someone to give me some. NYTS 2022 Version - How Get Cig: Asked NY1-How Get Cig: From Family National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigarettes: I got them from a family member. NYTS 2022 Version - How Get Cig: From Family NY1-How Get Cig: From Friend National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigarettes: I got them from a friend. NYTS 2022 Version - How Get Cig: From Friend NY1-How Get Cig: Myself National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigarettes: I bought them myself. NYTS 2022 Version - How Get Cig: Myself NY1-How Get Cig: Offered National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigarettes: Someone offered them to me. NYTS 2022 Version - How Get Cig: Offered NY1-How Get Cig: Other National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigarettes: I got them in some other way. NYTS 2022 Version - How Get Cig: Other NY1-How Get Cig: Someone Buy National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigarettes: I had someone else buy them for me. NYTS 2022 Version - How Get Cig: Someone Buy NY1-How Get Cig: Specify National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigarettes: I got them in some other way (specify). NYTS 2022 Version - How Get Cig: Specify NY1-How Get Cig: Took Store National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigarettes: I took them from a store or another person. NYTS 2022 Version - How Get Cig: Took Store NY1-How Get Cigars: Asked National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigars, cigarillos, or little cigars: I asked someone to give me some. NYTS 2022 Version - How Get Cigars: Asked NY1-How Get Cigars: From Family National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigars, cigarillos, or little cigars: I got them from a family member. NYTS 2022 Version - How Get Cigars: From Family NY1-How Get Cigars: From Friend National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigars, cigarillos, or little cigars: I got them from a friend. NYTS 2022 Version - How Get Cigars: From Friend NY1-How Get Cigars: Myself National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigars, cigarillos, or little cigars: I bought them myself. NYTS 2022 Version - How Get Cigars: Myself NY1-How Get Cigars: Offered National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigars, cigarillos, or little cigars: Someone offered them to me. NYTS 2022 Version - How Get Cigars: Offered NY1-How Get Cigars: Other National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigars, cigarillos, or little cigars: I got them in some other way. NYTS 2022 Version - How Get Cigars: Other NY1-How Get Cigars: Someone Buy National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigars, cigarillos, or little cigars: I had someone else buy them for me. NYTS 2022 Version - How Get Cigars: Someone Buy NY1-How Get Cigars: Specify National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigars, cigarillos, or little cigars: I got them in some other way (specify). NYTS 2022 Version - How Get Cigars: Specify NY1-How Get Cigars: Took Store National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your cigars, cigarillos, or little cigars: I took them from a store or another person. NYTS 2022 Version - How Get Cigars: Took Store NY1-How Get Dip: Asked National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your chewing tobacco, snuff, or dip: I asked someone to give me some. NYTS 2022 Version - How Get Dip: Asked NY1-How Get Dip: From Family National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your chewing tobacco, snuff, or dip: I got it from a family member. NYTS 2022 Version - How Get Dip: From Family NY1-How Get Dip: From Friend National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your chewing tobacco, snuff, or dip: I got it from a friend. NYTS 2022 Version - How Get Dip: From Friend NY1-How Get Dip: Myself National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your chewing tobacco, snuff, or dip: I bought it myself. NYTS 2022 Version - How Get Dip: Myself NY1-How Get Dip: Offered National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your chewing tobacco, snuff, or dip: Someone offered it to me. NYTS 2022 Version - How Get Dip: Offered NY1-How Get Dip: Other National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your chewing tobacco, snuff, or dip: I got it in some other way. NYTS 2022 Version - How Get Dip: Other NY1-How Get Dip: Someone Buy National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your chewing tobacco, snuff, or dip: I had someone else buy it for me. NYTS 2022 Version - How Get Dip: Someone Buy NY1-How Get Dip: Specify National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your chewing tobacco, snuff, or dip: I got it in some other way (specify). NYTS 2022 Version - How Get Dip: Specify NY1-How Get Dip: Took Store National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your chewing tobacco, snuff, or dip: I took it from a store or another person. NYTS 2022 Version - How Get Dip: Took Store NY1-How Get Dissolv: Asked National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your dissolvable tobacco products: I asked someone to give me some. NYTS 2022 Version - How Get Dissolv: Asked NY1-How Get Dissolv: From Family National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your dissolvable tobacco products: I got them from a family member. NYTS 2022 Version - How Get Dissolv: From Family NY1-How Get Dissolv: From Friend National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your dissolvable tobacco products: I got them from a friend. NYTS 2022 Version - How Get Dissolv: From Friend NY1-How Get Dissolv: Myself National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your dissolvable tobacco products: I bought them myself. NYTS 2022 Version - How Get Dissolv: Myself NY1-How Get Dissolv: Offered National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your dissolvable tobacco products: Someone offered them to me. NYTS 2022 Version - How Get Dissolv: Offered NY1-How Get Dissolv: Other National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your dissolvable tobacco products: I got them in some other way. NYTS 2022 Version - How Get Dissolv: Other NY1-How Get Dissolv: Someone Buy National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your dissolvable tobacco products: I had someone else buy them for me. NYTS 2022 Version - How Get Dissolv: Someone Buy NY1-How Get Dissolv: Specify National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your dissolvable tobacco products: I got them in some other way (specify). NYTS 2022 Version - How Get Dissolv: Specify NY1-How Get Dissolv: Took Store National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your dissolvable tobacco products: I took them from a store or another person. NYTS 2022 Version - How Get Dissolv: Took Store NY1-How Get E-Cig: Asked National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your e-cigarette devices, pods, cartridges, or e-liquid refills: I asked someone to give me some. NYTS 2022 Version - How Get E-Cig: Asked NY1-How Get E-Cig: From Family National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your e-cigarette devices, pods, cartridges, or e-liquid refills: I got them from a family member. NYTS 2022 Version - How Get E-Cig: From Family NY1-How Get E-Cig: From Friend National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your e-cigarette devices, pods, cartridges, or e-liquid refills: I got them from a friend. NYTS 2022 Version - How Get E-Cig: From Friend NY1-How Get E-Cig: Myself National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your e-cigarette devices, pods, cartridges, or e-liquid refills: I bought them myself. NYTS 2022 Version - How Get E-Cig: Myself NY1-How Get E-Cig: Offered National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your e-cigarette devices, pods, cartridges, or e-liquid refills: Someone offered them to me. NYTS 2022 Version - How Get E-Cig: Offered NY1-How Get E-Cig: Other National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your e-cigarette devices, pods, cartridges, or e-liquid refills: I got them in some other way. NYTS 2022 Version - How Get E-Cig: Other NY1-How Get E-Cig: Someone Buy National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your e-cigarette devices, pods, cartridges, or e-liquid refills: I had someone else buy them for me. NYTS 2022 Version - How Get E-Cig: Someone Buy NY1-How Get E-Cig: Specify National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your e-cigarette devices, pods, cartridges, or e-liquid refills: I got them in some other way (specify). NYTS 2022 Version - How Get E-Cig: Specify NY1-How Get E-Cig: Took Store National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your e-cigarette devices, pods, cartridges, or e-liquid refills: I took them from a store or another person. NYTS 2022 Version - How Get E-Cig: Took Store NY1-How Get Heated Tobacco: Asked National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your heated tobacco products: I asked someone to give me some. NYTS 2022 Version - How Get Heated Tobacco: Asked NY1-How Get Heated Tobacco: From Family National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your heated tobacco products: I got them from a family member. NYTS 2022 Version - How Get Heated Tobacco: From Family NY1-How Get Heated Tobacco: From Friend National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your heated tobacco products: I got them from a friend. NYTS 2022 Version - How Get Heated Tobacco: From Friend NY1-How Get Heated Tobacco: Myself National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your heated tobacco products: I bought them myself. NYTS 2022 Version - How Get Heated Tobacco: Myself NY1-How Get Heated Tobacco: Offered National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your heated tobacco products: Someone offered them to me. NYTS 2022 Version - How Get Heated Tobacco: Offered NY1-How Get Heated Tobacco: Other National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your heated tobacco products: I got them in some other way. NYTS 2022 Version - How Get Heated Tobacco: Other NY1-How Get Heated Tobacco: Someone Buy National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your heated tobacco products: I had someone else buy them for me. NYTS 2022 Version - How Get Heated Tobacco: Someone Buy NY1-How Get Heated Tobacco: Specify National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your heated tobacco products: I got them in some other way (specify). NYTS 2022 Version - How Get Heated Tobacco: Specify NY1-How Get Heated Tobacco: Took Store National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your heated tobacco products: I took them from a store or another person. NYTS 2022 Version - How Get Heated Tobacco: Took Store NY1-How Get Hookah: Asked National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your hookah tobacco: I asked someone to give me some. NYTS 2022 Version - How Get Hookah: Asked NY1-How Get Hookah: From Family National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your hookah tobacco: I got it from a family member. NYTS 2022 Version - How Get Hookah: From Family NY1-How Get Hookah: From Friend National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your hookah tobacco: I got it from a friend. NYTS 2022 Version - How Get Hookah: From Friend NY1-How Get Hookah: Myself National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your hookah tobacco: I bought it myself. NYTS 2022 Version - How Get Hookah: Myself NY1-How Get Hookah: Offered National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your hookah tobacco: Someone offered it to me. NYTS 2022 Version - How Get Hookah: Offered NY1-How Get Hookah: Other National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your hookah tobacco: I got it in some other way. NYTS 2022 Version - How Get Hookah: Other NY1-How Get Hookah: Someone Buy National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your hookah tobacco: I had someone else buy it for me. NYTS 2022 Version - How Get Hookah: Someone Buy NY1-How Get Hookah: Specify National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your hookah tobacco: I got it in some other way (specify). NYTS 2022 Version - How Get Hookah: Specify NY1-How Get Hookah: Took Store National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your hookah tobacco: I took it from a store or another person. NYTS 2022 Version - How Get Hookah: Took Store NY1-How Get Pipe Tobacco: Asked National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your pipe tobacco: I asked someone to give me some. NYTS 2022 Version - How Get Pipe Tobacco: Asked NY1-How Get Pipe Tobacco: From Family National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your pipe tobacco: I got it from a family member. NYTS 2022 Version - How Get Pipe Tobacco: From Family NY1-How Get Pipe Tobacco: From Friend National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your pipe tobacco: I got it from a friend. NYTS 2022 Version - How Get Pipe Tobacco: From Friend NY1-How Get Pipe Tobacco: Myself National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your pipe tobacco: I bought it myself. NYTS 2022 Version - How Get Pipe Tobacco: Myself NY1-How Get Pipe Tobacco: Offered National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your pipe tobacco: Someone offered it to me. NYTS 2022 Version - How Get Pipe Tobacco: Offered NY1-How Get Pipe Tobacco: Other National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your pipe tobacco: I got it in some other way. NYTS 2022 Version - How Get Pipe Tobacco: Other NY1-How Get Pipe Tobacco: Someone Buy National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your pipe tobacco: I had someone else buy it for me. NYTS 2022 Version - How Get Pipe Tobacco: Someone Buy NY1-How Get Pipe Tobacco: Specify National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your pipe tobacco: I got it in some other way (specify). NYTS 2022 Version - How Get Pipe Tobacco: Specify NY1-How Get Pipe Tobacco: Took Store National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your pipe tobacco: I took it from a store or another person. NYTS 2022 Version - How Get Pipe Tobacco: Took Store NY1-How Get Pouches: Asked National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your nicotine pouches: I asked someone to give me some. NYTS 2022 Version - How Get Pouches: Asked NY1-How Get Pouches: From Family National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your nicotine pouches: I got them from a family member. NYTS 2022 Version - How Get Pouches: From Family NY1-How Get Pouches: From Friend National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your nicotine pouches: I got them from a friend. NYTS 2022 Version - How Get Pouches: From Friend NY1-How Get Pouches: Myself National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your nicotine pouches: I bought them myself. NYTS 2022 Version - How Get Pouches: Myself NY1-How Get Pouches: Offered National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your nicotine pouches: Someone offered them to me. NYTS 2022 Version - How Get Pouches: Offered NY1-How Get Pouches: Other National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your nicotine pouches: I got them in some other way. NYTS 2022 Version - How Get Pouches: Other NY1-How Get Pouches: Someone Buy National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your nicotine pouches: I had someone else buy them for me. NYTS 2022 Version - How Get Pouches: Someone Buy NY1-How Get Pouches: Specify National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your nicotine pouches: I got them in some other way (specify). NYTS 2022 Version - How Get Pouches: Specify NY1-How Get Pouches: Took Store National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your nicotine pouches: I took them from a store or another person. NYTS 2022 Version - How Get Pouches: Took Store NY1-How Get RYO Cigs: Asked National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your roll-your-own cigarettes: I asked someone to give me some. NYTS 2022 Version - How Get RYO Cigs: Asked NY1-How Get RYO Cigs: From Family National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your roll-your-own cigarettes: I got them from a family member. NYTS 2022 Version - How Get RYO Cigs: From Family NY1-How Get RYO Cigs: From Friend National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your roll-your-own cigarettes: I got them from a friend. NYTS 2022 Version - How Get RYO Cigs: From Friend NY1-How Get RYO Cigs: Myself National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your roll-your-own cigarettes: I bought them myself. NYTS 2022 Version - How Get RYO Cigs: Myself NY1-How Get RYO Cigs: Offered National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your roll-your-own cigarettes: Someone offered them to me. NYTS 2022 Version - How Get RYO Cigs: Offered NY1-How Get RYO Cigs: Other National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your roll-your-own cigarettes: I got them in some other way. NYTS 2022 Version - How Get RYO Cigs: Other NY1-How Get RYO Cigs: Someone Buy National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your roll-your-own cigarettes: I had someone else buy them for me. NYTS 2022 Version - How Get RYO Cigs: Someone Buy NY1-How Get RYO Cigs: Specify National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your roll-your-own cigarettes: I got them in some other way (specify). NYTS 2022 Version - How Get RYO Cigs: Specify NY1-How Get RYO Cigs: Took Store National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your roll-your-own cigarettes: I took them from a store or another person. NYTS 2022 Version - How Get RYO Cigs: Took Store NY1-How Get Snus: Asked National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your snus: I asked someone to give me some. NYTS 2022 Version - How Get Snus: Asked NY1-How Get Snus: From Family National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your snus: I got it from a family member. NYTS 2022 Version - How Get Snus: From Family NY1-How Get Snus: From Friend National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your snus: I got it from a friend. NYTS 2022 Version - How Get Snus: From Friend NY1-How Get Snus: Myself National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your snus: I bought it myself. NYTS 2022 Version - How Get Snus: Myself NY1-How Get Snus: Offered National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your snus: Someone offered it to me. NYTS 2022 Version - How Get Snus: Offered NY1-How Get Snus: Other National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your snus: I got it in some other way. NYTS 2022 Version - How Get Snus: Other NY1-How Get Snus: Someone Buy National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your snus: I had someone else buy it for me. NYTS 2022 Version - How Get Snus: Someone Buy NY1-How Get Snus: Specify National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your snus: I got it in some other way (specify). NYTS 2022 Version - How Get Snus: Specify NY1-How Get Snus: Took Store National Youth Tobacco Survey 2022 - During the past 30 days, how did you get your snus: I took it from a store or another person. NYTS 2022 Version - How Get Snus: Took Store NY1-How Many Cigs Entire Life National Youth Tobacco Survey 2022 - About how many cigarettes have you smoked in your entire life? NYTS 2022 Version - How Many Cigs Entire Life NY1-How Many Computers Family Own National Youth Tobacco Survey 2022 - How many computers (including laptops and tablets, not including game consoles and smartphones) does your family own? NYTS 2022 Version - How Many Computers Family Own NY1-How Many Days Smoke Bidis National Youth Tobacco Survey 2022 - During the past 30 days, on how many days did you smoke bidis? NYTS 2022 Version - How Many Days Smoke Bidis NY1-How Many Days Smoke Cigars National Youth Tobacco Survey 2022 - During the past 30 days, on how many days did you smoke cigars, cigarillos, or little cigars? NYTS 2022 Version - How Many Days Smoke Cigars NY1-How Many Days Smoke Cigs National Youth Tobacco Survey 2022 - During the past 30 days, on how many days did you smoke cigarettes? NYTS 2022 Version - How Many Days Smoke Cigs NY1-How Many Days Smoke Hookah National Youth Tobacco Survey 2022 - During the past 30 days, on how many days did you smoke tobacco in a hookah or waterpipe? NYTS 2022 Version - How Many Days Smoke Hookah NY1-How Many Days Smoke Pipe Tobacco National Youth Tobacco Survey 2022 - During the past 30 days, on how many days did you smoke pipes filled with tobacco? NYTS 2022 Version - How Many Days Smoke Pipe Tobacco NY1-How Many Days Smoke RYO Cigs National Youth Tobacco Survey 2022 - During the past 30 days, on how many days did you smoke roll-your-own cigarettes? NYTS 2022 Version - How Many Days Smoke RYO Cigs NY1-How Many Days Use Any Tobacco National Youth Tobacco Survey 2022 - During the past 30 days, on how many days did you use any tobacco product(s)? NYTS 2022 Version - How Many Days Use Any Tobacco NY1-How Many Days Use Dip National Youth Tobacco Survey 2022 - During the past 30 days, on how many days did you use chewing tobacco, snuff, or dip? NYTS 2022 Version - How Many Days Use Dip NY1-How Many Days Use Dissolv Tobacco National Youth Tobacco Survey 2022 - During the past 30 days, on how many days did you use dissolvable tobacco products? NYTS 2022 Version - How Many Days Use Dissolv Tobacco NY1-How Many Days Use Heated Tobacco National Youth Tobacco Survey 2022 - During the past 30 days, on how many days did you use a "heated tobacco product"? NYTS 2022 Version - How Many Days Use Heated Tobacco NY1-How Many Days Use Pouch National Youth Tobacco Survey 2022 - During the past 30 days, on how many days did you use a "nicotine pouch"? NYTS 2022 Version - How Many Days Use Pouch NY1-How Many Days Use Snus National Youth Tobacco Survey 2022 - During the past 30 days, on how many days did you use snus? NYTS 2022 Version - How Many Days Use Snus NY1-How Many Times Travel With Family National Youth Tobacco Survey 2022 - During the past 12 months, how many times did you travel on vacation with your family? NYTS 2022 Version - How Many Times Travel With Family NY1-How Many You Think Smoke Cigs National Youth Tobacco Survey 2022 - Out of every 10 students in your grade at school, how many do you think smoke cigarettes? NYTS 2022 Version - How Many You Think Smoke Cigs NY1-How Many You Think Use E-Cigs National Youth Tobacco Survey 2022 - Out of every 10 students in your grade at school, how many do you think use e-cigarettes? NYTS 2022 Version - How Many You Think Use E-Cigs NY1-How Often Do You Use Social Media National Youth Tobacco Survey 2022 - How often do you use social media? NYTS 2022 Version - How Often Do You Use Social Media NY1-How Often Use Someone E-Cig National Youth Tobacco Survey 2022 - During the past 30 days, how often did you use someone else's e-cigarette device? NYTS 2022 Version - How Often Use Someone E-Cig NY1-How Often Warning Label Cig National Youth Tobacco Survey 2022 - During the past 30 days, how often did you see a warning label on a cigarette package? NYTS 2022 Version - How Often Warning Label Cig NY1-How Often Warning Label Cigar National Youth Tobacco Survey 2022 - During the past 30 days, how often did you see a warning label on a cigar, cigarillo, or little cigar package? NYTS 2022 Version - How Often Warning Label Cigar NY1-How Often Warning Label Dip National Youth Tobacco Survey 2022 - During the past 30 days, how often did you see a warning label on a package of chewing tobacco, snuff, or dip? NYTS 2022 Version - How Often Warning Label Dip NY1-How Often Warning Label E-Cig National Youth Tobacco Survey 2022 - During the past 30 days, how often did you see a warning label on an e-cigarette package? NYTS 2022 Version - How Often Warning Label E-Cig NY1-How Often Warning Label Hookah National Youth Tobacco Survey 2022 - During the past 30 days, how often did you see a warning label on a package of hookah tobacco? NYTS 2022 Version - How Often Warning Label Hookah NY1-How Old Are You National Youth Tobacco Survey 2022 - How old are you? NYTS 2022 Version - How Old Are You NY1-How Old When First Smoked Cig National Youth Tobacco Survey 2022 - How old were you when you first smoked a cigarette, even one or two puffs? NYTS 2022 Version - How Old When First Smoked Cig NY1-How Old When First Smoked Cigar National Youth Tobacco Survey 2022 - How old were you when you first smoked a cigar, cigarillo, or little cigar, even one or two puffs? NYTS 2022 Version - How Old When First Smoked Cigar NY1-How Old When First Smoked Hookah National Youth Tobacco Survey 2022 - How old were you when you first smoked tobacco in a hookah or waterpipe, even one or two puffs? NYTS 2022 Version - How Old When First Smoked Hookah NY1-How Old When First Used Dip National Youth Tobacco Survey 2022 - How old were you when you first used chewing tobacco, snuff, or dip, even just a small amount? NYTS 2022 Version - How Old When First Used Dip NY1-How Old When First Used E-Cig National Youth Tobacco Survey 2022 - How old were you when you first used an e-cigarette, even once or twice? NYTS 2022 Version - How Old When First Used E-Cig NY1-How Soon Wake Up Want to Use Tobacco National Youth Tobacco Survey 2022 - How soon after you wake up do you want to use a tobacco product of any kind? NYTS 2022 Version - How Soon Wake Up Want to Use Tobacco NY1-If Best Friends Offer Cig Smoke National Youth Tobacco Survey 2022 - If one of your best friends were to offer you a cigarette, would you smoke it? NYTS 2022 Version - If Best Friends Offer Cig Smoke NY1-If Best Friends Offer Cigar Smoke National Youth Tobacco Survey 2022 - If one of your best friends were to offer you a cigar, cigarillo, or little cigar, would you smoke it? NYTS 2022 Version - If Best Friends Offer Cigar Smoke NY1-If Best Friends Offer E-Cig Use National Youth Tobacco Survey 2022 - If one of your best friends were to offer you an e-cigarette, would you use it? NYTS 2022 Version - If Best Friends Offer E-Cig Use NY1-Internet How Often Ads E-Cigs National Youth Tobacco Survey 2022 - When you are using the Internet, how often do you see ads or promotions for e-cigarettes? NYTS 2022 Version - Internet How Often Ads E-Cigs NY1-Internet How Often See Ads Cigs National Youth Tobacco Survey 2022 - When you are using the Internet, how often do you see ads or promotions for cigarettes or other tobacco products? NYTS 2022 Version - Internet How Often See Ads Cigs NY1-Last Time Smoked Cig National Youth Tobacco Survey 2022 - When was the last time you smoked a cigarette, even one or two puffs? NYTS 2022 Version - Last Time Smoked Cig NY1-Last Time Used E-Cig National Youth Tobacco Survey 2022 - When was the last time you used an e-cigarette, even one or two times? NYTS 2022 Version - Last Time Used E-Cig NY1-Magazines How Often Ads E-Cigs National Youth Tobacco Survey 2022 - When you read newspapers or magazines, how often do you see ads or promotions for e-cigarettes? NYTS 2022 Version - Magazines How Often Ads E-Cigs NY1-Magazines How Often See Ads Cigs National Youth Tobacco Survey 2022 - When you read newspapers or magazines, how often do you see ads or promotions for cigarettes or other tobacco products? NYTS 2022 Version - Magazines How Often See Ads Cigs NY1-My Friends Think E-Cig Use Is National Youth Tobacco Survey 2022 - Please complete the following sentence. My friends think that e-cigarette use is. NYTS 2022 Version - My Friends Think E-Cig Use Is NY1-On Days Smoked How Many Cigars National Youth Tobacco Survey 2022 - During the past 30 days, on the days that you smoked, about how many cigars, cigarillos, or little cigars did you smoke per day? NYTS 2022 Version - On Days Smoked How Many Cigars NY1-On Days Smoked How Many Cigs National Youth Tobacco Survey 2022 - During the past 30 days, on the days you smoked, about how many cigarettes did you smoke per day? NYTS 2022 Version - On Days Smoked How Many Cigs NY1-Past 30 Days Menthol Cig Use National Youth Tobacco Survey 2022 - During the past 30 days, were the cigarettes that you usually smoked menthol? NYTS 2022 Version - Past 30 Days Menthol Cig Use NY1-Past 30 Days Use E-Cig National Youth Tobacco Survey 2022 - During the past 30 days, on how many days did you use e-cigarettes? NYTS 2022 Version - Past 30 Days Use E-Cig NY1-People Harm When Smoke Hookah National Youth Tobacco Survey 2022 - How much do you think people harm themselves when they smoke tobacco in a hookah or waterpipe some days but not every day? NYTS 2022 Version - People Harm When Smoke Hookah NY1-People Harm When Use Dip National Youth Tobacco Survey 2022 - How much do you think people harm themselves when they use chewing tobacco, snuff, dip, snus, or dissolvable tobacco products, some days but not every day? NYTS 2022 Version - People Harm When Use Dip NY1-People Harm When Use E-Cigs National Youth Tobacco Survey 2022 - How much do you think people harm themselves when they use e-cigarettes some days but not every day? NYTS 2022 Version - People Harm When Use E-Cigs NY1-Post Pictures of Using E-Cigs National Youth Tobacco Survey 2022 - When you use social media, how often do you post pictures or videos of yourself or someone else using e-cigarettes? NYTS 2022 Version - Post Pictures of Using E-Cigs NY1-Race: American Indian/Alaska Native National Youth Tobacco Survey 2022 - What race or races do you consider yourself to be: American Indian or Alaska Native. NYTS 2022 Version - Race: American Indian/Alaska Native NY1-Race: Asian National Youth Tobacco Survey 2022 - What race or races do you consider yourself to be: Asian. NYTS 2022 Version - Race: Asian NY1-Race: Black or African American National Youth Tobacco Survey 2022 - What race or races do you consider yourself to be: Black or African American. NYTS 2022 Version - Race: Black or African American NY1-Race: Native Hawaiian/Other Pacific National Youth Tobacco Survey 2022 - What race or races do you consider yourself to be: Native Hawaiian or Other Pacific Islander. NYTS 2022 Version - Race: Native Hawaiian/Other Pacific NY1-Race: White National Youth Tobacco Survey 2022 - What race or races do you consider yourself to be: White. NYTS 2022 Version - Race: White NY1-Ride in Vehicle Someone Smoking National Youth Tobacco Survey 2022 - During the past 7 days, on how many days did you ride in a vehicle when someone was smoking a tobacco product? NYTS 2022 Version - Ride in Vehicle Someone Smoking NY1-Ride in Vehicle Someone Using E-Cig National Youth Tobacco Survey 2022 - During the past 7 days, on how many days did you ride in a vehicle when someone was using an e-cigarette? NYTS 2022 Version - Ride in Vehicle Someone Using E-Cig NY1-Seriously Thinking Quitting Cig National Youth Tobacco Survey 2022 - Are you seriously thinking about quitting cigarettes? NYTS 2022 Version - Seriously Thinking Quitting Cig NY1-Seriously Thinking Quitting E-Cig National Youth Tobacco Survey 2022 - Are you seriously thinking about quitting e-cigarettes? NYTS 2022 Version - Seriously Thinking Quitting E-Cig NY1-Seriously Thinking Quitting Tobacco National Youth Tobacco Survey 2022 - Are you seriously thinking about quitting the use of all tobacco products? NYTS 2022 Version - Seriously Thinking Quitting Tobacco NY1-Sites Seen Posts E-Cigs: Facebook National Youth Tobacco Survey 2022 - On which social media sites have you seen posts or content related to e-cigarettes: Facebook. NYTS 2022 Version - Sites Seen Posts E-Cigs: Facebook NY1-Sites Seen Posts E-Cigs: Instagram National Youth Tobacco Survey 2022 - On which social media sites have you seen posts or content related to e-cigarettes: Instagram. NYTS 2022 Version - Sites Seen Posts E-Cigs: Instagram NY1-Sites Seen Posts E-Cigs: Other National Youth Tobacco Survey 2022 - On which social media sites have you seen posts or content related to e-cigarettes: Some other site. NYTS 2022 Version - Sites Seen Posts E-Cigs: Other NY1-Sites Seen Posts E-Cigs: Reddit National Youth Tobacco Survey 2022 - On which social media sites have you seen posts or content related to e-cigarettes: Reddit. NYTS 2022 Version - Sites Seen Posts E-Cigs: Reddit NY1-Sites Seen Posts E-Cigs: Snapchat National Youth Tobacco Survey 2022 - On which social media sites have you seen posts or content related to e-cigarettes: Snapchat. NYTS 2022 Version - Sites Seen Posts E-Cigs: Snapchat NY1-Sites Seen Posts E-Cigs: Specify National Youth Tobacco Survey 2022 - On which social media sites have you seen posts or content related to e-cigarettes: Some other site (specify). NYTS 2022 Version - Sites Seen Posts E-Cigs: Specify NY1-Sites Seen Posts E-Cigs: TikTok National Youth Tobacco Survey 2022 - On which social media sites have you seen posts or content related to e-cigarettes: TikTok. NYTS 2022 Version - Sites Seen Posts E-Cigs: TikTok NY1-Sites Seen Posts E-Cigs: Twitter National Youth Tobacco Survey 2022 - On which social media sites have you seen posts or content related to e-cigarettes: Twitter. NYTS 2022 Version - Sites Seen Posts E-Cigs: Twitter NY1-Sites Seen Posts E-Cigs: YouTube National Youth Tobacco Survey 2022 - On which social media sites have you seen posts or content related to e-cigarettes: YouTube. NYTS 2022 Version - Sites Seen Posts E-Cigs: YouTube NY1-Smoked Bidis National Youth Tobacco Survey 2022 - Have you ever smoked bidis, even just one time? NYTS 2022 Version - Smoked Bidis NY1-Social Media See Posts E-Cigs National Youth Tobacco Survey 2022 - When you use social media, how often do you see posts or content (pictures, videos, or text) related to e-cigarettes? NYTS 2022 Version - Social Media See Posts E-Cigs NY1-Social Media Shared Posts E-Cigs National Youth Tobacco Survey 2022 - When you use social media, how often have you liked, commented, or shared posts or content (pictures, videos, or text) related to e-cigarettes? NYTS 2022 Version - Social Media Shared Posts E-Cigs NY1-Someone Smoke in Home National Youth Tobacco Survey 2022 - During the past 7 days, on how many days did someone smoke tobacco products in your home while you were there? NYTS 2022 Version - Someone Smoke in Home NY1-Someone Use E-Cigs in Home National Youth Tobacco Survey 2022 - During the past 7 days, on how many days did someone use e-cigarettes in your home while you were there? NYTS 2022 Version - Someone Use E-Cigs in Home NY1-Speak Language Other Than English National Youth Tobacco Survey 2022 - Do you speak a language other than English at home? NYTS 2022 Version - Speak Language Other Than English NY1-Store How Often Ads E-Cigs National Youth Tobacco Survey 2022 - When you go to a convenience store, supermarket, gas station, kiosk/storefront, or shopping center, how often do you see ads or promotions for e-cigarettes? NYTS 2022 Version - Store How Often Ads E-Cigs NY1-Store How Often See Ads Cigs National Youth Tobacco Survey 2022 - When you go to a convenience store, supermarket, gas station, kiosk/storefront, or shopping center, how often do you see ads or promotions for cigarettes or other tobacco products? NYTS 2022 Version - Store How Often See Ads Cigs NY1-Think Cig Advertised as Low Nicotine National Youth Tobacco Survey 2022 - Compared to a typical cigarette, would you think that a cigarette advertised as low nicotine would be. NYTS 2022 Version - Think Cig Advertised as Low Nicotine NY1-Think People Harm When Smoke Cigar National Youth Tobacco Survey 2022 - How much do you think people harm themselves when they smoke cigars, cigarillos, or little cigars, some days but not every day? NYTS 2022 Version - Think People Harm When Smoke Cigar NY1-Think People Harm When Smoke Cigs National Youth Tobacco Survey 2022 - How much do you think people harm themselves when they smoke cigarettes some days but not every day? NYTS 2022 Version - Think People Harm When Smoke Cigs NY1-Think That E-Cigs National Youth Tobacco Survey 2022 - Do you think that e-cigarettes. NYTS 2022 Version - Think That E-Cigs NY1-Think Will Smoke Cig in Next Year National Youth Tobacco Survey 2022 - Do you think you will smoke a cigarette in the next year? NYTS 2022 Version - Think Will Smoke Cig in Next Year NY1-Think Will Smoke Cigar in Next Year National Youth Tobacco Survey 2022 - Do you think you will smoke a cigar, cigarillo, or little cigar in the next year? NYTS 2022 Version - Think Will Smoke Cigar in Next Year NY1-Think Will Try Cig Soon National Youth Tobacco Survey 2022 - Do you think that you will try a cigarette soon? NYTS 2022 Version - Think Will Try Cig Soon NY1-Think Will Try Cigar Soon National Youth Tobacco Survey 2022 - Do you think you will try a cigar, cigarillo, or little cigar soon? NYTS 2022 Version - Think Will Try Cigar Soon NY1-Think Will Try E-Cig Soon National Youth Tobacco Survey 2022 - Do you think that you will try an e-cigarette soon? NYTS 2022 Version - Think Will Try E-Cig Soon NY1-Think Will Use E-Cig in Next Year National Youth Tobacco Survey 2022 - Do you think you will use an e-cigarette in the next year? NYTS 2022 Version - Think Will Use E-Cig in Next Year NY1-Times Stopped Cig Trying Quit National Youth Tobacco Survey 2022 - During the past 12 months, how many times have you stopped smoking cigarettes for one day or longer because you were trying to quit smoking cigarettes for good? NYTS 2022 Version - Times Stopped Cig Trying Quit NY1-Times Stopped E-Cig Trying Quit National Youth Tobacco Survey 2022 - During the past 12 months, how many times have you stopped using e-cigarettes for one day or longer because you were trying to quit using e-cigarettes for good? NYTS 2022 Version - Times Stopped E-Cig Trying Quit NY1-Times Stopped Tobacco Trying Quit National Youth Tobacco Survey 2022 - During the past 12 months, how many times have you stopped using all tobacco products for one day or longer because you were trying to quit all tobacco products for good? NYTS 2022 Version - Times Stopped Tobacco Trying Quit NY1-Tried Quit E-Cig: Help from Doctor National Youth Tobacco Survey 2022 - When you tried to quit using e-cigarettes, did you use any of the following: Help, advice, or counseling from a doctor or health care provider. NYTS 2022 Version - Tried Quit E-Cig: Help from Doctor NY1-Tried Quit E-Cig: Help From Friend National Youth Tobacco Survey 2022 - When you tried to quit using e-cigarettes, did you use any of the following: Help or advice from a friend or peer. NYTS 2022 Version - Tried Quit E-Cig: Help From Friend NY1-Tried Quit E-Cig: Help From Parent National Youth Tobacco Survey 2022 - When you tried to quit using e-cigarettes, did you use any of the following: Help or advice from a parent or caregiver. NYTS 2022 Version - Tried Quit E-Cig: Help From Parent NY1-Tried Quit E-Cig: Help From Teacher National Youth Tobacco Survey 2022 - When you tried to quit using e-cigarettes, did you use any of the following: Help or advice from a teacher or coach. NYTS 2022 Version - Tried Quit E-Cig: Help From Teacher NY1-Tried Quit E-Cig: Help on Internet National Youth Tobacco Survey 2022 - When you tried to quit using e-cigarettes, did you use any of the following: Help or advice you found on the Internet. NYTS 2022 Version - Tried Quit E-Cig: Help on Internet NY1-Tried Quit E-Cig: Helpline National Youth Tobacco Survey 2022 - When you tried to quit using e-cigarettes, did you use any of the following: A telephone helpline or quitline. NYTS 2022 Version - Tried Quit E-Cig: Helpline NY1-Tried Quit E-Cig: Mobile App National Youth Tobacco Survey 2022 - When you tried to quit using e-cigarettes, did you use any of the following: A mobile app or texting program. NYTS 2022 Version - Tried Quit E-Cig: Mobile App NY1-Tried Quit E-Cig: Not Use Resources National Youth Tobacco Survey 2022 - When you tried to quit using e-cigarettes, did you use any of the following: I did not use any resources. NYTS 2022 Version - Tried Quit E-Cig: Not Use Resources NY1-Tried Quit E-Cig: Something Else National Youth Tobacco Survey 2022 - When you tried to quit using e-cigarettes, did you use any of the following: Something else. NYTS 2022 Version - Tried Quit E-Cig: Something Else NY1-Tried Quit E-Cig: Specify National Youth Tobacco Survey 2022 - When you tried to quit using e-cigarettes, did you use any of the following: Something else (specify). NYTS 2022 Version - Tried Quit E-Cig: Specify NY1-Tried Quit E-Cig: Treatment Hospital National Youth Tobacco Survey 2022 - When you tried to quit using e-cigarettes, did you use any of the following: Treatment from a hospital, medical center, or some other facility. NYTS 2022 Version - Tried Quit E-Cig: Treatment Hospital NY1-Type of Cigar Smoked: Cigarillos National Youth Tobacco Survey 2022 - During the past 30 days, which of the following types of cigars have you smoked: Cigarillos. NYTS 2022 Version - Type of Cigar Smoked: Cigarillos NY1-Type of Cigar Smoked: Don't Know National Youth Tobacco Survey 2022 - During the past 30 days, which of the following types of cigars have you smoked: Don't Know. NYTS 2022 Version - Type of Cigar Smoked: Don't Know NY1-Type of Cigar Smoked: Little Cigars National Youth Tobacco Survey 2022 - During the past 30 days, which of the following types of cigars have you smoked: Little Cigars. NYTS 2022 Version - Type of Cigar Smoked: Little Cigars NY1-Type of Cigar Smoked: Regular Cigars National Youth Tobacco Survey 2022 - During the past 30 days, which of the following types of cigars have you smoked: Regular cigars. NYTS 2022 Version - Type of Cigar Smoked: Regular Cigars NY1-Type of E-Cig Used National Youth Tobacco Survey 2022 - Which of the following best describes the type of e-cigarette you have used in the past 30 days? If you have used more than one type, please think about the one you use most often. NYTS 2022 Version - Type of E-Cig Used NY1-Used Dissolv Tobacco National Youth Tobacco Survey 2022 - Have you ever used dissolvable tobacco products, even just one time? NYTS 2022 Version - Used Dissolv Tobacco NY1-Using E-Cig at School: Bathroom National Youth Tobacco Survey 2022 - Have you ever seen anyone using an e-cigarette, such as JUUL, SMOK, Suorin, Vuse, blu, Puff Bar, or STIG in any locations while at school or on school property: Yes, inside a school bathroom or locker room. NYTS 2022 Version - Using E-Cig at School: Bathroom NY1-Using E-Cig at School: Classroom National Youth Tobacco Survey 2022 - Have you ever seen anyone using an e-cigarette, such as JUUL, SMOK, Suorin, Vuse, blu, Puff Bar, or STIG in any locations while at school or on school property: Yes, inside a classroom. NYTS 2022 Version - Using E-Cig at School: Classroom NY1-Using E-Cig at School: Inside Other National Youth Tobacco Survey 2022 - Have you ever seen anyone using an e-cigarette, such as JUUL, SMOK, Suorin, Vuse, blu, Puff Bar, or STIG in any locations while at school or on school property: Yes, inside some other area of the school (hallway, cafeteria). NYTS 2022 Version - Using E-Cig at School: Inside Other NY1-Using E-Cig at School: No National Youth Tobacco Survey 2022 - Have you ever seen anyone using an e-cigarette, such as JUUL, SMOK, Suorin, Vuse, blu, Puff Bar, or STIG in any locations while at school or on school property: No. NYTS 2022 Version - Using E-Cig at School: No NY1-Using E-Cig at School: Not Listed National Youth Tobacco Survey 2022 - Have you ever seen anyone using an e-cigarette, such as JUUL, SMOK, Suorin, Vuse, blu, Puff Bar, or STIG in any locations while at school or on school property: Yes, somewhere else not listed here. NYTS 2022 Version - Using E-Cig at School: Not Listed NY1-Using E-Cig at School: Outside Other National Youth Tobacco Survey 2022 - Have you ever seen anyone using an e-cigarette, such as JUUL, SMOK, Suorin, Vuse, blu, Puff Bar, or STIG in any locations while at school or on school property: Yes, outside of the school, such as in the parking lot, sidewalk, sports field, or other school grounds. NYTS 2022 Version - Using E-Cig at School: Outside Other NY1-Using E-Cig at School: Specify National Youth Tobacco Survey 2022 - Have you ever seen anyone using an e-cigarette, such as JUUL, SMOK, Suorin, Vuse, blu, Puff Bar, or STIG in any locations while at school or on school property: Yes, somewhere else not listed here (specify). NYTS 2022 Version - Using E-Cig at School: Specify NY1-Vaped 30 Days: Another Substance National Youth Tobacco Survey 2022 - Have you vaped any of the following substances during the past 30 days: Another substance. NYTS 2022 Version - Vaped 30 Days: Another Substance NY1-Vaped 30 Days: CBD or CBD Oils National Youth Tobacco Survey 2022 - Have you vaped any of the following substances during the past 30 days: CBD or CBD oils. NYTS 2022 Version - Vaped 30 Days: CBD or CBD Oils NY1-Vaped 30 Days: Marijuana National Youth Tobacco Survey 2022 - Have you vaped any of the following substances during the past 30 days: Marijuana (also called pot, weed, or cannabis), including THC, THC concentrates, hash oil, or waxes. NYTS 2022 Version - Vaped 30 Days: Marijuana NY1-Vaped 30 Days: Specify National Youth Tobacco Survey 2022 - Have you vaped any of the following substances during the past 30 days: Another substance (specify). NYTS 2022 Version - Vaped 30 Days: Specify NY1-Vaped 30 Days: Synthetic Marijuana National Youth Tobacco Survey 2022 - Have you vaped any of the following substances during the past 30 days: Synthetic marijuana or cannabinoids, such as K2 or Spice. NYTS 2022 Version - Vaped 30 Days: Synthetic Marijuana NY1-Visited Doctor Past 12 Months National Youth Tobacco Survey 2022 - Have you visited a doctor, dentist, or nurse in the past 12 months? NYTS 2022 Version - Visited Doctor Past 12 Months NY1-Watch TV How Often See Ads Cigs National Youth Tobacco Survey 2022 - When you watch TV or streaming services (such as Netflix, Hulu, or Amazon Prime), or go to the movies, how often do you see ads or promotions for cigarettes or other tobacco products? NYTS 2022 Version - Watch TV How Often See Ads Cigs NY1-Watch TV How Often See Ads E-Cigs National Youth Tobacco Survey 2022 - When you watch TV or streaming services (such as Netflix, Hulu, or Amazon Prime), or go to the movies, how often do you see ads or promotions for e-cigarettes? NYTS 2022 Version - Watch TV How Often See Ads E-Cigs NY1-Watch TV See People Using Cigs National Youth Tobacco Survey 2022 - When you watch TV or streaming services (such as Netflix, Hulu, or Amazon Prime), or go to the movies, how often do you see people or characters using cigarettes or other tobacco products? NYTS 2022 Version - Watch TV See People Using Cigs NY1-Watch TV See People Using E-Cigs National Youth Tobacco Survey 2022 - When you watch TV or streaming services (such as Netflix, Hulu, or Amazon Prime), or go to the movies, how often do you see people or characters using e-cigarettes? NYTS 2022 Version - Watch TV See People Using E-Cigs NY1-What Brand Cig Usually National Youth Tobacco Survey 2022 - During the past 30 days, what brand of cigarettes did you usually smoke? NYTS 2022 Version - What Brand Cig Usually NY1-What Brand Cig Usually: Specify National Youth Tobacco Survey 2022 - During the past 30 days, what brand of cigarettes did you usually smoke: Some other brand not listed here (Please specify). NYTS 2022 Version - What Brand Cig Usually: Specify NY1-What Brand E-Cig Usually National Youth Tobacco Survey 2022 - During the past 30 days, what brand of e-cigarettes did you usually use? NYTS 2022 Version - What Brand E-Cig Usually NY1-What Brand E-Cig Usually: Specify National Youth Tobacco Survey 2022 - During the past 30 days, what brand of e-cigarettes did you usually use? Some other brand not listed here (specify). NYTS 2022 Version - What Brand E-Cig Usually: Specify NY1-What Brands Cigs Smoke: American National Youth Tobacco Survey 2022 - During the past 30 days, what brands of cigarettes did you smoke: American Spirit. NYTS 2022 Version - What Brands Cigs Smoke: American NY1-What Brands Cigs Smoke: Camel National Youth Tobacco Survey 2022 - During the past 30 days, what brands of cigarettes did you smoke: Camel. NYTS 2022 Version - What Brands Cigs Smoke: Camel NY1-What Brands Cigs Smoke: GPC National Youth Tobacco Survey 2022 - During the past 30 days, what brands of cigarettes did you smoke: GPC, Basic, or Doral. NYTS 2022 Version - What Brands Cigs Smoke: GPC NY1-What Brands Cigs Smoke: Kool National Youth Tobacco Survey 2022 - During the past 30 days, what brands of cigarettes did you smoke: Kool. NYTS 2022 Version - What Brands Cigs Smoke: Kool NY1-What Brands Cigs Smoke: L&M National Youth Tobacco Survey 2022 - During the past 30 days, what brands of cigarettes did you smoke: L&M. NYTS 2022 Version - What Brands Cigs Smoke: L&M NY1-What Brands Cigs Smoke: Marlboro National Youth Tobacco Survey 2022 - During the past 30 days, what brands of cigarettes did you smoke: Marlboro. NYTS 2022 Version - What Brands Cigs Smoke: Marlboro NY1-What Brands Cigs Smoke: Maverick National Youth Tobacco Survey 2022 - During the past 30 days, what brands of cigarettes did you smoke: Maverick. NYTS 2022 Version - What Brands Cigs Smoke: Maverick NY1-What Brands Cigs Smoke: Newport National Youth Tobacco Survey 2022 - During the past 30 days, what brands of cigarettes did you smoke: Newport. NYTS 2022 Version - What Brands Cigs Smoke: Newport NY1-What Brands Cigs Smoke: Not Sure National Youth Tobacco Survey 2022 - During the past 30 days, what brands of cigarettes did you smoke: Not sure/I don't know the brand. NYTS 2022 Version - What Brands Cigs Smoke: Not Sure NY1-What Brands Cigs Smoke: Other National Youth Tobacco Survey 2022 - During the past 30 days, what brands of cigarettes did you smoke: Some other brand not listed here. NYTS 2022 Version - What Brands Cigs Smoke: Other NY1-What Brands Cigs Smoke: Pall Mall National Youth Tobacco Survey 2022 - During the past 30 days, what brands of cigarettes did you smoke: Pall Mall. NYTS 2022 Version - What Brands Cigs Smoke: Pall Mall NY1-What Brands Cigs Smoke: Parliament National Youth Tobacco Survey 2022 - During the past 30 days, what brands of cigarettes did you smoke: Parliament. NYTS 2022 Version - What Brands Cigs Smoke: Parliament NY1-What Brands Cigs Smoke: Specify National Youth Tobacco Survey 2022 - During the past 30 days, what brands of cigarettes did you smoke: Some other brand not listed here (Please specify). NYTS 2022 Version - What Brands Cigs Smoke: Specify NY1-What Brands Cigs Smoke: Winston National Youth Tobacco Survey 2022 - During the past 30 days, what brands of cigarettes did you smoke: Winston. NYTS 2022 Version - What Brands Cigs Smoke: Winston NY1-What E-Cig Brands Use: blu National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: blu. NYTS 2022 Version - What E-Cig Brands Use: blu NY1-What E-Cig Brands Use: Eonsmoke National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: Eonsmoke. NYTS 2022 Version - What E-Cig Brands Use: Eonsmoke NY1-What E-Cig Brands Use: JUUL National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: JUUL. NYTS 2022 Version - What E-Cig Brands Use: JUUL NY1-What E-Cig Brands Use: Leap National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: Leap. NYTS 2022 Version - What E-Cig Brands Use: Leap NY1-What E-Cig Brands Use: Logic National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: Logic. NYTS 2022 Version - What E-Cig Brands Use: Logic NY1-What E-Cig Brands Use: Mojo National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: Mojo. NYTS 2022 Version - What E-Cig Brands Use: Mojo NY1-What E-Cig Brands Use: NJOY National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: NJOY. NYTS 2022 Version - What E-Cig Brands Use: NJOY NY1-What E-Cig Brands Use: Not Sure National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: Not sure/I don't know the brand. NYTS 2022 Version - What E-Cig Brands Use: Not Sure NY1-What E-Cig Brands Use: Other National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: Some other brand(s) not listed here. NYTS 2022 Version - What E-Cig Brands Use: Other NY1-What E-Cig Brands Use: Posh National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: Posh. NYTS 2022 Version - What E-Cig Brands Use: Posh NY1-What E-Cig Brands Use: Puff Bar National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: Puff Bar. NYTS 2022 Version - What E-Cig Brands Use: Puff Bar NY1-What E-Cig Brands Use: SMOK National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: SMOK (including NOVO). NYTS 2022 Version - What E-Cig Brands Use: SMOK NY1-What E-Cig Brands Use: Specify National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: Some other brand(s) not listed here (specify). NYTS 2022 Version - What E-Cig Brands Use: Specify NY1-What E-Cig Brands Use: STIG National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: STIG. NYTS 2022 Version - What E-Cig Brands Use: STIG NY1-What E-Cig Brands Use: Suorin National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: Suorin. NYTS 2022 Version - What E-Cig Brands Use: Suorin NY1-What E-Cig Brands Use: Vuse National Youth Tobacco Survey 2022 - During the past 30 days, what e-cigarette brands did you use: Vuse. NYTS 2022 Version - What E-Cig Brands Use: Vuse NY1-What Grade Are You In National Youth Tobacco Survey 2022 - What grade are you in? NYTS 2022 Version - What Grade Are You In NY1-What Is Your Sex National Youth Tobacco Survey 2022 - What is your sex? NYTS 2022 Version - What Is Your Sex NY1-Where Buy Bidis: Delivery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your bidis: Through a delivery service (such as DoorDash or Postmates). NYTS 2022 Version - Where Buy Bidis: Delivery NY1-Where Buy Bidis: Did Not National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your bidis: I did not buy bidis during the past 30 days. NYTS 2022 Version - Where Buy Bidis: Did Not NY1-Where Buy Bidis: Drugstore National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your bidis: A drugstore. NYTS 2022 Version - Where Buy Bidis: Drugstore NY1-Where Buy Bidis: Gas National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your bidis: A gas station or convenience store. NYTS 2022 Version - Where Buy Bidis: Gas NY1-Where Buy Bidis: Grocery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your bidis: A grocery store. NYTS 2022 Version - Where Buy Bidis: Grocery NY1-Where Buy Bidis: Internet National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your bidis: On the Internet (such as a product or store website, eBay, or Facebook Marketplace). NYTS 2022 Version - Where Buy Bidis: Internet NY1-Where Buy Bidis: Kiosk National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your bidis: A mall or shopping center kiosk/stand. NYTS 2022 Version - Where Buy Bidis: Kiosk NY1-Where Buy Bidis: Mail National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your bidis: Through the mail. NYTS 2022 Version - Where Buy Bidis: Mail NY1-Where Buy Bidis: Other National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your bidis: Some other place not listed here. NYTS 2022 Version - Where Buy Bidis: Other NY1-Where Buy Bidis: Person National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your bidis: I bought them from another person (a friend, family member, or someone else). NYTS 2022 Version - Where Buy Bidis: Person NY1-Where Buy Bidis: Specify National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your bidis: Some other place not listed here (specify). NYTS 2022 Version - Where Buy Bidis: Specify NY1-Where Buy Bidis: Vape Shop National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your bidis: A vape shop or tobacco shop. NYTS 2022 Version - Where Buy Bidis: Vape Shop NY1-Where Buy Bidis: Vending National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your bidis: A vending machine. NYTS 2022 Version - Where Buy Bidis: Vending NY1-Where Buy Cig: Delivery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigarettes: Through a delivery service (such as DoorDash or Postmates). NYTS 2022 Version - Where Buy Cig: Delivery NY1-Where Buy Cig: Did Not National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigarettes: I did not buy cigarettes during the past 30 days. NYTS 2022 Version - Where Buy Cig: Did Not NY1-Where Buy Cig: Drugstore National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigarettes: A drugstore. NYTS 2022 Version - Where Buy Cig: Drugstore NY1-Where Buy Cig: Gas National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigarettes: A gas station or convenience store. NYTS 2022 Version - Where Buy Cig: Gas NY1-Where Buy Cig: Grocery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigarettes: A grocery store. NYTS 2022 Version - Where Buy Cig: Grocery NY1-Where Buy Cig: Kiosk National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigarettes: A mall or shopping center kiosk/stand. NYTS 2022 Version - Where Buy Cig: Kiosk NY1-Where Buy Cig: Mail National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigarettes: Through the mail. NYTS 2022 Version - Where Buy Cig: Mail NY1-Where Buy Cig: Other National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigarettes: Some other place not listed here. NYTS 2022 Version - Where Buy Cig: Other NY1-Where Buy Cig: Person National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigarettes: I bought them from another person (a friend, family member, or someone else). NYTS 2022 Version - Where Buy Cig: Person NY1-Where Buy Cig: Specify National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigarettes: Some other place not listed here (specify). NYTS 2022 Version - Where Buy Cig: Specify NY1-Where Buy Cig: Vape Shop National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigarettes: A vape shop or tobacco shop. NYTS 2022 Version - Where Buy Cig: Vape Shop NY1-Where Buy Cigars: Delivery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigars, cigarillos, or little cigars: Through a delivery service (such as DoorDash or Postmates). NYTS 2022 Version - Where Buy Cigars: Delivery NY1-Where Buy Cigars: Did Not National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigars, cigarillos, or little cigars: I did not buy cigars, cigarillos, or little cigars during the past 30 days. NYTS 2022 Version - Where Buy Cigars: Did Not NY1-Where Buy Cigars: Drugstore National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigars, cigarillos, or little cigars: A drugstore. NYTS 2022 Version - Where Buy Cigars: Drugstore NY1-Where Buy Cigars: Gas National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigars, cigarillos, or little cigars: A gas station or convenience store. NYTS 2022 Version - Where Buy Cigars: Gas NY1-Where Buy Cigars: Grocery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigars, cigarillos, or little cigars: A grocery store. NYTS 2022 Version - Where Buy Cigars: Grocery NY1-Where Buy Cigars: Internet National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigars, cigarillos, or little cigars: On the Internet (such as a product or store website, eBay, or Facebook Marketplace). NYTS 2022 Version - Where Buy Cigars: Internet NY1-Where Buy Cigars: Kiosk National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigars, cigarillos, or little cigars: A mall or shopping center kiosk/stand. NYTS 2022 Version - Where Buy Cigars: Kiosk NY1-Where Buy Cigars: Mail National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigars, cigarillos, or little cigars: Through the mail. NYTS 2022 Version - Where Buy Cigars: Mail NY1-Where Buy Cigars: Other National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigars, cigarillos, or little cigars: Some other place not listed here. NYTS 2022 Version - Where Buy Cigars: Other NY1-Where Buy Cigars: Person National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigars, cigarillos, or little cigars: I bought them from another person (a friend, family member, or someone else). NYTS 2022 Version - Where Buy Cigars: Person NY1-Where Buy Cigars: Specify National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigars, cigarillos, or little cigars: Some other place not listed here (specify). NYTS 2022 Version - Where Buy Cigars: Specify NY1-Where Buy Cigars: Vape Shop National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigars, cigarillos, or little cigars: A vape shop or tobacco shop. NYTS 2022 Version - Where Buy Cigars: Vape Shop NY1-Where Buy Cigars: Vending National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigars, cigarillos, or little cigars: A vending machine. NYTS 2022 Version - Where Buy Cigars: Vending NY1-Where Buy Cigs: Internet National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigarettes: On the Internet (such as a product or store website, eBay or Facebook Marketplace). NYTS 2022 Version - Where Buy Cigs: Internet NY1-Where Buy Cigs: Vending National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your cigarettes: A vending machine. NYTS 2022 Version - Where Buy Cigs: Vending NY1-Where Buy Dip: Delivery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your chewing tobacco, snuff, or dip: Through a delivery service (such as DoorDash or Postmates). NYTS 2022 Version - Where Buy Dip: Delivery NY1-Where Buy Dip: Did Not National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your chewing tobacco, snuff, or dip: I did not buy chewing tobacco, snuff, or dip during the past 30 days. NYTS 2022 Version - Where Buy Dip: Did Not NY1-Where Buy Dip: Drugstore National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your chewing tobacco, snuff, or dip: A drugstore. NYTS 2022 Version - Where Buy Dip: Drugstore NY1-Where Buy Dip: Gas National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your chewing tobacco, snuff, or dip: A gas station or convenience store. NYTS 2022 Version - Where Buy Dip: Gas NY1-Where Buy Dip: Grocery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your chewing tobacco, snuff, or dip: A grocery store. NYTS 2022 Version - Where Buy Dip: Grocery NY1-Where Buy Dip: Internet National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your chewing tobacco, snuff, or dip: On the Internet (such as a product or store website, eBay, or Facebook Marketplace). NYTS 2022 Version - Where Buy Dip: Internet NY1-Where Buy Dip: Kiosk National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your chewing tobacco, snuff, or dip: A mall or shopping center kiosk/stand. NYTS 2022 Version - Where Buy Dip: Kiosk NY1-Where Buy Dip: Mail National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your chewing tobacco, snuff, or dip: Through the mail. NYTS 2022 Version - Where Buy Dip: Mail NY1-Where Buy Dip: Other National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your chewing tobacco, snuff, or dip: Some other place not listed here. NYTS 2022 Version - Where Buy Dip: Other NY1-Where Buy Dip: Person National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your chewing tobacco, snuff, or dip: I bought it from another person (a friend, family member, or someone else). NYTS 2022 Version - Where Buy Dip: Person NY1-Where Buy Dip: Specify National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your chewing tobacco, snuff, or dip: Some other place not listed here (specify). NYTS 2022 Version - Where Buy Dip: Specify NY1-Where Buy Dip: Vape Shop National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your chewing tobacco, snuff, or dip: A vape shop or tobacco shop. NYTS 2022 Version - Where Buy Dip: Vape Shop NY1-Where Buy Dip: Vending National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your chewing tobacco, snuff, or dip: A vending machine. NYTS 2022 Version - Where Buy Dip: Vending NY1-Where Buy Dissolv: Delivery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your dissolvable tobacco products: Through a delivery service (such as DoorDash or Postmates). NYTS 2022 Version - Where Buy Dissolv: Delivery NY1-Where Buy Dissolv: Did Not National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your dissolvable tobacco products: I did not buy dissolvable tobacco products during the past 30 days. NYTS 2022 Version - Where Buy Dissolv: Did Not NY1-Where Buy Dissolv: Drugstore National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your dissolvable tobacco products: A drugstore. NYTS 2022 Version - Where Buy Dissolv: Drugstore NY1-Where Buy Dissolv: Gas National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your dissolvable tobacco products: A gas station or convenience store. NYTS 2022 Version - Where Buy Dissolv: Gas NY1-Where Buy Dissolv: Grocery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your dissolvable tobacco products: A grocery store. NYTS 2022 Version - Where Buy Dissolv: Grocery NY1-Where Buy Dissolv: Internet National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your dissolvable tobacco products: On the Internet (such as a website or a secondary source, like eBay or Facebook Marketplace). NYTS 2022 Version - Where Buy Dissolv: Internet NY1-Where Buy Dissolv: Kiosk National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your dissolvable tobacco products: A mall or shopping center kiosk/stand. NYTS 2022 Version - Where Buy Dissolv: Kiosk NY1-Where Buy Dissolv: Mail National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your dissolvable tobacco products: Through the mail. NYTS 2022 Version - Where Buy Dissolv: Mail NY1-Where Buy Dissolv: Other National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your dissolvable tobacco products: Some other place not listed here. NYTS 2022 Version - Where Buy Dissolv: Other NY1-Where Buy Dissolv: Person National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your dissolvable tobacco products: I bought them from another person (a friend, family member, or someone else). NYTS 2022 Version - Where Buy Dissolv: Person NY1-Where Buy Dissolv: Specify National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your dissolvable tobacco products: Some other place not listed here (specify). NYTS 2022 Version - Where Buy Dissolv: Specify NY1-Where Buy Dissolv: Vape Shop National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your dissolvable tobacco products: A vape shop or tobacco shop. NYTS 2022 Version - Where Buy Dissolv: Vape Shop NY1-Where Buy Dissolv: Vending National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your dissolvable tobacco products: A vending machine. NYTS 2022 Version - Where Buy Dissolv: Vending NY1-Where Buy E-Cig: Delivery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your e-cigarette devices, pods, cartridges, or e-liquid refills: Through a delivery service (such as DoorDash or Postmates). NYTS 2022 Version - Where Buy E-Cig: Delivery NY1-Where Buy E-Cig: Did Not National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your e-cigarette devices, pods, cartridges, or e-liquid refills: I did not buy e-cigarettes during the past 30 days. NYTS 2022 Version - Where Buy E-Cig: Did Not NY1-Where Buy E-Cig: Drugstore National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your e-cigarette devices, pods, cartridges, or e-liquid refills: A drugstore. NYTS 2022 Version - Where Buy E-Cig: Drugstore NY1-Where Buy E-Cig: Gas National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your e-cigarette devices, pods, cartridges, or e-liquid refills: A gas station or convenience store. NYTS 2022 Version - Where Buy E-Cig: Gas NY1-Where Buy E-Cig: Grocery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your e-cigarette devices, pods, cartridges, or e-liquid refills: A grocery store. NYTS 2022 Version - Where Buy E-Cig: Grocery NY1-Where Buy E-Cig: Internet National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your e-cigarette devices, pods, cartridges, or e-liquid refills: On the Internet (such as a product website or store website like eBay or Facebook Marketplace). NYTS 2022 Version - Where Buy E-Cig: Internet NY1-Where Buy E-Cig: Kiosk National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your e-cigarette devices, pods, cartridges, or e-liquid refills: A mall or shopping center kiosk/stand. NYTS 2022 Version - Where Buy E-Cig: Kiosk NY1-Where Buy E-Cig: Mail National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your e-cigarette devices, pods, cartridges, or e-liquid refills: Through the mail. NYTS 2022 Version - Where Buy E-Cig: Mail NY1-Where Buy E-Cig: Other National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your e-cigarette devices, pods, cartridges, or e-liquid refills: Some other place not listed here. NYTS 2022 Version - Where Buy E-Cig: Other NY1-Where Buy E-Cig: Person National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your e-cigarette devices, pods, cartridges, or e-liquid refills: I bought them from another person (a friend, family member, or someone else). NYTS 2022 Version - Where Buy E-Cig: Person NY1-Where Buy E-Cig: Specify National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your e-cigarette devices, pods, cartridges, or e-liquid refills: Some other place not listed here (specify). NYTS 2022 Version - Where Buy E-Cig: Specify NY1-Where Buy E-Cig: Vape Shop National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your e-cigarette devices, pods, cartridges, or e-liquid refills: A vape shop or tobacco shop. NYTS 2022 Version - Where Buy E-Cig: Vape Shop NY1-Where Buy E-Cig: Vending National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your e-cigarette devices, pods, cartridges, or e-liquid refills: A vending machine. NYTS 2022 Version - Where Buy E-Cig: Vending NY1-Where Buy Heated Tobacco: Delivery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your heated tobacco products: Through a delivery service (such as DoorDash or Postmates). NYTS 2022 Version - Where Buy Heated Tobacco: Delivery NY1-Where Buy Heated Tobacco: Did Not National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your heated tobacco products: I did not buy heated tobacco products during the past 30 days. NYTS 2022 Version - Where Buy Heated Tobacco: Did Not NY1-Where Buy Heated Tobacco: Drugstore National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your heated tobacco products: A drugstore. NYTS 2022 Version - Where Buy Heated Tobacco: Drugstore NY1-Where Buy Heated Tobacco: Gas National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your heated tobacco products: A gas station or convenience store. NYTS 2022 Version - Where Buy Heated Tobacco: Gas NY1-Where Buy Heated Tobacco: Grocery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your heated tobacco products: A grocery store. NYTS 2022 Version - Where Buy Heated Tobacco: Grocery NY1-Where Buy Heated Tobacco: Internet National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your heated tobacco products: On the Internet (such as a product or store website, eBay, or Facebook Marketplace). NYTS 2022 Version - Where Buy Heated Tobacco: Internet NY1-Where Buy Heated Tobacco: Kiosk National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your heated tobacco products: A mall or shopping center kiosk/stand. NYTS 2022 Version - Where Buy Heated Tobacco: Kiosk NY1-Where Buy Heated Tobacco: Mail National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your heated tobacco products: Through the mail. NYTS 2022 Version - Where Buy Heated Tobacco: Mail NY1-Where Buy Heated Tobacco: Other National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your heated tobacco products: Some other place not listed here. NYTS 2022 Version - Where Buy Heated Tobacco: Other NY1-Where Buy Heated Tobacco: Person National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your heated tobacco products: I bought them from another person (a friend, family member, or someone else). NYTS 2022 Version - Where Buy Heated Tobacco: Person NY1-Where Buy Heated Tobacco: Specify National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your heated tobacco products: Some other place not listed here (specify). NYTS 2022 Version - Where Buy Heated Tobacco: Specify NY1-Where Buy Heated Tobacco: Vape Shop National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your heated tobacco products: A vape shop or tobacco shop. NYTS 2022 Version - Where Buy Heated Tobacco: Vape Shop NY1-Where Buy Heated Tobacco: Vending National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your heated tobacco products: A vending machine. NYTS 2022 Version - Where Buy Heated Tobacco: Vending NY1-Where Buy Hookah: Delivery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your hookah tobacco: Through a delivery service (such as DoorDash or Postmates). NYTS 2022 Version - Where Buy Hookah: Delivery NY1-Where Buy Hookah: Did Not National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your hookah tobacco: I did not buy hookah tobacco during the past 30 days. NYTS 2022 Version - Where Buy Hookah: Did Not NY1-Where Buy Hookah: Drugstore National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your hookah tobacco: A drugstore. NYTS 2022 Version - Where Buy Hookah: Drugstore NY1-Where Buy Hookah: Gas National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your hookah tobacco: A gas station or convenience store. NYTS 2022 Version - Where Buy Hookah: Gas NY1-Where Buy Hookah: Grocery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your hookah tobacco: A grocery store. NYTS 2022 Version - Where Buy Hookah: Grocery NY1-Where Buy Hookah: Internet National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your hookah tobacco: On the Internet (such as a product or store website, eBay, or Facebook Marketplace). NYTS 2022 Version - Where Buy Hookah: Internet NY1-Where Buy Hookah: Kiosk National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your hookah tobacco: A mall or shopping center kiosk/stand. NYTS 2022 Version - Where Buy Hookah: Kiosk NY1-Where Buy Hookah: Mail National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your hookah tobacco: Through the mail. NYTS 2022 Version - Where Buy Hookah: Mail NY1-Where Buy Hookah: Other National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your hookah tobacco: Some other place not listed here. NYTS 2022 Version - Where Buy Hookah: Other NY1-Where Buy Hookah: Person National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your hookah tobacco: I bought it from another person (a friend, family member, or someone else). NYTS 2022 Version - Where Buy Hookah: Person NY1-Where Buy Hookah: Specify National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your hookah tobacco: Some other place not listed here (specify). NYTS 2022 Version - Where Buy Hookah: Specify NY1-Where Buy Hookah: Vape Shop National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your hookah tobacco: A vape shop or tobacco shop. NYTS 2022 Version - Where Buy Hookah: Vape Shop NY1-Where Buy Hookah: Vending National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your hookah tobacco: A vending machine. NYTS 2022 Version - Where Buy Hookah: Vending NY1-Where Buy Pipe Tobacco: Delivery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your pipe tobacco: Through a delivery service (such as DoorDash or Postmates). NYTS 2022 Version - Where Buy Pipe Tobacco: Delivery NY1-Where Buy Pipe Tobacco: Did Not National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your pipe tobacco: I did not buy pipe tobacco during the past 30 days. NYTS 2022 Version - Where Buy Pipe Tobacco: Did Not NY1-Where Buy Pipe Tobacco: Drugstore National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your pipe tobacco: A drugstore. NYTS 2022 Version - Where Buy Pipe Tobacco: Drugstore NY1-Where Buy Pipe Tobacco: Gas National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your pipe tobacco: A gas station or convenience store. NYTS 2022 Version - Where Buy Pipe Tobacco: Gas NY1-Where Buy Pipe Tobacco: Grocery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your pipe tobacco: A grocery store. NYTS 2022 Version - Where Buy Pipe Tobacco: Grocery NY1-Where Buy Pipe Tobacco: Internet National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your pipe tobacco: On the Internet (such as a product or store website, eBay, or Facebook Marketplace). NYTS 2022 Version - Where Buy Pipe Tobacco: Internet NY1-Where Buy Pipe Tobacco: Kiosk National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your pipe tobacco: A mall or shopping center kiosk/stand. NYTS 2022 Version - Where Buy Pipe Tobacco: Kiosk NY1-Where Buy Pipe Tobacco: Mail National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your pipe tobacco: Through the mail. NYTS 2022 Version - Where Buy Pipe Tobacco: Mail NY1-Where Buy Pipe Tobacco: Other National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your pipe tobacco: Some other place not listed here. NYTS 2022 Version - Where Buy Pipe Tobacco: Other NY1-Where Buy Pipe Tobacco: Person National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your pipe tobacco: I bought it from another person (a friend, family member, or someone else). NYTS 2022 Version - Where Buy Pipe Tobacco: Person NY1-Where Buy Pipe Tobacco: Specify National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your pipe tobacco: Some other place not listed here (specify). NYTS 2022 Version - Where Buy Pipe Tobacco: Specify NY1-Where Buy Pipe Tobacco: Vape Shop National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your pipe tobacco: A vape shop or tobacco shop. NYTS 2022 Version - Where Buy Pipe Tobacco: Vape Shop NY1-Where Buy Pipe Tobacco: Vending National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your pipe tobacco: A vending machine. NYTS 2022 Version - Where Buy Pipe Tobacco: Vending NY1-Where Buy Pouches: Delivery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your nicotine pouches: Through a delivery service (such as DoorDash or Postmates). NYTS 2022 Version - Where Buy Pouches: Delivery NY1-Where Buy Pouches: Did Not National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your nicotine pouches: I did not buy nicotine pouches during the past 30 days. NYTS 2022 Version - Where Buy Pouches: Did Not NY1-Where Buy Pouches: Drugstore National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your nicotine pouches: A drugstore. NYTS 2022 Version - Where Buy Pouches: Drugstore NY1-Where Buy Pouches: Gas National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your nicotine pouches: A gas station or convenience store. NYTS 2022 Version - Where Buy Pouches: Gas NY1-Where Buy Pouches: Grocery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your nicotine pouches: A grocery store. NYTS 2022 Version - Where Buy Pouches: Grocery NY1-Where Buy Pouches: Internet National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your nicotine pouches: On the Internet (such as a product or store website, eBay, or Facebook Marketplace). NYTS 2022 Version - Where Buy Pouches: Internet NY1-Where Buy Pouches: Kiosk National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your nicotine pouches: A mall or shopping center kiosk/stand. NYTS 2022 Version - Where Buy Pouches: Kiosk NY1-Where Buy Pouches: Mail National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your nicotine pouches: Through the mail. NYTS 2022 Version - Where Buy Pouches: Mail NY1-Where Buy Pouches: Other National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your nicotine pouches: Some other place not listed here. NYTS 2022 Version - Where Buy Pouches: Other NY1-Where Buy Pouches: Person National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your nicotine pouches: I bought them from another person (a friend, family member, or someone else). NYTS 2022 Version - Where Buy Pouches: Person NY1-Where Buy Pouches: Specify National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your nicotine pouches: Some other place not listed here (specify). NYTS 2022 Version - Where Buy Pouches: Specify NY1-Where Buy Pouches: Vape Shop National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your nicotine pouches: A vape shop or tobacco shop. NYTS 2022 Version - Where Buy Pouches: Vape Shop NY1-Where Buy Pouches: Vending National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your nicotine pouches: A vending machine. NYTS 2022 Version - Where Buy Pouches: Vending NY1-Where Buy RYO Cigs: Delivery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your roll-your-own cigarettes: Through a delivery service (such as DoorDash or Postmates). NYTS 2022 Version - Where Buy RYO Cigs: Delivery NY1-Where Buy RYO Cigs: Did Not National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your roll-your-own cigarettes: I did not buy roll-your-own cigarettes during the past 30 days. NYTS 2022 Version - Where Buy RYO Cigs: Did Not NY1-Where Buy RYO Cigs: Drugstore National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your roll-your-own cigarettes: A drugstore. NYTS 2022 Version - Where Buy RYO Cigs: Drugstore NY1-Where Buy RYO Cigs: Gas National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your roll-your-own cigarettes: A gas station or convenience store. NYTS 2022 Version - Where Buy RYO Cigs: Gas NY1-Where Buy RYO Cigs: Grocery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your roll-your-own cigarettes: A grocery store. NYTS 2022 Version - Where Buy RYO Cigs: Grocery NY1-Where Buy RYO Cigs: Internet National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your roll-your-own cigarettes: On the Internet (such as a product or store website, eBay, or Facebook Marketplace). NYTS 2022 Version - Where Buy RYO Cigs: Internet NY1-Where Buy RYO Cigs: Kiosk National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your roll-your-own cigarettes: A mall or shopping center kiosk/stand. NYTS 2022 Version - Where Buy RYO Cigs: Kiosk NY1-Where Buy RYO Cigs: Mail National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your roll-your-own cigarettes: Through the mail. NYTS 2022 Version - Where Buy RYO Cigs: Mail NY1-Where Buy RYO Cigs: Other National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your roll-your-own cigarettes: Some other place not listed here. NYTS 2022 Version - Where Buy RYO Cigs: Other NY1-Where Buy RYO Cigs: Person National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your roll-your-own cigarettes: I bought them from another person (a friend, family member, or someone else). NYTS 2022 Version - Where Buy RYO Cigs: Person NY1-Where Buy RYO Cigs: Specify National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your roll-your-own cigarettes: Some other place not listed here (specify). NYTS 2022 Version - Where Buy RYO Cigs: Specify NY1-Where Buy RYO Cigs: Vape Shop National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your roll-your-own cigarettes: A vape shop or tobacco shop. NYTS 2022 Version - Where Buy RYO Cigs: Vape Shop NY1-Where Buy RYO Cigs: Vending National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your roll-your-own cigarettes: A vending machine. NYTS 2022 Version - Where Buy RYO Cigs: Vending NY1-Where Buy Snus: Delivery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your snus: Through a delivery service (such as DoorDash or Postmates). NYTS 2022 Version - Where Buy Snus: Delivery NY1-Where Buy Snus: Did Not National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your snus: I did not buy snus during the past 30 days. NYTS 2022 Version - Where Buy Snus: Did Not NY1-Where Buy Snus: Drugstore National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your snus: A drugstore. NYTS 2022 Version - Where Buy Snus: Drugstore NY1-Where Buy Snus: Gas National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your snus: A gas station or convenience store. NYTS 2022 Version - Where Buy Snus: Gas NY1-Where Buy Snus: Grocery National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your snus: A grocery store. NYTS 2022 Version - Where Buy Snus: Grocery NY1-Where Buy Snus: Internet National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your snus: On the Internet (such as a product or store website, eBay, or Facebook Marketplace). NYTS 2022 Version - Where Buy Snus: Internet NY1-Where Buy Snus: Kiosk National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your snus: A mall or shopping center kiosk/stand. NYTS 2022 Version - Where Buy Snus: Kiosk NY1-Where Buy Snus: Mail National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your snus: Through the mail. NYTS 2022 Version - Where Buy Snus: Mail NY1-Where Buy Snus: Other National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your snus: Some other place not listed here. NYTS 2022 Version - Where Buy Snus: Other NY1-Where Buy Snus: Person National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your snus: I bought it from another person (a friend, family member, or someone else). NYTS 2022 Version - Where Buy Snus: Person NY1-Where Buy Snus: Specify National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your snus: Some other place not listed here (specify). NYTS 2022 Version - Where Buy Snus: Specify NY1-Where Buy Snus: Vape Shop National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your snus: A vape or tobacco shop. NYTS 2022 Version - Where Buy Snus: Vape Shop NY1-Where Buy Snus: Vending National Youth Tobacco Survey 2022 - During the past 30 days, where did you buy your snus: A vending machine. NYTS 2022 Version - Where Buy Snus: Vending NY1-Where Smoke Hookah: Cafe National Youth Tobacco Survey 2022 - During the past 30 days, where did you smoke tobacco in a hookah or waterpipe: At a cafe or restaurant. NYTS 2022 Version - Where Smoke Hookah: Cafe NY1-Where Smoke Hookah: Family House National Youth Tobacco Survey 2022 - During the past 30 days, where did you smoke tobacco in a hookah or waterpipe: At a family member's house, other than my house. NYTS 2022 Version - Where Smoke Hookah: Family House NY1-Where Smoke Hookah: Friend's House National Youth Tobacco Survey 2022 - During the past 30 days, where did you smoke tobacco in a hookah or waterpipe: At a friend's house. NYTS 2022 Version - Where Smoke Hookah: Friend's House NY1-Where Smoke Hookah: Hookah Bar National Youth Tobacco Survey 2022 - During the past 30 days, where did you smoke tobacco in a hookah or waterpipe: At a hookah bar. NYTS 2022 Version - Where Smoke Hookah: Hookah Bar NY1-Where Smoke Hookah: My House National Youth Tobacco Survey 2022 - During the past 30 days, where did you smoke tobacco in a hookah or waterpipe: At my house. NYTS 2022 Version - Where Smoke Hookah: My House NY1-Where Smoke Hookah: Other National Youth Tobacco Survey 2022 - During the past 30 days, where did you smoke tobacco in a hookah or waterpipe: Some other place not listed here. NYTS 2022 Version - Where Smoke Hookah: Other NY1-Which of the Following Describes You National Youth Tobacco Survey 2022 - Which of the following best describes you? NYTS 2022 Version - Which of the Following Describes You NY1-Who Posted E-Cigs: Celebrities National Youth Tobacco Survey 2022 - Who usually posted the content related to e-cigarettes on your social media: Celebrities or social media influencers. NYTS 2022 Version - Who Posted E-Cigs: Celebrities NY1-Who Posted E-Cigs: E-Cig Brands National Youth Tobacco Survey 2022 - Who usually posted the content related to e-cigarettes on your social media: E-cigarette brands or sellers. NYTS 2022 Version - Who Posted E-Cigs: E-Cig Brands NY1-Who Posted E-Cigs: News Articles National Youth Tobacco Survey 2022 - Who usually posted the content related to e-cigarettes on your social media: Online news articles. NYTS 2022 Version - Who Posted E-Cigs: News Articles NY1-Who Posted E-Cigs: Online Friends National Youth Tobacco Survey 2022 - Who usually posted the content related to e-cigarette son your social media: Online friends I have not met in real life. NYTS 2022 Version - Who Posted E-Cigs: Online Friends NY1-Who Posted E-Cigs: Other National Youth Tobacco Survey 2022 - Who usually posted the content related to e-cigarette son your social media: Other. NYTS 2022 Version - Who Posted E-Cigs: Other NY1-Who Posted E-Cigs: People I know National Youth Tobacco Survey 2022 - Who usually posted the content related to e-cigarettes on your social media: People I know in real life. NYTS 2022 Version - Who Posted E-Cigs: People I know NY1-Who Posted E-Cigs: Public Health National Youth Tobacco Survey 2022 - Who usually posted the content related to e-cigarette son your social media: Public health campaigns (e.g., Truth Initiative, Real Cost). NYTS 2022 Version - Who Posted E-Cigs: Public Health NY1-Who Posted E-Cigs: Specify National Youth Tobacco Survey 2022 - Who usually posted the content related to e-cigarettes on your social media: Other (specify). NYTS 2022 Version - Who Posted E-Cigs: Specify NY1-Why Curr E-Cig: Available Flavors National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: They are available in flavors, such as menthol, mint, candy, fruit, or chocolate. NYTS 2022 Version - Why Curr E-Cig: Available Flavors NY1-Why Curr E-Cig: Curious About Them National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: I am curious about them. NYTS 2022 Version - Why Curr E-Cig: Curious About Them NY1-Why Curr E-Cig: Easier to Get National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: They are easier to get than other tobacco products, such as cigarettes. NYTS 2022 Version - Why Curr E-Cig: Easier to Get NY1-Why Curr E-Cig: Family Member National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: A family member uses them. NYTS 2022 Version - Why Curr E-Cig: Family Member NY1-Why Curr E-Cig: Feeling Anxious National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: Because I feel anxious, stressed, or depressed. NYTS 2022 Version - Why Curr E-Cig: Feeling Anxious NY1-Why Curr E-Cig: Friend National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: A friend uses them. NYTS 2022 Version - Why Curr E-Cig: Friend NY1-Why Curr E-Cig: Get High or Buzz National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: To get a high or buzz from nicotine. NYTS 2022 Version - Why Curr E-Cig: Get High or Buzz NY1-Why Curr E-Cig: Less Harmful Other National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: They are less harmful than other forms of tobacco, such as cigarettes. NYTS 2022 Version - Why Curr E-Cig: Less Harmful Other NY1-Why Curr E-Cig: Other Reason National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: I use them for some other reason. NYTS 2022 Version - Why Curr E-Cig: Other Reason NY1-Why Curr E-Cig: Seen People TV National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: I've seen people on TV, online, or in movies use them. NYTS 2022 Version - Why Curr E-Cig: Seen People TV NY1-Why Curr E-Cig: Specify National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: I use them for some other reason (specify). NYTS 2022 Version - Why Curr E-Cig: Specify NY1-Why Curr E-Cig: They Cost Less National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: They cost less than other tobacco products, such as cigarettes. NYTS 2022 Version - Why Curr E-Cig: They Cost Less NY1-Why Curr E-Cig: Try Quit Other National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: To try to quit using other tobacco products, such as cigarettes. NYTS 2022 Version - Why Curr E-Cig: Try Quit Other NY1-Why Curr E-Cig: Unnoticed at Home National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: I can use them unnoticed at home or at school. NYTS 2022 Version - Why Curr E-Cig: Unnoticed at Home NY1-Why Curr E-Cig: Use to Do Tricks National Youth Tobacco Survey 2022 - Why do you currently use e-cigarettes: I can use them to do tricks. NYTS 2022 Version - Why Curr E-Cig: Use to Do Tricks NY1-Why First E-Cig: Available Flavors National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: They were available in flavors, such as menthol, mint, candy, fruit, or chocolate. NYTS 2022 Version - Why First E-Cig: Available Flavors NY1-Why First E-Cig: Could Do Tricks National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: I could use them to do tricks. NYTS 2022 Version - Why First E-Cig: Could Do Tricks NY1-Why First E-Cig: Curious About National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: I was curious about them. NYTS 2022 Version - Why First E-Cig: Curious About NY1-Why First E-Cig: Easier to Get National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: They were easier to get than other tobacco products, such as cigarettes. NYTS 2022 Version - Why First E-Cig: Easier to Get NY1-Why First E-Cig: Family Member National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: A family member used them. NYTS 2022 Version - Why First E-Cig: Family Member NY1-Why First E-Cig: Feeling Anxious National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: I was feeling anxious, stressed, or depressed. NYTS 2022 Version - Why First E-Cig: Feeling Anxious NY1-Why First E-Cig: Friend National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: A friend used them. NYTS 2022 Version - Why First E-Cig: Friend NY1-Why First E-Cig: Get High or Buzz National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: To get a high or buzz from nicotine. NYTS 2022 Version - Why First E-Cig: Get High or Buzz NY1-Why First E-Cig: Less Harmful Other National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: They are less harmful than other forms of tobacco, such as cigarettes. NYTS 2022 Version - Why First E-Cig: Less Harmful Other NY1-Why First E-Cig: Other Reason National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: I used them for some other reason. NYTS 2022 Version - Why First E-Cig: Other Reason NY1-Why First E-Cig: Seen People TV National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: I've seen people on TV, online, or in movies use them. NYTS 2022 Version - Why First E-Cig: Seen People TV NY1-Why First E-Cig: Specify National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: I used them for some other reason (specify). NYTS 2022 Version - Why First E-Cig: Specify NY1-Why First E-Cig: They Cost Less National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: They cost less than other tobacco products, such as cigarettes. NYTS 2022 Version - Why First E-Cig: They Cost Less NY1-Why First E-Cig: Try Quit Other National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: To try to quit using other tobacco products, such as cigarettes. NYTS 2022 Version - Why First E-Cig: Try Quit Other NY1-Why First E-Cig: Unnoticed at Home National Youth Tobacco Survey 2022 - Why did you first use an e-cigarette: I could use them unnoticed at home or at school. NYTS 2022 Version - Why First E-Cig: Unnoticed at Home NY1TN National Youth Tobacco Survey 2022 Questionnaire Test Name CDISC Questionnaire National Youth Tobacco Survey 2022 Version Test Name Terminology Negative Symptom Assessment-16 test code. NSA01-Prolonged Time to Respond Negative Symptom Assessment-16 - Prolonged time to respond. NSA-16 - Prolonged Time to Respond NSA01-Restricted Speech Quantity Negative Symptom Assessment-16 - Restricted speech quantity. NSA-16 - Restricted Speech Quantity NSA01-Impoverished Speech Content Negative Symptom Assessment-16 - Impoverished speech content. NSA-16 - Impoverished Speech Content NSA01-Inarticulate Speech Negative Symptom Assessment-16 - Inarticulate speech. NSA-16 - Inarticulate Speech NSA01-Emotion: Reduced Range Negative Symptom Assessment-16 - Emotion: Reduced range. NSA-16 - Emotion: Reduced Range NSA01-Affect Reduce Modulation Intensity Negative Symptom Assessment-16 - Affect: Reduced modulation of intensity. NSA-16 - Affect: Reduce Modulation Intensity NSA01-Affect: Reduced Display on Demand Negative Symptom Assessment-16 - Affect: Reduced display on demand. NSA-16 - Affect: Reduced Display on Demand NSA01-Reduced Social Drive Negative Symptom Assessment-16 - Reduced social drive. NSA-16 - Reduced Social Drive NSA01-Poor Rapport With Interviewer Negative Symptom Assessment-16 - Poor rapport with interviewer. NSA-16 - Poor Rapport With Interviewer NSA01-Interest Emotional/Phys Intimacy Negative Symptom Assessment-16 - Interest in emotional and physical intimacy. NSA-16 - Interest in Emotional and Physical Intimacy NSA01-Poor Grooming and Hygiene Negative Symptom Assessment-16 - Poor grooming and hygiene. NSA-16 - Poor Grooming and Hygiene NSA01-Reduced Sense of Purpose Negative Symptom Assessment-16 - Reduced sense of purpose. NSA-16 - Reduced Sense of Purpose NSA01-Reduced Interests Negative Symptom Assessment-16 - Reduced interests. NSA-16 - Reduced Interests NSA01-Reduced Daily Activity Negative Symptom Assessment-16 - Reduced daily activity. NSA-16 - Reduced Daily Activity NSA01-Reduced Expressive Gestures Negative Symptom Assessment-16 - Reduced expressive gestures. NSA-16 - Reduced Expressive Gestures NSA01-Slowed Movements Negative Symptom Assessment-16 - Slowed movements. NSA-16 - Slowed Movements NSA01-Global Negative Symptoms Rating Negative Symptom Assessment-16 - Global negative symptoms rating. NSA-16 - Global Negative Symptoms Rating NSA01-Global Neg Symptom Rating-Severity Negative Symptom Assessment-16 - Global negative symptoms rating - severity. NSA-16 - Global Negative Symptoms Rating-Severity NSA01-Global Level of Functioning Negative Symptom Assessment-16 - Global level of functioning. NSA-16 - Global Level of Functioning NSA01TC Negative Symptom Assessment-16 Clinical Classification Test Code CDISC Clinical Classification NSA-16 Test Code Terminology Negative Symptom Assessment-16 test name. NSA01-Affect Reduce Modulation Intensity Negative Symptom Assessment-16 - Affect: Reduced modulation of intensity. NSA-16 - Affect: Reduce Modulation Intensity NSA01-Affect: Reduced Display on Demand Negative Symptom Assessment-16 - Affect: Reduced display on demand. NSA-16 - Affect: Reduced Display on Demand NSA01-Emotion: Reduced Range Negative Symptom Assessment-16 - Emotion: Reduced range. NSA-16 - Emotion: Reduced Range NSA01-Global Level of Functioning Negative Symptom Assessment-16 - Global level of functioning. NSA-16 - Global Level of Functioning NSA01-Global Neg Symptom Rating-Severity Negative Symptom Assessment-16 - Global negative symptoms rating - severity. NSA-16 - Global Negative Symptoms Rating-Severity NSA01-Global Negative Symptoms Rating Negative Symptom Assessment-16 - Global negative symptoms rating. NSA-16 - Global Negative Symptoms Rating NSA01-Impoverished Speech Content Negative Symptom Assessment-16 - Impoverished speech content. NSA-16 - Impoverished Speech Content NSA01-Inarticulate Speech Negative Symptom Assessment-16 - Inarticulate speech. NSA-16 - Inarticulate Speech NSA01-Interest Emotional/Phys Intimacy Negative Symptom Assessment-16 - Interest in emotional and physical intimacy. NSA-16 - Interest in Emotional and Physical Intimacy NSA01-Poor Grooming and Hygiene Negative Symptom Assessment-16 - Poor grooming and hygiene. NSA-16 - Poor Grooming and Hygiene NSA01-Poor Rapport With Interviewer Negative Symptom Assessment-16 - Poor rapport with interviewer. NSA-16 - Poor Rapport With Interviewer NSA01-Prolonged Time to Respond Negative Symptom Assessment-16 - Prolonged time to respond. NSA-16 - Prolonged Time to Respond NSA01-Reduced Daily Activity Negative Symptom Assessment-16 - Reduced daily activity. NSA-16 - Reduced Daily Activity NSA01-Reduced Expressive Gestures Negative Symptom Assessment-16 - Reduced expressive gestures. NSA-16 - Reduced Expressive Gestures NSA01-Reduced Interests Negative Symptom Assessment-16 - Reduced interests. NSA-16 - Reduced Interests NSA01-Reduced Sense of Purpose Negative Symptom Assessment-16 - Reduced sense of purpose. NSA-16 - Reduced Sense of Purpose NSA01-Reduced Social Drive Negative Symptom Assessment-16 - Reduced social drive. NSA-16 - Reduced Social Drive NSA01-Restricted Speech Quantity Negative Symptom Assessment-16 - Restricted speech quantity. NSA-16 - Restricted Speech Quantity NSA01-Slowed Movements Negative Symptom Assessment-16 - Slowed movements. NSA-16 - Slowed Movements NSA01TN Negative Symptom Assessment-16 Clinical Classification Test Name CDISC Clinical Classification NSA-16 Test Name Terminology Terminology relevant to the test codes that describe nervous system physiology and morphological findings. ABR Wave I, Absolute Latency Auditory Brainstem Response Wave I, Absolute Latency A measurement of the absolute latency of the auditory brainstem response wave I of the auditory evoked potential waveform. Auditory Brainstem Response Wave I, Absolute Latency ABR Wave V, Amplitude Auditory Brainstem Response Wave V, Amplitude A measurement of the magnitude, or height, of the auditory brainstem response wave V of the auditory evoked potential waveform. Auditory Brainstem Response Wave V, Amplitude ABR Wave V, Absolute Latency Auditory Brainstem Response Wave V, Absolute Latency A measurement of the absolute latency of the auditory brainstem response wave V of the auditory evoked potential waveform. Auditory Brainstem Response Wave V, Absolute Latency ABR Wave V, Presence Auditory Brainstem Response Wave V, Presence An assessment of the presence of the auditory brainstem response wave V of the auditory evoked potential waveform. Auditory Brainstem Response Wave V, Presence Asymmetric Tonic Neck Reflex ATNR An involuntary, primal response in the neonate in which the arm extends to follow the infant's gaze, while the opposing arm and leg flex inward. Tonic Neck Reflex Blood Flow Rate The volume of blood per unit time passing through a specified location, such as a point in a blood vessel or an entire organ. Blood Flow Rate Body Movement An assessment of body movements that occur with or without apparent cause. Body Movement Assessment Involuntary Body Movement Spontaneous Body Movement An assessment of body movements that occur without apparent external cause. Spontaneous Body Movement Assessment Bradykinesia An evaluation of bradykinesia (slow movement). Bradykinesia Evaluation Boundary Shift Integral A measurement of change in volume of an organ or anatomical feature as determined by a shift in tissue boundary over time. Boundary Shift Integral Choline/Creatine A relative measurement (ratio) of the choline to the creatine in a biological specimen. Choline to Creatine Ratio Measurement Choline A measurement of the choline in a biological specimen. Choline Measurement Crawling Ability An evaluation of an individual's ability to crawl. Crawling Ability Evaluation Creatine A measurement of the creatine in a biological specimen. Creatine Measurement Creatine + Choline A measurement of the creatine plus choline in a biological specimen. Creatine and Choline Measurement Creatine+Phosphocreatine A measurement of the creatine plus phosphocreatine in a biological specimen. Creatine and Phosphocreatine Measurement Dysesthesia An evaluation of dysesthesia (distortion of a sense resulting in an abnormal and unpleasant sensation, usually described as burning, tingling, or numbness). Dysesthesia Evaluation Dystonia An evaluation of dystonia (a movement disorder characterized by sustained or intermittent muscle contractions, resulting in abnormal movements and/or postures). Dystonia Evaluation Facial Symmetry An assessment of visual balance and proportion between opposing structures in the face. Facial Symmetry Assessment Choline, Free + Glycerophosphorylcholine + Phosphorylcholine Choline, Free+GPC+PCh A measurement of the free choline plus glycerophosphorylcholine (GCP) plus phosphorylcholine (PCh) in a biological specimen. Free Choline and Glycerophosphorylcholine and Phosphorylcholine Measurement Glutamate C4 Enriched A measurement of the C4 enriched glutamate in a biological specimen. C4 Enriched Glutamate Measurement Glutamate C4 Enriched/Glutamate A relative measurement (ratio or percentage) of the C4 enriched glutamate to total glutamate in a biological specimen. C4 Enriched Glutamate to Total Glutamate Ratio Measurement Glutamine A measurement of the glutamine in a biological specimen. Glutamine Measurement Glutamine C4 Enriched A measurement of the C4 enriched glutamine in a biological specimen. C4 Enriched Glutamine Measurement Glutamine C4 Enriched/Glutamine A relative measurement (ratio or percentage) of the C4 enriched glutamine to total glutamine in a biological specimen. C4 Enriched Glutamine to Total Glutamine Ratio Measurement Glutamine/Creatine A relative measurement (ratio or percentage) of the glutamine to creatine in a biological specimen. Glutamine to Creatine Ratio Measurement Galant Reflex An involuntary, primal response in the neonate in which a finger is run down one side of the spine and the neonate laterally flexes toward that side. Galant Reflex Glutamate/Creatine Glutamic Acid/Creatine A relative measurement (ratio or percentage) of the glutamate to creatine in a biological specimen. Glutamate to Creatine Ratio Measurement Glutamate Glutamic Acid A measurement of the glutamate in a biological specimen. Glutamate Measurement Glutamate and Glutamine A measurement of the glutamate and glutamine in a biological specimen. Glutamate and Glutamine Measurement Glutamate and Glutamine C3 Enriched A measurement of the C3 enriched glutamate and glutamine in a biological specimen. C3 Enriched Glutamate and Glutamine Measurement Glutamate and Glutamine C3 Enriched/Glutamate and Glutamine Glutamate and Glutamine C3 Enriched/GLX A relative measurement (ratio or percentage) of the C3 enriched glutamate and glutamine to total glutamate and glutamine in a biological specimen. C3 Enriched Glutamate and Glutamine to Total Glutamate and Glutamine Ratio Measurement Glutamate and Glutamine Cycle Rate Glutamate-Glutamine Cycle Rate Glutamate/GABA-Glutamine Cycle Rate A measurement of the metabolic rate of the glutamate-glutamine cycle in a biological specimen. Glutamate-Creatine Cycle Rate Measurement Glycerophosphorylcholine + Phosphorylcholine GPC+PCh A measurement of the glycerophosphorylcholine (GPC) plus phosphorylcholine (PC) in a biological specimen. Glycerophosphorylcholine and Phosphorylcholine Measurement Graphesthesia An evaluation of graphesthesia (the ability to recognize symbols when they're traced on the skin). Graphesthesia Evaluation mI Myo-Inositol A measurement of the myo-inositol in a biological specimen. Myo-Inositol Measurement Myo-Inositol/Creatine A relative measurement (ratio or percentage) of the myo-inositol to creatine in a biological specimen. Myo-inositol/Creatine Ratio Lactate/Creatine Lactic Acid/Creatine A relative measurement (ratio or percentage) of the lactate to creatine in a biological specimen. Lactate to Creatine Ratio Measurement Moro Reflex An involuntary, primal response in the neonate to loud noise or the feeling of falling. The response is characterized by the infant's arms symmetrically spreading out to the side and then back to the midline, and involuntarily flexing the fingers and toes. Moro Reflex Muscle Tone An assessment to evaluate residual muscle tension, which may be subjectively assessed as resistance in response to passive stretch during resting state. Muscle Tone Assessment Muscle Strength An assessment to evaluate the ability to exert force on an object using muscles. Muscle Strength Assessment Muscular Rigidity An evaluation of muscular rigidity (an involuntary, persistent state of firm, tense muscles with marked resistance to passive movement). Muscular Rigidity Evaluation N145 Latency An assessment of the latency of the N145 or N2 wave of the visual evoked potential assessment waveform. N145 Latency N1 Sleep Duration Stage 1 Sleep Duration The length of time of N1 sleep. N1 Sleep Phase Duration N1 Sleep/Total Sleep Time A relative measurement (percentage) of the N1 sleep time to total sleep time. N1 Sleep to Total Sleep Time Ratio Measurement N2 Sleep Duration Stage 2 Sleep Duration The length of time of N2 sleep. N2 Sleep Phase Duration N2 Sleep/Total Sleep Time A relative measurement (percentage) of the N2 sleep time to total sleep time. N2 Sleep to Total Sleep Time Ratio Measurement N3 Sleep Duration Stage 3 Sleep Duration The length of time of N3 sleep. N3 Sleep Phase Duration N3 Sleep/Total Sleep Time A relative measurement (percentage) of the N3 sleep time to total sleep time. N3 Sleep to Total Sleep Time Ratio Measurement N1 Latency N75 Latency An assessment of the latency of the N75 or N1 wave of the visual evoked potential assessment waveform. N75 Latency N-Acetyl Aspartate A measurement of the N-acetyl aspartate in a biological specimen. N-Acetyl Aspartate Measurement N-Acetyl Aspartate/Choline A relative measurement (ratio) of the N-acetyl aspartate to the choline in a biological specimen. N-Acetyl Aspartate to Choline Ratio Measurement N-Acetyl Aspartate/Creatine A relative measurement (ratio) of the N-acetyl aspartate to the creatine in a biological specimen. N-Acetyl Aspartate to Creatine Ratio Measurement N-Acetyl Aspartate/Creatine+Choline A relative measurement (ratio) of the N-acetyl aspartate to the creatinine plus choline to the creatine in a biological specimen. N-Acetyl Aspartate to Creatine and Choline Ratio Measurement N-acetylaspartate + N-acetyl-aspartylglutamate NAA+NAAG A measurement of the N-acetylaspartate plus N-acetyl-aspartylglutamate in a biological specimen. N-acetylaspartate and N-acetyl-aspartylglutamate Measurement Nervous System Examination An observation, assessment or examination of the nervous system. Neurologic Examination Nystagmus An evaluation of nystagmus (involuntary, rapid eye movement). Nystagmus Assessment Overall Hearing Assessment An assessment to evaluate the overall hearing of an individual. Overall Hearing Assessment P100 Amplitude The magnitude, or height, of the P100 wave of the visual evoked potential assessment waveform. This assessment calculates the height from the N75 negative peak to the P100 positive peak. N75 to P100 Peak to Peak Amplitude P100 Latency An assessment of the latency of the P100 or P1 wave of the visual evoked potential assessment waveform. P100 Latency Peak Response Amplitude The maximum height change between the wave and the equilibrium point of a stimulus-response waveform. Peak Response Amplitude Peak Response Amplitude Latency A measurement of the time interval between a stimulus and the maximal response. Peak Response Amplitude Latency Body Coordination Coordination Physical Coordination An assessment to evaluate the ability to move multiple body parts in an orchestrated manner to achieve intended actions. Physical Coordination Assessment Palmar Grasp Reflex An involuntary, primal response in the neonate to grasp the fingers when their palm is touched. This reflex is present until six months of age. Grasp Reflex Plantar Grasp Reflex An involuntary, primal response in the neonate that is characterized by flexion of the toes when the sole of the foot is stroked. Plantar Grasp Reflex Reflex An assessment to evaluate an automatic, instinctive, and unlearned reaction to a stimulus. Reflex Assessment REM Duration The total amount of time an individual spends in rapid eye movement (REM) sleep. Rapid Eye Movement Sleep Phase Duration REM Latency The time between the onset of sleep and the onset of the first rapid eye movement (REM) cycle. Rapid Eye Movement Sleep Phase Latency REM/Total Sleep Time A relative measurement (percentage) of the rapid eye movement (REM) sleep time to total sleep time. REM to Total Sleep Time Ratio Measurement Rooting Reflex An involuntary, primal response in the neonate to search for the nipple when the cheek is touched. Rooting Reflex Sleep Efficiency A relative measurement (percentage) of the total sleep time (N1 sleep + N2 sleep + N3 sleep + REM sleep) to the total time spent in bed. Sleep Efficiency Skin Conductance The degree to which the skin can conduct electricity. Skin Conductance Sleep Onset Latency The duration of time between when the lights are turned off and when the individual falls asleep. Sleep Onset Latency Standing Ability An evaluation of an individual's ability to stand. Standing Ability Evaluation Stepping Reflex An involuntary, primal response in the neonate to take brisk steps when the feet are placed on a surface whilst in a supported standing position. Step Reflex Sucking Reflex An involuntary, primal response in the neonate when a nipple is placed on an infant's lips. Sucking Reflex Standard Uptake Value The ratio between the tissue radioactivity concentration at a point in time C(T) and the injected dose of radioactivity per kilogram of the patient's body weight. Standardized Uptake Value Standard Uptake Value Ratio The ratio between the uptake or binding of a radiopharmaceutical agent in an anatomical region of interest and a context-defined reference anatomical region. Standard Uptake Value Ratio Citric Acid Cycle Rate Krebs Cycle Citric Acid Rate TCA Cycle Rate Tricarboxylic Acid Cycle Rate A measurement of the metabolic rate of the tricarboxylic acid cycle in a biological specimen. Tricarboxylic Acid Cycle Rate Measurement Thickness The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. Thickness Tremor An evaluation of tremor (the shaking movement of the whole body or just a certain part of it, often caused by problems of the neurons responsible for muscle action). Tremor Evaluation Postural Tremor An evaluation of postural tremor (involuntary and rhythmic shaking of a body part that is held against gravity). Postural Tremor Evaluation Resting Tremor An evaluation of resting tremor (involuntary and rhythmic shaking of a body part that is relaxed and not held against gravity, and where the tremor amplitude decreases with voluntary movements). Resting Tremor Evaluation Total Sleep Time The total amount (duration) of sleep time from sleep onset to sleep offset, minus any wake after sleep onset (WASO) episodes during the total sleep period. Total Sleep Time Volume A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. Volume Measurement Walking Ability An evaluation of an individual's ability to walk. Walking Ability Evaluation Awake After Sleep Onset Wake After Sleep Onset Wake Time After Sleep Onset A measurement of the sum of durations of wakefulness episodes throughout the night, not including the wakefulness before sleep onset. Wake After Sleep Onset NVTESTCD Nervous System Findings Test Code CDISC SDTM Nervous System Physiology Test Code Terminology Terminology relevant to the test names that describe nervous system physiology and morphological findings. ABR Wave I, Absolute Latency Auditory Brainstem Response Wave I, Absolute Latency A measurement of the absolute latency of the auditory brainstem response wave I of the auditory evoked potential waveform. Auditory Brainstem Response Wave I, Absolute Latency ABR Wave V, Absolute Latency Auditory Brainstem Response Wave V, Absolute Latency A measurement of the absolute latency of the auditory brainstem response wave V of the auditory evoked potential waveform. Auditory Brainstem Response Wave V, Absolute Latency ABR Wave V, Amplitude Auditory Brainstem Response Wave V, Amplitude A measurement of the magnitude, or height, of the auditory brainstem response wave V of the auditory evoked potential waveform. Auditory Brainstem Response Wave V, Amplitude ABR Wave V, Presence Auditory Brainstem Response Wave V, Presence An assessment of the presence of the auditory brainstem response wave V of the auditory evoked potential waveform. Auditory Brainstem Response Wave V, Presence Asymmetric Tonic Neck Reflex ATNR An involuntary, primal response in the neonate in which the arm extends to follow the infant's gaze, while the opposing arm and leg flex inward. Tonic Neck Reflex Blood Flow Rate The volume of blood per unit time passing through a specified location, such as a point in a blood vessel or an entire organ. Blood Flow Rate Body Movement An assessment of body movements that occur with or without apparent cause. Body Movement Assessment Boundary Shift Integral A measurement of change in volume of an organ or anatomical feature as determined by a shift in tissue boundary over time. Boundary Shift Integral Bradykinesia An evaluation of bradykinesia (slow movement). Bradykinesia Evaluation Choline A measurement of the choline in a biological specimen. Choline Measurement Choline, Free + Glycerophosphorylcholine + Phosphorylcholine Choline, Free+GPC+PCh A measurement of the free choline plus glycerophosphorylcholine (GCP) plus phosphorylcholine (PCh) in a biological specimen. Free Choline and Glycerophosphorylcholine and Phosphorylcholine Measurement Choline/Creatine A relative measurement (ratio) of the choline to the creatine in a biological specimen. Choline to Creatine Ratio Measurement Crawling Ability An evaluation of an individual's ability to crawl. Crawling Ability Evaluation Creatine + Choline A measurement of the creatine plus choline in a biological specimen. Creatine and Choline Measurement Creatine A measurement of the creatine in a biological specimen. Creatine Measurement Creatine+Phosphocreatine A measurement of the creatine plus phosphocreatine in a biological specimen. Creatine and Phosphocreatine Measurement Dysesthesia An evaluation of dysesthesia (distortion of a sense resulting in an abnormal and unpleasant sensation, usually described as burning, tingling, or numbness). Dysesthesia Evaluation Dystonia An evaluation of dystonia (a movement disorder characterized by sustained or intermittent muscle contractions, resulting in abnormal movements and/or postures). Dystonia Evaluation Facial Symmetry An assessment of visual balance and proportion between opposing structures in the face. Facial Symmetry Assessment Galant Reflex An involuntary, primal response in the neonate in which a finger is run down one side of the spine and the neonate laterally flexes toward that side. Galant Reflex Glutamate and Glutamine C3 Enriched A measurement of the C3 enriched glutamate and glutamine in a biological specimen. C3 Enriched Glutamate and Glutamine Measurement Glutamate and Glutamine C3 Enriched/Glutamate and Glutamine Glutamate and Glutamine C3 Enriched/GLX A relative measurement (ratio or percentage) of the C3 enriched glutamate and glutamine to total glutamate and glutamine in a biological specimen. C3 Enriched Glutamate and Glutamine to Total Glutamate and Glutamine Ratio Measurement Glutamate and Glutamine A measurement of the glutamate and glutamine in a biological specimen. Glutamate and Glutamine Measurement Glutamate C4 Enriched A measurement of the C4 enriched glutamate in a biological specimen. C4 Enriched Glutamate Measurement Glutamate C4 Enriched/Glutamate A relative measurement (ratio or percentage) of the C4 enriched glutamate to total glutamate in a biological specimen. C4 Enriched Glutamate to Total Glutamate Ratio Measurement Glutamate Glutamic Acid A measurement of the glutamate in a biological specimen. Glutamate Measurement Glutamate and Glutamine Cycle Rate Glutamate-Glutamine Cycle Rate Glutamate/GABA-Glutamine Cycle Rate A measurement of the metabolic rate of the glutamate-glutamine cycle in a biological specimen. Glutamate-Creatine Cycle Rate Measurement Glutamate/Creatine Glutamic Acid/Creatine A relative measurement (ratio or percentage) of the glutamate to creatine in a biological specimen. Glutamate to Creatine Ratio Measurement Glutamine C4 Enriched A measurement of the C4 enriched glutamine in a biological specimen. C4 Enriched Glutamine Measurement Glutamine C4 Enriched/Glutamine A relative measurement (ratio or percentage) of the C4 enriched glutamine to total glutamine in a biological specimen. C4 Enriched Glutamine to Total Glutamine Ratio Measurement Glutamine A measurement of the glutamine in a biological specimen. Glutamine Measurement Glutamine/Creatine A relative measurement (ratio or percentage) of the glutamine to creatine in a biological specimen. Glutamine to Creatine Ratio Measurement Glycerophosphorylcholine + Phosphorylcholine GPC+PCh A measurement of the glycerophosphorylcholine (GPC) plus phosphorylcholine (PC) in a biological specimen. Glycerophosphorylcholine and Phosphorylcholine Measurement Graphesthesia An evaluation of graphesthesia (the ability to recognize symbols when they're traced on the skin). Graphesthesia Evaluation Lactate/Creatine Lactic Acid/Creatine A relative measurement (ratio or percentage) of the lactate to creatine in a biological specimen. Lactate to Creatine Ratio Measurement Moro Reflex An involuntary, primal response in the neonate to loud noise or the feeling of falling. The response is characterized by the infant's arms symmetrically spreading out to the side and then back to the midline, and involuntarily flexing the fingers and toes. Moro Reflex Muscle Strength An assessment to evaluate the ability to exert force on an object using muscles. Muscle Strength Assessment Muscle Tone An assessment to evaluate residual muscle tension, which may be subjectively assessed as resistance in response to passive stretch during resting state. Muscle Tone Assessment Muscular Rigidity An evaluation of muscular rigidity (an involuntary, persistent state of firm, tense muscles with marked resistance to passive movement). Muscular Rigidity Evaluation mI Myo-Inositol A measurement of the myo-inositol in a biological specimen. Myo-Inositol Measurement Myo-Inositol/Creatine A relative measurement (ratio or percentage) of the myo-inositol to creatine in a biological specimen. Myo-inositol/Creatine Ratio N-Acetyl Aspartate A measurement of the N-acetyl aspartate in a biological specimen. N-Acetyl Aspartate Measurement N-Acetyl Aspartate/Choline A relative measurement (ratio) of the N-acetyl aspartate to the choline in a biological specimen. N-Acetyl Aspartate to Choline Ratio Measurement N-Acetyl Aspartate/Creatine A relative measurement (ratio) of the N-acetyl aspartate to the creatine in a biological specimen. N-Acetyl Aspartate to Creatine Ratio Measurement N-Acetyl Aspartate/Creatine+Choline A relative measurement (ratio) of the N-acetyl aspartate to the creatinine plus choline to the creatine in a biological specimen. N-Acetyl Aspartate to Creatine and Choline Ratio Measurement N1 Sleep Duration Stage 1 Sleep Duration The length of time of N1 sleep. N1 Sleep Phase Duration N1 Sleep/Total Sleep Time A relative measurement (percentage) of the N1 sleep time to total sleep time. N1 Sleep to Total Sleep Time Ratio Measurement N145 Latency An assessment of the latency of the N145 or N2 wave of the visual evoked potential assessment waveform. N145 Latency N2 Sleep Duration Stage 2 Sleep Duration The length of time of N2 sleep. N2 Sleep Phase Duration N2 Sleep/Total Sleep Time A relative measurement (percentage) of the N2 sleep time to total sleep time. N2 Sleep to Total Sleep Time Ratio Measurement N3 Sleep Duration Stage 3 Sleep Duration The length of time of N3 sleep. N3 Sleep Phase Duration N3 Sleep/Total Sleep Time A relative measurement (percentage) of the N3 sleep time to total sleep time. N3 Sleep to Total Sleep Time Ratio Measurement N1 Latency N75 Latency An assessment of the latency of the N75 or N1 wave of the visual evoked potential assessment waveform. N75 Latency N-acetylaspartate + N-acetyl-aspartylglutamate NAA+NAAG A measurement of the N-acetylaspartate plus N-acetyl-aspartylglutamate in a biological specimen. N-acetylaspartate and N-acetyl-aspartylglutamate Measurement Nervous System Examination An observation, assessment or examination of the nervous system. Neurologic Examination Nystagmus An evaluation of nystagmus (involuntary, rapid eye movement). Nystagmus Assessment Overall Hearing Assessment An assessment to evaluate the overall hearing of an individual. Overall Hearing Assessment P100 Amplitude The magnitude, or height, of the P100 wave of the visual evoked potential assessment waveform. This assessment calculates the height from the N75 negative peak to the P100 positive peak. N75 to P100 Peak to Peak Amplitude P100 Latency An assessment of the latency of the P100 or P1 wave of the visual evoked potential assessment waveform. P100 Latency Palmar Grasp Reflex An involuntary, primal response in the neonate to grasp the fingers when their palm is touched. This reflex is present until six months of age. Grasp Reflex Peak Response Amplitude Latency A measurement of the time interval between a stimulus and the maximal response. Peak Response Amplitude Latency Peak Response Amplitude The maximum height change between the wave and the equilibrium point of a stimulus-response waveform. Peak Response Amplitude Body Coordination Coordination Physical Coordination An assessment to evaluate the ability to move multiple body parts in an orchestrated manner to achieve intended actions. Physical Coordination Assessment Plantar Grasp Reflex An involuntary, primal response in the neonate that is characterized by flexion of the toes when the sole of the foot is stroked. Plantar Grasp Reflex Postural Tremor An evaluation of postural tremor (involuntary and rhythmic shaking of a body part that is held against gravity). Postural Tremor Evaluation Reflex An assessment to evaluate an automatic, instinctive, and unlearned reaction to a stimulus. Reflex Assessment REM Duration The total amount of time an individual spends in rapid eye movement (REM) sleep. Rapid Eye Movement Sleep Phase Duration REM Latency The time between the onset of sleep and the onset of the first rapid eye movement (REM) cycle. Rapid Eye Movement Sleep Phase Latency REM/Total Sleep Time A relative measurement (percentage) of the rapid eye movement (REM) sleep time to total sleep time. REM to Total Sleep Time Ratio Measurement Resting Tremor An evaluation of resting tremor (involuntary and rhythmic shaking of a body part that is relaxed and not held against gravity, and where the tremor amplitude decreases with voluntary movements). Resting Tremor Evaluation Rooting Reflex An involuntary, primal response in the neonate to search for the nipple when the cheek is touched. Rooting Reflex Skin Conductance The degree to which the skin can conduct electricity. Skin Conductance Sleep Efficiency A relative measurement (percentage) of the total sleep time (N1 sleep + N2 sleep + N3 sleep + REM sleep) to the total time spent in bed. Sleep Efficiency Sleep Onset Latency The duration of time between when the lights are turned off and when the individual falls asleep. Sleep Onset Latency Involuntary Body Movement Spontaneous Body Movement An assessment of body movements that occur without apparent external cause. Spontaneous Body Movement Assessment Standard Uptake Value Ratio The ratio between the uptake or binding of a radiopharmaceutical agent in an anatomical region of interest and a context-defined reference anatomical region. Standard Uptake Value Ratio Standard Uptake Value The ratio between the tissue radioactivity concentration at a point in time C(T) and the injected dose of radioactivity per kilogram of the patient's body weight. Standardized Uptake Value Standing Ability An evaluation of an individual's ability to stand. Standing Ability Evaluation Stepping Reflex An involuntary, primal response in the neonate to take brisk steps when the feet are placed on a surface whilst in a supported standing position. Step Reflex Sucking Reflex An involuntary, primal response in the neonate when a nipple is placed on an infant's lips. Sucking Reflex Thickness The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. Thickness Total Sleep Time The total amount (duration) of sleep time from sleep onset to sleep offset, minus any wake after sleep onset (WASO) episodes during the total sleep period. Total Sleep Time Tremor An evaluation of tremor (the shaking movement of the whole body or just a certain part of it, often caused by problems of the neurons responsible for muscle action). Tremor Evaluation Citric Acid Cycle Rate Krebs Cycle Citric Acid Rate TCA Cycle Rate Tricarboxylic Acid Cycle Rate A measurement of the metabolic rate of the tricarboxylic acid cycle in a biological specimen. Tricarboxylic Acid Cycle Rate Measurement Volume A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. Volume Measurement Awake After Sleep Onset Wake After Sleep Onset Wake Time After Sleep Onset A measurement of the sum of durations of wakefulness episodes throughout the night, not including the wakefulness before sleep onset. Wake After Sleep Onset Walking Ability An evaluation of an individual's ability to walk. Walking Ability Evaluation NVTEST Nervous System Findings Test Name CDISC SDTM Nervous System Physiology Test Name Terminology Neuropathic Pain Scale test code. NPS01-Tell Us How Intense Your Pain Is Neuropathic Pain Scale - Please use the scale below to tell us how intense your pain is. NPS - Tell Us How Intense Your Pain Is NPS01-Tell Us How Sharp Your Pain Feels Neuropathic Pain Scale - Please use the scale below to tell us how sharp your pain feels. Words used to describe 'sharp' feelings include 'like a knife,' 'like a spike,' 'jabbing,' or 'like jolts.' NPS - Tell Us How Sharp Your Pain Feels NPS01-Tell Us How Hot Your Pain Feels Neuropathic Pain Scale - Please use the scale below to tell us how hot your pain feels. Words used to describe very hot pain include 'burning' and 'on fire.' NPS - Tell Us How Hot Your Pain Feels NPS01-Tell Us How Dull Your Pain Feels Neuropathic Pain Scale - Please use the scale below to tell us how dull your pain feels. Words used to describe very dull pain include 'like a dull toothache,' 'dull pain,' and 'like a bruise.' NPS - Tell Us How Dull Your Pain Feels NPS01-Tell Us How Cold Your Pain Feels Neuropathic Pain Scale - Please use the scale below to tell us how cold your pain feels. Words used to describe very cold pain included 'like ice' and 'freezing.' NPS - Tell Us How Cold Your Pain Feels NPS01-Sensitiv Skin to Light Touch/Cloth Neuropathic Pain Scale - Please use the scale below to tell us how sensitive your skin is to light touch or clothing. Words used to describe sensitive skin include 'like sunburned skin,' and 'raw skin.' NPS - Tell Us How Sensitive Your Skin is to Light Touch or Clothing NPS01-Tell Us How Itchy Your Pain Feels Neuropathic Pain Scale - Please use the scale below to tell us how itchy your pain feels. Words used to describe itchy pain include 'like poison oak' and 'like a mosquito bite.' NPS - Tell Us How Itchy Your Pain Feels NPS01-Describe Time Quality Of Your Pain Neuropathic Pain Scale - Which of the following best describes the time quality of your pain? Please check only one answer. NPS - Describe the Time Quality Of Your Pain NPS01-Describe the Background Pain Neuropathic Pain Scale - I feel a background pain all of the time and occasional flare-ups (break-through pain) some of the time. Describe the background pain. NPS - Describe the Background Pain NPS01-Describe the Flare-up Pain Neuropathic Pain Scale - I feel a background pain all of the time and occasional flare-ups (break-through pain) some of the time. Describe the flare-up (break-through) pain. NPS - Describe the Flare-up Pain NPS01-Describe Single Type Pain All Time Neuropathic Pain Scale - I feel a single type of pain all the time. Describe this pain. NPS - Describe the Single Type of Pain All Time NPS01-Describe the Occasional Pain Neuropathic Pain Scale - I fee a single type of pain only sometimes. Other times, I am pain free. Describe the occasional pain. NPS - Describe the Occasional Pain NPS01-Tell How Unpleasant Your Pain Feel Neuropathic Pain Scale - Now that you have told us the different physical aspects of your pain, the different types of sensations, we want you to tell us overall how unpleasant your pain is to you. Words used to describe very unpleasant pain include 'miserable' and intolerable.' Remember, pain can have a low intensity, buy still feel extremely unpleasant, and some kinds of pain can have a high intensity but be very tolerable. With this scale, please tell us how unpleasant your pain feels. NPS - Tell Us Overall How Unpleasant Your Pain is to You NPS01-How Intense is Your Deep Pain Neuropathic Pain Scale - Lastly, we want you to give us an estimate of the severity of your deep versus surface pain. We want your to rate each location of pain separately. We realize that it can be difficult to make these estimates, and most likely it will be a 'best guess,' but please give us your best estimate. How intense is your deep pain? NPS - How Intense is Your Deep Pain NPS01-How Intense is Your Surface Pain Neuropathic Pain Scale - Lastly, we want you to give us an estimate of the severity of your deep versus surface pain. We want your to rate each location of pain separately. We realize that it can be difficult to make these estimates, and most likely it will be a 'best guess,' but please give us your best estimate. How intense is your surface pain? NPS - How Intense is Your Surface Pain NPS01TC Neuropathic Pain Scale Questionnaire Test Code CDISC Questionnaire NPS Test Code Terminology Neuropathic Pain Scale test name. NPS01-Describe Single Type Pain All Time Neuropathic Pain Scale - I feel a single type of pain all the time. Describe this pain. NPS - Describe the Single Type of Pain All Time NPS01-Describe the Background Pain Neuropathic Pain Scale - I feel a background pain all of the time and occasional flare-ups (break-through pain) some of the time. Describe the background pain. NPS - Describe the Background Pain NPS01-Describe the Flare-up Pain Neuropathic Pain Scale - I feel a background pain all of the time and occasional flare-ups (break-through pain) some of the time. Describe the flare-up (break-through) pain. NPS - Describe the Flare-up Pain NPS01-Describe the Occasional Pain Neuropathic Pain Scale - I fee a single type of pain only sometimes. Other times, I am pain free. Describe the occasional pain. NPS - Describe the Occasional Pain NPS01-Describe Time Quality Of Your Pain Neuropathic Pain Scale - Which of the following best describes the time quality of your pain? Please check only one answer. NPS - Describe the Time Quality Of Your Pain NPS01-How Intense is Your Deep Pain Neuropathic Pain Scale - Lastly, we want you to give us an estimate of the severity of your deep versus surface pain. We want your to rate each location of pain separately. We realize that it can be difficult to make these estimates, and most likely it will be a 'best guess,' but please give us your best estimate. How intense is your deep pain? NPS - How Intense is Your Deep Pain NPS01-How Intense is Your Surface Pain Neuropathic Pain Scale - Lastly, we want you to give us an estimate of the severity of your deep versus surface pain. We want your to rate each location of pain separately. We realize that it can be difficult to make these estimates, and most likely it will be a 'best guess,' but please give us your best estimate. How intense is your surface pain? NPS - How Intense is Your Surface Pain NPS01-Sensitiv Skin to Light Touch/Cloth Neuropathic Pain Scale - Please use the scale below to tell us how sensitive your skin is to light touch or clothing. Words used to describe sensitive skin include 'like sunburned skin,' and 'raw skin.' NPS - Tell Us How Sensitive Your Skin is to Light Touch or Clothing NPS01-Tell How Unpleasant Your Pain Feel Neuropathic Pain Scale - Now that you have told us the different physical aspects of your pain, the different types of sensations, we want you to tell us overall how unpleasant your pain is to you. Words used to describe very unpleasant pain include 'miserable' and intolerable.' Remember, pain can have a low intensity, buy still feel extremely unpleasant, and some kinds of pain can have a high intensity but be very tolerable. With this scale, please tell us how unpleasant your pain feels. NPS - Tell Us Overall How Unpleasant Your Pain is to You NPS01-Tell Us How Cold Your Pain Feels Neuropathic Pain Scale - Please use the scale below to tell us how cold your pain feels. Words used to describe very cold pain included 'like ice' and 'freezing.' NPS - Tell Us How Cold Your Pain Feels NPS01-Tell Us How Dull Your Pain Feels Neuropathic Pain Scale - Please use the scale below to tell us how dull your pain feels. Words used to describe very dull pain include 'like a dull toothache,' 'dull pain,' and 'like a bruise.' NPS - Tell Us How Dull Your Pain Feels NPS01-Tell Us How Hot Your Pain Feels Neuropathic Pain Scale - Please use the scale below to tell us how hot your pain feels. Words used to describe very hot pain include 'burning' and 'on fire.' NPS - Tell Us How Hot Your Pain Feels NPS01-Tell Us How Intense Your Pain Is Neuropathic Pain Scale - Please use the scale below to tell us how intense your pain is. NPS - Tell Us How Intense Your Pain Is NPS01-Tell Us How Itchy Your Pain Feels Neuropathic Pain Scale - Please use the scale below to tell us how itchy your pain feels. Words used to describe itchy pain include 'like poison oak' and 'like a mosquito bite.' NPS - Tell Us How Itchy Your Pain Feels NPS01-Tell Us How Sharp Your Pain Feels Neuropathic Pain Scale - Please use the scale below to tell us how sharp your pain feels. Words used to describe 'sharp' feelings include 'like a knife,' 'like a spike,' 'jabbing,' or 'like jolts.' NPS - Tell Us How Sharp Your Pain Feels NPS01TN Neuropathic Pain Scale Questionnaire Test Name CDISC Questionnaire NPS Test Name Terminology The Neuropsychiatric Inventory test code. NPI1-Beliefs Untrue Neuropsychiatric Inventory - Does the patient have beliefs that you know are not true? (for example, insisting that people are trying to harm him/her or steal from him/her)? Has he/she said that family members are not who they say they are or that the house is not their home? I'm not asking about mere suspiciousness; I am interested if the patient is convinced that these things are happening to him/her. NPI - Have Beliefs That You Know are Not True NPI1-In Danger Neuropsychiatric Inventory - Does the patient believe that he/she is in danger - that others are planning to hurt him/her? NPI - He/She is in Danger NPI1-Others Are Stealing Neuropsychiatric Inventory - Does the patient believe that others are stealing from him/her? NPI - Others are Stealing From Him/Her NPI1-Spouse Having Affair Neuropsychiatric Inventory - Does the patient believe that his/her spouse is having an affair? NPI - His/Her Spouse is Having an Affair NPI1-Unwelcome Guests in House Neuropsychiatric Inventory - Does the patient believe that unwelcome guests are living in his/her house? NPI - Unwelcome Guests are Living in His/Her House NPI1-People Not Who They Claim Neuropsychiatric Inventory - Does the patient believe that his/her spouse or others are not who they claim to be? NPI - His/Her Spouse or Others Are Not Who They Claim To Be NPI1-House Not Their Home Neuropsychiatric Inventory - Does the patient believe that his/her house is not his/her home? NPI - His/Her House Is Not His/Her Home NPI1-Family Plans to Abandon Neuropsychiatric Inventory - Does the patient believe that family members plan to abandon him/her? NPI - Family Members Plan to Abandon Him/Her NPI1-TV/Magazine Figures Present Neuropsychiatric Inventory - Does the patient believe that television or magazine figures are actually present in the home? (Does he/she try to talk or interact with them?) NPI - Television or Magazine Figures Are Actually Present In the Home NPI1-Other Unusual Beliefs Neuropsychiatric Inventory - Does the patient believe any other unusual things that I haven't asked about? NPI - Any Other Unusual Things That I Haven't Asked About NPI1-Delusions Frequency Neuropsychiatric Inventory - Frequency of the delusions. NPI - Delusions Frequency NPI1-Delusions Severity Neuropsychiatric Inventory - Severity of the delusions. NPI - Delusions Severity NPI1-Delusions Distress Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? NPI - Delusions Distress NPI1-Delusions FxS Score Neuropsychiatric Inventory - Delusions: (frequency score x severity score). NPI - Delusions FxS Score NPI1-False Visions or Voices Neuropsychiatric Inventory - Does the patient have hallucinations such as seeing false visions or hearing false voices? Does he/she seem to see, hear or experience things that are not present? By this question we do not mean just mistaken beliefs such as stating that someone who has died is still alive; rather we are asking if the patient actually has abnormal experiences of sounds or visions. NPI - Hallucinations Such as Seeing False Visions or Hearing False Voices NPI1-Hearing Voices Neuropsychiatric Inventory - Does the patient describe hearing voices or act as if he/she hears voices? NPI - Describe Hearing Voices or Act as if He/She Hears Voices NPI1-Talk to People Not There Neuropsychiatric Inventory - Does the patient talk to people who are not there? NPI - Talk to People Who Are Not There NPI1-See Things Not Seen by Others Neuropsychiatric Inventory - Does the patient describe seeing things not seen by others or behave as if he/she is seeing things not seen by others (people, animals, lights, etc.)? NPI - Describe Seeing Things Not Seen by Others NPI1-Smell Odors Others Do Not Smell Neuropsychiatric Inventory - Does the patient report smelling odors not smelled by others? NPI - Report Smelling Odors Not Smelled by Others NPI1-Feel Things on Skin Neuropsychiatric Inventory - Does the patient describe feeling things on his/her skin or otherwise appear to be feeling things crawling or touching him/her? NPI - Describe Feeling Things on His/Her Skin NPI1-Taste without Known Cause Neuropsychiatric Inventory - Does the patient describe tastes that are without any known cause? NPI - Describe Tastes That Are Without Any Known Cause NPI1-Other Unusual Sensory Experience Neuropsychiatric Inventory - Does the patient describe any other unusual sensory experiences? NPI - Describe Any Other Unusual Sensory Experiences NPI1-Hallucinations Frequency Neuropsychiatric Inventory - Frequency of the hallucinations. NPI - Hallucinations Frequency NPI1-Hallucinations Severity Neuropsychiatric Inventory - Severity of the hallucinations. NPI - Hallucinations Severity NPI1-Hallucinations Distress Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? NPI - Hallucinations Distress NPI1-Hallucinations FxS Score Neuropsychiatric Inventory - Hallucinations: (frequency score x severity score). NPI - Hallucinations FxS Score NPI1-Refuse to Cooperate Neuropsychiatric Inventory - Does the patient have periods when he/she refuses to cooperate or won't let people help him/her? Is he/she hard to handle? NPI - Periods When He/She Refuses to Cooperate NPI1-Get Upset with Caregiver Neuropsychiatric Inventory - Does the patient get upset with those trying to care for him/her or resist activities such as bathing or changing clothes? NPI - Get Upset with Those Trying to Care for Him/Her NPI1-Stubborn Neuropsychiatric Inventory - Is the patient stubborn, having to have things his/her way? NPI - Stubborn NPI1-Uncooperative Neuropsychiatric Inventory - Is the patient uncooperative, resistive to help from others? NPI - Uncooperative NPI1-Other Behaviors Hard to Handle Neuropsychiatric Inventory - Does the patient have any other behaviors that make him/her hard to handle? NPI - Any Other Behaviors That Make Him/Her Hard to Handle NPI1-Shout or Curse Angrily Neuropsychiatric Inventory - Does the patient shout or curse angrily? NPI - Shout or Curse Angrily NPI1-Slam, Kick or Throw Things Neuropsychiatric Inventory - Does the patient slam doors, kick furniture, throw things? NPI - Slam doors, Kick Furniture, Throw Things NPI1-Hurt or Hit Others Neuropsychiatric Inventory - Does the patient attempt to hurt or hit others? NPI - Attempt to Hurt or Hit Others NPI1-Other Aggressive Behavior Neuropsychiatric Inventory - Does the patient have any other aggressive or agitated behaviors? NPI - Any Other Aggressive or Agitated Behaviors NPI1-Agitation/Aggression Frequency Neuropsychiatric Inventory - Frequency of the agitation/aggression. NPI - Agitation/Aggression Frequency NPI1-Agitation/Aggression Severity Neuropsychiatric Inventory - Severity of the agitation/aggression. NPI - Agitation/Aggression Severity NPI1-Agitation/Aggression Distress Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? NPI - Agitation/Aggression Distress NPI1-Agitation/Aggression FxS Score Neuropsychiatric Inventory - Agitation/Aggression: (frequency score x severity score). NPI - Agitation/Aggression FxS Score NPI1-Sad or Depressed Neuropsychiatric Inventory - Does the patient seem sad or depressed? Does he/she say that he/she feels sad or depressed? NPI - Seem Sad or Depressed NPI1-Tearfulness or Sobbing Neuropsychiatric Inventory - Does the patient have periods of tearfulness or sobbing that seem to indicate sadness? NPI - Periods of Tearfulness or Sobbing NPI1-Say or Act in Low Spirits Neuropsychiatric Inventory - Does the patient say, or act as if he/she is sad or in low spirits? NPI - Say, or Act as if He/She is Sad or in Low Spirits NPI1-Feel Like a Failure Neuropsychiatric Inventory - Does the patient put him/herself down or say that he/she feels like a failure? NPI - Put Him/Herself Down or Say That He/She Feels Like a Failure NPI1-Bad Person Neuropsychiatric Inventory - Does the patient say that he/she is a bad person or deserves to be punished? NPI - Say That He/She is a Bad Person NPI1-Discouraged Neuropsychiatric Inventory - Does the patient seem very discouraged or say that he/she has no future? NPI - Seem Very Discouraged NPI1-Burden to Family Neuropsychiatric Inventory - Does the patient say he/she is a burden to the family or that the family would be better off without him/her? NPI - Say He/She is a Burden to the Family NPI1-Wish for Death Neuropsychiatric Inventory - Does the patient express a wish for death or talk about killing himself/herself? NPI - Express a Wish for Death NPI1-Other Signs of Depression Neuropsychiatric Inventory - Does the patient show any other signs of depression or sadness? NPI - Show Any Other Signs of Depression or Sadness NPI1-Depression/Dysphoria Frequency Neuropsychiatric Inventory - Frequency of the depression/dysphoria. NPI - Depression/Dysphoria Frequency NPI1-Depression/Dysphoria Severity Neuropsychiatric Inventory - Severity of the depression/dysphoria. NPI - Depression/Dysphoria Severity NPI1-Depression/Dysphoria Distress Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? NPI - Depression/Dysphoria Distress NPI1-Depression/Dysphoria FxS Score Neuropsychiatric Inventory - Depression/Dysphoria: (frequency score x severity score). NPI - Depression/Dysphoria FxS Score NPI1-NPI Total Distress Score Neuropsychiatric Inventory - Sub-total of distress score. NPI - NPI Total Distress Score NPI1-Nervous or Worried Neuropsychiatric Inventory - Is the patient very nervous, worried, or frightened for no apparent reason? Does he/she seem very tense or fidgety? Is the patient afraid to be apart from you? NPI - Very Nervous, Worried, or Frightened for No Apparent Reason NPI1-Worried about Planned Event Neuropsychiatric Inventory - Does the patient say that he/she is worried about planned events? NPI - Say That He/She is Worried About Planned Events NPI1-Shaky or Unable to Relax Neuropsychiatric Inventory - Does the patient have periods of feeling shaky, unable to relax, or feeling excessively tense? NPI - Periods of Feeling Shaky, Unable to Relax, or Feeling Excessively Tense NPI1-Short of Breath, Gasp, Sigh Neuropsychiatric Inventory - Does the patient have periods of (or complain of) shortness of breath, gasping, or sighing for no apparent reason other than nervousness? NPI - Periods of Shortness of Breath, Gasping, or Sighing for No Apparent Reason NPI1-Butterflies or Racing Heart Neuropsychiatric Inventory - Does the patient complain of butterflies in his/her stomach, or of racing or pounding of the heart in association with nervousness? (Symptoms not explained by ill health). NPI - Complain of Butterflies, Racing or Pounding Heart NPI1-Avoid Places or Situations Neuropsychiatric Inventory - Does the patient avoid certain places or situations that make him/her more nervous such as riding in the car, meeting with friends, or being in crowds? NPI - Avoid Certain Places or Situations That Make Him/Her More Nervous NPI1-Nervous when Separated Neuropsychiatric Inventory - Does the patient become nervous and upset when separated from you (or his/her caregiver)? (Does he/she cling to you to keep from being separated?). NPI - Become Nervous and Upset When Separated From You NPI1-Other Signs of Anxiety Neuropsychiatric Inventory - Does the patient show any other signs of anxiety? NPI - Show Any Other Signs of Anxiety NPI1-Anxiety Frequency Neuropsychiatric Inventory - Frequency of the anxiety. NPI - Anxiety Frequency NPI1-Anxiety Severity Neuropsychiatric Inventory - Severity of the anxiety. NPI - Anxiety Severity NPI1-Anxiety Distress Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? NPI - Anxiety Distress NPI1-Anxiety FxS Score Neuropsychiatric Inventory - Anxiety: (frequency score x severity score). NPI - Anxiety FxS Score NPI1-Too Cheerful or Happy Neuropsychiatric Inventory - Does the patient seem too cheerful or too happy for no reason? I don't mean the normal happiness that comes from seeing friends, receiving presents, or spending time with family members. I am asking if the patient has a persistent and abnormally good mood or finds humor where others do not. NPI - Seem Too Cheerful or Too Happy for No Reason NPI1-Feel Good or Too Happy Neuropsychiatric Inventory - Does the patient appear to feel good or to be too happy, different from his/her usual self? NPI - Appear to Feel Good or to Be Too Happy NPI1-Humor Others Do Not Find Funny Neuropsychiatric Inventory - Does the patient find humor and laugh at things that others do not find funny? NPI - Fine Humor and Laugh at Things That Others Do Not Find Funny NPI1-Childish Sense of Humor Neuropsychiatric Inventory - Does the patient seem to have a childish sense of humor with a tendency to giggle or laugh inappropriately (such as when something unfortunate happens to others)? NPI - Seem to Have a Childish Sense of Humor NPI1-Jokes Others Do Not Find Funny Neuropsychiatric Inventory - Does the patient tell jokes or make remarks that are not funny to others but seem funny to him/her? NPI - Tell Jokes or Make Remarks That are Not Funny to Others NPI1-Childish Pranks Neuropsychiatric Inventory - Does he/she play childish pranks such as pinching or playing "keep away" for the fun of it? NPI - Play Childish Pranks NPI1-Talk Big Neuropsychiatric Inventory - Does the patient "talk big" or claim to have more abilities or wealth than is true? NPI - Talk Big or Claim to Have More Abilities or Wealth Than is True NPI1-Other Signs of Feeling Too Happy Neuropsychiatric Inventory - Does the patient show any other signs of feeling too good or being too happy? NPI - Show Any Other Signs of Feeling Too Good or Being Too Happy NPI1-Elation/Euphoria Frequency Neuropsychiatric Inventory - Frequency of the elation/euphoria. NPI - Elation/Euphoria Frequency NPI1-Elation/Euphoria Severity Neuropsychiatric Inventory - Severity of the elation/euphoria. NPI - Elation/Euphoria Severity NPI1-Elation/Euphoria Distress Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? NPI - Elation/Euphoria Distress NPI1-Elation/Euphoria FxS Score Neuropsychiatric Inventory - Elation/Euphoria: (frequency score x severity score). NPI - Elation/Euphoria FxS Score NPI1-Lost Interest in World Neuropsychiatric Inventory - Has the patient lost interest in the world around him/her? Has he/she lost interest in doing things or does he/she lack motivation for starting new activities? Is he/she more difficult to engage in conversation or in doing chores? Is the patient apathetic or indifferent? NPI - Lost Interest in the World Around Him/Her NPI1-Less Spontaneous or Active Neuropsychiatric Inventory - Does the patient seem less spontaneous and less active than usual? NPI - Seem Less Spontaneous and Less Active Than Usual NPI1-Less Likely Initiate Conversation Neuropsychiatric Inventory - Is the patient less likely to initiate a conversation? NPI - Less Likely Initiate to Initiate a Conversation NPI1-Less Affectionate Neuropsychiatric Inventory - Is the patient less affectionate or lacking in emotions when compared to his/her usual self? NPI - Less Affectionate or Lacking in Emotions NPI1-Contribute Less to Chores Neuropsychiatric Inventory - Does the patient contribute less to household chores? NPI - Contribute Less to Household Chores NPI1-Less Interest in Activities Neuropsychiatric Inventory - Does the patient seem less interested in the activities and plans of others? NPI - Less Interested in the Activities and Plans of Others NPI1-Lost Interest in Friends Neuropsychiatric Inventory - Has the patient lost interest in friends and family members? NPI - Lost Interest in Friends and Family Members NPI1-Less Enthusiastic Neuropsychiatric Inventory - Is the patient less enthusiastic about his/her usual interests? NPI - Less Enthusiastic About His/Her Usual Interests NPI1-Other Signs of Not Caring Neuropsychiatric Inventory - Does the patient show any other signs that he/she doesn't care about doing new things? NPI - Show Any Other Signs That He/She Doesn't Care About Doing New Things NPI1-Apathy/Indifference Frequency Neuropsychiatric Inventory - Frequency of the apathy/indifference. NPI - Apathy/Indifference Frequency NPI1-Apathy/Indifference Severity Neuropsychiatric Inventory - Severity of the apathy/indifference. NPI - Apathy/Indifference Severity NPI1-Apathy/Indifference Distress Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? NPI - Apathy/Indifference Distress NPI1-Apathy/Indifference FxS Score Neuropsychiatric Inventory - Apathy/Indifference: (frequency score x severity score). NPI - Apathy/Indifference FxS Score NPI1-Act Impulsively Neuropsychiatric Inventory - Does the patient seem to act impulsively without thinking? Does he/she do or say things that are not usually done or said in public? Does he/she do things that are embarrassing to you or others? NPI - Seem to Act Impulsively Without Thinking NPI1-Act Impulsively without Care Neuropsychiatric Inventory - Does the patient act impulsively without appearing to consider the consequences? NPI - Act Impulsively without Appearing to Consider the Consequences NPI1-Talk to Strangers Neuropsychiatric Inventory - Does the patient talk to total strangers as if he/she knew them? NPI - Talk to Total Strangers as if He/She Knew Them NPI1-Say Insensitive Things Neuropsychiatric Inventory - Does the patient say things to people that are insensitive or hurt their feelings? NPI - Say Things to People that are Insensitive NPI1-Make Crude Remarks Neuropsychiatric Inventory - Does the patient say crude things or make sexual remarks that he/she would not usually have said? NPI - Say Crude Things or Make Sexual Remarks NPI1-Talk Openly about Private Matters Neuropsychiatric Inventory - Does the patient talk openly about very personal or private matters not usually discussed in public? NPI - Talk Openly About Very Personal or Private Matters NPI1-Take Liberties or Touch Others Neuropsychiatric Inventory - Does the patient take liberties or touch or hug others in a way that is out of character for him/her? NPI - Take Liberties or Touch or Hug Others NPI1-Other Signs of Impulses Neuropsychiatric Inventory - Does the patient show any other signs of loss of control of his/her impulses? NPI - Show Any Other Signs of Loss of Control of His/Her Impulses NPI1-Disinhibition Frequency Neuropsychiatric Inventory - Frequency of the disinhibition. NPI - Disinhibition Frequency NPI1-Disinhibition Severity Neuropsychiatric Inventory - Severity of the disinhibition. NPI - Disinhibition Severity NPI1-Disinhibition Distress Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? NPI - Disinhibition Distress NPI1-Disinhibition FxS Score Neuropsychiatric Inventory - Disinhibition: (frequency score x severity score). NPI - Disinhibition FxS Score NPI1-Irritated and Easily Disturbed Neuropsychiatric Inventory - Does the patient get irritated and easily disturbed? Are his/her moods very changeable? Is he/she abnormally impatient? We do not mean frustration over memory loss or inability to perform usual tasks; we are interested to know if the patient has abnormal irritability, impatience, or rapid emotional changes different from his/her usual self. NPI - Get Irritated and Easily Disturbed NPI1-Bad Temper Neuropsychiatric Inventory - Does the patient have a bad temper, flying "off the handle" easily over little things? NPI - Bad Temper, Flying 'Off the Handle' Easily Over Little Things NPI1-Rapidly Change Moods Neuropsychiatric Inventory - Does the patient rapidly change moods from one to another, being fine one minute and angry the next? NPI - Rapidly Change Moods From One to Another NPI1-Sudden Anger Neuropsychiatric Inventory - Does the patient have sudden flashes of anger? NPI - Sudden Flares of Anger NPI1-Impatient Neuropsychiatric Inventory - Is the patient impatient, having trouble coping with delays or waiting for planned activities? NPI - Impatient, Having Trouble Coping with Delays NPI1-Cranky and Irritable Neuropsychiatric Inventory - Is the patient cranky and irritable? NPI - Cranky and Irritable NPI1-Argumentative Neuropsychiatric Inventory - Is the patient argumentative and difficult to get along with? NPI - Argumentative and Difficult to Get Along With NPI1-Other Signs of Irritability Neuropsychiatric Inventory - Does the patient show any other signs of irritability? NPI - Show Any Other Signs of Irritability NPI1-Irritability/Lability Frequency Neuropsychiatric Inventory - Frequency of the irritability/lability. NPI - Irritability/Lability Frequency NPI1-Irritability/Lability Severity Neuropsychiatric Inventory - Severity of the irritability/lability. NPI - Irritability/Lability Severity NPI1-Irritability/Lability Distress Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? NPI - Irritability/Lability Distress NPI1-Irritability/Lability FxS Score Neuropsychiatric Inventory - Irritability/Lability: (frequency score x severity score). NPI - Irritability/Lability FxS Score NPI1-Do Things Repeatedly Neuropsychiatric Inventory - Does the patient pace, do things over and over such as opening closets or drawers, or repeatedly pick at things or wind string or threads? NPI - Pace, Do Things Over and Over, Repeatedly Pick at Things NPI1-Pace Neuropsychiatric Inventory - Does the patient pace around the house without apparent purpose? NPI - Pace Around the House Without Apparent Purpose NPI1-Rummage Around and Unpack Neuropsychiatric Inventory - Does the patient rummage around opening and unpacking drawers or closets? NPI - Rummage Around Opening and Unpacking Drawers or Closets NPI1-Repeatedly Change Clothing Neuropsychiatric Inventory - Does the patient repeatedly put on and take off clothing? NPI - Repeatedly Put On and Take Off Clothing NPI1-Repetitive Activities or Habits Neuropsychiatric Inventory - Does the patient have repetitive activities or "habits" that he/she performs over and over? NPI - Repetitive Activities or 'Habits' NPI1-Repetitive Activities Neuropsychiatric Inventory - Does the patient engage in repetitive activities such as handling buttons, picking, wrapping string, etc.? NPI - Engage in Repetitive Activities NPI1-Fidget Excessively Neuropsychiatric Inventory - Does the patient fidget excessively, seem unable to sit still, or bounce his/her feet or tap his/her fingers a lot? NPI - Fidget Excessively, Seem Unable to Sit Still NPI1-Other Repetitive Activities Neuropsychiatric Inventory - Does the patient do any other activities over and over? NPI - Do Any Other Activities Over and Over NPI1-Aberrant Motor Behavior Frequency Neuropsychiatric Inventory - Frequency of the aberrant motor behavior. NPI - Aberrant Motor Behavior Frequency NPI1-Aberrant Motor Behavior Severity Neuropsychiatric Inventory - Severity of the aberrant motor behavior. NPI - Aberrant Motor Behavior Severity NPI1-Aberrant Motor Behavior Distress Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? NPI - Aberrant Motor Behavior Distress NPI1-Aberrant Motor Behavior FxS Score Neuropsychiatric Inventory - Aberrant Motor Behavior: (frequency score x severity score). NPI - Aberrant Motor Behavior FxS Score NPI1-Difficulty Sleeping Neuropsychiatric Inventory - Does the patient have difficulty sleeping (do not count as present if the patient simply gets up once or twice per night to go the bathroom and falls back asleep immediately)? Is he/she up at night? Does he/she wander at night, get dressed, or disturb your sleep? NPI - Difficulty Sleeping NPI1-Difficulty Falling Asleep Neuropsychiatric Inventory - Does the patient have difficulty falling asleep? NPI - Difficulty Falling Asleep NPI1-Get Up during Night Neuropsychiatric Inventory - Does the patient get up during the night (do not count if the patient gets up once or twice per night only to go to the bathroom and falls back asleep immediately)? NPI - Get Up During the Night NPI1-Wander or Pace at Night Neuropsychiatric Inventory - Does the patient wander, pace or get involved in inappropriate activities at night? NPI - Wander, Pace or Get Involved in Inappropriate Activities at Night NPI1-Awaken Caregiver during Night Neuropsychiatric Inventory - Does the patient awaken you during the night? NPI - Awaken You During the Night NPI1-Wake at Night and Think Morning Neuropsychiatric Inventory - Does the patient wake up at night, dress, and plan to go out thinking that it is morning and time to start the day? NPI - Wake Up at Night, Dress, and Plan to Go Out NPI1-Awaken Too Early in Morning Neuropsychiatric Inventory - Does the patient awaken too early in the morning (earlier than was his/her habit)? NPI - Awaken Too Early in Morning NPI1-Excessive Sleep during Day Neuropsychiatric Inventory - Does the patient sleep excessively during the day? NPI - Sleep Excessively During the Day NPI1-Other Nighttime Behaviors Neuropsychiatric Inventory - Does the patient have any other nighttime behaviors that bother you that we haven't talked about? NPI - Any Other Nighttime Behaviors That Bother You NPI1-Sleep/Nighttime Behavior Frequency Neuropsychiatric Inventory - Frequency of the nighttime behavior. NPI - Sleep and Nighttime Behavior Disorders Frequency NPI1-Sleep/Nighttime Behavior Severity Neuropsychiatric Inventory - Severity of the nighttime behavior. NPI - Sleep and Nighttime Behavior Disorders Severity NPI1-Sleep/Nighttime Behavior Distress Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? NPI - Sleep and Nighttime Behavior Disorders Distress NPI1-Sleep/Night Behav Disord FxS Score Neuropsychiatric Inventory - Sleep and Nighttime Behavior Disorders: (frequency score x severity score). NPI - Sleep/Night Behavior Disorder FxS Score NPI1-Change in Appetite or Weight Neuropsychiatric Inventory - Has he/she had any change in appetite, weight, or eating habits (count as NA if the patient is incapacitated and has to be fed)? Has there been any change in the type of food he/she prefers? NPI - Change in Appetite, Weight, or Eating Habits NPI1-Loss of Appetite Neuropsychiatric Inventory - Has he/she had a loss of appetite? NPI - Loss of Appetite NPI1-Increase in Appetite Neuropsychiatric Inventory - Has he/she had an increase in appetite? NPI - Increase in Appetite NPI1-Weight Loss Neuropsychiatric Inventory - Has he/she had a loss of weight? NPI - Loss of Weight NPI1-Weight Gain Neuropsychiatric Inventory - Has he/she gained weight? NPI - Gained Weight NPI1-Change in Eating Behavior Neuropsychiatric Inventory - Has he/she had a change in eating behavior such as putting too much food in his/her mouth at once? NPI - Change in Eating Behavior NPI1-Change in Kind of Food Neuropsychiatric Inventory - Has he/she had a change in the kind of food he/she likes such as eating too many sweets or other specific types of food? NPI - Change in Kind of Food He/She Likes NPI1-Develop Eating Behaviors Neuropsychiatric Inventory - Has he/she developed eating behaviors such as eating exactly the same types of food each day or eating the food in exactly the same order? NPI - Developed Eating Behaviors Such as Eating Exactly the Same Types of Food NPI1-Other Changes in Eating Neuropsychiatric Inventory - Have there been any other changes in appetite or eating that I haven't asked about? NPI - Any Other Changes in Appetite or Eating NPI1-Appetite/Eating Disorder Frequency Neuropsychiatric Inventory - Frequency of the changes in eating habits or appetite. NPI - Appetite and Eating Disorders Frequency NPI1-Appetite/Eating Disorder Severity Neuropsychiatric Inventory - Severity of the changes in eating habits or appetite. NPI - Appetite and Eating Disorders Severity NPI1-Appetite/Eating Disorder Distress Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? NPI - Appetite and Eating Disorders Distress NPI1-Appetite/Eating Disorders FxS Score Neuropsychiatric Inventory - Appetite and Eating Disorders: (frequency score x severity score). NPI - Appetite/Eating Disorders FxS Score NPI1-NPI Total Score Neuropsychiatric Inventory - Total of (Frequency Sub-total) x (Severity Sub-total). NPI - NPI Total Score NPI1TC Neuropsychiatric Inventory Questionnaire Test Code CDISC Questionnaire NPI Test Code Terminology The Neuropsychiatric Inventory test name. NPI1-Aberrant Motor Behavior Distress Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? NPI - Aberrant Motor Behavior Distress NPI1-Aberrant Motor Behavior Frequency Neuropsychiatric Inventory - Frequency of the aberrant motor behavior. NPI - Aberrant Motor Behavior Frequency NPI1-Aberrant Motor Behavior FxS Score Neuropsychiatric Inventory - Aberrant Motor Behavior: (frequency score x severity score). NPI - Aberrant Motor Behavior FxS Score NPI1-Aberrant Motor Behavior Severity Neuropsychiatric Inventory - Severity of the aberrant motor behavior. NPI - Aberrant Motor Behavior Severity NPI1-Act Impulsively without Care Neuropsychiatric Inventory - Does the patient act impulsively without appearing to consider the consequences? NPI - Act Impulsively without Appearing to Consider the Consequences NPI1-Act Impulsively Neuropsychiatric Inventory - Does the patient seem to act impulsively without thinking? Does he/she do or say things that are not usually done or said in public? Does he/she do things that are embarrassing to you or others? NPI - Seem to Act Impulsively Without Thinking NPI1-Agitation/Aggression Distress Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? NPI - Agitation/Aggression Distress NPI1-Agitation/Aggression Frequency Neuropsychiatric Inventory - Frequency of the agitation/aggression. NPI - Agitation/Aggression Frequency NPI1-Agitation/Aggression FxS Score Neuropsychiatric Inventory - Agitation/Aggression: (frequency score x severity score). NPI - Agitation/Aggression FxS Score NPI1-Agitation/Aggression Severity Neuropsychiatric Inventory - Severity of the agitation/aggression. NPI - Agitation/Aggression Severity NPI1-Anxiety Distress Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? NPI - Anxiety Distress NPI1-Anxiety Frequency Neuropsychiatric Inventory - Frequency of the anxiety. NPI - Anxiety Frequency NPI1-Anxiety FxS Score Neuropsychiatric Inventory - Anxiety: (frequency score x severity score). NPI - Anxiety FxS Score NPI1-Anxiety Severity Neuropsychiatric Inventory - Severity of the anxiety. NPI - Anxiety Severity NPI1-Apathy/Indifference Distress Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? NPI - Apathy/Indifference Distress NPI1-Apathy/Indifference Frequency Neuropsychiatric Inventory - Frequency of the apathy/indifference. NPI - Apathy/Indifference Frequency NPI1-Apathy/Indifference FxS Score Neuropsychiatric Inventory - Apathy/Indifference: (frequency score x severity score). NPI - Apathy/Indifference FxS Score NPI1-Apathy/Indifference Severity Neuropsychiatric Inventory - Severity of the apathy/indifference. NPI - Apathy/Indifference Severity NPI1-Appetite/Eating Disorder Distress Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? NPI - Appetite and Eating Disorders Distress NPI1-Appetite/Eating Disorder Frequency Neuropsychiatric Inventory - Frequency of the changes in eating habits or appetite. NPI - Appetite and Eating Disorders Frequency NPI1-Appetite/Eating Disorder Severity Neuropsychiatric Inventory - Severity of the changes in eating habits or appetite. NPI - Appetite and Eating Disorders Severity NPI1-Appetite/Eating Disorders FxS Score Neuropsychiatric Inventory - Appetite and Eating Disorders: (frequency score x severity score). NPI - Appetite/Eating Disorders FxS Score NPI1-Argumentative Neuropsychiatric Inventory - Is the patient argumentative and difficult to get along with? NPI - Argumentative and Difficult to Get Along With NPI1-Avoid Places or Situations Neuropsychiatric Inventory - Does the patient avoid certain places or situations that make him/her more nervous such as riding in the car, meeting with friends, or being in crowds? NPI - Avoid Certain Places or Situations That Make Him/Her More Nervous NPI1-Awaken Caregiver during Night Neuropsychiatric Inventory - Does the patient awaken you during the night? NPI - Awaken You During the Night NPI1-Awaken Too Early in Morning Neuropsychiatric Inventory - Does the patient awaken too early in the morning (earlier than was his/her habit)? NPI - Awaken Too Early in Morning NPI1-Bad Person Neuropsychiatric Inventory - Does the patient say that he/she is a bad person or deserves to be punished? NPI - Say That He/She is a Bad Person NPI1-Bad Temper Neuropsychiatric Inventory - Does the patient have a bad temper, flying "off the handle" easily over little things? NPI - Bad Temper, Flying 'Off the Handle' Easily Over Little Things NPI1-Beliefs Untrue Neuropsychiatric Inventory - Does the patient have beliefs that you know are not true? (for example, insisting that people are trying to harm him/her or steal from him/her)? Has he/she said that family members are not who they say they are or that the house is not their home? I'm not asking about mere suspiciousness; I am interested if the patient is convinced that these things are happening to him/her. NPI - Have Beliefs That You Know are Not True NPI1-Burden to Family Neuropsychiatric Inventory - Does the patient say he/she is a burden to the family or that the family would be better off without him/her? NPI - Say He/She is a Burden to the Family NPI1-Butterflies or Racing Heart Neuropsychiatric Inventory - Does the patient complain of butterflies in his/her stomach, or of racing or pounding of the heart in association with nervousness? (Symptoms not explained by ill health). NPI - Complain of Butterflies, Racing or Pounding Heart NPI1-Change in Appetite or Weight Neuropsychiatric Inventory - Has he/she had any change in appetite, weight, or eating habits (count as NA if the patient is incapacitated and has to be fed)? Has there been any change in the type of food he/she prefers? NPI - Change in Appetite, Weight, or Eating Habits NPI1-Change in Eating Behavior Neuropsychiatric Inventory - Has he/she had a change in eating behavior such as putting too much food in his/her mouth at once? NPI - Change in Eating Behavior NPI1-Change in Kind of Food Neuropsychiatric Inventory - Has he/she had a change in the kind of food he/she likes such as eating too many sweets or other specific types of food? NPI - Change in Kind of Food He/She Likes NPI1-Childish Pranks Neuropsychiatric Inventory - Does he/she play childish pranks such as pinching or playing "keep away" for the fun of it? NPI - Play Childish Pranks NPI1-Childish Sense of Humor Neuropsychiatric Inventory - Does the patient seem to have a childish sense of humor with a tendency to giggle or laugh inappropriately (such as when something unfortunate happens to others)? NPI - Seem to Have a Childish Sense of Humor NPI1-Contribute Less to Chores Neuropsychiatric Inventory - Does the patient contribute less to household chores? NPI - Contribute Less to Household Chores NPI1-Cranky and Irritable Neuropsychiatric Inventory - Is the patient cranky and irritable? NPI - Cranky and Irritable NPI1-Delusions Distress Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? NPI - Delusions Distress NPI1-Delusions Frequency Neuropsychiatric Inventory - Frequency of the delusions. NPI - Delusions Frequency NPI1-Delusions FxS Score Neuropsychiatric Inventory - Delusions: (frequency score x severity score). NPI - Delusions FxS Score NPI1-Delusions Severity Neuropsychiatric Inventory - Severity of the delusions. NPI - Delusions Severity NPI1-Depression/Dysphoria Distress Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? NPI - Depression/Dysphoria Distress NPI1-Depression/Dysphoria Frequency Neuropsychiatric Inventory - Frequency of the depression/dysphoria. NPI - Depression/Dysphoria Frequency NPI1-Depression/Dysphoria FxS Score Neuropsychiatric Inventory - Depression/Dysphoria: (frequency score x severity score). NPI - Depression/Dysphoria FxS Score NPI1-Depression/Dysphoria Severity Neuropsychiatric Inventory - Severity of the depression/dysphoria. NPI - Depression/Dysphoria Severity NPI1-Develop Eating Behaviors Neuropsychiatric Inventory - Has he/she developed eating behaviors such as eating exactly the same types of food each day or eating the food in exactly the same order? NPI - Developed Eating Behaviors Such as Eating Exactly the Same Types of Food NPI1-Difficulty Falling Asleep Neuropsychiatric Inventory - Does the patient have difficulty falling asleep? NPI - Difficulty Falling Asleep NPI1-Difficulty Sleeping Neuropsychiatric Inventory - Does the patient have difficulty sleeping (do not count as present if the patient simply gets up once or twice per night to go the bathroom and falls back asleep immediately)? Is he/she up at night? Does he/she wander at night, get dressed, or disturb your sleep? NPI - Difficulty Sleeping NPI1-Discouraged Neuropsychiatric Inventory - Does the patient seem very discouraged or say that he/she has no future? NPI - Seem Very Discouraged NPI1-Disinhibition Distress Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? NPI - Disinhibition Distress NPI1-Disinhibition Frequency Neuropsychiatric Inventory - Frequency of the disinhibition. NPI - Disinhibition Frequency NPI1-Disinhibition FxS Score Neuropsychiatric Inventory - Disinhibition: (frequency score x severity score). NPI - Disinhibition FxS Score NPI1-Disinhibition Severity Neuropsychiatric Inventory - Severity of the disinhibition. NPI - Disinhibition Severity NPI1-Do Things Repeatedly Neuropsychiatric Inventory - Does the patient pace, do things over and over such as opening closets or drawers, or repeatedly pick at things or wind string or threads? NPI - Pace, Do Things Over and Over, Repeatedly Pick at Things NPI1-Elation/Euphoria Distress Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? NPI - Elation/Euphoria Distress NPI1-Elation/Euphoria Frequency Neuropsychiatric Inventory - Frequency of the elation/euphoria. NPI - Elation/Euphoria Frequency NPI1-Elation/Euphoria FxS Score Neuropsychiatric Inventory - Elation/Euphoria: (frequency score x severity score). NPI - Elation/Euphoria FxS Score NPI1-Elation/Euphoria Severity Neuropsychiatric Inventory - Severity of the elation/euphoria. NPI - Elation/Euphoria Severity NPI1-Excessive Sleep during Day Neuropsychiatric Inventory - Does the patient sleep excessively during the day? NPI - Sleep Excessively During the Day NPI1-False Visions or Voices Neuropsychiatric Inventory - Does the patient have hallucinations such as seeing false visions or hearing false voices? Does he/she seem to see, hear or experience things that are not present? By this question we do not mean just mistaken beliefs such as stating that someone who has died is still alive; rather we are asking if the patient actually has abnormal experiences of sounds or visions. NPI - Hallucinations Such as Seeing False Visions or Hearing False Voices NPI1-Family Plans to Abandon Neuropsychiatric Inventory - Does the patient believe that family members plan to abandon him/her? NPI - Family Members Plan to Abandon Him/Her NPI1-Feel Good or Too Happy Neuropsychiatric Inventory - Does the patient appear to feel good or to be too happy, different from his/her usual self? NPI - Appear to Feel Good or to Be Too Happy NPI1-Feel Like a Failure Neuropsychiatric Inventory - Does the patient put him/herself down or say that he/she feels like a failure? NPI - Put Him/Herself Down or Say That He/She Feels Like a Failure NPI1-Feel Things on Skin Neuropsychiatric Inventory - Does the patient describe feeling things on his/her skin or otherwise appear to be feeling things crawling or touching him/her? NPI - Describe Feeling Things on His/Her Skin NPI1-Fidget Excessively Neuropsychiatric Inventory - Does the patient fidget excessively, seem unable to sit still, or bounce his/her feet or tap his/her fingers a lot? NPI - Fidget Excessively, Seem Unable to Sit Still NPI1-Get Up during Night Neuropsychiatric Inventory - Does the patient get up during the night (do not count if the patient gets up once or twice per night only to go to the bathroom and falls back asleep immediately)? NPI - Get Up During the Night NPI1-Get Upset with Caregiver Neuropsychiatric Inventory - Does the patient get upset with those trying to care for him/her or resist activities such as bathing or changing clothes? NPI - Get Upset with Those Trying to Care for Him/Her NPI1-Hallucinations Distress Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? NPI - Hallucinations Distress NPI1-Hallucinations Frequency Neuropsychiatric Inventory - Frequency of the hallucinations. NPI - Hallucinations Frequency NPI1-Hallucinations FxS Score Neuropsychiatric Inventory - Hallucinations: (frequency score x severity score). NPI - Hallucinations FxS Score NPI1-Hallucinations Severity Neuropsychiatric Inventory - Severity of the hallucinations. NPI - Hallucinations Severity NPI1-Hearing Voices Neuropsychiatric Inventory - Does the patient describe hearing voices or act as if he/she hears voices? NPI - Describe Hearing Voices or Act as if He/She Hears Voices NPI1-House Not Their Home Neuropsychiatric Inventory - Does the patient believe that his/her house is not his/her home? NPI - His/Her House Is Not His/Her Home NPI1-Humor Others Do Not Find Funny Neuropsychiatric Inventory - Does the patient find humor and laugh at things that others do not find funny? NPI - Fine Humor and Laugh at Things That Others Do Not Find Funny NPI1-Hurt or Hit Others Neuropsychiatric Inventory - Does the patient attempt to hurt or hit others? NPI - Attempt to Hurt or Hit Others NPI1-Impatient Neuropsychiatric Inventory - Is the patient impatient, having trouble coping with delays or waiting for planned activities? NPI - Impatient, Having Trouble Coping with Delays NPI1-In Danger Neuropsychiatric Inventory - Does the patient believe that he/she is in danger - that others are planning to hurt him/her? NPI - He/She is in Danger NPI1-Increase in Appetite Neuropsychiatric Inventory - Has he/she had an increase in appetite? NPI - Increase in Appetite NPI1-Irritability/Lability Distress Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? NPI - Irritability/Lability Distress NPI1-Irritability/Lability Frequency Neuropsychiatric Inventory - Frequency of the irritability/lability. NPI - Irritability/Lability Frequency NPI1-Irritability/Lability FxS Score Neuropsychiatric Inventory - Irritability/Lability: (frequency score x severity score). NPI - Irritability/Lability FxS Score NPI1-Irritability/Lability Severity Neuropsychiatric Inventory - Severity of the irritability/lability. NPI - Irritability/Lability Severity NPI1-Irritated and Easily Disturbed Neuropsychiatric Inventory - Does the patient get irritated and easily disturbed? Are his/her moods very changeable? Is he/she abnormally impatient? We do not mean frustration over memory loss or inability to perform usual tasks; we are interested to know if the patient has abnormal irritability, impatience, or rapid emotional changes different from his/her usual self. NPI - Get Irritated and Easily Disturbed NPI1-Jokes Others Do Not Find Funny Neuropsychiatric Inventory - Does the patient tell jokes or make remarks that are not funny to others but seem funny to him/her? NPI - Tell Jokes or Make Remarks That are Not Funny to Others NPI1-Less Affectionate Neuropsychiatric Inventory - Is the patient less affectionate or lacking in emotions when compared to his/her usual self? NPI - Less Affectionate or Lacking in Emotions NPI1-Less Enthusiastic Neuropsychiatric Inventory - Is the patient less enthusiastic about his/her usual interests? NPI - Less Enthusiastic About His/Her Usual Interests NPI1-Less Interest in Activities Neuropsychiatric Inventory - Does the patient seem less interested in the activities and plans of others? NPI - Less Interested in the Activities and Plans of Others NPI1-Less Likely Initiate Conversation Neuropsychiatric Inventory - Is the patient less likely to initiate a conversation? NPI - Less Likely Initiate to Initiate a Conversation NPI1-Less Spontaneous or Active Neuropsychiatric Inventory - Does the patient seem less spontaneous and less active than usual? NPI - Seem Less Spontaneous and Less Active Than Usual NPI1-Loss of Appetite Neuropsychiatric Inventory - Has he/she had a loss of appetite? NPI - Loss of Appetite NPI1-Lost Interest in Friends Neuropsychiatric Inventory - Has the patient lost interest in friends and family members? NPI - Lost Interest in Friends and Family Members NPI1-Lost Interest in World Neuropsychiatric Inventory - Has the patient lost interest in the world around him/her? Has he/she lost interest in doing things or does he/she lack motivation for starting new activities? Is he/she more difficult to engage in conversation or in doing chores? Is the patient apathetic or indifferent? NPI - Lost Interest in the World Around Him/Her NPI1-Make Crude Remarks Neuropsychiatric Inventory - Does the patient say crude things or make sexual remarks that he/she would not usually have said? NPI - Say Crude Things or Make Sexual Remarks NPI1-Nervous or Worried Neuropsychiatric Inventory - Is the patient very nervous, worried, or frightened for no apparent reason? Does he/she seem very tense or fidgety? Is the patient afraid to be apart from you? NPI - Very Nervous, Worried, or Frightened for No Apparent Reason NPI1-Nervous when Separated Neuropsychiatric Inventory - Does the patient become nervous and upset when separated from you (or his/her caregiver)? (Does he/she cling to you to keep from being separated?). NPI - Become Nervous and Upset When Separated From You NPI1-NPI Total Distress Score Neuropsychiatric Inventory - Sub-total of distress score. NPI - NPI Total Distress Score NPI1-NPI Total Score Neuropsychiatric Inventory - Total of (Frequency Sub-total) x (Severity Sub-total). NPI - NPI Total Score NPI1-Other Aggressive Behavior Neuropsychiatric Inventory - Does the patient have any other aggressive or agitated behaviors? NPI - Any Other Aggressive or Agitated Behaviors NPI1-Other Behaviors Hard to Handle Neuropsychiatric Inventory - Does the patient have any other behaviors that make him/her hard to handle? NPI - Any Other Behaviors That Make Him/Her Hard to Handle NPI1-Other Changes in Eating Neuropsychiatric Inventory - Have there been any other changes in appetite or eating that I haven't asked about? NPI - Any Other Changes in Appetite or Eating NPI1-Other Nighttime Behaviors Neuropsychiatric Inventory - Does the patient have any other nighttime behaviors that bother you that we haven't talked about? NPI - Any Other Nighttime Behaviors That Bother You NPI1-Other Repetitive Activities Neuropsychiatric Inventory - Does the patient do any other activities over and over? NPI - Do Any Other Activities Over and Over NPI1-Other Signs of Anxiety Neuropsychiatric Inventory - Does the patient show any other signs of anxiety? NPI - Show Any Other Signs of Anxiety NPI1-Other Signs of Depression Neuropsychiatric Inventory - Does the patient show any other signs of depression or sadness? NPI - Show Any Other Signs of Depression or Sadness NPI1-Other Signs of Feeling Too Happy Neuropsychiatric Inventory - Does the patient show any other signs of feeling too good or being too happy? NPI - Show Any Other Signs of Feeling Too Good or Being Too Happy NPI1-Other Signs of Impulses Neuropsychiatric Inventory - Does the patient show any other signs of loss of control of his/her impulses? NPI - Show Any Other Signs of Loss of Control of His/Her Impulses NPI1-Other Signs of Irritability Neuropsychiatric Inventory - Does the patient show any other signs of irritability? NPI - Show Any Other Signs of Irritability NPI1-Other Signs of Not Caring Neuropsychiatric Inventory - Does the patient show any other signs that he/she doesn't care about doing new things? NPI - Show Any Other Signs That He/She Doesn't Care About Doing New Things NPI1-Other Unusual Beliefs Neuropsychiatric Inventory - Does the patient believe any other unusual things that I haven't asked about? NPI - Any Other Unusual Things That I Haven't Asked About NPI1-Other Unusual Sensory Experience Neuropsychiatric Inventory - Does the patient describe any other unusual sensory experiences? NPI - Describe Any Other Unusual Sensory Experiences NPI1-Others Are Stealing Neuropsychiatric Inventory - Does the patient believe that others are stealing from him/her? NPI - Others are Stealing From Him/Her NPI1-Pace Neuropsychiatric Inventory - Does the patient pace around the house without apparent purpose? NPI - Pace Around the House Without Apparent Purpose NPI1-People Not Who They Claim Neuropsychiatric Inventory - Does the patient believe that his/her spouse or others are not who they claim to be? NPI - His/Her Spouse or Others Are Not Who They Claim To Be NPI1-Rapidly Change Moods Neuropsychiatric Inventory - Does the patient rapidly change moods from one to another, being fine one minute and angry the next? NPI - Rapidly Change Moods From One to Another NPI1-Refuse to Cooperate Neuropsychiatric Inventory - Does the patient have periods when he/she refuses to cooperate or won't let people help him/her? Is he/she hard to handle? NPI - Periods When He/She Refuses to Cooperate NPI1-Repeatedly Change Clothing Neuropsychiatric Inventory - Does the patient repeatedly put on and take off clothing? NPI - Repeatedly Put On and Take Off Clothing NPI1-Repetitive Activities or Habits Neuropsychiatric Inventory - Does the patient have repetitive activities or "habits" that he/she performs over and over? NPI - Repetitive Activities or 'Habits' NPI1-Repetitive Activities Neuropsychiatric Inventory - Does the patient engage in repetitive activities such as handling buttons, picking, wrapping string, etc.? NPI - Engage in Repetitive Activities NPI1-Rummage Around and Unpack Neuropsychiatric Inventory - Does the patient rummage around opening and unpacking drawers or closets? NPI - Rummage Around Opening and Unpacking Drawers or Closets NPI1-Sad or Depressed Neuropsychiatric Inventory - Does the patient seem sad or depressed? Does he/she say that he/she feels sad or depressed? NPI - Seem Sad or Depressed NPI1-Say Insensitive Things Neuropsychiatric Inventory - Does the patient say things to people that are insensitive or hurt their feelings? NPI - Say Things to People that are Insensitive NPI1-Say or Act in Low Spirits Neuropsychiatric Inventory - Does the patient say, or act as if he/she is sad or in low spirits? NPI - Say, or Act as if He/She is Sad or in Low Spirits NPI1-See Things Not Seen by Others Neuropsychiatric Inventory - Does the patient describe seeing things not seen by others or behave as if he/she is seeing things not seen by others (people, animals, lights, etc.)? NPI - Describe Seeing Things Not Seen by Others NPI1-Shaky or Unable to Relax Neuropsychiatric Inventory - Does the patient have periods of feeling shaky, unable to relax, or feeling excessively tense? NPI - Periods of Feeling Shaky, Unable to Relax, or Feeling Excessively Tense NPI1-Short of Breath, Gasp, Sigh Neuropsychiatric Inventory - Does the patient have periods of (or complain of) shortness of breath, gasping, or sighing for no apparent reason other than nervousness? NPI - Periods of Shortness of Breath, Gasping, or Sighing for No Apparent Reason NPI1-Shout or Curse Angrily Neuropsychiatric Inventory - Does the patient shout or curse angrily? NPI - Shout or Curse Angrily NPI1-Slam, Kick or Throw Things Neuropsychiatric Inventory - Does the patient slam doors, kick furniture, throw things? NPI - Slam doors, Kick Furniture, Throw Things NPI1-Sleep/Night Behav Disord FxS Score Neuropsychiatric Inventory - Sleep and Nighttime Behavior Disorders: (frequency score x severity score). NPI - Sleep/Night Behavior Disorder FxS Score NPI1-Sleep/Nighttime Behavior Distress Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? NPI - Sleep and Nighttime Behavior Disorders Distress NPI1-Sleep/Nighttime Behavior Frequency Neuropsychiatric Inventory - Frequency of the nighttime behavior. NPI - Sleep and Nighttime Behavior Disorders Frequency NPI1-Sleep/Nighttime Behavior Severity Neuropsychiatric Inventory - Severity of the nighttime behavior. NPI - Sleep and Nighttime Behavior Disorders Severity NPI1-Smell Odors Others Do Not Smell Neuropsychiatric Inventory - Does the patient report smelling odors not smelled by others? NPI - Report Smelling Odors Not Smelled by Others NPI1-Spouse Having Affair Neuropsychiatric Inventory - Does the patient believe that his/her spouse is having an affair? NPI - His/Her Spouse is Having an Affair NPI1-Stubborn Neuropsychiatric Inventory - Is the patient stubborn, having to have things his/her way? NPI - Stubborn NPI1-Sudden Anger Neuropsychiatric Inventory - Does the patient have sudden flashes of anger? NPI - Sudden Flares of Anger NPI1-Take Liberties or Touch Others Neuropsychiatric Inventory - Does the patient take liberties or touch or hug others in a way that is out of character for him/her? NPI - Take Liberties or Touch or Hug Others NPI1-Talk Big Neuropsychiatric Inventory - Does the patient "talk big" or claim to have more abilities or wealth than is true? NPI - Talk Big or Claim to Have More Abilities or Wealth Than is True NPI1-Talk Openly about Private Matters Neuropsychiatric Inventory - Does the patient talk openly about very personal or private matters not usually discussed in public? NPI - Talk Openly About Very Personal or Private Matters NPI1-Talk to People Not There Neuropsychiatric Inventory - Does the patient talk to people who are not there? NPI - Talk to People Who Are Not There NPI1-Talk to Strangers Neuropsychiatric Inventory - Does the patient talk to total strangers as if he/she knew them? NPI - Talk to Total Strangers as if He/She Knew Them NPI1-Taste without Known Cause Neuropsychiatric Inventory - Does the patient describe tastes that are without any known cause? NPI - Describe Tastes That Are Without Any Known Cause NPI1-Tearfulness or Sobbing Neuropsychiatric Inventory - Does the patient have periods of tearfulness or sobbing that seem to indicate sadness? NPI - Periods of Tearfulness or Sobbing NPI1-Too Cheerful or Happy Neuropsychiatric Inventory - Does the patient seem too cheerful or too happy for no reason? I don't mean the normal happiness that comes from seeing friends, receiving presents, or spending time with family members. I am asking if the patient has a persistent and abnormally good mood or finds humor where others do not. NPI - Seem Too Cheerful or Too Happy for No Reason NPI1-TV/Magazine Figures Present Neuropsychiatric Inventory - Does the patient believe that television or magazine figures are actually present in the home? (Does he/she try to talk or interact with them?) NPI - Television or Magazine Figures Are Actually Present In the Home NPI1-Uncooperative Neuropsychiatric Inventory - Is the patient uncooperative, resistive to help from others? NPI - Uncooperative NPI1-Unwelcome Guests in House Neuropsychiatric Inventory - Does the patient believe that unwelcome guests are living in his/her house? NPI - Unwelcome Guests are Living in His/Her House NPI1-Wake at Night and Think Morning Neuropsychiatric Inventory - Does the patient wake up at night, dress, and plan to go out thinking that it is morning and time to start the day? NPI - Wake Up at Night, Dress, and Plan to Go Out NPI1-Wander or Pace at Night Neuropsychiatric Inventory - Does the patient wander, pace or get involved in inappropriate activities at night? NPI - Wander, Pace or Get Involved in Inappropriate Activities at Night NPI1-Weight Gain Neuropsychiatric Inventory - Has he/she gained weight? NPI - Gained Weight NPI1-Weight Loss Neuropsychiatric Inventory - Has he/she had a loss of weight? NPI - Loss of Weight NPI1-Wish for Death Neuropsychiatric Inventory - Does the patient express a wish for death or talk about killing himself/herself? NPI - Express a Wish for Death NPI1-Worried about Planned Event Neuropsychiatric Inventory - Does the patient say that he/she is worried about planned events? NPI - Say That He/She is Worried About Planned Events NPI1TN Neuropsychiatric Inventory Questionnaire Test Name CDISC Questionnaire NPI Test Name Terminology A classification of usage or experience that falls into three categories; never, current, or former. Occurring in or belonging to the present time. (NCI) Current Previous Occurring prior to something else. (NCI) Previous Not ever; at no time in the past. Never NCF Never/Current/Former Classification CDISC SDTM Never/Current/Former Classification Terminology A terminology codelist based on the functional classification developed by the New York Heart Association (NYHA), for categorizing patients with defined or presumed cardiac disease. New York Heart Association Class I Without limitations of physical activity. Ordinary physical activity does not cause undue fatigue, palpitations, or dyspnea. New York Heart Association Class I New York Heart Association Class II Slight limitation of physical activity. The patient is comfortable at rest. Ordinary physical activity results in fatigue, palpitations, or dyspnea. New York Heart Association Class II New York Heart Association Class III Marked limitation of physical activity. The patient is comfortable at rest. Less than ordinary activity causes fatigue, palpitations, or dyspnea. New York Heart Association Class III New York Heart Association Class IV Inability to carry on any physical activity without discomfort. Heart failure symptoms are present even at rest or with minimal exertion. New York Heart Association Class IV NYHAC New York Heart Association Classification CDISC SDTM New York Heart Association Class Responses Terminology Nine-Hole Peg Test test code. NHPT01-Time to Complete 9-Hole Peg Test Nine-Hole Peg Test - Time in seconds to complete 9-Hole Peg Test. NHPT - Time to Complete 9-Hole Peg Test NHPT01-More Than Two Attempts Nine-Hole Peg Test - Did it take more than two attempts to get two successful trials? NHPT - More Than Two Attempts NHPT01TC Nine-Hole Peg Test Functional Test Test Code CDISC Functional Test NHPT Test Code Terminology Nine-Hole Peg Test test name. NHPT01-More Than Two Attempts Nine-Hole Peg Test - Did it take more than two attempts to get two successful trials? NHPT - More Than Two Attempts NHPT01-Time to Complete 9-Hole Peg Test Nine-Hole Peg Test - Time in seconds to complete 9-Hole Peg Test. NHPT - Time to Complete 9-Hole Peg Test NHPT01TN Nine-Hole Peg Test Functional Test Test Name CDISC Functional Test NHPT Test Name Terminology A term that is used to indicate a question with permissible values of yes/no/unknown/not applicable. No The non-affirmative response to a question. (NCI) No NA Not Applicable Determination of a value is not relevant in the current context. (NCI) Not Applicable U UNK Unknown Not known, not observed, not recorded, or refused. (NCI) Unknown Yes The affirmative response to a question. (NCI) Yes NY No Yes Response CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Parameters used to describe the levels of taxonomic and non-taxonomic nomenclature of a microorganism. Clade A taxonomic parameter for the specification of clade of the organism. Clade Genotype A non-taxonomic parameter that can specify the genotype of the organism. Organism by Genotype Geographical Origin A non-taxonomic parameter that can specify the geographic location where the organism was identified, collected or came from. Organism by Geographic Origin Group A non-taxonomic parameter that can specify the group of the organism. Organism by Group Isolate A non-taxonomic parameter that can specify the isolate of the organism. Organism Isolate Lineage A taxonomic parameter for the specification of lineage of the organism. Organism Lineage GenBank ID NCBI GenBank ID The accession number for a gene within the National Center for Biotechnology Information (NCBI) GenBank database. GenBank Accession Number NCBI Taxonomy ID The taxonomy identifier for an organism within the National Center for Biotechnology Information (NCBI) Taxonomy database. NCBI Taxonomy Identifier Pathotype A non-taxonomic parameter that can specify the pathotype of the organism, which is classified based on its resulting pathogenicity on a specified host. Pathotype Pseudotype Viral Backbone A non-taxonomic parameter that can specify the pseudotype viral backbone of the engineered virus. Organism Pseudotype Viral Backbone Species A taxonomic parameter for the specification of species of the organism. Species Spacer Oligonucleotide Type Spoligotype A non-taxonomic parameter that can specify the spoligotype of a microorganism. A spoligotype is obtained from reading of the unique spacer sequences in a highly conserved region in the genetic material of the microorganism. Spoligotype Strain Strain Number A non-taxonomic parameter that can specify the strain of the organism. Organism Strain Subtype A non-taxonomic parameter that can specify the subtype of the organism. Organism by Subtype Type A non-taxonomic parameter that can specify the type of the organism. Organism by Type Year of Collection A non-taxonomic parameter that can specify the year when the organism was collected or isolated. Organism by Year Collected OIPRM Non-host Organism Identifier Parameters CDISC SDTM Non-host Organism Identifiers Parameter Long Name Terminology Parameter codes used to describe the levels of taxonomic and non-taxonomic nomenclature of a microorganism. Clade A taxonomic parameter for the specification of clade of the organism. Clade Genotype A non-taxonomic parameter that can specify the genotype of the organism. Organism by Genotype Geographical Origin A non-taxonomic parameter that can specify the geographic location where the organism was identified, collected or came from. Organism by Geographic Origin Group A non-taxonomic parameter that can specify the group of the organism. Organism by Group Isolate A non-taxonomic parameter that can specify the isolate of the organism. Organism Isolate Lineage A taxonomic parameter for the specification of lineage of the organism. Organism Lineage GenBank ID NCBI GenBank ID The accession number for a gene within the National Center for Biotechnology Information (NCBI) GenBank database. GenBank Accession Number NCBI Taxonomy ID The taxonomy identifier for an organism within the National Center for Biotechnology Information (NCBI) Taxonomy database. NCBI Taxonomy Identifier Pathotype A non-taxonomic parameter that can specify the pathotype of the organism, which is classified based on its resulting pathogenicity on a specified host. Pathotype Pseudotype Viral Backbone A non-taxonomic parameter that can specify the pseudotype viral backbone of the engineered virus. Organism Pseudotype Viral Backbone Species A taxonomic parameter for the specification of species of the organism. Species Spacer Oligonucleotide Type Spoligotype A non-taxonomic parameter that can specify the spoligotype of a microorganism. A spoligotype is obtained from reading of the unique spacer sequences in a highly conserved region in the genetic material of the microorganism. Spoligotype Strain Strain Number A non-taxonomic parameter that can specify the strain of the organism. Organism Strain Subtype A non-taxonomic parameter that can specify the subtype of the organism. Organism by Subtype Type A non-taxonomic parameter that can specify the type of the organism. Organism by Type Year of Collection A non-taxonomic parameter that can specify the year when the organism was collected or isolated. Organism by Year Collected OIPRMCD Non-host Organism Identifier Parameters Code CDISC SDTM Non-host Organism Identifiers Parameter Code Terminology Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 test code. NSCLC1-Rate Coughing at Worst Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - How would you rate your coughing at its worst over the last 7 days? NSCLC-SAQ Version 1.0 - Rate Coughing at Worst NSCLC1-Rate Worst Pain in Chest Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - How would you rate the worst pain in your chest over the last 7 days? NSCLC-SAQ Version 1.0 - Rate Worst Pain in Chest NSCLC1-Rate Worst Pain Other Than Chest Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - How would you rate the worst pain in areas other than your chest over the last 7 days? NSCLC-SAQ Version 1.0 - Rate Worst Pain Other Than Chest NSCLC1-Short of Breath Usual Activities Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - How often did you feel short of breath during usual activities over the last 7 days? NSCLC-SAQ Version 1.0 - Short of Breath Usual Activities NSCLC1-How Often Low Energy Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - How often did you have low energy over the last 7 days? NSCLC-SAQ Version 1.0 - How Often Low Energy NSCLC1-How Often Tire Easily Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - How often did you tire easily over the last 7 days? NSCLC-SAQ Version 1.0 - How Often Tire Easily NSCLC1-How Often Poor Appetite Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - How often did you have a poor appetite over the last 7 days? NSCLC-SAQ Version 1.0 - How Often Poor Appetite NSCLC1-Cough Domain Subscore Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - Cough domain subscore. NSCLC-SAQ Version 1.0 - Cough Domain Subscore NSCLC1-Fatigue Domain Subscore Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - Fatigue domain subscore. NSCLC-SAQ Version 1.0 - Fatigue Domain Subscore NSCLC1-Pain Domain Subscore Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - Pain domain subscore. NSCLC-SAQ Version 1.0 - Pain Domain Subscore NSCLC1-Dyspnea Domain Subscore Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - Dyspnea domain subscore. NSCLC-SAQ Version 1.0 - Dyspnea Domain Subscore NSCLC1-Appetite Domain Subscore Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - Appetite domain subscore. NSCLC-SAQ Version 1.0 - Appetite Domain Subscore NSCLC1-Total Score Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - Total score. NSCLC-SAQ Version 1.0 - Total Score NSCLC1TC Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 Questionnaire Test Code CDISC Questionnaire NSCLC-SAQ Version 1.0 Test Code Terminology Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 test name. NSCLC1-Appetite Domain Subscore Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - Appetite domain subscore. NSCLC-SAQ Version 1.0 - Appetite Domain Subscore NSCLC1-Cough Domain Subscore Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - Cough domain subscore. NSCLC-SAQ Version 1.0 - Cough Domain Subscore NSCLC1-Dyspnea Domain Subscore Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - Dyspnea domain subscore. NSCLC-SAQ Version 1.0 - Dyspnea Domain Subscore NSCLC1-Fatigue Domain Subscore Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - Fatigue domain subscore. NSCLC-SAQ Version 1.0 - Fatigue Domain Subscore NSCLC1-How Often Low Energy Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - How often did you have low energy over the last 7 days? NSCLC-SAQ Version 1.0 - How Often Low Energy NSCLC1-How Often Poor Appetite Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - How often did you have a poor appetite over the last 7 days? NSCLC-SAQ Version 1.0 - How Often Poor Appetite NSCLC1-How Often Tire Easily Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - How often did you tire easily over the last 7 days? NSCLC-SAQ Version 1.0 - How Often Tire Easily NSCLC1-Pain Domain Subscore Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - Pain domain subscore. NSCLC-SAQ Version 1.0 - Pain Domain Subscore NSCLC1-Rate Coughing at Worst Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - How would you rate your coughing at its worst over the last 7 days? NSCLC-SAQ Version 1.0 - Rate Coughing at Worst NSCLC1-Rate Worst Pain in Chest Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - How would you rate the worst pain in your chest over the last 7 days? NSCLC-SAQ Version 1.0 - Rate Worst Pain in Chest NSCLC1-Rate Worst Pain Other Than Chest Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - How would you rate the worst pain in areas other than your chest over the last 7 days? NSCLC-SAQ Version 1.0 - Rate Worst Pain Other Than Chest NSCLC1-Short of Breath Usual Activities Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - How often did you feel short of breath during usual activities over the last 7 days? NSCLC-SAQ Version 1.0 - Short of Breath Usual Activities NSCLC1-Total Score Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - Total score. NSCLC-SAQ Version 1.0 - Total Score NSCLC1TN Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 Questionnaire Test Name CDISC Questionnaire NSCLC-SAQ Version 1.0 Test Name Terminology A terminology codelist that contains reasons for non-system PCI delay. Cardiac arrest which occurs before a percutaneous coronary intervention can take place. Cardiac Arrest Prior to Percutaneous Coronary Intervention Access to the subject's vasculature is troublesome or formidable. Difficult Vascular Access Placement of intracoronary devices across the coronary stenosis is troublesome or formidable. Difficulty Crossing Culprit Lesion During Percutaneous Coronary Intervention Intubation before PCI Endotracheal intubation which occurs before a percutaneous coronary intervention can take place. Endotracheal Intubation before Percutaneous Coronary Intervention Patient Delay in Providing Consent The subject has not provided consent in a timely manner for the procedure to take place. Subject Delay in Providing Consent NSYSPCID Non-system Reason for PCI Delay CDISC SDTM Non-system Reason for PCI Delay Terminology A terminology codelist to describe a normal or abnormal response. Aberrant Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm. (NCI) Abnormal Inconclusive Cannot distinguish between two or more possible values in the current context. (NCI) Indeterminate Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm. (NCI) Normal Not Assessable Not Evaluable Unable to be evaluated. (NCI) Unevaluable U UNK Unknown Not known, not observed, not recorded, or refused. (NCI) Unknown NORMABNM Normal Abnormal Response CDISC SDTM Normal Abnormal Response Terminology North Star Ambulatory Assessment test code. NSAA1-Stand North Star Ambulatory Assessment - Can you stand up tall for me for as long as you can and as still as you can. NSAA - Stand NSAA1-Walk North Star Ambulatory Assessment - Can you walk from A to B (state to and where from) for me. NSAA - Walk NSAA1-Stand Up From Chair North Star Ambulatory Assessment - Stand up from the chair keeping your arms folded if you can. NSAA - Stand Up From Chair NSAA1-Stand on One Leg - Right North Star Ambulatory Assessment - Can you stand on your right leg for as long as you can? NSAA - Stand on One Leg - Right NSAA1-Stand on One Leg - Left North Star Ambulatory Assessment - Can you stand on your left leg for as long as you can? NSAA - Stand on One Leg - Left NSAA1-Climb Box Step - Right North Star Ambulatory Assessment - Can you step onto the top of the box using your right leg first? NSAA - Climb Box Step - Right NSAA1-Climb Box Step - Left North Star Ambulatory Assessment - Can you step onto the top of the box using your left leg first? NSAA - Climb Box Step - Left NSAA1-Descend Box Step - Right North Star Ambulatory Assessment - Can you step down from the box using your right leg first? NSAA - Descend Box Step - Right NSAA1-Descend Box Step - Left North Star Ambulatory Assessment - Can you step down from the box using your left leg first? NSAA - Descend Box Step - Left NSAA1-Gets to Sitting North Star Ambulatory Assessment - Can you get from lying to sitting? NSAA - Gets to Sitting NSAA1-Rise From Floor North Star Ambulatory Assessment - Get up from the floor using as little support as possible and as fast as you can (from supine). NSAA - Rise From Floor NSAA1-Rise From Floor Time North Star Ambulatory Assessment - Time to get up from the floor using as little support as possible and as fast as you can (from supine) (seconds). NSAA - Rise From Floor Time NSAA1-Lifts Head North Star Ambulatory Assessment - Lift your head to look at your toes keeping your arms folded. NSAA - Lifts Head NSAA1-Stands on Heels North Star Ambulatory Assessment - Can you stand on your heels? NSAA - Stands on Heels NSAA1-Jump North Star Ambulatory Assessment - How high can you jump? NSAA - Jump NSAA1-Hop Right Leg North Star Ambulatory Assessment - Can you hop on your right leg? NSAA - Hop Right Leg NSAA1-Hop Left Leg North Star Ambulatory Assessment - Can you hop on your left leg? NSAA - Hop Left Leg NSAA1-Run (10m) North Star Ambulatory Assessment - Run as fast as you can to...(give point). NSAA - Run (10m) NSAA1-Run (10m) Time North Star Ambulatory Assessment - Time to run as fast as you can (seconds). NSAA - Run (10m) Time NSAA1-Total North Star Ambulatory Assessment - Total. NSAA - Total NSAA1TC North Star Ambulatory Assessment Clinical Classification Test Code CDISC Clinical Classification NSAA Test Code Terminology North Star Ambulatory Assessment test name. NSAA1-Climb Box Step - Left North Star Ambulatory Assessment - Can you step onto the top of the box using your left leg first? NSAA - Climb Box Step - Left NSAA1-Climb Box Step - Right North Star Ambulatory Assessment - Can you step onto the top of the box using your right leg first? NSAA - Climb Box Step - Right NSAA1-Descend Box Step - Left North Star Ambulatory Assessment - Can you step down from the box using your left leg first? NSAA - Descend Box Step - Left NSAA1-Descend Box Step - Right North Star Ambulatory Assessment - Can you step down from the box using your right leg first? NSAA - Descend Box Step - Right NSAA1-Gets to Sitting North Star Ambulatory Assessment - Can you get from lying to sitting? NSAA - Gets to Sitting NSAA1-Hop Left Leg North Star Ambulatory Assessment - Can you hop on your left leg? NSAA - Hop Left Leg NSAA1-Hop Right Leg North Star Ambulatory Assessment - Can you hop on your right leg? NSAA - Hop Right Leg NSAA1-Jump North Star Ambulatory Assessment - How high can you jump? NSAA - Jump NSAA1-Lifts Head North Star Ambulatory Assessment - Lift your head to look at your toes keeping your arms folded. NSAA - Lifts Head NSAA1-Rise From Floor Time North Star Ambulatory Assessment - Time to get up from the floor using as little support as possible and as fast as you can (from supine) (seconds). NSAA - Rise From Floor Time NSAA1-Rise From Floor North Star Ambulatory Assessment - Get up from the floor using as little support as possible and as fast as you can (from supine). NSAA - Rise From Floor NSAA1-Run (10m) Time North Star Ambulatory Assessment - Time to run as fast as you can (seconds). NSAA - Run (10m) Time NSAA1-Run (10m) North Star Ambulatory Assessment - Run as fast as you can to...(give point). NSAA - Run (10m) NSAA1-Stand on One Leg - Left North Star Ambulatory Assessment - Can you stand on your left leg for as long as you can? NSAA - Stand on One Leg - Left NSAA1-Stand on One Leg - Right North Star Ambulatory Assessment - Can you stand on your right leg for as long as you can? NSAA - Stand on One Leg - Right NSAA1-Stand Up From Chair North Star Ambulatory Assessment - Stand up from the chair keeping your arms folded if you can. NSAA - Stand Up From Chair NSAA1-Stand North Star Ambulatory Assessment - Can you stand up tall for me for as long as you can and as still as you can. NSAA - Stand NSAA1-Stands on Heels North Star Ambulatory Assessment - Can you stand on your heels? NSAA - Stands on Heels NSAA1-Total North Star Ambulatory Assessment - Total. NSAA - Total NSAA1-Walk North Star Ambulatory Assessment - Can you walk from A to B (state to and where from) for me. NSAA - Walk NSAA1TN North Star Ambulatory Assessment Clinical Classification Test Name CDISC Clinical Classification NSAA Test Name Terminology Indicates a task, process or examination that has either not been initiated or completed. (NCI) Indicates a task, process or examination that has either not been initiated or completed. (NCI) Not Done ND Not Done CDISC SDTM Not Done Terminology Terminology relevant to the Nottingham histologic grading system responses. (CW Ellston, O Ellis. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991 Nov;19(5):403-10.) G1 GRADE 1 Nottingham Grade 1 A histologic grade from the Nottingham grading system based on total Nottingham scores of 3, 4, or 5 and indicating that a cancerous lesion is well differentiated. (CW Ellston, O Ellis. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991 Nov;19(5):403-10.) Nottingham Grade 1 G2 GRADE 2 Nottingham Grade 2 A histologic grade from the Nottingham grading system based on total Nottingham scores of 6 or 7 and indicating that a cancerous lesion is moderately differentiated. (CW Ellston, O Ellis. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991 Nov;19(5):403-10.) Nottingham Grade 2 G3 GRADE 3 Nottingham Grade 3 A histologic grade from the Nottingham grading system based on total Nottingham scores of 8 or 9 and indicating that a cancerous lesion is poorly differentiated. (CW Ellston, O Ellis. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991 Nov;19(5):403-10.) Nottingham Grade 3 NOTGRDRS Nottingham Histologic Grade Response CDISC SDTM Nottingham Grading Scale Response Terminology Terminology relevant to the test codes that describe findings about a nutrition event or intervention. Event Frequency The number of times an event occurs within a given time period. Temporal Frequency Occurrence Indicator An indication as to whether something has happened, such as an event or incident. Occurrence Indicator Severity/Intensity The degree of something undesirable. Severity NTFATSCD Nutrition Findings About Test Code CDISC SDTM Nutrition Findings About Test Code Terminology Terminology relevant to the test names that describe findings about a nutrition event or intervention. Event Frequency The number of times an event occurs within a given time period. Temporal Frequency Occurrence Indicator An indication as to whether something has happened, such as an event or incident. Occurrence Indicator Severity/Intensity The degree of something undesirable. Severity NTFATS Nutrition Findings About Test Name CDISC SDTM Nutrition Findings About Test Name Terminology A terminology codelist relevant to the trial design developed to compare biomedical and/or health outcomes in pre-defined and non-assigned groups of individuals. Retrospective study in which individuals with an outcome (cases) are compared to those who do not have the outcome (controls). (CDISC Glossary) Case-Control Study A study in which the subject characteristics of the case, immediately prior to disease onset (sometimes called the hazard period), are compared to characteristics of same case at a prior time (i.e., control period). (ClinicalTrials.gov) Observational Case-Crossover Study A study in which the subject with the condition under study (the case) is compared against a theoretical/historical model of distribution that serves as a control. Case Study Study of a group of individuals, some of whom are exposed to a variable of interest, in which subjects are followed over time. (CDISC Glossary) Cohort Study A study in which geographically distinct study populations are compared with respect to a particular outcome. Ecologic or Community Based Study A study in which related or non-related family members are compared with respect to a particular outcome. Family Study OBSSMO Observational Study Model CDISC SDTM Observational Study Model Terminology A terminology codelist relevant to the sampling method used to assign study participants into groups or cohorts within an observational study. A non-random process used to select a study population in which the participants have been selected based on convenience or with a particular purpose in mind. Non-Probability Sampling Method An exclusively random process to guarantee that each participant or population has specified chance of selection, such as simple random sampling, systematic sampling, stratified random sampling, cluster sampling, and consecutive patient sampling. (clinicaltrials.gov) Equal Probability Sampling Method OBSSSM Observational Study Sampling Method CDISC SDTM Observational Study Sampling Method Terminology A terminology codelist relevant to the temporal relationship between the observation period and time of subject enrollment in an observational study. A study that measures the prevalence of health outcomes or determinants of health, or both, in a population at a point in time or over a short period. (CDISC Glossary) Cross-Sectional Study A prospective observational study designed to monitor health measures of individuals over a defined period of time. (CDISC Glossary) Longitudinal Study A study with planned observations collected predominantly before study start (i.e., backward-looking). (CDISC Glossary) Retrospective Study OBSSTP Observational Study Time Perspective CDISC SDTM Observational Study Time Perspective Terminology Observer Global Impression Generic Modification Version test code. OGI01-Severity Observer Global Impression - Considering all the ways your condition impacts you, how severe is your condition at this time? OGI Generic Modification Version - Severity OGI01-Change Observer Global Impression - Compared to <previously assessed protocol specified time point> how much has your condition changed? OGI Generic Modification Version - Change OGI01-Improvement Observer Global Impression - Compared to <previously assessed protocol specified time point> how much has your condition improved? OGI Generic Modification Version - Improvement OGI01TC Observer Global Impression Generic Modification Version Questionnaire Test Code CDISC Questionnaire Observer Global Impression Generic Modification Version Test Code Terminology Observer Global Impression Generic Modification Version test name. OGI01-Change Observer Global Impression - Compared to <previously assessed protocol specified time point> how much has your condition changed? OGI Generic Modification Version - Change OGI01-Improvement Observer Global Impression - Compared to <previously assessed protocol specified time point> how much has your condition improved? OGI Generic Modification Version - Improvement OGI01-Severity Observer Global Impression - Considering all the ways your condition impacts you, how severe is your condition at this time? OGI Generic Modification Version - Severity OGI01TN Observer Global Impression Generic Modification Version Questionnaire Test Name CDISC Questionnaire Observer Global Impression Generic Modification Version Test Name Terminology Terminology for oncology studies relevant to the result of response to treatment or therapy assessment within the disease response and clinical classification domain. The absence of change in the overall attenuation of the metastasis and in the peripheral rim, suggesting a lack of response to treatment. Absent Morphologic Response Cancer Antigen 125 50% Response The amount of cancer antigen 125 is reduced by 50% from protocol-defined baseline value(s). CA125 50% Response Cancer Antigen 125 75% Response The amount of cancer antigen 125 is reduced by 75% from protocol-defined baseline value(s). CA125 75% Response Clinical Complete Remission Clinical Complete Response The disappearance of all signs of cancer based on physical exam, such as palpation. Clinical Complete Response Complete Hematologic Remission Complete Hematologic Response The disappearance of cancer in response to treatment, including platelet and white blood cell counts returning to normal levels, a non-palpable spleen, and no immature white blood cells present in the blood unless it is a regenerating marrow following treatment. Complete Hematologic Response The return of a disease after a period of remission, as determined by clinical signs and symptoms. Clinical Relapse Complete Metabolic Response The disappearance of metabolic tumor activity in all relevant lesions. Tumor Complete Metabolic Response Central Nervous System Status 1 Central nervous system status defined as puncture nontraumatic without leukemic blasts after cytocentrifugation. (Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, Gelber R, Heerema N, Korn EL, Link M, Murphy S, Pui CH, Pullen J, Reamon G, Sallan SE, Sather H, Shuster J, Simon R, Trigg M, Tubergen D, Uckun F, Ungerleider R. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol. 1996 Jan;14(1):18-24.) CNS 1 Central Nervous System Status 2 Central nervous system status defined as puncture nontraumatic with less than or equal to 5 WBC/uL in cerebral spinal fluid with identifiable blasts.(Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, Gelber R, Heerema N, Korn EL, Link M, Murphy S, Pui CH, Pullen J, Reamon G, Sallan SE, Sather H, Shuster J, Simon R, Trigg M, Tubergen D, Uckun F, Ungerleider R. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol. 1996 Jan;14(1):18-24.) CNS 2 Central Nervous System Status 3 Central nervous system status defined as puncture nontraumatic with greater than 5 WBC/uL in cerebral spinal fluid with identifiable blasts. (Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, Gelber R, Heerema N, Korn EL, Link M, Murphy S, Pui CH, Pullen J, Reamon G, Sallan SE, Sather H, Shuster J, Simon R, Trigg M, Tubergen D, Uckun F, Ungerleider R. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol. 1996 Jan;14(1):18-24.) CNS 3 Clinical Partial Remission Clinical Partial Response A decrease in the size and the extent of tissue involvement by cancer, based on physical exam, such as palpation. Clinical Partial Response Complete Remission Complete Response The disappearance of all signs of cancer in response to treatment. (NCI) Complete Remission Complete Remission, CT-Based Complete Response, CT-Based The disappearance of all signs of cancer, based on CT scan and criteria-defined assessments. Complete Response by Computed Tomography Complete Remission with Partial Hematologic Recovery Complete Remission with Partial Hematological Recovery The disappearance of all signs of cancer in response to treatment accompanied by partial hematological/bone marrow recovery, based on pre-defined thresholds. Complete Remission with Partial Hematological Recovery Complete Remission with Incomplete Blood Count Recovery Complete Response with Incomplete Bone Marrow Recovery The disappearance of all signs of cancer in response to treatment accompanied by incomplete bone marrow recovery, as evidenced by persistent anemia, thrombocytopenia or neutropenia. Complete Response with Incomplete Bone Marrow Recovery CCgR CCyR Complete Cytogenetic Response CRc Cytogenetic Complete Remission Cytogenetic Complete Response The disappearance of all signs of cancer, including the absence of a detectable disease-related genetic abnormality, as determined by techniques such as karyotyping or FISH, in response to treatment. Cytogenetic Complete Response Minimal CgR A minimal decrease in abnormal karyotype, based on pre-defined thresholds. Cytogenetic Minimal Response Minor CgR A minor decrease in abnormal karyotype, based on pre-defined thresholds. Cytogenetic Minor Response No CgR No Cytogenetic Response No change in abnormal karyotype, based on pre-defined thresholds. Cytogenetic No Response Cytogenetic Partial Response Partial CgR A partial decrease in abnormal karyotype, based on pre-defined thresholds. Cytogenetic Partial Response Reduced Made less in size, amount, degree, or extent. Reduced A conversion from one disease diagnosis to another, which may be considered a progression to a worsening state. Disease Transformation Open to question. Equivocal No new lesions(s) and a decrease in lesion size, or a reduction in central necrosis or attenuation in one or more enhancing lesions, based on pre-defined thresholds. Favorable Response Hematologic Improvement-Erythroid Response An improvement in erythrocyte count as a response to treatment. Hematologic Improvement-Erythroid Response Hematologic Improvement-Neutrophil Response An improvement of neutrophil count as a response to treatment. Hematologic Improvement-Neutrophil Response Hematologic Improvement-Platelet Response An improvement of platelet count as a response to treatment. Hematologic Improvement-Platelet Response Radiographic progression which has been confirmed by additional imaging showing worsening of initial progression. iRECIST Confirmed Progressive Disease The disappearance of all signs of cancer following an initial apparent radiographic progression. iRECIST Complete Response Immunophenotypic Complete Response The disappearance of all signs of cancer, supported by the absence of phenotypically aberrant plasma cells (clonal) in bone marrow. (Rajkumar SV, Harousseau J, Durie B et al, Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1. Blood. 2011; 117(18):4691-4695) Immunophenotypic Complete Response Better A subjective response indicating that something has improved or gotten better. Improved A process of becoming larger, more intense, more extensive, more numerous, more important, or more likely. Increase A response that is neither favorable nor unfavorable. Indeterminate Response Inconclusive Cannot distinguish between two or more possible values in the current context. (NCI) Indeterminate A finding indicating that there is a decrease based on a predetermined threshold in the size and the extent of tissue involvement by cancer following an initial apparent radiographic progression. iRECIST Partial Response Complete disappearance of all lesions (whether measurable or not, and no new lesions). (irRECIST) irRECIST Complete Response Increase in tumor burden greater than or equal to 25% relative to nadir (minimum recorded tumor burden). (irRECIST) irRECIST Progressive Disease Decrease in tumor burden greater than or equal to 50% relative to baseline. (irRECIST) irRECIST Partial Response Not meeting criteria for irCR or irPR, in absence of irPD. (irRECIST) irRECIST Stable Disease Cancer that is neither decreasing nor increasing in extent or severity based on predetermined boundaries following an initial apparent radiographic progression. iRECIST Stable Disease Apparent radiographic progression which requires confirmation, per criteria, with additional imaging. iRECIST Unconfirmed Progressive Disease M1 Marrow Bone marrow classification of less than 5%. (Children's Oncology Group) M1 Marrow M2 Marrow Bone marrow classification of greater than or equal to 5% to less than 25%. (Children's Oncology Group) M2 Marrow M3 Marrow Bone marrow classification of greater than or equal to 25%. (Children's Oncology Group) M3 Marrow A major decrease in signs of cancer, supported by pathological examination and based on pre-defined thresholds. Major Pathologic Response Marrow Complete Remission Marrow Complete Response A decrease in the number of bone marrow plasma cells to protocol-defined level(s). Marrow Complete Response A minor decrease in signs of cancer, supported by pathological examination and based on pre-defined thresholds. Minor Pathologic Response CMR Complete Molecular Response Molecular Complete Remission Molecular Complete Response The disappearance of all signs of cancer, supported by molecular analysis. Molecular Complete Response Major Molecular Response MMolR MMR A decrease in signs of cancer, supported by molecular analysis. Molecular Major Response Morphologic Complete Remission Morphologic Complete Response The disappearance of all signs of cancer, supported by morphological analysis. Morphologic Complete Response Morphologic Complete Remission with Incomplete Blood Count Recovery Morphologic Complete Remission with Incomplete Bone Marrow Recovery The disappearance of all cells with morphologic characteristics of cancer, accompanied by incomplete bone marrow recovery, as evidenced by persistent anemia, thrombocytopenia or neutropenia. Morphologic Complete Remission with Incomplete Blood Count Recovery NEL No Evidence of Leukemia The disappearance of all cells with morphologic characteristics of leukemia, accompanied by bone marrow recovery, in response to treatment. Hematologic recovery is not required. Leukemia free state can be a hypocellular marrow. Morphologic Leukemia-Free State Minimal Response Minor Response A finding that refers to hematologic and solid malignancies and indicates that there is a minor improvement in the measures of disease burden, meeting a predetermined threshold, but not meeting partial response criteria. Minimal Response Minimal Residual Disease Relapse MRD Reappearance Relapse from MRD Negative Presence of residual disease based on pre-defined thresholds and return of quantifiable minimal residual disease positivity after a period of minimal residual disease negativity. Measurable Residual Disease Relapse Not Assessable Not Evaluable Unable to be evaluated. (NCI) Unevaluable No Evidence of Disease An absence of detectable disease. No Evidence of Disease An indication of a negative finding for a test or assessment, such as for a disease, condition, analyte, or microorganism. Negative Finding Non Complete Response/Non Progressive Disease Persistence of one or more non-target lesion(s) and/or maintenance of tumor marker levels above the normal limits. (Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228-247.) Non Complete Response/Non Progressive Disease Persistence of one or more non-target lesion(s) without unequivocal progression following an initial apparent radiographic progression. Non iRECIST Complete Response-Non iRECIST Unconfirmed Progressive Disease Non Progressive Disease Following a previous assessment of progressive disease unconfirmed (PDu) of non-target lesion(s), the subsequent required assessment does not confirm progressive disease. Non Progressive Disease Non-Quantifiable Minimal Residual Disease Positivity Presence of non-quantifiable minimal residual disease based on laboratory techniques. Non-Quantifiable Measurable Residual Disease Positivity An indication that the subject's steroid dose is the same as their physiologic replacement dose. No Steroid Use Beyond Physiologic Replacement Dose Not All Evaluated Not all target lesions were assessed. Or not all non-target lesions were assessed. Not All Lesions Evaluated Nodular Partial Response Remission with remaining lymphoid nodules reflecting residual disease. Nodular Partial Remission No Response No apparent change or worsening in lesion staging classification. No Response Hypo-attenuation of the metastases which may appear pseudocystic, perfectly homogeneous, and devoid of a recognizable peripheral rim. Optimal Morphologic Response Mixed attenuation and some homogeneity of the metastases with a partially resolved peripheral rim. Partial Morphologic Response Complete Pathological Response Pathologic Complete Remission Pathologic Complete Response The disappearance of all signs of cancer, supported by pathological examination. Pathologic Complete Response Progression from PR Progressive Disease from Partial Response Disease progression occurring after a partial response. Progression from Partial Response Disease Progression Progressive Disease A disease process that is increasing in extent or severity. (NCI) Progressive Disease Progressive Disease, CT-Based There is an increase in the size and extent of tissue involvement by cancer, based on CT scan and criteria-defined assessments. Progressive Disease by Computed Tomography Progression or Relapse After Hematologic Improvement Disease progression or the return of a disease after a period of remission, occurring after a hematologic improvement. Progression or Relapse After Hematologic Improvement PD Unconfirmed Unconfirmed Progressive Disease A disease process that is increasing in scope or severity but the criteria for progressive disease is not met. Unconfirmed Progressive Disease Progressive Metabolic Disease An increase of metabolic tumor activity in all relevant lesions, based on pre-defined thresholds, or the development of new lesions. Progressive Metabolic Disease Partial Metabolic Response A decrease of metabolic tumor activity in all relevant lesions, based on a pre-defined threshold. Partial Metabolic Response An indication of an affirmative finding for a test or assessment, such as for a disease, condition, analyte, or microorganism. Positive Finding Partial Response with Lymphocytosis PR-L PRL A decrease in the size and the extent of tissue involvement by cancer, accompanied by an increase in blood lymphocyte count above a predetermined threshold. Partial Response with Lymphocytosis Partial Remission Partial Response A finding indicating that there is a decrease based on a predetermined threshold in the size and the extent of tissue involvement by cancer. Partial Remission Partial Remission, CT-Based Partial Response, CT-Based A decrease in the size and extent of tissue involvement by cancer, based on CT scan and criteria-defined assessments. Partial Response by Computed Tomography Prostate Specific Antigen Progression The amount of prostate specific antigen is increased, based on pre-defined thresholds. PSA Progression PsP Apparent increase in lesion burden, not proven to be disease progression. Pseudoprogression PsR Apparent decrease in lesion burden, not proven to be favorable treatment response. Pseudoresponse Quantifiable Minimal Residual Disease Positivity Presence of quantifiable minimal residual disease based on laboratory techniques. Quantifiable Measurable Residual Disease Positivity Relapsed Disease From Complete Response or Partial Response The return of a disease after a period of complete remission or partial remission. Relapsed Disease From Complete or Partial Response Relapse from CR Relapsed Disease From Complete Response The return of a disease after a period of complete remission. Relapsed Disease From Complete Response Recurrent Disease The return of a disease after a period of remission. Recurrent Disease Stringent Complete Remission Stringent Complete Response The disappearance of all signs of cancer, including the absence of molecular or cytogenetic markers of disease, supported by additional biochemical, immunological and histopathological analyses. Stringent Complete Response Stable Disease Cancer that is neither decreasing nor increasing in extent or severity based on predetermined boundaries. (NCI) Stable Disease Stable Disease, CT-Based The size and extent of tissue involvement by cancer is neither decreasing nor increasing, based on CT scan and criteria-defined assessments. Stable Disease by Computed Tomography NMR No Metabolic Response Stable Metabolic Disease The absence of change or mild changes of metabolic tumor activity in all relevant lesions based on a pre-defined threshold. Stable Metabolic Disease Subject to little fluctuation; showing little if any change. (NCI) Stable The lack of expected or desired effect related to a therapy. (NCI) Lack of Efficacy Leaving no doubt; not open to question. (NCI) Unequivocal An increase in lesion size, based on a pre-defined threshold, or the development of new lesion(s), marked central fill-in of a lesion, or new enhancement of a previously homogeneously hypoattenuating nonenhancing mass. Unfavorable Response Very Good Partial Remission Very Good Partial Response Partial response with additional serum and urine M-protein reduction, but not meeting complete response. Very Good Partial Response In a declining condition or state. Worse ONCRSR Oncology Response Assessment Result CDISC SDTM Tumor Response Result Terminology Terminology for oncology studies relevant to the test codes that describe an assessment of response to treatment or therapy within the disease response and clinical classification domain. Anatomic Response An assessment of the anatomic response (based on changes in size of anatomic structures) of the disease to the therapy. Anatomic Response Best Overall Response Best Response An assessment of the most clinically favorable overall response of the disease to the therapy. Best Overall Response Bone Marrow Involvement Indicator An indication as to whether disease is present in the bone marrow. Bone Marrow Disease Involvement Indicator Bone Marrow Response An assessment of the disease response to therapy within the bone marrow. Bone Marrow Response BM Status Bone Marrow Status An assessment of the bone marrow, measured by a rating or scale, as a condition of disease response to therapy. Bone Marrow Disease Response Status Assessment Bone Response An assessment of the bone response of the disease to the therapy. Bone Response Clinical Response An assessment of the clinical response of the disease to the therapy. Clinical Response Circulating Lymphocytes Response An assessment of the disease response to therapy based on circulating lymphocyte count. Circulating Lymphocyte Response Central Nervous System Status CNS Status An assessment of the central nervous system, measured by a rating or scale, as a condition of disease response to therapy. Central Nervous System Disease Response Status Assessment Constitutional Symptoms A group of symptoms that affect an individual's general well being. Representative examples include fever, chills, fatigue, weakness, and weight loss. (NCI) Constitutional Symptom Clinical Performance Status An assessment of the clinical performance, measured by a rating or scale, as a condition of disease response to therapy. (NCI) Clinical Performance Status Cytogenetic Response An assessment of the cytogenetic response of the disease to the therapy. Cytogenetic Response Disease Recurrence Indicator An indication as to whether disease recurrence occurred. Disease Recurrence Indicator Extramedullary Disease Response An assessment of the disease response to therapy within an extramedullary region. Extramedullary Disease Response Assessment Hematologic Improvement An assessment of the improvement of specified blood cell counts as a response to treatment. Hematologic Improvement Hematologic Response An assessment of the hematologic response of the disease to the therapy. Hematologic Response Hemoglobin Response An assessment of the disease response to therapy based on hemoglobin measurement. Hemoglobin Response Liver Response An assessment of the disease response to therapy within the liver. Disease Response in Liver Metabolic Response An assessment of the metabolic response of the disease to the therapy. Metabolic Response Metastatic Indicator An indication as to whether disease metastasis has occurred. Metastatic Disease Indicator Major Pathological Response Indicator An indication as to whether major pathological response occurred. Major Pathological Response Indicator Minor Pathological Response Indicator An indication as to whether minor pathological response occurred. Minor Pathological Response Indicator Molecular Response An assessment of the molecular response of the disease to the therapy. Molecular Response Minimal Residual Disease Indicator MRD Indicator An indication as to whether the subject has minimal residual disease. Measurable Residual Disease Indicator Minimal Residual Disease Response MRD Response An assessment of the minimal residual disease response of the disease to the therapy. Measurable Residual Disease Response Morphologic Response An assessment of the morphologic response of the disease to the therapy. Morphologic Response Neurological Status An assessment of the nervous system, measured by a rating or scale, as a condition of disease response to therapy. Neurological Disease Response Status Assessment New Lesion Indicator An indication as to whether new lesions are present, in comparison to a previous timepoint. New Lesion Indicator New Lesion Progression An assessment of the equivocality of disease progression based on a newly identified lesion. New Lesion Progression New Lesion Worsening Indicator An indication as to whether the previously identified new lesions are showing signs of worsening. New Lesion Worsening Indicator Non-Target Enhancing Response An assessment of the response to the therapy of the non-target enhancing disease. (NCI) Non-Target Enhancing Lesion Response Non-Target Lesion Worsening Indicator An indication as to whether non-target lesions, which have previously shown progression, are showing additional signs of worsening. Non-Target Lesion Worsening Indicator Non-Target Non-Enhancing Response An assessment of the response to the therapy of the non-target non-enhancing disease. (NCI) Non-Target Non-Enhancing Lesion Response Non-target Response An assessment of the response of a non-target lesion(s) to the therapy. Response in Non-Target Lesion Overall Response An assessment of the overall response of the disease to the therapy. (NCI) Overall Response Pathologic Response An assessment of the pathologic response of the disease to the therapy. Pathologic Response Circulating Blasts Indicator Peripheral Blasts Indicator An indication as to whether peripheral blasts are present. Peripheral Blasts Indicator Disease Progression Indicator Progressive Disease Indicator An indication as to whether disease progression has occurred. Progressive Disease Indicator Platelets Response An assessment of the disease response to therapy based on platelet count. Platelet Response Radiologic Response An assessment of the radiologic response of the disease to the therapy. Radiologic Response Soft Tissue Response An assessment of the soft tissue response of the disease to the therapy. Soft Tissue Response Spleen Response An assessment of the disease response to therapy within the spleen. Disease Response in Spleen Steroid Use Status An assessment of steroid usage as a condition of disease response to therapy. (NCI) Steroid Use Status Symptomatic Deterioration A global deterioration of health status providing evidence of disease progression not covered by disease response criteria (eg. RECIST). Symptomatic Deterioration Tumor Marker Response An assessment of disease response to therapy based on tumor marker measurement. Tumor Marker Response Target Nodal Response An assessment of the response of a target nodal lesion(s) to the therapy. Target Nodal Response Target Response An assessment of the response of a target lesion(s) to the therapy. Response in Target Lesion Testicular Disease Indicator An indication as to whether testicular disease is present. Testicular Disease Indicator ONCRTSCD Oncology Response Assessment Test Code CDISC SDTM Tumor Response Assessment Test Code Terminology Terminology for oncology studies relevant to the test names that describe an assessment of response to treatment or therapy within the disease response and clinical classification domain. Anatomic Response An assessment of the anatomic response (based on changes in size of anatomic structures) of the disease to the therapy. Anatomic Response Best Overall Response Best Response An assessment of the most clinically favorable overall response of the disease to the therapy. Best Overall Response Bone Marrow Involvement Indicator An indication as to whether disease is present in the bone marrow. Bone Marrow Disease Involvement Indicator Bone Marrow Response An assessment of the disease response to therapy within the bone marrow. Bone Marrow Response BM Status Bone Marrow Status An assessment of the bone marrow, measured by a rating or scale, as a condition of disease response to therapy. Bone Marrow Disease Response Status Assessment Bone Response An assessment of the bone response of the disease to the therapy. Bone Response Circulating Lymphocytes Response An assessment of the disease response to therapy based on circulating lymphocyte count. Circulating Lymphocyte Response Clinical Performance Status An assessment of the clinical performance, measured by a rating or scale, as a condition of disease response to therapy. (NCI) Clinical Performance Status Clinical Response An assessment of the clinical response of the disease to the therapy. Clinical Response Central Nervous System Status CNS Status An assessment of the central nervous system, measured by a rating or scale, as a condition of disease response to therapy. Central Nervous System Disease Response Status Assessment Constitutional Symptoms A group of symptoms that affect an individual's general well being. Representative examples include fever, chills, fatigue, weakness, and weight loss. (NCI) Constitutional Symptom Cytogenetic Response An assessment of the cytogenetic response of the disease to the therapy. Cytogenetic Response Disease Recurrence Indicator An indication as to whether disease recurrence occurred. Disease Recurrence Indicator Extramedullary Disease Response An assessment of the disease response to therapy within an extramedullary region. Extramedullary Disease Response Assessment Hematologic Improvement An assessment of the improvement of specified blood cell counts as a response to treatment. Hematologic Improvement Hematologic Response An assessment of the hematologic response of the disease to the therapy. Hematologic Response Hemoglobin Response An assessment of the disease response to therapy based on hemoglobin measurement. Hemoglobin Response Liver Response An assessment of the disease response to therapy within the liver. Disease Response in Liver Major Pathological Response Indicator An indication as to whether major pathological response occurred. Major Pathological Response Indicator Metabolic Response An assessment of the metabolic response of the disease to the therapy. Metabolic Response Metastatic Indicator An indication as to whether disease metastasis has occurred. Metastatic Disease Indicator Minimal Residual Disease Indicator MRD Indicator An indication as to whether the subject has minimal residual disease. Measurable Residual Disease Indicator Minimal Residual Disease Response MRD Response An assessment of the minimal residual disease response of the disease to the therapy. Measurable Residual Disease Response Minor Pathological Response Indicator An indication as to whether minor pathological response occurred. Minor Pathological Response Indicator Molecular Response An assessment of the molecular response of the disease to the therapy. Molecular Response Morphologic Response An assessment of the morphologic response of the disease to the therapy. Morphologic Response Neurological Status An assessment of the nervous system, measured by a rating or scale, as a condition of disease response to therapy. Neurological Disease Response Status Assessment New Lesion Indicator An indication as to whether new lesions are present, in comparison to a previous timepoint. New Lesion Indicator New Lesion Progression An assessment of the equivocality of disease progression based on a newly identified lesion. New Lesion Progression New Lesion Worsening Indicator An indication as to whether the previously identified new lesions are showing signs of worsening. New Lesion Worsening Indicator Non-Target Enhancing Response An assessment of the response to the therapy of the non-target enhancing disease. (NCI) Non-Target Enhancing Lesion Response Non-Target Lesion Worsening Indicator An indication as to whether non-target lesions, which have previously shown progression, are showing additional signs of worsening. Non-Target Lesion Worsening Indicator Non-Target Non-Enhancing Response An assessment of the response to the therapy of the non-target non-enhancing disease. (NCI) Non-Target Non-Enhancing Lesion Response Non-target Response An assessment of the response of a non-target lesion(s) to the therapy. Response in Non-Target Lesion Overall Response An assessment of the overall response of the disease to the therapy. (NCI) Overall Response Pathologic Response An assessment of the pathologic response of the disease to the therapy. Pathologic Response Circulating Blasts Indicator Peripheral Blasts Indicator An indication as to whether peripheral blasts are present. Peripheral Blasts Indicator Platelets Response An assessment of the disease response to therapy based on platelet count. Platelet Response Disease Progression Indicator Progressive Disease Indicator An indication as to whether disease progression has occurred. Progressive Disease Indicator Radiologic Response An assessment of the radiologic response of the disease to the therapy. Radiologic Response Soft Tissue Response An assessment of the soft tissue response of the disease to the therapy. Soft Tissue Response Spleen Response An assessment of the disease response to therapy within the spleen. Disease Response in Spleen Steroid Use Status An assessment of steroid usage as a condition of disease response to therapy. (NCI) Steroid Use Status Symptomatic Deterioration A global deterioration of health status providing evidence of disease progression not covered by disease response criteria (eg. RECIST). Symptomatic Deterioration Target Nodal Response An assessment of the response of a target nodal lesion(s) to the therapy. Target Nodal Response Target Response An assessment of the response of a target lesion(s) to the therapy. Response in Target Lesion Testicular Disease Indicator An indication as to whether testicular disease is present. Testicular Disease Indicator Tumor Marker Response An assessment of disease response to therapy based on tumor marker measurement. Tumor Marker Response ONCRTS Oncology Response Assessment Test Name CDISC SDTM Tumor Response Assessment Test Name Terminology Terminology relevant to the test codes that describe findings from ophthalmic examinations. Astigmatism Axis A measurement of the location, in degrees, of the flatter principal meridian on a 180-degree scale, where 90 degrees designates the vertical meridian and 180 degrees designates the horizontal meridian. Astigmatism Axis Atrophy An evaluation of atrophy (decrease in size, deterioration, and/or wasting) in a biological specimen or location. Atrophy Assessment Cell Density A measurement of the number of cells contained in a unit of volume or area. Cell Density Cell Density, Maximum The maximum number in a group of values that represent the cell density. Maximum Cell Density Cell Density, Minimum The minimum number in a group of values that represent the cell density. Minimum Cell Density Cell Density, Mean The mean number in a group of values that represent the cell density. Mean Cell Density Cell Density, Standard Deviation The standard deviation in a group of values that represent the cell density. Standard Deviation of Cell Density Corrective Lens for Distance Indicator An indication as to whether an eye lens(es) is worn by the subject to correct for distance. Corrective Lens for Distance Indicator Corrective Lens Type for Distance A description of the type of eye lens(es) worn by the subject to correct for distance. Corrective Lens Type for Distance Corrective Lens Indicator An indication as to whether an eye lens(es) is worn by the subject to correct for any type of visual impairment. Corrective Lens Indicator Count Fingers Distance An assessment of the furthest distance at which a subject can perceive and accurately count the examiner's fingers. Counting Fingers Test Count Fingers Indicator An indication as to whether a subject can perceive and accurately count the examiner's fingers at a pre-specified distance. Counting Fingers Indicator Color The appearance of objects (or light sources) described in terms of a person's perception of their hue and lightness (or brightness) and saturation. (NCI) Color Cup to Disc Ratio The ratio of the diameter of the optic cup compared to the diameter of the optic disc. (NCI) Optic Cup to Disc Ratio Diabetic Macular Edema Grade The position on a scale to assess diabetic macular edema. Diabetic Macular Edema Grade Diabetic Retinopathy Grade The position on a scale to assess diabetic retinopathy. Diabetic Retinopathy Grade Detachment An evaluation of an abnormal separation between two normally attached structures. Tissue Detachment Assessment Diameter The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) Diameter Diameter, Minimum The minimum number in a group of values that represent the diameter of an object. Minimum Diameter Diameter, Mean The mean number in a group of values that represent the diameter of an object. Mean Diameter Diameter, Standard Deviation The standard deviation in a group of values that represent the diameter of an object. Standard Deviation of Diameter Edema An evaluation of edema (an excessive amount of watery fluid) in a biological specimen or location. Edema Evaluation Eye Drop Comfort Grade The position on a scale to assess the degree of comfort associated with the administration of an eye drop. Eye Drop Comfort Grade Fluid A evaluation of fluid in a biological specimen or location. Fluid Assessment Hand Motions Distance Hand Movements Distance An assessment of the furthest distance at which a subject can perceive hand motions. Hand Motion Test Hand Motions Indicator Hand Movements Indicator An indication as to whether a subject can perceive hand motions at a pre-specified distance. Hand Motion Indicator Hyperemia Grade The position on a scale to assess hyperemia. Hyperemia Grade Hyperemia An evaluation of hyperemia (an increased amount of blood) in a biological specimen or location. Hyperemia Evaluation Interpretation An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. Interpretation Intraocular Pressure The fluid pressure within the eye. Intraocular Pressure Longest Diameter The longest possible length of a straight line passing through the center of a circular or spheroid object that connects two points on the circumference. Longest Diameter Lens Status The condition or state of the lens of the eye. (NCI) Lens Status Light Perception Indicator An indication as to whether a subject can perceive light from a light source that is placed directly in front of the eye. Light Perception Indicator Log Score A number or range of numeric values on the log scale that measures performance, function, quality, or ability. Log Score Margin Limbal Distance A measurement of the distance from the inferior limbus to the central upper-eyelid margin, with the patient's gaze pointed upward. Margin Limbal Distance Minimum Angle of Resolution The smallest angle of separation that allows an image-forming device, including the retina, to distinguish two objects as distinct entities. Minimum Angle of Resolution Minimum Angle of Resolution, Log10 The base-10 logarithm of the minimum angle of resolution achieved by an individual during testing. Log10 Minimum Angle of Resolution Margin Reflex Distance 1 Margin to Reflex Distance 1 Marginal Reflex Distance 1 A measurement of the distance between the corneal light reflex to the central upper-eyelid margin, with the patient's gaze in the primary position (i.e., straight ahead). Margin Reflex Distance 1 Margin Reflex Distance 2 Margin to Reflex Distance 2 Marginal Reflex Distance 2 A measurement of the distance between the corneal light reflex to central lower-eyelid margin, with the patient's gaze in the primary position (i.e., straight ahead). Margin Reflex Distance 2 Neovascularization An evaluation of neovascularization (new vessel formation) in a biological specimen or location. Neovascularization Assessment Near-Point Accommodation The minimum distance from the retina that an object remains in clear focus. Near-Point Accommodation Number of Characters Read The integer that describes the number of characters read by the subject during an eye chart assessment. Number of Characters Read Number of Characters Unread The integer that describes the number of characters not able to be read by the subject during an eye chart assessment. Number of Characters Unread Number of Letters Correct The integer that describes the number of letters correctly identified by the subject during an eye chart assessment. Number of Correct Eye Chart Letters Number of Lines Read The integer that describes the number of lines read by the subject during an eye chart assessment. Number of Eye Chart Lines Read Number of Lines Unread The integer that describes the number of lines not able to be read by the subject during an eye chart assessment. Number of Lines Unread Ophthalmic Examination An observation, assessment or examination of the eye. Eye Examination Opacity An assessment of the degree of opaqueness or the lack of transparency. Opacity Measurement Reactivity A description of the action in response to some kind of stimulus. Reaction Cylindrical Refraction Error Cylindrical Refractive Error A measurement of the extent of defect in vision caused by a mismatch of optical power between the cylindrical and horizontal meridians, resulting in sub-optimal reflection of light onto the retina. (NCI) Cylindrical Refractive Error Spherical Refraction Error Spherical Refractive Error A measurement of the extent of defect in vision caused by a mismatch of optimal power between the cornea and/or lens and the length of the eyeball, resulting in sub-optimal reflection of light onto the retina. (NCI) Spherical Refractive Error Score A value (e.g., number, numeric range, ratio) that assesses and orders a result or response for purposes of comparison. Score Shape The spatial arrangement of something as distinct from its substance. (NCI) Shape Subject to Eye Chart Actual Distance The actual distance between the subject and the eye chart during an eye assessment. Actual Subject to Eye Chart Distance Subject to Eye Chart Planned Distance The planned distance between the subject and the eye chart during an eye assessment. Planned Subject to Eye Chart Distance Tear Break-up Time Tear Breakup Time Tear Film Breakup Time The interval of time between the last blink and the first appearance of a black spot in the fluorescein-stained tear film. Tear Breakup Time Assessment Lacrimation Tear Production Tear Secretion A measurement of the amount of tear production in a subject. Tear Secretion Amount Tear Secretion Rate A measurement of the amount of tears being secreted over a defined amount of time (e.g. 5 minutes). Tear Secretion Rate Thickness The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. Thickness Thickness, Maximum The maximum number in a group of values that represent the thickness of an object. Maximum Thickness Thickness, Minimum The minimum number in a group of values that represent the thickness of an object. Minimum Thickness Thickness, Mean The mean number in a group of values that represent the thickness of an object. Mean Thickness Thickness, Standard Deviation The standard deviation in a group of values that represent the thickness of an object. Standard Deviation of Thickness Visual Acuity Card Grating Frequency A measurement of the number of horizontal or vertical lines within a pre-determined unit of length on a visual acuity card. Acuity Card Grating Frequency OETESTCD Ophthalmic Exam Test Code CDISC SDTM Ophthalmic Exam Test Code Terminology Terminology relevant to the test names that describe findings from ophthalmic examinations. Astigmatism Axis A measurement of the location, in degrees, of the flatter principal meridian on a 180-degree scale, where 90 degrees designates the vertical meridian and 180 degrees designates the horizontal meridian. Astigmatism Axis Atrophy An evaluation of atrophy (decrease in size, deterioration, and/or wasting) in a biological specimen or location. Atrophy Assessment Cell Density A measurement of the number of cells contained in a unit of volume or area. Cell Density Cell Density, Maximum The maximum number in a group of values that represent the cell density. Maximum Cell Density Cell Density, Mean The mean number in a group of values that represent the cell density. Mean Cell Density Cell Density, Minimum The minimum number in a group of values that represent the cell density. Minimum Cell Density Cell Density, Standard Deviation The standard deviation in a group of values that represent the cell density. Standard Deviation of Cell Density Color The appearance of objects (or light sources) described in terms of a person's perception of their hue and lightness (or brightness) and saturation. (NCI) Color Corrective Lens for Distance Indicator An indication as to whether an eye lens(es) is worn by the subject to correct for distance. Corrective Lens for Distance Indicator Corrective Lens Indicator An indication as to whether an eye lens(es) is worn by the subject to correct for any type of visual impairment. Corrective Lens Indicator Corrective Lens Type for Distance A description of the type of eye lens(es) worn by the subject to correct for distance. Corrective Lens Type for Distance Count Fingers Distance An assessment of the furthest distance at which a subject can perceive and accurately count the examiner's fingers. Counting Fingers Test Count Fingers Indicator An indication as to whether a subject can perceive and accurately count the examiner's fingers at a pre-specified distance. Counting Fingers Indicator Cup to Disc Ratio The ratio of the diameter of the optic cup compared to the diameter of the optic disc. (NCI) Optic Cup to Disc Ratio Cylindrical Refraction Error Cylindrical Refractive Error A measurement of the extent of defect in vision caused by a mismatch of optical power between the cylindrical and horizontal meridians, resulting in sub-optimal reflection of light onto the retina. (NCI) Cylindrical Refractive Error Detachment An evaluation of an abnormal separation between two normally attached structures. Tissue Detachment Assessment Diabetic Macular Edema Grade The position on a scale to assess diabetic macular edema. Diabetic Macular Edema Grade Diabetic Retinopathy Grade The position on a scale to assess diabetic retinopathy. Diabetic Retinopathy Grade Diameter The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) Diameter Diameter, Mean The mean number in a group of values that represent the diameter of an object. Mean Diameter Diameter, Minimum The minimum number in a group of values that represent the diameter of an object. Minimum Diameter Diameter, Standard Deviation The standard deviation in a group of values that represent the diameter of an object. Standard Deviation of Diameter Edema An evaluation of edema (an excessive amount of watery fluid) in a biological specimen or location. Edema Evaluation Eye Drop Comfort Grade The position on a scale to assess the degree of comfort associated with the administration of an eye drop. Eye Drop Comfort Grade Fluid A evaluation of fluid in a biological specimen or location. Fluid Assessment Hand Motions Distance Hand Movements Distance An assessment of the furthest distance at which a subject can perceive hand motions. Hand Motion Test Hand Motions Indicator Hand Movements Indicator An indication as to whether a subject can perceive hand motions at a pre-specified distance. Hand Motion Indicator Hyperemia Grade The position on a scale to assess hyperemia. Hyperemia Grade Hyperemia An evaluation of hyperemia (an increased amount of blood) in a biological specimen or location. Hyperemia Evaluation Interpretation An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. Interpretation Intraocular Pressure The fluid pressure within the eye. Intraocular Pressure Lens Status The condition or state of the lens of the eye. (NCI) Lens Status Light Perception Indicator An indication as to whether a subject can perceive light from a light source that is placed directly in front of the eye. Light Perception Indicator Log Score A number or range of numeric values on the log scale that measures performance, function, quality, or ability. Log Score Longest Diameter The longest possible length of a straight line passing through the center of a circular or spheroid object that connects two points on the circumference. Longest Diameter Margin Limbal Distance A measurement of the distance from the inferior limbus to the central upper-eyelid margin, with the patient's gaze pointed upward. Margin Limbal Distance Margin Reflex Distance 1 Margin to Reflex Distance 1 Marginal Reflex Distance 1 A measurement of the distance between the corneal light reflex to the central upper-eyelid margin, with the patient's gaze in the primary position (i.e., straight ahead). Margin Reflex Distance 1 Margin Reflex Distance 2 Margin to Reflex Distance 2 Marginal Reflex Distance 2 A measurement of the distance between the corneal light reflex to central lower-eyelid margin, with the patient's gaze in the primary position (i.e., straight ahead). Margin Reflex Distance 2 Minimum Angle of Resolution The smallest angle of separation that allows an image-forming device, including the retina, to distinguish two objects as distinct entities. Minimum Angle of Resolution Minimum Angle of Resolution, Log10 The base-10 logarithm of the minimum angle of resolution achieved by an individual during testing. Log10 Minimum Angle of Resolution Near-Point Accommodation The minimum distance from the retina that an object remains in clear focus. Near-Point Accommodation Neovascularization An evaluation of neovascularization (new vessel formation) in a biological specimen or location. Neovascularization Assessment Number of Characters Read The integer that describes the number of characters read by the subject during an eye chart assessment. Number of Characters Read Number of Characters Unread The integer that describes the number of characters not able to be read by the subject during an eye chart assessment. Number of Characters Unread Number of Letters Correct The integer that describes the number of letters correctly identified by the subject during an eye chart assessment. Number of Correct Eye Chart Letters Number of Lines Read The integer that describes the number of lines read by the subject during an eye chart assessment. Number of Eye Chart Lines Read Number of Lines Unread The integer that describes the number of lines not able to be read by the subject during an eye chart assessment. Number of Lines Unread Opacity An assessment of the degree of opaqueness or the lack of transparency. Opacity Measurement Ophthalmic Examination An observation, assessment or examination of the eye. Eye Examination Reactivity A description of the action in response to some kind of stimulus. Reaction Score A value (e.g., number, numeric range, ratio) that assesses and orders a result or response for purposes of comparison. Score Shape The spatial arrangement of something as distinct from its substance. (NCI) Shape Spherical Refraction Error Spherical Refractive Error A measurement of the extent of defect in vision caused by a mismatch of optimal power between the cornea and/or lens and the length of the eyeball, resulting in sub-optimal reflection of light onto the retina. (NCI) Spherical Refractive Error Subject to Eye Chart Actual Distance The actual distance between the subject and the eye chart during an eye assessment. Actual Subject to Eye Chart Distance Subject to Eye Chart Planned Distance The planned distance between the subject and the eye chart during an eye assessment. Planned Subject to Eye Chart Distance Tear Break-up Time Tear Breakup Time Tear Film Breakup Time The interval of time between the last blink and the first appearance of a black spot in the fluorescein-stained tear film. Tear Breakup Time Assessment Tear Secretion Rate A measurement of the amount of tears being secreted over a defined amount of time (e.g. 5 minutes). Tear Secretion Rate Lacrimation Tear Production Tear Secretion A measurement of the amount of tear production in a subject. Tear Secretion Amount Thickness The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. Thickness Thickness, Maximum The maximum number in a group of values that represent the thickness of an object. Maximum Thickness Thickness, Mean The mean number in a group of values that represent the thickness of an object. Mean Thickness Thickness, Minimum The minimum number in a group of values that represent the thickness of an object. Minimum Thickness Thickness, Standard Deviation The standard deviation in a group of values that represent the thickness of an object. Standard Deviation of Thickness Visual Acuity Card Grating Frequency A measurement of the number of horizontal or vertical lines within a pre-determined unit of length on a visual acuity card. Acuity Card Grating Frequency OETEST Ophthalmic Exam Test Name CDISC SDTM Ophthalmic Exam Test Name Terminology Terminology relevant to the identification of a focus of ophthalmic observations. The eye positioned in the right orbit, Oculus Dexter. Right Eye The eye positioned in the left orbit, Oculus Sinister. Left Eye Of or pertaining to both the left and right eyes, Oculus Uterque. Both Eyes OEFOCUS Ophthalmic Focus of Study Specific Interest CDISC SDTM Ophthalmic Focus of Study Specific Interest Terminology A terminology codelist relevant to other important events that occur during a trial but are not driven by protocol requirements. The study subject has been assigned to a different study site. Study Site Transfer The study subject has been enrolled in an additional research study. Subject Entered Additional Research Study Identification of the treatment assignment to the subject, investigators, and/or other trial personnel. (CDISC Glossary) Unblinding The subject or parent/guardian withdraws their consent for the subject to participate in certain protocol-specified study activities, but does not withdraw consent from participation in the study as a whole. Withdrawal of Consent From Protocol-Specified Activity OTHEVENT Other Disposition Event Response CDISC SDTM Other Disposition Event Response Terminology A condition or event that is attributed to the adverse event and is the result or conclusion of the adverse event. (NCI) 5 FATAL Grade 5 The termination of life as a result of an adverse event. (NCI) Death Related to Adverse Event One of the possible results of an adverse event outcome that indicates that the event has not improved or recuperated. (NCI) Not Recovered from Adverse Event One of the possible results of an adverse event outcome where the subject recuperated but retained pathological conditions resulting from the prior disease or injury. (NCI) Recovered from Adverse Event with Sequelae One of the possible results of an adverse event outcome that indicates that the event has improved or recuperated. (NCI) Recovered from Adverse Event One of the possible results of an adverse event outcome that indicates that the event is improving. (NCI) Recovering or Resolving U UNK Unknown Not known, not observed, not recorded, or refused. (NCI) Unknown OUT Outcome of Event CDISC SDTM Adverse Event Outcome Terminology Paced Auditory Serial Addition Test test code. PASAT1-Total Correct Paced Auditory Serial Addition Test - Total correct. PASAT - Total Correct PASAT1-Percent Correct Paced Auditory Serial Addition Test - Percent correct. PASAT - Percent Correct PASAT1-More Than One Attempt Paced Auditory Serial Addition Test - Did it take more than one attempt to get one successful trial? PASAT - More Than One Attempt PASAT1-Total Correct in First Half Paced Auditory Serial Addition Test - Total correct in first half. PASAT - Total Correct in First Half PASAT1-Total Correct in Second Half Paced Auditory Serial Addition Test - Total correct in second half. PASAT - Total Correct in Second Half PASAT1-Total Commission Errors Paced Auditory Serial Addition Test - Total commission errors. PASAT - Total Commission Errors PASAT1-Total Omission Errors Paced Auditory Serial Addition Test - Total omission errors. PASAT - Total Omission Errors PASAT1TC Paced Auditory Serial Addition Test Functional Test Test Code CDISC Functional Test PASAT Test Code Terminology Paced Auditory Serial Addition Test test name. PASAT1-More Than One Attempt Paced Auditory Serial Addition Test - Did it take more than one attempt to get one successful trial? PASAT - More Than One Attempt PASAT1-Percent Correct Paced Auditory Serial Addition Test - Percent correct. PASAT - Percent Correct PASAT1-Total Commission Errors Paced Auditory Serial Addition Test - Total commission errors. PASAT - Total Commission Errors PASAT1-Total Correct in First Half Paced Auditory Serial Addition Test - Total correct in first half. PASAT - Total Correct in First Half PASAT1-Total Correct in Second Half Paced Auditory Serial Addition Test - Total correct in second half. PASAT - Total Correct in Second Half PASAT1-Total Correct Paced Auditory Serial Addition Test - Total correct. PASAT - Total Correct PASAT1-Total Omission Errors Paced Auditory Serial Addition Test - Total omission errors. PASAT - Total Omission Errors PASAT1TN Paced Auditory Serial Addition Test Functional Test Test Name CDISC Functional Test PASAT Test Name Terminology Paced Tapping test code. PTAP1-Total Trials Expected Paced Tapping - Total number of trials expected to be administered in the task. Paced Tapping - Total Trials Expected PTAP1-Total Trials Administered Paced Tapping - Total number of trials actually administered in the task. Paced Tapping - Total Trials Administered PTAP1-Total Trials Completed Paced Tapping - Total number of trials actually completed in the task. Paced Tapping - Total Trials Completed PTAP1-Total Interval Tone Admin All Paced Tapping - Total number of intertap intervals across all 4 toned tapping phases of each trial administered. Paced Tapping - Total Interval Tone Admin All PTAP1-Total Interval Tone Trim All Paced Tapping - Total number of intertap intervals across the 4 toned tapping phases of each trial, that were trimmed before analysis. Paced Tapping - Total Interval Tone Trim All PTAP1-Minimum Interval Tone All Paced Tapping - The minimum intertap interval within the tone-paced tapping phase across all trials (in milliseconds). Paced Tapping - Minimum Interval Tone All PTAP1-Maximum Interval Tone All Paced Tapping - The maximum intertap interval within the tone-paced tapping phase across all trials (in milliseconds). Paced Tapping - Maximum Interval Tone All PTAP1-Mean Interval Tone All Paced Tapping - The mean intertap interval within the tone-paced tapping phase across all trials (in milliseconds). Paced Tapping - Mean Interval Tone All PTAP1-Median Interval Tone All Paced Tapping - The median intertap interval within the tone-paced tapping phase across all trials (in milliseconds). Paced Tapping - Median Interval Tone All PTAP1-Variance Interval Tone All Paced Tapping - The variance of the intertap interval within the tone-paced tapping phase across all trials (in milliseconds). Paced Tapping - Variance Interval Tone All PTAP1-Deviation Interval Tone All Paced Tapping - The standard deviation of the intertap intervals within the tone-paced tapping phase across all trials. Paced Tapping - Deviation Interval Tone All PTAP1-Reciprocal Interval Tone All Paced Tapping - The reciprocal of the standard deviation of the intertap intervals within the tone-paced tapping phase across all trials. Paced Tapping - Reciprocal Interval Tone All PTAP1-Avg Sign Dev Interval Tone All Paced Tapping - The average signed deviation of the intertap intervals within the tone-paced tapping phase across all trials. Paced Tapping - Avg Sign Dev Interval Tone All PTAP1-Total Interval Self Admin All Paced Tapping - Total number of interlap intervals across all 4 trials administered (self-paced tapping phases). Paced Tapping - Total Interval Self Admin All PTAP1-Total Interval Self Trim All Paced Tapping - Total number of intertap intervals across all 4 trials that were trimmed before analysis (self-paced tapping phases). Paced Tapping - Total Interval Self Trim All PTAP1-Minimum Interval Self All Paced Tapping - The minimum intertap interval within the self-paced tapping phase across all trials (in milliseconds). Paced Tapping - Minimum Interval Self All PTAP1-Maximum Interval Self All Paced Tapping - The maximum intertap interval within the self-paced tapping phase across all trials (in milliseconds). Paced Tapping - Maximum Interval Self All PTAP1-Mean Interval Self All Paced Tapping - The mean intertap interval within the self-paced tapping phase across all trials (in milliseconds). Paced Tapping - Mean Interval Self All PTAP1-Median Interval Self All Paced Tapping - The median intertap interval within the self-paced tapping phase across all trials (in milliseconds). Paced Tapping - Median Interval Self All PTAP1-Variance Interval Self All Paced Tapping - The variance of the intertap interval within the self-paced tapping phase across all trials (in milliseconds). Paced Tapping - Variance Interval Self All PTAP1-Deviation Interval Self All Paced Tapping - The standard deviation of the intertap intervals within the self-paced tapping phase across all trials. Paced Tapping - Deviation Interval Self All PTAP1-Reciprocal Interval Self All Paced Tapping - The reciprocal of the standard deviation of the intertap intervals within the self-paced tapping phase across all trials. Paced Tapping - Reciprocal Interval Self All PTAP1-Avg Sign Dev Interval Self All Paced Tapping - The average signed deviation of the intertap intervals within the self-paced tapping phase across all trials. Paced Tapping - Avg Sign Dev Interval Self All PTAP1-Trials Expected in Trial Paced Tapping - Number of trials expected to be administered in Trial n. Paced Tapping - Trials Expected in Trial PTAP1-Trials Administered in Trial Paced Tapping - Number of trials actually administered in Trial n. Paced Tapping - Trials Administered in Trial PTAP1-Trials Completed in Trial Paced Tapping - Number of trials actually completed in Trial n. Paced Tapping - Trials Completed in Trial PTAP1-Num Intervals Expected Tone Trial Paced Tapping - Total number of intertap intervals expected for the tone-tapping phase of Trial n. Paced Tapping - Num Intervals Expected Tone Trial PTAP1-Num Intervals Trim Tone Trial Paced Tapping - Total number of intertap intervals within the tone-tapping phase of Trial n, that were trimmed before analysis. Paced Tapping - Num Intervals Trim Tone Trial PTAP1-Minimum Interval Tone Trial Paced Tapping - The minimum intertap interval within the tone-tapping phase of Trial n (in milliseconds). Paced Tapping - Minimum Interval Tone Trial PTAP1-Maximum Interval Tone Trial Paced Tapping - The maximum intertap interval within the tone-tapping phase of Trial n (in milliseconds). Paced Tapping - Maximum Interval Tone Trial PTAP1-Mean Interval Tone Trial Paced Tapping - The mean intertap interval within the tone-tapping phase of Trial n (in milliseconds). Paced Tapping - Mean Interval Tone Trial PTAP1-Median Interval Tone Trial Paced Tapping - The median intertap interval within the tone-tapping phase of Trial n (in milliseconds). Paced Tapping - Median Interval Tone Trial PTAP1-Variance Interval Tone Trial Paced Tapping - The variance of the intertap interval within the tone-tapping phase of Trial n (in milliseconds). Paced Tapping - Variance Interval Tone Trial PTAP1-Deviation Interval Tone Trial Paced Tapping - The standard deviation of the intertap intervals within the tone-tapping phase of Trial n. Paced Tapping - Deviation Interval Tone Trial PTAP1-Reciprocal Interval ToneTrial Paced Tapping - The reciprocal of the standard deviation of the intertap intervals within the tone-tapping phase of Trial n. Paced Tapping - Reciprocal Interval ToneTrial PTAP1-Avg Sign Dev Interval Tone Trial Paced Tapping - The average signed deviation of the intertap intervals within the tone-tapping phase of Trial n. Paced Tapping - Avg Sign Dev Interval Tone Trial PTAP1-Num Intervals Expected Self Trial Paced Tapping - Total number of intertap intervals expected for the self-paced tapping phase of Trial n. Paced Tapping - Num Intervals Expected Self Trial PTAP1-Num Intervals Trim Self Trial Paced Tapping - Total number of intertap intervals within the self-paced tapping phase of Trial n, that were trimmed before analysis. Paced Tapping - Num Intervals Trim Self Trial PTAP1-Minimum Interval Self Trial Paced Tapping - The minimum intertap interval within the self-paced tapping phase of Trial n (in milliseconds). Paced Tapping - Minimum Interval Self Trial PTAP1-Maximum Interval Self Trial Paced Tapping - The maximum intertap interval within the self-paced tapping phase of Trial n (in milliseconds). Paced Tapping - Maximum Interval Self Trial PTAP1-Mean Interval Self Trial Paced Tapping - The mean intertap interval within the self-paced tapping phase of Trial n (in milliseconds). Paced Tapping - Mean Interval Self Trial PTAP1-Median Interval Self Trial Paced Tapping - The median intertap interval within the self-paced tapping phase of Trial n (in milliseconds). Paced Tapping - Median Interval Self Trial PTAP1-Variance Interval Self Trial Paced Tapping - The variance of the intertap interval within the self-paced tapping phase of Trial n (in milliseconds). Paced Tapping - Variance Interval Self Trial PTAP1-Deviation Interval Self Trial Paced Tapping - The standard deviation of the intertap intervals within the self-paced tapping phase of Trial n. Paced Tapping - Deviation Interval Self Trial PTAP1-Reciprocal Interval Self Trial Paced Tapping - The reciprocal of the standard deviation of the intertap intervals within the self-paced tapping phase of Trial n. Paced Tapping - Reciprocal Interval Self Trial PTAP1-Avg Sign Dev Interval Self Trial Paced Tapping - The average signed deviation of the intertap intervals within the self-paced tapping phase of Trial n. Paced Tapping - Avg Sign Dev Interval Self Trial PTAP1TC Paced Tapping Functional Test Test Code CDISC Functional Test Paced Tapping Test Code Terminology Paced Tapping test name. PTAP1-Avg Sign Dev Interval Self All Paced Tapping - The average signed deviation of the intertap intervals within the self-paced tapping phase across all trials. Paced Tapping - Avg Sign Dev Interval Self All PTAP1-Avg Sign Dev Interval Self Trial Paced Tapping - The average signed deviation of the intertap intervals within the self-paced tapping phase of Trial n. Paced Tapping - Avg Sign Dev Interval Self Trial PTAP1-Avg Sign Dev Interval Tone All Paced Tapping - The average signed deviation of the intertap intervals within the tone-paced tapping phase across all trials. Paced Tapping - Avg Sign Dev Interval Tone All PTAP1-Avg Sign Dev Interval Tone Trial Paced Tapping - The average signed deviation of the intertap intervals within the tone-tapping phase of Trial n. Paced Tapping - Avg Sign Dev Interval Tone Trial PTAP1-Deviation Interval Self All Paced Tapping - The standard deviation of the intertap intervals within the self-paced tapping phase across all trials. Paced Tapping - Deviation Interval Self All PTAP1-Deviation Interval Self Trial Paced Tapping - The standard deviation of the intertap intervals within the self-paced tapping phase of Trial n. Paced Tapping - Deviation Interval Self Trial PTAP1-Deviation Interval Tone All Paced Tapping - The standard deviation of the intertap intervals within the tone-paced tapping phase across all trials. Paced Tapping - Deviation Interval Tone All PTAP1-Deviation Interval Tone Trial Paced Tapping - The standard deviation of the intertap intervals within the tone-tapping phase of Trial n. Paced Tapping - Deviation Interval Tone Trial PTAP1-Maximum Interval Self All Paced Tapping - The maximum intertap interval within the self-paced tapping phase across all trials (in milliseconds). Paced Tapping - Maximum Interval Self All PTAP1-Maximum Interval Self Trial Paced Tapping - The maximum intertap interval within the self-paced tapping phase of Trial n (in milliseconds). Paced Tapping - Maximum Interval Self Trial PTAP1-Maximum Interval Tone All Paced Tapping - The maximum intertap interval within the tone-paced tapping phase across all trials (in milliseconds). Paced Tapping - Maximum Interval Tone All PTAP1-Maximum Interval Tone Trial Paced Tapping - The maximum intertap interval within the tone-tapping phase of Trial n (in milliseconds). Paced Tapping - Maximum Interval Tone Trial PTAP1-Mean Interval Self All Paced Tapping - The mean intertap interval within the self-paced tapping phase across all trials (in milliseconds). Paced Tapping - Mean Interval Self All PTAP1-Mean Interval Self Trial Paced Tapping - The mean intertap interval within the self-paced tapping phase of Trial n (in milliseconds). Paced Tapping - Mean Interval Self Trial PTAP1-Mean Interval Tone All Paced Tapping - The mean intertap interval within the tone-paced tapping phase across all trials (in milliseconds). Paced Tapping - Mean Interval Tone All PTAP1-Mean Interval Tone Trial Paced Tapping - The mean intertap interval within the tone-tapping phase of Trial n (in milliseconds). Paced Tapping - Mean Interval Tone Trial PTAP1-Median Interval Self All Paced Tapping - The median intertap interval within the self-paced tapping phase across all trials (in milliseconds). Paced Tapping - Median Interval Self All PTAP1-Median Interval Self Trial Paced Tapping - The median intertap interval within the self-paced tapping phase of Trial n (in milliseconds). Paced Tapping - Median Interval Self Trial PTAP1-Median Interval Tone All Paced Tapping - The median intertap interval within the tone-paced tapping phase across all trials (in milliseconds). Paced Tapping - Median Interval Tone All PTAP1-Median Interval Tone Trial Paced Tapping - The median intertap interval within the tone-tapping phase of Trial n (in milliseconds). Paced Tapping - Median Interval Tone Trial PTAP1-Minimum Interval Self All Paced Tapping - The minimum intertap interval within the self-paced tapping phase across all trials (in milliseconds). Paced Tapping - Minimum Interval Self All PTAP1-Minimum Interval Self Trial Paced Tapping - The minimum intertap interval within the self-paced tapping phase of Trial n (in milliseconds). Paced Tapping - Minimum Interval Self Trial PTAP1-Minimum Interval Tone All Paced Tapping - The minimum intertap interval within the tone-paced tapping phase across all trials (in milliseconds). Paced Tapping - Minimum Interval Tone All PTAP1-Minimum Interval Tone Trial Paced Tapping - The minimum intertap interval within the tone-tapping phase of Trial n (in milliseconds). Paced Tapping - Minimum Interval Tone Trial PTAP1-Num Intervals Expected Self Trial Paced Tapping - Total number of intertap intervals expected for the self-paced tapping phase of Trial n. Paced Tapping - Num Intervals Expected Self Trial PTAP1-Num Intervals Expected Tone Trial Paced Tapping - Total number of intertap intervals expected for the tone-tapping phase of Trial n. Paced Tapping - Num Intervals Expected Tone Trial PTAP1-Num Intervals Trim Self Trial Paced Tapping - Total number of intertap intervals within the self-paced tapping phase of Trial n, that were trimmed before analysis. Paced Tapping - Num Intervals Trim Self Trial PTAP1-Num Intervals Trim Tone Trial Paced Tapping - Total number of intertap intervals within the tone-tapping phase of Trial n, that were trimmed before analysis. Paced Tapping - Num Intervals Trim Tone Trial PTAP1-Reciprocal Interval Self All Paced Tapping - The reciprocal of the standard deviation of the intertap intervals within the self-paced tapping phase across all trials. Paced Tapping - Reciprocal Interval Self All PTAP1-Reciprocal Interval Self Trial Paced Tapping - The reciprocal of the standard deviation of the intertap intervals within the self-paced tapping phase of Trial n. Paced Tapping - Reciprocal Interval Self Trial PTAP1-Reciprocal Interval Tone All Paced Tapping - The reciprocal of the standard deviation of the intertap intervals within the tone-paced tapping phase across all trials. Paced Tapping - Reciprocal Interval Tone All PTAP1-Reciprocal Interval ToneTrial Paced Tapping - The reciprocal of the standard deviation of the intertap intervals within the tone-tapping phase of Trial n. Paced Tapping - Reciprocal Interval ToneTrial PTAP1-Total Interval Self Admin All Paced Tapping - Total number of interlap intervals across all 4 trials administered (self-paced tapping phases). Paced Tapping - Total Interval Self Admin All PTAP1-Total Interval Self Trim All Paced Tapping - Total number of intertap intervals across all 4 trials that were trimmed before analysis (self-paced tapping phases). Paced Tapping - Total Interval Self Trim All PTAP1-Total Interval Tone Admin All Paced Tapping - Total number of intertap intervals across all 4 toned tapping phases of each trial administered. Paced Tapping - Total Interval Tone Admin All PTAP1-Total Interval Tone Trim All Paced Tapping - Total number of intertap intervals across the 4 toned tapping phases of each trial, that were trimmed before analysis. Paced Tapping - Total Interval Tone Trim All PTAP1-Total Trials Administered Paced Tapping - Total number of trials actually administered in the task. Paced Tapping - Total Trials Administered PTAP1-Total Trials Completed Paced Tapping - Total number of trials actually completed in the task. Paced Tapping - Total Trials Completed PTAP1-Total Trials Expected Paced Tapping - Total number of trials expected to be administered in the task. Paced Tapping - Total Trials Expected PTAP1-Trials Administered in Trial Paced Tapping - Number of trials actually administered in Trial n. Paced Tapping - Trials Administered in Trial PTAP1-Trials Completed in Trial Paced Tapping - Number of trials actually completed in Trial n. Paced Tapping - Trials Completed in Trial PTAP1-Trials Expected in Trial Paced Tapping - Number of trials expected to be administered in Trial n. Paced Tapping - Trials Expected in Trial PTAP1-Variance Interval Self All Paced Tapping - The variance of the intertap interval within the self-paced tapping phase across all trials (in milliseconds). Paced Tapping - Variance Interval Self All PTAP1-Variance Interval Self Trial Paced Tapping - The variance of the intertap interval within the self-paced tapping phase of Trial n (in milliseconds). Paced Tapping - Variance Interval Self Trial PTAP1-Variance Interval Tone All Paced Tapping - The variance of the intertap interval within the tone-paced tapping phase across all trials (in milliseconds). Paced Tapping - Variance Interval Tone All PTAP1-Variance Interval Tone Trial Paced Tapping - The variance of the intertap interval within the tone-tapping phase of Trial n (in milliseconds). Paced Tapping - Variance Interval Tone Trial PTAP1TN Paced Tapping Functional Test Test Name CDISC Functional Test Paced Tapping Test Name Terminology Pain Intensity test code. PI01-Pain Intensity Pain Intensity - Pain intensity for various time periods of evaluation. PI - Pain Intensity For Various Time Periods of Evaluation PI01-Average Pain Intensity Pain Intensity - Average pain intensity for various time periods of evaluation. PI - Average Pain Intensity For Various Time Periods of Evaluation PI01-Minimum Pain Intensity Pain Intensity - Minimum pain intensity for various time periods of evaluation. PI - Minimum Pain Intensity For Various Time Periods of Evaluation PI01-Maximum Pain Intensity Pain Intensity - Maximum pain intensity for various time periods of evaluation. PI - Maximum Pain Intensity For Various Time Periods of Evaluation PI01-Least Pain Intensity Pain Intensity - Least pain intensity for various time periods of evaluation. PI - Least Pain Intensity For Various Time Periods of Evaluation PI01-Worst Pain Intensity Pain Intensity - Worst pain intensity for various time periods of evaluation. PI - Worst Pain Intensity For Various Time Periods of Evaluation PI01TC Pain Intensity Questionnaire Test Code CDISC Questionnaire PI v1 Test Code Terminology Pain Intensity test name. PI01-Average Pain Intensity Pain Intensity - Average pain intensity for various time periods of evaluation. PI - Average Pain Intensity For Various Time Periods of Evaluation PI01-Least Pain Intensity Pain Intensity - Least pain intensity for various time periods of evaluation. PI - Least Pain Intensity For Various Time Periods of Evaluation PI01-Maximum Pain Intensity Pain Intensity - Maximum pain intensity for various time periods of evaluation. PI - Maximum Pain Intensity For Various Time Periods of Evaluation PI01-Minimum Pain Intensity Pain Intensity - Minimum pain intensity for various time periods of evaluation. PI - Minimum Pain Intensity For Various Time Periods of Evaluation PI01-Pain Intensity Pain Intensity - Pain intensity for various time periods of evaluation. PI - Pain Intensity For Various Time Periods of Evaluation PI01-Worst Pain Intensity Pain Intensity - Worst pain intensity for various time periods of evaluation. PI - Worst Pain Intensity For Various Time Periods of Evaluation PI01TN Pain Intensity Questionnaire Test Name CDISC Questionnaire PI v1 Test Name Terminology Pain Relief test code. PR01-Pain Relief Pain Relief - Pain relief for various time periods of evaluation. PR - Pain Relief For Various Time Periods of Evaluation PR01-Average Pain Relief Pain Relief - Average pain relief for various time periods of evaluation. PR - Average Pain Relief For Various Time Periods of Evaluation PR01-Minimum Pain Relief Pain Relief - Minimum pain relief for various time periods of evaluation. PR - Minimum Pain Relief For Various Time Periods of Evaluation PR01-Maximum Pain Relief Pain Relief - Maximum pain relief for various time periods of evaluation. PR - Maximum Pain Relief For Various Time Periods of Evaluation PR01-Least Pain Relief Pain Relief - Least pain relief for various time periods of evaluation. PR - Least Pain Relief For Various Time Periods of Evaluation PR01-Worst Pain Relief Pain Relief - Worst pain relief for various time periods of evaluation. PR - Worst Pain Relief For Various Time Periods of Evaluation PR01-Starting Pain at Least 1/2 Gone Pain Relief - Starting pain at least 1/2 Gone? PR - Starting Pain Half Gone PR01-Was there Perceptible Pain Relief Pain Relief - Was there perceptible pain relief? PR - Was There Perceptible Pain Relief PR01-Time to Perceptible Pain Relief Pain Relief - Time to perceptible pain relief. PR - Time to Perceptible Pain Relief PR01-Was there Meaningful Pain Relief Pain Relief - Was there meaningful pain relief? PR - Was There Meaningful Pain Relief PR01-Time to Meaningful Pain Relief Pain Relief - Time to meaningful pain relief. PR - Time to Meaningful Pain Relief PR01TC Pain Relief Questionnaire Test Code CDISC Questionnaire PR v1 Test Code Terminology Pain Relief test name. PR01-Average Pain Relief Pain Relief - Average pain relief for various time periods of evaluation. PR - Average Pain Relief For Various Time Periods of Evaluation PR01-Least Pain Relief Pain Relief - Least pain relief for various time periods of evaluation. PR - Least Pain Relief For Various Time Periods of Evaluation PR01-Maximum Pain Relief Pain Relief - Maximum pain relief for various time periods of evaluation. PR - Maximum Pain Relief For Various Time Periods of Evaluation PR01-Minimum Pain Relief Pain Relief - Minimum pain relief for various time periods of evaluation. PR - Minimum Pain Relief For Various Time Periods of Evaluation PR01-Pain Relief Pain Relief - Pain relief for various time periods of evaluation. PR - Pain Relief For Various Time Periods of Evaluation PR01-Starting Pain at Least 1/2 Gone Pain Relief - Starting pain at least 1/2 Gone? PR - Starting Pain Half Gone PR01-Time to Meaningful Pain Relief Pain Relief - Time to meaningful pain relief. PR - Time to Meaningful Pain Relief PR01-Time to Perceptible Pain Relief Pain Relief - Time to perceptible pain relief. PR - Time to Perceptible Pain Relief PR01-Was there Meaningful Pain Relief Pain Relief - Was there meaningful pain relief? PR - Was There Meaningful Pain Relief PR01-Was there Perceptible Pain Relief Pain Relief - Was there perceptible pain relief? PR - Was There Perceptible Pain Relief PR01-Worst Pain Relief Pain Relief - Worst pain relief for various time periods of evaluation. PR - Worst Pain Relief For Various Time Periods of Evaluation PR01TN Pain Relief Questionnaire Test Name CDISC Questionnaire PR v1 Test Name Terminology Terminology relevant to the test codes that describe findings about an pancreatic cancer event or intervention. Primary Site of Tumor Origin The anatomical location of the primary tumor site of disease. Primary Tumor Site PAFATSCD Pancreatic Cancer Findings About Test Code CDISC SDTM Pancreatic Cancer Findings About Test Code Terminology Terminology relevant to the test names that describe findings about an pancreatic cancer event or intervention. Primary Site of Tumor Origin The anatomical location of the primary tumor site of disease. Primary Tumor Site PAFATS Pancreatic Cancer Findings About Test Name CDISC SDTM Pancreatic Cancer Findings About Test Name Terminology Patient Determined Disease Steps test code. PDDS01-Category Describing Situation Patient Determined Disease Steps - This scale focuses mainly on how well you walk. You might not find a description that reflects your condition exactly, but please mark the one category that describes your situation the closest. PDDS - Category Describing Situation PDDS01TC Patient Determined Disease Steps Questionnaire Test Code CDISC Questionnaire PDDS Test Code Terminology Patient Determined Disease Steps test name. PDDS01-Category Describing Situation Patient Determined Disease Steps - This scale focuses mainly on how well you walk. You might not find a description that reflects your condition exactly, but please mark the one category that describes your situation the closest. PDDS - Category Describing Situation PDDS01TN Patient Determined Disease Steps Questionnaire Test Name CDISC Questionnaire PDDS Test Name Terminology Patient Global Impression Generic Modification Version test code. PGI01-Severity Patient Global Impression - Considering all the ways your condition impacts you, how severe is your condition at this time? PGI Generic Modification Version - Severity PGI01-Change Patient Global Impression - Compared to <previously assessed protocol specified time point> how much has your condition changed? PGI Generic Modification Version - Change PGI01-Improvement Patient Global Impression - Compared to <previously assessed protocol specified time point> how much has your condition improved? PGI Generic Modification Version - Improvement PGI01TC Patient Global Impression Generic Modification Version Questionnaire Test Code CDISC Questionnaire PGI Generic Modification Version Test Code Terminology Patient Global Impression Generic Modification Version test name. PGI01-Change Patient Global Impression - Compared to <previously assessed protocol specified time point> how much has your condition changed? PGI Generic Modification Version - Change PGI01-Improvement Patient Global Impression - Compared to <previously assessed protocol specified time point> how much has your condition improved? PGI Generic Modification Version - Improvement PGI01-Severity Patient Global Impression - Considering all the ways your condition impacts you, how severe is your condition at this time? PGI Generic Modification Version - Severity PGI01TN Patient Global Impression Generic Modification Version Questionnaire Test Name CDISC Questionnaire PGI Generic Modification Version Test Name Terminology Patient Health Questionnaire - 15 test code. PHQ02-Stomach Pain Patient Health Questionnaire - 15 - Stomach pain. PHQ-15 - Stomach Pain PHQ02-Back Pain Patient Health Questionnaire - 15 - Back pain. PHQ-15 - Back Pain PHQ02-Pain In Your Arms, Legs, or Joints Patient Health Questionnaire - 15 - Pain in your arms, legs, or joints (knees, hips, etc.). PHQ-15 - Pain In Your Arms, Legs, or Joints PHQ02-Menstrual Cramp/Problem Periods Patient Health Questionnaire - 15 - Menstrual cramps or other problems with your periods [Women only]. PHQ-15 - Menstrual Cramp or Other Problems with Your Periods PHQ02-Headaches Patient Health Questionnaire - 15 - Headaches. PHQ-15 - Headaches PHQ02-Chest Pain Patient Health Questionnaire - 15 - Chest pain. PHQ-15 - Chest Pain PHQ02-Dizziness Patient Health Questionnaire - 15 - Dizziness. PHQ-15 - Dizziness PHQ02-Fainting Spells Patient Health Questionnaire - 15 - Fainting spells. PHQ-15 - Fainting Spells PHQ02-Feeling Your Heart Pound or Race Patient Health Questionnaire - 15 - Feeling your heart pound or race. PHQ-15 - Feeling Your Heart Pound or Race PHQ02-Shortness of Breath Patient Health Questionnaire - 15 - Shortness of breath. PHQ-15 - Shortness of Breath PHQ02-Pain/Problems During Intercourse Patient Health Questionnaire - 15 - Pain or problems during sexual intercourse. PHQ-15 - Pain or Problems During Sexual Intercourse PHQ02-Constipation/Loose Bowels/Diarrhea Patient Health Questionnaire - 15 - Constipation, loose bowels, or diarrhea. PHQ-15 - Constipation, Loose Bowels, or Diarrhea PHQ02-Nausea, Gas, or Indigestion Patient Health Questionnaire - 15 - Nausea, gas, or indigestion. PHQ-15 - Nausea, Gas, or Indigestion PHQ02-Feeling Tired or Having Low Energy Patient Health Questionnaire - 15 - Feeling tired or having low energy. PHQ-15 - Feeling Tired or Having Low Energy PHQ02-Trouble Sleeping Patient Health Questionnaire - 15 - Trouble sleeping. PHQ-15 - Trouble Sleeping PHQ02-Total Score Patient Health Questionnaire - 15 - Total score. PHQ-15 - Total Score PHQ02TC Patient Health Questionnaire - 15 Item Questionnaire Test Code CDISC Questionnaire PHQ-15 Test Code Terminology Patient Health Questionnaire - 15 test name. PHQ02-Back Pain Patient Health Questionnaire - 15 - Back pain. PHQ-15 - Back Pain PHQ02-Chest Pain Patient Health Questionnaire - 15 - Chest pain. PHQ-15 - Chest Pain PHQ02-Constipation/Loose Bowels/Diarrhea Patient Health Questionnaire - 15 - Constipation, loose bowels, or diarrhea. PHQ-15 - Constipation, Loose Bowels, or Diarrhea PHQ02-Dizziness Patient Health Questionnaire - 15 - Dizziness. PHQ-15 - Dizziness PHQ02-Fainting Spells Patient Health Questionnaire - 15 - Fainting spells. PHQ-15 - Fainting Spells PHQ02-Feeling Tired or Having Low Energy Patient Health Questionnaire - 15 - Feeling tired or having low energy. PHQ-15 - Feeling Tired or Having Low Energy PHQ02-Feeling Your Heart Pound or Race Patient Health Questionnaire - 15 - Feeling your heart pound or race. PHQ-15 - Feeling Your Heart Pound or Race PHQ02-Headaches Patient Health Questionnaire - 15 - Headaches. PHQ-15 - Headaches PHQ02-Menstrual Cramp/Problem Periods Patient Health Questionnaire - 15 - Menstrual cramps or other problems with your periods [Women only]. PHQ-15 - Menstrual Cramp or Other Problems with Your Periods PHQ02-Nausea, Gas, or Indigestion Patient Health Questionnaire - 15 - Nausea, gas, or indigestion. PHQ-15 - Nausea, Gas, or Indigestion PHQ02-Pain In Your Arms, Legs, or Joints Patient Health Questionnaire - 15 - Pain in your arms, legs, or joints (knees, hips, etc.). PHQ-15 - Pain In Your Arms, Legs, or Joints PHQ02-Pain/Problems During Intercourse Patient Health Questionnaire - 15 - Pain or problems during sexual intercourse. PHQ-15 - Pain or Problems During Sexual Intercourse PHQ02-Shortness of Breath Patient Health Questionnaire - 15 - Shortness of breath. PHQ-15 - Shortness of Breath PHQ02-Stomach Pain Patient Health Questionnaire - 15 - Stomach pain. PHQ-15 - Stomach Pain PHQ02-Total Score Patient Health Questionnaire - 15 - Total score. PHQ-15 - Total Score PHQ02-Trouble Sleeping Patient Health Questionnaire - 15 - Trouble sleeping. PHQ-15 - Trouble Sleeping PHQ02TN Patient Health Questionnaire - 15 Item Questionnaire Test Name CDISC Questionnaire PHQ-15 Test Name Terminology Patient Health Questionnaire - 2 test code. PHQ04-Little Interest/Pleasure in Things The Patient Health Questionnaire-2 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Little interest or pleasure in doing things. PHQ-2 - Little Interest or Pleasure in Doing Things PHQ04-Feeling Down Depressed or Hopeless The Patient Health Questionnaire-2 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Feeling down, depressed or hopeless. PHQ-2 - Feeling Down, Depressed or Hopeless PHQ04TC Patient Health Questionnaire - 2 Item Questionnaire Test Code CDISC Questionnaire PHQ-2 Test Code Terminology Patient Health Questionnaire - 2 test name. PHQ04-Feeling Down Depressed or Hopeless The Patient Health Questionnaire-2 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Feeling down, depressed or hopeless. PHQ-2 - Feeling Down, Depressed or Hopeless PHQ04-Little Interest/Pleasure in Things The Patient Health Questionnaire-2 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Little interest or pleasure in doing things. PHQ-2 - Little Interest or Pleasure in Doing Things PHQ04TN Patient Health Questionnaire - 2 Item Questionnaire Test Name CDISC Questionnaire PHQ-2 Test Name Terminology Patient Health Questionnaire - 8 test code. PHQ05-Little Interest/Pleasure in Things Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Little interest or pleasure in doing things. PHQ-8 - Little Interest or Pleasure in Things PHQ05-Feeling Down Depressed or Hopeless Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Feeling down, depressed, or hopeless. PHQ-8 - Feeling Down Depressed or Hopeless PHQ05-Trouble Falling or Staying Asleep Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Trouble falling or staying asleep, or sleeping too much. PHQ-8 - Trouble Falling or Staying Asleep PHQ05-Feeling Tired or Little Energy Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Feeling tired or having little energy. PHQ-8 - Feeling Tired or Little Energy PHQ05-Poor Appetite or Overeating Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Poor appetite or overeating. PHQ-8 - Poor Appetite or Overeating PHQ05-Feeling Bad About Yourself Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Feeling bad about yourself--or that you are a failure or have let yourself or your family down. PHQ-8 - Feeling Bad About Yourself PHQ05-Trouble Concentrating on Things Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Trouble concentrating on things, such as reading the newspaper or watching television. PHQ-8 - Trouble Concentrating on Things PHQ05-Moving Slowly or Fidgety/Restless Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Moving or speaking so slowly that other people could have noticed? Or the opposite -- being so fidgety or restless that you have been moving around a lot more than usual. PHQ-8 - Moving Slowly or Fidgety or Restless PHQ05-Total Score Patient Health Questionnaire - 8 - Total Score. PHQ-8 - Total Score PHQ05TC Patient Health Questionnaire - 8 Questionnaire Test Code CDISC Questionnaire Patient Health Questionnaire - 8 Item Test Code Terminology Patient Health Questionnaire - 8 test name. PHQ05-Feeling Bad About Yourself Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Feeling bad about yourself--or that you are a failure or have let yourself or your family down. PHQ-8 - Feeling Bad About Yourself PHQ05-Feeling Down Depressed or Hopeless Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Feeling down, depressed, or hopeless. PHQ-8 - Feeling Down Depressed or Hopeless PHQ05-Feeling Tired or Little Energy Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Feeling tired or having little energy. PHQ-8 - Feeling Tired or Little Energy PHQ05-Little Interest/Pleasure in Things Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Little interest or pleasure in doing things. PHQ-8 - Little Interest or Pleasure in Things PHQ05-Moving Slowly or Fidgety/Restless Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Moving or speaking so slowly that other people could have noticed? Or the opposite -- being so fidgety or restless that you have been moving around a lot more than usual. PHQ-8 - Moving Slowly or Fidgety or Restless PHQ05-Poor Appetite or Overeating Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Poor appetite or overeating. PHQ-8 - Poor Appetite or Overeating PHQ05-Total Score Patient Health Questionnaire - 8 - Total Score. PHQ-8 - Total Score PHQ05-Trouble Concentrating on Things Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Trouble concentrating on things, such as reading the newspaper or watching television. PHQ-8 - Trouble Concentrating on Things PHQ05-Trouble Falling or Staying Asleep Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Trouble falling or staying asleep, or sleeping too much. PHQ-8 - Trouble Falling or Staying Asleep PHQ05TN Patient Health Questionnaire - 8 Questionnaire Test Name CDISC Questionnaire Patient Health Questionnaire - 8 Item Test Name Terminology Patient Health Questionnaire - 9 test code. PHQ01-Little Interest/Pleasure in Things Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Little interest or pleasure in doing things. PHQ-9 - Little Interest or Pleasure in Doing Things PHQ01-Feeling Down Depressed or Hopeless Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Feeling down, depressed, or hopeless. PHQ-9 - Feeling Down, Depressed, or Hopeless PHQ01-Trouble Falling or Staying Asleep Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Trouble falling or staying asleep, or sleeping too much. PHQ-9 - Trouble Falling or Staying Asleep, or Sleeping Too Much PHQ01-Feeling Tired or Little Energy Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Feeling tired or having little energy. PHQ-9 - Feeling Tired or Having Little Energy PHQ01-Poor Appetite or Overeating Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Poor appetite or overeating. PHQ-9 - Poor Appetite or Overeating PHQ01-Feeling Bad About Yourself Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Feeling bad about yourself - or that you are a failure or have let yourself or your family down. PHQ-9 - Feeling Bad About Yourself PHQ01-Trouble Concentrating on Things Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Trouble concentrating on things, such as reading the newspaper or watching television. PHQ-9 - Trouble Concentrating on Things PHQ01-Moving Slowly or Fidgety/Restless Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Moving or speaking so slowly that other people could have noticed? Or the opposite - being so fidgety or restless that you have been moving around a lot more than usual. PHQ-9 - Moving or Speaking Slowly or the Opposite being Fidgety or Restless PHQ01-Thoughts You Be Better Off Dead Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Thoughts that you would be better off dead or of hurting yourself in some way. PHQ-9 - Thoughts That You Would be Better Off Dead PHQ01-Difficult to Work/Take Care Things Patient Health Questionnaire - 9 - If you checked off any problems, how difficult have these problems made it for you to do your work, take care of things at home, or get along with other people? PHQ-9 - How Difficult have Problems Made it for You to Work, Take Care of Things, or Get Along with Other People PHQ01-Total Score Patient Health Questionnaire - 9 - Total score. PHQ-9 - Total Score PHQ01TC Patient Health Questionnaire - 9 Item Questionnaire Test Code CDISC Questionnaire PHQ-9 Test Code Terminology Patient Health Questionnaire - 9 test name. PHQ01-Difficult to Work/Take Care Things Patient Health Questionnaire - 9 - If you checked off any problems, how difficult have these problems made it for you to do your work, take care of things at home, or get along with other people? PHQ-9 - How Difficult have Problems Made it for You to Work, Take Care of Things, or Get Along with Other People PHQ01-Feeling Bad About Yourself Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Feeling bad about yourself - or that you are a failure or have let yourself or your family down. PHQ-9 - Feeling Bad About Yourself PHQ01-Feeling Down Depressed or Hopeless Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Feeling down, depressed, or hopeless. PHQ-9 - Feeling Down, Depressed, or Hopeless PHQ01-Feeling Tired or Little Energy Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Feeling tired or having little energy. PHQ-9 - Feeling Tired or Having Little Energy PHQ01-Little Interest/Pleasure in Things Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Little interest or pleasure in doing things. PHQ-9 - Little Interest or Pleasure in Doing Things PHQ01-Moving Slowly or Fidgety/Restless Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Moving or speaking so slowly that other people could have noticed? Or the opposite - being so fidgety or restless that you have been moving around a lot more than usual. PHQ-9 - Moving or Speaking Slowly or the Opposite being Fidgety or Restless PHQ01-Poor Appetite or Overeating Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Poor appetite or overeating. PHQ-9 - Poor Appetite or Overeating PHQ01-Thoughts You Be Better Off Dead Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Thoughts that you would be better off dead or of hurting yourself in some way. PHQ-9 - Thoughts That You Would be Better Off Dead PHQ01-Total Score Patient Health Questionnaire - 9 - Total score. PHQ-9 - Total Score PHQ01-Trouble Concentrating on Things Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Trouble concentrating on things, such as reading the newspaper or watching television. PHQ-9 - Trouble Concentrating on Things PHQ01-Trouble Falling or Staying Asleep Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Trouble falling or staying asleep, or sleeping too much. PHQ-9 - Trouble Falling or Staying Asleep, or Sleeping Too Much PHQ01TN Patient Health Questionnaire - 9 Item Questionnaire Test Name CDISC Questionnaire PHQ-9 Test Name Terminology Patient Health Questionnaire - 9 original result for PHQ0101 through PHQ0109 test and test code. PHQ0101 through PHQ0109-More than half the days Patient Health Questionnaire - 9 original result for PHQ0101 through PHQ0109-More than half the days. Patient Health Questionnaire - 9 PHQ0101 Through PHQ0109 Original Result - More than half the days PHQ0101 through PHQ0109-Nearly every day Patient Health Questionnaire - 9 original result for PHQ0101 through PHQ0109-Nearly every day. Patient Health Questionnaire - 9 PHQ0101 Through PHQ0109 Original Result - Nearly every day PHQ0101 through PHQ0109-Not at all Patient Health Questionnaire - 9 original result for PHQ0101 through PHQ0109-Not at all. Patient Health Questionnaire - 9 PHQ0101 Through PHQ0109 Original Result - Not at all PHQ0101 through PHQ0109-Several days Patient Health Questionnaire - 9 original result for PHQ0101 through PHQ0109-Several days. Patient Health Questionnaire - 9 PHQ0101 Through PHQ0109 Original Result - Several days PHQ0101T09OR Patient Health Questionnaire - 9 Questionnaire ORRES for PHQ0101 Through PHQ0109 TN/TC CDISC Questionnaire Patient Health Questionnaire - 9 PHQ0101 Through PHQ0109 Original Response Terminology Patient Health Questionnaire - 9 original result for PHQ0110 test and test code. PHQ0110-Extremely difficult Patient Health Questionnaire - 9 original result for PHQ0110-Extremely difficult. Patient Health Questionnaire - 9 PHQ0110 Original Result - Extremely difficult PHQ0110-Not difficult at all Patient Health Questionnaire - 9 original result for PHQ0110-Not difficult at all. Patient Health Questionnaire - 9 PHQ0110 Original Result - Not difficult at all PHQ0110-Somewhat difficult Patient Health Questionnaire - 9 original result for PHQ0110-Somewhat difficult. Patient Health Questionnaire - 9 PHQ0110 Original Result - Somewhat difficult PHQ0110-Very difficult Patient Health Questionnaire - 9 original result for PHQ0110-Very difficult. Patient Health Questionnaire - 9 PHQ0110 Original Result - Very difficult PHQ0110OR Patient Health Questionnaire - 9 Questionnaire ORRES for PHQ0110 TN/TC CDISC Questionnaire Patient Health Questionnaire - 9 PHQ0110 Original Response Terminology Patient Health Questionnaire - 9 standardized character result for PHQ0101 through PHQ0109 test and test code. PHQ0101 through PHQ0109-0 Patient Health Questionnaire - 9 standardized character result for PHQ0101 through PHQ0109-Not at all. Patient Health Questionnaire - 9 PHQ0101 Through PHQ0109 Standardized Character Result 0 PHQ0101 through PHQ0109-1 Patient Health Questionnaire - 9 standardized character result for PHQ0101 through PHQ0109-Several days. Patient Health Questionnaire - 9 PHQ0101 Through PHQ0109 Standardized Character Result 1 PHQ0101 through PHQ0109-2 Patient Health Questionnaire - 9 standardized character result for PHQ0101 through PHQ0109-More than half the days. Patient Health Questionnaire - 9 PHQ0101 Through PHQ0109 Standardized Character Result 2 PHQ0101 through PHQ0109-3 Patient Health Questionnaire - 9 standardized character result for PHQ0101 through PHQ0109-Nearly every day. Patient Health Questionnaire - 9 PHQ0101 Through PHQ0109 Standardized Character Result 3 PHQ0101T09STR Patient Health Questionnaire - 9 Questionnaire STRESC for PHQ0101 Through PHQ0109 TN/TC CDISC Questionnaire Patient Health Questionnaire - 9 PHQ0101 Through PHQ0109 Standardized Character Response Terminology Patient Health Questionnaire - 9 standardized character result for PHQ0110 test and test code. PHQ0110-Extremely difficult Patient Health Questionnaire - 9 standardized character result for PHQ0110-Extremely difficult. Patient Health Questionnaire - 9 PHQ0110 Standardized Character Result - Extremely difficult PHQ0110-Not difficult at all Patient Health Questionnaire - 9 standardized character result for PHQ0110-Not difficult at all. Patient Health Questionnaire - 9 PHQ0110 Standardized Character Result - Not difficult at all PHQ0110-Somewhat difficult Patient Health Questionnaire - 9 standardized character result for PHQ0110-Somewhat difficult. Patient Health Questionnaire - 9 PHQ0110 Standardized Character Result - Somewhat difficult PHQ0110-Very difficult Patient Health Questionnaire - 9 standardized character result for PHQ0110-Very difficult. Patient Health Questionnaire - 9 PHQ0110 Standardized Character Result - Very difficult PHQ0110STR Patient Health Questionnaire - 9 Questionnaire STRESC for PHQ0110 TN/TC CDISC Questionnaire Patient Health Questionnaire - 9 PHQ0110 Standardized Character Response Terminology Patient Health Questionnaire Screener Version test code. PHQ03-Stomach Pain Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by stomach pain? PHQ Screener Version - Stomach Pain PHQ03-Back Pain Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by back pain? PHQ Screener Version - Back Pain PHQ03-Pain in Your Arms/Legs/Joints Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by pain in your arms, legs, or joints (knees, hips, etc.)? PHQ Screener Version - Pain in Arms, Legs, Joints PHQ03-Menstrual Cramp/Problem Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by menstrual cramps or other problems with your periods? PHQ Screener Version - Menstrual Cramp or Other Problem PHQ03-Pain/Problems During Intercourse Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by pain or problems during sexual intercourse? PHQ Screener Version - Pain During Intercourse PHQ03-Headaches Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by headaches? PHQ Screener Version - Headaches PHQ03-Chest Pain Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by chest pain? PHQ Screener Version - Chest Pain PHQ03-Dizziness Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by dizziness? PHQ Screener Version - Dizziness PHQ03-Fainting Spells Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by fainting spells? PHQ Screener Version - Fainting Spells PHQ03-Feeling Your Heart Pound/Race Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by feeling your heart pound/race? PHQ Screener Version - Feeling Your Heart Pound or Race PHQ03-Shortness of Breath Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by shortness of breath? PHQ Screener Version - Shortness of Breath PHQ03-Constipation/Diarrhea Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by constipation, loose bowels, or diarrhea? PHQ Screener Version - Constipation or Diarrhea PHQ03-Nausea/Gas/Indigestion Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by nausea, gas, indigestion? PHQ Screener Version - Nausea, Gas or Indigestion PHQ03-Little Interest in Doing Things Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by little interest or pleasure in doing things? PHQ Screener Version - Little Interest in Doing Things PHQ03-Feeling Down/Depressed Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by feeling down, depressed, or hopeless? PHQ Screener Version - Feeling Down or Depressed PHQ03-Last 2 Week Trouble Falling Asleep Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by trouble falling or staying asleep, or sleeping too much? PHQ Screener Version - Last 2 Weeks, Trouble Falling or Staying Asleep PHQ03-Feeling Tired/Little Energy Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by feeling tired or having little energy? PHQ Screener Version - Feeling Tired or Little Energy PHQ03-Poor Appetite or Overeating Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by poor appetite or overeating? PHQ Screener Version - Poor Appetite or Overeating PHQ03-Feeling Bad About Yourself Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by feeling bad about yourself - or that you are a failure or have let yourself or your family down? PHQ Screener Version - Feeling Bad About Yourself PHQ03-Last 2 Week Trouble Concentrating Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by trouble concentrating on things, such as reading the newspaper or watching television? PHQ Screener Version - Last 2 Weeks, Trouble Concentrating PHQ03-Moving Slowly/Fidgety/Restless Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by moving or speaking so slowly that other people could have noticed? Or the opposite - being so fidgety or restless that you have been moving around a lot more than usual? PHQ Screener Version - Moving Slowly or Moving More PHQ03-Thoughts Be Better Off Dead Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by thoughts that you would be better off dead or of hurting yourself in some way? PHQ Screener Version - Thoughts Be Better Off Dead PHQ03-Anxiety Attack Patient Health Questionnaire Screener Version - In the last 4 weeks, have you had an anxiety attack - suddenly feeling fear or panic? PHQ Screener Version - Anxiety Attack PHQ03-Anxiety Attack Happened Before Patient Health Questionnaire Screener Version - Has this ever happened before? PHQ Screener Version - Anxiety Attack Happened Before PHQ03-Anxiety Attacks Come Suddenly Patient Health Questionnaire Screener Version - Do some of these attacks come suddenly out of the blue - that is, in situations where you don't expect to be nervous or uncomfortable? PHQ Screener Version - Anxiety Attacks Come Suddenly PHQ03-Anxiety Attacks Bother a Lot Patient Health Questionnaire Screener Version - Do these attacks bother you a lot or are you worried about having another attack? PHQ Screener Version - Anxiety Attacks Bother a Lot PHQ03-Anxiety Attack Short of Breath Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Were you short of breath? PHQ Screener Version - Anxiety Attack Short of Breath PHQ03-Anxiety Attack Heart Race/Pound Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did your heart race, pound, or skip? PHQ Screener Version - Anxiety Attack Heart Race or Pound PHQ03-Anxiety Attack Chest Pain Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you have chest pain or pressure? PHQ Screener Version - Anxiety Attack Chest Pain PHQ03-Anxiety Attack Sweat Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you sweat? PHQ Screener Version - Anxiety Attack Sweat PHQ03-Anxiety Attack Choking Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you feel as if you were choking? PHQ Screener Version - Anxiety Attack Choking PHQ03-Anxiety Attack Hot Flash/Chill Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you have hot flashes or chills? PHQ Screener Version - Anxiety Attack Hot Flash or Chill PHQ03-Anxiety Attack Nausea/Diarrhea Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you have nausea or an upset stomach, or the feeling that you were going to have diarrhea? PHQ Screener Version - Anxiety Attack Nausea or Diarrhea PHQ03-Anxiety Attack Dizzy/Faint Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you feel dizzy, unsteady, or faint? PHQ Screener Version - Anxiety Attack Dizzy or Faint PHQ03-Anxiety Attack Tingling/Numbness Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you have tingling or numbness in parts of your body? PHQ Screener Version - Anxiety Attack Tingling or Numbness PHQ03-Anxiety Attack Tremble/Shake Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you tremble or shake? PHQ Screener Version - Anxiety Attack Tremble or Shake PHQ03-Anxiety Attack Afraid You Dying Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Were you afraid you were dying? PHQ Screener Version - Anxiety Attack Afraid You Were Dying PHQ03-Feeling Nervous/Anxious Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by feeling nervous, anxious, on edge, or worrying a lot about different things? PHQ Screener Version - Feeling Nervous or Anxious PHQ03-Feeling Restless Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by feeling restless so that it is hard to sit still? PHQ Screener Version - Feeling Restless PHQ03-Getting Tired Easily Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by getting tired very easily? PHQ Screener Version - Getting Tired Easily PHQ03-Muscle Tension/Aches/Soreness Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by muscle tension, aches, or soreness? PHQ Screener Version - Muscle Tension PHQ03-Last 4 Week Trouble Falling Asleep Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by trouble falling asleep or staying asleep? PHQ Screener Version - Last 4 Weeks, Trouble Falling or Staying Asleep PHQ03-Last 4 Week Trouble Concentrating Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by trouble concentrating on things, such as reading a book or watching TV? PHQ Screener Version - Last 4 Weeks, Trouble Concentrating PHQ03-Becoming Easily Annoyed Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by becoming easily annoyed or irritable? PHQ Screener Version - Becoming Easily Annoyed PHQ03-No Control What/How Much Eat Patient Health Questionnaire Screener Version - Do you often feel that you can't control what or how much you eat? PHQ Screener Version - No Control What or How Much Eat PHQ03-Eat 2-Hours Large Amount Food Patient Health Questionnaire Screener Version - Do you often eat, within any 2 - hour period, what most people would regard as an unusually large amount of food? PHQ Screener Version - Often Eat Large Amount Food PHQ03-Eat a Lot Twice Week Patient Health Questionnaire Screener Version - Has this been as often, on average, as twice a week for the last 3 months? PHQ Screener Version - Eat a Lot Twice Week PHQ03-Made Yourself Vomit Patient Health Questionnaire Screener Version - In the last 3 months have you often done any of the following in order to avoid gaining weight: Made yourself vomit? PHQ Screener Version - Avoid Gaining Weight, Made Yourself Vomit PHQ03-Took Twice Dose of Laxatives Patient Health Questionnaire Screener Version - In the last 3 months have you often done any of the following in order to avoid gaining weight: Took more than twice the recommended dose of laxatives to avoid gaining weight? PHQ Screener Version - Avoid Gaining Weight, Took Twice Dose of Laxatives PHQ03-Fasted at Least 24 Hours Patient Health Questionnaire Screener Version - In the last 3 months have you often done any of the following in order to avoid gaining weight: Fasted - not eaten anything at all for at least 24 hours to avoid gaining weight? PHQ Screener Version - Avoid Gaining Weight, Fasted at Least 24 Hours PHQ03-Exercised Avoid Gaining Weight Patient Health Questionnaire Screener Version - In the last 3 months have you often done any of the following in order to avoid gaining weight: Exercised for more than an hour specifically to avoid gaining weight after binge eating? PHQ Screener Version - Avoid Gaining Weight, Exercise PHQ03-Avoid Gaining Weight Twice Week Patient Health Questionnaire Screener Version - If you checked "YES" to any of these ways of avoiding gaining weight, were any as often, on average, as twice a week? PHQ Screener Version - Avoid Gaining Weight Twice Week PHQ03-Drink Alcohol Patient Health Questionnaire Screener Version - Do you ever drink alcohol (including beer or wine)? PHQ Screener Version - Drink Alcohol PHQ03-Drank Alcohol With Health Problem Patient Health Questionnaire Screener Version - Have any of the following happened to you more than once in the last 6 months: You drank alcohol even though a doctor suggested that you stop drinking because of a problem with your health? PHQ Screener Version - Drank Alcohol With Health Problem PHQ03-Alcohol at Work/School Patient Health Questionnaire Screener Version - Have any of the following happened to you more than once in the last 6 months: You drank alcohol, were high from alcohol, or hung over while you were working, or going to school, or taking care of children or other responsibilities? PHQ Screener Version - Drank Alcohol at Work or School PHQ03-Missed Work Because of Drinking Patient Health Questionnaire Screener Version - Have any of the following happened to you more than once in the last 6 months: You missed or were late for work, school, or other activities because you were drinking or hung over? PHQ Screener Version - Missed Work Because of Drinking PHQ03-Problem With People While Drinking Patient Health Questionnaire Screener Version - Have any of the following happened to you more than once in the last 6 months: You had a problem getting along with other people while you were drinking? PHQ Screener Version - Problem Getting Along With People While Drinking PHQ03-Drove After Several Drinks Patient Health Questionnaire Screener Version - Have any of the following happened to you more than once in the last 6 months: You drove a car after having several drinks or after drinking too much? PHQ Screener Version - Drove Car After Several Drinks PHQ03-Problems Made It Difficult to Work Patient Health Questionnaire Screener Version - If you checked off any problems on this questionnaire, how difficult have these problems made it for you to do your work, take care of things at home, or get along with other people? PHQ Screener Version - Problems Made It Difficult to Work PHQ03TC Patient Health Questionnaire Screener Version Questionnaire Test Code CDISC Questionnaire PHQ Screener Version Test Code Terminology Patient Health Questionnaire Screener Version test name. PHQ03-Alcohol at Work/School Patient Health Questionnaire Screener Version - Have any of the following happened to you more than once in the last 6 months: You drank alcohol, were high from alcohol, or hung over while you were working, or going to school, or taking care of children or other responsibilities? PHQ Screener Version - Drank Alcohol at Work or School PHQ03-Anxiety Attack Afraid You Dying Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Were you afraid you were dying? PHQ Screener Version - Anxiety Attack Afraid You Were Dying PHQ03-Anxiety Attack Chest Pain Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you have chest pain or pressure? PHQ Screener Version - Anxiety Attack Chest Pain PHQ03-Anxiety Attack Choking Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you feel as if you were choking? PHQ Screener Version - Anxiety Attack Choking PHQ03-Anxiety Attack Dizzy/Faint Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you feel dizzy, unsteady, or faint? PHQ Screener Version - Anxiety Attack Dizzy or Faint PHQ03-Anxiety Attack Happened Before Patient Health Questionnaire Screener Version - Has this ever happened before? PHQ Screener Version - Anxiety Attack Happened Before PHQ03-Anxiety Attack Heart Race/Pound Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did your heart race, pound, or skip? PHQ Screener Version - Anxiety Attack Heart Race or Pound PHQ03-Anxiety Attack Hot Flash/Chill Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you have hot flashes or chills? PHQ Screener Version - Anxiety Attack Hot Flash or Chill PHQ03-Anxiety Attack Nausea/Diarrhea Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you have nausea or an upset stomach, or the feeling that you were going to have diarrhea? PHQ Screener Version - Anxiety Attack Nausea or Diarrhea PHQ03-Anxiety Attack Short of Breath Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Were you short of breath? PHQ Screener Version - Anxiety Attack Short of Breath PHQ03-Anxiety Attack Sweat Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you sweat? PHQ Screener Version - Anxiety Attack Sweat PHQ03-Anxiety Attack Tingling/Numbness Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you have tingling or numbness in parts of your body? PHQ Screener Version - Anxiety Attack Tingling or Numbness PHQ03-Anxiety Attack Tremble/Shake Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you tremble or shake? PHQ Screener Version - Anxiety Attack Tremble or Shake PHQ03-Anxiety Attack Patient Health Questionnaire Screener Version - In the last 4 weeks, have you had an anxiety attack - suddenly feeling fear or panic? PHQ Screener Version - Anxiety Attack PHQ03-Anxiety Attacks Bother a Lot Patient Health Questionnaire Screener Version - Do these attacks bother you a lot or are you worried about having another attack? PHQ Screener Version - Anxiety Attacks Bother a Lot PHQ03-Anxiety Attacks Come Suddenly Patient Health Questionnaire Screener Version - Do some of these attacks come suddenly out of the blue - that is, in situations where you don't expect to be nervous or uncomfortable? PHQ Screener Version - Anxiety Attacks Come Suddenly PHQ03-Avoid Gaining Weight Twice Week Patient Health Questionnaire Screener Version - If you checked "YES" to any of these ways of avoiding gaining weight, were any as often, on average, as twice a week? PHQ Screener Version - Avoid Gaining Weight Twice Week PHQ03-Back Pain Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by back pain? PHQ Screener Version - Back Pain PHQ03-Becoming Easily Annoyed Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by becoming easily annoyed or irritable? PHQ Screener Version - Becoming Easily Annoyed PHQ03-Chest Pain Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by chest pain? PHQ Screener Version - Chest Pain PHQ03-Constipation/Diarrhea Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by constipation, loose bowels, or diarrhea? PHQ Screener Version - Constipation or Diarrhea PHQ03-Dizziness Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by dizziness? PHQ Screener Version - Dizziness PHQ03-Drank Alcohol With Health Problem Patient Health Questionnaire Screener Version - Have any of the following happened to you more than once in the last 6 months: You drank alcohol even though a doctor suggested that you stop drinking because of a problem with your health? PHQ Screener Version - Drank Alcohol With Health Problem PHQ03-Drink Alcohol Patient Health Questionnaire Screener Version - Do you ever drink alcohol (including beer or wine)? PHQ Screener Version - Drink Alcohol PHQ03-Drove After Several Drinks Patient Health Questionnaire Screener Version - Have any of the following happened to you more than once in the last 6 months: You drove a car after having several drinks or after drinking too much? PHQ Screener Version - Drove Car After Several Drinks PHQ03-Eat 2-Hours Large Amount Food Patient Health Questionnaire Screener Version - Do you often eat, within any 2 - hour period, what most people would regard as an unusually large amount of food? PHQ Screener Version - Often Eat Large Amount Food PHQ03-Eat a Lot Twice Week Patient Health Questionnaire Screener Version - Has this been as often, on average, as twice a week for the last 3 months? PHQ Screener Version - Eat a Lot Twice Week PHQ03-Exercised Avoid Gaining Weight Patient Health Questionnaire Screener Version - In the last 3 months have you often done any of the following in order to avoid gaining weight: Exercised for more than an hour specifically to avoid gaining weight after binge eating? PHQ Screener Version - Avoid Gaining Weight, Exercise PHQ03-Fainting Spells Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by fainting spells? PHQ Screener Version - Fainting Spells PHQ03-Fasted at Least 24 Hours Patient Health Questionnaire Screener Version - In the last 3 months have you often done any of the following in order to avoid gaining weight: Fasted - not eaten anything at all for at least 24 hours to avoid gaining weight? PHQ Screener Version - Avoid Gaining Weight, Fasted at Least 24 Hours PHQ03-Feeling Bad About Yourself Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by feeling bad about yourself - or that you are a failure or have let yourself or your family down? PHQ Screener Version - Feeling Bad About Yourself PHQ03-Feeling Down/Depressed Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by feeling down, depressed, or hopeless? PHQ Screener Version - Feeling Down or Depressed PHQ03-Feeling Nervous/Anxious Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by feeling nervous, anxious, on edge, or worrying a lot about different things? PHQ Screener Version - Feeling Nervous or Anxious PHQ03-Feeling Restless Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by feeling restless so that it is hard to sit still? PHQ Screener Version - Feeling Restless PHQ03-Feeling Tired/Little Energy Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by feeling tired or having little energy? PHQ Screener Version - Feeling Tired or Little Energy PHQ03-Feeling Your Heart Pound/Race Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by feeling your heart pound/race? PHQ Screener Version - Feeling Your Heart Pound or Race PHQ03-Getting Tired Easily Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by getting tired very easily? PHQ Screener Version - Getting Tired Easily PHQ03-Headaches Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by headaches? PHQ Screener Version - Headaches PHQ03-Last 2 Week Trouble Concentrating Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by trouble concentrating on things, such as reading the newspaper or watching television? PHQ Screener Version - Last 2 Weeks, Trouble Concentrating PHQ03-Last 2 Week Trouble Falling Asleep Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by trouble falling or staying asleep, or sleeping too much? PHQ Screener Version - Last 2 Weeks, Trouble Falling or Staying Asleep PHQ03-Last 4 Week Trouble Concentrating Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by trouble concentrating on things, such as reading a book or watching TV? PHQ Screener Version - Last 4 Weeks, Trouble Concentrating PHQ03-Last 4 Week Trouble Falling Asleep Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by trouble falling asleep or staying asleep? PHQ Screener Version - Last 4 Weeks, Trouble Falling or Staying Asleep PHQ03-Little Interest in Doing Things Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by little interest or pleasure in doing things? PHQ Screener Version - Little Interest in Doing Things PHQ03-Made Yourself Vomit Patient Health Questionnaire Screener Version - In the last 3 months have you often done any of the following in order to avoid gaining weight: Made yourself vomit? PHQ Screener Version - Avoid Gaining Weight, Made Yourself Vomit PHQ03-Menstrual Cramp/Problem Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by menstrual cramps or other problems with your periods? PHQ Screener Version - Menstrual Cramp or Other Problem PHQ03-Missed Work Because of Drinking Patient Health Questionnaire Screener Version - Have any of the following happened to you more than once in the last 6 months: You missed or were late for work, school, or other activities because you were drinking or hung over? PHQ Screener Version - Missed Work Because of Drinking PHQ03-Moving Slowly/Fidgety/Restless Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by moving or speaking so slowly that other people could have noticed? Or the opposite - being so fidgety or restless that you have been moving around a lot more than usual? PHQ Screener Version - Moving Slowly or Moving More PHQ03-Muscle Tension/Aches/Soreness Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by muscle tension, aches, or soreness? PHQ Screener Version - Muscle Tension PHQ03-Nausea/Gas/Indigestion Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by nausea, gas, indigestion? PHQ Screener Version - Nausea, Gas or Indigestion PHQ03-No Control What/How Much Eat Patient Health Questionnaire Screener Version - Do you often feel that you can't control what or how much you eat? PHQ Screener Version - No Control What or How Much Eat PHQ03-Pain in Your Arms/Legs/Joints Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by pain in your arms, legs, or joints (knees, hips, etc.)? PHQ Screener Version - Pain in Arms, Legs, Joints PHQ03-Pain/Problems During Intercourse Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by pain or problems during sexual intercourse? PHQ Screener Version - Pain During Intercourse PHQ03-Poor Appetite or Overeating Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by poor appetite or overeating? PHQ Screener Version - Poor Appetite or Overeating PHQ03-Problem With People While Drinking Patient Health Questionnaire Screener Version - Have any of the following happened to you more than once in the last 6 months: You had a problem getting along with other people while you were drinking? PHQ Screener Version - Problem Getting Along With People While Drinking PHQ03-Problems Made It Difficult to Work Patient Health Questionnaire Screener Version - If you checked off any problems on this questionnaire, how difficult have these problems made it for you to do your work, take care of things at home, or get along with other people? PHQ Screener Version - Problems Made It Difficult to Work PHQ03-Shortness of Breath Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by shortness of breath? PHQ Screener Version - Shortness of Breath PHQ03-Stomach Pain Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by stomach pain? PHQ Screener Version - Stomach Pain PHQ03-Thoughts Be Better Off Dead Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by thoughts that you would be better off dead or of hurting yourself in some way? PHQ Screener Version - Thoughts Be Better Off Dead PHQ03-Took Twice Dose of Laxatives Patient Health Questionnaire Screener Version - In the last 3 months have you often done any of the following in order to avoid gaining weight: Took more than twice the recommended dose of laxatives to avoid gaining weight? PHQ Screener Version - Avoid Gaining Weight, Took Twice Dose of Laxatives PHQ03TN Patient Health Questionnaire Screener Version Questionnaire Test Name CDISC Questionnaire PHQ Screener Version Test Name Terminology Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 test code. PT01-Dry Mouth Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your dry mouth at its worst? PRO-CTCAE V1.0 - Dry Mouth Severity PT01-Difficulty Swallowing Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your difficulty swallowing at its worst? PRO-CTCAE V1.0 - Difficulty Swallowing Severity PT01-Mouth/Throat Sores Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your mouth or throat sores at their worst? PRO-CTCAE V1.0 - Mouth/Throat Sores Severity PT01-Mouth/Throat Sores Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did mouth or throat sores interfere with your usual or daily activities? PRO-CTCAE V1.0 - Mouth/Throat Sores Interference PT01-Cracking Corners of Mouth Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of skin cracking at the corners of your mouth at its worst? PRO-CTCAE V1.0 - Cracking Corners of Mouth Severity PT01-Voice Quality Changes Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any voice changes? PRO-CTCAE V1.0 - Voice Quality Changes Presence PT01-Hoarseness Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your hoarse voice at its worst? PRO-CTCAE V1.0 - Hoarseness Severity PT01-Taste Changes Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your problems with tasting food or drink at their worst? PRO-CTCAE V1.0 - Taste Changes Severity PT01-Decreased Appetite Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your decreased appetite at its worst? PRO-CTCAE V1.0 - Decreased Appetite Severity PT01-Decreased Appetite Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did decreased appetite interfere with your usual or daily activities? PRO-CTCAE V1.0 - Decreased Appetite Interference PT01-Nausea Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have nausea? PRO-CTCAE V1.0 - Nausea Frequency PT01-Nausea Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your nausea at its worst? PRO-CTCAE V1.0 - Nausea Severity PT01-Vomiting Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have vomiting? PRO-CTCAE V1.0 - Vomiting Frequency PT01-Vomiting Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your vomiting at its worst? PRO-CTCAE V1.0 - Vomiting Severity PT01-Heartburn Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have heartburn? PRO-CTCAE V1.0 - Heartburn Frequency PT01-Heartburn Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your heartburn at its worst? PRO-CTCAE V1.0 - Heartburn Severity PT01-Gas Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any increased passing of gas (flatulence)? PRO-CTCAE V1.0 - Gas Presence PT01-Bloating Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have bloating of the abdomen (belly)? PRO-CTCAE V1.0 - Bloating Frequency PT01-Bloating Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your bloating of the abdomen (belly) at its worst? PRO-CTCAE V1.0 - Bloating Severity PT01-Hiccups Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have hiccups? PRO-CTCAE V1.0 - Hiccups Frequency PT01-Hiccups Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your hiccups at their worst? PRO-CTCAE V1.0 - Hiccups Severity PT01-Constipation Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your constipation at its worst? PRO-CTCAE V1.0 - Constipation Severity PT01-Diarrhea Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have loose or watery stools (diarrhea/diarrhoea)? PRO-CTCAE V1.0 - Diarrhea Frequency PT01-Abdominal Pain Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have pain in the abdomen (belly area)? PRO-CTCAE V1.0 - Abdominal Pain Frequency PT01-Abdominal Pain Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your pain in the abdomen (belly area) at its worst? PRO-CTCAE V1.0 - Abdominal Pain Severity PT01-Abdominal Pain Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did pain in the abdomen (belly area) interfere with your usual or daily activities? PRO-CTCAE V1.0 - Abdominal Pain Interference PT01-Fecal Incontinence Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you lose control of bowel movements? PRO-CTCAE V1.0 - Fecal Incontinence Frequency PT01-Fecal Incontinence Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did loss of control of bowel movements interfere with your usual or daily activities? PRO-CTCAE V1.0 - Fecal Incontinence Interference PT01-Shortness of Breath Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your shortness of breath at its worst? PRO-CTCAE V1.0 - Shortness of Breath Severity PT01-Shortness of Breath Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did your shortness of breath interfere with your usual or daily activities? PRO-CTCAE V1.0 - Shortness of Breath Interference PT01-Cough Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your cough at its worst? PRO-CTCAE V1.0 - Cough Severity PT01-Cough Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did cough interfere with your usual or daily activities? PRO-CTCAE V1.0 - Cough Interference PT01-Wheezing Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your wheezing (whistling noise in the chest with breathing) at its worst? PRO-CTCAE V1.0 - Wheezing Severity PT01-Swelling Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have arm or leg swelling? PRO-CTCAE V1.0 - Swelling Frequency PT01-Swelling Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your arm or leg swelling at its worst? PRO-CTCAE V1.0 - Swelling Severity PT01-Swelling Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did arm or leg swelling interfere with your usual or daily activities? PRO-CTCAE V1.0 - Swelling Interference PT01-Heart Palpitations Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you feel a pounding or racing heartbeat (palpitations)? PRO-CTCAE V1.0 - Heart Palpitations Frequency PT01-Heart Palpitations Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your pounding or racing heartbeat (palpitations) at its worst? PRO-CTCAE V1.0 - Heart Palpitations Severity PT01-Rash Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any rash? PRO-CTCAE V1.0 - Rash Presence PT01-Skin Dryness Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your dry skin at its worst? PRO-CTCAE V1.0 - Skin Dryness Severity PT01-Acne Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your acne or pimples on the face or chest at its worst? PRO-CTCAE V1.0 - Acne Severity PT01-Hair Loss Amount Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any hair loss? PRO-CTCAE V1.0 - Hair Loss Amount PT01-Itching Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your itchy skin at its worst? PRO-CTCAE V1.0 - Itching Severity PT01-Hives Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any hives (itchy red bumps on the skin)? PRO-CTCAE V1.0 - Hives Presence PT01-Hand-Foot Syndrome Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your hand-foot syndrome (a rash of the hands or feet that can cause cracking, peeling, redness or pain) at its worst? PRO-CTCAE V1.0 - Hand-Foot Syndrome Severity PT01-Nail Loss Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you lose any fingernails or toenails? PRO-CTCAE V1.0 - Nail Loss Presence PT01-Nail Ridging Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any ridges or bumps on your fingernails or toenails? PRO-CTCAE V1.0 - Nail Ridging Presence PT01-Nail Discoloration Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any change in the color of your fingernails or toenails? PRO-CTCAE V1.0 - Nail Discoloration Presence PT01-Sensitivity to Sunlight Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any increased skin sensitivity to sunlight? PRO-CTCAE V1.0 - Sensitivity to Sunlight Presence PT01-Bed/Pressure Sores Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any bed sores? PRO-CTCAE V1.0 - Bed/Pressure Sores Presence PT01-Radiation Skin Reaction Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your skin burns from radiation at their worst? PRO-CTCAE V1.0 - Radiation Skin Reaction Severity PT01-Skin Darkening Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any unusual darkening of the skin? PRO-CTCAE V1.0 - Skin Darkening Presence PT01-Stretch Marks Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any stretch marks? PRO-CTCAE V1.0 - Stretch Marks Presence PT01-Numbness & Tingling Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your numbness or tingling in your hands or feet at its worst? PRO-CTCAE V1.0 - Numbness & Tingling Severity PT01-Numbness & Tingling Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did numbness or tingling in your hands or feet interfere with your usual or daily activities? PRO-CTCAE V1.0 - Numbness & Tingling Interference PT01-Dizziness Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your dizziness at its worst? PRO-CTCAE V1.0 - Dizziness Severity PT01-Dizziness Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did dizziness interfere with your usual or daily activities? PRO-CTCAE V1.0 - Dizziness Interference PT01-Blurred Vision Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your blurry vision at its worst? PRO-CTCAE V1.0 - Blurred Vision Severity PT01-Blurred Vision Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did blurry vision interfere with your usual or daily activities? PRO-CTCAE V1.0 - Blurred Vision Interference PT01-Flashing Lights in Eyes Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any flashing lights in front of your eyes? PRO-CTCAE V1.0 - Flashing Lights in Eyes Presence PT01-Visual Floaters Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any spots or lines (floaters) that drift in front of your eyes? PRO-CTCAE V1.0 - Visual Floaters Presence PT01-Watery Eyes Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your watery eyes (tearing) at their worst? PRO-CTCAE V1.0 - Watery Eyes Severity PT01-Watery Eyes Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did watery eyes (tearing) interfere with your usual or daily activities? PRO-CTCAE V1.0 - Watery Eyes Interference PT01-Ringing in Ears Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of ringing in your ears at its worst? PRO-CTCAE V1.0 - Ringing in Ears Severity PT01-Concentration Problems Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your problems with concentration at their worst? PRO-CTCAE V1.0 - Concentration Problems Severity PT01-Concentration Problems Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did problems with concentration interfere with your usual or daily activities? PRO-CTCAE V1.0 - Concentration Problems Interference PT01-Memory Problems Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your problems with memory at their worst? PRO-CTCAE V1.0 - Memory Problems Severity PT01-Memory Problems Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did problems with memory interfere with your usual or daily activities? PRO-CTCAE V1.0 - Memory Problems Interference PT01-General Pain Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have pain? PRO-CTCAE V1.0 - General Pain Frequency PT01-General Pain Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your pain at its worst? PRO-CTCAE V1.0 - General Pain Severity PT01-General Pain Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did pain interfere with your usual or daily activities? PRO-CTCAE V1.0 - General Pain Interference PT01-Headache Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have a headache? PRO-CTCAE V1.0 - Headache Frequency PT01-Headache Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your headache at its worst? PRO-CTCAE V1.0 - Headache Severity PT01-Headache Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did your headache interfere with your usual or daily activities? PRO-CTCAE V1.0 - Headache Interference PT01-Muscle Pain Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have aching muscles? PRO-CTCAE V1.0 - Muscle Pain Frequency PT01-Muscle Pain Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your aching muscles at their worst? PRO-CTCAE V1.0 - Muscle Pain Severity PT01-Muscle Pain Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did aching muscles interfere with your usual or daily activities? PRO-CTCAE V1.0 - Muscle Pain Interference PT01-Joint Pain Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have aching joints (such as elbows, knees, shoulders)? PRO-CTCAE V1.0 - Joint Pain Frequency PT01-Joint Pain Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your aching joints (such as elbows, knees, shoulders) at their worst? PRO-CTCAE V1.0 - Joint Pain Severity PT01-Joint Pain Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did aching joints (such as elbows, knees, shoulders) interfere with your usual or daily activities? PRO-CTCAE V1.0 - Joint Pain Interference PT01-Insomnia Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your insomnia (including difficulty falling asleep, staying asleep, or waking up early) at its worst? PRO-CTCAE V1.0 - Insomnia Severity PT01-Insomnia Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did insomnia (including difficulty falling asleep, staying asleep, or waking up early) interfere with your usual or daily activities? PRO-CTCAE V1.0 - Insomnia Interference PT01-Fatigue Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your fatigue, tiredness, or lack of energy at its worst? PRO-CTCAE V1.0 - Fatigue Severity PT01-Fatigue Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did fatigue, tiredness, or lack of energy interfere with your usual or daily activities? PRO-CTCAE V1.0 - Fatigue Interference PT01-Anxious Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you feel anxiety? PRO-CTCAE V1.0 - Anxious Frequency PT01-Anxious Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your anxiety at its worst? PRO-CTCAE V1.0 - Anxious Severity PT01-Anxious Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did anxiety interfere with your usual or daily activities? PRO-CTCAE V1.0 - Anxious Interference PT01-Discouraged Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you feel that nothing could cheer you up? PRO-CTCAE V1.0 - Discouraged Frequency PT01-Discouraged Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your feelings that nothing could cheer you up at their worst? PRO-CTCAE V1.0 - Discouraged Severity PT01-Discouraged Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did feeling that nothing could cheer you up interfere with your usual or daily activities? PRO-CTCAE V1.0 - Discouraged Interference PT01-Sad Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have sad or unhappy feelings? PRO-CTCAE V1.0 - Sad Frequency PT01-Sad Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your sad or unhappy feelings at their worst? PRO-CTCAE V1.0 - Sad Severity PT01-Sad Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did sad or unhappy feelings interfere with your usual or daily activities? PRO-CTCAE V1.0 - Sad Interference PT01-Irregular Menstrual Period Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any irregular menstrual periods? PRO-CTCAE V1.0 - Irregular Menstrual Period Presence PT01-Missed Menstrual Period Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you miss an expected menstrual period? PRO-CTCAE V1.0 - Missed Menstrual Period Presence PT01-Vaginal Discharge Amount Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any unusual vaginal discharge? PRO-CTCAE V1.0 - Vaginal Discharge Amount PT01-Vaginal Dryness Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your vaginal dryness at its worst? PRO-CTCAE V1.0 - Vaginal Dryness Severity PT01-Painful Urination Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your pain or burning with urination at its worst? PRO-CTCAE V1.0 - Painful Urination Severity PT01-Urinary Urgency Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you feel an urge to urinate all of a sudden? PRO-CTCAE V1.0 - Urinary Urgency Frequency PT01-Urinary Urgency Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did sudden urges to urinate interfere with your usual or daily activities? PRO-CTCAE V1.0 - Urinary Urgency Interference PT01-Urinary Frequency Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, were there times when you had to urinate frequently? PRO-CTCAE V1.0 - Urinary Frequency Frequency PT01-Urinary Frequency Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did frequent urination interfere with your usual or daily activities? PRO-CTCAE V1.0 - Urinary Frequency Interference PT01-Urine Color Change Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any urine color change? PRO-CTCAE V1.0 - Urine Color Change Presence PT01-Urinary Incontinence Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have loss of control of urine (leakage)? PRO-CTCAE V1.0 - Urinary Incontinence Frequency PT01-Urinary Incontinence Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did loss of control of urine (leakage) interfere with your usual or daily activities? PRO-CTCAE V1.0 - Urinary Incontinence Interference PT01-Achieve&Maintain Erection Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your difficulty getting or keeping an erection at its worst? PRO-CTCAE V1.0 - Achieve&Maintain Erection Severity PT01-Ejaculation Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have ejaculation problems? PRO-CTCAE V1.0 - Ejaculation Frequency PT01-Decreased Libido Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your decreased sexual interest at its worst? PRO-CTCAE V1.0 - Decreased Libido Severity PT01-Delayed Orgasm Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you feel that it took too long to have an orgasm or climax? PRO-CTCAE V1.0 - Delayed Orgasm Presence PT01-Unable to Have Orgasm Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, were you unable to have an orgasm or climax? PRO-CTCAE V1.0 - Unable to Have Orgasm Presence PT01-Pain w/Sexual Intercourse Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your pain during vaginal sex at its worst? PRO-CTCAE V1.0 - Pain w/Sexual Intercourse Severity PT01-Breast Swelling&Tenderness Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your breast area enlargement or tenderness at its worst? PRO-CTCAE V1.0 - Breast Swelling&Tenderness Severity PT01-Bruising Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you bruise easily (black and blue marks)? PRO-CTCAE V1.0 - Bruising Presence PT01-Chills Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have shivering or shaking chills? PRO-CTCAE V1.0 - Chills Frequency PT01-Chills Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your shivering or shaking chills at their worst? PRO-CTCAE V1.0 - Chills Severity PT01-Increased Sweating Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have unexpected or excessive sweating during the day or nighttime (not related to hot flashes/flushes)? PRO-CTCAE V1.0 - Increased Sweating Frequency PT01-Increased Sweating Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your unexpected or excessive sweating during the day or nighttime (not related to hot flashes/flushes) at its worst? PRO-CTCAE V1.0 - Increased Sweating Severity PT01-Decreased Sweating Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have an unexpected decrease in sweating? PRO-CTCAE V1.0 - Decreased Sweating Presence PT01-Hot Flashes Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have hot flashes/flushes? PRO-CTCAE V1.0 - Hot Flashes Frequency PT01-Hot Flashes Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your hot flashes/flushes at their worst? PRO-CTCAE V1.0 - Hot Flashes Severity PT01-Nosebleed Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have nosebleeds? PRO-CTCAE V1.0 - Nosebleed Frequency PT01-Nosebleed Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your nosebleeds at their worst? PRO-CTCAE V1.0 - Nosebleed Severity PT01-Pain&Swelling at Inj Site Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any pain, swelling, or redness at a site of drug injection or IV? PRO-CTCAE V1.0 - Pain&Swelling at Inj Site Presence PT01-Body Odor Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your body odor at its worst? PRO-CTCAE V1.0 - Body Odor Severity PT01-Any Other Symptoms Reported Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Do you have any other symptoms that you wish to report? PRO-CTCAE V1.0 - Any Other Symptoms Reported PT01-Other Symptom 1 Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 1? PRO-CTCAE V1.0 - Other Symptom 1 PT01-Other Symptom 1 Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 1 at its worst? PRO-CTCAE V1.0 - Other Symptom 1 Severity PT01-Other Symptom 2 Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 2? PRO-CTCAE V1.0 - Other Symptom 2 PT01-Other Symptom 2 Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 2 at its worst? PRO-CTCAE V1.0 - Other Symptom 2 Severity PT01-Other Symptom 3 Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 3? PRO-CTCAE V1.0 - Other Symptom 3 PT01-Other Symptom 3 Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 3 at its worst? PRO-CTCAE V1.0 - Other Symptom 3 Severity PT01-Other Symptom 4 Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 4? PRO-CTCAE V1.0 - Other Symptom 4 PT01-Other Symptom 4 Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 4 at its worst? PRO-CTCAE V1.0 - Other Symptom 4 Severity PT01-Other Symptom 5 Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 5? PRO-CTCAE V1.0 - Other Symptom 5 PT01-Other Symptom 5 Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 5 at its worst? PRO-CTCAE V1.0 - Other Symptom 5 Severity PT01-Other Symptom 6 Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 6? PRO-CTCAE V1.0 - Other Symptom 6 PT01-Other Symptom 6 Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 6 at its worst? PRO-CTCAE V1.0 - Other Symptom 6 Severity PT01-Other Symptom 7 Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 7? PRO-CTCAE V1.0 - Other Symptom 7 PT01-Other Symptom 7 Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 7 at its worst? PRO-CTCAE V1.0 - Other Symptom 7 Severity PT01-Other Symptom 8 Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 8? PRO-CTCAE V1.0 - Other Symptom 8 PT01-Other Symptom 8 Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 8 at its worst? PRO-CTCAE V1.0 - Other Symptom 8 Severity PT01-Other Symptom 9 Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 9? PRO-CTCAE V1.0 - Other Symptom 9 PT01-Other Symptom 9 Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 9 at its worst? PRO-CTCAE V1.0 - Other Symptom 9 Severity PT01-Other Symptom 10 Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 10? PRO-CTCAE V1.0 - Other Symptom 10 PT01-Other Symptom 10 Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 10 at its worst? PRO-CTCAE V1.0 - Other Symptom 10 Severity PT01TC Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 Questionnaire Test Code CDISC Questionnaire PRO-CTCAE Version 1.0 Test Code Terminology Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 test name. PT01-Abdominal Pain Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have pain in the abdomen (belly area)? PRO-CTCAE V1.0 - Abdominal Pain Frequency PT01-Abdominal Pain Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did pain in the abdomen (belly area) interfere with your usual or daily activities? PRO-CTCAE V1.0 - Abdominal Pain Interference PT01-Abdominal Pain Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your pain in the abdomen (belly area) at its worst? PRO-CTCAE V1.0 - Abdominal Pain Severity PT01-Achieve&Maintain Erection Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your difficulty getting or keeping an erection at its worst? PRO-CTCAE V1.0 - Achieve&Maintain Erection Severity PT01-Acne Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your acne or pimples on the face or chest at its worst? PRO-CTCAE V1.0 - Acne Severity PT01-Anxious Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you feel anxiety? PRO-CTCAE V1.0 - Anxious Frequency PT01-Anxious Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did anxiety interfere with your usual or daily activities? PRO-CTCAE V1.0 - Anxious Interference PT01-Anxious Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your anxiety at its worst? PRO-CTCAE V1.0 - Anxious Severity PT01-Any Other Symptoms Reported Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Do you have any other symptoms that you wish to report? PRO-CTCAE V1.0 - Any Other Symptoms Reported PT01-Bed/Pressure Sores Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any bed sores? PRO-CTCAE V1.0 - Bed/Pressure Sores Presence PT01-Bloating Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have bloating of the abdomen (belly)? PRO-CTCAE V1.0 - Bloating Frequency PT01-Bloating Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your bloating of the abdomen (belly) at its worst? PRO-CTCAE V1.0 - Bloating Severity PT01-Blurred Vision Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did blurry vision interfere with your usual or daily activities? PRO-CTCAE V1.0 - Blurred Vision Interference PT01-Blurred Vision Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your blurry vision at its worst? PRO-CTCAE V1.0 - Blurred Vision Severity PT01-Body Odor Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your body odor at its worst? PRO-CTCAE V1.0 - Body Odor Severity PT01-Breast Swelling&Tenderness Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your breast area enlargement or tenderness at its worst? PRO-CTCAE V1.0 - Breast Swelling&Tenderness Severity PT01-Bruising Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you bruise easily (black and blue marks)? PRO-CTCAE V1.0 - Bruising Presence PT01-Chills Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have shivering or shaking chills? PRO-CTCAE V1.0 - Chills Frequency PT01-Chills Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your shivering or shaking chills at their worst? PRO-CTCAE V1.0 - Chills Severity PT01-Concentration Problems Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did problems with concentration interfere with your usual or daily activities? PRO-CTCAE V1.0 - Concentration Problems Interference PT01-Concentration Problems Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your problems with concentration at their worst? PRO-CTCAE V1.0 - Concentration Problems Severity PT01-Constipation Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your constipation at its worst? PRO-CTCAE V1.0 - Constipation Severity PT01-Cough Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did cough interfere with your usual or daily activities? PRO-CTCAE V1.0 - Cough Interference PT01-Cough Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your cough at its worst? PRO-CTCAE V1.0 - Cough Severity PT01-Cracking Corners of Mouth Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of skin cracking at the corners of your mouth at its worst? PRO-CTCAE V1.0 - Cracking Corners of Mouth Severity PT01-Decreased Appetite Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did decreased appetite interfere with your usual or daily activities? PRO-CTCAE V1.0 - Decreased Appetite Interference PT01-Decreased Appetite Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your decreased appetite at its worst? PRO-CTCAE V1.0 - Decreased Appetite Severity PT01-Decreased Libido Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your decreased sexual interest at its worst? PRO-CTCAE V1.0 - Decreased Libido Severity PT01-Decreased Sweating Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have an unexpected decrease in sweating? PRO-CTCAE V1.0 - Decreased Sweating Presence PT01-Delayed Orgasm Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you feel that it took too long to have an orgasm or climax? PRO-CTCAE V1.0 - Delayed Orgasm Presence PT01-Diarrhea Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have loose or watery stools (diarrhea/diarrhoea)? PRO-CTCAE V1.0 - Diarrhea Frequency PT01-Difficulty Swallowing Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your difficulty swallowing at its worst? PRO-CTCAE V1.0 - Difficulty Swallowing Severity PT01-Discouraged Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you feel that nothing could cheer you up? PRO-CTCAE V1.0 - Discouraged Frequency PT01-Discouraged Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did feeling that nothing could cheer you up interfere with your usual or daily activities? PRO-CTCAE V1.0 - Discouraged Interference PT01-Discouraged Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your feelings that nothing could cheer you up at their worst? PRO-CTCAE V1.0 - Discouraged Severity PT01-Dizziness Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did dizziness interfere with your usual or daily activities? PRO-CTCAE V1.0 - Dizziness Interference PT01-Dizziness Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your dizziness at its worst? PRO-CTCAE V1.0 - Dizziness Severity PT01-Dry Mouth Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your dry mouth at its worst? PRO-CTCAE V1.0 - Dry Mouth Severity PT01-Ejaculation Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have ejaculation problems? PRO-CTCAE V1.0 - Ejaculation Frequency PT01-Fatigue Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did fatigue, tiredness, or lack of energy interfere with your usual or daily activities? PRO-CTCAE V1.0 - Fatigue Interference PT01-Fatigue Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your fatigue, tiredness, or lack of energy at its worst? PRO-CTCAE V1.0 - Fatigue Severity PT01-Fecal Incontinence Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you lose control of bowel movements? PRO-CTCAE V1.0 - Fecal Incontinence Frequency PT01-Fecal Incontinence Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did loss of control of bowel movements interfere with your usual or daily activities? PRO-CTCAE V1.0 - Fecal Incontinence Interference PT01-Flashing Lights in Eyes Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any flashing lights in front of your eyes? PRO-CTCAE V1.0 - Flashing Lights in Eyes Presence PT01-Gas Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any increased passing of gas (flatulence)? PRO-CTCAE V1.0 - Gas Presence PT01-General Pain Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have pain? PRO-CTCAE V1.0 - General Pain Frequency PT01-General Pain Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did pain interfere with your usual or daily activities? PRO-CTCAE V1.0 - General Pain Interference PT01-General Pain Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your pain at its worst? PRO-CTCAE V1.0 - General Pain Severity PT01-Hair Loss Amount Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any hair loss? PRO-CTCAE V1.0 - Hair Loss Amount PT01-Hand-Foot Syndrome Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your hand-foot syndrome (a rash of the hands or feet that can cause cracking, peeling, redness or pain) at its worst? PRO-CTCAE V1.0 - Hand-Foot Syndrome Severity PT01-Headache Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have a headache? PRO-CTCAE V1.0 - Headache Frequency PT01-Headache Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did your headache interfere with your usual or daily activities? PRO-CTCAE V1.0 - Headache Interference PT01-Headache Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your headache at its worst? PRO-CTCAE V1.0 - Headache Severity PT01-Heart Palpitations Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you feel a pounding or racing heartbeat (palpitations)? PRO-CTCAE V1.0 - Heart Palpitations Frequency PT01-Heart Palpitations Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your pounding or racing heartbeat (palpitations) at its worst? PRO-CTCAE V1.0 - Heart Palpitations Severity PT01-Heartburn Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have heartburn? PRO-CTCAE V1.0 - Heartburn Frequency PT01-Heartburn Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your heartburn at its worst? PRO-CTCAE V1.0 - Heartburn Severity PT01-Hiccups Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have hiccups? PRO-CTCAE V1.0 - Hiccups Frequency PT01-Hiccups Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your hiccups at their worst? PRO-CTCAE V1.0 - Hiccups Severity PT01-Hives Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any hives (itchy red bumps on the skin)? PRO-CTCAE V1.0 - Hives Presence PT01-Hoarseness Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your hoarse voice at its worst? PRO-CTCAE V1.0 - Hoarseness Severity PT01-Hot Flashes Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have hot flashes/flushes? PRO-CTCAE V1.0 - Hot Flashes Frequency PT01-Hot Flashes Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your hot flashes/flushes at their worst? PRO-CTCAE V1.0 - Hot Flashes Severity PT01-Increased Sweating Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have unexpected or excessive sweating during the day or nighttime (not related to hot flashes/flushes)? PRO-CTCAE V1.0 - Increased Sweating Frequency PT01-Increased Sweating Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your unexpected or excessive sweating during the day or nighttime (not related to hot flashes/flushes) at its worst? PRO-CTCAE V1.0 - Increased Sweating Severity PT01-Insomnia Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did insomnia (including difficulty falling asleep, staying asleep, or waking up early) interfere with your usual or daily activities? PRO-CTCAE V1.0 - Insomnia Interference PT01-Insomnia Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your insomnia (including difficulty falling asleep, staying asleep, or waking up early) at its worst? PRO-CTCAE V1.0 - Insomnia Severity PT01-Irregular Menstrual Period Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any irregular menstrual periods? PRO-CTCAE V1.0 - Irregular Menstrual Period Presence PT01-Itching Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your itchy skin at its worst? PRO-CTCAE V1.0 - Itching Severity PT01-Joint Pain Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have aching joints (such as elbows, knees, shoulders)? PRO-CTCAE V1.0 - Joint Pain Frequency PT01-Joint Pain Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did aching joints (such as elbows, knees, shoulders) interfere with your usual or daily activities? PRO-CTCAE V1.0 - Joint Pain Interference PT01-Joint Pain Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your aching joints (such as elbows, knees, shoulders) at their worst? PRO-CTCAE V1.0 - Joint Pain Severity PT01-Memory Problems Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did problems with memory interfere with your usual or daily activities? PRO-CTCAE V1.0 - Memory Problems Interference PT01-Memory Problems Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your problems with memory at their worst? PRO-CTCAE V1.0 - Memory Problems Severity PT01-Missed Menstrual Period Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you miss an expected menstrual period? PRO-CTCAE V1.0 - Missed Menstrual Period Presence PT01-Mouth/Throat Sores Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did mouth or throat sores interfere with your usual or daily activities? PRO-CTCAE V1.0 - Mouth/Throat Sores Interference PT01-Mouth/Throat Sores Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your mouth or throat sores at their worst? PRO-CTCAE V1.0 - Mouth/Throat Sores Severity PT01-Muscle Pain Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have aching muscles? PRO-CTCAE V1.0 - Muscle Pain Frequency PT01-Muscle Pain Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did aching muscles interfere with your usual or daily activities? PRO-CTCAE V1.0 - Muscle Pain Interference PT01-Muscle Pain Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your aching muscles at their worst? PRO-CTCAE V1.0 - Muscle Pain Severity PT01-Nail Discoloration Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any change in the color of your fingernails or toenails? PRO-CTCAE V1.0 - Nail Discoloration Presence PT01-Nail Loss Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you lose any fingernails or toenails? PRO-CTCAE V1.0 - Nail Loss Presence PT01-Nail Ridging Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any ridges or bumps on your fingernails or toenails? PRO-CTCAE V1.0 - Nail Ridging Presence PT01-Nausea Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have nausea? PRO-CTCAE V1.0 - Nausea Frequency PT01-Nausea Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your nausea at its worst? PRO-CTCAE V1.0 - Nausea Severity PT01-Nosebleed Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have nosebleeds? PRO-CTCAE V1.0 - Nosebleed Frequency PT01-Nosebleed Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your nosebleeds at their worst? PRO-CTCAE V1.0 - Nosebleed Severity PT01-Numbness & Tingling Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did numbness or tingling in your hands or feet interfere with your usual or daily activities? PRO-CTCAE V1.0 - Numbness & Tingling Interference PT01-Numbness & Tingling Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your numbness or tingling in your hands or feet at its worst? PRO-CTCAE V1.0 - Numbness & Tingling Severity PT01-Other Symptom 1 Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 1 at its worst? PRO-CTCAE V1.0 - Other Symptom 1 Severity PT01-Other Symptom 1 Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 1? PRO-CTCAE V1.0 - Other Symptom 1 PT01-Other Symptom 10 Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 10 at its worst? PRO-CTCAE V1.0 - Other Symptom 10 Severity PT01-Other Symptom 10 Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 10? PRO-CTCAE V1.0 - Other Symptom 10 PT01-Other Symptom 2 Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 2 at its worst? PRO-CTCAE V1.0 - Other Symptom 2 Severity PT01-Other Symptom 2 Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 2? PRO-CTCAE V1.0 - Other Symptom 2 PT01-Other Symptom 3 Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 3 at its worst? PRO-CTCAE V1.0 - Other Symptom 3 Severity PT01-Other Symptom 3 Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 3? PRO-CTCAE V1.0 - Other Symptom 3 PT01-Other Symptom 4 Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 4 at its worst? PRO-CTCAE V1.0 - Other Symptom 4 Severity PT01-Other Symptom 4 Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 4? PRO-CTCAE V1.0 - Other Symptom 4 PT01-Other Symptom 5 Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 5 at its worst? PRO-CTCAE V1.0 - Other Symptom 5 Severity PT01-Other Symptom 5 Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 5? PRO-CTCAE V1.0 - Other Symptom 5 PT01-Other Symptom 6 Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 6 at its worst? PRO-CTCAE V1.0 - Other Symptom 6 Severity PT01-Other Symptom 6 Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 6? PRO-CTCAE V1.0 - Other Symptom 6 PT01-Other Symptom 7 Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 7 at its worst? PRO-CTCAE V1.0 - Other Symptom 7 Severity PT01-Other Symptom 7 Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 7? PRO-CTCAE V1.0 - Other Symptom 7 PT01-Other Symptom 8 Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 8 at its worst? PRO-CTCAE V1.0 - Other Symptom 8 Severity PT01-Other Symptom 8 Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 8? PRO-CTCAE V1.0 - Other Symptom 8 PT01-Other Symptom 9 Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 9 at its worst? PRO-CTCAE V1.0 - Other Symptom 9 Severity PT01-Other Symptom 9 Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 9? PRO-CTCAE V1.0 - Other Symptom 9 PT01-Pain w/Sexual Intercourse Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your pain during vaginal sex at its worst? PRO-CTCAE V1.0 - Pain w/Sexual Intercourse Severity PT01-Pain&Swelling at Inj Site Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any pain, swelling, or redness at a site of drug injection or IV? PRO-CTCAE V1.0 - Pain&Swelling at Inj Site Presence PT01-Painful Urination Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your pain or burning with urination at its worst? PRO-CTCAE V1.0 - Painful Urination Severity PT01-Radiation Skin Reaction Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your skin burns from radiation at their worst? PRO-CTCAE V1.0 - Radiation Skin Reaction Severity PT01-Rash Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any rash? PRO-CTCAE V1.0 - Rash Presence PT01-Ringing in Ears Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of ringing in your ears at its worst? PRO-CTCAE V1.0 - Ringing in Ears Severity PT01-Sad Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have sad or unhappy feelings? PRO-CTCAE V1.0 - Sad Frequency PT01-Sad Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did sad or unhappy feelings interfere with your usual or daily activities? PRO-CTCAE V1.0 - Sad Interference PT01-Sad Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your sad or unhappy feelings at their worst? PRO-CTCAE V1.0 - Sad Severity PT01-Sensitivity to Sunlight Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any increased skin sensitivity to sunlight? PRO-CTCAE V1.0 - Sensitivity to Sunlight Presence PT01-Shortness of Breath Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did your shortness of breath interfere with your usual or daily activities? PRO-CTCAE V1.0 - Shortness of Breath Interference PT01-Shortness of Breath Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your shortness of breath at its worst? PRO-CTCAE V1.0 - Shortness of Breath Severity PT01-Skin Darkening Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any unusual darkening of the skin? PRO-CTCAE V1.0 - Skin Darkening Presence PT01-Skin Dryness Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your dry skin at its worst? PRO-CTCAE V1.0 - Skin Dryness Severity PT01-Stretch Marks Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any stretch marks? PRO-CTCAE V1.0 - Stretch Marks Presence PT01-Swelling Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have arm or leg swelling? PRO-CTCAE V1.0 - Swelling Frequency PT01-Swelling Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did arm or leg swelling interfere with your usual or daily activities? PRO-CTCAE V1.0 - Swelling Interference PT01-Swelling Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your arm or leg swelling at its worst? PRO-CTCAE V1.0 - Swelling Severity PT01-Taste Changes Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your problems with tasting food or drink at their worst? PRO-CTCAE V1.0 - Taste Changes Severity PT01-Unable to Have Orgasm Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, were you unable to have an orgasm or climax? PRO-CTCAE V1.0 - Unable to Have Orgasm Presence PT01-Urinary Frequency Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, were there times when you had to urinate frequently? PRO-CTCAE V1.0 - Urinary Frequency Frequency PT01-Urinary Frequency Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did frequent urination interfere with your usual or daily activities? PRO-CTCAE V1.0 - Urinary Frequency Interference PT01-Urinary Incontinence Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have loss of control of urine (leakage)? PRO-CTCAE V1.0 - Urinary Incontinence Frequency PT01-Urinary Incontinence Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did loss of control of urine (leakage) interfere with your usual or daily activities? PRO-CTCAE V1.0 - Urinary Incontinence Interference PT01-Urinary Urgency Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you feel an urge to urinate all of a sudden? PRO-CTCAE V1.0 - Urinary Urgency Frequency PT01-Urinary Urgency Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did sudden urges to urinate interfere with your usual or daily activities? PRO-CTCAE V1.0 - Urinary Urgency Interference PT01-Urine Color Change Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any urine color change? PRO-CTCAE V1.0 - Urine Color Change Presence PT01-Vaginal Discharge Amount Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any unusual vaginal discharge? PRO-CTCAE V1.0 - Vaginal Discharge Amount PT01-Vaginal Dryness Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your vaginal dryness at its worst? PRO-CTCAE V1.0 - Vaginal Dryness Severity PT01-Visual Floaters Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any spots or lines (floaters) that drift in front of your eyes? PRO-CTCAE V1.0 - Visual Floaters Presence PT01-Voice Quality Changes Presence Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any voice changes? PRO-CTCAE V1.0 - Voice Quality Changes Presence PT01-Vomiting Frequency Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have vomiting? PRO-CTCAE V1.0 - Vomiting Frequency PT01-Vomiting Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your vomiting at its worst? PRO-CTCAE V1.0 - Vomiting Severity PT01-Watery Eyes Interference Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did watery eyes (tearing) interfere with your usual or daily activities? PRO-CTCAE V1.0 - Watery Eyes Interference PT01-Watery Eyes Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your watery eyes (tearing) at their worst? PRO-CTCAE V1.0 - Watery Eyes Severity PT01-Wheezing Severity Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your wheezing (whistling noise in the chest with breathing) at its worst? PRO-CTCAE V1.0 - Wheezing Severity PT01TN Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 Questionnaire Test Name CDISC Questionnaire PRO-CTCAE Version 1.0 Test Name Terminology Terminology relevant to the test codes that describe findings about a pediatric event or intervention. Dietary Cholesterol A determination of the total cholesterol in a nutritional product or meal, or a portion thereof. Dietary Cholesterol Measurement Dietary Fat, Total A determination of the total fat in a nutritional product or meal, or a portion thereof. Total Dietary Fat Measurement Occurrence Indicator An indication as to whether something has happened, such as an event or incident. Occurrence Indicator PDFATSCD Pediatric Findings About Test Code CDISC SDTM Pediatric Findings About Test Code Terminology Terminology relevant to the test names that describe findings about a pediatric event or intervention. Dietary Cholesterol A determination of the total cholesterol in a nutritional product or meal, or a portion thereof. Dietary Cholesterol Measurement Dietary Fat, Total A determination of the total fat in a nutritional product or meal, or a portion thereof. Total Dietary Fat Measurement Occurrence Indicator An indication as to whether something has happened, such as an event or incident. Occurrence Indicator PDFATS Pediatric Findings About Test Name CDISC SDTM Pediatric Findings About Test Name Terminology Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue test code. FAC099-I Feel Tired Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I feel tired. Peds-FACIT-F - I Feel Tired FAC099-I Have Energy Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I have energy (or strength). Peds-FACIT-F - I Have Energy FAC099-Could Do My Usual Things at Home Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I could do my usual things at home. Peds-FACIT-F - Could Do My Usual Things at Home FAC099-Trouble Starting Things Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I had trouble starting things because I was too tired. Peds-FACIT-F - Trouble Starting Things FAC099-Trouble Finishing Things Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I had trouble finishing things because I was too tired. Peds-FACIT-F - Trouble Finishing Things FAC099-I Needed to Sleep During the Day Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I needed to sleep during the day. Peds-FACIT-F - I Needed to Sleep During the Day FAC099-Upset by Being Too Tired Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I got upset by being too tired to do things I wanted to do. Peds-FACIT-F - Upset by Being Too Tired FAC099-Hard for Me to Play With Friends Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - Being tired made it hard for me to play or go out with my friends as much as I'd like. Peds-FACIT-F - Hard for Me to Play With Friends FAC099-Needed Help Doing Usual Things Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I needed help doing my usual things at home. Peds-FACIT-F - Needed Help Doing Usual Things FAC099-I Feel Weak Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I feel weak. Peds-FACIT-F - I Feel Weak FAC099-I Was Too Tired to Eat Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I was too tired to eat. Peds-FACIT-F - I Was Too Tired to Eat FAC099-Being Tired Made Me Sad Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - Being tired made me sad. Peds-FACIT-F - Being Tired Made Me Sad FAC099-Being Tired Made Me Mad Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - Being tired made me mad (angry). Peds-FACIT-F - Being Tired Made Me Mad FAC099TC Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue Questionnaire Test Code CDISC Questionnaire Peds-FACIT-F Test Code Terminology Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue test name. FAC099-Being Tired Made Me Mad Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - Being tired made me mad (angry). Peds-FACIT-F - Being Tired Made Me Mad FAC099-Being Tired Made Me Sad Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - Being tired made me sad. Peds-FACIT-F - Being Tired Made Me Sad FAC099-Could Do My Usual Things at Home Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I could do my usual things at home. Peds-FACIT-F - Could Do My Usual Things at Home FAC099-Hard for Me to Play With Friends Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - Being tired made it hard for me to play or go out with my friends as much as I'd like. Peds-FACIT-F - Hard for Me to Play With Friends FAC099-I Feel Tired Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I feel tired. Peds-FACIT-F - I Feel Tired FAC099-I Feel Weak Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I feel weak. Peds-FACIT-F - I Feel Weak FAC099-I Have Energy Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I have energy (or strength). Peds-FACIT-F - I Have Energy FAC099-I Needed to Sleep During the Day Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I needed to sleep during the day. Peds-FACIT-F - I Needed to Sleep During the Day FAC099-I Was Too Tired to Eat Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I was too tired to eat. Peds-FACIT-F - I Was Too Tired to Eat FAC099-Needed Help Doing Usual Things Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I needed help doing my usual things at home. Peds-FACIT-F - Needed Help Doing Usual Things FAC099-Trouble Finishing Things Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I had trouble finishing things because I was too tired. Peds-FACIT-F - Trouble Finishing Things FAC099-Trouble Starting Things Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I had trouble starting things because I was too tired. Peds-FACIT-F - Trouble Starting Things FAC099-Upset by Being Too Tired Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I got upset by being too tired to do things I wanted to do. Peds-FACIT-F - Upset by Being Too Tired FAC099TN Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue Questionnaire Test Name CDISC Questionnaire Peds-FACIT-F Test Name Terminology Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported Version test code. PODCI2-Lift Heavy Books Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Lift heavy books? PODCI Adolescent Parent-Reported Version - Lift Heavy Books PODCI2-Pour a Half Gallon of Milk Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Pour a half gallon of milk? PODCI Adolescent Parent-Reported Version - Pour a Half Gallon of Milk PODCI2-Open a Jar Been Opened Before Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Open a jar that has been opened before? PODCI Adolescent Parent-Reported Version - Open a Jar Been Opened Before PODCI2-Use a Fork and Spoon Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Use a fork and spoon? PODCI Adolescent Parent-Reported Version - Use a Fork and Spoon PODCI2-Comb His/Her Hair Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Comb his/her hair? PODCI Adolescent Parent-Reported Version - Comb His or Her Hair PODCI2-Button Buttons Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Button buttons? PODCI Adolescent Parent-Reported Version - Button Buttons PODCI2-Put on His/Her Coat Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Put on his/her coat? PODCI Adolescent Parent-Reported Version - Put on His or Her Coat PODCI2-Write With a Pencil Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Write with a pencil? PODCI Adolescent Parent-Reported Version - Write With a Pencil PODCI2-Miss School Because of Health Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - On average, over the last 12 months, how often did your child miss school (camp, etc.) because of his/her health? PODCI Adolescent Parent-Reported Version - Miss School Because of Health PODCI2-How He/She Looks Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how happy has your child been with: How he/she looks? PODCI Adolescent Parent-Reported Version - How He or She Looks PODCI2-His/Her Body Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how happy has your child been with: His/her body? PODCI Adolescent Parent-Reported Version - His or Her Body PODCI2-What Clothes/Shoes He/She Wear Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how happy has your child been with: What clothes or shoes he/she can wear? PODCI Adolescent Parent-Reported Version - What Clothes or Shoes He or She Wear PODCI2-Ability Do Same Things Friends Do Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how happy has your child been with: His/her ability to do the same things his/her friends do? PODCI Adolescent Parent-Reported Version - Ability Do Same Things Friends Do PODCI2-His/Her Health in General Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how happy has your child been with: His/her health in general? PODCI Adolescent Parent-Reported Version - His or Her Health in General PODCI2-Feel Sick and Tired Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how much of the time: Did your child feel sick and tired? PODCI Adolescent Parent-Reported Version - Feel Sick and Tired PODCI2-Full of Pep and Energy Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how much of the time: Were your child full of pep and energy? PODCI Adolescent Parent-Reported Version - Full of Pep and Energy PODCI2-Pain/Discom Inter With Activities Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how much of the time: Did pain or discomfort interfere with your child's activities? PODCI Adolescent Parent-Reported Version - Pain or Discomfort Interfere With Activities PODCI2-Run Short Distances Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Run short distances? PODCI Adolescent Parent-Reported Version - Run Short Distances PODCI2-Bicycle or Tricycle Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Bicycle or tricycle? PODCI Adolescent Parent-Reported Version - Bicycle or Tricycle PODCI2-Climb Three Flights of Stairs Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Climb three flights of stairs? PODCI Adolescent Parent-Reported Version - Climb Three Flights of Stairs PODCI2-Climb One Flight of Stairs Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Climb one flight of stairs? PODCI Adolescent Parent-Reported Version - Climb One Flight of Stairs PODCI2-Walk More Than a Mile Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Walk more than a mile? PODCI Adolescent Parent-Reported Version - Walk More Than a Mile PODCI2-Walk Three Blocks Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Walk three blocks? PODCI Adolescent Parent-Reported Version - Walk Three Blocks PODCI2-Walk One Block Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Walk one block? PODCI Adolescent Parent-Reported Version - Walk One Block PODCI2-Get On and Off a Bus Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Get on and off a bus? PODCI Adolescent Parent-Reported Version - Get On and Off a Bus PODCI2-Need Help Walking and Climbing Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - How often does your child need help from another person for walking and climbing? PODCI Adolescent Parent-Reported Version - Need Help Walking and Climbing PODCI2-Use Assistive Devices for Walking Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - How often does your child use assistive devices (such as braces, crutches, or wheelchair) for walking and climbing? PODCI Adolescent Parent-Reported Version - Use Assistive Devices for Walking PODCI2-Stand Washing Hands at a Sink Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Stand while washing his/her hands and face at a sink? PODCI Adolescent Parent-Reported Version - Stand Washing Hands at a Sink PODCI2-Sit in Chair Without Holding On Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Sit in a regular chair without holding on? PODCI Adolescent Parent-Reported Version - Sit in Chair Without Holding On PODCI2-Get On and Off a Toilet or Chair Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Get on and off a toilet or chair? PODCI Adolescent Parent-Reported Version - Get On and Off a Toilet or Chair PODCI2-Get In and Out of Bed Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Get in and out of bed? PODCI Adolescent Parent-Reported Version - Get In and Out of Bed PODCI2-Turn Door Knobs Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Turn door knobs? PODCI Adolescent Parent-Reported Version - Turn Door Knobs PODCI2-Bend Over and Pick Up Something Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Bend over from a standing position and pick up something off the floor? PODCI Adolescent Parent-Reported Version - Bend Over and Pick Up Something PODCI2-Need Help Sitting and Standing Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - How often does your child need help from another person for sitting and standing? PODCI Adolescent Parent-Reported Version - Need Help Sitting and Standing PODCI2-Use Assistive Devices for Sitting Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - How often does your child use assistive devices (such as braces, crutches, or wheelchair) for sitting and standing? PODCI Adolescent Parent-Reported Version - Use Assistive Devices for Sitting PODCI2-Participate in Outdoor Activities Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Can your child participate in recreational outdoor activities with other children the same age (For example: bicycling, skating, hiking, jogging)? PODCI Adolescent Parent-Reported Version - Participate in Outdoor Activities PODCI2-Outdoor Limited by: Pain Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Pain? PODCI Adolescent Parent-Reported Version - Outdoor Limited by: Pain PODCI2-Outdoor Limited by: Health Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: General health? PODCI Adolescent Parent-Reported Version - Outdoor Limited by: Health PODCI2-Outdoor Limited by: Instructions Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Doctor or parent instructions? PODCI Adolescent Parent-Reported Version - Outdoor Limited by: Instructions PODCI2-Outdoor Limited by: Fear Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Fear the other kids won't like him/her? PODCI Adolescent Parent-Reported Version - Outdoor Limited by: Fear PODCI2-Outdoor Limited by: Dislike Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Dislike of recreational outdoor activities? PODCI Adolescent Parent-Reported Version - Outdoor Limited by: Dislike PODCI2-Outdoor Limited by: Too Young Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Too young? PODCI Adolescent Parent-Reported Version - Outdoor Limited by: Too Young PODCI2-Outdoor Limited by: Season Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Activity not in season? PODCI Adolescent Parent-Reported Version - Outdoor Limited by: Season PODCI2-Participate in Pickup Games Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Can your child participate in pickup games or sports with other children the same age (For example: tag, dodge ball, basketball, softball, soccer, catch, jump rope, touch football, hop scotch)? PODCI Adolescent Parent-Reported Version - Participate in Pickup Games PODCI2-Games Limited by: Pain Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Pain? PODCI Adolescent Parent-Reported Version - Games Limited by: Pain PODCI2-Games Limited by: Health Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: General health? PODCI Adolescent Parent-Reported Version - Games Limited by: Health PODCI2-Games Limited by: Instructions Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Doctor or parent instructions? PODCI Adolescent Parent-Reported Version - Games Limited by: Instructions PODCI2-Games Limited by: Fear Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Fear the other kids won't like him/her? PODCI Adolescent Parent-Reported Version - Games Limited by: Fear PODCI2-Games Limited by: Dislike Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Dislike of pickup games or sports? PODCI Adolescent Parent-Reported Version - Games Limited by: Dislike PODCI2-Games Limited by: Too Young Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Too young? PODCI Adolescent Parent-Reported Version - Games Limited by: Too Young PODCI2-Games Limited by: Season Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Activity not in season? PODCI Adolescent Parent-Reported Version - Games Limited by: Season PODCI2-Participate in Competitive Sports Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Can your child participate in competitive level sports with other children the same age (For example: hockey, basketball, soccer, football, baseball, swimming, running [track or cross country], gymnastics, or dance)? PODCI Adolescent Parent-Reported Version - Participate in Competitive Sports PODCI2-Comp Sports Limited by: Pain Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Pain? PODCI Adolescent Parent-Reported Version - Competitive Sports Limited by: Pain PODCI2-Comp Sports Limited by: Health Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: General health? PODCI Adolescent Parent-Reported Version - Competitive Sports Limited by: Health PODCI2-Comp Sports Limited by: Instruct Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Doctor or parent instructions? PODCI Adolescent Parent-Reported Version - Competitive Sports Limited by: Instructions PODCI2-Comp Sports Limited by: Fear Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Fear the other kids won't like him/her? PODCI Adolescent Parent-Reported Version - Competitive Sports Limited by: Fear PODCI2-Comp Sports Limited by: Dislike Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Dislike of pickup games or sports? PODCI Adolescent Parent-Reported Version - Competitive Sports Limited by: Dislike PODCI2-Comp Sports Limited by: Too Young Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Too young? PODCI Adolescent Parent-Reported Version - Competitive Sports Limited by: Too Young PODCI2-Comp Sports Limited by: Season Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Activity not in season? PODCI Adolescent Parent-Reported Version - Competitive Sports Limited by: Season PODCI2-Get Together With Friends Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - How often in the last week did your child get together and do things with friends? PODCI Adolescent Parent-Reported Version - Get Together With Friends PODCI2-Friends Limited by: Pain Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Pain? PODCI Adolescent Parent-Reported Version - Friends Limited by: Pain PODCI2-Friends Limited by: Health Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: General health? PODCI Adolescent Parent-Reported Version - Friends Limited by: Health PODCI2-Friends Limited by: Instructions Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Doctor or parent instructions? PODCI Adolescent Parent-Reported Version - Friends Limited by: Instructions PODCI2-Friends Limited by: Fear Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Fear the other kids won't like him/her? PODCI Adolescent Parent-Reported Version - Friends Limited by: Fear PODCI2-Friends Limited by: Not Around Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Friends not around? PODCI Adolescent Parent-Reported Version - Friends Limited by: Not Around PODCI2-Participate in Gym/Recess Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - How often in the last week did your child participate in gym/recess? PODCI Adolescent Parent-Reported Version - Participate in Gym or Recess PODCI2-Gym Limited by: Pain Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Pain? PODCI Adolescent Parent-Reported Version - Gym Limited by: Pain PODCI2-Gym Limited by: Health Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: General health? PODCI Adolescent Parent-Reported Version - Gym Limited by: Health PODCI2-Gym Limited by: Instructions Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Doctor or parent instructions? PODCI Adolescent Parent-Reported Version - Gym Limited by: Instructions PODCI2-Gym Limited by: Fear Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Fear the other kids won't like him/her? PODCI Adolescent Parent-Reported Version - Gym Limited by: Fear PODCI2-Gym Limited by: Dislike Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Dislike of gym/recess? PODCI Adolescent Parent-Reported Version - Gym Limited by: Dislike PODCI2-Gym Limited by: Not in Session Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: School not in session? PODCI Adolescent Parent-Reported Version - Gym Limited by: Not in Session PODCI2-Gym Limited by: Not Attend School Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Does not attend school? PODCI Adolescent Parent-Reported Version - Gym Limited by: Not Attend School PODCI2-Easy to Make Friends Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Is it easy or hard for your child to make friends with children his/her own age? PODCI Adolescent Parent-Reported Version - Easy to Make Friends PODCI2-Pain During the Last Week Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - How much pain has your child had during the last week? PODCI Adolescent Parent-Reported Version - Pain During the Last Week PODCI2-Pain Interfere With Activities Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how much did pain interfere with your child's normal activities (including at home, outside of the home, and at school)? PODCI Adolescent Parent-Reported Version - Pain Interfere With Activities PODCI2-Have Pain Relief Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To have pain relief. PODCI Adolescent Parent-Reported Version - Have Pain Relief PODCI2-Look Better Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To look better. PODCI Adolescent Parent-Reported Version - Look Better PODCI2-Feel Better Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To feel better about himself/herself. PODCI Adolescent Parent-Reported Version - Feel Better PODCI2-Sleep More Comfortably Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To sleep more comfortably. PODCI Adolescent Parent-Reported Version - Sleep More Comfortably PODCI2-Able to Do Activities at Home Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do activities at home. PODCI Adolescent Parent-Reported Version - Able to Do Activities at Home PODCI2-Able to Do More at School Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do more at school. PODCI Adolescent Parent-Reported Version - Able to Do More at School PODCI2-Able to Do More Play Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do more play or recreational activities. PODCI Adolescent Parent-Reported Version - Able to Do More Play PODCI2-Able to Do More Sports Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do more sports. PODCI Adolescent Parent-Reported Version - Able to Do More Sports PODCI2-Free From Pain as Adult Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To be free from pain or disability as an adult. PODCI Adolescent Parent-Reported Version - Free From Pain as Adult PODCI2-Spend Rest of Life With Condition Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If your child had to spend the rest of his/her life with his/her bone and muscle condition as it is right now, how would you feel about it? PODCI Adolescent Parent-Reported Version - Spend Rest of Life With Condition PODCI2-Up Extremity/Phys Function Scale Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Upper extremity and physical function core scale. PODCI Adolescent Parent-Reported Version - Upper Extremity and Physical Function Scale PODCI2-Transfer/Basic Mobility Scale Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Transfer and basic mobility core scale. PODCI Adolescent Parent-Reported Version - Transfer and Basic Mobility Scale PODCI2-Sports/Phys Function Scale Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Sports and physical functioning core scale. PODCI Adolescent Parent-Reported Version - Sports and Physical Function Scale PODCI2-Pain/Comfort Scale Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Pain/comfort core scale. PODCI Adolescent Parent-Reported Version - Pain or Comfort Scale PODCI2-Happiness Scale Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Happiness core scale. PODCI Adolescent Parent-Reported Version - Happiness Scale PODCI2-Global Functioning Scale Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Global functioning scale. PODCI Adolescent Parent-Reported Version - Global Functioning Scale PODCI2TC Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported Version Questionnaire Test Code CDISC Questionnaire PODCI Adolescent Parent-Reported Version Test Code Terminology Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported Version test name. PODCI2-Ability Do Same Things Friends Do Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how happy has your child been with: His/her ability to do the same things his/her friends do? PODCI Adolescent Parent-Reported Version - Ability Do Same Things Friends Do PODCI2-Able to Do Activities at Home Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do activities at home. PODCI Adolescent Parent-Reported Version - Able to Do Activities at Home PODCI2-Able to Do More at School Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do more at school. PODCI Adolescent Parent-Reported Version - Able to Do More at School PODCI2-Able to Do More Play Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do more play or recreational activities. PODCI Adolescent Parent-Reported Version - Able to Do More Play PODCI2-Able to Do More Sports Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do more sports. PODCI Adolescent Parent-Reported Version - Able to Do More Sports PODCI2-Bend Over and Pick Up Something Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Bend over from a standing position and pick up something off the floor? PODCI Adolescent Parent-Reported Version - Bend Over and Pick Up Something PODCI2-Bicycle or Tricycle Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Bicycle or tricycle? PODCI Adolescent Parent-Reported Version - Bicycle or Tricycle PODCI2-Button Buttons Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Button buttons? PODCI Adolescent Parent-Reported Version - Button Buttons PODCI2-Climb One Flight of Stairs Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Climb one flight of stairs? PODCI Adolescent Parent-Reported Version - Climb One Flight of Stairs PODCI2-Climb Three Flights of Stairs Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Climb three flights of stairs? PODCI Adolescent Parent-Reported Version - Climb Three Flights of Stairs PODCI2-Comb His/Her Hair Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Comb his/her hair? PODCI Adolescent Parent-Reported Version - Comb His or Her Hair PODCI2-Comp Sports Limited by: Dislike Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Dislike of pickup games or sports? PODCI Adolescent Parent-Reported Version - Competitive Sports Limited by: Dislike PODCI2-Comp Sports Limited by: Fear Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Fear the other kids won't like him/her? PODCI Adolescent Parent-Reported Version - Competitive Sports Limited by: Fear PODCI2-Comp Sports Limited by: Health Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: General health? PODCI Adolescent Parent-Reported Version - Competitive Sports Limited by: Health PODCI2-Comp Sports Limited by: Instruct Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Doctor or parent instructions? PODCI Adolescent Parent-Reported Version - Competitive Sports Limited by: Instructions PODCI2-Comp Sports Limited by: Pain Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Pain? PODCI Adolescent Parent-Reported Version - Competitive Sports Limited by: Pain PODCI2-Comp Sports Limited by: Season Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Activity not in season? PODCI Adolescent Parent-Reported Version - Competitive Sports Limited by: Season PODCI2-Comp Sports Limited by: Too Young Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Too young? PODCI Adolescent Parent-Reported Version - Competitive Sports Limited by: Too Young PODCI2-Easy to Make Friends Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Is it easy or hard for your child to make friends with children his/her own age? PODCI Adolescent Parent-Reported Version - Easy to Make Friends PODCI2-Feel Better Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To feel better about himself/herself. PODCI Adolescent Parent-Reported Version - Feel Better PODCI2-Feel Sick and Tired Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how much of the time: Did your child feel sick and tired? PODCI Adolescent Parent-Reported Version - Feel Sick and Tired PODCI2-Free From Pain as Adult Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To be free from pain or disability as an adult. PODCI Adolescent Parent-Reported Version - Free From Pain as Adult PODCI2-Friends Limited by: Fear Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Fear the other kids won't like him/her? PODCI Adolescent Parent-Reported Version - Friends Limited by: Fear PODCI2-Friends Limited by: Health Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: General health? PODCI Adolescent Parent-Reported Version - Friends Limited by: Health PODCI2-Friends Limited by: Instructions Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Doctor or parent instructions? PODCI Adolescent Parent-Reported Version - Friends Limited by: Instructions PODCI2-Friends Limited by: Not Around Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Friends not around? PODCI Adolescent Parent-Reported Version - Friends Limited by: Not Around PODCI2-Friends Limited by: Pain Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Pain? PODCI Adolescent Parent-Reported Version - Friends Limited by: Pain PODCI2-Full of Pep and Energy Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how much of the time: Were your child full of pep and energy? PODCI Adolescent Parent-Reported Version - Full of Pep and Energy PODCI2-Games Limited by: Dislike Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Dislike of pickup games or sports? PODCI Adolescent Parent-Reported Version - Games Limited by: Dislike PODCI2-Games Limited by: Fear Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Fear the other kids won't like him/her? PODCI Adolescent Parent-Reported Version - Games Limited by: Fear PODCI2-Games Limited by: Health Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: General health? PODCI Adolescent Parent-Reported Version - Games Limited by: Health PODCI2-Games Limited by: Instructions Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Doctor or parent instructions? PODCI Adolescent Parent-Reported Version - Games Limited by: Instructions PODCI2-Games Limited by: Pain Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Pain? PODCI Adolescent Parent-Reported Version - Games Limited by: Pain PODCI2-Games Limited by: Season Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Activity not in season? PODCI Adolescent Parent-Reported Version - Games Limited by: Season PODCI2-Games Limited by: Too Young Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Too young? PODCI Adolescent Parent-Reported Version - Games Limited by: Too Young PODCI2-Get In and Out of Bed Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Get in and out of bed? PODCI Adolescent Parent-Reported Version - Get In and Out of Bed PODCI2-Get On and Off a Bus Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Get on and off a bus? PODCI Adolescent Parent-Reported Version - Get On and Off a Bus PODCI2-Get On and Off a Toilet or Chair Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Get on and off a toilet or chair? PODCI Adolescent Parent-Reported Version - Get On and Off a Toilet or Chair PODCI2-Get Together With Friends Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - How often in the last week did your child get together and do things with friends? PODCI Adolescent Parent-Reported Version - Get Together With Friends PODCI2-Global Functioning Scale Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Global functioning scale. PODCI Adolescent Parent-Reported Version - Global Functioning Scale PODCI2-Gym Limited by: Dislike Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Dislike of gym/recess? PODCI Adolescent Parent-Reported Version - Gym Limited by: Dislike PODCI2-Gym Limited by: Fear Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Fear the other kids won't like him/her? PODCI Adolescent Parent-Reported Version - Gym Limited by: Fear PODCI2-Gym Limited by: Health Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: General health? PODCI Adolescent Parent-Reported Version - Gym Limited by: Health PODCI2-Gym Limited by: Instructions Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Doctor or parent instructions? PODCI Adolescent Parent-Reported Version - Gym Limited by: Instructions PODCI2-Gym Limited by: Not Attend School Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Does not attend school? PODCI Adolescent Parent-Reported Version - Gym Limited by: Not Attend School PODCI2-Gym Limited by: Not in Session Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: School not in session? PODCI Adolescent Parent-Reported Version - Gym Limited by: Not in Session PODCI2-Gym Limited by: Pain Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Pain? PODCI Adolescent Parent-Reported Version - Gym Limited by: Pain PODCI2-Happiness Scale Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Happiness core scale. PODCI Adolescent Parent-Reported Version - Happiness Scale PODCI2-Have Pain Relief Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To have pain relief. PODCI Adolescent Parent-Reported Version - Have Pain Relief PODCI2-His/Her Body Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how happy has your child been with: His/her body? PODCI Adolescent Parent-Reported Version - His or Her Body PODCI2-His/Her Health in General Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how happy has your child been with: His/her health in general? PODCI Adolescent Parent-Reported Version - His or Her Health in General PODCI2-How He/She Looks Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how happy has your child been with: How he/she looks? PODCI Adolescent Parent-Reported Version - How He or She Looks PODCI2-Lift Heavy Books Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Lift heavy books? PODCI Adolescent Parent-Reported Version - Lift Heavy Books PODCI2-Look Better Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To look better. PODCI Adolescent Parent-Reported Version - Look Better PODCI2-Miss School Because of Health Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - On average, over the last 12 months, how often did your child miss school (camp, etc.) because of his/her health? PODCI Adolescent Parent-Reported Version - Miss School Because of Health PODCI2-Need Help Sitting and Standing Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - How often does your child need help from another person for sitting and standing? PODCI Adolescent Parent-Reported Version - Need Help Sitting and Standing PODCI2-Need Help Walking and Climbing Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - How often does your child need help from another person for walking and climbing? PODCI Adolescent Parent-Reported Version - Need Help Walking and Climbing PODCI2-Open a Jar Been Opened Before Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Open a jar that has been opened before? PODCI Adolescent Parent-Reported Version - Open a Jar Been Opened Before PODCI2-Outdoor Limited by: Dislike Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Dislike of recreational outdoor activities? PODCI Adolescent Parent-Reported Version - Outdoor Limited by: Dislike PODCI2-Outdoor Limited by: Fear Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Fear the other kids won't like him/her? PODCI Adolescent Parent-Reported Version - Outdoor Limited by: Fear PODCI2-Outdoor Limited by: Health Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: General health? PODCI Adolescent Parent-Reported Version - Outdoor Limited by: Health PODCI2-Outdoor Limited by: Instructions Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Doctor or parent instructions? PODCI Adolescent Parent-Reported Version - Outdoor Limited by: Instructions PODCI2-Outdoor Limited by: Pain Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Pain? PODCI Adolescent Parent-Reported Version - Outdoor Limited by: Pain PODCI2-Outdoor Limited by: Season Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Activity not in season? PODCI Adolescent Parent-Reported Version - Outdoor Limited by: Season PODCI2-Outdoor Limited by: Too Young Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Too young? PODCI Adolescent Parent-Reported Version - Outdoor Limited by: Too Young PODCI2-Pain During the Last Week Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - How much pain has your child had during the last week? PODCI Adolescent Parent-Reported Version - Pain During the Last Week PODCI2-Pain Interfere With Activities Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how much did pain interfere with your child's normal activities (including at home, outside of the home, and at school)? PODCI Adolescent Parent-Reported Version - Pain Interfere With Activities PODCI2-Pain/Comfort Scale Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Pain/comfort core scale. PODCI Adolescent Parent-Reported Version - Pain or Comfort Scale PODCI2-Pain/Discom Inter With Activities Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how much of the time: Did pain or discomfort interfere with your child's activities? PODCI Adolescent Parent-Reported Version - Pain or Discomfort Interfere With Activities PODCI2-Participate in Competitive Sports Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Can your child participate in competitive level sports with other children the same age (For example: hockey, basketball, soccer, football, baseball, swimming, running [track or cross country], gymnastics, or dance)? PODCI Adolescent Parent-Reported Version - Participate in Competitive Sports PODCI2-Participate in Gym/Recess Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - How often in the last week did your child participate in gym/recess? PODCI Adolescent Parent-Reported Version - Participate in Gym or Recess PODCI2-Participate in Outdoor Activities Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Can your child participate in recreational outdoor activities with other children the same age (For example: bicycling, skating, hiking, jogging)? PODCI Adolescent Parent-Reported Version - Participate in Outdoor Activities PODCI2-Participate in Pickup Games Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Can your child participate in pickup games or sports with other children the same age (For example: tag, dodge ball, basketball, softball, soccer, catch, jump rope, touch football, hop scotch)? PODCI Adolescent Parent-Reported Version - Participate in Pickup Games PODCI2-Pour a Half Gallon of Milk Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Pour a half gallon of milk? PODCI Adolescent Parent-Reported Version - Pour a Half Gallon of Milk PODCI2-Put on His/Her Coat Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Put on his/her coat? PODCI Adolescent Parent-Reported Version - Put on His or Her Coat PODCI2-Run Short Distances Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Run short distances? PODCI Adolescent Parent-Reported Version - Run Short Distances PODCI2-Sit in Chair Without Holding On Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Sit in a regular chair without holding on? PODCI Adolescent Parent-Reported Version - Sit in Chair Without Holding On PODCI2-Sleep More Comfortably Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To sleep more comfortably. PODCI Adolescent Parent-Reported Version - Sleep More Comfortably PODCI2-Spend Rest of Life With Condition Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If your child had to spend the rest of his/her life with his/her bone and muscle condition as it is right now, how would you feel about it? PODCI Adolescent Parent-Reported Version - Spend Rest of Life With Condition PODCI2-Sports/Phys Function Scale Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Sports and physical functioning core scale. PODCI Adolescent Parent-Reported Version - Sports and Physical Function Scale PODCI2-Stand Washing Hands at a Sink Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Stand while washing his/her hands and face at a sink? PODCI Adolescent Parent-Reported Version - Stand Washing Hands at a Sink PODCI2-Transfer/Basic Mobility Scale Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Transfer and basic mobility core scale. PODCI Adolescent Parent-Reported Version - Transfer and Basic Mobility Scale PODCI2-Turn Door Knobs Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Turn door knobs? PODCI Adolescent Parent-Reported Version - Turn Door Knobs PODCI2-Up Extremity/Phys Function Scale Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Upper extremity and physical function core scale. PODCI Adolescent Parent-Reported Version - Upper Extremity and Physical Function Scale PODCI2-Use a Fork and Spoon Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Use a fork and spoon? PODCI Adolescent Parent-Reported Version - Use a Fork and Spoon PODCI2-Use Assistive Devices for Sitting Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - How often does your child use assistive devices (such as braces, crutches, or wheelchair) for sitting and standing? PODCI Adolescent Parent-Reported Version - Use Assistive Devices for Sitting PODCI2-Use Assistive Devices for Walking Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - How often does your child use assistive devices (such as braces, crutches, or wheelchair) for walking and climbing? PODCI Adolescent Parent-Reported Version - Use Assistive Devices for Walking PODCI2-Walk More Than a Mile Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Walk more than a mile? PODCI Adolescent Parent-Reported Version - Walk More Than a Mile PODCI2-Walk One Block Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Walk one block? PODCI Adolescent Parent-Reported Version - Walk One Block PODCI2-Walk Three Blocks Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Walk three blocks? PODCI Adolescent Parent-Reported Version - Walk Three Blocks PODCI2-What Clothes/Shoes He/She Wear Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how happy has your child been with: What clothes or shoes he/she can wear? PODCI Adolescent Parent-Reported Version - What Clothes or Shoes He or She Wear PODCI2-Write With a Pencil Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Write with a pencil? PODCI Adolescent Parent-Reported Version - Write With a Pencil PODCI2TN Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported Version Questionnaire Test Name CDISC Questionnaire PODCI Adolescent Parent-Reported Version Test Name Terminology Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported Version test code. PODCI3-Lift Heavy Books Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Lift heavy books? PODCI Adolescent Self-Reported Version - Lift Heavy Books PODCI3-Pour a Half Gallon of Milk Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Pour a half gallon of milk? PODCI Adolescent Self-Reported Version - Pour a Half Gallon of Milk PODCI3-Open a Jar Been Opened Before Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Open a jar that has been opened before? PODCI Adolescent Self-Reported Version - Open a Jar Been Opened Before PODCI3-Use a Fork and Spoon Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Use a fork and spoon? PODCI Adolescent Self-Reported Version - Use a Fork and Spoon PODCI3-Comb Your Hair Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Comb your hair? PODCI Adolescent Self-Reported Version - Comb Your Hair PODCI3-Button Buttons Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Button buttons? PODCI Adolescent Self-Reported Version - Button Buttons PODCI3-Put on Your Coat Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Put on your coat? PODCI Adolescent Self-Reported Version - Put on Your Coat PODCI3-Write With a Pencil Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Write with a pencil? PODCI Adolescent Self-Reported Version - Write With a Pencil PODCI3-Miss School Because of Health Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - On average, over the last 12 months, how often did you miss school (camp, etc.) because of your health? PODCI Adolescent Self-Reported Version - Miss School Because of Health PODCI3-How You Look Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how happy have you been with: How you look? PODCI Adolescent Self-Reported Version - How You Look PODCI3-Your Body Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how happy have you been with: Your body? PODCI Adolescent Self-Reported Version - Your Body PODCI3-What Clothes/Shoes You Can Wear Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how happy have you been with: What clothes or shoes you can wear? PODCI Adolescent Self-Reported Version - What Clothes or Shoes You Can Wear PODCI3-Ability Do Same Things Friends Do Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how happy have you been with: Your ability to do the same things your friends do? PODCI Adolescent Self-Reported Version - Ability Do Same Things Friends Do PODCI3-Your Health in General Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how happy have you been with: Your health in general? PODCI Adolescent Self-Reported Version - Your Health in General PODCI3-Feel Sick and Tired Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how much of the time: Did you feel sick and tired? PODCI Adolescent Self-Reported Version - Feel Sick and Tired PODCI3-Full of Pep and Energy Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how much of the time: Were you full of pep and energy? PODCI Adolescent Self-Reported Version - Full of Pep and Energy PODCI3-Pain/Discom Inter With Activities Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how much of the time: Did pain or discomfort interfere with your activities? PODCI Adolescent Self-Reported Version - Pain or Discomfort Interfere With Activities PODCI3-Run Short Distances Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Run short distances? PODCI Adolescent Self-Reported Version - Run Short Distances PODCI3-Bicycle or Tricycle Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Bicycle or tricycle? PODCI Adolescent Self-Reported Version - Bicycle or Tricycle PODCI3-Climb Three Flights of Stairs Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Climb three flights of stairs? PODCI Adolescent Self-Reported Version - Climb Three Flights of Stairs PODCI3-Climb One Flight of Stairs Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Climb one flight of stairs? PODCI Adolescent Self-Reported Version - Climb One Flight of Stairs PODCI3-Walk More Than a Mile Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Walk more than a mile? PODCI Adolescent Self-Reported Version - Walk More Than a Mile PODCI3-Walk Three Blocks Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Walk three blocks? PODCI Adolescent Self-Reported Version - Walk Three Blocks PODCI3-Walk One Block Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Walk one block? PODCI Adolescent Self-Reported Version - Walk One Block PODCI3-Get On and Off a Bus Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Get on and off a bus? PODCI Adolescent Self-Reported Version - Get On and Off a Bus PODCI3-Need Help Walking and Climbing Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - How often do you need help from another person for walking and climbing? PODCI Adolescent Self-Reported Version - Need Help Walking and Climbing PODCI3-Use Assistive Devices for Walking Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - How often do you use assistive devices (such as braces, crutches, or wheelchair) for walking and climbing? PODCI Adolescent Self-Reported Version - Use Assistive Devices for Walking PODCI3-Stand Washing Hands at a Sink Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Stand while washing your hands and face at a sink? PODCI Adolescent Self-Reported Version - Stand Washing Hands at a Sink PODCI3-Sit in Chair Without Holding On Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Sit in a regular chair without holding on? PODCI Adolescent Self-Reported Version - Sit in Chair Without Holding On PODCI3-Get On and Off a Toilet or Chair Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Get on and off a toilet or chair? PODCI Adolescent Self-Reported Version - Get On and Off a Toilet or Chair PODCI3-Get In and Out of Bed Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Get in and out of bed? PODCI Adolescent Self-Reported Version - Get In and Out of Bed PODCI3-Turn Door Knobs Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Turn door knobs? PODCI Adolescent Self-Reported Version - Turn Door Knobs PODCI3-Bend Over and Pick Up Something Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Bend over from a standing position and pick up something off the floor? PODCI Adolescent Self-Reported Version - Bend Over and Pick Up Something PODCI3-Need Help Sitting and Standing Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - How often do you need help from another person for sitting and standing? PODCI Adolescent Self-Reported Version - Need Help Sitting and Standing PODCI3-Use Assistive Devices for Sitting Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - How often do you use assistive devices (such as braces, crutches, or wheelchair) for sitting and standing? PODCI Adolescent Self-Reported Version - Use Assistive Devices for Sitting PODCI3-Participate in Outdoor Activities Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Can you participate in recreational outdoor activities with other kids the same age (For example: bicycling, skating, hiking, jogging)? PODCI Adolescent Self-Reported Version - Participate in Outdoor Activities PODCI3-Outdoor Limited by: Pain Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 36 above, was your activity limited by: Pain? PODCI Adolescent Self-Reported Version - Outdoor Limited by: Pain PODCI3-Outdoor Limited by: Health Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 36 above, was your activity limited by: General health? PODCI Adolescent Self-Reported Version - Outdoor Limited by: Health PODCI3-Outdoor Limited by: Instructions Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 36 above, was your activity limited by: Doctor or parent instructions? PODCI Adolescent Self-Reported Version - Outdoor Limited by: Instructions PODCI3-Outdoor Limited by: Fear Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 36 above, was your activity limited by: Fear the other kids won't like you? PODCI Adolescent Self-Reported Version - Outdoor Limited by: Fear PODCI3-Outdoor Limited by: Dislike Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 36 above, was your activity limited by: Dislike of recreational outdoor activities? PODCI Adolescent Self-Reported Version - Outdoor Limited by: Dislike PODCI3-Outdoor Limited by: Season Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 36 above, was your activity limited by: Activity not in season? PODCI Adolescent Self-Reported Version - Outdoor Limited by: Season PODCI3-Participate in Pickup Games Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Can you participate in pickup games or sports with other kids the same age (For example: tag, dodge ball, basketball, softball, soccer, catch, jump rope, touch football, hop scotch)? PODCI Adolescent Self-Reported Version - Participate in Pickup Games PODCI3-Games Limited by: Pain Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 43 above, was your activity limited by: Pain? PODCI Adolescent Self-Reported Version - Games Limited by: Pain PODCI3-Games Limited by: Health Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 43 above, was your activity limited by: General health? PODCI Adolescent Self-Reported Version - Games Limited by: Health PODCI3-Games Limited by: Instructions Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 43 above, was your activity limited by: Doctor or parent instructions? PODCI Adolescent Self-Reported Version - Games Limited by: Instructions PODCI3-Games Limited by: Fear Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 43 above, was your activity limited by: Fear the other kids won't like you? PODCI Adolescent Self-Reported Version - Games Limited by: Fear PODCI3-Games Limited by: Dislike Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 43 above, was your activity limited by: Dislike of pickup games or sports? PODCI Adolescent Self-Reported Version - Games Limited by: Dislike PODCI3-Games Limited by: Season Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 43 above, was your activity limited by: Activity not in season? PODCI Adolescent Self-Reported Version - Games Limited by: Season PODCI3-Participate in Competitive Sports Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Can you participate in competitive level sports with other kids the same age (For example: hockey, basketball, soccer, football, baseball, swimming, running [track or cross country], gymnastics, or dance)? PODCI Adolescent Self-Reported Version - Participate in Competitive Sports PODCI3-Comp Sports Limited by: Pain Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 50 above, was your activity limited by: Pain? PODCI Adolescent Self-Reported Version - Competitive Sports Limited by: Pain PODCI3-Comp Sports Limited by: Health Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 50 above, was your activity limited by: General health? PODCI Adolescent Self-Reported Version - Competitive Sports Limited by: Health PODCI3-Comp Sports Limited by: Instruct Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 50 above, was your activity limited by: Doctor or parent instructions? PODCI Adolescent Self-Reported Version - Competitive Sports Limited by: Instructions PODCI3-Comp Sports Limited by: Fear Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 50 above, was your activity limited by: Fear the other kids won't like you? PODCI Adolescent Self-Reported Version - Competitive Sports Limited by: Fear PODCI3-Comp Sports Limited by: Dislike Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 50 above, was your activity limited by: Dislike of pickup games or sports? PODCI Adolescent Self-Reported Version - Competitive Sports Limited by: Dislike PODCI3-Comp Sports Limited by: Season Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 50 above, was your activity limited by: Activity not in season? PODCI Adolescent Self-Reported Version - Competitive Sports Limited by: Season PODCI3-Get Together With Friends Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - How often in the last week did you get together and do things with friends? PODCI Adolescent Self-Reported Version - Get Together With Friends PODCI3-Friends Limited by: Pain Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 57 above, was your activity limited by: Pain? PODCI Adolescent Self-Reported Version - Friends Limited by: Pain PODCI3-Friends Limited by: Health Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 57 above, was your activity limited by: General health? PODCI Adolescent Self-Reported Version - Friends Limited by: Health PODCI3-Friends Limited by: Instructions Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 57 above, was your activity limited by: Doctor or parent instructions? PODCI Adolescent Self-Reported Version - Friends Limited by: Instructions PODCI3-Friends Limited by: Fear Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 57 above, was your activity limited by: Fear the other kids won't like you? PODCI Adolescent Self-Reported Version - Friends Limited by: Fear PODCI3-Friends Limited by: Not Around Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 57 above, was your activity limited by: Friends not around? PODCI Adolescent Self-Reported Version - Friends Limited by: Not Around PODCI3-Participate in Gym/Recess Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - How often in the last week did you participate in gym/recess? PODCI Adolescent Self-Reported Version - Participate in Gym or Recess PODCI3-Gym Limited by: Pain Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 63 above, was your activity limited by: Pain? PODCI Adolescent Self-Reported Version - Gym Limited by: Pain PODCI3-Gym Limited by: Health Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 63 above, was your activity limited by: General health? PODCI Adolescent Self-Reported Version - Gym Limited by: Health PODCI3-Gym Limited by: Instructions Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 63 above, was your activity limited by: Doctor or parent instructions? PODCI Adolescent Self-Reported Version - Gym Limited by: Instructions PODCI3-Gym Limited by: Fear Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 63 above, was your activity limited by: Fear the other kids won't like you? PODCI Adolescent Self-Reported Version - Gym Limited by: Fear PODCI3-Gym Limited by: Dislike Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 63 above, was your activity limited by: Dislike of gym/recess? PODCI Adolescent Self-Reported Version - Gym Limited by: Dislike PODCI3-Gym Limited by: Not in Session Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 63 above, was your activity limited by: School not in session? PODCI Adolescent Self-Reported Version - Gym Limited by: Not in Session PODCI3-Gym Limited by: Not Attend School Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 63 above, was your activity limited by: I don't attend school? PODCI Adolescent Self-Reported Version - Gym Limited by: Not Attend School PODCI3-Easy to Make Friends Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Is it easy or hard for you to make friends with kids your own age? PODCI Adolescent Self-Reported Version - Easy to Make Friends PODCI3-Pain During the Last Week Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - How much pain have you had during the last week? PODCI Adolescent Self-Reported Version - Pain During the Last Week PODCI3-Pain Interfere With Activities Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how much did pain interfere with your normal activities (including at home, outside of the home, and at school)? PODCI Adolescent Self-Reported Version - Pain Interfere With Activities PODCI3-Have Pain Relief Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To have pain relief. PODCI Adolescent Self-Reported Version - Have Pain Relief PODCI3-Look Better Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To look better. PODCI Adolescent Self-Reported Version - Look Better PODCI3-Feel Better Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To feel better about myself. PODCI Adolescent Self-Reported Version - Feel Better PODCI3-Sleep More Comfortably Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To sleep more comfortably. PODCI Adolescent Self-Reported Version - Sleep More Comfortably PODCI3-Able to Do Activities at Home Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To be able to do activities at home. PODCI Adolescent Self-Reported Version - Able to Do Activities at Home PODCI3-Able to Do More at School Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To be able to do more at school. PODCI Adolescent Self-Reported Version - Able to Do More at School PODCI3-Able to Do More Play Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To be able to do more play or recreational activities. PODCI Adolescent Self-Reported Version - Able to Do More Play PODCI3-Able to Do More Sports Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To be able to do more sports. PODCI Adolescent Self-Reported Version - Able to Do More Sports PODCI3-Free From Pain as Adult Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To be free from pain or disability as an adult. PODCI Adolescent Self-Reported Version - Free From Pain as Adult PODCI3-Spend Rest of Life With Condition Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you had to spend the rest of your life with your bone and muscle condition as it is right now, how would you feel about it? PODCI Adolescent Self-Reported Version - Spend Rest of Life With Condition PODCI3-Up Extremity/Phys Function Scale Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Upper extremity and physical function core scale. PODCI Adolescent Self-Reported Version - Upper Extremity and Physical Function Scale PODCI3-Transfer/Basic Mobility Scale Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Transfer and basic mobility core scale. PODCI Adolescent Self-Reported Version - Transfer and Basic Mobility Scale PODCI3-Sports/Phys Function Scale Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Sports and physical functioning core scale. PODCI Adolescent Self-Reported Version - Sports and Physical Function Scale PODCI3-Pain/Comfort Scale Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Pain/comfort core scale. PODCI Adolescent Self-Reported Version - Pain or Comfort Scale PODCI3-Happiness Scale Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Happiness core scale. PODCI Adolescent Self-Reported Version - Happiness Scale PODCI3-Global Functioning Scale Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Global functioning scale. PODCI Adolescent Self-Reported Version - Global Functioning Scale PODCI3TC Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported Version Questionnaire Test Code CDISC Questionnaire PODCI Adolescent Self-Reported Version Test Code Terminology Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported Version test name. PODCI3-Ability Do Same Things Friends Do Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how happy have you been with: Your ability to do the same things your friends do? PODCI Adolescent Self-Reported Version - Ability Do Same Things Friends Do PODCI3-Able to Do Activities at Home Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To be able to do activities at home. PODCI Adolescent Self-Reported Version - Able to Do Activities at Home PODCI3-Able to Do More at School Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To be able to do more at school. PODCI Adolescent Self-Reported Version - Able to Do More at School PODCI3-Able to Do More Play Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To be able to do more play or recreational activities. PODCI Adolescent Self-Reported Version - Able to Do More Play PODCI3-Able to Do More Sports Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To be able to do more sports. PODCI Adolescent Self-Reported Version - Able to Do More Sports PODCI3-Bend Over and Pick Up Something Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Bend over from a standing position and pick up something off the floor? PODCI Adolescent Self-Reported Version - Bend Over and Pick Up Something PODCI3-Bicycle or Tricycle Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Bicycle or tricycle? PODCI Adolescent Self-Reported Version - Bicycle or Tricycle PODCI3-Button Buttons Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Button buttons? PODCI Adolescent Self-Reported Version - Button Buttons PODCI3-Climb One Flight of Stairs Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Climb one flight of stairs? PODCI Adolescent Self-Reported Version - Climb One Flight of Stairs PODCI3-Climb Three Flights of Stairs Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Climb three flights of stairs? PODCI Adolescent Self-Reported Version - Climb Three Flights of Stairs PODCI3-Comb Your Hair Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Comb your hair? PODCI Adolescent Self-Reported Version - Comb Your Hair PODCI3-Comp Sports Limited by: Dislike Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 50 above, was your activity limited by: Dislike of pickup games or sports? PODCI Adolescent Self-Reported Version - Competitive Sports Limited by: Dislike PODCI3-Comp Sports Limited by: Fear Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 50 above, was your activity limited by: Fear the other kids won't like you? PODCI Adolescent Self-Reported Version - Competitive Sports Limited by: Fear PODCI3-Comp Sports Limited by: Health Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 50 above, was your activity limited by: General health? PODCI Adolescent Self-Reported Version - Competitive Sports Limited by: Health PODCI3-Comp Sports Limited by: Instruct Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 50 above, was your activity limited by: Doctor or parent instructions? PODCI Adolescent Self-Reported Version - Competitive Sports Limited by: Instructions PODCI3-Comp Sports Limited by: Pain Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 50 above, was your activity limited by: Pain? PODCI Adolescent Self-Reported Version - Competitive Sports Limited by: Pain PODCI3-Comp Sports Limited by: Season Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 50 above, was your activity limited by: Activity not in season? PODCI Adolescent Self-Reported Version - Competitive Sports Limited by: Season PODCI3-Easy to Make Friends Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Is it easy or hard for you to make friends with kids your own age? PODCI Adolescent Self-Reported Version - Easy to Make Friends PODCI3-Feel Better Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To feel better about myself. PODCI Adolescent Self-Reported Version - Feel Better PODCI3-Feel Sick and Tired Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how much of the time: Did you feel sick and tired? PODCI Adolescent Self-Reported Version - Feel Sick and Tired PODCI3-Free From Pain as Adult Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To be free from pain or disability as an adult. PODCI Adolescent Self-Reported Version - Free From Pain as Adult PODCI3-Friends Limited by: Fear Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 57 above, was your activity limited by: Fear the other kids won't like you? PODCI Adolescent Self-Reported Version - Friends Limited by: Fear PODCI3-Friends Limited by: Health Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 57 above, was your activity limited by: General health? PODCI Adolescent Self-Reported Version - Friends Limited by: Health PODCI3-Friends Limited by: Instructions Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 57 above, was your activity limited by: Doctor or parent instructions? PODCI Adolescent Self-Reported Version - Friends Limited by: Instructions PODCI3-Friends Limited by: Not Around Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 57 above, was your activity limited by: Friends not around? PODCI Adolescent Self-Reported Version - Friends Limited by: Not Around PODCI3-Friends Limited by: Pain Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 57 above, was your activity limited by: Pain? PODCI Adolescent Self-Reported Version - Friends Limited by: Pain PODCI3-Full of Pep and Energy Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how much of the time: Were you full of pep and energy? PODCI Adolescent Self-Reported Version - Full of Pep and Energy PODCI3-Games Limited by: Dislike Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 43 above, was your activity limited by: Dislike of pickup games or sports? PODCI Adolescent Self-Reported Version - Games Limited by: Dislike PODCI3-Games Limited by: Fear Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 43 above, was your activity limited by: Fear the other kids won't like you? PODCI Adolescent Self-Reported Version - Games Limited by: Fear PODCI3-Games Limited by: Health Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 43 above, was your activity limited by: General health? PODCI Adolescent Self-Reported Version - Games Limited by: Health PODCI3-Games Limited by: Instructions Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 43 above, was your activity limited by: Doctor or parent instructions? PODCI Adolescent Self-Reported Version - Games Limited by: Instructions PODCI3-Games Limited by: Pain Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 43 above, was your activity limited by: Pain? PODCI Adolescent Self-Reported Version - Games Limited by: Pain PODCI3-Games Limited by: Season Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 43 above, was your activity limited by: Activity not in season? PODCI Adolescent Self-Reported Version - Games Limited by: Season PODCI3-Get In and Out of Bed Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Get in and out of bed? PODCI Adolescent Self-Reported Version - Get In and Out of Bed PODCI3-Get On and Off a Bus Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Get on and off a bus? PODCI Adolescent Self-Reported Version - Get On and Off a Bus PODCI3-Get On and Off a Toilet or Chair Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Get on and off a toilet or chair? PODCI Adolescent Self-Reported Version - Get On and Off a Toilet or Chair PODCI3-Get Together With Friends Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - How often in the last week did you get together and do things with friends? PODCI Adolescent Self-Reported Version - Get Together With Friends PODCI3-Global Functioning Scale Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Global functioning scale. PODCI Adolescent Self-Reported Version - Global Functioning Scale PODCI3-Gym Limited by: Dislike Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 63 above, was your activity limited by: Dislike of gym/recess? PODCI Adolescent Self-Reported Version - Gym Limited by: Dislike PODCI3-Gym Limited by: Fear Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 63 above, was your activity limited by: Fear the other kids won't like you? PODCI Adolescent Self-Reported Version - Gym Limited by: Fear PODCI3-Gym Limited by: Health Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 63 above, was your activity limited by: General health? PODCI Adolescent Self-Reported Version - Gym Limited by: Health PODCI3-Gym Limited by: Instructions Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 63 above, was your activity limited by: Doctor or parent instructions? PODCI Adolescent Self-Reported Version - Gym Limited by: Instructions PODCI3-Gym Limited by: Not Attend School Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 63 above, was your activity limited by: I don't attend school? PODCI Adolescent Self-Reported Version - Gym Limited by: Not Attend School PODCI3-Gym Limited by: Not in Session Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 63 above, was your activity limited by: School not in session? PODCI Adolescent Self-Reported Version - Gym Limited by: Not in Session PODCI3-Gym Limited by: Pain Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 63 above, was your activity limited by: Pain? PODCI Adolescent Self-Reported Version - Gym Limited by: Pain PODCI3-Happiness Scale Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Happiness core scale. PODCI Adolescent Self-Reported Version - Happiness Scale PODCI3-Have Pain Relief Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To have pain relief. PODCI Adolescent Self-Reported Version - Have Pain Relief PODCI3-How You Look Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how happy have you been with: How you look? PODCI Adolescent Self-Reported Version - How You Look PODCI3-Lift Heavy Books Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Lift heavy books? PODCI Adolescent Self-Reported Version - Lift Heavy Books PODCI3-Look Better Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To look better. PODCI Adolescent Self-Reported Version - Look Better PODCI3-Miss School Because of Health Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - On average, over the last 12 months, how often did you miss school (camp, etc.) because of your health? PODCI Adolescent Self-Reported Version - Miss School Because of Health PODCI3-Need Help Sitting and Standing Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - How often do you need help from another person for sitting and standing? PODCI Adolescent Self-Reported Version - Need Help Sitting and Standing PODCI3-Need Help Walking and Climbing Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - How often do you need help from another person for walking and climbing? PODCI Adolescent Self-Reported Version - Need Help Walking and Climbing PODCI3-Open a Jar Been Opened Before Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Open a jar that has been opened before? PODCI Adolescent Self-Reported Version - Open a Jar Been Opened Before PODCI3-Outdoor Limited by: Dislike Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 36 above, was your activity limited by: Dislike of recreational outdoor activities? PODCI Adolescent Self-Reported Version - Outdoor Limited by: Dislike PODCI3-Outdoor Limited by: Fear Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 36 above, was your activity limited by: Fear the other kids won't like you? PODCI Adolescent Self-Reported Version - Outdoor Limited by: Fear PODCI3-Outdoor Limited by: Health Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 36 above, was your activity limited by: General health? PODCI Adolescent Self-Reported Version - Outdoor Limited by: Health PODCI3-Outdoor Limited by: Instructions Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 36 above, was your activity limited by: Doctor or parent instructions? PODCI Adolescent Self-Reported Version - Outdoor Limited by: Instructions PODCI3-Outdoor Limited by: Pain Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 36 above, was your activity limited by: Pain? PODCI Adolescent Self-Reported Version - Outdoor Limited by: Pain PODCI3-Outdoor Limited by: Season Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 36 above, was your activity limited by: Activity not in season? PODCI Adolescent Self-Reported Version - Outdoor Limited by: Season PODCI3-Pain During the Last Week Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - How much pain have you had during the last week? PODCI Adolescent Self-Reported Version - Pain During the Last Week PODCI3-Pain Interfere With Activities Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how much did pain interfere with your normal activities (including at home, outside of the home, and at school)? PODCI Adolescent Self-Reported Version - Pain Interfere With Activities PODCI3-Pain/Comfort Scale Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Pain/comfort core scale. PODCI Adolescent Self-Reported Version - Pain or Comfort Scale PODCI3-Pain/Discom Inter With Activities Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how much of the time: Did pain or discomfort interfere with your activities? PODCI Adolescent Self-Reported Version - Pain or Discomfort Interfere With Activities PODCI3-Participate in Competitive Sports Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Can you participate in competitive level sports with other kids the same age (For example: hockey, basketball, soccer, football, baseball, swimming, running [track or cross country], gymnastics, or dance)? PODCI Adolescent Self-Reported Version - Participate in Competitive Sports PODCI3-Participate in Gym/Recess Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - How often in the last week did you participate in gym/recess? PODCI Adolescent Self-Reported Version - Participate in Gym or Recess PODCI3-Participate in Outdoor Activities Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Can you participate in recreational outdoor activities with other kids the same age (For example: bicycling, skating, hiking, jogging)? PODCI Adolescent Self-Reported Version - Participate in Outdoor Activities PODCI3-Participate in Pickup Games Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Can you participate in pickup games or sports with other kids the same age (For example: tag, dodge ball, basketball, softball, soccer, catch, jump rope, touch football, hop scotch)? PODCI Adolescent Self-Reported Version - Participate in Pickup Games PODCI3-Pour a Half Gallon of Milk Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Pour a half gallon of milk? PODCI Adolescent Self-Reported Version - Pour a Half Gallon of Milk PODCI3-Put on Your Coat Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Put on your coat? PODCI Adolescent Self-Reported Version - Put on Your Coat PODCI3-Run Short Distances Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Run short distances? PODCI Adolescent Self-Reported Version - Run Short Distances PODCI3-Sit in Chair Without Holding On Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Sit in a regular chair without holding on? PODCI Adolescent Self-Reported Version - Sit in Chair Without Holding On PODCI3-Sleep More Comfortably Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To sleep more comfortably. PODCI Adolescent Self-Reported Version - Sleep More Comfortably PODCI3-Spend Rest of Life With Condition Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you had to spend the rest of your life with your bone and muscle condition as it is right now, how would you feel about it? PODCI Adolescent Self-Reported Version - Spend Rest of Life With Condition PODCI3-Sports/Phys Function Scale Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Sports and physical functioning core scale. PODCI Adolescent Self-Reported Version - Sports and Physical Function Scale PODCI3-Stand Washing Hands at a Sink Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Stand while washing your hands and face at a sink? PODCI Adolescent Self-Reported Version - Stand Washing Hands at a Sink PODCI3-Transfer/Basic Mobility Scale Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Transfer and basic mobility core scale. PODCI Adolescent Self-Reported Version - Transfer and Basic Mobility Scale PODCI3-Turn Door Knobs Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Turn door knobs? PODCI Adolescent Self-Reported Version - Turn Door Knobs PODCI3-Up Extremity/Phys Function Scale Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Upper extremity and physical function core scale. PODCI Adolescent Self-Reported Version - Upper Extremity and Physical Function Scale PODCI3-Use a Fork and Spoon Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Use a fork and spoon? PODCI Adolescent Self-Reported Version - Use a Fork and Spoon PODCI3-Use Assistive Devices for Sitting Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - How often do you use assistive devices (such as braces, crutches, or wheelchair) for sitting and standing? PODCI Adolescent Self-Reported Version - Use Assistive Devices for Sitting PODCI3-Use Assistive Devices for Walking Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - How often do you use assistive devices (such as braces, crutches, or wheelchair) for walking and climbing? PODCI Adolescent Self-Reported Version - Use Assistive Devices for Walking PODCI3-Walk More Than a Mile Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Walk more than a mile? PODCI Adolescent Self-Reported Version - Walk More Than a Mile PODCI3-Walk One Block Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Walk one block? PODCI Adolescent Self-Reported Version - Walk One Block PODCI3-Walk Three Blocks Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Walk three blocks? PODCI Adolescent Self-Reported Version - Walk Three Blocks PODCI3-What Clothes/Shoes You Can Wear Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how happy have you been with: What clothes or shoes you can wear? PODCI Adolescent Self-Reported Version - What Clothes or Shoes You Can Wear PODCI3-Write With a Pencil Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Write with a pencil? PODCI Adolescent Self-Reported Version - Write With a Pencil PODCI3-Your Body Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how happy have you been with: Your body? PODCI Adolescent Self-Reported Version - Your Body PODCI3-Your Health in General Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how happy have you been with: Your health in general? PODCI Adolescent Self-Reported Version - Your Health in General PODCI3TN Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported Version Questionnaire Test Name CDISC Questionnaire PODCI Adolescent Self-Reported Version Test Name Terminology Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported Version test code. PODCI1-Lift Heavy Books Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Lift heavy books? PODCI Pediatric Parent-Reported Version - Lift Heavy Books PODCI1-Pour a Half Gallon of Milk Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Pour a half gallon of milk? PODCI Pediatric Parent-Reported Version - Pour a Half Gallon of Milk PODCI1-Open a Jar Been Opened Before Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Open a jar that has been opened before? PODCI Pediatric Parent-Reported Version - Open a Jar Been Opened Before PODCI1-Use a Fork and Spoon Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Use a fork and spoon? PODCI Pediatric Parent-Reported Version - Use a Fork and Spoon PODCI1-Comb His/Her Hair Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Comb his/her hair? PODCI Pediatric Parent-Reported Version - Comb His or Her Hair PODCI1-Button Buttons Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Button buttons? PODCI Pediatric Parent-Reported Version - Button Buttons PODCI1-Put on His/Her Coat Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Put on his/her coat? PODCI Pediatric Parent-Reported Version - Put on His or Her Coat PODCI1-Write With a Pencil Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Write with a pencil? PODCI Pediatric Parent-Reported Version - Write With a Pencil PODCI1-Miss School Because of Health Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - On average, over the last 12 months, how often did your child miss school (preschool, day care, camp, etc.) because of his/her health? PODCI Pediatric Parent-Reported Version - Miss School Because of Health PODCI1-How He/She Looks Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how happy has your child been with: How he/she looks? PODCI Pediatric Parent-Reported Version - How He or She Looks PODCI1-His/Her Body Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how happy has your child been with: His/her body? PODCI Pediatric Parent-Reported Version - His or Her Body PODCI1-What Clothes/Shoes He/She Wear Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how happy has your child been with: What clothes or shoes he/she can wear? PODCI Pediatric Parent-Reported Version - What Clothes or Shoes He or She Wear PODCI1-Ability Do Same Things Friends Do Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how happy has your child been with: His/her ability to do the same things his/her friends do? PODCI Pediatric Parent-Reported Version - Ability Do Same Things Friends Do PODCI1-His/Her Health in General Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how happy has your child been with: His/her health in general? PODCI Pediatric Parent-Reported Version - His or Her Health in General PODCI1-Feel Sick and Tired Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how much of the time: Did your child feel sick and tired? PODCI Pediatric Parent-Reported Version - Feel Sick and Tired PODCI1-Full of Pep and Energy Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how much of the time: Were your child full of pep and energy? PODCI Pediatric Parent-Reported Version - Full of Pep and Energy PODCI1-Pain/Discom Inter With Activities Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how much of the time: Did pain or discomfort interfere with your child's activities? PODCI Pediatric Parent-Reported Version - Pain or Discomfort Interfere With Activities PODCI1-Run Short Distances Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Run short distances? PODCI Pediatric Parent-Reported Version - Run Short Distances PODCI1-Bicycle or Tricycle Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Bicycle or tricycle? PODCI Pediatric Parent-Reported Version - Bicycle or Tricycle PODCI1-Climb Three Flights of Stairs Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Climb three flights of stairs? PODCI Pediatric Parent-Reported Version - Climb Three Flights of Stairs PODCI1-Climb One Flight of Stairs Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Climb one flight of stairs? PODCI Pediatric Parent-Reported Version - Climb One Flight of Stairs PODCI1-Walk More Than a Mile Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Walk more than a mile? PODCI Pediatric Parent-Reported Version - Walk More Than a Mile PODCI1-Walk Three Blocks Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Walk three blocks? PODCI Pediatric Parent-Reported Version - Walk Three Blocks PODCI1-Walk One Block Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Walk one block? PODCI Pediatric Parent-Reported Version - Walk One Block PODCI1-Get On and Off a Bus Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Get on and off a bus? PODCI Pediatric Parent-Reported Version - Get On and Off a Bus PODCI1-Need Help Walking and Climbing Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - How often does your child need help from another person for walking and climbing? PODCI Pediatric Parent-Reported Version - Need Help Walking and Climbing PODCI1-Use Assistive Devices for Walking Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - How often does your child use assistive devices (such as braces, crutches, or wheelchair) for walking and climbing? PODCI Pediatric Parent-Reported Version - Use Assistive Devices for Walking PODCI1-Stand Washing Hands at a Sink Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Stand while washing his/her hands and face at a sink? PODCI Pediatric Parent-Reported Version - Stand Washing Hands at a Sink PODCI1-Sit in Chair Without Holding On Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Sit in a regular chair without holding on? PODCI Pediatric Parent-Reported Version - Sit in Chair Without Holding On PODCI1-Get On and Off a Toilet or Chair Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Get on and off a toilet or chair? PODCI Pediatric Parent-Reported Version - Get On and Off a Toilet or Chair PODCI1-Get In and Out of Bed Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Get in and out of bed? PODCI Pediatric Parent-Reported Version - Get In and Out of Bed PODCI1-Turn Door Knobs Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Turn door knobs? PODCI Pediatric Parent-Reported Version - Turn Door Knobs PODCI1-Bend Over and Pick Up Something Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Bend over from a standing position and pick up something off the floor? PODCI Pediatric Parent-Reported Version - Bend Over and Pick Up Something PODCI1-Need Help Sitting and Standing Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - How often does your child need help from another person for sitting and standing? PODCI Pediatric Parent-Reported Version - Need Help Sitting and Standing PODCI1-Use Assistive Devices for Sitting Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - How often does your child use assistive devices (such as braces, crutches, or wheelchair) for sitting and standing? PODCI Pediatric Parent-Reported Version - Use Assistive Devices for Sitting PODCI1-Participate in Outdoor Activities Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Can your child participate in recreational outdoor activities with other children the same age (For example: bicycling, tricycling, skating, hiking, jogging)? PODCI Pediatric Parent-Reported Version - Participate in Outdoor Activities PODCI1-Outdoor Limited by: Pain Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Pain? PODCI Pediatric Parent-Reported Version - Outdoor Limited by: Pain PODCI1-Outdoor Limited by: Health Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: General health? PODCI Pediatric Parent-Reported Version - Outdoor Limited by: Health PODCI1-Outdoor Limited by: Instructions Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Doctor or parent instructions? PODCI Pediatric Parent-Reported Version - Outdoor Limited by: Instructions PODCI1-Outdoor Limited by: Fear Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Fear the other kids won't like him/her? PODCI Pediatric Parent-Reported Version - Outdoor Limited by: Fear PODCI1-Outdoor Limited by: Dislike Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Dislike of recreational outdoor activities? PODCI Pediatric Parent-Reported Version - Outdoor Limited by: Dislike PODCI1-Outdoor Limited by: Too Young Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Too young? PODCI Pediatric Parent-Reported Version - Outdoor Limited by: Too Young PODCI1-Outdoor Limited by: Season Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Activity not in season? PODCI Pediatric Parent-Reported Version - Outdoor Limited by: Season PODCI1-Participate in Pickup Games Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Can your child participate in pickup games or sports with other children the same age (For example: tag, dodge ball, basketball, soccer, catch, jump rope, touch football, hop scotch)? PODCI Pediatric Parent-Reported Version - Participate in Pickup Games PODCI1-Games Limited by: Pain Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Pain? PODCI Pediatric Parent-Reported Version - Games Limited by: Pain PODCI1-Games Limited by: Health Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: General health? PODCI Pediatric Parent-Reported Version - Games Limited by: Health PODCI1-Games Limited by: Instructions Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Doctor or parent instructions? PODCI Pediatric Parent-Reported Version - Games Limited by: Instructions PODCI1-Games Limited by: Fear Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Fear the other kids won't like him/her? PODCI Pediatric Parent-Reported Version - Games Limited by: Fear PODCI1-Games Limited by: Dislike Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Dislike of pickup games or sports? PODCI Pediatric Parent-Reported Version - Games Limited by: Dislike PODCI1-Games Limited by: Too Young Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Too young? PODCI Pediatric Parent-Reported Version - Games Limited by: Too Young PODCI1-Games Limited by: Season Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Activity not in season? PODCI Pediatric Parent-Reported Version - Games Limited by: Season PODCI1-Participate in Competitive Sports Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Can your child participate in competitive level sports with other children the same age (For example: hockey, basketball, soccer, football, baseball, swimming, running [track or cross country], gymnastics, or dance)? PODCI Pediatric Parent-Reported Version - Participate in Competitive Sports PODCI1-Comp Sports Limited by: Pain Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Pain? PODCI Pediatric Parent-Reported Version - Competitive Sports Limited by: Pain PODCI1-Comp Sports Limited by: Health Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: General health? PODCI Pediatric Parent-Reported Version - Competitive Sports Limited by: Health PODCI1-Comp Sports Limited by: Instruct Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Doctor or parent instructions? PODCI Pediatric Parent-Reported Version - Competitive Sports Limited by: Instruction PODCI1-Comp Sports Limited by: Fear Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Fear the other kids won't like him/her? PODCI Pediatric Parent-Reported Version - Competitive Sports Limited by: Fear PODCI1-Comp Sports Limited by: Dislike Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Dislike of pickup games or sports? PODCI Pediatric Parent-Reported Version - Competitive Sports Limited by: Dislike PODCI1-Comp Sports Limited by: Too Young Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Too young? PODCI Pediatric Parent-Reported Version - Competitive Sports Limited by: Too Young PODCI1-Comp Sports Limited by: Season Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Activity not in season? PODCI Pediatric Parent-Reported Version - Competitive Sports Limited by: Season PODCI1-Get Together With Friends Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - How often in the last week did your child get together and do things with friends? PODCI Pediatric Parent-Reported Version - Get Together With Friends PODCI1-Friends Limited by: Pain Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Pain? PODCI Pediatric Parent-Reported Version - Friends Limited by: Pain PODCI1-Friends Limited by: Health Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: General health? PODCI Pediatric Parent-Reported Version - Friends Limited by: Health PODCI1-Friends Limited by: Instructions Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Doctor or parent instructions? PODCI Pediatric Parent-Reported Version - Friends Limited by: Instructions PODCI1-Friends Limited by: Fear Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Fear the other kids won't like him/her? PODCI Pediatric Parent-Reported Version - Friends Limited by: Fear PODCI1-Friends Limited by: Not Around Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Friends not around? PODCI Pediatric Parent-Reported Version - Friends Limited by: Not Around PODCI1-Participate in Gym/Recess Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - How often in the last week did your child participate in gym/recess? PODCI Pediatric Parent-Reported Version - Participate in Gym or Recess PODCI1-Gym Limited by: Pain Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Pain? PODCI Pediatric Parent-Reported Version - Gym Limited by: Pain PODCI1-Gym Limited by: Health Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: General health? PODCI Pediatric Parent-Reported Version - Gym Limited by: Health PODCI1-Gym Limited by: Instructions Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Doctor or parent instructions? PODCI Pediatric Parent-Reported Version - Gym Limited by: Instructions PODCI1-Gym Limited by: Fear Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Fear the other kids won't like him/her? PODCI Pediatric Parent-Reported Version - Gym Limited by: Fear PODCI1-Gym Limited by: Dislike Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Dislike of gym/recess? PODCI Pediatric Parent-Reported Version - Gym Limited by: Dislike PODCI1-Gym Limited by: Not in Session Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: School not in session? PODCI Pediatric Parent-Reported Version - Gym Limited by: Not in Session PODCI1-Gym Limited by: Not Attend School Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Does not attend school? PODCI Pediatric Parent-Reported Version - Gym Limited by: Not Attend School PODCI1-Easy to Make Friends Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Is it easy or hard for your child to make friends with children his/her own age? PODCI Pediatric Parent-Reported Version - Easy to Make Friends PODCI1-Pain During the Last Week Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - How much pain has your child had during the last week? PODCI Pediatric Parent-Reported Version - Pain During the Last Week PODCI1-Pain Interfere With Activities Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how much did pain interfere with your child's normal activities (including at home, outside of the home, and at school)? PODCI Pediatric Parent-Reported Version - Pain Interfere With Activities PODCI1-Have Pain Relief Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To have pain relief. PODCI Pediatric Parent-Reported Version - Have Pain Relief PODCI1-Look Better Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To look better. PODCI Pediatric Parent-Reported Version - Look Better PODCI1-Feel Better Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To feel better about himself/herself. PODCI Pediatric Parent-Reported Version - Feel Better PODCI1-Sleep More Comfortably Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To sleep more comfortably. PODCI Pediatric Parent-Reported Version - Sleep More Comfortably PODCI1-Able to Do Activities at Home Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do activities at home. PODCI Pediatric Parent-Reported Version - Able to Do Activities at Home PODCI1-Able to Do More at School Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do more at school. PODCI Pediatric Parent-Reported Version - Able to Do More at School PODCI1-Able to Do More Play Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do more play or recreational activities (biking, walking, doing things with friends). PODCI Pediatric Parent-Reported Version - Able to Do More Play PODCI1-Able to Do More Sports Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do more sports. PODCI Pediatric Parent-Reported Version - Able to Do More Sports PODCI1-Free From Pain as Adult Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To be free from pain or disability as an adult. PODCI Pediatric Parent-Reported Version - Free From Pain as Adult PODCI1-Spend Rest of Life With Condition Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If your child had to spend the rest of his/her life with his/her bone and muscle condition as it is right now, how would you feel about it? PODCI Pediatric Parent-Reported Version - Spend Rest of Life With Condition PODCI1-Up Extremity/Phys Function Scale Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Upper extremity and physical function core scale. PODCI Pediatric Parent-Reported Version - Upper Extremity and Physical Function Scale PODCI1-Transfer/Basic Mobility Scale Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Transfer and basic mobility core scale. PODCI Pediatric Parent-Reported Version - Transfer and Basic Mobility Scale PODCI1-Sports/Phys Function Scale Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Sports and physical functioning core scale. PODCI Pediatric Parent-Reported Version - Sports and Physical Function Scale PODCI1-Pain/Comfort Scale Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Pain/comfort core scale. PODCI Pediatric Parent-Reported Version - Pain or Comfort Scale PODCI1-Happiness Scale Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Happiness core scale. PODCI Pediatric Parent-Reported Version - Happiness Scale PODCI1-Global Functioning Scale Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Global functioning scale. PODCI Pediatric Parent-Reported Version - Global Functioning Scale PODCI1TC Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported Version Questionnaire Test Code CDISC Questionnaire PODCI Pediatric Parent-Reported Version Test Code Terminology Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported Version test name. PODCI1-Ability Do Same Things Friends Do Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how happy has your child been with: His/her ability to do the same things his/her friends do? PODCI Pediatric Parent-Reported Version - Ability Do Same Things Friends Do PODCI1-Able to Do Activities at Home Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do activities at home. PODCI Pediatric Parent-Reported Version - Able to Do Activities at Home PODCI1-Able to Do More at School Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do more at school. PODCI Pediatric Parent-Reported Version - Able to Do More at School PODCI1-Able to Do More Play Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do more play or recreational activities (biking, walking, doing things with friends). PODCI Pediatric Parent-Reported Version - Able to Do More Play PODCI1-Able to Do More Sports Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do more sports. PODCI Pediatric Parent-Reported Version - Able to Do More Sports PODCI1-Bend Over and Pick Up Something Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Bend over from a standing position and pick up something off the floor? PODCI Pediatric Parent-Reported Version - Bend Over and Pick Up Something PODCI1-Bicycle or Tricycle Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Bicycle or tricycle? PODCI Pediatric Parent-Reported Version - Bicycle or Tricycle PODCI1-Button Buttons Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Button buttons? PODCI Pediatric Parent-Reported Version - Button Buttons PODCI1-Climb One Flight of Stairs Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Climb one flight of stairs? PODCI Pediatric Parent-Reported Version - Climb One Flight of Stairs PODCI1-Climb Three Flights of Stairs Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Climb three flights of stairs? PODCI Pediatric Parent-Reported Version - Climb Three Flights of Stairs PODCI1-Comb His/Her Hair Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Comb his/her hair? PODCI Pediatric Parent-Reported Version - Comb His or Her Hair PODCI1-Comp Sports Limited by: Dislike Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Dislike of pickup games or sports? PODCI Pediatric Parent-Reported Version - Competitive Sports Limited by: Dislike PODCI1-Comp Sports Limited by: Fear Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Fear the other kids won't like him/her? PODCI Pediatric Parent-Reported Version - Competitive Sports Limited by: Fear PODCI1-Comp Sports Limited by: Health Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: General health? PODCI Pediatric Parent-Reported Version - Competitive Sports Limited by: Health PODCI1-Comp Sports Limited by: Instruct Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Doctor or parent instructions? PODCI Pediatric Parent-Reported Version - Competitive Sports Limited by: Instruction PODCI1-Comp Sports Limited by: Pain Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Pain? PODCI Pediatric Parent-Reported Version - Competitive Sports Limited by: Pain PODCI1-Comp Sports Limited by: Season Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Activity not in season? PODCI Pediatric Parent-Reported Version - Competitive Sports Limited by: Season PODCI1-Comp Sports Limited by: Too Young Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Too young? PODCI Pediatric Parent-Reported Version - Competitive Sports Limited by: Too Young PODCI1-Easy to Make Friends Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Is it easy or hard for your child to make friends with children his/her own age? PODCI Pediatric Parent-Reported Version - Easy to Make Friends PODCI1-Feel Better Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To feel better about himself/herself. PODCI Pediatric Parent-Reported Version - Feel Better PODCI1-Feel Sick and Tired Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how much of the time: Did your child feel sick and tired? PODCI Pediatric Parent-Reported Version - Feel Sick and Tired PODCI1-Free From Pain as Adult Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To be free from pain or disability as an adult. PODCI Pediatric Parent-Reported Version - Free From Pain as Adult PODCI1-Friends Limited by: Fear Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Fear the other kids won't like him/her? PODCI Pediatric Parent-Reported Version - Friends Limited by: Fear PODCI1-Friends Limited by: Health Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: General health? PODCI Pediatric Parent-Reported Version - Friends Limited by: Health PODCI1-Friends Limited by: Instructions Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Doctor or parent instructions? PODCI Pediatric Parent-Reported Version - Friends Limited by: Instructions PODCI1-Friends Limited by: Not Around Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Friends not around? PODCI Pediatric Parent-Reported Version - Friends Limited by: Not Around PODCI1-Friends Limited by: Pain Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Pain? PODCI Pediatric Parent-Reported Version - Friends Limited by: Pain PODCI1-Full of Pep and Energy Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how much of the time: Were your child full of pep and energy? PODCI Pediatric Parent-Reported Version - Full of Pep and Energy PODCI1-Games Limited by: Dislike Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Dislike of pickup games or sports? PODCI Pediatric Parent-Reported Version - Games Limited by: Dislike PODCI1-Games Limited by: Fear Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Fear the other kids won't like him/her? PODCI Pediatric Parent-Reported Version - Games Limited by: Fear PODCI1-Games Limited by: Health Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: General health? PODCI Pediatric Parent-Reported Version - Games Limited by: Health PODCI1-Games Limited by: Instructions Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Doctor or parent instructions? PODCI Pediatric Parent-Reported Version - Games Limited by: Instructions PODCI1-Games Limited by: Pain Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Pain? PODCI Pediatric Parent-Reported Version - Games Limited by: Pain PODCI1-Games Limited by: Season Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Activity not in season? PODCI Pediatric Parent-Reported Version - Games Limited by: Season PODCI1-Games Limited by: Too Young Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Too young? PODCI Pediatric Parent-Reported Version - Games Limited by: Too Young PODCI1-Get In and Out of Bed Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Get in and out of bed? PODCI Pediatric Parent-Reported Version - Get In and Out of Bed PODCI1-Get On and Off a Bus Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Get on and off a bus? PODCI Pediatric Parent-Reported Version - Get On and Off a Bus PODCI1-Get On and Off a Toilet or Chair Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Get on and off a toilet or chair? PODCI Pediatric Parent-Reported Version - Get On and Off a Toilet or Chair PODCI1-Get Together With Friends Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - How often in the last week did your child get together and do things with friends? PODCI Pediatric Parent-Reported Version - Get Together With Friends PODCI1-Global Functioning Scale Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Global functioning scale. PODCI Pediatric Parent-Reported Version - Global Functioning Scale PODCI1-Gym Limited by: Dislike Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Dislike of gym/recess? PODCI Pediatric Parent-Reported Version - Gym Limited by: Dislike PODCI1-Gym Limited by: Fear Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Fear the other kids won't like him/her? PODCI Pediatric Parent-Reported Version - Gym Limited by: Fear PODCI1-Gym Limited by: Health Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: General health? PODCI Pediatric Parent-Reported Version - Gym Limited by: Health PODCI1-Gym Limited by: Instructions Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Doctor or parent instructions? PODCI Pediatric Parent-Reported Version - Gym Limited by: Instructions PODCI1-Gym Limited by: Not Attend School Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Does not attend school? PODCI Pediatric Parent-Reported Version - Gym Limited by: Not Attend School PODCI1-Gym Limited by: Not in Session Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: School not in session? PODCI Pediatric Parent-Reported Version - Gym Limited by: Not in Session PODCI1-Gym Limited by: Pain Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Pain? PODCI Pediatric Parent-Reported Version - Gym Limited by: Pain PODCI1-Happiness Scale Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Happiness core scale. PODCI Pediatric Parent-Reported Version - Happiness Scale PODCI1-Have Pain Relief Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To have pain relief. PODCI Pediatric Parent-Reported Version - Have Pain Relief PODCI1-His/Her Body Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how happy has your child been with: His/her body? PODCI Pediatric Parent-Reported Version - His or Her Body PODCI1-His/Her Health in General Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how happy has your child been with: His/her health in general? PODCI Pediatric Parent-Reported Version - His or Her Health in General PODCI1-How He/She Looks Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how happy has your child been with: How he/she looks? PODCI Pediatric Parent-Reported Version - How He or She Looks PODCI1-Lift Heavy Books Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Lift heavy books? PODCI Pediatric Parent-Reported Version - Lift Heavy Books PODCI1-Look Better Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To look better. PODCI Pediatric Parent-Reported Version - Look Better PODCI1-Miss School Because of Health Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - On average, over the last 12 months, how often did your child miss school (preschool, day care, camp, etc.) because of his/her health? PODCI Pediatric Parent-Reported Version - Miss School Because of Health PODCI1-Need Help Sitting and Standing Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - How often does your child need help from another person for sitting and standing? PODCI Pediatric Parent-Reported Version - Need Help Sitting and Standing PODCI1-Need Help Walking and Climbing Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - How often does your child need help from another person for walking and climbing? PODCI Pediatric Parent-Reported Version - Need Help Walking and Climbing PODCI1-Open a Jar Been Opened Before Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Open a jar that has been opened before? PODCI Pediatric Parent-Reported Version - Open a Jar Been Opened Before PODCI1-Outdoor Limited by: Dislike Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Dislike of recreational outdoor activities? PODCI Pediatric Parent-Reported Version - Outdoor Limited by: Dislike PODCI1-Outdoor Limited by: Fear Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Fear the other kids won't like him/her? PODCI Pediatric Parent-Reported Version - Outdoor Limited by: Fear PODCI1-Outdoor Limited by: Health Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: General health? PODCI Pediatric Parent-Reported Version - Outdoor Limited by: Health PODCI1-Outdoor Limited by: Instructions Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Doctor or parent instructions? PODCI Pediatric Parent-Reported Version - Outdoor Limited by: Instructions PODCI1-Outdoor Limited by: Pain Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Pain? PODCI Pediatric Parent-Reported Version - Outdoor Limited by: Pain PODCI1-Outdoor Limited by: Season Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Activity not in season? PODCI Pediatric Parent-Reported Version - Outdoor Limited by: Season PODCI1-Outdoor Limited by: Too Young Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Too young? PODCI Pediatric Parent-Reported Version - Outdoor Limited by: Too Young PODCI1-Pain During the Last Week Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - How much pain has your child had during the last week? PODCI Pediatric Parent-Reported Version - Pain During the Last Week PODCI1-Pain Interfere With Activities Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how much did pain interfere with your child's normal activities (including at home, outside of the home, and at school)? PODCI Pediatric Parent-Reported Version - Pain Interfere With Activities PODCI1-Pain/Comfort Scale Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Pain/comfort core scale. PODCI Pediatric Parent-Reported Version - Pain or Comfort Scale PODCI1-Pain/Discom Inter With Activities Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how much of the time: Did pain or discomfort interfere with your child's activities? PODCI Pediatric Parent-Reported Version - Pain or Discomfort Interfere With Activities PODCI1-Participate in Competitive Sports Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Can your child participate in competitive level sports with other children the same age (For example: hockey, basketball, soccer, football, baseball, swimming, running [track or cross country], gymnastics, or dance)? PODCI Pediatric Parent-Reported Version - Participate in Competitive Sports PODCI1-Participate in Gym/Recess Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - How often in the last week did your child participate in gym/recess? PODCI Pediatric Parent-Reported Version - Participate in Gym or Recess PODCI1-Participate in Outdoor Activities Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Can your child participate in recreational outdoor activities with other children the same age (For example: bicycling, tricycling, skating, hiking, jogging)? PODCI Pediatric Parent-Reported Version - Participate in Outdoor Activities PODCI1-Participate in Pickup Games Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Can your child participate in pickup games or sports with other children the same age (For example: tag, dodge ball, basketball, soccer, catch, jump rope, touch football, hop scotch)? PODCI Pediatric Parent-Reported Version - Participate in Pickup Games PODCI1-Pour a Half Gallon of Milk Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Pour a half gallon of milk? PODCI Pediatric Parent-Reported Version - Pour a Half Gallon of Milk PODCI1-Put on His/Her Coat Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Put on his/her coat? PODCI Pediatric Parent-Reported Version - Put on His or Her Coat PODCI1-Run Short Distances Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Run short distances? PODCI Pediatric Parent-Reported Version - Run Short Distances PODCI1-Sit in Chair Without Holding On Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Sit in a regular chair without holding on? PODCI Pediatric Parent-Reported Version - Sit in Chair Without Holding On PODCI1-Sleep More Comfortably Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To sleep more comfortably. PODCI Pediatric Parent-Reported Version - Sleep More Comfortably PODCI1-Spend Rest of Life With Condition Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If your child had to spend the rest of his/her life with his/her bone and muscle condition as it is right now, how would you feel about it? PODCI Pediatric Parent-Reported Version - Spend Rest of Life With Condition PODCI1-Sports/Phys Function Scale Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Sports and physical functioning core scale. PODCI Pediatric Parent-Reported Version - Sports and Physical Function Scale PODCI1-Stand Washing Hands at a Sink Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Stand while washing his/her hands and face at a sink? PODCI Pediatric Parent-Reported Version - Stand Washing Hands at a Sink PODCI1-Transfer/Basic Mobility Scale Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Transfer and basic mobility core scale. PODCI Pediatric Parent-Reported Version - Transfer and Basic Mobility Scale PODCI1-Turn Door Knobs Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Turn door knobs? PODCI Pediatric Parent-Reported Version - Turn Door Knobs PODCI1-Up Extremity/Phys Function Scale Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Upper extremity and physical function core scale. PODCI Pediatric Parent-Reported Version - Upper Extremity and Physical Function Scale PODCI1-Use a Fork and Spoon Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Use a fork and spoon? PODCI Pediatric Parent-Reported Version - Use a Fork and Spoon PODCI1-Use Assistive Devices for Sitting Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - How often does your child use assistive devices (such as braces, crutches, or wheelchair) for sitting and standing? PODCI Pediatric Parent-Reported Version - Use Assistive Devices for Sitting PODCI1-Use Assistive Devices for Walking Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - How often does your child use assistive devices (such as braces, crutches, or wheelchair) for walking and climbing? PODCI Pediatric Parent-Reported Version - Use Assistive Devices for Walking PODCI1-Walk More Than a Mile Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Walk more than a mile? PODCI Pediatric Parent-Reported Version - Walk More Than a Mile PODCI1-Walk One Block Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Walk one block? PODCI Pediatric Parent-Reported Version - Walk One Block PODCI1-Walk Three Blocks Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Walk three blocks? PODCI Pediatric Parent-Reported Version - Walk Three Blocks PODCI1-What Clothes/Shoes He/She Wear Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how happy has your child been with: What clothes or shoes he/she can wear? PODCI Pediatric Parent-Reported Version - What Clothes or Shoes He or She Wear PODCI1-Write With a Pencil Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Write with a pencil? PODCI Pediatric Parent-Reported Version - Write With a Pencil PODCI1TN Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported Version Questionnaire Test Name CDISC Questionnaire PODCI Pediatric Parent-Reported Version Test Name Terminology Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report test code. PQL15-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to breathe. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard to Breathe PQL15-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sick easily. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Get Sick Easily PQL15-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sores and/or rashes. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Get Sores and/or Rashes PQL15-Legs Hurt Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's legs hurt. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Legs Hurt PQL15-Feel Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child feels tired. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Feel Tired PQL15-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's back feels stiff. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Back Feels Stiff PQL15-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child wakes up tired. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Wake Up Tired PQL15-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's hands are weak. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hands Are Weak PQL15-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use the bathroom. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard to Use Bathroom PQL15-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard to Gain or Lose Weight PQL15-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use his or her hands. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard to Use Hands PQL15-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to swallow food. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard to Swallow Food PQL15-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Long Time to Bathe or Shower PQL15-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets hurt accidentally. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Get Hurt Accidentally PQL15-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child takes a long time to eat. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Take Long Time to Eat PQL15-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard to Turn During Night PQL15-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard to Go Places With Equipment PQL15-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard Tell Doctors and Nurses How Feel PQL15-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard Ask Doctors and Nurses Questions PQL15-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard Explain Illness to People PQL15-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard for Family to Plan Activities PQL15-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to get enough rest. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard for Family to Rest PQL15-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: I think money is a problem in our family. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Money Problem in Our Family PQL15-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: I think our family has a lot of problems. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Family Has Lot of Problems PQL15-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child does not have the equipment he or she needs. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Do Not Have Equipment Need PQL15TC Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report Questionnaire Test Code CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child Test Code Terminology Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report test name. PQL15-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's back feels stiff. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Back Feels Stiff PQL15-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child does not have the equipment he or she needs. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Do Not Have Equipment Need PQL15-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: I think our family has a lot of problems. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Family Has Lot of Problems PQL15-Feel Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child feels tired. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Feel Tired PQL15-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets hurt accidentally. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Get Hurt Accidentally PQL15-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sick easily. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Get Sick Easily PQL15-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sores and/or rashes. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Get Sores and/or Rashes PQL15-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's hands are weak. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hands Are Weak PQL15-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard Ask Doctors and Nurses Questions PQL15-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard Explain Illness to People PQL15-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard for Family to Plan Activities PQL15-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to get enough rest. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard for Family to Rest PQL15-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard Tell Doctors and Nurses How Feel PQL15-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to breathe. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard to Breathe PQL15-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard to Gain or Lose Weight PQL15-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard to Go Places With Equipment PQL15-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to swallow food. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard to Swallow Food PQL15-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard to Turn During Night PQL15-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use the bathroom. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard to Use Bathroom PQL15-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use his or her hands. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard to Use Hands PQL15-Legs Hurt Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's legs hurt. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Legs Hurt PQL15-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Long Time to Bathe or Shower PQL15-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: I think money is a problem in our family. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Money Problem in Our Family PQL15-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child takes a long time to eat. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Take Long Time to Eat PQL15-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child wakes up tired. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Wake Up Tired PQL15TN Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report Questionnaire Test Name CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child Test Name Terminology Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child test code. PQL14-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard to breathe. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard to Breathe PQL14-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I get sick easily. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Get Sick Easily PQL14-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I get sores and/or rashes. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Get Sores and/or Rashes PQL14-Legs Hurt Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: My legs hurt. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Legs Hurt PQL14-Feel Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I feel tired. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Feel Tired PQL14-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: My back feels stiff. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Back Feels Stiff PQL14-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I wake up tired. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Wake Up Tired PQL14-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: My hands are weak. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hands Are Weak PQL14-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard to use the bathroom. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard to Use Bathroom PQL14-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard to gain or lose weight when I want to. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard to Gain or Lose Weight PQL14-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard to use my hands. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard to Use Hands PQL14-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard to swallow food. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard to Swallow Food PQL14-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It takes me a long time to bathe or shower. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Long Time to Bathe or Shower PQL14-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I get hurt accidentally. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Get Hurt Accidentally PQL14-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I take a long time to eat. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Take Long Time to Eat PQL14-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard to turn myself during the night. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard to Turn During Night PQL14-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard for me to go places with my equipment. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard to Go Places With Equipment PQL14-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard for me to tell the doctors and nurses how I feel. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard Tell Doctors and Nurses How Feel PQL14-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard for me to ask the doctors and nurses questions. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard Ask Doctors and Nurses Questions PQL14-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard for me to explain my illness to other people. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard Explain Illness to People PQL14-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard for my family to plan activities like vacations. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard for Family to Plan Activities PQL14-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard for my family to get enough rest. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard for Family to Rest PQL14-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I think money is a problem in our family. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Money Problem in Our Family PQL14-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I think my family has a lot of problems. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Family Has Lot of Problems PQL14-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I do not have the equipment I need. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Do Not Have Equipment Need PQL14TC Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Questionnaire Test Code CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Child Report Test Code Terminology Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child test name. PQL14-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: My back feels stiff. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Back Feels Stiff PQL14-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I do not have the equipment I need. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Do Not Have Equipment Need PQL14-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I think my family has a lot of problems. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Family Has Lot of Problems PQL14-Feel Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I feel tired. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Feel Tired PQL14-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I get hurt accidentally. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Get Hurt Accidentally PQL14-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I get sick easily. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Get Sick Easily PQL14-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I get sores and/or rashes. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Get Sores and/or Rashes PQL14-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: My hands are weak. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hands Are Weak PQL14-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard for me to ask the doctors and nurses questions. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard Ask Doctors and Nurses Questions PQL14-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard for me to explain my illness to other people. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard Explain Illness to People PQL14-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard for my family to plan activities like vacations. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard for Family to Plan Activities PQL14-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard for my family to get enough rest. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard for Family to Rest PQL14-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard for me to tell the doctors and nurses how I feel. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard Tell Doctors and Nurses How Feel PQL14-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard to breathe. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard to Breathe PQL14-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard to gain or lose weight when I want to. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard to Gain or Lose Weight PQL14-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard for me to go places with my equipment. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard to Go Places With Equipment PQL14-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard to swallow food. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard to Swallow Food PQL14-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard to turn myself during the night. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard to Turn During Night PQL14-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard to use the bathroom. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard to Use Bathroom PQL14-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard to use my hands. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard to Use Hands PQL14-Legs Hurt Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: My legs hurt. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Legs Hurt PQL14-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It takes me a long time to bathe or shower. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Long Time to Bathe or Shower PQL14-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I think money is a problem in our family. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Money Problem in Our Family PQL14-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I take a long time to eat. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Take Long Time to Eat PQL14-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I wake up tired. PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Wake Up Tired PQL14TN Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Questionnaire Test Name CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Child Report Test Name Terminology Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report test code. PQL13-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to breathe. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard to Breathe PQL13-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child gets sick easily. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Get Sick Easily PQL13-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child gets sores and/or rashes. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Get Sores and/or Rashes PQL13-Legs Hurt Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child's legs hurt. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Legs Hurt PQL13-Feel Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child feels tired. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Feel Tired PQL13-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child's back feels stiff. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Back Feels Stiff PQL13-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child wakes up tired. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Wake Up Tired PQL13-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child's hands are weak. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hands Are Weak PQL13-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to use the bathroom. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard to Use Bathroom PQL13-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to gain or lose weight when he or she wants to. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard to Gain or Lose Weight PQL13-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to use his or her hands. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard to Use Hands PQL13-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to swallow food. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard to Swallow Food PQL13-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It takes my child a long time to bathe or shower. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Long Time to Bathe or Shower PQL13-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child gets hurt accidentally. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Get Hurt Accidentally PQL13-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child takes a long time to eat. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Take Long Time to Eat PQL13-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to turn him or herself during the night. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard to Turn During Night PQL13-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to go places with his or her equipment. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard to Go Places With Equipment PQL13-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to tell the doctors and nurses how he or she feels. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard Tell Doctors and Nurses How Feel PQL13-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to ask the doctors and nurses questions. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard Ask Doctors and Nurses Questions PQL13-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to explain his or her illness to other people. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard Explain Illness to People PQL13-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for our family to plan activities like vacations. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard for Family to Plan Activities PQL13-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for our family to get enough rest. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard for Family to Rest PQL13-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: I think money is a problem in our family. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Money Problem in Our Family PQL13-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: I think our family has a lot of problems. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Family Has Lot of Problems PQL13-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child does not have the equipment he or she needs. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Do Not Have Equipment Need PQL13TC Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report Questionnaire Test Code CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen Test Code Terminology Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report test name. PQL13-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child's back feels stiff. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Back Feels Stiff PQL13-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child does not have the equipment he or she needs. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Do Not Have Equipment Need PQL13-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: I think our family has a lot of problems. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Family Has Lot of Problems PQL13-Feel Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child feels tired. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Feel Tired PQL13-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child gets hurt accidentally. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Get Hurt Accidentally PQL13-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child gets sick easily. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Get Sick Easily PQL13-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child gets sores and/or rashes. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Get Sores and/or Rashes PQL13-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child's hands are weak. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hands Are Weak PQL13-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to ask the doctors and nurses questions. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard Ask Doctors and Nurses Questions PQL13-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to explain his or her illness to other people. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard Explain Illness to People PQL13-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for our family to plan activities like vacations. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard for Family to Plan Activities PQL13-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for our family to get enough rest. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard for Family to Rest PQL13-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to tell the doctors and nurses how he or she feels. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard Tell Doctors and Nurses How Feel PQL13-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to breathe. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard to Breathe PQL13-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to gain or lose weight when he or she wants to. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard to Gain or Lose Weight PQL13-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to go places with his or her equipment. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard to Go Places With Equipment PQL13-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to swallow food. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard to Swallow Food PQL13-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to turn him or herself during the night. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard to Turn During Night PQL13-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to use the bathroom. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard to Use Bathroom PQL13-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to use his or her hands. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard to Use Hands PQL13-Legs Hurt Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child's legs hurt. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Legs Hurt PQL13-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It takes my child a long time to bathe or shower. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Long Time to Bathe or Shower PQL13-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: I think money is a problem in our family. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Money Problem in Our Family PQL13-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child takes a long time to eat. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Take Long Time to Eat PQL13-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child wakes up tired. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Wake Up Tired PQL13TN Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report Questionnaire Test Name CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen Test Name Terminology Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen test code. PQL12-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard to breathe. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard to Breathe PQL12-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I get sick easily. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Get Sick Easily PQL12-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I get sores and/or rashes. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Get Sores and/or Rashes PQL12-Legs Hurt Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: My legs hurt. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Legs Hurt PQL12-Feel Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I feel tired. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Feel Tired PQL12-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: My back feels stiff. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Back Feels Stiff PQL12-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I wake up tired. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Wake Up Tired PQL12-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: My hands are weak. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hands Are Weak PQL12-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard to use the bathroom. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard to Use Bathroom PQL12-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard to gain or lose weight when I want to. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard to Gain or Lose Weight PQL12-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard to use my hands. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard to Use Hands PQL12-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard to swallow food. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard to Swallow Food PQL12-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It takes me a long time to bathe or shower. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Long Time to Bathe or Shower PQL12-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I get hurt accidentally. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Get Hurt Accidentally PQL12-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I take a long time to eat. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Take Long Time to Eat PQL12-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard to turn myself during the night. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard to Turn During Night PQL12-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard for me to go places with my equipment. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard to Go Places With Equipment PQL12-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard for me to tell the doctors and nurses how I feel. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard Tell Doctors and Nurses How Feel PQL12-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard for me to ask the doctors and nurses questions. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard Ask Doctors and Nurses Questions PQL12-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard for me to explain my illness to other people. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard Explain Illness to People PQL12-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard for my family to plan activities like vacations. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard for Family to Plan Activities PQL12-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard for my family to get enough rest. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard for Family to Rest PQL12-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I think money is a problem in our family. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Money Problem in Our Family PQL12-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I think my family has a lot of problems. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Family Has Lot of Problems PQL12-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I do not have the equipment I need. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Do Not Have Equipment Need PQL12TC Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Questionnaire Test Code CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Teen Report Test Code Terminology Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen test name. PQL12-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: My back feels stiff. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Back Feels Stiff PQL12-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I do not have the equipment I need. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Do Not Have Equipment Need PQL12-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I think my family has a lot of problems. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Family Has Lot of Problems PQL12-Feel Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I feel tired. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Feel Tired PQL12-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I get hurt accidentally. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Get Hurt Accidentally PQL12-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I get sick easily. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Get Sick Easily PQL12-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I get sores and/or rashes. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Get Sores and/or Rashes PQL12-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: My hands are weak. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hands Are Weak PQL12-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard for me to ask the doctors and nurses questions. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard Ask Doctors and Nurses Questions PQL12-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard for me to explain my illness to other people. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard Explain Illness to People PQL12-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard for my family to plan activities like vacations. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard for Family to Plan Activities PQL12-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard for my family to get enough rest. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard for Family to Rest PQL12-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard for me to tell the doctors and nurses how I feel. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard Tell Doctors and Nurses How Feel PQL12-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard to breathe. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard to Breathe PQL12-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard to gain or lose weight when I want to. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard to Gain or Lose Weight PQL12-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard for me to go places with my equipment. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard to Go Places With Equipment PQL12-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard to swallow food. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard to Swallow Food PQL12-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard to turn myself during the night. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard to Turn During Night PQL12-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard to use the bathroom. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard to Use Bathroom PQL12-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard to use my hands. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard to Use Hands PQL12-Legs Hurt Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: My legs hurt. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Legs Hurt PQL12-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It takes me a long time to bathe or shower. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Long Time to Bathe or Shower PQL12-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I think money is a problem in our family. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Money Problem in Our Family PQL12-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I take a long time to eat. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Take Long Time to Eat PQL12-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I wake up tired. PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Wake Up Tired PQL12TN Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Questionnaire Test Name CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Teen Report Test Name Terminology Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report test code. PQL18-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to breathe. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard to Breathe PQL18-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sick easily. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Get Sick Easily PQL18-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sores and/or rashes. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Get Sores and/or Rashes PQL18-Legs Hurt Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's legs hurt. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Legs Hurt PQL18-Feel Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child feels tired. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Feel Tired PQL18-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's back feels stiff. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Back Feels Stiff PQL18-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child wakes up tired. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Wake Up Tired PQL18-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's hands are weak. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hands Are Weak PQL18-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use the bathroom. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard to Use Bathroom PQL18-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard to Gain or Lose Weight PQL18-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use his or her hands. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard to Use Hands PQL18-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to swallow food. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard to Swallow Food PQL18-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Long Time to Bathe or Shower PQL18-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets hurt accidentally. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Get Hurt Accidentally PQL18-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child takes a long time to eat. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Take Long Time to Eat PQL18-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard to Turn During Night PQL18-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard to Go Places With Equipment PQL18-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard Tell Doctors and Nurses How Feel PQL18-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard Ask Doctors and Nurses Questions PQL18-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard Explain Illness to People PQL18-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard for Family to Plan Activities PQL18-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to get enough rest. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard for Family to Rest PQL18-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: I think money is a problem in our family. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Money Problem in Our Family PQL18-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: I think our family has a lot of problems. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Family Has Lot of Problems PQL18-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child does not have the equipment he or she needs. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Do Not Have Equipment Need PQL18TC Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report Questionnaire Test Code CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler Test Code Terminology Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report test name. PQL18-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's back feels stiff. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Back Feels Stiff PQL18-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child does not have the equipment he or she needs. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Do Not Have Equipment Need PQL18-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: I think our family has a lot of problems. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Family Has Lot of Problems PQL18-Feel Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child feels tired. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Feel Tired PQL18-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets hurt accidentally. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Get Hurt Accidentally PQL18-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sick easily. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Get Sick Easily PQL18-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sores and/or rashes. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Get Sores and/or Rashes PQL18-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's hands are weak. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hands Are Weak PQL18-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard Ask Doctors and Nurses Questions PQL18-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard Explain Illness to People PQL18-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard for Family to Plan Activities PQL18-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to get enough rest. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard for Family to Rest PQL18-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard Tell Doctors and Nurses How Feel PQL18-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to breathe. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard to Breathe PQL18-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard to Gain or Lose Weight PQL18-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard to Go Places With Equipment PQL18-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to swallow food. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard to Swallow Food PQL18-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard to Turn During Night PQL18-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use the bathroom. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard to Use Bathroom PQL18-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use his or her hands. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard to Use Hands PQL18-Legs Hurt Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's legs hurt. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Legs Hurt PQL18-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Long Time to Bathe or Shower PQL18-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: I think money is a problem in our family. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Money Problem in Our Family PQL18-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child takes a long time to eat. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Take Long Time to Eat PQL18-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child wakes up tired. PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Wake Up Tired PQL18TN Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report Questionnaire Test Name CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler Test Name Terminology Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report test code. PQL11-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to breathe. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard to Breathe PQL11-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sick easily. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Get Sick Easily PQL11-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sores and/or rashes. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Get Sores and/or Rashes PQL11-Legs Hurt Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's legs hurt. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Legs Hurt PQL11-Feel Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child feels tired. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Feel Tired PQL11-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's back feels stiff. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Back Feels Stiff PQL11-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child wakes up tired. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Wake Up Tired PQL11-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's hands are weak. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hands Are Weak PQL11-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use the bathroom. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard to Use Bathroom PQL11-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard to Gain or Lose Weight PQL11-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use his or her hands. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard to Use Hands PQL11-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to swallow food. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard to Swallow Food PQL11-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Long Time to Bathe or Shower PQL11-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets hurt accidentally. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Get Hurt Accidentally PQL11-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child takes a long time to eat. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Take Long Time to Eat PQL11-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard to Turn During Night PQL11-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard to Go Places With Equipment PQL11-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard Tell Doctors and Nurses How Feel PQL11-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard Ask Doctors and Nurses Questions PQL11-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard Explain Illness to People PQL11-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard for Family to Plan Activities PQL11-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to get enough rest. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard for Family to Rest PQL11-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: I think money is a problem in our family. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Money Problem in Our Family PQL11-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: I think our family has a lot of problems. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Family Has Lot of Problems PQL11-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child does not have the equipment he or she needs. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Do Not Have Equipment Need PQL11TC Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report Questionnaire Test Code CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults Test Code Terminology Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report test name. PQL11-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's back feels stiff. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Back Feels Stiff PQL11-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child does not have the equipment he or she needs. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Do Not Have Equipment Need PQL11-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: I think our family has a lot of problems. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Family Has Lot of Problems PQL11-Feel Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child feels tired. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Feel Tired PQL11-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets hurt accidentally. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Get Hurt Accidentally PQL11-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sick easily. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Get Sick Easily PQL11-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sores and/or rashes. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Get Sores and/or Rashes PQL11-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's hands are weak. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hands Are Weak PQL11-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard Ask Doctors and Nurses Questions PQL11-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard Explain Illness to People PQL11-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard for Family to Plan Activities PQL11-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to get enough rest. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard for Family to Rest PQL11-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard Tell Doctors and Nurses How Feel PQL11-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to breathe. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard to Breathe PQL11-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard to Gain or Lose Weight PQL11-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard to Go Places With Equipment PQL11-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to swallow food. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard to Swallow Food PQL11-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard to Turn During Night PQL11-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use the bathroom. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard to Use Bathroom PQL11-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use his or her hands. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard to Use Hands PQL11-Legs Hurt Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's legs hurt. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Legs Hurt PQL11-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Long Time to Bathe or Shower PQL11-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: I think money is a problem in our family. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Money Problem in Our Family PQL11-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child takes a long time to eat. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Take Long Time to Eat PQL11-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child wakes up tired. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Wake Up Tired PQL11TN Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report Questionnaire Test Name CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults Test Name Terminology Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult test code. PQL10-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard to breathe. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard to Breathe PQL10-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I get sick easily. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Get Sick Easily PQL10-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I get sores and/or rashes. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Get Sores and/or Rashes PQL10-Legs Hurt Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: My legs hurt. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Legs Hurt PQL10-Feel Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I feel tired. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Feel Tired PQL10-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: My back feels stiff. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Back Feels Stiff PQL10-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I wake up tired. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Wake Up Tired PQL10-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: My hands are weak. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hands Are Weak PQL10-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard to use the bathroom. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard to Use Bathroom PQL10-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard to gain or lose weight when I want to. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard to Gain or Lose Weight PQL10-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard to use my hands. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard to Use Hands PQL10-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard to swallow food. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard to Swallow Food PQL10-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It takes me a long time to bathe or shower. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Long Time to Bathe or Shower PQL10-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I get hurt accidentally. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Get Hurt Accidentally PQL10-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I take a long time to eat. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Take Long Time to Eat PQL10-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard to turn myself during the night. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard to Turn During Night PQL10-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard for me to go places with my equipment. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard to Go Places With Equipment PQL10-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard for me to tell the doctors and nurses how I feel. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard Tell Doctors and Nurses How Feel PQL10-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard for me to ask the doctors and nurses questions. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard Ask Doctors and Nurses Questions PQL10-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard for me to explain my illness to other people. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard Explain Illness to People PQL10-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard for my family to plan activities like vacations. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard for Family to Plan Activities PQL10-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard for my family to get enough rest. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard for Family to Rest PQL10-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I think money is a problem in our family. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Money Problem in Our Family PQL10-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I think my family has a lot of problems. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Family Has Lot of Problems PQL10-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I do not have the equipment I need. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Do Not Have Equipment Need PQL10TC Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Questionnaire Test Code CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report Test Code Terminology Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult test name. PQL10-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: My back feels stiff. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Back Feels Stiff PQL10-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I do not have the equipment I need. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Do Not Have Equipment Need PQL10-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I think my family has a lot of problems. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Family Has Lot of Problems PQL10-Feel Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I feel tired. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Feel Tired PQL10-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I get hurt accidentally. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Get Hurt Accidentally PQL10-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I get sick easily. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Get Sick Easily PQL10-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I get sores and/or rashes. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Get Sores and/or Rashes PQL10-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: My hands are weak. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hands Are Weak PQL10-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard for me to ask the doctors and nurses questions. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard Ask Doctors and Nurses Questions PQL10-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard for me to explain my illness to other people. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard Explain Illness to People PQL10-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard for my family to plan activities like vacations. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard for Family to Plan Activities PQL10-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard for my family to get enough rest. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard for Family to Rest PQL10-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard for me to tell the doctors and nurses how I feel. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard Tell Doctors and Nurses How Feel PQL10-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard to breathe. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard to Breathe PQL10-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard to gain or lose weight when I want to. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard to Gain or Lose Weight PQL10-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard for me to go places with my equipment. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard to Go Places With Equipment PQL10-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard to swallow food. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard to Swallow Food PQL10-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard to turn myself during the night. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard to Turn During Night PQL10-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard to use the bathroom. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard to Use Bathroom PQL10-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard to use my hands. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard to Use Hands PQL10-Legs Hurt Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: My legs hurt. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Legs Hurt PQL10-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It takes me a long time to bathe or shower. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Long Time to Bathe or Shower PQL10-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I think money is a problem in our family. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Money Problem in Our Family PQL10-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I take a long time to eat. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Take Long Time to Eat PQL10-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I wake up tired. PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Wake Up Tired PQL10TN Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Questionnaire Test Name CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report Test Name Terminology Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report test code. PQL17-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to breathe. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard to Breathe PQL17-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sick easily. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Get Sick Easily PQL17-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sores and/or rashes. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Get Sores and/or Rashes PQL17-Legs Hurt Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's legs hurt. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Legs Hurt PQL17-Feel Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child feels tired. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Feel Tired PQL17-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's back feels stiff. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Back Feels Stiff PQL17-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child wakes up tired. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Wake Up Tired PQL17-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's hands are weak. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hands Are Weak PQL17-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use the bathroom. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard to Use Bathroom PQL17-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard to Gain or Lose Weight PQL17-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use his or her hands. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard to Use Hands PQL17-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to swallow food. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard to Swallow Food PQL17-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Long Time to Bathe or Shower PQL17-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets hurt accidentally. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Get Hurt Accidentally PQL17-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child takes a long time to eat. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Take Long Time to Eat PQL17-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard to Turn During Night PQL17-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard to Go Places With Equipment PQL17-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard Tell Doctors and Nurses How Feel PQL17-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard Ask Doctors and Nurses Questions PQL17-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard Explain Illness to People PQL17-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard for Family to Plan Activities PQL17-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to get enough rest. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard for Family to Rest PQL17-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: I think money is a problem in our family. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Money Problem in Our Family PQL17-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: I think our family has a lot of problems. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Family Has Lot of Problems PQL17-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child does not have the equipment he or she needs. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Do Not Have Equipment Need PQL17TC Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report Questionnaire Test Code CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child Test Code Terminology Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report test name. PQL17-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's back feels stiff. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Back Feels Stiff PQL17-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child does not have the equipment he or she needs. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Do Not Have Equipment Need PQL17-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: I think our family has a lot of problems. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Family Has Lot of Problems PQL17-Feel Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child feels tired. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Feel Tired PQL17-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets hurt accidentally. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Get Hurt Accidentally PQL17-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sick easily. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Get Sick Easily PQL17-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sores and/or rashes. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Get Sores and/or Rashes PQL17-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's hands are weak. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hands Are Weak PQL17-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard Ask Doctors and Nurses Questions PQL17-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard Explain Illness to People PQL17-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard for Family to Plan Activities PQL17-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to get enough rest. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard for Family to Rest PQL17-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard Tell Doctors and Nurses How Feel PQL17-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to breathe. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard to Breathe PQL17-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard to Gain or Lose Weight PQL17-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard to Go Places With Equipment PQL17-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to swallow food. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard to Swallow Food PQL17-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard to Turn During Night PQL17-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use the bathroom. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard to Use Bathroom PQL17-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use his or her hands. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard to Use Hands PQL17-Legs Hurt Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's legs hurt. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Legs Hurt PQL17-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Long Time to Bathe or Shower PQL17-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: I think money is a problem in our family. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Money Problem in Our Family PQL17-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child takes a long time to eat. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Take Long Time to Eat PQL17-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child wakes up tired. PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Wake Up Tired PQL17TN Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report Questionnaire Test Name CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child Test Name Terminology Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child test code. PQL16-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to breathe. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hard to Breathe PQL16-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: I get sick easily. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Get Sick Easily PQL16-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: I get sores and/or rashes. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Get Sores and/or Rashes PQL16-Legs Hurt Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: My legs hurt. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Legs Hurt PQL16-Feel Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: I feel tired. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Feel Tired PQL16-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: My back feels stiff. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Back Feels Stiff PQL16-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: I wake up tired. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Wake Up Tired PQL16-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: My hands are weak. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hands Are Weak PQL16-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to use the bathroom. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hard to Use Bathroom PQL16-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to gain or lose weight when I want to. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hard to Gain or Lose Weight PQL16-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to use my hands. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hard to Use Hands PQL16-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to swallow food. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hard to Swallow Food PQL16-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It takes me a long time to bathe or shower. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Long Time to Bathe or Shower PQL16-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: I get hurt accidentally. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Get Hurt Accidentally PQL16-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: I take a long time to eat. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Take Long Time to Eat PQL16-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to turn myself during the night. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hard to Turn During Night PQL16-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard for me to go places with my equipment. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hard to Go Places With Equipment PQL16TC Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Questionnaire Test Code CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report Test Code Terminology Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child test name. PQL16-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: My back feels stiff. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Back Feels Stiff PQL16-Feel Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: I feel tired. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Feel Tired PQL16-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: I get hurt accidentally. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Get Hurt Accidentally PQL16-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: I get sick easily. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Get Sick Easily PQL16-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: I get sores and/or rashes. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Get Sores and/or Rashes PQL16-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: My hands are weak. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hands Are Weak PQL16-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to breathe. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hard to Breathe PQL16-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to gain or lose weight when I want to. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hard to Gain or Lose Weight PQL16-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard for me to go places with my equipment. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hard to Go Places With Equipment PQL16-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to swallow food. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hard to Swallow Food PQL16-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to turn myself during the night. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hard to Turn During Night PQL16-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to use the bathroom. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hard to Use Bathroom PQL16-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to use my hands. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hard to Use Hands PQL16-Legs Hurt Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: My legs hurt. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Legs Hurt PQL16-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It takes me a long time to bathe or shower. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Long Time to Bathe or Shower PQL16-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: I take a long time to eat. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Take Long Time to Eat PQL16-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: I wake up tired. PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Wake Up Tired PQL16TN Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Questionnaire Test Name CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report Test Name Terminology Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report test code. PQL06-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to breathe. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard to Breathe PQL06-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sick easily. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Get Sick Easily PQL06-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sores and/or rashes. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Get Sores and/or Rashes PQL06-Legs Hurt Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child's legs hurt. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Legs Hurt PQL06-Feel Tired Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child feels tired. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Feel Tired PQL06-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child's back feels stiff. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Back Feels Stiff PQL06-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child wakes up tired. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Wake Up Tired PQL06-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child's hands are weak. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hands Are Weak PQL06-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use the bathroom. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard to Use Bathroom PQL06-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard to Gain or Lose Weight PQL06-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use his or her hands. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard to Use Hands PQL06-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to swallow food. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard to Swallow Food PQL06-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Long Time to Bathe or Shower PQL06-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child gets hurt accidentally. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Get Hurt Accidentally PQL06-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child takes a long time to eat. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Take Long Time to Eat PQL06-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard to Turn During Night PQL06-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard to Go Places With Equipment PQL06-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard Tell Doctors and Nurses How Feel PQL06-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard Ask Doctors and Nurses Questions PQL06-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard Explain Illness to People PQL06-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard for Family to Plan Activities PQL06-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to get enough rest. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard for Family to Rest PQL06-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: I think money is a problem in our family. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Money Problem in Our Family PQL06-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: I think our family has a lot of problems. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Family Has Lot of Problems PQL06-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child does not have the equipment he or she needs. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Do Not Have Equipment Need PQL06TC Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report Questionnaire Test Code CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Parent Report for Child Test Code Terminology Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report test name. PQL06-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child's back feels stiff. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Back Feels Stiff PQL06-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child does not have the equipment he or she needs. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Do Not Have Equipment Need PQL06-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: I think our family has a lot of problems. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Family Has Lot of Problems PQL06-Feel Tired Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child feels tired. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Feel Tired PQL06-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child gets hurt accidentally. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Get Hurt Accidentally PQL06-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sick easily. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Get Sick Easily PQL06-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sores and/or rashes. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Get Sores and/or Rashes PQL06-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child's hands are weak. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hands Are Weak PQL06-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard Ask Doctors and Nurses Questions PQL06-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard Explain Illness to People PQL06-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard for Family to Plan Activities PQL06-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to get enough rest. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard for Family to Rest PQL06-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard Tell Doctors and Nurses How Feel PQL06-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to breathe. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard to Breathe PQL06-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard to Gain or Lose Weight PQL06-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard to Go Places With Equipment PQL06-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to swallow food. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard to Swallow Food PQL06-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard to Turn During Night PQL06-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use the bathroom. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard to Use Bathroom PQL06-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use his or her hands. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard to Use Hands PQL06-Legs Hurt Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child's legs hurt. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Legs Hurt PQL06-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Long Time to Bathe or Shower PQL06-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: I think money is a problem in our family. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Money Problem in Our Family PQL06-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child takes a long time to eat. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Take Long Time to Eat PQL06-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child wakes up tired. PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Wake Up Tired PQL06TN Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report Questionnaire Test Name CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Parent Report for Child Test Name Terminology Pediatric Quality of Life Neuromuscular Module Version 3 Child test code. PQL05-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard to breathe. PedsQL Neuromuscular Module Version 3.0 Child Report - Hard to Breathe PQL05-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I get sick easily. PedsQL Neuromuscular Module Version 3.0 Child Report - Get Sick Easily PQL05-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I get sores and/or rashes. PedsQL Neuromuscular Module Version 3.0 Child Report - Get Sores and/or Rashes PQL05-Legs Hurt Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: My legs hurt. PedsQL Neuromuscular Module Version 3.0 Child Report - Legs Hurt PQL05-Feel Tired Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I feel tired. PedsQL Neuromuscular Module Version 3.0 Child Report - Feel Tired PQL05-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: My back feels stiff. PedsQL Neuromuscular Module Version 3.0 Child Report - Back Feels Stiff PQL05-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I wake up tired. PedsQL Neuromuscular Module Version 3.0 Child Report - Wake Up Tired PQL05-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: My hands are weak. PedsQL Neuromuscular Module Version 3.0 Child Report - Hands Are Weak PQL05-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard to use the bathroom. PedsQL Neuromuscular Module Version 3.0 Child Report - Hard to Use Bathroom PQL05-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard to gain or lose weight when I want to. PedsQL Neuromuscular Module Version 3.0 Child Report - Hard to Gain or Lose Weight PQL05-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard to use my hands. PedsQL Neuromuscular Module Version 3.0 Child Report - Hard to Use Hands PQL05-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard to swallow food. PedsQL Neuromuscular Module Version 3.0 Child Report - Hard to Swallow Food PQL05-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It takes me a long time to bathe or shower. PedsQL Neuromuscular Module Version 3.0 Child Report - Long Time to Bathe or Shower PQL05-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I get hurt accidentally. PedsQL Neuromuscular Module Version 3.0 Child Report - Get Hurt Accidentally PQL05-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I take a long time to eat. PedsQL Neuromuscular Module Version 3.0 Child Report - Take Long Time to Eat PQL05-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard to turn myself during the night. PedsQL Neuromuscular Module Version 3.0 Child Report - Hard to Turn During Night PQL05-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard for me to go places with my equipment. PedsQL Neuromuscular Module Version 3.0 Child Report - Hard to Go Places With Equipment PQL05-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard for me to tell the doctors and nurses how I feel. PedsQL Neuromuscular Module Version 3.0 Child Report - Hard Tell Doctors and Nurses How Feel PQL05-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard for me to ask the doctors and nurses questions. PedsQL Neuromuscular Module Version 3.0 Child Report - Hard Ask Doctors and Nurses Questions PQL05-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard for me to explain my illness to other people. PedsQL Neuromuscular Module Version 3.0 Child Report - Hard Explain Illness to People PQL05-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard for my family to plan activities like vacations. PedsQL Neuromuscular Module Version 3.0 Child Report - Hard for Family to Plan Activities PQL05-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard for my family to get enough rest. PedsQL Neuromuscular Module Version 3.0 Child Report - Hard for Family to Rest PQL05-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I think money is a problem in our family. PedsQL Neuromuscular Module Version 3.0 Child Report - Money Problem in Our Family PQL05-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I think my family has a lot of problems. PedsQL Neuromuscular Module Version 3.0 Child Report - Family Has Lot of Problems PQL05-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I do not have the equipment I need. PedsQL Neuromuscular Module Version 3.0 Child Report - Do Not Have Equipment Need PQL05TC Pediatric Quality of Life Neuromuscular Module Version 3 Child Questionnaire Test Code CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Child Report Test Code Terminology Pediatric Quality of Life Neuromuscular Module Version 3 Child test name. PQL05-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: My back feels stiff. PedsQL Neuromuscular Module Version 3.0 Child Report - Back Feels Stiff PQL05-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I do not have the equipment I need. PedsQL Neuromuscular Module Version 3.0 Child Report - Do Not Have Equipment Need PQL05-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I think my family has a lot of problems. PedsQL Neuromuscular Module Version 3.0 Child Report - Family Has Lot of Problems PQL05-Feel Tired Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I feel tired. PedsQL Neuromuscular Module Version 3.0 Child Report - Feel Tired PQL05-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I get hurt accidentally. PedsQL Neuromuscular Module Version 3.0 Child Report - Get Hurt Accidentally PQL05-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I get sick easily. PedsQL Neuromuscular Module Version 3.0 Child Report - Get Sick Easily PQL05-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I get sores and/or rashes. PedsQL Neuromuscular Module Version 3.0 Child Report - Get Sores and/or Rashes PQL05-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: My hands are weak. PedsQL Neuromuscular Module Version 3.0 Child Report - Hands Are Weak PQL05-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard for me to ask the doctors and nurses questions. PedsQL Neuromuscular Module Version 3.0 Child Report - Hard Ask Doctors and Nurses Questions PQL05-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard for me to explain my illness to other people. PedsQL Neuromuscular Module Version 3.0 Child Report - Hard Explain Illness to People PQL05-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard for my family to plan activities like vacations. PedsQL Neuromuscular Module Version 3.0 Child Report - Hard for Family to Plan Activities PQL05-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard for my family to get enough rest. PedsQL Neuromuscular Module Version 3.0 Child Report - Hard for Family to Rest PQL05-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard for me to tell the doctors and nurses how I feel. PedsQL Neuromuscular Module Version 3.0 Child Report - Hard Tell Doctors and Nurses How Feel PQL05-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard to breathe. PedsQL Neuromuscular Module Version 3.0 Child Report - Hard to Breathe PQL05-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard to gain or lose weight when I want to. PedsQL Neuromuscular Module Version 3.0 Child Report - Hard to Gain or Lose Weight PQL05-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard for me to go places with my equipment. PedsQL Neuromuscular Module Version 3.0 Child Report - Hard to Go Places With Equipment PQL05-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard to swallow food. PedsQL Neuromuscular Module Version 3.0 Child Report - Hard to Swallow Food PQL05-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard to turn myself during the night. PedsQL Neuromuscular Module Version 3.0 Child Report - Hard to Turn During Night PQL05-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard to use the bathroom. PedsQL Neuromuscular Module Version 3.0 Child Report - Hard to Use Bathroom PQL05-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard to use my hands. PedsQL Neuromuscular Module Version 3.0 Child Report - Hard to Use Hands PQL05-Legs Hurt Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: My legs hurt. PedsQL Neuromuscular Module Version 3.0 Child Report - Legs Hurt PQL05-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It takes me a long time to bathe or shower. PedsQL Neuromuscular Module Version 3.0 Child Report - Long Time to Bathe or Shower PQL05-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I think money is a problem in our family. PedsQL Neuromuscular Module Version 3.0 Child Report - Money Problem in Our Family PQL05-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I take a long time to eat. PedsQL Neuromuscular Module Version 3.0 Child Report - Take Long Time to Eat PQL05-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I wake up tired. PedsQL Neuromuscular Module Version 3.0 Child Report - Wake Up Tired PQL05TN Pediatric Quality of Life Neuromuscular Module Version 3 Child Questionnaire Test Name CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Child Report Test Name Terminology Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report test code. PQL04-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to breathe. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard to Breathe PQL04-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child gets sick easily. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Get Sick Easily PQL04-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child gets sores and/or rashes. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Get Sores and/or Rashes PQL04-Legs Hurt Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child's legs hurt. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Legs Hurt PQL04-Feel Tired Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child feels tired. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Feel Tired PQL04-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child's back feels stiff. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Back Feels Stiff PQL04-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child wakes up tired. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Wake Up Tired PQL04-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child's hands are weak. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hands Are Weak PQL04-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to use the bathroom. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard to Use Bathroom PQL04-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to gain or lose weight when he or she wants to. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard to Gain or Lose Weight PQL04-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to use his or her hands. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard to Use Hands PQL04-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to swallow food. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard to Swallow Food PQL04-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It takes my child a long time to bathe or shower. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Long Time to Bathe or Shower PQL04-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child gets hurt accidentally. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Get Hurt Accidentally PQL04-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child takes a long time to eat. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Take Long Time to Eat PQL04-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to turn him or herself during the night. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard to Turn During Night PQL04-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to go places with his or her equipment. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard to Go Places With Equipment PQL04-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to tell the doctors and nurses how he or she feels. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard Tell Doctors and Nurses How Feel PQL04-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to ask the doctors and nurses questions. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard Ask Doctors and Nurses Questions PQL04-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to explain his or her illness to other people. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard Explain Illness to People PQL04-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for our family to plan activities like vacations. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard for Family to Plan Activities PQL04-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for our family to get enough rest. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard for Family to Rest PQL04-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: I think money is a problem in our family. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Money Problem in Our Family PQL04-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: I think our family has a lot of problems. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Family Has Lot of Problems PQL04-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child does not have the equipment he or she needs. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Do Not Have Equipment Need PQL04TC Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report Questionnaire Test Code CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen Test Code Terminology Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report test name. PQL04-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child's back feels stiff. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Back Feels Stiff PQL04-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child does not have the equipment he or she needs. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Do Not Have Equipment Need PQL04-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: I think our family has a lot of problems. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Family Has Lot of Problems PQL04-Feel Tired Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child feels tired. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Feel Tired PQL04-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child gets hurt accidentally. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Get Hurt Accidentally PQL04-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child gets sick easily. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Get Sick Easily PQL04-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child gets sores and/or rashes. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Get Sores and/or Rashes PQL04-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child's hands are weak. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hands Are Weak PQL04-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to ask the doctors and nurses questions. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard Ask Doctors and Nurses Questions PQL04-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to explain his or her illness to other people. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard Explain Illness to People PQL04-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for our family to plan activities like vacations. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard for Family to Plan Activities PQL04-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for our family to get enough rest. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard for Family to Rest PQL04-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to tell the doctors and nurses how he or she feels. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard Tell Doctors and Nurses How Feel PQL04-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to breathe. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard to Breathe PQL04-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to gain or lose weight when he or she wants to. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard to Gain or Lose Weight PQL04-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to go places with his or her equipment. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard to Go Places With Equipment PQL04-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to swallow food. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard to Swallow Food PQL04-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to turn him or herself during the night. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard to Turn During Night PQL04-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to use the bathroom. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard to Use Bathroom PQL04-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to use his or her hands. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard to Use Hands PQL04-Legs Hurt Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child's legs hurt. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Legs Hurt PQL04-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It takes my child a long time to bathe or shower. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Long Time to Bathe or Shower PQL04-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: I think money is a problem in our family. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Money Problem in Our Family PQL04-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child takes a long time to eat. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Take Long Time to Eat PQL04-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child wakes up tired. PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Wake Up Tired PQL04TN Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report Questionnaire Test Name CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen Test Name Terminology Pediatric Quality of Life Neuromuscular Module Version 3 Teen test code. PQL03-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard to breathe. PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard to Breathe PQL03-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I get sick easily. PedsQL Neuromuscular Module Version 3.0 Teen Report - Get Sick Easily PQL03-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I get sores and/or rashes. PedsQL Neuromuscular Module Version 3.0 Teen Report - Get Sores and/or Rashes PQL03-Legs Hurt Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: My legs hurt. PedsQL Neuromuscular Module Version 3.0 Teen Report - Legs Hurt PQL03-Feel Tired Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I feel tired. PedsQL Neuromuscular Module Version 3.0 Teen Report - Feel Tired PQL03-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: My back feels stiff. PedsQL Neuromuscular Module Version 3.0 Teen Report - Back Feels Stiff PQL03-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I wake up tired. PedsQL Neuromuscular Module Version 3.0 Teen Report - Wake Up Tired PQL03-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: My hands are weak. PedsQL Neuromuscular Module Version 3.0 Teen Report - Hands Are Weak PQL03-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard to use the bathroom. PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard to Use Bathroom PQL03-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard to gain or lose weight when I want to. PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard to Gain or Lose Weight PQL03-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard to use my hands. PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard to Use Hands PQL03-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard to swallow food. PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard to Swallow Food PQL03-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It takes me a long time to bathe or shower. PedsQL Neuromuscular Module Version 3.0 Teen Report - Long Time to Bathe or Shower PQL03-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I get hurt accidentally. PedsQL Neuromuscular Module Version 3.0 Teen Report - Get Hurt Accidentally PQL03-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I take a long time to eat. PedsQL Neuromuscular Module Version 3.0 Teen Report - Take Long Time to Eat PQL03-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard to turn myself during the night. PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard to Turn During Night PQL03-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard for me to go places with my equipment. PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard to Go Places With Equipment PQL03-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard for me to tell the doctors and nurses how I feel. PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard Tell Doctors and Nurses How Feel PQL03-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard for me to ask the doctors and nurses questions. PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard Ask Doctors and Nurses Questions PQL03-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard for me to explain my illness to other people. PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard Explain Illness to People PQL03-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard for my family to plan activities like vacations. PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard for Family to Plan Activities PQL03-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard for my family to get enough rest. PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard for Family to Rest PQL03-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I think money is a problem in our family. PedsQL Neuromuscular Module Version 3.0 Teen Report - Money Problem in Our Family PQL03-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I think my family has a lot of problems. PedsQL Neuromuscular Module Version 3.0 Teen Report - Family Has Lot of Problems PQL03-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I do not have the equipment I need. PedsQL Neuromuscular Module Version 3.0 Teen Report - Do Not Have Equipment Need PQL03TC Pediatric Quality of Life Neuromuscular Module Version 3 Teen Questionnaire Test Code CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Teen Report Test Code Terminology Pediatric Quality of Life Neuromuscular Module Version 3 Teen test name. PQL03-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: My back feels stiff. PedsQL Neuromuscular Module Version 3.0 Teen Report - Back Feels Stiff PQL03-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I do not have the equipment I need. PedsQL Neuromuscular Module Version 3.0 Teen Report - Do Not Have Equipment Need PQL03-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I think my family has a lot of problems. PedsQL Neuromuscular Module Version 3.0 Teen Report - Family Has Lot of Problems PQL03-Feel Tired Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I feel tired. PedsQL Neuromuscular Module Version 3.0 Teen Report - Feel Tired PQL03-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I get hurt accidentally. PedsQL Neuromuscular Module Version 3.0 Teen Report - Get Hurt Accidentally PQL03-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I get sick easily. PedsQL Neuromuscular Module Version 3.0 Teen Report - Get Sick Easily PQL03-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I get sores and/or rashes. PedsQL Neuromuscular Module Version 3.0 Teen Report - Get Sores and/or Rashes PQL03-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: My hands are weak. PedsQL Neuromuscular Module Version 3.0 Teen Report - Hands Are Weak PQL03-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard for me to ask the doctors and nurses questions. PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard Ask Doctors and Nurses Questions PQL03-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard for me to explain my illness to other people. PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard Explain Illness to People PQL03-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard for my family to plan activities like vacations. PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard for Family to Plan Activities PQL03-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard for my family to get enough rest. PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard for Family to Rest PQL03-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard for me to tell the doctors and nurses how I feel. PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard Tell Doctors and Nurses How Feel PQL03-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard to breathe. PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard to Breathe PQL03-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard to gain or lose weight when I want to. PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard to Gain or Lose Weight PQL03-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard for me to go places with my equipment. PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard to Go Places With Equipment PQL03-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard to swallow food. PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard to Swallow Food PQL03-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard to turn myself during the night. PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard to Turn During Night PQL03-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard to use the bathroom. PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard to Use Bathroom PQL03-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard to use my hands. PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard to Use Hands PQL03-Legs Hurt Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: My legs hurt. PedsQL Neuromuscular Module Version 3.0 Teen Report - Legs Hurt PQL03-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It takes me a long time to bathe or shower. PedsQL Neuromuscular Module Version 3.0 Teen Report - Long Time to Bathe or Shower PQL03-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I think money is a problem in our family. PedsQL Neuromuscular Module Version 3.0 Teen Report - Money Problem in Our Family PQL03-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I take a long time to eat. PedsQL Neuromuscular Module Version 3.0 Teen Report - Take Long Time to Eat PQL03-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I wake up tired. PedsQL Neuromuscular Module Version 3.0 Teen Report - Wake Up Tired PQL03TN Pediatric Quality of Life Neuromuscular Module Version 3 Teen Questionnaire Test Name CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Teen Report Test Name Terminology Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report test code. PQL09-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to breathe. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard to Breathe PQL09-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sick easily. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Get Sick Easily PQL09-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sores and/or rashes. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Get Sores and/or Rashes PQL09-Legs Hurt Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child's legs hurt. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Legs Hurt PQL09-Feel Tired Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child feels tired. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Feel Tired PQL09-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child's back feels stiff. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Back Feels Stiff PQL09-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child wakes up tired. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Wake Up Tired PQL09-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child's hands are weak. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hands Are Weak PQL09-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use the bathroom. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard to Use Bathroom PQL09-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard to Gain or Lose Weight PQL09-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use his or her hands. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard to Use Hands PQL09-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to swallow food. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard to Swallow Food PQL09-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Long Time to Bathe or Shower PQL09-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child gets hurt accidentally. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Get Hurt Accidentally PQL09-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child takes a long time to eat. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Take Long Time to Eat PQL09-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard to Turn During Night PQL09-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard to Go Places With Equipment PQL09-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard Tell Doctors and Nurses How Feel PQL09-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard Ask Doctors and Nurses Questions PQL09-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard Explain Illness to People PQL09-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard for Family to Plan Activities PQL09-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to get enough rest. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard for Family to Rest PQL09-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: I think money is a problem in our family. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Money Problem in Our Family PQL09-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: I think our family has a lot of problems. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Family Has Lot of Problems PQL09-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child does not have the equipment he or she needs. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Do Not Have Equipment Need PQL09TC Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report Questionnaire Test Code CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Parent of Toddler Test Code Terminology Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report test name. PQL09-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child's back feels stiff. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Back Feels Stiff PQL09-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child does not have the equipment he or she needs. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Do Not Have Equipment Need PQL09-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: I think our family has a lot of problems. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Family Has Lot of Problems PQL09-Feel Tired Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child feels tired. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Feel Tired PQL09-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child gets hurt accidentally. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Get Hurt Accidentally PQL09-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sick easily. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Get Sick Easily PQL09-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sores and/or rashes. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Get Sores and/or Rashes PQL09-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child's hands are weak. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hands Are Weak PQL09-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard Ask Doctors and Nurses Questions PQL09-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard Explain Illness to People PQL09-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard for Family to Plan Activities PQL09-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to get enough rest. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard for Family to Rest PQL09-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard Tell Doctors and Nurses How Feel PQL09-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to breathe. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard to Breathe PQL09-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard to Gain or Lose Weight PQL09-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard to Go Places With Equipment PQL09-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to swallow food. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard to Swallow Food PQL09-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard to Turn During Night PQL09-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use the bathroom. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard to Use Bathroom PQL09-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use his or her hands. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard to Use Hands PQL09-Legs Hurt Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child's legs hurt. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Legs Hurt PQL09-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Long Time to Bathe or Shower PQL09-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: I think money is a problem in our family. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Money Problem in Our Family PQL09-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child takes a long time to eat. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Take Long Time to Eat PQL09-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child wakes up tired. PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Wake Up Tired PQL09TN Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report Questionnaire Test Name CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Parent of Toddler Test Name Terminology Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report test code. PQL02-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to breathe. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard to Breathe PQL02-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sick easily. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Get Sick Easily PQL02-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sores and/or rashes. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Get Sores and/or Rashes PQL02-Legs Hurt Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child's legs hurt. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Legs Hurt PQL02-Feel Tired Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child feels tired. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Feel Tired PQL02-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child's back feels stiff. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Back Feels Stiff PQL02-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child wakes up tired. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Wake Up Tired PQL02-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child's hands are weak. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hands Are Weak PQL02-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use the bathroom. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard to Use Bathroom PQL02-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard to Gain or Lose Weight PQL02-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use his or her hands. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard to Use Hands PQL02-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to swallow food. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard to Swallow Food PQL02-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Long Time to Bathe or Shower PQL02-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child gets hurt accidentally. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Get Hurt Accidentally PQL02-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child takes a long time to eat. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Take Long Time to Eat PQL02-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard to Turn During Night PQL02-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard to Go Places With Equipment PQL02-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard Tell Doctors and Nurses How Feel PQL02-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard Ask Doctors and Nurses Questions PQL02-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard Explain Illness to People PQL02-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard for Family to Plan Activities PQL02-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to get enough rest. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard for Family to Rest PQL02-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: I think money is a problem in our family. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Money Problem in Our Family PQL02-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: I think our family has a lot of problems. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Family Has Lot of Problems PQL02-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child does not have the equipment he or she needs. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Do Not Have Equipment Need PQL02TC Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report Questionnaire Test Code CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report Test Code Terminology Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report test name. PQL02-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child's back feels stiff. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Back Feels Stiff PQL02-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child does not have the equipment he or she needs. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Do Not Have Equipment Need PQL02-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: I think our family has a lot of problems. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Family Has Lot of Problems PQL02-Feel Tired Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child feels tired. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Feel Tired PQL02-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child gets hurt accidentally. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Get Hurt Accidentally PQL02-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sick easily. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Get Sick Easily PQL02-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sores and/or rashes. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Get Sores and/or Rashes PQL02-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child's hands are weak. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hands Are Weak PQL02-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard Ask Doctors and Nurses Questions PQL02-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard Explain Illness to People PQL02-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard for Family to Plan Activities PQL02-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to get enough rest. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard for Family to Rest PQL02-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard Tell Doctors and Nurses How Feel PQL02-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to breathe. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard to Breathe PQL02-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard to Gain or Lose Weight PQL02-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard to Go Places With Equipment PQL02-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to swallow food. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard to Swallow Food PQL02-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard to Turn During Night PQL02-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use the bathroom. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard to Use Bathroom PQL02-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use his or her hands. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard to Use Hands PQL02-Legs Hurt Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child's legs hurt. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Legs Hurt PQL02-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Long Time to Bathe or Shower PQL02-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: I think money is a problem in our family. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Money Problem in Our Family PQL02-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child takes a long time to eat. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Take Long Time to Eat PQL02-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child wakes up tired. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Wake Up Tired PQL02TN Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report Questionnaire Test Name CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report Test Name Terminology Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult test code. PQL01-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard to breathe. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard to Breathe PQL01-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I get sick easily. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Get Sick Easily PQL01-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I get sores and/or rashes. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Get Sores and/or Rashes PQL01-Legs Hurt Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: My legs hurt. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Legs Hurt PQL01-Feel Tired Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I feel tired. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Feel Tired PQL01-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: My back feels stiff. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Back Feels Stiff PQL01-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I wake up tired. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Wake Up Tired PQL01-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: My hands are weak. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hands Are Weak PQL01-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard to use the bathroom. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard to Use Bathroom PQL01-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard to gain or lose weight when I want to. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard to Gain or Lose Weight PQL01-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard to use my hands. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard to Use Hands PQL01-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard to swallow food. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard to Swallow Food PQL01-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It takes me a long time to bathe or shower. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Long Time to Bathe or Shower PQL01-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I get hurt accidentally. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Get Hurt Accidentally PQL01-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I take a long time to eat. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Take Long Time to Eat PQL01-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard to turn myself during the night. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard to Turn During Night PQL01-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard for me to go places with my equipment. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard to Go Places With Equipment PQL01-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard for me to tell the doctors and nurses how I feel. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard Tell Doctors and Nurses How Feel PQL01-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard for me to ask the doctors and nurses questions. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard Ask Doctors and Nurses Questions PQL01-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard for me to explain my illness to other people. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard Explain Illness to People PQL01-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard for my family to plan activities like vacations. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard for Family to Plan Activities PQL01-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard for my family to get enough rest. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard for Family to Rest PQL01-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I think money is a problem in our family. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Money Problem in Our Family PQL01-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I think my family has a lot of problems. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Family Has Lot of Problems PQL01-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I do not have the equipment I need. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Do Not Have Equipment Need PQL01TC Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Questionnaire Test Code CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Young Adult Report Test Code Terminology Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult test name. PQL01-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: My back feels stiff. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Back Feels Stiff PQL01-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I do not have the equipment I need. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Do Not Have Equipment Need PQL01-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I think my family has a lot of problems. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Family Has Lot of Problems PQL01-Feel Tired Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I feel tired. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Feel Tired PQL01-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I get hurt accidentally. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Get Hurt Accidentally PQL01-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I get sick easily. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Get Sick Easily PQL01-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I get sores and/or rashes. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Get Sores and/or Rashes PQL01-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: My hands are weak. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hands Are Weak PQL01-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard for me to ask the doctors and nurses questions. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard Ask Doctors and Nurses Questions PQL01-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard for me to explain my illness to other people. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard Explain Illness to People PQL01-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard for my family to plan activities like vacations. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard for Family to Plan Activities PQL01-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard for my family to get enough rest. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard for Family to Rest PQL01-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard for me to tell the doctors and nurses how I feel. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard Tell Doctors and Nurses How Feel PQL01-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard to breathe. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard to Breathe PQL01-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard to gain or lose weight when I want to. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard to Gain or Lose Weight PQL01-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard for me to go places with my equipment. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard to Go Places With Equipment PQL01-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard to swallow food. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard to Swallow Food PQL01-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard to turn myself during the night. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard to Turn During Night PQL01-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard to use the bathroom. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard to Use Bathroom PQL01-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard to use my hands. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard to Use Hands PQL01-Legs Hurt Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: My legs hurt. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Legs Hurt PQL01-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It takes me a long time to bathe or shower. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Long Time to Bathe or Shower PQL01-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I think money is a problem in our family. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Money Problem in Our Family PQL01-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I take a long time to eat. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Take Long Time to Eat PQL01-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I wake up tired. PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Wake Up Tired PQL01TN Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Questionnaire Test Name CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Young Adult Report Test Name Terminology Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report test code. PQL08-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to breathe. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard to Breathe PQL08-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sick easily. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Get Sick Easily PQL08-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sores and/or rashes. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Get Sores and/or Rashes PQL08-Legs Hurt Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child's legs hurt. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Legs Hurt PQL08-Feel Tired Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child feels tired. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Feel Tired PQL08-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child's back feels stiff. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Back Feels Stiff PQL08-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child wakes up tired. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Wake Up Tired PQL08-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child's hands are weak. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hands Are Weak PQL08-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use the bathroom. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard to Use Bathroom PQL08-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard to Gain or Lose Weight PQL08-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use his or her hands. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard to Use Hands PQL08-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to swallow food. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard to Swallow Food PQL08-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Long Time to Bathe or Shower PQL08-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child gets hurt accidentally. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Get Hurt Accidentally PQL08-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child takes a long time to eat. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Take Long Time to Eat PQL08-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard to Turn During Night PQL08-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard to Go Places With Equipment PQL08-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard Tell Doctors and Nurses How Feel PQL08-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard Ask Doctors and Nurses Questions PQL08-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard Explain Illness to People PQL08-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard for Family to Plan Activities PQL08-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to get enough rest. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard for Family to Rest PQL08-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: I think money is a problem in our family. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Money Problem in Our Family PQL08-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: I think our family has a lot of problems. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Family Has Lot of Problems PQL08-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child does not have the equipment he or she needs. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Do Not Have Equipment Need PQL08TC Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report Questionnaire Test Code CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child Test Code Terminology Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report test name. PQL08-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child's back feels stiff. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Back Feels Stiff PQL08-Do Not Have Equipment Need Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child does not have the equipment he or she needs. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Do Not Have Equipment Need PQL08-Family Has Lot of Problems Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: I think our family has a lot of problems. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Family Has Lot of Problems PQL08-Feel Tired Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child feels tired. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Feel Tired PQL08-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child gets hurt accidentally. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Get Hurt Accidentally PQL08-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sick easily. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Get Sick Easily PQL08-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sores and/or rashes. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Get Sores and/or Rashes PQL08-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child's hands are weak. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hands Are Weak PQL08-Hard Ask Doctors/Nurses Questions Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard Ask Doctors and Nurses Questions PQL08-Hard Explain Illness to People Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard Explain Illness to People PQL08-Hard for Family to Plan Activities Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard for Family to Plan Activities PQL08-Hard for Family to Rest Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to get enough rest. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard for Family to Rest PQL08-Hard Tell Doctors/Nurses How Feel Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard Tell Doctors and Nurses How Feel PQL08-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to breathe. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard to Breathe PQL08-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard to Gain or Lose Weight PQL08-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard to Go Places With Equipment PQL08-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to swallow food. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard to Swallow Food PQL08-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard to Turn During Night PQL08-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use the bathroom. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard to Use Bathroom PQL08-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use his or her hands. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard to Use Hands PQL08-Legs Hurt Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child's legs hurt. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Legs Hurt PQL08-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Long Time to Bathe or Shower PQL08-Money Problem in Our Family Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: I think money is a problem in our family. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Money Problem in Our Family PQL08-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child takes a long time to eat. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Take Long Time to Eat PQL08-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child wakes up tired. PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Wake Up Tired PQL08TN Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report Questionnaire Test Name CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child Test Name Terminology Pediatric Quality of Life Neuromuscular Module Version 3 Young Child test code. PQL07-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to breathe. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hard to Breathe PQL07-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: I get sick easily. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Get Sick Easily PQL07-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: I get sores and/or rashes. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Get Sores and/or Rashes PQL07-Legs Hurt Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: My legs hurt. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Legs Hurt PQL07-Feel Tired Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: I feel tired. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Feel Tired PQL07-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: My back feels stiff. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Back Feels Stiff PQL07-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: I wake up tired. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Wake Up Tired PQL07-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: My hands are weak. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hands Are Weak PQL07-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to use the bathroom. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hard to Use Bathroom PQL07-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to gain or lose weight when I want to. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hard to Gain or Lose Weight PQL07-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to use my hands. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hard to Use Hands PQL07-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to swallow food. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hard to Swallow Food PQL07-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It takes me a long time to bathe or shower. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Long Time to Bathe or Shower PQL07-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: I get hurt accidentally. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Get Hurt Accidentally PQL07-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: I take a long time to eat. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Take Long Time to Eat PQL07-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to turn myself during the night. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hard to Turn During Night PQL07-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard for me to go places with my equipment. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hard to Go Places With Equipment PQL07TC Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Questionnaire Test Code CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Young Child Report Test Code Terminology Pediatric Quality of Life Neuromuscular Module Version 3 Young Child test name. PQL07-Back Feels Stiff Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: My back feels stiff. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Back Feels Stiff PQL07-Feel Tired Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: I feel tired. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Feel Tired PQL07-Get Hurt Accidentally Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: I get hurt accidentally. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Get Hurt Accidentally PQL07-Get Sick Easily Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: I get sick easily. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Get Sick Easily PQL07-Get Sores and/or Rashes Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: I get sores and/or rashes. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Get Sores and/or Rashes PQL07-Hands Are Weak Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: My hands are weak. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hands Are Weak PQL07-Hard to Breathe Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to breathe. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hard to Breathe PQL07-Hard to Gain/Lose Weight Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to gain or lose weight when I want to. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hard to Gain or Lose Weight PQL07-Hard to Go Places With Equipment Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard for me to go places with my equipment. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hard to Go Places With Equipment PQL07-Hard to Swallow Food Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to swallow food. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hard to Swallow Food PQL07-Hard to Turn During Night Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to turn myself during the night. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hard to Turn During Night PQL07-Hard to Use Bathroom Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to use the bathroom. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hard to Use Bathroom PQL07-Hard to Use Hands Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to use my hands. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hard to Use Hands PQL07-Legs Hurt Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: My legs hurt. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Legs Hurt PQL07-Long Time to Bathe/Shower Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It takes me a long time to bathe or shower. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Long Time to Bathe or Shower PQL07-Take Long Time to Eat Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: I take a long time to eat. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Take Long Time to Eat PQL07-Wake Up Tired Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: I wake up tired. PedsQL Neuromuscular Module Version 3.0 Young Child Report - Wake Up Tired PQL07TN Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Questionnaire Test Name CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Young Child Report Test Name Terminology Penn State Electronic Cigarette Dependence Index test code. PSECD1-Times per Day You Use Your E-Cig Penn State Electronic Cigarette Dependence Index - How many times per day do you usually use your electronic cigarette? (assume one "time" consists of around 15 puffs, or lasts around 10 minutes). PSECDI - Times per Day You Use Your Electronic Cigarette PSECD1-First Use E-Cig After Wake Up Penn State Electronic Cigarette Dependence Index - On days that you can use your electronic cigarette freely, how soon after you wake up do you first use your electronic cigarette? PSECDI - First Use Electronic Cigarette After Wake Up PSECD1-Sometimes Awaken Night Use E-Cig Penn State Electronic Cigarette Dependence Index - Do you sometimes awaken at night to use your electronic cigarette? PSECDI - Sometimes Awaken Night Use Electronic Cigarette PSECD1-Nights per Week Awaken Use E-Cig Penn State Electronic Cigarette Dependence Index - If yes, how many nights per week do you typically awaken to do so? PSECDI - Nights per Week Awaken Use Electronic Cigarette PSECD1-Use an E-Cig B/c Hard to Quit Penn State Electronic Cigarette Dependence Index - Do you use an electronic cigarette now because it is really hard to quit (using e-cigs)? PSECDI - Use an Electronic Cigarette Because Hard to Quit PSECD1-Have Strong Cravings to Use E-Cig Penn State Electronic Cigarette Dependence Index - Do you ever have strong cravings to use an electronic cigarette? PSECDI - Have Strong Cravings to Use Electronic Cigarette PSECD1-How Strong Urges to Use E-Cig Penn State Electronic Cigarette Dependence Index - Over the past week, how strong have the urges to use an electronic cigarette been? PSECDI - How Strong Urges to Use Electronic Cigarette PSECD1-Hard Keep From Using E-Cig Penn State Electronic Cigarette Dependence Index - Is it hard to keep from using an electronic cigarette in places where you are not supposed to? PSECDI - Hard Keep From Using Electronic Cigarette PSECD1-More Irritable Couldn't Use E-Cig Penn State Electronic Cigarette Dependence Index - Did you feel more irritable because you couldn't use an electronic cigarette? PSECDI - More Irritable Couldn't Use Electronic Cigarette PSECD1-Nervous Couldn't Use E-Cig Penn State Electronic Cigarette Dependence Index - Did you feel nervous, restless or anxious because you couldn't use an electronic cigarette? PSECDI - Nervous Couldn't Use Electronic Cigarette PSECD1-Total Score Penn State Electronic Cigarette Dependence Index - Total score. PSECDI - Total Score PSECD1TC Penn State Electronic Cigarette Dependence Index Questionnaire Test Code CDISC Questionnaire Penn State Electronic Cigarette Dependence Index Test Code Terminology Penn State Electronic Cigarette Dependence Index test name. PSECD1-First Use E-Cig After Wake Up Penn State Electronic Cigarette Dependence Index - On days that you can use your electronic cigarette freely, how soon after you wake up do you first use your electronic cigarette? PSECDI - First Use Electronic Cigarette After Wake Up PSECD1-Hard Keep From Using E-Cig Penn State Electronic Cigarette Dependence Index - Is it hard to keep from using an electronic cigarette in places where you are not supposed to? PSECDI - Hard Keep From Using Electronic Cigarette PSECD1-Have Strong Cravings to Use E-Cig Penn State Electronic Cigarette Dependence Index - Do you ever have strong cravings to use an electronic cigarette? PSECDI - Have Strong Cravings to Use Electronic Cigarette PSECD1-How Strong Urges to Use E-Cig Penn State Electronic Cigarette Dependence Index - Over the past week, how strong have the urges to use an electronic cigarette been? PSECDI - How Strong Urges to Use Electronic Cigarette PSECD1-More Irritable Couldn't Use E-Cig Penn State Electronic Cigarette Dependence Index - Did you feel more irritable because you couldn't use an electronic cigarette? PSECDI - More Irritable Couldn't Use Electronic Cigarette PSECD1-Nervous Couldn't Use E-Cig Penn State Electronic Cigarette Dependence Index - Did you feel nervous, restless or anxious because you couldn't use an electronic cigarette? PSECDI - Nervous Couldn't Use Electronic Cigarette PSECD1-Nights per Week Awaken Use E-Cig Penn State Electronic Cigarette Dependence Index - If yes, how many nights per week do you typically awaken to do so? PSECDI - Nights per Week Awaken Use Electronic Cigarette PSECD1-Sometimes Awaken Night Use E-Cig Penn State Electronic Cigarette Dependence Index - Do you sometimes awaken at night to use your electronic cigarette? PSECDI - Sometimes Awaken Night Use Electronic Cigarette PSECD1-Times per Day You Use Your E-Cig Penn State Electronic Cigarette Dependence Index - How many times per day do you usually use your electronic cigarette? (assume one "time" consists of around 15 puffs, or lasts around 10 minutes). PSECDI - Times per Day You Use Your Electronic Cigarette PSECD1-Total Score Penn State Electronic Cigarette Dependence Index - Total score. PSECDI - Total Score PSECD1-Use an E-Cig B/c Hard to Quit Penn State Electronic Cigarette Dependence Index - Do you use an electronic cigarette now because it is really hard to quit (using e-cigs)? PSECDI - Use an Electronic Cigarette Because Hard to Quit PSECD1TN Penn State Electronic Cigarette Dependence Index Questionnaire Test Name CDISC Questionnaire Penn State Electronic Cigarette Dependence Index Test Name Terminology Performance of the Upper Limb Module for DMD Version 1.2 test code. PUL01-Preferred Arm Performance of the Upper Limb Module for DMD Version 1.2 - Preferred arm. PUL 1.2 - Preferred Arm PUL01-Elbow Contractures Performance of the Upper Limb Module for DMD Version 1.2 - Elbow contractures of the preferred arm. PUL 1.2 - Elbow Contractures PUL01-High Level Shoulder Dimension Performance of the Upper Limb Module for DMD Version 1.2 - High level shoulder dimension score. PUL 1.2 - High Level Shoulder Dimension PUL01-Mid Level Elbow Dimension Performance of the Upper Limb Module for DMD Version 1.2 - Mid level elbow dimension score. PUL 1.2 - Mid Level Elbow Dimension PUL01-Distal Wrist/Hand Dimension Performance of the Upper Limb Module for DMD Version 1.2 - Distal wrist and hand dimension score. PUL 1.2 - Distal Wrist or Hand Dimension PUL01-Total Score Performance of the Upper Limb Module for DMD Version 1.2 - Total Score. PUL 1.2 - Total Score PUL01-Entry Item Performance of the Upper Limb Module for DMD Version 1.2 - Entry item. PUL 1.2 - Entry Item PUL01-Shoulder Abduction to Shldr Hgt Performance of the Upper Limb Module for DMD Version 1.2 - Shoulder abduction to shoulder height. PUL 1.2 - Shoulder Abduction to Height PUL01-Shoulder Abduction Above Shldr Hgt Performance of the Upper Limb Module for DMD Version 1.2 - Shoulder abduction above shoulder height. PUL 1.2 - Shoulder Abduction Above Height PUL01-Shoulder Flexion to Shldr Height Performance of the Upper Limb Module for DMD Version 1.2 - Shoulder flexion to shoulder height. PUL 1.2 - Shoulder Flexion to Height PUL01-Shoulder Flexion Above Shldr Hgt Performance of the Upper Limb Module for DMD Version 1.2 - Shoulder flexion above shoulder height. PUL 1.2 - Shoulder Flexion Above Height PUL01-Hand(s) to Mouth Performance of the Upper Limb Module for DMD Version 1.2 - Hand(s) to mouth. PUL 1.2 - Hand(s) to Mouth PUL01-Hand(s) to Table From Lap Performance of the Upper Limb Module for DMD Version 1.2 - Hand(s) to table from lap. PUL 1.2 - Hand(s) to Table From Lap PUL01-Move Weight on Table Performance of the Upper Limb Module for DMD Version 1.2 - Move weight on table. PUL 1.2 - Move Weight on Table PUL01-Lifting Light Cans Performance of the Upper Limb Module for DMD Version 1.2 - Lifting light cans. PUL 1.2 - Lifting Light Cans PUL01-Lifting Light Cans Time Performance of the Upper Limb Module for DMD Version 1.2 - Lifting light cans, time. PUL 1.2 - Lifting Light Cans Time PUL01-Lifting Heavy Cans Performance of the Upper Limb Module for DMD Version 1.2 - Lifting heavy cans. PUL 1.2 - Lifting Heavy Cans PUL01-Lifting Heavy Cans Time Performance of the Upper Limb Module for DMD Version 1.2 - Lifting heavy cans, time. PUL 1.2 - Lifting Heavy Cans Time PUL01-Stacking Light Cans Performance of the Upper Limb Module for DMD Version 1.2 - Stacking light cans. PUL 1.2 - Stacking Light Cans PUL01-Stacking Light Cans Time Performance of the Upper Limb Module for DMD Version 1.2 - Stacking light cans, time. PUL 1.2 - Stacking Light Cans Time PUL01-Stacking Heavy Cans Performance of the Upper Limb Module for DMD Version 1.2 - Stacking heavy cans. PUL 1.2 - Stacking Heavy Cans PUL01-Stacking Heavy Cans Time Performance of the Upper Limb Module for DMD Version 1.2 - Stacking heavy cans, time. PUL 1.2 - Stacking Heavy Cans Time PUL01-Remove Lid From Container Performance of the Upper Limb Module for DMD Version 1.2 - Remove lid from container. PUL 1.2 - Remove Lid From Container PUL01-Tearing Paper Performance of the Upper Limb Module for DMD Version 1.2 - Tearing paper. PUL 1.2 - Tearing Paper PUL01-Tracing Path Performance of the Upper Limb Module for DMD Version 1.2 - Tracing path. PUL 1.2 - Tracing Path PUL01-Push on The Light Performance of the Upper Limb Module for DMD Version 1.2 - Push on the light. PUL 1.2 - Push on The Light PUL01-Supination Performance of the Upper Limb Module for DMD Version 1.2 - Supination. PUL 1.2 - Supination PUL01-Picking Up Coins Performance of the Upper Limb Module for DMD Version 1.2 - Picking up coins. PUL 1.2 - Picking Up Coins PUL01-Placing Finger on Number Diagram Performance of the Upper Limb Module for DMD Version 1.2 - Placing finger on number diagram. PUL 1.2 - Placing Finger on Number Diagram PUL01-Finger Pinch Grip Performance of the Upper Limb Module for DMD Version 1.2 - Finger pinch grip. PUL 1.2 - Finger Pinch Grip PUL01-3 Point Grip Performance of the Upper Limb Module for DMD Version 1.2 - 3 point grip. PUL 1.2 - 3 Point Grip PUL01-Thumb (Key) Grip Performance of the Upper Limb Module for DMD Version 1.2 - Thumb (key) grip. PUL 1.2 - Thumb (Key) Grip PUL01TC Performance of the Upper Limb Module for DMD Version 1.2 Functional Test Test Code CDISC Functional Test PUL 1.2 Test Code Terminology Performance of the Upper Limb Module for DMD Version 1.2 test name. PUL01-3 Point Grip Performance of the Upper Limb Module for DMD Version 1.2 - 3 point grip. PUL 1.2 - 3 Point Grip PUL01-Distal Wrist/Hand Dimension Performance of the Upper Limb Module for DMD Version 1.2 - Distal wrist and hand dimension score. PUL 1.2 - Distal Wrist or Hand Dimension PUL01-Elbow Contractures Performance of the Upper Limb Module for DMD Version 1.2 - Elbow contractures of the preferred arm. PUL 1.2 - Elbow Contractures PUL01-Entry Item Performance of the Upper Limb Module for DMD Version 1.2 - Entry item. PUL 1.2 - Entry Item PUL01-Finger Pinch Grip Performance of the Upper Limb Module for DMD Version 1.2 - Finger pinch grip. PUL 1.2 - Finger Pinch Grip PUL01-Hand(s) to Mouth Performance of the Upper Limb Module for DMD Version 1.2 - Hand(s) to mouth. PUL 1.2 - Hand(s) to Mouth PUL01-Hand(s) to Table From Lap Performance of the Upper Limb Module for DMD Version 1.2 - Hand(s) to table from lap. PUL 1.2 - Hand(s) to Table From Lap PUL01-High Level Shoulder Dimension Performance of the Upper Limb Module for DMD Version 1.2 - High level shoulder dimension score. PUL 1.2 - High Level Shoulder Dimension PUL01-Lifting Heavy Cans Time Performance of the Upper Limb Module for DMD Version 1.2 - Lifting heavy cans, time. PUL 1.2 - Lifting Heavy Cans Time PUL01-Lifting Heavy Cans Performance of the Upper Limb Module for DMD Version 1.2 - Lifting heavy cans. PUL 1.2 - Lifting Heavy Cans PUL01-Lifting Light Cans Time Performance of the Upper Limb Module for DMD Version 1.2 - Lifting light cans, time. PUL 1.2 - Lifting Light Cans Time PUL01-Lifting Light Cans Performance of the Upper Limb Module for DMD Version 1.2 - Lifting light cans. PUL 1.2 - Lifting Light Cans PUL01-Mid Level Elbow Dimension Performance of the Upper Limb Module for DMD Version 1.2 - Mid level elbow dimension score. PUL 1.2 - Mid Level Elbow Dimension PUL01-Move Weight on Table Performance of the Upper Limb Module for DMD Version 1.2 - Move weight on table. PUL 1.2 - Move Weight on Table PUL01-Picking Up Coins Performance of the Upper Limb Module for DMD Version 1.2 - Picking up coins. PUL 1.2 - Picking Up Coins PUL01-Placing Finger on Number Diagram Performance of the Upper Limb Module for DMD Version 1.2 - Placing finger on number diagram. PUL 1.2 - Placing Finger on Number Diagram PUL01-Preferred Arm Performance of the Upper Limb Module for DMD Version 1.2 - Preferred arm. PUL 1.2 - Preferred Arm PUL01-Push on The Light Performance of the Upper Limb Module for DMD Version 1.2 - Push on the light. PUL 1.2 - Push on The Light PUL01-Remove Lid From Container Performance of the Upper Limb Module for DMD Version 1.2 - Remove lid from container. PUL 1.2 - Remove Lid From Container PUL01-Shoulder Abduction Above Shldr Hgt Performance of the Upper Limb Module for DMD Version 1.2 - Shoulder abduction above shoulder height. PUL 1.2 - Shoulder Abduction Above Height PUL01-Shoulder Abduction to Shldr Hgt Performance of the Upper Limb Module for DMD Version 1.2 - Shoulder abduction to shoulder height. PUL 1.2 - Shoulder Abduction to Height PUL01-Shoulder Flexion Above Shldr Hgt Performance of the Upper Limb Module for DMD Version 1.2 - Shoulder flexion above shoulder height. PUL 1.2 - Shoulder Flexion Above Height PUL01-Shoulder Flexion to Shldr Height Performance of the Upper Limb Module for DMD Version 1.2 - Shoulder flexion to shoulder height. PUL 1.2 - Shoulder Flexion to Height PUL01-Stacking Heavy Cans Time Performance of the Upper Limb Module for DMD Version 1.2 - Stacking heavy cans, time. PUL 1.2 - Stacking Heavy Cans Time PUL01-Stacking Heavy Cans Performance of the Upper Limb Module for DMD Version 1.2 - Stacking heavy cans. PUL 1.2 - Stacking Heavy Cans PUL01-Stacking Light Cans Time Performance of the Upper Limb Module for DMD Version 1.2 - Stacking light cans, time. PUL 1.2 - Stacking Light Cans Time PUL01-Stacking Light Cans Performance of the Upper Limb Module for DMD Version 1.2 - Stacking light cans. PUL 1.2 - Stacking Light Cans PUL01-Supination Performance of the Upper Limb Module for DMD Version 1.2 - Supination. PUL 1.2 - Supination PUL01-Tearing Paper Performance of the Upper Limb Module for DMD Version 1.2 - Tearing paper. PUL 1.2 - Tearing Paper PUL01-Thumb (Key) Grip Performance of the Upper Limb Module for DMD Version 1.2 - Thumb (key) grip. PUL 1.2 - Thumb (Key) Grip PUL01-Total Score Performance of the Upper Limb Module for DMD Version 1.2 - Total Score. PUL 1.2 - Total Score PUL01-Tracing Path Performance of the Upper Limb Module for DMD Version 1.2 - Tracing path. PUL 1.2 - Tracing Path PUL01TN Performance of the Upper Limb Module for DMD Version 1.2 Functional Test Test Name CDISC Functional Test PUL 1.2 Test Name Terminology Performance of the Upper Limb Module for DMD Version 2.0 test code. PUL02-Shoulder Abduction Arms Above Head Performance of the Upper Limb Module for DMD Version 2.0 - Shoulder abduction both arms above head. PUL 2.0 - Shoulder Abduction Arms Above Head PUL02-Raise Both Arms to Shoulder Height Performance of the Upper Limb Module for DMD Version 2.0 - Raise both arms to shoulder height (elbows at shoulder height). PUL 2.0 - Raise Both Arms to Shoulder Height PUL02-Flexion Shoulder Height No Weights Performance of the Upper Limb Module for DMD Version 2.0 - Shoulder flexion to shoulder height (no weights). PUL 2.0 - Flexion Shoulder Height No Weights PUL02-Flexion to Shoulder Height 500g Performance of the Upper Limb Module for DMD Version 2.0 - Shoulder flexion to shoulder height with 500g weight. PUL 2.0 - Flexion to Shoulder Height 500g PUL02-Flexion Above Shoulder Height 500g Performance of the Upper Limb Module for DMD Version 2.0 - Shoulder flexion above shoulder height with 500g weight. PUL 2.0 - Flexion Above Shoulder Height 500g PUL02-Flexion Above Shoulder Height 1kg Performance of the Upper Limb Module for DMD Version 2.0 - Shoulder flexion above shoulder with 1 kg weight. PUL 2.0 - Flexion Above Shoulder Height 1kg PUL02-Hand(s) to Mouth Performance of the Upper Limb Module for DMD Version 2.0 - Hand(s) to mouth. PUL 2.0 - Hand(s) to Mouth PUL02-Hands to Table From Lap Performance of the Upper Limb Module for DMD Version 2.0 - Hands to table from lap. PUL 2.0 - Hands to Table From Lap PUL02-Move Weight on Table 100g Performance of the Upper Limb Module for DMD Version 2.0 - Move weight on table 100g. PUL 2.0 - Move Weight On Table 100g PUL02-Move Weight on Table 500g Performance of the Upper Limb Module for DMD Version 2.0 - Move weight on table 500g. PUL 2.0 - Move Weight On Table 500g PUL02-Move Weight on Table 1kg Performance of the Upper Limb Module for DMD Version 2.0 - Move weight on table 1kg. PUL 2.0 - Move Weight On Table 1kg PUL02-Lift Heavy Can Diagonally Performance of the Upper Limb Module for DMD Version 2.0 - Lift heavy can diagonally. PUL 2.0 - Lift Heavy Can Diagonally PUL02-Stack of Three Cans Performance of the Upper Limb Module for DMD Version 2.0 - Stack of three cans. PUL 2.0 - Stack of Three Cans PUL02-Stack of Five Cans Performance of the Upper Limb Module for DMD Version 2.0 - Stack of five cans. PUL 2.0 - Stack of Five Cans PUL02-Remove Lid From Container Performance of the Upper Limb Module for DMD Version 2.0 - Remove lid from container. PUL 2.0 - Remove Lid From Container PUL02-Tearing Paper Performance of the Upper Limb Module for DMD Version 2.0 - Tearing paper. PUL 2.0 - Tearing Paper PUL02-Tracing Path Performance of the Upper Limb Module for DMD Version 2.0 - Tracing path. PUL 2.0 - Tracing Path PUL02-Push on Light Performance of the Upper Limb Module for DMD Version 2.0 - Push on light. PUL 2.0 - Push on Light PUL02-Supination Performance of the Upper Limb Module for DMD Version 2.0 - Supination. PUL 2.0 - Supination PUL02-Picking Up Coins Performance of the Upper Limb Module for DMD Version 2.0 - Picking up coins. PUL 2.0 - Picking Up Coins PUL02-Placing Finger on Number Diagram Performance of the Upper Limb Module for DMD Version 2.0 - Placing finger on number diagram. PUL 2.0 - Placing Finger on Number Diagram PUL02-Pick Up 10g Weight Finger Pinch Performance of the Upper Limb Module for DMD Version 2.0 - Pick up 10g weight finger pinch. PUL 2.0 - Pick Up 10g Weight Finger Pinch PUL02-Preferred Arm Performance of the Upper Limb Module for DMD Version 2.0 - Preferred arm. PUL 2.0 - Preferred Arm PUL02-Right Elbow Extension ROM Performance of the Upper Limb Module for DMD Version 2.0 - Right elbow extension ROM. PUL 2.0 - Right Elbow Extension ROM PUL02-Left Elbow Extension ROM Performance of the Upper Limb Module for DMD Version 2.0 - Left elbow extension ROM. PUL 2.0 - Left Elbow Extension ROM PUL02-Right Available Supination ROM Performance of the Upper Limb Module for DMD Version 2.0 - Right available supination ROM. PUL 2.0 - Right Available Supination ROM PUL02-Left Available Supination ROM Performance of the Upper Limb Module for DMD Version 2.0 - Left available supination ROM. PUL 2.0 - Left Available Supination ROM PUL02-High Level Shoulder Dimension Performance of the Upper Limb Module for DMD Version 2.0 - High level shoulder dimension score. PUL 2.0 - High Level Shoulder Dimension PUL02-Mid Level Elbow Dimension Performance of the Upper Limb Module for DMD Version 2.0 - Mid level elbow dimension score. PUL 2.0 - Mid Level Elbow Dimension PUL02-Distal Wrist/Hand Dimension Performance of the Upper Limb Module for DMD Version 2.0 - Distal wrist and hand dimension score. PUL 2.0 - Distal Wrist or Hand Dimension PUL02-Total Score Performance of the Upper Limb Module for DMD Version 2.0 - Total score. PUL 2.0 - Total Score PUL02-Entry Item Performance of the Upper Limb Module for DMD Version 2.0 - Entry item. PUL 2.0 - Entry Item PUL02TC Performance of the Upper Limb Module for DMD Version 2.0 Functional Test Test Code CDISC Functional Test PUL 2.0 Test Code Terminology Performance of the Upper Limb Module for DMD Version 2.0 test name. PUL02-Distal Wrist/Hand Dimension Performance of the Upper Limb Module for DMD Version 2.0 - Distal wrist and hand dimension score. PUL 2.0 - Distal Wrist or Hand Dimension PUL02-Entry Item Performance of the Upper Limb Module for DMD Version 2.0 - Entry item. PUL 2.0 - Entry Item PUL02-Flexion Above Shoulder Height 1kg Performance of the Upper Limb Module for DMD Version 2.0 - Shoulder flexion above shoulder with 1 kg weight. PUL 2.0 - Flexion Above Shoulder Height 1kg PUL02-Flexion Above Shoulder Height 500g Performance of the Upper Limb Module for DMD Version 2.0 - Shoulder flexion above shoulder height with 500g weight. PUL 2.0 - Flexion Above Shoulder Height 500g PUL02-Flexion Shoulder Height No Weights Performance of the Upper Limb Module for DMD Version 2.0 - Shoulder flexion to shoulder height (no weights). PUL 2.0 - Flexion Shoulder Height No Weights PUL02-Flexion to Shoulder Height 500g Performance of the Upper Limb Module for DMD Version 2.0 - Shoulder flexion to shoulder height with 500g weight. PUL 2.0 - Flexion to Shoulder Height 500g PUL02-Hand(s) to Mouth Performance of the Upper Limb Module for DMD Version 2.0 - Hand(s) to mouth. PUL 2.0 - Hand(s) to Mouth PUL02-Hands to Table From Lap Performance of the Upper Limb Module for DMD Version 2.0 - Hands to table from lap. PUL 2.0 - Hands to Table From Lap PUL02-High Level Shoulder Dimension Performance of the Upper Limb Module for DMD Version 2.0 - High level shoulder dimension score. PUL 2.0 - High Level Shoulder Dimension PUL02-Left Available Supination ROM Performance of the Upper Limb Module for DMD Version 2.0 - Left available supination ROM. PUL 2.0 - Left Available Supination ROM PUL02-Left Elbow Extension ROM Performance of the Upper Limb Module for DMD Version 2.0 - Left elbow extension ROM. PUL 2.0 - Left Elbow Extension ROM PUL02-Lift Heavy Can Diagonally Performance of the Upper Limb Module for DMD Version 2.0 - Lift heavy can diagonally. PUL 2.0 - Lift Heavy Can Diagonally PUL02-Mid Level Elbow Dimension Performance of the Upper Limb Module for DMD Version 2.0 - Mid level elbow dimension score. PUL 2.0 - Mid Level Elbow Dimension PUL02-Move Weight on Table 100g Performance of the Upper Limb Module for DMD Version 2.0 - Move weight on table 100g. PUL 2.0 - Move Weight On Table 100g PUL02-Move Weight on Table 1kg Performance of the Upper Limb Module for DMD Version 2.0 - Move weight on table 1kg. PUL 2.0 - Move Weight On Table 1kg PUL02-Move Weight on Table 500g Performance of the Upper Limb Module for DMD Version 2.0 - Move weight on table 500g. PUL 2.0 - Move Weight On Table 500g PUL02-Pick Up 10g Weight Finger Pinch Performance of the Upper Limb Module for DMD Version 2.0 - Pick up 10g weight finger pinch. PUL 2.0 - Pick Up 10g Weight Finger Pinch PUL02-Picking Up Coins Performance of the Upper Limb Module for DMD Version 2.0 - Picking up coins. PUL 2.0 - Picking Up Coins PUL02-Placing Finger on Number Diagram Performance of the Upper Limb Module for DMD Version 2.0 - Placing finger on number diagram. PUL 2.0 - Placing Finger on Number Diagram PUL02-Preferred Arm Performance of the Upper Limb Module for DMD Version 2.0 - Preferred arm. PUL 2.0 - Preferred Arm PUL02-Push on Light Performance of the Upper Limb Module for DMD Version 2.0 - Push on light. PUL 2.0 - Push on Light PUL02-Raise Both Arms to Shoulder Height Performance of the Upper Limb Module for DMD Version 2.0 - Raise both arms to shoulder height (elbows at shoulder height). PUL 2.0 - Raise Both Arms to Shoulder Height PUL02-Remove Lid From Container Performance of the Upper Limb Module for DMD Version 2.0 - Remove lid from container. PUL 2.0 - Remove Lid From Container PUL02-Right Available Supination ROM Performance of the Upper Limb Module for DMD Version 2.0 - Right available supination ROM. PUL 2.0 - Right Available Supination ROM PUL02-Right Elbow Extension ROM Performance of the Upper Limb Module for DMD Version 2.0 - Right elbow extension ROM. PUL 2.0 - Right Elbow Extension ROM PUL02-Shoulder Abduction Arms Above Head Performance of the Upper Limb Module for DMD Version 2.0 - Shoulder abduction both arms above head. PUL 2.0 - Shoulder Abduction Arms Above Head PUL02-Stack of Five Cans Performance of the Upper Limb Module for DMD Version 2.0 - Stack of five cans. PUL 2.0 - Stack of Five Cans PUL02-Stack of Three Cans Performance of the Upper Limb Module for DMD Version 2.0 - Stack of three cans. PUL 2.0 - Stack of Three Cans PUL02-Supination Performance of the Upper Limb Module for DMD Version 2.0 - Supination. PUL 2.0 - Supination PUL02-Tearing Paper Performance of the Upper Limb Module for DMD Version 2.0 - Tearing paper. PUL 2.0 - Tearing Paper PUL02-Total Score Performance of the Upper Limb Module for DMD Version 2.0 - Total score. PUL 2.0 - Total Score PUL02-Tracing Path Performance of the Upper Limb Module for DMD Version 2.0 - Tracing path. PUL 2.0 - Tracing Path PUL02TN Performance of the Upper Limb Module for DMD Version 2.0 Functional Test Test Name CDISC Functional Test PUL 2.0 Test Name Terminology Perianal Crohn's Disease Activity Index test code. PDAI01-Discharge Perianal Crohn's Disease Activity Index - Discharge. PDAI - Discharge PDAI01-Pain/Restriction of Activities Perianal Crohn's Disease Activity Index - Pain/restriction of activities. PDAI - Pain/Restriction of Activities PDAI01-Restriction of Sexual Activity Perianal Crohn's Disease Activity Index - Restriction of sexual activity. PDAI - Restriction of Sexual Activity PDAI01-Type of Perianal Disease Perianal Crohn's Disease Activity Index - Type of perianal disease. PDAI - Type of Perianal Disease PDAI01-Degree of Induration Perianal Crohn's Disease Activity Index - Degree of induration. PDAI - Degree of Induration PDAI01-Total Score Perianal Crohn's Disease Activity Index - Total score. PDAI - Total Score PDAI01TC Perianal Crohn's Disease Activity Index Questionnaire Test Code CDISC Questionnaire Perianal Crohn's Disease Activity Index Test Code Terminology Perianal Crohn's Disease Activity Index test name. PDAI01-Degree of Induration Perianal Crohn's Disease Activity Index - Degree of induration. PDAI - Degree of Induration PDAI01-Discharge Perianal Crohn's Disease Activity Index - Discharge. PDAI - Discharge PDAI01-Pain/Restriction of Activities Perianal Crohn's Disease Activity Index - Pain/restriction of activities. PDAI - Pain/Restriction of Activities PDAI01-Restriction of Sexual Activity Perianal Crohn's Disease Activity Index - Restriction of sexual activity. PDAI - Restriction of Sexual Activity PDAI01-Total Score Perianal Crohn's Disease Activity Index - Total score. PDAI - Total Score PDAI01-Type of Perianal Disease Perianal Crohn's Disease Activity Index - Type of perianal disease. PDAI - Type of Perianal Disease PDAI01TN Perianal Crohn's Disease Activity Index Questionnaire Test Name CDISC Questionnaire Perianal Crohn's Disease Activity Index Test Name Terminology Terminology relevant to the test codes that describe the physical characteristics of an entity. Color The appearance of objects (or light sources) described in terms of a person's perception of their hue and lightness (or brightness) and saturation. (NCI) Color Consistency A description about the firmness or make-up of an entity. Consistency Depth The extent downward or inward; the perpendicular measurement from the surface downward to determine deepness. (NCI) Depth Description A written or verbal account, representation, statement, or explanation of something. (NCI) Description Diameter The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) Diameter Hair Cover A description of the quantity or quality of the hair or fur covering a biological entity. (NCI) Hair or Fur Cover Length The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI) Length Shape The spatial arrangement of something as distinct from its substance. (NCI) Shape Ulceration The formation or development of an ulcer. (NCI) Ulceration Width The extent or measurement of something from side to side. (NCI) Width PHSPRPCD Physical Properties Test Code CDISC SDTM Physical Properties Test Code Terminology Terminology relevant to the test names that describe the physical characteristics of an entity. Color The appearance of objects (or light sources) described in terms of a person's perception of their hue and lightness (or brightness) and saturation. (NCI) Color Consistency A description about the firmness or make-up of an entity. Consistency Depth The extent downward or inward; the perpendicular measurement from the surface downward to determine deepness. (NCI) Depth Description A written or verbal account, representation, statement, or explanation of something. (NCI) Description Diameter The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) Diameter Hair Cover A description of the quantity or quality of the hair or fur covering a biological entity. (NCI) Hair or Fur Cover Length The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI) Length Shape The spatial arrangement of something as distinct from its substance. (NCI) Shape Ulceration The formation or development of an ulcer. (NCI) Ulceration Width The extent or measurement of something from side to side. (NCI) Width PHSPRP Physical Properties Test Name CDISC SDTM Physical Properties Test Name Terminology Terminology relevant to the formula or analysis method associated with a pharmacokinetic parameter calculation. Linear-Logarithmic Trapezoidal Method An AUC calculation method that utilizes the linear trapezoidal interpolation rule up to the maximum concentration (Cmax) and Logarithmic trapezoidal interpolation for the remainder of the concentration curve. Linear-Logarithmic Trapezoidal Method Linear Trapezoidal - Logarithmic Interpolation Method An AUC calculation method that utilizes the linear trapezoidal interpolation rule for the entire concentration curve, except when partial areas are selected with no measured endpoint, then logarithmic interpolation is used to calculate the missing data. Linear Trapezoidal - Log Interpolation Method An AUC calculation method that utilizes the linear trapezoidal interpolation rule for the entire concentration curve. Linear Trapezoidal Method An AUC calculation method that utilizes linear trapezoidal interpolation between two points any time the measured concentration increases and logarithmic trapezoidal interpolation between two points any time the concentration decreases over the entire concentration curve. Linear Up Log Down Method PKANMET PK Analytical Method CDISC SDTM PK Analytical Method Terminology Parameters used to describe the time-concentration curve. Absolute Bioavailability The fraction of the treatment dose that reaches the systemic circulation; this is the ratio of the amount of drug in the system (area under the curve) after extravascular administration of a test formulation divided by the drug in the system (area under the curve) after IV administration. Absolute Bioavailability Accum Ratio AUC Infinity Obs The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration divided by the area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration during the initial dosing interval. Accumulation Ratio AUC Infinity Observed Accum Ratio AUC Infinity Pred The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration divided by the area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration during the initial dosing interval. Accumulation Ratio AUC Infinity Predicted Accum Ratio AUC T1 to T2 norm by dose The area under the curve from T1 to T2 at steady state divided by the area under the curve from T1 to T2 during the initial dosing interval, each divided by the associated dose. Accumulation Ratio AUC T1 to T2 Normalized by Dose Accum Ratio AUC to Last Nonzero Conc The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the area under the curve from the time of dosing to the last measurable concentration during the initial dosing interval. Accumulation Ratio AUC to Last Nonzero Concentration Accum Ratio AUCIFO Norm by Dose The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration divided by the area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration during the initial dosing interval, each divided by the associated dose. Accumulation Ratio AUC Infinity Observed Normalized by Dose Accum Ratio AUCIFP Norm by Dose The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration divided by the area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration during the initial dosing interval, each divided by the associated dose. Accumulation Ratio AUC Infinity Predicted Normalized by Dose Accum Ratio AUCTAU norm by dose The area under the curve (AUCTAU) at steady state divided by the area under the curve (AUCTAU) over the initial dosing interval, each divided by the associated dose. Accumulation Ratio AUC Over Dosing Interval Normalized by Dose Accum Ratio Cmax norm by dose The maximum concentration at steady state divided by the maximum concentration during the initial dosing interval, each divided by the associated dose. Accumulation Ratio Cmax Normalized by Dose Accum Ratio Cmin norm by dose The minimum concentration at steady state divided by the minimum concentration during the initial dosing interval, each divided by the associated dose. Accumulation Ratio Cmin Normalized by Dose Accum Ratio Ctrough norm by dose The trough concentration at steady state divided by the trough concentration during the initial dosing interval, each divided by the associated dose. Accumulation Ratio Ctrough Normalized by Dose Accumulation Index using Lambda z Predicted accumulation ratio for area under the curve (AUC) calculated using the Lambda z estimated from single dose data. Accumulation Index using Lambda z Accumulation Ratio AUC from T1 to T2 The area under the curve from T1 to T2 at steady state divided by the area under the curve from T1 to T2 during the initial dosing interval. Accumulation Ratio Area Under the Curve from T1 to T2 Accumulation Ratio AUCTAU The area under the curve over the dosing interval at steady state divided by the area under the curve over the initial dosing interval. Accumulation Ratio Area Under the Curve Accumulation Ratio Cmax The maximum concentration at steady state divided by the maximum concentration during the initial dosing interval. Accumulation Ratio Cmax Accumulation Ratio Cmin The minimum concentration at steady state divided by the minimum concentration during the initial dosing interval. Accumulation Ratio Cmin Accumulation Ratio Ctrough The trough concentration at steady state divided by the trough concentration during the initial dosing interval. Accumulation Ratio Ctrough Amt of Analyte at Steady State The amount of analyte in the body at steady state. Amount of Analyte at Steady State Amt of Analyte at Time T The amount of analyte in the body at any time t. Amount of Analyte at Time T Amt Rec from T1 to T2 Norm by BMI The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by body mass index. Amount Recovered from T1 to T2 Normalized by Body Mass Index Amt Rec from T1 to T2 Norm by SA The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by surface area. Amount Recovered from T1 to T2 Normalized by Surface Area Amt Rec from T1 to T2 Norm by WT The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by weight. Amount Recovered from T1 to T2 Normalized by Weight Amt Rec from T1 to T2 The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2. Amount Recovered from T1 to T2 Amt Rec Infinity Obs Norm by BMI The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index. Amount Recovered Infinity Observed Normalized by Body Mass Index Amt Rec Infinity Obs Norm by SA The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area. Amount Recovered Infinity Observed Normalized by Surface Area Amt Rec Infinity Obs Norm by WT The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight. Amount Recovered Infinity Observed Normalized by Weight Amt Rec Infinity Obs The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration. Amount Recovered Infinity Observed Amt Rec Infinity Pred Norm by BMI The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. Amount Recovered Infinity Predicted Normalized by Body Mass Index Amt Rec Infinity Pred Norm by SA The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area. Amount Recovered Infinity Predicted Normalized by Surface Area Amt Rec Infinity Pred Norm by WT The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight. Amount Recovered Infinity Predicted Normalized by Weight Amt Rec Infinity Pred The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration. Amount Recovered Infinity Predicted Amt Rec Over Dosing Interval Norm by BMI The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by body mass index. Amount Recovered Over Dosing Interval Normalized by Body Mass Index Amt Rec Over Dosing Interval Norm by SA The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by surface area. Amount Recovered Over Dosing Interval Normalized by Surface Area Amt Rec Over Dosing Interval Norm by WT The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by weight. Amount Recovered Over Dosing Interval Normalized by Weight Amt Rec Over Dosing Interval The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU). Amount Recovered Over Dosing Interval Amt Rec to Last Nonzero Conc The cumulative amount recovered from the specimen type specified in PPSPEC, from the time of dosing to the last non-zero concentration. Amount Recovered to Last Nonzero Concentration Apparent CL for Unbound Drug The total apparent clearance of the unbound fraction of drug, adjusted for bioavailability. Apparent Clearance for Unbound Drug AUC %Back Extrapolation Obs Applies only for intravascular bolus dosing. The area under the curve (AUC) from the first measured concentration value back extrapolated to the concentration value at time zero as a percentage of the area under the curve extrapolated to infinity using the observed value of the last non-zero concentration. Observed Area Under the Curve Percent Back Extrapolation AUC %Back Extrapolation Pred Applies only for intravascular bolus dosing. The area under the curve (AUC) from the first measured concentration value back extrapolated to the concentration value at time zero as a percentage of the area under the curve extrapolated to infinity using the predicted value of the last non-zero concentration. Predicted Area Under the Curve Percent Back Extrapolation AUC %Extrapolation Obs The area under the curve (AUC) from the last observed non-zero concentration value to infinity as a percentage of the area under the curve extrapolated to infinity. Observed Area Under the Curve Percent Extrapolation AUC %Extrapolation Pred The area under the curve (AUC) from the last predicted non-zero concentration value to infinity as a percentage of the area under the curve extrapolated to infinity. Predicted Area Under the Curve Percent Extrapolation AUC All Norm by BMI The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the body mass index, regardless of whether the last concentration is measurable or not. AUC All Normalized by Body Mass Index AUC All Norm by Dose The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the dose, regardless of whether the last concentration is measurable or not. AUC All Normalized by Dose AUC All Norm by SA The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the surface area, regardless of whether the last concentration is measurable or not. AUC All Normalized by Surface Area AUC All Norm by WT The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the weight, regardless of whether the last concentration is measurable or not. AUC All Normalized by Weight AUC All The area under the curve (AUC) from the time of dosing to the time of the last observation, regardless of whether the last concentration is measurable or not. Area Under the Curve All AUC from T1 to T2 Norm by BMI The area under the curve (AUC) over the interval from T1 to T2 divided by the body mass index. AUC from T1 to T2 Normalized by Body Mass Index AUC from T1 to T2 Norm by Dose The area under the curve (AUC) over the interval from T1 to T2 divided by the dose. AUC from T1 to T2 Normalized by Dose AUC from T1 to T2 Norm by SA The area under the curve (AUC) over the interval from T1 to T2 divided by the surface area. AUC from T1 to T2 Normalized by Surface Area AUC from T1 to T2 Norm by WT The area under the curve (AUC) over the interval from T1 to T2 divided by the weight. AUC from T1 to T2 Normalized by Weight AUC from T1 to T2 The area under the curve (AUC) over the interval from T1 to T2. Area Under the Curve from T1 to T2 AUC Infinity Obs LN Transformed The natural log transformed area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration. Natural Log Transformed Observed Area Under the Curve Infinity AUC Infinity Obs Norm by BMI The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index. AUC Infinity Observed Normalized by Body Mass Index AUC Infinity Obs Norm by Dose The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the dose. AUC Infinity Observed Normalized by Dose AUC Infinity Obs Norm by Dose/WT The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration divided by the body weight-adjusted dose. AUC Infinity Observed Normalized by Weight-Adjusted Dose AUC Infinity Obs Norm by SA The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area. AUC Infinity Observed Normalized by Surface Area AUC Infinity Obs Norm by WT The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight. AUC Infinity Observed Normalized by Weight AUC Infinity Obs The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration. Observed Area Under the Curve Infinity AUC Infinity Obs, Unbound Drug The portion of observed AUC to infinity, represented by the unbound fraction of drug. Observed Area Under the Curve Infinity of Unbound Drug AUC Infinity Pred Norm by BMI The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. AUC Infinity Predicted Normalized by Body Mass Index AUC Infinity Pred Norm by Dose The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the dose. Predicted Area Under the Curve Infinity by Dose AUC Infinity Pred Norm by SA The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area. AUC Infinity Predicted Normalized by Surface Area AUC Infinity Pred Norm by WT The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight. AUC Infinity Predicted Normalized by Weight AUC Infinity Pred The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration. Predicted Area Under the Curve Infinity AUC Infinity Pred, Unbound Drug The portion of predicted AUC to infinity, represented by the unbound fraction of drug. Predicted Area Under the Curve Infinity of Unbound Drug AUC Over Dosing Interval Norm by BMI The area under the curve (AUC) for the defined interval between doses (TAU) divided by the body mass index. AUC Over Dosing Interval Normalized by Body Mass Index AUC Over Dosing Interval Norm by Dose The area under the curve (AUC) for the defined interval between doses (TAU) divided by the dose. AUC Over Dosing Interval Normalized by Dose AUC Over Dosing Interval Norm by SA The area under the curve (AUC) for the defined interval between doses (TAU) divided by the surface area. AUC Over Dosing Interval Normalized by Surface Area AUC Over Dosing Interval Norm by WT The area under the curve (AUC) for the defined interval between doses (TAU) divided by the weight. AUC Over Dosing Interval Normalized by Weight AUC Over Dosing Interval The area under the curve (AUC) for the defined interval between doses (TAU). Area Under the Curve Over Dosing Interval AUC to Last Nonzero Conc LN Transformed The natural log transformed area under the curve (AUC) from the time of dosing to the last measurable concentration. Natural Log Transformed Area Under the Curve From Dosing to Last Concentration AUC to Last Nonzero Conc Norm by BMI The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the body mass index. AUC Dosing to Last Concentration Normalized by Body Mass Index AUC to Last Nonzero Conc Norm by Dose The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the dose. AUC Dosing to Last Concentration Normalized by Dose AUC to Last Nonzero Conc Norm by SA The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the surface area. AUC Dosing to Last Concentration Normalized by Surface Area AUC to Last Nonzero Conc Norm by WT The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the weight. AUC Dosing to Last Concentration Normalized by Weight AUC to Last Nonzero Conc The area under the curve (AUC) from the time of dosing to the last measurable concentration. Area Under the Curve From Dosing to Last Concentration AUC to Last Nonzero Conc, Unbound Drug The portion of the area under the curve (AUC) from the time of dosing to the last measurable concentration, represented by the unbound fraction of drug. Area Under the Curve From Dosing to Last Concentration of Unbound Drug AUC Infinity Pred Norm by Dose per Body Weight AUCIFPDW Norm by Dose/WT The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration divided by the body weight-adjusted dose. AUC Infinity Predicted Normalized by Weight-Adjusted Dose AUC from T1 to T2 Norm by Dose per Body Weight AUCINT Norm by Dose/kg WT The area under the curve (AUC) over the interval from T1 to T2 divided by the body weight-adjusted dose. AUC from T1 to T2 Normalized by Weight-Adjusted Dose AUC to Last Nonzero Conc Norm by Dose per Body Weight AUCLST Norm by Dose/WT The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the body weight-adjusted dose. AUC Dosing From Dosing to Last Concentration Normalized by Weight-Adjusted Dose AUC Over Dosing Interval Norm by Dose per Body Weight AUCTAU Norm by Dose/WT The area under the curve (AUC) for the defined interval between doses (TAU) divided by the body weight-adjusted dose. AUC Over Dosing Interval Normalized by Weight-Adjusted Dose AUMC % Extrapolation Obs The area under the moment curve (AUMC) from the last observed non-zero concentration value to infinity as a percentage of the area under the moment curve extrapolated to infinity. Observed Area Under the First Moment Curve Percent Extrapolation AUMC % Extrapolation Pred The area under the moment curve (AUMC) from the last predicted non-zero concentration value to infinity as a percentage of the area under the moment curve extrapolated to infinity. Predicted Area Under the First Moment Curve Percent Extrapolation AUMC Infinity Obs Norm by BMI The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index. AUMC Infinity Observed Normalized by Body Mass Index AUMC Infinity Obs Norm by Dose The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the dose. AUMC Infinity Observed Normalized by Dose AUMC Infinity Obs Norm by SA The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area. AUMC Infinity Observed Normalized by Surface Area AUMC Infinity Obs Norm by WT The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight. AUMC Infinity Observed Normalized by Weight AUMC Infinity Obs The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration. Observed Area Under the First Moment Curve Infinity AUMC Infinity Pred Norm by BMI The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. AUMC Infinity Predicted Normalized by Body Mass Index AUMC Infinity Pred Norm by Dose The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the dose. AUMC Infinity Predicted Normalized by Dose AUMC Infinity Pred Norm by SA The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area. AUMC Infinity Predicted Normalized by Surface Area AUMC Infinity Pred Norm by WT The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight. AUMC Infinity Predicted Normalized by Weight AUMC Infinity Pred The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration. Predicted Area Under the First Moment Curve Infinity AUMC Over Dosing Interval Norm by BMI The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the body mass index. AUMC Over Dosing Interval Normalized by Body Mass Index AUMC Over Dosing Interval Norm by Dose The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the dose. AUMC Over Dosing Interval Normalized by Dose AUMC Over Dosing Interval Norm by SA The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the surface area. AUMC Over Dosing Interval Normalized by Surface Area AUMC Over Dosing Interval Norm by WT The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the weight. AUMC Over Dosing Interval Normalized by Weight AUMC Over Dosing Interval The area under the first moment curve (AUMC) for the defined interval between doses (TAU). Area Under the First Moment Curve Over Dosing Interval AUMC to Last Nonzero Conc Norm by BMI The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the body mass index. AUMC Dosing to Last Concentration Normalized by Body Mass Index AUMC to Last Nonzero Conc Norm by Dose The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the dose. AUMC Dosing to Last Concentration Normalized by Dose AUMC to Last Nonzero Conc Norm by SA The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the surface area. AUMC Dosing to Last Concentration Normalized by Surface Area AUMC to Last Nonzero Conc Norm by WT The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the weight. AUMC Dosing to Last Concentration Normalized by Weight AUMC to Last Nonzero Conc The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration. Area Under the First Moment Curve From Dosing to Last Concentration AURC % Extrapolation Obs The area under the excretion rate curve (AURC) from the last observed non-zero rate value to infinity as a percentage of the area under the excretion rate curve extrapolated to infinity. Observed Area Under the Excretion Rate Curve Percent Extrapolation AURC % Extrapolation Pred The area under the excretion rate curve (AURC) from the last predicted non-zero rate value to infinity as a percentage of the area under the excretion rate curve extrapolated to infinity. Predicted Area Under the Excretion Rate Curve Percent Extrapolation AURC All Norm by BMI The area under the excretion rate curve (AURC) from time zero to the last measurable rate divided by the body mass index. AURC All Normalized by Body Mass Index AURC All Norm by Dose The area under the excretion rate curve (AURC) from time zero to the last measurable rate divided by the dose. AURC All Normalized by Dose AURC All Norm by SA The area under the excretion rate curve (AURC) from time zero to the last measurable rate divided by the surface area. AURC All Normalized by Surface Area AURC All Norm by WT The area under the excretion rate curve (AURC) from time zero to the last measurable rate divided by the weight. AURC All Normalized by Weight AURC All The area under the excretion rate curve (AURC) from time zero to the time of the last observation, regardless of whether the last observation is a measurable concentration or not. Area Under Excretion Rate Curve All AURC to Last Nonzero Rate Norm by BMI The area under the excretion rate curve (AURC) from time zero to the last measurable rate, divided by the body mass index. AURC Dosing to Last Concentration Normalized by Body Mass Index AURC to Last Nonzero Rate Norm by Dose The area under the excretion rate curve (AURC) from time zero to the last measurable rate, divided by the dose. AURC Dosing to Last Concentration Normalized by Dose AURC to Last Nonzero Rate Norm by SA The area under the excretion rate curve (AURC) from time zero to the last measurable rate, divided by the surface area. AURC Dosing to Last Concentration Normalized by Surface Area AURC to Last Nonzero Rate Norm by WT The area under the excretion rate curve (AURC) from time zero to the last measurable rate, divided by the weight. AURC Dosing to Last Concentration Normalized by Weight AURC from T1 to T2 Norm by BMI The area under the excretion rate curve (AURC) over the interval from T1 to T2 divided by the body mass index. AURC from T1 to T2 Normalized by Body Mass Index AURC from T1 to T2 Norm by Dose The area under the excretion rate curve (AURC) over the interval from T1 to T2 divided by the dose. AURC from T1 to T2 Normalized by Dose AURC from T1 to T2 Norm by SA The area under the excretion rate curve (AURC) over the interval from T1 to T2 divided by the surface area. AURC from T1 to T2 Normalized by Surface Area AURC from T1 to T2 Norm by WT The area under the excretion rate curve (AURC) over the interval from T1 to T2 divided by the weight. AURC from T1 to T2 Normalized by Weight AURC from T1 to T2 The area under the excretion rate curve (AURC) over the interval from T1 to T2. Area Under the Excretion Rate Curve from T1 to T2 AURC Infinity Obs Norm by BMI The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the body mass index. AURC Infinity Observed Normalized by Body Mass Index AURC Infinity Obs Norm by Dose The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the dose. AURC Infinity Observed Normalized by Dose AURC Infinity Obs Norm by SA The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the surface area. AURC Infinity Observed Normalized by Surface Area AURC Infinity Obs Norm by WT The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the weight. AURC Infinity Observed Normalized by Weight AURC Infinity Obs The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate. Observed Area Under the Excretion Rate Curve infinity AURC Infinity Pred Norm by BMI The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divided by the body mass index. AURC Infinity Predicted Normalized by Body Mass Index AURC Infinity Pred Norm by Dose The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divided by the dose. AURC Infinity Predicted Normalized by Dose AURC Infinity Pred Norm by SA The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divided by the surface area. AURC Infinity Predicted Normalized by Surface Area AURC Infinity Pred Norm by WT The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divided by the weight. AURC Infinity Predicted Normalized by Weight AURC Infinity Pred The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate. Predicted Area Under the Excretion Rate Curve Infinity AURC to Last Nonzero Rate The area under the excretion rate curve (AURC) from time zero to the time of the last measurable concentration. Area Under the Excretion Rate Curve From Dosing to Last Concentration Average Conc from T1 to T2 Norm by BMI The area under the curve over the interval from T1 to T2 (AUCINT) divided by the length of the interval and then divided by the body mass index. Average Concentration from T1 to T2 Normalized by Body Mass Index Average Conc from T1 to T2 Norm by Dose The area under the curve over the interval from T1 to T2 (AUCINT) divided by the length of the interval and then divided by the dose. Average Concentration from T1 to T2 Normalized by Dose Average Conc from T1 to T2 Norm by SA The area under the curve over the interval from T1 to T2 (AUCINT) divided by the length of the interval and then divided by the surface area. Average Concentration from T1 to T2 Normalized by Surface Area Average Conc from T1 to T2 Norm by WT The area under the curve over the interval from T1 to T2 (AUCINT) divided by the length of the interval and then divided by the weight. Average Concentration from T1 to T2 Normalized by Weight Average Conc from T1 to T2 The area under the curve over the interval from T1 to T2 (AUCINT) divided by the length of the interval. Average Concentration from T1 to T2 Average Conc Norm by BMI AUCTAU divided by TAU and then divided by the body mass index. Average Concentration Normalized by Body Mass Index Average Conc Norm by Dose AUCTAU divided by TAU and then divided by the dose. Average Concentration Normalized by Dose Average Conc Norm by SA AUCTAU divided by TAU and then divided by the surface area. Average Concentration Normalized by Surface Area Average Conc Norm by WT AUCTAU divided by TAU and then divided by the weight. Average Concentration Normalized by Weight Average Concentration Norm by Dose/WT AUCTAU divided by TAU divided by the body weight-adjusted dose. Average Concentration Normalized by Weight-Adjusted Dose Average Concentration AUCTAU divided by TAU. Average Concentration Average of Conc Trough The arithmetic average of two or more trough concentrations. Average of Trough Concentration Average Conc from T1 to T2 Norm by Dose per Body Weight CAVGINT Norm by Dose/WT The area under the curve over the interval from T1 to T2 (AUCINT) divided by the length of the interval divided by the body weight-adjusted dose. Average Concentration from T1 to T2 Normalized by Weight-Adjusted Dose Conc by BMI The concentration divided by body mass index. Concentration Divided by Body Mass Index Conc by Dose The concentration divided by dose. Concentration Divided by Dose Conc by SA The concentration divided by surface area. Concentration Divided by Surface Area Conc by WT The concentration divided by weight. Concentration Divided by Weight Conc Trough by BMI The trough concentration divided by body mass index. Trough Concentration Divided by Body Mass Index Conc Trough by Dose The trough concentration divided by dose. Trough Concentration Divided by Dose Conc Trough by SA The trough concentration divided by surface area. Trough Concentration Divided by Surface Area Conc Trough by WT The trough concentration divided by weight. Trough Concentration Divided by Weight Conc Trough Concentration Trough Ctrough Trough Level Concentration at end of a dosing interval, immediately before the next dose is administered. Trough Concentration Concentration at End Infusion The observed concentration at the end of the infusion. Concentration at End Infusion Concentration at Half Tmax The concentration that occurs at the midpoint time between dosing time and Tmax. Concentration at Half Tmax Correlation Between TimeX and Log ConcY The correlation between time (X) and log concentration (Y) for the points used in the estimation of lambda z. Time and Log Concentration Correlation Dosing Interval The duration of time between two doses. Dosing Interval Effective Half-Life The drug half-life that quantifies the accumulation ratio of a drug following multiple dosing. Effective Half-life Excret Rate from T1 to T2 Norm by BMI The excretion rate over the interval from T1 to T2 divided by the body mass index, determined for the specimen type specified in PPSPEC. Excretion Rate From T1 to T2 Normalized by BMI Excret Rate from T1 to T2 Norm by Dose The excretion rate over the interval from T1 to T2 divided by the dose, determined for the specimen type specified in PPSPEC. Excretion Rate From T1 to T2 Normalized by Dose Excret Rate from T1 to T2 Norm by SA The excretion rate over the interval from T1 to T2 divided by the surface area, determined for the specimen type specified in PPSPEC. Excretion Rate From T1 to T2 Normalized by SA Excret Rate from T1 to T2 Norm by WT The excretion rate over the interval from T1 to T2 divided by the weight, determined for the specimen type specified in PPSPEC. Excretion Rate From T1 to T2 Normalized by WT Excret Rate from T1 to T2 The excretion rate over the interval from T1 to T2, determined for the specimen type specified in PPSPEC. Excretion Rate From T1 to T2 Fluctuation% The difference between Cmin and Cmax standardized to Cavg, between dose time and Tau. Concentration Variability Between Dose Time and Tau Fract Excr from T1 to T2 The fraction of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2. Fractional Excretion from T1 to T2 Fraction Bound The percent or ratio of bound substance concentration to the total concentration. Fraction Bound Fraction of the Dose Metabolized The fraction of the bioavailable dose which has been metabolized. Fraction of the Dose Metabolized Fraction Unbound The percent or ratio of free substance concentration to the total concentration. (NCI) Fraction Unbound Half Tmax The midpoint time between dosing time and Tmax. Half Tmax Half-Life Distribution Half-life calculated from the distributional phase. Half-Life Distribution Half-Life Lambda z Terminal half-life. Terminal Half Life Half-Life TAU Half-life calculated within a dosing interval. Half-Life TAU Hemodialysis Clearance The clearance of a substance from the blood during a hemodialysis session. Hemodialysis Clearance Hemodialysis Extraction Ratio The fractional content of a substance removed from the blood during a hemodialysis session. Hemodialysis Extraction Ratio Initial Conc Norm by BMI Initial concentration divided by the body mass index. Given only for bolus IV models. Initial Concentration Normalized by Body Mass Index Initial Conc Norm by Dose Initial concentration divided by the dose. Given only for bolus IV models. Initial Concentration Normalized by Dose Initial Conc Norm by SA Initial concentration divided by the surface area. Given only for bolus IV models. Initial Concentration Normalized by Surface Area Initial Conc Norm by WT Initial concentration divided by the weight. Given only for bolus IV models. Initial Concentration Normalized by Weight Initial Conc Initial concentration. Given only for bolus IV models. Initial Concentration K Slope of Distribution The distribution rate constant. K Slope of Distribution Lambda z Lower Limit TAU The lower limit on time for values to be included in the calculation of Lambda z, calculated within a dosing interval. Lambda z Lower Limit TAU Lambda z Lower Limit The lower limit on time for values to be included in the calculation of Lambda z. Lambda Z Time Lower Limit Lambda z Span The interval of time covered by the data points used in the terminal disposition phase regression analysis, divided by half life. This yields the terminal disposition phase duration expressed as the number of half lives. Lambda Z Span Lambda z TAU The first order rate constant associated with the terminal (log-linear) portion of the curve, calculated within a dosing interval. Lambda z TAU Lambda z Upper Limit TAU The upper limit on time for values to be included in the calculation of Lambda z, calculated within a dosing interval. Lambda z Upper Limit TAU Lambda z Upper Limit The upper limit on time for values to be included in the calculation of Lambda z. Lambda Z Time Upper Limit Lambda z The first order rate constant associated with the terminal (log-linear) portion of the curve. Lambda Z Last Meas Excretion Rate Norm by BMI The last measurable (positive) excretion rate divided by the body mass index. Last Measurable Excretion Rate Normalized by Body Mass Index Last Meas Excretion Rate Norm by Dose The last measurable (positive) excretion rate divided by the dose. Last Measurable Excretion Rate Normalized by Dose Last Meas Excretion Rate Norm by SA The last measurable (positive) excretion rate divided by the surface area. Last Measurable Excretion Rate Normalized by Surface Area Last Meas Excretion Rate Norm by WT The last measurable (positive) excretion rate divided by the weight. Last Measurable Excretion Rate Normalized by Weight Last Meas Excretion Rate The last measurable (positive) excretion rate determined for the specimen type specified in PPSPEC. Last Measurable Observed Excretion Rate Last Nonzero Conc Norm by BMI The concentration corresponding to Tlast divided by the body mass index. Last Concentration Normalized by Body Mass Index Last Nonzero Conc Norm by Dose The concentration corresponding to Tlast divided by the dose. Last Concentration Normalized by Dose Last Nonzero Conc Norm by SA The concentration corresponding to Tlast divided by the surface area. Last Concentration Normalized by Surface Area Last Nonzero Conc Norm by WT The concentration corresponding to Tlast divided by the weight. Last Concentration Normalized by Weight Last Nonzero Conc The concentration corresponding to Tlast. Last Concentration Max Conc LN Transformed The natural log transformed maximum concentration occurring at Tmax. Natural Log Transformed Cmax Max Conc Norm by BMI The maximum concentration occurring at Tmax, divided by the body mass index. Maximum Concentration Normalized by Body Mass Index Max Conc Norm by Dose The maximum concentration occurring at Tmax, divided by the dose. Maximum Concentration Dose Normalized Max Conc Norm by Dose/WT The maximum concentration occurring at Tmax divided by the body weight-adjusted dose. Maximum Concentration Normalized by Weight-Adjusted Dose Max Conc Norm by SA The maximum concentration occurring at Tmax, divided by the surface area. Maximum Concentration Normalized by Surface Area Max Conc Norm by WT The maximum concentration occurring at Tmax, divided by the weight. Maximum Concentration Normalized by Weight Cmax Max Conc Maximum Concentration The maximum concentration occurring at Tmax. Cmax Max Conc, Unbound Drug The maximum concentration represented by the unbound fraction of drug, occurring at Tmax. Maximum Concentration of Unbound Drug Max Excretion Rate Norm by BMI The maximum excretion rate divided by the body mass index. Maximum Observed Excretion Rate Normalized by Body Mass Index Max Excretion Rate Norm by Dose The maximum excretion rate divided by the dose. Maximum Observed Excretion Rate Normalized by Dose Max Excretion Rate Norm by SA The maximum excretion rate divided by the surface area. Maximum Observed Excretion Rate Normalized by Surface Area Max Excretion Rate Norm by WT The maximum excretion rate divided by the weight. Maximum Observed Excretion Rate Normalized by Weight Max Excretion Rate The maximum excretion rate determined for the specimen type specified in PPSPEC. Maximum Observed Excretion Rate Mean Absorption Time Mean absorption time of a substance administered by extravascular dosing. Mean Absorption Time Metabolic Ratio of Accumulation Ratios The metabolic ratio of two accumulation ratio values. Metabolic Ratio of Accumulation Ratios Midpoint of Interval of Last Nonzero ER The midpoint of collection interval associated with last measurable excretion rate. Collection Interval Midpoint Midpoint of Interval of Maximum ER The midpoint of collection interval associated with the maximum excretion rate. Time of Maximum Observed Excretion Rate Min Conc Norm by BMI The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the body mass index. Minimum Concentration Normalized by Body Mass Index Min Conc Norm by Dose The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the dose. Minimum Concentration Normalized by Dose Min Conc Norm by Dose/WT The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the body weight-adjusted dose. Minimum Concentration Normalized by Weight-Adjusted Dose Min Conc Norm by SA The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the surface area. Minimum Concentration Normalized by Surface Area Min Conc Norm by WT The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the weight. Minimum Concentration Normalized by Weight Cmin Min Conc Minimum Concentration The minimum concentration between dose time and dose time plus Tau (at Tmin). Cmin MRT Extravasc Infinity Obs The mean residence time (MRT) extrapolated to infinity for a substance administered by extravascular dosing, calculated using the observed value of the last non-zero concentration. Extravascular MRT includes Mean Absorption Time (MAT). Mean Residence Time Infinity Observed by Extravascular Dose MRT Extravasc Infinity Pred The mean residence time (MRT) extrapolated to infinity for a substance administered by extravascular dosing, calculated using the predicted value of the last non-zero concentration. Extravascular MRT includes Mean Absorption Time (MAT). Mean Residence Time Infinity Predicted by Extravascular Dose MRT Extravasc to Last Nonzero Conc Mean residence time (MRT) from the time of dosing to the time of the last measurable concentration for a substance administered by extravascular dosing. Extravascular MRT includes Mean Absorption Time (MAT). Mean Residence Time to Last Nonzero Concentration by Extravascular Dose MRT IV Bolus Infinity Obs The mean residence time (MRT) extrapolated to infinity for a substance administered by intravascular bolus dosing, calculated using the observed value of the last non-zero concentration. Mean Residence Time Infinity Observed by Intravascular Bolus Dose MRT IV Bolus Infinity Pred The mean residence time (MRT) extrapolated to infinity for a substance administered by intravascular bolus dosing, calculated using the predicted value of the last non-zero concentration. Mean Residence Time Infinity Predicted by Intravascular Bolus Dose MRT IV Bolus to Last Nonzero Conc Mean residence time (MRT) from the time of dosing to the time of the last measurable concentration, for a substance administered by intravascular bolus dosing. Mean Residence Time to Last Nonzero Concentration by Intravascular Bolus Dose MRT IV Cont Inf Infinity Obs The mean residence time (MRT) extrapolated to infinity for a substance administered by constant rate of continuous intravascular infusion, calculated using the observed value of the last non-zero concentration. Mean Residence Time Intravenous Continuous Infusion Infinity Observed MRT IV Cont Inf Infinity Pred The mean residence time (MRT) extrapolated to infinity for a substance administered by constant rate of continuous intravascular infusion, calculated using the predicted value of the last non-zero concentration. Mean Residence Time Intravenous Continuous Infusion Infinity Predicted MRT IV Cont Inf to Last Nonzero Conc Mean residence time (MRT) from the time of dosing to the time of the last measurable concentration, for a substance administered by constant rate of continuous intravascular infusion. Mean Residence Time Intravenous Continuous Infusion to Last Nonzero Concentration Nonrenal CL Norm by BMI The total clearance of a substance from the blood minus the renal clearance divided by the body mass index. Nonrenal Clearance Normalized by BMI Nonrenal CL Norm by Dose The total clearance of a substance from the blood minus the renal clearance divided by the dose. Nonrenal Clearance Normalized by Dose Nonrenal CL Norm by SA The total clearance of a substance from the blood minus the renal clearance divided by the surface area. Nonrenal Clearance Normalized by SA Nonrenal CL Norm by WT The total clearance of a substance from the blood minus the renal clearance divided by the weight. Nonrenal Clearance Normalized by WT Nonrenal CL The total clearance of a substance from the blood less the renal clearance. Nonrenal Clearance Number of Points for Lambda z TAU The number of time points used in computing Lambda z determined in a dosing interval. Number of Points for Lambda z TAU Number of Points for Lambda z The number of time points used in computing Lambda z. Sum of Lambda Z Timepoints Pct Rec from T1 to T2 Norm by BMI The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by body mass index. Percent Recovered from T1 to T2 Normalized by Body Mass Index Pct Rec from T1 to T2 Norm by SA The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by surface area. Percent Recovered from T1 to T2 Normalized by Surface Area Pct Rec from T1 to T2 Norm by WT The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by weight. Percent Recovered from T1 to T2 Normalized by Weight Pct Rec from T1 to T2 The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2. Percent Recovered from T1 to T2 Pct Rec Infinity Obs Norm by BMI The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index. Percent Recovered Infinity Observed Normalized by Body Mass Index Pct Rec Infinity Obs Norm by SA The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area. Percent Recovered Infinity Observed Normalized by Surface Area Pct Rec Infinity Obs Norm by WT The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight. Percent Recovered Infinity Observed Normalized by Weight Pct Rec Infinity Obs The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration. Percent Recovered Infinity Observed Pct Rec Infinity Pred Norm by BMI The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. Percent Recovered Infinity Predicted Normalized by Body Mass Index Pct Rec Infinity Pred Norm by SA The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area. Percent Recovered Infinity Predicted Normalized by Surface Area Pct Rec Infinity Pred Norm by WT The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight. Percent Recovered Infinity Predicted Normalized by Weight Pct Rec Infinity Pred The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration. Percent Recovered Infinity Predicted Pct Rec Over Dosing Interval Norm by BMI The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by the body mass index. Percent Recovered Over Dosing Interval Normalized by Body Mass Index Pct Rec Over Dosing Interval Norm by SA The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by surface area. Percent Recovered Over Dosing Interval Normalized by Surface Area Pct Rec Over Dosing Interval Norm by WT The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by weight. Percent Recovered Over Dosing Interval Normalized by Weight Pct Rec Over Dosing Interval The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU). Percent Recovered Over Dosing Interval Pct Rec to Last Nonzero Conc The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, from the time of dosing to the last non-zero concentration. Percent Recovered To Last Nonzero Concentration Peak Trough Ratio The maximum concentration during a dosing interval divided by the concentration at the end of the dosing interval. Peak Trough Ratio R Squared Adjusted The goodness of fit statistic for the terminal elimination phase, adjusted for the number of time points used in the estimation of Lambda z. Adjusted R Squared R Squared The goodness of fit statistic for the terminal elimination phase. R Squared Ratio Amt Rec from T1 to T2 The ratio of two amount recovered from T1 to T2 values. Ratio Amount Recovered from T1 to T2 Ratio Amt Rec Infinity Obs The ratio of two amount recovered infinity observed values. Ratio Amount Recovered Infinity Observed Ratio AUC All The ratio of two AUC All values. AUC All Ratio Ratio AUC from T1 to T2 Norm by Dose The ratio of two AUC from T1 to T2 normalized by dose values. Ratio AUC from T1 to T2 Normalized by Dose Ratio AUC from T1 to T2 The ratio of two AUC from T1 to T2 values. Ratio AUC From T1 to T2 Ratio AUC Infinity Obs Norm by Dose The ratio of two AUC infinity observed normalized by dose values. Ratio AUC Infinity Observed Normalized by Dose Ratio AUC Infinity Obs The ratio of two AUC infinity observed values. Area Under the Curve Ratio Infinity Observed Ratio AUC Infinity Pred The ratio of two AUC infinity predicted values. Area Under the Curve Ratio Infinity Predicted Ratio AUC Over Dosing Interval The ratio of two AUCTAU values. Ratio AUC Over Dosing Interval Ratio AUC to Last Nonzero Conc The ratio of two AUC to last nonzero concentration values. Ratio AUC to Last Nonzero Concentration Ratio AUC The ratio of two AUC values. Area Under the Curve Ratio Ratio Average Concentration The ratio of two average concentration values. Average Concentration Ratio Ratio CMAX The ratio of two Cmax values. Cmax to Cmax Ratio Measurement Ratio Conc Trough The ratio of two CTROUGH values. Ratio Concentration Trough Ratio Concentration The ratio of two concentration values. Concentration Ratio Ratio Max Conc Norm by Dose The ratio of two maximum concentration normalized by dose values. Ratio Maximum Concentration Normalized by Dose Ratio Min Conc The ratio of two cmin values. Minimum Concentration Ratio Ratio of CMAX to CMIN The ratio of Cmax value to Cmin value. Cmax to Cmin Ratio Measurement Ratio AUC to Last Nonzero Conc Norm by Dose The ratio of two AUC to last nonzero concentration normalized by dose values. Ratio AUC to Last Nonzero Concentration Normalized by Dose Relative Bioavailability The fraction of the treatment dose that reaches the systemic circulation relative to a reference route or reference formulation. The ratio of the amount of drug in the system (area under the curve) after administration of a test formulation divided by the drug in the system after a non-IV administration of a reference formulation and/or reference route. Relative Bioavailability Renal CL as Pct CL EV The portion of total clearance attributed to the kidneys expressed as a percentage, following extravascular administration. Renal Clearance to Total Clearance Ratio Measurement After Oral Dosing Renal CL as Pct CL IV The portion of total clearance attributed to the kidneys expressed as a percentage, following intravenous administration. Renal Clearance to Total Clearance Ratio Measurement After Intravenous Dosing Renal CL for Dose Int Norm by BMI The clearance of a substance from the blood by the kidneys, calculated using AUCTAU, divided by the body mass index. Renal Clearance for Dose Interval Normalized by Body Mass Index Renal CL for Dose Int Norm by Dose The clearance of a substance from the blood by the kidneys, calculated using AUCTAU, divided by the dose. Renal Clearance for Dose Interval Normalized by Dose Renal CL for Dose Int Norm by SA The clearance of a substance from the blood by the kidneys, calculated using AUCTAU, divided by the surface area. Renal Clearance for Dose Interval Normalized by Surface Area Renal CL for Dose Int Norm by WT The clearance of a substance from the blood by the kidneys, calculated using AUCTAU, divided by the weight. Renal Clearance for Dose Interval Normalized by Weight Renal CL for Dose Int The clearance of a substance from the blood by the kidneys, calculated using AUCTAU. Renal Clearance for Dose Interval Renal CL for Unbound Drug The unbound fraction of drug within the portion of total clearance attributed to the kidneys. Renal Clearance for Unbound Drug Renal CL from T1 to T2 Norm by BMI The clearance of a substance from the blood by the kidneys over the interval from T1 to T2 divided by the body mass index. Renal Clearance from T1 to T2 Normalized by Body Mass Index Renal CL from T1 to T2 Norm by Dose The clearance of a substance from the blood by the kidneys over the interval from T1 to T2 divided by the dose. Renal Clearance from T1 to T2 Normalized by Dose Renal CL from T1 to T2 Norm by SA The clearance of a substance from the blood by the kidneys over the interval from T1 to T2 divided by the surface area. Renal Clearance from T1 to T2 Normalized by Surface Area Renal CL from T1 to T2 Norm by WT The clearance of a substance from the blood by the kidneys over the interval from T1 to T2 divided by the weight. Renal Clearance from T1 to T2 Normalized by Weight Renal CL from T1 to T2 The clearance of a substance from the blood by the kidneys over the interval from T1 to T2. Renal Clearance from T1 to T2 Renal CL Norm by BMI The clearance of a substance from the blood by the kidneys divided by the body mass index. Renal Clearance Normalized by BMI Renal CL Norm by Dose The clearance of a substance from the blood by the kidneys divided by the dose. Renal Clearance Normalized by Dose Renal CL Norm by SA The clearance of a substance from the blood by the kidneys divided by the surface area. Renal Clearance Normalized by SA Renal CL Norm by WT The clearance of a substance from the blood by the kidneys divided by the weight. Renal Clearance Normalized by WT Renal CL The clearance of a substance from the blood by the kidneys. Renal Clearance Stationarity Ratio AUC The area under the curve (AUCTAU) at steady state divided by the area under the curve extrapolated to infinity for the initial dosing interval. Stationarity Ratio Area Under the Curve Sum of Urine Vol The sum of urine volumes that are used for PK parameters. Sum Urine Volume Swing The difference between Cmax and Cmin standardized to Cmin within a dosing interval. PK Swing Time of CMAX Time of CMAX Observation The time of maximum observed concentration sampled during a dosing interval. Tmax Time of CMIN Time of CMIN Observation The time of minimum observed concentration sampled during a dosing interval. Tmin Time of Last Nonzero Conc The time of the last measurable (positive) concentration. Time of Last Nonzero Concentration Time Until First Nonzero Conc The time prior to the first measurable (non-zero) concentration. Time until First Nonzero Concentration Total CL by F for Dose Int Norm by BMI The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the body mass index. Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Body Mass Index Total CL by F for Dose Int Norm by Dose The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the dose. Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Dose Total CL by F for Dose Int Norm by SA The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the surface area. Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Surface Area Total CL by F for Dose Int Norm by WT The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the weight. Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Weight Total CL by F for Dose Int The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU. Total Body Clearance by Fraction of Dose for Dose Interval Total CL for Dose Int Norm by BMI The total body clearance for intravascular administration, calculated using AUCTAU, divided by the body mass index. Total Body Clearance for Dose Interval Normalized by Body Mass Index Total CL for Dose Int Norm by Dose The total body clearance for intravascular administration, calculated using AUCTAU, divided by the dose. Total Body Clearance for Dose Interval Normalized by Dose Total CL for Dose Int Norm by SA The total body clearance for intravascular administration, calculated using AUCTAU, divided by the surface area. Total Body Clearance for Dose Interval Normalized by Surface Area Total CL for Dose Int Norm by WT The total body clearance for intravascular administration, calculated using AUCTAU, divided by the weight. Total Body Clearance for Dose Interval Normalized by Weight Total CL for Dose Int The total body clearance for intravascular administration, calculated using AUCTAU. Total Body Clearance for Dose Interval Total CL Obs by F Norm by BMI The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the AUCINF based on the observed value of the last non-zero concentration, divided by the body mass index. Total Clearance Observed by Fraction Dose Normalized by Body Mass Index Total CL Obs by F Norm by Dose The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the AUCINF based on the observed value of the last non-zero concentration, divided by the dose. Total Clearance Observed by Fraction Dose Normalized by Dose Total CL Obs by F Norm by SA The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the AUCINF based on the observed value of the last non-zero concentration, divided by the surface area. Total Clearance Observed by Fraction Dose Normalized by Surface Area Total CL Obs by F Norm by WT The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the AUCINF based on the observed value of the last non-zero concentration, divided by the weight. Total Clearance Observed by Fraction Dose Normalized by Weight Total CL Obs by F The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the AUCINF based on the observed value of the last non-zero concentration. Observed Total Body Clearance by Fraction of Dose Absorbed Total CL Obs for Unbound Drug The total body clearance for intravascular administration divided by the fraction of drug unbound, calculated using the AUCINF based on the observed value of the last non-zero concentration. Total Clearance Observed for Unbound Drug Total CL Obs Norm by BMI The total body clearance for intravascular administration, calculated using the AUCINF based on the observed value of the last non-zero concentration, divided by the body mass index. Total Clearance Observed Normalized by Body Mass Index Total CL Obs Norm by Dose The total body clearance for intravascular administration, calculated using the AUCINF based on the observed value of the last non-zero concentration, divided by the dose. Total Clearance Observed Normalized by Dose Total CL Obs Norm by SA The total body clearance for intravascular administration, calculated using the AUCINF based on the observed value of the last non-zero concentration, divided by the surface area. Total Clearance Observed Normalized by Surface Area Total CL Obs Norm by WT The total body clearance for intravascular administration, calculated using the AUCINF based on the observed value of the last non-zero concentration, divided by the weight. Total Clearance Observed Normalized by Weight Total CL Obs The total body clearance for intravascular administration, calculated using the AUCINF based on the observed value of the last non-zero concentration. Observed Total Body Clearance Rate Total CL Pred by F Norm by BMI The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the AUCINF based on the predicted value of the last non-zero concentration, divided by body mass index. Total Clearance Predicted by Fraction Dose Normalized by Body Mass Index Total CL Pred by F Norm by Dose The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the AUCINF based on the predicted value of the last non-zero concentration, divided by the dose. Total Clearance Predicted by Fraction Dose Normalized by Dose Total CL Pred by F Norm by SA The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the AUCINF based on the predicted value of the last non-zero concentration, divided by the surface area. Total Clearance Predicted by Fraction Dose Normalized by Surface Area Total CL Pred by F Norm by WT The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the AUCINF based on the predicted value of the last non-zero concentration, divided by the weight. Total Clearance Predicted by Fraction Dose Normalized by Weight Total CL Pred by F The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the AUCINF based on the predicted value of the last non-zero concentration. Predicted Total Body Clearance by Fraction of Dose Absorbed Total CL Pred for Unbound Drug The total body clearance for intravascular administration divided by the fraction of drug unbound, calculated using the AUCINF based on the predicted value of the last non-zero concentration. Total Clearance Predicted for Unbound Drug Total CL Pred Norm by BMI The total body clearance for intravascular administration, calculated using the AUCINF based on the predicted value of the last non-zero concentration, divided by the body mass index. Total Clearance Predicted Normalized by Body Mass Index Total CL Pred Norm by Dose The total body clearance for intravascular administration, calculated using the AUCINF based on the predicted value of the last non-zero concentration, divided by the dose. Total Clearance Predicted Normalized by Dose Total CL Pred Norm by SA The total body clearance for intravascular administration, calculated using the AUCINF based on the predicted value of the last non-zero concentration, divided by the surface area. Total Clearance Predicted Normalized by Surface Area Total CL Pred Norm by WT The total body clearance for intravascular administration, calculated using the AUCINF based on the predicted value of the last non-zero concentration, divided by the weight. Total Clearance Predicted Normalized by Weight Total CL Pred The total body clearance for intravascular administration, calculated using the AUCINF based on the predicted value of the last non-zero concentration. Predicted Total Body Clearance Rate Trough Peak Ratio The concentration at the start of a dosing interval divided by the maximum concentration during the dosing interval. Trough Peak Ratio Vol Dist Initial Norm by BMI The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the body mass index. Initial Volume of Distribution Normalized by Body Mass Index Vol Dist Initial Norm by Dose The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the dose. Initial Volume of Distribution Normalized by Dose Vol Dist Initial Norm by SA The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the surface area. Initial Volume of Distribution Normalized by Surface Area Vol Dist Initial Norm by WT The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the weight. Initial Volume of Distribution Normalized by Weight Vol Dist Initial The initial volume of distribution for a substance administered by bolus intravascular dosing. Initial Volume of Distribution Vol Dist Steady State Obs by B The volume of distribution at steady state based on the observed CLST for a substance administered, divided by the fraction of bound drug. Volume of Distribution Steady State Observed by Bound Drug Vol Dist Steady State Obs by F The volume of distribution at steady state based on the observed CLST for a substance administered by extravascular dosing, divided by the fraction of dose absorbed. Volume of Distribution Steady State Observed by Fraction of Dose Absorbed Vol Dist Steady State Obs by UB The volume of distribution at steady state based on the observed CLST for a substance administered, divided by the fraction of unbound drug. Volume of Distribution Steady State Observed by Unbound Drug Vol Dist Steady State Obs Norm by BMI The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the body mass index. Observed Steady State Volume of Distribution Normalized by Body Mass Index Vol Dist Steady State Obs Norm by Dose The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the dose. Observed Steady State Volume of Distribution Normalized by Dose Vol Dist Steady State Obs Norm by SA The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the surface area. Observed Steady State Volume of Distribution Normalized by Surface Area Vol Dist Steady State Obs Norm by WT The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the weight. Observed Steady State Volume of Distribution Normalized by Weight Vol Dist Steady State Obs The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing. Observed Steady State Volume of Distribution Vol Dist Steady State Pred by B The volume of distribution at steady state based on the predicted CLST for a substance administered, divided by the fraction of bound drug. Volume of Distribution Steady State Predicted by Bound Drug Vol Dist Steady State Pred by F The volume of distribution at steady state based on the predicted CLST for a substance administered by extravascular dosing, divided by the fraction of dose absorbed. Volume of Distribution Steady State Predicted by Fraction of Dose Absorbed Vol Dist Steady State Pred by UB The volume of distribution at steady state based on the predicted CLST for a substance administered, divided by the fraction of unbound drug. Volume of Distribution Steady State Predicted by Unbound Drug Vol Dist Steady State Pred Norm by BMI The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the body mass index. Predicted Steady State Volume of Distribution Normalized by Body Mass Index Vol Dist Steady State Pred Norm by Dose The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the dose. Predicted Steady State Volume of Distribution Normalized by Dose Vol Dist Steady State Pred Norm by SA The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the surface area. Predicted Steady State Volume of Distribution Normalized by Surface Area Vol Dist Steady State Pred Norm by WT The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the weight. Predicted Steady State Volume of Distribution Normalized by Weight Vol Dist Steady State Pred The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing. Predicted Steady State Volume of Distribution Vz for Dose Int by F Norm by BMI The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the body mass index. Volume of Distribution for Dosing Interval by Fraction Normalized by Body Mass Index Vz for Dose Int by F Norm by Dose The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the dose. Volume of Distribution for Dosing Interval by Fraction Normalized by Dose Vz for Dose Int by F Norm by SA The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the surface area. Volume of Distribution for Dosing Interval by Fraction Normalized by Surface Area Vz for Dose Int by F Norm by WT The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the weight. Volume of Distribution for Dosing Interval by Fraction Normalized by Weight Vz for Dose Int by F The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU. Volume of Distribution for Dosing Interval by Fraction Vz for Dose Int Norm by BMI The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the body mass index. Volume of Distribution for Dosing Interval Normalized by Body Mass Index Vz for Dose Int Norm by Dose The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the dose. Volume of Distribution for Dosing Interval Normalized by Dose Vz for Dose Int Norm by SA The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the surface area. Volume of Distribution for Dosing Interval Normalized by Surface Area Vz for Dose Int Norm by WT The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the weight. Volume of Distribution for Dosing Interval Normalized by Weight Vz for Dose Int The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU. Volume of Distribution for Dosing Interval Vz Obs by F for UB The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration and corrected for unbound drug. Observed Volume of Distribution of Absorbed Fraction for Unbound Drug Vz Obs by F Norm by BMI The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the body mass index. Volume of Distribution of Fraction Dose Observed Normalized by Body Mass Index Vz Obs by F Norm by Dose The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the dose. Volume of Distribution of Fraction Dose Observed Normalized by Dose Vz Obs by F Norm by SA The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the surface area. Volume of Distribution of Fraction Dose Observed Normalized by Surface Area Vz Obs by F Norm by WT The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the weight. Volume of Distribution of Fraction Dose Observed Normalized by Weight Vz Obs by F The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration. Observed Volume of Distribution of Absorbed Fraction Vz Obs for UB The volume of distribution associated with the terminal slope following administration, calculated using the observed value of the last non-zero concentration and corrected for unbound drug. Volume of Distribution Observed for Unbound Drug Vz Obs Norm by BMI The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the body mass index. Volume of Distribution Observed Normalized by Body Mass Index Vz Obs Norm by Dose The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the dose. Observed Volume of Distribution Normalized by Dose Vz Obs Norm by SA The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the surface area. Volume of Distribution Observed Normalized by Surface Area Vz Obs Norm by WT The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the weight. Volume of Distribution Observed Normalized by Weight Vz Obs The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration. Observed Volume of Distribution Vz Pred by F for UB The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value at the time of the last non-zero concentration and corrected for unbound drug. Volume of Distribution of Fraction Dose Predicted Corrected for Unbound Drug Vz Pred by F Norm by BMI The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. Volume of Distribution of Fraction Dose Predicted Normalized by Body Mass Index Vz Pred by F Norm by Dose The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the dose. Volume of Distribution of Fraction Dose Predicted Normalized by Dose Vz Pred by F Norm by SA The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the surface area. Volume of Distribution of Fraction Dose Predicted Normalized by Surface Area Vz Pred by F Norm by WT The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the weight. Volume of Distribution of Fraction Dose Predicted Normalized by Weight Vz Pred by F The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration. Predicted Volume of Distribution of Absorbed Fraction Vz Pred for UB The volume of distribution associated with the terminal slope following administration, calculated using the predicted value at the time of the last non-zero concentration and corrected for unbound drug. Volume of Distribution Predicted for Unbound Drug Vz Pred Norm by BMI The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. Volume of Distribution Predicted Normalized by Body Mass Index Vz Pred Norm by Dose The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the dose. Predicted Volume of Distribution Normalized by Dose Vz Pred Norm by SA The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the surface area. Volume of Distribution Predicted Normalized by Surface Area Vz Pred Norm by WT The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the weight. Volume of Distribution Predicted Normalized by Weight Vz Pred The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration. Predicted Volume of Distribution PKPARM PK Parameters CDISC SDTM Pharmacokinetic Parameter Long Name Terminology Parameter codes used to describe the time-concentration curve. Accumulation Index using Lambda z Predicted accumulation ratio for area under the curve (AUC) calculated using the Lambda z estimated from single dose data. Accumulation Index using Lambda z Amt of Analyte at Steady State The amount of analyte in the body at steady state. Amount of Analyte at Steady State Amt of Analyte at Time T The amount of analyte in the body at any time t. Amount of Analyte at Time T Accumulation Ratio AUCTAU The area under the curve over the dosing interval at steady state divided by the area under the curve over the initial dosing interval. Accumulation Ratio Area Under the Curve Accum Ratio AUCTAU norm by dose The area under the curve (AUCTAU) at steady state divided by the area under the curve (AUCTAU) over the initial dosing interval, each divided by the associated dose. Accumulation Ratio AUC Over Dosing Interval Normalized by Dose Accum Ratio AUC Infinity Obs The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration divided by the area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration during the initial dosing interval. Accumulation Ratio AUC Infinity Observed Accum Ratio AUC Infinity Pred The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration divided by the area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration during the initial dosing interval. Accumulation Ratio AUC Infinity Predicted Accum Ratio AUC T1 to T2 norm by dose The area under the curve from T1 to T2 at steady state divided by the area under the curve from T1 to T2 during the initial dosing interval, each divided by the associated dose. Accumulation Ratio AUC T1 to T2 Normalized by Dose Accumulation Ratio AUC from T1 to T2 The area under the curve from T1 to T2 at steady state divided by the area under the curve from T1 to T2 during the initial dosing interval. Accumulation Ratio Area Under the Curve from T1 to T2 Accum Ratio AUCIFO Norm by Dose The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration divided by the area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration during the initial dosing interval, each divided by the associated dose. Accumulation Ratio AUC Infinity Observed Normalized by Dose Accum Ratio AUCIFP Norm by Dose The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration divided by the area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration during the initial dosing interval, each divided by the associated dose. Accumulation Ratio AUC Infinity Predicted Normalized by Dose Accum Ratio AUC to Last Nonzero Conc The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the area under the curve from the time of dosing to the last measurable concentration during the initial dosing interval. Accumulation Ratio AUC to Last Nonzero Concentration Accumulation Ratio Cmax The maximum concentration at steady state divided by the maximum concentration during the initial dosing interval. Accumulation Ratio Cmax Accum Ratio Cmax norm by dose The maximum concentration at steady state divided by the maximum concentration during the initial dosing interval, each divided by the associated dose. Accumulation Ratio Cmax Normalized by Dose Accumulation Ratio Cmin The minimum concentration at steady state divided by the minimum concentration during the initial dosing interval. Accumulation Ratio Cmin Accum Ratio Cmin norm by dose The minimum concentration at steady state divided by the minimum concentration during the initial dosing interval, each divided by the associated dose. Accumulation Ratio Cmin Normalized by Dose Accum Ratio Ctrough norm by dose The trough concentration at steady state divided by the trough concentration during the initial dosing interval, each divided by the associated dose. Accumulation Ratio Ctrough Normalized by Dose Accumulation Ratio Ctrough The trough concentration at steady state divided by the trough concentration during the initial dosing interval. Accumulation Ratio Ctrough AUC All The area under the curve (AUC) from the time of dosing to the time of the last observation, regardless of whether the last concentration is measurable or not. Area Under the Curve All AUC All Norm by BMI The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the body mass index, regardless of whether the last concentration is measurable or not. AUC All Normalized by Body Mass Index AUC All Norm by Dose The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the dose, regardless of whether the last concentration is measurable or not. AUC All Normalized by Dose AUC All Norm by SA The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the surface area, regardless of whether the last concentration is measurable or not. AUC All Normalized by Surface Area AUC All Norm by WT The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the weight, regardless of whether the last concentration is measurable or not. AUC All Normalized by Weight AUC Infinity Obs The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration. Observed Area Under the Curve Infinity AUC Infinity Obs Norm by BMI The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index. AUC Infinity Observed Normalized by Body Mass Index AUC Infinity Obs Norm by Dose The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the dose. AUC Infinity Observed Normalized by Dose AUC Infinity Obs Norm by Dose/WT The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration divided by the body weight-adjusted dose. AUC Infinity Observed Normalized by Weight-Adjusted Dose AUC Infinity Obs LN Transformed The natural log transformed area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration. Natural Log Transformed Observed Area Under the Curve Infinity AUC Infinity Obs Norm by SA The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area. AUC Infinity Observed Normalized by Surface Area AUC Infinity Obs, Unbound Drug The portion of observed AUC to infinity, represented by the unbound fraction of drug. Observed Area Under the Curve Infinity of Unbound Drug AUC Infinity Obs Norm by WT The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight. AUC Infinity Observed Normalized by Weight AUC Infinity Pred The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration. Predicted Area Under the Curve Infinity AUC Infinity Pred Norm by BMI The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. AUC Infinity Predicted Normalized by Body Mass Index AUC Infinity Pred Norm by Dose The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the dose. Predicted Area Under the Curve Infinity by Dose AUC Infinity Pred Norm by Dose per Body Weight AUCIFPDW Norm by Dose/WT The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration divided by the body weight-adjusted dose. AUC Infinity Predicted Normalized by Weight-Adjusted Dose AUC Infinity Pred Norm by SA The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area. AUC Infinity Predicted Normalized by Surface Area AUC Infinity Pred, Unbound Drug The portion of predicted AUC to infinity, represented by the unbound fraction of drug. Predicted Area Under the Curve Infinity of Unbound Drug AUC Infinity Pred Norm by WT The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight. AUC Infinity Predicted Normalized by Weight AUC from T1 to T2 The area under the curve (AUC) over the interval from T1 to T2. Area Under the Curve from T1 to T2 AUC from T1 to T2 Norm by BMI The area under the curve (AUC) over the interval from T1 to T2 divided by the body mass index. AUC from T1 to T2 Normalized by Body Mass Index AUC from T1 to T2 Norm by Dose The area under the curve (AUC) over the interval from T1 to T2 divided by the dose. AUC from T1 to T2 Normalized by Dose AUC from T1 to T2 Norm by Dose per Body Weight AUCINT Norm by Dose/kg WT The area under the curve (AUC) over the interval from T1 to T2 divided by the body weight-adjusted dose. AUC from T1 to T2 Normalized by Weight-Adjusted Dose AUC from T1 to T2 Norm by SA The area under the curve (AUC) over the interval from T1 to T2 divided by the surface area. AUC from T1 to T2 Normalized by Surface Area AUC from T1 to T2 Norm by WT The area under the curve (AUC) over the interval from T1 to T2 divided by the weight. AUC from T1 to T2 Normalized by Weight AUC to Last Nonzero Conc The area under the curve (AUC) from the time of dosing to the last measurable concentration. Area Under the Curve From Dosing to Last Concentration AUC to Last Nonzero Conc Norm by BMI The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the body mass index. AUC Dosing to Last Concentration Normalized by Body Mass Index AUC to Last Nonzero Conc Norm by Dose The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the dose. AUC Dosing to Last Concentration Normalized by Dose AUC to Last Nonzero Conc Norm by Dose per Body Weight AUCLST Norm by Dose/WT The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the body weight-adjusted dose. AUC Dosing From Dosing to Last Concentration Normalized by Weight-Adjusted Dose AUC to Last Nonzero Conc LN Transformed The natural log transformed area under the curve (AUC) from the time of dosing to the last measurable concentration. Natural Log Transformed Area Under the Curve From Dosing to Last Concentration AUC to Last Nonzero Conc Norm by SA The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the surface area. AUC Dosing to Last Concentration Normalized by Surface Area AUC to Last Nonzero Conc, Unbound Drug The portion of the area under the curve (AUC) from the time of dosing to the last measurable concentration, represented by the unbound fraction of drug. Area Under the Curve From Dosing to Last Concentration of Unbound Drug AUC to Last Nonzero Conc Norm by WT The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the weight. AUC Dosing to Last Concentration Normalized by Weight AUC %Back Extrapolation Obs Applies only for intravascular bolus dosing. The area under the curve (AUC) from the first measured concentration value back extrapolated to the concentration value at time zero as a percentage of the area under the curve extrapolated to infinity using the observed value of the last non-zero concentration. Observed Area Under the Curve Percent Back Extrapolation AUC %Back Extrapolation Pred Applies only for intravascular bolus dosing. The area under the curve (AUC) from the first measured concentration value back extrapolated to the concentration value at time zero as a percentage of the area under the curve extrapolated to infinity using the predicted value of the last non-zero concentration. Predicted Area Under the Curve Percent Back Extrapolation AUC %Extrapolation Obs The area under the curve (AUC) from the last observed non-zero concentration value to infinity as a percentage of the area under the curve extrapolated to infinity. Observed Area Under the Curve Percent Extrapolation AUC %Extrapolation Pred The area under the curve (AUC) from the last predicted non-zero concentration value to infinity as a percentage of the area under the curve extrapolated to infinity. Predicted Area Under the Curve Percent Extrapolation AUC Over Dosing Interval The area under the curve (AUC) for the defined interval between doses (TAU). Area Under the Curve Over Dosing Interval AUC Over Dosing Interval Norm by BMI The area under the curve (AUC) for the defined interval between doses (TAU) divided by the body mass index. AUC Over Dosing Interval Normalized by Body Mass Index AUC Over Dosing Interval Norm by Dose The area under the curve (AUC) for the defined interval between doses (TAU) divided by the dose. AUC Over Dosing Interval Normalized by Dose AUC Over Dosing Interval Norm by Dose per Body Weight AUCTAU Norm by Dose/WT The area under the curve (AUC) for the defined interval between doses (TAU) divided by the body weight-adjusted dose. AUC Over Dosing Interval Normalized by Weight-Adjusted Dose AUC Over Dosing Interval Norm by SA The area under the curve (AUC) for the defined interval between doses (TAU) divided by the surface area. AUC Over Dosing Interval Normalized by Surface Area AUC Over Dosing Interval Norm by WT The area under the curve (AUC) for the defined interval between doses (TAU) divided by the weight. AUC Over Dosing Interval Normalized by Weight AUMC Infinity Obs The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration. Observed Area Under the First Moment Curve Infinity AUMC Infinity Obs Norm by BMI The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index. AUMC Infinity Observed Normalized by Body Mass Index AUMC Infinity Obs Norm by Dose The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the dose. AUMC Infinity Observed Normalized by Dose AUMC Infinity Obs Norm by SA The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area. AUMC Infinity Observed Normalized by Surface Area AUMC Infinity Obs Norm by WT The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight. AUMC Infinity Observed Normalized by Weight AUMC Infinity Pred The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration. Predicted Area Under the First Moment Curve Infinity AUMC Infinity Pred Norm by BMI The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. AUMC Infinity Predicted Normalized by Body Mass Index AUMC Infinity Pred Norm by Dose The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the dose. AUMC Infinity Predicted Normalized by Dose AUMC Infinity Pred Norm by SA The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area. AUMC Infinity Predicted Normalized by Surface Area AUMC Infinity Pred Norm by WT The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight. AUMC Infinity Predicted Normalized by Weight AUMC to Last Nonzero Conc The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration. Area Under the First Moment Curve From Dosing to Last Concentration AUMC to Last Nonzero Conc Norm by BMI The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the body mass index. AUMC Dosing to Last Concentration Normalized by Body Mass Index AUMC to Last Nonzero Conc Norm by Dose The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the dose. AUMC Dosing to Last Concentration Normalized by Dose AUMC to Last Nonzero Conc Norm by SA The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the surface area. AUMC Dosing to Last Concentration Normalized by Surface Area AUMC to Last Nonzero Conc Norm by WT The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the weight. AUMC Dosing to Last Concentration Normalized by Weight AUMC % Extrapolation Obs The area under the moment curve (AUMC) from the last observed non-zero concentration value to infinity as a percentage of the area under the moment curve extrapolated to infinity. Observed Area Under the First Moment Curve Percent Extrapolation AUMC % Extrapolation Pred The area under the moment curve (AUMC) from the last predicted non-zero concentration value to infinity as a percentage of the area under the moment curve extrapolated to infinity. Predicted Area Under the First Moment Curve Percent Extrapolation AUMC Over Dosing Interval The area under the first moment curve (AUMC) for the defined interval between doses (TAU). Area Under the First Moment Curve Over Dosing Interval AUMC Over Dosing Interval Norm by BMI The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the body mass index. AUMC Over Dosing Interval Normalized by Body Mass Index AUMC Over Dosing Interval Norm by Dose The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the dose. AUMC Over Dosing Interval Normalized by Dose AUMC Over Dosing Interval Norm by SA The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the surface area. AUMC Over Dosing Interval Normalized by Surface Area AUMC Over Dosing Interval Norm by WT The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the weight. AUMC Over Dosing Interval Normalized by Weight AURC All The area under the excretion rate curve (AURC) from time zero to the time of the last observation, regardless of whether the last observation is a measurable concentration or not. Area Under Excretion Rate Curve All AURC All Norm by BMI The area under the excretion rate curve (AURC) from time zero to the last measurable rate divided by the body mass index. AURC All Normalized by Body Mass Index AURC All Norm by Dose The area under the excretion rate curve (AURC) from time zero to the last measurable rate divided by the dose. AURC All Normalized by Dose AURC All Norm by SA The area under the excretion rate curve (AURC) from time zero to the last measurable rate divided by the surface area. AURC All Normalized by Surface Area AURC All Norm by WT The area under the excretion rate curve (AURC) from time zero to the last measurable rate divided by the weight. AURC All Normalized by Weight AURC Infinity Obs The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate. Observed Area Under the Excretion Rate Curve infinity AURC Infinity Obs Norm by BMI The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the body mass index. AURC Infinity Observed Normalized by Body Mass Index AURC Infinity Obs Norm by Dose The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the dose. AURC Infinity Observed Normalized by Dose AURC Infinity Obs Norm by SA The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the surface area. AURC Infinity Observed Normalized by Surface Area AURC Infinity Obs Norm by WT The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the weight. AURC Infinity Observed Normalized by Weight AURC Infinity Pred The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate. Predicted Area Under the Excretion Rate Curve Infinity AURC Infinity Pred Norm by BMI The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divided by the body mass index. AURC Infinity Predicted Normalized by Body Mass Index AURC Infinity Pred Norm by Dose The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divided by the dose. AURC Infinity Predicted Normalized by Dose AURC Infinity Pred Norm by SA The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divided by the surface area. AURC Infinity Predicted Normalized by Surface Area AURC Infinity Pred Norm by WT The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divided by the weight. AURC Infinity Predicted Normalized by Weight AURC from T1 to T2 The area under the excretion rate curve (AURC) over the interval from T1 to T2. Area Under the Excretion Rate Curve from T1 to T2 AURC from T1 to T2 Norm by BMI The area under the excretion rate curve (AURC) over the interval from T1 to T2 divided by the body mass index. AURC from T1 to T2 Normalized by Body Mass Index AURC from T1 to T2 Norm by Dose The area under the excretion rate curve (AURC) over the interval from T1 to T2 divided by the dose. AURC from T1 to T2 Normalized by Dose AURC from T1 to T2 Norm by SA The area under the excretion rate curve (AURC) over the interval from T1 to T2 divided by the surface area. AURC from T1 to T2 Normalized by Surface Area AURC from T1 to T2 Norm by WT The area under the excretion rate curve (AURC) over the interval from T1 to T2 divided by the weight. AURC from T1 to T2 Normalized by Weight AURC to Last Nonzero Rate The area under the excretion rate curve (AURC) from time zero to the time of the last measurable concentration. Area Under the Excretion Rate Curve From Dosing to Last Concentration AURC to Last Nonzero Rate Norm by BMI The area under the excretion rate curve (AURC) from time zero to the last measurable rate, divided by the body mass index. AURC Dosing to Last Concentration Normalized by Body Mass Index AURC to Last Nonzero Rate Norm by Dose The area under the excretion rate curve (AURC) from time zero to the last measurable rate, divided by the dose. AURC Dosing to Last Concentration Normalized by Dose AURC to Last Nonzero Rate Norm by SA The area under the excretion rate curve (AURC) from time zero to the last measurable rate, divided by the surface area. AURC Dosing to Last Concentration Normalized by Surface Area AURC to Last Nonzero Rate Norm by WT The area under the excretion rate curve (AURC) from time zero to the last measurable rate, divided by the weight. AURC Dosing to Last Concentration Normalized by Weight AURC % Extrapolation Obs The area under the excretion rate curve (AURC) from the last observed non-zero rate value to infinity as a percentage of the area under the excretion rate curve extrapolated to infinity. Observed Area Under the Excretion Rate Curve Percent Extrapolation AURC % Extrapolation Pred The area under the excretion rate curve (AURC) from the last predicted non-zero rate value to infinity as a percentage of the area under the excretion rate curve extrapolated to infinity. Predicted Area Under the Excretion Rate Curve Percent Extrapolation Initial Conc Initial concentration. Given only for bolus IV models. Initial Concentration Initial Conc Norm by BMI Initial concentration divided by the body mass index. Given only for bolus IV models. Initial Concentration Normalized by Body Mass Index Initial Conc Norm by Dose Initial concentration divided by the dose. Given only for bolus IV models. Initial Concentration Normalized by Dose Initial Conc Norm by SA Initial concentration divided by the surface area. Given only for bolus IV models. Initial Concentration Normalized by Surface Area Initial Conc Norm by WT Initial concentration divided by the weight. Given only for bolus IV models. Initial Concentration Normalized by Weight Average Concentration AUCTAU divided by TAU. Average Concentration Average Conc Norm by BMI AUCTAU divided by TAU and then divided by the body mass index. Average Concentration Normalized by Body Mass Index Average Conc Norm by Dose AUCTAU divided by TAU and then divided by the dose. Average Concentration Normalized by Dose Average Concentration Norm by Dose/WT AUCTAU divided by TAU divided by the body weight-adjusted dose. Average Concentration Normalized by Weight-Adjusted Dose Average Conc from T1 to T2 The area under the curve over the interval from T1 to T2 (AUCINT) divided by the length of the interval. Average Concentration from T1 to T2 Average Conc from T1 to T2 Norm by BMI The area under the curve over the interval from T1 to T2 (AUCINT) divided by the length of the interval and then divided by the body mass index. Average Concentration from T1 to T2 Normalized by Body Mass Index Average Conc from T1 to T2 Norm by Dose The area under the curve over the interval from T1 to T2 (AUCINT) divided by the length of the interval and then divided by the dose. Average Concentration from T1 to T2 Normalized by Dose Average Conc from T1 to T2 Norm by SA The area under the curve over the interval from T1 to T2 (AUCINT) divided by the length of the interval and then divided by the surface area. Average Concentration from T1 to T2 Normalized by Surface Area Average Conc from T1 to T2 Norm by WT The area under the curve over the interval from T1 to T2 (AUCINT) divided by the length of the interval and then divided by the weight. Average Concentration from T1 to T2 Normalized by Weight Average Conc Norm by SA AUCTAU divided by TAU and then divided by the surface area. Average Concentration Normalized by Surface Area Average of Conc Trough The arithmetic average of two or more trough concentrations. Average of Trough Concentration Average Conc Norm by WT AUCTAU divided by TAU and then divided by the weight. Average Concentration Normalized by Weight Average Conc from T1 to T2 Norm by Dose per Body Weight CAVGINT Norm by Dose/WT The area under the curve over the interval from T1 to T2 (AUCINT) divided by the length of the interval divided by the body weight-adjusted dose. Average Concentration from T1 to T2 Normalized by Weight-Adjusted Dose Concentration at Half Tmax The concentration that occurs at the midpoint time between dosing time and Tmax. Concentration at Half Tmax Total CL Obs by F The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the AUCINF based on the observed value of the last non-zero concentration. Observed Total Body Clearance by Fraction of Dose Absorbed Total CL Obs by F Norm by BMI The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the AUCINF based on the observed value of the last non-zero concentration, divided by the body mass index. Total Clearance Observed by Fraction Dose Normalized by Body Mass Index Total CL Obs by F Norm by Dose The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the AUCINF based on the observed value of the last non-zero concentration, divided by the dose. Total Clearance Observed by Fraction Dose Normalized by Dose Total CL Obs by F Norm by SA The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the AUCINF based on the observed value of the last non-zero concentration, divided by the surface area. Total Clearance Observed by Fraction Dose Normalized by Surface Area Total CL Obs by F Norm by WT The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the AUCINF based on the observed value of the last non-zero concentration, divided by the weight. Total Clearance Observed by Fraction Dose Normalized by Weight Total CL Pred by F The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the AUCINF based on the predicted value of the last non-zero concentration. Predicted Total Body Clearance by Fraction of Dose Absorbed Total CL Pred by F Norm by BMI The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the AUCINF based on the predicted value of the last non-zero concentration, divided by body mass index. Total Clearance Predicted by Fraction Dose Normalized by Body Mass Index Total CL Pred by F Norm by Dose The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the AUCINF based on the predicted value of the last non-zero concentration, divided by the dose. Total Clearance Predicted by Fraction Dose Normalized by Dose Total CL Pred by F Norm by SA The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the AUCINF based on the predicted value of the last non-zero concentration, divided by the surface area. Total Clearance Predicted by Fraction Dose Normalized by Surface Area Total CL Pred by F Norm by WT The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the AUCINF based on the predicted value of the last non-zero concentration, divided by the weight. Total Clearance Predicted by Fraction Dose Normalized by Weight Total CL by F for Dose Int The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU. Total Body Clearance by Fraction of Dose for Dose Interval Total CL by F for Dose Int Norm by BMI The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the body mass index. Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Body Mass Index Total CL by F for Dose Int Norm by Dose The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the dose. Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Dose Total CL by F for Dose Int Norm by SA The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the surface area. Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Surface Area Total CL by F for Dose Int Norm by WT The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the weight. Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Weight Apparent CL for Unbound Drug The total apparent clearance of the unbound fraction of drug, adjusted for bioavailability. Apparent Clearance for Unbound Drug Total CL Obs The total body clearance for intravascular administration, calculated using the AUCINF based on the observed value of the last non-zero concentration. Observed Total Body Clearance Rate Total CL Obs Norm by BMI The total body clearance for intravascular administration, calculated using the AUCINF based on the observed value of the last non-zero concentration, divided by the body mass index. Total Clearance Observed Normalized by Body Mass Index Total CL Obs Norm by Dose The total body clearance for intravascular administration, calculated using the AUCINF based on the observed value of the last non-zero concentration, divided by the dose. Total Clearance Observed Normalized by Dose Total CL Obs Norm by SA The total body clearance for intravascular administration, calculated using the AUCINF based on the observed value of the last non-zero concentration, divided by the surface area. Total Clearance Observed Normalized by Surface Area Total CL Obs for Unbound Drug The total body clearance for intravascular administration divided by the fraction of drug unbound, calculated using the AUCINF based on the observed value of the last non-zero concentration. Total Clearance Observed for Unbound Drug Total CL Obs Norm by WT The total body clearance for intravascular administration, calculated using the AUCINF based on the observed value of the last non-zero concentration, divided by the weight. Total Clearance Observed Normalized by Weight Total CL Pred The total body clearance for intravascular administration, calculated using the AUCINF based on the predicted value of the last non-zero concentration. Predicted Total Body Clearance Rate Total CL Pred Norm by BMI The total body clearance for intravascular administration, calculated using the AUCINF based on the predicted value of the last non-zero concentration, divided by the body mass index. Total Clearance Predicted Normalized by Body Mass Index Total CL Pred Norm by Dose The total body clearance for intravascular administration, calculated using the AUCINF based on the predicted value of the last non-zero concentration, divided by the dose. Total Clearance Predicted Normalized by Dose Total CL Pred Norm by SA The total body clearance for intravascular administration, calculated using the AUCINF based on the predicted value of the last non-zero concentration, divided by the surface area. Total Clearance Predicted Normalized by Surface Area Total CL Pred for Unbound Drug The total body clearance for intravascular administration divided by the fraction of drug unbound, calculated using the AUCINF based on the predicted value of the last non-zero concentration. Total Clearance Predicted for Unbound Drug Total CL Pred Norm by WT The total body clearance for intravascular administration, calculated using the AUCINF based on the predicted value of the last non-zero concentration, divided by the weight. Total Clearance Predicted Normalized by Weight Renal CL as Pct CL EV The portion of total clearance attributed to the kidneys expressed as a percentage, following extravascular administration. Renal Clearance to Total Clearance Ratio Measurement After Oral Dosing Renal CL as Pct CL IV The portion of total clearance attributed to the kidneys expressed as a percentage, following intravenous administration. Renal Clearance to Total Clearance Ratio Measurement After Intravenous Dosing Last Nonzero Conc The concentration corresponding to Tlast. Last Concentration Last Nonzero Conc Norm by BMI The concentration corresponding to Tlast divided by the body mass index. Last Concentration Normalized by Body Mass Index Last Nonzero Conc Norm by Dose The concentration corresponding to Tlast divided by the dose. Last Concentration Normalized by Dose Last Nonzero Conc Norm by SA The concentration corresponding to Tlast divided by the surface area. Last Concentration Normalized by Surface Area Last Nonzero Conc Norm by WT The concentration corresponding to Tlast divided by the weight. Last Concentration Normalized by Weight Total CL for Dose Int The total body clearance for intravascular administration, calculated using AUCTAU. Total Body Clearance for Dose Interval Total CL for Dose Int Norm by BMI The total body clearance for intravascular administration, calculated using AUCTAU, divided by the body mass index. Total Body Clearance for Dose Interval Normalized by Body Mass Index Total CL for Dose Int Norm by Dose The total body clearance for intravascular administration, calculated using AUCTAU, divided by the dose. Total Body Clearance for Dose Interval Normalized by Dose Total CL for Dose Int Norm by SA The total body clearance for intravascular administration, calculated using AUCTAU, divided by the surface area. Total Body Clearance for Dose Interval Normalized by Surface Area Total CL for Dose Int Norm by WT The total body clearance for intravascular administration, calculated using AUCTAU, divided by the weight. Total Body Clearance for Dose Interval Normalized by Weight Cmax Max Conc Maximum Concentration The maximum concentration occurring at Tmax. Cmax Max Conc Norm by BMI The maximum concentration occurring at Tmax, divided by the body mass index. Maximum Concentration Normalized by Body Mass Index Max Conc Norm by Dose The maximum concentration occurring at Tmax, divided by the dose. Maximum Concentration Dose Normalized Max Conc Norm by Dose/WT The maximum concentration occurring at Tmax divided by the body weight-adjusted dose. Maximum Concentration Normalized by Weight-Adjusted Dose Max Conc LN Transformed The natural log transformed maximum concentration occurring at Tmax. Natural Log Transformed Cmax Max Conc Norm by SA The maximum concentration occurring at Tmax, divided by the surface area. Maximum Concentration Normalized by Surface Area Max Conc, Unbound Drug The maximum concentration represented by the unbound fraction of drug, occurring at Tmax. Maximum Concentration of Unbound Drug Max Conc Norm by WT The maximum concentration occurring at Tmax, divided by the weight. Maximum Concentration Normalized by Weight Cmin Min Conc Minimum Concentration The minimum concentration between dose time and dose time plus Tau (at Tmin). Cmin Min Conc Norm by BMI The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the body mass index. Minimum Concentration Normalized by Body Mass Index Min Conc Norm by Dose The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the dose. Minimum Concentration Normalized by Dose Min Conc Norm by Dose/WT The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the body weight-adjusted dose. Minimum Concentration Normalized by Weight-Adjusted Dose Min Conc Norm by SA The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the surface area. Minimum Concentration Normalized by Surface Area Min Conc Norm by WT The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the weight. Minimum Concentration Normalized by Weight Conc by BMI The concentration divided by body mass index. Concentration Divided by Body Mass Index Conc by Dose The concentration divided by dose. Concentration Divided by Dose Concentration at End Infusion The observed concentration at the end of the infusion. Concentration at End Infusion Conc by SA The concentration divided by surface area. Concentration Divided by Surface Area Conc by WT The concentration divided by weight. Concentration Divided by Weight Correlation Between TimeX and Log ConcY The correlation between time (X) and log concentration (Y) for the points used in the estimation of lambda z. Time and Log Concentration Correlation Conc Trough Concentration Trough Ctrough Trough Level Concentration at end of a dosing interval, immediately before the next dose is administered. Trough Concentration Conc Trough by BMI The trough concentration divided by body mass index. Trough Concentration Divided by Body Mass Index Conc Trough by Dose The trough concentration divided by dose. Trough Concentration Divided by Dose Conc Trough by SA The trough concentration divided by surface area. Trough Concentration Divided by Surface Area Conc Trough by WT The trough concentration divided by weight. Trough Concentration Divided by Weight Half-Life Distribution Half-life calculated from the distributional phase. Half-Life Distribution Effective Half-Life The drug half-life that quantifies the accumulation ratio of a drug following multiple dosing. Effective Half-life Excret Rate from T1 to T2 The excretion rate over the interval from T1 to T2, determined for the specimen type specified in PPSPEC. Excretion Rate From T1 to T2 Excret Rate from T1 to T2 Norm by BMI The excretion rate over the interval from T1 to T2 divided by the body mass index, determined for the specimen type specified in PPSPEC. Excretion Rate From T1 to T2 Normalized by BMI Excret Rate from T1 to T2 Norm by Dose The excretion rate over the interval from T1 to T2 divided by the dose, determined for the specimen type specified in PPSPEC. Excretion Rate From T1 to T2 Normalized by Dose Excret Rate from T1 to T2 Norm by SA The excretion rate over the interval from T1 to T2 divided by the surface area, determined for the specimen type specified in PPSPEC. Excretion Rate From T1 to T2 Normalized by SA Excret Rate from T1 to T2 Norm by WT The excretion rate over the interval from T1 to T2 divided by the weight, determined for the specimen type specified in PPSPEC. Excretion Rate From T1 to T2 Normalized by WT Last Meas Excretion Rate The last measurable (positive) excretion rate determined for the specimen type specified in PPSPEC. Last Measurable Observed Excretion Rate Last Meas Excretion Rate Norm by BMI The last measurable (positive) excretion rate divided by the body mass index. Last Measurable Excretion Rate Normalized by Body Mass Index Last Meas Excretion Rate Norm by Dose The last measurable (positive) excretion rate divided by the dose. Last Measurable Excretion Rate Normalized by Dose Last Meas Excretion Rate Norm by SA The last measurable (positive) excretion rate divided by the surface area. Last Measurable Excretion Rate Normalized by Surface Area Last Meas Excretion Rate Norm by WT The last measurable (positive) excretion rate divided by the weight. Last Measurable Excretion Rate Normalized by Weight Max Excretion Rate The maximum excretion rate determined for the specimen type specified in PPSPEC. Maximum Observed Excretion Rate Max Excretion Rate Norm by BMI The maximum excretion rate divided by the body mass index. Maximum Observed Excretion Rate Normalized by Body Mass Index Max Excretion Rate Norm by Dose The maximum excretion rate divided by the dose. Maximum Observed Excretion Rate Normalized by Dose Max Excretion Rate Norm by SA The maximum excretion rate divided by the surface area. Maximum Observed Excretion Rate Normalized by Surface Area Max Excretion Rate Norm by WT The maximum excretion rate divided by the weight. Maximum Observed Excretion Rate Normalized by Weight Midpoint of Interval of Last Nonzero ER The midpoint of collection interval associated with last measurable excretion rate. Collection Interval Midpoint Midpoint of Interval of Maximum ER The midpoint of collection interval associated with the maximum excretion rate. Time of Maximum Observed Excretion Rate Absolute Bioavailability The fraction of the treatment dose that reaches the systemic circulation; this is the ratio of the amount of drug in the system (area under the curve) after extravascular administration of a test formulation divided by the drug in the system (area under the curve) after IV administration. Absolute Bioavailability Fraction Bound The percent or ratio of bound substance concentration to the total concentration. Fraction Bound Fluctuation% The difference between Cmin and Cmax standardized to Cavg, between dose time and Tau. Concentration Variability Between Dose Time and Tau Fraction of the Dose Metabolized The fraction of the bioavailable dose which has been metabolized. Fraction of the Dose Metabolized Relative Bioavailability The fraction of the treatment dose that reaches the systemic circulation relative to a reference route or reference formulation. The ratio of the amount of drug in the system (area under the curve) after administration of a test formulation divided by the drug in the system after a non-IV administration of a reference formulation and/or reference route. Relative Bioavailability Fract Excr from T1 to T2 The fraction of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2. Fractional Excretion from T1 to T2 Fraction Unbound The percent or ratio of free substance concentration to the total concentration. (NCI) Fraction Unbound Hemodialysis Clearance The clearance of a substance from the blood during a hemodialysis session. Hemodialysis Clearance Hemodialysis Extraction Ratio The fractional content of a substance removed from the blood during a hemodialysis session. Hemodialysis Extraction Ratio Half Tmax The midpoint time between dosing time and Tmax. Half Tmax K Slope of Distribution The distribution rate constant. K Slope of Distribution Lambda z The first order rate constant associated with the terminal (log-linear) portion of the curve. Lambda Z Half-Life Lambda z Terminal half-life. Terminal Half Life Lambda z Lower Limit The lower limit on time for values to be included in the calculation of Lambda z. Lambda Z Time Lower Limit Lambda z Lower Limit TAU The lower limit on time for values to be included in the calculation of Lambda z, calculated within a dosing interval. Lambda z Lower Limit TAU Number of Points for Lambda z The number of time points used in computing Lambda z. Sum of Lambda Z Timepoints Number of Points for Lambda z TAU The number of time points used in computing Lambda z determined in a dosing interval. Number of Points for Lambda z TAU Lambda z Span The interval of time covered by the data points used in the terminal disposition phase regression analysis, divided by half life. This yields the terminal disposition phase duration expressed as the number of half lives. Lambda Z Span Lambda z TAU The first order rate constant associated with the terminal (log-linear) portion of the curve, calculated within a dosing interval. Lambda z TAU Lambda z Upper Limit The upper limit on time for values to be included in the calculation of Lambda z. Lambda Z Time Upper Limit Lambda z Upper Limit TAU The upper limit on time for values to be included in the calculation of Lambda z, calculated within a dosing interval. Lambda z Upper Limit TAU Mean Absorption Time Mean absorption time of a substance administered by extravascular dosing. Mean Absorption Time Metabolic Ratio of Accumulation Ratios The metabolic ratio of two accumulation ratio values. Metabolic Ratio of Accumulation Ratios MRT Extravasc Infinity Obs The mean residence time (MRT) extrapolated to infinity for a substance administered by extravascular dosing, calculated using the observed value of the last non-zero concentration. Extravascular MRT includes Mean Absorption Time (MAT). Mean Residence Time Infinity Observed by Extravascular Dose MRT Extravasc Infinity Pred The mean residence time (MRT) extrapolated to infinity for a substance administered by extravascular dosing, calculated using the predicted value of the last non-zero concentration. Extravascular MRT includes Mean Absorption Time (MAT). Mean Residence Time Infinity Predicted by Extravascular Dose MRT Extravasc to Last Nonzero Conc Mean residence time (MRT) from the time of dosing to the time of the last measurable concentration for a substance administered by extravascular dosing. Extravascular MRT includes Mean Absorption Time (MAT). Mean Residence Time to Last Nonzero Concentration by Extravascular Dose MRT IV Bolus Infinity Obs The mean residence time (MRT) extrapolated to infinity for a substance administered by intravascular bolus dosing, calculated using the observed value of the last non-zero concentration. Mean Residence Time Infinity Observed by Intravascular Bolus Dose MRT IV Bolus Infinity Pred The mean residence time (MRT) extrapolated to infinity for a substance administered by intravascular bolus dosing, calculated using the predicted value of the last non-zero concentration. Mean Residence Time Infinity Predicted by Intravascular Bolus Dose MRT IV Bolus to Last Nonzero Conc Mean residence time (MRT) from the time of dosing to the time of the last measurable concentration, for a substance administered by intravascular bolus dosing. Mean Residence Time to Last Nonzero Concentration by Intravascular Bolus Dose MRT IV Cont Inf Infinity Obs The mean residence time (MRT) extrapolated to infinity for a substance administered by constant rate of continuous intravascular infusion, calculated using the observed value of the last non-zero concentration. Mean Residence Time Intravenous Continuous Infusion Infinity Observed MRT IV Cont Inf Infinity Pred The mean residence time (MRT) extrapolated to infinity for a substance administered by constant rate of continuous intravascular infusion, calculated using the predicted value of the last non-zero concentration. Mean Residence Time Intravenous Continuous Infusion Infinity Predicted MRT IV Cont Inf to Last Nonzero Conc Mean residence time (MRT) from the time of dosing to the time of the last measurable concentration, for a substance administered by constant rate of continuous intravascular infusion. Mean Residence Time Intravenous Continuous Infusion to Last Nonzero Concentration Nonrenal CL The total clearance of a substance from the blood less the renal clearance. Nonrenal Clearance Nonrenal CL Norm by BMI The total clearance of a substance from the blood minus the renal clearance divided by the body mass index. Nonrenal Clearance Normalized by BMI Nonrenal CL Norm by Dose The total clearance of a substance from the blood minus the renal clearance divided by the dose. Nonrenal Clearance Normalized by Dose Nonrenal CL Norm by SA The total clearance of a substance from the blood minus the renal clearance divided by the surface area. Nonrenal Clearance Normalized by SA Nonrenal CL Norm by WT The total clearance of a substance from the blood minus the renal clearance divided by the weight. Nonrenal Clearance Normalized by WT Peak Trough Ratio The maximum concentration during a dosing interval divided by the concentration at the end of the dosing interval. Peak Trough Ratio R Squared The goodness of fit statistic for the terminal elimination phase. R Squared R Squared Adjusted The goodness of fit statistic for the terminal elimination phase, adjusted for the number of time points used in the estimation of Lambda z. Adjusted R Squared Ratio AUC The ratio of two AUC values. Area Under the Curve Ratio Ratio AUC All The ratio of two AUC All values. AUC All Ratio Ratio AUC Infinity Obs The ratio of two AUC infinity observed values. Area Under the Curve Ratio Infinity Observed Ratio AUC Infinity Pred The ratio of two AUC infinity predicted values. Area Under the Curve Ratio Infinity Predicted Ratio AUC from T1 to T2 Norm by Dose The ratio of two AUC from T1 to T2 normalized by dose values. Ratio AUC from T1 to T2 Normalized by Dose Ratio AUC from T1 to T2 The ratio of two AUC from T1 to T2 values. Ratio AUC From T1 to T2 Ratio AUC Infinity Obs Norm by Dose The ratio of two AUC infinity observed normalized by dose values. Ratio AUC Infinity Observed Normalized by Dose Ratio AUC to Last Nonzero Conc Norm by Dose The ratio of two AUC to last nonzero concentration normalized by dose values. Ratio AUC to Last Nonzero Concentration Normalized by Dose Ratio AUC to Last Nonzero Conc The ratio of two AUC to last nonzero concentration values. Ratio AUC to Last Nonzero Concentration Ratio AUC Over Dosing Interval The ratio of two AUCTAU values. Ratio AUC Over Dosing Interval Ratio Average Concentration The ratio of two average concentration values. Average Concentration Ratio Ratio CMAX The ratio of two Cmax values. Cmax to Cmax Ratio Measurement Ratio Max Conc Norm by Dose The ratio of two maximum concentration normalized by dose values. Ratio Maximum Concentration Normalized by Dose Ratio Min Conc The ratio of two cmin values. Minimum Concentration Ratio Ratio Concentration The ratio of two concentration values. Concentration Ratio Ratio Conc Trough The ratio of two CTROUGH values. Ratio Concentration Trough Ratio of CMAX to CMIN The ratio of Cmax value to Cmin value. Cmax to Cmin Ratio Measurement Ratio Amt Rec Infinity Obs The ratio of two amount recovered infinity observed values. Ratio Amount Recovered Infinity Observed Ratio Amt Rec from T1 to T2 The ratio of two amount recovered from T1 to T2 values. Ratio Amount Recovered from T1 to T2 Amt Rec Infinity Obs The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration. Amount Recovered Infinity Observed Amt Rec Infinity Obs Norm by BMI The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index. Amount Recovered Infinity Observed Normalized by Body Mass Index Amt Rec Infinity Obs Norm by SA The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area. Amount Recovered Infinity Observed Normalized by Surface Area Amt Rec Infinity Obs Norm by WT The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight. Amount Recovered Infinity Observed Normalized by Weight Amt Rec Infinity Pred The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration. Amount Recovered Infinity Predicted Amt Rec Infinity Pred Norm by BMI The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. Amount Recovered Infinity Predicted Normalized by Body Mass Index Amt Rec Infinity Pred Norm by SA The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area. Amount Recovered Infinity Predicted Normalized by Surface Area Amt Rec Infinity Pred Norm by WT The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight. Amount Recovered Infinity Predicted Normalized by Weight Amt Rec from T1 to T2 The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2. Amount Recovered from T1 to T2 Amt Rec from T1 to T2 Norm by BMI The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by body mass index. Amount Recovered from T1 to T2 Normalized by Body Mass Index Amt Rec from T1 to T2 Norm by SA The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by surface area. Amount Recovered from T1 to T2 Normalized by Surface Area Amt Rec from T1 to T2 Norm by WT The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by weight. Amount Recovered from T1 to T2 Normalized by Weight Amt Rec to Last Nonzero Conc The cumulative amount recovered from the specimen type specified in PPSPEC, from the time of dosing to the last non-zero concentration. Amount Recovered to Last Nonzero Concentration Amt Rec Over Dosing Interval The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU). Amount Recovered Over Dosing Interval Amt Rec Over Dosing Interval Norm by BMI The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by body mass index. Amount Recovered Over Dosing Interval Normalized by Body Mass Index Amt Rec Over Dosing Interval Norm by SA The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by surface area. Amount Recovered Over Dosing Interval Normalized by Surface Area Amt Rec Over Dosing Interval Norm by WT The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by weight. Amount Recovered Over Dosing Interval Normalized by Weight Pct Rec Infinity Obs The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration. Percent Recovered Infinity Observed Pct Rec Infinity Obs Norm by BMI The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index. Percent Recovered Infinity Observed Normalized by Body Mass Index Pct Rec Infinity Obs Norm by SA The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area. Percent Recovered Infinity Observed Normalized by Surface Area Pct Rec Infinity Obs Norm by WT The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight. Percent Recovered Infinity Observed Normalized by Weight Pct Rec Infinity Pred The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration. Percent Recovered Infinity Predicted Pct Rec Infinity Pred Norm by BMI The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. Percent Recovered Infinity Predicted Normalized by Body Mass Index Pct Rec Infinity Pred Norm by SA The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area. Percent Recovered Infinity Predicted Normalized by Surface Area Pct Rec Infinity Pred Norm by WT The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight. Percent Recovered Infinity Predicted Normalized by Weight Pct Rec from T1 to T2 The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2. Percent Recovered from T1 to T2 Pct Rec from T1 to T2 Norm by BMI The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by body mass index. Percent Recovered from T1 to T2 Normalized by Body Mass Index Pct Rec from T1 to T2 Norm by SA The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by surface area. Percent Recovered from T1 to T2 Normalized by Surface Area Pct Rec from T1 to T2 Norm by WT The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by weight. Percent Recovered from T1 to T2 Normalized by Weight Pct Rec to Last Nonzero Conc The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, from the time of dosing to the last non-zero concentration. Percent Recovered To Last Nonzero Concentration Pct Rec Over Dosing Interval The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU). Percent Recovered Over Dosing Interval Pct Rec Over Dosing Interval Norm by BMI The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by the body mass index. Percent Recovered Over Dosing Interval Normalized by Body Mass Index Pct Rec Over Dosing Interval Norm by SA The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by surface area. Percent Recovered Over Dosing Interval Normalized by Surface Area Pct Rec Over Dosing Interval Norm by WT The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by weight. Percent Recovered Over Dosing Interval Normalized by Weight Renal CL The clearance of a substance from the blood by the kidneys. Renal Clearance Renal CL Norm by BMI The clearance of a substance from the blood by the kidneys divided by the body mass index. Renal Clearance Normalized by BMI Renal CL Norm by Dose The clearance of a substance from the blood by the kidneys divided by the dose. Renal Clearance Normalized by Dose Renal CL Norm by SA The clearance of a substance from the blood by the kidneys divided by the surface area. Renal Clearance Normalized by SA Renal CL Norm by WT The clearance of a substance from the blood by the kidneys divided by the weight. Renal Clearance Normalized by WT Renal CL for Dose Int The clearance of a substance from the blood by the kidneys, calculated using AUCTAU. Renal Clearance for Dose Interval Renal CL from T1 to T2 The clearance of a substance from the blood by the kidneys over the interval from T1 to T2. Renal Clearance from T1 to T2 Renal CL from T1 to T2 Norm by BMI The clearance of a substance from the blood by the kidneys over the interval from T1 to T2 divided by the body mass index. Renal Clearance from T1 to T2 Normalized by Body Mass Index Renal CL from T1 to T2 Norm by Dose The clearance of a substance from the blood by the kidneys over the interval from T1 to T2 divided by the dose. Renal Clearance from T1 to T2 Normalized by Dose Renal CL from T1 to T2 Norm by SA The clearance of a substance from the blood by the kidneys over the interval from T1 to T2 divided by the surface area. Renal Clearance from T1 to T2 Normalized by Surface Area Renal CL from T1 to T2 Norm by WT The clearance of a substance from the blood by the kidneys over the interval from T1 to T2 divided by the weight. Renal Clearance from T1 to T2 Normalized by Weight Renal CL for Dose Int Norm by BMI The clearance of a substance from the blood by the kidneys, calculated using AUCTAU, divided by the body mass index. Renal Clearance for Dose Interval Normalized by Body Mass Index Renal CL for Dose Int Norm by Dose The clearance of a substance from the blood by the kidneys, calculated using AUCTAU, divided by the dose. Renal Clearance for Dose Interval Normalized by Dose Renal CL for Dose Int Norm by SA The clearance of a substance from the blood by the kidneys, calculated using AUCTAU, divided by the surface area. Renal Clearance for Dose Interval Normalized by Surface Area Renal CL for Dose Int Norm by WT The clearance of a substance from the blood by the kidneys, calculated using AUCTAU, divided by the weight. Renal Clearance for Dose Interval Normalized by Weight Renal CL for Unbound Drug The unbound fraction of drug within the portion of total clearance attributed to the kidneys. Renal Clearance for Unbound Drug Stationarity Ratio AUC The area under the curve (AUCTAU) at steady state divided by the area under the curve extrapolated to infinity for the initial dosing interval. Stationarity Ratio Area Under the Curve Swing The difference between Cmax and Cmin standardized to Cmin within a dosing interval. PK Swing Dosing Interval The duration of time between two doses. Dosing Interval Half-Life TAU Half-life calculated within a dosing interval. Half-Life TAU Time Until First Nonzero Conc The time prior to the first measurable (non-zero) concentration. Time until First Nonzero Concentration Time of Last Nonzero Conc The time of the last measurable (positive) concentration. Time of Last Nonzero Concentration Time of CMAX Time of CMAX Observation The time of maximum observed concentration sampled during a dosing interval. Tmax Time of CMIN Time of CMIN Observation The time of minimum observed concentration sampled during a dosing interval. Tmin Trough Peak Ratio The concentration at the start of a dosing interval divided by the maximum concentration during the dosing interval. Trough Peak Ratio Vol Dist Initial The initial volume of distribution for a substance administered by bolus intravascular dosing. Initial Volume of Distribution Vol Dist Initial Norm by BMI The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the body mass index. Initial Volume of Distribution Normalized by Body Mass Index Vol Dist Initial Norm by Dose The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the dose. Initial Volume of Distribution Normalized by Dose Vol Dist Initial Norm by SA The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the surface area. Initial Volume of Distribution Normalized by Surface Area Vol Dist Initial Norm by WT The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the weight. Initial Volume of Distribution Normalized by Weight Sum of Urine Vol The sum of urine volumes that are used for PK parameters. Sum Urine Volume Vol Dist Steady State Obs The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing. Observed Steady State Volume of Distribution Vol Dist Steady State Obs Norm by BMI The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the body mass index. Observed Steady State Volume of Distribution Normalized by Body Mass Index Vol Dist Steady State Obs by B The volume of distribution at steady state based on the observed CLST for a substance administered, divided by the fraction of bound drug. Volume of Distribution Steady State Observed by Bound Drug Vol Dist Steady State Obs Norm by Dose The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the dose. Observed Steady State Volume of Distribution Normalized by Dose Vol Dist Steady State Obs by F The volume of distribution at steady state based on the observed CLST for a substance administered by extravascular dosing, divided by the fraction of dose absorbed. Volume of Distribution Steady State Observed by Fraction of Dose Absorbed Vol Dist Steady State Obs Norm by SA The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the surface area. Observed Steady State Volume of Distribution Normalized by Surface Area Vol Dist Steady State Obs by UB The volume of distribution at steady state based on the observed CLST for a substance administered, divided by the fraction of unbound drug. Volume of Distribution Steady State Observed by Unbound Drug Vol Dist Steady State Obs Norm by WT The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the weight. Observed Steady State Volume of Distribution Normalized by Weight Vol Dist Steady State Pred The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing. Predicted Steady State Volume of Distribution Vol Dist Steady State Pred Norm by BMI The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the body mass index. Predicted Steady State Volume of Distribution Normalized by Body Mass Index Vol Dist Steady State Pred by B The volume of distribution at steady state based on the predicted CLST for a substance administered, divided by the fraction of bound drug. Volume of Distribution Steady State Predicted by Bound Drug Vol Dist Steady State Pred Norm by Dose The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the dose. Predicted Steady State Volume of Distribution Normalized by Dose Vol Dist Steady State Pred by F The volume of distribution at steady state based on the predicted CLST for a substance administered by extravascular dosing, divided by the fraction of dose absorbed. Volume of Distribution Steady State Predicted by Fraction of Dose Absorbed Vol Dist Steady State Pred Norm by SA The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the surface area. Predicted Steady State Volume of Distribution Normalized by Surface Area Vol Dist Steady State Pred by UB The volume of distribution at steady state based on the predicted CLST for a substance administered, divided by the fraction of unbound drug. Volume of Distribution Steady State Predicted by Unbound Drug Vol Dist Steady State Pred Norm by WT The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the weight. Predicted Steady State Volume of Distribution Normalized by Weight Vz Obs by F The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration. Observed Volume of Distribution of Absorbed Fraction Vz Obs by F Norm by BMI The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the body mass index. Volume of Distribution of Fraction Dose Observed Normalized by Body Mass Index Vz Obs by F Norm by Dose The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the dose. Volume of Distribution of Fraction Dose Observed Normalized by Dose Vz Obs by F Norm by SA The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the surface area. Volume of Distribution of Fraction Dose Observed Normalized by Surface Area Vz Obs by F for UB The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration and corrected for unbound drug. Observed Volume of Distribution of Absorbed Fraction for Unbound Drug Vz Obs by F Norm by WT The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the weight. Volume of Distribution of Fraction Dose Observed Normalized by Weight Vz Pred by F The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration. Predicted Volume of Distribution of Absorbed Fraction Vz Pred by F Norm by BMI The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. Volume of Distribution of Fraction Dose Predicted Normalized by Body Mass Index Vz Pred by F Norm by Dose The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the dose. Volume of Distribution of Fraction Dose Predicted Normalized by Dose Vz Pred by F Norm by SA The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the surface area. Volume of Distribution of Fraction Dose Predicted Normalized by Surface Area Vz Pred by F for UB The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value at the time of the last non-zero concentration and corrected for unbound drug. Volume of Distribution of Fraction Dose Predicted Corrected for Unbound Drug Vz Pred by F Norm by WT The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the weight. Volume of Distribution of Fraction Dose Predicted Normalized by Weight Vz for Dose Int by F The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU. Volume of Distribution for Dosing Interval by Fraction Vz for Dose Int by F Norm by BMI The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the body mass index. Volume of Distribution for Dosing Interval by Fraction Normalized by Body Mass Index Vz for Dose Int by F Norm by Dose The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the dose. Volume of Distribution for Dosing Interval by Fraction Normalized by Dose Vz for Dose Int by F Norm by SA The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the surface area. Volume of Distribution for Dosing Interval by Fraction Normalized by Surface Area Vz for Dose Int by F Norm by WT The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the weight. Volume of Distribution for Dosing Interval by Fraction Normalized by Weight Vz Obs The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration. Observed Volume of Distribution Vz Obs Norm by BMI The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the body mass index. Volume of Distribution Observed Normalized by Body Mass Index Vz Obs Norm by Dose The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the dose. Observed Volume of Distribution Normalized by Dose Vz Obs Norm by SA The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the surface area. Volume of Distribution Observed Normalized by Surface Area Vz Obs for UB The volume of distribution associated with the terminal slope following administration, calculated using the observed value of the last non-zero concentration and corrected for unbound drug. Volume of Distribution Observed for Unbound Drug Vz Obs Norm by WT The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the weight. Volume of Distribution Observed Normalized by Weight Vz Pred The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration. Predicted Volume of Distribution Vz Pred Norm by BMI The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. Volume of Distribution Predicted Normalized by Body Mass Index Vz Pred Norm by Dose The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the dose. Predicted Volume of Distribution Normalized by Dose Vz Pred Norm by SA The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the surface area. Volume of Distribution Predicted Normalized by Surface Area Vz Pred for UB The volume of distribution associated with the terminal slope following administration, calculated using the predicted value at the time of the last non-zero concentration and corrected for unbound drug. Volume of Distribution Predicted for Unbound Drug Vz Pred Norm by WT The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the weight. Volume of Distribution Predicted Normalized by Weight Vz for Dose Int The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU. Volume of Distribution for Dosing Interval Vz for Dose Int Norm by BMI The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the body mass index. Volume of Distribution for Dosing Interval Normalized by Body Mass Index Vz for Dose Int Norm by Dose The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the dose. Volume of Distribution for Dosing Interval Normalized by Dose Vz for Dose Int Norm by SA The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the surface area. Volume of Distribution for Dosing Interval Normalized by Surface Area Vz for Dose Int Norm by WT The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the weight. Volume of Distribution for Dosing Interval Normalized by Weight PKPARMCD PK Parameters Code CDISC SDTM Pharmacokinetic Parameter Short Name Terminology Units of measure for pharmacokinetic data and parameters. Percentage One hundred times the quotient of one quantity divided by another, with the same units of measurement. Percentage Percentage of the administered dose recovered per gram of matrix or tissue, normalized by the sample weight. Percent Administered Dose Recovered Per Gram (Bq/g)/(Bq/g) (Bq/g)/(kBq/kg) Becquerel per gram, divided by dose per kilogram body weight or Becquerel per gram, divided by dose per gram body weight. Becquerel per Gram per Kilobecquerel per Kilogram (Bq/mL)/(Bq/g) (Bq/mL)/(kBq/kg) Becquerel per milliliter, divided by dose per kilogram body weight or Becquerel per milliliter, divided by dose per gram body weight. Becquerel per Milliliter per Kilobecquerel per Kilogram (h*Bq/g)/(Bq/g) (h*Bq/g)/(kBq/kg) Hours times Becquerel per gram (area under the curve), divided by dose per kilogram body weight or hours times Becquerel per gram (area under the curve), divided by dose per gram body weight. Hour Times Becquerel per Gram per Kilobecquerel per Kilogram (h*Bq/mL)/(Bq/g) (h*Bq/mL)/(kBq/kg) Hours times Becquerel per milliliter (area under the curve), divided by dose per kilogram body weight or hours times Becquerel per milliliter (area under the curve), divided by dose per gram body weight. Hour Times Becquerel per Milliliter per Kilobecquerel per Kilogram Liters per day (flow rate), divided by kilograms per meter squared (body mass index). Liter per Day per Kilogram per Meter Squared (L/day)/(mg/day) (mL/day)/(ug/day) Liters per day (flow rate), divided by milligrams per day (daily dose) or milliliters per day (flow rate), divided by micrograms per day (daily dose). Liter per Day per Milligram per Day (L/day)/(mg/kg) (mL/day)/(ug/kg) Liters per day (flow rate), divided by milligrams per kilogram (dose normalized by body weight) or milliliters per day (flow rate), divided by micrograms per kilogram (dose normalized by body weight). Liter per Day per Milligram per Kilogram (L/day)/(mg/kg/day) (mL/day)/(ug/kg/day) Liters per day (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milliliters per day (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). Liter per Day per Milligram per Kilogram per Day (L/day)/(mg/m2) (mL/day)/(ug/m2) Liters per day (flow rate), divided by milligrams per meter squared (dose normalized by surface area) or milliliters per day (flow rate), divided by micrograms per meter squared (dose normalized by surface area). Liter per Day per Milligram per Meter Squared (L/day)/(mg/m2/day) (mL/day)/(ug/m2/day) Liters per day (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milliliters per day (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). Liter per Day per Milligram per Meter Squared per Day Liters per day (flow rate), divided by micrograms per day (daily dose). Liter per Day per Microgram per Day Liters per day (flow rate), divided by micrograms per kilogram (dose normalized by body weight). Liter per Day per Microgram per Kilogram Liters per day (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). Liter per Day per Microgram per Kilogram per Day Liters per day (flow rate), divided by micrograms per meter squared (dose normalized by surface area). Liter per Day per Microgram per Meter Squared Liters per day (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). Liter per Day per Microgram per Meter Squared per Day (L/day)/g (mL/day)/mg Liters per day (flow rate), divided by grams (weight) or milliliters per day (flow rate), divided by milligrams (dose). Liter per Gram per Day (L/day)/kg (mL/day)/g mL/g/day Milliliters per gram per day or liters per day (flow rate), divided by kilograms (weight) or milliliters per day (flow rate), divided by grams (weight). Milliliter per Gram per Day Liters per day (flow rate), divided by meters squared (surface area). Liter per Day per Meter Squared (L/day)/mg (mL/day)/ug Liters per day (flow rate), divided by milligrams (dose) or milliliters per day (flow rate), divided by micrograms (dose). Liter per Milligram per Day Liters per day (flow rate), divided by micrograms (dose). Liter per Microgram per Day Liters per hour (flow rate), divided by kilograms per meter squared (body mass index). Liter per Hour per Kilogram per Meter Squared (L/h)/(mg/day) (mL/h)/(ug/day) Liters per hour (flow rate), divided by milligrams per day (daily dose) or milliliters per hour (flow rate), divided by micrograms per day (daily dose). Liter per Hour per Milligram per Day (L/h)/(mg/kg) (mL/h)/(ug/kg) Liters per hour (flow rate), divided by milligrams per kilogram (dose normalized by body weight) or milliliters per hour (flow rate), divided by micrograms per kilogram (dose normalized by body weight). Liter per Hour per Milligram per Kilogram (L/h)/(mg/kg/day) (mL/h)/(ug/kg/day) Liters per hour (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milliliters per hour (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). Liter per Hour per Milligram per Kilogram per Day (L/h)/(mg/m2) (mL/h)/(ug/m2) Liters per hour (flow rate), divided by milligrams per meter squared (dose normalized by surface area) or milliliters per hour (flow rate), divided by micrograms per meter squared (dose normalized by surface area). Liter per Hour per Milligram per Meter Squared (L/h)/(mg/m2/day) (mL/h)/(ug/m2/day) Liters per hour (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milliliters per hour (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). Liter per Hour per Milligram per Meter Squared per Day Liters per hour (flow rate), divided by micrograms per day (daily dose). Liter per Hour per Microgram per Day Liters per hour (flow rate), divided by micrograms per kilogram (dose normalized by body weight). Liter per Hour per Microgram per Kilogram Liters per hour (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). Liter per Hour per Microgram per Kilogram per Day Liters per hour (flow rate), divided by micrograms per meter squared (dose normalized by surface area). Liter per Hour per Microgram per Meter Squared Liters per hour (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). Liter per Hour per Microgram per Meter Squared per Day (L/h)/g (mL/h)/mg Liters per hour (flow rate), divided by grams (weight) or milliliters per hour (flow rate), divided by milligrams (dose). Liter per Gram per Hour (L/h)/kg (mL/h)/g mL/g/h Milliliters per gram per hour or liters per hour (flow rate), divided by kilograms (weight) or milliliters per hour (flow rate), divided by grams (weight). Milliliter per Gram per Hour (L/h)/m2 L/h/m2 Liters per hour (flow rate), divided by meters squared (surface area). Liter Per Hour Per Square Meter (L/h)/mg (mL/h)/ug Liters per hour (flow rate), divided by milligrams (dose) or milliliters per hour (flow rate), divided by micrograms (dose). Liter per Milligram per Hour Liters per hour (flow rate), divided by micrograms (dose). Liter per Microgram per Hour Liters per minute (flow rate), divided by kilograms per meter squared (body mass index). Liter per Minute per Kilogram per Meter Squared (L/min)/(mg/day) (mL/min)/(ug/day) Liters per minute (flow rate), divided by milligrams per day (daily dose) or milliliters per minute (flow rate), divided by micrograms per day (daily dose). Liter per Minute per Milligram per Day (L/min)/(mg/kg) (mL/min)/(ug/kg) Liters per minute (flow rate), divided by milligrams per kilogram (dose normalized by body weight) or milliliters per minute (flow rate), divided by micrograms per kilogram (dose normalized by body weight). Liter per Minute per Milligram per Kilogram (L/min)/(mg/kg/day) (mL/min)/(ug/kg/day) Liters per minute (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milliliters per minute (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). Liter per Minute per Milligram per Kilogram per Day (L/min)/(mg/m2) (mL/min)/(ug/m2) Liters per minute (flow rate), divided by milligrams per meter squared (dose normalized by surface area) or milliliters per minute (flow rate), divided by micrograms per meter squared (dose normalized by surface area). Liter per Minute per Milligram per Meter Squared (L/min)/(mg/m2/day) (mL/min)/(ug/m2/day) Liters per minute (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milliliters per minute (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). Liter per Minute per Milligram per Meter Squared per Day Liters per minute (flow rate), divided by micrograms per day (daily dose). Liter per Minute per Microgram per Day Liters per minute (flow rate), divided by micrograms per kilogram (dose normalized by body weight). Liter per Minute per Microgram per Kilogram Liters per minute (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). Liter per Minute per Microgram per Kilogram per Day Liters per minute (flow rate), divided by micrograms per meter squared (dose normalized by surface area). Liter per Minute per Microgram per Meter Squared Liters per minute (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). Liter per Minute per Microgram per Meter Squared per Day (L/min)/g (mL/min)/mg Liters per minute (flow rate), divided by grams (weight) or milliliters per minute (flow rate), divided by milligrams (dose). Liter per Gram per Minute (L/min)/kg (mL/min)/g mL/g/min Milliliters per gram per minute or liters per minute (flow rate), divided by kilograms (weight) or milliliters per minute (flow rate), divided by grams (weight). Milliliter per Gram per Minute (L/min)/m2 L/min/m2 Liters per minute (flow rate), divided by meters squared (surface area). Liter Per Minute Per Square Meter (L/min)/mg (mL/min)/ug Liters per minute (flow rate), divided by milligrams (dose) or milliliters per minute (flow rate), divided by micrograms (dose). Liter per Milligram per Minute Liters per minute (flow rate), divided by micrograms (dose). Liter per Microgram per Minute Milliliters per day (flow rate), divided by kilograms per meter squared (body mass index). Milliliter per Day per Kilogram per Meter Squared Milliliters per day (flow rate), divided by milligrams per day (daily dose). Milliliter per Day per Milligram per Day Milliliters per day (flow rate), divided by milligrams per kilogram (dose normalized by body weight). Milliliter per Day per Milligram per Kilogram Milliliters per day (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight). Milliliter per Day per Milligram per Kilogram per Day Milliliters per day (flow rate), divided by milligrams per meter squared (dose normalized by surface area). Milliliter per Day per Milligram per Meter Squared Milliliters per day (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area). Milliliter per Day per Milligram per Meter Squared per Day (mL/day)/kg mL/kg/day Milliliters per kilogram per day or milliliters per day (flow rate), divided by kilograms (weight). Milliliter per Kilogram per Day Milliliters per day (flow rate), divided by meters squared (surface area). Milliliter per Day per Meter Squared Milliliters per hour (flow rate), divided by kilograms per meter squared (body mass index). Milliliter per Hour per Kilogram per Meter Squared Milliliters per hour (flow rate), divided by milligrams per day (daily dose). Milliliter per Hour per Milligram per Day Milliliters per hour (flow rate), divided by milligrams per kilogram (dose normalized by body weight). Milliliter per Hour per Milligram per Kilogram Milliliters per hour (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight). Milliliter per Hour per Milligram per Kilogram per Day Milliliters per hour (flow rate), divided by milligrams per meter squared (dose normalized by surface area). Milliliter per Hour per Milligram per Meter Squared Milliliters per hour (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area). Milliliter per Hour per Milligram per Meter Squared per Day (mL/h)/kg mL/kg/h Milliliters per kilogram per hour or milliliters per hour (flow rate), divided by kilograms (weight). Milliliter per Kilogram per Hour Milliliters per hour (flow rate), divided by meters squared (surface area). Milliliter per Hour per Meter Squared Milliliters per minute (flow rate), divided by kilograms per meter squared (body mass index). Milliliter per Minute per Kilogram per Meter Squared Milliliters per minute (flow rate), divided by milligrams per day (daily dose). Milliliter per Minute per Milligram per Day Milliliters per minute (flow rate), divided by milligrams per kilogram (dose normalized by body weight). Milliliter per Minute per Milligram per Kilogram Milliliters per minute (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight). Milliliter per Minute per Milligram per Kilogram per Day Milliliters per minute (flow rate), divided by milligrams per meter squared (dose normalized by surface area). Milliliter per Minute per Milligram per Meter Squared Milliliters per minute (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area). Milliliter per Minute per Milligram per Meter Squared per Day (mL/min)/kg mL/kg/min Milliliters per kilogram per minute or milliliters per minute (flow rate), divided by kilograms (weight). Milliliter per Kilogram per Minute Milliliters per minute (flow rate), divided by meters squared (surface area). Milliliter per Minute per Meter Squared /day Daily Per Day A rate of occurrences within a period of time equal to one day. Daily Per Hour A rate of occurrences within a period of time equal to one hour. Per Hour A rate of occurrences within a period of time equal to one minute. Per Minute Becquerel A unit of activity of a radionuclide, equal to one nuclear disintegration or other nuclear transition from a particular energy state occurring in an amount of a radionuclide during one second-long time interval.(NCI) Becquerel Becquerel per Gram A unit of specific radioactivity (massic activity) equal to activity of one Becquerel of the sample with total mass of one gram.(NCI) Becquerel per Gram Becquerel per Kilogram A unit of specific radioactivity (massic activity) equal to activity of one Becquerel of the sample with total mass of one kilogram.(NCI) Becquerel per Kilogram Becquerel per Liter A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Becquerel per unit volume equal to one liter.(NCI) Becquerel per Liter Becquerel per Milligram kBq/g Kilobecquerel per Gram A unit of specific radioactivity (massic activity) equal to activity of one Becquerel of the sample with total mass of one milligram.(NCI) Becquerel per Milligram Becquerel per Milliliter kBq/L Kilobecquerel per Liter A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Becquerel per unit volume equal to one milliliter or one kilobecquerel per liter.(NCI) Becquerel per Milliliter Becquerel per Microgram Bq/mcg Bq/ug kBq/mg Kilobecquerel per Milligram MBq/g Megabecquerel per Gram A unit of specific radioactivity (massic activity) equal to activity of one Becquerel of the sample with total mass of one microgram, or equal to activity of one kilobecquerel of the sample with total mass of one milligram. Becquerel per Microgram Becquerel per Microliter kBq/mL Kilobecquerel per Milliliter MBq/L Megabecquerel per Liter A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Becquerel per unit volume equal to one millionth of a liter.(NCI) Becquerel per Microliter A unit of concentration expressed as a number of copies per unit volume equal to one milliliter. Copies per Milliliter A unit of concentration expressed as a number of copies per unit volume equal to one microgram. Copies per Microgram A unit of concentration expressed as a number of copies per unit volume equal to one microliter. Copies per Microliter A unit of measurement of time equal to 24 hours. Day Days times femtograms per milliliter (area under the curve). Day Times Femtogram per Milliliter Days times femtograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). Day Times Femtogram per Milliliter per Kilogram per Meter Squared Days times femtograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Day Times Femtogram Per Milliliter Per Milligram Per Gram Days times femtograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Day Times Femtogram Per Milliliter Per Milligram Per Gram Per Day day*fg/mL/g day*pg/mL/kg Days times picograms per milliliter (area under the curve), divided by kilograms (weight) or days times femtograms per milliliter (area under the curve), divided by grams (weight). Day Times Femtogram Per Milliliter Per Gram Days times femtograms per milliliter (area under the curve), divided by kilograms (weight). Day Times Femtogram Per Milliliter Per Kilogram Days times femtograms per milliliter (area under the curve), divided by meters squared (surface area). Day Times Femtogram per Milliliter per Meter Squared Days times grams per milliliter (area under the curve). Day Times Gram per Milliliter Days times grams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). Day Times Gram per Milliliter per Kilogram per Meter Squared Days times grams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Day Times gram Per Milliliter Per Milligram Per Gram Days times grams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Day Times gram Per Milliliter Per Milligram Per Gram Per Day Days times grams per milliliter (area under the curve), divided by grams (weight). Day Times Gram Per Milliliter Per Gram day*g/mL/kg day*mg/mL/g day*ng/mL/ug day*ug/mL/mg Days times grams per milliliter (area under the curve), divided by kilograms (weight); or days times milligrams per milliliter (area under the curve), divided by grams (weight); or days times micrograms per milliliter (area under the curve), divided by milligrams (dose); or days times nanograms per milliliter (area under the curve), divided by micrograms (dose). Day Times Gram Per Milliliter Per Kilogram Days times grams per milliliter (area under the curve), divided by meters squared (surface area). Day Times Gram per Milliliter per Meter Squared Days times milligrams per milliliter (area under the curve). Day Times Milligram per Milliliter Days times milligrams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). Day Times Milligram per Milliliter per Kilogram per Meter Squared Days times milligrams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Day Times Milligram Per Milliliter Per Milligram Per Gram Days times milligrams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Day Times Milligram Per Milliliter Per Milligram Per Gram Per Day Days times milligrams per milliliter (area under the curve), divided by meters squared (surface area). Day Times Milligram per Milliliter per Meter Squared Days times millimoles per liter (area under the curve). Day Times Micromole per Milliliter Days times millimoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). Day Times Millimole per Liter per Kilogram per Meter Squared Days times millimoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Day Times Millimole Per Liter Per Milligram Per Gram Days times millimoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Day Times Millimole Per Liter Per Milligram Per Gram Per Day day*mmol/L/g day*mol/L/kg Days times moles per liter (area under the curve), divided by kilograms (weight) or days times millimoles per liter (area under the curve), divided by grams (weight). Day Times Millimole Per Liter Per Gram Days times millimoles per liter (area under the curve), divided by meters squared (surface area). Day Times Millimole per Liter per Meter Squared Days times moles per liter (area under the curve). Day Times Millimole per Milliliter Days times moles per liter (area under the curve), divided by kilograms per meter squared (body mass index). Day Times Mole per Liter per Kilogram per Meter Squared Days times moles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Day Times mole Per Liter Per Milligram Per Gram Days times moles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Day Times mole Per Liter Per Milligram Per Gram Per Day Days times moles per liter (area under the curve), divided by grams (weight). Day Times Mole Per Liter Per Gram Days times moles per liter (area under the curve), divided by meters squared (surface area). Day Times Mole per Liter per Meter Squared Days times nanograms per milliliter (area under the curve). Day Times Nanogram per Milliliter Days times nanograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). Day Times Nanogram per Milliliter per Kilogram per Meter Squared Days times nanograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Day Times Nanogram Per Milliliter Per Milligram Per Gram Days times nanograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Day Times Nanogram Per Milliliter Per Milligram Per Gram Per Day day*ng/mL/kg day*pg/mL/g Days times nanograms per milliliter (area under the curve), divided by kilograms (weight) or days times picograms per milliliter (area under the curve), divided by grams (weight). Day Times Nanogram Per Milliliter Per Kilogram Days times nanograms per milliliter (area under the curve), divided by meters squared (surface area). Day Times Nanogram per Milliliter per Meter Squared Days times nanomoles per liter (area under the curve). Day Times Picomole per Milliliter Days times nanomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). Day Times Nanomole per Liter per Kilogram per Meter Squared Days times nanomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Day Times Nanomole Per Liter Per Milligram Per Gram Days times nanomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Day Times Nanomole Per Liter Per Milligram Per Gram Per Day day*nmol/L/kg day*pmol/L/g Days times nanomoles per liter (area under the curve), divided by kilograms (weight) or days times picomoles per liter (area under the curve), divided by grams (weight). Day Times Nanomole Per Liter Per Kilogram Days times nanomoles per liter (area under the curve), divided by meters squared (surface area). Day Times Nanomole per Liter per Meter Squared Days times picograms per milliliter (area under the curve). Day Times Picogram per Milliliter Days times picograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). Day Times Picogram per Milliliter per Kilogram per Meter Squared Days times picograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Day Times Picogram Per Milliliter Per Milligram Per Gram Days times picograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Day Times Picogram Per Milliliter Per Milligram Per Gram Per Day Days times picograms per milliliter (area under the curve), divided by meters squared (surface area). Day Times Picogram per Milliliter per Meter Squared Days times picomoles per liter (area under the curve). Day Times Picomole per Liter Days times picomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). Day Times Picomole per Liter per Kilogram per Meter Squared Days times picomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Day Times Picomole Per Liter Per Milligram Per Gram Days times picomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Day Times Picomole Per Liter Per Milligram Per Gram Per Day Days times picomoles per liter (area under the curve), divided by kilograms (weight). Day Times Picomole Per Liter Per Kilogram Days times picomoles per liter (area under the curve), divided by meters squared (surface area). Day Times Picomole per Liter per Meter Squared Days times micrograms per milliliter (area under the curve). Day Times Microgram per Milliliter Days times micrograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). Day Times Microgram per Milliliter per Kilogram per Meter Squared Days times micrograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Day Times Microgram Per Milliliter Per Milligram Per Gram Days times micrograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Day Times Microgram Per Milliliter Per Milligram Per Gram Per Day Days times micrograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). Day Times Microgram per Milliliter Times Kilogram per Milligram day*mg/mL/kg day*ug/mL/g Days times milligrams per milliliter (area under the curve), divided by kilograms (weight) or days times micrograms per milliliter (area under the curve), divided by grams (weight). Day Times Microgram Per Milliliter Per Gram day*ng/mL/g day*ug/mL/kg Days times micrograms per milliliter (area under the curve), divided by kilograms (weight) or days times nanograms per milliliter (area under the curve), divided by grams (weight). Day Times Microgram Per Milliliter Per Kilogram Days times micrograms per milliliter (area under the curve), divided by meters squared (surface area). Day Times Microgram per Milliliter per Meter Squared Days times micromoles per liter (area under the curve). Day Times Nanomole per Milliliter Days times micromoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). Day Times Micromole per Liter per Kilogram per Meter Squared Days times micromoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Day Times Micromole Per Liter Per Milligram Per Gram Days times micromoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Day Times Micromole Per Liter Per Milligram Per Gram Per Day day*mmol/L/kg day*umol/L/g Days times millimoles per liter (area under the curve), divided by kilograms (weight) or days times micromoles per liter (area under the curve), divided by grams (weight). Day Times Micromole Per Liter Per Gram day*nmol/L/g day*umol/L/kg Days times micromoles per liter (area under the curve), divided by kilograms (weight) or days times nanomoles per liter (area under the curve), divided by grams (weight). Day Times Micromole Per Liter Per Kilogram Days times micromoles per liter (area under the curve), divided by meters squared (surface area). Day Times Micromole per Liter per Meter Squared DNA Copies per Milliliter The unit of concentration of deoxyribonucleic acid (DNA) copies expressed as a number of copies in unit volume equal to one milliliter. DNA Copies per Milliliter A unit of measurement equal to the number of deoxyribonucleic acid (DNA) copies per unit of mass equal to one microgram. DNA Copies Per Microgram fg/mL pg/L A unit of concentration or mass density equal to one femtogram of substance per milliliter of solution or one picogram of substance per liter of solution. Femtogram per Milliliter Femtograms per milliliter (concentration), divided by kilograms per meter squared (body mass index). Femtogram per Milliliter per Kilogram per Meter Squared Femtograms per milliliter (concentration), divided by milligrams per day (daily dose). Femtogram per Milliliter per Milligram per Day Femtograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight). Femtogram per Milliliter per Milligram per Kilogram Femtograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight). Femtogram per Milliliter per Milligram per Kilogram per Day Femtograms per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area). Femtogram per Milliliter per Milligram per Meter Squared Femtograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area). Femtogram per Milliliter per Milligram per Meter Squared per Day fg/mL/(ug/day) pg/mL/(mg/day) Picograms per milliliter (concentration), divided by milligrams per day (daily dose) or femtograms per milliliter (concentration), divided by micrograms per day (daily dose). Femtogram per Milliliter per Microgram per Day fg/mL/(ug/m2) pg/mL/(mg/m2) Picograms per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or femtograms per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Femtogram per Milliliter per Microgram per Meter Squared fg/mL/(ug/m2/day) pg/mL/(mg/m2/day) Picograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or femtograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Femtogram per Milliliter per Microgram per Meter Squared per Day fg/mL/g pg/mL/kg Picograms per milliliter (concentration), divided by kilograms (weight) or femtograms per milliliter (concentration), divided by grams (weight). Femtogram per Milliliter per Gram Femtograms per milliliter (concentration), divided by kilograms (weight). Femtogram per Milliliter per Kilogram Femtograms per milliliter (concentration), divided by meters squared (surface area). Femtogram per Milliliter per Meter Squared fg/mL/ug ng/mL/g pg/mL/mg ug/mL/kg Micrograms per milliliter (concentration), divided by kilograms (weight) or nanograms per milliliter (concentration), divided by grams (weight) or picograms per milliliter (concentration), divided by milligrams (dose) or femtograms per milliliter (concentration), divided by micrograms (dose). Femtogram per Milliliter per Microgram Proportion of 1 A unit for expressing a percentage as a decimal whereby the total value is measured as a fraction of the numeric 1. Fraction of 1 Gram A unit of mass equal to one thousandth (1E-3) of a kilogram, the kilogram being the base unit of mass in the International System of Units (SI). Gram g/24h A unit of mass flow rate equal to one gram per day. Gram per 24 Hours A unit of mass flow rate or dose administration rate equal to one gram per hour. Gram per Hour A unit of mass flow rate or dose administration rate equal to one gram per minute. Gram per Minute g/mL Gram per Milliliter gram/mL kg/L Kilogram per Liter mg/uL A unit of concentration or mass density equal to one gram of substance per milliliter of solution or one kilogram of substance per liter of solution. Kilogram per Liter Grams per milliliter (concentration), divided by kilograms per meter squared (body mass index). Gram per Milliliter per Kilogram per Meter Squared g/mL/(mg/day) mg/mL/(ug/day) Grams per milliliter (concentration), divided by milligrams per day (daily dose) or milligrams per milliliter (concentration), divided by micrograms per day (daily dose). Gram per Milliliter per Milligram per Day g/mL/(mg/kg) mg/mL/(ug/kg) Grams per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or milligrams per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Gram Per Milliliter Per Milligram Per Kilogram g/mL/(mg/kg/day) mg/mL/(ug/kg/day) Grams per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milligrams per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Gram Per Milliliter Per Milligram Per Kilogram Per Day g/mL/(mg/m2) mg/mL/(ug/m2) Grams per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or milligrams per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Gram per Milliliter per Milligram per Meter Squared g/mL/(mg/m2/day) mg/mL/(ug/m2/day) Grams per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milligrams per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Gram per Milliliter per Milligram per Meter Squared per Day Grams per milliliter (concentration), divided by micrograms per day (daily dose). Gram per Milliliter per Microgram per Day Grams per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Gram per Milliliter per Microgram per Kilogram Grams per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Gram per Milliliter per Microgram per Kilogram per Day Grams per milliliter (concentration), divided by micrograms per meter squared (dose normalized by body weight). Gram per Milliliter per Microgram per Meter Squared Grams per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Gram per Milliliter per Microgram per Meter Squared per Day g/mL/g mg/mL/mg ug/mL/ug Grams per milliliter (concentration), divided by grams (weight) or milligrams per milliliter (concentration), divided by milligrams (dose) or micrograms per milliliter (concentration), divided by micrograms (dose). Gram per Milliliter per Gram Grams per milliliter (concentration), divided by meters squared (surface area). Gram per Milliliter per Meter Squared g/mL/mg mg/mL/ug Grams per milliliter (concentration), divided by milligrams (dose) or milligrams per milliliter (concentration), divided by micrograms (dose). Gram per Milliliter per Milligram Grams per milliliter (concentration), divided by micrograms (dose). Gram per Milliliter per Microgram Gigabecquerel A unit of radioactivity equal to one billion nuclear disintegrations or other nuclear transformations per second, or to 1E9 Becquerels. (NCI) Gigabecquerel GBq/g Gigabecquerel per Gram kBq/ug Kilobecquerel per Microgram MBq/mg Megabecquerel per Milligram A unit of specific radioactivity (massic activity) equal to activity of one gigabecquerel of the sample with total mass of one gram, or equal to activity of one megabecquerel of the sample with total mass of one milligram. Gigabecquerel per Gram Gigabecquerel per Milligram MBq/mcg MBq/ug Megabecquerel per Microgram A unit of specific radioactivity (massic activity) equal to activity of one gigabecquerel of the sample with total mass of one milligram.(NCI) Gigabecquerel per Milligram Gigabecquerel per nanoliter. Gigabecquerel/nL GBq/mcg Gigabecquerel per Microgram MBq/ng Megabecquerel per nanogram A unit of specific radioactivity (massic activity) equal to activity of one gigabecquerel of the sample with total mass of one microgram.(NCI) Gigabecquerel per Microgram Gigabecquerel per microliter. Gigabecquerel per Microliter h Hours hr A unit of measurement of time equal to 60 minutes. Hour Hours times Becquerel per gram (area under the curve). Hour Times Becquerel per Gram Hours times Becquerel per milliliter (area under the curve). Hour Times Becquerel per milliliter Hours times DNA copies per microgram (area under the curve). Hours Times DNA Copies Per Microgram Hours times femtograms per milliliter (area under the curve). Hour Times Femtogram per Milliliter Hours times femtograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). Hour Times Femtogram per Milliliter per Kilogram per Meter Squared Hours times femtograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Hour Times Femtogram Per Milliliter Per Milligram Per Gram Hours times femtograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Hour Times Femtogram Per Milliliter Per Milligram Per Gram Per Day Hours times femtograms per milliliter (area under the curve), divided by kilograms (weight). Hour Times Femtogram Per Milliliter Per Kilogram Hours times femtograms per milliliter (area under the curve), divided by meters squared (surface area). Hour Times Femtogram per Milliliter per Meter Squared h*kg/L h*mg/uL Hours times grams per milliliter (area under the curve). Hour Times Gram per Milliliter Hours times grams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). Hour Times Gram per Milliliter per Kilogram per Meter Squared Hours times grams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Hour Times gram Per Milliliter Per Milligram Per Gram Hours times grams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Hour Times gram Per Milliliter Per Milligram Per Gram Per Day Hours times grams per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). Hour Times Gram Per Milliliter Per Milligram Per Kilogram Hours times grams per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight). Hour Times Gram Per Milliliter Per Milligram Per Kilogram Per Day Hours times grams per milliliter (area under the curve), divided by grams (weight). Hour Times Gram Per Milliliter Per Gram Hours times grams per milliliter (area under the curve), divided by meters squared (surface area). Hour Times Gram per Milliliter per Meter Squared Hours times milligrams per milliliter (area under the curve). Hour Times Milligram per Milliliter Hours times milligrams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). Hour Times Milligram per Milliliter per Kilogram per Meter Squared Hours times milligrams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Hour Times Milligram Per Milliliter Per Milligram Per Gram Hours times milligrams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Hour Times Milligram Per Milliliter Per Milligram Per Gram Per Day Hours times milligrams per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). Hour Times Milligram Per Milliliter Per Milligram Per Kilogram Hours times milligrams per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight). Hour Times Milligram Per Milliliter Per Milligram Per Kilogram Per Day Hours times milligrams per milliliter (area under the curve), divided by meters squared (surface area). Hour Times Milligram per Milliliter per Meter Squared mIU*h/mL Hours times milli international unit per milliliter (area under the curve). Hour Times Milli-international Unit per Milliliter Hours times millimoles per liter (area under the curve). Hour Times Micromole per Milliliter Hours times millimoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). Hour Times Millimole per Liter per Kilogram per Meter Squared Hours times millimoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Hour Times Millimole Per Liter Per Milligram Per Gram Hours times millimoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Hour Times Millimole Per Liter Per Milligram Per Gram Per Day h*mmol/L/g h*mol/L/kg Hours times moles per liter (area under the curve), divided by kilograms (weight) or hours times millimoles per liter (area under the curve), divided by grams (weight). Hour times Millimole Per Liter Per Gram h*mmol/L/kg h*nmol/L/mg h*pmol/L/ug h*umol/L/g Hours times millimoles per liter (area under the curve), divided by kilograms (weight); or hours times micromoles per liter (area under the curve), divided by grams (weight); or hours times nanomoles per liter (area under the curve), divided by milligrams (dose); or hours times picomoles per liter (area under the curve), divided by micrograms (dose). Hour Times Millimole Per Liter Per Kilogram Hours times millimoles per liter (area under the curve), divided by meters squared (surface area). Hour Times Millimole per Liter per Meter Squared Hours times moles per liter (area under the curve). Hour Times Millimole per Milliliter Hours times moles per liter (area under the curve), divided by kilograms per meter squared (body mass index). Hour Times Mole per Liter per Kilogram per Meter Squared Hours times moles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Hour Times mole Per Liter Per Milligram Per Gram Hours times moles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Hour Times mole Per Liter Per Milligram Per Gram Per Day h*mmol/L/mg h*mol/L/g h*umol/L/ug Hours times millimoles per liter (area under the curve), divided by kilograms (weight); or hours times micromoles per liter (area under the curve), divided by grams (weight); or hours times nanomoles per liter (area under the curve), divided by milligrams (dose); or hours times picomoles per liter (area under the curve), divided by micrograms (dose). Hour times Mole Per Liter Per Gram Hours times moles per liter (area under the curve), divided by meters squared (surface area). Hour Times Mole per Liter per Meter Squared h*ug/L Hours times nanograms per milliliter (area under the curve). Hour Times Nanogram per Milliliter Hours times nanograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). Hour Times Nanogram per Milliliter per Kilogram per Meter Squared Hour times nanograms per milliliter (area under the curve), divided by milligrams per centimeter squared (body mass index). Hours Times Nanogram Per Milliliter Per Milligram Per Square Centimeter Hours times nanograms per milliliter (area under the curve), divided by milligrams per centimeter squared per day (daily dose normalized by surface area). Hour Times Nanogram Per Milliliter Per Milligram Per Centimeter Squared Per Day Hours times nanograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Hour Times Nanogram Per Milliliter Per Milligram Per Gram Hours times nanograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Hour Times Nanogram Per Milliliter Per Milligram Per Gram Per Day Hours times nanograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). Hour Times Nanogram per Milliliter per Milligram per Kilogram Hours times nanograms per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight). Hour Times Nanogram Per Milliliter Per Milligram Per Kilogram Per Day Hours times nanograms per milliliter (area under the curve), divided by milligrams per meter squared (dose normalized by surface area). Hour Times Nanogram per Milliliter per Milligram per Meter Squared h*ng/mL/g h*pg/mL/mg h*ug/mL/kg Hours times micrograms per milliliter (area under the curve), divided by kilograms (weight) or hours times nanograms per milliliter (area under the curve), divided by grams (weight) or hours times picograms per milliliter (area under the curve), divided by milligrams (dose). Hour Times Nanogram per Milliliter per Gram h*ng/mL/kg h*pg/mL/g Hours times nanograms per milliliter (area under the curve), divided by kilograms (weight) or hours times picograms per milliliter (area under the curve), divided by grams (weight). Hour Times Nanogram per Milliliter per Kilogram Hours times nanograms per milliliter (area under the curve), divided by meters squared (surface area). Hour Times Nanogram per Milliliter per Meter Squared h*mg/mL/kg h*ng/mL/mg h*ug/mL/g Hours times milligrams per milliliter (area under the curve), divided by kilograms (weight) or hours times micrograms per milliliter (area under the curve), divided by grams (weight) or hours times nanograms per milliliter (area under the curve), divided by milligrams (dose). Hour Times Nanogram per Milliliter per Milligram Hours times nanogram equivalents per milliliter (area under the curve obtained based on radioactivity measurements). Hour Times Nanogram Equivalents Per Milliliter Hours times nanogram equivalents per milliliter (area under the curve obtained based on radioactivity measurements), divided by milligram equivalents (radiolabeled dose). Hour Times Nanogram Equivalents Per Milliliter Per Milligram Equivalents Hours times nanomoles per liter (area under the curve). Hour Times Picomole per Milliliter Hours times nanomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). Hour Times Nanomole per Liter per Kilogram per Meter Squared Hours times nanomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Hour Times Nanomole Per Liter Per Milligram Per Gram Hours times nanomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Hour Times Nanomole Per Liter Per Milligram Per Gram Per Day Hours times nanomoles per liter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). Hour Times Nanomole per Liter per Milligram per Kilogram Hours times nanomoles per liter (area under the curve), divided by meters squared (surface area). Hour Times Nanomole per Liter per Meter Squared Hours times nanomole equivalents per liter (area under the curve obtained based on equivalent substance, e.g., radioactivity measurements). Hours Times Nanomole Equivalents Per Liter Hours times nanomole equivalents per liter (area under the curve obtained based on equivalent substance, e.g., radioactivity measurements), divided by milligram. Hours Times Nanomole Equivalents Per Liter Per Milligram Hours times nanomole equivalents per liter (area under the curve obtained based on equivalent substance, e.g., radioactivity measurements), divided by microgram. Hours Times Nanomole Equivalents Per Liter Per Microgram Hours times picograms per milliliter (area under the curve). Hour Times Picogram per Milliliter Hours times picograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). Hour Times Picogram per Milliliter per Kilogram per Meter Squared Hours times picograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Hour Times Picogram Per Milliliter Per Milligram Per Gram Hours times picograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Hour Times Picogram Per Milliliter Per Milligram Per Gram Per Day Hours times picograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). Hour Times Picogram Per Milliliter Per Milligram Per Kilogram Hours times picograms per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight). Hour Times Picogram Per Milliliter Per Milligram Per Kilogram Per Day h*fg/mL/g h*pg/mL/kg Hours times picograms per milliliter (area under the curve), divided by kilograms (weight) or hours times femtograms per milliliter (area under the curve), divided by grams (weight). Hour Times Picogram per Milliliter per Kilogram Hours times picograms per milliliter (area under the curve), divided by meters squared (surface area). Hour Times Picogram per Milliliter per Meter Squared h*ngEq/L Hours times picogram equivalents per milliliter (area under the curve obtained based on radioactivity measurements). Hour Times Picogram Equivalents Per Milliliter Hours times picogram equivalents per milliliter (area under the curve obtained based on radioactivity measurements), divided by milligram equivalents (radiolabeled dose). Hour Times Picogram Equivalents Per Milliliter Per Milligram Equivalents Hours times picomoles per liter (area under the curve). Hour Times Femtomole per Milliliter Hours times picomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). Hour Times Picomole per Liter per Kilogram per Meter Squared Hours times picomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Hour Times Picomole Per Liter Per Milligram Per Gram Hours times picomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Hour Times Picomole Per Liter Per Milligram Per Gram Per Day Hours times picomoles per liter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). Hour Times Picomole Per Liter Per Milligram Per Kilogram h*nmol/L/kg h*pmol/L/g Hours times nanomoles per liter (area under the curve), divided by kilograms (weight) or hours times picomoles per liter (area under the curve), divided by grams (weight). Hour times Picomole Per Liter Per Gram Hours times picomoles per liter (area under the curve), divided by kilograms (weight). Hour Times Picomole Per Liter Per Kilogram Hours times picomoles per liter (area under the curve), divided by meters squared (surface area). Hour Times Picomole per Liter per Meter Squared h*mg/kg h*ng/mg Hours times micrograms per gram (area under the curve). Hour Times Microgram Per Gram h*mg/L Hours times micrograms per milliliter (area under the curve). Hour Times Microgram per Milliliter Hours times micrograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). Hour Times Microgram per Milliliter per Kilogram per Meter Squared Hours times micrograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Hour Times Microgram Per Milliliter Per Milligram Per Gram Hours times micrograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Hour Times Microgram Per Milliliter Per Milligram Per Gram Per Day Hours times micrograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). Hour Times Microgram Per Milliliter Per Milligram Per Kilogram h*ng/mL/(ug/kg/day) h*ug/mL/(mg/kg/day) Hour times nanograms per milliliter (area under the curve), divided by micrograms per kilogram per day (daily dose normalized by body weight), or hour times micrograms per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight). Hour Times Microgram Per Milliliter Per Milligram Per Kilogram Per Day Hours times micrograms per milliliter (area under the curve), divided by meters squared (surface area). Hour Times Microgram per Milliliter per Meter Squared h*g/mL/kg h*mg/mL/g h*ug/mL/mg Hours times grams per milliliter (area under the curve), divided by kilograms (weight) or hours times milligrams per milliliter (area under the curve), divided by grams (weight) or hours times micrograms per milliliter (area under the curve), divided by milligrams (dose). Hour Times Microgram per Milliliter per Milligram Hours times microgram equivalents per milliliter (area under the curve obtained based on radioactivity measurements). Hour Times Microgram Equivalents Per Milliliter Hours times microgram equivalents per milliliter (area under the curve obtained based on radioactivity measurements ), divided by milligram equivalents (radiolabeled dose). Hour Times Microgram Equivalents Per Milliliter Per Milligram Equivalents uIU*h/mL Hours times micro international unit per milliliter (area under the curve). Hour Times Micro-international Unit per Milliliter Hours times micromoles per liter (area under the curve). Hour Times Nanomole per Milliliter Hours times micromoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). Hour Times Micromole per Liter per Kilogram per Meter Squared Hours times micromoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Hour Times Micromole Per Liter Per Milligram Per Gram Hours times micromoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Hour Times Micromole Per Liter Per Milligram Per Gram Per Day Hours times micromoles per liter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). Hour Times Micromole per Liter per Milligram per Kilogram h*nmol/L/g h*umol/L/kg Hours times micromoles per liter (area under the curve), divided by kilograms (weight) or hours times nanomoles per liter (area under the curve), divided by grams (weight). Hour Times Micromole Per Liter Per Kilogram Hours times micromoles per liter (area under the curve), divided by meters squared (surface area). Hour Times Micromole per Liter per Meter Squared h*h*DNA copies/ug Hours squared times DNA copies per microgram (area under the moment curve). Hours Squared Time DNA Copies Per Microgram h*h*mg/mL h2*g/L h2*ug/uL h^2*mg/mL mg*h2/mL Hours squared times milligrams per milliliter. Hour Squared Times Milligram per Milliliter Hours squared times millimoles per liter (area under the moment curve). Hour Squared Times Micromole per Milliliter Hours squared times moles per liter (area under the moment curve). Hour Squared Times Millimole per Milliliter h*h*ng/mL h2*ug/L h^2*ng/mL ng*h2/mL Hours squared times nanograms per milliliter. Hour Squared Times Nanogram per Milliliter Hours squared times nanomoles per liter (area under the moment curve). Hour Squared Times Picomole per Milliliter h*h*pg/mL h2*ng/L h^2*pg/mL pg*h2/mL Hours squared times picogram per milliliter. Hour Squared Times Picogram per Milliliter Hours squared times picomoles per liter (area under the moment curve). Hour Squared Times Picomole Per Liter h*h*ug/mL h2*mcg/mL h2*mg/L h^2*ug/mL ug*h2/mL Hours squared times micrograms per milliliter. Hour Squared Times Microgram per Milliliter h*h*ug/mL/(mg/kg) h2*mcg/mL/(mg/kg) h2*mg/L/(mg/kg) h^2*ug/mL/(mg/kg) ug*h2/mL/(mg/kg) Hours squared times micrograms per milliliter, divided by milligrams per kilogram (dose normalized by body weight). Hours Squared Times Micrograms per Milliliter Divided by Milligrams per Kilogram Hours squared times micromoles per liter (area under the moment curve). Hour Squared Times Micromole Per Liter IE International Unit The unitage assigned by the WHO (World Health Organization) to International Biological Standards - substances, classed as biological according to the criteria provided by WHO Expert Committee on Biological Standardization, to enable the results of biological and immunological assay procedures to be expressed in the same way throughout the world. The definition of an international unit is generally arbitrary and technical, and has to be officially approved by the International Conference for Unification of Formulae.(NCI) International Unit A unit of substance (biologic activity) flow rate equal to one international unit per day. International Unit per Day IU/h A unit of substance (biologic activity) flow rate equal to one international unit per hour. International Unit per Hour IU/min A unit of substance (biologic activity) flow rate equal to one international unit per minute. International Unit per Minute IE/mL International Unit per Milliliter Kilo International Unit per Liter kIU/L A unit of concentration (biologic activity) equal to one international unit of substance per milliliter of solution. International Unit per Milliliter International units per milliliter (concentration), divided by kilograms per meter squared (body mass index). International Unit per Milliliter per Kilogram per Meter Squared IU/mL/(mg/day) mIU/mL/(ug/day) International units per milliliter (concentration), divided by milligrams per day (daily dose) or milli-international units per milliliter (concentration), divided by micrograms per day (daily dose). International Unit per Milliliter per Milligram per Day IU/mL/(mg/kg) mIU/mL/(ug/kg) International units per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or milli-international units per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). International Unit per Milliliter per Milligram per Kilogram IU/mL/(mg/kg/day) mIU/mL/(ug/kg/day) International units per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milli-international units per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). International Unit per Milliliter per Milligram per Kilogram per Day IU/mL/(mg/m2) mIU/mL/(ug/m2) International units per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or milli-international units per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). International Unit per Milliliter per Milligram per Meter Squared IU/mL/(mg/m2/day) mIU/mL/(ug/m2/day) International units per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milli-international units per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). International Unit per Milliliter per Milligram per Meter Squared per Day International units per milliliter (concentration), divided by micrograms per day (daily dose). International Unit per Milliliter per Microgram per Day International units per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). International Unit per Milliliter per Microgram per Kilogram International units per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). International Unit per Milliliter per Microgram per Kilogram per Day International units per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). International Unit per Milliliter per Microgram per Meter Squared International units per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). International Unit per Milliliter per Microgram per Meter Squared per Day IU/mL/g mIU/mL/mg uIU/mL/ug International units per milliliter (concentration), divided by grams (weight) or milli-international units per milliliter (concentration), divided by milligrams (dose) or micro-international units per milliliter (concentration), divided by micrograms (dose). International Unit per Milliliter per Gram IU/mL/kg mIU/mL/g uIU/mL/mg International units per milliliter (concentration), divided by kilograms (weight) or milli-international units per milliliter (concentration), divided by grams (weight) or micro-international units per milliliter (concentration), divided by milligrams (dose). International Unit per Milliliter per Kilogram International units per milliliter (concentration), divided by meters squared (surface area). International Unit per Milliliter per Meter Squared IU/mL/mg mIU/mL/ug International units per milliliter (concentration), divided by milligrams (dose) or milli-international units per milliliter (concentration), divided by micrograms (dose). International Unit per Milliliter per Milligram International units per milliliter (concentration), divided by micrograms (dose). International Unit per Milliliter per Microgram Kilobecquerel A unit of radioactivity equal to one thousand nuclear disintegrations or other nuclear transformations per second, or to 1E3 Becquerels. (NCI) Kilobecquerel GBq/L Gigabecquerel per Liter Kilobecquerel per Microliter MBq/mL Megabecquerel per Milliliter A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one thousand Becquerels per unit volume equal to one millionth of a liter.(NCI) Kilobecquerel per Microliter Liter A unit of volume equal to one thousandth (1E-3) of a cubic meter, the cubic meter being the standard derived unit of volume in the International System of Units (SI). Liter Liters (volume), divided by kilograms per meter squared (body mass index). Liter per Kilogram per Meter Squared mL/(ug/day) Liters (volume), divided by milligrams per day (daily dose). Liter Divided by Milligram Per Day Liters (volume), divided by milligrams per kilogram (dose normalized by body weight). Liter per Milligram per Kilogram L/(mg/kg/day) mL/(ug/kg/day) Liters (volume), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milliliters (volume), divided by micrograms per kilogram per day (daily dose normalized by body weight). Liter per Milligram per Kilogram per Day mL/(ug/m2) Liters (volume), divided by milligrams per meter squared (dose normalized by surface area). Liter Divided by Milligram per Meter Squared L/(mg/m2/day) mL/(ug/m2/day) Liters (volume), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milliliters (volume), divided by micrograms per meter squared per day (daily dose normalized by surface area). Liter per Milligram per Meter Squared per Day Liters (volume), divided by micrograms per day (daily dose). Liter Divided by Microgram per Day Liters (volume), divided by micrograms per kilogram (dose normalized by body weight). Liter per Microgram per Kilogram Liters (volume), divided by micrograms per kilogram per day (daily dose normalized by body weight). Liter per Microgram per Kilogram per Day Liters (volume), divided by micrograms per meter squared (dose normalized by surface area). Liter per Microgram per Meter Squared Liters (volume), divided by micrograms per meter squared per day (daily dose normalized by surface area). Liter per Microgram per Meter Squared per Day A unit of flow rate equal to one liter per day. Liter per Day mL/mg Liters (volume), divided by grams (weight) or milliliters (volume), divided by milligrams (dose). Cubic Meter per Kilogram A unit of flow rate equal to one liter per hour. Liter per Hour L/kg mL/g Liters (volume) divided by kilograms (weight) or milliliters (volume), divided by grams (weight). Liter per Kilogram Liters (volume), divided by meters squared (surface area). Liter per Meter Squared L/mg mL/ug Liters (volume), divided by milligrams (dose) or milliliters (volume), divided by micrograms (dose). Liter per Milligram A unit of flow rate equal to one liter per minute. Liter per Minute Liters (volume), divided by micrograms (dose). Liter per Microgram Megabecquerel A unit of radioactivity equal to one million nuclear disintegrations or other nuclear transformations per second, or to 1E6 Becquerels. (NCI) Megabecquerel GBq/mL Gigabecquerel per Milliliter MBq/uL Megabecquerel per Microliter A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one million Becquerels per unit volume equal to one millionth of a liter, or defined as a concentration of a radionuclide with an activity equal to one billion Becquerels per unit volume equal to one thousandth of a liter. Megabecquerel per Microliter Milligram A unit of mass equal to one thousandth (1E-3) of a gram. Milligram A unit of mass flow rate equal to one milligram per day. Milligram per 24 Hours mg% Milligram per Deciliter A unit of mass concentration defined as the concentration of one milligram of a substance in unit volume of the mixture equal to one cubic deciliter or 100 cubic centimeters. It is also a unit of mass density (volumic mass) defined as the density of substance which mass equal to one milligram occupies the volume one cubic deciliter or 100 cubic centimeters.(NCI) Milligram per Deciliter A unit of mass flow rate equal to one milligram per hour. Milligram per Hour Milligram per Kilogram Nanogram per Milligram ng/mg ug/g Milligrams (weight), divided by kilograms (weight) or nanograms (weight) per milligrams (weight). Milligram per Kilogram Milligram per Kilogram per Day A dose calculation unit expressed in milligram(s) per kilogram per period of time equal to twenty-four hours. (NCI) Milligram per Kilogram per Day A unit of mass flow rate equal to one milligram per minute. Milligram per Minute g/L Gram per Liter kg/m3 Kilogram per Cubic Meter mg/mL Microgram per Microliter Milligram per Milliliter ug/uL A unit of concentration or mass density equal to one milligram of substance per milliliter of solution or one gram of substance per liter of solution. Kilogram per Cubic Meter Milligrams per milliliter (concentration), divided by kilograms per meter squared (body mass index). Milligram per Milliliter per Kilogram per Meter Squared mg/mL/(mg/day) ug/mL/(ug/day) Milligrams per milliliter (concentration), divided by milligrams per day (daily dose) or micrograms per milliliter (concentration), divided by micrograms per day (daily dose). Milligram per Milliliter per Milligram per Day mg/mL/(mg/kg) ug/mL/(ug/kg) Milligrams per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or micrograms per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Milligram Per Milliliter Per Milligram Per Kilogram mg/mL/(mg/kg/day) ug/mL/(ug/kg/day) Milligrams per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or micrograms per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Milligram Per Milliliter Per Milligram Per Kilogram Per Day mg/mL/(mg/m2) ug/mL/(ug/m2) Milligrams per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or micrograms per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Milligram per Milliliter per Milligram per Meter Squared mg/mL/(mg/m2/day) ug/mL/(ug/m2/day) Milligrams per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or micrograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Milligram per Milliliter per Milligram per Meter Squared per Day Milligrams per milliliter (concentration), divided by meters squared (surface area). Milligram per Milliliter per Meter Squared Milligram Equivalent A unit of relative amount of substance equal to one thousandth of a gram of an equivalent weight. Milligram Equivalent Minute A unit of measurement of time equal to 60 seconds. Minute Minutes times femtograms per milliliter (area under the curve). Minute Times Femtogram per Milliliter Minutes times femtograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). Minute Times Femtogram per Milliliter per Kilogram per Meter Squared Minutes times femtograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Minute Times Femtogram Per Milliliter Per Milligram Per Gram Minutes times femtograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Minute Times Femtogram Per Milliliter Per Milligram Per Gram Per Day min*fg/mL/g min*pg/mL/kg Minutes times picograms per milliliter (area under the curve), divided by kilograms (weight) or minutes times femtograms per milliliter (area under the curve), divided by grams (weight). Minute Times Femtogram Per Milliliter Per Gram Minutes times femtograms per milliliter (area under the curve), divided by kilograms (weight). Minute Times Femtogram Per Milliliter Per Kilogram Minutes times femtograms per milliliter (area under the curve), divided by meters squared (surface area). Minute Times Femtogram per Milliliter per Meter Squared Minutes times grams per milliliter (area under the curve). Minute Times Gram per Milliliter Minutes times grams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). Minute Times Gram per Milliliter per Kilogram per Meter Squared Minutes times grams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Minute Times gram Per Milliliter Per Milligram Per Gram Minutes times grams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Minute Times gram Per Milliliter Per Milligram Per Gram Per Day Minutes times grams per milliliter (area under the curve), divided by grams (weight). Minute Times Gram Per Milliliter Per Gram min*g/mL/kg min*mg/mL/g Minutes times grams per milliliter (area under the curve), divided by kilograms (weight) or minutes times milligrams per milliliter (area under the curve), divided by grams (weight). Minute Times Gram Per Milliliter Per Kilogram Minutes times grams per milliliter (area under the curve), divided by meters squared (surface area). Minute Times Gram per Milliliter per Meter Squared Minutes times milligrams per milliliter (area under the curve). Minute Times Milligram per Milliliter Minutes times milligrams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). Minute Times Milligram per Milliliter per Kilogram per Meter Squared Minutes times milligrams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Minute Times Milligram Per Milliliter Per Milligram Per Gram Minutes times milligrams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Minute Times Milligram Per Milliliter Per Milligram Per Gram Per Day Minutes times milligrams per milliliter (area under the curve), divided by meters squared (surface area). Minute Times Milligram per Milliliter per Meter Squared Minutes times millimoles per liter (area under the curve). Minute Times Micromole per Milliliter Minutes times millimoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). Minute Times Millimole per Liter per Kilogram per Meter Squared Minutes times millimoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Minute Times Millimole Per Liter Per Milligram Per Gram Minutes times millimoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Minute Times Millimole Per Liter Per Milligram Per Gram Per Day min*mmol/L/g min*mol/L/kg Minutes times moles per liter (area under the curve), divided by kilograms (weight) or minutes times millimoles per liter (area under the curve), divided by grams (weight). Minute Times Millimole Per Liter Per Gram Minutes times millimoles per liter (area under the curve), divided by meters squared (surface area). Minute Times Millimole per Liter per Meter Squared Minutes times moles per liter (area under the curve). Minute Times Millimole per Milliliter Minutes times moles per liter (area under the curve), divided by kilograms per meter squared (body mass index). Minute Times Mole per Liter per Kilogram per Meter Squared Minutes times moles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Minute Times mole Per Liter Per Milligram Per Gram Minutes times moles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Minute Times mole Per Liter Per Milligram Per Gram Per Day Minutes times moles per liter (area under the curve), divided by grams (weight). Minute Times Mole Per Liter Per Gram Minutes times moles per liter (area under the curve), divided by meters squared (surface area). Minute Times Mole per Liter per Meter Squared Minutes times nanograms per milliliter (area under the curve). Minute Times Nanogram per Milliliter Minutes times nanograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). Minute Times Nanogram per Milliliter per Kilogram per Meter Squared Minutes times nanograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Minute Times Nanogram Per Milliliter Per Milligram Per Gram Minutes times nanograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Minute Times Nanogram Per Milliliter Per Milligram Per Gram Per Day min*ng/mL/kg min*pg/mL/g Minutes times nanograms per milliliter (area under the curve), divided by kilograms (weight) or minutes times picograms per milliliter (area under the curve), divided by grams (weight). Minute Times Nanogram Per Milliliter Per Kilogram Minutes times nanograms per milliliter (area under the curve), divided by meters squared (surface area). Minute Times Nanogram per Milliliter per Meter Squared Minutes times nanomoles per liter (area under the curve). Minute Times Picomole per Milliliter Minutes times nanomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). Minute Times Nanomole per Liter per Kilogram per Meter Squared Minutes times nanomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Minute Times Nanomole Per Liter Per Milligram Per Gram Minutes times nanomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Minute Times Nanomole Per Liter Per Milligram Per Gram Per Day min*nmol/L/kg min*pmol/L/g Minutes times nanomoles per liter (area under the curve), divided by kilograms (weight) or minutes times picomoles per liter (area under the curve), divided by grams (weight). Minute Times Nanomole Per Liter Per Kilogram Minutes times nanomoles per liter (area under the curve), divided by meters squared (surface area). Minute Times Nanomole per Liter per Meter Squared Minutes times picograms per milliliter (area under the curve). Minute Times Picogram per Milliliter Minutes times picograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). Minute Times Picogram per Milliliter per Kilogram per Meter Squared Minutes times picograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Minute Times Picogram Per Milliliter Per Milligram Per Gram Minutes times picograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Minute Times Picogram Per Milliliter Per Milligram Per Gram Per Day Minutes times picograms per milliliter (area under the curve), divided by meters squared (surface area). Minute Times Picogram per Milliliter per Meter Squared Minutes times picomoles per liter (area under the curve). Minute Times Picomole Per Liter Minutes times picomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). Minute Times Picomole per Liter per Kilogram per Meter Squared Minutes times picomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Minute Times Picomole Per Liter Per Milligram Per Gram Minutes times picomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Minute Times Picomole Per Liter Per Milligram Per Gram Per Day Minutes times picomoles per liter (area under the curve), divided by kilograms (weight). Minute Times Picomole Per Liter Per Kilogram Minutes times picomoles per liter (area under the curve), divided by meters squared (surface area). Minute Times Picomole per Liter per Meter Squared Minutes times micrograms per milliliter (area under the curve). Minute Times Microgram per Milliliter Minutes times micrograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). Minute Times Microgram per Milliliter per Kilogram per Meter Squared Minutes times micrograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Minute Times Microgram Per Milliliter Per Milligram Per Gram Minutes times micrograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Minute Times Microgram Per Milliliter Per Milligram Per Gram Per Day min*mg/mL/kg min*ug/mL/g Minutes times milligrams per milliliter (area under the curve), divided by kilograms (weight) or minutes times micrograms per milliliter (area under the curve), divided by grams (weight). Minute Times Microgram Per Milliliter Per Gram min*ng/mL/g min*ug/mL/kg Minutes times micrograms per milliliter (area under the curve), divided by kilograms (weight) or minutes times nanograms per milliliter (area under the curve), divided by grams (weight). Minute Times Microgram Per Milliliter Per Kilogram Minutes times micrograms per milliliter (area under the curve), divided by meters squared (surface area). Minute Times Microgram per Milliliter per Meter Squared Minutes times micromoles per liter (area under the curve). Minute Times Nanomole per Milliliter Minutes times micromoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). Minute Times Micromole per Liter per Kilogram per Meter Squared Minutes times micromoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). Minute Times Micromole Per Liter Per Milligram Per Gram Minutes times micromoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). Minute Times Micromole Per Liter Per Milligram Per Gram Per Day min*mmol/L/kg min*umol/L/g Minutes times millimoles per liter (area under the curve), divided by kilograms (weight) or minutes times micromoles per liter (area under the curve), divided by grams (weight). Minute Times Micromole Per Liter Per Gram min*nmol/L/g min*umol/L/kg Minutes times micromoles per liter (area under the curve), divided by kilograms (weight) or minutes times nanomoles per liter (area under the curve), divided by grams (weight). Minute Times Micromole Per Liter Per Kilogram Minutes times micromoles per liter (area under the curve), divided by meters squared (surface area). Minute Times Micromole per Liter per Meter Squared IE/L International Unit per Liter IU/L mIU/mL A unit of concentration (biologic activity) equal to one milli-international unit of substance per milliliter of solution or one international unit of substance per liter of solution. International Unit per Liter Milli-international units per milliliter (concentration), divided by kilograms per meter squared (body mass index). Milli-International Unit per Milliliter per Kilogram per Meter Squared mIU/mL/(mg/day) uIU/mL/(ug/day) Milli-international units per milliliter (concentration), divided by milligrams per day (daily dose) or micro-international units per milliliter (concentration), divided by micrograms per day (daily dose). Milli-International Unit per Milliliter per Milligram per Day mIU/mL/(mg/kg) uIU/mL/(ug/kg) Milli-international units per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or micro-international units per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Milli-International Unit per Milliliter per Milligram per Kilogram mIU/mL/(mg/kg/day) uIU/mL/(ug/kg/day) Milli-international units per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or micro-international units per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Milli-International Unit per Milliliter per Milligram per Kilogram per Day mIU/mL/(mg/m2) uIU/mL/(ug/m2) Milli-international units per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or micro-international units per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Milli-International Unit per Milliliter per Milligram per Meter Squared mIU/mL/(mg/m2/day) uIU/mL/(ug/m2/day) Milli-international units per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or micro-international units per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Milli-International Unit per Milliliter per Milligram per Meter Squared per Day mIU/mL/kg uIU/mL/g Milli-international units per milliliter (concentration), divided by kilograms (weight) or micro-international units per milliliter (concentration), divided by grams (weight). Milli-International Unit per Milliliter per Kilogram Milli-international units per milliliter (concentration), divided by meters squared (surface area). Milli-International Unit per Milliliter per Meter Squared cc cm3 Cubic Centimeter Milliliter A unit of volume equal to one thousandth (1E-3) of a liter. Milliliter Milliliters (volume), divided by kilograms per meter squared (body mass index). Milliliter per Kilogram per Meter Squared Milliliters (volume), divided by milligrams per day (daily dose). Milliliter per Milligram per Day Milliliters (volume), divided by milligrams per kilogram (dose normalized by body weight). Milliliter per Milligram per Kilogram Milliliters (volume), divided by milligrams per kilogram per day (daily dose normalized by body weight). Milliliter per Milligram per Kilogram per Day Milliliters (volume), divided by milligrams per meter squared (dose normalized by surface area). Milliliter per Milligram per Meter Squared Milliliters (volume), divided by milligrams per meter squared per day (daily dose normalized by surface area). Milliliter per Milligram per Meter Squared per Day Milliliters (volume), divided by micrograms per kilogram (dose normalized by body weight). Milliliter per Microgram per Kilogram mL/24h A unit of flow rate equal to one milliliter per day. Milliliter per 24 Hours cc/hr cm3/h A unit of flow rate equal to one milliliter per hour. Milliliter per Hour Milliliters (volume) divided by kilograms (weight). Milliliter per Kilogram Milliliters (volume) divided by meters squared (surface area). Milliliter per Square Meter A unit of flow rate equal to one milliliter per minute. Milliliter per Minute Millimole A unit of amount of substance equal to one thousandth (1E-3) of a mole. Millimole A unit of substance flow rate equal to one millimole per hour. Millimole per Hour mcmol/mL Micromole per Milliliter Millimole per Liter mmol/L mol/m3 Mole per Cubic Meter nmol/uL umol/mL A unit of concentration (molarity unit) equal to one millimole of solute per liter of solution. Millimole per Liter Millimoles per liter (concentration), divided by kilograms per meter squared (body mass index). Millimole per Liter per Kilogram per Meter Squared mmol/L/(mg/day) umol/L/(ug/day) Millimoles per liter (concentration), divided by milligrams per day (daily dose) or micromoles per liter (concentration), divided by micrograms per day (daily dose). Millimole per Liter per Milligram per Day mmol/L/(mg/kg) umol/L/(ug/kg) Millimoles per liter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or micromoles per liter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Millimole per Liter per Milligram per Kilogram mmol/L/(mg/kg/day) umol/L/(ug/kg/day) Millimoles per liter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or micromoles per liter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Millimole per Liter per Milligram per Kilogram per Day mmol/L/(mg/m2) umol/L/(ug/m2) Millimoles per liter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or micromoles per liter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Millimole per Liter per Milligram per Meter Squared mmol/L/(mg/m2/day) umol/L/(ug/m2/day) Millimoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or micromoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Millimole per Liter per Milligram per Meter Squared per Day mmol/L/(ug/day) mol/L/(mg/day) Moles per liter (concentration), divided by milligrams per day (daily dose) or millimoles per liter (concentration), divided by micrograms per day (daily dose). Millimole per Liter per Microgram per Day mmol/L/(ug/kg) mol/L/(mg/kg) Moles per liter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or millimoles per liter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Millimole per Liter per Microgram per Kilogram mmol/L/(ug/kg/day) mol/L/(mg/kg/day) Moles per liter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or millimoles per liter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Millimole per Liter per Microgram per Kilogram per Day mmol/L/(ug/m2) mol/L/(mg/m2) Moles per liter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or millimoles per liter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Millimole per Liter per Microgram per Meter Squared mmol/L/(ug/m2/day) mol/L/(mg/m2/day) Moles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or millimoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Millimole per Liter per Microgram per Meter Squared per Day mmol/L/g mol/L/kg nmol/L/ug umol/L/mg Moles per liter (concentration), divided by kilograms (weight) or millimoles per liter (concentration), divided by grams (weight) or micromoles per liter (concentration), divided by milligrams (dose) or nanomoles per liter (concentration), divided by micrograms (dose). Millimole per Liter per Gram Millimoles per liter (concentration), divided by meters squared (surface area). Millimole per Liter per Meter Squared mmol/L/mg mol/L/g umol/L/ug Moles per liter (concentration), divided by grams (weight) or millimoles per liter (concentration), divided by milligrams (dose) or micromoles per liter (concentration), divided by micrograms (dose). Millimole per Liter per Milligram mmol/L/ug mol/L/mg Moles per liter (concentration), divided by milligrams (dose) or millimoles per liter (concentration), divided by micrograms (dose). Millimole per Liter per Microgram A unit of substance flow rate equal to one millimole per minute. Millimole per Minute Mole The base unit of amount of substance in the International System of Units (SI). It is equal to the same number of elementary units as there are atoms in 0.012 kg of carbon-12. Mole A unit of substance flow rate equal to one mole per day. Mole per Day A unit of substance flow rate equal to one mole per hour. Mole per Hour mmol/mL mol/L Mole per Liter A unit of concentration (molarity unit) equal to one mole of solute in one liter of solution.(NCI) Mole per Liter Moles per liter (concentration), divided by kilograms per meter squared (body mass index). Mole per Liter per Kilogram per Meter Squared Moles per liter (concentration), divided by micrograms per day (daily dose). Mole per Liter per Microgram per Day Moles per liter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Mole per Liter per Microgram per Kilogram Moles per liter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Mole per Liter per Microgram per Kilogram per Day Moles per liter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Mole per Liter per Microgram per Meter Squared Moles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Mole per Liter per Microgram per Meter Squared per Day Moles per liter (concentration), divided by meters squared (surface area). Mole per Liter per Meter Squared Moles per liter (concentration), divided by micrograms (dose). Mole per Liter per Microgram A unit of substance flow rate equal to one mole per minute. Mole per Minute Nanogram A unit of mass equal to one billionth (1E-9) of a gram. Nanogram A unit of mass flow rate equal to one nanogram per day. Nanogram per Day A unit of mass flow rate equal to one nanogram per hour. Nanogram per Hour Nanograms per kilogram per minute. Nanogram per Kilogram per Minute A unit of mass flow rate equal to one nanogram per minute. Nanogram per Minute mcg/L mg/m3 Microgram per Liter Milligram per Cubic Meter Nanogram per Milliliter ng/mL ug/L A unit of concentration or mass density equal to one nanogram of substance per milliliter of solution or one microgram of substance per liter of solution. Microgram per Liter Nanograms per milliliter (concentration), divided by kilograms per meter squared (body mass index). Nanogram per Milliliter per Kilogram per Meter Squared Nanograms per milliliter (concentration), divided by milligrams per centimeter squared (body mass index). Nanogram Per Milliliter Per Milligram Per Square Centimeter ng/mL/(mg/day) pg/mL/(ug/day) Nanograms per milliliter (concentration), divided by milligrams per day (daily dose) or picograms per milliliter (concentration), divided by micrograms per day (daily dose). Nanogram per Milliliter per Milligram per Day ng/mL/(mg/kg) pg/mL/(ug/kg) Nanograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or picograms per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Nanogram Per Milliliter Per Milligram Per Kilogram ng/mL/(mg/kg/day) pg/mL/(ug/kg/day) Nanograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or picograms per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Nanogram Per Milliliter Per Milligram Per Kilogram Per Day ng/mL/(mg/m2) pg/mL/(ug/m2) Nanograms per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or picograms per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Nanogram per Milliliter per Milligram per Meter Squared ng/mL/(mg/m2/day) pg/mL/(ug/m2/day) Nanograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or picograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Nanogram per Milliliter per Milligram per Meter Squared per Day ng/mL/(ug/day) ug/mL/(mg/day) Micrograms per milliliter (concentration), divided by milligrams per day (daily dose) or nanograms per milliliter (concentration), divided by micrograms per day (daily dose). Nanogram per Milliliter per Microgram per Day ng/mL/(ug/m2) ug/mL/(mg/m2) Micrograms per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or nanograms per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Nanogram per Milliliter per Microgram per Meter Squared ng/mL/(ug/m2/day) ug/mL/(mg/m2/day) Micrograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or nanograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Nanogram per Milliliter per Microgram per Meter Squared per Day fg/mL/mg ng/mL/kg pg/mL/g Nanograms per milliliter (concentration), divided by kilograms (weight) or picograms per milliliter (concentration), divided by grams (weight) or femtograms per milliliter (concentration), divided by milligrams (dose). Nanogram per Milliliter per Kilogram Nanograms per milliliter (concentration), divided by meters squared (surface area). Nanogram per Milliliter per Meter Squared mg/mL/kg ng/mL/mg pg/mL/ug ug/mL/g Milligrams per milliliter (concentration), divided by kilograms (weight) or micrograms per milliliter (concentration), divided by grams (weight) or nanograms per milliliter (concentration), divided by milligrams (dose) or picograms per milliliter (concentration), divided by micrograms (dose). Nanogram per Milliliter per Milligram Nanogram Equivalent A unit of relative amount of substance equal to one billionth of a gram of an equivalent weight. Nanogram Equivalents Nanogram equivalents of a substance per gram of matrix or tissue (e.g., radiolabeled dose). Nanogram Equivalents Per Gram ngEq/mL ugEq/L A concentration unit measured as the number of microgram equivalents of solute per liter of solution, or as the number of nanogram equivalents of solute per milliliter of solution. Microgram Equivalent per Liter Nanogram equivalents of a substance per milliliter, divided by milligram equivalents (e.g., radiolabeled dose). Nanogram Equivalents Per Milliliter Per Milligram Equivalents Nanomole A unit of amount of substance equal to one billionth (1E-9) of a mole. (NCI) Nanomole A unit of substance flow rate equal to one nanomole per day. Nanomole per Day nmol/g pmol/mg umol/kg Nanomoles per gram. Nanomole per Gram A unit of substance flow rate equal to one nanomole per hour. Nanomole per Hour nmol/kg pmol/g Nanomoles (amount), divided by kilograms (weight) or picomoles per gram. Nanomole per Kilogram Nanomole per Liter pmol/mL A unit of concentration (molarity unit) equal to one nanomole of solute per liter of solution. Nanomole per Liter Nanomoles per liter (concentration), divided by kilograms per meter squared (body mass index). Nanomole per Liter per Kilogram per Meter Squared nmol/L/(mg/day) pmol/L/(ug/day) Nanomoles per liter (concentration), divided by milligrams per day (daily dose) or picomoles per liter (concentration), divided by micrograms per day (daily dose). Nanomole per Liter per Milligram per Day nmol/L/(mg/kg) pmol/L/(ug/kg) Nanomoles per liter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or picomoles per liter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Nanomole per Liter per Milligram per Kilogram nmol/L/(mg/kg/day) pmol/L/(ug/kg/day) Nanomoles per liter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or picomoles per liter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Nanomole per Liter per Milligram per Kilogram per Day nmol/L/(mg/m2) pmol/L/(ug/m2) Nanomoles per liter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or picomoles per liter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Nanomole per Liter per Milligram per Meter Squared nmol/L/(mg/m2/day) pmol/L/(ug/m2/day) Nanomoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or picomoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Nanomole per Liter per Milligram per Meter Squared per Day nmol/L/(ug/day) umol/L/(mg/day) Micromoles per liter (concentration), divided by milligrams per day (daily dose) or nanomoles per liter (concentration), divided by micrograms per day (daily dose). Nanomole per Liter per Microgram per Day nmol/L/(ug/kg) umol/L/(mg/kg) Micromoles per liter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or nanomoles per liter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Nanomole per Liter per Microgram per Kilogram nmol/L/(ug/kg/day) umol/L/(mg/kg/day) Micromoles per liter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or nanomoles per liter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Nanomole per Liter per Microgram per Kilogram per Day nmol/L/(ug/m2) umol/L/(mg/m2) Micromoles per liter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or nanomoles per liter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Nanomole per Liter per Microgram per Meter Squared nmol/L/(ug/m2/day) umol/L/(mg/m2/day) Micromoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or nanomoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Nanomole per Liter per Microgram per Meter Squared per Day nmol/L/g pmol/L/mg umol/L/kg Micromoles per liter (concentration), divided by kilograms (weight) or nanomoles per liter (concentration), divided by grams (weight) or picomoles per liter (concentration), divided by milligrams (dose). Nanomole per Liter per Gram nmol/L/kg pmol/L/g Nanomoles per liter (concentration), divided by kilograms (weight) or picomoles per liter (concentration), divided by grams (weight). Nanomole per Liter per Kilogram Nanomoles per liter (concentration), divided by meters squared (surface area). Nanomole per Liter per Meter Squared A unit of substance flow rate equal to one nanomole per minute. Nanomole per Minute A unit of relative amount of substance equal to one billionth of a mole of an equivalent weight. Nanomole Equivalents Nanomole equivalents of a substance per kilogram of matrix or tissue (e.g., radiolabeled dose). Nanomole Equivalents Per Kilogram Nanomole equivalents of a substance per liter of matrix or fluid (e.g., radiolabeled dose). Nanomole Equivalents Per Liter Nanomole equivalents of a substance per liter, divided by milligram (e.g., radiolabeled dose). Nanomole Equivalents Per Liter Per Milligram Nanomole equivalents of a substance per liter, divided by microgram (e.g., radiolabeled dose). Nanomole Equivalents Per Liter Per Microgram A unit of mass flow rate equal to one picogram per day. Picogram per Day A unit of mass flow rate equal to one picogram per hour. Picogram per Hour mcg/kg Microgram per Kilogram ng/g pg/mg ug/kg A unit of a mass fraction expressed as a number of micrograms of substance per kilogram of mixture. The unit is also used as a dose calculation unit.(NCI) Microgram per Kilogram A unit of mass flow rate equal to one picogram per minute. Picogram per Minute Microgram per Cubic Meter ng/L pg/mL ug/m3 A unit of concentration or mass density equal to one picogram of substance per milliliter of solution or one nanogram of substance per liter of solution. Nanogram per Liter Picograms per milliliter (concentration), divided by kilograms per meter squared (body mass index). Picogram per Milliliter per Kilogram per Meter Squared fg/mL/(ug/kg) pg/mL/(mg/kg) Picograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or femtograms per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Picogram Per Milliliter Per Milligram Per Kilogram fg/mL/(ug/kg/day) pg/mL/(mg/kg/day) Picograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or femtograms per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Picogram Per Milliliter Per Milligram Per Kilogram Per Day Picograms per milliliter (concentration), divided by meters squared (surface area). Picogram per Milliliter per Meter Squared Picogram equivalents of a substance per gram of matrix or tissue (e.g., radiolabeled dose). Picogram Equivalents Per Gram ngEq/L Picogram equivalents of a substance per milliliter of matrix or fluid (e.g., radiolabeled dose). Picogram Equivalents Per Milliliter Picogram equivalents of a substance per milliliter, divided by milligram equivalents (e.g., radiolabeled dose). Picogram Equivalents Per Milliliter Per Milligram Equivalents Picomole A unit of amount of substance equal to a trillionth (1E-12) of a mole. (NCI) Picomole Femtomole per Milliliter fmol/mL Picomole per Liter A unit of concentration (molarity unit) equal to one picomole of solute per liter of solution. Picomole per Liter Picomoles per liter (concentration), divided by kilograms per meter squared (body mass index). Picomole per Liter per Kilogram per Meter Squared Picomoles per liter (concentration), divided by milligrams per day (daily dose). Picomole per Liter per Milligram per Day Picomoles per liter (concentration), divided by milligrams per kilogram (dose normalized by body weight). Picomole per Liter per Milligram per Kilogram Picomoles per liter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight). Picomole per Liter per Milligram per Kilogram per Day Picomoles per liter (concentration), divided by milligrams per meter squared (dose normalized by surface area). Picomole per Liter per Milligram per Meter Squared Picomoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area). Picomole per Liter per Milligram per Meter Squared per Day Picomoles per liter (concentration), divided by kilograms (weight). Picomole per Liter per Kilogram Picomoles per liter (concentration), divided by meters squared (surface area). Picomole per Liter per Meter Squared mmol/L/kg nmol/L/mg pmol/L/ug umol/L/g Millimoles per liter (concentration), divided by kilograms (weight) or micromoles per liter (concentration), divided by grams (weight) or nanomoles per liter (concentration), divided by milligrams (dose) or picomoles per liter (concentration), divided by micrograms (dose). Picomole per Liter per Microgram The quotient of one quantity divided by another, with the same units of measurement. Ratio mU/mL Unit per Liter A unit of substance concentration equal to the concentration at which one liter of mixture contains one unit of a substance. Unit per Liter mcg Microgram A unit of mass equal to one millionth (1E-6) of a gram. Microgram mcg/day A unit of mass flow rate equal to one microgram per day. Microgram per Day Microgram per Deciliter A unit of mass concentration defined as the concentration of one microgram of a substance per unit volume of the mixture equal to one deciliter. The concept also refers to the unit of mass density (volumic mass) defined as the density of substance which mass equal to one microgram occupies the volume one deciliter. (NCI) Microgram per Deciliter mcg/h A unit of mass flow rate equal to one microgram per hour. Microgram per Hour mcg/min A unit of mass flow rate equal to one microgram per minute. Microgram per Minute g/m3 Gram per Cubic Meter mcg/mL mg/L Microgram per Milliliter Milligram per Liter ng/uL ug/mL A unit of concentration or mass density equal to one microgram of substance per milliliter of solution or one milligram of substance per liter of solution. Microgram per Milliliter Micrograms per milliliter (concentration), divided by kilograms per meter squared (body mass index). Microgram per Milliliter per Kilogram per Meter Squared ng/mL/(ug/kg) ug/mL/(mg/kg) Micrograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or nanograms per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Microgram Per Milliliter Per Milligram Per Kilogram ng/mL/(ug/kg/day) ug/mL/(mg/kg/day) Micrograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or nanograms per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Microgram Per Milliliter Per Milligram Per Kilogram Per Day Micrograms per milliliter (concentration), divided by meters squared (surface area). Microgram per Milliliter per Meter Squared g/mL/kg mg/mL/g ng/mL/ug ug/mL/mg Grams per milliliter (concentration), divided by kilograms (weight) or milligrams per milliliter (concentration), divided by grams (weight) or micrograms per milliliter (concentration), divided by milligrams (dose) or nanograms per milliliter (concentration), divided by micrograms (dose). Milligram per Liter per Milligram Microgram Equivalent A unit of relative amount of substance equal to one millionth of a gram of an equivalent weight. Microgram Equivalent mgEq/kg Milligram Equivalents/Kilogram ngEq/mg ugEq/g Microgram equivalents of a substance per gram of matrix or tissue (e.g., radiolabeled dose). Microgram Equivalents Per Gram mgEq/L ngEq/uL A concentration unit measured as a number of microgram equivalent of solute per milliliter of solution. Microgram Equivalents Per Milliliter Microgram equivalents of a substance per milliliter, divided by milligram equivalents (e.g., radiolabeled dose). Microgram Equivalents Per Milliliter Per Milligram Equivalents mcIU/mL Micro-International Unit per milliliter mIE/L mIU/L uIU/mL A unit of concentration (biologic activity) equal to one micro-international unit of substance per milliliter of solution or one milli-international unit of substance per liter of solution. Microinternational Unit per Milliliter Micro-international units per milliliter (concentration), divided by kilograms per meter squared (body mass index). Micro-International Units per Milliliter per Kilogram per Meter Squared Micro-international units per milliliter (concentration), divided by milligrams per day (daily dose). Micro-International Units per Milliliter per Milligram per Day Micro-international units per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight). Micro-International Units per Milliliter per Milligram per Kilogram Micro-international units per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight). Micro-International Units per Milliliter per Milligram per Kilogram per Day Micro-international units per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area). Micro-International Units per Milliliter per Milligram per Meter Squared Micro-international units per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area). Micro-International Units per Milliliter per Milligram per Meter Squared per Day Micro-international units per milliliter (concentration), divided by kilograms (weight). Micro-International Units per Milliliter per Kilogram Micro-international units per milliliter (concentration), divided by meters squared (surface area). Micro-International Units per Milliliter per Meter Squared mcmol Micromole A unit of amount of substance equal to one millionth (1E-6) of a mole. (NCI) Micromole mcmol/day A unit of substance flow rate equal to one micromole per day. Micromole per 24 Hours A unit of substance flow rate equal to one micromole per hour. Micromole per Hour nmol/mL A unit of concentration (molarity unit) equal to one micromole of solute per liter of solution. Micromole per Liter Micromoles per liter (concentration), divided by kilograms per meter squared (body mass index). Micromole per Liter per Kilogram per Meter Squared Micromoles per liter (concentration), divided by meters squared (surface area). Micromole per Liter per Meter Squared mcmol/min A unit of substance flow rate equal to one micromole per minute. Micromole per Minute Vector Genomes/dose Vector Genomic Copies/dose VGC/dose A unit for cloning vector amount expressed as the number of vector genomes per dose. Vector Genomes per Dose Vector Genomes per Kilogram Vector Genomic Copies/kg VGC/kg A unit for the vector amount expressed as the number of vector genomes per kilogram of body weight. Vector Genomes per Kilogram Vector Genomes/mL Vector Genomic Copies/mL VGC/mL A unit for cloning vector concentration expressed as the number of vector genomes per milliliter. Vector Genomes per Milliliter PKUNIT PK Units of Measure CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology Units of measure for pharmacokinetic parameters normalized by dose amount in milligrams. (L/day)/(mg/day) (mL/day)/(ug/day) Liters per day (flow rate), divided by milligrams per day (daily dose) or milliliters per day (flow rate), divided by micrograms per day (daily dose). Liter per Day per Milligram per Day (L/day)/(mg/kg) (mL/day)/(ug/kg) Liters per day (flow rate), divided by milligrams per kilogram (dose normalized by body weight) or milliliters per day (flow rate), divided by micrograms per kilogram (dose normalized by body weight). Liter per Day per Milligram per Kilogram (L/day)/(mg/kg/day) (mL/day)/(ug/kg/day) Liters per day (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milliliters per day (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). Liter per Day per Milligram per Kilogram per Day (L/day)/(mg/m2) (mL/day)/(ug/m2) Liters per day (flow rate), divided by milligrams per meter squared (dose normalized by surface area) or milliliters per day (flow rate), divided by micrograms per meter squared (dose normalized by surface area). Liter per Day per Milligram per Meter Squared (L/day)/(mg/m2/day) (mL/day)/(ug/m2/day) Liters per day (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milliliters per day (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). Liter per Day per Milligram per Meter Squared per Day (L/day)/mg (mL/day)/ug Liters per day (flow rate), divided by milligrams (dose) or milliliters per day (flow rate), divided by micrograms (dose). Liter per Milligram per Day (L/h)/(mg/day) (mL/h)/(ug/day) Liters per hour (flow rate), divided by milligrams per day (daily dose) or milliliters per hour (flow rate), divided by micrograms per day (daily dose). Liter per Hour per Milligram per Day (L/h)/(mg/kg) (mL/h)/(ug/kg) Liters per hour (flow rate), divided by milligrams per kilogram (dose normalized by body weight) or milliliters per hour (flow rate), divided by micrograms per kilogram (dose normalized by body weight). Liter per Hour per Milligram per Kilogram (L/h)/(mg/kg/day) (mL/h)/(ug/kg/day) Liters per hour (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milliliters per hour (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). Liter per Hour per Milligram per Kilogram per Day (L/h)/(mg/m2) (mL/h)/(ug/m2) Liters per hour (flow rate), divided by milligrams per meter squared (dose normalized by surface area) or milliliters per hour (flow rate), divided by micrograms per meter squared (dose normalized by surface area). Liter per Hour per Milligram per Meter Squared (L/h)/(mg/m2/day) (mL/h)/(ug/m2/day) Liters per hour (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milliliters per hour (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). Liter per Hour per Milligram per Meter Squared per Day (L/h)/mg (mL/h)/ug Liters per hour (flow rate), divided by milligrams (dose) or milliliters per hour (flow rate), divided by micrograms (dose). Liter per Milligram per Hour (L/min)/(mg/day) (mL/min)/(ug/day) Liters per minute (flow rate), divided by milligrams per day (daily dose) or milliliters per minute (flow rate), divided by micrograms per day (daily dose). Liter per Minute per Milligram per Day (L/min)/(mg/kg) (mL/min)/(ug/kg) Liters per minute (flow rate), divided by milligrams per kilogram (dose normalized by body weight) or milliliters per minute (flow rate), divided by micrograms per kilogram (dose normalized by body weight). Liter per Minute per Milligram per Kilogram (L/min)/(mg/kg/day) (mL/min)/(ug/kg/day) Liters per minute (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milliliters per minute (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). Liter per Minute per Milligram per Kilogram per Day (L/min)/(mg/m2) (mL/min)/(ug/m2) Liters per minute (flow rate), divided by milligrams per meter squared (dose normalized by surface area) or milliliters per minute (flow rate), divided by micrograms per meter squared (dose normalized by surface area). Liter per Minute per Milligram per Meter Squared (L/min)/(mg/m2/day) (mL/min)/(ug/m2/day) Liters per minute (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milliliters per minute (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). Liter per Minute per Milligram per Meter Squared per Day (L/min)/mg (mL/min)/ug Liters per minute (flow rate), divided by milligrams (dose) or milliliters per minute (flow rate), divided by micrograms (dose). Liter per Milligram per Minute Milliliters per day (flow rate), divided by milligrams per day (daily dose). Milliliter per Day per Milligram per Day Milliliters per day (flow rate), divided by milligrams per kilogram (dose normalized by body weight). Milliliter per Day per Milligram per Kilogram Milliliters per day (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight). Milliliter per Day per Milligram per Kilogram per Day Milliliters per day (flow rate), divided by milligrams per meter squared (dose normalized by surface area). Milliliter per Day per Milligram per Meter Squared Milliliters per day (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area). Milliliter per Day per Milligram per Meter Squared per Day (L/day)/g (mL/day)/mg Liters per day (flow rate), divided by grams (weight) or milliliters per day (flow rate), divided by milligrams (dose). Liter per Gram per Day Milliliters per hour (flow rate), divided by milligrams per day (daily dose). Milliliter per Hour per Milligram per Day Milliliters per hour (flow rate), divided by milligrams per kilogram (dose normalized by body weight). Milliliter per Hour per Milligram per Kilogram Milliliters per hour (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight). Milliliter per Hour per Milligram per Kilogram per Day Milliliters per hour (flow rate), divided by milligrams per meter squared (dose normalized by surface area). Milliliter per Hour per Milligram per Meter Squared Milliliters per hour (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area). Milliliter per Hour per Milligram per Meter Squared per Day (L/h)/g (mL/h)/mg Liters per hour (flow rate), divided by grams (weight) or milliliters per hour (flow rate), divided by milligrams (dose). Liter per Gram per Hour Milliliters per minute (flow rate), divided by milligrams per day (daily dose). Milliliter per Minute per Milligram per Day Milliliters per minute (flow rate), divided by milligrams per kilogram (dose normalized by body weight). Milliliter per Minute per Milligram per Kilogram Milliliters per minute (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight). Milliliter per Minute per Milligram per Kilogram per Day Milliliters per minute (flow rate), divided by milligrams per meter squared (dose normalized by surface area). Milliliter per Minute per Milligram per Meter Squared Milliliters per minute (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area). Milliliter per Minute per Milligram per Meter Squared per Day (L/min)/g (mL/min)/mg Liters per minute (flow rate), divided by grams (weight) or milliliters per minute (flow rate), divided by milligrams (dose). Liter per Gram per Minute Days times micrograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). Day Times Microgram per Milliliter Times Kilogram per Milligram day*g/mL/kg day*mg/mL/g day*ng/mL/ug day*ug/mL/mg Days times grams per milliliter (area under the curve), divided by kilograms (weight); or days times milligrams per milliliter (area under the curve), divided by grams (weight); or days times micrograms per milliliter (area under the curve), divided by milligrams (dose); or days times nanograms per milliliter (area under the curve), divided by micrograms (dose). Day Times Gram Per Milliliter Per Kilogram Femtograms per milliliter (concentration), divided by milligrams per day (daily dose). Femtogram per Milliliter per Milligram per Day Femtograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight). Femtogram per Milliliter per Milligram per Kilogram Femtograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight). Femtogram per Milliliter per Milligram per Kilogram per Day Femtograms per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area). Femtogram per Milliliter per Milligram per Meter Squared Femtograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area). Femtogram per Milliliter per Milligram per Meter Squared per Day fg/mL/mg ng/mL/kg pg/mL/g Nanograms per milliliter (concentration), divided by kilograms (weight) or picograms per milliliter (concentration), divided by grams (weight) or femtograms per milliliter (concentration), divided by milligrams (dose). Nanogram per Milliliter per Kilogram g/mL/(mg/day) mg/mL/(ug/day) Grams per milliliter (concentration), divided by milligrams per day (daily dose) or milligrams per milliliter (concentration), divided by micrograms per day (daily dose). Gram per Milliliter per Milligram per Day g/mL/(mg/kg) mg/mL/(ug/kg) Grams per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or milligrams per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Gram Per Milliliter Per Milligram Per Kilogram g/mL/(mg/kg/day) mg/mL/(ug/kg/day) Grams per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milligrams per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Gram Per Milliliter Per Milligram Per Kilogram Per Day g/mL/(mg/m2) mg/mL/(ug/m2) Grams per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or milligrams per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Gram per Milliliter per Milligram per Meter Squared g/mL/(mg/m2/day) mg/mL/(ug/m2/day) Grams per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milligrams per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Gram per Milliliter per Milligram per Meter Squared per Day g/mL/mg mg/mL/ug Grams per milliliter (concentration), divided by milligrams (dose) or milligrams per milliliter (concentration), divided by micrograms (dose). Gram per Milliliter per Milligram Hours times grams per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). Hour Times Gram Per Milliliter Per Milligram Per Kilogram Hours times grams per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight). Hour Times Gram Per Milliliter Per Milligram Per Kilogram Per Day Hours times milligrams per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). Hour Times Milligram Per Milliliter Per Milligram Per Kilogram Hours times milligrams per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight). Hour Times Milligram Per Milliliter Per Milligram Per Kilogram Per Day h*mmol/L/mg h*mol/L/g h*umol/L/ug Hours times millimoles per liter (area under the curve), divided by kilograms (weight); or hours times micromoles per liter (area under the curve), divided by grams (weight); or hours times nanomoles per liter (area under the curve), divided by milligrams (dose); or hours times picomoles per liter (area under the curve), divided by micrograms (dose). Hour times Mole Per Liter Per Gram Hours times nanograms per milliliter (area under the curve), divided by milligrams per centimeter squared per day (daily dose normalized by surface area). Hour Times Nanogram Per Milliliter Per Milligram Per Centimeter Squared Per Day Hours times nanograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). Hour Times Nanogram per Milliliter per Milligram per Kilogram Hours times nanograms per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight). Hour Times Nanogram Per Milliliter Per Milligram Per Kilogram Per Day Hours times nanograms per milliliter (area under the curve), divided by milligrams per meter squared (dose normalized by surface area). Hour Times Nanogram per Milliliter per Milligram per Meter Squared h*mg/mL/kg h*ng/mL/mg h*ug/mL/g Hours times milligrams per milliliter (area under the curve), divided by kilograms (weight) or hours times micrograms per milliliter (area under the curve), divided by grams (weight) or hours times nanograms per milliliter (area under the curve), divided by milligrams (dose). Hour Times Nanogram per Milliliter per Milligram Hours times nanomoles per liter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). Hour Times Nanomole per Liter per Milligram per Kilogram h*mmol/L/kg h*nmol/L/mg h*pmol/L/ug h*umol/L/g Hours times millimoles per liter (area under the curve), divided by kilograms (weight); or hours times micromoles per liter (area under the curve), divided by grams (weight); or hours times nanomoles per liter (area under the curve), divided by milligrams (dose); or hours times picomoles per liter (area under the curve), divided by micrograms (dose). Hour Times Millimole Per Liter Per Kilogram Hours times nanomole equivalents per liter (area under the curve obtained based on equivalent substance, e.g., radioactivity measurements), divided by milligram. Hours Times Nanomole Equivalents Per Liter Per Milligram Hours times picograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). Hour Times Picogram Per Milliliter Per Milligram Per Kilogram Hours times picograms per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight). Hour Times Picogram Per Milliliter Per Milligram Per Kilogram Per Day h*ng/mL/g h*pg/mL/mg h*ug/mL/kg Hours times micrograms per milliliter (area under the curve), divided by kilograms (weight) or hours times nanograms per milliliter (area under the curve), divided by grams (weight) or hours times picograms per milliliter (area under the curve), divided by milligrams (dose). Hour Times Nanogram per Milliliter per Gram Hours times picomoles per liter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). Hour Times Picomole Per Liter Per Milligram Per Kilogram Hours times micrograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). Hour Times Microgram Per Milliliter Per Milligram Per Kilogram h*ng/mL/(ug/kg/day) h*ug/mL/(mg/kg/day) Hour times nanograms per milliliter (area under the curve), divided by micrograms per kilogram per day (daily dose normalized by body weight), or hour times micrograms per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight). Hour Times Microgram Per Milliliter Per Milligram Per Kilogram Per Day h*g/mL/kg h*mg/mL/g h*ug/mL/mg Hours times grams per milliliter (area under the curve), divided by kilograms (weight) or hours times milligrams per milliliter (area under the curve), divided by grams (weight) or hours times micrograms per milliliter (area under the curve), divided by milligrams (dose). Hour Times Microgram per Milliliter per Milligram Hours times micromoles per liter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). Hour Times Micromole per Liter per Milligram per Kilogram IU/mL/(mg/day) mIU/mL/(ug/day) International units per milliliter (concentration), divided by milligrams per day (daily dose) or milli-international units per milliliter (concentration), divided by micrograms per day (daily dose). International Unit per Milliliter per Milligram per Day IU/mL/(mg/kg) mIU/mL/(ug/kg) International units per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or milli-international units per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). International Unit per Milliliter per Milligram per Kilogram IU/mL/(mg/kg/day) mIU/mL/(ug/kg/day) International units per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milli-international units per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). International Unit per Milliliter per Milligram per Kilogram per Day IU/mL/(mg/m2) mIU/mL/(ug/m2) International units per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or milli-international units per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). International Unit per Milliliter per Milligram per Meter Squared IU/mL/(mg/m2/day) mIU/mL/(ug/m2/day) International units per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milli-international units per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). International Unit per Milliliter per Milligram per Meter Squared per Day IU/mL/mg mIU/mL/ug International units per milliliter (concentration), divided by milligrams (dose) or milli-international units per milliliter (concentration), divided by micrograms (dose). International Unit per Milliliter per Milligram Liters (volume), divided by milligrams per kilogram (dose normalized by body weight). Liter per Milligram per Kilogram L/(mg/kg/day) mL/(ug/kg/day) Liters (volume), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milliliters (volume), divided by micrograms per kilogram per day (daily dose normalized by body weight). Liter per Milligram per Kilogram per Day L/(mg/m2/day) mL/(ug/m2/day) Liters (volume), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milliliters (volume), divided by micrograms per meter squared per day (daily dose normalized by surface area). Liter per Milligram per Meter Squared per Day L/mg mL/ug Liters (volume), divided by milligrams (dose) or milliliters (volume), divided by micrograms (dose). Liter per Milligram mg/mL/(mg/day) ug/mL/(ug/day) Milligrams per milliliter (concentration), divided by milligrams per day (daily dose) or micrograms per milliliter (concentration), divided by micrograms per day (daily dose). Milligram per Milliliter per Milligram per Day mg/mL/(mg/kg) ug/mL/(ug/kg) Milligrams per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or micrograms per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Milligram Per Milliliter Per Milligram Per Kilogram mg/mL/(mg/kg/day) ug/mL/(ug/kg/day) Milligrams per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or micrograms per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Milligram Per Milliliter Per Milligram Per Kilogram Per Day mg/mL/(mg/m2) ug/mL/(ug/m2) Milligrams per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or micrograms per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Milligram per Milliliter per Milligram per Meter Squared mg/mL/(mg/m2/day) ug/mL/(ug/m2/day) Milligrams per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or micrograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Milligram per Milliliter per Milligram per Meter Squared per Day g/mL/g mg/mL/mg ug/mL/ug Grams per milliliter (concentration), divided by grams (weight) or milligrams per milliliter (concentration), divided by milligrams (dose) or micrograms per milliliter (concentration), divided by micrograms (dose). Gram per Milliliter per Gram mIU/mL/(mg/day) uIU/mL/(ug/day) Milli-international units per milliliter (concentration), divided by milligrams per day (daily dose) or micro-international units per milliliter (concentration), divided by micrograms per day (daily dose). Milli-International Unit per Milliliter per Milligram per Day mIU/mL/(mg/kg) uIU/mL/(ug/kg) Milli-international units per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or micro-international units per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Milli-International Unit per Milliliter per Milligram per Kilogram mIU/mL/(mg/kg/day) uIU/mL/(ug/kg/day) Milli-international units per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or micro-international units per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Milli-International Unit per Milliliter per Milligram per Kilogram per Day mIU/mL/(mg/m2) uIU/mL/(ug/m2) Milli-international units per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or micro-international units per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Milli-International Unit per Milliliter per Milligram per Meter Squared mIU/mL/(mg/m2/day) uIU/mL/(ug/m2/day) Milli-international units per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or micro-international units per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Milli-International Unit per Milliliter per Milligram per Meter Squared per Day IU/mL/g mIU/mL/mg uIU/mL/ug International units per milliliter (concentration), divided by grams (weight) or milli-international units per milliliter (concentration), divided by milligrams (dose) or micro-international units per milliliter (concentration), divided by micrograms (dose). International Unit per Milliliter per Gram Milliliters (volume), divided by milligrams per day (daily dose). Milliliter per Milligram per Day Milliliters (volume), divided by milligrams per kilogram (dose normalized by body weight). Milliliter per Milligram per Kilogram Milliliters (volume), divided by milligrams per kilogram per day (daily dose normalized by body weight). Milliliter per Milligram per Kilogram per Day Milliliters (volume), divided by milligrams per meter squared (dose normalized by surface area). Milliliter per Milligram per Meter Squared Milliliters (volume), divided by milligrams per meter squared per day (daily dose normalized by surface area). Milliliter per Milligram per Meter Squared per Day mmol/L/(mg/day) umol/L/(ug/day) Millimoles per liter (concentration), divided by milligrams per day (daily dose) or micromoles per liter (concentration), divided by micrograms per day (daily dose). Millimole per Liter per Milligram per Day mmol/L/(mg/kg) umol/L/(ug/kg) Millimoles per liter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or micromoles per liter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Millimole per Liter per Milligram per Kilogram mmol/L/(mg/kg/day) umol/L/(ug/kg/day) Millimoles per liter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or micromoles per liter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Millimole per Liter per Milligram per Kilogram per Day mmol/L/(mg/m2) umol/L/(ug/m2) Millimoles per liter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or micromoles per liter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Millimole per Liter per Milligram per Meter Squared mmol/L/(mg/m2/day) umol/L/(ug/m2/day) Millimoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or micromoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Millimole per Liter per Milligram per Meter Squared per Day mmol/L/mg mol/L/g umol/L/ug Moles per liter (concentration), divided by grams (weight) or millimoles per liter (concentration), divided by milligrams (dose) or micromoles per liter (concentration), divided by micrograms (dose). Millimole per Liter per Milligram mmol/L/(ug/day) mol/L/(mg/day) Moles per liter (concentration), divided by milligrams per day (daily dose) or millimoles per liter (concentration), divided by micrograms per day (daily dose). Millimole per Liter per Microgram per Day mmol/L/(ug/kg) mol/L/(mg/kg) Moles per liter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or millimoles per liter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Millimole per Liter per Microgram per Kilogram mmol/L/(ug/kg/day) mol/L/(mg/kg/day) Moles per liter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or millimoles per liter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Millimole per Liter per Microgram per Kilogram per Day mmol/L/(ug/m2) mol/L/(mg/m2) Moles per liter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or millimoles per liter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Millimole per Liter per Microgram per Meter Squared mmol/L/(ug/m2/day) mol/L/(mg/m2/day) Moles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or millimoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Millimole per Liter per Microgram per Meter Squared per Day mmol/L/ug mol/L/mg Moles per liter (concentration), divided by milligrams (dose) or millimoles per liter (concentration), divided by micrograms (dose). Millimole per Liter per Microgram Milligram per Kilogram Nanogram per Milligram ng/mg ug/g Milligrams (weight), divided by kilograms (weight) or nanograms (weight) per milligrams (weight). Milligram per Kilogram ng/mL/(mg/day) pg/mL/(ug/day) Nanograms per milliliter (concentration), divided by milligrams per day (daily dose) or picograms per milliliter (concentration), divided by micrograms per day (daily dose). Nanogram per Milliliter per Milligram per Day ng/mL/(mg/kg) pg/mL/(ug/kg) Nanograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or picograms per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Nanogram Per Milliliter Per Milligram Per Kilogram ng/mL/(mg/kg/day) pg/mL/(ug/kg/day) Nanograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or picograms per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Nanogram Per Milliliter Per Milligram Per Kilogram Per Day ng/mL/(mg/m2) pg/mL/(ug/m2) Nanograms per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or picograms per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Nanogram per Milliliter per Milligram per Meter Squared ng/mL/(mg/m2/day) pg/mL/(ug/m2/day) Nanograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or picograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Nanogram per Milliliter per Milligram per Meter Squared per Day mg/mL/kg ng/mL/mg pg/mL/ug ug/mL/g Milligrams per milliliter (concentration), divided by kilograms (weight) or micrograms per milliliter (concentration), divided by grams (weight) or nanograms per milliliter (concentration), divided by milligrams (dose) or picograms per milliliter (concentration), divided by micrograms (dose). Nanogram per Milliliter per Milligram nmol/L/(mg/day) pmol/L/(ug/day) Nanomoles per liter (concentration), divided by milligrams per day (daily dose) or picomoles per liter (concentration), divided by micrograms per day (daily dose). Nanomole per Liter per Milligram per Day nmol/L/(mg/kg) pmol/L/(ug/kg) Nanomoles per liter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or picomoles per liter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Nanomole per Liter per Milligram per Kilogram nmol/L/(mg/kg/day) pmol/L/(ug/kg/day) Nanomoles per liter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or picomoles per liter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Nanomole per Liter per Milligram per Kilogram per Day nmol/L/(mg/m2) pmol/L/(ug/m2) Nanomoles per liter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or picomoles per liter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Nanomole per Liter per Milligram per Meter Squared nmol/L/(mg/m2/day) pmol/L/(ug/m2/day) Nanomoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or picomoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Nanomole per Liter per Milligram per Meter Squared per Day mmol/L/kg nmol/L/mg pmol/L/ug umol/L/g Millimoles per liter (concentration), divided by kilograms (weight) or micromoles per liter (concentration), divided by grams (weight) or nanomoles per liter (concentration), divided by milligrams (dose) or picomoles per liter (concentration), divided by micrograms (dose). Picomole per Liter per Microgram Nanomole equivalents of a substance per liter, divided by milligram (e.g., radiolabeled dose). Nanomole Equivalents Per Liter Per Milligram mcg/kg Microgram per Kilogram ng/g pg/mg ug/kg A unit of a mass fraction expressed as a number of micrograms of substance per kilogram of mixture. The unit is also used as a dose calculation unit.(NCI) Microgram per Kilogram fg/mL/(ug/day) pg/mL/(mg/day) Picograms per milliliter (concentration), divided by milligrams per day (daily dose) or femtograms per milliliter (concentration), divided by micrograms per day (daily dose). Femtogram per Milliliter per Microgram per Day fg/mL/(ug/kg) pg/mL/(mg/kg) Picograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or femtograms per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Picogram Per Milliliter Per Milligram Per Kilogram fg/mL/(ug/kg/day) pg/mL/(mg/kg/day) Picograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or femtograms per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Picogram Per Milliliter Per Milligram Per Kilogram Per Day fg/mL/(ug/m2) pg/mL/(mg/m2) Picograms per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or femtograms per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Femtogram per Milliliter per Microgram per Meter Squared fg/mL/(ug/m2/day) pg/mL/(mg/m2/day) Picograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or femtograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Femtogram per Milliliter per Microgram per Meter Squared per Day fg/mL/ug ng/mL/g pg/mL/mg ug/mL/kg Micrograms per milliliter (concentration), divided by kilograms (weight) or nanograms per milliliter (concentration), divided by grams (weight) or picograms per milliliter (concentration), divided by milligrams (dose) or femtograms per milliliter (concentration), divided by micrograms (dose). Femtogram per Milliliter per Microgram Picomoles per liter (concentration), divided by milligrams per day (daily dose). Picomole per Liter per Milligram per Day Picomoles per liter (concentration), divided by milligrams per kilogram (dose normalized by body weight). Picomole per Liter per Milligram per Kilogram Picomoles per liter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight). Picomole per Liter per Milligram per Kilogram per Day Picomoles per liter (concentration), divided by milligrams per meter squared (dose normalized by surface area). Picomole per Liter per Milligram per Meter Squared Picomoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area). Picomole per Liter per Milligram per Meter Squared per Day nmol/L/g pmol/L/mg umol/L/kg Micromoles per liter (concentration), divided by kilograms (weight) or nanomoles per liter (concentration), divided by grams (weight) or picomoles per liter (concentration), divided by milligrams (dose). Nanomole per Liter per Gram Gram per Kilogram mg/g Microgram per Milligram Milligram per Gram ug/mg Grams (weight), divided by kilograms (weight) or micrograms (weight) per milligrams (weight). Gram per Kilogram ng/mL/(ug/day) ug/mL/(mg/day) Micrograms per milliliter (concentration), divided by milligrams per day (daily dose) or nanograms per milliliter (concentration), divided by micrograms per day (daily dose). Nanogram per Milliliter per Microgram per Day ng/mL/(ug/kg) ug/mL/(mg/kg) Micrograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or nanograms per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Microgram Per Milliliter Per Milligram Per Kilogram ng/mL/(ug/kg/day) ug/mL/(mg/kg/day) Micrograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or nanograms per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Microgram Per Milliliter Per Milligram Per Kilogram Per Day ng/mL/(ug/m2) ug/mL/(mg/m2) Micrograms per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or nanograms per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Nanogram per Milliliter per Microgram per Meter Squared ng/mL/(ug/m2/day) ug/mL/(mg/m2/day) Micrograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or nanograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Nanogram per Milliliter per Microgram per Meter Squared per Day g/mL/kg mg/mL/g ng/mL/ug ug/mL/mg Grams per milliliter (concentration), divided by kilograms (weight) or milligrams per milliliter (concentration), divided by grams (weight) or micrograms per milliliter (concentration), divided by milligrams (dose) or nanograms per milliliter (concentration), divided by micrograms (dose). Milligram per Liter per Milligram Micro-international units per milliliter (concentration), divided by milligrams per day (daily dose). Micro-International Units per Milliliter per Milligram per Day Micro-international units per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight). Micro-International Units per Milliliter per Milligram per Kilogram Micro-international units per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight). Micro-International Units per Milliliter per Milligram per Kilogram per Day Micro-international units per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area). Micro-International Units per Milliliter per Milligram per Meter Squared Micro-international units per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area). Micro-International Units per Milliliter per Milligram per Meter Squared per Day IU/mL/kg mIU/mL/g uIU/mL/mg International units per milliliter (concentration), divided by kilograms (weight) or milli-international units per milliliter (concentration), divided by grams (weight) or micro-international units per milliliter (concentration), divided by milligrams (dose). International Unit per Milliliter per Kilogram nmol/L/(ug/day) umol/L/(mg/day) Micromoles per liter (concentration), divided by milligrams per day (daily dose) or nanomoles per liter (concentration), divided by micrograms per day (daily dose). Nanomole per Liter per Microgram per Day nmol/L/(ug/kg) umol/L/(mg/kg) Micromoles per liter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or nanomoles per liter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Nanomole per Liter per Microgram per Kilogram nmol/L/(ug/kg/day) umol/L/(mg/kg/day) Micromoles per liter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or nanomoles per liter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Nanomole per Liter per Microgram per Kilogram per Day nmol/L/(ug/m2) umol/L/(mg/m2) Micromoles per liter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or nanomoles per liter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Nanomole per Liter per Microgram per Meter Squared nmol/L/(ug/m2/day) umol/L/(mg/m2/day) Micromoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or nanomoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Nanomole per Liter per Microgram per Meter Squared per Day mmol/L/g mol/L/kg nmol/L/ug umol/L/mg Moles per liter (concentration), divided by kilograms (weight) or millimoles per liter (concentration), divided by grams (weight) or micromoles per liter (concentration), divided by milligrams (dose) or nanomoles per liter (concentration), divided by micrograms (dose). Millimole per Liter per Gram PKUDMG PK Units of Measure - Dose mg CDISC SDTM PK Unit of Measure Milligram Dose Terminology Units of measure for pharmacokinetic parameters normalized by dose amount in micrograms. Liters per day (flow rate), divided by micrograms per day (daily dose). Liter per Day per Microgram per Day Liters per day (flow rate), divided by micrograms per kilogram (dose normalized by body weight). Liter per Day per Microgram per Kilogram Liters per day (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). Liter per Day per Microgram per Kilogram per Day Liters per day (flow rate), divided by micrograms per meter squared (dose normalized by surface area). Liter per Day per Microgram per Meter Squared Liters per day (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). Liter per Day per Microgram per Meter Squared per Day Liters per day (flow rate), divided by micrograms (dose). Liter per Microgram per Day Liters per hour (flow rate), divided by micrograms per day (daily dose). Liter per Hour per Microgram per Day Liters per hour (flow rate), divided by micrograms per kilogram (dose normalized by body weight). Liter per Hour per Microgram per Kilogram Liters per hour (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). Liter per Hour per Microgram per Kilogram per Day Liters per hour (flow rate), divided by micrograms per meter squared (dose normalized by surface area). Liter per Hour per Microgram per Meter Squared Liters per hour (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). Liter per Hour per Microgram per Meter Squared per Day Liters per hour (flow rate), divided by micrograms (dose). Liter per Microgram per Hour Liters per minute (flow rate), divided by micrograms per day (daily dose). Liter per Minute per Microgram per Day Liters per minute (flow rate), divided by micrograms per kilogram (dose normalized by body weight). Liter per Minute per Microgram per Kilogram Liters per minute (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). Liter per Minute per Microgram per Kilogram per Day Liters per minute (flow rate), divided by micrograms per meter squared (dose normalized by surface area). Liter per Minute per Microgram per Meter Squared Liters per minute (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). Liter per Minute per Microgram per Meter Squared per Day Liters per minute (flow rate), divided by micrograms (dose). Liter per Microgram per Minute (L/day)/(mg/day) (mL/day)/(ug/day) Liters per day (flow rate), divided by milligrams per day (daily dose) or milliliters per day (flow rate), divided by micrograms per day (daily dose). Liter per Day per Milligram per Day (L/day)/(mg/kg) (mL/day)/(ug/kg) Liters per day (flow rate), divided by milligrams per kilogram (dose normalized by body weight) or milliliters per day (flow rate), divided by micrograms per kilogram (dose normalized by body weight). Liter per Day per Milligram per Kilogram (L/day)/(mg/kg/day) (mL/day)/(ug/kg/day) Liters per day (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milliliters per day (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). Liter per Day per Milligram per Kilogram per Day (L/day)/(mg/m2) (mL/day)/(ug/m2) Liters per day (flow rate), divided by milligrams per meter squared (dose normalized by surface area) or milliliters per day (flow rate), divided by micrograms per meter squared (dose normalized by surface area). Liter per Day per Milligram per Meter Squared (L/day)/(mg/m2/day) (mL/day)/(ug/m2/day) Liters per day (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milliliters per day (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). Liter per Day per Milligram per Meter Squared per Day (L/day)/mg (mL/day)/ug Liters per day (flow rate), divided by milligrams (dose) or milliliters per day (flow rate), divided by micrograms (dose). Liter per Milligram per Day (L/h)/(mg/day) (mL/h)/(ug/day) Liters per hour (flow rate), divided by milligrams per day (daily dose) or milliliters per hour (flow rate), divided by micrograms per day (daily dose). Liter per Hour per Milligram per Day (L/h)/(mg/kg) (mL/h)/(ug/kg) Liters per hour (flow rate), divided by milligrams per kilogram (dose normalized by body weight) or milliliters per hour (flow rate), divided by micrograms per kilogram (dose normalized by body weight). Liter per Hour per Milligram per Kilogram (L/h)/(mg/kg/day) (mL/h)/(ug/kg/day) Liters per hour (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milliliters per hour (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). Liter per Hour per Milligram per Kilogram per Day (L/h)/(mg/m2) (mL/h)/(ug/m2) Liters per hour (flow rate), divided by milligrams per meter squared (dose normalized by surface area) or milliliters per hour (flow rate), divided by micrograms per meter squared (dose normalized by surface area). Liter per Hour per Milligram per Meter Squared (L/h)/(mg/m2/day) (mL/h)/(ug/m2/day) Liters per hour (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milliliters per hour (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). Liter per Hour per Milligram per Meter Squared per Day (L/h)/mg (mL/h)/ug Liters per hour (flow rate), divided by milligrams (dose) or milliliters per hour (flow rate), divided by micrograms (dose). Liter per Milligram per Hour (L/min)/(mg/day) (mL/min)/(ug/day) Liters per minute (flow rate), divided by milligrams per day (daily dose) or milliliters per minute (flow rate), divided by micrograms per day (daily dose). Liter per Minute per Milligram per Day (L/min)/(mg/kg) (mL/min)/(ug/kg) Liters per minute (flow rate), divided by milligrams per kilogram (dose normalized by body weight) or milliliters per minute (flow rate), divided by micrograms per kilogram (dose normalized by body weight). Liter per Minute per Milligram per Kilogram (L/min)/(mg/kg/day) (mL/min)/(ug/kg/day) Liters per minute (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milliliters per minute (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). Liter per Minute per Milligram per Kilogram per Day (L/min)/(mg/m2) (mL/min)/(ug/m2) Liters per minute (flow rate), divided by milligrams per meter squared (dose normalized by surface area) or milliliters per minute (flow rate), divided by micrograms per meter squared (dose normalized by surface area). Liter per Minute per Milligram per Meter Squared (L/min)/(mg/m2/day) (mL/min)/(ug/m2/day) Liters per minute (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milliliters per minute (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). Liter per Minute per Milligram per Meter Squared per Day (L/min)/mg (mL/min)/ug Liters per minute (flow rate), divided by milligrams (dose) or milliliters per minute (flow rate), divided by micrograms (dose). Liter per Milligram per Minute Days times nanograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). Day Times Nanogram Per Milliliter Per Milligram Per Kilogram day*g/mL/kg day*mg/mL/g day*ng/mL/ug day*ug/mL/mg Days times grams per milliliter (area under the curve), divided by kilograms (weight); or days times milligrams per milliliter (area under the curve), divided by grams (weight); or days times micrograms per milliliter (area under the curve), divided by milligrams (dose); or days times nanograms per milliliter (area under the curve), divided by micrograms (dose). Day Times Gram Per Milliliter Per Kilogram fg/mL/(ug/day) pg/mL/(mg/day) Picograms per milliliter (concentration), divided by milligrams per day (daily dose) or femtograms per milliliter (concentration), divided by micrograms per day (daily dose). Femtogram per Milliliter per Microgram per Day fg/mL/(ug/kg) pg/mL/(mg/kg) Picograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or femtograms per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Picogram Per Milliliter Per Milligram Per Kilogram fg/mL/(ug/kg/day) pg/mL/(mg/kg/day) Picograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or femtograms per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Picogram Per Milliliter Per Milligram Per Kilogram Per Day fg/mL/(ug/m2) pg/mL/(mg/m2) Picograms per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or femtograms per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Femtogram per Milliliter per Microgram per Meter Squared fg/mL/(ug/m2/day) pg/mL/(mg/m2/day) Picograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or femtograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Femtogram per Milliliter per Microgram per Meter Squared per Day fg/mL/ug ng/mL/g pg/mL/mg ug/mL/kg Micrograms per milliliter (concentration), divided by kilograms (weight) or nanograms per milliliter (concentration), divided by grams (weight) or picograms per milliliter (concentration), divided by milligrams (dose) or femtograms per milliliter (concentration), divided by micrograms (dose). Femtogram per Milliliter per Microgram Grams per milliliter (concentration), divided by micrograms per day (daily dose). Gram per Milliliter per Microgram per Day Grams per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Gram per Milliliter per Microgram per Kilogram Grams per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Gram per Milliliter per Microgram per Kilogram per Day Grams per milliliter (concentration), divided by micrograms per meter squared (dose normalized by body weight). Gram per Milliliter per Microgram per Meter Squared Grams per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Gram per Milliliter per Microgram per Meter Squared per Day Grams per milliliter (concentration), divided by micrograms (dose). Gram per Milliliter per Microgram h*ng/mL/(ug/kg/day) h*ug/mL/(mg/kg/day) Hour times nanograms per milliliter (area under the curve), divided by micrograms per kilogram per day (daily dose normalized by body weight), or hour times micrograms per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight). Hour Times Microgram Per Milliliter Per Milligram Per Kilogram Per Day Hours times nanomole equivalents per liter (area under the curve obtained based on equivalent substance, e.g., radioactivity measurements), divided by microgram. Hours Times Nanomole Equivalents Per Liter Per Microgram h*mmol/L/kg h*nmol/L/mg h*pmol/L/ug h*umol/L/g Hours times millimoles per liter (area under the curve), divided by kilograms (weight); or hours times micromoles per liter (area under the curve), divided by grams (weight); or hours times nanomoles per liter (area under the curve), divided by milligrams (dose); or hours times picomoles per liter (area under the curve), divided by micrograms (dose). Hour Times Millimole Per Liter Per Kilogram h*mmol/L/mg h*mol/L/g h*umol/L/ug Hours times millimoles per liter (area under the curve), divided by kilograms (weight); or hours times micromoles per liter (area under the curve), divided by grams (weight); or hours times nanomoles per liter (area under the curve), divided by milligrams (dose); or hours times picomoles per liter (area under the curve), divided by micrograms (dose). Hour times Mole Per Liter Per Gram International units per milliliter (concentration), divided by micrograms per day (daily dose). International Unit per Milliliter per Microgram per Day International units per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). International Unit per Milliliter per Microgram per Kilogram International units per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). International Unit per Milliliter per Microgram per Kilogram per Day International units per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). International Unit per Milliliter per Microgram per Meter Squared International units per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). International Unit per Milliliter per Microgram per Meter Squared per Day International units per milliliter (concentration), divided by micrograms (dose). International Unit per Milliliter per Microgram Liters (volume), divided by micrograms per kilogram (dose normalized by body weight). Liter per Microgram per Kilogram Liters (volume), divided by micrograms per kilogram per day (daily dose normalized by body weight). Liter per Microgram per Kilogram per Day Liters (volume), divided by micrograms per meter squared (dose normalized by surface area). Liter per Microgram per Meter Squared Liters (volume), divided by micrograms per meter squared per day (daily dose normalized by surface area). Liter per Microgram per Meter Squared per Day Liters (volume), divided by micrograms (dose). Liter per Microgram g/mL/(mg/day) mg/mL/(ug/day) Grams per milliliter (concentration), divided by milligrams per day (daily dose) or milligrams per milliliter (concentration), divided by micrograms per day (daily dose). Gram per Milliliter per Milligram per Day g/mL/(mg/kg) mg/mL/(ug/kg) Grams per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or milligrams per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Gram Per Milliliter Per Milligram Per Kilogram g/mL/(mg/kg/day) mg/mL/(ug/kg/day) Grams per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milligrams per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Gram Per Milliliter Per Milligram Per Kilogram Per Day g/mL/(mg/m2) mg/mL/(ug/m2) Grams per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or milligrams per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Gram per Milliliter per Milligram per Meter Squared g/mL/(mg/m2/day) mg/mL/(ug/m2/day) Grams per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milligrams per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Gram per Milliliter per Milligram per Meter Squared per Day g/mL/mg mg/mL/ug Grams per milliliter (concentration), divided by milligrams (dose) or milligrams per milliliter (concentration), divided by micrograms (dose). Gram per Milliliter per Milligram IU/mL/(mg/day) mIU/mL/(ug/day) International units per milliliter (concentration), divided by milligrams per day (daily dose) or milli-international units per milliliter (concentration), divided by micrograms per day (daily dose). International Unit per Milliliter per Milligram per Day IU/mL/(mg/kg) mIU/mL/(ug/kg) International units per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or milli-international units per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). International Unit per Milliliter per Milligram per Kilogram IU/mL/(mg/kg/day) mIU/mL/(ug/kg/day) International units per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milli-international units per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). International Unit per Milliliter per Milligram per Kilogram per Day IU/mL/(mg/m2) mIU/mL/(ug/m2) International units per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or milli-international units per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). International Unit per Milliliter per Milligram per Meter Squared IU/mL/(mg/m2/day) mIU/mL/(ug/m2/day) International units per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milli-international units per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). International Unit per Milliliter per Milligram per Meter Squared per Day IU/mL/mg mIU/mL/ug International units per milliliter (concentration), divided by milligrams (dose) or milli-international units per milliliter (concentration), divided by micrograms (dose). International Unit per Milliliter per Milligram L/(mg/kg/day) mL/(ug/kg/day) Liters (volume), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milliliters (volume), divided by micrograms per kilogram per day (daily dose normalized by body weight). Liter per Milligram per Kilogram per Day L/(mg/m2/day) mL/(ug/m2/day) Liters (volume), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milliliters (volume), divided by micrograms per meter squared per day (daily dose normalized by surface area). Liter per Milligram per Meter Squared per Day mmol/L/(ug/day) mol/L/(mg/day) Moles per liter (concentration), divided by milligrams per day (daily dose) or millimoles per liter (concentration), divided by micrograms per day (daily dose). Millimole per Liter per Microgram per Day mmol/L/(ug/kg) mol/L/(mg/kg) Moles per liter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or millimoles per liter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Millimole per Liter per Microgram per Kilogram mmol/L/(ug/kg/day) mol/L/(mg/kg/day) Moles per liter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or millimoles per liter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Millimole per Liter per Microgram per Kilogram per Day mmol/L/(ug/m2) mol/L/(mg/m2) Moles per liter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or millimoles per liter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Millimole per Liter per Microgram per Meter Squared mmol/L/(ug/m2/day) mol/L/(mg/m2/day) Moles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or millimoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Millimole per Liter per Microgram per Meter Squared per Day mmol/L/ug mol/L/mg Moles per liter (concentration), divided by milligrams (dose) or millimoles per liter (concentration), divided by micrograms (dose). Millimole per Liter per Microgram Moles per liter (concentration), divided by micrograms per day (daily dose). Mole per Liter per Microgram per Day Moles per liter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Mole per Liter per Microgram per Kilogram Moles per liter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Mole per Liter per Microgram per Kilogram per Day Moles per liter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Mole per Liter per Microgram per Meter Squared Moles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Mole per Liter per Microgram per Meter Squared per Day Moles per liter (concentration), divided by micrograms (dose). Mole per Liter per Microgram ng/mL/(ug/day) ug/mL/(mg/day) Micrograms per milliliter (concentration), divided by milligrams per day (daily dose) or nanograms per milliliter (concentration), divided by micrograms per day (daily dose). Nanogram per Milliliter per Microgram per Day ng/mL/(ug/kg) ug/mL/(mg/kg) Micrograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or nanograms per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Microgram Per Milliliter Per Milligram Per Kilogram ng/mL/(ug/kg/day) ug/mL/(mg/kg/day) Micrograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or nanograms per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Microgram Per Milliliter Per Milligram Per Kilogram Per Day ng/mL/(ug/m2) ug/mL/(mg/m2) Micrograms per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or nanograms per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Nanogram per Milliliter per Microgram per Meter Squared ng/mL/(ug/m2/day) ug/mL/(mg/m2/day) Micrograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or nanograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Nanogram per Milliliter per Microgram per Meter Squared per Day g/mL/kg mg/mL/g ng/mL/ug ug/mL/mg Grams per milliliter (concentration), divided by kilograms (weight) or milligrams per milliliter (concentration), divided by grams (weight) or micrograms per milliliter (concentration), divided by milligrams (dose) or nanograms per milliliter (concentration), divided by micrograms (dose). Milligram per Liter per Milligram nmol/L/(ug/day) umol/L/(mg/day) Micromoles per liter (concentration), divided by milligrams per day (daily dose) or nanomoles per liter (concentration), divided by micrograms per day (daily dose). Nanomole per Liter per Microgram per Day nmol/L/(ug/kg) umol/L/(mg/kg) Micromoles per liter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or nanomoles per liter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Nanomole per Liter per Microgram per Kilogram nmol/L/(ug/kg/day) umol/L/(mg/kg/day) Micromoles per liter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or nanomoles per liter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Nanomole per Liter per Microgram per Kilogram per Day nmol/L/(ug/m2) umol/L/(mg/m2) Micromoles per liter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or nanomoles per liter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Nanomole per Liter per Microgram per Meter Squared nmol/L/(ug/m2/day) umol/L/(mg/m2/day) Micromoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or nanomoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Nanomole per Liter per Microgram per Meter Squared per Day mmol/L/g mol/L/kg nmol/L/ug umol/L/mg Moles per liter (concentration), divided by kilograms (weight) or millimoles per liter (concentration), divided by grams (weight) or micromoles per liter (concentration), divided by milligrams (dose) or nanomoles per liter (concentration), divided by micrograms (dose). Millimole per Liter per Gram Nanomole equivalents of a substance per liter, divided by microgram (e.g., radiolabeled dose). Nanomole Equivalents Per Liter Per Microgram ng/mL/(mg/day) pg/mL/(ug/day) Nanograms per milliliter (concentration), divided by milligrams per day (daily dose) or picograms per milliliter (concentration), divided by micrograms per day (daily dose). Nanogram per Milliliter per Milligram per Day ng/mL/(mg/kg) pg/mL/(ug/kg) Nanograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or picograms per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Nanogram Per Milliliter Per Milligram Per Kilogram ng/mL/(mg/kg/day) pg/mL/(ug/kg/day) Nanograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or picograms per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Nanogram Per Milliliter Per Milligram Per Kilogram Per Day ng/mL/(mg/m2) pg/mL/(ug/m2) Nanograms per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or picograms per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Nanogram per Milliliter per Milligram per Meter Squared ng/mL/(mg/m2/day) pg/mL/(ug/m2/day) Nanograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or picograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Nanogram per Milliliter per Milligram per Meter Squared per Day mg/mL/kg ng/mL/mg pg/mL/ug ug/mL/g Milligrams per milliliter (concentration), divided by kilograms (weight) or micrograms per milliliter (concentration), divided by grams (weight) or nanograms per milliliter (concentration), divided by milligrams (dose) or picograms per milliliter (concentration), divided by micrograms (dose). Nanogram per Milliliter per Milligram nmol/L/(mg/day) pmol/L/(ug/day) Nanomoles per liter (concentration), divided by milligrams per day (daily dose) or picomoles per liter (concentration), divided by micrograms per day (daily dose). Nanomole per Liter per Milligram per Day nmol/L/(mg/kg) pmol/L/(ug/kg) Nanomoles per liter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or picomoles per liter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Nanomole per Liter per Milligram per Kilogram nmol/L/(mg/kg/day) pmol/L/(ug/kg/day) Nanomoles per liter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or picomoles per liter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Nanomole per Liter per Milligram per Kilogram per Day nmol/L/(mg/m2) pmol/L/(ug/m2) Nanomoles per liter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or picomoles per liter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Nanomole per Liter per Milligram per Meter Squared nmol/L/(mg/m2/day) pmol/L/(ug/m2/day) Nanomoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or picomoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Nanomole per Liter per Milligram per Meter Squared per Day mmol/L/kg nmol/L/mg pmol/L/ug umol/L/g Millimoles per liter (concentration), divided by kilograms (weight) or micromoles per liter (concentration), divided by grams (weight) or nanomoles per liter (concentration), divided by milligrams (dose) or picomoles per liter (concentration), divided by micrograms (dose). Picomole per Liter per Microgram mg/mL/(mg/day) ug/mL/(ug/day) Milligrams per milliliter (concentration), divided by milligrams per day (daily dose) or micrograms per milliliter (concentration), divided by micrograms per day (daily dose). Milligram per Milliliter per Milligram per Day mg/mL/(mg/kg) ug/mL/(ug/kg) Milligrams per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or micrograms per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Milligram Per Milliliter Per Milligram Per Kilogram mg/mL/(mg/kg/day) ug/mL/(ug/kg/day) Milligrams per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or micrograms per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Milligram Per Milliliter Per Milligram Per Kilogram Per Day mg/mL/(mg/m2) ug/mL/(ug/m2) Milligrams per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or micrograms per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Milligram per Milliliter per Milligram per Meter Squared mg/mL/(mg/m2/day) ug/mL/(ug/m2/day) Milligrams per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or micrograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Milligram per Milliliter per Milligram per Meter Squared per Day g/mL/g mg/mL/mg ug/mL/ug Grams per milliliter (concentration), divided by grams (weight) or milligrams per milliliter (concentration), divided by milligrams (dose) or micrograms per milliliter (concentration), divided by micrograms (dose). Gram per Milliliter per Gram mIU/mL/(mg/day) uIU/mL/(ug/day) Milli-international units per milliliter (concentration), divided by milligrams per day (daily dose) or micro-international units per milliliter (concentration), divided by micrograms per day (daily dose). Milli-International Unit per Milliliter per Milligram per Day mIU/mL/(mg/kg) uIU/mL/(ug/kg) Milli-international units per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or micro-international units per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Milli-International Unit per Milliliter per Milligram per Kilogram mIU/mL/(mg/kg/day) uIU/mL/(ug/kg/day) Milli-international units per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or micro-international units per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Milli-International Unit per Milliliter per Milligram per Kilogram per Day mIU/mL/(mg/m2) uIU/mL/(ug/m2) Milli-international units per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or micro-international units per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Milli-International Unit per Milliliter per Milligram per Meter Squared mIU/mL/(mg/m2/day) uIU/mL/(ug/m2/day) Milli-international units per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or micro-international units per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Milli-International Unit per Milliliter per Milligram per Meter Squared per Day IU/mL/g mIU/mL/mg uIU/mL/ug International units per milliliter (concentration), divided by grams (weight) or milli-international units per milliliter (concentration), divided by milligrams (dose) or micro-international units per milliliter (concentration), divided by micrograms (dose). International Unit per Milliliter per Gram mmol/L/(mg/day) umol/L/(ug/day) Millimoles per liter (concentration), divided by milligrams per day (daily dose) or micromoles per liter (concentration), divided by micrograms per day (daily dose). Millimole per Liter per Milligram per Day mmol/L/(mg/kg) umol/L/(ug/kg) Millimoles per liter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or micromoles per liter (concentration), divided by micrograms per kilogram (dose normalized by body weight). Millimole per Liter per Milligram per Kilogram mmol/L/(mg/kg/day) umol/L/(ug/kg/day) Millimoles per liter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or micromoles per liter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). Millimole per Liter per Milligram per Kilogram per Day mmol/L/(mg/m2) umol/L/(ug/m2) Millimoles per liter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or micromoles per liter (concentration), divided by micrograms per meter squared (dose normalized by surface area). Millimole per Liter per Milligram per Meter Squared mmol/L/(mg/m2/day) umol/L/(ug/m2/day) Millimoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or micromoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). Millimole per Liter per Milligram per Meter Squared per Day mmol/L/mg mol/L/g umol/L/ug Moles per liter (concentration), divided by grams (weight) or millimoles per liter (concentration), divided by milligrams (dose) or micromoles per liter (concentration), divided by micrograms (dose). Millimole per Liter per Milligram PKUDUG PK Units of Measure - Dose ug CDISC SDTM PK Unit of Measure Microgram Dose Terminology Units of measure for pharmacokinetic parameters normalized by weight in grams. (L/day)/g (mL/day)/mg Liters per day (flow rate), divided by grams (weight) or milliliters per day (flow rate), divided by milligrams (dose). Liter per Gram per Day (L/h)/g (mL/h)/mg Liters per hour (flow rate), divided by grams (weight) or milliliters per hour (flow rate), divided by milligrams (dose). Liter per Gram per Hour (L/min)/g (mL/min)/mg Liters per minute (flow rate), divided by grams (weight) or milliliters per minute (flow rate), divided by milligrams (dose). Liter per Gram per Minute (L/day)/kg (mL/day)/g mL/g/day Milliliters per gram per day or liters per day (flow rate), divided by kilograms (weight) or milliliters per day (flow rate), divided by grams (weight). Milliliter per Gram per Day (L/h)/kg (mL/h)/g mL/g/h Milliliters per gram per hour or liters per hour (flow rate), divided by kilograms (weight) or milliliters per hour (flow rate), divided by grams (weight). Milliliter per Gram per Hour (L/min)/kg (mL/min)/g mL/g/min Milliliters per gram per minute or liters per minute (flow rate), divided by kilograms (weight) or milliliters per minute (flow rate), divided by grams (weight). Milliliter per Gram per Minute day*fg/mL/g day*pg/mL/kg Days times picograms per milliliter (area under the curve), divided by kilograms (weight) or days times femtograms per milliliter (area under the curve), divided by grams (weight). Day Times Femtogram Per Milliliter Per Gram Days times grams per milliliter (area under the curve), divided by grams (weight). Day Times Gram Per Milliliter Per Gram day*g/mL/kg day*mg/mL/g day*ng/mL/ug day*ug/mL/mg Days times grams per milliliter (area under the curve), divided by kilograms (weight); or days times milligrams per milliliter (area under the curve), divided by grams (weight); or days times micrograms per milliliter (area under the curve), divided by milligrams (dose); or days times nanograms per milliliter (area under the curve), divided by micrograms (dose). Day Times Gram Per Milliliter Per Kilogram day*mmol/L/g day*mol/L/kg Days times moles per liter (area under the curve), divided by kilograms (weight) or days times millimoles per liter (area under the curve), divided by grams (weight). Day Times Millimole Per Liter Per Gram Days times moles per liter (area under the curve), divided by grams (weight). Day Times Mole Per Liter Per Gram day*ng/mL/g day*ug/mL/kg Days times micrograms per milliliter (area under the curve), divided by kilograms (weight) or days times nanograms per milliliter (area under the curve), divided by grams (weight). Day Times Microgram Per Milliliter Per Kilogram day*nmol/L/g day*umol/L/kg Days times micromoles per liter (area under the curve), divided by kilograms (weight) or days times nanomoles per liter (area under the curve), divided by grams (weight). Day Times Micromole Per Liter Per Kilogram day*ng/mL/kg day*pg/mL/g Days times nanograms per milliliter (area under the curve), divided by kilograms (weight) or days times picograms per milliliter (area under the curve), divided by grams (weight). Day Times Nanogram Per Milliliter Per Kilogram day*nmol/L/kg day*pmol/L/g Days times nanomoles per liter (area under the curve), divided by kilograms (weight) or days times picomoles per liter (area under the curve), divided by grams (weight). Day Times Nanomole Per Liter Per Kilogram day*mg/mL/kg day*ug/mL/g Days times milligrams per milliliter (area under the curve), divided by kilograms (weight) or days times micrograms per milliliter (area under the curve), divided by grams (weight). Day Times Microgram Per Milliliter Per Gram day*mmol/L/kg day*umol/L/g Days times millimoles per liter (area under the curve), divided by kilograms (weight) or days times micromoles per liter (area under the curve), divided by grams (weight). Day Times Micromole Per Liter Per Gram fg/mL/g pg/mL/kg Picograms per milliliter (concentration), divided by kilograms (weight) or femtograms per milliliter (concentration), divided by grams (weight). Femtogram per Milliliter per Gram g/mL/g mg/mL/mg ug/mL/ug Grams per milliliter (concentration), divided by grams (weight) or milligrams per milliliter (concentration), divided by milligrams (dose) or micrograms per milliliter (concentration), divided by micrograms (dose). Gram per Milliliter per Gram h*fg/mL/g h*pg/mL/kg Hours times picograms per milliliter (area under the curve), divided by kilograms (weight) or hours times femtograms per milliliter (area under the curve), divided by grams (weight). Hour Times Picogram per Milliliter per Kilogram Hours times grams per milliliter (area under the curve), divided by grams (weight). Hour Times Gram Per Milliliter Per Gram h*g/mL/kg h*mg/mL/g h*ug/mL/mg Hours times grams per milliliter (area under the curve), divided by kilograms (weight) or hours times milligrams per milliliter (area under the curve), divided by grams (weight) or hours times micrograms per milliliter (area under the curve), divided by milligrams (dose). Hour Times Microgram per Milliliter per Milligram h*mmol/L/g h*mol/L/kg Hours times moles per liter (area under the curve), divided by kilograms (weight) or hours times millimoles per liter (area under the curve), divided by grams (weight). Hour times Millimole Per Liter Per Gram h*mmol/L/mg h*mol/L/g h*umol/L/ug Hours times millimoles per liter (area under the curve), divided by kilograms (weight); or hours times micromoles per liter (area under the curve), divided by grams (weight); or hours times nanomoles per liter (area under the curve), divided by milligrams (dose); or hours times picomoles per liter (area under the curve), divided by micrograms (dose). Hour times Mole Per Liter Per Gram h*ng/mL/g h*pg/mL/mg h*ug/mL/kg Hours times micrograms per milliliter (area under the curve), divided by kilograms (weight) or hours times nanograms per milliliter (area under the curve), divided by grams (weight) or hours times picograms per milliliter (area under the curve), divided by milligrams (dose). Hour Times Nanogram per Milliliter per Gram h*nmol/L/g h*umol/L/kg Hours times micromoles per liter (area under the curve), divided by kilograms (weight) or hours times nanomoles per liter (area under the curve), divided by grams (weight). Hour Times Micromole Per Liter Per Kilogram h*ng/mL/kg h*pg/mL/g Hours times nanograms per milliliter (area under the curve), divided by kilograms (weight) or hours times picograms per milliliter (area under the curve), divided by grams (weight). Hour Times Nanogram per Milliliter per Kilogram h*nmol/L/kg h*pmol/L/g Hours times nanomoles per liter (area under the curve), divided by kilograms (weight) or hours times picomoles per liter (area under the curve), divided by grams (weight). Hour times Picomole Per Liter Per Gram h*mg/mL/kg h*ng/mL/mg h*ug/mL/g Hours times milligrams per milliliter (area under the curve), divided by kilograms (weight) or hours times micrograms per milliliter (area under the curve), divided by grams (weight) or hours times nanograms per milliliter (area under the curve), divided by milligrams (dose). Hour Times Nanogram per Milliliter per Milligram h*mmol/L/kg h*nmol/L/mg h*pmol/L/ug h*umol/L/g Hours times millimoles per liter (area under the curve), divided by kilograms (weight); or hours times micromoles per liter (area under the curve), divided by grams (weight); or hours times nanomoles per liter (area under the curve), divided by milligrams (dose); or hours times picomoles per liter (area under the curve), divided by micrograms (dose). Hour Times Millimole Per Liter Per Kilogram IU/mL/g mIU/mL/mg uIU/mL/ug International units per milliliter (concentration), divided by grams (weight) or milli-international units per milliliter (concentration), divided by milligrams (dose) or micro-international units per milliliter (concentration), divided by micrograms (dose). International Unit per Milliliter per Gram mL/mg Liters (volume), divided by grams (weight) or milliliters (volume), divided by milligrams (dose). Cubic Meter per Kilogram g/mL/kg mg/mL/g ng/mL/ug ug/mL/mg Grams per milliliter (concentration), divided by kilograms (weight) or milligrams per milliliter (concentration), divided by grams (weight) or micrograms per milliliter (concentration), divided by milligrams (dose) or nanograms per milliliter (concentration), divided by micrograms (dose). Milligram per Liter per Milligram min*fg/mL/g min*pg/mL/kg Minutes times picograms per milliliter (area under the curve), divided by kilograms (weight) or minutes times femtograms per milliliter (area under the curve), divided by grams (weight). Minute Times Femtogram Per Milliliter Per Gram Minutes times grams per milliliter (area under the curve), divided by grams (weight). Minute Times Gram Per Milliliter Per Gram min*g/mL/kg min*mg/mL/g Minutes times grams per milliliter (area under the curve), divided by kilograms (weight) or minutes times milligrams per milliliter (area under the curve), divided by grams (weight). Minute Times Gram Per Milliliter Per Kilogram min*mmol/L/g min*mol/L/kg Minutes times moles per liter (area under the curve), divided by kilograms (weight) or minutes times millimoles per liter (area under the curve), divided by grams (weight). Minute Times Millimole Per Liter Per Gram Minutes times moles per liter (area under the curve), divided by grams (weight). Minute Times Mole Per Liter Per Gram min*ng/mL/g min*ug/mL/kg Minutes times micrograms per milliliter (area under the curve), divided by kilograms (weight) or minutes times nanograms per milliliter (area under the curve), divided by grams (weight). Minute Times Microgram Per Milliliter Per Kilogram min*nmol/L/g min*umol/L/kg Minutes times micromoles per liter (area under the curve), divided by kilograms (weight) or minutes times nanomoles per liter (area under the curve), divided by grams (weight). Minute Times Micromole Per Liter Per Kilogram min*ng/mL/kg min*pg/mL/g Minutes times nanograms per milliliter (area under the curve), divided by kilograms (weight) or minutes times picograms per milliliter (area under the curve), divided by grams (weight). Minute Times Nanogram Per Milliliter Per Kilogram min*nmol/L/kg min*pmol/L/g Minutes times nanomoles per liter (area under the curve), divided by kilograms (weight) or minutes times picomoles per liter (area under the curve), divided by grams (weight). Minute Times Nanomole Per Liter Per Kilogram min*mg/mL/kg min*ug/mL/g Minutes times milligrams per milliliter (area under the curve), divided by kilograms (weight) or minutes times micrograms per milliliter (area under the curve), divided by grams (weight). Minute Times Microgram Per Milliliter Per Gram min*mmol/L/kg min*umol/L/g Minutes times millimoles per liter (area under the curve), divided by kilograms (weight) or minutes times micromoles per liter (area under the curve), divided by grams (weight). Minute Times Micromole Per Liter Per Gram IU/mL/kg mIU/mL/g uIU/mL/mg International units per milliliter (concentration), divided by kilograms (weight) or milli-international units per milliliter (concentration), divided by grams (weight) or micro-international units per milliliter (concentration), divided by milligrams (dose). International Unit per Milliliter per Kilogram L/kg mL/g Liters (volume) divided by kilograms (weight) or milliliters (volume), divided by grams (weight). Liter per Kilogram mmol/L/g mol/L/kg nmol/L/ug umol/L/mg Moles per liter (concentration), divided by kilograms (weight) or millimoles per liter (concentration), divided by grams (weight) or micromoles per liter (concentration), divided by milligrams (dose) or nanomoles per liter (concentration), divided by micrograms (dose). Millimole per Liter per Gram mmol/L/mg mol/L/g umol/L/ug Moles per liter (concentration), divided by grams (weight) or millimoles per liter (concentration), divided by milligrams (dose) or micromoles per liter (concentration), divided by micrograms (dose). Millimole per Liter per Milligram mcg/kg Microgram per Kilogram ng/g pg/mg ug/kg A unit of a mass fraction expressed as a number of micrograms of substance per kilogram of mixture. The unit is also used as a dose calculation unit.(NCI) Microgram per Kilogram fg/mL/ug ng/mL/g pg/mL/mg ug/mL/kg Micrograms per milliliter (concentration), divided by kilograms (weight) or nanograms per milliliter (concentration), divided by grams (weight) or picograms per milliliter (concentration), divided by milligrams (dose) or femtograms per milliliter (concentration), divided by micrograms (dose). Femtogram per Milliliter per Microgram nmol/g pmol/mg umol/kg Nanomoles per gram. Nanomole per Gram nmol/L/g pmol/L/mg umol/L/kg Micromoles per liter (concentration), divided by kilograms (weight) or nanomoles per liter (concentration), divided by grams (weight) or picomoles per liter (concentration), divided by milligrams (dose). Nanomole per Liter per Gram fg/mL/mg ng/mL/kg pg/mL/g Nanograms per milliliter (concentration), divided by kilograms (weight) or picograms per milliliter (concentration), divided by grams (weight) or femtograms per milliliter (concentration), divided by milligrams (dose). Nanogram per Milliliter per Kilogram nmol/L/kg pmol/L/g Nanomoles per liter (concentration), divided by kilograms (weight) or picomoles per liter (concentration), divided by grams (weight). Nanomole per Liter per Kilogram mg/mL/kg ng/mL/mg pg/mL/ug ug/mL/g Milligrams per milliliter (concentration), divided by kilograms (weight) or micrograms per milliliter (concentration), divided by grams (weight) or nanograms per milliliter (concentration), divided by milligrams (dose) or picograms per milliliter (concentration), divided by micrograms (dose). Nanogram per Milliliter per Milligram mIU/mL/kg uIU/mL/g Milli-international units per milliliter (concentration), divided by kilograms (weight) or micro-international units per milliliter (concentration), divided by grams (weight). Milli-International Unit per Milliliter per Kilogram mmol/L/kg nmol/L/mg pmol/L/ug umol/L/g Millimoles per liter (concentration), divided by kilograms (weight) or micromoles per liter (concentration), divided by grams (weight) or nanomoles per liter (concentration), divided by milligrams (dose) or picomoles per liter (concentration), divided by micrograms (dose). Picomole per Liter per Microgram PKUWG PK Units of Measure - Weight g CDISC SDTM PK Unit of Measure Gram Weight Terminology Units of measure for pharmacokinetic parameters normalized by weight in kilograms. (L/day)/kg (mL/day)/g mL/g/day Milliliters per gram per day or liters per day (flow rate), divided by kilograms (weight) or milliliters per day (flow rate), divided by grams (weight). Milliliter per Gram per Day (L/h)/kg (mL/h)/g mL/g/h Milliliters per gram per hour or liters per hour (flow rate), divided by kilograms (weight) or milliliters per hour (flow rate), divided by grams (weight). Milliliter per Gram per Hour (L/min)/kg (mL/min)/g mL/g/min Milliliters per gram per minute or liters per minute (flow rate), divided by kilograms (weight) or milliliters per minute (flow rate), divided by grams (weight). Milliliter per Gram per Minute (mL/day)/kg mL/kg/day Milliliters per kilogram per day or milliliters per day (flow rate), divided by kilograms (weight). Milliliter per Kilogram per Day (mL/h)/kg mL/kg/h Milliliters per kilogram per hour or milliliters per hour (flow rate), divided by kilograms (weight). Milliliter per Kilogram per Hour (mL/min)/kg mL/kg/min Milliliters per kilogram per minute or milliliters per minute (flow rate), divided by kilograms (weight). Milliliter per Kilogram per Minute day*g/mL/kg day*mg/mL/g day*ng/mL/ug day*ug/mL/mg Days times grams per milliliter (area under the curve), divided by kilograms (weight); or days times milligrams per milliliter (area under the curve), divided by grams (weight); or days times micrograms per milliliter (area under the curve), divided by milligrams (dose); or days times nanograms per milliliter (area under the curve), divided by micrograms (dose). Day Times Gram Per Milliliter Per Kilogram day*mg/mL/kg day*ug/mL/g Days times milligrams per milliliter (area under the curve), divided by kilograms (weight) or days times micrograms per milliliter (area under the curve), divided by grams (weight). Day Times Microgram Per Milliliter Per Gram day*mmol/L/kg day*umol/L/g Days times millimoles per liter (area under the curve), divided by kilograms (weight) or days times micromoles per liter (area under the curve), divided by grams (weight). Day Times Micromole Per Liter Per Gram day*mmol/L/g day*mol/L/kg Days times moles per liter (area under the curve), divided by kilograms (weight) or days times millimoles per liter (area under the curve), divided by grams (weight). Day Times Millimole Per Liter Per Gram day*ng/mL/kg day*pg/mL/g Days times nanograms per milliliter (area under the curve), divided by kilograms (weight) or days times picograms per milliliter (area under the curve), divided by grams (weight). Day Times Nanogram Per Milliliter Per Kilogram day*nmol/L/kg day*pmol/L/g Days times nanomoles per liter (area under the curve), divided by kilograms (weight) or days times picomoles per liter (area under the curve), divided by grams (weight). Day Times Nanomole Per Liter Per Kilogram day*fg/mL/g day*pg/mL/kg Days times picograms per milliliter (area under the curve), divided by kilograms (weight) or days times femtograms per milliliter (area under the curve), divided by grams (weight). Day Times Femtogram Per Milliliter Per Gram Days times picomoles per liter (area under the curve), divided by kilograms (weight). Day Times Picomole Per Liter Per Kilogram day*ng/mL/g day*ug/mL/kg Days times micrograms per milliliter (area under the curve), divided by kilograms (weight) or days times nanograms per milliliter (area under the curve), divided by grams (weight). Day Times Microgram Per Milliliter Per Kilogram day*nmol/L/g day*umol/L/kg Days times micromoles per liter (area under the curve), divided by kilograms (weight) or days times nanomoles per liter (area under the curve), divided by grams (weight). Day Times Micromole Per Liter Per Kilogram Femtograms per milliliter (concentration), divided by kilograms (weight). Femtogram per Milliliter per Kilogram g/mL/kg mg/mL/g ng/mL/ug ug/mL/mg Grams per milliliter (concentration), divided by kilograms (weight) or milligrams per milliliter (concentration), divided by grams (weight) or micrograms per milliliter (concentration), divided by milligrams (dose) or nanograms per milliliter (concentration), divided by micrograms (dose). Milligram per Liter per Milligram h*g/mL/kg h*mg/mL/g h*ug/mL/mg Hours times grams per milliliter (area under the curve), divided by kilograms (weight) or hours times milligrams per milliliter (area under the curve), divided by grams (weight) or hours times micrograms per milliliter (area under the curve), divided by milligrams (dose). Hour Times Microgram per Milliliter per Milligram h*mg/mL/kg h*ng/mL/mg h*ug/mL/g Hours times milligrams per milliliter (area under the curve), divided by kilograms (weight) or hours times micrograms per milliliter (area under the curve), divided by grams (weight) or hours times nanograms per milliliter (area under the curve), divided by milligrams (dose). Hour Times Nanogram per Milliliter per Milligram h*mmol/L/kg h*nmol/L/mg h*pmol/L/ug h*umol/L/g Hours times millimoles per liter (area under the curve), divided by kilograms (weight); or hours times micromoles per liter (area under the curve), divided by grams (weight); or hours times nanomoles per liter (area under the curve), divided by milligrams (dose); or hours times picomoles per liter (area under the curve), divided by micrograms (dose). Hour Times Millimole Per Liter Per Kilogram h*mmol/L/g h*mol/L/kg Hours times moles per liter (area under the curve), divided by kilograms (weight) or hours times millimoles per liter (area under the curve), divided by grams (weight). Hour times Millimole Per Liter Per Gram h*ng/mL/kg h*pg/mL/g Hours times nanograms per milliliter (area under the curve), divided by kilograms (weight) or hours times picograms per milliliter (area under the curve), divided by grams (weight). Hour Times Nanogram per Milliliter per Kilogram h*nmol/L/kg h*pmol/L/g Hours times nanomoles per liter (area under the curve), divided by kilograms (weight) or hours times picomoles per liter (area under the curve), divided by grams (weight). Hour times Picomole Per Liter Per Gram h*fg/mL/g h*pg/mL/kg Hours times picograms per milliliter (area under the curve), divided by kilograms (weight) or hours times femtograms per milliliter (area under the curve), divided by grams (weight). Hour Times Picogram per Milliliter per Kilogram Hours times picomoles per liter (area under the curve), divided by kilograms (weight). Hour Times Picomole Per Liter Per Kilogram h*ng/mL/g h*pg/mL/mg h*ug/mL/kg Hours times micrograms per milliliter (area under the curve), divided by kilograms (weight) or hours times nanograms per milliliter (area under the curve), divided by grams (weight) or hours times picograms per milliliter (area under the curve), divided by milligrams (dose). Hour Times Nanogram per Milliliter per Gram h*nmol/L/g h*umol/L/kg Hours times micromoles per liter (area under the curve), divided by kilograms (weight) or hours times nanomoles per liter (area under the curve), divided by grams (weight). Hour Times Micromole Per Liter Per Kilogram IU/mL/kg mIU/mL/g uIU/mL/mg International units per milliliter (concentration), divided by kilograms (weight) or milli-international units per milliliter (concentration), divided by grams (weight) or micro-international units per milliliter (concentration), divided by milligrams (dose). International Unit per Milliliter per Kilogram L/kg mL/g Liters (volume) divided by kilograms (weight) or milliliters (volume), divided by grams (weight). Liter per Kilogram mg/mL/kg ng/mL/mg pg/mL/ug ug/mL/g Milligrams per milliliter (concentration), divided by kilograms (weight) or micrograms per milliliter (concentration), divided by grams (weight) or nanograms per milliliter (concentration), divided by milligrams (dose) or picograms per milliliter (concentration), divided by micrograms (dose). Nanogram per Milliliter per Milligram min*g/mL/kg min*mg/mL/g Minutes times grams per milliliter (area under the curve), divided by kilograms (weight) or minutes times milligrams per milliliter (area under the curve), divided by grams (weight). Minute Times Gram Per Milliliter Per Kilogram min*mg/mL/kg min*ug/mL/g Minutes times milligrams per milliliter (area under the curve), divided by kilograms (weight) or minutes times micrograms per milliliter (area under the curve), divided by grams (weight). Minute Times Microgram Per Milliliter Per Gram min*mmol/L/kg min*umol/L/g Minutes times millimoles per liter (area under the curve), divided by kilograms (weight) or minutes times micromoles per liter (area under the curve), divided by grams (weight). Minute Times Micromole Per Liter Per Gram min*mmol/L/g min*mol/L/kg Minutes times moles per liter (area under the curve), divided by kilograms (weight) or minutes times millimoles per liter (area under the curve), divided by grams (weight). Minute Times Millimole Per Liter Per Gram min*ng/mL/kg min*pg/mL/g Minutes times nanograms per milliliter (area under the curve), divided by kilograms (weight) or minutes times picograms per milliliter (area under the curve), divided by grams (weight). Minute Times Nanogram Per Milliliter Per Kilogram min*nmol/L/kg min*pmol/L/g Minutes times nanomoles per liter (area under the curve), divided by kilograms (weight) or minutes times picomoles per liter (area under the curve), divided by grams (weight). Minute Times Nanomole Per Liter Per Kilogram min*fg/mL/g min*pg/mL/kg Minutes times picograms per milliliter (area under the curve), divided by kilograms (weight) or minutes times femtograms per milliliter (area under the curve), divided by grams (weight). Minute Times Femtogram Per Milliliter Per Gram Minutes times picomoles per liter (area under the curve), divided by kilograms (weight). Minute Times Picomole Per Liter Per Kilogram min*ng/mL/g min*ug/mL/kg Minutes times micrograms per milliliter (area under the curve), divided by kilograms (weight) or minutes times nanograms per milliliter (area under the curve), divided by grams (weight). Minute Times Microgram Per Milliliter Per Kilogram min*nmol/L/g min*umol/L/kg Minutes times micromoles per liter (area under the curve), divided by kilograms (weight) or minutes times nanomoles per liter (area under the curve), divided by grams (weight). Minute Times Micromole Per Liter Per Kilogram mIU/mL/kg uIU/mL/g Milli-international units per milliliter (concentration), divided by kilograms (weight) or micro-international units per milliliter (concentration), divided by grams (weight). Milli-International Unit per Milliliter per Kilogram Milliliters (volume) divided by kilograms (weight). Milliliter per Kilogram mmol/L/kg nmol/L/mg pmol/L/ug umol/L/g Millimoles per liter (concentration), divided by kilograms (weight) or micromoles per liter (concentration), divided by grams (weight) or nanomoles per liter (concentration), divided by milligrams (dose) or picomoles per liter (concentration), divided by micrograms (dose). Picomole per Liter per Microgram mmol/L/g mol/L/kg nmol/L/ug umol/L/mg Moles per liter (concentration), divided by kilograms (weight) or millimoles per liter (concentration), divided by grams (weight) or micromoles per liter (concentration), divided by milligrams (dose) or nanomoles per liter (concentration), divided by micrograms (dose). Millimole per Liter per Gram Nanograms per kilogram per minute. Nanogram per Kilogram per Minute fg/mL/mg ng/mL/kg pg/mL/g Nanograms per milliliter (concentration), divided by kilograms (weight) or picograms per milliliter (concentration), divided by grams (weight) or femtograms per milliliter (concentration), divided by milligrams (dose). Nanogram per Milliliter per Kilogram nmol/kg pmol/g Nanomoles (amount), divided by kilograms (weight) or picomoles per gram. Nanomole per Kilogram nmol/L/kg pmol/L/g Nanomoles per liter (concentration), divided by kilograms (weight) or picomoles per liter (concentration), divided by grams (weight). Nanomole per Liter per Kilogram fg/mL/g pg/mL/kg Picograms per milliliter (concentration), divided by kilograms (weight) or femtograms per milliliter (concentration), divided by grams (weight). Femtogram per Milliliter per Gram Picomoles per liter (concentration), divided by kilograms (weight). Picomole per Liter per Kilogram fg/mL/ug ng/mL/g pg/mL/mg ug/mL/kg Micrograms per milliliter (concentration), divided by kilograms (weight) or nanograms per milliliter (concentration), divided by grams (weight) or picograms per milliliter (concentration), divided by milligrams (dose) or femtograms per milliliter (concentration), divided by micrograms (dose). Femtogram per Milliliter per Microgram Micro-international units per milliliter (concentration), divided by kilograms (weight). Micro-International Units per Milliliter per Kilogram nmol/L/g pmol/L/mg umol/L/kg Micromoles per liter (concentration), divided by kilograms (weight) or nanomoles per liter (concentration), divided by grams (weight) or picomoles per liter (concentration), divided by milligrams (dose). Nanomole per Liter per Gram PKUWKG PK Units of Measure - Weight kg CDISC SDTM PK Unit of Measure Kilogram Weight Terminology Qualifier for anatomical location or specimen further detailing the portion or totality, which means arrangement of, or apportioning of an entity. Being or representing the total number of individual entities. All Whole Being or representing the complete extent of a single entity. Whole Of or pertaining to one half of a whole. Half More than one. (NCI) Multiple Being or representing an incomplete extent of a single entity. Partial One of the parts into which something is divided. Segment One. Single PORTOT Portion/Totality CDISC SDTM Portion/Totality Terminology Terminology codelist used with Body Position within CDISC. Recumbent Lying down. (NCI) Recumbent Position Fowlers A semi-sitting position whereby the head of an adjustable bed is elevated to the desired height, about 60-90 cm, to produce angulation of the body, usually 45 degrees to 60 degrees. Knees may or may not be bent. (NCI) Fowler's Position Lateral Decubitus Lying down on one side. Lateral Decubitus Position Left lateral decubitus A recumbent left lateral side position. (NCI) Left Lateral Decubitus Position Prone An anterior recumbent body position whereby the person lies on its stomach and faces downward. (NCI) Prone Position Reverse Trendelenburg A supine position with the person inclined at an angle of 45 degrees so that the head is higher than the pelvis. (NCI) Reverse Trendelenburg Right lateral decubitus A recumbent right lateral side position. (NCI) Right Lateral Decubitus Position Semi-Fowlers A semi-sitting or semi-reclined body position whereby the head is elevated on an angle of approximately 30 degrees. (NCI) Semi-Fowler's Position Semi-Supine A semi-sitting or semi-reclined body position in which the head is elevated above horizontal. (NCI) Semi-Recumbent Sitting The state or act of one who sits; the posture of one who occupies a seat. (NCI) Sitting Sitting With Legs Dangling A position where the legs of a subject dangle, or hang down, while sitting. Sitting With Legs Dependent Sling A position in which the subject's body is supported by a sling. Patient in Body Sling Orthostatic Standing The act of assuming or maintaining an erect upright position. (NCI) Standing A position where the subject is standing and bent forward at the waist. Standing, Bent Forward Supine A posterior recumbent body position whereby the person lies on its back and faces upward. (NCI) Supine Position Trendelenburg A supine position with the person inclined at an angle of 45 degrees so that the pelvis is higher than the head. (NCI) Trendelenburg Unconstrained The ability to move body parts and limbs without physical restriction. (NCI) Unconstrained Body Movement POSITION Position CDISC SDTM Body Position Terminology Positive and Negative Syndrome Scale test code. PANSS1-Delusions Positive and Negative Syndrome Scale - Delusions. PANSS - Delusions PANSS1-Conceptual Disorganization Positive and Negative Syndrome Scale - Conceptual disorganization. PANSS - Conceptual Disorganization PANSS1-Hallucinatory Behavior Positive and Negative Syndrome Scale - Hallucinatory behavior. PANSS - Hallucinatory Behavior PANSS1-Excitement Positive and Negative Syndrome Scale - Excitement. PANSS - Excitement PANSS1-Grandiosity Positive and Negative Syndrome Scale - Grandiosity. PANSS - Grandiosity PANSS1-Suspiciousness/Persecution Positive and Negative Syndrome Scale - Suspiciousness/persecution. PANSS - Suspiciousness or Persecution PANSS1-Hostility Positive and Negative Syndrome Scale - Hostility. PANSS - Hostility PANSS1-Blunted Affect Positive and Negative Syndrome Scale - Blunted affect. PANSS - Blunted Affect PANSS1-Emotional Withdrawal Positive and Negative Syndrome Scale - Emotional withdrawal. PANSS - Emotional Withdrawal PANSS1-Poor Rapport Positive and Negative Syndrome Scale - Poor rapport. PANSS - Poor Rapport PANSS1-Passive/Apathetic Social Withdraw Positive and Negative Syndrome Scale - Passive/apathetic social withdrawal. PANSS - Passive or Apathetic Social Withdrawal PANSS1-Difficulty in Abstract Thinking Positive and Negative Syndrome Scale - Difficulty in abstract thinking. PANSS - Difficulty in Abstract Thinking PANSS1-Lack of Spontaneity Positive and Negative Syndrome Scale - Lack of spontaneity and flow of conversation. PANSS - Lack of Spontaneity PANSS1-Stereotyped Thinking Positive and Negative Syndrome Scale - Stereotyped thinking. PANSS - Stereotyped Thinking PANSS1-Somatic Concern Positive and Negative Syndrome Scale - Somatic concern. PANSS - Somatic Concern PANSS1-Anxiety Positive and Negative Syndrome Scale - Anxiety. PANSS - Anxiety PANSS1-Guilt Feelings Positive and Negative Syndrome Scale - Guilt feelings. PANSS - Guilt Feelings PANSS1-Tension Positive and Negative Syndrome Scale - Tension. PANSS - Tension PANSS1-Mannerisms and Posturing Positive and Negative Syndrome Scale - Mannerisms and posturing. PANSS - Mannerisms and Posturing PANSS1-Depression Positive and Negative Syndrome Scale - Depression. PANSS - Depression PANSS1-Motor Retardation Positive and Negative Syndrome Scale - Motor retardation. PANSS - Motor Retardation PANSS1-Uncooperativeness Positive and Negative Syndrome Scale - Uncooperativeness. PANSS - Uncooperativeness PANSS1-Unusual Thought Content Positive and Negative Syndrome Scale - Unusual thought content. PANSS - Unusual Thought Content PANSS1-Disorientation Positive and Negative Syndrome Scale - Disorientation. PANSS - Disorientation PANSS1-Poor Attention Positive and Negative Syndrome Scale - Poor attention. PANSS - Poor Attention PANSS1-Lack of Judgment and Insight Positive and Negative Syndrome Scale - Lack of judgment and insight. PANSS - Lack of Judgement PANSS1-Disturbance of Volition Positive and Negative Syndrome Scale - Disturbance of volition. PANSS - Disturbance of Volition PANSS1-Poor Impulse Control Positive and Negative Syndrome Scale - Poor impulse control. PANSS - Poor Impulse Control PANSS1-Preoccupation Positive and Negative Syndrome Scale - Preoccupation. PANSS - Preoccupation PANSS1-Active Social Avoidance Positive and Negative Syndrome Scale - Active social avoidance. PANSS - Active Social Avoidance PANSS1TC Positive and Negative Syndrome Scale Clinical Classification Test Code CDISC Clinical Classification PANSS Test Code Terminology Positive and Negative Syndrome Scale test name. PANSS1-Active Social Avoidance Positive and Negative Syndrome Scale - Active social avoidance. PANSS - Active Social Avoidance PANSS1-Anxiety Positive and Negative Syndrome Scale - Anxiety. PANSS - Anxiety PANSS1-Blunted Affect Positive and Negative Syndrome Scale - Blunted affect. PANSS - Blunted Affect PANSS1-Conceptual Disorganization Positive and Negative Syndrome Scale - Conceptual disorganization. PANSS - Conceptual Disorganization PANSS1-Delusions Positive and Negative Syndrome Scale - Delusions. PANSS - Delusions PANSS1-Depression Positive and Negative Syndrome Scale - Depression. PANSS - Depression PANSS1-Difficulty in Abstract Thinking Positive and Negative Syndrome Scale - Difficulty in abstract thinking. PANSS - Difficulty in Abstract Thinking PANSS1-Disorientation Positive and Negative Syndrome Scale - Disorientation. PANSS - Disorientation PANSS1-Disturbance of Volition Positive and Negative Syndrome Scale - Disturbance of volition. PANSS - Disturbance of Volition PANSS1-Emotional Withdrawal Positive and Negative Syndrome Scale - Emotional withdrawal. PANSS - Emotional Withdrawal PANSS1-Excitement Positive and Negative Syndrome Scale - Excitement. PANSS - Excitement PANSS1-Grandiosity Positive and Negative Syndrome Scale - Grandiosity. PANSS - Grandiosity PANSS1-Guilt Feelings Positive and Negative Syndrome Scale - Guilt feelings. PANSS - Guilt Feelings PANSS1-Hallucinatory Behavior Positive and Negative Syndrome Scale - Hallucinatory behavior. PANSS - Hallucinatory Behavior PANSS1-Hostility Positive and Negative Syndrome Scale - Hostility. PANSS - Hostility PANSS1-Lack of Judgment and Insight Positive and Negative Syndrome Scale - Lack of judgment and insight. PANSS - Lack of Judgement PANSS1-Lack of Spontaneity Positive and Negative Syndrome Scale - Lack of spontaneity and flow of conversation. PANSS - Lack of Spontaneity PANSS1-Mannerisms and Posturing Positive and Negative Syndrome Scale - Mannerisms and posturing. PANSS - Mannerisms and Posturing PANSS1-Motor Retardation Positive and Negative Syndrome Scale - Motor retardation. PANSS - Motor Retardation PANSS1-Passive/Apathetic Social Withdraw Positive and Negative Syndrome Scale - Passive/apathetic social withdrawal. PANSS - Passive or Apathetic Social Withdrawal PANSS1-Poor Attention Positive and Negative Syndrome Scale - Poor attention. PANSS - Poor Attention PANSS1-Poor Impulse Control Positive and Negative Syndrome Scale - Poor impulse control. PANSS - Poor Impulse Control PANSS1-Poor Rapport Positive and Negative Syndrome Scale - Poor rapport. PANSS - Poor Rapport PANSS1-Preoccupation Positive and Negative Syndrome Scale - Preoccupation. PANSS - Preoccupation PANSS1-Somatic Concern Positive and Negative Syndrome Scale - Somatic concern. PANSS - Somatic Concern PANSS1-Stereotyped Thinking Positive and Negative Syndrome Scale - Stereotyped thinking. PANSS - Stereotyped Thinking PANSS1-Suspiciousness/Persecution Positive and Negative Syndrome Scale - Suspiciousness/persecution. PANSS - Suspiciousness or Persecution PANSS1-Tension Positive and Negative Syndrome Scale - Tension. PANSS - Tension PANSS1-Uncooperativeness Positive and Negative Syndrome Scale - Uncooperativeness. PANSS - Uncooperativeness PANSS1-Unusual Thought Content Positive and Negative Syndrome Scale - Unusual thought content. PANSS - Unusual Thought Content PANSS1TN Positive and Negative Syndrome Scale Clinical Classification Test Name CDISC Clinical Classification PANSS Test Name Terminology A terminology codelist relevant to the categorization of individuals with or without the potential for having tuberculosis. An individual that has tested positive for pulmonary, laryngeal, or pleural tuberculosis and may or may not present with cavitary disease. High-priority Tuberculosis Subject An individual that has had limited exposure to an individual with tuberculosis and has a low probability of having had a recent infection. Low-priority Tuberculosis Subject An individual that has tested negative for pulmonary, laryngeal, or pleural tuberculosis but has had a non-cavitary chest x-ray that is consistent with tuberculosis. Medium-priority Tuberculosis Subject PRITBCON Priority of Tuberculosis Contact CDISC SDTM Priority of Tuberculosis Contact Terminology A terminology codelist to describe any activity considered to be a therapeutic or diagnostic procedure. 3D CRT A process by which a dose of radiation is automatically shaped to closely conform to the entire volume of the tumor, so that surrounding normal tissue is spared and treatment toxicity is decreased. (NCI) 3-Dimensional Conformal Radiation Therapy Removal, separation, detachment, extirpation or eradication of a body part, pathway or function by surgery, chemical destruction, morbid process, or noxious substance. (NCI) Ablation Therapy An invasive therapeutic procedure to destroy tissue in an accessory pathways in the atrioventricular conduction system that contributes to arrhythmia. Ablation of Cardiac Accessory Pathway An invasive therapeutic procedure to destroy tissue in the cardiac atria that is the source of an arrhythmia. Atrial Ablation An invasive therapeutic procedure to destroy tissue in the AV-node that contributes to arrhythmia. Ablation of Cardiac Atrioventricular Node Cardiac Ablation An invasive therapeutic procedure to destroy tissue in the heart used to correct heart arrhythmias. Cardiac Ablation Removal, separation, detachment, extirpation or eradication of a body part, pathway or function by chemical means. (NCI) Chemical Ablation Removal, separation, detachment, extirpation or eradication of a body part, pathway or function by light amplification by stimulated emission of radiation. (NCI) Laser Ablation An invasive therapeutic procedure to destroy tissue in the cardiac ventricles that is the source of an arrhythmia. Ventricular Ablation Allogenic Stem Cell Transplantation Stem cell transfer or transplantation from a donor other than one's self. Allogeneic Stem Cell Transplantation Dilation of the valve between the left ventricle of the heart and the aorta by inflating a balloon. Aortic Balloon Valvotomy Surgery performed with the purpose of replacing a degenerated, calcified, malformed, dysfunctional, etc. aortic valve with a bioprosthetic, homograft, or autograft valve. Aortic Valve Replacement Total Artificial Heart Implantation Implantation of a prosthetic device into the body to replace the function of both cardiac ventricles and all four cardiac valves, typically as a bridge to transplantation. Total Artificial Heart Implantation Repair of atrial septum. Closure of Cardiac Atrial Septum Stem cell transfer or transplantation in which the patient is their own donor. Autologous Stem Cell Transplantation BIPAP Ventilation BPAP Ventilation A type of non-invasive mechanical ventilation procedure that that uses bilevel positive airway pressure to support spontaneous breathing activity. Biphasic Positive Airway Pressure Right Lung Bilobectomy Surgical removal of two lobes of the right lung. Bilobectomy The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis. Biopsy Procedure CNB Core Needle Biopsy Needle Biopsy A type of biopsy in which a tissue sample is removed using a needle with a relatively large diameter. Core Biopsy Excision Biopsy Excisional Biopsy A type of biopsy in which an entire lesion is removed for microscopic examination. Excisional Biopsy A type of biopsy in which part of a lesion is removed for microscopic examination. Incisional Biopsy A type of biopsy in which a disk of tissue is removed using a punch device. Punch Biopsy CRT-D Implantation A surgical procedure in which a cardiac pacing device with a built-in cardioverter defibrillator is placed under the skin, with leads positioned in the right atrium and both ventricles. Cardiac Resynchronization Therapy Defibrillator Implantation A mechanical fluid removal technique that involves the pressure-driven movement of plasma water and solutes from whole blood across a semipermeable membrane. Blood Ultrafiltration BMT A therapeutic procedure to replace diseased or pathologic bone marrow with transplanted, healthy bone marrow cells. Bone Marrow Transplantation A type of radiation therapy in which radioactive material is placed inside the body, into a tumor or body cavity. Brachytherapy A type of brachytherapy in which radioactive material sealed in needles, seeds, wires, or catheters is placed directly into a tumor or body tissue. Interstitial Radiation Therapy A type of brachytherapy in which radioactive material sealed in needles, seeds, wires, or catheters is placed directly into a body cavity such as the chest cavity or the vagina. Intracavitary Radiation Therapy Any of a number of implantable cardiac devices meant to aid the heart in carrying out its functions. Cardiac Assist Device A procedure in which a thin plastic tube (catheter) is inserted into an artery or vein in the arm or leg and then advanced into the chambers of the heart or into the coronary arteries. Cardiac Catheterization Biventricular Cardiac Pacemaker Procedure CRT An invasive procedure that includes an electronic device that stimulates both right and left cardiac ventricles to improve coordination of ventricular contraction. Cardiac Resynchronization Therapy A procedure performed during a percutaneous coronary intervention in which a device is deployed into the lumen of a coronary artery to expand and support the vessel wall such that the vessel remains patent and blood flow is uninhibited. Cardiac Stent Placement Heart Transplant A surgical procedure in which a damaged heart is removed and replaced by another heart from a suitable donor. Heart Transplantation CHEMICAL CARDIOVERSION The administration of pharmacologic agents to correct abnormal heart rhythm. Chemical Cardioversion ELECTRICAL CARDIOVERSION The administration of electric current to correct abnormal heart rhythm. Electric Cardioversion A surgical procedure to remove the clouded lens from the eye, and oftentimes replace it with an artificial lens. Cataract Surgery The use of synthetic or naturally-occurring chemicals for the treatment of diseases. Chemotherapy Surgical removal of the gallbladder. Cholecystectomy Endoscopic examination of the luminal surface of the colon. Colonoscopy CPAP Ventilation A type of non-invasive mechanical ventilation procedure that uses continuous positive airway pressure to support spontaneous breathing activity. Continuous Positive Airway Pressure A type of ECG gated MRI in which the images are enhanced by the addition of contrast agents into the body. Contrast Enhanced ECG Gated MRI Aortocoronary Bypass CAB CABG Coronary Artery Bypass Coronary Artery Bypass Graft Coronary Artery Bypass Graft Surgery Coronary Artery Bypass Grafting Heart Bypass A procedure performed to bypass partially or completely occluded coronary arteries with veins and/or arteries harvested from elsewhere in the body, thereby improving the blood supply to the coronary circulation supplying the myocardium (heart muscle). Coronary Artery Bypass Surgery Removal, separation, detachment, extirpation or eradication of a body part, pathway or function by freezing. (NCI) Cryosurgery The therapeutic use of cold or refrigeration. Cryotherapy CAT Scan Computed Axial Tomography Computed Tomography Computerized Tomography CT An imaging technique for examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis. Computed Tomography The removal of tissue with a curette (a spoon-shaped instrument with a sharp edge). Curettage Procedure A type of digital fundus photography that makes use of a significantly wider viewing angle than traditional fundus photography. Digital Wide Field Fundus Photography A type of ECG gated MRI in which the images are not enhanced by the addition of contrast agents into the body. ECG Gated MRI Without Contrast A type of magnetic resonance imaging in which data is acquired during a specified portion of the cardiac cycle, allowing for the collection of stop motion imaging of the heart. ECG Gated MRI A procedure for destroying tissue using an electrical current. Electrocauterization Excision of an atheromatous plaque. (NCI) Endarterectomy EGD Upper Endoscopy An endoscopic procedure that visualizes the upper part of the gastrointestinal tract up to and including the duodenum. Esophagogastroduodenoscopy The act of cutting out; the surgical removal of part or all of a structure or organ. (NCI) Excision Celiotomy Creation of a surgical opening into the abdominal cavity for examination of the contents of the abdominal cavity as a means of diagnosis. Exploratory Laparotomy A type of radiation therapy in which high-energy beams are delivered to the tumor from outside of the body. External Beam Radiation Therapy The use of an adsorbing hemofilter in an external blood purification device to reduce cytokine levels in the blood. Extracorporeal Cytokine Adsorption Hemofiltration ECMO A technique that utilizes a device to pump a patient's blood outside of the body, oxygenate it, and return it to the body. Extracorporeal Membrane Oxygenation Heart Valve Surgery Any surgical procedure performed for the purpose of repairing or replacing a degenerated, calcified, malformed, or dysfunctional heart valve. Cardiac Valve Procedure A therapeutic procedure that involves the transplantation of hematopoietic stem cells, either with the patient as their own donor or from a donor to a patient. Hematopoietic Cell Transplantation A therapeutic procedure involving the extracorporeal removal of harmful waste and fluids from the blood using a dialysis machine. Following dialysis, the blood is returned to the body. Hemodialysis A mechanical fluid removal technique that involves the pressure-driven movement of plasma water and solutes from whole blood through a system of extracorporeal filters, with simultaneous reinfusion of replacement fluid into the body to keep volume homeostasis. Hemofiltration A type of brachytherapy that targets a cancerous tissue with high doses of radiation through the use of inserted temporary implants. High-Dose Rate Brachytherapy HFNC Oxygen Therapy The delivery of heated, humidified, oxygen-enriched gas via nasal cannula at flow rates greater than those typically delivered by standard-flow oxygen devices. High-Flow Nasal Cannula Oxygen Therapy An electrocardiographic method for collecting continuous ECG waveforms with a variable number of discrete leads with duration longer than the standard 10 second ECG. Holter recording may be performed in patients who are ambulatory, and may collect data for 24 hours or longer. Holter Monitoring A therapy designed to induce changes in a patient's immune status. Immunotherapy Implantable Cardioverter Defibrillator Procedure A procedure involving an electronic device implanted in the body that delivers electrical stimulation to the heart to treat tachycardia. It may also have the capability to treat bradycardia. Implantable Cardioverter-Defibrillator Placement Infrared Coagulation The use of an intense beam of light, such as a laser, to seal off blood vessels or destroy tissue. (NCI) Infrared Photocoagulation Therapy An advanced form of 3-Dimensional Conformal Radiation Therapy (3D CRT) that involves the use of varying intensities of small radiation beams to produce dosage distributions that are more precise than those possible with 3D CRT. (NCI) Intensity-Modulated Radiation Therapy A type of mechanical circulatory support procedure in which a balloon catheter inserted into the proximal descending aorta is inflated immediately after aortic valve closure in diastole and deflated just before aortic valve opening in systole, with the augmentation of coronary blood flow during diastole increasing coronary blood flow and systemic perfusion. Intra-aortic Balloon Pump Counterpulsation A type of mechanical ventilation procedure that uses an invasive means, such as an endotracheal tube or tracheostomy tube, to deliver oxygenated air into the lungs. Invasive Mechanical Ventilation Lead Procedure A procedure involving one or more wires used for pacemaker or implantable defibrillator devices. Cardiac Lead Procedure The therapeutic blockage of the muscular pouch in the left atrium. Intentional Left Cardiac Atrial Appendage Occlusion Procedure Surgical removal of the left portion of the colon. Left Colectomy LVAD Implantation LVAD Insertion A procedure involving the implantation of a mechanical cardiac pump which receives blood from the left ventricle and delivers it to the aorta. (NCI) Left Ventricular Assist Device Insertion An examination and assessment of the inability of the left ventricle to effectively pump blood to the body. Left Cardiac Ventricular Systolic Dysfunction Evaluation Surgical removal of a lobe of an organ. Lobectomy Any immunotherapy that targets, or is restricted to, a specific anatomical location. Local Immunotherapy Procedure LAR Lower Anterior Rectal Resection Resection of the rectum through an incision in the lower abdomen. Low Anterior Resection A type of brachytherapy that targets a cancerous tissue with low doses of radiation through the use of inserted temporary or permanent implants. Low-Dose Rate Brachytherapy Surgical removal of a discrete mass. Lumpectomy Lymph Node Dissection Lymph Node Excision Surgical removal of the lymph node(s). Lymphadenectomy A procedure that mechanically assists or replaces spontaneous breathing in patients by use of a powered device that forces oxygenated air into or out of the lungs through positive and/or negative pressure. Mechanical Ventilation Surgical removal of metastases. Metastasectomy Microwave Thermotherapy Any therapeutic procedure in which microwave irradiation is used for the purpose of heating and destroying targeted tissue. Microwave Thermotherapy Dilation of the valve between the left atrium and the left ventricle of the heart by inflating a balloon. Mitral Balloon Valvotomy Dilation of the valve between the left atrium and the left ventricle of the heart by use of a surgeon's finger or rigid instrument. Mitral Commissurotomy Surgery performed for the purpose of reducing regurgitation of the mitral valve. Mitral Valve Repair Surgery performed with the purpose of replacing a degenerated, calcified, malformed, dysfunctional, etc. mitral valve with bioprosthetic, homograft or autograft valve. Mitral Valve Replacement Surgical removal of one or both breasts, including the areola, nipple, and the majority of the axillary lymph nodes, but sparing the pectoralis major muscle. Modified Radical Mastectomy A dermatologic procedure used to treat certain forms of skin cancer in which tissue is removed and immediately tested via frozen section; tissue continues to be removed until clear margins are achieved. Mohs Surgery Magnetic Resonance Imaging MRIs sMRI Structural MRI Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders. Magnetic Resonance Imaging Gated Heart Pool Scan Radionuclide Ventriculogram Scan Radionuclide Ventriculography RNV Scan A multi-gated acquisition (MUGA) scan and a form of radionuclide imaging that provides a comprehensive look at blood flow and the function of the lower chambers of the heart ventricles. Multigated Acquisition Scan An operative procedure that does not involve the heart or the blood vessels. Non-Cardiovascular Surgery NIV Non-Invasive Ventilation A type of mechanical ventilation procedure that uses a non-invasive means, such as a face mask or nasal mask, to deliver oxygenated air into the lungs. Non-Invasive Mechanical Ventilation Pacemaker Procedure A procedure involving an electronic device that delivers electrical stimulation to the heart to treat bradycardia. Pacemaker Procedure Placement of a stent within the pancreas. Pancreatic Stent Placement Kausch-Whipple Procedure Pancreatoduodenectomy Whipple Procedure Surgical removal of the head of the pancreas, the first part of the small intestine (duodenum), the gallbladder and the bile duct. (Mayo Clinic) Whipple Procedure A biospecimen collection and staining procedure in which secretions and superficial cells of the cervix are collected and stained with the Papanicolaou stain followed by microscopic examination to identify the presence of abnormal cells. Pap Smear Surgical removal of part of the pancreas. Partial Pancreatectomy PCI A percutaneous coronary intervention (PCI) is the placement of an angioplasty guide wire, balloon, or other device (e.g. stent, atherectomy, brachytherapy, or thrombectomy catheter) into a native coronary artery or coronary artery bypass graft for the purpose of mechanical coronary revascularization. Examples of things not considered to be PCI procedures include intravascular ultrasound, measurements of coronary flow reserve, or measurements of fractional flow reserve. Percutaneous Coronary Intervention Invasive procedure through a puncture in the skin, performed for the purpose of reducing regurgitation of the mitral valve. Percutaneous Mitral Valve Repair PVAD Insertion PVAD Placement A minimally invasive procedure in which a catheter is inserted into the femoral artery or vein in order to temporarily connect a mechanical circulatory support device that is worn outside the body to the circulatory system. Percutaneous Ventricular Assist Device Placement Removal or resection of the pericardium. Pericardial Stripping A procedure in which an opening is made in the pericardium. Pericardial Window Procedure The aspiration of excess fluid between the pericardium and the heart. Pericardiocentesis A therapeutic procedure that involves the transplantation of stem cells harvested from the circulating blood of a patient or donor. Peripheral Blood Stem Cell Transplantation PVI A peripheral vascular intervention is a catheter-based or open surgical procedure designed to improve arterial or venous blood flow or otherwise modify or revise vascular conduits. In general, the intention to perform percutaneous vascular intervention is denoted by the insertion of a guide wire into an artery or vein. For the sake of simplicity, this definition applies to the extracranial carotid artery and other non-cardiac arteries and veins, while it excludes the lymphatics and intracranial vessels. Peripheral Vascular Intervention Blood Draw Venipuncture The collection of blood from a vein, most commonly via needle venipuncture. Phlebotomy PDT Use of light and photosensitizing agents to treat cancer and other conditions. Photodynamic Therapy The process by which an image is acquired by recording light emissions. Photography The treatment of a disorder by exposure to light, including ultraviolet and infrared radiation. (Bartleby.com) Phototherapy Physical Exam A systemic evaluation of the body and its functions using visual inspection, palpation, percussion and auscultation. Physical Examination The surgical removal of all or part of the pleura. (NCI) Pleurectomy A therapeutic surgical procedure in which the pleural space is surgically eliminated by the adherence of the visceral and parietal pleurae. (NCI) Pleurodesis Surgical removal of a polypoid lesion from the mucosal surface. Polypectomy PAP Therapy Any type of non-invasive mechanical ventilation procedure that uses positive airway pressure to support spontaneous breathing activity. Positive Airway Pressure Therapies Surgery performed with the purpose of replacing a degenerated, calcified, malformed, dysfunctional, etc. pulmonary valve with bioprosthetic, homograft or autograft valve. Pulmonary Valve Replacement Dilation of the valve between the right ventricle and the pulmonary artery of the heart by inflating a balloon. Pulmonic Valvuloplasty A procedure to block the lacrimal puncta and prevent tear drainage, either manually or with a device. Punctal Occlusion The surgical removal of the entire bladder, a portion of the urethra, adjacent lymph nodes, and additional genitourinary structures, including the prostate and a portion of the vas deferens in men, and the ovaries, fallopian tubes, uterus, and a portion of the vagina in women. Radical Cystectomy Surgical removal of one or both breasts, including the areola, nipple, axillary lymph nodes, and pectoral muscles. Radical Mastectomy Radiation Therapy Radiotherapy Use of targeted or whole body radiation to treat a disease. Radiation Therapy Surgical removal of a structure or organ, which was not completely removed in an earlier attempt. Re-Excision Surgical restoration of form and/or function of a body part. Reconstructive Surgery RRT Any of the procedures used to supplement or substitute for the blood-filtering function of the kidneys. Renal Replacement Therapy Surgical removal of the right portion of the colon. Right Colectomy RVAD Implantation RVAD Insertion A procedure involving the implantation of a mechanical pump which receives blood from the right ventricle and delivers it to the pulmonary artery. Right Ventricular Assist Device Insertion Gamma Scan An imaging technique that uses a small dose of a radioactive chemical (isotope) called a tracer that can detect sites of cancer growth, trauma, infection or degenerative disorders. The tracer, which is either injected into a vein or swallowed, travels through the bloodstream to the target organ, and emits gamma rays, which are detected by a gamma camera and analyzed by a computer to form an image of the target organ. (NCI) Radionuclide Imaging Segmental Resection Surgical removal of a segment of an organ or partial resection of a gland. Segmentectomy Surgical removal and examination of the lymph node which is first in receiving the lymphatic drainage of a specified anatomic location. Sentinel Lymph Node Biopsy A cardiac catheterization procedure to relieve symptoms in patients with severe obstructive hypertrophic cardiomyopathy. A catheter is used to inject alcohol into a septal artery supplying the heart muscle responsible for the obstruction, destroying the muscle tissue and relieving the obstruction. Septal Ablation Surgical removal of thin slices of tissue from a structure or organ, done with a razor blade or scalpel. Shave Excision Surgical removal of the sigmoid colon. Sigmoidectomy A dual-modality imaging technique that merges data from single-photon emission computed tomography (SPECT) and computed tomography (CT) to provide structural and functional information. Single Photon Tomography and Computed Tomography Scan Suction Blistering The creation of an artificially induced skin blister by the application of mechanical pressure to an area of skin, causing in vivo separation of the epidermis and dermis. Suction Blister Technique Cox Maze A cardiac procedure intended to inhibit atrial fibrillation, in which a series of incisions are made in the atria to block abnormal electrical circuits that contribute to atrial fibrillation. Surgical Maze Procedure The removal of excess fluid via needle puncture from the thoracic cavity. Thoracentesis TWR A minimally invasive surgical procedure in which video-assisted thoracoscopy is used to remove of a wedge-shaped portion of tissue from a lung lobe. Thorascopic Wedge Resection of the Lung Surgical removal of the entire colon. Total Colectomy Surgical removal of the entire pancreas. Total Pancreatectomy Tracheotomy Creation of a surgical opening into the trachea. Tracheotomy Transcatheter Aortic Valve Implantation Use of a thin tube to deliver an artificial valve apparatus between the left ventricle of the heart and the aorta. Transcatheter Aortic Valve Implantation TIPS Placement An interventional radiologic procedure in which a shunt is placed in the liver to establish communication between the portal vein and hepatic vein for the treatment of portal hypertension. Transjugular Intrahepatic Portosystemic Shunt TTE A non-invasive cardiac ultrasound performed by placing the transducer on the chest. Transthoracic Echocardiography Test TURBT A surgical procedure in which a resectoscope is passed through the urethra into the bladder to diagnose and remove all or part of a bladder tumor. Transurethral Resection of Bladder Tumor Surgical removal of the transverse colon. Transverse Colectomy Surgery performed for the purpose of reducing regurgitation of the cardiac valve between the right atrium and right ventricle. Cardiac Tricuspid Valve Repair Surgery performed with the purpose of replacing a degenerated, calcified, malformed, dysfunctional, etc. tricuspid valve with bioprosthetic, homograft or autograft valve. Tricuspid Valve Replacement A therapeutic procedure that involves the transplantation of hematopoietic stem cells collected from the umbilical cord or placenta. Umbilical Cord Blood Transplantation Cardiac surgical procedure performed for the removal of an aneurysm from the ventricular wall. Ventricular Aneurysm Resection Repair of ventricular septum. Closure of Cardiac Ventricle Septum Static X-Ray A radiographic procedure using the emission of x-rays, a type of penetrating energy wave. X-Ray Imaging PROCEDUR Procedure CDISC SDTM Procedure Terminology A terminology codelist that describes the degree of urgency for a procedure. Elective procedures can be deferred without increased risk of compromised outcome. Patient's clinical condition is currently stable and has been stable in the days/weeks prior. The clinical situation does not demand that the procedure take place at a specified time. Elective Surgical Procedure Emergency procedures must be performed as soon as possible because of substantial concerns that delay could lead to death. Clinical situation demands that procedure should be performed immediately or in next available room, even if it means another case must be rescheduled. Emergency Performing a salvage procedure is the last resort. The clinical situation involves either ongoing life support measures, life support measures for more than 60 seconds during the prior 10 minutes, or unanticipated institution of extracorporeal circulatory support. Salvage Therapy Deferring an urgent procedure increases risk of adverse outcome or clinical deterioration. Clinical situation warrants performing urgent procedures during the current episode of care to avoid compromising patient safety. Urgent Procedure PRURGNCY Procedure Urgency Status CDISC SDTM Procedure Urgency Status Terminology PROMIS Item Bank v1.0 - Fatigue - Short Form 7a test code. PA136-Often Feel Tired PROMIS Item Bank v1.0 - Fatigue - Short Form 7a - How often did you feel tired? PROMIS IB Version 1.0 Fatigue SF 7a - Often Feel Tired PA136-Often Extreme Exhaustion PROMIS Item Bank v1.0 - Fatigue - Short Form 7a - How often did you experience extreme exhaustion? PROMIS IB Version 1.0 Fatigue SF 7a - Often Extreme Exhaustion PA136-Often Run Out of Energy PROMIS Item Bank v1.0 - Fatigue - Short Form 7a - How often did you run out of energy? PROMIS IB Version 1.0 Fatigue SF 7a - Often Run Out of Energy PA136-Often Fatigue Limit You at Work PROMIS Item Bank v1.0 - Fatigue - Short Form 7a - How often did your fatigue limit you at work (include work at home)? PROMIS IB Version 1.0 Fatigue SF 7a - Often Fatigue Limit You at Work PA136-Often Too Tired to Think Clearly PROMIS Item Bank v1.0 - Fatigue - Short Form 7a - How often were you too tired to think clearly? PROMIS IB Version 1.0 Fatigue SF 7a - Often Too Tired to Think Clearly PA136-Often Too Tired Take Bath/Shower PROMIS Item Bank v1.0 - Fatigue - Short Form 7a - How often were you too tired to take a bath or shower? PROMIS IB Version 1.0 Fatigue SF 7a - Often Too Tired Take Bath or Shower PA136-Often Energy Exercise Strenuously PROMIS Item Bank v1.0 - Fatigue - Short Form 7a - How often did you have enough energy to exercise strenuously? PROMIS IB Version 1.0 Fatigue SF 7a - Often Energy Exercise Strenuously PA136TC PROMIS Item Bank v1.0 - Fatigue - Short Form 7a Questionnaire Test Code CDISC Questionnaire PROMIS Item Bank Version 1.0 Fatigue Short Form 7a Test Code Terminology PROMIS Item Bank v1.0 - Fatigue - Short Form 7a test name. PA136-Often Energy Exercise Strenuously PROMIS Item Bank v1.0 - Fatigue - Short Form 7a - How often did you have enough energy to exercise strenuously? PROMIS IB Version 1.0 Fatigue SF 7a - Often Energy Exercise Strenuously PA136-Often Extreme Exhaustion PROMIS Item Bank v1.0 - Fatigue - Short Form 7a - How often did you experience extreme exhaustion? PROMIS IB Version 1.0 Fatigue SF 7a - Often Extreme Exhaustion PA136-Often Fatigue Limit You at Work PROMIS Item Bank v1.0 - Fatigue - Short Form 7a - How often did your fatigue limit you at work (include work at home)? PROMIS IB Version 1.0 Fatigue SF 7a - Often Fatigue Limit You at Work PA136-Often Feel Tired PROMIS Item Bank v1.0 - Fatigue - Short Form 7a - How often did you feel tired? PROMIS IB Version 1.0 Fatigue SF 7a - Often Feel Tired PA136-Often Run Out of Energy PROMIS Item Bank v1.0 - Fatigue - Short Form 7a - How often did you run out of energy? PROMIS IB Version 1.0 Fatigue SF 7a - Often Run Out of Energy PA136-Often Too Tired Take Bath/Shower PROMIS Item Bank v1.0 - Fatigue - Short Form 7a - How often were you too tired to take a bath or shower? PROMIS IB Version 1.0 Fatigue SF 7a - Often Too Tired Take Bath or Shower PA136-Often Too Tired to Think Clearly PROMIS Item Bank v1.0 - Fatigue - Short Form 7a - How often were you too tired to think clearly? PROMIS IB Version 1.0 Fatigue SF 7a - Often Too Tired to Think Clearly PA136TN PROMIS Item Bank v1.0 - Fatigue - Short Form 7a Questionnaire Test Name CDISC Questionnaire PROMIS Item Bank Version 1.0 Fatigue Short Form 7a Test Name Terminology PROMIS Item Bank v1.0 - Sleep Disturbance - Short Form 4a test code. PA215-My Sleep Quality Was PROMIS Item Bank v1.0 - Sleep Disturbance - Short Form 4a - My sleep quality was. PROMIS IB Version 1.0 Sleep Disturbance SF 4a - My Sleep Quality Was PA215-My Sleep Was Refreshing PROMIS Item Bank v1.0 - Sleep Disturbance - Short Form 4a - My sleep was refreshing. PROMIS IB Version 1.0 Sleep Disturbance SF 4a - My Sleep Was Refreshing PA215-I Had a Problem With My Sleep PROMIS Item Bank v1.0 - Sleep Disturbance - Short Form 4a - I had a problem with my sleep. PROMIS IB Version 1.0 Sleep Disturbance SF 4a - I Had a Problem With My Sleep PA215-I Had Difficulty Falling Asleep PROMIS Item Bank v1.0 - Sleep Disturbance - Short Form 4a - I had difficulty falling asleep. PROMIS IB Version 1.0 Sleep Disturbance SF 4a - I Had Difficulty Falling Asleep PA215TC PROMIS Item Bank v1.0 - Sleep Disturbance - Short Form 4a Questionnaire Test Code CDISC Questionnaire PROMIS Item Bank v1.0 - Sleep Disturbance - Short Form 4a Test Code Terminology PROMIS Item Bank v1.0 - Sleep Disturbance - Short Form 4a test name. PA215-I Had a Problem With My Sleep PROMIS Item Bank v1.0 - Sleep Disturbance - Short Form 4a - I had a problem with my sleep. PROMIS IB Version 1.0 Sleep Disturbance SF 4a - I Had a Problem With My Sleep PA215-I Had Difficulty Falling Asleep PROMIS Item Bank v1.0 - Sleep Disturbance - Short Form 4a - I had difficulty falling asleep. PROMIS IB Version 1.0 Sleep Disturbance SF 4a - I Had Difficulty Falling Asleep PA215-My Sleep Quality Was PROMIS Item Bank v1.0 - Sleep Disturbance - Short Form 4a - My sleep quality was. PROMIS IB Version 1.0 Sleep Disturbance SF 4a - My Sleep Quality Was PA215-My Sleep Was Refreshing PROMIS Item Bank v1.0 - Sleep Disturbance - Short Form 4a - My sleep was refreshing. PROMIS IB Version 1.0 Sleep Disturbance SF 4a - My Sleep Was Refreshing PA215TN PROMIS Item Bank v1.0 - Sleep Disturbance - Short Form 4a Questionnaire Test Name CDISC Questionnaire PROMIS Item Bank v1.0 - Sleep Disturbance - Short Form 4a Test Name Terminology PROMIS Item Bank v2.0 - Cognitive Function - Abilities Subset - Short Form 6a test code. PA020-My Mind Has Been as Sharp as Usual PROMIS Item Bank v2.0 - Cognitive Function - Abilities Subset - Short Form 6a - My mind has been as sharp as usual. PROMIS IB Version 2.0 Cognitive Function Abilities Subset SF 6a - My Mind Has Been as Sharp as Usual PA020-Memory Has Been as Good as Usual PROMIS Item Bank v2.0 - Cognitive Function - Abilities Subset - Short Form 6a - My memory has been as good as usual. PROMIS IB Version 2.0 Cognitive Function Abilities Subset SF 6a - Memory Has Been as Good as Usual PA020-Thinking Has Been as Fast as Usual PROMIS Item Bank v2.0 - Cognitive Function - Abilities Subset - Short Form 6a - My thinking has been as fast as usual. PROMIS IB Version 2.0 Cognitive Function Abilities Subset SF 6a - Thinking Has Been as Fast as Usual PA020-Keep Track Even If Interrupted PROMIS Item Bank v2.0 - Cognitive Function - Abilities Subset - Short Form 6a - I have been able to keep track of what I am doing, even if I am interrupted. PROMIS IB Version 2.0 Cognitive Function Abilities Subset SF 6a - Keep Track Even If Interrupted PA020-I Have Been Able to Concentrate PROMIS Item Bank v2.0 - Cognitive Function - Abilities Subset - Short Form 6a - I have been able to concentrate. PROMIS IB Version 2.0 Cognitive Function Abilities Subset SF 6a - I Have Been Able to Concentrate PA020-Think Clearly Without Extra Effort PROMIS Item Bank v2.0 - Cognitive Function - Abilities Subset - Short Form 6a - I have been able to think clearly without extra effort. PROMIS IB Version 2.0 Cognitive Function Abilities Subset SF 6a - Think Clearly Without Extra Effort PA020TC PROMIS Item Bank v2.0 - Cognitive Function - Abilities Subset - Short Form 6a Questionnaire Test Code CDISC Questionnaire PROMIS Item Bank v2.0 - Cognitive Function - Abilities Subset - Short Form 6a Test Code Terminology PROMIS Item Bank v2.0 - Cognitive Function - Abilities Subset - Short Form 6a test name. PA020-I Have Been Able to Concentrate PROMIS Item Bank v2.0 - Cognitive Function - Abilities Subset - Short Form 6a - I have been able to concentrate. PROMIS IB Version 2.0 Cognitive Function Abilities Subset SF 6a - I Have Been Able to Concentrate PA020-Keep Track Even If Interrupted PROMIS Item Bank v2.0 - Cognitive Function - Abilities Subset - Short Form 6a - I have been able to keep track of what I am doing, even if I am interrupted. PROMIS IB Version 2.0 Cognitive Function Abilities Subset SF 6a - Keep Track Even If Interrupted PA020-Memory Has Been as Good as Usual PROMIS Item Bank v2.0 - Cognitive Function - Abilities Subset - Short Form 6a - My memory has been as good as usual. PROMIS IB Version 2.0 Cognitive Function Abilities Subset SF 6a - Memory Has Been as Good as Usual PA020-My Mind Has Been as Sharp as Usual PROMIS Item Bank v2.0 - Cognitive Function - Abilities Subset - Short Form 6a - My mind has been as sharp as usual. PROMIS IB Version 2.0 Cognitive Function Abilities Subset SF 6a - My Mind Has Been as Sharp as Usual PA020-Think Clearly Without Extra Effort PROMIS Item Bank v2.0 - Cognitive Function - Abilities Subset - Short Form 6a - I have been able to think clearly without extra effort. PROMIS IB Version 2.0 Cognitive Function Abilities Subset SF 6a - Think Clearly Without Extra Effort PA020-Thinking Has Been as Fast as Usual PROMIS Item Bank v2.0 - Cognitive Function - Abilities Subset - Short Form 6a - My thinking has been as fast as usual. PROMIS IB Version 2.0 Cognitive Function Abilities Subset SF 6a - Thinking Has Been as Fast as Usual PA020TN PROMIS Item Bank v2.0 - Cognitive Function - Abilities Subset - Short Form 6a Questionnaire Test Name CDISC Questionnaire PROMIS Item Bank v2.0 - Cognitive Function - Abilities Subset - Short Form 6a Test Name Terminology PROMIS Item Bank v2.0 - Cognitive Function - Short Form 6a test code. PA016-My Thinking Has Been Slow PROMIS Item Bank v2.0 - Cognitive Function - Short Form 6a - My thinking has been slow. PROMIS IB Version 2.0 Cognitive Function SF 6a - My Thinking Has Been Slow PA016-Brain Not Working as Well as Usual PROMIS Item Bank v2.0 - Cognitive Function - Short Form 6a - It has seemed like my brain was not working as well as usual. PROMIS IB Version 2.0 Cognitive Function SF 6a - Brain Not Working as Well as Usual PA016-Had to Work Harder to Keep Track PROMIS Item Bank v2.0 - Cognitive Function - Short Form 6a - I have had to work harder than usual to keep track of what I was doing. PROMIS IB Version 2.0 Cognitive Function SF 6a - Had to Work Harder to Keep Track PA016-Trouble Shift Activities Thinking PROMIS Item Bank v2.0 - Cognitive Function - Short Form 6a - I have had trouble shifting back and forth between different activities that require thinking. PROMIS IB Version 2.0 Cognitive Function SF 6a - Trouble Shift Activities Thinking PA016-Had Trouble Concentrating PROMIS Item Bank v2.0 - Cognitive Function - Short Form 6a - I have had trouble concentrating. PROMIS IB Version 2.0 Cognitive Function SF 6a - Had Trouble Concentrating PA016-Work Hard Pay Attention or Mistake PROMIS Item Bank v2.0 - Cognitive Function - Short Form 6a - I have had to work really hard to pay attention or I would make a mistake. PROMIS IB Version 2.0 Cognitive Function SF 6a - Work Hard Pay Attention or Mistake PA016TC PROMIS Item Bank v2.0 - Cognitive Function - Short Form 6a Questionnaire Test Code CDISC Questionnaire PROMIS Item Bank Version 2.0 Cognitive Function Short Form 6a Test Code Terminology PROMIS Item Bank v2.0 - Cognitive Function - Short Form 6a test name. PA016-Brain Not Working as Well as Usual PROMIS Item Bank v2.0 - Cognitive Function - Short Form 6a - It has seemed like my brain was not working as well as usual. PROMIS IB Version 2.0 Cognitive Function SF 6a - Brain Not Working as Well as Usual PA016-Had to Work Harder to Keep Track PROMIS Item Bank v2.0 - Cognitive Function - Short Form 6a - I have had to work harder than usual to keep track of what I was doing. PROMIS IB Version 2.0 Cognitive Function SF 6a - Had to Work Harder to Keep Track PA016-Had Trouble Concentrating PROMIS Item Bank v2.0 - Cognitive Function - Short Form 6a - I have had trouble concentrating. PROMIS IB Version 2.0 Cognitive Function SF 6a - Had Trouble Concentrating PA016-My Thinking Has Been Slow PROMIS Item Bank v2.0 - Cognitive Function - Short Form 6a - My thinking has been slow. PROMIS IB Version 2.0 Cognitive Function SF 6a - My Thinking Has Been Slow PA016-Trouble Shift Activities Thinking PROMIS Item Bank v2.0 - Cognitive Function - Short Form 6a - I have had trouble shifting back and forth between different activities that require thinking. PROMIS IB Version 2.0 Cognitive Function SF 6a - Trouble Shift Activities Thinking PA016-Work Hard Pay Attention or Mistake PROMIS Item Bank v2.0 - Cognitive Function - Short Form 6a - I have had to work really hard to pay attention or I would make a mistake. PROMIS IB Version 2.0 Cognitive Function SF 6a - Work Hard Pay Attention or Mistake PA016TN PROMIS Item Bank v2.0 - Cognitive Function - Short Form 6a Questionnaire Test Name CDISC Questionnaire PROMIS Item Bank Version 2.0 Cognitive Function Short Form 6a Test Name Terminology PROMIS-29 Profile v2.1 test code. PA261-Able Do Chores Such as Vacuuming PROMIS-29 Profile v2.1 - Are you able to do chores such as vacuuming or yard work? PROMIS-29 Profile Version 2.1 - Able Do Chores Such as Vacuuming PA261-Able Up & Down Stairs Normal Pace PROMIS-29 Profile v2.1 - Are you able to go up and down stairs at a normal pace? PROMIS-29 Profile Version 2.1 - Able Up and Down Stairs Normal Pace PA261-Able Walk at Least 15 Minutes PROMIS-29 Profile v2.1 - Are you able to go for a walk of at least 15 minutes? PROMIS-29 Profile Version 2.1 - Able Walk at Least 15 Minutes PA261-Able to Run Errands and Shop PROMIS-29 Profile v2.1 - Are you able to run errands and shop? PROMIS-29 Profile Version 2.1 - Able to Run Errands and Shop PA261-I Felt Fearful PROMIS-29 Profile v2.1 - I felt fearful. PROMIS-29 Profile Version 2.1 - I Felt Fearful PA261-Hard Focus Anything Other Anxiety PROMIS-29 Profile v2.1 - I found it hard to focus on anything other than my anxiety. PROMIS-29 Profile Version 2.1 - Hard Focus Anything Other Anxiety PA261-My Worries Overwhelmed Me PROMIS-29 Profile v2.1 - My worries overwhelmed me. PROMIS-29 Profile Version 2.1 - My Worries Overwhelmed Me PA261-I Felt Uneasy PROMIS-29 Profile v2.1 - I felt uneasy. PROMIS-29 Profile Version 2.1 - I Felt Uneasy PA261-I Felt Worthless PROMIS-29 Profile v2.1 - I felt worthless. PROMIS-29 Profile Version 2.1 - I Felt Worthless PA261-I Felt Helpless PROMIS-29 Profile v2.1 - I felt helpless. PROMIS-29 Profile Version 2.1 - I Felt Helpless PA261-I Felt Depressed PROMIS-29 Profile v2.1 - I felt depressed. PROMIS-29 Profile Version 2.1 - I Felt Depressed PA261-I Felt Hopeless PROMIS-29 Profile v2.1 - I felt hopeless. PROMIS-29 Profile Version 2.1 - I Felt Hopeless PA261-I Feel Fatigued PROMIS-29 Profile v2.1 - I feel fatigued. PROMIS-29 Profile Version 2.1 - I Feel Fatigued PA261-Trouble Starting Things I Am Tired PROMIS-29 Profile v2.1 - I have trouble starting things because I am tired. PROMIS-29 Profile Version 2.1 - Trouble Starting Things I Am Tired PA261-How Run-down Feel on Average PROMIS-29 Profile v2.1 - How run-down did you feel on average? PROMIS-29 Profile Version 2.1 - How Run-down Feel on Average PA261-How Fatigued on Average PROMIS-29 Profile v2.1 - How fatigued were you on average? PROMIS-29 Profile Version 2.1 - How Fatigued on Average PA261-My Sleep Quality Was PROMIS-29 Profile v2.1 - My sleep quality was. PROMIS-29 Profile Version 2.1 - My Sleep Quality Was PA261-My Sleep Was Refreshing PROMIS-29 Profile v2.1 - My sleep was refreshing. PROMIS-29 Profile Version 2.1 - My Sleep Was Refreshing PA261-I Had a Problem With My Sleep PROMIS-29 Profile v2.1 - I had a problem with my sleep. PROMIS-29 Profile Version 2.1 - I Had a Problem With My Sleep PA261-I Had Difficulty Falling Asleep PROMIS-29 Profile v2.1 - I had difficulty falling asleep. PROMIS-29 Profile Version 2.1 - I Had Difficulty Falling Asleep PA261-Trouble Leisure Activities Others PROMIS-29 Profile v2.1 - I have trouble doing all of my regular leisure activities with others. PROMIS-29 Profile Version 2.1 - Trouble Leisure Activities Others PA261-Trouble Doing Family Activities PROMIS-29 Profile v2.1 - I have trouble doing all of the family activities that I want to do. PROMIS-29 Profile Version 2.1 - Trouble Doing Family Activities PA261-Trouble Doing All of My Usual Work PROMIS-29 Profile v2.1 - I have trouble doing all of my usual work (include work at home). PROMIS-29 Profile Version 2.1 - Trouble Doing All of My Usual Work PA261-Trouble Doing Activities Friends PROMIS-29 Profile v2.1 - I have trouble doing all of the activities with friends that I want to do. PROMIS-29 Profile Version 2.1 - Trouble Doing Activities Friends PA261-Pain Interfere Day to Day Activ PROMIS-29 Profile v2.1 - How much did pain interfere with your day to day activities? PROMIS-29 Profile Version 2.1 - Pain Interfere Day to Day Activ PA261-Pain Interfere Work Around Home PROMIS-29 Profile v2.1 - How much did pain interfere with work around the home? PROMIS-29 Profile Version 2.1 - Pain Interfere Work Around Home PA261-Pain Interfere Participate Social PROMIS-29 Profile v2.1 - How much did pain interfere with your ability to participate in social activities? PROMIS-29 Profile Version 2.1 - Pain Interfere Participate Social PA261-Pain Interfere Household Chores PROMIS-29 Profile v2.1 - How much did pain interfere with your household chores? PROMIS-29 Profile Version 2.1 - Pain Interfere Household Chores PA261-How You Rate Your Pain on Average PROMIS-29 Profile v2.1 - How would you rate your pain on average? PROMIS-29 Profile Version 2.1 - How You Rate Your Pain on Average PA261TC PROMIS-29 Profile v2.1 Questionnaire Test Code CDISC Questionnaire PROMIS-29 Profile Version 2.1 Test Code Terminology PROMIS-29 Profile v2.1 test name. PA261-Able Do Chores Such as Vacuuming PROMIS-29 Profile v2.1 - Are you able to do chores such as vacuuming or yard work? PROMIS-29 Profile Version 2.1 - Able Do Chores Such as Vacuuming PA261-Able to Run Errands and Shop PROMIS-29 Profile v2.1 - Are you able to run errands and shop? PROMIS-29 Profile Version 2.1 - Able to Run Errands and Shop PA261-Able Up & Down Stairs Normal Pace PROMIS-29 Profile v2.1 - Are you able to go up and down stairs at a normal pace? PROMIS-29 Profile Version 2.1 - Able Up and Down Stairs Normal Pace PA261-Able Walk at Least 15 Minutes PROMIS-29 Profile v2.1 - Are you able to go for a walk of at least 15 minutes? PROMIS-29 Profile Version 2.1 - Able Walk at Least 15 Minutes PA261-Hard Focus Anything Other Anxiety PROMIS-29 Profile v2.1 - I found it hard to focus on anything other than my anxiety. PROMIS-29 Profile Version 2.1 - Hard Focus Anything Other Anxiety PA261-How Fatigued on Average PROMIS-29 Profile v2.1 - How fatigued were you on average? PROMIS-29 Profile Version 2.1 - How Fatigued on Average PA261-How Run-down Feel on Average PROMIS-29 Profile v2.1 - How run-down did you feel on average? PROMIS-29 Profile Version 2.1 - How Run-down Feel on Average PA261-How You Rate Your Pain on Average PROMIS-29 Profile v2.1 - How would you rate your pain on average? PROMIS-29 Profile Version 2.1 - How You Rate Your Pain on Average PA261-I Feel Fatigued PROMIS-29 Profile v2.1 - I feel fatigued. PROMIS-29 Profile Version 2.1 - I Feel Fatigued PA261-I Felt Depressed PROMIS-29 Profile v2.1 - I felt depressed. PROMIS-29 Profile Version 2.1 - I Felt Depressed PA261-I Felt Fearful PROMIS-29 Profile v2.1 - I felt fearful. PROMIS-29 Profile Version 2.1 - I Felt Fearful PA261-I Felt Helpless PROMIS-29 Profile v2.1 - I felt helpless. PROMIS-29 Profile Version 2.1 - I Felt Helpless PA261-I Felt Hopeless PROMIS-29 Profile v2.1 - I felt hopeless. PROMIS-29 Profile Version 2.1 - I Felt Hopeless PA261-I Felt Uneasy PROMIS-29 Profile v2.1 - I felt uneasy. PROMIS-29 Profile Version 2.1 - I Felt Uneasy PA261-I Felt Worthless PROMIS-29 Profile v2.1 - I felt worthless. PROMIS-29 Profile Version 2.1 - I Felt Worthless PA261-I Had a Problem With My Sleep PROMIS-29 Profile v2.1 - I had a problem with my sleep. PROMIS-29 Profile Version 2.1 - I Had a Problem With My Sleep PA261-I Had Difficulty Falling Asleep PROMIS-29 Profile v2.1 - I had difficulty falling asleep. PROMIS-29 Profile Version 2.1 - I Had Difficulty Falling Asleep PA261-My Sleep Quality Was PROMIS-29 Profile v2.1 - My sleep quality was. PROMIS-29 Profile Version 2.1 - My Sleep Quality Was PA261-My Sleep Was Refreshing PROMIS-29 Profile v2.1 - My sleep was refreshing. PROMIS-29 Profile Version 2.1 - My Sleep Was Refreshing PA261-My Worries Overwhelmed Me PROMIS-29 Profile v2.1 - My worries overwhelmed me. PROMIS-29 Profile Version 2.1 - My Worries Overwhelmed Me PA261-Pain Interfere Day to Day Activ PROMIS-29 Profile v2.1 - How much did pain interfere with your day to day activities? PROMIS-29 Profile Version 2.1 - Pain Interfere Day to Day Activ PA261-Pain Interfere Household Chores PROMIS-29 Profile v2.1 - How much did pain interfere with your household chores? PROMIS-29 Profile Version 2.1 - Pain Interfere Household Chores PA261-Pain Interfere Participate Social PROMIS-29 Profile v2.1 - How much did pain interfere with your ability to participate in social activities? PROMIS-29 Profile Version 2.1 - Pain Interfere Participate Social PA261-Pain Interfere Work Around Home PROMIS-29 Profile v2.1 - How much did pain interfere with work around the home? PROMIS-29 Profile Version 2.1 - Pain Interfere Work Around Home PA261-Trouble Doing Activities Friends PROMIS-29 Profile v2.1 - I have trouble doing all of the activities with friends that I want to do. PROMIS-29 Profile Version 2.1 - Trouble Doing Activities Friends PA261-Trouble Doing All of My Usual Work PROMIS-29 Profile v2.1 - I have trouble doing all of my usual work (include work at home). PROMIS-29 Profile Version 2.1 - Trouble Doing All of My Usual Work PA261-Trouble Doing Family Activities PROMIS-29 Profile v2.1 - I have trouble doing all of the family activities that I want to do. PROMIS-29 Profile Version 2.1 - Trouble Doing Family Activities PA261-Trouble Leisure Activities Others PROMIS-29 Profile v2.1 - I have trouble doing all of my regular leisure activities with others. PROMIS-29 Profile Version 2.1 - Trouble Leisure Activities Others PA261-Trouble Starting Things I Am Tired PROMIS-29 Profile v2.1 - I have trouble starting things because I am tired. PROMIS-29 Profile Version 2.1 - Trouble Starting Things I Am Tired PA261TN PROMIS-29 Profile v2.1 Questionnaire Test Name CDISC Questionnaire PROMIS-29 Profile Version 2.1 Test Name Terminology A terminology codelist based on the standardized or preprinted name of the protocol deviation that occurs. The adverse drug reaction was not reported within the required timeframe. Adverse Drug Reaction Reported Late The adverse event(s) was not reported within the required timeframe. Adverse Event Reported Late The study assessment(s) was partially performed. Study Assessment Incomplete The study assessment(s) was incorrectly performed. Study Assessment Incorrectly Performed The study assessment(s) was not performed. Study Assessment Not Performed The study assessment(s) was performed outside of the specified timing window. Study Assessment Performed Outside of Timing Window The study device was incorrectly calibrated. Study Device Incorrectly Calibrated Follow-up information for the adverse drug reaction was not reported within the required timeframe. Follow Up for Adverse Drug Reaction Reported Late Follow-up information for the adverse event(s) was not reported within the required timeframe. Follow Up for Adverse Event Reported Late Follow-up information for the pregnancy was not reported within the required timeframe. Follow Up for Pregnancy Reported Late Follow-up information for the serious adverse event(s) was not reported within the required timeframe. Follow up for Serious Adverse Event Reported Late The incorrect dosage regimen for the background medication and/or rescue medication was administered to the subject/participant. Incorrect Dosage Regimen for the Background Medication/Rescue Medication The incorrect dosage regimen for the study intervention was administered to the subject/participant. Incorrect Dosage Regimen For the Study Intervention The actual treatment kit number received and used by the subject/participant did not correspond to the assigned kit number. Incorrect Treatment Kit Used The incorrect route of administration for the background medication and/or rescue medication was administered to the subject/participant. Incorrect Route of Administration for the Background Medication/Rescue Medication The incorrect route of administration for the study intervention was administered to the subject/participant. Incorrect Route of Administration for the Study Intervention The subject/participant received the incorrect study intervention. Incorrect Study Intervention The informed consent form was not signed and/or dated in accordance with local regulatory guidelines. Informed Consent Not Signed/Dated per Local Regulatory Guidelines The informed consent form was signed and/or dated after study procedures were initiated. Informed Consent Signed/Dated After Study Procedures Initiated The subject/participant was non-compliant with the study intervention. Non-compliance with Study Intervention The pregnancy was not reported within the required timeframe. Pregnancy Reported Late The biological sample was incorrectly processed. Biological Sample Incorrectly Processed The serious adverse event(s) was not reported within the required timeframe. Serious Adverse Event Reported Late The study intervention was administered to the subject/participant outside of the planned administration window. Study Intervention Administered Outside the Protocol-Defined Window The subject/participant met one or more exclusion criteria but was still enrolled in the study. Subject Enrolled but Exclusion Criteria Met The subject/participant did not meet one or more inclusion criteria but was still enrolled in the study. Subject Enrolled but Inclusion Criteria Not Met The subject/participant met the withdrawal criteria from study intervention, but continued study intervention. Subject Met Study Intervention Withdrawal Criteria but Was Not Withdrawn The subject/participant met the withdrawal criteria for the study, but remained in the study. Subject Met Study Withdrawal Criteria but Was Not Withdrawn The subject/participant used a prohibited device. Use of Prohibited Device The subject/participant used or took a prohibited medication. Use of Prohibited Medication DVDECOD Protocol Deviations Dictionary Derived Term CDISC SDTM Protocol Deviations Dictionary Derived Term Terminology A terminology codelist relevant to protocol-specified, point-in-time events during a study. An indication that the subject has declined to continue into a subsequent trial Element. Declined to Continue Into Next Trial Element An indication that the subject has declined to continue into the survival follow-up phase of the trial. Declined To Continue Into Survival Follow-Up The subject has fulfilled the criteria needed to enter or continue in the study. Eligibility Criteria Met By Subject The subject has not fulfilled the criteria needed to enter or continue in the study. Did Not Meet Eligibility Criteria The subject has met eligibility criteria and is enrolled in the study. The subject may or may not subsequently be randomized. Subject Entered Into Trial Informed Assent Assent given by a minor or adult who is unable to give informed consent on their own behalf, to participate in a clinical trial. Assent must be accompanied by consent from a parent or legal guardian for full participation in the study. Informed Assent Additional consent denied by a subject or parent/guardian for participation in a specific protocol-specified study activity, but does not indicate denial of consent for general participation in a clinical trial. Informed Consent Declined For Protocol-Specified Activity Additional consent given by a subject or parent/guardian for participation in a specific protocol-specified study activity. Informed Consent Obtained For Protocol-Specified Activity A process that provides the subject with explanations that will help in making decisions about whether to begin or continue participating in a study, after having achieved an understanding of the potential risks and benefits. Informed consent is an ongoing, interactive process rather than a one-time information session. Informed Consent An indication that the subject has opted to continue into a subsequent trial Element. Opted to Continue Into Next Trial Element An indication that the subject has opted to continue into the survival follow-up phase of the trial. Opted To Continue Into Survival Follow-Up Participants are assigned to arms of a clinical trial by chance. Subject is Randomized Participants are re-assigned by chance to arms of a clinical trial. Re-randomized PROTMLST Protocol Milestone CDISC SDTM Protocol Milestone Terminology A terminology codelist of responses relevant to the risk of the protocol-defined activities, procedures, and interventions to the study subjects. The potential future harm that may arise from some present action or attribute or condition is almost certain. High Risk The potential future harm that may arise from some present action or attribute or condition is moderate. Intermediate Risk The potential future harm that may arise from some present action or attribute or condition is small. Low Risk The potential future harm that may arise from some present action or attribute or condition is minimal. Minimal Risk U UNK Unknown Not known, not observed, not recorded, or refused. (NCI) Unknown RSKASMT Protocol Risk Assessment Response CDISC SDTM Protocol Risk Assessment Response Codelist Psoriasis Area and Severity Index Version Bozek test code. PASI05-Head: Erythema/Redness Psoriasis Area and Severity Index Version Bozek - Head: Erythema/Redness score. PASI Bozek Version - Head: Erythema/Redness PASI05-Head: Thickness/Induration Psoriasis Area and Severity Index Version Bozek - Head: Thickness/Induration score. PASI Bozek Version - Head: Thickness/Induration PASI05-Head: Desquamation/Scaling Psoriasis Area and Severity Index Version Bozek - Head: Desquamation/Scaling score. PASI Bozek Version - Head: Desquamation/Scaling PASI05-Head: Area Score Psoriasis Area and Severity Index Version Bozek - Head: Area score. PASI Bozek Version - Head: Area Score PASI05-Up Extrem: Erythema/Redness Psoriasis Area and Severity Index Version Bozek - Upper Extremities: Erythema/Redness score. PASI Bozek Version - Upper Extremities: Erythema/Redness PASI05-Up Extrem: Thickness/Induration Psoriasis Area and Severity Index Version Bozek - Upper Extremities: Thickness/Induration score. PASI Bozek Version - Upper Extremities: Thickness/Induration PASI05-Up Extrem: Desquamation/Scaling Psoriasis Area and Severity Index Version Bozek - Upper Extremities: Desquamation/Scaling score. PASI Bozek Version - Upper Extremities: Desquamation/Scaling PASI05-Up Extrem: Area Score Psoriasis Area and Severity Index Version Bozek - Upper Extremities: Area score. PASI Bozek Version - Upper Extremities: Area Score PASI05-Trunk: Erythema/Redness Psoriasis Area and Severity Index Version Bozek - Trunk: Erythema/Redness score. PASI Bozek Version - Trunk: Erythema/Redness PASI05-Trunk: Thickness/Induration Psoriasis Area and Severity Index Version Bozek - Trunk: Thickness/Induration score. PASI Bozek Version - Trunk: Thickness/Induration PASI05-Trunk: Desquamation/Scaling Psoriasis Area and Severity Index Version Bozek - Trunk: Desquamation/Scaling score. PASI Bozek Version - Trunk: Desquamation/Scaling PASI05-Trunk: Area Score Psoriasis Area and Severity Index Version Bozek - Trunk: Area score. PASI Bozek Version - Trunk: Area Score PASI05-Low Extrem: Erythema/Redness Psoriasis Area and Severity Index Version Bozek - Lower Extremities: Erythema/Redness score. PASI Bozek Version - Lower Extremities: Erythema/Redness PASI05-Low Extrem: Thickness/Induration Psoriasis Area and Severity Index Version Bozek - Lower Extremities: Thickness/Induration score. PASI Bozek Version - Lower Extremities: Thickness/Induration PASI05-Low Extrem: Desquamation/Scaling Psoriasis Area and Severity Index Version Bozek - Lower Extremities: Desquamation/Scaling score. PASI Bozek Version - Lower Extremities: Desquamation/Scaling PASI05-Low Extrem: Area Score Psoriasis Area and Severity Index Version Bozek - Lower Extremities: Area score. PASI Bozek Version - Lower Extremities: Area Score PASI05-Head: Sum of Scores Psoriasis Area and Severity Index Version Bozek - Head: Sum of scores. PASI Bozek Version - Head: Sum of Scores PASI05-Head: Sum X Area Psoriasis Area and Severity Index Version Bozek - Head: Sum of scores x area score. PASI Bozek Version - Head: Sum X Area PASI05-Head: Sum X Area X 0.1 Psoriasis Area and Severity Index Version Bozek - Head: Sum x area x 0.1. PASI Bozek Version - Head: Sum X Area X 0.1 PASI05-Up Extrem: Sum of Scores Psoriasis Area and Severity Index Version Bozek - Upper Extremities: Sum of scores. PASI Bozek Version - Upper Extremities: Sum of Scores PASI05-Up Extrem: Sum X Area Psoriasis Area and Severity Index Version Bozek - Upper Extremities: Sum of scores x area score. PASI Bozek Version - Upper Extremities: Sum X Area PASI05-Up Extrem: Sum X Area X 0.2 Psoriasis Area and Severity Index Version Bozek - Upper Extremities: Sum x area x 0.2. PASI Bozek Version - Upper Extremities: Sum X Area X 0.2 PASI05-Trunk: Sum of Scores Psoriasis Area and Severity Index Version Bozek - Trunk: Sum of scores. PASI Bozek Version - Trunk: Sum of Scores PASI05-Trunk: Sum X Area Psoriasis Area and Severity Index Version Bozek - Trunk: Sum of scores x area score. PASI Bozek Version - Trunk: Sum X Area PASI05-Trunk: Sum X Area X 0.3 Psoriasis Area and Severity Index Version Bozek - Trunk: Sum x area x 0.3. PASI Bozek Version - Trunk: Sum X Area X 0.3 PASI05-Low Extrem: Sum of Scores Psoriasis Area and Severity Index Version Bozek - Lower Extremities: Sum of scores. PASI Bozek Version - Lower Extremities: Sum of Scores PASI05-Low Extrem: Sum X Area Psoriasis Area and Severity Index Version Bozek - Lower Extremities: Sum of scores x area score. PASI Bozek Version - Lower Extremities: Sum X Area PASI05-Low Extrem: Sum X Area X 0.4 Psoriasis Area and Severity Index Version Bozek - Lower Extremities: Sum x area x 0.4. PASI Bozek Version - Lower Extremities: Sum X Area X 0.4 PASI05-Total Sum Psoriasis Area and Severity Index Version Bozek - Total sum. PASI Bozek Version - Total Sum PASI05TC Psoriasis Area and Severity Index Version Bozek Clinical Classification Test Code CDISC Clinical Classification Psoriasis Area and Severity Index Bozek Version Test Code Terminology Psoriasis Area and Severity Index Version Bozek test name. PASI05-Head: Area Score Psoriasis Area and Severity Index Version Bozek - Head: Area score. PASI Bozek Version - Head: Area Score PASI05-Head: Desquamation/Scaling Psoriasis Area and Severity Index Version Bozek - Head: Desquamation/Scaling score. PASI Bozek Version - Head: Desquamation/Scaling PASI05-Head: Erythema/Redness Psoriasis Area and Severity Index Version Bozek - Head: Erythema/Redness score. PASI Bozek Version - Head: Erythema/Redness PASI05-Head: Sum of Scores Psoriasis Area and Severity Index Version Bozek - Head: Sum of scores. PASI Bozek Version - Head: Sum of Scores PASI05-Head: Sum X Area X 0.1 Psoriasis Area and Severity Index Version Bozek - Head: Sum x area x 0.1. PASI Bozek Version - Head: Sum X Area X 0.1 PASI05-Head: Sum X Area Psoriasis Area and Severity Index Version Bozek - Head: Sum of scores x area score. PASI Bozek Version - Head: Sum X Area PASI05-Head: Thickness/Induration Psoriasis Area and Severity Index Version Bozek - Head: Thickness/Induration score. PASI Bozek Version - Head: Thickness/Induration PASI05-Low Extrem: Area Score Psoriasis Area and Severity Index Version Bozek - Lower Extremities: Area score. PASI Bozek Version - Lower Extremities: Area Score PASI05-Low Extrem: Desquamation/Scaling Psoriasis Area and Severity Index Version Bozek - Lower Extremities: Desquamation/Scaling score. PASI Bozek Version - Lower Extremities: Desquamation/Scaling PASI05-Low Extrem: Erythema/Redness Psoriasis Area and Severity Index Version Bozek - Lower Extremities: Erythema/Redness score. PASI Bozek Version - Lower Extremities: Erythema/Redness PASI05-Low Extrem: Sum of Scores Psoriasis Area and Severity Index Version Bozek - Lower Extremities: Sum of scores. PASI Bozek Version - Lower Extremities: Sum of Scores PASI05-Low Extrem: Sum X Area X 0.4 Psoriasis Area and Severity Index Version Bozek - Lower Extremities: Sum x area x 0.4. PASI Bozek Version - Lower Extremities: Sum X Area X 0.4 PASI05-Low Extrem: Sum X Area Psoriasis Area and Severity Index Version Bozek - Lower Extremities: Sum of scores x area score. PASI Bozek Version - Lower Extremities: Sum X Area PASI05-Low Extrem: Thickness/Induration Psoriasis Area and Severity Index Version Bozek - Lower Extremities: Thickness/Induration score. PASI Bozek Version - Lower Extremities: Thickness/Induration PASI05-Total Sum Psoriasis Area and Severity Index Version Bozek - Total sum. PASI Bozek Version - Total Sum PASI05-Trunk: Area Score Psoriasis Area and Severity Index Version Bozek - Trunk: Area score. PASI Bozek Version - Trunk: Area Score PASI05-Trunk: Desquamation/Scaling Psoriasis Area and Severity Index Version Bozek - Trunk: Desquamation/Scaling score. PASI Bozek Version - Trunk: Desquamation/Scaling PASI05-Trunk: Erythema/Redness Psoriasis Area and Severity Index Version Bozek - Trunk: Erythema/Redness score. PASI Bozek Version - Trunk: Erythema/Redness PASI05-Trunk: Sum of Scores Psoriasis Area and Severity Index Version Bozek - Trunk: Sum of scores. PASI Bozek Version - Trunk: Sum of Scores PASI05-Trunk: Sum X Area X 0.3 Psoriasis Area and Severity Index Version Bozek - Trunk: Sum x area x 0.3. PASI Bozek Version - Trunk: Sum X Area X 0.3 PASI05-Trunk: Sum X Area Psoriasis Area and Severity Index Version Bozek - Trunk: Sum of scores x area score. PASI Bozek Version - Trunk: Sum X Area PASI05-Trunk: Thickness/Induration Psoriasis Area and Severity Index Version Bozek - Trunk: Thickness/Induration score. PASI Bozek Version - Trunk: Thickness/Induration PASI05-Up Extrem: Area Score Psoriasis Area and Severity Index Version Bozek - Upper Extremities: Area score. PASI Bozek Version - Upper Extremities: Area Score PASI05-Up Extrem: Desquamation/Scaling Psoriasis Area and Severity Index Version Bozek - Upper Extremities: Desquamation/Scaling score. PASI Bozek Version - Upper Extremities: Desquamation/Scaling PASI05-Up Extrem: Erythema/Redness Psoriasis Area and Severity Index Version Bozek - Upper Extremities: Erythema/Redness score. PASI Bozek Version - Upper Extremities: Erythema/Redness PASI05-Up Extrem: Sum of Scores Psoriasis Area and Severity Index Version Bozek - Upper Extremities: Sum of scores. PASI Bozek Version - Upper Extremities: Sum of Scores PASI05-Up Extrem: Sum X Area X 0.2 Psoriasis Area and Severity Index Version Bozek - Upper Extremities: Sum x area x 0.2. PASI Bozek Version - Upper Extremities: Sum X Area X 0.2 PASI05-Up Extrem: Sum X Area Psoriasis Area and Severity Index Version Bozek - Upper Extremities: Sum of scores x area score. PASI Bozek Version - Upper Extremities: Sum X Area PASI05-Up Extrem: Thickness/Induration Psoriasis Area and Severity Index Version Bozek - Upper Extremities: Thickness/Induration score. PASI Bozek Version - Upper Extremities: Thickness/Induration PASI05TN Psoriasis Area and Severity Index Version Bozek Clinical Classification Test Name CDISC Clinical Classification Psoriasis Area and Severity Index Bozek Version Test Name Terminology Psoriasis Area and Severity Index Version EMA test code. PASI04-Head: Erythema/Redness Psoriasis Area and Severity Index Version EMA - Head: Erythema/Redness score. PASI EMA Version - Head: Erythema/Redness PASI04-Head: Thickness/Induration Psoriasis Area and Severity Index Version EMA - Head: Thickness/Induration score. PASI EMA Version - Head: Thickness/Induration PASI04-Head: Desquamation/Scaling Psoriasis Area and Severity Index Version EMA - Head: Desquamation/Scaling score. PASI EMA Version - Head: Desquamation/Scaling PASI04-Head: Area Score Psoriasis Area and Severity Index Version EMA - Head: Area score. PASI EMA Version - Head: Area Score PASI04-Up Extrem: Erythema/Redness Psoriasis Area and Severity Index Version EMA - Upper Extremities: Erythema/Redness score. PASI EMA Version - Upper Extremities: Erythema/Redness PASI04-Up Extrem: Thickness/Induration Psoriasis Area and Severity Index Version EMA - Upper Extremities: Thickness/Induration score. PASI EMA Version - Upper Extremities: Thickness/Induration PASI04-Up Extrem: Desquamation/Scaling Psoriasis Area and Severity Index Version EMA - Upper Extremities: Desquamation/Scaling score. PASI EMA Version - Upper Extremities: Desquamation/Scaling PASI04-Up Extrem: Area Score Psoriasis Area and Severity Index Version EMA - Upper Extremities: Area score. PASI EMA Version - Upper Extremities: Area Score PASI04-Trunk: Erythema/Redness Psoriasis Area and Severity Index Version EMA - Trunk: Erythema/Redness score. PASI EMA Version - Trunk: Erythema/Redness PASI04-Trunk: Thickness/Induration Psoriasis Area and Severity Index Version EMA - Trunk: Thickness/Induration score. PASI EMA Version - Trunk: Thickness/Induration PASI04-Trunk: Desquamation/Scaling Psoriasis Area and Severity Index Version EMA - Trunk: Desquamation/Scaling score. PASI EMA Version - Trunk: Desquamation/Scaling PASI04-Trunk: Area Score Psoriasis Area and Severity Index Version EMA - Trunk: Area score. PASI EMA Version - Trunk: Area Score PASI04-Low Extrem: Erythema/Redness Psoriasis Area and Severity Index Version EMA - Lower Extremities: Erythema/Redness score. PASI EMA Version - Lower Extremities: Erythema/Redness PASI04-Low Extrem: Thickness/Induration Psoriasis Area and Severity Index Version EMA - Lower Extremities: Thickness/Induration score. PASI EMA Version - Lower Extremities: Thickness/Induration PASI04-Low Extrem: Desquamation/Scaling Psoriasis Area and Severity Index Version EMA - Lower Extremities: Desquamation/Scaling score. PASI EMA Version - Lower Extremities: Desquamation/Scaling PASI04-Low Extrem: Area Score Psoriasis Area and Severity Index Version EMA - Lower Extremities: Area score. PASI EMA Version - Lower Extremities: Area Score PASI04-Head: Sum of Scores Psoriasis Area and Severity Index Version EMA - Head: Sum of scores. PASI EMA Version - Head: Sum of Scores PASI04-Head: Sum X Area Psoriasis Area and Severity Index Version EMA - Head: Sum of scores x area score. PASI EMA Version - Head: Sum X Area PASI04-Head: Sum X Area X 0.1 Psoriasis Area and Severity Index Version EMA - Head: Sum x area x 0.1. PASI EMA Version - Head: Sum X Area X 0.1 PASI04-Up Extrem: Sum of Scores Psoriasis Area and Severity Index Version EMA - Upper Extremities: Sum of scores. PASI EMA Version - Upper Extremities: Sum of Scores PASI04-Up Extrem: Sum X Area Psoriasis Area and Severity Index Version EMA - Upper Extremities: Sum of scores x area score. PASI EMA Version - Upper Extremities: Sum X Area PASI04-Up Extrem: Sum X Area X 0.2 Psoriasis Area and Severity Index Version EMA - Upper Extremities: Sum x area x 0.2. PASI EMA Version - Upper Extremities: Sum X Area X 0.2 PASI04-Trunk: Sum of Scores Psoriasis Area and Severity Index Version EMA - Trunk: Sum of scores. PASI EMA Version - Trunk: Sum of Scores PASI04-Trunk: Sum X Area Psoriasis Area and Severity Index Version EMA - Trunk: Sum of scores x area score. PASI EMA Version - Trunk: Sum X Area PASI04-Trunk: Sum X Area X 0.3 Psoriasis Area and Severity Index Version EMA - Trunk: Sum x area x 0.3. PASI EMA Version - Trunk: Sum X Area X 0.3 PASI04-Low Extrem: Sum of Scores Psoriasis Area and Severity Index Version EMA - Lower Extremities: Sum of scores. PASI EMA Version - Lower Extremities: Sum of Scores PASI04-Low Extrem: Sum X Area Psoriasis Area and Severity Index Version EMA - Lower Extremities: Sum of scores x area score. PASI EMA Version - Lower Extremities: Sum X Area PASI04-Low Extrem: Sum X Area X 0.4 Psoriasis Area and Severity Index Version EMA - Lower Extremities: Sum x area x 0.4. PASI EMA Version - Lower Extremities: Sum X Area X 0.4 PASI04-Total Sum Psoriasis Area and Severity Index Version EMA - Total sum. PASI EMA Version - Total Sum PASI04TC Psoriasis Area and Severity Index Version EMA Clinical Classification Test Code CDISC Clinical Classification Psoriasis Area and Severity Index European Medical Agency Version Test Code Terminology Psoriasis Area and Severity Index Version EMA test name. PASI04-Head: Area Score Psoriasis Area and Severity Index Version EMA - Head: Area score. PASI EMA Version - Head: Area Score PASI04-Head: Desquamation/Scaling Psoriasis Area and Severity Index Version EMA - Head: Desquamation/Scaling score. PASI EMA Version - Head: Desquamation/Scaling PASI04-Head: Erythema/Redness Psoriasis Area and Severity Index Version EMA - Head: Erythema/Redness score. PASI EMA Version - Head: Erythema/Redness PASI04-Head: Sum of Scores Psoriasis Area and Severity Index Version EMA - Head: Sum of scores. PASI EMA Version - Head: Sum of Scores PASI04-Head: Sum X Area X 0.1 Psoriasis Area and Severity Index Version EMA - Head: Sum x area x 0.1. PASI EMA Version - Head: Sum X Area X 0.1 PASI04-Head: Sum X Area Psoriasis Area and Severity Index Version EMA - Head: Sum of scores x area score. PASI EMA Version - Head: Sum X Area PASI04-Head: Thickness/Induration Psoriasis Area and Severity Index Version EMA - Head: Thickness/Induration score. PASI EMA Version - Head: Thickness/Induration PASI04-Low Extrem: Area Score Psoriasis Area and Severity Index Version EMA - Lower Extremities: Area score. PASI EMA Version - Lower Extremities: Area Score PASI04-Low Extrem: Desquamation/Scaling Psoriasis Area and Severity Index Version EMA - Lower Extremities: Desquamation/Scaling score. PASI EMA Version - Lower Extremities: Desquamation/Scaling PASI04-Low Extrem: Erythema/Redness Psoriasis Area and Severity Index Version EMA - Lower Extremities: Erythema/Redness score. PASI EMA Version - Lower Extremities: Erythema/Redness PASI04-Low Extrem: Sum of Scores Psoriasis Area and Severity Index Version EMA - Lower Extremities: Sum of scores. PASI EMA Version - Lower Extremities: Sum of Scores PASI04-Low Extrem: Sum X Area X 0.4 Psoriasis Area and Severity Index Version EMA - Lower Extremities: Sum x area x 0.4. PASI EMA Version - Lower Extremities: Sum X Area X 0.4 PASI04-Low Extrem: Sum X Area Psoriasis Area and Severity Index Version EMA - Lower Extremities: Sum of scores x area score. PASI EMA Version - Lower Extremities: Sum X Area PASI04-Low Extrem: Thickness/Induration Psoriasis Area and Severity Index Version EMA - Lower Extremities: Thickness/Induration score. PASI EMA Version - Lower Extremities: Thickness/Induration PASI04-Total Sum Psoriasis Area and Severity Index Version EMA - Total sum. PASI EMA Version - Total Sum PASI04-Trunk: Area Score Psoriasis Area and Severity Index Version EMA - Trunk: Area score. PASI EMA Version - Trunk: Area Score PASI04-Trunk: Desquamation/Scaling Psoriasis Area and Severity Index Version EMA - Trunk: Desquamation/Scaling score. PASI EMA Version - Trunk: Desquamation/Scaling PASI04-Trunk: Erythema/Redness Psoriasis Area and Severity Index Version EMA - Trunk: Erythema/Redness score. PASI EMA Version - Trunk: Erythema/Redness PASI04-Trunk: Sum of Scores Psoriasis Area and Severity Index Version EMA - Trunk: Sum of scores. PASI EMA Version - Trunk: Sum of Scores PASI04-Trunk: Sum X Area X 0.3 Psoriasis Area and Severity Index Version EMA - Trunk: Sum x area x 0.3. PASI EMA Version - Trunk: Sum X Area X 0.3 PASI04-Trunk: Sum X Area Psoriasis Area and Severity Index Version EMA - Trunk: Sum of scores x area score. PASI EMA Version - Trunk: Sum X Area PASI04-Trunk: Thickness/Induration Psoriasis Area and Severity Index Version EMA - Trunk: Thickness/Induration score. PASI EMA Version - Trunk: Thickness/Induration PASI04-Up Extrem: Area Score Psoriasis Area and Severity Index Version EMA - Upper Extremities: Area score. PASI EMA Version - Upper Extremities: Area Score PASI04-Up Extrem: Desquamation/Scaling Psoriasis Area and Severity Index Version EMA - Upper Extremities: Desquamation/Scaling score. PASI EMA Version - Upper Extremities: Desquamation/Scaling PASI04-Up Extrem: Erythema/Redness Psoriasis Area and Severity Index Version EMA - Upper Extremities: Erythema/Redness score. PASI EMA Version - Upper Extremities: Erythema/Redness PASI04-Up Extrem: Sum of Scores Psoriasis Area and Severity Index Version EMA - Upper Extremities: Sum of scores. PASI EMA Version - Upper Extremities: Sum of Scores PASI04-Up Extrem: Sum X Area X 0.2 Psoriasis Area and Severity Index Version EMA - Upper Extremities: Sum x area x 0.2. PASI EMA Version - Upper Extremities: Sum X Area X 0.2 PASI04-Up Extrem: Sum X Area Psoriasis Area and Severity Index Version EMA - Upper Extremities: Sum of scores x area score. PASI EMA Version - Upper Extremities: Sum X Area PASI04-Up Extrem: Thickness/Induration Psoriasis Area and Severity Index Version EMA - Upper Extremities: Thickness/Induration score. PASI EMA Version - Upper Extremities: Thickness/Induration PASI04TN Psoriasis Area and Severity Index Version EMA Clinical Classification Test Name CDISC Clinical Classification Psoriasis Area and Severity Index European Medical Agency Version Test Name Terminology Psoriasis Area and Severity Index Version Feldman test code. PASI02-Head: Erythema/Redness Psoriasis Area and Severity Index Version Feldman - Head: Erythema/Redness score. PASI Feldman Version - Head: Erythema/Redness PASI02-Head: Thickness/Induration Psoriasis Area and Severity Index Version Feldman - Head: Thickness/Induration score. PASI Feldman Version - Head: Thickness/Induration PASI02-Head: Desquamation/Scaling Psoriasis Area and Severity Index Version Feldman - Head: Desquamation/Scaling score. PASI Feldman Version - Head: Desquamation/Scaling PASI02-Head: Area Score Psoriasis Area and Severity Index Version Feldman - Head: Area score. PASI Feldman Version - Head: Area Score PASI02-Up Extrem: Erythema/Redness Psoriasis Area and Severity Index Version Feldman - Upper Extremities: Erythema/Redness score. PASI Feldman Version - Upper Extremities: Erythema/Redness PASI02-Up Extrem: Thickness/Induration Psoriasis Area and Severity Index Version Feldman - Upper Extremities: Thickness/Induration score. PASI Feldman Version - Upper Extremities: Thickness/Induration PASI02-Up Extrem: Desquamation/Scaling Psoriasis Area and Severity Index Version Feldman - Upper Extremities: Desquamation/Scaling score. PASI Feldman Version - Upper Extremities: Desquamation/Scaling PASI02-Up Extrem: Area Score Psoriasis Area and Severity Index Version Feldman - Upper Extremities: Area score. PASI Feldman Version - Upper Extremities: Area Score PASI02-Trunk: Erythema/Redness Psoriasis Area and Severity Index Version Feldman - Trunk: Erythema/Redness score. PASI Feldman Version - Trunk: Erythema/Redness PASI02-Trunk: Thickness/Induration Psoriasis Area and Severity Index Version Feldman - Trunk: Thickness/Induration score. PASI Feldman Version - Trunk: Thickness/Induration PASI02-Trunk: Desquamation/Scaling Psoriasis Area and Severity Index Version Feldman - Trunk: Desquamation/Scaling score. PASI Feldman Version - Trunk: Desquamation/Scaling PASI02-Trunk: Area Score Psoriasis Area and Severity Index Version Feldman - Trunk: Area score. PASI Feldman Version - Trunk: Area Score PASI02-Low Extrem: Erythema/Redness Psoriasis Area and Severity Index Version Feldman - Lower Extremities: Erythema/Redness score. PASI Feldman Version - Lower Extremities: Erythema/Redness PASI02-Low Extrem: Thickness/Induration Psoriasis Area and Severity Index Version Feldman - Lower Extremities: Thickness/Induration score. PASI Feldman Version - Lower Extremities: Thickness/Induration PASI02-Low Extrem: Desquamation/Scaling Psoriasis Area and Severity Index Version Feldman - Lower Extremities: Desquamation/Scaling score. PASI Feldman Version - Lower Extremities: Desquamation/Scaling PASI02-Low Extrem: Area Score Psoriasis Area and Severity Index Version Feldman - Lower Extremities: Area score. PASI Feldman Version - Lower Extremities: Area Score PASI02-Head: Sum of Scores Psoriasis Area and Severity Index Version Feldman - Head: Sum of scores. PASI Feldman Version - Head: Sum of Scores PASI02-Head: Sum X Area Psoriasis Area and Severity Index Version Feldman - Head: Sum of scores x area score. PASI Feldman Version - Head: Sum X Area PASI02-Head: Sum X Area X 0.1 Psoriasis Area and Severity Index Version Feldman - Head: Sum x area x 0.1. PASI Feldman Version - Head: Sum X Area X 0.1 PASI02-Up Extrem: Sum of Scores Psoriasis Area and Severity Index Version Feldman - Upper Extremities: Sum of scores. PASI Feldman Version - Upper Extremities: Sum of Scores PASI02-Up Extrem: Sum X Area Psoriasis Area and Severity Index Version Feldman - Upper Extremities: Sum of scores x area score. PASI Feldman Version - Upper Extremities: Sum X Area PASI02-Up Extrem: Sum X Area X 0.2 Psoriasis Area and Severity Index Version Feldman - Upper Extremities: Sum x area x 0.2. PASI Feldman Version - Upper Extremities: Sum X Area X 0.2 PASI02-Trunk: Sum of Scores Psoriasis Area and Severity Index Version Feldman - Trunk: Sum of scores. PASI Feldman Version - Trunk: Sum of Scores PASI02-Trunk: Sum X Area Psoriasis Area and Severity Index Version Feldman - Trunk: Sum of scores x area score. PASI Feldman Version - Trunk: Sum X Area PASI02-Trunk: Sum X Area X 0.3 Psoriasis Area and Severity Index Version Feldman - Trunk: Sum x area x 0.3. PASI Feldman Version - Trunk: Sum X Area X 0.3 PASI02-Low Extrem: Sum of Scores Psoriasis Area and Severity Index Version Feldman - Lower Extremities: Sum of scores. PASI Feldman Version - Lower Extremities: Sum of Scores PASI02-Low Extrem: Sum X Area Psoriasis Area and Severity Index Version Feldman - Lower Extremities: Sum of scores x area score. PASI Feldman Version - Lower Extremities: Sum X Area PASI02-Low Extrem: Sum X Area X 0.4 Psoriasis Area and Severity Index Version Feldman - Lower Extremities: Sum x area x 0.4. PASI Feldman Version - Lower Extremities: Sum X Area X 0.4 PASI02-Total Sum Psoriasis Area and Severity Index Version Feldman - Total sum. PASI Feldman Version - Total Sum PASI02TC Psoriasis Area and Severity Index Version Feldman Clinical Classification Test Code CDISC Clinical Classification PASI Feldman Version Test Code Terminology Psoriasis Area and Severity Index Version Feldman test name. PASI02-Head: Area Score Psoriasis Area and Severity Index Version Feldman - Head: Area score. PASI Feldman Version - Head: Area Score PASI02-Head: Desquamation/Scaling Psoriasis Area and Severity Index Version Feldman - Head: Desquamation/Scaling score. PASI Feldman Version - Head: Desquamation/Scaling PASI02-Head: Erythema/Redness Psoriasis Area and Severity Index Version Feldman - Head: Erythema/Redness score. PASI Feldman Version - Head: Erythema/Redness PASI02-Head: Sum of Scores Psoriasis Area and Severity Index Version Feldman - Head: Sum of scores. PASI Feldman Version - Head: Sum of Scores PASI02-Head: Sum X Area X 0.1 Psoriasis Area and Severity Index Version Feldman - Head: Sum x area x 0.1. PASI Feldman Version - Head: Sum X Area X 0.1 PASI02-Head: Sum X Area Psoriasis Area and Severity Index Version Feldman - Head: Sum of scores x area score. PASI Feldman Version - Head: Sum X Area PASI02-Head: Thickness/Induration Psoriasis Area and Severity Index Version Feldman - Head: Thickness/Induration score. PASI Feldman Version - Head: Thickness/Induration PASI02-Low Extrem: Area Score Psoriasis Area and Severity Index Version Feldman - Lower Extremities: Area score. PASI Feldman Version - Lower Extremities: Area Score PASI02-Low Extrem: Desquamation/Scaling Psoriasis Area and Severity Index Version Feldman - Lower Extremities: Desquamation/Scaling score. PASI Feldman Version - Lower Extremities: Desquamation/Scaling PASI02-Low Extrem: Erythema/Redness Psoriasis Area and Severity Index Version Feldman - Lower Extremities: Erythema/Redness score. PASI Feldman Version - Lower Extremities: Erythema/Redness PASI02-Low Extrem: Sum of Scores Psoriasis Area and Severity Index Version Feldman - Lower Extremities: Sum of scores. PASI Feldman Version - Lower Extremities: Sum of Scores PASI02-Low Extrem: Sum X Area X 0.4 Psoriasis Area and Severity Index Version Feldman - Lower Extremities: Sum x area x 0.4. PASI Feldman Version - Lower Extremities: Sum X Area X 0.4 PASI02-Low Extrem: Sum X Area Psoriasis Area and Severity Index Version Feldman - Lower Extremities: Sum of scores x area score. PASI Feldman Version - Lower Extremities: Sum X Area PASI02-Low Extrem: Thickness/Induration Psoriasis Area and Severity Index Version Feldman - Lower Extremities: Thickness/Induration score. PASI Feldman Version - Lower Extremities: Thickness/Induration PASI02-Total Sum Psoriasis Area and Severity Index Version Feldman - Total sum. PASI Feldman Version - Total Sum PASI02-Trunk: Area Score Psoriasis Area and Severity Index Version Feldman - Trunk: Area score. PASI Feldman Version - Trunk: Area Score PASI02-Trunk: Desquamation/Scaling Psoriasis Area and Severity Index Version Feldman - Trunk: Desquamation/Scaling score. PASI Feldman Version - Trunk: Desquamation/Scaling PASI02-Trunk: Erythema/Redness Psoriasis Area and Severity Index Version Feldman - Trunk: Erythema/Redness score. PASI Feldman Version - Trunk: Erythema/Redness PASI02-Trunk: Sum of Scores Psoriasis Area and Severity Index Version Feldman - Trunk: Sum of scores. PASI Feldman Version - Trunk: Sum of Scores PASI02-Trunk: Sum X Area X 0.3 Psoriasis Area and Severity Index Version Feldman - Trunk: Sum x area x 0.3. PASI Feldman Version - Trunk: Sum X Area X 0.3 PASI02-Trunk: Sum X Area Psoriasis Area and Severity Index Version Feldman - Trunk: Sum of scores x area score. PASI Feldman Version - Trunk: Sum X Area PASI02-Trunk: Thickness/Induration Psoriasis Area and Severity Index Version Feldman - Trunk: Thickness/Induration score. PASI Feldman Version - Trunk: Thickness/Induration PASI02-Up Extrem: Area Score Psoriasis Area and Severity Index Version Feldman - Upper Extremities: Area score. PASI Feldman Version - Upper Extremities: Area Score PASI02-Up Extrem: Desquamation/Scaling Psoriasis Area and Severity Index Version Feldman - Upper Extremities: Desquamation/Scaling score. PASI Feldman Version - Upper Extremities: Desquamation/Scaling PASI02-Up Extrem: Erythema/Redness Psoriasis Area and Severity Index Version Feldman - Upper Extremities: Erythema/Redness score. PASI Feldman Version - Upper Extremities: Erythema/Redness PASI02-Up Extrem: Sum of Scores Psoriasis Area and Severity Index Version Feldman - Upper Extremities: Sum of scores. PASI Feldman Version - Upper Extremities: Sum of Scores PASI02-Up Extrem: Sum X Area X 0.2 Psoriasis Area and Severity Index Version Feldman - Upper Extremities: Sum x area x 0.2. PASI Feldman Version - Upper Extremities: Sum X Area X 0.2 PASI02-Up Extrem: Sum X Area Psoriasis Area and Severity Index Version Feldman - Upper Extremities: Sum of scores x area score. PASI Feldman Version - Upper Extremities: Sum X Area PASI02-Up Extrem: Thickness/Induration Psoriasis Area and Severity Index Version Feldman - Upper Extremities: Thickness/Induration score. PASI Feldman Version - Upper Extremities: Thickness/Induration PASI02TN Psoriasis Area and Severity Index Version Feldman Clinical Classification Test Name CDISC Clinical Classification PASI Feldman Version Test Name Terminology Psoriasis Area and Severity Index Version Fredriksson test code. PASI03-Head: Erythema/Redness Psoriasis Area and Severity Index Version Fredriksson - Head: Erythema/Redness score. PASI Fredriksson Version - Head: Erythema/Redness PASI03-Head: Thickness/Induration Psoriasis Area and Severity Index Version Fredriksson - Head: Thickness/Induration score. PASI Fredriksson Version - Head: Thickness/Induration PASI03-Head: Desquamation/Scaling Psoriasis Area and Severity Index Version Fredriksson - Head: Desquamation/Scaling score. PASI Fredriksson Version - Head: Desquamation/Scaling PASI03-Head: Area Score Psoriasis Area and Severity Index Version Fredriksson - Head: Area score. PASI Fredriksson Version - Head: Area Score PASI03-Up Extrem: Erythema/Redness Psoriasis Area and Severity Index Version Fredriksson - Upper Extremities: Erythema/Redness score. PASI Fredriksson Version - Upper Extremities: Erythema/Redness PASI03-Up Extrem: Thickness/Induration Psoriasis Area and Severity Index Version Fredriksson - Upper Extremities: Thickness/Induration score. PASI Fredriksson Version - Upper Extremities: Thickness/Induration PASI03-Up Extrem: Desquamation/Scaling Psoriasis Area and Severity Index Version Fredriksson - Upper Extremities: Desquamation/Scaling score. PASI Fredriksson Version - Upper Extremities: Desquamation/Scaling PASI03-Up Extrem: Area Score Psoriasis Area and Severity Index Version Fredriksson - Upper Extremities: Area score. PASI Fredriksson Version - Upper Extremities: Area Score PASI03-Trunk: Erythema/Redness Psoriasis Area and Severity Index Version Fredriksson - Trunk: Erythema/Redness score. PASI Fredriksson Version - Trunk: Erythema/Redness PASI03-Trunk: Thickness/Induration Psoriasis Area and Severity Index Version Fredriksson - Trunk: Thickness/Induration score. PASI Fredriksson Version - Trunk: Thickness/Induration PASI03-Trunk: Desquamation/Scaling Psoriasis Area and Severity Index Version Fredriksson - Trunk: Desquamation/Scaling score. PASI Fredriksson Version - Trunk: Desquamation/Scaling PASI03-Trunk: Area Score Psoriasis Area and Severity Index Version Fredriksson - Trunk: Area score. PASI Fredriksson Version - Trunk: Area Score PASI03-Low Extrem: Erythema/Redness Psoriasis Area and Severity Index Version Fredriksson - Lower Extremities: Erythema/Redness score. PASI Fredriksson Version - Lower Extremities: Erythema/Redness PASI03-Low Extrem: Thickness/Induration Psoriasis Area and Severity Index Version Fredriksson - Lower Extremities: Thickness/Induration score. PASI Fredriksson Version - Lower Extremities: Thickness/Induration PASI03-Low Extrem: Desquamation/Scaling Psoriasis Area and Severity Index Version Fredriksson - Lower Extremities: Desquamation/Scaling score. PASI Fredriksson Version - Lower Extremities: Desquamation/Scaling PASI03-Low Extrem: Area Score Psoriasis Area and Severity Index Version Fredriksson - Lower Extremities: Area score. PASI Fredriksson Version - Lower Extremities: Area Score PASI03-Head: Sum of Scores Psoriasis Area and Severity Index Version Fredriksson - Head: Sum of scores. PASI Fredriksson Version - Head: Sum of Scores PASI03-Head: Sum X Area Psoriasis Area and Severity Index Version Fredriksson - Head: Sum of scores x area score. PASI Fredriksson Version - Head: Sum X Area PASI03-Head: Sum X Area X 0.1 Psoriasis Area and Severity Index Version Fredriksson - Head: Sum x area x 0.1. PASI Fredriksson Version - Head: Sum X Area X 0.1 PASI03-Up Extrem: Sum of Scores Psoriasis Area and Severity Index Version Fredriksson - Upper Extremities: Sum of scores. PASI Fredriksson Version - Upper Extremities: Sum of Scores PASI03-Up Extrem: Sum X Area Psoriasis Area and Severity Index Version Fredriksson - Upper Extremities: Sum of scores x area score. PASI Fredriksson Version - Upper Extremities: Sum X Area PASI03-Up Extrem: Sum X Area X 0.2 Psoriasis Area and Severity Index Version Fredriksson - Upper Extremities: Sum x area x 0.2. PASI Fredriksson Version - Upper Extremities: Sum X Area X 0.2 PASI03-Trunk: Sum of Scores Psoriasis Area and Severity Index Version Fredriksson - Trunk: Sum of scores. PASI Fredriksson Version - Trunk: Sum of Scores PASI03-Trunk: Sum X Area Psoriasis Area and Severity Index Version Fredriksson - Trunk: Sum of scores x area score. PASI Fredriksson Version - Trunk: Sum X Area PASI03-Trunk: Sum X Area X 0.3 Psoriasis Area and Severity Index Version Fredriksson - Trunk: Sum x area x 0.3. PASI Fredriksson Version - Trunk: Sum X Area X 0.3 PASI03-Low Extrem: Sum of Scores Psoriasis Area and Severity Index Version Fredriksson - Lower Extremities: Sum of scores. PASI Fredriksson Version - Lower Extremities: Sum of Scores PASI03-Low Extrem: Sum X Area Psoriasis Area and Severity Index Version Fredriksson - Lower Extremities: Sum of scores x area score. PASI Fredriksson Version - Lower Extremities: Sum X Area PASI03-Low Extrem: Sum X Area X 0.4 Psoriasis Area and Severity Index Version Fredriksson - Lower Extremities: Sum x area x 0.4. PASI Fredriksson Version - Lower Extremities: Sum X Area X 0.4 PASI03-Total Sum Psoriasis Area and Severity Index Version Fredriksson - Total sum. PASI Fredriksson Version - Total Sum PASI03TC Psoriasis Area and Severity Index Version Fredriksson Clinical Classification Test Code CDISC Clinical Classification Psoriasis Area and Severity Index Fredriksson Version Test Code Terminology Psoriasis Area and Severity Index Version Fredriksson test name. PASI03-Head: Area Score Psoriasis Area and Severity Index Version Fredriksson - Head: Area score. PASI Fredriksson Version - Head: Area Score PASI03-Head: Desquamation/Scaling Psoriasis Area and Severity Index Version Fredriksson - Head: Desquamation/Scaling score. PASI Fredriksson Version - Head: Desquamation/Scaling PASI03-Head: Erythema/Redness Psoriasis Area and Severity Index Version Fredriksson - Head: Erythema/Redness score. PASI Fredriksson Version - Head: Erythema/Redness PASI03-Head: Sum of Scores Psoriasis Area and Severity Index Version Fredriksson - Head: Sum of scores. PASI Fredriksson Version - Head: Sum of Scores PASI03-Head: Sum X Area X 0.1 Psoriasis Area and Severity Index Version Fredriksson - Head: Sum x area x 0.1. PASI Fredriksson Version - Head: Sum X Area X 0.1 PASI03-Head: Sum X Area Psoriasis Area and Severity Index Version Fredriksson - Head: Sum of scores x area score. PASI Fredriksson Version - Head: Sum X Area PASI03-Head: Thickness/Induration Psoriasis Area and Severity Index Version Fredriksson - Head: Thickness/Induration score. PASI Fredriksson Version - Head: Thickness/Induration PASI03-Low Extrem: Area Score Psoriasis Area and Severity Index Version Fredriksson - Lower Extremities: Area score. PASI Fredriksson Version - Lower Extremities: Area Score PASI03-Low Extrem: Desquamation/Scaling Psoriasis Area and Severity Index Version Fredriksson - Lower Extremities: Desquamation/Scaling score. PASI Fredriksson Version - Lower Extremities: Desquamation/Scaling PASI03-Low Extrem: Erythema/Redness Psoriasis Area and Severity Index Version Fredriksson - Lower Extremities: Erythema/Redness score. PASI Fredriksson Version - Lower Extremities: Erythema/Redness PASI03-Low Extrem: Sum of Scores Psoriasis Area and Severity Index Version Fredriksson - Lower Extremities: Sum of scores. PASI Fredriksson Version - Lower Extremities: Sum of Scores PASI03-Low Extrem: Sum X Area X 0.4 Psoriasis Area and Severity Index Version Fredriksson - Lower Extremities: Sum x area x 0.4. PASI Fredriksson Version - Lower Extremities: Sum X Area X 0.4 PASI03-Low Extrem: Sum X Area Psoriasis Area and Severity Index Version Fredriksson - Lower Extremities: Sum of scores x area score. PASI Fredriksson Version - Lower Extremities: Sum X Area PASI03-Low Extrem: Thickness/Induration Psoriasis Area and Severity Index Version Fredriksson - Lower Extremities: Thickness/Induration score. PASI Fredriksson Version - Lower Extremities: Thickness/Induration PASI03-Total Sum Psoriasis Area and Severity Index Version Fredriksson - Total sum. PASI Fredriksson Version - Total Sum PASI03-Trunk: Area Score Psoriasis Area and Severity Index Version Fredriksson - Trunk: Area score. PASI Fredriksson Version - Trunk: Area Score PASI03-Trunk: Desquamation/Scaling Psoriasis Area and Severity Index Version Fredriksson - Trunk: Desquamation/Scaling score. PASI Fredriksson Version - Trunk: Desquamation/Scaling PASI03-Trunk: Erythema/Redness Psoriasis Area and Severity Index Version Fredriksson - Trunk: Erythema/Redness score. PASI Fredriksson Version - Trunk: Erythema/Redness PASI03-Trunk: Sum of Scores Psoriasis Area and Severity Index Version Fredriksson - Trunk: Sum of scores. PASI Fredriksson Version - Trunk: Sum of Scores PASI03-Trunk: Sum X Area X 0.3 Psoriasis Area and Severity Index Version Fredriksson - Trunk: Sum x area x 0.3. PASI Fredriksson Version - Trunk: Sum X Area X 0.3 PASI03-Trunk: Sum X Area Psoriasis Area and Severity Index Version Fredriksson - Trunk: Sum of scores x area score. PASI Fredriksson Version - Trunk: Sum X Area PASI03-Trunk: Thickness/Induration Psoriasis Area and Severity Index Version Fredriksson - Trunk: Thickness/Induration score. PASI Fredriksson Version - Trunk: Thickness/Induration PASI03-Up Extrem: Area Score Psoriasis Area and Severity Index Version Fredriksson - Upper Extremities: Area score. PASI Fredriksson Version - Upper Extremities: Area Score PASI03-Up Extrem: Desquamation/Scaling Psoriasis Area and Severity Index Version Fredriksson - Upper Extremities: Desquamation/Scaling score. PASI Fredriksson Version - Upper Extremities: Desquamation/Scaling PASI03-Up Extrem: Erythema/Redness Psoriasis Area and Severity Index Version Fredriksson - Upper Extremities: Erythema/Redness score. PASI Fredriksson Version - Upper Extremities: Erythema/Redness PASI03-Up Extrem: Sum of Scores Psoriasis Area and Severity Index Version Fredriksson - Upper Extremities: Sum of scores. PASI Fredriksson Version - Upper Extremities: Sum of Scores PASI03-Up Extrem: Sum X Area X 0.2 Psoriasis Area and Severity Index Version Fredriksson - Upper Extremities: Sum x area x 0.2. PASI Fredriksson Version - Upper Extremities: Sum X Area X 0.2 PASI03-Up Extrem: Sum X Area Psoriasis Area and Severity Index Version Fredriksson - Upper Extremities: Sum of scores x area score. PASI Fredriksson Version - Upper Extremities: Sum X Area PASI03-Up Extrem: Thickness/Induration Psoriasis Area and Severity Index Version Fredriksson - Upper Extremities: Thickness/Induration score. PASI Fredriksson Version - Upper Extremities: Thickness/Induration PASI03TN Psoriasis Area and Severity Index Version Fredriksson Clinical Classification Test Name CDISC Clinical Classification Psoriasis Area and Severity Index Fredriksson Version Test Name Terminology Terminology relevant to the test codes that describe findings about a psoriasis event or intervention. QOL Impact Quality of Life Impact The effect or consequence of an event or condition on an individual's sense of well-being and ability to enjoy life. Quality of Life Impact Severity/Intensity The degree of something undesirable. Severity PSFATSCD Psoriasis Findings About Test Code CDISC SDTM Psoriasis Findings About Test Code Terminology Terminology relevant to the test names that describe findings about a psoriasis event or intervention. QOL Impact Quality of Life Impact The effect or consequence of an event or condition on an individual's sense of well-being and ability to enjoy life. Quality of Life Impact Severity/Intensity The degree of something undesirable. Severity PSFATS Psoriasis Findings About Test Name CDISC SDTM Psoriasis Findings About Test Name Terminology Terminology relevant to the technique or procedure used to determine how the response or result for an item in a questionnaire, rating, or scale was determined. Likert Scale 3-Point A questionnaire, rating and scale (QRS) data type using a 3-point Likert Scale. Likert Scale 3-Point Likert Scale 5-Point A questionnaire, rating and scale (QRS) data type using a 5-point Likert Scale. Likert Scale 5-Point Likert Scale 7-Point A questionnaire, rating and scale (QRS) data type using a 7-point Likert Scale. Likert Scale 7-Point NRS 10-Point Numeric Rating Scale 10-Point A questionnaire, rating and scale (QRS) data type using a 10-point numerical rating scale (NRS). Numerical Rating Scale 10-Point NRS 11-Point Numeric Rating Scale 11-Point A questionnaire, rating and scale (QRS) data type using a 11-point numerical rating scale (NRS). Numerical Rating Scale 11-Point NRS 21-Point Numeric Rating Scale 21-Point A questionnaire, rating and scale (QRS) data type using a 21-point numerical rating scale (NRS). Numerical Rating Scale 21-Point NRS 5-Point Numeric Rating Scale 5-Point A questionnaire, rating and scale (QRS) data type using a 5-point numerical rating scale (NRS). Numerical Rating Scale 5-Point NRS 6-Point Numeric Rating Scale 6-Point A questionnaire, rating and scale (QRS) data type using a 6-point numerical rating scale (NRS). Numerical Rating Scale 6-Point NRS 7-Point Numeric Rating Scale 7-Point A questionnaire, rating and scale (QRS) data type using a 7-point numerical rating scale (NRS). Numerical Rating Scale 7-Point VRS 4-Point A questionnaire, rating and scale (QRS) data type using a 4-point verbal rating scale (VRS). Verbal Rating Scale 4-Point VRS 5-Point A questionnaire, rating and scale (QRS) data type using a 5-point verbal rating scale (VRS). Verbal Rating Scale 5-Point VRS 6-Point A questionnaire, rating and scale (QRS) data type using a 6-point verbal rating scale (VRS). Verbal Rating Scale 6-Point VAS (0-100) A questionnaire, rating and scale (QRS) data type using a visual analog scale (VAS) 0-100 scale with no units. Visual Analog Scale (0-100) VAS (1-10) A questionnaire, rating and scale (QRS) data type using a visual analog scale (VAS) 1-10 scale with no units. Visual Analog Scale (1-10) VAS (1-100) A questionnaire, rating and scale (QRS) data type using a visual analog scale (VAS) 1-100 scale with no units. Visual Analog Scale (1-100) VAS (1-50) A questionnaire, rating and scale (QRS) data type using a visual analog scale (VAS) 1-50 scale with no units. Visual Analog Scale (1-50) VAS (10 cm) A questionnaire, rating and scale (QRS) data type using a visual analog scale (VAS) 10 cm scale. Visual Analog Scale (10 cm) VAS (100 mm) A questionnaire, rating and scale (QRS) data type using a visual analog scale (VAS) 100 mm scale. Visual Analog Scale (100 mm) VAS (50 mm) A questionnaire, rating and scale (QRS) data type using a visual analog scale (VAS) 50 mm scale. Visual Analog Scale (50 mm) QRSMTHOD QRS Method CDISC SDTM QRS Method Terminology Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form test code. QLES2-Physical Health Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Physical health? Q-LES-Q-SF - Physical Health QLES2-Mood Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Mood? Q-LES-Q-SF - Mood QLES2-Work Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Work? Q-LES-Q-SF - Work QLES2-Household Activities Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Household activities? Q-LES-Q-SF - Household Activities QLES2-Social Relationships Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Social relationships? Q-LES-Q-SF - Social Relationships QLES2-Family Relationships Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Family relationships? Q-LES-Q-SF - Family Relationships QLES2-Leisure Time Activities Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Leisure time activities? Q-LES-Q-SF - Leisure Time Activities QLES2-Ability to Function in Daily Life Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Ability to function in daily life? Q-LES-Q-SF - Ability to Function in Daily Life QLES2-Sex Drive, Interest, Performance Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Sexual drive, interest and/or performance? Q-LES-Q-SF - Sex Drive, Interest, Performance QLES2-Economic Status Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Economic status? Q-LES-Q-SF - Economic Status QLES2-Living/Housing Situation Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Living/housing situation? Q-LES-Q-SF - Living or Housing Situation QLES2-Ability to Get Around Physically Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Ability to get around physically without feeling dizzy or unsteady or falling? Q-LES-Q-SF - Ability to Get Around Physically QLES2-Vision Ability to Do Work/Hobbies Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Your vision in terms of ability to do work or hobbies? Q-LES-Q-SF - Vision Ability to Do Work or Hobbies QLES2-Overall Sense of Well Being Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Overall sense of well being? Q-LES-Q-SF - Overall Sense of Well Being QLES2-Medication Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Medication? Q-LES-Q-SF - Medication QLES2-Rate Overall Life Satisfaction Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - How would you rate your overall life satisfaction and contentment during the past week? Q-LES-Q-SF - Rate Overall Life Satisfaction QLES2TC Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form Test Code CDISC Questionnaire Q-LES-Q-SF Test Code Terminology Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form test name. QLES2-Ability to Function in Daily Life Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Ability to function in daily life? Q-LES-Q-SF - Ability to Function in Daily Life QLES2-Ability to Get Around Physically Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Ability to get around physically without feeling dizzy or unsteady or falling? Q-LES-Q-SF - Ability to Get Around Physically QLES2-Economic Status Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Economic status? Q-LES-Q-SF - Economic Status QLES2-Family Relationships Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Family relationships? Q-LES-Q-SF - Family Relationships QLES2-Household Activities Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Household activities? Q-LES-Q-SF - Household Activities QLES2-Leisure Time Activities Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Leisure time activities? Q-LES-Q-SF - Leisure Time Activities QLES2-Living/Housing Situation Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Living/housing situation? Q-LES-Q-SF - Living or Housing Situation QLES2-Medication Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Medication? Q-LES-Q-SF - Medication QLES2-Mood Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Mood? Q-LES-Q-SF - Mood QLES2-Overall Sense of Well Being Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Overall sense of well being? Q-LES-Q-SF - Overall Sense of Well Being QLES2-Physical Health Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Physical health? Q-LES-Q-SF - Physical Health QLES2-Rate Overall Life Satisfaction Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - How would you rate your overall life satisfaction and contentment during the past week? Q-LES-Q-SF - Rate Overall Life Satisfaction QLES2-Sex Drive, Interest, Performance Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Sexual drive, interest and/or performance? Q-LES-Q-SF - Sex Drive, Interest, Performance QLES2-Social Relationships Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Social relationships? Q-LES-Q-SF - Social Relationships QLES2-Vision Ability to Do Work/Hobbies Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Your vision in terms of ability to do work or hobbies? Q-LES-Q-SF - Vision Ability to Do Work or Hobbies QLES2-Work Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Work? Q-LES-Q-SF - Work QLES2TN Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form Test Name CDISC Questionnaire Q-LES-Q-SF Test Name Terminology Quality Of Life Enjoyment And Satisfaction Questionnaire test code. QLES1-Free of Aches, Pains, Discomfort Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Been completely free of aches, pains, or discomfort? Q-LES-Q - Free of Aches, Pains, Discomfort QLES1-Felt Rested Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt rested? Q-LES-Q - Felt Rested QLES1-Felt Energetic Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt energetic? Q-LES-Q - Felt Energetic QLES1-Felt in Excellent Physical Health Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt in excellent physical health? Q-LES-Q - Felt in Excellent Physical Health QLES1-At Least Very Good Physical Health Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt in at least very good physical health? Q-LES-Q - At Least Very Good Physical Health QLES1-Free of Worry of Physical Health Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Been free of worry about your physical health? Q-LES-Q - Free of Worry of Physical Health QLES1-Felt You Got Enough Sleep Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt you got enough sleep? Q-LES-Q - Felt You Got Enough Sleep QLES1-Be as Physically Active as Needed Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt able to be as physically active as needed? Q-LES-Q - Be as Physically Active as Needed QLES1-Felt Well Coordinated Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt well coordinated? Q-LES-Q - Felt Well Coordinated QLES1-Felt Memory Was Functioning Well Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt your memory was functioning well? Q-LES-Q - Felt Memory Was Functioning Well QLES1-Felt Good Physically Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt good physically? Q-LES-Q - Felt Good Physically QLES1-Felt Full of Pep and Vitality Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt full of pep and vitality? Q-LES-Q - Felt Full of Pep and Vitality QLES1-Free of Visual Problems Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Been free of visual problems? Q-LES-Q - Free of Visual Problems QLES1-Felt Clearheaded Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt clearheaded? Q-LES-Q - Felt Clearheaded QLES1-Felt Satisfied With Your Life Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt satisfied with your life? Q-LES-Q - Felt Satisfied With Your Life QLES1-Felt Good About Your Appearance Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt good about your appearance? Q-LES-Q - Felt Good About Your Appearance QLES1-Felt Happy or Cheerful Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt happy or cheerful? Q-LES-Q - Felt Happy or Cheerful QLES1-Felt Independent Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt independent? Q-LES-Q - Felt Independent QLES1-Felt Content Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt content? Q-LES-Q - Felt Content QLES1-Able to Communicate With Others Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt able to communicate with others? Q-LES-Q - Able to Communicate With Others QLES1-Taking Care of Your Appearance Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt interested in taking care of your appearance (hair, clothing) and personal hygiene (bathing, dressing)? Q-LES-Q - Taking Care of Your Appearance QLES1-Felt Able to Make Decisions Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt able to make decisions? Q-LES-Q - Felt Able to Make Decisions QLES1-Felt Relaxed Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt relaxed? Q-LES-Q - Felt Relaxed QLES1-Felt Good About Your Life Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt good about your life? Q-LES-Q - Felt Good About Your Life QLES1-Able to Travel About When Needed Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt able to travel about to get things done when needed (walk, use car, bus, train, or whatever is available as needed)? Q-LES-Q - Able to Travel About to Get Things Done When Needed QLES1-Able to Deal With Life's Problems Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt able to deal with life's problems? Q-LES-Q - Able to Deal With Life's Problems QLES1-Able to Take Care of Yourself Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt able to take care of yourself? Q-LES-Q - Able to Take Care of Yourself QLES1-Have a Job Quality Of Life Enjoyment And Satisfaction Questionnaire - Do you have a job? Q-LES-Q - Have a Job QLES1-Work for Yourself Quality Of Life Enjoyment And Satisfaction Questionnaire - Do you work for yourself? Q-LES-Q - Work for Yourself QLES1-Do Volunteer Work Quality Of Life Enjoyment And Satisfaction Questionnaire - Do you do volunteer work? Q-LES-Q - Do Volunteer Work QLES1-Reason for Not Working Quality Of Life Enjoyment And Satisfaction Questionnaire - Reason not having a job, working for yourself, and not doing volunteer work? Q-LES-Q - Reason for Not Working QLES1-Enjoyed Your Work Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Enjoyed your work? Q-LES-Q - Enjoyed Your Work QLES1-Solved Work Problem Without Stress Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Solved work problems or dealt with them without undue stress? Q-LES-Q - Solved Work Problem Without Stress QLES1-Thought Clearly About Work Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Thought clearly about work? Q-LES-Q - Thought Clearly About Work QLES1-Decisive About Work/Made Decisions Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Been decisive about work, or made decisions when needed? Q-LES-Q - Decisive About Work or Made Decisions QLES1-Accomplished What You Wanted to Do Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Accomplished what you wanted to do? Q-LES-Q - Accomplished What You Wanted to Do QLES1-Pleased With Work Accomplishments Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Been pleased with your work accomplishments? Q-LES-Q - Pleased With Work Accomplishments QLES1-Worked Well Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Worked well? Q-LES-Q - Worked Well QLES1-Been Interested in Your Work Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Been interested in your work? Q-LES-Q - Been Interested in Your Work QLES1-Concentrated on Work Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Concentrated on work? Q-LES-Q - Concentrated on Work QLES1-Worked Carefully Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Worked carefully? Q-LES-Q - Worked Carefully QLES1-Kept Up With Expected Work Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Kept up with expected work? Q-LES-Q - Kept Up With Expected Work QLES1-Taken Care of Work by Yourself Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Taken care of work by yourself when it was necessary? Q-LES-Q - Taken Care of Work by Yourself QLES1-Communicated/Interacted With Ease Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Communicated and interacted with ease with others while working? Q-LES-Q - Communicated and Interacted With Ease QLES1-Responsible for Household Quality Of Life Enjoyment And Satisfaction Questionnaire - Are you responsible for any household duties/housework/homemaker activities (e.g., cleaning, shopping, doing dishes, food shopping or preparation) for your-self or for other people? Q-LES-Q - Responsible for Household QLES1-Reason for No Household Activities Quality Of Life Enjoyment And Satisfaction Questionnaire - Reason for no household duties/housework/homemaker activities (e.g., cleaning, shopping doing dishes, food shopping or preparation) for your-self or for other people? Q-LES-Q - Reason for No Household Activities QLES1-Kept Room Clean to Satisfaction Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Kept your room/apartment/house cleaned to your satisfaction? Q-LES-Q - Kept Room Clean to Satisfaction QLES1-Paid Bills, Done Banking Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Paid the bills, done the banking to your satisfaction? Q-LES-Q - Paid Bills, Done Banking QLES1-Shopped for Food/Household Items Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Shopped for food or other household items to your satisfaction? Q-LES-Q - Shopped for Food or Household Items QLES1-Prepared Food or Obtained Food Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Prepared food or obtained food to your satisfaction? Q-LES-Q - Prepared Food or Obtained Food QLES1-Taken Care of Laundry/Cleaning Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Taken care of the laundry/cleaning to your satisfaction? Q-LES-Q - Taken Care of Laundry or Cleaning QLES1-Accomplish Household Activities Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Had a feeling of accomplishment with regard to household activities? Q-LES-Q - Accomplish Household Activities QLES1-Thought Clearly Household Activ Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Concentrated and thought clearly about what household activities needed to be done? Q-LES-Q - Thought Clearly Household Activities to be Done QLES1-Solved House Problems w/o Stress Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Solved household problems or dealt with them without undue stress? Q-LES-Q - Solved House Problems Without Stress QLES1-Decisive Household Activities Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Been decisive or made decisions when needed with regard to household activities? Q-LES-Q - Decisive With Regard to Household Activities QLES1-Made Repairs Household Maintenance Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Made repairs or taken care of household maintenance as needed? Q-LES-Q - Made Repairs or Household Maintenance QLES1-Taken Courses/Going to Class Quality Of Life Enjoyment And Satisfaction Questionnaire - Have you been taking any courses, going to class, or been involved in any type of course work, school or college studies during the past week? Q-LES-Q - Taken Courses or Going to Class QLES1-Reason for No Courses Quality Of Life Enjoyment And Satisfaction Questionnaire - Reason not taking any courses, going to class, or been involved in any type of course work, school or college studies during the past week. Q-LES-Q - Reason for No Courses QLES1-Enjoyed Course/Class Work Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Enjoyed the course/class work? Q-LES-Q - Enjoyed Course or Class Work QLES1-Looked Forward to Course Work Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Looked forward to getting to work on the course/class work? Q-LES-Q - Looked Forward to Course Work QLES1-Course/Class Work Without Stress Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Dealt with the course/class work without undue stress? Q-LES-Q - Dealt With Course or Class Work Without Stress QLES1-Thought Clearly About Course Work Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Thought clearly about the course/class work? Q-LES-Q - Thought Clearly About Course Work QLES1-Decisive About Course Work Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Been decisive about the course/class work when needed? Q-LES-Q - Decisive About Course Work QLES1-Pleased With Course Accomplishment Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Been pleased with your course/class work accomplishments? Q-LES-Q - Pleased With Course Accomplishment QLES1-Interested in Your Course Work Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Been interested in your course/class work? Q-LES-Q - Interested in Your Course Work QLES1-Concentrated on Course Work Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Concentrated on the course/class work? Q-LES-Q - Concentrated on Course Work QLES1-Felt Good Doing Course Work Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt good while doing your course/class work? Q-LES-Q - Felt Good Doing Course Work QLES1-Communicated With Ease at Course Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Communicated and interacted with ease with others at your course/class? Q-LES-Q - Communicated With Ease at Course QLES1-Use Time for a Leisure Activity Quality Of Life Enjoyment And Satisfaction Questionnaire - When you had time, how often did you use that time for a leisure time activity? Q-LES-Q - Use Time for a Leisure Activity QLES1-Enjoy the Leisure Activities Quality Of Life Enjoyment And Satisfaction Questionnaire - How often did you enjoy the leisure activities? Q-LES-Q - Enjoy the Leisure Activities QLES1-Look Forward to Leisure Activities Quality Of Life Enjoyment And Satisfaction Questionnaire - How often did you look forward to the leisure activities before spending time at them? Q-LES-Q - Look Forward to Leisure Activities QLES1-Concentrate on Leisure Activities Quality Of Life Enjoyment And Satisfaction Questionnaire - How often did you concentrate on the leisure activities and pay attention to them? Q-LES-Q - Concentrate on Leisure Activities QLES1-Solve or Deal Without Undue Stress Quality Of Life Enjoyment And Satisfaction Questionnaire - If a problem arose in your leisure activities, how often did you solve it or deal with it without undue stress? Q-LES-Q - Solve or Deal Without Undue Stress QLES1-Leisure Activity Sustain Interest Quality Of Life Enjoyment And Satisfaction Questionnaire - How often did the leisure activities sustain your interest? Q-LES-Q - Leisure Activity Sustain Interest QLES1-Enjoyed Being With Friends Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Enjoyed talking with or being with friends or relatives? Q-LES-Q - Enjoyed Being With Friends QLES1-Getting Together With Friends Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Looked forward to getting together with friends or relatives? Q-LES-Q - Getting Together With Friends QLES1-Made Social Plans With Friends Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Made social plans with friends or relatives for future activities? Q-LES-Q - Made Social Plans With Friends QLES1-Enjoyed Talking With Co-workers Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Enjoyed talking with co-workers or neighbors? Q-LES-Q - Enjoyed Talking With Co-workers QLES1-Patient With Others Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Been patient with others when others were irritating in their actions or words? Q-LES-Q - Patient With Others QLES1-Interested in Problems of People Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Been interested in the problems of other people? Q-LES-Q - Interested in Problems of People QLES1-Felt Affection Toward People Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Felt affection toward one or more people? Q-LES-Q - Felt Affection Toward People QLES1-Gotten Along Well With People Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Gotten along well with other people? Q-LES-Q - Gotten Along Well With People QLES1-Joked or Laughed With Other People Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Joked or laughed with other people? Q-LES-Q - Joked or Laughed With Other People QLES1-Met Needs of Friends or Relatives Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Felt you met the needs of friends or relatives? Q-LES-Q - Met Needs of Friends or Relatives QLES1-Relationships Without Problems Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Felt your relationships with your friends or relatives were without major problems or conflicts? Q-LES-Q - Relationships Without Problems QLES1-Physical Health Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Physical health? Q-LES-Q - Physical Health QLES1-Mood Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Mood? Q-LES-Q - Mood QLES1-Work Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Work? Q-LES-Q - Work QLES1-Household Activities Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Household activities? Q-LES-Q - Household Activities QLES1-Social Relationships Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Social relationships? Q-LES-Q - Social Relationships QLES1-Family Relationships Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Family relationships? Q-LES-Q - Family Relationships QLES1-Leisure Time Activities Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Leisure time activities? Q-LES-Q - Leisure Time Activities QLES1-Ability to Function in Daily Life Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Ability to function in daily life? Q-LES-Q - Ability to Function in Daily Life QLES1-Sex Drive, Interest, Performance Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Sexual drive, interest and/or performance? Q-LES-Q - Sex Drive, Interest, Performance QLES1-Economic Status Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Economic status? Q-LES-Q - Economic Status QLES1-Living/Housing Situation Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Living/housing situation? Q-LES-Q - Living or Housing Situation QLES1-Ability to Get Around Physically Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Ability to get around physically without feeling dizzy or unsteady or falling? Q-LES-Q - Ability to Get Around Physically QLES1-Vision Ability to Do Work/Hobbies Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: your vision in terms of ability to do work or hobbies? Q-LES-Q - Vision Ability to Do Work or Hobbies QLES1-Overall Sense of Well Being Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Overall sense of well being? Q-LES-Q - Overall Sense of Well Being QLES1-Medication Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Medication? Q-LES-Q - Medication QLES1-Rate Overall Life Satisfaction Quality Of Life Enjoyment And Satisfaction Questionnaire - How would you rate your overall life satisfaction and contentment during the past week? Q-LES-Q - Rate Overall Life Satisfaction QLES1TC Quality Of Life Enjoyment And Satisfaction Questionnaire Test Code CDISC Questionnaire Q-LES-Q Test Code Terminology Quality Of Life Enjoyment And Satisfaction Questionnaire test name. QLES1-Ability to Function in Daily Life Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Ability to function in daily life? Q-LES-Q - Ability to Function in Daily Life QLES1-Ability to Get Around Physically Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Ability to get around physically without feeling dizzy or unsteady or falling? Q-LES-Q - Ability to Get Around Physically QLES1-Able to Communicate With Others Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt able to communicate with others? Q-LES-Q - Able to Communicate With Others QLES1-Able to Deal With Life's Problems Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt able to deal with life's problems? Q-LES-Q - Able to Deal With Life's Problems QLES1-Able to Take Care of Yourself Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt able to take care of yourself? Q-LES-Q - Able to Take Care of Yourself QLES1-Able to Travel About When Needed Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt able to travel about to get things done when needed (walk, use car, bus, train, or whatever is available as needed)? Q-LES-Q - Able to Travel About to Get Things Done When Needed QLES1-Accomplish Household Activities Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Had a feeling of accomplishment with regard to household activities? Q-LES-Q - Accomplish Household Activities QLES1-Accomplished What You Wanted to Do Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Accomplished what you wanted to do? Q-LES-Q - Accomplished What You Wanted to Do QLES1-At Least Very Good Physical Health Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt in at least very good physical health? Q-LES-Q - At Least Very Good Physical Health QLES1-Be as Physically Active as Needed Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt able to be as physically active as needed? Q-LES-Q - Be as Physically Active as Needed QLES1-Been Interested in Your Work Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Been interested in your work? Q-LES-Q - Been Interested in Your Work QLES1-Communicated With Ease at Course Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Communicated and interacted with ease with others at your course/class? Q-LES-Q - Communicated With Ease at Course QLES1-Communicated/Interacted With Ease Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Communicated and interacted with ease with others while working? Q-LES-Q - Communicated and Interacted With Ease QLES1-Concentrate on Leisure Activities Quality Of Life Enjoyment And Satisfaction Questionnaire - How often did you concentrate on the leisure activities and pay attention to them? Q-LES-Q - Concentrate on Leisure Activities QLES1-Concentrated on Course Work Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Concentrated on the course/class work? Q-LES-Q - Concentrated on Course Work QLES1-Concentrated on Work Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Concentrated on work? Q-LES-Q - Concentrated on Work QLES1-Course/Class Work Without Stress Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Dealt with the course/class work without undue stress? Q-LES-Q - Dealt With Course or Class Work Without Stress QLES1-Decisive About Course Work Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Been decisive about the course/class work when needed? Q-LES-Q - Decisive About Course Work QLES1-Decisive About Work/Made Decisions Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Been decisive about work, or made decisions when needed? Q-LES-Q - Decisive About Work or Made Decisions QLES1-Decisive Household Activities Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Been decisive or made decisions when needed with regard to household activities? Q-LES-Q - Decisive With Regard to Household Activities QLES1-Do Volunteer Work Quality Of Life Enjoyment And Satisfaction Questionnaire - Do you do volunteer work? Q-LES-Q - Do Volunteer Work QLES1-Economic Status Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Economic status? Q-LES-Q - Economic Status QLES1-Enjoy the Leisure Activities Quality Of Life Enjoyment And Satisfaction Questionnaire - How often did you enjoy the leisure activities? Q-LES-Q - Enjoy the Leisure Activities QLES1-Enjoyed Being With Friends Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Enjoyed talking with or being with friends or relatives? Q-LES-Q - Enjoyed Being With Friends QLES1-Enjoyed Course/Class Work Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Enjoyed the course/class work? Q-LES-Q - Enjoyed Course or Class Work QLES1-Enjoyed Talking With Co-workers Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Enjoyed talking with co-workers or neighbors? Q-LES-Q - Enjoyed Talking With Co-workers QLES1-Enjoyed Your Work Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Enjoyed your work? Q-LES-Q - Enjoyed Your Work QLES1-Family Relationships Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Family relationships? Q-LES-Q - Family Relationships QLES1-Felt Able to Make Decisions Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt able to make decisions? Q-LES-Q - Felt Able to Make Decisions QLES1-Felt Affection Toward People Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Felt affection toward one or more people? Q-LES-Q - Felt Affection Toward People QLES1-Felt Clearheaded Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt clearheaded? Q-LES-Q - Felt Clearheaded QLES1-Felt Content Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt content? Q-LES-Q - Felt Content QLES1-Felt Energetic Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt energetic? Q-LES-Q - Felt Energetic QLES1-Felt Full of Pep and Vitality Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt full of pep and vitality? Q-LES-Q - Felt Full of Pep and Vitality QLES1-Felt Good About Your Appearance Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt good about your appearance? Q-LES-Q - Felt Good About Your Appearance QLES1-Felt Good About Your Life Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt good about your life? Q-LES-Q - Felt Good About Your Life QLES1-Felt Good Doing Course Work Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt good while doing your course/class work? Q-LES-Q - Felt Good Doing Course Work QLES1-Felt Good Physically Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt good physically? Q-LES-Q - Felt Good Physically QLES1-Felt Happy or Cheerful Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt happy or cheerful? Q-LES-Q - Felt Happy or Cheerful QLES1-Felt in Excellent Physical Health Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt in excellent physical health? Q-LES-Q - Felt in Excellent Physical Health QLES1-Felt Independent Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt independent? Q-LES-Q - Felt Independent QLES1-Felt Memory Was Functioning Well Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt your memory was functioning well? Q-LES-Q - Felt Memory Was Functioning Well QLES1-Felt Relaxed Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt relaxed? Q-LES-Q - Felt Relaxed QLES1-Felt Rested Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt rested? Q-LES-Q - Felt Rested QLES1-Felt Satisfied With Your Life Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt satisfied with your life? Q-LES-Q - Felt Satisfied With Your Life QLES1-Felt Well Coordinated Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt well coordinated? Q-LES-Q - Felt Well Coordinated QLES1-Felt You Got Enough Sleep Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt you got enough sleep? Q-LES-Q - Felt You Got Enough Sleep QLES1-Free of Aches, Pains, Discomfort Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Been completely free of aches, pains, or discomfort? Q-LES-Q - Free of Aches, Pains, Discomfort QLES1-Free of Visual Problems Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Been free of visual problems? Q-LES-Q - Free of Visual Problems QLES1-Free of Worry of Physical Health Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Been free of worry about your physical health? Q-LES-Q - Free of Worry of Physical Health QLES1-Getting Together With Friends Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Looked forward to getting together with friends or relatives? Q-LES-Q - Getting Together With Friends QLES1-Gotten Along Well With People Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Gotten along well with other people? Q-LES-Q - Gotten Along Well With People QLES1-Have a Job Quality Of Life Enjoyment And Satisfaction Questionnaire - Do you have a job? Q-LES-Q - Have a Job QLES1-Household Activities Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Household activities? Q-LES-Q - Household Activities QLES1-Interested in Problems of People Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Been interested in the problems of other people? Q-LES-Q - Interested in Problems of People QLES1-Interested in Your Course Work Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Been interested in your course/class work? Q-LES-Q - Interested in Your Course Work QLES1-Joked or Laughed With Other People Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Joked or laughed with other people? Q-LES-Q - Joked or Laughed With Other People QLES1-Kept Room Clean to Satisfaction Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Kept your room/apartment/house cleaned to your satisfaction? Q-LES-Q - Kept Room Clean to Satisfaction QLES1-Kept Up With Expected Work Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Kept up with expected work? Q-LES-Q - Kept Up With Expected Work QLES1-Leisure Activity Sustain Interest Quality Of Life Enjoyment And Satisfaction Questionnaire - How often did the leisure activities sustain your interest? Q-LES-Q - Leisure Activity Sustain Interest QLES1-Leisure Time Activities Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Leisure time activities? Q-LES-Q - Leisure Time Activities QLES1-Living/Housing Situation Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Living/housing situation? Q-LES-Q - Living or Housing Situation QLES1-Look Forward to Leisure Activities Quality Of Life Enjoyment And Satisfaction Questionnaire - How often did you look forward to the leisure activities before spending time at them? Q-LES-Q - Look Forward to Leisure Activities QLES1-Looked Forward to Course Work Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Looked forward to getting to work on the course/class work? Q-LES-Q - Looked Forward to Course Work QLES1-Made Repairs Household Maintenance Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Made repairs or taken care of household maintenance as needed? Q-LES-Q - Made Repairs or Household Maintenance QLES1-Made Social Plans With Friends Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Made social plans with friends or relatives for future activities? Q-LES-Q - Made Social Plans With Friends QLES1-Medication Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Medication? Q-LES-Q - Medication QLES1-Met Needs of Friends or Relatives Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Felt you met the needs of friends or relatives? Q-LES-Q - Met Needs of Friends or Relatives QLES1-Mood Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Mood? Q-LES-Q - Mood QLES1-Overall Sense of Well Being Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Overall sense of well being? Q-LES-Q - Overall Sense of Well Being QLES1-Paid Bills, Done Banking Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Paid the bills, done the banking to your satisfaction? Q-LES-Q - Paid Bills, Done Banking QLES1-Patient With Others Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Been patient with others when others were irritating in their actions or words? Q-LES-Q - Patient With Others QLES1-Physical Health Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Physical health? Q-LES-Q - Physical Health QLES1-Pleased With Course Accomplishment Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Been pleased with your course/class work accomplishments? Q-LES-Q - Pleased With Course Accomplishment QLES1-Pleased With Work Accomplishments Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Been pleased with your work accomplishments? Q-LES-Q - Pleased With Work Accomplishments QLES1-Prepared Food or Obtained Food Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Prepared food or obtained food to your satisfaction? Q-LES-Q - Prepared Food or Obtained Food QLES1-Rate Overall Life Satisfaction Quality Of Life Enjoyment And Satisfaction Questionnaire - How would you rate your overall life satisfaction and contentment during the past week? Q-LES-Q - Rate Overall Life Satisfaction QLES1-Reason for No Courses Quality Of Life Enjoyment And Satisfaction Questionnaire - Reason not taking any courses, going to class, or been involved in any type of course work, school or college studies during the past week. Q-LES-Q - Reason for No Courses QLES1-Reason for No Household Activities Quality Of Life Enjoyment And Satisfaction Questionnaire - Reason for no household duties/housework/homemaker activities (e.g., cleaning, shopping doing dishes, food shopping or preparation) for your-self or for other people? Q-LES-Q - Reason for No Household Activities QLES1-Reason for Not Working Quality Of Life Enjoyment And Satisfaction Questionnaire - Reason not having a job, working for yourself, and not doing volunteer work? Q-LES-Q - Reason for Not Working QLES1-Relationships Without Problems Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Felt your relationships with your friends or relatives were without major problems or conflicts? Q-LES-Q - Relationships Without Problems QLES1-Responsible for Household Quality Of Life Enjoyment And Satisfaction Questionnaire - Are you responsible for any household duties/housework/homemaker activities (e.g., cleaning, shopping, doing dishes, food shopping or preparation) for your-self or for other people? Q-LES-Q - Responsible for Household QLES1-Sex Drive, Interest, Performance Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Sexual drive, interest and/or performance? Q-LES-Q - Sex Drive, Interest, Performance QLES1-Shopped for Food/Household Items Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Shopped for food or other household items to your satisfaction? Q-LES-Q - Shopped for Food or Household Items QLES1-Social Relationships Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Social relationships? Q-LES-Q - Social Relationships QLES1-Solve or Deal Without Undue Stress Quality Of Life Enjoyment And Satisfaction Questionnaire - If a problem arose in your leisure activities, how often did you solve it or deal with it without undue stress? Q-LES-Q - Solve or Deal Without Undue Stress QLES1-Solved House Problems w/o Stress Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Solved household problems or dealt with them without undue stress? Q-LES-Q - Solved House Problems Without Stress QLES1-Solved Work Problem Without Stress Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Solved work problems or dealt with them without undue stress? Q-LES-Q - Solved Work Problem Without Stress QLES1-Taken Care of Laundry/Cleaning Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Taken care of the laundry/cleaning to your satisfaction? Q-LES-Q - Taken Care of Laundry or Cleaning QLES1-Taken Care of Work by Yourself Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Taken care of work by yourself when it was necessary? Q-LES-Q - Taken Care of Work by Yourself QLES1-Taken Courses/Going to Class Quality Of Life Enjoyment And Satisfaction Questionnaire - Have you been taking any courses, going to class, or been involved in any type of course work, school or college studies during the past week? Q-LES-Q - Taken Courses or Going to Class QLES1-Taking Care of Your Appearance Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt interested in taking care of your appearance (hair, clothing) and personal hygiene (bathing, dressing)? Q-LES-Q - Taking Care of Your Appearance QLES1-Thought Clearly About Course Work Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Thought clearly about the course/class work? Q-LES-Q - Thought Clearly About Course Work QLES1-Thought Clearly About Work Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Thought clearly about work? Q-LES-Q - Thought Clearly About Work QLES1-Thought Clearly Household Activ Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Concentrated and thought clearly about what household activities needed to be done? Q-LES-Q - Thought Clearly Household Activities to be Done QLES1-Use Time for a Leisure Activity Quality Of Life Enjoyment And Satisfaction Questionnaire - When you had time, how often did you use that time for a leisure time activity? Q-LES-Q - Use Time for a Leisure Activity QLES1-Vision Ability to Do Work/Hobbies Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: your vision in terms of ability to do work or hobbies? Q-LES-Q - Vision Ability to Do Work or Hobbies QLES1-Work for Yourself Quality Of Life Enjoyment And Satisfaction Questionnaire - Do you work for yourself? Q-LES-Q - Work for Yourself QLES1-Work Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Work? Q-LES-Q - Work QLES1-Worked Carefully Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Worked carefully? Q-LES-Q - Worked Carefully QLES1-Worked Well Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Worked well? Q-LES-Q - Worked Well QLES1TN Quality Of Life Enjoyment And Satisfaction Questionnaire Test Name CDISC Questionnaire Q-LES-Q Test Name Terminology Quality of Life in Inflammatory Bowel Disease Questionnaire test code. IBDQ01-How Frequent Bowel Movements Quality of Life in Inflammatory Bowel Disease Questionnaire - How frequent have your bowel movements been during the last two weeks? IBDQ - How Frequent Bowel Movements IBDQ01-Fatigue Been a Problem Quality of Life in Inflammatory Bowel Disease Questionnaire - How often has the feeling of fatigue or of being tired and worn out been a problem for you during the last 2 weeks? IBDQ - Fatigue Been a Problem IBDQ01-Felt Frustrated Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you felt frustrated, impatient or restless? IBDQ - Felt Frustrated IBDQ01-Unable to Attend School or Work Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you been unable to attend school or do your work because of your bowel problem? IBDQ - Unable to Attend School or Work IBDQ01-Bowel Movements Been Loose Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have your bowel movements been loose? IBDQ - Bowel Movements Been Loose IBDQ01-How Much Energy Have You Had Quality of Life in Inflammatory Bowel Disease Questionnaire - How much energy have you had during the last 2 weeks? IBDQ - How Much Energy Have You Had IBDQ01-Feel Worried About Surgery Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks did you feel worried about the possibility of needing to have surgery because of your bowel problem? IBDQ - Feel Worried About Surgery IBDQ01-Delay/Cancel Social Engagement Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you had to delay or cancel a social engagement because of your bowel problem? IBDQ - Delay or Cancel Social Engagement IBDQ01-Troubled by Cramps in Abdomen Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you been troubled by cramps in your abdomen? IBDQ - Troubled by Cramps in Abdomen IBDQ01-Felt Generally Unwell Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you felt generally unwell? IBDQ - Felt Generally Unwell IBDQ01-Fear of Not Finding a Washroom Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you been troubled because of fear of not finding a washroom? IBDQ - Fear of Not Finding a Washroom IBDQ01-Difficulty Doing Leisure/Sports Quality of Life in Inflammatory Bowel Disease Questionnaire - How much difficulty have you had, as a result of your bowel problems, doing leisure or sports activities you would have liked to have done during the last 2 weeks? IBDQ - Difficulty Doing Leisure or Sports IBDQ01-Troubled by Pain in Abdomen Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you been troubled by pain in the abdomen? IBDQ - Troubled by Pain in Abdomen IBDQ01-Problems Getting Sleep/Waking Up Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you had problems getting a good night's sleep, or been troubled by waking up during the night? IBDQ - Problems Getting Sleep or Waking Up IBDQ01-Felt Depressed or Discouraged Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you felt depressed or discouraged? IBDQ - Felt Depressed or Discouraged IBDQ01-Avoid Events Where No Washroom Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you had to avoid attending events where there was no washroom close at hand? IBDQ - Avoid Events Where No Washroom IBDQ01-Problem Passing Large Amounts Gas Quality of Life in Inflammatory Bowel Disease Questionnaire - Overall, in the last 2 weeks, how much of a problem have you had with passing large amounts of gas? IBDQ - Problem Passing Large Amounts Gas IBDQ01-Problem Maintaining Weight Quality of Life in Inflammatory Bowel Disease Questionnaire - Overall, in the last 2 weeks, how much of a problem have you had maintaining or getting to, the weight you would like to be at? IBDQ - Problem Maintaining Weight IBDQ01-Felt Worried or Anxious Quality of Life in Inflammatory Bowel Disease Questionnaire - In general, how often during the last 2 weeks have you felt worried or anxious? IBDQ - Felt Worried or Anxious IBDQ01-Troubled by Abdominal Bloating Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 week have you been troubled by a feeling of abdominal bloating? IBDQ - Troubled by Abdominal Bloating IBDQ01-Felt Relaxed and Free of Tension Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you felt relaxed and free of tension? IBDQ - Felt Relaxed and Free of Tension IBDQ01-Problem With Rectal Bleeding Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you had a problem with rectal bleeding with your bowel movements? IBDQ - Problem With Rectal Bleeding IBDQ01-Felt Embarrassed Bowel Problem Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you felt embarrassed as a result of your bowel problem? IBDQ - Felt Embarrassed Bowel Problem IBDQ01-Go to Bathroom Bowels Empty Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you been troubled by a feeling of having to go to the bathroom even though your bowels were empty? IBDQ - Go to Bathroom Bowels Empty IBDQ01-Felt Tearful or Upset Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you felt tearful or upset? IBDQ - Felt Tearful or Upset IBDQ01-Accidental Soiling of Underpants Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you been troubled by accidental soiling of your underpants? IBDQ - Accidental Soiling of Underpants IBDQ01-Felt Angry Bowel Problem Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you felt angry as a result of your bowel problem? IBDQ - Felt Angry Bowel Problem IBDQ01-Limited Sexual Activity Quality of Life in Inflammatory Bowel Disease Questionnaire - To what extent has your bowel problem limited sexual activity during the last 2 weeks? IBDQ - Limited Sexual Activity IBDQ01-Nausea or Sick to Your Stomach Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you been troubled by nausea or feeling sick to your stomach? IBDQ - Nausea or Sick to Your Stomach IBDQ01-Felt Irritable Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you felt irritable? IBDQ - Felt Irritable IBDQ01-Lack of Understanding From Others Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the past 2 weeks have you felt a lack of understanding from others? IBDQ - Lack of Understanding From Others IBDQ01-Satisfied With Personal Life Quality of Life in Inflammatory Bowel Disease Questionnaire - How satisfied, happy, or pleased have you been with your personal life during the past 2 weeks? IBDQ - Satisfied With Personal Life IBDQ01TC Quality of Life in Inflammatory Bowel Disease Questionnaire Test Code CDISC Questionnaire IBDQ Test Code Terminology Quality of Life in Inflammatory Bowel Disease Questionnaire test name. IBDQ01-Accidental Soiling of Underpants Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you been troubled by accidental soiling of your underpants? IBDQ - Accidental Soiling of Underpants IBDQ01-Avoid Events Where No Washroom Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you had to avoid attending events where there was no washroom close at hand? IBDQ - Avoid Events Where No Washroom IBDQ01-Bowel Movements Been Loose Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have your bowel movements been loose? IBDQ - Bowel Movements Been Loose IBDQ01-Delay/Cancel Social Engagement Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you had to delay or cancel a social engagement because of your bowel problem? IBDQ - Delay or Cancel Social Engagement IBDQ01-Difficulty Doing Leisure/Sports Quality of Life in Inflammatory Bowel Disease Questionnaire - How much difficulty have you had, as a result of your bowel problems, doing leisure or sports activities you would have liked to have done during the last 2 weeks? IBDQ - Difficulty Doing Leisure or Sports IBDQ01-Fatigue Been a Problem Quality of Life in Inflammatory Bowel Disease Questionnaire - How often has the feeling of fatigue or of being tired and worn out been a problem for you during the last 2 weeks? IBDQ - Fatigue Been a Problem IBDQ01-Fear of Not Finding a Washroom Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you been troubled because of fear of not finding a washroom? IBDQ - Fear of Not Finding a Washroom IBDQ01-Feel Worried About Surgery Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks did you feel worried about the possibility of needing to have surgery because of your bowel problem? IBDQ - Feel Worried About Surgery IBDQ01-Felt Angry Bowel Problem Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you felt angry as a result of your bowel problem? IBDQ - Felt Angry Bowel Problem IBDQ01-Felt Depressed or Discouraged Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you felt depressed or discouraged? IBDQ - Felt Depressed or Discouraged IBDQ01-Felt Embarrassed Bowel Problem Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you felt embarrassed as a result of your bowel problem? IBDQ - Felt Embarrassed Bowel Problem IBDQ01-Felt Frustrated Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you felt frustrated, impatient or restless? IBDQ - Felt Frustrated IBDQ01-Felt Generally Unwell Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you felt generally unwell? IBDQ - Felt Generally Unwell IBDQ01-Felt Irritable Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you felt irritable? IBDQ - Felt Irritable IBDQ01-Felt Relaxed and Free of Tension Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you felt relaxed and free of tension? IBDQ - Felt Relaxed and Free of Tension IBDQ01-Felt Tearful or Upset Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you felt tearful or upset? IBDQ - Felt Tearful or Upset IBDQ01-Felt Worried or Anxious Quality of Life in Inflammatory Bowel Disease Questionnaire - In general, how often during the last 2 weeks have you felt worried or anxious? IBDQ - Felt Worried or Anxious IBDQ01-Go to Bathroom Bowels Empty Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you been troubled by a feeling of having to go to the bathroom even though your bowels were empty? IBDQ - Go to Bathroom Bowels Empty IBDQ01-How Frequent Bowel Movements Quality of Life in Inflammatory Bowel Disease Questionnaire - How frequent have your bowel movements been during the last two weeks? IBDQ - How Frequent Bowel Movements IBDQ01-How Much Energy Have You Had Quality of Life in Inflammatory Bowel Disease Questionnaire - How much energy have you had during the last 2 weeks? IBDQ - How Much Energy Have You Had IBDQ01-Lack of Understanding From Others Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the past 2 weeks have you felt a lack of understanding from others? IBDQ - Lack of Understanding From Others IBDQ01-Limited Sexual Activity Quality of Life in Inflammatory Bowel Disease Questionnaire - To what extent has your bowel problem limited sexual activity during the last 2 weeks? IBDQ - Limited Sexual Activity IBDQ01-Nausea or Sick to Your Stomach Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you been troubled by nausea or feeling sick to your stomach? IBDQ - Nausea or Sick to Your Stomach IBDQ01-Problem Maintaining Weight Quality of Life in Inflammatory Bowel Disease Questionnaire - Overall, in the last 2 weeks, how much of a problem have you had maintaining or getting to, the weight you would like to be at? IBDQ - Problem Maintaining Weight IBDQ01-Problem Passing Large Amounts Gas Quality of Life in Inflammatory Bowel Disease Questionnaire - Overall, in the last 2 weeks, how much of a problem have you had with passing large amounts of gas? IBDQ - Problem Passing Large Amounts Gas IBDQ01-Problem With Rectal Bleeding Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you had a problem with rectal bleeding with your bowel movements? IBDQ - Problem With Rectal Bleeding IBDQ01-Problems Getting Sleep/Waking Up Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you had problems getting a good night's sleep, or been troubled by waking up during the night? IBDQ - Problems Getting Sleep or Waking Up IBDQ01-Satisfied With Personal Life Quality of Life in Inflammatory Bowel Disease Questionnaire - How satisfied, happy, or pleased have you been with your personal life during the past 2 weeks? IBDQ - Satisfied With Personal Life IBDQ01-Troubled by Abdominal Bloating Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 week have you been troubled by a feeling of abdominal bloating? IBDQ - Troubled by Abdominal Bloating IBDQ01-Troubled by Cramps in Abdomen Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you been troubled by cramps in your abdomen? IBDQ - Troubled by Cramps in Abdomen IBDQ01-Troubled by Pain in Abdomen Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you been troubled by pain in the abdomen? IBDQ - Troubled by Pain in Abdomen IBDQ01-Unable to Attend School or Work Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you been unable to attend school or do your work because of your bowel problem? IBDQ - Unable to Attend School or Work IBDQ01TN Quality of Life in Inflammatory Bowel Disease Questionnaire Test Name CDISC Questionnaire IBDQ Test Name Terminology Questionnaire on Smoking Urges-Brief test code. QSUB01-Desire Cigarette Right Now Questionnaire on Smoking Urges-Brief - I have a desire for a cigarette right now. Brief Questionnaire of Smoking Urges - Desire Cigarette Right Now QSUB01-Nothing Better Than Cigarette Now Questionnaire on Smoking Urges-Brief - Nothing would be better than smoking a cigarette right now. Brief Questionnaire of Smoking Urges - Nothing Better Than Cigarette Now QSUB01-Probably Would Smoke Now Questionnaire on Smoking Urges-Brief - If it were possible, I probably would smoke now. Brief Questionnaire of Smoking Urges - Probably Would Smoke Now QSUB01-Control Things Better Could Smoke Questionnaire on Smoking Urges-Brief - I could control things better right now if I could smoke. Brief Questionnaire of Smoking Urges - Control Things Better Could Smoke QSUB01-All I Want Right Now Is Cigarette Questionnaire on Smoking Urges-Brief - All I want right now is a cigarette. Brief Questionnaire of Smoking Urges - All I Want Right Now Is Cigarette QSUB01-Have an Urge for a Cigarette Questionnaire on Smoking Urges-Brief - I have an urge for a cigarette. Brief Questionnaire of Smoking Urges - Have an Urge for a Cigarette QSUB01-A Cigarette Would Taste Good Now Questionnaire on Smoking Urges-Brief - A cigarette would taste good now. Brief Questionnaire of Smoking Urges - A Cigarette Would Taste Good Now QSUB01-Do Anything for a Cigarette Now Questionnaire on Smoking Urges-Brief - I would do almost anything for a cigarette right now. Brief Questionnaire of Smoking Urges - Do Anything for a Cigarette Now QSUB01-Smoking Make Me Less Depressed Questionnaire on Smoking Urges-Brief - Smoking would make me less depressed. Brief Questionnaire of Smoking Urges - Smoking Make Me Less Depressed QSUB01-Going Smoke as Soon as Possible Questionnaire on Smoking Urges-Brief - I am going to smoke as soon as possible. Brief Questionnaire of Smoking Urges - Going Smoke as Soon as Possible QSUB01-Factor 1 Scale Questionnaire on Smoking Urges-Brief - Factor 1 scale. Brief Questionnaire of Smoking Urges - Factor 1 Scale QSUB01-Factor 2 Scale Questionnaire on Smoking Urges-Brief - Factor 2 scale. Brief Questionnaire of Smoking Urges - Factor 2 Scale QSUB01-General Factor Scale Questionnaire on Smoking Urges-Brief - General factor scale. Brief Questionnaire of Smoking Urges - General Factor Scale QSUB01TC Questionnaire on Smoking Urges-Brief Test Code CDISC Brief Questionnaire of Smoking Urges Test Code Terminology Questionnaire on Smoking Urges-Brief test name. QSUB01-A Cigarette Would Taste Good Now Questionnaire on Smoking Urges-Brief - A cigarette would taste good now. Brief Questionnaire of Smoking Urges - A Cigarette Would Taste Good Now QSUB01-All I Want Right Now Is Cigarette Questionnaire on Smoking Urges-Brief - All I want right now is a cigarette. Brief Questionnaire of Smoking Urges - All I Want Right Now Is Cigarette QSUB01-Control Things Better Could Smoke Questionnaire on Smoking Urges-Brief - I could control things better right now if I could smoke. Brief Questionnaire of Smoking Urges - Control Things Better Could Smoke QSUB01-Desire Cigarette Right Now Questionnaire on Smoking Urges-Brief - I have a desire for a cigarette right now. Brief Questionnaire of Smoking Urges - Desire Cigarette Right Now QSUB01-Do Anything for a Cigarette Now Questionnaire on Smoking Urges-Brief - I would do almost anything for a cigarette right now. Brief Questionnaire of Smoking Urges - Do Anything for a Cigarette Now QSUB01-Factor 1 Scale Questionnaire on Smoking Urges-Brief - Factor 1 scale. Brief Questionnaire of Smoking Urges - Factor 1 Scale QSUB01-Factor 2 Scale Questionnaire on Smoking Urges-Brief - Factor 2 scale. Brief Questionnaire of Smoking Urges - Factor 2 Scale QSUB01-General Factor Scale Questionnaire on Smoking Urges-Brief - General factor scale. Brief Questionnaire of Smoking Urges - General Factor Scale QSUB01-Going Smoke as Soon as Possible Questionnaire on Smoking Urges-Brief - I am going to smoke as soon as possible. Brief Questionnaire of Smoking Urges - Going Smoke as Soon as Possible QSUB01-Have an Urge for a Cigarette Questionnaire on Smoking Urges-Brief - I have an urge for a cigarette. Brief Questionnaire of Smoking Urges - Have an Urge for a Cigarette QSUB01-Nothing Better Than Cigarette Now Questionnaire on Smoking Urges-Brief - Nothing would be better than smoking a cigarette right now. Brief Questionnaire of Smoking Urges - Nothing Better Than Cigarette Now QSUB01-Probably Would Smoke Now Questionnaire on Smoking Urges-Brief - If it were possible, I probably would smoke now. Brief Questionnaire of Smoking Urges - Probably Would Smoke Now QSUB01-Smoking Make Me Less Depressed Questionnaire on Smoking Urges-Brief - Smoking would make me less depressed. Brief Questionnaire of Smoking Urges - Smoking Make Me Less Depressed QSUB01TN Questionnaire on Smoking Urges-Brief Test Name CDISC Brief Questionnaire of Smoking Urges Test Name Terminology Quick Inventory of Depressive Symptomatology Clinician-Rated Version test code. QIDSC1-Sleep Onset Insomnia Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Sleep onset insomnia. QIDS-C - Sleep Onset Insomnia QIDSC1-Mid-Nocturnal Insomnia Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Mid-nocturnal insomnia. QIDS-C - Mid-Nocturnal Insomnia QIDSC1-Early Morning Insomnia Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Early morning insomnia. QIDS-C - Early Morning Insomnia QIDSC1-Hypersomnia Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Hypersomnia. QIDS-C - Hypersomnia QIDSC1-Mood (Sad) Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Mood (sad). QIDS-C - Mood (Sad) QIDSC1-Appetite (Decreased) Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Appetite (decreased). QIDS-C - Appetite (Decreased) QIDSC1-Appetite (Increased) Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Appetite (increased). QIDS-C - Appetite (Increased) QIDSC1-Weight (Decrease) Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Weight (decrease) within the last two weeks. QIDS-C - Weight (Decrease) QIDSC1-Weight (Increase) Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Weight (increase) within the last two weeks. QIDS-C - Weight (Increase) QIDSC1-Concentration/Decision Making Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Concentration/decision making. QIDS-C - Concentration or Decision Making QIDSC1-Outlook (Self) Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Outlook (self). QIDS-C - Outlook (Self) QIDSC1-Suicidal Ideation Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Suicidal ideation. QIDS-C - Suicidal Ideation QIDSC1-Involvement Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Involvement. QIDS-C - Involvement QIDSC1-Energy/Fatiguability Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Energy/fatiguability. QIDS-C - Energy or Fatiguability QIDSC1-Psychomotor Slowing Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Psychomotor slowing. QIDS-C - Psychomotor Slowing QIDSC1-Psychomotor Agitation Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Psychomotor agitation. QIDS-C - Psychomotor Agitation QIDSC1-Highest Score Sleep Items Quick Inventory of Depressive Symptomatology - Clinician-Rated - Enter the highest score on any 1 of the 4 sleep items. QIDS-C - Highest Score Sleep Items QIDSC1-High Score Appetite/Weight Items Quick Inventory of Depressive Symptomatology - Clinician-Rated - Enter the highest score on any 1 of the 4 appetite/weight change items. QIDS-C - High Score Appetite or Weight Items QIDSC1-Highest Score Psychomotor Items Quick Inventory of Depressive Symptomatology - Clinician-Rated - Enter the highest score on either of the 2 psychomotor items. QIDS-C - Highest Score Psychomotor Items QIDSC1-Total Score Quick Inventory of Depressive Symptomatology - Clinician-Rated - Total score. QIDS-C - Total Score QIDSC1TC Quick Inventory of Depressive Symptomatology Clinician-Rated Version Clinical Classification Test Code CDISC Clinical Classification QIDS-C Test Code Terminology Quick Inventory of Depressive Symptomatology Clinician-Rated Version test name. QIDSC1-Appetite (Decreased) Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Appetite (decreased). QIDS-C - Appetite (Decreased) QIDSC1-Appetite (Increased) Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Appetite (increased). QIDS-C - Appetite (Increased) QIDSC1-Concentration/Decision Making Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Concentration/decision making. QIDS-C - Concentration or Decision Making QIDSC1-Early Morning Insomnia Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Early morning insomnia. QIDS-C - Early Morning Insomnia QIDSC1-Energy/Fatiguability Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Energy/fatiguability. QIDS-C - Energy or Fatiguability QIDSC1-High Score Appetite/Weight Items Quick Inventory of Depressive Symptomatology - Clinician-Rated - Enter the highest score on any 1 of the 4 appetite/weight change items. QIDS-C - High Score Appetite or Weight Items QIDSC1-Highest Score Psychomotor Items Quick Inventory of Depressive Symptomatology - Clinician-Rated - Enter the highest score on either of the 2 psychomotor items. QIDS-C - Highest Score Psychomotor Items QIDSC1-Highest Score Sleep Items Quick Inventory of Depressive Symptomatology - Clinician-Rated - Enter the highest score on any 1 of the 4 sleep items. QIDS-C - Highest Score Sleep Items QIDSC1-Hypersomnia Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Hypersomnia. QIDS-C - Hypersomnia QIDSC1-Involvement Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Involvement. QIDS-C - Involvement QIDSC1-Mid-Nocturnal Insomnia Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Mid-nocturnal insomnia. QIDS-C - Mid-Nocturnal Insomnia QIDSC1-Mood (Sad) Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Mood (sad). QIDS-C - Mood (Sad) QIDSC1-Outlook (Self) Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Outlook (self). QIDS-C - Outlook (Self) QIDSC1-Psychomotor Agitation Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Psychomotor agitation. QIDS-C - Psychomotor Agitation QIDSC1-Psychomotor Slowing Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Psychomotor slowing. QIDS-C - Psychomotor Slowing QIDSC1-Sleep Onset Insomnia Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Sleep onset insomnia. QIDS-C - Sleep Onset Insomnia QIDSC1-Suicidal Ideation Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Suicidal ideation. QIDS-C - Suicidal Ideation QIDSC1-Total Score Quick Inventory of Depressive Symptomatology - Clinician-Rated - Total score. QIDS-C - Total Score QIDSC1-Weight (Decrease) Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Weight (decrease) within the last two weeks. QIDS-C - Weight (Decrease) QIDSC1-Weight (Increase) Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Weight (increase) within the last two weeks. QIDS-C - Weight (Increase) QIDSC1TN Quick Inventory of Depressive Symptomatology Clinician-Rated Version Clinical Classification Test Name CDISC Clinical Classification QIDS-C Test Name Terminology Quick Inventory of Depressive Symptomatology Self-Report Version test code. QIDSR1-Falling Asleep Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Falling asleep. QIDS-SR - Falling Asleep QIDSR1-Sleep During the Night Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Sleep during the night. QIDS-SR - Sleep During the Night QIDSR1-Waking Up Too Early Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Waking up too early. QIDS-SR - Waking Up Too Early QIDSR1-Sleeping Too Much Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Sleeping too much. QIDS-SR - Sleeping Too Much QIDSR1-Feeling Sad Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling sad. QIDS-SR - Feeling Sad QIDSR1-Decreased Appetite Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Decreased appetite. QIDS-SR - Decreased Appetite QIDSR1-Increased Appetite Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Increased appetite. QIDS-SR - Increased Appetite QIDSR1-Decreased Weight Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: within the last two weeks: Decreased weight. QIDS-SR - Decreased Weight QIDSR1-Increased Weight Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: within the last two weeks: Increased weight. QIDS-SR - Increased Weight QIDSR1-Concentration/Decision Making Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Concentration/decision making. QIDS-SR - Concentration or Decision Making QIDSR1-View of Myself Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: View of myself. QIDS-SR - View of Myself QIDSR1-Thoughts of Death or Suicide Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Thoughts of death or suicide. QIDS-SR - Thoughts of Death or Suicide QIDSR1-General Interest Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: General interest. QIDS-SR - General Interest QIDSR1-Energy Level Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Energy level. QIDS-SR - Energy Level QIDSR1-Feeling Slowed Down Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling slowed down. QIDS-SR - Feeling Slowed Down QIDSR1-Feeling Restless Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling restless. QIDS-SR - Feeling Restless QIDSR1-Highest Score Sleep Items Quick Inventory of Depressive Symptomatology - Self-Report - Enter the highest score on any 1 of the 4 sleep items. QIDS-SR - Highest Score Sleep Items QIDSR1-High Score Appetite/Weight Items Quick Inventory of Depressive Symptomatology - Self-Report - Enter the highest score on any 1 of the 4 appetite/weight change items. QIDS-SR - High Score Appetite or Weight Items QIDSR1-Highest Score Psychomotor Items Quick Inventory of Depressive Symptomatology - Self-Report - Enter the highest score on either of the 2 psychomotor items. QIDS-SR - Highest Score Psychomotor Items QIDSR1-Total Score Quick Inventory of Depressive Symptomatology - Self-Report - Total score. QIDS-SR - Total Score QIDSR1TC Quick Inventory of Depressive Symptomatology Self-Report Version Questionnaire Test Code CDISC Questionnaire QIDS-SR Test Code Terminology Quick Inventory of Depressive Symptomatology Self-Report Version test name. QIDSR1-Concentration/Decision Making Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Concentration/decision making. QIDS-SR - Concentration or Decision Making QIDSR1-Decreased Appetite Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Decreased appetite. QIDS-SR - Decreased Appetite QIDSR1-Decreased Weight Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: within the last two weeks: Decreased weight. QIDS-SR - Decreased Weight QIDSR1-Energy Level Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Energy level. QIDS-SR - Energy Level QIDSR1-Falling Asleep Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Falling asleep. QIDS-SR - Falling Asleep QIDSR1-Feeling Restless Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling restless. QIDS-SR - Feeling Restless QIDSR1-Feeling Sad Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling sad. QIDS-SR - Feeling Sad QIDSR1-Feeling Slowed Down Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling slowed down. QIDS-SR - Feeling Slowed Down QIDSR1-General Interest Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: General interest. QIDS-SR - General Interest QIDSR1-High Score Appetite/Weight Items Quick Inventory of Depressive Symptomatology - Self-Report - Enter the highest score on any 1 of the 4 appetite/weight change items. QIDS-SR - High Score Appetite or Weight Items QIDSR1-Highest Score Psychomotor Items Quick Inventory of Depressive Symptomatology - Self-Report - Enter the highest score on either of the 2 psychomotor items. QIDS-SR - Highest Score Psychomotor Items QIDSR1-Highest Score Sleep Items Quick Inventory of Depressive Symptomatology - Self-Report - Enter the highest score on any 1 of the 4 sleep items. QIDS-SR - Highest Score Sleep Items QIDSR1-Increased Appetite Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Increased appetite. QIDS-SR - Increased Appetite QIDSR1-Increased Weight Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: within the last two weeks: Increased weight. QIDS-SR - Increased Weight QIDSR1-Sleep During the Night Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Sleep during the night. QIDS-SR - Sleep During the Night QIDSR1-Sleeping Too Much Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Sleeping too much. QIDS-SR - Sleeping Too Much QIDSR1-Thoughts of Death or Suicide Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Thoughts of death or suicide. QIDS-SR - Thoughts of Death or Suicide QIDSR1-Total Score Quick Inventory of Depressive Symptomatology - Self-Report - Total score. QIDS-SR - Total Score QIDSR1-View of Myself Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: View of myself. QIDS-SR - View of Myself QIDSR1-Waking Up Too Early Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Waking up too early. QIDS-SR - Waking Up Too Early QIDSR1TN Quick Inventory of Depressive Symptomatology Self-Report Version Questionnaire Test Name CDISC Questionnaire QIDS-SR Test Name Terminology A terminology codelist relevant to the race of an individual as collected on the case report form. The native people of Australia. Aboriginal Australian Afghanistani A person having origins in any of the original peoples of Afghanistan. Afghanistani Afro-American A person having origins in the original peoples of sub-Saharan Africa and the United States. African American Afro-Caribbean A person having origins in the original peoples of sub-Saharan Africa and the Caribbean. African Caribbean A person having origins in any of the original peoples of Africa. African The native people of Alaska. Alaska Native A person having origins in any of the original peoples of North and South America (including Central America), and who maintains tribal affiliation or community attachment. (FDA) American Indian or Alaska Native The native people of North America. American Indian A person having origins in any of the original peoples of the Arabian peninsula and surrounding territories in the Middle East and northern Africa. Arab A person having origins in any of the original peoples of Aruba. Aruban A person having origins in the original peoples of Asia and the United States. Asian American A person having origins in any of the original peoples of the Indian subcontinent. Asian Indian A person having origins in any of the original peoples of the Far East, Southeast Asia, or the Indian subcontinent including, for example, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and Vietnam. (FDA) Asian A person having origins in any of the original peoples of the Bahamas. Bahamian A person having origins in any of the original peoples of Bangladesh. Bangladeshi A person having origins in any of the original peoples of Barbados. Barbadian A person having origins in any of the original peoples of Belize. Belizean A person having origins in any of the original peoples of Bermuda. Bermudan A person having origins in any of the original peoples of Bhutan. Bhutanese A person having origins in the original peoples of sub-Saharan Africa and Central America. Black Central American A person having origins in any of the black racial groups of Africa. Terms such as "Haitian" or "Negro" can be used in addition to "Black or African American." (FDA) Black or African American A person whose ancestry is from one or more of the indigenous African peoples of South Africa. Black South African A person having origins in the original peoples of sub-Saharan Africa and South America. Black South American A person having origins in the original peoples of sub-Saharan Africa or the Caribbean. Black A person having origins in any of the original peoples of Botswana. Botswanan A person having origins in any of the original peoples of Brazil. Brazilian A person having origins in any of the original peoples of Myanmar (formerly Burma). Burmese Cape Verdean A person having origins in any of the original peoples of Cabo Verde (Cape Verde). Cabo Verdean A person having origins in any of the original peoples of Cambodia (formerly Kampuchea). Cambodian The native people of Canada. Canadian Indian The native people of the Caribbean. Caribbean Indian A person having origins in any of the original peoples of the Caribbean. Caribbean Race A person having origins in any of the original peoples of the Cayman Islands. Cayman Islander The native people of Central America. Central American Indian A person having origins in any of the original peoples of Central Asia. Central Asian The native people of the Mariana Islands, including the United States territories of Guam and the Commonwealth of the Northern Mariana Islands in Micronesia. Chamorran A person having origins in any of the original peoples of China. Chinese The native peoples of the Chuuk State in the Federated States of Micronesia. Chuukese Columbian A person having origins in any of the original peoples of Columbia. Colombian A person having origins in any of the original peoples of Comoros. Comorian A person having origins in any of the original peoples of the Democratic Republic of the Congo . Congolese A person having origins in any of the original peoples of Dominica. Dominica Islander A person having origins in any of the original peoples of the Dominican Republic. Dominican A person having origins in any of the original peoples of East Asia. East Asian A person having origins in any of the original peoples of Eastern Europe. Eastern European A person having origins in any of the original peoples of Egypt. Egyptian A person having origins in any of the original peoples of England. English A person having origins in any of the original peoples of Ethiopia. Ethiopian A person having origins in any of the original peoples of Europe. European Fiji Islander A person having origins in any of the original peoples of Fiji. Fiji Islander A person having origins in any of the original peoples of the Philippines. Filipino A person having origins in any of the original peoples of France. French A person having origins in any of the original peoples of Germany. German A person having origins in any of the original peoples of Ghana. Ghanian The native people of Greenland. Greenland Eskimo A person having origins in the original peoples of the United States territories of Guam and the Commonwealth of the Northern Mariana Islands in Micronesia. Guamanian or Chamorro A person having origins in any of the original peoples of Guam. Guamanian A person having origins in any of the original peoples of Guatemala. Guatemalan A person having origins in any of the original peoples of Guyana. Guyanese A person having origins in any of the original peoples of Haiti. Haitian A person of Mexican, Puerto Rican, Cuban, Central or South American or other Spanish culture or origin, regardless of race. (NCI) Hispanic or Latino The native people originating in China around the Yellow River or Hoang Ho. Hmong A person having origins in any of the original peoples of Honduras. Honduran A person having origins in any of the original peoples of Indonesia. Indonesian The native people inhabiting the territory spanning the Norton Sound on the Bering Sea to the Canadian border. Inupiat Eskimo A person having origins in any of the original peoples of Iran. Iranian A person having origins in any of the original peoples of Iraq. Iraqi A person having origins in any of the original peoples of Ireland. Irish A person having origins in any of the original peoples of Israel. Israeli A person having origins in any of the original peoples of Italy. Italian A person having origins in any of the original peoples of Iwo Jima. Iwo Jiman A person having origins in any of the original peoples of Jamaica. Jamaican A person having origins in any of the original peoples of Japan. Japanese The native people of the Western Cape in southern Africa. Khoisan A person having origins in any of the original peoples of North and South Korea. Korean A person having origins in any of the original peoples of Laos. Laotian The native people of Latin America (Mexico, South and Central America). Latin American Indian A person of Latin American descent. Latin American A person having origins in any of the original peoples of Lebanon. Lebanese A person having origins in any of the original peoples of Liberia. Liberian A person having origins in any of the original peoples of Madagascar. Malagasy A person having origins in any of the original peoples of Malaysia. Malaysian A person having origins in any of the original peoples of the Maldives. Maldivian The native people of New Zealand. Maori A person having origins in any of the original peoples of the Marshall Islands. Marshallese A person having origins in any of the original peoples of Mauritania. Mauritanian A person having origins in any of the original peoples of the countries surrounding the Mediterranean sea. Mediterranean A person having origins in any of the original peoples of Melanesia. Melanesian A person having origins in any of the original peoples of Micronesia. Micronesian Individuals with origins in any of the original peoples of the Middle East or North Africa. Middle Eastern or North African A person having origins in any of the original peoples of the Middle East. Middle Eastern A person having origins in any of the original peoples of Mongolia. Mongolian A person having origins in any of the original peoples of Morocco. Moroccan A person having origins in any of the original peoples of Namibia. Namibian Denotes a person having origins in any of the original peoples of Hawaii, Guam, Samoa, or other Pacific Islands. The term covers particularly people who identify themselves as part-Hawaiian, Native Hawaiian, Guamanian or Chamorro, Carolinian, Samoan, Chuu. (FDA) Native Hawaiian or Other Pacific Islander A person having origins in any of the original peoples of Hawaii. (NCI) Native Hawaiian A person having origins in any of the original peoples of Nepal. Nepalese A person having origins in any of the original peoples of Nigeria. Nigerian A person having origins in any of the original peoples of North Africa. North Coast of Africa A person having origins in any of the original peoples of Northern Europe. Northern European A person having origins in any of the original peoples of Norway. Norwegian Not reported Not provided or available. Not Reported A person having origins in any of the original peoples of Okinawa. Okinawan A person having origins in the original peoples of the Pacific Islands, but not Guam, Hawaii, the Mariana Islands or Samoa. (NCI) Other Pacific Islander Other Different than the one(s) previously specified or mentioned. (NCI) Other A person having origins in any of the original peoples of Pakistan. Pakistani A person having origins in any of the original peoples of Palau. Palauan A person having origins in any of the original peoples of Poland. Polish A person having origins in any of the original peoples of Polynesia. Polynesian A person having origins in any of the original peoples of Russia. Russian Salvadorian A person having origins in any of the original peoples of El Salvador. Salvadoran A person having origins in any of the original peoples of Samoa. (NCI) Samoan A person having origins in any of the original peoples of Scotland. Scottish The native Yupik people inhabiting the coast of the Chukchi Peninsula in the far northeast of the Russian Federation and on St. Lawrence Island in Alaska. Siberian Eskimo A person having origins in any of the original peoples of Singapore. Singaporean Somalian A person having origins in any of the original peoples of Somalia. Somali The native people of South America. South American Indian A person having origins in any of the original peoples of the South Asia. South Asian A person having origins in any of the original peoples of Southeast Asia. Southeast Asian A person whose ancestry is from one or more of the indigenous Southern African peoples and one or more of the naturalized racial groups of Southern Africa (typically Western European, South Asian, or Southeastern Asian). Southern African Coloured A person having origins in any of the original peoples of Sri Lanka. Sri Lankan A person having origins in any of the original peoples of sub-Saharan Africa. Sub-Saharan African A person having origins in any of the original peoples of Suriname. Surinamese A person having origins in any of the original peoples of Sweden. Swedish A person having origins in any of the original peoples of Syria. Syrian A person having origins in any of the original peoples of Tahiti. Tahitian A person having origins in any of the original peoples of Taiwan. Taiwanese A person having origins in any of the original peoples of Thailand. Thai A person having origins in any of the original peoples of Tobago. Tobagoan A person having origins in any of the original peoples of Tonga. Tongan A person having origins in any of the original peoples of Trinidad. Trinidadian U UNK Unknown Not known, not observed, not recorded, or refused. (NCI) Unknown A person having origins in any of the original peoples of Viet Nam. Vietnamese A person having origins in any of the original peoples of Western Asia. Western Asian A person having origins in any of the original peoples of the West Indies. West Indian A person having origins in any of the original peoples of Western Europe. Western European A person having origins in the original peoples of Europe, the Middle East, or North Africa, and the Caribbean. White Caribbean A person having origins in the original peoples of Europe, the Middle East, or North Africa, and Central America. White Central American A person having origins in the original peoples of Europe, the Middle East, or North Africa, and South America. White South American Denotes a person with European, Middle Eastern, or North African ancestral origin who identifies, or is identified, as White. (FDA) White A person having origins in any of the original peoples of Yemen. Yemeni The native people inhabiting western, southwestern, and southcentral Alaska and the Russian Far East. Yupik Eskimo A person having origins in any of the original peoples of Zaire. Zairean RACEC Race As Collected CDISC SDTM Collected Race Terminology RAND 36-Item Health Survey 1.0 test code. R3601-Would You Say Your Health Is RAND 36-Item Health Survey 1.0 - In general, would you say your health is: RAND-36 - Rate Your Health R3601-Health Now Compared to 1 Year Ago RAND 36-Item Health Survey 1.0 - Compared to one year ago, how would you rate your health in general now? RAND-36 - Rate Your Health Compared to One Year Ago R3601-Health Limit Vigorous Activities RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Vigorous activities, such as running, lifting heavy objects, participating in strenuous sports. RAND-36 - Health Limit Vigorous Activities R3601-Health Limit Moderate Activities RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. RAND-36 - Health Limit Moderate Activities R3601-Health Limit Carrying Groceries RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Lifting or carrying groceries. RAND-36 - Health Limit Lifting Groceries R3601-Health Limit Climb Several Flights RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Climbing several flights of stairs. RAND-36 - Health Limit Climbing Several Flights R3601-Health Limit Climb One Flight RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Climbing one flight of stairs. RAND-36 - Health Limit Climbing One Flight R3601-Health Limit Bending or Kneeling RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Bending, kneeling, or stooping. RAND-36 - Health Limit Bending or Stooping R3601-Health Limit Walk More Than Mile RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Walking more than a mile. RAND-36 - Health Limit Walking More Than A Mile R3601-Health Limit Walk Several Blocks RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Walking several blocks. RAND-36 - Health Limit Walking Several Blocks R3601-Health Limit Walk One Block RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Walking one block. RAND-36 - Health Limit Walking One Block R3601-Health Limit Bathing/Dressing Self RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Bathing or dressing yourself. RAND-36 - Health Limit Bathing or Dressing R3601-Phys Health: Cut Work Time RAND 36-Item Health Survey 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Cut down the amount of time you spent on work or other activities. RAND-36 - Physical Health Cut Down Time Spent on Work R3601-Phys Health: Accomplish Less RAND 36-Item Health Survey 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Accomplished less than you would like. RAND-36 - Physical Health Accomplished Less R3601-Phys Health: Limit Kind of Work RAND 36-Item Health Survey 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Were limited in the kind of work or other activities. RAND-36 - Physical Health Limited in the Kind of Work R3601-Phys Health: Difficulty Performing RAND 36-Item Health Survey 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Had difficulty performing the work or other activities. RAND-36 - Physical Health Difficulty Performing Work R3601-Emotional Problem: Cut Work Time RAND 36-Item Health Survey 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems: Cut down the amount of time you spent on work or other activities. RAND-36 - Emotional Problem Cut Down Time Spent on Work R3601-Emotional Problem: Accomplish Less RAND 36-Item Health Survey 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems: Accomplished less than you would like. RAND-36 - Emotional Problem Accomplished Less R3601-Emotional Problem: Less Careful RAND 36-Item Health Survey 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems: Didn't do work or other activities as carefully as usual. RAND-36 - Emotional Problem Did Not Do Work as Carefully R3601-Extent Interfered Social Activity RAND 36-Item Health Survey 1.0 - During the past 4 weeks, to what extent has your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors, or groups? RAND-36 - Extend Physical Health or Emotional Problems Interfere With Social Activities R3601-How Much Bodily Pain Have You Had RAND 36-Item Health Survey 1.0 - How much bodily pain have you had during the past 4 weeks? RAND-36 - Bodily Pain R3601-Did Pain Interfere With Your Work RAND 36-Item Health Survey 1.0 - During the past 4 weeks, how much did pain interfere with your normal work? RAND-36 - Pain Interfere With Normal Work R3601-Did You Feel Full of Pep RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Did you feel full of pep? RAND-36 - Feel Full of Pep R3601-Have Been a Very Nervous Person RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Have you been a very nervous person? RAND-36 - Been a Nervous Person R3601-Have Felt So Down in the Dumps RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Have you felt so down in the dumps that nothing could cheer you up? RAND-36 - Felt Nothing Could Cheer You Up R3601-Have You Felt Calm and Peaceful RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Have you felt calm and peaceful? RAND-36 - Felt Calm and Peaceful R3601-Did You Have a Lot of Energy RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Did you have a lot of energy? RAND-36 - Have a Lot of Energy R3601-Have Felt Downhearted and Blue RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Have you felt downhearted and blue? RAND-36 - Felt Downhearted and Blue R3601-Did You Feel Worn Out RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Did you feel worn out? RAND-36 - Feel Worn Out R3601-Have You Been a Happy Person RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Have you been a happy person? RAND-36 - Been a Happy Person R3601-Did You Feel Tired RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Did you feel tired? RAND-36 - Feel Tired R3601-Amt Time Interfere Social Activity RAND 36-Item Health Survey 1.0 - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities? RAND-36 - Time Physical Health or Emotional Problems Interfere With Social Activities R3601-Get Sick Easier Than Other People RAND 36-Item Health Survey 1.0 - How TRUE or FALSE is each of the following statements for you: I seem to get sick a little easier than other people. RAND-36 - Get Sick Easier Than Other R3601-I Am as Healthy as Anybody I Know RAND 36-Item Health Survey 1.0 - How TRUE or FALSE is each of the following statements for you: I am as healthy as anybody I know. RAND-36 - As Healthy as Anybody R3601-I Expect My Health to Get Worse RAND 36-Item Health Survey 1.0 - How TRUE or FALSE is each of the following statements for you: I expect my health to get worse. RAND-36 - Expect Health to Get Worse R3601-My Health Is Excellent RAND 36-Item Health Survey 1.0 - How TRUE or FALSE is each of the following statements for you: My health is excellent. RAND-36 - My Health is Excellent R3601TC RAND 36-Item Health Survey 1.0 Questionnaire Test Code CDISC Questionnaire RAND 36-Item Health Survey 1.0 Test Code Terminology RAND 36-Item Health Survey 1.0 test name. R3601-Amt Time Interfere Social Activity RAND 36-Item Health Survey 1.0 - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities? RAND-36 - Time Physical Health or Emotional Problems Interfere With Social Activities R3601-Did Pain Interfere With Your Work RAND 36-Item Health Survey 1.0 - During the past 4 weeks, how much did pain interfere with your normal work? RAND-36 - Pain Interfere With Normal Work R3601-Did You Feel Full of Pep RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Did you feel full of pep? RAND-36 - Feel Full of Pep R3601-Did You Feel Tired RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Did you feel tired? RAND-36 - Feel Tired R3601-Did You Feel Worn Out RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Did you feel worn out? RAND-36 - Feel Worn Out R3601-Did You Have a Lot of Energy RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Did you have a lot of energy? RAND-36 - Have a Lot of Energy R3601-Emotional Problem: Accomplish Less RAND 36-Item Health Survey 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems: Accomplished less than you would like. RAND-36 - Emotional Problem Accomplished Less R3601-Emotional Problem: Cut Work Time RAND 36-Item Health Survey 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems: Cut down the amount of time you spent on work or other activities. RAND-36 - Emotional Problem Cut Down Time Spent on Work R3601-Emotional Problem: Less Careful RAND 36-Item Health Survey 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems: Didn't do work or other activities as carefully as usual. RAND-36 - Emotional Problem Did Not Do Work as Carefully R3601-Extent Interfered Social Activity RAND 36-Item Health Survey 1.0 - During the past 4 weeks, to what extent has your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors, or groups? RAND-36 - Extend Physical Health or Emotional Problems Interfere With Social Activities R3601-Get Sick Easier Than Other People RAND 36-Item Health Survey 1.0 - How TRUE or FALSE is each of the following statements for you: I seem to get sick a little easier than other people. RAND-36 - Get Sick Easier Than Other R3601-Have Been a Very Nervous Person RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Have you been a very nervous person? RAND-36 - Been a Nervous Person R3601-Have Felt Downhearted and Blue RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Have you felt downhearted and blue? RAND-36 - Felt Downhearted and Blue R3601-Have Felt So Down in the Dumps RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Have you felt so down in the dumps that nothing could cheer you up? RAND-36 - Felt Nothing Could Cheer You Up R3601-Have You Been a Happy Person RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Have you been a happy person? RAND-36 - Been a Happy Person R3601-Have You Felt Calm and Peaceful RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Have you felt calm and peaceful? RAND-36 - Felt Calm and Peaceful R3601-Health Limit Bathing/Dressing Self RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Bathing or dressing yourself. RAND-36 - Health Limit Bathing or Dressing R3601-Health Limit Bending or Kneeling RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Bending, kneeling, or stooping. RAND-36 - Health Limit Bending or Stooping R3601-Health Limit Carrying Groceries RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Lifting or carrying groceries. RAND-36 - Health Limit Lifting Groceries R3601-Health Limit Climb One Flight RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Climbing one flight of stairs. RAND-36 - Health Limit Climbing One Flight R3601-Health Limit Climb Several Flights RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Climbing several flights of stairs. RAND-36 - Health Limit Climbing Several Flights R3601-Health Limit Moderate Activities RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. RAND-36 - Health Limit Moderate Activities R3601-Health Limit Vigorous Activities RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Vigorous activities, such as running, lifting heavy objects, participating in strenuous sports. RAND-36 - Health Limit Vigorous Activities R3601-Health Limit Walk More Than Mile RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Walking more than a mile. RAND-36 - Health Limit Walking More Than A Mile R3601-Health Limit Walk One Block RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Walking one block. RAND-36 - Health Limit Walking One Block R3601-Health Limit Walk Several Blocks RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Walking several blocks. RAND-36 - Health Limit Walking Several Blocks R3601-Health Now Compared to 1 Year Ago RAND 36-Item Health Survey 1.0 - Compared to one year ago, how would you rate your health in general now? RAND-36 - Rate Your Health Compared to One Year Ago R3601-How Much Bodily Pain Have You Had RAND 36-Item Health Survey 1.0 - How much bodily pain have you had during the past 4 weeks? RAND-36 - Bodily Pain R3601-I Am as Healthy as Anybody I Know RAND 36-Item Health Survey 1.0 - How TRUE or FALSE is each of the following statements for you: I am as healthy as anybody I know. RAND-36 - As Healthy as Anybody R3601-I Expect My Health to Get Worse RAND 36-Item Health Survey 1.0 - How TRUE or FALSE is each of the following statements for you: I expect my health to get worse. RAND-36 - Expect Health to Get Worse R3601-My Health Is Excellent RAND 36-Item Health Survey 1.0 - How TRUE or FALSE is each of the following statements for you: My health is excellent. RAND-36 - My Health is Excellent R3601-Phys Health: Accomplish Less RAND 36-Item Health Survey 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Accomplished less than you would like. RAND-36 - Physical Health Accomplished Less R3601-Phys Health: Cut Work Time RAND 36-Item Health Survey 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Cut down the amount of time you spent on work or other activities. RAND-36 - Physical Health Cut Down Time Spent on Work R3601-Phys Health: Difficulty Performing RAND 36-Item Health Survey 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Had difficulty performing the work or other activities. RAND-36 - Physical Health Difficulty Performing Work R3601-Phys Health: Limit Kind of Work RAND 36-Item Health Survey 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Were limited in the kind of work or other activities. RAND-36 - Physical Health Limited in the Kind of Work R3601-Would You Say Your Health Is RAND 36-Item Health Survey 1.0 - In general, would you say your health is: RAND-36 - Rate Your Health R3601TN RAND 36-Item Health Survey 1.0 Questionnaire Test Name CDISC Questionnaire RAND 36-Item Health Survey 1.0 Test Name Terminology RAND Social Support Survey Instrument test code. RSSS01-Count on to Listen to You RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone you can count on to listen to you when you need to talk. RAND Social Support Survey - Count on to Listen to You RSSS01-Give You Info to Help Understand RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to give you information to help you understand a situation. RAND Social Support Survey - Give You Info to Help Understand RSSS01-Give You Advice About a Crisis RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to give you good advice about a crisis. RAND Social Support Survey - Give You Advice About a Crisis RSSS01-Confide in/Talk to About Yourself RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to confide in or talk to about yourself or your problems. RAND Social Support Survey - Confide in or Talk to About Yourself RSSS01-Advice You Really Want RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone whose advice you really want. RAND Social Support Survey - Advice You Really Want RSSS01-Share Your Private Worries/Fears RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to share your most private worries and fears with. RAND Social Support Survey - Share Your Private Worries and Fears RSSS01-Turn to Suggestions Personal Prob RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to turn to for suggestions about how to deal with a personal problem. RAND Social Support Survey - Suggestions to Deal With Personal Problem RSSS01-Understands Your Problems RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone who understands your problems. RAND Social Support Survey - Understands Your Problems RSSS01-Help If You Were Confined to Bed RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to help you if you were confined to bed. RAND Social Support Survey - Help If You Were Confined to Bed RSSS01-Take You to the Doctor If Needed RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to take you to the doctor if you needed it. RAND Social Support Survey - Take You to the Doctor If Needed RSSS01-Prepare Your Meals If Unable RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to prepare your meals if you were unable to do it yourself. RAND Social Support Survey - Prepare Your Meals If Unable RSSS01-Help With Daily Chores If Sick RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to help with daily chores if you were sick. RAND Social Support Survey - Help With Daily Chores If Sick RSSS01-Shows You Love and Affection RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone who shows you love and affection. RAND Social Support Survey - Shows You Love and Affection RSSS01-Love and Make You Feel Wanted RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to love and make you feel wanted. RAND Social Support Survey - Love and Make You Feel Wanted RSSS01-Hugs You RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone who hugs you. RAND Social Support Survey - Hugs You RSSS01-Have a Good Time With RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to have a good time with. RAND Social Support Survey - Have a Good Time With RSSS01-Get Together With for Relaxation RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to get together with for relaxation. RAND Social Support Survey - Get Together With for Relaxation RSSS01-Do Something Enjoyable With RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to do something enjoyable with. RAND Social Support Survey - Do Something Enjoyable With RSSS01-Help You Get Your Mind Off Things RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to do things with to help you get your mind off things. RAND Social Support Survey - Help You Get Your Mind Off Things RSSS01TC RAND Social Support Survey Instrument Questionnaire Test Code CDISC Questionnaire RAND Social Support Survey Test Code Terminology RAND Social Support Survey Instrument test name. RSSS01-Advice You Really Want RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone whose advice you really want. RAND Social Support Survey - Advice You Really Want RSSS01-Confide in/Talk to About Yourself RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to confide in or talk to about yourself or your problems. RAND Social Support Survey - Confide in or Talk to About Yourself RSSS01-Count on to Listen to You RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone you can count on to listen to you when you need to talk. RAND Social Support Survey - Count on to Listen to You RSSS01-Do Something Enjoyable With RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to do something enjoyable with. RAND Social Support Survey - Do Something Enjoyable With RSSS01-Get Together With for Relaxation RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to get together with for relaxation. RAND Social Support Survey - Get Together With for Relaxation RSSS01-Give You Advice About a Crisis RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to give you good advice about a crisis. RAND Social Support Survey - Give You Advice About a Crisis RSSS01-Give You Info to Help Understand RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to give you information to help you understand a situation. RAND Social Support Survey - Give You Info to Help Understand RSSS01-Have a Good Time With RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to have a good time with. RAND Social Support Survey - Have a Good Time With RSSS01-Help If You Were Confined to Bed RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to help you if you were confined to bed. RAND Social Support Survey - Help If You Were Confined to Bed RSSS01-Help With Daily Chores If Sick RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to help with daily chores if you were sick. RAND Social Support Survey - Help With Daily Chores If Sick RSSS01-Help You Get Your Mind Off Things RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to do things with to help you get your mind off things. RAND Social Support Survey - Help You Get Your Mind Off Things RSSS01-Hugs You RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone who hugs you. RAND Social Support Survey - Hugs You RSSS01-Love and Make You Feel Wanted RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to love and make you feel wanted. RAND Social Support Survey - Love and Make You Feel Wanted RSSS01-Prepare Your Meals If Unable RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to prepare your meals if you were unable to do it yourself. RAND Social Support Survey - Prepare Your Meals If Unable RSSS01-Share Your Private Worries/Fears RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to share your most private worries and fears with. RAND Social Support Survey - Share Your Private Worries and Fears RSSS01-Shows You Love and Affection RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone who shows you love and affection. RAND Social Support Survey - Shows You Love and Affection RSSS01-Take You to the Doctor If Needed RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to take you to the doctor if you needed it. RAND Social Support Survey - Take You to the Doctor If Needed RSSS01-Turn to Suggestions Personal Prob RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to turn to for suggestions about how to deal with a personal problem. RAND Social Support Survey - Suggestions to Deal With Personal Problem RSSS01-Understands Your Problems RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone who understands your problems. RAND Social Support Survey - Understands Your Problems RSSS01TN RAND Social Support Survey Instrument Questionnaire Test Name CDISC Questionnaire RAND Social Support Survey Test Name Terminology The reason that a Coronary Sinus Access or Left Ventricular (CS/LV) lead was not implanted. The coronary sinus/left ventricular lead was not implanted because the operator was unable to obtain acceptable pacing thresholds. Unable to Obtain Acceptable Pacing Thresholds The coronary sinus/left ventricular lead was not implanted because the lead position resulted in undesirable stimulation of the diaphragm. Cardiac Lead Position Results in Undesirable Stimulation of Diaphragm The coronary sinus/left ventricular lead was not implanted because a lead had been previously implanted. Previously Implanted Cardiac Lead The coronary sinus/left ventricular lead was not implanted because the operator was unable to obtain satisfactory coronary sinus access. Unable to Obtain Satisfactory Coronary Sinus Access The coronary sinus/left ventricular lead was not implanted because the operator was unable to obtain satisfactory vascular access. Unable to Obtain Satisfactory Vascular Access The coronary sinus/left ventricular lead was not implanted because the coronary sinus was dissected. Unable to Position Lead Due to Coronary Sinus Dissection The coronary sinus/left ventricular lead was not implanted because the operator was unable to position the lead in the tributary vein of the coronary sinus. Unable to Position Lead In tributary Vein of Coronary Sinus CSLVLNIM Reason CS/LV Lead Not Implanted CDISC SDTM Reason Coronary Sinus Access or Left Ventricular Lead Not Implanted Terminology Terminology relevant to the reason the treatment was administered. A lack of response to the first cycle of therapy. Failure After First Treatment A lack of response to more than one cycle of therapy. Failure After Multiple Treatments A previous episode of failure by a subject to follow medical advice, take medication as directed, or adhere to a prescribed course of treatment. Previous Study Subject Noncompliance Recurrent Disease The return of a disease after a period of remission. Recurrent Disease REASTRT Reason For Treatment CDISC SDTM Reason For Treatment Terminology Terminology relevant to the reason the drug or therapy was temporarily ceased. A patient's failure to remember to take a dose of medication. Forgot to Take Medication Dose An inability to absorb or metabolize certain substances in the normal way. Intolerance Medications that were lost because they were put in the wrong place. Medication Misplaced Failure of a study subject to comply with an aspect of the study. Subject Noncompliance The lack of expected or desired effect related to a therapy. (NCI) Lack of Efficacy Leisure time away from work devoted to rest or pleasure. Vacation REASTINT Reason for Treatment Interruption CDISC SDTM Reason for Treatment Interruption Terminology A description of the results relative to the normal or expected range of values. Reported values outside the typical or expected range. (NCI) Abnormal Reference Range Reported values above the typical or expected range. (NCI) Value Above Reference Range Reported values below the typical or expected range. (NCI) Value Below Reference Range Reported values within the typical or expected range. (NCI) Normal Reference Range NRIND Reference Range Indicator CDISC SDTM Reference Range Indicator The relative relationship of a timepoint to a reference timepoint. The time period following a point or another period of time. (NCI) Post Earlier in time or order. (NCI) Prior Before or at some point in a given period of time. Before or During Occurring or operating at the same time. Concurrent At some point in a given period of time. (NCI) During Within a certain period of time or after a certain point or period in time. (NCI) During or After Continuous Remain in force or carry on without letup; keep or maintain in unaltered condition; exist in time or space without stop or interruption. (NCI) Continue U UNK Unknown Not known, not observed, not recorded, or refused. (NCI) Unknown STENRF Relation to Reference Period CDISC SDTM Relation to Reference Period Terminology A terminology codelist relevant to the relationship of a person to a study subject. A person whose association to an individual is unintentional. Accidental Association Biological Maternal Aunt A female relative who is a sibling of the biological mother, and who both share a common ancestor. (NCI) Biological Maternal Aunt Biological Paternal Aunt A female relative who is a sibling of the biological father, and who both share a common ancestor. (NCI) Biological Paternal Aunt Biological Aunt A female relative who is a sibling of either of the biological parents, and who share a common ancestor. (NCI) Biological Aunt An individual that shares genetic makeup with another individual. Biological Relative An individual that does not share any genetic makeup with another individual. Biologically Unrelated Half-brother with Mother as Common Parent A male who shares with his sibling the genetic makeup inherited from only the biological mother. Half-brother with Mother as Common Parent Half-brother with Father as Common Parent A male who shares with his sibling the genetic makeup inherited from only the biological father. Half-brother with Father as Common Parent Biological Brother A male who shares with his sibling the genetic makeup inherited from one or both of their shared biological parents. Biological Brother A male who shares with his sibling the genetic makeup inherited from both of the biological parents. Full Brother Half Brother A male who shares with his sibling the genetic makeup inherited from only one of the biological parents. Half Brother Caregiver Carer Caretaker The primary person in charge of the care of a patient, usually a family member or a designated health care professional. (NCI) Caregiver A biological or non-biological first generation offspring, including but not limited to biological children (including those born outside of marriage), adopted children, step children, and foster children. (NCI) Child Relation Biological Child A son or daughter with genetic makeup inherited from the parent. Offspring Clinician An individual, such as a physician, nurse practitioner or other health care professional, who takes responsibility for a subject's care. Clinician Biological Maternal Cousin A relative who is the offspring of a sibling of the biological mother and share a common ancestor. Biological Maternal Cousin Biological Paternal Cousin A relative who is the offspring of a sibling of the biological father and share a common ancestor. Biological Paternal Cousin Biological Cousin A relative who is the offspring of a sibling of either of the biological parents, and who share a common ancestor. (NCI) Biological Cousin A female progeny with genetic makeup inherited from the parent. Biological Daughter Domestic Partner Person declares that a domestic partnership relationship exists. (HL7) Domestic Partnership Donor One that contributes something. (NCI) Donor Someone from whom blood is removed for transplantation or other purpose. Blood Donor Someone from whom one or more kidneys are removed for transplantation or other purpose. Kidney Donor Organ Donor Someone from whom an organ is removed for transplantation or other purpose. Organ Donor Tissue Donor Someone from whom tissue is removed for transplantation or other purpose. Tissue Donor One who instructs or educates others. Teacher Family Member Any of the individuals who are descended from a common progenitor, related by marriage or other legal tie. Family Member A male parent. Father The biological father of the offspring of the female subject. Biological Father of Subject's Child Biological Father A male who contributes to the genetic makeup of his offspring through the fertilization of an ovum by his sperm. (NCI) Biological Father A male who has acquired children through marriage. Step Father A person whom an individual knows, likes, and trusts. (NCI) Friend Biological Grandchild A biological child of an individual's biological child. Biological Grandchild Biological Maternal Grandfather A male relative who is the biological father of the biological mother. (NCI) Biological Maternal Grandfather Biological Paternal Grandfather A male relative who is the biological father of the biological father. (NCI) Biological Paternal Grandfather Biological Grandfather A male relative who is the biological father of either the biological mother or the biological father. (NCI) Biological Grandfather Biological Maternal Grandmother A female relative who is the biological mother of the biological mother. (NCI) Biological Maternal Grandmother Biological Paternal Grandmother A female relative who is the biological mother of the biological father. (NCI) Biological Paternal Grandmother Biological Grandmother A female relative who is the biological mother of either the biological mother or the biological father. (NCI) Biological Grandmother A relative who is the biological parent of the biological mother. Maternal Biological Grandparent A relative who is the biological parent of the biological father. Paternal Biological Grandparent Biological Grandparent A biological parent of the biological father or biological mother. Biological Grandparent An individual who is authorized under applicable law to be legally responsible for the care and keeping of an individual who is not responsible for their own care. Guardian An individual who is considered part of the social unit comprising one or more individuals living together (all of whom need not be related) in the same dwelling. Household Member A male partner in marriage. (NCI) Husband LAR An individual, or judicial, or other body authorized under applicable law to make legal decisions on behalf of another individual. Legally Acceptable Representative A female parent. Mother The biological mother of the offspring of the male subject. Biological Mother of Subject's Child Biological Mother A female who contributes to the genetic makeup of her offspring from the fertilization of her ovum. (NCI) Biological Mother A female who has acquired children through marriage. Stepmother The biological son of one's biological sibling. Biological Nephew Nurse A professional healthcare provider who has graduated from a nursing program. Nurse A person with a biological or adoptive relationship to a child and has a role as that child's parent. Parent Pregnancy Partner An individual who provides support to a pregnant individual. Pregnancy Partner Any individual related biologically or legally to another individual. Relative Any biological relative of an individual's biological father. Biological Relative, Paternal Any individual related biologically to another individual and considered immediate family as in the case of a parent, sibling or child. (NCI) First Degree Biological Relative Any individual related biologically to another individual and considered one degree removed from the immediate family as in the case of grandparents, aunts and uncles. (NCI) Second Degree Biological Relative First Degree Relative Any individual related biologically or legally to another individual and considered immediate family as in the case of a spouse, parent, sibling or child. First Degree Relative Any individual related biologically or legally to another individual and residing in the same residence. Household Relative Any individual related biologically or legally to another individual and not residing in the same residence. Non-household Relative Second Degree Relative Any individual related biologically or legally to another individual and considered one degree removed from the immediate family as in the case of in-laws, grandparents, aunts and uncles. Second Degree Relative Third Degree Relative Any individual related biologically or legally to another individual and considered two degrees removed from the immediate family as in the case of cousins. Third Degree Relative Any individual with whom the subject attends or attended the same school. Schoolmate Sexual Partner A person with whom one has had sexual relations. Sexual Partner A person's brother or sister. Sibling Biological Sibling A person's brother or sister with whom they share a genetic makeup inherited from their shared biological parents. Biological Sibling A person's brother or sister with whom they share a genetic makeup inherited from both of their shared biological parents. Full Sibling A person's brother or sister with whom they share a genetic makeup inherited from one of their shared biological parents. Half Sibling SO A gender-neutral term for a person's partner in an intimate or romantic relationship without disclosing or presuming marital status or sexual orientation. [The NCI Thesaurus contains biomedical terminologies that NCI does not own or control. This concept contains gender-related content that does not comply with Executive Order 14168.] Significant Other Half-sister with Mother as Common Parent A female who shares with her sibling the genetic makeup inherited from only the biological mother. Half-sister with Mother as Common Parent Half-sister with Father as Common Parent A female who shares with her sibling the genetic makeup inherited from only the biological father. Half-sister with Father as Common Parent Biological Sister A female who shares with her sibling the genetic makeup inherited from one or both of their shared biological parents. Biological Sister A female who shares with her sibling the genetic makeup inherited from both of the biological parents. Full Sister Half Sister A female who shares with her sibling the genetic makeup inherited from only one of the biological parents. Half Sister A male progeny with genetic makeup inherited from the parent. Biological Son Spouse A person's partner in marriage. (NCI) Spouse An individual that is believed likely to have transmitted a disease to another individual. Suspected Source Case Technician A person skilled in the performance of the technical or procedural aspects of a profession. (NCI) Technician Twin Either of two offspring born from the same pregnancy. (NCI) Twin Dizygotic Twin Either of the two offspring resulting from two separately fertilized ovums during the same pregnancy. Fraternal Twin Monozygotic Twin Either of the two offspring resulting from a shared ovum. (NCI) Identical Twin Biological Maternal Uncle A male relative who is a sibling of the biological mother, and who both share a common ancestor. (NCI) Biological Maternal Uncle Biological Paternal Uncle A male relative who is a sibling of the biological father, and who both share a common ancestor. (NCI) Biological Paternal Uncle Biological Uncle A male relative who is a sibling of either of the biological parents, and who share a common ancestor. (NCI) Biological Uncle A female partner in marriage. Wife RELSUB Relationship to Subject CDISC SDTM Relationship to Subject Terminology The description of relationship types between a record or set of records. A side of a dataset-to-dataset relationship that contains more than one element. Many Relationship Type A textual representation of the numeral 1. One RELTYPE Relationship Type CDISC SDTM Relationship Type Terminology A terminology codelist for the physiological test codes related to the male and female reproductive systems. Number of Abortions A measurement of the total number of instances in which there has been a spontaneous termination of pregnancy (miscarriage) or elective termination of pregnancy. Number of Abortions Actual Date of Delivery The date on which the delivery event occurred. Actual Date of Delivery Adrenarche Age The age at onset of adrenal androgen-mediated secondary sexual characteristics. Adrenarche Age Actively Menstruating Indicator An indication as to whether the subject is menstruating at the time the question is asked. Actively Menstruating Indicator Birth Control Method The method by which conception or impregnation is prevented. Birth Control Method Number of Continuous Days of Bleed/Spot The number of days one has experienced continuous menstrual bleeding and/or spotting. Number of Continuous Days of Menstrual Bleeding and/or Spotting Abnormal Bleeding Indicator An indication as to whether there is the presence of abnormal bleeding. Abnormal Bleeding Indicator Blistering Indicator An indication as to whether blistering occurred. Blistering Indicator Breastfeeding End Date The date on which breastfeeding ended. Breastfeeding End Date Breastfeeding Start Date The date on which breastfeeding started. Breastfeeding Start Date Number Full Term Live Births A measurement of the total number of live birth events at which the gestational age of the neonate is 39 weeks and 0 days through 40 weeks and 6 days. Number of Full Term Live Births Number of Live Births A measurement of the total number of live-born offspring a female has delivered. Number of Live Births Number of Births A measurement of the total number of birth events experienced by a female. Number of Births Number of Premature Live Births A measurement of the total number of live birth events at which the gestational age of the neonate is less than 37 weeks and 0 days. Number of Premature Live Births Number of Stillbirths A measurement of the total number of birth events at which the fetus is of at least 20 weeks gestation, or of a birth weight of at least 350 grams if the gestational age is unknown, which is born without signs of life at the time of delivery, and with an Apgar score of zero at both one and five minutes. Number of Stillbirths Live Birth Indicator An indication as to whether the subject has ever delivered live-born offspring. Live Birth Indicator Multiple Birth Indicator Plurality Indicator An indication as to whether any single pregnancy resulted in multiple fetuses birthed (live or dead), regardless of gestational age and whether the fetuses were birthed on different dates. Multiple Birth Indicator Bleed/Spot Between Menstrual Periods Ind Bleeding or Spotting Between Menstrual Periods Indicator An indication as to whether the individual has experienced bleeding or spotting between menstrual periods. Bleeding or Spotting Between Menstrual Periods Indicator Bartholin's Gland Abnormality Indicator An indication as to whether the Bartholin's gland is abnormal. Bartholin's Gland Abnormality Indicator Congenital Abnormality Indicator An indication as to whether any abnormality was present at birth or during the neonatal period. Congenital Abnormality Indicator Childbearing Potential An indicator as to whether the female subject has the potential to become pregnant. (NCI) Childbearing Potential Condom Use for Most Recent Sexual Intercourse Indicator Condom Use Most Recent Sex Interc Ind An indication as to whether a condom was used during the most recent occurrence of sexual intercourse. Condom Use for Most Recent Sexual Intercourse Indicator Condom Use Frequency Desc Condom Use Frequency Description A description of the regularity with which a condom is used during sexual activity. Condom Use Frequency Number of C-Sections Number of Cesarean Sections A measurement of the total number of cesarean section delivery events experienced by the individual. Number of Cesarean Sections Current Number of Fetuses The number of fetuses present in utero during a single pregnancy event at the time the question was asked. Current Number of Fetuses Mode of Delivery Description of the method by which a fetus is delivered. Delivery Procedure Discharge Indicator An indication as to whether there is the presence of discharge. Discharge Indicator Ecchymosis Indicator An indication as to whether ecchymosis is present. Ecchymosis Indicator Ectopic Pregnancy Indicator An indication as to whether an ectopic pregnancy has occurred. Ectopic Pregnancy Indicator Number of Ectopic Pregnancies A measurement of the total number of ectopic pregnancies experienced by a female subject. Number of Ectopic Pregnancies Estimated Date of Conception An approximate calculated date at which the conception event took place. Estimated Date of Conception Edema Indicator An indication as to whether edema is present. Edema Indicator Estimated Date of Delivery An approximate calculation of the delivery date. Expected Date of Confinement Estimated Gestational Age An approximate calculation of the gestational age of the fetus, neonate, or infant. Estimated Gestational Age Est Next Menstrual Period Start Date Estimated Next Menstrual Period Start Date The approximate date of the first day of the next menstrual cycle. Estimated Next Menstrual Period Start Date Number of Early Term Births A measurement of the total number of birth events at which the gestational age of the neonate is 37 weeks and 0 days through 38 weeks and 6 days. Number of Early Term Births Erythema Indicator Redness Indicator An indication as to whether erythema is present. Erythema Indicator Number of Late Fetal Deaths A measurement of the total number of fetal deaths (death of a fetus at 16 weeks, 0 days to 19 weeks, 6 days of gestation) experienced by a female subject. Number of Late Fetal Deaths Follicular Phase End Date The date on which the follicular phase of the menstrual cycle ended. Follicular Phase End Date Follicular Phase Start Date The date on which the follicular phase of the menstrual cycle started. Follicular Phase Start Date First Menstrual Period Start Date The date of the first day of the first menstrual cycle. First Menstrual Period Start Date Age at First Sexual Intercourse The age at which first sexual intercourse occurred. Age at First Sexual Intercourse Age at First Oral Sex The age at which first oral sex occurred. Age at First Oral Sex Number of Full Term Births A measurement of the total number of birth events (both live and dead) at which the gestational age of the neonate is 39 weeks and 0 days through 40 weeks and 6 days. Number of Full Term Births Fundal Height A measurement of the distance between the pubic symphysis and the top of the palpable uterus. Fundal Height Gravida Gravida Indicator An indication as to whether the subject is or has ever been pregnant. Gravida Has Menstrual Periods Indicator An indication as to whether the subject experiences menstrual cycles. Has Menstrual Periods Indicator Hosp Due to Pregnancy Complication Ind Hospitalized Due to Pregnancy Complication Indicator An indication as to whether the individual was hospitalized due to a pregnancy complication. Hospitalized Due to Pregnancy Complication Indicator Induced Abortion Indicator An indication as to whether the female subject has ever had an induced abortion procedure. Induced Abortion Indicator Number of Induced Abortions A measurement of the total number of induced abortions experienced by a female subject. Number of Induced Abortions Infertility Indicator An indication as to whether the individual has experienced infertility. Infertility Indicator Interpretation An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. Interpretation Irregular Menstrual Periods Indicator An indication as to whether the individual has experienced irregular menstrual periods. Irregular Menstrual Periods Indicator Late-Luteal Phase End Date The date on which the late-luteal phase of the menstrual cycle ended. Late-Luteal Phase End Date Late-Luteal Phase Start Date The date on which the late-luteal phase of the menstrual cycle started. Late-Luteal Phase Start Date Elapsed Time Since LMP The interval of time since the individual's last menstrual period. Elapsed Time Since Last Menstrual Period Last Menstrual Period Start Date The date of the first day of the most recent menstrual cycle. Last Menstrual Period Mass Indicator An indication as to whether a mass is present. Mass Indicator Menarche Age The age at which the first menstruation event occurred. (NCI) Age at Menarche Menarche Indicator An indication as to whether the individual's first menstruation event has occurred. Menarche Indicator Menses End Date Menstrual Cycle End Date The date on which the menstrual cycle ended. Menses End Date Menses Flow Duration The length of time during which menses is expelled from the uterus. Menses Duration Menses Flow Rate Description A subjective description of the menstrual flow rate during a menstrual cycle. Menses Flow Rate Description Menopause Age The age at which permanent cessation of menses occurred. (NCI) Age at Menopause Menopause Status The status of a female with respect to menopause. Menopause Status Menstrual Cycle Regularity A description of how an individual's menstrual cycle conforms to a consistent temporal pattern. Menstrual Cycle Regularity Menstrual Cycle Duration The length of time of the menses cycle, measured from the beginning of one menstrual period to the beginning of the next. Menstrual Cycle Duration Average Menstrual Cycle Duration Average Menstrual Cycle Length The average length of time of the menses cycle. Average Menstrual Cycle Duration Menses Start Date Menstrual Cycle Start Date The date on which the menstrual cycle started. Menses Start Date Mid-Follicular Phase End Date The date on which the mid-follicular phase of the menstrual cycle ended. Mid-Follicular Phase End Date Mid-Follicular Phase Start Date The date on which the mid-follicular phase of the menstrual cycle started. Mid-Follicular Phase Start Date Hydatidiform Mole Indicator Molar Pregnancy Indicator An indication as to whether a molar pregnancy (hydatidiform mole) has occurred. Molar Pregnancy Indicator Mid-Luteal Phase End Date The date on which the mid-luteal phase of the menstrual cycle ended. Mid-Luteal Phase End Date Mid-Luteal Phase Start Date The date on which the mid-luteal phase of the menstrual cycle started. Mid-Luteal Phase Start Date Date of Most Recent Sexual Intercourse The date of the most recent occurrence of sexual intercourse. Date of Last Sexual Intercourse Miscarriage Indicator Spontaneous Abortion Indicator An indication as to whether any pregnancies resulted in miscarriages. Miscarriage Indicator Motion Tenderness Indicator An indication as to whether there are symptoms of motion tenderness. Motion Tenderness Indicator Ovulation Phase End Date The date on which the ovulation phase of the menstrual cycle ended. Ovulation Phase End Date Ovulation Phase Start Date The date on which the ovulation phase of the menstrual cycle started. Ovulation Phase Start Date Parity The number of pregnancies reaching 20 weeks and 0 days of gestation or beyond, regardless of the number of fetuses or outcomes. (NICHD) Parity Pregnancy Confirmed Indicator An indication as to whether the subject's pregnancy has been confirmed. Pregnancy Confirmed Indicator Peeling Indicator An indication as to whether there is the presence of peeling. Peeling Indicator Post-Partum Indicator An indication as to whether the subject is in the stages of recovery post pregnancy and birth event. Post-Partum Indicator Products of Conception Examined Ind Products of Conception Examined Indicator An indication as to whether the products of conception have been examined. Products of Conception Examined Indicator Pregnant Indicator An indication as to whether the subject or associated person is pregnant at the time the question is asked. Pregnancy Indicator Number of Pregnancies A measurement of the total number of pregnancy events experienced by a female. Number of Pregnancies Pregnant During the Study An indicator as to whether a female is pregnant during the study period. (NCI) Pregnant During the Study Number of Premature Births A measurement of the total number of birth events (both live and dead) at which the gestational age of the neonate is less than 37 weeks and 0 days. Number of Premature Births Date Pregnancy Ended The date on which the pregnancy ended. Pregnancy End Date Pregnancy Outcome The end result of a pregnancy. Pregnancy Outcome Number of Previous Pregnancies A measurement of the total number of pregnancy events experienced by the female subject prior to the current pregnancy. Number of Previous Pregnancies Pregnancy Suspected Indicator An indication as to whether the subject or associated person suspects that they are pregnant at the time the question is asked. Pregnancy Suspected Indicator Puberty Age The age at which puberty began. Puberty Age Puberty Indicator An indication as to whether the individual is undergoing or has undergone puberty. Puberty Indicator Pustule Indicator An indication as to whether a pustule is present. Pustule Indicator Rash Indicator An indication as to whether rash is present. Rash Indicator Reproductive System Examination An observation, assessment or examination of the reproductive system. Reproductive System Examination Subj Currently Breastfeeding a Child Ind Subject Currently Breastfeeding a Child Indicator An indication as to whether the individual is currently breastfeeding a child. Subject Currently Breastfeeding a Child Indicator Duration of Sexual Abstinence The length of time during which the individual abstained from sexual activity. Duration of Sexual Abstinence Skene's Gland Abnormality Indicator An indication as to whether the Skene's gland is abnormal. Skene's Gland Abnormality Indicator Number of Miscarriages Number of Spontaneous Abortions A measurement of the total number of spontaneous abortions (in which the fetus is less than 20 weeks gestational age) experienced by a female subject. Number of Spontaneous Abortions Surgically Sterile Indicator An indication as to whether the individual has been surgically sterilized. Individual Surgically Sterile Indicator Stillbirth Indicator An indication as to whether any pregnancies resulted in stillbirths. Stillbirth Indicator Total Number of Female Sexual Partners The number of females with whom one has engaged in sexual activity within a specified time interval. Number of Female Sexual Partners Total Number of Male Sexual Partners The number of males with whom one has engaged in sexual activity within a specified time interval. Number of Male Sexual Partners Number of New Female Sexual Partners The number of new female sexual partners within a specified time interval. Number of New Female Sexual Partners Number of New Male Sexual Partners The number of new male sexual partners within a specified time interval. Number of New Male Sexual Partners Number of New Oral Sexual Partners The number of new individuals with whom one has engaged in oral sex within a specified time interval. Number of New Oral Sexual Partners Total Number of Oral Sexual Partners The number of individuals with whom one has engaged in oral sexual activity within a specified time interval. Number of Oral Sexual Partners Thickness The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. Thickness Thelarche Age The age at onset of breast development. Thelarche Age Tenderness Indicator An indication as to whether there are symptoms of tenderness. Tenderness Indicator Term Pregnancy Category A classification of the gestation duration of the pregnancy at the time of delivery. Term Pregnancy Category Total Number of Sexual Partners The total number of individuals with whom one has engaged in sexual activity within a specified time interval. Total Number of Sexual Partners Ulcer Indicator An indication as to whether an ulcer is present. Ulcer Indicator Number of Vaginal Deliveries A measurement of the total number of vaginal delivery events experienced by the individual. Number of Vaginal Deliveries Vaginal Bleeding/Spotting Freq Desc Vaginal Bleeding/Spotting Frequency Description A description of the frequency at which vaginal bleeding and/or spotting has occurred. Vaginal Bleeding and/or Spotting Frequency Description RPTESTCD Reproductive System Findings Test Code CDISC SDTM Reproductive System Findings Test Code Terminology A terminology codelist for the physiological test names related to the male and female reproductive systems. Abnormal Bleeding Indicator An indication as to whether there is the presence of abnormal bleeding. Abnormal Bleeding Indicator Actively Menstruating Indicator An indication as to whether the subject is menstruating at the time the question is asked. Actively Menstruating Indicator Actual Date of Delivery The date on which the delivery event occurred. Actual Date of Delivery Adrenarche Age The age at onset of adrenal androgen-mediated secondary sexual characteristics. Adrenarche Age Age at First Oral Sex The age at which first oral sex occurred. Age at First Oral Sex Age at First Sexual Intercourse The age at which first sexual intercourse occurred. Age at First Sexual Intercourse Average Menstrual Cycle Duration Average Menstrual Cycle Length The average length of time of the menses cycle. Average Menstrual Cycle Duration Bartholin's Gland Abnormality Indicator An indication as to whether the Bartholin's gland is abnormal. Bartholin's Gland Abnormality Indicator Birth Control Method The method by which conception or impregnation is prevented. Birth Control Method Bleed/Spot Between Menstrual Periods Ind Bleeding or Spotting Between Menstrual Periods Indicator An indication as to whether the individual has experienced bleeding or spotting between menstrual periods. Bleeding or Spotting Between Menstrual Periods Indicator Blistering Indicator An indication as to whether blistering occurred. Blistering Indicator Breastfeeding End Date The date on which breastfeeding ended. Breastfeeding End Date Breastfeeding Start Date The date on which breastfeeding started. Breastfeeding Start Date Childbearing Potential An indicator as to whether the female subject has the potential to become pregnant. (NCI) Childbearing Potential Condom Use Frequency Desc Condom Use Frequency Description A description of the regularity with which a condom is used during sexual activity. Condom Use Frequency Condom Use for Most Recent Sexual Intercourse Indicator Condom Use Most Recent Sex Interc Ind An indication as to whether a condom was used during the most recent occurrence of sexual intercourse. Condom Use for Most Recent Sexual Intercourse Indicator Congenital Abnormality Indicator An indication as to whether any abnormality was present at birth or during the neonatal period. Congenital Abnormality Indicator Current Number of Fetuses The number of fetuses present in utero during a single pregnancy event at the time the question was asked. Current Number of Fetuses Date of Most Recent Sexual Intercourse The date of the most recent occurrence of sexual intercourse. Date of Last Sexual Intercourse Date Pregnancy Ended The date on which the pregnancy ended. Pregnancy End Date Discharge Indicator An indication as to whether there is the presence of discharge. Discharge Indicator Duration of Sexual Abstinence The length of time during which the individual abstained from sexual activity. Duration of Sexual Abstinence Ecchymosis Indicator An indication as to whether ecchymosis is present. Ecchymosis Indicator Ectopic Pregnancy Indicator An indication as to whether an ectopic pregnancy has occurred. Ectopic Pregnancy Indicator Edema Indicator An indication as to whether edema is present. Edema Indicator Elapsed Time Since LMP The interval of time since the individual's last menstrual period. Elapsed Time Since Last Menstrual Period Erythema Indicator Redness Indicator An indication as to whether erythema is present. Erythema Indicator Est Next Menstrual Period Start Date Estimated Next Menstrual Period Start Date The approximate date of the first day of the next menstrual cycle. Estimated Next Menstrual Period Start Date Estimated Date of Conception An approximate calculated date at which the conception event took place. Estimated Date of Conception Estimated Date of Delivery An approximate calculation of the delivery date. Expected Date of Confinement Estimated Gestational Age An approximate calculation of the gestational age of the fetus, neonate, or infant. Estimated Gestational Age First Menstrual Period Start Date The date of the first day of the first menstrual cycle. First Menstrual Period Start Date Follicular Phase End Date The date on which the follicular phase of the menstrual cycle ended. Follicular Phase End Date Follicular Phase Start Date The date on which the follicular phase of the menstrual cycle started. Follicular Phase Start Date Fundal Height A measurement of the distance between the pubic symphysis and the top of the palpable uterus. Fundal Height Gravida Gravida Indicator An indication as to whether the subject is or has ever been pregnant. Gravida Has Menstrual Periods Indicator An indication as to whether the subject experiences menstrual cycles. Has Menstrual Periods Indicator Hosp Due to Pregnancy Complication Ind Hospitalized Due to Pregnancy Complication Indicator An indication as to whether the individual was hospitalized due to a pregnancy complication. Hospitalized Due to Pregnancy Complication Indicator Induced Abortion Indicator An indication as to whether the female subject has ever had an induced abortion procedure. Induced Abortion Indicator Infertility Indicator An indication as to whether the individual has experienced infertility. Infertility Indicator Interpretation An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. Interpretation Irregular Menstrual Periods Indicator An indication as to whether the individual has experienced irregular menstrual periods. Irregular Menstrual Periods Indicator Last Menstrual Period Start Date The date of the first day of the most recent menstrual cycle. Last Menstrual Period Late-Luteal Phase End Date The date on which the late-luteal phase of the menstrual cycle ended. Late-Luteal Phase End Date Late-Luteal Phase Start Date The date on which the late-luteal phase of the menstrual cycle started. Late-Luteal Phase Start Date Live Birth Indicator An indication as to whether the subject has ever delivered live-born offspring. Live Birth Indicator Mass Indicator An indication as to whether a mass is present. Mass Indicator Menarche Age The age at which the first menstruation event occurred. (NCI) Age at Menarche Menarche Indicator An indication as to whether the individual's first menstruation event has occurred. Menarche Indicator Menopause Age The age at which permanent cessation of menses occurred. (NCI) Age at Menopause Menopause Status The status of a female with respect to menopause. Menopause Status Menses End Date Menstrual Cycle End Date The date on which the menstrual cycle ended. Menses End Date Menses Flow Duration The length of time during which menses is expelled from the uterus. Menses Duration Menses Flow Rate Description A subjective description of the menstrual flow rate during a menstrual cycle. Menses Flow Rate Description Menses Start Date Menstrual Cycle Start Date The date on which the menstrual cycle started. Menses Start Date Menstrual Cycle Duration The length of time of the menses cycle, measured from the beginning of one menstrual period to the beginning of the next. Menstrual Cycle Duration Menstrual Cycle Regularity A description of how an individual's menstrual cycle conforms to a consistent temporal pattern. Menstrual Cycle Regularity Mid-Follicular Phase End Date The date on which the mid-follicular phase of the menstrual cycle ended. Mid-Follicular Phase End Date Mid-Follicular Phase Start Date The date on which the mid-follicular phase of the menstrual cycle started. Mid-Follicular Phase Start Date Mid-Luteal Phase End Date The date on which the mid-luteal phase of the menstrual cycle ended. Mid-Luteal Phase End Date Mid-Luteal Phase Start Date The date on which the mid-luteal phase of the menstrual cycle started. Mid-Luteal Phase Start Date Miscarriage Indicator Spontaneous Abortion Indicator An indication as to whether any pregnancies resulted in miscarriages. Miscarriage Indicator Mode of Delivery Description of the method by which a fetus is delivered. Delivery Procedure Hydatidiform Mole Indicator Molar Pregnancy Indicator An indication as to whether a molar pregnancy (hydatidiform mole) has occurred. Molar Pregnancy Indicator Motion Tenderness Indicator An indication as to whether there are symptoms of motion tenderness. Motion Tenderness Indicator Multiple Birth Indicator Plurality Indicator An indication as to whether any single pregnancy resulted in multiple fetuses birthed (live or dead), regardless of gestational age and whether the fetuses were birthed on different dates. Multiple Birth Indicator Number Full Term Live Births A measurement of the total number of live birth events at which the gestational age of the neonate is 39 weeks and 0 days through 40 weeks and 6 days. Number of Full Term Live Births Number of Abortions A measurement of the total number of instances in which there has been a spontaneous termination of pregnancy (miscarriage) or elective termination of pregnancy. Number of Abortions Number of Births A measurement of the total number of birth events experienced by a female. Number of Births Number of C-Sections Number of Cesarean Sections A measurement of the total number of cesarean section delivery events experienced by the individual. Number of Cesarean Sections Number of Continuous Days of Bleed/Spot The number of days one has experienced continuous menstrual bleeding and/or spotting. Number of Continuous Days of Menstrual Bleeding and/or Spotting Number of Early Term Births A measurement of the total number of birth events at which the gestational age of the neonate is 37 weeks and 0 days through 38 weeks and 6 days. Number of Early Term Births Number of Ectopic Pregnancies A measurement of the total number of ectopic pregnancies experienced by a female subject. Number of Ectopic Pregnancies Total Number of Female Sexual Partners The number of females with whom one has engaged in sexual activity within a specified time interval. Number of Female Sexual Partners Number of Full Term Births A measurement of the total number of birth events (both live and dead) at which the gestational age of the neonate is 39 weeks and 0 days through 40 weeks and 6 days. Number of Full Term Births Number of Induced Abortions A measurement of the total number of induced abortions experienced by a female subject. Number of Induced Abortions Number of Late Fetal Deaths A measurement of the total number of fetal deaths (death of a fetus at 16 weeks, 0 days to 19 weeks, 6 days of gestation) experienced by a female subject. Number of Late Fetal Deaths Number of Live Births A measurement of the total number of live-born offspring a female has delivered. Number of Live Births Total Number of Male Sexual Partners The number of males with whom one has engaged in sexual activity within a specified time interval. Number of Male Sexual Partners Number of New Female Sexual Partners The number of new female sexual partners within a specified time interval. Number of New Female Sexual Partners Number of New Male Sexual Partners The number of new male sexual partners within a specified time interval. Number of New Male Sexual Partners Number of New Oral Sexual Partners The number of new individuals with whom one has engaged in oral sex within a specified time interval. Number of New Oral Sexual Partners Total Number of Oral Sexual Partners The number of individuals with whom one has engaged in oral sexual activity within a specified time interval. Number of Oral Sexual Partners Number of Pregnancies A measurement of the total number of pregnancy events experienced by a female. Number of Pregnancies Number of Premature Births A measurement of the total number of birth events (both live and dead) at which the gestational age of the neonate is less than 37 weeks and 0 days. Number of Premature Births Number of Premature Live Births A measurement of the total number of live birth events at which the gestational age of the neonate is less than 37 weeks and 0 days. Number of Premature Live Births Number of Previous Pregnancies A measurement of the total number of pregnancy events experienced by the female subject prior to the current pregnancy. Number of Previous Pregnancies Number of Miscarriages Number of Spontaneous Abortions A measurement of the total number of spontaneous abortions (in which the fetus is less than 20 weeks gestational age) experienced by a female subject. Number of Spontaneous Abortions Number of Stillbirths A measurement of the total number of birth events at which the fetus is of at least 20 weeks gestation, or of a birth weight of at least 350 grams if the gestational age is unknown, which is born without signs of life at the time of delivery, and with an Apgar score of zero at both one and five minutes. Number of Stillbirths Number of Vaginal Deliveries A measurement of the total number of vaginal delivery events experienced by the individual. Number of Vaginal Deliveries Ovulation Phase End Date The date on which the ovulation phase of the menstrual cycle ended. Ovulation Phase End Date Ovulation Phase Start Date The date on which the ovulation phase of the menstrual cycle started. Ovulation Phase Start Date Parity The number of pregnancies reaching 20 weeks and 0 days of gestation or beyond, regardless of the number of fetuses or outcomes. (NICHD) Parity Peeling Indicator An indication as to whether there is the presence of peeling. Peeling Indicator Post-Partum Indicator An indication as to whether the subject is in the stages of recovery post pregnancy and birth event. Post-Partum Indicator Pregnancy Confirmed Indicator An indication as to whether the subject's pregnancy has been confirmed. Pregnancy Confirmed Indicator Pregnancy Outcome The end result of a pregnancy. Pregnancy Outcome Pregnancy Suspected Indicator An indication as to whether the subject or associated person suspects that they are pregnant at the time the question is asked. Pregnancy Suspected Indicator Pregnant During the Study An indicator as to whether a female is pregnant during the study period. (NCI) Pregnant During the Study Pregnant Indicator An indication as to whether the subject or associated person is pregnant at the time the question is asked. Pregnancy Indicator Products of Conception Examined Ind Products of Conception Examined Indicator An indication as to whether the products of conception have been examined. Products of Conception Examined Indicator Puberty Age The age at which puberty began. Puberty Age Puberty Indicator An indication as to whether the individual is undergoing or has undergone puberty. Puberty Indicator Pustule Indicator An indication as to whether a pustule is present. Pustule Indicator Rash Indicator An indication as to whether rash is present. Rash Indicator Reproductive System Examination An observation, assessment or examination of the reproductive system. Reproductive System Examination Skene's Gland Abnormality Indicator An indication as to whether the Skene's gland is abnormal. Skene's Gland Abnormality Indicator Stillbirth Indicator An indication as to whether any pregnancies resulted in stillbirths. Stillbirth Indicator Subj Currently Breastfeeding a Child Ind Subject Currently Breastfeeding a Child Indicator An indication as to whether the individual is currently breastfeeding a child. Subject Currently Breastfeeding a Child Indicator Surgically Sterile Indicator An indication as to whether the individual has been surgically sterilized. Individual Surgically Sterile Indicator Tenderness Indicator An indication as to whether there are symptoms of tenderness. Tenderness Indicator Term Pregnancy Category A classification of the gestation duration of the pregnancy at the time of delivery. Term Pregnancy Category Thelarche Age The age at onset of breast development. Thelarche Age Thickness The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. Thickness Total Number of Sexual Partners The total number of individuals with whom one has engaged in sexual activity within a specified time interval. Total Number of Sexual Partners Ulcer Indicator An indication as to whether an ulcer is present. Ulcer Indicator Vaginal Bleeding/Spotting Freq Desc Vaginal Bleeding/Spotting Frequency Description A description of the frequency at which vaginal bleeding and/or spotting has occurred. Vaginal Bleeding and/or Spotting Frequency Description RPTEST Reproductive System Findings Test Name CDISC SDTM Reproductive System Findings Test Name Terminology A terminology codelist based on the test codes for physiological findings related to the respiratory system, including the organs that are involved in breathing such as the nose, throat, larynx, trachea, bronchi and lungs. Additional Disease-Related Findings A determination of additional abnormalities and/or other observations that may be associated with the disease of interest, for which a targeted test has not been identified in the data. Additional Disease-Related Findings Air Trapping A measurement of the gas retention in a specified intrapulmonary space at the end of exhalation. Air Trapping Measurement Alveolar Volume VA The quantity of gas that enters the alveoli during inspiration. Alveolar Volume Airway Volume The total volume of gas in a specified airway or set of airways at a specified point in time in the respiratory cycle. Airway Volume Percent Predicted Airway Volume The total volume of gas in a specified airway or set of airways at a specified point in time in the respiratory cycle, expressed as a proportion of the predicted normal value. Percent Predicted Airway Volume Airway Wall Volume The volume of the entirety of the airway tissue in a specified intrapulmonary region. Airway Wall Volume Blood Flow Rate The volume of blood per unit time passing through a specified location, such as a point in a blood vessel or an entire organ. Blood Flow Rate Diffusion Capacity of Lung for CO TLCO Transfer Factor of Lung for CO The volume of the carbon monoxide that is transferred from inspired air into the pulmonary capillary blood. Carbon Monoxide Diffusing Capability Test HGB Corrected DLCO The diffusing capacity of the lungs for carbon monoxide adjusted for hemoglobin concentration. Hemoglobin Corrected Diffusion Capacity of the Lung for Carbon Monoxide Percent Predicted HGB Corrected DLCO The diffusing capacity of the lungs for carbon monoxide expressed as a proportion of the predicted normal value, adjusted for hemoglobin concentration. Percent Predicted Hemoglobin Corrected Diffusion Capacity of the Lung for Carbon Monoxide HGB Corrected DLCO/VA The diffusing capacity of the lungs for carbon monoxide expressed as a proportion of the alveolar volume, adjusted for hemoglobin concentration. Hemoglobin Corrected Diffusion Capacity of the Lung for Carbon Monoxide/Alveolar Volume Ratio Percent Predicted HGB Corrected DLCO/VA The proportion of diffusing capacity of the lungs for carbon monoxide to the alveolar volume expressed as a proportion of the predicted normal value, adjusted for hemoglobin concentration. Percent Predicted Hemoglobin Corrected Diffusion Capacity of the Lung for Carbon Monoxide/Alveolar Volume Ratio Mean Diffusion Capacity of Lung for CO The mean volume of the carbon monoxide that is transferred from inspired air into the pulmonary capillary blood. Mean Carbon Monoxide Diffusing Capability Test Percent Predicted DLCO The diffusing capacity of the lungs for carbon monoxide expressed as a proportion of the predicted normal value. Percent Predicted Diffusion Capacity of the Lung for Carbon Monoxide DLCO/VA The diffusing capacity of the lungs for carbon monoxide expressed as a proportion of the alveolar volume. Diffusion Capacity of the Lung for Carbon Monoxide/Alveolar Volume Ratio Percent Predicted DLCO/VA The proportion of the diffusing capacity of the lungs for carbon monoxide to alveolar volume, expressed as a proportion of the predicted normal value. Percent Predicted Diffusion Capacity of the Lung for Carbon Monoxide/Alveolar Volume Ratio Dominant Lung Pattern A subjective assessment of the primary lung abnormality pattern, generally based on size, distribution, and/or amount. Dominant Lung Pattern Assessment Dominant Lung Pattern Distribution A subjective assessment of the distribution of the primary lung abnormality pattern. Dominant Lung Pattern Distribution Assessment Effusion Indicator An indication as to whether effusion is present. Effusion Indicator Effusion Volume The amount of three dimensional space occupied by the effusion fluid. Effusion Volume Measurement Elastance A measure of the resistance of a system to expand, i.e. the pressure change that is required to elicit a unit volume change in the lungs. Elastance is the reciprocal of compliance. Elastance Expiratory Reserve Volume The maximum volume of air a subject can exhale from the lungs after a tidal exhalation. Expiratory Reserve Volume Percent Predicted ERV The maximum volume of air a subject can exhale from the lungs after a tidal exhalation as a proportion of the predicted normal value. Percent Predicted Expiratory Reserve Volume Forced Expiratory Volume in 0.05 S/FVC Forced Expiratory Volume in 0.05 Seconds over FVC The ratio of the volume of gas that is forcibly exhaled during the first 0.05 seconds following maximal inhalation to that of the forced vital capacity. Forced Expiratory Volume in 0.05 Second to FVC Ratio Measurement Forced Expiratory Volume in 0.1 S/FVC Forced Expiratory Volume in 0.1 Seconds over FVC The ratio of the volume of gas that is forcibly exhaled during the first 0.1 seconds following maximal inhalation to that of the forced vital capacity. Forced Expiratory Volume in 0.1 Second to FVC Ratio Measurement Forced Expiratory Volume in 0.2 S/FVC Forced Expiratory Volume in 0.2 Seconds over FVC The ratio of the volume of gas that is forcibly exhaled during the first 0.2 seconds following maximal inhalation to that of the forced vital capacity. Forced Expiratory Volume in 0.2 Second to FVC Ratio Measurement Expiratory Vital Capacity The maximum volume of air an individual can exhale from the point of maximal inhalation. Expiratory Vital Capacity Percent Predicted EVC The maximum volume of air an individual can exhale from the point of maximal inhalation as a percentage of the predicted normal value. Percent Predicted Expiratory Vital Capacity Expiration Relaxation Time The time required to exhale 63.2% of the total expiratory volume, as measured from the start of exhalation. Expiration Relaxation Time Forced Expiratory Flow 25-75% The mean forced expiratory flow rate at 25-75% of the forced vital capacity. (NCI) Forced Expiratory Flow at 25-75 Percent Percent Predicted FEF25-75 The mean forced expiratory flow rate at 25-75% of the forced vital capacity as a proportion of the predicted normal value. (NCI) Percent Predicted Forced Expiratory Flow at 25-75 Percent Forced Expiratory Flow 50% The mean forced expiratory flow rate at 50% of the forced vital capacity. (NCI) Forced Expiratory Flow at 50 Percent Forced Vital Capacity Forced Expiratory Flow in 0.05 Second The forced expiratory flow rate during the first 0.05 second of a forced exhalation. Forced Expiratory Flow in 0.05 Second Forced Expiratory Flow in 0.1 Second The forced expiratory flow rate during the first 0.1 second of a forced exhalation. Forced Expiratory Flow in 0.1 Second Forced Expiratory Flow in 0.2 Second The forced expiratory flow rate during the first 0.2 second of a forced exhalation. Forced Expiratory Flow in 0.2 Second Forced Expiratory Time The time taken to fully expirate air from the lungs. Forced Expiratory Time Forced Expiratory Volume in 1 Second The volume of air that can be forcibly exhaled during the first second following maximal inhalation. Forced Expiratory Volume in 1 Second FEV1/FVC A relative measurement (ratio or percentage) of the forced expiratory volume during the first second of exhalation to the largest observed expired volume during a forced vital capacity maneuver. Forced Expiratory Volume in 1 Second to Forced Vital Capacity Ratio Measurement FEV1/FVC6 A relative measurement (ratio or percentage) of the forced expiratory volume during the first second of exhalation to the observed expired volume during the first six seconds of a forced vital capacity maneuver. Forced Expiratory Volume in 1 Second to Forced Vital Capacity in 6 Seconds Percent Predicted FEV1/FVC A measurement (ratio or percentage) of FEV1/FVC relative to the predicted normal value. Percent Predicted Forced Expiratory Volume in 1 Second Divided by Forced Vital Capacity Percent Predicted FEV1 Forced expiratory volume in one second as a proportion of the predicted normal value. Percent Predicted Forced Expiratory Volume in 1 Second FEV1 Reversibility The change in FEV1 following administration of a bronchodilator relative to the pre-treatment FEV1 value. Forced Expiratory Volume in 1 Second Reversibility FEV1/SVC A relative measurement (ratio or percentage) of the forced expiratory volume during the first second of exhalation to the largest observed expired volume during a slow vital capacity maneuver. Forced Expiratory Volume in 1 Second to Slow Vital Capacity Ratio Measurement Forced Expiratory Volume in 3 Seconds The volume of air that can be forcibly exhaled during the first three seconds following maximal inhalation. Forced Expiratory Volume in 3 Seconds FEV3/FVC A relative measurement (ratio or percentage) of the forced expiratory volume during the first three seconds of exhalation to the largest observed expired volume during a forced vital capacity maneuver. Forced Expiratory Volume in 3 Seconds to Forced Vital Capacity Ratio Measurement Percent Predicted FEV3 Forced expiratory volume in three seconds as a proportion of the predicted normal value. Percent Predicted Forced Expiratory Volume in 3 Seconds Forced Expiratory Volume in 6 Seconds The volume of air that can be forcibly exhaled during the first six seconds following maximal inhalation. Forced Expiratory Volume in 6 Seconds Percent Predicted FEV6 Forced expiratory volume in six seconds as a proportion of the predicted normal value. Percent Predicted Forced Expiratory Volume in 6 Seconds Forced Expiratory Volume in 0.05 Second The volume of air that can be forcibly exhaled during the first 0.05 second following maximal inhalation. Forced Expiratory Volume in 0.05 Second Forced Expiratory Volume in 0.1 Second The volume of air that can be forcibly exhaled during the first 0.1 second following maximal inhalation. Forced Expiratory Volume in 0.1 Second Forced Expiratory Volume in 0.2 Second The volume of air that can be forcibly exhaled during the first 0.2 second following maximal inhalation. Forced Expiratory Volume in 0.2 Second Forced Expiratory Volume in 0.5 Second The volume of air that can be forcibly exhaled during the first half second following maximal inhalation. Forced Expiratory Volume in 0.5 Second Forced Expiratory Volume in 0.75 Second The volume of air that can be forcibly exhaled during the first 0.75 second following maximal inhalation. Forced Expiratory Volume in 0.75 Second FEV at PEF Forced Expiratory Volume at Peak Expiratory Flow The volume of gas that is forcibly exhaled at the peak of expiratory flow. Forced Expiratory Volume at Peak Expiratory Flow Forced Inspiratory Flow at 25% The forced inspiratory flow rate at the point on the inspiratory flow-volume curve where 25 percent of the total volume of air has been inhaled. Forced Inspiratory Flow at 25% Forced Inspiratory Flow at 50% The forced inspiratory flow rate at the point on the inspiratory flow-volume curve where 50 percent of the total volume of air has been inhaled. Forced Inspiratory Flow at 50% Forced Inspiratory Flow at 75% The forced inspiratory flow rate at the point on the inspiratory flow-volume curve where 75 percent of the total volume of air has been inhaled. Forced Inspiratory Flow at 75% Maximum Forced Inspiratory Flow The fastest rate of inspired air achieved during a forced inspiration maneuver. Maximum Forced Inspiratory Flow Percent Predicted FIFmax The fastest rate of inspired air achieved during a forced inspiration maneuver expressed as a percentage of the expected result value for healthy individuals with similar characteristics. Percent Predicted Forced Inspiratory Flow Maximum Fraction of Inspired Oxygen A measurement of the volumetric fraction of oxygen in the inhaled gas. Fraction of Inspired Oxygen Forced Inspiratory Volume in 1 Second The volume of air that a subject can breathe in during the first second of inhalation after maximum exhalation. Forced Inspiratory Volume in 1 Second Percent Predicted FIV1 The volume of air that a subject can breathe in during the first second of inhalation after maximum exhalation as a proportion of the predicted normal value. Percent Predicted Forced Inspiratory Volume in 1 Second Forced Inspiratory Vital Capacity The difference in lung volume between maximal expiration to residual volume followed immediately by full inspiration to total lung capacity during forceful inhalation. Forced Inspiratory Vital Capacity Functional Residual Capacity The volume of air remaining in the lungs after a normal exhalation. (NCI) Functional Residual Capacity Percent Predicted FRC The functional residual capacity as a proportion of the predicted normal value. Percent Predicted Functional Residual Capacity Forced Vital Capacity The volume of air that can be forcibly exhaled following maximal inhalation. Forced Vital Capacity Forced Vital Capacity in 6 Seconds The volume of air that can be forcibly exhaled during the first six seconds following maximal inhalation. Forced Vital Capacity in 6 Seconds Percent Predicted Forced Vital Capacity Forced vital capacity as a proportion of the predicted normal value. Percent Predicted Forced Vital Capacity Airway Conductance The instantaneous rate of air flow in the airway, expressed as the pressure difference between any given part of the airway and the alveoli; it is the reciprocal of airway resistance (Raw). Airway Conductance Inspiratory Capacity The maximum volume of air a subject can inhale into the lungs after a tidal exhalation (IRV plus TV). Inspiratory Capacity Percent Predicted Inspiratory Capacity The maximum volume of air a subject can inhale into the lungs after a tidal exhalation (IRV plus TV) as a proportion of the predicted normal value. Percent Predicted Inspiratory Capacity IC Reversibility The change in IC following administration of a bronchodilator relative to the pre-treatment IC value. Inspiratory Capacity Reversibility Inertance The measure of the force of the column of air in the conducting airways. Pulmonary Inertance Infiltrates Indicator An indication as to whether infiltrates have occurred. Infiltrates Indicator Interpretation An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. Interpretation Inspiratory Reserve Volume The maximum volume of air a subject can inhale into the lungs after a tidal inhalation. Inspiratory Reserve Volume Percent Predicted IRV The maximum volume of air a subject can inhale into the lungs after a tidal inhalation as a proportion of the predicted normal value. Percent Predicted Inspiratory Reserve Volume Inspiratory Vital Capacity The maximum volume of air an individual can inhale from the point of maximal exhalation. Inspiratory Vital Capacity Percent Predicted IVC The maximum volume of air an individual can inhale from the point of maximal exhalation as a percentage of the predicted normal value. Percent Predicted Inspiratory Vital Capacity Lung Clearance Index A representative measurement of the number of times the volume of air in the lung at the start of the washout (the Functional Residual Capacity) must be recycled to eliminate the tracer to the pre-defined endpoint. Lung Clearance Index LCI to 1/40th Initial Concentration LCI to 2.5% Initial Concentration Lung Clearance Index to 1/40th Initial Concentration Lung Clearance Index to 2.5% Initial Concentration A representative measurement of the number of times the volume of air in the lung at the start of the washout (the Functional Residual Capacity) must be recycled to decrease the tracer to 2.5% (or 1/40th) of its initial concentration. Lung Clearance Index to 2.5% Initial Concentration LCI to 1/20th Initial Concentration LCI to 5% Initial Concentration Lung Clearance Index to 1/20th Initial Concentration Lung Clearance Index to 5% Initial Concentration A representative measurement of the number of times the volume of air in the lung at the start of the washout (the Functional Residual Capacity) must be recycled to decrease the tracer to 5% (or 1/20th) of its initial concentration. Lung Clearance Index to 5% Initial Concentration Lobar Volume The total volume of gas in a lobe of the lung at a specified point in time during the respiratory cycle. Lobar Volume Percent Predicted Lobar Volume The total volume of gas in a lobe of the lung at a specified point in time during the respiratory cycle, as a proportion of the predicted normal value. Percent Predicted Lobar Volume Malignancy Evidence Description The basis for the determination that a malignancy is present. Evidence of Malignant Disease Description Malignancy Indicator An indication as to whether a malignancy is present. Malignant Disease Indicator Maximal Expiratory Pressure The greatest amount of pressure that can be generated by exhaling against a mouthpiece, which is a measure of the strength of respiratory muscles. (NCI) Maximal Expiratory Pressure Percent Predicted MEP The greatest amount of pressure that can be generated by exhaling against a mouthpiece, which is a measure of the strength of respiratory muscles expressed as a proportion of the predicted normal value. (NCI) Percent Predicted Maximal Expiratory Pressure Maximal Inspiratory Pressure Negative Inspiratory Force NIF The greatest amount of pressure that can be generated during inhalation against a fully occluded airway, which is used to measure the strength of respiratory muscles. (NCI) Maximal Inspiratory Pressure Percent Predicted MIP The greatest amount of pressure that can be generated during inhalation against a fully occluded airway, which is used to measure the strength of respiratory muscles expressed as a proportion of the predicted normal value. (NCI) Percent Predicted Maximal Inspiratory Pressure Minute Ventilation Minute Volume VE The amount of gas inspired or expired in one minute. Minute Volume Oxygenation Index A measurement of the efficiency of oxygen exchange by the lungs, which is calculated by multiplying the fraction of inspired oxygen (FiO2) (in %) to mean airway pressure (Mpaw), and dividing by pressure of arterial oxygen (PaO2). Oxygenation Index Oxygen Pulse The volume of oxygen per heartbeat consumed by the body while at rest. Oxygen Pulse Oxygen Saturation A measurement of the oxygen-hemoglobin saturation of a volume of blood. Oxygen Saturation Measurement Peak Cough Flow The maximum rate of air flow expelled through the mouth, endotracheal, or tracheostomy tube during a cough. (NCI) Peak Cough Flow Peak Expiratory Flow The maximum rate of exhalation. Peak Expiratory Flow Percent Predicted Peak Expiratory Flow The maximal flow achieved during the maximally forced expiration initiated at maximum inhalation as a proportion of the predicted normal value. Percent Predicted Peak Expiratory Flow PEF Reversibility The change in PEF following administration of a bronchodilator relative to the pre-treatment PEF value. Peak Expiratory Flow Reversibility Peak Expiratory Flow Time The time from the start of the test until the subject reaches his maximum expiratory gas flow rate. Peak Expiratory Flow Time Peak Inspiratory Flow The maximum rate of inhalation. Peak Inspiratory Flow Rate Pulmonary Reactance A measurement of the ability of the lung to store energy, which is required for passive expiration. Pulmonary Reactance Pneumonia Indicator An indication as to whether pneumonia has occurred. Pneumonia Indicator Peak Nasal Inspiratory Flow The maximal flow achieved during the maximally forced inspiration through the nose initiated at maximum exhalation. (NCI) Peak Nasal Inspiratory Flow PAO2/FIO2 PP Arterial O2/Fraction Inspired O2 A relative measurement (ratio or percentage) of the force per unit area (pressure) of oxygen dissolved in arterial blood to the percentage oxygen of an inhaled mixture of gasses. Partial Pressure Arterial Oxygen to Fraction Inspired Oxygen Ratio Measurement Quasi-Static Compliance The static elastic recoil pressure of the lungs at a given lung volume. Quasi-Static Compliance Airway Resistance A measurement of respiratory tract resistance to airflow during inspiration and expiration. Airway Resistance Percent Predicted Airway Resistance A measurement of respiratory tract resistance to airflow during inspiration and expiration, as a proportion of the predicted normal value. Percent Predicted Airway Resistance Respiratory System Examination An observation, assessment or examination of the respiratory system. Respiratory System Examination Relative Size Change An assessment of the size difference in comparison to a baseline or previous value. Relative Size Change Respiratory Exchange Ratio The ratio between the amount of carbon dioxide produced and oxygen consumed in one breath. Respiratory Exchange Ratio Total Respiratory System Resistance A calculated value based on all factors that influence the flow of gas from the airway opening to the alveoli, including airway resistance, and tissue resistance of the lung and chest wall. (NCI) Total Respiratory System Resistance Residual Volume The volume of air remaining in the lungs after maximum exhalation. Residual Volume Percent Predicted Residual Volume The volume of air remaining in the lungs after maximum exhalation as a proportion of the predicted normal value. Percent Predicted Residual Volume Salazar-Knowles Equation Parameter A A representation of the exponential function described by the Salazar-Knowles equation, and an estimation of a subject's inspiratory capacity. Salazar-Knowles Equation Parameter A Salazar-Knowles Equation Parameter B The difference between the volume at total lung capacity and the hypothesized volume at a transpulmonary pressure of zero. Salazar-Knowles Equation Parameter B Salazar-Knowles Equation, K The reflection of the curvature of the upper portion of the deflationary limb of the pressure-volume curve. Salazar-Knowles Equation, K Parameter Oxygen Saturation/Fraction Inspired O2 A relative measurement (ratio or percentage) of the oxygen-hemoglobin saturation of a volume of blood to the volumetric fraction of oxygen in the inhaled gas. Oxygen Saturation/Fraction Inspired O2 Specific Airway Volume A parameter used in functional respiratory imaging, derived by dividing the airway volume of a specified intrapulmonary region by the total volume of the same specified intrapulmonary region. Specific Airway Volume Percent Predicted Specific Airway Volume A parameter used in functional respiratory imaging, derived by dividing the airway volume of a specified intrapulmonary region by the total volume of the same specified intrapulmonary region, expressed as a proportion of the predicted normal value. Percent Predicted Specific Airway Volume Specific Airway Conductance A measurement of the airway conductance relative to lung volume. (NCI) Specific Airway Conductance Specific Airway Resistance A measurement used to describe airway behavior irrespective of lung volume; it is calculated as airway resistance (Raw) multiplied by functional residual capacity (FRC). Specific Airway Resistance Percent Predicted Sp Airway Resistance Percent Predicted Specific Airway Resistance A measurement used to describe airway behavior irrespective of lung volume; it is calculated as airway resistance (Raw) multiplied by functional residual capacity (FRC), as a proportion of the predicted normal value. Percent Predicted Specific Airway Resistance Slow Vital Capacity The maximum volume of air that can be exhaled after slow maximum inhalation. Slow Vital Capacity Percent Predicted Slow Vital Capacity The maximum volume of air that can be exhaled after slow maximum inhalation as a proportion of the predicted normal value. Percent Predicted Slow Vital Capacity Thoracic Gas Volume The absolute volume of air contained in the thoracic cavity at any given point in time and at any level of alveolar pressure. Thoracic Gas Volume Total Lung Capacity The total volume of air in the lungs after maximum inhalation. Total Lung Capacity Percent Predicted Total Lung Capacity The total volume of air in the lungs after maximum inhalation as a proportion of the predicted normal value. Percent Predicted Total Lung Capacity Tissue Elastance A measurement of the reflection of energy conservation within a given tissue. Tissue Elastance Tissue Hysteresivity The energy dissipated relative to the elastic energy stored in the tissue in a P-V cycle. (Fredberg JJ, Stamenovic D. On the imperfect elasticity of lung tissue. J Appl Physiol (1985). 1989 Dec;67(6):2408-19). Tissue Hysteresivity Measurement Tidal Volume The volume of air moved into and out of the lungs during breathing at rest. Tidal Volume Percent Predicted Tidal Volume The volume of air moved into and out of the lungs during breathing at rest as a proportion of the predicted normal value. Percent Predicted Tidal Volume Oxygen Consumption The rate at which oxygen is absorbed and utilized by any given tissue in the body. Oxygen Consumption Maximal Oxygen Consumption The maximum rate of oxygen utilization at which oxygen uptake no longer increases and beyond which no level of effort can raise it. Maximal Oxygen Uptake Estimated Maximal Aerobic Capacity Maximal Oxygen Consumption, Estimated The predicted maximum rate of oxygen uptake that is derived from physiological responses to submaximal exercise performance and is used as a measure of cardiorespiratory fitness. Maximal Oxygen Consumption, Estimated First Ventilatory Threshold Ventilatory Threshold 1 The point during activity or exercise at which ventilation begins to increase at a faster rate than oxygen consumption. This threshold is characterized by aerobic metabolism. First Ventilatory Threshold Anaerobic Threshold Lactate Threshold Respiratory Compensation Threshold Second Ventilatory Threshold Ventilatory Threshold 2 The point during activity or exercise at which the effort to ventilate increases such that the exerciser experiences duress and can no longer speak. This threshold is characterized by anaerobic metabolism and lactate buildup. Second Ventilatory Threshold RETESTCD Respiratory Test Code CDISC SDTM Respiratory Test Code Terminology A terminology codelist based on the test names for physiological findings related to the respiratory system, including the organs that are involved in breathing such as the nose, throat, larynx, trachea, bronchi and lungs. Additional Disease-Related Findings A determination of additional abnormalities and/or other observations that may be associated with the disease of interest, for which a targeted test has not been identified in the data. Additional Disease-Related Findings Air Trapping A measurement of the gas retention in a specified intrapulmonary space at the end of exhalation. Air Trapping Measurement Airway Conductance The instantaneous rate of air flow in the airway, expressed as the pressure difference between any given part of the airway and the alveoli; it is the reciprocal of airway resistance (Raw). Airway Conductance Airway Resistance A measurement of respiratory tract resistance to airflow during inspiration and expiration. Airway Resistance Airway Volume The total volume of gas in a specified airway or set of airways at a specified point in time in the respiratory cycle. Airway Volume Airway Wall Volume The volume of the entirety of the airway tissue in a specified intrapulmonary region. Airway Wall Volume Alveolar Volume VA The quantity of gas that enters the alveoli during inspiration. Alveolar Volume Blood Flow Rate The volume of blood per unit time passing through a specified location, such as a point in a blood vessel or an entire organ. Blood Flow Rate Diffusion Capacity of Lung for CO TLCO Transfer Factor of Lung for CO The volume of the carbon monoxide that is transferred from inspired air into the pulmonary capillary blood. Carbon Monoxide Diffusing Capability Test DLCO/VA The diffusing capacity of the lungs for carbon monoxide expressed as a proportion of the alveolar volume. Diffusion Capacity of the Lung for Carbon Monoxide/Alveolar Volume Ratio Dominant Lung Pattern Distribution A subjective assessment of the distribution of the primary lung abnormality pattern. Dominant Lung Pattern Distribution Assessment Dominant Lung Pattern A subjective assessment of the primary lung abnormality pattern, generally based on size, distribution, and/or amount. Dominant Lung Pattern Assessment Effusion Indicator An indication as to whether effusion is present. Effusion Indicator Effusion Volume The amount of three dimensional space occupied by the effusion fluid. Effusion Volume Measurement Elastance A measure of the resistance of a system to expand, i.e. the pressure change that is required to elicit a unit volume change in the lungs. Elastance is the reciprocal of compliance. Elastance Expiration Relaxation Time The time required to exhale 63.2% of the total expiratory volume, as measured from the start of exhalation. Expiration Relaxation Time Expiratory Reserve Volume The maximum volume of air a subject can exhale from the lungs after a tidal exhalation. Expiratory Reserve Volume Expiratory Vital Capacity The maximum volume of air an individual can exhale from the point of maximal inhalation. Expiratory Vital Capacity FEV at PEF Forced Expiratory Volume at Peak Expiratory Flow The volume of gas that is forcibly exhaled at the peak of expiratory flow. Forced Expiratory Volume at Peak Expiratory Flow FEV1 Reversibility The change in FEV1 following administration of a bronchodilator relative to the pre-treatment FEV1 value. Forced Expiratory Volume in 1 Second Reversibility FEV1/FVC A relative measurement (ratio or percentage) of the forced expiratory volume during the first second of exhalation to the largest observed expired volume during a forced vital capacity maneuver. Forced Expiratory Volume in 1 Second to Forced Vital Capacity Ratio Measurement FEV1/FVC6 A relative measurement (ratio or percentage) of the forced expiratory volume during the first second of exhalation to the observed expired volume during the first six seconds of a forced vital capacity maneuver. Forced Expiratory Volume in 1 Second to Forced Vital Capacity in 6 Seconds FEV1/SVC A relative measurement (ratio or percentage) of the forced expiratory volume during the first second of exhalation to the largest observed expired volume during a slow vital capacity maneuver. Forced Expiratory Volume in 1 Second to Slow Vital Capacity Ratio Measurement FEV3/FVC A relative measurement (ratio or percentage) of the forced expiratory volume during the first three seconds of exhalation to the largest observed expired volume during a forced vital capacity maneuver. Forced Expiratory Volume in 3 Seconds to Forced Vital Capacity Ratio Measurement Forced Expiratory Flow 25-75% The mean forced expiratory flow rate at 25-75% of the forced vital capacity. (NCI) Forced Expiratory Flow at 25-75 Percent Forced Expiratory Flow 50% The mean forced expiratory flow rate at 50% of the forced vital capacity. (NCI) Forced Expiratory Flow at 50 Percent Forced Vital Capacity Forced Expiratory Flow in 0.05 Second The forced expiratory flow rate during the first 0.05 second of a forced exhalation. Forced Expiratory Flow in 0.05 Second Forced Expiratory Flow in 0.1 Second The forced expiratory flow rate during the first 0.1 second of a forced exhalation. Forced Expiratory Flow in 0.1 Second Forced Expiratory Flow in 0.2 Second The forced expiratory flow rate during the first 0.2 second of a forced exhalation. Forced Expiratory Flow in 0.2 Second Forced Expiratory Time The time taken to fully expirate air from the lungs. Forced Expiratory Time Forced Expiratory Volume in 0.05 S/FVC Forced Expiratory Volume in 0.05 Seconds over FVC The ratio of the volume of gas that is forcibly exhaled during the first 0.05 seconds following maximal inhalation to that of the forced vital capacity. Forced Expiratory Volume in 0.05 Second to FVC Ratio Measurement Forced Expiratory Volume in 0.05 Second The volume of air that can be forcibly exhaled during the first 0.05 second following maximal inhalation. Forced Expiratory Volume in 0.05 Second Forced Expiratory Volume in 0.1 S/FVC Forced Expiratory Volume in 0.1 Seconds over FVC The ratio of the volume of gas that is forcibly exhaled during the first 0.1 seconds following maximal inhalation to that of the forced vital capacity. Forced Expiratory Volume in 0.1 Second to FVC Ratio Measurement Forced Expiratory Volume in 0.1 Second The volume of air that can be forcibly exhaled during the first 0.1 second following maximal inhalation. Forced Expiratory Volume in 0.1 Second Forced Expiratory Volume in 0.2 S/FVC Forced Expiratory Volume in 0.2 Seconds over FVC The ratio of the volume of gas that is forcibly exhaled during the first 0.2 seconds following maximal inhalation to that of the forced vital capacity. Forced Expiratory Volume in 0.2 Second to FVC Ratio Measurement Forced Expiratory Volume in 0.2 Second The volume of air that can be forcibly exhaled during the first 0.2 second following maximal inhalation. Forced Expiratory Volume in 0.2 Second Forced Expiratory Volume in 0.5 Second The volume of air that can be forcibly exhaled during the first half second following maximal inhalation. Forced Expiratory Volume in 0.5 Second Forced Expiratory Volume in 0.75 Second The volume of air that can be forcibly exhaled during the first 0.75 second following maximal inhalation. Forced Expiratory Volume in 0.75 Second Forced Expiratory Volume in 1 Second The volume of air that can be forcibly exhaled during the first second following maximal inhalation. Forced Expiratory Volume in 1 Second Forced Expiratory Volume in 3 Seconds The volume of air that can be forcibly exhaled during the first three seconds following maximal inhalation. Forced Expiratory Volume in 3 Seconds Forced Expiratory Volume in 6 Seconds The volume of air that can be forcibly exhaled during the first six seconds following maximal inhalation. Forced Expiratory Volume in 6 Seconds Forced Inspiratory Flow at 25% The forced inspiratory flow rate at the point on the inspiratory flow-volume curve where 25 percent of the total volume of air has been inhaled. Forced Inspiratory Flow at 25% Forced Inspiratory Flow at 50% The forced inspiratory flow rate at the point on the inspiratory flow-volume curve where 50 percent of the total volume of air has been inhaled. Forced Inspiratory Flow at 50% Forced Inspiratory Flow at 75% The forced inspiratory flow rate at the point on the inspiratory flow-volume curve where 75 percent of the total volume of air has been inhaled. Forced Inspiratory Flow at 75% Forced Inspiratory Vital Capacity The difference in lung volume between maximal expiration to residual volume followed immediately by full inspiration to total lung capacity during forceful inhalation. Forced Inspiratory Vital Capacity Forced Inspiratory Volume in 1 Second The volume of air that a subject can breathe in during the first second of inhalation after maximum exhalation. Forced Inspiratory Volume in 1 Second Forced Vital Capacity in 6 Seconds The volume of air that can be forcibly exhaled during the first six seconds following maximal inhalation. Forced Vital Capacity in 6 Seconds Forced Vital Capacity The volume of air that can be forcibly exhaled following maximal inhalation. Forced Vital Capacity Fraction of Inspired Oxygen A measurement of the volumetric fraction of oxygen in the inhaled gas. Fraction of Inspired Oxygen Functional Residual Capacity The volume of air remaining in the lungs after a normal exhalation. (NCI) Functional Residual Capacity HGB Corrected DLCO The diffusing capacity of the lungs for carbon monoxide adjusted for hemoglobin concentration. Hemoglobin Corrected Diffusion Capacity of the Lung for Carbon Monoxide HGB Corrected DLCO/VA The diffusing capacity of the lungs for carbon monoxide expressed as a proportion of the alveolar volume, adjusted for hemoglobin concentration. Hemoglobin Corrected Diffusion Capacity of the Lung for Carbon Monoxide/Alveolar Volume Ratio IC Reversibility The change in IC following administration of a bronchodilator relative to the pre-treatment IC value. Inspiratory Capacity Reversibility Inertance The measure of the force of the column of air in the conducting airways. Pulmonary Inertance Infiltrates Indicator An indication as to whether infiltrates have occurred. Infiltrates Indicator Inspiratory Capacity The maximum volume of air a subject can inhale into the lungs after a tidal exhalation (IRV plus TV). Inspiratory Capacity Inspiratory Reserve Volume The maximum volume of air a subject can inhale into the lungs after a tidal inhalation. Inspiratory Reserve Volume Inspiratory Vital Capacity The maximum volume of air an individual can inhale from the point of maximal exhalation. Inspiratory Vital Capacity Interpretation An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. Interpretation LCI to 1/40th Initial Concentration LCI to 2.5% Initial Concentration Lung Clearance Index to 1/40th Initial Concentration Lung Clearance Index to 2.5% Initial Concentration A representative measurement of the number of times the volume of air in the lung at the start of the washout (the Functional Residual Capacity) must be recycled to decrease the tracer to 2.5% (or 1/40th) of its initial concentration. Lung Clearance Index to 2.5% Initial Concentration LCI to 1/20th Initial Concentration LCI to 5% Initial Concentration Lung Clearance Index to 1/20th Initial Concentration Lung Clearance Index to 5% Initial Concentration A representative measurement of the number of times the volume of air in the lung at the start of the washout (the Functional Residual Capacity) must be recycled to decrease the tracer to 5% (or 1/20th) of its initial concentration. Lung Clearance Index to 5% Initial Concentration Lobar Volume The total volume of gas in a lobe of the lung at a specified point in time during the respiratory cycle. Lobar Volume Lung Clearance Index A representative measurement of the number of times the volume of air in the lung at the start of the washout (the Functional Residual Capacity) must be recycled to eliminate the tracer to the pre-defined endpoint. Lung Clearance Index Malignancy Evidence Description The basis for the determination that a malignancy is present. Evidence of Malignant Disease Description Malignancy Indicator An indication as to whether a malignancy is present. Malignant Disease Indicator Maximal Expiratory Pressure The greatest amount of pressure that can be generated by exhaling against a mouthpiece, which is a measure of the strength of respiratory muscles. (NCI) Maximal Expiratory Pressure Maximal Inspiratory Pressure Negative Inspiratory Force NIF The greatest amount of pressure that can be generated during inhalation against a fully occluded airway, which is used to measure the strength of respiratory muscles. (NCI) Maximal Inspiratory Pressure Maximal Oxygen Consumption The maximum rate of oxygen utilization at which oxygen uptake no longer increases and beyond which no level of effort can raise it. Maximal Oxygen Uptake Estimated Maximal Aerobic Capacity Maximal Oxygen Consumption, Estimated The predicted maximum rate of oxygen uptake that is derived from physiological responses to submaximal exercise performance and is used as a measure of cardiorespiratory fitness. Maximal Oxygen Consumption, Estimated Maximum Forced Inspiratory Flow The fastest rate of inspired air achieved during a forced inspiration maneuver. Maximum Forced Inspiratory Flow Mean Diffusion Capacity of Lung for CO The mean volume of the carbon monoxide that is transferred from inspired air into the pulmonary capillary blood. Mean Carbon Monoxide Diffusing Capability Test Minute Ventilation Minute Volume VE The amount of gas inspired or expired in one minute. Minute Volume Oxygen Consumption The rate at which oxygen is absorbed and utilized by any given tissue in the body. Oxygen Consumption Oxygen Pulse The volume of oxygen per heartbeat consumed by the body while at rest. Oxygen Pulse Oxygen Saturation A measurement of the oxygen-hemoglobin saturation of a volume of blood. Oxygen Saturation Measurement Oxygen Saturation/Fraction Inspired O2 A relative measurement (ratio or percentage) of the oxygen-hemoglobin saturation of a volume of blood to the volumetric fraction of oxygen in the inhaled gas. Oxygen Saturation/Fraction Inspired O2 Oxygenation Index A measurement of the efficiency of oxygen exchange by the lungs, which is calculated by multiplying the fraction of inspired oxygen (FiO2) (in %) to mean airway pressure (Mpaw), and dividing by pressure of arterial oxygen (PaO2). Oxygenation Index Peak Cough Flow The maximum rate of air flow expelled through the mouth, endotracheal, or tracheostomy tube during a cough. (NCI) Peak Cough Flow Peak Expiratory Flow Time The time from the start of the test until the subject reaches his maximum expiratory gas flow rate. Peak Expiratory Flow Time Peak Expiratory Flow The maximum rate of exhalation. Peak Expiratory Flow Peak Inspiratory Flow The maximum rate of inhalation. Peak Inspiratory Flow Rate Peak Nasal Inspiratory Flow The maximal flow achieved during the maximally forced inspiration through the nose initiated at maximum exhalation. (NCI) Peak Nasal Inspiratory Flow PEF Reversibility The change in PEF following administration of a bronchodilator relative to the pre-treatment PEF value. Peak Expiratory Flow Reversibility Percent Predicted Airway Resistance A measurement of respiratory tract resistance to airflow during inspiration and expiration, as a proportion of the predicted normal value. Percent Predicted Airway Resistance Percent Predicted Airway Volume The total volume of gas in a specified airway or set of airways at a specified point in time in the respiratory cycle, expressed as a proportion of the predicted normal value. Percent Predicted Airway Volume Percent Predicted DLCO The diffusing capacity of the lungs for carbon monoxide expressed as a proportion of the predicted normal value. Percent Predicted Diffusion Capacity of the Lung for Carbon Monoxide Percent Predicted DLCO/VA The proportion of the diffusing capacity of the lungs for carbon monoxide to alveolar volume, expressed as a proportion of the predicted normal value. Percent Predicted Diffusion Capacity of the Lung for Carbon Monoxide/Alveolar Volume Ratio Percent Predicted ERV The maximum volume of air a subject can exhale from the lungs after a tidal exhalation as a proportion of the predicted normal value. Percent Predicted Expiratory Reserve Volume Percent Predicted EVC The maximum volume of air an individual can exhale from the point of maximal inhalation as a percentage of the predicted normal value. Percent Predicted Expiratory Vital Capacity Percent Predicted FEF25-75 The mean forced expiratory flow rate at 25-75% of the forced vital capacity as a proportion of the predicted normal value. (NCI) Percent Predicted Forced Expiratory Flow at 25-75 Percent Percent Predicted FEV1 Forced expiratory volume in one second as a proportion of the predicted normal value. Percent Predicted Forced Expiratory Volume in 1 Second Percent Predicted FEV1/FVC A measurement (ratio or percentage) of FEV1/FVC relative to the predicted normal value. Percent Predicted Forced Expiratory Volume in 1 Second Divided by Forced Vital Capacity Percent Predicted FEV3 Forced expiratory volume in three seconds as a proportion of the predicted normal value. Percent Predicted Forced Expiratory Volume in 3 Seconds Percent Predicted FEV6 Forced expiratory volume in six seconds as a proportion of the predicted normal value. Percent Predicted Forced Expiratory Volume in 6 Seconds Percent Predicted FIFmax The fastest rate of inspired air achieved during a forced inspiration maneuver expressed as a percentage of the expected result value for healthy individuals with similar characteristics. Percent Predicted Forced Inspiratory Flow Maximum Percent Predicted FIV1 The volume of air that a subject can breathe in during the first second of inhalation after maximum exhalation as a proportion of the predicted normal value. Percent Predicted Forced Inspiratory Volume in 1 Second Percent Predicted Forced Vital Capacity Forced vital capacity as a proportion of the predicted normal value. Percent Predicted Forced Vital Capacity Percent Predicted FRC The functional residual capacity as a proportion of the predicted normal value. Percent Predicted Functional Residual Capacity Percent Predicted HGB Corrected DLCO The diffusing capacity of the lungs for carbon monoxide expressed as a proportion of the predicted normal value, adjusted for hemoglobin concentration. Percent Predicted Hemoglobin Corrected Diffusion Capacity of the Lung for Carbon Monoxide Percent Predicted HGB Corrected DLCO/VA The proportion of diffusing capacity of the lungs for carbon monoxide to the alveolar volume expressed as a proportion of the predicted normal value, adjusted for hemoglobin concentration. Percent Predicted Hemoglobin Corrected Diffusion Capacity of the Lung for Carbon Monoxide/Alveolar Volume Ratio Percent Predicted Inspiratory Capacity The maximum volume of air a subject can inhale into the lungs after a tidal exhalation (IRV plus TV) as a proportion of the predicted normal value. Percent Predicted Inspiratory Capacity Percent Predicted IRV The maximum volume of air a subject can inhale into the lungs after a tidal inhalation as a proportion of the predicted normal value. Percent Predicted Inspiratory Reserve Volume Percent Predicted IVC The maximum volume of air an individual can inhale from the point of maximal exhalation as a percentage of the predicted normal value. Percent Predicted Inspiratory Vital Capacity Percent Predicted Lobar Volume The total volume of gas in a lobe of the lung at a specified point in time during the respiratory cycle, as a proportion of the predicted normal value. Percent Predicted Lobar Volume Percent Predicted MEP The greatest amount of pressure that can be generated by exhaling against a mouthpiece, which is a measure of the strength of respiratory muscles expressed as a proportion of the predicted normal value. (NCI) Percent Predicted Maximal Expiratory Pressure Percent Predicted MIP The greatest amount of pressure that can be generated during inhalation against a fully occluded airway, which is used to measure the strength of respiratory muscles expressed as a proportion of the predicted normal value. (NCI) Percent Predicted Maximal Inspiratory Pressure Percent Predicted Peak Expiratory Flow The maximal flow achieved during the maximally forced expiration initiated at maximum inhalation as a proportion of the predicted normal value. Percent Predicted Peak Expiratory Flow Percent Predicted Residual Volume The volume of air remaining in the lungs after maximum exhalation as a proportion of the predicted normal value. Percent Predicted Residual Volume Percent Predicted Slow Vital Capacity The maximum volume of air that can be exhaled after slow maximum inhalation as a proportion of the predicted normal value. Percent Predicted Slow Vital Capacity Percent Predicted Sp Airway Resistance Percent Predicted Specific Airway Resistance A measurement used to describe airway behavior irrespective of lung volume; it is calculated as airway resistance (Raw) multiplied by functional residual capacity (FRC), as a proportion of the predicted normal value. Percent Predicted Specific Airway Resistance Percent Predicted Specific Airway Volume A parameter used in functional respiratory imaging, derived by dividing the airway volume of a specified intrapulmonary region by the total volume of the same specified intrapulmonary region, expressed as a proportion of the predicted normal value. Percent Predicted Specific Airway Volume Percent Predicted Tidal Volume The volume of air moved into and out of the lungs during breathing at rest as a proportion of the predicted normal value. Percent Predicted Tidal Volume Percent Predicted Total Lung Capacity The total volume of air in the lungs after maximum inhalation as a proportion of the predicted normal value. Percent Predicted Total Lung Capacity Pneumonia Indicator An indication as to whether pneumonia has occurred. Pneumonia Indicator PAO2/FIO2 PP Arterial O2/Fraction Inspired O2 A relative measurement (ratio or percentage) of the force per unit area (pressure) of oxygen dissolved in arterial blood to the percentage oxygen of an inhaled mixture of gasses. Partial Pressure Arterial Oxygen to Fraction Inspired Oxygen Ratio Measurement Pulmonary Reactance A measurement of the ability of the lung to store energy, which is required for passive expiration. Pulmonary Reactance Quasi-Static Compliance The static elastic recoil pressure of the lungs at a given lung volume. Quasi-Static Compliance Relative Size Change An assessment of the size difference in comparison to a baseline or previous value. Relative Size Change Residual Volume The volume of air remaining in the lungs after maximum exhalation. Residual Volume Respiratory Exchange Ratio The ratio between the amount of carbon dioxide produced and oxygen consumed in one breath. Respiratory Exchange Ratio Respiratory System Examination An observation, assessment or examination of the respiratory system. Respiratory System Examination Salazar-Knowles Equation Parameter A A representation of the exponential function described by the Salazar-Knowles equation, and an estimation of a subject's inspiratory capacity. Salazar-Knowles Equation Parameter A Salazar-Knowles Equation Parameter B The difference between the volume at total lung capacity and the hypothesized volume at a transpulmonary pressure of zero. Salazar-Knowles Equation Parameter B Salazar-Knowles Equation, K The reflection of the curvature of the upper portion of the deflationary limb of the pressure-volume curve. Salazar-Knowles Equation, K Parameter Slow Vital Capacity The maximum volume of air that can be exhaled after slow maximum inhalation. Slow Vital Capacity Specific Airway Conductance A measurement of the airway conductance relative to lung volume. (NCI) Specific Airway Conductance Specific Airway Resistance A measurement used to describe airway behavior irrespective of lung volume; it is calculated as airway resistance (Raw) multiplied by functional residual capacity (FRC). Specific Airway Resistance Specific Airway Volume A parameter used in functional respiratory imaging, derived by dividing the airway volume of a specified intrapulmonary region by the total volume of the same specified intrapulmonary region. Specific Airway Volume Thoracic Gas Volume The absolute volume of air contained in the thoracic cavity at any given point in time and at any level of alveolar pressure. Thoracic Gas Volume Tidal Volume The volume of air moved into and out of the lungs during breathing at rest. Tidal Volume Tissue Elastance A measurement of the reflection of energy conservation within a given tissue. Tissue Elastance Tissue Hysteresivity The energy dissipated relative to the elastic energy stored in the tissue in a P-V cycle. (Fredberg JJ, Stamenovic D. On the imperfect elasticity of lung tissue. J Appl Physiol (1985). 1989 Dec;67(6):2408-19). Tissue Hysteresivity Measurement Total Lung Capacity The total volume of air in the lungs after maximum inhalation. Total Lung Capacity Total Respiratory System Resistance A calculated value based on all factors that influence the flow of gas from the airway opening to the alveoli, including airway resistance, and tissue resistance of the lung and chest wall. (NCI) Total Respiratory System Resistance First Ventilatory Threshold Ventilatory Threshold 1 The point during activity or exercise at which ventilation begins to increase at a faster rate than oxygen consumption. This threshold is characterized by aerobic metabolism. First Ventilatory Threshold Anaerobic Threshold Lactate Threshold Respiratory Compensation Threshold Second Ventilatory Threshold Ventilatory Threshold 2 The point during activity or exercise at which the effort to ventilate increases such that the exerciser experiences duress and can no longer speak. This threshold is characterized by anaerobic metabolism and lactate buildup. Second Ventilatory Threshold RETEST Respiratory Test Name CDISC SDTM Respiratory Test Name Terminology Terminology relevant to the values that classifies the scale of the original result value with respect to whether the result is, for example, ordinal, nominal, quantitative, or narrative. Nar A textual description of the particulars of an act, occurrence, or course of events. Narrative Nom A scale or classification with no inherent order to the values, which uses named categories or labels. Nominal Scale Ord A scale that uses an ordered set of values where the difference between successive designations may not be constant. Ordinal Scale Qn A numeric measure of a physical attribute of an entity or substance. Quantitative Concept SemiQn An estimated numeric measure of an entity or substance whose values could be a range, non-linear, or non-continuous. Semi-Quantitative Concept RSLSCLRS Result Scale Response CDISC SDTM Result Scale Response Terminology Terminology relevant to the values that describe the result type. Aper Appearance The outward or visible aspect of an entity. Appearance ACnc The quantity of a specified substance, which is subject to individual judgment, preference, or predetermined reference, in a unit volume or weight of another substance. Arbitrary Concentration Area The extent of a 2-dimensional surface enclosed within a boundary. (NCI) Area ArVRat The volume consumed, produced, excreted, or otherwise changed per area per unit of time. Areic Volume Rate CCnc The quantity of a specified substance, which is based on catalytic activity, in a unit volume or weight of another substance. Catalytic Concentration CCnt The total amount of catalytic activity for a substance contained within an entity. Catalytic Content CFr.DF Decimal Catalytic Fraction The catalytic activity of a component substance to the catalytic activity of the whole represented as a decimal between 0 and 1. Catalytic Decimal Fraction CFr The catalytic activity of a component substance to the catalytic activity of the whole. Catalytic Fraction CSub Enzymatic Activity/Substance The enzymatic activity of a specified component divided by the number of molar entities. Catalytic Substance Activity EntMass The weight of a specified component divided by the number of entities. Entitic Mass Entitic Substance Amount EntSub The molar amount of a specified component divided by the number of entities. Entitic Substance EntVol The volume of a specified component divided by the number of entities. Entitic Volume Fluorescent Intensity The degree or magnitude of fluorescent light emission. Fluorescence Intensity Imp A diagnostic statement that is an interpretation or abstraction of an observation(s). Impression A dimensionless value which assigns a single number derived from a set of related values in order to quantify trends and evaluate a value or quantity as compared with a standard or a base value. Index Value LaCnc The quantity, expressed as the log of the arbitrary concentration of a specified substance, in a unit volume or weight of another substance. Log Arbitrary Concentration LnCnc The quantity, expressed as the log of the count, of a specified entity in a unit volume or weight of another substance. Log Number Concentration LsCnc The quantity, expressed as the log of the moles, of a specified substance in a unit volume or weight of another substance. Log Substance Concentration MCnc The quantity, expressed as a weight, of a specified substance in a unit volume or weight of another substance. Mass Concentration MCnt The weight of a component substance per unit weight of a sample. Mass Content MFr.DF The weight of a component substance to the weight of the whole represented as a decimal between 0 and 1. Mass Decimal Fraction MFr The weight of a component substance to the weight of the whole. Mass Fraction MRat The weight consumed, produced, excreted, or otherwise changed per unit of time. Mass Rate MRto The quotient of the weight of one substance divided by the weight of another substance. Mass Ratio Mass The amount of matter in an object. Mass Morph A statement about the form and/or structure of a target entity. Morphology MoM The individual test result relative to the median value of a reference set of test results. Multiple of the Median Naric The number of specified entities per unit of area. Number Areic NCnc The number of specified entities in a unit volume or weight of a substance. Number Concentration NFr The number of component entities to the total number of entities. Number Fraction Count Num Number Count An absolute count of the number of entities. Count OR The ratio of the probability of an event occurring in one group to the probability of it occurring in another group, or to a sample-based estimate of that ratio. Odds Ratio Osmol The number of solute particles per liter of solution. Osmolarity PPres The pressure exerted by a single component of a mixture of gases. Partial Pressure PctDiff The difference between two numbers divided by the average of the two numbers, multiplied by 100. Percent Difference Centile Prctl Any of the 99 intermediate points that divide an ordered set of scores into 100 parts, each of which contains one-hundredth of the total. Percentile Prid An indication of the presence of an entity which, if present, is identified. Presence and Identity PrThr An indication of the presence of an entity which, if present, is in an amount above a predetermined threshold. Presence and Threshold Quintile Any of the 4 intermediate points that divide an ordered set of scores into 5 parts, each of which contains one-twentieth of the total. Quintile Ratio The relationship in quantity, amount, or size between two entities or activities. Ratio Result Type RelACnc The quantity of a specified substance, which is subject to individual judgment, preference, or predetermined reference, in a unit volume or weight of another substance, relative to a comparator. Relative Arbitrary Concentration RelCCnc The quantity of a specified substance, which is based on catalytic activity, in a unit volume or weight of another substance, relative to a comparator. Relative Catalytic Concentration Rden The density of a specified substance, relative to a comparator. Relative Density RelMCnc The quantity, expressed as a weight, of a specified substance in a unit volume or weight of another substance, relative to a comparator. Relative Mass Concentration RelTime The time of a specified activity, relative to a comparator. Relative Time SatFr The degree or extent to which something is dissolved, absorbed, or bound compared with the maximum physical limit under defined conditions. Saturation Fraction Score A value (e.g., number, numeric range, ratio) that assesses and orders a result or response for purposes of comparison. Score Molar Concentration SCnc The quantity, expressed in moles, of a specified substance in a unit volume or weight of another substance. Molar Concentration Molar Fraction SFr The molar amount of a component substance to the molar amount of the whole. Molar Fraction Molar Rate SRat The molar amount of substance consumed, produced, excreted, or otherwise changed per unit of time. Molar Rate Molar Ratio SRto The quotient of the molar amount of one substance, divided by the molar amount of another substance. Molar Ratio ThreshNum The number or limit on a scale that defines when a threshold, or cut-off, is reached. Threshold Number TRto The quotient of one activity time interval divided by another activity time interval. Time Ratio Duration Time Time Duration The length of time during which something continues. Duration Titr Titre Concentration of a substance in a solution as determined by the quantitative reaction with added measured volume(s) of a solution of the precisely known concentration(s) of a standard reagent. Titer Type An identifiable class based on common distinguishable qualities. Type Vel The speed of an entity in a given direction. Velocity Visc Viscosity The resistance of a liquid to sheer forces and flow. (NCI) Viscosity VFr.DF Quotient of the volume of a component substance to the sum of the volumes of all component substances represented as a decimal between 0 and 1. Volume Decimal Fraction VFr Quotient of the volume of a component substance to the sum of the volumes of all component substances. Volume Fraction VRat The volume consumed, produced, excreted, or otherwise changed per unit of time. Volume Rate Vol The amount of three dimensional space occupied by an object or the capacity of a space or container. (NCI) Volume ZScore The number of positive or negative standard deviations of a measured value from the mean of its population. Z-Score RESTYPRS Result Type Response CDISC SDTM Result Type Response Terminology Revised Fibromyalgia Impact Questionnaire test code. FIQR01-Brush or Comb Your Hair Revised Fibromyalgia Impact Questionnaire - Brush or comb your hair. FIQR - Brush or Comb Your Hair FIQR01-Walk Continuously for 20 Minutes Revised Fibromyalgia Impact Questionnaire - Walk continuously for 20 minutes. FIQR - Walk Continuously for 20 Minutes FIQR01-Prepare a Homemade Meal Revised Fibromyalgia Impact Questionnaire - Prepare a homemade meal. FIQR - Prepare a Homemade Meal FIQR01-Vacuum Scrub or Sweep Floors Revised Fibromyalgia Impact Questionnaire - Vacuum, scrub or sweep floors. FIQR - Vacuum Scrub or Sweep Floors FIQR01-Lift/Carry Bag Full of Groceries Revised Fibromyalgia Impact Questionnaire - Lift and carry a bag full of groceries. FIQR - Lift and Carry a Bag Full of Groceries FIQR01-Climb One Flight of Stairs Revised Fibromyalgia Impact Questionnaire - Climb one flight of stairs. FIQR - Climb One Flight of Stairs FIQR01-Change Bed Sheets Revised Fibromyalgia Impact Questionnaire - Change bed sheets. FIQR - Change Bed Sheets FIQR01-Sit in a Chair for 45 Minutes Revised Fibromyalgia Impact Questionnaire - Sit in a chair for 45 minutes. FIQR - Sit in a Chair for 45 Minutes FIQR01-Go Shopping for Groceries Revised Fibromyalgia Impact Questionnaire - Go shopping for groceries. FIQR - Go Shopping for Groceries FIQR01-Fibromyalgia Prevented Goals Revised Fibromyalgia Impact Questionnaire - Fibromyalgia prevented me from accomplishing goals for the week. FIQR - Fibromyalgia Prevented Me from Accomplishing Goals for the Week FIQR01-Overwhelmed by Fibromyalgia Revised Fibromyalgia Impact Questionnaire - I was completely overwhelmed by my fibromyalgia symptoms. FIQR - I was Completely Overwhelmed by My Fibromyalgia Symptoms FIQR01-Pain Revised Fibromyalgia Impact Questionnaire - Please rate your level of pain. FIQR - Pain FIQR01-Energy Revised Fibromyalgia Impact Questionnaire - Please rate your level of energy. FIQR - Energy FIQR01-Stiffness Revised Fibromyalgia Impact Questionnaire - Please rate your level of stiffness. FIQR - Stiffness FIQR01-Your Sleep Revised Fibromyalgia Impact Questionnaire - Please rate the quality of your sleep. FIQR - Your Sleep FIQR01-Depression Revised Fibromyalgia Impact Questionnaire - Please rate your level of depression. FIQR - Depression FIQR01-Memory Problems Revised Fibromyalgia Impact Questionnaire - Please rate your level of memory problems. FIQR - Memory Problems FIQR01-Anxiety Revised Fibromyalgia Impact Questionnaire - Please rate your level of anxiety. FIQR - Anxiety FIQR01-Tenderness to Touch Revised Fibromyalgia Impact Questionnaire - Please rate your level of tenderness to touch. FIQR - Tenderness to Touch FIQR01-Balance Problems Revised Fibromyalgia Impact Questionnaire - Please rate your level of balance problems. FIQR - Balance Problems FIQR01-Sensitivity Noise/Light/Odor/Cold Revised Fibromyalgia Impact Questionnaire - Please rate your level of sensitivity to loud noises, bright lights, odors and cold. FIQR - Sensitivity to Loud Noises, Bright Lights, Odors and Cold FIQR01-Activities Sub-Total Revised Fibromyalgia Impact Questionnaire - Sub-total for activities subcategory. FIQR - Activities Sub-Total FIQR01-Overall Impact Sub-Total Revised Fibromyalgia Impact Questionnaire - Sub-total for overall impact subcategory. FIQR - Overall Impact Sub-Total FIQR01-Symptoms Sub-Total Revised Fibromyalgia Impact Questionnaire - Sub-total for symptoms subcategory. FIQR - Symptoms Sub-Total FIQR01-FIQR Total Revised Fibromyalgia Impact Questionnaire - FIQR total. FIQR - FIQR Total FIQR01TC Revised Fibromyalgia Impact Questionnaire Questionnaire Test Code CDISC Questionnaire FIQR Test Code Terminology Revised Fibromyalgia Impact Questionnaire test name. FIQR01-Activities Sub-Total Revised Fibromyalgia Impact Questionnaire - Sub-total for activities subcategory. FIQR - Activities Sub-Total FIQR01-Anxiety Revised Fibromyalgia Impact Questionnaire - Please rate your level of anxiety. FIQR - Anxiety FIQR01-Balance Problems Revised Fibromyalgia Impact Questionnaire - Please rate your level of balance problems. FIQR - Balance Problems FIQR01-Brush or Comb Your Hair Revised Fibromyalgia Impact Questionnaire - Brush or comb your hair. FIQR - Brush or Comb Your Hair FIQR01-Change Bed Sheets Revised Fibromyalgia Impact Questionnaire - Change bed sheets. FIQR - Change Bed Sheets FIQR01-Climb One Flight of Stairs Revised Fibromyalgia Impact Questionnaire - Climb one flight of stairs. FIQR - Climb One Flight of Stairs FIQR01-Depression Revised Fibromyalgia Impact Questionnaire - Please rate your level of depression. FIQR - Depression FIQR01-Energy Revised Fibromyalgia Impact Questionnaire - Please rate your level of energy. FIQR - Energy FIQR01-Fibromyalgia Prevented Goals Revised Fibromyalgia Impact Questionnaire - Fibromyalgia prevented me from accomplishing goals for the week. FIQR - Fibromyalgia Prevented Me from Accomplishing Goals for the Week FIQR01-FIQR Total Revised Fibromyalgia Impact Questionnaire - FIQR total. FIQR - FIQR Total FIQR01-Go Shopping for Groceries Revised Fibromyalgia Impact Questionnaire - Go shopping for groceries. FIQR - Go Shopping for Groceries FIQR01-Lift/Carry Bag Full of Groceries Revised Fibromyalgia Impact Questionnaire - Lift and carry a bag full of groceries. FIQR - Lift and Carry a Bag Full of Groceries FIQR01-Memory Problems Revised Fibromyalgia Impact Questionnaire - Please rate your level of memory problems. FIQR - Memory Problems FIQR01-Overall Impact Sub-Total Revised Fibromyalgia Impact Questionnaire - Sub-total for overall impact subcategory. FIQR - Overall Impact Sub-Total FIQR01-Overwhelmed by Fibromyalgia Revised Fibromyalgia Impact Questionnaire - I was completely overwhelmed by my fibromyalgia symptoms. FIQR - I was Completely Overwhelmed by My Fibromyalgia Symptoms FIQR01-Pain Revised Fibromyalgia Impact Questionnaire - Please rate your level of pain. FIQR - Pain FIQR01-Prepare a Homemade Meal Revised Fibromyalgia Impact Questionnaire - Prepare a homemade meal. FIQR - Prepare a Homemade Meal FIQR01-Sensitivity Noise/Light/Odor/Cold Revised Fibromyalgia Impact Questionnaire - Please rate your level of sensitivity to loud noises, bright lights, odors and cold. FIQR - Sensitivity to Loud Noises, Bright Lights, Odors and Cold FIQR01-Sit in a Chair for 45 Minutes Revised Fibromyalgia Impact Questionnaire - Sit in a chair for 45 minutes. FIQR - Sit in a Chair for 45 Minutes FIQR01-Stiffness Revised Fibromyalgia Impact Questionnaire - Please rate your level of stiffness. FIQR - Stiffness FIQR01-Symptoms Sub-Total Revised Fibromyalgia Impact Questionnaire - Sub-total for symptoms subcategory. FIQR - Symptoms Sub-Total FIQR01-Tenderness to Touch Revised Fibromyalgia Impact Questionnaire - Please rate your level of tenderness to touch. FIQR - Tenderness to Touch FIQR01-Vacuum Scrub or Sweep Floors Revised Fibromyalgia Impact Questionnaire - Vacuum, scrub or sweep floors. FIQR - Vacuum Scrub or Sweep Floors FIQR01-Walk Continuously for 20 Minutes Revised Fibromyalgia Impact Questionnaire - Walk continuously for 20 minutes. FIQR - Walk Continuously for 20 Minutes FIQR01-Your Sleep Revised Fibromyalgia Impact Questionnaire - Please rate the quality of your sleep. FIQR - Your Sleep FIQR01TN Revised Fibromyalgia Impact Questionnaire Questionnaire Test Name CDISC Questionnaire FIQR Test Name Terminology Rey Auditory Verbal Learning Test test code. AVL02-List A Word 1 Auditory Verbal Learning Test - List A, Word 1. AVLT-REY - List A Word 1 AVL02-List A Word 2 Auditory Verbal Learning Test - List A, Word 2. AVLT-REY - List A Word 2 AVL02-List A Word 3 Auditory Verbal Learning Test - List A, Word 3. AVLT-REY - List A Word 3 AVL02-List A Word 4 Auditory Verbal Learning Test - List A, Word 4. AVLT-REY - List A Word 4 AVL02-List A Word 5 Auditory Verbal Learning Test - List A, Word 5. AVLT-REY - List A Word 5 AVL02-List A Word 6 Auditory Verbal Learning Test - List A, Word 6. AVLT-REY - List A Word 6 AVL02-List A Word 7 Auditory Verbal Learning Test - List A, Word 7. AVLT-REY - List A Word 7 AVL02-List A Word 8 Auditory Verbal Learning Test - List A, Word 8. AVLT-REY - List A Word 8 AVL02-List A Word 9 Auditory Verbal Learning Test - List A, Word 9. AVLT-REY - List A Word 9 AVL02-List A Word 10 Auditory Verbal Learning Test - List A, Word 10. AVLT-REY - List A Word 10 AVL02-List A Word 11 Auditory Verbal Learning Test - List A, Word 11. AVLT-REY - List A Word 11 AVL02-List A Word 12 Auditory Verbal Learning Test - List A, Word 12. AVLT-REY - List A Word 12 AVL02-List A Word 13 Auditory Verbal Learning Test - List A, Word 13. AVLT-REY - List A Word 13 AVL02-List A Word 14 Auditory Verbal Learning Test - List A, Word 14. AVLT-REY - List A Word 14 AVL02-List A Word 15 Auditory Verbal Learning Test - List A, Word 15. AVLT-REY - List A Word 15 AVL02-List A Total Auditory Verbal Learning Test - The number of List A words recalled from a trial. AVLT-REY - List A Total AVL02-List A Intrusions Auditory Verbal Learning Test - The number of List A intrusions while recalling from a trial. AVLT-REY - List A Intrusions AVL02-List B Word 1 Auditory Verbal Learning Test - List B, Word 1. AVLT-REY - List B Word 1 AVL02-List B Word 2 Auditory Verbal Learning Test - List B, Word 2. AVLT-REY - List B Word 2 AVL02-List B Word 3 Auditory Verbal Learning Test - List B, Word 3. AVLT-REY - List B Word 3 AVL02-List B Word 4 Auditory Verbal Learning Test - List B, Word 4. AVLT-REY - List B Word 4 AVL02-List B Word 5 Auditory Verbal Learning Test - List B, Word 5. AVLT-REY - List B Word 5 AVL02-List B Word 6 Auditory Verbal Learning Test - List B, Word 6. AVLT-REY - List B Word 6 AVL02-List B Word 7 Auditory Verbal Learning Test - List B, Word 7. AVLT-REY - List B Word 7 AVL02-List B Word 8 Auditory Verbal Learning Test - List B, Word 8. AVLT-REY - List B Word 8 AVL02-List B Word 9 Auditory Verbal Learning Test - List B, Word 9. AVLT-REY - List B Word 9 AVL02-List B Word 10 Auditory Verbal Learning Test - List B, Word 10. AVLT-REY - List B Word 10 AVL02-List B Word 11 Auditory Verbal Learning Test - List B, Word 11. AVLT-REY - List B Word 11 AVL02-List B Word 12 Auditory Verbal Learning Test - List B, Word 12. AVLT-REY - List B Word 12 AVL02-List B Word 13 Auditory Verbal Learning Test - List B, Word 13. AVLT-REY - List B Word 13 AVL02-List B Word 14 Auditory Verbal Learning Test - List B, Word 14. AVLT-REY - List B Word 14 AVL02-List B Word 15 Auditory Verbal Learning Test - List B, Word 15. AVLT-REY - List B Word 15 AVL02- List B Total Auditory Verbal Learning Test - The number of words recalled from List B trial. AVLT-REY - List B Total AVL02-List B Intrusions Auditory Verbal Learning Test - The number of intrusions while recalling from List B trial. AVLT-REY - List B Intrusions AVL02-Recognition Total Auditory Verbal Learning Test - The number of words correct on recognition test. AVLT-REY - Recognition Total AVL02-Recognition Intrusions Auditory Verbal Learning Test - The number of intrusions on recognition test. AVLT-REY - Recognition Intrusions AVL02TC Rey Auditory Verbal Learning Test Functional Test Test Code CDISC Functional Test AVLT-REY Test Code Terminology Rey Auditory Verbal Learning Test test name. AVL02- List B Total Auditory Verbal Learning Test - The number of words recalled from List B trial. AVLT-REY - List B Total AVL02-List A Intrusions Auditory Verbal Learning Test - The number of List A intrusions while recalling from a trial. AVLT-REY - List A Intrusions AVL02-List A Total Auditory Verbal Learning Test - The number of List A words recalled from a trial. AVLT-REY - List A Total AVL02-List A Word 1 Auditory Verbal Learning Test - List A, Word 1. AVLT-REY - List A Word 1 AVL02-List A Word 10 Auditory Verbal Learning Test - List A, Word 10. AVLT-REY - List A Word 10 AVL02-List A Word 11 Auditory Verbal Learning Test - List A, Word 11. AVLT-REY - List A Word 11 AVL02-List A Word 12 Auditory Verbal Learning Test - List A, Word 12. AVLT-REY - List A Word 12 AVL02-List A Word 13 Auditory Verbal Learning Test - List A, Word 13. AVLT-REY - List A Word 13 AVL02-List A Word 14 Auditory Verbal Learning Test - List A, Word 14. AVLT-REY - List A Word 14 AVL02-List A Word 15 Auditory Verbal Learning Test - List A, Word 15. AVLT-REY - List A Word 15 AVL02-List A Word 2 Auditory Verbal Learning Test - List A, Word 2. AVLT-REY - List A Word 2 AVL02-List A Word 3 Auditory Verbal Learning Test - List A, Word 3. AVLT-REY - List A Word 3 AVL02-List A Word 4 Auditory Verbal Learning Test - List A, Word 4. AVLT-REY - List A Word 4 AVL02-List A Word 5 Auditory Verbal Learning Test - List A, Word 5. AVLT-REY - List A Word 5 AVL02-List A Word 6 Auditory Verbal Learning Test - List A, Word 6. AVLT-REY - List A Word 6 AVL02-List A Word 7 Auditory Verbal Learning Test - List A, Word 7. AVLT-REY - List A Word 7 AVL02-List A Word 8 Auditory Verbal Learning Test - List A, Word 8. AVLT-REY - List A Word 8 AVL02-List A Word 9 Auditory Verbal Learning Test - List A, Word 9. AVLT-REY - List A Word 9 AVL02-List B Intrusions Auditory Verbal Learning Test - The number of intrusions while recalling from List B trial. AVLT-REY - List B Intrusions AVL02-List B Word 1 Auditory Verbal Learning Test - List B, Word 1. AVLT-REY - List B Word 1 AVL02-List B Word 10 Auditory Verbal Learning Test - List B, Word 10. AVLT-REY - List B Word 10 AVL02-List B Word 11 Auditory Verbal Learning Test - List B, Word 11. AVLT-REY - List B Word 11 AVL02-List B Word 12 Auditory Verbal Learning Test - List B, Word 12. AVLT-REY - List B Word 12 AVL02-List B Word 13 Auditory Verbal Learning Test - List B, Word 13. AVLT-REY - List B Word 13 AVL02-List B Word 14 Auditory Verbal Learning Test - List B, Word 14. AVLT-REY - List B Word 14 AVL02-List B Word 15 Auditory Verbal Learning Test - List B, Word 15. AVLT-REY - List B Word 15 AVL02-List B Word 2 Auditory Verbal Learning Test - List B, Word 2. AVLT-REY - List B Word 2 AVL02-List B Word 3 Auditory Verbal Learning Test - List B, Word 3. AVLT-REY - List B Word 3 AVL02-List B Word 4 Auditory Verbal Learning Test - List B, Word 4. AVLT-REY - List B Word 4 AVL02-List B Word 5 Auditory Verbal Learning Test - List B, Word 5. AVLT-REY - List B Word 5 AVL02-List B Word 6 Auditory Verbal Learning Test - List B, Word 6. AVLT-REY - List B Word 6 AVL02-List B Word 7 Auditory Verbal Learning Test - List B, Word 7. AVLT-REY - List B Word 7 AVL02-List B Word 8 Auditory Verbal Learning Test - List B, Word 8. AVLT-REY - List B Word 8 AVL02-List B Word 9 Auditory Verbal Learning Test - List B, Word 9. AVLT-REY - List B Word 9 AVL02-Recognition Intrusions Auditory Verbal Learning Test - The number of intrusions on recognition test. AVLT-REY - Recognition Intrusions AVL02-Recognition Total Auditory Verbal Learning Test - The number of words correct on recognition test. AVLT-REY - Recognition Total AVL02TN Rey Auditory Verbal Learning Test Functional Test Test Name CDISC Functional Test AVLT-REY Test Name Terminology Reynolds Cardiovascular Disease 10-Year Risk Score test code. RCVD01-Reynolds CVD 10-Year Risk Score Reynolds Cardiovascular Disease 10-Year Risk Score - Cardiovascular disease 10-year risk score. Reynolds CVD 10-Year Risk Score - Risk Score RCVD01TC Reynolds Cardiovascular Disease 10-Year Risk Score Clinical Classification Test Code CDISC Clinical Classification Reynolds CVD 10-Year Risk Score Test Code Terminology Reynolds Cardiovascular Disease 10-Year Risk Score test name. RCVD01-Reynolds CVD 10-Year Risk Score Reynolds Cardiovascular Disease 10-Year Risk Score - Cardiovascular disease 10-year risk score. Reynolds CVD 10-Year Risk Score - Risk Score RCVD01TN Reynolds Cardiovascular Disease 10-Year Risk Score Clinical Classification Test Name CDISC Clinical Classification Reynolds CVD 10-Year Risk Score Test Name Terminology Richmond Agitation-Sedation Scale test code. RASS01-Score Richmond Agitation-Sedation Scale - Score. RASS - Score RASS01TC Richmond Agitation-Sedation Scale Clinical Classification Test Code CDISC Clinical Classification RASS Test Code Terminology Richmond Agitation-Sedation Scale test name. RASS01-Score Richmond Agitation-Sedation Scale - Score. RASS - Score RASS01TN Richmond Agitation-Sedation Scale Clinical Classification Test Name CDISC Clinical Classification RASS Test Name Terminology Riker Sedation-Agitation Scale test code. SAS01-Score Riker Sedation-Agitation Scale - Score. SAS - Score SAS01TC Riker Sedation-Agitation Scale Clinical Classification Test Code CDISC Clinical Classification SAS Test Code Terminology Riker Sedation-Agitation Scale test name. SAS01-Score Riker Sedation-Agitation Scale - Score. SAS - Score SAS01TN Riker Sedation-Agitation Scale Clinical Classification Test Name CDISC Clinical Classification SAS Test Name Terminology Rising From Floor test code. RISEF1-Was Rising From Floor Performed Rising From Floor - Was Rising From Floor performed? Rising From Floor - Was Rising From Floor Performed RISEF1-Time to Rise From Floor Rising From Floor - If yes, time taken to rise from floor. Rising From Floor - Time to Rise From Floor RISEF1-Wear Orthoses Rising From Floor - If yes, did subject wear orthoses? Rising From Floor - Wear Orthoses RISEF1-Test Grade Rising From Floor - Test grade. Rising From Floor - Test Grade RISEF1TC Rising From Floor Functional Test Test Code CDISC Functional Test Rising From Floor Test Code Terminology Rising From Floor test name. RISEF1-Test Grade Rising From Floor - Test grade. Rising From Floor - Test Grade RISEF1-Time to Rise From Floor Rising From Floor - If yes, time taken to rise from floor. Rising From Floor - Time to Rise From Floor RISEF1-Was Rising From Floor Performed Rising From Floor - Was Rising From Floor performed? Rising From Floor - Was Rising From Floor Performed RISEF1-Wear Orthoses Rising From Floor - If yes, did subject wear orthoses? Rising From Floor - Wear Orthoses RISEF1TN Rising From Floor Functional Test Test Name CDISC Functional Test Rising From Floor Test Name Terminology Rivermead Post Concussion Symptoms Questionnaire test code. RPQ01-Headaches Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Headaches. RPQ - Headaches RPQ01-Feelings of Dizziness Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Feelings of dizziness. RPQ - Feelings of Dizziness RPQ01-Nausea and/or Vomiting Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Nausea and/or vomiting. RPQ - Nausea and/or Vomiting RPQ01-Noise Sensitivity/Loud Noise Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Noise sensitivity, easily upset by loud noise. RPQ - Noise Sensitivity RPQ01-Sleep Disturbance Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Sleep disturbance. RPQ - Sleep Disturbance RPQ01-Fatigue, Tiring More Easily Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Fatigue, tiring more easily. RPQ - Fatigue, Tiring More Easily RPQ01-Being Irritable, Easily Angered Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Being irritable, easily angered. RPQ - Being Irritable, Easily Angered RPQ01-Feeling Depressed or Tearful Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Feeling depressed or tearful. RPQ - Feeling Depressed or Tearful RPQ01-Feeling Frustrated or Impatient Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Feeling frustrated or impatient. RPQ - Feeling Frustrated or Impatient RPQ01-Forgetfulness, Poor Memory Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Forgetfulness, poor memory. RPQ - Forgetfulness, Poor Memory RPQ01-Poor Concentration Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Poor concentration. RPQ - Poor Concentration RPQ01-Taking Longer to Think Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Taking longer to think. RPQ - Taking Longer to Think RPQ01-Blurred Vision Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Blurred vision. RPQ - Blurred Vision RPQ01-Light Sensitivity/Bright Light Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Light sensitivity, easily upset by bright light. RPQ - Light Sensitivity RPQ01-Double Vision Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Double vision. RPQ - Double Vision RPQ01-Restlessness Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Restlessness. RPQ - Restlessness RPQ01-Any Other Difficulties 1 (Text) Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, are you experiencing any other difficulties 1? (Text). RPQ - Any Other Difficulties 1 (Text) RPQ01-Any Other Difficulties 1 Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, are you experiencing any other difficulties 1? RPQ - Any Other Difficulties 1 (number) RPQ01-Any Other Difficulties 2 (Text) Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, are you experiencing any other difficulties 2? (Text). RPQ - Any Other Difficulties 2 (Text) RPQ01-Any Other Difficulties 2 Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, are you experiencing any other difficulties 2? RPQ - Any Other Difficulties 2 (Number) RPQ01TC Rivermead Post Concussion Symptoms Questionnaire Questionnaire Test Code CDISC Questionnaire RPQ Test Code Terminology Rivermead Post Concussion Symptoms Questionnaire test name. RPQ01-Any Other Difficulties 1 (Text) Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, are you experiencing any other difficulties 1? (Text). RPQ - Any Other Difficulties 1 (Text) RPQ01-Any Other Difficulties 1 Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, are you experiencing any other difficulties 1? RPQ - Any Other Difficulties 1 (number) RPQ01-Any Other Difficulties 2 (Text) Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, are you experiencing any other difficulties 2? (Text). RPQ - Any Other Difficulties 2 (Text) RPQ01-Any Other Difficulties 2 Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, are you experiencing any other difficulties 2? RPQ - Any Other Difficulties 2 (Number) RPQ01-Being Irritable, Easily Angered Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Being irritable, easily angered. RPQ - Being Irritable, Easily Angered RPQ01-Blurred Vision Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Blurred vision. RPQ - Blurred Vision RPQ01-Double Vision Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Double vision. RPQ - Double Vision RPQ01-Fatigue, Tiring More Easily Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Fatigue, tiring more easily. RPQ - Fatigue, Tiring More Easily RPQ01-Feeling Depressed or Tearful Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Feeling depressed or tearful. RPQ - Feeling Depressed or Tearful RPQ01-Feeling Frustrated or Impatient Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Feeling frustrated or impatient. RPQ - Feeling Frustrated or Impatient RPQ01-Feelings of Dizziness Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Feelings of dizziness. RPQ - Feelings of Dizziness RPQ01-Forgetfulness, Poor Memory Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Forgetfulness, poor memory. RPQ - Forgetfulness, Poor Memory RPQ01-Headaches Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Headaches. RPQ - Headaches RPQ01-Light Sensitivity/Bright Light Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Light sensitivity, easily upset by bright light. RPQ - Light Sensitivity RPQ01-Nausea and/or Vomiting Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Nausea and/or vomiting. RPQ - Nausea and/or Vomiting RPQ01-Noise Sensitivity/Loud Noise Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Noise sensitivity, easily upset by loud noise. RPQ - Noise Sensitivity RPQ01-Poor Concentration Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Poor concentration. RPQ - Poor Concentration RPQ01-Restlessness Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Restlessness. RPQ - Restlessness RPQ01-Sleep Disturbance Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Sleep disturbance. RPQ - Sleep Disturbance RPQ01-Taking Longer to Think Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Taking longer to think. RPQ - Taking Longer to Think RPQ01TN Rivermead Post Concussion Symptoms Questionnaire Questionnaire Test Name CDISC Questionnaire RPQ Test Name Terminology Rockport One Mile Walk Test Version 1.0 test code. ROCK01-Time To Complete One Mile Walk Rockport One Mile Walk Test - Time to complete one-mile walk. RFWT Version 1 - Time To Complete One Mile Walk ROCK01TC Rockport One Mile Walk Test Version 1.0 Functional Test Test Code CDISC Functional Test RFWT Version 1 Test Code Terminology Rockport One Mile Walk Test Version 1.0 test name. ROCK01-Time To Complete One Mile Walk Rockport One Mile Walk Test - Time to complete one-mile walk. RFWT Version 1 - Time To Complete One Mile Walk ROCK01TN Rockport One Mile Walk Test Version 1.0 Functional Test Test Name CDISC Functional Test RFWT Version 1 Test Name Terminology Roland Morris Disability Questionnaire test code. RDQ01-Stay at Home Roland Morris Disability Questionnaire - I stay at home most of the time because of my back. RDQ - Stay at Home RDQ01-Change Position Frequently Roland Morris Disability Questionnaire - I change position frequently to try and get my back comfortable. RDQ - Change Position Frequently RDQ01-Walk More Slowly Roland Morris Disability Questionnaire - I walk more slowly than usual because of my back. RDQ - Walk More Slowly RDQ01-Not Do Any Usual Jobs Roland Morris Disability Questionnaire - Because of my back, I am not doing any of the jobs that I usually do around the house. RDQ - Not Do Any Usual House Jobs RDQ01-Use Handrail to Get Upstairs Roland Morris Disability Questionnaire - Because of my back, I use a handrail to get upstairs. RDQ - Use Handrail to Get Upstairs RDQ01-Lie Down to Rest More Often Roland Morris Disability Questionnaire - Because of my back, I lie down to rest more often. RDQ - Lie Down to Rest More Often RDQ01-Hold on to Get Out of a Chair Roland Morris Disability Questionnaire - Because of my back, I have to hold on to something to get out of an easy chair. RDQ - Hold on to Get Out of a Chair RDQ01-Get Other People to Do Things Roland Morris Disability Questionnaire - Because of my back, I try to get other people to do things for me. RDQ - Get Other People to Do Things RDQ01-Get Dressed More Slowly Roland Morris Disability Questionnaire - I get dressed more slowly then usual because of my back. RDQ - Get Dressed More Slowly RDQ01-Only Stand for Short Periods Roland Morris Disability Questionnaire - I only stand for short periods of time because of my back. RDQ - Only Stand for Short Periods RDQ01-Try Not to Bend or Kneel Roland Morris Disability Questionnaire - Because of my back, I try not to bend or kneel down. RDQ - Try Not to Bend or Kneel RDQ01-Difficult to Get Out of a Chair Roland Morris Disability Questionnaire - I find it difficult to get out of a chair because of my back. RDQ - Difficult to Get Out of a Chair RDQ01-Painful Almost All the Time Roland Morris Disability Questionnaire - My back is painful almost all the time. RDQ - Painful Almost All the Time RDQ01-Difficult to Turn Over in Bed Roland Morris Disability Questionnaire - I find it difficult to turn over in bed because of my back. RDQ - Difficult to Turn Over in Bed RDQ01-Appetite is Not Very Good Roland Morris Disability Questionnaire - My appetite is not very good because of my back pain. RDQ - Appetite is Not Very Good RDQ01-Trouble Putting on Socks/Stockings Roland Morris Disability Questionnaire - I have trouble putting on my socks (or stockings) because of the pain in my back. RDQ - Trouble Putting on Socks or Stockings RDQ01-Only Walk Short Distances Roland Morris Disability Questionnaire - I only walk short distances because of my back. RDQ - Only Walk Short Distances RDQ01-Sleep Less Well Roland Morris Disability Questionnaire - I sleep less well because of my back. RDQ - Sleep Less Well RDQ01-Get Dressed With Help Roland Morris Disability Questionnaire - Because of my back pain, I get dressed with help from someone else. RDQ - Get Dressed With Help RDQ01-Sit Down Most of the Day Roland Morris Disability Questionnaire - I sit down for most of the day because of my back. RDQ - Sit Down Most of the Day RDQ01-Avoid Heavy Jobs Roland Morris Disability Questionnaire - I avoid heavy jobs around the house because of my back. RDQ - Avoid Heavy Jobs RDQ01-More Irritable With People Roland Morris Disability Questionnaire - Because of my back pain, I am more irritable and bad tempered with people than usual. RDQ - More Irritable With People RDQ01-Go Upstairs More Slowly Roland Morris Disability Questionnaire - Because of my back, I go upstairs more slowly than usual. RDQ - Go Upstairs More Slowly RDQ01-Stay in Bed Roland Morris Disability Questionnaire - I stay in bed most of the time because of my back. RDQ - Stay in Bed RDQ01-RDQ Total Score Roland Morris Disability Questionnaire - RDQ total derived score. RDQ - Total Derived Score RDQ01TC Roland Morris Disability Questionnaire Questionnaire Test Code CDISC Questionnaire RDQ Test Code Terminology Roland Morris Disability Questionnaire test name. RDQ01-Appetite is Not Very Good Roland Morris Disability Questionnaire - My appetite is not very good because of my back pain. RDQ - Appetite is Not Very Good RDQ01-Avoid Heavy Jobs Roland Morris Disability Questionnaire - I avoid heavy jobs around the house because of my back. RDQ - Avoid Heavy Jobs RDQ01-Change Position Frequently Roland Morris Disability Questionnaire - I change position frequently to try and get my back comfortable. RDQ - Change Position Frequently RDQ01-Difficult to Get Out of a Chair Roland Morris Disability Questionnaire - I find it difficult to get out of a chair because of my back. RDQ - Difficult to Get Out of a Chair RDQ01-Difficult to Turn Over in Bed Roland Morris Disability Questionnaire - I find it difficult to turn over in bed because of my back. RDQ - Difficult to Turn Over in Bed RDQ01-Get Dressed More Slowly Roland Morris Disability Questionnaire - I get dressed more slowly then usual because of my back. RDQ - Get Dressed More Slowly RDQ01-Get Dressed With Help Roland Morris Disability Questionnaire - Because of my back pain, I get dressed with help from someone else. RDQ - Get Dressed With Help RDQ01-Get Other People to Do Things Roland Morris Disability Questionnaire - Because of my back, I try to get other people to do things for me. RDQ - Get Other People to Do Things RDQ01-Go Upstairs More Slowly Roland Morris Disability Questionnaire - Because of my back, I go upstairs more slowly than usual. RDQ - Go Upstairs More Slowly RDQ01-Hold on to Get Out of a Chair Roland Morris Disability Questionnaire - Because of my back, I have to hold on to something to get out of an easy chair. RDQ - Hold on to Get Out of a Chair RDQ01-Lie Down to Rest More Often Roland Morris Disability Questionnaire - Because of my back, I lie down to rest more often. RDQ - Lie Down to Rest More Often RDQ01-More Irritable With People Roland Morris Disability Questionnaire - Because of my back pain, I am more irritable and bad tempered with people than usual. RDQ - More Irritable With People RDQ01-Not Do Any Usual Jobs Roland Morris Disability Questionnaire - Because of my back, I am not doing any of the jobs that I usually do around the house. RDQ - Not Do Any Usual House Jobs RDQ01-Only Stand for Short Periods Roland Morris Disability Questionnaire - I only stand for short periods of time because of my back. RDQ - Only Stand for Short Periods RDQ01-Only Walk Short Distances Roland Morris Disability Questionnaire - I only walk short distances because of my back. RDQ - Only Walk Short Distances RDQ01-Painful Almost All the Time Roland Morris Disability Questionnaire - My back is painful almost all the time. RDQ - Painful Almost All the Time RDQ01-RDQ Total Score Roland Morris Disability Questionnaire - RDQ total derived score. RDQ - Total Derived Score RDQ01-Sit Down Most of the Day Roland Morris Disability Questionnaire - I sit down for most of the day because of my back. RDQ - Sit Down Most of the Day RDQ01-Sleep Less Well Roland Morris Disability Questionnaire - I sleep less well because of my back. RDQ - Sleep Less Well RDQ01-Stay at Home Roland Morris Disability Questionnaire - I stay at home most of the time because of my back. RDQ - Stay at Home RDQ01-Stay in Bed Roland Morris Disability Questionnaire - I stay in bed most of the time because of my back. RDQ - Stay in Bed RDQ01-Trouble Putting on Socks/Stockings Roland Morris Disability Questionnaire - I have trouble putting on my socks (or stockings) because of the pain in my back. RDQ - Trouble Putting on Socks or Stockings RDQ01-Try Not to Bend or Kneel Roland Morris Disability Questionnaire - Because of my back, I try not to bend or kneel down. RDQ - Try Not to Bend or Kneel RDQ01-Use Handrail to Get Upstairs Roland Morris Disability Questionnaire - Because of my back, I use a handrail to get upstairs. RDQ - Use Handrail to Get Upstairs RDQ01-Walk More Slowly Roland Morris Disability Questionnaire - I walk more slowly than usual because of my back. RDQ - Walk More Slowly RDQ01TN Roland Morris Disability Questionnaire Questionnaire Test Name CDISC Questionnaire RDQ Test Name Terminology A terminology codelist relevant to the pathway by which a substance is administered in order to reach the site of action in the body. Administration to or by way of the ear. (FDA) Auricular Route of Administration Administration directed toward the cheek, generally from within the mouth. (FDA) Buccal Route of Administration Administration to the conjunctiva, the delicate membrane that lines the eyelids and covers the exposed surface of the eyeball. (FDA) Conjunctival Route of Administration Administration to the skin. (FDA) Cutaneous Route of Administration Administration to a tooth or teeth. (FDA) Dental Route of Administration Administration by way of food or water. Dietary Route of Administration Administration of through the diffusion of substance through a membrane in an electric field. (FDA) Electro-osmosis Route of Administration Intracervical Route of Administration Administration within the canal of the cervix uteri. Synonymous with the term intracervical. (FDA) Endocervical Route of Administration Administration within the nasal sinuses of the head. (FDA) Endosinusial Route of Administration Intratracheal Route of Administration Administration directly into the trachea. Synonymous with the term intratracheal. (FDA) Endotracheal Route of Administration Administration directly into the intestines. (FDA) Enteral Route of Administration Administration upon or over the dura mater. (FDA) Epidural Route of Administration Administration to the outside of the membrane enveloping the fetus. (FDA) Extraamniotic Route of Administration Administration outside of the body. (FDA) Extracorporeal Circulation Route of Administration Administration through the stomach and into the jejunum, usually by a tube passed through the skin, stomach, and into the jejunum. Gastrojejunal Route of Administration Administration through hemodialysate fluid. (FDA) Administration via Hemodialysis Submersion Route of Administration Administration via partial or complete submersion in a specified environment such as liquid or air. Immersion Route of Exposure Administration that results in substances passing into tissue spaces or into cells. (FDA) Infiltration Route of Administration Administration to or in the interstices of a tissue. (FDA) Interstitial Route of Administration Administration within the abdomen. (FDA) Intraabdominal Route of Administration Administration within the amnion. (FDA) Intraamniotic Route of Administration Administration within an artery or arteries. (FDA) Intraarterial Route of Administration Administration within a joint. (FDA) Intraarticular Route of Administration Administration within the bile, bile ducts or gallbladder. (FDA) Intrabiliary Route of Administration Administration within a bronchus. (FDA) Intrabronchial Route of Administration Administration within a bursa. (FDA) Intrabursal Route of Administration Administration by injection directly into the anterior chamber of the eye. Intracameral Route of Administration Administration within the heart. (FDA) Intracardiac Route of Administration Administration within a cartilage; endochondral. (FDA) Intracartilaginous Route of Administration Administration within the cauda equina. (FDA) Intracaudal Route of Administration Administration within a pathologic cavity, such as occurs in the lung in tuberculosis. (FDA) Intracavernous Route of Administration Administration within a non-pathologic cavity, such as that of the cervix, uterus, or penis, or such as that is formed as the result of a wound. (FDA) Intracavitary Route of Administration Administration within the cerebrum. (FDA) Intracerebral Route of Administration Administration within the cisterna magna cerebellomedularis. (FDA) Intracisternal Route of Administration Administration within the cochlea. Intracochlear Route of Administration Administration within the cornea (the transparent structure forming the anterior part of the fibrous tunic of the eye). (FDA) Intracorneal Route of Administration Administration of a drug within a portion of a tooth which is covered by enamel and which is separated from the roots by a slightly constricted region known as the neck. (FDA) Intracoronal Dental Route of Administration Administration within the coronary arteries. (FDA) Intracoronary Route of Administration Administration within the dilatable spaces of the corporus cavernosa of the penis. (FDA) Intracorpus Cavernosum Route of Administration Administration within the dermis. (FDA) Intradermal Route of Administration Administration within a disc. (FDA) Intradiscal Route of Administration Administration within the duct of a gland. (FDA) Intraductal Route of Administration Administration within the duodenum. (FDA) Intraduodenal Route of Administration Administration within or beneath the dura. (FDA) Intradural Route of Administration Administration within the epidermis. (FDA) Intraepidermal Route of Administration Administration within the esophagus. (FDA) Intraesophageal Route of Administration Administration directly into the stomach, usually by means of a tube. Intragastric Route of Administration Administration within the gingivae. (FDA) Intragingival Route of Administration Administration into the liver. Intrahepatic Route of Administration Administration within the distal portion of the small intestine, from the jejunum to the cecum. (FDA) Intraileal Route of Administration Administration into the jejunum. Intrajejunal Route of Administration Administration within or introduced directly into a localized lesion. (FDA) Intralesional Route of Administration Administration within the lumen of a tube. (FDA) Intraluminal Route of Administration Administration within the lymph. (FDA) Intralymphatic Route of Administration Administration of a drug into mammary tissue. Intramammary Route of Administration Administration within the mandible. Intramandibular Route of Administration Administration within the marrow cavity of a bone. (FDA) Intramedullary Route of Administration Administration within the meninges (the three membranes that envelope the brain and spinal cord). (FDA) Intrameningeal Route of Administration Administration within a muscle. (FDA) Intramuscular Route of Administration Administration within a lymph node. Intranodal Route of Administration Administration within the eye. (FDA) Intraocular Route of Administration Administration within the marrow of the bone. Intraosseous Route of Administration Administration within the ovary. (FDA) Intraovarian Route of Administration Administration into the palate. Intrapalatal Route of Administration Administration within or into the parenchyma of a targeted organ. Intraparenchymal Route of Administration Administration within the pericardium. (FDA) Intrapericardial Route of Administration Administration within the peritoneal cavity. (FDA) Intraperitoneal Route of Administration Administration within the pleura. (FDA) Intrapleural Route of Administration Administration within the prostate gland. (FDA) Intraprostatic Route of Administration Administration within the lungs or its bronchi. (FDA) Intrapulmonary Route of Administration Administration of a drug into the rumen of an animal. Intraruminal Route of Administration Administration within the nasal or periorbital sinuses. (FDA) Intrasinal Route of Administration Administration within the vertebral column. (FDA) Intraspinal Route of Administration Administration via Stoma Administration into a stoma. Administration via Stoma Administration within the site of surgery. Intrasurgical Site Route of Administration Administration within the synovial cavity of a joint. (FDA) Intrasynovial Route of Administration Administration within a tendon. (FDA) Intratendinous Route of Administration Administration within the testicle. (FDA) Intratesticular Route of Administration Administration within the thalamus. Intrathalamic Route of Administration Administration within the cerebrospinal fluid at any level of the cerebrospinal axis, including injection into the cerebral ventricles. (FDA) Intrathecal Route of Administration Administration within the thorax (internal to the ribs); synonymous with the term endothoracic. (FDA) Endothoracic Route of Administration Administration within the tubules of an organ. (FDA) Intratubular Route of Administration Intratumor Route of Administration Administration within a tumor. (FDA) Intratumoral Route of Administration Administration within the auris media. (FDA) Intratympanic Route of Administration Administration within the uterus. (FDA) Intrauterine Route of Administration Administration within the vagina. Intravaginal Route of Administration Administration within a vessel or vessels. (FDA) Intravascular Route of Administration Administration within or into a vein or veins all at once. (FDA) Intravenous Bolus Administration within or into a vein or veins over a sustained period of time. (FDA) Intravenous Drip Administration within or into a vein or veins. (FDA) Intravenous Route of Administration Administration within a ventricle. (FDA) Intraventricular Route of Administration Administration within the bladder. (FDA) Intravesical Route of Administration Administration within the vitreous body of the eye. (FDA) Intravitreal Route of Administration Administration by means of an electric current where ions of soluble salts migrate into the tissues of the body. (FDA) Iontophoresis Route of Administration Administration to bathe or flush open wounds or body cavities. (FDA) Irrigation Route of Administration Administration directly upon the larynx. (FDA) Laryngeal Route of Administration Administration through microdialysate fluid. Microdialysis Route of Administration Intranasal Route of Administration Administration to the nose; administered by way of the nose. (FDA) Nasal Route of Administration Administration through the nose and into the duodenum, usually by means of a tube. Nasoduodenal Route of Administration Administration through the nose and into the stomach, usually by means of a tube. (FDA) Nasogastric Route of Administration Administration through the nose and into the jejunum, usually by means of a tube. Nasojejunal Route of Administration Routes of administration are not applicable. (FDA) Route of Administration Not Applicable Administration by the topical route which is then covered by a dressing which occludes the area. (FDA) Occlusive Dressing Technique Administration to the external eye. (FDA) Ophthalmic Route of Administration For nonclinical studies, administration through the mouth and into the stomach, usually by means of an oral gavage tube. Oral Gavage Route of Administration Intraoral Route of Administration PO Administration to or by way of the mouth. (FDA) Oral Route of Administration Administration through the mouth and into the stomach, usually by means of a tube. Orogastric Route of Administration Administration across the mucosa of the oral cavity. Oromucosal Route of Administration Administration directly to the mouth and pharynx. (FDA) Oropharyngeal Route of Administration Administration by injection, infusion, or implantation. (FDA) Parenteral Route of Administration Administration through the skin. (FDA) Percutaneous Route of Administration Administration around a joint. (FDA) Periarticular Route of Administration Administration to the outside of the dura mater of the spinal cord. (FDA) Peridural Route of Administration Administration surrounding a nerve or nerves. (FDA) Perineural Route of Administration Administration around a tooth. (FDA) Periodontal Route of Administration Administration into the area surrounding a vein. (NCI) Perivenous Route of Administration Administration directly upon the pharynx. Pharyngeal Route of Administration Administration to the rectum. (FDA) Rectal Route of Administration Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect. (FDA) Inhalation Route of Administration Administration behind the pons or behind the eyeball. (FDA) Retrobulbar Route of Administration Administration into any soft tissue. (FDA) Soft Tissue Route of Administration Administration beneath the arachnoid. (FDA) Subarachnoid Route of Administration Administration beneath the conjunctiva. (FDA) Subconjunctival Route of Administration SC Subdermal Route of Administration Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL. (FDA) Subcutaneous Route of Administration Administration between the dura mater and the arachnoid mater. Subdural Route of Administration Administration beneath the tongue. (FDA) Sublingual Route of Administration Administration beneath the mucous membrane. (FDA) Submucosal Route of Administration Administration beneath the retina. Subretinal Route of Administration Administration by injection through the membrane covering the muscles and nerves at the back of the eyeball. Subtenon Route of Administration Administration above the choroid. Suprachoroidal Route of Administration TOP Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL. (FDA) Topical Route of Administration Administration through the dermal layer of the skin to the systemic circulation by diffusion. (FDA) Transdermal Route of Administration Administration through the vertebral foramen into the epidural space. Transforaminal Route of Administration Administration by ingestion of colostrum or breast milk. Transmammary Route of Administration Administration across the mucosa. (FDA) Mucosal Route of Administration Administration through or across the placenta. (FDA) Transplacental Route of Administration Administration through the wall of the trachea. (FDA) Transtracheal Route of Administration Administration across or through the tympanic cavity. (FDA) Transtympanic Route of Administration Route of administration has not yet been assigned. (FDA) Unassigned Route of Administration Route of administration is unknown. (FDA) Unknown Route of Administration Administration into the ureter. (FDA) Ureteral Route of Administration Administration into the urethra. (FDA) Intraurethral Route of Administration Administration into the vagina. (FDA) Vaginal Route of Administration ROUTE Route of Administration Response CDISC SDTM Route of Administration Terminology Rutgeerts Score original result for RUTG0101 test and test code. RUTG0101-<5 aphthous lesions Rutgeerts Score original result for RUTG0101-Less than 5 aphthous lesions. Rutgeerts Score RUTG0101 Original Result - Less Than 5 Aphthous Lesions RUTG0101->5 aphthous lesions with normal mucosa between the lesions, or skip areas of larger lesions or lesions confined to the ileocolonic anastomosis (i.e., <1 cm in length) Rutgeerts Score original result for RUTG0101-Greater than 5 aphthous lesions with normal mucosa between the lesions, or skip areas of larger lesions or lesions confined to the ileocolonic anastomosis (i.e., less than 1 cm in length). Rutgeerts Score RUTG0101 Original Result - Greater Than 5 Aphthous Lesions With Normal Mucosa Between the Lesions, or Skip Areas of Larger Lesions or Lesions Confined to the Ileocolonic Anastomosis (i.e., Less Than 1 cm in Length) RUTG0101-diffuse aphthous ileitis with diffusely inflamed mucosa Rutgeerts Score original result for RUTG0101-Diffuse aphthous ileitis with diffusely inflamed mucosa. Rutgeerts Score RUTG0101 Original Result - Diffuse Aphthous Ileitis With Diffusely Inflamed Mucosa RUTG0101-diffuse inflammation with already larger ulcers, nodules, and/or narrowing Rutgeerts Score original result for RUTG0101-Diffuse inflammation with already larger ulcers, nodules, and/or narrowing. Rutgeerts Score RUTG0101 Original Result - Diffuse Inflammation With Already Larger Ulcers, Nodules, and/or Narrowing RUTG0101-no lesions Rutgeerts Score original result for RUTG0101-No lesions. Rutgeerts Score RUTG0101 Original Result - No Lesions RUTG0101OR Rutgeerts Score Clinical Classification ORRES for RUTG0101 TN/TC CDISC Clinical Classification Rutgeerts Score RUTG0101 Original Response Terminology Rutgeerts Score standardized character result for RUTG0101 test and test code. RUTG0101-i0 Rutgeerts Score standardized character result for RUTG0101-No lesions. Rutgeerts Score RUTG0101 Standardized Character Result i0 RUTG0101-i1 Rutgeerts Score standardized character result for RUTG0101-Less than 5 aphthous lesions. Rutgeerts Score RUTG0101 Standardized Character Result i1 RUTG0101-i2 Rutgeerts Score standardized character result for RUTG0101-Greater than 5 aphthous lesions with normal mucosa between the lesions, or skip areas of larger lesions or lesions confined to the ileocolonic anastomosis (i.e., less than 1 cm in length). Rutgeerts Score RUTG0101 Standardized Character Result i2 RUTG0101-i3 Rutgeerts Score standardized character result for RUTG0101-Diffuse aphthous ileitis with diffusely inflamed mucosa. Rutgeerts Score RUTG0101 Standardized Character Result i3 RUTG0101-i4 Rutgeerts Score standardized character result for RUTG0101-Diffuse inflammation with already larger ulcers, nodules, and/or narrowing. Rutgeerts Score RUTG0101 Standardized Character Result i4 RUTG0101STR Rutgeerts Score Clinical Classification STRESC for RUTG0101 TN/TC CDISC Clinical Classification Rutgeerts Score RUTG0101 Standardized Character Response Terminology Rutgeerts Score test code. RUTG01-Rutgeerts Score Rutgeerts Score - Rutgeerts score. Rutgeerts Score - Rutgeerts Score RUTG01TC Rutgeerts Score Clinical Classification Test Code CDISC Clinical Classification Rutgeerts Score Test Code Terminology Rutgeerts Score test name. RUTG01-Rutgeerts Score Rutgeerts Score - Rutgeerts score. Rutgeerts Score - Rutgeerts Score RUTG01TN Rutgeerts Score Clinical Classification Test Name CDISC Clinical Classification Rutgeerts Score Test Name Terminology Satisfaction With Life Scale test code. SWLS01-My Life is Close to Ideal Satisfaction With Life Scale - In most ways my life is close to ideal. SWLS - My Life is Close to Ideal SWLS01-My Life Conditions are Excellent Satisfaction With Life Scale - The conditions of my life are excellent. SWLS - Life Conditions are Excellent SWLS01-I Am Satisfied with My Life Satisfaction With Life Scale - I am satisfied with my life. SWLS - Satisfied with My Life SWLS01-Have Gotten Important Things Satisfaction With Life Scale - So far I have gotten the important things I want in life. SWLS - Have Gotten Important Things SWLS01-Live Life Over Change Nothing Satisfaction With Life Scale - If I could live my life over, I would change almost nothing. SWLS - Live Life Over Change Nothing SWLS01TC Satisfaction With Life Scale Questionnaire Test Code CDISC Questionnaire SWLS Test Code Terminology Satisfaction With Life Scale test name. SWLS01-Have Gotten Important Things Satisfaction With Life Scale - So far I have gotten the important things I want in life. SWLS - Have Gotten Important Things SWLS01-I Am Satisfied with My Life Satisfaction With Life Scale - I am satisfied with my life. SWLS - Satisfied with My Life SWLS01-Live Life Over Change Nothing Satisfaction With Life Scale - If I could live my life over, I would change almost nothing. SWLS - Live Life Over Change Nothing SWLS01-My Life Conditions are Excellent Satisfaction With Life Scale - The conditions of my life are excellent. SWLS - Life Conditions are Excellent SWLS01-My Life is Close to Ideal Satisfaction With Life Scale - In most ways my life is close to ideal. SWLS - My Life is Close to Ideal SWLS01TN Satisfaction With Life Scale Questionnaire Test Name CDISC Questionnaire SWLS Test Name Terminology Terminology relevant to the test codes that describe findings about a schizophrenia event or intervention. Most Severe Acute Stressor The agent, stimulus, activity, or event that causes stress with an acute frequency, which has the highest level of severity. Most Severe Acute Stressor Age At First Episode The age at which the first episode occurred. Age at First Episode Age At First Hospitalization The age at which the first hospitalization event occurred. Age at First Hospitalization Age At First Treatment The age at which the first treatment for the condition occurred. Age at First Treatment Most Severe Chronic Stressor The agent, stimulus, activity, or event that causes stress with a chronic frequency, which has the highest level of severity. Most Severe Chronic Stressor Clinic Stay Indicator An indication as to whether the subject was admitted to a healthcare clinic. Clinic Stay Indicator Number of Episodes The total number of episodes that have occurred for the condition. Number of Episodes Number Of Hospitalizations The total number of hospitalization events that have occurred for the condition. Number of Hospitalizations Longitudinal Course A description of the series of events, including signs and symptoms, that define the course of a chronic disease over time. Clinical Course of Disease Occurrence Indicator An indication as to whether something has happened, such as an event or incident. Occurrence Indicator Treatment Environmental Setting Treatment Setting The surroundings or environment within which the subject receives therapeutic treatment for the condition. Treatment Environmental Setting SZFATSCD Schizophrenia Findings About Test Code CDISC SDTM Schizophrenia Findings About Test Code Terminology Terminology relevant to the test names that describe findings about a schizophrenia event or intervention. Age At First Episode The age at which the first episode occurred. Age at First Episode Age At First Hospitalization The age at which the first hospitalization event occurred. Age at First Hospitalization Age At First Treatment The age at which the first treatment for the condition occurred. Age at First Treatment Clinic Stay Indicator An indication as to whether the subject was admitted to a healthcare clinic. Clinic Stay Indicator Longitudinal Course A description of the series of events, including signs and symptoms, that define the course of a chronic disease over time. Clinical Course of Disease Most Severe Acute Stressor The agent, stimulus, activity, or event that causes stress with an acute frequency, which has the highest level of severity. Most Severe Acute Stressor Most Severe Chronic Stressor The agent, stimulus, activity, or event that causes stress with a chronic frequency, which has the highest level of severity. Most Severe Chronic Stressor Number of Episodes The total number of episodes that have occurred for the condition. Number of Episodes Number Of Hospitalizations The total number of hospitalization events that have occurred for the condition. Number of Hospitalizations Occurrence Indicator An indication as to whether something has happened, such as an event or incident. Occurrence Indicator Treatment Environmental Setting Treatment Setting The surroundings or environment within which the subject receives therapeutic treatment for the condition. Treatment Environmental Setting SZFATS Schizophrenia Findings About Test Name CDISC SDTM Schizophrenia Findings About Test Name Terminology Screener and Opioid Assessment for Patients with Pain - Revised test code. SOAPR1-How Often Mood Swings Screener and Opioid Assessment for Patients with Pain - Revised - How often do you have mood swings? SOAPP-R - How Often Mood Swings SOAPR1-Need Higher Doses of Medication Screener and Opioid Assessment for Patients with Pain - Revised - How often have you felt a need for higher doses of medication to treat your pain? SOAPP-R - Need Higher Doses of Medication SOAPR1-Felt Impatient With Doctors Screener and Opioid Assessment for Patients with Pain - Revised - How often have you felt impatient with your doctors? SOAPP-R - Felt Impatient With Doctors SOAPR1-Felt That Things Are Overwhelming Screener and Opioid Assessment for Patients with Pain - Revised - How often have you felt that things are just too overwhelming that you can't handle them? SOAPP-R - Felt That Things Are Overwhelming SOAPR1-How Often Tension at Home Screener and Opioid Assessment for Patients with Pain - Revised - How often is there tension in the home? SOAPP-R - How Often Tension at Home SOAPR1-How Often Counted Pain Pills Screener and Opioid Assessment for Patients with Pain - Revised - How often have you counted pain pills to see how many are remaining? SOAPP-R - How Often Counted Pain Pills SOAPR1-Concerned People Will Judge You Screener and Opioid Assessment for Patients with Pain - Revised - How often have you been concerned that people will judge you for taking pain medication? SOAPP-R - Concerned People Will Judge You SOAPR1-How Often Feel Bored Screener and Opioid Assessment for Patients with Pain - Revised - How often do you feel bored? SOAPP-R - How Often Feel Bored SOAPR1-How Often Taken More Pain Med Screener and Opioid Assessment for Patients with Pain - Revised - How often have you taken more pain medication than you were supposed to? SOAPP-R - How Often Taken More Pain Medication SOAPR1-Worried About Being Left Alone Screener and Opioid Assessment for Patients with Pain - Revised - How often have you worried about being left alone? SOAPP-R - Worried About Being Left Alone SOAPR1-Felt Craving for Medication Screener and Opioid Assessment for Patients with Pain - Revised - How often have you felt a craving for medication? SOAPP-R - Felt Craving for Medication SOAPR1-Expressed Concern Over Med Use Screener and Opioid Assessment for Patients with Pain - Revised - How often have others expressed concern over your use of medication? SOAPP-R - Others Expressed Concern Over Medication Use SOAPR1-How Often Friends Had Problem Screener and Opioid Assessment for Patients with Pain - Revised - How often have any of your close friends had a problem with alcohol or drugs? SOAPP-R - How Often Friends Had Problem SOAPR1-Others Told You Bad Temper Screener and Opioid Assessment for Patients with Pain - Revised - How often have others told you that you had a bad temper? SOAPP-R - Others Told You Bad Temper SOAPR1-Felt Consumed to Get Pain Med Screener and Opioid Assessment for Patients with Pain - Revised - How often have you felt consumed by the need to get pain medication? SOAPP-R - Felt Consumed to Get Pain Medication SOAPR1-Run Out of Pain Med Early Screener and Opioid Assessment for Patients with Pain - Revised - How often have you run out of pain medication early? SOAPP-R - Run Out of Pain Medication Early SOAPR1-Kept From What You Deserve Screener and Opioid Assessment for Patients with Pain - Revised - How often have others kept you from getting what you deserve? SOAPP-R - Others Kept You From what You Deserve SOAPR1-Legal Problems or Arrested Screener and Opioid Assessment for Patients with Pain - Revised - How often, in your lifetime, have you had legal problems or been arrested? SOAPP-R - Legal Problems or Arrested SOAPR1-Attended AA or NA Meeting Screener and Opioid Assessment for Patients with Pain - Revised - How often have you attended an AA or NA meeting? SOAPP-R - Attended AA or NA Meeting SOAPR1-Argument Someone Got Hurt Screener and Opioid Assessment for Patients with Pain - Revised - How often have you been in an argument that was so out of control that someone got hurt? SOAPP-R - Argument Where Someone Got Hurt SOAPR1-How Often Sexually Abused Screener and Opioid Assessment for Patients with Pain - Revised - How often have you been sexually abused? SOAPP-R - How Often Sexually Abused SOAPR1-Suggested Drug or Alcohol Problem Screener and Opioid Assessment for Patients with Pain - Revised - How often have others suggested that you have a drug or alcohol problem? SOAPP-R - Others Suggested Drug or Alcohol Problem SOAPR1-How Often Borrowed Pain Meds Screener and Opioid Assessment for Patients with Pain - Revised - How often have you had to borrow pain medications from your family or friends? SOAPP-R - How Often Borrowed Pain Medication SOAPR1-Treated for Alcohol or Drug Prob Screener and Opioid Assessment for Patients with Pain - Revised - How often have you been treated for an alcohol or drug problem? SOAPP-R - Treated for Alcohol or Drug Problem SOAPR1-Any Additional Information Screener and Opioid Assessment for Patients with Pain - Revised - Please include any additional information you wish about the above answers. SOAPP-R - Any Additional Information SOAPR1-Score Screener and Opioid Assessment for Patients with Pain - Revised - Score. SOAPP-R - Score SOAPR1TC Screener and Opioid Assessment for Patients with Pain - Revised Questionnaire Test Code CDISC Questionnaire SOAPP-R Test Code Terminology Screener and Opioid Assessment for Patients with Pain - Revised test name. SOAPR1-Any Additional Information Screener and Opioid Assessment for Patients with Pain - Revised - Please include any additional information you wish about the above answers. SOAPP-R - Any Additional Information SOAPR1-Argument Someone Got Hurt Screener and Opioid Assessment for Patients with Pain - Revised - How often have you been in an argument that was so out of control that someone got hurt? SOAPP-R - Argument Where Someone Got Hurt SOAPR1-Attended AA or NA Meeting Screener and Opioid Assessment for Patients with Pain - Revised - How often have you attended an AA or NA meeting? SOAPP-R - Attended AA or NA Meeting SOAPR1-Concerned People Will Judge You Screener and Opioid Assessment for Patients with Pain - Revised - How often have you been concerned that people will judge you for taking pain medication? SOAPP-R - Concerned People Will Judge You SOAPR1-Expressed Concern Over Med Use Screener and Opioid Assessment for Patients with Pain - Revised - How often have others expressed concern over your use of medication? SOAPP-R - Others Expressed Concern Over Medication Use SOAPR1-Felt Consumed to Get Pain Med Screener and Opioid Assessment for Patients with Pain - Revised - How often have you felt consumed by the need to get pain medication? SOAPP-R - Felt Consumed to Get Pain Medication SOAPR1-Felt Craving for Medication Screener and Opioid Assessment for Patients with Pain - Revised - How often have you felt a craving for medication? SOAPP-R - Felt Craving for Medication SOAPR1-Felt Impatient With Doctors Screener and Opioid Assessment for Patients with Pain - Revised - How often have you felt impatient with your doctors? SOAPP-R - Felt Impatient With Doctors SOAPR1-Felt That Things Are Overwhelming Screener and Opioid Assessment for Patients with Pain - Revised - How often have you felt that things are just too overwhelming that you can't handle them? SOAPP-R - Felt That Things Are Overwhelming SOAPR1-How Often Borrowed Pain Meds Screener and Opioid Assessment for Patients with Pain - Revised - How often have you had to borrow pain medications from your family or friends? SOAPP-R - How Often Borrowed Pain Medication SOAPR1-How Often Counted Pain Pills Screener and Opioid Assessment for Patients with Pain - Revised - How often have you counted pain pills to see how many are remaining? SOAPP-R - How Often Counted Pain Pills SOAPR1-How Often Feel Bored Screener and Opioid Assessment for Patients with Pain - Revised - How often do you feel bored? SOAPP-R - How Often Feel Bored SOAPR1-How Often Friends Had Problem Screener and Opioid Assessment for Patients with Pain - Revised - How often have any of your close friends had a problem with alcohol or drugs? SOAPP-R - How Often Friends Had Problem SOAPR1-How Often Mood Swings Screener and Opioid Assessment for Patients with Pain - Revised - How often do you have mood swings? SOAPP-R - How Often Mood Swings SOAPR1-How Often Sexually Abused Screener and Opioid Assessment for Patients with Pain - Revised - How often have you been sexually abused? SOAPP-R - How Often Sexually Abused SOAPR1-How Often Taken More Pain Med Screener and Opioid Assessment for Patients with Pain - Revised - How often have you taken more pain medication than you were supposed to? SOAPP-R - How Often Taken More Pain Medication SOAPR1-How Often Tension at Home Screener and Opioid Assessment for Patients with Pain - Revised - How often is there tension in the home? SOAPP-R - How Often Tension at Home SOAPR1-Kept From What You Deserve Screener and Opioid Assessment for Patients with Pain - Revised - How often have others kept you from getting what you deserve? SOAPP-R - Others Kept You From what You Deserve SOAPR1-Legal Problems or Arrested Screener and Opioid Assessment for Patients with Pain - Revised - How often, in your lifetime, have you had legal problems or been arrested? SOAPP-R - Legal Problems or Arrested SOAPR1-Need Higher Doses of Medication Screener and Opioid Assessment for Patients with Pain - Revised - How often have you felt a need for higher doses of medication to treat your pain? SOAPP-R - Need Higher Doses of Medication SOAPR1-Others Told You Bad Temper Screener and Opioid Assessment for Patients with Pain - Revised - How often have others told you that you had a bad temper? SOAPP-R - Others Told You Bad Temper SOAPR1-Run Out of Pain Med Early Screener and Opioid Assessment for Patients with Pain - Revised - How often have you run out of pain medication early? SOAPP-R - Run Out of Pain Medication Early SOAPR1-Score Screener and Opioid Assessment for Patients with Pain - Revised - Score. SOAPP-R - Score SOAPR1-Suggested Drug or Alcohol Problem Screener and Opioid Assessment for Patients with Pain - Revised - How often have others suggested that you have a drug or alcohol problem? SOAPP-R - Others Suggested Drug or Alcohol Problem SOAPR1-Treated for Alcohol or Drug Prob Screener and Opioid Assessment for Patients with Pain - Revised - How often have you been treated for an alcohol or drug problem? SOAPP-R - Treated for Alcohol or Drug Problem SOAPR1-Worried About Being Left Alone Screener and Opioid Assessment for Patients with Pain - Revised - How often have you worried about being left alone? SOAPP-R - Worried About Being Left Alone SOAPR1TN Screener and Opioid Assessment for Patients with Pain - Revised Questionnaire Test Name CDISC Questionnaire SOAPP-R Test Name Terminology Terminology relevant to the test codes that describe the death diagnosis and related details. Age at Death The age at which death occurred. (NCI) Age at Death Autopsy Indicator An indication as to whether an autopsy was performed. (NCI) Autopsy Indicator Cond Under Study Contrib to Death Ind Condition Under Study Contributed to Death Indicator An indication as to whether the condition under study contributed to the cause of death. Disease Indication Under Study Contributed to Death Indicator Death Certificate Obtained Indicator An indication as to whether a death certificate was obtained. (NCI) Death Certification Indicator Death Expected Indicator An indication as to whether the death was expected. Death Expected Indicator Death Witnessed Indicator An indication as to whether the death event was witnessed by another individual. Death Witnessed Indicator Hospital Medical Record Obtained Ind Hospital Medical Record Obtained Indicator An indication as to whether a hospital medical record was obtained. Hospital Medical Record Indicator Hospitalized at Time of Death Indicator An indication as to whether the subject was hospitalized at the time of death. Hospitalized at Time of Death Indicator Information Source for Cause of Death The person or authoritative source that provided the cause of death. Information Source for Cause of Death Location of Death The physical location at which the subject ceased to live. Location of Death Primary Cause of Death The primary significant event which ultimately led to death. Primary Cause of Death Sudden Death Indicator An indication as to whether death was unexpected or occurred without warning. Sudden Death Indicator Secondary Cause of Death The secondary significant event which ultimately led to death. Secondary Cause of Death DTHDXCD SDTM Death Diagnosis and Details Test Code CDISC SDTM Death Diagnosis Test Code Terminology Terminology relevant to the test names that describe the death diagnosis and related details. Age at Death The age at which death occurred. (NCI) Age at Death Autopsy Indicator An indication as to whether an autopsy was performed. (NCI) Autopsy Indicator Cond Under Study Contrib to Death Ind Condition Under Study Contributed to Death Indicator An indication as to whether the condition under study contributed to the cause of death. Disease Indication Under Study Contributed to Death Indicator Death Certificate Obtained Indicator An indication as to whether a death certificate was obtained. (NCI) Death Certification Indicator Death Expected Indicator An indication as to whether the death was expected. Death Expected Indicator Death Witnessed Indicator An indication as to whether the death event was witnessed by another individual. Death Witnessed Indicator Hospital Medical Record Obtained Ind Hospital Medical Record Obtained Indicator An indication as to whether a hospital medical record was obtained. Hospital Medical Record Indicator Hospitalized at Time of Death Indicator An indication as to whether the subject was hospitalized at the time of death. Hospitalized at Time of Death Indicator Information Source for Cause of Death The person or authoritative source that provided the cause of death. Information Source for Cause of Death Location of Death The physical location at which the subject ceased to live. Location of Death Primary Cause of Death The primary significant event which ultimately led to death. Primary Cause of Death Secondary Cause of Death The secondary significant event which ultimately led to death. Secondary Cause of Death Sudden Death Indicator An indication as to whether death was unexpected or occurred without warning. Sudden Death Indicator DTHDX SDTM Death Diagnosis and Details Test Name CDISC SDTM Death Diagnosis Test Name Terminology Terminology related to the short name for a CDISC domain. Adverse Events Adverse Experiences An events domain used for data describing unintended signs (including an abnormal laboratory finding, for example), symptoms, or diseases temporally associated with the defined study period. Adverse Event Domain Procedure Agents An interventions domain that contains the agents administered to the subject as part of a procedure or assessment, as opposed to drugs, medications and therapies administered with therapeutic intent. Procedure Agents Domain Relationship between Associated Persons and Subjects A dataset used to represent relationships between associated persons (individuals who are not study subjects, but about whom data is collected) and study subjects. Relationship between Associated Persons and Subjects Domain Biospecimen Events An events domain that documents actions taken that affect or may affect a specimen (e.g., specimen collection, freezing and thawing, aliquoting, transportation). Biospecimen Events Domain Biospecimen Findings A specimen-based findings domain that contains data related to biospecimen characteristics. Biospecimen Domain Clinical Events An events domain that contains clinical events of interest that would not be classified as adverse events. Clinical Events Domain Concomitant/Prior Medications An interventions domain that contains concomitant and prior medications used by the subject, such as those given on an as needed basis or condition-appropriate medications. Concomitant Medication Domain Comments A special-purpose domain that contains comments that may be collected alongside other data. Comment Domain Cell Phenotype Findings A specimen-based findings domain that contains data related to the characterization of cell phenotype, lineage, and function based on expression of specific markers in single cell or particle suspensions. Cell Phenotype Findings Domain Cardiovascular System Findings A findings domain that contains physiological and morphological findings related to the cardiovascular system, including the heart, blood vessels and lymphatic vessels. Cardiovascular System Findings Domain Product Accountability A findings domain that contains the accountability of study product, such as information on the receipt, dispensing, return, and packaging. Product Accountability Domain Demographics for Multiple Participations A special-purpose domain that includes a set of standard variables that describe each participation of a subject in a clinical study. Demographics for Multiple Participations Domain Death Diagnosis and Details A findings domain that contains the diagnosis of the cause of death for a subject. Death Diagnosis Domain Device Events An events domain that contains data for device-related events. Device Events Domain Device Identifiers A special-purpose domain containing information that identifies a specific device unit. Device Identifiers Domain Demographics A special-purpose domain that includes a set of essential standard variables that describe each subject in a clinical or nonclinical study. One record will exist for each subject. Demographics Domain Device Properties A findings domain that contains the device characteristics that do not vary over the course of the study. Device Properties Domain Device-Subject Relationships A special-purpose domain that contains the linkage of each subject to the device(s) to which they may have been exposed during the study. Device to Subject Relationship Domain Disposition An events domain that contains information encompassing and representing data related to subject disposition. Disposition Domain Device Tracking and Disposition A events domain that contains the logistics and disposition information specific to a given device. Device Tracking and Disposition Domain Device In-Use A findings domain that contains the measurements and settings that are intentionally set on a device when it is in use. These are characteristics that exist for the device, and have a specific setting for a use instance. Device-In-Use Domain Protocol Deviations An events domain that contains protocol violations and deviations during the course of the study. Protocol Deviations Domain Device Exposure An interventions domain that contains a subject's exposure to a medical device under study. Device Exposure Domain Event Adjudication A findings about domain that contains the results from the adjudication of events. Event Adjudication Domain Exposure as Collected An interventions domain that contains information about protocol-specified study intervention or investigational product administrations, as collected. Exposure as Collected Domain Endocrine System Findings A findings domain that contains physiological and morphological findings related to the endocrine system, including the glands and cells that make hormones that are released directly into the blood and travel to tissues and organs all over the body. Endocrine System Findings Domain ECG Test Results A findings domain that contains ECG data, including position of the subject, method of evaluation, all cycle measurements and all findings from the ECG including an overall interpretation if collected or derived. Electrocardiogram Domain Environmental Storage Conditions A study reference dataset that provides a consistent identifier (STOCONID) for the representation of a set of environmental conditions under which a test article is stored, and contains a list of those conditions. Environmental Storage Conditions Domain Exposure An interventions domain that contains the details of a subject's exposure to protocol-specified study intervention or investigational product. Study interventions or Investigational products may be any intervention that is prospectively defined as a test material within a study, and is typically but not always supplied to the subject. Exposure Domain Findings About Events or Interventions A findings domain that contains the findings about an event or intervention that cannot be represented within an events or interventions domain record or as a supplemental qualifier. Findings About Events or Interventions Domain Functional Tests A findings domain that contains data for named, stand-alone, task-based evaluations designed to provide an assessment of mobility, dexterity, or cognitive ability. Functional Tests Domain Genomics Findings A specimen-based findings domain that contains data related to the structure, function, evolution, mapping, and editing of subject and non-host organism genomic material of interest. This domain includes but is not limited to assessments and results for genetic variation and transcription, and summary measures derived from these assessments. The GF domain is used for findings from characteristics assessed from nucleic acids and may include subsequent inferences and/or predictions about related proteins/amino acids. Genomics Findings Domain Gastrointestinal System Findings A findings domain that contains physiological and morphological findings related to the gastrointestinal system, including the esophagus, stomach, small and large intestine, anus, liver, biliary tract and pancreas. Digestive System Findings Domain Hematopoietic System Findings A findings domain that contains physiological and morphological findings related to the hematopoietic system, including the bone marrow and lymph nodes involved in the production of blood. Hematopoietic System Findings Domain Healthcare Encounters A events domain that contains data for inpatient and outpatient healthcare events (e.g., hospitalization, nursing home stay, rehabilitation facility stay, ambulatory surgery). Healthcare Encounters Domain Inclusion/Exclusion Criteria Not Met A findings domain that contains those criteria that cause the subject to be in violation of the inclusion/exclusion criteria. Inclusion Exclusion Criteria Not Met Domain Integumentary System Findings A findings domain that contains physiological and morphological findings related to the integumentary system, including the epidermis, dermis, and all of their derivatives including hairs, nails, sudoriferous glands, and sebaceous glands. Integumentary System Findings Domain Non-Tobacco Ingredients A special-purpose domain that provides an identifier for each unique non-tobacco ingredient (IGDCMPID) in a tobacco product, and lists those ingredients and their attributes that contribute to their uniqueness. Non-Tobacco Ingredients Domain Ingredient Quantities by Component A special purpose domain for representing the quantity of an ingredient/component of a product by the parent ingredient/component in which it occurs. Ingredient Quantities by Component Domain Immunogenicity Specimen Assessments A specimen-based findings domain for assessments of antigen induced humoral or cell-mediated immune response in the subject. Immunogenicity Specimen Assessments Domain Tobacco Ingredients A special-purpose domain that provides an identifier for each unique tobacco ingredient (IGDCMPID) in a tobacco product, and lists those tobacco ingredients and their attributes that contribute to their uniqueness. Tobacco Ingredients Domain Laboratory Test Results A specimen-based findings domain that contains laboratory test data such as hematology, clinical chemistry and urinalysis. This domain does not include microbiology or pharmacokinetic data, which are stored in separate domains. Laboratory Data Domain Microbiology Specimen A speicmen-based findings domain that represents non-host organisms identified including bacteria, viruses, parasites, protozoa and fungi. Microbiology Specimen Domain Medical History An events domain that contains data that includes the subject's prior medical history at the start of the trial. Medical History Domain Microscopic Findings A specimen-based findings domain that contains histopathology findings and microscopic evaluations. Microscopic Findings Domain Musculoskeletal System Findings A findings domain that contains physiological and morphological findings related to the system of muscles, tendons, ligaments, bones, joints, and associated tissues. Musculoskeletal Findings, Connective and Soft Tissue Findings Domain Meal Data An interventions domain that contains information describing a subject's food product consumption. Meal Data Domain Microbiology Susceptibility A specimen-based findings domain that represents drug susceptibility testing results only. This includes phenotypic testing (where drug is added directly to a culture of organisms) and genotypic tests that provide results in terms of susceptible or resistant. Drug susceptibility testing may occur on a wide variety of non-host organisms, including bacteria, viruses, fungi, protozoa and parasites. Microbiology Susceptibility Domain Nervous System Findings A findings domain that contains physiological and morphological findings related to the nervous system, including the brain, spinal cord, the cranial and spinal nerves, autonomic ganglia and plexuses. Nervous System Findings Domain Ophthalmic Examinations A findings domain that contains tests that measure a subject's ocular health and visual status, including tests of visual acuity, and to detect abnormalities in the components of the visual system. Ophthalmic Examinations Domain Non-host Organism Identifiers A special-purpose domain containing information that identifies levels of taxonomic nomenclature of microbes or parasites that have been either experimentally determined in the course of a study or are previously known, as in the case of lab strains used as reference in the study. Non-host Organism Identifiers Domain Pharmacokinetics Concentrations A specimen-based findings domain that contains data related to absorption, distribution, metabolism, and elimination of a study product or its metabolites. Pharmacokinetic Concentration Domain Tobacco Product Design Parameters A special-purpose domain that lists the target, minimum, and maximum allowable values for design parameters of a product as allowed per manufacturer specifications. Therefore these data are not experimentally determined. Tobacco Product Design Parameters Domain Physical Examination A findings domain that contains findings observed during a physical examination where the body is evaluated by inspection, palpation, percussion, and auscultation. Physical Exam Domain Pool Definition A dataset that identifies individual subjects included in a pool of subjects for which a single observation record (pool level) is captured. Pool Definition Dataset Pharmacokinetics Parameters A findings domain that contains pharmacokinetic parameters derived from pharmacokinetic concentration-time data. Pharmacokinetic Parameters Domain Procedures An interventions domain that contains interventional activity intended to have diagnostic, preventive, therapeutic, or palliative effects. Procedure Domain Tobacco Product Testing A findings domain for representing results of testing tobacco product samples, not biological specimens from human subjects. Tobacco Product Testing Domain Questionnaires A findings domain that contains data for named, stand-alone instruments designed to provide an assessment of a concept. Questionnaires have a defined standard structure, format, and content; consist of conceptually related items that are typically scored; and have documented methods for administration and analysis. Questionnaire Domain Respiratory System Findings A findings domain that contains physiological and morphological findings related to the respiratory system, including the organs that are involved in breathing such as the nose, throat, larynx, trachea, bronchi and lungs. Respiratory Domain Related Records A dataset used to describe relationships between records for a subject within or across domains, and relationships of records across datasets. Related Records Dataset Related Specimens A dataset used to represent relationships between specimens. Related Specimens Dataset Related Subjects A dataset used to represent relationships between study subjects. Related Subjects Dataset Reproductive System Findings A findings domain that contains physiological and morphological findings related to the male and female reproductive systems. Reproductive System Findings Domain Disease Response and Clin Classification A findings domain for the assessment of disease response to therapy, or clinical classification based on published criteria. Disease Response Domain Serious Adverse Events An events domain that contains data describing untoward medical occurrences considered serious (SAE) in a patient or subjects that are administered a pharmaceutical product and which may not necessarily have a causal relationship with the treatment. Serious Adverse Events Domain Subject Characteristics A findings domain containing attributes of the subject as an extension of demographics data, including socioeconomic and other qualities, traits, or features. Subject Characteristics Domain Subject Elements A special-purpose domain that contains the actual order of elements followed by the subject, together with the start date/time and end date/time for each element. Subject Element Domain Subject Disease Milestones A special-purpose domain that is designed to record the timing, for each subject, of disease milestones that have been defined in the Trial Disease Milestones (TM) domain. Subject Disease Milestones Domain Skin Response A findings about domain for submitting dermal responses to antigens. Skin Response Domain Subject Status A findings domain that contains the subject's status that is evaluated periodically to determine if it has changed. Subject Status Domain Substance Use An interventions domain that contains substance use information that may be used to assess the efficacy and/or safety of therapies or investigational products that look to mitigate the effects of chronic substance use. Substance Use Domain Subject Visits A special-purpose domain that contains information for each subject's actual and planned visits and contact events. Subject Visits Domain Trial Arms A trial design domain that contains each planned arm in the trial. Trial Arms Domain Trial Disease Assessments A trial design domain that provides information on the protocol-specified disease assessment schedule, to be used for comparison with the actual occurrence of the efficacy assessments in order to determine whether there was good compliance with the schedule. Trial Disease Assessments Domain Trial Elements A trial design domain that contains each planned element in the trial. Trial Elements Domain Trial Inclusion/Exclusion Criteria A trial design domain that contains one record for each of the inclusion and exclusion criteria for the trial. This domain is not subject oriented. Trial Inclusion and Exclusion Criteria Domain Trial Disease Milestones A trial design domain that is used to describe disease milestones, which are observations or activities anticipated to occur in the course of the disease under study, and which trigger the collection of data. Trial Disease Milestones Domain Tobacco Product Identifiers and Descriptors A study reference dataset that provides a consistent identifier (SPTOBID) for the representation of a tobacco product. The dataset contains a list of the identifying and descriptive characteristics of the tobacco product. Tobacco Product Identifiers and Descriptors Domain Tumor/Lesion Results A findings domain that represents quantitative measurements and/or qualitative assessments of the tumors, lesions, or locations of interest identified in the Tumor/Lesion Identification (TU) domain. Tumor Results Domain Trial Summary A trial design domain that contains one record for each trial summary characteristic. Trial Summary Domain Tumor/Lesion Identification A findings domain that represents data that uniquely identifies tumors, lesions, or locations of interest under study. Tumor Identifier Domain Trial Visits A trial design domain that contains the planned order and number of visits in the study within each arm. Trial Visits Domain Urinary System Findings A findings domain that contains physiological and morphological findings related to the urinary tract, including the organs involved in the creation and excretion of urine such as the kidneys, ureters, bladder and urethra. Urinary System Findings Domain Vital Signs A findings domain that contains data related to vital sign measurements. Vital Signs Domain DOMAIN SDTM Domain Abbreviation CDISC SDTM Submission Domain Abbreviation Terminology Terminology for the test codes concerned with the clinical findings from a specimen that are visible by microscopic analysis. Abnormal Cells A measurement of the abnormal cells in a biological specimen. Abnormal Cell Count Acidophil Bodies Acidophil Body An evaluation of acidophil bodies in a biological specimen. Acidophil Body Assessment ALK Protein A measurement of the ALK receptor tyrosine kinase in a biological specimen. ALK Protein Measurement Alpha-Methylacyl Coenzyme A Racemase A measurement of the alpha-methylacyl coenzyme A racemase in a biological specimen. Alpha-Methylacyl Coenzyme A Racemase Measurement Apoptotic Cells A measurement of the apoptotic cells in a biological specimen. Apoptotic Cell Count Apoptotic Cells/Total Cells A relative measurement (ratio or percentage) of the apoptotic cells to total cells in a biological specimen. Apoptotic Cell to Total Cell Count Architectural Changes An evaluation of tissue architectural changes in a biological specimen. Architectural Changes Assessment Area The extent of a 2-dimensional surface enclosed within a boundary. (NCI) Area Arteriolar Hyaline Thickening An evaluation of the arteriolar hyaline thickening of vessels in a biological specimen. Arteriolar Hyaline Thickening Assessment Androgen Receptor Variant 7 AR-V7 A measurement of the androgen receptor variant 7 in a biological specimen. Androgen Receptor Variant 7 Measurement Total Assessed Cells Total Cells A measurement of the total number of cells that are observed during the evaluation, or assessed as part of the protocol-defined assay. Total Assessed Cells Count Adequate Surgical Margins Indicator An indication as to whether there is adequate distance of apparently non-tumorous tissue from the resected tumor. Adequate Surgical Margin Indicator B7 Family Member, H3 B7 Homolog 3 B7 Homolog 3 Protein B7-H3 CD276 Molecule A measurement of the B7 homolog 3 protein in a biological specimen. B7 Homolog 3 Measurement B7 Family Member, H4 B7 Homolog 4 B7 Homolog 4 Protein B7 Superfamily Member 1 B7-H4 Protein B7S1 V-Set Domain Containing T Cell Activation Inhibitor 1 A measurement of the B7 homolog 4 protein in a biological specimen. B7 Homolog 4 Measurement Banff Diagnostic Category Renal The histologic evaluation and diagnosis of the type of renal allograft rejection based on kidney biopsies and the Banff Working Classification from the Banff Foundation for Allograft Pathology. (NCI) Banff Renal Diagnostic Category Assessment Basophils/Total Cells A relative measurement (ratio or percentage) of the basophils to total cells in a biological specimen (for example a bone marrow specimen). Basophil to Total Cell Ratio Measurement Apoptosis Regulator BCL-2 B-Cell Lymphoma 2 BCL-2 Bcl-2 BCL2 A measurement of BCL2 in a biological specimen. B-Cell Lymphoma 2 Measurement B-Cell Lymphoma 6 BCL-6 Bcl-6 BCL5 BCL6 BCL6 Transcription Repressor Zinc Finger And BTB Domain-Containing Protein 27 Zinc Finger Protein 51 A measurement of the B-cell lymphoma 6 protein in a biological specimen. B-Cell Lymphoma 6 Protein Measurement Blood Cell Lineage Hyperplasia Type The determination of the lineage of the hyperplastic blood cells in a biological specimen. Blood Cell Lineage Hyperplasia Type Assessment Beta-defensin 1 A measurement of the beta-defensin 1 in a biological specimen. Beta-defensin 1 Measurement Beta-defensin 2 A measurement of the beta-defensin 2 in a biological specimen. Beta-defensin 2 Measurement BK-1 Receptor Bradykinin Receptor B1 A measurement of the bradykinin receptor B1 in a biological specimen. Bradykinin Receptor B1 Measurement Number of Biopsy Specimens Affected The total number of biopsy specimens in which a finding has been observed. Number of Biopsy Specimens Affected Blasts/Total Cells A relative measurement (ratio or percentage) of the blasts to total cells in a biological specimen. Blasts to Total Cells Ratio Measurement Blood Vessel Density An evaluation of the blood vessel density in a biological specimen. Blood Vessel Density Myeloblasts/Total Cells A relative measurement (ratio or percentage) of the myeloblasts to total cells in a biological specimen (for example a bone marrow specimen). Myeloblast to Total Cell Ratio Measurement Megakaryoblasts/Total Cells A relative measurement (ratio or percentage) of the megakaryoblasts to total cells in a biological specimen (for example a bone marrow specimen). Megakaryoblast to Total Cell Ratio Measurement Breast Cancer Type 1 Susceptibility Prot A measurement of BRCA1 protein in a biological specimen. Breast Cancer Type 1 Susceptibility Protein Measurement B-Cell Lymphoma 1 Protein BCL-1 BCL1 Cyclin D1 G1/S-specific Cyclin-D1 Parathyroid Adenomatosis 1 PRAD1 A measurement of cyclin D1 in a biological specimen. Cyclin D1 Measurement C-C Chemokine Receptor Type 8 C-C Motif Chemokine Receptor 8 CCR-8 CDw198 Antigen A measurement of the CCR8, chemokine (C-C motif) receptor type 8, in a biological specimen. C-C Chemokine Receptor Type 8 Measurement CD34 CD34 Molecule CD34 Protein CD34 Sialomucin Hematopoietic Progenitor Cell Antigen CD34 A measurement of the CD34 sialomucin in a biological specimen. CD34 Measurement CD3 CD3 Complex CD3 T-Cell Marker A measurement of the CD3 T-cell marker in a biological specimen. CD3 T-Cell Marker Measurement CD8 CD8 Complex T-Cell Surface Glycoprotein CD8 A measurement of the T-cell surface glycoprotein CD8 in a biological specimen. T-Cell Surface Glycoprotein CD8 Measurement Cadherin 6 K-Cadherin KCAD A measurement of the cadherin 6 in a biological specimen. Cadherin 6 Measurement CDX2 Antigen A measurement of the CDX2 antigen in a biological specimen. CDX2 Antigen Measurement Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 CEA Cell Adhesion Molecule 5 Soluble CD66e A measurement of the carcinoembryonic antigen (CEA) cell adhesion molecule 5 in a biological specimen. CEA Cell Adhesion Molecule 5 Measurement Cell Distribution An interpretive assessment of the proportion of various cell types in a biological specimen. Cell Distribution Measurement Cellular Differentiation An evaluation of cellular maturity and specialization in a biological specimen. Cellular Differentiation Assessment Cells Total Cells A measurement of the total nucleated cells in a biological specimen. Cell Count Cellularity Cellularity Grade A measurement of the degree, quality or condition of cells in a biological specimen. Cellularity Measurement Cell Morphology An examination or assessment of the form and structure of cells. Cell Morphology Assessment Chronic Inflammatory Infiltrate An evaluation of chronic inflammatory infiltrate in a biological specimen. Chronic Inflammatory Infiltrate Assessment Collagen Fibrosis An evaluation of collagen fibrosis in a biological specimen. Collagen Fibrosis Assessment Clonal Cells/Total Cells A relative measurement (ratio or percentage) of the clonal cells to total cells in a biological specimen (for example a bone marrow specimen). Clonal Cells to Total Cells Ratio Measurement BHLH Transcription Factor c-Myc Cellular Myc MYC Proto-Oncogene Myc Proto-Oncogene Protein MYCC Tumor Protein c-myc A measurement of the c-Myc in a biological specimen. c-Myc Measurement Number of Malignant Biopsy Cores A measurement of the total number of core biopsies that contain malignant tissue. (NCI) Number of Malignant Biopsy Cores Crypt Abscess An evaluation of crypt abscess in a biological specimen. Crypt Abscess Assessment Crypt Architectural Damage An evaluation of the extent of the architectural damage to the crypts in a biological specimen. Crypt Architectural Damage Assessment Cryptitis An evaluation of cryptitis in a biological specimen. Cryptitis Assessment Cytokeratin 16 A measurement of the cytokeratin 16 in a biological specimen. Cytokeratin 16 Measurement Cytogenetic Examination An assessment by microscopic analysis of chromosomal and subchromosomal structure and function. Cytogenetic Analysis Dendritic Cell-Lysosomal-Assoc Memb Prot A measurement of the dendritic cell-lysosomal-associated membrane protein in a biological specimen. Dendritic Cell Lysosomal-Associated Membrane Protein Measurement DC Plasmacytoid Plasmacytoid Dendritic Cells A measurement of the plasmacytoid dendritic cells in a biological specimen. Plasmacytoid Dendritic Cell Count DC Plasmacytoid Sub Plasmacytoid Dendritic Cells Sub-Population A measurement of a sub-population of plasmacytoid dendritic cells in a biological specimen. Plasmacytoid Dendritic Cell Subpopulation Count Depth The extent downward or inward; the perpendicular measurement from the surface downward to determine deepness. (NCI) Depth Diagnostic A process to identify the disease, condition, or injury that explains the symptoms and signs occurring in a patient. Diagnosis Assessment Depth of Tumor Cell Infiltration Depth of Tumor Invasion An evaluation of the downward or inward extent of tumor invasion into a tissue. Depth of Tumor Invasion Dysplasia An evaluation of dysplasia in a biological specimen. Dysplasia Assessment Epidermal Growth Factor Receptor ERBB1 HER1 A measurement of the epidermal growth factor receptor in a biological specimen. Epidermal Growth Factor Receptor Measurement EGFR Variant Protein A measurement of the EGFR protein with a specified variation(s) (mutations, deletions, insertions, etc.) in a biological specimen. EGFR Variant Protein Measurement Extramural Venous Invasion An evaluation of extramural venous invasion in a biological specimen. Extramural Venous Invasion Assessment Distance to Extranodal Extension A measurement of the distance of the extent of the malignant neoplasm beyond the lymph node capsule. Distance to Extranodal Extension Eosinophils/Total Cells A relative measurement (ratio or percentage) of the eosinophils to total cells in a biological specimen (for example a bone marrow specimen). Eosinophils to Total Cell Ratio Measurement Epithelial Damage An evaluation of epithelial damage in a biological specimen. Epithelial Damage Assessment Squamous Cells/Total Cells Squamous Epithelial Cells/Total Cells A relative measurement (ratio or percentage) of the squamous epithelial cells to total cells in a biological specimen. Squamous Epithelial Cells to Total Cells Ratio Measurement Epithelial Integrity An evaluation of the integrity of the epithelium in a biological specimen. Epithelial Integrity Assessment Erythrodysplasia Erythroid Cell Dysplasia Erythroid Dysplasia An evaluation of erythroid dysplasia in a biological specimen. Erythroid Dysplasia Assessment Erythroid Cell Proliferation Erythroid Proliferation An evaluation of erythroid lineage cell proliferation in a biological specimen. Erythroid Proliferation Measurement Epi RBM Lngth, Intact/Epi RBM Lngth, Tot Epithelial RBM Length, Intact/Epithelial RBM Length, Total A relative measurement (ratio or percentage) of the intact epithelial reticular basement membrane length to the total epithelial reticular basement membrane length in a biological specimen. Intact Epithelial Reticular Basement Membrane Length to Total Epithelial Reticular Basement Membrane Length Ratio Measurement Erosion and/or Ulceration An evaluation of the erosion and/or ulceration in a biological specimen. Erosion and/or Ulceration Assessment Erythroid Precursor Cells Erythroid Precursors A measurement of the erythroid precursors in a biological specimen. Erythroid Precursor Cell Count Erythroid Precursor Cells/Total Cells Erythroid Precursors/Total Cells A relative measurement (ratio or percentage) of the erythroid precursors to total cells in a biological specimen. Erythroid Precursor Cells to Total Cells Ratio Measurement ER ESR Estrogen Receptor Oestrogen Receptor A measurement of estrogen receptor protein in a biological specimen. Estrogen Receptor Measurement Fibroblasts A measurement of the fibroblasts in a biological specimen. Fibroblast Count Fibrosis An evaluation of fibrosis in a biological specimen. Fibrosis Assessment Folate Hydrolase 1 A measurement of the folate hydrolase 1 in a biological specimen. Folate Hydrolase 1 Measurement AIID DIETER Forkhead Box P3 Forkhead Box Protein 3 IPEX JM2 PIDX SCURFIN XPID A measurement of the forkhead box protein 3 in a biological specimen. Forkhead Box Protein P3 Measurement General Histopathologic Examination, Qualitative General Histopathological Exam, Qual A qualitative microscopic examination of tissue sections to determine the presence of pathologic finding(s). This term is intended to be used for non-targeted examinations. Qualitative Histopathologic Examination Glomerulitis An evaluation of glomerulitis in a biological specimen. Glomerulitis Assessment Glomerulopathy An evaluation of glomerulopathy in a biological specimen. Glomerulopathy Assessment Goblet Cells A measurement of the goblet cells in a biological specimen. Goblet Cell Count Goblet Cells/Epithelial Cells A relative measurement (ratio or percentage) of the goblet cells to total epithelial cells in a biological specimen. Goblet Cell to Epithelial Cell Ratio Measurement Glypican 3 Glypican-3 Heparan Sulphate Proteoglycan A measurement of the glypican 3 protein in a biological specimen. Glypican 3 Measurement Granulocyte Proliferation An evaluation of granulocyte proliferation in a biological specimen. Granulocyte Proliferation Measurement Granulocytes Segmented/Total Cells Segmented Granulocytes/Total Cells A relative measurement (ratio or percentage) of the segmented granulocytes to total cells in a biological specimen. Segmented Granulocyte to Total Cell Ratio Measurement Granuloma An evaluation of granuloma(s) in a biological specimen. Granuloma Assessment C11 CCPI CGL1 CSPB CTLA1 CTSGL1 Granzyme B HLP SECT A measurement of the granzyme B in a biological specimen. Granzyme B Measurement Ballooning Degeneration Hepatocellular Ballooning An evaluation of hepatocellular ballooning in a biological specimen. Hepatocellular Ballooning Assessment ErbB-2 ERBB2 HER2/NEU Human Epidermal Growth Factor Receptor 2 A measurement of HER2 protein in a biological specimen. Human Epidermal Growth Factor Receptor 2 Measurement EGFR3 Erb-B2 Receptor Tyrosine Kinase 3 ErbB-3 ERBB3 ErbB3 HER3 Human Epidermal Growth Factor Receptor 3 A measurement of HER3 protein in a biological specimen. Human Epidermal Growth Factor Receptor 3 Measurement c-Met Hepatocyte Growth Factor Receptor MET Proto-Oncogene, Receptor Tyrosine Kinase Tyrosine-Protein Kinase Met A measurement of the hepatocyte growth factor receptor in a biological specimen. Hepatocyte Growth Factor Receptor Measurement Histologic Type of Cancer The determination of the histologic type of cancer in a biological specimen. Histologic Type of Cancer Hematopoietic Cells/Adipocytes Hematopoietic Cells/Fat Cells Hematopoietic Cells/Lipocytes A relative measurement (ratio) of the hematopoietic cells to adipocytes in a biological specimen. Hematopoietic Cells to Adipocytes Ratio Measurement Intercellular Adhesion Molecule 1 Soluble CD54 A measurement of the intercellular adhesion molecule 1 in a biological specimen. Intercellular Adhesion Molecule 1 Measurement Intraepidermal Nerve Fiber Density A measurement of the intraepidermal nerve fiber density in a biological specimen. Intraepidermal Nerve Fiber Density Epithelial Neoplasia Intraepithelial Neoplasia An evaluation of intraepithelial neoplasia in a biological specimen. Intraepithelial Neoplasia Assessment Immune Cell Infiltrate Immune Cell Infiltration An evaluation of the immune cell infiltration in a biological specimen. Immune Cell Infiltration Assessment Number of Involved Lymph Node Levels Number of Involved Lymph Node Stations Number of Positive Lymph Node Levels Number of Positive Lymph Node Stations A measurement of the number of levels of lymph nodes that contain neoplastic cells. Number of Involved Lymph Node Levels Intimal Arteritis An evaluation of intimal arteritis in a biological specimen. Intimal Arteritis Assessment Interstitial Fibrosis An evaluation of interstitial fibrosis in a biological specimen. Interstitial Fibrosis Assessment Interferon Regulatory Factor 4 Multiple Myeloma Oncogene 1 MUM1 A measurement of the interferon regulatory factor 4 protein in a biological specimen. Interferon Regulatory Factor 4 Measurement FE Iron A measurement of the iron in a biological specimen. Iron Measurement CD61 GP3A Integrin Subunit Beta 3 Platelet Glycoprotein IIIa A measurement of the integrin subunit beta 3 in a biological specimen. Integrin Subunit Beta 3 Measurement Ki-67 KI67 MKI67 pKi-67 A measurement of the Ki-67 protein in a biological specimen. Ki67 Measurement Megakaryocytes A measurement of the megakaryocytes per unit of a biological specimen. Megakaryocyte Count Megakaryocytes Sub-Population/Megakaryocytes Megakaryocytes Sub/Megakaryocytes A relative measurement (ratio or percentage) of a sub-population of megakaryocytes to total megakaryocytes in a biological specimen. Megakaryocyte Subpopulation to Megakaryocyte Ratio Measurement Keratinocytes A measurement of the keratinocytes in a biological specimen. Keratinocyte Measurement CD223 Antigen LAG-3 Lymphocyte Activation Gene 3 Protein Lymphocyte Activation Gene-3 A measurement of the lymphocyte activation gene-3 protein in a biological specimen. Lymphocyte Activation Gene-3 Protein Measurement Lipocalin-2 Neutrophil Gelatinase-Associated Lipocalin NGAL Oncogene 24p3 A measurement of lipocalin-2 in a biological specimen. Lipocalin-2 Measurement Length The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI) Length Leukoerythroblastosis An evaluation of leukoerythroblastosis in a biological specimen. Leukoerythroblastosis Measurement CD5 LEU1 Lymphocyte Antigen T1/Leu-1 T-Cell Surface Glycoprotein CD5 A measurement of the lymphocyte antigen T1/Leu-1 in a biological specimen. T-Cell Surface Glycoprotein CD5 Measurement CD20 LEU-16 Leukocyte Surface Antigen Leu-16 Membrane Spanning 4-Domains A1 A measurement of the membrane spanning 4-domains A1 protein in a biological specimen. Membrane Spanning 4-Domains A1 Measurement CD4 CD4 Molecule Leu-3 T-Cell Surface Antigen T4/Leu-3 A measurement of the T-cell surface antigen T4/Leu-3 in a biological specimen. T-Cell Surface Glycoprotein CD4 Measurement Lymphocyte Function-Associated Antigen 1 A measurement of the lymphocyte function-associated antigen 1 in a biological specimen. Lymphocyte Function-Associated Antigen 1 Measurement Leukemic B-Lymphocytes/Total Cells A relative measurement (ratio or percentage) of the leukemic B-lymphocytes to total cells in a biological specimen. Leukemic B-Lymphocyte to Total Cell Ratio Measurement Lymph Node Extracapsular Spread An evaluation of lymph node extracapsular spread by the tumor in a biological specimen. Lymph Node Extracapsular Spread Assessment Lymph Node Involvement Indicator Positive Lymph Node Indicator An indication as to whether cancer is present in the lymph nodes. Lymph Node Involvement Indicator Number of Lymph Nodes Involved Number of Lymph Nodes Positive for Neoplastic Cells A measurement of the total number of lymph nodes that contain neoplastic cells. Number of Lymph Nodes Involved With Neoplastic Cells Lymph Node State A condition or state of a lymph node at a particular time. Lymph Node State Lobular Inflammation An evaluation of lobular inflammation in a biological specimen. Lobular Inflammation Assessment Large Lipogranuloma An evaluation of large lipogranuloma in a biological specimen. Large Lipogranuloma Assessment Epithelial Lymphocytes/Enterocytes Intraepithelial Lymphocytes/Enterocytes A relative measurement (ratio or percentage) of the lymphocytes to enterocytes within the epithelium of a biological specimen. Intraepithelial Lymphocytes to Enterocytes Ratio Measurement Lymphocytes A measurement of the lymphocytes in a biological specimen. Lymphocyte Count Lymphocytes/Total Cells A relative measurement (ratio or percentage) of the lymphocytes to total cells in a biological specimen (for example a bone marrow specimen). Lymphocyte to Total Cell Ratio Measurement Lymphoma Cells A measurement of the malignant lymphocytes in a biological specimen. Lymphoma Cell Count Lymphoma Cells/Total Cells A relative measurement (ratio or percentage) of the lymphoma cells to total cells in a biological specimen. Lymphoma Cell to Total Cell Ratio Measurement Lymphoid Aggregates A measurement of the lymphoid aggregates in a biological specimen. Lymphoid Aggregates Measurement Lymphatic Invasion An evaluation of lymphatic invasion in a biological specimen. Lymphatic Invasion Assessment Lymphoma T+B-Lymphocytes/Total Cells A relative measurement (ratio or percentage) of the lymphoma T-lymphocytes and B-lymphocytes to total cells in a biological specimen. Lymphoma T and B-Lymphocyte to Total Cell Ratio Measurement Mallory Body Mallory Hyaline Mallory's Hyaline Mallory-Denk Body An evaluation of Mallory bodies in a biological specimen. Mallory Body Assessment Mast Cells/Total Cells A relative measurement (ratio or percentage) of the mast cells to total cells in a biological specimen. Mast Cell to Total Cell Ratio Measurement Max Dimension Largest Metastatic Deposit Maximum Dimension of the Largest Metastatic Deposit A measurement of the maximum dimension (longest or widest) of the largest metastatic deposit. Maximum Dimension of Largest Metastatic Deposit Microgranuloma An evaluation of microgranuloma in a biological specimen. Microgranuloma Assessment Mononuc Cell Interstitial Inflammation An evaluation of mononuclear cell interstitial inflammation in a biological specimen. Mononuclear Cell Interstitial Inflammation Assessment Megamitochondria An evaluation of megamitochondria in a biological specimen. Megamitochondria Assessment Erythroid Precursors/Total Cells Maturing Erythroid Cells/Total Cells Maturing Erythroid/Total Cells Total Erythroid Precursors/Total Cells A relative measurement (ratio or percentage) of the maturing erythroid cells to total cells in a biological specimen. Maturing Erythroid Cell to Total Cell Ratio Measurement Metamyelocytes/Total Cells A relative measurement (ratio or percentage ) of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) to total cells in a biological specimen (for example a bone marrow specimen). Metamyelocyte to Total Cell Ratio Measurement Microscopic Examination An assessment by microscope (e.g., light, electron, confocal, etc.). Microscopic Examination Mitotic Figure Mitotic Figures A measurement of the cells containing mitotic figures in a biological specimen. Mitotic Figure Assessment Mitotic Count Score Mitotic Score An evaluation of the mitotic score in a biological specimen. Mitotic Rate Score Megakaryocyte Cell Morphology An examination or assessment of the form and structure of megakaryocyte cells. Megakaryocyte Cell Morphology Assessment Megakaryocyte Proliferation An evaluation of megakaryocyte proliferation in a biological specimen. Megakaryocyte Proliferation Measurement Megakaryocyte Pattern Distribution Megakaryocyte Topographic Distribution An interpretive assessment of the locational pattern of megakaryocytes present in a biological specimen. Megakaryocyte Topographic Distribution Assessment Megakaryocytic Dysplasia An evaluation of megakaryocytic dysplasia in a biological specimen. Megakaryocytic Dysplasia Assessment MART1 Melan-A Melanoma Antigen Recognized By T-Cells 1 A measurement of the melan-A in a biological specimen. MART-1 Antigen Measurement MutL Homolog 1 A measurement of the MLH1 mismatch repair protein in a biological specimen. MutL Homolog 1 Measurement MutL Homolog 3 A measurement of the MLH3 mismatch repair protein in a biological specimen. MutL Homolog 3 Measurement Mismatch Repair Proteins Interpretation The determination of the meaning of protein expression assessments across multiple mismatch repair proteins. Mismatch Repair Proteins Interpretation Mismatch Repair Proteins MMR Proteins An evaluation of the mismatch repair proteins in a biological specimen. Mismatch Repair Protein Measurement Mononuclear Cells Mononucleated Cells A measurement of the mononuclear cells in a biological specimen. Mononuclear Cell Count Infilt of Mono Cells in Lamina Propria Infiltration of Mononuclear Cells in Lamina Propria An evaluation of infiltration of mononuclear cells in the lamina propria in a biological specimen. Infiltration of Mononuclear Cells in Lamina Propria Assessment Monoblasts/Total Cells A relative measurement (ratio or percentage) of the monoblasts to total cells in a biological specimen. Monoblast to Total Cell Ratio Measurement Monocytes/Total Cells A relative measurement (ratio or percentage) of the monocytes to total cells in a biological specimen (for example a bone marrow specimen). Monocytes to Total Cell Ratio Measurement Macrophage, Pigmented Pigmented Macrophage An evaluation of pigmented macrophages in a biological specimen. Pigmented Macrophage Assessment MutS Homolog 2 A measurement of the MSH2 mismatch repair protein in a biological specimen. MutS Homolog 2 Measurement MutS Homolog 3 A measurement of the MSH3 mismatch repair protein in a biological specimen. MutS Homolog 3 Measurement MutS Homolog 6 A measurement of the MSH6 mismatch repair protein in a biological specimen. MutS Homolog 6 Measurement Mesangial Matrix An evaluation of mesangial matrix in a biological specimen. Mesangial Matrix Assessment CAK1 Antigen Mesothelin Pre-Pro-Megakaryocyte-Potentiating Factor A measurement of the mesothelin in a biological specimen Mesothelin Measurement Methylthioadenosine Phosphorylase MTA Phosphorylase MTAPase S-Methyl-5'-Thioadenosine Phosphorylase A measurement of the methylthioadenosine phosphorylase in a biological specimen Methylthioadenosine Phosphorylase Measurement Microvesicular Steatosis An evaluation of microvesicular steatosis in a biological specimen. Microvesicular Steatosis Assessment Myeloid Cell Dysplasia Myeloid Dysplasia An evaluation of myeloid dysplasia in a biological specimen. Myeloid Dysplasia Assessment Myeloid Cell Proliferation Myeloid Proliferation An evaluation of myeloid lineage cell proliferation in a biological specimen. Myeloid Proliferation Measurement Myeloid Cells Sub-Population/Myeloid Cells Myeloid Cells Sub/Myeloid Cells A relative measurement (ratio or percentage) of a sub-population of myeloid cells to total myeloid cells in a biological specimen. Myeloid Cell Subpopulation to Myeloid Cell Ratio Measurement Myelocytes/Total Cells A relative measurement (ratio or percentage) of the myelocytes to total cells in a biological specimen (for example a bone marrow specimen). Myelocyte to Total Cell Ratio Measurement Myelofibrosis An evaluation of myelofibrosis in a biological specimen. Myelofibrosis Assessment Myeloid/Erythroid Ratio A relative measurement of myeloid progenitor cells to erythrocyte precursor cells in a biological specimen. Myeloid to Erythroid Ratio Measurement CD56 Neural Cell Adhesion Molecule 1 A measurement of the neural cell adhesion molecule 1 in a biological specimen. Neural Cell Adhesion Molecule 1 Measurement Nuclear Pleomorphism An evaluation of nuclear pleomorphism in a biological specimen. Nuclear Pleomorphism Assessment Nectin 4 Nectin Cell Adhesion Molecule 4 Nectin-4 A measurement of the nectin 4 in a biological specimen. Nectin 4 Measurement Neoplastic Cells A measurement of the neoplastic cells in a biological specimen. Tumor Cell Count Cancer Cellularity Neoplastic Cells/Total Cells Tumor Cells/Total Cells A relative measurement (ratio or percentage) of the neoplastic cells to total cells in a biological specimen. Cancer Cellularity Measurement Neutrophils Band Form/Total Cells A relative measurement (ratio or percentage) of the banded neutrophils to total cells in a biological specimen. Neutrophil Band Form to Total Cell Ratio Measurement Neutrophils in Epithelium An evaluation of neutrophils in the epithelium in a biological specimen. Neutrophils in Epithelium Assessment Lamina Propria Neutrophils Neutrophils in Lamina Propria An evaluation of neutrophils in the lamina propria in a biological specimen. Neutrophils in Lamina Propria Assessment Neutrophils, Segmented/Total Cells A relative measurement (ratio or percentage) of segmented neutrophils to total cells in a biological specimen. Segmented Neutrophil to Total Cell Ratio Measurement NK2 Homeobox 1 TEBP Thyroid Transcription Factor 1 TTF1 A measurement of NK2 homeobox 1 protein in a biological specimen. NK2 Homeobox 1 Measurement Nodule An evaluation of nodule(s) in a biological specimen. Nodule Assessment Normal Cells/Total Cells A relative measurement (ratio or percentage) of the normal cells to total cells in a biological specimen. Normal Cell to Total Cell Ratio Measurement 5'-NT 5'-Nucleotidase 5'-Nucleotidase Ecto CD73 E5NT Ecto-5'-Nucleotidase A measurement of ecto-5'-nucleotidase in a biological specimen. Ecto-5'-Nucleotidase Measurement Glycogenated Nuclei Nuclei, Glycogenated An evaluation of glycogenated nuclei in a biological specimen. Glycogenated Nuclei Assessment Histologic Grade Overall Tumor Grade Tumor Grade An assigned tumor grade based on a defined scoring system. Histologic Grade CDK4I Cyclin Dependent Kinase Inhibitor 2A p16 p16 p16 Inhibitors of CDK4 p16-INK4a A measurement of the p16-INK4A in a biological specimen. p16-INK4A Measurement Tumor Protein p53 A measurement of the tumor protein p53 in a biological specimen. Cellular Tumor Antigen p53 Measurement Prostatic Acid Phosphatase A measurement of the prostatic acid phosphatase in a biological specimen. Prostatic Acid Phosphatase Measurement PAX3-FKHR Fusion Protein A measurement of the PAX3-FKHR fusion protein in a biological specimen. PAX3-FKHR Fusion Protein Measurement B-Cell Lineage Specific Activator Protein BSAP Paired Box 5 PAX-5 A measurement of the paired box 5 protein in a biological specimen Paired Box 5 Measurement Percentage of In situ Carcinoma A relative measurement (percentage) of in situ component present in a carcinoma compared to the entire malignant cellular proliferation. (NCI) Percentage of in situ Carcinoma CD274 PD-L1 Programmed Cell Death 1 Ligand 1 Programmed Death Ligand 1 A measurement of the programmed death ligand 1 in a biological specimen. Programmed Death Ligand 1 Measurement CD31 Antigen PECAM PECAM-1 PECAM1 Platelet And Endothelial Cell Adhesion Molecule 1 Platelet Endo Cell Adhesion Molecule 1 Platelet Endothelial Adhesion Molecule Soluble CD31 A measurement of the platelet and endothelial cell adhesion molecule 1 in a biological specimen. Platelet Endothelial Cell Adhesion Molecule 1 Measurement Mature Plasma Cells/Total Cells A relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to total cells in a biological specimen (for example a bone marrow specimen). Mature Plasma Cell to Total Cell Ratio Measurement Plasma Cells/Total Cells Total Plasma Cells/Total Cells A relative measurement (ratio or percentage) of the total plasma cells to total cells in a biological specimen. Plasma Cell to Total Cell Ratio Measurement HMB-45 HMB45 Melanocyte Protein PMEL Melanosomal Matrix Protein17 PMEL17 Premelanosome Protein A measurement of the premalanosome protein in a biological specimen. Melanocyte Protein PMEL Measurement Precancerous Cells Premalignant Lesions An evaluation of premalignant cells in a biological specimen. Premalignant Cell Count Premalignant Cell Morphology An examination or assessment of the form and structure of premalignant cells. Premalignant Cell Morphology Assessment Polymorphonuclear Cells in Epithelium An evaluation of polymorphonuclear cells in the epithelium in a biological specimen. Polymorphonuclear Cells in Epithelium Assessment Infilt of PMN Cells in Lamina Propria Infiltration of Polymorphonuclear Cells in Lamina Propria An evaluation of infiltration of polymorphonuclear cells in the lamina propria in a biological specimen. Infiltration of Polymorphonuclear Cells in Lamina Propria Assessment PMS1 Homolog 1 A measurement of the PMS1 mismatch repair protein in a biological specimen. PMS1 Homolog 1 Measurement PMS1 Homolog 2 A measurement of the PMS2 mismatch repair protein in a biological specimen. PMS1 Homolog 2 Measurement Proliferating Myeloid Cells/Total Cells A relative measurement (ratio or percentage) of the proliferating myeloid cells to total cells in a biological specimen. Proliferating Myeloid Cell to Total Cell Ratio Measurement Perineural Invasion An evaluation of perineural invasion in a biological specimen. Perineural Invasion Assessment Paneth Cell Metaplasia An evaluation of paneth cell metaplasia in a biological specimen. Paneth Cell Metaplasia Assessment Portal Inflammation An evaluation of portal inflammation in a biological specimen. Portal Inflammation Assessment Protein Phosphatase 1, Regulatory Subunit 130 RB Transcriptional Corepressor 1 Retinoblastoma 1 Retinoblastoma Protein A measurement of the retinoblastoma protein in a biological specimen Retinoblastoma Protein Measurement NR3C3 PGR PgR PR Progesterone Receptor A measurement of the progesterone receptor protein in a biological specimen. Progesterone Receptor Measurement Promonocytes/Total Cells A relative measurement (ratio or percentage) of the promonocytes to total cells in a biological specimen (for example a bone marrow specimen). Promonocyte to Total Cell Ratio Measurement Promyelocytes/Total Cells A relative measurement (ratio or percentage) of the promyelocytes (immature myelocytes) to total cells in a biological specimen (for example a bone marrow specimen). Promyelocyte to Total Cell Ratio Measurement Peritubular Capillaritis An evaluation of peritubular capillaritis in a biological specimen. Peritubular Capillaritis Assessment Phosphatase and Tensin Homolog A measurement of the phosphatase and tensin homolog in a biological specimen. Phosphatase and Tensin Homolog Measurement Karyopyknotic Cells Pyknotic Cells A measurement of the pyknotic cells in a biological specimen. Pyknotic Cell Count Polysaccharides and Mucosubstances A measurement of the polysaccharides and mucosubstances in a biological specimen. Polysaccharides and Mucosubstances Measurement Erythrocyte Cell Morphology RBC Morphology Red Blood Cell Morphology An examination or assessment of the form and structure of red blood cells. Erythrocyte Cell Morphology Reticulocytes/Total Cells A relative measurement (ratio or percentage) of reticulocytes to total cells in a biological specimen. Reticulocyte to Total Cell Ratio Measurement ROS Proto-oncogene 1 Protein ROS1 Protein A measurement of the ROS proto-oncogene 1 protein in a biological specimen. ROS1 Protein Measurement Reticulin Fibrosis An evaluation of reticulin fibrosis in a biological specimen. Reticulin Fibrosis Assessment S100 Calcium Binding Proteins A measurement of the S100 family of calcium binding proteins in a biological specimen. S100 Calcium Binding Protein Measurement S100 Calcium Binding Protein A7 A measurement of the S100 calcium binding protein A7 in a biological specimen. S100 Calcium Binding Protein A7 Measurement S100 Calcium-Binding Protein B A measure of the S100 calcium-binding protein B in a biological specimen. S100 Calcium-Binding Protein B Measurement CD68 CD68 Molecule GP110 SCARD1 Scavenger Receptor Class D, Member 1 A measurement of the scavenger receptor class D, member 1 in a biological specimen. Scavenger Receptor Class D, Member 1 Measurement C-Kit CD117 KIT Proto-Oncogene, Receptor Tyrosine Kinase Mast/Stem Cell Growth Factor Rec Kit Mast/Stem Cell Growth Factor Receptor Kit A measurement of the mast/stem cell growth factor receptor kit in a biological specimen. Mast/Stem Cell Growth Factor Receptor Kit Measurement Closest Surgical Margin Distance Distance to True Margin Surface Excision Margin Distance Resection Margin Distance Surgical Margin Surgical Margin Distance True Margin Surface Distance A measurement of the distance from the tumor border to the closest surgical margin. Surgical Margin Distance Measurement Surgical Margin Involvement Region The anatomical region or plane containing neoplastic tissue that has been left outside the boundary of a resected specimen within the patient. Anatomic Site for Involved Surgical Margin Surgical Margins Status The determination of the presence of actual or potential neoplastic tissue which has been left outside the boundary of a resected specimen within the patient. (NCI) Surgical Margins Status SOX-10 SRY-Box 10 SRY-Box Transcription Factor 10 A measurement of the SRY-box transcription factor 10 in a biological specimen. SRY-Box Transcription Factor 10 Measurement Stromal Cells/Total Cells A relative measurement (ratio or percentage) of the stromal cells to total cells in a biological specimen. Stromal Cell to Total Cell Ratio Measurement Steatosis Extent Steatosis Grade An evaluation of the amount or degree of steatosis (fatty tissue) in a biological specimen. Steatosis Extent Steatosis Location An evaluation of the predominant distribution pattern of steatosis (fatty tissue) in a biological specimen. Steatosis Location CD138 Molecule Heparan Sulfate Proteoglycan Fibroblast Growth Factor Receptor Syndecan 1 A measurement of the syndecan 1 in a biological specimen. Syndecan 1 Measurement Cell Surface Glycoprotein Trop-2 EGP1 Epithelial Glycoprotein-1 TROP2 Trophoblast Cell Surface Antigen 2 Tumor Assoc Calcium Signal Transducer 2 Tumor Associated Calcium Signal Transducer 2 A measurement of the tumor associated calcium signal transducer 2 in a biological specimen. Tumor Associated Calcium Signal Transducer 2 Measurement Tubule Formation An evaluation of tubule formation in a biological specimen. Tubule Formation Assessment Transforming Growth Factor Beta 1 A measurement of the transforming growth factor beta 1 in a biological specimen. Transforming Growth Factor Beta 1 Measurement Thickness The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. Thickness T-Cell Immunoreceptor with Ig and ITIM Domains TIGIT WUCAM A measurement of the T-cell immunoreceptor with Ig and ITIM domains in a biological specimen. T-Cell Immunoreceptor with Ig and ITIM Domains Measurement TIL Tumor-Infiltrating Lymphocyte Cells Tumor-Infiltrating Lymphocytes A measurement of the tumor-infiltrating lymphocyte cells in a biological specimen. Tumor-Infiltrating Lymphocyte Count Hepatitis A Virus Cellular Receptor 2 Kidney Injury Molecule-3 KIM-3 T-Cell Ig and Mucin Domain Protein 3 T-Cell Immunoglobulin And Mucin Domain 3 A measurement of the T-cell immunoglobulin and mucin domain protein 3 in a biological specimen. T-Cell Immunoglobulin and Mucin Domain Protein 3 Measurement Number of Abnormal Tissue Samples The total number of tissue samples in which a pathological abnormality has been observed. Number of Abnormal Tissue Samples Tertiary Lymphoid Structures TLSs An evaluation of tertiary lymphoid structures in a biological specimen. Tertiary Lymphoid Structure Assessment Invasive Margin Tumor Border Configuration Tumor Margin Configuration An evaluation of the morphologic appearance at the point where the tumor meets adjacent, non-tumor tissue. Tumor Margin Configuration Assessment Tumor Differentiation An evaluation of the tissue architecture of the tumor in comparison to the non-pathological tissue the tumor arose from. Tumor Differentiation Assessment Infiltrating Cancer Indicator Infiltrating Tumor Indicator Invasive Tumor Indicator Tumor Infiltration Indicator An indication as to whether tumor infiltration has occurred. Tumor Infiltration Indicator Tumor Infiltration Pattern An evaluation of the tumor infiltration pattern in a biological specimen. Tumor Infiltration Pattern Assessment CD134 Antigen OX40L Receptor T-Cell Activation Antigen OX40 TNF Receptor Superfamily Member 4 A measurement of the TNF receptor superfamily member 4 (CD134; OX40) in a biological specimen. TNF Receptor Superfamily Member 4 Measurement Transitional Cells/Tumor Cells A relative measurement (ratio or percentage) of the transitional cells to the tumor cells in a biological specimen. Transitional Cell to Tumor Cell Ratio Measurement Tubular Atrophy An evaluation of tubular atrophy in a biological specimen. Tubular Atrophy Assessment Tubulitis An evaluation of tubulitis in a biological specimen. Tubulitis Assessment Tumor Regression An evaluation of tumor regression in a biological specimen. Tumor Regression Assessment Ulceration An evaluation of ulceration in a biological specimen. Ulceration Assessment Unspecified Cells A measurement of the cells not otherwise identified or specified in a biological specimen. Count of Unspecified Cells Vascular Invasion An evaluation of vascular invasion in a biological specimen. Vascular Invasion Assessment Vascular Fibrous Intimal Thickening An evaluation of the fibrointimal thickening of vessels in a biological specimen. Vascular Fibrous Intimal Thickening Assessment Leukocytes White Blood Cells A measurement of the leukocytes in a biological specimen. Leukocyte Count Leukocyte Cell Morphology WBC Morphology White Blood Cell Morphology An examination or assessment of the form and structure of white blood cells. Leukocyte Cell Morphology Width The extent or measurement of something from side to side. (NCI) Width MITSCD SDTM Microscopic Findings Test Code CDISC SDTM Microscopic Findings Test Code Terminology Terminology for the test names concerned with the clinical findings from a specimen that are visible by microscopic analysis. Abnormal Cells A measurement of the abnormal cells in a biological specimen. Abnormal Cell Count Acidophil Bodies Acidophil Body An evaluation of acidophil bodies in a biological specimen. Acidophil Body Assessment Adequate Surgical Margins Indicator An indication as to whether there is adequate distance of apparently non-tumorous tissue from the resected tumor. Adequate Surgical Margin Indicator ALK Protein A measurement of the ALK receptor tyrosine kinase in a biological specimen. ALK Protein Measurement Alpha-Methylacyl Coenzyme A Racemase A measurement of the alpha-methylacyl coenzyme A racemase in a biological specimen. Alpha-Methylacyl Coenzyme A Racemase Measurement Androgen Receptor Variant 7 AR-V7 A measurement of the androgen receptor variant 7 in a biological specimen. Androgen Receptor Variant 7 Measurement Apoptotic Cells A measurement of the apoptotic cells in a biological specimen. Apoptotic Cell Count Apoptotic Cells/Total Cells A relative measurement (ratio or percentage) of the apoptotic cells to total cells in a biological specimen. Apoptotic Cell to Total Cell Count Architectural Changes An evaluation of tissue architectural changes in a biological specimen. Architectural Changes Assessment Area The extent of a 2-dimensional surface enclosed within a boundary. (NCI) Area Arteriolar Hyaline Thickening An evaluation of the arteriolar hyaline thickening of vessels in a biological specimen. Arteriolar Hyaline Thickening Assessment B7 Family Member, H3 B7 Homolog 3 B7 Homolog 3 Protein B7-H3 CD276 Molecule A measurement of the B7 homolog 3 protein in a biological specimen. B7 Homolog 3 Measurement B7 Family Member, H4 B7 Homolog 4 B7 Homolog 4 Protein B7 Superfamily Member 1 B7-H4 Protein B7S1 V-Set Domain Containing T Cell Activation Inhibitor 1 A measurement of the B7 homolog 4 protein in a biological specimen. B7 Homolog 4 Measurement Banff Diagnostic Category Renal The histologic evaluation and diagnosis of the type of renal allograft rejection based on kidney biopsies and the Banff Working Classification from the Banff Foundation for Allograft Pathology. (NCI) Banff Renal Diagnostic Category Assessment Basophils/Total Cells A relative measurement (ratio or percentage) of the basophils to total cells in a biological specimen (for example a bone marrow specimen). Basophil to Total Cell Ratio Measurement Apoptosis Regulator BCL-2 B-Cell Lymphoma 2 BCL-2 Bcl-2 BCL2 A measurement of BCL2 in a biological specimen. B-Cell Lymphoma 2 Measurement B-Cell Lymphoma 6 BCL-6 Bcl-6 BCL5 BCL6 BCL6 Transcription Repressor Zinc Finger And BTB Domain-Containing Protein 27 Zinc Finger Protein 51 A measurement of the B-cell lymphoma 6 protein in a biological specimen. B-Cell Lymphoma 6 Protein Measurement Beta-defensin 1 A measurement of the beta-defensin 1 in a biological specimen. Beta-defensin 1 Measurement Beta-defensin 2 A measurement of the beta-defensin 2 in a biological specimen. Beta-defensin 2 Measurement Blasts/Total Cells A relative measurement (ratio or percentage) of the blasts to total cells in a biological specimen. Blasts to Total Cells Ratio Measurement Blood Cell Lineage Hyperplasia Type The determination of the lineage of the hyperplastic blood cells in a biological specimen. Blood Cell Lineage Hyperplasia Type Assessment Blood Vessel Density An evaluation of the blood vessel density in a biological specimen. Blood Vessel Density BK-1 Receptor Bradykinin Receptor B1 A measurement of the bradykinin receptor B1 in a biological specimen. Bradykinin Receptor B1 Measurement Breast Cancer Type 1 Susceptibility Prot A measurement of BRCA1 protein in a biological specimen. Breast Cancer Type 1 Susceptibility Protein Measurement C-C Chemokine Receptor Type 8 C-C Motif Chemokine Receptor 8 CCR-8 CDw198 Antigen A measurement of the CCR8, chemokine (C-C motif) receptor type 8, in a biological specimen. C-C Chemokine Receptor Type 8 Measurement BHLH Transcription Factor c-Myc Cellular Myc MYC Proto-Oncogene Myc Proto-Oncogene Protein MYCC Tumor Protein c-myc A measurement of the c-Myc in a biological specimen. c-Myc Measurement Cadherin 6 K-Cadherin KCAD A measurement of the cadherin 6 in a biological specimen. Cadherin 6 Measurement CD3 CD3 Complex CD3 T-Cell Marker A measurement of the CD3 T-cell marker in a biological specimen. CD3 T-Cell Marker Measurement CD34 CD34 Molecule CD34 Protein CD34 Sialomucin Hematopoietic Progenitor Cell Antigen CD34 A measurement of the CD34 sialomucin in a biological specimen. CD34 Measurement CDX2 Antigen A measurement of the CDX2 antigen in a biological specimen. CDX2 Antigen Measurement Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 CEA Cell Adhesion Molecule 5 Soluble CD66e A measurement of the carcinoembryonic antigen (CEA) cell adhesion molecule 5 in a biological specimen. CEA Cell Adhesion Molecule 5 Measurement Cell Distribution An interpretive assessment of the proportion of various cell types in a biological specimen. Cell Distribution Measurement Cell Morphology An examination or assessment of the form and structure of cells. Cell Morphology Assessment Cells Total Cells A measurement of the total nucleated cells in a biological specimen. Cell Count Cellular Differentiation An evaluation of cellular maturity and specialization in a biological specimen. Cellular Differentiation Assessment Cellularity Cellularity Grade A measurement of the degree, quality or condition of cells in a biological specimen. Cellularity Measurement Chronic Inflammatory Infiltrate An evaluation of chronic inflammatory infiltrate in a biological specimen. Chronic Inflammatory Infiltrate Assessment Clonal Cells/Total Cells A relative measurement (ratio or percentage) of the clonal cells to total cells in a biological specimen (for example a bone marrow specimen). Clonal Cells to Total Cells Ratio Measurement Collagen Fibrosis An evaluation of collagen fibrosis in a biological specimen. Collagen Fibrosis Assessment Crypt Abscess An evaluation of crypt abscess in a biological specimen. Crypt Abscess Assessment Crypt Architectural Damage An evaluation of the extent of the architectural damage to the crypts in a biological specimen. Crypt Architectural Damage Assessment Cryptitis An evaluation of cryptitis in a biological specimen. Cryptitis Assessment B-Cell Lymphoma 1 Protein BCL-1 BCL1 Cyclin D1 G1/S-specific Cyclin-D1 Parathyroid Adenomatosis 1 PRAD1 A measurement of cyclin D1 in a biological specimen. Cyclin D1 Measurement Cytogenetic Examination An assessment by microscopic analysis of chromosomal and subchromosomal structure and function. Cytogenetic Analysis Cytokeratin 16 A measurement of the cytokeratin 16 in a biological specimen. Cytokeratin 16 Measurement DC Plasmacytoid Sub Plasmacytoid Dendritic Cells Sub-Population A measurement of a sub-population of plasmacytoid dendritic cells in a biological specimen. Plasmacytoid Dendritic Cell Subpopulation Count DC Plasmacytoid Plasmacytoid Dendritic Cells A measurement of the plasmacytoid dendritic cells in a biological specimen. Plasmacytoid Dendritic Cell Count Dendritic Cell-Lysosomal-Assoc Memb Prot A measurement of the dendritic cell-lysosomal-associated membrane protein in a biological specimen. Dendritic Cell Lysosomal-Associated Membrane Protein Measurement Depth of Tumor Cell Infiltration Depth of Tumor Invasion An evaluation of the downward or inward extent of tumor invasion into a tissue. Depth of Tumor Invasion Depth The extent downward or inward; the perpendicular measurement from the surface downward to determine deepness. (NCI) Depth Diagnostic A process to identify the disease, condition, or injury that explains the symptoms and signs occurring in a patient. Diagnosis Assessment Distance to Extranodal Extension A measurement of the distance of the extent of the malignant neoplasm beyond the lymph node capsule. Distance to Extranodal Extension Dysplasia An evaluation of dysplasia in a biological specimen. Dysplasia Assessment 5'-NT 5'-Nucleotidase 5'-Nucleotidase Ecto CD73 E5NT Ecto-5'-Nucleotidase A measurement of ecto-5'-nucleotidase in a biological specimen. Ecto-5'-Nucleotidase Measurement EGFR Variant Protein A measurement of the EGFR protein with a specified variation(s) (mutations, deletions, insertions, etc.) in a biological specimen. EGFR Variant Protein Measurement Eosinophils/Total Cells A relative measurement (ratio or percentage) of the eosinophils to total cells in a biological specimen (for example a bone marrow specimen). Eosinophils to Total Cell Ratio Measurement Epi RBM Lngth, Intact/Epi RBM Lngth, Tot Epithelial RBM Length, Intact/Epithelial RBM Length, Total A relative measurement (ratio or percentage) of the intact epithelial reticular basement membrane length to the total epithelial reticular basement membrane length in a biological specimen. Intact Epithelial Reticular Basement Membrane Length to Total Epithelial Reticular Basement Membrane Length Ratio Measurement Epidermal Growth Factor Receptor ERBB1 HER1 A measurement of the epidermal growth factor receptor in a biological specimen. Epidermal Growth Factor Receptor Measurement Epithelial Damage An evaluation of epithelial damage in a biological specimen. Epithelial Damage Assessment Epithelial Integrity An evaluation of the integrity of the epithelium in a biological specimen. Epithelial Integrity Assessment Erosion and/or Ulceration An evaluation of the erosion and/or ulceration in a biological specimen. Erosion and/or Ulceration Assessment Erythrocyte Cell Morphology RBC Morphology Red Blood Cell Morphology An examination or assessment of the form and structure of red blood cells. Erythrocyte Cell Morphology Erythrodysplasia Erythroid Cell Dysplasia Erythroid Dysplasia An evaluation of erythroid dysplasia in a biological specimen. Erythroid Dysplasia Assessment Erythroid Precursor Cells Erythroid Precursors A measurement of the erythroid precursors in a biological specimen. Erythroid Precursor Cell Count Erythroid Precursor Cells/Total Cells Erythroid Precursors/Total Cells A relative measurement (ratio or percentage) of the erythroid precursors to total cells in a biological specimen. Erythroid Precursor Cells to Total Cells Ratio Measurement Erythroid Cell Proliferation Erythroid Proliferation An evaluation of erythroid lineage cell proliferation in a biological specimen. Erythroid Proliferation Measurement ER ESR Estrogen Receptor Oestrogen Receptor A measurement of estrogen receptor protein in a biological specimen. Estrogen Receptor Measurement Extramural Venous Invasion An evaluation of extramural venous invasion in a biological specimen. Extramural Venous Invasion Assessment Fibroblasts A measurement of the fibroblasts in a biological specimen. Fibroblast Count Fibrosis An evaluation of fibrosis in a biological specimen. Fibrosis Assessment Folate Hydrolase 1 A measurement of the folate hydrolase 1 in a biological specimen. Folate Hydrolase 1 Measurement AIID DIETER Forkhead Box P3 Forkhead Box Protein 3 IPEX JM2 PIDX SCURFIN XPID A measurement of the forkhead box protein 3 in a biological specimen. Forkhead Box Protein P3 Measurement General Histopathologic Examination, Qualitative General Histopathological Exam, Qual A qualitative microscopic examination of tissue sections to determine the presence of pathologic finding(s). This term is intended to be used for non-targeted examinations. Qualitative Histopathologic Examination Glomerulitis An evaluation of glomerulitis in a biological specimen. Glomerulitis Assessment Glomerulopathy An evaluation of glomerulopathy in a biological specimen. Glomerulopathy Assessment Glypican 3 Glypican-3 Heparan Sulphate Proteoglycan A measurement of the glypican 3 protein in a biological specimen. Glypican 3 Measurement Goblet Cells A measurement of the goblet cells in a biological specimen. Goblet Cell Count Goblet Cells/Epithelial Cells A relative measurement (ratio or percentage) of the goblet cells to total epithelial cells in a biological specimen. Goblet Cell to Epithelial Cell Ratio Measurement Granulocyte Proliferation An evaluation of granulocyte proliferation in a biological specimen. Granulocyte Proliferation Measurement Granulocytes Segmented/Total Cells Segmented Granulocytes/Total Cells A relative measurement (ratio or percentage) of the segmented granulocytes to total cells in a biological specimen. Segmented Granulocyte to Total Cell Ratio Measurement Granuloma An evaluation of granuloma(s) in a biological specimen. Granuloma Assessment C11 CCPI CGL1 CSPB CTLA1 CTSGL1 Granzyme B HLP SECT A measurement of the granzyme B in a biological specimen. Granzyme B Measurement Hematopoietic Cells/Adipocytes Hematopoietic Cells/Fat Cells Hematopoietic Cells/Lipocytes A relative measurement (ratio) of the hematopoietic cells to adipocytes in a biological specimen. Hematopoietic Cells to Adipocytes Ratio Measurement Ballooning Degeneration Hepatocellular Ballooning An evaluation of hepatocellular ballooning in a biological specimen. Hepatocellular Ballooning Assessment c-Met Hepatocyte Growth Factor Receptor MET Proto-Oncogene, Receptor Tyrosine Kinase Tyrosine-Protein Kinase Met A measurement of the hepatocyte growth factor receptor in a biological specimen. Hepatocyte Growth Factor Receptor Measurement Histologic Type of Cancer The determination of the histologic type of cancer in a biological specimen. Histologic Type of Cancer ErbB-2 ERBB2 HER2/NEU Human Epidermal Growth Factor Receptor 2 A measurement of HER2 protein in a biological specimen. Human Epidermal Growth Factor Receptor 2 Measurement EGFR3 Erb-B2 Receptor Tyrosine Kinase 3 ErbB-3 ERBB3 ErbB3 HER3 Human Epidermal Growth Factor Receptor 3 A measurement of HER3 protein in a biological specimen. Human Epidermal Growth Factor Receptor 3 Measurement Immune Cell Infiltrate Immune Cell Infiltration An evaluation of the immune cell infiltration in a biological specimen. Immune Cell Infiltration Assessment Infilt of Mono Cells in Lamina Propria Infiltration of Mononuclear Cells in Lamina Propria An evaluation of infiltration of mononuclear cells in the lamina propria in a biological specimen. Infiltration of Mononuclear Cells in Lamina Propria Assessment Infilt of PMN Cells in Lamina Propria Infiltration of Polymorphonuclear Cells in Lamina Propria An evaluation of infiltration of polymorphonuclear cells in the lamina propria in a biological specimen. Infiltration of Polymorphonuclear Cells in Lamina Propria Assessment CD61 GP3A Integrin Subunit Beta 3 Platelet Glycoprotein IIIa A measurement of the integrin subunit beta 3 in a biological specimen. Integrin Subunit Beta 3 Measurement Intercellular Adhesion Molecule 1 Soluble CD54 A measurement of the intercellular adhesion molecule 1 in a biological specimen. Intercellular Adhesion Molecule 1 Measurement Interferon Regulatory Factor 4 Multiple Myeloma Oncogene 1 MUM1 A measurement of the interferon regulatory factor 4 protein in a biological specimen. Interferon Regulatory Factor 4 Measurement Interstitial Fibrosis An evaluation of interstitial fibrosis in a biological specimen. Interstitial Fibrosis Assessment Intimal Arteritis An evaluation of intimal arteritis in a biological specimen. Intimal Arteritis Assessment Intraepidermal Nerve Fiber Density A measurement of the intraepidermal nerve fiber density in a biological specimen. Intraepidermal Nerve Fiber Density Epithelial Lymphocytes/Enterocytes Intraepithelial Lymphocytes/Enterocytes A relative measurement (ratio or percentage) of the lymphocytes to enterocytes within the epithelium of a biological specimen. Intraepithelial Lymphocytes to Enterocytes Ratio Measurement Epithelial Neoplasia Intraepithelial Neoplasia An evaluation of intraepithelial neoplasia in a biological specimen. Intraepithelial Neoplasia Assessment FE Iron A measurement of the iron in a biological specimen. Iron Measurement Keratinocytes A measurement of the keratinocytes in a biological specimen. Keratinocyte Measurement Ki-67 KI67 MKI67 pKi-67 A measurement of the Ki-67 protein in a biological specimen. Ki67 Measurement Large Lipogranuloma An evaluation of large lipogranuloma in a biological specimen. Large Lipogranuloma Assessment Length The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI) Length Leukemic B-Lymphocytes/Total Cells A relative measurement (ratio or percentage) of the leukemic B-lymphocytes to total cells in a biological specimen. Leukemic B-Lymphocyte to Total Cell Ratio Measurement Leukocyte Cell Morphology WBC Morphology White Blood Cell Morphology An examination or assessment of the form and structure of white blood cells. Leukocyte Cell Morphology Leukocytes White Blood Cells A measurement of the leukocytes in a biological specimen. Leukocyte Count Leukoerythroblastosis An evaluation of leukoerythroblastosis in a biological specimen. Leukoerythroblastosis Measurement Lipocalin-2 Neutrophil Gelatinase-Associated Lipocalin NGAL Oncogene 24p3 A measurement of lipocalin-2 in a biological specimen. Lipocalin-2 Measurement Lobular Inflammation An evaluation of lobular inflammation in a biological specimen. Lobular Inflammation Assessment Lymph Node Extracapsular Spread An evaluation of lymph node extracapsular spread by the tumor in a biological specimen. Lymph Node Extracapsular Spread Assessment Lymph Node Involvement Indicator Positive Lymph Node Indicator An indication as to whether cancer is present in the lymph nodes. Lymph Node Involvement Indicator Lymph Node State A condition or state of a lymph node at a particular time. Lymph Node State Lymphatic Invasion An evaluation of lymphatic invasion in a biological specimen. Lymphatic Invasion Assessment CD223 Antigen LAG-3 Lymphocyte Activation Gene 3 Protein Lymphocyte Activation Gene-3 A measurement of the lymphocyte activation gene-3 protein in a biological specimen. Lymphocyte Activation Gene-3 Protein Measurement CD5 LEU1 Lymphocyte Antigen T1/Leu-1 T-Cell Surface Glycoprotein CD5 A measurement of the lymphocyte antigen T1/Leu-1 in a biological specimen. T-Cell Surface Glycoprotein CD5 Measurement Lymphocyte Function-Associated Antigen 1 A measurement of the lymphocyte function-associated antigen 1 in a biological specimen. Lymphocyte Function-Associated Antigen 1 Measurement Lymphocytes A measurement of the lymphocytes in a biological specimen. Lymphocyte Count Lymphocytes/Total Cells A relative measurement (ratio or percentage) of the lymphocytes to total cells in a biological specimen (for example a bone marrow specimen). Lymphocyte to Total Cell Ratio Measurement Lymphoid Aggregates A measurement of the lymphoid aggregates in a biological specimen. Lymphoid Aggregates Measurement Lymphoma Cells A measurement of the malignant lymphocytes in a biological specimen. Lymphoma Cell Count Lymphoma Cells/Total Cells A relative measurement (ratio or percentage) of the lymphoma cells to total cells in a biological specimen. Lymphoma Cell to Total Cell Ratio Measurement Lymphoma T+B-Lymphocytes/Total Cells A relative measurement (ratio or percentage) of the lymphoma T-lymphocytes and B-lymphocytes to total cells in a biological specimen. Lymphoma T and B-Lymphocyte to Total Cell Ratio Measurement Macrophage, Pigmented Pigmented Macrophage An evaluation of pigmented macrophages in a biological specimen. Pigmented Macrophage Assessment Mallory Body Mallory Hyaline Mallory's Hyaline Mallory-Denk Body An evaluation of Mallory bodies in a biological specimen. Mallory Body Assessment Mast Cells/Total Cells A relative measurement (ratio or percentage) of the mast cells to total cells in a biological specimen. Mast Cell to Total Cell Ratio Measurement C-Kit CD117 KIT Proto-Oncogene, Receptor Tyrosine Kinase Mast/Stem Cell Growth Factor Rec Kit Mast/Stem Cell Growth Factor Receptor Kit A measurement of the mast/stem cell growth factor receptor kit in a biological specimen. Mast/Stem Cell Growth Factor Receptor Kit Measurement Mature Plasma Cells/Total Cells A relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to total cells in a biological specimen (for example a bone marrow specimen). Mature Plasma Cell to Total Cell Ratio Measurement Erythroid Precursors/Total Cells Maturing Erythroid Cells/Total Cells Maturing Erythroid/Total Cells Total Erythroid Precursors/Total Cells A relative measurement (ratio or percentage) of the maturing erythroid cells to total cells in a biological specimen. Maturing Erythroid Cell to Total Cell Ratio Measurement Max Dimension Largest Metastatic Deposit Maximum Dimension of the Largest Metastatic Deposit A measurement of the maximum dimension (longest or widest) of the largest metastatic deposit. Maximum Dimension of Largest Metastatic Deposit Megakaryoblasts/Total Cells A relative measurement (ratio or percentage) of the megakaryoblasts to total cells in a biological specimen (for example a bone marrow specimen). Megakaryoblast to Total Cell Ratio Measurement Megakaryocyte Cell Morphology An examination or assessment of the form and structure of megakaryocyte cells. Megakaryocyte Cell Morphology Assessment Megakaryocyte Proliferation An evaluation of megakaryocyte proliferation in a biological specimen. Megakaryocyte Proliferation Measurement Megakaryocyte Pattern Distribution Megakaryocyte Topographic Distribution An interpretive assessment of the locational pattern of megakaryocytes present in a biological specimen. Megakaryocyte Topographic Distribution Assessment Megakaryocytes Sub-Population/Megakaryocytes Megakaryocytes Sub/Megakaryocytes A relative measurement (ratio or percentage) of a sub-population of megakaryocytes to total megakaryocytes in a biological specimen. Megakaryocyte Subpopulation to Megakaryocyte Ratio Measurement Megakaryocytes A measurement of the megakaryocytes per unit of a biological specimen. Megakaryocyte Count Megakaryocytic Dysplasia An evaluation of megakaryocytic dysplasia in a biological specimen. Megakaryocytic Dysplasia Assessment Megamitochondria An evaluation of megamitochondria in a biological specimen. Megamitochondria Assessment MART1 Melan-A Melanoma Antigen Recognized By T-Cells 1 A measurement of the melan-A in a biological specimen. MART-1 Antigen Measurement CD20 LEU-16 Leukocyte Surface Antigen Leu-16 Membrane Spanning 4-Domains A1 A measurement of the membrane spanning 4-domains A1 protein in a biological specimen. Membrane Spanning 4-Domains A1 Measurement Mesangial Matrix An evaluation of mesangial matrix in a biological specimen. Mesangial Matrix Assessment CAK1 Antigen Mesothelin Pre-Pro-Megakaryocyte-Potentiating Factor A measurement of the mesothelin in a biological specimen Mesothelin Measurement Metamyelocytes/Total Cells A relative measurement (ratio or percentage ) of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) to total cells in a biological specimen (for example a bone marrow specimen). Metamyelocyte to Total Cell Ratio Measurement Methylthioadenosine Phosphorylase MTA Phosphorylase MTAPase S-Methyl-5'-Thioadenosine Phosphorylase A measurement of the methylthioadenosine phosphorylase in a biological specimen Methylthioadenosine Phosphorylase Measurement Microgranuloma An evaluation of microgranuloma in a biological specimen. Microgranuloma Assessment Microscopic Examination An assessment by microscope (e.g., light, electron, confocal, etc.). Microscopic Examination Microvesicular Steatosis An evaluation of microvesicular steatosis in a biological specimen. Microvesicular Steatosis Assessment Mismatch Repair Proteins Interpretation The determination of the meaning of protein expression assessments across multiple mismatch repair proteins. Mismatch Repair Proteins Interpretation Mitotic Figure Mitotic Figures A measurement of the cells containing mitotic figures in a biological specimen. Mitotic Figure Assessment Mitotic Count Score Mitotic Score An evaluation of the mitotic score in a biological specimen. Mitotic Rate Score Mismatch Repair Proteins MMR Proteins An evaluation of the mismatch repair proteins in a biological specimen. Mismatch Repair Protein Measurement Monoblasts/Total Cells A relative measurement (ratio or percentage) of the monoblasts to total cells in a biological specimen. Monoblast to Total Cell Ratio Measurement Monocytes/Total Cells A relative measurement (ratio or percentage) of the monocytes to total cells in a biological specimen (for example a bone marrow specimen). Monocytes to Total Cell Ratio Measurement Mononuc Cell Interstitial Inflammation An evaluation of mononuclear cell interstitial inflammation in a biological specimen. Mononuclear Cell Interstitial Inflammation Assessment Mononuclear Cells Mononucleated Cells A measurement of the mononuclear cells in a biological specimen. Mononuclear Cell Count MutL Homolog 1 A measurement of the MLH1 mismatch repair protein in a biological specimen. MutL Homolog 1 Measurement MutL Homolog 3 A measurement of the MLH3 mismatch repair protein in a biological specimen. MutL Homolog 3 Measurement MutS Homolog 2 A measurement of the MSH2 mismatch repair protein in a biological specimen. MutS Homolog 2 Measurement MutS Homolog 3 A measurement of the MSH3 mismatch repair protein in a biological specimen. MutS Homolog 3 Measurement MutS Homolog 6 A measurement of the MSH6 mismatch repair protein in a biological specimen. MutS Homolog 6 Measurement Myeloblasts/Total Cells A relative measurement (ratio or percentage) of the myeloblasts to total cells in a biological specimen (for example a bone marrow specimen). Myeloblast to Total Cell Ratio Measurement Myelocytes/Total Cells A relative measurement (ratio or percentage) of the myelocytes to total cells in a biological specimen (for example a bone marrow specimen). Myelocyte to Total Cell Ratio Measurement Myelofibrosis An evaluation of myelofibrosis in a biological specimen. Myelofibrosis Assessment Myeloid Cells Sub-Population/Myeloid Cells Myeloid Cells Sub/Myeloid Cells A relative measurement (ratio or percentage) of a sub-population of myeloid cells to total myeloid cells in a biological specimen. Myeloid Cell Subpopulation to Myeloid Cell Ratio Measurement Myeloid Cell Dysplasia Myeloid Dysplasia An evaluation of myeloid dysplasia in a biological specimen. Myeloid Dysplasia Assessment Myeloid Cell Proliferation Myeloid Proliferation An evaluation of myeloid lineage cell proliferation in a biological specimen. Myeloid Proliferation Measurement Myeloid/Erythroid Ratio A relative measurement of myeloid progenitor cells to erythrocyte precursor cells in a biological specimen. Myeloid to Erythroid Ratio Measurement Nectin 4 Nectin Cell Adhesion Molecule 4 Nectin-4 A measurement of the nectin 4 in a biological specimen. Nectin 4 Measurement Neoplastic Cells A measurement of the neoplastic cells in a biological specimen. Tumor Cell Count Cancer Cellularity Neoplastic Cells/Total Cells Tumor Cells/Total Cells A relative measurement (ratio or percentage) of the neoplastic cells to total cells in a biological specimen. Cancer Cellularity Measurement CD56 Neural Cell Adhesion Molecule 1 A measurement of the neural cell adhesion molecule 1 in a biological specimen. Neural Cell Adhesion Molecule 1 Measurement Neutrophils Band Form/Total Cells A relative measurement (ratio or percentage) of the banded neutrophils to total cells in a biological specimen. Neutrophil Band Form to Total Cell Ratio Measurement Neutrophils in Epithelium An evaluation of neutrophils in the epithelium in a biological specimen. Neutrophils in Epithelium Assessment Lamina Propria Neutrophils Neutrophils in Lamina Propria An evaluation of neutrophils in the lamina propria in a biological specimen. Neutrophils in Lamina Propria Assessment Neutrophils, Segmented/Total Cells A relative measurement (ratio or percentage) of segmented neutrophils to total cells in a biological specimen. Segmented Neutrophil to Total Cell Ratio Measurement NK2 Homeobox 1 TEBP Thyroid Transcription Factor 1 TTF1 A measurement of NK2 homeobox 1 protein in a biological specimen. NK2 Homeobox 1 Measurement Nodule An evaluation of nodule(s) in a biological specimen. Nodule Assessment Normal Cells/Total Cells A relative measurement (ratio or percentage) of the normal cells to total cells in a biological specimen. Normal Cell to Total Cell Ratio Measurement Nuclear Pleomorphism An evaluation of nuclear pleomorphism in a biological specimen. Nuclear Pleomorphism Assessment Glycogenated Nuclei Nuclei, Glycogenated An evaluation of glycogenated nuclei in a biological specimen. Glycogenated Nuclei Assessment Number of Abnormal Tissue Samples The total number of tissue samples in which a pathological abnormality has been observed. Number of Abnormal Tissue Samples Number of Biopsy Specimens Affected The total number of biopsy specimens in which a finding has been observed. Number of Biopsy Specimens Affected Number of Involved Lymph Node Levels Number of Involved Lymph Node Stations Number of Positive Lymph Node Levels Number of Positive Lymph Node Stations A measurement of the number of levels of lymph nodes that contain neoplastic cells. Number of Involved Lymph Node Levels Number of Lymph Nodes Involved Number of Lymph Nodes Positive for Neoplastic Cells A measurement of the total number of lymph nodes that contain neoplastic cells. Number of Lymph Nodes Involved With Neoplastic Cells Number of Malignant Biopsy Cores A measurement of the total number of core biopsies that contain malignant tissue. (NCI) Number of Malignant Biopsy Cores Histologic Grade Overall Tumor Grade Tumor Grade An assigned tumor grade based on a defined scoring system. Histologic Grade CDK4I Cyclin Dependent Kinase Inhibitor 2A p16 p16 p16 Inhibitors of CDK4 p16-INK4a A measurement of the p16-INK4A in a biological specimen. p16-INK4A Measurement B-Cell Lineage Specific Activator Protein BSAP Paired Box 5 PAX-5 A measurement of the paired box 5 protein in a biological specimen Paired Box 5 Measurement Paneth Cell Metaplasia An evaluation of paneth cell metaplasia in a biological specimen. Paneth Cell Metaplasia Assessment PAX3-FKHR Fusion Protein A measurement of the PAX3-FKHR fusion protein in a biological specimen. PAX3-FKHR Fusion Protein Measurement Percentage of In situ Carcinoma A relative measurement (percentage) of in situ component present in a carcinoma compared to the entire malignant cellular proliferation. (NCI) Percentage of in situ Carcinoma Perineural Invasion An evaluation of perineural invasion in a biological specimen. Perineural Invasion Assessment Peritubular Capillaritis An evaluation of peritubular capillaritis in a biological specimen. Peritubular Capillaritis Assessment Phosphatase and Tensin Homolog A measurement of the phosphatase and tensin homolog in a biological specimen. Phosphatase and Tensin Homolog Measurement CD31 Antigen PECAM PECAM-1 PECAM1 Platelet And Endothelial Cell Adhesion Molecule 1 Platelet Endo Cell Adhesion Molecule 1 Platelet Endothelial Adhesion Molecule Soluble CD31 A measurement of the platelet and endothelial cell adhesion molecule 1 in a biological specimen. Platelet Endothelial Cell Adhesion Molecule 1 Measurement PMS1 Homolog 1 A measurement of the PMS1 mismatch repair protein in a biological specimen. PMS1 Homolog 1 Measurement PMS1 Homolog 2 A measurement of the PMS2 mismatch repair protein in a biological specimen. PMS1 Homolog 2 Measurement Polymorphonuclear Cells in Epithelium An evaluation of polymorphonuclear cells in the epithelium in a biological specimen. Polymorphonuclear Cells in Epithelium Assessment Polysaccharides and Mucosubstances A measurement of the polysaccharides and mucosubstances in a biological specimen. Polysaccharides and Mucosubstances Measurement Portal Inflammation An evaluation of portal inflammation in a biological specimen. Portal Inflammation Assessment Premalignant Cell Morphology An examination or assessment of the form and structure of premalignant cells. Premalignant Cell Morphology Assessment Precancerous Cells Premalignant Lesions An evaluation of premalignant cells in a biological specimen. Premalignant Cell Count HMB-45 HMB45 Melanocyte Protein PMEL Melanosomal Matrix Protein17 PMEL17 Premelanosome Protein A measurement of the premalanosome protein in a biological specimen. Melanocyte Protein PMEL Measurement NR3C3 PGR PgR PR Progesterone Receptor A measurement of the progesterone receptor protein in a biological specimen. Progesterone Receptor Measurement CD274 PD-L1 Programmed Cell Death 1 Ligand 1 Programmed Death Ligand 1 A measurement of the programmed death ligand 1 in a biological specimen. Programmed Death Ligand 1 Measurement Proliferating Myeloid Cells/Total Cells A relative measurement (ratio or percentage) of the proliferating myeloid cells to total cells in a biological specimen. Proliferating Myeloid Cell to Total Cell Ratio Measurement Promonocytes/Total Cells A relative measurement (ratio or percentage) of the promonocytes to total cells in a biological specimen (for example a bone marrow specimen). Promonocyte to Total Cell Ratio Measurement Promyelocytes/Total Cells A relative measurement (ratio or percentage) of the promyelocytes (immature myelocytes) to total cells in a biological specimen (for example a bone marrow specimen). Promyelocyte to Total Cell Ratio Measurement Prostatic Acid Phosphatase A measurement of the prostatic acid phosphatase in a biological specimen. Prostatic Acid Phosphatase Measurement Karyopyknotic Cells Pyknotic Cells A measurement of the pyknotic cells in a biological specimen. Pyknotic Cell Count Reticulin Fibrosis An evaluation of reticulin fibrosis in a biological specimen. Reticulin Fibrosis Assessment Reticulocytes/Total Cells A relative measurement (ratio or percentage) of reticulocytes to total cells in a biological specimen. Reticulocyte to Total Cell Ratio Measurement Protein Phosphatase 1, Regulatory Subunit 130 RB Transcriptional Corepressor 1 Retinoblastoma 1 Retinoblastoma Protein A measurement of the retinoblastoma protein in a biological specimen Retinoblastoma Protein Measurement ROS Proto-oncogene 1 Protein ROS1 Protein A measurement of the ROS proto-oncogene 1 protein in a biological specimen. ROS1 Protein Measurement S100 Calcium Binding Protein A7 A measurement of the S100 calcium binding protein A7 in a biological specimen. S100 Calcium Binding Protein A7 Measurement S100 Calcium Binding Proteins A measurement of the S100 family of calcium binding proteins in a biological specimen. S100 Calcium Binding Protein Measurement S100 Calcium-Binding Protein B A measure of the S100 calcium-binding protein B in a biological specimen. S100 Calcium-Binding Protein B Measurement CD68 CD68 Molecule GP110 SCARD1 Scavenger Receptor Class D, Member 1 A measurement of the scavenger receptor class D, member 1 in a biological specimen. Scavenger Receptor Class D, Member 1 Measurement Squamous Cells/Total Cells Squamous Epithelial Cells/Total Cells A relative measurement (ratio or percentage) of the squamous epithelial cells to total cells in a biological specimen. Squamous Epithelial Cells to Total Cells Ratio Measurement SOX-10 SRY-Box 10 SRY-Box Transcription Factor 10 A measurement of the SRY-box transcription factor 10 in a biological specimen. SRY-Box Transcription Factor 10 Measurement Steatosis Extent Steatosis Grade An evaluation of the amount or degree of steatosis (fatty tissue) in a biological specimen. Steatosis Extent Steatosis Location An evaluation of the predominant distribution pattern of steatosis (fatty tissue) in a biological specimen. Steatosis Location Stromal Cells/Total Cells A relative measurement (ratio or percentage) of the stromal cells to total cells in a biological specimen. Stromal Cell to Total Cell Ratio Measurement Closest Surgical Margin Distance Distance to True Margin Surface Excision Margin Distance Resection Margin Distance Surgical Margin Surgical Margin Distance True Margin Surface Distance A measurement of the distance from the tumor border to the closest surgical margin. Surgical Margin Distance Measurement Surgical Margin Involvement Region The anatomical region or plane containing neoplastic tissue that has been left outside the boundary of a resected specimen within the patient. Anatomic Site for Involved Surgical Margin Surgical Margins Status The determination of the presence of actual or potential neoplastic tissue which has been left outside the boundary of a resected specimen within the patient. (NCI) Surgical Margins Status CD138 Molecule Heparan Sulfate Proteoglycan Fibroblast Growth Factor Receptor Syndecan 1 A measurement of the syndecan 1 in a biological specimen. Syndecan 1 Measurement Hepatitis A Virus Cellular Receptor 2 Kidney Injury Molecule-3 KIM-3 T-Cell Ig and Mucin Domain Protein 3 T-Cell Immunoglobulin And Mucin Domain 3 A measurement of the T-cell immunoglobulin and mucin domain protein 3 in a biological specimen. T-Cell Immunoglobulin and Mucin Domain Protein 3 Measurement CD4 CD4 Molecule Leu-3 T-Cell Surface Antigen T4/Leu-3 A measurement of the T-cell surface antigen T4/Leu-3 in a biological specimen. T-Cell Surface Glycoprotein CD4 Measurement CD8 CD8 Complex T-Cell Surface Glycoprotein CD8 A measurement of the T-cell surface glycoprotein CD8 in a biological specimen. T-Cell Surface Glycoprotein CD8 Measurement Tertiary Lymphoid Structures TLSs An evaluation of tertiary lymphoid structures in a biological specimen. Tertiary Lymphoid Structure Assessment Thickness The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. Thickness T-Cell Immunoreceptor with Ig and ITIM Domains TIGIT WUCAM A measurement of the T-cell immunoreceptor with Ig and ITIM domains in a biological specimen. T-Cell Immunoreceptor with Ig and ITIM Domains Measurement CD134 Antigen OX40L Receptor T-Cell Activation Antigen OX40 TNF Receptor Superfamily Member 4 A measurement of the TNF receptor superfamily member 4 (CD134; OX40) in a biological specimen. TNF Receptor Superfamily Member 4 Measurement Total Assessed Cells Total Cells A measurement of the total number of cells that are observed during the evaluation, or assessed as part of the protocol-defined assay. Total Assessed Cells Count Plasma Cells/Total Cells Total Plasma Cells/Total Cells A relative measurement (ratio or percentage) of the total plasma cells to total cells in a biological specimen. Plasma Cell to Total Cell Ratio Measurement Transforming Growth Factor Beta 1 A measurement of the transforming growth factor beta 1 in a biological specimen. Transforming Growth Factor Beta 1 Measurement Transitional Cells/Tumor Cells A relative measurement (ratio or percentage) of the transitional cells to the tumor cells in a biological specimen. Transitional Cell to Tumor Cell Ratio Measurement Tubular Atrophy An evaluation of tubular atrophy in a biological specimen. Tubular Atrophy Assessment Tubule Formation An evaluation of tubule formation in a biological specimen. Tubule Formation Assessment Tubulitis An evaluation of tubulitis in a biological specimen. Tubulitis Assessment Cell Surface Glycoprotein Trop-2 EGP1 Epithelial Glycoprotein-1 TROP2 Trophoblast Cell Surface Antigen 2 Tumor Assoc Calcium Signal Transducer 2 Tumor Associated Calcium Signal Transducer 2 A measurement of the tumor associated calcium signal transducer 2 in a biological specimen. Tumor Associated Calcium Signal Transducer 2 Measurement Invasive Margin Tumor Border Configuration Tumor Margin Configuration An evaluation of the morphologic appearance at the point where the tumor meets adjacent, non-tumor tissue. Tumor Margin Configuration Assessment Tumor Differentiation An evaluation of the tissue architecture of the tumor in comparison to the non-pathological tissue the tumor arose from. Tumor Differentiation Assessment Infiltrating Cancer Indicator Infiltrating Tumor Indicator Invasive Tumor Indicator Tumor Infiltration Indicator An indication as to whether tumor infiltration has occurred. Tumor Infiltration Indicator Tumor Infiltration Pattern An evaluation of the tumor infiltration pattern in a biological specimen. Tumor Infiltration Pattern Assessment Tumor Protein p53 A measurement of the tumor protein p53 in a biological specimen. Cellular Tumor Antigen p53 Measurement Tumor Regression An evaluation of tumor regression in a biological specimen. Tumor Regression Assessment TIL Tumor-Infiltrating Lymphocyte Cells Tumor-Infiltrating Lymphocytes A measurement of the tumor-infiltrating lymphocyte cells in a biological specimen. Tumor-Infiltrating Lymphocyte Count Ulceration An evaluation of ulceration in a biological specimen. Ulceration Assessment Unspecified Cells A measurement of the cells not otherwise identified or specified in a biological specimen. Count of Unspecified Cells Vascular Fibrous Intimal Thickening An evaluation of the fibrointimal thickening of vessels in a biological specimen. Vascular Fibrous Intimal Thickening Assessment Vascular Invasion An evaluation of vascular invasion in a biological specimen. Vascular Invasion Assessment Width The extent or measurement of something from side to side. (NCI) Width MITS SDTM Microscopic Findings Test Name CDISC SDTM Microscopic Findings Test Name Terminology A terminology codelist relevant to the version of the CDISC Study Data Tabulation Model that is being used in the study submission. SDTM Version 1.1 Version 1.1 of the CDISC Study Data Tabulation Model (SDTM). CDISC SDTM Model Version 1.1 SDTM Version 1.2 Version 1.2 of the CDISC Study Data Tabulation Model (SDTM). CDISC SDTM Model Version 1.2 SDTM Version 1.3 Version 1.3 of the CDISC Study Data Tabulation Model (SDTM). CDISC SDTM Model Version 1.3 SDTM Version 1.4 Version 1.4 of the CDISC Study Data Tabulation Model (SDTM). CDISC SDTM Model Version 1.4 SDTM Version 1.5 Version 1.5 of the CDISC Study Data Tabulation Model (SDTM). CDISC SDTM Model Version 1.5 SDTM Version 1.6 Version 1.6 of the CDISC Study Data Tabulation Model (SDTM). CDISC SDTM Model Version 1.6 SDTM Version 1.7 Version 1.7 of the CDISC Study Data Tabulation Model (SDTM). CDISC SDTM Model Version 1.7 SDTM Version 2.0 Version 2.0 of the CDISC Study Data Tabulation Model (SDTM). CDISC SDTM Model Version 2.0 SDTMVRS SDTM Version Response CDISC SDTM Model Version ResponseTerminology A terminology codelist relevant to the version of the CDISC Study Data Tabulation Model implementation guide for medical devices that is being used in the study submission. SDTMIG Medical Device Version 1.0 SDTMIG-MD Version 1.0 Version 1.0 of the CDISC Study Data Tabulation Model (SDTM) Implementation Guide for medical devices. CDISC SDTM Implementation Guide Medical Device Version 1.0 SDTMIG Medical Device Version 1.1 SDTMIG-MD Version 1.1 Version 1.1 of the CDISC Study Data Tabulation Model (SDTM) Implementation Guide for medical devices. CDISC SDTM Implementation Guide Medical Device Version 1.1 SDTMDVRS SDTMIG Medical Device Version Response CDISC SDTM SDTMIG Medical Device Version Response Terminology A terminology codelist relevant to the version of the CDISC Study Data Tabulation Model implementation guide that is being used in the study submission. SDTMIG Version 3.1.1 Version 3.1.1 of the CDISC Study Data Tabulation Model (SDTM) Implementation Guide. CDISC SDTM Implementation Guide Version 3.1.1 SDTMIG Version 3.1.2 Version 3.1.2 of the CDISC Study Data Tabulation Model (SDTM) Implementation Guide. CDISC SDTM Implementation Guide Version 3.1.2 SDTMIG Version 3.1.3 Version 3.1.3 of the CDISC Study Data Tabulation Model (SDTM) Implementation Guide. CDISC SDTM Implementation Guide Version 3.1.3 SDTMIG Version 3.2 Version 3.2 of the CDISC Study Data Tabulation Model (SDTM) Implementation Guide. CDISC SDTM Implementation Guide Version 3.2 SDTMIG Version 3.3 Version 3.3 of the CDISC Study Data Tabulation Model (SDTM) Implementation Guide. CDISC SDTM Implementation Guide Version 3.3 SDTMIG Version 3.4 Version 3.4 of the CDISC Study Data Tabulation Model (SDTM) Implementation Guide. CDISC SDTM Implementation Guide Version 3.4 SDTMIG Version 3.1.2 Amendment 1 Amendment 1 of the 3.1.2 version of the CDISC Study Data Tabulation Model (SDTM) Implementation Guide. CDISC SDTM Implementation Guide Version 3.1.2 Amendment 1 SDTMIGRS SDTMIG Version Response CDISC SDTM Implementation Guide Version Response Terminology Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0101 test and test code. SOFA0101-< 100 with respiratory support (mechanical ventilation including CPAP) Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0101-PaO2/FiO2 less than 100 mmHg with respiratory support (mechanical ventilation including CPAP). Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0101 Original Result - < 100 with respiratory support (mechanical ventilation including CPAP) SOFA0101-< 200 with respiratory support (mechanical ventilation including CPAP) Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0101-PaO2/FiO2 less than 200 mmHg with respiratory support (mechanical ventilation including CPAP). Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0101 Original Result - < 200 with respiratory support (mechanical ventilation including CPAP) SOFA0101-< 300 Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0101-PaO2/FiO2 less than 300 mmHg. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0101 Original Result - < 300 SOFA0101-< 400 Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0101-PaO2/FiO2 less than 400 mmHg. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0101 Original Result - < 400 SOFA0101->= 400 Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0101-PaO2/FiO2 greater than or equal to 400 mmHg. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0101 Original Result - >= 400 SOFA0101OR Sepsis-related Organ Failure Assessment 27MAR2024 Clinical Classification ORRES for SOFA0101 TN/TC CDISC Clinical Classification Sepsis-related Organ Failure Assessment 27MAR2024 SOFA0101 Original Response Terminology Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0102 test and test code. SOFA0102-< 100 Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0102-Platelets less than 100 10^3/mm^3. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0102 Original Result - < 100 SOFA0102-< 150 Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0102-Platelets less than 150 10^3/mm^3. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0102 Original Result - < 150 SOFA0102-< 20 Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0102-Platelets less than 20 10^3/mm^3. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0102 Original Result - < 20 SOFA0102-< 50 Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0102-Platelets less than 50 10^3/mm^3. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0102 Original Result - < 50 SOFA0102->= 150 Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0102-Platelets greater than or equal to 150 10^3/mm^3. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0102 Original Result - >= 150 SOFA0102OR Sepsis-related Organ Failure Assessment 27MAR2024 Clinical Classification ORRES for SOFA0102 TN/TC CDISC Clinical Classification Sepsis-related Organ Failure Assessment 27MAR2024 SOFA0102 Original Response Terminology Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0103 test and test code. SOFA0103-1.2 - 1.9 20 - 32 Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0103-Bilirubin 1.2 - 1.9 mg/dL; 20 - 32 umol/L. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0103 Original Result - 1.2 - 1.9; 20 - 32 SOFA0103-2.0 - 5.9 33 - 101 Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0103-Bilirubin 2.0 - 5.9 mg/dL; 33 - 101 umol/L. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0103 Original Result - 2.0 - 5.9; 33 - 101 SOFA0103-6.0 - 11.9 102 - 204 Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0103-Bilirubin 6.0 - 11.9 mg/dL; 102 - 204 umol/L. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0103 Original Result - 6.0 - 11.9; 102 - 204 SOFA0103-< 1.2 < 20 Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0103-Bilirubin less than 1.2 mg/dL; less than 20 umol/L. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0103 Original Result - < 1.2; < 20 SOFA0103-> 12.0 > 204 Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0103-Bilirubin greater than 12.0 mg/dL; greater than 204 umol/L. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0103 Original Result - > 12.0; > 204 SOFA0103OR Sepsis-related Organ Failure Assessment 27MAR2024 Clinical Classification ORRES for SOFA0103 TN/TC CDISC Clinical Classification Sepsis-related Organ Failure Assessment 27MAR2024 SOFA0103 Original Response Terminology Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0104 test and test code. SOFA0104-Dopamine <= 5 Dobutamine (any dose) Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0104-Dopamine less than or equal to 5 ug/kg/min; Dobutamine (any dose) ug/kg/min. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0104 Original Result - Dopamine <= 5; Dobutamine (any dose) SOFA0104-Dopamine > 15 Epinephrine > 0.1 Norepinephrine > 0.1 Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0104-Dopamine greater than 15 ug/kg/min; Epinephrine greater than 0.1 ug/kg/min; Norepinephrine greater than 0.1 ug/kg/min. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0104 Original Result - Dopamine > 15; Epinephrine > 0.1; Norepinephrine > 0.1 SOFA0104-Dopamine > 5 Epinephrine <= 0.1 Norepinephrine <= 0.1 Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0104-Dopamine greater than 5 ug/kg/min; Epinephrine less than or equal to 0.1 ug/kg/min; Norepinephrine less than or equal to 0.1 ug/kg/min. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0104 Original Result - Dopamine > 5; Epinephrine <= 0.1; Norepinephrine <= 0.1 SOFA0104-MAP < 70 Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0104-MAP less than 70 mmHg. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0104 Original Result - MAP < 70 SOFA0104-MAP >= 70 Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0104-MAP greater than or equal to 70 mmHg. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0104 Original Result - MAP >= 70 SOFA0104OR Sepsis-related Organ Failure Assessment 27MAR2024 Clinical Classification ORRES for SOFA0104 TN/TC CDISC Clinical Classification Sepsis-related Organ Failure Assessment 27MAR2024 SOFA0104 Original Response Terminology Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0105 test and test code. SOFA0105-10 - 12 Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0105-Glasgow Coma Score 10 - 12. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0105 Original Result - 10 - 12 SOFA0105-13 - 14 Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0105-Glasgow Coma Score 13 - 14. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0105 Original Result - 13 - 14 SOFA0105-15 Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0105-Glasgow Coma Score 15. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0105 Original Result - 15 SOFA0105-6 - 9 Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0105-Glasgow Coma Score 6 - 9. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0105 Original Result - 6 - 9 SOFA0105-< 6 Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0105-Glasgow Coma Score less than 6. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0105 Original Result - < 6 SOFA0105OR Sepsis-related Organ Failure Assessment 27MAR2024 Clinical Classification ORRES for SOFA0105 TN/TC CDISC Clinical Classification Sepsis-related Organ Failure Assessment 27MAR2024 SOFA0105 Original Response Terminology Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0106 test and test code. SOFA0106-1.2 - 1.9 110 - 170 Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0106-Creatinine 1.2 - 1.9 mg/dL; 110 - 170 umol/L. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0106 Original Result - 1.2 - 1.9; 110 - 170 SOFA0106-2.0 - 3.4 171 - 299 Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0106-Creatinine 2.0 - 3.4 mg/dL; 171 - 299 umol/L. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0106 Original Result - 2.0 - 3.4; 171 - 299 SOFA0106-3.5 - 4.9 300 - 440 < 500 Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0106-Creatinine 3.5 - 4.9 mg/dL; 300 - 440 umol/L; Urine output less than 500 mL/day. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0106 Original Result -3.5 - 4.9; 300 - 440; < 500 SOFA0106-< 1.2 < 110 Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0106-Creatinine less than 1.2 mg/dL; less than 110 umol/L. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0106 Original Result - < 1.2; < 110 SOFA0106-> 5 > 440 < 200 Sepsis-related Organ Failure Assessment 27MAR2024 original result for SOFA0106-Creatinine greater than 5 mg/dL; greater than 440 umol/L; Urine output less than 200 mL/day. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0106 Original Result - > 5; > 440; < 200 SOFA0106OR Sepsis-related Organ Failure Assessment 27MAR2024 Clinical Classification ORRES for SOFA0106 TN/TC CDISC Clinical Classification Sepsis-related Organ Failure Assessment 27MAR2024 SOFA0106 Original Response Terminology Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0101 test and test code. SOFA0101-0 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0101-PaO2/FiO2 greater than or equal to 400 mmHg. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0101 Standardized Character Result 0 SOFA0101-1 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0101-PaO2/FiO2 less than 400 mmHg. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0101 Standardized Character Result 1 SOFA0101-2 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0101-PaO2/FiO2 less than 300 mmHg. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0101 Standardized Character Result 2 SOFA0101-3 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0101-PaO2/FiO2 less than 200 mmHg with respiratory support (mechanical ventilation including CPAP). Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0101 Standardized Character Result 3 SOFA0101-4 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0101-PaO2/FiO2 less than 100 mmHg with respiratory support (mechanical ventilation including CPAP). Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0101 Standardized Character Result 4 SOFA0101STR Sepsis-related Organ Failure Assessment 27MAR2024 Clinical Classification STRESC for SOFA0101 TN/TC CDISC Clinical Classification Sepsis-related Organ Failure Assessment 27MAR2024 SOFA0101 Standardized Character Response Terminology Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0102 test and test code. SOFA0102-0 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0102-Platelets greater than or equal to 150 10^3/mm^3. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0102 Standardized Character Result 0 SOFA0102-1 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0102-Platelets less than 150 10^3/mm^3. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0102 Standardized Character Result 1 SOFA0102-2 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0102-Platelets less than 100 10^3/mm^3. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0102 Standardized Character Result 2 SOFA0102-3 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0102-Platelets less than 50 10^3/mm^3. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0102 Standardized Character Result 3 SOFA0102-4 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0102-Platelets less than 20 10^3/mm^3. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0102 Standardized Character Result 4 SOFA0102STR Sepsis-related Organ Failure Assessment 27MAR2024 Clinical Classification STRESC for SOFA0102 TN/TC CDISC Clinical Classification Sepsis-related Organ Failure Assessment 27MAR2024 SOFA0102 Standardized Character Response Terminology Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0103 test and test code. SOFA0103-0 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0103-Bilirubin less than 1.2 mg/dL; less than 20 umol/L. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0103 Standardized Character Result 0 SOFA0103-1 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0103-Bilirubin 1.2 - 1.9 mg/dL; 20 - 32 umol/L. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0103 Standardized Character Result 1 SOFA0103-2 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0103-Bilirubin 2.0 - 5.9 mg/dL; 33 - 101 umol/L. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0103 Standardized Character Result 2 SOFA0103-3 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0103-Bilirubin 6.0 - 11.9 mg/dL; 102 - 204 umol/L. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0103 Standardized Character Result 3 SOFA0103-4 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0103-Bilirubin greater than 12.0 mg/dL; greater than 204 umol/L. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0103 Standardized Character Result 4 SOFA0103STR Sepsis-related Organ Failure Assessment 27MAR2024 Clinical Classification STRESC for SOFA0103 TN/TC CDISC Clinical Classification Sepsis-related Organ Failure Assessment 27MAR2024 SOFA0103 Standardized Character Response Terminology Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0104 test and test code. SOFA0104-0 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0104-MAP greater than or equal to 70 mmHg. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0104 Standardized Character Result 0 SOFA0104-1 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0104-MAP less than 70 mmHg. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0104 Standardized Character Result 1 SOFA0104-2 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0104-Dopamine less than or equal to 5 ug/kg/min; Dobutamine (any dose) ug/kg/min. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0104 Standardized Character Result 2 SOFA0104-3 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0104-Dopamine greater than 5 ug/kg/min; Epinephrine less than or equal to 0.1 ug/kg/min; Norepinephrine less than or equal to 0.1 ug/kg/min. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0104 Standardized Character Result 3 SOFA0104-4 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0104-Dopamine greater than 15 ug/kg/min; Epinephrine greater than 0.1 ug/kg/min; Norepinephrine greater than 0.1 ug/kg/min. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0104 Standardized Character Result 4 SOFA0104STR Sepsis-related Organ Failure Assessment 27MAR2024 Clinical Classification STRESC for SOFA0104 TN/TC CDISC Clinical Classification Sepsis-related Organ Failure Assessment 27MAR2024 SOFA0104 Standardized Character Response Terminology Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0105 test and test code. SOFA0105-0 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0105-Glasgow Coma Score 15. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0105 Standardized Character Result 0 SOFA0105-1 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0105-Glasgow Coma Score 13 - 14. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0105 Standardized Character Result 1 SOFA0105-2 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0105-Glasgow Coma Score 10 - 12. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0105 Standardized Character Result 2 SOFA0105-3 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0105-Glasgow Coma Score 6 - 9. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0105 Standardized Character Result 3 SOFA0105-4 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0105-Glasgow Coma Score less than 6. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0105 Standardized Character Result 4 SOFA0105STR Sepsis-related Organ Failure Assessment 27MAR2024 Clinical Classification STRESC for SOFA0105 TN/TC CDISC Clinical Classification Sepsis-related Organ Failure Assessment 27MAR2024 SOFA0105 Standardized Character Response Terminology Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0106 test and test code. SOFA0106-0 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0106-Creatinine less than 1.2 mg/dL; less than 110 umol/L. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0106 Standardized Character Result 0 SOFA0106-1 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0106-Creatinine 1.2 - 1.9 mg/dL; 110 - 170 umol/L. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0106 Standardized Character Result 1 SOFA0106-2 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0106-Creatinine 2.0 - 3.4 mg/dL; 171 - 299 umol/L. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0106 Standardized Character Result 2 SOFA0106-3 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0106-Creatinine 3.5 - 4.9 mg/dL; Creatinine 300 - 440 umol/L; Urine output less than 500 mL/day. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0106 Standardized Character Result 3 SOFA0106-4 Sepsis-related Organ Failure Assessment 27MAR2024 standardized character result for SOFA0106-Creatinine greater than 5 mg/dL; Creatinine greater than 440 umol/L; Urine output less than 200 mL/day. Sepsis-related Organ Failure Assessment 27th March 2024 Version SOFA0106 Standardized Character Result 4 SOFA0106STR Sepsis-related Organ Failure Assessment 27MAR2024 Clinical Classification STRESC for SOFA0106 TN/TC CDISC Clinical Classification Sepsis-related Organ Failure Assessment 27MAR2024 SOFA0106 Standardized Character Response Terminology Sepsis-related Organ Failure Assessment 27MAR2024 test code. SOFA01-Respiration: PaO2/FiO2 Sepsis-related Organ Failure Assessment 27MAR2024 - Respiration: PaO2/FiO2. SOFA 27th March 2024 Version - Respiration: PaO2/FiO2 SOFA01-Coagulation: Platelets Sepsis-related Organ Failure Assessment 27MAR2024 - Coagulation: platelets. SOFA 27th March 2024 Version - Coagulation: Platelets SOFA01-Liver: Bilirubin Sepsis-related Organ Failure Assessment 27MAR2024 - Liver: bilirubin. SOFA 27th March 2024 Version - Liver: Bilirubin SOFA01-Cardiovascular: Hypotension Sepsis-related Organ Failure Assessment 27MAR2024 - Cardiovascular: hypotension. SOFA 27th March 2024 Version - Cardiovascular: Hypotension SOFA01-CNS: Glasgow Coma Score Sepsis-related Organ Failure Assessment 27MAR2024 - Central Nervous System: Glasgow Coma Score. SOFA 27th March 2024 Version - CNS: Glasgow Coma Score SOFA01-Renal: Creatinine or Urine Output Sepsis-related Organ Failure Assessment 27MAR2024 - Renal: creatinine or urine output. SOFA 27th March 2024 Version - Renal: Creatinine or Urine Output SOFA01-Total SOFA Score Sepsis-related Organ Failure Assessment 27MAR2024 - Total SOFA score. SOFA 27th March 2024 Version - Total SOFA Score SOFA01TC Sepsis-related Organ Failure Assessment 27MAR2024 Clinical Classification Test Code CDISC Clinical Classification Sepsis-related Organ Failure Assessment 27th March 2024 Version Test Code Terminology Sepsis-related Organ Failure Assessment 27MAR2024 test name. SOFA01-Cardiovascular: Hypotension Sepsis-related Organ Failure Assessment 27MAR2024 - Cardiovascular: hypotension. SOFA 27th March 2024 Version - Cardiovascular: Hypotension SOFA01-CNS: Glasgow Coma Score Sepsis-related Organ Failure Assessment 27MAR2024 - Central Nervous System: Glasgow Coma Score. SOFA 27th March 2024 Version - CNS: Glasgow Coma Score SOFA01-Coagulation: Platelets Sepsis-related Organ Failure Assessment 27MAR2024 - Coagulation: platelets. SOFA 27th March 2024 Version - Coagulation: Platelets SOFA01-Liver: Bilirubin Sepsis-related Organ Failure Assessment 27MAR2024 - Liver: bilirubin. SOFA 27th March 2024 Version - Liver: Bilirubin SOFA01-Renal: Creatinine or Urine Output Sepsis-related Organ Failure Assessment 27MAR2024 - Renal: creatinine or urine output. SOFA 27th March 2024 Version - Renal: Creatinine or Urine Output SOFA01-Respiration: PaO2/FiO2 Sepsis-related Organ Failure Assessment 27MAR2024 - Respiration: PaO2/FiO2. SOFA 27th March 2024 Version - Respiration: PaO2/FiO2 SOFA01-Total SOFA Score Sepsis-related Organ Failure Assessment 27MAR2024 - Total SOFA score. SOFA 27th March 2024 Version - Total SOFA Score SOFA01TN Sepsis-related Organ Failure Assessment 27MAR2024 Clinical Classification Test Name CDISC Clinical Classification Sepsis-related Organ Failure Assessment 27th March 2024 Version Test Name Terminology Terminology relevant to a severity scale that describes the degree or intensity of a notable event or finding. Greater or bigger in degree, quality, significance, or extent. Major Slight in degree, quality, or extent. Mild The smallest value in quantity or degree in a set of values. Minimum Lesser or smaller in degree, quality, significance, or extent. Minor Middling or intermediate in degree, quality or extent. Moderate Intensely bad in degree, quality, or extent. Severe U UNK Unknown Not known, not observed, not recorded, or refused. (NCI) Unknown SEVRS Severity Response CDISC SDTM Severity Response Terminology A scale that defines the degree or state of disease existing in a patient as a result of the occurrence of an adverse event. (NCI) 1 Grade 1 A type of adverse event that is usually transient and may require only minimal treatment or therapeutic intervention. The event does not generally interfere with usual activities of daily living. Mild Adverse Event 2 Grade 2 A type of adverse event that is usually alleviated with additional specific therapeutic intervention. The event interferes with usual activities of daily living, causing discomfort but poses no significant or permanent risk of harm to the research participant. Moderate Adverse Event 3 Grade 3 A type of adverse event that interrupts usual activities of daily living, or significantly affects clinical status, or may require intensive therapeutic intervention. Severe Adverse Event AESEV Severity/Intensity Scale for Adverse Events CDISC SDTM Severity Intensity Scale for Adverse Event Terminology A terminology codelist relevant to the assemblage of physical properties or qualities by which male is distinguished from female; the physical difference between male and female; the distinguishing peculiarity of male or female. Female A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. [The NCI Thesaurus contains biomedical terminologies that NCI does not own or control. This concept contains gender-related content that does not comply with Executive Order 14168.] Female A person (one of unisexual specimens) who is born with genitalia and/or secondary sexual characteristics of indeterminate sex, or which combine features of both sexes. (NCI) Intersex Male A person who belongs to the sex that normally produces sperm. The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. [The NCI Thesaurus contains biomedical terminologies that NCI does not own or control. This concept contains gender-related content that does not comply with Executive Order 14168.] Male U UNK Unknown Not known, not observed, not recorded, or refused. (NCI) Unknown SEX Sex CDISC SDTM Sex of Individual Terminology A terminology codelist relevant to the sex assigned to a neonate. Female A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. [The NCI Thesaurus contains biomedical terminologies that NCI does not own or control. This concept contains gender-related content that does not comply with Executive Order 14168.] Female A person (one of unisexual specimens) who is born with genitalia and/or secondary sexual characteristics of indeterminate sex, or which combine features of both sexes. (NCI) Intersex Male A person who belongs to the sex that normally produces sperm. The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. [The NCI Thesaurus contains biomedical terminologies that NCI does not own or control. This concept contains gender-related content that does not comply with Executive Order 14168.] Male Not reported Not provided or available. Not Reported SEXABRTH Sex Assigned At Birth Response CDISC SDTM Sex Assigned At Birth Response Terminology A terminology codelist relevant to the specific sex, either male, female, or mixed of the subject group being studied. One and the other; relating to or being two in conjunction. (NCI) Both Female A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. [The NCI Thesaurus contains biomedical terminologies that NCI does not own or control. This concept contains gender-related content that does not comply with Executive Order 14168.] Female Male A person who belongs to the sex that normally produces sperm. The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. [The NCI Thesaurus contains biomedical terminologies that NCI does not own or control. This concept contains gender-related content that does not comply with Executive Order 14168.] Male SEXPOP Sex of Participants Response CDISC SDTM Sex of Study Group Terminology A terminology codelist relevant to the pattern of a person's emotional, romantic, and/or sexual attractions. Describes a person who experiences little or no romantic attraction to others, and/or lacks interest in forming romantic relationships. Aromantic people may still have intimate relationships. (Fenway Health) Aromantic Describes a person who experiences little or no sexual attraction to others. Asexual people may still engage in sexual activity. (Fenway Health) Asexual A sexual orientation that describes a person who is emotionally and physically attracted to women/females and men/males. Some people define bisexuality as attraction to all genders. (Fenway Health) [The NCI Thesaurus contains biomedical terminologies that NCI does not own or control. This concept contains gender-related content that does not comply with Executive Order 14168.] Bisexuality A sexual orientation describing people who are primarily emotionally and physically attracted to people of the same sex and/or gender as themselves. Commonly used to describe men who are primarily attracted to men, but can also describe women attracted to women. (Fenway Health) [The NCI Thesaurus contains biomedical terminologies that NCI does not own or control. This concept contains gender-related content that does not comply with Executive Order 14168.] Homosexuality A sexual orientation that describes a woman who is primarily emotionally and physically attracted to other women. (Fenway Health) Lesbian Not reported Not provided or available. Not Reported A sexual orientation that describes a person who is emotionally and physically attracted to people of all gender identities, or whose attractions are not related to other people's gender. (Fenway Health) [The NCI Thesaurus contains biomedical terminologies that NCI does not own or control. This concept contains gender-related content that does not comply with Executive Order 14168.] Pansexuality An umbrella term describing people who think of their sexual orientation or gender identity as outside of societal norms. Some people view the term queer as more fluid and inclusive than traditional categories for sexual orientation and gender identity. Although queer was historically used as a slur, it has been reclaimed by many as a term of empowerment. Nonetheless, some still find the term offensive. (Fenway Health) [The NCI Thesaurus contains biomedical terminologies that NCI does not own or control. This concept contains gender-related content that does not comply with Executive Order 14168.] Queer A sexual orientation that describes women who are primarily emotionally and physically attracted to men, and men who are primarily emotionally and physically attracted to women. Also referred to as straight. (Fenway health) Heterosexuality U UNK Unknown Not known, not observed, not recorded, or refused. (NCI) Unknown SEXORIRS Sexual Orientation Response CDISC SDTM Sexual Orientation Response Terminology SF-6Dv2 Health Utility Survey Acute, English Version 2.0 test code. SF6D2-Health Limit Physical Activities SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - Does your health now limit you in your physical activities? SF6D Version 2.0 Acute - Health Limit Physical Activities SF6D2-Accomplished Less Due to Problems SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - During the past week how much of the time have you accomplished less than you would like at work or during other regular daily activities as a result of your physical health or emotional problems? SF6D Version 2.0 Acute - Accomplished Less Due to Problems SF6D2-How Much Bodily Pain Have You Had SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - During the past week, how much bodily pain have you had? SF6D Version 2.0 Acute - How Much Bodily Pain Have You Had SF6D2-Time Have You Felt Worn Out SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - During the past week, how much of the time have you felt worn out? SF6D Version 2.0 Acute - Time Have You Felt Worn Out SF6D2-Interfered With Social Activities SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - During the past week, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting with friends, relatives, etc.)? SF6D Version 2.0 Acute - Interfered With Social Activities SF6D2-Time Felt Depressed/Very Nervous SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - During the past week, how much of the time have you felt depressed or very nervous? SF6D Version 2.0 Acute - Time Felt Depressed/Very Nervous SF6D2-Utility Index Score UK Weights SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - Utility index score United Kingdom weights. SF6D Version 2.0 Acute - Utility Index Score UK Weights SF6D2-Utility Index Score CN Weights SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - Utility index score Canada weights. SF6D Version 2.0 Acute - Utility Index Score CN Weights SF6D2-Utility Index Score AU Weights SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - Utility index score Australia weights. SF6D Version 2.0 Acute - Utility Index Score AU Weights SF6D2-Utility Index Score US Weights SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - Utility index score United States weights. SF6D Version 2.0 Acute - Utility Index Score US Weights SF6D2TC SF-6Dv2 Health Utility Survey Acute, English Version 2.0 Questionnaire Test Code CDISC Questionnaire SF6D Version 2.0 Acute Test Code Terminology SF-6Dv2 Health Utility Survey Acute, English Version 2.0 test name. SF6D2-Accomplished Less Due to Problems SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - During the past week how much of the time have you accomplished less than you would like at work or during other regular daily activities as a result of your physical health or emotional problems? SF6D Version 2.0 Acute - Accomplished Less Due to Problems SF6D2-Health Limit Physical Activities SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - Does your health now limit you in your physical activities? SF6D Version 2.0 Acute - Health Limit Physical Activities SF6D2-How Much Bodily Pain Have You Had SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - During the past week, how much bodily pain have you had? SF6D Version 2.0 Acute - How Much Bodily Pain Have You Had SF6D2-Interfered With Social Activities SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - During the past week, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting with friends, relatives, etc.)? SF6D Version 2.0 Acute - Interfered With Social Activities SF6D2-Time Felt Depressed/Very Nervous SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - During the past week, how much of the time have you felt depressed or very nervous? SF6D Version 2.0 Acute - Time Felt Depressed/Very Nervous SF6D2-Time Have You Felt Worn Out SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - During the past week, how much of the time have you felt worn out? SF6D Version 2.0 Acute - Time Have You Felt Worn Out SF6D2-Utility Index Score AU Weights SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - Utility index score Australia weights. SF6D Version 2.0 Acute - Utility Index Score AU Weights SF6D2-Utility Index Score CN Weights SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - Utility index score Canada weights. SF6D Version 2.0 Acute - Utility Index Score CN Weights SF6D2-Utility Index Score UK Weights SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - Utility index score United Kingdom weights. SF6D Version 2.0 Acute - Utility Index Score UK Weights SF6D2-Utility Index Score US Weights SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - Utility index score United States weights. SF6D Version 2.0 Acute - Utility Index Score US Weights SF6D2TN SF-6Dv2 Health Utility Survey Acute, English Version 2.0 Questionnaire Test Name CDISC Questionnaire SF6D Version 2.0 Acute Test Name Terminology SF-6Dv2 Health Utility Survey Standard, English Version 2.0 test code. SF6D1-Health Limit Physical Activities SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - Does your health now limit you in your physical activities? SF6D Version 2.0 Standard - Health Limit Physical Activities SF6D1-Accomplished Less Due to Problems SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - During the past 4 weeks, how much of the time have you accomplished less than you would like at work or during other regular daily activities as a result of your physical health or emotional problems? SF6D Version 2.0 Standard - Accomplished Less Due to Problems SF6D1-How Much Bodily Pain Have You Had SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - During the past 4 weeks, how much bodily pain have you had? SF6D Version 2.0 Standard - How Much Bodily Pain Have You Had SF6D1-Time Have You Felt Worn Out SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - During the past 4 weeks, how much of the time have you felt worn out? SF6D Version 2.0 Standard - Time Have You Felt Worn Out SF6D1-Interfered With Social Activities SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting with friends, relatives, etc.)? SF6D Version 2.0 Standard - Interfered With Social Activities SF6D1-Time Felt Depressed/Very Nervous SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - During the past 4 weeks, how much of the time have you felt depressed or very nervous? SF6D Version 2.0 Standard - Time Felt Depressed/Very Nervous SF6D1-Utility Index Score UK Weights SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - Utility index score United Kingdom weights. SF6D Version 2.0 Standard - Utility Index Score UK Weights SF6D1-Utility Index Score CN Weights SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - Utility index score Canada weights. SF6D Version 2.0 Standard - Utility Index Score CN Weights SF6D1-Utility Index Score AU Weights SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - Utility index score Australia weights. SF6D Version 2.0 Standard - Utility Index Score AU Weights SF6D1-Utility Index Score US Weights SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - Utility index score United States weights. SF6D Version 2.0 Standard - Utility Index Score US Weights SF6D1TC SF-6Dv2 Health Utility Survey Standard, English Version 2.0 Questionnaire Test Code CDISC Questionnaire SF6D Version 2.0 Standard Test Code Terminology SF-6Dv2 Health Utility Survey Standard, English Version 2.0 test name. SF6D1-Accomplished Less Due to Problems SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - During the past 4 weeks, how much of the time have you accomplished less than you would like at work or during other regular daily activities as a result of your physical health or emotional problems? SF6D Version 2.0 Standard - Accomplished Less Due to Problems SF6D1-Health Limit Physical Activities SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - Does your health now limit you in your physical activities? SF6D Version 2.0 Standard - Health Limit Physical Activities SF6D1-How Much Bodily Pain Have You Had SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - During the past 4 weeks, how much bodily pain have you had? SF6D Version 2.0 Standard - How Much Bodily Pain Have You Had SF6D1-Interfered With Social Activities SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting with friends, relatives, etc.)? SF6D Version 2.0 Standard - Interfered With Social Activities SF6D1-Time Felt Depressed/Very Nervous SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - During the past 4 weeks, how much of the time have you felt depressed or very nervous? SF6D Version 2.0 Standard - Time Felt Depressed/Very Nervous SF6D1-Time Have You Felt Worn Out SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - During the past 4 weeks, how much of the time have you felt worn out? SF6D Version 2.0 Standard - Time Have You Felt Worn Out SF6D1-Utility Index Score AU Weights SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - Utility index score Australia weights. SF6D Version 2.0 Standard - Utility Index Score AU Weights SF6D1-Utility Index Score CN Weights SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - Utility index score Canada weights. SF6D Version 2.0 Standard - Utility Index Score CN Weights SF6D1-Utility Index Score UK Weights SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - Utility index score United Kingdom weights. SF6D Version 2.0 Standard - Utility Index Score UK Weights SF6D1-Utility Index Score US Weights SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - Utility index score United States weights. SF6D Version 2.0 Standard - Utility Index Score US Weights SF6D1TN SF-6Dv2 Health Utility Survey Standard, English Version 2.0 Questionnaire Test Name CDISC Questionnaire SF6D Version 2.0 Standard Test Name Terminology Sheehan Disability Scale test code. SDS01-Work/School Sheehan Disability Scale - The symptoms have disrupted your work/school work. SDS - Symptoms Disrupted Work/School Work SDS01-No Work/Study - Unrelated Disorder Sheehan Disability Scale - I have not worked/studied at all during the past week for reasons unrelated to the disorder. SDS - Not Worked/Studied in Past Week for Reason Unrelated to Disorder SDS01-Social Life Sheehan Disability Scale - The symptoms have disrupted your social life/leisure activities. SDS - Symptoms Disrupted Social Life/Leisure Activities SDS01-Family Life/Home Responsibilities Sheehan Disability Scale - The symptoms have disrupted your family life/home responsibilities. SDS - Symptoms Disrupted Family Life/Home Responsibilities SDS01-Days Lost Sheehan Disability Scale - On how many days in the last week did your symptoms cause you to miss school or work or leave you unable to carry out your normal daily responsibilities? SDS - Days Lost SDS01-Days Underproductive Sheehan Disability Scale - On how many days in the last week did you feel so impaired by your symptoms, that even though you went to school or work or had other daily responsibilities, your productivity was reduced? SDS - Days Underproductive SDS01TC Sheehan Disability Scale Questionnaire Test Code CDISC Questionnaire SDS Test Code Terminology Sheehan Disability Scale test name. SDS01-Days Lost Sheehan Disability Scale - On how many days in the last week did your symptoms cause you to miss school or work or leave you unable to carry out your normal daily responsibilities? SDS - Days Lost SDS01-Days Underproductive Sheehan Disability Scale - On how many days in the last week did you feel so impaired by your symptoms, that even though you went to school or work or had other daily responsibilities, your productivity was reduced? SDS - Days Underproductive SDS01-Family Life/Home Responsibilities Sheehan Disability Scale - The symptoms have disrupted your family life/home responsibilities. SDS - Symptoms Disrupted Family Life/Home Responsibilities SDS01-No Work/Study - Unrelated Disorder Sheehan Disability Scale - I have not worked/studied at all during the past week for reasons unrelated to the disorder. SDS - Not Worked/Studied in Past Week for Reason Unrelated to Disorder SDS01-Social Life Sheehan Disability Scale - The symptoms have disrupted your social life/leisure activities. SDS - Symptoms Disrupted Social Life/Leisure Activities SDS01-Work/School Sheehan Disability Scale - The symptoms have disrupted your work/school work. SDS - Symptoms Disrupted Work/School Work SDS01TN Sheehan Disability Scale Questionnaire Test Name CDISC Questionnaire SDS Test Name Terminology Short Form 10 Health Survey for Children Acute, US Version 1.0 test code. SF102-In General You Say Child Health Is The Short Form 10 Health Survey Children Acute, US Version 1.0 - In general, would you say your child's health is. SF10 v1.0 Children Acute - In General You Say Child Health Is SF102-Doing Things That Take Some Energy The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, has your child been limited in any of the following activities due to HEALTH problems - Doing things that take some energy such as riding a bike or skating? SF10 v1.0 Children Acute - Doing Things That Take Some Energy SF102-Bending/Lifting/Stooping The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, has your child been limited in any of the following activities due to HEALTH problems - bending, lifting, or stooping? SF10 v1.0 Children Acute - Bending, Lifting, Stooping SF102-Physical: Schoolwork/Activities The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, has your child been limited in the KIND of schoolwork or activities with friends he/she could do because of PHYSICAL health problems? SF10 v1.0 Children Acute - Physical: Schoolwork, Activities SF102-Emotional: Schoolwork/Activities The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, has your child been limited in the KIND of schoolwork or activities with friends he/she could do because of EMOTIONAL or BEHAVIORAL problems? SF10 v1.0 Children Acute - Emotional: Schoolwork, Activities SF102-How Much Bodily Pain Child Had The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, how much bodily pain or discomfort has your child had? SF10 v1.0 Children Acute - How Much Bodily Pain Child Had SF102-Felt About His/Her Friendships The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, how satisfied do you think your child has felt about his/her friendships? SF10 v1.0 Children Acute - Felt About His/Her Friendships SF102-Felt About His/Her Life Overall The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, how satisfied do you think your child has felt about his/her life overall? SF10 v1.0 Children Acute - Felt About His/Her Life Overall SF102-Acted Bothered or Upset The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, how much of the time do you think your child acted bothered or upset? SF10 v1.0 Children Acute - Acted Bothered or Upset SF102-His/Her Behavior Is The Short Form 10 Health Survey Children Acute, US Version 1.0 - Compared to other children your child's age, in general would you say his/her behavior is. SF10 v1.0 Children Acute - His/Her Behavior Is SF102TC Short Form 10 Health Survey for Children Acute, US Version 1.0 Questionnaire Test Code CDISC Questionnaire SF10 v1.0 Children Acute Test Code Terminology Short Form 10 Health Survey for Children Acute, US Version 1.0 test name. SF102-Acted Bothered or Upset The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, how much of the time do you think your child acted bothered or upset? SF10 v1.0 Children Acute - Acted Bothered or Upset SF102-Bending/Lifting/Stooping The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, has your child been limited in any of the following activities due to HEALTH problems - bending, lifting, or stooping? SF10 v1.0 Children Acute - Bending, Lifting, Stooping SF102-Doing Things That Take Some Energy The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, has your child been limited in any of the following activities due to HEALTH problems - Doing things that take some energy such as riding a bike or skating? SF10 v1.0 Children Acute - Doing Things That Take Some Energy SF102-Emotional: Schoolwork/Activities The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, has your child been limited in the KIND of schoolwork or activities with friends he/she could do because of EMOTIONAL or BEHAVIORAL problems? SF10 v1.0 Children Acute - Emotional: Schoolwork, Activities SF102-Felt About His/Her Friendships The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, how satisfied do you think your child has felt about his/her friendships? SF10 v1.0 Children Acute - Felt About His/Her Friendships SF102-Felt About His/Her Life Overall The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, how satisfied do you think your child has felt about his/her life overall? SF10 v1.0 Children Acute - Felt About His/Her Life Overall SF102-His/Her Behavior Is The Short Form 10 Health Survey Children Acute, US Version 1.0 - Compared to other children your child's age, in general would you say his/her behavior is. SF10 v1.0 Children Acute - His/Her Behavior Is SF102-How Much Bodily Pain Child Had The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, how much bodily pain or discomfort has your child had? SF10 v1.0 Children Acute - How Much Bodily Pain Child Had SF102-In General You Say Child Health Is The Short Form 10 Health Survey Children Acute, US Version 1.0 - In general, would you say your child's health is. SF10 v1.0 Children Acute - In General You Say Child Health Is SF102-Physical: Schoolwork/Activities The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, has your child been limited in the KIND of schoolwork or activities with friends he/she could do because of PHYSICAL health problems? SF10 v1.0 Children Acute - Physical: Schoolwork, Activities SF102TN Short Form 10 Health Survey for Children Acute, US Version 1.0 Questionnaire Test Name CDISC Questionnaire SF10 v1.0 Children Acute Test Name Terminology Short Form 10 Health Survey for Children Standard, US Version 1.0 test code. SF101-In General You Say Child Health Is The Short Form 10 Health Survey Children Standard, US Version 1.0 - In general, would you say your child's health is. SF10 v1.0 Children Standard - In General You Say Child Health Is SF101-Doing Things That Take Some Energy The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, has your child been limited in any activities due to HEALTH problems - Doing things that take some energy such as riding a bike or skating? SF10 v1.0 Children Standard - Doing Things That Take Some Energy SF101-Bending/Lifting/Stooping The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, has your child been limited in any activities due to HEALTH problems - bending, lifting, or stooping? SF10 v1.0 Children Standard - Bending, Lifting, Stooping SF101-Physical: Schoolwork/Activities The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, has your child been limited in the KIND of schoolwork or activities with friends he/she could do because of PHYSICAL health problems? SF10 v1.0 Children Standard - Physical: Schoolwork, Activities SF101-Emotional: Schoolwork/Activities The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, has your child been limited in the KIND of schoolwork or activities with friends he/she could do because of EMOTIONAL or BEHAVIORAL problems?. SF10 v1.0 Children Standard - Emotional: Schoolwork, Activities SF101-How Much Bodily Pain Child Had The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, how much bodily pain or discomfort has your child had? SF10 v1.0 Children Standard - How Much Bodily Pain Child Had SF101-Felt About His/Her Friendships The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, how satisfied do you think your child has felt about his/her friendships? SF10 v1.0 Children Standard - Felt About His/Her Friendships SF101-Felt About His/Her Life Overall The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, how satisfied do you think your child has felt about his/her life overall? SF10 v1.0 Children Standard - Felt About His/Her Life Overall SF101-Acted Bothered or Upset The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, how much of the time do you think your child acted bothered or upset? SF10 v1.0 Children Standard - Acted Bothered or Upset SF101-His/Her Behavior Is The Short Form 10 Health Survey Children Standard, US Version 1.0 - Compared to other children your child's age, in general would you say his/her behavior is. SF10 v1.0 Children Standard - His/Her Behavior Is SF101TC Short Form 10 Health Survey for Children Standard, US Version 1.0 Questionnaire Test Code CDISC Questionnaire SF10 v1.0 Children Standard Test Code Terminology Short Form 10 Health Survey for Children Standard, US Version 1.0 test name. SF101-Acted Bothered or Upset The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, how much of the time do you think your child acted bothered or upset? SF10 v1.0 Children Standard - Acted Bothered or Upset SF101-Bending/Lifting/Stooping The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, has your child been limited in any activities due to HEALTH problems - bending, lifting, or stooping? SF10 v1.0 Children Standard - Bending, Lifting, Stooping SF101-Doing Things That Take Some Energy The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, has your child been limited in any activities due to HEALTH problems - Doing things that take some energy such as riding a bike or skating? SF10 v1.0 Children Standard - Doing Things That Take Some Energy SF101-Emotional: Schoolwork/Activities The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, has your child been limited in the KIND of schoolwork or activities with friends he/she could do because of EMOTIONAL or BEHAVIORAL problems?. SF10 v1.0 Children Standard - Emotional: Schoolwork, Activities SF101-Felt About His/Her Friendships The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, how satisfied do you think your child has felt about his/her friendships? SF10 v1.0 Children Standard - Felt About His/Her Friendships SF101-Felt About His/Her Life Overall The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, how satisfied do you think your child has felt about his/her life overall? SF10 v1.0 Children Standard - Felt About His/Her Life Overall SF101-His/Her Behavior Is The Short Form 10 Health Survey Children Standard, US Version 1.0 - Compared to other children your child's age, in general would you say his/her behavior is. SF10 v1.0 Children Standard - His/Her Behavior Is SF101-How Much Bodily Pain Child Had The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, how much bodily pain or discomfort has your child had? SF10 v1.0 Children Standard - How Much Bodily Pain Child Had SF101-In General You Say Child Health Is The Short Form 10 Health Survey Children Standard, US Version 1.0 - In general, would you say your child's health is. SF10 v1.0 Children Standard - In General You Say Child Health Is SF101-Physical: Schoolwork/Activities The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, has your child been limited in the KIND of schoolwork or activities with friends he/she could do because of PHYSICAL health problems? SF10 v1.0 Children Standard - Physical: Schoolwork, Activities SF101TN Short Form 10 Health Survey for Children Standard, US Version 1.0 Questionnaire Test Name CDISC Questionnaire SF10 v1.0 Children Standard Test Name Terminology Short Form 12 Health Survey Acute, US Version 1.0 test code. SF122-In General You Say Your Health Is The Short Form 12 Health Survey Acute, US Version 1.0 - In general, would you say your health is. SF12 v1.0 Acute - In General You Say Your Health Is SF122-Limit Moderate Activities The Short Form 12 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. SF12 v1.0 Acute - Limit Moderate Activities SF122-Limit Climbing Several Flights The Short Form 12 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - climbing several flights of stairs. SF12 v1.0 Acute - Limit Climbing Several Flights SF122-Physical: Accomplished Less The Short Form 12 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. SF12 v1.0 Acute - Physical: Accomplished Less SF122-Physical: Limited Kind of Work The Short Form 12 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. SF12 v1.0 Acute - Physical: Limited Kind of Work SF122-Emotional: Accomplished Less The Short Form 12 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. SF12 v1.0 Acute - Emotional: Accomplished Less SF122-Emotional: Did Work Less Carefully The Short Form 12 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. SF12 v1.0 Acute - Emotional: Did Work Less Carefully SF122-Pain Interfere With Normal Work The Short Form 12 Health Survey Acute, US Version 1.0 - During the past week, how much did pain interfere with your normal work (including both work outside the home and housework)? SF12 v1.0 Acute - Pain Interfere With Normal Work SF122-Have You Felt Calm and Peaceful The Short Form 12 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt calm and peaceful? SF12 v1.0 Acute - Have You Felt Calm and Peaceful SF122-Did You Have a Lot of Energy The Short Form 12 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you have a lot of energy? SF12 v1.0 Acute - Did You Have a Lot of Energy SF122-You Felt Downhearted and Blue The Short Form 12 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt downhearted and blue? SF12 v1.0 Acute - You Felt Downhearted and Blue SF122-Time Phys/Emotional Interfered The Short Form 12 Health Survey Acute, US Version 1.0 - During the past week, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting friends, relatives, etc.)? SF12 v1.0 Acute - Time Physical Health, Emotional Interfered SF122-Physical Component Score The Short Form 12 Health Survey Acute, US Version 1.0 - Physical component score. SF12 v1.0 Acute - Physical Component Score SF122-Mental Component Score The Short Form 12 Health Survey Acute, US Version 1.0 - Mental component score. SF12 v1.0 Acute - Mental Component Score SF122-SF-6D_R2 (Util Index Rel 2) Score The Short Form 12 Health Survey Acute, US Version 1.0 - SF-6D_R2 (utility index release 2) score. SF12 v1.0 Acute - SF-6D_R2 Score SF122TC Short Form 12 Health Survey Acute, US Version 1.0 Questionnaire Test Code CDISC Questionnaire SF12 v1.0 Acute Test Code Terminology Short Form 12 Health Survey Acute, US Version 1.0 test name. SF122-Did You Have a Lot of Energy The Short Form 12 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you have a lot of energy? SF12 v1.0 Acute - Did You Have a Lot of Energy SF122-Emotional: Accomplished Less The Short Form 12 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. SF12 v1.0 Acute - Emotional: Accomplished Less SF122-Emotional: Did Work Less Carefully The Short Form 12 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. SF12 v1.0 Acute - Emotional: Did Work Less Carefully SF122-Have You Felt Calm and Peaceful The Short Form 12 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt calm and peaceful? SF12 v1.0 Acute - Have You Felt Calm and Peaceful SF122-In General You Say Your Health Is The Short Form 12 Health Survey Acute, US Version 1.0 - In general, would you say your health is. SF12 v1.0 Acute - In General You Say Your Health Is SF122-Limit Climbing Several Flights The Short Form 12 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - climbing several flights of stairs. SF12 v1.0 Acute - Limit Climbing Several Flights SF122-Limit Moderate Activities The Short Form 12 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. SF12 v1.0 Acute - Limit Moderate Activities SF122-Mental Component Score The Short Form 12 Health Survey Acute, US Version 1.0 - Mental component score. SF12 v1.0 Acute - Mental Component Score SF122-Pain Interfere With Normal Work The Short Form 12 Health Survey Acute, US Version 1.0 - During the past week, how much did pain interfere with your normal work (including both work outside the home and housework)? SF12 v1.0 Acute - Pain Interfere With Normal Work SF122-Physical Component Score The Short Form 12 Health Survey Acute, US Version 1.0 - Physical component score. SF12 v1.0 Acute - Physical Component Score SF122-Physical: Accomplished Less The Short Form 12 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. SF12 v1.0 Acute - Physical: Accomplished Less SF122-Physical: Limited Kind of Work The Short Form 12 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. SF12 v1.0 Acute - Physical: Limited Kind of Work SF122-SF-6D_R2 (Util Index Rel 2) Score The Short Form 12 Health Survey Acute, US Version 1.0 - SF-6D_R2 (utility index release 2) score. SF12 v1.0 Acute - SF-6D_R2 Score SF122-Time Phys/Emotional Interfered The Short Form 12 Health Survey Acute, US Version 1.0 - During the past week, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting friends, relatives, etc.)? SF12 v1.0 Acute - Time Physical Health, Emotional Interfered SF122-You Felt Downhearted and Blue The Short Form 12 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt downhearted and blue? SF12 v1.0 Acute - You Felt Downhearted and Blue SF122TN Short Form 12 Health Survey Acute, US Version 1.0 Questionnaire Test Name CDISC Questionnaire SF12 v1.0 Acute Test Name Terminology Short Form 12 Health Survey Acute, US Version 2.0 test code. SF124-In General You Say Your Health Is The Short Form 12 Health Survey Acute, US Version 2.0 - In general, would you say your health is. SF12 v2.0 Acute - In General You Say Your Health Is SF124-Limit Moderate Activities The Short Form 12 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. SF12 v2.0 Acute - Limit Moderate Activities SF124-Limit Climbing Several Flights The Short Form 12 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - climbing several flights of stairs. SF12 v2.0 Acute - Limit Climbing Several Flights SF124-Physical: Accomplished Less The Short Form 12 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. SF12 v2.0 Acute - Physical: Accomplished Less SF124-Physical: Limited Kind of Work The Short Form 12 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. SF12 v2.0 Acute - Physical: Limited Kind of Work SF124-Emotional: Accomplished Less The Short Form 12 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. SF12 v2.0 Acute - Emotional: Accomplished Less SF124-Emotional: Did Work Less Carefully The Short Form 12 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. SF12 v2.0 Acute - Emotional: Did Work Less Carefully SF124-Pain Interfere With Normal Work The Short Form 12 Health Survey Acute, US Version 2.0 - During the past week, how much did pain interfere with your normal work (including both work outside the home and housework)? SF12 v2.0 Acute - Pain Interfere With Normal Work SF124-Have You Felt Calm and Peaceful The Short Form 12 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt calm and peaceful? SF12 v2.0 Acute - Have You Felt Calm and Peaceful SF124-Did You Have a Lot of Energy The Short Form 12 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you have a lot of energy? SF12 v2.0 Acute - Did You Have a Lot of Energy SF124-You Felt Downhearted and Depressed The Short Form 12 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt downhearted and depressed? SF12 v2.0 Acute - You Felt Downhearted and Depressed SF124-Time Phys/Emotional Interfered The Short Form 12 Health Survey Acute, US Version 2.0 - During the past week, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting with friends, relatives, etc.)? SF12 v2.0 Acute - Time Physical Health, Emotional Interfered SF124-Physical Functioning 0-100 Score The Short Form 12 Health Survey Acute, US Version 2.0 - Physical functioning 0-100 score. SF12 v2.0 Acute - Physical Functioning 0-100 Score SF124-Role Physical 0-100 Score The Short Form 12 Health Survey Acute, US Version 2.0 - Role physical 0-100 score. SF12 v2.0 Acute - Role Physical 0-100 Score SF124-Bodily Pain 0-100 Score The Short Form 12 Health Survey Acute, US Version 2.0 - Bodily pain 0-100 score. SF12 v2.0 Acute - Bodily Pain 0-100 Score SF124-General Health 0-100 Score The Short Form 12 Health Survey Acute, US Version 2.0 - General health 0-100 score. SF12 v2.0 Acute - General Health 0-100 Score SF124-Vitality 0-100 Score The Short Form 12 Health Survey Acute, US Version 2.0 - Vitality 0-100 score. SF12 v2.0 Acute - Vitality 0-100 Score SF124-Social Functioning 0-100 Score The Short Form 12 Health Survey Acute, US Version 2.0 - Social functioning 0-100 score. SF12 v2.0 Acute - Social Functioning 0-100 Score SF124-Role Emotional 0-100 Score The Short Form 12 Health Survey Acute, US Version 2.0 - Role emotional 0-100 score. SF12 v2.0 Acute - Role Emotional 0-100 Score SF124-Mental Health 0-100 Score The Short Form 12 Health Survey Acute, US Version 2.0 - Mental health 0-100 score. SF12 v2.0 Acute - Mental Health 0-100 Score SF124-Phys Functioning Norm-Based Score The Short Form 12 Health Survey Acute, US Version 2.0 - Physical functioning norm-based score. SF12 v2.0 Acute - Phys Functioning Norm-Based Score SF124-Role Physical Norm-Based Score The Short Form 12 Health Survey Acute, US Version 2.0 - Role physical norm-based score. SF12 v2.0 Acute - Role Physical Norm-Based Score SF124-Bodily Pain Norm-Based Score The Short Form 12 Health Survey Acute, US Version 2.0 - Bodily pain norm-based score. SF12 v2.0 Acute - Bodily Pain Norm-Based Score SF124-General Health Norm-Based Score The Short Form 12 Health Survey Acute, US Version 2.0 - General health norm-based score. SF12 v2.0 Acute - General Health Norm-Based Score SF124-Vitality Norm-Based Score The Short Form 12 Health Survey Acute, US Version 2.0 - Vitality norm-based score. SF12 v2.0 Acute - Vitality Norm-Based Score SF124-Social Function Norm-Based Score The Short Form 12 Health Survey Acute, US Version 2.0 - Social function norm-based score. SF12 v2.0 Acute - Social Function Norm-Based Score SF124-Role Emotional Norm-Based Score The Short Form 12 Health Survey Acute, US Version 2.0 - Role emotional norm-based score. SF12 v2.0 Acute - Role Emotional Norm-Based Score SF124-Mental Health Norm-Based Score The Short Form 12 Health Survey Acute, US Version 2.0 - Mental health norm-based score. SF12 v2.0 Acute - Mental Health Norm-Based Score SF124-Physical Component Score The Short Form 12 Health Survey Acute, US Version 2.0 - Physical component score. SF12 v2.0 Acute - Physical Component Score SF124-Mental Component Score The Short Form 12 Health Survey Acute, US Version 2.0 - Mental component score. SF12 v2.0 Acute - Mental Component Score SF124-SF-6D_R2 (Util Index Rel 2) Score The Short Form 12 Health Survey Acute, US Version 2.0 - SF-6D_R2 (utility index release 2) score. SF12 v2.0 Acute - SF-6D_R2 (Util Index Rel 2) Score SF124TC Short Form 12 Health Survey Acute, US Version 2.0 Questionnaire Test Code CDISC Questionnaire SF12 v2.0 Acute Test Code Terminology Short Form 12 Health Survey Acute, US Version 2.0 test name. SF124-Bodily Pain 0-100 Score The Short Form 12 Health Survey Acute, US Version 2.0 - Bodily pain 0-100 score. SF12 v2.0 Acute - Bodily Pain 0-100 Score SF124-Bodily Pain Norm-Based Score The Short Form 12 Health Survey Acute, US Version 2.0 - Bodily pain norm-based score. SF12 v2.0 Acute - Bodily Pain Norm-Based Score SF124-Did You Have a Lot of Energy The Short Form 12 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you have a lot of energy? SF12 v2.0 Acute - Did You Have a Lot of Energy SF124-Emotional: Accomplished Less The Short Form 12 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. SF12 v2.0 Acute - Emotional: Accomplished Less SF124-Emotional: Did Work Less Carefully The Short Form 12 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. SF12 v2.0 Acute - Emotional: Did Work Less Carefully SF124-General Health 0-100 Score The Short Form 12 Health Survey Acute, US Version 2.0 - General health 0-100 score. SF12 v2.0 Acute - General Health 0-100 Score SF124-General Health Norm-Based Score The Short Form 12 Health Survey Acute, US Version 2.0 - General health norm-based score. SF12 v2.0 Acute - General Health Norm-Based Score SF124-Have You Felt Calm and Peaceful The Short Form 12 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt calm and peaceful? SF12 v2.0 Acute - Have You Felt Calm and Peaceful SF124-In General You Say Your Health Is The Short Form 12 Health Survey Acute, US Version 2.0 - In general, would you say your health is. SF12 v2.0 Acute - In General You Say Your Health Is SF124-Limit Climbing Several Flights The Short Form 12 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - climbing several flights of stairs. SF12 v2.0 Acute - Limit Climbing Several Flights SF124-Limit Moderate Activities The Short Form 12 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. SF12 v2.0 Acute - Limit Moderate Activities SF124-Mental Component Score The Short Form 12 Health Survey Acute, US Version 2.0 - Mental component score. SF12 v2.0 Acute - Mental Component Score SF124-Mental Health 0-100 Score The Short Form 12 Health Survey Acute, US Version 2.0 - Mental health 0-100 score. SF12 v2.0 Acute - Mental Health 0-100 Score SF124-Mental Health Norm-Based Score The Short Form 12 Health Survey Acute, US Version 2.0 - Mental health norm-based score. SF12 v2.0 Acute - Mental Health Norm-Based Score SF124-Pain Interfere With Normal Work The Short Form 12 Health Survey Acute, US Version 2.0 - During the past week, how much did pain interfere with your normal work (including both work outside the home and housework)? SF12 v2.0 Acute - Pain Interfere With Normal Work SF124-Phys Functioning Norm-Based Score The Short Form 12 Health Survey Acute, US Version 2.0 - Physical functioning norm-based score. SF12 v2.0 Acute - Phys Functioning Norm-Based Score SF124-Physical Component Score The Short Form 12 Health Survey Acute, US Version 2.0 - Physical component score. SF12 v2.0 Acute - Physical Component Score SF124-Physical Functioning 0-100 Score The Short Form 12 Health Survey Acute, US Version 2.0 - Physical functioning 0-100 score. SF12 v2.0 Acute - Physical Functioning 0-100 Score SF124-Physical: Accomplished Less The Short Form 12 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. SF12 v2.0 Acute - Physical: Accomplished Less SF124-Physical: Limited Kind of Work The Short Form 12 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. SF12 v2.0 Acute - Physical: Limited Kind of Work SF124-Role Emotional 0-100 Score The Short Form 12 Health Survey Acute, US Version 2.0 - Role emotional 0-100 score. SF12 v2.0 Acute - Role Emotional 0-100 Score SF124-Role Emotional Norm-Based Score The Short Form 12 Health Survey Acute, US Version 2.0 - Role emotional norm-based score. SF12 v2.0 Acute - Role Emotional Norm-Based Score SF124-Role Physical 0-100 Score The Short Form 12 Health Survey Acute, US Version 2.0 - Role physical 0-100 score. SF12 v2.0 Acute - Role Physical 0-100 Score SF124-Role Physical Norm-Based Score The Short Form 12 Health Survey Acute, US Version 2.0 - Role physical norm-based score. SF12 v2.0 Acute - Role Physical Norm-Based Score SF124-SF-6D_R2 (Util Index Rel 2) Score The Short Form 12 Health Survey Acute, US Version 2.0 - SF-6D_R2 (utility index release 2) score. SF12 v2.0 Acute - SF-6D_R2 (Util Index Rel 2) Score SF124-Social Function Norm-Based Score The Short Form 12 Health Survey Acute, US Version 2.0 - Social function norm-based score. SF12 v2.0 Acute - Social Function Norm-Based Score SF124-Social Functioning 0-100 Score The Short Form 12 Health Survey Acute, US Version 2.0 - Social functioning 0-100 score. SF12 v2.0 Acute - Social Functioning 0-100 Score SF124-Time Phys/Emotional Interfered The Short Form 12 Health Survey Acute, US Version 2.0 - During the past week, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting with friends, relatives, etc.)? SF12 v2.0 Acute - Time Physical Health, Emotional Interfered SF124-Vitality 0-100 Score The Short Form 12 Health Survey Acute, US Version 2.0 - Vitality 0-100 score. SF12 v2.0 Acute - Vitality 0-100 Score SF124-Vitality Norm-Based Score The Short Form 12 Health Survey Acute, US Version 2.0 - Vitality norm-based score. SF12 v2.0 Acute - Vitality Norm-Based Score SF124-You Felt Downhearted and Depressed The Short Form 12 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt downhearted and depressed? SF12 v2.0 Acute - You Felt Downhearted and Depressed SF124TN Short Form 12 Health Survey Acute, US Version 2.0 Questionnaire Test Name CDISC Questionnaire SF12 v2.0 Acute Test Name Terminology Short Form 12 Health Survey Standard, US Version 1.0 test code. SF121-In General You Say Your Health Is The Short Form 12 Health Survey Standard, US Version 1.0 - In general, would you say your health is. SF12 v1.0 Standard - In General You Say Your Health Is SF121-Limit Moderate Activities The Short Form 12 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. SF12 v1.0 Standard - Limit Moderate Activities SF121-Limit Climbing Several Flights The Short Form 12 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - climbing several flights of stairs. SF12 v1.0 Standard - Limit Climbing Several Flights SF121-Physical: Accomplished Less The Short Form 12 Health Survey Standard, US Version 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. SF12 v1.0 Standard - Physical: Accomplished Less SF121-Physical: Limited Kind of Work The Short Form 12 Health Survey Standard, US Version 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. SF12 v1.0 Standard - Physical: Limited Kind of Work SF121-Emotional: Accomplished Less The Short Form 12 Health Survey Standard, US Version 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. SF12 v1.0 Standard - Emotional: Accomplished Less SF121-Emotional: Did Work Less Carefully The Short Form 12 Health Survey Standard, US Version 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. SF12 v1.0 Standard - Emotional: Did Work Less Carefully SF121-Pain Interfere With Normal Work The Short Form 12 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the home and housework)? SF12 v1.0 Standard - Pain Interfere With Normal Work SF121-Have You Felt Calm and Peaceful The Short Form 12 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt calm and peaceful? SF12 v1.0 Standard - Have You Felt Calm and Peaceful SF121-Did You Have a Lot of Energy The Short Form 12 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you have a lot of energy? SF12 v1.0 Standard - Did You Have a Lot of Energy SF121-You Felt Downhearted and Blue The Short Form 12 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt downhearted and blue? SF12 v1.0 Standard - You Felt Downhearted and Blue SF121-Time Phys/Emotional Interfered The Short Form 12 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting friends, relatives, etc.)? SF12 v1.0 Standard - Time Physical Health, Emotional Interfered SF121-Physical Component Score The Short Form 12 Health Survey Standard, US Version 1.0 - Physical component score. SF12 v1.0 Standard - Physical Component Score SF121-Mental Component Score The Short Form 12 Health Survey Standard, US Version 1.0 - Mental component score. SF12 v1.0 Standard - Mental Component Score SF121-SF-6D_R2 (Util Index Rel 2) Score The Short Form 12 Health Survey Standard, US Version 1.0 - SF-6D_R2 (utility index release 2) score. SF12 v1.0 Standard - SF-6D_R2 Score SF121TC Short Form 12 Health Survey Standard, US Version 1.0 Questionnaire Test Code CDISC Questionnaire SF12 v1.0 Standard Test Code Terminology Short Form 12 Health Survey Standard, US Version 1.0 test name. SF121-Did You Have a Lot of Energy The Short Form 12 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you have a lot of energy? SF12 v1.0 Standard - Did You Have a Lot of Energy SF121-Emotional: Accomplished Less The Short Form 12 Health Survey Standard, US Version 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. SF12 v1.0 Standard - Emotional: Accomplished Less SF121-Emotional: Did Work Less Carefully The Short Form 12 Health Survey Standard, US Version 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. SF12 v1.0 Standard - Emotional: Did Work Less Carefully SF121-Have You Felt Calm and Peaceful The Short Form 12 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt calm and peaceful? SF12 v1.0 Standard - Have You Felt Calm and Peaceful SF121-In General You Say Your Health Is The Short Form 12 Health Survey Standard, US Version 1.0 - In general, would you say your health is. SF12 v1.0 Standard - In General You Say Your Health Is SF121-Limit Climbing Several Flights The Short Form 12 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - climbing several flights of stairs. SF12 v1.0 Standard - Limit Climbing Several Flights SF121-Limit Moderate Activities The Short Form 12 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. SF12 v1.0 Standard - Limit Moderate Activities SF121-Mental Component Score The Short Form 12 Health Survey Standard, US Version 1.0 - Mental component score. SF12 v1.0 Standard - Mental Component Score SF121-Pain Interfere With Normal Work The Short Form 12 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the home and housework)? SF12 v1.0 Standard - Pain Interfere With Normal Work SF121-Physical Component Score The Short Form 12 Health Survey Standard, US Version 1.0 - Physical component score. SF12 v1.0 Standard - Physical Component Score SF121-Physical: Accomplished Less The Short Form 12 Health Survey Standard, US Version 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. SF12 v1.0 Standard - Physical: Accomplished Less SF121-Physical: Limited Kind of Work The Short Form 12 Health Survey Standard, US Version 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. SF12 v1.0 Standard - Physical: Limited Kind of Work SF121-SF-6D_R2 (Util Index Rel 2) Score The Short Form 12 Health Survey Standard, US Version 1.0 - SF-6D_R2 (utility index release 2) score. SF12 v1.0 Standard - SF-6D_R2 Score SF121-Time Phys/Emotional Interfered The Short Form 12 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting friends, relatives, etc.)? SF12 v1.0 Standard - Time Physical Health, Emotional Interfered SF121-You Felt Downhearted and Blue The Short Form 12 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt downhearted and blue? SF12 v1.0 Standard - You Felt Downhearted and Blue SF121TN Short Form 12 Health Survey Standard, US Version 1.0 Questionnaire Test Name CDISC Questionnaire SF12 v1.0 Standard Test Name Terminology Short Form 12 Health Survey Standard, US Version 2.0 test code. SF123-In General You Say Your Health Is The Short Form 12 Health Survey Standard, US Version 2.0 - In general, would you say your health is. SF12 v2.0 Standard - In General You Say Your Health Is SF123-Limit Moderate Activities The Short Form 12 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. SF12 v2.0 Standard - Limit Moderate Activities SF123-Limit Climbing Several Flights The Short Form 12 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - climbing several flights of stairs. SF12 v2.0 Standard - Limit Climbing Several Flights SF123-Physical: Accomplished Less The Short Form 12 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. SF12 v2.0 Standard - Physical: Accomplished Less SF123-Physical: Limited Kind of Work The Short Form 12 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. SF12 v2.0 Standard - Physical: Limited Kind of Work SF123-Emotional: Accomplished Less The Short Form 12 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. SF12 v2.0 Standard - Emotional: Accomplished Less SF123-Emotional: Did Work Less Carefully The Short Form 12 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. SF12 v2.0 Standard - Emotional: Did Work Less Carefully SF123-Pain Interfere With Normal Work The Short Form 12 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the home and housework)? SF12 v2.0 Standard - Pain Interfere With Normal Work SF123-Have You Felt Calm and Peaceful The Short Form 12 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt calm and peaceful? SF12 v2.0 Standard - Have You Felt Calm and Peaceful SF123-Did You Have a Lot of Energy The Short Form 12 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you have a lot of energy? SF12 v2.0 Standard - Did You Have a Lot of Energy SF123-You Felt Downhearted and Depressed The Short Form 12 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt downhearted and depressed? SF12 v2.0 Standard - You Felt Downhearted and Depressed SF123-Time Phys/Emotional Interfered The Short Form 12 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting with friends, relatives, etc.)? SF12 v2.0 Standard - Time Physical Health, Emotional Interfered SF123-Physical Functioning 0-100 Score The Short Form 12 Health Survey Standard, US Version 2.0 - Physical functioning 0-100 score. SF12 v2.0 Standard - Physical Functioning 0-100 Score SF123-Role Physical 0-100 Score The Short Form 12 Health Survey Standard, US Version 2.0 - Role physical 0-100 score. SF12 v2.0 Standard - Role Physical 0-100 Score SF123-Bodily Pain 0-100 Score The Short Form 12 Health Survey Standard, US Version 2.0 - Bodily pain 0-100 score. SF12 v2.0 Standard - Bodily Pain 0-100 Score SF123-General Health 0-100 Score The Short Form 12 Health Survey Standard, US Version 2.0 - General health 0-100 score. SF12 v2.0 Standard - General Health 0-100 Score SF123-Vitality 0-100 Score The Short Form 12 Health Survey Standard, US Version 2.0 - Vitality 0-100 score. SF12 v2.0 Standard - Vitality 0-100 Score SF123-Social Functioning 0-100 Score The Short Form 12 Health Survey Standard, US Version 2.0 - Social functioning 0-100 score. SF12 v2.0 Standard - Social Functioning 0-100 Score SF123-Role Emotional 0-100 Score The Short Form 12 Health Survey Standard, US Version 2.0 - Role emotional 0-100 score. SF12 v2.0 Standard - Role Emotional 0-100 Score SF123-Mental Health 0-100 Score The Short Form 12 Health Survey Standard, US Version 2.0 - Mental health 0-100 score. SF12 v2.0 Standard - Mental Health 0-100 Score SF123-Phys Functioning Norm-Based Score The Short Form 12 Health Survey Standard, US Version 2.0 - Physical functioning norm-based score. SF12 v2.0 Standard - Phys Functioning Norm-Based Score SF123-Role Physical Norm-Based Score The Short Form 12 Health Survey Standard, US Version 2.0 - Role physical norm-based score. SF12 v2.0 Standard - Role Physical Norm-Based Score SF123-Bodily Pain Norm-Based Score The Short Form 12 Health Survey Standard, US Version 2.0 - Bodily pain norm-based score. SF12 v2.0 Standard - Bodily Pain Norm-Based Score SF123-General Health Norm-Based Score The Short Form 12 Health Survey Standard, US Version 2.0 - General health norm-based score. SF12 v2.0 Standard - General Health Norm-Based Score SF123-Vitality Norm-Based Score The Short Form 12 Health Survey Standard, US Version 2.0 - Vitality norm-based score. SF12 v2.0 Standard - Vitality Norm-Based Score SF123-Social Function Norm-Based Score The Short Form 12 Health Survey Standard, US Version 2.0 - Social function norm-based score. SF12 v2.0 Standard - Social Function Norm-Based Score SF123-Role Emotional Norm-Based Score The Short Form 12 Health Survey Standard, US Version 2.0 - Role emotional norm-based score. SF12 v2.0 Standard - Role Emotional Norm-Based Score SF123-Mental Health Norm-Based Score The Short Form 12 Health Survey Standard, US Version 2.0 - Mental health norm-based score. SF12 v2.0 Standard - Mental Health Norm-Based Score SF123-Physical Component Score The Short Form 12 Health Survey Standard, US Version 2.0 - Physical component score. SF12 v2.0 Standard - Physical Component Score SF123-Mental Component Score The Short Form 12 Health Survey Standard, US Version 2.0 - Mental component score. SF12 v2.0 Standard - Mental Component Score SF123-SF-6D_R2 (Util Index Rel 2) Score The Short Form 12 Health Survey Standard, US Version 2.0 - SF-6D_R2 (utility index release 2) score. SF12 v2.0 Standard - SF-6D_R2 (Util Index Rel 2) Score SF123TC Short Form 12 Health Survey Standard, US Version 2.0 Questionnaire Test Code CDISC Questionnaire SF12 v2.0 Standard Test Code Terminology Short Form 12 Health Survey Standard, US Version 2.0 test name. SF123-Bodily Pain 0-100 Score The Short Form 12 Health Survey Standard, US Version 2.0 - Bodily pain 0-100 score. SF12 v2.0 Standard - Bodily Pain 0-100 Score SF123-Bodily Pain Norm-Based Score The Short Form 12 Health Survey Standard, US Version 2.0 - Bodily pain norm-based score. SF12 v2.0 Standard - Bodily Pain Norm-Based Score SF123-Did You Have a Lot of Energy The Short Form 12 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you have a lot of energy? SF12 v2.0 Standard - Did You Have a Lot of Energy SF123-Emotional: Accomplished Less The Short Form 12 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. SF12 v2.0 Standard - Emotional: Accomplished Less SF123-Emotional: Did Work Less Carefully The Short Form 12 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. SF12 v2.0 Standard - Emotional: Did Work Less Carefully SF123-General Health 0-100 Score The Short Form 12 Health Survey Standard, US Version 2.0 - General health 0-100 score. SF12 v2.0 Standard - General Health 0-100 Score SF123-General Health Norm-Based Score The Short Form 12 Health Survey Standard, US Version 2.0 - General health norm-based score. SF12 v2.0 Standard - General Health Norm-Based Score SF123-Have You Felt Calm and Peaceful The Short Form 12 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt calm and peaceful? SF12 v2.0 Standard - Have You Felt Calm and Peaceful SF123-In General You Say Your Health Is The Short Form 12 Health Survey Standard, US Version 2.0 - In general, would you say your health is. SF12 v2.0 Standard - In General You Say Your Health Is SF123-Limit Climbing Several Flights The Short Form 12 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - climbing several flights of stairs. SF12 v2.0 Standard - Limit Climbing Several Flights SF123-Limit Moderate Activities The Short Form 12 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. SF12 v2.0 Standard - Limit Moderate Activities SF123-Mental Component Score The Short Form 12 Health Survey Standard, US Version 2.0 - Mental component score. SF12 v2.0 Standard - Mental Component Score SF123-Mental Health 0-100 Score The Short Form 12 Health Survey Standard, US Version 2.0 - Mental health 0-100 score. SF12 v2.0 Standard - Mental Health 0-100 Score SF123-Mental Health Norm-Based Score The Short Form 12 Health Survey Standard, US Version 2.0 - Mental health norm-based score. SF12 v2.0 Standard - Mental Health Norm-Based Score SF123-Pain Interfere With Normal Work The Short Form 12 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the home and housework)? SF12 v2.0 Standard - Pain Interfere With Normal Work SF123-Phys Functioning Norm-Based Score The Short Form 12 Health Survey Standard, US Version 2.0 - Physical functioning norm-based score. SF12 v2.0 Standard - Phys Functioning Norm-Based Score SF123-Physical Component Score The Short Form 12 Health Survey Standard, US Version 2.0 - Physical component score. SF12 v2.0 Standard - Physical Component Score SF123-Physical Functioning 0-100 Score The Short Form 12 Health Survey Standard, US Version 2.0 - Physical functioning 0-100 score. SF12 v2.0 Standard - Physical Functioning 0-100 Score SF123-Physical: Accomplished Less The Short Form 12 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. SF12 v2.0 Standard - Physical: Accomplished Less SF123-Physical: Limited Kind of Work The Short Form 12 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. SF12 v2.0 Standard - Physical: Limited Kind of Work SF123-Role Emotional 0-100 Score The Short Form 12 Health Survey Standard, US Version 2.0 - Role emotional 0-100 score. SF12 v2.0 Standard - Role Emotional 0-100 Score SF123-Role Emotional Norm-Based Score The Short Form 12 Health Survey Standard, US Version 2.0 - Role emotional norm-based score. SF12 v2.0 Standard - Role Emotional Norm-Based Score SF123-Role Physical 0-100 Score The Short Form 12 Health Survey Standard, US Version 2.0 - Role physical 0-100 score. SF12 v2.0 Standard - Role Physical 0-100 Score SF123-Role Physical Norm-Based Score The Short Form 12 Health Survey Standard, US Version 2.0 - Role physical norm-based score. SF12 v2.0 Standard - Role Physical Norm-Based Score SF123-SF-6D_R2 (Util Index Rel 2) Score The Short Form 12 Health Survey Standard, US Version 2.0 - SF-6D_R2 (utility index release 2) score. SF12 v2.0 Standard - SF-6D_R2 (Util Index Rel 2) Score SF123-Social Function Norm-Based Score The Short Form 12 Health Survey Standard, US Version 2.0 - Social function norm-based score. SF12 v2.0 Standard - Social Function Norm-Based Score SF123-Social Functioning 0-100 Score The Short Form 12 Health Survey Standard, US Version 2.0 - Social functioning 0-100 score. SF12 v2.0 Standard - Social Functioning 0-100 Score SF123-Time Phys/Emotional Interfered The Short Form 12 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting with friends, relatives, etc.)? SF12 v2.0 Standard - Time Physical Health, Emotional Interfered SF123-Vitality 0-100 Score The Short Form 12 Health Survey Standard, US Version 2.0 - Vitality 0-100 score. SF12 v2.0 Standard - Vitality 0-100 Score SF123-Vitality Norm-Based Score The Short Form 12 Health Survey Standard, US Version 2.0 - Vitality norm-based score. SF12 v2.0 Standard - Vitality Norm-Based Score SF123-You Felt Downhearted and Depressed The Short Form 12 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt downhearted and depressed? SF12 v2.0 Standard - You Felt Downhearted and Depressed SF123TN Short Form 12 Health Survey Standard, US Version 2.0 Questionnaire Test Name CDISC Questionnaire SF12 v2.0 Standard Test Name Terminology Short Form 8 Health Survey Acute, US Version 1.0 test code. SF82-Overall How You Rate Your Health The Short Form 8 Health Survey Acute, US Version 1.0 - Overall, how would you rate your health during the past week? SF8 v1.0 Acute - Overall How You Rate Your Health SF82-How Much Limit Physical Activities The Short Form 8 Health Survey Acute, US Version 1.0 - During the past week, how much did physical health problems limit your usual physical activities (walking, climbing stairs)? SF8 v1.0 Acute - How Much Limit Physical Activities SF82-Difficulty Doing Daily Work The Short Form 8 Health Survey Acute, US Version 1.0 - During the past week, how much difficulty did you have doing your daily work, both at home and away from home, because of your physical health? SF8 v1.0 Acute - Difficulty Doing Daily Work SF82-How Much Bodily Pain Have You Had The Short Form 8 Health Survey Acute, US Version 1.0 - How much bodily pain have you had during the past week? SF8 v1.0 Acute - How Much Bodily Pain Have You Had SF82-How Much Energy Did You Have The Short Form 8 Health Survey Acute, US Version 1.0 - During the past week, how much energy did you have? SF8 v1.0 Acute - How Much Energy Did You Have SF82-Physical/Emotional Limit Activities The Short Form 8 Health Survey Acute, US Version 1.0 - During the past week, how much did your physical health or emotional problems limit your usual social activities with family or friends? SF8 v1.0 Acute - Physical, Emotional Limit Activities SF82-Bothered by Emotional Problems The Short Form 8 Health Survey Acute, US Version 1.0 - During the past week, how much have you been bothered by emotional problems (such as feeling anxious, depressed or irritable)? SF8 v1.0 Acute - Bothered by Emotional Problems SF82-Emotional Problems Keep From Work The Short Form 8 Health Survey Acute, US Version 1.0 - During the past week, how much did personal or emotional problems keep you from doing your usual work, school or other daily activities? SF8 v1.0 Acute - Emotional Problems Keep From Work SF82-Phys. Functioning Norm-Based Score The Short Form 8 Health Survey Acute, US Version 1.0 - Physical functioning norm-based score. SF8 v1.0 Acute - Physical Functioning Norm-Based Score SF82-Role Physical Norm-Based Score The Short Form 8 Health Survey Acute, US Version 1.0 - Role physical norm-based score. SF8 v1.0 Acute - Role Physical Norm-Based Score SF82-Bodily Pain Norm-Based Score The Short Form 8 Health Survey Acute, US Version 1.0 - Bodily pain norm-based score. SF8 v1.0 Acute - Bodily Pain Norm-Based Score SF82-General Health Norm-Based Score The Short Form 8 Health Survey Acute, US Version 1.0 - General health norm-based score. SF8 v1.0 Acute - General Health Norm-Based Score SF82-Vitality Norm-Based Score The Short Form 8 Health Survey Acute, US Version 1.0 - Vitality norm-based score. SF8 v1.0 Acute - Vitality Norm-Based Score SF82-Social Functioning Norm-Based Score The Short Form 8 Health Survey Acute, US Version 1.0 - Social functioning norm-based score. SF8 v1.0 Acute - Social Functioning Norm-Based Score SF82-Role Emotional Norm-Based Score The Short Form 8 Health Survey Acute, US Version 1.0 - Role emotional norm-based score. SF8 v1.0 Acute - Role Emotional Norm-Based Score SF82-Mental Health Norm-Based Score The Short Form 8 Health Survey Acute, US Version 1.0 - Mental health norm-based score. SF8 v1.0 Acute - Mental Health Norm-Based Score SF82-Physical Component Score The Short Form 8 Health Survey Acute, US Version 1.0 - Physical component score. SF8 v1.0 Acute - Physical Component Score SF82-Mental Component Score The Short Form 8 Health Survey Acute, US Version 1.0 - Mental component score. SF8 v1.0 Acute - Mental Component Score SF82TC Short Form 8 Health Survey Acute, US Version 1.0 Questionnaire Test Code CDISC Questionnaire SF8 v1.0 Acute Test Code Terminology Short Form 8 Health Survey Acute, US Version 1.0 test name. SF82-Bodily Pain Norm-Based Score The Short Form 8 Health Survey Acute, US Version 1.0 - Bodily pain norm-based score. SF8 v1.0 Acute - Bodily Pain Norm-Based Score SF82-Bothered by Emotional Problems The Short Form 8 Health Survey Acute, US Version 1.0 - During the past week, how much have you been bothered by emotional problems (such as feeling anxious, depressed or irritable)? SF8 v1.0 Acute - Bothered by Emotional Problems SF82-Difficulty Doing Daily Work The Short Form 8 Health Survey Acute, US Version 1.0 - During the past week, how much difficulty did you have doing your daily work, both at home and away from home, because of your physical health? SF8 v1.0 Acute - Difficulty Doing Daily Work SF82-Emotional Problems Keep From Work The Short Form 8 Health Survey Acute, US Version 1.0 - During the past week, how much did personal or emotional problems keep you from doing your usual work, school or other daily activities? SF8 v1.0 Acute - Emotional Problems Keep From Work SF82-General Health Norm-Based Score The Short Form 8 Health Survey Acute, US Version 1.0 - General health norm-based score. SF8 v1.0 Acute - General Health Norm-Based Score SF82-How Much Bodily Pain Have You Had The Short Form 8 Health Survey Acute, US Version 1.0 - How much bodily pain have you had during the past week? SF8 v1.0 Acute - How Much Bodily Pain Have You Had SF82-How Much Energy Did You Have The Short Form 8 Health Survey Acute, US Version 1.0 - During the past week, how much energy did you have? SF8 v1.0 Acute - How Much Energy Did You Have SF82-How Much Limit Physical Activities The Short Form 8 Health Survey Acute, US Version 1.0 - During the past week, how much did physical health problems limit your usual physical activities (walking, climbing stairs)? SF8 v1.0 Acute - How Much Limit Physical Activities SF82-Mental Component Score The Short Form 8 Health Survey Acute, US Version 1.0 - Mental component score. SF8 v1.0 Acute - Mental Component Score SF82-Mental Health Norm-Based Score The Short Form 8 Health Survey Acute, US Version 1.0 - Mental health norm-based score. SF8 v1.0 Acute - Mental Health Norm-Based Score SF82-Overall How You Rate Your Health The Short Form 8 Health Survey Acute, US Version 1.0 - Overall, how would you rate your health during the past week? SF8 v1.0 Acute - Overall How You Rate Your Health SF82-Phys. Functioning Norm-Based Score The Short Form 8 Health Survey Acute, US Version 1.0 - Physical functioning norm-based score. SF8 v1.0 Acute - Physical Functioning Norm-Based Score SF82-Physical Component Score The Short Form 8 Health Survey Acute, US Version 1.0 - Physical component score. SF8 v1.0 Acute - Physical Component Score SF82-Physical/Emotional Limit Activities The Short Form 8 Health Survey Acute, US Version 1.0 - During the past week, how much did your physical health or emotional problems limit your usual social activities with family or friends? SF8 v1.0 Acute - Physical, Emotional Limit Activities SF82-Role Emotional Norm-Based Score The Short Form 8 Health Survey Acute, US Version 1.0 - Role emotional norm-based score. SF8 v1.0 Acute - Role Emotional Norm-Based Score SF82-Role Physical Norm-Based Score The Short Form 8 Health Survey Acute, US Version 1.0 - Role physical norm-based score. SF8 v1.0 Acute - Role Physical Norm-Based Score SF82-Social Functioning Norm-Based Score The Short Form 8 Health Survey Acute, US Version 1.0 - Social functioning norm-based score. SF8 v1.0 Acute - Social Functioning Norm-Based Score SF82-Vitality Norm-Based Score The Short Form 8 Health Survey Acute, US Version 1.0 - Vitality norm-based score. SF8 v1.0 Acute - Vitality Norm-Based Score SF82TN Short Form 8 Health Survey Acute, US Version 1.0 Questionnaire Test Name CDISC Questionnaire SF8 v1.0 Acute Test Name Terminology Short Form 8 Health Survey Standard, US Version 1.0 test code. SF81-Overall How You Rate Your Health The Short Form 8 Health Survey Standard, US Version 1.0 - Overall, how would you rate your health during the past 4 weeks? SF8 v1.0 Standard - Overall How You Rate Your Health SF81-How Much Limit Physical Activities The Short Form 8 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much did physical health problems limit your usual physical activities (walking, climbing stairs)?. SF8 v1.0 Standard - How Much Limit Physical Activities SF81-Difficulty Doing Daily Work The Short Form 8 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much difficulty did you have doing your daily work, both at home and away from home, because of your physical health? SF8 v1.0 Standard - Difficulty Doing Daily Work SF81-How Much Bodily Pain You Have Had The Short Form 8 Health Survey Standard, US Version 1.0 - How much bodily pain have you had during the past 4 weeks? SF8 v1.0 Standard - How Much Bodily Pain You Have Had SF81-How Much Energy Did You Have The Short Form 8 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much energy did you have? SF8 v1.0 Standard - How Much Energy Did You Have SF81-Physical/Emotional Limit Activities The Short Form 8 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much did your physical health or emotional problems limit your usual social activities with family or friends? SF8 v1.0 Standard - Physical, Emotional Limit Activities SF81-Bothered by Emotional Problems The Short Form 8 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much have you been bothered by emotional problems (such as feeling anxious, depressed or irritable)? SF8 v1.0 Standard - Bothered by Emotional Problems SF81-Emotional Problems Keep From Work The Short Form 8 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much did personal or emotional problems keep you from doing your usual work, school or other daily activities? SF8 v1.0 Standard - Emotional Problems Keep From Work SF81-Phys. Functioning Norm-Based Score The Short Form 8 Health Survey Standard, US Version 1.0 - Physical functioning norm-based score. SF8 v1.0 Standard - Physical Functioning Norm-Based Score SF81-Role Physical Norm-Based Score The Short Form 8 Health Survey Standard, US Version 1.0 - Role physical norm-based score. SF8 v1.0 Standard - Role Physical Norm-Based Score SF81-Bodily Pain Norm-Based Score The Short Form 8 Health Survey Standard, US Version 1.0 - Bodily pain norm-based score. SF8 v1.0 Standard - Bodily Pain Norm-Based Score SF81-General Health Norm-Based Score The Short Form 8 Health Survey Standard, US Version 1.0 - General health norm-based score. SF8 v1.0 Standard - General Health Norm-Based Score SF81-Vitality Norm-Based Score The Short Form 8 Health Survey Standard, US Version 1.0 - Vitality norm-based score. SF8 v1.0 Standard - Vitality Norm-Based Score SF81-Social Functioning Norm-Based Score The Short Form 8 Health Survey Standard, US Version 1.0 - Social functioning norm-based score. SF8 v1.0 Standard - Social Functioning Norm-Based Score SF81-Role Emotional Norm-Based Score The Short Form 8 Health Survey Standard, US Version 1.0 - Role emotional norm-based score. SF8 v1.0 Standard - Role Emotional Norm-Based Score SF81-Mental Health Norm-Based Score The Short Form 8 Health Survey Standard, US Version 1.0 - Mental health norm-based score. SF8 v1.0 Standard - Mental Health Norm-Based Score SF81-Physical Component Score The Short Form 8 Health Survey Standard, US Version 1.0 - Physical component score. SF8 v1.0 Standard - Physical Component Score SF81-Mental Component Score The Short Form 8 Health Survey Standard, US Version 1.0 - Mental component score. SF8 v1.0 Standard - Mental Component Score SF81TC Short Form 8 Health Survey Standard, US Version 1.0 Questionnaire Test Code CDISC Questionnaire SF8 v1.0 Standard Test Code Terminology Short Form 8 Health Survey Standard, US Version 1.0 test name. SF81-Bodily Pain Norm-Based Score The Short Form 8 Health Survey Standard, US Version 1.0 - Bodily pain norm-based score. SF8 v1.0 Standard - Bodily Pain Norm-Based Score SF81-Bothered by Emotional Problems The Short Form 8 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much have you been bothered by emotional problems (such as feeling anxious, depressed or irritable)? SF8 v1.0 Standard - Bothered by Emotional Problems SF81-Difficulty Doing Daily Work The Short Form 8 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much difficulty did you have doing your daily work, both at home and away from home, because of your physical health? SF8 v1.0 Standard - Difficulty Doing Daily Work SF81-Emotional Problems Keep From Work The Short Form 8 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much did personal or emotional problems keep you from doing your usual work, school or other daily activities? SF8 v1.0 Standard - Emotional Problems Keep From Work SF81-General Health Norm-Based Score The Short Form 8 Health Survey Standard, US Version 1.0 - General health norm-based score. SF8 v1.0 Standard - General Health Norm-Based Score SF81-How Much Bodily Pain You Have Had The Short Form 8 Health Survey Standard, US Version 1.0 - How much bodily pain have you had during the past 4 weeks? SF8 v1.0 Standard - How Much Bodily Pain You Have Had SF81-How Much Energy Did You Have The Short Form 8 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much energy did you have? SF8 v1.0 Standard - How Much Energy Did You Have SF81-How Much Limit Physical Activities The Short Form 8 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much did physical health problems limit your usual physical activities (walking, climbing stairs)?. SF8 v1.0 Standard - How Much Limit Physical Activities SF81-Mental Component Score The Short Form 8 Health Survey Standard, US Version 1.0 - Mental component score. SF8 v1.0 Standard - Mental Component Score SF81-Mental Health Norm-Based Score The Short Form 8 Health Survey Standard, US Version 1.0 - Mental health norm-based score. SF8 v1.0 Standard - Mental Health Norm-Based Score SF81-Overall How You Rate Your Health The Short Form 8 Health Survey Standard, US Version 1.0 - Overall, how would you rate your health during the past 4 weeks? SF8 v1.0 Standard - Overall How You Rate Your Health SF81-Phys. Functioning Norm-Based Score The Short Form 8 Health Survey Standard, US Version 1.0 - Physical functioning norm-based score. SF8 v1.0 Standard - Physical Functioning Norm-Based Score SF81-Physical Component Score The Short Form 8 Health Survey Standard, US Version 1.0 - Physical component score. SF8 v1.0 Standard - Physical Component Score SF81-Physical/Emotional Limit Activities The Short Form 8 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much did your physical health or emotional problems limit your usual social activities with family or friends? SF8 v1.0 Standard - Physical, Emotional Limit Activities SF81-Role Emotional Norm-Based Score The Short Form 8 Health Survey Standard, US Version 1.0 - Role emotional norm-based score. SF8 v1.0 Standard - Role Emotional Norm-Based Score SF81-Role Physical Norm-Based Score The Short Form 8 Health Survey Standard, US Version 1.0 - Role physical norm-based score. SF8 v1.0 Standard - Role Physical Norm-Based Score SF81-Social Functioning Norm-Based Score The Short Form 8 Health Survey Standard, US Version 1.0 - Social functioning norm-based score. SF8 v1.0 Standard - Social Functioning Norm-Based Score SF81-Vitality Norm-Based Score The Short Form 8 Health Survey Standard, US Version 1.0 - Vitality norm-based score. SF8 v1.0 Standard - Vitality Norm-Based Score SF81TN Short Form 8 Health Survey Standard, US Version 1.0 Questionnaire Test Name CDISC Questionnaire SF8 v1.0 Standard Test Name Terminology Short Physical Performance Battery Version 1.2 test code. SPPB1-Side-by-Side Score Short Physical Performance Battery V1.2 - Side-By-Side Stand: Side-by-side score. SPPB Version 1.2 - Side-by-Side Score SPPB1-Side-by-Side Seconds Held If <10 Short Physical Performance Battery V1.2 - Side-By-Side Stand: Number of seconds held if less than 10 sec. SPPB Version 1.2 - Side-by-Side Seconds Held If <10 SPPB1-Semi-Tandem Stand Score Short Physical Performance Battery V1.2 - Semi-Tandem Stand: Semi-tandem stand score. SPPB Version 1.2 - Semi-Tandem Stand Score SPPB1-Semi-Tandem Seconds Held If <10 Short Physical Performance Battery V1.2 - Semi-Tandem Stand: Number of seconds held if less than 10 sec. SPPB Version 1.2 - Semi-Tandem Seconds Held If <10 SPPB1-Tandem Stand Score Short Physical Performance Battery V1.2 - Tandem Stand: Tandem stand score. SPPB Version 1.2 - Tandem Stand Score SPPB1-Tandem Seconds If <10 Short Physical Performance Battery V1.2 - Tandem Stand: Number of seconds if less than 10 sec. SPPB Version 1.2 - Tandem Seconds If <10 SPPB1-Did Not Attempt Test Balance Short Physical Performance Battery V1.2 - Balance Tests: If participant did not attempt test. SPPB Version 1.2 - Did Not Attempt Test Balance SPPB1-Did Not Attempt Balance Specify Short Physical Performance Battery V1.2 - Balance Tests: If participant did not attempt test: Other (specify). SPPB Version 1.2 - Did Not Attempt Balance Specify SPPB1-Total Balance Tests Score Short Physical Performance Battery V1.2 - Total balance tests score. SPPB Version 1.2 - Total Balance Tests Score SPPB1-Length of Walk Test Course Short Physical Performance Battery V1.2 - Gait Speed Test: Length of walk test course. SPPB Version 1.2 - Length of Walk Test Course SPPB1-Time for 3 or 4 Meters 1st Gait Short Physical Performance Battery V1.2 - Gait Speed Test - First Gait Speed Test: Time for 3 or 4 meters. SPPB Version 1.2 - Time for 3 or 4 Meters 1st Gait SPPB1-Did Not Attempt 1st Gait Short Physical Performance Battery V1.2 - Gait Speed Test - First Gait Speed Test: If participant did not attempt test. SPPB Version 1.2 - Did Not Attempt 1st Gait SPPB1-Did Not Attempt 1st Gait Specify Short Physical Performance Battery V1.2 - Gait Speed Test - First Gait Speed Test: If participant did not attempt test: Other (specify). SPPB Version 1.2 - Did Not Attempt 1st Gait Specify SPPB1-Aids Used 1st Gait Short Physical Performance Battery V1.2 - Gait Speed Test - First Gait Speed Test: Aids used for first walk. SPPB Version 1.2 - Aids Used 1st Gait SPPB1-Aids Used 1st Gait Specify Short Physical Performance Battery V1.2 - Gait Speed Test - First Gait Speed Test: Aids used for first walk: Other (specify). SPPB Version 1.2 - Aids Used 1st Gait Specify SPPB1-Time for 3 or 4 Meters - 2nd Gait Short Physical Performance Battery V1.2 - Gait Speed Test - Second Gait Speed Test: Time for 3 or 4 meters. SPPB Version 1.2 - Time for 3 or 4 Meters - 2nd Gait SPPB1-Did Not Attempt or Failed 2nd Gait Short Physical Performance Battery V1.2 - Gait Speed Test - Second Gait Speed Test: If participant did not attempt or failed. SPPB Version 1.2 - Did Not Attempt or Failed 2nd Gait SPPB1-Did Not Attempt 2nd Gait Specify Short Physical Performance Battery V1.2 - Gait Speed Test - Second Gait Speed Test: If participant did not attempt or failed: Other (specify). SPPB Version 1.2 - Did Not Attempt 2nd Gait Specify SPPB1-Aids Used 2nd Gait Short Physical Performance Battery V1.2 - Gait Speed Test - Second Gait Speed Test: Aids used for second walk. SPPB Version 1.2 - Aids Used 2nd Gait SPPB1-Aids Used 2nd Gait Specify Short Physical Performance Battery V1.2 - Gait Speed Test - Second Gait Speed Test: Aids used for second walk: Other (specify). SPPB Version 1.2 - Aids Used 2nd Gait Specify SPPB1-For 4-Meter Walk Short Physical Performance Battery V1.2 - Gait Speed Test: For 4-meter walk. SPPB Version 1.2 - For 4-Meter Walk SPPB1-For 3-Meter Walk Short Physical Performance Battery V1.2 - Gait Speed Test: For 3-meter walk. SPPB Version 1.2 - For 3-Meter Walk SPPB1-Safe to Stand Without Help Short Physical Performance Battery V1.2 - Chair Stand Test - Single Chair Stand Test: Safe to stand without help. SPPB Version 1.2 - Safe to Stand Without Help SPPB1-Results Single Chair Short Physical Performance Battery V1.2 - Chair Stand Test - Single Chair Stand Test: Results. SPPB Version 1.2 - Results Single Chair SPPB1-Did Not Attempt Single Chair Short Physical Performance Battery V1.2 - Chair Stand Test - Single Chair Stand Test: If participant did not attempt or failed. SPPB Version 1.2 - Did Not Attempt Single Chair SPPB1-Not Attempt Single Chair Specify Short Physical Performance Battery V1.2 - Chair Stand Test - Single Chair Stand Test: If participant did not attempt or failed: Other (specify). SPPB Version 1.2 - Not Attempt Single Chair Specify SPPB1-Safe to Stand Five Times Short Physical Performance Battery V1.2 - Chair Stand Test - Repeated Chair Stand Test: Safe to stand five times. SPPB Version 1.2 - Safe to Stand Five Times SPPB1-Time to Complete Five Stands Short Physical Performance Battery V1.2 - Chair Stand Test - Repeated Chair Stand Test: Time to complete five stands. SPPB Version 1.2 - Time to Complete Five Stands SPPB1-Did Not Attempt Repeated Chair Short Physical Performance Battery V1.2 - Chair Stand Test - Repeated Chair Stand Test: If participant did not attempt test or failed. SPPB Version 1.2 - Did Not Attempt Repeated Chair SPPB1-Not Attempt Repeated Chair Specify Short Physical Performance Battery V1.2 - Chair Stand Test - Repeated Chair Stand Test: If participant did not attempt test or failed: Other (specify). SPPB Version 1.2 - Not Attempt Repeated Chair Specify SPPB1-Chair Stand Score Repeated Short Physical Performance Battery V1.2 - Chair Stand Test - Repeated Chair Stand Test: Chair stand score. SPPB Version 1.2 - Chair Stand Score Repeated SPPB1-Total Score Short Physical Performance Battery V1.2 - Total score. SPPB Version 1.2 - Total Score SPPB1TC Short Physical Performance Battery Version 1.2 Functional Test Test Code CDISC Functional Test SPPB Version 1.2 Test Code Terminology Short Physical Performance Battery Version 1.2 test name. SPPB1-Aids Used 1st Gait Specify Short Physical Performance Battery V1.2 - Gait Speed Test - First Gait Speed Test: Aids used for first walk: Other (specify). SPPB Version 1.2 - Aids Used 1st Gait Specify SPPB1-Aids Used 1st Gait Short Physical Performance Battery V1.2 - Gait Speed Test - First Gait Speed Test: Aids used for first walk. SPPB Version 1.2 - Aids Used 1st Gait SPPB1-Aids Used 2nd Gait Specify Short Physical Performance Battery V1.2 - Gait Speed Test - Second Gait Speed Test: Aids used for second walk: Other (specify). SPPB Version 1.2 - Aids Used 2nd Gait Specify SPPB1-Aids Used 2nd Gait Short Physical Performance Battery V1.2 - Gait Speed Test - Second Gait Speed Test: Aids used for second walk. SPPB Version 1.2 - Aids Used 2nd Gait SPPB1-Chair Stand Score Repeated Short Physical Performance Battery V1.2 - Chair Stand Test - Repeated Chair Stand Test: Chair stand score. SPPB Version 1.2 - Chair Stand Score Repeated SPPB1-Did Not Attempt 1st Gait Specify Short Physical Performance Battery V1.2 - Gait Speed Test - First Gait Speed Test: If participant did not attempt test: Other (specify). SPPB Version 1.2 - Did Not Attempt 1st Gait Specify SPPB1-Did Not Attempt 1st Gait Short Physical Performance Battery V1.2 - Gait Speed Test - First Gait Speed Test: If participant did not attempt test. SPPB Version 1.2 - Did Not Attempt 1st Gait SPPB1-Did Not Attempt 2nd Gait Specify Short Physical Performance Battery V1.2 - Gait Speed Test - Second Gait Speed Test: If participant did not attempt or failed: Other (specify). SPPB Version 1.2 - Did Not Attempt 2nd Gait Specify SPPB1-Did Not Attempt Balance Specify Short Physical Performance Battery V1.2 - Balance Tests: If participant did not attempt test: Other (specify). SPPB Version 1.2 - Did Not Attempt Balance Specify SPPB1-Did Not Attempt or Failed 2nd Gait Short Physical Performance Battery V1.2 - Gait Speed Test - Second Gait Speed Test: If participant did not attempt or failed. SPPB Version 1.2 - Did Not Attempt or Failed 2nd Gait SPPB1-Did Not Attempt Repeated Chair Short Physical Performance Battery V1.2 - Chair Stand Test - Repeated Chair Stand Test: If participant did not attempt test or failed. SPPB Version 1.2 - Did Not Attempt Repeated Chair SPPB1-Did Not Attempt Single Chair Short Physical Performance Battery V1.2 - Chair Stand Test - Single Chair Stand Test: If participant did not attempt or failed. SPPB Version 1.2 - Did Not Attempt Single Chair SPPB1-Did Not Attempt Test Balance Short Physical Performance Battery V1.2 - Balance Tests: If participant did not attempt test. SPPB Version 1.2 - Did Not Attempt Test Balance SPPB1-For 3-Meter Walk Short Physical Performance Battery V1.2 - Gait Speed Test: For 3-meter walk. SPPB Version 1.2 - For 3-Meter Walk SPPB1-For 4-Meter Walk Short Physical Performance Battery V1.2 - Gait Speed Test: For 4-meter walk. SPPB Version 1.2 - For 4-Meter Walk SPPB1-Length of Walk Test Course Short Physical Performance Battery V1.2 - Gait Speed Test: Length of walk test course. SPPB Version 1.2 - Length of Walk Test Course SPPB1-Not Attempt Repeated Chair Specify Short Physical Performance Battery V1.2 - Chair Stand Test - Repeated Chair Stand Test: If participant did not attempt test or failed: Other (specify). SPPB Version 1.2 - Not Attempt Repeated Chair Specify SPPB1-Not Attempt Single Chair Specify Short Physical Performance Battery V1.2 - Chair Stand Test - Single Chair Stand Test: If participant did not attempt or failed: Other (specify). SPPB Version 1.2 - Not Attempt Single Chair Specify SPPB1-Results Single Chair Short Physical Performance Battery V1.2 - Chair Stand Test - Single Chair Stand Test: Results. SPPB Version 1.2 - Results Single Chair SPPB1-Safe to Stand Five Times Short Physical Performance Battery V1.2 - Chair Stand Test - Repeated Chair Stand Test: Safe to stand five times. SPPB Version 1.2 - Safe to Stand Five Times SPPB1-Safe to Stand Without Help Short Physical Performance Battery V1.2 - Chair Stand Test - Single Chair Stand Test: Safe to stand without help. SPPB Version 1.2 - Safe to Stand Without Help SPPB1-Semi-Tandem Seconds Held If <10 Short Physical Performance Battery V1.2 - Semi-Tandem Stand: Number of seconds held if less than 10 sec. SPPB Version 1.2 - Semi-Tandem Seconds Held If <10 SPPB1-Semi-Tandem Stand Score Short Physical Performance Battery V1.2 - Semi-Tandem Stand: Semi-tandem stand score. SPPB Version 1.2 - Semi-Tandem Stand Score SPPB1-Side-by-Side Score Short Physical Performance Battery V1.2 - Side-By-Side Stand: Side-by-side score. SPPB Version 1.2 - Side-by-Side Score SPPB1-Side-by-Side Seconds Held If <10 Short Physical Performance Battery V1.2 - Side-By-Side Stand: Number of seconds held if less than 10 sec. SPPB Version 1.2 - Side-by-Side Seconds Held If <10 SPPB1-Tandem Seconds If <10 Short Physical Performance Battery V1.2 - Tandem Stand: Number of seconds if less than 10 sec. SPPB Version 1.2 - Tandem Seconds If <10 SPPB1-Tandem Stand Score Short Physical Performance Battery V1.2 - Tandem Stand: Tandem stand score. SPPB Version 1.2 - Tandem Stand Score SPPB1-Time for 3 or 4 Meters - 2nd Gait Short Physical Performance Battery V1.2 - Gait Speed Test - Second Gait Speed Test: Time for 3 or 4 meters. SPPB Version 1.2 - Time for 3 or 4 Meters - 2nd Gait SPPB1-Time for 3 or 4 Meters 1st Gait Short Physical Performance Battery V1.2 - Gait Speed Test - First Gait Speed Test: Time for 3 or 4 meters. SPPB Version 1.2 - Time for 3 or 4 Meters 1st Gait SPPB1-Time to Complete Five Stands Short Physical Performance Battery V1.2 - Chair Stand Test - Repeated Chair Stand Test: Time to complete five stands. SPPB Version 1.2 - Time to Complete Five Stands SPPB1-Total Balance Tests Score Short Physical Performance Battery V1.2 - Total balance tests score. SPPB Version 1.2 - Total Balance Tests Score SPPB1-Total Score Short Physical Performance Battery V1.2 - Total score. SPPB Version 1.2 - Total Score SPPB1TN Short Physical Performance Battery Version 1.2 Functional Test Test Name CDISC Functional Test SPPB Version 1.2 Test Name Terminology Short-Form McGill Pain Questionnaire-2 test code. SFMP2-Throbbing Pain Short-Form McGill Pain Questionnaire-2 - Throbbing pain. SF-MPQ-2 - Throbbing Pain SFMP2-Shooting Pain Short-Form McGill Pain Questionnaire-2 - Shooting pain. SF-MPQ-2 - Shooting Pain SFMP2-Stabbing Pain Short-Form McGill Pain Questionnaire-2 - Stabbing pain. SF-MPQ-2 - Stabbing Pain SFMP2-Sharp Pain Short-Form McGill Pain Questionnaire-2 - Sharp pain. SF-MPQ-2 - Sharp Pain SFMP2-Cramping Pain Short-Form McGill Pain Questionnaire-2 - Cramping pain. SF-MPQ-2 - Cramping Pain SFMP2-Gnawing Pain Short-Form McGill Pain Questionnaire-2 - Gnawing pain. SF-MPQ-2 - Gnawing Pain SFMP2-Hot-burning Pain Short-Form McGill Pain Questionnaire-2 - Hot-burning pain. SF-MPQ-2 - Hot-burning Pain SFMP2-Aching Pain Short-Form McGill Pain Questionnaire-2 - Aching pain. SF-MPQ-2 - Aching Pain SFMP2-Heavy Pain Short-Form McGill Pain Questionnaire-2 - Heavy pain. SF-MPQ-2 - Heavy Pain SFMP2-Tender Short-Form McGill Pain Questionnaire-2 - Tender. SF-MPQ-2 - Tender SFMP2-Splitting Pain Short-Form McGill Pain Questionnaire-2 - Splitting pain. SF-MPQ-2 - Splitting Pain SFMP2-Tiring-Exhausting Short-Form McGill Pain Questionnaire-2 - Tiring-exhausting. SF-MPQ-2 - Tiring-Exhausting SFMP2-Sickening Short-Form McGill Pain Questionnaire-2 - Sickening. SF-MPQ-2 - Sickening SFMP2-Fearful Short-Form McGill Pain Questionnaire-2 - Fearful. SF-MPQ-2 - Fearful SFMP2-Punishing-Cruel Short-Form McGill Pain Questionnaire-2 - Punishing-cruel. SF-MPQ-2 - Punishing-Cruel SFMP2-Electric-Shock Pain Short-Form McGill Pain Questionnaire-2 - Electric-shock pain. SF-MPQ-2 - Electric-Shock Pain SFMP2-Cold-Freezing Pain Short-Form McGill Pain Questionnaire-2 - Cold-freezing pain. SF-MPQ-2 - Cold-Freezing Pain SFMP2-Piercing Short-Form McGill Pain Questionnaire-2 - Piercing. SF-MPQ-2 - Piercing SFMP2-Pain Caused by Light Touch Short-Form McGill Pain Questionnaire-2 - Pain caused by light touch. SF-MPQ-2 - Pain Caused by Light Touch SFMP2-Itching Short-Form McGill Pain Questionnaire-2 - Itching. SF-MPQ-2 - Itching SFMP2-Tingling or 'Pins and Needles' Short-Form McGill Pain Questionnaire-2 - Tingling or 'pins and needles'. SF-MPQ-2 - Tingling or 'Pins and Needles' SFMP2-Numbness Short-Form McGill Pain Questionnaire-2 - Numbness. SF-MPQ-2 - Numbness SFMP2TC Short-Form McGill Pain Questionnaire-2 Questionnaire Test Code CDISC Questionnaire Short-Form MPQ-2 Test Code Terminology Short-Form McGill Pain Questionnaire-2 test name. SFMP2-Aching Pain Short-Form McGill Pain Questionnaire-2 - Aching pain. SF-MPQ-2 - Aching Pain SFMP2-Cold-Freezing Pain Short-Form McGill Pain Questionnaire-2 - Cold-freezing pain. SF-MPQ-2 - Cold-Freezing Pain SFMP2-Cramping Pain Short-Form McGill Pain Questionnaire-2 - Cramping pain. SF-MPQ-2 - Cramping Pain SFMP2-Electric-Shock Pain Short-Form McGill Pain Questionnaire-2 - Electric-shock pain. SF-MPQ-2 - Electric-Shock Pain SFMP2-Fearful Short-Form McGill Pain Questionnaire-2 - Fearful. SF-MPQ-2 - Fearful SFMP2-Gnawing Pain Short-Form McGill Pain Questionnaire-2 - Gnawing pain. SF-MPQ-2 - Gnawing Pain SFMP2-Heavy Pain Short-Form McGill Pain Questionnaire-2 - Heavy pain. SF-MPQ-2 - Heavy Pain SFMP2-Hot-burning Pain Short-Form McGill Pain Questionnaire-2 - Hot-burning pain. SF-MPQ-2 - Hot-burning Pain SFMP2-Itching Short-Form McGill Pain Questionnaire-2 - Itching. SF-MPQ-2 - Itching SFMP2-Numbness Short-Form McGill Pain Questionnaire-2 - Numbness. SF-MPQ-2 - Numbness SFMP2-Pain Caused by Light Touch Short-Form McGill Pain Questionnaire-2 - Pain caused by light touch. SF-MPQ-2 - Pain Caused by Light Touch SFMP2-Piercing Short-Form McGill Pain Questionnaire-2 - Piercing. SF-MPQ-2 - Piercing SFMP2-Punishing-Cruel Short-Form McGill Pain Questionnaire-2 - Punishing-cruel. SF-MPQ-2 - Punishing-Cruel SFMP2-Sharp Pain Short-Form McGill Pain Questionnaire-2 - Sharp pain. SF-MPQ-2 - Sharp Pain SFMP2-Shooting Pain Short-Form McGill Pain Questionnaire-2 - Shooting pain. SF-MPQ-2 - Shooting Pain SFMP2-Sickening Short-Form McGill Pain Questionnaire-2 - Sickening. SF-MPQ-2 - Sickening SFMP2-Splitting Pain Short-Form McGill Pain Questionnaire-2 - Splitting pain. SF-MPQ-2 - Splitting Pain SFMP2-Stabbing Pain Short-Form McGill Pain Questionnaire-2 - Stabbing pain. SF-MPQ-2 - Stabbing Pain SFMP2-Tender Short-Form McGill Pain Questionnaire-2 - Tender. SF-MPQ-2 - Tender SFMP2-Throbbing Pain Short-Form McGill Pain Questionnaire-2 - Throbbing pain. SF-MPQ-2 - Throbbing Pain SFMP2-Tingling or 'Pins and Needles' Short-Form McGill Pain Questionnaire-2 - Tingling or 'pins and needles'. SF-MPQ-2 - Tingling or 'Pins and Needles' SFMP2-Tiring-Exhausting Short-Form McGill Pain Questionnaire-2 - Tiring-exhausting. SF-MPQ-2 - Tiring-Exhausting SFMP2TN Short-Form McGill Pain Questionnaire-2 Questionnaire Test Name CDISC Questionnaire Short-Form MPQ-2 Test Name Terminology Simple Endoscopic Score for Crohn's Disease Version 1 test code. SES01-Ileum: Explored Simple Endoscopic Score for Crohn's Disease Version 1 - Was ileum explored? SES-CD Version 1 - Ileum: Explored SES01-Ileum: Size of Ulcers Simple Endoscopic Score for Crohn's Disease Version 1 - Size of ulcers - ileum. SES-CD Version 1 - Ileum: Size of Ulcers SES01-Ileum: Ulcerated Surface Simple Endoscopic Score for Crohn's Disease Version 1 - Ulcerated surface - ileum. SES-CD Version 1 - Ileum: Ulcerated Surface SES01-Ileum: Affected Surface Simple Endoscopic Score for Crohn's Disease Version 1 - Affected surface - ileum. SES-CD Version 1 - Ileum: Affected Surface SES01-Ileum: Presence of Narrowing Simple Endoscopic Score for Crohn's Disease Version 1 - Presence of narrowing - ileum. SES-CD Version 1 - Ileum: Presence of Narrowing SES01-Right Colon: Explored Simple Endoscopic Score for Crohn's Disease Version 1 - Was right colon explored? SES-CD Version 1 - Right Colon: Explored SES01-Right Colon: Size of Ulcers Simple Endoscopic Score for Crohn's Disease Version 1 - Size of ulcers - right colon. SES-CD Version 1 - Right Colon: Size of Ulcers SES01-Right Colon: Ulcerated Surface Simple Endoscopic Score for Crohn's Disease Version 1 - Ulcerated surface - right colon. SES-CD Version 1 - Right Colon: Ulcerated Surface SES01-Right Colon: Affected Surface Simple Endoscopic Score for Crohn's Disease Version 1 - Affected surface - right colon. SES-CD Version 1 - Right Colon: Affected Surface SES01-Right Colon: Presence of Narrowing Simple Endoscopic Score for Crohn's Disease Version 1 - Presence of narrowing - right colon. SES-CD Version 1 - Right Colon: Presence of Narrowing SES01-Trans Colon: Explored Simple Endoscopic Score for Crohn's Disease Version 1 - Was transverse colon explored? SES-CD Version 1 - Trans Colon: Explored SES01-Trans Colon: Size of Ulcers Simple Endoscopic Score for Crohn's Disease Version 1 - Size of ulcers - transverse colon. SES-CD Version 1 - Trans Colon: Size of Ulcers SES01-Trans Colon: Ulcerated Surface Simple Endoscopic Score for Crohn's Disease Version 1 - Ulcerated surface - transverse colon. SES-CD Version 1 - Trans Colon: Ulcerated Surface SES01-Trans Colon: Affected Surface Simple Endoscopic Score for Crohn's Disease Version 1 - Affected surface - transverse colon. SES-CD Version 1 - Trans Colon: Affected Surface SES01-Trans Colon: Presence of Narrowing Simple Endoscopic Score for Crohn's Disease Version 1 - Presence of narrowing - transverse colon. SES-CD Version 1 - Trans Colon: Presence of Narrowing SES01-Left Colon: Explored Simple Endoscopic Score for Crohn's Disease Version 1 - Was sigmoid and left colon explored? SES-CD Version 1 - Left Colon: Explored SES01-Left Colon: Size of Ulcers Simple Endoscopic Score for Crohn's Disease Version 1 - Size of ulcers - sigmoid and left colon. SES-CD Version 1 - Left Colon: Size of Ulcers SES01-Left Colon: Ulcerated Surface Simple Endoscopic Score for Crohn's Disease Version 1 - Ulcerated surface - sigmoid and left colon. SES-CD Version 1 - Left Colon: Ulcerated Surface SES01-Left Colon: Affected Surface Simple Endoscopic Score for Crohn's Disease Version 1 - Affected surface - sigmoid and left colon. SES-CD Version 1 - Left Colon: Affected Surface SES01-Left Colon: Presence of Narrowing Simple Endoscopic Score for Crohn's Disease Version 1 - Presence of narrowing - sigmoid and left colon. SES-CD Version 1 - Left Colon: Presence of Narrowing SES01-Rectum: Explored Simple Endoscopic Score for Crohn's Disease Version 1 - Was rectum explored? SES-CD Version 1 - Rectum: Explored SES01-Rectum: Size of Ulcers Simple Endoscopic Score for Crohn's Disease Version 1 - Size of ulcers - rectum. SES-CD Version 1 - Rectum: Size of Ulcers SES01-Rectum: Ulcerated Surface Simple Endoscopic Score for Crohn's Disease Version 1 - Ulcerated surface - rectum. SES-CD Version 1 - Rectum: Ulcerated Surface SES01-Rectum: Affected Surface Simple Endoscopic Score for Crohn's Disease Version 1 - Affected surface - rectum. SES-CD Version 1 - Rectum: Affected Surface SES01-Rectum: Presence of Narrowing Simple Endoscopic Score for Crohn's Disease Version 1 - Presence of narrowing - rectum. SES-CD Version 1 - Rectum: Presence of Narrowing SES01-Ileum Subscore Simple Endoscopic Score for Crohn's Disease Version 1 - Ileum subscore. SES-CD Version 1 - Ileum Subscore SES01-Right Colon Subscore Simple Endoscopic Score for Crohn's Disease Version 1 - Right colon subscore. SES-CD Version 1 - Right Colon Subscore SES01-Trans Colon Subscore Simple Endoscopic Score for Crohn's Disease Version 1 - Transverse colon subscore. SES-CD Version 1 - Trans Colon Subscore SES01-Left Colon Subscore Simple Endoscopic Score for Crohn's Disease Version 1 - Sigmoid and left colon subscore. SES-CD Version 1 - Left Colon Subscore SES01-Rectum Subscore Simple Endoscopic Score for Crohn's Disease Version 1 - Rectum subscore. SES-CD Version 1 - Rectum Subscore SES01-Total Score Simple Endoscopic Score for Crohn's Disease Version 1 - SES-CD total score. SES-CD Version 1 - Total Score SES01TC Simple Endoscopic Score for Crohn's Disease Version 1 Clinical Classification Test Code CDISC Clinical Classification SES-CD Version 1 Test Code Terminology Simple Endoscopic Score for Crohn's Disease Version 1 test name. SES01-Ileum Subscore Simple Endoscopic Score for Crohn's Disease Version 1 - Ileum subscore. SES-CD Version 1 - Ileum Subscore SES01-Ileum: Affected Surface Simple Endoscopic Score for Crohn's Disease Version 1 - Affected surface - ileum. SES-CD Version 1 - Ileum: Affected Surface SES01-Ileum: Explored Simple Endoscopic Score for Crohn's Disease Version 1 - Was ileum explored? SES-CD Version 1 - Ileum: Explored SES01-Ileum: Presence of Narrowing Simple Endoscopic Score for Crohn's Disease Version 1 - Presence of narrowing - ileum. SES-CD Version 1 - Ileum: Presence of Narrowing SES01-Ileum: Size of Ulcers Simple Endoscopic Score for Crohn's Disease Version 1 - Size of ulcers - ileum. SES-CD Version 1 - Ileum: Size of Ulcers SES01-Ileum: Ulcerated Surface Simple Endoscopic Score for Crohn's Disease Version 1 - Ulcerated surface - ileum. SES-CD Version 1 - Ileum: Ulcerated Surface SES01-Left Colon Subscore Simple Endoscopic Score for Crohn's Disease Version 1 - Sigmoid and left colon subscore. SES-CD Version 1 - Left Colon Subscore SES01-Left Colon: Affected Surface Simple Endoscopic Score for Crohn's Disease Version 1 - Affected surface - sigmoid and left colon. SES-CD Version 1 - Left Colon: Affected Surface SES01-Left Colon: Explored Simple Endoscopic Score for Crohn's Disease Version 1 - Was sigmoid and left colon explored? SES-CD Version 1 - Left Colon: Explored SES01-Left Colon: Presence of Narrowing Simple Endoscopic Score for Crohn's Disease Version 1 - Presence of narrowing - sigmoid and left colon. SES-CD Version 1 - Left Colon: Presence of Narrowing SES01-Left Colon: Size of Ulcers Simple Endoscopic Score for Crohn's Disease Version 1 - Size of ulcers - sigmoid and left colon. SES-CD Version 1 - Left Colon: Size of Ulcers SES01-Left Colon: Ulcerated Surface Simple Endoscopic Score for Crohn's Disease Version 1 - Ulcerated surface - sigmoid and left colon. SES-CD Version 1 - Left Colon: Ulcerated Surface SES01-Rectum Subscore Simple Endoscopic Score for Crohn's Disease Version 1 - Rectum subscore. SES-CD Version 1 - Rectum Subscore SES01-Rectum: Affected Surface Simple Endoscopic Score for Crohn's Disease Version 1 - Affected surface - rectum. SES-CD Version 1 - Rectum: Affected Surface SES01-Rectum: Explored Simple Endoscopic Score for Crohn's Disease Version 1 - Was rectum explored? SES-CD Version 1 - Rectum: Explored SES01-Rectum: Presence of Narrowing Simple Endoscopic Score for Crohn's Disease Version 1 - Presence of narrowing - rectum. SES-CD Version 1 - Rectum: Presence of Narrowing SES01-Rectum: Size of Ulcers Simple Endoscopic Score for Crohn's Disease Version 1 - Size of ulcers - rectum. SES-CD Version 1 - Rectum: Size of Ulcers SES01-Rectum: Ulcerated Surface Simple Endoscopic Score for Crohn's Disease Version 1 - Ulcerated surface - rectum. SES-CD Version 1 - Rectum: Ulcerated Surface SES01-Right Colon Subscore Simple Endoscopic Score for Crohn's Disease Version 1 - Right colon subscore. SES-CD Version 1 - Right Colon Subscore SES01-Right Colon: Affected Surface Simple Endoscopic Score for Crohn's Disease Version 1 - Affected surface - right colon. SES-CD Version 1 - Right Colon: Affected Surface SES01-Right Colon: Explored Simple Endoscopic Score for Crohn's Disease Version 1 - Was right colon explored? SES-CD Version 1 - Right Colon: Explored SES01-Right Colon: Presence of Narrowing Simple Endoscopic Score for Crohn's Disease Version 1 - Presence of narrowing - right colon. SES-CD Version 1 - Right Colon: Presence of Narrowing SES01-Right Colon: Size of Ulcers Simple Endoscopic Score for Crohn's Disease Version 1 - Size of ulcers - right colon. SES-CD Version 1 - Right Colon: Size of Ulcers SES01-Right Colon: Ulcerated Surface Simple Endoscopic Score for Crohn's Disease Version 1 - Ulcerated surface - right colon. SES-CD Version 1 - Right Colon: Ulcerated Surface SES01-Total Score Simple Endoscopic Score for Crohn's Disease Version 1 - SES-CD total score. SES-CD Version 1 - Total Score SES01-Trans Colon Subscore Simple Endoscopic Score for Crohn's Disease Version 1 - Transverse colon subscore. SES-CD Version 1 - Trans Colon Subscore SES01-Trans Colon: Affected Surface Simple Endoscopic Score for Crohn's Disease Version 1 - Affected surface - transverse colon. SES-CD Version 1 - Trans Colon: Affected Surface SES01-Trans Colon: Explored Simple Endoscopic Score for Crohn's Disease Version 1 - Was transverse colon explored? SES-CD Version 1 - Trans Colon: Explored SES01-Trans Colon: Presence of Narrowing Simple Endoscopic Score for Crohn's Disease Version 1 - Presence of narrowing - transverse colon. SES-CD Version 1 - Trans Colon: Presence of Narrowing SES01-Trans Colon: Size of Ulcers Simple Endoscopic Score for Crohn's Disease Version 1 - Size of ulcers - transverse colon. SES-CD Version 1 - Trans Colon: Size of Ulcers SES01-Trans Colon: Ulcerated Surface Simple Endoscopic Score for Crohn's Disease Version 1 - Ulcerated surface - transverse colon. SES-CD Version 1 - Trans Colon: Ulcerated Surface SES01TN Simple Endoscopic Score for Crohn's Disease Version 1 Clinical Classification Test Name CDISC Clinical Classification SES-CD Version 1 Test Name Terminology A terminology codelist relevant to the physical magnitude of something. Of considerable or relatively great size, extent, or capacity. (NCI) Large Mid-way between small and large in number, quantity, magnitude or extent. (NCI) Medium Limited in number, quantity, magnitude or extent. (NCI) Small SIZE Size Response CDISC SDTM Size Terminology A terminology codelist based on the test codes for dermal responses to antigens. Allergen Skin Response Index A relative measurement (ratio or percentage) of the allergen wheal size to the positive control wheal size in an allergen skin test. Allergen Skin Response Index Measurement Allergen Skin Response Intensity A semi-quantitative assessment of the intensity of the wheal and flare reaction. Allergen Skin Response Intensity Measurement Blistering Indicator An indication as to whether blistering occurred. Blistering Indicator Diameter The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) Diameter Flare Size The size of the area of redness that forms around the site of an antigenic challenge to the skin. Antigenic Skin Flare Size Measurement Flare Longest Diameter The longest diameter of the area of redness that forms at the site of an antigenic skin response. Antigenic Skin Flare Longest Diameter Measurement Flare Mean Diameter The mean diameter of the area of redness that forms around the site of an antigenic challenge to the skin. Antigenic Skin Flare Mean Diameter Measurement Induration Longest Diameter The longest diameter of an area of hardness in the skin. (NCI) Induration Longest Diameter Interpretation An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. Interpretation Reaction Grade The position on a scale to assess the degree of the response to a stimulus or intervention. Reaction Grade Wheal Size A semi-quantitative size assessment of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin. Wheal Size Measurement Wheal Diameter Interpretation The process of evaluating the wheal diameter in response to an allergen, based on a threshold size. Wheal Diameter Interpretation Wheal Longest Diameter The longest diameter of the flat, circular, slightly raised area that forms at the site of an antigenic skin response. Wheal Longest Diameter Wheal Mean Diameter The mean diameter of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin. Wheal Mean Diameter SRTESTCD Skin Response Test Code CDISC SDTM Skin Response Test Code Terminology A terminology codelist based on the test names for dermal responses to antigens. Allergen Skin Response Index A relative measurement (ratio or percentage) of the allergen wheal size to the positive control wheal size in an allergen skin test. Allergen Skin Response Index Measurement Allergen Skin Response Intensity A semi-quantitative assessment of the intensity of the wheal and flare reaction. Allergen Skin Response Intensity Measurement Blistering Indicator An indication as to whether blistering occurred. Blistering Indicator Diameter The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) Diameter Flare Longest Diameter The longest diameter of the area of redness that forms at the site of an antigenic skin response. Antigenic Skin Flare Longest Diameter Measurement Flare Mean Diameter The mean diameter of the area of redness that forms around the site of an antigenic challenge to the skin. Antigenic Skin Flare Mean Diameter Measurement Flare Size The size of the area of redness that forms around the site of an antigenic challenge to the skin. Antigenic Skin Flare Size Measurement Induration Longest Diameter The longest diameter of an area of hardness in the skin. (NCI) Induration Longest Diameter Interpretation An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. Interpretation Reaction Grade The position on a scale to assess the degree of the response to a stimulus or intervention. Reaction Grade Wheal Diameter Interpretation The process of evaluating the wheal diameter in response to an allergen, based on a threshold size. Wheal Diameter Interpretation Wheal Longest Diameter The longest diameter of the flat, circular, slightly raised area that forms at the site of an antigenic skin response. Wheal Longest Diameter Wheal Mean Diameter The mean diameter of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin. Wheal Mean Diameter Wheal Size A semi-quantitative size assessment of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin. Wheal Size Measurement SRTEST Skin Response Test Name CDISC SDTM Skin Response Test Name Terminology A terminology codelist relevant to the distinctive characteristic of the skin marked by the amount of sebum secreted by sebaceous glands. The pores are generally fine with a papery thin texture that feels dry to the touch. Usually flaky and dull looking. Dry Skin The pores are visible but not large. The texture is neither fine or thick and it neither feels dry or oily to the touch. Normal Skin The pores of the skin are generally large and visible with a coarse or thick texture. It has a tendency to look dull and greasy and feels oily to the touch. Oily Skin SKINTYP Skin Type Response CDISC SDTM Skin Type Terminology A terminology codelist relevant to the social factors such as personal behavior, lifestyle, or environment belonging to the subject which are known to increase the likelihood of infection and disease. An individual that has come into contact with a disease source. Subject in Contact With Disease Source An individual who is presently or not long ago worked or offered to assist without pay at a temporary housing facility for persons without a stable or permanent residence. Current or Recent Employee or Volunteer in Homeless Shelter An individual who is presently or not long ago worked or offered to assist without pay at an institution where persons are confined for punishment and to protect the public. Current or Recent Employee or Volunteer in Jail or Prison An individual who is presently or not long ago worked or offered to assist without pay at a residential health care facility for persons with chronic illness or disability. Current or Recent Employee or Volunteer in Nursing Home The individual has one or more tattoos. Currently or Previously Tattooed An individual without a stable or permanent residence within the last 365 days. Homeless During Past Year An individual that has migrated from an area with a high incidence of a disease. Immigrant From High Disease Burden Area The state of being confined to jail or prison. Incarceration An individual that resided in a camp for those displaced from their homeland. Lived in Refugee Camp An individual that lives at a healthcare facility that provides rehabilitative, restorative, and/or ongoing skilled nursing care to patients or residents in need of assistance with activities of daily living. Long-term Facility Resident An individual who moves from one location to another location within or outside of their homeland for work. Migratory Worker An individual that has fled an area, which has a high incidence of a disease, for their own safety. Refugee From High Disease Burden Area An individual that has traveled to an area with a high incidence of a disease. Travel to High Burden Area The state of not having a job. Unemployed RISKSOC Social Risk Factor CDISC SDTM Social Risk Factor Terminology Terminology relevant to the method used in specimen collection. A technique in which suction is used to remove bodily fluid or tissue. Aspiration The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis. Biopsy Procedure CNB Core Needle Biopsy Needle Biopsy A type of biopsy in which a tissue sample is removed using a needle with a relatively large diameter. Core Biopsy Excision Biopsy Excisional Biopsy A type of biopsy in which an entire lesion is removed for microscopic examination. Excisional Biopsy A type of urine collection method in which a sterile wipe is applied to the area around the urethra and the collection cup is placed into the urine mid-stream, after urination has begun. Clean Catch Mid-Stream The removal of tissue or fluid specimens from the body via a catheter. Catheterization Collection Method The removal of tissue with a curette (a spoon-shaped instrument with a sharp edge). Curettage Procedure The act of cutting out; the surgical removal of part or all of a structure or organ. (NCI) Excision A technique in which material is cleared from the throat or lungs by coughing it up and spitting it out. Expectorate The removal of tissue specimens or fluid from the living body with a thin needle. Fine-Needle Aspiration A technique in which the tip of a finger is pricked with a lancing device to obtain a small quantity of capillary blood. Finger Stick A technique in which a specimen flows out of the body through a tube due to the force of gravity. Gravity Drip Collection Method A non-invasive specimen collection technique where cellulose acetate filter paper is applied to a body surface (e.g., ocular surface) to collect superficial epithelial cells, which can be air-dried or fixed and then stained for histological, immunohistological, or molecular analysis. Impression Cytology A technique in which hypotonic saline is inhaled, followed by expectoration. Induced Expectoration Technique Wash A technique in which a fluid is introduced and collected from a body cavity or location. Lavage Leukocyte Adsorptive Apheresis Leukocytopheresis White Blood Cell Reduction Apheresis A procedure that separates and collects white blood cells from the peripheral blood while returning the remainder to the donor's circulation. Leukapheresis A technique in which a small amount of fluid is introduced and collected from a more localized body cavity or location. Mini-Lavage PBS Protected Specimen Brush Sampling Protected Specimen Brushing PSB The removal of tissue specimens or fluid from the living body with a sterile brush catheter that is pushed out of its sealed sheath at a specific sampling location. Protected-Brush Sampling A surgical procedure in which tissue is removed from the body. Resection A technique in which a tufted material on the end of a stick is rubbed against a surface. Swab Adhesive Tape Method A technique for specimen collection that utilizes an adhesive-based ribbon. Tape Adhesion Specimen Collection Method CLMETH Specimen Collection Method CDISC SDTM Specimen Collection Method Terminology The physical state or quality of a biological specimen. Agglutinated Specimen A specimen that has undergone agglutination, a process by which particles collect to form a cohesive mass or cluster. Agglutinated Specimen Autolyzed Specimen A specimen that has undergone autolysis, or self-digestion by the specimen's own digestive enzymes. (NCI) Autolyzed Specimen Calcified Specimen A specimen that has undergone calcification. (NCI) Calcified Specimen Cauterized Specimen A specimen that has been cauterized. Cauterized Specimen Clotted Specimen Coagulated Specimen A specimen that has become coagulated. (NCI) Clotted Specimen Concentrated Specimen A specimen that has undergone concentration to increase the content of a targeted entity. Concentrated Specimen Contaminated Specimen The presence of any substance or organism that makes a preparation impure. (NCI) Contaminated Diluted Specimen A specimen that has been reduced in strength or concentration by the addition of diluent. Diluted Specimen Dried Specimen A specimen that has become desiccated or dehydrated. Dried Specimen Fresh Specimen A specimen that is analyzed in the state that it was collected. Fresh Specimen Frozen Specimen A specimen that has been subjected to and immobilized by severe cold. (NCI) Frozen Specimen Gelled Specimen A specimen that has a gelatinous consistency. (NCI) Gelatinous Specimen Hemolysis in Specimen Hemolyzed Specimen A specimen that has undergone the destruction of red blood cells followed by the release of the hemoglobin. (NCI) Hemolysis in Specimen Icteric Specimen A specimen that exhibits a yellowish pigmentation due to jaundice. (NCI) Icteric Specimen Lactescent Specimen A specimen that has become or appears milky. Lactescent Specimen Lipemic Specimen A specimen that consists of or contains excessive amounts of fat and fatty substances. (NCI) Lipemic Specimen Non-Hemolyzed Specimen A specimen that has not undergone the destruction of red blood cells followed by the release of the hemoglobin. Non-Hemolyzed Specimen Paraffin Block Paraffin-Embedded Specimen A specimen that has been fixed and preserved in paraffin. Paraffin Embedded Tissue Precipitated Specimen A specimen that has undergone precipitation, a process by which solids are settled out of a solution. Precipitated Specimen Refrigerated Specimen A specimen that has been kept or preserved at a low temperature in a refrigerator. (NCI) Refrigerated Specimen Specimen at Ambient Temperature Specimen at Room Temperature A specimen that has been subjected to and adjusted to the average ambient temperature of a room, usually considered to be around 20 degrees C (68 degrees F). (NCI) Specimen at Room Temperature Solidified Specimen A specimen that has a regular, firm consistency and retains a definite size and shape. Solidified Specimen Thawed Specimen A specimen that has changed from a frozen to a liquid or semi-liquid state. Thawed Specimen Specimen with Atypical Color Specimen with Unexpected Color A specimen that has an unanticipated color. Specimen with Unexpected Color Specimen with Unexpected Odor A specimen that has an unanticipated odor. Specimen with Unexpected Odor SPECCOND Specimen Condition CDISC SDTM Specimen Condition Terminology The name and description of a biological specimen. The fluid that is abnormally collected in localized areas of damaged tissue within the body, usually composed of living and dead white blood cells, bacteria, and dead tissue. Abscess Fluid Body Fat Fat Tissue Connective tissue consisting primarily of adipocytes (fat cells) and supporting structural matrix. Adipose Tissue The gas from the alveoli of the lungs. Alveolar Air Aqua Amnii The fluid within the amniotic cavity which surrounds and protects the developing embryo. (NCI) Amniotic Fluid Aqueous Humour The watery fluid which is present in the anterior and posterior chambers of the eye. (NCI) Aqueous Humor Oxygenated blood which is transported with nutrients to body tissues through the arterial system. The exception is blood within the pulmonary artery which carries deoxygenated blood to the lungs. (NCI) Arterial Blood Blood present in the umbilical arteries at the time of delivery. Arterial Cord Blood A plasma sample that is prepared from arterial blood. Arterial Plasma Capillary blood collected from a puncture site that has been warmed or treated with creams containing a hyperemic or vasodilatory agent to increase arterial blood flow. Arterialized Capillary Blood Fatty tissue which is deposited in the inner lining of the arterial wall. (NCI) Atherosclerotic Plaque A type of tear produced continually to keep the cornea moist; contains salts, water, and mucus. Basal Tear Fluid composed of waste products, bile acids, salts, cholesterol, and electrolytes. It is produced by the liver and may be stored in the gallbladder (if present). Bile Peripheral Blood Whole Blood A liquid tissue with the primary function of transporting oxygen and carbon dioxide. It supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Blood BMMC Any cell with a single nucleus found in the bone marrow, for example lymphocytes, monocytes, mesenchymal stem cells and hematopoietic progenitor cells. Bone Marrow Mononuclear Cell The tissue occupying the spaces of some bones. It consists of blood vessel sinuses and a network of hematopoietic cells. Bone Marrow The solid, spongey portion of bone marrow, consisting of blood vessel sinuses, hematopoietic cells, and trabecular bone. Bone Marrow Core Biopsy Sample Bone Marrow Aspirate The liquid portion of bone marrow, consisting of small tissue fragments, hematopoietic cells, and peripheral blood. Bone Marrow Aspirate Calcified connective tissue that forms the skeletal components of the body. (NCI) Bone A liquid produced by the mammary gland. Mammary Gland Milk The middle fraction of an anticoagulated blood specimen following separation by centrifugation. It contains most of the white blood cells and platelets. Buffy Coat Calculi A concretion of material in the body, usually composed of mineral salts. Representative examples include gallbladder stones, kidney stones, and salivary gland stones. Stone A mixture of arterial blood, venous blood and interstitial fluid, which is found in the capillaries. Capillary Blood A plasma sample that is prepared from capillary blood. Capillary Plasma Myocardium The striated muscle tissue of the heart enveloped by the epicardium and the endocardium. (NCI) Myocardium A cell sample that has been compacted by centrifugation. Cell Pellet CSF The fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord. (NCI) Cerebrospinal Fluid A wax secreted by glands in the ear canal. Cerumen The watery fluid secreted from the glands and associated structures of the cervicovaginal region. Cervicovaginal Secretion CTC A metastatic cancer cell found in the peripheral blood. (NCI) Circulating Tumor Cell A thick, protein-rich substance secreted by the breasts during the second half of pregnancy and for a few days after birth before the breast milk comes in. Human Colostrum Umbilical Cord Blood Blood present in the umbilical vessels at the time of delivery. Umbilical Cord Blood Umbilical Cord Plasma The fluid (acellular) portion of the circulating blood with retained clotting components from the cord blood of a newborn baby. Umbilical Cord Plasma Umbilical Cord Serum The clear portion of the blood that remains after the removal of the blood cells and the clotting proteins from the cord blood of a newborn baby. Umbilical Cord Serum The cells and connective tissue from the inner layer of the two main layers of the skin. The dermis has connective tissue, blood vessels, oil and sweat glands, nerves, hair follicles, and other structures. It is made up of a thin upper layer called the papillary dermis, and a thick lower layer called the reticular dermis. Dermis Dialysate The fluid which runs through a dialysis machine and captures, for discard or analysis, the excess water and waste from the blood stream through diffusion and ultrafiltration. (NCI) Dialysis Fluid PD Fluid Peritoneal Dialysate The dialysis fluid which is collected from the peritoneal space and captures, for discard or analysis, the excess water and waste from the blood stream through diffusion and ultrafiltration. (NCI) Peritoneal Dialysis Fluid Normal or abnormal secretions expelled from a body location. Discharge Body Fluid Endogenously generated droplets present in exhaled air, containing water and non-volatile material, which originate from the surfactant and respiratory tract lining fluid from the most distal airways. Distal Respiratory Exhaled Particles Emesis Vomitus Partially digested gastric contents that are returned to the mouth or beyond via the vomit reflex present in some species. Vomitus Psychic Tear A type of tear produced in response to negative or positive emotions; contains higher amounts of proteins and stress-related hormones in comparison to other tear types. Emotional Tear A specimen that consists of the cells and connective tissue of the endometrium. Endometrial Tissue Endotracheal Aspirate Fluid ETA Fluid Tracheal Aspirate Tracheal Aspirate Fluid The fluid collected from the lumen of the trachea. Endotracheal Fluid The cells and connective tissue from the epithelial portion of the skin (cutis). It consists of the following layers: stratum corneum (horny layer), stratum granulosum (granular layer), stratum spinosum (prickle cell layer), and stratum basale (basal cell layer). Epidermis Any of the cells of the epithelium, which covers the body and lines its cavities and glands. Epithelial Cell RBC Red Blood Cells Cell specialized for oxygen transport, having a high concentration of hemoglobin in the cytoplasm and little else; biconcave, anucleate discs, 7nm diameter in mammals. Erythrocyte Expired air that has been condensed. Exhaled Breath Condensate Exhaled Breath Expired Breath The air that moves out of the chest during expiration. It contains a higher percentage of carbon dioxide and a lower percentage of oxygen compared to the inhaled air. (NCI) Expired Air Accumulation of extravasated fluid containing inflammatory cells and fibrin. Necrotic debris and/or other cellular and extracellular components may also be present. Exudate A connective tissue cell that secretes collagen, a component of the extracellular matrix. Fibroblast Liquid substances produced by the body. Body Fluid or Substance Stomach Contents The contents of the stomach that may include undigested food mixed with juices secreted by the gastric mucosal glands. (NCI) Gastric Content The fluid produced by the stomach glands, composed of gastric acids and enzymes. (NCI) Gastric Fluid A type of leukocyte containing a nucleus and cytoplasmic granules. Granulocytes are subdivided according to the staining properties of their granules into eosinophils, basophils, and neutrophils. Granulocyte A tube-like invagination of the epidermis from which the hair shaft develops and into which the sebaceous glands open; the follicle is lined by a cellular inner and outer root sheath of epidermal origin and is invested with a fibrous sheath derived from the dermis. (NCI) Hair Follicle Hair The filamentous outgrowth of the epidermis. (NCI) Hair The liquid, solid or semi-solid lying below a liquid residue, which is separated by crystallization, precipitation or centrifugation of a plasma sample. (NCI) Plasma Infranatant The liquid, solid or semi-solid lying below a liquid residue, which is separated by crystallization, precipitation or centrifugation of a pleural fluid sample. (NCI) Pleural Fluid Infranatant The liquid, solid or semi-solid lying below a liquid residue, which is separated by crystallization, precipitation or centrifugation of a serum sample. (NCI) Serum Infranatant The extracellular fluid component found in the spaces between tissues. This excludes plasma and transcellular fluid. Interstitial Fluid Microbial Isolate A specific individual microbe and its genetically identical progeny separated on a single occasion from a sample taken from a host or culture system. Isolate The keratin-producing cell of the epidermis that forms in the deep basal layer of the stratified epithelium. Keratinocyte Wash Fluid Fluid introduced and collected from a body cavity or location by lavage or wash procedure. Lavage Fluid Blood cells that are devoid of hemoglobin, capable of amoeboid motion and phagocytosis, and act as the principal components of the immune system. Leukocyte Vaginal discharge occurring during the post-partum period. It consists of a mixture of blood, mucus, and placental remnants. (NCI) Lochia Pulmonary surfactant lines the lung epithelium and lowers surface tension to prevent collapse at end-expiration. Deficiency of pulmonary surfactant results in respiratory distress syndrome (RDS) in premature infants. Lung surfactant is synthesized in alveolar type II cells, stored in lamellar bodies and secreted via exocytosis. (NCI) Lung Surfactant Tissue composed of specialized cells that are organized as a definite organ, situated along the course of lymphatic vessels, and consisting of an outer cortical and an inner medullary part. Lymph Node Tissue A clear, transparent, sometimes faintly yellow and slightly opalescent fluid that is collected from the tissues throughout the body, flows in the lymphatic vessels (through the lymph nodes), and is eventually added to the venous blood circulation. Lymph consists of a clear liquid portion, varying numbers of white blood cells (chiefly lymphocytes), and a few red blood cells. (NCI) Lymph White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Lymphocyte The cellular debris and fluid produced by lysis of cells. Lysate The newborn's first intestinal discharge. It is a dark-green, thick substance composed of mucus, intestinal secretions, hair, and intestinal mucosa cells. (NCI) Meconium The discharged blood from the uterus during the reproductive years. The discharge occurs approximately once a month. (NCI) Menstrual Blood The de-oxygenated blood flowing into the right side of the heart, composed of a mixture of venous blood from the entirety of the systemic circulation. Mixed Venous Blood A large, phagocytic mononuclear leukocyte produced in the vertebrate bone marrow and released into the blood; containing a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte The thick fluid secreted by the mucus glands in the aerodigestive tract and the vagina. (NCI) Mucus Tissue responsible for body and internal organ movement. Muscle tissue is composed of specialized contractile cells. Muscle Tissue Nail The cutaneous plate on the dorsal surface of the distal end of a finger or toe. (NCI) Nail Cells resembling large granular lymphocytes that do not express markers of either T or B cell lineage. These cells express Fc receptors for IgG and can kill target cells using antibody-dependent cell-mediated cytotoxicity. They can also use perforin to kill cells in the absence of antibody, and may occur without previous sensitization. Natural Killer Cell The fluid within the pericardial cavity. Pericardial Effusion PBMC A peripheral blood cell with a single nucleus, for example lymphocytes and monocytes. Peripheral Blood Mononuclear Cell PBSC An immature (progenitor) cell circulating in the peripheral blood. It has the capacity for replication and differentiation to mature blood cells. Peripheral Blood Stem Cell The fluid within the peritoneal cavity. Peritoneal Fluid Sweat The liquid secreted by the sweat glands. (NCI) Sweat The fluid that is produced from the movement of whole blood across a semipermeable membrane in response to a pressure gradient, removing blood cells and large proteins. Plasma Ultrafiltrate The fluid (acellular) portion of the circulating blood with retained clotting components. Plasma PPP A plasma sample that is prepared from whole blood, which has undergone a number of centrifugation steps to decrease the amount of platelets. (NCI) Platelet-poor Plasma PRP A plasma sample that is prepared from whole blood, which has undergone a number of centrifugation steps to concentrate the amount of platelets. (NCI) Platelet-rich Plasma Thrombocyte An irregular, disc-shaped structure in the blood that assists in blood clotting. Platelets are not blood cells, they are fragments of large bone marrow cells called megakaryocytes. (NCI) Platelet The fluid within the pleural cavity. Pleural Fluid The serous membrane that lines the wall of the thoracic cavity and the surface of the lungs. Pleura A slightly alkaline, white fluid secreted from the prostate and is a constituent of semen. Prostatic Fluid A yellowish substance produced during bacterial inflammation. It contains necrotic cells and cells fighting the infection. (NCI) Pus A type of tear produced in response to irritation from foreign particles, vapors, bright lights, or peppery substances; contains higher amounts of antibodies in comparison to other tear types. Reflex Tear Immature erythrocytes that have just undergone extrusion of their cell nucleus. They still contain some organelles that gradually decrease in number as the cells mature. Reticulocyte A clear liquid secreted by the salivary glands. Saliva A thick, oily substance produced by the sebaceous glands located in the dermis. (NCI) Sebum The fluid containing the spermatozoa, secreted by the testes and accessory reproductive glands of the male. Semen Part of the ejaculated fluid. It contains secretions from the seminal vesicles, Cowper gland, and prostate gland. Seminal Fluid Ser/Plas/Bld A specimen type consisting of serum or plasma or blood. Serum or Plasma or Blood Ser/Plas The non-cellular portion of the circulating blood, with or without the clotting proteins present. Serum or Plasma Sera The clear portion of the blood that remains after the removal of the blood cells and the clotting proteins. (NCI) Serum Voluntary, striated muscle tissue predominantly associated with the skeleton. Skeletal Muscle Tissue Tissue composed of three layers, epidermis, dermis and subcutis which protect underlying muscles and organs. Skin Tissue A white secretion of the sebaceous glands of the foreskin. (NCI) Smegma Primarily involuntary, non-striated muscle tissue of the internal organs and blood vessels. Smooth Muscle Tissue Soft Tissue Refers to muscle, fat, fibrous tissue, blood vessels, organ parenchyma, or other supporting tissue of the body. Soft Tissue Sperm Cell The male reproductive cell that is formed in the testicle. A sperm consists of a head, a body, and a tail that provides propulsion. Spermatozoon Material containing mucus, cellular debris, microorganisms and sometimes blood or pus. It is ejected through the mouth from the lungs, bronchi, and trachea. (NCI) Sputum Feces The material discharged from the bowel during defecation. It consists of undigested food, intestinal mucus, epithelial cells, and bacteria. (NCI) Feces Striated muscles are appendicular and axial muscles typically connected at either or both ends to the bony skeleton of the body. Striated muscle fibers contain a highly organized, contractile cytoskeletal apparatus with a striated microscopic appearance; muscle contraction is typically under voluntary control. (NCI) Striated Muscle Tissue The liquid lying above a liquid, solid or semi-solid residue, which is separated by crystallization, precipitation or centrifugation of a cerebrospinal fluid sample. (NCI) Cerebrospinal Fluid Supernatant The liquid lying above a liquid, solid or semi-solid residue, which is separated by crystallization, precipitation or centrifugation of a lavage fluid sample. Lavage Fluid Supernatant The liquid lying above a liquid, solid or semi-solid residue, which is separated by crystallization, precipitation or centrifugation of a peritoneal fluid sample. (NCI) Peritoneal Supernatant The liquid lying above a liquid, solid or semi-solid residue, which is separated by crystallization, precipitation or centrifugation of a plasma sample. (NCI) Plasma Supernatant The liquid lying above a liquid, solid or semi-solid residue, which is separated by crystallization, precipitation or centrifugation of a pleural fluid sample. (NCI) Pleural Fluid Supernatant The liquid lying above a liquid, solid or semi-solid residue, which is separated by crystallization, precipitation or centrifugation of a serum or plasma sample. (NCI) Serum or Plasma Supernatant The liquid lying above a liquid, solid or semi-solid residue, which is separated by crystallization, precipitation or centrifugation of a serum sample. (NCI) Serum Supernatant A heterogeneous and variable aggregate of body fluids, tissues, cells, microorganisms, and other materials that are collected from a swab biospecimen collection procedure. Swabbed Material Synovia The fluid within a joint capsule. Synovial Fluid The fluid secreted by the lacrimal apparatus. Tear An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function. (NCI) Tissue The fluid that passes through the wall of the veins and capillaries to the surrounding tissues because of increased intravascular pressure. It has low protein content. (NCI) Transudate A tumor sample, or entire tumor that is removed for examination. Tumor Tissue Sample Material separated from urine. Urine Sediment The fluid produced by the kidneys. Urine Deoxygenated blood containing urea and other waste products which is transported through the venous system to the heart and lungs. The exception is blood within the pulmonary vein which is oxygenated and travels from the lungs to the left atrium of the heart. (NCI) Venous Blood Blood present in the umbilical vein at the time of delivery. Venous Cord Blood A plasma sample that is prepared from venous blood. Venous Plasma The clear colorless transparent jelly that fills the posterior chamber of the eyeball. (NCI) Vitreous Humor The nerve tissue forming the bulk of the deep parts of the brain and the superficial parts of the spinal cord. It is composed of nerve cell processes, i.e. extensions (axons), which connect various gray matter areas of the brain to each other and carry nerve impulses to and from the nerve cell bodies within the central nervous system (neurons). (NCI) White Matter SPECTYPE Specimen Type CDISC SDTM Specimen Type Terminology St. George's Respiratory Questionnaire for COPD Patients test code. SGRQC1-Describe Your Current Health St. George's Respiratory Questionnaire - Please check one box to show how you describe your current health. SGRQ-C - Description of Your Current Health SGRQC1-I Cough St. George's Respiratory Questionnaire - I cough. SGRQ-C - Cough SGRQC1-I Bring Up Phlegm St. George's Respiratory Questionnaire - I bring up phlegm (sputum). SGRQ-C - Bring Up Phlegm SGRQC1-I Have Shortness of Breath St. George's Respiratory Questionnaire - I have shortness of breath. SGRQ-C - Have Shortness of Breath SGRQC1-I Have Attacks of Wheezing St. George's Respiratory Questionnaire - I have attacks of wheezing. SGRQ-C - Have Attacks of Wheezing SGRQC1-How Many Respiratory Attacks St. George's Respiratory Questionnaire - How many respiratory attacks did you have during the last year? SGRQ-C - Number of Respiratory Attacks Last Year SGRQC1-How Often Do You Have Good Days St. George's Respiratory Questionnaire - How often do you have good days (with few respiratory problems)? SGRQ-C - Good Days with Few Respiratory Problems SGRQC1-Wheeze Worse in the Morning St. George's Respiratory Questionnaire - If you wheeze, is it worse when you get up in the morning? SGRQ-C - Wheezing Worse In the Morning SGRQC1-Describe Your Resp Problems St. George's Respiratory Questionnaire - How would you describe your respiratory problems? SGRQ-C - Description of Your Respiratory Problems SGRQC1-Washing or Dressing Yourself St. George's Respiratory Questionnaire - Questions about what activities usually make you feel breathless: Washing or dressing yourself. SGRQ-C - Feel Breathless Washing or Dressing Yourself SGRQC1-Walking Around the House St. George's Respiratory Questionnaire - Questions about what activities usually make you feel breathless: Walking around the house. SGRQ-C - Feel Breathless Walking Around the House SGRQC1-Walking Outside on Level Ground St. George's Respiratory Questionnaire - Questions about what activities usually make you feel breathless: Walking outside on level ground. SGRQ-C - Feel Breathless Walking Outside on Level Ground SGRQC1-Walking Up a Flight of Stairs St. George's Respiratory Questionnaire - Questions about what activities usually make you feel breathless: Walking up a flight of stairs. SGRQ-C - Feel Breathless Walking Up a Flight of Stairs SGRQC1-Walking Up Hills St. George's Respiratory Questionnaire - Questions about what activities usually make you feel breathless: Walking up hills. SGRQ-C - Feel Breathless Walking Up Hills SGRQC1-Coughing Hurts St. George's Respiratory Questionnaire - Some more questions about your cough and breathlessness: Coughing hurts. SGRQ-C - Coughing Hurts SGRQC1-Coughing Makes Me Tired St. George's Respiratory Questionnaire - Some more questions about your cough and breathlessness: Coughing makes me tired. SGRQ-C - Coughing Makes Me Tired SGRQC1-Short of Breath When Talk St. George's Respiratory Questionnaire - Some more questions about your cough and breathlessness: I am short of breath when I talk. SGRQ-C - Short of Breath When Talk SGRQC1-Short of Breath When Bend Over St. George's Respiratory Questionnaire - Some more questions about your cough and breathlessness: I am short of breath when I bend over. SGRQ-C - Short of Breath When Bend Over SGRQC1-Coughing Disturbs My Sleep St. George's Respiratory Questionnaire - Some more questions about your cough and breathlessness: My coughing or breathing disturbs my sleep. SGRQ-C - Coughing Disturbs My Sleep SGRQC1-Get Exhausted Easily St. George's Respiratory Questionnaire - Some more questions about your cough and breathlessness: I get exhausted easily. SGRQ-C - Get Exhausted Easily SGRQC1-Cough Is Embarrassing in Public St. George's Respiratory Questionnaire - Questions about other effects that your respiratory problems may have on you: My cough or breathing is embarrassing in public. SGRQ-C - Cough Is Embarrassing in Public SGRQC1-Respiratory Problems a Nuisance St. George's Respiratory Questionnaire - Questions about other effects that your respiratory problems may have on you: My respiratory problems are a nuisance to my family, friends or neighbours. SGRQ-C - Respiratory Problems a Nuisance to Family, Friends or Neighbours SGRQC1-Afraid When Cannot Catch Breath St. George's Respiratory Questionnaire - Questions about other effects that your respiratory problems may have on you: I get afraid or panic when I cannot catch my breath. SGRQ-C - Afraid or Panic When Cannot Catch Breath SGRQC1-Not in Control of Resp Problems St. George's Respiratory Questionnaire - Questions about other effects that your respiratory problems may have on you: I feel that I am not in control of my respiratory problems. SGRQ-C - Not in Control of Respiratory Problems SGRQC1-Frail Because of Resp Problems St. George's Respiratory Questionnaire - Questions about other effects that your respiratory problems may have on you: I have become frail or an invalid because of my respiratory problems. SGRQ-C - Become Frail Because of Respiratory Problems SGRQC1-Exercise Is Not Safe for Me St. George's Respiratory Questionnaire - Questions about other effects that your respiratory problems may have on you: Exercise is not safe for me. SGRQ-C - Exercise Is Not Safe for Me SGRQC1-Everything Too Much Effort St. George's Respiratory Questionnaire - Questions about other effects that your respiratory problems may have on you: Everything seems too much of an effort. SGRQ-C - Everything Seems Too Much Effort SGRQC1-Take a Long Time to Get Washed St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: I take a long time to get washed or dressed. SGRQ-C - Take a Long Time to Get Washed or Dressed SGRQC1-Cannot Take a Bath or Shower St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: I cannot take a bath or shower, or I take a long time to do it. SGRQ-C - Cannot Take a Bath or Shower SGRQC1-Walk Slow Than Others My Age St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: I walk slower than other people my age, or I stop to rest. SGRQ-C - Walk Slower Than Other People My Age SGRQC1-Jobs Take a Long Time St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: Jobs such as household chores take a long time, or I have to stop to rest. SGRQ-C - Jobs Take a Long Time SGRQC1-Walk Up Flight of Stairs Slowly St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: If I walk up one flight of stairs, I have to go slowly or stop. SGRQ-C - Walk Up Flight of Stairs Slowly SGRQC1-If I Hurry, I Have to Stop St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: If I hurry or walk fast, I have to stop or slow down. SGRQ-C - If Walk Fast Have to Stop SGRQC1-Difficult to Walk Up Hills St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as walk up hills, carry things up stairs, light gardening such as weeding, dance, bowl or play golf. SGRQ-C - Difficult to Walk Up Hills SGRQC1-Difficult to Carry Heavy Loads St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as carry heavy loads, dig in the garden or shovel snow, jog or walk briskly (5 miles per hour), play tennis or swim. SGRQ-C - Difficult to Carry Heavy Loads SGRQC1-Cannot Play Sports St. George's Respiratory Questionnaire - We would like to know how your respiratory problems usually affect your daily life: I cannot play sports or do other physical activities. SGRQ-C - Respiratory Problems Affect Daily Life: Cannot Play Sports SGRQC1-Cannot Go Out for Entertainment St. George's Respiratory Questionnaire - We would like to know how your respiratory problems usually affect your daily life: I cannot go out for entertainment or recreation. SGRQ-C - Respiratory Problems Affect Daily Life: Cannot Go Out for Entertainment SGRQC1-Cannot Go Out to Do Shopping St. George's Respiratory Questionnaire - We would like to know how your respiratory problems usually affect your daily life: I cannot go out of the house to do the shopping. SGRQ-C - Respiratory Problems Affect Daily Life: Cannot Go Out to Do Shopping SGRQC1-Cannot Do Household Chores St. George's Respiratory Questionnaire - We would like to know how your respiratory problems usually affect your daily life: I cannot do household chores. SGRQ-C - Respiratory Problems Affect Daily Life: Cannot Do Household Chores SGRQC1-Cannot Move Far From My Bed St. George's Respiratory Questionnaire - We would like to know how your respiratory problems usually affect your daily life: I cannot move far from my bed or chair. SGRQ-C - Respiratory Problems Affect Daily Life: Cannot Move Far From Bed SGRQC1-How Resp Problems Affect You St. George's Respiratory Questionnaire - How do your respiratory problems affect you? SGRQ-C - How Respiratory Problems Affect You SGRQC1TC St. George's Respiratory Questionnaire for COPD Patients Questionnaire Test Code CDISC Questionnaire SGRQ-C Test Code Terminology St. George's Respiratory Questionnaire for COPD Patients test name. SGRQC1-Afraid When Cannot Catch Breath St. George's Respiratory Questionnaire - Questions about other effects that your respiratory problems may have on you: I get afraid or panic when I cannot catch my breath. SGRQ-C - Afraid or Panic When Cannot Catch Breath SGRQC1-Cannot Do Household Chores St. George's Respiratory Questionnaire - We would like to know how your respiratory problems usually affect your daily life: I cannot do household chores. SGRQ-C - Respiratory Problems Affect Daily Life: Cannot Do Household Chores SGRQC1-Cannot Go Out for Entertainment St. George's Respiratory Questionnaire - We would like to know how your respiratory problems usually affect your daily life: I cannot go out for entertainment or recreation. SGRQ-C - Respiratory Problems Affect Daily Life: Cannot Go Out for Entertainment SGRQC1-Cannot Go Out to Do Shopping St. George's Respiratory Questionnaire - We would like to know how your respiratory problems usually affect your daily life: I cannot go out of the house to do the shopping. SGRQ-C - Respiratory Problems Affect Daily Life: Cannot Go Out to Do Shopping SGRQC1-Cannot Move Far From My Bed St. George's Respiratory Questionnaire - We would like to know how your respiratory problems usually affect your daily life: I cannot move far from my bed or chair. SGRQ-C - Respiratory Problems Affect Daily Life: Cannot Move Far From Bed SGRQC1-Cannot Play Sports St. George's Respiratory Questionnaire - We would like to know how your respiratory problems usually affect your daily life: I cannot play sports or do other physical activities. SGRQ-C - Respiratory Problems Affect Daily Life: Cannot Play Sports SGRQC1-Cannot Take a Bath or Shower St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: I cannot take a bath or shower, or I take a long time to do it. SGRQ-C - Cannot Take a Bath or Shower SGRQC1-Cough Is Embarrassing in Public St. George's Respiratory Questionnaire - Questions about other effects that your respiratory problems may have on you: My cough or breathing is embarrassing in public. SGRQ-C - Cough Is Embarrassing in Public SGRQC1-Coughing Disturbs My Sleep St. George's Respiratory Questionnaire - Some more questions about your cough and breathlessness: My coughing or breathing disturbs my sleep. SGRQ-C - Coughing Disturbs My Sleep SGRQC1-Coughing Hurts St. George's Respiratory Questionnaire - Some more questions about your cough and breathlessness: Coughing hurts. SGRQ-C - Coughing Hurts SGRQC1-Coughing Makes Me Tired St. George's Respiratory Questionnaire - Some more questions about your cough and breathlessness: Coughing makes me tired. SGRQ-C - Coughing Makes Me Tired SGRQC1-Describe Your Current Health St. George's Respiratory Questionnaire - Please check one box to show how you describe your current health. SGRQ-C - Description of Your Current Health SGRQC1-Describe Your Resp Problems St. George's Respiratory Questionnaire - How would you describe your respiratory problems? SGRQ-C - Description of Your Respiratory Problems SGRQC1-Difficult to Carry Heavy Loads St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as carry heavy loads, dig in the garden or shovel snow, jog or walk briskly (5 miles per hour), play tennis or swim. SGRQ-C - Difficult to Carry Heavy Loads SGRQC1-Difficult to Walk Up Hills St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as walk up hills, carry things up stairs, light gardening such as weeding, dance, bowl or play golf. SGRQ-C - Difficult to Walk Up Hills SGRQC1-Everything Too Much Effort St. George's Respiratory Questionnaire - Questions about other effects that your respiratory problems may have on you: Everything seems too much of an effort. SGRQ-C - Everything Seems Too Much Effort SGRQC1-Exercise Is Not Safe for Me St. George's Respiratory Questionnaire - Questions about other effects that your respiratory problems may have on you: Exercise is not safe for me. SGRQ-C - Exercise Is Not Safe for Me SGRQC1-Frail Because of Resp Problems St. George's Respiratory Questionnaire - Questions about other effects that your respiratory problems may have on you: I have become frail or an invalid because of my respiratory problems. SGRQ-C - Become Frail Because of Respiratory Problems SGRQC1-Get Exhausted Easily St. George's Respiratory Questionnaire - Some more questions about your cough and breathlessness: I get exhausted easily. SGRQ-C - Get Exhausted Easily SGRQC1-How Many Respiratory Attacks St. George's Respiratory Questionnaire - How many respiratory attacks did you have during the last year? SGRQ-C - Number of Respiratory Attacks Last Year SGRQC1-How Often Do You Have Good Days St. George's Respiratory Questionnaire - How often do you have good days (with few respiratory problems)? SGRQ-C - Good Days with Few Respiratory Problems SGRQC1-How Resp Problems Affect You St. George's Respiratory Questionnaire - How do your respiratory problems affect you? SGRQ-C - How Respiratory Problems Affect You SGRQC1-I Bring Up Phlegm St. George's Respiratory Questionnaire - I bring up phlegm (sputum). SGRQ-C - Bring Up Phlegm SGRQC1-I Cough St. George's Respiratory Questionnaire - I cough. SGRQ-C - Cough SGRQC1-I Have Attacks of Wheezing St. George's Respiratory Questionnaire - I have attacks of wheezing. SGRQ-C - Have Attacks of Wheezing SGRQC1-I Have Shortness of Breath St. George's Respiratory Questionnaire - I have shortness of breath. SGRQ-C - Have Shortness of Breath SGRQC1-If I Hurry, I Have to Stop St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: If I hurry or walk fast, I have to stop or slow down. SGRQ-C - If Walk Fast Have to Stop SGRQC1-Jobs Take a Long Time St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: Jobs such as household chores take a long time, or I have to stop to rest. SGRQ-C - Jobs Take a Long Time SGRQC1-Not in Control of Resp Problems St. George's Respiratory Questionnaire - Questions about other effects that your respiratory problems may have on you: I feel that I am not in control of my respiratory problems. SGRQ-C - Not in Control of Respiratory Problems SGRQC1-Respiratory Problems a Nuisance St. George's Respiratory Questionnaire - Questions about other effects that your respiratory problems may have on you: My respiratory problems are a nuisance to my family, friends or neighbours. SGRQ-C - Respiratory Problems a Nuisance to Family, Friends or Neighbours SGRQC1-Short of Breath When Bend Over St. George's Respiratory Questionnaire - Some more questions about your cough and breathlessness: I am short of breath when I bend over. SGRQ-C - Short of Breath When Bend Over SGRQC1-Short of Breath When Talk St. George's Respiratory Questionnaire - Some more questions about your cough and breathlessness: I am short of breath when I talk. SGRQ-C - Short of Breath When Talk SGRQC1-Take a Long Time to Get Washed St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: I take a long time to get washed or dressed. SGRQ-C - Take a Long Time to Get Washed or Dressed SGRQC1-Walk Slow Than Others My Age St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: I walk slower than other people my age, or I stop to rest. SGRQ-C - Walk Slower Than Other People My Age SGRQC1-Walk Up Flight of Stairs Slowly St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: If I walk up one flight of stairs, I have to go slowly or stop. SGRQ-C - Walk Up Flight of Stairs Slowly SGRQC1-Walking Around the House St. George's Respiratory Questionnaire - Questions about what activities usually make you feel breathless: Walking around the house. SGRQ-C - Feel Breathless Walking Around the House SGRQC1-Walking Outside on Level Ground St. George's Respiratory Questionnaire - Questions about what activities usually make you feel breathless: Walking outside on level ground. SGRQ-C - Feel Breathless Walking Outside on Level Ground SGRQC1-Walking Up a Flight of Stairs St. George's Respiratory Questionnaire - Questions about what activities usually make you feel breathless: Walking up a flight of stairs. SGRQ-C - Feel Breathless Walking Up a Flight of Stairs SGRQC1-Walking Up Hills St. George's Respiratory Questionnaire - Questions about what activities usually make you feel breathless: Walking up hills. SGRQ-C - Feel Breathless Walking Up Hills SGRQC1-Washing or Dressing Yourself St. George's Respiratory Questionnaire - Questions about what activities usually make you feel breathless: Washing or dressing yourself. SGRQ-C - Feel Breathless Washing or Dressing Yourself SGRQC1-Wheeze Worse in the Morning St. George's Respiratory Questionnaire - If you wheeze, is it worse when you get up in the morning? SGRQ-C - Wheezing Worse In the Morning SGRQC1TN St. George's Respiratory Questionnaire for COPD Patients Questionnaire Test Name CDISC Questionnaire SGRQ-C Test Name Terminology St. George's Respiratory Questionnaire Past 3 Months Version test code. SGRQ01-Describe Your Current Health St. George's Respiratory Questionnaire Past 3 Months Version - Please check one box to show how you describe your current health. SGRQ Past 3 Months Version - Describe Your Current Health SGRQ01-I Have Coughed St. George's Respiratory Questionnaire Past 3 Months Version - Over the past 3 months, I have coughed. SGRQ Past 3 Months Version - I Have Coughed SGRQ01-I Have Brought Up Phlegm St. George's Respiratory Questionnaire Past 3 Months Version - Over the past 3 months, I have brought up phlegm (sputum). SGRQ Past 3 Months Version - I Have Brought Up Phlegm SGRQ01-I Have Had Shortness of Breath St. George's Respiratory Questionnaire Past 3 Months Version - Over the past 3 months, I have had shortness of breath. SGRQ Past 3 Months Version - I Have Had Shortness of Breath SGRQ01-I Have Had Wheezing Attacks St. George's Respiratory Questionnaire Past 3 Months Version - Over the past 3 months, I have had wheezing attacks. SGRQ Past 3 Months Version - I Have Had Wheezing Attacks SGRQ01-Times Suffered Sev Resp Attacks St. George's Respiratory Questionnaire Past 3 Months Version - How many times during the past 3 months have you suffered from severe or very unpleasant respiratory attacks? SGRQ Past 3 Months Version - Times Suffered From Severe Respiratory Attacks SGRQ01-How Long Worst Resp Attack Last St. George's Respiratory Questionnaire Past 3 Months Version - How long did the worst respiratory attack last? SGRQ Past 3 Months Version - How Long Did Worst Respiratory Attack Last SGRQ01-How Many Good Days Have You Had St. George's Respiratory Questionnaire Past 3 Months Version - Over the past 3 months, in a typical week, how many good days (with few respiratory problems) have you had? SGRQ Past 3 Months Version - How Many Good Days You Had SGRQ01-Wheeze Worse in the Morning St. George's Respiratory Questionnaire Past 3 Months Version - If you wheeze, is it worse when you get up in the morning? SGRQ Past 3 Months Version - Wheeze Worse When Get Up in the Morning SGRQ01-Describe Your Resp Condition St. George's Respiratory Questionnaire Past 3 Months Version - How would you describe your respiratory condition? SGRQ Past 3 Months Version - Describe Your Respiratory Condition SGRQ01-If You Have Ever Held a Job St. George's Respiratory Questionnaire Past 3 Months Version - If you have ever held a job. SGRQ Past 3 Months Version - Held a Job SGRQ01-Sitting or Lying Still St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about what activities usually make you feel short of breath these days: Sitting or lying still. SGRQ Past 3 Months Version - Sitting or Lying Still SGRQ01-Washing or Dressing Yourself St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about what activities usually make you feel short of breath these days: Washing or dressing yourself. SGRQ Past 3 Months Version - Washing or Dressing Yourself SGRQ01-Walking Around the House St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about what activities usually make you feel short of breath these days: Walking around the house. SGRQ Past 3 Months Version - Walking Around the House SGRQ01-Walking Outside on Level Ground St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about what activities usually make you feel short of breath these days: Walking outside on level ground. SGRQ Past 3 Months Version - Walking Outside on Level Ground SGRQ01-Walking Up a Flight of Stairs St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about what activities usually make you feel short of breath these days: Walking up a flight of stairs. SGRQ Past 3 Months Version - Walking Up a Flight of Stairs SGRQ01-Walking Up Hills St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about what activities usually make you feel short of breath these days: Walking up hills. SGRQ Past 3 Months Version - Walking Up Hills SGRQ01-Playing Sports St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about what activities usually make you feel short of breath these days: Playing sports or other physical activities. SGRQ Past 3 Months Version - Playing Sports or Other Physical Activities SGRQ01-Coughing Hurts St. George's Respiratory Questionnaire Past 3 Months Version - These are more questions about your cough and shortness of breath these days: Coughing hurts. SGRQ Past 3 Months Version - Coughing Hurts SGRQ01-Coughing Makes Me Tired St. George's Respiratory Questionnaire Past 3 Months Version - These are more questions about your cough and shortness of breath these days: Coughing makes me tired. SGRQ Past 3 Months Version - Coughing Makes Me Tired SGRQ01-Short of Breath When I Talk St. George's Respiratory Questionnaire Past 3 Months Version - These are more questions about your cough and shortness of breath these days: I am short of breath when I talk. SGRQ Past 3 Months Version - Short of Breath When I Talk SGRQ01-Short of Breath When Bend Over St. George's Respiratory Questionnaire Past 3 Months Version - These are more questions about your cough and shortness of breath these days: I am short of breath when I bend over. SGRQ Past 3 Months Version - Short of Breath When Bend Over SGRQ01-Coughing Disturbs My Sleep St. George's Respiratory Questionnaire Past 3 Months Version - These are more questions about your cough and shortness of breath these days: My coughing or breathing disturbs my sleep. SGRQ Past 3 Months Version - Coughing Disturbs My Sleep SGRQ01-I Get Exhausted Easily St. George's Respiratory Questionnaire Past 3 Months Version - These are more questions about your cough and shortness of breath these days: I get exhausted easily. SGRQ Past 3 Months Version - I Get Exhausted Easily SGRQ01-Cough Is Embarrassing in Public St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: My cough or breathing is embarrassing in public. SGRQ Past 3 Months Version - My Cough is Embarrassing in Public SGRQ01-Respiratory Problems a Nuisance St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: My respiratory problems are a nuisance to my family, friends or neighbors. SGRQ Past 3 Months Version - Respiratory Problems a Nuisance to Family SGRQ01-Afraid When Cannot Catch Breath St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: I get afraid or panic when I cannot catch my breath. SGRQ Past 3 Months Version - Get Afraid When Cannot Catch My Breath SGRQ01-Not in Control of Resp Problems St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: I feel that I am not in control of my respiratory problems. SGRQ Past 3 Months Version - Not in Control of My Respiratory Problems SGRQ01-Not Expect Probs to Get Better St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: I do not expect my respiratory problems to get any better. SGRQ Past 3 Months Version - Not Expect Respiratory Problems Get Better SGRQ01-I Have Become Frail St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: I have become frail or an invalid because of my respiratory problems. SGRQ Past 3 Months Version - Become Frail or Invalid Because of My Respiratory Problems SGRQ01-Exercise Is Not Safe for Me St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: Exercise is not safe for me. SGRQ Past 3 Months Version - Exercise Is Not Safe for Me SGRQ01-Everything Too Much Effort St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: Everything seems too much of an effort. SGRQ Past 3 Months Version - Everything Too Much Effort SGRQ01-Treatment Does Not Help Me Much St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about your respiratory treatment: My treatment does not help me very much. SGRQ Past 3 Months Version - Treatment Does Not Help Me Much SGRQ01-Embarrassed Using Med in Public St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about your respiratory treatment: I get embarrassed using my medication in public. SGRQ Past 3 Months Version - Embarrassed Using Medication in Public SGRQ01-Unpleasant Side Effect From Med St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about your respiratory treatment: I have unpleasant side effects from my medication. SGRQ Past 3 Months Version - Unpleasant Side Effects From Medication SGRQ01-Treatment Interferes With Life St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about your respiratory treatment: My treatment interferes with my life a lot. SGRQ Past 3 Months Version - Treatment Interferes With My Life SGRQ01-Take a Long Time to Get Washed St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: I take a long time to get washed or dressed. SGRQ Past 3 Months Version - Take Long Time to Get Washed or Dressed SGRQ01-I Cannot Take a Bath or Shower St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: I cannot take a bath or shower, or I take a long time to do it. SGRQ Past 3 Months Version - Cannot Take a Bath or Shower SGRQ01-I Walk Slower Than Other People St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: I walk slower than other people my age, or I stop to rest. SGRQ Past 3 Months Version - Walk Slower Than Other People My Age SGRQ01-Jobs Take a Long Time St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: Jobs such as household chores take a long time, or I have to stop to rest. SGRQ Past 3 Months Version - Jobs Take Long Time or I Have to Stop SGRQ01-Walk Up Flight of Stairs Slowly St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: If I walk up one flight of stairs, I have to go slowly or stop. SGRQ Past 3 Months Version - If Walk Up One Flight of Stairs I Have to Go Slow SGRQ01-If I Hurry, I Have to Stop St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: If I hurry or walk fast, I have to stop or slow down. SGRQ Past 3 Months Version - If Walk Fast I Have to Stop or Slow Down SGRQ01-Difficult to Walk Up Hills St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as walk up hills, carry things up stairs, light gardening such as weeding, dance, bowl or play golf. SGRQ Past 3 Months Version - Breathing Makes Difficult to Walk Up Hills SGRQ01-Difficult to Carry Heavy Loads St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as carry heavy loads, dig in the garden or shovel snow, jog or walk briskly (5 miles per hour), play tennis or swim. SGRQ Past 3 Months Version - Breathing Makes Difficult to Carry Heavy Loads SGRQ01-Difficult to Do Very Heavy Work St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as very heavy manual work, ride a bike, run, swim fast, or play competitive sports. SGRQ Past 3 Months Version - Breathing Makes Difficult to Do Heavy Manual Work SGRQ01-I Cannot Play Sports St. George's Respiratory Questionnaire Past 3 Months Version - We would like to know how your respiratory problems usually affect your daily life: I cannot play sports or do other physical activities. SGRQ Past 3 Months Version - Cannot Play Sports or Do Physical Activities SGRQ01-Cannot Go Out for Entertainment St. George's Respiratory Questionnaire Past 3 Months Version - We would like to know how your respiratory problems usually affect your daily life: I cannot go out for entertainment or recreation. SGRQ Past 3 Months Version - Cannot Go Out for Entertainment SGRQ01-Cannot Go Out to Do Shopping St. George's Respiratory Questionnaire Past 3 Months Version - We would like to know how your respiratory problems usually affect your daily life: I cannot go out of the house to do the shopping. SGRQ Past 3 Months Version - Cannot Go Out to Do Shopping SGRQ01-I Cannot Do Household Chores St. George's Respiratory Questionnaire Past 3 Months Version - We would like to know how your respiratory problems usually affect your daily life: I cannot do household chores. SGRQ Past 3 Months Version - Cannot Do Household Chores SGRQ01-I Cannot Move Far From My Bed St. George's Respiratory Questionnaire Past 3 Months Version - We would like to know how your respiratory problems usually affect your daily life: I cannot move far from my bed or chair. SGRQ Past 3 Months Version - Cannot Move Far From Bed or Chair SGRQ01-How Resp Problems Affect You St. George's Respiratory Questionnaire Past 3 Months Version - Best describe how your respiratory problems affect you. SGRQ Past 3 Months Version - How Respiratory Problems Affect You SGRQ01TC St. George's Respiratory Questionnaire Past 3 Months Version Questionnaire Test Code CDISC Questionnaire SGRQ Past 3 Months Version Test Code Terminology St. George's Respiratory Questionnaire Past 3 Months Version test name. SGRQ01-Afraid When Cannot Catch Breath St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: I get afraid or panic when I cannot catch my breath. SGRQ Past 3 Months Version - Get Afraid When Cannot Catch My Breath SGRQ01-Cannot Go Out for Entertainment St. George's Respiratory Questionnaire Past 3 Months Version - We would like to know how your respiratory problems usually affect your daily life: I cannot go out for entertainment or recreation. SGRQ Past 3 Months Version - Cannot Go Out for Entertainment SGRQ01-Cannot Go Out to Do Shopping St. George's Respiratory Questionnaire Past 3 Months Version - We would like to know how your respiratory problems usually affect your daily life: I cannot go out of the house to do the shopping. SGRQ Past 3 Months Version - Cannot Go Out to Do Shopping SGRQ01-Cough Is Embarrassing in Public St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: My cough or breathing is embarrassing in public. SGRQ Past 3 Months Version - My Cough is Embarrassing in Public SGRQ01-Coughing Disturbs My Sleep St. George's Respiratory Questionnaire Past 3 Months Version - These are more questions about your cough and shortness of breath these days: My coughing or breathing disturbs my sleep. SGRQ Past 3 Months Version - Coughing Disturbs My Sleep SGRQ01-Coughing Hurts St. George's Respiratory Questionnaire Past 3 Months Version - These are more questions about your cough and shortness of breath these days: Coughing hurts. SGRQ Past 3 Months Version - Coughing Hurts SGRQ01-Coughing Makes Me Tired St. George's Respiratory Questionnaire Past 3 Months Version - These are more questions about your cough and shortness of breath these days: Coughing makes me tired. SGRQ Past 3 Months Version - Coughing Makes Me Tired SGRQ01-Describe Your Current Health St. George's Respiratory Questionnaire Past 3 Months Version - Please check one box to show how you describe your current health. SGRQ Past 3 Months Version - Describe Your Current Health SGRQ01-Describe Your Resp Condition St. George's Respiratory Questionnaire Past 3 Months Version - How would you describe your respiratory condition? SGRQ Past 3 Months Version - Describe Your Respiratory Condition SGRQ01-Difficult to Carry Heavy Loads St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as carry heavy loads, dig in the garden or shovel snow, jog or walk briskly (5 miles per hour), play tennis or swim. SGRQ Past 3 Months Version - Breathing Makes Difficult to Carry Heavy Loads SGRQ01-Difficult to Do Very Heavy Work St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as very heavy manual work, ride a bike, run, swim fast, or play competitive sports. SGRQ Past 3 Months Version - Breathing Makes Difficult to Do Heavy Manual Work SGRQ01-Difficult to Walk Up Hills St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as walk up hills, carry things up stairs, light gardening such as weeding, dance, bowl or play golf. SGRQ Past 3 Months Version - Breathing Makes Difficult to Walk Up Hills SGRQ01-Embarrassed Using Med in Public St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about your respiratory treatment: I get embarrassed using my medication in public. SGRQ Past 3 Months Version - Embarrassed Using Medication in Public SGRQ01-Everything Too Much Effort St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: Everything seems too much of an effort. SGRQ Past 3 Months Version - Everything Too Much Effort SGRQ01-Exercise Is Not Safe for Me St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: Exercise is not safe for me. SGRQ Past 3 Months Version - Exercise Is Not Safe for Me SGRQ01-How Long Worst Resp Attack Last St. George's Respiratory Questionnaire Past 3 Months Version - How long did the worst respiratory attack last? SGRQ Past 3 Months Version - How Long Did Worst Respiratory Attack Last SGRQ01-How Many Good Days Have You Had St. George's Respiratory Questionnaire Past 3 Months Version - Over the past 3 months, in a typical week, how many good days (with few respiratory problems) have you had? SGRQ Past 3 Months Version - How Many Good Days You Had SGRQ01-How Resp Problems Affect You St. George's Respiratory Questionnaire Past 3 Months Version - Best describe how your respiratory problems affect you. SGRQ Past 3 Months Version - How Respiratory Problems Affect You SGRQ01-I Cannot Do Household Chores St. George's Respiratory Questionnaire Past 3 Months Version - We would like to know how your respiratory problems usually affect your daily life: I cannot do household chores. SGRQ Past 3 Months Version - Cannot Do Household Chores SGRQ01-I Cannot Move Far From My Bed St. George's Respiratory Questionnaire Past 3 Months Version - We would like to know how your respiratory problems usually affect your daily life: I cannot move far from my bed or chair. SGRQ Past 3 Months Version - Cannot Move Far From Bed or Chair SGRQ01-I Cannot Play Sports St. George's Respiratory Questionnaire Past 3 Months Version - We would like to know how your respiratory problems usually affect your daily life: I cannot play sports or do other physical activities. SGRQ Past 3 Months Version - Cannot Play Sports or Do Physical Activities SGRQ01-I Cannot Take a Bath or Shower St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: I cannot take a bath or shower, or I take a long time to do it. SGRQ Past 3 Months Version - Cannot Take a Bath or Shower SGRQ01-I Get Exhausted Easily St. George's Respiratory Questionnaire Past 3 Months Version - These are more questions about your cough and shortness of breath these days: I get exhausted easily. SGRQ Past 3 Months Version - I Get Exhausted Easily SGRQ01-I Have Become Frail St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: I have become frail or an invalid because of my respiratory problems. SGRQ Past 3 Months Version - Become Frail or Invalid Because of My Respiratory Problems SGRQ01-I Have Brought Up Phlegm St. George's Respiratory Questionnaire Past 3 Months Version - Over the past 3 months, I have brought up phlegm (sputum). SGRQ Past 3 Months Version - I Have Brought Up Phlegm SGRQ01-I Have Coughed St. George's Respiratory Questionnaire Past 3 Months Version - Over the past 3 months, I have coughed. SGRQ Past 3 Months Version - I Have Coughed SGRQ01-I Have Had Shortness of Breath St. George's Respiratory Questionnaire Past 3 Months Version - Over the past 3 months, I have had shortness of breath. SGRQ Past 3 Months Version - I Have Had Shortness of Breath SGRQ01-I Have Had Wheezing Attacks St. George's Respiratory Questionnaire Past 3 Months Version - Over the past 3 months, I have had wheezing attacks. SGRQ Past 3 Months Version - I Have Had Wheezing Attacks SGRQ01-I Walk Slower Than Other People St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: I walk slower than other people my age, or I stop to rest. SGRQ Past 3 Months Version - Walk Slower Than Other People My Age SGRQ01-If I Hurry, I Have to Stop St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: If I hurry or walk fast, I have to stop or slow down. SGRQ Past 3 Months Version - If Walk Fast I Have to Stop or Slow Down SGRQ01-If You Have Ever Held a Job St. George's Respiratory Questionnaire Past 3 Months Version - If you have ever held a job. SGRQ Past 3 Months Version - Held a Job SGRQ01-Jobs Take a Long Time St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: Jobs such as household chores take a long time, or I have to stop to rest. SGRQ Past 3 Months Version - Jobs Take Long Time or I Have to Stop SGRQ01-Not Expect Probs to Get Better St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: I do not expect my respiratory problems to get any better. SGRQ Past 3 Months Version - Not Expect Respiratory Problems Get Better SGRQ01-Not in Control of Resp Problems St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: I feel that I am not in control of my respiratory problems. SGRQ Past 3 Months Version - Not in Control of My Respiratory Problems SGRQ01-Playing Sports St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about what activities usually make you feel short of breath these days: Playing sports or other physical activities. SGRQ Past 3 Months Version - Playing Sports or Other Physical Activities SGRQ01-Respiratory Problems a Nuisance St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: My respiratory problems are a nuisance to my family, friends or neighbors. SGRQ Past 3 Months Version - Respiratory Problems a Nuisance to Family SGRQ01-Short of Breath When Bend Over St. George's Respiratory Questionnaire Past 3 Months Version - These are more questions about your cough and shortness of breath these days: I am short of breath when I bend over. SGRQ Past 3 Months Version - Short of Breath When Bend Over SGRQ01-Short of Breath When I Talk St. George's Respiratory Questionnaire Past 3 Months Version - These are more questions about your cough and shortness of breath these days: I am short of breath when I talk. SGRQ Past 3 Months Version - Short of Breath When I Talk SGRQ01-Sitting or Lying Still St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about what activities usually make you feel short of breath these days: Sitting or lying still. SGRQ Past 3 Months Version - Sitting or Lying Still SGRQ01-Take a Long Time to Get Washed St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: I take a long time to get washed or dressed. SGRQ Past 3 Months Version - Take Long Time to Get Washed or Dressed SGRQ01-Times Suffered Sev Resp Attacks St. George's Respiratory Questionnaire Past 3 Months Version - How many times during the past 3 months have you suffered from severe or very unpleasant respiratory attacks? SGRQ Past 3 Months Version - Times Suffered From Severe Respiratory Attacks SGRQ01-Treatment Does Not Help Me Much St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about your respiratory treatment: My treatment does not help me very much. SGRQ Past 3 Months Version - Treatment Does Not Help Me Much SGRQ01-Treatment Interferes With Life St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about your respiratory treatment: My treatment interferes with my life a lot. SGRQ Past 3 Months Version - Treatment Interferes With My Life SGRQ01-Unpleasant Side Effect From Med St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about your respiratory treatment: I have unpleasant side effects from my medication. SGRQ Past 3 Months Version - Unpleasant Side Effects From Medication SGRQ01-Walk Up Flight of Stairs Slowly St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: If I walk up one flight of stairs, I have to go slowly or stop. SGRQ Past 3 Months Version - If Walk Up One Flight of Stairs I Have to Go Slow SGRQ01-Walking Around the House St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about what activities usually make you feel short of breath these days: Walking around the house. SGRQ Past 3 Months Version - Walking Around the House SGRQ01-Walking Outside on Level Ground St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about what activities usually make you feel short of breath these days: Walking outside on level ground. SGRQ Past 3 Months Version - Walking Outside on Level Ground SGRQ01-Walking Up a Flight of Stairs St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about what activities usually make you feel short of breath these days: Walking up a flight of stairs. SGRQ Past 3 Months Version - Walking Up a Flight of Stairs SGRQ01-Walking Up Hills St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about what activities usually make you feel short of breath these days: Walking up hills. SGRQ Past 3 Months Version - Walking Up Hills SGRQ01-Washing or Dressing Yourself St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about what activities usually make you feel short of breath these days: Washing or dressing yourself. SGRQ Past 3 Months Version - Washing or Dressing Yourself SGRQ01-Wheeze Worse in the Morning St. George's Respiratory Questionnaire Past 3 Months Version - If you wheeze, is it worse when you get up in the morning? SGRQ Past 3 Months Version - Wheeze Worse When Get Up in the Morning SGRQ01TN St. George's Respiratory Questionnaire Past 3 Months Version Questionnaire Test Name CDISC Questionnaire SGRQ Past 3 Months Version Test Name Terminology St. George's Respiratory Questionnaire Past 4 Weeks Version test code. SGRQ02-Describe Your Current Health St. George's Respiratory Questionnaire Past 4 Weeks Version - Please check one box to show how you describe your current health. SGRQ Past 4 Weeks Version - Describe Your Current Health SGRQ02-I Have Coughed St. George's Respiratory Questionnaire Past 4 Weeks Version - Over the past 4 weeks, I have coughed. SGRQ Past 4 Weeks Version - I Have Coughed SGRQ02-I Have Brought Up Phlegm St. George's Respiratory Questionnaire Past 4 Weeks Version - Over the past 4 weeks, I have brought up phlegm (sputum). SGRQ Past 4 Weeks Version - I Have Brought Up Phlegm SGRQ02-I Have Had Shortness of Breath St. George's Respiratory Questionnaire Past 4 Weeks Version - Over the past 4 weeks, I have had shortness of breath. SGRQ Past 4 Weeks Version - I Have Had Shortness of Breath SGRQ02-I Have Had Wheezing Attacks St. George's Respiratory Questionnaire Past 4 Weeks Version - Over the past 4 weeks, I have had wheezing attacks. SGRQ Past 4 Weeks Version - I Have Had Wheezing Attacks SGRQ02-Times Suffered Sev Resp Attacks St. George's Respiratory Questionnaire Past 4 Weeks Version - How many times during the past 4 weeks have you suffered from severe or very unpleasant respiratory attacks? SGRQ Past 4 Weeks Version - Times Suffered From Severe Respiratory Attacks SGRQ02-How Long Worst Resp Attack Last St. George's Respiratory Questionnaire Past 4 Weeks Version - How long did the worst respiratory attack last? SGRQ Past 4 Weeks Version - How Long Did Worst Respiratory Attack Last SGRQ02-How Many Good Days Have You Had St. George's Respiratory Questionnaire Past 4 Weeks Version - Over the past 4 weeks, in a typical week, how many good days (with few respiratory problems) have you had? SGRQ Past 4 Weeks Version - How Many Good Days You Had SGRQ02-Wheeze Worse in the Morning St. George's Respiratory Questionnaire Past 4 Weeks Version - If you wheeze, is it worse when you get up in the morning? SGRQ Past 4 Weeks Version - Wheeze Worse When Get Up in the Morning SGRQ02-Describe Your Resp Condition St. George's Respiratory Questionnaire Past 4 Weeks Version - How would you describe your respiratory condition? SGRQ Past 4 Weeks Version - Describe Your Respiratory Condition SGRQ02-If You Have Ever Held a Job St. George's Respiratory Questionnaire Past 4 Weeks Version - If you have ever held a job. SGRQ Past 4 Weeks Version - Held a Job SGRQ02-Sitting or Lying Still St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about what activities usually make you feel short of breath these days: Sitting or lying still. SGRQ Past 4 Weeks Version - Sitting or Lying Still SGRQ02-Washing or Dressing Yourself St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about what activities usually make you feel short of breath these days: Washing or dressing yourself. SGRQ Past 4 Weeks Version - Washing or Dressing Yourself SGRQ02-Walking Around the House St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about what activities usually make you feel short of breath these days: Walking around the house. SGRQ Past 4 Weeks Version - Walking Around the House SGRQ02-Walking Outside on Level Ground St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about what activities usually make you feel short of breath these days: Walking outside on level ground. SGRQ Past 4 Weeks Version - Walking Outside on Level Ground SGRQ02-Walking Up a Flight of Stairs St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about what activities usually make you feel short of breath these days: Walking up a flight of stairs. SGRQ Past 4 Weeks Version - Walking Up a Flight of Stairs SGRQ02-Walking Up Hills St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about what activities usually make you feel short of breath these days: Walking up hills. SGRQ Past 4 Weeks Version - Walking Up Hills SGRQ02-Playing Sports St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about what activities usually make you feel short of breath these days: Playing sports or other physical activities. SGRQ Past 4 Weeks Version - Playing Sports or Other Physical Activities SGRQ02-Coughing Hurts St. George's Respiratory Questionnaire Past 4 Weeks Version - These are more questions about your cough and shortness of breath these days: Coughing hurts. SGRQ Past 4 Weeks Version - Coughing Hurts SGRQ02-Coughing Makes Me Tired St. George's Respiratory Questionnaire Past 4 Weeks Version - These are more questions about your cough and shortness of breath these days: Coughing makes me tired. SGRQ Past 4 Weeks Version - Coughing Makes Me Tired SGRQ02-Short of Breath When I Talk St. George's Respiratory Questionnaire Past 4 Weeks Version - These are more questions about your cough and shortness of breath these days: I am short of breath when I talk. SGRQ Past 4 Weeks Version - Short of Breath When I Talk SGRQ02-Short of Breath When Bend Over St. George's Respiratory Questionnaire Past 4 Weeks Version - These are more questions about your cough and shortness of breath these days: I am short of breath when I bend over. SGRQ Past 4 Weeks Version - Short of Breath When Bend Over SGRQ02-Coughing Disturbs My Sleep St. George's Respiratory Questionnaire Past 4 Weeks Version - These are more questions about your cough and shortness of breath these days: My coughing or breathing disturbs my sleep. SGRQ Past 4 Weeks Version - Coughing Disturbs My Sleep SGRQ02-I Get Exhausted Easily St. George's Respiratory Questionnaire Past 4 Weeks Version - These are more questions about your cough and shortness of breath these days: I get exhausted easily. SGRQ Past 4 Weeks Version - I Get Exhausted Easily SGRQ02-Cough Is Embarrassing in Public St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: My cough or breathing is embarrassing in public. SGRQ Past 4 Weeks Version - My Cough is Embarrassing in Public SGRQ02-Respiratory Problems a Nuisance St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: My respiratory problems are a nuisance to my family, friends or neighbors. SGRQ Past 4 Weeks Version - Respiratory Problems a Nuisance to Family SGRQ02-Afraid When Cannot Catch Breath St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: I get afraid or panic when I cannot catch my breath. SGRQ Past 4 Weeks Version - Get Afraid When Cannot Catch My Breath SGRQ02-Not in Control of Resp Problems St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: I feel that I am not in control of my respiratory problems. SGRQ Past 4 Weeks Version - Not in Control of My Respiratory Problems SGRQ02-Not Expect Probs to Get Better St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: I do not expect my respiratory problems to get any better. SGRQ Past 4 Weeks Version - Not Expect Respiratory Problems Get Better SGRQ02-I Have Become Frail St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: I have become frail or an invalid because of my respiratory problems. SGRQ Past 4 Weeks Version - Become Frail or Invalid Because of My Respiratory Problems SGRQ02-Exercise Is Not Safe for Me St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: Exercise is not safe for me. SGRQ Past 4 Weeks Version - Exercise Is Not Safe for Me SGRQ02-Everything Too Much Effort St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: Everything seems too much of an effort. SGRQ Past 4 Weeks Version - Everything Too Much Effort SGRQ02-Treatment Does Not Help Me Much St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about your respiratory treatment: My treatment does not help me very much. SGRQ Past 4 Weeks Version - Treatment Does Not Help Me Much SGRQ02-Embarrassed Using Med in Public St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about your respiratory treatment: I get embarrassed using my medication in public. SGRQ Past 4 Weeks Version - Embarrassed Using Medication in Public SGRQ02-Unpleasant Side Effect From Med St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about your respiratory treatment: I have unpleasant side effects from my medication. SGRQ Past 4 Weeks Version - Unpleasant Side Effects From Medication SGRQ02-Treatment Interferes With Life St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about your respiratory treatment: My treatment interferes with my life a lot. SGRQ Past 4 Weeks Version - Treatment Interferes With My Life SGRQ02-Take a Long Time to Get Washed St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: I take a long time to get washed or dressed. SGRQ Past 4 Weeks Version - Take Long Time to Get Washed or Dressed SGRQ02-I Cannot Take a Bath or Shower St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: I cannot take a bath or shower, or I take a long time to do it. SGRQ Past 4 Weeks Version - Cannot Take A Bath or Shower SGRQ02-I Walk Slower Than Other People St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: I walk slower than other people my age, or I stop to rest. SGRQ Past 4 Weeks Version - Walk Slower Than Other People My Age SGRQ02-Jobs Take a Long Time St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: Jobs such as household chores take a long time, or I have to stop to rest. SGRQ Past 4 Weeks Version - Jobs Take Long Time or I Have to Stop SGRQ02-Walk Up Flight of Stairs Slowly St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: If I walk up one flight of stairs, I have to go slowly or stop. SGRQ Past 4 Weeks Version - If Walk Up One Flight of Stairs I Have to Go Slow SGRQ02-If I Hurry, I Have to Stop St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: If I hurry or walk fast, I have to stop or slow down. SGRQ Past 4 Weeks Version - If Walk Fast I Have to Stop or Slow Down SGRQ02-Difficult to Walk Up Hills St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as walk up hills, carry things up stairs, light gardening such as weeding, dance, bowl or play golf. SGRQ Past 4 Weeks Version - Breathing Makes Difficult to Walk Up Hills SGRQ02-Difficult to Carry Heavy Loads St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as carry heavy loads, dig in the garden or shovel snow, jog or walk briskly (5 miles per hour), play tennis or swim. SGRQ Past 4 Weeks Version - Breathing Makes Difficult to Carry Heavy Loads SGRQ02-Difficult to Do Very Heavy Work St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as very heavy manual work, ride a bike, run, swim fast, or play competitive sports. SGRQ Past 4 Weeks Version - Breathing Makes Difficult to Do Heavy Manual Work SGRQ02-I Cannot Play Sports St. George's Respiratory Questionnaire Past 4 Weeks Version - We would like to know how your respiratory problems usually affect your daily life: I cannot play sports or do other physical activities. SGRQ Past 4 Weeks Version - Cannot Play Sports or Do Physical Activities SGRQ02-Cannot Go Out for Entertainment St. George's Respiratory Questionnaire Past 4 Weeks Version - We would like to know how your respiratory problems usually affect your daily life: I cannot go out for entertainment or recreation. SGRQ Past 4 Weeks Version - Cannot Go Out for Entertainment SGRQ02-Cannot Go Out to Do Shopping St. George's Respiratory Questionnaire Past 4 Weeks Version - We would like to know how your respiratory problems usually affect your daily life: I cannot go out of the house to do the shopping. SGRQ Past 4 Weeks Version - Cannot Go Out to Do Shopping SGRQ02-I Cannot Do Household Chores St. George's Respiratory Questionnaire Past 4 Weeks Version - We would like to know how your respiratory problems usually affect your daily life: I cannot do household chores. SGRQ Past 4 Weeks Version - Cannot Do Household Chores SGRQ02-I Cannot Move Far From My Bed St. George's Respiratory Questionnaire Past 4 Weeks Version - We would like to know how your respiratory problems usually affect your daily life: I cannot move far from my bed or chair. SGRQ Past 4 Weeks Version - Cannot Move Far From Bed or Chair SGRQ02-How Resp Problems Affect You St. George's Respiratory Questionnaire Past 4 Weeks Version - Best describe how your respiratory problems affect you. SGRQ Past 4 Weeks Version - How Respiratory Problems Affect You SGRQ02TC St. George's Respiratory Questionnaire Past 4 Weeks Version Questionnaire Test Code CDISC Questionnaire SGRQ Past 4 Weeks Version Test Code Terminology St. George's Respiratory Questionnaire Past 4 Weeks Version test name. SGRQ02-Afraid When Cannot Catch Breath St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: I get afraid or panic when I cannot catch my breath. SGRQ Past 4 Weeks Version - Get Afraid When Cannot Catch My Breath SGRQ02-Cannot Go Out for Entertainment St. George's Respiratory Questionnaire Past 4 Weeks Version - We would like to know how your respiratory problems usually affect your daily life: I cannot go out for entertainment or recreation. SGRQ Past 4 Weeks Version - Cannot Go Out for Entertainment SGRQ02-Cannot Go Out to Do Shopping St. George's Respiratory Questionnaire Past 4 Weeks Version - We would like to know how your respiratory problems usually affect your daily life: I cannot go out of the house to do the shopping. SGRQ Past 4 Weeks Version - Cannot Go Out to Do Shopping SGRQ02-Cough Is Embarrassing in Public St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: My cough or breathing is embarrassing in public. SGRQ Past 4 Weeks Version - My Cough is Embarrassing in Public SGRQ02-Coughing Disturbs My Sleep St. George's Respiratory Questionnaire Past 4 Weeks Version - These are more questions about your cough and shortness of breath these days: My coughing or breathing disturbs my sleep. SGRQ Past 4 Weeks Version - Coughing Disturbs My Sleep SGRQ02-Coughing Hurts St. George's Respiratory Questionnaire Past 4 Weeks Version - These are more questions about your cough and shortness of breath these days: Coughing hurts. SGRQ Past 4 Weeks Version - Coughing Hurts SGRQ02-Coughing Makes Me Tired St. George's Respiratory Questionnaire Past 4 Weeks Version - These are more questions about your cough and shortness of breath these days: Coughing makes me tired. SGRQ Past 4 Weeks Version - Coughing Makes Me Tired SGRQ02-Describe Your Current Health St. George's Respiratory Questionnaire Past 4 Weeks Version - Please check one box to show how you describe your current health. SGRQ Past 4 Weeks Version - Describe Your Current Health SGRQ02-Describe Your Resp Condition St. George's Respiratory Questionnaire Past 4 Weeks Version - How would you describe your respiratory condition? SGRQ Past 4 Weeks Version - Describe Your Respiratory Condition SGRQ02-Difficult to Carry Heavy Loads St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as carry heavy loads, dig in the garden or shovel snow, jog or walk briskly (5 miles per hour), play tennis or swim. SGRQ Past 4 Weeks Version - Breathing Makes Difficult to Carry Heavy Loads SGRQ02-Difficult to Do Very Heavy Work St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as very heavy manual work, ride a bike, run, swim fast, or play competitive sports. SGRQ Past 4 Weeks Version - Breathing Makes Difficult to Do Heavy Manual Work SGRQ02-Difficult to Walk Up Hills St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as walk up hills, carry things up stairs, light gardening such as weeding, dance, bowl or play golf. SGRQ Past 4 Weeks Version - Breathing Makes Difficult to Walk Up Hills SGRQ02-Embarrassed Using Med in Public St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about your respiratory treatment: I get embarrassed using my medication in public. SGRQ Past 4 Weeks Version - Embarrassed Using Medication in Public SGRQ02-Everything Too Much Effort St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: Everything seems too much of an effort. SGRQ Past 4 Weeks Version - Everything Too Much Effort SGRQ02-Exercise Is Not Safe for Me St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: Exercise is not safe for me. SGRQ Past 4 Weeks Version - Exercise Is Not Safe for Me SGRQ02-How Long Worst Resp Attack Last St. George's Respiratory Questionnaire Past 4 Weeks Version - How long did the worst respiratory attack last? SGRQ Past 4 Weeks Version - How Long Did Worst Respiratory Attack Last SGRQ02-How Many Good Days Have You Had St. George's Respiratory Questionnaire Past 4 Weeks Version - Over the past 4 weeks, in a typical week, how many good days (with few respiratory problems) have you had? SGRQ Past 4 Weeks Version - How Many Good Days You Had SGRQ02-How Resp Problems Affect You St. George's Respiratory Questionnaire Past 4 Weeks Version - Best describe how your respiratory problems affect you. SGRQ Past 4 Weeks Version - How Respiratory Problems Affect You SGRQ02-I Cannot Do Household Chores St. George's Respiratory Questionnaire Past 4 Weeks Version - We would like to know how your respiratory problems usually affect your daily life: I cannot do household chores. SGRQ Past 4 Weeks Version - Cannot Do Household Chores SGRQ02-I Cannot Move Far From My Bed St. George's Respiratory Questionnaire Past 4 Weeks Version - We would like to know how your respiratory problems usually affect your daily life: I cannot move far from my bed or chair. SGRQ Past 4 Weeks Version - Cannot Move Far From Bed or Chair SGRQ02-I Cannot Play Sports St. George's Respiratory Questionnaire Past 4 Weeks Version - We would like to know how your respiratory problems usually affect your daily life: I cannot play sports or do other physical activities. SGRQ Past 4 Weeks Version - Cannot Play Sports or Do Physical Activities SGRQ02-I Cannot Take a Bath or Shower St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: I cannot take a bath or shower, or I take a long time to do it. SGRQ Past 4 Weeks Version - Cannot Take A Bath or Shower SGRQ02-I Get Exhausted Easily St. George's Respiratory Questionnaire Past 4 Weeks Version - These are more questions about your cough and shortness of breath these days: I get exhausted easily. SGRQ Past 4 Weeks Version - I Get Exhausted Easily SGRQ02-I Have Become Frail St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: I have become frail or an invalid because of my respiratory problems. SGRQ Past 4 Weeks Version - Become Frail or Invalid Because of My Respiratory Problems SGRQ02-I Have Brought Up Phlegm St. George's Respiratory Questionnaire Past 4 Weeks Version - Over the past 4 weeks, I have brought up phlegm (sputum). SGRQ Past 4 Weeks Version - I Have Brought Up Phlegm SGRQ02-I Have Coughed St. George's Respiratory Questionnaire Past 4 Weeks Version - Over the past 4 weeks, I have coughed. SGRQ Past 4 Weeks Version - I Have Coughed SGRQ02-I Have Had Shortness of Breath St. George's Respiratory Questionnaire Past 4 Weeks Version - Over the past 4 weeks, I have had shortness of breath. SGRQ Past 4 Weeks Version - I Have Had Shortness of Breath SGRQ02-I Have Had Wheezing Attacks St. George's Respiratory Questionnaire Past 4 Weeks Version - Over the past 4 weeks, I have had wheezing attacks. SGRQ Past 4 Weeks Version - I Have Had Wheezing Attacks SGRQ02-I Walk Slower Than Other People St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: I walk slower than other people my age, or I stop to rest. SGRQ Past 4 Weeks Version - Walk Slower Than Other People My Age SGRQ02-If I Hurry, I Have to Stop St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: If I hurry or walk fast, I have to stop or slow down. SGRQ Past 4 Weeks Version - If Walk Fast I Have to Stop or Slow Down SGRQ02-If You Have Ever Held a Job St. George's Respiratory Questionnaire Past 4 Weeks Version - If you have ever held a job. SGRQ Past 4 Weeks Version - Held a Job SGRQ02-Jobs Take a Long Time St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: Jobs such as household chores take a long time, or I have to stop to rest. SGRQ Past 4 Weeks Version - Jobs Take Long Time or I Have to Stop SGRQ02-Not Expect Probs to Get Better St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: I do not expect my respiratory problems to get any better. SGRQ Past 4 Weeks Version - Not Expect Respiratory Problems Get Better SGRQ02-Not in Control of Resp Problems St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: I feel that I am not in control of my respiratory problems. SGRQ Past 4 Weeks Version - Not in Control of My Respiratory Problems SGRQ02-Playing Sports St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about what activities usually make you feel short of breath these days: Playing sports or other physical activities. SGRQ Past 4 Weeks Version - Playing Sports or Other Physical Activities SGRQ02-Respiratory Problems a Nuisance St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: My respiratory problems are a nuisance to my family, friends or neighbors. SGRQ Past 4 Weeks Version - Respiratory Problems a Nuisance to Family SGRQ02-Short of Breath When Bend Over St. George's Respiratory Questionnaire Past 4 Weeks Version - These are more questions about your cough and shortness of breath these days: I am short of breath when I bend over. SGRQ Past 4 Weeks Version - Short of Breath When Bend Over SGRQ02-Short of Breath When I Talk St. George's Respiratory Questionnaire Past 4 Weeks Version - These are more questions about your cough and shortness of breath these days: I am short of breath when I talk. SGRQ Past 4 Weeks Version - Short of Breath When I Talk SGRQ02-Sitting or Lying Still St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about what activities usually make you feel short of breath these days: Sitting or lying still. SGRQ Past 4 Weeks Version - Sitting or Lying Still SGRQ02-Take a Long Time to Get Washed St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: I take a long time to get washed or dressed. SGRQ Past 4 Weeks Version - Take Long Time to Get Washed or Dressed SGRQ02-Times Suffered Sev Resp Attacks St. George's Respiratory Questionnaire Past 4 Weeks Version - How many times during the past 4 weeks have you suffered from severe or very unpleasant respiratory attacks? SGRQ Past 4 Weeks Version - Times Suffered From Severe Respiratory Attacks SGRQ02-Treatment Does Not Help Me Much St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about your respiratory treatment: My treatment does not help me very much. SGRQ Past 4 Weeks Version - Treatment Does Not Help Me Much SGRQ02-Treatment Interferes With Life St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about your respiratory treatment: My treatment interferes with my life a lot. SGRQ Past 4 Weeks Version - Treatment Interferes With My Life SGRQ02-Unpleasant Side Effect From Med St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about your respiratory treatment: I have unpleasant side effects from my medication. SGRQ Past 4 Weeks Version - Unpleasant Side Effects From Medication SGRQ02-Walk Up Flight of Stairs Slowly St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: If I walk up one flight of stairs, I have to go slowly or stop. SGRQ Past 4 Weeks Version - If Walk Up One Flight of Stairs I Have to Go Slow SGRQ02-Walking Around the House St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about what activities usually make you feel short of breath these days: Walking around the house. SGRQ Past 4 Weeks Version - Walking Around the House SGRQ02-Walking Outside on Level Ground St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about what activities usually make you feel short of breath these days: Walking outside on level ground. SGRQ Past 4 Weeks Version - Walking Outside on Level Ground SGRQ02-Walking Up a Flight of Stairs St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about what activities usually make you feel short of breath these days: Walking up a flight of stairs. SGRQ Past 4 Weeks Version - Walking Up a Flight of Stairs SGRQ02-Walking Up Hills St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about what activities usually make you feel short of breath these days: Walking up hills. SGRQ Past 4 Weeks Version - Walking Up Hills SGRQ02-Washing or Dressing Yourself St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about what activities usually make you feel short of breath these days: Washing or dressing yourself. SGRQ Past 4 Weeks Version - Washing or Dressing Yourself SGRQ02-Wheeze Worse in the Morning St. George's Respiratory Questionnaire Past 4 Weeks Version - If you wheeze, is it worse when you get up in the morning? SGRQ Past 4 Weeks Version - Wheeze Worse When Get Up in the Morning SGRQ02TN St. George's Respiratory Questionnaire Past 4 Weeks Version Questionnaire Test Name CDISC Questionnaire SGRQ Past 4 Weeks Version Test Name Terminology Stanford Sleepiness Scale original result for SSS0101 test and test code. SSS0101-A little foggy not at peak let down Stanford Sleepiness Scale original result for SSS0101-A little foggy; not at peak; let down. Stanford Sleepiness Scale SSS0101 Original Result - A Little Foggy; Not at Peak; Let Down SSS0101-Almost in reverie sleep onset soon lost struggle to remain awake Stanford Sleepiness Scale original result for SSS0101-Almost in reverie; sleep onset soon; lost struggle to remain awake. Stanford Sleepiness Scale SSS0101 Original Result - Almost in Reverie; Sleep Onset Soon; Lost Struggle to Remain Awake SSS0101-Feeling active and vital alert wide awake Stanford Sleepiness Scale original result for SSS0101-Feeling active and vital; alert; wide awake. Stanford Sleepiness Scale SSS0101 Original Result - Feeling Active and Vital; Alert; Wide Awake SSS0101-Fogginess beginning to lose interest in remaining awake slowed down Stanford Sleepiness Scale original result for SSS0101-Fogginess; beginning to lose interest in remaining awake; slowed down. Stanford Sleepiness Scale SSS0101 Original Result - Fogginess; Beginning to Lose Interest in Remaining Awake; Slowed Down SSS0101-Functioning at a high level, but not at peak able to concentrate Stanford Sleepiness Scale original result for SSS0101-Functioning at a high level, but not at peak; able to concentrate. Stanford Sleepiness Scale SSS0101 Original Result - Functioning at a High Level, But Not at Peak; Able to Concentrate SSS0101-Relaxed awake not at full alertness responsive Stanford Sleepiness Scale original result for SSS0101-Relaxed; awake; not at full alertness; responsive. Stanford Sleepiness Scale SSS0101 Original Result - Relaxed; Awake; Not at Full Alertness; Responsive SSS0101-Sleepiness prefer to be lying down fighting sleep woozy Stanford Sleepiness Scale original result for SSS0101-Sleepiness; prefer to be lying down; fighting sleep; woozy. Stanford Sleepiness Scale SSS0101 Original Result - Sleepiness; Prefer to Be Lying Down; Fighting Sleep; Woozy SSS0101OR Stanford Sleepiness Scale Questionnaire ORRES for SSS0101 TN/TC CDISC Questionnaire Stanford Sleepiness Scale SSS0101 Original Response Terminology Stanford Sleepiness Scale standardized character result for SSS0101 test and test code. SSS0101-1 Stanford Sleepiness Scale standardized character result for SSS0101-Feeling active and vital; alert; wide awake. Stanford Sleepiness Scale SSS0101 Standardized Character Result 1 SSS0101-2 Stanford Sleepiness Scale standardized character result for SSS0101-Functioning at a high level, but not at peak; able to concentrate. Stanford Sleepiness Scale SSS0101 Standardized Character Result 2 SSS0101-3 Stanford Sleepiness Scale standardized character result for SSS0101-Relaxed; awake; not at full alertness; responsive. Stanford Sleepiness Scale SSS0101 Standardized Character Result 3 SSS0101-4 Stanford Sleepiness Scale standardized character result for SSS0101-A little foggy; not at peak; let down. Stanford Sleepiness Scale SSS0101 Standardized Character Result 4 SSS0101-5 Stanford Sleepiness Scale standardized character result for SSS0101-Fogginess; beginning to lose interest in remaining awake; slowed down. Stanford Sleepiness Scale SSS0101 Standardized Character Result 5 SSS0101-6 Stanford Sleepiness Scale standardized character result for SSS0101-Sleepiness; prefer to be lying down; fighting sleep; woozy. Stanford Sleepiness Scale SSS0101 Standardized Character Result 6 SSS0101-7 Stanford Sleepiness Scale standardized character result for SSS0101-Almost in reverie; sleep onset soon; lost struggle to remain awake. Stanford Sleepiness Scale SSS0101 Standardized Character Result 7 SSS0101STR Stanford Sleepiness Scale Questionnaire STRESC for SSS0101 TN/TC CDISC Questionnaire Stanford Sleepiness Scale SSS0101 Standardized Character Response Terminology Stanford Sleepiness Scale test code. SSS01-Degree of Sleepiness Stanford Sleepiness Scale - Degree of sleepiness. SSS - Degree of Sleepiness SSS01TC Stanford Sleepiness Scale Questionnaire Test Code CDISC Questionnaire Stanford Sleepiness Scale Test Code Terminology Stanford Sleepiness Scale test name. SSS01-Degree of Sleepiness Stanford Sleepiness Scale - Degree of sleepiness. SSS - Degree of Sleepiness SSS01TN Stanford Sleepiness Scale Questionnaire Test Name CDISC Questionnaire Stanford Sleepiness Scale Test Name Terminology Stent Thrombosis Coronary ARC Grade test code. STCG01-STC ARC Grade Stent Thrombosis Coronary ARC Grade - A grading system to describe the coronary stent thrombosis per the classification schema described by the Academic Research Consortium. ARC STC Grade - Stent Thrombosis Coronary ARC Grade STCG01TC Stent Thrombosis Coronary ARC Grade Clinical Classification Test Code CDISC Clinical Classification ARC STC Grade Test Code Terminology Stent Thrombosis Coronary ARC Grade test name. STCG01-STC ARC Grade Stent Thrombosis Coronary ARC Grade - A grading system to describe the coronary stent thrombosis per the classification schema described by the Academic Research Consortium. ARC STC Grade - Stent Thrombosis Coronary ARC Grade STCG01TN Stent Thrombosis Coronary ARC Grade Clinical Classification Test Name CDISC Clinical Classification ARC STC Grade Test Name Terminology A terminology codelist relevant to the Academic Research Council grade for the probability that coronary artery stent thrombosis has occurred. Includes acute ischemic symptoms at rest, acute post ischemic ECG, positive biomarkers and pathological evidence. Definite stent thrombosis is considered to have occurred when there is either angiographic or pathological confirmation. Angiographic confirmation is the presence of a thrombus at coronary angiography that originates in the stent or in the segment 5 mm proximal or distal to the stent, with the presence of at least 1 of 3 clinical criteria within a 48-hour time window: 1) acute onset of ischemic symptoms at rest; 2) new ischemic ECG changes that suggest acute ischemia; or 3) typical rise and fall in cardiac biomarkers. Pathological confirmation is evidence of recent thrombus within the stent determined at autopsy or via examination of tissue retrieved following thrombectomy. (Cutlip DE, Windecker S, Mehran R, et al. Clinical End Points in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351) ARC Definite Stent Thrombosis Possible stent thrombosis is considered to have occurred with any unexplained death more than 30 days after intracoronary stenting. (Cutlip DE, Windecker S, Mehran R, et al. Clinical End Points in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351) ARC Possible Stent Thrombosis Includes death within 30 days and myocardial infarction of stent territory. Probable stent thrombosis is considered to have occurred after intracoronary stenting in the following situations: 1) any unexplained death within the first 30 days; or 2) irrespective of the time after the index procedure, any MI that is related to documented acute ischemia in the territory of the implanted stent without angiographic confirmation of stent thrombosis and in the absence of any other obvious cause. (Cutlip DE, Windecker S, Mehran R, et al. Clinical End Points in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351) ARC Probable Stent Thrombosis STCARCRS Stent Thrombosis, Coronary ARC Grade Responses CDISC SDTM ARC Coronary Stent Thrombosis Grade Responses Terminology A terminology codelist relevant to the Academic Research Council grade for the timing of the stent thrombosis after stent implantation. 0 to 24 hours after stent implantation. (Cutlip DE, Windecker S, Mehran R, et al. Clinical Endpoints in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351) ARC Stent Thrombosis Timing Acute Greater than 30 days to 1 year after stent implantation. (Cutlip DE, Windecker S, Mehran R, et al. Clinical Endpoints in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351) ARC Stent Thrombosis Timing Late Greater than 24 hours to 30 days after stent implantation. (Cutlip DE, Windecker S, Mehran R, et al. Clinical Endpoints in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351) ARC Stent Thrombosis Timing Subacute Greater than 1 year after stent implantation. (Cutlip DE, Windecker S, Mehran R, et al. Clinical Endpoints in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351) ARC Stent Thrombosis Timing Very Late STCTIMRS Stent Thrombosis, Coronary, ARC Timing Responses CDISC SDTM ARC Coronary Stent Thrombosis Timing Terminology A terminology codelist relevant to the nature of the investigation for which study information is being collected. Compassionate Use Studies that provide a means for obtaining an experimental drug or device for patients who are not adequately treated by existing therapy, who do not meet the eligibility criteria for enrollment, or who are otherwise unable to participate in another clinical study. Expanded Access Study Studies in which individuals are assigned by an investigator based on a protocol to receive specific interventions. Subjects may receive diagnostic, therapeutic or other types of interventions. The assignment of the intervention may or may not be random. The individuals are then followed and biomedical and/or health outcomes are assessed. Interventional Study Study in which the researchers observe the effect of a risk factor (e.g., exposure), diagnostic test, treatment or other covariate within a study population, and where the investigator does not assign specific interventions. (CDISC Glossary) Observational Study Observational studies which include an organized system that uses observational methods to collect uniform data (clinical and other) prospectively for a population defined by a particular disorder/disease, condition (including susceptibility to a disorder), or exposure (including products, health care services, and/or procedures) and that serves a predetermined scientific, clinical, or policy purpose. Patient registries may be single purpose or on-going data collection programs that address one or more questions. (AHRQ) Patient Registry Study STYPE Study Type Response CDISC SDTM Study Type Terminology Terminology relevant to the subcategory for disposition events. The act of taking part in a study. Study Participation The act of taking part in the treatment phase of a study. Study Treatment Phase Participation DSSCAT Subcategory for Disposition Event CDISC SDTM Subcategory for Disposition Event Terminology The test code representing each subject characteristic. Appropriate Development For Age Indicator Appropriate Developmental Age Indicator An indication as to whether the subject's chronological age matches their physical, emotional, social, and cognitive functioning. Appropriate Developmental Age Indicator Age Started Smoking The age at which the individual began smoking. Age When First Smoked a Cigarette Question Num 1st Degree Relatives, Biological Number of First Degree Relatives, Biological The number of first degree relatives that are biologically related to the subject. Number of First Degree Biological Relatives Number of Brothers, Biological The number of brothers that are biologically related to the subject. (NCI) Number of Biological Brothers Number of Sisters, Biological The number of sisters that are biologically related to the subject. (NCI) Number of Biological Sisters Birth Country Country of Birth The name of the country in which the subject was born. Birth Country Birth Country Code Country of Birth Code A coded value specifying the name of the country in which the subject was born. Birth Country Code Breast Fed Indicator An indication as to whether the subject was breast fed (received mother's milk) as an infant. Breast Fed Indicator Birth Plurality The number of fetuses delivered live or dead at any time in the pregnancy, regardless of gestational age or if the fetuses were delivered at different dates in the pregnancy. (CDC) Birth Plurality Number of Children in Household The number of children (including neonates) residing in the household. Number of Children in Household Contact Investigation Indicator An indication as to whether a contact investigation (a public health activity whereby individuals who have been exposed to a person with a suspected or confirmed contagious illness are identified for contact tracing) has been carried out for the subject. Disease Contact Investigation Indicator County of Permanent Address The county identified as the individual's permanent residence. County of Permanent Address Entry Date from Ptntl Cntry Disease Exp The date on which the subject arrived in the reporting country from the country of potential disease exposure. Entry Date from Country of Potential Disease Exposure Country of Potential Disease Exposure System of classification based on the nation in which an individual was exposed to a disease, regardless of the nation in which he/she currently resides. Country of Potential Disease Exposure Country of Permanent Address The country identified as the individual's permanent residence. Country of Permanent Address Day Care Indicator Daycare Indicator An indication as to whether the individual is enrolled at a daycare facility. Enrolled in Daycare Indicator Deceased Donor Donation Type The conditions under which an organ is harvested from a dead donor, including the condition of the donor and the environment. Deceased Donor Donation Condition District of Potential Disease Exposure The district in which the individual was potentially exposed to a disease. District of Potential Disease Exposure District of Permanent Address The district identified as the individual's permanent residence. District of Permanent Address Donor Status at Time of Organ Donation The donor's state or condition of being either living or brain dead at the time of organ harvesting. Donor Status at Time of Organ Donation Dwelling Type A characterization or classification of the physical location where the individual resides. Living Quarters Estimated Date of Delivery An approximate calculation of the delivery date. Expected Date of Confinement Level of Education Attained Highest level of education that a person has attained. Education Level Number of Years of Education The number of years of education that a person has completed. Number of Years of Education Estimated Gestational Age An approximate calculation of the gestational age of the fetus, neonate, or infant. Estimated Gestational Age Employee Job Occupation Type of Work A code specifying the job performed by the employee for the employer. For example, accountant, programmer analyst, patient care associate, staff nurse, etc. Occupation Employment Status The state or condition of an individual's employment. Employment Status Fertility Status The status of an individual with respect to their ability to produce offspring. Fertility Status Full-Time Student Indicator An indication as to whether the subject is a full-time student. Full-Time Student Indicator Gender Identity A person's internally held sense of their gender, which may or may not correspond to the individual's genotypic or phenotypic sex. [The NCI Thesaurus contains biomedical terminologies that NCI does not own or control. This concept contains gender-related content that does not comply with Executive Order 14168.] Gender Identity GPS Coord of Potential Disease Exposure GPS Coordinates of Potential Disease Exposure The global position system (GPS) coordinates for the location at which an individual was potentially exposed to a disease. GPS Coordinates of Potential Disease Exposure Gestational Age at Birth The gestational age of the subject at birth. Gestational Age at Birth Dominant Hand The preferred hand of use for controlled and efficient performance of motor tasks. Dominant Hand Employer Based Health Insurance Ind An indication as to whether the subject is covered by their own or a family member's employer-based health insurance. Employer Based Health Insurance Indicator Indian Health Service Insurance Ind An indication as to whether the subject is covered by their own or a family member's U.S. Indian Health Service insurance. Indian Health Service Insurance Indicator Health Insurance Indicator An indication as to whether the subject is covered by health insurance. Health Insurance Indicator Military Health Insurance Indicator An indication as to whether the subject is covered by their own or a family member's military-based health insurance. Military Health Insurance Indicator Private Health Insurance Indicator An indication as to whether the subject is covered by their own or a family member's privately-bought health insurance. Private Health Insurance Indicator CDC HIV High Risk Donor Indicator An indication as to whether an organ donor may fall into one or more behavioral categories associated with increased risk of human immunodeficiency virus (HIV) infection, as defined by the 1994 Centers for Disease Control (CDC) Public Health Service Criteria for High Risk Behavior (Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. Centers for Disease Control and Prevention. MMWR Recomm Rep 1994; 43: 1-17). CDC HIV High Risk Donor Indicator Income Level An indication of the position on a scale measuring revenue or monetary support. Income Level Infant Less Than One Year Indicator An indication as to whether the subject is less than one year of age. Infant Less Than One Year Indicator Intersex Diagnosis Indicator An indication as to whether the participant or subject has been diagnosed as intersex. Intersex Diagnosis Indicator Longest Duration of Abstinence The longest amount of time during which the individual abstained from an activity. Longest Duration of Abstinence Primary Language Spoken The main language that is spoken by the subject most frequently or dominantly. Primary Language Spoken Secondary Language Spoken Additional language(s) that is spoken by the subject but not considered the primary language. Secondary Language Spoken Living with Subject Indicator An indication as to whether the associated person is living with the subject. (NCI) Living with Subject Indicator Marital Status The state or condition of a person's matrimonial status. Marital Status Medicaid Indicator An indication as to whether the subject is covered by Medicaid. Medicaid Indicator Medicare Indicator An indication as to whether the subject is covered by Medicare. Medicare Indicator Military Status The status of an individual with regard to military service. Military Status National Origin System of classification based on nation from which a person originates, regardless of the nation in which he/she currently resides. National Origin Business Type Occupation Type Occupational Industry Work Industry Type of business that compensates for work or assigns work to an unpaid worker or volunteer. (USCDI) Occupational Industry Physical Activity Lifestyle A description of the subject's lifestyle with respect to physical activity. Physical Activity Lifestyle Number of People in Household The total number of people residing in the household. Number of People in Household Premature Birth Indicator An indication as to whether the subject was born prior to 37 weeks and 0 days gestation. Premature Birth Indicator Priority of Disease Contact The categorization of individuals with or without the potential for having a particular disease. Priority of Disease Contact Member of High Risk Population An indication that a subject is part of a population group that has a greater chance of contracting a disease or disorder. Member of High Risk Population Social Risk Factor Social factors such as personal behavior, lifestyle, or environment belonging to the subject which are known to increase the likelihood of infection and disease. Social Risk Factor Employee Salary Type A code specifying the method used by the employer to compute the employee's salary or wages. For example, hourly, annual, or commission. Employee Salary Type Setting of Contact The environment within which the person may have come into contact with a disease carrier, or played the role of a disease carrier. Setting of Disease Contact Sex Assigned at Birth The sex assigned to an infant, most often based on the infant's anatomical and other biological characteristics. Sometimes referred to as birth sex, natal sex, biological sex, or sex; however, sex assigned at birth is the recommended term. (Fenway Health) Sex Assigned at Birth Sexual Orientation The pattern of a person's emotional, romantic, and/or sexual attractions. Sexual Orientation Second Hand Smoke Exposure Status The status of an individual with regard to secondhand smoke exposure. Second Hand Smoke Exposure Status Fitzpatrick Skin Classification Skin Classification Test to categorize the sensitivity of a subject's skin to sunlight. (Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871.) Fitzpatrick Classification Scale Small for Gestational Age Indicator An indication as to whether the fetus or infant is small for the gestational age. Small for Gestational Age Indicator Socioeconomic Class Socioeconomic Classification A characterization or classification of an individual that takes into account economics, demographics, and social interactions, used to stratify individual behaviors within a society or culture. Socioeconomic Class State-Specific Health Ins Program Name State-Specific Health Insurance Program Name The name of the U.S. state-specific health insurance program. State-Specific Health Insurance Program Name State-Specific Medicaid Program Name The name of the U.S. state-specific Medicaid program. State-Specific Medicaid Program Name State-Specific Medicare Program Name The name of the U.S. state-specific Medicare program. State-Specific Medicare Program Name Student Indicator An indication as to whether the subject or associated person is enrolled in school. Student Indicator Sex for Clinical Use An arbitrary categorization of individuals based on the assemblage of physical properties related to reproduction, and commonly associated with the designation of such categories as female and male. This designation is based on some combination of observable information from organ inventories, morphological assessment, hormone assessments, genetic testing, observed primary and secondary sex characteristics, menstrual status, and/or obstetric history. Current sex designation may or may not be the same as an individual's sex assigned or reported at birth. (NCI) Sex Assigned for Clinical Purpose Symptom A physical or mental experience or observation reported by a patient that may indicate a disease. Symptom Tobacco Cessation Counseling Indicator An indication as to whether the individual has received tobacco cessation counseling. Tobacco Cessation Counseling Indicator Tribal Affiliation A tribe or band with which a person associates. (USCDI) Tribal Affiliation Twin Type The classification of the two offspring born from the same pregnancy. Twin Type Type of Contact Identification and clinical investigation of disease contacts. Type of Contagion Contact Homeless Indicator Unhoused Indicator An indication as to whether the subject is unhoused. Unhoused Indicator Village of Permanent Address The village identified as the individual's permanent residence. Village of Permanent Address Number of Work Days Per Week The number of days per week the subject works. Number of Work Days Per Week Question SCTESTCD Subject Characteristic Test Code CDISC SDTM Subject Characteristic Test Code Terminology The test name representing each subject characteristic. Age Started Smoking The age at which the individual began smoking. Age When First Smoked a Cigarette Question Appropriate Development For Age Indicator Appropriate Developmental Age Indicator An indication as to whether the subject's chronological age matches their physical, emotional, social, and cognitive functioning. Appropriate Developmental Age Indicator Birth Country Code Country of Birth Code A coded value specifying the name of the country in which the subject was born. Birth Country Code Birth Country Country of Birth The name of the country in which the subject was born. Birth Country Birth Plurality The number of fetuses delivered live or dead at any time in the pregnancy, regardless of gestational age or if the fetuses were delivered at different dates in the pregnancy. (CDC) Birth Plurality Breast Fed Indicator An indication as to whether the subject was breast fed (received mother's milk) as an infant. Breast Fed Indicator CDC HIV High Risk Donor Indicator An indication as to whether an organ donor may fall into one or more behavioral categories associated with increased risk of human immunodeficiency virus (HIV) infection, as defined by the 1994 Centers for Disease Control (CDC) Public Health Service Criteria for High Risk Behavior (Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. Centers for Disease Control and Prevention. MMWR Recomm Rep 1994; 43: 1-17). CDC HIV High Risk Donor Indicator Contact Investigation Indicator An indication as to whether a contact investigation (a public health activity whereby individuals who have been exposed to a person with a suspected or confirmed contagious illness are identified for contact tracing) has been carried out for the subject. Disease Contact Investigation Indicator Country of Permanent Address The country identified as the individual's permanent residence. Country of Permanent Address Country of Potential Disease Exposure System of classification based on the nation in which an individual was exposed to a disease, regardless of the nation in which he/she currently resides. Country of Potential Disease Exposure County of Permanent Address The county identified as the individual's permanent residence. County of Permanent Address Day Care Indicator Daycare Indicator An indication as to whether the individual is enrolled at a daycare facility. Enrolled in Daycare Indicator Deceased Donor Donation Type The conditions under which an organ is harvested from a dead donor, including the condition of the donor and the environment. Deceased Donor Donation Condition District of Permanent Address The district identified as the individual's permanent residence. District of Permanent Address District of Potential Disease Exposure The district in which the individual was potentially exposed to a disease. District of Potential Disease Exposure Dominant Hand The preferred hand of use for controlled and efficient performance of motor tasks. Dominant Hand Donor Status at Time of Organ Donation The donor's state or condition of being either living or brain dead at the time of organ harvesting. Donor Status at Time of Organ Donation Dwelling Type A characterization or classification of the physical location where the individual resides. Living Quarters Employee Job Occupation Type of Work A code specifying the job performed by the employee for the employer. For example, accountant, programmer analyst, patient care associate, staff nurse, etc. Occupation Employee Salary Type A code specifying the method used by the employer to compute the employee's salary or wages. For example, hourly, annual, or commission. Employee Salary Type Employer Based Health Insurance Ind An indication as to whether the subject is covered by their own or a family member's employer-based health insurance. Employer Based Health Insurance Indicator Employment Status The state or condition of an individual's employment. Employment Status Entry Date from Ptntl Cntry Disease Exp The date on which the subject arrived in the reporting country from the country of potential disease exposure. Entry Date from Country of Potential Disease Exposure Estimated Date of Delivery An approximate calculation of the delivery date. Expected Date of Confinement Estimated Gestational Age An approximate calculation of the gestational age of the fetus, neonate, or infant. Estimated Gestational Age Fertility Status The status of an individual with respect to their ability to produce offspring. Fertility Status Full-Time Student Indicator An indication as to whether the subject is a full-time student. Full-Time Student Indicator Gender Identity A person's internally held sense of their gender, which may or may not correspond to the individual's genotypic or phenotypic sex. [The NCI Thesaurus contains biomedical terminologies that NCI does not own or control. This concept contains gender-related content that does not comply with Executive Order 14168.] Gender Identity Gestational Age at Birth The gestational age of the subject at birth. Gestational Age at Birth GPS Coord of Potential Disease Exposure GPS Coordinates of Potential Disease Exposure The global position system (GPS) coordinates for the location at which an individual was potentially exposed to a disease. GPS Coordinates of Potential Disease Exposure Health Insurance Indicator An indication as to whether the subject is covered by health insurance. Health Insurance Indicator Income Level An indication of the position on a scale measuring revenue or monetary support. Income Level Indian Health Service Insurance Ind An indication as to whether the subject is covered by their own or a family member's U.S. Indian Health Service insurance. Indian Health Service Insurance Indicator Infant Less Than One Year Indicator An indication as to whether the subject is less than one year of age. Infant Less Than One Year Indicator Intersex Diagnosis Indicator An indication as to whether the participant or subject has been diagnosed as intersex. Intersex Diagnosis Indicator Level of Education Attained Highest level of education that a person has attained. Education Level Living with Subject Indicator An indication as to whether the associated person is living with the subject. (NCI) Living with Subject Indicator Longest Duration of Abstinence The longest amount of time during which the individual abstained from an activity. Longest Duration of Abstinence Marital Status The state or condition of a person's matrimonial status. Marital Status Medicaid Indicator An indication as to whether the subject is covered by Medicaid. Medicaid Indicator Medicare Indicator An indication as to whether the subject is covered by Medicare. Medicare Indicator Member of High Risk Population An indication that a subject is part of a population group that has a greater chance of contracting a disease or disorder. Member of High Risk Population Military Health Insurance Indicator An indication as to whether the subject is covered by their own or a family member's military-based health insurance. Military Health Insurance Indicator Military Status The status of an individual with regard to military service. Military Status National Origin System of classification based on nation from which a person originates, regardless of the nation in which he/she currently resides. National Origin Num 1st Degree Relatives, Biological Number of First Degree Relatives, Biological The number of first degree relatives that are biologically related to the subject. Number of First Degree Biological Relatives Number of Brothers, Biological The number of brothers that are biologically related to the subject. (NCI) Number of Biological Brothers Number of Children in Household The number of children (including neonates) residing in the household. Number of Children in Household Number of People in Household The total number of people residing in the household. Number of People in Household Number of Sisters, Biological The number of sisters that are biologically related to the subject. (NCI) Number of Biological Sisters Number of Work Days Per Week The number of days per week the subject works. Number of Work Days Per Week Question Number of Years of Education The number of years of education that a person has completed. Number of Years of Education Business Type Occupation Type Occupational Industry Work Industry Type of business that compensates for work or assigns work to an unpaid worker or volunteer. (USCDI) Occupational Industry Physical Activity Lifestyle A description of the subject's lifestyle with respect to physical activity. Physical Activity Lifestyle Premature Birth Indicator An indication as to whether the subject was born prior to 37 weeks and 0 days gestation. Premature Birth Indicator Primary Language Spoken The main language that is spoken by the subject most frequently or dominantly. Primary Language Spoken Priority of Disease Contact The categorization of individuals with or without the potential for having a particular disease. Priority of Disease Contact Private Health Insurance Indicator An indication as to whether the subject is covered by their own or a family member's privately-bought health insurance. Private Health Insurance Indicator Second Hand Smoke Exposure Status The status of an individual with regard to secondhand smoke exposure. Second Hand Smoke Exposure Status Secondary Language Spoken Additional language(s) that is spoken by the subject but not considered the primary language. Secondary Language Spoken Setting of Contact The environment within which the person may have come into contact with a disease carrier, or played the role of a disease carrier. Setting of Disease Contact Sex Assigned at Birth The sex assigned to an infant, most often based on the infant's anatomical and other biological characteristics. Sometimes referred to as birth sex, natal sex, biological sex, or sex; however, sex assigned at birth is the recommended term. (Fenway Health) Sex Assigned at Birth Sex for Clinical Use An arbitrary categorization of individuals based on the assemblage of physical properties related to reproduction, and commonly associated with the designation of such categories as female and male. This designation is based on some combination of observable information from organ inventories, morphological assessment, hormone assessments, genetic testing, observed primary and secondary sex characteristics, menstrual status, and/or obstetric history. Current sex designation may or may not be the same as an individual's sex assigned or reported at birth. (NCI) Sex Assigned for Clinical Purpose Sexual Orientation The pattern of a person's emotional, romantic, and/or sexual attractions. Sexual Orientation Fitzpatrick Skin Classification Skin Classification Test to categorize the sensitivity of a subject's skin to sunlight. (Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871.) Fitzpatrick Classification Scale Small for Gestational Age Indicator An indication as to whether the fetus or infant is small for the gestational age. Small for Gestational Age Indicator Social Risk Factor Social factors such as personal behavior, lifestyle, or environment belonging to the subject which are known to increase the likelihood of infection and disease. Social Risk Factor Socioeconomic Class Socioeconomic Classification A characterization or classification of an individual that takes into account economics, demographics, and social interactions, used to stratify individual behaviors within a society or culture. Socioeconomic Class State-Specific Health Ins Program Name State-Specific Health Insurance Program Name The name of the U.S. state-specific health insurance program. State-Specific Health Insurance Program Name State-Specific Medicaid Program Name The name of the U.S. state-specific Medicaid program. State-Specific Medicaid Program Name State-Specific Medicare Program Name The name of the U.S. state-specific Medicare program. State-Specific Medicare Program Name Student Indicator An indication as to whether the subject or associated person is enrolled in school. Student Indicator Symptom A physical or mental experience or observation reported by a patient that may indicate a disease. Symptom Tobacco Cessation Counseling Indicator An indication as to whether the individual has received tobacco cessation counseling. Tobacco Cessation Counseling Indicator Tribal Affiliation A tribe or band with which a person associates. (USCDI) Tribal Affiliation Twin Type The classification of the two offspring born from the same pregnancy. Twin Type Type of Contact Identification and clinical investigation of disease contacts. Type of Contagion Contact Homeless Indicator Unhoused Indicator An indication as to whether the subject is unhoused. Unhoused Indicator Village of Permanent Address The village identified as the individual's permanent residence. Village of Permanent Address SCTEST Subject Characteristic Test Name CDISC SDTM Subject Characteristic Test Name Terminology Terminology relevant to subject status responses. Living; showing characteristics of life. Alive Died The absence of life or state of being dead. (NCI) Dead U UNK Unknown Not known, not observed, not recorded, or refused. (NCI) Unknown SSTATRS Subject Status Response CDISC SDTM Subject Status Response Terminology Terminology relevant to test codes for the subject's status, which is evaluated periodically to determine if it has changed. Follow-Up Availability Status The state or condition of the subject's availability to provide information about their health status after they are no longer receiving study treatment. Follow-Up Availability Status Information Source for Survival Status The person or authoritative source that provided the information on survival status. Information Source for Survival Status Latest Date Last Known Alive Latest Date Subject Confirmed Alive The most recent date on which the subject was known to be alive. Latest Date Subject Confirmed Alive Survival Status The state or condition of being living or deceased; also includes the case where the vital status is unknown. Vital Status SSTESTCD Subject Status Test Code CDISC SDTM Subject Status Test Code Terminology Terminology relevant to test names for the subject's status, which is evaluated periodically to determine if it has changed. Follow-Up Availability Status The state or condition of the subject's availability to provide information about their health status after they are no longer receiving study treatment. Follow-Up Availability Status Information Source for Survival Status The person or authoritative source that provided the information on survival status. Information Source for Survival Status Latest Date Last Known Alive Latest Date Subject Confirmed Alive The most recent date on which the subject was known to be alive. Latest Date Subject Confirmed Alive Survival Status The state or condition of being living or deceased; also includes the case where the vital status is unknown. Vital Status SSTEST Subject Status Test Name CDISC SDTM Subject Status Test Name Terminology Subjective Opiate Withdrawal Scale test code. SOWSA1-I Feel Anxious Subjective Opiate Withdrawal Scale - I feel anxious. SOWS Subjective (Handelsman) - I Feel Anxious SOWSA1-I Feel Like Yawning Subjective Opiate Withdrawal Scale - I feel like yawning. SOWS Subjective (Handelsman) - I Feel Like Yawning SOWSA1-I'm Perspiring Subjective Opiate Withdrawal Scale - I'm perspiring. SOWS Subjective (Handelsman) - I'm Perspiring SOWSA1-My Eyes Are Tearing Subjective Opiate Withdrawal Scale - My eyes are tearing. SOWS Subjective (Handelsman) - My Eyes Are Tearing SOWSA1-My Nose is Running Subjective Opiate Withdrawal Scale - My nose is running. SOWS Subjective (Handelsman) - My Nose is Running SOWSA1-I Have Goose Flesh Subjective Opiate Withdrawal Scale - I have goose flesh. SOWS Subjective (Handelsman) - I Have Goose Flesh SOWSA1-I Am Shaking Subjective Opiate Withdrawal Scale - I am shaking. SOWS Subjective (Handelsman) - I Am Shaking SOWSA1-I Have Hot Flashes Subjective Opiate Withdrawal Scale - I have hot flashes. SOWS Subjective (Handelsman) - I Have Hot Flashes SOWSA1-I Have Cold Flashes Subjective Opiate Withdrawal Scale - I have cold flashes. SOWS Subjective (Handelsman) - I Have Cold Flashes SOWSA1-My Bones and Muscles Ache Subjective Opiate Withdrawal Scale - My bones and muscles ache. SOWS Subjective (Handelsman) - My Bones and Muscles Ache SOWSA1-I Feel Restless Subjective Opiate Withdrawal Scale - I feel restless. SOWS Subjective (Handelsman) - I Feel Restless SOWSA1-I Feel Nauseous Subjective Opiate Withdrawal Scale - I feel nauseous. SOWS Subjective (Handelsman) - I Feel Nauseous SOWSA1-I Feel Like Vomiting Subjective Opiate Withdrawal Scale - I feel like vomiting. SOWS Subjective (Handelsman) - I Feel Like Vomiting SOWSA1-My Muscles Twitch Subjective Opiate Withdrawal Scale - My muscles twitch. SOWS Subjective (Handelsman) - My Muscles Twitch SOWSA1-I Have Cramps in My Stomach Subjective Opiate Withdrawal Scale - I have cramps in my stomach. SOWS Subjective (Handelsman) - I Have Cramps in My Stomach SOWSA1-I Feel Like Shooting Up Now Subjective Opiate Withdrawal Scale - I feel like shooting up now. SOWS Subjective (Handelsman) - I Feel Like Shooting Up Now SOWSA1TC Subjective Opiate Withdrawal Scale Questionnaire Test Code CDISC Questionnaire SOWS Subjective Test Code Terminology Subjective Opiate Withdrawal Scale test name. SOWSA1-I Am Shaking Subjective Opiate Withdrawal Scale - I am shaking. SOWS Subjective (Handelsman) - I Am Shaking SOWSA1-I Feel Anxious Subjective Opiate Withdrawal Scale - I feel anxious. SOWS Subjective (Handelsman) - I Feel Anxious SOWSA1-I Feel Like Shooting Up Now Subjective Opiate Withdrawal Scale - I feel like shooting up now. SOWS Subjective (Handelsman) - I Feel Like Shooting Up Now SOWSA1-I Feel Like Vomiting Subjective Opiate Withdrawal Scale - I feel like vomiting. SOWS Subjective (Handelsman) - I Feel Like Vomiting SOWSA1-I Feel Like Yawning Subjective Opiate Withdrawal Scale - I feel like yawning. SOWS Subjective (Handelsman) - I Feel Like Yawning SOWSA1-I Feel Nauseous Subjective Opiate Withdrawal Scale - I feel nauseous. SOWS Subjective (Handelsman) - I Feel Nauseous SOWSA1-I Feel Restless Subjective Opiate Withdrawal Scale - I feel restless. SOWS Subjective (Handelsman) - I Feel Restless SOWSA1-I Have Cold Flashes Subjective Opiate Withdrawal Scale - I have cold flashes. SOWS Subjective (Handelsman) - I Have Cold Flashes SOWSA1-I Have Cramps in My Stomach Subjective Opiate Withdrawal Scale - I have cramps in my stomach. SOWS Subjective (Handelsman) - I Have Cramps in My Stomach SOWSA1-I Have Goose Flesh Subjective Opiate Withdrawal Scale - I have goose flesh. SOWS Subjective (Handelsman) - I Have Goose Flesh SOWSA1-I Have Hot Flashes Subjective Opiate Withdrawal Scale - I have hot flashes. SOWS Subjective (Handelsman) - I Have Hot Flashes SOWSA1-I'm Perspiring Subjective Opiate Withdrawal Scale - I'm perspiring. SOWS Subjective (Handelsman) - I'm Perspiring SOWSA1-My Bones and Muscles Ache Subjective Opiate Withdrawal Scale - My bones and muscles ache. SOWS Subjective (Handelsman) - My Bones and Muscles Ache SOWSA1-My Eyes Are Tearing Subjective Opiate Withdrawal Scale - My eyes are tearing. SOWS Subjective (Handelsman) - My Eyes Are Tearing SOWSA1-My Muscles Twitch Subjective Opiate Withdrawal Scale - My muscles twitch. SOWS Subjective (Handelsman) - My Muscles Twitch SOWSA1-My Nose is Running Subjective Opiate Withdrawal Scale - My nose is running. SOWS Subjective (Handelsman) - My Nose is Running SOWSA1TN Subjective Opiate Withdrawal Scale Questionnaire Test Name CDISC Questionnaire SOWS Subjective Test Name Terminology A terminology codelist that describes syndromes or conditions that put a subject at risk for sudden death. Ventricular arrhythmia associated with Brugada syndrome Polymorphic ventricular tachycardia in the absence of structural heart disease, associated with a baseline ECG pattern during sinus rhythm showing right bundle branch block with ST segment elevation in leads V1 through V3. It can also be characterized by documentation of ECG patterns associated with Brugada Syndrome, some of which may be unmasked when provoked with drugs. The most common genetic mutations identified for Brugada syndrome are in the sodium channel gene SCN5A. Brugada Syndrome Ventricular Arrhythmia by ECG Finding Ventricular Tachycardia associated with syncope and/or cardiac arrest triggered by emotion or exercise in patients whose baseline ECG is normal. Catecholaminergic Polymorphic Ventricular Tachycardia by ECG Finding Ventricular tachycardia or ventricular fibrillation whose cause is unknown. Idiopathic Primary Ventricular Tachycardia/Ventricular Flutter by ECG Finding Ventricular arrhythmia associated with long QT syndrome Long QT Syndrome includes prolongation of the corrected QT interval beyond 440 ms for adult males, 460 ms for adult females and 50 ms in the presence of ventricular depolarization abnormalities (i.e., bundle branch blocks or IVCB more than 120 ms. A normal QT interval in a resting ECG with a failure to shorten with an increase in heart rate qualifies as Long QT Syndrome. Long QT Syndrome Ventricular arrhythmia associated with short QT syndrome Short QT Syndrome is characterized by a QT interval of less than or equal to 300 ms. Short QT Syndrome SDTHSDTP Sudden Death Syndrome Type CDISC SDTM Sudden Death Syndrome Type Terminology Suicidal Ideation Questionnaire test code. SIQ01-Would Be Better If I Was Not Alive Suicidal Ideation Questionnaire - I thought it would be better if I was not alive. SIQ - Would Be Better If I Was Not Alive SIQ01-I Thought About Killing Myself Suicidal Ideation Questionnaire - I thought about killing myself. SIQ - I Thought About Killing Myself SIQ01-I Thought How I Would Kill Myself Suicidal Ideation Questionnaire - I thought about how I would kill myself. SIQ - I Thought How I Would Kill Myself SIQ01-I Thought When I Would Kill Myself Suicidal Ideation Questionnaire - I thought about when I would kill myself. SIQ - I Thought When I Would Kill Myself SIQ01-I Thought About People Dying Suicidal Ideation Questionnaire - I thought about people dying. SIQ - I Thought About People Dying SIQ01-I Thought About Death Suicidal Ideation Questionnaire - I thought about death. SIQ - I Thought About Death SIQ01-What to Write in a Suicide Note Suicidal Ideation Questionnaire - I thought about what to write in a suicide note. SIQ - What to Write in a Suicide Note SIQ01-I Thought About Writing a Will Suicidal Ideation Questionnaire - I thought about writing a will. SIQ - I Thought About Writing a Will SIQ01-Tell People I Plan to Kill Myself Suicidal Ideation Questionnaire - I thought about telling people I plan to kill myself. SIQ - Tell People I Plan to Kill Myself SIQ01-People Happier If Not Around Suicidal Ideation Questionnaire - I thought that people would be happier if I were not around. SIQ - People Happier If Not Around SIQ01-How People Feel If I Killed Myself Suicidal Ideation Questionnaire - I thought about how people would feel if I killed myself. SIQ - How People Feel If I Killed Myself SIQ01-I Wished I Were Dead Suicidal Ideation Questionnaire - I wished I were dead. SIQ - I Wished I Were Dead SIQ01-How Easy It Would Be to End It All Suicidal Ideation Questionnaire - I thought about how easy it would be to end it all. SIQ - How Easy It Would Be to End It All SIQ01-Killing Myself Would Solve Problem Suicidal Ideation Questionnaire - I thought that killing myself would solve my problems. SIQ - Killing Myself Would Solve Problem SIQ01-Others Better Off If I Was Dead Suicidal Ideation Questionnaire - I thought others would be better off if I was dead. SIQ - Others Better Off If I Was Dead SIQ01-Wished I Had the Nerve Kill Myself Suicidal Ideation Questionnaire - I wished I had the nerve to kill myself. SIQ - Wished I Had the Nerve Kill Myself SIQ01-Wished I Had Never Been Born Suicidal Ideation Questionnaire - I wished that I had never been born. SIQ - Wished I Had Never Been Born SIQ01-If Had Chance I Would Kill Myself Suicidal Ideation Questionnaire - I thought if I had the chance I would kill myself. SIQ - If Had Chance I Would Kill Myself SIQ01-Thought Way People Kill Themselves Suicidal Ideation Questionnaire - I thought about ways people kill themselves. SIQ - Thought Way People Kill Themselves SIQ01-Thought Killing Myself Not Do It Suicidal Ideation Questionnaire - I thought about killing myself, but would not do it. SIQ - Thought Killing Myself Not Do It SIQ01-Thought About Having Bad Accident Suicidal Ideation Questionnaire - I thought about having a bad accident. SIQ - Thought About Having Bad Accident SIQ01-Thought Life Was Not Worth Living Suicidal Ideation Questionnaire - I thought that life was not worth living. SIQ - Thought Life Was Not Worth Living SIQ01-My Life Was Too Rotten to Continue Suicidal Ideation Questionnaire - I thought that my life was too rotten to continue. SIQ - My Life Was Too Rotten to Continue SIQ01-Only Way Be Noticed Is Kill Myself Suicidal Ideation Questionnaire - I thought that the only way to be noticed is to kill myself. SIQ - Only Way Be Noticed Is Kill Myself SIQ01-People Realize Worth Caring About Suicidal Ideation Questionnaire - I thought that if I killed myself people would realize I was worth caring about. SIQ - People Realize Worth Caring About SIQ01-No One Cared If I Lived or Died Suicidal Ideation Questionnaire - I thought that no one cared if I lived or died. SIQ - No One Cared If I Lived or Died SIQ01-Hurting Myself but Not Kill Myself Suicidal Ideation Questionnaire - I thought about hurting myself but not really killing myself. SIQ - Hurting Myself but Not Kill Myself SIQ01-Wondered If Had Nerve Kill Myself Suicidal Ideation Questionnaire - I wondered if I had the nerve to kill myself. SIQ - Wondered If Had Nerve Kill Myself SIQ01-If Things Not Better I Kill Myself Suicidal Ideation Questionnaire - I thought that if things did not get better I would kill myself. SIQ - If Things Not Better I Kill Myself SIQ01-Wished I Had Right to Kill Myself Suicidal Ideation Questionnaire - I wished that I had the right to kill myself. SIQ - Wished I Had Right to Kill Myself SIQ01-TS Suicidal Ideation Questionnaire - TS (total raw score). SIQ - TS SIQ01-Total % Suicidal Ideation Questionnaire - Total standardization sample %. SIQ - Total % SIQ01-Specific %: Standard Sample 1 Suicidal Ideation Questionnaire - Specific standardization %: Sample 1. SIQ - Specific %: Standard Sample 1 SIQ01-Specific %: Standard Sample 2 Suicidal Ideation Questionnaire - Specific standardization %: Sample 2. SIQ - Specific %: Standard Sample 2 SIQ01-Specific %: Standard Sample 3 Suicidal Ideation Questionnaire - Specific standardization %: Sample 3. SIQ - Specific %: Standard Sample 3 SIQ01-Critical Item 1 Suicidal Ideation Questionnaire - Critical item 1. SIQ - Critical Item 1 SIQ01-Critical Item 2 Suicidal Ideation Questionnaire - Critical item 2. SIQ - Critical Item 2 SIQ01-Critical Item 3 Suicidal Ideation Questionnaire - Critical item 3. SIQ - Critical Item 3 SIQ01-Critical Item 4 Suicidal Ideation Questionnaire - Critical item 4. SIQ - Critical Item 4 SIQ01-Critical Item 5 Suicidal Ideation Questionnaire - Critical item 5. SIQ - Critical Item 5 SIQ01-Critical Item 6 Suicidal Ideation Questionnaire - Critical item 6. SIQ - Critical Item 6 SIQ01-Critical Item 7 Suicidal Ideation Questionnaire - Critical item 7. SIQ - Critical Item 7 SIQ01-Critical Item 8 Suicidal Ideation Questionnaire - Critical item 8. SIQ - Critical Item 8 SIQ01TC Suicidal Ideation Questionnaire Test Code CDISC Questionnaire SIQ Test Code Terminology Suicidal Ideation Questionnaire test name. SIQ01-Critical Item 1 Suicidal Ideation Questionnaire - Critical item 1. SIQ - Critical Item 1 SIQ01-Critical Item 2 Suicidal Ideation Questionnaire - Critical item 2. SIQ - Critical Item 2 SIQ01-Critical Item 3 Suicidal Ideation Questionnaire - Critical item 3. SIQ - Critical Item 3 SIQ01-Critical Item 4 Suicidal Ideation Questionnaire - Critical item 4. SIQ - Critical Item 4 SIQ01-Critical Item 5 Suicidal Ideation Questionnaire - Critical item 5. SIQ - Critical Item 5 SIQ01-Critical Item 6 Suicidal Ideation Questionnaire - Critical item 6. SIQ - Critical Item 6 SIQ01-Critical Item 7 Suicidal Ideation Questionnaire - Critical item 7. SIQ - Critical Item 7 SIQ01-Critical Item 8 Suicidal Ideation Questionnaire - Critical item 8. SIQ - Critical Item 8 SIQ01-How Easy It Would Be to End It All Suicidal Ideation Questionnaire - I thought about how easy it would be to end it all. SIQ - How Easy It Would Be to End It All SIQ01-How People Feel If I Killed Myself Suicidal Ideation Questionnaire - I thought about how people would feel if I killed myself. SIQ - How People Feel If I Killed Myself SIQ01-Hurting Myself but Not Kill Myself Suicidal Ideation Questionnaire - I thought about hurting myself but not really killing myself. SIQ - Hurting Myself but Not Kill Myself SIQ01-I Thought About Death Suicidal Ideation Questionnaire - I thought about death. SIQ - I Thought About Death SIQ01-I Thought About Killing Myself Suicidal Ideation Questionnaire - I thought about killing myself. SIQ - I Thought About Killing Myself SIQ01-I Thought About People Dying Suicidal Ideation Questionnaire - I thought about people dying. SIQ - I Thought About People Dying SIQ01-I Thought About Writing a Will Suicidal Ideation Questionnaire - I thought about writing a will. SIQ - I Thought About Writing a Will SIQ01-I Thought How I Would Kill Myself Suicidal Ideation Questionnaire - I thought about how I would kill myself. SIQ - I Thought How I Would Kill Myself SIQ01-I Thought When I Would Kill Myself Suicidal Ideation Questionnaire - I thought about when I would kill myself. SIQ - I Thought When I Would Kill Myself SIQ01-I Wished I Were Dead Suicidal Ideation Questionnaire - I wished I were dead. SIQ - I Wished I Were Dead SIQ01-If Had Chance I Would Kill Myself Suicidal Ideation Questionnaire - I thought if I had the chance I would kill myself. SIQ - If Had Chance I Would Kill Myself SIQ01-If Things Not Better I Kill Myself Suicidal Ideation Questionnaire - I thought that if things did not get better I would kill myself. SIQ - If Things Not Better I Kill Myself SIQ01-Killing Myself Would Solve Problem Suicidal Ideation Questionnaire - I thought that killing myself would solve my problems. SIQ - Killing Myself Would Solve Problem SIQ01-My Life Was Too Rotten to Continue Suicidal Ideation Questionnaire - I thought that my life was too rotten to continue. SIQ - My Life Was Too Rotten to Continue SIQ01-No One Cared If I Lived or Died Suicidal Ideation Questionnaire - I thought that no one cared if I lived or died. SIQ - No One Cared If I Lived or Died SIQ01-Only Way Be Noticed Is Kill Myself Suicidal Ideation Questionnaire - I thought that the only way to be noticed is to kill myself. SIQ - Only Way Be Noticed Is Kill Myself SIQ01-Others Better Off If I Was Dead Suicidal Ideation Questionnaire - I thought others would be better off if I was dead. SIQ - Others Better Off If I Was Dead SIQ01-People Happier If Not Around Suicidal Ideation Questionnaire - I thought that people would be happier if I were not around. SIQ - People Happier If Not Around SIQ01-People Realize Worth Caring About Suicidal Ideation Questionnaire - I thought that if I killed myself people would realize I was worth caring about. SIQ - People Realize Worth Caring About SIQ01-Specific %: Standard Sample 1 Suicidal Ideation Questionnaire - Specific standardization %: Sample 1. SIQ - Specific %: Standard Sample 1 SIQ01-Specific %: Standard Sample 2 Suicidal Ideation Questionnaire - Specific standardization %: Sample 2. SIQ - Specific %: Standard Sample 2 SIQ01-Specific %: Standard Sample 3 Suicidal Ideation Questionnaire - Specific standardization %: Sample 3. SIQ - Specific %: Standard Sample 3 SIQ01-Tell People I Plan to Kill Myself Suicidal Ideation Questionnaire - I thought about telling people I plan to kill myself. SIQ - Tell People I Plan to Kill Myself SIQ01-Thought About Having Bad Accident Suicidal Ideation Questionnaire - I thought about having a bad accident. SIQ - Thought About Having Bad Accident SIQ01-Thought Killing Myself Not Do It Suicidal Ideation Questionnaire - I thought about killing myself, but would not do it. SIQ - Thought Killing Myself Not Do It SIQ01-Thought Life Was Not Worth Living Suicidal Ideation Questionnaire - I thought that life was not worth living. SIQ - Thought Life Was Not Worth Living SIQ01-Thought Way People Kill Themselves Suicidal Ideation Questionnaire - I thought about ways people kill themselves. SIQ - Thought Way People Kill Themselves SIQ01-Total % Suicidal Ideation Questionnaire - Total standardization sample %. SIQ - Total % SIQ01-TS Suicidal Ideation Questionnaire - TS (total raw score). SIQ - TS SIQ01-What to Write in a Suicide Note Suicidal Ideation Questionnaire - I thought about what to write in a suicide note. SIQ - What to Write in a Suicide Note SIQ01-Wished I Had Never Been Born Suicidal Ideation Questionnaire - I wished that I had never been born. SIQ - Wished I Had Never Been Born SIQ01-Wished I Had Right to Kill Myself Suicidal Ideation Questionnaire - I wished that I had the right to kill myself. SIQ - Wished I Had Right to Kill Myself SIQ01-Wished I Had the Nerve Kill Myself Suicidal Ideation Questionnaire - I wished I had the nerve to kill myself. SIQ - Wished I Had the Nerve Kill Myself SIQ01-Wondered If Had Nerve Kill Myself Suicidal Ideation Questionnaire - I wondered if I had the nerve to kill myself. SIQ - Wondered If Had Nerve Kill Myself SIQ01-Would Be Better If I Was Not Alive Suicidal Ideation Questionnaire - I thought it would be better if I was not alive. SIQ - Would Be Better If I Was Not Alive SIQ01TN Suicidal Ideation Questionnaire Test Name CDISC Questionnaire SIQ Test Name Terminology Suicidal Ideation Questionnaire-JR test code. SIQ02-Would Be Better If I Was Not Alive Suicidal Ideation Questionnaire-JR - I thought it would be better if I was not live. SIQ-JR - Would Be Better If I Was Not Alive SIQ02-I Thought About Killing Myself Suicidal Ideation Questionnaire-JR - I thought about killing myself. SIQ-JR - I Thought About Killing Myself SIQ02-I Thought How I Would Kill Myself Suicidal Ideation Questionnaire-JR - I thought about how I would kill myself. SIQ-JR - I Thought How I Would Kill Myself SIQ02-I Thought When I Would Kill Myself Suicidal Ideation Questionnaire-JR - I thought about when I would kill myself. SIQ-JR - I Thought When I Would Kill Myself SIQ02-I Thought About People Dying Suicidal Ideation Questionnaire-JR - I thought about people dying. SIQ-JR - I Thought About People Dying SIQ02-I Thought About Death Suicidal Ideation Questionnaire-JR - I thought about death. SIQ-JR - I Thought About Death SIQ02-What to Write in a Suicide Note Suicidal Ideation Questionnaire-JR - I thought about what to write in a suicide note. SIQ-JR - What to Write in a Suicide Note SIQ02-I Thought About Writing a Will Suicidal Ideation Questionnaire-JR - I thought about writing a will. SIQ-JR - I Thought About Writing a Will SIQ02-Tell People I Plan to Kill Myself Suicidal Ideation Questionnaire-JR - I thought about telling people I plan to kill myself. SIQ-JR - Tell People I Plan to Kill Myself SIQ02-How People Feel If I Killed Myself Suicidal Ideation Questionnaire-JR - I thought about how people would feel if I killed myself. SIQ-JR - How People Feel If I Killed Myself SIQ02-I Wished I Were Dead Suicidal Ideation Questionnaire-JR - I wished I were dead. SIQ-JR - I Wished I Were Dead SIQ02-Killing Myself Would Solve Problem Suicidal Ideation Questionnaire-JR - I thought that killing myself would solve my problems. SIQ-JR - Killing Myself Would Solve Problem SIQ02-Others Be Happier If I Was Dead Suicidal Ideation Questionnaire-JR - I thought that others would be happier if I was dead. SIQ-JR - Others Be Happier If I Was Dead SIQ02-Wished I Had Never Been Born Suicidal Ideation Questionnaire-JR - I wished that I had never been born. SIQ-JR - Wished I Had Never Been Born SIQ02-No One Cared If I Lived or Died Suicidal Ideation Questionnaire-JR - I thought that no one cared if I lived or died. SIQ-JR - No One Cared If I Lived or Died SIQ02-TS Suicidal Ideation Questionnaire-JR - TS (total raw score). SIQ-JR - TS SIQ02-Total % Suicidal Ideation Questionnaire-JR - Total standardization sample %. SIQ-JR - Total % SIQ02-Specific %: Standard Sample 1 Suicidal Ideation Questionnaire-JR - Specific standardization %: Sample 1. SIQ-JR - Specific %: Standard Sample 1 SIQ02-Specific %: Standard Sample 2 Suicidal Ideation Questionnaire-JR - Specific standardization %: Sample 2. SIQ-JR - Specific %: Standard Sample 2 SIQ02-Specific %: Standard Sample 3 Suicidal Ideation Questionnaire-JR - Specific standardization %: Sample 3. SIQ-JR - Specific %: Standard Sample 3 SIQ02-Critical Item 1 Suicidal Ideation Questionnaire-JR - Critical item 1. SIQ-JR - Critical Item 1 SIQ02-Critical Item 2 Suicidal Ideation Questionnaire-JR - Critical item 2. SIQ-JR - Critical Item 2 SIQ02-Critical Item 3 Suicidal Ideation Questionnaire-JR - Critical item 3. SIQ-JR - Critical Item 3 SIQ02-Critical Item 4 Suicidal Ideation Questionnaire-JR - Critical item 4. SIQ-JR - Critical Item 4 SIQ02-Critical Item 5 Suicidal Ideation Questionnaire-JR - Critical item 5. SIQ-JR - Critical Item 5 SIQ02-Critical Item 6 Suicidal Ideation Questionnaire-JR - Critical item 6. SIQ-JR - Critical Item 6 SIQ02TC Suicidal Ideation Questionnaire-JR Questionnaire Test Code CDISC Questionnaire SIQ-JR Test Code Terminology Suicidal Ideation Questionnaire-JR test name. SIQ02-Critical Item 1 Suicidal Ideation Questionnaire-JR - Critical item 1. SIQ-JR - Critical Item 1 SIQ02-Critical Item 2 Suicidal Ideation Questionnaire-JR - Critical item 2. SIQ-JR - Critical Item 2 SIQ02-Critical Item 3 Suicidal Ideation Questionnaire-JR - Critical item 3. SIQ-JR - Critical Item 3 SIQ02-Critical Item 4 Suicidal Ideation Questionnaire-JR - Critical item 4. SIQ-JR - Critical Item 4 SIQ02-Critical Item 5 Suicidal Ideation Questionnaire-JR - Critical item 5. SIQ-JR - Critical Item 5 SIQ02-Critical Item 6 Suicidal Ideation Questionnaire-JR - Critical item 6. SIQ-JR - Critical Item 6 SIQ02-How People Feel If I Killed Myself Suicidal Ideation Questionnaire-JR - I thought about how people would feel if I killed myself. SIQ-JR - How People Feel If I Killed Myself SIQ02-I Thought About Death Suicidal Ideation Questionnaire-JR - I thought about death. SIQ-JR - I Thought About Death SIQ02-I Thought About Killing Myself Suicidal Ideation Questionnaire-JR - I thought about killing myself. SIQ-JR - I Thought About Killing Myself SIQ02-I Thought About People Dying Suicidal Ideation Questionnaire-JR - I thought about people dying. SIQ-JR - I Thought About People Dying SIQ02-I Thought About Writing a Will Suicidal Ideation Questionnaire-JR - I thought about writing a will. SIQ-JR - I Thought About Writing a Will SIQ02-I Thought How I Would Kill Myself Suicidal Ideation Questionnaire-JR - I thought about how I would kill myself. SIQ-JR - I Thought How I Would Kill Myself SIQ02-I Thought When I Would Kill Myself Suicidal Ideation Questionnaire-JR - I thought about when I would kill myself. SIQ-JR - I Thought When I Would Kill Myself SIQ02-I Wished I Were Dead Suicidal Ideation Questionnaire-JR - I wished I were dead. SIQ-JR - I Wished I Were Dead SIQ02-Killing Myself Would Solve Problem Suicidal Ideation Questionnaire-JR - I thought that killing myself would solve my problems. SIQ-JR - Killing Myself Would Solve Problem SIQ02-No One Cared If I Lived or Died Suicidal Ideation Questionnaire-JR - I thought that no one cared if I lived or died. SIQ-JR - No One Cared If I Lived or Died SIQ02-Others Be Happier If I Was Dead Suicidal Ideation Questionnaire-JR - I thought that others would be happier if I was dead. SIQ-JR - Others Be Happier If I Was Dead SIQ02-Specific %: Standard Sample 1 Suicidal Ideation Questionnaire-JR - Specific standardization %: Sample 1. SIQ-JR - Specific %: Standard Sample 1 SIQ02-Specific %: Standard Sample 2 Suicidal Ideation Questionnaire-JR - Specific standardization %: Sample 2. SIQ-JR - Specific %: Standard Sample 2 SIQ02-Specific %: Standard Sample 3 Suicidal Ideation Questionnaire-JR - Specific standardization %: Sample 3. SIQ-JR - Specific %: Standard Sample 3 SIQ02-Tell People I Plan to Kill Myself Suicidal Ideation Questionnaire-JR - I thought about telling people I plan to kill myself. SIQ-JR - Tell People I Plan to Kill Myself SIQ02-Total % Suicidal Ideation Questionnaire-JR - Total standardization sample %. SIQ-JR - Total % SIQ02-TS Suicidal Ideation Questionnaire-JR - TS (total raw score). SIQ-JR - TS SIQ02-What to Write in a Suicide Note Suicidal Ideation Questionnaire-JR - I thought about what to write in a suicide note. SIQ-JR - What to Write in a Suicide Note SIQ02-Wished I Had Never Been Born Suicidal Ideation Questionnaire-JR - I wished that I had never been born. SIQ-JR - Wished I Had Never Been Born SIQ02-Would Be Better If I Was Not Alive Suicidal Ideation Questionnaire-JR - I thought it would be better if I was not live. SIQ-JR - Would Be Better If I Was Not Alive SIQ02TN Suicidal Ideation Questionnaire-JR Questionnaire Test Name CDISC Questionnaire SIQ-JR Test Name Terminology Terminology relevant to the clinical evidence to support reason for re-treatment of disease. Objective evidence of bacterial infection perceptible to the examiner by laboratory procedure. Bacteriological Finding Clinical Signs Objective evidence of disease perceptible to the examiner (sign) and subjective evidence of disease perceived by the subject (symptom). Sign or Symptom Objective evidence of disease perceptible to the examiner by radiological procedure. Radiologic Finding EVDRETRT Supporting Evidence for Re-Treatment CDISC SDTM Supporting Evidence for Re-Treatment Terminology Symbol Digit Modalities Test test code. SDMT01-Total Score Symbol Digit Modalities Test - Total score. SDMT - Total Score SDMT01TC Symbol Digit Modalities Test Functional Test Test Code CDISC Functional Test SDMT Test Code Terminology Symbol Digit Modalities Test test name. SDMT01-Total Score Symbol Digit Modalities Test - Total score. SDMT - Total Score SDMT01TN Symbol Digit Modalities Test Functional Test Test Name CDISC Functional Test SDMT Test Name Terminology Symptom Impact Questionnaire test code. SIQR01-Brush or Comb Your Hair Symptom Impact Questionnaire - Brush or comb your hair. SIQR - Brush or Comb Your Hair SIQR01-Walk Continuously for 20 Minutes Symptom Impact Questionnaire - Walk continuously for 20 minutes. SIQR - Walk Continuously for 20 Minutes SIQR01-Prepare a Homemade Meal Symptom Impact Questionnaire - Prepare a homemade meal. SIQR - Prepare a Homemade Meal SIQR01-Vacuum Scrub or Sweep Floors Symptom Impact Questionnaire - Vacuum, scrub or sweep floors. SIQR - Vacuum Scrub or Sweep Floors SIQR01-Lift/Carry Bag Full of Groceries Symptom Impact Questionnaire - Lift and carry a bag full of groceries. SIQR - Lift and Carry a Bag Full of Groceries SIQR01-Climb One Flight of Stairs Symptom Impact Questionnaire - Climb one flight of stairs. SIQR - Climb One Flight of Stairs SIQR01-Change Bed Sheets Symptom Impact Questionnaire - Change bed sheets. SIQR - Change Bed Sheets SIQR01-Sit in a Chair for 45 Minutes Symptom Impact Questionnaire - Sit in a chair for 45 minutes. SIQR - Sit in a Chair for 45 Minutes SIQR01-Go Shopping for Groceries Symptom Impact Questionnaire - Go shopping for groceries. SIQR - Go Shopping for Groceries SIQR01-Prevent from Accomplishing Goals Symptom Impact Questionnaire - My medical problems prevented me from accomplishing goals for week. SIQR - My Medical Problem Prevented Me from Accomplishing Goals for the Week SIQR01-Overwhelmed by Medical Problems Symptom Impact Questionnaire - I was completely overwhelmed by my medical problems. SIQR - I was Completely Overwhelmed by My Medical Problem SIQR01-Pain Symptom Impact Questionnaire - Please rate your level of pain. SIQR - Pain SIQR01-Energy Symptom Impact Questionnaire - Please rate your level of energy. SIQR - Energy SIQR01-Stiffness Symptom Impact Questionnaire - Please rate your level of stiffness. SIQR - Stiffness SIQR01-Your Sleep Symptom Impact Questionnaire - Please rate the quality of your sleep. SIQR - Your Sleep SIQR01-Depression Symptom Impact Questionnaire - Please rate your level of depression. SIQR - Depression SIQR01-Memory Problems Symptom Impact Questionnaire - Please rate your level of memory problems. SIQR - Memory Problems SIQR01-Anxiety Symptom Impact Questionnaire - Please rate your level of anxiety. SIQR - Anxiety SIQR01-Tenderness to Touch Symptom Impact Questionnaire - Please rate your level of tenderness to touch. SIQR - Tenderness to Touch SIQR01-Balance Problems Symptom Impact Questionnaire - Please rate your level of balance problems. SIQR - Balance Problems SIQR01-Sensitivity Noise/Light/Odor/Cold Symptom Impact Questionnaire - Please rate your level of sensitivity to loud noises, bright lights, odors and cold. SIQR - Sensitivity to Loud Noises, Bright Lights, Odors and Cold SIQR01TC Symptom Impact Questionnaire Questionnaire Test Code CDISC Questionnaire SIQR Test Code Terminology Symptom Impact Questionnaire test name. SIQR01-Anxiety Symptom Impact Questionnaire - Please rate your level of anxiety. SIQR - Anxiety SIQR01-Balance Problems Symptom Impact Questionnaire - Please rate your level of balance problems. SIQR - Balance Problems SIQR01-Brush or Comb Your Hair Symptom Impact Questionnaire - Brush or comb your hair. SIQR - Brush or Comb Your Hair SIQR01-Change Bed Sheets Symptom Impact Questionnaire - Change bed sheets. SIQR - Change Bed Sheets SIQR01-Climb One Flight of Stairs Symptom Impact Questionnaire - Climb one flight of stairs. SIQR - Climb One Flight of Stairs SIQR01-Depression Symptom Impact Questionnaire - Please rate your level of depression. SIQR - Depression SIQR01-Energy Symptom Impact Questionnaire - Please rate your level of energy. SIQR - Energy SIQR01-Go Shopping for Groceries Symptom Impact Questionnaire - Go shopping for groceries. SIQR - Go Shopping for Groceries SIQR01-Lift/Carry Bag Full of Groceries Symptom Impact Questionnaire - Lift and carry a bag full of groceries. SIQR - Lift and Carry a Bag Full of Groceries SIQR01-Memory Problems Symptom Impact Questionnaire - Please rate your level of memory problems. SIQR - Memory Problems SIQR01-Overwhelmed by Medical Problems Symptom Impact Questionnaire - I was completely overwhelmed by my medical problems. SIQR - I was Completely Overwhelmed by My Medical Problem SIQR01-Pain Symptom Impact Questionnaire - Please rate your level of pain. SIQR - Pain SIQR01-Prepare a Homemade Meal Symptom Impact Questionnaire - Prepare a homemade meal. SIQR - Prepare a Homemade Meal SIQR01-Prevent from Accomplishing Goals Symptom Impact Questionnaire - My medical problems prevented me from accomplishing goals for week. SIQR - My Medical Problem Prevented Me from Accomplishing Goals for the Week SIQR01-Sensitivity Noise/Light/Odor/Cold Symptom Impact Questionnaire - Please rate your level of sensitivity to loud noises, bright lights, odors and cold. SIQR - Sensitivity to Loud Noises, Bright Lights, Odors and Cold SIQR01-Sit in a Chair for 45 Minutes Symptom Impact Questionnaire - Sit in a chair for 45 minutes. SIQR - Sit in a Chair for 45 Minutes SIQR01-Stiffness Symptom Impact Questionnaire - Please rate your level of stiffness. SIQR - Stiffness SIQR01-Tenderness to Touch Symptom Impact Questionnaire - Please rate your level of tenderness to touch. SIQR - Tenderness to Touch SIQR01-Vacuum Scrub or Sweep Floors Symptom Impact Questionnaire - Vacuum, scrub or sweep floors. SIQR - Vacuum Scrub or Sweep Floors SIQR01-Walk Continuously for 20 Minutes Symptom Impact Questionnaire - Walk continuously for 20 minutes. SIQR - Walk Continuously for 20 Minutes SIQR01-Your Sleep Symptom Impact Questionnaire - Please rate the quality of your sleep. SIQR - Your Sleep SIQR01TN Symptom Impact Questionnaire Questionnaire Test Name CDISC Questionnaire SIQR Test Name Terminology Symptoms of Major Depressive Disorder Scale v1.0 test code. SMDDS1-How Sad Have You Felt Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how sad have you felt? SMDDS Version 1.0 - How Sad Have You Felt SMDDS1-How Hopeless Have You Felt Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how hopeless have you felt? SMDDS Version 1.0 - How Hopeless Have You Felt SMDDS1-How Irritable Have You Felt Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how irritable have you felt? SMDDS Version 1.0 - How Irritable Have You Felt SMDDS1-How Overwhelmed Have You Felt Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how overwhelmed have you felt? SMDDS Version 1.0 - How Overwhelmed Have You Felt SMDDS1-How Worried Have You Felt Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how worried have you felt? SMDDS Version 1.0 - How Worried Have You Felt SMDDS1-How Tired Have You Felt Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how tired have you felt? SMDDS Version 1.0 - How Tired Have You Felt SMDDS1-How Difficult Stop Think Problems Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how difficult was it for you to stop thinking about your problems? SMDDS Version 1.0 - How Difficult Stop Think Problems SMDDS1-How Difficult to Concentrate Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how difficult was it for you to concentrate? SMDDS Version 1.0 - How Difficult to Concentrate SMDDS1-How Difficult to Enjoy Daily Life Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how difficult was it for you to enjoy your daily life? SMDDS Version 1.0 - How Difficult to Enjoy Daily Life SMDDS1-How Often Problem With Sleep Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how often did you have a problem with your sleep (falling asleep, staying asleep, or sleeping too much)? SMDDS Version 1.0 - How Often Problem With Sleep SMDDS1-How Often Have Poor Appetite Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how often did you have a poor appetite? SMDDS Version 1.0 - How Often Have Poor Appetite SMDDS1-How Often Did You Over Eat Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how often did you over eat? SMDDS Version 1.0 - How Often Did You Over Eat SMDDS1-How Much Push Yourself Do Things Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how much of the time did you have to push yourself to do things? SMDDS Version 1.0 - How Much Push Yourself Do Things SMDDS1-How Much Feel Like Doing Nothing Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how much of the time did you feel like doing nothing? SMDDS Version 1.0 - How Much Feel Like Doing Nothing SMDDS1-How Much Blame Yourself Bad Thing Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how much of the time did you blame yourself when bad things happened? SMDDS Version 1.0 - How Much Blame Yourself Bad Thing SMDDS1-How Much Feel Not Worth Living Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how much of the time did you feel that life is not worth living? SMDDS Version 1.0 - How Much Feel Not Worth Living SMDDS1-Negative Emotions/Mood Subscore Symptoms of Major Depressive Disorder Scale v1.0 - Negative emotions/mood subscore. SMDDS Version 1.0 - Negative Emotions/Mood Subscore SMDDS1-Anxiety Subscore Symptoms of Major Depressive Disorder Scale v1.0 - Anxiety subscore. SMDDS Version 1.0 - Anxiety Subscore SMDDDS1-Low Energy Subscore Symptoms of Major Depressive Disorder Scale v1.0 - Low energy subscore. SMDDS Version 1.0 - SMDDDS1-Low Energy Subscore SMDDS1-Cognition Subscore Symptoms of Major Depressive Disorder Scale v1.0 - Cognition subscore. SMDDS Version 1.0 - Cognition Subscore SMDDS1-Sleep Disturbances Subscore Symptoms of Major Depressive Disorder Scale v1.0 - Sleep disturbances subscore. SMDDS Version 1.0 - Sleep Disturbances Subscore SMDDS1-Eating Behavior Subscore Symptoms of Major Depressive Disorder Scale v1.0 - Eating behavior subscore. SMDDS Version 1.0 - Eating Behavior Subscore SMDDS1-Low Motivation Subscore Symptoms of Major Depressive Disorder Scale v1.0 - Low motivation subscore. SMDDS Version 1.0 - Low Motivation Subscore SMDDS1-Sense of Self Subscore Symptoms of Major Depressive Disorder Scale v1.0 - Sense of self subscore. SMDDS Version 1.0 - Sense of Self Subscore SMDDS1-Self-Harm/Suicide Subscore Symptoms of Major Depressive Disorder Scale v1.0 - Self-harm/suicide subscore. SMDDS Version 1.0 - Self-Harm/Suicide Subscore SMDDS1-Total Score Symptoms of Major Depressive Disorder Scale v1.0 - Total score. SMDDS Version 1.0 - Total Score SMDDS1TC Symptoms of Major Depressive Disorder Scale v1.0 Questionnaire Test Code CDISC Questionnaire SMDDS Version 1.0 Test Code Terminology Symptoms of Major Depressive Disorder Scale v1.0 test name. SMDDDS1-Low Energy Subscore Symptoms of Major Depressive Disorder Scale v1.0 - Low energy subscore. SMDDS Version 1.0 - SMDDDS1-Low Energy Subscore SMDDS1-Anxiety Subscore Symptoms of Major Depressive Disorder Scale v1.0 - Anxiety subscore. SMDDS Version 1.0 - Anxiety Subscore SMDDS1-Cognition Subscore Symptoms of Major Depressive Disorder Scale v1.0 - Cognition subscore. SMDDS Version 1.0 - Cognition Subscore SMDDS1-Eating Behavior Subscore Symptoms of Major Depressive Disorder Scale v1.0 - Eating behavior subscore. SMDDS Version 1.0 - Eating Behavior Subscore SMDDS1-How Difficult Stop Think Problems Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how difficult was it for you to stop thinking about your problems? SMDDS Version 1.0 - How Difficult Stop Think Problems SMDDS1-How Difficult to Concentrate Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how difficult was it for you to concentrate? SMDDS Version 1.0 - How Difficult to Concentrate SMDDS1-How Difficult to Enjoy Daily Life Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how difficult was it for you to enjoy your daily life? SMDDS Version 1.0 - How Difficult to Enjoy Daily Life SMDDS1-How Hopeless Have You Felt Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how hopeless have you felt? SMDDS Version 1.0 - How Hopeless Have You Felt SMDDS1-How Irritable Have You Felt Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how irritable have you felt? SMDDS Version 1.0 - How Irritable Have You Felt SMDDS1-How Much Blame Yourself Bad Thing Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how much of the time did you blame yourself when bad things happened? SMDDS Version 1.0 - How Much Blame Yourself Bad Thing SMDDS1-How Much Feel Like Doing Nothing Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how much of the time did you feel like doing nothing? SMDDS Version 1.0 - How Much Feel Like Doing Nothing SMDDS1-How Much Feel Not Worth Living Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how much of the time did you feel that life is not worth living? SMDDS Version 1.0 - How Much Feel Not Worth Living SMDDS1-How Much Push Yourself Do Things Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how much of the time did you have to push yourself to do things? SMDDS Version 1.0 - How Much Push Yourself Do Things SMDDS1-How Often Did You Over Eat Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how often did you over eat? SMDDS Version 1.0 - How Often Did You Over Eat SMDDS1-How Often Have Poor Appetite Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how often did you have a poor appetite? SMDDS Version 1.0 - How Often Have Poor Appetite SMDDS1-How Often Problem With Sleep Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how often did you have a problem with your sleep (falling asleep, staying asleep, or sleeping too much)? SMDDS Version 1.0 - How Often Problem With Sleep SMDDS1-How Overwhelmed Have You Felt Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how overwhelmed have you felt? SMDDS Version 1.0 - How Overwhelmed Have You Felt SMDDS1-How Sad Have You Felt Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how sad have you felt? SMDDS Version 1.0 - How Sad Have You Felt SMDDS1-How Tired Have You Felt Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how tired have you felt? SMDDS Version 1.0 - How Tired Have You Felt SMDDS1-How Worried Have You Felt Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how worried have you felt? SMDDS Version 1.0 - How Worried Have You Felt SMDDS1-Low Motivation Subscore Symptoms of Major Depressive Disorder Scale v1.0 - Low motivation subscore. SMDDS Version 1.0 - Low Motivation Subscore SMDDS1-Negative Emotions/Mood Subscore Symptoms of Major Depressive Disorder Scale v1.0 - Negative emotions/mood subscore. SMDDS Version 1.0 - Negative Emotions/Mood Subscore SMDDS1-Self-Harm/Suicide Subscore Symptoms of Major Depressive Disorder Scale v1.0 - Self-harm/suicide subscore. SMDDS Version 1.0 - Self-Harm/Suicide Subscore SMDDS1-Sense of Self Subscore Symptoms of Major Depressive Disorder Scale v1.0 - Sense of self subscore. SMDDS Version 1.0 - Sense of Self Subscore SMDDS1-Sleep Disturbances Subscore Symptoms of Major Depressive Disorder Scale v1.0 - Sleep disturbances subscore. SMDDS Version 1.0 - Sleep Disturbances Subscore SMDDS1-Total Score Symptoms of Major Depressive Disorder Scale v1.0 - Total score. SMDDS Version 1.0 - Total Score SMDDS1TN Symptoms of Major Depressive Disorder Scale v1.0 Questionnaire Test Name CDISC Questionnaire SMDDS Version 1.0 Test Name Terminology Tanner Scale Boy original result for TANN0201 test and test code. TANN0201-Stage 1 Tanner Scale Boy original result for TANN0201-Stage 1: Pre-adolescent. Testes, scrotum, and penis are of about the same size and proportion as in early childhood. Tanner Scale Boy TANN0201 Original Result - Stage 1 TANN0201-Stage 2 Tanner Scale Boy original result for TANN0201-Stage 2: The scrotum and testes have enlarged and there is a change in the texture of the scrotal skin. There is also some reddening of the scrotal skin but this cannot be detected on black and white photographs. Tanner Scale Boy TANN0201 Original Result - Stage 2 TANN0201-Stage 3 Tanner Scale Boy original result for TANN0201-Stage 3: Growth of the penis has occurred, at first mainly in length but with some increase in breadth. There has been further growth of testes and scrotum. Tanner Scale Boy TANN0201 Original Result - Stage 3 TANN0201-Stage 4 Tanner Scale Boy original result for TANN0201-Stage 4: Penis further enlarged in length and breadth with development of glans. Testes and scrotum further enlarged. There is also further darkening of the scrotal skin, but this is difficult to detect on photographs. Tanner Scale Boy TANN0201 Original Result - Stage 4 TANN0201-Stage 5 Tanner Scale Boy original result for TANN0201-Stage 5: Genitalia adult in size and shape. No further enlargement takes place after Stage 5 is reached. Tanner Scale Boy TANN0201 Original Result - Stage 5 TANN0201OR Tanner Scale Boy Clinical Classification ORRES for TANN0201 TN/TC CDISC Clinical Classification Tanner Scale Boy TANN0201 Original Response Terminology Tanner Scale Boy original result for TANN0202 test and test code. TANN0202-Stage 1 Tanner Scale Boy original result for TANN0202-Stage 1: Pre-adolescent. The velus over the pubes is no further developed than that over the abdominal wall, i.e. no pubic hair. Tanner Scale Boy TANN0202 Original Result - Stage 1 TANN0202-Stage 2 Tanner Scale Boy original result for TANN0202-Stage 2: Sparse growth of long, slightly pigmented, downy hair, straight or only slightly curled, appearing chiefly at the base of the penis. This stage is difficult to see on photographs, particularly of fair-haired subjects. Although the rating 'Stage 2' was used in this study, it cannot be regarded as reliable, and the ages at which subjects are said to have reached Stage 2 are almost certainly too late. Tanner Scale Boy TANN0202 Original Result - Stage 2 TANN0202-Stage 3 Tanner Scale Boy original result for TANN0202-Stage 3: Considerably darker, coarser, and more curled. The hair spreads sparsely over the junction of the pubes. This and subsequent stages were clearly recognizable on the photographs. Tanner Scale Boy TANN0202 Original Result - Stage 3 TANN0202-Stage 4 Tanner Scale Boy original result for TANN0202-Stage 4: Hair is now adult in type, but the area covered by it is still considerably smaller than in most adults. There is no spread to the medial surface of the thighs. Tanner Scale Boy TANN0202 Original Result - Stage 4 TANN0202-Stage 5 Tanner Scale Boy original result for TANN0202-Stage 5: Adult in quantity and type, distributed as an inverse triangle of the classically feminine pattern. Spread to the medial surface of the thighs but not up the linea alba or elsewhere above the base of the inverse triangle. Tanner Scale Boy TANN0202 Original Result - Stage 5 TANN0202OR Tanner Scale Boy Clinical Classification ORRES for TANN0202 TN/TC CDISC Clinical Classification Tanner Scale Boy TANN0202 Original Response Terminology Tanner Scale Boy standardized character result for TANN0201 test and test code. TANN0201-Stage 1 Tanner Scale Boy standardized character result for TANN0201-Stage 1: Pre-adolescent. Testes, scrotum, and penis are of about the same size and proportion as in early childhood. Tanner Scale Boy TANN0201 Standardized Character Result Stage 1 TANN0201-Stage 2 Tanner Scale Boy standardized character result for TANN0201-Stage 2: The scrotum and testes have enlarged and there is a change in the texture of the scrotal skin. There is also some reddening of the scrotal skin but this cannot be detected on black and white photographs. Tanner Scale Boy TANN0201 Standardized Character Result Stage 2 TANN0201-Stage 3 Tanner Scale Boy standardized character result for TANN0201-Stage 3: Growth of the penis has occurred, at first mainly in length but with some increase in breadth. There has been further growth of testes and scrotum. Tanner Scale Boy TANN0201 Standardized Character Result Stage 3 TANN0201-Stage 4 Tanner Scale Boy standardized character result for TANN0201-Stage 4: Penis further enlarged in length and breadth with development of glans. Testes and scrotum further enlarged. There is also further darkening of the scrotal skin, but this is difficult to detect on photographs. Tanner Scale Boy TANN0201 Standardized Character Result Stage 4 TANN0201-Stage 5 Tanner Scale Boy standardized character result for TANN0201-Stage 5: Genitalia adult in size and shape. No further enlargement takes place after Stage 5 is reached. Tanner Scale Boy TANN0201 Standardized Character Result Stage 5 TANN0201STR Tanner Scale Boy Clinical Classification STRESC for TANN0201 TN/TC CDISC Clinical Classification Tanner Scale Boy TANN0201 Standardized Character Response Terminology Tanner Scale Boy standardized character result for TANN0202 test and test code. TANN0202-Stage 1 Tanner Scale Boy standardized character result for TANN0202-Stage 1: Pre-adolescent. The velus over the pubes is no further developed than that over the abdominal wall, i.e. no pubic hair. Tanner Scale Boy TANN0202 Standardized Character Result Stage 1 TANN0202-Stage 2 Tanner Scale Boy standardized character result for TANN0202-Stage 2: Sparse growth of long, slightly pigmented, downy hair, straight or only slightly curled, appearing chiefly at the base of the penis. This stage is difficult to see on photographs, particularly of fair-haired subjects. Although the rating 'Stage 2' was used in this study, it cannot be regarded as reliable, and the ages at which subjects are said to have reached Stage 2 are almost certainly too late. Tanner Scale Boy TANN0202 Standardized Character Result Stage 2 TANN0202-Stage 3 Tanner Scale Boy standardized character result for TANN0202-Stage 3: Considerably darker, coarser, and more curled. The hair spreads sparsely over the junction of the pubes. This and subsequent stages were clearly recognizable on the photographs. Tanner Scale Boy TANN0202 Standardized Character Result Stage 3 TANN0202-Stage 4 Tanner Scale Boy standardized character result for TANN0202-Stage 4: Hair is now adult in type, but the area covered by it is still considerably smaller than in most adults. There is no spread to the medial surface of the thighs. Tanner Scale Boy TANN0202 Standardized Character Result Stage 4 TANN0202-Stage 5 Tanner Scale Boy standardized character result for TANN0202-Stage 5: Adult in quantity and type, distributed as an inverse triangle of the classically feminine pattern. Spread to the medial surface of the thighs but not up the linea alba or elsewhere above the base of the inverse triangle. Tanner Scale Boy TANN0202 Standardized Character Result Stage 5 TANN0202STR Tanner Scale Boy Clinical Classification STRESC for TANN0202 TN/TC CDISC Clinical Classification Tanner Scale Boy TANN0202 Standardized Character Response Terminology Tanner Scale Boy test code. TANN02-Genitalia Stages Tanner Scale Boy - Genitalia stages. Tanner Scale-Boy - Genitalia Stages TANN02-Pubic Hair Stages Tanner Scale Boy - Pubic hair stages. Tanner Scale-Boy - Pubic Hair Stages TANN02TC Tanner Scale Boy Clinical Classification Test Code CDISC Clinical Classification Tanner Scale-Boy Test Code Terminology Tanner Scale Boy test name. TANN02-Genitalia Stages Tanner Scale Boy - Genitalia stages. Tanner Scale-Boy - Genitalia Stages TANN02-Pubic Hair Stages Tanner Scale Boy - Pubic hair stages. Tanner Scale-Boy - Pubic Hair Stages TANN02TN Tanner Scale Boy Clinical Classification Test Name CDISC Clinical Classification Tanner Scale-Boy Test Name Terminology Tanner Scale Girl original result for TANN0101 test and test code. TANN0101-Stage 1 Tanner Scale Girl original result for TANN0101-Stage 1: Pre-adolescent; elevation of papilla only. Tanner Scale Girl TANN0101 Original Result - Stage 1 TANN0101-Stage 2 Tanner Scale Girl original result for TANN0101-Stage 2: Breast bud stage; elevation of breast and papilla as a small mound, enlargement of areola diameter. Tanner Scale Girl TANN0101 Original Result - Stage 2 TANN0101-Stage 3 Tanner Scale Girl original result for TANN0101-Stage 3: Further enlargement of breast and areola, with no separation of their contours. Tanner Scale Girl TANN0101 Original Result - Stage 3 TANN0101-Stage 4 Tanner Scale Girl original result for TANN0101-Stage 4: Projection of areola and papilla to form a secondary mound above the level of the breast. Tanner Scale Girl TANN0101 Original Result - Stage 4 TANN0101-Stage 5 Tanner Scale Girl original result for TANN0101-Stage 5: Mature stage; projection of papilla only, due to recession of the areola to the general contour of the breast. Tanner Scale Girl TANN0101 Original Result - Stage 5 TANN0101OR Tanner Scale Girl Clinical Classification ORRES for TANN0101 TN/TC CDISC Clinical Classification Tanner Scale Girl TANN0101 Original Response Terminology Tanner Scale Girl original result for TANN0102 test and test code. TANN0102-Stage 1 Tanner Scale Girl original result for TANN0102-Stage 1: Pre-adolescent; the vellus over the pubes is not further developed than that over the anterior abdominal wall, i.e. no pubic hair. Tanner Scale Girl TANN0102 Original Result - Stage 1 TANN0102-Stage 2 Tanner Scale Girl original result for TANN0102-Stage 2: Sparse growth of long, slightly pigmented, downy hair, straight or only slightly curled, appearing chiefly along the labia. This stage is difficult to see on photographs, particularly of fair-haired subjects. Though Stage 2 rating was used in this study, it cannot be regarded as reliable, and the ages at which subjects are said to have reached Stage 2 are almost certainly too late. Tanner Scale Girl TANN0102 Original Result - Stage 2 TANN0102-Stage 3 Tanner Scale Girl original result for TANN0102-Stage 3: Considerably darker, coarser, and more curled. The hair spreads sparsely over the junction of the pubes. This and subsequent stages were clearly recognizable on the photographs. Tanner Scale Girl TANN0102 Original Result - Stage 3 TANN0102-Stage 4 Tanner Scale Girl original result for TANN0102-Stage 4: Hair is now adult in type, but the area covered by it is still considerably smaller than in most adults. There is no spread to the medial surface of the thighs. Tanner Scale Girl TANN0102 Original Result - Stage 4 TANN0102-Stage 5 Tanner Scale Girl original result for TANN0102-Stage 5: Adult in quantity and type, distributed as an inverse triangle of the classically feminine pattern. Spread to the medial surface of the thighs, but not up the linea alba or elsewhere above the base of the inverse triangle. Tanner Scale Girl TANN0102 Original Result - Stage 5 TANN0102OR Tanner Scale Girl Clinical Classification ORRES for TANN0102 TN/TC CDISC Clinical Classification Tanner Scale Girl TANN0102 Original Response Terminology Tanner Scale Girl standardized character result for TANN0101 test and test code. TANN0101-Stage 1 Tanner Scale Girl standardized character result for TANN0101-Stage 1: Pre-adolescent; elevation of papilla only. Tanner Scale Girl TANN0101 Standardized Character Result Stage 1 TANN0101-Stage 2 Tanner Scale Girl standardized character result for TANN0101-Stage 2: Breast bud stage; elevation of breast and papilla as a small mound, enlargement of areola diameter. Tanner Scale Girl TANN0101 Standardized Character Result Stage 2 TANN0101-Stage 3 Tanner Scale Girl standardized character result for TANN0101-Stage 3: Further enlargement of breast and areola, with no separation of their contours. Tanner Scale Girl TANN0101 Standardized Character Result Stage 3 TANN0101-Stage 4 Tanner Scale Girl standardized character result for TANN0101-Stage 4: Projection of areola and papilla to form a secondary mound above the level of the breast. Tanner Scale Girl TANN0101 Standardized Character Result Stage 4 TANN0101-Stage 5 Tanner Scale Girl standardized character result for TANN0101-Stage 5: Mature stage; projection of papilla only, due to recession of the areola to the general contour of the breast. Tanner Scale Girl TANN0101 Standardized Character Result Stage 5 TANN0101STR Tanner Scale Girl Clinical Classification STRESC for TANN0101 TN/TC CDISC Clinical Classification Tanner Scale Girl TANN0101 Standardized Character Response Terminology Tanner Scale Girl standardized character result for TANN0102 test and test code. TANN0102-Stage 1 Tanner Scale Girl standardized character result for TANN0102-Stage 1: Pre-adolescent; the vellus over the pubes is not further developed than that over the anterior abdominal wall, i.e. no pubic hair. Tanner Scale Girl TANN0102 Standardized Character Result Stage 1 TANN0102-Stage 2 Tanner Scale Girl standardized character result for TANN0102-Stage 2: Sparse growth of long, slightly pigmented, downy hair, straight or only slightly curled, appearing chiefly along the labia. This stage is difficult to see on photographs, particularly of fair-haired subjects. Though Stage 2 rating was used in this study, it cannot be regarded as reliable, and the ages at which subjects are said to have reached Stage 2 are almost certainly too late. Tanner Scale Girl TANN0102 Standardized Character Result Stage 2 TANN0102-Stage 3 Tanner Scale Girl standardized character result for TANN0102-Stage 3: Considerably darker, coarser, and more curled. The hair spreads sparsely over the junction of the pubes. This and subsequent stages were clearly recognizable on the photographs. Tanner Scale Girl TANN0102 Standardized Character Result Stage 3 TANN0102-Stage 4 Tanner Scale Girl standardized character result for TANN0102-Stage 4: Hair is now adult in type, but the area covered by it is still considerably smaller than in most adults. There is no spread to the medial surface of the thighs. Tanner Scale Girl TANN0102 Standardized Character Result Stage 4 TANN0102-Stage 5 Tanner Scale Girl standardized character result for TANN0102-Stage 5: Adult in quantity and type, distributed as an inverse triangle of the classically feminine pattern. Spread to the medial surface of the thighs, but not up the linea alba or elsewhere above the base of the inverse triangle. Tanner Scale Girl TANN0102 Standardized Character Result Stage 5 TANN0102STR Tanner Scale Girl Clinical Classification STRESC for TANN0102 TN/TC CDISC Clinical Classification Tanner Scale Girl TANN0102 Standardized Character Response Terminology Tanner Scale Girl test code. TANN01-Breast Stages Tanner Scale Girl - Breast stages. Tanner Scale-Girl - Breast Stages TANN01-Pubic Hair Stages Tanner Scale Girl - Pubic hair stages. Tanner Scale-Girl - Pubic Hair Stages TANN01TC Tanner Scale Girl Clinical Classification Test Code CDISC Clinical Classification Tanner Scale-Girl Test Code Terminology Tanner Scale Girl test name. TANN01-Breast Stages Tanner Scale Girl - Breast stages. Tanner Scale-Girl - Breast Stages TANN01-Pubic Hair Stages Tanner Scale Girl - Pubic hair stages. Tanner Scale-Girl - Pubic Hair Stages TANN01TN Tanner Scale Girl Clinical Classification Test Name CDISC Clinical Classification Tanner Scale-Girl Test Name Terminology Terminology relevant to the values that describe a textual description of any planned condition imposed on the test system at the time the test is performed. 1D Cold Incubation The test system has been incubated in cold storage for one day. One Day Cold Incubation The test system contains excess amount of the binding agent. Saturated Condition With Binding Agent The test system contains APTEM thromboelastometry assay reagent. With APTEM Reagent The test system contains EXTEM thromboelastometry assay reagent. With EXTEM Reagent The test system contains FIBTEM thromboelastometry assay reagent. With FIBTEM Reagent The test system contains HEPTEM thromboelastometry assay reagent. With HEPTEM Reagent The test system contains inducing agent. With Inducing Agent The test system contains INTEM thromboelastometry assay reagent. With INTEM Reagent The test system contains stimulating agent. With Stimulating Agent The test system does not contain binding agent. Without Binding Agent The test system does not contain stimulating agent. Without Stimulating Agent TESTCOND Test Condition Response CDISC Test Condition Response Terminology Terminology relevant to the values that describe the sensitivity of the methodology with respect to observation, detection, or quantification. Any test methodology that is able to detect or quantify a finding at a high sensitivity level, as compared to the sensitivities of other concurrently available methods. High Sensitivity Method Any test methodology that is able to detect or quantify a finding at a low sensitivity level, as compared to the sensitivities of other concurrently available methods. Low Sensitivity Method Any test methodology that is able to detect or quantify a finding at an ultra-high sensitivity level, as compared to the sensitivities of other concurrently available methods. Ultra-High Sensitivity Method TSTMTHSN Test Method Sensitivity CDISC SDTM Test Method Sensitivity Terminology A terminology codelist relevant to the description of the high-level purpose of the test at the operational level. A test whose operational purpose is to verify the presence or absence of a substance or organism. Confirmatory Test A qualitative summary assessment and categorization of the subject's status across all collection events during the time period specified. Overall Subject Status A test whose operational purpose is to determine the amount or concentration of a substance or organism. Quantification Test A test whose operational purpose is to determine the presence or absence of a substance or organism. Screening Test TSTOPOBJ Test Operational Objective CDISC Test Operational Objective Terminology The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index test code. BODE01-Body-mass Index Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index - Body-mass index. BODE Index - Body-mass Index BODE01-FEV1 % Predicted Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index - FEV1 (% of predicted). BODE Index - FEV1 Percent Predicted BODE01-MMRC Dyspnea Scale Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index - MMRC dyspnea scale. BODE Index - MMRC Dyspnea Scale BODE01-Distance Walked in 6 Minutes Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index - Distance walked in 6 min (in meter). BODE Index - Distance Walked in 6 Minutes BODE01-BODE Score Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index - BODE score. BODE Index - Score BODE01TC The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index Clinical Classification Test Code CDISC Clinical Classification BODE Index Test Code Terminology The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index test name. BODE01-BODE Score Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index - BODE score. BODE Index - Score BODE01-Body-mass Index Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index - Body-mass index. BODE Index - Body-mass Index BODE01-Distance Walked in 6 Minutes Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index - Distance walked in 6 min (in meter). BODE Index - Distance Walked in 6 Minutes BODE01-FEV1 % Predicted Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index - FEV1 (% of predicted). BODE Index - FEV1 Percent Predicted BODE01-MMRC Dyspnea Scale Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index - MMRC dyspnea scale. BODE Index - MMRC Dyspnea Scale BODE01TN The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index Clinical Classification Test Name CDISC Clinical Classification BODE Index Test Name Terminology The Expanded Prostate Cancer Index Composite for Clinical Practice test code. EPIC2-Overall Problem Urinary Function Expanded Prostate Cancer Index Composite for Clinical Practice - Overall, how much of a problem has your urinary function been for you? EPIC-CP - Overall Problem Urinary Function EPIC2-Best Describes Urinary Control Expanded Prostate Cancer Index Composite for Clinical Practice - Which of the following best describes your urinary control? EPIC-CP - Best Describes Urinary Control EPIC2-Pads or Adult Diapers per Day Expanded Prostate Cancer Index Composite for Clinical Practice - How many pads or adult diapers per day have you been using for urinary leakage? EPIC-CP - Adult Diapers Used per Day EPIC2-Problem Urinary Dripping/Leakage Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has urinary dripping or leakage been for you? EPIC-CP - Problem Urinary Dripping/Leakage EPIC2-Problem Pain/Burning w/Urination Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Pain or burning with urination. EPIC-CP - Pain or Burning With Urination EPIC2-Problem Weak Stream/Incompl Empty Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Weak urine stream/incomplete bladder emptying. EPIC-CP - Weak Urine Stream or Incomplete Bladder Emptying EPIC2-Problem Need to Urinate Frequently Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Need to urinate frequently. EPIC-CP - Need to Urinate Frequently EPIC2-Problem Rectal Pain/Urgent Bowel Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Rectal pain or urgency of bowel movements. EPIC-CP - Rectal Pain or Urgency of Bowel Movements EPIC2-Problem Increased Freq Bowel Move Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Increased frequency of your bowel movements. EPIC-CP - Increased Frequency of Bowel Movements EPIC2-Overall Problem Bowel Habits Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Overall problems with your bowel habits. EPIC-CP - Overall Problems With Bowel Habits EPIC2-Rate Ability to Reach Orgasm Expanded Prostate Cancer Index Composite for Clinical Practice - How would you rate your ability to reach orgasm (climax)? EPIC-CP - Rate Ability to Reach Orgasm EPIC2-Quality of Your Erections Expanded Prostate Cancer Index Composite for Clinical Practice - How would you describe the usual quality of your erections? EPIC-CP - Quality of Erections EPIC2-Overall Problem Sexual Function Expanded Prostate Cancer Index Composite for Clinical Practice - Overall, how much of a problem has your sexual function or lack of sexual function been for you? EPIC-CP - Problem Lack of Sexual Function EPIC2-Problem Hot Flash/Breast Tender Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Hot flashes or breast tenderness/enlargement. EPIC-CP - Hot Flashes or Breast Tenderness EPIC2-Problem Feeling Depressed Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Feeling depressed. EPIC-CP - Feeling Depressed EPIC2-Problem Lack of Energy Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Lack of energy. EPIC-CP - Lack of Energy EPIC2-Urinary Incontinence Symptom Score Expanded Prostate Cancer Index Composite for Clinical Practice - Urinary incontinence symptom score. EPIC-CP - Urinary Incontinence Symptom Score EPIC2-Urinary Irrit/Obstr Symptom Score Expanded Prostate Cancer Index Composite for Clinical Practice - Urinary irritation/obstruction symptom score. EPIC-CP - Urinary Irritation/Obstruction Symptom Score EPIC2-Bowel Symptom Score Expanded Prostate Cancer Index Composite for Clinical Practice - Bowel symptom score. EPIC-CP - Bowel Symptom Score EPIC2-Sexual Symptom Score Expanded Prostate Cancer Index Composite for Clinical Practice - Sexual symptom score. EPIC-CP - Sexual Symptom Score EPIC2-Vitality/Hormonal Symptom Score Expanded Prostate Cancer Index Composite for Clinical Practice - Vitality/hormonal symptom score. EPIC-CP - Vitality/Hormonal Symptom Score EPIC2-Overall Prostate Cancer QOL Score Expanded Prostate Cancer Index Composite for Clinical Practice - Overall prostate cancer QOL score. EPIC-CP - Overall Score EPIC2TC The Expanded Prostate Cancer Index Composite for Clinical Practice Questionnaire Test Code CDISC Questionnaire EPIC-CP Test Code Terminology The Expanded Prostate Cancer Index Composite for Clinical Practice test name. EPIC2-Best Describes Urinary Control Expanded Prostate Cancer Index Composite for Clinical Practice - Which of the following best describes your urinary control? EPIC-CP - Best Describes Urinary Control EPIC2-Bowel Symptom Score Expanded Prostate Cancer Index Composite for Clinical Practice - Bowel symptom score. EPIC-CP - Bowel Symptom Score EPIC2-Overall Problem Bowel Habits Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Overall problems with your bowel habits. EPIC-CP - Overall Problems With Bowel Habits EPIC2-Overall Problem Sexual Function Expanded Prostate Cancer Index Composite for Clinical Practice - Overall, how much of a problem has your sexual function or lack of sexual function been for you? EPIC-CP - Problem Lack of Sexual Function EPIC2-Overall Problem Urinary Function Expanded Prostate Cancer Index Composite for Clinical Practice - Overall, how much of a problem has your urinary function been for you? EPIC-CP - Overall Problem Urinary Function EPIC2-Overall Prostate Cancer QOL Score Expanded Prostate Cancer Index Composite for Clinical Practice - Overall prostate cancer QOL score. EPIC-CP - Overall Score EPIC2-Pads or Adult Diapers per Day Expanded Prostate Cancer Index Composite for Clinical Practice - How many pads or adult diapers per day have you been using for urinary leakage? EPIC-CP - Adult Diapers Used per Day EPIC2-Problem Feeling Depressed Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Feeling depressed. EPIC-CP - Feeling Depressed EPIC2-Problem Hot Flash/Breast Tender Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Hot flashes or breast tenderness/enlargement. EPIC-CP - Hot Flashes or Breast Tenderness EPIC2-Problem Increased Freq Bowel Move Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Increased frequency of your bowel movements. EPIC-CP - Increased Frequency of Bowel Movements EPIC2-Problem Lack of Energy Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Lack of energy. EPIC-CP - Lack of Energy EPIC2-Problem Need to Urinate Frequently Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Need to urinate frequently. EPIC-CP - Need to Urinate Frequently EPIC2-Problem Pain/Burning w/Urination Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Pain or burning with urination. EPIC-CP - Pain or Burning With Urination EPIC2-Problem Rectal Pain/Urgent Bowel Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Rectal pain or urgency of bowel movements. EPIC-CP - Rectal Pain or Urgency of Bowel Movements EPIC2-Problem Urinary Dripping/Leakage Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has urinary dripping or leakage been for you? EPIC-CP - Problem Urinary Dripping/Leakage EPIC2-Problem Weak Stream/Incompl Empty Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Weak urine stream/incomplete bladder emptying. EPIC-CP - Weak Urine Stream or Incomplete Bladder Emptying EPIC2-Quality of Your Erections Expanded Prostate Cancer Index Composite for Clinical Practice - How would you describe the usual quality of your erections? EPIC-CP - Quality of Erections EPIC2-Rate Ability to Reach Orgasm Expanded Prostate Cancer Index Composite for Clinical Practice - How would you rate your ability to reach orgasm (climax)? EPIC-CP - Rate Ability to Reach Orgasm EPIC2-Sexual Symptom Score Expanded Prostate Cancer Index Composite for Clinical Practice - Sexual symptom score. EPIC-CP - Sexual Symptom Score EPIC2-Urinary Incontinence Symptom Score Expanded Prostate Cancer Index Composite for Clinical Practice - Urinary incontinence symptom score. EPIC-CP - Urinary Incontinence Symptom Score EPIC2-Urinary Irrit/Obstr Symptom Score Expanded Prostate Cancer Index Composite for Clinical Practice - Urinary irritation/obstruction symptom score. EPIC-CP - Urinary Irritation/Obstruction Symptom Score EPIC2-Vitality/Hormonal Symptom Score Expanded Prostate Cancer Index Composite for Clinical Practice - Vitality/hormonal symptom score. EPIC-CP - Vitality/Hormonal Symptom Score EPIC2TN The Expanded Prostate Cancer Index Composite for Clinical Practice Questionnaire Test Name CDISC Questionnaire EPIC-CP Test Name Terminology The Expanded Prostate Cancer Index Composite Short Form test code. EPIC1-How Often Have You Leaked Urine The Expanded Prostate Cancer Index Composite Short Form - Over the past 4 weeks, how often have you leaked urine? EPIC-26 - How Often Have You Leaked Urine EPIC1-Best Describes Urinary Control The Expanded Prostate Cancer Index Composite Short Form - Which of the following best describes your urinary control during the last 4 weeks? EPIC-26 - Best Describes Urinary Control EPIC1-Pads or Adult Diapers per Day The Expanded Prostate Cancer Index Composite Short Form - How many pads or adult diapers per day did you usually use to control leakage during the last 4 weeks? EPIC-26 - Pads or Adult Diapers per Day EPIC1-Problem Dripping or Leaking Urine The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you during the last 4 weeks? Dripping or leaking urine. EPIC-26 - Dripping or Leaking Urine EPIC1-Problem Pain/Burning on Urination The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you during the last 4 weeks? Pain or burning on urination. EPIC-26 - Pain or Burning on Urination EPIC1-Problem Bleeding With Urination The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you during the last 4 weeks? Bleeding with urination. EPIC-26 - Bleeding With Urination EPIC1-Problem Weak Urine Stream/Emptying The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you during the last 4 weeks? Weak urine stream or incomplete emptying. EPIC-26 - Weak Urine Stream or Incomplete Emptying EPIC1-Problem Need to Urinate Frequently The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you during the last 4 weeks? Need to urinate frequently during the day. EPIC-26 - Urinate Frequently During the Day EPIC1-Overall Problem Urinary Function The Expanded Prostate Cancer Index Composite Short Form - Overall, how big a problem has your urinary function been for you during the last 4 weeks? EPIC-26 - Overall Problem Urinary Function EPIC1-Problem Urgency of Bowel Movement The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you? Urgency to have a bowel movement. EPIC-26 - Urgency to Have a Bowel Movement EPIC1-Problem Increased Freq Bowel Move The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you? Increased frequency of bowel movements. EPIC-26 - Increased Frequency of Bowel Movements EPIC1-Problem Losing Control of Stools The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you? Losing control of your stools. EPIC-26 - Losing Control of Stools EPIC1-Problem Bloody Stools The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you? Bloody stools. EPIC-26 - Bloody Stools EPIC1-Problem Abdom/Pelvic/Rectal Pain The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you? Abdominal/pelvic/rectal pain. EPIC-26 - Abdominal or Pelvic or Rectal Pain EPIC1-Overall Problem Bowel Habits The Expanded Prostate Cancer Index Composite Short Form - Overall, how big a problem have your bowel habits been for you during the last 4 weeks? EPIC-26 - Overall Problem Bowel Habits EPIC1-Rate Ability to Have an Erection The Expanded Prostate Cancer Index Composite Short Form - How would you rate each of the following during the last 4 weeks? Your ability to have an erection? EPIC-26 - Ability to Have an Erection EPIC1-Rate Ability to Reach Orgasm The Expanded Prostate Cancer Index Composite Short Form - How would you rate each of the following during the last 4 weeks? Your ability to reach orgasm (climax)? EPIC-26 - Ability to Reach Orgasm EPIC1-Quality of Your Erections The Expanded Prostate Cancer Index Composite Short Form - How would you describe the usual quality of your erections during the last 4 weeks? EPIC-26 - Quality of Erections EPIC1-Frequency of Your Erections The Expanded Prostate Cancer Index Composite Short Form - How would you describe the frequency of your erections during the last 4 weeks? EPIC-26 - Frequency of Erections EPIC1-Rate Ability to Function Sexually The Expanded Prostate Cancer Index Composite Short Form - Overall, how would you rate your ability to function sexually during the last 4 weeks? EPIC-26 - Ability to Function Sexually EPIC1-Overall Problem Sexual Function The Expanded Prostate Cancer Index Composite Short Form - Overall, how big a problem has your sexual function or lack of sexual function been for you during the last 4 weeks? EPIC-26 - Overall Problem Sexual Function EPIC1-Problem Hot Flashes The Expanded Prostate Cancer Index Composite Short Form - How big a problem during the last 4 weeks, if any, has each of the following been for you? Hot flashes. EPIC-26 - Hot Flashes EPIC1-Problem Breast Tender/Enlargement The Expanded Prostate Cancer Index Composite Short Form - How big a problem during the last 4 weeks, if any, has each of the following been for you? Breast tenderness/enlargement. EPIC-26 - Breast Tender or Enlargement EPIC1-Problem Feeling Depressed The Expanded Prostate Cancer Index Composite Short Form - How big a problem during the last 4 weeks, if any, has each of the following been for you? Feeling depressed. EPIC-26 - Feeling Depressed EPIC1-Problem Lack of Energy The Expanded Prostate Cancer Index Composite Short Form - How big a problem during the last 4 weeks, if any, has each of the following been for you? Lack of energy. EPIC-26 - Lack of Energy EPIC1-Problem Change in Body Weight The Expanded Prostate Cancer Index Composite Short Form - How big a problem during the last 4 weeks, if any, has each of the following been for you? Change in body weight. EPIC-26 - Change in Body Weight EPIC1TC The Expanded Prostate Cancer Index Composite Short Form Questionnaire Test Code CDISC Questionnaire EPIC-26 Test Code Terminology The Expanded Prostate Cancer Index Composite Short Form test name. EPIC1-Best Describes Urinary Control The Expanded Prostate Cancer Index Composite Short Form - Which of the following best describes your urinary control during the last 4 weeks? EPIC-26 - Best Describes Urinary Control EPIC1-Frequency of Your Erections The Expanded Prostate Cancer Index Composite Short Form - How would you describe the frequency of your erections during the last 4 weeks? EPIC-26 - Frequency of Erections EPIC1-How Often Have You Leaked Urine The Expanded Prostate Cancer Index Composite Short Form - Over the past 4 weeks, how often have you leaked urine? EPIC-26 - How Often Have You Leaked Urine EPIC1-Overall Problem Bowel Habits The Expanded Prostate Cancer Index Composite Short Form - Overall, how big a problem have your bowel habits been for you during the last 4 weeks? EPIC-26 - Overall Problem Bowel Habits EPIC1-Overall Problem Sexual Function The Expanded Prostate Cancer Index Composite Short Form - Overall, how big a problem has your sexual function or lack of sexual function been for you during the last 4 weeks? EPIC-26 - Overall Problem Sexual Function EPIC1-Overall Problem Urinary Function The Expanded Prostate Cancer Index Composite Short Form - Overall, how big a problem has your urinary function been for you during the last 4 weeks? EPIC-26 - Overall Problem Urinary Function EPIC1-Pads or Adult Diapers per Day The Expanded Prostate Cancer Index Composite Short Form - How many pads or adult diapers per day did you usually use to control leakage during the last 4 weeks? EPIC-26 - Pads or Adult Diapers per Day EPIC1-Problem Abdom/Pelvic/Rectal Pain The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you? Abdominal/pelvic/rectal pain. EPIC-26 - Abdominal or Pelvic or Rectal Pain EPIC1-Problem Bleeding With Urination The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you during the last 4 weeks? Bleeding with urination. EPIC-26 - Bleeding With Urination EPIC1-Problem Bloody Stools The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you? Bloody stools. EPIC-26 - Bloody Stools EPIC1-Problem Breast Tender/Enlargement The Expanded Prostate Cancer Index Composite Short Form - How big a problem during the last 4 weeks, if any, has each of the following been for you? Breast tenderness/enlargement. EPIC-26 - Breast Tender or Enlargement EPIC1-Problem Change in Body Weight The Expanded Prostate Cancer Index Composite Short Form - How big a problem during the last 4 weeks, if any, has each of the following been for you? Change in body weight. EPIC-26 - Change in Body Weight EPIC1-Problem Dripping or Leaking Urine The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you during the last 4 weeks? Dripping or leaking urine. EPIC-26 - Dripping or Leaking Urine EPIC1-Problem Feeling Depressed The Expanded Prostate Cancer Index Composite Short Form - How big a problem during the last 4 weeks, if any, has each of the following been for you? Feeling depressed. EPIC-26 - Feeling Depressed EPIC1-Problem Hot Flashes The Expanded Prostate Cancer Index Composite Short Form - How big a problem during the last 4 weeks, if any, has each of the following been for you? Hot flashes. EPIC-26 - Hot Flashes EPIC1-Problem Increased Freq Bowel Move The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you? Increased frequency of bowel movements. EPIC-26 - Increased Frequency of Bowel Movements EPIC1-Problem Lack of Energy The Expanded Prostate Cancer Index Composite Short Form - How big a problem during the last 4 weeks, if any, has each of the following been for you? Lack of energy. EPIC-26 - Lack of Energy EPIC1-Problem Losing Control of Stools The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you? Losing control of your stools. EPIC-26 - Losing Control of Stools EPIC1-Problem Need to Urinate Frequently The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you during the last 4 weeks? Need to urinate frequently during the day. EPIC-26 - Urinate Frequently During the Day EPIC1-Problem Pain/Burning on Urination The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you during the last 4 weeks? Pain or burning on urination. EPIC-26 - Pain or Burning on Urination EPIC1-Problem Urgency of Bowel Movement The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you? Urgency to have a bowel movement. EPIC-26 - Urgency to Have a Bowel Movement EPIC1-Problem Weak Urine Stream/Emptying The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you during the last 4 weeks? Weak urine stream or incomplete emptying. EPIC-26 - Weak Urine Stream or Incomplete Emptying EPIC1-Quality of Your Erections The Expanded Prostate Cancer Index Composite Short Form - How would you describe the usual quality of your erections during the last 4 weeks? EPIC-26 - Quality of Erections EPIC1-Rate Ability to Function Sexually The Expanded Prostate Cancer Index Composite Short Form - Overall, how would you rate your ability to function sexually during the last 4 weeks? EPIC-26 - Ability to Function Sexually EPIC1-Rate Ability to Have an Erection The Expanded Prostate Cancer Index Composite Short Form - How would you rate each of the following during the last 4 weeks? Your ability to have an erection? EPIC-26 - Ability to Have an Erection EPIC1-Rate Ability to Reach Orgasm The Expanded Prostate Cancer Index Composite Short Form - How would you rate each of the following during the last 4 weeks? Your ability to reach orgasm (climax)? EPIC-26 - Ability to Reach Orgasm EPIC1TN The Expanded Prostate Cancer Index Composite Short Form Questionnaire Test Name CDISC Questionnaire EPIC-26 Test Name Terminology The Functional Assessment of Cancer Therapy-General Version 4 test code. FAC001-I Have a Lack of Energy Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: I have a lack of energy. FACT-G Version 4 - I Have a Lack of Energy FAC001-I Have Nausea Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: I have nausea. FACT-G Version 4 - I Have Nausea FAC001-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. FACT-G Version 4 - Trouble Meeting Needs of Family FAC001-I Have Pain Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: I have pain. FACT-G Version 4 - I have pain FAC001-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: I am bothered by side effects of treatment. FACT-G Version 4 - Bothered by Treatment Side Effect FAC001-I Feel Ill Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: I feel ill. FACT-G Version 4 - I Feel Ill FAC001-I Am Forced to Spend Time in Bed Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: I am forced to spend time in bed. FACT-G Version 4 - I Am Forced to Spend Time in Bed FAC001-I Feel Close to My Friends Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: I feel close to my friends. FACT-G Version 4 - I Feel Close to My Friends FAC001-Get Emotional Support From Family Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: I get emotional support from my family. FACT-G Version 4 - I Get Emotional Support From My Family FAC001-I Get Support From My Friends Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: I get support from my friends. FACT-G Version 4 - I Get Support From My Friends FAC001-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: My family has accepted my illness. FACT-G Version 4 - My Family Has Accepted My Illness FAC001-Satisfied Communication Illness Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. FACT-G Version 4 - Satisfied With Family Communication FAC001-I Feel Close to My Partner Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). FACT-G Version 4 - I Feel Close to My Partner FAC001-I Am Satisfied With My Sex Life Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: I am satisfied with my sex life. FACT-G Version 4 - I Am Satisfied With My Sex Life FAC001-I Feel Sad Functional Assessment of Cancer Therapy-General Version 4 - Emotional Well-Being: I feel sad. FACT-G Version 4 - I Feel Sad FAC001-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy-General Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. FACT-G Version 4 - Satisfied With How I Am Coping With Illness FAC001-Losing Hope Against Illness Functional Assessment of Cancer Therapy-General Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. FACT-G Version 4 - Losing Hope Against Illness FAC001-I Feel Nervous Functional Assessment of Cancer Therapy-General Version 4 - Emotional Well-Being: I feel nervous. FACT-G Version 4 - I Feel Nervous FAC001-I Worry About Dying Functional Assessment of Cancer Therapy-General Version 4 - Emotional Well-Being: I worry about dying. FACT-G Version 4 - I Worry About Dying FAC001-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-General Version 4 - Emotional Well-Being: I worry that my condition will get worse. FACT-G Version 4 - Worry My Condition Will Get Worse FAC001-I Am Able to Work Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: I am able to work (include work at home). FACT-G Version 4 - I Am Able to Work FAC001-My Work Is Fulfilling Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. FACT-G Version 4 - My Work Is Fulfilling FAC001-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: I am able to enjoy life. FACT-G Version 4 - I Am Able to Enjoy Life FAC001-I Have Accepted My Illness Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: I have accepted my illness. FACT-G Version 4 - I Have Accepted My Illness FAC001-I Am Sleeping Well Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: I am sleeping well. FACT-G Version 4 - I Am Sleeping Well FAC001-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. FACT-G Version 4 - Enjoy Things I Usually Do for Fun FAC001-Content With Quality of My Life Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: I am content with the quality of my life right now. FACT-G Version 4 - Content With Quality of My Life FAC001-Physical Subscale Score Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: Subscale score. FACT-G Version 4 - Physical Subscale Score FAC001-Social/Family Subscale Score Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: Subscale score. FACT-G Version 4 - Social/Family Subscale Score FAC001-Emotional Subscale Score Functional Assessment of Cancer Therapy-General Version 4 - Emotional Well-Being: Subscale score. FACT-G Version 4 - Emotional Subscale Score FAC001-Functional Subscale Score Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: Subscale score. FACT-G Version 4 - Functional Subscale Score FAC001-Total Score Functional Assessment of Cancer Therapy-General Version 4 - FACT-G total score. FACT-G Version 4 - Total Score FAC001TC The Functional Assessment of Cancer Therapy-General Version 4 Questionnaire Test Code CDISC Questionnaire FACT-G Version 4 Test Code Terminology The Functional Assessment of Cancer Therapy-General Version 4 test name. FAC001-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: I am bothered by side effects of treatment. FACT-G Version 4 - Bothered by Treatment Side Effect FAC001-Content With Quality of My Life Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: I am content with the quality of my life right now. FACT-G Version 4 - Content With Quality of My Life FAC001-Emotional Subscale Score Functional Assessment of Cancer Therapy-General Version 4 - Emotional Well-Being: Subscale score. FACT-G Version 4 - Emotional Subscale Score FAC001-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. FACT-G Version 4 - Enjoy Things I Usually Do for Fun FAC001-Functional Subscale Score Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: Subscale score. FACT-G Version 4 - Functional Subscale Score FAC001-Get Emotional Support From Family Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: I get emotional support from my family. FACT-G Version 4 - I Get Emotional Support From My Family FAC001-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: I am able to enjoy life. FACT-G Version 4 - I Am Able to Enjoy Life FAC001-I Am Able to Work Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: I am able to work (include work at home). FACT-G Version 4 - I Am Able to Work FAC001-I Am Forced to Spend Time in Bed Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: I am forced to spend time in bed. FACT-G Version 4 - I Am Forced to Spend Time in Bed FAC001-I Am Satisfied With My Sex Life Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: I am satisfied with my sex life. FACT-G Version 4 - I Am Satisfied With My Sex Life FAC001-I Am Sleeping Well Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: I am sleeping well. FACT-G Version 4 - I Am Sleeping Well FAC001-I Feel Close to My Friends Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: I feel close to my friends. FACT-G Version 4 - I Feel Close to My Friends FAC001-I Feel Close to My Partner Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). FACT-G Version 4 - I Feel Close to My Partner FAC001-I Feel Ill Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: I feel ill. FACT-G Version 4 - I Feel Ill FAC001-I Feel Nervous Functional Assessment of Cancer Therapy-General Version 4 - Emotional Well-Being: I feel nervous. FACT-G Version 4 - I Feel Nervous FAC001-I Feel Sad Functional Assessment of Cancer Therapy-General Version 4 - Emotional Well-Being: I feel sad. FACT-G Version 4 - I Feel Sad FAC001-I Get Support From My Friends Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: I get support from my friends. FACT-G Version 4 - I Get Support From My Friends FAC001-I Have a Lack of Energy Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: I have a lack of energy. FACT-G Version 4 - I Have a Lack of Energy FAC001-I Have Accepted My Illness Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: I have accepted my illness. FACT-G Version 4 - I Have Accepted My Illness FAC001-I Have Nausea Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: I have nausea. FACT-G Version 4 - I Have Nausea FAC001-I Have Pain Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: I have pain. FACT-G Version 4 - I have pain FAC001-I Worry About Dying Functional Assessment of Cancer Therapy-General Version 4 - Emotional Well-Being: I worry about dying. FACT-G Version 4 - I Worry About Dying FAC001-Losing Hope Against Illness Functional Assessment of Cancer Therapy-General Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. FACT-G Version 4 - Losing Hope Against Illness FAC001-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: My family has accepted my illness. FACT-G Version 4 - My Family Has Accepted My Illness FAC001-My Work Is Fulfilling Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. FACT-G Version 4 - My Work Is Fulfilling FAC001-Physical Subscale Score Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: Subscale score. FACT-G Version 4 - Physical Subscale Score FAC001-Satisfied Communication Illness Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. FACT-G Version 4 - Satisfied With Family Communication FAC001-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy-General Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. FACT-G Version 4 - Satisfied With How I Am Coping With Illness FAC001-Social/Family Subscale Score Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: Subscale score. FACT-G Version 4 - Social/Family Subscale Score FAC001-Total Score Functional Assessment of Cancer Therapy-General Version 4 - FACT-G total score. FACT-G Version 4 - Total Score FAC001-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. FACT-G Version 4 - Trouble Meeting Needs of Family FAC001-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-General Version 4 - Emotional Well-Being: I worry that my condition will get worse. FACT-G Version 4 - Worry My Condition Will Get Worse FAC001TN The Functional Assessment of Cancer Therapy-General Version 4 Questionnaire Test Name CDISC Questionnaire FACT-G Version 4 Test Name Terminology The Functional Assessment of Cancer Therapy-Prostate Version 4 test code. FAC023-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Prostate Version 4 - Physical Well-Being: I have a lack of energy. FACT-P Version 4 - I Have a Lack of Energy FAC023-I Have Nausea Functional Assessment of Cancer Therapy-Prostate Version 4 - Physical Well-Being: I have nausea. FACT-P Version 4 - I Have Nausea FAC023-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-Prostate Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. FACT-P Version 4 - Trouble Meeting Needs of Family FAC023-I Have Pain Functional Assessment of Cancer Therapy-Prostate Version 4 - Physical Well-Being: I have pain. FACT-P Version 4 - I Have Pain FAC023-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy-Prostate Version 4 - Physical Well-Being: I am bothered by side effects of treatment. FACT-P Version 4 - Bothered by Treatment Side Effect FAC023-I Feel Ill Functional Assessment of Cancer Therapy-Prostate Version 4 - Physical Well-Being: I feel ill. FACT-P Version 4 - I Feel Ill FAC023-I Am Forced to Spend Time in Bed Functional Assessment of Cancer Therapy-Prostate Version 4 - Physical Well-Being: I am forced to spend time in bed. FACT-P Version 4 - I Am Forced to Spend Time in Bed FAC023-I Feel Close to My Friends Functional Assessment of Cancer Therapy-Prostate Version 4 - Social/Family Well-Being: I feel close to my friends. FACT-P Version 4 - I Feel Close to My Friends FAC023-Get Emotional Support From Family Functional Assessment of Cancer Therapy-Prostate Version 4 - Social/Family Well-Being: I get emotional support from my family. FACT-P Version 4 - Get Emotional Support From Family FAC023-I Get Support From My Friends Functional Assessment of Cancer Therapy-Prostate Version 4 - Social/Family Well-Being: I get support from my friends. FACT-P Version 4 - I Get Support From My Friends FAC023-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy-Prostate Version 4 - Social/Family Well-Being: My family has accepted my illness. FACT-P Version 4 - My Family Has Accepted My Illness FAC023-Satisfied Communication Illness Functional Assessment of Cancer Therapy-Prostate Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. FACT-P Version 4 - Satisfied With Family Communication FAC023-I Feel Close to My Partner Functional Assessment of Cancer Therapy-Prostate Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). FACT-P Version 4 - I Feel Close to My Partner FAC023-I Am Satisfied With My Sex Life Functional Assessment of Cancer Therapy-Prostate Version 4 - Social/Family Well-Being: I am satisfied with my sex life. FACT-P Version 4 - I Am Satisfied With My Sex Life FAC023-I Feel Sad Functional Assessment of Cancer Therapy-Prostate Version 4 - Emotional Well-Being: I feel sad. FACT-P Version 4 - I Feel Sad FAC023-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy-Prostate Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. FACT-P Version 4 - Satisfied With How I Am Coping FAC023-Losing Hope Against Illness Functional Assessment of Cancer Therapy-Prostate Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. FACT-P Version 4 - Losing Hope Against Illness FAC023-I Feel Nervous Functional Assessment of Cancer Therapy-Prostate Version 4 - Emotional Well-Being: I feel nervous. FACT-P Version 4 - I Feel Nervous FAC023-I Worry About Dying Functional Assessment of Cancer Therapy-Prostate Version 4 - Emotional Well-Being: I worry about dying. FACT-P Version 4 - I Worry About Dying FAC023-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Prostate Version 4 - Emotional Well-Being: I worry that my condition will get worse. FACT-P Version 4 - Worry My Condition Will Get Worse FAC023-I Am Able to Work Functional Assessment of Cancer Therapy-Prostate Version 4 - Functional Well-Being: I am able to work (include work at home). FACT-P Version 4 - I Am Able to Work FAC023-My Work Is Fulfilling Functional Assessment of Cancer Therapy-Prostate Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. FACT-P Version 4 - My Work Is Fulfilling FAC023-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-Prostate Version 4 - Functional Well-Being: I am able to enjoy life. FACT-P Version 4 - I Am Able to Enjoy Life FAC023-I Have Accepted My Illness Functional Assessment of Cancer Therapy-Prostate Version 4 - Functional Well-Being: I have accepted my illness. FACT-P Version 4 - I Have Accepted My Illness FAC023-I Am Sleeping Well Functional Assessment of Cancer Therapy-Prostate Version 4 - Functional Well-Being: I am sleeping well. FACT-P Version 4 - I Am Sleeping Well FAC023-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy-Prostate Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. FACT-P Version 4 - Enjoy Things I Usually Do for Fun FAC023-Content With Quality of My Life Functional Assessment of Cancer Therapy-Prostate Version 4 - Functional Well-Being: I am content with the quality of my life right now. FACT-P Version 4 - Content With Quality of My Life FAC023-I Am Losing Weight Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I am losing weight. FACT-P Version 4 - I Am Losing Weight FAC023-I Have a Good Appetite Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I have a good appetite. FACT-P Version 4 - I Have a Good Appetite FAC023-Have Aches/Pains That Bother Me Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I have aches and pains that bother me. FACT-P Version 4 - Have Aches and Pains That Bother Me FAC023-Certain Parts of Body Have Pain Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I have certain parts of my body where I experience pain. FACT-P Version 4 - Certain Parts of Body Experience Pain FAC023-Pain Keeps Me From Doing Things Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: My pain keeps me from doing things I want to do. FACT-P Version 4 - Pain Keeps Me From Doing Things FAC023-Satisfied With Comfort Level Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I am satisfied with my present comfort level. FACT-P Version 4 - Satisfied With Comfort Level FAC023-I Am Able to Feel Like a Man Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I am able to feel like a man. FACT-P Version 4 - I Am Able to Feel Like a Man FAC023-I Have Trouble Moving My Bowels Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I have trouble moving my bowels. FACT-P Version 4 - I Have Trouble Moving My Bowels FAC023-I Have Difficulty Urinating Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I have difficulty urinating. FACT-P Version 4 - I Have Difficulty Urinating FAC023-I Urinate More Frequently Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I urinate more frequently than usual. FACT-P Version 4 - I Urinate More Frequently FAC023-Problem Urinating Limits Activity Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: My problems with urinating limit my activities. FACT-P Version 4 - Problem Urinating Limits Activity FAC023-Able to Have/Maintain Erection Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I am able to have and maintain an erection. FACT-P Version 4 - Able to Have and Maintain an Erection FAC023TC The Functional Assessment of Cancer Therapy-Prostate Version 4 Questionnaire Test Code CDISC Questionnaire FACT-P Version 4 Test Code Terminology The Functional Assessment of Cancer Therapy-Prostate Version 4 test name. FAC023-Able to Have/Maintain Erection Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I am able to have and maintain an erection. FACT-P Version 4 - Able to Have and Maintain an Erection FAC023-Bothered by Treatment Side Effect Functional Assessment of Cancer Therapy-Prostate Version 4 - Physical Well-Being: I am bothered by side effects of treatment. FACT-P Version 4 - Bothered by Treatment Side Effect FAC023-Certain Parts of Body Have Pain Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I have certain parts of my body where I experience pain. FACT-P Version 4 - Certain Parts of Body Experience Pain FAC023-Content With Quality of My Life Functional Assessment of Cancer Therapy-Prostate Version 4 - Functional Well-Being: I am content with the quality of my life right now. FACT-P Version 4 - Content With Quality of My Life FAC023-Enjoy Things I Usually Do for Fun Functional Assessment of Cancer Therapy-Prostate Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. FACT-P Version 4 - Enjoy Things I Usually Do for Fun FAC023-Get Emotional Support From Family Functional Assessment of Cancer Therapy-Prostate Version 4 - Social/Family Well-Being: I get emotional support from my family. FACT-P Version 4 - Get Emotional Support From Family FAC023-Have Aches/Pains That Bother Me Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I have aches and pains that bother me. FACT-P Version 4 - Have Aches and Pains That Bother Me FAC023-I Am Able to Enjoy Life Functional Assessment of Cancer Therapy-Prostate Version 4 - Functional Well-Being: I am able to enjoy life. FACT-P Version 4 - I Am Able to Enjoy Life FAC023-I Am Able to Feel Like a Man Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I am able to feel like a man. FACT-P Version 4 - I Am Able to Feel Like a Man FAC023-I Am Able to Work Functional Assessment of Cancer Therapy-Prostate Version 4 - Functional Well-Being: I am able to work (include work at home). FACT-P Version 4 - I Am Able to Work FAC023-I Am Forced to Spend Time in Bed Functional Assessment of Cancer Therapy-Prostate Version 4 - Physical Well-Being: I am forced to spend time in bed. FACT-P Version 4 - I Am Forced to Spend Time in Bed FAC023-I Am Losing Weight Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I am losing weight. FACT-P Version 4 - I Am Losing Weight FAC023-I Am Satisfied With My Sex Life Functional Assessment of Cancer Therapy-Prostate Version 4 - Social/Family Well-Being: I am satisfied with my sex life. FACT-P Version 4 - I Am Satisfied With My Sex Life FAC023-I Am Sleeping Well Functional Assessment of Cancer Therapy-Prostate Version 4 - Functional Well-Being: I am sleeping well. FACT-P Version 4 - I Am Sleeping Well FAC023-I Feel Close to My Friends Functional Assessment of Cancer Therapy-Prostate Version 4 - Social/Family Well-Being: I feel close to my friends. FACT-P Version 4 - I Feel Close to My Friends FAC023-I Feel Close to My Partner Functional Assessment of Cancer Therapy-Prostate Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). FACT-P Version 4 - I Feel Close to My Partner FAC023-I Feel Ill Functional Assessment of Cancer Therapy-Prostate Version 4 - Physical Well-Being: I feel ill. FACT-P Version 4 - I Feel Ill FAC023-I Feel Nervous Functional Assessment of Cancer Therapy-Prostate Version 4 - Emotional Well-Being: I feel nervous. FACT-P Version 4 - I Feel Nervous FAC023-I Feel Sad Functional Assessment of Cancer Therapy-Prostate Version 4 - Emotional Well-Being: I feel sad. FACT-P Version 4 - I Feel Sad FAC023-I Get Support From My Friends Functional Assessment of Cancer Therapy-Prostate Version 4 - Social/Family Well-Being: I get support from my friends. FACT-P Version 4 - I Get Support From My Friends FAC023-I Have a Good Appetite Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I have a good appetite. FACT-P Version 4 - I Have a Good Appetite FAC023-I Have a Lack of Energy Functional Assessment of Cancer Therapy-Prostate Version 4 - Physical Well-Being: I have a lack of energy. FACT-P Version 4 - I Have a Lack of Energy FAC023-I Have Accepted My Illness Functional Assessment of Cancer Therapy-Prostate Version 4 - Functional Well-Being: I have accepted my illness. FACT-P Version 4 - I Have Accepted My Illness FAC023-I Have Difficulty Urinating Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I have difficulty urinating. FACT-P Version 4 - I Have Difficulty Urinating FAC023-I Have Nausea Functional Assessment of Cancer Therapy-Prostate Version 4 - Physical Well-Being: I have nausea. FACT-P Version 4 - I Have Nausea FAC023-I Have Pain Functional Assessment of Cancer Therapy-Prostate Version 4 - Physical Well-Being: I have pain. FACT-P Version 4 - I Have Pain FAC023-I Have Trouble Moving My Bowels Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I have trouble moving my bowels. FACT-P Version 4 - I Have Trouble Moving My Bowels FAC023-I Urinate More Frequently Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I urinate more frequently than usual. FACT-P Version 4 - I Urinate More Frequently FAC023-I Worry About Dying Functional Assessment of Cancer Therapy-Prostate Version 4 - Emotional Well-Being: I worry about dying. FACT-P Version 4 - I Worry About Dying FAC023-Losing Hope Against Illness Functional Assessment of Cancer Therapy-Prostate Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. FACT-P Version 4 - Losing Hope Against Illness FAC023-My Family Has Accepted My Illness Functional Assessment of Cancer Therapy-Prostate Version 4 - Social/Family Well-Being: My family has accepted my illness. FACT-P Version 4 - My Family Has Accepted My Illness FAC023-My Work Is Fulfilling Functional Assessment of Cancer Therapy-Prostate Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. FACT-P Version 4 - My Work Is Fulfilling FAC023-Pain Keeps Me From Doing Things Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: My pain keeps me from doing things I want to do. FACT-P Version 4 - Pain Keeps Me From Doing Things FAC023-Problem Urinating Limits Activity Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: My problems with urinating limit my activities. FACT-P Version 4 - Problem Urinating Limits Activity FAC023-Satisfied Communication Illness Functional Assessment of Cancer Therapy-Prostate Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. FACT-P Version 4 - Satisfied With Family Communication FAC023-Satisfied With Comfort Level Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I am satisfied with my present comfort level. FACT-P Version 4 - Satisfied With Comfort Level FAC023-Satisfied With How I Am Coping Functional Assessment of Cancer Therapy-Prostate Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. FACT-P Version 4 - Satisfied With How I Am Coping FAC023-Trouble Meeting Needs of Family Functional Assessment of Cancer Therapy-Prostate Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. FACT-P Version 4 - Trouble Meeting Needs of Family FAC023-Worry My Condition Will Get Worse Functional Assessment of Cancer Therapy-Prostate Version 4 - Emotional Well-Being: I worry that my condition will get worse. FACT-P Version 4 - Worry My Condition Will Get Worse FAC023TN The Functional Assessment of Cancer Therapy-Prostate Version 4 Questionnaire Test Name CDISC Questionnaire FACT-P Version 4 Test Name Terminology The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes test code. GMSS01-More Satisfied With My Diabetes The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Helps me feel more satisfied with how things are going with my diabetes. GMSS Version Type 1 Diabetes - More Satisfied With My Diabetes GMSS01-Think About Diabetes More The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Makes me think about diabetes more than I want to. GMSS Version Type 1 Diabetes - Think About Diabetes More GMSS01-Takes Too Much Time to Use The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Takes too much time to use. GMSS Version Type 1 Diabetes - Takes Too Much Time to Use GMSS01-Doesn't Seem as Accurate The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Doesn't seem to be as accurate as I would like it to be. GMSS Version Type 1 Diabetes - Doesn't Seem as Accurate GMSS01-Makes Me Worry a Lot The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Makes me worry a lot. GMSS Version Type 1 Diabetes - Makes Me Worry a Lot GMSS01-Is Too Much of a Hassle to Use The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Is too much of a hassle to use. GMSS Version Type 1 Diabetes - Is Too Much of a Hassle to Use GMSS01-Gives Me Numbers I Don't Trust The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Gives me numbers that I don't entirely trust. GMSS Version Type 1 Diabetes - Gives Me Numbers I Don't Trust GMSS01-Feel Less Restricted by Diabetes The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Helps me feel less restricted by diabetes. GMSS Version Type 1 Diabetes - Feel Less Restricted by Diabetes GMSS01-More Frustrated With My Diabetes The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Makes me feel more frustrated with my diabetes. GMSS Version Type 1 Diabetes - More Frustrated With My Diabetes GMSS01-Be More Spontaneous in My Life The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Helps me be more spontaneous in my life. GMSS Version Type 1 Diabetes - Be More Spontaneous in My Life GMSS01-Too Many Skin Irritations/Bruises The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Causes too many skin irritations or bruises. GMSS Version Type 1 Diabetes - Too Many Skin Irritations/Bruises GMSS01-Gives Me Results Don't Make Sense The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Often gives me results that don't make sense. GMSS Version Type 1 Diabetes - Gives Me Results Don't Make Sense GMSS01-Feel More Down and Depressed The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Makes me feel more down and depressed. GMSS Version Type 1 Diabetes - Feel More Down and Depressed GMSS01-More Open to New Experiences The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Helps me be more open to new experiences in life. GMSS Version Type 1 Diabetes - More Open to New Experiences GMSS01-Is Too Painful to Use The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Is too painful to use. GMSS Version Type 1 Diabetes - Is Too Painful to Use GMSS01-Subscale: Openness The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - Subscale: Openness. GMSS Version Type 1 Diabetes - Subscale: Openness GMSS01-Subscale: Emotional Burden The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - Subscale: Emotional burden. GMSS Version Type 1 Diabetes - Subscale: Emotional Burden GMSS01-Subscale: Behavioral Burden The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - Subscale: Behavioral burden. GMSS Version Type 1 Diabetes - Subscale: Behavioral Burden GMSS01-Subscale: Trust The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - Subscale: Trust. GMSS Version Type 1 Diabetes - Subscale: Trust GMSS01-Total Scale The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - Total scale. GMSS Version Type 1 Diabetes - Total Scale GMSS01TC The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes Questionnaire Test Code CDISC Questionnaire GMSS Version Type 1 Diabetes Test Code Terminology The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes test name. GMSS01-Be More Spontaneous in My Life The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Helps me be more spontaneous in my life. GMSS Version Type 1 Diabetes - Be More Spontaneous in My Life GMSS01-Doesn't Seem as Accurate The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Doesn't seem to be as accurate as I would like it to be. GMSS Version Type 1 Diabetes - Doesn't Seem as Accurate GMSS01-Feel Less Restricted by Diabetes The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Helps me feel less restricted by diabetes. GMSS Version Type 1 Diabetes - Feel Less Restricted by Diabetes GMSS01-Feel More Down and Depressed The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Makes me feel more down and depressed. GMSS Version Type 1 Diabetes - Feel More Down and Depressed GMSS01-Gives Me Numbers I Don't Trust The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Gives me numbers that I don't entirely trust. GMSS Version Type 1 Diabetes - Gives Me Numbers I Don't Trust GMSS01-Gives Me Results Don't Make Sense The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Often gives me results that don't make sense. GMSS Version Type 1 Diabetes - Gives Me Results Don't Make Sense GMSS01-Is Too Much of a Hassle to Use The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Is too much of a hassle to use. GMSS Version Type 1 Diabetes - Is Too Much of a Hassle to Use GMSS01-Is Too Painful to Use The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Is too painful to use. GMSS Version Type 1 Diabetes - Is Too Painful to Use GMSS01-Makes Me Worry a Lot The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Makes me worry a lot. GMSS Version Type 1 Diabetes - Makes Me Worry a Lot GMSS01-More Frustrated With My Diabetes The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Makes me feel more frustrated with my diabetes. GMSS Version Type 1 Diabetes - More Frustrated With My Diabetes GMSS01-More Open to New Experiences The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Helps me be more open to new experiences in life. GMSS Version Type 1 Diabetes - More Open to New Experiences GMSS01-More Satisfied With My Diabetes The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Helps me feel more satisfied with how things are going with my diabetes. GMSS Version Type 1 Diabetes - More Satisfied With My Diabetes GMSS01-Subscale: Behavioral Burden The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - Subscale: Behavioral burden. GMSS Version Type 1 Diabetes - Subscale: Behavioral Burden GMSS01-Subscale: Emotional Burden The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - Subscale: Emotional burden. GMSS Version Type 1 Diabetes - Subscale: Emotional Burden GMSS01-Subscale: Openness The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - Subscale: Openness. GMSS Version Type 1 Diabetes - Subscale: Openness GMSS01-Subscale: Trust The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - Subscale: Trust. GMSS Version Type 1 Diabetes - Subscale: Trust GMSS01-Takes Too Much Time to Use The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Takes too much time to use. GMSS Version Type 1 Diabetes - Takes Too Much Time to Use GMSS01-Think About Diabetes More The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Makes me think about diabetes more than I want to. GMSS Version Type 1 Diabetes - Think About Diabetes More GMSS01-Too Many Skin Irritations/Bruises The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Causes too many skin irritations or bruises. GMSS Version Type 1 Diabetes - Too Many Skin Irritations/Bruises GMSS01-Total Scale The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - Total scale. GMSS Version Type 1 Diabetes - Total Scale GMSS01TN The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes Questionnaire Test Name CDISC Questionnaire GMSS Version Type 1 Diabetes Test Name Terminology The National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 test code. FAC052-I Have a Lack of Energy National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have a lack of energy. NCCN-FACT-FPSI 17 Version 2 - I Have a Lack of Energy FAC052-I Have Pain National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have pain. NCCN-FACT-FPSI 17 Version 2 - I Have Pain FAC052-I Have Difficulty Urinating National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have difficulty urinating. NCCN-FACT-FPSI 17 Version 2 - I Have Difficulty Urinating FAC052-I Am Losing Weight National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I am losing weight. NCCN-FACT-FPSI 17 Version 2 - I Am Losing Weight FAC052-I Have Bone Pain National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have bone pain. NCCN-FACT-FPSI 17 Version 2 - I Have Bone Pain FAC052-I Feel Fatigued National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I feel fatigued. NCCN-FACT-FPSI 17 Version 2 - I Feel Fatigued FAC052-I Have Weakness in My Legs National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have weakness in my legs. NCCN-FACT-FPSI 17 Version 2 - I Have Weakness in My Legs FAC052-Pain Keeps Me From Doing Things National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - My pain keeps me from doing things I want to do. NCCN-FACT-FPSI 17 Version 2 - Pain Keeps Me From Doing Things FAC052-I Have a Good Appetite National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have a good appetite. NCCN-FACT-FPSI 17 Version 2 - I Have a Good Appetite FAC052-I Am Sleeping Well National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I am sleeping well. NCCN-FACT-FPSI 17 Version 2 - I Am Sleeping Well FAC052-Worry My Condition Will Get Worse National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I worry that my condition will get worse. NCCN-FACT-FPSI 17 Version 2 - Worry My Condition Will Get Worse FAC052-I Have Nausea National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have nausea. NCCN-FACT-FPSI 17 Version 2 - I Have Nausea FAC052-I Have Trouble Moving My Bowels National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have trouble moving my bowels. NCCN-FACT-FPSI 17 Version 2 - I Have Trouble Moving My Bowels FAC052-I Am Satisfied With My Sex Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I am satisfied with my sex life. NCCN-FACT-FPSI 17 Version 2 - I Am Satisfied With My Sex Life FAC052-Bothered by Treatment Side Effect National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I am bothered by side effects of treatment. NCCN-FACT-FPSI 17 Version 2 - Bothered by Treatment Side Effect FAC052-I Am Able to Enjoy Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I am able to enjoy life. NCCN-FACT-FPSI 17 Version 2 - I Am Able to Enjoy Life FAC052-Content With Quality of My Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I am content with the quality of my life right now. NCCN-FACT-FPSI 17 Version 2 - Content With Quality of My Life FAC052TC The National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 Questionnaire Test Code CDISC Questionnaire NCCN-FACT-FPSI 17 Version 2 Test Code Terminology The National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 test name. FAC052-Bothered by Treatment Side Effect National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I am bothered by side effects of treatment. NCCN-FACT-FPSI 17 Version 2 - Bothered by Treatment Side Effect FAC052-Content With Quality of My Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I am content with the quality of my life right now. NCCN-FACT-FPSI 17 Version 2 - Content With Quality of My Life FAC052-I Am Able to Enjoy Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I am able to enjoy life. NCCN-FACT-FPSI 17 Version 2 - I Am Able to Enjoy Life FAC052-I Am Losing Weight National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I am losing weight. NCCN-FACT-FPSI 17 Version 2 - I Am Losing Weight FAC052-I Am Satisfied With My Sex Life National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I am satisfied with my sex life. NCCN-FACT-FPSI 17 Version 2 - I Am Satisfied With My Sex Life FAC052-I Am Sleeping Well National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I am sleeping well. NCCN-FACT-FPSI 17 Version 2 - I Am Sleeping Well FAC052-I Feel Fatigued National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I feel fatigued. NCCN-FACT-FPSI 17 Version 2 - I Feel Fatigued FAC052-I Have a Good Appetite National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have a good appetite. NCCN-FACT-FPSI 17 Version 2 - I Have a Good Appetite FAC052-I Have a Lack of Energy National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have a lack of energy. NCCN-FACT-FPSI 17 Version 2 - I Have a Lack of Energy FAC052-I Have Bone Pain National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have bone pain. NCCN-FACT-FPSI 17 Version 2 - I Have Bone Pain FAC052-I Have Difficulty Urinating National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have difficulty urinating. NCCN-FACT-FPSI 17 Version 2 - I Have Difficulty Urinating FAC052-I Have Nausea National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have nausea. NCCN-FACT-FPSI 17 Version 2 - I Have Nausea FAC052-I Have Pain National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have pain. NCCN-FACT-FPSI 17 Version 2 - I Have Pain FAC052-I Have Trouble Moving My Bowels National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have trouble moving my bowels. NCCN-FACT-FPSI 17 Version 2 - I Have Trouble Moving My Bowels FAC052-I Have Weakness in My Legs National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have weakness in my legs. NCCN-FACT-FPSI 17 Version 2 - I Have Weakness in My Legs FAC052-Pain Keeps Me From Doing Things National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - My pain keeps me from doing things I want to do. NCCN-FACT-FPSI 17 Version 2 - Pain Keeps Me From Doing Things FAC052-Worry My Condition Will Get Worse National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I worry that my condition will get worse. NCCN-FACT-FPSI 17 Version 2 - Worry My Condition Will Get Worse FAC052TN The National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 Questionnaire Test Name CDISC Questionnaire NCCN-FACT-FPSI 17 Version 2 Test Name Terminology The Oswestry Disability Index Version 2.1a test code. ODI01-Pain Intensity The Oswestry Disability Index Version 2.1a - Section 1 - Pain intensity. ODI v2.1a - Pain Intensity ODI01-Personal Care The Oswestry Disability Index Version 2.1a - Section 2 - Personal care (washing, dressing, etc.). ODI v2.1a - Personal Care ODI01-Lifting The Oswestry Disability Index Version 2.1a - Section 3 - Lifting. ODI v2.1a - Lifting ODI01-Walking The Oswestry Disability Index Version 2.1a - Section 4 - Walking. ODI v2.1a - Walking ODI01-Sitting The Oswestry Disability Index Version 2.1a - Section 5 - Sitting. ODI v2.1a - Sitting ODI01-Standing The Oswestry Disability Index Version 2.1a - Section 6 - Standing. ODI v2.1a - Standing ODI01-Sleeping The Oswestry Disability Index Version 2.1a - Section 7 - Sleeping. ODI v2.1a - Sleeping ODI01-Sex Life The Oswestry Disability Index Version 2.1a - Section 8 - Sex life (if applicable). ODI v2.1a - Sex Life ODI01-Social Life The Oswestry Disability Index Version 2.1a - Section 9 - Social life. ODI v2.1a - Social Life ODI01-Travelling The Oswestry Disability Index Version 2.1a - Section 10 - Travelling. ODI v2.1a - Travelling ODI01-Oswestry Disability Index The Oswestry Disability Index Version 2.1a - Your ODI. ODI v2.1a - Oswestry Disability Index ODI01TC The Oswestry Disability Index Version 2.1a Questionnaire Test Code CDISC Questionnaire ODI v2.1a Test Code Terminology The Oswestry Disability Index Version 2.1a test name. ODI01-Lifting The Oswestry Disability Index Version 2.1a - Section 3 - Lifting. ODI v2.1a - Lifting ODI01-Oswestry Disability Index The Oswestry Disability Index Version 2.1a - Your ODI. ODI v2.1a - Oswestry Disability Index ODI01-Pain Intensity The Oswestry Disability Index Version 2.1a - Section 1 - Pain intensity. ODI v2.1a - Pain Intensity ODI01-Personal Care The Oswestry Disability Index Version 2.1a - Section 2 - Personal care (washing, dressing, etc.). ODI v2.1a - Personal Care ODI01-Sex Life The Oswestry Disability Index Version 2.1a - Section 8 - Sex life (if applicable). ODI v2.1a - Sex Life ODI01-Sitting The Oswestry Disability Index Version 2.1a - Section 5 - Sitting. ODI v2.1a - Sitting ODI01-Sleeping The Oswestry Disability Index Version 2.1a - Section 7 - Sleeping. ODI v2.1a - Sleeping ODI01-Social Life The Oswestry Disability Index Version 2.1a - Section 9 - Social life. ODI v2.1a - Social Life ODI01-Standing The Oswestry Disability Index Version 2.1a - Section 6 - Standing. ODI v2.1a - Standing ODI01-Travelling The Oswestry Disability Index Version 2.1a - Section 10 - Travelling. ODI v2.1a - Travelling ODI01-Walking The Oswestry Disability Index Version 2.1a - Section 4 - Walking. ODI v2.1a - Walking ODI01TN The Oswestry Disability Index Version 2.1a Questionnaire Test Name CDISC Questionnaire ODI v2.1a Test Name Terminology The Overactive Bladder Questionnaire test code. OABQ01-Frequent Urination During Daytime The Overactive Bladder Questionnaire - Frequent urination during the daytime hours? OAB-q - Frequent Urination During the Daytime OABQ01-Uncomfortable Urge to Urinate The Overactive Bladder Questionnaire - An uncomfortable urge to urinate? OAB-q - Uncomfortable Urge to Urinate OABQ01-Sudden Urge to Urinate No Warning The Overactive Bladder Questionnaire - A sudden urge to urinate with little or no warning? OAB-q - Sudden Urge to Urinate with Little or No Warning OABQ01-Accidental Loss of Urine The Overactive Bladder Questionnaire - Accidental loss of small amounts of urine? OAB-q - Accidental Loss of Urine OABQ01-Nighttime Urination The Overactive Bladder Questionnaire - Nighttime urination? OAB-q - Nighttime Urination OABQ01-Waking Up at Night had to Urinate The Overactive Bladder Questionnaire - Waking up at night because you had to urinate? OAB-q - Waking Up at Night Because You had to Urinate OABQ01-Uncontrollable Urge to Urinate The Overactive Bladder Questionnaire - An uncontrollable urge to urinate? OAB-q - Uncontrollable Urge to Urinate OABQ01-Urine Loss Strong Desire Urinate The Overactive Bladder Questionnaire - Urine loss associated with a strong desire to urinate? OAB-q - Urine Loss Associated with a Strong Desire to Urinate OABQ01-Carefully Plan Your Commute The Overactive Bladder Questionnaire - Made you carefully plan your commute? OAB-q - Carefully Plan Your Commute OABQ01-Feel Drowsy or Sleepy During Day The Overactive Bladder Questionnaire - Caused you to feel drowsy or sleepy during the day? OAB-q - Feel Drowsy or Sleepy During the Day OABQ01-Plan 'Escape Routes' to Restrooms The Overactive Bladder Questionnaire - Caused you to plan "escape routes" to restrooms in public places? OAB-q - Plan 'Escape Routes' to Restrooms OABQ01-Caused You Distress The Overactive Bladder Questionnaire - Caused you distress? OAB-q - Caused You Distress OABQ01-Frustrated You The Overactive Bladder Questionnaire - Frustrated you? OAB-q - Frustrated You OABQ01-Feel Something Wrong with You The Overactive Bladder Questionnaire - Made you feel like there is something wrong with you? OAB-q - Feel Like There is Something Wrong with You OABQ01-Interfered with Good Night's Rest The Overactive Bladder Questionnaire - Interfered with your ability to get a good night's rest? OAB-q - Interfered with a Good Night's Rest OABQ01-Decrease Your Physical Activities The Overactive Bladder Questionnaire - Caused you to decrease your physical activities (exercising, sports, etc.)? OAB-q - Decrease Your Physical Activities OABQ01-Prevented From Feeling Rested The Overactive Bladder Questionnaire - Prevented you from feeling rested upon waking in the morning? OAB-q - Prevented You From Feeling Rested Upon Waking OABQ01-Frustrated Family and Friends The Overactive Bladder Questionnaire - Frustrated your family and friends? OAB-q - Frustrated Your Family and Friends OABQ01-Caused You Anxiety or Worry The Overactive Bladder Questionnaire - Caused you anxiety or worry? OAB-q - Caused You Anxiety or Worry OABQ01-Stay Home More Often Than Prefer The Overactive Bladder Questionnaire - Caused you to stay home more often than you would prefer? OAB-q - Stay Home More Often Than You Would Prefer OABQ01-Adjust Travel Plans Near Restroom The Overactive Bladder Questionnaire - Caused you to adjust your travel plans so that you are always near a restroom? OAB-q - Adjust Your Travel Plans so That You are Always Near a Restroom OABQ01-Avoid Act Away From Restroom The Overactive Bladder Questionnaire - Made you avoid activities away from restrooms (i.e., walks, running, hiking)? OAB-q - Avoid Activities Away From Restrooms OABQ01-Amount of Time Spend in Restroom The Overactive Bladder Questionnaire - Made you frustrated or annoyed about the amount of time you spend in the restroom? OAB-q - Frustrated or Annoyed About the Amount of Time You Spend in the Restroom OABQ01-Awakened You During Sleep The Overactive Bladder Questionnaire - Awakened you during sleep? OAB-q - Awakened You During Sleep OABQ01-Worry About Odor or Hygiene The Overactive Bladder Questionnaire - Made you worry about odor or hygiene? OAB-q - Made You Worry About Odor or Hygiene OABQ01-Uncomfortable Travel with Others The Overactive Bladder Questionnaire - Made you uncomfortable while traveling with others because of needing to stop for a restroom? OAB-q - Uncomfortable While Traveling With Others OABQ01-Affected Relationships The Overactive Bladder Questionnaire - Affected your relationships with family and friends? OAB-q - Affected Your Relationships with Family and Friends OABQ01-Decrease Participating Gatherings The Overactive Bladder Questionnaire - Caused you to decrease participating in social gatherings, such as parties or visits with family or friends? OAB-q - Decrease Participating in Social Gatherings OABQ01-Caused You Embarrassment The Overactive Bladder Questionnaire - Caused you embarrassment? OAB-q - Caused You Embarrassment OABQ01-Interfered with Getting Sleep The Overactive Bladder Questionnaire - Interfered with getting the amount of sleep you needed? OAB-q - Interfered with Getting Sleep OABQ01-Caused Problems Partner/Spouse The Overactive Bladder Questionnaire - Caused you to have problems with your partner or spouse? OAB-q - Caused Problems with Your Partner or Spouse OABQ01-Plan Activities More Carefully The Overactive Bladder Questionnaire - Caused you to plan activities more carefully? OAB-q - Plan Activities More Carefully OABQ01-Locate Closest Restroom The Overactive Bladder Questionnaire - Caused you to locate the closest restroom as soon as you arrive at a place you have never been? OAB-q - Locate Closest Restroom as Soon as You Arrive OABQ01TC The Overactive Bladder Questionnaire Questionnaire Test Code CDISC Questionnaire OAB-q Test Code Terminology The Overactive Bladder Questionnaire test name. OABQ01-Accidental Loss of Urine The Overactive Bladder Questionnaire - Accidental loss of small amounts of urine? OAB-q - Accidental Loss of Urine OABQ01-Adjust Travel Plans Near Restroom The Overactive Bladder Questionnaire - Caused you to adjust your travel plans so that you are always near a restroom? OAB-q - Adjust Your Travel Plans so That You are Always Near a Restroom OABQ01-Affected Relationships The Overactive Bladder Questionnaire - Affected your relationships with family and friends? OAB-q - Affected Your Relationships with Family and Friends OABQ01-Amount of Time Spend in Restroom The Overactive Bladder Questionnaire - Made you frustrated or annoyed about the amount of time you spend in the restroom? OAB-q - Frustrated or Annoyed About the Amount of Time You Spend in the Restroom OABQ01-Avoid Act Away From Restroom The Overactive Bladder Questionnaire - Made you avoid activities away from restrooms (i.e., walks, running, hiking)? OAB-q - Avoid Activities Away From Restrooms OABQ01-Awakened You During Sleep The Overactive Bladder Questionnaire - Awakened you during sleep? OAB-q - Awakened You During Sleep OABQ01-Carefully Plan Your Commute The Overactive Bladder Questionnaire - Made you carefully plan your commute? OAB-q - Carefully Plan Your Commute OABQ01-Caused Problems Partner/Spouse The Overactive Bladder Questionnaire - Caused you to have problems with your partner or spouse? OAB-q - Caused Problems with Your Partner or Spouse OABQ01-Caused You Anxiety or Worry The Overactive Bladder Questionnaire - Caused you anxiety or worry? OAB-q - Caused You Anxiety or Worry OABQ01-Caused You Distress The Overactive Bladder Questionnaire - Caused you distress? OAB-q - Caused You Distress OABQ01-Caused You Embarrassment The Overactive Bladder Questionnaire - Caused you embarrassment? OAB-q - Caused You Embarrassment OABQ01-Decrease Participating Gatherings The Overactive Bladder Questionnaire - Caused you to decrease participating in social gatherings, such as parties or visits with family or friends? OAB-q - Decrease Participating in Social Gatherings OABQ01-Decrease Your Physical Activities The Overactive Bladder Questionnaire - Caused you to decrease your physical activities (exercising, sports, etc.)? OAB-q - Decrease Your Physical Activities OABQ01-Feel Drowsy or Sleepy During Day The Overactive Bladder Questionnaire - Caused you to feel drowsy or sleepy during the day? OAB-q - Feel Drowsy or Sleepy During the Day OABQ01-Feel Something Wrong with You The Overactive Bladder Questionnaire - Made you feel like there is something wrong with you? OAB-q - Feel Like There is Something Wrong with You OABQ01-Frequent Urination During Daytime The Overactive Bladder Questionnaire - Frequent urination during the daytime hours? OAB-q - Frequent Urination During the Daytime OABQ01-Frustrated Family and Friends The Overactive Bladder Questionnaire - Frustrated your family and friends? OAB-q - Frustrated Your Family and Friends OABQ01-Frustrated You The Overactive Bladder Questionnaire - Frustrated you? OAB-q - Frustrated You OABQ01-Interfered with Getting Sleep The Overactive Bladder Questionnaire - Interfered with getting the amount of sleep you needed? OAB-q - Interfered with Getting Sleep OABQ01-Interfered with Good Night's Rest The Overactive Bladder Questionnaire - Interfered with your ability to get a good night's rest? OAB-q - Interfered with a Good Night's Rest OABQ01-Locate Closest Restroom The Overactive Bladder Questionnaire - Caused you to locate the closest restroom as soon as you arrive at a place you have never been? OAB-q - Locate Closest Restroom as Soon as You Arrive OABQ01-Nighttime Urination The Overactive Bladder Questionnaire - Nighttime urination? OAB-q - Nighttime Urination OABQ01-Plan 'Escape Routes' to Restrooms The Overactive Bladder Questionnaire - Caused you to plan "escape routes" to restrooms in public places? OAB-q - Plan 'Escape Routes' to Restrooms OABQ01-Plan Activities More Carefully The Overactive Bladder Questionnaire - Caused you to plan activities more carefully? OAB-q - Plan Activities More Carefully OABQ01-Prevented From Feeling Rested The Overactive Bladder Questionnaire - Prevented you from feeling rested upon waking in the morning? OAB-q - Prevented You From Feeling Rested Upon Waking OABQ01-Stay Home More Often Than Prefer The Overactive Bladder Questionnaire - Caused you to stay home more often than you would prefer? OAB-q - Stay Home More Often Than You Would Prefer OABQ01-Sudden Urge to Urinate No Warning The Overactive Bladder Questionnaire - A sudden urge to urinate with little or no warning? OAB-q - Sudden Urge to Urinate with Little or No Warning OABQ01-Uncomfortable Travel with Others The Overactive Bladder Questionnaire - Made you uncomfortable while traveling with others because of needing to stop for a restroom? OAB-q - Uncomfortable While Traveling With Others OABQ01-Uncomfortable Urge to Urinate The Overactive Bladder Questionnaire - An uncomfortable urge to urinate? OAB-q - Uncomfortable Urge to Urinate OABQ01-Uncontrollable Urge to Urinate The Overactive Bladder Questionnaire - An uncontrollable urge to urinate? OAB-q - Uncontrollable Urge to Urinate OABQ01-Urine Loss Strong Desire Urinate The Overactive Bladder Questionnaire - Urine loss associated with a strong desire to urinate? OAB-q - Urine Loss Associated with a Strong Desire to Urinate OABQ01-Waking Up at Night had to Urinate The Overactive Bladder Questionnaire - Waking up at night because you had to urinate? OAB-q - Waking Up at Night Because You had to Urinate OABQ01-Worry About Odor or Hygiene The Overactive Bladder Questionnaire - Made you worry about odor or hygiene? OAB-q - Made You Worry About Odor or Hygiene OABQ01TN The Overactive Bladder Questionnaire Questionnaire Test Name CDISC Questionnaire OAB-q Test Name Terminology The Overactive Bladder Questionnaire Short Form test code. OABQ02-Uncomfortable Urge to Urinate The Overactive Bladder Questionnaire Short Form - An uncomfortable urge to urinate? OAB-q Short Form - Uncomfortable Urge to Urinate OABQ02-Sudden Urge to Urinate No Warning The Overactive Bladder Questionnaire Short Form - A sudden urge to urinate with little or no warning? OAB-q Short Form - Sudden Urge to Urinate with Little or No Warning OABQ02-Accidental Loss of Urine The Overactive Bladder Questionnaire Short Form - Accidental loss of small amounts of urine? OAB-q Short Form - Accidental Loss of Urine OABQ02-Nighttime Urination The Overactive Bladder Questionnaire Short Form - Nighttime urination? OAB-q Short Form - Nighttime Urination OABQ02-Waking Up at Night had to Urinate The Overactive Bladder Questionnaire Short Form - Waking up at night because you had to urinate? OAB-q Short Form - Waking Up at Night Because You had to Urinate OABQ02-Urine Loss Strong Desire Urinate The Overactive Bladder Questionnaire Short Form - Urine loss associated with strong desire to urinate? OAB-q Short Form - Urine Loss Associated with a Strong Desire to Urinate OABQ02-Plan 'Escape Routes' to Restrooms The Overactive Bladder Questionnaire Short Form - Caused you to plan "escape routes" to restrooms in public places? OAB-q Short Form - Plan 'Escape Routes' to Restrooms OABQ02-Feel Something is Wrong with You The Overactive Bladder Questionnaire Short Form - Made you feel like there is something wrong with you? OAB-q Short Form - Feel Like There is Something Wrong with You OABQ02-Interfered with Good Night's Rest The Overactive Bladder Questionnaire Short Form - Interfered with your ability to get a good night's rest? OAB-q Short Form - Interfered with a Good Night's Rest OABQ02-Frustrated about Time in Restroom The Overactive Bladder Questionnaire Short Form - Made you frustrated or annoyed about the amount of time you spend in the restroom? OAB-q Short Form - Frustrated or Annoyed About the Amount of Time You Spend in the Restroom OABQ02-Avoid Activ Away From Restroom The Overactive Bladder Questionnaire Short Form - Made you avoid activities away from restrooms (i.e., walks, running, hiking)? OAB-q Short Form - Avoid Activities Away From Restrooms OABQ02-Awakened You During Sleep The Overactive Bladder Questionnaire Short Form - Awakened you during sleep? OAB-q Short Form - Awakened You During Sleep OABQ02-Decrease Physical Activities The Overactive Bladder Questionnaire Short Form - Caused you to decrease your physical activities (exercising, sports, etc.)? OAB-q Short Form - Decrease Your Physical Activities OABQ02-Caused Problems Partner/Spouse The Overactive Bladder Questionnaire Short Form - Caused you to have problems with your partner or spouse? OAB-q Short Form - Caused Problems with Your Partner or Spouse OABQ02-Uncomfortable Travel with Others The Overactive Bladder Questionnaire Short Form - Made you uncomfortable while travelling with others because of needing to stop for a restroom? OAB-q Short Form - Uncomfortable While Traveling With Others OABQ02-Affected Relationships The Overactive Bladder Questionnaire Short Form - Affected your relationships with family and friends? OAB-q Short Form - Affected Your Relationships with Family and Friends OABQ02-Interfered with Getting Sleep The Overactive Bladder Questionnaire Short Form - Interfered with getting the amount of sleep you needed? OAB-q Short Form - Interfered with Getting Sleep OABQ02-Caused You Embarrassment The Overactive Bladder Questionnaire Short Form - Caused you embarrassment? OAB-q Short Form - Caused You Embarrassment OABQ02-Locate Closest Restroom The Overactive Bladder Questionnaire Short Form - Caused you to locate the closest restroom as soon as you arrive at a place you have never been? OAB-q Short Form - Locate Closest Restroom as Soon as You Arrive OABQ02TC The Overactive Bladder Questionnaire Short Form Questionnaire Test Code CDISC Questionnaire OAB-q Short Form Test Code Terminology The Overactive Bladder Questionnaire Short Form test name. OABQ02-Accidental Loss of Urine The Overactive Bladder Questionnaire Short Form - Accidental loss of small amounts of urine? OAB-q Short Form - Accidental Loss of Urine OABQ02-Affected Relationships The Overactive Bladder Questionnaire Short Form - Affected your relationships with family and friends? OAB-q Short Form - Affected Your Relationships with Family and Friends OABQ02-Avoid Activ Away From Restroom The Overactive Bladder Questionnaire Short Form - Made you avoid activities away from restrooms (i.e., walks, running, hiking)? OAB-q Short Form - Avoid Activities Away From Restrooms OABQ02-Awakened You During Sleep The Overactive Bladder Questionnaire Short Form - Awakened you during sleep? OAB-q Short Form - Awakened You During Sleep OABQ02-Caused Problems Partner/Spouse The Overactive Bladder Questionnaire Short Form - Caused you to have problems with your partner or spouse? OAB-q Short Form - Caused Problems with Your Partner or Spouse OABQ02-Caused You Embarrassment The Overactive Bladder Questionnaire Short Form - Caused you embarrassment? OAB-q Short Form - Caused You Embarrassment OABQ02-Decrease Physical Activities The Overactive Bladder Questionnaire Short Form - Caused you to decrease your physical activities (exercising, sports, etc.)? OAB-q Short Form - Decrease Your Physical Activities OABQ02-Feel Something is Wrong with You The Overactive Bladder Questionnaire Short Form - Made you feel like there is something wrong with you? OAB-q Short Form - Feel Like There is Something Wrong with You OABQ02-Frustrated about Time in Restroom The Overactive Bladder Questionnaire Short Form - Made you frustrated or annoyed about the amount of time you spend in the restroom? OAB-q Short Form - Frustrated or Annoyed About the Amount of Time You Spend in the Restroom OABQ02-Interfered with Getting Sleep The Overactive Bladder Questionnaire Short Form - Interfered with getting the amount of sleep you needed? OAB-q Short Form - Interfered with Getting Sleep OABQ02-Interfered with Good Night's Rest The Overactive Bladder Questionnaire Short Form - Interfered with your ability to get a good night's rest? OAB-q Short Form - Interfered with a Good Night's Rest OABQ02-Locate Closest Restroom The Overactive Bladder Questionnaire Short Form - Caused you to locate the closest restroom as soon as you arrive at a place you have never been? OAB-q Short Form - Locate Closest Restroom as Soon as You Arrive OABQ02-Nighttime Urination The Overactive Bladder Questionnaire Short Form - Nighttime urination? OAB-q Short Form - Nighttime Urination OABQ02-Plan 'Escape Routes' to Restrooms The Overactive Bladder Questionnaire Short Form - Caused you to plan "escape routes" to restrooms in public places? OAB-q Short Form - Plan 'Escape Routes' to Restrooms OABQ02-Sudden Urge to Urinate No Warning The Overactive Bladder Questionnaire Short Form - A sudden urge to urinate with little or no warning? OAB-q Short Form - Sudden Urge to Urinate with Little or No Warning OABQ02-Uncomfortable Travel with Others The Overactive Bladder Questionnaire Short Form - Made you uncomfortable while travelling with others because of needing to stop for a restroom? OAB-q Short Form - Uncomfortable While Traveling With Others OABQ02-Uncomfortable Urge to Urinate The Overactive Bladder Questionnaire Short Form - An uncomfortable urge to urinate? OAB-q Short Form - Uncomfortable Urge to Urinate OABQ02-Urine Loss Strong Desire Urinate The Overactive Bladder Questionnaire Short Form - Urine loss associated with strong desire to urinate? OAB-q Short Form - Urine Loss Associated with a Strong Desire to Urinate OABQ02-Waking Up at Night had to Urinate The Overactive Bladder Questionnaire Short Form - Waking up at night because you had to urinate? OAB-q Short Form - Waking Up at Night Because You had to Urinate OABQ02TN The Overactive Bladder Questionnaire Short Form Questionnaire Test Name CDISC Questionnaire OAB-q Short Form Test Name Terminology The Prostate Cancer Specific Quality of Life Instrument test code. PROS01-Pain Prostate Cancer Specific Quality of Life Instrument - Pain. PROSQOLI - Pain PROS01-Physical Activity Prostate Cancer Specific Quality of Life Instrument - Physical activity. PROSQOLI - Physical Activity PROS01-Fatigue Prostate Cancer Specific Quality of Life Instrument - Fatigue. PROSQOLI - Fatigue PROS01-Appetite Prostate Cancer Specific Quality of Life Instrument - Appetite. PROSQOLI - Appetite PROS01-Constipation Prostate Cancer Specific Quality of Life Instrument - Constipation. PROSQOLI - Constipation PROS01-Urinary Problems Prostate Cancer Specific Quality of Life Instrument - Urinary problems. PROSQOLI - Urinary Problems PROS01-Enjoying Time Friends/Family Prostate Cancer Specific Quality of Life Instrument - Enjoying time with friends and family. PROSQOLI - Enjoying Time with Friends and Family PROS01-Mood Prostate Cancer Specific Quality of Life Instrument - Mood. PROSQOLI - Mood PROS01-Overall Well-Being Prostate Cancer Specific Quality of Life Instrument - Overall Well-Being (How do you feel?). PROSQOLI - Overall Well-Being PROS01-Present Pain Intensity Prostate Cancer Specific Quality of Life Instrument - Present pain intensity: Please circle the appropriate number according to how much pain you felt on average during the past 24 hours. PROSQOLI - Present Pain Intensity PROS01TC The Prostate Cancer Specific Quality of Life Instrument Questionnaire Test Code CDISC Questionnaire PROSQOLI Test Code Terminology The Prostate Cancer Specific Quality of Life Instrument test name. PROS01-Appetite Prostate Cancer Specific Quality of Life Instrument - Appetite. PROSQOLI - Appetite PROS01-Constipation Prostate Cancer Specific Quality of Life Instrument - Constipation. PROSQOLI - Constipation PROS01-Enjoying Time Friends/Family Prostate Cancer Specific Quality of Life Instrument - Enjoying time with friends and family. PROSQOLI - Enjoying Time with Friends and Family PROS01-Fatigue Prostate Cancer Specific Quality of Life Instrument - Fatigue. PROSQOLI - Fatigue PROS01-Mood Prostate Cancer Specific Quality of Life Instrument - Mood. PROSQOLI - Mood PROS01-Overall Well-Being Prostate Cancer Specific Quality of Life Instrument - Overall Well-Being (How do you feel?). PROSQOLI - Overall Well-Being PROS01-Pain Prostate Cancer Specific Quality of Life Instrument - Pain. PROSQOLI - Pain PROS01-Physical Activity Prostate Cancer Specific Quality of Life Instrument - Physical activity. PROSQOLI - Physical Activity PROS01-Present Pain Intensity Prostate Cancer Specific Quality of Life Instrument - Present pain intensity: Please circle the appropriate number according to how much pain you felt on average during the past 24 hours. PROSQOLI - Present Pain Intensity PROS01-Urinary Problems Prostate Cancer Specific Quality of Life Instrument - Urinary problems. PROSQOLI - Urinary Problems PROS01TN The Prostate Cancer Specific Quality of Life Instrument Questionnaire Test Name CDISC Questionnaire PROSQOLI Test Name Terminology The PTSD Checklist for DSM-5 test code. PCL01-Repeated Disturbing Memories The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Repeated, disturbing, and unwanted memories of the stressful experience? PCL-5 - Repeated Disturbing Memories PCL01-Repeated Disturbing Dreams The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Repeated, disturbing dreams of the stressful experience? PCL-5 - Repeated Disturbing Dreams PCL01-Suddenly Feeling Happening Again The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Suddenly feeling or acting as if the stressful experience were actually happening again (as if you were actually back there reliving it)? PCL-5 - Suddenly Feeling Happening Again PCL01-Feel Upset When Reminded The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Feeling very upset when something reminded you of the stressful experience? PCL-5 - Feel Upset When Reminded PCL01-Strong Physical Reactions The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Having strong physical reactions when something reminded you of the stressful experience (for example, heart pounding, trouble breathing, sweating)? PCL-5 - Strong Physical Reactions PCL01-Avoid Memories/Thoughts/Feelings The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Avoiding memories, thoughts, or feelings related to the stressful experience? PCL-5 - Avoid Memories, Thoughts or Feelings PCL01-Avoid External Reminders The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Avoiding external reminders of the stressful experience (for example, people, places, conversations, activities, objects, or situations)? PCL-5 - Avoid External Reminders PCL01-Trouble Remembering Important Part The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Trouble remembering important parts of the stressful experience? PCL-5 - Trouble Remembering Important Parts PCL01-Strong Negative Beliefs The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Having strong negative beliefs about yourself, other people, or the world (for example, having thoughts such as: I am bad, there is something seriously wrong with me, no one can be trusted, the world is completely dangerous)? PCL-5 - Strong Negative Beliefs PCL01-Blaming Yourself/Someone Else The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Blaming yourself or someone else for the stressful experience or what happened after it? PCL-5 - Blaming Yourself or Someone Else PCL01-Strong Negative Feelings The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Having strong negative feelings such as fear, horror, anger, guilt, or shame? PCL-5 - Strong Negative Feelings PCL01-Loss of Interest in Activities The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Loss of interest in activities that you used to enjoy? PCL-5 - Loss of Interest in Activities PCL01-Feeling Distant From People The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Feeling distant or cut off from other people? PCL-5 - Feeling Distant From People PCL01-Trouble Experiencing Pos Feelings The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Trouble experiencing positive feelings (for example, being unable to feel happiness or have loving feelings for people close to you)? PCL-5 - Trouble Experiencing Positive Feelings PCL01-Irritable Behavior/Angry Outbursts The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Irritable behavior, angry outbursts, or acting aggressively? PCL-5 - Irritable Behavior or Angry Outbursts PCL01-Taking Too Many Risks/Cause Harm The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Taking too many risks or doing things that could cause you harm? PCL-5 - Taking Too Many Risks or Cause Harm PCL01-Being Superalert/Watchful/on Guard The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Being "superalert" or watchful or on guard? PCL-5 - Being Super Alert or Watchful PCL01-Feeling Jumpy or Easily Startled The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Feeling jumpy or easily startled? PCL-5 - Feeling Jumpy or Easily Startled PCL01-Having Difficulty Concentrating The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Having difficulty concentrating? PCL-5 - Having Difficulty Concentrating PCL01-Trouble Falling or Staying Asleep The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Trouble falling or staying asleep? PCL-5 - Trouble Falling or Staying Asleep PCL01TC The PTSD Checklist for DSM-5 Questionnaire Test Code CDISC Questionnaire PCL-5 Test Code Terminology The PTSD Checklist for DSM-5 test name. PCL01-Avoid External Reminders The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Avoiding external reminders of the stressful experience (for example, people, places, conversations, activities, objects, or situations)? PCL-5 - Avoid External Reminders PCL01-Avoid Memories/Thoughts/Feelings The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Avoiding memories, thoughts, or feelings related to the stressful experience? PCL-5 - Avoid Memories, Thoughts or Feelings PCL01-Being Superalert/Watchful/on Guard The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Being "superalert" or watchful or on guard? PCL-5 - Being Super Alert or Watchful PCL01-Blaming Yourself/Someone Else The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Blaming yourself or someone else for the stressful experience or what happened after it? PCL-5 - Blaming Yourself or Someone Else PCL01-Feel Upset When Reminded The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Feeling very upset when something reminded you of the stressful experience? PCL-5 - Feel Upset When Reminded PCL01-Feeling Distant From People The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Feeling distant or cut off from other people? PCL-5 - Feeling Distant From People PCL01-Feeling Jumpy or Easily Startled The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Feeling jumpy or easily startled? PCL-5 - Feeling Jumpy or Easily Startled PCL01-Having Difficulty Concentrating The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Having difficulty concentrating? PCL-5 - Having Difficulty Concentrating PCL01-Irritable Behavior/Angry Outbursts The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Irritable behavior, angry outbursts, or acting aggressively? PCL-5 - Irritable Behavior or Angry Outbursts PCL01-Loss of Interest in Activities The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Loss of interest in activities that you used to enjoy? PCL-5 - Loss of Interest in Activities PCL01-Repeated Disturbing Dreams The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Repeated, disturbing dreams of the stressful experience? PCL-5 - Repeated Disturbing Dreams PCL01-Repeated Disturbing Memories The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Repeated, disturbing, and unwanted memories of the stressful experience? PCL-5 - Repeated Disturbing Memories PCL01-Strong Negative Beliefs The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Having strong negative beliefs about yourself, other people, or the world (for example, having thoughts such as: I am bad, there is something seriously wrong with me, no one can be trusted, the world is completely dangerous)? PCL-5 - Strong Negative Beliefs PCL01-Strong Negative Feelings The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Having strong negative feelings such as fear, horror, anger, guilt, or shame? PCL-5 - Strong Negative Feelings PCL01-Strong Physical Reactions The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Having strong physical reactions when something reminded you of the stressful experience (for example, heart pounding, trouble breathing, sweating)? PCL-5 - Strong Physical Reactions PCL01-Suddenly Feeling Happening Again The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Suddenly feeling or acting as if the stressful experience were actually happening again (as if you were actually back there reliving it)? PCL-5 - Suddenly Feeling Happening Again PCL01-Taking Too Many Risks/Cause Harm The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Taking too many risks or doing things that could cause you harm? PCL-5 - Taking Too Many Risks or Cause Harm PCL01-Trouble Experiencing Pos Feelings The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Trouble experiencing positive feelings (for example, being unable to feel happiness or have loving feelings for people close to you)? PCL-5 - Trouble Experiencing Positive Feelings PCL01-Trouble Falling or Staying Asleep The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Trouble falling or staying asleep? PCL-5 - Trouble Falling or Staying Asleep PCL01-Trouble Remembering Important Part The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Trouble remembering important parts of the stressful experience? PCL-5 - Trouble Remembering Important Parts PCL01TN The PTSD Checklist for DSM-5 Questionnaire Test Name CDISC Questionnaire PCL-5 Test Name Terminology The Short Form 36 Health Survey Acute, US Version 1.0 test code. SF362-In General You Say Your Health Is The Short Form 36 Health Survey Acute, US Version 1.0 - In general, would you say your health is. SF-36 v1.0 Acute - In General You Say Your Health Is SF362-Comp Week Ago Rate Gen Health Now The Short Form 36 Health Survey Acute, US Version 1.0 - Compared to one week ago, how would you rate your health in general now? SF-36 v1.0 Acute - Comp Week Ago Rate Gen Health Now SF362-Limit Vigorous Activities The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - vigorous activities, such as running, lifting heavy objects, participating in strenuous sports. SF-36 v1.0 Acute - Limit Vigorous Activities SF362-Limit Moderate Activities The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. SF-36 v1.0 Acute - Limit Moderate Activities SF362-Limit Lifting or Carrying The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - lifting or carrying groceries. SF-36 v1.0 Acute - Limit Lifting or Carrying SF362-Limit Climbing Several Flights The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - climbing several flights of stairs. SF-36 v1.0 Acute - Limit Climbing Several Flights SF362-Limit Climbing One Flight Stairs The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - climbing one flight of stairs. SF-36 v1.0 Acute - Limit Climbing One Flight Stairs SF362-Limit Bending/Kneeling/Stooping The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - bending, kneeling, or stooping. SF-36 v1.0 Acute - Limit Bending/Kneeling/Stooping SF362-Limit Walking More Than a Mile The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - walking more than a mile. SF-36 v1.0 Acute - Limit Walking More Than a Mile SF362-Limit Walking Several Blocks The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - walking several blocks. SF-36 v1.0 Acute - Limit Walking Several Blocks SF362-Limit Walking One Block The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - walking one block. SF-36 v1.0 Acute - Limit Walking One Block SF362-Limit Bathing or Dressing Yourself The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - bathing or dressing yourself. SF-36 v1.0 Acute - Limit Bathing or Dressing Yourself SF362-Physical: Cut Down Time on Work The Short Form 36 Health Survey Acute, US Version 1.0 (SF36 V1.0 ACUTE) -During the past week, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - cut down on the amount of time you spent on work or other activities. SF-36 v1.0 Acute - Physical: Cut Down Time on Work SF362-Physical: Accomplished Less The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. SF-36 v1.0 Acute - Physical: Accomplished Less SF362-Physical: Limited Kind of Work The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. SF-36 v1.0 Acute - Physical: Limited Kind of Work SF362-Physical: Difficulty Perform Work The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - had difficulty performing the work or other activities (for example, it took extra effort). SF-36 v1.0 Acute - Physical: Difficulty Perform Work SF362-Emotional: Cut Down Time on Work The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - cut down on the amount of time you spent on work or other activities. SF-36 v1.0 Acute - Emotional: Cut Down Time on Work SF362-Emotional: Accomplished Less The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. SF-36 v1.0 Acute - Emotional: Accomplished Less SF362-Emotional: Did Work Less Carefully The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. SF-36 v1.0 Acute - Emotional: Did Work Less Carefully SF362-Extent Phys/Emotional Interfered The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, to what extent has your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors, or groups? SF-36 v1.0 Acute - Extent Phys/Emotional Interfered SF362-How Much Bodily Pain Have You Had The Short Form 36 Health Survey Acute, US Version 1.0 - How much bodily pain have you had during the past week? SF-36 v1.0 Acute - How Much Bodily Pain Have You Had SF362-Pain Interfere With Normal Work The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, how much did pain interfere with your normal work (including both work outside the home and housework)? SF-36 v1.0 Acute - Pain Interfere With Normal Work SF362-Did You Feel Full of Pep The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you feel full of pep. SF-36 v1.0 Acute - Did You Feel Full of Pep SF362-Have You Been Very Nervous Person The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you been a very nervous person. SF-36 v1.0 Acute - Have You Been Very Nervous Person SF362-Felt Down Nothing Cheer You Up The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt so down in the dumps that nothing could cheer you up. SF-36 v1.0 Acute - Felt Down Nothing Cheer You Up SF362-Have You Felt Calm and Peaceful The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt calm and peaceful. SF-36 v1.0 Acute - Have You Felt Calm and Peaceful SF362-Did You Have a Lot of Energy The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you have a lot of energy. SF-36 v1.0 Acute - Did You Have a Lot of Energy SF362-You Felt Downhearted and Blue The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt downhearted and blue. SF-36 v1.0 Acute - You Felt Downhearted and Blue SF362-Did You Feel Worn Out The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you feel worn out. SF-36 v1.0 Acute - Did You Feel Worn Out SF362-Have You Been a Happy Person The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you been a happy person. SF-36 v1.0 Acute - Have You Been a Happy Person SF362-Did You Feel Tired The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you feel tired. SF-36 v1.0 Acute - Did You Feel Tired SF362-Time Phys/Emotional Interfered The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting friends, relatives, etc.)? SF-36 v1.0 Acute - Time Phys/Emotional Interfered SF362-Get Sick Little Easier Than Other The Short Form 36 Health Survey Acute, US Version 1.0 - How TRUE or FALSE is the following statement for you - I seem to get sick a little easier than other people. SF-36 v1.0 Acute - Get Sick Little Easier Than Other SF362-I Am as Healthy as Anybody I Know The Short Form 36 Health Survey Acute, US Version 1.0 - How TRUE or FALSE is the following statement for you - I am as healthy as anybody I know. SF-36 v1.0 Acute - I Am as Healthy as Anybody I Know SF362-I Expect My Health to Get Worse The Short Form 36 Health Survey Acute, US Version 1.0 - How TRUE or FALSE is the following statement for you - I expect my health to get worse. SF-36 v1.0 Acute - I Expect My Health to Get Worse SF362-My Health is Excellent The Short Form 36 Health Survey Acute, US Version 1.0 - How TRUE or FALSE is the following statement for you - my health is excellent SF-36 v1.0 Acute - My Health is Excellent SF362-Physical Functioning 0-100 Score The Short Form 36 Health Survey Acute, US Version 1.0 - Physical functioning 0-100 score. SF-36 v1.0 Acute - Physical Functioning 0-100 Score SF362-Role Physical 0-100 Score The Short Form 36 Health Survey Acute, US Version 1.0 - Role physical 0-100 score. SF-36 v1.0 Acute - Role Physical 0-100 Score SF362-Bodily Pain 0-100 Score The Short Form 36 Health Survey Acute, US Version 1.0 - Bodily pain 0-100 score. SF-36 v1.0 Acute - Bodily Pain 0-100 Score SF362-General Health 0-100 Score The Short Form 36 Health Survey Acute, US Version 1.0 - General health 0-100 score. SF-36 v1.0 Acute - General Health 0-100 Score SF362-Vitality 0-100 Score The Short Form 36 Health Survey Acute, US Version 1.0 - Vitality 0-100 score. SF-36 v1.0 Acute - Vitality 0-100 Score SF362-Social Functioning 0-100 Score The Short Form 36 Health Survey Acute, US Version 1.0 - Social functioning 0-100 score. SF-36 v1.0 Acute - Social Functioning 0-100 Score SF362-Role Emotional 0-100 Score The Short Form 36 Health Survey Acute, US Version 1.0 - Role emotional 0-100 score. SF-36 v1.0 Acute - Role Emotional 0-100 Score SF362-Mental Health 0-100 Score The Short Form 36 Health Survey Acute, US Version 1.0 - Mental health 0-100 score. SF-36 v1.0 Acute - Mental Health 0-100 Score SF362-Phys Functioning Norm-Based Score The Short Form 36 Health Survey Acute, US Version 1.0 - Phys functioning norm-based score. SF-36 v1.0 Acute - Phys Functioning Norm-Based Score SF362-Role Physical Norm-Based Score The Short Form 36 Health Survey Acute, US Version 1.0 - Role physical norm-based score. SF-36 v1.0 Acute - Role Physical Norm-Based Score SF362-Bodily Pain Norm-Based Score The Short Form 36 Health Survey Acute, US Version 1.0 - Bodily pain norm-based score. SF-36 v1.0 Acute - Bodily Pain Norm-Based Score SF362-General Health Norm-Based Score The Short Form 36 Health Survey Acute, US Version 1.0 - General health norm-based score. SF-36 v1.0 Acute - General Health Norm-Based Score SF362-Vitality Norm-Based Score The Short Form 36 Health Survey Acute, US Version 1.0 - Vitality norm-based score. SF-36 v1.0 Acute - Vitality Norm-Based Score SF362-Social Function Norm-Based Score The Short Form 36 Health Survey Acute, US Version 1.0 - Social function norm-based score. SF-36 v1.0 Acute - Social Function Norm-Based Score SF362-Role Emotional Norm-Based Score The Short Form 36 Health Survey Acute, US Version 1.0 - Role emotional norm-based score. SF-36 v1.0 Acute - Role Emotional Norm-Based Score SF362-Mental Health Norm-Based Score The Short Form 36 Health Survey Acute, US Version 1.0 - Mental health norm-based score. SF-36 v1.0 Acute - Mental Health Norm-Based Score SF362-Physical Component Score The Short Form 36 Health Survey Acute, US Version 1.0 - Physical component score. SF-36 v1.0 Acute - Physical Component Score SF362-Mental Component Score The Short Form 36 Health Survey Acute, US Version 1.0 - Mental component score. SF-36 v1.0 Acute - Mental Component Score SF362-SF-6D (Utility Index) Score The Short Form 36 Health Survey Acute, US Version 1.0 - 6D (utility index) score. SF-36 v1.0 Acute - SF-6D (Utility Index) Score SF362-SF-6D_R2 (Util Index Rel 2) Score The Short Form 36 Health Survey Acute, US Version 1.0 - 6D_R2 (util index rel 2) score. SF-36 v1.0 Acute - SF-6D_R2 (Util Index Rel 2) Score SF362-Response Consistency Score The Short Form 36 Health Survey Acute, US Version 1.0 - Response consistency score. SF-36 v1.0 Acute - Response Consistency Score SF362TC The Short Form 36 Health Survey Acute, US Version 1.0 Questionnaire Test Code CDISC Questionnaire SF36 v1.0 Acute Test Code Terminology The Short Form 36 Health Survey Acute, US Version 1.0 test name. SF362-Bodily Pain 0-100 Score The Short Form 36 Health Survey Acute, US Version 1.0 - Bodily pain 0-100 score. SF-36 v1.0 Acute - Bodily Pain 0-100 Score SF362-Bodily Pain Norm-Based Score The Short Form 36 Health Survey Acute, US Version 1.0 - Bodily pain norm-based score. SF-36 v1.0 Acute - Bodily Pain Norm-Based Score SF362-Comp Week Ago Rate Gen Health Now The Short Form 36 Health Survey Acute, US Version 1.0 - Compared to one week ago, how would you rate your health in general now? SF-36 v1.0 Acute - Comp Week Ago Rate Gen Health Now SF362-Did You Feel Full of Pep The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you feel full of pep. SF-36 v1.0 Acute - Did You Feel Full of Pep SF362-Did You Feel Tired The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you feel tired. SF-36 v1.0 Acute - Did You Feel Tired SF362-Did You Feel Worn Out The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you feel worn out. SF-36 v1.0 Acute - Did You Feel Worn Out SF362-Did You Have a Lot of Energy The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you have a lot of energy. SF-36 v1.0 Acute - Did You Have a Lot of Energy SF362-Emotional: Accomplished Less The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. SF-36 v1.0 Acute - Emotional: Accomplished Less SF362-Emotional: Cut Down Time on Work The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - cut down on the amount of time you spent on work or other activities. SF-36 v1.0 Acute - Emotional: Cut Down Time on Work SF362-Emotional: Did Work Less Carefully The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. SF-36 v1.0 Acute - Emotional: Did Work Less Carefully SF362-Extent Phys/Emotional Interfered The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, to what extent has your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors, or groups? SF-36 v1.0 Acute - Extent Phys/Emotional Interfered SF362-Felt Down Nothing Cheer You Up The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt so down in the dumps that nothing could cheer you up. SF-36 v1.0 Acute - Felt Down Nothing Cheer You Up SF362-General Health 0-100 Score The Short Form 36 Health Survey Acute, US Version 1.0 - General health 0-100 score. SF-36 v1.0 Acute - General Health 0-100 Score SF362-General Health Norm-Based Score The Short Form 36 Health Survey Acute, US Version 1.0 - General health norm-based score. SF-36 v1.0 Acute - General Health Norm-Based Score SF362-Get Sick Little Easier Than Other The Short Form 36 Health Survey Acute, US Version 1.0 - How TRUE or FALSE is the following statement for you - I seem to get sick a little easier than other people. SF-36 v1.0 Acute - Get Sick Little Easier Than Other SF362-Have You Been a Happy Person The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you been a happy person. SF-36 v1.0 Acute - Have You Been a Happy Person SF362-Have You Been Very Nervous Person The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you been a very nervous person. SF-36 v1.0 Acute - Have You Been Very Nervous Person SF362-Have You Felt Calm and Peaceful The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt calm and peaceful. SF-36 v1.0 Acute - Have You Felt Calm and Peaceful SF362-How Much Bodily Pain Have You Had The Short Form 36 Health Survey Acute, US Version 1.0 - How much bodily pain have you had during the past week? SF-36 v1.0 Acute - How Much Bodily Pain Have You Had SF362-I Am as Healthy as Anybody I Know The Short Form 36 Health Survey Acute, US Version 1.0 - How TRUE or FALSE is the following statement for you - I am as healthy as anybody I know. SF-36 v1.0 Acute - I Am as Healthy as Anybody I Know SF362-I Expect My Health to Get Worse The Short Form 36 Health Survey Acute, US Version 1.0 - How TRUE or FALSE is the following statement for you - I expect my health to get worse. SF-36 v1.0 Acute - I Expect My Health to Get Worse SF362-In General You Say Your Health Is The Short Form 36 Health Survey Acute, US Version 1.0 - In general, would you say your health is. SF-36 v1.0 Acute - In General You Say Your Health Is SF362-Limit Bathing or Dressing Yourself The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - bathing or dressing yourself. SF-36 v1.0 Acute - Limit Bathing or Dressing Yourself SF362-Limit Bending/Kneeling/Stooping The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - bending, kneeling, or stooping. SF-36 v1.0 Acute - Limit Bending/Kneeling/Stooping SF362-Limit Climbing One Flight Stairs The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - climbing one flight of stairs. SF-36 v1.0 Acute - Limit Climbing One Flight Stairs SF362-Limit Climbing Several Flights The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - climbing several flights of stairs. SF-36 v1.0 Acute - Limit Climbing Several Flights SF362-Limit Lifting or Carrying The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - lifting or carrying groceries. SF-36 v1.0 Acute - Limit Lifting or Carrying SF362-Limit Moderate Activities The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. SF-36 v1.0 Acute - Limit Moderate Activities SF362-Limit Vigorous Activities The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - vigorous activities, such as running, lifting heavy objects, participating in strenuous sports. SF-36 v1.0 Acute - Limit Vigorous Activities SF362-Limit Walking More Than a Mile The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - walking more than a mile. SF-36 v1.0 Acute - Limit Walking More Than a Mile SF362-Limit Walking One Block The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - walking one block. SF-36 v1.0 Acute - Limit Walking One Block SF362-Limit Walking Several Blocks The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - walking several blocks. SF-36 v1.0 Acute - Limit Walking Several Blocks SF362-Mental Component Score The Short Form 36 Health Survey Acute, US Version 1.0 - Mental component score. SF-36 v1.0 Acute - Mental Component Score SF362-Mental Health 0-100 Score The Short Form 36 Health Survey Acute, US Version 1.0 - Mental health 0-100 score. SF-36 v1.0 Acute - Mental Health 0-100 Score SF362-Mental Health Norm-Based Score The Short Form 36 Health Survey Acute, US Version 1.0 - Mental health norm-based score. SF-36 v1.0 Acute - Mental Health Norm-Based Score SF362-My Health is Excellent The Short Form 36 Health Survey Acute, US Version 1.0 - How TRUE or FALSE is the following statement for you - my health is excellent SF-36 v1.0 Acute - My Health is Excellent SF362-Pain Interfere With Normal Work The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, how much did pain interfere with your normal work (including both work outside the home and housework)? SF-36 v1.0 Acute - Pain Interfere With Normal Work SF362-Phys Functioning Norm-Based Score The Short Form 36 Health Survey Acute, US Version 1.0 - Phys functioning norm-based score. SF-36 v1.0 Acute - Phys Functioning Norm-Based Score SF362-Physical Component Score The Short Form 36 Health Survey Acute, US Version 1.0 - Physical component score. SF-36 v1.0 Acute - Physical Component Score SF362-Physical Functioning 0-100 Score The Short Form 36 Health Survey Acute, US Version 1.0 - Physical functioning 0-100 score. SF-36 v1.0 Acute - Physical Functioning 0-100 Score SF362-Physical: Accomplished Less The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. SF-36 v1.0 Acute - Physical: Accomplished Less SF362-Physical: Cut Down Time on Work The Short Form 36 Health Survey Acute, US Version 1.0 (SF36 V1.0 ACUTE) -During the past week, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - cut down on the amount of time you spent on work or other activities. SF-36 v1.0 Acute - Physical: Cut Down Time on Work SF362-Physical: Difficulty Perform Work The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - had difficulty performing the work or other activities (for example, it took extra effort). SF-36 v1.0 Acute - Physical: Difficulty Perform Work SF362-Physical: Limited Kind of Work The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. SF-36 v1.0 Acute - Physical: Limited Kind of Work SF362-Response Consistency Score The Short Form 36 Health Survey Acute, US Version 1.0 - Response consistency score. SF-36 v1.0 Acute - Response Consistency Score SF362-Role Emotional 0-100 Score The Short Form 36 Health Survey Acute, US Version 1.0 - Role emotional 0-100 score. SF-36 v1.0 Acute - Role Emotional 0-100 Score SF362-Role Emotional Norm-Based Score The Short Form 36 Health Survey Acute, US Version 1.0 - Role emotional norm-based score. SF-36 v1.0 Acute - Role Emotional Norm-Based Score SF362-Role Physical 0-100 Score The Short Form 36 Health Survey Acute, US Version 1.0 - Role physical 0-100 score. SF-36 v1.0 Acute - Role Physical 0-100 Score SF362-Role Physical Norm-Based Score The Short Form 36 Health Survey Acute, US Version 1.0 - Role physical norm-based score. SF-36 v1.0 Acute - Role Physical Norm-Based Score SF362-SF-6D (Utility Index) Score The Short Form 36 Health Survey Acute, US Version 1.0 - 6D (utility index) score. SF-36 v1.0 Acute - SF-6D (Utility Index) Score SF362-SF-6D_R2 (Util Index Rel 2) Score The Short Form 36 Health Survey Acute, US Version 1.0 - 6D_R2 (util index rel 2) score. SF-36 v1.0 Acute - SF-6D_R2 (Util Index Rel 2) Score SF362-Social Function Norm-Based Score The Short Form 36 Health Survey Acute, US Version 1.0 - Social function norm-based score. SF-36 v1.0 Acute - Social Function Norm-Based Score SF362-Social Functioning 0-100 Score The Short Form 36 Health Survey Acute, US Version 1.0 - Social functioning 0-100 score. SF-36 v1.0 Acute - Social Functioning 0-100 Score SF362-Time Phys/Emotional Interfered The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting friends, relatives, etc.)? SF-36 v1.0 Acute - Time Phys/Emotional Interfered SF362-Vitality 0-100 Score The Short Form 36 Health Survey Acute, US Version 1.0 - Vitality 0-100 score. SF-36 v1.0 Acute - Vitality 0-100 Score SF362-Vitality Norm-Based Score The Short Form 36 Health Survey Acute, US Version 1.0 - Vitality norm-based score. SF-36 v1.0 Acute - Vitality Norm-Based Score SF362-You Felt Downhearted and Blue The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt downhearted and blue. SF-36 v1.0 Acute - You Felt Downhearted and Blue SF362TN The Short Form 36 Health Survey Acute, US Version 1.0 Questionnaire Test Name CDISC Questionnaire SF36 v1.0 Acute Test Name Terminology The Short Form 36 Health Survey Acute, US Version 2.0 test code. SF364-In General You Say Your Health Is The Short Form 36 Health Survey Acute, US Version 2.0 - In general, would you say your health is. SF-36 v2.0 Acute - In General You Say Your Health Is SF364-Comp Week Ago Rate Gen Health Now The Short Form 36 Health Survey Acute, US Version 2.0 - Compared to one week ago, how would you rate your health in general now? SF-36 v2.0 Acute - Comp Week Ago Rate Gen Health Now SF364-Limit Vigorous Activities The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - vigorous activities, such as running, lifting heavy objects, participating in strenuous sports. SF-36 v2.0 Acute - Limit Vigorous Activities SF364-Limit Moderate Activities The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. SF-36 v2.0 Acute - Limit Moderate Activities SF364-Limit Lifting or Carrying The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - lifting or carrying groceries. SF-36 v2.0 Acute - Limit Lifting or Carrying SF364-Limit Climbing Several Flights The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - climbing several flights of stairs. SF-36 v2.0 Acute - Limit Climbing Several Flights SF364-Limit Climbing One Flight Stairs The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - climbing one flight of stairs. SF-36 v2.0 Acute - Limit Climbing One Flight Stairs SF364-Limit Bending/Kneeling/Stooping The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - bending, kneeling, or stooping. SF-36 v2.0 Acute - Limit Bending/Kneeling/Stooping SF364-Limit Walking More Than a Mile The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - walking more than a mile. SF-36 v2.0 Acute - Limit Walking More Than a Mile SF364-Limit Walking Several Hundred Yds The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - walking several hundred yards. SF-36 v2.0 Acute - Limit Walking Several Hundred Yds SF364-Limit Walking One Hundred Yards The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - walking one hundred yards. SF-36 v2.0 Acute - Limit Walking One Hundred Yards SF364-Limit Bathing or Dressing Yourself The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - bathing or dressing yourself. SF-36 v2.0 Acute - Limit Bathing or Dressing Yourself SF364-Physical: Cut Down Time on Work The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - cut down on the amount of time you spent on work or other activities. SF-36 v2.0 Acute - Physical: Cut Down Time on Work SF364-Physical: Accomplished Less The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. SF-36 v2.0 Acute - Physical: Accomplished Less SF364-Physical: Limited Kind of Work The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. SF-36 v2.0 Acute - Physical: Limited Kind of Work SF364-Physical: Difficulty Perform Work The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - had difficulty performing the work or other activities (for example, it took extra effort). SF-36 v2.0 Acute - Physical: Difficulty Perform Work SF364-Emotional: Cut Down Time on Work The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - cut down on the amount of time you spent on work or other activities. SF-36 v2.0 Acute - Emotional: Cut Down Time on Work SF364-Emotional: Accomplished Less The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. SF-36 v2.0 Acute - Emotional: Accomplished Less SF364-Emotional: Did Work Less Carefully The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. SF-36 v2.0 Acute - Emotional: Did Work Less Carefully SF364-Extent Phys/Emotional Interfered The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, to what extent has your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors, or groups? SF-36 v2.0 Acute - Extent Phys/Emotional Interfered SF364-How Much Bodily Pain Have You Had The Short Form 36 Health Survey Acute, US Version 2.0 - How much bodily pain have you had during the past week? SF-36 v2.0 Acute - How Much Bodily Pain Have You Had SF364-Pain Interfere With Normal Work The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much did pain interfere with your normal work (including both work outside the home and housework)? SF-36 v2.0 Acute - Pain Interfere With Normal Work SF364-Did You Feel Full of Life The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you feel full of life. SF-36 v2.0 Acute - Did You Feel Full of Life SF364-Have You Been Very Nervous The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you been very nervous. SF-36 v2.0 Acute - Have You Been Very Nervous SF364-Felt Down Nothing Cheer You Up The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt so down in the dumps that nothing could cheer you up. SF-36 v2.0 Acute - Felt Down Nothing Cheer You Up SF364-Have You Felt Calm and Peaceful The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt calm and peaceful. SF-36 v2.0 Acute - Have You Felt Calm and Peaceful SF364-Did You Have a Lot of Energy The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you have a lot of energy. SF-36 v2.0 Acute - Did You Have a Lot of Energy SF364-You Felt Downhearted and Depressed The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt downhearted and depressed. SF-36 v2.0 Acute - You Felt Downhearted and Depressed SF364-Did You Feel Worn Out The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you feel worn out. SF-36 v2.0 Acute - Did You Feel Worn Out SF364-Have You Been Happy The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you been happy. SF-36 v2.0 Acute - Have You Been Happy SF364-Did You Feel Tired The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you feel tired. SF-36 v2.0 Acute - Did You Feel Tired SF364-Time Phys/Emotional Interfered The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting friends, relatives, etc.)? SF-36 v2.0 Acute - Time Phys/Emotional Interfered SF364-Get Sick Little Easier Than Other The Short Form 36 Health Survey Acute, US Version 2.0 - How TRUE or FALSE is the following statement for you - I seem to get sick a little easier than other people. SF-36 v2.0 Acute - Get Sick Little Easier Than Other SF364-I Am as Healthy as Anybody I Know The Short Form 36 Health Survey Acute, US Version 2.0 - How TRUE or FALSE is the following statement for you - I am as healthy as anybody I know. SF-36 v2.0 Acute - I Am as Healthy as Anybody I Know SF364-I Expect My Health to Get Worse The Short Form 36 Health Survey Acute, US Version 2.0 - How TRUE or FALSE is the following statement for you - I expect my health to get worse. SF-36 v2.0 Acute - I Expect My Health to Get Worse SF364-My Health is Excellent The Short Form 36 Health Survey Acute, US Version 2.0 - How TRUE or FALSE is the following statement for you - my health is excellent SF-36 v2.0 Acute - My Health is Excellent SF364-Physical Functioning 0-100 Score The Short Form 36 Health Survey Acute, US Version 2.0 - Physical functioning 0-100 score. SF-36 v2.0 Acute - Physical Functioning 0-100 Score SF364-Role Physical 0-100 Score The Short Form 36 Health Survey Acute, US Version 2.0 - Role physical 0-100 score. SF-36 v2.0 Acute - Role Physical 0-100 Score SF364-Bodily Pain 0-100 Score The Short Form 36 Health Survey Acute, US Version 2.0 - Bodily pain 0-100 score. SF-36 v2.0 Acute - Bodily Pain 0-100 Score SF364-General Health 0-100 Score The Short Form 36 Health Survey Acute, US Version 2.0 - General health 0-100 score. SF-36 v2.0 Acute - General Health 0-100 Score SF364-Vitality 0-100 Score The Short Form 36 Health Survey Acute, US Version 2.0 - Vitality 0-100 score. SF-36 v2.0 Acute - Vitality 0-100 Score SF364-Social Functioning 0-100 Score The Short Form 36 Health Survey Acute, US Version 2.0 - Social functioning 0-100 score. SF-36 v2.0 Acute - Social Functioning 0-100 Score SF364-Role Emotional 0-100 Score The Short Form 36 Health Survey Acute, US Version 2.0 - Role emotional 0-100 score. SF-36 v2.0 Acute - Role Emotional 0-100 Score SF364-Mental Health 0-100 Score The Short Form 36 Health Survey Acute, US Version 2.0 - Mental health 0-100 score. SF-36 v2.0 Acute - Mental Health 0-100 Score SF364-Phys Functioning Norm-Based Score The Short Form 36 Health Survey Acute, US Version 2.0 - Phys functioning norm-based score. SF-36 v2.0 Acute - Phys Functioning Norm-Based Score SF364-Role Physical Norm-Based Score The Short Form 36 Health Survey Acute, US Version 2.0 - Role physical norm-based score. SF-36 v2.0 Acute - Role Physical Norm-Based Score SF364-Bodily Pain Norm-Based Score The Short Form 36 Health Survey Acute, US Version 2.0 - Bodily pain norm-based score. SF-36 v2.0 Acute - Bodily Pain Norm-Based Score SF364-General Health Norm-Based Score The Short Form 36 Health Survey Acute, US Version 2.0 - General health norm-based score. SF-36 v2.0 Acute - General Health Norm-Based Score SF364-Vitality Norm-Based Score The Short Form 36 Health Survey Acute, US Version 2.0 - Vitality norm-based score. SF-36 v2.0 Acute - Vitality Norm-Based Score SF364-Social Function Norm-Based Score The Short Form 36 Health Survey Acute, US Version 2.0 - Social function norm-based score. SF-36 v2.0 Acute - Social Function Norm-Based Score SF364-Role Emotional Norm-Based Score The Short Form 36 Health Survey Acute, US Version 2.0 - Role emotional norm-based score. SF-36 v2.0 Acute - Role Emotional Norm-Based Score SF364-Mental Health Norm-Based Score The Short Form 36 Health Survey Acute, US Version 2.0 - Mental health norm-based score. SF-36 v2.0 Acute - Mental Health Norm-Based Score SF364-Physical Component Score The Short Form 36 Health Survey Acute, US Version 2.0 - Physical component score. SF-36 v2.0 Acute - Physical Component Score SF364-Mental Component Score The Short Form 36 Health Survey Acute, US Version 2.0 - Mental component score. SF-36 v2.0 Acute - Mental Component Score SF364-SF-6D (Utility Index) Score The Short Form 36 Health Survey Acute, US Version 2.0 - 6D (utility index) score. SF-36 v2.0 Acute - SF-6D (Utility Index) Score SF364-SF-6D_R2 (Util Index Rel 2) Score The Short Form 36 Health Survey Acute, US Version 2.0 - 6D_R2 (util index rel 2) score. SF-36 v2.0 Acute - SF-6D_R2 (Util Index Rel 2) Score SF364-Mental Health Enhanced Score The Short Form 36 Health Survey Acute, US Version 2.0 - Mental health enhanced score. SF-36 v2.0 Acute - Mental Health Enhanced Score SF364-Response Consistency Score The Short Form 36 Health Survey Acute, US Version 2.0 - Response consistency score. SF-36 v2.0 Acute - Response Consistency Score SF364-Utility Index Score UK Weights The Short Form 36 Health Survey Acute, US Version 2.0 - Utility index score United Kingdom weights. SF-36 v2.0 Acute - Utility Index Score UK Weights SF364-Utility Index Score CN Weights The Short Form 36 Health Survey Acute, US Version 2.0 - Utility index score Canada weights. SF-36 v2.0 Acute - Utility Index Score CN Weights SF364-Utility Index Score AU Weights The Short Form 36 Health Survey Acute, US Version 2.0 - Utility index score Australia weights. SF-36 v2.0 Acute - Utility Index Score AU Weights SF364-Utility Index Score US Weights The Short Form 36 Health Survey Acute, US Version 2.0 - Utility index score United States weights. SF-36 v2.0 Acute - Utility Index Score US Weights SF364TC The Short Form 36 Health Survey Acute, US Version 2.0 Questionnaire Test Code CDISC Questionnaire SF36 v2.0 Acute Test Code Terminology The Short Form 36 Health Survey Acute, US Version 2.0 test name. SF364-Bodily Pain 0-100 Score The Short Form 36 Health Survey Acute, US Version 2.0 - Bodily pain 0-100 score. SF-36 v2.0 Acute - Bodily Pain 0-100 Score SF364-Bodily Pain Norm-Based Score The Short Form 36 Health Survey Acute, US Version 2.0 - Bodily pain norm-based score. SF-36 v2.0 Acute - Bodily Pain Norm-Based Score SF364-Comp Week Ago Rate Gen Health Now The Short Form 36 Health Survey Acute, US Version 2.0 - Compared to one week ago, how would you rate your health in general now? SF-36 v2.0 Acute - Comp Week Ago Rate Gen Health Now SF364-Did You Feel Full of Life The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you feel full of life. SF-36 v2.0 Acute - Did You Feel Full of Life SF364-Did You Feel Tired The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you feel tired. SF-36 v2.0 Acute - Did You Feel Tired SF364-Did You Feel Worn Out The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you feel worn out. SF-36 v2.0 Acute - Did You Feel Worn Out SF364-Did You Have a Lot of Energy The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you have a lot of energy. SF-36 v2.0 Acute - Did You Have a Lot of Energy SF364-Emotional: Accomplished Less The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. SF-36 v2.0 Acute - Emotional: Accomplished Less SF364-Emotional: Cut Down Time on Work The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - cut down on the amount of time you spent on work or other activities. SF-36 v2.0 Acute - Emotional: Cut Down Time on Work SF364-Emotional: Did Work Less Carefully The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. SF-36 v2.0 Acute - Emotional: Did Work Less Carefully SF364-Extent Phys/Emotional Interfered The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, to what extent has your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors, or groups? SF-36 v2.0 Acute - Extent Phys/Emotional Interfered SF364-Felt Down Nothing Cheer You Up The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt so down in the dumps that nothing could cheer you up. SF-36 v2.0 Acute - Felt Down Nothing Cheer You Up SF364-General Health 0-100 Score The Short Form 36 Health Survey Acute, US Version 2.0 - General health 0-100 score. SF-36 v2.0 Acute - General Health 0-100 Score SF364-General Health Norm-Based Score The Short Form 36 Health Survey Acute, US Version 2.0 - General health norm-based score. SF-36 v2.0 Acute - General Health Norm-Based Score SF364-Get Sick Little Easier Than Other The Short Form 36 Health Survey Acute, US Version 2.0 - How TRUE or FALSE is the following statement for you - I seem to get sick a little easier than other people. SF-36 v2.0 Acute - Get Sick Little Easier Than Other SF364-Have You Been Happy The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you been happy. SF-36 v2.0 Acute - Have You Been Happy SF364-Have You Been Very Nervous The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you been very nervous. SF-36 v2.0 Acute - Have You Been Very Nervous SF364-Have You Felt Calm and Peaceful The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt calm and peaceful. SF-36 v2.0 Acute - Have You Felt Calm and Peaceful SF364-How Much Bodily Pain Have You Had The Short Form 36 Health Survey Acute, US Version 2.0 - How much bodily pain have you had during the past week? SF-36 v2.0 Acute - How Much Bodily Pain Have You Had SF364-I Am as Healthy as Anybody I Know The Short Form 36 Health Survey Acute, US Version 2.0 - How TRUE or FALSE is the following statement for you - I am as healthy as anybody I know. SF-36 v2.0 Acute - I Am as Healthy as Anybody I Know SF364-I Expect My Health to Get Worse The Short Form 36 Health Survey Acute, US Version 2.0 - How TRUE or FALSE is the following statement for you - I expect my health to get worse. SF-36 v2.0 Acute - I Expect My Health to Get Worse SF364-In General You Say Your Health Is The Short Form 36 Health Survey Acute, US Version 2.0 - In general, would you say your health is. SF-36 v2.0 Acute - In General You Say Your Health Is SF364-Limit Bathing or Dressing Yourself The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - bathing or dressing yourself. SF-36 v2.0 Acute - Limit Bathing or Dressing Yourself SF364-Limit Bending/Kneeling/Stooping The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - bending, kneeling, or stooping. SF-36 v2.0 Acute - Limit Bending/Kneeling/Stooping SF364-Limit Climbing One Flight Stairs The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - climbing one flight of stairs. SF-36 v2.0 Acute - Limit Climbing One Flight Stairs SF364-Limit Climbing Several Flights The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - climbing several flights of stairs. SF-36 v2.0 Acute - Limit Climbing Several Flights SF364-Limit Lifting or Carrying The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - lifting or carrying groceries. SF-36 v2.0 Acute - Limit Lifting or Carrying SF364-Limit Moderate Activities The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. SF-36 v2.0 Acute - Limit Moderate Activities SF364-Limit Vigorous Activities The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - vigorous activities, such as running, lifting heavy objects, participating in strenuous sports. SF-36 v2.0 Acute - Limit Vigorous Activities SF364-Limit Walking More Than a Mile The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - walking more than a mile. SF-36 v2.0 Acute - Limit Walking More Than a Mile SF364-Limit Walking One Hundred Yards The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - walking one hundred yards. SF-36 v2.0 Acute - Limit Walking One Hundred Yards SF364-Limit Walking Several Hundred Yds The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - walking several hundred yards. SF-36 v2.0 Acute - Limit Walking Several Hundred Yds SF364-Mental Component Score The Short Form 36 Health Survey Acute, US Version 2.0 - Mental component score. SF-36 v2.0 Acute - Mental Component Score SF364-Mental Health 0-100 Score The Short Form 36 Health Survey Acute, US Version 2.0 - Mental health 0-100 score. SF-36 v2.0 Acute - Mental Health 0-100 Score SF364-Mental Health Enhanced Score The Short Form 36 Health Survey Acute, US Version 2.0 - Mental health enhanced score. SF-36 v2.0 Acute - Mental Health Enhanced Score SF364-Mental Health Norm-Based Score The Short Form 36 Health Survey Acute, US Version 2.0 - Mental health norm-based score. SF-36 v2.0 Acute - Mental Health Norm-Based Score SF364-My Health is Excellent The Short Form 36 Health Survey Acute, US Version 2.0 - How TRUE or FALSE is the following statement for you - my health is excellent SF-36 v2.0 Acute - My Health is Excellent SF364-Pain Interfere With Normal Work The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much did pain interfere with your normal work (including both work outside the home and housework)? SF-36 v2.0 Acute - Pain Interfere With Normal Work SF364-Phys Functioning Norm-Based Score The Short Form 36 Health Survey Acute, US Version 2.0 - Phys functioning norm-based score. SF-36 v2.0 Acute - Phys Functioning Norm-Based Score SF364-Physical Component Score The Short Form 36 Health Survey Acute, US Version 2.0 - Physical component score. SF-36 v2.0 Acute - Physical Component Score SF364-Physical Functioning 0-100 Score The Short Form 36 Health Survey Acute, US Version 2.0 - Physical functioning 0-100 score. SF-36 v2.0 Acute - Physical Functioning 0-100 Score SF364-Physical: Accomplished Less The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. SF-36 v2.0 Acute - Physical: Accomplished Less SF364-Physical: Cut Down Time on Work The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - cut down on the amount of time you spent on work or other activities. SF-36 v2.0 Acute - Physical: Cut Down Time on Work SF364-Physical: Difficulty Perform Work The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - had difficulty performing the work or other activities (for example, it took extra effort). SF-36 v2.0 Acute - Physical: Difficulty Perform Work SF364-Physical: Limited Kind of Work The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. SF-36 v2.0 Acute - Physical: Limited Kind of Work SF364-Response Consistency Score The Short Form 36 Health Survey Acute, US Version 2.0 - Response consistency score. SF-36 v2.0 Acute - Response Consistency Score SF364-Role Emotional 0-100 Score The Short Form 36 Health Survey Acute, US Version 2.0 - Role emotional 0-100 score. SF-36 v2.0 Acute - Role Emotional 0-100 Score SF364-Role Emotional Norm-Based Score The Short Form 36 Health Survey Acute, US Version 2.0 - Role emotional norm-based score. SF-36 v2.0 Acute - Role Emotional Norm-Based Score SF364-Role Physical 0-100 Score The Short Form 36 Health Survey Acute, US Version 2.0 - Role physical 0-100 score. SF-36 v2.0 Acute - Role Physical 0-100 Score SF364-Role Physical Norm-Based Score The Short Form 36 Health Survey Acute, US Version 2.0 - Role physical norm-based score. SF-36 v2.0 Acute - Role Physical Norm-Based Score SF364-SF-6D (Utility Index) Score The Short Form 36 Health Survey Acute, US Version 2.0 - 6D (utility index) score. SF-36 v2.0 Acute - SF-6D (Utility Index) Score SF364-SF-6D_R2 (Util Index Rel 2) Score The Short Form 36 Health Survey Acute, US Version 2.0 - 6D_R2 (util index rel 2) score. SF-36 v2.0 Acute - SF-6D_R2 (Util Index Rel 2) Score SF364-Social Function Norm-Based Score The Short Form 36 Health Survey Acute, US Version 2.0 - Social function norm-based score. SF-36 v2.0 Acute - Social Function Norm-Based Score SF364-Social Functioning 0-100 Score The Short Form 36 Health Survey Acute, US Version 2.0 - Social functioning 0-100 score. SF-36 v2.0 Acute - Social Functioning 0-100 Score SF364-Time Phys/Emotional Interfered The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting friends, relatives, etc.)? SF-36 v2.0 Acute - Time Phys/Emotional Interfered SF364-Utility Index Score AU Weights The Short Form 36 Health Survey Acute, US Version 2.0 - Utility index score Australia weights. SF-36 v2.0 Acute - Utility Index Score AU Weights SF364-Utility Index Score CN Weights The Short Form 36 Health Survey Acute, US Version 2.0 - Utility index score Canada weights. SF-36 v2.0 Acute - Utility Index Score CN Weights SF364-Utility Index Score UK Weights The Short Form 36 Health Survey Acute, US Version 2.0 - Utility index score United Kingdom weights. SF-36 v2.0 Acute - Utility Index Score UK Weights SF364-Utility Index Score US Weights The Short Form 36 Health Survey Acute, US Version 2.0 - Utility index score United States weights. SF-36 v2.0 Acute - Utility Index Score US Weights SF364-Vitality 0-100 Score The Short Form 36 Health Survey Acute, US Version 2.0 - Vitality 0-100 score. SF-36 v2.0 Acute - Vitality 0-100 Score SF364-Vitality Norm-Based Score The Short Form 36 Health Survey Acute, US Version 2.0 - Vitality norm-based score. SF-36 v2.0 Acute - Vitality Norm-Based Score SF364-You Felt Downhearted and Depressed The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt downhearted and depressed. SF-36 v2.0 Acute - You Felt Downhearted and Depressed SF364TN The Short Form 36 Health Survey Acute, US Version 2.0 Questionnaire Test Name CDISC Questionnaire SF36 v2.0 Acute Test Name Terminology The Short Form 36 Health Survey Standard, US Version 1.0 test code. SF361-In General You Say Your Health Is The Short Form 36 Health Survey Standard, US Version 1.0 - In general, would you say your health is. SF36 v1.0 Standard - In General You Say Your Health Is SF361-Comp Year Ago Rate Gen Health Now The Short Form 36 Health Survey Standard, US Version 1.0 - Compared to one year ago, how would you rate your health in general now? SF36 v1.0 Standard - Comp Year Ago Rate Gen Health Now SF361-Limit Vigorous Activities The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - vigorous activities, such as running, lifting heavy objects, participating in strenuous sports. SF36 v1.0 Standard - Limit Vigorous Activities SF361-Limit Moderate Activities The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. SF36 v1.0 Standard - Limit Moderate Activities SF361-Limit Lifting or Carrying The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - lifting or carrying groceries. SF36 v1.0 Standard - Limit Lifting or Carrying SF361-Limit Climbing Several Flights The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - climbing several flights of stairs. SF36 v1.0 Standard - Limit Climbing Several Flights SF361-Limit Climbing One Flight Stairs The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - climbing one flight of stairs. SF36 v1.0 Standard - Limit Climbing One Flight Stairs SF361-Limit Bending/Kneeling/Stooping The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - bending, kneeling, or stooping. SF36 v1.0 Standard - Limit Bending/Kneeling/Stooping SF361-Limit Walking More Than a Mile The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - walking more than a mile. SF36 v1.0 Standard - Limit Walking More Than a Mile SF361-Limit Walking Several Blocks The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - walking several blocks. SF36 v1.0 Standard - Limit Walking Several Blocks SF361-Limit Walking One Block The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - walking one block. SF36 v1.0 Standard - Limit Walking One Block SF361-Limit Bathing or Dressing Yourself The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - bathing or dressing yourself. SF36 v1.0 Standard - Limit Bathing or Dressing Yourself SF361-Physical: Cut Down Time on Work The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - cut down on the amount of time you spent on work or other activities. SF36 v1.0 Standard - Physical: Cut Down Time on Work SF361-Physical: Accomplished Less The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. SF36 v1.0 Standard - Physical: Accomplished Less SF361-Physical: Limited Kind of Work The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. SF36 v1.0 Standard - Physical: Limited Kind of Work SF361-Physical: Difficulty Perform Work The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - had difficulty performing the work or other activities (for example, it took extra effort). SF36 v1.0 Standard - Physical: Difficulty Perform Work SF361-Emotional: Cut Down Time on Work The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - cut down on the amount of time you spent on work or other activities. SF36 v1.0 Standard - Emotional: Cut Down Time on Work SF361-Emotional: Accomplished Less The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. SF36 v1.0 Standard - Emotional: Accomplished Less SF361-Emotional: Did Work Less Carefully The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. SF36 v1.0 Standard - Emotional: Did Work Less Carefully SF361-Extent Phys/Emotional Interfered The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, to what extent has your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors, or groups? SF36 v1.0 Standard - Extent Phys/Emotional Interfered SF361-How Much Bodily Pain Have You Had The Short Form 36 Health Survey Standard, US Version 1.0 - How much bodily pain have you had during the past 4 weeks? SF36 v1.0 Standard - How Much Bodily Pain Have You Had SF361-Pain Interfere With Normal Work The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the home and housework)? SF36 v1.0 Standard - Pain Interfere With Normal Work SF361-Did You Feel Full of Pep The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you feel full of pep. SF36 v1.0 Standard - Did You Feel Full of Pep SF361-Have You Been Very Nervous Person The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you been a very nervous person. SF36 v1.0 Standard - Have You Been Very Nervous Person SF361-Felt Down Nothing Cheer You Up The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt so down in the dumps that nothing could cheer you up. SF36 v1.0 Standard - Felt Down Nothing Cheer You Up SF361-Have You Felt Calm and Peaceful The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt calm and peaceful. SF36 v1.0 Standard - Have You Felt Calm and Peaceful SF361-Did You Have a Lot of Energy The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you have a lot of energy. SF36 v1.0 Standard - Did You Have a Lot of Energy SF361-You Felt Downhearted and Blue The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt downhearted and blue. SF36 v1.0 Standard - You Felt Downhearted and Blue SF361-Did You Feel Worn Out The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you feel worn out. SF36 v1.0 Standard - Did You Feel Worn Out SF361-Have You Been Happy Person The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you been a happy person. SF36 v1.0 Standard - Have You Been Happy Person SF361-Did You Feel Tired The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you feel tired. SF36 v1.0 Standard - Did You Feel Tired SF361-Time Phys/Emotional Interfered The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting friends, relatives, etc.)? SF36 v1.0 Standard - Time Phys/Emotional Interfered SF361-Get Sick Little Easier Than Other The Short Form 36 Health Survey Standard, US Version 1.0 - How TRUE or FALSE is the following statement for you - I seem to get sick a little easier than other people. SF36 v1.0 Standard - Get Sick Little Easier Than Other SF361-I Am as Healthy as Anybody I Know The Short Form 36 Health Survey Standard, US Version 1.0 - How TRUE or FALSE is the following statement for you - I am as healthy as anybody I know. SF36 v1.0 Standard - I Am as Healthy as Anybody I Know SF361-I Expect My Health to Get Worse The Short Form 36 Health Survey Standard, US Version 1.0 - How TRUE or FALSE is the following statement for you - I expect my health to get worse. SF36 v1.0 Standard - I Expect My Health to Get Worse SF361-My Health is Excellent The Short Form 36 Health Survey Standard, US Version 1.0 - How TRUE or FALSE is the following statement for you - my health is excellent SF36 v1.0 Standard - My Health is Excellent SF361-Physical Functioning 0-100 Score The Short Form 36 Health Survey Standard, US Version 1.0 - Physical functioning 0-100 score. SF36 v1.0 Standard - Physical Functioning 0-100 Score SF361-Role Physical 0-100 Score The Short Form 36 Health Survey Standard, US Version 1.0 - Role physical 0-100 score. SF36 v1.0 Standard - Role Physical 0-100 Score SF361-Bodily Pain 0-100 Score The Short Form 36 Health Survey Standard, US Version 1.0 - Bodily pain 0-100 score. SF36 v1.0 Standard - Bodily Pain 0-100 Score SF361-General Health 0-100 Score The Short Form 36 Health Survey Standard, US Version 1.0 - General health 0-100 score. SF36 v1.0 Standard - General Health 0-100 Score SF361-Vitality 0-100 Score The Short Form 36 Health Survey Standard, US Version 1.0 - Vitality 0-100 score. SF36 v1.0 Standard - Vitality 0-100 Score SF361-Social Functioning 0-100 Score The Short Form 36 Health Survey Standard, US Version 1.0 - Social functioning 0-100 score. SF36 v1.0 Standard - Social Functioning 0-100 Score SF361-Role Emotional 0-100 Score The Short Form 36 Health Survey Standard, US Version 1.0 - Role emotional 0-100 score. SF36 v1.0 Standard - Role Emotional 0-100 Score SF361-Mental Health 0-100 Score The Short Form 36 Health Survey Standard, US Version 1.0 - Mental health 0-100 score. SF36 v1.0 Standard - Mental Health 0-100 Score SF361-Phys Functioning Norm-Based Score The Short Form 36 Health Survey Standard, US Version 1.0 - Phys functioning norm-based score. SF36 v1.0 Standard - Phys Functioning Norm-Based Score SF361-Role Physical Norm-Based Score The Short Form 36 Health Survey Standard, US Version 1.0 - Role physical norm-based score. SF36 v1.0 Standard - Role Physical Norm-Based Score SF361-Bodily Pain Norm-Based Score The Short Form 36 Health Survey Standard, US Version 1.0 - Bodily pain norm-based score. SF36 v1.0 Standard - Bodily Pain Norm-Based Score SF361-General Health Norm-Based Score The Short Form 36 Health Survey Standard, US Version 1.0 - General health norm-based score. SF36 v1.0 Standard - General Health Norm-Based Score SF361-Vitality Norm-Based Score The Short Form 36 Health Survey Standard, US Version 1.0 - Vitality norm-based score. SF36 v1.0 Standard - Vitality Norm-Based Score SF361-Social Function Norm-Based Score The Short Form 36 Health Survey Standard, US Version 1.0 - Social function norm-based score. SF36 v1.0 Standard - Social Function Norm-Based Score SF361-Role Emotional Norm-Based Score The Short Form 36 Health Survey Standard, US Version 1.0 - Role emotional norm-based score. SF36 v1.0 Standard - Role Emotional Norm-Based Score SF361-Mental Health Norm-Based Score The Short Form 36 Health Survey Standard, US Version 1.0 - Mental health norm-based score. SF36 v1.0 Standard - Mental Health Norm-Based Score SF361-Physical Component Score The Short Form 36 Health Survey Standard, US Version 1.0 - Physical component score. SF36 v1.0 Standard - Physical Component Score SF361-Mental Component Score The Short Form 36 Health Survey Standard, US Version 1.0 - Mental component score. SF36 v1.0 Standard - Mental Component Score SF361-SF-6D (Utility Index) Score The Short Form 36 Health Survey Standard, US Version 1.0 - 6D (utility index) score. SF36 v1.0 Standard - SF-6D (Utility Index) Score SF361-SF-6D_R2 (Util Index Rel 2) Score The Short Form 36 Health Survey Standard, US Version 1.0 - 6D_R2 (util index rel 2) score. SF36 v1.0 Standard - SF-6D_R2 (Util Index Rel 2) Score SF361-Response Consistency Score The Short Form 36 Health Survey Standard, US Version 1.0 - Response consistency score. SF36 v1.0 Standard - Response Consistency Score SF361TC The Short Form 36 Health Survey Standard, US Version 1.0 Questionnaire Test Code CDISC Questionnaire SF36 v1.0 Standard Test Code Terminology The Short Form 36 Health Survey Standard, US Version 1.0 test name. SF361-Bodily Pain 0-100 Score The Short Form 36 Health Survey Standard, US Version 1.0 - Bodily pain 0-100 score. SF36 v1.0 Standard - Bodily Pain 0-100 Score SF361-Bodily Pain Norm-Based Score The Short Form 36 Health Survey Standard, US Version 1.0 - Bodily pain norm-based score. SF36 v1.0 Standard - Bodily Pain Norm-Based Score SF361-Comp Year Ago Rate Gen Health Now The Short Form 36 Health Survey Standard, US Version 1.0 - Compared to one year ago, how would you rate your health in general now? SF36 v1.0 Standard - Comp Year Ago Rate Gen Health Now SF361-Did You Feel Full of Pep The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you feel full of pep. SF36 v1.0 Standard - Did You Feel Full of Pep SF361-Did You Feel Tired The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you feel tired. SF36 v1.0 Standard - Did You Feel Tired SF361-Did You Feel Worn Out The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you feel worn out. SF36 v1.0 Standard - Did You Feel Worn Out SF361-Did You Have a Lot of Energy The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you have a lot of energy. SF36 v1.0 Standard - Did You Have a Lot of Energy SF361-Emotional: Accomplished Less The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. SF36 v1.0 Standard - Emotional: Accomplished Less SF361-Emotional: Cut Down Time on Work The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - cut down on the amount of time you spent on work or other activities. SF36 v1.0 Standard - Emotional: Cut Down Time on Work SF361-Emotional: Did Work Less Carefully The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. SF36 v1.0 Standard - Emotional: Did Work Less Carefully SF361-Extent Phys/Emotional Interfered The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, to what extent has your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors, or groups? SF36 v1.0 Standard - Extent Phys/Emotional Interfered SF361-Felt Down Nothing Cheer You Up The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt so down in the dumps that nothing could cheer you up. SF36 v1.0 Standard - Felt Down Nothing Cheer You Up SF361-General Health 0-100 Score The Short Form 36 Health Survey Standard, US Version 1.0 - General health 0-100 score. SF36 v1.0 Standard - General Health 0-100 Score SF361-General Health Norm-Based Score The Short Form 36 Health Survey Standard, US Version 1.0 - General health norm-based score. SF36 v1.0 Standard - General Health Norm-Based Score SF361-Get Sick Little Easier Than Other The Short Form 36 Health Survey Standard, US Version 1.0 - How TRUE or FALSE is the following statement for you - I seem to get sick a little easier than other people. SF36 v1.0 Standard - Get Sick Little Easier Than Other SF361-Have You Been Happy Person The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you been a happy person. SF36 v1.0 Standard - Have You Been Happy Person SF361-Have You Been Very Nervous Person The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you been a very nervous person. SF36 v1.0 Standard - Have You Been Very Nervous Person SF361-Have You Felt Calm and Peaceful The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt calm and peaceful. SF36 v1.0 Standard - Have You Felt Calm and Peaceful SF361-How Much Bodily Pain Have You Had The Short Form 36 Health Survey Standard, US Version 1.0 - How much bodily pain have you had during the past 4 weeks? SF36 v1.0 Standard - How Much Bodily Pain Have You Had SF361-I Am as Healthy as Anybody I Know The Short Form 36 Health Survey Standard, US Version 1.0 - How TRUE or FALSE is the following statement for you - I am as healthy as anybody I know. SF36 v1.0 Standard - I Am as Healthy as Anybody I Know SF361-I Expect My Health to Get Worse The Short Form 36 Health Survey Standard, US Version 1.0 - How TRUE or FALSE is the following statement for you - I expect my health to get worse. SF36 v1.0 Standard - I Expect My Health to Get Worse SF361-In General You Say Your Health Is The Short Form 36 Health Survey Standard, US Version 1.0 - In general, would you say your health is. SF36 v1.0 Standard - In General You Say Your Health Is SF361-Limit Bathing or Dressing Yourself The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - bathing or dressing yourself. SF36 v1.0 Standard - Limit Bathing or Dressing Yourself SF361-Limit Bending/Kneeling/Stooping The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - bending, kneeling, or stooping. SF36 v1.0 Standard - Limit Bending/Kneeling/Stooping SF361-Limit Climbing One Flight Stairs The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - climbing one flight of stairs. SF36 v1.0 Standard - Limit Climbing One Flight Stairs SF361-Limit Climbing Several Flights The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - climbing several flights of stairs. SF36 v1.0 Standard - Limit Climbing Several Flights SF361-Limit Lifting or Carrying The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - lifting or carrying groceries. SF36 v1.0 Standard - Limit Lifting or Carrying SF361-Limit Moderate Activities The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. SF36 v1.0 Standard - Limit Moderate Activities SF361-Limit Vigorous Activities The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - vigorous activities, such as running, lifting heavy objects, participating in strenuous sports. SF36 v1.0 Standard - Limit Vigorous Activities SF361-Limit Walking More Than a Mile The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - walking more than a mile. SF36 v1.0 Standard - Limit Walking More Than a Mile SF361-Limit Walking One Block The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - walking one block. SF36 v1.0 Standard - Limit Walking One Block SF361-Limit Walking Several Blocks The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - walking several blocks. SF36 v1.0 Standard - Limit Walking Several Blocks SF361-Mental Component Score The Short Form 36 Health Survey Standard, US Version 1.0 - Mental component score. SF36 v1.0 Standard - Mental Component Score SF361-Mental Health 0-100 Score The Short Form 36 Health Survey Standard, US Version 1.0 - Mental health 0-100 score. SF36 v1.0 Standard - Mental Health 0-100 Score SF361-Mental Health Norm-Based Score The Short Form 36 Health Survey Standard, US Version 1.0 - Mental health norm-based score. SF36 v1.0 Standard - Mental Health Norm-Based Score SF361-My Health is Excellent The Short Form 36 Health Survey Standard, US Version 1.0 - How TRUE or FALSE is the following statement for you - my health is excellent SF36 v1.0 Standard - My Health is Excellent SF361-Pain Interfere With Normal Work The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the home and housework)? SF36 v1.0 Standard - Pain Interfere With Normal Work SF361-Phys Functioning Norm-Based Score The Short Form 36 Health Survey Standard, US Version 1.0 - Phys functioning norm-based score. SF36 v1.0 Standard - Phys Functioning Norm-Based Score SF361-Physical Component Score The Short Form 36 Health Survey Standard, US Version 1.0 - Physical component score. SF36 v1.0 Standard - Physical Component Score SF361-Physical Functioning 0-100 Score The Short Form 36 Health Survey Standard, US Version 1.0 - Physical functioning 0-100 score. SF36 v1.0 Standard - Physical Functioning 0-100 Score SF361-Physical: Accomplished Less The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. SF36 v1.0 Standard - Physical: Accomplished Less SF361-Physical: Cut Down Time on Work The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - cut down on the amount of time you spent on work or other activities. SF36 v1.0 Standard - Physical: Cut Down Time on Work SF361-Physical: Difficulty Perform Work The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - had difficulty performing the work or other activities (for example, it took extra effort). SF36 v1.0 Standard - Physical: Difficulty Perform Work SF361-Physical: Limited Kind of Work The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. SF36 v1.0 Standard - Physical: Limited Kind of Work SF361-Response Consistency Score The Short Form 36 Health Survey Standard, US Version 1.0 - Response consistency score. SF36 v1.0 Standard - Response Consistency Score SF361-Role Emotional 0-100 Score The Short Form 36 Health Survey Standard, US Version 1.0 - Role emotional 0-100 score. SF36 v1.0 Standard - Role Emotional 0-100 Score SF361-Role Emotional Norm-Based Score The Short Form 36 Health Survey Standard, US Version 1.0 - Role emotional norm-based score. SF36 v1.0 Standard - Role Emotional Norm-Based Score SF361-Role Physical 0-100 Score The Short Form 36 Health Survey Standard, US Version 1.0 - Role physical 0-100 score. SF36 v1.0 Standard - Role Physical 0-100 Score SF361-Role Physical Norm-Based Score The Short Form 36 Health Survey Standard, US Version 1.0 - Role physical norm-based score. SF36 v1.0 Standard - Role Physical Norm-Based Score SF361-SF-6D (Utility Index) Score The Short Form 36 Health Survey Standard, US Version 1.0 - 6D (utility index) score. SF36 v1.0 Standard - SF-6D (Utility Index) Score SF361-SF-6D_R2 (Util Index Rel 2) Score The Short Form 36 Health Survey Standard, US Version 1.0 - 6D_R2 (util index rel 2) score. SF36 v1.0 Standard - SF-6D_R2 (Util Index Rel 2) Score SF361-Social Function Norm-Based Score The Short Form 36 Health Survey Standard, US Version 1.0 - Social function norm-based score. SF36 v1.0 Standard - Social Function Norm-Based Score SF361-Social Functioning 0-100 Score The Short Form 36 Health Survey Standard, US Version 1.0 - Social functioning 0-100 score. SF36 v1.0 Standard - Social Functioning 0-100 Score SF361-Time Phys/Emotional Interfered The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting friends, relatives, etc.)? SF36 v1.0 Standard - Time Phys/Emotional Interfered SF361-Vitality 0-100 Score The Short Form 36 Health Survey Standard, US Version 1.0 - Vitality 0-100 score. SF36 v1.0 Standard - Vitality 0-100 Score SF361-Vitality Norm-Based Score The Short Form 36 Health Survey Standard, US Version 1.0 - Vitality norm-based score. SF36 v1.0 Standard - Vitality Norm-Based Score SF361-You Felt Downhearted and Blue The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt downhearted and blue. SF36 v1.0 Standard - You Felt Downhearted and Blue SF361TN The Short Form 36 Health Survey Standard, US Version 1.0 Questionnaire Test Name CDISC Questionnaire SF36 v1.0 Standard Test Name Terminology The Short Form 36 Health Survey Standard, US Version 2.0 test code. SF363-In General You Say Your Health Is The Short Form 36 Health Survey Standard, US Version 2.0 - In general, would you say your health is. SF-36 v2.0 Standard - In General You Say Your Health Is SF363-Comp Year Ago Rate Gen Health Now The Short Form 36 Health Survey Standard, US Version 2.0 - Compared to one year ago, how would you rate your health in general now? SF-36 v2.0 Standard - Comp Year Ago Rate Gen Health Now SF363-Limit Vigorous Activities The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - vigorous activities, such as running, lifting heavy objects, participating in strenuous sports. SF-36 v2.0 Standard - Limit Vigorous Activities SF363-Limit Moderate Activities The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. SF-36 v2.0 Standard - Limit Moderate Activities SF363-Limit Lifting or Carrying The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - lifting or carrying groceries. SF-36 v2.0 Standard - Limit Lifting or Carrying SF363-Limit Climbing Several Flights The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - climbing several flights of stairs. SF-36 v2.0 Standard - Limit Climbing Several Flights SF363-Limit Climbing One Flight Stairs The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - climbing one flight of stairs. SF-36 v2.0 Standard - Limit Climbing One Flight Stairs SF363-Limit Bending/Kneeling/Stooping The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - bending, kneeling, or stooping. SF-36 v2.0 Standard - Limit Bending/Kneeling/Stooping SF363-Limit Walking More Than a Mile The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - walking more than a mile. SF-36 v2.0 Standard - Limit Walking More Than a Mile SF363-Limit Walking Several Hundred Yds The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - walking several hundred yards. SF-36 v2.0 Standard - Limit Walking Several Hundred Yds SF363-Limit Walking One Hundred Yards The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - walking one hundred yards. SF-36 v2.0 Standard - Limit Walking One Hundred Yards SF363-Limit Bathing or Dressing Yourself The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - bathing or dressing yourself. SF-36 v2.0 Standard - Limit Bathing or Dressing Yourself SF363-Physical: Cut Down Time on Work The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - cut down on the amount of time you spent on work or other activities. SF-36 v2.0 Standard - Physical: Cut Down Time on Work SF363-Physical: Accomplished Less The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. SF-36 v2.0 Standard - Physical: Accomplished Less SF363-Physical: Limited Kind of Work The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. SF-36 v2.0 Standard - Physical: Limited Kind of Work SF363-Physical: Difficulty Perform Work The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - had difficulty performing the work or other activities (for example, it took extra effort). SF-36 v2.0 Standard - Physical: Difficulty Perform Work SF363-Emotional: Cut Down Time on Work The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - cut down on the amount of time you spent on work or other activities. SF-36 v2.0 Standard - Emotional: Cut Down Time on Work SF363-Emotional: Accomplished Less The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. SF-36 v2.0 Standard - Emotional: Accomplished Less SF363-Emotional: Did Work Less Carefully The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. SF-36 v2.0 Standard - Emotional: Did Work Less Carefully SF363-Extent Phys/Emotional Interfered The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, to what extent has your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors, or groups? SF-36 v2.0 Standard - Extent Phys/Emotional Interfered SF363-How Much Bodily Pain Have You Had The Short Form 36 Health Survey Standard, US Version 2.0 - How much bodily pain have you had during the past 4 weeks? SF-36 v2.0 Standard - How Much Bodily Pain Have You Had SF363-Pain Interfere With Normal Work The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the home and housework)? SF-36 v2.0 Standard - Pain Interfere With Normal Work SF363-Did You Feel Full of Life The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you feel full of life. SF-36 v2.0 Standard - Did You Feel Full of Life SF363-Have You Been Very Nervous The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you been very nervous. SF-36 v2.0 Standard - Have You Been Very Nervous SF363-Felt Down Nothing Cheer You Up The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt so down in the dumps that nothing could cheer you up. SF-36 v2.0 Standard - Felt Down Nothing Cheer You Up SF363-Have You Felt Calm and Peaceful The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt calm and peaceful. SF-36 v2.0 Standard - Have You Felt Calm and Peaceful SF363-Did You Have a Lot of Energy The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you have a lot of energy. SF-36 v2.0 Standard - Did You Have a Lot of Energy SF363-You Felt Downhearted and Depressed The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt downhearted and depressed. SF-36 v2.0 Standard - You Felt Downhearted and Depressed SF363-Did You Feel Worn Out The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you feel worn out. SF-36 v2.0 Standard - Did You Feel Worn Out SF363-Have You Been Happy The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you been happy. SF-36 v2.0 Standard - Have You Been Happy SF363-Did You Feel Tired The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you feel tired. SF-36 v2.0 Standard - Did You Feel Tired SF363-Time Phys/Emotional Interfered The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting friends, relatives, etc.)? SF-36 v2.0 Standard - Time Phys/Emotional Interfered SF363-Get Sick Little Easier Than Other The Short Form 36 Health Survey Standard, US Version 2.0 - How TRUE or FALSE is the following statement for you - I seem to get sick a little easier than other people. SF-36 v2.0 Standard - Get Sick Little Easier Than Other SF363-I Am as Healthy as Anybody I Know The Short Form 36 Health Survey Standard, US Version 2.0 - How TRUE or FALSE is the following statement for you - I am as healthy as anybody I know. SF-36 v2.0 Standard - I Am as Healthy as Anybody I Know SF363-I Expect My Health to Get Worse The Short Form 36 Health Survey Standard, US Version 2.0 - How TRUE or FALSE is the following statement for you - I expect my health to get worse. SF-36 v2.0 Standard - I Expect My Health to Get Worse SF363-My Health is Excellent The Short Form 36 Health Survey Standard, US Version 2.0 - How TRUE or FALSE is the following statement for you - my health is excellent SF-36 v2.0 Standard - My Health is Excellent SF363-Physical Functioning 0-100 Score The Short Form 36 Health Survey Standard, US Version 2.0 - Physical functioning 0-100 score. SF-36 v2.0 Standard - Physical Functioning 0-100 Score SF363-Role Physical 0-100 Score The Short Form 36 Health Survey Standard, US Version 2.0 - Role physical 0-100 score. SF-36 v2.0 Standard - Role Physical 0-100 Score SF363-Bodily Pain 0-100 Score The Short Form 36 Health Survey Standard, US Version 2.0 - Bodily pain 0-100 score. SF-36 v2.0 Standard - Bodily Pain 0-100 Score SF363-General Health 0-100 Score The Short Form 36 Health Survey Standard, US Version 2.0 - General health 0-100 score. SF-36 v2.0 Standard - General Health 0-100 Score SF363-Vitality 0-100 Score The Short Form 36 Health Survey Standard, US Version 2.0 - Vitality 0-100 score. SF-36 v2.0 Standard - Vitality 0-100 Score SF363-Social Functioning 0-100 Score The Short Form 36 Health Survey Standard, US Version 2.0 - Social functioning 0-100 score. SF-36 v2.0 Standard - Social Functioning 0-100 Score SF363-Role Emotional 0-100 Score The Short Form 36 Health Survey Standard, US Version 2.0 - Role emotional 0-100 score. SF-36 v2.0 Standard - Role Emotional 0-100 Score SF363-Mental Health 0-100 Score The Short Form 36 Health Survey Standard, US Version 2.0 - Mental health 0-100 score. SF-36 v2.0 Standard - Mental Health 0-100 Score SF363-Phys Functioning Norm-Based Score The Short Form 36 Health Survey Standard, US Version 2.0 - Phys functioning norm-based score. SF-36 v2.0 Standard - Phys Functioning Norm-Based Score SF363-Role Physical Norm-Based Score The Short Form 36 Health Survey Standard, US Version 2.0 - Role physical norm-based score. SF-36 v2.0 Standard - Role Physical Norm-Based Score SF363-Bodily Pain Norm-Based Score The Short Form 36 Health Survey Standard, US Version 2.0 - Bodily pain norm-based score. SF-36 v2.0 Standard - Bodily Pain Norm-Based Score SF363-General Health Norm-Based Score The Short Form 36 Health Survey Standard, US Version 2.0 - General health norm-based score. SF-36 v2.0 Standard - General Health Norm-Based Score SF363-Vitality Norm-Based Score The Short Form 36 Health Survey Standard, US Version 2.0 - Vitality norm-based score. SF-36 v2.0 Standard - Vitality Norm-Based Score SF363-Social Function Norm-Based Score The Short Form 36 Health Survey Standard, US Version 2.0 - Social function norm-based score. SF-36 v2.0 Standard - Social Function Norm-Based Score SF363-Role Emotional Norm-Based Score The Short Form 36 Health Survey Standard, US Version 2.0 - Role emotional norm-based score. SF-36 v2.0 Standard - Role Emotional Norm-Based Score SF363-Mental Health Norm-Based Score The Short Form 36 Health Survey Standard, US Version 2.0 - Mental health norm-based score. SF-36 v2.0 Standard - Mental Health Norm-Based Score SF363-Physical Component Score The Short Form 36 Health Survey Standard, US Version 2.0 - Physical component score. SF-36 v2.0 Standard - Physical Component Score SF363-Mental Component Score The Short Form 36 Health Survey Standard, US Version 2.0 - Mental component score. SF-36 v2.0 Standard - Mental Component Score SF363-SF-6D (Utility Index) Score The Short Form 36 Health Survey Standard, US Version 2.0 - 6D (utility index) score. SF-36 v2.0 Standard - SF-6D (Utility Index) Score SF363-SF-6D_R2 (Util Index Rel 2) Score The Short Form 36 Health Survey Standard, US Version 2.0 - 6D_R2 (util index rel 2) score. SF-36 v2.0 Standard - SF-6D_R2 (Util Index Rel 2) Score SF363-Mental Health Enhanced Score The Short Form 36 Health Survey Standard, US Version 2.0 - Mental health enhanced score. SF-36 v2.0 Standard - Mental Health Enhanced Score SF363-Response Consistency Score The Short Form 36 Health Survey Standard, US Version 2.0 - Response consistency score. SF-36 v2.0 Standard - Response Consistency Score SF363-Utility Index Score UK Weights The Short Form 36 Health Survey Standard, US Version 2.0 - Utility index score United Kingdom weights. SF-36 v2.0 Standard - Utility Index Score UK Weights SF363-Utility Index Score CN Weights The Short Form 36 Health Survey Standard, US Version 2.0 - Utility index score Canada weights. SF-36 v2.0 Standard - Utility Index Score CN Weights SF363-Utility Index Score AU Weights The Short Form 36 Health Survey Standard, US Version 2.0 - Utility index score Australia weights. SF-36 v2.0 Standard - Utility Index Score AU Weights SF363-Utility Index Score US Weights The Short Form 36 Health Survey Standard, US Version 2.0 - Utility index score United States weights. SF-36 v2.0 Standard - Utility Index Score US Weights SF363TC The Short Form 36 Health Survey Standard, US Version 2.0 Questionnaire Test Code CDISC Questionnaire SF36 v2.0 Standard Test Code Terminology The Short Form 36 Health Survey Standard, US Version 2.0 test name. SF363-Bodily Pain 0-100 Score The Short Form 36 Health Survey Standard, US Version 2.0 - Bodily pain 0-100 score. SF-36 v2.0 Standard - Bodily Pain 0-100 Score SF363-Bodily Pain Norm-Based Score The Short Form 36 Health Survey Standard, US Version 2.0 - Bodily pain norm-based score. SF-36 v2.0 Standard - Bodily Pain Norm-Based Score SF363-Comp Year Ago Rate Gen Health Now The Short Form 36 Health Survey Standard, US Version 2.0 - Compared to one year ago, how would you rate your health in general now? SF-36 v2.0 Standard - Comp Year Ago Rate Gen Health Now SF363-Did You Feel Full of Life The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you feel full of life. SF-36 v2.0 Standard - Did You Feel Full of Life SF363-Did You Feel Tired The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you feel tired. SF-36 v2.0 Standard - Did You Feel Tired SF363-Did You Feel Worn Out The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you feel worn out. SF-36 v2.0 Standard - Did You Feel Worn Out SF363-Did You Have a Lot of Energy The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you have a lot of energy. SF-36 v2.0 Standard - Did You Have a Lot of Energy SF363-Emotional: Accomplished Less The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. SF-36 v2.0 Standard - Emotional: Accomplished Less SF363-Emotional: Cut Down Time on Work The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - cut down on the amount of time you spent on work or other activities. SF-36 v2.0 Standard - Emotional: Cut Down Time on Work SF363-Emotional: Did Work Less Carefully The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. SF-36 v2.0 Standard - Emotional: Did Work Less Carefully SF363-Extent Phys/Emotional Interfered The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, to what extent has your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors, or groups? SF-36 v2.0 Standard - Extent Phys/Emotional Interfered SF363-Felt Down Nothing Cheer You Up The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt so down in the dumps that nothing could cheer you up. SF-36 v2.0 Standard - Felt Down Nothing Cheer You Up SF363-General Health 0-100 Score The Short Form 36 Health Survey Standard, US Version 2.0 - General health 0-100 score. SF-36 v2.0 Standard - General Health 0-100 Score SF363-General Health Norm-Based Score The Short Form 36 Health Survey Standard, US Version 2.0 - General health norm-based score. SF-36 v2.0 Standard - General Health Norm-Based Score SF363-Get Sick Little Easier Than Other The Short Form 36 Health Survey Standard, US Version 2.0 - How TRUE or FALSE is the following statement for you - I seem to get sick a little easier than other people. SF-36 v2.0 Standard - Get Sick Little Easier Than Other SF363-Have You Been Happy The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you been happy. SF-36 v2.0 Standard - Have You Been Happy SF363-Have You Been Very Nervous The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you been very nervous. SF-36 v2.0 Standard - Have You Been Very Nervous SF363-Have You Felt Calm and Peaceful The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt calm and peaceful. SF-36 v2.0 Standard - Have You Felt Calm and Peaceful SF363-How Much Bodily Pain Have You Had The Short Form 36 Health Survey Standard, US Version 2.0 - How much bodily pain have you had during the past 4 weeks? SF-36 v2.0 Standard - How Much Bodily Pain Have You Had SF363-I Am as Healthy as Anybody I Know The Short Form 36 Health Survey Standard, US Version 2.0 - How TRUE or FALSE is the following statement for you - I am as healthy as anybody I know. SF-36 v2.0 Standard - I Am as Healthy as Anybody I Know SF363-I Expect My Health to Get Worse The Short Form 36 Health Survey Standard, US Version 2.0 - How TRUE or FALSE is the following statement for you - I expect my health to get worse. SF-36 v2.0 Standard - I Expect My Health to Get Worse SF363-In General You Say Your Health Is The Short Form 36 Health Survey Standard, US Version 2.0 - In general, would you say your health is. SF-36 v2.0 Standard - In General You Say Your Health Is SF363-Limit Bathing or Dressing Yourself The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - bathing or dressing yourself. SF-36 v2.0 Standard - Limit Bathing or Dressing Yourself SF363-Limit Bending/Kneeling/Stooping The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - bending, kneeling, or stooping. SF-36 v2.0 Standard - Limit Bending/Kneeling/Stooping SF363-Limit Climbing One Flight Stairs The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - climbing one flight of stairs. SF-36 v2.0 Standard - Limit Climbing One Flight Stairs SF363-Limit Climbing Several Flights The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - climbing several flights of stairs. SF-36 v2.0 Standard - Limit Climbing Several Flights SF363-Limit Lifting or Carrying The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - lifting or carrying groceries. SF-36 v2.0 Standard - Limit Lifting or Carrying SF363-Limit Moderate Activities The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. SF-36 v2.0 Standard - Limit Moderate Activities SF363-Limit Vigorous Activities The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - vigorous activities, such as running, lifting heavy objects, participating in strenuous sports. SF-36 v2.0 Standard - Limit Vigorous Activities SF363-Limit Walking More Than a Mile The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - walking more than a mile. SF-36 v2.0 Standard - Limit Walking More Than a Mile SF363-Limit Walking One Hundred Yards The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - walking one hundred yards. SF-36 v2.0 Standard - Limit Walking One Hundred Yards SF363-Limit Walking Several Hundred Yds The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - walking several hundred yards. SF-36 v2.0 Standard - Limit Walking Several Hundred Yds SF363-Mental Component Score The Short Form 36 Health Survey Standard, US Version 2.0 - Mental component score. SF-36 v2.0 Standard - Mental Component Score SF363-Mental Health 0-100 Score The Short Form 36 Health Survey Standard, US Version 2.0 - Mental health 0-100 score. SF-36 v2.0 Standard - Mental Health 0-100 Score SF363-Mental Health Enhanced Score The Short Form 36 Health Survey Standard, US Version 2.0 - Mental health enhanced score. SF-36 v2.0 Standard - Mental Health Enhanced Score SF363-Mental Health Norm-Based Score The Short Form 36 Health Survey Standard, US Version 2.0 - Mental health norm-based score. SF-36 v2.0 Standard - Mental Health Norm-Based Score SF363-My Health is Excellent The Short Form 36 Health Survey Standard, US Version 2.0 - How TRUE or FALSE is the following statement for you - my health is excellent SF-36 v2.0 Standard - My Health is Excellent SF363-Pain Interfere With Normal Work The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the home and housework)? SF-36 v2.0 Standard - Pain Interfere With Normal Work SF363-Phys Functioning Norm-Based Score The Short Form 36 Health Survey Standard, US Version 2.0 - Phys functioning norm-based score. SF-36 v2.0 Standard - Phys Functioning Norm-Based Score SF363-Physical Component Score The Short Form 36 Health Survey Standard, US Version 2.0 - Physical component score. SF-36 v2.0 Standard - Physical Component Score SF363-Physical Functioning 0-100 Score The Short Form 36 Health Survey Standard, US Version 2.0 - Physical functioning 0-100 score. SF-36 v2.0 Standard - Physical Functioning 0-100 Score SF363-Physical: Accomplished Less The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. SF-36 v2.0 Standard - Physical: Accomplished Less SF363-Physical: Cut Down Time on Work The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - cut down on the amount of time you spent on work or other activities. SF-36 v2.0 Standard - Physical: Cut Down Time on Work SF363-Physical: Difficulty Perform Work The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - had difficulty performing the work or other activities (for example, it took extra effort). SF-36 v2.0 Standard - Physical: Difficulty Perform Work SF363-Physical: Limited Kind of Work The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. SF-36 v2.0 Standard - Physical: Limited Kind of Work SF363-Response Consistency Score The Short Form 36 Health Survey Standard, US Version 2.0 - Response consistency score. SF-36 v2.0 Standard - Response Consistency Score SF363-Role Emotional 0-100 Score The Short Form 36 Health Survey Standard, US Version 2.0 - Role emotional 0-100 score. SF-36 v2.0 Standard - Role Emotional 0-100 Score SF363-Role Emotional Norm-Based Score The Short Form 36 Health Survey Standard, US Version 2.0 - Role emotional norm-based score. SF-36 v2.0 Standard - Role Emotional Norm-Based Score SF363-Role Physical 0-100 Score The Short Form 36 Health Survey Standard, US Version 2.0 - Role physical 0-100 score. SF-36 v2.0 Standard - Role Physical 0-100 Score SF363-Role Physical Norm-Based Score The Short Form 36 Health Survey Standard, US Version 2.0 - Role physical norm-based score. SF-36 v2.0 Standard - Role Physical Norm-Based Score SF363-SF-6D (Utility Index) Score The Short Form 36 Health Survey Standard, US Version 2.0 - 6D (utility index) score. SF-36 v2.0 Standard - SF-6D (Utility Index) Score SF363-SF-6D_R2 (Util Index Rel 2) Score The Short Form 36 Health Survey Standard, US Version 2.0 - 6D_R2 (util index rel 2) score. SF-36 v2.0 Standard - SF-6D_R2 (Util Index Rel 2) Score SF363-Social Function Norm-Based Score The Short Form 36 Health Survey Standard, US Version 2.0 - Social function norm-based score. SF-36 v2.0 Standard - Social Function Norm-Based Score SF363-Social Functioning 0-100 Score The Short Form 36 Health Survey Standard, US Version 2.0 - Social functioning 0-100 score. SF-36 v2.0 Standard - Social Functioning 0-100 Score SF363-Time Phys/Emotional Interfered The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting friends, relatives, etc.)? SF-36 v2.0 Standard - Time Phys/Emotional Interfered SF363-Utility Index Score AU Weights The Short Form 36 Health Survey Standard, US Version 2.0 - Utility index score Australia weights. SF-36 v2.0 Standard - Utility Index Score AU Weights SF363-Utility Index Score CN Weights The Short Form 36 Health Survey Standard, US Version 2.0 - Utility index score Canada weights. SF-36 v2.0 Standard - Utility Index Score CN Weights SF363-Utility Index Score UK Weights The Short Form 36 Health Survey Standard, US Version 2.0 - Utility index score United Kingdom weights. SF-36 v2.0 Standard - Utility Index Score UK Weights SF363-Utility Index Score US Weights The Short Form 36 Health Survey Standard, US Version 2.0 - Utility index score United States weights. SF-36 v2.0 Standard - Utility Index Score US Weights SF363-Vitality 0-100 Score The Short Form 36 Health Survey Standard, US Version 2.0 - Vitality 0-100 score. SF-36 v2.0 Standard - Vitality 0-100 Score SF363-Vitality Norm-Based Score The Short Form 36 Health Survey Standard, US Version 2.0 - Vitality norm-based score. SF-36 v2.0 Standard - Vitality Norm-Based Score SF363-You Felt Downhearted and Depressed The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt downhearted and depressed. SF-36 v2.0 Standard - You Felt Downhearted and Depressed SF363TN The Short Form 36 Health Survey Standard, US Version 2.0 Questionnaire Test Name CDISC Questionnaire SF36 v2.0 Standard Test Name Terminology The Work Productivity and Activity Impairment - General Health Version 2.0 test code. WPAI02-Currently Employed Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - Are you currently employed (working for pay)? WPAI-GH Version 2 - Currently Employed WPAI02-Hours Miss Work Health Problems Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - During the past seven days, how many hours did you miss from work because of your health problems? WPAI-GH Version 2 - Hours Miss Work Health Problems WPAI02-Hours Miss Work Other Reason Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - During the past seven days, how many hours did you miss from work because of any other reason, such as vacation, holidays, time off to participate in this study? WPAI-GH Version 2 - Hours Miss Work Other Reason WPAI02-Hours Actually Work Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - During the past seven days, how many hours did you actually work? WPAI-GH Version 2 - Hours Actually Work WPAI02-Problems Affect Productivity Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - During the past seven days, how much did your health problems affect your productivity while you were working? WPAI-GH Version 2 - Problems Affect Productivity WPAI02-Problems Affect Daily Activities Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - During the past seven days, how much did your health problems affect your ability to do your regular daily activities, other than work at a job? WPAI-GH Version 2 - Problems Affect Daily Activities WPAI02-Absenteeism Score Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - Absenteeism score. WPAI-GH Version 2 - Absenteeism Score WPAI02-Presenteeism Score Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - Presenteeism score. WPAI-GH Version 2 - Presenteeism Score WPAI02-Work Productivity Loss Score Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - Work productivity loss score. WPAI-GH Version 2 - Work Productivity Loss Score WPAI02-Activity Impairment Score Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - Activity impairment score. WPAI-GH Version 2 - Activity Impairment Score WPAI02TC The Work Productivity and Activity Impairment - General Health Version 2.0 Questionnaire Test Code CDISC Questionnaire WPAI-GH Version 2 Test Code Terminology The Work Productivity and Activity Impairment - General Health Version 2.0 test name. WPAI02-Absenteeism Score Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - Absenteeism score. WPAI-GH Version 2 - Absenteeism Score WPAI02-Activity Impairment Score Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - Activity impairment score. WPAI-GH Version 2 - Activity Impairment Score WPAI02-Currently Employed Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - Are you currently employed (working for pay)? WPAI-GH Version 2 - Currently Employed WPAI02-Hours Actually Work Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - During the past seven days, how many hours did you actually work? WPAI-GH Version 2 - Hours Actually Work WPAI02-Hours Miss Work Health Problems Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - During the past seven days, how many hours did you miss from work because of your health problems? WPAI-GH Version 2 - Hours Miss Work Health Problems WPAI02-Hours Miss Work Other Reason Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - During the past seven days, how many hours did you miss from work because of any other reason, such as vacation, holidays, time off to participate in this study? WPAI-GH Version 2 - Hours Miss Work Other Reason WPAI02-Presenteeism Score Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - Presenteeism score. WPAI-GH Version 2 - Presenteeism Score WPAI02-Problems Affect Daily Activities Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - During the past seven days, how much did your health problems affect your ability to do your regular daily activities, other than work at a job? WPAI-GH Version 2 - Problems Affect Daily Activities WPAI02-Problems Affect Productivity Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - During the past seven days, how much did your health problems affect your productivity while you were working? WPAI-GH Version 2 - Problems Affect Productivity WPAI02-Work Productivity Loss Score Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - Work productivity loss score. WPAI-GH Version 2 - Work Productivity Loss Score WPAI02TN The Work Productivity and Activity Impairment - General Health Version 2.0 Questionnaire Test Name CDISC Questionnaire WPAI-GH Version 2 Test Name Terminology Timed 25-Foot Walk Test test code. T25FW1-Time to Complete 25-Foot Walk Timed 25-Foot Walk - Time in seconds to complete 25-foot walk. T25FW - Time to Complete 25-Foot Walk T25FW1-More Than Two Attempts Timed 25-Foot Walk - Did it take more than two attempts to get two successful trials? T25FW - More Than Two Attempts T25FW1-Did Patient Wear AFO Timed 25-Foot Walk - Did patient wear an AFO? T25FW - Did Patient Wear AFO T25FW1-Was Assistive Device Used Timed 25-Foot Walk - Was assistive device used? T25FW - Was Assistive Device Used T25FW1TC Timed 25-Foot Walk Test Functional Test Test Code CDISC Functional Test T25FW Test Code Terminology Timed 25-Foot Walk Test test name. T25FW1-Did Patient Wear AFO Timed 25-Foot Walk - Did patient wear an AFO? T25FW - Did Patient Wear AFO T25FW1-More Than Two Attempts Timed 25-Foot Walk - Did it take more than two attempts to get two successful trials? T25FW - More Than Two Attempts T25FW1-Time to Complete 25-Foot Walk Timed 25-Foot Walk - Time in seconds to complete 25-foot walk. T25FW - Time to Complete 25-Foot Walk T25FW1-Was Assistive Device Used Timed 25-Foot Walk - Was assistive device used? T25FW - Was Assistive Device Used T25FW1TN Timed 25-Foot Walk Test Functional Test Test Name CDISC Functional Test T25FW Test Name Terminology Timed Up and Go Test test code. TUG01-Time to Complete TUG Test Timed Up and Go - Time in seconds to complete TUG test. TUG - Time to Complete TUG Test TUG01TC Timed Up and Go Test Functional Test Test Code CDISC Functional Test TUG Test Code Terminology Timed Up and Go Test test name. TUG01-Time to Complete TUG Test Timed Up and Go - Time in seconds to complete TUG test. TUG - Time to Complete TUG Test TUG01TN Timed Up and Go Test Functional Test Test Name CDISC Functional Test TUG Test Name Terminology A terminology codelist of acceptable values to describe TIMI Flow. Thrombolysis in Myocardial Infarction Flow - 0 No perfusion. There is no antegrade flow beyond the point of occlusion. (Chesebro JH, Knatterud GL, Roberts R, et al, Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge, Circulation 76, No. 1, 142-154, 1987) Thrombolysis in Myocardial Infarction Flow-0 Thrombolysis in Myocardial Infarction Flow - 1 Penetration without perfusion. Contrast material passes beyond the area of obstruction but "hangs up" and fails to opacify the entire coronary bed distal to the obstruction for the duration of the cineangiographic filming sequence. (Chesebro JH, Knatterud GL, Roberts R, et al, Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge, Circulation 76, No. 1, 142-154, 1987) Thrombolysis in Myocardial Infarction Flow-1 Thrombolysis in Myocardial Infarction Flow - 2 Partial perfusion. The contrast material passes across the obstruction and opacifies the coronary bed distal to the obstruction. However, the rate of entry of contrast material into the vessel distal to the obstruction or its rate of clearance from the distal bed (or both) is perceptibly slower than its entry into or clearance from comparable areas not perfused by the previously occluded vessel (e.g., the opposite coronary artery or the coronary bed proximal to the obstruction). (Chesebro JH, Knatterud GL, Roberts R, et al, Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge, Circulation 76, No. 1, 142-154, 1987) Thrombolysis in Myocardial Infarction Flow-2 Thrombolysis in Myocardial Infarction Flow - 3 Complete perfusion. Antegrade flow into the bed distal to the obstruction occurs as promptly as into the bed from the involved bed and is as rapid as clearance from an uninvolved bed in the same vessel or the opposite artery. (Chesebro JH, Knatterud GL, Roberts R, et al, Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge, Circulation 76, No. 1, 142-154, 1987) Thrombolysis in Myocardial Infarction Flow-3 TIMIFLRS TIMI Flow Responses CDISC SDTM Thrombolysis in Myocardial Infarction Flow Responses Terminology Terminology relevant to the test codes that describe findings about a tobacco event or intervention. Age Started Smoking The age at which the individual began smoking. Age When First Smoked a Cigarette Question Longest Duration of Abstinence The longest amount of time during which the individual abstained from an activity. Longest Duration of Abstinence Tobacco Cessation Counseling Indicator An indication as to whether the individual has received tobacco cessation counseling. Tobacco Cessation Counseling Indicator Universal Product Code UPC UPC Code A barcode symbology composed of a 12-digit number and a series of black lines of varying widths, creating a symbol that is used to uniquely identify a product. Universal Product Code TIFATSCD Tobacco Findings About Test Code CDISC SDTM Tobacco Findings About Test Code Terminology Terminology relevant to the test names that describe findings about a tobacco event or intervention. Age Started Smoking The age at which the individual began smoking. Age When First Smoked a Cigarette Question Longest Duration of Abstinence The longest amount of time during which the individual abstained from an activity. Longest Duration of Abstinence Tobacco Cessation Counseling Indicator An indication as to whether the individual has received tobacco cessation counseling. Tobacco Cessation Counseling Indicator Universal Product Code UPC UPC Code A barcode symbology composed of a 12-digit number and a series of black lines of varying widths, creating a symbol that is used to uniquely identify a product. Universal Product Code TIFATS Tobacco Findings About Test Name CDISC SDTM Tobacco Findings About Test Name Terminology A terminology codelist containing the responses for a tobacco product category. A tobacco product that meets the definition of the term "cigarette" in section 3(1) of the Federal Cigarette Labeling and Advertising Act (any roll of tobacco wrapped in paper or in any substance not containing tobacco), and includes tobacco, in any form, that is functional in the product, which, because of its appearance, the type of tobacco used in the filler, or its packaging and labeling, is likely to be offered to, or purchased by, consumers as a cigarette or as roll-your-own tobacco (FD&C Act Section 900(3); 15 U.S.C. Ch. 36: CIGARETTE LABELING AND ADVERTISING). Note: The US FDA uses the term "cigarettes" to refer to combusted cigarettes, unless specifically stated otherwise. In general, the term is not meant to include any noncombusted tobacco products that meet the definition of cigarette in Section 900(3) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. Section 387(3)). Cigarette A tobacco product that (1) is not a cigarette and (2) is a roll of tobacco wrapped in leaf tobacco or any substance containing tobacco. (FDA CTP Glossary; 26 U.S.C. Section 5702(a)) Cigar A tobacco product that is a device used to deliver e-liquid in aerosol form for inhalation. (FDA CTP Glossary) Electronic Nicotine Delivery Device Heat Not Burn HTP Tobacco Heating System Any tobacco product or associated parts and components that, because of its appearance, type, packaging, labeling, or associated parts and components, heats tobacco filler and can be used with e-liquids and/or other consumables. This includes products that meet the definition of a cigarette and are not burned like a cigarette. Heated Tobacco Product Any tobacco product or associated parts and components that, because of its appearance, type, packaging, labeling, or associated parts and components, is intended for use in a smoking pipe with a bowl and a stem. Pipe Tobacco Product RYO Product Any tobacco product or associated parts and components that, because of its appearance, type, packaging, labeling or associated parts and components, is suitable for use by consumers for making cigarettes. Roll-your-own Tobacco Product Any tobacco product that is intended to be placed in the oral or nasal cavity. It may consist of cut, ground, powdered, or leaf tobacco. Smokeless Tobacco Product Hookah Tobacco Product Shisha Tobacco Product Any tobacco product or associated parts and components that, because of its appearance, type, packaging, labeling, or associated parts and components, burns tobacco filler in a bowl and generates smoke that passes through a liquid into a hose and/or mouthpiece. Waterpipe Tobacco Product TPCATRS Tobacco Product Category Response CDISC ADaM Tobacco Product Category Response Terminology A terminology codelist relevant to the codes for tobacco product design parameters. Airflow Rate The speed of the movement of air. Airflow Rate Battery Capacity The total electric energy stored in a battery. Battery Capacity Battery Nominal Voltage The average voltage that a battery can output when fully charged. Battery Nominal Voltage Battery Charging Temperature Limits The safe range of charging temperatures for a battery. Battery Charging Temperature Limits Battery C-Rate Battery Current Rating C-Rate The rate at which a battery is discharged relative to its maximum capacity. Battery Current Rating Battery Current Operating Range The range of current that a battery puts out to heat a heating element. Battery Current Operating Range Battery Discharge Temperature Limits The safe range of discharging temperatures for a battery. Battery Discharge Temperature Limits Battery End of Discharge Voltage The voltage at which a battery is considered completely discharged. Battery End of Discharge Voltage Battery Maximum Charging Current The greatest amount of current that a battery can accept during charging. Battery Maximum Charging Current Battery Maximum Discharging Current The greatest amount of current that a battery can discharge. Battery Maximum Discharging Current Battery Upper Limit Charging Voltage The maximum voltage in charge for a battery. Battery Upper Limit Charging Voltage Battery Voltage Operating Range The maximum voltage in charge and minimum voltage in discharge for a battery. Battery Voltage Operating Range Cigarette Base Paper Permeability The ease of passage of liquids, gases, or specific chemicals through the paper product that is used to wrap cigarettes. Cigarette Base Paper Permeability Cigarette Base Paper Porosity The amount of empty space in the paper product that is used to wrap cigarettes. Cigarette Base Paper Porosity Cigarette Paper Length The length of the paper product that is used to wrap the cigarette tobacco rod. Cigarette Paper Length Circumference The length of the closed curve of a circle; the size of something as given by the distance around it. (NCI) Circumference Cigarette Paper Band Diffusivity An assessment of the gas or particle diffusivity across the cellulosic bands present on some cigarette papers, used to reduce a cigarette's smolder ability. Cigarette Paper Band Diffusivity Cigarette Paper Band Permeability An assessment of the gas or particle permeability through the cellulosic bands present on some cigarette papers, used to reduce a cigarette's smolder ability. Cigarette Paper Band Permeability Cigarette Paper Band Porosity An assessment of the porosity of the cellulosic bands present on some cigarette papers, used to reduce a cigarette's smolder ability. Cigarette Paper Band Porosity Cigarette Paper Band Space An assessment of the length of the spacing between two adjacent cellulosic bands present on some cigarette papers, used to reduce a cigarette's smolder ability. Cigarette Paper Band Space Cigarette Paper Band Width An assessment of the width of the cellulosic bands present on some cigarette papers, used to reduce a cigarette's smolder ability. Cigarette Paper Band Width Cartridge Volume The volume of a container that holds liquids or other substances and is part of a larger apparatus. Cartridge Volume Count Median Diameter The median of the count distribution. Count Median Diameter Denier Per Filament The linear mass density of fibers per individual filament. Denier Per Filament Draw Resistance The resistance of the tobacco rod and filter to air flow. Draw Resistance E-Liquid Viscosity The resistance of an e-liquid to sheer forces and flow. E-Liquid Viscosity E-Liquid Volume The amount of three dimensional space occupied by e-liquid. E-Liquid Volume Filter Density The mass of filter media per unit volume. Filter Density Filter Pressure Drop A measure of a filter's resistance to airflow. Filter Pressure Drop Filter Efficiency The percentage of contaminants removed by a filter medium. Filter Efficiency Filter Length The length of a product filter. Product Filter Length Heating Element Diameter The diameter of a heating element within a device. Heating Element Diameter Heating Element Configuration The design of a heating element within a device. Heating Element Configuration Heating Element Length The length of a heating element within a device. Heating Element Length Number of Heating Elements The number of heating elements within a device. Number of Heating Elements Heating Element Range The temperature range of a heating element within a device during operation. Heating Element Range Heating Element Resistance The resistance encountered by the electrical current in a heating element within a device. Heating Element Resistance Inhaled Aerosol Temperature The temperature of inhaled solid or liquid particles dispersed in a gas that is drawn into the body by breathing. Inhaled Aerosol Temperature Length The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI) Length Moisture Moisture Content The total amount of water and other volatiles in an ingredient, component, or product. Moisture Content Nicotine Dissolution Rate The rate at which nicotine dissolves in a medium. Nicotine Dissolution Rate PDU Current Operating Range The maximum to minimum operating current for a power distribution unit. Power Distribution Unit Current Operating Range PDU Current Cut-off The maximum operating current for a power distribution unit. Power Distribution Unit Current Cut-off PDU Temperature Cut-off The maximum operating temperature for a power distribution unit. Power Distribution Unit Temperature Cut-off PDU Voltage Operating Range The minimum to maximum operating voltage for a power distribution unit. Power Distribution Unit Voltage Operating Range PDU Wattage Operating Range The maximum to minimum operating wattage for a power distribution unit. Power Distribution Unit Wattage Operating Range Particulate Matter 2.5 The total number of particles or droplets per unit volume in the air that are 2.5 microns or less in width. Particulate Matter at 2.5um or Less Measurement Particle Number Concentration The total number of particles per unit volume. Particle Number Concentration Portion Length The length of an individual unit of use along the longest edge. Portion Length Portion Mass The mass of an individual unit of use. Portion Mass Pouch Material Porosity The amount of empty space in the paper material of a pouch. Pouch Material Porosity Pouch Material Basis Weight The weight of a paper material based on standard size. Pouch Material Basis Weight Portion Material Thickness The distance between two opposing sides of the same fully-connected surface within an individual unit of use. Portion Material Thickness Portion Width The width of an individual unit of use along the second longest edge. Portion Width Puff Count The number of draws a tobacco product will deliver. Puff Count Tobacco Filler Mass The mass of tobacco filler in a tobacco product. Tobacco Filler Mass Total Denier The linear mass density of fibers. Total Denier Tobacco Cut Size The physical dimensions of tobacco in a tobacco product. Tobacco Cut Size Tobacco Particle Size The width of particles in tobacco smoke. Tobacco Particle Size Tobacco Rod Density The density of cut tobacco filler within its wrapper. Tobacco Rod Density Tipping Paper Length The length of the outer wrapping of the filter section of a product used to join the filter to the tobacco rod. Tipping Paper Length Filter Ventilation Vf An assessment of the air entering the product through the filter joining paper (tipping paper) between the covered part of the mouth end and the beginning of the tobacco rod. (CORESTA) Filter Ventilation Total Ventilation The percentage of total air flow drawn through the sample via the sides of the filter, generally through perforations. (CORESTA) Total Product Ventilation PDPARMCD Tobacco Product Design Parameters Code CDISC SDTM Tobacco Product Design Parameters Code Terminology A terminology codelist relevant to the names for tobacco product design parameters. Airflow Rate The speed of the movement of air. Airflow Rate Battery C-Rate Battery Current Rating C-Rate The rate at which a battery is discharged relative to its maximum capacity. Battery Current Rating Battery Capacity The total electric energy stored in a battery. Battery Capacity Battery Charging Temperature Limits The safe range of charging temperatures for a battery. Battery Charging Temperature Limits Battery Current Operating Range The range of current that a battery puts out to heat a heating element. Battery Current Operating Range Battery Discharge Temperature Limits The safe range of discharging temperatures for a battery. Battery Discharge Temperature Limits Battery End of Discharge Voltage The voltage at which a battery is considered completely discharged. Battery End of Discharge Voltage Battery Maximum Charging Current The greatest amount of current that a battery can accept during charging. Battery Maximum Charging Current Battery Maximum Discharging Current The greatest amount of current that a battery can discharge. Battery Maximum Discharging Current Battery Nominal Voltage The average voltage that a battery can output when fully charged. Battery Nominal Voltage Battery Upper Limit Charging Voltage The maximum voltage in charge for a battery. Battery Upper Limit Charging Voltage Battery Voltage Operating Range The maximum voltage in charge and minimum voltage in discharge for a battery. Battery Voltage Operating Range Cartridge Volume The volume of a container that holds liquids or other substances and is part of a larger apparatus. Cartridge Volume Cigarette Base Paper Permeability The ease of passage of liquids, gases, or specific chemicals through the paper product that is used to wrap cigarettes. Cigarette Base Paper Permeability Cigarette Base Paper Porosity The amount of empty space in the paper product that is used to wrap cigarettes. Cigarette Base Paper Porosity Cigarette Paper Band Diffusivity An assessment of the gas or particle diffusivity across the cellulosic bands present on some cigarette papers, used to reduce a cigarette's smolder ability. Cigarette Paper Band Diffusivity Cigarette Paper Band Permeability An assessment of the gas or particle permeability through the cellulosic bands present on some cigarette papers, used to reduce a cigarette's smolder ability. Cigarette Paper Band Permeability Cigarette Paper Band Porosity An assessment of the porosity of the cellulosic bands present on some cigarette papers, used to reduce a cigarette's smolder ability. Cigarette Paper Band Porosity Cigarette Paper Band Space An assessment of the length of the spacing between two adjacent cellulosic bands present on some cigarette papers, used to reduce a cigarette's smolder ability. Cigarette Paper Band Space Cigarette Paper Band Width An assessment of the width of the cellulosic bands present on some cigarette papers, used to reduce a cigarette's smolder ability. Cigarette Paper Band Width Cigarette Paper Length The length of the paper product that is used to wrap the cigarette tobacco rod. Cigarette Paper Length Circumference The length of the closed curve of a circle; the size of something as given by the distance around it. (NCI) Circumference Count Median Diameter The median of the count distribution. Count Median Diameter Denier Per Filament The linear mass density of fibers per individual filament. Denier Per Filament Draw Resistance The resistance of the tobacco rod and filter to air flow. Draw Resistance E-Liquid Viscosity The resistance of an e-liquid to sheer forces and flow. E-Liquid Viscosity E-Liquid Volume The amount of three dimensional space occupied by e-liquid. E-Liquid Volume Filter Density The mass of filter media per unit volume. Filter Density Filter Efficiency The percentage of contaminants removed by a filter medium. Filter Efficiency Filter Length The length of a product filter. Product Filter Length Filter Pressure Drop A measure of a filter's resistance to airflow. Filter Pressure Drop Filter Ventilation Vf An assessment of the air entering the product through the filter joining paper (tipping paper) between the covered part of the mouth end and the beginning of the tobacco rod. (CORESTA) Filter Ventilation Heating Element Configuration The design of a heating element within a device. Heating Element Configuration Heating Element Diameter The diameter of a heating element within a device. Heating Element Diameter Heating Element Length The length of a heating element within a device. Heating Element Length Heating Element Range The temperature range of a heating element within a device during operation. Heating Element Range Heating Element Resistance The resistance encountered by the electrical current in a heating element within a device. Heating Element Resistance Inhaled Aerosol Temperature The temperature of inhaled solid or liquid particles dispersed in a gas that is drawn into the body by breathing. Inhaled Aerosol Temperature Length The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI) Length Moisture Moisture Content The total amount of water and other volatiles in an ingredient, component, or product. Moisture Content Nicotine Dissolution Rate The rate at which nicotine dissolves in a medium. Nicotine Dissolution Rate Number of Heating Elements The number of heating elements within a device. Number of Heating Elements Particle Number Concentration The total number of particles per unit volume. Particle Number Concentration Particulate Matter 2.5 The total number of particles or droplets per unit volume in the air that are 2.5 microns or less in width. Particulate Matter at 2.5um or Less Measurement PDU Current Cut-off The maximum operating current for a power distribution unit. Power Distribution Unit Current Cut-off PDU Current Operating Range The maximum to minimum operating current for a power distribution unit. Power Distribution Unit Current Operating Range PDU Temperature Cut-off The maximum operating temperature for a power distribution unit. Power Distribution Unit Temperature Cut-off PDU Voltage Operating Range The minimum to maximum operating voltage for a power distribution unit. Power Distribution Unit Voltage Operating Range PDU Wattage Operating Range The maximum to minimum operating wattage for a power distribution unit. Power Distribution Unit Wattage Operating Range Portion Length The length of an individual unit of use along the longest edge. Portion Length Portion Mass The mass of an individual unit of use. Portion Mass Portion Material Thickness The distance between two opposing sides of the same fully-connected surface within an individual unit of use. Portion Material Thickness Portion Width The width of an individual unit of use along the second longest edge. Portion Width Pouch Material Basis Weight The weight of a paper material based on standard size. Pouch Material Basis Weight Pouch Material Porosity The amount of empty space in the paper material of a pouch. Pouch Material Porosity Puff Count The number of draws a tobacco product will deliver. Puff Count Tipping Paper Length The length of the outer wrapping of the filter section of a product used to join the filter to the tobacco rod. Tipping Paper Length Tobacco Cut Size The physical dimensions of tobacco in a tobacco product. Tobacco Cut Size Tobacco Filler Mass The mass of tobacco filler in a tobacco product. Tobacco Filler Mass Tobacco Particle Size The width of particles in tobacco smoke. Tobacco Particle Size Tobacco Rod Density The density of cut tobacco filler within its wrapper. Tobacco Rod Density Total Denier The linear mass density of fibers. Total Denier Total Ventilation The percentage of total air flow drawn through the sample via the sides of the filter, generally through perforations. (CORESTA) Total Product Ventilation PDPARM Tobacco Product Design Parameters Name CDISC SDTM Tobacco Product Design Parameters Name Terminology A terminology codelist relevant to the specimen material type associated with tobacco products. A suspension of solid or liquid particles in a gas Aerosol A liquid that is typically a mixture of propylene glycol and/or vegetable glycerin, nicotine, flavoring, water, and other ingredients, which is converted into an aerosol by an e-cigarette device. E-Liquid A visible suspension of carbon and other particulate matter, typically emitted from a burning substance. Smoke Tobacco, with or without other ingredients, that is used as a component of a finished product or as a finished product, and is not a binder or wrapper. Tobacco Filler Tobacco grows naturally on a tobacco plant, primarily leaves and stems, including after curing, drying, or cutting. (FDA CTP) Tobacco SPECPT Tobacco Product Testing Specimen Type CDISC SDTM Tobacco Product Testing Specimen Type Terminology Terminology relevant to the test codes that describe tobacco product testing. 2-Amino-9H-pyrido[2,3-b]indole A alpha C A-alpha-C A measurement of the 2-amino-9h-pyrido[2,3-b]indole in a specimen. 2-Amino-9H-pyrido[2,3-b]indole Measurement 4-ABP 4-Aminobiphenyl A measurement of the 4-aminobiphenyl in a specimen. 4-Aminobiphenyl Measurement Acetamide A measurement of the acetamide in a specimen. Acetamide Measurement Acetate Acetic Acid A measurement of the acetate in a specimen. Acetate Measurement 3-hydroxy-2-butanone 3-Hydroxybutanone Acetoin Acetyl Methyl Carbinol A measurement of the acetoin in a specimen. Acetoin Measurement Acetone A measurement of the acetone in a specimen. Acetone Measurement Acrylamide A measurement of the acrylamide in a specimen. Acrylamide Measurement Acrolein A measurement of the acrolein in a specimen. Acrolein Measurement Acrylonitrile A measurement of the acrylonitrile in a specimen. Acrylonitrile Measurement Acetaldehyde A measurement of the acetaldehyde in a specimen. Acetaldehyde Measurement 2,3-Pentanedione Acetyl propionyl Acetylpropionyl A measurement of the acetyl propionyl in a specimen. Acetyl Propionyl Measurement Aerobic Colony Count A measurement of the number of aerobic colonies in a sample. Aerobic Colony Count Aflatoxin B1 A measurement of the aflatoxin B1 in a specimen. Aflatoxin B1 Measurement Airflow Rate The speed of the movement of air. Airflow Rate Ammonia NH3 A measurement of the ammonia in a specimen. Ammonia Measurement 1-Aminonaphthalene 1-Naphthylamine A measurement of the 1-aminonaphthalene in a specimen. 1-Aminonaphthalene Measurement 2-Aminonaphthalene 2-Naphthylamine A measurement of the 2-aminonaphthalene in a specimen. 2-Aminonaphthalene Measurement Anabasine A measurement of the anabasine in a specimen. Anabasine Measurement Anatabine A measurement of the anatabine in a specimen. Anatabine Measurement Arsenic As A measurement of the arsenic in a specimen. Arsenic Measurement Battery Capacity The total electric energy stored in a battery. Battery Capacity Battery Nominal Voltage The average voltage that a battery can output when fully charged. Battery Nominal Voltage Benzene A measurement of the benzene in a specimen. Benzene Measurement BE Beryllium A measurement of the beryllium in a specimen. Beryllium Measurement Benzoate Benzoic Acid A measurement of the benzoic acid in a specimen. Benzoic Acid Measurement Battery Charging Temperature Limits The safe range of charging temperatures for a battery. Battery Charging Temperature Limits Battery C-Rate Battery Current Rating C-Rate The rate at which a battery is discharged relative to its maximum capacity. Battery Current Rating Battery Current Operating Range The range of current that a battery puts out to heat a heating element. Battery Current Operating Range Battery Discharge Temperature Limits The safe range of discharging temperatures for a battery. Battery Discharge Temperature Limits Battery End of Discharge Voltage The voltage at which a battery is considered completely discharged. Battery End of Discharge Voltage Battery Maximum Charging Current The greatest amount of current that a battery can accept during charging. Battery Maximum Charging Current Battery Maximum Discharging Current The greatest amount of current that a battery can discharge. Battery Maximum Discharging Current Battery Upper Limit Charging Voltage The maximum voltage in charge for a battery. Battery Upper Limit Charging Voltage Battery Voltage Operating Range The maximum voltage in charge and minimum voltage in discharge for a battery. Battery Voltage Operating Range Butanal Butyraldehyde A measurement of the butyraldehyde in a specimen. Butyraldehyde Measurement 1-Butanol Butan-1-ol Butanol Butyl Alcohol n-Butanol N-Butyl Alcohol A measurement of the n-butanol in a specimen. n-Butanol Measurement 1,3-Butadiene A measurement of the 1,3-butadiene in a specimen. 1,3-Butadiene Measurement Benz(a)anthracene Benz[a]anthracene Benzo(a)anthracene Benzo[a]anthracene A measurement of the benzo[a]anthracene in a specimen. Benzo[a]anthracene Measurement Benzyl acetate Benzyl Acetic Acid A measurement of the benzyl acetate in a specimen. Benzyl Acetate Measurement 3,4-Benzpyrene Benz(a)pyrene Benz[a]pyrene Benzo(a)pyrene Benzo[a]pyrene A measurement of the benzo[a]pyrene in a specimen. Benzo[a]pyrene Measurement Benz(b)fluoranthene Benz[b]fluoranthene Benzo(b)fluoranthene Benzo[b]fluoranthene A measurement of the benzo[b]fluoranthene in a specimen. Benzo[b]fluoranthene Measurement 1-Benzofuran Benz(b)furan Benz[b]furan Benzo(b)furan Benzo[b]furan Benzofuran Coumarone A measurement of the benzo[b]furan in a specimen. Benzo[b]furan Measurement Benz(c)phenanthrene Benz[c]phenanthrene Benzo(c)phenanthrene Benzo[c]phenanthrene A measurement of the benzo[c]phenanthrene in a specimen. Benzo[c]phenanthrene Measurement Benz(j)aceanthrylene Benz[j]aceanthrylene Benzo(j)aceanthrylene Benzo[j]aceanthrylene A measurement of the benzo[j]aceanthrylene in a specimen. Benzo[j]aceanthrylene Measurement Benz(k)fluoranthene Benz[k]fluoranthene Benzo(k)fluoranthene Benzo[k]fluoranthene A measurement of the benzo[k]fluoranthene in a specimen. Benzo[k]fluoranthene Measurement Cadmium A measurement of the cadmium in a specimen. Cadmium Measurement 2-Carbamoyl Methyl Mercapturic Acid 2-Carbamoylethylmercapturic Acid 2CaEMA Acrylamide Mercapturic Acid Acrylamide Micturate N-Acetyl-S-carbamoylethyl-L-cysteine A measurement of the 2-carbamoylethylmercapturic acid in a specimen. 2-Carbamoylethylmercapturic Acid Measurement Caffeate Caffeic Acid A measurement of the caffeate in a specimen. Caffeate Measurement Catechol A measurement of the catechol in a specimen. Catechol Measurement Cigarette Base Paper Permeability The ease of passage of liquids, gases, or specific chemicals through the paper product that is used to wrap cigarettes. Cigarette Base Paper Permeability Cigarette Base Paper Porosity The amount of empty space in the paper product that is used to wrap cigarettes. Cigarette Base Paper Porosity Chromium CR A measurement of the chromium in a specimen. Chromium Measurement Chrysene A measurement of the chrysene in a specimen. Chrysene Measurement Cigarette Paper Length The length of the paper product that is used to wrap the cigarette tobacco rod. Cigarette Paper Length Circumference The length of the closed curve of a circle; the size of something as given by the distance around it. (NCI) Circumference Chlorinated Dioxins and/or Furans A measurement of the chlorinated dioxins and/or furans in a specimen. Chlorinated Dioxins and/or Furans Measurement Carbon Monoxide A measurement of the carbon monoxide in a specimen. Carbon Monoxide Measurement CO Cobalt A measurement of the cobalt in a specimen. Cobalt Measurement Coumarin A measurement of the coumarin in a specimen. Coumarin Measurement Cigarette Paper Band Diffusivity An assessment of the gas or particle diffusivity across the cellulosic bands present on some cigarette papers, used to reduce a cigarette's smolder ability. Cigarette Paper Band Diffusivity Cigarette Paper Band Permeability An assessment of the gas or particle permeability through the cellulosic bands present on some cigarette papers, used to reduce a cigarette's smolder ability. Cigarette Paper Band Permeability Cigarette Paper Band Porosity An assessment of the porosity of the cellulosic bands present on some cigarette papers, used to reduce a cigarette's smolder ability. Cigarette Paper Band Porosity Cigarette Paper Band Space An assessment of the length of the spacing between two adjacent cellulosic bands present on some cigarette papers, used to reduce a cigarette's smolder ability. Cigarette Paper Band Space Cigarette Paper Band Width An assessment of the width of the cellulosic bands present on some cigarette papers, used to reduce a cigarette's smolder ability. Cigarette Paper Band Width Acepyrene Cyclopenta(c,d)pyrene Cyclopenta[c,d]pyrene A measurement of the cyclopenta[c,d]pyrene in a specimen. Cyclopenta[c,d]pyrene Measurement Benzol Cresols Cresols (o-, m-, and p-cresol) Cresylic acid Hydroxytoluene Toluenol A measurement of the total cresols (o-, m-, and p-cresol) in a specimen. Cresol Measurement Crotonaldehyde A measurement of the crotonaldehyde in a specimen. Crotonaldehyde Measurement Cartridge Volume The volume of a container that holds liquids or other substances and is part of a larger apparatus. Cartridge Volume Count Median Diameter The median of the count distribution. Count Median Diameter Cotinine Glucuronide Cotinine N-B-D-Glucuronide Cotinine N-beta-D-Glucuronide Cotinine-Glucuronide Cotinine-N-Glucuronide A measurement of the cotinine glucuronide in a specimen. Cotinine Glucuronide Measurement Cotinine-N-Oxide Cotinine-n-Oxide A measurement of the cotinine-N-oxide in a specimen. Cotinine-N-Oxide Measurement Diacetyl A measurement of the diacetyl in a specimen. Diacetyl Measurement Dibenz(a,e)pyrene Dibenz[a,e]pyrene Dibenzo(a,e)pyrene Dibenzo[a,e]pyrene A measurement of the dibenzo[a,e]pyrene in a specimen. Dibenzo[a,e]pyrene Measurement Dibenz(a,h)anthracene Dibenz[a,h]anthracene Dibenzo(a,h)anthracene Dibenzo[a,h]anthracene A measurement of the dibenzo[a,h]anthracene in a specimen. Dibenzo[a,h]anthracene Measurement Dibenz(a,h)pyrene Dibenz[a,h]pyrene Dibenzo(a,h)pyrene Dibenzo[a,h]pyrene A measurement of the dibenzo[a,h]pyrene in a specimen. Dibenzo[a,h]pyrene Measurement Dibenz(a,i)pyrene Dibenz[a,i]pyrene Dibenzo(a,i)pyrene Dibenzo[a,i]pyrene A measurement of the dibenzo[a,i]pyrene in a specimen. Dibenzo[a,i]pyrene Measurement Dibenz(a,l)pyrene Dibenz[a,l]pyrene Dibenzo(a,l)pyrene Dibenzo[a,l]pyrene A measurement of the dibenzo[a,l]pyrene in a specimen. Dibenzo[a,l]pyrene Measurement Diethylene Glycol A measurement of the diethylene glycol in a specimen. Diethylene Glycol Measurement 2,6-Dimethylaniline 2,6-Xylidine o-Xylidine A measurement of the 2,6-dimethylaniline in a specimen. 2,6-Dimethylaniline Measurement Denier Per Filament The linear mass density of fibers per individual filament. Denier Per Filament Draw Resistance The resistance of the tobacco rod and filter to air flow. Draw Resistance Ethyl 3-Oxobutanoate Ethyl Acetoacetate Ethyl Acetoacetic Acid Ethyl Acetylacetate A measurement of the ethyl acetoacetate in a specimen. Ethyl Acetoacetate Measurement E-Liquid Viscosity The resistance of an e-liquid to sheer forces and flow. E-Liquid Viscosity E-Liquid Volume The amount of three dimensional space occupied by e-liquid. E-Liquid Volume Ethyl Acetate Ethyl Acetic Acid A measurement of the ethyl acetate in a specimen. Ethyl Acetate Measurement Ethylbenzene A measurement of the ethylbenzene in a specimen. Ethylbenzene Measurement Ethyl Carbamate Urethane A measurement of the ethyl carbamate in a specimen. Ethyl Carbamate Measurement Ethane-1,2-diol Ethylene Glycol A measurement of the ethylene glycol in a specimen. Ethylene Glycol Measurement Ethylene Oxide A measurement of the ethylene oxide in a specimen. Ethylene Oxide Measurement Filter Density The mass of filter media per unit volume. Filter Density Filter Pressure Drop A measure of a filter's resistance to airflow. Filter Pressure Drop Filter Efficiency The percentage of contaminants removed by a filter medium. Filter Efficiency Filter Length The length of a product filter. Product Filter Length Formaldehyde Formic Aldehyde Methanal A measurement of the formaldehyde in a specimen. Formaldehyde Measurement Furan A measurement of the furan in a specimen. Furan Measurement 2-Furaldehyde Furfural A measurement of the furfural in a specimen. Furfural Measurement 2-Amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole Glu-P-1 A measurement of the Glu-P-1 in a specimen. Glu-P-1 Measurement 2-Aminodipyrido[1,2-a:3',2'-d]imidazole Glu-P-2 A measurement of the Glu-P-2 in a specimen. Glu-P-2 Measurement Glycidol A measurement of the glycidol in a specimen. Glycidol Measurement Glycerol A measurement of the total glycerol in a specimen. Glycerol Measurement aw Water Activity A measurement of the ratio of water vapor pressure in the sample to water vapor pressure of pure water Water Activity Measurement Hydrogen Cyanide A measurement of the hydrogen cyanide in a specimen. Hydrogen Cyanide Measurement Heating Element Diameter The diameter of a heating element within a device. Heating Element Diameter Heating Element Configuration The design of a heating element within a device. Heating Element Configuration Heating Element Length The length of a heating element within a device. Heating Element Length Number of Heating Elements The number of heating elements within a device. Number of Heating Elements Heating Element Range The temperature range of a heating element within a device during operation. Heating Element Range Heating Element Resistance The resistance encountered by the electrical current in a heating element within a device. Heating Element Resistance Hydrazine Levoxine A measurement of the hydrazine in a specimen. Hydrazine Measurement Indeno(1,2,3-cd)pyrene Indeno[1,2,3-cd]pyrene o-Phenylenepyrene A measurement of the indeno[1,2,3-cd]pyrene in a specimen. Indeno[1,2,3-cd]pyrene Measurement Isoamyl Acetate Isoamyl Acetic Acid Isopentyl Acetate A measurement of the isoamyl acetate in a specimen. Isoamyl Acetate Measurement 2-Methylpropyl Ethanoate Isobutyl Acetate Isobutyl Acetic Acid A measurement of the isobutyl acetate in a specimen. Isobutyl Acetate Measurement Inhaled Aerosol Temperature The temperature of inhaled solid or liquid particles dispersed in a gas that is drawn into the body by breathing. Inhaled Aerosol Temperature Isoprene A measurement of the isoprene in a specimen. Isoprene Measurement Lead Pb A measurement of the lead in a specimen. Lead Measurement Length The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI) Length 2-Amino-3-Methyl-9H-Pyrido[2,3-b]indole MeA-a-C Mea-Alpha-C A measurement of the 2-Amino-3-Methyl-9H-Pyrido[2,3-b]indole in a specimen. 2-Amino-3-Methyl-9H-Pyrido[2,3-b]indole Measurement Hg Mercury A measurement of the mercury in a specimen. Mercury Measurement MHBMA Monohydroxybutyl Mercapturate Monohydroxybutyl Mercapturic Acid A measurement of the monohydroxybutyl mercapturic acid in a specimen. Monohydroxybutyl Mercapturic Acid Measurement Moisture Moisture Content The total amount of water and other volatiles in an ingredient, component, or product. Moisture Content MEK Methyl Ethyl Ketone A measurement of the methyl ethyl ketone in a specimen. Methyl Ethyl Ketone Measurement Methyl Acetate Methyl Acetic Acid A measurement of the methyl acetate in a specimen. Methyl Acetate Measurement 5-Methylchrysene A measurement of the 5-methylchrysene in a specimen. 5-Methylchrysene Measurement 2-Amino-3-Methylimidazo[4,5-f]quinoline IQ N3-IQ A measurement of the 2-amino-3-methylimidazo[4,5-f]quinoline in a specimen. 2-Amino-3-Methylimidazo[4,5-f]quinoline Measurement Nitrobenzene A measurement of the nitrobenzene in a specimen. Nitrobenzene Measurement Nicotine 1-N-Oxide Nicotine-1 N-Oxide A measurement of the nicotine 1-N-oxide in a specimen. Nicotine 1-N-Oxide Measurement Nicotine Glucuronide Nicotine N-glucuronide Nicotine-Glucuronide A measurement of the nicotine glucuronide in a specimen. Nicotine Glucuronide Measurement N-Nitrosodiethylamine NDEA A measurement of the N-nitrosodiethylamine in a specimen. N-Nitrosodiethylamine Measurement N-Nitrosodiethanolamine NDELA A measurement of the N-nitrosodiethanolamine in a specimen. N-Nitrosodiethanolamine Measurement N-Nitrosodimethylamine NDMA A measurement of the N-nitrosodimethylamine in a specimen. N-Nitrosodimethylamine Measurement Dry Particulate Matter, Nicotine-Free Nicotine-Free Dry Particulate Matter A measurement of the nicotine-free dry particulate matter in a specimen. Nicotine-Free Dry Particulate Matter Measurement Ni Nickel A measurement of the nickel in a specimen. Nickel Measurement Nicotine A measurement of the nicotine in a specimen. Nicotine Measurement Nicotine Dissolution Rate The rate at which nicotine dissolves in a medium. Nicotine Dissolution Rate N-Nitrosomethylethylamine NEMA NMEA A measurement of the N-nitrosomethylethylamine in a specimen. N-Nitrosomethylethylamine Measurement Nitromethane A measurement of the nitromethane in a specimen. Nitromethane Measurement N-Nitrosomorpholine NMOR A measurement of the N-nitrosomorpholine in a specimen. N-Nitrosomorpholine Measurement 4-(Methylnitrosamino)-4-(3-pyridyl)-1-butanol NNAL A measurement of the total 4-(methylnitrosamino)-4-(3-pyridyl)-1-butanol (NNAL) in a specimen. NNAL Measurement 4-(Methylnitrosamino)-4-(3-pyridyl)-1-butanol, Free NNAL, Free A measurement of the free 4-(methylnitrosamino)-4-(3-pyridyl)-1-butanol (NNAL, Free) in a specimen. Free NNAL Measurement NNAL-N-Gluc NNAL-N-Glucuronide A measurement of the NNAL-N-gluc in a specimen. NNAL-N-Gluc Measurement NNAL-O-Gluc NNAL-O-Glucuronide A measurement of the NNAL-O-gluc in a specimen. NNAL-O-Gluc Measurement N'-Nitrosoanabasine N-Nitrosoanabasine A measurement of the N-nitrosoanabasine in a specimen. N-Nitrosoanabasine Measurement N'-Nitrosoanatabine N-Nitrosoanatabine A measurement of the N-nitrosoanatabine in a specimen. N-Nitrosoanatabine Measurement 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Nicotine-Derived Nitrosamine Ketone NNK A measurement of the nicotine-derived nitrosamine ketone in a specimen. Nicotine-Derived Nitrosamine Ketone Measurement N-Nitrosonornicotine NNN A measurement of the N-nitrosonornicotine in a specimen. N-Nitrosonornicotine Measurement NNN-Glucuronide NNN-N-Glucuronide A measurement of the NNN-glucuronide in a specimen. NNN-Glucuronide Measurement Nornicotine A measurement of the nornicotine in a biological specimen. Nornicotine Measurement Naphthalene A measurement of the naphthalene in a specimen. Naphthalene Measurement N-Nitrosopiperidine NPIP A measurement of the N-nitrosopiperidine in a specimen. N-Nitrosopiperidine Measurement 2-Nitropropane 2-NP A measurement of the 2-nitropropane in a specimen. 2-Nitropropane Measurement N-Nitrosopyrrolidine NPYR A measurement of the N-nitrosopyrrolidine in a specimen. N-Nitrosopyrrolidine Measurement N-Nitrososarcosine NSAR A measurement of the N-nitrososarcosine in a specimen. N-Nitrososarcosine Measurement 2-Anisidine 2-Methoxyaniline o-Anisidine Ortho-Anisidine A measurement of the o-anisidine in a specimen. o-Anisidine Measurement 3-Hydroxybenz(a)pyrene 3-Hydroxybenz[a]pyrene 3-Hydroxybenzo(a)pyrene 3-Hydroxybenzo[a]pyrene A measurement of the 3-hydroxybenzo[a]pyrene in a specimen. 3-Hydroxybenzo[a]pyrene Measurement 2-Hydroxyfluorene A measurement of the 2-hydroxyfluorene in a specimen. 2-Hydroxyfluorene Measurement 3-Hydroxyfluorene A measurement of the 3-hydroxyfluorene in a specimen. 3-Hydroxyfluorene Measurement 1-Hydroxynaphthalene 1-Naphthol A measurement of the 1-hydroxynaphthalene in a specimen. 1-Hydroxynaphthalene Measurement 2-Hydroxynaphthalene 2-NAP 2-Naphthol A measurement of the 2-hydroxynaphthalene in a specimen. 2-Hydroxynaphthalene Measurement 1-Hydroxyphenanthrene A measurement of the 1-hydroxyphenanthrene in a specimen. 1-Hydroxyphenanthrene Measurement 2-3PHE 2-Hydroxyphenanthrene A measurement of the 2-hydroxyphenanthrene in a specimen. 2-Hydroxyphenanthrene Measurement 3-Hydroxyphenanthrene A measurement of the 3-hydroxyphenanthrene in a specimen. 3-Hydroxyphenanthrene Measurement 1-Hydroxypyrene A measurement of the 1-hydroxypyrene in a specimen. 1-Hydroxypyrene Measurement 2-Methylaniline 2-Toluidine o-Toluidine Ortho-Toluidine A measurement of the o-toluidine in a specimen. o-Toluidine Measurement PDU Current Operating Range The maximum to minimum operating current for a power distribution unit. Power Distribution Unit Current Operating Range PDU Current Cut-off The maximum operating current for a power distribution unit. Power Distribution Unit Current Cut-off PDU Temperature Cut-off The maximum operating temperature for a power distribution unit. Power Distribution Unit Temperature Cut-off PDU Voltage Operating Range The minimum to maximum operating voltage for a power distribution unit. Power Distribution Unit Voltage Operating Range PDU Wattage Operating Range The maximum to minimum operating wattage for a power distribution unit. Power Distribution Unit Wattage Operating Range pH The negative logarithm (base 10) of the concentration of hydronium ions, which is used as a measure of the acidity or alkalinity of a fluid. pH Carbolic Acid Hydroxybenzene Oxybenzene Phenic Acid Phenol Phenylic Acid A measurement of the phenol in a specimen. Phenol Measurement 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]pyridine PhIP A measurement of the PhIP (2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]pyridine) in a specimen. PhIP Measurement Particulate Matter 2.5 The total number of particles or droplets per unit volume in the air that are 2.5 microns or less in width. Particulate Matter at 2.5um or Less Measurement Phenylmercapturate Phenylmercapturic Acid A measurement of the phenylmercapturic acid in a specimen. Phenylmercapturic Acid Measurement Particle Number Concentration The total number of particles per unit volume. Particle Number Concentration Po-210 Polonium-210 Radium F A measurement of the polonium-210 in a specimen. Polonium-210 Measurement Propionate Propionic Acid A measurement of the propionate in a specimen. Propionate Measurement Propionaldehyde A measurement of the propionaldehyde in a specimen. Propionaldehyde Measurement a-Propylene Glycol Alpha Propylene Glycol Propane-1,2-diol Propylene Glycol A measurement of the propylene glycol in a specimen. Propylene Glycol Measurement 1,2-Epoxypropane 2-Methyloxirane Propylene Oxide A measurement of the propylene oxide in a specimen. Propylene Oxide Measurement Portion Length The length of an individual unit of use along the longest edge. Portion Length Portion Mass The mass of an individual unit of use. Portion Mass Pouch Material Porosity The amount of empty space in the paper material of a pouch. Pouch Material Porosity Pouch Material Basis Weight The weight of a paper material based on standard size. Pouch Material Basis Weight Portion Material Thickness The distance between two opposing sides of the same fully-connected surface within an individual unit of use. Portion Material Thickness Portion Width The width of an individual unit of use along the second longest edge. Portion Width Puff Count The number of draws a tobacco product will deliver. Puff Count Quinoline A measurement of the quinoline in a specimen. Quinoline Measurement Selenium A measurement of the selenium in a specimen. Selenium Measurement S-Phenyl Mercapturic Acid S-Phenylmercapturate S-Phenylmercapturic Acid S-PMA A measurement of the S-phenylmercapturic acid in a specimen. S-Phenylmercapturic Acid Measurement Cinnamene Ethenylbenzene Phenylethylene Styrene Vinylbenzene A measurement of the styrene in a specimen. Styrene Measurement Hydroxycotinine Trans-3-Hydroxycotinine A measurement of the trans-3-hydroxycotinine in a specimen. Trans-3-Hydroxycotinine Measurement 3HC-Gluc Trans-3-Hydroxycotinine Glucuronide A measurement of the trans-3-hydroxycotinine glucuronide in a specimen. Trans-3-Hydroxycotinine Glucuronide Measurement Tobacco Filler Mass The mass of tobacco filler in a tobacco product. Tobacco Filler Mass Tobacco-Specific Nitrosamines A measurement of the tobacco-specific nitrosamines in a specimen. Tobacco-Specific Nitrosamines Measurement Tobacco Tar Tobacco Total Aerosol Residue A measurement of the tobacco tar in a specimen. Tobacco Tar Measurement Total Denier The linear mass density of fibers. Total Denier Tobacco Cut Size The physical dimensions of tobacco in a tobacco product. Tobacco Cut Size Methylbenzene Phenylmethane Toluene Toluol A measurement of the toluene in a specimen. Toluene Measurement Tobacco Particle Size The width of particles in tobacco smoke. Tobacco Particle Size Tobacco Rod Density The density of cut tobacco filler within its wrapper. Tobacco Rod Density Tipping Paper Length The length of the outer wrapping of the filter section of a product used to join the filter to the tobacco rod. Tipping Paper Length 3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole Trp-P-1 A measurement of the Trp-P-1 in a specimen. Trp-P-1 Measurement 1-Methyl-3-amino-5H-pyrido[4,3-b]indole Trp-P-2 A measurement of the Trp-P-2 in a specimen. Trp-P-2 Measurement Uranium-235 A measurement of the uranium-235 in a specimen. Uranium-235 Measurement Uranium-238 A measurement of the uranium-238 in a specimen. Uranium-238 Measurement Filter Ventilation Vf An assessment of the air entering the product through the filter joining paper (tipping paper) between the covered part of the mouth end and the beginning of the tobacco rod. (CORESTA) Filter Ventilation Total Ventilation The percentage of total air flow drawn through the sample via the sides of the filter, generally through perforations. (CORESTA) Total Product Ventilation Vinyl Acetate Vinyl Acetic Acid A measurement of the vinyl acetate in a specimen. Vinyl Acetate Measurement Vinyl Chloride A measurement of the vinyl chloride in a specimen. Vinyl Chloride Measurement Yeast and/or Mold Colony Count A measurement of the total number of yeast and/or mold colonies in a sample. Yeast and/or Mold Colony Count PTTESTCD Tobacco Product Testing Test Code CDISC SDTM Tobacco Product Testing Test Code Terminology Terminology relevant to the test names that describe tobacco product testing. 1,3-Butadiene A measurement of the 1,3-butadiene in a specimen. 1,3-Butadiene Measurement 1-Aminonaphthalene 1-Naphthylamine A measurement of the 1-aminonaphthalene in a specimen. 1-Aminonaphthalene Measurement 1-Hydroxynaphthalene 1-Naphthol A measurement of the 1-hydroxynaphthalene in a specimen. 1-Hydroxynaphthalene Measurement 1-Hydroxyphenanthrene A measurement of the 1-hydroxyphenanthrene in a specimen. 1-Hydroxyphenanthrene Measurement 1-Hydroxypyrene A measurement of the 1-hydroxypyrene in a specimen. 1-Hydroxypyrene Measurement 2,6-Dimethylaniline 2,6-Xylidine o-Xylidine A measurement of the 2,6-dimethylaniline in a specimen. 2,6-Dimethylaniline Measurement 2-Amino-3-Methyl-9H-Pyrido[2,3-b]indole MeA-a-C Mea-Alpha-C A measurement of the 2-Amino-3-Methyl-9H-Pyrido[2,3-b]indole in a specimen. 2-Amino-3-Methyl-9H-Pyrido[2,3-b]indole Measurement 2-Amino-3-Methylimidazo[4,5-f]quinoline IQ N3-IQ A measurement of the 2-amino-3-methylimidazo[4,5-f]quinoline in a specimen. 2-Amino-3-Methylimidazo[4,5-f]quinoline Measurement 2-Amino-9H-pyrido[2,3-b]indole A alpha C A-alpha-C A measurement of the 2-amino-9h-pyrido[2,3-b]indole in a specimen. 2-Amino-9H-pyrido[2,3-b]indole Measurement 2-Aminonaphthalene 2-Naphthylamine A measurement of the 2-aminonaphthalene in a specimen. 2-Aminonaphthalene Measurement 2-Carbamoyl Methyl Mercapturic Acid 2-Carbamoylethylmercapturic Acid 2CaEMA Acrylamide Mercapturic Acid Acrylamide Micturate N-Acetyl-S-carbamoylethyl-L-cysteine A measurement of the 2-carbamoylethylmercapturic acid in a specimen. 2-Carbamoylethylmercapturic Acid Measurement 2-Hydroxyfluorene A measurement of the 2-hydroxyfluorene in a specimen. 2-Hydroxyfluorene Measurement 2-Hydroxynaphthalene 2-NAP 2-Naphthol A measurement of the 2-hydroxynaphthalene in a specimen. 2-Hydroxynaphthalene Measurement 2-3PHE 2-Hydroxyphenanthrene A measurement of the 2-hydroxyphenanthrene in a specimen. 2-Hydroxyphenanthrene Measurement 2-Nitropropane 2-NP A measurement of the 2-nitropropane in a specimen. 2-Nitropropane Measurement 3-Hydroxybenz(a)pyrene 3-Hydroxybenz[a]pyrene 3-Hydroxybenzo(a)pyrene 3-Hydroxybenzo[a]pyrene A measurement of the 3-hydroxybenzo[a]pyrene in a specimen. 3-Hydroxybenzo[a]pyrene Measurement 3-Hydroxyfluorene A measurement of the 3-hydroxyfluorene in a specimen. 3-Hydroxyfluorene Measurement 3-Hydroxyphenanthrene A measurement of the 3-hydroxyphenanthrene in a specimen. 3-Hydroxyphenanthrene Measurement 4-ABP 4-Aminobiphenyl A measurement of the 4-aminobiphenyl in a specimen. 4-Aminobiphenyl Measurement 5-Methylchrysene A measurement of the 5-methylchrysene in a specimen. 5-Methylchrysene Measurement Acetaldehyde A measurement of the acetaldehyde in a specimen. Acetaldehyde Measurement Acetamide A measurement of the acetamide in a specimen. Acetamide Measurement Acetate Acetic Acid A measurement of the acetate in a specimen. Acetate Measurement 3-hydroxy-2-butanone 3-Hydroxybutanone Acetoin Acetyl Methyl Carbinol A measurement of the acetoin in a specimen. Acetoin Measurement Acetone A measurement of the acetone in a specimen. Acetone Measurement 2,3-Pentanedione Acetyl propionyl Acetylpropionyl A measurement of the acetyl propionyl in a specimen. Acetyl Propionyl Measurement Acrolein A measurement of the acrolein in a specimen. Acrolein Measurement Acrylamide A measurement of the acrylamide in a specimen. Acrylamide Measurement Acrylonitrile A measurement of the acrylonitrile in a specimen. Acrylonitrile Measurement Aerobic Colony Count A measurement of the number of aerobic colonies in a sample. Aerobic Colony Count Aflatoxin B1 A measurement of the aflatoxin B1 in a specimen. Aflatoxin B1 Measurement Airflow Rate The speed of the movement of air. Airflow Rate Ammonia NH3 A measurement of the ammonia in a specimen. Ammonia Measurement Anabasine A measurement of the anabasine in a specimen. Anabasine Measurement Anatabine A measurement of the anatabine in a specimen. Anatabine Measurement Arsenic As A measurement of the arsenic in a specimen. Arsenic Measurement Battery C-Rate Battery Current Rating C-Rate The rate at which a battery is discharged relative to its maximum capacity. Battery Current Rating Battery Capacity The total electric energy stored in a battery. Battery Capacity Battery Charging Temperature Limits The safe range of charging temperatures for a battery. Battery Charging Temperature Limits Battery Current Operating Range The range of current that a battery puts out to heat a heating element. Battery Current Operating Range Battery Discharge Temperature Limits The safe range of discharging temperatures for a battery. Battery Discharge Temperature Limits Battery End of Discharge Voltage The voltage at which a battery is considered completely discharged. Battery End of Discharge Voltage Battery Maximum Charging Current The greatest amount of current that a battery can accept during charging. Battery Maximum Charging Current Battery Maximum Discharging Current The greatest amount of current that a battery can discharge. Battery Maximum Discharging Current Battery Nominal Voltage The average voltage that a battery can output when fully charged. Battery Nominal Voltage Battery Upper Limit Charging Voltage The maximum voltage in charge for a battery. Battery Upper Limit Charging Voltage Battery Voltage Operating Range The maximum voltage in charge and minimum voltage in discharge for a battery. Battery Voltage Operating Range Benzene A measurement of the benzene in a specimen. Benzene Measurement Benz(a)anthracene Benz[a]anthracene Benzo(a)anthracene Benzo[a]anthracene A measurement of the benzo[a]anthracene in a specimen. Benzo[a]anthracene Measurement 3,4-Benzpyrene Benz(a)pyrene Benz[a]pyrene Benzo(a)pyrene Benzo[a]pyrene A measurement of the benzo[a]pyrene in a specimen. Benzo[a]pyrene Measurement Benz(b)fluoranthene Benz[b]fluoranthene Benzo(b)fluoranthene Benzo[b]fluoranthene A measurement of the benzo[b]fluoranthene in a specimen. Benzo[b]fluoranthene Measurement 1-Benzofuran Benz(b)furan Benz[b]furan Benzo(b)furan Benzo[b]furan Benzofuran Coumarone A measurement of the benzo[b]furan in a specimen. Benzo[b]furan Measurement Benz(c)phenanthrene Benz[c]phenanthrene Benzo(c)phenanthrene Benzo[c]phenanthrene A measurement of the benzo[c]phenanthrene in a specimen. Benzo[c]phenanthrene Measurement Benz(j)aceanthrylene Benz[j]aceanthrylene Benzo(j)aceanthrylene Benzo[j]aceanthrylene A measurement of the benzo[j]aceanthrylene in a specimen. Benzo[j]aceanthrylene Measurement Benz(k)fluoranthene Benz[k]fluoranthene Benzo(k)fluoranthene Benzo[k]fluoranthene A measurement of the benzo[k]fluoranthene in a specimen. Benzo[k]fluoranthene Measurement Benzoate Benzoic Acid A measurement of the benzoic acid in a specimen. Benzoic Acid Measurement Benzyl acetate Benzyl Acetic Acid A measurement of the benzyl acetate in a specimen. Benzyl Acetate Measurement BE Beryllium A measurement of the beryllium in a specimen. Beryllium Measurement Butanal Butyraldehyde A measurement of the butyraldehyde in a specimen. Butyraldehyde Measurement Cadmium A measurement of the cadmium in a specimen. Cadmium Measurement Caffeate Caffeic Acid A measurement of the caffeate in a specimen. Caffeate Measurement Carbon Monoxide A measurement of the carbon monoxide in a specimen. Carbon Monoxide Measurement Cartridge Volume The volume of a container that holds liquids or other substances and is part of a larger apparatus. Cartridge Volume Catechol A measurement of the catechol in a specimen. Catechol Measurement Chlorinated Dioxins and/or Furans A measurement of the chlorinated dioxins and/or furans in a specimen. Chlorinated Dioxins and/or Furans Measurement Chromium CR A measurement of the chromium in a specimen. Chromium Measurement Chrysene A measurement of the chrysene in a specimen. Chrysene Measurement Cigarette Base Paper Permeability The ease of passage of liquids, gases, or specific chemicals through the paper product that is used to wrap cigarettes. Cigarette Base Paper Permeability Cigarette Base Paper Porosity The amount of empty space in the paper product that is used to wrap cigarettes. Cigarette Base Paper Porosity Cigarette Paper Band Diffusivity An assessment of the gas or particle diffusivity across the cellulosic bands present on some cigarette papers, used to reduce a cigarette's smolder ability. Cigarette Paper Band Diffusivity Cigarette Paper Band Permeability An assessment of the gas or particle permeability through the cellulosic bands present on some cigarette papers, used to reduce a cigarette's smolder ability. Cigarette Paper Band Permeability Cigarette Paper Band Porosity An assessment of the porosity of the cellulosic bands present on some cigarette papers, used to reduce a cigarette's smolder ability. Cigarette Paper Band Porosity Cigarette Paper Band Space An assessment of the length of the spacing between two adjacent cellulosic bands present on some cigarette papers, used to reduce a cigarette's smolder ability. Cigarette Paper Band Space Cigarette Paper Band Width An assessment of the width of the cellulosic bands present on some cigarette papers, used to reduce a cigarette's smolder ability. Cigarette Paper Band Width Cigarette Paper Length The length of the paper product that is used to wrap the cigarette tobacco rod. Cigarette Paper Length Circumference The length of the closed curve of a circle; the size of something as given by the distance around it. (NCI) Circumference CO Cobalt A measurement of the cobalt in a specimen. Cobalt Measurement Cotinine Glucuronide Cotinine N-B-D-Glucuronide Cotinine N-beta-D-Glucuronide Cotinine-Glucuronide Cotinine-N-Glucuronide A measurement of the cotinine glucuronide in a specimen. Cotinine Glucuronide Measurement Cotinine-N-Oxide Cotinine-n-Oxide A measurement of the cotinine-N-oxide in a specimen. Cotinine-N-Oxide Measurement Coumarin A measurement of the coumarin in a specimen. Coumarin Measurement Count Median Diameter The median of the count distribution. Count Median Diameter Benzol Cresols Cresols (o-, m-, and p-cresol) Cresylic acid Hydroxytoluene Toluenol A measurement of the total cresols (o-, m-, and p-cresol) in a specimen. Cresol Measurement Crotonaldehyde A measurement of the crotonaldehyde in a specimen. Crotonaldehyde Measurement Acepyrene Cyclopenta(c,d)pyrene Cyclopenta[c,d]pyrene A measurement of the cyclopenta[c,d]pyrene in a specimen. Cyclopenta[c,d]pyrene Measurement Denier Per Filament The linear mass density of fibers per individual filament. Denier Per Filament Diacetyl A measurement of the diacetyl in a specimen. Diacetyl Measurement Dibenz(a,e)pyrene Dibenz[a,e]pyrene Dibenzo(a,e)pyrene Dibenzo[a,e]pyrene A measurement of the dibenzo[a,e]pyrene in a specimen. Dibenzo[a,e]pyrene Measurement Dibenz(a,h)anthracene Dibenz[a,h]anthracene Dibenzo(a,h)anthracene Dibenzo[a,h]anthracene A measurement of the dibenzo[a,h]anthracene in a specimen. Dibenzo[a,h]anthracene Measurement Dibenz(a,h)pyrene Dibenz[a,h]pyrene Dibenzo(a,h)pyrene Dibenzo[a,h]pyrene A measurement of the dibenzo[a,h]pyrene in a specimen. Dibenzo[a,h]pyrene Measurement Dibenz(a,i)pyrene Dibenz[a,i]pyrene Dibenzo(a,i)pyrene Dibenzo[a,i]pyrene A measurement of the dibenzo[a,i]pyrene in a specimen. Dibenzo[a,i]pyrene Measurement Dibenz(a,l)pyrene Dibenz[a,l]pyrene Dibenzo(a,l)pyrene Dibenzo[a,l]pyrene A measurement of the dibenzo[a,l]pyrene in a specimen. Dibenzo[a,l]pyrene Measurement Diethylene Glycol A measurement of the diethylene glycol in a specimen. Diethylene Glycol Measurement Draw Resistance The resistance of the tobacco rod and filter to air flow. Draw Resistance Dry Particulate Matter, Nicotine-Free Nicotine-Free Dry Particulate Matter A measurement of the nicotine-free dry particulate matter in a specimen. Nicotine-Free Dry Particulate Matter Measurement E-Liquid Viscosity The resistance of an e-liquid to sheer forces and flow. E-Liquid Viscosity E-Liquid Volume The amount of three dimensional space occupied by e-liquid. E-Liquid Volume Ethyl Acetate Ethyl Acetic Acid A measurement of the ethyl acetate in a specimen. Ethyl Acetate Measurement Ethyl 3-Oxobutanoate Ethyl Acetoacetate Ethyl Acetoacetic Acid Ethyl Acetylacetate A measurement of the ethyl acetoacetate in a specimen. Ethyl Acetoacetate Measurement Ethyl Carbamate Urethane A measurement of the ethyl carbamate in a specimen. Ethyl Carbamate Measurement Ethylbenzene A measurement of the ethylbenzene in a specimen. Ethylbenzene Measurement Ethane-1,2-diol Ethylene Glycol A measurement of the ethylene glycol in a specimen. Ethylene Glycol Measurement Ethylene Oxide A measurement of the ethylene oxide in a specimen. Ethylene Oxide Measurement Filter Density The mass of filter media per unit volume. Filter Density Filter Efficiency The percentage of contaminants removed by a filter medium. Filter Efficiency Filter Length The length of a product filter. Product Filter Length Filter Pressure Drop A measure of a filter's resistance to airflow. Filter Pressure Drop Filter Ventilation Vf An assessment of the air entering the product through the filter joining paper (tipping paper) between the covered part of the mouth end and the beginning of the tobacco rod. (CORESTA) Filter Ventilation Formaldehyde Formic Aldehyde Methanal A measurement of the formaldehyde in a specimen. Formaldehyde Measurement Furan A measurement of the furan in a specimen. Furan Measurement 2-Furaldehyde Furfural A measurement of the furfural in a specimen. Furfural Measurement 2-Amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole Glu-P-1 A measurement of the Glu-P-1 in a specimen. Glu-P-1 Measurement 2-Aminodipyrido[1,2-a:3',2'-d]imidazole Glu-P-2 A measurement of the Glu-P-2 in a specimen. Glu-P-2 Measurement Glycerol A measurement of the total glycerol in a specimen. Glycerol Measurement Glycidol A measurement of the glycidol in a specimen. Glycidol Measurement Heating Element Configuration The design of a heating element within a device. Heating Element Configuration Heating Element Diameter The diameter of a heating element within a device. Heating Element Diameter Heating Element Length The length of a heating element within a device. Heating Element Length Heating Element Range The temperature range of a heating element within a device during operation. Heating Element Range Heating Element Resistance The resistance encountered by the electrical current in a heating element within a device. Heating Element Resistance Hydrazine Levoxine A measurement of the hydrazine in a specimen. Hydrazine Measurement Hydrogen Cyanide A measurement of the hydrogen cyanide in a specimen. Hydrogen Cyanide Measurement Indeno(1,2,3-cd)pyrene Indeno[1,2,3-cd]pyrene o-Phenylenepyrene A measurement of the indeno[1,2,3-cd]pyrene in a specimen. Indeno[1,2,3-cd]pyrene Measurement Inhaled Aerosol Temperature The temperature of inhaled solid or liquid particles dispersed in a gas that is drawn into the body by breathing. Inhaled Aerosol Temperature Isoamyl Acetate Isoamyl Acetic Acid Isopentyl Acetate A measurement of the isoamyl acetate in a specimen. Isoamyl Acetate Measurement 2-Methylpropyl Ethanoate Isobutyl Acetate Isobutyl Acetic Acid A measurement of the isobutyl acetate in a specimen. Isobutyl Acetate Measurement Isoprene A measurement of the isoprene in a specimen. Isoprene Measurement Lead Pb A measurement of the lead in a specimen. Lead Measurement Length The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI) Length Hg Mercury A measurement of the mercury in a specimen. Mercury Measurement Methyl Acetate Methyl Acetic Acid A measurement of the methyl acetate in a specimen. Methyl Acetate Measurement MEK Methyl Ethyl Ketone A measurement of the methyl ethyl ketone in a specimen. Methyl Ethyl Ketone Measurement Moisture Moisture Content The total amount of water and other volatiles in an ingredient, component, or product. Moisture Content MHBMA Monohydroxybutyl Mercapturate Monohydroxybutyl Mercapturic Acid A measurement of the monohydroxybutyl mercapturic acid in a specimen. Monohydroxybutyl Mercapturic Acid Measurement 1-Butanol Butan-1-ol Butanol Butyl Alcohol n-Butanol N-Butyl Alcohol A measurement of the n-butanol in a specimen. n-Butanol Measurement N'-Nitrosoanabasine N-Nitrosoanabasine A measurement of the N-nitrosoanabasine in a specimen. N-Nitrosoanabasine Measurement N'-Nitrosoanatabine N-Nitrosoanatabine A measurement of the N-nitrosoanatabine in a specimen. N-Nitrosoanatabine Measurement N-Nitrosodiethanolamine NDELA A measurement of the N-nitrosodiethanolamine in a specimen. N-Nitrosodiethanolamine Measurement N-Nitrosodiethylamine NDEA A measurement of the N-nitrosodiethylamine in a specimen. N-Nitrosodiethylamine Measurement N-Nitrosodimethylamine NDMA A measurement of the N-nitrosodimethylamine in a specimen. N-Nitrosodimethylamine Measurement N-Nitrosomethylethylamine NEMA NMEA A measurement of the N-nitrosomethylethylamine in a specimen. N-Nitrosomethylethylamine Measurement N-Nitrosomorpholine NMOR A measurement of the N-nitrosomorpholine in a specimen. N-Nitrosomorpholine Measurement N-Nitrosonornicotine NNN A measurement of the N-nitrosonornicotine in a specimen. N-Nitrosonornicotine Measurement N-Nitrosopiperidine NPIP A measurement of the N-nitrosopiperidine in a specimen. N-Nitrosopiperidine Measurement N-Nitrosopyrrolidine NPYR A measurement of the N-nitrosopyrrolidine in a specimen. N-Nitrosopyrrolidine Measurement N-Nitrososarcosine NSAR A measurement of the N-nitrososarcosine in a specimen. N-Nitrososarcosine Measurement Naphthalene A measurement of the naphthalene in a specimen. Naphthalene Measurement Ni Nickel A measurement of the nickel in a specimen. Nickel Measurement Nicotine 1-N-Oxide Nicotine-1 N-Oxide A measurement of the nicotine 1-N-oxide in a specimen. Nicotine 1-N-Oxide Measurement Nicotine Dissolution Rate The rate at which nicotine dissolves in a medium. Nicotine Dissolution Rate Nicotine Glucuronide Nicotine N-glucuronide Nicotine-Glucuronide A measurement of the nicotine glucuronide in a specimen. Nicotine Glucuronide Measurement Nicotine A measurement of the nicotine in a specimen. Nicotine Measurement 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Nicotine-Derived Nitrosamine Ketone NNK A measurement of the nicotine-derived nitrosamine ketone in a specimen. Nicotine-Derived Nitrosamine Ketone Measurement Nitrobenzene A measurement of the nitrobenzene in a specimen. Nitrobenzene Measurement Nitromethane A measurement of the nitromethane in a specimen. Nitromethane Measurement 4-(Methylnitrosamino)-4-(3-pyridyl)-1-butanol NNAL A measurement of the total 4-(methylnitrosamino)-4-(3-pyridyl)-1-butanol (NNAL) in a specimen. NNAL Measurement 4-(Methylnitrosamino)-4-(3-pyridyl)-1-butanol, Free NNAL, Free A measurement of the free 4-(methylnitrosamino)-4-(3-pyridyl)-1-butanol (NNAL, Free) in a specimen. Free NNAL Measurement NNAL-N-Gluc NNAL-N-Glucuronide A measurement of the NNAL-N-gluc in a specimen. NNAL-N-Gluc Measurement NNAL-O-Gluc NNAL-O-Glucuronide A measurement of the NNAL-O-gluc in a specimen. NNAL-O-Gluc Measurement NNN-Glucuronide NNN-N-Glucuronide A measurement of the NNN-glucuronide in a specimen. NNN-Glucuronide Measurement Nornicotine A measurement of the nornicotine in a biological specimen. Nornicotine Measurement Number of Heating Elements The number of heating elements within a device. Number of Heating Elements 2-Anisidine 2-Methoxyaniline o-Anisidine Ortho-Anisidine A measurement of the o-anisidine in a specimen. o-Anisidine Measurement 2-Methylaniline 2-Toluidine o-Toluidine Ortho-Toluidine A measurement of the o-toluidine in a specimen. o-Toluidine Measurement Particle Number Concentration The total number of particles per unit volume. Particle Number Concentration Particulate Matter 2.5 The total number of particles or droplets per unit volume in the air that are 2.5 microns or less in width. Particulate Matter at 2.5um or Less Measurement PDU Current Cut-off The maximum operating current for a power distribution unit. Power Distribution Unit Current Cut-off PDU Current Operating Range The maximum to minimum operating current for a power distribution unit. Power Distribution Unit Current Operating Range PDU Temperature Cut-off The maximum operating temperature for a power distribution unit. Power Distribution Unit Temperature Cut-off PDU Voltage Operating Range The minimum to maximum operating voltage for a power distribution unit. Power Distribution Unit Voltage Operating Range PDU Wattage Operating Range The maximum to minimum operating wattage for a power distribution unit. Power Distribution Unit Wattage Operating Range pH The negative logarithm (base 10) of the concentration of hydronium ions, which is used as a measure of the acidity or alkalinity of a fluid. pH Carbolic Acid Hydroxybenzene Oxybenzene Phenic Acid Phenol Phenylic Acid A measurement of the phenol in a specimen. Phenol Measurement Phenylmercapturate Phenylmercapturic Acid A measurement of the phenylmercapturic acid in a specimen. Phenylmercapturic Acid Measurement 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]pyridine PhIP A measurement of the PhIP (2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]pyridine) in a specimen. PhIP Measurement Po-210 Polonium-210 Radium F A measurement of the polonium-210 in a specimen. Polonium-210 Measurement Portion Length The length of an individual unit of use along the longest edge. Portion Length Portion Mass The mass of an individual unit of use. Portion Mass Portion Material Thickness The distance between two opposing sides of the same fully-connected surface within an individual unit of use. Portion Material Thickness Portion Width The width of an individual unit of use along the second longest edge. Portion Width Pouch Material Basis Weight The weight of a paper material based on standard size. Pouch Material Basis Weight Pouch Material Porosity The amount of empty space in the paper material of a pouch. Pouch Material Porosity Propionaldehyde A measurement of the propionaldehyde in a specimen. Propionaldehyde Measurement Propionate Propionic Acid A measurement of the propionate in a specimen. Propionate Measurement a-Propylene Glycol Alpha Propylene Glycol Propane-1,2-diol Propylene Glycol A measurement of the propylene glycol in a specimen. Propylene Glycol Measurement 1,2-Epoxypropane 2-Methyloxirane Propylene Oxide A measurement of the propylene oxide in a specimen. Propylene Oxide Measurement Puff Count The number of draws a tobacco product will deliver. Puff Count Quinoline A measurement of the quinoline in a specimen. Quinoline Measurement S-Phenyl Mercapturic Acid S-Phenylmercapturate S-Phenylmercapturic Acid S-PMA A measurement of the S-phenylmercapturic acid in a specimen. S-Phenylmercapturic Acid Measurement Selenium A measurement of the selenium in a specimen. Selenium Measurement Cinnamene Ethenylbenzene Phenylethylene Styrene Vinylbenzene A measurement of the styrene in a specimen. Styrene Measurement Tipping Paper Length The length of the outer wrapping of the filter section of a product used to join the filter to the tobacco rod. Tipping Paper Length Tobacco Cut Size The physical dimensions of tobacco in a tobacco product. Tobacco Cut Size Tobacco Filler Mass The mass of tobacco filler in a tobacco product. Tobacco Filler Mass Tobacco Particle Size The width of particles in tobacco smoke. Tobacco Particle Size Tobacco Rod Density The density of cut tobacco filler within its wrapper. Tobacco Rod Density Tobacco Tar Tobacco Total Aerosol Residue A measurement of the tobacco tar in a specimen. Tobacco Tar Measurement Tobacco-Specific Nitrosamines A measurement of the tobacco-specific nitrosamines in a specimen. Tobacco-Specific Nitrosamines Measurement Methylbenzene Phenylmethane Toluene Toluol A measurement of the toluene in a specimen. Toluene Measurement Total Denier The linear mass density of fibers. Total Denier Total Ventilation The percentage of total air flow drawn through the sample via the sides of the filter, generally through perforations. (CORESTA) Total Product Ventilation 3HC-Gluc Trans-3-Hydroxycotinine Glucuronide A measurement of the trans-3-hydroxycotinine glucuronide in a specimen. Trans-3-Hydroxycotinine Glucuronide Measurement Hydroxycotinine Trans-3-Hydroxycotinine A measurement of the trans-3-hydroxycotinine in a specimen. Trans-3-Hydroxycotinine Measurement 3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole Trp-P-1 A measurement of the Trp-P-1 in a specimen. Trp-P-1 Measurement 1-Methyl-3-amino-5H-pyrido[4,3-b]indole Trp-P-2 A measurement of the Trp-P-2 in a specimen. Trp-P-2 Measurement Uranium-235 A measurement of the uranium-235 in a specimen. Uranium-235 Measurement Uranium-238 A measurement of the uranium-238 in a specimen. Uranium-238 Measurement Vinyl Acetate Vinyl Acetic Acid A measurement of the vinyl acetate in a specimen. Vinyl Acetate Measurement Vinyl Chloride A measurement of the vinyl chloride in a specimen. Vinyl Chloride Measurement aw Water Activity A measurement of the ratio of water vapor pressure in the sample to water vapor pressure of pure water Water Activity Measurement Yeast and/or Mold Colony Count A measurement of the total number of yeast and/or mold colonies in a sample. Yeast and/or Mold Colony Count PTTEST Tobacco Product Testing Test Name CDISC SDTM Tobacco Product Testing Test Name Terminology A terminology codelist relevant to the codes for tobacco product parameters. Battery Capacity The total electric energy stored in a battery. Battery Capacity Characterizing Flavor A taste, aroma, or sensation that is imparted either prior to or during consumption of a product or any of its components or parts. Characterizing Flavor Circumference The length of the closed curve of a circle; the size of something as given by the distance around it. (NCI) Circumference Diameter The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) Diameter Disposable Cartridge Indicator An indication as to whether the tobacco product contains a disposable cartridge. Disposable Electronic Cigarette Cartridge Indicator E-Liquid Volume The amount of three dimensional space occupied by e-liquid. E-Liquid Volume FDA STN FDA Submission Tracking Number The number that CTP assigns to submissions that are received from an applicant, such as a PMTA and a supplemental PMTA. (US FDA 21 CFR 1114.3) FDA CTP Submission Tracking Number Length The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI) Length Nicotine Concentration The amount of nicotine expressed as mass per volume. Nicotine Concentration Package Type A pack, box, carton, or container of any kind or, if no other container, any wrapping (including cellophane), in which a product is offered for sale, sold, or otherwise distributed to consumers. (FDA CTP) Package Type Product Quantity The mass, volume, or number of units of product. Product Quantity a-Propylene Glycol Alpha Propylene Glycol Propane-1,2-diol Propylene Glycol A measurement of the propylene glycol in a specimen. Propylene Glycol Measurement Portion Count The number of individual units of use. Portion Count Portion Length The length of an individual unit of use along the longest edge. Portion Length Portion Mass The mass of an individual unit of use. Portion Mass Portion Material Thickness The distance between two opposing sides of the same fully-connected surface within an individual unit of use. Portion Material Thickness Portion Width The width of an individual unit of use along the second longest edge. Portion Width Tobacco Product Category, Other A characterization or categorization of the tobacco product that is different than the one(s) previously specified or mentioned. Other Tobacco Product Category Tobacco Product Category A characterization or categorization of the tobacco product. Tobacco Product Category Tobacco Product Manufacturer Any person, including any repacker or relabeler, who (A) manufactures, fabricates, assembles, processes, or labels a tobacco product; or (B) imports a finished tobacco product for sale or distribution in the United States. (Family Smoking Prevention and Tobacco Control Act, 15 U.S.C. Section 1331-1340) Tobacco Product Manufacturer Tobacco Product Subcategory A subdivision of a tobacco product category. Tobacco Product Subcategory Tobacco Product Subcategory, Other A subdivision of a tobacco product category that is different than the one(s) previously specified or mentioned. Other Tobacco Product Subcategory Trade Name A commercial name granted by a naming authority for use in marketing a drug/device product. (CDISC Glossary) Proprietary Name Vegetable Glycerin A measurement of the vegetable glycerin in a sample. Vegetable Glycerin Measurement Total Ventilation The percentage of total air flow drawn through the sample via the sides of the filter, generally through perforations. (CORESTA) Total Product Ventilation Wattage The amount of electrical power consumed or generated as expressed in watts. Wattage TOPARMCD Tobacco Products Parameter Code CDISC SDTM Tobacco Products Parameter Code Terminology A terminology codelist relevant to the names for tobacco product parameters. Battery Capacity The total electric energy stored in a battery. Battery Capacity Characterizing Flavor A taste, aroma, or sensation that is imparted either prior to or during consumption of a product or any of its components or parts. Characterizing Flavor Circumference The length of the closed curve of a circle; the size of something as given by the distance around it. (NCI) Circumference Diameter The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) Diameter Disposable Cartridge Indicator An indication as to whether the tobacco product contains a disposable cartridge. Disposable Electronic Cigarette Cartridge Indicator E-Liquid Volume The amount of three dimensional space occupied by e-liquid. E-Liquid Volume FDA STN FDA Submission Tracking Number The number that CTP assigns to submissions that are received from an applicant, such as a PMTA and a supplemental PMTA. (US FDA 21 CFR 1114.3) FDA CTP Submission Tracking Number Length The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI) Length Nicotine Concentration The amount of nicotine expressed as mass per volume. Nicotine Concentration Package Type A pack, box, carton, or container of any kind or, if no other container, any wrapping (including cellophane), in which a product is offered for sale, sold, or otherwise distributed to consumers. (FDA CTP) Package Type Portion Count The number of individual units of use. Portion Count Portion Length The length of an individual unit of use along the longest edge. Portion Length Portion Mass The mass of an individual unit of use. Portion Mass Portion Material Thickness The distance between two opposing sides of the same fully-connected surface within an individual unit of use. Portion Material Thickness Portion Width The width of an individual unit of use along the second longest edge. Portion Width Product Quantity The mass, volume, or number of units of product. Product Quantity a-Propylene Glycol Alpha Propylene Glycol Propane-1,2-diol Propylene Glycol A measurement of the propylene glycol in a specimen. Propylene Glycol Measurement Tobacco Product Category A characterization or categorization of the tobacco product. Tobacco Product Category Tobacco Product Category, Other A characterization or categorization of the tobacco product that is different than the one(s) previously specified or mentioned. Other Tobacco Product Category Tobacco Product Manufacturer Any person, including any repacker or relabeler, who (A) manufactures, fabricates, assembles, processes, or labels a tobacco product; or (B) imports a finished tobacco product for sale or distribution in the United States. (Family Smoking Prevention and Tobacco Control Act, 15 U.S.C. Section 1331-1340) Tobacco Product Manufacturer Tobacco Product Subcategory A subdivision of a tobacco product category. Tobacco Product Subcategory Tobacco Product Subcategory, Other A subdivision of a tobacco product category that is different than the one(s) previously specified or mentioned. Other Tobacco Product Subcategory Total Ventilation The percentage of total air flow drawn through the sample via the sides of the filter, generally through perforations. (CORESTA) Total Product Ventilation Trade Name A commercial name granted by a naming authority for use in marketing a drug/device product. (CDISC Glossary) Proprietary Name Vegetable Glycerin A measurement of the vegetable glycerin in a sample. Vegetable Glycerin Measurement Wattage The amount of electrical power consumed or generated as expressed in watts. Wattage TOPARM Tobacco Products Parameter Name CDISC SDTM Tobacco Products Parameter Name Terminology The status of the subject's completion of the tobacco study or a segment of the study, or the reason the subject discontinued the tobacco study or segment of the study. Any unfavorable physical or psychological effect in a person that is temporally associated with the use of or exposure to a product, whether or not the person uses the product, and whether or not the effect is considered to be related to the use of or exposure to the product. (FDA) Adverse Experience To possess every necessary or normal part or component or step; having come or been brought to a conclusion. (NCI) Complete Died The absence of life or state of being dead. (NCI) Dead An indication that the subject has not been able to meet protocol-defined continuation criteria and will not continue to participate in the clinical trial. Failure To Meet Continuation Criteria An indication that the subject has been unable to fulfill/satisfy the criteria required for assignment into a randomized group. Failure to Meet Randomization Criteria A position, opinion or judgment reached after consideration by the study investigator, as pertains to the subject. Investigator Decision A problem with some logistical aspect of a clinical study, either on the part of the participant or the site. Logistical Problem With Clinical Study The loss or lack of continuation of a subject to follow-up. Lost To Follow-Up An indication that a study product was changed or discontinued because it is no longer beneficial to the subject or patient, based on the primary objective for which it is being administered and assessed. No Longer Benefiting An indication that a subject has not followed the instructions related to a device that is not under study. Non-Compliance With Non-Study Device An indication that a subject has not followed the instructions related to a device under study. Non-Compliance With Study Device An indication that a subject has not agreed with or followed the instructions related to the study product. Non-Compliance with Study Product An indication that a subject has not followed the schedule of study activities. Non-Compliance With Study Schedule An indication that the study subject's partner is pregnant. Partner Pregnancy Subject Pregnancy An indication that the subject is pregnant. Pregnant Subject A variation from processes or procedures defined in a protocol. Deviations usually do not preclude the overall evaluability of subject data for either efficacy or safety, and are often acknowledged and accepted in advance by the sponsor. NOTE: Good clinical practice recommends that deviations be summarized by site and by category as part of the report of study results so that the possible importance of the deviations to the findings of the study can be assessed. Compare to protocol violation. [See ICH E3] (CDISC Glossary) Protocol Deviation A significant departure from processes or procedures that were required by the protocol. Violations often result in data that are not deemed evaluable for a per-protocol analysis, and may require that the subject(s) who violate the protocol be discontinued from the study. Compare to protocol deviation. (CDISC Glossary) Protocol Violation An indication that the patient has met one or multiple protocol-specified withdrawal criteria and has been removed from the study or from one or more segments of the study. Protocol-Specified Withdrawal Criterion Met Randomized in Error An indication that the subject was randomized but should not have been. Randomized By Mistake A healing process and/or an outcome implying relative health. The term is typically used in the context of direct and indirect effects of sickness or injury. (NCI) Recovery An indication that the study subject needs to be treated with a medication that is prohibited per the protocol. Requires Prohibited Medication Failure to Meet Inclusion/Exclusion Criteria The potential subject who does not meet eligibility (inclusion/exclusion) criteria during the screening period. Trial Screen Failure An indication that the subject did not complete the screening process. Screening Not Completed An indication that a study was stopped at a particular study site by its applicant. Site Terminated by Applicant An indication that a study was stopped by its applicant. Study Terminated by Applicant A problem with some technical aspect of a clinical study, usually related to an instrument. (NCI) Technical Problem An indication that a study participant has been removed from the study or from one or more segments of the study by the parent or legal guardian. Study Subject Withdrawal by Parent or Guardian Dropout The subject-initiated act of discontinuing participation in the study as a whole or one or more aspects of the study (e.g., a study period or use of biospecimens). Withdrawal by Subject Informed Assent Withdrawn An indication that the assent to participate in the study, or one or more components of the study, has been revoked. Withdrawal of Assent Informed Consent Withdrawn An indication that the consent to participate in the study, or one or more components of the study, has been revoked. Study Consent Withdrawn TNCOMPLT Tobacco Study Completion/Reason for Non-Completion CDISC SDTM Tobacco Study Completion/Reason for Non-Completion Terminology Trail Making Test test code. TMT01-Time to Complete Trails A Trail Making Test - Time (in seconds) to complete Trails A. TMT - Time to Complete Trails A TMT01-Time to Complete Trails B Trail Making Test - Time (in seconds) to complete Trails B. TMT - Time to Complete Trails B TMT01TC Trail Making Test Functional Test Test Code CDISC Functional Test TMT Test Code Terminology Trail Making Test test name. TMT01-Time to Complete Trails A Trail Making Test - Time (in seconds) to complete Trails A. TMT - Time to Complete Trails A TMT01-Time to Complete Trails B Trail Making Test - Time (in seconds) to complete Trails B. TMT - Time to Complete Trails B TMT01TN Trail Making Test Functional Test Test Name CDISC Functional Test TMT Test Name Terminology Transition Dyspnea Index test code. TDI01-Change in Functional Impairment Transition Dyspnea Index - Change in functional impairment. TDI - Change in Functional Impairment TDI01-Change in Magnitude of Task Transition Dyspnea Index - Change in magnitude of task. TDI - Change in Magnitude of Task TDI01-Change in Magnitude of Effort Transition Dyspnea Index - Change in magnitude of effort. TDI - Change in Magnitude of Effort TDI01-Transition Focal Score Transition Dyspnea Index - Transition focal score. TDI - Transition Focal Score TDI01TC Transition Dyspnea Index Clinical Classification Test Code CDISC Clinical Classification TDI Test Code Terminology Transition Dyspnea Index test name. TDI01-Change in Functional Impairment Transition Dyspnea Index - Change in functional impairment. TDI - Change in Functional Impairment TDI01-Change in Magnitude of Effort Transition Dyspnea Index - Change in magnitude of effort. TDI - Change in Magnitude of Effort TDI01-Change in Magnitude of Task Transition Dyspnea Index - Change in magnitude of task. TDI - Change in Magnitude of Task TDI01-Transition Focal Score Transition Dyspnea Index - Transition focal score. TDI - Transition Focal Score TDI01TN Transition Dyspnea Index Clinical Classification Test Name CDISC Clinical Classification TDI Test Name Terminology Trauma Symptom Checklist for Children test code. TSCC01-Bad Dreams or Nightmares Trauma Symptom Checklist for Children - Bad dreams or nightmares. TSCC - Bad Dreams or Nightmares TSCC01-Afraid Something Bad Might Happen Trauma Symptom Checklist for Children - Feeling afraid something bad might happen. TSCC - Afraid Something Bad Might Happen TSCC01-Scary Ideas Just Pop Into My Head Trauma Symptom Checklist for Children - Scary ideas or pictures just pop into my head. TSCC - Scary Ideas Just Pop Into My Head TSCC01-Wanting to Say Dirty Words Trauma Symptom Checklist for Children - Wanting to say dirty words. TSCC - Wanting to Say Dirty Words TSCC01-Pretending I am Someone Else Trauma Symptom Checklist for Children - Pretending I am someone else. TSCC - Pretending I am Someone Else TSCC01-Arguing Too Much Trauma Symptom Checklist for Children - Arguing too much. TSCC - Arguing Too Much TSCC01-Feeling Lonely Trauma Symptom Checklist for Children - Feeling lonely. TSCC - Feeling Lonely TSCC01-Touching Private Parts Too Much Trauma Symptom Checklist for Children - Touching my private parts too much. TSCC - Touching Private Parts Too Much TSCC01-Feeling Sad or Unhappy Trauma Symptom Checklist for Children - Feeling sad or unhappy. TSCC - Feeling Sad or Unhappy TSCC01-Remembering Things I Didn't Like Trauma Symptom Checklist for Children - Remembering things that happened that I didn't like. TSCC - Remembering Things I Didn't Like TSCC01-Going Away in My Mind Trauma Symptom Checklist for Children - Going away in my mind, trying not to think. TSCC - Going Away in My Mind TSCC01-Remembering Scary Things Trauma Symptom Checklist for Children - Remembering scary things. TSCC - Remembering Scary Things TSCC01-Wanting to Yell and Break Things Trauma Symptom Checklist for Children - Wanting to yell and break things. TSCC - Wanting to Yell and Break Things TSCC01-Crying Trauma Symptom Checklist for Children - Crying. TSCC - Crying TSCC01-Getting Scared All of Sudden Trauma Symptom Checklist for Children - Getting scared all of a sudden and don't know why. TSCC - Getting Scared All of Sudden TSCC01-Getting Mad and Can't Calm Down Trauma Symptom Checklist for Children - Getting mad and can't calm down. TSCC - Getting Mad and Can't Calm Down TSCC01-Thinking About Having Sex Trauma Symptom Checklist for Children - Thinking about having sex. TSCC - Thinking About Having Sex TSCC01-Feeling Dizzy Trauma Symptom Checklist for Children - Feeling dizzy. TSCC - Feeling Dizzy TSCC01-Wanting to Yell at People Trauma Symptom Checklist for Children - Wanting to yell at people. TSCC - Wanting to Yell at People TSCC01-Wanting to Hurt Myself Trauma Symptom Checklist for Children - Wanting to hurt myself. TSCC - Wanting to Hurt Myself TSCC01-Wanting to Hurt Other People Trauma Symptom Checklist for Children - Wanting to hurt other people. TSCC - Wanting to Hurt Other People TSCC01-Think Touch People Private Parts Trauma Symptom Checklist for Children - Thinking about touching other people's private parts. TSCC - Think Touch People Private Parts TSCC01-Think About Sex When Don't Want Trauma Symptom Checklist for Children - Thinking about sex when I don't want to. TSCC - Think About Sex When Don't Want TSCC01-Feeling Scared of Men Trauma Symptom Checklist for Children - Feeling scared of men. TSCC - Feeling Scared of Men TSCC01-Feeling Scared of Women Trauma Symptom Checklist for Children - Feeling scared of women. TSCC - Feeling Scared of Women TSCC01-Washing Myself Because Feel Dirty Trauma Symptom Checklist for Children - Washing myself because I feel dirty on the inside. TSCC - Washing Myself Because Feel Dirty TSCC01-Feeling Stupid or Bad Trauma Symptom Checklist for Children - Feeling stupid or bad. TSCC - Feeling Stupid or Bad TSCC01-Feeling Like Did Something Wrong Trauma Symptom Checklist for Children - Feeling like I did something wrong. TSCC - Feeling Like Did Something Wrong TSCC01-Feeling Like Things Aren't Real Trauma Symptom Checklist for Children - Feeling like things aren't real. TSCC - Feeling Like Things Aren't Real TSCC01-Forgetting Things Trauma Symptom Checklist for Children - Forgetting things, can't remember things. TSCC - Forgetting Things TSCC01-Feeling Like I'm Not in My Body Trauma Symptom Checklist for Children - Feeling like I'm not in my body. TSCC - Feeling Like I'm Not in My Body TSCC01-Feeling Nervous or Jumpy Inside Trauma Symptom Checklist for Children - Feeling nervous or jumpy inside. TSCC - Feeling Nervous or Jumpy Inside TSCC01-Feeling Afraid Trauma Symptom Checklist for Children - Feeling afraid. TSCC - Feeling Afraid TSCC01-Not Trusting People Because Sex Trauma Symptom Checklist for Children - Not trusting people because they might want sex. TSCC - Not Trusting People Because Sex TSCC01-Can't Stop Thinking Something Bad Trauma Symptom Checklist for Children - Can't stop thinking about something bad that happened to me. TSCC - Can't Stop Thinking Something Bad TSCC01-Getting Into Fights Trauma Symptom Checklist for Children - Getting into fights. TSCC - Getting Into Fights TSCC01-Feeling Mean Trauma Symptom Checklist for Children - Feeling mean. TSCC - Feeling Mean TSCC01-Pretending I'm Somewhere Else Trauma Symptom Checklist for Children - Pretending I'm somewhere else. TSCC - Pretending I'm Somewhere Else TSCC01-Being Afraid of the Dark Trauma Symptom Checklist for Children - Being afraid of the dark. TSCC - Being Afraid of the Dark TSCC01-Scared When Think About Sex Trauma Symptom Checklist for Children - Getting scared or upset when I think about sex. TSCC - Scared When Think About Sex TSCC01-Worrying About Things Trauma Symptom Checklist for Children - Worrying about things. TSCC - Worrying About Things TSCC01-Feeling Like Nobody Likes Me Trauma Symptom Checklist for Children - Feeling like nobody likes me. TSCC - Feeling Like Nobody Likes Me TSCC01-Remembering Things Don't Want To Trauma Symptom Checklist for Children - Remembering things I don't want to remember. TSCC - Remembering Things Don't Want To TSCC01-Having Sex Feelings in My Body Trauma Symptom Checklist for Children - Having sex feelings in my body. TSCC - Having Sex Feelings in My Body TSCC01-My Mind Going Empty or Blank Trauma Symptom Checklist for Children - My mind going empty or blank. TSCC - My Mind Going Empty or Blank TSCC01-Feeling Like I Hate People Trauma Symptom Checklist for Children - Feeling like I hate people. TSCC - Feeling Like I Hate People TSCC01-Can't Stop Thinking About Sex Trauma Symptom Checklist for Children - Can't stop thinking about sex. TSCC - Can't Stop Thinking About Sex TSCC01-Trying Not to Have Any Feelings Trauma Symptom Checklist for Children - Trying not to have any feelings. TSCC - Trying Not to Have Any Feelings TSCC01-Feeling Mad Trauma Symptom Checklist for Children - Feeling mad. TSCC - Feeling Mad TSCC01-Feeling Afraid Somebody Kill Me Trauma Symptom Checklist for Children - Feeling afraid somebody will kill me. TSCC - Feeling Afraid Somebody Kill Me TSCC01-Wishing Bad Things Never Happened Trauma Symptom Checklist for Children - Wishing bad things had never happened. TSCC - Wishing Bad Things Never Happened TSCC01-Wanting to Kill Myself Trauma Symptom Checklist for Children - Wanting to kill myself. TSCC - Wanting to Kill Myself TSCC01-Daydreaming Trauma Symptom Checklist for Children - Daydreaming. TSCC - Daydreaming TSCC01-Getting Upset People Talk Sex Trauma Symptom Checklist for Children - Getting upset when people talk about sex. TSCC - Getting Upset People Talk Sex TSCC01TC Trauma Symptom Checklist for Children Questionnaire Test Code CDISC Questionnaire TSCC Test Code Terminology Trauma Symptom Checklist for Children test name. TSCC01-Afraid Something Bad Might Happen Trauma Symptom Checklist for Children - Feeling afraid something bad might happen. TSCC - Afraid Something Bad Might Happen TSCC01-Arguing Too Much Trauma Symptom Checklist for Children - Arguing too much. TSCC - Arguing Too Much TSCC01-Bad Dreams or Nightmares Trauma Symptom Checklist for Children - Bad dreams or nightmares. TSCC - Bad Dreams or Nightmares TSCC01-Being Afraid of the Dark Trauma Symptom Checklist for Children - Being afraid of the dark. TSCC - Being Afraid of the Dark TSCC01-Can't Stop Thinking About Sex Trauma Symptom Checklist for Children - Can't stop thinking about sex. TSCC - Can't Stop Thinking About Sex TSCC01-Can't Stop Thinking Something Bad Trauma Symptom Checklist for Children - Can't stop thinking about something bad that happened to me. TSCC - Can't Stop Thinking Something Bad TSCC01-Crying Trauma Symptom Checklist for Children - Crying. TSCC - Crying TSCC01-Daydreaming Trauma Symptom Checklist for Children - Daydreaming. TSCC - Daydreaming TSCC01-Feeling Afraid Somebody Kill Me Trauma Symptom Checklist for Children - Feeling afraid somebody will kill me. TSCC - Feeling Afraid Somebody Kill Me TSCC01-Feeling Afraid Trauma Symptom Checklist for Children - Feeling afraid. TSCC - Feeling Afraid TSCC01-Feeling Dizzy Trauma Symptom Checklist for Children - Feeling dizzy. TSCC - Feeling Dizzy TSCC01-Feeling Like Did Something Wrong Trauma Symptom Checklist for Children - Feeling like I did something wrong. TSCC - Feeling Like Did Something Wrong TSCC01-Feeling Like I Hate People Trauma Symptom Checklist for Children - Feeling like I hate people. TSCC - Feeling Like I Hate People TSCC01-Feeling Like I'm Not in My Body Trauma Symptom Checklist for Children - Feeling like I'm not in my body. TSCC - Feeling Like I'm Not in My Body TSCC01-Feeling Like Nobody Likes Me Trauma Symptom Checklist for Children - Feeling like nobody likes me. TSCC - Feeling Like Nobody Likes Me TSCC01-Feeling Like Things Aren't Real Trauma Symptom Checklist for Children - Feeling like things aren't real. TSCC - Feeling Like Things Aren't Real TSCC01-Feeling Lonely Trauma Symptom Checklist for Children - Feeling lonely. TSCC - Feeling Lonely TSCC01-Feeling Mad Trauma Symptom Checklist for Children - Feeling mad. TSCC - Feeling Mad TSCC01-Feeling Mean Trauma Symptom Checklist for Children - Feeling mean. TSCC - Feeling Mean TSCC01-Feeling Nervous or Jumpy Inside Trauma Symptom Checklist for Children - Feeling nervous or jumpy inside. TSCC - Feeling Nervous or Jumpy Inside TSCC01-Feeling Sad or Unhappy Trauma Symptom Checklist for Children - Feeling sad or unhappy. TSCC - Feeling Sad or Unhappy TSCC01-Feeling Scared of Men Trauma Symptom Checklist for Children - Feeling scared of men. TSCC - Feeling Scared of Men TSCC01-Feeling Scared of Women Trauma Symptom Checklist for Children - Feeling scared of women. TSCC - Feeling Scared of Women TSCC01-Feeling Stupid or Bad Trauma Symptom Checklist for Children - Feeling stupid or bad. TSCC - Feeling Stupid or Bad TSCC01-Forgetting Things Trauma Symptom Checklist for Children - Forgetting things, can't remember things. TSCC - Forgetting Things TSCC01-Getting Into Fights Trauma Symptom Checklist for Children - Getting into fights. TSCC - Getting Into Fights TSCC01-Getting Mad and Can't Calm Down Trauma Symptom Checklist for Children - Getting mad and can't calm down. TSCC - Getting Mad and Can't Calm Down TSCC01-Getting Scared All of Sudden Trauma Symptom Checklist for Children - Getting scared all of a sudden and don't know why. TSCC - Getting Scared All of Sudden TSCC01-Getting Upset People Talk Sex Trauma Symptom Checklist for Children - Getting upset when people talk about sex. TSCC - Getting Upset People Talk Sex TSCC01-Going Away in My Mind Trauma Symptom Checklist for Children - Going away in my mind, trying not to think. TSCC - Going Away in My Mind TSCC01-Having Sex Feelings in My Body Trauma Symptom Checklist for Children - Having sex feelings in my body. TSCC - Having Sex Feelings in My Body TSCC01-My Mind Going Empty or Blank Trauma Symptom Checklist for Children - My mind going empty or blank. TSCC - My Mind Going Empty or Blank TSCC01-Not Trusting People Because Sex Trauma Symptom Checklist for Children - Not trusting people because they might want sex. TSCC - Not Trusting People Because Sex TSCC01-Pretending I am Someone Else Trauma Symptom Checklist for Children - Pretending I am someone else. TSCC - Pretending I am Someone Else TSCC01-Pretending I'm Somewhere Else Trauma Symptom Checklist for Children - Pretending I'm somewhere else. TSCC - Pretending I'm Somewhere Else TSCC01-Remembering Scary Things Trauma Symptom Checklist for Children - Remembering scary things. TSCC - Remembering Scary Things TSCC01-Remembering Things Don't Want To Trauma Symptom Checklist for Children - Remembering things I don't want to remember. TSCC - Remembering Things Don't Want To TSCC01-Remembering Things I Didn't Like Trauma Symptom Checklist for Children - Remembering things that happened that I didn't like. TSCC - Remembering Things I Didn't Like TSCC01-Scared When Think About Sex Trauma Symptom Checklist for Children - Getting scared or upset when I think about sex. TSCC - Scared When Think About Sex TSCC01-Scary Ideas Just Pop Into My Head Trauma Symptom Checklist for Children - Scary ideas or pictures just pop into my head. TSCC - Scary Ideas Just Pop Into My Head TSCC01-Think About Sex When Don't Want Trauma Symptom Checklist for Children - Thinking about sex when I don't want to. TSCC - Think About Sex When Don't Want TSCC01-Think Touch People Private Parts Trauma Symptom Checklist for Children - Thinking about touching other people's private parts. TSCC - Think Touch People Private Parts TSCC01-Thinking About Having Sex Trauma Symptom Checklist for Children - Thinking about having sex. TSCC - Thinking About Having Sex TSCC01-Touching Private Parts Too Much Trauma Symptom Checklist for Children - Touching my private parts too much. TSCC - Touching Private Parts Too Much TSCC01-Trying Not to Have Any Feelings Trauma Symptom Checklist for Children - Trying not to have any feelings. TSCC - Trying Not to Have Any Feelings TSCC01-Wanting to Hurt Myself Trauma Symptom Checklist for Children - Wanting to hurt myself. TSCC - Wanting to Hurt Myself TSCC01-Wanting to Hurt Other People Trauma Symptom Checklist for Children - Wanting to hurt other people. TSCC - Wanting to Hurt Other People TSCC01-Wanting to Kill Myself Trauma Symptom Checklist for Children - Wanting to kill myself. TSCC - Wanting to Kill Myself TSCC01-Wanting to Say Dirty Words Trauma Symptom Checklist for Children - Wanting to say dirty words. TSCC - Wanting to Say Dirty Words TSCC01-Wanting to Yell and Break Things Trauma Symptom Checklist for Children - Wanting to yell and break things. TSCC - Wanting to Yell and Break Things TSCC01-Wanting to Yell at People Trauma Symptom Checklist for Children - Wanting to yell at people. TSCC - Wanting to Yell at People TSCC01-Washing Myself Because Feel Dirty Trauma Symptom Checklist for Children - Washing myself because I feel dirty on the inside. TSCC - Washing Myself Because Feel Dirty TSCC01-Wishing Bad Things Never Happened Trauma Symptom Checklist for Children - Wishing bad things had never happened. TSCC - Wishing Bad Things Never Happened TSCC01-Worrying About Things Trauma Symptom Checklist for Children - Worrying about things. TSCC - Worrying About Things TSCC01TN Trauma Symptom Checklist for Children Questionnaire Test Name CDISC Questionnaire TSCC Test Name Terminology Trauma Symptom Checklist for Young Children test code. TSCYC1-Temper Tantrums Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Temper tantrums. TSCYC - Temper Tantrums TSCYC1-Looking Sad Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Looking sad. TSCYC - Looking Sad TSCYC1-Telling a Lie Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Telling a lie. TSCYC - Telling a Lie TSCYC1-Bad Dreams or Nightmares Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Bad dreams or nightmares. TSCYC - Bad Dreams or Nightmares TSCYC1-Living in a Fantasy World Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Living in a fantasy world. TSCYC - Living in a Fantasy World TSCYC1-Seeming to Know More About Sex Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Seeming to know more about sex than he or she should. TSCYC - Seeming to Know More About Sex TSCYC1-Being Easily Scared Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Being easily scared. TSCYC - Being Easily Scared TSCYC1-Not Wanting to Go Somewhere Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Not wanting to go somewhere that reminded him or her of a bad thing from the past. TSCYC - Not Wanting to Go Somewhere TSCYC1-Worrying Food Was Poisoned Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Worrying that his or her food was poisoned. TSCYC - Worrying Food Was Poisoned TSCYC1-Flinching When Someone Moved Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Flinching or jumping when someone moved quickly or there was a loud noise. TSCYC - Flinching When Someone Moved TSCYC1-Being Bothered by Memories Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Being bothered by memories of something that happened to him or her. TSCYC - Being Bothered by Memories TSCYC1-Worrying Someone Might Be Sexual Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Worrying that someone might be sexual with him or her. TSCYC - Worrying Someone Might Be Sexual TSCYC1-Not Wanting to Talk Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Not wanting to talk about something that happened to him or her. TSCYC - Not Wanting to Talk TSCYC1-Not Do Something Supposed to Do Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Not doing something he or she was supposed to do. TSCYC - Not Do Something Supposed to Do TSCYC1-Breaking Things on Purpose Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Breaking things on purpose. TSCYC - Breaking Things on Purpose TSCYC1-Talking About Sexual Things Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Talking about sexual things. TSCYC - Talking About Sexual Things TSCYC1-Having Trouble Concentrating Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Having trouble concentrating. TSCYC - Having Trouble Concentrating TSCYC1-Blaming for Things Weren't Fault Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Blaming himself or herself for things that weren't his or her fault. TSCYC - Blaming for Things Weren't Fault TSCYC1-Acting Frightened Reminded Past Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Acting frightened when he or she was reminded of something that happened in the past. TSCYC - Acting Frightened Reminded Past TSCYC1-Pretending to Have Sex Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Pretending to have sex. TSCYC - Pretending to Have Sex TSCYC1-Worrying Bad Things in Future Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Worrying that bad things would happen in the future. TSCYC - Worrying Bad Things in Future TSCYC1-Arguing Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Arguing. TSCYC - Arguing TSCYC1-Getting Into Physical Fights Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Getting into physical fights. TSCYC - Getting Into Physical Fights TSCYC1-Drawing Pictures Upsetting Thing Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Drawing pictures about an upsetting thing that happened to him or her. TSCYC - Drawing Pictures Upsetting Thing TSCYC1-Not Noticing What He or She Doing Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Not noticing what he or she was doing. TSCYC - Not Noticing What He or She Doing TSCYC1-Having Trouble Sitting Still Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Having trouble sitting still. TSCYC - Having Trouble Sitting Still TSCYC1-Playing Games Something Bad Past Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Playing games about something bad that actually happened to him or her in the past. TSCYC - Playing Games Something Bad Past TSCYC1-Seeming to Be in a Daze Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Seeming to be in a daze. TSCYC - Seeming to Be in a Daze TSCYC1-Trouble Remember Upsetting Thing Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Having trouble remembering an upsetting thing that happened in the past. TSCYC - Trouble Remember Upsetting Thing TSCYC1-Using Drugs Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Using drugs. TSCYC - Using Drugs TSCYC1-Fear of the Dark Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Fear of the dark. TSCYC - Fear of the Dark TSCYC1-Being Afraid to Be Alone Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Being afraid to be alone. TSCYC - Being Afraid to Be Alone TSCYC1-Spacing Out Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Spacing out. TSCYC - Spacing Out TSCYC1-Being Too Aggressive Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Being too aggressive. TSCYC - Being Too Aggressive TSCYC1-Touching Other Private Parts Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Touching other children's or adults' private parts (under or over clothes). TSCYC - Touching Other Private Parts TSCYC1-Seeing Bad Happened in the Past Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Suddenly seeing, feeling, or hearing something bad that happened in the past. TSCYC - Seeing Bad Happened in the Past TSCYC1-Hearing Voices to Hurt Someone Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Hearing voices telling him or her to hurt someone. TSCYC - Hearing Voices to Hurt Someone TSCYC1-Staring Off Into Space Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Staring off into space. TSCYC - Staring Off Into Space TSCYC1-Changing Subject About Bad Thing Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Changing the subject or not answering when he or she was asked about a bad thing that happened to him or her. TSCYC - Changing Subject About Bad Thing TSCYC1-Having a Nervous Breakdown Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Having a nervous breakdown. TSCYC - Having a Nervous Breakdown TSCYC1-Not Happy Like Other Children Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not laughing or being happy like other children. TSCYC - Not Happy Like Other Children TSCYC1-Crying at Night Frightened Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Crying at night because he or she was frightened. TSCYC - Crying at Night Frightened TSCYC1-Hitting Adults Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Hitting adults (including parents). TSCYC - Hitting Adults TSCYC1-Being Frightened of Men Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Being frightened of men. TSCYC - Being Frightened of Men TSCYC1-Not Being Able to Pay Attention Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not being able to pay attention. TSCYC - Not Being Able to Pay Attention TSCYC1-Seeming to Be Million Miles Away Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Seeming to be a million miles away. TSCYC - Seeming to Be Million Miles Away TSCYC1-Being Easily Startled Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Being easily startled. TSCYC - Being Easily Startled TSCYC1-Watching Out for Possible Danger Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Watching out everywhere for possible danger. TSCYC - Watching Out for Possible Danger TSCYC1-No Longer Doing Things Enjoy Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: No longer doing things that he or she used to enjoy. TSCYC - No Longer Doing Things Enjoy TSCYC1-Frightened Something Sexual Seen Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Becoming frightened or disturbed when something sexual was mentioned or seen. TSCYC - Frightened Something Sexual Seen TSCYC1-Not Sleeping for Two or More Days Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not sleeping for two or more days. TSCYC - Not Sleeping for Two or More Days TSCYC1-Not Paying Attention in Own World Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not paying attention because he or she was in his or her own world. TSCYC - Not Paying Attention in Own World TSCYC1-Making Mistakes Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Making mistakes. TSCYC - Making Mistakes TSCYC1-Crying for No Obvious Reason Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Crying for no obvious reason. TSCYC - Crying for No Obvious Reason TSCYC1-Not Wanting to Be Around Someone Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not wanting to be around someone who did something bad to him or her or reminded him or her of something bad. TSCYC - Not Wanting to Be Around Someone TSCYC1-Being Tense Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Being tense. TSCYC - Being Tense TSCYC1-Worrying About People's Safety Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Worrying about other people's safety. TSCYC - Worrying About People's Safety TSCYC1-Very Angry Over a Little Thing Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Becoming very angry over a little thing. TSCYC - Very Angry Over a Little Thing TSCYC1-Drawing Pictures About Sex Things Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Drawing pictures about sexual things. TSCYC - Drawing Pictures About Sex Things TSCYC1-Pulling His or Her Hair Out Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Pulling his or her hair out. TSCYC - Pulling His or Her Hair Out TSCYC1-Calling Himself or Herself Bad Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Calling himself or herself bad, stupid, or ugly. TSCYC - Calling Himself or Herself Bad TSCYC1-Throwing Things at Friends/Family Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Throwing things at friends or family members. TSCYC - Throwing Things at Friends/Family TSCYC1-Getting Upset About the Past Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Getting upset about something in the past. TSCYC - Getting Upset About the Past TSCYC1-Temporary Blindness or Paralysis Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Temporary blindness or paralysis. TSCYC - Temporary Blindness or Paralysis TSCYC1-Getting Upset Something Sexual Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Getting upset about something sexual. TSCYC - Getting Upset Something Sexual TSCYC1-Not Going to Bed First Time Asked Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not going to bed at night the first time he or she was asked. TSCYC - Not Going to Bed First Time Asked TSCYC1-Fear He or She Killed by Someone Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Fear that he or she would be killed by someone. TSCYC - Fear He or She Killed by Someone TSCYC1-Saying Nobody Liked Him or Her Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Saying that nobody liked him or her. TSCYC - Saying Nobody Liked Him or Her TSCYC1-Crying When Reminded From Past Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Crying when he or she was reminded of something from the past. TSCYC - Crying When Reminded From Past TSCYC1-Saying Bad Didn't Happen Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Saying that something bad didn't happen to him or her even though it did happen. TSCYC - Saying Bad Didn't Happen TSCYC1-Saying He or She Wanted to Die Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Saying he or she wanted to die or be killed. TSCYC - Saying He or She Wanted to Die TSCYC1-Acting as If Didn't Have Feelings Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Acting as if he or she didn't have any feelings about something bad that happened to him or her. TSCYC - Acting as If Didn't Have Feelings TSCYC1-Whining Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Whining. TSCYC - Whining TSCYC1-Not Sleeping Well Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not sleeping well. TSCYC - Not Sleeping Well TSCYC1-Worrying About Sexual Things Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Worrying about sexual things. TSCYC - Worrying About Sexual Things TSCYC1-Being Frightened by Things Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Being frightened by things that didn't used to scare him or her. TSCYC - Being Frightened by Things TSCYC1-Hallucinating Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Hallucinating. TSCYC - Hallucinating TSCYC1-Acting Like He/She Was in Trance Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Acting like he or she was in a trance. TSCYC - Acting Like He or She Was in Trance TSCYC1-Forgetting His or Her Own Name Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Forgetting his or her own name. TSCYC - Forgetting His or Her Own Name TSCYC1-Upset When Reminded Bad Happened Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Getting upset when he or she was reminded of something bad that happened. TSCYC - Upset When Reminded Bad Happened TSCYC1-Avoiding Bad Happened in Past Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Avoiding things that reminded him or her of a bad thing that had happened in the past. TSCYC - Avoiding Bad Happened in Past TSCYC1-Acting Jumpy Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Acting jumpy. TSCYC - Acting Jumpy TSCYC1-Making a Mess Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Making a mess. TSCYC - Making a Mess TSCYC1-Acting Sad or Depressed Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Acting sad or depressed. TSCYC - Acting Sad or Depressed TSCYC1-Being Absent-minded Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Being so absent-minded that he or she didn't notice what was going on around him or her. TSCYC - Being Absent-minded TSCYC1-Not Wanting to Eat Certain Foods Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not wanting to eat certain foods. TSCYC - Not Wanting to Eat Certain Foods TSCYC1-Yelling at Family/Friend/Teachers Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Yelling at family, friends, or teachers. TSCYC - Yelling at Family, Friends or Teachers TSCYC1-Not Playing Because Depressed Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not playing because he or she was depressed. TSCYC - Not Playing Because Depressed TSCYC1-Being Disobedient Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Being disobedient. TSCYC - Being Disobedient TSCYC1-Intentionally Hurt Other Children Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Intentionally hurting other children or family members. TSCYC - Intentionally Hurt Other Children TSCYC1TC Trauma Symptom Checklist for Young Children Questionnaire Test Code CDISC Questionnaire TSCYC Test Code Terminology Trauma Symptom Checklist for Young Children test name. TSCYC1-Acting as If Didn't Have Feelings Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Acting as if he or she didn't have any feelings about something bad that happened to him or her. TSCYC - Acting as If Didn't Have Feelings TSCYC1-Acting Frightened Reminded Past Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Acting frightened when he or she was reminded of something that happened in the past. TSCYC - Acting Frightened Reminded Past TSCYC1-Acting Jumpy Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Acting jumpy. TSCYC - Acting Jumpy TSCYC1-Acting Like He/She Was in Trance Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Acting like he or she was in a trance. TSCYC - Acting Like He or She Was in Trance TSCYC1-Acting Sad or Depressed Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Acting sad or depressed. TSCYC - Acting Sad or Depressed TSCYC1-Arguing Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Arguing. TSCYC - Arguing TSCYC1-Avoiding Bad Happened in Past Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Avoiding things that reminded him or her of a bad thing that had happened in the past. TSCYC - Avoiding Bad Happened in Past TSCYC1-Bad Dreams or Nightmares Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Bad dreams or nightmares. TSCYC - Bad Dreams or Nightmares TSCYC1-Being Absent-minded Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Being so absent-minded that he or she didn't notice what was going on around him or her. TSCYC - Being Absent-minded TSCYC1-Being Afraid to Be Alone Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Being afraid to be alone. TSCYC - Being Afraid to Be Alone TSCYC1-Being Bothered by Memories Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Being bothered by memories of something that happened to him or her. TSCYC - Being Bothered by Memories TSCYC1-Being Disobedient Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Being disobedient. TSCYC - Being Disobedient TSCYC1-Being Easily Scared Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Being easily scared. TSCYC - Being Easily Scared TSCYC1-Being Easily Startled Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Being easily startled. TSCYC - Being Easily Startled TSCYC1-Being Frightened by Things Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Being frightened by things that didn't used to scare him or her. TSCYC - Being Frightened by Things TSCYC1-Being Frightened of Men Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Being frightened of men. TSCYC - Being Frightened of Men TSCYC1-Being Tense Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Being tense. TSCYC - Being Tense TSCYC1-Being Too Aggressive Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Being too aggressive. TSCYC - Being Too Aggressive TSCYC1-Blaming for Things Weren't Fault Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Blaming himself or herself for things that weren't his or her fault. TSCYC - Blaming for Things Weren't Fault TSCYC1-Breaking Things on Purpose Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Breaking things on purpose. TSCYC - Breaking Things on Purpose TSCYC1-Calling Himself or Herself Bad Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Calling himself or herself bad, stupid, or ugly. TSCYC - Calling Himself or Herself Bad TSCYC1-Changing Subject About Bad Thing Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Changing the subject or not answering when he or she was asked about a bad thing that happened to him or her. TSCYC - Changing Subject About Bad Thing TSCYC1-Crying at Night Frightened Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Crying at night because he or she was frightened. TSCYC - Crying at Night Frightened TSCYC1-Crying for No Obvious Reason Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Crying for no obvious reason. TSCYC - Crying for No Obvious Reason TSCYC1-Crying When Reminded From Past Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Crying when he or she was reminded of something from the past. TSCYC - Crying When Reminded From Past TSCYC1-Drawing Pictures About Sex Things Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Drawing pictures about sexual things. TSCYC - Drawing Pictures About Sex Things TSCYC1-Drawing Pictures Upsetting Thing Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Drawing pictures about an upsetting thing that happened to him or her. TSCYC - Drawing Pictures Upsetting Thing TSCYC1-Fear He or She Killed by Someone Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Fear that he or she would be killed by someone. TSCYC - Fear He or She Killed by Someone TSCYC1-Fear of the Dark Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Fear of the dark. TSCYC - Fear of the Dark TSCYC1-Flinching When Someone Moved Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Flinching or jumping when someone moved quickly or there was a loud noise. TSCYC - Flinching When Someone Moved TSCYC1-Forgetting His or Her Own Name Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Forgetting his or her own name. TSCYC - Forgetting His or Her Own Name TSCYC1-Frightened Something Sexual Seen Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Becoming frightened or disturbed when something sexual was mentioned or seen. TSCYC - Frightened Something Sexual Seen TSCYC1-Getting Into Physical Fights Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Getting into physical fights. TSCYC - Getting Into Physical Fights TSCYC1-Getting Upset About the Past Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Getting upset about something in the past. TSCYC - Getting Upset About the Past TSCYC1-Getting Upset Something Sexual Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Getting upset about something sexual. TSCYC - Getting Upset Something Sexual TSCYC1-Hallucinating Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Hallucinating. TSCYC - Hallucinating TSCYC1-Having a Nervous Breakdown Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Having a nervous breakdown. TSCYC - Having a Nervous Breakdown TSCYC1-Having Trouble Concentrating Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Having trouble concentrating. TSCYC - Having Trouble Concentrating TSCYC1-Having Trouble Sitting Still Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Having trouble sitting still. TSCYC - Having Trouble Sitting Still TSCYC1-Hearing Voices to Hurt Someone Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Hearing voices telling him or her to hurt someone. TSCYC - Hearing Voices to Hurt Someone TSCYC1-Hitting Adults Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Hitting adults (including parents). TSCYC - Hitting Adults TSCYC1-Intentionally Hurt Other Children Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Intentionally hurting other children or family members. TSCYC - Intentionally Hurt Other Children TSCYC1-Living in a Fantasy World Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Living in a fantasy world. TSCYC - Living in a Fantasy World TSCYC1-Looking Sad Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Looking sad. TSCYC - Looking Sad TSCYC1-Making a Mess Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Making a mess. TSCYC - Making a Mess TSCYC1-Making Mistakes Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Making mistakes. TSCYC - Making Mistakes TSCYC1-No Longer Doing Things Enjoy Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: No longer doing things that he or she used to enjoy. TSCYC - No Longer Doing Things Enjoy TSCYC1-Not Being Able to Pay Attention Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not being able to pay attention. TSCYC - Not Being Able to Pay Attention TSCYC1-Not Do Something Supposed to Do Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Not doing something he or she was supposed to do. TSCYC - Not Do Something Supposed to Do TSCYC1-Not Going to Bed First Time Asked Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not going to bed at night the first time he or she was asked. TSCYC - Not Going to Bed First Time Asked TSCYC1-Not Happy Like Other Children Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not laughing or being happy like other children. TSCYC - Not Happy Like Other Children TSCYC1-Not Noticing What He or She Doing Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Not noticing what he or she was doing. TSCYC - Not Noticing What He or She Doing TSCYC1-Not Paying Attention in Own World Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not paying attention because he or she was in his or her own world. TSCYC - Not Paying Attention in Own World TSCYC1-Not Playing Because Depressed Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not playing because he or she was depressed. TSCYC - Not Playing Because Depressed TSCYC1-Not Sleeping for Two or More Days Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not sleeping for two or more days. TSCYC - Not Sleeping for Two or More Days TSCYC1-Not Sleeping Well Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not sleeping well. TSCYC - Not Sleeping Well TSCYC1-Not Wanting to Be Around Someone Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not wanting to be around someone who did something bad to him or her or reminded him or her of something bad. TSCYC - Not Wanting to Be Around Someone TSCYC1-Not Wanting to Eat Certain Foods Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not wanting to eat certain foods. TSCYC - Not Wanting to Eat Certain Foods TSCYC1-Not Wanting to Go Somewhere Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Not wanting to go somewhere that reminded him or her of a bad thing from the past. TSCYC - Not Wanting to Go Somewhere TSCYC1-Not Wanting to Talk Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Not wanting to talk about something that happened to him or her. TSCYC - Not Wanting to Talk TSCYC1-Playing Games Something Bad Past Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Playing games about something bad that actually happened to him or her in the past. TSCYC - Playing Games Something Bad Past TSCYC1-Pretending to Have Sex Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Pretending to have sex. TSCYC - Pretending to Have Sex TSCYC1-Pulling His or Her Hair Out Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Pulling his or her hair out. TSCYC - Pulling His or Her Hair Out TSCYC1-Saying Bad Didn't Happen Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Saying that something bad didn't happen to him or her even though it did happen. TSCYC - Saying Bad Didn't Happen TSCYC1-Saying He or She Wanted to Die Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Saying he or she wanted to die or be killed. TSCYC - Saying He or She Wanted to Die TSCYC1-Saying Nobody Liked Him or Her Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Saying that nobody liked him or her. TSCYC - Saying Nobody Liked Him or Her TSCYC1-Seeing Bad Happened in the Past Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Suddenly seeing, feeling, or hearing something bad that happened in the past. TSCYC - Seeing Bad Happened in the Past TSCYC1-Seeming to Be in a Daze Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Seeming to be in a daze. TSCYC - Seeming to Be in a Daze TSCYC1-Seeming to Be Million Miles Away Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Seeming to be a million miles away. TSCYC - Seeming to Be Million Miles Away TSCYC1-Seeming to Know More About Sex Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Seeming to know more about sex than he or she should. TSCYC - Seeming to Know More About Sex TSCYC1-Spacing Out Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Spacing out. TSCYC - Spacing Out TSCYC1-Staring Off Into Space Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Staring off into space. TSCYC - Staring Off Into Space TSCYC1-Talking About Sexual Things Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Talking about sexual things. TSCYC - Talking About Sexual Things TSCYC1-Telling a Lie Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Telling a lie. TSCYC - Telling a Lie TSCYC1-Temper Tantrums Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Temper tantrums. TSCYC - Temper Tantrums TSCYC1-Temporary Blindness or Paralysis Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Temporary blindness or paralysis. TSCYC - Temporary Blindness or Paralysis TSCYC1-Throwing Things at Friends/Family Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Throwing things at friends or family members. TSCYC - Throwing Things at Friends/Family TSCYC1-Touching Other Private Parts Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Touching other children's or adults' private parts (under or over clothes). TSCYC - Touching Other Private Parts TSCYC1-Trouble Remember Upsetting Thing Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Having trouble remembering an upsetting thing that happened in the past. TSCYC - Trouble Remember Upsetting Thing TSCYC1-Upset When Reminded Bad Happened Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Getting upset when he or she was reminded of something bad that happened. TSCYC - Upset When Reminded Bad Happened TSCYC1-Using Drugs Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Using drugs. TSCYC - Using Drugs TSCYC1-Very Angry Over a Little Thing Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Becoming very angry over a little thing. TSCYC - Very Angry Over a Little Thing TSCYC1-Watching Out for Possible Danger Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Watching out everywhere for possible danger. TSCYC - Watching Out for Possible Danger TSCYC1-Whining Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Whining. TSCYC - Whining TSCYC1-Worrying About People's Safety Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Worrying about other people's safety. TSCYC - Worrying About People's Safety TSCYC1-Worrying About Sexual Things Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Worrying about sexual things. TSCYC - Worrying About Sexual Things TSCYC1-Worrying Bad Things in Future Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Worrying that bad things would happen in the future. TSCYC - Worrying Bad Things in Future TSCYC1-Worrying Food Was Poisoned Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Worrying that his or her food was poisoned. TSCYC - Worrying Food Was Poisoned TSCYC1-Worrying Someone Might Be Sexual Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Worrying that someone might be sexual with him or her. TSCYC - Worrying Someone Might Be Sexual TSCYC1-Yelling at Family/Friend/Teachers Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Yelling at family, friends, or teachers. TSCYC - Yelling at Family, Friends or Teachers TSCYC1TN Trauma Symptom Checklist for Young Children Questionnaire Test Name CDISC Questionnaire TSCYC Test Name Terminology Terminology relevant to the intended disease outcome for which the treatment is given. Any action or response that serves to eliminate disease and prevent recurrence. Cure Any action or response, without curative intent, that mitigates some or all of the unpleasant effects of a disease or condition. Palliative Prophylaxis Practices or interventions used to maintain health and prevent disease or injury. (CDISC Glossary) Preventive Intervention Any action or process to maximize comfort, minimize side effects, or mitigate against a decline in the participant's health or function. (clinicaltrials.gov) Supportive Care U UNK Unknown Not known, not observed, not recorded, or refused. (NCI) Unknown TRTINTNT Treatment Intent CDISC SDTM Treatment Intent Terminology Treatment Satisfaction Questionnaire for Medication Version 1.4 test code. TSQM01-Med to Prevent/Treat Condition Treatment Satisfaction Questionnaire for Medication - How satisfied or dissatisfied are you with the ability of the medication to prevent or treat your condition? TSQM Version 1.4 - Medication to Prevent or Treat Condition TSQM01-Way Medication Relieves Symptoms Treatment Satisfaction Questionnaire for Medication - How satisfied or dissatisfied are you with the way the medication relieves your symptoms? TSQM Version 1.4 - Way Medication Relieves Symptoms TSQM01-Time Takes Med to Start Working Treatment Satisfaction Questionnaire for Medication - How satisfied or dissatisfied are you with the amount of time it takes the medication to start working? TSQM Version 1.4 - Time Takes Medication to Start Working TSQM01-Experience Any Side Effect at All Treatment Satisfaction Questionnaire for Medication - As a result of taking this medication, do you experience any side effects at all? TSQM Version 1.4 - Experience Any Side Effect at All TSQM01-How Bothersome Are Side Effects Treatment Satisfaction Questionnaire for Medication - How bothersome are the side effects of the medication you take to treat your condition? TSQM Version 1.4 - How Bothersome Are Side Effects TSQM01-Interfere With Physical Health Treatment Satisfaction Questionnaire for Medication - To what extent do the side effects interfere with your physical health and ability to function (i.e., strength, energy levels, etc.)? TSQM Version 1.4 - Interfere With Physical Health TSQM01-Interfere With Mental Function Treatment Satisfaction Questionnaire for Medication - To what extent do the side effects interfere with your mental function (i.e., ability to think clearly, stay awake, etc.)? TSQM Version 1.4 - Interfere With Mental Function TSQM01-Side Effect Affect Overall Satisf Treatment Satisfaction Questionnaire for Medication - To what degree have medication side effects affected your overall satisfaction with the medication? TSQM Version 1.4 - Side Effect Affect Overall Satisfaction TSQM01-Easy/Difficult Use Medication Treatment Satisfaction Questionnaire for Medication - How easy or difficult is it to use the medication in its current form? TSQM Version 1.4 - Easy or Difficult Use Medication TSQM01-Easy/Difficult to Plan Use of Med Treatment Satisfaction Questionnaire for Medication - How easy or difficult is it to plan when you will use the medication each time? TSQM Version 1.4 - Easy or Difficult to Plan Use of Medication TSQM01-Convenient/Inconvenient Take Med Treatment Satisfaction Questionnaire for Medication - How convenient or inconvenient is it to take the medication as instructed? TSQM Version 1.4 - Convenient or Inconvenient Take Medication TSQM01-Confident Med Is Good for You Treatment Satisfaction Questionnaire for Medication - Overall, how confident are you that taking this medication is a good thing for you? TSQM Version 1.4 - Confident Medication Is Good for You TSQM01-Certain Good Things Outweigh Bad Treatment Satisfaction Questionnaire for Medication - How certain are you that the good things about your medication outweigh the bad things? TSQM Version 1.4 - Certain Good Things Outweigh Bad TSQM01-Satisfied/Dissatisfied With Med Treatment Satisfaction Questionnaire for Medication - Taking all things into account, how satisfied or dissatisfied are you with this medication? TSQM Version 1.4 - Satisfied or Dissatisfied With Medication TSQM01TC Treatment Satisfaction Questionnaire for Medication Version 1.4 Questionnaire Test Code CDISC Questionnaire TSQM Version 1.4 Test Code Terminology Treatment Satisfaction Questionnaire for Medication Version 1.4 test name. TSQM01-Certain Good Things Outweigh Bad Treatment Satisfaction Questionnaire for Medication - How certain are you that the good things about your medication outweigh the bad things? TSQM Version 1.4 - Certain Good Things Outweigh Bad TSQM01-Confident Med Is Good for You Treatment Satisfaction Questionnaire for Medication - Overall, how confident are you that taking this medication is a good thing for you? TSQM Version 1.4 - Confident Medication Is Good for You TSQM01-Convenient/Inconvenient Take Med Treatment Satisfaction Questionnaire for Medication - How convenient or inconvenient is it to take the medication as instructed? TSQM Version 1.4 - Convenient or Inconvenient Take Medication TSQM01-Easy/Difficult to Plan Use of Med Treatment Satisfaction Questionnaire for Medication - How easy or difficult is it to plan when you will use the medication each time? TSQM Version 1.4 - Easy or Difficult to Plan Use of Medication TSQM01-Easy/Difficult Use Medication Treatment Satisfaction Questionnaire for Medication - How easy or difficult is it to use the medication in its current form? TSQM Version 1.4 - Easy or Difficult Use Medication TSQM01-Experience Any Side Effect at All Treatment Satisfaction Questionnaire for Medication - As a result of taking this medication, do you experience any side effects at all? TSQM Version 1.4 - Experience Any Side Effect at All TSQM01-How Bothersome Are Side Effects Treatment Satisfaction Questionnaire for Medication - How bothersome are the side effects of the medication you take to treat your condition? TSQM Version 1.4 - How Bothersome Are Side Effects TSQM01-Interfere With Mental Function Treatment Satisfaction Questionnaire for Medication - To what extent do the side effects interfere with your mental function (i.e., ability to think clearly, stay awake, etc.)? TSQM Version 1.4 - Interfere With Mental Function TSQM01-Interfere With Physical Health Treatment Satisfaction Questionnaire for Medication - To what extent do the side effects interfere with your physical health and ability to function (i.e., strength, energy levels, etc.)? TSQM Version 1.4 - Interfere With Physical Health TSQM01-Med to Prevent/Treat Condition Treatment Satisfaction Questionnaire for Medication - How satisfied or dissatisfied are you with the ability of the medication to prevent or treat your condition? TSQM Version 1.4 - Medication to Prevent or Treat Condition TSQM01-Satisfied/Dissatisfied With Med Treatment Satisfaction Questionnaire for Medication - Taking all things into account, how satisfied or dissatisfied are you with this medication? TSQM Version 1.4 - Satisfied or Dissatisfied With Medication TSQM01-Side Effect Affect Overall Satisf Treatment Satisfaction Questionnaire for Medication - To what degree have medication side effects affected your overall satisfaction with the medication? TSQM Version 1.4 - Side Effect Affect Overall Satisfaction TSQM01-Time Takes Med to Start Working Treatment Satisfaction Questionnaire for Medication - How satisfied or dissatisfied are you with the amount of time it takes the medication to start working? TSQM Version 1.4 - Time Takes Medication to Start Working TSQM01-Way Medication Relieves Symptoms Treatment Satisfaction Questionnaire for Medication - How satisfied or dissatisfied are you with the way the medication relieves your symptoms? TSQM Version 1.4 - Way Medication Relieves Symptoms TSQM01TN Treatment Satisfaction Questionnaire for Medication Version 1.4 Questionnaire Test Name CDISC Questionnaire TSQM Version 1.4 Test Name Terminology Terminology relevant to the clinical trial or treatment setting for the therapy of interest. A clinical trial or treatment setting in which the therapy of interest is considered adjuvant. Adjuvant Therapy Clinical Trial Setting A clinical trial or treatment setting in which the therapy of interest is considered conditioning therapy. Conditioning Clinical Trial Setting A clinical trial or treatment setting in which the therapy of interest is considered consolidation therapy. Consolidation Clinical Trial Setting A clinical trial or treatment setting in which the therapy of interest is considered definitive. Definitive Clinical Trial Setting A clinical trial or treatment setting in which the therapy of interest is considered induction therapy. Induction Clinical Trial Setting A clinical trial or treatment setting in which the therapy of interest is used to treat locally advanced disease. Locally Advanced Disease Clinical Trial Setting A clinical trial or treatment setting in which the therapy of interest is considered maintenance therapy. Maintenance Clinical Trial Setting A clinical trial or treatment setting in which the therapy of interest is used to treat metastatic disease. Metastatic Disease Clinical Trial Setting A clinical trial or treatment setting in which the therapy of interest is considered mobilization therapy. Mobilization Clinical Trial Setting A clinical trial or treatment setting in which the therapy of interest is considered neo-adjuvant. Neoadjuvant Therapy Clinical Trial Setting A clinical trial or treatment setting in which the therapy of interest is considered preventative. Preventative Therapy Clinical Trial Setting Any action that serves to increase the toxic or lethal effect of radiation therapy on cells, through physical, chemical, or pharmaceutical intervention. Radiosensitization A clinical trial or treatment setting in which the therapy of interest is used to treat recurrent disease. Recurrent Disease Clinical Trial Setting A clinical trial or treatment setting in which the therapy of interest is considered salvage therapy. Salvage Clinical Trial Setting A clinical trial or treatment setting in which the therapy of interest is considered a transplant. Transplant Study U UNK Unknown Not known, not observed, not recorded, or refused. (NCI) Unknown TRTSET Treatment Setting CDISC SDTM Treatment Setting Terminology A terminology codelist relevant to the type of experimental design used to describe the level of awareness of the study subjects and/ or study personnel as it relates to the respective intervention(s) or assessments being observed, received or administered. Double Masked Double-Masked A study in which neither the subject nor the study personnel interacting with the subject or data during the study knows what intervention a subject is receiving. Double Blind Study A study in which the study personnel who measure, record, or assess the subject do not know which intervention the subject is receiving or, in the context of observational studies, do not know the external factors to which a subject has been exposed. Observer Blind Study A study in which the therapeutic treatment is open label but the dosing information of the investigational medicinal product (IMP) is double-blinded. Open Label for Treatment And Double Blind to Dose A study in which subjects and study personnel know which intervention each subject is receiving. Open Label Study Single Masked Single-Masked A study in which one party, either the subject or study personnel, does not know which intervention is administered to the subject. Single Blind Study TBLIND Trial Blinding Schema Response CDISC SDTM Trial Blinding Schema Terminology A terminology codelist relevant to the responses for the planned purpose of the therapy, device, or agent under study in the clinical trial. Basic Research A type of study designed to examine the basic mechanism of action (e.g., physiology, biomechanics) of an intervention. (ClinicalTrials.gov) Basic Research A type of study designed to evaluate intervention(s) aimed to cure a disease or condition. Cure Study An intervention of a device product is being evaluated to determine the feasibility of the product or to test a prototype device and not health outcomes. Such studies are conducted to confirm the design and operating specifications of a device before beginning a full clinical trial. (ClinicalTrials.gov) Device Feasibility Study A type of study designed to evaluate intervention(s) aimed at identifying a disease or condition. Diagnosis Study A type of study designed to evaluate the effects of treatment(s) intended to cause a change in disease, syndrome, or condition beyond the point of treatment administration. Disease Modifying Treatment Study A type of study designed to evaluate the delivery, processes, management, organization or financing of health care. (ClinicalTrials.gov) Health Services Research A type of study designed to identify actions necessary to eliminate or reduce the risk to human life or well-being as a result of a particular medication or treatment regimen. (NCI) Adverse Effect Mitigation Study Prophylaxis Study A type of study designed to identify actions necessary to permanently eliminate or reduce the long-term risk to human life as a result of a particular medication or treatment regimen. Prevention Study A type of study designed to assess or examine methods of identifying a condition (or risk factors for a condition) in people who are not yet known to have the condition (or risk factor). (Clinicaltrials.gov) Screening Study A type of study designed to evaluate one or more interventions where the primary intent is to maximize comfort, minimize side effects or mitigate against a decline in the subject's health or function. In general, supportive care interventions are not intended to cure a disease. (ClinicalTrials.gov) Supportive Care Study Therapy Trial A type of study designed to evaluate intervention(s) for treatment of disease, syndrome or condition. Treatment Study TINDTP Trial Intent Type Response CDISC SDTM Trial Indication Type Terminology A terminology codelist relevant to a step in the clinical research and development of a therapy from initial clinical trials to post-approval studies. 0 Phase 0 Trial Pre-clinical Trial Trial Phase 0 First-in-human trials, in a small number of subjects, that are conducted before Phase 1 trials and are intended to assess new candidate therapeutic and imaging agents. The study agent is administered at a low dose for a limited time, and there is no therapeutic or diagnostic intent. NOTE: FDA Guidance for Industry, Investigators, and Reviewers: Exploratory IND Studies, January 2006 classifies such studies as Phase 1. NOTE: A Phase 0 study might not include any drug delivery but may be an exploration of human material from a study (e.g., tissue samples or biomarker determinations). [Improving the Quality of Cancer Clinical Trials: Workshop summary-Proceedings of the National Cancer Policy Forum Workshop, improving the Quality of Cancer Clinical Trials (Washington, DC, Oct 2007)] (CDISC glossary) Early Phase 1 Trial NA Not Applicable Determination of a value is not relevant in the current context. (NCI) Not Applicable 1 Trial Phase 1 The initial introduction of an investigational new drug into humans. Phase 1 studies are typically closely monitored and may be conducted in patients or normal volunteer subjects. NOTE: These studies are designed to determine the metabolism and pharmacologic actions of the drug in humans, the side effects associated with increasing doses, and, if possible, to gain early evidence on effectiveness. During Phase 1, sufficient information about the drug's pharmacokinetics and pharmacological effects should be obtained to permit the design of well-controlled, scientifically valid, Phase 2 studies. The total number of subjects and patients included in Phase I studies varies with the drug, but is generally in the range of 20 to 80. Phase 1 studies also include studies of drug metabolism, structure-activity relationships, and mechanism of action in humans, as well as studies in which investigational drugs are used as research tools to explore biological phenomena or disease processes. [After FDA CDER Handbook, ICH E8] (CDISC glossary) Phase I Trial 1-2 Trial Phase 1-2 A class of clinical study that combines elements characteristic of traditional Phase I and Phase II trials. See also Phase I, Phase II. Phase I/II Trial 1/2/3 Trial Phase 1/2/3 A study that begins as a Phase I study and transitions into Phases II and III based upon successful completion of each previous portion. Phase I/II/III Trial 1/3 Trial Phase 1/3 A study that begins as a Phase I study and transitions into a Phase III study upon successful completion of the Phase I portion. Phase I/III Trial 1A Trial Phase 1A A type of phase 1 trial with a single ascending dose (dose escalation) in a smaller group of patients (in comparison to a Phase 1B). Phase Ia Trial 1B Trial Phase 1B A type of phase 1 trial with multiple ascending doses (dose expansion) in a larger group of patients (in comparison to a Phase 1A). Phase Ib Trial 2 Trial Phase 2 Phase that includes the controlled clinical trials conducted to evaluate the safety and efficacy of the drug in a limited number of patients with the disease or condition under study. Objectives can be dose-ranging (dose-response, frequency of dosing), type of patients, or numerous other characteristics of safety and efficacy. [After 21 CRF Part 312.21 Phases of an investigation] See also phase, phase 2a, phase 2b. (CDISC Glossary) Phase II Trial 2-3 Trial Phase 2-3 A class of clinical study that combines elements characteristic of traditional Phase II and Phase III trials. Phase II/III Trial 2A Trial Phase 2A Early Phase 2 trials that focus on a proof-of-concept assessment of efficacy and safety in a small number of patients. [After FDA Guidance for industry end of Phase 2a meetings, September 2009] (CDISC Glossary) Phase IIa Trial 2B Trial Phase 2B Later Phase 2 trials, in transition to Phase 3, where the study populations more closely reflect the population, dosage, and condition for intended use. [Clarification of FDA Guidance for industry end of Phase 2a meetings, September 2009; Discussion in Peter B. Gilbert. SOME DESIGN ISSUES IN PHASE 2B VERSUS PHASE 3 PREVENTION TRIALS FOR TESTING EFFICACY OF PRODUCTS OR CONCEPTS. Stat Med. 2010 May 10; 29(10): 1061-1071.] Phase IIb Trial 3 Trial Phase 3 Phase that includes the controlled clinical trials intended to confirm safety and effectiveness, evaluate the overall benefit-risk relationship, and to provide substantial evidence for regulatory approval and labeling. NOTE: Phase 3 studies usually include from several hundred to several thousand subjects. [After ICH E8; Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products Draft Guidance for Industry. December 2019] See also phase, phase 3b. (CDISC Glossary) Phase III Trial 3A Trial Phase 3A A classification typically assigned retrospectively to a Phase III trial upon determination by regulatory authorities of a need for a Phase III B trial. (NCI) Phase IIIa Trial 3B Trial Phase 3B Later Phase 3 trial done near the time of approval to elicit additional findings. NOTE: Dossier review may continue while associated Phase 3b trials are conducted. These trials may be required as a condition of regulatory authority approval. Phase 3a is in common usage but not reflected in regulatory guidance. (CDISC Glossary) Phase IIIb Trial 4 Trial Phase 4 Post-approval studies to delineate additional information about the drug's risks, benefits, and optimal use that may be requested by regulatory authorities in conjunction with marketing approval. NOTE: Phase 4 studies could include, but would not be limited to, studying different doses or schedules of administration than were used in Phase 2 studies, use of the drug in other patient populations or other stages of the disease, or use of the drug over a longer period of time. [after FDA CDER handbook, ICH E8] See also phase. (CDISC Glossary) Phase IV Trial 5 Trial Phase 5 Postmarketing surveillance is sometimes referred to as Phase V. Phase V Trial TPHASE Trial Phase Response CDISC SDTM Trial Phase Terminology The test code for an individual characteristic of a clinical trial, e.g. description of trial design, trial blinding schema, and primary objective of trial. Actual Number of Subjects Actual number of subjects enrolled; may include subjects who were not randomized. Actual Subject Number Adaptive Design Indicate if the study includes a prospectively planned opportunity for modification of one or more specified aspects of the study design and hypotheses based on analysis of data (usually interim data) from subjects in the study. Adaptive Study Design Indicator Added on to Existing Treatments The addition of a therapeutic or other study product to the existing regimen in a study, where both entities remain as discrete products. Test Product Added to Existing Treatment Planned Maximum Age of Subjects The anticipated maximum age of the subjects to be entered in a clinical trial. (NCI) Planned Maximum Age of Subjects Planned Minimum Age of Subjects The anticipated minimum age of the subjects to be entered in a clinical trial. (NCI) Planned Minimum Age of Subjects Applicant Applicant Organization Applicant Organization Name Any party, which may include the tobacco manufacturer and its authorized representative, who is subject to FDA's jurisdiction under chapter IX of the FD&C Act and submits an application to FDA for authority to market a tobacco product. (After PMTA Rule 21 CFR Part 1114 2021; SE Final Rule 21 CFR Part 1107 2021) US FDA Tobacco Product Applicant Biospecimen Retention Contains DNA Ind An indication as to whether retained biospecimens contain DNA. Retained Biospecimen Contains DNA Indicator Biospecimen Retention Indicator An indication as to whether biospecimens were retained. Biospecimen Retention Indicator Challenge Agent Name The name of the non-investigational medicinal product (NIMP) given to trial subjects to produce a physiological response that is necessary before the pharmacological action of the investigational medicinal product can be assessed. [After Recommendations from the expert group on clinical trials for the implementation of Regulation (EU) No 536/2014' dd 28 June 2017] Challenge Agent Name Citation Used in Study A bibliographical reference related to a particular study. Clinical Study Citation Commercial Sponsor Status The state or condition of the sponsor as pertains to whether the sponsor is considered a commercial entity. Sponsor Commercial Status Comparative Treatment Name A therapeutically active agent that is intended to provide reference measurements for the experimental protocol of a clinical trial. Active Comparator Drug Contact E-Mail Address E-mail address of study contact. Study Contact E-mail Address Contact Mailing Address Mailing address of study contact. Study Contact Postal Address Contact Name Name of study contact. Study Contact Name Contact Phone Number Phone number of study contact. Study Contact Telephone Number Contact Role The role that the responsible individual or entity plays with respect to being a contact for the study. Study Contact Role Confirmed Response Minimum Duration The protocol specified minimum amount of time needed to meet the definition of a confirmed response to treatment. Confirmed Response Minimum Duration Clinical Study Report Archive Date The date when the clinical study report was archived. Clinical Study Report Archive Date CDISC Therapeutic Area User Guide The name and version of the CDISC therapeutic area user guide that is being used in the study submission. CDISC Therapeutic Area User Guide Name and Version Background Treatment Current Therapy or Treatment The name of a protocol-specified background treatment(s), that is (are) a medication currently being taken as a standard of care for a particular condition/disease. Current Therapy Data Cutoff Description Text that describes the cutoff date. Data Cutoff Date Description Data Cutoff Date A date which indicates any data collected by this date will be used for analysis. Data Cutoff Date Delayed Graft Function Diagnostic Criteria Delayed Graft Function Dx Criteria A standard by which the determination of delayed graft function (DGF) is established. Delayed Graft Function Diagnostic Criteria Name Data Monitoring Committee Indicator An indication as to whether the clinical trial has an appointed data monitoring committee. Data Monitoring Committee Indicator Dose Level Dose per Administration The quantity of an agent (e.g., drug, product, substance, radiation) within a single administration. Dose Dose Form Physical characteristics of a product, (e.g., tablet, capsule, solution) that contains a substance, generally (but not necessarily) in association with 1 or more other ingredients. Pharmaceutical Dosage Form Dosing Frequency The number of doses administered per a specific interval. Dose Frequency Dose Regimen The planned schedule for the administration of an agent (e.g., drug, product, substance, radiation). Dose Regimen Dose Units The unit of measure for the dosage form. Dosage Form Unit Diagnostic Criteria A standard from which a judgment concerning a medical diagnosis can be established. Diagnostic Criteria ECG Reading Blinded Indicates whether assessors of ECGs for this study were blinded to subject identity, timing and treatment. ECG Evaluator Blinding Parameters ECG Continuous Monitoring Indicates whether the 10-second ECGs for this study were extracted from a continuous recording. ECG Continuous Monitoring Indicator ECG Planned Primary Lead The ECG lead which was planned to be used for ECG interval measurements for this study. ECG Planned Primary Lead for Study ECG Used Same Lead Indicates whether all ECG interval measurements for the study were based on the same lead. ECG Used Same Lead Indicator ECG Read Method The degree of automation involved in assessing the ECGs for this study. ECG Read Method Degree of Automation ECG Replicates at Baseline Indicates whether this study includes replicate ECGs for time points during the baseline portion of the study. ECG Replicates at Baseline Indicator ECG Replicates On-Treatment Indicates whether this study includes replicate ECGs for time points during the on-treatment portion of the study. ECG Replicates On-Treatment Indicator ECG Twave Algorithm The algorithm used to identify the end of the T wave for ECGs for this study. ECG T Wave Algorithm Email Address for XML File The Email address to which copies of the XML format of the EudraCT application should be sent. E-mail Address for XML File Feedback EMA Decision Number for PIP An alphanumeric code assigned by the European Medicines Agency (EMA) to an EMA regulatory decision for a pediatric investigation plan (PIP). EMA Decision Number for Pediatric Investigation Plan Epi/Pandemic Related Disruption Ind Epidemic Related Disruption Indicator An indication as to whether the study disruption was caused by the epidemic or pandemic. Epidemic or Pandemic Related Disruption Indicator Name of Epi/Pandemic Name of Epidemic and/or Pandemic The literal identifier of the epidemic and/or pandemic. Name of Epidemic or Pandemic EudraCT Resubmission Indicator An indication as to whether the trial being submitted to the EudraCT is a trial that has been previously submitted to the EudraCT system. EudraCT Resubmission Indicator EudraVigilance Sender ID A unique identifier assigned to the organization that is transmitting an adverse drug reaction report to the EudraVigilance system. EudraVigilance Sender Identifier EudraVigilance Sender Organization The name of the group or institution that is transmitting an adverse drug reaction report to the EudraVigilance system. EudraVigilance Sender Organization Expanded Access Record NCT Number The unique alphanumeric identifier for the study with associated expanded access record, as assigned by the clinicaltrials.gov protocol registration and results system (PRS). Clinicaltrials.gov NCT Number for the Expanded Access Record Expanded Access Status Status indicating availability of an experimental drug or device outside any clinical trial protocol. (clinicaltrials.gov) Trial Expanded Access Status Extension Trial Indicator An indication as to whether the clinical trial is an extension trial. Extension Trial Indicator Planned Country of Investigational Sites The country name of planned study facility which has received IRB approval. Planned Country of Investigational Site FDA-Regulated Device Study Indicator An indication as to whether the study involves an FDA-regulated device. FDA-Regulated Device Study Indicator FDA-Regulated Drug Study Indicator An indication as to whether the study involves an FDA-regulated drug. FDA-Regulated Drug Study Indicator FDA Technical Specification The name and version of the FDA technical specification that is being used in the study submission. FDA Technical Specification Name and Version Healthy Subject Indicator Indicate if persons who have not had the condition(s) being studied or otherwise related conditions or symptoms, as specified in the eligibility requirements, may participate in the study. Healthy Subject Indicator Indication for Use Trial Disease/Condition Indication Trial Disease/Condition Indication Description A narrative representation of the condition, disease or disorder that the clinical trial is intended to investigate or address. Trial Indication Intervention Model The general design of the strategy for assigning interventions to participants in a clinical study. (clinicaltrials.gov) Intervention Model Intervention Type The kind of product or procedure studied in a trial. Intervention Type Protocol Keyword A word or small set of words designed to convey the focus of the protocol. Protocol Keyword Trial Length Planned length of observation for a single subject. Trial Length Country of Manufacture The name of the country within which the final product under study is produced. Country of Manufacture Multiple Site EU State Trial Indicator An indication as to whether the clinical study is being conducted at multiple sites within the European Union member state concerned by the application. Multiple Site European Union State Trial Indicator Planned Number of Arms The planned number of intervention groups. Planned Number of Arms Number of Groups/Cohorts The number of groups or cohorts that are part of the study. Number of Groups or Cohorts Number of Trial Sites EU State The total number of trial sites within the European Union member state concerned by the application. Number of Trial Sites within European Union State Study Exploratory Objective Trial Exploratory Objective Additional scientific question(s) within the study that enable further discovery research, beyond the primary and secondary objectives. Trial Exploratory Objective Study Primary Objective Trial Primary Objective The main scientific question(s) the study is designed to answer. (CDISC Glossary) Trial Primary Objective Study Secondary Objective Trial Secondary Objective The supportive or ancillary scientific question(s) the study is designed to answer. (CDISC Glossary) Trial Secondary Objective Observational Model The trial design developed to compare biomedical and/or health outcomes in pre-defined and non-assigned groups of individuals. Observational Model Observational Time Perspective The temporal relationship between the observation period and time of subject enrollment. (ClinicalTrials.gov) Observational Time Perspective of Study Obs Study Population Description A description of the population from which the groups or cohorts will be selected within an observational study. Observational Study Population Description Observational Study Sampling Method The sampling method used to assign study participants into groups or cohorts within an observational study. Observational Study Sampling Method Obs Study Sampling Method Description A textual description of the sampling method used to assign study participants into groups or cohorts within an observational study. Observational Study Sampling Method Description Ongoing Study Indicator An indication as to whether the study is in progress. Ongoing Study Indicator Additional Outcome Measure Additional key measures that will be used to evaluate the intervention(s) or, for observational studies, that are a focus of the study. These are the outcome measures not used to assess primary or secondary objectives. Additional Outcome Measure Exploratory Outcome Measure The outcome measure(s) that is part of a pre-specified analysis plan used to evaluate the exploratory endpoint(s) associated with exploratory study objective(s) and/or any other measures, excluding post-hoc measures, that are a focus of the study. (After clinicaltrials.gov) Exploratory Outcome Measure Primary Outcome Measure The outcome measure(s) of greatest importance specified in the protocol, usually the one(s) used in the power calculation, to evaluate the primary endpoint(s) associated with the primary study objective(s). (After Clinicaltrials.gov) Primary Outcome Measure Secondary Outcome Measure The outcome measure(s) that is part of a pre-specified analysis plan used to evaluate the secondary endpoint(s) associated with secondary study objective(s) and/or used to evaluate any measure(s) ancillary to the primary or secondary endpoint(s). (After Clinicaltrials.gov). Secondary Outcome Measure Post Authorization Safety Study Ind An indication as to whether the clinical study is a post authorization safety study. Post Authorization Safety Study Indicator Pharmacologic Class The pharmacological class of the investigational product. Pharmacological Class of Investigational Therapy Pediatric Postmarket Study Indicator An indication as to whether the study is a pediatric postmarket study. Pediatric Postmarket Study Indicator Pediatric Study Indicator An indication as to whether the study is a pediatric study. Pediatric Study Indicator Pediatric Investigation Plan Indicator An indication as to whether the trial is part of a pediatric investigation plan (PIP). Pediatric Investigation Plan Indicator Anticipated Enrollment Planned Enrollment Planned Number of Subjects Target Enrollment The planned number of subjects intended to be enrolled within a study to reach a pre-specified sample size (in any cohort or the entire study). Planned Subject Number Planned Trial Duration The approximate period of time over which the clinical trial is expected to occur. Planned Trial Duration Protocol Risk Assessment The risk of the protocol-defined activities, procedures, and interventions to the study subjects. Protocol Risk Assessment Planned Treatment Duration The period of time during which the treatment is intended to be given. Planned Treatment Duration PubMed ID for Citation Used in Study A globally unique identifier for a biomedical article, as assigned by PubMed. PubMed Unique Identifier Trial is Randomized The process of assigning trial subjects to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. NOTE: Unequal randomization is used to allocate subjects into groups at a differential rate; for example, three subjects may be assigned to a treatment group for every one assigned to the control group. [ICH E6 1.48] See also balanced study. (CDISC glossary) Randomization Randomization Quotient The randomization quotient is the number of planned subjects to be exposed to investigational therapy, independent of dose or other factors, divided by the total number of planned subjects. Randomization Quotient Rare Disease Indicator An indication as to whether the condition under study is considered a rare disease. Rare Disease Indicator Registry Identifier Identification numbers assigned to the protocol by clinicaltrials.gov, EudraCT, or other registries. Clinical Trial Registry Identifier Resubmission Letter An alphabetic character that describes the incremental order of trial resubmissions. Resubmission Letter Relapse Criteria A standard from which a judgment concerning a disease relapse can be established. Relapse Criteria Route of Administration The way in which an agent is introduced into, or onto, the body. Route of Administration Retained Biospecimen Description A textual description of the specimen types that are retained as reserve samples. Retained Biospecimen Description Request for XML Copy of Study Indicator An indication as to whether the registrant would like to receive an XML copy of their study as saved on EudraCT. Study Saved as XML Indicator Stable Disease Minimum Duration The protocol specified minimum amount of time needed to meet the definition of stable disease. Stable Disease Minimum Duration SDTM IG Version SDTM Implementation Guide Version SDTMIG Version The version of the CDISC Study Data Tabulation Model implementation guide that is being used in the study submission. Study Data Tabulation Model Implementation Guide Version SDTM IG Medical Device Version SDTM Implementation Guide Medical Device Version SDTMIG Medical Device Version SDTMIG-MD Version The version of the CDISC Study Data Tabulation Model implementation guide for medical devices that is being used in the study submission. SDTM Implementation Guide Medical Device Version SDTM Version The version of the CDISC Study Data Tabulation Model that is being used in the study submission. Study Data Tabulation Model Version Secure Delivery XML Required Indicator An indication as to whether the XML copy of the EudraCT application requires secure E-mail delivery. Requires Secure Email Delivery of XML Indicator Study End Date The date on which the final data item for a clinical study was collected from the last study participant (that is, last subject, last visit, or as otherwise defined in the study protocol). (CDISC Glossary) Clinical Study End Date Severity Criteria A standard from which a judgment concerning the severity of an event, disease or condition can be established. Severity Criteria Sex of Participants The specific sex, either male, female, or mixed of the subject group being studied. (NCI) Sex of Study Group Clinical Study Sponsor Sponsor Study Sponsor An individual, company, institution, or organization that takes responsibility for the initiation, management, and/or financing of a clinical study. [After ICH E6, WHO, 21 CFR 50.3 (e), and after IDMP] Clinical Study Sponsor Sponsor's Study Reference ID The reference identifier by which the study is known to the sponsor. This may be different from the STUDYID if the data were collected under a different identifier (e.g., used in a situation where a contract facility performs the study and provides a final report). Sponsor Study Reference Identifier SUSAR Reporting to EVCTM Indicator An indication as to whether suspected unexpected serious adverse reactions (SUSAR) will be reported to a EudraVigiliance clinical trial module (EVCTM). SUSAR Reporting to EudraVigiliance Clinical Trial Module Indicator SUSAR Reporting to NCA Indicator An indication as to whether suspected unexpected serious adverse reactions (SUSAR) will be reported to national competent authorities (NCA). SUSAR Reporting to National Competent Authority Indicator Single Site EU State Trial Indicator An indication as to whether the clinical study is being conducted at only one site within the European Union member state concerned by the application. Single Site European Union State Trial Indicator Study Start Date The earliest date of informed consent among any subject (Date/Time of Informed Consent, RFICDTC) that enrolled in the study. For studies conducted without informed consent (i.e., emergency use) use the date of treatment. Dates for subjects who were screen failures are not included. [After US FDA, Providing Regulatory Submissions In Electronic Format - Standardized Study Data Guidance for Industry, June 2021] Study Start Date Substudy Details A textual description of the substudy. Substudy Details Substudy Planned Indicator An indication as to whether a study performed on a subgroup of subjects included in the original trial (substudy) is planned for the current study. Substudy Planned Indicator Study Stop Rules The rule, regulation and/or condition that determines the point in time when a clinical trial will be terminated. (NCI) Study Stop Rule Stratification Factor Selected factors that are used during randomization to ensure there is balance of these factors across all subjects within each arm of a study. The subject level values of these factors may be used as fixed effects in statistical models and for sensitivity analyses. Stratification Factors Study Type Study Type Classification The nature of the investigation for which study information is being collected. (After clinicaltrials.gov) Study Type Study Blinding Design Study Blinding Schema Study Masking Design Trial Blinding Design Trial Blinding Schema Trial Masking Design The type of experimental design used to describe the level of awareness of the study subjects and/ or study personnel as it relates to the respective intervention(s) or assessments being observed, received or administered. Trial Blinding Schema Tobacco Product Any product made or derived from tobacco, or containing nicotine from any source, that is intended for human consumption, including any component, part, or accessory of a tobacco product (except for raw materials other than tobacco used in manufacturing a component, part, or accessory of a tobacco product). (FDA CTP) Tobacco Product Control Type Comparator against which the study treatment is evaluated. Control Type Diagnosis Group A grouping of individuals on the basis of a shared procedure or disease, or lack thereof. Diagnosis Group Therapeutic Area A categorization of a disease, disorder, or other condition based on common characteristics and often associated with a medical specialty focusing on research and development of specific therapeutic interventions for the purpose of treatment and prevention. Therapeutic Area Tobacco IG Version Tobacco Implementation Guide Version The version of the CDISC tobacco implementation guide that is being used in the study submission. CDISC Tobacco Implementation Guide Version Trial Intent Type The planned purpose of the therapy, device, or agent under study in the clinical trial. Clinical Study by Intent Official Study Title Study Title Trial Title The sponsor-defined name of the clinical study. Trial Title Trial Phase Trial Phase Classification A step in the clinical research and development of a therapy from initial clinical trials to post-approval studies. NOTE: Clinical trials are generally categorized into four (sometimes five) phases. A therapeutic intervention may be evaluated in two or more phases simultaneously in different trials, and some trials may overlap two different phases. [21 CFR section 312.21; After ICH Topic E8 NOTE FOR GUIDANCE ON GENERAL CONSIDERATIONS FOR CLINICAL TRIALS, CPMP/ICH/291/95 March 1998] Trial Phase Target Follow-Up Duration The anticipated time period over which each study participant is to be followed. (ClinicalTrials.gov) Planned Follow-Up Duration Investigational Interventional Investigational Therapy or Treatment The drug, device, therapy, procedure, or process under investigation in a clinical study that is believed to have an effect on outcomes of interest in a study (e.g., health-related quality of life, efficacy, safety, pharmacoeconomics). [After https://grants.nih.gov/grants/policy/faq_clinical_trial_definition.htm#5224; https://grants.nih.gov/policy/clinical-trials/protocol-template.htm] See also test articles, devices, drug product, combination product, treatment, diagnosis. Contrast with investigational medicinal product. Protocol Agent Trial Scope Trial Type The nature of the interventional study for which information is being collected. Trial Type URL Related to Study The uniform resource locator (URL) related to a particular study. Study Protocol Uniform Resource Locator URL Related to Study Description A textual description of the uniform resource locator (URL) related to a particular study. Study Protocol Uniform Resource Locator Description TSPARMCD Trial Summary Parameter Test Code CDISC SDTM Trial Summary Parameter Short Name Terminology The test name for an individual characteristic of a clinical trial, e.g. description of trial design, trial blinding schema, and primary objective of trial. Actual Number of Subjects Actual number of subjects enrolled; may include subjects who were not randomized. Actual Subject Number Adaptive Design Indicate if the study includes a prospectively planned opportunity for modification of one or more specified aspects of the study design and hypotheses based on analysis of data (usually interim data) from subjects in the study. Adaptive Study Design Indicator Added on to Existing Treatments The addition of a therapeutic or other study product to the existing regimen in a study, where both entities remain as discrete products. Test Product Added to Existing Treatment Additional Outcome Measure Additional key measures that will be used to evaluate the intervention(s) or, for observational studies, that are a focus of the study. These are the outcome measures not used to assess primary or secondary objectives. Additional Outcome Measure Applicant Applicant Organization Applicant Organization Name Any party, which may include the tobacco manufacturer and its authorized representative, who is subject to FDA's jurisdiction under chapter IX of the FD&C Act and submits an application to FDA for authority to market a tobacco product. (After PMTA Rule 21 CFR Part 1114 2021; SE Final Rule 21 CFR Part 1107 2021) US FDA Tobacco Product Applicant Biospecimen Retention Contains DNA Ind An indication as to whether retained biospecimens contain DNA. Retained Biospecimen Contains DNA Indicator Biospecimen Retention Indicator An indication as to whether biospecimens were retained. Biospecimen Retention Indicator CDISC Therapeutic Area User Guide The name and version of the CDISC therapeutic area user guide that is being used in the study submission. CDISC Therapeutic Area User Guide Name and Version Challenge Agent Name The name of the non-investigational medicinal product (NIMP) given to trial subjects to produce a physiological response that is necessary before the pharmacological action of the investigational medicinal product can be assessed. [After Recommendations from the expert group on clinical trials for the implementation of Regulation (EU) No 536/2014' dd 28 June 2017] Challenge Agent Name Citation Used in Study A bibliographical reference related to a particular study. Clinical Study Citation Clinical Study Report Archive Date The date when the clinical study report was archived. Clinical Study Report Archive Date Clinical Study Sponsor Sponsor Study Sponsor An individual, company, institution, or organization that takes responsibility for the initiation, management, and/or financing of a clinical study. [After ICH E6, WHO, 21 CFR 50.3 (e), and after IDMP] Clinical Study Sponsor Commercial Sponsor Status The state or condition of the sponsor as pertains to whether the sponsor is considered a commercial entity. Sponsor Commercial Status Comparative Treatment Name A therapeutically active agent that is intended to provide reference measurements for the experimental protocol of a clinical trial. Active Comparator Drug Confirmed Response Minimum Duration The protocol specified minimum amount of time needed to meet the definition of a confirmed response to treatment. Confirmed Response Minimum Duration Contact E-Mail Address E-mail address of study contact. Study Contact E-mail Address Contact Mailing Address Mailing address of study contact. Study Contact Postal Address Contact Name Name of study contact. Study Contact Name Contact Phone Number Phone number of study contact. Study Contact Telephone Number Contact Role The role that the responsible individual or entity plays with respect to being a contact for the study. Study Contact Role Control Type Comparator against which the study treatment is evaluated. Control Type Country of Manufacture The name of the country within which the final product under study is produced. Country of Manufacture Background Treatment Current Therapy or Treatment The name of a protocol-specified background treatment(s), that is (are) a medication currently being taken as a standard of care for a particular condition/disease. Current Therapy Data Cutoff Date A date which indicates any data collected by this date will be used for analysis. Data Cutoff Date Data Cutoff Description Text that describes the cutoff date. Data Cutoff Date Description Data Monitoring Committee Indicator An indication as to whether the clinical trial has an appointed data monitoring committee. Data Monitoring Committee Indicator Delayed Graft Function Diagnostic Criteria Delayed Graft Function Dx Criteria A standard by which the determination of delayed graft function (DGF) is established. Delayed Graft Function Diagnostic Criteria Name Diagnosis Group A grouping of individuals on the basis of a shared procedure or disease, or lack thereof. Diagnosis Group Diagnostic Criteria A standard from which a judgment concerning a medical diagnosis can be established. Diagnostic Criteria Dose Form Physical characteristics of a product, (e.g., tablet, capsule, solution) that contains a substance, generally (but not necessarily) in association with 1 or more other ingredients. Pharmaceutical Dosage Form Dose Level Dose per Administration The quantity of an agent (e.g., drug, product, substance, radiation) within a single administration. Dose Dose Regimen The planned schedule for the administration of an agent (e.g., drug, product, substance, radiation). Dose Regimen Dose Units The unit of measure for the dosage form. Dosage Form Unit Dosing Frequency The number of doses administered per a specific interval. Dose Frequency ECG Continuous Monitoring Indicates whether the 10-second ECGs for this study were extracted from a continuous recording. ECG Continuous Monitoring Indicator ECG Planned Primary Lead The ECG lead which was planned to be used for ECG interval measurements for this study. ECG Planned Primary Lead for Study ECG Read Method The degree of automation involved in assessing the ECGs for this study. ECG Read Method Degree of Automation ECG Reading Blinded Indicates whether assessors of ECGs for this study were blinded to subject identity, timing and treatment. ECG Evaluator Blinding Parameters ECG Replicates at Baseline Indicates whether this study includes replicate ECGs for time points during the baseline portion of the study. ECG Replicates at Baseline Indicator ECG Replicates On-Treatment Indicates whether this study includes replicate ECGs for time points during the on-treatment portion of the study. ECG Replicates On-Treatment Indicator ECG Twave Algorithm The algorithm used to identify the end of the T wave for ECGs for this study. ECG T Wave Algorithm ECG Used Same Lead Indicates whether all ECG interval measurements for the study were based on the same lead. ECG Used Same Lead Indicator EMA Decision Number for PIP An alphanumeric code assigned by the European Medicines Agency (EMA) to an EMA regulatory decision for a pediatric investigation plan (PIP). EMA Decision Number for Pediatric Investigation Plan Email Address for XML File The Email address to which copies of the XML format of the EudraCT application should be sent. E-mail Address for XML File Feedback Epi/Pandemic Related Disruption Ind Epidemic Related Disruption Indicator An indication as to whether the study disruption was caused by the epidemic or pandemic. Epidemic or Pandemic Related Disruption Indicator EudraCT Resubmission Indicator An indication as to whether the trial being submitted to the EudraCT is a trial that has been previously submitted to the EudraCT system. EudraCT Resubmission Indicator EudraVigilance Sender ID A unique identifier assigned to the organization that is transmitting an adverse drug reaction report to the EudraVigilance system. EudraVigilance Sender Identifier EudraVigilance Sender Organization The name of the group or institution that is transmitting an adverse drug reaction report to the EudraVigilance system. EudraVigilance Sender Organization Expanded Access Record NCT Number The unique alphanumeric identifier for the study with associated expanded access record, as assigned by the clinicaltrials.gov protocol registration and results system (PRS). Clinicaltrials.gov NCT Number for the Expanded Access Record Expanded Access Status Status indicating availability of an experimental drug or device outside any clinical trial protocol. (clinicaltrials.gov) Trial Expanded Access Status Exploratory Outcome Measure The outcome measure(s) that is part of a pre-specified analysis plan used to evaluate the exploratory endpoint(s) associated with exploratory study objective(s) and/or any other measures, excluding post-hoc measures, that are a focus of the study. (After clinicaltrials.gov) Exploratory Outcome Measure Extension Trial Indicator An indication as to whether the clinical trial is an extension trial. Extension Trial Indicator FDA Technical Specification The name and version of the FDA technical specification that is being used in the study submission. FDA Technical Specification Name and Version FDA-Regulated Device Study Indicator An indication as to whether the study involves an FDA-regulated device. FDA-Regulated Device Study Indicator FDA-Regulated Drug Study Indicator An indication as to whether the study involves an FDA-regulated drug. FDA-Regulated Drug Study Indicator Healthy Subject Indicator Indicate if persons who have not had the condition(s) being studied or otherwise related conditions or symptoms, as specified in the eligibility requirements, may participate in the study. Healthy Subject Indicator Intervention Model The general design of the strategy for assigning interventions to participants in a clinical study. (clinicaltrials.gov) Intervention Model Intervention Type The kind of product or procedure studied in a trial. Intervention Type Investigational Interventional Investigational Therapy or Treatment The drug, device, therapy, procedure, or process under investigation in a clinical study that is believed to have an effect on outcomes of interest in a study (e.g., health-related quality of life, efficacy, safety, pharmacoeconomics). [After https://grants.nih.gov/grants/policy/faq_clinical_trial_definition.htm#5224; https://grants.nih.gov/policy/clinical-trials/protocol-template.htm] See also test articles, devices, drug product, combination product, treatment, diagnosis. Contrast with investigational medicinal product. Protocol Agent Multiple Site EU State Trial Indicator An indication as to whether the clinical study is being conducted at multiple sites within the European Union member state concerned by the application. Multiple Site European Union State Trial Indicator Name of Epi/Pandemic Name of Epidemic and/or Pandemic The literal identifier of the epidemic and/or pandemic. Name of Epidemic or Pandemic Number of Groups/Cohorts The number of groups or cohorts that are part of the study. Number of Groups or Cohorts Number of Trial Sites EU State The total number of trial sites within the European Union member state concerned by the application. Number of Trial Sites within European Union State Obs Study Population Description A description of the population from which the groups or cohorts will be selected within an observational study. Observational Study Population Description Obs Study Sampling Method Description A textual description of the sampling method used to assign study participants into groups or cohorts within an observational study. Observational Study Sampling Method Description Observational Model The trial design developed to compare biomedical and/or health outcomes in pre-defined and non-assigned groups of individuals. Observational Model Observational Study Sampling Method The sampling method used to assign study participants into groups or cohorts within an observational study. Observational Study Sampling Method Observational Time Perspective The temporal relationship between the observation period and time of subject enrollment. (ClinicalTrials.gov) Observational Time Perspective of Study Ongoing Study Indicator An indication as to whether the study is in progress. Ongoing Study Indicator Pediatric Investigation Plan Indicator An indication as to whether the trial is part of a pediatric investigation plan (PIP). Pediatric Investigation Plan Indicator Pediatric Postmarket Study Indicator An indication as to whether the study is a pediatric postmarket study. Pediatric Postmarket Study Indicator Pediatric Study Indicator An indication as to whether the study is a pediatric study. Pediatric Study Indicator Pharmacologic Class The pharmacological class of the investigational product. Pharmacological Class of Investigational Therapy Planned Country of Investigational Sites The country name of planned study facility which has received IRB approval. Planned Country of Investigational Site Planned Maximum Age of Subjects The anticipated maximum age of the subjects to be entered in a clinical trial. (NCI) Planned Maximum Age of Subjects Planned Minimum Age of Subjects The anticipated minimum age of the subjects to be entered in a clinical trial. (NCI) Planned Minimum Age of Subjects Planned Number of Arms The planned number of intervention groups. Planned Number of Arms Anticipated Enrollment Planned Enrollment Planned Number of Subjects Target Enrollment The planned number of subjects intended to be enrolled within a study to reach a pre-specified sample size (in any cohort or the entire study). Planned Subject Number Planned Treatment Duration The period of time during which the treatment is intended to be given. Planned Treatment Duration Planned Trial Duration The approximate period of time over which the clinical trial is expected to occur. Planned Trial Duration Post Authorization Safety Study Ind An indication as to whether the clinical study is a post authorization safety study. Post Authorization Safety Study Indicator Primary Outcome Measure The outcome measure(s) of greatest importance specified in the protocol, usually the one(s) used in the power calculation, to evaluate the primary endpoint(s) associated with the primary study objective(s). (After Clinicaltrials.gov) Primary Outcome Measure Protocol Keyword A word or small set of words designed to convey the focus of the protocol. Protocol Keyword Protocol Risk Assessment The risk of the protocol-defined activities, procedures, and interventions to the study subjects. Protocol Risk Assessment PubMed ID for Citation Used in Study A globally unique identifier for a biomedical article, as assigned by PubMed. PubMed Unique Identifier Randomization Quotient The randomization quotient is the number of planned subjects to be exposed to investigational therapy, independent of dose or other factors, divided by the total number of planned subjects. Randomization Quotient Rare Disease Indicator An indication as to whether the condition under study is considered a rare disease. Rare Disease Indicator Registry Identifier Identification numbers assigned to the protocol by clinicaltrials.gov, EudraCT, or other registries. Clinical Trial Registry Identifier Relapse Criteria A standard from which a judgment concerning a disease relapse can be established. Relapse Criteria Request for XML Copy of Study Indicator An indication as to whether the registrant would like to receive an XML copy of their study as saved on EudraCT. Study Saved as XML Indicator Resubmission Letter An alphabetic character that describes the incremental order of trial resubmissions. Resubmission Letter Retained Biospecimen Description A textual description of the specimen types that are retained as reserve samples. Retained Biospecimen Description Route of Administration The way in which an agent is introduced into, or onto, the body. Route of Administration SDTM IG Version SDTM Implementation Guide Version SDTMIG Version The version of the CDISC Study Data Tabulation Model implementation guide that is being used in the study submission. Study Data Tabulation Model Implementation Guide Version SDTM Version The version of the CDISC Study Data Tabulation Model that is being used in the study submission. Study Data Tabulation Model Version SDTM IG Medical Device Version SDTM Implementation Guide Medical Device Version SDTMIG Medical Device Version SDTMIG-MD Version The version of the CDISC Study Data Tabulation Model implementation guide for medical devices that is being used in the study submission. SDTM Implementation Guide Medical Device Version Secondary Outcome Measure The outcome measure(s) that is part of a pre-specified analysis plan used to evaluate the secondary endpoint(s) associated with secondary study objective(s) and/or used to evaluate any measure(s) ancillary to the primary or secondary endpoint(s). (After Clinicaltrials.gov). Secondary Outcome Measure Secure Delivery XML Required Indicator An indication as to whether the XML copy of the EudraCT application requires secure E-mail delivery. Requires Secure Email Delivery of XML Indicator Severity Criteria A standard from which a judgment concerning the severity of an event, disease or condition can be established. Severity Criteria Sex of Participants The specific sex, either male, female, or mixed of the subject group being studied. (NCI) Sex of Study Group Single Site EU State Trial Indicator An indication as to whether the clinical study is being conducted at only one site within the European Union member state concerned by the application. Single Site European Union State Trial Indicator Sponsor's Study Reference ID The reference identifier by which the study is known to the sponsor. This may be different from the STUDYID if the data were collected under a different identifier (e.g., used in a situation where a contract facility performs the study and provides a final report). Sponsor Study Reference Identifier Stable Disease Minimum Duration The protocol specified minimum amount of time needed to meet the definition of stable disease. Stable Disease Minimum Duration Stratification Factor Selected factors that are used during randomization to ensure there is balance of these factors across all subjects within each arm of a study. The subject level values of these factors may be used as fixed effects in statistical models and for sensitivity analyses. Stratification Factors Study End Date The date on which the final data item for a clinical study was collected from the last study participant (that is, last subject, last visit, or as otherwise defined in the study protocol). (CDISC Glossary) Clinical Study End Date Study Start Date The earliest date of informed consent among any subject (Date/Time of Informed Consent, RFICDTC) that enrolled in the study. For studies conducted without informed consent (i.e., emergency use) use the date of treatment. Dates for subjects who were screen failures are not included. [After US FDA, Providing Regulatory Submissions In Electronic Format - Standardized Study Data Guidance for Industry, June 2021] Study Start Date Study Stop Rules The rule, regulation and/or condition that determines the point in time when a clinical trial will be terminated. (NCI) Study Stop Rule Study Type Study Type Classification The nature of the investigation for which study information is being collected. (After clinicaltrials.gov) Study Type Substudy Details A textual description of the substudy. Substudy Details Substudy Planned Indicator An indication as to whether a study performed on a subgroup of subjects included in the original trial (substudy) is planned for the current study. Substudy Planned Indicator SUSAR Reporting to EVCTM Indicator An indication as to whether suspected unexpected serious adverse reactions (SUSAR) will be reported to a EudraVigiliance clinical trial module (EVCTM). SUSAR Reporting to EudraVigiliance Clinical Trial Module Indicator SUSAR Reporting to NCA Indicator An indication as to whether suspected unexpected serious adverse reactions (SUSAR) will be reported to national competent authorities (NCA). SUSAR Reporting to National Competent Authority Indicator Target Follow-Up Duration The anticipated time period over which each study participant is to be followed. (ClinicalTrials.gov) Planned Follow-Up Duration Therapeutic Area A categorization of a disease, disorder, or other condition based on common characteristics and often associated with a medical specialty focusing on research and development of specific therapeutic interventions for the purpose of treatment and prevention. Therapeutic Area Tobacco IG Version Tobacco Implementation Guide Version The version of the CDISC tobacco implementation guide that is being used in the study submission. CDISC Tobacco Implementation Guide Version Tobacco Product Any product made or derived from tobacco, or containing nicotine from any source, that is intended for human consumption, including any component, part, or accessory of a tobacco product (except for raw materials other than tobacco used in manufacturing a component, part, or accessory of a tobacco product). (FDA CTP) Tobacco Product Study Blinding Design Study Blinding Schema Study Masking Design Trial Blinding Design Trial Blinding Schema Trial Masking Design The type of experimental design used to describe the level of awareness of the study subjects and/ or study personnel as it relates to the respective intervention(s) or assessments being observed, received or administered. Trial Blinding Schema Indication for Use Trial Disease/Condition Indication Trial Disease/Condition Indication Description A narrative representation of the condition, disease or disorder that the clinical trial is intended to investigate or address. Trial Indication Study Exploratory Objective Trial Exploratory Objective Additional scientific question(s) within the study that enable further discovery research, beyond the primary and secondary objectives. Trial Exploratory Objective Trial Intent Type The planned purpose of the therapy, device, or agent under study in the clinical trial. Clinical Study by Intent Trial is Randomized The process of assigning trial subjects to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. NOTE: Unequal randomization is used to allocate subjects into groups at a differential rate; for example, three subjects may be assigned to a treatment group for every one assigned to the control group. [ICH E6 1.48] See also balanced study. (CDISC glossary) Randomization Trial Length Planned length of observation for a single subject. Trial Length Trial Phase Trial Phase Classification A step in the clinical research and development of a therapy from initial clinical trials to post-approval studies. NOTE: Clinical trials are generally categorized into four (sometimes five) phases. A therapeutic intervention may be evaluated in two or more phases simultaneously in different trials, and some trials may overlap two different phases. [21 CFR section 312.21; After ICH Topic E8 NOTE FOR GUIDANCE ON GENERAL CONSIDERATIONS FOR CLINICAL TRIALS, CPMP/ICH/291/95 March 1998] Trial Phase Study Primary Objective Trial Primary Objective The main scientific question(s) the study is designed to answer. (CDISC Glossary) Trial Primary Objective Study Secondary Objective Trial Secondary Objective The supportive or ancillary scientific question(s) the study is designed to answer. (CDISC Glossary) Trial Secondary Objective Official Study Title Study Title Trial Title The sponsor-defined name of the clinical study. Trial Title Trial Scope Trial Type The nature of the interventional study for which information is being collected. Trial Type URL Related to Study Description A textual description of the uniform resource locator (URL) related to a particular study. Study Protocol Uniform Resource Locator Description URL Related to Study The uniform resource locator (URL) related to a particular study. Study Protocol Uniform Resource Locator TSPARM Trial Summary Parameter Test Name CDISC SDTM Trial Summary Parameter Long Name Terminology A terminology codelist relevant to the type of primary outcome or endpoint that the protocol is designed to evaluate. A type of study designed to evaluate the strength of the bond between an adhesive and the application surface. Adhesion Performance Study A type of study designed to evaluate the effects of alcohol on investigational product safety and/or efficacy. Alcohol Effect Study A study of the degree to which or rate at which a drug or other substance is absorbed or becomes available at the site of physiological activity after administration. (NCI) Bioavailability Study A study most often used to compare the efficacy of different formulations to treat a given disease. It is the testing of an old versus a new formulation in healthy volunteers or subjects with the disease under study and usually in one dose. (NCI) Therapeutic Equivalency Study A type of study designed to evaluate whether a biologic test article is highly similar in function and effect to an existing biologic that has already been clinically tested and approved for use. Biosimilarity Study A type of study designed to evaluate the interaction between a device and a drug, where the use of one may affect the disposition, function, efficacy, or safety of the other. Device-Drug Interaction Study A type of study designed to evaluate intervention(s) aimed at identifying a disease or condition. Diagnosis Study An early phase clinical study with the objective of determining the optimal dose of an investigational product. Dose Finding Study A type of study designed to evaluate the relationship between dose and resulting exposure. Dose Proportionality Study A study of the effect of dose changes on the efficacy of a drug in order to determine the dose-response relationship and optimal dose of a therapy. Dose Response Study A type of study designed to evaluate the interaction between drugs, where the use of one may affect the disposition, efficacy, or safety of the other. Drug-Drug Interaction Study Electrocardiographic Study A study that evaluates the effect of a treatment on cardiac electrical activity, as assessed by electrocardiography. Electrocardiographic Study A study of the relative therapeutic efficacy of treatment of a disease. Usually this is a Phase II or III study. (NCI) Efficacy Study Studies that are conducted to assess the effect of food on the rate and extent of absorption of a drug, either compared to a fasted state or to a reference drug. Food Effect Study A study that assesses an agent's ability to provoke an immune response. Immunogenicity Study A type of study designed to evaluate the overall pathways of metabolism and excretion of a drug, and to identify and/or quantify metabolites in plasma and excreta. Mass Balance Study A study of the biochemical and physiological effect of a drug and the mechanism of drug action and the relationship between drug concentration and effect. (NCI) Pharmacodynamic Study A study that assesses the value associated with a given drug in therapeutic and economic terms. This type of study is multidisciplinary in nature and takes into consideration the social and economic costs (resource utilization costs including direct, indirect, and intangible costs) of drug therapy in addition to its direct therapeutic benefits. Analyses relate the difference in therapeutic benefits to the difference in costs between treatment alternatives. (NCI) Pharmacoeconomic Study A study that assesses variation in DNA sequence, usually within a single gene, and its effect on drug response. Pharmacogenetic Study A study that identifies or assesses variations within the entire genome, including DNA, RNA, or transcriptional elements, and its effects on drug response. Pharmacogenomic Study A study of the process by which a drug is absorbed, distributed, metabolized, and eliminated by the body. (NCI) Pharmacokinetic Study A type of study designed to evaluate the effect of body position during and/or after administration of the investigational product. Position Effect Trial Prophylaxis Study A type of study designed to identify actions necessary to permanently eliminate or reduce the long-term risk to human life as a result of a particular medication or treatment regimen. Prevention Study A type of study designed to evaluate the expected, acute types of immunological responses, sometimes considered excessive, following agent administration. Reactogenicity Study A study that assesses the medical risks to a subject. Safety is usually assessed by examining a wide range of clinical parameters, including adverse events, vital signs, physical exam, laboratory tests. Safety Study A type of study designed to evaluate the effect of the investigational product on the physiologic act of swallowing. Swallowing Function Trial TQT Study A type of study designed to evaluate the ability of an investigational product and/or approved drug to delay cardiac ventricular repolarization as detected by QT prolongation and other ECG parameters. Thorough QT Study A type of safety study that assesses the degree to which overt adverse effects can be tolerated by the subject. Tolerability Study Therapy Trial A type of study designed to evaluate intervention(s) for treatment of disease, syndrome or condition. Treatment Study A type of study designed to evaluate the user experience with a product. Usability Testing Study A type of study designed to evaluate the effects of water on investigational product safety and/or efficacy. Water Effect Trial TTYPE Trial Type Response CDISC SDTM Trial Type Terminology Terminology relevant to the test codes that describe findings about a tuberculosis event or intervention. Drug Resistance Status The state or condition of not responding to a pharmacological agent. Drug Resistance Status Longest Diameter The longest possible length of a straight line passing through the center of a circular or spheroid object that connects two points on the circumference. Longest Diameter Occurrence Indicator An indication as to whether something has happened, such as an event or incident. Occurrence Indicator Total Number A measurement of the total number of entities. Total Number TBFATSCD Tuberculosis Findings About Test Code CDISC SDTM Tuberculosis Findings About Test Code Terminology Terminology relevant to the test names that describe findings about a tuberculosis event or intervention. Drug Resistance Status The state or condition of not responding to a pharmacological agent. Drug Resistance Status Longest Diameter The longest possible length of a straight line passing through the center of a circular or spheroid object that connects two points on the circumference. Longest Diameter Occurrence Indicator An indication as to whether something has happened, such as an event or incident. Occurrence Indicator Total Number A measurement of the total number of entities. Total Number TBFATS Tuberculosis Findings About Test Name CDISC SDTM Tuberculosis Findings About Test Name Terminology Terminology relevant to the test codes that describe tumor or lesion assessments for identification purposes. Cardiovascular Lesion Indicator An indication as to whether a cardiovascular lesion is present. Cardiovascular Lesion Indicator Disease Recurrence Relative Location A description of the region or relative location for the disease recurrence. Disease Recurrence Relative Location Fibrotic Lesion Indicator An indication as to whether a fibrotic lesion is present. Fibrotic Lesion Indicator Graft Lesion Identification An indication that a graft with a lesion has been located and characterized. Graft Lesion Identification Hepatomegaly Indicator An indication as to whether hepatomegaly (enlarged liver) is present. Hepatomegaly Indicator Lesion Identification An indication that a lesion has been located and characterized. Lesion Identification Limb Lesion Identification An indication that a limb containing a lesion has been selected and characterized. Limb Associated Lesion Identification Measurable Tumor Indicator An indication as to whether a measurable tumor is present. Measurable Tumor Indicator Metastatic Tumor Site Indicator An indication as to whether an anatomical location contains metastases. Metastatic Tumor Site Indicator Non-Target Indicator An indication as to whether a non-target tumor, lesion, or site of disease is present. Non-Target Indicator Primary Tumor Site Indicator An indication as to whether an anatomical location is the primary tumor site of disease. Primary Tumor Site Indicator Splenomegaly Indicator An indication as to whether splenomegaly (enlarged spleen) is present. Splenomegaly Indicator Target Indicator An indication as to whether a target tumor, lesion, or site of disease is present. Target Indicator Bone Tumors Indicator An indication as to whether bone tumors are present. Bone Tumors Indicator Extramedullary Disease Indicator An indication as to whether extramedullary disease is present. Extramedullary Disease Indicator Tumor Merged An assessment as to whether multiple tumors have coalesced into one tumor. Confluent Tumor Masses Assessment Tumor Identification A classification of malignant disease manifestation as part of the response assessment. Tumor Identification Tumor Split An assessment as to whether a single tumor has divided into two or more tumors. Tumor Fragmentation Assessment Vessel Lesion Identification An indication that a vessel with a lesion has been located and characterized. Vessel Lesion Identification TUTESTCD Tumor or Lesion Identification Test Code CDISC SDTM Tumor Identification Test Code Terminology Terminology relevant to the test names that describe tumor or lesion assessments for identification purposes. Bone Tumors Indicator An indication as to whether bone tumors are present. Bone Tumors Indicator Cardiovascular Lesion Indicator An indication as to whether a cardiovascular lesion is present. Cardiovascular Lesion Indicator Disease Recurrence Relative Location A description of the region or relative location for the disease recurrence. Disease Recurrence Relative Location Extramedullary Disease Indicator An indication as to whether extramedullary disease is present. Extramedullary Disease Indicator Fibrotic Lesion Indicator An indication as to whether a fibrotic lesion is present. Fibrotic Lesion Indicator Graft Lesion Identification An indication that a graft with a lesion has been located and characterized. Graft Lesion Identification Hepatomegaly Indicator An indication as to whether hepatomegaly (enlarged liver) is present. Hepatomegaly Indicator Lesion Identification An indication that a lesion has been located and characterized. Lesion Identification Limb Lesion Identification An indication that a limb containing a lesion has been selected and characterized. Limb Associated Lesion Identification Measurable Tumor Indicator An indication as to whether a measurable tumor is present. Measurable Tumor Indicator Metastatic Tumor Site Indicator An indication as to whether an anatomical location contains metastases. Metastatic Tumor Site Indicator Non-Target Indicator An indication as to whether a non-target tumor, lesion, or site of disease is present. Non-Target Indicator Primary Tumor Site Indicator An indication as to whether an anatomical location is the primary tumor site of disease. Primary Tumor Site Indicator Splenomegaly Indicator An indication as to whether splenomegaly (enlarged spleen) is present. Splenomegaly Indicator Target Indicator An indication as to whether a target tumor, lesion, or site of disease is present. Target Indicator Tumor Identification A classification of malignant disease manifestation as part of the response assessment. Tumor Identification Tumor Merged An assessment as to whether multiple tumors have coalesced into one tumor. Confluent Tumor Masses Assessment Tumor Split An assessment as to whether a single tumor has divided into two or more tumors. Tumor Fragmentation Assessment Vessel Lesion Identification An indication that a vessel with a lesion has been located and characterized. Vessel Lesion Identification TUTEST Tumor or Lesion Identification Test Name CDISC SDTM Tumor Identification Test Name Terminology Terminology relevant to tumor or lesion identification test results. Benign For neoplasms, a non-infiltrating and non-metastasizing neoplastic process that is characterized by the absence of morphologic features associated with malignancy (e.g., severe atypia, nuclear pleomorphism, tumor cell necrosis, and abnormal mitoses). For other conditions, a process that is mild in nature and not dangerous to health. (NCI) Benign A localized pathological or traumatic structural change, damage, deformity, or discontinuity of the bone. Bone Lesion Identification Site of Disease The anatomical location at which the disease is present. Disease Involvement Site Of or belonging to an area on the body that is far apart in relation to a point of origin. Distant A localized pathological or traumatic structural change, damage, deformity, or discontinuity situated outside the medulla. Extramedullary Lesion Of or belonging to a restricted area on the body in relation to a point of origin. Local The identification of an anatomical location that may contain a tumor, lesion or site of disease, and is part of the assessment of the response to the therapeutic intervention. Anatomical Location of Interest Of or belonging to either a local and/or regional area of the body in relation to a point of origin. Local-Regional The identification of a tumor, lesion, or site of disease that is present at baseline and will be quantifiably measured. Measured Tumor Identification A localized pathological or traumatic structural change, damage, deformity, or discontinuity of the bone, which has not been previously seen or characterized. New Bone Lesion Lesion Identification The identification of a tumor, lesion, or site of disease, located outside of or independent of any lymph nodes, which was not detected at baseline. New Extranodal Lesion Identification The identification of a tumor, lesion, or site of disease, located at or near the lymph node, which was not detected at baseline. New Nodal Lesion Identification New Non-Index The identification of a tumor, lesion, or site of disease that will be assessed qualitatively over time, and which was not detected at baseline. New Non-Target Lesion Identification New Index The identification of a tumor, lesion, or site of disease that will be assessed quantitatively over time, and which was not detected at baseline. New Target Lesion Identification The identification of a tumor, lesion, or site of disease which has not been previously seen or characterized. New Lesion Identification The identification of a tumor, lesion, or site of disease that is incapable of being measured at baseline. Non-Measurable Tumor Identification The identification of a contrast-enhancing tumor, lesion, or site of disease that is present at baseline and not considered a target, but may be part of the objective assessment of the response to the therapeutic intervention. Non-target Enhancing Lesion Identification The identification of a tumor or lesion located outside of or independent of any lymph nodes that is present at baseline and not considered a target, but may be part of the assessment of the response to the therapeutic intervention. Non-Target Extra Nodal Lesion Identification The identification of a tumor or lesion located at or near the lymph node that is present at baseline and not considered a target, but may be part of the assessment of the response to the therapeutic intervention. Non-Target Nodal Lesion Identification The identification of a non-contrast-enhancing tumor, lesion, or site of disease that is present at baseline and not considered a target, but may be part of the assessment of the response to the therapeutic intervention. Non-target Non-enhancing Lesion Identification Non-Index The identification of a tumor, lesion or site of disease that is present at baseline and not considered a target, but may be part of the objective assessment of the response to the therapeutic intervention. Non-Target Lesion Identification The identification of a tumor, lesion, or site of disease that is present at baseline and will not be quantifiably measured. Not Measured Tumor Identification The identification of a tumor, lesion, or site of disease that is present at the site of origin. Primary Lesion Of or belonging to a broader area or region of the body in relation to a point of origin. Regional The identification of a tumor or lesion that is present at baseline, located outside of or independent of any lymph nodes, and is the target of the therapeutic intervention. Target Extra Nodal Tumor Identification The identification of a tumor or lesion located at or near the lymph node that is present at baseline and is the target of the therapeutic intervention. Target Nodal Tumor Identification The identification of a nodule that is the target of the therapeutic intervention. Target Nodule Tumor Identification Index The identification of a tumor, lesion, or site of disease that is present at baseline and is the target of the therapeutic intervention. Target Lesion Identification U UNK Unknown Not known, not observed, not recorded, or refused. (NCI) Unknown TUIDRS Tumor or Lesion Identification Test Results CDISC SDTM Tumor and Lesion Identification Test Result Terminology Terminology relevant to the test codes that describe the assessment or measurement of a tumor, lesion or site of disease. Absolute Change Baseline in Sum of PPD The current sum of products of perpendicular diameters minus the baseline sum of products of perpendicular diameters. Absolute Change From Baseline in Sum of Products of Perpendicular Diameter Absolute Change From Nadir The current value minus the lowest value previously recorded. Absolute Change From Nadir Absolute Change Frm LPERP Nadir to LPERP The absolute change (positive or negative) between the current longest perpendicular diameter of a lesion and its smallest previously recorded (nadir) longest perpendicular diameter. Absolute Change From Longest Perpendicular At Nadir To Longest Perpendicular Absolute Change Nadir in Organ Enlarge Absolute Change Nadir in Organ Enlargement The current organ enlargement minus the lowest organ enlargement previously recorded. (NCI) Absolute Change from Nadir in Organ Enlargement Absolute Change Nadir in Sum of Diam The current sum of diameters minus the lowest sum of diameters previously recorded. Absolute Change from Nadir in Sum of Diameter Absolute Change Nadir in Sum of PPD The current sum of products of perpendicular diameters minus the lowest sum of products of perpendicular diameters previously recorded. Absolute Change From Nadir in Sum of Products of Perpendicular Diameter Absolute Change From PPD Nadir in LDIAM The absolute change (positive or negative) in the longest diameter of the lesion from the timepoint at which the product of perpendicular diameters of the lesion is the smallest. Absolute Change in Longest Diameter From Nadir Product of Perpendicular Diameters Timepoint Absolute Change From PPD Nadir in LPERP The absolute change (positive or negative) in the longest perpendicular of the lesion from the timepoint at which the product of perpendicular diameters of the lesion is the smallest. Absolute Change in Longest Perpendicular from Nadir Product of Perpendicular Diameters Timepoint Area The extent of a 2-dimensional surface enclosed within a boundary. (NCI) Area Bone Marrow Tracer Uptake A visually assessed combination of extent and intensity of tracer uptake within the bone marrow. Bone Marrow Tracer Uptake Number of Bone Lesions The number of lesions within the bone. Number of Bone Lesions Calcification Indicator An indication as to whether calcification is present. Calcification Indicator Curie Absolute Score Curie Score A scoring system used to measure metastatic response to therapy using 123I-metaiodobenzylguanidine scintigraphy, in which 10 regions of the body are scored. (Ady N, Zucker JM, Asselain B, Edeline V, Bonnin F, Michon J, Gongora R, Manil L. A new 123I-MIBG whole body scan scoring method--application to the prediction of the response of metastases to induction chemotherapy in stage IV neuroblastoma. Eur J Cancer. 1995;31A(2):256-61.; Matthay KK, Edeline V, Lumbroso J, Tanguy ML, Asselain B, Zucker JM, Valteau-Couanet D, Hartmann O, Michon J. Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma. J Clin Oncol. 2003 Jul 1;21(13):2486-91.) Curie Scoring System Diameter The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) Diameter FDG PET 5PS Score A 5 point scale originally devised by Barrington et al. (2014) to assess the response to treatment of lymphoma by FDG-PET scanning, and has since been validated to assess treatment responses in a number of additional solid and non-solid tumors. London Deauville Criteria Point Scale Longest Diameter The longest possible length of a straight line passing through the center of a circular or spheroid object that connects two points on the circumference. Longest Diameter Lesion Elevation Severity/Intensity An assessment of the severity of a lesion that is heightened or raised above the surface plane of the body. Severity of Elevated Lesion Lesion Erythema Severity/Intensity An assessment of the severity of a lesion that has red discoloration. Severity of Erythematous Lesion Lesion Failure Indicator An indication as to whether lesion failure occurred. Lesion Failure Indicator Lesion Revascularization Indicator An indication as to whether repeat revascularization of a lesion occurred. Lesion Revascularization Indicator Lesion Success Indicator An indication as to whether a performed procedure of a target lesion is considered successful. Lesion Success Indicator Lesion Scaling Severity/Intensity An assessment of the severity of a lesion that has flaking dead skin and an increase of keratin in the stratum corneum of the lesion. Severity of Scaling Lesion Lesion Thickness A measurement of the distance between two opposite surfaces of a lesion. Lesion Thickness Limb Failure Indicator An indication as to whether limb failure occurred. Limb Failure Indicator Number of Lymph Nodes Examined The number of lymph nodes that were examined. Number of Lymph Nodes Examined Number of Lymph Nodes Positive The number of subject lymph nodes that were positive for presence of disease. Number of Lymph Nodes Positive Lymph Node State A condition or state of a lymph node at a particular time. Lymph Node State Location of Greatest Uptake A description of the body region or location that contains the largest amount of radioactive tracer. Location of Greatest Uptake Longest Perpendicular Short Axis Diameter The longest possible straight line or plane through a body or figure that is at a right angle to a given line or plane. Longest Perpendicular Lesion Revas Ischemia Indicator An indication as to whether clinical or functional ischemia is present before lesion revascularization occurred. Lesion Revascularization Ischemia Indicator Lesion Revas Clinical Indicator An indication as to whether an appropriate clinical context was present before lesion revascularization occurred. Lesion Revascularization Clinical Indicator Metabolic Imaging Interpretation An interpretive summary of the metabolic activity of a tumor or lesion based on imaging analysis. Metabolic Imaging Interpretation Two or More New Bone Lesions Indicator An indication as to whether there are two or more new bone lesions, in comparison to a reference timepoint. Two or More New Bone Lesions Indicator Number of New Bone Lesions The number of new lesions within the bone, in comparison to a reference timepoint. Number of New Bone Lesions New Tumor Confirmed The verification/confirmation by other methods or modalities that a tumor, which has not been previously seen or characterized, is present in the subject. New Tumor Confirmation Organ Enlargement, Quantitative A quantitative measurement of the increase in organ size or dimension, relative to a defined value. Quantitative Organ Enlargement Assessment Organ State A condition or state of an organ at a particular time. Organ State Organ Vertical Length The linear extent along the craniocaudal axis from one end of an organ to the other end. (NCI) Organ Craniocaudal Length Measurement Overall Tracer Uptake Compared to Baseline Overall Tracer Uptake Compared to BL A visually assessed combination of extent and intensity of tracer uptake, as compared to baseline. Overall Tracer Uptake Compared to Baseline Overall Tracer Uptake Compared to Nadir A visually assessed combination of extent and intensity of tracer uptake, as compared to nadir. Overall Tracer Uptake Compared to Nadir Palpable State A condition or state of the lesion with regards to its palpability status at a particular point in time. Palpable State Two or More Persist New Bone Lesions Ind Two or More Persisting New Bone Lesions Indicator An indication as to whether there are two or more bone lesions previously identified as new and are considered to be persisting. Two or More Persisting New Bone Lesions Indicator Percent Change Baseline in PPD The (current product of perpendicular diameters minus the baseline product of perpendicular diameters) divided by the baseline product of perpendicular diameters, multiplied by 100. Percent Change From Baseline in Products of Perpendicular Diameter Percent Change Baseline in Sum of Diam The (current sum of diameters minus the baseline sum of diameters) divided by the baseline sum of diameters, multiplied by 100. Percent Change From Baseline in Sum of Diameter Percent Change Baseline Sum Longest Diam The (current sum of longest diameters minus the baseline sum of longest diameters) divided by the baseline sum of longest diameters, multiplied by 100. Percent Change From Baseline in Sum of Longest Diameter Percent Change Baseline in Organ Enlarge Percent Change Baseline in Organ Enlargement The (current organ enlargement minus the baseline organ enlargement) divided by the baseline organ enlargement, multiplied by 100. (NCI) Percent Change from Baseline in Organ Enlargement Percent Change Baseline in Sum of PPD The (current sum of products of perpendicular diameters minus the baseline sum of products of perpendicular diameters) divided by the baseline sum of products of perpendicular diameters, multiplied by 100. Percent Change From Baseline in Sum of Products of Perpendicular Diameter Percent Change Baseline in Sum of Volume The (current sum of volumes minus the baseline sum of volumes) divided by the baseline sum of volumes, multiplied by 100. Percent Change From Baseline in Sum of Volume Percent Change From Baseline The (current value minus the baseline value) divided by the baseline value, multiplied by 100. Percent Change From Baseline Percent Change From Nadir The (current value minus the lowest value previously recorded) divided by the lowest value previously recorded, multiplied by 100. Percent Change From Nadir Percent Change Nadir in Organ Enlarge Percent Change Nadir in Organ Enlargement The (current organ enlargement minus the lowest organ enlargement previously recorded) divided by the lowest organ enlargement previously recorded, multiplied by 100. (NCI) Percent Change from Nadir in Organ Enlargement Percent Change Nadir in PPD The (current product of perpendicular diameters minus the lowest product of perpendicular diameters previously recorded) divided by the lowest product of perpendicular diameters previously recorded, multiplied by 100. Percent Change from Nadir in Product of Perpendicular Diameters Percent Change Nadir in Sum of Diam The (current sum of diameters minus the lowest sum of diameters previously recorded) divided by the lowest sum of diameters previously recorded, multiplied by 100. Percent Change From Nadir in Sum of Diameter Percent Change Nadir in Sum Longest Diam The (current sum of longest diameters minus the lowest sum of longest diameters previously recorded) divided by the lowest sum of longest diameters previously recorded, multiplied by 100. Percent Change From Nadir in Sum of Longest Diameter Percent Change Nadir in Sum of PPD The (current sum of products of perpendicular diameters minus the lowest sum of products of perpendicular diameters previously recorded) divided by the lowest sum of products of perpendicular diameters previously recorded, multiplied by 100. Percent Change From Nadir in Sum of Products of Perpendicular Diameters Percent Change Nadir in Sum of Volume The (current sum of volumes minus the lowest sum of volumes previously recorded) divided by the lowest sum of volumes previously recorded, multiplied by 100. Percent Change Nadir in Sum of Volume PPD Product of Perpendicular Diameters The longest diameter multiplied by its longest perpendicular diameter. Product of Perpendicular Diameters Radiodensity The transparency of a material to the passage of X-rays and other forms of radiation. Radiodensity Relative MIBG Score The absolute score for bone lesions at time of response assessment divided by the absolute score for bone lesions at baseline before therapeutic interventions. (Park JR, Bagatell R, Cohn SL, Pearson AD, Villablanca JG, Berthold F, Burchill S, Boubaker A, McHugh K, Nuchtern JG, London WB, Seibel NL, Lindwasser OW, Maris JM, Brock P, Schleiermacher G, Ladenstein R, Matthay KK, Valteau-Couanet D. Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting. J Clin Oncol. 2017 Aug 1;35(22):2580-2587.) Relative Metaiodobenzylguanidine Score Siopen Absolute Score Siopen Score A scoring system used to measure metastatic response to therapy using 123I-metaiodobenzylguanidine scintigraphy, in which 12 regions of the body are scored. (Lewington V, Lambert B, Poetschger U, Sever ZB, Giammarile F, McEwan AJB, Castellani R, Lynch T, Shulkin B, Drobics M, Staudenherz A, Ladenstein R. 123I-mIBG scintigraphy in neuroblastoma: development of a SIOPEN semi-quantitative reporting method by an international panel. Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):234-241.) Siopen Scoring System Standardized Uptake Value Maximum Corrected for Lean Body Mass SUV Maximum Corrected for Lean Body Mass The standardized uptake value corrected for lean body mass of the pixel or voxel with the strongest signal, within a defined area or volume of interest (VOI). Maximum Standardized Uptake Value Corrected for Lean Body Mass Standardized Uptake Value Mean Corrected for Lean Body Mass SUV Mean Corrected for Lean Body Mass The arithmetic mean of a group of standardized uptake values corrected for lean body mass within a defined area or volume of interest (VOI). Mean Standardized Uptake Value Corrected for Lean Body Mass Standardized Uptake Value Peak Corrected for Lean Body Mass SUV Peak Corrected for Lean Body Mass The peak of standardized uptake value corrected for lean body mass distribution, generated by a histogram of all SUV values, across a defined area or volume of interest (VOI). Peak Standardized Uptake Value Corrected for Lean Body Mass Sum of Diameter A calculation of the aggregated diameter values. Sum of Diameters Sum of Longest Diameter A calculation of the aggregated longest diameter values. Sum of Longest Diameters Sum of Longest Perpendicular A calculation of the aggregated longest perpendicular values. Sum of Longest Perpendiculars Sum Diameters of Non Lymph Node Tumors A calculation of the aggregated diameter values for tumors other than the lymph nodes. Sum of Diameters of Non Lymph Node Tumors Sum Diameters of Non-Pleural Lesions A calculation of the aggregated diameter values for tumors other than the pleural lesions. Sum of Diameters of Non-Pleural Lesions SPD Sum of Products of Perpendicular Diam Sum of Products of Perpendicular Diameters The result of the addition of the products of perpendicular diameters. Sum of Products of Perpendicular Diameters Sum of Viable Diameter A calculation of the aggregated diameter values taken from the viable portion of the tumor mass. Sum of Viable Diameters Sum of Volume A calculation of the aggregated volume values. Sum of Volumes Standardized Uptake Value Maximum The standardized (by total body weight) uptake value of the pixel or voxel with the strongest signal, within a defined area or volume of interest (VOI). Standardized Uptake Value Maximum Average Metabolic Standard Uptake Value Standardized Uptake Value Mean The arithmetic mean of a group of standardized (by total body weight) uptake values within a defined area or volume of interest (VOI). Standardized Uptake Value Mean The standardized (by total body weight) uptake value of the pixel or voxel with the lowest signal, within a defined area or volume of interest (VOI). Standardized Uptake Value Minimum Standardized Uptake Value Peak The maximum average (peak) of standardized (by total body weight) uptake value distribution, generated by a histogram of all SUV values, across a defined area or volume of interest (VOI). Standardized Uptake Value Peak Tumor State A condition or state of a tumor at a particular time. Tumor Status Viable Diameter The diameter of the portion of the tumor mass that is capable of growth, proliferation and metastasis. Viable Tumor Diameter Volume A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. Volume Measurement Vessel Failure Indicator An indication as to whether vessel failure occurred. Vessel Failure Indicator Vessel Patency Indicator An indication as to whether an artery is patent (free of TLR or restenosis) following intervention. Vessel Patency Indicator Vessel Revascularization Indicator An indication as to whether repeat revascularization of an artery containing a lesion occurred. Vessel Revascularization Indicator TRTESTCD Tumor or Lesion Properties Test Code CDISC SDTM Tumor or Lesion Properties Test Code Terminology Terminology relevant to the test names that describe the assessment or measurement of a tumor, lesion or site of disease. Absolute Change Baseline in Sum of PPD The current sum of products of perpendicular diameters minus the baseline sum of products of perpendicular diameters. Absolute Change From Baseline in Sum of Products of Perpendicular Diameter Absolute Change Frm LPERP Nadir to LPERP The absolute change (positive or negative) between the current longest perpendicular diameter of a lesion and its smallest previously recorded (nadir) longest perpendicular diameter. Absolute Change From Longest Perpendicular At Nadir To Longest Perpendicular Absolute Change From Nadir The current value minus the lowest value previously recorded. Absolute Change From Nadir Absolute Change From PPD Nadir in LDIAM The absolute change (positive or negative) in the longest diameter of the lesion from the timepoint at which the product of perpendicular diameters of the lesion is the smallest. Absolute Change in Longest Diameter From Nadir Product of Perpendicular Diameters Timepoint Absolute Change From PPD Nadir in LPERP The absolute change (positive or negative) in the longest perpendicular of the lesion from the timepoint at which the product of perpendicular diameters of the lesion is the smallest. Absolute Change in Longest Perpendicular from Nadir Product of Perpendicular Diameters Timepoint Absolute Change Nadir in Organ Enlarge Absolute Change Nadir in Organ Enlargement The current organ enlargement minus the lowest organ enlargement previously recorded. (NCI) Absolute Change from Nadir in Organ Enlargement Absolute Change Nadir in Sum of Diam The current sum of diameters minus the lowest sum of diameters previously recorded. Absolute Change from Nadir in Sum of Diameter Absolute Change Nadir in Sum of PPD The current sum of products of perpendicular diameters minus the lowest sum of products of perpendicular diameters previously recorded. Absolute Change From Nadir in Sum of Products of Perpendicular Diameter Area The extent of a 2-dimensional surface enclosed within a boundary. (NCI) Area Bone Marrow Tracer Uptake A visually assessed combination of extent and intensity of tracer uptake within the bone marrow. Bone Marrow Tracer Uptake Calcification Indicator An indication as to whether calcification is present. Calcification Indicator Curie Absolute Score Curie Score A scoring system used to measure metastatic response to therapy using 123I-metaiodobenzylguanidine scintigraphy, in which 10 regions of the body are scored. (Ady N, Zucker JM, Asselain B, Edeline V, Bonnin F, Michon J, Gongora R, Manil L. A new 123I-MIBG whole body scan scoring method--application to the prediction of the response of metastases to induction chemotherapy in stage IV neuroblastoma. Eur J Cancer. 1995;31A(2):256-61.; Matthay KK, Edeline V, Lumbroso J, Tanguy ML, Asselain B, Zucker JM, Valteau-Couanet D, Hartmann O, Michon J. Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma. J Clin Oncol. 2003 Jul 1;21(13):2486-91.) Curie Scoring System Diameter The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) Diameter FDG PET 5PS Score A 5 point scale originally devised by Barrington et al. (2014) to assess the response to treatment of lymphoma by FDG-PET scanning, and has since been validated to assess treatment responses in a number of additional solid and non-solid tumors. London Deauville Criteria Point Scale Lesion Elevation Severity/Intensity An assessment of the severity of a lesion that is heightened or raised above the surface plane of the body. Severity of Elevated Lesion Lesion Erythema Severity/Intensity An assessment of the severity of a lesion that has red discoloration. Severity of Erythematous Lesion Lesion Failure Indicator An indication as to whether lesion failure occurred. Lesion Failure Indicator Lesion Revas Clinical Indicator An indication as to whether an appropriate clinical context was present before lesion revascularization occurred. Lesion Revascularization Clinical Indicator Lesion Revas Ischemia Indicator An indication as to whether clinical or functional ischemia is present before lesion revascularization occurred. Lesion Revascularization Ischemia Indicator Lesion Revascularization Indicator An indication as to whether repeat revascularization of a lesion occurred. Lesion Revascularization Indicator Lesion Scaling Severity/Intensity An assessment of the severity of a lesion that has flaking dead skin and an increase of keratin in the stratum corneum of the lesion. Severity of Scaling Lesion Lesion Success Indicator An indication as to whether a performed procedure of a target lesion is considered successful. Lesion Success Indicator Lesion Thickness A measurement of the distance between two opposite surfaces of a lesion. Lesion Thickness Limb Failure Indicator An indication as to whether limb failure occurred. Limb Failure Indicator Location of Greatest Uptake A description of the body region or location that contains the largest amount of radioactive tracer. Location of Greatest Uptake Longest Diameter The longest possible length of a straight line passing through the center of a circular or spheroid object that connects two points on the circumference. Longest Diameter Longest Perpendicular Short Axis Diameter The longest possible straight line or plane through a body or figure that is at a right angle to a given line or plane. Longest Perpendicular Lymph Node State A condition or state of a lymph node at a particular time. Lymph Node State Metabolic Imaging Interpretation An interpretive summary of the metabolic activity of a tumor or lesion based on imaging analysis. Metabolic Imaging Interpretation New Tumor Confirmed The verification/confirmation by other methods or modalities that a tumor, which has not been previously seen or characterized, is present in the subject. New Tumor Confirmation Number of Bone Lesions The number of lesions within the bone. Number of Bone Lesions Number of Lymph Nodes Examined The number of lymph nodes that were examined. Number of Lymph Nodes Examined Number of Lymph Nodes Positive The number of subject lymph nodes that were positive for presence of disease. Number of Lymph Nodes Positive Number of New Bone Lesions The number of new lesions within the bone, in comparison to a reference timepoint. Number of New Bone Lesions Organ Enlargement, Quantitative A quantitative measurement of the increase in organ size or dimension, relative to a defined value. Quantitative Organ Enlargement Assessment Organ State A condition or state of an organ at a particular time. Organ State Organ Vertical Length The linear extent along the craniocaudal axis from one end of an organ to the other end. (NCI) Organ Craniocaudal Length Measurement Overall Tracer Uptake Compared to Baseline Overall Tracer Uptake Compared to BL A visually assessed combination of extent and intensity of tracer uptake, as compared to baseline. Overall Tracer Uptake Compared to Baseline Overall Tracer Uptake Compared to Nadir A visually assessed combination of extent and intensity of tracer uptake, as compared to nadir. Overall Tracer Uptake Compared to Nadir Palpable State A condition or state of the lesion with regards to its palpability status at a particular point in time. Palpable State Percent Change Baseline in Organ Enlarge Percent Change Baseline in Organ Enlargement The (current organ enlargement minus the baseline organ enlargement) divided by the baseline organ enlargement, multiplied by 100. (NCI) Percent Change from Baseline in Organ Enlargement Percent Change Baseline in PPD The (current product of perpendicular diameters minus the baseline product of perpendicular diameters) divided by the baseline product of perpendicular diameters, multiplied by 100. Percent Change From Baseline in Products of Perpendicular Diameter Percent Change Baseline in Sum of Diam The (current sum of diameters minus the baseline sum of diameters) divided by the baseline sum of diameters, multiplied by 100. Percent Change From Baseline in Sum of Diameter Percent Change Baseline in Sum of PPD The (current sum of products of perpendicular diameters minus the baseline sum of products of perpendicular diameters) divided by the baseline sum of products of perpendicular diameters, multiplied by 100. Percent Change From Baseline in Sum of Products of Perpendicular Diameter Percent Change Baseline in Sum of Volume The (current sum of volumes minus the baseline sum of volumes) divided by the baseline sum of volumes, multiplied by 100. Percent Change From Baseline in Sum of Volume Percent Change Baseline Sum Longest Diam The (current sum of longest diameters minus the baseline sum of longest diameters) divided by the baseline sum of longest diameters, multiplied by 100. Percent Change From Baseline in Sum of Longest Diameter Percent Change From Baseline The (current value minus the baseline value) divided by the baseline value, multiplied by 100. Percent Change From Baseline Percent Change From Nadir The (current value minus the lowest value previously recorded) divided by the lowest value previously recorded, multiplied by 100. Percent Change From Nadir Percent Change Nadir in Organ Enlarge Percent Change Nadir in Organ Enlargement The (current organ enlargement minus the lowest organ enlargement previously recorded) divided by the lowest organ enlargement previously recorded, multiplied by 100. (NCI) Percent Change from Nadir in Organ Enlargement Percent Change Nadir in PPD The (current product of perpendicular diameters minus the lowest product of perpendicular diameters previously recorded) divided by the lowest product of perpendicular diameters previously recorded, multiplied by 100. Percent Change from Nadir in Product of Perpendicular Diameters Percent Change Nadir in Sum Longest Diam The (current sum of longest diameters minus the lowest sum of longest diameters previously recorded) divided by the lowest sum of longest diameters previously recorded, multiplied by 100. Percent Change From Nadir in Sum of Longest Diameter Percent Change Nadir in Sum of Diam The (current sum of diameters minus the lowest sum of diameters previously recorded) divided by the lowest sum of diameters previously recorded, multiplied by 100. Percent Change From Nadir in Sum of Diameter Percent Change Nadir in Sum of PPD The (current sum of products of perpendicular diameters minus the lowest sum of products of perpendicular diameters previously recorded) divided by the lowest sum of products of perpendicular diameters previously recorded, multiplied by 100. Percent Change From Nadir in Sum of Products of Perpendicular Diameters Percent Change Nadir in Sum of Volume The (current sum of volumes minus the lowest sum of volumes previously recorded) divided by the lowest sum of volumes previously recorded, multiplied by 100. Percent Change Nadir in Sum of Volume PPD Product of Perpendicular Diameters The longest diameter multiplied by its longest perpendicular diameter. Product of Perpendicular Diameters Radiodensity The transparency of a material to the passage of X-rays and other forms of radiation. Radiodensity Relative MIBG Score The absolute score for bone lesions at time of response assessment divided by the absolute score for bone lesions at baseline before therapeutic interventions. (Park JR, Bagatell R, Cohn SL, Pearson AD, Villablanca JG, Berthold F, Burchill S, Boubaker A, McHugh K, Nuchtern JG, London WB, Seibel NL, Lindwasser OW, Maris JM, Brock P, Schleiermacher G, Ladenstein R, Matthay KK, Valteau-Couanet D. Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting. J Clin Oncol. 2017 Aug 1;35(22):2580-2587.) Relative Metaiodobenzylguanidine Score Siopen Absolute Score Siopen Score A scoring system used to measure metastatic response to therapy using 123I-metaiodobenzylguanidine scintigraphy, in which 12 regions of the body are scored. (Lewington V, Lambert B, Poetschger U, Sever ZB, Giammarile F, McEwan AJB, Castellani R, Lynch T, Shulkin B, Drobics M, Staudenherz A, Ladenstein R. 123I-mIBG scintigraphy in neuroblastoma: development of a SIOPEN semi-quantitative reporting method by an international panel. Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):234-241.) Siopen Scoring System Standardized Uptake Value Maximum The standardized (by total body weight) uptake value of the pixel or voxel with the strongest signal, within a defined area or volume of interest (VOI). Standardized Uptake Value Maximum Average Metabolic Standard Uptake Value Standardized Uptake Value Mean The arithmetic mean of a group of standardized (by total body weight) uptake values within a defined area or volume of interest (VOI). Standardized Uptake Value Mean The standardized (by total body weight) uptake value of the pixel or voxel with the lowest signal, within a defined area or volume of interest (VOI). Standardized Uptake Value Minimum Standardized Uptake Value Peak The maximum average (peak) of standardized (by total body weight) uptake value distribution, generated by a histogram of all SUV values, across a defined area or volume of interest (VOI). Standardized Uptake Value Peak Sum Diameters of Non Lymph Node Tumors A calculation of the aggregated diameter values for tumors other than the lymph nodes. Sum of Diameters of Non Lymph Node Tumors Sum Diameters of Non-Pleural Lesions A calculation of the aggregated diameter values for tumors other than the pleural lesions. Sum of Diameters of Non-Pleural Lesions Sum of Diameter A calculation of the aggregated diameter values. Sum of Diameters Sum of Longest Diameter A calculation of the aggregated longest diameter values. Sum of Longest Diameters Sum of Longest Perpendicular A calculation of the aggregated longest perpendicular values. Sum of Longest Perpendiculars SPD Sum of Products of Perpendicular Diam Sum of Products of Perpendicular Diameters The result of the addition of the products of perpendicular diameters. Sum of Products of Perpendicular Diameters Sum of Viable Diameter A calculation of the aggregated diameter values taken from the viable portion of the tumor mass. Sum of Viable Diameters Sum of Volume A calculation of the aggregated volume values. Sum of Volumes Standardized Uptake Value Maximum Corrected for Lean Body Mass SUV Maximum Corrected for Lean Body Mass The standardized uptake value corrected for lean body mass of the pixel or voxel with the strongest signal, within a defined area or volume of interest (VOI). Maximum Standardized Uptake Value Corrected for Lean Body Mass Standardized Uptake Value Mean Corrected for Lean Body Mass SUV Mean Corrected for Lean Body Mass The arithmetic mean of a group of standardized uptake values corrected for lean body mass within a defined area or volume of interest (VOI). Mean Standardized Uptake Value Corrected for Lean Body Mass Standardized Uptake Value Peak Corrected for Lean Body Mass SUV Peak Corrected for Lean Body Mass The peak of standardized uptake value corrected for lean body mass distribution, generated by a histogram of all SUV values, across a defined area or volume of interest (VOI). Peak Standardized Uptake Value Corrected for Lean Body Mass Tumor State A condition or state of a tumor at a particular time. Tumor Status Two or More New Bone Lesions Indicator An indication as to whether there are two or more new bone lesions, in comparison to a reference timepoint. Two or More New Bone Lesions Indicator Two or More Persist New Bone Lesions Ind Two or More Persisting New Bone Lesions Indicator An indication as to whether there are two or more bone lesions previously identified as new and are considered to be persisting. Two or More Persisting New Bone Lesions Indicator Vessel Failure Indicator An indication as to whether vessel failure occurred. Vessel Failure Indicator Vessel Patency Indicator An indication as to whether an artery is patent (free of TLR or restenosis) following intervention. Vessel Patency Indicator Vessel Revascularization Indicator An indication as to whether repeat revascularization of an artery containing a lesion occurred. Vessel Revascularization Indicator Viable Diameter The diameter of the portion of the tumor mass that is capable of growth, proliferation and metastasis. Viable Tumor Diameter Volume A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. Volume Measurement TRTEST Tumor or Lesion Properties Test Name CDISC SDTM Tumor or Lesion Properties Test Name Terminology Terminology relevant to the results from the assessment or measurement of a tumor, lesion or site of disease. Not existing in a specified place at a specified time. (NCI) Absent Reduced Made less in size, amount, degree, or extent. Reduced An indication that the increase is homogenously dispersed. Diffusely Increased An increase in size, volume, or quantity in comparison to nadir. Enlargement from Nadir An increase in size, volume, quantity or scope in comparison to normal or previous state. Enlargement Open to question. Equivocal An indication that the increase is concentrated in a specific area(s). Focally Increased An increase in size, volume, or quantity in comparison to a previous state that was enlarged from nadir. Further Enlargement from Nadir An increase in size, volume, quantity or scope in comparison to a previous enlarged state. Further Enlargement A process of becoming larger, more intense, more extensive, more numerous, more important, or more likely. Increase Not Assessable Not Evaluable Unable to be evaluated. (NCI) Unevaluable An indication of a negative finding for a test or assessment, such as for a disease, condition, analyte, or microorganism. Negative Finding The absence of disease or pathology. (NCI) Non-Pathological Incapable of being handled, touched or felt through palpation. (NCI) Non-Palpable Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm. (NCI) Normal Capable of being handled, touched or felt through palpation. (NCI) Palpable Manifesting disease or pathology. Pathologic An indication of an affirmative finding for a test or assessment, such as for a disease, condition, analyte, or microorganism. Positive Finding Being or existing in a specified place or at the specified time. (NCI) Present In an unchanged or similar condition. Unchanged Leaving no doubt; not open to question. (NCI) Unequivocal TRPROPRS Tumor or Lesion Properties Test Result CDISC SDTM Tumor or Lesion Properties Test Result Terminology Terminology relevant to the test codes that describe findings about Type 1 Diabetes event or intervention. Action Taken With Device An action taken with a device as the result of the event. Action Taken with Device Action Taken With Subject Action taken with respect to a subject in a study. Action Taken With Subject Number of Alcoholic Drinks The total number of alcoholic drinks. Number of Alcoholic Drinks Measurement Calories Burned A measurement of the number of calories expended. Calories Burned Cumulative Exposure The total amount that a subject is exposed to over time. Cumulative Exposure Dietary Alpha Carotene A determination of the alpha carotene in a nutritional product or meal, or a portion thereof. Dietary Alpha Carotene Measurement Dietary Added Sugar A determination of the total added sugars in a nutritional product or meal, or a portion thereof. Dietary Added Sugar Measurement Dietary Alcohol Dietary Ethanol A determination of the total amount of alcohol in a nutritional product or meal, or a portion thereof. Dietary Alcohol Measurement Dietary 20:4 Arachidonate Dietary 20:4 Arachidonic Acid Dietary Arachidonic Acid A determination of the total 20:4 arachidonic acid in a nutritional product or meal, or a portion thereof. Dietary Arachidonic Acid Measurement Dietary Alpha Tocopherol A determination of the alpha tocopherol in a nutritional product or meal, or a portion thereof. Dietary Alpha Tocopherol Measurement Dietary Added Vitamin B12 A determination of the total added vitamin B12 in a nutritional product or meal, or a portion thereof. Dietary Added Vitamin B12 Measurement Dietary Added Vitamin E A determination of the total added vitamin E in a nutritional product or meal, or a portion thereof. Dietary Added Vitamin E Measurement Dietary Beta Carotene A determination of the beta carotene in a nutritional product or meal, or a portion thereof. Dietary Beta Carotene Measurement Dietary Beans and Peas A determination of the total beans and peas in a nutritional product or meal, or a portion thereof. Dietary Beans and Peas Measurement Dietary 4:0 Butyrate Dietary 4:0 Butyric Acid Dietary Butyric Acid A determination of the total 4:0 butyric acid in a nutritional product or meal, or a portion thereof. Dietary Butyric Acid Measurement Dietary Calcium A determination of the total calcium in a nutritional product or meal, or a portion thereof. Dietary Calcium Measurement Dietary Caffeine A determination of the caffeine in a nutritional product or meal, or a portion thereof. Dietary Caffeine Measurement Dietary Calories A determination of the total dietary calories in a nutritional product or meal, or a portion thereof. Dietary Calories Measurement Dietary 6:0 Caproate Dietary 6:0 Caproic Acid Dietary Caproic Acid A determination of the total 6:0 caproic acid in a nutritional product or meal, or a portion thereof. Dietary Caproic Acid Measurement Dietary 10:0 Caprate Dietary 10:0 Capric Acid Dietary Capric Acid A determination of the total 10:0 capric acid in a nutritional product or meal, or a portion thereof. Dietary Capric Acid Measurement Dietary 8:0 Caprylate Dietary 8:0 Caprylic Acid Dietary Caprylic Acid A determination of the total 8:0 caprylic acid in a nutritional product or meal, or a portion thereof. Dietary Caprylic Acid Measurement Dietary Total Carbohydrate A determination of the total carbohydrate in a nutritional product or meal, or a portion thereof. Total Dietary Carbohydrate Measurement Dietary Cheese A determination of the total cheese in a nutritional product or meal, or a portion thereof. Dietary Cheese Measurement Dietary Cholesterol A determination of the total cholesterol in a nutritional product or meal, or a portion thereof. Dietary Cholesterol Measurement Dietary Choline A determination of the choline in a nutritional product or meal, or a portion thereof. Dietary Choline Measurement Dietary Citrus, Melons, and Berries A determination of the total citrus, melons, and berries in a nutritional product or meal, or a portion thereof. Dietary Citrus, Melons, and Berries Measurement Dietary 22:5 Clupanodonate Dietary 22:5 Clupanodonic Acid Dietary Clupanodonic Acid A determination of the total 22:5 clupanodonic acid in a nutritional product or meal, or a portion thereof. Dietary Clupanodonic Acid Measurement Dietary Beta-Cryptoxanthin A determination of the beta-cryptoxanthin in a nutritional product or meal, or a portion thereof. Dietary Beta-Cryptoxanthin Measurement Dietary Copper A determination of the total copper in a nutritional product or meal, or a portion thereof. Dietary Copper Measurement Dietary Total Dairy A determination of the total dairy (food products produced from or containing milk) in a nutritional product or meal, or a portion thereof. Dietary Dairy Measurement Dietary 22:6 Docosahexaenoate Dietary 22:6 Docosahexaenoic Acid Dietary Docosahexaenoic Acid A determination of the total 22:6 docosahexaenoic acid in a nutritional product or meal, or a portion thereof. Dietary Docosahexaenoic Acid Measurement Dietary Eggs A determination of the eggs in a nutritional product or meal, or a portion thereof. Dietary Eggs Measurement Dietary 22:1 Erucate Dietary 22:1 Erucic Acid Dietary Erucic Acid A determination of the total 22:1 erucic acid in a nutritional product or meal, or a portion thereof. Dietary Erucic Acid Measurement Dietary Fat, Monounsaturated A determination of the total monounsaturated fat in a nutritional product or meal, or a portion thereof. Dietary Monounsaturated Fat Measurement Dietary Fat, Polyunsaturated A determination of the total polyunsaturated fat in a nutritional product or meal, or a portion thereof. Dietary Polyunsaturated Fat Measurement Dietary Fat, Saturated A determination of the total saturated fat in a nutritional product or meal, or a portion thereof. Dietary Saturated Fat Measurement Dietary Fat, Total A determination of the total fat in a nutritional product or meal, or a portion thereof. Total Dietary Fat Measurement Dietary Iron A determination of the total iron in a nutritional product or meal, or a portion thereof. Dietary Iron Measurement DFE Dietary Folate Equivalents The sum of food folate and normalized folic acid (as food folate equivalents) in a nutritional product or meal, or a portion thereof. Dietary Folate Equivalents Measurement Dietary Fiber A determination of the total fiber in a nutritional product or meal, or a portion thereof. Dietary Fiber Measurement Dietary Food Folate A determination of the naturally occurring folate in a nutritional product or meal, or a portion thereof. Dietary Food Folate Measurement Dietary Folic Acid A determination of the folic acid in a nutritional product or meal, or a portion thereof. Dietary Folic Acid Measurement Dietary Total Folate A determination of the total folate (supplemental folic acid + food folate) in a nutritional product or meal, or a portion thereof. Dietary Total Folate Measurement Dietary Fruit Juice A determination of the fruit juice in a nutritional product or meal, or a portion thereof. Dietary Fruit Juice Measurement Dietary Fruit A determination of the total fruit in a nutritional product or meal, or a portion thereof. Dietary Fruit Measurement Dietary 20:1 Gadoleate Dietary 20:1 Gadoleic Acid Dietary Gadoleic Acid A determination of the total 20:1 gadoleic acid in a nutritional product or meal, or a portion thereof. Dietary Gadoleic Acid Measurement Dietary Grain A determination of the total grain in a nutritional product or meal, or a portion thereof. Dietary Grain Measurement Dietary Grain, Refined A determination of the total refined grains in a nutritional product or meal, or a portion thereof. Dietary Grain, Refined Measurement Dietary Whole Grains A determination of the whole grains in a nutritional product or meal, or a portion thereof. Dietary Whole Grains Measurement Dispensed Amount The quantity of a product that has been dispensed. (NCI) Dispensed Amount Distance The actual or calculated span between two points (real or virtual). Distance Dietary Potassium A determination of the total potassium in a nutritional product or meal, or a portion thereof. Dietary Potassium Measurement Dietary 12:0 Laurate Dietary 12:0 Lauric Acid Dietary Lauric Acid A determination of the total 12:0 lauric acid in a nutritional product or meal, or a portion thereof. Dietary Lauric Acid Measurement Dietary 18:2 Linoleate Dietary 18:2 Linoleic Acid Dietary Linoleic Acid A determination of the total 18:2 linoleic acid in a nutritional product or meal, or a portion thereof. Dietary Linoleic Acid Measurement Dietary 18:3 Linolenate Dietary 18:3 Linolenic Acid Dietary Linolenic Acid A determination of the total 18:3 linolenic acid in a nutritional product or meal, or a portion thereof. Dietary Linolenic Acid Measurement Dietary Lutein and Zeaxanthin A determination of the lutein and zeaxanthin in a nutritional product or meal, or a portion thereof. Dietary Lutein and Zeaxanthin Measurement Dietary Lycopene A determination of the lycopene in a nutritional product or meal, or a portion thereof. Dietary Lycopene Measurement Dietary Meat A determination of the total meat in a nutritional product or meal, or a portion thereof. Dietary Meat Measurement Dietary Meat, Cured A determination of the cured meat in a nutritional product or meal, or a portion thereof. Dietary Meat, Cured Measurement Dietary Meat, Organ A determination of the organ meat in a nutritional product or meal, or a portion thereof. Dietary Meat, Organ Measurement Dietary Meat, Poultry, and Seafood A determination of the total meat, poultry, and seafood in a nutritional product or meal, or a portion thereof. Dietary Meat, Poultry, and Seafood Measurement Dietary Magnesium A determination of the total magnesium in a nutritional product or meal, or a portion thereof. Dietary Magnesium Measurement Dietary Milk A determination of the milk in a nutritional product or meal, or a portion thereof. Dietary Milk Measurement Dietary Moisture A determination of the moisture content in a nutritional product or meal, or a portion thereof. Dietary Moisture Measurement Dietary 14:0 Myristate Dietary 14:0 Myristic Acid Dietary Myristic Acid A determination of the total 14:0 myristic acid in a nutritional product or meal, or a portion thereof. Dietary Myristic Acid Measurement Dietary Sodium A determination of the total sodium in a nutritional product or meal, or a portion thereof. Dietary Sodium Measurement Dietary Niacin Dietary Vitamin B3 A determination of the niacin in a nutritional product or meal, or a portion thereof. Dietary Niacin Measurement Dietary Nuts and Seeds A determination of the total nuts and seeds in a nutritional product or meal, or a portion thereof. Dietary Nuts and Seeds Measurement Dietary Oils A determination of the oils in a nutritional product or meal, or a portion thereof. Dietary Oils Measurement Dietary 18:1 Oleate Dietary 18:1 Oleic Acid Dietary Oleic Acid A determination of the total 18:1 oleic acid in a nutritional product or meal, or a portion thereof. Dietary Oleic Acid Measurement Dietary Phosphorus A determination of the phosphorus in a nutritional product or meal, or a portion thereof. Dietary Phosphorus Measurement Dietary 16:0 Palmitate Dietary 16:0 Palmitic Acid Dietary Palmitic Acid A determination of the total 16:0 palmitic acid in a nutritional product or meal, or a portion thereof. Dietary Palmitic Acid Measurement Dietary 16:1 Palmitoleate Dietary 16:1 Palmitoleic Acid Dietary Palmitoleic Acid A determination of the total 16:1 palmitoleic acid in a nutritional product or meal, or a portion thereof. Dietary Palmitoleic Acid Measurement Dietary 18:4 Parinarate Dietary 18:4 Parinaric Acid Dietary Parinaric Acid A determination of the total 18:4 parinaric acid in a nutritional product or meal, or a portion thereof. Dietary Parinaric Acid Measurement Dietary Potatoes A determination of the potatoes in a nutritional product or meal, or a portion thereof. Dietary Potatoes Measurement Dietary Poultry A determination of the poultry in a nutritional product or meal, or a portion thereof. Dietary Poultry Measurement Dietary Protein A determination of the total protein in a nutritional product or meal, or a portion thereof. Dietary Protein Measurement Dietary Protein Foods A determination of the protein-rich food in a nutritional product or meal, or a portion thereof. Dietary Protein Foods Measurement Dietary Retinol Dietary Vitamin A A determination of the retinol in a nutritional product or meal, or a portion thereof. Dietary Retinol Measurement Dietary Riboflavin Dietary Vitamin B2 A determination of the riboflavin in a nutritional product or meal, or a portion thereof. Dietary Riboflavin Measurement Dietary Selenium A determination of the total selenium in a nutritional product or meal, or a portion thereof. Dietary Selenium Measurement Dietary Seafood High in n-3 Fatty Acids A determination of the seafood high in n-3 fatty acids in a nutritional product or meal, or a portion thereof. Dietary Seafood High in n-3 Fatty Acids Measurement Dietary Seafood Low in n-3 Fatty Acids A determination of the seafood low in n-3 fatty acids in a nutritional product or meal, or a portion thereof. Dietary Seafood Low in n-3 Fatty Acids Measurement Dietary Solid Fats A determination of the solid fats in a nutritional product or meal, or a portion thereof. Dietary Solid Fats Measurement Dietary Soy Products A determination of the soy-containing products in a nutritional product or meal, or a portion thereof. Dietary Soy Products Measurement Dietary 18:0 Stearate Dietary 18:0 Stearic Acid Dietary Stearic Acid A determination of the total 18:0 stearic acid in a nutritional product or meal, or a portion thereof. Dietary Stearic Acid Measurement Dietary Total Sugars A determination of the total sugars in a nutritional product or meal, or a portion thereof. Dietary Sugar Measurement Dietary Theobromine A determination of the theobromine in a nutritional product or meal, or a portion thereof. Dietary Theobromine Measurement Dietary Thiamin Dietary Thiamine Dietary Vitamin B1 A determination of the thiamine in a nutritional product or meal, or a portion thereof. Dietary Thiamine Measurement Dietary 20:5 Timnodonate Dietary 20:5 Timnodonic Acid Dietary Timnodonic Acid A determination of the total 20:5 timnodonic acid in a nutritional product or meal, or a portion thereof. Dietary Timnodonic Acid Measurement Dietary Tomatoes A determination of the tomatoes in a nutritional product or meal, or a portion thereof. Dietary Tomatoes Measurement Dietary Vegetable A determination of the total vegetables in a nutritional product or meal, or a portion thereof. Dietary Vegetable Measurement Dietary Vegetables, Dark Green A determination of the total dark green vegetables in a nutritional product or meal, or a portion thereof. Dietary Vegetables, Dark Green Measurement Dietary Vegetables, Red and Orange A determination of the total red and orange vegetables in a nutritional product or meal, or a portion thereof. Dietary Vegetables, Red and Orange Measurement Dietary Vegetables, Starchy A determination of the total starchy vegetables in a nutritional product or meal, or a portion thereof. Dietary Vegetables, Starchy Measurement Dietary Vitamin A A determination of the total vitamin A in a nutritional product or meal, or a portion thereof. Dietary Vitamin A Measurement Dietary Vitamin B12 A determination of the total vitamin B12 in a nutritional product or meal, or a portion thereof. Dietary Vitamin B12 Measurement Dietary Vitamin B6 A determination of the total vitamin B6 in a nutritional product or meal, or a portion thereof. Dietary Vitamin B6 Measurement Dietary Vitamin C A determination of the total vitamin C in a nutritional product or meal, or a portion thereof. Dietary Vitamin C Measurement Dietary Vitamin D A determination of the total vitamin D in a nutritional product or meal, or a portion thereof. Dietary Vitamin D Measurement Dietary Vitamin K A determination of the total vitamin K in a nutritional product or meal, or a portion thereof. Dietary Vitamin K Measurement Dietary Yogurt A determination of the yogurt in a nutritional product or meal, or a portion thereof. Dietary Yogurt Measurement Dietary Zinc A determination of the total Zinc in a nutritional product or meal, or a portion thereof. Dietary Zinc Measurement Number of Episodes The total number of episodes that have occurred for the condition. Number of Episodes Estimated Entity Weight Estimated Weight An approximate determination of the weight of the entity. Estimated Weight Exercise Duration The length of time an individual spends exercising. Exercise Duration Exercise Intensity A determination or assessment of the degree or magnitude of an individual's exertion during physical activity. Exercise Intensity Exercise Compliance A determination or assessment of the extent to which an individual adheres to a fitness program. Exercise Compliance Number of Laps Completed The number of laps completed around a course or circuit. Number of Laps Completed Precipitating Factor The factor that causes or triggers the onset of an occurrence. Precipitating Factor Prepared Amount The quantity of a product that has been made ready for use. Prepared Amount Remaining Amount The quantity of a product that remains after dosing, consumption, or use. Remaining Amount Returned Amount The quantity of a product that has been returned. (NCI) Returned Amount Relationship to Device An assessment of the likelihood that the device was the cause of the event. Relationship to Device Speed A scalar measure of the rate of movement of the object expressed as the distance traveled divided by the elapsed time. Speed Number of Steps Taken The number of footsteps taken by an individual. Number of Steps Taken Total Time Paused The total amount of time during which an event, operation or activity has been interrupted or stopped. Total Time Paused Total Time Physically Active The total amount of time during which an individual was actively engaged in physical activity. Total Time Physically Active D1FATSCD Type 1 Diabetes Findings About Test Code CDISC SDTM Type 1 Diabetes Findings About Test Code Terminology Terminology relevant to the test names that describe findings about Type 1 Diabetes event or intervention. Action Taken With Device An action taken with a device as the result of the event. Action Taken with Device Action Taken With Subject Action taken with respect to a subject in a study. Action Taken With Subject Calories Burned A measurement of the number of calories expended. Calories Burned Cumulative Exposure The total amount that a subject is exposed to over time. Cumulative Exposure Dietary Added Sugar A determination of the total added sugars in a nutritional product or meal, or a portion thereof. Dietary Added Sugar Measurement Dietary Added Vitamin B12 A determination of the total added vitamin B12 in a nutritional product or meal, or a portion thereof. Dietary Added Vitamin B12 Measurement Dietary Added Vitamin E A determination of the total added vitamin E in a nutritional product or meal, or a portion thereof. Dietary Added Vitamin E Measurement Dietary Alcohol Dietary Ethanol A determination of the total amount of alcohol in a nutritional product or meal, or a portion thereof. Dietary Alcohol Measurement Dietary Alpha Carotene A determination of the alpha carotene in a nutritional product or meal, or a portion thereof. Dietary Alpha Carotene Measurement Dietary Alpha Tocopherol A determination of the alpha tocopherol in a nutritional product or meal, or a portion thereof. Dietary Alpha Tocopherol Measurement Dietary 20:4 Arachidonate Dietary 20:4 Arachidonic Acid Dietary Arachidonic Acid A determination of the total 20:4 arachidonic acid in a nutritional product or meal, or a portion thereof. Dietary Arachidonic Acid Measurement Dietary Beans and Peas A determination of the total beans and peas in a nutritional product or meal, or a portion thereof. Dietary Beans and Peas Measurement Dietary Beta Carotene A determination of the beta carotene in a nutritional product or meal, or a portion thereof. Dietary Beta Carotene Measurement Dietary Beta-Cryptoxanthin A determination of the beta-cryptoxanthin in a nutritional product or meal, or a portion thereof. Dietary Beta-Cryptoxanthin Measurement Dietary 4:0 Butyrate Dietary 4:0 Butyric Acid Dietary Butyric Acid A determination of the total 4:0 butyric acid in a nutritional product or meal, or a portion thereof. Dietary Butyric Acid Measurement Dietary Caffeine A determination of the caffeine in a nutritional product or meal, or a portion thereof. Dietary Caffeine Measurement Dietary Calcium A determination of the total calcium in a nutritional product or meal, or a portion thereof. Dietary Calcium Measurement Dietary Calories A determination of the total dietary calories in a nutritional product or meal, or a portion thereof. Dietary Calories Measurement Dietary 10:0 Caprate Dietary 10:0 Capric Acid Dietary Capric Acid A determination of the total 10:0 capric acid in a nutritional product or meal, or a portion thereof. Dietary Capric Acid Measurement Dietary 6:0 Caproate Dietary 6:0 Caproic Acid Dietary Caproic Acid A determination of the total 6:0 caproic acid in a nutritional product or meal, or a portion thereof. Dietary Caproic Acid Measurement Dietary 8:0 Caprylate Dietary 8:0 Caprylic Acid Dietary Caprylic Acid A determination of the total 8:0 caprylic acid in a nutritional product or meal, or a portion thereof. Dietary Caprylic Acid Measurement Dietary Cheese A determination of the total cheese in a nutritional product or meal, or a portion thereof. Dietary Cheese Measurement Dietary Cholesterol A determination of the total cholesterol in a nutritional product or meal, or a portion thereof. Dietary Cholesterol Measurement Dietary Choline A determination of the choline in a nutritional product or meal, or a portion thereof. Dietary Choline Measurement Dietary Citrus, Melons, and Berries A determination of the total citrus, melons, and berries in a nutritional product or meal, or a portion thereof. Dietary Citrus, Melons, and Berries Measurement Dietary 22:5 Clupanodonate Dietary 22:5 Clupanodonic Acid Dietary Clupanodonic Acid A determination of the total 22:5 clupanodonic acid in a nutritional product or meal, or a portion thereof. Dietary Clupanodonic Acid Measurement Dietary Copper A determination of the total copper in a nutritional product or meal, or a portion thereof. Dietary Copper Measurement Dietary 22:6 Docosahexaenoate Dietary 22:6 Docosahexaenoic Acid Dietary Docosahexaenoic Acid A determination of the total 22:6 docosahexaenoic acid in a nutritional product or meal, or a portion thereof. Dietary Docosahexaenoic Acid Measurement Dietary Eggs A determination of the eggs in a nutritional product or meal, or a portion thereof. Dietary Eggs Measurement Dietary 22:1 Erucate Dietary 22:1 Erucic Acid Dietary Erucic Acid A determination of the total 22:1 erucic acid in a nutritional product or meal, or a portion thereof. Dietary Erucic Acid Measurement Dietary Fat, Monounsaturated A determination of the total monounsaturated fat in a nutritional product or meal, or a portion thereof. Dietary Monounsaturated Fat Measurement Dietary Fat, Polyunsaturated A determination of the total polyunsaturated fat in a nutritional product or meal, or a portion thereof. Dietary Polyunsaturated Fat Measurement Dietary Fat, Saturated A determination of the total saturated fat in a nutritional product or meal, or a portion thereof. Dietary Saturated Fat Measurement Dietary Fat, Total A determination of the total fat in a nutritional product or meal, or a portion thereof. Total Dietary Fat Measurement Dietary Fiber A determination of the total fiber in a nutritional product or meal, or a portion thereof. Dietary Fiber Measurement DFE Dietary Folate Equivalents The sum of food folate and normalized folic acid (as food folate equivalents) in a nutritional product or meal, or a portion thereof. Dietary Folate Equivalents Measurement Dietary Folic Acid A determination of the folic acid in a nutritional product or meal, or a portion thereof. Dietary Folic Acid Measurement Dietary Food Folate A determination of the naturally occurring folate in a nutritional product or meal, or a portion thereof. Dietary Food Folate Measurement Dietary Fruit Juice A determination of the fruit juice in a nutritional product or meal, or a portion thereof. Dietary Fruit Juice Measurement Dietary Fruit A determination of the total fruit in a nutritional product or meal, or a portion thereof. Dietary Fruit Measurement Dietary 20:1 Gadoleate Dietary 20:1 Gadoleic Acid Dietary Gadoleic Acid A determination of the total 20:1 gadoleic acid in a nutritional product or meal, or a portion thereof. Dietary Gadoleic Acid Measurement Dietary Grain A determination of the total grain in a nutritional product or meal, or a portion thereof. Dietary Grain Measurement Dietary Grain, Refined A determination of the total refined grains in a nutritional product or meal, or a portion thereof. Dietary Grain, Refined Measurement Dietary Iron A determination of the total iron in a nutritional product or meal, or a portion thereof. Dietary Iron Measurement Dietary 12:0 Laurate Dietary 12:0 Lauric Acid Dietary Lauric Acid A determination of the total 12:0 lauric acid in a nutritional product or meal, or a portion thereof. Dietary Lauric Acid Measurement Dietary 18:2 Linoleate Dietary 18:2 Linoleic Acid Dietary Linoleic Acid A determination of the total 18:2 linoleic acid in a nutritional product or meal, or a portion thereof. Dietary Linoleic Acid Measurement Dietary 18:3 Linolenate Dietary 18:3 Linolenic Acid Dietary Linolenic Acid A determination of the total 18:3 linolenic acid in a nutritional product or meal, or a portion thereof. Dietary Linolenic Acid Measurement Dietary Lutein and Zeaxanthin A determination of the lutein and zeaxanthin in a nutritional product or meal, or a portion thereof. Dietary Lutein and Zeaxanthin Measurement Dietary Lycopene A determination of the lycopene in a nutritional product or meal, or a portion thereof. Dietary Lycopene Measurement Dietary Magnesium A determination of the total magnesium in a nutritional product or meal, or a portion thereof. Dietary Magnesium Measurement Dietary Meat A determination of the total meat in a nutritional product or meal, or a portion thereof. Dietary Meat Measurement Dietary Meat, Cured A determination of the cured meat in a nutritional product or meal, or a portion thereof. Dietary Meat, Cured Measurement Dietary Meat, Organ A determination of the organ meat in a nutritional product or meal, or a portion thereof. Dietary Meat, Organ Measurement Dietary Meat, Poultry, and Seafood A determination of the total meat, poultry, and seafood in a nutritional product or meal, or a portion thereof. Dietary Meat, Poultry, and Seafood Measurement Dietary Milk A determination of the milk in a nutritional product or meal, or a portion thereof. Dietary Milk Measurement Dietary Moisture A determination of the moisture content in a nutritional product or meal, or a portion thereof. Dietary Moisture Measurement Dietary 14:0 Myristate Dietary 14:0 Myristic Acid Dietary Myristic Acid A determination of the total 14:0 myristic acid in a nutritional product or meal, or a portion thereof. Dietary Myristic Acid Measurement Dietary Niacin Dietary Vitamin B3 A determination of the niacin in a nutritional product or meal, or a portion thereof. Dietary Niacin Measurement Dietary Nuts and Seeds A determination of the total nuts and seeds in a nutritional product or meal, or a portion thereof. Dietary Nuts and Seeds Measurement Dietary Oils A determination of the oils in a nutritional product or meal, or a portion thereof. Dietary Oils Measurement Dietary 18:1 Oleate Dietary 18:1 Oleic Acid Dietary Oleic Acid A determination of the total 18:1 oleic acid in a nutritional product or meal, or a portion thereof. Dietary Oleic Acid Measurement Dietary 16:0 Palmitate Dietary 16:0 Palmitic Acid Dietary Palmitic Acid A determination of the total 16:0 palmitic acid in a nutritional product or meal, or a portion thereof. Dietary Palmitic Acid Measurement Dietary 16:1 Palmitoleate Dietary 16:1 Palmitoleic Acid Dietary Palmitoleic Acid A determination of the total 16:1 palmitoleic acid in a nutritional product or meal, or a portion thereof. Dietary Palmitoleic Acid Measurement Dietary 18:4 Parinarate Dietary 18:4 Parinaric Acid Dietary Parinaric Acid A determination of the total 18:4 parinaric acid in a nutritional product or meal, or a portion thereof. Dietary Parinaric Acid Measurement Dietary Phosphorus A determination of the phosphorus in a nutritional product or meal, or a portion thereof. Dietary Phosphorus Measurement Dietary Potassium A determination of the total potassium in a nutritional product or meal, or a portion thereof. Dietary Potassium Measurement Dietary Potatoes A determination of the potatoes in a nutritional product or meal, or a portion thereof. Dietary Potatoes Measurement Dietary Poultry A determination of the poultry in a nutritional product or meal, or a portion thereof. Dietary Poultry Measurement Dietary Protein Foods A determination of the protein-rich food in a nutritional product or meal, or a portion thereof. Dietary Protein Foods Measurement Dietary Protein A determination of the total protein in a nutritional product or meal, or a portion thereof. Dietary Protein Measurement Dietary Retinol Dietary Vitamin A A determination of the retinol in a nutritional product or meal, or a portion thereof. Dietary Retinol Measurement Dietary Riboflavin Dietary Vitamin B2 A determination of the riboflavin in a nutritional product or meal, or a portion thereof. Dietary Riboflavin Measurement Dietary Seafood High in n-3 Fatty Acids A determination of the seafood high in n-3 fatty acids in a nutritional product or meal, or a portion thereof. Dietary Seafood High in n-3 Fatty Acids Measurement Dietary Seafood Low in n-3 Fatty Acids A determination of the seafood low in n-3 fatty acids in a nutritional product or meal, or a portion thereof. Dietary Seafood Low in n-3 Fatty Acids Measurement Dietary Selenium A determination of the total selenium in a nutritional product or meal, or a portion thereof. Dietary Selenium Measurement Dietary Sodium A determination of the total sodium in a nutritional product or meal, or a portion thereof. Dietary Sodium Measurement Dietary Solid Fats A determination of the solid fats in a nutritional product or meal, or a portion thereof. Dietary Solid Fats Measurement Dietary Soy Products A determination of the soy-containing products in a nutritional product or meal, or a portion thereof. Dietary Soy Products Measurement Dietary 18:0 Stearate Dietary 18:0 Stearic Acid Dietary Stearic Acid A determination of the total 18:0 stearic acid in a nutritional product or meal, or a portion thereof. Dietary Stearic Acid Measurement Dietary Theobromine A determination of the theobromine in a nutritional product or meal, or a portion thereof. Dietary Theobromine Measurement Dietary Thiamin Dietary Thiamine Dietary Vitamin B1 A determination of the thiamine in a nutritional product or meal, or a portion thereof. Dietary Thiamine Measurement Dietary 20:5 Timnodonate Dietary 20:5 Timnodonic Acid Dietary Timnodonic Acid A determination of the total 20:5 timnodonic acid in a nutritional product or meal, or a portion thereof. Dietary Timnodonic Acid Measurement Dietary Tomatoes A determination of the tomatoes in a nutritional product or meal, or a portion thereof. Dietary Tomatoes Measurement Dietary Total Carbohydrate A determination of the total carbohydrate in a nutritional product or meal, or a portion thereof. Total Dietary Carbohydrate Measurement Dietary Total Dairy A determination of the total dairy (food products produced from or containing milk) in a nutritional product or meal, or a portion thereof. Dietary Dairy Measurement Dietary Total Folate A determination of the total folate (supplemental folic acid + food folate) in a nutritional product or meal, or a portion thereof. Dietary Total Folate Measurement Dietary Total Sugars A determination of the total sugars in a nutritional product or meal, or a portion thereof. Dietary Sugar Measurement Dietary Vegetable A determination of the total vegetables in a nutritional product or meal, or a portion thereof. Dietary Vegetable Measurement Dietary Vegetables, Dark Green A determination of the total dark green vegetables in a nutritional product or meal, or a portion thereof. Dietary Vegetables, Dark Green Measurement Dietary Vegetables, Red and Orange A determination of the total red and orange vegetables in a nutritional product or meal, or a portion thereof. Dietary Vegetables, Red and Orange Measurement Dietary Vegetables, Starchy A determination of the total starchy vegetables in a nutritional product or meal, or a portion thereof. Dietary Vegetables, Starchy Measurement Dietary Vitamin A A determination of the total vitamin A in a nutritional product or meal, or a portion thereof. Dietary Vitamin A Measurement Dietary Vitamin B12 A determination of the total vitamin B12 in a nutritional product or meal, or a portion thereof. Dietary Vitamin B12 Measurement Dietary Vitamin B6 A determination of the total vitamin B6 in a nutritional product or meal, or a portion thereof. Dietary Vitamin B6 Measurement Dietary Vitamin C A determination of the total vitamin C in a nutritional product or meal, or a portion thereof. Dietary Vitamin C Measurement Dietary Vitamin D A determination of the total vitamin D in a nutritional product or meal, or a portion thereof. Dietary Vitamin D Measurement Dietary Vitamin K A determination of the total vitamin K in a nutritional product or meal, or a portion thereof. Dietary Vitamin K Measurement Dietary Whole Grains A determination of the whole grains in a nutritional product or meal, or a portion thereof. Dietary Whole Grains Measurement Dietary Yogurt A determination of the yogurt in a nutritional product or meal, or a portion thereof. Dietary Yogurt Measurement Dietary Zinc A determination of the total Zinc in a nutritional product or meal, or a portion thereof. Dietary Zinc Measurement Dispensed Amount The quantity of a product that has been dispensed. (NCI) Dispensed Amount Distance The actual or calculated span between two points (real or virtual). Distance Estimated Entity Weight Estimated Weight An approximate determination of the weight of the entity. Estimated Weight Exercise Compliance A determination or assessment of the extent to which an individual adheres to a fitness program. Exercise Compliance Exercise Duration The length of time an individual spends exercising. Exercise Duration Exercise Intensity A determination or assessment of the degree or magnitude of an individual's exertion during physical activity. Exercise Intensity Number of Alcoholic Drinks The total number of alcoholic drinks. Number of Alcoholic Drinks Measurement Number of Episodes The total number of episodes that have occurred for the condition. Number of Episodes Number of Laps Completed The number of laps completed around a course or circuit. Number of Laps Completed Number of Steps Taken The number of footsteps taken by an individual. Number of Steps Taken Precipitating Factor The factor that causes or triggers the onset of an occurrence. Precipitating Factor Prepared Amount The quantity of a product that has been made ready for use. Prepared Amount Relationship to Device An assessment of the likelihood that the device was the cause of the event. Relationship to Device Remaining Amount The quantity of a product that remains after dosing, consumption, or use. Remaining Amount Returned Amount The quantity of a product that has been returned. (NCI) Returned Amount Speed A scalar measure of the rate of movement of the object expressed as the distance traveled divided by the elapsed time. Speed Total Time Paused The total amount of time during which an event, operation or activity has been interrupted or stopped. Total Time Paused Total Time Physically Active The total amount of time during which an individual was actively engaged in physical activity. Total Time Physically Active D1FATS Type 1 Diabetes Findings About Test Name CDISC SDTM Type 1 Diabetes Findings About Test Name Terminology Unified Huntington's Disease Rating Scale '99 test code. UHDR1-Ocular Pursuit: Horizontal Unified Huntington's Disease Rating Scale '99 - Ocular pursuit, horizontal. UHDRS 1999 Version - Ocular Pursuit: Horizontal UHDR1-Ocular Pursuit: Vertical Unified Huntington's Disease Rating Scale '99 - Ocular pursuit, vertical. UHDRS 1999 Version - Ocular Pursuit: Vertical UHDR1-Saccade Initiation: Horizontal Unified Huntington's Disease Rating Scale '99 - Saccade initiation, horizontal. UHDRS 1999 Version - Saccade Initiation: Horizontal UHDR1-Saccade Initiation: Vertical Unified Huntington's Disease Rating Scale '99 - Saccade initiation, vertical. UHDRS 1999 Version - Saccade Initiation: Vertical UHDR1-Saccade Velocity: Horizontal Unified Huntington's Disease Rating Scale '99 - Saccade velocity, horizontal. UHDRS 1999 Version - Saccade Velocity: Horizontal UHDR1-Saccade Velocity: Vertical Unified Huntington's Disease Rating Scale '99 - Saccade velocity, vertical. UHDRS 1999 Version - Saccade Velocity: Vertical UHDR1-Dysarthria Unified Huntington's Disease Rating Scale '99 - Dysarthria. UHDRS 1999 Version - Dysarthria UHDR1-Tongue Protrusion Unified Huntington's Disease Rating Scale '99 - Tongue protrusion. UHDRS 1999 Version - Tongue Protrusion UHDR1-Finger Taps: Right Unified Huntington's Disease Rating Scale '99 - Finger taps, right. UHDRS 1999 Version - Finger Taps: Right UHDR1-Finger Taps: Left Unified Huntington's Disease Rating Scale '99 - Finger taps, left. UHDRS 1999 Version - Finger Taps: Left UHDR1-Pronate/Supinate: Hands: Right Unified Huntington's Disease Rating Scale '99 - Pronate/supinate-hands, right. UHDRS 1999 Version - Pronate/Supinate: Hands: Right UHDR1-Pronate/Supinate: Hands: Left Unified Huntington's Disease Rating Scale '99 - Pronate/supinate-hands, left. UHDRS 1999 Version - Pronate/Supinate: Hands: Left UHDR1-Luria Unified Huntington's Disease Rating Scale '99 - Luria (fist-hand palm test). UHDRS 1999 Version - Luria UHDR1-Rigidity: Arms: Right Unified Huntington's Disease Rating Scale '99 - Rigidity-arms, right. UHDRS 1999 Version - Rigidity: Arms: Right UHDR1-Rigidity: Arms: Left Unified Huntington's Disease Rating Scale '99 - Rigidity-arms, left. UHDRS 1999 Version - Rigidity: Arms: Left UHDR1-Bradykinesia: Body Unified Huntington's Disease Rating Scale '99 - Bradykinesia-body. UHDRS 1999 Version - Bradykinesia: Body UHDR1-Maximal Dystonia: Trunk Unified Huntington's Disease Rating Scale '99 - Maximal dystonia-Trunk. UHDRS 1999 Version - Maximal Dystonia: Trunk UHDR1-Maximal Dystonia: RUE Unified Huntington's Disease Rating Scale '99 - Maximal dystonia-RUE. UHDRS 1999 Version - Maximal Dystonia: RUE UHDR1-Maximal Dystonia: LUE Unified Huntington's Disease Rating Scale '99 - Maximal dystonia-LUE. UHDRS 1999 Version - Maximal Dystonia: LUE UHDR1-Maximal Dystonia: RLE Unified Huntington's Disease Rating Scale '99 - Maximal dystonia-RLE. UHDRS 1999 Version - Maximal Dystonia: RLE UHDR1-Maximal Dystonia: LLE Unified Huntington's Disease Rating Scale '99 - Maximal dystonia-LLE. UHDRS 1999 Version - Maximal Dystonia: LLE UHDR1-Maximal Chorea: Face Unified Huntington's Disease Rating Scale '99 - Maximal chorea-Face. UHDRS 1999 Version - Maximal Chorea: Face UHDR1-Maximal Chorea: BOL Unified Huntington's Disease Rating Scale '99 - Maximal chorea-BOL. UHDRS 1999 Version - Maximal Chorea: BOL UHDR1-Maximal Chorea: Trunk Unified Huntington's Disease Rating Scale '99 - Maximal chorea-Trunk. UHDRS 1999 Version - Maximal Chorea: Trunk UHDR1-Maximal Chorea: RUE Unified Huntington's Disease Rating Scale '99 - Maximal chorea-RUE. UHDRS 1999 Version - Maximal Chorea: RUE UHDR1-Maximal Chorea: LUE Unified Huntington's Disease Rating Scale '99 - Maximal chorea-LUE. UHDRS 1999 Version - Maximal Chorea: LUE UHDR1-Maximal Chorea: RLE Unified Huntington's Disease Rating Scale '99 - Maximal chorea-RLE. UHDRS 1999 Version - Maximal Chorea: RLE UHDR1-Maximal Chorea: LLE Unified Huntington's Disease Rating Scale '99 - Maximal chorea-LLE. UHDRS 1999 Version - Maximal Chorea: LLE UHDR1-Gait Unified Huntington's Disease Rating Scale '99 - Gait. UHDRS 1999 Version - Gait UHDR1-Tandem Walking Unified Huntington's Disease Rating Scale '99 - Tandem walking. UHDRS 1999 Version - Tandem Walking UHDR1-Retropulsion Pull Test Unified Huntington's Disease Rating Scale '99 - Retropulsion pull test. UHDRS 1999 Version - Retropulsion Pull Test UHDR1-Diagnosis Confidence Level Unified Huntington's Disease Rating Scale '99 - Diagnosis confidence level: To what degree are you confident that this person meets the operational definition of the unequivocal presence of an otherwise unexplained extrapyramidal movement disorder (e.g., chorea, dystonia, bradykinesia, rigidity) in a subject at risk of HD? UHDRS 1999 Version - Diagnosis Confidence Level UHDR1-Verbal Fluency Test Unified Huntington's Disease Rating Scale '99 - Verbal fluency test (raw score). UHDRS 1999 Version - Verbal Fluency Test UHDR1-Symbol Digit Modalities Test Unified Huntington's Disease Rating Scale '99 - Symbol digit modalities test (raw score). UHDRS 1999 Version - Symbol Digit Modalities Test UHDR1-Depressed Mood: Frequency Unified Huntington's Disease Rating Scale '99 - Depressed mood: Frequency: Within the past month, how often have you been feeling sad, down or "blue"? UHDRS 1999 Version - Depressed Mood: Frequency UHDR1-Depressed Mood: Severity Unified Huntington's Disease Rating Scale '99 - Depressed mood: Severity: How has your mood affected your daily activities? [Evidence of sad mood from behavioral observation includes sad voice or expression, tearfulness.]. UHDRS 1999 Version - Depressed Mood: Severity UHDR1-Apathy: Frequency Unified Huntington's Disease Rating Scale '99 - Apathy: Frequency: Within the past month, how often have you found that you have lost interest in things that used to be important to you? UHDRS 1999 Version - Apathy: Frequency UHDR1-Apathy: Severity Unified Huntington's Disease Rating Scale '99 - Apathy: Severity: How has apathy impacted your ability to carry out daily activities? UHDRS 1999 Version - Apathy: Severity UHDR1-Self-esteem/Guilt: Frequency Unified Huntington's Disease Rating Scale '99 - Self-esteem/guilt: Frequency: Within the past month, how often have you been feeling badly about yourself? UHDRS 1999 Version - Self-esteem/Guilt: Frequency UHDR1-Self-esteem/Guilt: Severity Unified Huntington's Disease Rating Scale '99 - Self-esteem/guilt: Severity: How have these feelings affected your daily activities? UHDRS 1999 Version - Self-esteem/Guilt: Severity UHDR1-Suicidal Thoughts: Frequency Unified Huntington's Disease Rating Scale '99 - Suicidal thoughts: Frequency: Within the past month, how often have you thought about hurting yourself or ending it all? UHDRS 1999 Version - Suicidal Thoughts: Frequency UHDR1-Suicidal Thoughts: Severity Unified Huntington's Disease Rating Scale '99 - Suicidal thoughts: Severity: Do you have a plan in mind to end it all? Have you taken any steps toward carrying out your plan? UHDRS 1999 Version - Suicidal Thoughts: Severity UHDR1-Anxiety: Frequency Unified Huntington's Disease Rating Scale '99 - Anxiety: Frequency: Within the past month, how often have you found yourself worrying about things? UHDRS 1999 Version - Anxiety: Frequency UHDR1-Anxiety: Severity Unified Huntington's Disease Rating Scale '99 - Anxiety: Severity: How much has nervousness or worry affected your daily activities? UHDRS 1999 Version - Anxiety: Severity UHDR1-Irritable Behavior: Frequency Unified Huntington's Disease Rating Scale '99 - Irritable behavior: Frequency: In the past month, how often have you felt impatient, irritable, or "cranky"? UHDRS 1999 Version - Irritable Behavior: Frequency UHDR1-Irritable Behavior: Severity Unified Huntington's Disease Rating Scale '99 - Irritable behavior: Severity: How has irritability impacted your ability to get along with others? UHDRS 1999 Version - Irritable Behavior: Severity UHDR1-Disruptive Behavior: Frequency Unified Huntington's Disease Rating Scale '99 - Disruptive or aggressive behavior: Frequency: Within the past month, how often have you had emotional or temper outbursts? How often have you had times when you lost control of yourself? UHDRS 1999 Version - Disruptive Behavior: Frequency UDHR1-Disruptive Behavior: Severity Unified Huntington's Disease Rating Scale '99 - Disruptive or aggressive behavior: Severity: Have you used threats or hostile words? Have you hit or shoved or thrown things or expressed your temper in a physical way? UHDRS 1999 Version - UDHR1-Disruptive Behavior: Severity UHDR1-Perseverative Thinking: Frequency Unified Huntington's Disease Rating Scale '99 - Perseverative/obsessional thinking: Frequency: Within the past month, how often have you found yourself getting stuck on certain ideas? How often have you been bothered by thoughts, images, or fears that keep coming back even if you try not to have them? UHDRS 1999 Version - Perseverative Thinking: Frequency UDHR1-Perseverative Thinking: Severity Unified Huntington's Disease Rating Scale '99 - Perseverative/obsessional thinking: Severity: Have do repeated thoughts impact your daily life? UHDRS 1999 Version - UDHR1-Perseverative Thinking: Severity UHDR1-Compulsive Behavior: Frequency Unified Huntington's Disease Rating Scale '99 - Compulsive behavior: Frequency: Within the past month, how often have you found yourself doing certain things over and over again (counting, washing, checking)? UHDRS 1999 Version - Compulsive Behavior: Frequency UDHR1-Compulsive Behavior: Severity Unified Huntington's Disease Rating Scale '99 - Compulsive behavior: Severity: Are you unable to resist doing some of these things? UHDRS 1999 Version - UDHR1-Compulsive Behavior: Severity UHDR1-Delusions: Frequency Unified Huntington's Disease Rating Scale '99 - Delusions: Frequency: How often does it seem like people are out to get you, people are controlling you, or you are very suspicious of others? Do you have special powers or importance? UHDRS 1999 Version - Delusions: Frequency UDHR1-Delusions: Severity Unified Huntington's Disease Rating Scale '99 - Delusions: Severity: When you feel suspicious (insert delusion here), are you able to convince yourself that it is not rational? [Severity should reflect the behavior's impact on the individual's ability to carry out daily activities as indicated by response choices.]. UHDRS 1999 Version - UDHR1-Delusions: Severity UHDR1-Hallucinations: Frequency Unified Huntington's Disease Rating Scale '99 - Hallucinations: Frequency: How often have you heard things that other people couldn't hear, or seen things that other people couldn't see? UHDRS 1999 Version - Hallucinations: Frequency UDHR1-Hallucinations: Severity Unified Huntington's Disease Rating Scale '99 - Hallucinations: Severity: When you see or hear things (insert hallucination here), are you able to convince yourself that it is not rational? [Severity should reflect the behavior's impact on the individual's ability to carry out daily activities as indicated by response choices.]. UHDRS 1999 Version - UDHR1-Hallucinations: Severity UDHR1-Examiner Believe Subject Confused Unified Huntington's Disease Rating Scale '99 - Confusion is defined as intermittent or persistent disorganized thinking, perceptual disturbances or disorientation to time, place, or person. Does the examiner believe the subject is confused? UHDRS 1999 Version - UDHR1-Examiner Believe Subject Confused UDHR1-Confusion Altered Performance Unified Huntington's Disease Rating Scale '99 - If yes: Does the examiner believe that this has altered the performance on the UHDRS? UHDRS 1999 Version - UDHR1-Confusion Altered Performance UDHR1-Examiner Believe Signs of Dementia Unified Huntington's Disease Rating Scale '99 - Dementia is defined as progressive impairment in memory, abstract thinking or judgment that interferes with work or usual social activities and relationships. Does the examiner believe that the participant is showing signs of dementia? UHDRS 1999 Version - UDHR1-Examiner Believe Signs of Dementia UDHR1-Dementia Altered Performance Unified Huntington's Disease Rating Scale '99 - If yes: Does the examiner believe that this has altered the performance on the UHDRS? UHDRS 1999 Version - UDHR1-Dementia Altered Performance UDHR1-Examiner Believe Signs Depression Unified Huntington's Disease Rating Scale '99 - Depression is defined as persistent depressed mood, anhedonia, or vegetative signs sufficient to interfere with daily functioning. Does the examiner believe that the participant is showing signs of depression? UHDRS 1999 Version - UDHR1-Examiner Believe Signs Depression UHDR1-Pharmacotherapy of Depression Unified Huntington's Disease Rating Scale '99 - In the opinion of the examiner, is a clinical evaluation or follow up warranted for possible pharmacotherapy of depression? UHDRS 1999 Version - Pharmacotherapy of Depression UHDR1-Pharmacotherapy of Irritability Unified Huntington's Disease Rating Scale '99 - In the opinion of the examiner, is a clinical evaluation or follow up warranted for possible pharmacotherapy of irritability? UHDRS 1999 Version - Pharmacotherapy of Irritability UHDR1-Behavior Assessment Obtained From Unified Huntington's Disease Rating Scale '99 - Was the Behavioral Assessment information obtained from. UHDRS 1999 Version - Behavior Assessment Obtained From UHDR1-Gainful Employment Accustomed Work Unified Huntington's Disease Rating Scale '99 - Could the subject engage in gainful employment in his/her accustomed work? UHDRS 1999 Version - Gainful Employment Accustomed Work UHDR1-Any Gainful Employment Unified Huntington's Disease Rating Scale '99 - Could the subject engage in any kind of gainful employment? UHDRS 1999 Version - Any Gainful Employment UHDR1-Volunteer or Non Gainful Work Unified Huntington's Disease Rating Scale '99 - Could the subject engage in any kind of volunteer or non gainful work? UHDRS 1999 Version - Volunteer or Non Gainful Work UHDR1-Manage Finances Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject manage his/her finances (monthly) without any help? UHDRS 1999 Version - Manage Finances Without Help UHDR1-Shop for Groceries Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject shop for groceries without help? UHDRS 1999 Version - Shop for Groceries Without Help UHDR1-Handle Money as Purchaser Unified Huntington's Disease Rating Scale '99 - Could the subject handle money as a purchaser in a simple cash (store) transaction? UHDRS 1999 Version - Handle Money as Purchaser UHDR1-Supervise Children Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject supervise children without help? UHDRS 1999 Version - Supervise Children Without Help UHDR1-Operate Automobile Safely Unified Huntington's Disease Rating Scale '99 - Could the subject operate an automobile safely and independently? UHDRS 1999 Version - Operate Automobile Safely UHDR1-Do Housework Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject do his/her own housework without help? UHDRS 1999 Version - Do Housework Without Help UHDR1-Do Laundry Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject do his/her own laundry (wash/dry) without help? UHDRS 1999 Version - Do Laundry Without Help UHDR1-Prepare Own Meals Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject prepare his/her own meals without help? UHDRS 1999 Version - Prepare Own Meals Without Help UHDR1-Use Telephone Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject use the telephone without help? UHDRS 1999 Version - Use Telephone Without Help UHDR1-Take Medications Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject take his/her own medications without help? UHDRS 1999 Version - Take Medications Without Help UHDR1-Feed Himself/Herself Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject feed himself/herself without help? UHDRS 1999 Version - Feed Himself/Herself Without Help UHDR1-Dress Himself/Herself Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject dress himself/herself without help? UHDRS 1999 Version - Dress Himself/Herself Without Help UHDR1-Bathe Himself/Herself Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject bathe himself/herself without help? UHDRS 1999 Version - Bathe Himself/Herself Without Help UHDR1-Public Transportation Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject use public transportation to get places without help? UHDRS 1999 Version - Public Transportation Without Help UHDR1-Walk Own Neighborhood Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject walk to places in his/her own neighborhood without help? UHDRS 1999 Version - Walk Own Neighborhood Without Help UHDR1-Walk Without Falling Unified Huntington's Disease Rating Scale '99 - Could the subject walk without falling? UHDRS 1999 Version - Walk Without Falling UHDR1-Walk Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject walk without help? UHDRS 1999 Version - Walk Without Help UHDR1-Comb Hair Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject comb hair without help? UHDRS 1999 Version - Comb Hair Without Help UHDR1-Transfer Chair Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject transfer between chairs without help? UHDRS 1999 Version - Transfer Chair Without Help UHDR1-Get in and Out of Bed Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject get in and out of bed without help? UHDRS 1999 Version - Get in and Out of Bed Without Help UHDR1-Use Toilet/Commode Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject use the toilet/commode without help? UHDRS 1999 Version - Use Toilet/Commode Without Help UHDR1-Care Provided at Home Unified Huntington's Disease Rating Scale '99 - Could the subject's care still be provided at home? UHDRS 1999 Version - Care Provided at Home UHDR1-Functional Assess Obtained From Unified Huntington's Disease Rating Scale '99 - Was the Functional Assessment information obtained from. UHDRS 1999 Version - Functional Assess Obtained From UHDR1-Current Level Subject Independence Unified Huntington's Disease Rating Scale '99 - Please indicate the most accurate current level of subject's independence (only increments of 5 are acceptable). UHDRS 1999 Version - Current Level Subject Independence UHDR1-Occupation Unified Huntington's Disease Rating Scale '99 - Occupation. UHDRS 1999 Version - Occupation UHDR1-Finances Unified Huntington's Disease Rating Scale '99 - Finances. UHDRS 1999 Version - Finances UHDR1-Domestic Chores Unified Huntington's Disease Rating Scale '99 - Domestic Chores. UHDRS 1999 Version - Domestic Chores UHDR1-ADL Unified Huntington's Disease Rating Scale '99 - ADL. UHDRS 1999 Version - ADL UHDR1-Care Level Unified Huntington's Disease Rating Scale '99 - Care Level. UHDRS 1999 Version - Care Level UHDR1-Functional Capacity Obtained From Unified Huntington's Disease Rating Scale '99 - Was the Functional Capacity information obtained from. UHDRS 1999 Version - Functional Capacity Obtained From UHDR1-Purpose of This Visit Unified Huntington's Disease Rating Scale '99 - What was the purpose of this visit? UHDRS 1999 Version - Purpose of This Visit UHDR1-Since Last Assessment Opinion Unified Huntington's Disease Rating Scale '99 - Since your last assessment of the subject, in your opinion, has the subject. UHDRS 1999 Version - Since Last Assessment Opinion UHDR1-Since Last Assessment Feel Unified Huntington's Disease Rating Scale '99 - Since your last assessment does the subject feel. UHDRS 1999 Version - Since Last Assessment Feel UHDR1-Believe Subject Has Manifest HD Unified Huntington's Disease Rating Scale '99 - Based on the entire UHDRS (Motor, Cognitive, Behavioral and Functional components) do you believe with a confidence level >= 99% that this subject has manifest HD? UHDRS 1999 Version - Believe Subject Has Manifest HD UHDR1-Permanently Institutionalized Unified Huntington's Disease Rating Scale '99 - Since the last visit, has the subject been permanently institutionalized? UHDRS 1999 Version - Permanently Institutionalized UHDR1-Continue to Be Assessed for Study Unified Huntington's Disease Rating Scale '99 - If the subject was institutionalized will the subject continue to be assessed for this study? UHDRS 1999 Version - Continue to Be Assessed for Study UHDR1-Total Motor Score Unified Huntington's Disease Rating Scale '99 - Total Motor score. UHDRS 1999 Version - Total Motor Score UHDR1-Total Behavior Score Unified Huntington's Disease Rating Scale '99 - Total Behavior score. UHDRS 1999 Version - Total Behavior Score UHDR1-Mood Subscale Score Unified Huntington's Disease Rating Scale '99 - Mood subscale score of the total behavior score. UHDRS 1999 Version - Mood Subscale Score UHDR1-Behavior Subscale Score Unified Huntington's Disease Rating Scale '99 - Behavior subscale score of the total behavior score. UHDRS 1999 Version - Behavior Subscale Score UHDR1-Psychosis Subscale Score Unified Huntington's Disease Rating Scale '99 - Psychosis subscale score of the total behavior score. UHDRS 1999 Version - Psychosis Subscale Score UHDR1-Obsessive Subscale Score Unified Huntington's Disease Rating Scale '99 - Obsessive subscale score of the total behavior score. UHDRS 1999 Version - Obsessive Subscale Score UHDR1-Total Functional Capacity Score Unified Huntington's Disease Rating Scale '99 - Total functional capacity score. UHDRS 1999 Version - Total Functional Capacity Score UHDR1-Independence Scale Score Unified Huntington's Disease Rating Scale '99 - Independence scale score. UHDRS 1999 Version - Independence Scale Score UHDR1-Functional Checklist Score Unified Huntington's Disease Rating Scale '99 - Functional checklist score. UHDRS 1999 Version - Functional Checklist Score UHDR1TC Unified Huntington's Disease Rating Scale '99 Clinical Classification Test Code CDISC Clinical Classification UHDRS 1999 Version Test Code Terminology Unified Huntington's Disease Rating Scale '99 test name. UDHR1-Compulsive Behavior: Severity Unified Huntington's Disease Rating Scale '99 - Compulsive behavior: Severity: Are you unable to resist doing some of these things? UHDRS 1999 Version - UDHR1-Compulsive Behavior: Severity UDHR1-Confusion Altered Performance Unified Huntington's Disease Rating Scale '99 - If yes: Does the examiner believe that this has altered the performance on the UHDRS? UHDRS 1999 Version - UDHR1-Confusion Altered Performance UDHR1-Delusions: Severity Unified Huntington's Disease Rating Scale '99 - Delusions: Severity: When you feel suspicious (insert delusion here), are you able to convince yourself that it is not rational? [Severity should reflect the behavior's impact on the individual's ability to carry out daily activities as indicated by response choices.]. UHDRS 1999 Version - UDHR1-Delusions: Severity UDHR1-Dementia Altered Performance Unified Huntington's Disease Rating Scale '99 - If yes: Does the examiner believe that this has altered the performance on the UHDRS? UHDRS 1999 Version - UDHR1-Dementia Altered Performance UDHR1-Disruptive Behavior: Severity Unified Huntington's Disease Rating Scale '99 - Disruptive or aggressive behavior: Severity: Have you used threats or hostile words? Have you hit or shoved or thrown things or expressed your temper in a physical way? UHDRS 1999 Version - UDHR1-Disruptive Behavior: Severity UDHR1-Examiner Believe Signs Depression Unified Huntington's Disease Rating Scale '99 - Depression is defined as persistent depressed mood, anhedonia, or vegetative signs sufficient to interfere with daily functioning. Does the examiner believe that the participant is showing signs of depression? UHDRS 1999 Version - UDHR1-Examiner Believe Signs Depression UDHR1-Examiner Believe Signs of Dementia Unified Huntington's Disease Rating Scale '99 - Dementia is defined as progressive impairment in memory, abstract thinking or judgment that interferes with work or usual social activities and relationships. Does the examiner believe that the participant is showing signs of dementia? UHDRS 1999 Version - UDHR1-Examiner Believe Signs of Dementia UDHR1-Examiner Believe Subject Confused Unified Huntington's Disease Rating Scale '99 - Confusion is defined as intermittent or persistent disorganized thinking, perceptual disturbances or disorientation to time, place, or person. Does the examiner believe the subject is confused? UHDRS 1999 Version - UDHR1-Examiner Believe Subject Confused UDHR1-Hallucinations: Severity Unified Huntington's Disease Rating Scale '99 - Hallucinations: Severity: When you see or hear things (insert hallucination here), are you able to convince yourself that it is not rational? [Severity should reflect the behavior's impact on the individual's ability to carry out daily activities as indicated by response choices.]. UHDRS 1999 Version - UDHR1-Hallucinations: Severity UDHR1-Perseverative Thinking: Severity Unified Huntington's Disease Rating Scale '99 - Perseverative/obsessional thinking: Severity: Have do repeated thoughts impact your daily life? UHDRS 1999 Version - UDHR1-Perseverative Thinking: Severity UHDR1-ADL Unified Huntington's Disease Rating Scale '99 - ADL. UHDRS 1999 Version - ADL UHDR1-Anxiety: Frequency Unified Huntington's Disease Rating Scale '99 - Anxiety: Frequency: Within the past month, how often have you found yourself worrying about things? UHDRS 1999 Version - Anxiety: Frequency UHDR1-Anxiety: Severity Unified Huntington's Disease Rating Scale '99 - Anxiety: Severity: How much has nervousness or worry affected your daily activities? UHDRS 1999 Version - Anxiety: Severity UHDR1-Any Gainful Employment Unified Huntington's Disease Rating Scale '99 - Could the subject engage in any kind of gainful employment? UHDRS 1999 Version - Any Gainful Employment UHDR1-Apathy: Frequency Unified Huntington's Disease Rating Scale '99 - Apathy: Frequency: Within the past month, how often have you found that you have lost interest in things that used to be important to you? UHDRS 1999 Version - Apathy: Frequency UHDR1-Apathy: Severity Unified Huntington's Disease Rating Scale '99 - Apathy: Severity: How has apathy impacted your ability to carry out daily activities? UHDRS 1999 Version - Apathy: Severity UHDR1-Bathe Himself/Herself Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject bathe himself/herself without help? UHDRS 1999 Version - Bathe Himself/Herself Without Help UHDR1-Behavior Assessment Obtained From Unified Huntington's Disease Rating Scale '99 - Was the Behavioral Assessment information obtained from. UHDRS 1999 Version - Behavior Assessment Obtained From UHDR1-Behavior Subscale Score Unified Huntington's Disease Rating Scale '99 - Behavior subscale score of the total behavior score. UHDRS 1999 Version - Behavior Subscale Score UHDR1-Believe Subject Has Manifest HD Unified Huntington's Disease Rating Scale '99 - Based on the entire UHDRS (Motor, Cognitive, Behavioral and Functional components) do you believe with a confidence level >= 99% that this subject has manifest HD? UHDRS 1999 Version - Believe Subject Has Manifest HD UHDR1-Bradykinesia: Body Unified Huntington's Disease Rating Scale '99 - Bradykinesia-body. UHDRS 1999 Version - Bradykinesia: Body UHDR1-Care Level Unified Huntington's Disease Rating Scale '99 - Care Level. UHDRS 1999 Version - Care Level UHDR1-Care Provided at Home Unified Huntington's Disease Rating Scale '99 - Could the subject's care still be provided at home? UHDRS 1999 Version - Care Provided at Home UHDR1-Comb Hair Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject comb hair without help? UHDRS 1999 Version - Comb Hair Without Help UHDR1-Compulsive Behavior: Frequency Unified Huntington's Disease Rating Scale '99 - Compulsive behavior: Frequency: Within the past month, how often have you found yourself doing certain things over and over again (counting, washing, checking)? UHDRS 1999 Version - Compulsive Behavior: Frequency UHDR1-Continue to Be Assessed for Study Unified Huntington's Disease Rating Scale '99 - If the subject was institutionalized will the subject continue to be assessed for this study? UHDRS 1999 Version - Continue to Be Assessed for Study UHDR1-Current Level Subject Independence Unified Huntington's Disease Rating Scale '99 - Please indicate the most accurate current level of subject's independence (only increments of 5 are acceptable). UHDRS 1999 Version - Current Level Subject Independence UHDR1-Delusions: Frequency Unified Huntington's Disease Rating Scale '99 - Delusions: Frequency: How often does it seem like people are out to get you, people are controlling you, or you are very suspicious of others? Do you have special powers or importance? UHDRS 1999 Version - Delusions: Frequency UHDR1-Depressed Mood: Frequency Unified Huntington's Disease Rating Scale '99 - Depressed mood: Frequency: Within the past month, how often have you been feeling sad, down or "blue"? UHDRS 1999 Version - Depressed Mood: Frequency UHDR1-Depressed Mood: Severity Unified Huntington's Disease Rating Scale '99 - Depressed mood: Severity: How has your mood affected your daily activities? [Evidence of sad mood from behavioral observation includes sad voice or expression, tearfulness.]. UHDRS 1999 Version - Depressed Mood: Severity UHDR1-Diagnosis Confidence Level Unified Huntington's Disease Rating Scale '99 - Diagnosis confidence level: To what degree are you confident that this person meets the operational definition of the unequivocal presence of an otherwise unexplained extrapyramidal movement disorder (e.g., chorea, dystonia, bradykinesia, rigidity) in a subject at risk of HD? UHDRS 1999 Version - Diagnosis Confidence Level UHDR1-Disruptive Behavior: Frequency Unified Huntington's Disease Rating Scale '99 - Disruptive or aggressive behavior: Frequency: Within the past month, how often have you had emotional or temper outbursts? How often have you had times when you lost control of yourself? UHDRS 1999 Version - Disruptive Behavior: Frequency UHDR1-Do Housework Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject do his/her own housework without help? UHDRS 1999 Version - Do Housework Without Help UHDR1-Do Laundry Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject do his/her own laundry (wash/dry) without help? UHDRS 1999 Version - Do Laundry Without Help UHDR1-Domestic Chores Unified Huntington's Disease Rating Scale '99 - Domestic Chores. UHDRS 1999 Version - Domestic Chores UHDR1-Dress Himself/Herself Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject dress himself/herself without help? UHDRS 1999 Version - Dress Himself/Herself Without Help UHDR1-Dysarthria Unified Huntington's Disease Rating Scale '99 - Dysarthria. UHDRS 1999 Version - Dysarthria UHDR1-Feed Himself/Herself Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject feed himself/herself without help? UHDRS 1999 Version - Feed Himself/Herself Without Help UHDR1-Finances Unified Huntington's Disease Rating Scale '99 - Finances. UHDRS 1999 Version - Finances UHDR1-Finger Taps: Left Unified Huntington's Disease Rating Scale '99 - Finger taps, left. UHDRS 1999 Version - Finger Taps: Left UHDR1-Finger Taps: Right Unified Huntington's Disease Rating Scale '99 - Finger taps, right. UHDRS 1999 Version - Finger Taps: Right UHDR1-Functional Assess Obtained From Unified Huntington's Disease Rating Scale '99 - Was the Functional Assessment information obtained from. UHDRS 1999 Version - Functional Assess Obtained From UHDR1-Functional Capacity Obtained From Unified Huntington's Disease Rating Scale '99 - Was the Functional Capacity information obtained from. UHDRS 1999 Version - Functional Capacity Obtained From UHDR1-Functional Checklist Score Unified Huntington's Disease Rating Scale '99 - Functional checklist score. UHDRS 1999 Version - Functional Checklist Score UHDR1-Gainful Employment Accustomed Work Unified Huntington's Disease Rating Scale '99 - Could the subject engage in gainful employment in his/her accustomed work? UHDRS 1999 Version - Gainful Employment Accustomed Work UHDR1-Gait Unified Huntington's Disease Rating Scale '99 - Gait. UHDRS 1999 Version - Gait UHDR1-Get in and Out of Bed Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject get in and out of bed without help? UHDRS 1999 Version - Get in and Out of Bed Without Help UHDR1-Hallucinations: Frequency Unified Huntington's Disease Rating Scale '99 - Hallucinations: Frequency: How often have you heard things that other people couldn't hear, or seen things that other people couldn't see? UHDRS 1999 Version - Hallucinations: Frequency UHDR1-Handle Money as Purchaser Unified Huntington's Disease Rating Scale '99 - Could the subject handle money as a purchaser in a simple cash (store) transaction? UHDRS 1999 Version - Handle Money as Purchaser UHDR1-Independence Scale Score Unified Huntington's Disease Rating Scale '99 - Independence scale score. UHDRS 1999 Version - Independence Scale Score UHDR1-Irritable Behavior: Frequency Unified Huntington's Disease Rating Scale '99 - Irritable behavior: Frequency: In the past month, how often have you felt impatient, irritable, or "cranky"? UHDRS 1999 Version - Irritable Behavior: Frequency UHDR1-Irritable Behavior: Severity Unified Huntington's Disease Rating Scale '99 - Irritable behavior: Severity: How has irritability impacted your ability to get along with others? UHDRS 1999 Version - Irritable Behavior: Severity UHDR1-Luria Unified Huntington's Disease Rating Scale '99 - Luria (fist-hand palm test). UHDRS 1999 Version - Luria UHDR1-Manage Finances Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject manage his/her finances (monthly) without any help? UHDRS 1999 Version - Manage Finances Without Help UHDR1-Maximal Chorea: BOL Unified Huntington's Disease Rating Scale '99 - Maximal chorea-BOL. UHDRS 1999 Version - Maximal Chorea: BOL UHDR1-Maximal Chorea: Face Unified Huntington's Disease Rating Scale '99 - Maximal chorea-Face. UHDRS 1999 Version - Maximal Chorea: Face UHDR1-Maximal Chorea: LLE Unified Huntington's Disease Rating Scale '99 - Maximal chorea-LLE. UHDRS 1999 Version - Maximal Chorea: LLE UHDR1-Maximal Chorea: LUE Unified Huntington's Disease Rating Scale '99 - Maximal chorea-LUE. UHDRS 1999 Version - Maximal Chorea: LUE UHDR1-Maximal Chorea: RLE Unified Huntington's Disease Rating Scale '99 - Maximal chorea-RLE. UHDRS 1999 Version - Maximal Chorea: RLE UHDR1-Maximal Chorea: RUE Unified Huntington's Disease Rating Scale '99 - Maximal chorea-RUE. UHDRS 1999 Version - Maximal Chorea: RUE UHDR1-Maximal Chorea: Trunk Unified Huntington's Disease Rating Scale '99 - Maximal chorea-Trunk. UHDRS 1999 Version - Maximal Chorea: Trunk UHDR1-Maximal Dystonia: LLE Unified Huntington's Disease Rating Scale '99 - Maximal dystonia-LLE. UHDRS 1999 Version - Maximal Dystonia: LLE UHDR1-Maximal Dystonia: LUE Unified Huntington's Disease Rating Scale '99 - Maximal dystonia-LUE. UHDRS 1999 Version - Maximal Dystonia: LUE UHDR1-Maximal Dystonia: RLE Unified Huntington's Disease Rating Scale '99 - Maximal dystonia-RLE. UHDRS 1999 Version - Maximal Dystonia: RLE UHDR1-Maximal Dystonia: RUE Unified Huntington's Disease Rating Scale '99 - Maximal dystonia-RUE. UHDRS 1999 Version - Maximal Dystonia: RUE UHDR1-Maximal Dystonia: Trunk Unified Huntington's Disease Rating Scale '99 - Maximal dystonia-Trunk. UHDRS 1999 Version - Maximal Dystonia: Trunk UHDR1-Mood Subscale Score Unified Huntington's Disease Rating Scale '99 - Mood subscale score of the total behavior score. UHDRS 1999 Version - Mood Subscale Score UHDR1-Obsessive Subscale Score Unified Huntington's Disease Rating Scale '99 - Obsessive subscale score of the total behavior score. UHDRS 1999 Version - Obsessive Subscale Score UHDR1-Occupation Unified Huntington's Disease Rating Scale '99 - Occupation. UHDRS 1999 Version - Occupation UHDR1-Ocular Pursuit: Horizontal Unified Huntington's Disease Rating Scale '99 - Ocular pursuit, horizontal. UHDRS 1999 Version - Ocular Pursuit: Horizontal UHDR1-Ocular Pursuit: Vertical Unified Huntington's Disease Rating Scale '99 - Ocular pursuit, vertical. UHDRS 1999 Version - Ocular Pursuit: Vertical UHDR1-Operate Automobile Safely Unified Huntington's Disease Rating Scale '99 - Could the subject operate an automobile safely and independently? UHDRS 1999 Version - Operate Automobile Safely UHDR1-Permanently Institutionalized Unified Huntington's Disease Rating Scale '99 - Since the last visit, has the subject been permanently institutionalized? UHDRS 1999 Version - Permanently Institutionalized UHDR1-Perseverative Thinking: Frequency Unified Huntington's Disease Rating Scale '99 - Perseverative/obsessional thinking: Frequency: Within the past month, how often have you found yourself getting stuck on certain ideas? How often have you been bothered by thoughts, images, or fears that keep coming back even if you try not to have them? UHDRS 1999 Version - Perseverative Thinking: Frequency UHDR1-Pharmacotherapy of Depression Unified Huntington's Disease Rating Scale '99 - In the opinion of the examiner, is a clinical evaluation or follow up warranted for possible pharmacotherapy of depression? UHDRS 1999 Version - Pharmacotherapy of Depression UHDR1-Pharmacotherapy of Irritability Unified Huntington's Disease Rating Scale '99 - In the opinion of the examiner, is a clinical evaluation or follow up warranted for possible pharmacotherapy of irritability? UHDRS 1999 Version - Pharmacotherapy of Irritability UHDR1-Prepare Own Meals Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject prepare his/her own meals without help? UHDRS 1999 Version - Prepare Own Meals Without Help UHDR1-Pronate/Supinate: Hands: Left Unified Huntington's Disease Rating Scale '99 - Pronate/supinate-hands, left. UHDRS 1999 Version - Pronate/Supinate: Hands: Left UHDR1-Pronate/Supinate: Hands: Right Unified Huntington's Disease Rating Scale '99 - Pronate/supinate-hands, right. UHDRS 1999 Version - Pronate/Supinate: Hands: Right UHDR1-Psychosis Subscale Score Unified Huntington's Disease Rating Scale '99 - Psychosis subscale score of the total behavior score. UHDRS 1999 Version - Psychosis Subscale Score UHDR1-Public Transportation Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject use public transportation to get places without help? UHDRS 1999 Version - Public Transportation Without Help UHDR1-Purpose of This Visit Unified Huntington's Disease Rating Scale '99 - What was the purpose of this visit? UHDRS 1999 Version - Purpose of This Visit UHDR1-Retropulsion Pull Test Unified Huntington's Disease Rating Scale '99 - Retropulsion pull test. UHDRS 1999 Version - Retropulsion Pull Test UHDR1-Rigidity: Arms: Left Unified Huntington's Disease Rating Scale '99 - Rigidity-arms, left. UHDRS 1999 Version - Rigidity: Arms: Left UHDR1-Rigidity: Arms: Right Unified Huntington's Disease Rating Scale '99 - Rigidity-arms, right. UHDRS 1999 Version - Rigidity: Arms: Right UHDR1-Saccade Initiation: Horizontal Unified Huntington's Disease Rating Scale '99 - Saccade initiation, horizontal. UHDRS 1999 Version - Saccade Initiation: Horizontal UHDR1-Saccade Initiation: Vertical Unified Huntington's Disease Rating Scale '99 - Saccade initiation, vertical. UHDRS 1999 Version - Saccade Initiation: Vertical UHDR1-Saccade Velocity: Horizontal Unified Huntington's Disease Rating Scale '99 - Saccade velocity, horizontal. UHDRS 1999 Version - Saccade Velocity: Horizontal UHDR1-Saccade Velocity: Vertical Unified Huntington's Disease Rating Scale '99 - Saccade velocity, vertical. UHDRS 1999 Version - Saccade Velocity: Vertical UHDR1-Self-esteem/Guilt: Frequency Unified Huntington's Disease Rating Scale '99 - Self-esteem/guilt: Frequency: Within the past month, how often have you been feeling badly about yourself? UHDRS 1999 Version - Self-esteem/Guilt: Frequency UHDR1-Self-esteem/Guilt: Severity Unified Huntington's Disease Rating Scale '99 - Self-esteem/guilt: Severity: How have these feelings affected your daily activities? UHDRS 1999 Version - Self-esteem/Guilt: Severity UHDR1-Shop for Groceries Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject shop for groceries without help? UHDRS 1999 Version - Shop for Groceries Without Help UHDR1-Since Last Assessment Feel Unified Huntington's Disease Rating Scale '99 - Since your last assessment does the subject feel. UHDRS 1999 Version - Since Last Assessment Feel UHDR1-Since Last Assessment Opinion Unified Huntington's Disease Rating Scale '99 - Since your last assessment of the subject, in your opinion, has the subject. UHDRS 1999 Version - Since Last Assessment Opinion UHDR1-Suicidal Thoughts: Frequency Unified Huntington's Disease Rating Scale '99 - Suicidal thoughts: Frequency: Within the past month, how often have you thought about hurting yourself or ending it all? UHDRS 1999 Version - Suicidal Thoughts: Frequency UHDR1-Suicidal Thoughts: Severity Unified Huntington's Disease Rating Scale '99 - Suicidal thoughts: Severity: Do you have a plan in mind to end it all? Have you taken any steps toward carrying out your plan? UHDRS 1999 Version - Suicidal Thoughts: Severity UHDR1-Supervise Children Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject supervise children without help? UHDRS 1999 Version - Supervise Children Without Help UHDR1-Symbol Digit Modalities Test Unified Huntington's Disease Rating Scale '99 - Symbol digit modalities test (raw score). UHDRS 1999 Version - Symbol Digit Modalities Test UHDR1-Take Medications Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject take his/her own medications without help? UHDRS 1999 Version - Take Medications Without Help UHDR1-Tandem Walking Unified Huntington's Disease Rating Scale '99 - Tandem walking. UHDRS 1999 Version - Tandem Walking UHDR1-Tongue Protrusion Unified Huntington's Disease Rating Scale '99 - Tongue protrusion. UHDRS 1999 Version - Tongue Protrusion UHDR1-Total Behavior Score Unified Huntington's Disease Rating Scale '99 - Total Behavior score. UHDRS 1999 Version - Total Behavior Score UHDR1-Total Functional Capacity Score Unified Huntington's Disease Rating Scale '99 - Total functional capacity score. UHDRS 1999 Version - Total Functional Capacity Score UHDR1-Total Motor Score Unified Huntington's Disease Rating Scale '99 - Total Motor score. UHDRS 1999 Version - Total Motor Score UHDR1-Transfer Chair Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject transfer between chairs without help? UHDRS 1999 Version - Transfer Chair Without Help UHDR1-Use Telephone Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject use the telephone without help? UHDRS 1999 Version - Use Telephone Without Help UHDR1-Use Toilet/Commode Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject use the toilet/commode without help? UHDRS 1999 Version - Use Toilet/Commode Without Help UHDR1-Verbal Fluency Test Unified Huntington's Disease Rating Scale '99 - Verbal fluency test (raw score). UHDRS 1999 Version - Verbal Fluency Test UHDR1-Volunteer or Non Gainful Work Unified Huntington's Disease Rating Scale '99 - Could the subject engage in any kind of volunteer or non gainful work? UHDRS 1999 Version - Volunteer or Non Gainful Work UHDR1-Walk Own Neighborhood Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject walk to places in his/her own neighborhood without help? UHDRS 1999 Version - Walk Own Neighborhood Without Help UHDR1-Walk Without Falling Unified Huntington's Disease Rating Scale '99 - Could the subject walk without falling? UHDRS 1999 Version - Walk Without Falling UHDR1-Walk Without Help Unified Huntington's Disease Rating Scale '99 - Could the subject walk without help? UHDRS 1999 Version - Walk Without Help UHDR1TN Unified Huntington's Disease Rating Scale '99 Clinical Classification Test Name CDISC Clinical Classification UHDRS 1999 Version Test Name Terminology Unified Parkinson's Disease Rating Scale test code. UPD1-Mentation:Intellectual Impairment Unified Parkinson's Disease Rating Scale - Mentation, behavior and mood: Intellectual impairment. UPDRS - Mentation, Behavior and Mood: Intellectual Impairment UPD1-Mentation:Thought Disorder Unified Parkinson's Disease Rating Scale - Mentation, behavior and mood: Thought disorder. UPDRS - Mentation, Behavior and Mood: Thought Disorder UPD1-Mentation:Depression Unified Parkinson's Disease Rating Scale - Mentation, behavior and mood: Depression. UPDRS - Mentation, Behavior and Mood: Depression UPD1-Mentation:Motivation/Initiative Unified Parkinson's Disease Rating Scale - Mentation, behavior and mood: Motivation/Initiative. UPDRS - Mentation, Behavior and Mood: Motivation/Initiative UPD1-Activities:Speech Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Speech. UPDRS - Activities of Daily Living: Speech UPD1-Activities:Salivation Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Salivation. UPDRS - Activities of Daily Living: Salivation UPD1-Activities:Swallowing Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Swallowing. UPDRS - Activities of Daily Living: Swallowing UPD1-Activities:Handwriting Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Handwriting. UPDRS - Activities of Daily Living: Handwriting UPD1-Activities:Cut Food/Handle Utensil Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Cutting food and handling utensils. UPDRS - Activities of Daily Living: Cutting Food and Handling Utensils UPD1-Activities:Dressing Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Dressing. UPDRS - Activities of Daily Living: Dressing UPD1-Activities:Hygiene Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Hygiene. UPDRS - Activities of Daily Living: Hygiene UPD1-Activities:Turn Bed/Adj Clothes Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Turning in bed and adjusting bed clothes. UPDRS - Activities of Daily Living: Turning in Bed and Adjusting Bed Clothes UPD1-Activities:Falling Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Falling (unrelated to freezing). UPDRS - Activities of Daily Living: Falling UPD1-Activities:Freezing When Walking Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Freezing when walking. UPDRS - Activities of Daily Living: Freezing When Walking UPD1-Activities:Walking Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Walking. UPDRS - Activities of Daily Living: Walking UPD1-Activities:Tremor Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Tremor (Symptomatic complaint of tremor in any part of body.). UPDRS - Activities of Daily Living: Tremor UPD1-Activities:Sensory Complaints Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Sensory complaints related to Parkinsonism. UPDRS - Activities of Daily Living: Sensory Complaints Related to Parkinsonism UPD1-Motor:Speech Unified Parkinson's Disease Rating Scale - Motor examination: Speech. UPDRS - Motor Examination: Speech UPD1-Motor:Facial Expression Unified Parkinson's Disease Rating Scale - Motor examination: Facial expression. UPDRS - Motor Examination: Facial Expression UPD1-Motor:Tremor at Rest:Face Lips Chin Unified Parkinson's Disease Rating Scale - Motor examination: Tremor at rest: face, lips, chin. UPDRS - Motor Examination: Tremor at Rest, Face, Lips, Chin UPD1-Motor:Tremor at Rest:Hands: Right Unified Parkinson's Disease Rating Scale - Motor examination: Tremor at rest: Hands: Right. UPDRS - Motor Examination: Tremor at Rest, Hands, Right UPD1-Motor:Tremor at Rest:Hands: Left Unified Parkinson's Disease Rating Scale - Motor examination: Tremor at rest: Hands: Left. UPDRS - Motor Examination: Tremor at Rest, Hands, Left UPD1-Motor:Tremor at Rest:Feet: Right Unified Parkinson's Disease Rating Scale - Motor examination: Tremor at rest: Feet: Right. UPDRS - Motor Examination: Tremor at Rest, Feet, Right UPD1-Motor:Tremor at Rest:Feet: Left Unified Parkinson's Disease Rating Scale - Motor examination: Tremor at rest: Feet: Left. UPDRS - Motor Examination: Tremor at Rest, Feet, Left UPD1--Motor:Action Tremor:Hand: Right Unified Parkinson's Disease Rating Scale - Motor examination: Action tremor: Hand: Right. UPDRS - Motor Examination: Action Tremor, Hand, Right UPD1--Motor:Action Tremor:Hand: Left Unified Parkinson's Disease Rating Scale - Motor examination: Action tremor: Hand: Left. UPDRS - Motor Examination: Action Tremor, Hand, Left UPD1-Motor:Rigidity Neck Unified Parkinson's Disease Rating Scale - Motor examination: Rigidity neck. UPDRS - Motor Examination: Rigidity Neck UPD1-Motor:Rigidity Upper Extrem: Right Unified Parkinson's Disease Rating Scale - Motor examination: Rigidity upper extremity: Right. UPDRS - Motor Examination: Rigidity Upper Extremity, Right UPD1-Motor:Rigidity Upper Extrem: Left Unified Parkinson's Disease Rating Scale - Motor examination: Rigidity upper extremity: Left. UPDRS - Motor Examination: Rigidity Upper Extremity, Left UPD1-Motor:Rigidity Lower Extrem: Right Unified Parkinson's Disease Rating Scale - Motor examination: Rigidity lower extremity: Right. UPDRS - Motor Examination: Rigidity Lower Extremity, Right UPD1-Motor:Rigidity Lower Extrem: Left Unified Parkinson's Disease Rating Scale - Motor examination: Rigidity lower extremity: Left. UPDRS - Motor Examination: Rigidity Lower Extremity, Left UPD1-Motor:Finger Taps: Right Unified Parkinson's Disease Rating Scale - Motor examination: Finger taps: Right. UPDRS - Motor Examination: Finger Taps, Right UPD1-Motor:Finger Taps: Left Unified Parkinson's Disease Rating Scale - Motor examination: Finger taps: Left. UPDRS - Motor Examination: Finger Taps, Left UPD1-Motor:Hand Grips: Right Unified Parkinson's Disease Rating Scale - Motor examination: Hand grips: Right. UPDRS - Motor Examination: Hand Grips, Right UPD1-Motor:Hand Grips: Left Unified Parkinson's Disease Rating Scale - Motor examination: Hand grips: Left. UPDRS - Motor Examination: Hand Grips, Left UPD1-Motor:Hand Pronate/Supinate: Right Unified Parkinson's Disease Rating Scale - Motor examination: Hand pronate/supinate: Right. UPDRS - Motor Examination: Hand Pronate/Supinate, Right UPD1-Motor:Hand Pronate/Supinate: Left Unified Parkinson's Disease Rating Scale - Motor examination: Hand pronate/supinate: Left. UPDRS - Motor Examination: Hand Pronate/Supinate, Left UPD1-Motor:Leg Agility: Right Unified Parkinson's Disease Rating Scale - Motor examination: Leg agility: Right. UPDRS - Motor Examination: Leg Agility, Right UPD1-Motor:Leg Agility: Left Unified Parkinson's Disease Rating Scale - Motor examination: Leg agility: Left. UPDRS - Motor Examination: Leg Agility, Left UPD1-Motor:Arising from Chair Unified Parkinson's Disease Rating Scale - Motor examination: Arising from chair (Patient attempts to rise from a straightbacked chair, with arms folded across chest.). UPDRS - Motor Examination: Arising from Chair UPD1-Motor:Posture Unified Parkinson's Disease Rating Scale - Motor examination: Posture. UPDRS - Motor Examination: Posture UPD1-Motor:Gait Unified Parkinson's Disease Rating Scale - Motor examination: Gait. UPDRS - Motor Examination: Gait UPD1-Motor:Postural Stability Unified Parkinson's Disease Rating Scale - Motor examination: Postural stability (Response to sudden, strong posterior displacement produced by pull on shoulders while patient erect with eyes open and feet slightly apart. Patient is prepared.). UPDRS - Motor Examination: Postural Stability UPD1-Motor:Bradykinesia and Hypokinesia Unified Parkinson's Disease Rating Scale - Motor examination: Body bradykinesia and hypokinesia (Combining slowness, hesitancy, decreased arm swing, small amplitude, and poverty of movement in general.). UPDRS - Motor Examination: Body Bradykinesia and Hypokinesia UPD1-Complications:Dyskinesias Duration Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Dyskinesias, Duration: What proportion of the waking day are dyskinesias present? (Historical information.). UPDRS - Complications of Therapy: Dyskinesias - Duration UPD1-Complications:Dyskinesias Disable Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Dyskinesias, Disability: How disabling are the dyskinesias? (Historical information; may be modified by office examination.). UPDRS - Complications of Therapy: Dyskinesias - Disability UPD1-Complications:Dyskinesias Painful Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Dyskinesias, Painful dyskinesias: How painful are the dyskinesias? UPDRS - Complications of Therapy: Dyskinesias - Painful Dyskinesias UPD1-Complications:Dyskinesias Dystonia Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Dyskinesias, Presence of early morning dystonia (Historical information.). UPDRS - Complications of Therapy: Dyskinesias - Presence of Early Morning Dystonia UPD1-Complications:Fluct Predictable Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Clinical fluctuations, Are 'off' periods predictable? UPDRS - Complications of Therapy: Clinical Fluctuations - Off Periods Predictable UPD1-Complications:Fluct Unpredictable Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Clinical fluctuations, Are 'off' periods unpredictable? UPDRS - Complications of Therapy: Clinical Fluctuations - Off Periods Unpredictable UPD1-Complications:Fluct Suddenly Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Clinical fluctuations, Do 'off' periods come on suddenly, within a few seconds? UPDRS - Complications of Therapy: Clinical Fluctuations - Off Periods Sudden UPD1-Complications:Fluct Average Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Clinical fluctuations, What proportion of the waking day is the patient 'off' on average? UPDRS - Complications of Therapy: Clinical Fluctuations - Average Off Periods Per Day UPD1-Complications:Anorex Nausea Vomit Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Other complications, Does the patient have anorexia, nausea, or vomiting? UPDRS - Complications of Therapy: Other Complications - Anorexia, Nausea, or Vomiting UPD1-Complications:Insomnia Hypersomnol Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Other complications, Any sleep disturbances, such as insomnia or hypersomnolence? UPDRS - Complications of Therapy: Other Complications - Sleep Disturbances UPD1-Complications:Symptom Orthostasis Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Other complications, Does the patient have symptomatic orthostasis? (Record the patient's blood pressure, height and weight on the scoring form). UPDRS - Complications of Therapy: Other Complications - Symptomatic Orthostasis UPD1-Blood Pressure: Seated Unified Parkinson's Disease Rating Scale - Blood pressure: Seated. UPDRS - Symptomatic Orthostasis: Blood Pressure, Seated UPD1-Blood Pressure: Supine Unified Parkinson's Disease Rating Scale - Blood pressure: Supine. UPDRS - Symptomatic Orthostasis: Blood Pressure, Supine UPD1-Blood Pressure: Standing Unified Parkinson's Disease Rating Scale - Blood pressure: Standing. UPDRS - Symptomatic Orthostasis: Blood Pressure, Standing UPD1-Weight Unified Parkinson's Disease Rating Scale - Weight. UPDRS - Symptomatic Orthostasis: Weight UPD1-Pulse: Seated Unified Parkinson's Disease Rating Scale - Pulse: Seated. UPDRS - Symptomatic Orthostasis: Pulse, Seated UPD1-Pulse: Standing Unified Parkinson's Disease Rating Scale - Pulse: Standing. UPDRS - Symptomatic Orthostasis: Pulse, Standing UPD1-Modified Hoehn and Yahr Staging Unified Parkinson's Disease Rating Scale - Modified Hoehn and Yahr Staging. UPDRS - Modified Hoehn and Yahr Staging UPD1-Schwab/England % ADL Score (PD) Unified Parkinson's Disease Rating Scale - Schwab and England % ADL Score (PD). UPDRS - Schwab and England % ADL Score (PD) UPD1-Schwab/England % ADL (Dyskinesia) Unified Parkinson's Disease Rating Scale - Schwab and England % ADL (with dyskinesia). UPDRS - Schwab and England % ADL (With Dyskinesia) UPD1-Mentation, Behavior, Mood Sub-Total Unified Parkinson's Disease Rating Scale - Mentation, behavior and mood sub-total. UPDRS - Mentation, Behavior and Mood Sub-total UPD1-Activities Daily Living Sub-Total Unified Parkinson's Disease Rating Scale - Activities of daily living sub-total. UPDRS - Activities of Daily Living Sub-total UPD1-Motor Examination Sub-Total Unified Parkinson's Disease Rating Scale - Motor examination sub-total. UPDRS - Motor Examination Sub-total UPD1-UPDRS Total Unified Parkinson's Disease Rating Scale - UPDRS total. UPDRS - UPDRS Total UPD1TC Unified Parkinson's Disease Rating Scale Clinical Classification Test Code CDISC Clinical Classification UPDRS Test Code Terminology Unified Parkinson's Disease Rating Scale test name. UPD1--Motor:Action Tremor:Hand: Left Unified Parkinson's Disease Rating Scale - Motor examination: Action tremor: Hand: Left. UPDRS - Motor Examination: Action Tremor, Hand, Left UPD1--Motor:Action Tremor:Hand: Right Unified Parkinson's Disease Rating Scale - Motor examination: Action tremor: Hand: Right. UPDRS - Motor Examination: Action Tremor, Hand, Right UPD1-Activities Daily Living Sub-Total Unified Parkinson's Disease Rating Scale - Activities of daily living sub-total. UPDRS - Activities of Daily Living Sub-total UPD1-Activities:Cut Food/Handle Utensil Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Cutting food and handling utensils. UPDRS - Activities of Daily Living: Cutting Food and Handling Utensils UPD1-Activities:Dressing Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Dressing. UPDRS - Activities of Daily Living: Dressing UPD1-Activities:Falling Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Falling (unrelated to freezing). UPDRS - Activities of Daily Living: Falling UPD1-Activities:Freezing When Walking Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Freezing when walking. UPDRS - Activities of Daily Living: Freezing When Walking UPD1-Activities:Handwriting Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Handwriting. UPDRS - Activities of Daily Living: Handwriting UPD1-Activities:Hygiene Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Hygiene. UPDRS - Activities of Daily Living: Hygiene UPD1-Activities:Salivation Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Salivation. UPDRS - Activities of Daily Living: Salivation UPD1-Activities:Sensory Complaints Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Sensory complaints related to Parkinsonism. UPDRS - Activities of Daily Living: Sensory Complaints Related to Parkinsonism UPD1-Activities:Speech Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Speech. UPDRS - Activities of Daily Living: Speech UPD1-Activities:Swallowing Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Swallowing. UPDRS - Activities of Daily Living: Swallowing UPD1-Activities:Tremor Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Tremor (Symptomatic complaint of tremor in any part of body.). UPDRS - Activities of Daily Living: Tremor UPD1-Activities:Turn Bed/Adj Clothes Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Turning in bed and adjusting bed clothes. UPDRS - Activities of Daily Living: Turning in Bed and Adjusting Bed Clothes UPD1-Activities:Walking Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Walking. UPDRS - Activities of Daily Living: Walking UPD1-Blood Pressure: Seated Unified Parkinson's Disease Rating Scale - Blood pressure: Seated. UPDRS - Symptomatic Orthostasis: Blood Pressure, Seated UPD1-Blood Pressure: Standing Unified Parkinson's Disease Rating Scale - Blood pressure: Standing. UPDRS - Symptomatic Orthostasis: Blood Pressure, Standing UPD1-Blood Pressure: Supine Unified Parkinson's Disease Rating Scale - Blood pressure: Supine. UPDRS - Symptomatic Orthostasis: Blood Pressure, Supine UPD1-Complications:Anorex Nausea Vomit Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Other complications, Does the patient have anorexia, nausea, or vomiting? UPDRS - Complications of Therapy: Other Complications - Anorexia, Nausea, or Vomiting UPD1-Complications:Dyskinesias Disable Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Dyskinesias, Disability: How disabling are the dyskinesias? (Historical information; may be modified by office examination.). UPDRS - Complications of Therapy: Dyskinesias - Disability UPD1-Complications:Dyskinesias Duration Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Dyskinesias, Duration: What proportion of the waking day are dyskinesias present? (Historical information.). UPDRS - Complications of Therapy: Dyskinesias - Duration UPD1-Complications:Dyskinesias Dystonia Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Dyskinesias, Presence of early morning dystonia (Historical information.). UPDRS - Complications of Therapy: Dyskinesias - Presence of Early Morning Dystonia UPD1-Complications:Dyskinesias Painful Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Dyskinesias, Painful dyskinesias: How painful are the dyskinesias? UPDRS - Complications of Therapy: Dyskinesias - Painful Dyskinesias UPD1-Complications:Fluct Average Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Clinical fluctuations, What proportion of the waking day is the patient 'off' on average? UPDRS - Complications of Therapy: Clinical Fluctuations - Average Off Periods Per Day UPD1-Complications:Fluct Predictable Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Clinical fluctuations, Are 'off' periods predictable? UPDRS - Complications of Therapy: Clinical Fluctuations - Off Periods Predictable UPD1-Complications:Fluct Suddenly Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Clinical fluctuations, Do 'off' periods come on suddenly, within a few seconds? UPDRS - Complications of Therapy: Clinical Fluctuations - Off Periods Sudden UPD1-Complications:Fluct Unpredictable Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Clinical fluctuations, Are 'off' periods unpredictable? UPDRS - Complications of Therapy: Clinical Fluctuations - Off Periods Unpredictable UPD1-Complications:Insomnia Hypersomnol Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Other complications, Any sleep disturbances, such as insomnia or hypersomnolence? UPDRS - Complications of Therapy: Other Complications - Sleep Disturbances UPD1-Complications:Symptom Orthostasis Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Other complications, Does the patient have symptomatic orthostasis? (Record the patient's blood pressure, height and weight on the scoring form). UPDRS - Complications of Therapy: Other Complications - Symptomatic Orthostasis UPD1-Mentation, Behavior, Mood Sub-Total Unified Parkinson's Disease Rating Scale - Mentation, behavior and mood sub-total. UPDRS - Mentation, Behavior and Mood Sub-total UPD1-Mentation:Depression Unified Parkinson's Disease Rating Scale - Mentation, behavior and mood: Depression. UPDRS - Mentation, Behavior and Mood: Depression UPD1-Mentation:Intellectual Impairment Unified Parkinson's Disease Rating Scale - Mentation, behavior and mood: Intellectual impairment. UPDRS - Mentation, Behavior and Mood: Intellectual Impairment UPD1-Mentation:Motivation/Initiative Unified Parkinson's Disease Rating Scale - Mentation, behavior and mood: Motivation/Initiative. UPDRS - Mentation, Behavior and Mood: Motivation/Initiative UPD1-Mentation:Thought Disorder Unified Parkinson's Disease Rating Scale - Mentation, behavior and mood: Thought disorder. UPDRS - Mentation, Behavior and Mood: Thought Disorder UPD1-Modified Hoehn and Yahr Staging Unified Parkinson's Disease Rating Scale - Modified Hoehn and Yahr Staging. UPDRS - Modified Hoehn and Yahr Staging UPD1-Motor Examination Sub-Total Unified Parkinson's Disease Rating Scale - Motor examination sub-total. UPDRS - Motor Examination Sub-total UPD1-Motor:Arising from Chair Unified Parkinson's Disease Rating Scale - Motor examination: Arising from chair (Patient attempts to rise from a straightbacked chair, with arms folded across chest.). UPDRS - Motor Examination: Arising from Chair UPD1-Motor:Bradykinesia and Hypokinesia Unified Parkinson's Disease Rating Scale - Motor examination: Body bradykinesia and hypokinesia (Combining slowness, hesitancy, decreased arm swing, small amplitude, and poverty of movement in general.). UPDRS - Motor Examination: Body Bradykinesia and Hypokinesia UPD1-Motor:Facial Expression Unified Parkinson's Disease Rating Scale - Motor examination: Facial expression. UPDRS - Motor Examination: Facial Expression UPD1-Motor:Finger Taps: Left Unified Parkinson's Disease Rating Scale - Motor examination: Finger taps: Left. UPDRS - Motor Examination: Finger Taps, Left UPD1-Motor:Finger Taps: Right Unified Parkinson's Disease Rating Scale - Motor examination: Finger taps: Right. UPDRS - Motor Examination: Finger Taps, Right UPD1-Motor:Gait Unified Parkinson's Disease Rating Scale - Motor examination: Gait. UPDRS - Motor Examination: Gait UPD1-Motor:Hand Grips: Left Unified Parkinson's Disease Rating Scale - Motor examination: Hand grips: Left. UPDRS - Motor Examination: Hand Grips, Left UPD1-Motor:Hand Grips: Right Unified Parkinson's Disease Rating Scale - Motor examination: Hand grips: Right. UPDRS - Motor Examination: Hand Grips, Right UPD1-Motor:Hand Pronate/Supinate: Left Unified Parkinson's Disease Rating Scale - Motor examination: Hand pronate/supinate: Left. UPDRS - Motor Examination: Hand Pronate/Supinate, Left UPD1-Motor:Hand Pronate/Supinate: Right Unified Parkinson's Disease Rating Scale - Motor examination: Hand pronate/supinate: Right. UPDRS - Motor Examination: Hand Pronate/Supinate, Right UPD1-Motor:Leg Agility: Left Unified Parkinson's Disease Rating Scale - Motor examination: Leg agility: Left. UPDRS - Motor Examination: Leg Agility, Left UPD1-Motor:Leg Agility: Right Unified Parkinson's Disease Rating Scale - Motor examination: Leg agility: Right. UPDRS - Motor Examination: Leg Agility, Right UPD1-Motor:Postural Stability Unified Parkinson's Disease Rating Scale - Motor examination: Postural stability (Response to sudden, strong posterior displacement produced by pull on shoulders while patient erect with eyes open and feet slightly apart. Patient is prepared.). UPDRS - Motor Examination: Postural Stability UPD1-Motor:Posture Unified Parkinson's Disease Rating Scale - Motor examination: Posture. UPDRS - Motor Examination: Posture UPD1-Motor:Rigidity Lower Extrem: Left Unified Parkinson's Disease Rating Scale - Motor examination: Rigidity lower extremity: Left. UPDRS - Motor Examination: Rigidity Lower Extremity, Left UPD1-Motor:Rigidity Lower Extrem: Right Unified Parkinson's Disease Rating Scale - Motor examination: Rigidity lower extremity: Right. UPDRS - Motor Examination: Rigidity Lower Extremity, Right UPD1-Motor:Rigidity Neck Unified Parkinson's Disease Rating Scale - Motor examination: Rigidity neck. UPDRS - Motor Examination: Rigidity Neck UPD1-Motor:Rigidity Upper Extrem: Left Unified Parkinson's Disease Rating Scale - Motor examination: Rigidity upper extremity: Left. UPDRS - Motor Examination: Rigidity Upper Extremity, Left UPD1-Motor:Rigidity Upper Extrem: Right Unified Parkinson's Disease Rating Scale - Motor examination: Rigidity upper extremity: Right. UPDRS - Motor Examination: Rigidity Upper Extremity, Right UPD1-Motor:Speech Unified Parkinson's Disease Rating Scale - Motor examination: Speech. UPDRS - Motor Examination: Speech UPD1-Motor:Tremor at Rest:Face Lips Chin Unified Parkinson's Disease Rating Scale - Motor examination: Tremor at rest: face, lips, chin. UPDRS - Motor Examination: Tremor at Rest, Face, Lips, Chin UPD1-Motor:Tremor at Rest:Feet: Left Unified Parkinson's Disease Rating Scale - Motor examination: Tremor at rest: Feet: Left. UPDRS - Motor Examination: Tremor at Rest, Feet, Left UPD1-Motor:Tremor at Rest:Feet: Right Unified Parkinson's Disease Rating Scale - Motor examination: Tremor at rest: Feet: Right. UPDRS - Motor Examination: Tremor at Rest, Feet, Right UPD1-Motor:Tremor at Rest:Hands: Left Unified Parkinson's Disease Rating Scale - Motor examination: Tremor at rest: Hands: Left. UPDRS - Motor Examination: Tremor at Rest, Hands, Left UPD1-Motor:Tremor at Rest:Hands: Right Unified Parkinson's Disease Rating Scale - Motor examination: Tremor at rest: Hands: Right. UPDRS - Motor Examination: Tremor at Rest, Hands, Right UPD1-Pulse: Seated Unified Parkinson's Disease Rating Scale - Pulse: Seated. UPDRS - Symptomatic Orthostasis: Pulse, Seated UPD1-Pulse: Standing Unified Parkinson's Disease Rating Scale - Pulse: Standing. UPDRS - Symptomatic Orthostasis: Pulse, Standing UPD1-Schwab/England % ADL (Dyskinesia) Unified Parkinson's Disease Rating Scale - Schwab and England % ADL (with dyskinesia). UPDRS - Schwab and England % ADL (With Dyskinesia) UPD1-Schwab/England % ADL Score (PD) Unified Parkinson's Disease Rating Scale - Schwab and England % ADL Score (PD). UPDRS - Schwab and England % ADL Score (PD) UPD1-UPDRS Total Unified Parkinson's Disease Rating Scale - UPDRS total. UPDRS - UPDRS Total UPD1-Weight Unified Parkinson's Disease Rating Scale - Weight. UPDRS - Symptomatic Orthostasis: Weight UPD1TN Unified Parkinson's Disease Rating Scale Clinical Classification Test Name CDISC Clinical Classification UPDRS Test Name Terminology Terminology codelist used for units within CDISC. Percent Inhibition The rate of measured normal activity minus inhibited activity, divided by the rate of normal activity of a given object. It is expressed as a percentage. Percent Inhibition Percentage One hundred times the quotient of one quantity divided by another, with the same units of measurement. Percentage Percent Volume per Volume vol% A percent ratio of volume to volume, defined by the equation: [volume of solute (in ml)/ volume of solution (in ml)](100), typically used for admixtures of solutions.(NCI) Percent Volume per Volume Percent Weight per Volume A percent ratio of weight to volume, defined by the equation: [weight of solute (in gm)/volume of solution (in dl)](100). Since the numerator and denominator of this ratio have different units, it is not a true percentage. A 1% w/v solution is defined as being 1 gram of solute dissolved in 100 milliliters of solvent.(NCI) Percent Mass per Volume Percent Weight per Weight A percent ratio of weight to weight, defined by the equation: [weight of solute (in gm)/weight of solution (in gm)](100).(NCI) Percent Mass per Mass min*%/h A unit of measurement expressed as the percentage times minutes divided by hours. Percentage times Minute per Hour Percent per Minute A unit of frequency expressed as the percentage of entities or events per minute. Percent per Minute Percent per Second A unit of frequency expressed as the percentage of entities or events per second. Percent per Second mmHg*min*m2/L A unit of resistance equal to the number of millimeters of mercury times minutes, per unit of volume equal to one liter times meters squared. Millimeter Mercury times Minute per Liter times Square Meter Per 10 High Powered Fields A unit of measurement of the number of entities per unit of area equal to ten high powered fields. Per 10 High Powered Fields Natural number unit of measurement for a portion of a particular type of entities per 100 total cells. Per 100 Cells Natural number unit of measurement for a portion of a particular type of cell per one hundred enterocytes. per 100 Enterocytes Per 100 High Powered Fields A unit of measurement of the number of entities per unit of area equal to one hundred high powered fields. Per 100 High Powered Fields Natural number unit of measurement for a portion of a particular type of cell (excluding red blood cell subtypes) per one hundred red blood cells. Per 100 Red Blood Cells Per 100 White Blood Cells Natural number unit of measurement for a portion of a particular type of cell (excluding white blood cell subtypes) per 100 white blood cells. Per 100 White Blood Cells per 100x Field A unit of measurement of the number of entities per microscopic field at 100x magnification. Per 100x Field /1000 RBC Natural number unit of measurement for a portion of a particular type of cell (excluding red blood cell subtypes) per one thousand red blood cells. Per Thousand Red Blood Cells A unit equal to one thousand entities used as a denominator to build a derived unit expressed as a ratio. (NCI) Per Thousand A unit equal to ten thousand entities used as a denominator to build a derived unit expressed as a ratio. (NCI) Per Ten Thousand A unit equal to one hundred thousand entities used as a denominator to build a derived unit expressed as a ratio. (NCI) Per Hundred Thousand A unit equal to one million entities used as a denominator to build a derived unit expressed as a ratio. (NCI) Per Million A unit equal to two square millimeters used as a denominator to build a derived unit expressed as a ratio. Per Two Square Millimeters Per 200 High Powered Fields A unit of measurement of the number of entities per unit of area equal to 200 high powered fields. Per 200 High Powered Fields /2x10^3 RBC Natural number unit of measurement for a portion of a particular type of cell (excluding red blood cell subtypes) per 2000 red blood cells. Per 2000 Red Blood Cells Natural number unit of measurement for a portion of a particular type of cell (excluding white blood cell subtypes) per 2500 white blood cells. Per 2500 White Blood Cells A volume unit equal to 4.0 milliliters used as a denominator to build a derived unit expressed as a ratio. per 4.0 Milliliters Per 40 High Powered Fields A unit of measurement of the number of entities per unit of area equal to 40 high powered fields. Per 40 High Powered Fields Natural number unit of measurement for a portion of a particular type of entities per 400 total cells. Per 400 Cells Natural number unit of measurement for a portion of a particular type of entities per 50 total cells. Per 50 Cells Natural number unit of measurement for a portion of a particular type of cell (excluding white blood cell subtypes) per 500 white blood cells. Per 500 White Blood Cells Natural number unit of measurement for a portion of a particular type of cell (excluding white blood cell subtypes) per 50,000 white blood cells. Per 50,000 White Blood Cells A volume unit equal to 7.5 milliliters used as a denominator to build a derived unit expressed as a ratio. per 7.5 Milliliters Per Animal A unit equal to one animal used as a denominator to build a derived unit expressed as a ratio. Per Animal Natural number unit of measurement for a portion of a particular type of entities per one cell. Per Cell A volume unit equal to one centimeter cubed used as a denominator to build a derived unit expressed as a ratio. Per Cubic Centimeter A unit of pressure equal to one centimeter of water used as a denominator to build a derived unit expressed as a ratio. (NCI) Per Centimeter of Water /day Daily Per Day A rate of occurrences within a period of time equal to one day. Daily /Whole Exome /Whole-Exome A unit equal to an exome used as a denominator to build a derived unit expressed as a ratio. Per Exome Per Gram A unit equal to one gram used as a denominator to build a derived unit expressed as a ratio. Per Gram Per Hour A rate of occurrences within a period of time equal to one hour. Per Hour Per High Powered Field A unit of measure equal to the instances of an entity per visual field of a microscope set to a high magnification power. Per High Powered Field A unit equal to one kilogram used as a denominator to build a derived unit expressed as a ratio. (NCI) Per Kilogram Per Low Powered Field A unit of measure equal to the instances of an entity per visual field of a microscope set to a low magnification power. Per Low Powered Field /Large Square Neubauer A unit of measure equal to the instances of an entity per large square (with a 1 mm2 area) in a Neubauer chamber. Per Large Square Neubauer Chamber /10^6 BP /Mb /Mbp Per Megabase Pair A unit equal to one million base pairs used as a denominator to build a derived unit expressed as a ratio. Per Megabase Pair A rate of occurrences within a period of time equal to one minute. Per Minute A unit of length equal to one millimeter used as a denominator to build a derived unit expressed as a ratio. Per Millimeter An area unit equal to one millimeter squared used as a denominator to build a derived unit expressed as a ratio. per Square Millimeter Every Month Per Month Every month. (NCI) Monthly 1/ms ms^-1 Reciprocal of Millisecond A rate of occurrences within a period of time equal to one second. Per Millisecond Per Culture Plate Per Plate A unit of measure equal to the instances of an entity per culture plate. Per Plate /sec A rate of occurrences within a period of time equal to one second. Per Second A unit equal to one square micrometer used as a denominator to build a derived unit expressed as a ratio. per Square Micrometer Per Visual Field A unit of measure equal to the instances of an entity per visual field of a microscope. (NCI) Per Visual Field /Well Per Culture Plate Well Per Well A unit of measure equal to the instances of an entity per culture plate well. Per Culture Plate Well Every week Per Week QS Every week. (NCI) Weekly /(s*kPa) A unit of resistance equal to the inverse of one second times one kilopascal. One per Second Times Kilopascal 10^1 copies/mL Ten Copies per Milliliter A unit of measurement equal to ten copies of an entity per unit of volume equal to one milliliter. Ten Copies per Milliliter 10^1 IU/mL Ten International Units per Milliliter A unit of measurement equal to ten international units of an entity per unit of volume equal to one milliliter. Ten International Units per Milliliter 10^2 copies/mL Hundred copies per Milliliter A unit of measurement equal to one hundred copies of an entity per unit of volume equal to one milliliter. Hundred Copies per Milliliter 100 International units/Milliliter 10^2 IU/mL 10^5 IU/L A unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one hundred international units per one milliliter of system volume.(NCI) 100 International Units per Milliliter Ten Billion Copies per Milliliter The unit of concentration expressed as the number of 10 to the tenth power copies in unit volume equal to one milliliter. (NCI) Ten Billion Copies per Milliliter Ten Billion International Units per Milliliter A unit of measurement equal to 10 to the tenth power of the number of international units of an entity per unit of volume equal to one milliliter. Ten Billion International Units per Milliliter 10^10 Viral Particles/dose A unit for virus amount equal to 10 to the tenth power of the number of viral particles per dose. Ten Billion Viral Particles per Dose 10^10 Viral Particles/mL A unit for virus concentration equal to 10 to the tenth power of the number of viral particles per milliliter. Ten Billion Viral Particles per Milliliter 10^4/mm3 10^4/uL 10^7/mL A unit of measurement equal to 10 to the tenth power of entities per unit of volume equal to one liter. (NCI) Ten Billion Per Liter 10^5/mm3 10^5/uL 10^8/mL A unit of measurement equal to 10 to the eleventh power of entities per unit of volume equal to one liter. Hundred Billion Per Liter Tera International Unit per Liter TIU/L Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of 10^12 international unit per one liter of system volume.(NCI) Tera International Unit Per Liter /pL 1/pL 10^6/mm3 10^6/uL M/uL Mill/mcL T/L Tera/L TI/L A unit of measurement equal to 10 to the twelfth power of the number of entities per unit of volume equal to one liter. Million per Microliter Thousand CFU Thousand Colony Forming Units A unit of measurement of colony forming cells or microorganisms equal to 10 to the third power colony forming units. Thousand Colony Forming Units Thousand CFU/g Thousand Colony Forming Units per Gram A unit of measurement of colony forming cells or microorganisms equal to 10 to the third power colony forming units. Thousand Colony Forming Units per Gram Thousand CFU/mL Thousand Colony Forming Units per Milliliter A unit of measurement of colony forming cells or microorganisms in a unit volume of substance of interest defined as the number of 10 to the third power colony forming units in one milliliter of substance. Thousand Colony Forming Units per Milliliter The unit of concentration expressed as the number of 10 to the third power copies in unit volume equal to one milliliter. (NCI) Thousand Copies per Milliliter A unit of measurement equal to 10 to the third power of the number of deoxyribonucleic acid (DNA) copies per unit of volume equal to one milliliter. Thousand DNA Copies per Milliliter Thousand International Units per Milliliter A unit of measurement equal to 10 to the third power of the number of international units of an entity per unit of volume equal to one milliliter. Thousand International Units per Milliliter Thousand Organisms A unit of measure of quantity of organisms expressed in 10 to the third power of organisms. Thousand Organisms Thousand Organisms per Gram Thousand Organisms/g A unit of measure of organism content expressed in 10 to the third power of organisms per unit of mass equal to one gram. Thousand Organisms per Gram Thousand Organisms per Milliliter Thousand Organisms/mL A unit of measure of organism concentration expressed in 10 to the third power of organisms per unit of volume equal to one milliliter. Thousand Organisms per Milliliter A unit of measurement equal to 10 to the third power of the number of ribonucleic acid (RNA) copies per unit of volume equal to one milliliter. Thousand RNA Copies per Milliliter A dosing unit for the number of therapeutic cells administered, expressed as 10 to the third power. Thousand Therapeutic Cells Dosing Unit A unit of measurement equal to 10 to the third power of the number of entities per unit of area equal to one high powered field. Thousand per High Powered Field /mL 1/mL A unit of measurement equal to 10 to the third power of entities per unit of volume equal to one liter. Thousand Per Liter Ten Thousand CFU Ten Thousand Colony Forming Units A unit of measurement of colony forming cells or microorganisms equal to 10 to the fourth power colony forming units. Ten Thousand Colony Forming Units Ten Thousand CFU/mL Ten Thousand Colony Forming Units per Milliliter A unit of measurement of colony forming cells or microorganisms in a unit volume of substance of interest defined as the number of 10 to the fourth power colony forming units in one milliliter of substance. Ten Thousand Colony Forming Units Per Liter Ten Thousand Copies per Milliliter The unit of concentration expressed as the number of 10 to the fourth power copies in unit volume equal to one milliliter. (NCI) Ten Thousand Copies per Milliliter Ten Thousand International Units per Milliliter A unit of measurement equal to 10 to the fourth power of the number of international units of an entity per unit of volume equal to one milliliter. Ten Thousand International Units per Milliliter A unit of measurement equal to 10 to the fourth power of the number of entities per unit of area equal to one high powered field. Ten Thousand per High Powered Field A unit of measurement equal to 10 to the fourth power of entities per unit of volume equal to one liter. Thousand per Deciliter Hundred Thousand CFU Hundred Thousand Colony Forming Units A unit of measurement of colony forming cells or microorganisms equal to 10 to the fifth power colony forming units. (NCI) Hundred Thousand Colony Forming Units Hundred Thousand CFU/mL Hundred Thousand Colony Forming Units per Milliliter A unit of measurement of colony forming cells or microorganisms in a unit volume of substance of interest defined as the number of 10 to the fifth power colony forming units in one milliliter of substance. Hundred Thousand Colony Forming Units per Milliliter Hundred Thousand copies per Milliliter The unit of concentration expressed as the number of 10 to the fifth power copies in unit volume equal to one milliliter. (NCI) Hundred Thousand Copies per Milliliter Hundred Thousand International Units A unit of measurement equal to 10 to the fifth power of the number of international units of an entity per unit of volume equal to one milliliter. (NCI) Hundred Thousand International Units A dosing unit for the number of therapeutic cells administered, expressed as 10 to the fifth power. Hundred Thousand Therapeutic Cells Dosing Unit A unit of measurement equal to 10 to the fifth power of the number of entities per unit of area equal to one high powered field. Hundred Thousand per High Powered Field 10^2/g 10^5/kg A unit of measurement equal to 10 to the fifth power of the number of entities per unit of mass equal to one kilogram. Hundred Thousand Per Kilogram 10^2/mL A unit of measurement equal to 10 to the fifth power of entities per unit of volume equal to one liter. Hundred Thousand Per Liter Million CFU Million Colony Forming Units A unit of measurement of colony forming cells or microorganisms equal to 10 to the sixth power colony forming units. Million Colony Forming Units Million CFU/g Million Colony Forming Units per Gram A unit of measurement of colony forming cells or microorganisms in a unit mass of substance of interest defined as the number of 10 to the sixth power colony forming units in one gram of substance. Million Colony Forming Units per Gram Million CFU/mL Million Colony Forming Units per Milliliter A unit of measurement of colony forming cells or microorganisms in a unit volume of substance of interest defined as the number of 10 to the sixth power colony forming units in one milliliter of substance. Million Colony Forming Units per Milliliter The unit of concentration expressed as the number of 10 to the sixth power copies in unit volume equal to one milliliter. (NCI) Million Copies per Milliliter A unit of measurement equal to 10 to the sixth power of the number of deoxyribonucleic acid (DNA) copies per unit of volume equal to one milliliter. Million DNA Copies per Milliliter Million International Units Million IU A unit of biological activity equal to 10 to the sixth power international units. Million International Units A unit of measurement equal to 10 to the sixth power of the number of international units of an entity per unit of volume equal to one milliliter. Million International Units per Milliliter Million Organisms A unit of measure of quantity of organisms expressed in 10 to the sixth power of organisms. Million Organisms Million Organisms per Gram Million Organisms/g A unit of measure of organism content expressed in 10 to the sixth power of organisms per unit of mass equal to one gram. Million Organisms per Gram Million Organisms per Milligram Million Organisms/mg A unit of measure of organism content expressed in 10 to the sixth power of organisms per unit of mass equal to one milligram. Million Organisms per Milligram Million Organisms per Milliliter Million Organisms/mL A unit of measure of organism concentration expressed in 10 to the sixth power of organisms per unit of volume equal to one milliliter. Million Organisms per Milliliter One Million PFU One Million Plaque Forming Units A unit of measurement of infectious entities with numbers equal to 10 to the sixth power plaque forming units. Million Plaque Forming Units A unit of measurement equal to 10 to the sixth power of the number of ribonucleic acid (RNA) copies per unit of volume equal to one milliliter. Million RNA Copies per Milliliter 10^6 50 Percent Tissue Culture Infective Dose per Dose A potency unit equal to the potency at which one dose of preparation contains one million (10^6) 50 percent tissue culture infective doses. Million Tissue Culture Infectious Dose 50% A dosing unit for the number of therapeutic cells administered, expressed as 10 to the sixth power. Million Therapeutic Cells Dosing Unit Million U Million Units A unit of measure equal to 10 to the sixth power of arbitrary units. Million Units A unit of measurement equal to 10 to the sixth power of entities per unit equal to one ejaculation. Million Per Ejaculate Unit /ug 1/ug 10^3/mg 10^9/kg A unit of measurement equal to 10 to the sixth power of the number of entities per unit of mass equal to one gram. Million per Gram A unit of measurement equal to 10 to the sixth power of the number of entities per unit of area equal to one high powered field. Million per High Powered Field 10^3/g A unit of measurement equal to 10 to the sixth power of the number of entities per unit of mass equal to one kilogram. Million per Kilogram /mm3 /uL 1/mm3 1/uL 10^3/mL M/L Mega/L A unit of measurement equal to 10 to the sixth power of the number of entities per unit of volume equal to one liter. Thousand per Milliliter Ten Million CFU Ten Million Colony Forming Units A unit of measurement of colony forming cells or microorganisms equal to 10 to the seventh power colony forming units. Ten Million Colony Forming Units Ten Million CFU/mL Ten Million Colony Forming Units per Milliliter A unit of measurement of colony forming cells or microorganisms in a unit volume of substance of interest defined as the number of 10 to the seventh power colony forming units in one milliliter of substance. Ten Million Colony Forming Units Per Liter Ten Million copies per Milliliter The unit of concentration expressed as the number of 10 to the seventh power copies in unit volume equal to one milliliter. (NCI) Ten Million Copies per Milliliter Ten Million International Units per Milliliter A unit of measurement equal to 10 to the seventh power of the number of international units of an entity per unit of volume equal to one milliliter. (NCI) Ten Million International Units per Milliliter Ten Million PFU Ten Million Plaque Forming Units A unit of measurement of plaque forming cells or microorganisms with numbers equal to 10 to the seventh power plaque forming units. Ten Million Plaque Forming Units 10^7 50 Percent Tissue Culture Infective Dose per Dose A potency unit equal to the potency at which one dose of preparation contains ten million (10^7) 50 percent tissue culture infective doses. Ten Million Tissue Culture Infectious Dose 50% 10/mg 10^4/g A unit of measurement equal to 10 to the seventh power of the number of entities per unit of mass equal to one kilogram. Ten Million Per Kilogram 10^6/dL A unit of measurement equal to 10 to the seventh power of the number of entities per unit of volume equal to one liter. Ten Million per Liter Hundred Million CFU Hundred Million Colony Forming Units A unit of measurement of colony forming cells or microorganisms equal to 10 to the eighth power colony forming units. (NCI) Hundred Million Colony Forming Units One Hundred Million Copies per Milliliter The unit of concentration expressed as the number of 10 to the eight power copies in unit volume equal to one milliliter. (NCI) One Hundred Million Copies per Milliliter One Hundred Million International Units One Hundred Million IU A unit of biological activity equal to 10 to the eighth power international units. Hundred Million International Units One Hundred Million International Units per Milliliter A unit of measurement equal to 10 to the eight power of the number of international units of an entity per unit of volume equal to one milliliter. (NCI) One Hundred Million International Units per Milliliter Hundred Million PFU Hundred Million Plaque Forming Units A unit of measurement of plaque forming cells or microorganisms with numbers equal to 10 to the eighth power of plaque forming units. Hundred Million Plaque Forming Units 10^8 50 Percent Tissue Culture Infective Dose per Dose A potency unit equal to the potency at which one dose of preparation contains one million (10^8) 50 percent tissue culture infective doses. Hundred Million Tissue Culture Infectious Dose 50% 10^2/mm3 10^2/uL 10^5/mL A unit of measurement equal to 10 to the eighth power of entities per unit of volume equal to one liter. Hundred Million Per Liter Billion CFU Billion Colony Forming Units A unit of measurement of colony forming cells or microorganisms equal to 10 to the ninth power colony forming units. Billion Colony Forming Units Billion CFU/g Billion Colony Forming Units per Gram A unit of measurement of colony forming cells or microorganisms in a unit mass of substance of interest defined as the number of 10 to the ninth power colony forming units in one gram of substance. Billion Colony Forming Units per Gram Billion CFU/mL Billion Colony Forming Units per Milliliter A unit of measurement of colony forming cells or microorganisms in a unit volume of substance of interest defined as the number of 10 to the ninth power colony forming units in one milliliter of substance. Billion Colony Forming Units per Milliliter Billion Copies per Milliliter The unit of concentration expressed as the number of 10 to the ninth power copies in unit volume equal to one milliliter. (NCI) Billion Copies per Milliliter Billion International Units per Milliliter A unit of measurement equal to 10 to the ninth power of the number of international units of an entity per unit of volume equal to one milliliter. (NCI) Billion International Units per Milliliter Billion Organisms A unit of measure of quantity of organisms expressed in 10 to the ninth power of organisms. Billion Organisms Billion Organisms per Gram Billion Organisms/g A unit of measure of organism content expressed in 10 to the ninth power of organisms per unit of mass equal to one gram. Billion Organisms per Gram Billion Organisms per Milligram Billion Organisms/mg A unit of measure of organism content expressed in 10 to the ninth power of organisms per unit of mass equal to one milligram. Billion Organisms per Milligram Billion Organisms per Milliliter Billion Organisms/mL A unit of measure of organism concentration expressed in 10 to the ninth power of organisms per unit of volume equal to one milliliter. Billion Organisms per Milliliter Billion PFU Billion Plaque Forming Units A unit of measurement of infectious entities with numbers equal to 10 to the ninth power of plaque forming units. Billion Plaque Forming Units A dosing unit for the number of therapeutic cells administered, expressed as 10 to the ninth power. Billion Therapeutic Cells Dosing Unit A dose calculation unit equal to 10 to the ninth power of the number of entities per single dose. Billion per Dose /ng 1/ng 10^12/kg 10^3/ug 10^6/mg A unit of measurement equal to 10 to the ninth power of the number of entities per unit of mass equal to one gram. Billion per Gram /nL 1/nL 10^3/mm3 10^3/uL 10^6/mL G/L GI/L Giga per Liter Giga/L K/cumm Thou/mcL A unit of measurement equal to 10 to the ninth power of the number of entities per unit of volume equal to one liter. Billion per Liter 10^12/mL 10^15/L 10^3/pL 10^6/nL A unit of measurement equal to 10 to the ninth power of entities per unit of volume equal to one microliter. Billion per Microliter Antibody Binding Capacity Unit A unit of measure for the number of target molecules per cell as determined by actual binding of a labeled antibody to a target. Antibody Binding Capacity Unit Absorbance Unit AU A unit of optical density expressed as a logarithm of absorbance of light transmitted through a partially absorbing substance. Absorbance Unit Absorbance Unit per Minute AU/min A unit of a speed of optical density change expressed as a logarithm of absorbance of light transmitted through a partially absorbing substance per minute. (NCI) Absorbance Unit per Minute AU/mL A unit of optical density expressed as a logarithm of absorbance of light transmitted through a partially absorbing substance per unit of volume equal to one milliliter. Absorbance Unit per Milliliter Act Dosing Unit Actuation Dosing Unit A dosing measurement based on the actuation unit, which represents the number of times a dosing device is operated to administer a dose. Actuation Dosing Unit Arbitrary Fluorescence Unit Arbitrary unit(s) of fluorescent luminescence. (NCI) Arbitrary Fluorescence Units Attogram A unit of mass equal to one quintillionth of a gram (1E-18 gram). (NCI) Attogram Arbitrary Aggregation Unit AU An arbitrary unit of measure for particle aggregation which is derived from an increase in sample impedance as aggregation occurs. Aggregation Unit Antigen Unit per Milliliter A measure of an antigen potency defined as a number of antigen units per one milliliter of product.(NCI) Antigen Unit per Milliliter Arithmetic Mean Fluorescence Intensity Unit A unit of measure for the arithmetic mean fluorescence intensity. Arithmetic Mean Fluorescence Intensity Unit Attomole A unit of amount of substance equal to one quintillionth of a mole (1E-18 mole). (NCI) Attomole Ampere A unit of electric current, named after the French physicist Andre Ampere. It is that constant current which, if maintained in two straight parallel conductors of infinite length and zero diameter separated by one meter in a vacuum, would produce between these conductors a force equal to 2(1E7) Newton per meter of length. This is dependent upon the definitions of the meter, kilogram, and second. One Ampere represents 6.24 x 1(E18) unit electric charge carriers, such as electrons, passing a specified fixed point in one second. (NCI) Ampere Ampule Dosing Unit A dosing measurement based on the ampule unit.(NCI) Ampule Dosing Unit Atomic Mass Unit A small unit of mass used to express atomic and molecular masses. (NCI) Atomic Mass Unit AU A unit of enzyme concentration which is defined as the amount of enzyme that can digest urea-denatured hemoglobin at the same initial rate as one milliequivalent of tyrosine at standard conditions. Anson Unit Anti-Xa Activity International Unit A unit of unfractionated or low molecular weight heparin anticoagulation potency determined as the amount that neutralizes one unit of coagulation factor Xa preparation defined as an international biological standard by WHO (World Health Organization) First International Low Molecular Weight Heparin Reference Standard.(NCI) Anti-Xa Activity International Unit Anti-Xa Activity International Unit per Milliliter A specific anticoagulation activity of unfractionated or low molecular weight heparin on factor Xa, expressed as a number of international anti-Xa heparin units per one milliliter of plasma.(NCI) Anti-Xa Activity International Unit per Milliliter AU A unit of antibody concentration measured by comparison against a known concentration of antibodies in a standard reference specimen. Antibody Unit [APL'U] Immunoglobin A Phospholipid Units A unit for semiquantitative measurement of IgA autoantibodies to proteins associated with negatively charged phospholipids evaluated against an established reference standard. IgA Phospholipid Unit Immunoglobin A Phospholipid Units per Milliliter A unit for semiquantitative measurement of IgA autoantibodies to proteins associated with negatively charged phospholipids evaluated against an established reference standard, per unit of volume equal to one milliliter. Immunoglobin A Phospholipid Unit per Milliliter Application Dosing Unit A dosing measurement based on the amount of substance applied. Application Unit Immunoglobin A Phosphatidylserine Units Phosphatidylserine IgA Antibody Unit A unit for semiquantitative measurement of IgA autoantibodies to proteins associated with phosphatidylserine evaluated against an established reference standard. (NCI) Phosphatidylserine IgA Antibody Unit Immunoglobin A Phosphatidylserine Units/mL Phosphatidylserine IgA Antibody Unit/mL Unit of measure of potency of allergenic product expressed as a number of immunoglobin A phosphatidylserine units per one milliliter of formulation. Phosphatidylserine IgA Antibody Unit per Milliliter AU A unit based on or subject to individual judgment, preference, or predetermined reference. (NCI) Arbitrary Unit AU/mL A unit based on or subject to individual judgment, preference, or predetermined reference per unit of volume equal to one milliliter. Arbitrary Unit per Milliliter AU A unit of proteolytic activity for trypsin and/or chymotrypsin that, upon incubation with the hemoglobin substrate, will release a quantity of phenolic substances that react with Folin-Ciocalteu phenol reagent to produce a colorimetric change of equal intensity to that produced from the reaction of one microgram of tyrosine with Folin-Ciocalteu phenol reagent. Armour Unit Atmosphere A unit of pressure, equal to a barometer reading of 760 mm Hg. 1 atmosphere is 101325 Pascals and 1.01325 bar. This unit of pressure is roughly equal to the average atmospheric pressure at sea level on the earth.(NCI) Atmosphere Allergy Unit per Milliliter kAU/L kUA/L UA/mL Unit of measure of potency of allergenic product expressed as a number of allergy units per one milliliter of formulation.(NCI) Allergy Unit per Milliliter Bag Dosing Unit A dosing measurement based on the bag unit.(NCI) Bag Dosing Unit Bar Dosing Unit A dosing measurement based on the bar unit.(NCI) Bar Dosing Unit BAU Bioequivalent Allergy Unit A unit used for standardization of an allergenic product based on evaluation of product potency against reference standard in combined in vivo (skin test) and in vitro (IgE-based ELISA) testing.(NCI) Bioequivalent Allergy Unit BAU/mL Bioequivalent Allergy Unit per Milliliter Unit of measure of potency of allergenic product expressed as a number of bioequivalent allergy units per one milliliter of formulation. Bioequivalent Allergy Unit per Milliliter Biological Unit per Milliliter Unit of measure of potency of allergenic product expressed as a number of biological units per one milliliter of formulation. Biological Allergy Unit per Milliliter The unit of measure for the number of times in which light paths are interrupted by movement. Beam Break Unit Beats per Minute BPM bpm The number of heartbeats measured per minute time. (NCI) Beats per Minute Bel A logarithmic ratio unit (base-10 logarithms) used to express relative magnitude of a physical quantity (usually power or intensity) in comparison with a specified or implied reference level. Particularly, Bel is used as a unit of relative sound intensity. In the latter context it is equal to ten decibels or to approximately 1.151293 nepers.(NCI) Bel BAU Binding Antibody Unit A unit of measure defined by WHO used for the comparison of antibody binding assays that detect the same class of immunoglobulins with the same specificity. Binding Antibody Unit BAU/mL Binding Antibody Unit per Milliliter A unit of concentration expressed as the number of binding antibody units per one milliliter. Binding Antibody Unit per Milliliter Biscuit Dosing Unit A measurement based on the biscuit unit. Biscuit Dosing Unit A unit of measure to quantify the number of rectangular areas in a city surrounded by streets. Block Unit of Distance Bolus Dosing Unit A dosing measurement based on the bolus unit.(NCI) Bolus Dosing Unit Bottle Dosing Unit A dosing measurement based on the bottle unit.(NCI) Bottle Dosing Unit Bowl Dosing Unit A dosing measurement based on the bowl unit. Bowl Dosing Unit Box Dosing Unit A dosing measurement based on the box unit.(NCI) Box Dosing Unit BASE PAIRS A number representing the paired nucleotides in a DNA or RNA sequence. Base Pair Unit Becquerel A unit of activity of a radionuclide, equal to one nuclear disintegration or other nuclear transition from a particular energy state occurring in an amount of a radionuclide during one second-long time interval.(NCI) Becquerel Becquerel per Gram A unit of specific radioactivity (massic activity) equal to activity of one Becquerel of the sample with total mass of one gram.(NCI) Becquerel per Gram Becquerel per Kilogram A unit of specific radioactivity (massic activity) equal to activity of one Becquerel of the sample with total mass of one kilogram.(NCI) Becquerel per Kilogram Becquerel per Liter A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Becquerel per unit volume equal to one liter.(NCI) Becquerel per Liter Becquerel per Milligram kBq/g Kilobecquerel per Gram A unit of specific radioactivity (massic activity) equal to activity of one Becquerel of the sample with total mass of one milligram.(NCI) Becquerel per Milligram Becquerel per Milliliter kBq/L Kilobecquerel per Liter A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Becquerel per unit volume equal to one milliliter or one kilobecquerel per liter.(NCI) Becquerel per Milliliter Becquerel per Microgram Bq/mcg Bq/ug kBq/mg Kilobecquerel per Milligram MBq/g Megabecquerel per Gram A unit of specific radioactivity (massic activity) equal to activity of one Becquerel of the sample with total mass of one microgram, or equal to activity of one kilobecquerel of the sample with total mass of one milligram. Becquerel per Microgram Becquerel per Microliter kBq/mL Kilobecquerel per Milliliter MBq/L Megabecquerel per Liter A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Becquerel per unit volume equal to one millionth of a liter.(NCI) Becquerel per Microliter Breaths per 30 Seconds breaths/30s The number of breaths (inhalation and exhalation) taken within a period of time equal to thirty seconds. Breaths per Thirty Seconds Breaths per Minute The number of breaths (inhalation and exhalation) taken per minute time. (NCI) Breaths per Minute Bethesda Unit A unit of measurement for blood coagulation inhibitor activity, expressed in the amount of an inhibitor neutralizing 50% of a coagulant during the incubation period. Bethesda Unit Bethesda Unit per Milliliter A unit of measurement for blood coagulation inhibitor activity, expressed as a Bethesda Unit per unit of volume equal to one milliliter. (NCI) Bethesda Unit per Milliliter Degree Celsius A unit of temperature of the temperature scale designed so that the freezing point of water is 0 degrees and the boiling point is 100 degrees at standard atmospheric pressure. The current official definition of the Celsius sets 0.01 C to be at the triple point of water and a degree to be 1/273.16 of the difference in temperature between the triple point of water and absolute zero. One degree Celsius represents the same temperature difference as one Kelvin. (NCI) Degree Celsius Complement Activity Enzyme Unit A unit of measurement for enzymatic activity of plasma and membrane-bound proteins that comprise a complement system and their split products. Complement Activity Enzyme Unit Calorie A measurement of nutritional energy. The quantity of thermal energy required to raise one gram of water one degree Centigrade under standard conditions. 1 calorie equals 4.186 joules. (NCI) calorie Can Dosing Unit A dosing measurement based on the can unit.(NCI) Can Dosing Unit Capful Dosing Unit A unit of measure equal to the amount that the cap on the bottle can contain. Capful Dosing Unit Caplet Dosing Unit A dosing measurement based on the caplet unit. Caplet Dosing Unit cap Capsule Dosing Unit A dosing measurement based on the capsule unit.(NCI) Capsule Dosing Unit Cartridge Dosing Unit A dosing measurement based on the cartridge unit.(NCI) Cartridge Dosing Unit 50 Percent Cell Culture Infective Dose per Dose A potency unit equal to the potency at which one dose of preparation contains one 50 percent cell culture infective dose.(NCI) 50 Percent Cell Culture Infective Dose per Dose 50 Percent Cell Culture Infective Dose per Milliliter A potency unit equal to the potency at which one milliliter of preparation contains one 50 percent cell culture infective dose. (NCI) 50 Percent Cell Culture Infective Dose per Milliliter Candela The candela is the basic unit of luminous intensity. It is the luminous intensity in a given direction of a small monochromatic light source at 540 terahertz emitting 1/683 watt per steradian in that direction. This is dependent upon the definitions of the meter, kilogram, and second.(NCI) Candela A unit of luminous intensity expressed as one candela in one second of light emittance per square meter of area. Candela Second per Square Meter A unit of luminous intensity expressed as one candela per square meter of area. Candela per Square Meter Colony Forming Unit per Gram A unit of measurement of colony forming cells or microorganisms in a unit mass of substance of interest defined as the number of colony forming units in one gram of substance. Colony Forming Unit per Gram Colony Forming Unit per Milliliter A unit of measurement of colony forming cells or microorganisms in a unit volume of substance of interest defined as the number of colony forming units in one milliliter of substance. Colony Forming Unit per Milliliter Centigram A unit of mass equal to one hundredth of a gram.(NCI) Centigram Cobalt Gray Equivalent A unit of relative biological effectiveness of protons equivalent to cobalt-60 gamma rays. Cobalt Gray Equivalent Centigray The metric unit of absorbed radiation dose equal to the absorption of one hundredth of joule of radiation energy per kilogram of matter. Centigray Curie A unit of radioactivity defined as 3.7 E10 atomic disintegrations or other nuclear transformations per second. One Curie is equal to 37 gigabecquerels.(NCI) Curie Curie per Gram mCi/mg Microcurie per Microgram Millicurie per Milligram uCi/ug A unit of specific radioactivity (massic activity) equal to activity of one Curie of the sample with total mass of one gram.(NCI) Curie per Gram Curie per Kilogram mCi/g Microcurie per Milligram Millicurie per Gram uCi/mg A unit of specific radioactivity (massic activity) equal to activity of one Curie of the sample with total mass of one kilogram.(NCI) Curie per Kilogram Curie per Liter Microcurie per Microliter uCi/uL A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Curie per unit volume equal to one liter.(NCI) Curie per Liter Curie per Milligram mCi/ug Millicurie per Microgram A unit of specific radioactivity (massic activity) equal to activity of one Curie of the sample with total mass of one milligram.(NCI) Curie per Milligram Curie per Milliliter A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Curie per unit volume equal to one milliliter.(NCI) Curie per Milliliter mCi/umol uCi/nmol A unit of radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Curie in one millimole of substance. Curie per Millimole Ci/mcg Curie per Microgram A unit of specific radioactivity (massic activity) equal to activity of one Curie of the sample with total mass of one microgram.(NCI) Curie per Microgram Ci/mcL Curie per Microliter A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Curie per unit volume equal to one millionth of a liter.(NCI) Curie per Microliter Cigar Dosing Unit A dosing measurement based on the cigar unit. Cigar Dosing Unit Cigarette Dosing Unit A dosing measurement based on the cigarette unit. Cigarette Dosing Unit Centiliter The unit of volume equal to one hundredth of a liter or 10 milliliters or 10 cubic centimeters or 0.6102 cubic inch. Centiliter A unit of pressure defined by a column of water with a height of one centimeter, frequently used to measure central venous pressure, intracranial pressure, and for pressures during mechanical ventilation. Centimeters of Water Centimeter A basic unit of length equal to one hundredth of a meter or approximately 0.393700787 inch. Centimeter Centimeters per Minute A unit of both speed (scalar) and velocity (vector), defined as the distance of one centimeter travelled per unit time equal to one minute. (NCI) Centimeter Per Minute cm/sec A unit of both speed (scalar) and velocity (vector), defined as the distance of one centimeter travelled per unit time equal to one second. (NCI) Centimeter per Second Square Centimeter A unit of area measurement equal to a square measuring one centimeter on each side. One square centimeter is equal to 1E-4 square meter. (NCI) Square Centimeter A SI derived metric unit of kinematic viscosity expressed as centimeters squared per second. Square Centimeter per Second A unit of pressure defined as centimeters of water times seconds per unit of volume equal to one milliliter. Centimeter of Water Times Second per Milliliter A unit of pressure defined as centimeters of water times seconds squared per unit of volume equal to one milliliter. Centimeter of Water Times Second Squared per Milliliter A unit of pressure defined as centimeters of water per unit of volume equal to one milliliter. Centimeter of Water per Milliliter A unit of pressure defined as centimeters of water per unit of volume equal to one milliliter per unit of time equal to one second. Centimeter of Water per Milliliter per Second Centimeter of Mercury A unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one centimeter rise of mercury in a barometer at the Earth's surface. Centimeters of Mercury Centimole A unit of amount of substance equal to one hundredth of a mole (1E-2 mole). (NCI) Centimole Millimoles per Deciliter mmol/dL A unit of concentration (molarity unit) equal to one centimole of solute in one liter of solution. (NCI) Centimole per Liter Coat Dosing Unit A dosing measurement based on the coat unit.(NCI) Coat Dosing Unit Container Dosing Unit A dosing measurement based on the container unit.(NCI) Container Dosing Unit A unit of concentration expressed as a number of copies per cell. (NCI) Copies per Cell A unit of concentration expressed as a number of copies per unit volume equal to one milliliter. Copies per Milliliter A unit of concentration expressed as a number of copies per unit volume equal to one microgram. Copies per Microgram A unit of concentration expressed as a number of copies per unit volume equal to one microliter. Copies per Microliter Coulomb A unit of quantity of electricity, equal to the quantity of charge transferred in one second across a conductor in which there is a constant current of one Ampere.(NCI) Coulomb Centipoise Millipascal Second s*mPa A unit of dynamic viscosity equal to one hundredth of a poise. Centipoise Counts per Minute A unit of frequency expressed as the detection rate of ionization events per minute. Count per Minute 10^-2 sec Centisecond csec A unit of time equal to one hundredth of a second (1E-2 seconds). (NCI) Centisecond Coresta Unit A unit of measure for air permeability defined as the volumetric flow rate of air (cm3 min-1) passing through a 1 cm2 sample of substrate at an applied pressure difference of 1 kPa. Coresta Unit Cup Equivalent cup-eq A unit of relative amount of a substance equal to one cup. Cup Equivalent Cup Dosing Unit A dosing measurement based on the cup unit.(NCI) Cup Dosing Unit Cuts Per Inch A unit of measure equal to the number of physical cuts made per one inch of a tobacco leaf. Cuts per Inch cpcm Grating Cycles per Centimeter A unit of measure for the number of repeating vertical or horizontal bars per unit of length equal to one centimeter on a visual acuity testing card. Grating Cycles per Centimeter Cycle per Minute A unit of frequency equal to the frequency at which one complete execution of a periodically repeated phenomenon, alternation, event, or sequence of events occurs per unit of time equal to one minute.(NCI) Cycle per Minute Cylinder Dosing Unit A dosing measurement based on the cylinder unit.(NCI) Cylinder Dosing Unit D Antigen Unit A unit of potency of poliovirus vaccine used for poliomyelitis prevention. The unit is poliovirus type-specific.(NCI) D Antigen Unit D Antigen Unit per Milliliter A unit of potency of poliovirus vaccine expressed as a number of D antigen units per one milliliter of vaccine formulation.(NCI) D Antigen Unit per Milliliter Decamole per Liter mol/dL Moles per Deciliter A unit of concentration (molarity unit) equal to one decamole of solute in one liter of solution. (NCI) Decamole Per Liter Decapascal A SI derived unit of pressure equivalent to ten pascals. Decapascal Days times nanograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). Day Times Nanogram Per Milliliter Per Milligram Per Kilogram A unit of measurement of time equal to 24 hours. Day A unit of measurement equal to the number of days within a period of time equal to one month. Days Per Month days/week A unit of measurement equal to the number of days within a period of time equal to one week. Days Per Week Decibel A unit of measure representing the intensity of an electrical signal or sound which is equal to ten times the logarithm of the ratio of two signals. Decibel D-Dimer Unit A unit of measure for the concentration of fibrin degradation products in a sample, calculated based upon the mass of D-dimers contained within that sample. (NCI) D-Dimer Unit Degree Unit of Plane Angle Degrees A unit of plane angle measurement equal to the length of the arc cut out by the angle, divided by the circumference of the circle, and multiplied by 360. The symbol for degrees is a small superscript circle. One radian is about 57 degrees and one degree is pi/180 radians.(NCI) Degree Unit of Plane Angle A unit of rotation expressed as the number of degrees per unit of length equal to one millimeter. Degree Per Millimeter A unit of angular velocity defined as the number of degrees per unit of time equal to one second. Degrees Per Second sq. deg. A unit of solid angle equal to approximately 3.0462x10^-4 steradians. Degrees Squared Diopter A unit of measurement of the optical power of a curved mirror or lens represented by the inverse of the focal length in meters. Diopter Dip Dosing Unit Snuff Dosing Unit A dosing measurement based on the dip unit. Dip Dosing Unit Disk Dosing Unit A dosing measurement based on the disk unit.(NCI) Disk Dosing Unit Deciliter The unit of volume equal to one tenth of a liter. Accepted for use with the SI. (NCI) Deciliter Decimole A unit of amount of substance equal to one tenth of a mole (1E-1 mole). (NCI) Decimole DNA Copies per Milliliter The unit of concentration of deoxyribonucleic acid (DNA) copies expressed as a number of copies in unit volume equal to one milliliter. DNA Copies per Milliliter A unit of measurement equal to the number of deoxyribonucleic acid (DNA) copies per unit of mass equal to one microgram. DNA Copies Per Microgram Disintegrations per Minute A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds. (NCI) Disintegration per Minute Disintegrations per Minute per 0.5 Milliliter A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds in a volume unit equal to a half milliliter. Disintegrations per Minute per 0.5 Milliliter Disintegrations per Minute per 100 milligrams dpm/cg A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds in a mass unit equal to one hundred milligrams. Disintegration per Minute per 100 milligrams Disintegrations per Minute per Gram A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds in a mass unit equal to one gram. Disintegration per Minute per Gram Disintegrations per Minute per Milligram A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds in a mass unit equal to one milligram. Disintegration per Minute per Milligram Disintegrations per Minute per Milliliter A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds in a volume unit equal to one milliliter. Disintegration per Minute per Milliliter Dram A unit of mass equal to 1/16 Avoirdupois ounce or 1/256 Avoirdupois pound. One dram equals approximately 1.7718451953125 grams.(NCI) Dram Mass Unit Drink Dosing Unit A dosing measurement based on the drink unit. Drink Dosing Unit Drip A unit of measure of volume defined as the amount of liquid dispensed as one drop from a dropper dispenser. The volume of a drop depends on the physical properties of the liquid dispensed, the dispenser device, and the technique used to produce the drop. (NCI) Drop Drum Dosing Unit A dosing measurement based on the drum unit.(NCI) Drum Dosing Unit Dyne A unit of force defined as the force that accelerates a mass of one gram at the rate of one centimeter per second squared. One dyne is equal to 1E-5 Newton and 2.248E-6 pounds of force. (NCI) Dyne dyne*sec/cm5 A unit of measure for the pressure difference in dynes times seconds per centimeter to the fifth power. Dyne Second per Centimeter to the Fifth Power eCigarette Dosing Unit Electronic Cigarette Dosing Unit A dosing measurement based on the electronic cigarette unit. Electronic Cigarette Dosing Unit Electrochemiluminescence Unit A unit for measuring concentration or/and reactivity of a test substance as defined in the literature reference standard for the particular quantitative electrochemiluminescent method. (NCI) Electrochemiluminescence Unit EIA value Enzyme Immunoassay Unit A unit for measuring concentration or/and reactivity of a test substance (an antigen or antibody of interest) as defined in the literature reference standard for the particular quantitative enzyme immunoassay method. Enzyme Immunoassay Unit 50 Percent Embryo Infective Dose per Dose A potency unit for measuring infectious activity of a biologic product or an infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent embryo infective dose.(NCI) 50 Percent Embryo Infective Dose per Dose 50 Percent Embryo Infective Dose per Milliliter A potency unit equal to the potency at which one milliliter of preparation contains one 50 percent embryo infective dose. 50 Percent Embryo Infective Dose per Milliliter A unit of volume equal to the amount of seminal fluid produced by a single ejaculation event. Ejaculate Unit Enzyme-Linked Immunosorbent Assay Unit A unit for measuring concentration or/and reactivity of a test substance (an antigen or antibody of interest) as defined in the literature reference standard for the particular quantitative enzyme-linked immunosorbent assay method. The enzyme-linked immunosorbent assay unit is used to express potency of immunologically active substances and products, e.g. vaccines.(NCI) Enzyme-Linked Immunosorbent Assay Unit Enzyme-Linked Immunosorbent Assay Unit per Dose A unit for measuring potency of immunologically active substance in a product determined as reactivity in a quantitative immunoassay for particular antigen or antibody and expressed per quantity of preparation used as a single dose.(NCI) Enzyme-Linked Immunosorbent Assay Unit per Dose Enzyme-Linked Immunosorbent Assay Unit per Milliliter A unit for measuring potency of immunologically active substance in a product determined as reactivity in a quantitative immunoassay for particular antigen or antibody and expressed per unit volume equal to one milliliter.(NCI) Enzyme-Linked Immunosorbent Assay Unit per Milliliter Endotoxin Unit EU An arbitrary unit of endotoxin activity based on the activity of 0.2 ng of reference standard endotoxin, EC-2, and equivalent to 5 Endotoxin U/ng. Endotoxin Unit Endotoxin Unit per Milliliter EU/mL A unit of measure equal to one endotoxin unit per milliliter, which is equivalent to approximately 0.1 to 0.2 ng/mL endotoxin. Endotoxin Unit per Milliliter Envelope Dosing Unit A dosing measurement based on the envelope unit. Envelope Dosing Unit Enzyme Unit EU A unit of catalytic activity measurement defined as the quantity of a particular enzyme that catalyzes the transformation of one micromole of the substrate per minute under standard conditions for specified assay system. Enzyme Unit Enzyme Unit per Gram of Hemoglobin EU/g Hb A unit of concentration (biologic activity) equal to one enzyme unit of substance per gram of hemoglobin. Enzyme Unit per Gram Hemoglobin Enzyme Unit/L EU/L Unit of catalytic activity concentration defined as activity equal to one enzyme unit per one liter of system volume. Enzyme Unit per Liter A unit of concentration (catalytic activity) equal to one enzyme unit of substance per one square meter of surface area. Enzyme Unit per Meter Squared Enzyme U/mg Tprot Enzyme Unit per Milligram of Protein A unit of concentration (biologic activity) equal to one enzyme unit of substance per milligram of total protein. Enzyme Unit per Milligram of Protein European Pharmacopoeia Unit An arbitrary unit established by the European Pharmacopoeia. European Pharmacopoeia Unit Equivalent Weight A unit of relative amount of a substance that combines with or displaces 8.0 grams of oxygen or 1.008 gram of hydrogen. The unit is usually expressed in grams and is equal to the amount of substance that gains or loses one mole of electrons in a redox reaction, or to the amount of substances that releases or accepts one mole of hydrogen ions in a neutralization reaction; or to the amount of electrolyte that carries one mole of positive or negative charge. This is a large unit and measurements are more often done in its derivatives, e.g. in milliequivalents.(NCI) Equivalent Weight Ehrlich Units EU/dL A unit of measure equal to one milligram of urobilinogen per deciliter. Ehrlich Unit A unit of measurement for the number of specified occurrences. Event Unit Degree Fahrenheit The Fahrenheit temperature scale is named after the German physicist Gabriel Fahrenheit (1686-1736), who proposed it in 1724. In this scale, the freezing point of water is 32 degrees Fahrenheit and the boiling point is 212 degrees, placing the boiling and melting points of water 180 degrees apart. In this scale a degree Fahrenheit is 5/9ths of a Kelvin (or of a degree Celsius), and minus 40 degrees Fahrenheit is equal to minus 40 degrees Celsius. (NCI) Degree Fahrenheit Farad A unit of capacitance equal to the capacitance of a capacitor having an equal and opposite charge of one coulomb on each plate and a potential difference of one volt between the plates.(NCI) Farad Fibrinogen Equivalent Units A unit of measure for the concentration of fibrin degradation products in a sample, calculated based upon the mass of fibrinogen contained within that sample. Fibrinogen Equivalent Unit Focus-forming Units A unit of measurement of the number of visible clusters of transformed or infected cells. Focus Forming Unit Focus Forming Units/mL A unit of measure expressed in focus forming unit(s) per milliliter of dosing volume. Focus Forming Unit per Milliliter Femtogram A unit of mass equal to one quadrillionth of a gram (1E-15 gram). (NCI) Femtogram Film Dosing Unit A dosing measurement based on the film unit. Film Dosing Unit Fingertip Unit of Length FTU A traditional unit of length defined as the length from the tip of the index finger to the first finger crease. Fingertip Unit of Length Fingertip Dosing Unit FTU An arbitrary dosing unit used predominantly for semisolid topical formulations such as cream, ointment, paste, etc. One fingertip unit is the amount of a product that is squeezed out from a standard tube with 5-millimeter diameter nozzle along an adult's fingertip. A fingertip length is defined from the tip of the index finger to the first finger crease. A fingertip dosing unit varies with age and size of the body. The average fingertip unit is equal to approximately 0.5 gram for an adult male and 0.4 gram for an adult female.(NCI) Fingertip Dosing Unit Fluorescence Intensity Unit MFI A unit of measure for the fluorescence intensity when the mathematic calculation is unspecified or unknown. Fluorescence Intensity Unit Cubic Micrometer Cubic Micron Femtoliter um3 The unit of volume equal 1E-15 liter. Femtoliter Femtomole A unit of amount of substance equal to one quadrillionth of a mole (1E-15 mole). (NCI) Femtomole Femtomole per Gram A molality unit that describes the amount of substance, expressed in femtomole(s) per gram. (NCI) Femtomole per Gram Femtomole per Liter A unit of concentration (molarity unit) equal to one quadrillionth of a mole (1E-15 mole) of solute in one liter of solution. (NCI) Femtomole per Liter Femtomoles per Liter per Second fmol/L/sec A concentration unit equal to one femtomole of solute in one liter of solution per unit of time equal to one second. (NCI) Femtomole per Liter per Second Fluid Ounce Imperial A traditional unit of liquid volume equal in the British Imperial system to 1/20 pint, or 1.733871 cubic inches or 28.413063 milliliters. Fluid Ounce British Fluid Ounce US A traditional unit of liquid volume equal in the US customary system to 1/16 pint, or 1.804687 cubic inches or 29.573531 milliliters. Fluid Ounce US Proportion of 1 A unit for expressing a percentage as a decimal whereby the total value is measured as a fraction of the numeric 1. Fraction of 1 F/s FPS Frames per Second Frames/sec A unit of measure equal to the number of visual frames per unit of time equal to one second. (NCI) Frames Per Second Foot A unit of length defined by the U.S. National Bureau of Standards as 30.48 centimeters. It is equal to 0.3048 meter, 12 inches, or to approximately 0.999998 survey foot.(NCI) International Foot Square Foot A unit of area equal to 144 square inches, 929.0304 square centimeters, or 9.290304E-2 square meters.(NCI) Square Foot Standard Cubic Foot A unit used in physical chemistry to express the amount of substance of an ideal gas in one cubic foot at 60 degrees Fahrenheit and pressure of one atmosphere.(NCI) Standard Cubic Foot gI Grams Iodine A dosing unit defined as the number of grams of iodine in an administered dose. Grams Iodine gI/L Grams Iodine Per Liter mgI/mL A dosing concentration unit defined as the number of grams of iodine per liter of volume in an administered dose. Grams Iodine Per Liter Gram A unit of mass equal to one thousandth (1E-3) of a kilogram, the kilogram being the base unit of mass in the International System of Units (SI). Gram Grams per 100 Grams A concentration unit expressed as the amount of a substance (in grams) contained in 100 grams of a sample or specimen. Gram per One Hundred Grams Den Denier A unit of measure for the linear mass density of fibers in grams per 9000 meters of the fiber. Gram per 9000 Meters Gram per Animal A unit of measure expressed in gram(s) per animal. Gram per Animal Gram per Animal per Day A unit of measure expressed in gram(s) per animal per period of time equal to twenty-four hours. Gram per Animal per Day Gram per Animal per Week A unit of measure expressed in gram(s) per animal per period of time equal to seven days. Gram per Animal per Week Gram per Cage A unit of measure expressed in gram(s) per cage. Gram per Cage Gram per Cage per Day A unit of measure expressed in gram(s) per cage per period of time equal to twenty-four hours. Gram per Cage per Day Gram per Cage per Week A unit of measure expressed in gram(s) per cage per period of time equal to seven days. Gram per Cage per Week Gram per Square Centimeter A unit of area density defined as a spread rate at which one gram of a substance is spread over the area of one square centimeter. The unit is also used as a dose calculation unit.(NCI) Gram per Square Centimeter A unit of area density defined as a spread rate at which one gram of a substance is spread over the area of one cubed centimeter. Gram per Cubic Centimeter g/24h A unit of mass flow rate equal to one gram per day. Gram per 24 Hours g% Gram per Deciliter A unit of mass concentration defined as the concentration of one gram of a substance per unit volume of the mixture equal to one deciliter (100 milliliters). The concept also refers to the metric unit of mass density (volumic mass) defined as the density of substance which mass equal to one gram occupies the volume one deciliter.(NCI) Gram per Deciliter kg/kg mcg/mcg mg/mg ug/ug A unit of a mass fraction expressed as a number of grams of substance per gram of mixture. Gram per Gram Gram per Gram per Day A unit of measure expressed in gram(s) per gram per period of time equal to twenty-four hours. Gram per Gram per Day Gram per Kilogram mg/g Microgram per Milligram Milligram per Gram ug/mg Grams (weight), divided by kilograms (weight) or micrograms (weight) per milligrams (weight). Gram per Kilogram Gram per Kilogram per Day mg/g/day Milligram per Gram per Day A dose administration rate unit equal to the rate at which one gram of a product per kilogram of body mass is delivered or administered over the period of one day. (NCI) Gram per Kilogram per Day g/L Gram per Liter kg/m3 Kilogram per Cubic Meter mg/mL Microgram per Microliter Milligram per Milliliter ug/uL A unit of concentration or mass density equal to one milligram of substance per milliliter of solution or one gram of substance per liter of solution. Kilogram per Cubic Meter Gram per Square Meter A unit of area density defined as a spread rate at which one gram of a substance is spread over the area of one square meter. It is equal to approximately 0.029 4935 ounce per square yard. Also used as a dose calculation unit.(NCI) Gram per Square Meter g/h*m2 A unit of measurement expressed as grams per square meter times a unit of time equal to one hour. Gram per Hour times Square Meter Gram per Square Meter per Day A dose calculation unit expressed in gram(s) per square meter per period of time equal to twenty-four hours. Gram per Square Meter per Day mg/mmol A unit of mass commonly used to express the molar mass of a substance in gram(s) per mole. (NCI) Gram per Mole g/2000lb g/Short ton g/US ton A unit of measure expressed in gram(s) per short ton (US). Gram per Short Ton A unit of concentration or mass density equal to one gram of substance per unit(s) of substance. Gram Per Unit Gram per Week A unit of mass flow rate equal to one gram per week or a dose administration rate unit equal to the rate at which a gram of a product is delivered or administered over the time period of one week. Gram per Week Gauss The unit of magnetic flux density. A field of one Gauss exerts a force on a conductor, placed in the field of 0.1 dyne per Ampere of current per centimeter of conductor. One Gauss represents a magnetic flux of one Maxwell per square centimeter of cross-section perpendicular to the field. One Gauss equals 10-4 Tesla.(NCI) Gauss Gigabecquerel A unit of radioactivity equal to one billion nuclear disintegrations or other nuclear transformations per second, or to 1E9 Becquerels. (NCI) Gigabecquerel GBq/g Gigabecquerel per Gram kBq/ug Kilobecquerel per Microgram MBq/mg Megabecquerel per Milligram A unit of specific radioactivity (massic activity) equal to activity of one gigabecquerel of the sample with total mass of one gram, or equal to activity of one megabecquerel of the sample with total mass of one milligram. Gigabecquerel per Gram Gigabecquerel per Milligram MBq/mcg MBq/ug Megabecquerel per Microgram A unit of specific radioactivity (massic activity) equal to activity of one gigabecquerel of the sample with total mass of one milligram.(NCI) Gigabecquerel per Milligram GBq/mcg Gigabecquerel per Microgram MBq/ng Megabecquerel per nanogram A unit of specific radioactivity (massic activity) equal to activity of one gigabecquerel of the sample with total mass of one microgram.(NCI) Gigabecquerel per Microgram kBq/pmol MBq/nmol A unit of radioactivity (massic activity) equal to the activity of one gigabecquerel in one micromole of substance. Gigabecquerel per Micromole GE Genomic Equivalents A unit defined as the number of whole organism genomes in a sample. (NCI) Genomic Equivalents GE/mL Genomic Equivalents per Milliliter A unit of concentration defined as the number of genomic equivalents per milliliter. (NCI) Genomic Equivalents per Milliliter mgEq/mL Milligram Equivalents/Milliliter ngEq/nL ugEq/uL A concentration unit measured as a number of milligram equivalents of solute per milliliter of solution. Milligram Equivalents Per Milliliter Glass Dosing Unit A dosing measurement based on the glass unit. (NCI) Glass Dosing Unit A dosing measurement based on the globule unit. Globule Unit Geometric Mean Fluorescence Intensity Unit A unit of measure for the geometric mean fluorescence intensity. Geometric Mean Fluorescence Intensity Unit A unit for measuring potency of immunologically active substance in a product determined as reactivity in a glycoprotein enzyme-linked immunosorbent assay for particular antigen or antibody and expressed per unit volume equal to one milliliter. Glycoprotein-ELISA Unit Per Milliliter [GPL'U] Immunoglobin G Phospholipid Units A unit for semiquantitative measurement of IgG autoantibodies to proteins associated with negatively charged phospholipids evaluated against an established reference standard. (NCI) IgG Phospholipid Unit Immunoglobin G Phospholipid Units per Milliliter A unit for semiquantitative measurement of IgG autoantibodies to proteins associated with negatively charged phospholipids evaluated against an established reference standard, per unit of volume equal to one milliliter. Immunoglobin G Phospholipid Unit per Milliliter Immunoglobin G Phosphatidylserine Units Phosphatidylserine IgG Antibody Unit A unit for semiquantitative measurement of IgG autoantibodies to proteins associated with phosphatidylserine evaluated against an established reference standard. (NCI) Phosphatidylserine IgG Antibody Unit Immunoglobin G Phosphatidylserine Units/mL Phosphatidylserine IgG Antibody Unit/mL Unit of measure of potency of allergenic product expressed as a number of immunoglobin G phosphatidylserine units per one milliliter of formulation. Phosphatidylserine IgG Antibody Unit per Milliliter Grain A unit of mass derived from the weight of a grain and equal to one seven-thousandth of a pound, or 1/480 troy ounce, or 64.79891 milligrams. The original English grain unit based on the mass of a ripe grain barleycorn was larger the corresponding grain units of France and other European nations which were based on the weight of the smaller wheat grain.(NCI) Grain A unit of acceleration expressed as a multiple of the force of gravity on earth (1 gravitational unit = 9.81m/s2). Unit of Gravity Metric Drop A unit of volume equal to 0.05 milliliter (20 drops/ml).(NCI) Metric Drop Gummy Dosing Unit A dosing measurement based on the gummy unit. Chewable Gel Dosing Unit Gray A unit of absorbed radiation dose. One gray is equal to an absorbed dose of one joule per kilogram of matter, or to 100 rads.(NCI) Gray Gray/Hour A unit of absorbed radiation dose rate defined as the number of Grays per hour. Gray per Hour Gray/Minute A unit of absorbed radiation dose rate defined as the number of Grays per minute. Gray per Minute A unit of measure for the area under an effect curve (AUEC) defined as hours times percent. Hour Times Percent h*ug/L Hours times nanograms per milliliter (area under the curve). Hour Times Nanogram per Milliliter Hours times nanomoles per liter (area under the curve). Hour Times Picomole per Milliliter hours/week A unit of measurement equal to the number of hours within a period of time equal to one week. Hours Per Week Hand Unit of Length A traditional unit of length equal to 4 inches or 10.16 centimeters. Hand Unit of Length Henry A unit of electric inductance. A coil with an inductance of one Henry requires a flux of one Weber for each Ampere of induced current. If it is the current which changes, then the induced field will generate a potential difference within the coil: if the inductance is one Henry a current change of one Ampere per second generates a potential difference of one volt. The Henry is a large unit; inductances in practical circuits are measured in millihenrys or microhenrys.(NCI) Henry Histamine Equivalent Prick Unit Unit of measure of potency of allergenic product expressed as a number of histamine equivalent prick units. Histamine Equivalent Prick Unit Homeopathic Dilution Unit A dosing measurement based on the homeopathic dilution unit.(NCI) Homeopathic Dilution Unit HU The unit of measure for the radiodensity of a substance. The radiodensity of distilled water at standard temperature and pressure is zero on the Hounsfield scale. Hounsfield Unit h Hours hr A unit of measurement of time equal to 60 minutes. Hour Hectopascal A SI derived unit of pressure equivalent to one hundred pascals, 1 millibar or 0.0145 pounds per square inch. Hectopascal Hours per Day A unit of measurement equal to the number of hours within a period of time equal to one day. Hour per Day Cycle per Second cycle/sec Hertz A unit of frequency equal to one cycle per second.(NCI) Hertz Hz/sec A unit of frequency rate change defined as the number of Hertz per unit of time equal to one second. Hertz Per Second Implant Dosing Unit A dosing measurement based on the implant unit.(NCI) Implant Dosing Unit Inch A traditional unit of length equal to 2.54 centimeters. (NCI) Inch Square Inch A unit of area equal to the area of a square with sides of one inch. It is equal to 6.4516 square centimeters.(NCI) Square Inch Inhalation Dosing Unit A dosing measurement based on the inhalation unit.(NCI) Inhalation Dosing Unit Injection Dosing Unit A dosing measurement based on the injection unit. Injection Dosing Unit IE International Unit The unitage assigned by the WHO (World Health Organization) to International Biological Standards - substances, classed as biological according to the criteria provided by WHO Expert Committee on Biological Standardization, to enable the results of biological and immunological assay procedures to be expressed in the same way throughout the world. The definition of an international unit is generally arbitrary and technical, and has to be officially approved by the International Conference for Unification of Formulae.(NCI) International Unit A unit of substance (biologic activity) flow rate equal to one international unit per day. International Unit per Day 10 IU/L International Units per Deciliter Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one deciliter of system volume. International Unit per Deciliter A unit of concentration (biologic activity) equal to one international unit of substance per gram of hemoglobin. International Unit per Gram Hemoglobin International Unit per Gram A unit of measure of quantity of substance per unit mass, expressed in terms of the International Unit per grams.(NCI) International Unit per Gram IU/h A unit of substance (biologic activity) flow rate equal to one international unit per hour. International Unit per Hour International Unit per Kilogram An arbitrary unit of substance content expressed in international units of biological activity per one kilogram of mass of the system. It is also used as a dose calculation unit expressed in international units of biological activity per one kilogram of body mass.(NCI) International Unit per Kilogram International units per Kilogram per Hour A dose calculation unit equal to one international unit (an arbitrary unit of biological activity) of a product per one kilogram of body mass administered per unit of time equal to one hour.(NCI) International Unit per Kilogram per Hour IE/L International Unit per Liter IU/L mIU/mL A unit of concentration (biologic activity) equal to one milli-international unit of substance per milliliter of solution or one international unit of substance per liter of solution. International Unit per Liter International Unit per Milligram A unit of measure of quantity of substance per unit mass, expressed in terms of international units per milligram. International Unit per Milligram IE/mL International Unit per Milliliter Kilo International Unit per Liter kIU/L A unit of concentration (biologic activity) equal to one international unit of substance per milliliter of solution. International Unit per Milliliter A unit of concentration (biologic activity) equal to one international unit of substance per millimole of substance. International Unit per Millimole A unit of radiant exposure defined as a unit of energy equal to one Joule applied to a unit of area equal to one square centimeter. Joule per Square Centimeter Jar Dosing Unit A dosing measurement based on the jar unit.(NCI) Jar Dosing Unit JDF U Juvenile Diabetes Foundation Unit A unit of measure, defined by the Juvenile Diabetes Foundation, used to quantify islet cell antibodies in a biological sample. Juvenile Diabetes Foundation Unit Joule A unit of electrical, mechanical, and thermal energy (as well as work and quantity of heat), equal to the work done when the point of application of a force of one Newton is displaced through a distance of one meter in the direction of the force or the work done when a current of one Ampere passes through a resistance of one ohm for one second. One joule is equal to 0.23889 gram-calorie (mean).(NCI) Joule Kelvin A basic unit of thermodynamic temperature, one of the seven base units of the International System of Units (Systeme International d'Unites, SI). It is 1/273.16th of the thermodynamic temperature of the triple point of water. This sets the size of the kelvin unit for temperature differences and defines the thermodynamic temperature of an equilibrium mixture of waters ice-liquid-vapor as 273.16 K, where 0 K is the lowest possible temperature ("absolute zero"). Kelvin A unit of phosphatase concentration that can free one milligram of phenol from disodium phenylphosphate at standard conditions, per unit volume of the mixture equal to one deciliter. (NCI) King-Armstrong Unit per Deciliter Kallikrein Inhibitor Unit A dosing measurement based on the Kallikrein inhibitor unit.(NCI) Kallikrein Inhibitor Unit Katal A unit for measuring catalytic (e.g. enzymatic) activity, the ability of the compound to accelerate the chemical reaction by providing a lower energy pathway between the reactants and the products. One katal is that catalytic activity which will raise the rate of reaction by one mole per second in a specified assay system. When the katal is used, the measurand should be specified by reference to the measurement procedure; the measurement procedure must identify the indicator reaction. The katal is not used to express a rate of reaction itself, which should be expressed in moles per second.(NCI) Katal Kilobecquerel A unit of radioactivity equal to one thousand nuclear disintegrations or other nuclear transformations per second, or to 1E3 Becquerels. (NCI) Kilobecquerel GBq/L Gigabecquerel per Liter Kilobecquerel per Microliter MBq/mL Megabecquerel per Milliliter A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one thousand Becquerels per unit volume equal to one millionth of a liter.(NCI) Kilobecquerel per Microliter Kilogram-Calorie A unit of energy defined as the amount of heat required to raise the temperature of one kilogram of pure water by one degree Centigrade under standard conditions (the specific heat of the water at 15 degrees Celsius and the constant pressure of 101.325 kilopascals or one atm being defined as unity), equal to approximately 4.1855 kJ. It is also is used by nutritionists in measuring the energy-producing potential of food as a unit of potential energy contained by a substance, which can be liberated when the material is oxidized, usually by combustion in the presence of oxygen.(NCI) Calorie A unit of energy equal to one kilocalorie per day. (NCI) Kilocalorie per Day Kilodalton Kilounified Atomic Mass Unit ku A mass unit equal to one thousand daltons. Kilodalton KeV Kiloelectronvolt A unit of energy equal to 1000 electronvolts, or (approximately) 1,602 177 x 10-16 joule. Kiloelectronvolt Kilogram The base unit of mass in the International System of Units (SI) equal to the mass of the international prototype kilogram, a platinum-iridium cylinder in the custody of the International Bureau of Weights and Measures. Kilogram A unit of measure equal to kilograms per length unit equal to one centimeter. Kilogram per Centimeter Kilogram per Square Centimeter A unit of spread rate of a substance by mass expressed in kilograms per area unit equal to one square centimeter, used also as a measure of area density and as a dose calculation unit.(NCI) Kilogram per Square Centimeter g/mL Gram per Milliliter gram/mL kg/L Kilogram per Liter mg/uL A unit of concentration or mass density equal to one gram of substance per milliliter of solution or one kilogram of substance per liter of solution. Kilogram per Liter Kilogram per Square Meter A unit expressed as kilogram of mass per square meter of area.(NCI) Kilogram per Square Meter g/mmol A unit of mass commonly used to express the molar mass of a substance in kilogram(s) per mole. Kilogram per Mole kilohertz A unit of measure denoting the frequency equal to 1000 cycles per second meaning e.g. that the cylical waveform changes from one state to the other (from one polarity to the other) 1000 times per second. (NCI) Kilohertz Kit Dosing Unit A dosing measurement based on the kit unit.(NCI) Kit Dosing Unit Kilo International Unit A unit equal to one thousand international units.(NCI) Kilointernational Unit Kilometer A unit of distance equal to 1000 meters, 0.621 miles, 1094 yards, or 3281 feet.(NCI) Kilometer Kilometer Per Hour A unit of both speed (scalar) and velocity (vector), defined as the distance of one thousand meters travelled per unit time equal to one hour.(NCI) Kilometer per Hour kdyn/cm2 Kilonewton per Centimeter Squared The kilonewton per centimeter squared is an SI derived unit of pressure; one newton is computed as the force necessary to accelerate a mass of one gram at the rate of one centimeter per second squared. One kilonewton per centimeter squared is descriptive of the amount of force exerted in a particular area. This measurement is frequently used when describing conditions of cellular movement. (NCI) Kilonewton per Centimeter Squared Kilopascal A SI derived unit of pressure equivalent to 1000 newtons per square meter or 10000 bars or to 0.145 pound per square inch. (NCI) Kilopascal kPa/L/sec Pa/mL/sec A unit of resistance equal to the number of kilopascals per unit of volume equal to one liter per unit of time equal to one second. (NCI) Kilopascal Per Liter Per Second 10^3 sec Kilosecond ksec A unit of time equal to one thousand seconds (1E3 seconds). (NCI) Kilosecond Kilo United States Pharmacopeia Unit A unit of potency equal to one thousand US Pharmacopoeia Units.(NCI) Kilo United States Pharmacopeia Unit Kilovolt A unit of electric potential and electromotive force equal to one thousand volts. Kilovolt Liter A unit of volume equal to one thousandth (1E-3) of a cubic meter, the cubic meter being the standard derived unit of volume in the International System of Units (SI). Liter A unit of flow rate equal to one liter per day. Liter per Day A unit of flow rate equal to one liter per hour. Liter per Hour (L/h)/m2 L/h/m2 Liters per hour (flow rate), divided by meters squared (surface area). Liter Per Hour Per Square Meter L/kg mL/g Liters (volume) divided by kilograms (weight) or milliliters (volume), divided by grams (weight). Liter per Kilogram dL/dL Liter per Liter mL/mL uL/uL A unit of volume concentration equal to the number of liters per unit of volume equal to one liter. Liter Per Liter A dose calculation unit expressed in liter(s) per square meter per period of time equal to one second. Liter per Square Meter per Second A unit of flow rate equal to one liter per minute. Liter per Minute (L/min)/m2 L/min/m2 Liters per minute (flow rate), divided by meters squared (surface area). Liter Per Minute Per Square Meter L/sec Liters per second. Liter per Second A unit of conductance equal to the number of liters per unit of time equal to one second per unit of pressure equal to one kilopascal. Liter per Second per Kilopascal lb lb_av Pound A traditional unit of mass. By international agreement, one avoirdupois pound is equal to exactly 0.453 592 37 kilogram, 16 ounces, or 1.215 28 troy pounds. (NCI) Pound Lens Dosing Unit A dosing measurement based on the lens unit. Lens Dosing Unit Linear Foot-pound Linear ft*lbf Linear Pounds Feet A unit of measure that equals the work required to move one pound a linear distance of one foot in the direction of the applied force. Linear Foot Pound A dosing unit based on lipase activity. Lipase Unit A dosing unit based on lipase activity per kilogram of body mass. Lipase Units per Kilogram Lumen A unit of luminous flux. It is the amount of light that falls on a unit area at unit distance from a source of one candela.(NCI) Lumen Log10 50 Percent Cell Culture Infective Dose per Dose A logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent cell culture infective dose.(NCI) Log10 50 Percent Cell Culture Infective Dose per Dose A logarithmic-scale (base 10) unit for measuring colony forming units per unit of mass equal to one gram. Log10 Colony Forming Units per Gram A logarithmic-scale (base 10) unit for measuring colony forming units per unit of volume equal to one milliliter. Log10 Colony Forming Units per Milliliter A logarithmic-scale (base 10) unit for measuring the number of copies of an entity. log10 Copy A logarithmic-scale (base 10) unit for measuring copies per unit of volume equal to one milliliter. Log10 Copies per Milliliter Log10 50 Percent Embryo Infective Dose per Dose A logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent embryo infective dose.(NCI) Log10 50 Percent Embryo Infective Dose per Dose Log10 Enzyme-Linked Immunosorbent Assay Unit A logarithmic-scale (base 10) unit for measuring concentration and/or reactivity of a test substance (an antigen or antibody of interest) as defined in the literature reference for the particular quantitative enzyme-linked immunosorbent assay method.(NCI) Log10 Enzyme-Linked Immunosorbent Assay Unit Log10 Enzyme-Linked Immunosorbent Assay Unit per Dose A logarithmic-scale (base 10) unit for measuring potency of immunologically active substance in a product determined as reactivity in a quantitative immunoassay for particular antigen or antibody and expressed per quantity of preparation used as a single dose.(NCI) Log10 Enzyme-Linked Immunosorbent Assay Unit per Dose A logarithmic-scale (base 10) unit for measuring international units per unit of volume equal to one milliliter. Log10 International Units per Milliliter log10 arcmin log10 arcminutes A logarithmic-scale (base 10) unit for measuring angular equal to 1/60 degree or to 60 arcseconds. Log10 Arcminutes A logarithmic-scale (base 10) unit for measuring plaque forming units. Log10 Plaque Forming Unit A logarithmic-scale (base 10) unit for measuring plaque forming units per unit of volume equal to one milliliter. log10 Plaque Forming Units Per Milliliter Log10 50 Percent Tissue Culture Infective Dose A logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at 50 percent tissue culture infective dose. Log10 50 Percent Tissue Culture Infective Dose Log10 50 Percent Tissue Culture Infective Dose per Dose A logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent tissue culture infective dose.(NCI) Log10 50 Percent Tissue Culture Infective Dose per Dose Log10 50 Percent Tissue Culture Infective Dose per Milliliter A logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at which one milliliter of infectious material contains one 50 percent tissue culture infective dose. Log10 50 Percent Tissue Culture Infective Dose per Milliliter Log10 50 Percent Tissue Culture Infective Dose per Microliter A logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at which one microliter of infectious material contains one 50 percent tissue culture infective dose. Log10 50 Percent Tissue Culture Infective Dose per Microliter A logarithmic-scale (base 10) unit for measuring concentration of a substance in a solution as determined by the quantitative reaction with added measured volume(s) of a solution of the precisely known concentration(s) of a standard reagent. Log10 Titer Log10 Arbitrary Units per Milliliter A logarithmic-scale (base 10) unit for measuring arbitrary units per unit of volume equal to one milliliter. Log10 Arbitrary Units per Milliliter Lozenge Dosing Unit A dosing measurement based on the lozenge unit.(NCI) Lozenge Dosing Unit Imperial ton Long ton UK ton A traditional unit of mass in the United Kingdom equal to 2,240 pounds or 1.017 metric tons. Long Ton Lux A unit of illuminance equal to the direct illumination on a surface that is everywhere one meter from a uniform point source of one candela; a unit of illuminance that is equal to one lumen per square meter.(NCI) Lux Meter A meter is defined as the length of the path traveled by light in a vacuum during a time interval of 1/299 792 458 of a second and is equal to 1.093 61 yards.(NCI) Meter m% A unit of measure for the distance saturation product (DSP) defined as meters walked times percent oxygen saturation. Meters Times Percent m/sec Meter Per Second A unit of both speed (scalar) and velocity (vector), defined as the distance of one meter travelled per unit time equal to one second.(NCI) Meter per Second m/sec2 A unit of acceleration equal to one meter per unit of time equal to one second squared. Meter per Second Squared Square Meter The standard derived unit of area in the International System of Units (SI) equal to the area of a square whose sides are one meter long. Square Meter m2/sec Square Meter per Second A unit of measure defined as square meter per second. Meter Squared per Second Cubic Meter A unit of volume or capacity equal to the volume of a cube with edges one meter in length. It is equal to 1,000 liters; 1,000 cubic decimeters; 10(E6) cubic centimeters; 25.3 cubic feet; 6.29 barrels.(NCI) Cubic Meter Minimum Alveolar Concentration 50% A unit of potency for inhalational gases defined as the concentration of gas in the lung required to immobilize 50 percent of individuals in response to a stimulus, such as pain. Minimum Alveolar Concentration 50 Percent Milliampere Hour Milliampere-Hour A unit of energy or power equal to one thousandth of an ampere hour. Milliampere Hour Milliampere A unit of electric current equal to one thousandth of an ampere. (NCI) Milliampere A unit of enzymatic activity defined a one milli-Anson unit per unit volume equal to one milliliter. Milli-Anson Unit per Milliliter Mask Dosing Unit A dosing measurement based on the mask unit. Mask Dosing Unit Mb Mbp Megabase Pair A number representing one million paired nucleotides in a DNA or RNA sequence. Megabase Pair Megabecquerel A unit of radioactivity equal to one million nuclear disintegrations or other nuclear transformations per second, or to 1E6 Becquerels. (NCI) Megabecquerel GBq/mL Gigabecquerel per Milliliter MBq/uL Megabecquerel per Microliter A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one million Becquerels per unit volume equal to one millionth of a liter, or defined as a concentration of a radionuclide with an activity equal to one billion Becquerels per unit volume equal to one thousandth of a liter. Megabecquerel per Microliter Millicurie A unit of radioactivity equal to one thousandth of a Curie or 37 megabecquerels, and corresponding to a radioactivity of 37 millions of atomic disintegrations per second.(NCI) Millicurie Microcurie per Gram Millicurie per Kilogram uCi/g A unit of specific radioactivity (massic activity) equal to activity of one millicurie of the sample with total mass of one kilogram.(NCI) Millicurie per Kilogram Microcurie per Milliliter Millicurie per Liter uCi/mL A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one thousandth of a Curie per unit volume equal to one liter.(NCI) Millicurie per Liter Median Fluorescence Intensity Unit MFI A unit of measure for the median fluorescence intensity. Median Fluorescence Intensity Unit Milliequivalent A unit of relative amount of a substance equal to one thousandth of an equivalent weight.(NCI) Milliequivalent Milliequivalents per Day A unit of relative amount of substance flow rate equivalent to the rate at which one thousandth of an equivalent of substance travels to a given object or space over a period of time equal to twenty four hours.(NCI) Milliequivalent per 24 Hours Milliequivalent per Deciliter A concentration unit measured as a number of milliequivalents of solute per deciliter of solution. (NCI) Milliequivalent per Deciliter Milliequivalent Per Gram A unit of relative amount of substance content equivalent to the content at which one gram of mixture contains one thousandth of an equivalent of a component. The unit is also used as a dose calculation unit.(NCI) Milliequivalent per Gram Milliequivalents per Hour A unit of relative amount of substance flow rate equivalent to the rate at which one thousandth of an equivalent of substance travels to a given object or space over a period of time equal to one hour. (NCI) Milliequivalent per Hour Milliequivalent Per Kilogram A unit of relative amount of substance content equivalent to the content at which one kilogram of mixture contains one thousandth of an equivalent of a component. The unit is also used as a dose calculation unit.(NCI) Milliequivalent per Kilogram Milliequivalent Per Liter Millivalent per Liter mval/L A concentration unit measured as a number of milliequivalents of solute per liter of solution.(NCI) Milliequivalent per Liter Milliequivalent per Milliliter A concentration unit expressed in milliequivalent(s) of solute per milliliter of solution. (NCI) Milliequivalent per Milliliter Milliequivalent per Millimole A concentration unit measured as a number of one thousandth of an equivalent weight per millimole of substance. (NCI) Milliequivalent per Millimole mEq/mcg Milliequivalent Per Microgram A unit of relative amount of substance content equivalent to the content at which one millionth of a gram of mixture contains one thousandth of an equivalent of a component. The unit is also used as a dose calculation unit.(NCI) Milliequivalent per Microgram Milliequivalent Per Microliter A concentration unit measured as a number of milliequivalents of solute per microliter of solution.(NCI) Milliequivalent per Microliter Molecules of Equivalent Soluble Fluorochromes A unit of measure of the fluorescence intensity of a fluorochrome-labeled sample, which is equivalent to the fluorescence intensity of a solution containing an equivalent number of molecules of free fluorochrome in solution, under identical experimental conditions. Molecule of Equivalent Soluble Fluorochrome Metabolic Equivalent of Task A unit of energy expenditure equal to the ratio of metabolic rate during physical activity versus a reference metabolic rate. Metabolic Equivalent of Task Unit A unit of energy expenditure equal to the number of metabolic equivalent of task units times the number of hours of performed activity. Metabolic Equivalent of Task Hours A unit of energy expenditure equal to the number of metabolic equivalent of task units times the number of minutes of performed activity. Metabolic Equivalent of Task Minute 10^6 Electronvolts 10^6 eV Megaelectronvolt A unit of energy equal to 1,000,000 electronvolts, or (approximately) 1,602 177 x 10-13 joule. Megaelectronvolt mgI Milligrams Iodine A dosing unit defined as the number of milligrams of iodine in an administered dose. Milligrams Iodine Milligram A unit of mass equal to one thousandth (1E-3) of a gram. Milligram Milligram per Animal A unit of measure expressed in milligram(s) per animal. Milligram per Animal A unit of measure expressed in milligram(s) per inspiration or expiration of breath. Milligram Per Breath A unit of measure expressed in milligram(s) per capsule. Milligram per Capsule A unit of mass equal to one milligram per cigarette unit. Milligram per Cigarette A unit of area density defined as a spread rate at which one milligram of a substance is spread over the area of one square centimeter. The unit is also used as a dose calculation unit. Milligram per Squared Centimeter A unit of mass flow rate equal to one milligram per day. Milligram per 24 Hours mg% Milligram per Deciliter A unit of mass concentration defined as the concentration of one milligram of a substance in unit volume of the mixture equal to one cubic deciliter or 100 cubic centimeters. It is also a unit of mass density (volumic mass) defined as the density of substance which mass equal to one milligram occupies the volume one cubic deciliter or 100 cubic centimeters.(NCI) Milligram per Deciliter A unit of measure expressed in milligram(s) per dose. Milligram per Dose Milligram per Gram per Hour A dose calculation unit expressed in milligram(s) per gram per period of time equal to sixty minutes. (NCI) Milligram per Gram per Hour Milligram per Gram per Minute A dose calculation unit expressed in milligram(s) per gram per period of time equal to sixty seconds. (NCI) Milligram per Gram per Minute A unit of mass flow rate equal to one milligram per hour. Milligram per Hour Milligram per Kilogram Nanogram per Milligram ng/mg ug/g Milligrams (weight), divided by kilograms (weight) or nanograms (weight) per milligrams (weight). Milligram per Kilogram Milligram per Kilogram per Day A dose calculation unit expressed in milligram(s) per kilogram per period of time equal to twenty-four hours. (NCI) Milligram per Kilogram per Day A dose calculation unit expressed in milligram(s) per kilogram per single dose. Milligram per Kilogram per Dose Milligram per Kilogram per Hour A dose calculation unit equal to one thousandth of a gram of a preparation per one kilogram of body mass administered per unit of time equal to one hour.(NCI) Milligram per Kilogram per Hour Milligram per Kilogram per Minute A dose calculation unit equal to one thousandth of a gram of a preparation per one kilogram of body mass administered per unit of time equal to one minute.(NCI) Milligram per Kilogram per Minute Milligram per Kilogram per Week A dose calculation unit expressed in milligram(s) per kilogram per period of time equal to seven days. (NCI) Milligram Per Kilogram Per Week A unit of equivalent concentration equal to the number of milligrams of D-dimer per unit volume equal to one liter. Milligram per Liter D-Dimer Unit FEU mg/L mg FEU/L mg-L-FEU A unit of equivalent concentration equal to the number of milligrams of fibrinogen per unit volume equal to one liter. Milligram per Liter Fibrinogen Equivalent Units g/m3 Gram per Cubic Meter mcg/mL mg/L Microgram per Milliliter Milligram per Liter ng/uL ug/mL A unit of concentration or mass density equal to one microgram of substance per milliliter of solution or one milligram of substance per liter of solution. Microgram per Milliliter Milligram per Square Meter A unit of area density equal to approximately 2.94935E-5 ounce per square yard. Also used as a dose calculation unit.(NCI) Milligram per Square Meter Milligram per Square Meter per Day A dose calculation unit expressed in milligram(s) per square meter per period of time equal to twenty-four hours. (NCI) Milligram per Square Meter per Day Milligram per Square Meter per Hour A dose calculation unit expressed in milligram(s) per square meter per period of time equal to sixty minutes. (NCI) Milligram per Square Meter per Hour Milligram per Square Meter per Minute A dose calculation unit expressed in milligram(s) per square meter per period of time equal to sixty seconds. (NCI) Milligram per Square Meter per Minute Milligram per Square Meter per Week A dose calculation unit expressed in milligram(s) per square meter per period of time equal to seven days. Milligram per Square Meter per Week A unit of mass flow rate equal to one milligram per minute. Milligram per Minute g/L/24 Hours g/L/day mg/mL/24 Hours A dose calculation unit expressed in milligrams per milliliter per day. Gram per Liter per Day Milligram per Milliliter per Minute A unit expressed in milligrams per milliliter per period of time equal to sixty seconds. Milligram per Milliliter per Minute ug/mmol A unit of mass commonly used to express the molar mass of a substance in milligram(s) per mole. Milligram per Mole A unit of mass equal to one milligram per puff unit. Milligram per Puff A unit of measure expressed in milligram(s) per tablet. Milligram Per Tablet Milligram per Week A unit of mass flow rate equal to one milligram per week or a dose administration rate unit equal to the rate at which a milligram of a product is delivered or administered over the time period of one week. Milligram per Week A unit of mass concentration defined as one square milligram of a substance in unit volume of the mixture equal to one square deciliter. Square Milligram per Square Deciliter Milligram Equivalent A unit of relative amount of substance equal to one thousandth of a gram of an equivalent weight. Milligram Equivalent Megahertz The SI derived unit of frequency; equal to one million oscillations per second or to 1E6 hertz. (NCI) Megahertz International Mile A unit of distance equal to 5280 international feet, 1760 international yards, or 1609.344 meters.(NCI) Mile Minute A unit of measurement of time equal to 60 seconds. Minute Minutes times milligrams per milliliter (area under the curve). Minute Times Milligram per Milliliter Minutes per Day A unit of measurement equal to the number of minutes within a period of time equal to one day. Minute per Day mcIU/mL Micro-International Unit per milliliter mIE/L mIU/L uIU/mL A unit of concentration (biologic activity) equal to one micro-international unit of substance per milliliter of solution or one milli-international unit of substance per liter of solution. Microinternational Unit per Milliliter Milli-International Unit per Square Meter A unit expressed as a number of milli-international units per one square meter of a body surface area. Milliinternational Unit per Square Meter A unit of radiant exposure defined as a unit of energy equal to one millijoule applied to a unit of area equal to one square centimeter. Millijoules per Square Centimeter Millikatal A unit of catalytic activity measurement equal to one thousandth of one katal (1E-3 katal). (NCI) Millikatal Millikatal/Liter A unit of catalytic activity measurement equal to one thousandth of one katal (1E-3 katal) per liter. Millikatal per Liter cc cm3 Cubic Centimeter Milliliter A unit of volume equal to one thousandth (1E-3) of a liter. Milliliter A unit of volume defined as milliliters times centimeter of water. Milliliter Times Centimeter of Water A unit of flow rate expressed as the number of milliliters, divided by the number of minutes times a unit of volume equal to 100 milliliters. Milliliter Per Minute Times One Hundred Milliliters A unit of flow rate expressed as the number of milliliters per 100g of material (e.g., tissue) per minute. Milliliter per 100 Grams per Minute Milliliter per Animal A unit of measure expressed in milliliter(s) per animal. Milliliter per Animal Milliliter per Animal per Day A unit of measure expressed in milliliter(s) per animal per period of time equal to twenty-four hours. Milliliter per Animal per Day Milliliter per Animal per Week A unit of measure expressed in milliliter(s) per animal per period of time equal to seven days. Milliliter per Animal per Week A unit of measure expressed in milliliter(s) per heart beat. Milliliter per Heartbeat Milliliter per Breath A unit of measure expressed in milliliter(s) per inspiration or expiration of breath. Milliliter per Breath Milliliter per Cage A unit of measure expressed in milliliter(s) per cage. Milliliter per Cage Milliliter per Cage per Day A unit of measure expressed in milliliter(s) per cage per period of time equal to twenty-four hours. Milliliter per Cage per Day Milliliter per Cage per Week A unit of measure expressed in milliliter(s) per cage expressed per period of time equal to seven days. Milliliter per Cage per Week A unit of pressure expressed in milliliter(s) per centimeter of water. (NCI) Milliliter per Centimeter of Water dL/m Milliliter per Centimeter A unit of measure equal to the number of milliliters per unit of length equal to one centimeter. (NCI) Milliliter per Centimeter mL/mL/min A unit of flow rate equal to one milliliter per cubic centimeter per unit of time equal to one minute. Milliliter per Cubic Centimeter per Minute mL/24h A unit of flow rate equal to one milliliter per day. Milliliter per 24 Hours Milliliters per Deciliter A unit of volume concentration equal to the number of milliliters per unit of volume equal to one deciliter. Milliliter per Deciliter A unit of measure expressed in milliliter(s) per dose. Milliliter per Dose (L/day)/kg (mL/day)/g mL/g/day Milliliters per gram per day or liters per day (flow rate), divided by kilograms (weight) or milliliters per day (flow rate), divided by grams (weight). Milliliter per Gram per Day (L/h)/kg (mL/h)/g mL/g/h Milliliters per gram per hour or liters per hour (flow rate), divided by kilograms (weight) or milliliters per hour (flow rate), divided by grams (weight). Milliliter per Gram per Hour (L/min)/kg (mL/min)/g mL/g/min Milliliters per gram per minute or liters per minute (flow rate), divided by kilograms (weight) or milliliters per minute (flow rate), divided by grams (weight). Milliliter per Gram per Minute cc/hr cm3/h A unit of flow rate equal to one milliliter per hour. Milliliter per Hour Milliliters (volume) divided by kilograms (weight). Milliliter per Kilogram (mL/day)/kg mL/kg/day Milliliters per kilogram per day or milliliters per day (flow rate), divided by kilograms (weight). Milliliter per Kilogram per Day (mL/h)/kg mL/kg/h Milliliters per kilogram per hour or milliliters per hour (flow rate), divided by kilograms (weight). Milliliter per Kilogram per Hour (mL/min)/kg mL/kg/min Milliliters per kilogram per minute or milliliters per minute (flow rate), divided by kilograms (weight). Milliliter per Kilogram per Minute Milliliters (volume) divided by meters squared (surface area). Milliliter per Square Meter Milliliter per Square Meter per Day A dose calculation unit expressed in milliliter(s) per square meter per period of time equal to twenty-four hours. (NCI) Milliliter per Square Meter per Day Milliliter per Square Meter per Hour A dose calculation unit expressed in milliliter(s) per square meter per period of time equal to sixty minutes. (NCI) Milliliter per Square Meter per Hour Milliliter per Square Meter per Minute mL/min/m2 A dose calculation unit expressed in milliliter(s) per square meter per period of time equal to sixty seconds. (NCI) Milliliter per Square Meter per Minute A unit of flow rate equal to one milliliter per minute. Milliliter per Minute mL/min/1.73m2 A metric unit of volumetric flow rate defined as the rate at which one milliliter of matter travels during the period of time equal to one minute per 1.73 meters squared of body surface area. Milliliter per Minute per 1.73 m2 of Body Surface Area Milliliter per Minute per Torr A unit of measure equal to the number of milliliters per unit of time equal to one minute per unit of pressure equal to one milliter of mercury (mmHg). Milliliter per Minute per Millimeters of Mercury Milliliters per Millimeter of Mercury A unit equal to the volume in milliliters per one millimeter rise of mercury in a barometer at the Earth's surface. (NCI) Milliliters Per Millimeter of Mercury A unit of gas diffusion capacity equal to one milliliter per millimeter of mercury per minute per liter of volume. Milliliter per Minute per Millimeters of Mercury per Liter mL/sec Milliliters per second. Milliliter per Second mL/sec/1.73m2 A metric unit of volumetric flow rate defined as the rate at which one milliliter of matter travels during the period of time equal to one second per 1.73 meters squared of body surface area. Milliliter Per Second Per 1.73 Meter Squared mL/kg/s A metric unit of volumetric flow rate defined as the rate at which one milliliter of substance travels during the period of time equal to one second per kilogram. Milliliter per Kilogram per Second mL/sec/m2 A metric unit of volumetric flow rate defined as the rate at which one milliliter of matter travels during the period of time equal to one second per meter squared. Milliliter Per Second Per Square Meter A unit of pressure defined by a column of water with a height of one millimeter. Millimeter of Water Column Millimeter A unit of measure equal to one thousandth of a meter. (NCI) Millimeter Millimeters per Two Hours A unit of both speed (scalar) and velocity (vector), defined as the distance of one centimeter travelled per unit time equal to two hours. (NCI) Millimeter per Two Hours Millimeter per Hour A unit of both speed (scalar) and velocity (vector), defined as the distance of one millimeter travels per unit time equal to one hour.(NCI) Millimeter per Hour Millimeters per Minute A unit of both speed (scalar) and velocity (vector), defined as the distance of one millimeter travelled per unit time equal to one minute. (NCI) Millimeter Per Minute Millimeters per Second mm/sec A unit of both speed (scalar) and velocity (vector), defined as the distance of one millimeter travelled per unit time equal to one second. (NCI) Millimeter Per Second Square Millimeter A unit of area measurement equal to a square measuring one millimeter on each side. One square millimeter is equal to 10(E-2) square centimeter and 10(E-6) square meter.(NCI) Square Millimeter Square Millimeters per Microsecond A SI derived metric unit of kinematic viscosity expressed as millimeters squared per microsecond. Square Millimeter per Microsecond A unit defined as the volume, in cubic millimeters, per area equal to one square millimeter per unit of time equal to one year. Cubic Millimeter per Square Millimeter per Year Millimeters of Aluminum Equivalents A unit defined as the thickness, in millimeters, of aluminum that has the equivalent degree of attenuation, under specified conditions, as the material that is the target of the procedure. Millimeters of Aluminum Equivalents Millimeter of Mercury A unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one millimeter rise of mercury in a barometer at the Earth's surface. (NCI) Millimeter of Mercury A unit of pressure equal to millimeters of mercury times the number of heartbeats measured per minute unit of time. Millimeters of Mercury times Beats per Minute A unit of resistance equal to the number of millimeters of mercury times meters squared, per unit of volume equal to one liter per unit of time equal to one minute. Millimeter Mercury times Square Meter per Liter per Minute Hybrid Resistance Units Wood Units A unit of resistance equal to the number of millimeters of mercury times minutes, per unit of volume equal to one liter. Hybrid Resistance Units A unit of resistance equal to the number of millimeters of mercury per unit of volume equal to one liter per unit of time equal to one minute. Millimeter Mercury Per Liter Per Minute Millimeter of Mercury per Second mmHg/sec A rate of inflation or deflation of a manometric device based on the unit of pressure equal to 133,332 Pa or 1.316E10-3 standard atmosphere during period of time equal to one sixtieth of a minute. (NCI) Millimeter of Mercury per Second Millimole A unit of amount of substance equal to one thousandth (1E-3) of a mole. Millimole mmol/24h A unit of substance flow rate equal to one millimole per day. Millimole per 24 Hours Millimole per Gram A unit amount of substance content (molality unit) defined as one mole of solute per one kilogram of solvent.(NCI) Mole per Kilogram A unit of substance flow rate equal to one millimole per hour. Millimole per Hour Millimole per Kilogram A unit of amount of substance content (molality unit) defined as one thousandth of mole (1E-3 mole) of solute per one kilogram of solvent. (NCI) Millimole per Kilogram A dose calculation unit expressed in millimole(s) per kilogram per period of time equal to one second. Millimole per Kilogram per Second mcmol/mL Micromole per Milliliter Millimole per Liter mmol/L mol/m3 Mole per Cubic Meter nmol/uL umol/mL A unit of concentration (molarity unit) equal to one millimole of solute per liter of solution. Millimole per Liter mmol/(day*L) mmol/(L*day) mmol/day/L A concentration unit equal to one millimole of solute in one liter of solution per unit of time equal to 24 hours. Millimole per Liter per Day mmol/(h*L) mmol/(L*h) mmol/h/L umol/(h*mL) umol/(mL*h) umol/h/mL umol/mL/h A concentration unit equal to one millimole of solute in one liter of solution per unit of time equal to one hour. Millimole per Liter per Hour A unit of gas diffusion capacity equal to one millimole per minute per kilopascal. Millimoles per Minute per Kilopascal A unit of gas diffusion capacity equal to one millimole per minute per kilopascal per liter of volume. Millimole per Minute per Thousand Pascal per Liter mmol/mol CREAT umol/mmol CREATININE A unit of fraction expressed as the ratio of the amount of a substance in solution, in millimoles, to the amount of creatinine in the mixture, in moles. Millimole Per Mole of Creatinine umol/mmol A unit of fraction expressed as the ratio of the amount of a substance in solution, in millimoles, to the amount of a different substance in the mixture, in moles. Millimole per Mole Millimoles per Second mmol/sec A unit of substance flow rate equal to one millimole per second. Millimole per Second A unit of concentration (molarity unit) equal to one square millimole of solute per square liter of solution. Square Millimole per Square Liter MilliMerck Unit per Milliliter A unit of concentration based on the vaccine specific number of titers that are the geometric mean titer at which an individual is considered to convert from a seronegative to a seropositive response due to the vaccine. MilliMerck Unit per Milliliter Millinewton A unit of force equal to one thousandth of a Newton. Millinewton Mean Fluorescence Intensity Unit MFI A unit of measure for the mean fluorescence intensity when the mathematic calculation is unspecified or unknown. Mean Fluorescence Intensity Unit Mole The base unit of amount of substance in the International System of Units (SI). It is equal to the same number of elementary units as there are atoms in 0.012 kg of carbon-12. Mole A unit of substance flow rate equal to one mole per day. Mole per Day mmol/mg A unit of amount of substance content (molality unit) defined as one mole of solute per one gram of solvent.(NCI) Mole per Gram mmol/mL mol/L Mole per Liter A unit of concentration (molarity unit) equal to one mole of solute in one liter of solution.(NCI) Mole per Liter Mole per Milligram A unit of amount of substance content (molality unit) defined as one mole of solute per one milligram of solvent.(NCI) Mole per Milligram Mole per Milliliter A unit of concentration (molarity unit) equal to one mole of solute in one milliliter of solution.(NCI) Mole per Milliliter mmol/mmol Mole per Mole A unit of fraction expressed as the ratio of the amount of substance of solute in moles to the amount of substance of the mixture in moles.(NCI) Mole per Mole Month One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks. (NCI) Month Milliosmole A unit of osmotic pressure equal to one thousandth of an osmole or osmotic pressure of 0.001 molar solution of a substance that does not dissociate. (NCI) Milliosmole Milliosmole per Kilogram A unit of osmotic pressure equal to one thousandth of an osmole per kilogram substance. Milliosmole per Kilogram A unit of osmotic pressure equal to one thousandth of an osmole per unit of volume equal to one Liter. Milliosmole per Liter Millipascal A SI derived unit of pressure equivalent to one thousandth of one pascal. (NCI) Millipascal A SI derived unit of pressure equivalent to one thousandth of one pascal per unit of time equal to one second. Millipascal per Second Miles per Hour A unit of both speed (scalar) and velocity (vector), defined as the distance of one mile travelled per unit time equal to one hour. (NCI) Mile Per Hour [MPL'U] Immunoglobin M Phospholipid Units A unit for semiquantitative measurement of IgM autoantibodies to proteins associated with negatively charged phospholipids evaluated against an established reference standard. IgM Phospholipid Unit Immunoglobin M Phospholipid Units per Milliliter A unit for semiquantitative measurement of IgM autoantibodies to proteins associated with negatively charged phospholipids evaluated against an established reference standard, per unit of volume equal to one milliliter. Immunoglobin M Phospholipid Unit per Milliliter Immunoglobin M Phosphatidylserine Units Phosphatidylserine IgM Antibody Unit A unit for semiquantitative measurement of IgM autoantibodies to proteins associated with phosphatidylserine evaluated against an established reference standard. (NCI) Phosphatidylserine IgM Antibody Unit Immunoglobin M Phosphatidylserine Units/mL Phosphatidylserine IgM Antibody Unit/mL Unit of measure of potency of allergenic product expressed as a number of immunoglobin M phosphatidylserine units per one milliliter of formulation. Phosphatidylserine IgM Antibody Unit per Milliliter Megarad Mrd A unit of absorbed radiation dose equal to one million rad (10E6 rad), or 10000 Gy (10E4 Gy). Megarad Millisecond ms msec A unit of time, which is equal to one thousandth of a second.(NCI) Millisecond A unit of measure equal to one millisecond per one millimeter of mercury (mmHg). Millisecond per Millimeter Mercury A unit of time, which is equal to one thousandth of a second squared. Square Millisecond Milliunit A quantity equivalent to one thousandth of a unit (10E-3 unit). Milliunit An arbitrary unit of substance content expressed in milliunit(s) per gram. Milliunit per Gram uU/mL An arbitrary unit of substance concentration equal to the concentration at which one liter of mixture contains one thousandth of a unit of a substance. Microunit per Milliliter Millivolt A unit of electric potential and electromotive force equal to one thousandth of a volt.(NCI) Millivolt Millivolt * Minutes A SI derived unit of magnetic flux, equal to the flux that produces in a circuit of one turn an electromotive force of one millivolt, when the flux is uniformly reduced to zero within one minute. (NCI) Millivolt Minute mV/sec uV/msec A SI derived rate unit equal to one millivolt per unit of time equal to one second. Millivolt per Second Millivolt Squared per Hertz Millivolt^2/Hertz A unit equal to one thousandth of a volt squared per unit of frequency equal to one Hertz. Millivolt Squared per Hertz Nanocurie A unit of radioactivity equal to one billionth of Curie or 37 Becquerels, and corresponding to a radioactivity of 37 atomic disintegrations per second.(NCI) Nanocurie Nebule Dosing Unit A unit of measurement based on the nebule dosing unit.(NCI) Nebule Dosing Unit Newton A unit of force which, when applied in a vacuum to a body having a mass of one kilogram, causes an acceleration of one meter per second squared. It is equal to 1E5 dynes. (NCI) Newton NFIU NIU Normalized Fluorescence Intensity Unit Normalized Intensity Unit A relative fluorescence intensity unit that is adjusted to a reference standard. (NCI) Normalized Fluorescence Intensity Unit Nanogram A unit of mass equal to one billionth (1E-9) of a gram. Nanogram A unit of mass equal to one nanogram per cigarette unit. Nanogram per Cigarette A unit of mass flow rate equal to one nanogram per day. Nanogram per Day Nanogram per Deciliter A unit of mass concentration defined as the concentration of one nanogram of a substance in unit volume of the mixture equal to one deciliter. The concept also refers to the unit of mass density (volumic mass) defined as the density of substance which mass equal to one nanogram occupies the volume one deciliter.(NCI) Nanogram per Deciliter fg/mg Nanogram per Kilogram pg/g A unit expressed as the number of nanogram(s) per kilogram. Nanogram per Kilogram Microgram per Cubic Meter ng/L pg/mL ug/m3 A unit of concentration or mass density equal to one picogram of substance per milliliter of solution or one nanogram of substance per liter of solution. Nanogram per Liter fg/umol pg/mmol A unit of mass commonly used to express the molar mass of a substance in nanogram(s) per mole. Nanogram per Mole A unit of mass equal to one nanogram per puff unit. Nanogram per Puff Nanogram Equivalent A unit of relative amount of substance equal to one billionth of a gram of an equivalent weight. Nanogram Equivalents Nanogram equivalents of a substance per gram of matrix or tissue (e.g., radiolabeled dose). Nanogram Equivalents Per Gram pgEq/mL A concentration unit measured as a number of nanogram equivalent of solute per liter of solution. Nanogram Equivalents Per Liter Nanokatal A unit of catalytic activity measurement equal to one billionth of one katal (1E-9 katal). (NCI) Nanokatal Nanokatals per Gram Hemoglobin A unit of catalytic activity equal to one billionth of one katal (10E-9 katal) per gram of hemoglobin. Nanokatal per Gram Hemoglobin Nanokatal per Liter A unit of catalytic activity concentration defined as the catalytic activity of the component equal to one billionth of one katal (1E-9 katal) in the unit volume of the system equal to one liter. (NCI) Nanokatal per Liter Nanoliter A unit of volume equal to one billionth of a liter (1E-9 liter). (NCI) Nanoliter Nanometer A unit of length equal to one billionth of a meter (1E-9 meter). Nanometer is used as a unit for light wavelength measurement. (NCI) Nanometer Nanometers per Minute A unit of both speed (scalar) and velocity (vector), defined as the distance of one nanometer travelled per unit time equal to one minute. Nanometer Per Minute Nanomoles Bone Collagen Equivalents per Liter A unit of relative amount of substance concentration equal to nanomoles of bone collagen equivalent weight per unit of volume equal to one liter. Nanomole Bone Collagen Equivalent per Liter Nanomoles Bone Collagen Equivalents per Millimole A unit of relative amount of substance concentration equal to nanomoles of bone collagen equivalent weight per unit of substance concentration equal to one millimole. Nanomole Bone Collagen Equivalent per Millimole Nanomoles Bone Collagen Equivalents per Nanomole A unit of relative amount of substance concentration equal to nanomoles of bone collagen equivalent weight per unit of substance concentration equal to one nanomole. Nanomole Bone Collagen Equivalents per Nanomole Nanomole A unit of amount of substance equal to one billionth (1E-9) of a mole. (NCI) Nanomole A unit of substance flow rate equal to one nanomole per day. Nanomole per Day A unit of concentration (molarity unit) equal to one nanomole of solute in one deciliter of solution. Nanomole per Deciliter nmol/g pmol/mg umol/kg Nanomoles per gram. Nanomole per Gram pmol/g/day A dose calculation unit expressed in nanomole(s) per kilogram per period of time equal to twenty-four hours. Nanomole per Kilogram per Day Nanomole per Liter pmol/mL A unit of concentration (molarity unit) equal to one nanomole of solute per liter of solution. Nanomole per Liter pmol/mL/h A rate unit expressed in nanomole(s) per liter of solution per period of time equal to sixty minutes. Nanomole per Liter per Hour nmol*min/L pmol/mL/min A rate unit equal to the number of nanomoles per unit of volume equal to one liter per unit of time equal to one minute. Nanomole per Liter per Minute nmol/(L*s) nmol/(s*L) nmol/s/L A concentration unit equal to one nanomole of solute in one liter of solution per unit of time equal to one second. Nanomole per Liter per Second mmol/kg/h umol/g/h A dose calculation unit expressed in nanomole(s) per milligram per period of time equal to one hour. Nanomole per Milligram per Hour mmol/kg/min umol/g/min A dose calculation unit expressed in nanomole(s) per milligram per period of time equal to one minute. Nanomole per Milligram per Minute Nanomole per Milliliter per Minute A unit of concentration (molarity unit) equal to one billionth of a mole (1E-9 mole) of solute in one milliliter of solution to be administered per minute of time. Nanomole per Minute per Milliliter pmol/mmol A unit of fraction expressed as the ratio of the amount of a substance in solution, in nanomoles, to the amount of a different substance in the mixture, in moles. Nanomole per Mole A unit of relative amount of substance equal to one billionth of a mole of an equivalent weight. Nanomole Equivalents Nanosecond nsec A unit of time equal to one billionth of a second. (NCI) Nanosecond Nanounit per Centiliter An arbitrary unit of substance content expressed in nanounit(s) per centiliter. (NCI) Nanounit Per Centiliter OD OD_Unit Optical Density Unit A unit of optical density expressed as the degree of absorption of light at a specified wavelength by a solution or suspension. Unit of Optical Density Ohm A unit of electrical resistance equal to the resistance between two points on a conductor when a potential difference of one volt between them produces a current of one Ampere. Ohm is also used to measure impedance and reactance for complex resistance. A measurement in ohms is the reciprocal of a measurement in Siemens. (NCI) Ohm Opsonization Index 50% A potency unit equal to the dilution of serum that causes opsonization and phagocytosis of 50% of the bacteria in a sample. (NCI) Opsonization Index 50% A unit of measure of quantity of organisms. Organism-Based Unit Organisms Per Gram A unit of measure of organism content expressed in organisms per unit of mass equal to one gram. Organism Per Gram Organisms Per Milliliter A unit of measure of organism concentration expressed in organisms per unit of volume equal to one milliliter. Organism Per Milliliter Osmole A unit of osmotic pressure equal to that of an ideal solution of a nondissociating substance that has a concentration of one mole of solute per liter of solution.(NCI) Osmole Ounce Equivalent oz-eq A unit of relative amount of a substance equal to one ounce. Ounce Equivalent Ounce A unit of mass, the avoirdupois ounce is equal to 1/16 pound, or 28.3495 grams, or 0.911 457 troy ounce.(NCI) Ounce Poise A unit of dynamic viscosity equal to one pascal-second. Poise Pascal A unit of pressure equivalent to one Newton per square meter or 10 bars or to 1.45x10(E-4) pounds per square inch.(NCI) Pascal /Year Every Year Per Annum Per Year A frequency rate of occurrences of something within a period of time equal to three hundred sixty-five days. Per Year A quantification of lifetime tobacco exposure defined as (number of cigarettes smoked per day x number of years smoked)/20. One pack-year is smoking 20 cigarettes a day for one year. Pack Year A number of individual items packaged as a unit. Pack Dosage Form Pack Dosing Unit Package Dosing Unit A dosing measurement based on the package unit.(NCI) Package Dosing Unit Packet Dosing Unit A dosing measurement based on the packet unit.(NCI) Packet Dosing Unit Patch Dosing Unit A dosing measurement based on the patch unit.(NCI) Patch Dosing Unit Pellet Dosing Unit A dosing measurement based on the pellet unit.(NCI) Pellet Dosing Unit Plaque Forming Unit A unit of measurement of plaque forming cells or microorganisms. Plaque Forming Unit A unit of measure expressed in plaque forming unit(s) per animal. Plaque Forming Units per Animal Plaque Forming Unit per Dose A unit of measure expressed in plaque forming unit(s) per dose. Plaque Forming Unit per Dose Plaque Forming Unit per Milliliter A unit of measure expressed in plaque forming unit(s) per milliliter of dosing volume. Plaque Forming Unit per Milliliter Picogram A unit of mass equal to one trillionth of a gram (1E-12 gram). (NCI) Picogram A unit of mass equal to one trillionth of a gram (1E-12 gram) per cell. Picogram Per Cell Picogram per Deciliter Picograms per deciliter. Picogram per Deciliter fg/mL pg/L A unit of concentration or mass density equal to one femtogram of substance per milliliter of solution or one picogram of substance per liter of solution. Femtogram per Milliliter An arbitrary unit of substance concentration equal to the yield from a blood pheresis procedure. Pheresis Unit Pill Dosing Unit A dosing measurement based on the pill unit. Pill Dosing Unit Pipe Dosing Unit A dosing measurement based on the pipe unit. Pipe Dosing Unit The smallest resolvable rectangular area of an image, either on a screen or stored in memory. (NCI) Pixel Pixels per Centimeter PPCM A unit of image resolution expressed in the numbers of pixels per centimeter in the horizontal or vertical direction. Pixels per Centimeter Pixels per Inch PPI A unit of image resolution expressed in the numbers of pixels per inch in the horizontal or vertical direction. Pixels per Inch Picokatal A unit of catalytic activity measurement equal to trillionth of one katal (1E-12 katal). (NCI) Picokatal Picokatal per Liter Unit of catalytic activity concentration defined as activity equal to a picokatal per one liter of the system volume. Picokatal per Liter Picoliter A unit of volume equal to one trillionth of a liter (1E-12 liter). (NCI) Picoliter Plug Dosing Unit A dosing measurement based on the plug unit. Plug Dosing Unit Picometer A unit of length equal to one trillionth of a meter (1E-12 meter). (NCI) Picometer Picomole A unit of amount of substance equal to a trillionth (1E-12) of a mole. (NCI) Picomole A unit of concentration (molarity unit) equal to one picomole of substance per 10^10 cells. Picomole per Ten Billion Cells A unit of concentration (molarity unit) equal to one picomole of substance per 10^9 cells. Picomole per Billion Cells A unit of substance flow rate equal to one picomole per day. Picomole per Day Picomoles per Deciliter A unit of concentration (molarity unit) equal to one picomole of solute per deciliter of solution. Picomole per Deciliter nmol/kg pmol/g Nanomoles (amount), divided by kilograms (weight) or picomoles per gram. Nanomole per Kilogram Femtomole per Milliliter fmol/mL Picomole per Liter A unit of concentration (molarity unit) equal to one picomole of solute per liter of solution. Picomole per Liter Picomoles per Liter per Hour A rate unit expressed in picomole(s) per liter of solution per period of time equal to sixty minutes. Picomole per Liter per Hour A rate unit expressed as the number of picomoles per punch observational unit per hour. Picomole per Punch Observational Unit per Hour Protein Nitrogen Unit per Milliliter Unit of measure of potency of an allergenic product expressed as a number of protein nitrogen units per one milliliter of formulation. Allergenic Protein Nitrogen Unit per Milliliter A numeric unit used to quantify a score. Point Pouch Dosing Unit A dosing measurement based on the pouch unit.(NCI) Pouch Dosing Unit Part per Billion A unit of measure referring to one entity counted per one billion entities.(NCI) Part Per Billion Part per Million A unit of measurement referring to one entity counted per one million entities.(NCI) Part Per Million Part per Thousand per mil per mille permil A unit of proportion equal to 1E-3. (NCI) Part per Thousand Parts per Trillion A unit of measure referring to one entity counted per one trillion entities.(NCI) Part Per Trillion Pressor Unit A dosing measurement based on the pressor unit.(NCI) Pressor Unit Picosecond psec A unit of time equal to one trillionth of a second. (NCI) Picosecond Pounds per Square Inch A unit of pressure equivalent to 6.894757 kilopascals, or 703.0696 kilograms per square meter, or 51.71507 millimeters of mercury.(NCI) Pound per Square Inch British Pint Imperial Pint A traditional unit of volume equal to 20 British fluid ounces, 34.678 cubic inches or approximately 568.261 milliliters. Pint British US Pint A United States liquid unit equal to 16 US fluid ounces or 28.875 cubic inches or approximately 473.177 milliliters. Pint Puff Dosing Unit A means of delivering a defined dose of a therapeutic aerolized solution into either the upper or lower respiratory tract. Metered-dose inhalers or spray pumps are devices that provide a puff dose for delivery into either the oral or the nasal cavity.(NCI) Puff Dosing Unit Puffs Per Minute The number of inhalational puffs taken per minute unit of time. Puffs per Minute Pump Dosing Unit A dosing measurement based on the pump unit. Pump Dosing Unit Quantity Sufficient A quantity of an ingredient or product needed to bring up a volume or weight of the preparation to a final amount as it is indicated in the prescription; also refers to a determination of an adequate supply of medicine to fulfill either a prescribed amount or a sufficient quantity to provide treatment over a specified time frame.(NCI) Quantity Sufficient Rad The special unit for absorbed radiation dose, which is the amount of energy from any type of ionizing radiation (e.g., alpha, beta, gamma, neutrons, etc.) deposited in any medium (e.g., water, tissue, air). A dose of one rad means the absorption of 100 ergs per gram of absorbing tissue. One rad is equal to 0.01 gray.(NCI) Rad radian/s Radians Per Second A unit of angular velocity equal to one radian per second. Radians Per Second Radioactive Seed Implant Dosing Unit A dosing measurement based on the radioactive seed implant unit. Radioactive Seed Implant Dosing Unit Retinol Activity Equivalent A unit of biological activity expressed in equivalents of retinol activity. Retinol Equivalent The quotient of one quantity divided by another, with the same units of measurement. Ratio Relative Unit RU An arbitrary unit of measure that is expressed in relation to a test-specific internal standard; it is dependent on instrument and measurement parameters. Relative Unit Relative Unit per Milliliter RU/mL An arbitrary unit of measure that is expressed in relation to a test-specific internal standard per unit of volume equal to one milliliter; it is dependent on instrument and measurement parameters. Relative Unit per Milliliter Relative Fluorescence Intensity Unit Relative Fluorescence Unit Relative Intensity Unit RFIU RIU An arbitrary unit used to measure the intensity of the emitted fluorescent light in a sample; it is dependent on instrument and measurement parameters. Relative Fluorescence Intensity Unit Ring Dosing Unit A dosing measurement based on the ring unit.(NCI) Ring Dosing Unit Light Unit LU Luminometer Unit Relative Light Unit Relative Luminescence Unit An arbitrary unit used to measure the intensity of the emitted light from a sample; it is dependent on instrument and measurement parameters. Relative Luminescence Unit RNA Copies per Milliliter The unit of concentration of Ribonucleic Acid (RNA) copies expressed as a number of copies in unit volume equal to one milliliter.(NCI) RNA Copy per Milliliter A unit of measurement equal to the number of ribonucleic acid (RNA) copies per unit of mass equal to one microgram. RNA Copies per Microgram Roentgen A unit of exposure to ionizing radiation. One Roentgen is the amount of gamma or x-rays required to produce ions resulting in a charge of 2.58E-4 Coulombs/kilogram of air under standard conditions.(NCI) Roentgen Revolution per Minute A unit of frequency equal to one revolution per unit of time equal to one minute.(NCI) Revolution per Minute sec Second The base unit of time in the International System of Units (SI) equal to the duration of 9,192,631,770 periods of the specified light radiation corresponding to the transition between the two hyperfine levels of the cesium 133 atom in its ground state at 0 K. Second Kilopascal Second kPa*s A unit of resistance (dynamic viscosity) equal to one second times one kilopascal. Second Times Kilopascal sec/hr Seconds per Hour A rate unit expressed in seconds per period of time equal to sixty minutes. Seconds Per Hour A unit of oxygen transfer function expressed as the reciprocal of time in seconds, times the reciprocal of oxygen concentration. Reciprocal of Seconds Times Percent O2 Concentration Sachet dosing unit A dosing unit that contains a solid pharmaceutical preparation in the form of a small packet or bag made from a flexible, often porous material.(NCI) Sachet Dosing Unit Standard IgA Anti-Beta 2 Glycoprotein 1 Units Standard IgA Anti-Beta 2 GP1 Units An arbitrary unit for the quantitation of IgA antibodies to beta-2 glycoprotein 1, which has been normalized and calibrated to an assay standard. Standard IgA Anti-Beta 2 Glycoprotein 1 Unit Standardized Biological Unit per Milliliter Unit of measure of potency of allergenic product expressed as a number of standardized biological units per one milliliter of formulation. Standardized Allergy Biological Unit per Milliliter Standard Cubic Meter A unit used in physical chemistry to express the amount of substance of an ideal gas in one cubic meter at standard conditions: temperature 273.15 K and pressure of one atmosphere (101.325 kilopascals).(NCI) Standard Cubic Meter Scoopful Dosing Unit A dosing measurement based on the scoopful unit.(NCI) Scoopful Dosing Unit A dosing measurement based on the serving unit. Serving Dosing Unit SFU/10^5 PBMC Spots/10^5 PBMC A unit of activity of cell-mediated immunity expressed as a quantity of spot forming cells per one hundred thousand peripheral blood mononuclear cells. Spot Forming Units Per Ten Thousand Peripheral Blood Mononuclear Cells SFU/10^6 PBMC Spots/10^6 PBMC A unit of activity of cell-mediated immunity expressed as a quantity of spot forming cells per million peripheral blood mononuclear cells. Spot Forming Units Per Million Peripheral Blood Mononuclear Cells SFU/2x10^5 PBMC Spots/2x10^5 PBMC A unit of activity of cell-mediated immunity expressed as a quantity of spot forming cells per two hundred thousand peripheral blood mononuclear cells. Spot Forming Units Per Twenty Thousand Peripheral Blood Mononuclear Cells SFU/Well Spot Forming Cells/Well Spots/Well A unit of activity of cell-mediated immunity expressed as a quantity of spot forming cells per one culture plate well. Spot Forming Cells per Well Standard IgG Anti-Beta 2 Glycoprotein 1 Units Standard IgG Anti-Beta 2 GP1 Units An arbitrary unit for the quantitation of IgG antibodies to beta-2 glycoprotein 1, which has been normalized and calibrated to an assay standard. Standard IgG Anti-Beta 2 Glycoprotein 1 Unit Shockwave Dosing Unit A dosing measurement based on the shock wave unit. Shockwave Dosing Unit Siemens A unit of electrical conductance, admittance, and susceptance. A conductor has a conductance of one Siemens if an electrical potential difference of one volt produces a one Ampere current in it. The conductance in Siemens is the reciprocal of its resistance in ohms.(NCI) Siemens Standard IgM Anti-Beta 2 Glycoprotein 1 Units Standard IgM Anti-Beta 2 GP1 Units An arbitrary unit for the quantitation of IgM antibodies to beta-2 glycoprotein 1, which has been normalized and calibrated to an assay standard. Standard IgM Anti-Beta 2 Glycoprotein 1 Unit Spray Dosing Unit A dosing measurement based on the spray unit.(NCI) Spray Dosing Unit SQ-u/mL Standardized Quality Unit per Milliliter Standardized Quality Unit/mL Unit of measure of potency of allergenic product expressed as a number of standardized quality units per one milliliter of formulation. Standardized Allergy Quality Unit per Milliliter A unit of measure to quantify the number of strides taken during a normal walking gait. Step Unit of Distance The number of steps, picking up one foot and putting it back down, occurring within a minute unit of time. Steps Per Minute Short ton US ton A traditional unit of mass in the United States equal to 2,000 pounds or 0.907 metric tons. Short Ton Strip Dosing Unit A dosing measurement based on the strip unit.(NCI) Strip Dosing Unit Suppository Dosing Unit A dosing measurement based on the suppository unit.(NCI) Suppository Dosing Unit Sievert A unit of equivalent radiation dose. One Sv is received when the actual absorbed dose of ionizing radiation, after being multiplied by the dimensionless factors Q (the relative biological efficiency or quality factor) and N (the product of any other multiplying factors that takes into account the distribution of energy throughout the dose), is one joule per kilogram. In this scheme, the relationship between the absorbed dose of radiation D and the dose equivalent H is, therefore, given by H = QND. Both Q and N are stipulated by the International Commission on Radiological Protection. One Sv is equal to 100 rem.(NCI) Sievert Syringe Dosing Unit A dosing measurement based on the syringe unit.(NCI) Syringe Dosing Unit tab Tablet Dosing Unit A dosing measurement based on the tablet unit.(NCI) Tablet Dosing Unit Tampon Dosing Unit A dosing measurement based on the tampon unit.(NCI) Tampon Dosing Unit Tablespoon Dosing Unit A dosing measurement based on the tablespoon unit. Tablespoon Dosing Unit 50 Percent Tissue Culture Infective Dose per Dose A potency unit equal to the potency at which one dose of preparation contains one 50 percent tissue culture infective dose.(NCI) 50 Percent Tissue Culture Infective Dose per Dose Tesla A unit of magnetic flux density equal to the magnitude of the magnetic field vector necessary to produce a force of one Newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one Weber per square meter.(NCI) Tesla A dosing unit for the number of therapeutic cells administered. Therapeutic Cells Dosing Unit A dosing unit for the number of therapeutic cells given per meter squared of body surface area. Therapeutic Cells per Square Meter Titr Titre Concentration of a substance in a solution as determined by the quantitative reaction with added measured volume(s) of a solution of the precisely known concentration(s) of a standard reagent. Titer Metric ton A metric unit of mass equal to 1,000 kilograms, or 0.984 long tons and 1.102 short tons. Ton Torr A non-SI manometric unit of pressure equal to 1/760 of a standard atmosphere (a standard atmosphere being defined as equal to 101325 pascals). One Torr is equal to 133.3223684 pascals. Torr Trace Dosing Unit An extremely small amount.(NCI) Trace Dosing Unit A unit of biological activity described as the number of viral particles in solution that are capable of infecting a cell and stimulating expression of a transgene. Transducing Unit Unit of measure of potency expressed as a number of transducing units per one milliliter of solution. Transducing Unit per Milliliter Troche Dosing Unit A dosing measurement based on the troche unit.(NCI) Troche Dosing Unit Teaspoon Equivalent tsp-eq A unit of relative amount of a substance equal to one teaspoon. Teaspoon Equivalent Teaspoon Dosing Unit A dosing measurement based on the teaspoon unit. Teaspoon Dosing Unit Tube Dosing Unit A dosing measurement based on the tube unit.(NCI) Tube Dosing Unit Tuberculin Unit An arbitrary unit of tuberculin dosage defined by comparison of clinical response with a preparation of the purified protein derivative standardized for use in humans for tuberculin skin test reaction.(NCI) Tuberculin Unit Tuberculin Unit per 100 Microliters A unit of biologic activity of tuberculin expressed as a number of arbitrary units of tuberculin in 0.1mL, or 100uL, of preparation. Tuberculin Unit per 100 Microliters Tuberculin Unit per Milliliter A unit of biologic activity of tuberculin expressed as a number of arbitrary units of tuberculin in one milliliter of preparation.(NCI) Tuberculin Unit per Milliliter Unit A single undivided thing occurring in the composition of something else; a unit representing equivalence with a reference measurement. Unit CARR U Carratelli Unit An arbitrary unit of substance concentration expressed in milligrams per a volume of hydrogen peroxide. One Carratelli unit is equal to 0.8mg substance per liter of hydrogen peroxide. Carratelli Unit A unit of substance content expressed in units of biological activity per 10^12 red blood cells. Unit per Trillion Red Blood Cells Unit per Animal A dosing unit expressed in unit(s) per animal. Unit per Animal Unit per Centiliter A unit of substance content expressed in unit(s) per centiliter. Unit Per Centiliter Unit per Deciliter A unit of substance content expressed in unit(s) per deciliter. Unit Per Deciliter A unit of concentration (biologic activity) equal to one unit of substance per gram of hemoglobin. Unit Per Gram Hemoglobin Unit per Gram A unit of substance content expressed in unit(s) per gram. Unit per Gram Unit per Gram per Day A unit of substance rate expressed in unit(s) per gram per period of time equal to twenty-four hours. Unit per Gram per Day Unit per Gram per Hour A unit of substance rate expressed in unit(s) per gram per period of time equal to sixty minutes. Unit per Gram per Hour Unit per Gram per Minute A unit of substance rate expressed in unit(s) per gram per period of time equal to sixty seconds. Unit per Gram per Minute Unit per Hour Unit/h A unit of measure equal to unit(s) per period of time equal to sixty minutes. Unit per Hour Unit per Kilogram A unit of substance content expressed in units of biological activity per unit of mass equal to one kilogram. Unit per kilogram is also used as a dose calculation unit expressed in arbitrary units per one kilogram of body mass. Unit per Kilogram Unit per Kilogram per Day A unit of substance rate expressed in unit(s) per kilogram per period of time equal to twenty-four hours. Unit per Kilogram per Day Unit per Kilogram per Hour A unit of substance rate expressed in unit(s) per kilogram per period of time equal to sixty minutes. Unit per Kilogram per Hour Unit per Kilogram per Minute A unit of substance rate expressed in unit(s) per kilogram per period of time equal to sixty seconds. Unit per Kilogram per Minute mU/mL Unit per Liter A unit of substance concentration equal to the concentration at which one liter of mixture contains one unit of a substance. Unit per Liter Unit per Square Meter A unit expressed as a number of arbitrary units of substance per one square meter of a body surface area. Unit per Square Meter Unit per Square Meter per Day A unit of substance rate expressed in unit(s) per square meter per period of time equal to twenty-four hours. Unit per Square Meter per Day Unit per Square Meter per Hour A unit of substance rate expressed in unit(s) per square meter per period of time equal to sixty minutes. Unit per Square Meter per Hour Unit per Square Meter per Minute A unit of substance rate expressed in unit(s) per square meter per period of time equal to sixty seconds. Unit per Square Meter per Minute Unit per Milligram A unit of substance content expressed in unit(s) per milligram. Unit per Milligram kU/L Unit per Milliliter A unit of substance content expressed in unit(s) per milliliter. Unit per Milliliter Unit per Millimole A unit of substance concentration equal to the concentration at which one millimole of a mixture contains one unit of a substance. Unit per Millimole mcCi Microcurie A unit of radioactivity equal to one millionth of a Curie or 37 kilobecquerels, and corresponding to a radioactivity of 37 000 atomic disintegrations per second.(NCI) Microcurie mcCi/kg Microcurie per Kilogram A unit of specific radioactivity (massic activity) equal to activity of one microcurie of the sample with total mass of one kilogram.(NCI) Microcurie per Kilogram mcCi/L Microcurie per Liter A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one millionth of a Curie per unit volume equal to one liter.(NCI) Microcurie per Liter Microequivalent A unit of relative amount of a substance equal to one millionth of an equivalent weight.(NCI) Microequivalent Microequivalent per Liter Nanoequivalent per Milliliter nEq/mL A concentration unit measured as a number of microequivalents of solute per liter of solution. Microequivalent per Liter mcg Microgram A unit of mass equal to one millionth (1E-6) of a gram. Microgram Microgram per Animal A unit of measure expressed in microgram(s) per animal. Microgram per Animal A unit of mass equal to one microgram per cigarette unit. Microgram per Cigarette mcg/cm2 A unit of area density defined as a spread rate at which one microgram of a substance is spread over the area of one square centimeter. The unit is also used as a dose calculation unit. Microgram per Square Centimeter mcg/day A unit of mass flow rate equal to one microgram per day. Microgram per Day Microgram per Deciliter A unit of mass concentration defined as the concentration of one microgram of a substance per unit volume of the mixture equal to one deciliter. The concept also refers to the unit of mass density (volumic mass) defined as the density of substance which mass equal to one microgram occupies the volume one deciliter. (NCI) Microgram per Deciliter A unit of measure expressed in microgram(s) per dose. Microgram per Dose Microgram per Gram per Day A dose calculation unit expressed in microgram(s) per gram per period of time equal to twenty-four hours. (NCI) Microgram per Gram per Day Microgram per Gram per Hour A dose calculation unit expressed in microgram(s) per gram per period of time equal to sixty minutes. (NCI) Microgram per Gram per Hour Microgram per Gram per Minute A dose calculation unit expressed in microgram(s) per gram per period of time equal to sixty seconds. (NCI) Microgram per Gram per Minute mcg/h A unit of mass flow rate equal to one microgram per hour. Microgram per Hour mcg/kg Microgram per Kilogram ng/g pg/mg ug/kg A unit of a mass fraction expressed as a number of micrograms of substance per kilogram of mixture. The unit is also used as a dose calculation unit.(NCI) Microgram per Kilogram Microgram per Kilogram per Day A dose calculation unit expressed in microgram(s) per kilogram per period of time equal to twenty-four hours. (NCI) Microgram per Kilogram per Day Microgram per Kilogram per Hour A dose calculation unit expressed in microgram(s) per kilogram per period of time equal to sixty minutes. (NCI) Microgram per Kilogram per Hour Gamma per Kilogram per Minute gamma/kg/min mcg/kg/min Microgram per Kilogram per Minute A dose calculation unit equal to one millionth of a gram of a preparation per one kilogram of body mass administered per unit of time equal to one minute.(NCI) Microgram per Kilogram per Minute Microgram per Kilogram per Week A dose calculation unit expressed in microgram(s) per kilogram per period of time equal to seven days. Microgram per Kilogram per Week A unit of equivalent concentration equal to the number of micrograms of D-dimer per unit volume equal to one liter. (NCI) Micrograms DDU Per Liter FEU ug/L ng/mL FEU ug FEU/L ug-L-FEU A unit of equivalent concentration equal to the number of micrograms of fibrinogen per unit volume equal to one liter. Microgram per Liter Fibrinogen Equivalent Units mcg/L mg/m3 Microgram per Liter Milligram per Cubic Meter Nanogram per Milliliter ng/mL ug/L A unit of concentration or mass density equal to one nanogram of substance per milliliter of solution or one microgram of substance per liter of solution. Microgram per Liter ng/mL/h A rate unit equal to the number of micrograms per unit of volume equal to one liter per unit of time equal to one hour. Microgram per Liter per Hour Microgram per Square Meter A dose calculation unit expressed in microgram(s) per square meter. Microgram per Square Meter Microgram per Square Meter per Day A dose calculation unit expressed in microgram(s) per square meter per period of time equal to twenty-four hours. (NCI) Microgram per Square Meter per Day Microgram per Square Meter per Hour A dose calculation unit expressed in microgram(s) per square meter per period of time equal to sixty minutes. (NCI) Microgram per Square Meter per Hour Microgram per Square Meter per Minute A dose calculation unit expressed in microgram(s) per square meter per period of time equal to sixty seconds. (NCI) Microgram per Square Meter per Minute mcg/min A unit of mass flow rate equal to one microgram per minute. Microgram per Minute Microgram per Milliliter per Hour A dose calculation unit expressed in microgram(s) per milliliter of solution per period of time equal to sixty minutes. (NCI) Microgram per Milliliter per Hour ng/mmol pg/umol A unit of mass commonly used to express the molar mass of a substance in microgram(s) per mole. Microgram per Mole A unit of mass equal to one microgram per puff unit. Microgram per Puff Microgram Equivalent A unit of relative amount of substance equal to one millionth of a gram of an equivalent weight. Microgram Equivalent mgEq/kg Milligram Equivalents/Kilogram ngEq/mg ugEq/g Microgram equivalents of a substance per gram of matrix or tissue (e.g., radiolabeled dose). Microgram Equivalents Per Gram ngEq/mL ugEq/L A concentration unit measured as the number of microgram equivalents of solute per liter of solution, or as the number of nanogram equivalents of solute per milliliter of solution. Microgram Equivalent per Liter mgEq/L ngEq/uL A concentration unit measured as a number of microgram equivalent of solute per milliliter of solution. Microgram Equivalents Per Milliliter A unit of concentration (biologic activity) equal to one micro-international unit of substance per deciliter of solution. Micro-International Unit per Deciliter A unit of concentration (biologic activity) equal to one micro-international unit of substance per liter of solution. Micro-International Unit per Liter mckat Microkatal A unit of catalytic activity measurement equal to one millionth of katal (1E-6 katal). (NCI) Microkatal mckat/10^12 RBC Unit of catalytic activity concentration defined as activity equal to one millionth of katal per 10^12 erythrocytes. Microkatal per Trillion Erythrocytes Microkatals per Gram Hemoglobin A unit of catalytic activity equal to one millionth of one katal (10E-6 katal) per gram of hemoglobin. Microkatal per Gram Hemoglobin mckat/L Microkatal per Liter Unit of catalytic activity concentration defined as activity equal to one millionth of katal per one liter of the system volume.(NCI) Microkatal per Liter mcL Microliter mm3 A unit of volume accepted for use with the SI and equal to one millionth of a liter (1E-6 liter). (NCI) Microliter A unit of measure expressed in microliter(s) per dose. Microliter per Dose (uL/day)/kg uL/kg/day Microliters per kilogram per day or microliters per day (flow rate), divided by kilograms (weight). Microliter per Kilogram per Day fL/nL nL/mL pL/uL A unit of volume concentration equal to one microliter per unit of volume equal to one liter. Microliter per Liter mcL/mL Microliter per Milliliter mL/L A unit of volume fraction expressed as a number of microliters of the constituent per the volume of the system represented in milliliters.(NCI) Microliter per Milliliter mcm Micron A unit of length in metric system equal to 1E-6 meter, or micrometer. (NCI) Micron A unit of length equal to one micrometer per unit of time equal to one day. Micrometer per Day Micrometers per Second micron/sec um/sec A unit of both speed (scalar) and velocity (vector), defined as the distance of one micrometer travelled per unit time equal to one second. Micrometer per Second MicroSquare Meter A SI unit of area measurement equal to a square whose sides are one micrometer long. (NCI) Square Micrometer mcmol Micromole A unit of amount of substance equal to one millionth (1E-6) of a mole. (NCI) Micromole mcmol/day A unit of substance flow rate equal to one micromole per day. Micromole per 24 Hours A unit of concentration (molarity unit) equal to one micromole of solute per deciliter of solution. (NCI) Micromole per Deciliter A unit of fraction expressed as the ratio of the number of micromoles of substance per unit of time equal to one hour, to the amount of a different substance, in millimoles. Micromole per Hour per Millimole A unit of concentration (molarity unit) equal to one millionth of a mole (1E-6 mole) per kilogram of a substance per period of time equal to sixty seconds. Micromole per Kilogram per Minute nmol/mL A unit of concentration (molarity unit) equal to one micromole of solute per liter of solution. Micromole per Liter nmol/mL/h A concentration unit equal to one micromole of solute in one liter of solution per unit of time equal to one hour. Micromole per Liter per Hour A concentration unit equal to one micromole of solute in one liter of solution per unit of time equal to one minute. Micromole per Liter per Minute Micromoles per Liter per Second umol/(L*s) umol/(s*L) umol/L/sec umol/s/L A concentration unit equal to one micromole of solute in one liter of solution per unit of time equal to one second. (NCI) Micromole Per Liter Per Second Micromole per Milligram per Minute A unit of concentration (molarity unit) equal to one millionth of a mole (1E-6 mole) per milligram of a substance per period of time equal to sixty seconds. (NCI) Micromole per Milligram per Minute mcmol/min A unit of substance flow rate equal to one micromole per minute. Micromole per Minute nmol/mmol A unit of fraction expressed as the ratio of the amount of a substance in solution, in micromoles, to the amount of a different substance in the mixture, in moles. Micromole per Mole Microosmole A unit of osmotic pressure equal to one millionth of an osmole or the osmotic pressure of a 1E-6 molar solution of a substance that does not dissociate. (NCI) Microosmole Microsecond usec A unit of time equal to one millionth of a second. (NCI) Microsecond uS A unit of electrical conductance, admittance, and susceptance equal to one millionth of a Siemens (10E-6 Siemens). (NCI) Microsiemens United States Pharmacopeia Unit An arbitrary unit established and approved by the United States Pharmacopeia. United States Pharmacopeia Unit An arbitrary unit of substance content expressed in microunit(s) per deciliter. Micro-Unit per Deciliter An arbitrary unit of substance content expressed in microunit(s) per liter. Micro-Unit per Liter mcV Microvolt A unit of an electric potential and electromotive force equal to one millionth of a volt.(NCI) Microvolt Microvolt * Seconds uV*sec A SI derived unit of magnetic flux, equal to the flux that produces in a circuit of one turn an electromotive force of one microvolt, when the flux is uniformly reduced to zero within one second. (NCI) Microvolt Second A unit of electromotive force equal to a microvolt squared. Microvolts Squared Volt A unit of electric potential and electromotive force, equal to the difference of electric potential between two points on a conducting wire carrying a constant current of one Ampere when the power dissipated between the points is one watt. This is equivalent to the potential difference across a resistance of one ohm when one Ampere of current flows through it.(NCI) Volt V/s V/sec Volt per Second A SI derived rate unit equal to one volt per unit of time equal to one second. Volt Per Second Vector Genomes/dose Vector Genomic Copies/dose VGC/dose A unit for cloning vector amount expressed as the number of vector genomes per dose. Vector Genomes per Dose Vector Genomes per Kilogram Vector Genomic Copies/kg VGC/kg A unit for the vector amount expressed as the number of vector genomes per kilogram of body weight. Vector Genomes per Kilogram Vector Genomes/mL Vector Genomic Copies/mL VGC/mL A unit for cloning vector concentration expressed as the number of vector genomes per milliliter. Vector Genomes per Milliliter Vial Dosing Unit A dosing measurement based on the vial unit.(NCI) Vial Dosing Unit A type of pixel created from overlying two adjacent real pixels to create an additional virtual image of a pixel that is visible to the human eye. Virtual Pixel Volume Pixel The smallest distinguishable part or element of a three-dimensional space or image. Voxel Viral Particles/dose A unit for virus amount expressed as the number of viral particles per dose. Viral Particles per Dose Viral Particles/mL A unit for virus concentration expressed as the number of viral particles per milliliter. Viral Particles per Milliliter Wafer Dosing Unit A dosing measurement based on the wafer unit.(NCI) Wafer Dosing Unit A unit of power equal to the power which in one second produces or transfers the energy of one joule. The unit is used in measurements of power emitted, transferred or received as radiation, sound waves, heat flow rate, and rate of energy transfer. Equal to 1/746 of horsepower.(NCI) Watt V*s V*sec Volt Second Volt-second Weber A unit of magnetic flux, equal to the flux that produces in a circuit of one turn an electromotive force of one volt, when the flux is uniformly reduced to zero within one second.(NCI) Weber Week Any period of seven consecutive days. (NCI) Week Yard A unit of length equal to 3 feet, or 36 inches, or 0.9144 meter.(NCI) Yard Year The period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period. (NCI) Year UNIT Unit CDISC SDTM Unit of Measure Terminology The unit used to record and describe the result of a test investigating a vital sign. (NCI) Percentage One hundred times the quotient of one quantity divided by another, with the same units of measurement. Percentage Beats per Minute BPM bpm The number of heartbeats measured per minute time. (NCI) Beats per Minute Breaths per Minute The number of breaths (inhalation and exhalation) taken per minute time. (NCI) Breaths per Minute Degree Celsius A unit of temperature of the temperature scale designed so that the freezing point of water is 0 degrees and the boiling point is 100 degrees at standard atmospheric pressure. The current official definition of the Celsius sets 0.01 C to be at the triple point of water and a degree to be 1/273.16 of the difference in temperature between the triple point of water and absolute zero. One degree Celsius represents the same temperature difference as one Kelvin. (NCI) Degree Celsius Centimeter A basic unit of length equal to one hundredth of a meter or approximately 0.393700787 inch. Centimeter Centimeter of Mercury A unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one centimeter rise of mercury in a barometer at the Earth's surface. Centimeters of Mercury Deciliter The unit of volume equal to one tenth of a liter. Accepted for use with the SI. (NCI) Deciliter Degree Fahrenheit The Fahrenheit temperature scale is named after the German physicist Gabriel Fahrenheit (1686-1736), who proposed it in 1724. In this scale, the freezing point of water is 32 degrees Fahrenheit and the boiling point is 212 degrees, placing the boiling and melting points of water 180 degrees apart. In this scale a degree Fahrenheit is 5/9ths of a Kelvin (or of a degree Celsius), and minus 40 degrees Fahrenheit is equal to minus 40 degrees Celsius. (NCI) Degree Fahrenheit Foot A unit of length defined by the U.S. National Bureau of Standards as 30.48 centimeters. It is equal to 0.3048 meter, 12 inches, or to approximately 0.999998 survey foot.(NCI) International Foot Gram A unit of mass equal to one thousandth (1E-3) of a kilogram, the kilogram being the base unit of mass in the International System of Units (SI). Gram Cycle per Second cycle/sec Hertz A unit of frequency equal to one cycle per second.(NCI) Hertz Inch A traditional unit of length equal to 2.54 centimeters. (NCI) Inch Kelvin A basic unit of thermodynamic temperature, one of the seven base units of the International System of Units (Systeme International d'Unites, SI). It is 1/273.16th of the thermodynamic temperature of the triple point of water. This sets the size of the kelvin unit for temperature differences and defines the thermodynamic temperature of an equilibrium mixture of waters ice-liquid-vapor as 273.16 K, where 0 K is the lowest possible temperature ("absolute zero"). Kelvin A unit of energy equal to one kilocalorie per day. (NCI) Kilocalorie per Day Kilogram The base unit of mass in the International System of Units (SI) equal to the mass of the international prototype kilogram, a platinum-iridium cylinder in the custody of the International Bureau of Weights and Measures. Kilogram Kilogram per Square Meter A unit expressed as kilogram of mass per square meter of area.(NCI) Kilogram per Square Meter Liter A unit of volume equal to one thousandth (1E-3) of a cubic meter, the cubic meter being the standard derived unit of volume in the International System of Units (SI). Liter lb lb_av Pound A traditional unit of mass. By international agreement, one avoirdupois pound is equal to exactly 0.453 592 37 kilogram, 16 ounces, or 1.215 28 troy pounds. (NCI) Pound Meter A meter is defined as the length of the path traveled by light in a vacuum during a time interval of 1/299 792 458 of a second and is equal to 1.093 61 yards.(NCI) Meter Square Meter The standard derived unit of area in the International System of Units (SI) equal to the area of a square whose sides are one meter long. Square Meter Metabolic Equivalent of Task A unit of energy expenditure equal to the ratio of metabolic rate during physical activity versus a reference metabolic rate. Metabolic Equivalent of Task Unit Millimeter A unit of measure equal to one thousandth of a meter. (NCI) Millimeter Millimeter of Mercury A unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one millimeter rise of mercury in a barometer at the Earth's surface. (NCI) Millimeter of Mercury Millisecond ms msec A unit of time, which is equal to one thousandth of a second.(NCI) Millisecond Ounce A unit of mass, the avoirdupois ounce is equal to 1/16 pound, or 28.3495 grams, or 0.911 457 troy ounce.(NCI) Ounce Pascal A unit of pressure equivalent to one Newton per square meter or 10 bars or to 1.45x10(E-4) pounds per square inch.(NCI) Pascal The quotient of one quantity divided by another, with the same units of measurement. Ratio sec Second The base unit of time in the International System of Units (SI) equal to the duration of 9,192,631,770 periods of the specified light radiation corresponding to the transition between the two hyperfine levels of the cesium 133 atom in its ground state at 0 K. Second A unit of power equal to the power which in one second produces or transfers the energy of one joule. The unit is used in measurements of power emitted, transferred or received as radiation, sound waves, heat flow rate, and rate of energy transfer. Equal to 1/746 of horsepower.(NCI) Watt VSRESU Units for Vital Signs Results CDISC SDTM Unit for Vital Sign Result Terminology Urgency Perception Scale test code. UPS01-Describe Your Desire to Urinate Urgency Perception Scale - Which of the following would typically describe your experience when you have a desire to urinate. UPS - Describe Your Experience When You Desire to Urinate UPS01TC Urgency Perception Scale Questionnaire Test Code CDISC Questionnaire UPS Test Code Terminology Urgency Perception Scale test name. UPS01-Describe Your Desire to Urinate Urgency Perception Scale - Which of the following would typically describe your experience when you have a desire to urinate. UPS - Describe Your Experience When You Desire to Urinate UPS01TN Urgency Perception Scale Questionnaire Test Name CDISC Questionnaire UPS Test Name Terminology A terminology codelist to describe the test code for examinations of the urinary system. Blood Flow Rate The volume of blood per unit time passing through a specified location, such as a point in a blood vessel or an entire organ. Blood Flow Rate Color A measurement of the color of a biological specimen. Color Assessment Graft Status The condition of the donated organ or tissue. (NCI) Graft Status Hematoma Indicator An indication as to whether hematoma has occurred. Hematoma Indicator Length The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI) Length Proton Density Fat Fraction An estimated measurement of the fat in a targeted tissue through proton density assessments via magnetic resonance imaging. Proton Density Fat Fraction Number of Renal Arteries A measurement of the total number of renal arteries. Number of Renal Arteries Number of Renal Veins A measurement of the total number of renal veins. Number of Renal Veins Surgical Damage Indicator An indication as to whether surgical damage has occurred. Surgical Damage Indicator Urinary System Examination An observation, assessment or examination of the urinary system. Urinary System Examination Urinary Flow Rate Urine Flow Rate The volume of urine voided per unit of time. Urine Flow Rate Urinary Flow Time Urine Flow Time The amount of time over which a urinary voiding event occurs. Urine Flow Time Voided Urine Volume Voided Volume A measurement of the volume of urine excreted during a urinary voiding event. Voided Urine Volume URNSTSCD Urinary System Test Code CDISC SDTM Urinary System Test Code Terminology A terminology codelist to describe the test name for examinations of the urinary system. Blood Flow Rate The volume of blood per unit time passing through a specified location, such as a point in a blood vessel or an entire organ. Blood Flow Rate Color A measurement of the color of a biological specimen. Color Assessment Graft Status The condition of the donated organ or tissue. (NCI) Graft Status Hematoma Indicator An indication as to whether hematoma has occurred. Hematoma Indicator Length The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI) Length Number of Renal Arteries A measurement of the total number of renal arteries. Number of Renal Arteries Number of Renal Veins A measurement of the total number of renal veins. Number of Renal Veins Proton Density Fat Fraction An estimated measurement of the fat in a targeted tissue through proton density assessments via magnetic resonance imaging. Proton Density Fat Fraction Surgical Damage Indicator An indication as to whether surgical damage has occurred. Surgical Damage Indicator Urinary System Examination An observation, assessment or examination of the urinary system. Urinary System Examination Urinary Flow Rate Urine Flow Rate The volume of urine voided per unit of time. Urine Flow Rate Urinary Flow Time Urine Flow Time The amount of time over which a urinary voiding event occurs. Urine Flow Time Voided Urine Volume Voided Volume A measurement of the volume of urine excreted during a urinary voiding event. Voided Urine Volume URNSTS Urinary System Test Name CDISC SDTM Urinary System Test Name Terminology Terminology relevant to the source of information regarding the subject's vaccination status. A mark left (usually on the skin) by the healing of injured tissue. Scar An individual's perspective or subjective interpretation of an event or information. Self-Report The collecting, abstracting, and coding of printed or written information for future reference. Written Documentation VCNEVD Vaccination Evidence Source CDISC SDTM Vaccination Evidence Source Terminology Terminology relevant to the test codes that describe findings about a vaccines event or intervention. AE Improve/Resolve with Dechallenge Ind AE Improve/Resolve with Dechallenge Indicator An indication as to whether an adverse event improves or disappears after stopping a study treatment. Positive Dechallenge Reaction Indicator AE Reappear/Worsen with Rechallenge Ind AE Reappear/Worsen with Rechallenge Indicator An indication as to whether an adverse event reappears or worsens after restarting a study treatment. Positive Rechallenge Indicator Aper Appearance The outward or visible aspect of an entity. Appearance Distribution A description of the arrangement or dissemination of a finding within an area of focus. Distribution Pattern Finding Description Number of Episodes The total number of episodes that have occurred for the condition. Number of Episodes Greatest Circ at Point of Interest Greatest Circumference at Point of Interest Largest Circumference at Point of Interest The circumferential measurement of an entity or object of interest at its widest point. Greatest Circumference at Point of Interest Longest Diameter The longest possible length of a straight line passing through the center of a circular or spheroid object that connects two points on the circumference. Longest Diameter Number of Lesions The number of lesions observed. Number of Lesions Needle Gauge A number representing the outer diameter of a needle. (NCI) Needle Gauge Nearest Joint The anatomical joint in closest proximity to the entity or object of interest. Nearest Joint Occurrence Indicator An indication as to whether something has happened, such as an event or incident. Occurrence Indicator Prevents Daily Activities Indicator An indication as to whether the event or intervention prevents or has prevented the performance of daily activities. Prevents Daily Activities Indicator Pruritus Indicator An indicator as to whether the subject has symptoms of itchiness. Pruritus Indicator Severity/Intensity The degree of something undesirable. Severity Toxicity Grade A standardized categorical classification of the severity of an event or finding. Toxicity Grade VNFATSCD Vaccines Findings About Test Code CDISC SDTM Vaccines Findings About Test Code Terminology Terminology relevant to the test names that describe findings about a vaccines event or intervention. AE Improve/Resolve with Dechallenge Ind AE Improve/Resolve with Dechallenge Indicator An indication as to whether an adverse event improves or disappears after stopping a study treatment. Positive Dechallenge Reaction Indicator AE Reappear/Worsen with Rechallenge Ind AE Reappear/Worsen with Rechallenge Indicator An indication as to whether an adverse event reappears or worsens after restarting a study treatment. Positive Rechallenge Indicator Aper Appearance The outward or visible aspect of an entity. Appearance Distribution A description of the arrangement or dissemination of a finding within an area of focus. Distribution Pattern Finding Description Greatest Circ at Point of Interest Greatest Circumference at Point of Interest Largest Circumference at Point of Interest The circumferential measurement of an entity or object of interest at its widest point. Greatest Circumference at Point of Interest Longest Diameter The longest possible length of a straight line passing through the center of a circular or spheroid object that connects two points on the circumference. Longest Diameter Nearest Joint The anatomical joint in closest proximity to the entity or object of interest. Nearest Joint Needle Gauge A number representing the outer diameter of a needle. (NCI) Needle Gauge Number of Episodes The total number of episodes that have occurred for the condition. Number of Episodes Number of Lesions The number of lesions observed. Number of Lesions Occurrence Indicator An indication as to whether something has happened, such as an event or incident. Occurrence Indicator Prevents Daily Activities Indicator An indication as to whether the event or intervention prevents or has prevented the performance of daily activities. Prevents Daily Activities Indicator Pruritus Indicator An indicator as to whether the subject has symptoms of itchiness. Pruritus Indicator Severity/Intensity The degree of something undesirable. Severity Toxicity Grade A standardized categorical classification of the severity of an event or finding. Toxicity Grade VNFATS Vaccines Findings About Test Name CDISC SDTM Vaccines Findings About Test Name Terminology Veterans Administration Lung Study Group test code. VALG01-Cancer Stage Veterans Administration Lung Study Group - Cancer stage. VALG - Cancer Stage VALG01TC Veterans Administration Lung Study Group Clinical Classification Test Code CDISC Clinical Classification VALG Test Code Terminology Veterans Administration Lung Study Group test name. VALG01-Cancer Stage Veterans Administration Lung Study Group - Cancer stage. VALG - Cancer Stage VALG01TN Veterans Administration Lung Study Group Clinical Classification Test Name CDISC Clinical Classification VALG Test Name Terminology Vignos Lower Extremity Rating Scale test code. VLERS1-Vignos Lower Extremity Rating Vignos Lower Extremity Rating Scale - Vignos rating scale. VLERS - Vignos Lower Extremity Rating VLERS1TC Vignos Lower Extremity Rating Scale Clinical Classification Test Code CDISC Clinical Classification VLERS Test Code Terminology Vignos Lower Extremity Rating Scale test name. VLERS1-Vignos Lower Extremity Rating Vignos Lower Extremity Rating Scale - Vignos rating scale. VLERS - Vignos Lower Extremity Rating VLERS1TN Vignos Lower Extremity Rating Scale Clinical Classification Test Name CDISC Clinical Classification VLERS Test Name Terminology The test code given to the test that analyzes a particular set of vital signs including temperature, respiratory rate, heart rate, and blood pressure. Ankle-Brachial Index The ratio of ankle systolic pressure to brachial systolic pressure, used to assess arterial insufficiency in the lower extremities. Ankle-Brachial Index Abdominal Skinfold Thickness A measurement for determining the subcutaneous fat layer thickness whereby a pinch of skin approximately five centimeters to the right of the umbilicus is measured using calipers. (NCI) Abdominal Skinfold Thickness Arm Span Armspan Reach Wingspan A measurement of the length from the tip of the middle finger on one hand to the tip of the middle finger on the other hand with the individual standing against the wall with both arms abducted to 90 degrees, the elbows and wrists extended, and the palms facing directly forward. (Philip H. Quanjer, Andre Capderou, Mumtaz M. Mazicioglu, Ashutosh N. Aggarwal, Sudip Datta Banik, Stevo Popovic, Francis A.K. Tayie, Mohammad Golshan, Mary S.M. Ip, Marc Zelter. European Respiratory Journal 2014 44: 905-912) Arm Span Body Cell Mass An estimated measurement of the total mass of metabolically active cells in the body. Body Cell Mass Measurement Body Length-for-Age Percentile An assessed relationship of an individual's body length and age to that of a reference population, expressed as a percentile. Body Length-for-Age Percentile Body Mass Index A general indicator of the body fat an individual is carrying based upon the ratio of weight to height. (NCI) Body Mass Index BMI-for-Age Percentile An assessed relationship of an individual's body mass index and age to that of a reference population, expressed as a percentile. BMI-for-Age Percentile Basal Metabolic Rate The measurement of a subject's energy expenditure when at rest. Basal Metabolic Rate Body Length The linear extent in space from one end of the body to the other end, or the extent of the body from beginning to end. Total Body Length Body Fat Measurement A measurement of the total fat mass within the subject's body. (NCI) Body Fat Measurement Birth Weight A measurement of the weight of a neonate at birth. Birth Weight Body Surface Area A measure of the 2-dimensional extent of the body surface (i.e., the skin). Body surface area (BSA) can be calculated by mathematical formula or from a chart that relates height to weight. BSA is often an important factor in dosing. (NCI) Body Surface Area Calf Circumference A circumferential measurement of the lower leg in the region of the calf at the widest point. Calf Circumference Chest Circumference The distance around an individual's chest. Chest Circumference Capillary Refill Time The amount of time it takes for a capillary bed to refill with blood after pressure blanching. Capillary Refill Test Crown-to-Heel Length A measurement of the length of the body from the crown of the head to the bottom of the heel. Crown to Heel Length Diastolic Blood Pressure-for-Age Percentile Diastolic BP-for-Age Percentile An assessed relationship of an individual's diastolic blood pressure and age to that of a reference population, expressed as a percentile. Diastolic Blood Pressure-for-Age Percentile Diastolic Blood Pressure-for-Height Percentile Diastolic BP-for-Height Percentile An assessed relationship of an individual's diastolic blood pressure and height to that of a reference population, expressed as a percentile. Diastolic Blood Pressure-for-Height Percentile Diastolic Blood Pressure The minimum blood pressure in the systemic arterial circulation during the cardiac cycle. Diastolic Blood Pressure Extracellular Body Water Extracellular Water A measurement of the quantity of water in the extracellular compartments within the body. Extracellular Water Measurement ECW/TBW Extracellular Water/Total Body Water A relative measurement (ratio or percentage) of the quantity of water in extracellular compartments to the total quantity of water within the body. Extracellular Water to Total Body Water Ratio Measurement Energy Expenditure A measurement of the amount of energy used to carry out a physiological or physical function. Energy Expenditure Estimated Body Weight Estimated Weight An approximate determination of the body weight of the subject. Estimated Body Weight Forearm Circumference The distance around an individual's forearm. Forearm Circumference Fraction of Inspired Oxygen A measurement of the volumetric fraction of oxygen in the inhaled gas. Fraction of Inspired Oxygen Body Frame Size The categorization of a person's body frame into small, medium and large based on the measurement of wrist circumference or the breadth of the elbow. (NCI) Body Frame Size Fetal Estimated Weight An approximate determination of the weight of the fetus. Fetal Estimated Weight Fetal Head Circumference A circumferential measurement of the fetal head at the widest point. Fetal Head Circumference Fetal Heart Rate Fetal HR The number of fetal heartbeats per unit of time. Fetal Heart Rate Fetal Mandibular Length A measurement of the length of the fetal mandible. Fetal Mandibular Length Fetal SAD Fetal Sagittal Abdominal Diameter A measurement of the sagittal abdominal diameter of the fetus. Fetal Sagittal Abdominal Diameter Fetal Size-for-Gestational Age Category An assessed relationship of the fetal size and gestational age to that of a reference population, expressed as a category. Fetal Size-for-Gestational Age Category Fetal Weight-for-Gest Age Percentile Fetal Weight-for-Gestational Age Percentile An assessed relationship of the fetal weight and gestational age to that of a reference population, expressed as a percentile. Fetal Weight-for-Gestational Age Percentile Head Circumference-for-Age Percentile Head Occipital-Frontal Circumference-for-Age Percentile An assessed relationship of an individual's head circumference and age to that of a reference population, expressed as a percentile. Head Circumference-for-Age Percentile Head Circumference A circumferential measurement of the head at the widest point. Head Circumference Height The vertical measurement or distance from the base to the top of an object; the vertical dimension of extension. (NCI) Height Hip Circumference The distance around an individual's pelvic area or hips. Hip Circumference Heart Rate The number of heartbeats per unit of time, usually expressed as beats per minute. (NCI) Heart Rate Heart Rate Variability, Average Standard Deviation NN Interval Heart Rate Variability, SDANN A measurement of the fluctuation in the time intervals between adjacent heartbeats, based on the average standard deviation of the means of consecutive 5 minute NN intervals over a period of time. Heart Rate Variability, Average Standard Deviation NN Interval Measurement Heart Rate Variability, SDNN Heart Rate Variability, Standard Deviation NN Interval A measurement of the fluctuation in the time intervals between adjacent heartbeats, based on the standard deviation of the NN interval. Heart Rate Variability, Standard Deviation NN Interval Measurement Height-for-Age Percentile An assessed relationship of an individual's height and age to that of a reference population, expressed as a percentile. Height-for-Age Percentile Ideal Body Weight A person's optimum weight as calculated by a standard methodology. Ideal Body Weight Interpretation An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. Interpretation Knee to Heel Length A measurement of the length of the lower leg from the top of the knee to the bottom of the heel. This measurement may be taken with a knemometer or calipers. (NCI) Knee to Heel Length Measurement Lean Body Mass The weight of all organs and tissue in an individual less the weight of the individual's body fat. Lean Body Mass Lean Body Mass/Total Body Mass The relative measurement (percentage) of the individual's lean body weight to total body weight. Lean Body Mass to Total Body Mass Ratio Measurement Lean Tissue Mass The weight of a tissue part or whole tissue in an individual less the weight of the individual's body fat within that tissue part or whole tissue. Lean Tissue Mass Measurement Mandibular Length A measurement of the length of the mandible. Mandibular Length Mean Arterial Pressure The mean pressure of the blood within the arterial circulation. Mean Arterial Pressure Maximum Predicted Heart Rate The predicted upper limit for an individual's heart rate, which is calculated as 220 minus the subject's age for men, and 210 minus the subject's age for women. Maximum Predicted Heart Rate Mid-Upper Arm Circumference The distance around an individual's upper arm, at the widest point. Mid-Upper Arm Circumference Neck Circumference A circumferential measurement of the neck, just below the larynx. Neck Circumference Oxygen Saturation A measurement of the oxygen-hemoglobin saturation of a volume of blood. Oxygen Saturation Measurement Pulse Rate The rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomical sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot. (NCI) Pulse Rate Pulse Pressure The change in systolic to diastolic pressure which produces a pulse. Pulse Pressure Respiratory Rate The rate of breathing (inhalation and exhalation) measured within in a unit time, usually expressed as breaths per minute. (NCI) Respiratory Rate Sagittal Abdominal Diameter A standard measure of visceral obesity, or abdominal fat, which is measured from the patient's back to upper abdomen between the bottom of the rib cage and the top of the pelvic area. This measurement may be taken with the patient standing or in the supine position. (NCI) Sagittal Abdominal Diameter Oxygen Saturation/Fraction Inspired O2 A relative measurement (ratio or percentage) of the oxygen-hemoglobin saturation of a volume of blood to the volumetric fraction of oxygen in the inhaled gas. Oxygen Saturation/Fraction Inspired O2 Systolic Blood Pressure-for-Age Percentile Systolic BP-for-Age Percentile An assessed relationship of an individual's systolic blood pressure and age to that of a reference population, expressed as a percentile. Systolic Blood Pressure-for-Age Percentile Systolic Blood Pressure-for-Height Percentile Systolic BP-for-Height Percentile An assessed relationship of an individual's systolic blood pressure and height to that of a reference population, expressed as a percentile. Systolic Blood Pressure-for-Height Percentile Subscapular Skinfold Thickness A measurement of the thickness of a pinch of skin situated below or on the underside of the scapula. (NCI) Subscapular Skinfold Thickness Systolic Blood Pressure The maximum blood pressure in the systemic arterial circulation during the cardiac cycle. Systolic Blood Pressure Total Body Water A measurement of the quantity of water within the body, including both the intracellular and extracellular compartments. Total Body Water Measurement Total Body Water/Total Body Mass A relative measurement (ratio or percentage) of an individual's total body water weight to total body weight. Total Body Water to Total Body Mass Ratio Measurement Body Temperature Temperature A measurement of the temperature of the body. Body Temperature Core Body Temperature A measurement of the temperature within the deep tissues of the body. Core Body Temperature Peripheral Body Temperature A measurement of the temperature of the body at or near its surface. Peripheral Body Temperature Tibial Length A measurement of the length of the tibia. Tibial Length Triceps Skinfold Thickness A measurement of the thickness of a pinch of skin on the triceps. (NCI) Triceps Skinfold Thickness Ulnar Length A measurement of the length of the ulna. Ulnar Length Waist to Hip Ratio A relative measurement (ratio) of the waist circumference to the hip circumference. Waist-Hip Ratio Waist to Heel Length A measurement from the top of the waist to the bottom of the heel. Waist to Heel Length Weight The vertical force exerted by a mass as a result of gravity. (NCI) Weight Waist Circumference The distance around an individual's midsection or waist. Waist Circumference Weight-for-Age Percentile An assessed relationship of an individual's weight and age to that of a reference population, expressed as a percentile. Weight-for-Age Percentile Weight-for-Height Percentile An assessed relationship of an individual's weight and height to that of a reference population, expressed as a percentile. Weight-for-Height Percentile VSTESTCD Vital Signs Test Code CDISC SDTM Vital Sign Test Code Terminology The test name given to the test that analyzes a particular set of vital signs including temperature, respiratory rate, heart rate, and blood pressure. Abdominal Skinfold Thickness A measurement for determining the subcutaneous fat layer thickness whereby a pinch of skin approximately five centimeters to the right of the umbilicus is measured using calipers. (NCI) Abdominal Skinfold Thickness Ankle-Brachial Index The ratio of ankle systolic pressure to brachial systolic pressure, used to assess arterial insufficiency in the lower extremities. Ankle-Brachial Index Arm Span Armspan Reach Wingspan A measurement of the length from the tip of the middle finger on one hand to the tip of the middle finger on the other hand with the individual standing against the wall with both arms abducted to 90 degrees, the elbows and wrists extended, and the palms facing directly forward. (Philip H. Quanjer, Andre Capderou, Mumtaz M. Mazicioglu, Ashutosh N. Aggarwal, Sudip Datta Banik, Stevo Popovic, Francis A.K. Tayie, Mohammad Golshan, Mary S.M. Ip, Marc Zelter. European Respiratory Journal 2014 44: 905-912) Arm Span Basal Metabolic Rate The measurement of a subject's energy expenditure when at rest. Basal Metabolic Rate Birth Weight A measurement of the weight of a neonate at birth. Birth Weight BMI-for-Age Percentile An assessed relationship of an individual's body mass index and age to that of a reference population, expressed as a percentile. BMI-for-Age Percentile Body Cell Mass An estimated measurement of the total mass of metabolically active cells in the body. Body Cell Mass Measurement Body Fat Measurement A measurement of the total fat mass within the subject's body. (NCI) Body Fat Measurement Body Frame Size The categorization of a person's body frame into small, medium and large based on the measurement of wrist circumference or the breadth of the elbow. (NCI) Body Frame Size Body Length The linear extent in space from one end of the body to the other end, or the extent of the body from beginning to end. Total Body Length Body Length-for-Age Percentile An assessed relationship of an individual's body length and age to that of a reference population, expressed as a percentile. Body Length-for-Age Percentile Body Mass Index A general indicator of the body fat an individual is carrying based upon the ratio of weight to height. (NCI) Body Mass Index Body Surface Area A measure of the 2-dimensional extent of the body surface (i.e., the skin). Body surface area (BSA) can be calculated by mathematical formula or from a chart that relates height to weight. BSA is often an important factor in dosing. (NCI) Body Surface Area Calf Circumference A circumferential measurement of the lower leg in the region of the calf at the widest point. Calf Circumference Capillary Refill Time The amount of time it takes for a capillary bed to refill with blood after pressure blanching. Capillary Refill Test Chest Circumference The distance around an individual's chest. Chest Circumference Core Body Temperature A measurement of the temperature within the deep tissues of the body. Core Body Temperature Crown-to-Heel Length A measurement of the length of the body from the crown of the head to the bottom of the heel. Crown to Heel Length Diastolic Blood Pressure The minimum blood pressure in the systemic arterial circulation during the cardiac cycle. Diastolic Blood Pressure Diastolic Blood Pressure-for-Age Percentile Diastolic BP-for-Age Percentile An assessed relationship of an individual's diastolic blood pressure and age to that of a reference population, expressed as a percentile. Diastolic Blood Pressure-for-Age Percentile Diastolic Blood Pressure-for-Height Percentile Diastolic BP-for-Height Percentile An assessed relationship of an individual's diastolic blood pressure and height to that of a reference population, expressed as a percentile. Diastolic Blood Pressure-for-Height Percentile Energy Expenditure A measurement of the amount of energy used to carry out a physiological or physical function. Energy Expenditure Estimated Body Weight Estimated Weight An approximate determination of the body weight of the subject. Estimated Body Weight Extracellular Body Water Extracellular Water A measurement of the quantity of water in the extracellular compartments within the body. Extracellular Water Measurement ECW/TBW Extracellular Water/Total Body Water A relative measurement (ratio or percentage) of the quantity of water in extracellular compartments to the total quantity of water within the body. Extracellular Water to Total Body Water Ratio Measurement Fetal Estimated Weight An approximate determination of the weight of the fetus. Fetal Estimated Weight Fetal Head Circumference A circumferential measurement of the fetal head at the widest point. Fetal Head Circumference Fetal Heart Rate Fetal HR The number of fetal heartbeats per unit of time. Fetal Heart Rate Fetal Mandibular Length A measurement of the length of the fetal mandible. Fetal Mandibular Length Fetal SAD Fetal Sagittal Abdominal Diameter A measurement of the sagittal abdominal diameter of the fetus. Fetal Sagittal Abdominal Diameter Fetal Size-for-Gestational Age Category An assessed relationship of the fetal size and gestational age to that of a reference population, expressed as a category. Fetal Size-for-Gestational Age Category Fetal Weight-for-Gest Age Percentile Fetal Weight-for-Gestational Age Percentile An assessed relationship of the fetal weight and gestational age to that of a reference population, expressed as a percentile. Fetal Weight-for-Gestational Age Percentile Forearm Circumference The distance around an individual's forearm. Forearm Circumference Fraction of Inspired Oxygen A measurement of the volumetric fraction of oxygen in the inhaled gas. Fraction of Inspired Oxygen Head Circumference A circumferential measurement of the head at the widest point. Head Circumference Head Circumference-for-Age Percentile Head Occipital-Frontal Circumference-for-Age Percentile An assessed relationship of an individual's head circumference and age to that of a reference population, expressed as a percentile. Head Circumference-for-Age Percentile Heart Rate Variability, Average Standard Deviation NN Interval Heart Rate Variability, SDANN A measurement of the fluctuation in the time intervals between adjacent heartbeats, based on the average standard deviation of the means of consecutive 5 minute NN intervals over a period of time. Heart Rate Variability, Average Standard Deviation NN Interval Measurement Heart Rate Variability, SDNN Heart Rate Variability, Standard Deviation NN Interval A measurement of the fluctuation in the time intervals between adjacent heartbeats, based on the standard deviation of the NN interval. Heart Rate Variability, Standard Deviation NN Interval Measurement Heart Rate The number of heartbeats per unit of time, usually expressed as beats per minute. (NCI) Heart Rate Height The vertical measurement or distance from the base to the top of an object; the vertical dimension of extension. (NCI) Height Height-for-Age Percentile An assessed relationship of an individual's height and age to that of a reference population, expressed as a percentile. Height-for-Age Percentile Hip Circumference The distance around an individual's pelvic area or hips. Hip Circumference Ideal Body Weight A person's optimum weight as calculated by a standard methodology. Ideal Body Weight Interpretation An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. Interpretation Knee to Heel Length A measurement of the length of the lower leg from the top of the knee to the bottom of the heel. This measurement may be taken with a knemometer or calipers. (NCI) Knee to Heel Length Measurement Lean Body Mass The weight of all organs and tissue in an individual less the weight of the individual's body fat. Lean Body Mass Lean Body Mass/Total Body Mass The relative measurement (percentage) of the individual's lean body weight to total body weight. Lean Body Mass to Total Body Mass Ratio Measurement Lean Tissue Mass The weight of a tissue part or whole tissue in an individual less the weight of the individual's body fat within that tissue part or whole tissue. Lean Tissue Mass Measurement Mandibular Length A measurement of the length of the mandible. Mandibular Length Maximum Predicted Heart Rate The predicted upper limit for an individual's heart rate, which is calculated as 220 minus the subject's age for men, and 210 minus the subject's age for women. Maximum Predicted Heart Rate Mean Arterial Pressure The mean pressure of the blood within the arterial circulation. Mean Arterial Pressure Mid-Upper Arm Circumference The distance around an individual's upper arm, at the widest point. Mid-Upper Arm Circumference Neck Circumference A circumferential measurement of the neck, just below the larynx. Neck Circumference Oxygen Saturation A measurement of the oxygen-hemoglobin saturation of a volume of blood. Oxygen Saturation Measurement Oxygen Saturation/Fraction Inspired O2 A relative measurement (ratio or percentage) of the oxygen-hemoglobin saturation of a volume of blood to the volumetric fraction of oxygen in the inhaled gas. Oxygen Saturation/Fraction Inspired O2 Peripheral Body Temperature A measurement of the temperature of the body at or near its surface. Peripheral Body Temperature Pulse Pressure The change in systolic to diastolic pressure which produces a pulse. Pulse Pressure Pulse Rate The rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomical sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot. (NCI) Pulse Rate Respiratory Rate The rate of breathing (inhalation and exhalation) measured within in a unit time, usually expressed as breaths per minute. (NCI) Respiratory Rate Sagittal Abdominal Diameter A standard measure of visceral obesity, or abdominal fat, which is measured from the patient's back to upper abdomen between the bottom of the rib cage and the top of the pelvic area. This measurement may be taken with the patient standing or in the supine position. (NCI) Sagittal Abdominal Diameter Subscapular Skinfold Thickness A measurement of the thickness of a pinch of skin situated below or on the underside of the scapula. (NCI) Subscapular Skinfold Thickness Systolic Blood Pressure The maximum blood pressure in the systemic arterial circulation during the cardiac cycle. Systolic Blood Pressure Systolic Blood Pressure-for-Age Percentile Systolic BP-for-Age Percentile An assessed relationship of an individual's systolic blood pressure and age to that of a reference population, expressed as a percentile. Systolic Blood Pressure-for-Age Percentile Systolic Blood Pressure-for-Height Percentile Systolic BP-for-Height Percentile An assessed relationship of an individual's systolic blood pressure and height to that of a reference population, expressed as a percentile. Systolic Blood Pressure-for-Height Percentile Body Temperature Temperature A measurement of the temperature of the body. Body Temperature Tibial Length A measurement of the length of the tibia. Tibial Length Total Body Water A measurement of the quantity of water within the body, including both the intracellular and extracellular compartments. Total Body Water Measurement Total Body Water/Total Body Mass A relative measurement (ratio or percentage) of an individual's total body water weight to total body weight. Total Body Water to Total Body Mass Ratio Measurement Triceps Skinfold Thickness A measurement of the thickness of a pinch of skin on the triceps. (NCI) Triceps Skinfold Thickness Ulnar Length A measurement of the length of the ulna. Ulnar Length Waist Circumference The distance around an individual's midsection or waist. Waist Circumference Waist to Heel Length A measurement from the top of the waist to the bottom of the heel. Waist to Heel Length Waist to Hip Ratio A relative measurement (ratio) of the waist circumference to the hip circumference. Waist-Hip Ratio Weight The vertical force exerted by a mass as a result of gravity. (NCI) Weight Weight-for-Age Percentile An assessed relationship of an individual's weight and age to that of a reference population, expressed as a percentile. Weight-for-Age Percentile Weight-for-Height Percentile An assessed relationship of an individual's weight and height to that of a reference population, expressed as a percentile. Weight-for-Height Percentile VSTEST Vital Signs Test Name CDISC SDTM Vital Sign Test Name Terminology Voice Handicap Index test code. VHI01-Voice Makes Difficult to Hear Me Voice Handicap Index - My voice makes it difficult for people to hear me. VHI - Voice Makes Difficult to Hear Me VHI01-People Difficulty Understanding Me Voice Handicap Index - People have difficulty understanding me in a noisy room. VHI - People Difficulty Understanding Me VHI01-Family Has Difficulty Hearing Me Voice Handicap Index - My family has difficulty hearing me when I call them throughout the house. VHI - Family Has Difficulty Hearing Me VHI01-Use Phone Less Often Voice Handicap Index - I use the phone less often than I would like to. VHI - Use Phone Less Often VHI01-Avoid People Because of My Voice Voice Handicap Index - I tend to avoid groups of people because of my voice. VHI - Avoid People Because of My Voice VHI01-Speak Friends Less Often B/c Voice Voice Handicap Index - I speak with friends, neighbors, or relatives less often because of my voice. VHI - Speak Friends Less Often Because Voice VHI01-Repeat Myself Speak Face-to-Face Voice Handicap Index - People ask me to repeat myself when speaking face-to-face. VHI - Repeat Myself Speak Face-to-Face VHI01-Voice Difficulties Restrict Life Voice Handicap Index - My voice difficulties restrict my personal and social life. VHI - Voice Difficulties Restrict Life VHI01-Left Out of Conversation B/c Voice Voice Handicap Index - I feel left out of conversations because of my voice. VHI - Left Out of Conversation Because Voice VHI01-Voice Problem Causes Lose Income Voice Handicap Index - My voice problem causes me to lose income. VHI - Voice Problem Causes Lose Income VHI01-I Run Out of Air When I Talk Voice Handicap Index - I run out of air when I talk. VHI - I Run Out of Air When I Talk VHI01-Sound Voice Varies Throughout Day Voice Handicap Index - The sound of my voice varies throughout the day. VHI - Sound Voice Varies Throughout Day VHI01-People Ask What's Wrong w/ Voice Voice Handicap Index - People ask, "What's wrong with your voice?" VHI - People Ask What's Wrong With Voice VHI01-My Voice Sounds Creaky and Dry Voice Handicap Index - My voice sounds creaky and dry. VHI - My Voice Sounds Creaky and Dry VHI01-Have to Strain to Produce Voice Voice Handicap Index - I feel as though I have to strain to produce voice. VHI - Have to Strain to Produce Voice VHI01-Clarity of Voice is Unpredictable Voice Handicap Index - The clarity of my voice is unpredictable. VHI - Clarity of Voice is Unpredictable VHI01-Change Voice to Sound Different Voice Handicap Index - I try to change my voice to sound different. VHI - Change Voice to Sound Different VHI01-Use Great Deal of Effort to Speak Voice Handicap Index - I use a great deal of effort to speak. VHI - Use Great Deal of Effort to Speak VHI01-My Voice is Worse in the Evening Voice Handicap Index - My voice is worse in the evening. VHI - My Voice is Worse in the Evening VHI01-Voice Gives Out on Me Speaking Voice Handicap Index - My voice "gives out" on me in the middle of speaking. VHI - Voice Gives Out on Me Speaking VHI01-Tense Talking to Others B/c Voice Voice Handicap Index - I am tense when talking to others because of my voice. VHI - Tense Talking to Others Because Voice VHI01-People Seem Irritated w/ My Voice Voice Handicap Index - People seem irritated with my voice. VHI - People Seem Irritated With My Voice VHI01-People Don't Understand Voice Prob Voice Handicap Index - I find other people don't understand my voice problem. VHI - People Don't Understand Voice Problem VHI01-My Voice Problem Upsets Me Voice Handicap Index - My voice problem upsets me. VHI - My Voice Problem Upsets Me VHI01-Less Outgoing B/c of Voice Problem Voice Handicap Index - I am less outgoing because of my voice problem. VHI - Less Outgoing Because of Voice Problem VHI01-Voice Makes Me Feel Handicapped Voice Handicap Index - My voice makes me feels handicapped. VHI - Voice Makes Me Feel Handicapped VHI01-Feel Annoyed People Ask Me Repeat Voice Handicap Index - I feel annoyed when people ask me to repeat. VHI - Feel Annoyed People Ask Me Repeat VHI01-Embarrassed People Ask Me Repeat Voice Handicap Index - I feel embarrassed when people ask me to repeat. VHI - Embarrassed People Ask Me Repeat VHI01-Voice Makes Me Feel Incompetent Voice Handicap Index - My voice makes me feel incompetent. VHI - Voice Makes Me Feel Incompetent VHI01-I Am Ashamed of My Voice Problem Voice Handicap Index - I am ashamed of my voice problem. VHI - I Am Ashamed of My Voice Problem VHI01-Part I-F Subtotal Voice Handicap Index - Part I-F subtotal. VHI - Part I-F Subtotal VHI01-Part II-P Subtotal Voice Handicap Index - Part II-P subtotal. VHI - Part II-P Subtotal VHI01-Part III-E Subtotal Voice Handicap Index - Part III-E subtotal. VHI - Part III-E Subtotal VHI01-Total Score Voice Handicap Index - Total score. VHI - Total Score VHI01TC Voice Handicap Index Questionnaire Test Code CDISC Questionnaire Voice Handicap Index Test Code Terminology Voice Handicap Index test name. VHI01-Avoid People Because of My Voice Voice Handicap Index - I tend to avoid groups of people because of my voice. VHI - Avoid People Because of My Voice VHI01-Change Voice to Sound Different Voice Handicap Index - I try to change my voice to sound different. VHI - Change Voice to Sound Different VHI01-Clarity of Voice is Unpredictable Voice Handicap Index - The clarity of my voice is unpredictable. VHI - Clarity of Voice is Unpredictable VHI01-Embarrassed People Ask Me Repeat Voice Handicap Index - I feel embarrassed when people ask me to repeat. VHI - Embarrassed People Ask Me Repeat VHI01-Family Has Difficulty Hearing Me Voice Handicap Index - My family has difficulty hearing me when I call them throughout the house. VHI - Family Has Difficulty Hearing Me VHI01-Feel Annoyed People Ask Me Repeat Voice Handicap Index - I feel annoyed when people ask me to repeat. VHI - Feel Annoyed People Ask Me Repeat VHI01-Have to Strain to Produce Voice Voice Handicap Index - I feel as though I have to strain to produce voice. VHI - Have to Strain to Produce Voice VHI01-I Am Ashamed of My Voice Problem Voice Handicap Index - I am ashamed of my voice problem. VHI - I Am Ashamed of My Voice Problem VHI01-I Run Out of Air When I Talk Voice Handicap Index - I run out of air when I talk. VHI - I Run Out of Air When I Talk VHI01-Left Out of Conversation B/c Voice Voice Handicap Index - I feel left out of conversations because of my voice. VHI - Left Out of Conversation Because Voice VHI01-Less Outgoing B/c of Voice Problem Voice Handicap Index - I am less outgoing because of my voice problem. VHI - Less Outgoing Because of Voice Problem VHI01-My Voice is Worse in the Evening Voice Handicap Index - My voice is worse in the evening. VHI - My Voice is Worse in the Evening VHI01-My Voice Problem Upsets Me Voice Handicap Index - My voice problem upsets me. VHI - My Voice Problem Upsets Me VHI01-My Voice Sounds Creaky and Dry Voice Handicap Index - My voice sounds creaky and dry. VHI - My Voice Sounds Creaky and Dry VHI01-Part I-F Subtotal Voice Handicap Index - Part I-F subtotal. VHI - Part I-F Subtotal VHI01-Part II-P Subtotal Voice Handicap Index - Part II-P subtotal. VHI - Part II-P Subtotal VHI01-Part III-E Subtotal Voice Handicap Index - Part III-E subtotal. VHI - Part III-E Subtotal VHI01-People Ask What's Wrong w/ Voice Voice Handicap Index - People ask, "What's wrong with your voice?" VHI - People Ask What's Wrong With Voice VHI01-People Difficulty Understanding Me Voice Handicap Index - People have difficulty understanding me in a noisy room. VHI - People Difficulty Understanding Me VHI01-People Don't Understand Voice Prob Voice Handicap Index - I find other people don't understand my voice problem. VHI - People Don't Understand Voice Problem VHI01-People Seem Irritated w/ My Voice Voice Handicap Index - People seem irritated with my voice. VHI - People Seem Irritated With My Voice VHI01-Repeat Myself Speak Face-to-Face Voice Handicap Index - People ask me to repeat myself when speaking face-to-face. VHI - Repeat Myself Speak Face-to-Face VHI01-Sound Voice Varies Throughout Day Voice Handicap Index - The sound of my voice varies throughout the day. VHI - Sound Voice Varies Throughout Day VHI01-Speak Friends Less Often B/c Voice Voice Handicap Index - I speak with friends, neighbors, or relatives less often because of my voice. VHI - Speak Friends Less Often Because Voice VHI01-Tense Talking to Others B/c Voice Voice Handicap Index - I am tense when talking to others because of my voice. VHI - Tense Talking to Others Because Voice VHI01-Total Score Voice Handicap Index - Total score. VHI - Total Score VHI01-Use Great Deal of Effort to Speak Voice Handicap Index - I use a great deal of effort to speak. VHI - Use Great Deal of Effort to Speak VHI01-Use Phone Less Often Voice Handicap Index - I use the phone less often than I would like to. VHI - Use Phone Less Often VHI01-Voice Difficulties Restrict Life Voice Handicap Index - My voice difficulties restrict my personal and social life. VHI - Voice Difficulties Restrict Life VHI01-Voice Gives Out on Me Speaking Voice Handicap Index - My voice "gives out" on me in the middle of speaking. VHI - Voice Gives Out on Me Speaking VHI01-Voice Makes Difficult to Hear Me Voice Handicap Index - My voice makes it difficult for people to hear me. VHI - Voice Makes Difficult to Hear Me VHI01-Voice Makes Me Feel Handicapped Voice Handicap Index - My voice makes me feels handicapped. VHI - Voice Makes Me Feel Handicapped VHI01-Voice Makes Me Feel Incompetent Voice Handicap Index - My voice makes me feel incompetent. VHI - Voice Makes Me Feel Incompetent VHI01-Voice Problem Causes Lose Income Voice Handicap Index - My voice problem causes me to lose income. VHI - Voice Problem Causes Lose Income VHI01TN Voice Handicap Index Questionnaire Test Name CDISC Questionnaire Voice Handicap Index Test Name Terminology A grading system to describe the severity of hepatic encephalopathy based on the level of mental status by the West Haven Hepatic Encephalopathy Grade. Minimal - symptoms or pathological characteristics include minimal hepatic encephalopathy, lack of detectable changes in personality or behavior, minimal changes in memory, concentration and intellectual function, and absence of coordination asterixis. (Adapted from: Hepatic Encephalopathy. David C Wolf. http://emedicine.medscape.com/article/186101-overview) West Haven Hepatic Encephalopathy Grade 0 Mild - symptoms or pathological characteristics include trivial lack of awareness, shortened attention span, impaired ability to perform addition or subtraction, hypersomnia, insomnia, or inversion of sleep pattern, euphoria, depression or irritability, mild confusion, slowing of ability to perform mental tasks. (Adapted from: Hepatic Encephalopathy. David C Wolf. http://emedicine.medscape.com/article/186101-overview.) West Haven Hepatic Encephalopathy Grade 1 Moderate - symptoms or pathological characteristics include lethargy or apathy, disorientation, inappropriate behavior, slurred speech, obvious asterixis, drowsiness, lethargy, gross deficits in ability to perform mental tasks, obvious personality changes, inappropriate behavior, and intermittent disorientation, unsurely regarding time. (Adapted from: Hepatic Encephalopathy. David C Wolf. http://emedicine.medscape.com/article/186101-overview.) West Haven Hepatic Encephalopathy Grade 2 Severe - symptoms or pathological characteristics include somnolence with some arousability, inability to perform mental tasks, disorientation about time and place, marked confusion, amnesia, occasional fits of rage, present but incomprehensible speech. (Adapted from: Hepatic Encephalopathy. David C Wolf. http://emedicine.medscape.com/article/186101-overview.) West Haven Hepatic Encephalopathy Grade 3 Coma - symptoms or pathological characteristics include coma with or without response to painful stimuli. (Adapted from: Hepatic Encephalopathy. David C Wolf. http://emedicine.medscape.com/article/186101-overview.) West Haven Hepatic Encephalopathy Grade 4 HEPENCGR West Haven Hepatic Encephalopathy Grade CDISC SDTM West Haven Hepatic Encephalopathy Grade Terminology West Haven Hepatic Encephalopathy Grade test code. WHEG01-WH Hepatic Encephalopathy Grade West Haven Hepatic Encephalopathy Grade - Grade. West Haven Criteria - West Haven Hepatic Encephalopathy Grade WHEG01TC West Haven Hepatic Encephalopathy Grade Clinical Classification Test Code CDISC Clinical Classification West Haven Criteria Test Code Terminology West Haven Hepatic Encephalopathy Grade test name. WHEG01-WH Hepatic Encephalopathy Grade West Haven Hepatic Encephalopathy Grade - Grade. West Haven Criteria - West Haven Hepatic Encephalopathy Grade WHEG01TN West Haven Hepatic Encephalopathy Grade Clinical Classification Test Name CDISC Clinical Classification West Haven Criteria Test Name Terminology WHO Clinical Staging of HIV/AIDS for Adults and Adolescents test code. WHIVS1-WHO Clinical Stage of HIV/AIDS WHO Clinical Staging of HIV/AIDS for Adults and Adolescents - WHO clinical stage of HIV/AIDS. WHO Clinical Staging of HIV/AIDS for Adults and Adolescents - WHO Clinical Stage of HIV/AIDS WHIVS1TC WHO Clinical Staging of HIV/AIDS for Adults and Adolescents Clinical Classification Test Code CDISC Clinical Classification WHO Clinical Staging of HIV/AIDS for Adults and Adolescents Test Code Terminology WHO Clinical Staging of HIV/AIDS for Adults and Adolescents test name. WHIVS1-WHO Clinical Stage of HIV/AIDS WHO Clinical Staging of HIV/AIDS for Adults and Adolescents - WHO clinical stage of HIV/AIDS. WHO Clinical Staging of HIV/AIDS for Adults and Adolescents - WHO Clinical Stage of HIV/AIDS WHIVS1TN WHO Clinical Staging of HIV/AIDS for Adults and Adolescents Clinical Classification Test Name CDISC Clinical Classification WHO Clinical Staging of HIV/AIDS for Adults and Adolescents Test Name Terminology WHO Clinical Staging of HIV/AIDS for Children test code. WHIVS2-WHO Clinical Stage of HIV/AIDS WHO Clinical Staging of HIV/AIDS for Children - WHO clinical stage of HIV/AIDS. WHO Clinical Staging of HIV/AIDS for Children - WHO Clinical Stage of HIV/AIDS WHIVS2TC WHO Clinical Staging of HIV/AIDS for Children Clinical Classification Test Code CDISC Clinical Classification WHO Clinical Staging of HIV/AIDS for Children Test Code Terminology WHO Clinical Staging of HIV/AIDS for Children test name. WHIVS2-WHO Clinical Stage of HIV/AIDS WHO Clinical Staging of HIV/AIDS for Children - WHO clinical stage of HIV/AIDS. WHO Clinical Staging of HIV/AIDS for Children - WHO Clinical Stage of HIV/AIDS WHIVS2TN WHO Clinical Staging of HIV/AIDS for Children Clinical Classification Test Name CDISC Clinical Classification WHO Clinical Staging of HIV/AIDS for Children Test Name Terminology Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 test code. WPAI01-Currently Employed Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - Are you currently employed (working for pay)? WPAI:SHP v2.0 - Currently Employed WPAI01-Missed Work Hours Due to Problem Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - During the past seven days, how many hours did you miss from work because of problems associated with your problem? WPAI:SHP v2.0 - Missed Work Hours Due to Problem WPAI01-Missed Work Hours Due to Other Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - During the past seven days, how many hours did you miss from work because of any other reason, such as vacation, holidays, time off to participate in this study? WPAI:SHP v2.0 - Missed Work Hours Due to Other Reasons WPAI01-Hours Actually Worked Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - During the past seven days, how many hours did you actually work? WPAI:SHP v2.0 - Hours Actually Worked WPAI01-Problem Affect Productivity Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - During the past seven days, how much did your problem affect your productivity while you were working? WPAI:SHP v2.0 - Problem Affects Productivity WPAI01-Problem Affect Reg Daily Activity Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - During the past seven days, how much did your problem affect your ability to do your regular daily activities, other than work at a job? WPAI:SHP v2.0 - Problem Affects Regular Daily Activity WPAI01-Absenteeism Score Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - Absenteeism score. WPAI:SHP v2.0 - Absenteeism Score WPAI01-Presenteeism Score Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - Presenteeism score. WPAI:SHP v2.0 - Presenteeism Score WPAI01-Work Productivity Loss Score Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - Work productivity loss score. WPAI:SHP v2.0 - Work Productivity Loss Score WPAI01-Activity Impairment Score Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - Activity impairment score. WPAI:SHP v2.0 - Activity Impairment Score WPAI01TC Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 Questionnaire Test Code CDISC Questionnaire WPAI:SHP v2.0 Test Code Terminology Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 test name. WPAI01-Absenteeism Score Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - Absenteeism score. WPAI:SHP v2.0 - Absenteeism Score WPAI01-Activity Impairment Score Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - Activity impairment score. WPAI:SHP v2.0 - Activity Impairment Score WPAI01-Currently Employed Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - Are you currently employed (working for pay)? WPAI:SHP v2.0 - Currently Employed WPAI01-Hours Actually Worked Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - During the past seven days, how many hours did you actually work? WPAI:SHP v2.0 - Hours Actually Worked WPAI01-Missed Work Hours Due to Other Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - During the past seven days, how many hours did you miss from work because of any other reason, such as vacation, holidays, time off to participate in this study? WPAI:SHP v2.0 - Missed Work Hours Due to Other Reasons WPAI01-Missed Work Hours Due to Problem Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - During the past seven days, how many hours did you miss from work because of problems associated with your problem? WPAI:SHP v2.0 - Missed Work Hours Due to Problem WPAI01-Presenteeism Score Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - Presenteeism score. WPAI:SHP v2.0 - Presenteeism Score WPAI01-Problem Affect Productivity Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - During the past seven days, how much did your problem affect your productivity while you were working? WPAI:SHP v2.0 - Problem Affects Productivity WPAI01-Problem Affect Reg Daily Activity Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - During the past seven days, how much did your problem affect your ability to do your regular daily activities, other than work at a job? WPAI:SHP v2.0 - Problem Affects Regular Daily Activity WPAI01-Work Productivity Loss Score Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - Work productivity loss score. WPAI:SHP v2.0 - Work Productivity Loss Score WPAI01TN Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 Questionnaire Test Name CDISC Questionnaire WPAI:SHP v2.0 Test Name Terminology World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer test code. WD4-Sex as Observed World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Record sex as observed. WHODAS 2.0 12+24-item Version Interviewer-administered - Observed Sex WD4-How Old Are You Now World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - How old are you now? WHODAS 2.0 12+24-item Version Interviewer-administered - How Old Are You Now WD4-Years Studying in School/College World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - How many years in all did you spend studying in school, college or university? WHODAS 2.0 12+24-item Version Interviewer-administered - Years Studying in School or College WD4-Current Marital Status World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - What is your current marital status? WHODAS 2.0 12+24-item Version Interviewer-administered - Current Marital Status WD4-Describes Main Work Status Best World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Which describes your main work status best? WHODAS 2.0 12+24-item Version Interviewer-administered - Describes Main Work Status Best WD4-Remembering to Do Important Things World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Remembering to do important things? WHODAS 2.0 12+24-item Version Interviewer-administered - Remembering to Do Important Things WD4-Finding Solutions to Problems World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Analysing and finding solutions to problems in day-to-day life? WHODAS 2.0 12+24-item Version Interviewer-administered - Finding Solutions to Problems WD4-Understanding What People Say World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Generally understanding what people say? WHODAS 2.0 12+24-item Version Interviewer-administered - Understanding What People Say WD4-Starting/Maintaining Conversation World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Starting and maintaining a conversation? WHODAS 2.0 12+24-item Version Interviewer-administered - Starting or Maintaining Conversation WD4-Standing Up From Sitting Down World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Standing up from sitting down? WHODAS 2.0 12+24-item Version Interviewer-administered - Standing Up From Sitting Down WD4-Moving Around Inside Your Home World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Moving around inside your home? WHODAS 2.0 12+24-item Version Interviewer-administered - Moving Around Inside Your Home WD4-Getting Out of Your Home World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Getting out of your home? WHODAS 2.0 12+24-item Version Interviewer-administered - Getting Out of Your Home WD4-Eating World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Eating? WHODAS 2.0 12+24-item Version Interviewer-administered - Eating WD4-Staying By Yourself for a Few Days World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Staying by yourself for a few days? WHODAS 2.0 12+24-item Version Interviewer-administered - Staying By Yourself for a Few Days WD4-Get Along with People Close to You World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Getting along with people who are close to you? WHODAS 2.0 12+24-item Version Interviewer-administered - Get Along with People Close to You WD4-Making New Friends World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Making new friends? WHODAS 2.0 12+24-item Version Interviewer-administered - Making New Friends WD4-Sexual Activities World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Sexual activities? WHODAS 2.0 12+24-item Version Interviewer-administered - Sexual Activities WD4-Reduce or Miss Household Work World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, on how many days did you reduce or completely miss household work because of your health condition? WHODAS 2.0 12+24-item Version Interviewer-administered - Reduce or Miss Household Work WD4-Miss Work Half Day or More World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, on how many days did you miss work for half a day or more because of your health condition? WHODAS 2.0 12+24-item Version Interviewer-administered - Miss Work Half Day or More WD4-Earn Less Money World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Did you earn less money as the result of a health condition? WHODAS 2.0 12+24-item Version Interviewer-administered - Earn Less Money WD4-Doing Important Household Tasks World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days, how much difficulty did you have in: Doing your most important household tasks well? WHODAS 2.0 12+24-item Version Interviewer-administered - Doing Important Household Tasks WD4-Getting Household Work Done Needed World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days, how much difficulty did you have in: Getting all the household work done that you needed to do? WHODAS 2.0 12+24-item Version Interviewer-administered - Getting Household Work Done Needed WD4-Getting Household Work Done Quickly World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days, how much difficulty did you have in: Getting your household work done as quickly as needed? WHODAS 2.0 12+24-item Version Interviewer-administered - Getting Household Work Done Quickly WD4-Doing Important Work/School Tasks World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Doing your most important work/school tasks well? WHODAS 2.0 12+24-item Version Interviewer-administered - Doing Important Work or School Tasks WD4-Getting All Work Done You Need World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Getting all the work done that you need to do? WHODAS 2.0 12+24-item Version Interviewer-administered - Getting All Work Done You Need WD4-Getting Work Done Quickly as Needed World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Getting your work done as quickly as needed? WHODAS 2.0 12+24-item Version Interviewer-administered - Getting Work Done Quickly as Needed WD4-Had to Work at a Lower Level World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Have you had to work at a lower level because of a health condition? WHODAS 2.0 12+24-item Version Interviewer-administered - Had to Work at a Lower Level WD4-Problem Because of Barriers in World World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days: How much of a problem did you have because of barriers or hindrances in the world around you? WHODAS 2.0 12+24-item Version Interviewer-administered - Problem Because of Barriers in World WD4-Problem Living With Dignity World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days: How much of a problem did you have living with dignity because of the attitudes and actions of others? WHODAS 2.0 12+24-item Version Interviewer-administered - Problem Living With Dignity WD4-Time Spend on Your Health Condition World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days: How much time did you spend on your health condition, or its consequences? WHODAS 2.0 12+24-item Version Interviewer-administered - Time Spend on Your Health Condition WD4-Drain on Financial Resources World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days: How much has your health been a drain on the financial resources of you or your family? WHODAS 2.0 12+24-item Version Interviewer-administered - Drain on Financial Resources WD4-Problem Did Your Family Have World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days: How much of a problem did your family have because of your health problems? WHODAS 2.0 12+24-item Version Interviewer-administered - Problem Did Your Family Have WD4-Problem Doing Things for Relaxation World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days: How much of a problem did you have in doing things by yourself for relaxation or pleasure? WHODAS 2.0 12+24-item Version Interviewer-administered - Problem Doing Things for Relaxation WD4-Living Situation at Interview World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Living situation at time of interview. WHODAS 2.0 12+24-item Version Interviewer-administered - Living Situation at Interview WD4-How Many Days Difficulties Present World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Overall, in the past 30 days, how many days were these difficulties present? WHODAS 2.0 12+24-item Version Interviewer-administered - How Many Days Difficulties Present WD4-Days Unable to Carry Out Activities World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, for how many days were you totally unable to carry out your usual activities or work because of any health condition? WHODAS 2.0 12+24-item Version Interviewer-administered - Days Unable to Carry Out Activities WD4-How Many Days Reduce Activities World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, not counting the days that you were totally unable, for how many days did you cut back or reduce your usual activities or work because of any health condition? WHODAS 2.0 12+24-item Version Interviewer-administered - How Many Days Reduce Activities WD4-Standing for Long Periods World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Standing for long periods such as 30 minutes? WHODAS 2.0 12+24-item Version Interviewer-administered - Standing for Long Periods WD4-Dealing With People You Do Not Know World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Dealing with people you do not know? WHODAS 2.0 12+24-item Version Interviewer-administered - Dealing With People You Do Not Know WD4-Maintaining a Fiendship World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Maintaining a friendship? WHODAS 2.0 12+24-item Version Interviewer-administered - Maintaining a Fiendship WD4-Your Day-to-Day Work World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Your day-to-day work? WHODAS 2.0 12+24-item Version Interviewer-administered - Your Day-to-Day Work WD4-Care of Household Responsibilities World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Taking care of your household responsibilities? WHODAS 2.0 12+24-item Version Interviewer-administered - Care of Household Responsibilities WD4-Learning a New Task World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Learning a new task, for example, learning how to get to a new place? WHODAS 2.0 12+24-item Version Interviewer-administered - Learning a New Task WD4-Problem Joining Community Activities World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Joining in community activities (for example, festivities, religious or other activities) in the same way as anyone else can? WHODAS 2.0 12+24-item Version Interviewer-administered - Problem Joining Community Activities WD4-Emotionally Affected by Health World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: How much have you been emotionally affected by your health problems? WHODAS 2.0 12+24-item Version Interviewer-administered - Emotionally Affected by Health WD4-Concentrating for Ten Minutes World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Concentrating on doing something for ten minutes? WHODAS 2.0 12+24-item Version Interviewer-administered - Concentrating for Ten Minutes WD4-Walking a Long Distance World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Walking a long distance such as a kilometre [or equivalent]? WHODAS 2.0 12+24-item Version Interviewer-administered - Walking a Long Distance WD4-Washing Your Whole Body World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Washing your whole body? WHODAS 2.0 12+24-item Version Interviewer-administered - Washing Your Whole Body WD4-Getting Dressed World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Getting dressed? WHODAS 2.0 12+24-item Version Interviewer-administered - Getting Dressed WD4TC World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer Questionnaire Test Code CDISC Questionnaire WHODAS 2.0 12+24-item Version Interviewer-administered Test Code Terminology World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer test name. WD4-Care of Household Responsibilities World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Taking care of your household responsibilities? WHODAS 2.0 12+24-item Version Interviewer-administered - Care of Household Responsibilities WD4-Concentrating for Ten Minutes World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Concentrating on doing something for ten minutes? WHODAS 2.0 12+24-item Version Interviewer-administered - Concentrating for Ten Minutes WD4-Current Marital Status World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - What is your current marital status? WHODAS 2.0 12+24-item Version Interviewer-administered - Current Marital Status WD4-Days Unable to Carry Out Activities World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, for how many days were you totally unable to carry out your usual activities or work because of any health condition? WHODAS 2.0 12+24-item Version Interviewer-administered - Days Unable to Carry Out Activities WD4-Dealing With People You Do Not Know World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Dealing with people you do not know? WHODAS 2.0 12+24-item Version Interviewer-administered - Dealing With People You Do Not Know WD4-Describes Main Work Status Best World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Which describes your main work status best? WHODAS 2.0 12+24-item Version Interviewer-administered - Describes Main Work Status Best WD4-Doing Important Household Tasks World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days, how much difficulty did you have in: Doing your most important household tasks well? WHODAS 2.0 12+24-item Version Interviewer-administered - Doing Important Household Tasks WD4-Doing Important Work/School Tasks World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Doing your most important work/school tasks well? WHODAS 2.0 12+24-item Version Interviewer-administered - Doing Important Work or School Tasks WD4-Drain on Financial Resources World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days: How much has your health been a drain on the financial resources of you or your family? WHODAS 2.0 12+24-item Version Interviewer-administered - Drain on Financial Resources WD4-Earn Less Money World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Did you earn less money as the result of a health condition? WHODAS 2.0 12+24-item Version Interviewer-administered - Earn Less Money WD4-Eating World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Eating? WHODAS 2.0 12+24-item Version Interviewer-administered - Eating WD4-Emotionally Affected by Health World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: How much have you been emotionally affected by your health problems? WHODAS 2.0 12+24-item Version Interviewer-administered - Emotionally Affected by Health WD4-Finding Solutions to Problems World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Analysing and finding solutions to problems in day-to-day life? WHODAS 2.0 12+24-item Version Interviewer-administered - Finding Solutions to Problems WD4-Get Along with People Close to You World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Getting along with people who are close to you? WHODAS 2.0 12+24-item Version Interviewer-administered - Get Along with People Close to You WD4-Getting All Work Done You Need World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Getting all the work done that you need to do? WHODAS 2.0 12+24-item Version Interviewer-administered - Getting All Work Done You Need WD4-Getting Dressed World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Getting dressed? WHODAS 2.0 12+24-item Version Interviewer-administered - Getting Dressed WD4-Getting Household Work Done Needed World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days, how much difficulty did you have in: Getting all the household work done that you needed to do? WHODAS 2.0 12+24-item Version Interviewer-administered - Getting Household Work Done Needed WD4-Getting Household Work Done Quickly World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days, how much difficulty did you have in: Getting your household work done as quickly as needed? WHODAS 2.0 12+24-item Version Interviewer-administered - Getting Household Work Done Quickly WD4-Getting Out of Your Home World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Getting out of your home? WHODAS 2.0 12+24-item Version Interviewer-administered - Getting Out of Your Home WD4-Getting Work Done Quickly as Needed World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Getting your work done as quickly as needed? WHODAS 2.0 12+24-item Version Interviewer-administered - Getting Work Done Quickly as Needed WD4-Had to Work at a Lower Level World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Have you had to work at a lower level because of a health condition? WHODAS 2.0 12+24-item Version Interviewer-administered - Had to Work at a Lower Level WD4-How Many Days Difficulties Present World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Overall, in the past 30 days, how many days were these difficulties present? WHODAS 2.0 12+24-item Version Interviewer-administered - How Many Days Difficulties Present WD4-How Many Days Reduce Activities World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, not counting the days that you were totally unable, for how many days did you cut back or reduce your usual activities or work because of any health condition? WHODAS 2.0 12+24-item Version Interviewer-administered - How Many Days Reduce Activities WD4-How Old Are You Now World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - How old are you now? WHODAS 2.0 12+24-item Version Interviewer-administered - How Old Are You Now WD4-Learning a New Task World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Learning a new task, for example, learning how to get to a new place? WHODAS 2.0 12+24-item Version Interviewer-administered - Learning a New Task WD4-Living Situation at Interview World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Living situation at time of interview. WHODAS 2.0 12+24-item Version Interviewer-administered - Living Situation at Interview WD4-Maintaining a Fiendship World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Maintaining a friendship? WHODAS 2.0 12+24-item Version Interviewer-administered - Maintaining a Fiendship WD4-Making New Friends World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Making new friends? WHODAS 2.0 12+24-item Version Interviewer-administered - Making New Friends WD4-Miss Work Half Day or More World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, on how many days did you miss work for half a day or more because of your health condition? WHODAS 2.0 12+24-item Version Interviewer-administered - Miss Work Half Day or More WD4-Moving Around Inside Your Home World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Moving around inside your home? WHODAS 2.0 12+24-item Version Interviewer-administered - Moving Around Inside Your Home WD4-Problem Because of Barriers in World World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days: How much of a problem did you have because of barriers or hindrances in the world around you? WHODAS 2.0 12+24-item Version Interviewer-administered - Problem Because of Barriers in World WD4-Problem Did Your Family Have World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days: How much of a problem did your family have because of your health problems? WHODAS 2.0 12+24-item Version Interviewer-administered - Problem Did Your Family Have WD4-Problem Doing Things for Relaxation World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days: How much of a problem did you have in doing things by yourself for relaxation or pleasure? WHODAS 2.0 12+24-item Version Interviewer-administered - Problem Doing Things for Relaxation WD4-Problem Joining Community Activities World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Joining in community activities (for example, festivities, religious or other activities) in the same way as anyone else can? WHODAS 2.0 12+24-item Version Interviewer-administered - Problem Joining Community Activities WD4-Problem Living With Dignity World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days: How much of a problem did you have living with dignity because of the attitudes and actions of others? WHODAS 2.0 12+24-item Version Interviewer-administered - Problem Living With Dignity WD4-Reduce or Miss Household Work World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, on how many days did you reduce or completely miss household work because of your health condition? WHODAS 2.0 12+24-item Version Interviewer-administered - Reduce or Miss Household Work WD4-Remembering to Do Important Things World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Remembering to do important things? WHODAS 2.0 12+24-item Version Interviewer-administered - Remembering to Do Important Things WD4-Sex as Observed World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Record sex as observed. WHODAS 2.0 12+24-item Version Interviewer-administered - Observed Sex WD4-Sexual Activities World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Sexual activities? WHODAS 2.0 12+24-item Version Interviewer-administered - Sexual Activities WD4-Standing for Long Periods World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Standing for long periods such as 30 minutes? WHODAS 2.0 12+24-item Version Interviewer-administered - Standing for Long Periods WD4-Standing Up From Sitting Down World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Standing up from sitting down? WHODAS 2.0 12+24-item Version Interviewer-administered - Standing Up From Sitting Down WD4-Starting/Maintaining Conversation World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Starting and maintaining a conversation? WHODAS 2.0 12+24-item Version Interviewer-administered - Starting or Maintaining Conversation WD4-Staying By Yourself for a Few Days World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Staying by yourself for a few days? WHODAS 2.0 12+24-item Version Interviewer-administered - Staying By Yourself for a Few Days WD4-Time Spend on Your Health Condition World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days: How much time did you spend on your health condition, or its consequences? WHODAS 2.0 12+24-item Version Interviewer-administered - Time Spend on Your Health Condition WD4-Understanding What People Say World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Generally understanding what people say? WHODAS 2.0 12+24-item Version Interviewer-administered - Understanding What People Say WD4-Walking a Long Distance World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Walking a long distance such as a kilometre [or equivalent]? WHODAS 2.0 12+24-item Version Interviewer-administered - Walking a Long Distance WD4-Washing Your Whole Body World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Washing your whole body? WHODAS 2.0 12+24-item Version Interviewer-administered - Washing Your Whole Body WD4-Years Studying in School/College World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - How many years in all did you spend studying in school, college or university? WHODAS 2.0 12+24-item Version Interviewer-administered - Years Studying in School or College WD4-Your Day-to-Day Work World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Your day-to-day work? WHODAS 2.0 12+24-item Version Interviewer-administered - Your Day-to-Day Work WD4TN World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer Questionnaire Test Name CDISC Questionnaire WHODAS 2.0 12+24-item Version Interviewer-administered Test Name Terminology World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer test code. WD1-Sex as Observed World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - Record sex as observed. WHODAS 2.0 12-item Version Interviewer-administered - Observed Sex WD1-How Old Are You Now World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - How old are you now? WHODAS 2.0 12-item Version Interviewer-administered - How Old Are You Now WD1-Years Studying in School/College World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - How many years in all did you spend studying in school, college or university? WHODAS 2.0 12-item Version Interviewer-administered - Years Studying in School or College WD1-Current Marital Status World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - What is your current marital status? WHODAS 2.0 12-item Version Interviewer-administered - Current Marital Status WD1-Describes Main Work Status Best World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - Which describes your main work status best? WHODAS 2.0 12-item Version Interviewer-administered - Describes Main Work Status Best WD1-Living Situation at Interview World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - Living situation at time of interview. WHODAS 2.0 12-item Version Interviewer-administered - Living Situation at Interview WD1-How Many Days Difficulties Present World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - Overall, in the past 30 days, how many days were these difficulties present? WHODAS 2.0 12-item Version Interviewer-administered - How Many Days Difficulties Present WD1-Days Unable to Carry Out Activities World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, for how many days were you totally unable to carry out your usual activities or work because of any health condition? WHODAS 2.0 12-item Version Interviewer-administered - Days Unable to Carry Out Activities WD1-How Many Days Reduce Activities World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, not counting the days that you were totally unable, for how many days did you cut back or reduce your usual activities or work because of any health condition? WHODAS 2.0 12-item Version Interviewer-administered - How Many Days Reduce Activities WD1-Standing for Long Periods World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Standing for long periods such as 30 minutes? WHODAS 2.0 12-item Version Interviewer-administered - Standing for Long Periods WD1-Dealing With People You Do Not Know World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Dealing with people you do not know? WHODAS 2.0 12-item Version Interviewer-administered - Dealing With People You Do Not Know WD1-Maintaining a Friendship World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Maintaining a friendship? WHODAS 2.0 12-item Version Interviewer-administered - Maintaining a Friendship WD1-Your Day-to-Day Work/School World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Your day-to-day work/school? WHODAS 2.0 12-item Version Interviewer-administered - Your Day-to-Day Work or School WD1-Care of Household Responsibilities World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Taking care of your household responsibilities? WHODAS 2.0 12-item Version Interviewer-administered - Care of Household Responsibilities WD1-Learning a New Task World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Learning a new task, for example, learning how to get to a new place? WHODAS 2.0 12-item Version Interviewer-administered - Learning a New Task WD1-Problem Joining Community Activities World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: How much of a problem did you have joining in community activities (for example, festivities, religious or other activities) in the same way as anyone else can? WHODAS 2.0 12-item Version Interviewer-administered - Problem Joining Community Activities WD1-Emotionally Affected by Health World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: How much have you been emotionally affected by your health problems? WHODAS 2.0 12-item Version Interviewer-administered - Emotionally Affected by Health WD1-Concentrating for Ten Minutes World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Concentrating on doing something for ten minutes? WHODAS 2.0 12-item Version Interviewer-administered - Concentrating for Ten Minutes WD1-Walking a Long Distance World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Walking a long distance such as a kilometre [or equivalent]? WHODAS 2.0 12-item Version Interviewer-administered - Walking a Long Distance WD1-Washing Your Whole Body World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Washing your whole body? WHODAS 2.0 12-item Version Interviewer-administered - Washing Your Whole Body WD1-Getting Dressed World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Getting dressed? WHODAS 2.0 12-item Version Interviewer-administered - Getting Dressed WD1TC World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer Questionnaire Test Code CDISC Questionnaire WHODAS 2.0 12-item Version Interviewer-administered Test Code Terminology World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer test name. WD1-Care of Household Responsibilities World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Taking care of your household responsibilities? WHODAS 2.0 12-item Version Interviewer-administered - Care of Household Responsibilities WD1-Concentrating for Ten Minutes World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Concentrating on doing something for ten minutes? WHODAS 2.0 12-item Version Interviewer-administered - Concentrating for Ten Minutes WD1-Current Marital Status World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - What is your current marital status? WHODAS 2.0 12-item Version Interviewer-administered - Current Marital Status WD1-Days Unable to Carry Out Activities World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, for how many days were you totally unable to carry out your usual activities or work because of any health condition? WHODAS 2.0 12-item Version Interviewer-administered - Days Unable to Carry Out Activities WD1-Dealing With People You Do Not Know World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Dealing with people you do not know? WHODAS 2.0 12-item Version Interviewer-administered - Dealing With People You Do Not Know WD1-Describes Main Work Status Best World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - Which describes your main work status best? WHODAS 2.0 12-item Version Interviewer-administered - Describes Main Work Status Best WD1-Emotionally Affected by Health World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: How much have you been emotionally affected by your health problems? WHODAS 2.0 12-item Version Interviewer-administered - Emotionally Affected by Health WD1-Getting Dressed World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Getting dressed? WHODAS 2.0 12-item Version Interviewer-administered - Getting Dressed WD1-How Many Days Difficulties Present World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - Overall, in the past 30 days, how many days were these difficulties present? WHODAS 2.0 12-item Version Interviewer-administered - How Many Days Difficulties Present WD1-How Many Days Reduce Activities World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, not counting the days that you were totally unable, for how many days did you cut back or reduce your usual activities or work because of any health condition? WHODAS 2.0 12-item Version Interviewer-administered - How Many Days Reduce Activities WD1-How Old Are You Now World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - How old are you now? WHODAS 2.0 12-item Version Interviewer-administered - How Old Are You Now WD1-Learning a New Task World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Learning a new task, for example, learning how to get to a new place? WHODAS 2.0 12-item Version Interviewer-administered - Learning a New Task WD1-Living Situation at Interview World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - Living situation at time of interview. WHODAS 2.0 12-item Version Interviewer-administered - Living Situation at Interview WD1-Maintaining a Friendship World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Maintaining a friendship? WHODAS 2.0 12-item Version Interviewer-administered - Maintaining a Friendship WD1-Problem Joining Community Activities World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: How much of a problem did you have joining in community activities (for example, festivities, religious or other activities) in the same way as anyone else can? WHODAS 2.0 12-item Version Interviewer-administered - Problem Joining Community Activities WD1-Sex as Observed World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - Record sex as observed. WHODAS 2.0 12-item Version Interviewer-administered - Observed Sex WD1-Standing for Long Periods World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Standing for long periods such as 30 minutes? WHODAS 2.0 12-item Version Interviewer-administered - Standing for Long Periods WD1-Walking a Long Distance World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Walking a long distance such as a kilometre [or equivalent]? WHODAS 2.0 12-item Version Interviewer-administered - Walking a Long Distance WD1-Washing Your Whole Body World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Washing your whole body? WHODAS 2.0 12-item Version Interviewer-administered - Washing Your Whole Body WD1-Years Studying in School/College World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - How many years in all did you spend studying in school, college or university? WHODAS 2.0 12-item Version Interviewer-administered - Years Studying in School or College WD1-Your Day-to-Day Work/School World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Your day-to-day work/school? WHODAS 2.0 12-item Version Interviewer-administered - Your Day-to-Day Work or School WD1TN World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer Questionnaire Test Name CDISC Questionnaire WHODAS 2.0 12-item Version Interviewer-administered Test Name Terminology World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy test code. WD2-How Many Days Difficulties Present World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - Overall, in the past 30 days, how many days were these difficulties present? WHODAS 2.0 12-item Version Proxy-administered - How Many Days Difficulties Present WD2-Days Unable to Carry Out Activities World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, for how many days were you totally unable to carry out your usual activities or work because of any health condition? WHODAS 2.0 12-item Version Proxy-administered - Days Unable to Carry Out Activities WD2-How Many Days Reduce Activities World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, not counting the days that you were totally unable, for how many days did you cut back or reduce your usual activities or work because of any health condition? WHODAS 2.0 12-item Version Proxy-administered - How Many Days Reduce Activities WD2-I Am (Fill in Blank) of This Person World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - I am the (Fill in the Blank) of this person. WHODAS 2.0 12-item Version Proxy-administered - I Am the (Fill in the Blank) of This Person WD2-Standing for Long Periods World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Standing for long periods such as 30 minutes? WHODAS 2.0 12-item Version Proxy-administered - Standing for Long Periods WD2-Dealing With People Does Not Know World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Dealing with people he or she does not know? WHODAS 2.0 12-item Version Proxy-administered - Dealing With People Does Not Know WD2-Maintaining a Friendship World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Maintaining a friendship? WHODAS 2.0 12-item Version Proxy-administered - Maintaining a Friendship WD2-Your Day-to-Day Work/School World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: His or her day-to-day work? WHODAS 2.0 12-item Version Proxy-administered - Your Day-to-Day Work or School WD2-Care of Household Responsibilities World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Taking care of his or her household responsibilities? WHODAS 2.0 12-item Version Proxy-administered - Care of Household Responsibilities WD2-Learning a New Task World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Learning a new task, for example, learning how to get to a new place? WHODAS 2.0 12-item Version Proxy-administered - Learning a New Task WD2-Problem Joining Community Activities World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: How much of a problem did your relative have joining in community activities (for example, festivities, religious or other activities) in the same way as anyone else can? WHODAS 2.0 12-item Version Proxy-administered - Problem Joining Community Activities WD2-Emotionally Affected by Health World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: How much has your relative been emotionally affected by his or her health condition? WHODAS 2.0 12-item Version Proxy-administered - Emotionally Affected by Health WD2-Concentrating for Ten Minutes World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Concentrating on doing something for ten minutes? WHODAS 2.0 12-item Version Proxy-administered - Concentrating for Ten Minutes WD2-Walking a Long Distance World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Walking a long distance such as a kilometre [or equivalent]? WHODAS 2.0 12-item Version Proxy-administered - Walking a Long Distance WD2-Washing His/Her Whole Body World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Washing his or her whole body? WHODAS 2.0 12-item Version Proxy-administered - Washing His or Her Whole Body WD2-Getting Dressed World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Getting dressed? WHODAS 2.0 12-item Version Proxy-administered - Getting Dressed WD2TC World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy Questionnaire Test Code CDISC Questionnaire WHODAS 2.0 12-item Version Proxy-administered Test Code Terminology World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy test name. WD2-Care of Household Responsibilities World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Taking care of his or her household responsibilities? WHODAS 2.0 12-item Version Proxy-administered - Care of Household Responsibilities WD2-Concentrating for Ten Minutes World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Concentrating on doing something for ten minutes? WHODAS 2.0 12-item Version Proxy-administered - Concentrating for Ten Minutes WD2-Days Unable to Carry Out Activities World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, for how many days were you totally unable to carry out your usual activities or work because of any health condition? WHODAS 2.0 12-item Version Proxy-administered - Days Unable to Carry Out Activities WD2-Dealing With People Does Not Know World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Dealing with people he or she does not know? WHODAS 2.0 12-item Version Proxy-administered - Dealing With People Does Not Know WD2-Emotionally Affected by Health World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: How much has your relative been emotionally affected by his or her health condition? WHODAS 2.0 12-item Version Proxy-administered - Emotionally Affected by Health WD2-Getting Dressed World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Getting dressed? WHODAS 2.0 12-item Version Proxy-administered - Getting Dressed WD2-How Many Days Difficulties Present World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - Overall, in the past 30 days, how many days were these difficulties present? WHODAS 2.0 12-item Version Proxy-administered - How Many Days Difficulties Present WD2-How Many Days Reduce Activities World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, not counting the days that you were totally unable, for how many days did you cut back or reduce your usual activities or work because of any health condition? WHODAS 2.0 12-item Version Proxy-administered - How Many Days Reduce Activities WD2-I Am (Fill in Blank) of This Person World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - I am the (Fill in the Blank) of this person. WHODAS 2.0 12-item Version Proxy-administered - I Am the (Fill in the Blank) of This Person WD2-Learning a New Task World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Learning a new task, for example, learning how to get to a new place? WHODAS 2.0 12-item Version Proxy-administered - Learning a New Task WD2-Maintaining a Friendship World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Maintaining a friendship? WHODAS 2.0 12-item Version Proxy-administered - Maintaining a Friendship WD2-Problem Joining Community Activities World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: How much of a problem did your relative have joining in community activities (for example, festivities, religious or other activities) in the same way as anyone else can? WHODAS 2.0 12-item Version Proxy-administered - Problem Joining Community Activities WD2-Standing for Long Periods World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Standing for long periods such as 30 minutes? WHODAS 2.0 12-item Version Proxy-administered - Standing for Long Periods WD2-Walking a Long Distance World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Walking a long distance such as a kilometre [or equivalent]? WHODAS 2.0 12-item Version Proxy-administered - Walking a Long Distance WD2-Washing His/Her Whole Body World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Washing his or her whole body? WHODAS 2.0 12-item Version Proxy-administered - Washing His or Her Whole Body WD2-Your Day-to-Day Work/School World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: His or her day-to-day work? WHODAS 2.0 12-item Version Proxy-administered - Your Day-to-Day Work or School WD2TN World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy Questionnaire Test Name CDISC Questionnaire WHODAS 2.0 12-item Version Proxy-administered Test Name Terminology World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self test code. WD3-How Many Days Difficulties Present World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - Overall, in the past 30 days, how many days were these difficulties present? WHODAS 2.0 12-item Version Self-administered - How Many Days Difficulties Present WD3-Days Unable to Carry Out Activities World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, for how many days were you totally unable to carry out your usual activities or work because of any health condition? WHODAS 2.0 12-item Version Self-administered - Days Unable to Carry Out Activities WD3-How Many Days Reduce Activities World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, not counting the days that you were totally unable, for how many days did you cut back or reduce your usual activities or work because of any health condition? WHODAS 2.0 12-item Version Self-administered - How Many Days Reduce Activities WD3-Standing for Long Periods World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Standing for long periods such as 30 minutes? WHODAS 2.0 12-item Version Self-administered - Standing for Long Periods WD3-Dealing With People You Do Not Know World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Dealing with people you do not know? WHODAS 2.0 12-item Version Self-administered - Dealing With People You Do Not Know WD3-Maintaining a Friendship World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Maintaining a friendship? WHODAS 2.0 12-item Version Self-administered - Maintaining a Friendship WD3-Your Day-to-Day Work/School World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Your day-to-day work? WHODAS 2.0 12-item Version Self-administered - Your Day-to-Day Work or School WD3-Care of Household Responsibilities World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Taking care of your household responsibilities? WHODAS 2.0 12-item Version Self-administered - Care of Household Responsibilities WD3-Learning a New Task World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Learning a new task, for example, learning how to get to a new place? WHODAS 2.0 12-item Version Self-administered - Learning a New Task WD3-Problem Joining Community Activities World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: How much of a problem did you have joining in community activities (for example, festivities, religious or other activities) in the same way as anyone else can? WHODAS 2.0 12-item Version Self-administered - Problem Joining Community Activities WD3-Emotionally Affected by Health World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: How much have you been emotionally affected by your health problems? WHODAS 2.0 12-item Version Self-administered - Emotionally Affected by Health WD3-Concentrating for Ten Minutes World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Concentrating on doing something for ten minutes? WHODAS 2.0 12-item Version Self-administered - Concentrating for Ten Minutes WD3-Walking a Long Distance World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Walking a long distance such as a kilometre [or equivalent]? WHODAS 2.0 12-item Version Self-administered - Walking a Long Distance WD3-Washing Your Whole Body World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Washing your whole body? WHODAS 2.0 12-item Version Self-administered - Washing Your Whole Body WD3-Getting Dressed World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Getting dressed? WHODAS 2.0 12-item Version Self-administered - Getting Dressed WD3TC World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self Questionnaire Test Code CDISC Questionnaire WHODAS 2.0 12-item Version Self-administered Test Code Terminology World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self test name. WD3-Care of Household Responsibilities World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Taking care of your household responsibilities? WHODAS 2.0 12-item Version Self-administered - Care of Household Responsibilities WD3-Concentrating for Ten Minutes World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Concentrating on doing something for ten minutes? WHODAS 2.0 12-item Version Self-administered - Concentrating for Ten Minutes WD3-Days Unable to Carry Out Activities World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, for how many days were you totally unable to carry out your usual activities or work because of any health condition? WHODAS 2.0 12-item Version Self-administered - Days Unable to Carry Out Activities WD3-Dealing With People You Do Not Know World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Dealing with people you do not know? WHODAS 2.0 12-item Version Self-administered - Dealing With People You Do Not Know WD3-Emotionally Affected by Health World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: How much have you been emotionally affected by your health problems? WHODAS 2.0 12-item Version Self-administered - Emotionally Affected by Health WD3-Getting Dressed World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Getting dressed? WHODAS 2.0 12-item Version Self-administered - Getting Dressed WD3-How Many Days Difficulties Present World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - Overall, in the past 30 days, how many days were these difficulties present? WHODAS 2.0 12-item Version Self-administered - How Many Days Difficulties Present WD3-How Many Days Reduce Activities World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, not counting the days that you were totally unable, for how many days did you cut back or reduce your usual activities or work because of any health condition? WHODAS 2.0 12-item Version Self-administered - How Many Days Reduce Activities WD3-Learning a New Task World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Learning a new task, for example, learning how to get to a new place? WHODAS 2.0 12-item Version Self-administered - Learning a New Task WD3-Maintaining a Friendship World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Maintaining a friendship? WHODAS 2.0 12-item Version Self-administered - Maintaining a Friendship WD3-Problem Joining Community Activities World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: How much of a problem did you have joining in community activities (for example, festivities, religious or other activities) in the same way as anyone else can? WHODAS 2.0 12-item Version Self-administered - Problem Joining Community Activities WD3-Standing for Long Periods World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Standing for long periods such as 30 minutes? WHODAS 2.0 12-item Version Self-administered - Standing for Long Periods WD3-Walking a Long Distance World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Walking a long distance such as a kilometre [or equivalent]? WHODAS 2.0 12-item Version Self-administered - Walking a Long Distance WD3-Washing Your Whole Body World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Washing your whole body? WHODAS 2.0 12-item Version Self-administered - Washing Your Whole Body WD3-Your Day-to-Day Work/School World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Your day-to-day work? WHODAS 2.0 12-item Version Self-administered - Your Day-to-Day Work or School WD3TN World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self Questionnaire Test Name CDISC Questionnaire WHODAS 2.0 12-item Version Self-administered Test Name Terminology World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer test code. WD5-Sex as Observed World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Record sex as observed. WHODAS 2.0 36-item Version Interviewer-administered - Sex as Observed WD5-How Old Are You Now World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - How old are you now? WHODAS 2.0 36-item Version Interviewer-administered - How Old Are You Now WD5-Years Studying in School/College World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - How many years in all did you spend studying in school, college or university? WHODAS 2.0 36-item Version Interviewer-administered - Years Studying in School or College WD5-Current Marital Status World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - What is your current marital status? WHODAS 2.0 36-item Version Interviewer-administered - Current Marital Status WD5-Describes Main Work Status Best World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Which describes your main work status best? WHODAS 2.0 36-item Version Interviewer-administered - Describes Main Work Status Best WD5-Concentrating for Ten Minutes World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Concentrating on doing something for ten minutes? WHODAS 2.0 36-item Version Interviewer-administered - Concentrating for Ten Minutes WD5-Remembering to Do Important Things World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Remembering to do important things? WHODAS 2.0 36-item Version Interviewer-administered - Remembering to Do Important Things WD5-Finding Solutions to Problems World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Analysing and finding solutions to problems in day-to-day life? WHODAS 2.0 36-item Version Interviewer-administered - Finding Solutions to Problems WD5-Learning a New Task World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Learning a new task, for example, learning how to get to a new place? WHODAS 2.0 36-item Version Interviewer-administered - Learning a New Task WD5-Understanding What People Say World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Generally understanding what people say? WHODAS 2.0 36-item Version Interviewer-administered - Understanding What People Say WD5-Starting/Maintaining Conversation World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Starting and maintaining a conversation? WHODAS 2.0 36-item Version Interviewer-administered - Starting or Maintaining Conversation WD5-Standing for Long Periods World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Standing for long periods such as 30 minutes? WHODAS 2.0 36-item Version Interviewer-administered - Standing for Long Periods WD5-Standing Up From Sitting Down World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Standing up from sitting down? WHODAS 2.0 36-item Version Interviewer-administered - Standing Up From Sitting Down WD5-Moving Around Inside Your Home World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Moving around inside your home? WHODAS 2.0 36-item Version Interviewer-administered - Moving Around Inside Your Home WD5-Washing Your Whole Body World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Washing your whole body? WHODAS 2.0 36-item Version Interviewer-administered - Washing Your Whole Body WD5-Getting Dressed World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Getting dressed? WHODAS 2.0 36-item Version Interviewer-administered - Getting Dressed WD5-Eating World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Eating? WHODAS 2.0 36-item Version Interviewer-administered - Eating WD5-Staying by Yourself for a Few Days World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Staying by yourself for a few days? WHODAS 2.0 36-item Version Interviewer-administered - Staying by Yourself for a Few Days WD5-Dealing With People You Do Not Know World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Dealing with people you do not know? WHODAS 2.0 36-item Version Interviewer-administered - Dealing With People You Do Not Know WD5-Maintaining a Friendship World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Maintaining a friendship? WHODAS 2.0 36-item Version Interviewer-administered - Maintaining a Friendship WD5-Get Along With People Close to You World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Getting along with people who are close to you? WHODAS 2.0 36-item Version Interviewer-administered - Get Along With People Close to You WD5-Making New Friends World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Making new friends? WHODAS 2.0 36-item Version Interviewer-administered - Making New Friends WD5-Sexual Activities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Sexual activities? WHODAS 2.0 36-item Version Interviewer-administered - Sexual Activities WD5-Days Reduce or Miss Household Work World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, on how many days did you reduce or completely miss household work because of your health condition? WHODAS 2.0 36-item Version Interviewer-administered - Days Reduce or Miss Household Work WD5-How Many Days Did You Miss Work World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, on how many days did you miss work for half a day or more because of your health condition? WHODAS 2.0 36-item Version Interviewer-administered - How Many Days Did You Miss Work WD5-Care of Household Responsibilities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days, how much difficulty did you have in: Taking care of your household responsibilities? WHODAS 2.0 36-item Version Interviewer-administered - Care of Household Responsibilities WD5-Earn Less Money World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Did you earn less money as the result of a health condition? WHODAS 2.0 36-item Version Interviewer-administered - Earn Less Money WD5-Doing Important Household Tasks World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days, how much difficulty did you have in: Doing your most important household tasks well? WHODAS 2.0 36-item Version Interviewer-administered - Doing Important Household Tasks WD5-Getting Household Work Done Needed World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days, how much difficulty did you have in: Getting all the household work done that you needed to do? WHODAS 2.0 36-item Version Interviewer-administered - Getting Household Work Done Needed WD5-Getting Household Work Done Quickly World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days, how much difficulty did you have in: Getting your household work done as quickly as needed? WHODAS 2.0 36-item Version Interviewer-administered - Getting Household Work Done Quickly WD5-Your Day-to-Day Work/School World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Your day-to-day work/school? WHODAS 2.0 36-item Version Interviewer-administered - Your Day-to-Day Work or School WD5-Doing Important Work/School Tasks World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Doing your most important work/school tasks well? WHODAS 2.0 36-item Version Interviewer-administered - Doing Important Work or School Tasks WD5-Getting All Work Done You Need World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Getting all the work done that you need to do? WHODAS 2.0 36-item Version Interviewer-administered - Getting All Work Done You Need to Do WD5-Getting Work Done Quickly as Needed World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Getting your work done as quickly as needed? WHODAS 2.0 36-item Version Interviewer-administered - Getting Work Done Quickly as Needed WD5-Had to Work at a Lower Level World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Have you had to work at a lower level because of a health condition? WHODAS 2.0 36-item Version Interviewer-administered - Had to Work at a Lower Level WD5-Problem Joining Community Activities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much of a problem did you have joining in community activities (for example, festivities, religious or other activities) in the same way as anyone else can? WHODAS 2.0 36-item Version Interviewer-administered - Problem Joining Community Activities WD5-Problem Because of Barriers in World World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much of a problem did you have because of barriers or hindrances in the world around you? WHODAS 2.0 36-item Version Interviewer-administered - Problem Because of Barriers in World WD5-Problem Living with Dignity World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much of a problem did you have living with dignity because of the attitudes and actions of others? WHODAS 2.0 36-item Version Interviewer-administered - Problem Living with Dignity WD5-Time Spend on Your Health Condition World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much time did you spend on your health condition or its consequences? WHODAS 2.0 36-item Version Interviewer-administered - Time Spend on Your Health Condition WD5-Emotionally Affected by Health World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much have you been emotionally affected by your health condition? WHODAS 2.0 36-item Version Interviewer-administered - Emotionally Affected by Health WD5-Drain on Financial Resources World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much has your health been a drain on the financial resources of you or your family? WHODAS 2.0 36-item Version Interviewer-administered - Drain on Financial Resources WD5-Problem Did Your Family Have World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much of a problem did your family have because of your health problems? WHODAS 2.0 36-item Version Interviewer-administered - How Much Problem Did Your Family Have WD5-Problem Doing Things for Relaxation World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much of a problem did you have in doing things by yourself for relaxation or pleasure? WHODAS 2.0 36-item Version Interviewer-administered - Problem Doing Things for Relaxation WD5-Living Situation at Interview World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Living situation at time of interview. WHODAS 2.0 36-item Version Interviewer-administered - Living Situation at Interview WD5-How Many Days Difficulties Present World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Overall, in the past 30 days, how many days were these difficulties present? WHODAS 2.0 36-item Version Interviewer-administered - How Many Days Difficulties Present WD5-Days Unable to Carry Out Activities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, for how many days were you totally unable to carry out your usual activities or work because of any health condition? WHODAS 2.0 36-item Version Interviewer-administered - Days Unable to Carry Out Activities WD5-How Many Days Reduce Activities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, not counting the days that you were totally unable, for how many days did you cut back or reduce your usual activities or work because of any health condition? WHODAS 2.0 36-item Version Interviewer-administered - How Many Days Reduce Activities WD5-Getting Out of Your Home World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Getting out of your home? WHODAS 2.0 36-item Version Interviewer-administered - Getting Out of Your Home WD5-Walking a Long Distance World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Walking a long distance such as a kilometre [or equivalent]? WHODAS 2.0 36-item Version Interviewer-administered - Walking a Long Distance WD5TC World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer Questionnaire Test Code CDISC Questionnaire WHODAS 2.0 36-item Version Interviewer-administered Test Code Terminology World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer test name. WD5-Care of Household Responsibilities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days, how much difficulty did you have in: Taking care of your household responsibilities? WHODAS 2.0 36-item Version Interviewer-administered - Care of Household Responsibilities WD5-Concentrating for Ten Minutes World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Concentrating on doing something for ten minutes? WHODAS 2.0 36-item Version Interviewer-administered - Concentrating for Ten Minutes WD5-Current Marital Status World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - What is your current marital status? WHODAS 2.0 36-item Version Interviewer-administered - Current Marital Status WD5-Days Reduce or Miss Household Work World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, on how many days did you reduce or completely miss household work because of your health condition? WHODAS 2.0 36-item Version Interviewer-administered - Days Reduce or Miss Household Work WD5-Days Unable to Carry Out Activities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, for how many days were you totally unable to carry out your usual activities or work because of any health condition? WHODAS 2.0 36-item Version Interviewer-administered - Days Unable to Carry Out Activities WD5-Dealing With People You Do Not Know World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Dealing with people you do not know? WHODAS 2.0 36-item Version Interviewer-administered - Dealing With People You Do Not Know WD5-Describes Main Work Status Best World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Which describes your main work status best? WHODAS 2.0 36-item Version Interviewer-administered - Describes Main Work Status Best WD5-Doing Important Household Tasks World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days, how much difficulty did you have in: Doing your most important household tasks well? WHODAS 2.0 36-item Version Interviewer-administered - Doing Important Household Tasks WD5-Doing Important Work/School Tasks World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Doing your most important work/school tasks well? WHODAS 2.0 36-item Version Interviewer-administered - Doing Important Work or School Tasks WD5-Drain on Financial Resources World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much has your health been a drain on the financial resources of you or your family? WHODAS 2.0 36-item Version Interviewer-administered - Drain on Financial Resources WD5-Earn Less Money World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Did you earn less money as the result of a health condition? WHODAS 2.0 36-item Version Interviewer-administered - Earn Less Money WD5-Eating World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Eating? WHODAS 2.0 36-item Version Interviewer-administered - Eating WD5-Emotionally Affected by Health World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much have you been emotionally affected by your health condition? WHODAS 2.0 36-item Version Interviewer-administered - Emotionally Affected by Health WD5-Finding Solutions to Problems World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Analysing and finding solutions to problems in day-to-day life? WHODAS 2.0 36-item Version Interviewer-administered - Finding Solutions to Problems WD5-Get Along With People Close to You World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Getting along with people who are close to you? WHODAS 2.0 36-item Version Interviewer-administered - Get Along With People Close to You WD5-Getting All Work Done You Need World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Getting all the work done that you need to do? WHODAS 2.0 36-item Version Interviewer-administered - Getting All Work Done You Need to Do WD5-Getting Dressed World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Getting dressed? WHODAS 2.0 36-item Version Interviewer-administered - Getting Dressed WD5-Getting Household Work Done Needed World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days, how much difficulty did you have in: Getting all the household work done that you needed to do? WHODAS 2.0 36-item Version Interviewer-administered - Getting Household Work Done Needed WD5-Getting Household Work Done Quickly World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days, how much difficulty did you have in: Getting your household work done as quickly as needed? WHODAS 2.0 36-item Version Interviewer-administered - Getting Household Work Done Quickly WD5-Getting Out of Your Home World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Getting out of your home? WHODAS 2.0 36-item Version Interviewer-administered - Getting Out of Your Home WD5-Getting Work Done Quickly as Needed World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Getting your work done as quickly as needed? WHODAS 2.0 36-item Version Interviewer-administered - Getting Work Done Quickly as Needed WD5-Had to Work at a Lower Level World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Have you had to work at a lower level because of a health condition? WHODAS 2.0 36-item Version Interviewer-administered - Had to Work at a Lower Level WD5-How Many Days Did You Miss Work World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, on how many days did you miss work for half a day or more because of your health condition? WHODAS 2.0 36-item Version Interviewer-administered - How Many Days Did You Miss Work WD5-How Many Days Difficulties Present World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Overall, in the past 30 days, how many days were these difficulties present? WHODAS 2.0 36-item Version Interviewer-administered - How Many Days Difficulties Present WD5-How Many Days Reduce Activities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, not counting the days that you were totally unable, for how many days did you cut back or reduce your usual activities or work because of any health condition? WHODAS 2.0 36-item Version Interviewer-administered - How Many Days Reduce Activities WD5-How Old Are You Now World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - How old are you now? WHODAS 2.0 36-item Version Interviewer-administered - How Old Are You Now WD5-Learning a New Task World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Learning a new task, for example, learning how to get to a new place? WHODAS 2.0 36-item Version Interviewer-administered - Learning a New Task WD5-Living Situation at Interview World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Living situation at time of interview. WHODAS 2.0 36-item Version Interviewer-administered - Living Situation at Interview WD5-Maintaining a Friendship World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Maintaining a friendship? WHODAS 2.0 36-item Version Interviewer-administered - Maintaining a Friendship WD5-Making New Friends World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Making new friends? WHODAS 2.0 36-item Version Interviewer-administered - Making New Friends WD5-Moving Around Inside Your Home World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Moving around inside your home? WHODAS 2.0 36-item Version Interviewer-administered - Moving Around Inside Your Home WD5-Problem Because of Barriers in World World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much of a problem did you have because of barriers or hindrances in the world around you? WHODAS 2.0 36-item Version Interviewer-administered - Problem Because of Barriers in World WD5-Problem Did Your Family Have World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much of a problem did your family have because of your health problems? WHODAS 2.0 36-item Version Interviewer-administered - How Much Problem Did Your Family Have WD5-Problem Doing Things for Relaxation World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much of a problem did you have in doing things by yourself for relaxation or pleasure? WHODAS 2.0 36-item Version Interviewer-administered - Problem Doing Things for Relaxation WD5-Problem Joining Community Activities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much of a problem did you have joining in community activities (for example, festivities, religious or other activities) in the same way as anyone else can? WHODAS 2.0 36-item Version Interviewer-administered - Problem Joining Community Activities WD5-Problem Living with Dignity World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much of a problem did you have living with dignity because of the attitudes and actions of others? WHODAS 2.0 36-item Version Interviewer-administered - Problem Living with Dignity WD5-Remembering to Do Important Things World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Remembering to do important things? WHODAS 2.0 36-item Version Interviewer-administered - Remembering to Do Important Things WD5-Sex as Observed World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Record sex as observed. WHODAS 2.0 36-item Version Interviewer-administered - Sex as Observed WD5-Sexual Activities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Sexual activities? WHODAS 2.0 36-item Version Interviewer-administered - Sexual Activities WD5-Standing for Long Periods World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Standing for long periods such as 30 minutes? WHODAS 2.0 36-item Version Interviewer-administered - Standing for Long Periods WD5-Standing Up From Sitting Down World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Standing up from sitting down? WHODAS 2.0 36-item Version Interviewer-administered - Standing Up From Sitting Down WD5-Starting/Maintaining Conversation World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Starting and maintaining a conversation? WHODAS 2.0 36-item Version Interviewer-administered - Starting or Maintaining Conversation WD5-Staying by Yourself for a Few Days World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Staying by yourself for a few days? WHODAS 2.0 36-item Version Interviewer-administered - Staying by Yourself for a Few Days WD5-Time Spend on Your Health Condition World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much time did you spend on your health condition or its consequences? WHODAS 2.0 36-item Version Interviewer-administered - Time Spend on Your Health Condition WD5-Understanding What People Say World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Generally understanding what people say? WHODAS 2.0 36-item Version Interviewer-administered - Understanding What People Say WD5-Walking a Long Distance World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Walking a long distance such as a kilometre [or equivalent]? WHODAS 2.0 36-item Version Interviewer-administered - Walking a Long Distance WD5-Washing Your Whole Body World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Washing your whole body? WHODAS 2.0 36-item Version Interviewer-administered - Washing Your Whole Body WD5-Years Studying in School/College World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - How many years in all did you spend studying in school, college or university? WHODAS 2.0 36-item Version Interviewer-administered - Years Studying in School or College WD5-Your Day-to-Day Work/School World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Your day-to-day work/school? WHODAS 2.0 36-item Version Interviewer-administered - Your Day-to-Day Work or School WD5TN World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer Questionnaire Test Name CDISC Questionnaire WHODAS 2.0 36-item Version Interviewer-administered Test Name Terminology World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy test code. WD6-Concentrating for Ten Minutes World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Concentrating on doing something for ten minutes? WHODAS 2.0 36-item Version Proxy-administered - Concentrating for Ten Minutes WD6-Remembering to Do Important Things World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Remembering to do important things? WHODAS 2.0 36-item Version Proxy-administered - Remembering to Do Important Things WD6-Finding Solutions to Problems World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Analysing and finding solutions to problems in day-to-day life? WHODAS 2.0 36-item Version Proxy-administered - Finding Solutions to Problems WD6-Learning a New Task World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Learning a new task, for example, learning how to get to a new place? WHODAS 2.0 36-item Version Proxy-administered - Learning a New Task WD6-Understanding What People Say World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Generally understanding what people say? WHODAS 2.0 36-item Version Proxy-administered - Understanding What People Say WD6-Starting/Maintaining Conversation World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Starting and maintaining a conversation? WHODAS 2.0 36-item Version Proxy-administered - Starting or Maintaining Conversation WD6-Standing for Long Periods World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Standing for long periods such as 30 minutes? WHODAS 2.0 36-item Version Proxy-administered - Standing for Long Periods WD6-Standing Up From Sitting Down World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Standing up from sitting down? WHODAS 2.0 36-item Version Proxy-administered - Standing Up From Sitting Down WD6-Moving Around Inside Their Home World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Moving around inside their home? WHODAS 2.0 36-item Version Proxy-administered - Moving Around Inside Their Home WD6-Washing His/Her Whole Body World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Washing his or her whole body? WHODAS 2.0 36-item Version Proxy-administered - Washing His or Her Whole Body WD6-Getting Dressed World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Getting dressed? WHODAS 2.0 36-item Version Proxy-administered - Getting Dressed WD6-Eating World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Eating? WHODAS 2.0 36-item Version Proxy-administered - Eating WD6-Staying by Him/Herself a Few Days World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Staying by himself or herself for a few days? WHODAS 2.0 36-item Version Proxy-administered - Staying by Him or Herself a Few Days WD6-Dealing With People Does Not Know World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Dealing with people he or she does not know? WHODAS 2.0 36-item Version Proxy-administered - Dealing With People Does Not Know WD6-Maintaining a Friendship World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Maintaining a friendship? WHODAS 2.0 36-item Version Proxy-administered - Maintaining a Friendship WD6-Get Along With People Close to Him World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Getting along with people who are close to him or her? WHODAS 2.0 36-item Version Proxy-administered - Get Along With People Close to Him WD6-Making New Friends World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Making new friends? WHODAS 2.0 36-item Version Proxy-administered - Making New Friends WD6-Sexual Activities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Sexual activities? WHODAS 2.0 36-item Version Proxy-administered - Sexual Activities WD6-Care of Household Responsibilities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Taking care of his or her household responsibilities? WHODAS 2.0 36-item Version Proxy-administered - Care of Household Responsibilities WD6-Doing Important Household Tasks World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Doing his or her most important household tasks well? WHODAS 2.0 36-item Version Proxy-administered - Doing Important Household Tasks WD6-Getting Household Work Done Needed World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Getting all the household work done that is needed? WHODAS 2.0 36-item Version Proxy-administered - Getting Household Work Done Needed WD6-Getting Household Work Done Quickly World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Getting the household work done as quickly as needed? WHODAS 2.0 36-item Version Proxy-administered - Getting Household Work Done Quickly WD6-Their Day-to-Day Work/School World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: His or her day-to-day work/school? WHODAS 2.0 36-item Version Proxy-administered - Their Day-to-Day Work or School WD6-Doing Important Work/School Tasks World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Doing his or her most important work/school tasks well? WHODAS 2.0 36-item Version Proxy-administered - Doing Important Work or School Tasks WD6-Getting All Work Done You Need World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Getting all the work done that is needed? WHODAS 2.0 36-item Version Proxy-administered - Getting All Work Done You Need WD6-Getting Work Done Quickly as Needed World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Getting the work done as quickly as needed? WHODAS 2.0 36-item Version Proxy-administered - Getting Work Done Quickly as Needed WD6-Problem Joining Community Activities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much of a problem did your relative have in joining in community activities (for example, festivities, religious or other activities) in the same way as anyone else can? WHODAS 2.0 36-item Version Proxy-administered - Problem Joining Community Activities WD6-Problem Because of Barriers in World World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much of a problem did your relative have because of barriers or hindrances in the world around him or her? WHODAS 2.0 36-item Version Proxy-administered - Problem Because of Barriers in World WD6-Problem Living with Dignity World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much of a problem did your relative have living with dignity because of the attitudes and actions of others? WHODAS 2.0 36-item Version Proxy-administered - Problem Living with Dignity WD6-Time Spend on Your Health Condition World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much time did your relative spend on his or her health condition, or its consequences? WHODAS 2.0 36-item Version Proxy-administered - Time Spend on Your Health Condition WD6-Emotionally Affected by Health World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much has your relative been emotionally affected by his or her health condition? WHODAS 2.0 36-item Version Proxy-administered - Emotionally Affected by Health WD6-Drain on Financial Resources World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much has his or her health been a drain on his or her financial resources or on the financial resources of other relatives? WHODAS 2.0 36-item Version Proxy-administered - Drain on Financial Resources WD6-Problem Did Your Family Have World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much of a problem did you or the rest of his or her family have because of his or her health problems? WHODAS 2.0 36-item Version Proxy-administered - Problem Did Your Family Have WD6-Problem Doing Things for Relaxation World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much of a problem did your relative have in doing things by himself or herself for relaxation or pleasure? WHODAS 2.0 36-item Version Proxy-administered - Problem Doing Things for Relaxation WD6-How Many Days Difficulties Present World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Overall, in the past 30 days, how many days were these difficulties present? WHODAS 2.0 36-item Version Proxy-administered - How Many Days Difficulties Present WD6-Days Unable to Carry Out Activities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, for how many days was your relative totally unable to carry out his or her usual activities or work because of any health condition? WHODAS 2.0 36-item Version Proxy-administered - Days Unable to Carry Out Activities WD6-How Many Days Reduce Activities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, not counting the days that your relative was totally unable, for how many days did your relative cut back or reduce his or her usual activities or work because of any health condition? WHODAS 2.0 36-item Version Proxy-administered - How Many Days Reduce Activities WD6-I Am (Fill in Blank) of This Person World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - I am the (Fill in the Blank) of this person. WHODAS 2.0 36-item Version Proxy-administered - I Am (Fill in the Blank) of this Person WD6-Getting Out of Their Home World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Getting out of their home? WHODAS 2.0 36-item Version Proxy-administered - Getting Out of Their Home WD6-Walking a Long Distance World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Walking a long distance such as a kilometre [or equivalent]? WHODAS 2.0 36-item Version Proxy-administered - Walking a Long Distance WD6TC World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy Questionnaire Test Code CDISC Questionnaire WHODAS 2.0 36-item Version Proxy-administered Test Code Terminology World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy test name. WD6-Care of Household Responsibilities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Taking care of his or her household responsibilities? WHODAS 2.0 36-item Version Proxy-administered - Care of Household Responsibilities WD6-Concentrating for Ten Minutes World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Concentrating on doing something for ten minutes? WHODAS 2.0 36-item Version Proxy-administered - Concentrating for Ten Minutes WD6-Days Unable to Carry Out Activities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, for how many days was your relative totally unable to carry out his or her usual activities or work because of any health condition? WHODAS 2.0 36-item Version Proxy-administered - Days Unable to Carry Out Activities WD6-Dealing With People Does Not Know World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Dealing with people he or she does not know? WHODAS 2.0 36-item Version Proxy-administered - Dealing With People Does Not Know WD6-Doing Important Household Tasks World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Doing his or her most important household tasks well? WHODAS 2.0 36-item Version Proxy-administered - Doing Important Household Tasks WD6-Doing Important Work/School Tasks World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Doing his or her most important work/school tasks well? WHODAS 2.0 36-item Version Proxy-administered - Doing Important Work or School Tasks WD6-Drain on Financial Resources World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much has his or her health been a drain on his or her financial resources or on the financial resources of other relatives? WHODAS 2.0 36-item Version Proxy-administered - Drain on Financial Resources WD6-Eating World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Eating? WHODAS 2.0 36-item Version Proxy-administered - Eating WD6-Emotionally Affected by Health World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much has your relative been emotionally affected by his or her health condition? WHODAS 2.0 36-item Version Proxy-administered - Emotionally Affected by Health WD6-Finding Solutions to Problems World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Analysing and finding solutions to problems in day-to-day life? WHODAS 2.0 36-item Version Proxy-administered - Finding Solutions to Problems WD6-Get Along With People Close to Him World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Getting along with people who are close to him or her? WHODAS 2.0 36-item Version Proxy-administered - Get Along With People Close to Him WD6-Getting All Work Done You Need World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Getting all the work done that is needed? WHODAS 2.0 36-item Version Proxy-administered - Getting All Work Done You Need WD6-Getting Dressed World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Getting dressed? WHODAS 2.0 36-item Version Proxy-administered - Getting Dressed WD6-Getting Household Work Done Needed World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Getting all the household work done that is needed? WHODAS 2.0 36-item Version Proxy-administered - Getting Household Work Done Needed WD6-Getting Household Work Done Quickly World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Getting the household work done as quickly as needed? WHODAS 2.0 36-item Version Proxy-administered - Getting Household Work Done Quickly WD6-Getting Out of Their Home World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Getting out of their home? WHODAS 2.0 36-item Version Proxy-administered - Getting Out of Their Home WD6-Getting Work Done Quickly as Needed World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Getting the work done as quickly as needed? WHODAS 2.0 36-item Version Proxy-administered - Getting Work Done Quickly as Needed WD6-How Many Days Difficulties Present World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Overall, in the past 30 days, how many days were these difficulties present? WHODAS 2.0 36-item Version Proxy-administered - How Many Days Difficulties Present WD6-How Many Days Reduce Activities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, not counting the days that your relative was totally unable, for how many days did your relative cut back or reduce his or her usual activities or work because of any health condition? WHODAS 2.0 36-item Version Proxy-administered - How Many Days Reduce Activities WD6-I Am (Fill in Blank) of This Person World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - I am the (Fill in the Blank) of this person. WHODAS 2.0 36-item Version Proxy-administered - I Am (Fill in the Blank) of this Person WD6-Learning a New Task World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Learning a new task, for example, learning how to get to a new place? WHODAS 2.0 36-item Version Proxy-administered - Learning a New Task WD6-Maintaining a Friendship World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Maintaining a friendship? WHODAS 2.0 36-item Version Proxy-administered - Maintaining a Friendship WD6-Making New Friends World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Making new friends? WHODAS 2.0 36-item Version Proxy-administered - Making New Friends WD6-Moving Around Inside Their Home World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Moving around inside their home? WHODAS 2.0 36-item Version Proxy-administered - Moving Around Inside Their Home WD6-Problem Because of Barriers in World World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much of a problem did your relative have because of barriers or hindrances in the world around him or her? WHODAS 2.0 36-item Version Proxy-administered - Problem Because of Barriers in World WD6-Problem Did Your Family Have World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much of a problem did you or the rest of his or her family have because of his or her health problems? WHODAS 2.0 36-item Version Proxy-administered - Problem Did Your Family Have WD6-Problem Doing Things for Relaxation World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much of a problem did your relative have in doing things by himself or herself for relaxation or pleasure? WHODAS 2.0 36-item Version Proxy-administered - Problem Doing Things for Relaxation WD6-Problem Joining Community Activities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much of a problem did your relative have in joining in community activities (for example, festivities, religious or other activities) in the same way as anyone else can? WHODAS 2.0 36-item Version Proxy-administered - Problem Joining Community Activities WD6-Problem Living with Dignity World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much of a problem did your relative have living with dignity because of the attitudes and actions of others? WHODAS 2.0 36-item Version Proxy-administered - Problem Living with Dignity WD6-Remembering to Do Important Things World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Remembering to do important things? WHODAS 2.0 36-item Version Proxy-administered - Remembering to Do Important Things WD6-Sexual Activities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Sexual activities? WHODAS 2.0 36-item Version Proxy-administered - Sexual Activities WD6-Standing for Long Periods World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Standing for long periods such as 30 minutes? WHODAS 2.0 36-item Version Proxy-administered - Standing for Long Periods WD6-Standing Up From Sitting Down World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Standing up from sitting down? WHODAS 2.0 36-item Version Proxy-administered - Standing Up From Sitting Down WD6-Starting/Maintaining Conversation World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Starting and maintaining a conversation? WHODAS 2.0 36-item Version Proxy-administered - Starting or Maintaining Conversation WD6-Staying by Him/Herself a Few Days World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Staying by himself or herself for a few days? WHODAS 2.0 36-item Version Proxy-administered - Staying by Him or Herself a Few Days WD6-Their Day-to-Day Work/School World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: His or her day-to-day work/school? WHODAS 2.0 36-item Version Proxy-administered - Their Day-to-Day Work or School WD6-Time Spend on Your Health Condition World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much time did your relative spend on his or her health condition, or its consequences? WHODAS 2.0 36-item Version Proxy-administered - Time Spend on Your Health Condition WD6-Understanding What People Say World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Generally understanding what people say? WHODAS 2.0 36-item Version Proxy-administered - Understanding What People Say WD6-Walking a Long Distance World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Walking a long distance such as a kilometre [or equivalent]? WHODAS 2.0 36-item Version Proxy-administered - Walking a Long Distance WD6-Washing His/Her Whole Body World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Washing his or her whole body? WHODAS 2.0 36-item Version Proxy-administered - Washing His or Her Whole Body WD6TN World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy Questionnaire Test Name CDISC Questionnaire WHODAS 2.0 36-item Version Proxy-administered Test Name Terminology World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self test code. WD7-Concentrating for Ten Minutes World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Concentrating on doing something for ten minutes? WHODAS 2.0 36-item Version Self-administered - Concentrating for Ten Minutes WD7-Remembering to Do Important Things World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Remembering to do important things? WHODAS 2.0 36-item Version Self-administered - Remembering to Do Important Things WD7-Finding Solutions to Problems World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Analysing and finding solutions to problems in day-to-day life? WHODAS 2.0 36-item Version Self-administered - Finding Solutions to Problems WD7-Learning a New Task World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Learning a new task, for example, learning how to get to a new place? WHODAS 2.0 36-item Version Self-administered - Learning a New Task WD7-Understanding What People Say World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Generally understanding what people say? WHODAS 2.0 36-item Version Self-administered - Understanding What People Say WD7-Starting/Maintaining Conversation World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Starting and maintaining a conversation? WHODAS 2.0 36-item Version Self-administered - Starting or Maintaining Conversation WD7-Standing for Long Periods World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Standing for long periods such as 30 minutes? WHODAS 2.0 36-item Version Self-administered - Standing for Long Periods WD7-Standing Up From Sitting Down World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Standing up from sitting down? WHODAS 2.0 36-item Version Self-administered - Standing Up From Sitting Down WD7-Moving Around Inside Your Home World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Moving around inside your home? WHODAS 2.0 36-item Version Self-administered - Moving Around Inside Your Home WD7-Getting Out of Your Home World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Getting out of your home? WHODAS 2.0 36-item Version Self-administered - Getting Out of Your Home WD7-Walking a Long Distance World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Walking a long distance such as a kilometre [or equivalent]? WHODAS 2.0 36-item Version Self-administered - Walking a Long Distance WD7-Washing Your Whole Body World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - in the past 30 days, how much difficulty did you have in: Washing your whole body? WHODAS 2.0 36-item Version Self-administered - Washing Your Whole Body WD7-Getting Dressed World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Getting dressed? WHODAS 2.0 36-item Version Self-administered - Getting Dressed WD7-Eating World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Eating? WHODAS 2.0 36-item Version Self-administered - Eating WD7-Staying by Yourself for a Few Days World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Staying by yourself for a few days? WHODAS 2.0 36-item Version Self-administered - Staying by Yourself for a Few Days WD7-Dealing With People You Do Not Know World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Dealing with people you do not know? WHODAS 2.0 36-item Version Self-administered - Dealing With People You Do Not Know WD7-Maintaining a Friendship World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Maintaining a friendship? WHODAS 2.0 36-item Version Self-administered - Maintaining a Friendship WD7-Get Along With People Close to You World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Getting along with people who are close to you? WHODAS 2.0 36-item Version Self-administered - Get Along With People Close to You WD7-Making New Friends World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Making new friends? WHODAS 2.0 36-item Version Self-administered - Making New Friends WD7-Sexual Activities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Sexual activities? WHODAS 2.0 36-item Version Self-administered - Sexual Activities WD7-Care of Household Responsibilities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Taking care of your household responsibilities? WHODAS 2.0 36-item Version Self-administered - Care of Household Responsibilities WD7-Doing Important Household Tasks World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Doing most important household tasks well? WHODAS 2.0 36-item Version Self-administered - Doing Important Household Tasks WD7-Getting Household Work Done Needed World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Getting all the household work done that you needed to do? WHODAS 2.0 36-item Version Self-administered - Getting Household Work Done Needed WD7-Getting Household Work Done Quickly World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Getting your household work done as quickly as needed? WHODAS 2.0 36-item Version Self-administered - Getting Household Work Done Quickly WD7-Your Day-to-Day Work/School World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - Because of your health condition, in the past 30 days, how much difficulty did you have in: your day-to-day work/school? WHODAS 2.0 36-item Version Self-administered - Your Day-to-Day Work or School WD7-Doing Important Work/School Tasks World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - Because of your health condition, in the past 30 days, how much difficulty did you have in: Doing your most important work/school tasks well? WHODAS 2.0 36-item Version Self-administered - Doing Important Work or School Tasks WD7-Getting All Work Done You Need World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - Because of your health condition, in the past 30 days, how much difficulty did you have in: Getting all the work done that you need to do? WHODAS 2.0 36-item Version Self-administered - Getting All Work Done You Need WD7-Getting Work Done Quickly as Needed World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - Because of your health condition, in the past 30 days, how much difficulty did you have in: Getting your work done as quickly as needed? WHODAS 2.0 36-item Version Self-administered - Getting Work Done Quickly as Needed WD7-Problem Joining Community Activities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much of a problem did you have in joining in community activities (for example, festivities, religious or other activities) in the same way as anyone else can? WHODAS 2.0 36-item Version Self-administered - Problem Joining Community Activities WD7-Problem Because of Barriers in World World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much of a problem did you have because of barriers or hindrances in the world around you? WHODAS 2.0 36-item Version Self-administered - Problem Because of Barriers in World WD7-Problem Living with Dignity World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much of a problem did you have living with dignity because of the attitudes and actions of others? WHODAS 2.0 36-item Version Self-administered - Problem Living with Dignity WD7-Time Spend on Your Health Condition World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much time did you spend on your health condition, or its consequences? WHODAS 2.0 36-item Version Self-administered - Time Spend on Your Health Condition WD7-Emotionally Affected by Health World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much have you been emotionally affected by your health condition? WHODAS 2.0 36-item Version Self-administered - Emotionally Affected by Health WD7-Drain on Financial Resources World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much has your health been a drain on the financial resources of you or your family? WHODAS 2.0 36-item Version Self-administered - Drain on Financial Resources WD7-Problem Did Your Family Have World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much of a problem did your family have because of your health problems? WHODAS 2.0 36-item Version Self-administered - Problem Did Your Family Have WD7-Problem Doing Things for Relaxation World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much of a problem did you have in doing things by yourself for relaxation or pleasure? WHODAS 2.0 36-item Version Self-administered - Problem Doing Things for Relaxation WD7-How Many Days Difficulties Present World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - Overall, in the past 30 days, how many days were these difficulties present? WHODAS 2.0 36-item Version Self-administered - How Many Days Difficulties Present WD7-Days Unable to Carry Out Activities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, for how many days were you totally unable to carry out your usual activities or work because of any health condition? WHODAS 2.0 36-item Version Self-administered - Days Unable to Carry Out Activities WD7-How Many Days Reduce Activities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, not counting the days that you were totally unable, for how many days did you cut back or reduce your usual activities or work because of any health condition? WHODAS 2.0 36-item Version Self-administered - How Many Days Reduce Activities WD7TC World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self Questionnaire Test Code CDISC Questionnaire WHODAS 2.0 36-item Version Self-administered Test Code Terminology World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self test name. WD7-Care of Household Responsibilities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Taking care of your household responsibilities? WHODAS 2.0 36-item Version Self-administered - Care of Household Responsibilities WD7-Concentrating for Ten Minutes World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Concentrating on doing something for ten minutes? WHODAS 2.0 36-item Version Self-administered - Concentrating for Ten Minutes WD7-Days Unable to Carry Out Activities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, for how many days were you totally unable to carry out your usual activities or work because of any health condition? WHODAS 2.0 36-item Version Self-administered - Days Unable to Carry Out Activities WD7-Dealing With People You Do Not Know World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Dealing with people you do not know? WHODAS 2.0 36-item Version Self-administered - Dealing With People You Do Not Know WD7-Doing Important Household Tasks World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Doing most important household tasks well? WHODAS 2.0 36-item Version Self-administered - Doing Important Household Tasks WD7-Doing Important Work/School Tasks World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - Because of your health condition, in the past 30 days, how much difficulty did you have in: Doing your most important work/school tasks well? WHODAS 2.0 36-item Version Self-administered - Doing Important Work or School Tasks WD7-Drain on Financial Resources World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much has your health been a drain on the financial resources of you or your family? WHODAS 2.0 36-item Version Self-administered - Drain on Financial Resources WD7-Eating World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Eating? WHODAS 2.0 36-item Version Self-administered - Eating WD7-Emotionally Affected by Health World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much have you been emotionally affected by your health condition? WHODAS 2.0 36-item Version Self-administered - Emotionally Affected by Health WD7-Finding Solutions to Problems World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Analysing and finding solutions to problems in day-to-day life? WHODAS 2.0 36-item Version Self-administered - Finding Solutions to Problems WD7-Get Along With People Close to You World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Getting along with people who are close to you? WHODAS 2.0 36-item Version Self-administered - Get Along With People Close to You WD7-Getting All Work Done You Need World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - Because of your health condition, in the past 30 days, how much difficulty did you have in: Getting all the work done that you need to do? WHODAS 2.0 36-item Version Self-administered - Getting All Work Done You Need WD7-Getting Dressed World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Getting dressed? WHODAS 2.0 36-item Version Self-administered - Getting Dressed WD7-Getting Household Work Done Needed World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Getting all the household work done that you needed to do? WHODAS 2.0 36-item Version Self-administered - Getting Household Work Done Needed WD7-Getting Household Work Done Quickly World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Getting your household work done as quickly as needed? WHODAS 2.0 36-item Version Self-administered - Getting Household Work Done Quickly WD7-Getting Out of Your Home World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Getting out of your home? WHODAS 2.0 36-item Version Self-administered - Getting Out of Your Home WD7-Getting Work Done Quickly as Needed World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - Because of your health condition, in the past 30 days, how much difficulty did you have in: Getting your work done as quickly as needed? WHODAS 2.0 36-item Version Self-administered - Getting Work Done Quickly as Needed WD7-How Many Days Difficulties Present World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - Overall, in the past 30 days, how many days were these difficulties present? WHODAS 2.0 36-item Version Self-administered - How Many Days Difficulties Present WD7-How Many Days Reduce Activities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, not counting the days that you were totally unable, for how many days did you cut back or reduce your usual activities or work because of any health condition? WHODAS 2.0 36-item Version Self-administered - How Many Days Reduce Activities WD7-Learning a New Task World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Learning a new task, for example, learning how to get to a new place? WHODAS 2.0 36-item Version Self-administered - Learning a New Task WD7-Maintaining a Friendship World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Maintaining a friendship? WHODAS 2.0 36-item Version Self-administered - Maintaining a Friendship WD7-Making New Friends World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Making new friends? WHODAS 2.0 36-item Version Self-administered - Making New Friends WD7-Moving Around Inside Your Home World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Moving around inside your home? WHODAS 2.0 36-item Version Self-administered - Moving Around Inside Your Home WD7-Problem Because of Barriers in World World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much of a problem did you have because of barriers or hindrances in the world around you? WHODAS 2.0 36-item Version Self-administered - Problem Because of Barriers in World WD7-Problem Did Your Family Have World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much of a problem did your family have because of your health problems? WHODAS 2.0 36-item Version Self-administered - Problem Did Your Family Have WD7-Problem Doing Things for Relaxation World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much of a problem did you have in doing things by yourself for relaxation or pleasure? WHODAS 2.0 36-item Version Self-administered - Problem Doing Things for Relaxation WD7-Problem Joining Community Activities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much of a problem did you have in joining in community activities (for example, festivities, religious or other activities) in the same way as anyone else can? WHODAS 2.0 36-item Version Self-administered - Problem Joining Community Activities WD7-Problem Living with Dignity World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much of a problem did you have living with dignity because of the attitudes and actions of others? WHODAS 2.0 36-item Version Self-administered - Problem Living with Dignity WD7-Remembering to Do Important Things World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Remembering to do important things? WHODAS 2.0 36-item Version Self-administered - Remembering to Do Important Things WD7-Sexual Activities World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Sexual activities? WHODAS 2.0 36-item Version Self-administered - Sexual Activities WD7-Standing for Long Periods World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Standing for long periods such as 30 minutes? WHODAS 2.0 36-item Version Self-administered - Standing for Long Periods WD7-Standing Up From Sitting Down World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Standing up from sitting down? WHODAS 2.0 36-item Version Self-administered - Standing Up From Sitting Down WD7-Starting/Maintaining Conversation World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Starting and maintaining a conversation? WHODAS 2.0 36-item Version Self-administered - Starting or Maintaining Conversation WD7-Staying by Yourself for a Few Days World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Staying by yourself for a few days? WHODAS 2.0 36-item Version Self-administered - Staying by Yourself for a Few Days WD7-Time Spend on Your Health Condition World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much time did you spend on your health condition, or its consequences? WHODAS 2.0 36-item Version Self-administered - Time Spend on Your Health Condition WD7-Understanding What People Say World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Generally understanding what people say? WHODAS 2.0 36-item Version Self-administered - Understanding What People Say WD7-Walking a Long Distance World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Walking a long distance such as a kilometre [or equivalent]? WHODAS 2.0 36-item Version Self-administered - Walking a Long Distance WD7-Washing Your Whole Body World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - in the past 30 days, how much difficulty did you have in: Washing your whole body? WHODAS 2.0 36-item Version Self-administered - Washing Your Whole Body WD7-Your Day-to-Day Work/School World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - Because of your health condition, in the past 30 days, how much difficulty did you have in: your day-to-day work/school? WHODAS 2.0 36-item Version Self-administered - Your Day-to-Day Work or School WD7TN World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self Questionnaire Test Name CDISC Questionnaire WHODAS 2.0 36-item Version Self-administered Test Name Terminology